PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Jalili, M				Jalili, Mahdi			Resiliency of EEG-Based Brain Functional Networks	PLOS ONE			English	Article							GRAPH-THEORETICAL ANALYSIS; SCALE-FREE NETWORKS; COMPLEX NETWORKS; ATTACK TOLERANCE; CONNECTIVITY; ERROR; SYNCHRONIZABILITY; EFFICIENCY; CASCADE	Applying tools available in network science and graph theory to study brain networks has opened a new era in understanding brain mechanisms. Brain functional networks extracted from EEG time series have been frequently studied in health and diseases. In this manuscript, we studied failure resiliency of EEG-based brain functional networks. The network structures were extracted by analysing EEG time series obtained from 30 healthy subjects in resting state eyes-closed conditions. As the network structure was extracted, we measured a number of metrics related to their resiliency. In general, the brain networks showed worse resilient behaviour as compared to corresponding random networks with the same degree sequences. Brain networks had higher vulnerability than the random ones (P < 0.05), indicating that their global efficiency (i.e., communicability between the regions) is more affected by removing the important nodes. Furthermore, the breakdown happened as a result of cascaded failures in brain networks was severer (i.e., less nodes survived) as compared to randomized versions (P < 0.05). These results suggest that real EEG-based networks have not been evolved to possess optimal resiliency against failures.	RMIT Univ, Sch Elect & Comp Engn, Melbourne, Vic, Australia	Royal Melbourne Institute of Technology (RMIT)	Jalili, M (corresponding author), RMIT Univ, Sch Elect & Comp Engn, Melbourne, Vic, Australia.	Mahdi.Jalili@rmit.eud.au		Jalili, Mahdi/0000-0002-0517-9420	Australian Research Council [DE140100620]	Australian Research Council(Australian Research Council)	This work was supported by Australian Research Council project DE140100620. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Asztalos A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084563; Baggio HC, 2014, HUM BRAIN MAPP, V35, P4620, DOI 10.1002/hbm.22499; Barabasi AL, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2012.0375; Baronchelli A, 2013, TRENDS COGN SCI, V17, P348, DOI 10.1016/j.tics.2013.04.010; Barzegaran E, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00335; Basu P, 2013, IEEE J SEL AREA COMM, V31, P993, DOI 10.1109/JSAC.2013.130601; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Crucitti P, 2003, PHYSICA A, V320, P622, DOI 10.1016/S0378-4371(02)01545-5; Fornari E, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.11.014; Fornito A, 2015, EUR NEUROPSYCHOPHARM, V25, P733, DOI 10.1016/j.euroneuro.2014.02.011; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Jalili M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001059; Jalili M, 2011, COMPUT BIOL MED, V41, P1178, DOI 10.1016/j.compbiomed.2011.05.004; Jalili M, 2011, J INFORMETR, V5, P422, DOI 10.1016/j.joi.2011.03.002; Jalili M, 2011, PHYSICA A, V390, P4588, DOI 10.1016/j.physa.2011.06.053; Kayser J, 2006, CLIN NEUROPHYSIOL, V117, P348, DOI 10.1016/j.clinph.2005.08.034; Knyazeva MG, 2011, J NEUROL NEUROSUR PS, V82, P505, DOI 10.1136/jnnp.2010.224873; Latora V, 2003, EUR PHYS J B, V32, P249, DOI 10.1140/epjb/e2003-00095-5; Melian CJ, 2002, ECOL LETT, V5, P705, DOI 10.1046/j.1461-0248.2002.00386.x; Micheloyannis S, 2006, SCHIZOPHR RES, V87, P60, DOI 10.1016/j.schres.2006.06.028; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Mirzasoleiman B, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.046114; Motter AE, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.098701; Motter AE, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.065102; Nunez PL, 1997, ELECTROEN CLIN NEURO, V103, P499, DOI 10.1016/S0013-4694(97)00066-7; Perc M, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033027; Pievani M, 2011, LANCET NEUROL, V10, P829, DOI 10.1016/S1474-4422(11)70158-2; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Srinivasan R, 2007, J NEUROSCI METH, V166, P41, DOI 10.1016/j.jneumeth.2007.06.026; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Sun S, 2007, PHYSICA A, V373, P851, DOI 10.1016/j.physa.2006.05.049; Tahaei MS, 2012, IEEE T NEUR SYS REH, V20, P636, DOI 10.1109/TNSRE.2012.2202127; Wang JJ, 2014, CLIN NEUROPHYSIOL, V125, P1744, DOI 10.1016/j.clinph.2013.12.120; Westdrop AF, 1993, BIOM ENG C NEW ORL L; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572; Xia YX, 2008, IEEE T CIRCUITS-II, V55, P65, DOI 10.1109/TCSII.2007.908954; Xia YX, 2010, PHYSICA A, V389, P1281, DOI 10.1016/j.physa.2009.11.037; Zalesky A, 2012, NEUROIMAGE, V60, P2096, DOI 10.1016/j.neuroimage.2012.02.001; Zhou CS, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.238103	47	5	5	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135333	10.1371/journal.pone.0135333	http://dx.doi.org/10.1371/journal.pone.0135333			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295341	Green Published, gold, Green Submitted			2022-12-26	WOS:000359926900026
J	Quave, CL; Lyles, JT; Kavanaugh, JS; Nelson, K; Parlet, CP; Crosby, HA; Heilmann, KP; Horswill, AR				Quave, Cassandra L.; Lyles, James T.; Kavanaugh, Jeffery S.; Nelson, Kate; Parlet, Corey P.; Crosby, Heidi A.; Heilmann, Kristopher P.; Horswill, Alexander R.			Castanea sativa (European Chestnut) Leaf Extracts Rich in Ursene and Oleanene Derivatives Block Staphylococcus aureus Virulence and Pathogenesis without Detectable Resistance	PLOS ONE			English	Article							QUORUM SENSING INHIBITORS; ACCESSORY GENE REGULATOR; SKIN; AGR; INFECTIONS; EPIDEMIOLOGY; DETERMINANTS; ANTIOXIDANT; EXPRESSION; HEMOLYSIN	The Mediterranean is home to a rich history of medical traditions that have developed under the influence of diverse cultures over millennia. Today, many such traditions are still alive in the folk medical practices of local people. Investigation of botanical folk medicines used in the treatment of skin and soft tissue infections led us to study Castanea sativa (European Chestnut) for its potential antibacterial activity. Here, we report the quorum sensing inhibitory activity of refined and chemically characterized European Chestnut leaf extracts, rich in oleanene and ursene derivatives (pentacyclic triterpenes), against all Staphylococcus aureus accessory gene regulator (agr) alleles. We present layers of evidence of agr blocking activity (IC50 1.56-25 mu gmL(-1)), as measured in toxin outputs, reporter assays hemolytic activity, cytotoxicity studies, and an in vivo abscess model. We demonstrate the extract's lack of cytotoxicity to human keratinocytes and murine skin, as well as lack of growth inhibitory activity against S. aureus and a panel of skin commensals. Lastly, we demonstrate that serial passaging of the extract does not result in acquisition of resistance to the quorum quenching composition. In conclusion, through disruption of quorum sensing in the absence of growth inhibition, this study provides insight into the role that non-biocide inhibitors of virulence may play in future antibiotic therapies.	[Quave, Cassandra L.; Lyles, James T.] Emory Univ, Ctr Study Human Hlth, Atlanta, GA 30322 USA; [Quave, Cassandra L.; Nelson, Kate] Emory Univ, Sch Med, Dept Dermatol, Atlanta, GA 30322 USA; [Kavanaugh, Jeffery S.; Parlet, Corey P.; Crosby, Heidi A.; Heilmann, Kristopher P.; Horswill, Alexander R.] Univ Iowa, Dept Microbiol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	Emory University; Emory University; University of Iowa	Quave, CL (corresponding author), Emory Univ, Ctr Study Human Hlth, Atlanta, GA 30322 USA.	cquave@emory.edu	Quave, Cassandra/AAD-2066-2020	Quave, Cassandra/0000-0001-9615-7886; Crosby, Heidi/0000-0002-0360-0779	National Institutes of Health, National Center for Complementary and Alternative Medicine [R01 AT007052]; NIH T32 training grant [AI007511]; National Center for Complementary & Integrative Health [R01AT007052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007343] Funding Source: NIH RePORTER	National Institutes of Health, National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Center for Complementary & Alternative Medicine); NIH T32 training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the National Institutes of Health, National Center for Complementary and Alternative Medicine (R01 AT007052, PI: C.L.Q. and Co-I: A.R.H.). The content is solely the responsibility of the authors and does not necessarily reflect the official views of NCCAM or NIH. C.P.P. and H.A.C. were supported by NIH T32 training grant AI007511. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida IF, 2015, J PHOTOCH PHOTOBIO B, V144, P28, DOI 10.1016/j.jphotobiol.2015.01.010; Almeida IF, 2008, BASIC CLIN PHARMACOL, V103, P461, DOI 10.1111/j.1742-7843.2008.00301.x; Almeida IF, 2008, J PHOTOCH PHOTOBIO B, V91, P87, DOI 10.1016/j.jphotobiol.2008.02.001; Almeida IF, 2010, AAPS PHARMSCITECH, V11, P120, DOI 10.1208/s12249-009-9360-9; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Beenken KE, 2003, INFECT IMMUN, V71, P4206, DOI 10.1128/IAI.71.7.4206-4211.2003; Boles BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010146; CDC U, 2013, ANTIBIOTIC RESISTANC; Clinical and Laboratory Standards Institute, 2013, M100S23 CLIN LAB STA; Clinical and Laboratory Standards Institute (CLSI), 2010, M45A2 CLSI; COX PA, 1994, SCI AM, V270, P82, DOI 10.1038/scientificamerican0694-82; Daly SM, 2015, ANTIMICROB AGENTS CH, V59, P2223, DOI 10.1128/AAC.04564-14; Daum RS, 2007, NEW ENGL J MED, V357, P380, DOI 10.1056/NEJMcp070747; Elfawal MA, 2015, P NATL ACAD SCI USA, V112, P821, DOI 10.1073/pnas.1413127112; Figueroa M, 2014, J NAT PROD, V77, P1351, DOI 10.1021/np5000704; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; Geisinger E, 2008, J BIOL CHEM, V283, P8930, DOI 10.1074/jbc.M710227200; Geisinger E, 2009, P NATL ACAD SCI USA, V106, P1216, DOI 10.1073/pnas.0807760106; GILLASPY AF, 1995, INFECT IMMUN, V63, P3373, DOI 10.1128/IAI.63.9.3373-3380.1995; Gordon CP, 2013, J MED CHEM, V56, P1389, DOI 10.1021/jm3014635; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Henry F, COSMETIC COMPOSITION; Hersh AL, 2008, ARCH INTERN MED, V168, P1585, DOI 10.1001/archinte.168.14.1585; Heyer G, 2002, INFECT IMMUN, V70, P127, DOI 10.1128/IAI.70.1.127-133.2002; Ibberson CB, 2014, INFECT IMMUN, V82, P4253, DOI 10.1128/IAI.01710-14; Kennedy AD, 2008, P NATL ACAD SCI USA, V105, P1327, DOI 10.1073/pnas.0710217105; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; Kirchdoerfer RN, 2011, J BIOL CHEM, V286, P17351, DOI 10.1074/jbc.M111.231258; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Ling LL, 2015, NATURE, V517, P455, DOI 10.1038/nature14098; Malik A, 2002, CHEM NAT COMPD+, V38, P612, DOI 10.1023/A:1022667611501; Mayville P, 1999, P NATL ACAD SCI USA, V96, P1218, DOI 10.1073/pnas.96.4.1218; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Montgomery CP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015177; Muszer M, 2015, ARCH IMMUNOL THER EX, V63, P287, DOI 10.1007/s00005-015-0332-3; Naik S, 2015, NATURE, V520, P104, DOI 10.1038/nature14052; Nakayama J, 2009, ANTIMICROB AGENTS CH, V53, P580, DOI 10.1128/AAC.00995-08; Nielsen A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084992; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; Olson ME, 2013, INFECT IMMUN, V81, P1316, DOI 10.1128/IAI.01242-12; Otto M, 2000, BIOTECHNIQUES, V28, P1088, DOI 10.2144/00286bm07; Otto M, 2014, CURR OPIN MICROBIOL, V17, P32, DOI 10.1016/j.mib.2013.11.004; Park J, 2007, CHEM BIOL, V14, P1119, DOI 10.1016/j.chembiol.2007.08.013; Parker D, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00284-14; Pieroni A, 2004, J ETHNOPHARMACOL, V91, P331, DOI 10.1016/j.jep.2004.01.015; Pignatti S, 2002, FLORA DITALIA; Quave CL, 2008, J ETHNOPHARMACOL, V118, P418, DOI 10.1016/j.jep.2008.05.005; Quave CL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00706; Quave CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028737; Quave CL, 2011, PLANTA MED, V77, P188, DOI 10.1055/s-0030-1250145; Ross-Gillespie A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00054; Schmidt BM, 2007, NAT CHEM BIOL, V3, P360, DOI 10.1038/nchembio0707-360; Schwan WR, 2003, FEMS IMMUNOL MED MIC, V38, P23, DOI 10.1016/S0928-8244(03)00098-1; Somerville GA, 2003, J BACTERIOL, V185, P6686, DOI 10.1128/JB.185.22.6686-6694.2003; Spaan AN, 2013, ANNU REV MICROBIOL, V67, P629, DOI 10.1146/annurev-micro-092412-155746; Stryjewski ME, 2008, CLIN INFECT DIS, V46, pS368, DOI 10.1086/533593; Sully EK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004174; Talekar SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097314; Thoendel M, 2011, CHEM REV, V111, P117, DOI 10.1021/cr100370n; Tsai TH, 2010, FOOD CHEM, V119, P964, DOI 10.1016/j.foodchem.2009.07.062; Tsuji BT, 2007, DIAGN MICR INFEC DIS, V58, P41, DOI 10.1016/j.diagmicrobio.2006.10.021; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Wardenburg JB, 2007, INFECT IMMUN, V75, P1040, DOI 10.1128/IAI.01313-06; WHO, 2003, GUID GOOD AGR COLL P; Wright JD, 2003, FEMS MICROBIOL LETT, V218, P377, DOI 10.1016/S0378-1097(02)01193-X; Wright JS, 2005, P NATL ACAD SCI USA, V102, P1691, DOI 10.1073/pnas.0407661102; Zhu J, 2013, CURR OPIN PHARMACOL, V13, P688, DOI 10.1016/j.coph.2013.07.003	68	71	74	4	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136486	10.1371/journal.pone.0136486	http://dx.doi.org/10.1371/journal.pone.0136486			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295163	Green Published, gold			2022-12-26	WOS:000359926900115
J	Rockett, IRH; Hobbs, GR; Wu, D; Jia, HM; Nolte, KB; Smith, GS; Putnam, SL; Caine, ED				Rockett, Ian R. H.; Hobbs, Gerald R.; Wu, Dan; Jia, Haomiao; Nolte, Kurt B.; Smith, Gordon S.; Putnam, Sandra L.; Caine, Eric D.			Variable Classification of Drug-Intoxication Suicides across US States: A Partial Artifact of Forensics?	PLOS ONE			English	Article							OF-DEATH ANALYSIS; UNITED-STATES; UNDETERMINED DEATHS; MEDICAL EXAMINERS; PUBLIC-HEALTH; MORTALITY; CORONERS; MISCLASSIFICATION; TRENDS; COMORBIDITY	Background The 21st-century epidemic of pharmaceutical and other drug-intoxication deaths in the United States (US) has likely precipitated an increase in misclassified, undercounted suicides. Drug-intoxication suicides are highly prone to be misclassified as accident or undetermined. Misclassification adversely impacts suicide and other injury mortality surveillance, etiologic understanding, prevention, and hence clinical and public health policy formation and practice. Objective To evaluate whether observed variation in the relative magnitude of drug-intoxication suicides across US states is a partial artifact of the scope and quality of toxicological testing and type of medicolegal death investigation system. Methods This was a national, state-based, ecological study of 111,583 drug-intoxication fatalities, whose manner of death was suicide, accident, or undetermined. The proportion of (nonhomicide) drug-intoxication deaths classified by medical examiners and coroners as suicide was analyzed relative to the proportion of death certificates citing one or more specific drugs and two types of state death investigation systems. Our model incorporated five sociodemographic covariates. Data covered the period 2008-2010, and derived from NCHS's Multiple Cause-of-Death public use files. Results Across states, the proportion of drug-intoxication suicides ranged from 0.058 in Louisiana to 0.286 in South Dakota and the rate from 1 per 100,000 population in North Dakota to 4 in New Mexico. There was a low correlation between combined accident and undetermined drug-intoxication death rates and corresponding suicide rates (Spearman's rho =0.38; p<0.01). Citation of 1 or more specific drugs on the death certificate was positively associated with the relative odds of a state classifying a nonhomicide drug-intoxication death as suicide rather than accident or undetermined, adjusting for region and type of state death investigation system (odds ratio, 1.062; 95% CI, 1.016-1.110). Region, too, was a significant predictor. Relative to the South, a 10% increase in drug citation was associated with 43% (95% CI, 11%-83%), 41% (95% CI, 7%-85%), and 33% (95% CI, 1%-76%) higher odds of a suicide classification in the West, Midwest, and Northeast, respectively. Conclusion Large interstate variation in the relative magnitude of nonhomicide drug-intoxication deaths classified as suicide by medical examiners and coroners in the US appears partially an artifact of geographic region and degree of toxicological assessment in the case ascertainment process. Etiologic understanding and prevention of drug-induced suicides and other drug-intoxication deaths first require rigorous standardization involving accurate concepts, definitions, and case ascertainment.	[Rockett, Ian R. H.] W Virginia Univ, Sch Publ Hlth, Injury Control Res Ctr, Morgantown, WV 26506 USA; [Rockett, Ian R. H.] W Virginia Univ, Sch Publ Hlth, Dept Epidemiol, Morgantown, WV 26506 USA; [Hobbs, Gerald R.] W Virginia Univ, Dept Stat, Morgantown, WV 26506 USA; [Wu, Dan] Guangdong Med Coll, Dept Psychol, Dongguan, Guandong, Peoples R China; [Wu, Dan] Zhejiang Univ, Sch Med, Dept Social Med, Hangzhou 310003, Zhejiang, Peoples R China; [Jia, Haomiao] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY USA; [Jia, Haomiao] Columbia Univ, Sch Nursing, New York, NY USA; [Nolte, Kurt B.] Univ New Mexico, Sch Med, Dept Pathol, Off Med Investigator, Albuquerque, NM 87131 USA; [Smith, Gordon S.] Univ Maryland, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Putnam, Sandra L.] Social Solut Int Inc, Silver Spring, MD USA; [Caine, Eric D.] Univ Rochester, Med Ctr, Injury Control Res Ctr Suicide Prevent, Rochester, NY 14642 USA; [Caine, Eric D.] Univ Rochester, Med Ctr, Dept Psychiat, Rochester, NY 14642 USA	West Virginia University; West Virginia University; West Virginia University; Guangdong Medical University; Zhejiang University; Columbia University; Columbia University; University of New Mexico; University System of Maryland; University of Maryland Baltimore; University of Rochester; University of Rochester	Rockett, IRH (corresponding author), W Virginia Univ, Sch Publ Hlth, Injury Control Res Ctr, Morgantown, WV 26506 USA.	irockett@hsc.wvu.edu	Jia, Haomiao/AAU-8276-2021	Smith, Gordon/0000-0002-2911-3071	Centers for Disease Control and Prevention (CDC) [5R49CE002109, R49CE002093]; National Institute on Alcohol Abuse and Alcoholism (NIAAA) [R01AA18707]; Social Solutions International, Inc.; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL [R49CE002093, R49CE002109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018707] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Social Solutions International, Inc.; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research received partial support from grants 5R49CE002109 and R49CE002093 from the Centers for Disease Control and Prevention (CDC), and grant R01AA18707 from the National Institute on Alcohol Abuse and Alcoholism (NIAAA); http://www.cdc.gov/grants/; http://www.niaaa.nih.gov/grant-funding. The funders provided support in the form of salaries for three authors [I.R.H.R., E.D.C., G.S.S.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. At the time of the study, S.L.P. worked for a Small Disadvantaged Business (SDB), Social Solutions International, Inc., through a subcontract with the National Institute on Drug Abuse (NIDA); http://www.socialsolutions.biz/about-us/company-overview/. Her contributions to the research were made in her leisure time. Social Solutions International, Inc. provided support in the form of salary for author S.L.P. (although the salary was not related to this study) and Social Solutions International, Inc. did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Bohnert ASB, 2013, INJURY PREV, V19, P326, DOI 10.1136/injuryprev-2012-040631; Breiding MJ, 2006, INJURY PREV, V12, P49, DOI 10.1136/ip.2006.012591; Cantor C, 2001, PSYCHOPATHOLOGY, V34, P140, DOI 10.1159/000049297; Centers for Disease Control and Prevention, WEB BAS INJ STAT QUE; Chen Li Hui, 2014, NCHS Data Brief, P1; Committee on Identifying the Needs of the Forensic Sciences Community: National Research Council, 2009, STRENGTH FOR SCI US; Dart RC, 2015, NEW ENGL J MED, V372, P241, DOI [10.1056/NEJMsa1406143, 10.1056/NEJMc1501822]; Davis GG, 2013, ACAD FORENSIC PATHOL, V3, P62; De Leo D, 2006, CRISIS, V27, P4, DOI 10.1027/0227-5910.27.1.4; Division of Violence Prevention National Center for Injury Prevention and Control Centers for Disease Control and Prevention, 1994, MMWR, V46, P789; Gunnell D, 2013, PSYCHOL MED, V43, P1415, DOI 10.1017/S0033291712002401; Hanzlick R., 2007, DEATH INVESTIGATION; Hanzlick R, 2007, AM J FOREN MED PATH, V28, P279, DOI 10.1097/PAF.0b013e31815b4d5a; Hanzlick R, 2006, ARCH PATHOL LAB MED, V130, P1274; Huguet N, 2012, SUICIDE LIFE-THREAT, V42, P185, DOI 10.1111/j.1943-278X.2012.00081.x; JARVIS GK, 1991, SUICIDE LIFE-THREAT, V21, P115; Klugman J, 2013, SOC SCI QUART, V94, P462, DOI 10.1111/j.1540-6237.2012.00937.x; Linsley KR, 2001, BRIT J PSYCHIAT, V178, P465, DOI 10.1192/bjp.178.5.465; Mack KA, 2013, MMWR-MORBID MORTAL W, V62, P161; National Commission on Forensic Science, 2015, ACCR MED DEATH INV O; OCARROLL PW, 1989, SUICIDE LIFE-THREAT, V19, P1; Ohberg A, 1998, ACTA PSYCHIAT SCAND, V98, P214, DOI 10.1111/j.1600-0447.1998.tb10069.x; OVENSTONE IM, 1973, BRIT J PSYCHIAT, V123, P15, DOI 10.1192/bjp.123.1.15; PLATT S, 1988, SOC PSYCH PSYCH EPID, V23, P217, DOI 10.1007/BF01787820; Pritchard C, 2015, COMMUNITY MENT HLT J, V51, P365, DOI 10.1007/s10597-014-9810-z; Rockett IRH, 2007, INJURY PREV, V13, P311, DOI 10.1136/ip.2007.015230; Rockett IRH, 2014, AM J PUBLIC HEALTH, V104, pE49, DOI 10.2105/AJPH.2014.302244; Rockett IRH, 2014, JAMA PSYCHIAT, V71, P231, DOI 10.1001/jamapsychiatry.2013.3738; Rockett IRH, 2011, SUICIDOL ONLINE-SOL, V2, P48; Rockett IRH, 2010, CRISIS, V31, P227, DOI 10.1027/0227-5910/a000071; Rockett IRH, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-705; Rockett IRH, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-35; Rockett IRH, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-10; Rockett IRH, 2012, AM J PUBLIC HEALTH, V102, pe84, DOI [10.2105/AJPH.2012.300960, DOI 10.2105/AJPH.2012.300960]; Rockett IRH, 2015, JAMA PSYCHI IN PRESS; ROSENBERG ML, 1988, J FORENSIC SCI, V33, P1445; Ruzicka LT, 2005, SOC SCI MED, V61, P333, DOI 10.1016/j.socscimed.2004.12.005; Salib E, 1996, MED SCI LAW, V36, P237, DOI 10.1177/002580249603600310; Stanistreet D, 2001, MED SCI LAW, V41, P111, DOI 10.1177/002580240104100205; US Public Health Service, 2001, NAT STRAT SUIC PREV; Varnik P, 2010, SCAND J PUBLIC HEALT, V38, P395, DOI 10.1177/1403494809354360; Vichi M, 2010, PSYCHIAT RES, V175, P89, DOI 10.1016/j.psychres.2008.12.008; Warner M, 2013, ACAD FORENSIC PATHOL, V3, P231, DOI [DOI 10.23907/2013.029, 10.23907/2013.029]; William III Massello, 1985, J FORENSIC SCI, V31, P1000; World Health Organization, INT CLASS DIS	45	44	44	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135296	10.1371/journal.pone.0135296	http://dx.doi.org/10.1371/journal.pone.0135296			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5MR	26295155	Green Submitted, Green Published, gold			2022-12-26	WOS:000359926900025
J	Sun, PF; Lin, H; Wang, G; Zhang, XM; Zhang, QC; Zhao, YH				Sun, Pengfei; Lin, Hui; Wang, Guan; Zhang, Ximing; Zhang, Qichun; Zhao, Yuhua			Wheat Bran Enhances the Cytotoxicity of Immobilized Alcaligenes aquatilis F8 against Microcystis aeruginosa	PLOS ONE			English	Article							ACID-HYDROLYSIS; FRESH-WATER; DEGRADATION; STRAW; PRETREATMENT; STRATEGIES; ALGINATE; STARCH; BLOOMS	Algicidal bacteria offer a promising option for killing cyanobacteria. Therefore, a new Alcaligenes aquatilis strain F8 was isolated to control Microcystis aeruginosa in this study. The algicidal activity of strain F8 was dependent on the cell density of M. aeruginosa, and the maximal algicidal rate of the free bacterium reached 88.45% within 72 h. With a view to its application to the control of M. aeruginosa in the natural environment, strain F8 was immobilized in sodium alginate beads, but immobilization of the strain decreased its algicidal rate compared to that of the free bacterium. However, addition of wheat bran to the sodium alginate matrix used to immobilize strain F8 not only eliminated the adverse effects of immobilization on the bacteria but also resulted in an 8.83% higher algicidal rate of the immobilized than free bacteria. Exclusion and recovery methods were used to identify key ingredients of wheat bran and gain insight into the mechanism underlying the observed enhancement of algicidal activity. This analysis indicated that certain factors in wheat bran, including vitamins B-1, B-2, B-9, and E were responsible for promoting bacterial growth and thereby improving the algicidal rate of immobilized strain F8. Our findings indicate that wheat bran is able to improve the algicidal efficiency of A. aquatilis strain F8 for killing M. aeruginosa and is a good source of not only carbon and nitrogen but also vitamins for bacteria.	[Sun, Pengfei; Wang, Guan; Zhang, Ximing; Zhao, Yuhua] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Lin, Hui] Zhejiang Acad Agr Sci, Inst Environm Resource & Soil Fertilizer, Hangzhou, Zhejiang, Peoples R China; [Zhang, Qichun] Zhejiang Univ, Coll Environm & Resource Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang Academy of Agricultural Sciences; Zhejiang University	Zhang, QC (corresponding author), Zhejiang Univ, Coll Environm & Resource Sci, Hangzhou 310003, Zhejiang, Peoples R China.	qczhang@zju.edu.cn; microbeapply@zju.edu.cn	Sun, Pengfei/GNM-5684-2022; Zhang, Qichun/AAN-6970-2020; LIN, HUI/AEA-6702-2022	Sun, Pengfei/0000-0002-2881-6461; LIN, HUI/0000-0002-5446-8069	Major State Basic Research Development Program of China (973 Program) [2015CB150502]; National Natural Science Foundation of China [41271335, 31470191]; Science and Technology Project of Zhejiang Province [2011C13016, 2014C33019]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Zhejiang Province	This study was supported by the Major State Basic Research Development Program of China (973 Program) (2015CB150502), the National Natural Science Foundation of China (41271335; 31470191), and the Science and Technology Project of Zhejiang Province (2011C13016; 2014C33019).	Aguilar R, 2002, J FOOD ENG, V55, P309, DOI 10.1016/S0260-8774(02)00106-1; Bjerre AB, 1996, BIOTECHNOL BIOENG, V49, P568, DOI 10.1002/(SICI)1097-0290(19960305)49:5<568::AID-BIT10>3.3.CO;2-4; Choi HJ, 2005, BIOL CONTROL, V33, P335, DOI 10.1016/j.biocontrol.2005.03.007; de Ory I, 2004, PROCESS BIOCHEM, V39, P547, DOI 10.1016/S0032-9592(03)00136-5; Huang C, 2009, BIORESOURCE TECHNOL, V100, P4535, DOI 10.1016/j.biortech.2009.04.022; Hui J., 2011, J ANHUI AGR SCI, V39, P834; Huisman J, 2005, SPRINGER AQUATIC E 3, VSpringer Aquatic Ecology, Ser. 3; Idris A, 2006, PROCESS BIOCHEM, V41, P1117, DOI 10.1016/j.procbio.2005.12.002; Iranmahboob J, 2002, BIOMASS BIOENERG, V22, P401, DOI 10.1016/S0961-9534(02)00016-8; Jung SW, 2008, J APPL MICROBIOL, V105, P186, DOI 10.1111/j.1365-2672.2008.03733.x; Kang YH, 2007, J APPL MICROBIOL, V103, P1983, DOI 10.1111/j.1365-2672.2007.03439.x; Kang YH, 2012, HYDROBIOLOGIA, V683, P151, DOI 10.1007/s10750-011-0951-6; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LIN H, 2013, MATH PROBL ENG, V2013, P1, DOI DOI 10.1371/J0URNAL.P0NE.0060516; Livingston L.R., 1968, YALE J BIOL MED, V40, P324; Manage PM, 2000, AQUAT MICROB ECOL, V22, P111, DOI 10.3354/ame022111; Manohar S, 2001, APPL MICROBIOL BIOT, V55, P311, DOI 10.1007/s002530000488; Mattila P, 2001, J AGR FOOD CHEM, V49, P2343, DOI 10.1021/jf001525d; MCGRATH R, 1972, ANAL BIOCHEM, V49, P95, DOI 10.1016/0003-2697(72)90245-X; Mu R, 2014, AFR J BIOTECHNOL, V11, P460; Mu RM, 2007, J ENVIRON SCI-CHINA, V19, P1336, DOI 10.1016/S1001-0742(07)60218-6; Pan G, 2006, ENVIRON POLLUT, V141, P195, DOI 10.1016/j.envpol.2005.08.041; Patil NK, 2006, INT BIODETER BIODEGR, V57, P82, DOI 10.1016/j.ibiod.2005.11.007; Powell LW, 1990, IMMOBILIZED BIOCATAL, P369; Pruckler M, 2014, LWT-FOOD SCI TECHNOL, V56, P211, DOI 10.1016/j.lwt.2013.12.004; Saha BC, 2010, NEW BIOTECHNOL, V27, P10, DOI 10.1016/j.nbt.2009.10.005; Smith VH, 1999, ENVIRON POLLUT, V100, P179, DOI 10.1016/S0269-7491(99)00091-3; Sun PF, 2015, J HAZARD MATER, V284, P215, DOI 10.1016/j.jhazmat.2014.11.025; Sun PengFei, 2013, Journal of Zhejiang University (Agriculture and Life Sciences), V39, P613; Surette MG, 1998, P NATL ACAD SCI USA, V95, P7046, DOI 10.1073/pnas.95.12.7046; TABATA S, 1971, STARKE, V23, P267, DOI 10.1002/star.19710230803; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tsuji K, 2006, CHEMOSPHERE, V65, P117, DOI 10.1016/j.chemosphere.2006.02.018; Wang YJ, 2003, CARBOHYD POLYM, V52, P327, DOI 10.1016/S0144-8617(02)00323-5; Weng Q, 1999, J GUIZHOU NORMAL U N, V18, P49; Wright JD, 1989, COMP TECHNICAL EVALU, P949; Zhang H, 2011, LIMNOLOGICA, V41, P70, DOI 10.1016/j.limno.2010.08.001; Zhang W.H, 2001, RES ENV SCI, V14, P57	38	14	14	6	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136429	10.1371/journal.pone.0136429	http://dx.doi.org/10.1371/journal.pone.0136429			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295573	Green Published, gold, Green Submitted			2022-12-26	WOS:000359926900109
J	Basten, S; Verropoulou, G				Basten, Stuart; Verropoulou, Georgia			A Re-Interpretation of the 'Two-child Norm' in Post-Transitional Demographic Systems: Fertility Intentions in Taiwan	PLOS ONE			English	Article							SON PREFERENCE; EAST-ASIA; GENDER; POPULATION; EXPERIENCE; COUNTRIES; EMERGENCE; BEHAVIOR; DECLINE; RISE	Taiwan currently has one of the lowest fertility rates in the world, leading to projections of rapid population ageing and decline. In common with other territories in Pacific Asia, policies designed to support childbearing have recently been introduced. Some optimism for the future success of these policies has been drawn from the fact that the 'ideal' number of children stated in Taiwanese surveys is over two. In this way, Taiwan appears to fit the 'two-child norm' model identified for Europe and North America. Furthermore, this feature has led commentators to state that Taiwan is not in a 'low fertility trap'-where positive feedback mechanisms emanating from the normalisation of small families, slow economic growth and ageing/declining population mean attempts to increase fertility become ever less likely to succeed. Using a recent national representative survey, and arguing that 'intentions' are a more reliable guide to understanding the circumstances of family formation, this paper explores fertility intentions in Taiwan with a special focus on women at parity one and parity two. This will form the first full-length examination of fertility intentions in Taiwan published in English and one of the few studies of Pacific Asia that reports a micro-level analysis. We argue that using intentions should provide a better 'barometer' of attitudes towards child-bearing in Taiwan, and that through micro-level analysis, we can better identify the predictors of intentions that could, in turn, provide useful clues both for projections as well as shaping policy responses. While we found some evidence for a 'two-child norm' among childless women, this could be an unrealistic ideal. This is supported by the fact that a majority of women with one child do not intend to have another.	[Basten, Stuart] Univ Oxford, Dept Social Policy & Intervent, Oxford, England; [Verropoulou, Georgia] Univ Piraeus, Dept Stat & Insurance Sci, Piraeus, Greece	University of Oxford; University of Piraeus	Basten, S (corresponding author), Univ Oxford, Dept Social Policy & Intervent, Oxford, England.	stuart.basten@spi.ox.ac.uk	Gietel-Basten, Stuart A/I-8513-2015	Gietel-Basten, Stuart A/0000-0002-5818-8283; Verropoulou, Georgia/0000-0001-6544-2086	Economic and Social Research Council (UK): The gap between fertility ideals and reality in East Asia: a mixed-method comparative study of Beijing Municipality and Taiwan [ES/K001434/1]; Economic and Social Research Council [ES/K001434/1] Funding Source: researchfish; ESRC [ES/K001434/1] Funding Source: UKRI	Economic and Social Research Council (UK): The gap between fertility ideals and reality in East Asia: a mixed-method comparative study of Beijing Municipality and Taiwan; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	Funded by Economic and Social Research Council (UK): The gap between fertility ideals and reality in East Asia: a mixed-method comparative study of Beijing Municipality and Taiwan (http://www.esrc.ac.uk/my-esrc/grants/ES.K001434.1/read) Grant No. ES/K001434/1.	[Anonymous], 2005, AGEING PENSION REFOR; Basten S., 2014, WORLD POPULATION HUM, P39, DOI DOI 10.1093/ACPROF:OSO/9780198703167.003.0003; Basten S, 2013, REEXAMINING FERTILIT; Basten S., 2010, FINNISH YB POPULATIO, P67; Basten SA, 2015, POP ASS AM ANN M APR; Basten S, 2013, ASIAN SOC WORK POLIC, V7, P242, DOI 10.1111/aswp.12015; Basten S, 2013, ASIAN POPUL STUD, V9, P322, DOI 10.1080/17441730.2013.836394; Basten S, 2013, PALGR MAC STUD FAM, P185; Basten Stuart., 2013, CHILDBEARING PREFERE; Becker G.S., 1993, TREATISE FAMILY, DOI DOI 10.4159/9780674020665; BECKER GS, 1965, ECON J, V75, P493, DOI 10.2307/2228949; BECKER GS, 1973, J POLIT ECON, V81, pS279, DOI 10.1086/260166; Bongaarts J, 2012, POPUL DEV REV, V38, P83, DOI 10.1111/j.1728-4457.2012.00473.x; Bongaarts J, 2001, POPUL DEV REV, V27, P260; BUTZ WP, 1979, AM ECON REV, V69, P318; Cernada G, 2007, INT Q COMMUNITY HEAL, V27, P99, DOI 10.2190/IQ.27.2.b; Chen Y.-H., 2012, JAPANESE J POPULATIO, V10, P78; Cheng CY, 2007, J CHINESE PHILOS, V34, P1, DOI 10.1111/j.1540-6253.2007.00397.x; Choe MK, 2004, ANN M POP ASS AM BOS; Chuang H-L, 2008, AM J ECON SOCIOL, V62, P435, DOI [10.1111/1536-7150.00221, DOI 10.1111/1536-7150.00221]; Coleman D, 2011, POPUL DEV REV, V37, P217, DOI 10.1111/j.1728-4457.2011.00385.x; Commission of the European Communities, 2005, COM200594 COMM EUR C; Davis D. S., 2014, WIVES HUSBANDS LOVER, P1; Easterlin RA, 1980, BIRTH AND FORTUNE TH; Esping-Andersen G., 2009, INCOMPLETE REVOLUTIO; Frejka T, 2010, POPUL DEV REV, V36, P579, DOI 10.1111/j.1728-4457.2010.00347.x; Goldstein J, 2003, POPUL RES POLICY REV, V22, P479, DOI 10.1023/B:POPU.0000020962.80895.4a; Hayford SR, 2009, DEMOGRAPHY, V46, P765, DOI 10.1353/dem.0.0073; Heiland F, 2008, EUR J POPUL, V24, P129, DOI 10.1007/s10680-008-9162-x; HERMALIN AI, 1979, STUD FAMILY PLANN, V10, P75, DOI 10.2307/1965677; Ho H.-Z., 2013, FATHER INVOLVEMENT Y, P329; Ho H-Z, 2011, INT J PARENTS ED, V5, P35; Hou JW., 2014, SOCIAL SCI CHINA, V35, P78; Jeon Y, 2005, J POPUL ECON, V18, P1, DOI 10.1007/s00148-004-0190-5; Lee M., 2009, JAPANESE J POPULATIO, V7, P71; LEE RD, 1980, POP STUD-J DEMOG, V34, P205, DOI 10.1080/00324728.1980.10410385; Lesthaeghe R, 2014, P NATL ACAD SCI USA, V111, P18112, DOI 10.1073/pnas.1420441111; Lin MH, 2010, AGEING RES REV, V9, pS23, DOI 10.1016/j.arr.2010.07.004; Lin TC, 2009, DEMOGR RES, V20, P377, DOI 10.4054/DemRes.2009.20.16; Lin WI, 2009, ASIAN SOC WORK POLIC, V3, P95, DOI 10.1111/j.1753-1411.2009.00027.x; Lutz Wolfgang, 2006, VIENNA YB POPULATION, V4, P167, DOI DOI 10.1553/POPULATIONYEARBOOK2006S167; Mason Andrew, 2006, Genus, V62, P11; McDonald P, 2013, DEMOGR RES, V28, P981, DOI 10.4054/DemRes.2013.28.34; McDonald P, 2009, ROUT RES PUB SOC POL, P23; McDonald Peter, 2000, J POPULATION RES, V17, P1, DOI DOI 10.1007/BF03029445; Merli M Giovanna, 2011, Population (Engl Ed), V66, P519; Miettinen A, 2011, DEMOGR RES, V24, P469, DOI 10.4054/DemRes.2011.24.20; Mills M, 2008, DEMOGR RES, V18, DOI 10.4054/DemRes.2008.18.1; Morgan SP, 2010, POPUL DEV REV, V36, P91, DOI 10.1111/j.1728-4457.2010.00319.x; Myrskyla M, 2013, POPUL DEV REV, V39, P31, DOI 10.1111/j.1728-4457.2013.00572.x; NAIR NK, 1980, STUD FAMILY PLANN, V11, P255, DOI 10.2307/1966243; NAMBOODIRI NK, 1972, POP STUD-J DEMOG, V26, P185, DOI 10.1080/00324728.1972.10405545; Poston D. L. J., 2014, FAMILY SOCIAL CHANGE, P265; Pradhan I, 2012, DEMOGR INDIA, V41, P53; Pradhan I, 2014, ASIAN POPUL STUD, V10, P163, DOI 10.1080/17441730.2014.909962; Quesnel-Vallee A, 2003, POPUL RES POLICY REV, V22, P497, DOI 10.1023/B:POPU.0000021074.33415.c1; Retherford RD, 1996, POP STUD-J DEMOG, V50, P5, DOI 10.1080/0032472031000149016; Roy R. N., 2014, TRANSITION PARENTHOO; Schoen R, 1999, J MARRIAGE FAM, V61, P790, DOI 10.2307/353578; Sobotka T, 2014, POPUL DEV REV, V40, P391, DOI 10.1111/j.1728-4457.2014.00691.x; Sobotka T, 2011, POPUL DEV REV, V37, P267, DOI 10.1111/j.1728-4457.2011.00411.x; Straughan P., 2008, ULTRALOW FERTILITY P; Testa MR, 2014, ADV LIFE COURSE RES, V21, P28, DOI 10.1016/j.alcr.2014.01.005; Testa MR, 2014, DEMOGR RES, V31, P687, DOI 10.4054/DemRes.2014.31.23; Tu E. J.-C., 2007, TRANSITION CHALLENGE, P71; UNFPA, 2011, IMP DEM CHANG THAIL; United Nations Population Division (UNPD), 2013, WORLD POP PROSP 2012; Wang L.-R., 2014, CONT SOCIAL ISSUES E, P235; Yap Mui Teng, 2003, J POPULATION SOCIAL, V1, P643; Yu W-H., 2009, GENDERED TRAJECTORIE; Yu WH, 2006, J MARRIAGE FAM, V68, P1057, DOI 10.1111/j.1741-3737.2006.00313.x; Zheng ZhenZhen, 2009, Asian Population Studies, V5, P329, DOI 10.1080/17441730903351701	72	13	13	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135105	10.1371/journal.pone.0135105	http://dx.doi.org/10.1371/journal.pone.0135105			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5KH	26291083	gold, Green Published, Green Submitted			2022-12-26	WOS:000359919900014
J	Patai, AV; Valcz, G; Hollosi, P; Kalmar, A; Peterfia, B; Patai, A; Wichmann, B; Spisak, S; Bartak, BK; Leiszter, K; Toth, K; Sipos, F; Kovalszky, I; Peter, Z; Miheller, P; Tulassay, Z; Molnar, B				Patai, Arpad V.; Valcz, Gabor; Hollosi, Peter; Kalmar, Alexandra; Peterfia, Balint; Patai, Arpad; Wichmann, Barnabas; Spisak, Sandor; Bartak, Barbara Kinga; Leiszter, Katalin; Toth, Kinga; Sipos, Ferenc; Kovalszky, Ilona; Peter, Zoltan; Miheller, Pal; Tulassay, Zsolt; Molnar, Bela			Comprehensive DNA Methylation Analysis Reveals a Common Ten-Gene Methylation Signature in Colorectal Adenomas and Carcinomas	PLOS ONE			English	Article							FREQUENT EPIGENETIC INACTIVATION; CANCER; GENE; COLON; MARKER; HYPERMETHYLATION; IDENTIFICATION; PROGRESSION; MUTATIONS; PHENOTYPE	Microarray analysis of promoter hypermethylation provides insight into the role and extent of DNA methylation in the development of colorectal cancer (CRC) and may be co-monitored with the appearance of driver mutations. Colonic biopsy samples were obtained endoscopically from 10 normal, 23 adenoma (17 low-grade (LGD) and 6 high-grade dysplasia (HGD)), and 8 ulcerative colitis (UC) patients (4 active and 4 inactive). CRC samples were obtained from 24 patients (17 primary, 7 metastatic (MCRC)), 7 of them with synchronous LGD. Field effects were analyzed in tissues 1 cm (n = 5) and 10 cm (n = 5) from the margin of CRC. Tissue materials were studied for DNA methylation status using a 96 gene panel and for KRAS and BRAF mutations. Expression levels were assayed using whole genomic mRNA arrays. SFRP1 was further examined by immunohistochemistry. HT29 cells were treated with 5-aza-2' deoxycytidine to analyze the reversal possibility of DNA methylation. More than 85% of tumor samples showed hypermethylation in 10 genes (SFRP1, SST, BNC1, MAL, SLIT2, SFRP2, SLIT3, ALDH1A3, TMEFF2, WIF1), whereas the frequency of examined mutations were below 25%. These genes distinguished precancerous and cancerous lesions from inflamed and healthy tissue. The mRNA alterations that might be caused by systematic methylation could be partly reversed by demethylation treatment. Systematic changes in methylation patterns were observed early in CRC carcinogenesis, occuring in precursor lesions and CRC. Thus we conclude that DNA hypermethylation is an early and systematic event in colorectal carcinogenesis, and it could be potentially reversed by systematic demethylation therapy, but it would need more in vitro and in vivo experiments to support this theory.	[Patai, Arpad V.; Kalmar, Alexandra; Bartak, Barbara Kinga; Leiszter, Katalin; Toth, Kinga; Sipos, Ferenc; Peter, Zoltan; Miheller, Pal; Tulassay, Zsolt; Molnar, Bela] Semmelweis Univ, Dept Med 2, H-1085 Budapest, Hungary; [Valcz, Gabor; Peterfia, Balint; Wichmann, Barnabas; Spisak, Sandor; Tulassay, Zsolt; Molnar, Bela] Hungarian Acad Sci, Mol Med Res Grp, Budapest, Hungary; [Hollosi, Peter; Kovalszky, Ilona] Semmelweis Univ, Dept Pathol & Expt Canc Res 1, H-1085 Budapest, Hungary; [Hollosi, Peter] Hungarian Acad Sci, Tumor Progress Res Grp, Budapest, Hungary; [Patai, Arpad] Markusovszky Univ Teaching Hosp, Dept Gastroenterol & Med, Szombathely, Hungary; [Spisak, Sandor] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA	Semmelweis University; Hungarian Academy of Sciences; Semmelweis University; Hungarian Academy of Sciences; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Patai, AV (corresponding author), Semmelweis Univ, Dept Med 2, H-1085 Budapest, Hungary.	arpad.patai@gmail.com	Kovalszky, Ilona/ABH-2832-2020; Sipos, Ferenc/GYV-6182-2022	Kovalszky, Ilona/0000-0002-0179-3378; Miheller, Pal/0000-0002-7396-3145	National Office for Research and Technology, Hungary [TECH_08-A1/2-2008-0114]; Hungarian Scientific Research Fund (OTKA) [K 111743]	National Office for Research and Technology, Hungary(National Office for Research and Technology); Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This study was supported by the National Office for Research and Technology, Hungary, (Grant number: TECH_08-A1/2-2008-0114) and by the Hungarian Scientific Research Fund (OTKA, Grant number: K 111743, www.magzrt.hu and www.otka.hu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed D, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.35; An B, 2010, INT J CANCER, V127, P2095, DOI 10.1002/ijc.25225; Belshaw NJ, 2010, CARCINOGENESIS, V31, P1158, DOI 10.1093/carcin/bgq077; Boumber YA, 2007, CANCER RES, V67, P1997, DOI 10.1158/0008-5472.CAN-06-3093; Caldwell GM, 2004, CANCER RES, V64, P883, DOI 10.1158/0008-5472.CAN-03-1346; Cancer Genome Atlas Network, 2012, NATURE, V487, P330, DOI [10.1038/nature11252, DOI 10.1038/NATURE11252]; Chung W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002079; Cui Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002990; Dallol A, 2003, CANCER RES, V63, P1054; Dickinson RE, 2004, BRIT J CANCER, V91, P2071, DOI 10.1038/sj.bjc.6602222; Ebert MPA, 2005, NEOPLASIA, V7, P771, DOI 10.1593/neo.05235; Galamb O, 2010, BRIT J CANCER, V102, P765, DOI 10.1038/sj.bjc.6605515; Galamb O, 2008, CANCER EPIDEM BIOMAR, V17, P2835, DOI 10.1158/1055-9965.EPI-08-0231; Galamb O, 2009, CELL ONCOL, V31, P19, DOI 10.3233/CLO-2009-0458; Goel A, 2012, GASTROENTEROLOGY, V143, P1442, DOI 10.1053/j.gastro.2012.09.032; Hatzaki A, 2001, MOL CELL PROBE, V15, P243, DOI 10.1006/mcpr.2001.0367; Hinoue T, 2012, GENOME RES, V22, P271, DOI 10.1101/gr.117523.110; Holemon H, 2007, BIOTECHNIQUES, V43, P683, DOI 10.2144/000112597; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ju HX, 2011, AM J PATHOL, V178, P1835, DOI 10.1016/j.ajpath.2010.12.045; Kann L, 2006, CLIN CHEM, V52, P2299, DOI 10.1373/clinchem.2007.070896; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Lind GE, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-13; Luo YX, 2014, GASTROENTEROLOGY, V147, P418, DOI 10.1053/j.gastro.2014.04.039; Mizukami H, 2008, ANTICANCER RES, V28, P2697; Mori Y, 2006, GASTROENTEROLOGY, V131, P797, DOI 10.1053/j.gastro.2006.06.006; Niwa T, 2010, ADV GENET, V71, P41, DOI [10.1016/S0065-2660(10)71002-6, 10.1016/B978-0-12-380864-6.00002-X]; Oh T, 2013, J MOL DIAGN, V15, P498, DOI 10.1016/j.jmoldx.2013.03.004; Okochi-Takada E, 2006, INT J CANCER, V119, P1338, DOI 10.1002/ijc.22025; Patai AV, 2013, WORLD J GASTROENTERO, V19, P607, DOI 10.3748/wjg.v19.i5.607; Patai AV, 2012, DIGEST DIS, V30, P310, DOI 10.1159/000337004; Qi J, 2006, WORLD J GASTROENTERO, V12, P7113, DOI 10.3748/wjg.v12.i44.7113; R Core Team, 2021, R LANGUAGE ENV STAT; Richman SD, 2009, J CLIN ONCOL, V27, P5931, DOI 10.1200/JCO.2009.22.4295; Sato H, 2007, CARCINOGENESIS, V28, P2459, DOI 10.1093/carcin/bgm178; Schuebel KE, 2007, PLOS GENET, V3, P1709, DOI 10.1371/journal.pgen.0030157; Shames DS, 2006, PLOS MED, V3, P2244, DOI 10.1371/journal.pmed.0030486; Shen LL, 2005, JNCI-J NATL CANCER I, V97, P1330, DOI 10.1093/jnci/dji275; Sipos F, 2013, EPIGENOMICS-UK, V5, P569, DOI 10.2217/epi.13.52; Spisak S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046215; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Taniguchi H, 2005, ONCOGENE, V24, P7946, DOI 10.1038/sj.onc.1208910; Toth K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046000; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Valcz G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106143; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Whitehall VLJ, 2001, CANCER RES, V61, P827; Yagi K, 2010, CLIN CANCER RES, V16, P21, DOI 10.1158/1078-0432.CCR-09-2006; Zhong X, 2013, J CANCER RES CLIN, V139, P485, DOI 10.1007/s00432-012-1353-5	50	37	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0133836	10.1371/journal.pone.0133836	http://dx.doi.org/10.1371/journal.pone.0133836			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291085	Green Published, gold, Green Submitted			2022-12-26	WOS:000359919900003
J	Zheng, YN; Tang, L; Huang, WH; Yan, RY; Ren, FF; Luo, L; Zhang, L				Zheng, Yaning; Tang, Lin; Huang, Wenhan; Yan, Ruyu; Ren, Feifeng; Luo, Lei; Zhang, Ling			Anti-Inflammatory Effects of Ang-(1-7) in Ameliorating HFD-Induced Renal Injury through LDLr-SREBP2-SCAP Pathway	PLOS ONE			English	Article							HEPATIC STEATOSIS; LIPID-METABOLISM; ANGIOTENSIN 1-7; INFLAMMATION; OBESITY; MICE; RECEPTOR; DAMAGE; MAS; RATS	The angiotensin converting enzyme 2-angiotensin-(1-7)-Mas axis (ACE2-Ang-(1-7)-Mas axis) is reported to participate in lipid metabolism in kidney, but its precise effects and underlying mechanisms remain unknown. We hypothesized that Ang-(1-7) reduces lipid accumulation and improves renal injury through the low density lipoprotein receptor-sterol regulatory element binding proteins 2-SREBP cleavage activating protein (LDLr-SREBP2-SCAP) system by suppressing inflammation in high fat diet (HFD)-fed mice. In this study, male C57BL/6 mice were randomized into four groups: STD (standard diet)+saline, HFD+saline, HFD+Ang-(1-7) and STD+Ang-(1-7). After 10 weeks of feeding, mice were administered Ang-(1-7) or saline for two weeks. We found that high inflammation status induced by HFD disrupted the LDLr-SREBP2-SCAP feedback system. Treatment of mice fed a high-fat diet with Ang-(1-7) induced significant improvement in inflammatory status, following the downregulation of LDLr, SREBP2 and SCAP, and then, decreased lipid deposition in kidney and improved renal injury. In conclusion, the anti-inflammatory effect of Ang-(1-7) alleviates renal injury triggered by lipid metabolic disorders through a LDLr-SREBP2-SCAP pathway.	[Zheng, Yaning; Tang, Lin; Huang, Wenhan; Yan, Ruyu; Ren, Feifeng; Luo, Lei; Zhang, Ling] Chongqing Med Univ, Affiliated Hosp 2, Dept Nephrol, Chongqing 400010, Peoples R China	Chongqing Medical University	Tang, L (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Dept Nephrol, Chongqing 400010, Peoples R China.	hopetang@163.com			National Natural Science Youth Foundation of China [81200519]	National Natural Science Youth Foundation of China(National Natural Science Foundation of China (NSFC))	This work was conducted using grants from the National Natural Science Youth Foundation of China (NO. 81200519, Lin Tang). The funder was the main study designer and participated in preparation of the manuscript.	Alfie J, 2011, REV RECENT CLIN TRIA, V6, P134, DOI 10.2174/157488711795177912; Boini KM, 2010, J PHARMACOL EXP THER, V334, P839, DOI 10.1124/jpet.110.168815; Bosnyak S, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/192567; Chen Y, 2007, AM J PHYSIOL-RENAL, V293, pF680, DOI 10.1152/ajprenal.00209.2007; Coimbra TM, 2000, KIDNEY INT, V57, P167, DOI 10.1046/j.1523-1755.2000.00836.x; da Silveira KD, 2010, J IMMUNOL, V185, P5569, DOI 10.4049/jimmunol.1000314; Decleves AE, 2011, J AM SOC NEPHROL, V22, P1846, DOI 10.1681/ASN.2011010026; Esteban V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005406; Felizardo Raphael Jose Ferreira, 2014, World J Nephrol, V3, P50, DOI 10.5527/wjn.v3.i3.50; Feltenberger JD, 2013, HYPERTENSION, V62, P324, DOI 10.1161/HYPERTENSIONAHA.111.00919; Fraga-Silva RA, 2011, CLINICS, V66, P837, DOI 10.1590/S1807-59322011000500021; FUJIOKA S, 1987, METABOLISM, V36, P54, DOI 10.1016/0026-0495(87)90063-1; Furuhashi M, 2004, J HYPERTENS, V22, P1977, DOI 10.1097/00004872-200410000-00021; Gariballa S, 2014, NUTRIENTS, V6, P4872, DOI 10.3390/nu6114872; Giani JF, 2012, AM J PHYSIOL-RENAL, V302, pF1606, DOI 10.1152/ajprenal.00063.2012; Giani JF, 2011, AM J PHYSIOL-RENAL, V300, pF272, DOI 10.1152/ajprenal.00278.2010; Grobe JL, 2006, AM J PHYSIOL-HEART C, V290, pH2417, DOI 10.1152/ajpheart.01170.2005; Grobe N, 2012, AM J PHYSIOL-ENDOC M, V302, pE1016, DOI 10.1152/ajpendo.00515.2011; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Harcourt BE, 2012, NEPHROLOGY, V17, P257, DOI 10.1111/j.1440-1797.2011.01547.x; Santos SHS, 2008, DIABETES, V57, P340, DOI 10.2337/db07-0953; Huang WH, 2014, BIOCHEM BIOPH RES CO, V450, P1051, DOI 10.1016/j.bbrc.2014.06.107; Joyner J, 2007, AM J PHYSIOL-REG I, V293, pR169, DOI 10.1152/ajpregu.00387.2006; KASISKE BL, 1990, KIDNEY INT, V37, P880, DOI 10.1038/ki.1990.62; Lai YH, 2013, HORM METAB RES, V45, P38, DOI 10.1055/s-0032-1321871; Lee HS, 1997, KIDNEY INT, V51, P1151, DOI 10.1038/ki.1997.158; Lee W, 2012, AM J CHINESE MED, V40, P1217, DOI 10.1142/S0192415X12500905; Mangge H, 2014, WORLD J CARDIOL, V6, P462, DOI 10.4330/wjc.v6.i6.462; Mercadel L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099781; Meune C, 2011, J CARDIOVASC PHARM T, V16, P368, DOI 10.1177/1074248410391667; Mori J, 2014, CIRC-HEART FAIL, V7, P327, DOI 10.1161/CIRCHEARTFAILURE.113.000672; Regenhardt RW, 2013, NEUROPHARMACOLOGY, V71, P154, DOI 10.1016/j.neuropharm.2013.03.025; Ruan XZ, 2001, KIDNEY INT, V60, P1716, DOI 10.1046/j.1523-1755.2001.00025.x; Santos EL, 2009, BIOCHEM PHARMACOL, V78, P951, DOI 10.1016/j.bcp.2009.06.018; Santos RAS, 2007, CURR OPIN NEPHROL HY, V16, P122, DOI 10.1097/MNH.0b013e328031f362; Santos RAS, 2013, J ENDOCRINOL, V216, pR1, DOI 10.1530/JOE-12-0341; Santos SHS, 2010, ARTERIOSCL THROM VAS, V30, P953, DOI 10.1161/ATVBAHA.109.200493; Santos SHS, 2014, PEPTIDES, V59, P34, DOI 10.1016/j.peptides.2014.07.002; Santos SHS, 2013, PEPTIDES, V46, P47, DOI 10.1016/j.peptides.2013.05.010; Stemmer K, 2012, DIS MODEL MECH, V5, P627, DOI 10.1242/dmm.009407; Sun H, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/592576; Tomiyama-Hanayama M, 2009, AM J PHYSIOL-RENAL, V297, pF679, DOI 10.1152/ajprenal.90680.2008; van Vark LC, 2012, EUR HEART J, V33, P2088, DOI 10.1093/eurheartj/ehs075; Wang XQ, 2014, CHINESE MED J-PEKING, V127, P2953, DOI 10.3760/cma.j.issn.0366-6999.20133011; Xu ZE, 2011, AM J PHYSIOL-RENAL, V301, pF713, DOI 10.1152/ajprenal.00341.2010; Zhang HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032746; Zhang JD, 2010, AM J PHYSIOL-RENAL, V298, pF579, DOI 10.1152/ajprenal.00548.2009; Zhang Kun, 2014, P 14THWORKSHOP DOMAI, P1, DOI DOI 10.1038/KI.2014.274	48	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136187	10.1371/journal.pone.0136187	http://dx.doi.org/10.1371/journal.pone.0136187			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291618	gold, Green Published, Green Submitted			2022-12-26	WOS:000359919900062
J	De Blasio, MJ; Boije, M; Vaughan, OR; Bernstein, BS; Davies, KL; Plein, A; Kempster, SL; Smith, GCS; Charnock-Jones, DS; Blache, D; Wooding, FBP; Giussani, DA; Fowden, AL; Forhead, AJ				De Blasio, Miles J.; Boije, Maria; Vaughan, Owen R.; Bernstein, Brett S.; Davies, Katie L.; Plein, Alice; Kempster, Sarah L.; Smith, Gordon C. S.; Charnock-Jones, D. Stephen; Blache, Dominique; Wooding, F. B. Peter; Giussani, Dino A.; Fowden, Abigail L.; Forhead, Alison J.			Developmental Expression and Glucocorticoid Control of the Leptin Receptor in Fetal Ovine Lung	PLOS ONE			English	Article							LATE-GESTATION; PROTEIN EXPRESSION; PLASMA LEPTIN; FETUS; DEXAMETHASONE; SHEEP; LONG; GENE; IDENTIFICATION; METABOLISM	The effects of endogenous and synthetic glucocorticoids on fetal lung maturation are well-established, although the role of leptin in lung development before birth is unclear. This study examined mRNA and protein levels of the signalling long-form leptin receptor (Ob-Rb) in fetal ovine lungs towards term, and after experimental manipulation of glucocorticoid levels in utero by fetal cortisol infusion or maternal dexamethasone treatment. In fetal ovine lungs, Ob-Rb protein was localised to bronchiolar epithelium, bronchial cartilage, vascular endothelium, alveolar macrophages and type II pneumocytes. Pulmonary Ob-Rb mRNA abundance increased between 100 (0.69 fractional gestational age) and 144 days (0.99) of gestation, and by 2-4-fold in response to fetal cortisol infusion and maternal dexamethasone treatment. In contrast, pulmonary Ob-Rb protein levels decreased near term and were halved by glucocorticoid treatment, without any significant change in phosphorylated signal transducer and activator of transcription-3 (pSTAT3) at Ser727, total STAT3 or the pulmonary pSTAT3: STAT3 ratio. Leptin mRNA was undetectable in fetal ovine lungs at the gestational ages studied. These findings demonstrate differential control of pulmonary Ob-Rb transcript abundance and protein translation, and/or post-translational processing, by glucocorticoids in utero. Localisation of Ob-Rb in the fetal ovine lungs, including alveolar type II pneumocytes, suggests a role for leptin signalling in the control of lung growth and maturation before birth.	[De Blasio, Miles J.; Boije, Maria; Vaughan, Owen R.; Bernstein, Brett S.; Davies, Katie L.; Plein, Alice; Wooding, F. B. Peter; Giussani, Dino A.; Fowden, Abigail L.; Forhead, Alison J.] Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge, England; [Kempster, Sarah L.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England; [Kempster, Sarah L.; Smith, Gordon C. S.; Charnock-Jones, D. Stephen] Univ Cambridge, Dept Obstet & Gynaecol, Rosie Hosp, Cambridge, England; [Blache, Dominique] Univ Western Australia, Sch Anim Biol, Perth, WA 6009, Australia; [Forhead, Alison J.] Oxford Brookes Univ, Dept Biol & Med Sci, Oxford OX3 0BP, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of Western Australia; Oxford Brookes University	Forhead, AJ (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge, England.	ajf1005@cam.ac.uk	Bernstein, Brett Sydney/AAW-5807-2020; Blache, Dominique/H-4991-2014; De Blasio, Miles/AAB-7234-2019; Charnock-Jones, D. Stephen/B-3743-2009; Charnock-Jones, D. Stephen/AAE-3391-2020; Smith, Gordon/A-8070-2008; De Blasio, Miles J/GQB-1536-2022	Bernstein, Brett Sydney/0000-0001-7225-3793; Blache, Dominique/0000-0003-3476-3068; De Blasio, Miles/0000-0002-4797-5193; Charnock-Jones, D. Stephen/0000-0002-2936-4890; Charnock-Jones, D. Stephen/0000-0002-2936-4890; Smith, Gordon/0000-0003-2124-0997; De Blasio, Miles J/0000-0002-4797-5193; kempster, sarah/0000-0002-4309-1489; Giussani, Dino/0000-0002-1308-1204; Forhead, Alison/0000-0003-2125-4811	Biotechnology and Biological Sciences Research Council [S18103, BB/H01697X/1]; BBSRC [BB/H01697X/1, BB/E002668/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E002668/1] Funding Source: researchfish; British Heart Foundation [RG/06/006/22028, RG/11/16/29260] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation)	This work was supported by the Biotechnology and Biological Sciences Research Council (grant numbers S18103 and BB/H01697X/1).	Bergen HT, 2002, AM J RESP CELL MOL, V27, P71, DOI 10.1165/ajrcmb.27.1.4540; Blache D, 2000, J ENDOCRINOL, V165, P625, DOI 10.1677/joe.0.1650625; Bolt RJ, 2001, PEDIATR PULM, V32, P76, DOI 10.1002/ppul.1092; Byerly MS, 2009, AM J PHYSIOL-REG I, V296, pR1180, DOI 10.1152/ajpregu.90813.2008; Caperna TJ, 2005, DOMEST ANIM ENDOCRIN, V29, P582, DOI 10.1016/j.domaniend.2005.03.005; Chen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069297; COMLINE RS, 1972, J PHYSIOL-LONDON, V222, P233, DOI 10.1113/jphysiol.1972.sp009795; Dardeno TA, 2010, FRONT NEUROENDOCRIN, V31, P377, DOI 10.1016/j.yfrne.2010.06.002; De Blasio MJ, 2013, J DEV ORIG HLTH DIS, V4, pS51; Figenschau Y, 2001, BIOCHEM BIOPH RES CO, V287, P190, DOI 10.1006/bbrc.2001.5543; Forhead AJ, 2002, ENDOCRINOLOGY, V143, P1166, DOI 10.1210/en.143.4.1166; Forhead AJ, 2007, ENDOCRINOLOGY, V148, P800, DOI 10.1210/en.2006-1194; Forhead AJ, 2006, ENDOCRINOLOGY, V147, P5988, DOI 10.1210/en.2006-0712; Forhead AJ, 2009, J PHYSIOL-LONDON, V587, P1145, DOI 10.1113/jphysiol.2008.167072; FOWDEN AL, 1995, J PHYSIOL-LONDON, V482, P203, DOI 10.1113/jphysiol.1995.sp020510; Fowden AL, 1998, P NUTR SOC, V57, P113, DOI 10.1079/PNS19980017; Franko KL, 2007, J ENDOCRINOL, V192, P67, DOI 10.1677/joe.1.07063; Fruhbeck G, 2006, BIOCHEM J, V393, P7, DOI 10.1042/BJ20051578; Garcia-Crespo David, 2005, BMC Vet Res, V1, P3, DOI 10.1186/1746-6148-1-3; Henson MC, 2004, REPRODUCTION, V127, P87, DOI 10.1530/rep.1.00037; Hikita M, 2000, BIOCHEM BIOPH RES CO, V271, P703, DOI 10.1006/bbrc.2000.2692; Hoggard N, 1997, P NATL ACAD SCI USA, V94, P11073, DOI 10.1073/pnas.94.20.11073; Hooper SB, 2001, FETAL GROWTH AND DEVELOPMENT, P114; Huang K, 2008, J APPL PHYSIOL, V105, P249, DOI 10.1152/japplphysiol.00052.2007; Kirwin SM, 2006, PEDIATR RES, V60, P200, DOI 10.1203/01.pdr.0000227478.29271.52; Ladenburger A, 2010, AM J PHYSIOL-LUNG C, V299, pL578, DOI 10.1152/ajplung.00055.2010; Liu YS, 2012, TOXICOL APPL PHARM, V262, P205, DOI 10.1016/j.taap.2012.05.002; Liu ZJ, 2004, PEDIATR INT, V46, P561, DOI 10.1111/j.1442-200x.2004.01945.x; Lollmann B, 1997, BIOCHEM BIOPH RES CO, V238, P648, DOI 10.1006/bbrc.1997.7205; Mancuso P, 2004, AM J PHYSIOL-LUNG C, V287, pL497, DOI 10.1152/ajplung.00010.2004; Mancuso P, 2002, J IMMUNOL, V168, P4018, DOI 10.4049/jimmunol.168.8.4018; Margetic S, 2002, INT J OBESITY, V26, P1407, DOI 10.1038/sj.ijo.0802142; O'Connor DM, 2007, ENDOCRINOLOGY, V148, P3750, DOI 10.1210/en.2007-0310; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; ROBINSON PM, 1983, Q J EXP PHYSIOL CMS, V68, P15, DOI 10.1113/expphysiol.1983.sp002697; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Royal College of Obstetricians and Gynaecologists, 2010, GREEN TOP GUIDELINE; Sato A, 2011, AM J PHYSIOL-LUNG C, V300, pL498, DOI 10.1152/ajplung.00418.2010; Shekhawat PS, 1998, PEDIATR RES, V43, P338, DOI 10.1203/00006450-199803000-00005; Smolinska N, 2009, ANIM REPROD SCI, V113, P125, DOI 10.1016/j.anireprosci.2008.06.001; Su YX, 2013, AM J PHYSIOL-ENDOC M, V304, pE1404, DOI 10.1152/ajpendo.00013.2013; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Torday JS, 2002, AM J PHYSIOL-LUNG C, V282, pL405, DOI 10.1152/ajplung.2002.282.3.L405; Tsuchiya T, 1999, EUR J PHARMACOL, V365, P273, DOI 10.1016/S0014-2999(98)00884-X; Uotani S, 1999, DIABETES, V48, P279, DOI 10.2337/diabetes.48.2.279; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wyrwoll CS, 2005, MOL CELL ENDOCRINOL, V241, P73, DOI 10.1016/j.mce.2005.05.003; Xu D, 2012, TOXICOL LETT, V209, P282, DOI 10.1016/j.toxlet.2012.01.006; Yuen BSJ, 1999, J ENDOCRINOL, V163, pR11, DOI 10.1677/joe.0.163R011; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	50	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136115	10.1371/journal.pone.0136115	http://dx.doi.org/10.1371/journal.pone.0136115			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287800	gold, Green Published, Green Submitted			2022-12-26	WOS:000360018600111
J	Gomez, DL; O'Driscoll, M; Sheets, TP; Hruban, RH; Oberholzer, J; McGarrigle, JJ; Shamblott, MJ				Gomez, Danielle L.; O'Driscoll, Marci; Sheets, Timothy P.; Hruban, Ralph H.; Oberholzer, Jose; McGarrigle, James J.; Shamblott, Michael J.			Neurogenin 3 Expressing Cells in the Human Exocrine Pancreas Have the Capacity for Endocrine Cell Fate	PLOS ONE			English	Article							ADULT-MOUSE PANCREAS; BETA-CELLS; IN-VITRO; PROGENITOR CELLS; ACINAR-CELL; DUCTAL CELLS; TRANSCRIPTION FACTOR; HEMATOPOIETIC STEM; EPITHELIAL-CELLS; DIFFERENTIATION	Neurogenin 3 (NGN3) is necessary and sufficient for endocrine differentiation during pancreatic development and is expressed by a population of progenitor cells that give rise exclusively to hormone-secreting cells within islets. NGN3 protein can be detected in the adult rodent pancreas only following certain types of injury, when it is transiently expressed by exocrine cells undergoing reprogramming to an endocrine cell fate. Here, NGN3 protein can be detected in 2% of acinar and duct cells in living biopsies of histologically normal adult human pancreata and 10% in cadaveric biopsies of organ donor pancreata. The percentage and total number of NGN3+ cells increase during culture without evidence of proliferation or selective cell death. Isolation of highly purified and viable NGN3+ cell populations can be achieved based on coexpression of the cell surface glycoprotein CD133. Transcriptome and targeted expression analyses of isolated CD133+/NGN3+ cells indicate that they are distinct from surrounding exocrine tissue with respect to expression phenotype and Notch signaling activity, but retain high level mRNA expression of genes indicative of acinar and duct cell function. NGN3+ cells have an mRNA expression profile that resembles that of mouse early endocrine progenitor cells. During in vitro differentiation, NGN3+ cells express genes in a pattern characteristic of endocrine development and result in cells that resemble beta cells on the basis of coexpression of insulin C-peptide, chromogranin A and pancreatic and duodenal homeobox 1. NGN3 expression in the adult human exocrine pancreas marks a dedifferentiating cell population with the capacity to take on an endocrine cell fate. These cells represent a potential source for the treatment of diabetes either through ex vivo manipulation, or in vivo by targeting mechanisms controlling their population size and endocrine cell fate commitment.	[Gomez, Danielle L.; O'Driscoll, Marci; Shamblott, Michael J.] Univ S Florida, Dept Pediat, Childrens Res Inst, Morsani Coll Med, St Petersburg, FL 33701 USA; [Sheets, Timothy P.; Shamblott, Michael J.] Johns Hopkins Univ, Dept Gynecol & Obstet, Baltimore, MD USA; [Hruban, Ralph H.] Johns Hopkins Univ, Sch Med, Dept Pathol & Oncol, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD USA; [Oberholzer, Jose; McGarrigle, James J.] Univ Illinois, Dept Surg, Chicago, IL 60680 USA; [Oberholzer, Jose] Univ Illinois, Dept Bioengn, Chicago, IL USA	State University System of Florida; University of South Florida; Johns Hopkins University; Johns Hopkins University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Shamblott, MJ (corresponding author), Univ S Florida, Dept Pediat, Childrens Res Inst, Morsani Coll Med, St Petersburg, FL 33701 USA.	mshamblo@health.usf.edu			University of South Florida/All Children's Foundation Sam's Club/Walmart Chair of Pediatrics; Juvenile Diabetes Research Foundation [2-2008-65]	University of South Florida/All Children's Foundation Sam's Club/Walmart Chair of Pediatrics; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation)	The main source of funding for this work came from The University of South Florida/All Children's Foundation Sam's Club/Walmart Chair of Pediatrics (MJS). These funds were given as a gift by associate and customers of Sam's Club and Walmart. It did not involve any additional employment, consultancy, intellectual property licensing, product development or marketing. Additional funding was from the Juvenile Diabetes Research Foundation www.jdrf.org grant number 2-2008-65 (M.J.S.) and gifts from the Mayhew Family (M.J.S), Chicago Diabetes Project (M.J.S) and John Horst (M.J.S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afelik S, 2012, DEVELOPMENT, V139, P1744, DOI 10.1242/dev.075804; Anderson KR, 2009, J BIOL CHEM, V284, P31236, DOI 10.1074/jbc.M109.048694; Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Arda HE, 2013, DEV CELL, V25, P5, DOI 10.1016/j.devcel.2013.03.016; Artner I, 2010, DIABETES, V59, P2530, DOI 10.2337/db10-0190; Baeyens L, 2006, CELL DEATH DIFFER, V13, P1892, DOI 10.1038/sj.cdd.4401883; Baeyens L, 2005, DIABETOLOGIA, V48, P49, DOI 10.1007/s00125-004-1606-1; Baeyens L, 2014, NAT BIOTECHNOL, V32, P76, DOI 10.1038/nbt.2747; Bai G, 2007, DEV CELL, V13, P283, DOI 10.1016/j.devcel.2007.05.014; Bauman M, 2008, HUMAN EMBRYONI UNPUB; Bhanot UK, 2009, LAB INVEST, V89, P489, DOI 10.1038/labinvest.2009.19; Bonner-Weir S, 2000, P NATL ACAD SCI USA, V97, P7999, DOI 10.1073/pnas.97.14.7999; BONNERWEIR S, 1993, DIABETES, V42, P1715, DOI 10.2337/diabetes.42.12.1715; Brennand K, 2007, PLOS BIOL, V5, P1520, DOI 10.1371/journal.pbio.0050163; Clark GO, 2007, BIOCHEM BIOPH RES CO, V356, P587, DOI 10.1016/j.bbrc.2007.03.017; Cnop M, 2010, DIABETOLOGIA, V53, P321, DOI 10.1007/s00125-009-1562-x; Corbeil D, 1998, BLOOD, V91, P2625, DOI 10.1182/blood.V91.7.2625.2625_2625_2626; Corbeil D, 2014, P NATL ACAD SCI USA, V111, pE1451, DOI 10.1073/pnas.1400195111; Desai BM, 2007, J CLIN INVEST, V117, P971, DOI 10.1172/JCI29988; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Esni F, 2004, DEVELOPMENT, V131, P4213, DOI 10.1242/dev.01280; Figeac F, 2012, MOL THER, V20, P1944, DOI 10.1038/mt.2012.112; Fukuda A, 2006, J CLIN INVEST, V116, P1484, DOI 10.1172/JCI27704; Gao R, 2003, DIABETES, V52, P2007, DOI 10.2337/diabetes.52.8.2007; Gasa R, 2004, P NATL ACAD SCI USA, V101, P13245, DOI 10.1073/pnas.0405301101; Gershengorn MC, 2004, SCIENCE, V306, P2261, DOI 10.1126/science.1101968; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Hald J, 2003, DEV BIOL, V260, P426, DOI 10.1016/S0012-1606(03)00326-9; Heremans Y, 2002, J CELL BIOL, V159, P303, DOI 10.1083/jcb.200203074; Houbracken I, 2011, GASTROENTEROLOGY, V141, P731, DOI 10.1053/j.gastro.2011.04.050; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang HP, 2000, MOL CELL BIOL, V20, P3292, DOI 10.1128/MCB.20.9.3292-3307.2000; Jennings RE, 2013, DIABETES, V62, P3514, DOI 10.2337/db12-1479; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Jensen J, 2000, DIABETES, V49, P163, DOI 10.2337/diabetes.49.2.163; Jogi A, 2002, J BIOL CHEM, V277, P9118, DOI 10.1074/jbc.M107713200; Jorgensen MC, 2007, ENDOCR REV, V28, P685, DOI 10.1210/er.2007-0016; KerrConte J, 1996, DIABETES, V45, P1108, DOI 10.2337/diabetes.45.8.1108; Kim HS, 2013, J ENDOCRINOL, V217, P241, DOI 10.1530/JOE-12-0474; Koblas T, 2008, TRANSPL P, V40, P415, DOI 10.1016/j.transproceed.2008.02.017; Landsman L, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001143; Lee JC, 2001, DIABETES, V50, P928, DOI 10.2337/diabetes.50.5.928; Lemper M, 2015, CELL DEATH DIFFER, V22, P1117, DOI 10.1038/cdd.2014.193; Li WC, J CELL SCI 16, V123, P2792; Lipsett M, 2002, DIABETES, V51, P1834, DOI 10.2337/diabetes.51.6.1834; Lyttle BM, 2008, DIABETOLOGIA, V51, P1169, DOI 10.1007/s00125-008-1006-z; Mak AB, 2011, J BIOL CHEM, V286, P41046, DOI 10.1074/jbc.M111.261545; Minami K, 2005, P NATL ACAD SCI USA, V102, P15116, DOI 10.1073/pnas.0507567102; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; NAYA FJ, 1995, GENE DEV, V9, P1009, DOI 10.1101/gad.9.8.1009; Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323; Negi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030415; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; Nishimura W, 2006, DEV BIOL, V293, P526, DOI 10.1016/j.ydbio.2006.02.028; PARSA I, 1985, CANCER RES, V45, P1285; Perl S, 2010, J CLIN ENDOCR METAB, V95, pE234, DOI 10.1210/jc.2010-0932; Qu XL, 2013, DEV BIOL, V376, P1, DOI 10.1016/j.ydbio.2013.01.021; Reichert M, 2011, J CLIN INVEST, V121, P4572, DOI 10.1172/JCI57131; RICORDI C, 1989, DIABETES, V38, P140, DOI 10.2337/diab.38.1.S140; RICORDI C, 1988, DIABETES, V37, P413, DOI 10.2337/diabetes.37.4.413; Rovira M, 2011, P NATL ACAD SCI USA, V108, P19264, DOI 10.1073/pnas.1113081108; Rovira M, 2010, P NATL ACAD SCI USA, V107, P75, DOI 10.1073/pnas.0912589107; Sancho R, 2014, CELL STEM CELL, V15, P139, DOI 10.1016/j.stem.2014.06.019; Sarkar SA, 2008, DIABETOLOGIA, V51, P285, DOI 10.1007/s00125-007-0880-0; Sawey ET, 2007, P NATL ACAD SCI USA, V104, P19327, DOI 10.1073/pnas.0705953104; Schaffer AE, 2010, DEV CELL, V18, P1022, DOI 10.1016/j.devcel.2010.05.015; Schwitzgebel VM, 2000, DEVELOPMENT, V127, P3533; Shamblott MJ, 2001, P NATL ACAD SCI USA, V98, P113, DOI 10.1073/pnas.021537998; Shmelkov SV, 2004, BLOOD, V103, P2055, DOI 10.1182/blood-2003-06-1881; Street CN, 2004, DIABETES, V53, P3107, DOI 10.2337/diabetes.53.12.3107; Sugiyama T, 2007, P NATL ACAD SCI USA, V104, P175, DOI 10.1073/pnas.0609490104; Swales N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037055; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; TERAZONO K, 1988, J BIOL CHEM, V263, P2111; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Van de Casteele M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.52; Wang S, 2009, P NATL ACAD SCI USA, V106, P9715, DOI 10.1073/pnas.0904247106; Wang ZY, 2014, CELL METAB, V19, P872, DOI 10.1016/j.cmet.2014.03.010; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Xiao XW, 2013, J BIOL CHEM, V288, P25297, DOI 10.1074/jbc.M113.484022; Xiao XW, 2013, J CLIN INVEST, V123, P2207, DOI 10.1172/JCI66323; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Yatoh S, 2007, DIABETES, V56, P1802, DOI 10.2337/db06-1670; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; Zhou Q, 2007, DEV CELL, V13, P103, DOI 10.1016/j.devcel.2007.06.001; Zulewski H, 2001, DIABETES, V50, P521, DOI 10.2337/diabetes.50.3.521	94	36	39	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0133862	10.1371/journal.pone.0133862	http://dx.doi.org/10.1371/journal.pone.0133862			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288179	gold, Green Published, Green Submitted			2022-12-26	WOS:000360018600011
J	Kaneko, F; Blanchard, C; Lebar, N; Nazarian, B; Kavounoudias, A; Romaiguere, P				Kaneko, Fuminari; Blanchard, Caroline; Lebar, Nicolas; Nazarian, Bruno; Kavounoudias, Anne; Romaiguere, Patricia			Brain Regions Associated to a Kinesthetic Illusion Evoked by Watching a Video of One's Own Moving Hand	PLOS ONE			English	Article							PRIMARY MOTOR CORTEX; RUBBER HAND; SELF-MOTION; TENDON VIBRATION; MUSCLE VIBRATION; BODY OWNERSHIP; VISUAL-MOTION; AREAS; PERCEPTION; MOVEMENT	It is well known that kinesthetic illusions can be induced by stimulation of several sensory systems (proprioception, touch, vision...). In this study we investigated the cerebral network underlying a kinesthetic illusion induced by visual stimulation by using functionalmagnetic resonance imaging (fMRI) in humans. Participants were instructed to keep their hand still while watching the video of their own moving hand (Self Hand) or that of someone else's moving hand (Other Hand). In the Self Hand condition they experienced an illusory sensation that their hand was moving whereas the Other Hand condition did not induce any kinesthetic illusion. The contrast between the Self Hand and Other Hand conditions showed significant activation in the left dorsal and ventral premotor cortices, in the left Superior and Inferior Parietal lobules, at the right Occipito-Temporal junction as well as in bilateral Insula and Putamen. Most strikingly, there was no activation in the primary motor and somatosensory cortices, whilst previous studies have reported significant activation in these regions for vibrationinduced kinesthetic illusions. To our knowledge, this is the first study that indicates that humans can experience kinesthetic perception without activation in the primarymotor and somatosensory areas. We conclude that under some conditions watching a video of one's ownmoving hand could lead to activation of a network that is usually involved in processing copies of efference, thus leading to the illusory perception that the real hand is indeed moving.	[Kaneko, Fuminari; Blanchard, Caroline; Lebar, Nicolas; Kavounoudias, Anne; Romaiguere, Patricia] Aix Marseille Univ, CNRS, Lab Neurosci Integrat & Adaptat, NIA UMR 7260,FR3C FR3512, Marseille, France; [Nazarian, Bruno] Aix Marseille Univ, CNRS, Inst Neurosci Timone, INT UMR 7289,IRMf Ctr, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Romaiguere, P (corresponding author), Aix Marseille Univ, CNRS, Lab Neurosci Integrat & Adaptat, NIA UMR 7260,FR3C FR3512, Marseille, France.	Patricia.Romaiguere@univ-amu.fr	BLANCHARD, Caroline/N-6392-2014	BLANCHARD, Caroline/0000-0002-3055-1511; Kaneko, Fuminari/0000-0001-7125-0689	Japan Society for the Promotion of Science (JSPS Excellent Young Researcher Overseas Visit Program); JSPS KAKENHI [23300202]	Japan Society for the Promotion of Science (JSPS Excellent Young Researcher Overseas Visit Program); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	FK was supported by the Japan Society for the Promotion of Science (JSPS Excellent Young Researcher Overseas Visit Program) and JSPS KAKENHI (Grant-in-Aid for Scientific Research (B) 23300202).	Aoyama T, 2012, NEUROSCI LETT, V514, P106, DOI 10.1016/j.neulet.2012.02.069; Beer J, 2002, EXP BRAIN RES, V143, P78, DOI 10.1007/s00221-001-0947-y; Blanchard C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062475; BONNET M, 1973, ELECTROEN CLIN NEURO, V34, P810; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; BRANDT T, 1972, PFLUG ARCH EUR J PHY, pR98; Brett M., 2002, 8 INT C FUNCT MAPP H; Brozzoli C, 2012, J NEUROSCI, V32, P14573, DOI 10.1523/JNEUROSCI.2660-12.2012; BURKE D, 1976, J PHYSIOL-LONDON, V261, P673, DOI 10.1113/jphysiol.1976.sp011580; Caetano G, 2007, P NATL ACAD SCI USA, V104, P9058, DOI 10.1073/pnas.0702453104; Casini L, 2006, BRAIN RES, V1121, P200, DOI 10.1016/j.brainres.2006.08.124; Christensen MS, 2007, NAT NEUROSCI, V10, P417, DOI 10.1038/nn1873; Cochin S, 1998, ELECTROEN CLIN NEURO, V107, P287, DOI 10.1016/S0013-4694(98)00071-6; Collins DF, 1996, J PHYSIOL-LONDON, V496, P857, DOI 10.1113/jphysiol.1996.sp021733; Confalonieri L., 2012, ISRN NEUROL, V2012, DOI DOI 10.5402/2012/613595; Costantini M, 2007, CONSCIOUS COGN, V16, P229, DOI 10.1016/j.concog.2007.01.001; Desmurget M, 2009, SCIENCE, V324, P811, DOI 10.1126/science.1169896; Deutschlander A, 2004, HUM BRAIN MAPP, V21, P143, DOI 10.1002/hbm.10155; Dohle C, 2009, NEUROREHAB NEURAL RE, V23, P209, DOI 10.1177/1545968308324786; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Duclos C, 2007, NEUROIMAGE, V34, P774, DOI 10.1016/j.neuroimage.2006.06.050; Dummer T, 2009, PERCEPTION, V38, P271, DOI 10.1068/p5921; Dushanova J, 2010, EUR J NEUROSCI, V31, P386, DOI 10.1111/j.1460-9568.2009.07067.x; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; Eickhoff SB, 2006, NEUROIMAGE, V32, P570, DOI 10.1016/j.neuroimage.2006.04.204; EKLUND G, 1972, J NEUROL NEUROSUR PS, V35, P606, DOI 10.1136/jnnp.35.5.606; Ferri S, 2013, NEUROIMAGE, V66, P412, DOI 10.1016/j.neuroimage.2012.10.060; Gao Q, 2011, NEUROIMAGE, V54, P1280, DOI 10.1016/j.neuroimage.2010.08.071; Gerardin E, 2000, CEREB CORTEX, V10, P1093, DOI 10.1093/cercor/10.11.1093; GILHODES JC, 1986, EXP BRAIN RES, V61, P395; Goble DJ, 2011, J NEUROSCI, V31, P16344, DOI 10.1523/JNEUROSCI.4159-11.2011; GOODWIN GM, 1972, SCIENCE, V175, P1382, DOI 10.1126/science.175.4028.1382; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; Graziano MSA, 2000, EXP BRAIN RES, V135, P259, DOI 10.1007/s002210000518; Guerraz M, 2012, NEUROSCIENCE, V223, P258, DOI 10.1016/j.neuroscience.2012.07.059; Guillot A, 2008, NEUROIMAGE, V41, P1471, DOI 10.1016/j.neuroimage.2008.03.042; Haans A, 2008, BODY IMAGE, V5, P389, DOI 10.1016/j.bodyim.2008.04.003; Hanakawa T, 2003, J NEUROPHYSIOL, V89, P989, DOI 10.1152/jn.00132.2002; Hanakawa T, 2008, CEREB CORTEX, V18, P2775, DOI 10.1093/cercor/bhn036; Hari R, 1998, P NATL ACAD SCI USA, V95, P15061, DOI 10.1073/pnas.95.25.15061; Hetu S, 2013, NEUROSCI BIOBEHAV R, V37, P930, DOI 10.1016/j.neubiorev.2013.03.017; Indovina I, 2013, NEUROIMAGE, V71, P114, DOI 10.1016/j.neuroimage.2013.01.005; Kalckert A, 2014, CONSCIOUS COGN, V30, P118, DOI 10.1016/j.concog.2014.08.022; Kalckert A, 2014, CONSCIOUS COGN, V26, P117, DOI 10.1016/j.concog.2014.02.003; Kalckert A, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00040; Kammers MPM, 2009, NEUROPSYCHOLOGIA, V47, P204, DOI 10.1016/j.neuropsychologia.2008.07.028; Kaneko F, 2007, NEUROSCIENCE, V149, P976, DOI 10.1016/j.neuroscience.2007.07.028; Karnath HO, 2010, BRAIN STRUCT FUNCT, V214, P411, DOI 10.1007/s00429-010-0250-4; Kasess CH, 2008, NEUROIMAGE, V40, P828, DOI 10.1016/j.neuroimage.2007.11.040; Kavounoudias A, 2008, NEUROPSYCHOLOGIA, V46, P567, DOI 10.1016/j.neuropsychologia.2007.10.002; Kleinschmidt A, 2002, NEUROIMAGE, V16, P873, DOI 10.1006/nimg.2002.1181; Kovacs G, 2008, CEREB CORTEX, V18, P1779, DOI 10.1093/cercor/bhm203; Lappe M, 1999, TRENDS COGN SCI, V3, P329, DOI 10.1016/S1364-6613(99)01364-9; Longo MR, 2009, PERCEPTION, V38, P69, DOI 10.1068/p6045; Metral M, 2014, NEUROPSYCHOLOGIA, V52, P11, DOI 10.1016/j.neuropsychologia.2013.10.027; Moseley GL, 2011, CURR BIOL, V21, pR583, DOI 10.1016/j.cub.2011.06.031; Myers A, 2008, NEUROIMAGE, V42, P1669, DOI 10.1016/j.neuroimage.2008.05.045; Naito E, 1999, J NEUROSCI, V19, P6134, DOI 10.1523/JNEUROSCI.19-14-06134.1999; Naito E, 2005, J NEUROPHYSIOL, V93, P1020, DOI 10.1152/jn.00637.2004; Naito E, 2007, EUR J NEUROSCI, V25, P3476, DOI 10.1111/j.1460-9568.2007.05587.x; Nishitani N, 2000, P NATL ACAD SCI USA, V97, P913, DOI 10.1073/pnas.97.2.913; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Palmisano S, 1998, PERCEPTION, V27, P1067, DOI 10.1068/p271067; Petkova VI, 2011, CURR BIOL, V21, P1118, DOI 10.1016/j.cub.2011.05.022; Radovanovic S, 2002, EXP BRAIN RES, V143, P276, DOI 10.1007/s00221-001-0994-4; Ramachandran VS, 2009, BRAIN, V132, P1693, DOI 10.1093/brain/awp135; Raos V, 2004, NEUROIMAGE, V23, P193, DOI 10.1016/j.neuroimage.2004.04.024; Raos V, 2007, J NEUROSCI, V27, P12675, DOI 10.1523/JNEUROSCI.2988-07.2007; ROLL JP, 1982, EXP BRAIN RES, V47, P177; ROLL JP, 1989, EXP BRAIN RES, V76, P213; Romaiguere P, 2005, NEUROREPORT, V16, P693, DOI 10.1097/00001756-200505120-00008; Romaiguere P, 2003, COGNITIVE BRAIN RES, V16, P74, DOI 10.1016/S0926-6410(02)00221-5; Rothgangel AS, 2011, INT J REHABIL RES, V34, P1, DOI 10.1097/MRR.0b013e3283441e98; Smith AT, 2008, J VISION, V8, DOI 10.1167/8.10.1; Solodkin A, 2004, CEREB CORTEX, V14, P1246, DOI 10.1093/cercor/bhh086; Tsakiris M, 2005, COGN NEUROPSYCHOL, V22, P387, DOI 10.1080/02643290442000158; Tsakiris M, 2007, CEREB CORTEX, V17, P2235, DOI 10.1093/cercor/bhl131; Tsakiris M, 2006, CONSCIOUS COGN, V15, P423, DOI 10.1016/j.concog.2005.09.004; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P703, DOI 10.1016/j.neuropsychologia.2009.09.034; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vocks S, 2010, COGN AFFECT BEHAV NE, V10, P422, DOI 10.3758/CABN.10.3.422	83	39	39	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0131970	10.1371/journal.pone.0131970	http://dx.doi.org/10.1371/journal.pone.0131970			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287488	Green Published, gold, Green Submitted			2022-12-26	WOS:000360018600002
J	Katsumi, H; Sano, J; Nishikawa, M; Hanzawa, K; Sakane, T; Yamamoto, A				Katsumi, Hidemasa; Sano, Jun-ichi; Nishikawa, Makiya; Hanzawa, Keiko; Sakane, Toshiyasu; Yamamoto, Akira			Molecular Design of Bisphosphonate-Modified Proteins for Efficient Bone Targeting In Vivo	PLOS ONE			English	Article							NITROSATED SERUM-ALBUMIN; POLYETHYLENE-GLYCOL; DISPOSITION CHARACTERISTICS; PHARMACOKINETIC ANALYSIS; CHEMICAL-MODIFICATION; CHARGE-DENSITY; NITRIC-OXIDE; DELIVERY; METASTASIS; DRUG	To establish a rational molecular design for bisphosphonate (BP)-modified proteins for efficient bone targeting, a pharmacokinetic study was performed using a series of alendronate (ALN), a nitrogen-containing BP, modified proteins with various molecular weights and varying degrees of modification. Four proteins with different molecular weight-yeast glutathione reductase (GR; MW: 112,000 Da), bovine serum albumin (BSA; MW: 67,000 Da), recombinant human superoxide dismutase (SOD; MW: 32,000 Da), and chicken egg white lysozyme (LZM; MW: 14,000 Da)-were modified with ALN to obtain ALN-modified proteins. Pharmacokinetic analysis of the tissue distribution of the ALN-modified and unmodified proteins was performed after radiolabeling them with indium-111 (In-111) by using a bifunctional chelating agent. Calculation of tissue uptake clearances revealed that the bone uptake clearances of In-111-ALN-modified proteins were proportional to the degree of ALN modification. In-111-GR-ALN and BSA-ALN, the two high-molecular-weight proteins, efficiently accumulated in bones, regardless of the degree of ALN modification. Approximately 36 and 34% of the dose, respectively, was calculated to be delivered to the bones. In contrast, the maximum amounts taken up by bone were 18 and 13% of the dose for In-111-SOD-ALN(32) and LZM-ALN(9), respectively, because of their high renal clearance. In-111-SOD modified with both polyethylene glycol (PEG) and ALN (In-111-PEG-SOD-ALN) was efficiently delivered to the bone. Approximately 36% of the dose was estimated to be delivered to the bones. In an experimental bone metastasis mouse model, treatment with PEG-SOD-ALN significantly reduced the number of tumor cells in the bone of the mice. These results indicate that the combination of PEG and ALN modification is a promising approach for efficient bone targeting of proteins with a high total-body clearance.	[Katsumi, Hidemasa; Sano, Jun-ichi; Hanzawa, Keiko; Sakane, Toshiyasu; Yamamoto, Akira] Kyoto Pharmaceut Univ, Dept Biopharmaceut, Kyoto 607, Japan; [Nishikawa, Makiya] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut & Drug Metab, Kyoto, Japan	Kyoto Pharmaceutical University; Kyoto University	Katsumi, H (corresponding author), Kyoto Pharmaceut Univ, Dept Biopharmaceut, Kyoto 607, Japan.	hkatsumi@mb.kyoto-phu.ac.jp			Kyoto Pharmaceutical University Fund for the Promotion of Scientific Research; Kyoto Pharmaceutical University	Kyoto Pharmaceutical University Fund for the Promotion of Scientific Research; Kyoto Pharmaceutical University	This work was supported by the Kyoto Pharmaceutical University Fund for the Promotion of Scientific Research. HK recieved the funding from Kyoto Pharmaceutical University (internal to our organization). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUCHOWSKI A, 1977, J BIOL CHEM, V252, P3578; Ames B. N., 1966, METHOD ENZYMOL, P115, DOI DOI 10.1016/0076-6879(66)08014-5; Azim H, 2013, EXPERT REV ANTICANC, V13, P195, DOI [10.1586/era.12.177, 10.1586/ERA.12.177]; Doschak MR, 2009, MOL PHARMACEUT, V6, P634, DOI 10.1021/mp8002368; El-Mabhouh A, 2004, CANCER BIOTHER RADIO, V19, P627, DOI 10.1089/cbr.2004.19.627; FLEISCH H, 1987, CLIN ORTHOP RELAT R, P72; Futami J, 2001, BIOCHEMISTRY-US, V40, P7518, DOI 10.1021/bi010248g; GERLOWSKI LE, 1983, J PHARM SCI, V72, P1103, DOI 10.1002/jps.2600721003; Gittens SA, 2005, ADV DRUG DELIVER REV, V57, P1011, DOI 10.1016/j.addr.2004.12.015; HABEEB AFS, 1966, ANAL BIOCHEM, V14, P328, DOI 10.1016/0003-2697(66)90275-2; Hirabayashi H, 2003, CLIN PHARMACOKINET, V42, P1319, DOI 10.2165/00003088-200342150-00002; HNATOWICH DJ, 1982, INT J APPL RADIAT IS, V33, P327, DOI 10.1016/0020-708X(82)90144-2; Hyoudou K, 2004, CLIN CANCER RES, V10, P7685, DOI 10.1158/1078-0432.CCR-04-1020; Katsumi H, 2005, J PHARMACOL EXP THER, V314, P1117, DOI 10.1124/jpet.105.087429; Katsumi H, 2004, J PHARM SCI-US, V93, P2343, DOI 10.1002/jps.20147; Katsumi H, 2014, FREE RADICAL BIO MED, V69, P318, DOI 10.1016/j.freeradbiomed.2014.01.036; Lambrinoudaki I, 2006, ANN NY ACAD SCI, V1092, P397, DOI 10.1196/annals.1365.036; Lin JH, 1996, BONE, V18, P75, DOI 10.1016/8756-3282(95)00445-9; Low SA, 2012, ADV DRUG DELIVER REV, V64, P1189, DOI 10.1016/j.addr.2012.01.012; Ma SF, 2005, J CONTROL RELEASE, V102, P583, DOI 10.1016/j.jconrel.2004.11.006; Mihara K, 1993, PHARM RES, V10, P23; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; NISHIDA K, 1991, PHARMACEUT RES, V8, P437, DOI 10.1023/A:1015886708598; NISHIKAWA M, 1995, PHARMACEUT RES, V12, P209, DOI 10.1023/A:1016222808484; Nishikawa M, 2006, EXPERT OPIN DRUG DEL, V3, P355, DOI 10.1517/17425247.3.3.355; Porras AG, 1999, CLIN PHARMACOKINET, V36, P315, DOI 10.2165/00003088-199936050-00002; Sarin H, 2010, VASC CELL, V2, DOI 10.1186/2040-2384-2-14; TAKAKURA Y, 1990, PHARMACEUT RES, V7, P339, DOI 10.1023/A:1015807119753; Takakura Y, 1996, PHARMACEUT RES, V13, P820, DOI 10.1023/A:1016084508097; TAKAKURA Y, 1987, PHARMACEUT RES, V4, P293, DOI 10.1023/A:1016489002393; TALMAGE RV, 1970, AM J ANAT, V129, P467, DOI 10.1002/aja.1001290408; Tu SM, 2008, CANCER J, V14, P35, DOI 10.1097/PPO.0b013e318161d32d; Uludag H, 2002, BIOTECHNOL PROGR, V18, P604, DOI 10.1021/bp0200447; Wang D, 2005, ADV DRUG DELIVER REV, V57, P1049, DOI 10.1016/j.addr.2004.12.011; YAMAOKA K, 1981, J PHARMACOBIO-DYNAM, V4, P879, DOI 10.1248/bpb1978.4.879; Yamasaki Y, 2002, J PHARMACOL EXP THER, V301, P467, DOI 10.1124/jpet.301.2.467; Yamasaki Y, 2003, EUR J PHARM SCI, V18, P305, DOI 10.1016/S0928-0987(03)00021-6; Zheng YL, 2012, J PHARM SCI-US, V101, P552, DOI 10.1002/jps.22773; Zojer N, 1999, DRUG SAFETY, V21, P389, DOI 10.2165/00002018-199921050-00004	39	14	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135966	10.1371/journal.pone.0135966	http://dx.doi.org/10.1371/journal.pone.0135966			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287482	gold, Green Submitted, Green Published			2022-12-26	WOS:000360018600091
J	Gagnaire, V; Jardin, J; Rabah, H; Briard-Bion, V; Jan, G				Gagnaire, Valerie; Jardin, Julien; Rabah, Houem; Briard-Bion, Valerie; Jan, Gwenael			Emmental Cheese Environment Enhances Propionibacterium freudenreichii Stress Tolerance	PLOS ONE			English	Article							IN-VITRO; PROTEOMIC ANALYSIS; PROTEIN-SYNTHESIS; ACID ADAPTATION; INDUCED COLITIS; BILE-SALTS; METABOLISM; APOPTOSIS; SUSCEPTIBILITY; IDENTIFICATION	Dairy propionibacteria are actinomycetales found in various fermented food products. The main species, Propionibacterium freudenreichii, is generally recognized as safe and used both as probiotic and as cheese starter. Its probiotic efficacy tightly depends on its tolerance towards digestive stresses, which can be largely modulated by the ingested delivery vehicle. Indeed, tolerance of this bacterium is enhanced when it is consumed within a fermented dairy product, compared to a dried probiotic preparation. We investigated both stress tolerance and protein neosynthesis upon growth in i) chemically defined or ii) aqueous phase of Emmental cheeses. Although the same final population level was reached in both media, a slower growth and an enhanced survival of CIRM BIA 1 strain of P. freudenreichii subsp. shermanii was observed in Emmental juice, compared to chemically defined medium. This was accompanied by differences in substrates used and products released as well as overexpression of various early stress adaptation proteins in Emmental juice, compared to chemically defined medium, implied in protein folding, in aspartate catabolism, in biosynthesis of valine, leucine and isoleucine, in pyruvate metabolism in citrate cycle, in the propionate metabolism, as well as in oxidoreductases. All these changes led to a higher digestive stress tolerance after growth in Emmental juice. Mechanisms of stress adaptation were induced in this environment, in accordance with enhanced survival. This opens perspectives for the use of hard and semi-hard cheeses as delivery vehicle for probiotics with enhanced efficacy.	[Gagnaire, Valerie; Jardin, Julien; Rabah, Houem; Briard-Bion, Valerie; Jan, Gwenael] INRA, STLO UMR1253, Sci & Technol Lait & Oeuf, F-35042 Rennes, France; [Gagnaire, Valerie; Jardin, Julien; Rabah, Houem; Briard-Bion, Valerie; Jan, Gwenael] AGROCAMPUS OUEST, STLO UMR1253, Rennes, France	INRAE; Institut Agro; Agrocampus Ouest	Gagnaire, V (corresponding author), INRA, STLO UMR1253, Sci & Technol Lait & Oeuf, F-35042 Rennes, France.	valerie.gagnaire@rennes.inra.fr	JARDIN, Julien/A-3241-2012; Gagnaire, Valérie/V-1338-2017	JARDIN, Julien/0000-0003-0520-9391; Gagnaire, Valérie/0000-0003-3186-0620	French National Agency for Research [ANR-2010-ALIA-016]	French National Agency for Research(French National Research Agency (ANR))	GJ received funding from the French National Agency for Research (http://www.anr-surfing.eu): ANR-2010-ALIA-016 project, called Starter SURFace against INflammation of the Gut (SURFING). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasiou R, 2006, INT J FOOD MICROBIOL, V108, P301, DOI 10.1016/j.ijfoodmicro.2005.11.015; Begley M, 2002, APPL ENVIRON MICROB, V68, P6005, DOI 10.1128/AEM.68.12.6005-6012.2002; Bougle D, 1999, SCAND J GASTROENTERO, V34, P144, DOI 10.1080/00365529950172998; Boyaval P, 1999, LAIT, V79, P59, DOI 10.1051/lait:199914; Castro JM, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/723056; Cousin FJ, 2012, FOOD MICROBIOL, V32, P135, DOI 10.1016/j.fm.2012.05.003; Cousin FJ, 2011, DAIRY SCI TECHNOL, V91, P1, DOI 10.1051/dst/2010032; CROW VL, 1986, APPL ENVIRON MICROB, V52, P359, DOI 10.1128/AEM.52.2.359-365.1986; Dalmasso M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029083; Falentin H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011748; Fitz A., 1878, BER DTSCH CHEM GES, V11, P1890, DOI [10.1002/cber.187801102180, DOI 10.1002/CBER.187801102180]; Flahaut S, 1996, FEMS MICROBIOL LETT, V138, P49, DOI 10.1016/0378-1097(96)00080-8; Foligne B, 2013, GUT, V62, P1227, DOI 10.1136/gutjnl-2012-304393; Foligne B, 2010, APPL ENVIRON MICROB, V76, P8259, DOI 10.1128/AEM.01976-10; FROHLICHWYDER MT, 2004, CHEESE CHEM PHYS MIC, V2, P141, DOI DOI 10.1016/S1874-558X(04)80042-3; Gagnaire V, 1998, J DAIRY RES, V65, P119, DOI 10.1017/S0022029997002525; Gagnaire V, 2001, LAIT, V81, P339, DOI 10.1051/lait:2001136; Havenaar R, 2011, BENEF MICROBES, V2, P103, DOI 10.3920/BM2011.0003; Herve C, 2007, INT J FOOD MICROBIOL, V113, P303, DOI 10.1016/j.ijfoodmicro.2006.08.013; Hu YB, 2010, FEBS LETT, V584, P2311, DOI 10.1016/j.febslet.2010.03.045; Hugenholtz J, 2002, LAIT, V82, P103, DOI 10.1051/lait:2001009; Isawa K, 2002, BIOSCI BIOTECH BIOCH, V66, P679, DOI 10.1271/bbb.66.679; Jan G, 2007, WOODHEAD PUBL FOOD S, P165, DOI 10.1533/9781845693107.2.165; Jan G, 2002, LAIT, V82, P131, DOI 10.1051/lait:2001012; Jan G, 2002, CELL DEATH DIFFER, V9, P179, DOI 10.1038/sj.cdd.4400935; Jan G, 2001, APPL ENVIRON MICROB, V67, P2029, DOI 10.1128/AEM.67.5.2029-2036.2001; Jan G, 2000, LAIT, V80, P325, DOI 10.1051/lait:2000128; Lan A, 2008, BRIT J NUTR, V100, P1251, DOI 10.1017/S0007114508978284; Lan A, 2007, APOPTOSIS, V12, P573, DOI 10.1007/s10495-006-0010-3; Le Boucher C, 2013, FOOD CHEM, V141, P1032, DOI 10.1016/j.foodchem.2013.03.094; Le Marechal C, 2015, J PROTEOMICS, V113, P447, DOI 10.1016/j.jprot.2014.07.018; Lee S, 2014, J FOOD PROTECT, V77, P1794, DOI 10.4315/0362-028X.JFP-14-070; Leverrier P, 2005, FOOD MICROBIOL, V22, P11, DOI 10.1016/j.fm.2004.05.003; Leverrier P, 2004, ARCH MICROBIOL, V181, P215, DOI 10.1007/s00203-003-0646-0; Leverrier P, 2003, APPL ENVIRON MICROB, V69, P3809, DOI 10.1128/AEM.69.7.3809-3818.2003; Morris JS, 2010, J PROTEOME RES, V9, P595, DOI 10.1021/pr9005603; Okada Y, 2006, GUT, V55, P681, DOI 10.1136/gut.2005.070490; Okada Y, 2006, GASTROENTEROLOGY, V130, pA313; R Core Team, 2014, LANG ENV STAT COMP; Rallu F, 1996, ANTON LEEUW INT J G, V70, P243, DOI 10.1007/BF00395935; SALVATBRUNAUD D, 1995, LAIT, V75, P239, DOI 10.1051/lait:1995316; SalvatBrunaud D, 1997, J DAIRY RES, V64, P573, DOI 10.1017/S0022029997002410; SPACKMAN DH, 1958, ANAL CHEM, V30, P1190, DOI 10.1021/ac60139a006; Thierry A, 2002, LAIT, V82, P17, DOI 10.1051/lait:2001002; Thierry A., 2011, ENCY DAIRY SCI, P403; Thierry A, 2011, INT J FOOD MICROBIOL, V149, P19, DOI 10.1016/j.ijfoodmicro.2011.04.026; Wood JM, 2011, ANNU REV MICROBIOL, V65, P215, DOI 10.1146/annurev-micro-090110-102815; Wu RN, 2011, INT J FOOD MICROBIOL, V147, P181, DOI 10.1016/j.ijfoodmicro.2011.04.003	48	24	24	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135780	10.1371/journal.pone.0135780	http://dx.doi.org/10.1371/journal.pone.0135780			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275229	gold, Green Published, Green Submitted			2022-12-26	WOS:000359493600110
J	Wang, HY; Yue, ZH; Wu, JL; Liu, T; Mo, Y; Jiang, XY; Sun, LZ				Wang, Haiyan; Yue, Zhihui; Wu, Jinlang; Liu, Ting; Mo, Ying; Jiang, Xiaoyun; Sun, Liangzhong			The Accumulation of VEGFA in the Glomerular Basement Membrane and Its Relationship with Podocyte Injury and Proteinuria in Alport Syndrome	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; FILTRATION BARRIER; KIDNEY PODOCYTES; AUTOCRINE; PHOSPHORYLATION; OVEREXPRESSION; RECRUITMENT; ACTIVATION; RECEPTORS; INDUCTION	The pathogenesis of proteinuria in Alport syndrome (AS) remains unclear. Vascular endothelial growth factor A (VEGFA) is a key regulator of the glomerular filtration barrier (GFB). This study explored the expression of VEGFA in the glomeruli and its accumulation in the glomerular basement membrane (GBM) and their relationship with podocyte injury and proteinuria in Alport syndrome (AS). Clinical data and renal tissues of control patients (11 cases) and AS patients (25 cases) were included. AS patients were further divided into 2 groups according to the quantities of their urinary protein: mild to moderate proteinuria group (proteinuria <50 mg/kg/d, 15 cases) and heavy proteinuria group (proteinuria >= 50 mg/kg/d, 10 cases). The expression and distribution of VEGFA and VEGF receptor 2 (VEGFR2) in the GFB, the phosphorylation of VEGFR2 (p-VEGFR2) and nephrin (p-nephrin), and the expression of synaptopodin and nephrin in the glomeruli were detected by immune electron microscopy and/or immunofluorescence, and their relationships to proteinuria in AS patients were analyzed. The accumulation of VEGFA in the GBM was increased in AS patients. The expression of VEGFA and the levels of p-VEGFR2 and p-nephrin in glomeruli were increased and were positively correlated with the degree of proteinuria in AS patients. The expression of synaptopodin and nephrin were decreased and were negatively correlated with the degree of proteinuria in AS patients. The over expressed VEGFA in the glomeruli and its accumulation in the GBM may activate the VEGFA-VEGFR2 and nephrin signaling pathways and lead to podocyte injury and occurrence of proteinuria in AS.	[Wang, Haiyan; Yue, Zhihui; Liu, Ting; Mo, Ying; Jiang, Xiaoyun; Sun, Liangzhong] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pediat, Childrens Kidney Dis Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Haiyan] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Pediat, Guangzhou 510275, Guangdong, Peoples R China; [Wu, Jinlang] Sun Yat Sen Univ, Dept Electron Microscopy, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Sun, LZ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pediat, Childrens Kidney Dis Ctr, Guangzhou 510275, Guangdong, Peoples R China.	sunlzh@mail.sysu.edu.cn	Sun, Liangzhong/GQH-9346-2022	Sun, Liangzhong/0000-0003-1962-8626	National Natural Science Foundation of China [81470913]; Guangdong Natural Science Foundation [S2012010009405, S2013010015536]; Guangdong Science and Technology Planning Project [2011B031800126, 2013B021800117]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Guangdong Science and Technology Planning Project	The study was supported by the National Natural Science Foundation of China (Grant No. 81470913), Guangdong Natural Science Foundation (Grant Nos. S2012010009405 and S2013010015536) and Guangdong Science and Technology Planning Project (Grant Nos. 2011B031800126 and 2013B021800117).	Bertuccio C, 2011, J BIOL CHEM, V286, P39933, DOI 10.1074/jbc.M111.241620; Eremina V, 2003, J CLIN INVEST, V111, P707, DOI 10.1172/JCI200317423; Eremina V, 2007, NEPHRON PHYSIOL, V106, P32, DOI 10.1159/000101798; Fan LY, 2002, NEPHRON, V90, P95, DOI 10.1159/000046320; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Flinter F, 1997, J MED GENET, V34, P326, DOI 10.1136/jmg.34.4.326; Gagliardini E, 2010, J AM SOC NEPHROL, V21, P2081, DOI 10.1681/ASN.2010020199; Gao XB, 2005, DEVELOPMENT, V132, P5437, DOI 10.1242/dev.02095; Guan FX, 2006, AM J PHYSIOL-RENAL, V291, pF422, DOI 10.1152/ajprenal.00448.2005; Guan N, 2010, ZHONGHUA SHEN ZANG B, V26, P748; Harita Y, 2009, J BIOL CHEM, V284, P8951, DOI 10.1074/jbc.M806851200; Heidet L, 2009, J AM SOC NEPHROL, V20, P1210, DOI 10.1681/ASN.2008090984; Hohenstein B, 2010, NEPHROL DIAL TRANSPL, V25, P3170, DOI 10.1093/ndt/gfq200; Jais JP, 2000, J AM SOC NEPHROL, V11, P649, DOI 10.1681/ASN.V114649; Karki P, 2009, NEPAL J OPHTHALMOL, V1, P139; Lamalice L, 2006, J BIOL CHEM, V281, P34009, DOI 10.1074/jbc.M603928200; Muller-Deile J, 2009, AM J PHYSIOL-RENAL, V297, pF1656, DOI 10.1152/ajprenal.00275.2009; Schliehe C, 2011, J CONTROL RELEASE, V151, P278, DOI 10.1016/j.jconrel.2011.01.005; Schumacher VA, 2011, J AM SOC NEPHROL, V22, P1286, DOI 10.1681/ASN.2010080860; SIMON M, 1995, AM J PHYSIOL-RENAL, V268, pF240, DOI 10.1152/ajprenal.1995.268.2.F240; Sison K, 2010, J AM SOC NEPHROL, V21, P1691, DOI 10.1681/ASN.2010030295; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; Veron D, 2010, AM J PATHOL, V177, P2225, DOI 10.2353/ajpath.2010.091146; Veron D, 2010, KIDNEY INT, V77, P989, DOI 10.1038/ki.2010.64; Wang HY, 2013, ZHONGGUO BING LI SHE, V29, P361; Yanagida-Asanuma E, 2007, AM J PATHOL, V171, P415, DOI 10.2353/ajpath.2007.070075	26	13	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135648	10.1371/journal.pone.0135648	http://dx.doi.org/10.1371/journal.pone.0135648			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274923	gold, Green Submitted, Green Published			2022-12-26	WOS:000359493600087
J	Nanos-Webb, A; Bui, T; Karakas, C; Zhang, D; Carey, JPW; Mills, GB; Hunt, KK; Keyomarsi, K				Nanos-Webb, A.; Bui, T.; Karakas, C.; Zhang, D.; Carey, J. P. W.; Mills, G. B.; Hunt, K. K.; Keyomarsi, K.			PKCiota promotes ovarian tumor progression through deregulation of cyclin E	ONCOGENE			English	Article							KINASE-C-IOTA; BREAST-CANCER; PKC-IOTA; E OVEREXPRESSION; POOR-PROGNOSIS; ATYPICAL PKC; CELL-CYCLE; EXPRESSION; ACTIVATION; CARCINOMA	The high frequency of relapse of epithelial ovarian tumors treated with standard chemotherapy has highlighted the necessity to identify targeted therapies that can improve patient outcomes. The dynamic relationship between cyclin E and PKCiota frequent overexpression in high-grade ovarian tumors poses a novel pathway for therapeutic investigation. We hypothesized that a phosphoinositide 3-kinase (PI3K)-dependent signaling pathway activating PKCiota perpetuates cyclin E deregulation during ovarian tumorigenesis. We observed a positive correlation between PKCiota and cyclin E in a panel of 19 ovarian cancer cell lines. Modulation of cyclin E had no effect on PKCiota knockdown/overexpression; however, PKCiota differentially regulated cyclin E expression. In the serous ovarian cancer cells (IGROV and OVCAR-3), shPKCiota decreased proliferation, caused a G1 arrest and significantly prolonged overall survival in xenograft mouse models. In vitro, shPKCiota decreased the ability of IGROV cells to grow under anchorage-independent conditions and form aberrant acini, which was dependent on Ad-cyclin E or Ad-LMW-E expression. Reverse-phase protein array analysis of PKCiota wild-type, catalytic active, dominant-negative protein isoforms strengthened the association between phospho-PKCiota levels and PI3K pathway activation. Inhibitors of PI3K coordinately decreased phospho-PKCiota and cyclin E protein levels. In conclusion, we have identified a PI3K/PKCiota/cyclin E signaling pathway as a therapeutic target during ovarian tumorigenesis.	[Nanos-Webb, A.; Bui, T.; Karakas, C.; Carey, J. P. W.; Keyomarsi, K.] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, 6565 MD Anderson Blvd,Unit 1052, Houston, TX 77030 USA; [Zhang, D.; Mills, G. B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Hunt, K. K.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Keyomarsi, K (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, 6565 MD Anderson Blvd,Unit 1052, Houston, TX 77030 USA.	kkeyomar@mdanderson.org	Keyomarsi, Khandan/H-2716-2016	Keyomarsi, Khandan/0000-0002-5440-0849; Carey, Jason PW/0000-0002-9729-1742	NIH [CA87458, CA1522228]; NCI CCSG [CA16672]; NATIONAL CANCER INSTITUTE [P50CA116199, R01CA152228, P30CA016672, P50CA083639, R01CA087548] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI CCSG; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by NIH grants CA87458 and CA1522228 to KK and by NCI CCSG grant CA16672 to MD Anderson Cancer Center.	Akimoto K, 1998, BIOCHEM J, V335, P417, DOI 10.1042/bj3350417; Akli S, 2004, BREAST CANCER RES, V6, P188, DOI 10.1186/bcr905; Akli S, 2007, CANCER RES, V67, P7212, DOI 10.1158/0008-5472.CAN-07-0599; Akli S, 2011, CANCER RES, V71, P3377, DOI 10.1158/0008-5472.CAN-10-4086; Awadelkarim KD, 2012, INT J CANCER, V131, P2852, DOI 10.1002/ijc.27600; Bagheri-Yarmand R, 2010, CANCER RES, V70, P5074, DOI 10.1158/0008-5472.CAN-09-4094; Bagheri-Yarmand R, 2010, CANCER RES, V70, P5085, DOI 10.1158/0008-5472.CAN-09-4095; Baldwin RM, 2006, ONCOGENE, V25, P2909, DOI 10.1038/sj.onc.1209312; Bales E, 2005, CANCER RES, V65, P692; Bedrosian I, 2004, ONCOGENE, V23, P2648, DOI 10.1038/sj.onc.1207408; Bedrosian I, 2007, CLIN CANCER RES, V13, P4800, DOI 10.1158/1078-0432.CCR-07-0142; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Coghlan MP, 2000, MOL CELL BIOL, V20, P2880, DOI 10.1128/MCB.20.8.2880-2889.2000; Courjal F, 1996, INT J CANCER, V69, P247; Duong MT, 2013, CANCER RES, V73, P5556, DOI 10.1158/0008-5472.CAN-13-0013; Eder AM, 2005, P NATL ACAD SCI USA, V102, P12519, DOI 10.1073/pnas.0505641102; Erdogan E, 2009, CLIN CANCER RES, V15, P1527, DOI 10.1158/1078-0432.CCR-08-2459; Evans JD, 2003, AM J CLIN PATHOL, V119, P392, DOI 10.1309/BKPC9DX98R781B87; Fang F, 1996, SCIENCE, V271, P499, DOI 10.1126/science.271.5248.499; Farley J, 2003, CANCER RES, V63, P1235; Fields AP, 2007, PHARMACOL RES, V55, P487, DOI 10.1016/j.phrs.2007.04.015; Jamieson L, 1999, J BIOL CHEM, V274, P3927, DOI 10.1074/jbc.274.7.3927; Justilien V, 2014, CANCER CELL, V25, P139, DOI 10.1016/j.ccr.2014.01.008; Kang JS, 1996, MOL CELL BIOL, V16, P3370; Kanoh Y, 2003, ENDOCRINOLOGY, V144, P947, DOI 10.1210/en.2002-221017; Karst AM, 2014, CANCER RES, V74, P1141, DOI 10.1158/0008-5472.CAN-13-2247; Keyomarsi K, 2002, NEW ENGL J MED, V347, P1566, DOI 10.1056/NEJMoa021153; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Lakhani SR, 2004, CLIN CANCER RES, V10, P2473, DOI 10.1158/1078-0432.CCR-1029-3; Murray NR, 2011, J CELL PHYSIOL, V226, P879, DOI 10.1002/jcp.22463; Nanos-Webb A, 2012, BREAST CANCER RES TR, V132, P575, DOI 10.1007/s10549-011-1638-4; Paget JA, 2012, ONCOGENE, V31, P3584, DOI 10.1038/onc.2011.524; Rath SL, 2014, BIOCHEMISTRY-US, V53, P4612, DOI 10.1021/bi5004052; Regala RP, 2005, J BIOL CHEM, V280, P31109, DOI 10.1074/jbc.M505402200; Rosse C, 2014, P NATL ACAD SCI USA, V111, pE1872, DOI 10.1073/pnas.1400749111; Standaert ML, 1999, J BIOL CHEM, V274, P14074, DOI 10.1074/jbc.274.20.14074; Tan DSP, 2008, J CLIN ONCOL, V26, P5530, DOI 10.1200/JCO.2008.16.1703; Tibes R, 2006, MOL CANCER THER, V5, P2512, DOI 10.1158/1535-7163.MCT-06-0334; Weichert W, 2003, INT J ONCOL, V23, P633; Wingate H, 2003, CELL CYCLE, V2, P461, DOI 10.4161/cc.2.5.464; Zhang L, 2006, CANCER RES, V66, P4627, DOI 10.1158/0008-5472.CAN-05-4527	41	15	16	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 12	2016	35	19					2428	2440		10.1038/onc.2015.301	http://dx.doi.org/10.1038/onc.2015.301			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DM2GQ	26279297	Green Accepted			2022-12-26	WOS:000376165500002
J	Hazra, S; Henderson, JN; Liles, K; Hilton, MT; Wachter, RM				Hazra, Suratna; Henderson, J. Nathan; Liles, Kevin; Hilton, Matthew T.; Wachter, Rebekka M.			Regulation of Ribulose-1,5-bisphosphate Carboxylase/Oxygenase (Rubisco) Activase PRODUCT INHIBITION, COOPERATIVITY, AND MAGNESIUM ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEASE FTSH; METALLOPROTEASE FTSH; SUBUNIT INTERACTIONS; CRYSTAL-STRUCTURE; HEXAMERIC RING; ATP HYDROLYSIS; AAA+ PROTEINS; ATPASES; COMPLEX; DOMAIN	In many photosynthetic organisms, tight-binding Rubisco inhibitors are released by the motor protein Rubisco activase (Rca). In higher plants, Rca plays a pivotal role in regulating CO2 fixation. Here, the ATPase activity of 0.005 mM tobacco Rca was monitored under steady-state conditions, and global curve fitting was utilized to extract kinetic constants. The k(cat) was best fit by 22.3 +/- 4.9 min(-1), the Km for ATP by 0.104 +/- 0.024 mM, and the K-i for ADP by 0.037 +/- 0.007 mM. Without ADP, the Hill coefficient for ATP hydrolysis was extracted to be 1.0 +/- 0.1, indicating noncooperative behavior of homo-oligomeric Rca assemblies. However, the addition of ADP was shown to introduce positive cooperativity between two or more subunits (Hill coefficient 1.9 +/- 0.2), allowing for regulation via the prevailing ATP/ADP ratio. ADP-mediated activation was not observed, although larger amounts led to competitive product inhibition of hydrolytic activity. The catalytic efficiency increased 8.4-fold upon cooperative binding of a second magnesium ion (Hill coefficient 2.5 +/- 0.5), suggesting at least three conformational states (ATP-bound, ADP-bound, and empty) within assemblies containing an average of about six subunits. The addition of excess Rubisco (24:1, L8S8/Rca6) and crowding agents did not modify catalytic rates. However, high magnesium provided for thermal Rca stabilization. We propose that magnesium mediates the formation of closed hexameric toroids capable of high turnover rates and amenable to allosteric regulation. We suggest that in vivo, the Rca hydrolytic activity is tuned by fluctuating [Mg2+] in response to changes in available light.	[Wachter, Rebekka M.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; Arizona State Univ, Ctr Bioenergy & Photosynth, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Wachter, RM (corresponding author), Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA.	rwachter@asu.edu			United States Department of Energy, Office of Basic Energy Sciences, Photosynthetic Systems Grant [DE-FG02-09-ER16123]	United States Department of Energy, Office of Basic Energy Sciences, Photosynthetic Systems Grant(United States Department of Energy (DOE))	This work was supported by United States Department of Energy, Office of Basic Energy Sciences, Photosynthetic Systems Grant DE-FG02-09-ER16123 (to R. M. W). The authors declare that they have no conflicts of interest with the contents of this article.	Andersson I, 2008, J EXP BOT, V59, P1555, DOI 10.1093/jxb/ern091; Andralojc PJ, 2012, BIOCHEM J, V442, P733, DOI 10.1042/BJ20111443; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Barta C, 2010, ARCH BIOCHEM BIOPHYS, V499, P17, DOI 10.1016/j.abb.2010.04.022; Barthelme D, 2014, P NATL ACAD SCI USA, V111, pE1687, DOI 10.1073/pnas.1404823111; Bieniossek C, 2006, P NATL ACAD SCI USA, V103, P3066, DOI 10.1073/pnas.0600031103; Blayney MJ, 2011, J AM SOC MASS SPECTR, V22, P1588, DOI 10.1007/s13361-011-0187-8; Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; Bracher A, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2014.2, 10.1038/nplants.2014.2]; Carmo-Silva AE, 2013, PLANT PHYSIOL, V161, P1645, DOI 10.1104/pp.112.213348; Chakraborty M, 2012, BIOPHYS J, V103, P949, DOI 10.1016/j.bpj.2012.07.034; CraftsBrandner SJ, 1997, PLANT PHYSIOL, V114, P439, DOI 10.1104/pp.114.2.439; Dhar A, 2010, P NATL ACAD SCI USA, V107, P17586, DOI 10.1073/pnas.1006760107; Durao P, 2015, NAT CHEM BIOL, V11, P148, DOI [10.1038/NCHEMBIO.1715, 10.1038/nchembio.1715]; Fodje MN, 2001, J MOL BIOL, V311, P111, DOI 10.1006/jmbi.2001.4834; Frasch WD, 1995, PHOTOSYNTHESIS: FROM LIGHT TO BIOSPHERE, VOL 5, P257; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hartman JJ, 1999, SCIENCE, V286, P782, DOI 10.1126/science.286.5440.782; Hasse D, 2015, ACTA CRYSTALLOGR D, V71, P800, DOI 10.1107/S1399004715001182; Hauser T, 2015, NAT PLANTS, V1, P1, DOI [10.1038/NPLANTS.2015.65, 10.1038/nplants.2015.65]; Henderson JN, 2013, BBA-PROTEINS PROTEOM, V1834, P87, DOI 10.1016/j.bbapap.2012.09.006; Henderson JN, 2011, J BIOL CHEM, V286, P35683, DOI 10.1074/jbc.C111.289595; Ishijima S, 2003, ARCH BIOCHEM BIOPHYS, V412, P126, DOI 10.1016/S0003-9861(03)00038-9; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Kallis RP, 2000, PLANT PHYSIOL, V123, P1077, DOI 10.1104/pp.123.3.1077; Keown JR, 2014, BIOCHEM J, V464, P413, DOI 10.1042/BJ20140676; Keown JR, 2013, J BIOL CHEM, V288, P20607, DOI 10.1074/jbc.M113.466383; Kress W, 2007, BIOCHEMISTRY-US, V46, P6183, DOI 10.1021/bi602616t; Krzywda S, 2002, STRUCTURE, V10, P1073, DOI 10.1016/S0969-2126(02)00806-7; Kuriata AM, 2014, BIOCHEMISTRY-US, V53, P7232, DOI 10.1021/bi500968h; Lee SY, 2003, GENE DEV, V17, P2552, DOI 10.1101/gad.1125603; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; Lilley RM, 1997, PLANT PHYSIOL, V114, P605, DOI 10.1104/pp.114.2.605; Lin MT, 2014, NATURE, V513, P547, DOI 10.1038/nature13776; MORRISON JF, 1961, BIOCHIM BIOPHYS ACTA, V52, P82, DOI 10.1016/0006-3002(61)90906-4; Mueller-Cajar O, 2011, NATURE, V479, P194, DOI 10.1038/nature10568; Neuwald AF, 1999, GENOME RES, V9, P27; Niwa H, 2002, STRUCTURE, V10, P1415, DOI 10.1016/S0969-2126(02)00855-9; Ogura T, 2004, J STRUCT BIOL, V146, P106, DOI 10.1016/j.jsb.2003.11.008; Page AN, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.210187; Parry MAJ, 2013, J EXP BOT, V64, P717, DOI 10.1093/jxb/ers336; Pearce FG, 2006, BIOCHEM J, V399, P525, DOI 10.1042/BJ20060430; Pearce FG, 2003, J BIOL CHEM, V278, P32526, DOI 10.1074/jbc.M305493200; Portis AR, 2003, PHOTOSYNTH RES, V75, P11, DOI 10.1023/A:1022458108678; Pulido NO, 2010, BIOCHEMISTRY-US, V49, P5258, DOI 10.1021/bi1006767; SALVUCCI ME, 1992, ARCH BIOCHEM BIOPHYS, V298, P688, DOI 10.1016/0003-9861(92)90467-B; Salvucci ME, 2003, PLANTA, V216, P736, DOI 10.1007/s00425-002-0923-1; Scales JC, 2014, PHOTOSYNTH RES, V119, P355, DOI 10.1007/s11120-013-9964-5; Simonetta KR, 2009, CELL, V137, P659, DOI 10.1016/j.cell.2009.03.044; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Smith DM, 2011, CELL, V144, P526, DOI 10.1016/j.cell.2011.02.005; Snider J, 2008, BIOCHEM SOC T, V36, P72, DOI 10.1042/BST0360072; Stinson BM, 2015, NAT STRUCT MOL BIOL, V22, P411, DOI 10.1038/nsmb.3012; Stinson BM, 2013, CELL, V153, P628, DOI 10.1016/j.cell.2013.03.029; Stotz M, 2011, NAT STRUCT MOL BIOL, V18, P1366, DOI 10.1038/nsmb.2171; Suno R, 2006, MOL CELL, V22, P575, DOI 10.1016/j.molcel.2006.04.020; Wachter RM, 2013, PHOTOSYNTH RES, V117, P557, DOI 10.1007/s11120-013-9827-0; Wang DF, 2006, PHOTOSYNTH RES, V88, P185, DOI 10.1007/s11120-006-9051-2; Wang J, 2001, STRUCTURE, V9, P177, DOI 10.1016/S0969-2126(01)00570-6; Wang J, 2001, STRUCTURE, V9, P1107, DOI 10.1016/S0969-2126(01)00670-0; WANG ZY, 1991, BIOCHIM BIOPHYS ACTA, V1079, P263, DOI 10.1016/0167-4838(91)90067-A; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Zhang N, 1999, P NATL ACAD SCI USA, V96, P9438, DOI 10.1073/pnas.96.16.9438; Zhao ML, 2015, NATURE, V518, P61, DOI 10.1038/nature14148	66	40	41	0	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24222	24236		10.1074/jbc.M115.651745	http://dx.doi.org/10.1074/jbc.M115.651745			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26283786	hybrid, Green Published			2022-12-26	WOS:000362218900015
J	Castiglioni, L; Colazzo, F; Fontana, L; Colombo, GI; Piacentini, L; Bono, E; Milano, G; Paleari, S; Palermo, A; Guerrini, U; Tremoli, E; Sironi, L				Castiglioni, Laura; Colazzo, Francesca; Fontana, Lucia; Colombo, Gualtiero I.; Piacentini, Luca; Bono, Elisa; Milano, Giuseppina; Paleari, Serena; Palermo, Annamaria; Guerrini, Uliano; Tremoli, Elena; Sironi, Luigi			Evaluation of Left Ventricle Function by Regional Fractional Area Change (RFAC) in a Mouse Model of Myocardial Infarction Secondary to Valsartan Treatment	PLOS ONE			English	Article							CARDIOVASCULAR-MAGNETIC-RESONANCE; LEFT ATRIAL VOLUME; HEART-FAILURE; MATRIX METALLOPROTEINASES; DIASTOLIC DYSFUNCTION; ANGIOTENSIN-II; POSTMYOCARDIAL INFARCTION; TISSUE INHIBITORS; EXPRESSION; FIBROSIS	Aim Left ventricle (LV) regional fractional area change (RFAC) measured by cardiac magnetic resonance (CMR) allows the non-invasive localization and quantification of the degree of myocardial infarction (MI), and could be applied to assess the effectiveness of pharmacological or regenerative therapies. Here we investigate the ability of RFAC to identify regional dysfunction and discriminate the effect of pharmacological treatment with valsartan, a selective antagonist of angiotensin II type 1 receptor, in a model of MI. Methods and Results C57BL/6N mice, undergoing coronary artery ligation, were divided into two groups: untreated (MI) or treated with valsartan (MI+Val). Sham-operated mice were used as a control. Cardiac dimensions and function were assessed at baseline, 24 hours, 1 and 4 weeks post surgery by CMR and echocardiography. At sacrifice histology and whole-genome gene expression profiling were performed. RFAC was able to detect significant differences between treatment groups whereas the global ejection fraction was not. RFAC showed greater loss of regional contraction in remote non-infarcted myocardium in MI group than in MI+Val group. Consistently, in the same region MI+Val mice showed reduced myocyte hypertrophy, fibroblast proliferation, and fibrosis and modulation of target genes; in addition, left atrium volumes, appendage length and duct contraction were preserved. Conclusion In this study, RFAC effectively estimated the degree of systolic dysfunction and discriminated the regions preserved by pharmacological treatment. RFAC index is a promising tool to monitor changes in LV contraction and to assess the effectiveness of therapeutic regimens in clinical settings.	[Castiglioni, Laura; Paleari, Serena; Palermo, Annamaria; Guerrini, Uliano; Tremoli, Elena; Sironi, Luigi] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy; [Colazzo, Francesca; Fontana, Lucia; Colombo, Gualtiero I.; Piacentini, Luca; Bono, Elisa; Milano, Giuseppina; Tremoli, Elena; Sironi, Luigi] Ctr Cardiol Monzino IRCCS, Milan, Italy	University of Milan; IRCCS Centro Cardiologico Monzino	Sironi, L (corresponding author), Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy.	luigi.sironi@unimi.it	Piacentini, Luca/K-8908-2016; Bono, Elisa/AAN-3108-2020; Colombo, Gualtiero I./B-4737-2010; Sironi, Luigi/S-8174-2016; Fontana, Lucia/J-8778-2015; TREMOLI, ELENA/I-8126-2018	Piacentini, Luca/0000-0003-1022-4481; Bono, Elisa/0000-0002-5212-3446; Colombo, Gualtiero I./0000-0002-7348-1939; castiglioni, laura/0000-0002-0772-3231; Fontana, Lucia/0000-0001-9564-2310; Milano, Giuseppina/0000-0002-5560-4667; TREMOLI, ELENA/0000-0002-0929-6106; COLAZZO, FRANCESCA/0000-0002-5782-1606; SIRONI, LUIGI/0000-0002-4738-3454	University of Milan Fellowship; Centro Cardiologico Monzino, IRCCS	University of Milan Fellowship; Centro Cardiologico Monzino, IRCCS	This work was supported by funding from Centro Cardiologico Monzino, IRCCS (Ricerca Corrente-RC2013) and University of Milan Fellowship (to L. Castiglioni).	Assomull RG, 2006, J AM COLL CARDIOL, V48, P1977, DOI 10.1016/j.jacc.2006.07.049; Boixel C, 2003, J AM COLL CARDIOL, V42, P336, DOI 10.1016/S0735-1097(03)00578-3; Cacciapuoti Fulvio, 2012, J Cardiovasc Ultrasound, V20, P25, DOI 10.4250/jcu.2012.20.1.25; Caiani EG, 2006, J CARDIOVASC MAGN R, V8, P427, DOI 10.1080/10976640600599486; Colazzo F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125541; Constantine G, 2004, LANCET, V363, P2162, DOI 10.1016/S0140-6736(04)16509-4; de Gasparo M, 2000, J Renin Angiotensin Aldosterone Syst, V1, pS3; Douglas PS, 2003, J AM COLL CARDIOL, V42, P1206, DOI 10.1016/S0735-1097(03)00956-2; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fassler R, 1996, EXP CELL RES, V222, P111, DOI 10.1006/excr.1996.0014; Franzosi M, 2011, COMPUT BIOL MED, V41, P829, DOI 10.1016/j.compbiomed.2011.06.021; Friedrich MG, 2008, JACC-CARDIOVASC IMAG, V1, P652, DOI 10.1016/j.jcmg.2008.07.011; GREENBERG B, 1979, AM HEART J, V98, P742, DOI 10.1016/0002-8703(79)90473-3; Hendel RC, 2006, J AM COLL CARDIOL, V48, P1475, DOI 10.1016/j.jacc.2006.07.003; Karamitsos TD, 2009, J AM COLL CARDIOL, V54, P1407, DOI 10.1016/j.jacc.2009.04.094; Kim S, 2000, PHARMACOL REV, V52, P11; Kramer CM, 1997, J AM COLL CARDIOL, V30, P1625, DOI 10.1016/S0735-1097(97)00406-3; Kwong RY, 2008, CIRCULATION, V118, P1011, DOI 10.1161/CIRCULATIONAHA.107.727826; Lambert E, 2004, CRIT REV ONCOL HEMAT, V49, P187, DOI 10.1016/j.critrevonc.2003.09.008; LEW WYW, 1985, CIRC RES, V56, P351, DOI 10.1161/01.RES.56.3.351; Li DS, 1999, CIRCULATION, V100, P87, DOI 10.1161/01.CIR.100.1.87; Lovelock JD, 2005, AM J PHYSIOL-HEART C, V288, pH461, DOI 10.1152/ajpheart.00402.2004; Mahrholdt H, 2002, CIRCULATION, V106, P2322, DOI 10.1161/01.CIR.0000036368.63317.1C; Mewton N, 2011, J AM COLL CARDIOL, V57, P891, DOI 10.1016/j.jacc.2010.11.013; Oishi Y, 2006, LIFE SCI, V80, P82, DOI 10.1016/j.lfs.2006.08.033; Okayama S, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-87; Pennell DJ, 2004, EUR HEART J, V25, P1940, DOI 10.1016/j.ehj.2004.06.040; Pritchett AM, 2005, J AM COLL CARDIOL, V45, P87, DOI 10.1016/j.jacc.2004.09.054; Ramirez TA, 2014, J MOL CELL CARDIOL, V72, P326, DOI 10.1016/j.yjmcc.2014.04.007; Schroen B, 2004, CIRC RES, V95, P515, DOI 10.1161/01.RES.0000141019.20332.3e; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; Strom A, 2006, CARDIOVASC RES, V69, P755, DOI 10.1016/j.cardiores.2005.12.001; Sun Y, 2009, CARDIOVASC RES, V81, P482, DOI 10.1093/cvr/cvn333; Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981; Tarnavski O, 2004, PHYSIOL GENOMICS, V16, P349, DOI 10.1152/physiolgenomics.00041.2003; Tsang TSM, 2002, AM J CARDIOL, V90, P1284, DOI 10.1016/S0002-9149(02)02864-3; UNGER T, 2002, AM J CARDIOL, V89, P3; VAZIRI SM, 1995, HYPERTENSION, V25, P1155, DOI 10.1161/01.HYP.25.6.1155; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wong M, 2002, J AM COLL CARDIOL, V40, P970, DOI 10.1016/S0735-1097(02)02063-6; Wu L, 2001, CIRCULATION, V104, P2716, DOI 10.1161/hc4601.099404; Zhao QW, 2004, HYPERTENSION, V44, P264, DOI 10.1161/01.HYP.0000138688.78906.6b	42	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135778	10.1371/journal.pone.0135778	http://dx.doi.org/10.1371/journal.pone.0135778			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291973	Green Published, gold, Green Submitted			2022-12-26	WOS:000359919900032
J	Pacholewska, A; Jagannathan, V; Drogemuller, M; Klukowska-Rotzler, J; Lanz, S; Hamza, E; Dermitzakis, ET; Marti, E; Leeb, T; Gerber, V				Pacholewska, Alicja; Jagannathan, Vidhya; Droegemueller, Michaela; Klukowska-Roetzler, Jolanta; Lanz, Simone; Hamza, Eman; Dermitzakis, Emmanouil T.; Marti, Eliane; Leeb, Tosso; Gerber, Vincent			Impaired Cell Cycle Regulation in a Natural Equine Model of Asthma	PLOS ONE			English	Article							RECURRENT AIRWAY-OBSTRUCTION; NF-KAPPA-B; DIFFERENTIAL EXPRESSION ANALYSIS; ANAPHASE-PROMOTING COMPLEX; MESSENGER-RNA EXPRESSION; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; BRONCHOALVEOLAR LAVAGE FLUID; EXPERIMENTAL ALLERGIC-ASTHMA; CANCER THERAPEUTIC TARGET; DELTA T-CELLS	Recurrent airway obstruction (RAO) is a common and potentially debilitating lower airway disease in horses, which shares many similarities with human asthma. In susceptible horses RAO exacerbation is caused by environmental allergens and irritants present in hay dust. The objective of this study was the identification of genes and pathways involved in the pathology of RAO by global transcriptome analyses in stimulated peripheral blood mononuclear cells (PBMCs). We performed RNA-seq on PBMCs derived from 40 RAO affected and 45 control horses belonging to three cohorts of Warmblood horses: two half-sib families and one group of unrelated horses. PBMCs were stimulated with hay dust extract, lipopolysaccharides, a recombinant parasite antigen, or left unstimulated. The total dataset consisted of 561 individual samples. We detected significant differences in the expression profiles between RAO and control horses. Differential expression (DE) was most marked upon stimulation with hay dust extract. An important novel finding was a strong upregulation of CXCL13 together with many genes involved in cell cycle regulation in stimulated samples from RAO affected horses, in addition to changes in the expression of several HIF-1 transcription factor target genes. The RAO condition alters systemic changes observed as differential expression profiles of PBMCs. Those changes also depended on the cohort and stimulation of the samples and were dominated by genes involved in immune cell trafficking, development, and cell cycle regulation. Our findings indicate an important role of CXCL13, likely macrophage or Th17 derived, and the cell cycle regulator CDC20 in the immune response in RAO.	[Pacholewska, Alicja; Klukowska-Roetzler, Jolanta; Lanz, Simone; Gerber, Vincent] Univ Bern, Swiss Inst Equine Med, Vetsuisse Fac, Bern, Switzerland; [Pacholewska, Alicja; Klukowska-Roetzler, Jolanta; Lanz, Simone; Gerber, Vincent] Agroscope, Bern, Switzerland; [Pacholewska, Alicja; Jagannathan, Vidhya; Droegemueller, Michaela; Klukowska-Roetzler, Jolanta; Leeb, Tosso] Univ Bern, Inst Genet, Vetsuisse Fac, Bern, Switzerland; [Klukowska-Roetzler, Jolanta] Univ Hosp Bern, Dept Pediat, Div Pediat Hematol Oncol, CH-3010 Bern, Switzerland; [Hamza, Eman; Marti, Eliane] Univ Bern, Dept Clin Res & Vet Publ Hlth, Clin Immunol Grp, Bern, Switzerland; [Hamza, Eman] Cairo Univ, Dept Zoonoses, Fac Vet Med, Cairo, Egypt; [Dermitzakis, Emmanouil T.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Dermitzakis, Emmanouil T.] Swiss Inst Bioinformat, Inst Genet & Genom Geneva, Geneva, Switzerland	University of Bern; Swiss Federal Research Station Agroscope; University of Bern; University of Bern; University Hospital of Bern; University of Bern; Egyptian Knowledge Bank (EKB); Cairo University; University of Geneva; Swiss Institute of Bioinformatics	Pacholewska, A (corresponding author), Univ Bern, Swiss Inst Equine Med, Vetsuisse Fac, Bern, Switzerland.	alicja.pacholewska@vetsuisse.unibe.ch	Leeb, Tosso/G-3187-2014; Pacholewska, Alicja/A-3267-2015; Jagannathan, Vidhya/P-1055-2019	Leeb, Tosso/0000-0003-0553-4880; Pacholewska, Alicja/0000-0002-4888-4883; Jagannathan, Vidhya/0000-0002-8155-0041; Hamza, Eman/0000-0001-9798-842X	Swiss National Science Foundation [310030-138295, 310000-116803/1]; Swiss Institute of Equine Medicine Research (ismequine.ch)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Institute of Equine Medicine Research (ismequine.ch)	The presented study was funded by Swiss National Science Foundation (www.snf.ch): grant No. 310030-138295 and 310000-116803/1; and Swiss Institute of Equine Medicine Research (ismequine.ch). VG and EM received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad T, 2012, AM J RESP CELL MOL, V47, P1, DOI 10.1165/rcmb.2011-0203OC; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Ansotegui I, 2013, WHITE BOOK ON ALLERG; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Augsten M, 2009, P NATL ACAD SCI USA, V106, P3414, DOI 10.1073/pnas.0813144106; Baek KJ, 2013, CLIN IMMUNOL, V147, P27, DOI 10.1016/j.clim.2013.02.004; Blain KY, 2007, BIOCHEMISTRY-US, V46, P10008, DOI 10.1021/bi700936w; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Blouin CC, 2004, BLOOD, V103, P1124, DOI 10.1182/blood-2003-07-2427; Boldman K. G., 1993, MANUAL USE MTDFREML; Brundler P, 2011, Vet J, V190, pe12, DOI 10.1016/j.tvjl.2010.12.029; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Carlsen HS, 2004, BLOOD, V104, P3021, DOI 10.1182/blood-2004-02-0701; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Castro A, 2005, ONCOGENE, V24, P314, DOI 10.1038/sj.onc.1207973; Cordeau ME, 2004, VET IMMUNOL IMMUNOP, V97, P87, DOI 10.1016/j.vetimm.2003.08.013; Dalton JE, 2004, J IMMUNOL, V173, P3660, DOI 10.4049/jimmunol.173.6.3660; Dalton JE, 2003, J IMMUNOL, V171, P6488, DOI 10.4049/jimmunol.171.12.6488; Debrue M, 2005, VET IMMUNOL IMMUNOP, V105, P25, DOI 10.1016/j.vetimm.2004.12.013; Deifl S, 2014, ALLERGY, V69, P1602, DOI 10.1111/all.12501; DUFFY DL, 1990, AM REV RESPIR DIS, V142, P1351, DOI 10.1164/ajrccm/142.6_Pt_1.1351; EDFORSLUBS ML, 1971, ACTA ALLERGOL, V26, P249, DOI 10.1111/j.1398-9995.1971.tb01300.x; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Fehr AR, 2013, J VIROL, V87, P8818, DOI 10.1128/JVI.00088-13; Festa ED, 2009, MULT SCLER J, V15, P1271, DOI 10.1177/1352458509107017; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; Gerard NP, 2002, CURR OPIN IMMUNOL, V14, P705, DOI 10.1016/S0952-7915(02)00410-7; Gerber V, 2009, J VET INTERN MED, V23, P626, DOI 10.1111/j.1939-1676.2009.0292.x; GREEN JA, 1969, SCIENCE, V164, P1415, DOI 10.1126/science.164.3886.1415; Guo J, 2009, INT ARCH ALLERGY IMM, V149, P98, DOI 10.1159/000189191; Hamza E, 2008, VET IMMUNOL IMMUNOP, V122, P65, DOI 10.1016/j.vetimm.2007.10.018; Hansen S, 2014, VET IMMUNOL IMMUNOP, V158, P238, DOI 10.1016/j.vetimm.2014.02.001; Henriquez C, 2014, VET IMMUNOL IMMUNOP, V158, P128, DOI 10.1016/j.vetimm.2013.12.005; Horohov DW, 2005, VET IMMUNOL IMMUNOP, V108, P237, DOI 10.1016/j.vetimm.2005.07.013; Huang HC, 2009, CANCER CELL, V16, P347, DOI 10.1016/j.ccr.2009.08.020; Huerta-Yepez S, 2011, ALLERGY, V66, P909, DOI 10.1111/j.1398-9995.2011.02594.x; Jiang JH, 2011, BIOCHEM BIOPH RES CO, V415, P325, DOI 10.1016/j.bbrc.2011.10.055; Jost U, 2007, EQUINE VET J, V39, P236, DOI 10.2746/042516407X171110; Baay-Guzman GJ, 2012, CHEST, V141, P886, DOI 10.1378/chest.11-0633; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; Karnati HK, 2015, VET RES COMMUN, V39, P73, DOI 10.1007/s11259-014-9621-2; Karp CL, 2000, NAT IMMUNOL, V1, P221, DOI 10.1038/79759; Kato T, 2012, J SURG ONCOL, V106, P423, DOI 10.1002/jso.23109; Kehrli D, 2015, J VET INTERN MED, V29, P320, DOI 10.1111/jvim.12473; Kidokoro T, 2008, ONCOGENE, V27, P1562, DOI 10.1038/sj.onc.1210799; Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030; Kleiber C, 2005, VET IMMUNOL IMMUNOP, V104, P91, DOI 10.1016/j.vetimm.2004.10.002; Klier J, 2011, VET IMMUNOL IMMUNOP, V144, P79, DOI 10.1016/j.vetimm.2011.07.009; Klukowska-Rotzler J, 2012, ANIM GENET, V43, P450, DOI 10.1111/j.1365-2052.2011.02277.x; Kohl J, 2007, CURR OPIN PHARMACOL, V7, P283, DOI 10.1016/j.coph.2007.01.005; Lajoie S, 2010, NAT IMMUNOL, V11, P928, DOI 10.1038/ni.1926; Lanz S, 2013, VET IMMUNOL IMMUNOP, V155, P229, DOI 10.1016/j.vetimm.2013.07.005; Laumen E, 2010, EQUINE VET J, V42, P142, DOI 10.2746/042516409X479586; Lavoie JP, 2001, AM J RESP CRIT CARE, V164, P1410, DOI 10.1164/ajrccm.164.8.2012091; Leclere M, 2011, RESPIROLOGY, V16, P1027, DOI 10.1111/j.1440-1843.2011.02033.x; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; Lindberg A, 2004, AM J VET RES, V65, P289, DOI 10.2460/ajvr.2004.65.289; MARTI E, 1991, EQUINE VET J, V23, P457, DOI 10.1111/j.2042-3306.1991.tb03761.x; Masteller EL, 2014, DRUG DISCOV TODAY, V19, P1212, DOI 10.1016/j.drudis.2014.05.016; MCFADDEN ER, 1968, NEW ENGL J MED, V278, P1027, DOI 10.1056/NEJM196805092781901; McMahon S, 2006, J BIOL CHEM, V281, P24171, DOI 10.1074/jbc.M604507200; Meraouna A, 2006, BLOOD, V108, P432, DOI 10.1182/blood-2005-06-2383; Mo JH, 2014, AM J RHINOL ALLERGY, V28, pE100, DOI 10.2500/ajra.2014.28.4025; Molet S, 2001, J ALLERGY CLIN IMMUN, V108, P430, DOI 10.1067/mai.2001.117929; Moran G, 2011, VET MED-CZECH, V56, P1, DOI 10.17221/1566-VETMED; Mullane K, 2014, BIOCHEM PHARMACOL, V87, P131, DOI 10.1016/j.bcp.2013.06.026; NAKAYAMA T, 1983, INFECT IMMUN, V40, P486, DOI 10.1128/IAI.40.2.486-492.1983; Neuhaus S, 2010, J VET INTERN MED, V24, P407, DOI 10.1111/j.1939-1676.2009.0465.x; Nials AT, 2008, DIS MODEL MECH, V1, P213, DOI 10.1242/dmm.000323; Niedzwiedz A, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-29; Nishi H, 2004, MOL CELL BIOL, V24, P6076, DOI 10.1128/MCB.24.13.6076-6083.2004; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; OBEL NJ, 1948, ACTA PHARMACOL TOX, V4, P71; Pacholewska A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122011; Pirie RS, 2003, CLIN EXP ALLERGY, V33, P1289, DOI 10.1046/j.1365-2745.2003.01651.x; Pirie RS, 2003, CLIN EXP ALLERGY, V33, P676, DOI 10.1046/j.1365-2222.2003.01640.x; Pirie RS, 2002, EQUINE VET J, V34, P343, DOI 10.2746/042516402776249236; Portales-Casamar E, 2009, NUCLEIC ACIDS RES, V37, pD54, DOI 10.1093/nar/gkn783; Poynter ME, 2004, J IMMUNOL, V173, P7003, DOI 10.4049/jimmunol.173.11.7003; Pu D, 2014, EXP THER MED, V8, P1914, DOI 10.3892/etm.2014.2025; Ramseyer A, 2007, J VET INTERN MED, V21, P149, DOI 10.1892/0891-6640(2007)21[149:EOGAEF]2.0.CO;2; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sarmiento J, 2013, VET RES COMMUN, V37, P333, DOI 10.1007/s11259-013-9571-0; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Schott J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004368; SchulzKnappe P, 1996, J EXP MED, V183, P295, DOI 10.1084/jem.183.1.295; SIMPSON H, 1968, BRIT MED J, V3, P460, DOI 10.1136/bmj.3.5616.460; Singh RP, 2014, AUTOIMMUN REV, V13, P1174, DOI 10.1016/j.autrev.2014.08.019; Sood A, 2012, CHEST, V142, P425, DOI 10.1378/chest.11-2519; Strina A, 2014, EMERG THEMES EPIDEMI, V11, DOI 10.1186/1742-7622-11-5; Swinburne JE, 2009, MAMM GENOME, V20, P504, DOI 10.1007/s00335-009-9214-5; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; Takagi R, 2008, J IMMUNOL, V181, P186, DOI 10.4049/jimmunol.181.1.186; Tang MLK, 2006, PHARMACOL THERAPEUT, V112, P474, DOI 10.1016/j.pharmthera.2006.05.001; Tello D, 2011, CELL METAB, V14, P768, DOI 10.1016/j.cmet.2011.10.008; Temesi G, 2014, ALLERGY ASTHMA IMMUN, V6, P496, DOI 10.4168/aair.2014.6.6.496; Toussaint M, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-64; Turlej RK, 2001, THORAX, V56, P696, DOI 10.1136/thorax.56.9.696; Turnquist HR, 2010, BLOOD, V115, P4758, DOI 10.1182/blood-2009-10-251488; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; Voelkel NF, 2009, IMMUNOL CELL BIOL, V87, P601, DOI 10.1038/icb.2009.45; WADDELL JA, 1967, BRIT MED J, V2, P402, DOI 10.1136/bmj.2.5549.402; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; Wan LX, 2014, DEV CELL, V29, P377, DOI 10.1016/j.devcel.2014.04.022; Wang C, 2014, NAT BIOTECHNOL, V32, P926, DOI 10.1038/nbt.3001; Wang Q, 2010, J IMMUNOL, V185, P834, DOI 10.4049/jimmunol.0901490; Wang YM, 2014, EUR J IMMUNOL, V44, P1575, DOI 10.1002/eji.201344365; Wasch R, 2005, ONCOGENE, V24, P1, DOI 10.1038/sj.onc.1208017; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Wu MX, 1998, SCIENCE, V281, P998, DOI 10.1126/science.281.5379.998; Xia XB, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r113; Zaslona Z, 2014, J IMMUNOL, V193, P4245, DOI 10.4049/jimmunol.1400580; Zhang X, 2010, EXPERT REV CLIN IMMU, V6, P269, DOI 10.1586/ECI.09.84	120	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136103	10.1371/journal.pone.0136103	http://dx.doi.org/10.1371/journal.pone.0136103			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26292153	Green Submitted, Green Published, gold			2022-12-26	WOS:000359919900055
J	Smith, M; Berdel, D; Nowak, D; Heinrich, J; Schulz, H				Smith, Maia; Berdel, Dietrich; Nowak, Dennis; Heinrich, Joachim; Schulz, Holger			Sport Engagement by Accelerometry under Field Conditions in German Adolescents: Results from GINIPlus	PLOS ONE			English	Article							VIGOROUS PHYSICAL-ACTIVITY; CHILDREN; SEDENTARY; CHILDHOOD; PATTERNS; SUCCESS; WOMEN; AGE	Introduction Sporting activities differ in their ability to promote moderate-to-vigorous physical activity (MVPA). To assess adolescents' engagement in sport under field conditions we used accelerometers to measure their MVPA levels during sport. We pay special attention to differences between team and individual sport and between common sports. Methods Diary data and 7-day accelerometry from 1054 Germans ages 15-17 were combined to measure physical activity. 1373 diaried episodes of more than 40 common sports were identified from 626 participants and grouped into team and individual sport. We modeled the effect of team and individual sport, and described levels of MVPA and episodes of no MVPA for all recorded sports. Results German boys and girls averaged 43 (SD 21) and 37 (SD 24) minutes MVPA per day. Boys got 2.2 times as much MVPA per minute during team compared to individual sport (p< 0.0001) but there was no significant difference for girls. Percent of time spent in MVPA during sport ranged from6% for weight training to 74% for jogging, with individual sports averaging 10-30% and team sports 30-50%. 11% of sport episodes had no MVPA: half of episodes of cycling, 5% of jogging, and none for tennis or badminton. An episode of individual sport was 17 times more likely to have no MVPA than an episode of team sport (p< 0.0001). Conclusion Under field condition, adolescents were active for only a fraction of diaried sporting time. As measured by accelerometry, individual sport often produced no MVPA. Characteristics of the sport, such as team vs. individual, were more predictive of MVPA than were characteristics of the participant, such as background activity levels.	[Smith, Maia; Heinrich, Joachim; Schulz, Holger] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 1, Munich, Germany; [Berdel, Dietrich] Marien Hosp Wesel, Dept Pediat, Wesel, Germany; [Nowak, Dennis; Heinrich, Joachim; Schulz, Holger] German Ctr Lung Res, CPC M, Munich, Germany; [Nowak, Dennis] Univ Munich, Inst & Outpatient Clin Occupat Social & Environm, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; St. Marien Hospital; University of Munich	Schulz, H (corresponding author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 1, Munich, Germany.	schulz@helmholtz-muenchen.de	Schulz, Holger/J-5643-2015; Heinrich, Joachim/N-1720-2013	Schulz, Holger/0000-0002-1157-200X; Heinrich, Joachim/0000-0002-9620-1629; Smith, Maia Phillips/0000-0002-1154-1158	Mead Johnson; Nestle; Comprehensive Pneumology Center Munich (CPC-M)	Mead Johnson; Nestle(Nestle SA); Comprehensive Pneumology Center Munich (CPC-M)	The 15 year follow up of the GINIplus study was mainly covered from the respective budgets of the initial 4 study centres (Wesel, LMU Munich, Deutsche Rentenversicherung (DRV) Bayern Sud, Helmholtz Centre Munich), partly by the Federal Ministry for the Environment, and by the budget of the IUF - Leibniz Research Institute for Environmental Medicine at the University of Dusseldorf. Further support was obtained from the companies Mead Johnson and Nestle and by cooperation in European Studies (e.g Medall, ESCAPE). In addition, this work was supported by the Comprehensive Pneumology Center Munich (CPC-M) as member of the German Center for Lung Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carnes A, 2014, GENDER DIFFERENCES E; Chung AE, 2012, CLIN PEDIATR, V51, P122, DOI 10.1177/0009922811417291; Colley Rachel C, 2011, Health Rep, V22, P7; Deaner RO, 2015, PEERJ, V3, DOI 10.7717/peerj.884; DiLorenzo TM, 1998, PREV MED, V27, P470, DOI 10.1006/pmed.1998.0307; Ekelund U, 2012, JAMA-J AM MED ASSOC, V307, P704, DOI 10.1001/jama.2012.156; Fairclough S, 2004, HLTH ED RES THEORY P, V20, P14; Freedson P, 2005, MED SCI SPORT EXER, V37, pS523, DOI 10.1249/01.mss.0000185658.28284.ba; Gill D, 1988, SPORT PSYCHOL, V2, P212, DOI DOI 10.1123/TSP.2.3.212; Guinhouya BC, 2013, PUBLIC HEALTH, V127, P301, DOI 10.1016/j.puhe.2013.01.020; Heilman ME, 2007, J APPL PSYCHOL, V92, P81, DOI 10.1037/0021-9010.92.1.81; Heilman ME, 2004, J APPL PSYCHOL, V89, P416, DOI 10.1037/0021-9010.89.3.416; Heinrich J, GERMAN INTERVENTIONA; Kozey SL, 2010, MED SCI SPORT EXER, V42, P1776, DOI 10.1249/MSS.0b013e3181d479f2; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; LeBlanc AGW, 2010, PEDIATR EXERC SCI, V22, P523, DOI 10.1123/pes.22.4.523; Malina RM, 2001, QUEST, V53, P346, DOI 10.1080/00336297.2001.10491751; Matthews CE, 2012, MED SCI SPORT EXER, V44, pS68, DOI 10.1249/MSS.0b013e3182399e5b; Morales J, 2013, AM ALL HLTH PHYS ED; Nader PR, 2008, JAMA-J AM MED ASSOC, V300, P295, DOI 10.1001/jama.300.3.295; Pfitzner R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065192; Riddoch CJ, 2007, ARCH DIS CHILD, V92, P963, DOI 10.1136/adc.2006.112136; Ridgers ND, 2005, PREV MED, V41, P102, DOI 10.1016/j.ypmed.2004.10.023; Ruiz JR, 2011, AM J EPIDEMIOL, V174, P173, DOI 10.1093/aje/kwr068; Sheehan D, 2014, CAN C LEIS RES 2014; Sirard JR, 2001, SPORTS MED, V31, P439, DOI 10.2165/00007256-200131060-00004; Smith M, 2014, HDB PHYS ED RES ROLE, P203; Steele RM, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-88; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; US Department of Health & Human Services, 2008, PHYS ACT GUID AM, DOI DOI 10.4085/1062-6050-44.1.5; USCDC, 2010, STRAT IMPR QUAL PHYS; Verloigne M., 2012, INT J BEHAV NUTR PHY, V31, P9; von Berg A, 2010, CLIN EXP ALLERGY, V40, P627, DOI 10.1111/j.1365-2222.2009.03444.x; Wann DL, 1999, J SPORT BEHAV, V22; Weber B, 2008, J PERS SOC PSYCHOL, V93, P973; Weisberg YJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00178	36	14	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135630	10.1371/journal.pone.0135630	http://dx.doi.org/10.1371/journal.pone.0135630			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291984	Green Published, gold, Green Submitted			2022-12-26	WOS:000359919900021
J	Marin, I				Marin, Ignacio			Origin and Diversification of Meprin Proteases	PLOS ONE			English	Article							CIONA-INTESTINALIS; ASTACIN FAMILY; ALPHA-SUBUNIT; BETA-SUBUNIT; GENE; METALLOPROTEASES; EXPRESSION; EVOLUTION; ENDOPEPTIDASES; LOCALIZATION	Meprins are astacin metalloproteases with a characteristic, easily recognizable structure, given that they are the only proteases with both MAM and MATH domains plus a transmembrane region. So far assumed to be vertebrate-specific, it is shown here, using a combination of evolutionary and genomic analyses, that meprins originated before the urochordates/vertebrates split. In particular, three genes encoding structurally typical meprin proteins are arranged in tandem in the genome of the urochordate Ciona intestinalis. Phylogenetic analyses showed that the protease and MATH domains present in the meprin-like proteins encoded by the Ciona genes are very similar in sequence to the domains found in vertebrate meprins, which supports them having a common origin. While many vertebrates have the two canonical meprin-encoding genes orthologous to human MEP1A and MEP1B (which respectively encode for the proteins known as meprin a and meprin beta), a single gene has been found so far in the genome of the chondrichthyan fish Callorhinchus milii, and additional meprin-encoding genes are present in some species. Particularly, a group of bony fish species have genes encoding highly divergent meprins, here named meprin-F. Genes encoding meprin-F proteins, derived from MEP1B genes, are abundant in some species, as the Amazon molly, Poecilia formosa, which has 7 of them. Finally, it is confirmed that the MATH domains of meprins are very similar to the ones in TRAF ubiquitin ligases, which suggests that meprins originated when protease and TRAF E3-encoding sequences were combined.	CSIC, IBV, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV)	Marin, I (corresponding author), CSIC, IBV, Valencia, Spain.	imarin@ibv.csic.es	Marin, Ignacio/A-9524-2009	Marin, Ignacio/0000-0002-1315-8961	Ministerio de Economia y Competitividad (Spanish Government) [BFU2011-30063]	Ministerio de Economia y Competitividad (Spanish Government)(Spanish Government)	This study was supported by Ministerio de Economia y Competitividad (Spanish Government) Grant BFU2011-30063. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arolas JL, 2012, P NATL ACAD SCI USA, V109, P16131, DOI 10.1073/pnas.1211076109; Banerjee S, 2009, MUCOSAL IMMUNOL, V2, P220, DOI 10.1038/mi.2009.3; BARNES K, 1989, BIOCHEM J, V264, P335, DOI 10.1042/bj2640335; Becker-Pauly C, 2007, J INVEST DERMATOL, V127, P1115, DOI 10.1038/sj.jid.5700675; Becker-Pauly C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009233; Becker-Pauly C, 2009, J MOL BIOL, V385, P236, DOI 10.1016/j.jmb.2008.10.062; BECKMANN G, 1993, TRENDS BIOCHEM SCI, V18, P40, DOI 10.1016/0968-0004(93)90049-S; Bertenshaw GP, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P900, DOI 10.1016/B978-0-12-382219-2.00189-7; Bertenshaw GP, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P910, DOI 10.1016/B978-0-12-382219-2.00190-3; BEYNON RJ, 1981, BIOCHEM J, V199, P591, DOI 10.1042/bj1990591; Biasin V, 2014, J PATHOL, V233, P7, DOI 10.1002/path.4303; BOND JS, 1995, PROTEIN SCI, V4, P1247, DOI 10.1002/pro.5560040701; Broder C, 2013, P NATL ACAD SCI USA, V110, P14219, DOI 10.1073/pnas.1305464110; Broder C, 2013, BIOCHEM J, V450, P253, DOI 10.1042/BJ20121751; BUTLER PE, 1988, J BIOL CHEM, V263, P13419; DUMERMUTH E, 1991, J BIOL CHEM, V266, P21381; Eagle ARR, 2005, HUM GENET, V118, P12, DOI 10.1007/s00439-005-0019-7; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; GORBEA CM, 1993, J BIOL CHEM, V268, P21035; Huxley-Jones J, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-63; Jefferson T, 2013, CELL MOL LIFE SCI, V70, P309, DOI 10.1007/s00018-012-1106-2; JIANG WP, 1992, J BIOL CHEM, V267, P9185; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kaushal GP, 2013, AM J PHYSIOL-RENAL, V304, pF1150, DOI 10.1152/ajprenal.00014.2013; KOUNNAS MZ, 1991, J BIOL CHEM, V266, P17350; Kronenberg D, 2010, J INVEST DERMATOL, V130, P2727, DOI 10.1038/jid.2010.202; Lam UDP, 2014, GENE, V537, P245, DOI 10.1016/j.gene.2013.12.055; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Marin I, 2008, J MOL EVOL, V67, P41, DOI 10.1007/s00239-008-9122-4; Marin I, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-63; Marin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068536; Marin I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050030; Mohrlen F, 2003, EUR J BIOCHEM, V270, P4909, DOI 10.1046/j.1432-1033.2003.03891.x; Mohrlen F, 2006, EVOL DEV, V8, P223, DOI 10.1111/j.1525-142X.2006.00092.x; Nicholas KB, 1997, GENEDOC A TOOL FOR E; Norman LP, 2003, MOL CELL BIOL, V23, P1221, DOI 10.1128/MCB.23.4.1221-1230.2003; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Rawlins ND, 2013, HDB PROTEOLYTIC ENZY, V1, P325; Satou Y, 2005, ZOOL SCI, V22, P837, DOI 10.2108/zsj.22.837; Satou Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r152; Schutte A, 2007, BIOL CHEM, V388, P523, DOI 10.1515/BC.2007.060; Sterchi EE, 2008, MOL ASPECTS MED, V29, P309, DOI 10.1016/j.mam.2008.08.002; Stocker W., 2013, PROTEASES STRUCTURE, P235, DOI DOI 10.1007/978-3-7091-0885-7; Sun Q, 2009, EXP HEMATOL, V37, P346, DOI 10.1016/j.exphem.2008.10.016; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Uren AG, 1996, TRENDS BIOCHEM SCI, V21, P244, DOI 10.1016/S0968-0004(96)30022-4; Gomis-Ruth FX, 2012, BIOL CHEM, V393, P1027, DOI 10.1515/hsz-2012-0149; Yan L, 2000, DEVELOPMENT, V127, P129; Zapata JM, 2007, ADV EXP MED BIOL, V597, P1; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	52	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135924	10.1371/journal.pone.0135924	http://dx.doi.org/10.1371/journal.pone.0135924			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288188	Green Published, gold, Green Submitted			2022-12-26	WOS:000360018600086
J	Oudman, T; Hin, V; Dekinga, A; van Gils, JA				Oudman, Thomas; Hin, Vincent; Dekinga, Anne; van Gils, Jan A.			The Effect of Digestive Capacity on the Intake Rate of Toxic and Non-Toxic Prey in an Ecological Context	PLOS ONE			English	Article							KNOTS CALIDRIS-CANUTUS; RED KNOTS; ANNUAL CYCLE; ORGAN SIZE; BEHAVIOR; MOLLUSCIVORE; PREDICTIONS; ADAPTATIONS; SHOREBIRDS; HERBIVORES	Digestive capacity often limits food intake rate in animals. Many species can flexibly adjust digestive organ mass, enabling them to increase intake rate in times of increased energy requirement and/or scarcity of high-quality prey. However, some prey species are defended by secondary compounds, thereby forcing a toxin limitation on the forager's intake rate, a constraint that potentially cannot be alleviated by enlarging digestive capacity. Hence, physiological flexibility may have a differential effect on intake of different prey types, and consequently on dietary preferences. We tested this effect in red knots (Calidris canutus canutus), medium-sized migratory shorebirds that feed on hard-shelled, usually mollusc, prey. Because they ingest their prey whole and crush the shell in their gizzard, the intake rate of red knots is generally constrained by digestive capacity. However, one of their main prey, the bivalve Loripes lucinalis, imposes a toxin constraint due to its symbiosis with sulphide-oxidizing bacteria. We manipulated gizzard sizes of red knots through prolonged exposure to hard-shelled or soft foods. We then measured maximum intake rates of toxic Loripes versus a non-toxic bivalve, Dosinia isocardia. We found that intake of Dosinia exponentially increased with gizzard mass, confirming earlier results with nontoxic prey, whereas intake of Loripes was independent of gizzard mass. Using linear programming, we show that this leads to markedly different expected diet preferences in red knots that try to maximize energy intake rate with a small versus a large gizzard. Intra-and inter-individual variation in digestive capacity is found in many animal species. Hence, the here proposed functional link with individual differences in foraging decisions may be general. We emphasize the potential relevance of individual variation in physiology when studying trophic interactions.	[Oudman, Thomas; Hin, Vincent; Dekinga, Anne; van Gils, Jan A.] NIOZ Royal Netherlands Inst Sea Res, Dept Marine Ecol, Texel, Netherlands	Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Oudman, T (corresponding author), NIOZ Royal Netherlands Inst Sea Res, Dept Marine Ecol, Texel, Netherlands.	Thomas.Oudman@nioz.nl	van Gils, Jan/B-5544-2008	van Gils, Jan/0000-0002-4132-8243; Hin, Vincent/0000-0002-9497-1224	Nederlandse organisatie voor Wetenschappelijk Onderzoek (NWO) [864.09.002]	Nederlandse organisatie voor Wetenschappelijk Onderzoek (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was funded by Nederlandse organisatie voor Wetenschappelijk Onderzoek (NWO) (grant number: 864.09.002; URL: www.nwo.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmedou Salem MV, 2014, ESTUAR COAST SHELF S, V136, P26, DOI 10.1016/j.ecss.2013.11.009; BAGARINAO T, 1992, AQUAT TOXICOL, V24, P21, DOI 10.1016/0166-445X(92)90015-F; Battley PF, 2005, J AVIAN BIOL, V36, P494, DOI 10.1111/j.0908-8857.2005.03730.x; BELOVSKY GE, 1978, THEOR POPUL BIOL, V14, P105, DOI 10.1016/0040-5809(78)90007-2; BELOVSKY GE, 1994, J MAMMAL, V75, P816, DOI 10.2307/1382464; Berenbaum MR, 1992, HERBIVORES THEIR INT, VII; Bijleveld AI, 2015, ECOLOGY, V96, P1943, DOI 10.1890/14-1845.1; Bijleveld AI, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3135; Buehler DM, 2008, PHILOS T R SOC B, V363, P247, DOI 10.1098/rstb.2007.2138; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Curley EAM, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0152; Dekinga A, 2001, J EXP BIOL, V204, P2167; DEKINGA A, 1993, BIRD STUDY, V40, P144, DOI 10.1080/00063659309477140; Dietz MW, 1999, PHYSIOL BIOCHEM ZOOL, V72, P28, DOI 10.1086/316648; Dingemanse NJ, 2013, J ANIM ECOL, V82, P39, DOI 10.1111/1365-2656.12013; Grieshaber MK, 1998, ANNU REV PHYSIOL, V60, P33, DOI 10.1146/annurev.physiol.60.1.33; Hall JO, 2007, VETERINARY TOXICOLOGY: BASIC AND CLINICAL PRINCIPLES, P465; HAMMOND KA, 1994, PHYSIOL ZOOL, V67, P1479, DOI 10.1086/physzool.67.6.30163908; Jeschke JM, 2002, ECOL MONOGR, V72, P95, DOI 10.1890/0012-9615(2002)072[0095:PFRDBH]2.0.CO;2; JOHNSON M, 1994, SYMBIOSIS, V17, P1; Leyrer J, 2013, J ORNITHOL, V154, P933, DOI 10.1007/s10336-013-0959-y; Leyrer J, 2012, BEHAV ECOL, V23, P1226, DOI 10.1093/beheco/ars106; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; McWilliams SR, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0308; Olsson J, 2007, BIOL J LINN SOC, V90, P517, DOI 10.1111/j.1095-8312.2007.00742.x; Onrust J, 2013, BIRD STUDY, V60, P298, DOI 10.1080/00063657.2013.811213; Oudman T, 2014, AM NAT, V183, P650, DOI 10.1086/675759; Piersma T, 1997, TRENDS ECOL EVOL, V12, P134, DOI 10.1016/S0169-5347(97)01003-3; PIERSMA T, 1993, AUK, V110, P552, DOI 10.2307/4088419; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; SECOR SM, 1995, J EXP BIOL, V198, P1313; Starck JM, 1999, ZOOL ANZ, V238, P87; van den Hout PJ, 2014, ANIM BEHAV, V88, P137, DOI 10.1016/j.anbehav.2013.11.020; van der Geest M, 2014, MAR ECOL PROG SER, V501, P113, DOI 10.3354/meps10702; van der Geest M, 2011, J EXP MAR BIOL ECOL, V399, P1, DOI 10.1016/j.jembe.2011.01.003; van der Heide T, 2012, SCIENCE, V336, P1432, DOI 10.1126/science.1219973; van Gils JA, 2005, P ROY SOC B-BIOL SCI, V272, P2609, DOI 10.1098/rspb.2005.3245; Van Gils JA, 2005, J ANIM ECOL, V74, P105, DOI 10.1111/j.1365-2656.2004.00903.x; van Gils JA, 2003, J EXP BIOL, V206, P3369, DOI 10.1242/jeb.00546; van Gils JA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0861; van Gils JA, 2012, ECOLOGY, V93, P1143, DOI 10.1890/11-1282.1; WESTOBY M, 1974, AM NAT, V108, P290, DOI 10.1086/282908; Yang HY, 2013, J EXP BIOL, V216, P3627, DOI 10.1242/jeb.083576	43	7	7	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136144	10.1371/journal.pone.0136144	http://dx.doi.org/10.1371/journal.pone.0136144			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287951	Green Published, gold			2022-12-26	WOS:000360018600112
J	Schwemmer, MA; Feng, SF; Holmes, PJ; Gottlieb, J; Cohen, JD				Schwemmer, Michael A.; Feng, Samuel F.; Holmes, Philip J.; Gottlieb, Jacqueline; Cohen, Jonathan D.			A Multi-Area Stochastic Model for a Covert Visual Search Task	PLOS ONE			English	Article							PERCEPTUAL DECISION; SUPERIOR COLLICULUS; AREA LIP; PARIETAL; INFORMATION; REPRESENTATION; ACCUMULATOR; MECHANISM; ATTENTION; CHOICE	Decisions typically comprise several elements. For example, attention must be directed towards specific objects, their identities recognized, and a choice made among alternatives. Pairs of competing accumulators and drift-diffusion processes provide good models of evidence integration in two-alternative perceptual choices, but more complex tasks requiring the coordination of attention and decision making involve multistage processing and multiple brain areas. Here we consider a task in which a target is located among distractors and its identity reported by lever release. The data comprise reaction times, accuracies, and single unit recordings from two monkeys' lateral interparietal area (LIP) neurons. LIP firing rates distinguish between targets and distractors, exhibit stimulus set size effects, and show response-hemifield congruence effects. These data motivate our model, which uses coupled sets of leaky competing accumulators to represent processes hypothesized to occur in feature-selective areas and limb motor and pre-motor areas, together with the visual selection process occurring in LIP. Model simulations capture the electrophysiological and behavioral data, and fitted parameters suggest that different connection weights between LIP and the other cortical areas may account for the observed behavioral differences between the animals.	[Schwemmer, Michael A.] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA; [Feng, Samuel F.] Khalifa Univ, Dept Appl Math & Sci, Abu Dhabi, U Arab Emirates; [Holmes, Philip J.] Princeton Univ, Program Appl & Computat Math, Dept Mech & Aerosp Engn, Princeton, NJ 08544 USA; [Holmes, Philip J.; Cohen, Jonathan D.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Gottlieb, Jacqueline] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Cohen, Jonathan D.] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA	University System of Ohio; Ohio State University; Khalifa University of Science & Technology; Princeton University; Princeton University; Columbia University; Princeton University	Schwemmer, MA (corresponding author), Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA.	schwemmer.2@mbi.osu.edu		Feng, Samuel/0000-0001-9046-2601	Air Force Office of Scientific Research [FA9550-07-1-0537, FA9550-07-1-0528]; National Institutes of Health [P50 MH62196, T32MH065214]; National Eye Institute; Alfred P. Sloan Foundation; Keck Foundation; Klingenstein Fund; McKnight Endowment Fund for Neuroscience; Mathematical Biosciences Institute; National Science Foundation [DMS-0931642]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH065214, P50MH062196] Funding Source: NIH RePORTER	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Keck Foundation(W.M. Keck Foundation); Klingenstein Fund(Klingenstein Philanthropies); McKnight Endowment Fund for Neuroscience; Mathematical Biosciences Institute; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Air Force Office of Scientific Research grants FA9550-07-1-0537 (SF, PH, and JC) and FA9550-07-1-0528 (PH and JC) and the National Institutes of Health grant P50 MH62196 (PH and JC). SF and MS benefitted from postdoctoral fellowships supplied by National Institutes of Health grant T32MH065214. JG acknowledges support from the National Eye Institute, the Alfred P. Sloan Foundation, the Keck Foundation, the Klingenstein Fund, and the McKnight Endowment Fund for Neuroscience. MS is currently supported in part by the Mathematical Biosciences Institute and the National Science Foundation under grant DMS-0931642. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balan PF, 2009, J NEUROSCI, V29, P8166, DOI 10.1523/JNEUROSCI.0243-09.2009; Balan PF, 2008, PLOS BIOL, V6, P1443, DOI 10.1371/journal.pbio.0060158; Bisley JW, 2010, ANNU REV NEUROSCI, V33, P1, DOI 10.1146/annurev-neuro-060909-152823; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Bogacz R, 2010, Q J EXP PSYCHOL, V63, P863, DOI 10.1080/17470210903091643; Borra E, 2008, CEREB CORTEX, V18, P1094, DOI 10.1093/cercor/bhm146; Borra E, 2014, CEREB CORTEX, V24, P1054, DOI 10.1093/cercor/bhs392; Buschman TJ, 2009, NEURON, V63, P386, DOI 10.1016/j.neuron.2009.06.020; COHEN JD, 1994, J COGNITIVE NEUROSCI, V6, P377, DOI 10.1162/jocn.1994.6.4.377; Deco G, 2013, PROG NEUROBIOL, V103, P194, DOI 10.1016/j.pneurobio.2012.01.010; Denys K, 2004, J NEUROSCI, V24, P2551, DOI 10.1523/JNEUROSCI.3569-03.2004; DErrico J, 2022, FMINSEARCHBND FMINSE; Ding L, 2012, NEURON, V75, P865, DOI 10.1016/j.neuron.2012.07.021; Eckhoff P, 2011, SIAM J APPL DYN SYST, V10, P148, DOI 10.1137/090770096; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Feng S., 2012, THESIS PRINCETON U; Feng S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000284; Fogassi L, 2005, CURR OPIN NEUROBIOL, V15, P626, DOI 10.1016/j.conb.2005.10.015; Gamberini M, 2009, J COMP NEUROL, V513, P622, DOI 10.1002/cne.21980; Gold JI, 2000, NATURE, V404, P390, DOI 10.1038/35006062; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Gottlieb J, 2004, SCIENCE, V303, P317, DOI 10.1126/science.1093922; GROSS CG, 1992, PHILOS T ROY SOC B, V335, P3, DOI 10.1098/rstb.1992.0001; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; Gross CG, 2008, NEUROPSYCHOLOGIA, V46, P841, DOI 10.1016/j.neuropsychologia.2007.11.009; Hanks TD, 2006, NAT NEUROSCI, V9, P682, DOI 10.1038/nn1683; Horwitz GD, 2004, J NEUROPHYSIOL, V91, P2281, DOI 10.1152/jn.00872.2003; Lehmann SJ, 2013, J NEUROSCI, V33, P7038, DOI 10.1523/JNEUROSCI.5568-12.2013; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; Miller KD, 2012, NEURAL COMPUT, V24, P25, DOI 10.1162/NECO_a_00221; Murata A, 2000, J NEUROPHYSIOL, V83, P2580, DOI 10.1152/jn.2000.83.5.2580; Oristaglio J, 2006, J NEUROSCI, V26, P8310, DOI 10.1523/JNEUROSCI.1779-06.2006; Plantenga T., 2009, HOPSPACK 2 0 USER MA; Purcell BA, 2012, J NEUROSCI, V32, P3433, DOI 10.1523/JNEUROSCI.4622-11.2012; Purcell BA, 2010, PSYCHOL REV, V117, P1113, DOI 10.1037/a0020311; Ratcliff R, 2003, J NEUROPHYSIOL, V90, P1392, DOI 10.1152/jn.01049.2002; Ratcliff R, 2002, PSYCHON B REV, V9, P438, DOI 10.3758/BF03196302; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Rorie AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009308; Sawaki R, 2012, J NEUROSCI, V32, P10725, DOI 10.1523/JNEUROSCI.1864-12.2012; Schwarzlose RF, 2008, P NATL ACAD SCI USA, V105, P4447, DOI 10.1073/pnas.0800431105; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Simen P, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00183; Simen P, 2009, J EXP PSYCHOL HUMAN, V35, P1865, DOI 10.1037/a0016926; Squire RF, 2013, ANNU REV NEUROSCI, V36, P451, DOI 10.1146/annurev-neuro-062111-150439; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; Vandekerckhove J., 2008, GEN SIMULATED ANNEAL; WICKELGREN WA, 1977, ACTA PSYCHOL, V41, P67, DOI 10.1016/0001-6918(77)90012-9; Wong KF, 2006, J NEUROSCI, V26, P1314, DOI 10.1523/JNEUROSCI.3733-05.2006; Yates J, 2014, COSYNE 2014 MAIN M	52	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136097	10.1371/journal.pone.0136097	http://dx.doi.org/10.1371/journal.pone.0136097			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287613	Green Submitted, gold, Green Published			2022-12-26	WOS:000360018600108
J	Trend, S; de Jong, E; Lloyd, ML; Kok, CH; Richmond, P; Doherty, DA; Simmer, K; Kakulas, F; Strunk, T; Currie, A				Trend, Stephanie; de Jong, Emma; Lloyd, Megan L.; Kok, Chooi Heen; Richmond, Peter; Doherty, Dorota A.; Simmer, Karen; Kakulas, Foteini; Strunk, Tobias; Currie, Andrew			Leukocyte Populations in Human Preterm and Term Breast Milk Identified by Multicolour Flow Cytometry	PLOS ONE			English	Article							MOTHERS DELIVERING PRETERM; NEONATAL IMMUNE-SYSTEM; COLOSTRAL LEUKOCYTES; LYMPHOCYTE SUBSETS; PROMOTES DEVELOPMENT; T-CELLS; BLOOD; MACROPHAGES; MECHANISMS; PROTEINS	Background Extremely preterm infants are highly susceptible to bacterial infections but breast milk provides some protection. It is unknown if leukocyte numbers and subsets in milk differ between term and preterm breast milk. This study serially characterised leukocyte populations in breast milk of mothers of preterm and term infants using multicolour flow cytometry methods for extended differential leukocyte counts in blood. Methods Sixty mothers of extremely preterm (<28 weeks gestational age), very preterm (28-31 wk), and moderately preterm (32-36 wk), as well as term (37-41 wk) infants were recruited. Colostrum (d2-5), transitional (d8-12) and mature milk (d26-30) samples were collected, cells isolated, and leukocyte subsets analysed using flow cytometry. Results The major CD45+ leukocyte populations circulating in blood were also detectable in breast milk but at different frequencies. Progression of lactation was associated with decreasing CD45+ leukocyte concentration, as well as increases in the relative frequencies of neutrophils and immature granulocytes, and decreases in the relative frequencies of eosinophils, myeloid and B cell precursors, and CD16-monocytes. No differences were observed between preterm and term breast milk in leukocyte concentration, though minor differences between preterm groups in some leukocyte frequencies were observed. Conclusions Flow cytometry is a useful tool to identify and quantify leukocyte subsets in breast milk. The stage of lactation is associated with major changes in milk leukocyte composition in this population. Fresh preterm breast milk is not deficient in leukocytes, but shorter gestation may be associated with minor differences in leukocyte subset frequencies in preterm compared to term breast milk.	[Trend, Stephanie; de Jong, Emma; Lloyd, Megan L.; Kok, Chooi Heen; Simmer, Karen; Strunk, Tobias; Currie, Andrew] Univ Western Australia, Ctr Neonatal Res & Educ, Perth, WA 6009, Australia; [Trend, Stephanie; de Jong, Emma; Richmond, Peter; Currie, Andrew] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia; [de Jong, Emma; Currie, Andrew] Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia; [Lloyd, Megan L.] Univ Western Australia, Sch Pathol & Lab Med, Perth, WA 6009, Australia; [Kok, Chooi Heen; Simmer, Karen; Strunk, Tobias] King Edward Mem Hosp Women, Neonatal Clin Care Unit, Perth, WA, Australia; [Doherty, Dorota A.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia; [Kakulas, Foteini] Univ Western Australia, Sch Chem & Biochem, Perth, WA 6009, Australia	University of Western Australia; University of Western Australia; Murdoch University; University of Western Australia; King Edward Memorial Hospital; University of Western Australia; University of Western Australia; University of Western Australia	Currie, A (corresponding author), Univ Western Australia, Ctr Neonatal Res & Educ, Perth, WA 6009, Australia.	a.currie@murdoch.edu.au	Strunk, Tobias/AIE-3407-2022; Lloyd, Megan/B-5690-2008; Currie, Andrew/C-2778-2015; Richmond, Peter C/G-3379-2012; de Jong, Emma/AHC-9300-2022	Strunk, Tobias/0000-0001-7079-2339; Lloyd, Megan/0000-0002-0140-1215; Richmond, Peter C/0000-0001-7562-7228; de Jong, Emma/0000-0002-2501-6119; Simmer, Karen/0000-0003-4777-9069; Trend, Stephanie/0000-0003-0210-3452; Currie, Andrew/0000-0002-5193-3404	Centre for Neonatal Research and Education, Women and Infants Research Foundation (WIRF); Princess Margaret Hospital (PMH) foundation; WIRF; Medela AG (Switzerland)	Centre for Neonatal Research and Education, Women and Infants Research Foundation (WIRF); Princess Margaret Hospital (PMH) foundation; WIRF; Medela AG (Switzerland)	Funding: ST received postgraduate scholarships from the Centre for Neonatal Research and Education, Women and Infants Research Foundation (WIRF), and the Princess Margaret Hospital (PMH) foundation. TS and ST received an early career grant from WIRF for this work. FH was the recipient of an unrestricted research grant by Medela AG (Switzerland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armogida SA, 2004, ALLERGY ASTHMA PROC, V25, P297; Bjornsson S, 2008, CYTOM PART B-CLIN CY, V74B, P91, DOI 10.1002/cyto.b.20382; Castellote C, 2011, J NUTR, V141, P1181, DOI 10.3945/jn.110.133652; Chatterton DEW, 2013, INT J BIOCHEM CELL B, V45, P1730, DOI 10.1016/j.biocel.2013.04.028; Cossey V, 2013, NEONATOLOGY, V103, P170, DOI 10.1159/000345419; Currie AJ, 2011, INFECT IMMUN, V79, P1588, DOI 10.1128/IAI.00535-10; DAWARKADAS AM, 1991, J TROP PEDIATRICS, V37, P214, DOI 10.1093/tropej/37.5.214; EGLINTON BA, 1994, IMMUNOL CELL BIOL, V72, P306, DOI 10.1038/icb.1994.46; Faucher JL, 2007, CYTOM PART A, V71A, P934, DOI 10.1002/cyto.a.20457; GOLDMAN AS, 1982, J PEDIATR-US, V101, P901, DOI 10.1016/S0022-3476(82)80007-3; Harrington AM, 2012, AM J CLIN PATHOL, V137, P800, DOI 10.1309/AJCPN4G1IZPABRLH; Hassiotou F, 2013, CLIN TRANSL IMMUNOL, V2, DOI 10.1038/cti.2013.1; Hassiotou F, 2013, J HUM LACT, V29, P171, DOI 10.1177/0890334413477242; Hawkes JS, 1999, PEDIATR RES, V45, P648, DOI 10.1203/00006450-199905010-00006; Hulspas R, 2009, CYTOM PART B-CLIN CY, V76B, P355, DOI 10.1002/cyto.b.20485; JAIN L, 1989, ARCH DIS CHILD-FETAL, V64, P930, DOI 10.1136/adc.64.7_Spec_No.930; JAIN N, 1991, ACTA PAEDIATR SCAND, V80, P395, DOI 10.1111/j.1651-2227.1991.tb11872.x; Jo Y, 2011, KOREAN J LAB MED, V31, P131, DOI 10.3343/kjlm.2011.31.3.131; JOHNSON DF, 1980, INFECT IMMUN, V28, P314; Lavoie PM, 2010, J INFECT DIS, V202, P1754, DOI 10.1086/657143; Lay JC, 2011, INHAL TOXICOL, V23, P392, DOI 10.3109/08958378.2011.575568; LIEBHABER M, 1977, J PEDIATR-US, V91, P897, DOI 10.1016/S0022-3476(77)80885-8; Maecker HT, 2006, CYTOM PART A, V69A, P1037, DOI 10.1002/cyto.a.20333; Marchant EA, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/586076; Melville JM, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00079; Njemini R, 2014, SCAND J IMMUNOL, V79, P75, DOI 10.1111/sji.12142; O'Connell FP, 2004, AM J CLIN PATHOL, V121, P254, DOI 10.1309/617DWB5GNFWXHW4L; OZKARAGOZ F, 1988, PEDIATR RES, V23, P449, DOI 10.1203/00006450-198805000-00001; Park SH, 2014, CYTOM PART B-CLIN CY, V86, P244, DOI [10.1002/cyto.b.21123, 10.1002/cytob.21123]; Patel AL, 2013, J PERINATOL, V33, P514, DOI 10.1038/jp.2013.2; Peroni DG, 2013, J MATERN-FETAL NEO M, V26, P137, DOI 10.3109/14767058.2012.733744; Reber AJ, 2008, VET IMMUNOL IMMUNOP, V123, P305, DOI 10.1016/j.vetimm.2008.02.009; Reber AJ, 2008, VET IMMUNOL IMMUNOP, V123, P186, DOI 10.1016/j.vetimm.2008.01.034; Reber AJ, 2006, VET IMMUNOL IMMUNOP, V109, P139, DOI 10.1016/j.vetimm.2005.08.014; Redline Raymond W, 2004, Semin Neonatol, V9, P265, DOI 10.1016/j.siny.2003.09.005; Riskin A, 2012, PEDIATR RES, V71, P220, DOI 10.1038/pr.2011.34; RODRIGUEZ C, 1989, ACTA PAEDIATR SCAND, V78, P337, DOI 10.1111/j.1651-2227.1989.tb11088.x; Roussel M, 2010, CYTOM PART A, V77A, P552, DOI 10.1002/cyto.a.20893; SCHLESINGER L, 1989, J PEDIATR GASTR NUTR, V8, P89, DOI 10.1097/00005176-198901000-00017; SCHNORR KL, 1984, J REPROD IMMUNOL, V6, P329, DOI 10.1016/0165-0378(84)90031-7; Tarcan A, 2004, BIOL NEONATE, V86, P22, DOI 10.1159/000076918; Trend S, 2015, ANTIBACTERIAL DEFENC; Tuaillon E, 2009, J IMMUNOL, V182, P7155, DOI 10.4049/jimmunol.0803107; van de Geijn GJ, 2011, CYTOM PART A, V79A, P694, DOI 10.1002/cyto.a.21105; van Galen P, 2014, NATURE, V510, P268, DOI 10.1038/nature13228; World Health Organization March of Dimes The Partnership for Maternal NCH Save the Children, 2012, PARTN MAT NCH SAV CH	46	51	53	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135580	10.1371/journal.pone.0135580	http://dx.doi.org/10.1371/journal.pone.0135580			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288195	Green Published, gold, Green Submitted			2022-12-26	WOS:000360018600056
J	Sun, QH; Chou, GX				Sun, Qinhu; Chou, Guixin			Isoflavonoids from Crotalaria albida Inhibit Adipocyte Differentiation and Lipid Accumulation in 3T3-L1 Cells via Suppression of PPAR-gamma Pathway	PLOS ONE			English	Article							PHYTOESTROGEN GENISTEIN; FLAVONOIDS; RATS; ROOTS	Two 2 ''-isopropenyl dihydrofuran isoflavonoids (1 and 3), one 2 ''-isopropenyl dihydrofuran chromone (2), as well as 13 known compounds were isolated from the herbs of Crotalaria albida. Their structures and relative configurations were elucidated via NMR and HRESIMS analyses. The 2 '' S absolute configuration of 1 and 2 were deduced by comparing their NOESY spectra with that of 3, which was determined via single crystal X-ray diffraction (CuK alpha). The 3R absolute configuration of 1 was determined by CD. Compounds 1, 2, and 3 inhibit the adipocyte differentiation and lipid accumulation of 3T3-L1 through down-regulation of PPAR-gamma activity.	[Sun, Qinhu; Chou, Guixin] Shanghai Univ Tradit Chinese Med, MOE Key Lab Standardizat Chinese Med, Inst Chinese Mat Med, Shanghai, Peoples R China; [Sun, Qinhu; Chou, Guixin] Shanghai R&D Ctr Standardizat Chinese Med, Shanghai, Peoples R China	Shanghai University of Traditional Chinese Medicine	Chou, GX (corresponding author), Shanghai Univ Tradit Chinese Med, MOE Key Lab Standardizat Chinese Med, Inst Chinese Mat Med, Shanghai, Peoples R China.	chouguixinzyb@126.com			National Nature Science Foundation of China [21272159]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding provided by http://www.nsfc.gov.cn/, National Nature Science Foundation of China, Guixin Chou, No. 21272159.	Alencar SM, 2007, J ETHNOPHARMACOL, V113, P278, DOI 10.1016/j.jep.2007.06.005; Babu UV, 1998, PHYTOCHEMISTRY, V48, P1457, DOI 10.1016/S0031-9422(97)00876-5; Deodato B, 1999, BRIT J PHARMACOL, V128, P1683, DOI 10.1038/sj.bjp.0702973; Djiogue S, 2009, J NAT PROD, V72, P1603, DOI 10.1021/np900271m; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Fanti P, 1998, OSTEOPOROSIS INT, V8, P274, DOI 10.1007/s001980050065; Gong ZW, 2009, ENDOCRINOLOGY, V150, P104, DOI 10.1210/en.2008-0322; Harbourne JB, 1992, THE FLAVONOIDS ADVAN; Hu HB, 2011, CHEM PHARM BULL, V59, P135, DOI 10.1248/cpb.59.135; Huang C, 2006, BIOCHEM BIOPH RES CO, V348, P571, DOI 10.1016/j.bbrc.2006.07.095; HUTCHINS AM, 1995, J AM DIET ASSOC, V95, P769, DOI 10.1016/S0002-8223(95)00214-6; JURD L, 1972, PHYTOCHEMISTRY, V11, P2535, DOI 10.1016/S0031-9422(00)88532-5; Kaplan F, 2001, J CARDIOVASC RISK, V8, P211, DOI 10.1097/00043798-200108000-00005; LAMARTINIERE CA, 1995, CARCINOGENESIS, V16, P2833, DOI 10.1093/carcin/16.11.2833; Lawson MA, 2006, TETRAHEDRON LETT, V47, P451, DOI 10.1016/j.tetlet.2005.11.069; [李云志 LI Yun-zhi], 2009, [中草药, Chinese Traditional and Herbal Drugs], V40, P1195; MARKHAM KR, 1978, TETRAHEDRON, V34, P1389, DOI 10.1016/0040-4020(78)88336-7; Matsuura N, 2005, BIOSCI BIOTECH BIOCH, V69, P2470, DOI 10.1271/bbb.69.2470; Meng QH, 1999, BBA-MOL CELL BIOL L, V1438, P369, DOI 10.1016/S1388-1981(99)00062-1; Mezei O, 2003, J NUTR, V133, P1238; Ngadjui BT, 1999, PHYTOCHEMISTRY, V51, P119, DOI 10.1016/S0031-9422(98)00621-9; Pakala Rajbabu, 2004, Cardiovasc Radiat Med, V5, P97, DOI 10.1016/j.carrad.2004.03.006; Priyarega S, 2003, DES MONOMERS POLYM, V6, P187, DOI 10.1163/156855503768338241; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Sciences CAo, 1993, FLORA CHINA; Sun Q-H, 2012, THE 10TH NATIONAL SY, P481; Sun QH, 2013, PHYTOCHEM LETT, V6, P449, DOI 10.1016/j.phytol.2013.05.011; Toebes AHW, 2005, J AGR FOOD CHEM, V53, P4660, DOI 10.1021/jf047995f; Ubukata M, 2007, BIOORG MED CHEM LETT, V17, P4767, DOI 10.1016/j.bmcl.2007.06.059; WAGNER H, 1976, TETRAHEDRON LETT, P1799; Weng JR, 2002, HELV CHIM ACTA, V85, P847, DOI 10.1002/1522-2675(200203)85:3<847::AID-HLCA847>3.0.CO;2-6; Zhang GP, 2009, J NAT PROD, V72, P1265, DOI 10.1021/np900144c; Zhang PC, 2003, J ASIAN NAT PROD RES, V5, P131, DOI 10.1080/1028602021000054982; Zhang S, 2010, ACTA CHIM SINICA, V68, P2227; Zhang Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep07375; Zhang Y, 2012, PPAR RES, V2012, DOI 10.1155/2012/374936	37	10	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135893	10.1371/journal.pone.0135893	http://dx.doi.org/10.1371/journal.pone.0135893			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285147	Green Submitted, gold, Green Published			2022-12-26	WOS:000359666100086
J	Sun, WC; Song, H; Yao, XL; Ishidaira, H; Xu, ZX				Sun, Wenchao; Song, Hao; Yao, Xiaolei; Ishidaira, Hiroshi; Xu, Zongxue			Changes in Remotely Sensed Vegetation Growth Trend in the Heihe Basin of Arid Northwestern China	PLOS ONE			English	Article							RIVER-BASIN; CLIMATE-CHANGE; TIME-SERIES; NDVI; DYNAMICS; COVER; PATTERNS	The Heihe River Basin (HRB) is the second largest inland river basin in China, characterized by high diversity in geomorphology and irrigated agriculture in middle reaches. To improve the knowledge about the relationship between biotic and hydrological processes, this study used Global Inventory Modeling and Mapping Studies Normalized Difference Vegetation Index (NDVI) data (1982-2006) to analyze spatiotemporal variations in vegetation growth by using the Mann-Kendall test together with Sen's slope estimator. The results indicate that 10.1% and 1.6% of basin area exhibit statistically significant (p < 0.05) upward and downward trends, and maximum magnitude is 0.066/10a and 0.026/10a, respectively. More specifically, an increasing trend was observed in the Qilian Mountains and Hexi Corridor and a decreasing trend detected in the transitional region between them. Increases in precipitation and temperature may be one possible reason for the changes of vegetation growth in the Qilian Mountains. And decreasing trend in transitional region may be driven by the changes in precipitation. Increases of irrigation contribute to the upward trend of NDVI for cropland in the Hexi Corridor, reflecting that agricultural development becomes more intensive. Our study demonstrates the complexity of the response of vegetation growth in the HRB to climate change and anthropogenic activities and correspondingly adopting mechanistic ecological models capable of describing both factors is favorable for reasonable predictions of future vegetation growth. It is also indicated that improving irrigation water use efficiency is one practical strategy to balance water demand between human and natural ecosystems in the HRB.	[Sun, Wenchao; Song, Hao; Yao, Xiaolei; Xu, Zongxue] Beijing Normal Univ, Coll Water Sci, Beijing 100875, Peoples R China; [Sun, Wenchao; Song, Hao; Yao, Xiaolei; Xu, Zongxue] JCGCS, Beijing, Peoples R China; [Ishidaira, Hiroshi] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Kofu, Yamanashi, Japan	Beijing Normal University; University of Yamanashi	Sun, WC (corresponding author), Beijing Normal Univ, Coll Water Sci, Beijing 100875, Peoples R China.	sunny@bnu.edu.cn	Sun, Wenchao/C-7019-2012		National Natural Science Foundation of China [91125015, 41201018]; National Key Technology R&D Program of China [2013BAB05B04]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology R&D Program of China(National Key Technology R&D Program); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the National Natural Science Foundation of China (Grant No. 91125015, 41201018), National Key Technology R&D Program of China (Grant No. 2013BAB05B04), and Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An D, J CHINA HYDRO, V33, P85; ASRAR G, 1984, AGRON J, V76, P300, DOI 10.2134/agronj1984.00021962007600020029x; Baudena M, 2007, ADV WATER RESOUR, V30, P1320, DOI 10.1016/j.advwatres.2006.11.006; Cao L, 2013, ECOHYDROLOGY, V6, P917, DOI 10.1002/eco.1245; Dai C, 2008, RESOUR SCI, V44, P182; Dai C, 2008, RESOUR SCI, V44, P177; de Beurs KM, 2005, GLOBAL CHANGE BIOL, V11, P779, DOI 10.1111/j.1365-2486.2005.00949.x; DOdorico P., 2006, DRYLAND ECOHYDROLOGY; Dregne H.E., 1992, DEGRADATION RESTORAT; [凡炳文 Fan Bingwen], 2012, [干旱地区农业研究, Agricultural Research in the Arid Areas], V30, P101; Hashimoto H, 2010, GLOBAL CHANGE BIOL, V16, P255, DOI 10.1111/j.1365-2486.2009.01921.x; Hess T, 1996, J ENVIRON MANAGE, V48, P249, DOI 10.1006/jema.1996.0076; Ji XB, 2006, ENVIRON GEOL, V50, P793, DOI 10.1007/s00254-006-0251-z; Kendall M. G., 1975, RANK CORRELATION MET; Li ZL, 2014, STOCH ENV RES RISK A, V28, P1709, DOI 10.1007/s00477-013-0828-5; [李占玲 Li Zhanling], 2011, [资源科学, Resources Science], V33, P1877; Li Z, 2013, REMOTE SENS ENVIRON, V138, P232, DOI 10.1016/j.rse.2013.07.020; [刘敏 Liu Min], 2004, [中国沙漠, Journal of Desert Research], V24, P162; Los SO, 2013, GLOBAL BIOGEOCHEM CY, V27, P318, DOI 10.1002/gbc.20027; Lu L, 2003, J ARID ENVIRON, V53, P395, DOI 10.1006/jare.2002.1032; Ma MG, 2006, INT J REMOTE SENS, V27, P3473, DOI 10.1080/01431160600593031; Mann HB, 1945, ECONOMETRICA, V13, P245, DOI 10.2307/1907187; Matthews HD, 2004, CLIM DYNAM, V22, P461, DOI 10.1007/s00382-004-0392-2; Neeti N, 2012, REMOTE SENS LETT, V3, P433, DOI 10.1080/01431161.2011.616238; Piao SL, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002888; Piao SL, 2011, GLOBAL CHANGE BIOL, V17, P3228, DOI 10.1111/j.1365-2486.2011.02419.x; Pinzon JE, 2005, INTERD MATH SCI, V5, P167; Pouliot D, 2009, INT J REMOTE SENS, V30, P149, DOI 10.1080/01431160802302090; Reynolds JF, 2007, SCIENCE, V316, P847, DOI 10.1126/science.1131634; SEN PK, 1968, J AM STAT ASSOC, V63, P1379; Slaymaker O., 1998, PHYS GEOGRAPHY GLOBA; Strengers BJ, 2010, INT J CLIMATOL, V30, P2055, DOI 10.1002/joc.2132; Tan K, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003530; Wu DH, 2014, REMOTE SENS-BASEL, V6, P4217, DOI 10.3390/rs6054217; Xi HY, 2010, HYDROGEOL J, V18, P791, DOI 10.1007/s10040-009-0562-8; Yue S, 2004, WATER RESOUR MANAG, V18, P201, DOI 10.1023/B:WARM.0000043140.61082.60; Zhang YL, 2013, GLOBAL PLANET CHANGE, V108, P139, DOI 10.1016/j.gloplacha.2013.06.012; Zheng S, 2009, S TO N WATER TRANSFE, V7, P77; [郑世泽 ZHENG Shi-ze], 2009, [南水北调与水利科技, South-to-North Water Transfers and Water Science & Technology], V7, P45; Zhu JT, 2012, ECOHYDROLOGY, V5, P628, DOI 10.1002/eco.249	40	10	10	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135376	10.1371/journal.pone.0135376	http://dx.doi.org/10.1371/journal.pone.0135376			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284656	Green Published, gold, Green Submitted			2022-12-26	WOS:000359666100034
J	Yokoyama, A; Yokoyama, T; Matsui, T; Mizukami, T; Kimura, M; Matsushita, S; Higuchi, S; Maruyama, K				Yokoyama, Akira; Yokoyama, Tetsuji; Matsui, Toshifumi; Mizukami, Takeshi; Kimura, Mitsuru; Matsushita, Sachio; Higuchi, Susumu; Maruyama, Katsuya			Alcohol Dehydrogenase-1B (rs1229984) and Aldehyde Dehydrogenase-2 (rs671) Genotypes Are Strong Determinants of the Serum Triglyceride and Cholesterol Levels of Japanese Alcoholic Men	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; INDUCED FATTY LIVER; MIDDLE-AGED MEN; GENETIC POLYMORPHISMS; ADIPONECTIN LEVELS; LIPID-METABOLISM; ALDH2 GENOTYPES; ETHANOL; CONSUMPTION; RISK	Background Elevated serum triglyceride (TG) and high-density-lipoprotein cholesterol (HDL-C) levels are common in drinkers. The fast-metabolizing alcohol dehydrogenase-1B encoded by the ADH1B*2 allele (vs. ADH1B*1/*1 genotype) and inactive aldehyde dehydrogenase-2 encoded by the ALDH2*2 allele (vs. ALDH2*1/*1 genotype) modify ethanol metabolism and are prevalent (approximate to 90% and approximate to 40%, respectively) in East Asians. We attempted to evaluate the associations between the ADH1B and ALDH2 genotypes and lipid levels in alcoholics. Methods The population consisted of 1806 Japanese alcoholic men (>= 40 years) who had undergone ADH1B and ALDH2 genotyping and whose serum TG, total cholesterol, and HDL-C levels in the fasting state had been measured within 3 days after admission. Results High serum levels of TG (>= 150 mg/dl), HDL-C (>80 mg/dl), and low-density-lipoprotein cholesterol (LDL-C calculated by the Friedewald formula >= 140 mg/dl) were observed in 24.3%, 16.8%, and 15.6%, respectively, of the subjects. Diabetes, cirrhosis, smoking, and body mass index (BMI) affected the serum lipid levels. Multivariate analysis revealed that the presence of the ADH1B* 2 allele and the active ALDH2*1/*1 genotype increased the odds ratio (OR; 95% confidence interval) for a high TG level (2.22[1.67-2.94] and 1.39[0.99-1.96], respectively), and decreased the OR for a high HDL-C level (0.37[0.28-0.49] and 0.51 [0.37-0.69], respectively). The presence of the ADH1B*2 allele decreased the OR for a high LDL-C level (0.60[0.45-0.80]). The ADH1B*2 plus ALDH2*1/*1 combination yielded the highest ORs for high TG levels and lowest OR for a high HDL-C level. The genotype effects were more prominent in relation to the higher levels of TG (>= 220 mg/dl) and HDL-C (>= 100 mg/dl). Conclusions The fast-metabolizing ADH1B and active ALDH2, and especially a combination of the two were strongly associated with higher serum TG levels and lower serum HDL-C levels of alcoholics. The fast-metabolizing ADH1B was associated with lower serum LDL-C levels.	[Yokoyama, Akira; Matsui, Toshifumi; Mizukami, Takeshi; Kimura, Mitsuru; Matsushita, Sachio; Higuchi, Susumu; Maruyama, Katsuya] Natl Hosp Org Kurihama Med & Addict Ctr, Yokosuka, Kanagawa 2390841, Japan; [Yokoyama, Tetsuji] Natl Inst Publ Hlth, Dept Hlth Promot, Saitama 3510104, Japan; [Matsui, Toshifumi] Kyorin Univ Hosp, Dept Geriatr Med, Tokyo 1818611, Japan	National Institute of Public Health - Japan; Kyorin University	Yokoyama, A (corresponding author), Natl Hosp Org Kurihama Med & Addict Ctr, Yokosuka, Kanagawa 2390841, Japan.	a_yokoyama@kurihama1.hosp.go.jp		Matsui, Toshifumi/0000-0002-8478-2809				[Anonymous], HIMAN KENKYU; [Anonymous], 1994, ALCOHOL CLIN EXP RES, V34, P1246, DOI [10.1111/j.1530-0277.2010.01202.x, DOI 10.1111/J.1530-0277.2010.01202.X]; BARAONA E, 1979, J LIPID RES, V20, P289; Brien SE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d636; Chen XT, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-776; Cicognani C, 1997, ARCH INTERN MED, V157, P792, DOI 10.1001/archinte.157.7.792; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Galli A, 2001, J BIOL CHEM, V276, P68, DOI 10.1074/jbc.M008791200; GOEDDE HW, 1992, HUM GENET, V88, P344; Hao PP, 2010, ATHEROSCLEROSIS, V212, P213, DOI 10.1016/j.atherosclerosis.2010.05.024; Hashimoto Y, 2002, CLIN CHEM, V48, P1043; HIGUCHI S, 1995, AM J PSYCHIAT, V152, P1219; Holmes MV, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4164; Husemoen LLN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011735; Ikehara S, 2008, STROKE, V39, P2936, DOI 10.1161/STROKEAHA.108.520288; Iso H, 2004, STROKE, V35, P1124, DOI 10.1161/01.STR.0000124459.33597.00; Japan Atherosclerosis Society, 2007, JAP ATH SOC JAS GUID; Kawamoto R, 2010, J ATHEROSCLER THROMB, V17, P953, DOI 10.5551/jat.4879; Kloner RA, 2007, CIRCULATION, V116, P1306, DOI 10.1161/CIRCULATIONAHA.106.678375; Kwon HJ, 2014, HEPATOLOGY, V60, P146, DOI 10.1002/hep.27036; Lieber CS, 1999, ALCOHOL CLIN EXP RES, V23, P991, DOI 10.1111/j.1530-0277.1999.tb04217.x; Lu YK, 2008, HEPATOLOGY, V47, P1483, DOI 10.1002/hep.22222; Maeda S, 2014, ALCOHOL CLIN EXP RES, V38, P1559, DOI 10.1111/acer.12406; MIZOI Y, 1994, ALCOHOL ALCOHOLISM, V29, P707; Nishida M, 2007, MED MOL MORPHOL, V40, P55, DOI 10.1007/s00795-007-0366-7; Nishise Y, 2010, J CLIN ENDOCR METAB, V95, P3828, DOI 10.1210/jc.2009-1862; Patra J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-258; POWNALL HJ, 1994, J LIPID RES, V35, P2105; Silva ERDE, 2000, CIRCULATION, V102, P2347, DOI 10.1161/01.CIR.102.19.2347; Sozio M, 2008, AM J PHYSIOL-ENDOC M, V295, pE10, DOI 10.1152/ajpendo.00011.2008; Tan AH, 2012, HUM MOL GENET, V21, P1658, DOI 10.1093/hmg/ddr587; Wakabayashi I, 2008, ALCOHOL ALCOHOLISM, V43, P274, DOI 10.1093/alcalc/agn005; Wang X, 2013, STROKE, V44, P1833, DOI 10.1161/STROKEAHA.113.001326; Yokoyama A, 2014, ALCOHOL ALCOHOL; Yokoyama A, 2014, ALCOHOL CLIN EXP RES, V38, P1237, DOI 10.1111/acer.12372; Yokoyama A, 2014, ALCOHOL ALCOHOLISM, V49, P31, DOI 10.1093/alcalc/agt136; Yokoyama A, 2013, ALCOHOL CLIN EXP RES, V37, P1391, DOI 10.1111/acer.12108; Yokoyama A, 2013, ALCOHOL CLIN EXP RES, V37, P1123, DOI 10.1111/acer.12069; Yokoyama A, 2012, INT J CANCER, V130, P2949, DOI 10.1002/ijc.26296; Yokoyama A, 2010, ALCOHOL CLIN EXP RES, V34, P1246, DOI 10.1111/j.1530-0277.2010.01202.x; You M, 2002, J BIOL CHEM, V277, P29342, DOI 10.1074/jbc.M202411200	41	16	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0133460	10.1371/journal.pone.0133460	http://dx.doi.org/10.1371/journal.pone.0133460			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284938	gold, Green Submitted, Green Published			2022-12-26	WOS:000359666100004
J	Nishikawa, Y; Furukawa, A; Shiga, I; Muroi, Y; Ishii, T; Hongo, Y; Takahashi, S; Sugawara, T; Koshino, H; Ohnishi, M				Nishikawa, Yoshifumi; Furukawa, Ayumi; Shiga, Ikumi; Muroi, Yoshikage; Ishii, Toshiaki; Hongo, Yayoi; Takahashi, Shunya; Sugawara, Tatsuya; Koshino, Hiroyuki; Ohnishi, Masao			Cytoprotective Effects of Lysophospholipids from Sea Cucumber Holothuria atra	PLOS ONE			English	Article							PLATELET-ACTIVATING-FACTOR; STICHOPUS-JAPONICUS SELENKA; ANTIFUNGAL GLYCOSIDES; HOLOTOXIN-A; CELLS; LYSOPHOSPHATIDYLCHOLINES; INVERTEBRATES; BIOSYNTHESIS; SAPOGENOL; EXTRACTS	Lysophospholipids are important signaling molecules in animals and metazoan cells. They are widely distributed among marine invertebrates, where their physiological roles are unknown. Sea cucumbers produce unique lysophospholipids. In this study, two lysophospholipids were detected in Holothuria atra for the first time, lyso-platelet activating factor and lysophosphatidylcholine, with nuclear magnetic resonance and liquid chromatography-time-of-flight mass spectrometric analyses. The lipid fraction of H. atra contained lyso-platelet activating factor and lysophosphatidylcholine, and inhibited H2O2-induced apoptosis in the macrophage cell line J774A. 1. The antioxidant activity of the lysophospholipid-containing lipid fraction of H. atra was confirmed with the oxygen radical absorbance capacity method. Our results suggest that the lysophospholipids from H. atra are potential therapeutic agents for the inflammation induced by oxidative stress.	[Nishikawa, Yoshifumi; Furukawa, Ayumi; Shiga, Ikumi] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 080, Japan; [Muroi, Yoshikage; Ishii, Toshiaki] Obihiro Univ Agr & Vet Med, Dept Basic Vet Med, Obihiro, Hokkaido 080, Japan; [Hongo, Yayoi; Takahashi, Shunya; Koshino, Hiroyuki] RIKEN, Ctr Sustainable Resource Sci, Wako, Saitama, Japan; [Sugawara, Tatsuya] Kyoto Univ, Grad Sch Agr, Div Appl Biosci, Kyoto, Japan; [Ohnishi, Masao] Obihiro Univ Agr & Vet Med, Dept Food Sci, Obihiro, Hokkaido 080, Japan	Obihiro University of Agriculture & Veterinary Medicine; Obihiro University of Agriculture & Veterinary Medicine; RIKEN; Kyoto University; Obihiro University of Agriculture & Veterinary Medicine	Nishikawa, Y (corresponding author), Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Inada Cho, Obihiro, Hokkaido 080, Japan.	nisikawa@obihiro.ac.jp	Koshino, Hiroyuki/N-7948-2015; Koshino, Hiroyuki/ABF-4899-2021	Koshino, Hiroyuki/0000-0002-0954-9839; Koshino, Hiroyuki/0000-0002-0954-9839; Sugawara, Tatsuya/0000-0002-1203-5521	MEXT, Japan; Lipid Dynamics Program of RIKEN; Grants-in-Aid for Scientific Research [15K07421] Funding Source: KAKEN	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Lipid Dynamics Program of RIKEN; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Global COE Program "Frontier Program for Animal Global Health and Hygiene", MEXT, Japan. This work was also supported in part by the Lipid Dynamics Program of RIKEN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althunibat O.Y., 2009, EUR J SCI RES, V37, P376; BAZAN NG, 1995, J NEUROTRAUM, V12, P791, DOI 10.1089/neu.1995.12.791; BENVENISTE J, 1972, J EXP MED, V136, P1356, DOI 10.1084/jem.136.6.1356; Bin Hashim Ridzwan, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P614, DOI 10.12980/APJTB.4.201414B154; BRACHWITZ H, 1995, PHARMACOL THERAPEUT, V66, P39, DOI 10.1016/0163-7258(95)00001-W; Burke JE, 2009, J LIPID RES, V50, pS237, DOI 10.1194/jlr.R800033-JLR200; Butler AJ, 1996, J CHEM ECOL, V22, P2041, DOI 10.1007/BF02040094; Chen GQ, 2005, J LIPID RES, V46, P623, DOI 10.1194/jlr.C400018-JLR200; CONVERT O, 1984, BIOCHIM BIOPHYS ACTA, V794, P320, DOI 10.1016/0005-2760(84)90162-0; Croset M, 2000, BIOCHEM J, V345, P61, DOI 10.1042/0264-6021:3450061; Esmat AY, 2013, NUTRITION, V29, P258, DOI 10.1016/j.nut.2012.06.004; Hamel Jean-Francois, 2004, FAO Fisheries Technical Paper, V463, P359; Herencia F, 1998, LIFE SCI, V62, pPL115, DOI 10.1016/S0024-3205(97)01188-0; Ibrahim CO, 1995, BIOSCI PENANG, V6, P40; KITAGAWA I, 1976, CHEM PHARM BULL, V24, P266; KITAGAWA I, 1976, CHEM PHARM BULL, V24, P275; MANGOLD HK, 1987, LIPIDS, V22, P789, DOI 10.1007/BF02535533; Ogushi M, 2005, FOOD SCI TECHNOL RES, V11, P202, DOI 10.3136/fstr.11.202; Perry SW, 1998, J BIOL CHEM, V273, P17660, DOI 10.1074/jbc.273.28.17660; Sevastou I, 2013, BBA-MOL CELL BIOL L, V1831, P42, DOI 10.1016/j.bbalip.2012.07.019; Shin BA, 1999, J NAT PROD, V62, P1554, DOI 10.1021/np990303a; Shindou H, 2007, J BIOL CHEM, V282, P6532, DOI 10.1074/jbc.M609641200; Steel HC, 2002, APMIS, V110, P158, DOI 10.1034/j.1600-0463.2002.100206.x; Sugawara T, 2006, BIOSCI BIOTECH BIOCH, V70, P2906, DOI 10.1271/bbb.60318; SUGIURA T, 1992, BIOCHIM BIOPHYS ACTA, V1126, P298, DOI 10.1016/0005-2760(92)90244-P; Vadas P, 2008, NEW ENGL J MED, V358, P28, DOI 10.1056/NEJMoa070030; Welch EJ, 2009, MOL PHARMACOL, V75, P227, DOI 10.1124/mol.108.051003; Wiesner P, 2009, J LIPID RES, V50, P574, DOI 10.1194/jlr.D800028-JLR200; Yamada K, 2002, YAKUGAKU ZASSHI, V122, P1133, DOI 10.1248/yakushi.122.1133; YAYLI N, 1994, J NAT PROD, V57, P84, DOI 10.1021/np50103a012; Zhang P, 2014, DEV COMP IMMUNOL, V44, P370, DOI 10.1016/j.dci.2014.01.013	31	8	9	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135701	10.1371/journal.pone.0135701	http://dx.doi.org/10.1371/journal.pone.0135701			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275144	Green Submitted, Green Published, gold			2022-12-26	WOS:000359493600099
J	Cuskin, F; Basle, A; Ladeveze, S; Day, AM; Gilbert, HJ; Davies, GJ; Potocki-Veronese, G; Lowe, EC				Cuskin, Fiona; Basle, Arnaud; Ladeveze, Simon; Day, Alison M.; Gilbert, Harry J.; Davies, Gideon J.; Potocki-Veronese, Gabrielle; Lowe, Elisabeth C.			The GH130 Family of Mannoside Phosphorylases Contains Glycoside Hydrolases That Target beta-1,2-Mannosidic Linkages in Candida Mannan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							4-O-BETA-D-MANNOSYL-D-GLUCOSE PHOSPHORYLASE; PSEUDOMONAS-CELLULOSA; RESIDUES; ALBICANS; POLYSACCHARIDES; MECHANISM; DISCOVERY; CATALYSIS; XYLANASE; BINDING	The depolymerization of complex glycans is an important biological process that is of considerable interest to environmentally relevant industries. beta-Mannose is a major component of plant structural polysaccharides and eukaryotic N-glycans. These linkages are primarily cleaved by glycoside hydrolases, although recently, a family of glycoside phosphorylases, GH130, have also been shown to target beta-1,2- and beta-1,4-mannosidic linkages. In these phosphorylases, bond cleavage was mediated by a single displacement reaction in which phosphate functions as the catalytic nucleophile. A cohort of GH130 enzymes, however, lack the conserved basic residues that bind the phosphate nucleophile, and it was proposed that these enzymes function as glycoside hydrolases. Here we show that two Bacteroides enzymes, BT3780 and BACOVA_03624, which lack the phosphate binding residues, are indeed beta-mannosidases that hydrolyze beta-1,2-mannosidic linkages through an inverting mechanism. Because the genes encoding these enzymes are located in genetic loci that orchestrate the depolymerization of yeast alpha-mannans, it is likely that the two enzymes target the beta-1,2-mannose residues that cap the glycan produced by Candida albicans. The crystal structure of BT3780 in complex with mannose bound in the -1 and +1 subsites showed that a pair of glutamates, Glu(227) and Glu(268), hydrogen bond to O-1 of alpha-mannose, and either of these residues may function as the catalytic base. The candidate catalytic acid and the other residues that interact with the active site mannose are conserved in both GH130 mannoside phosphorylases and beta-1,2-mannosidases. Functional phylogeny identified a conserved lysine, Lys(199) in BT3780, as a key specificity determinant for beta-1,2-mannosidic linkages.	[Cuskin, Fiona; Basle, Arnaud; Day, Alison M.; Gilbert, Harry J.; Lowe, Elisabeth C.] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Ladeveze, Simon; Potocki-Veronese, Gabrielle] Univ Toulouse, INSA UPS INP, LISBP, F-31077 Toulouse, France; [Ladeveze, Simon; Potocki-Veronese, Gabrielle] CNRS, UMR5504, F-31400 Toulouse, France; [Ladeveze, Simon; Potocki-Veronese, Gabrielle] INRA, Ingn Syst Biol & Proc UMR792, F-31400 Toulouse, France; [Davies, Gideon J.] Univ York, Dept Chem, York Struct Biol Lab, York YO10 5DD, N Yorkshire, England	Newcastle University - UK; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); University of York - UK	Gilbert, HJ (corresponding author), Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	harry.gilbert@ncl.ac.uk	Veronese, Gabrielle/GTF-3473-2022; Davies, Gideon J/A-9042-2011	Davies, Gideon J/0000-0002-7343-776X; Cuskin, Fiona/0000-0003-4287-4921; Lowe, Elisabeth/0000-0001-9812-0614; Basle, Arnaud/0000-0002-4899-3086	Wellcome Trust [WT097907AIA]; Biotechnology and Biological Sciences Research Council [BB/K016393/1, BB/G016127/1]; European Research Council "Glycopoise"; BBSRC [BB/K016393/1, BB/G016127/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council "Glycopoise"; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Wellcome Trust Grant WT097907AIA (to H. J. G. A. B., F. C., and E. C. L), Biotechnology and Biological Sciences Research Council Grants BB/K016393/1 (to A. M. D.) and BB/G016127/1 (to G. J. D.), and grants from the European Research Council "Glycopoise" (to G. J. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Armand S., 1995, BIOCHEMISTRY-US, V34, P15619, DOI DOI 10.1021/BI00048A003; BARRAS F, 1992, FEBS LETT, V300, P145, DOI 10.1016/0014-5793(92)80183-H; Bolam DN, 1996, BIOCHEMISTRY-US, V35, P16195, DOI 10.1021/bi961866d; Brett C. T., 1996, TOPICS PLANT FUNCTIO; Cardozo FTGS, 2013, INT J BIOL MACROMOL, V57, P265, DOI 10.1016/j.ijbiomac.2013.03.026; Charnock SJ, 1997, J BIOL CHEM, V272, P2942, DOI 10.1074/jbc.272.5.2942; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chiku K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114882; Cuskin F, 2015, NATURE, V517, P165, DOI 10.1038/nature13995; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Fulop V, 1998, CELL, V94, P161, DOI 10.1016/S0092-8674(00)81416-6; Gilbert HJ, 2010, PLANT PHYSIOL, V153, P444, DOI 10.1104/pp.110.156646; Gorin P A, 1968, Adv Carbohydr Chem Biochem, V23, P367; Hancock SM, 2006, CURR OPIN CHEM BIOL, V10, P509, DOI 10.1016/j.cbpa.2006.07.015; Himmel ME, 2009, CURR OPIN BIOTECH, V20, P316, DOI 10.1016/j.copbio.2009.05.005; Hogg D, 2001, J BIOL CHEM, V276, P31186, DOI 10.1074/jbc.M010290200; Jaito N, 2014, BIOSCI BIOTECH BIOCH, V78, P263, DOI 10.1080/09168451.2014.882760; Jouault T, 2006, J IMMUNOL, V177, P4679, DOI 10.4049/jimmunol.177.7.4679; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kawahara R, 2012, J BIOL CHEM, V287, P42389, DOI 10.1074/jbc.M112.390336; Kostylev M, 2011, APPL ENVIRON MICROB, V77, P6274, DOI 10.1128/AEM.05532-11; Ladeveze S, 2015, ACTA CRYSTALLOGR D, V71, P1335, DOI 10.1107/S1399004715006604; Ladeveze S, 2013, J BIOL CHEM, V288, P32370, DOI 10.1074/jbc.M113.483628; Lee JS, 2009, CARBOHYD POLYM, V78, P162, DOI 10.1016/j.carbpol.2009.04.036; LI RK, 1993, J BIOL CHEM, V268, P18293; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; McIntosh LP, 1996, BIOCHEMISTRY-US, V35, P9958, DOI 10.1021/bi9613234; MIYAKAWA Y, 1992, INFECT IMMUN, V60, P2493, DOI 10.1128/IAI.60.6.2493-2499.1992; Molinari M, 2007, NAT CHEM BIOL, V3, P313, DOI 10.1038/nchembio880; Nakae S, 2013, J MOL BIOL, V425, P4468, DOI 10.1016/j.jmb.2013.08.002; Neer EJ, 1996, CELL, V84, P175, DOI 10.1016/S0092-8674(00)80969-1; Nihira T, 2013, J BIOL CHEM, V288, P27366, DOI 10.1074/jbc.M113.469080; Nurizzo D, 2002, STRUCTURE, V10, P547, DOI 10.1016/S0969-2126(02)00742-6; Ralton JE, 2003, J BIOL CHEM, V278, P40757, DOI 10.1074/jbc.M307660200; Senoura T, 2011, BIOCHEM BIOPH RES CO, V408, P701, DOI 10.1016/j.bbrc.2011.04.095; SHERMAN F, 1991, METHODS ENZYMOL, V194, P3; Tailford LE, 2008, NAT CHEM BIOL, V4, P306, DOI 10.1038/nchembio.81; Thompson AJ, 2012, P NATL ACAD SCI USA, V109, P781, DOI 10.1073/pnas.1111482109; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang YL, 2008, J BIOL CHEM, V283, P31551, DOI 10.1074/jbc.M803409200	45	24	24	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					25023	25033		10.1074/jbc.M115.681460	http://dx.doi.org/10.1074/jbc.M115.681460			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26286752	Green Published, hybrid			2022-12-26	WOS:000362598300031
J	Nakatsu, Y; Iwashita, M; Sakoda, H; Ono, H; Nagata, K; Matsunaga, Y; Fukushima, T; Fujishiro, M; Kushiyama, A; Kamata, H; Takahashi, SI; Katagiri, H; Honda, H; Kiyonari, H; Uchida, T; Asano, T				Nakatsu, Yusuke; Iwashita, Misaki; Sakoda, Hideyuki; Ono, Hiraku; Nagata, Kengo; Matsunaga, Yasuka; Fukushima, Toshiaki; Fujishiro, Midori; Kushiyama, Akifumi; Kamata, Hideaki; Takahashi, Shin-Ichiro; Katagiri, Hideki; Honda, Hiroaki; Kiyonari, Hiroshi; Uchida, Takafumi; Asano, Tomichiro			Prolyl Isomerase Pin1 Negatively Regulates AMP-activated Protein Kinase (AMPK) by Associating with the CBS Domain in the gamma Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; SKELETAL-MUSCLE; ENERGY-EXPENDITURE; UPSTREAM KINASE; PHOSPHORYLATION; LKB1; METABOLISM; SIRT1; CELL; PGC-1-ALPHA	AMP-activated protein kinase (AMPK) plays a critical role in metabolic regulation. In this study, first, it was revealed that Pin1 associates with any isoform of gamma, but not with either the alpha or the beta subunit, of AMPK. The association between Pin1 and the AMPK gamma 1 subunit is mediated by the WW domain of Pin1 and the Thr211Pro-containing motif located in the CBS domain of the gamma 1 subunit. Importantly, overexpression of Pin1 suppressed AMPK phosphorylation in response to either 2-deoxyglucose or biguanide stimulation, whereas Pin1 knockdown by siRNAs or treatment with Pin1 inhibitors enhanced it. The experiments using recombinant Pin1, AMPK, LKB1, and PP2C proteins revealed that the protective effect of AMP against PP2C-induced AMPK alpha subunit dephosphorylation was markedly suppressed by the addition of Pin1. In good agreement with the in vitro data, the level of AMPK phosphorylation as well as the expressions of mitochondria-related genes, such as PGC-1 alpha, which are known to be positively regulated by AMPK, were markedly higher with reduced triglyceride accumulation in the muscles of Pin1 KO mice as compared with controls. These findings suggest that Pin1 plays an important role in the pathogenic mechanisms underlying impaired glucose and lipid metabolism, functioning as a negative regulator of AMPK.	[Nakatsu, Yusuke; Nagata, Kengo; Matsunaga, Yasuka; Fukushima, Toshiaki; Kamata, Hideaki; Asano, Tomichiro] Hiroshima Univ, Dept Med Sci, Grad Sch Med, Minami Ku, 1-2-3 Kasumi, Hiroshima, Hiroshima 7348553, Japan; [Iwashita, Misaki] Hiroshima Univ, Dept Dent Sci Hlth Promot, Grad Sch Biomed Sci, Minami Ku, Hiroshima, Hiroshima 7348553, Japan; [Honda, Hiroaki] Hiroshima Univ, Dept Dis Model, Res Inst Radiat Biol & Med, Minami Ku, Hiroshima, Hiroshima 7348553, Japan; [Sakoda, Hideyuki; Fujishiro, Midori] Univ Tokyo, Grad Sch Med, Dept Internal Med, Bunkyo Ku, Tokyo 1130033, Japan; [Ono, Hiraku] Saitama Med Univ, Sch Med, Dept Endocrinol & Diabet, Moroyama, Saitama 3500495, Japan; [Kushiyama, Akifumi] Asahi Life Fdn, Inst Adult Dis, Div Diabet & Metab, Chiyoda Ku, Tokyo 1030002, Japan; [Takahashi, Shin-Ichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan; [Katagiri, Hideki] Tohoku Univ, Grad Sch Med, Div Mol Metab & Diabet, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Kiyonari, Hiroshi] RIKEN, Ctr Life Sci Technol, Anim Resource Dev Unit, Chuou Ku, Kobe, Hyogo 6500047, Japan; [Kiyonari, Hiroshi] RIKEN, Ctr Life Sci Technol, Genet Engn Team, Div Biofunct Dynam Imaging,Chuou Ku, Kobe, Hyogo 6500047, Japan; [Uchida, Takafumi] Tohoku Univ, Grad Sch Agr Sci, Dept Mol Cell Biol, Sendai, Miyagi 9818555, Japan	Hiroshima University; Hiroshima University; Hiroshima University; University of Tokyo; Saitama Medical University; Asahi Life Foundation; University of Tokyo; Tohoku University; RIKEN; RIKEN; Tohoku University	Asano, T (corresponding author), Hiroshima Univ, Dept Med Sci, Grad Sch Med, Minami Ku, 1-2-3 Kasumi, Hiroshima, Hiroshima 7348553, Japan.	tasano@hiroshima-u.ac.jp	Kushiyama, Akifumi/W-5988-2019; Kushiyama, Akifumi/A-6386-2011; Kiyonari, Hiroshi/N-7936-2015; 祐介, 中津/AAP-8396-2020; Kamata, Hideaki/N-3907-2017	Kushiyama, Akifumi/0000-0003-1385-7487; Kushiyama, Akifumi/0000-0003-1385-7487; Takahashi, Shin-Ichiro/0000-0002-2323-2010; Uchida, Takafumi/0000-0003-3665-4906; Nakatsu, Yusuke/0000-0003-3279-1276; Iwashita, Misaki/0000-0002-8557-346X	Ministry of Education, Science, Sports, and Culture, Japan; Ono Medical Research Foundation; Tsuchiya Medical Foundation; Hiroshima University Fujii Research Promotion Fund; Grants-in-Aid for Scientific Research [15H01382, 26252064] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ono Medical Research Foundation; Tsuchiya Medical Foundation; Hiroshima University Fujii Research Promotion Fund; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by a Grant-in-Aid for Scientific Research (C) (to N. Y.) and a Grant-in-Aid for Scientific Research (B) (to T. A.) from the Ministry of Education, Science, Sports, and Culture, Japan, and grants from the Ono Medical Research Foundation, the Tsuchiya Medical Foundation, and the 2012 Hiroshima University Fujii Research Promotion Fund. The authors declare that they have no conflicts of interest with the contents of this article.	Adams J, 2004, PROTEIN SCI, V13, P155, DOI 10.1110/ps.03340004; Andersson U, 2004, J BIOL CHEM, V279, P12005, DOI 10.1074/jbc.C300557200; Bandyopadhyay GK, 2006, DIABETES, V55, P2277, DOI 10.2337/db06-0062; Ben-Shlomo S, 2011, J HEPATOL, V54, P1214, DOI 10.1016/j.jhep.2010.09.032; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; Butterfield DA, 2006, J NEUROCHEM, V98, P1697, DOI 10.1111/j.1471-4159.2006.03995.x; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; Dorfman J, 2008, MOL BIOL CELL, V19, P1614, DOI 10.1091/mbc.E07-05-0454; Fila C, 2008, J BIOL CHEM, V283, P21714, DOI 10.1074/jbc.M710264200; Gowans GJ, 2013, CELL METAB, V18, P556, DOI 10.1016/j.cmet.2013.08.019; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Khanal P, 2013, MOL CARCINOGEN, V52, P813, DOI 10.1002/mc.21920; Lessard SJ, 2009, ENDOCRINOLOGY, V150, P4883, DOI 10.1210/en.2009-0158; Liou YC, 2011, TRENDS BIOCHEM SCI, V36, P501, DOI 10.1016/j.tibs.2011.07.001; Liu Y, 2006, BIOCHEM BIOPH RES CO, V339, P701, DOI 10.1016/j.bbrc.2005.11.068; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Lu KP, 1996, NATURE, V380, P544; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Lu PJ, 1999, NATURE, V399, P784; Martin TL, 2006, J BIOL CHEM, V281, P18933, DOI 10.1074/jbc.M512831200; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Nakatsu Y, 2012, J BIOL CHEM, V287, P44526, DOI 10.1074/jbc.M112.397133; Nakatsu Y, 2011, J BIOL CHEM, V286, P20812, DOI 10.1074/jbc.M110.206904; Nakatsu Y, 2010, J BIOL CHEM, V285, P33018, DOI 10.1074/jbc.M110.137836; O'Neill HM, 2011, P NATL ACAD SCI USA, V108, P16092, DOI 10.1073/pnas.1105062108; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; Potter A, 2010, BIOORG MED CHEM LETT, V20, P6483, DOI 10.1016/j.bmcl.2010.09.063; Potter AJ, 2010, BIOORG MED CHEM LETT, V20, P586, DOI 10.1016/j.bmcl.2009.11.090; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Steinberg GR, 2010, J BIOL CHEM, V285, P37198, DOI 10.1074/jbc.M110.102434; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Treebak JT, 2006, DIABETES, V55, P2051, DOI 10.2337/db06-0175; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	51	25	26	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24255	24266		10.1074/jbc.M115.658559	http://dx.doi.org/10.1074/jbc.M115.658559			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26276391	hybrid, Green Published			2022-12-26	WOS:000362218900017
J	Brydegaard, M				Brydegaard, Mikkel			Towards Quantitative Optical Cross Sections in Entomological Laser Radar - Potential of Temporal and Spherical Parameterizations for Identifying Atmospheric Fauna	PLOS ONE			English	Article							IRIDESCENCE; FLIGHT; AGE	In recent years, the field of remote sensing of birds and insects in the atmosphere (the aerial fauna) has advanced considerably, and modern electro-optic methods now allow the assessment of the abundance and fluxes of pests and beneficials on a landscape scale. These techniques have the potential to significantly increase our understanding of, and ability to quantify and manage, the ecological environment. This paper presents a concept whereby laser radar observations of atmospheric fauna can be parameterized and table values for absolute cross sections can be catalogued to allow for the study of focal species such as disease vectors and pests. Wing-beat oscillations are parameterized with a discrete set of harmonics and the spherical scatter function is parameterized by a reduced set of symmetrical spherical harmonics. A first order spherical model for insect scatter is presented and supported experimentally, showing angular dependence of wing beat harmonic content. The presented method promises to give insights into the flight heading directions of species in the atmosphere and has the potential to shed light onto the km-range spread of pests and disease vectors.	[Brydegaard, Mikkel] Lund Univ, Dept Phys, Lund Laser Ctr, SE-22362 Lund, Sweden; [Brydegaard, Mikkel] Lund Univ, Dept Biol, Ctr Anim Movement Res, SE-22362 Lund, Sweden; [Brydegaard, Mikkel] Norsk Elektro Opt AS, Hyspex, N-2019 Skedsmokorset, Norway	Lund University; Lund University	Brydegaard, M (corresponding author), Lund Univ, Dept Phys, Lund Laser Ctr, Solvegatan 14, SE-22362 Lund, Sweden.	mikkel.brydegaard@fysik.lth.se			Swedish Research Council through Linnaeus grants; Lund Laser Centre	Swedish Research Council through Linnaeus grants; Lund Laser Centre	The continuous support from Ernst van Groningen, International Science Program, Uppsala, is greatly appreciated. Hyperspectral imaging was performed with Hyspex push broom cameras, kindly provided by Norsk Elektro Optikk A/S. This project also received funding from the Swedish Research Council through Linnaeus grants to the Centre for Animal Movement Research and the Lund Laser Centre. Mikkel Brydegaard is employed part time by Norsk Elektro Optikk AS and part time by Lund University. The specific roles of the author are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, ACM SIGKDD INT C KNO; Brydegaard M, 2012, THESIS TRYCKERIET E; Brydegaard M, 2015, ILRC NEW YORK US, V27; Brydegaard M, 2014, ADVANTAGES SHORTWAVE; Brydegaard M., 2015, APPL SPECTR IN PRESS; Brydegaard M., 2015, SPIE, DOI [10.1117/2.1201506.005977, DOI 10.1117/2.1201506.005977]; Brydegaard M, 2014, PROG ELECTROMAGN RES, V147, P141, DOI 10.2528/PIER14101001; Brydegaard M, 2013, APPL SPECTROSC, V67, P477, DOI 10.1366/12-06860; Chapman JW, 2012, P NATL ACAD SCI USA, V109, P14924, DOI 10.1073/pnas.1207255109; Combes SA, 2012, J EXP BIOL, V215, P903, DOI 10.1242/jeb.059394; Drake V. J, 2012, LIPOIC ACID; Eagles D, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-135; Fujii T., 2005, LASER REMOTE SENSING; Gauthreaux SA, 2003, AUK, V120, P266, DOI 10.1642/0004-8038(2003)120[0266:ROABC]2.0.CO;2; Gebru A, 2014, J APPL REMOTE SENS, V8, DOI 10.1117/1.JRS.8.083503; Grafarend E.W., 2012, APPL LINEAR NONLINEA, DOI 10.1080/14498596.2013.815147; Guan Z., 2010, APPL OPTICS, V49, P1; Hoffman DS, 2007, APPL OPTICS, V46, P3007, DOI 10.1364/AO.46.003007; Hooper W. P., 2010, J APPL REMOTE SENS, V4, P4; Kissling WD, 2014, BIOL REV, V89, P511, DOI 10.1111/brv.12065; Kjellman J, 2015, THESIS LUND U; Koul O, 2008, AREAWIDE PEST MANAGEMENT: THEORY AND IMPLEMENTATION, P560, DOI 10.1079/9781845933722.0560; Malmqvist E, 2015, INT LAS RAD C NYC US, V27; Mayagaya VS, 2009, AM J TROP MED HYG, V81, P622, DOI 10.4269/ajtmh.2009.09-0192; Moore A, 2002, ANN ENTOMOL SOC AM, V95, P1, DOI 10.1603/0013-8746(2002)095[0001:AIOOSA]2.0.CO;2; Muirhead-Thomson RC., 1991, TRAP RESPONSES FLYIN, V1st edn, DOI DOI 10.1007/s13355-015-0390-3; NATO, 2010, LAS BAS STAND OFF DE; Ovaskainen O, 2008, P NATL ACAD SCI USA, V105, P19090, DOI 10.1073/pnas.0802066105; Peiris K., 2014, AM J AGR SCI TECHNOL, V2, P49, DOI [10.7726/ajast.2014.1006, DOI 10.7726/AJAST.2014.1006]; Price P.W., 2011, INSECT ECOLOGY BEHAV; Reed SC, 1941, FREQUENCY WING BEAT; Reynolds DR, 1996, MED VET ENTOMOL, V10, P185, DOI 10.1111/j.1365-2915.1996.tb00727.x; Runemark A, 2012, IEEE J SEL TOP QUANT, V18, P1573, DOI 10.1109/JSTQE.2012.2184528; Sharma V, 2009, SCIENCE, V325, P449, DOI 10.1126/science.1172051; Shaw JA, 2005, OPT EXPRESS, V13, P5853, DOI 10.1364/OPEX.13.005853; Shevtsova E, 2011, P NATL ACAD SCI USA, V108, P668, DOI 10.1073/pnas.1017393108; Svensson EI, 2010, EVOLUTION, V64, P3101, DOI 10.1111/j.1558-5646.2010.01085.x; Torok S., 2013, THESIS LUND U	38	39	41	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135231	10.1371/journal.pone.0135231	http://dx.doi.org/10.1371/journal.pone.0135231			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295706	Green Published, gold, Green Submitted			2022-12-26	WOS:000359926900020
J	von Wowern, E; Ostling, G; Nilsson, PM; Olofsson, P				von Wowern, Emma; Ostling, Gerd; Nilsson, Peter M.; Olofsson, Per			Digital Photoplethysmography for Assessment of Arterial Stiffness: Repeatability and Comparison with Applanation Tonometry	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; AORTIC AUGMENTATION INDEX; VENTRICULAR EJECTION TIME; FINGER PHOTOPLETHYSMOGRAM; HYPERTENSIVE PATIENTS; CARDIOVASCULAR RISK; VOLUME PULSE; HEART-RATE; PLETHYSMOGRAPHY; REPRODUCIBILITY	Introduction Arterial stiffness is an independent risk factor for cardiovascular morbidity and can be assessed by applanation tonometry by measuring pulse wave velocity (PWV) and augmentation index (AIX) by pressure pulse wave analysis (PWA). As an inexpensive and operator independent alternative, photoelectric plethysmography (PPG) has been introduced with analysis of the digital volume pulse wave (DPA) and its second derivatives of wave reflections. Objective The objective was to investigate the repeatability of arterial stiffness parameters measured by digital pulse wave analysis (DPA) and the associations to applanation tonometry parameters. Methods and Results 112 pregnant and non-pregnant individuals of different ages and genders were examined with SphygmoCor arterial wall tonometry and Meridian DPA finger photoplethysmography. Coefficients of repeatability, Bland-Altman plots, intraclass correlation coefficients and correlations to heart rate (HR) and body height were calculated for DPA variables, and the DPA variables were compared to tonometry variables left ventricular ejection time (LVET), PWV and AIX. No DPA variable showed any systematic measurement error or excellent repeatability, but dicrotic index (DI), dicrotic dilatation index (DDI), cardiac ejection elasticity index (EEI), aging index (AI) and second derivatives of the crude pulse wave curve, b/a and e/a, showed good repeatability. Overall, the correlations to AIX were better than to PWV, with correlations coefficients >0.70 for EEI, AI and b/a. Considering the level of repeatability and the correlations to tonometry, the overall best DPA parameters were EEI, AI and b/a. The two pansystolic time parameters, ejection time compensated ( ETc) by DPA and LVET by tonometry, showed a significant but weak correlation. Conclusion For estimation of the LV function, ETc, EEI and b/a are suitable, for large artery stiffness EEI, and for small arteries DI and DDI. The only global parameter, AI, showed a high repeatability and the overall best correlations with AIX and PWV.	[von Wowern, Emma; Olofsson, Per] Lund Univ, Skane Univ Hosp, Inst Clin Sci, Dept Obstet & Gynecol, Malmo, Sweden; [Ostling, Gerd; Nilsson, Peter M.] Lund Univ, Skane Univ Hosp, Inst Clin Sci, Med Res Unit,Dept Internal Med, Malmo, Sweden	Lund University; Skane University Hospital; Lund University; Skane University Hospital	von Wowern, E (corresponding author), Lund Univ, Skane Univ Hosp, Inst Clin Sci, Dept Obstet & Gynecol, Malmo, Sweden.	emma.von_wowern@med.lu.se		Venkatasubramanian, Siddharth/0000-0002-5860-0768	Lund University Medical Faculty; Region Skane	Lund University Medical Faculty; Region Skane	The study was supported by grants from the Lund University Medical Faculty and Region Skane. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONELLI L, 1994, PROCEEDINGS OF THE 16TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY - ENGINEERING ADVANCES: NEW OPPORTUNITIES FOR BIOMEDICAL ENGINEERS, PTS 1&2, P1216, DOI 10.1109/IEMBS.1994.415400; Avolio A, 2002, J HYPERTENS, V20, P2341, DOI 10.1097/00004872-200212000-00007; Bartlett JW, 2008, ULTRASOUND OBST GYN, V31, P466, DOI 10.1002/uog.5256; Bazett H. C., 1920, HEART, V7, P35; Blacher J, 1999, HYPERTENSION, V33, P1111, DOI 10.1161/01.HYP.33.5.1111; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bortolotto LA, 2000, AM J HYPERTENS, V13, P165, DOI 10.1016/S0895-7061(99)00192-2; Boutouyrie P, 2002, HYPERTENSION, V39, P10, DOI 10.1161/hy0102.099031; CHIRIFE R, 1971, AM HEART J, V82, P222, DOI 10.1016/0002-8703(71)90269-9; Davies JI, 2003, J HYPERTENS, V21, P463, DOI 10.1097/00004872-200303000-00004; DORLAS JC, 1985, BRIT J ANAESTH, V57, P524, DOI 10.1093/bja/57.5.524; Elgendi M, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-139; Elgendi M, 2014, COMPUT METH PROG BIO, V117, P125, DOI 10.1016/j.cmpb.2014.08.001; Elgendi M, 2012, CURR CARDIOL REV, V8, P215, DOI 10.2174/157340312803217184; Elgendi M, 2012, CURR CARDIOL REV, V8, P14, DOI 10.2174/157340312801215782; Gonzalez R, 2008, COMPUTERS IN CARDIOLOGY 2008, VOLS 1 AND 2, P177, DOI 10.1109/CIC.2008.4749006; Hashimoto J, 2002, J HYPERTENS, V20, P2415, DOI 10.1097/00004872-200212000-00021; Hyun Jae Baek, 2007, 6th International Special Topic Conference on Information Technology Applications in Biomedicine, 2007, P70; Imanaga I, 1998, JPN HEART J, V39, P775; ISHIKAWA H, 1975, JPN CIRC J, V39, P133, DOI 10.1253/jcj.39.133; Jang DG, 2015, IEEE J BIOMED HEALTH, V19, P256, DOI 10.1109/JBHI.2014.2306679; Jang DG, 2010, INT CONF SIGN PROCES, P1742, DOI 10.1109/ICOSP.2010.5656481; Jang DG, 2010, INT CONF SIGN PROCES, P1734, DOI 10.1109/ICOSP.2010.5656472; Janner JH, 2012, J HUM HYPERTENS, V26, P476, DOI 10.1038/jhh.2011.59; Kawaguchi M, 2003, CIRCULATION, V107, P714, DOI 10.1161/01.CIR.0000048123.22359.A0; Kelly RP, 2001, HYPERTENSION, V37, P1429, DOI 10.1161/01.HYP.37.6.1429; Korhonen I, 2009, ACTA ANAESTH SCAND, V53, P975, DOI 10.1111/j.1399-6576.2009.02026.x; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; LEWIS RP, 1977, CIRCULATION, V56, P146, DOI 10.1161/01.CIR.56.2.146; Millasseau SC, 2006, J HYPERTENS, V24, P1449, DOI 10.1097/01.hjh.0000239277.05068.87; Millasseau SC, 2002, CLIN SCI, V103, P371, DOI 10.1042/cs1030371; Millasseau SC, 2000, HYPERTENSION, V36, P952, DOI 10.1161/01.HYP.36.6.952; Murray WB, 1996, J CLIN MONITOR, V12, P365, DOI 10.1007/BF02077634; Nichols W, 1998, MCDONALDS BLOOD FLOW; Nichols WW, 2005, AM J HYPERTENS, V18, p3S, DOI 10.1016/j.amjhyper.2004.10.009; Nurnberger J, 2002, J HYPERTENS, V20, P2407, DOI 10.1097/00004872-200212000-00020; Otsuka T, 2006, CIRC J, V70, P304, DOI 10.1253/circj.70.304; Ozawa T., 1978, MYAKUHA, V8, P22; Patvardhan E, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/253758; PORTNEY LG, 1993, FDN CLIN RES APPL PR, P509; Quan H, 1996, BIOMETRICS, V52, P1195, DOI 10.2307/2532835; Salvi V, 2010, BRIT J PHARMACOL, V159, P34, DOI 10.1111/j.1476-5381.2009.00427.x; Sharma T., 2012, THESIS THAPAR U PATI; Skinner SL, CLIN GUIDE PULSE WAV; Takada H, 1996, MED PROG TECHNOL, V21, P205, DOI 10.1023/A:1016936206694; Takazawa K, 1998, HYPERTENSION, V32, P365, DOI 10.1161/01.HYP.32.2.365; Vas S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059809, 10.1371/journal.pone.0073990]; WEISSLER AM, 1961, AM HEART J, V62, P367, DOI 10.1016/0002-8703(61)90403-3; Wilkinson IB, 2002, AM J HYPERTENS, V15, P24, DOI 10.1016/S0895-7061(01)02252-X; Yasmin, 1999, QJM-INT J MED, V92, P595, DOI 10.1093/qjmed/92.10.595	51	54	57	5	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135659	10.1371/journal.pone.0135659	http://dx.doi.org/10.1371/journal.pone.0135659			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291079	Green Published, gold, Green Submitted			2022-12-26	WOS:000359919900025
J	Liu, Y; Wang, L; Cai, ZF; Zhao, P; Peng, CJ; Zhao, LJ; Wan, CD				Liu, Yao; Wang, Ling; Cai, Zhifang; Zhao, Peng; Peng, Cijun; Zhao, Lijin; Wan, Chidan			The Decrease of Peripheral Blood CD4+T Cells Indicates Abdominal Compartment Syndrome in Severe Acute Pancreatitis	PLOS ONE			English	Article							INTRAABDOMINAL HYPERTENSION; PRACTICE GUIDELINES; LYMPHOCYTE SUBSETS; PROSPECTIVE COHORT; REDUCTION	Objective Few data are available on the role of T lymphocytes and inflammatory cytokines in abdominal compartment syndrome (ACS) in severe acute pancreatitis (SAP). We conducted a retrospective study to assess the risk factors associated with ACS in SAP. Methods A total of 76 SAP patients who were admitted within 24 hours after symptom onset in our study. There were 36 patients suffering from ACS and 40 from intra-abdominal hypertension (IAH). On the 1st, 3rd and 7th days after hospital admission, the following variables were assessed: serum value of C-reactive protein (CRP), and the proportions of peripheral CD4(+) and CD8(+) T lymphocytes. Acute Physiology and Chronic Health Evaluation II (APACHE II) score, and computed tomography severity index (CTSI) score were assessed on days 1 and 7 after hospitalization. Results Compared with the patients with IAH, ACS patients showed statistically higher CRP value on 7th day after hospital admission, proportions of CD4(+) T cells on days 1, 3, 7 and CD4(+)/CD8(+) ratio on day 1 were significantly lower (P < 0.05, respectively). A CD4(+) T cell proportion of 30.3% on the 1st day indicated ACS with an area under the curve (AUC) of 0.774, a sensitivity with 82.5% and specificity with 72.0%, respectively. Sensitivity/specificity for predicting ACS in SAP patients on day 1 was 70.0%/68.0% for CD4(+)/CD8(+) ratio, 72.2%/65.0% for APACHE II score. Conclusions The reduction of peripheral blood CD4(+) T lymphocytes is associated with ACS in SAP, and may act as a potential predictor of ACS in SAP.	[Liu, Yao; Wan, Chidan] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Hepatobiliary Surg, Wuhan 430074, Hubei Province, Peoples R China; [Liu, Yao; Wang, Ling; Cai, Zhifang; Zhao, Peng; Peng, Cijun; Zhao, Lijin] Zunyi Med Coll, Affiliated Hosp, Dept Hepatobiliary & Pancreat Surg, Zunyi, Guizhou Provinc, Peoples R China	Huazhong University of Science & Technology; Zunyi Medical University	Peng, CJ (corresponding author), Zunyi Med Coll, Affiliated Hosp, Dept Hepatobiliary & Pancreat Surg, Zunyi, Guizhou Provinc, Peoples R China.	cijunpeng@163.com; chidanwan@126.com						Al-Bahrani AZ, 2008, PANCREAS, V36, P39, DOI 10.1097/mpa.0b013e318149f5bf; [Anonymous], 2005, GUT, V54, pi1; Balthazar EJ, 2002, RADIOLOGY, V223, P603, DOI 10.1148/radiol.2233010680; Banks PA, 1997, AM J GASTROENTEROL, V92, P377; Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779; Bhatia M, 2005, PANCREATOLOGY, V5, P132, DOI 10.1159/000085265; Carroll JK, 2007, AM FAM PHYSICIAN, V75, P1513; CURLEY PJ, 1993, BRIT J SURG, V80, P1312, DOI 10.1002/bjs.1800801031; De Waele JJ, 2005, CRIT CARE, V9, pR452, DOI 10.1186/cc3754; Demols A, 2000, GASTROENTEROLOGY, V118, P582, DOI 10.1016/S0016-5085(00)70265-4; Deng ZG, 2011, WORLD J GASTROENTERO, V17, P4911, DOI 10.3748/wjg.v17.i44.4911; Group of Pancreas Surgery Chinese Society of Surgery Chinese Medical Association, 2007, Zhonghua Wai Ke Za Zhi, V45, P727; Gurleyik G, 2005, J PANCREAS, V6, P562; Johnson CD, 2004, GUT, V53, P1340, DOI 10.1136/gut.2004.039883; Ke L, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000108; Kirkpatrick AW, 2013, INTENS CARE MED, V39, P1190, DOI 10.1007/s00134-013-2906-z; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; Mitchell RMS, 2003, LANCET, V361, P1447, DOI 10.1016/S0140-6736(03)13139-X; Nakayama S, 2014, PANCREAS, V43, P28, DOI 10.1097/MPA.0b013e3182a7c76b; Nawaz H, 2013, AM J GASTROENTEROL, V108, P1911, DOI 10.1038/ajg.2013.348; Oiva J, 2010, CRIT CARE, V14, DOI 10.1186/cc9329; Patel A, 2007, AM J ROENTGENOL, V189, P1037, DOI 10.2214/AJR.07.2092; PEZZILLI R, 1995, PANCREAS, V11, P95, DOI 10.1097/00006676-199507000-00010; Pietruczuk M, 2006, WORLD J GASTROENTERO, V12, P5344, DOI 10.3748/wjg.v12.i33.5344; Takeyama Y, 2000, J GASTROINTEST SURG, V4, P379, DOI 10.1016/S1091-255X(00)80016-5; Werner J, 2003, PANCREATOLOGY, V3, P115, DOI 10.1159/000070079; Wu BU, 2008, GUT, V57, P1698, DOI 10.1136/gut.2008.152702	28	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135768	10.1371/journal.pone.0135768	http://dx.doi.org/10.1371/journal.pone.0135768			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287969	Green Submitted, Green Published, gold			2022-12-26	WOS:000360018600067
J	Vieira, FG; Ping, QG; Moreno, AJ; Kidd, JD; Thompson, K; Jiang, BB; Lincecum, JM; Wang, MZ; De Zutter, GS; Tassinari, VR; Levine, B; Hatzipetros, T; Gill, A; Perrin, S				Vieira, Fernando G.; Ping, Qinggong; Moreno, Andy J.; Kidd, Joshua D.; Thompson, Kenneth; Jiang, Bingbing; Lincecum, John M.; Wang, Monica Z.; De Zutter, Gerard S.; Tassinari, Valerie R.; Levine, Beth; Hatzipetros, Theo; Gill, Alan; Perrin, Steven			Guanabenz Treatment Accelerates Disease in a Mutant SOD1 Mouse Model of ALS	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; SUBUNIT	Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterized by loss of motor neurons. The mechanisms leading to motor neuron degeneration in ALS are unclear. However, there is evidence for involvement of endoplasmic reticulum (ER) stress and the unfolded protein response (UPR) in ALS, notably in mutant SOD1 mediated models of ALS. Stress induced phosphorylation of the eIF2 alpha subunit by eukaryotic translation initiation factor 2-alpha kinase 3 Perk activates the UPR. Guanabenz is a centrally acting alpha2 adrenergic receptor agonist shown to interact with a regulatory subunit of the protein phosphatase, Pp1/Gadd34, and selectively disrupt the dephosphorylation of the alpha subunit of eukaryotic initiation factor 2 (eif2alpha). Here we demonstrate that guanabenz is protective in fibroblasts expressing G93A mutant SOD1 when they are exposed to tunicamycin mediated ER stress. However, in contrast to other reports, guanabenz treatment accelerated ALS-like disease progression in a strain of mutant SOD1 transgenic ALS mice. This study highlights challenges of pharmacological interventions of cellular stress responses in whole animal models of ALS.	[Vieira, Fernando G.; Ping, Qinggong; Moreno, Andy J.; Kidd, Joshua D.; Thompson, Kenneth; Jiang, Bingbing; Lincecum, John M.; Wang, Monica Z.; De Zutter, Gerard S.; Tassinari, Valerie R.; Levine, Beth; Hatzipetros, Theo; Gill, Alan; Perrin, Steven] ALS Therapy Dev Inst, Cambridge, MA 02139 USA		Vieira, FG (corresponding author), ALS Therapy Dev Inst, Cambridge, MA 02139 USA.	fvieira@als.net	Vieira, Fernando/L-6246-2013; Vieira, Fernando/ABG-9082-2020	Vieira, Fernando/0000-0003-2996-6418; Vieira, Fernando/0000-0003-2996-6418	ALS Therapy Development Institute	ALS Therapy Development Institute	Funding: The authors received no specific funding for this work. The ALS Therapy Development Institute is a not-for-profit independent 503c organization funded primarily by private donations. The private donations come from 10's of thousands of ALS patients and their families and friends. These revenues are disclosed yearly in the authors' organization's audited financials (http://www.als.net/About-ALS-TDI/ALS-TDI-Annual-Reports.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Atkin JD, 2008, NEUROBIOL DIS, V30, P400, DOI 10.1016/j.nbd.2008.02.009; Committee for the Update of the Guide for the Care and Use of Laboratory Animals Division on Earth and Life Studies Institute for Laboratory Animal Research, 2010, GUIDE CARE USE LAB A, V8th; ELBEIN AD, 1981, TRENDS BIOCHEM SCI, V6, P219, DOI 10.1016/0968-0004(81)90080-3; Gill A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006489; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Huang BS, 1998, HYPERTENSION, V32, P1028, DOI 10.1161/01.HYP.32.6.1028; Ilieva EV, 2007, BRAIN, V130, P3111, DOI 10.1093/brain/awm190; Ito Y, 2009, NEUROBIOL DIS, V36, P470, DOI 10.1016/j.nbd.2009.08.013; Jiang HQ, 2014, NEUROSCIENCE, V277, P132, DOI 10.1016/j.neuroscience.2014.03.047; Jiang HY, 2003, MOL CELL BIOL, V23, P5651, DOI 10.1128/MCB.23.16.5651-5663.2003; Kikuchi H, 2006, P NATL ACAD SCI USA, V103, P6025, DOI 10.1073/pnas.0509227103; Kim HJ, 2014, NAT GENET, V46, P152, DOI 10.1038/ng.2853; Ludolph Albert C, 2007, Amyotroph Lateral Scler, V8, P217, DOI 10.1080/17482960701292837; Ludolph AC, 2010, AMYOTROPH LATERAL SC, V11, P38, DOI 10.3109/17482960903545334; Matus Soledad, 2013, Int J Cell Biol, V2013, P674751, DOI 10.1155/2013/674751; Mitsumoto H, 2014, LANCET NEUROL, V13, P1127, DOI 10.1016/S1474-4422(14)70129-2; Moreno JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006767; Perrin S, 2014, NATURE, V507, P423, DOI 10.1038/507423a; Rowland LP, 1998, J NEUROL SCI, V160, pS6, DOI 10.1016/S0022-510X(98)00193-2; Saxena S, 2009, NAT NEUROSCI, V12, P627, DOI 10.1038/nn.2297; Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300; Tribouillard-Tanvier D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001981; Tsaytler P, 2013, FEBS J, V280, P766, DOI 10.1111/j.1742-4658.2012.08535.x; Tsaytler P, 2011, SCIENCE, V332, P91, DOI 10.1126/science.1201396; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vieira FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091608; Wang LJ, 2014, NEUROBIOL DIS, V71, P317, DOI 10.1016/j.nbd.2014.08.010; Wang LJ, 2014, HUM MOL GENET, V23, P2629, DOI 10.1093/hmg/ddt658; Wang LJ, 2011, HUM MOL GENET, V20, P1008, DOI 10.1093/hmg/ddq546; Zhu H, 2003, BRAIN RES, V964, P9, DOI 10.1016/S0006-8993(02)03754-X; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	32	56	58	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135570	10.1371/journal.pone.0135570	http://dx.doi.org/10.1371/journal.pone.0135570			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288094	gold, Green Submitted, Green Published			2022-12-26	WOS:000360018600054
J	Brunsch, M; Schubert, D; Gube, M; Ring, C; Hanisch, L; Linde, J; Krause, K; Kothe, E				Brunsch, Melanie; Schubert, Daniela; Gube, Matthias; Ring, Christiane; Hanisch, Lisa; Linde, Joerg; Krause, Katrin; Kothe, Erika			Dynein Heavy Chain, Encoded by Two Genes in Agaricomycetes, Is Required for Nuclear Migration in Schizophyllum commune	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; MICROTUBULE PLUS-END; SEQUENCE COUNT DATA; MATING-TYPE GENES; CYTOPLASMIC DYNEIN; ASPERGILLUS-NIDULANS; FILAMENTOUS FUNGI; PHEROMONE GENES; MOTOR PROTEINS; MIXED MODELS	The white-rot fungus Schizophyllum commune (Agaricomycetes) was used to study the cell biology of microtubular trafficking during mating interactions, when the two partners exchange nuclei, which are transported along microtubule tracks. For this transport activity, the motor protein dynein is required. In S. commune, the dynein heavy chain is encoded in two parts by two separate genes, dhc1 and dhc2. The N-terminal protein Dhc1 supplies the dimerization domain, while Dhc2 encodes the motor machinery and the microtubule binding domain. This split motor protein is unique to Basidiomycota, where three different sequence patterns suggest independent split events during evolution. To investigate the function of the dynein heavy chain, the gene dhc1 and the motor domain in dhc2 were deleted. Both resulting mutants were viable, but revealed phenotypes in hyphal growth morphology and mating behavior as well as in sexual development. Viability of strain Delta dhc2 is due to the higher expression of kinesin-2 and kinesin-14, which was proven via RNA sequencing.	[Brunsch, Melanie; Schubert, Daniela; Gube, Matthias; Ring, Christiane; Hanisch, Lisa; Krause, Katrin; Kothe, Erika] Univ Jena, Inst Microbiol, Microbial Commun, D-07743 Jena, Germany; [Linde, Joerg] Leibniz Inst Nat Prod Res & Infect Biol, Hans Knoll Inst, Res Grp Syst Biol & Bioinformat, D-07745 Jena, Germany	Friedrich Schiller University of Jena; Hans Knoll Institute (HKI)	Kothe, E (corresponding author), Univ Jena, Inst Microbiol, Microbial Commun, Neugasse 25, D-07743 Jena, Germany.	erika.kothe@uni-jena.de		Gube, Matthias/0000-0001-5101-3096	DFG - GSC [24]	DFG - GSC	This work was supported by DFG - GSC 24, http://dfg.de/Leibniz Association ILRS, http://www.ilrs.hki-jena.de/BMBF, http://www.bmbf.de/.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], 1966, GENETICS SEXUALITY H; Asai DJ, 2004, J EUKARYOT MICROBIOL, V51, P23, DOI 10.1111/j.1550-7408.2004.tb00157.x; Asai DJ, 2001, TRENDS CELL BIOL, V11, P196, DOI 10.1016/S0962-8924(01)01970-5; Bruno KS, 1996, P NATL ACAD SCI USA, V93, P4775, DOI 10.1073/pnas.93.10.4775; COOKE WB, 1961, MYCOLOGIA, V53, P575, DOI 10.2307/3756459; de Jong JF, 2010, FEMS MICROBIOL LETT, V310, P91, DOI 10.1111/j.1574-6968.2010.02052.x; Ebersberger I, 2012, MOL BIOL EVOL, V29, P1319, DOI 10.1093/molbev/msr285; Falnikar A, 2011, MOL BIOL CELL, V22, P1561, DOI 10.1091/mbc.E10-11-0905; Ferenz NP, 2010, SEMIN CELL DEV BIOL, V21, P255, DOI 10.1016/j.semcdb.2010.01.019; Fink G, 2009, NAT CELL BIOL, V11, P717, DOI 10.1038/ncb1877; FISCHER R, 1995, J CELL BIOL, V128, P485, DOI 10.1083/jcb.128.4.485; Gola S, 2003, J BASIC MICROB, V43, P104, DOI 10.1002/jobm.200390010; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hardcastle TJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-422; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; Hirakawa E, 2000, P NATL ACAD SCI USA, V97, P2533, DOI 10.1073/pnas.050585297; Hjelm RP, 2010, ACTA CRYSTALLOGR D, V66, P1218, DOI 10.1107/S0907444910021323; HOLZBAUR ELF, 1994, ANNU REV CELL BIOL, V10, P339, DOI 10.1146/annurev.cb.10.110194.002011; Hoyt MA, 1997, P NATL ACAD SCI USA, V94, P12747, DOI 10.1073/pnas.94.24.12747; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; King SM, 2000, J CELL SCI, V113, P2521; KOLTIN Y, 1968, SCIENCE, V160, P85, DOI 10.1126/science.160.3823.85; Kothe E, 1996, FEMS MICROBIOL REV, V18, P65, DOI 10.1016/0168-6445(96)00003-4; Markus SM, 2011, CYTOSKELETON, V68, P157, DOI 10.1002/cm.20502; Matheny PB, 2006, CAN J BOT, V84, P1794, DOI 10.1139/B06-128; Miller MA, 2010, CREATING CIPRES SCI; MUNOZRIVAS A, 1986, MOL GEN GENET, V205, P103, DOI 10.1007/BF02428038; Ohm RA, 2010, NAT BIOTECHNOL, V28, P957, DOI 10.1038/nbt.1643; Oiwa K, 2005, CURR OPIN CELL BIOL, V17, P98, DOI 10.1016/j.ceb.2004.12.006; Palmer GE, 2006, FEMS MICROBIOL LETT, V262, P1, DOI 10.1111/j.1574-6968.2006.00341.x; Pfister KK, 2006, PLOS GENET, V2, P11, DOI 10.1371/journal.pgen.0020001; PLAMANN M, 1994, J CELL BIOL, V127, P139, DOI 10.1083/jcb.127.1.139; RAJU TR, 1982, BRAIN RES, V248, P196, DOI 10.1016/0006-8993(82)91165-9; Ramakrishnan C, 2002, PROTEIN ENG, V15, P783, DOI 10.1093/protein/15.10.783; Rambaut A, 2009, FIGTREE V1 3 1; Rambaut A, 2009, TRACER V1 5; RAPER JR, 1958, GENETICS, V43, P530; RAPER JR, 1974, HDB GENETICS, V1, P597; RAUDASKOSKI M, 1982, T BRIT MYCOL SOC, V78, P475, DOI 10.1016/S0007-1536(82)80154-X; Raudaskoski M, 1998, FUNGAL GENET BIOL, V24, P207, DOI 10.1006/fgbi.1998.1069; Raudaskoski M, 2010, EUKARYOT CELL, V9, P847, DOI 10.1128/EC.00319-09; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schuster M, 2011, EMBO J, V30, P652, DOI 10.1038/emboj.2010.360; Shima T, 2006, P NATL ACAD SCI USA, V103, P17736, DOI 10.1073/pnas.0606794103; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steinberg G, 2007, TRENDS MICROBIOL, V15, P14, DOI 10.1016/j.tim.2006.11.007; Straube A, 2001, EMBO J, V20, P5091, DOI 10.1093/emboj/20.18.5091; Suelmann R, 2000, RES MICROBIOL, V151, P247, DOI 10.1016/S0923-2508(00)00151-0; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; WENDLAND J, 1995, EMBO J, V14, P5271, DOI 10.1002/j.1460-2075.1995.tb00211.x; WESSELS JGH, 1991, J GEN MICROBIOL, V137, P2439, DOI 10.1099/00221287-137-10-2439; Xiang X, 2003, CURR OPIN MICROBIOL, V6, P628, DOI 10.1016/j.mib.2003.10.009; Xiang X, 2003, J CELL BIOL, V160, P289, DOI 10.1083/jcb.200212168; XIANG X, 1994, P NATL ACAD SCI USA, V91, P2100, DOI 10.1073/pnas.91.6.2100; Yamamoto A, 2003, J CELL SCI, V116, P4501, DOI 10.1242/jcs.00835; Zhang J, 2010, J CELL SCI, V123, P3596, DOI 10.1242/jcs.075259	65	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135616	10.1371/journal.pone.0135616	http://dx.doi.org/10.1371/journal.pone.0135616			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284622	Green Submitted, Green Published, gold			2022-12-26	WOS:000359666100050
J	Ferguson, TW; Zacharias, J; Walker, SR; Collister, D; Rigatto, C; Tangri, N; Komenda, P				Ferguson, Thomas W.; Zacharias, James; Walker, Simon R.; Collister, David; Rigatto, Claudio; Tangri, Navdeep; Komenda, Paul			An Economic Assessment Model of Rural and Remote Satellite Hemodialysis Units	PLOS ONE			English	Article							STAGE RENAL-DISEASE; PERITONEAL-DIALYSIS; CARDIOVASCULAR-DISEASE; COST-EFFECTIVENESS; HOME HEMODIALYSIS; TECHNIQUE FAILURE; MORTALITY; CARE; MODALITY; DELIVERY	Background Kidney Failure is epidemic in many remote communities in Canada. In-centre hemodialysis is provided within these settings in satellite hemodialysis units. The key cost drivers of this program have not been fully described. Such information is important in informing the design of programs aimed at optimizing efficiency in providing dialysis and preventative chronic kidney disease care in remote communities. Design, Setting, Participants, and Measurements We constructed a cost model based on data derived from 16 of Manitoba, Canada's remote satellite units. We included all costs for operation of the unit, transportation, treatment, and capital costs. All costs were presented in 2013 Canadian dollars. Results The annual per-patient cost of providing hemodialysis in the satellite units ranged from $80,372 to $215,918 per patient, per year. The median per patient, per year cost was $99,888 (IQR $89,057-$122,640). Primary cost drivers were capital costs related to construction, human resource expenses, and expenses for return to tertiary care centres for health care. Costs related to transport considerably increased estimates in units that required plane or helicopter transfers. Conclusions Satellite hemodialysis units in remote areas are more expensive on a per-patient basis than hospital hemodialysis and satellite hemodialysis available in urban areas. In some rural, remote locations, better value for money may reside in local surveillance and prevention programs in addition support for home dialysis therapies over construction of new satellite hemodialysis units.	[Zacharias, James; Walker, Simon R.; Collister, David; Rigatto, Claudio; Tangri, Navdeep; Komenda, Paul] Univ Manitoba, Dept Med, Nephrol Sect, Winnipeg, MB, Canada; [Ferguson, Thomas W.; Zacharias, James; Tangri, Navdeep] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB R3T 2N2, Canada	University of Manitoba; University of Manitoba	Komenda, P (corresponding author), Univ Manitoba, Dept Med, Nephrol Sect, Winnipeg, MB, Canada.	paulkomenda@yahoo.com		Tangri, Navdeep/0000-0002-5075-6370; Zacharias, James/0000-0002-4887-5338	Research Manitoba; KRESCENT New Investigator Award; MHRC Establishment Award	Research Manitoba; KRESCENT New Investigator Award(Canadian Institutes of Health Research (CIHR)); MHRC Establishment Award	TF receives funding from a Graduate Studentship from the University of Manitoba through the Manitoba Health Research Council (now Research Manitoba). (http://researchmanitoba.ca)-Research Manitoba, formerly Manitoba Health Research Council. NT is supported by the KRESCENT New Investigator Award and the MHRC Establishment Award. The KRESCENT New investigator award is a joint initiative of the Kidney Foundation of Canada, Canadian Institute of Health Research and the Canadian Society of Nephrology. None of the other authors have any declarations. (http://researchmanitoba.ca)-Research Manitoba, formerly Manitoba Health Research Council (http://www.krescent.ca/Page.aspx?pid=444)-KRESCENT New investigator award. The funders had no role in study design, data collection and analysis, decision to published, or preparation of the manuscript.	Bello AK, 2012, NEPHROL DIAL TRANSPL, V27, P3849, DOI 10.1093/ndt/gfs267; Bernstein K, 2010, CLIN J AM SOC NEPHRO, V5, P645, DOI 10.2215/CJN.04550709; BILINSKY RT, 1971, J AMER MED ASSOC, V218, P1809; Brundisini F, 2013, Ont Health Technol Assess Ser, V13, P1; CAMBI V, 1971, LANCET, V2, P1158; Canadian Institute for Health Information, 2014, CAN ORG REPL REG ANN; Chui BK, 2013, AM J KIDNEY DIS, V61, P104, DOI 10.1053/j.ajkd.2012.07.010; de Wit GA, 1998, HEALTH POLICY, V44, P215, DOI 10.1016/S0168-8510(98)00017-7; Diamant MJ, 2011, CLIN J AM SOC NEPHRO, V6, P1692, DOI 10.2215/CJN.07650810; Diamant MJ, 2010, CLIN J AM SOC NEPHRO, V5, P268, DOI 10.2215/CJN.05190709; Foley RN, 1998, J NEPHROL, V11, P239; Goeree R, 1995, CLIN INVEST MED, V18, P455; Gonzalez-Perez JG, 2005, INT J TECHNOL ASSESS, V21, P32, DOI 10.1017/S026646230505004X; Klarenbach S, 2014, J AM SOC NEPHROL, V25, P587, DOI 10.1681/ASN.2013040360; Komenda P, 2014, CMAJ OPEN IN PRESS; Komenda P, 2012, KIDNEY INT, V81, P307, DOI 10.1038/ki.2011.338; Lee H, 2002, AM J KIDNEY DIS, V40, P611, DOI 10.1053/ajkd.2002.34924; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Levin A, 2000, AM J KIDNEY DIS, V36, pS24, DOI 10.1053/ajkd.2000.19928; Lim WH, 2011, NEPHROL DIAL TRANSPL, V26, P3366, DOI 10.1093/ndt/gfr070; Manitoba Health, 2013, MAN PHYS MAN; Manitoba Renal Program, 2014, EL KIDN HLTH REC; Maripuri S, 2012, CLIN J AM SOC NEPHRO, V7, P1121, DOI 10.2215/CJN.10831011; May S., 2013, NEPHROLOGY CARLTON; McFarlane P, 2011, SEMIN DIALYSIS, V24, P678, DOI 10.1111/j.1525-139X.2011.01007.x; Moist LM, 2008, AM J KIDNEY DIS, V51, P641, DOI 10.1053/j.ajkd.2007.12.021; Mowatt G, 2003, Health Technol Assess, V7, P1; O'Hare AM, 2006, KIDNEY INT, V69, P343, DOI 10.1038/sj.ki.5000044; Prakash S, 2007, NEPHROL DIAL TRANSPL, V22, P2297, DOI 10.1093/ndt/gfm176; Roderick P, 2004, AM J KIDNEY DIS, V44, P121, DOI 10.1053/j.ajkd.2004.03.031; Sennfalt K, 2002, PERITON DIALYSIS INT, V22, P39; SHAPIRO FL, 1968, ANN INTERN MED, V69, P673, DOI 10.7326/0003-4819-69-4-673; Smith KB, 2008, AUST J RURAL HEALTH, V16, P56, DOI 10.1111/j.1440-1584.2008.00953.x; Soroka Steven D, 2005, Hemodial Int, V9, P196, DOI 10.1111/j.1492-7535.2005.01132.x; Statistics Canada, 2014, CONS PRIC IND HLTH P; Tonelli M, 2007, KIDNEY INT, V72, P1023, DOI 10.1038/sj.ki.5002443; Tonelli M, 2007, CAN MED ASSOC J, V177, P1039, DOI 10.1503/cmaj.070343; Walker R, 2014, NEPHROLOGY, V19, P459, DOI 10.1111/nep.12269; WILSON R, 1994, CAN FAM PHYSICIAN, V40, P1934; Zacharias J, 2011, SEMIN DIALYSIS, V24, P653, DOI 10.1111/j.1525-139X.2011.01004.x; Zacharias JM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-290	41	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135587	10.1371/journal.pone.0135587	http://dx.doi.org/10.1371/journal.pone.0135587			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284357	Green Published, gold, Green Submitted			2022-12-26	WOS:000359666100048
J	Kentish, SJ; Frisby, CL; Kritas, S; Li, H; Hatzinikolas, G; O'Donnell, TA; Wittert, GA; Page, AJ				Kentish, Stephen J.; Frisby, Claudine L.; Kritas, Stamatiki; Li, Hui; Hatzinikolas, George; O'Donnell, Tracey A.; Wittert, Gary A.; Page, Amanda J.			TRPV1 Channels and Gastric Vagal Afferent Signalling in Lean and High Fat Diet Induced Obese Mice	PLOS ONE			English	Article							RECEPTOR POTENTIAL CHANNELS; GASTROINTESTINAL SATIETY SIGNALS; SENSORY NEURONS; ION CHANNELS; FOOD-INTAKE; CAPSAICIN; NUCLEUS; MECHANOSENSITIVITY; MECHANORECEPTORS; MODULATION	Aim Within the gastrointestinal tract vagal afferents play a role in control of food intake and satiety signalling. Activation of mechanosensitive gastric vagal afferents induces satiety. However, gastric vagal afferent responses to mechanical stretch are reduced in high fat diet mice. Transient receptor potential vanilloid 1 channels (TRPV1) are expressed in vagal afferents and knockout of TRPV1 reduces gastro-oesophageal vagal afferent responses to stretch. We aimed to determine the role of TRPV1 on gastric vagal afferent mechanosensitivity and food intake in lean and HFD-induced obese mice. Methods TRPV1+/+ and -/- mice were fed either a standard laboratory diet or high fat diet for 20wks. Gastric emptying of a solid meal and gastric vagal afferent mechanosensitivity was determined. Results Gastric emptying was delayed in high fat diet mice but there was no difference between TRPV1+/+ and -/- mice on either diet. TRPV1 mRNA expression in whole nodose ganglia of TRPV1+/+ mice was similar in both dietary groups. The TRPV1 agonist N-oleoyldopamine potentiated the response of tension receptors in standard laboratory diet but not high fat diet mice. Food intake was greater in the standard laboratory diet TRPV1-/- compared to TRPV1+/+ mice. This was associated with reduced response of tension receptors to stretch in standard laboratory diet TRPV1-/- mice. Tension receptor responses to stretch were decreased in high fat diet compared to standard laboratory diet TRPV1+/+ mice; an effect not observed in TRPV1-/- mice. Disruption of TRPV1 had no effect on the response of mucosal receptors to mucosal stroking in mice on either diet. Conclusion TRPV1 channels selectively modulate gastric vagal afferent tension receptor mechanosensitivity and may mediate the reduction in gastric vagal afferent mechanosensitivity in high fat diet-induced obesity.	[Kentish, Stephen J.; Frisby, Claudine L.; Li, Hui; Hatzinikolas, George; O'Donnell, Tracey A.; Wittert, Gary A.; Page, Amanda J.] Univ Adelaide, Discipline Med, Ctr Nutr & Gastrointestinal Dis, Adelaide, SA, Australia; [Kentish, Stephen J.; Frisby, Claudine L.; Li, Hui; Hatzinikolas, George; O'Donnell, Tracey A.; Wittert, Gary A.; Page, Amanda J.] SAHMRI, Adelaide, SA, Australia; [Wittert, Gary A.; Page, Amanda J.] Royal Adelaide Hosp, Adelaide, SA 5000, Australia; [Kritas, Stamatiki] Womens & Childrens Hosp, Adelaide, SA, Australia	University of Adelaide; South Australian Health & Medical Research Institute (SAHMRI); Royal Adelaide Hospital; Womens & Childrens Hospital Australia	Page, AJ (corresponding author), Univ Adelaide, Discipline Med, Ctr Nutr & Gastrointestinal Dis, Adelaide, SA, Australia.	Amanda.page@adelaide.edu.au	wittert, gary/AAE-2398-2019	Page, Amanda/0000-0002-7086-5865; Li, Hui/0000-0002-1010-516X; Wittert, Gary/0000-0001-6818-6065	Royal Adelaide Hospital Gum Bequest	Royal Adelaide Hospital Gum Bequest	This work was supported by Royal Adelaide Hospital Gum Bequest. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balistreri CR, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/802078; BECKER JM, 1983, AM J PHYSIOL, V245, pG334, DOI 10.1152/ajpgi.1983.245.3.G334; Beglinger C, 2006, PHYSIOL BEHAV, V89, P460, DOI 10.1016/j.physbeh.2006.05.048; Bielefeldt K, 2008, AM J PHYSIOL-GASTR L, V294, pG130, DOI 10.1152/ajpgi.00388.2007; Bielefeldt K, 2006, AM J PHYSIOL-GASTR L, V291, pG987, DOI 10.1152/ajpgi.00080.2006; BLACKSHAW LA, 1987, J AUTONOM NERV SYST, V18, P19; Cioffi DL, 2007, CIRC RES, V100, P934, DOI 10.1161/01.RES.0000265139.10277.62; Daly DM, 2011, J PHYSIOL-LONDON, V589, P2857, DOI 10.1113/jphysiol.2010.204594; Derbenev AV, 2006, J NEUROSCI, V26, P9666, DOI 10.1523/JNEUROSCI.1591-06.2006; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Doyle MW, 2002, J NEUROSCI, V22, P8222; Faussone-Pellegrini MS, 2005, HISTOCHEM CELL BIOL, V124, P61, DOI 10.1007/s00418-005-0025-9; Garami A, 2011, J NEUROSCI, V31, P1721, DOI 10.1523/JNEUROSCI.4671-10.2011; HEDDLE R, 1989, J GASTROEN HEPATOL, V4, P437, DOI 10.1111/j.1440-1746.1989.tb01741.x; Jin YH, 2004, J NEUROSCI, V24, P4709, DOI 10.1523/JNEUROSCI.0753-04.2004; Jones RCW, 2005, J NEUROSCI, V25, P10981, DOI 10.1523/JNEUROSCI.0703-05.2005; Kentish SJ, 2013, INT J OBESITY, DOI [10.1038/ijo.2013, DOI 10.1038/IJ0.2013.138]; Kentish S, 2012, J PHYSIOL-LONDON, V590, P209, DOI 10.1113/jphysiol.2011.222158; Kentish SJ, 2013, J PHYSIOL-LONDON, V591, P1921, DOI 10.1113/jphysiol.2012.247577; Lee E, 2015, FASEB J, V29, P3182, DOI 10.1096/fj.14-268300; Lee KJ, 2004, ALIMENT PHARM THER, V19, P415, DOI 10.1046/j.1365-2036.2004.01823.x; Li H, 2013, ACTA PHYSIOL, V209, P179, DOI 10.1111/apha.12154; Liedtke W, 2005, CELL MOL LIFE SCI, V62, P2985, DOI 10.1007/s00018-005-5181-5; Little TJ, 2011, PHYSIOL BEHAV, V104, P613, DOI 10.1016/j.physbeh.2011.04.038; Liu DY, 2008, HYPERTENS RES, V31, P1989, DOI 10.1291/hypres.31.1989; Ludy MJ, 2012, CHEM SENSES, V37, P103, DOI 10.1093/chemse/bjr100; Marshall NJ, 2013, HYPERTENSION, V61, P246, DOI 10.1161/HYPERTENSIONAHA.112.201434; Motter AL, 2008, FEBS LETT, V582, P2257, DOI 10.1016/j.febslet.2008.05.021; O'Neil RG, 2003, NEWS PHYSIOL SCI, V18, P226, DOI 10.1152/nips.01468.2003; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Page AJ, 2004, GASTROENTEROLOGY, V127, P1739, DOI 10.1053/j.gastro.2004.08.061; Page AJ, 2002, J NEUROPHYSIOL, V87, P2095, DOI 10.1152/jn.00785.2001; Powley TL, 2004, PHYSIOL BEHAV, V82, P69, DOI 10.1016/j.physbeh.2004.04.037; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Rasouli N, 2008, J CLIN ENDOCR METAB, V93, pS64, DOI 10.1210/jc.2008-1613; Rohacs T, 2009, CELL CALCIUM, V45, P554, DOI 10.1016/j.ceca.2009.03.011; Rong WF, 2004, J PHYSIOL-LONDON, V560, P867, DOI 10.1113/jphysiol.2004.071746; Symonds E, 2003, EUR J PHARMACOL, V470, P95, DOI 10.1016/S0014-2999(03)01779-5; Toth A, 2009, VITAM HORM, V81, P389, DOI 10.1016/S0083-6729(09)81015-7; Wang GJ, 2008, NEUROIMAGE, V39, P1824, DOI 10.1016/j.neuroimage.2007.11.008; Wang XB, 2005, J PHYSIOL-LONDON, V564, P541, DOI 10.1113/jphysiol.2004.081844; Wanner SP, 2011, AGING-US, V3, P450, DOI 10.18632/aging.100306; Ward SM, 2003, J COMP NEUROL, V465, P121, DOI 10.1002/cne.10801; Woods SC, 2004, AM J PHYSIOL-GASTR L, V286, pG7, DOI 10.1152/ajpgi.00448.2003; Yao XQ, 2005, NEUROSIGNALS, V14, P273, DOI 10.1159/000093042; Yoshioka M, 1999, BRIT J NUTR, V82, P115, DOI 10.1017/S0007114599001269; Young RL, 2008, NEUROGASTROENT MOTIL, V20, P708, DOI 10.1111/j.1365-2982.2007.01071.x; Zhang L, 2004, AM J PHYSIOL-GASTR L, V286, pG983, DOI 10.1152/ajpgi.00441.2003; Zhang LL, 2007, CIRC RES, V100, P1063, DOI 10.1161/01.RES.0000262653.84850.8b; Zhao H, 2010, AM J PHYSIOL-GASTR L, V298, pG212, DOI 10.1152/ajpgi.00396.2009; Zsombok A, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12160	51	31	32	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135892	10.1371/journal.pone.0135892	http://dx.doi.org/10.1371/journal.pone.0135892			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285043	Green Published, gold, Green Submitted			2022-12-26	WOS:000359666100085
J	Kolbe, T; Palme, R; Tichy, A; Rullcke, T				Kolbe, Thomas; Palme, Rupert; Tichy, Alexander; Ruellcke, Thomas			Lifetime Dependent Variation of Stress Hormone Metabolites in Feces of Two Laboratory Mouse Strains	PLOS ONE			English	Article							CORTICOSTERONE METABOLITES; RECEPTOR EXPRESSION; SEASONAL-VARIATION; BONE-MARROW; MICE; CORTISOL; SEX; GLUCOCORTICOIDS; EXCRETION; RESPONSES	Non-invasive measurement of stress hormone metabolites in feces has become routine practice for the evaluation of distress and pain in animal experiments. Since metabolism and excretion of glucocorticoids may be variable, awareness and adequate consideration of influencing factors are essential for accurate monitoring of adrenocortical activity. Reference values are usually provided by baselines compiled prior to the experiment and by age matched controls. The comparison of stress hormone levels between animals of different ages or between studies looking at hormone levels at the beginning and at the end of a long term study might be biased by age-related effects. In this study we analyzed fecal corticosterone metabolites (FCM) during the lifetime of untreated female mice of the strains C57BL/6NCrl and Crl:CD1. For this purpose feces for each individual mouse were collected every two months over a period of 24 hours, at intervals of four hours, until the age of 26 months. Results of the study revealed that age of the animals had a significant impact on the level and circadian rhythm of stress hormone metabolites. Furthermore, long-term observation of mice revealed a strain specific excretion profile of FCM influenced by strong seasonal variability.	[Kolbe, Thomas] Univ Vet Med Vienna, Biomodels Austria, Vienna, Austria; [Kolbe, Thomas] Univ Nat Resources & Life Sci, IFA Tulln, Tulln, Austria; [Palme, Rupert] Univ Vet Med Vienna, Unit Physiol Pathophysiol & Expt Endocrinol, Vienna, Austria; [Tichy, Alexander] Univ Vet Med Vienna, Bioinformat & Biostat Platform, Vienna, Austria; [Ruellcke, Thomas] Univ Vet Med Vienna, Inst Lab Anim Sci, Vienna, Austria	University of Veterinary Medicine Vienna; University of Natural Resources & Life Sciences, Vienna; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna	Rullcke, T (corresponding author), Univ Vet Med Vienna, Inst Lab Anim Sci, Vienna, Austria.	thomas.ruelicke@vetmeduni.ac.at	Palme, Rupert/A-3499-2008; Kolbe, Thomas/H-8215-2018	Palme, Rupert/0000-0001-9466-3662; Kolbe, Thomas/0000-0003-2974-8066				Bizon JL, 2001, EUR J NEUROSCI, V14, P1739, DOI 10.1046/j.0953-816x.2001.01781.x; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Bundgaard CJ, 2012, IN VIVO, V26, P883; Dalm S, 2005, NEUROENDOCRINOLOGY, V81, P372, DOI 10.1159/000089555; Dmitrieva NO, 2013, PSYCHONEUROENDOCRINO, V38, P2354, DOI 10.1016/j.psyneuen.2013.05.003; Douglas AJ, 2003, ENDOCRINOLOGY, V144, P5268, DOI 10.1210/en.2003-0461; DRICKAMER LC, 1990, LAB ANIM SCI, V40, P284; Figueiredo HF, 2007, AM J PHYSIOL-ENDOC M, V292, pE1173, DOI 10.1152/ajpendo.00102.2006; Gold PW, 2015, MOL PSYCHIATR, V20, P32, DOI 10.1038/mp.2014.163; Harper JM, 2000, PHYSIOL BIOCHEM ZOOL, V73, P12, DOI 10.1086/316721; Haus E, 1997, CHRONOBIOL INT, V14, P347, DOI 10.3109/07420529709001456; Heaney JLJ, 2012, PSYCHONEUROENDOCRINO, V37, P341, DOI 10.1016/j.psyneuen.2011.07.001; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Ishida A, 2005, CELL METAB, V2, P297, DOI 10.1016/j.cmet.2005.09.009; Jones BC, 1998, PSYCHONEUROENDOCRINO, V23, P505; Kalliokoski O, 2015, GEN COMP ENDOCR, V211, P147, DOI 10.1016/j.ygcen.2014.12.008; Kalliokoski O, 2012, IN VIVO, V26, P213; Kolbe T, 2016, REPROD FERT DEVELOP, V28, P969, DOI 10.1071/RD14372; Kolbe T, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.092445; LINKOWSKI P, 1985, J CLIN ENDOCR METAB, V61, P429, DOI 10.1210/jcem-61-3-429; Mahler M, 2014, LAB ANIM-UK, V48, P178, DOI 10.1177/0023677213516312; Meyer L, 2006, BEHAV BRAIN RES, V167, P342, DOI 10.1016/j.bbr.2005.09.023; Mizoguchi K, 2009, NEUROSCIENCE, V159, P259, DOI 10.1016/j.neuroscience.2008.12.020; Nagayama H, 1998, PSYCHOPHARMACOLOGY, V135, P279, DOI 10.1007/s002130050510; NELSON JF, 1995, NEUROBIOL AGING, V16, P837, DOI 10.1016/0197-4580(95)00072-M; Nicholson A, 2009, J AM ASSOC LAB ANIM, V48, P740; Oster H, 2006, CELL METAB, V4, P163, DOI 10.1016/j.cmet.2006.07.002; Palme R, 2005, ANN NY ACAD SCI, V1040, P162, DOI 10.1196/annals.1327.021; Palme R, 2012, ANIM WELFARE, V21, P331, DOI 10.7120/09627286.21.3.331; Pfeiffenberger U, 2015, LAB ANIM-UK, V49, P121, DOI 10.1177/0023677214559627; Reddy AB, 2007, HEPATOLOGY, V45, P1478, DOI 10.1002/hep.21571; Roberts AJ, 1995, BEHAV NEUROSCI, V109, P1199, DOI 10.1037/0735-7044.109.6.1199; Romero LM, 2002, GEN COMP ENDOCR, V128, P1; Shanks N, 2000, P NATL ACAD SCI USA, V97, P5645, DOI 10.1073/pnas.090571897; Sollars PJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111944; SPACKMAN DH, 1978, SCIENCE, V200, P87, DOI 10.1126/science.635580; Spani D, 2003, LAB ANIM-UK, V37, P54, DOI 10.1258/002367703762226692; Sudo N, 2004, J PHYSIOL-LONDON, V558, P263, DOI 10.1113/jphysiol.2004.063388; TAKAHASHI H, 1987, JPN J PHARMACOL, V43, P441, DOI 10.1254/jjp.43.441; Touma C, 2005, ANN NY ACAD SCI, V1046, P54, DOI 10.1196/annals.1343.006; Touma C, 2004, HORM BEHAV, V45, P10, DOI 10.1016/j.yhbeh.2003.07.002; Touma C, 2003, GEN COMP ENDOCR, V130, P267, DOI 10.1016/S0016-6480(02)00620-2; Touma C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004325; Voigtlander T, 2006, EUR J NEUROSCI, V23, P2723, DOI 10.1111/j.1460-9568.2006.04801.x; Walker MK, 2012, TOXICOL APPL PHARM, V260, P65, DOI 10.1016/j.taap.2012.01.025; Wong ML, 2000, P NATL ACAD SCI USA, V97, P325, DOI 10.1073/pnas.97.1.325; Wright-Williams S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075948	47	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0136112	10.1371/journal.pone.0136112	http://dx.doi.org/10.1371/journal.pone.0136112			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284365	Green Published, Green Submitted, gold			2022-12-26	WOS:000359666100104
J	Levy, GV; Banuelos, CP; Nittolo, AG; Ortiz, GE; Mendiondo, N; Moretti, G; Tekiel, VS; Sanchez, DO				Levy, Gabriela V.; Banuelos, Carolina P.; Nittolo, Analia G.; Ortiz, Gaston E.; Mendiondo, Nicolas; Moretti, Georgina; Tekiel, Valeria S.; Sanchez, Daniel O.			Depletion of the SR-Related Protein TbRRM1 Leads to Cell Cycle Arrest and Apoptosis-Like Death in Trypanosoma brucei	PLOS ONE			English	Article							TARGETING ESSENTIAL PATHWAYS; GENE-EXPRESSION; PROTOZOAN MECHANISMS; PROCYCLIC FORM; CCCH PROTEIN; CYTOKINESIS; DIFFERENTIATION; SEGREGATION; PROGRESSION; HOMOLOGY	Arginine-Serine (RS) domain-containing proteins are RNA binding proteins with multiple functions in RNA metabolism. In mammalian cells this group of proteins is also implicated in regulation and coordination of cell cycle and apoptosis. In trypanosomes, an early branching group within the eukaryotic lineage, this group of proteins is represented by 3 members, two of them are SR proteins and have been recently shown to be involved in rRNA processing as well as in pre-mRNA splicing and stability. Here we report our findings on the 3rd member, the SR-related protein TbRRM1. In the present study, we showed that TbRRM1 ablation by RNA-interference in T. brucei procyclic cells leads to cell-cycle block, abnormal cell elongation compatible with the nozzle phenotype and cell death by an apoptosis-like mechanism. Our results expand the role of the trypanosomal RS-domain containing proteins in key cellular processes such as cell cycle and apoptosis-like death, roles also carried out by the mammalian SR proteins, and thus suggesting a conserved function in this phylo-genetically conserved protein family.	[Levy, Gabriela V.; Banuelos, Carolina P.; Nittolo, Analia G.; Ortiz, Gaston E.; Mendiondo, Nicolas; Moretti, Georgina; Tekiel, Valeria S.; Sanchez, Daniel O.] Univ Nacl San Martin IIB UNSAM, Inst Invest Biotecnol, Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Levy, GV (corresponding author), Univ Nacl San Martin IIB UNSAM, Inst Invest Biotecnol, Consejo Nacl Invest Cient & Tecn CONICET, 25 Mayo & Francia Gral San Martin, Buenos Aires, DF, Argentina.	gvlevy@gmail.com		Tekiel, Valeria/0000-0003-2981-2312; sanchez, daniel/0000-0002-5427-7764; Ortiz, Gaston/0000-0002-5073-3355; Levy, Gabriela Vanesa/0000-0002-7638-3509	National Agency for promotion of Science and Technology, (ANPCyT, Argentina) [PICT 2012-1419]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, Argentina) [112 201101 00837]; Fogarty International Center of the U.S. National Institutes of Health [TW007888]	National Agency for promotion of Science and Technology, (ANPCyT, Argentina)(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Fogarty International Center of the U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	National Agency for promotion of Science and Technology, (ANPCyT, Argentina. PICT 2012-1419 to DOS). Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, Argentina. PIP 2012 nro 112 201101 00837 to DOS). GM was supported in part by a Training Grant from the Fogarty International Center of the U.S. National Institutes of Health (grant TW007888).	Akiyoshi B, 2014, CELL, V156, P1247, DOI 10.1016/j.cell.2014.01.049; Alsford S, 2011, GENOME RES, V21, P915, DOI 10.1101/gr.115089.110; Boucher N, 2007, J BIOL CHEM, V282, P13780, DOI 10.1074/jbc.M700780200; Brun R, 2010, LANCET, V375, P148, DOI 10.1016/S0140-6736(09)60829-1; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; De Gaudenzi J, 2005, EUKARYOT CELL, V4, P2106, DOI 10.1128/EC.4.12.2106-2114.2005; Duszenko M, 2006, TRENDS PARASITOL, V22, P536, DOI 10.1016/j.pt.2006.08.010; Gupta SK, 2014, RNA BIOL, V11, P715, DOI 10.4161/rna.29143; Hammarton TC, 2007, MOL BIOCHEM PARASIT, V153, P1, DOI 10.1016/j.molbiopara.2007.01.017; Hammarton TC, 2004, J BIOL CHEM, V279, P24757, DOI 10.1074/jbc.M401276200; Hendriks EF, 2001, EMBO J, V20, P6700, DOI 10.1093/emboj/20.23.6700; Ismaili N, 1999, MOL BIOCHEM PARASIT, V102, P103, DOI 10.1016/S0166-6851(99)00091-2; Ismaili N, 2000, MOL BIOCHEM PARASIT, V106, P109, DOI 10.1016/S0166-6851(99)00205-4; KILMARTIN JV, 1982, J CELL BIOL, V93, P576, DOI 10.1083/jcb.93.3.576; Kramer S, 2011, TRENDS PARASITOL, V27, P23, DOI 10.1016/j.pt.2010.06.011; Kumar P, 2006, EUKARYOT CELL, V5, P92, DOI 10.1128/EC.5.1.92-102.2006; LaCount DJ, 2000, MOL BIOCHEM PARASIT, V111, P67, DOI 10.1016/S0166-6851(00)00300-5; Li XL, 2005, GENE DEV, V19, P2705, DOI 10.1101/gad.1359305; Li ZY, 2012, EUKARYOT CELL, V11, P1180, DOI 10.1128/EC.00145-12; Li ZY, 2003, J BIOL CHEM, V278, P20652, DOI 10.1074/jbc.M301635200; Liang XH, 2003, EUKARYOT CELL, V2, P830, DOI 10.1128/EC.2.5.830-840.2003; Liao SH, 2010, EXP CELL RES, V316, P704, DOI 10.1016/j.yexcr.2009.12.017; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Manger ID, 2001, MOL BIOCHEM PARASIT, V116, P239, DOI 10.1016/S0166-6851(01)00322-X; Martinez-Calvillo S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/525241; May SF, 2012, MOL MICROBIOL, V84, P77, DOI 10.1111/j.1365-2958.2012.08008.x; McKean PG, 2003, CURR OPIN MICROBIOL, V6, P600, DOI 10.1016/j.mib.2003.10.010; Mollinedo F, 2003, APOPTOSIS, V8, P413, DOI 10.1023/A:1025513106330; Montagna GN, 2006, J BIOL CHEM, V281, P33949, DOI 10.1074/jbc.M604951200; Moore MJ, 2010, CELL, V142, P625, DOI 10.1016/j.cell.2010.07.019; Naguleswaran A, 2015, MBIO, V6, DOI 10.1128/mBio.00114-15; Nazer E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043715; Nazer E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024184; Nazer E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019920; Nilsson D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001037; Palfi Z, 2000, P NATL ACAD SCI USA, V97, P8967, DOI 10.1073/pnas.150236097; Palfi Z, 2005, NUCLEIC ACIDS RES, V33, P2493, DOI 10.1093/nar/gki548; Palfi Z, 2009, GENE DEV, V23, P1650, DOI 10.1101/gad.526109; Paterou A, 2006, J BIOL CHEM, V281, P39002, DOI 10.1074/jbc.M604280200; Ploubidou A, 1999, J CELL SCI, V112, P4641; Portal D, 2003, MOL BIOCHEM PARASIT, V127, P37, DOI 10.1016/S0166-6851(02)00301-8; ROBINSON DR, 1995, J CELL BIOL, V128, P1163, DOI 10.1083/jcb.128.6.1163; Siegel TN, 2008, MOL BIOCHEM PARASIT, V160, P171, DOI 10.1016/j.molbiopara.2008.04.004; Siegel TN, 2011, TRENDS PARASITOL, V27, P434, DOI 10.1016/j.pt.2011.05.006; Smirlis D, 2011, VIRULENCE, V2, P253, DOI 10.4161/viru.2.3.16278; Smirlis D, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-107; Subota I, 2011, MOL BIOL CELL, V22, P4205, DOI 10.1091/mbc.E11-06-0511; Timms MW, 2002, MOL BIOL CELL, V13, P3747, DOI 10.1091/mbc.E02-05-0266; Tu XM, 2005, MOL BIOL CELL, V16, P97, DOI 10.1091/mbc.E04-05-0368; VANHAMME L, 1995, MICROBIOL REV, V59, P223, DOI 10.1128/MMBR.59.2.223-240.1995; VICKERMAN K, 1985, BRIT MED BULL, V41, P105, DOI 10.1093/oxfordjournals.bmb.a072036; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; WOODWARD R, 1990, J CELL SCI, V95, P49; Zhong XY, 2009, MOL CELL, V35, P1, DOI 10.1016/j.molcel.2009.06.016	54	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0136070	10.1371/journal.pone.0136070	http://dx.doi.org/10.1371/journal.pone.0136070			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284933	Green Published, Green Submitted, gold			2022-12-26	WOS:000359666100100
J	Li, W; Cheng, JM; Yu, KL; Epstein, HE; Du, GZ				Li, Wei; Cheng, Ji-Min; Yu, Kai-Liang; Epstein, Howard E.; Du, Guo-Zhen			Niche and Neutral Processes Together Determine Diversity Loss in Response to Fertilization in an Alpine Meadow Community	PLOS ONE			English	Article							PLANT TRAITS; FUNCTIONAL TRAITS; NITROGEN DEPOSITION; RELATIVE ABUNDANCE; SPECIES ABUNDANCE; FIELD EXPERIMENT; COMPETITION; COEXISTENCE; ECOLOGY; NUTRIENT	Fertilization via nutrient deposition and agricultural inputs is one of the most important factors driving decreases in plant diversity. However, we still do not fully understand which processes (niche process or neutral process) are more important in leading to decreases in plant diversity caused by fertilization. A hypothesis-based approach was used to test the relative importance of niche versus neutral processes along a fertilization gradient in an alpine meadow community on the eastern Tibetan plateau, China. Niche overlap values were calculated for species biomass, and the null model was used to generate the values of niche overlap expected at random. A linear regression modeling was used to evaluate the relationship between functional traits (specific leaf area, leaf dry matter content, and leaf total nitrogen concentration) and species relative abundance. Our results demonstrated that observed niche overlap for species biomass was significantly higher than expected at lower fertilization gradients. Moreover, we also found a significantly negative correlation between species relative abundance and specific leaf area and leaf dry matter content, but a significantly positive correlation between relative abundance and leaf nitrogen concentration at lower fertilization gradients. However, these relationships were not significant at higher fertilization gradients. We concluded that community assembly is dynamic progression along the environmental gradients, and niche and neutral processes may together determine species diversity loss in response to fertilization.	[Li, Wei; Cheng, Ji-Min] Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling 712100, Shaanxi, Peoples R China; [Li, Wei; Cheng, Ji-Min] Chinese Acad Sci, Inst Soil & Water Conservat, Yangling 712100, Shaanxi, Peoples R China; [Li, Wei; Cheng, Ji-Min] Minist Water Resource, Yangling 712100, Shaanxi, Peoples R China; [Yu, Kai-Liang; Epstein, Howard E.] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22904 USA; [Du, Guo-Zhen] Lanzhou Univ, Sch Life Sci, Lanzhou 730000, Peoples R China	Northwest A&F University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; University of Virginia; Lanzhou University	Li, W (corresponding author), Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling 712100, Shaanxi, Peoples R China.	liwei20116@gmail.com			Key Program of National Natural Science Foundation of China [40930533]; Natural Science Foundation of China [41230852]; Key Program of Chinese Academy of Sciences [KJZD-EW-TZ-G10]; Northwest A F University [Z109021107, Z109021307, QN2013070]; West Light Foundation of Chinese Academy of Sciences [K318021305]; China Scholarship Council	Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program of Chinese Academy of Sciences(Chinese Academy of Sciences); Northwest A F University; West Light Foundation of Chinese Academy of Sciences(Chinese Academy of Sciences); China Scholarship Council(China Scholarship Council)	This study was supported by Key Program of National Natural Science Foundation of China (40930533), Natural Science Foundation of China (41230852), Key Program of Chinese Academy of Sciences (KJZD-EW-TZ-G10), Northwest A & F University (Z109021107, Z109021307, QN2013070), West Light Foundation of Chinese Academy of Sciences (K318021305) and the China Scholarship Council.	Adler PB, 2007, ECOL LETT, V10, P95, DOI 10.1111/j.1461-0248.2006.00996.x; Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Clark CM, 2008, NATURE, V451, P712, DOI 10.1038/nature06503; Cleland EE, 2010, ANN NY ACAD SCI, V1195, P46, DOI 10.1111/j.1749-6632.2010.05458.x; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Cornwell WK, 2010, J ECOL, V98, P814, DOI 10.1111/j.1365-2745.2010.01662.x; Cornwell WK, 2009, ECOL MONOGR, V79, P109, DOI 10.1890/07-1134.1; Diaz S, 2004, J VEG SCI, V15, P295, DOI 10.1111/j.1654-1103.2004.tb02266.x; Dickson TL, 2014, ECOLOGY, V95, P2443, DOI 10.1890/13-1875.1; Diekmann M, 2002, J ECOL, V90, P108, DOI 10.1046/j.0022-0477.2001.00639.x; Ellwood MDF, 2009, ECOL LETT, V12, P277, DOI 10.1111/j.1461-0248.2009.01284.x; Gilbert B, 2009, AM NAT, V174, P850, DOI 10.1086/647903; Gravel D, 2006, ECOL LETT, V9, P399, DOI 10.1111/j.1461-0248.2006.00884.x; Grime JP, 2006, J VEG SCI, V17, P255, DOI 10.1111/j.1654-1103.2006.tb02444.x; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; Grime P., 2001, PLANT STRATEGIES VEG; Gross N, 2007, J ECOL, V95, P1296, DOI 10.1111/j.1365-2745.2007.01303.x; Harpole WS, 2006, ECOL LETT, V9, P15, DOI 10.1111/j.1461-0248.2005.00836.x; Hautier Y, 2009, SCIENCE, V324, P636, DOI 10.1126/science.1169640; Hou, 1982, VEGETATION MAP PEOPL; Hubbell SP, 2005, FUNCT ECOL, V19, P166, DOI 10.1111/j.0269-8463.2005.00965.x; Hubbell Stephen P., 2001, V32, pi; Klein JA, 2007, ECOL APPL, V17, P541, DOI 10.1890/05-0685; Lamb EG, 2009, J ECOL, V97, P155, DOI 10.1111/j.1365-2745.2008.01454.x; Li W, 2013, NORD J BOT, V31, P247, DOI 10.1111/j.1756-1051.2012.01511.x; Li W, 2011, J PLANT ECOL, V4, P138, DOI 10.1093/jpe/rtq031; Lloret F, 2004, GLOBAL ECOL BIOGEOGR, V13, P37, DOI 10.1111/j.1466-882X.2004.00064.x; Luo YJ, 2006, J VEG SCI, V17, P417, DOI 10.1658/1100-9233(2006)17[417:IOATAF]2.0.CO;2; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; Mason NWH, 2008, J ANIM ECOL, V77, P661, DOI 10.1111/j.1365-2656.2008.01379.x; Mason NWH, 2011, J ECOL, V99, P788, DOI 10.1111/j.1365-2745.2011.01801.x; Mayfield MM, 2010, ECOL LETT, V13, P1085, DOI 10.1111/j.1461-0248.2010.01509.x; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Mouillot D, 2007, OECOLOGIA, V152, P729, DOI 10.1007/s00442-007-0688-0; NEWMAN EI, 1973, NATURE, V244, P310, DOI 10.1038/244310a0; Niu KC, 2008, BASIC APPL ECOL, V9, P485, DOI 10.1016/j.baae.2007.06.015; PIELOU E C, 1969, P286; Poorter H, 1999, NEW PHYTOL, V143, P163, DOI 10.1046/j.1469-8137.1999.00428.x; Poorter H, 1999, HANDBOOK OF FUNCTIONAL PLANT ECOLOGY, P81; Reader RJ, 1998, PLANT ECOL, V134, P43, DOI 10.1023/A:1009700100343; Reich PB, 2008, ECOL LETT, V11, P793, DOI 10.1111/j.1461-0248.2008.01185.x; Shipley B, 2000, ECOSCIENCE, V7, P183, DOI 10.1080/11956860.2000.11682587; Shipley B, 2010, PLANT TRAITS VEGETAT; Shipley B, 2006, SCIENCE, V314, P812, DOI 10.1126/science.1131344; Silvertown J, 2004, TRENDS ECOL EVOL, V19, P605, DOI 10.1016/j.tree.2004.09.003; Soudzilovskaia NA, 2005, J VEG SCI, V16, P399, DOI 10.1111/j.1654-1103.2005.tb02379.x; Stevens MHH, 1999, J ECOL, V87, P490, DOI 10.1046/j.1365-2745.1999.00374.x; Sugihara G, 2003, P NATL ACAD SCI USA, V100, P5246, DOI 10.1073/pnas.0831096100; Sun XM, 2016, J PLANT ECOL, V9, P201, DOI 10.1093/jpe/rtv037; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Uriarte M, 2003, P NATL ACAD SCI USA, V100, P1787, DOI 10.1073/pnas.0337167100; Weiher E, 1999, J VEG SCI, V10, P609, DOI 10.2307/3237076; Weiher E, 1998, OIKOS, V81, P309, DOI 10.2307/3547051; Westoby M, 2006, TRENDS ECOL EVOL, V21, P261, DOI 10.1016/j.tree.2006.02.004; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wright IJ, 2001, FUNCT ECOL, V15, P423, DOI 10.1046/j.0269-8463.2001.00542.x; Yang ZL, 2015, OECOLOGIA, V179, P261, DOI 10.1007/s00442-015-3313-7; Yang ZL, 2013, OECOLOGIA, V171, P495, DOI 10.1007/s00442-012-2433-6; Zhou SR, 2006, FUNCT ECOL, V20, P509, DOI 10.1111/j.1365-2435.2006.01132.x; Zhou Shu-Rong, 2006, Zhiwu Shengtai Xuebao, V30, P868; Zhou XL, 2016, J PLANT ECOL, V9, P144, DOI 10.1093/jpe/rtv043	61	4	5	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0134560	10.1371/journal.pone.0134560	http://dx.doi.org/10.1371/journal.pone.0134560			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26280919	Green Published, Green Submitted, gold			2022-12-26	WOS:000359664300008
J	You, Y; Zheng, QD; Dong, YY; Wang, YH; Zhang, L; Xue, TC; Xie, XY; Hu, C; Wang, ZM; Chen, RX; Wang, YH; Cui, JF; Ren, ZG				You, Yang; Zheng, Qiongdan; Dong, Yinying; Wang, Yaohui; Zhang, Lan; Xue, Tongchun; Xie, Xiaoying; Hu, Chao; Wang, Zhiming; Chen, Rongxin; Wang, Yanhong; Cui, Jiefeng; Ren, Zhenggang			Higher Matrix Stiffness Upregulates Osteopontin Expression in Hepatocellular Carcinoma Cells Mediated by Integrin beta 1/GSK3 beta/beta-Catenin Signaling Pathway	PLOS ONE			English	Article							HEPATITIS-B; CANCER; GROWTH; METASTASIS; MICROENVIRONMENT; OVEREXPRESSION; PROGNOSIS; RECEPTOR; COLLAGEN; ENHANCER	Increased stromal stiffness is associated with hepatocellular carcinoma (HCC) development and progression. However, the molecular mechanism by which matrix stiffness stimuli modulate HCC progress is largely unknown. In this study, we explored whether matrix stiffness-mediated effects on osteopontin (OPN) expression occur in HCC cells. We used a previously reported in vitro culture system with tunable matrix stiffness and found that OPN expression was remarkably upregulated in HCC cells with increasing matrix stiffness. Furthermore, the phosphorylation level of GSK3 beta and the expression of nuclear beta-catenin were also elevated, indicating that GSK3 beta/beta-catenin pathway might be involved in OPN regulation. Knock-down analysis of integrin beta 1 showed that OPN expression and p-GSK3 beta level were downregulated in HCC cells grown on high stiffness substrate compared with controls. Simultaneously, inhibition of GSK-3 beta led to accumulation of beta-catenin in the cytoplasm and its enhanced nuclear translocation, further triggered the rescue of OPN expression, suggesting that the integrin beta 1/GSK-3 beta/beta-catenin pathway is specifically activated for matrix stiffness-mediated OPN upregulation in HCC cells. Tissue microarray analysis confirmed that OPN expression was positively correlated with the expression of LOX and COL1. Taken together, high matrix stiffness upregulated OPN expression in HCC cells via the integrin beta 1/GSK-3 beta/beta-catenin signaling pathway. It highlights a new insight into a pathway involving physical mechanical signal and biochemical signal molecules which contributes to OPN expression in HCC cells.	[You, Yang; Zheng, Qiongdan; Dong, Yinying; Zhang, Lan; Xue, Tongchun; Xie, Xiaoying; Chen, Rongxin; Wang, Yanhong; Cui, Jiefeng; Ren, Zhenggang] Fudan Univ, Zhongshan Hosp, Liver Canc Inst, 136 Xue Yuan Rd, Shanghai 200032, Peoples R China; [You, Yang; Zheng, Qiongdan; Dong, Yinying; Zhang, Lan; Xue, Tongchun; Xie, Xiaoying; Chen, Rongxin; Wang, Yanhong; Cui, Jiefeng; Ren, Zhenggang] Minist Educ, Key Lab Carcinogenesis & Canc Invas, Shanghai 200032, Peoples R China; [Wang, Yaohui] Fudan Univ, Shanghai Canc Ctr, Dept Intervent Radiol, Shanghai 200032, Peoples R China; [Hu, Chao] Fudan Univ, Zhongshan Hosp, Dept Urol, Shanghai 200032, Peoples R China; [Wang, Zhiming] Fudan Univ, Zhongshan Hosp Subdiv, Dept Oncol, Shanghai 200052, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Cui, JF (corresponding author), Fudan Univ, Zhongshan Hosp, Liver Canc Inst, 136 Xue Yuan Rd, Shanghai 200032, Peoples R China.	cui.jiefeng@zs-hospital.sh.cn; ren.zhenggang@zs-hospital.sh.cn	Wang, Yanbo/HFZ-8018-2022; wang, yi/GVT-8516-2022; Dong, Yinying/HHC-3041-2022; wang, yan/GSE-6489-2022	Hu, Chao/0000-0001-5895-6038	National Natural Science Foundation of China [81071902, 81272583]; Shanghai Science and Technology Programme [11JC1402100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Programme	This study was sponsored by grants from the National Natural Science Foundation of China (Nos. 81071902, 81272583) and the Shanghai Science and Technology Programme (11JC1402100).	Basson MD, 2008, CANCER RES, V68, P2, DOI 10.1158/0008-5472.CAN-07-2992; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Bergamini C, 2007, HEPATOLOGY, V46, P1801, DOI 10.1002/hep.21936; Brabek J, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-22; Burkhalter RJ, 2011, J BIOL CHEM, V286, P23467, DOI 10.1074/jbc.M110.199539; Cadigan K.M., 2012, COLD SPRING HARB PER, V4; Chen HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038378; Chen RX, 2010, J GASTROEN HEPATOL, V25, P1435, DOI 10.1111/j.1440-1746.2010.06277.x; Cho H, 2008, J CANCER RES CLIN, V134, P909, DOI 10.1007/s00432-007-0351-5; Chuang CY, 2012, GENE, V492, P262, DOI 10.1016/j.gene.2011.10.019; Denhardt DT, 2003, CLIN EXP METASTAS, V20, P77, DOI 10.1023/A:1022550721404; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Dong YY, 2014, BIOCHEM BIOPH RES CO, V444, P427, DOI 10.1016/j.bbrc.2014.01.079; El-Tanani M, 2004, J BIOL CHEM, V279, P20794, DOI 10.1074/jbc.M311131200; El-Tanani MK, 2008, FRONT BIOSCI, V13, P4276, DOI 10.2741/3004; Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004; Faouzi S, 1999, J HEPATOL, V30, P275, DOI 10.1016/S0168-8278(99)80074-9; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; Fiorino S, 2014, J PANCREAS, V15, P151, DOI 10.6092/1590-8577/2099; Georges PC, 2007, AM J PHYSIOL-GASTR L, V293, pG1147, DOI 10.1152/ajpgi.00032.2007; Guirouilh J, 2000, INT J ONCOL, V17, P777; Huang S, 2005, CANCER CELL, V8, P175, DOI 10.1016/j.ccr.2005.08.009; Huang XB, 2013, ARTIF ORGANS, V37, P166, DOI 10.1111/j.1525-1594.2012.01546.x; Kang S, 2007, J BIOL CHEM, V282, P14515, DOI 10.1074/jbc.M700030200; Kim Sung Hoon, 2009, Korean J Hepatol, V15, P320, DOI 10.3350/kjhep.2009.15.3.320; Kumar CC, 1998, ONCOGENE, V17, P1365, DOI 10.1038/sj.onc.1202172; Leal-Egana A, 2012, J MECH BEHAV BIOMED, V9, P113, DOI 10.1016/j.jmbbm.2012.01.013; Li TWH, 2006, MOL CELL BIOL, V26, P5284, DOI 10.1128/MCB.00105-06; Liang Y, 2011, BIOMATERIALS, V32, P9308, DOI 10.1016/j.biomaterials.2011.08.045; Lin F, 2011, MOL BIOL REP, V38, P5205, DOI 10.1007/s11033-010-0671-4; Liu C, 2015, BIOTECHNOL APPL BIOC, V62, P556, DOI 10.1002/bab.1302; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Maegdefrau U, 2009, J PATHOL, V218, P520, DOI 10.1002/path.2563; Masuzaki R, 2008, J CLIN GASTROENTEROL, V42, P839, DOI 10.1097/MCG.0b013e318050074f; Mitra A, 2012, ONCOGENE, V31, P4472, DOI 10.1038/onc.2011.623; Ooi LPJ, 1997, J HEPATOL, V26, P798, DOI 10.1016/S0168-8278(97)80245-0; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pan HW, 2003, CANCER-AM CANCER SOC, V98, P119, DOI 10.1002/cncr.11487; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Ramachandran S, 2013, MOL BIOL REP, V40, P3623, DOI 10.1007/s11033-012-2436-8; Ravindranath A, 2011, BRIT J CANCER, V105, P542, DOI 10.1038/bjc.2011.269; Ribeiro SA, 2008, INT J BIOL MARKER, V23, P154; Schrader J, 2011, HEPATOLOGY, V53, P1192, DOI 10.1002/hep.24108; Silva R, 2008, ARTERIOSCL THROM VAS, V28, P1703, DOI 10.1161/ATVBAHA.108.172015; Sun J, 2010, J CANCER RES CLIN, V136, P1, DOI 10.1007/s00432-009-0629-x; Tuck AB, 2007, J CELL BIOCHEM, V102, P859, DOI 10.1002/jcb.21520; Visintin I, 2008, CLIN CANCER RES, V14, P1065, DOI 10.1158/1078-0432.CCR-07-1569; Wang HB, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0113880, 10.1371/journal.pone.0089155, 10.1371/journal.pone.0091730]; Weber GF, 2010, BRIT J CANCER, V103, P861, DOI 10.1038/sj.bjc.6605834; Weber GF, 2001, BBA-REV CANCER, V1552, P61, DOI 10.1016/S0304-419X(01)00037-3; Wong CCL, 2014, HEPATOLOGY, V60, P1645, DOI 10.1002/hep.27320; Ye QH, 2003, NAT MED, V9, P416, DOI 10.1038/nm843; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Yin M, 2007, CLIN GASTROENTEROL H, V5, P1207, DOI 10.1016/j.cgh.2007.06.012; Yoshioka K, 2014, HEPATOL RES; Zhang H, 2006, J CANCER RES CLIN, V132, P709, DOI 10.1007/s00432-006-0119-3; Zhao G, 2010, J SURG ONCOL, V102, P482, DOI 10.1002/jso.21613; Zhao J, 2008, GASTROENTEROLOGY, V135, P956, DOI 10.1053/j.gastro.2008.05.025	58	26	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0134243	10.1371/journal.pone.0134243	http://dx.doi.org/10.1371/journal.pone.0134243			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26280346	Green Published, gold, Green Submitted			2022-12-26	WOS:000359664300003
J	Niu, LL; Li, SM; Liang, HM; Li, H				Niu, Leilei; Li, Shumin; Liang, Huamao; Li, Hua			The hMLH1-93G > A Polymorphism and Risk of Ovarian Cancer in the Chinese Population	PLOS ONE			English	Article							DNA MISMATCH REPAIR; SINGLE-NUCLEOTIDE POLYMORPHISM; PROMOTER POLYMORPHISM; LUNG-CANCER; HMLH1 GENE; MLH1; IDENTIFICATION; MECHANISMS; CARCINOMA; PATHWAYS	Background As a mismatch repair (MMR) gene, hMLH1 plays an important role in the maintenance of chromosomal integrity. Several studies have investigated the associations of hMLH1 -93G>A (rs1800734) and Ile219Val (rs1799977) in diverse tumor types with discordant results, but their roles in ovarian cancer in the Chinese population remains to be elucidated. Methods In a case-control analysis, we assessed the association between these two polymorphisms and ovarian cancer risk in 421 ovarian cancer patients and 689 control subjects in the Chinese population using logistic regression. Results We found that the variant hMLH1 genotypes (-93AA and AG) are associated with risk of ovarian cancer (adjusted odds ratio [OR] = 2.02, 95% confidence interval [CI] = 1.42-2.89) compared with the -93GG genotype. The A allele increases the risk of ovarian cancer in a dose-dependent manner (P<10(-4)). Functional test showed that -93A allele increased hMLH1 promoter transcriptional activity and the luciferase activity. However, no significant difference was found in the genotype frequencies at the Ile219Val site between the cases and controls. Conclusions These findings indicate that the -93G>A polymorphism in hMLH1 may affect ovarian cancer susceptibility in the Chinese population.	[Niu, Leilei; Liang, Huamao; Li, Hua] Peking Univ, Dept Obstet & Gynecol, Hosp 3, Beijing 100871, Peoples R China; [Li, Shumin; Li, Hua] Chinese Acad Med Sci, Dept Gynecol Oncol, Canc Hosp, Beijing 100730, Peoples R China	Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS	Li, H (corresponding author), Peking Univ, Dept Obstet & Gynecol, Hosp 3, Beijing 100871, Peoples R China.	hua.li88@sina.com			National Natural Scientific Foundation of China [81202040]; Beijing Municipal Natural Science Foundation [7142167]; Beijing Nova Program [2009B03]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); Beijing Nova Program(Beijing Municipal Science & Technology Commission)	This study was supported by the National Natural Scientific Foundation of China grants (No. 81202040 to HL), Beijing Municipal Natural Science Foundation (No. 7142167 to HL) and Beijing Nova Program (No. 2009B03 to HL).	An Y, 2008, LUNG CANCER, V59, P164, DOI 10.1016/j.lungcan.2007.08.003; Bandera CA, 2005, J REPROD MED, V50, P399; Banescu C, 2013, GENE, V526, P478, DOI 10.1016/j.gene.2013.05.054; Beiner ME, 2006, CANCER EPIDEM BIOMAR, V15, P1636, DOI 10.1158/1055-9965.EPI-06-0257; Bernstein C, 2002, MUTAT RES-REV MUTAT, V511, P145, DOI 10.1016/S1383-5742(02)00009-1; Burmester JK, 2004, HUM HERED, V57, P172, DOI 10.1159/000081443; Fredriksson H, 2006, EUR J CANCER, V42, P2802, DOI 10.1016/j.ejca.2006.04.024; Goodfellow PJ, 2003, P NATL ACAD SCI USA, V100, P5908, DOI 10.1073/pnas.1030231100; Green H, 2006, CLIN CANCER RES, V12, P854, DOI 10.1158/1078-0432.CCR-05-0950; Guo SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056213; HIBI K, 1992, ONCOGENE, V7, P445; Hsieh P, 2001, MUTAT RES-DNA REPAIR, V486, P71, DOI 10.1016/S0921-8777(01)00088-X; Hubner RA, 2007, J NATL CANCER I, V99, P1490, DOI 10.1093/jnci/djm137; Ilyas M, 1999, EUR J CANCER, V35, P1986, DOI 10.1016/S0959-8049(99)00298-1; Ito E, 1999, BIOCHEM BIOPH RES CO, V256, P488, DOI 10.1006/bbrc.1999.0368; Jha R, 2013, GENE, V526, P223, DOI 10.1016/j.gene.2013.05.014; Jiang L, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3225; Jiang L, 2011, BREAST CANCER RES TR, V126, P487, DOI 10.1007/s10549-010-1094-6; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Kang S, 2006, EXP MOL MED, V38, P320, DOI 10.1038/emm.2006.38; Kim Jin C, 2004, Fam Cancer, V3, P129; KOLODNER RD, 1995, TRENDS BIOCHEM SCI, V20, P397, DOI 10.1016/S0968-0004(00)89087-8; Lee KM, 2005, CLIN CANCER RES, V11, P4620, DOI 10.1158/1078-0432.CCR-04-2534; Li JH, 2005, WORLD J GASTROENTERO, V11, P3144, DOI 10.3748/wjg.v11.i20.3144; Li N, 2013, MOL BIOL REP, V40, P3749, DOI 10.1007/s11033-012-2451-9; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; McDaid JR, 2009, BRIT J CANCER, V101, P441, DOI 10.1038/sj.bjc.6605186; Odicino F, 2008, INT J GYNECOL OBSTET, V101, P205, DOI 10.1016/j.ijgo.2007.11.004; Okada T, 2005, INT J CANCER, V116, P925, DOI 10.1002/ijc.21118; Park SH, 2004, INT J CANCER, V112, P678, DOI 10.1002/ijc.20359; Peltomaki P, 2003, J CLIN ONCOL, V21, P1174, DOI 10.1200/JCO.2003.04.060; Raptis S, 2007, JNCI-J NATL CANCER I, V99, P463, DOI 10.1093/jnci/djk095; Ries LAG, 2003, ONCOLOGIST, V8, P541; Shi Wen-ping, 2010, Zhonghua Yu Fang Yi Xue Za Zhi, V44, P235; Shih CM, 2010, INT J MOL MED, V25, P165, DOI 10.3892/ijmm_00000327; Shin KH, 2002, CANCER RES, V62, P38; Stojic L, 2004, DNA REPAIR, V3, P1091, DOI 10.1016/j.dnarep.2004.06.006; Tanaka Y, 2009, BIOCHEM BIOPH RES CO, V383, P440, DOI 10.1016/j.bbrc.2009.04.025; Vo C, 2007, OBSTET GYN CLIN N AM, V34, P687, DOI 10.1016/j.ogc.2007.09.008; Yan L, 2009, DIS ESOPHAGUS, V22, P396, DOI 10.1111/j.1442-2050.2008.00912.x; Zheng J, 2012, CARCINOGENESIS, V33, P2409, DOI 10.1093/carcin/bgs307; Zheng J, 2012, INT J CANCER, V130, P1981, DOI 10.1002/ijc.26253; Zheng J, 2011, MOL CARCINOGEN, V50, P689, DOI 10.1002/mc.20803	43	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135822	10.1371/journal.pone.0135822	http://dx.doi.org/10.1371/journal.pone.0135822			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275295	Green Published, Green Submitted, gold			2022-12-26	WOS:000359493600121
J	Wong, K; Kozlov, G; Zhang, YL; Gehring, K				Wong, Kathy; Kozlov, Guennadi; Zhang, Yinglu; Gehring, Kalle			Structure of the Legionella Effector, lpg1496, Suggests a Role in Nucleotide Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; SYSTEM; IDENTIFICATION; TRANSLOCATION; CONSERVATION; MACROPHAGES; VIRULENCE; DISEASE; DOMAIN	Pathogenic Gram-negative bacteria use specialized secretion systems that translocate bacterial proteins, termed effectors, directly into host cells where they interact with host proteins and biochemical processes for the benefit of the pathogen. lpg1496 is a previously uncharacterized effector of Legionella pneumophila, the causative agent of Legionnaires disease. Here, we crystallized three nucleotide binding domains from lpg1496. The C-terminal domain, which is conserved among the SidE family of effectors, is formed of two largely alpha-helical lobes with a nucleotide binding cleft. A structural homology search has shown similarity to phosphodiesterases involved in cleavage of cyclic nucleotides. We have also crystallized a novel domain that occurs twice in the N-terminal half of the protein that we term the KLAMP domain due to the presence of homologous domains in bacterial histidine kinase-like ATP binding region-containing proteins and S-adenosylmethionine-dependent methyltransferase proteins. Both KLAMP structures are very similar but selectively bind 3',5'-cAMP and ADP. A co-crystal of the KLAMP1 domain with 3',5'-cAMP reveals the contribution of Tyr-61 and Tyr-69 that produces pi-stacking interactions with the adenine ring of the nucleotide. Our study provides the first structural insights into two novel nucleotide binding domains associated with bacterial virulence.	[Gehring, Kalle] McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada; McGill Univ, Grp Rech Axe Struct Prot, Montreal, PQ H3G 0B1, Canada	McGill University; McGill University	Gehring, K (corresponding author), McGill Univ, Dept Biochem, 3649 Promenade Sir William Osier,Rm 473, Montreal, PQ H3G 0B1, Canada.	kalle.gehring@mcgill.ca	Gehring, Kalle/I-4403-2013; Gehring, Kalle/N-2945-2019	Gehring, Kalle/0000-0001-6500-1184; Gehring, Kalle/0000-0001-6500-1184	National Science Foundation (NSF); NIGMS, National Institutes of Health (NIH)/via NSF Award [DMR-0225180]; Center for Research Resources, NIH [RR-01646]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103485] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); NIGMS, National Institutes of Health (NIH)/via NSF Award; Center for Research Resources, NIH; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Miroslaw Cygler (University of Saskatchewan) for the initial construct of lpg1496, Dr. Irena Ekiel for helpful discussions, and the laboratory of Dr. Alexander Yakunin (University of Toronto) for screening potential substrates of lpg1496. Data were acquired at the Macromolecular Diffraction (MacCHESS) facility at the Cornell High Energy Synchrotron Source (CHESS). CHESS is supported by the National Science Foundation (NSF) and NIGMS, National Institutes of Health (NIH)/via NSF Award DMR-0225180, and the MacCHESS resource is supported by Center for Research Resources, NIH Award RR-01646.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; Bardill JP, 2005, MOL MICROBIOL, V56, P90, DOI 10.1111/j.1365-2958.2005.04539.x; Burstein D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000508; Chang B, 2005, INFECT IMMUN, V73, P4272, DOI 10.1128/IAI.73.7.4272-4280.2005; Coers J, 2000, MOL MICROBIOL, V38, P719, DOI 10.1046/j.1365-2958.2000.02176.x; Conover GM, 2003, MOL MICROBIOL, V48, P305, DOI 10.1046/j.1365-2958.2003.03400.x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FRASER DW, 1977, NEW ENGL J MED, V297, P1189, DOI 10.1056/NEJM197712012972201; Goddard D., 2008, SPARKY 3; Han S, 1999, NAT STRUCT BIOL, V6, P932, DOI 10.1038/13300; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HOSTETTER MK, 1995, BIOCHEM MOL MED, V55, P122, DOI 10.1006/bmme.1995.1042; Jeong KC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004695; Kurinov IV, 2004, ARZNEIMITTELFORSCH, V54, P692; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Luo ZQ, 2004, P NATL ACAD SCI USA, V101, P841, DOI 10.1073/pnas.0304916101; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MORRISON DC, 1987, ANNU REV MED, V38, P417, DOI 10.1146/annurev.me.38.020187.002221; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nagai H, 2005, P NATL ACAD SCI USA, V102, P826, DOI 10.1073/pnas.0406239101; Ninio S, 2005, MOL MICROBIOL, V55, P912, DOI 10.1111/j.1365-2958.2004.04435.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; ROSENSTREICH DL, 1977, J INFECT DIS, V136, pS239, DOI 10.1093/infdis/136.Supplement.S239; Serezani CH, 2007, AM J RESP CELL MOL, V37, P562, DOI 10.1165/rcmb.2007-0153OC; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873; Wang H, 2007, MOL MICROBIOL, V66, P1029, DOI 10.1111/j.1365-2958.2007.05976.x	30	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					24727	24737		10.1074/jbc.M115.671263	http://dx.doi.org/10.1074/jbc.M115.671263			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26294765	Green Published, hybrid			2022-12-26	WOS:000362598300009
J	Estrella, NL; Clark, AL; Desjardins, CA; Nocco, SE; Naya, FJ				Estrella, Nelsa L.; Clark, Amanda L.; Desjardins, Cody A.; Nocco, Sarah E.; Naya, Francisco J.			MEF2D Deficiency in Neonatal Cardiomyocytes Triggers Cell Cycle Re-entry and Programmed Cell Death in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOXO TRANSCRIPTION FACTORS; MYOCYTE ENHANCER FACTOR-2; LARGE GENE LISTS; CARDIAC-HYPERTROPHY; SIGNALING PATHWAYS; MOUSE HEART; PROLIFERATION; AKT; APOPTOSIS; MUSCLE	The cardiomyocyte cell cycle is a poorly understood process. Mammalian cardiomyocytes permanently withdraw from the cell cycle shortly after birth but can re-enter the cell cycle and proliferate when subjected to injury within a brief temporal window in the neonatal period. Thus, investigating the mechanisms of cell cycle regulation in neonatal cardiomyocytes may provide critical insight into the molecular events that prevent adult myocytes from proliferating in response to injury or stress. MEF2D is a key transcriptional mediator of pathological remodeling in the adult heart downstream of various stress-promoting insults, However, the specific gene programs regulated by MEF2D in cardioniyocytes are unknown. By performing genome-wide transcriptome analysis using MEF2D-depleted neonatal cardiomyocytes, we found a significant impairment in the cell cycle, characterized by the up-regulation of numerous positive cell cycle regulators. Expression of Pten, the primary negative regulator of PI3K1Akt, was significantly reduced in 1\4E1'2D-deficient cardiomyocytes and found to be a direct target gene of MEF2D. Consistent with these findings mutant cardioniyocytes showed activation of the PI3K/Akt survival pathway. Paradoxically, prolonged deficiency of MEF2D in neonatal cardiornyocytes did not trigger proliferation but instead resulted in programmed cell death, which is likely mediated by the EH transcription factor. These results demonstrate a critical role for MEF2D in cell cycle regulation of post-mitotic, neonatal cardiomyocytes in vitro.	[Estrella, Nelsa L.; Clark, Amanda L.; Desjardins, Cody A.; Nocco, Sarah E.; Naya, Francisco J.] Boston Univ, Dept Biol, Program Cell & Mol Biol, Boston, MA 02215 USA	Boston University	Naya, FJ (corresponding author), Boston Univ, Dept Biol, 24 Cummington Mall, Boston, MA 02215 USA.	fnaya@bu.edu			National Heart, Lung, and Blood Institute, National Institutes of Health [HL73304]; Beckman Scholars Program; Boston University Bioinformatics CTSI [U54-TR001012]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [U54TR001012] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073304] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Beckman Scholars Program; Boston University Bioinformatics CTSI; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Heart, Lung, and Blood Institute, National Institutes of Health Grant HL73304 (to F. J. N.) and a diversity supplement (parent Grant HL73304) (to N. L. E.). This work was also supported by the Beckman Scholars Program (to S. E. N.) and Boston University Bioinformatics CTSI Grant U54-TR001012. The authors declare that they have no conflicts of interest with the contents of this article.	Agah R, 1997, J CLIN INVEST, V100, P2722, DOI 10.1172/JCI119817; Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Chan SF, 2014, J NEUROSCI, V34, P4640, DOI 10.1523/JNEUROSCI.2510-12.2014; Chen JH, 2013, CIRC RES, V112, P1557, DOI 10.1161/CIRCRESAHA.112.300658; Crackower MA, 2002, CELL, V110, P737, DOI 10.1016/S0092-8674(02)00969-8; Ebelt H, 2005, CIRC RES, V96, P509, DOI 10.1161/01.RES.0000159705.17322.57; el Azzouzi H, 2010, EUR J HEART FAIL, V12, P4, DOI 10.1093/eurjhf/hfp165; Estrella NL, 2015, J BIOL CHEM, V290, P1256, DOI 10.1074/jbc.M114.589838; Estrella N, 2014, CELL MOL LIFE SCI, V71, P1641, DOI 10.1007/s00018-013-1512-0; Evans-Anderson HJ, 2008, CIRC RES, V102, P686, DOI 10.1161/CIRCRESAHA.107.163428; Ewen EP, 2011, J BIOL CHEM, V286, P29644, DOI 10.1074/jbc.M111.268094; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; Gong XM, 2003, NEURON, V38, P33, DOI 10.1016/S0896-6273(03)00191-0; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Herrup K, 2007, NAT REV NEUROSCI, V8, P368, DOI 10.1038/nrn2124; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Kim Y, 2008, J CLIN INVEST, V118, P124, DOI 10.1172/JCI33255; Konno T, 2010, P NATL ACAD SCI USA, V107, P18097, DOI 10.1073/pnas.1012826107; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Lin ZQ, 2015, CIRC RES, V116, P35, DOI 10.1161/CIRCRESAHA.115.304457; Mahmoud AI, 2013, NATURE, V497, P249, DOI 10.1038/nature12054; Matsui T, 2001, CIRCULATION, V104, P330; Matsui T, 1999, CIRCULATION, V100, P2373, DOI 10.1161/01.CIR.100.23.2373; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Ni YG, 2006, CIRCULATION, V114, P1159, DOI 10.1161/CIRCULATIONAHA.106.637124; Oudit GY, 2008, CARDIOVASC RES, V78, P505, DOI 10.1093/cvr/cvn041; Oudit GY, 2004, J MOL CELL CARDIOL, V37, P449, DOI 10.1016/j.yjmcc.2004.05.015; Passier R, 2000, J CLIN INVEST, V105, P1395, DOI 10.1172/JCI8551; Pasumarthi KBS, 2002, CIRC RES, V90, P1044, DOI 10.1161/01.RES.0000020201.44772.67; Polager S, 2008, TRENDS CELL BIOL, V18, P528, DOI 10.1016/j.tcb.2008.08.003; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; RUMYANTSEV PP, 1977, INT REV CYTOL, V51, P187; Sengupta A, 2013, CIRC RES, V112, P267, DOI 10.1161/CIRCRESAHA.112.277442; Skurk C, 2005, J BIOL CHEM, V280, P20814, DOI 10.1074/jbc.M500528200; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Sussman MA, 2011, PHYSIOL REV, V91, P1023, DOI 10.1152/physrev.00024.2010; Tang XL, 2005, J NEUROSCI, V25, P4823, DOI 10.1523/JNEUROSCI.1331-05.2005; Worby CA, 2014, ANNU REV BIOCHEM, V83, P641, DOI 10.1146/annurev-biochem-082411-113907; Xin M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002278; Zacchigna S, 2014, CARDIOVASC RES, V102, P312, DOI 10.1093/cvr/cvu057; Zebrowski DC, 2013, REV PHYSIOL BIOCH P, V165, P67, DOI 10.1007/112_2013_12	48	18	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24367	24380		10.1074/jbc.M115.666461	http://dx.doi.org/10.1074/jbc.M115.666461			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26294766	Green Published, hybrid			2022-12-26	WOS:000362218900025
J	Naftulin, JS; Kimchi, EY; Cash, SS				Naftulin, Jason S.; Kimchi, Eyal Y.; Cash, Sydney S.			Streamlined, Inexpensive 3D Printing of the Brain and Skull	PLOS ONE			English	Article							MODEL; FABRICATION; SCAFFOLDS; ACCURACY; HAND	Neuroimaging technologies such as Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) collect three-dimensional data (3D) that is typically viewed on two-dimensional (2D) screens. Actual 3D models, however, allow interaction with real objects such as implantable electrode grids, potentially improving patient specific neurosurgical planning and personalized clinical education. Desktop 3D printers can now produce relatively inexpensive, good quality prints. We describe our process for reliably generating life-sized 3D brain prints from MRIs and 3D skull prints from CTs. We have integrated a standardized, primarily open-source process for 3D printing brains and skulls. We describe how to convert clinical neuroimaging Digital Imaging and Communications in Medicine (DICOM) images to stereolithography (STL) files, a common 3D object file format that can be sent to 3D printing services. We additionally share how to convert these STL files to machine instruction gcode files, for reliable in-house printing on desktop, open-source 3D printers. We have successfully printed over 19 patient brain hemispheres from 7 patients on two different open-source desktop 3D printers. Each brain hemisphere costs approximately $3-4 in consumable plastic filament as described, and the total process takes 14-17 hours, almost all of which is unsupervised (preprocessing = 4-6 hr; printing = 9-11 hr, post-processing = < 30 min). Printing a matching portion of a skull costs $1-5 in consumable plastic filament and takes less than 14 hr, in total. We have developed a streamlined, cost-effective process for 3D printing brain and skull models. We surveyed healthcare providers and patients who confirmed that rapid-prototype patient specific 3D models may help interdisciplinary surgical planning and patient education. The methods we describe can be applied for other clinical, research, and educational purposes.	[Naftulin, Jason S.; Kimchi, Eyal Y.; Cash, Sydney S.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Kimchi, Eyal Y.; Cash, Sydney S.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Kimchi, EY (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.	ekimchi@partners.org	Chan, Simmy/AAD-9046-2021		National Institute of Neurological Disorders and Stroke [T32-NS048005, R01-NS062092]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062092, T32NS048005] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by grants from the National Institute of Neurological Disorders and Stroke (http://www.ninds.nih.gov/) (T32-NS048005 EYK, R01-NS062092 SSC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JW, 2015, BRIT J OPHTHALMOL, V99, P1162, DOI 10.1136/bjophthalmol-2014-306189; Chung KJ, 2015, FOOT ANKLE INT, V36, P1504, DOI 10.1177/1071100715595695; Cohen J, 2015, AM J OTOLARYNG, V36, P619, DOI 10.1016/j.amjoto.2015.02.012; Davison AP, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00022; Delgado J, 2014, NEUROINFORMATICS, V12, P413, DOI 10.1007/s12021-013-9214-1; Fasel JHD, 2013, ANN ROY COLL SURG, V95, P401, DOI 10.1308/003588413X13629960046994; Gaetani R, 2015, BIOMATERIALS, V61, P339, DOI 10.1016/j.biomaterials.2015.05.005; Gerstle TL, 2014, PLAST RECONSTR SURG, V133, P446, DOI 10.1097/01.prs.0000436844.92623.d3; He Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06973; Jung J, 2015, INT J RADIAT ONCOL, V92, P745, DOI 10.1016/j.ijrobp.2015.02.055; McMenamin PG, 2014, ANAT SCI EDUC, V7, P479, DOI 10.1002/ase.1475; Michalski MH, 2014, JAMA-J AM MED ASSOC, V312, P2213, DOI 10.1001/jama.2014.9542; Mohanty S, 2015, MAT SCI ENG C-MATER, V55, P569, DOI 10.1016/j.msec.2015.06.002; Owusu JA, 2015, CURR OPIN OTOLARYNGO, V23, P261, DOI 10.1097/MOO.0000000000000175; Park JH, 2015, BIOMATERIALS, V62, P106, DOI 10.1016/j.biomaterials.2015.05.008; Park SW, 2015, J ORAL MAXIL SURG, V73, P1540, DOI 10.1016/j.joms.2015.03.025; Pati F, 2015, BIOMATERIALS, V62, P164, DOI 10.1016/j.biomaterials.2015.05.043; Pietrabissa A, 2016, SURG ENDOSC, V30, P366, DOI 10.1007/s00464-015-4185-y; Preece D, 2013, ANAT SCI EDUC, V6, P216, DOI 10.1002/ase.1345; Rengier F, 2010, INT J COMPUT ASS RAD, V5, P335, DOI 10.1007/s11548-010-0476-x; Rosenzweig DH, 2015, INT J MOL SCI, V16, P15118, DOI 10.3390/ijms160715118; Salmi M, 2013, J CRANIO MAXILL SURG, V41, P603, DOI 10.1016/j.jcms.2012.11.041; Samuel BP, 2015, J DIGIT IMAGING, V28, P459, DOI 10.1007/s10278-014-9761-5; Schubert C, 2014, BRIT J OPHTHALMOL, V98, P159, DOI 10.1136/bjophthalmol-2013-304446; Tan HT, 2015, J RECONSTR MICROSURG, V31, P369, DOI 10.1055/s-0035-1546419; Tumbleston JR, 2015, SCIENCE, V347, P1349, DOI 10.1126/science.aaa2397; Waran V, 2015, SIMUL HEALTHC, V10, P43, DOI 10.1097/SIH.0000000000000060; Waran V, 2014, J SURG EDUC, V71, P193, DOI 10.1016/j.jsurg.2013.08.010; West SJ, 2014, REGION ANESTH PAIN M, V39, P429, DOI 10.1097/AAP.0000000000000136; Xu WH, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.08.02; Zuniga Jorge, 2015, BMC Res Notes, V8, P10, DOI 10.1186/s13104-015-0971-9	31	75	77	2	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136198	10.1371/journal.pone.0136198	http://dx.doi.org/10.1371/journal.pone.0136198			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295459	Green Published, Green Submitted, gold			2022-12-26	WOS:000359926900081
J	Miyai, M; Eikawa, S; Hosoi, A; Iino, T; Matsushita, H; Isobe, M; Uenaka, A; Udono, H; Nakajima, J; Nakayama, E; Kakimi, K				Miyai, Manami; Eikawa, Shingo; Hosoi, Akihiro; Iino, Tamaki; Matsushita, Hirokazu; Isobe, Midori; Uenaka, Akiko; Udono, Heiichiro; Nakajima, Jun; Nakayama, Eiichi; Kakimi, Kazuhiro			Detection and Tracking of NY-ESO-1-Specific CD8(+) T Cells by High-Throughput T Cell Receptor beta (TCRB) Gene Rearrangements Sequencing in a Peptide-Vaccinated Patient	PLOS ONE			English	Article							INTERFERON-GAMMA; IDENTIFICATION; SECRETION; ANTITUMOR; RESPONSES	Comprehensive immunological evaluation is crucial for monitoring patients undergoing antigen-specific cancer immunotherapy. The identification and quantification of T cell responses is most important for the further development of such therapies. Using well-characterized clinical samples from a high responder patient (TK-f01) in an NY-ESO-1f peptide vaccine study, we performed high-throughput T cell receptor beta-chain (TCRB) gene next generation sequencing (NGS) to monitor the frequency of NY-ESO-1-specific CD8(+) T cells. We compared these results with those of conventional immunological assays, such as IFN-gamma capture, tetramer binding and limiting dilution clonality assays. We sequenced human TCRB complementarity-determining region 3 (CDR3) rearrangements of two NY-ESO-1f specific CD8(+) T cell clones, 6-8L and 2F6, as well as PBMCs over the course of peptide vaccination. Clone 6-8L possessed the TCRB CDR3 gene TCRBV11-03*01 and BJ02-01*01 with amino acid sequence CASSLRGNEQFF, whereas 2F6 possessed TCRBV05-08*01 and BJ02-04*01 (CASSLVGTNIQYF). Using these two sequences as models, we evaluated the frequency of NY-ESO-1-specific CD8(+) T cells in PBMCs ex vivo. The 6-8L CDR3 sequence was the second most frequent in PBMC and was present at high frequency (0.7133%) even prior to vaccination, and sustained over the course of vaccination. Despite a marked expansion of NY-ESO-1-specific CD8(+) T cells detected from the first through 6th vaccination by tetramer staining and IFN-gamma capture assays, as evaluated by CDR3 sequencing the frequency did not increase with increasing rounds of peptide vaccination. By clonal analysis using 12 day in vitro stimulation, the frequency of B*52:01-restricted NY-ESO-1f peptide-specific CD8(+) T cells in PBMCs was estimated as only 0.0023%, far below the 0.7133% by NGS sequencing. Thus, assays requiring in vitro stimulation might be underestimating the frequency of clones with lower proliferation potential. High-throughput TCRB sequencing using NGS can potentially better estimate the actual frequency of antigen-specific T cells and thus provide more accurate patient monitoring.	[Miyai, Manami; Hosoi, Akihiro; Iino, Tamaki; Matsushita, Hirokazu; Kakimi, Kazuhiro] Tokyo Univ Hosp, Dept Immunotherapeut, Bunkyo Ku, Tokyo 113, Japan; [Eikawa, Shingo; Udono, Heiichiro] Okayama Univ, Dept Immunol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Okayama 7008530, Japan; [Isobe, Midori; Uenaka, Akiko; Nakayama, Eiichi] Kawasaki Univ Med Welf, Fac Hlth & Welf, Kurashiki, Okayama, Japan; [Nakajima, Jun] Tokyo Univ Hosp, Dept Thorac Surg, Bunkyo Ku, Tokyo 113, Japan	University of Tokyo; Okayama University; University of Tokyo	Kakimi, K (corresponding author), Tokyo Univ Hosp, Dept Immunotherapeut, Bunkyo Ku, Tokyo 113, Japan.	kakimi@m.u-tokyo.ac.jp		Nakajima, Jun/0000-0003-1174-0816	Project for Development of Innovative research on Cancer Therapeutics (P-Direct) of the Ministry of Education, Culture, Sports, Science and Technology [24501329]	Project for Development of Innovative research on Cancer Therapeutics (P-Direct) of the Ministry of Education, Culture, Sports, Science and Technology	This study was supported in part by a Grant-in-Aid for Scientific Research (24501329 KK) and a research program of the Project for Development of Innovative research on Cancer Therapeutics (P-Direct, EN and KK) of the Ministry of Education, Culture, Sports, Science and Technology (24501329 KK) [http://www.mext.go.jp/english/]. The study sponsors had no involvement in study design, collection, analysis, and interpretation of data, writing the report, or the decision to submit the report for publication.	Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Boyd SD, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000540; Carlson CS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3680; Cha E, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008211; Desombere I, 2004, J IMMUNOL METHODS, V286, P167, DOI 10.1016/j.jim.2004.01.001; Eikawa S, 2013, INT J CANCER, V132, P345, DOI 10.1002/ijc.27682; Freeman JD, 2009, GENOME RES, V19, P1817, DOI 10.1101/gr.092924.109; Germeau C, 2005, J EXP MED, V201, P241, DOI 10.1084/jem.20041379; Gros A, 2014, J CLIN INVEST, V124, P2246, DOI [10.1172/JC173639, 10.1172/JCI73639]; Janetzki S, 2009, IMMUNITY, V31, P527, DOI 10.1016/j.immuni.2009.09.007; Kakimi K, 2011, INT J CANCER, V129, P2836, DOI 10.1002/ijc.25955; Keilholz U, 2002, J IMMUNOTHER, V25, P97, DOI 10.1097/00002371-200203000-00001; Keilhoz U, 2006, CLIN CANCER RES, V12, p2346S, DOI 10.1158/1078-0432.CCR-05-2540; Lossius A, 2014, EUR J IMMUNOL, V44, P3439, DOI 10.1002/eji.201444662; Lurquin C, 2005, J EXP MED, V201, P249, DOI 10.1084/jem.20041378; Maino VC, 1998, CYTOMETRY, V34, P207, DOI 10.1002/(SICI)1097-0320(19981015)34:5<207::AID-CYTO1>3.0.CO;2-J; MANZ R, 1995, P NATL ACAD SCI USA, V92, P1921, DOI 10.1073/pnas.92.6.1921; Morishima S, 2007, INT J CANCER, V120, P594, DOI 10.1002/ijc.22312; Nakasone H, 2014, BONE MARROW TRANSPL, V49, P87, DOI 10.1038/bmt.2013.122; Pittet MJ, 2001, J IMMUNOL, V166, P7634, DOI 10.4049/jimmunol.166.12.7634; Robert L, 2014, CLIN CANCER RES, V20, P2424, DOI 10.1158/1078-0432.CCR-13-2648; Robins H, 2012, J IMMUNOL METHODS, V375, P14, DOI 10.1016/j.jim.2011.09.001; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; Six A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00413; Valmori D, 2002, J IMMUNOL, V168, P4231, DOI 10.4049/jimmunol.168.8.4231; Wu D, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003656	26	6	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136086	10.1371/journal.pone.0136086	http://dx.doi.org/10.1371/journal.pone.0136086			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291626	Green Published, gold, Green Submitted			2022-12-26	WOS:000359919900051
J	Pelini, SL; Maran, AM; Chen, AR; Kaseman, J; Crowther, TW				Pelini, Shannon L.; Maran, Audrey M.; Chen, Angus R.; Kaseman, Justine; Crowther, Thomas W.			Higher Trophic Levels Overwhelm Climate Change Impacts on Terrestrial Ecosystem Functioning	PLOS ONE			English	Article							TOP-DOWN; COMMUNITY COMPOSITION; SOIL BIODIVERSITY; CARBON-CYCLE; BOTTOM-UP; FOOD-WEB; INVERTEBRATES; RESPIRATION; RESPONSES; DYNAMICS	Forest floor food webs play pivotal roles in carbon cycling, but they are rarely considered in models of carbon fluxes, including soil carbon dioxide emissions (respiration), under climatic warming. The indirect effects of invertebrates on heterotrophic (microbial and invertebrate) respiration through interactions with microbial communities are significant and will be altered by warming. However, the interactive effects of invertebrates and warming on heterotrophic respiration in the field are poorly understood. In this study we combined field and common garden laboratory approaches to examine relationships between warming, forest floor food web structure, and heterotrophic respiration. We found that soil animals can overwhelm the effects of warming (to 5 degrees Celsius above ambient) on heterotrophic respiration. In particular, the presence of higher trophic levels and burrowing detritivores strongly determined heterotrophic respiration rates in temperate forest soils. These effects were, however, context-dependent, with greater effects in a lower-latitude site. Without isolating and including the significant impact of invertebrates, climate models will be incomplete, hindering well-informed policy decisions.	[Pelini, Shannon L.; Maran, Audrey M.; Kaseman, Justine] Bowling Green State Univ, Dept Biol Sci, Bowling Green, OH 43403 USA; [Chen, Angus R.; Kaseman, Justine] Harvard Univ, Harvard Forest, Petersham, MA 01366 USA; [Crowther, Thomas W.] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA	University System of Ohio; Bowling Green State University; Harvard University; Yale University	Crowther, TW (corresponding author), Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA.	thomas.crowther11@gmail.com		Crowther, Thomas/0000-0001-5674-8913	United States National Science Foundation [DBI 10-03938, DBI 1459519]; Building Strength Program at Bowling Green State University; Yale University's Climate and Energy Institute; British Ecological Society; United States Department of Energy Program for Ecosystem Research [DE-FG02-08ER64510]	United States National Science Foundation(National Science Foundation (NSF)); Building Strength Program at Bowling Green State University; Yale University's Climate and Energy Institute; British Ecological Society; United States Department of Energy Program for Ecosystem Research	Funding was provided by United States National Science Foundation Long Term Ecological Research (DBI 10-03938) and Research Experiences for Undergraduates (DBI 1459519) awards to Harvard Forest. SLP received funds from the Building Strength Program at Bowling Green State University. TWC received funds from Yale University's Climate and Energy Institute and the British Ecological Society. The authors thank Rob Dunn, Aaron Ellison, Nick Gotelli, and Nate Sanders for allowing use of the warming chambers, funded by United States Department of Energy Program for Ecosystem Research (DE-FG02-08ER64510). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2010, NAT GEOSCI, V3, P336, DOI 10.1038/NGEO846; Bardgett RD, 2008, ISME J, V2, P805, DOI 10.1038/ismej.2008.58; Barrett JE, 2008, GLOBAL CHANGE BIOL, V14, P1734, DOI 10.1111/j.1365-2486.2008.01611.x; Barton BT, 2009, ECOLOGY, V90, P2346, DOI 10.1890/08-2254.1; Baveye P, 2009, UNCERTAINTIES ENV MO; Best ML, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00302.1; Bradford MA, 2002, SCIENCE, V298, P615, DOI 10.1126/science.1075805; Bradford MA, 2008, ECOL LETT, V11, P1316, DOI 10.1111/j.1461-0248.2008.01251.x; Crowther T, 2015, PNAS IN PRESS; Crowther TW, 2013, ECOLOGY, V94, P2518, DOI 10.1890/13-0197.1; Crowther TW, 2011, ECOL LETT, V14, P1134, DOI 10.1111/j.1461-0248.2011.01682.x; Crowther TW, 2011, SOIL BIOL BIOCHEM, V43, P2060, DOI 10.1016/j.soilbio.2011.06.003; Crowther TW, 2011, FUNGAL ECOL, V4, P333, DOI 10.1016/j.funeco.2011.05.001; Crumsey JM, 2013, ECOLOGY, V94, P2827, DOI 10.1890/12-1555.1; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Ellison AM, 2009, ANTS CLIMATE CHANGE; Heemsbergen DA, 2004, SCIENCE, V306, P1019, DOI 10.1126/science.1101865; Jochum M, 2012, PHILOS T R SOC B, V367, P2962, DOI 10.1098/rstb.2012.0237; Kuiper I, 2013, GLOBAL CHANGE BIOL, V19, P2814, DOI 10.1111/gcb.12232; Laakso J, 1999, OECOLOGIA, V120, P279, DOI 10.1007/s004420050859; Lang B, 2012, J ANIM ECOL, V81, P516, DOI 10.1111/j.1365-2656.2011.01931.x; Lavelle P, 2006, EUR J SOIL BIOL, V42, pS3, DOI 10.1016/j.ejsobi.2006.10.002; Lubbers IM, 2013, NAT CLIM CHANGE, V3, P187, DOI [10.1038/NCLIMATE1692, 10.1038/nclimate1692]; Makoto K, 2014, SOIL BIOL BIOCHEM, V72, P19, DOI 10.1016/j.soilbio.2014.01.016; Manning P, 2006, ECOL LETT, V9, P1015, DOI 10.1111/j.1461-0248.2006.00959.x; Mikola J, 1998, ECOLOGY, V79, P153, DOI 10.1890/0012-9658(1998)079[0153:NEOTCI]2.0.CO;2; Moore JC, 2003, ECOLOGY, V84, P846, DOI 10.1890/0012-9658(2003)084[0846:TIBDPI]2.0.CO;2; Nielsen UN, 2011, EUR J SOIL SCI, V62, P105, DOI 10.1111/j.1365-2389.2010.01314.x; Pelini SL, 2011, METHODS ECOL EVOL, V2, P534, DOI 10.1111/j.2041-210X.2011.00100.x; Post E, 2008, P NATL ACAD SCI USA, V105, P12353, DOI 10.1073/pnas.0802421105; POUGH FH, 1987, FOREST ECOL MANAG, V20, P1, DOI 10.1016/0378-1127(87)90146-0; Prather CM, 2013, BIOL REV, V88, P327, DOI 10.1111/brv.12002; Rouifed S, 2010, OECOLOGIA, V163, P247, DOI 10.1007/s00442-009-1528-1; Schlesinger WH, 2000, BIOGEOCHEMISTRY, V48, P7, DOI 10.1023/A:1006247623877; Schmitz OJ, 2014, ECOSYSTEMS, V17, P344, DOI 10.1007/s10021-013-9715-7; Scott-Denton LE, 2006, GLOBAL CHANGE BIOL, V12, P205, DOI 10.1111/j.1365-2486.2005.01064.x; Setala Heikki, 2005, P308; Suttle KB, 2007, SCIENCE, V315, P640, DOI 10.1126/science.1136401; Wall DH, 2008, GLOBAL CHANGE BIOL, V14, P2661, DOI 10.1111/j.1365-2486.2008.01672.x; Wall DH, 2013, SOIL ECOLOGY AND ECOSYSTEM SERVICES, P1; Wardle DA, 2006, ECOL LETT, V9, P870, DOI 10.1111/j.1461-0248.2006.00931.x; Wieder WR, 2013, NAT CLIM CHANGE, V3, P909, DOI [10.1038/nclimate1951, 10.1038/NCLIMATE1951]; Zhao C, 2013, J ANIM ECOL, V82, P749, DOI 10.1111/1365-2656.12058	43	6	6	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136344	10.1371/journal.pone.0136344	http://dx.doi.org/10.1371/journal.pone.0136344			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26292214	Green Published, gold, Green Submitted			2022-12-26	WOS:000359919900078
J	Raats, JW; van Eijsden, WA; Crolla, RMPH; Steyerberg, EW; van der Laan, L				Raats, Jelle W.; van Eijsden, Wilbert A.; Crolla, Rogier M. P. H.; Steyerberg, Ewout W.; van der Laan, Lijckle			Risk Factors and Outcomes for Postoperative Delirium after Major Surgery in Elderly Patients	PLOS ONE			English	Article							ABDOMINAL AORTIC-ANEURYSM; COLORECTAL SURGERY; COGNITIVE DYSFUNCTION; GERIATRIC POPULATION; VASCULAR-SURGERY; ADVERSE OUTCOMES; HIP FRACTURE; OPEN REPAIR; IMPLEMENTATION; VALIDATION	Background Early identification of patients at risk for delirium is important, since adequate well timed interventions could prevent occurrence of delirium and related detrimental outcomes. The aim of this study is to evaluate prognostic factors for delirium, including factors describing frailty, in elderly patients undergoing major surgery. Methods We included patients of 65 years and older, who underwent elective surgery from March 2013 to November 2014. Patients had surgery for Abdominal Aortic Aneurysm (AAA) or colorectal cancer. Delirium was scored prospectively using the Delirium Observation Screening Scale. Pre- and peri-operative predictors of delirium were analyzed using regression analysis. Outcomes after delirium included adverse events, length of hospital stay, discharge destination and mortality. Results We included 232 patients. 51 (22%) underwent surgery for AAA and 181 (78%) for colorectal cancer. Postoperative delirium occurred in 35 patients (15%). Predictors of postoperative delirium included: delirium in medical history (Odds Ratio 12 [95% Confidence Interval 2.7-50]), advancing age (Odds Ratio 2.0 [95% Confidence Interval 1.1-3.8]) per 10 years, and ASA-score >= 3 (Odds Ratio 2.6 [95% Confidence Interval 1.1-5.9]). Occurrence of delirium was related to an increase in adverse events, length of hospital stay and mortality. Conclusion Postoperative delirium is a frequent complication after major surgery in elderly patients and is related to an increase in adverse events, length of hospital stay, and mortality. A delirium in the medical history, advanced age, and ASA-score may assist in defining patients at increased risk for delirium. Further attention to prevention of delirium is essential in elderly patients undergoing major surgery.	[Raats, Jelle W.; van Eijsden, Wilbert A.; Crolla, Rogier M. P. H.; van der Laan, Lijckle] Amphia Hosp, Dept Surg, Breda, Netherlands; [Steyerberg, Ewout W.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands	Amphia Hospital; Erasmus University Rotterdam; Erasmus MC	Raats, JW (corresponding author), Amphia Hosp, Dept Surg, Breda, Netherlands.	JRaats@amphia.nl	Crolla, Rogier/L-9847-2019	Crolla, Rogier/0000-0003-2617-1791; van der laan, lijckle/0000-0001-5631-594X				[Anonymous], 2012, EPIC HYPERSPACE; Ansaloni L, 2010, BRIT J SURG, V97, P273, DOI 10.1002/bjs.6843; Bekker Alex Y, 2003, Best Pract Res Clin Anaesthesiol, V17, P259, DOI 10.1016/S1521-6896(03)00005-3; Bilotta F, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-170; Bohner H, 2003, ANN SURG, V238, P149, DOI 10.1097/00000658-200307000-00019; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; De Bruin JL, 2010, NEW ENGL J MED, V362, P1881, DOI 10.1056/NEJMoa0909499; de Mheen PJMV, 2007, QUAL SAF HEALTH CARE, V16, P428, DOI 10.1136/qshc.2006.021071; Deiner S, 2009, Br J Anaesth, V103 Suppl 1, pi41, DOI 10.1093/bja/aep291; Desormais I, 2014, EUR J VASC ENDOVASC, V48, P202, DOI 10.1016/j.ejvs.2014.04.005; Engelberger S, 2012, INT SURG, V97, P129, DOI 10.9738/CC125.1; Epstein D, 2014, BRIT J SURG, V101, P623, DOI 10.1002/bjs.9464; Freter SH, 2005, AGE AGEING, V34, P169, DOI 10.1093/ageing/afh245; Greenhalgh RM, 2010, NEW ENGL J MED, V362, P1863, DOI 10.1056/NEJMoa0909305; Inouye SK, 1999, NEW ENGL J MED, V340, P669, DOI 10.1056/NEJM199903043400901; Joosten E, 2006, GERONTOLOGY, V52, P382, DOI 10.1159/000095126; Kalisvaart KJ, 2006, J AM GERIATR SOC, V54, P817, DOI 10.1111/j.1532-5415.2006.00704.x; Kehlet H, 2005, BRIT J SURG, V92, P3, DOI 10.1002/bjs.4841; Kiran RP, 2013, ANN SURG, V257, P905, DOI 10.1097/SLA.0b013e318269d337; Koebrugge B, 2010, VASCULAR, V18, P279, DOI 10.2310/6670.2010.00052; Korc-Grodzicki B, 2014, ANN SURG; Kruizenga HM, 2005, CLIN NUTR, V24, P75, DOI 10.1016/j.clnu.2004.07.015; Laurila JV, 2008, J PSYCHOSOM RES, V65, P249, DOI 10.1016/j.jpsychores.2008.05.026; Litaker D, 2001, GEN HOSP PSYCHIAT, V23, P84, DOI 10.1016/S0163-8343(01)00117-7; Marang-van de Mheen PJ, 2006, QUAL SAF HEALTH CARE, V15, P320, DOI 10.1136/qshc.2005.016220; MARCANTONIO ER, 1994, JAMA-J AM MED ASSOC, V271, P134, DOI 10.1001/jama.271.2.134; Marcantonio ER, 2001, J AM GERIATR SOC, V49, P516, DOI 10.1046/j.1532-5415.2001.49108.x; Noimark D, 2009, AGE AGEING, V38, P368, DOI 10.1093/ageing/afp024; Olin K, 2005, BRIT J SURG, V92, P1559, DOI 10.1002/bjs.5053; Patti R, 2011, EUR J ONCOL NURS, V15, P519, DOI 10.1016/j.ejon.2011.01.004; Raats JW, 2015, INT J SURG, V18, P216, DOI 10.1016/j.ijsu.2015.04.080; Raats JW SS, 2015, J GASTROINTESTINAL S; Rudolph JL, 2008, ANAESTHESIA, V63, P941, DOI 10.1111/j.1365-2044.2008.05523.x; Scheffer AC, 2011, INT J GERIATR PSYCH, V26, P284, DOI 10.1002/gps.2526; Schneider F, 2002, GEN HOSP PSYCHIAT, V24, P28, DOI 10.1016/S0163-8343(01)00168-2; Schuurmans Marieke J, 2003, Res Theory Nurs Pract, V17, P31, DOI 10.1891/088971803780956425; Siddiqi N, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005563.pub2; Steinmetz J, 2010, MINERVA ANESTESIOL, V76, P745; Steyerberg E., 2009, CLIN PREDICTION MODE; Tei M, 2010, SURG ENDOSC, V24, P2135, DOI 10.1007/s00464-010-0911-7; Wallace Meredith, 2007, Urol Nurs, V27, P93; WEED HG, 1995, LARYNGOSCOPE, V105, P1066, DOI 10.1288/00005537-199510000-00011; Zakriya KJ, 2002, ANESTH ANALG, V94, P1628, DOI 10.1097/00000539-200206000-00050	43	138	140	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136071	10.1371/journal.pone.0136071	http://dx.doi.org/10.1371/journal.pone.0136071			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291459	Green Submitted, Green Published, gold			2022-12-26	WOS:000359919900049
J	Schlinkert, H; Westphal, C; Clough, Y; Laszlo, Z; Ludwig, M; Tscharntke, T				Schlinkert, Hella; Westphal, Catrin; Clough, Yann; Laszlo, Zoltan; Ludwig, Martin; Tscharntke, Teja			Plant Size as Determinant of Species Richness of Herbivores, Natural Enemies and Pollinators across 21 Brassicaceae Species	PLOS ONE			English	Article							BODY-SIZE; ARCHITECTURE; PARASITOIDS; DIVERSITY; SPECIFICITY; VISITATION; EVOLUTION; ABUNDANCE; DYNAMICS; INSECTS	Large plants are often more conspicuous and more attractive for associated animals than small plants, e.g. due to their wider range of resources. Therefore, plant size can positively affect species richness of associated animals, as shown for single groups of herbivores, but studies usually consider intraspecific size differences of plants in unstandardised environments. As comprehensive tests of interspecific plant size differences under standardised conditions are missing so far, we investigated effects of plant size on species richness of all associated arthropods using a common garden experiment with 21 Brassicaceae species covering a broad interspecific plant size gradient from 10 to 130 cm height. We recorded plant associated ecto-and endophagous herbivores, their natural enemies and pollinators on and in each aboveground plant organ, i.e. flowers, fruits, leaves and stems. Plant size (measured as height from the ground), the number of different plant organ entities and their biomass were assessed. Increasing plant size led to increased species richness of associated herbivores, natural enemies and pollinating insects. This pattern was found for ectophagous and endophagous herbivores, their natural enemies, as well as for herbivores associated with leaves and fruits and their natural enemies, independently of the additional positive effects of resource availability (i.e. organ biomass or number of entities and, regarding natural enemies, herbivore species richness). We found a lower R-2 for pollinators compared to herbivores and natural enemies, probably caused by the high importance of flower characteristics for pollinator species richness besides plant size. Overall, the increase in plant height from 10 to 130 cm led to a 2.7-fold increase in predicted total arthropod species richness. In conclusion, plant size is a comprehensive driver of species richness of the plant associated arthropods, including pollinators, herbivores and their natural enemies, whether they are endophagous or ectophagous or associated with leaves or fruits.	[Schlinkert, Hella; Westphal, Catrin; Clough, Yann; Ludwig, Martin; Tscharntke, Teja] Univ Gottingen, Agroecol, D-37073 Gottingen, Germany; [Clough, Yann] Ctr Environm & Climate Res, Lund, Sweden; [Laszlo, Zoltan] Univ Babes Bolyai, Hungarian Dept Biol & Ecol, R-3400 Cluj Napoca, Romania; [Ludwig, Martin] Leibniz Univ Hannover, Inst Hort Prod Syst, Dept Phytomed, D-30167 Hannover, Germany	University of Gottingen; Babes Bolyai University from Cluj; Leibniz University Hannover	Schlinkert, H (corresponding author), Univ Gottingen, Agroecol, D-37073 Gottingen, Germany.	hella.schlinkert@agr.uni-goettingen.de	Laszlo, Zoltan/F-8651-2011; Westphal, Catrin/F-9560-2015; Tscharntke, Teja/N-5123-2014; Clough, Yann/B-9739-2014	Laszlo, Zoltan/0000-0001-5064-4785; Westphal, Catrin/0000-0002-2615-1339; Clough, Yann/0000-0002-2901-7602; Ludwig, Hella/0000-0001-7645-9529	State of Lower Saxony; University of Gottingen	State of Lower Saxony(European Commission); University of Gottingen	H.S. was supported by the State of Lower Saxony (Ministry of Science and Culture) in the frame of the Cluster of Excellence "Functional Biodiversity Research". The publication was funded by the University of Gottingen in the funding program Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, BIODIVERSITYR PACKAG; Araujo APA, 2006, AUSTRAL ECOL, V31, P343, DOI 10.1111/j.1442-9993.2006.01563.x; BACH CE, 1981, OECOLOGIA, V50, P370, DOI 10.1007/BF00344978; Barton K., MUMIN MULTIMODEL INF; Blanckenhorn WU, 2000, Q REV BIOL, V75, P385, DOI 10.1086/393620; BROWN JH, 1986, NATURE, V324, P248, DOI 10.1038/324248a0; Bruce TJA, 2005, TRENDS PLANT SCI, V10, P269, DOI 10.1016/j.tplants.2005.04.003; Buchanan AL, 2013, OECOLOGIA, V173, P473, DOI 10.1007/s00442-013-2629-4; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; BYRNE DN, 1991, ANNU REV ENTOMOL, V36, P431, DOI 10.1146/annurev.en.36.010191.002243; CHAO A, 1993, BIOMETRIKA, V80, P193, DOI 10.2307/2336768; COHEN D, 1993, EVOL BIOL, V27, P197; Donnelly SE, 1998, AM J BOT, V85, P1618, DOI 10.2307/2446490; Espirito-Santo MM, 2007, OECOLOGIA, V153, P353, DOI 10.1007/s00442-007-0737-8; Feeny P., 1976, BIOCHEMICAL INTERACT, V10, P1, DOI [10.1007/978-1-4684-2646-5_1, DOI 10.1007/978-1-4684-2646-5_1]; GEBER MA, 1985, ECOLOGY, V66, P762; Gomez JM, 2003, AM NAT, V162, P242, DOI 10.1086/376574; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; HAWKINS BA, 1990, ECOL ENTOMOL, V15, P275, DOI 10.1111/j.1365-2311.1990.tb00809.x; HAWKINS BA, 1987, NATURE, V326, P788, DOI 10.1038/326788a0; Haysom KA, 1998, ECOL ENTOMOL, V23, P377, DOI 10.1046/j.1365-2311.1998.00152.x; Hegland SJ, 2005, OECOLOGIA, V145, P586, DOI 10.1007/s00442-005-0165-6; Heiberger RM, HH STAT ANAL DATA DI; Hemptinne JL, 2012, BIOL INVASIONS, V14, P595, DOI 10.1007/s10530-011-0101-0; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; HODEK I, 1993, BIOCONTROL SCI TECHN, V3, P91, DOI 10.1080/09583159309355264; HUNTER MD, 1992, ECOLOGY, V73, P724; KAY QON, 1976, NATURE, V261, P230, DOI 10.1038/261230a0; KLINKHAMER PGL, 1989, OIKOS, V54, P201, DOI 10.2307/3565267; Klotz S, 2002, BIOLFLOR DATENBANK B; Knops JMH, 1999, ECOL LETT, V2, P286, DOI 10.1046/j.1461-0248.1999.00083.x; LAWTON JH, 1979, J ANIM ECOL, V48, P619, DOI 10.2307/4183; LAWTON JH, 1983, ANNU REV ENTOMOL, V28, P23, DOI 10.1146/annurev.en.28.010183.000323; Leong JM, 1999, ECOL ENTOMOL, V24, P329, DOI 10.1046/j.1365-2311.1999.00196.x; Maj A, 2011, IMMFIT GOODNESS OF F; McCormick AC, 2012, TRENDS PLANT SCI, V17, P303, DOI 10.1016/j.tplants.2012.03.012; Murchie AK, 1997, J CHEM ECOL, V23, P917, DOI 10.1023/B:JOEC.0000006380.59526.bd; NEUVONEN S, 1981, OECOLOGIA, V51, P364, DOI 10.1007/BF00540907; Ohashi K, 2002, FUNCT ECOL, V16, P492, DOI 10.1046/j.1365-2435.2002.00644.x; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Pinheiro J., NLME LINEAR NONLINEA; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; PRICE PW, 1991, OIKOS, V62, P244, DOI 10.2307/3545270; R Development Core Team, R LANG ENV STAT COMP; Raguso RA, 2008, ANNU REV ECOL EVOL S, V39, P549, DOI 10.1146/annurev.ecolsys.38.091206.095601; Remmel T, 2009, J ANIM ECOL, V78, P973, DOI 10.1111/j.1365-2656.2009.01566.x; Reudler Talsma JH, 2008, J CHEM ECOL, V34, P1202, DOI 10.1007/s10886-008-9519-y; Riihimaki J, 2006, ECOL ENTOMOL, V31, P227, DOI 10.1111/j.1365-2311.2006.00784.x; Rutledge CE, 1996, CHEMOECOLOGY, V7, P121, DOI 10.1007/BF01245964; Sabbahi R, 2005, J ECON ENTOMOL, V98, P367, DOI 10.1603/0022-0493-98.2.367; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Schlinkert H, 2014, PLANT SIZE GRADIENT, DOI [10.6084/m9.figshare.1246843, DOI 10.6084/M9.FIGSHARE.1246843]; SOUTHWOOD TRE, 1988, OIKOS, V52, P3, DOI 10.2307/3565974; Strong D., 1984, INSECTS PLANTS COMMU; TSCHARNTKE T, 1995, ANNU REV ENTOMOL, V40, P535, DOI 10.1146/annurev.en.40.010195.002535; Ulber B, 2010, BIOCONTROL-BASED INTEGRATED MANAGEMENT OF OILSEED RAPE PESTS, P45, DOI 10.1007/978-90-481-3983-5_2; WESTOBY M, 1984, ADV ECOL RES, V14, P167, DOI 10.1016/S0065-2504(08)60171-3; Williams IH, 2010, BIOCONTROL-BASED INTEGRATED MANAGEMENT OF OILSEED RAPE PESTS, P1, DOI 10.1007/978-90-481-3983-5_1; Williams IH, 2010, BIOCONTROL-BASED INTEGRATED MANAGEMENT OF OILSEED RAPE PESTS, P215, DOI 10.1007/978-90-481-3983-5_7; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	60	34	34	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135928	10.1371/journal.pone.0135928	http://dx.doi.org/10.1371/journal.pone.0135928			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291614	Green Published, Green Submitted, gold			2022-12-26	WOS:000359919900040
J	Silvestri, A; Palumbo, F; Rasi, I; Posca, D; Pavlidou, T; Paoluzi, S; Castagnoli, L; Cesareni, G				Silvestri, Alessandra; Palumbo, Francesco; Rasi, Ignazio; Posca, Daniela; Pavlidou, Theodora; Paoluzi, Serena; Castagnoli, Luisa; Cesareni, Giovanni			Metformin Induces Apoptosis and Downregulates Pyruvate Kinase M2 in Breast Cancer Cells Only When Grown in Nutrient-Poor Conditions	PLOS ONE			English	Article							PROTEIN-KINASE; DIABETIC-PATIENTS; TUMOR-CELLS; COMPLEX I; INHIBITION; METAANALYSIS; METABOLISM; INITIATION; EXPRESSION; THERAPY	Introduction Metformin is proposed as adjuvant therapy in cancer treatment because of its ability to limit cancer incidence by negatively modulating the PI3K/AKT/mTOR pathway. In vitro, in addition to inhibiting cancer cell proliferation, metformin can also induce apoptosis. The molecular mechanism underlying this second effect is still poorly characterized and published data are often contrasting. We investigated how nutrient availability can modulate metformin-induced apoptosis in three breast cancer cell lines. Material and Methods MCF7, SKBR3 and MDA-MB-231 cells were plated in MEM medium supplemented with increasing glucose concentrations or in DMEM medium and treated with 10 mM metformin. Cell viability was monitored by Trypan Blue assay and treatment effects on Akt/mTOR pathway and on apoptosis were analysed by Western Blot. Moreover, we determined the level of expression of pyruvate kinase M2 (PKM2), a well-known glycolytic enzyme expressed in cancer cells. Results Our results showed that metformin can induce apoptosis in breast cancer cells when cultured at physiological glucose concentrations and that the pro-apoptotic effect was completely abolished when cells were grown in high glucose/high amino acid medium. Induction of apoptosis was found to be dependent on AMPK activation but, at least partially, independent of TORC1 inactivation. Finally, we showed that, in nutrient-poor conditions, metformin was able to modulate the intracellular glycolytic equilibrium by downregulating PKM2 expression and that this mechanism was mediated by AMPK activation. Conclusion We demonstrated that metformin induces breast cancer cell apoptosis and PKM2 downregulation only in nutrient-poor conditions. Not only glucose levels but also amino acid concentration can influence the observed metformin inhibitory effect on the mTOR pathway as well as its pro-apoptotic effect. These data demonstrate that the reduction of nutrient supply in tumors can increase metformin efficacy and that modulation of PKM2 expression/activity could be a promising strategy to boost metformin anti-cancer effect.	[Silvestri, Alessandra; Palumbo, Francesco; Rasi, Ignazio; Posca, Daniela; Pavlidou, Theodora; Paoluzi, Serena; Castagnoli, Luisa; Cesareni, Giovanni] Univ Roma Tor Vergata, Dept Biol, Mol Genet Lab, I-00173 Rome, Italy; [Cesareni, Giovanni] Fdn Santa Lucia, IRCCS, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Rome Tor Vergata; IRCCS Santa Lucia	Silvestri, A (corresponding author), Cpo Cellular Phen & Oncol GmbH, Berlin, Germany.	silvestri.alessandra@gmail.com	Palumbo, Francesco/ABH-9395-2020; Cesareni, Gianni/AAW-1382-2020	Castagnoli, Luisa/0000-0001-5283-8671; Silvestri, Alessandra/0000-0003-4891-1826; Palumbo, Francesco/0000-0002-5352-6773	Ministry of Education, Italy [RBAP11LP2W]	Ministry of Education, Italy(Ministry of Education, Universities and Research (MIUR))	Funding provided by Ministry of Education, Italy; Grant Number: RBAP11LP2W; Grant Recipient: GC.	Adler AI, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1668; Alimova IN, 2009, CELL CYCLE, V8, P909, DOI 10.4161/cc.8.6.7933; Bailey CJ, 2008, CARDIOVASC DRUG THER, V22, P215, DOI 10.1007/s10557-008-6092-0; Berstein LM, 2011, MED ONCOL, V28, P1260, DOI 10.1007/s12032-010-9572-6; Blandino G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1859; BRINCK U, 1994, VIRCHOWS ARCH, V424, P177; Brunmair B, 2004, DIABETES, V53, P1052, DOI 10.2337/diabetes.53.4.1052; Chen GX, 2015, AM J CANCER RES, V5, P1423; Cheong JH, 2011, MOL CANCER THER, V10, P2350, DOI 10.1158/1535-7163.MCT-11-0497; Cossor FI, 2013, CANCER EPIDEMIOL, V37, P742, DOI 10.1016/j.canep.2013.04.015; DeCensi A, 2010, CANCER PREV RES, V3, P1451, DOI 10.1158/1940-6207.CAPR-10-0157; Deng XS, 2012, CELL CYCLE, V11, P367, DOI 10.4161/cc.11.2.18813; Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310; Dowling RJO, 2012, J MOL ENDOCRINOL, V48, pR31, DOI 10.1530/JME-12-0007; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Goldberg MS, 2012, J EXP MED, V209, P217, DOI 10.1084/jem.20111487; Gupta V, 2010, PROTEIN SCI, V19, P2031, DOI 10.1002/pro.505; Hwang YP, 2010, BRIT J PHARMACOL, V160, P1195, DOI 10.1111/j.1476-5381.2010.00762.x; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Israelsen WJ, 2013, CELL, V155, P397, DOI 10.1016/j.cell.2013.09.025; Janzer A, 2014, P NATL ACAD SCI USA, V111, P10574, DOI 10.1073/pnas.1409844111; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kalinsky K, 2014, CANCER INVEST, V32, P150, DOI 10.3109/07357907.2014.889706; Liu BL, 2009, CELL CYCLE, V8, P2031, DOI 10.4161/cc.8.13.8814; Lord JM, 2003, BRIT MED J, V327, P951, DOI 10.1136/bmj.327.7421.951; Malki A, 2011, ONCOL RES, V19, P275, DOI 10.3727/096504011X13021877989838; Marini C, 2013, CELL CYCLE, V12, P3490, DOI 10.4161/cc.26461; Meiers P, 2010, SAN ANTONIO BREAST S, V70; Menendez JA, 2012, CELL CYCLE, V11, P2782, DOI 10.4161/cc.20948; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; REINACHER M, 1981, VIRCHOWS ARCH B, V37, P79, DOI 10.1007/BF02892557; Steinberg P, 1999, VIRCHOWS ARCH, V434, P213, DOI 10.1007/s004280050330; Viollet B, 2012, CLIN SCI, V122, P253, DOI 10.1042/CS20110386; Wahdan-Alaswad R, 2013, CELL CYCLE, V12, P3759, DOI 10.4161/cc.26641; Zakikhani M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049513; Zakikhani M, 2010, BREAST CANCER RES TR, V123, P271, DOI 10.1007/s10549-010-0763-9; Zhuang YX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108444; Zhuang YX, 2011, MOL CANCER RES, V9, P603, DOI 10.1158/1541-7786.MCR-10-0343; Zordoky BNM, 2014, BBA-GEN SUBJECTS, V1840, P1943, DOI 10.1016/j.bbagen.2014.01.023	42	37	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136250	10.1371/journal.pone.0136250	http://dx.doi.org/10.1371/journal.pone.0136250			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291325	Green Published, Green Submitted, gold			2022-12-26	WOS:000359919900070
J	Lehtinen, S; Lees, J; Bahler, J; Shawe-Taylor, J; Orengo, C				Lehtinen, Sonja; Lees, Jon; Baehler, Juerg; Shawe-Taylor, John; Orengo, Christine			Gene Function Prediction from Functional Association Networks Using Kernel Partial Least Squares Regression	PLOS ONE			English	Article							PROTEIN FUNCTION; SPARSE PLS; ONTOLOGY; INTEGRATION; GENEMANIA	With the growing availability of large-scale biological datasets, automated methods of extracting functionally meaningful information from this data are becoming increasingly important. Data relating to functional association between genes or proteins, such as co-expression or functional association, is often represented in terms of gene or protein networks. Several methods of predicting gene function from these networks have been proposed. However, evaluating the relative performance of these algorithms may not be trivial: concerns have been raised over biases in different benchmarking methods and datasets, particularly relating to non-independence of functional association data and test data. In this paper we propose a new network-based gene function prediction algorithm using a commute-time kernel and partial least squares regression (Compass). We compare Compass to GeneMANIA, a leading network-based prediction algorithm, using a number of different benchmarks, and find that Compass outperforms GeneMANIA on these benchmarks. We also explicitly explore problems associated with the non-independence of functional association data and test data. We find that a benchmark based on the Gene Ontology database, which, directly or indirectly, incorporates information from other databases, may considerably overestimate the performance of algorithms exploiting functional association data for prediction.	[Lehtinen, Sonja] UCL, CoMPLEX, London, England; [Lehtinen, Sonja; Lees, Jon; Orengo, Christine] UCL, Inst Struct & Mol Biol, London, England; [Baehler, Juerg] UCL, Dept Genet Evolut & Environm, London, England; [Shawe-Taylor, John] UCL, Dept Comp Sci, London, England	University of London; University College London; University of London; Birkbeck University London; University College London; University of London; University College London; University of London; University College London	Orengo, C (corresponding author), UCL, Inst Struct & Mol Biol, London, England.	c.orengo@ucl.ac.uk	Bahler, Jurg/B-4572-2009	Bahler, Jurg/0000-0003-4036-1532; Shawe-Taylor, John/0000-0002-2030-0073	Biotechnology and Biological Sciences Research Council [974619, BB/M020088/1] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/L002817/1] Funding Source: Medline; Medical Research Council [MR/K006584/1] Funding Source: Medline; Wellcome Trust [095598] Funding Source: Medline; BBSRC [BB/L002817/1, BB/M020088/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; Bastien P, 2015, BIOINFORMATICS, V31, P397, DOI 10.1093/bioinformatics/btu660; Cao KAL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-253; CASTILLO LP, 2008, GENOME BIOL S1, V9, pS2, DOI DOI 10.1186/GB-2008-9-S1-S2; Chen BR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069084; Deng MH, 2003, J COMPUT BIOL, V10, P947, DOI 10.1089/106652703322756168; Dessimoz C, 2013, TRENDS GENET, V29, P609, DOI 10.1016/j.tig.2013.09.005; Gillis Jesse, 2013, BMC Bioinformatics, V14 Suppl 3, pS15; Gillis J, 2013, BIOINFORMATICS, V29, P476, DOI 10.1093/bioinformatics/bts727; Gillis J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017258; Heriche JK, 2014, MOL BIOL CELL, V25, P2522, DOI 10.1091/mbc.E13-04-0221; Ito H, 2010, J BIOL CHEM, V285, P34616, DOI 10.1074/jbc.M110.175562; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kourmpetis YAI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009293; Lanckriet GRG, 2003, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2004, P300; Lee H, 2006, OMICS, V10, P40, DOI 10.1089/omi.2006.10.40; Lees JG, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035008; Letovsky S, 2003, BIOINFORMATICS, V19, pi197, DOI 10.1093/bioinformatics/btg1026; Montojo J, 2010, BIOINFORMATICS, V26, P2927, DOI 10.1093/bioinformatics/btq562; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Nabieva E, 2005, BIOINFORMATICS, V21, pI302, DOI 10.1093/bioinformatics/bti1054; Perez-Enciso M, 2003, HUM GENET, V112, P581, DOI 10.1007/s00439-003-0921-9; Radivojac P, 2013, NAT METHODS, V10, P221, DOI [10.1038/NMETH.2340, 10.1038/nmeth.2340]; Rao V Srinivasa, 2014, Int J Proteomics, V2014, P147648, DOI 10.1155/2014/147648; Rogers MF, 2009, BIOINFORMATICS, V25, P1173, DOI 10.1093/bioinformatics/btp122; Roux AE, 2006, AGING CELL, V5, P345, DOI 10.1111/j.1474-9726.2006.00225.x; Schmidt EE, 2013, NUCLEIC ACIDS RES, V41, pD1021, DOI 10.1093/nar/gks1170; Shawe-Taylor J, 2004, KERNEL METHODS FOR P; Sideri T, 2014, PARALLEL PROFILING O, VG3; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Tsuda K, 2005, BIOINFORMATICS, V21, P59, DOI 10.1093/bioinformatics/bti1110; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Yen L, 2007, LECT NOTES COMPUT SC, V4426, P1037	35	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0134668	10.1371/journal.pone.0134668	http://dx.doi.org/10.1371/journal.pone.0134668			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288239	Green Published, Green Submitted, gold			2022-12-26	WOS:000360018600027
J	Li, JW; Kendall, G				Li, Jiawei; Kendall, Graham			On Nash Equilibrium and Evolutionarily Stable States That Are Not Characterised by the Folk Theorem	PLOS ONE			English	Article							ITERATED PRISONERS-DILEMMA; REPEATED GAMES; COOPERATION; EMERGENCE; EXTORTION; STABILITY	In evolutionary game theory, evolutionarily stable states are characterised by the folk theorem because exact solutions to the replicator equation are difficult to obtain. It is generally assumed that the folk theorem, which is the fundamental theory for non-cooperative games, defines all Nash equilibria in infinitely repeated games. Here, we prove that Nash equilibria that are not characterised by the folk theorem do exist. By adopting specific reactive strategies, a group of players can be better off by coordinating their actions in repeated games. We call it a type-k equilibrium when a group of k players coordinate their actions and they have no incentive to deviate from their strategies simultaneously. The existence and stability of the type-k equilibrium in general games is discussed. This study shows that the sets of Nash equilibria and evolutionarily stable states have greater cardinality than classic game theory has predicted in many repeated games.	[Li, Jiawei; Kendall, Graham] Univ Nottingham, ASAP Res Grp, Sch Comp Sci, Nottingham NG8 1BB, England; [Kendall, Graham] Univ Nottingham, Sch Comp Sci, Semenyih 43500, Selangor Darul, Malaysia	University of Nottingham; University of Nottingham Malaysia	Li, JW (corresponding author), Univ Nottingham, ASAP Res Grp, Sch Comp Sci, Jubilee Campus,Wollaton Rd, Nottingham NG8 1BB, England.	jiawei.li@nottingham.ac.uk		Li, Jiawei/0000-0003-4685-2615	Engineering and Physical Sciences Research Council UK [EP/H000968/1]	Engineering and Physical Sciences Research Council UK(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by Engineering and Physical Sciences Research Council UK EP/H000968/1 (http://gow.epsrc.ac.uk/NGBOViewGrant.aspx?GrantRef=EP/H000968/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABREU D, 1994, ECONOMETRICA, V62, P939, DOI 10.2307/2951739; Aumann R., 1970, VALUES NONATOMIC GAM; Aumann RJ, 1959, CONTRIBUTIONS THEORY, VIV; Baye MR, 1999, ECON LETT, V65, P59, DOI 10.1016/S0165-1765(99)00118-4; Braun DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000468; Cressman R, 2003, ECON LEARN SOC EVOL, P1; Cressman R, 2014, P NATL ACAD SCI USA, V111, P10810, DOI 10.1073/pnas.1400823111; DUTTA PK, 1995, J ECON THEORY, V66, P1, DOI 10.1006/jeth.1995.1030; Ely JC, 2002, J ECON THEORY, V102, P84, DOI 10.1006/jeth.2000.2774; FERRIERE R, 1995, P ROY SOC B-BIOL SCI, V259, P77, DOI 10.1098/rspb.1995.0012; FRIEDMAN JW, 1971, REV ECON STUD, V38, P1, DOI 10.2307/2296617; FUDENBERG D, 1986, ECONOMETRICA, V54, P533, DOI 10.2307/1911307; FUDENBERG D, 1991, J ECON THEORY, V54, P26, DOI 10.1016/0022-0531(91)90103-B; Hauert C, 1997, P ROY SOC B-BIOL SCI, V264, P513, DOI 10.1098/rspb.1997.0073; Hilbe C, 2013, P NATL ACAD SCI USA, V110, P6913, DOI 10.1073/pnas.1214834110; Horner J, 2006, ECONOMETRICA, V74, P1499, DOI 10.1111/j.1468-0262.2006.00717.x; Killingback T, 1999, P ROY SOC B-BIOL SCI, V266, P1723, DOI 10.1098/rspb.1999.0838; Krams I, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1475; Li JW, 2013, IEEE T CYBERNETICS, V43, P2044, DOI 10.1109/TCYB.2013.2239986; Li JW, 2013, IEEE T COMP INTEL AI, V5, P242, DOI 10.1109/TCIAIG.2013.2261894; Li JW, 2011, IEEE T COMP INTEL AI, V3, P348, DOI 10.1109/TCIAIG.2011.2166268; MATSUSHIMA H, 1991, ECON LETT, V35, P253, DOI 10.1016/0165-1765(91)90139-C; Maynard Smith J., 1982, pi; McCabe KA, 2000, P NATL ACAD SCI USA, V97, P3777, DOI 10.1073/pnas.040577397; Meloni S, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.067101; Mertens JF, 2004, INT J GAME THEORY, V32, P387, DOI 10.1007/s001820400166; Moreno D, 1996, GAME ECON BEHAV, V17, P80, DOI 10.1006/game.1996.0095; Nowak MA, 2004, NATURE, V428, P646, DOI 10.1038/nature02414; Obara I, 2009, J ECON THEORY, V144, P120, DOI 10.1016/j.jet.2007.08.005; Olson M., 2009, LOGIC COLLECTIVE ACT, V124; Perc M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015117; Poncela J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002449; Press WH, 2012, P NATL ACAD SCI USA, V109, P10409, DOI 10.1073/pnas.1206569109; RUBINSTEIN A, 1979, J ECON THEORY, V21, P1, DOI 10.1016/0022-0531(79)90002-4; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Shenoy P. P., 1979, International Journal of Game Theory, V8, P133, DOI 10.1007/BF01770064; Stewart AJ, 2012, P NATL ACAD SCI USA, V109, P10134, DOI 10.1073/pnas.1208087109; Wen Q, 2002, REV ECON STUD, V69, P493, DOI 10.1111/1467-937X.00214	38	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136032	10.1371/journal.pone.0136032	http://dx.doi.org/10.1371/journal.pone.0136032			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288088	Green Submitted, gold, Green Published			2022-12-26	WOS:000360018600099
J	Singh, V; Pandita, SK; Tewari, R; van Hengstum, PJ; Pillai, SSK; Agnihotri, D; Kumar, K; Bhat, GD				Singh, Vartika; Pandita, Sundeep K.; Tewari, Rajni; van Hengstum, Peter J.; Pillai, Suresh S. K.; Agnihotri, Deepa; Kumar, Kamlesh; Bhat, G. D.			Thecamoebians (Testate Amoebae) Straddling the Permian-Triassic Boundary in the Guryul Ravine Section, India: Evolutionary and Palaeoecological Implications	PLOS ONE			English	Article							VASE-SHAPED MICROFOSSILS; MASS-EXTINCTION; ARCELLACEANS THECAMOEBIANS; MOLECULAR PHYLOGENY; BRITISH-COLUMBIA; CARBON-ISOTOPE; CHUAR GROUP; MARINE; BASIN; CLASSIFICATION	Exceptionally well-preserved organic remains of thecamoebians (testate amoebae) were preserved in marine sediments that straddle the greatest extinction event in the Phanerozoic: the Permian-Triassic Boundary. Outcrops from the Late Permian Zewan Formation and the Early Triassic Khunamuh Formation are represented by a complete sedimentary sequence at the Guryul Ravine Section in Kashmir, India, which is an archetypal Permian-Triassic boundary sequence [1]. Previous biostratigraphic analysis provides chronological control for the section, and a perspective of faunal turnover in the brachiopods, ammonoids, bivalves, conodonts, gastropods and foraminifera. Thecamoebians were concentrated from bulk sediments using palynological procedures, which isolated the organic constituents of preserved thecamoebian tests. The recovered individuals demonstrate exceptional similarity to the modern thecamoebian families Centropyxidae, Arcellidae, Hyalospheniidae and Trigonopyxidae, however, the vast majority belong to the Centropyxidae. This study further confirms the morphologic stability of the thecamoebian lineages through the Phanerozoic, and most importantly, their apparent little response to an infamous biological crisis in Earth's history.	[Singh, Vartika; Tewari, Rajni; Pillai, Suresh S. K.; Agnihotri, Deepa; Kumar, Kamlesh] Birbal Sahni Inst Paleobot, Lucknow 226007, Uttar Pradesh, India; [Pandita, Sundeep K.] Univ Jammu, Dept Geol, Jammu 180006, India; [van Hengstum, Peter J.] Texas A&M Univ, Dept Marine Sci, Galveston, TX 77553 USA; [Bhat, G. D.] Jammu & Kashmir Govt, Directorate Geol & Min, Srinagar 190002, Jammu & Kashmir, India	Department of Science & Technology (India); Birbal Sahni Institute of Palaeobotany (BSIP); University of Jammu; Texas A&M University System	Tewari, R (corresponding author), Birbal Sahni Inst Paleobot, 53 Univ Rd, Lucknow 226007, Uttar Pradesh, India.	rajni_tewari@bsip.res.in	van Hengstum, Pete/AHC-5291-2022	van Hengstum, Pete/0000-0002-1125-2858	Birbal Sahni Institute of Palaeobotany, India	Birbal Sahni Institute of Palaeobotany, India(Department of Science & Technology (India))	Funding: This work was supported by the Birbal Sahni Institute of Palaeobotany, India.	Algeo T, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001823; Algeo TJ, 2007, PALAEOGEOGR PALAEOCL, V252, P328, DOI 10.1016/j.palaeo.2006.11.050; Algeo TJ, 2013, GLOBAL PLANET CHANGE, V105, P52, DOI 10.1016/j.gloplacha.2012.02.008; B RADLEY, 1931, US GEOLOGICAL SURVEY, P58; Bassi D, 2008, PALAEONTOLOGY, V51, P1335, DOI 10.1111/j.1475-4983.2008.00817.x; Bhat GM., 1997, GEOLOGY S ASIA 2 GEO, V7, P205; Boeuf O, 1997, CR ACAD SCI II A, V325, P623, DOI 10.1016/S1251-8050(97)89464-5; Bowring SA, 1998, SCIENCE, V280, P1039, DOI 10.1126/science.280.5366.1039; Brookfield ME, 2003, PALAEOGEOGR PALAEOCL, V198, P353, DOI 10.1016/S0031-0182(03)00476-0; Burgess SD, 2014, P NATL ACAD SCI USA, V111, P1; Carpenter W B, 1861, NATURAL HIST REV, V1, P456; Carter HJ., 1856, ANN MAG NAT HIST, V18, P221, DOI DOI 10.1080/00222935608697625; Cavalier-Smith T, 1998, BIOL REV, V73, P203, DOI 10.1017/S0006323198005167; Cavalier-Smith T, 2004, EUR J PROTISTOL, V40, P21, DOI 10.1016/j.ejop.2003.10.001; Cavalier-Smith T, 2009, J EUKARYOT MICROBIOL, V56, P26, DOI 10.1111/j.1550-7408.2008.00373.x; Charman DJ, 1998, HOLOCENE, V8, P209, DOI 10.1191/095968398676389446; Charman DJ, 2000, QUATERNARY RES ASS T, V9, P147, DOI DOI 10.1016/J.QUASCIREV.2004.03.008; DEFLANDRE GEORGES, 1929, ARCH PROTISTENK, V67, P322; Ehrenberg C. G., 1838, BLICK TIEFERE ORGANI; Ehrenberg C. G., 1841, KONIGLICHE AKADEMIE, P81; Ehrenberg C. G., 1832, PHYS ABHANDLUNGEN, P1; Erwin D. H, 1993, GREAT PALEOZOIC CRIS; ERWIN DH, 1994, NATURE, V367, P231, DOI 10.1038/367231a0; Farooqui A, 2014, EUR J PROTISTOL, V50, P89, DOI 10.1016/j.ejop.2013.05.003; Foissner W, 2001, EUR J PROTISTOL, V37, P167, DOI 10.1078/0932-4739-00012; Foissner W, 2000, ACTA PROTOZOOL, V39, P257; Frenguelli G., 1933, BULLETTINO UNIONE MA, V52, P33; FURNISH WM, 1973, SCIENCE, V180, P188, DOI 10.1126/science.180.4082.188; Gehrels WR, 2001, J QUATERNARY SCI, V16, P201, DOI 10.1002/jqs.588; Henderson C.M., 1997, P 30 INT GEOL C, V11, P143; Henderson CM, 1997, B CAN PETROL GEOL, V45, P693; Isozaki Y, 1997, SCIENCE, V276, P235, DOI 10.1126/science.276.5310.235; Jennings HS, 1916, GENETICS, V1, P407; Jin YG, 2000, SCIENCE, V289, P432, DOI 10.1126/science.289.5478.432; Jung W., 1942, ARCH PRO TISTENK, V95, P253; Kaiho K, 2001, GEOLOGY, V29, P815, DOI 10.1130/0091-7613(2001)029<0815:EPCBAB>2.0.CO;2; Kapoor HM, 1996, PALEOZOIC MESOZOIC B; Kent WS, 1880, MANUAL INFUSORIA INC, P472; Korte C, 2010, J ASIAN EARTH SCI, V37, P293, DOI 10.1016/j.jseaes.2009.08.012; Kovary J., 1956, Foldtani Kozlony, V86, P266; Krull ES, 2004, PALAEOGEOGR PALAEOCL, V204, P297, DOI 10.1016/S0031-0182(03)00732-6; Krystyn L, 2003, PALAEOGEOGR PALAEOCL, V191, P329, DOI 10.1016/S0031-0182(02)00670-3; Kumar A, 2011, J MICROPALAEONTOL, V30, P75, DOI 10.1144/0262-821X10-021; Kumar Arun, 1998, Palaeontologia Electronica, V1, pUnpaginated; LOIEBLICH JR. A. R., 1964, TREATISE INVERTEBRAT; Martin-Gonzalez A, 2009, NATURWISSENSCHAFTEN, V96, P551, DOI 10.1007/s00114-009-0508-y; MATSUDA T, 1984, Journal of Geosciences Osaka City University, V27, P119; MATSUDA T, 1983, Journal of Geosciences Osaka City University, V26, P87; MATSUDA T, 1982, Journal of Geosciences Osaka City University, V25, P87; Matsuda T., 1981, Journal of Geosciences Osaka City University, V24, P75; Medioli F.S., 1999, Palaeontologia Electronica, V2, P1; MEDIOLI FS, 1990, NATO ADV SCI I C-MAT, V327, P813; MEDIOLI FS, 1987, J FORAMIN RES, V17, P28, DOI 10.2113/gsjfr.17.1.28; MEDIOLI FS, 1990, NATO ADV SCI I C-MAT, V327, P793; Medioli FS, 1983, SPECIAL PUBLICATION, V21, P63; Medioli FS, 2003, PALAEONTOL ELECTRON, V6, P1; Mundil R, 2001, EARTH PLANET SC LETT, V187, P131, DOI 10.1016/S0012-821X(01)00274-6; Mundil R, 2004, SCIENCE, V305, P1760, DOI 10.1126/science.1101012; Nakazawa K, 1981, PALAEONTOLOGIA INDIC, V46, P1; Nakazawa K, 1975, SERIES GEOLOGY MINER, V41, P1; Ogden C.G., 1980, ATLAS FRESHWATER TES; Patterson RT, 2002, J PALEOLIMNOL, V28, P297, DOI 10.1023/A:1021621622090; Pawlowski J, 2009, J EUKARYOT MICROBIOL, V56, P16, DOI 10.1111/j.1550-7408.2008.00379.x; Penard E., 1902; POINAR GO, 1993, SCIENCE, V259, P222, DOI 10.1126/science.259.5092.222; Porter SM, 2000, PALEOBIOLOGY, V26, P360, DOI 10.1666/0094-8373(2000)026<0360:TAITNE>2.0.CO;2; Porter SM, 2003, J PALEONTOL, V77, P409, DOI 10.1666/0022-3360(2003)077<0409:VMFTNC>2.0.CO;2; Proemse BC, 2013, GEOLOGY, V41, P967, DOI 10.1130/G34466.1; Reinhardt EG, 2006, GEOLOGY, V34, P1061, DOI 10.1130/G22780A.1; Retallack GJ, 2003, GEOL SOC AM BULL, V115, P1133, DOI 10.1130/B25215.1; Sarkar A, 2003, PALAEOGEOGR PALAEOCL, V191, P1, DOI 10.1016/S0031-0182(02)00636-3; Schiller W., 1999, MAINZER NATURWISS AR, V37, P55; Schiller Wolfgang, 1997, Courier Forschungsinstitut Senckenberg, V201, P385; Schiller Wolfgang, 1998, Geologische Abhandlungen Hessen, V104, P173; Schmidt AR, 2004, PALAEONTOLOGY, V47, P185, DOI 10.1111/j.0031-0239.2004.00368.x; Schmidt AR, 2001, CRETACEOUS RES, V22, P423, DOI 10.1006/cres.2001.0267; Schonborn W, 1999, J EUKARYOT MICROBIOL, V46, P571, DOI 10.1111/j.1550-7408.1999.tb05133.x; Schultze F. E, 1877, ARCH MIKROSKOPISCHE, V13, P9; SCOTT D. B., 2001, MONITORING COASTAL E; Shen Shu Zhong, 2006, Palaeoworld, V15, P3, DOI 10.1016/j.palwor.2006.03.005; Shen SZ, 2011, SCIENCE, V334, P1367, DOI 10.1126/science.1213454; Shen SZ, 2002, PALEOBIOLOGY, V28, P449, DOI 10.1666/0094-8373(2002)028<0449:PEPOPB>2.0.CO;2; Smirnov A, 2005, PROTIST, V156, P129, DOI 10.1016/j.protis.2005.06.002; Smirnov AV, 2011, PROTIST, V162, P545, DOI 10.1016/j.protis.2011.04.004; Smith RMH, 2001, GEOLOGY, V29, P1147, DOI 10.1130/0091-7613(2001)029<1147:POVEAA>2.0.CO;2; Song HJ, 2013, NAT GEOSCI, V6, P52, DOI [10.1038/NGEO1649, 10.1038/ngeo1649]; Tewari R, 2014, EARTH SCI IN PRESS; Twitchett RJ, 2004, GEOLOGY, V32, P805, DOI 10.1130/G20585.1; Twitchett RJ, 2001, GEOLOGY, V29, P351, DOI 10.1130/0091-7613(2001)029<0351:RASCOM>2.0.CO;2; van Hengstum PJ, 2008, J FORAMIN RES, V38, P305, DOI 10.2113/gsjfr.38.4.305; van Hengstum PJ, 2007, J FORAMIN RES, V37, P300, DOI 10.2113/gsjfr.37.4.300; van Hengstum PJ, 2010, QUATERNARY SCI REV, V29, P2788, DOI 10.1016/j.quascirev.2010.06.034; Vasicek M., 1957, Acta Musei Nationalis Pragae, V13B, P333; VONSTEIN SFN, 1859, KONIGLICHE BOHMISHCE, V10, P41; Waggoner Benjamin M., 1996, Paleobios, V17, P20; Waggoner Benjamin M., 1996, Paleobios, V17, P17; WANG K, 1994, GEOLOGY, V22, P580, DOI 10.1130/0091-7613(1994)022<0580:PTEOCE>2.3.CO;2; WIGHTMAN WG, 1994, PALAEOGEOGR PALAEOCL, V106, P187, DOI 10.1016/0031-0182(94)90010-8; WIGNALL PB, 1992, PALAEOGEOGR PALAEOCL, V93, P21, DOI 10.1016/0031-0182(92)90182-5; Wignall PB, 2003, PALAIOS, V18, P153, DOI 10.1669/0883-1351(2003)18<153:CDRFTU>2.0.CO;2; Wignall PB, 1998, GEOL MAG, V135, P47, DOI 10.1017/S0016756897008121; Wolf Monika, 1995, Palaeontologische Zeitschrift, V69, P1; Woodland WA, 1998, HOLOCENE, V8, P261, DOI 10.1191/095968398667004497	103	16	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135593	10.1371/journal.pone.0135593	http://dx.doi.org/10.1371/journal.pone.0135593			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288245	Green Submitted, Green Published, gold			2022-12-26	WOS:000360018600057
J	Schiavano, GF; De Santi, M; Brandi, G; Fanelli, M; Bucchini, A; Giamperi, L; Giomaro, G				Schiavano, Giuditta Fiorella; De Santi, Mauro; Brandi, Giorgio; Fanelli, Mirco; Bucchini, Anahi; Giamperi, Laura; Giomaro, Giovanna			Inhibition of Breast Cancer Cell Proliferation and In Vitro Tumorigenesis by a New Red Apple Cultivar	PLOS ONE			English	Article							ANTIPROLIFERATIVE ACTIVITY; ANTIOXIDANT ACTIVITY; MAMMARY-TUMORS; FLAVONOIDS; COLON; VEGETABLES; APOPTOSIS; FRUIT; JUICE; CHEMOPREVENTION	Purpose The aim of this study was to evaluate the antiproliferative activity in breast cancer cells and the inhibition of tumorigenesis in pre-neoplastic cells of a new apple cultivar with reddish pulp, called the Pelingo apple. Methods The antiproliferative activity was evaluated in MCF-7 and MDA-MB-231 human breast cancer cells. The inhibition of tumorigenesis was performed in JB6 promotion-sensitive (P+) cells. Results Results showed that Pelingo apple juice is characterized by a very high polyphenol content and strongly inhibited breast cancer cell proliferation. Its antiproliferative activity was found to be higher than the other five apple juices tested. Pelingo juice induced cell accumulation in the G2/M phase of the cell cycle and autophagy through overexpression of p21, inhibition of extracellular signal-regulated kinases 1/2 (ERK1/2) activity and an increase in lipidated microtubule-associated protein-1 light chain-3 beta (LC3B). Remarkably, Pelingo juice inhibited the 12-o-tetra-decanoyl-phorbol-13-acetate (TPA)-induced tumorigenesis of JB6 P+ cells, suppressing colony formation in semi-solid medium and TPA-induced ERK1/2 phosphorylation. Conclusions Our data indicate that the Pelingo apple is rich in food components that can markedly inhibit in vitro tumorigenesis and growth of human breast cancer cells and could provide natural bioactive non-nutrient compounds, with potential chemopreventive activity.	[Schiavano, Giuditta Fiorella; De Santi, Mauro; Brandi, Giorgio; Fanelli, Mirco] Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, PU, Italy; [Bucchini, Anahi; Giamperi, Laura; Giomaro, Giovanna] Univ Urbino Carlo Bo, Dept Earth Life & Environm Sci, Urbino, PU, Italy	University of Urbino; University of Urbino	Schiavano, GF (corresponding author), Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, PU, Italy.	giuditta.schiavano@uniurb.it	De Santi, Mauro/F-5401-2013; Fanelli, Mirco/F-2665-2011	De Santi, Mauro/0000-0003-2983-8344; Fanelli, Mirco/0000-0002-9649-8661; Schiavano, Giuditta Fiorella/0000-0002-1427-3486; Bucchini, Anahi Elena Ada/0000-0003-3100-9262; Brandi, Giorgio/0000-0003-1380-6137				Amatori S, 2010, BRIT J CANCER, V103, P239, DOI 10.1038/sj.bjc.6605745; Barth SW, 2005, CARCINOGENESIS, V26, P1414, DOI 10.1093/carcin/bgi082; BLOCK G, 1992, NUTR CANCER, V18, P1, DOI 10.1080/01635589209514201; Boeing H, 2012, EUR J NUTR, V51, P637, DOI 10.1007/s00394-012-0380-y; Boyer J, 2004, NUTR J, V3, DOI 10.1186/1475-2891-3-5; Brandi G, 2005, J NUTR, V135, P1503, DOI 10.1093/jn/135.6.1503; Brandi G, 2003, CANCER RES, V63, P4028; Chen MS, 2004, IN VIVO, V18, P73; Dalla Ragione L., 2006, ARCHEOLOGIA ARBOREA, P102; Danaei G, 2005, LANCET, V366, P1784, DOI 10.1016/S0140-6736(05)67725-2; de Pascual-Teresa Sonia, 2008, Phytochemistry Reviews, V7, P281, DOI 10.1007/s11101-007-9074-0; De Santi M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2855; Eberhardt MV, 2000, NATURE, V405, P903, DOI 10.1038/35016148; Elisia I, 2007, FOOD CHEM, V101, P1052, DOI 10.1016/j.foodchem.2006.02.060; Fraternale D, 2011, REC NAT PROD, V5, P202; Gallus S, 2005, ANN ONCOL, V16, P1841, DOI 10.1093/annonc/mdi361; Galluzzi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043249; Gescher AJ, 2008, PLANTA MED, V74, P1523, DOI 10.1055/s-0028-1088300; Giomaro G, 2014, CHEM CENT J, V8, DOI 10.1186/1752-153X-8-45; HAGERMAN AE, 1994, METHOD ENZYMOL, V234, P429; He X, 2008, J AGR FOOD CHEM, V56, P9905, DOI 10.1021/jf8015255; He XJ, 2007, J AGR FOOD CHEM, V55, P4366, DOI 10.1021/jf063563o; Hyson DA, 2011, ADV NUTR, V2, P408, DOI 10.3945/an.111.000513; Kang NJ, 2011, PHARMACOL THERAPEUT, V130, P310, DOI 10.1016/j.pharmthera.2011.02.004; Key TJ, 2011, BRIT J CANCER, V104, P6, DOI 10.1038/sj.bjc.6606032; Knekt P, 1997, AM J EPIDEMIOL, V146, P223, DOI 10.1093/oxfordjournals.aje.a009257; Vieira FGK, 2009, ARCH LATINOAM NUTR, V59, P101; Kuntz S, 1999, EUR J NUTR, V38, P133, DOI 10.1007/s003940050054; Lagiou P, 2004, CANCER CAUSE CONTROL, V15, P67, DOI 10.1023/B:CACO.0000016619.18041.b0; Le Marchand L, 2000, JNCI-J NATL CANCER I, V92, P154, DOI 10.1093/jnci/92.2.154; Li JX, 2012, CARCINOGENESIS, V33, P459, DOI 10.1093/carcin/bgr281; Liu JR, 2009, J AGR FOOD CHEM, V57, P297, DOI 10.1021/jf801826w; Liu R. H., 2001, NY FRUIT Q, V9, P15; Liu RH, 2004, J NUTR, V134, p3479S, DOI 10.1093/jn/134.12.3479S; Liu RH, 2005, J AGR FOOD CHEM, V53, P2341, DOI 10.1021/jf058010c; Liu X, 2004, ONCOGENE, V23, P763, DOI 10.1038/sj.onc.1207188; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mari A, 2010, FOOD CHEM, V123, P157, DOI 10.1016/j.foodchem.2010.04.023; McCann MJ, 2007, FOOD CHEM TOXICOL, V45, P1224, DOI 10.1016/j.fct.2007.01.003; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; Pedro M, 2006, TOXICOL LETT, V164, P24, DOI 10.1016/j.toxlet.2005.11.007; Peterson J, 2003, BRIT J CANCER, V89, P1255, DOI 10.1038/sj.bjc.6601271; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Sporn MB, 2002, NAT REV CANCER, V2, P537, DOI 10.1038/nrc844; Steeves MA, 2010, CURR OPIN CELL BIOL, V22, P218, DOI 10.1016/j.ceb.2009.12.013; Steward WP, 2013, BRIT J CANCER, V109, P1, DOI 10.1038/bjc.2013.280; Sun J, 2002, J AGR FOOD CHEM, V50, P7449, DOI 10.1021/jf0207530; Sun J, 2008, J AGR FOOD CHEM, V56, P11661, DOI 10.1021/jf8021223; Tow WW, 2011, J FOOD SCI, V76, pT163, DOI 10.1111/j.1750-3841.2011.02314.x; Tzulker R, 2007, J AGR FOOD CHEM, V55, P9559, DOI 10.1021/jf071413n; Veeriah S, 2006, MOL CARCINOGEN, V45, P164, DOI 10.1002/mc.20158; Wendt J, 2006, ONCOGENE, V25, P972, DOI 10.1038/sj.onc.1209031; Willett WC, 1995, ENVIRON HEALTH PERSP, V103, P165, DOI 10.2307/3432305; Willett WC, 2002, SCIENCE, V296, P695, DOI 10.1126/science.1071055; Zessner H, 2008, MOL NUTR FOOD RES, V52, pS28, DOI 10.1002/mnfr.200700317	56	22	23	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135840	10.1371/journal.pone.0135840	http://dx.doi.org/10.1371/journal.pone.0135840			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284516	gold, Green Submitted, Green Published			2022-12-26	WOS:000359666100073
J	Winklewski, PJ; Tkachenko, Y; Mazur, K; Kot, J; Gruszecki, M; Guminski, W; Czuszynski, K; Wtorek, J; Frydrychowski, AF				Winklewski, Pawel J.; Tkachenko, Yurii; Mazur, Kamila; Kot, Jacek; Gruszecki, Marcin; Guminski, Wojciech; Czuszynski, Krzysztof; Wtorek, Jerzy; Frydrychowski, Andrzej F.			Sympathetic Activation Does Not Affect the Cardiac and Respiratory Contribution to the Relationship between Blood Pressure and Pial Artery Pulsation Oscillations in Healthy Subjects	PLOS ONE			English	Article							AUTONOMIC NERVOUS-SYSTEM; SUBARACHNOID SPACE; FUNDAMENTAL RELATIONSHIPS; CEREBRAL AUTOREGULATION; NONINVASIVE METHOD; WAVELET TRANSFORM; ACUTE HYPOTENSION; CROSS-TALK; FLOW; WIDTH	Introduction Using a novel method called near-infrared transillumination backscattering sounding (NIR-T/BSS) that allows for the non-invasive measurement of pial artery pulsation (cc-TQ) and subarachnoid width (sas-TQ) in humans, we assessed the influence of sympathetic activation on the cardiac and respiratory contribution to blood pressure (BP) cc-TQ oscillations in healthy subjects. Methods The pial artery and subarachnoid width response to handgrip (HGT) and cold test (CT) were studied in 20 healthy subjects. The cc-TQ and sas-TQ were measured using NIR-T/BSS; cerebral blood flow velocity (CBFV) was measured using Doppler ultrasound of the left internal carotid artery; heart rate (HR) and beat-to-beat mean BP were recorded using a continuous finger-pulse photoplethysmography; respiratory rate (RR), minute ventilation (MV), end-tidal CO2 (EtCO2) and end-tidal O-2 (EtO2) were measured using a metabolic and spirometry module of the medical monitoring system. Wavelet transform analysis was used to assess the relationship between BP and cc-TQ oscillations. Results HGT evoked an increase in BP (+15.9%; P<0.001), HR (14.7; P<0.001), SaO(2) (+0.5; P<0.001) EtO2 (+2.1; P<0.05) RR (+9.2%; P = 0.05) and MV (+15.5%; P<0.001), while sasTQ was diminished (-8.12%; P<0.001), and a clear trend toward cc-TQ decline was observed (-11.0%; NS). CBFV (+2.9%; NS) and EtCO2 (-0.7; NS) did not change during HGT. CT evoked an increase in BP (+7.4%; P<0.001), sas-TQ (+3.5%; P<0.05) and SaO(2)(+0.3%; P<0.05). HR (+2.3%; NS), CBFV (+2.0%; NS), EtO2 (-0.7%; NS) and EtCO2 (+0.9%; NS) remained unchanged. A trend toward decreased cc-TQ was observed (-5.1%; NS). The sas-TQ response was biphasic with elevation during the first 40 seconds (+8.8% vs. baseline; P<0.001) and subsequent decline (+4.1% vs. baseline; P<0.05). No change with respect to wavelet coherence and wavelet phase coherence was found between the BP and cc-TQ oscillations. Conclusions Short sympathetic activation does not affect the cardiac and respiratory contribution to the relationship between BP-cc-TQ oscillations. HGT and CT display divergent effects on the width of the subarachnoid space, an indirect marker of changes in intracranial pressure.	[Winklewski, Pawel J.; Frydrychowski, Andrzej F.] Med Univ Gdansk, Inst Human Physiol, Gdansk, Poland; [Tkachenko, Yurii; Kot, Jacek] Med Univ Gdansk, Inst Maritime & Trop Med, Natl Ctr Hyperbar Med, Gdynia, Poland; [Mazur, Kamila; Czuszynski, Krzysztof; Wtorek, Jerzy] Gdansk Univ Technol, Dept Biomed Engn, Fac Elect Telecommun & Informat, Gdansk, Poland; [Gruszecki, Marcin] Med Univ Gdansk, Dept Radiol Informat & Stat, Gdansk, Poland; [Guminski, Wojciech] Gdansk Univ Technol, Dept Comp Commun, Fac Elect Telecommun & Informat, Gdansk, Poland	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Gdansk University of Technology; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Gdansk University of Technology	Winklewski, PJ (corresponding author), Med Univ Gdansk, Inst Human Physiol, Gdansk, Poland.	pawelwinklewski@wp.pl	Gumiński, Wojciech/B-5004-2013; Kot, Jacek/I-5284-2012; Wtorek, Jerzy/AAD-3731-2019	Gumiński, Wojciech/0000-0002-3113-3450; Kot, Jacek/0000-0001-5604-8407; 	European Union [264816]; Medical University of Gdansk; NIRT sp. z o. o., Wierzbice, Poland	European Union(European Commission); Medical University of Gdansk(Medical University Gdansk); NIRT sp. z o. o., Wierzbice, Poland	The study was conducted as a part of the PHYPODE Marie Curie Initial Training Networks (FP7-PEOPLE-2010-ITN) and received funding from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FRP/2007-2013/under the Research Executive Agency grant agreement [grant number 264816]. Funding came also from the Medical University of Gdansk and NIRT sp. z o. o., Wierzbice, Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumbach GL, 1996, HYPERTENSION, V27, P159, DOI 10.1161/01.HYP.27.2.159; Bernjak A, 2012, J PHYSIOL-LONDON, V590, P363, DOI 10.1113/jphysiol.2011.214528; Bhambhani Y, 2006, J REHABIL RES DEV, V43, P845, DOI 10.1682/JRRD.2005.09.0151; Cassaglia PA, 2008, AM J PHYSIOL-REG I, V294, pR1255, DOI 10.1152/ajpregu.00332.2007; Cassaglia PA, 2009, J APPL PHYSIOL, V106, P1050, DOI 10.1152/japplphysiol.91349.2008; Cassaglia PA, 2008, SLEEP, V31, P1729, DOI 10.1093/sleep/31.12.1729; Cui RF, 2014, MICROVASC RES, V93, P14, DOI 10.1016/j.mvr.2014.02.008; Frydrychowski AE, 2002, IEEE T BIO-MED ENG, V49, P887, DOI 10.1109/TBME.2002.800786; Frydrychowski AF, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2753756; Frydrychowski AF, 2011, ACTA NEUROBIOL EXP, V71, P313; Frydrychowski AF, 2011, MICROVASC RES, V82, P156, DOI 10.1016/j.mvr.2011.05.005; Georgiadis D, 2000, EUR HEART J, V21, P407, DOI 10.1053/euhj.1999.1742; Gustin SM, 2011, J NEUROSCI, V31, P5956, DOI 10.1523/JNEUROSCI.5980-10.2011; Henskens LHG, 2008, HYPERTENSION, V52, P1120, DOI 10.1161/HYPERTENSIONAHA.108.119024; Heusser K, 2009, HYPERTENSION, V53, P719, DOI 10.1161/HYPERTENSIONAHA.108.127530; KONTOS HA, 1978, AM J PHYSIOL, V234, pH371, DOI 10.1152/ajpheart.1978.234.4.H371; Li ZY, 2013, J CEREBR BLOOD F MET, V33, P692, DOI 10.1038/jcbfm.2013.4; Li ZY, 2011, MICROVASC RES, V82, P304, DOI 10.1016/j.mvr.2011.08.004; Lucas SJE, 2013, J APPL PHYSIOL, V115, P202, DOI 10.1152/japplphysiol.00128.2013; Macey PM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105261; Macey PM, 2012, AUTON NEUROSCI-BASIC, V168, P72, DOI 10.1016/j.autneu.2012.01.009; Ogoh S, 2008, J APPL PHYSIOL, V105, P1370, DOI 10.1152/japplphysiol.zdg-8199.pcpcomm.2008; Ogoh S, 2010, J PHYSIOL-LONDON, V588, P365, DOI 10.1113/jphysiol.2009.180844; Ogoh S, 2009, J APPL PHYSIOL, V107, P1370, DOI 10.1152/japplphysiol.00573.2009; Panerai RB, 2014, MED ENG PHYS, V36, P576, DOI 10.1016/j.medengphy.2013.09.004; Safar ME, 2010, ACTA PHYSIOL, V198, P417, DOI 10.1111/j.1748-1716.2009.02073.x; Shiogai Y, 2010, PHYS REP, V488, P51, DOI 10.1016/j.physrep.2009.12.003; Stankovski T, 2013, J APPL PHYSIOL, V115, P1806, DOI 10.1152/japplphysiol.00802.2013; Stefanovska A, 1999, IEEE T BIO-MED ENG, V46, P1230, DOI 10.1109/10.790500; Stefanovska A, 2007, IEEE ENG MED BIOL, V26, P25, DOI [10.1109/EMB.2007.907088, 10.1109/MEMB.2007.907088]; Tzeng YC, 2014, J APPL PHYSIOL, V117, P1037, DOI 10.1152/japplphysiol.00366.2014; Tzeng YC, 2014, EUR J APPL PHYSIOL, V114, P545, DOI 10.1007/s00421-013-2667-y; Tzeng YC, 2010, J APPL PHYSIOL, V108, P1162, DOI 10.1152/japplphysiol.01390.2009; van Lieshout JJ, 2008, J APPL PHYSIOL, V105, P1364, DOI 10.1152/japplphysiol.90597.2008; von Hehn CA, 2012, NEURON, V73, P638, DOI 10.1016/j.neuron.2012.02.008; Wagner BP, 2003, INTENS CARE MED, V29, P196, DOI 10.1007/s00134-002-1592-z; Willie CK, 2014, J PHYSIOL-LONDON, V592, P841, DOI 10.1113/jphysiol.2013.268953; Wilson TD, 2005, J CEREBR BLOOD F MET, V25, P136, DOI 10.1038/sj.jcbfm.9600015; Winklewski PJ, 2015, MICROVASC RES, V99, P86, DOI 10.1016/j.mvr.2015.03.003; Winklewski PJ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0213-4; Winklewski PJ, 2013, DIVING HYPERB MED, V43, P148; Winklewski PJ, 2013, BLOOD PRESSURE, V22, P27, DOI 10.3109/08037051.2012.701407; Winklewski PJ, 2015, PLOS ONE; Wszedybyl-Winklewska M, 2015, J HYPERTENS, V33, P1811, DOI 10.1097/HJH.0000000000000613; Wszedybyl-Winklewska M, 2012, ACTA NEUROBIOL EXP, V72, P80; Wszedybyl-Winklewska M, 2011, MICROVASC RES, V82, P369, DOI 10.1016/j.mvr.2011.08.003	46	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135751	10.1371/journal.pone.0135751	http://dx.doi.org/10.1371/journal.pone.0135751			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284650	Green Published, Green Submitted, gold			2022-12-26	WOS:000359666100066
J	Kilfoil, KM; Mayne, E; Scott, L; Stevens, W				Kilfoil, Kim Michelle; Mayne, Elizabeth; Scott, Lesley; Stevens, Wendy			A High Burden Human Immunodeficiency Virus and Tuberculosis Resource Limited Setting, Gains from Including Xpert MTB/RIF in the Diagnostic Algorithm of Fluid Specimens Submitted for Exclusion of Lymphoma by Immunophenotypic Analysis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; EXTRAPULMONARY TUBERCULOSIS; RIFAMPIN RESISTANCE; NONRESPIRATORY SPECIMENS; RAPID DIAGNOSIS; ASSAY; METAANALYSIS; SAMPLES	This study investigated the benefit of incorporating Xpert MTB/RIF into the diagnostic algorithm of fluid specimens received for immunophenotypic analysis to exclude lymphoma. It was found that in a high burden HIV/TB setting, like South Africa, 130/229 (57%) of fluid specimens referred for immunophenotypic analysis to exclude lymphoma are not referred for concurrent MTBC liquid culture testing by the treating clinician. Of 99/229 (43%) specimens with corresponding culture results, Xpert sensitivity and specificity were 50% (CI: 26-75%) and 99% (CI: 91-100%) respectively. This demonstrates that incorporation of Xpert into the laboratory diagnostic algorithm in the immunophenotypic laboratory would improve patient work-up and care.	[Kilfoil, Kim Michelle; Mayne, Elizabeth; Scott, Lesley; Stevens, Wendy] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Dept Mol Med & Haematol, Johannesburg, South Africa; [Scott, Lesley; Stevens, Wendy] Natl Hlth Lab Serv, Natl Prior Program, Johannesburg, South Africa	University of Witwatersrand; National Health Laboratory Service	Kilfoil, KM (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Dept Mol Med & Haematol, Johannesburg, South Africa.	kim.kilfoil@nhls.ac.za		Mayne, Elizabeth/0000-0002-6360-3488; Scott, Lesley/0000-0001-6573-9525	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) [3U2GPS0001328-04]	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This project has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) under the terms of 3U2GPS0001328-04 (to LS and WS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armand S, 2011, J CLIN MICROBIOL, V49, P1772, DOI 10.1128/JCM.02157-10; Blakemore R, 2010, J CLIN MICROBIOL, V48, P2495, DOI 10.1128/JCM.00128-10; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Boehme CC, 2011, LANCET, V6736, P1; Carbone A, 2009, BLOOD, V113, P1213, DOI 10.1182/blood-2008-09-180315; Causse M, 2011, J CLIN MICROBIOL, V49, P3065, DOI 10.1128/JCM.00491-11; Chang K, 2012, J INFECTION, V64, P580, DOI 10.1016/j.jinf.2012.02.012; Das DK, 2006, DIAGN CYTOPATHOL, V34, P335, DOI 10.1002/dc.20432; Friedrich SO, 2011, J CLIN MICROBIOL, V49, P4341, DOI 10.1128/JCM.05454-11; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Hillemann D, 2011, J CLIN MICROBIOL, V49, P1202, DOI 10.1128/JCM.02268-10; Ioannidis P, 2011, J CLIN MICROBIOL, V49, P3068, DOI 10.1128/JCM.00718-11; Ligthelm LJ, 2011, J CLIN MICROBIOL, V49, P3967, DOI 10.1128/JCM.01310-11; Malbruny B, 2011, INT J TUBERC LUNG D, V15, P553, DOI 10.5588/ijtld.10.0497; Marlowe EM, 2011, J CLIN MICROBIOL, V49, P1621, DOI 10.1128/JCM.02214-10; Moure R, 2012, J CLIN MICROBIOL, V50, P513, DOI 10.1128/JCM.06467-11; Moure R, 2011, J CLIN MICROBIOL, V49, P1137, DOI 10.1128/JCM.01831-10; Pai M, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-6; Scott LE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001061; Scott LE, 2014, J CLIN MICROBIOL, V52, P1818, DOI 10.1128/JCM.03553-13; Swerdlow SH CE, 2008, WHO CLASSIFICATION T; Teo J, 2011, J CLIN MICROBIOL, V49, P3659, DOI 10.1128/JCM.00211-11; Tortoli E, 2012, EUR RESPIR J, V40, P442, DOI 10.1183/09031936.00176311; Vadwai V, 2011, J CLIN MICROBIOL, V49, P2540, DOI 10.1128/JCM.02319-10; World Health Organization, WHO REP GLOB TUB CON; World Health Organization, WHO GLOB TUB REP 201; World Health Organization, WHO TUB COUNTR PROF; World Health Organization, AUT REAL TIM NUCL AC	28	3	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0134404	10.1371/journal.pone.0134404	http://dx.doi.org/10.1371/journal.pone.0134404			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26280548	Green Submitted, Green Published, gold			2022-12-26	WOS:000359664300005
J	Oliver, CJ; Softley, S; Williamson, SM; Stevenson, PC; Wright, GA				Oliver, Caitlin J.; Softley, Samantha; Williamson, Sally M.; Stevenson, Philip C.; Wright, Geraldine A.			Pyrethroids and Nectar Toxins Have Subtle Effects on the Motor Function, Grooming and Wing Fanning Behaviour of Honeybees (Apis mellifera)	PLOS ONE			English	Article							LEARNING PERFORMANCES; SODIUM-CHANNEL; APHID HONEYDEW; PESTICIDE; EXPOSURE; INSECTICIDES; BUMBLEBEES; RESIDUES; MEMORY; SITES	Sodium channels, found ubiquitously in animal muscle cells and neurons, are one of the main target sites of many naturally-occurring, insecticidal plant compounds and agricultural pesticides. Pyrethroids, derived from compounds found only in the Asteraceae, are particularly toxic to insects and have been successfully used as pesticides including on flowering crops that are visited by pollinators. Pyrethrins, from which they were derived, occur naturally in the nectar of some flowering plant species. We know relatively little about how such compounds-i.e., compounds that target sodium channels-influence pollinators at low or sub-lethal doses. Here, we exposed individual adult forager honeybees to several compounds that bind to sodium channels to identify whether these compounds affect motor function. Using an assay previously developed to identify the effect of drugs and toxins on individual bees, we investigated how acute exposure to 10 ng doses (1 ppm) of the pyrethroid insecticides (cyfluthrin, tau-fluvalinate, allethrin and permethrin) and the nectar toxins (aconitine and grayanotoxin I) affected honeybee locomotion, grooming and wing fanning behaviour. Bees exposed to these compounds spent more time upside down and fanning their wings. They also had longer bouts of standing still. Bees exposed to the nectar toxin, aconitine, and the pyrethroid, allethrin, also spent less time grooming their antennae. We also found that the concentration of the nectar toxin, grayanotoxin I (GTX), fed to bees affected the time spent upside down (i.e., failure to perform the righting reflex). Our data show that low doses of pyrethroids and other nectar toxins that target sodium channels mainly influence motor function through their effect on the righting reflex of adult worker honeybees.	[Oliver, Caitlin J.; Softley, Samantha; Williamson, Sally M.; Wright, Geraldine A.] Newcastle Univ, Inst Neurosci, Ctr Behav & Evolut, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Oliver, Caitlin J.; Softley, Samantha; Williamson, Sally M.] Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Stevenson, Philip C.] Royal Bot Gardens, Jodrell Lab, Richmond, Surrey, England; [Stevenson, Philip C.] Univ Greenwich, Nat Resources Inst, Chatham, Kent, England	Newcastle University - UK; Newcastle University - UK; Royal Botanic Gardens, Kew; University of Greenwich	Wright, GA (corresponding author), Newcastle Univ, Inst Neurosci, Ctr Behav & Evolut, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	jeri.wright@ncl.ac.uk	Stevenson, Philip C/E-8822-2013; stevenson, philip c/E-8741-2013	Stevenson, Philip C/0000-0002-0736-3619; stevenson, philip c/0000-0002-0736-3619	Biotechnology and Biological Sciences Research Council [BB/I000143/1, BB/I000968/1]; Natural Environment Research Council [BB/I000143/1, BB/I000968/1]; Wellcome Trust [BB/I000143/1, BB/I000968/1]; Defra [BB/I000143/1, BB/I000968/1]; Scottish Government under the Insect Pollinators Initiative [BB/I000143/1, BB/I000968/1]; BBSRC [BB/I000143/1, BB/I000968/1, BB/I000445/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I000445/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Wellcome Trust(Wellcome TrustEuropean Commission); Defra(Department for Environment, Food & Rural Affairs (DEFRA)); Scottish Government under the Insect Pollinators Initiative; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded jointly by two grants from the Biotechnology and Biological Sciences Research Council, Natural Environment Research Council, the Wellcome Trust, Defra, and the Scottish Government under the Insect Pollinators Initiative: grant BB/I000143/1 to GAW and grant BB/I000968/1 to GAW and PCS.	Adler LS, 2000, OIKOS, V91, P409, DOI 10.1034/j.1600-0706.2000.910301.x; Ahmad M, 2003, J ECON ENTOMOL, V96, P875, DOI 10.1603/0022-0493-96.3.875; Baron GL, 2014, J APPL ECOL, V51, P460, DOI 10.1111/1365-2664.12205; Becher MA, 2013, J APPL ECOL, V50, P868, DOI 10.1111/1365-2664.12112; BISHOP JA, 1994, J KANSAS ENTOMOL SOC, V67, P220; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Bortolotti Laura, 2003, Bulletin of Insectology, V56, P63; Breeze TD, 2011, AGR ECOSYST ENVIRON, V142, P137, DOI 10.1016/j.agee.2011.03.020; Catterall WA, 2007, TOXICON, V49, P124, DOI 10.1016/j.toxicon.2006.09.022; ChemSpider, 2015, GRAYAN; ChemSpider, 2015, 3 ALL 2 METH 4 OX 2; ChemSpider, 2015, CHRYS AC EST ALL; ChemSpider, 2015, CIS CYFL; Choudhary A, 2008, ENVIRON MONIT ASSESS, V144, P143, DOI 10.1007/s10661-007-9952-3; Decourtye A, 2005, ARCH ENVIRON CON TOX, V48, P242, DOI 10.1007/s00244-003-0262-7; Department for Environment Food & Rural Affairs (DEFRA), 2013, NEON; Du YZ, 2013, P NATL ACAD SCI USA, V110, P11785, DOI 10.1073/pnas.1305118110; Front Matter, 2007, STAT POLL N AM; Frost EH, 2013, J EXP BIOL, V216, P2931, DOI 10.1242/jeb.086538; Fussnecker BL, 2006, J INSECT PHYSIOL, V52, P1083, DOI 10.1016/j.jinsphys.2006.07.008; Gosselin M, 2013, ECOL ENTOMOL, V38, P400, DOI 10.1111/een.12032; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Grdisa M, 2013, CHEM BIODIVERS, V10, P460, DOI 10.1002/cbdv.201200015; Gunasekara AS, 2004, ENV FATE PYRETHRINS; Hardstone MC, 2010, PEST MANAG SCI, V66, P1171, DOI 10.1002/ps.2001; Hurst V, 2014, J COMP PHYSIOL A, V200, P881, DOI 10.1007/s00359-014-0932-0; Johnson RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054092; Kadala A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112194; Katsuda Y, 2012, TOP CURR CHEM, V314, P1, DOI 10.1007/128_2011_252; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; LOMBET A, 1988, BRAIN RES, V459, P44, DOI 10.1016/0006-8993(88)90284-3; Maze IS, 2006, J INSECT PHYSIOL, V52, P1243, DOI 10.1016/j.jinsphys.2006.09.006; Medrzycki Piotr, 2003, Bulletin of Insectology, V56, P59; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; O'Reilly AO, 2014, PEST MANAG SCI, V70, P369, DOI 10.1002/ps.3561; Ramirez-Romero R, 2005, APIDOLOGIE, V36, P601, DOI 10.1051/apido:2005039; Retschnig G, 2014, J INVERTEBR PATHOL, V118, P18, DOI 10.1016/j.jip.2014.02.008; SHIRES SW, 1984, PESTIC SCI, V15, P543, DOI 10.1002/ps.2780150603; Su SK, 2007, J INSECT PHYSIOL, V53, P411, DOI 10.1016/j.jinsphys.2007.01.002; Tan JG, 2005, MOL PHARMACOL, V67, P513, DOI 10.1124/mol.104.006205; Tiedeken EJ, 2014, J EXP BIOL, V217, P1620, DOI 10.1242/jeb.097543; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Wang SY, 2003, CELL SIGNAL, V15, P151, DOI 10.1016/S0898-6568(02)00085-2; Williamson SM, 2014, ECOTOXICOLOGY, V23, P1409, DOI 10.1007/s10646-014-1283-x; Williamson SM, 2013, J EXP BIOL, V216, P1799, DOI 10.1242/jeb.083931; Winston, 1987, BIOL HONEYBEE; Yang EC, 2008, J ECON ENTOMOL, V101, P1743, DOI 10.1603/0022-0493-101.6.1743; Zhou T, 2011, PESTIC BIOCHEM PHYS, V100, P35, DOI 10.1016/j.pestbp.2011.02.001	48	21	23	1	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0133733	10.1371/journal.pone.0133733	http://dx.doi.org/10.1371/journal.pone.0133733			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26280999	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000359664300001
J	Dansereau, E; Gakidou, E; Ng, M; Achan, J; Burstein, R; DeCenso, B; Gasasira, A; Ikilezi, G; Kisia, C; Masters, SH; Njuguna, P; Odeny, TA; Okiro, EA; Roberts, DA; Duber, HC				Dansereau, Emily; Gakidou, Emmanuela; Ng, Marie; Achan, Jane; Burstein, Roy; DeCenso, Brendan; Gasasira, Anne; Ikilezi, Gloria; Kisia, Caroline; Masters, Samuel H.; Njuguna, Pamela; Odeny, Thomas A.; Okiro, Emelda A.; Roberts, D. Allen; Duber, Herbert C.			Trends and Determinants of Antiretroviral Therapy Patient Monitoring Practices in Kenya and Uganda	PLOS ONE			English	Article							RESOURCE-CONSTRAINED SETTINGS; HIV-1 DRUG-RESISTANCE; AFRICA; MORTALITY; FAILURE; CHALLENGES; COUNTRIES	Introduction Patients receiving antiretroviral therapy (ART) require routine monitoring to track response to treatment and assess for treatment failure. This study aims to identify gaps in monitoring practices in Kenya and Uganda. Methods We conducted a systematic retrospective chart review of adults who initiated ART between 2007 and 2012. We assessed the availability of baseline measurements (CD4 count, weight, and WHO stage) and ongoing CD4 and weight monitoring according to national guidelines in place at the time. Mixed-effects logistic regression models were used to analyze facility and patient factors associated with meeting monitoring guidelines. Results From 2007 to 2012, at least 88% of patients per year in Uganda had a recorded weight at initiation, while in Kenya there was a notable increase from 69% to 90%. Patients with a documented baseline CD4 count increased from 69% to about 80% in both countries. In 2012, 83% and 86% of established patients received the recommended quarterly weight monitoring in Kenya and Uganda, respectively, while semiannual CD4 monitoring was less common (49% in Kenya and 38% in Uganda). Initiating at a more advanced WHO stage was associated with a lower odds of baseline CD4 testing. On-site CD4 analysis capacity was associated with increased odds of CD4 testing at baseline and in the future. Discussion Substantial gaps were noted in ongoing CD4 monitoring of patients on ART. Although guidelines have since changed, limited laboratory capacity is likely to remain a significant issue in monitoring patients on ART, with important implications for ensuring quality care.	[Dansereau, Emily; Gakidou, Emmanuela; Ng, Marie; Burstein, Roy; Ikilezi, Gloria; Roberts, D. Allen; Duber, Herbert C.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Achan, Jane] Makerere Univ, Dept Pediat & Child Hlth, Kampala, Uganda; [DeCenso, Brendan] RTI Int, Res Triangle Pk, NC USA; [Gasasira, Anne] African Leaders Malaria Alliance, Kampala, Uganda; [Kisia, Caroline] Action Africa Hlth Int, Nairobi, Kenya; [Masters, Samuel H.] Univ N Carolina, Chapel Hill, NC USA; [Njuguna, Pamela] IFC World Bank Grp, Nairobi, Kenya; [Odeny, Thomas A.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Okiro, Emelda A.] Bill & Melinda Gates Fdn, Seattle, WA USA	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Makerere University; Research Triangle Institute; University of North Carolina; University of North Carolina Chapel Hill; The World Bank; University of Washington; University of Washington Seattle; Bill & Melinda Gates Foundation	Duber, HC (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.	hduber@uw.edu		Roberts, Allen/0000-0003-3660-6330; Masters, Samuel/0000-0001-7581-8219; Duber, Herbert/0000-0002-5077-3170; Okiro, Emelda/0000-0001-9543-8360	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Funding for this work was provided by the Bill & Melinda Gates Foundation. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. One of the authors is currently employed as a consultant by a commercial entity (PN), but was employed by Action Africa Help International-Kenya at the time of the study. No commercial entities had any role in any component of this study or its funding.	Belec L, 2011, FUTURE MICROBIOL, V6, P1251, DOI [10.2217/fmb.11.121, 10.2217/FMB.11.121]; Buscher A, 2013, AIDS PATIENT CARE ST, V27, P459, DOI 10.1089/apc.2013.0105; Duff P, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-37; [Government of Kenya Ministry of Health], 2011, GUIDELINES FOR ANTIR; [Government of Kenya Ministry of Health], 2005, GUIDELINES FOR ANTIR; Hamers RL, 2013, CURR OPIN HIV AIDS, V8, P19, DOI 10.1097/COH.0b013e32835b7f94; Hamers RL, 2012, CLIN INFECT DIS, V54, P1660, DOI 10.1093/cid/cis254; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; Hyle EP, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001725; Institute for Health Metrics and Evaluation (IHME), 2014, EALTH SERVICE PROVIS; Institute for Health Metrics and Evaluation (IHME), 2015, ACCESS BOTTLENECKS C; Institute for Health Metrics and Evaluation (IHME), 2014, HEALTH SERVICE PROVI; Liu EJ, 2011, J INFECT DIS, V204, P282, DOI 10.1093/infdis/jir246; Lynen L, 2010, CURR OPIN HIV AIDS, V5, P1, DOI 10.1097/COH.0b013e3283333762; Mermin J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6792; Ministry of health, 2008, NATIONAL ANTIRETROVI; Mugyenyi P, 2009, IMPACT OF ROUTINE LA; [National AIDS and STI Control Program (NASCOP) Kenya Ministry of Health (MOH)], 2014, GUIDELINES ON USE OF; National AIDS Control Council, 2014, KENYA AIDS RESPONSE; Olmsted SS, 2010, AM J CLIN PATHOL, V134, P374, DOI 10.1309/AJCPDQOSB7QR5GLR; Petersen ML, 2014, AIDS, V28, P2097, DOI 10.1097/QAD.0000000000000349; Riolexus AA, 2014, VIRAL LOAD MONITORIN; Selke HM, 2010, JAIDS-J ACQ IMM DEF, V55, P483, DOI 10.1097/QAI.0b013e3181eb5edb; Shafiee H, 2015, ANNU REV MED, V66, P387, DOI 10.1146/annurev-med-092112-143017; Siapka M, 2014, B WORLD HEALTH ORGAN, V92, P499, DOI 10.2471/BLT.13.127639; Siedner MJ, 2013, AIDS, V27, P1503, DOI 10.1097/QAD.0b013e32835fd873; Sigaloff KCE, 2011, JAIDS-J ACQ IMM DEF, V58, P23, DOI 10.1097/QAI.0b013e318227fc34; Tuller DM, 2010, AIDS BEHAV, V14, P778, DOI 10.1007/s10461-009-9533-2; Uganda AIDS Commission, 2014, HIV AND AIDS UGANDA; Uganda Ministry of Health (MOH), 2013, ADDENDUM TO THE NATI; UNAIDS, ACCESS TO ANTIRETROV; UNAIDS and MSF, 2012, STRAT TOOLS POL GET, P1; WHO, 2013, CONSOLIDATED GUIDELI; World Health Organization, 2013, GLOBAL UPDATE ON HIV; World Health Organization, ANTIRETROVIRAL THERA; Wynberg E, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18809; Yiannoutsos CT, 2012, SEX TRANSM INFECT, V88, pI33, DOI 10.1136/sextrans-2012-050658	37	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135653	10.1371/journal.pone.0135653	http://dx.doi.org/10.1371/journal.pone.0135653			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO9KD	26275151	gold, Green Published, Green Submitted			2022-12-26	WOS:000359493600089
J	Zeynalov, E; Jones, SM; Seo, JW; Snell, LD; Elliott, JP				Zeynalov, Emil; Jones, Susan M.; Seo, Jeong-Woo; Snell, Lawrence D.; Elliott, J. Paul			Arginine-Vasopressin Receptor Blocker Conivaptan Reduces Brain Edema and Blood-Brain Barrier Disruption after Experimental Stroke in Mice	PLOS ONE			English	Article							V-1 RECEPTOR; ANTIDIURETIC-HORMONE; INAPPROPRIATE SECRETION; AQP4 EXPRESSION; ANTAGONIST; HYPONATREMIA; SR49059; OSMOTHERAPY; DAMAGE	Background Stroke is a major cause of morbidity and mortality. Stroke is complicated by brain edema and blood-brain barrier (BBB) disruption, and is often accompanied by increased release of arginine-vasopressin (AVP). AVP acts through V1a and V2 receptors to trigger hyponatremia, vasospasm, and platelet aggregation which can exacerbate brain edema. The AVP receptor blockers conivaptan (V1a and V2) and tolvaptan (V2) are used to correct hyponatremia, but their effect on post-ischemic brain edema and BBB disruption remains to be elucidated. Therefore, we conducted this study to investigate if these drugs can prevent brain edema and BBB disruption in mice after stroke. Methods Experimental mice underwent the filament model of middle cerebral artery occlusion (MCAO) with reperfusion. Mice were treated with conivaptan, tolvaptan, or vehicle. Treatments were initiated immediately at reperfusion and administered IV (conivaptan) or orally (tolvaptan) for 48 hours. Physiological variables, neurological deficit scores (NDS), plasma and urine sodium and osmolality were recorded. Brain water content (BWC) and Evans Blue (EB) extravasation index were evaluated at the end point. Results Both conivaptan and tolvaptan produced aquaresis as indicated by changes in plasma and urine sodium levels. However plasma and urine osmolality was changed only by conivaptan. Unlike tolvaptan, conivaptan improved NDS and reduced BWC in the ipsilateral hemisphere: from 81.66 +/- 0.43% (vehicle) to 78.28 +/- 0.48% (conivaptan, 0.2 mg, p < 0.05 vs vehicle). Conivaptan also attenuated the EB extravasation from 1.22 +/- 0.08 (vehicle) to 1.01 +/- 0.02 (conivaptan, 0.2 mg, p < 0.05). Conclusion Continuous IV infusion with conivaptan for 48 hours after experimental stroke reduces brain edema, and BBB disruption. Conivaptan but not tolvaptan may potentially be used in patients to prevent brain edema after stroke.	[Zeynalov, Emil; Jones, Susan M.; Seo, Jeong-Woo] Swedish Med Ctr, Neurotrauma Res, Englewood, CO 80110 USA; [Snell, Lawrence D.] Colorado Neurol Inst, Englewood, CO USA; [Elliott, J. Paul] Colorado Brain & Spine Inst, Englewood, CO USA		Zeynalov, E (corresponding author), Swedish Med Ctr, Neurotrauma Res, Englewood, CO 80110 USA.	emil.zeynalov@healthonecares.com		Jones, Susan/0000-0002-9801-1239	Swedish Medical Center Research Grant	Swedish Medical Center Research Grant	This work was supported by the Swedish Medical Center Research Grant, awarded to Dr. J. Paul Elliott to lead a stroke research program. The Swedish Medical Center provided facilities and budget management of the relevant research activities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, Drugs R D, V5, P94; [Anonymous], 2006, MED LETT DRUGS THER, V48, P51; Barreca T, 2001, CEREBROVASC DIS, V11, P113, DOI 10.1159/000047622; Baylis PH, 2003, INT J BIOCHEM CELL B, V35, P1495, DOI 10.1016/S1357-2725(03)00139-0; Bemana I, 1999, NEUROSURGERY, V44, P148, DOI 10.1097/00006123-199901000-00091; Bhardwaj A, 2006, ANN NEUROL, V59, P229, DOI 10.1002/ana.20788; Chen CH, 2007, NEUROCRIT CARE, V7, P92, DOI 10.1007/s12028-007-0033-9; Coussement J, 2012, AM J NEPHROL, V35, P265, DOI 10.1159/000336716; D'Auria D, 2012, TRANSL MED UNISA, V3, P1; Dhar R, 2011, NEUROCRIT CARE, V14, P97, DOI 10.1007/s12028-010-9366-x; Galton C, 2011, NEUROCRIT CARE, V14, P354, DOI 10.1007/s12028-011-9525-8; Ge YQ, 2005, AM J PHYSIOL-RENAL, V288, pF912, DOI 10.1152/ajprenal.00432.2004; Ghali JK, 2008, CARDIOLOGY, V111, P147, DOI 10.1159/000121596; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Goldsmith SR, 2008, J CARD FAIL, V14, P641, DOI 10.1016/j.cardfail.2008.06.003; Hedna VS, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0213-0; Hockel K, 2012, STROKE, V43, P227, DOI 10.1161/STROKEAHA.111.626168; Hoggatt AF, 2010, J AM ASSOC LAB ANIM, V49, P329; Kleindienst A, 2006, ACTA NEUROCHIR SUPPL, V96, P303; Kleindienst A, 2013, ACTA NEUROCHIR, V155, P151, DOI 10.1007/s00701-012-1558-z; Krieg SM, 2015, J NEUROTRAUM, V32, P221, DOI 10.1089/neu.2013.3274; Laczi Ferenc, 2008, Orvosi Hetilap, V149, P1347, DOI 10.1556/OH.2008.28409; Liu XQ, 2010, NEUROCRIT CARE, V12, P124, DOI 10.1007/s12028-009-9277-x; Manaenko A, 2011, ACTA NEUROCHIR SUPPL, V111, P191, DOI 10.1007/978-3-7091-0693-8_32; Manaenko A, 2011, NEUROCHEM INT, V58, P542, DOI 10.1016/j.neuint.2011.01.018; Marmarou CR, 2014, BRAIN RES, V1581, P89, DOI 10.1016/j.brainres.2014.06.005; Nase G, 2008, GLIA, V56, P895, DOI 10.1002/glia.20664; O'Donnell ME, 2005, AM J PHYSIOL-CELL PH, V289, pC283, DOI 10.1152/ajpcell.00001.2005; Taya K, 2008, ACTA NEUROCHIR SUPPL, V102, P425, DOI 10.1007/978-3-211-85578-2_83; Thibonnier M, 2001, ANNU REV PHARMACOL, V41, P175, DOI 10.1146/annurev.pharmtox.41.1.175; Vakili A, 2005, J CEREBR BLOOD F MET, V25, P1012, DOI 10.1038/sj.jcbfm.9600097; Vantyghem MC, 2011, ANN ENDOCRINOL-PARIS, V72, P500, DOI 10.1016/j.ando.2011.10.001; Velez JCQ, 2010, NEPHROL DIAL TRANSPL, V25, P1524, DOI 10.1093/ndt/gfp731; Villabona Carles, 2010, Endocrinol Nutr, V57 Suppl 2, P41, DOI 10.1016/S1575-0922(10)70021-8; Weber R, 1997, HYPERTENSION, V30, P1121, DOI 10.1161/01.HYP.30.5.1121; Westermaier Thomas, 2012, Exp Transl Stroke Med, V4, P8, DOI 10.1186/2040-7378-4-8; Wun T, 1996, BRIT J HAEMATOL, V92, P968, DOI 10.1046/j.1365-2141.1996.436975.x; Xing Chi Hong, 2005, Hiroshima Journal of Medical Sciences, V54, P93; Zeynalov E, 2008, CRIT CARE MED, V36, P2634, DOI 10.1097/CCM.0b013e3181847853; Zeynalov E, 2014, CRIT CARE MED, V42	40	30	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0136121	10.1371/journal.pone.0136121	http://dx.doi.org/10.1371/journal.pone.0136121			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275173	Green Published, Green Submitted, gold			2022-12-26	WOS:000359493600149
J	Ruiz-Raya, F; Soler, M; Sanchez-Perez, LLI; Ibanez-Alamo, JD				Ruiz-Raya, Francisco; Soler, Manuel; Sanchez-Perez, Lucia L. I.; Ibanez-Alamo, Juan Diego			Could a Factor That Does Not Affect Egg Recognition Influence the Decision of Rejection?	PLOS ONE			English	Article							CUCKOO CUCULUS-CANORUS; REED WARBLERS; BROOD PARASITISM; MODEL SYSTEM; HOST; DISCRIMINATION; SIZE; COEVOLUTION; ADAPTATIONS; EJECTION	Rejection of the parasitic egg is the most important defence of hosts against brood parasites. However, this response is variable among and within species, and egg discrimination is not always followed by egg rejection. Low risk of parasitism and high risk of rejection costs may lead to the acceptance of the parasitic egg even if it has been previously recognized. The main aim of this paper is to answer a relevant question: can a single egg trait provoke the acceptance of an experimental egg previously recognized as foreign? Increased egg mass should hamper the ejection of an egg that has been discriminated because ejection of a heavy egg may imply higher rejection costs for hosts. We have tested this prediction by experimentally parasitizing natural nests of Common Blackbirds (Turdus merula) with non-mimetic model eggs of different mass (heavy, normal-weight, and light) while controlling for potential confounding factors such as egg size and colour. Our results showed that blackbirds more frequently accepted heavy eggs, even when previously recognized. This differential acceptance may be related to insufficient motivation to assume the higher costs that the ejection of a heavy egg could impose.	[Ruiz-Raya, Francisco; Soler, Manuel; Sanchez-Perez, Lucia L. I.; Ibanez-Alamo, Juan Diego] Univ Granada, Fac Ciencias, Dept Zool, Granada, Spain; [Soler, Manuel] Univ Granada, Unidad Asociada CSIC, Grp Coevoluc, Granada, Spain; [Ibanez-Alamo, Juan Diego] Univ Groningen, Ctr Ecol & Evolutionary Studies, Anim Ecol Grp, Groningen, Netherlands; [Ibanez-Alamo, Juan Diego] CSIC, Estn Biol Donana, Dept Wetland Ecol, E-41080 Seville, Spain	University of Granada; Consejo Superior de Investigaciones Cientificas (CSIC); University of Granada; University of Groningen; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Ruiz-Raya, F (corresponding author), Univ Granada, Fac Ciencias, Dept Zool, Granada, Spain.	fraruiz@correo.ugr.es	Ruiz-Raya, Francisco/L-8639-2019; Ibáñez-Álamo, Juan Diego/H-7624-2019	Ruiz-Raya, Francisco/0000-0002-4646-1975; Ibanez Alamo, Juan Diego/0000-0002-2136-1767	Consejeria Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia [CVI-6653]	Consejeria Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia(Junta de Andalucia)	Financial support has been provided by the Consejeria Economia, Innovacion, Ciencia y Empleo, Junta de Andalucia (research project CVI-6653). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez F, 1996, IBIS, V138, P340, DOI 10.1111/j.1474-919X.1996.tb04349.x; Alvarez F, 2003, ARDEA, V91, P127; Antonov A, 2008, BEHAV ECOL, V19, P100, DOI 10.1093/beheco/arm102; Antonov A, 2009, BIOL LETTERS, V5, P169, DOI 10.1098/rsbl.2008.0645; Aviles JM, 2011, J EVOLUTION BIOL, V24, P314, DOI 10.1111/j.1420-9101.2010.02168.x; Aviles JM, 2004, ANIM BEHAV, V67, P951, DOI 10.1016/j.anbehav.2003.08.022; Brooke MD, 1998, P ROY SOC B-BIOL SCI, V265, P1277, DOI 10.1098/rspb.1998.0430; BROOKE MD, 1988, NATURE, V335, P630; Cherry MI, 2001, P ROY SOC B-BIOL SCI, V268, P565, DOI 10.1098/rspb.2000.1414; Christians JK, 2002, BIOL REV, V77, P1, DOI 10.1017/S1464793101005784; Davies N.B., 2000, CUCKOOS COWBIRDS OTH; Davies NB, 1996, P ROY SOC B-BIOL SCI, V263, P925, DOI 10.1098/rspb.1996.0137; DAVIES NB, 1988, ANIM BEHAV, V36, P262, DOI 10.1016/S0003-3472(88)80269-0; DAVIES NB, 1989, J ANIM ECOL, V58, P207, DOI 10.2307/4995; DEEMING DC, 1989, J MORPHOL, V201, P179, DOI 10.1002/jmor.1052010207; Ibanez-Alamo JD, 2010, BIOL J LINN SOC, V101, P759, DOI 10.1111/j.1095-8312.2010.01543.x; Finger J., 1992, GUIDE THEORY PRACTIC; Grim T, 2011, J ANIM ECOL, V80, P508, DOI 10.1111/j.1365-2656.2010.01798.x; Hauber ME, 2006, BIOL LETTERS, V2, P177, DOI 10.1098/rsbl.2005.0438; Honza M, 2005, J AVIAN BIOL, V36, P517, DOI 10.1111/j.0908-8857.2005.03358.x; Honza M, 2007, BIOL J LINN SOC, V92, P269, DOI 10.1111/j.1095-8312.2007.00848.x; Ibanez-Alamo JD, 2012, BEHAV ECOL SOCIOBIOL, V66, P1067, DOI 10.1007/s00265-012-1357-9; Lahti DC, 2002, ANIM BEHAV, V63, P1135, DOI 10.1006/anbe.2002.3009; Langmore NE, 2005, BEHAV ECOL, V16, P686, DOI 10.1093/beheco/ari041; Lindholm AK, 2000, BEHAVIOUR, V137, P25, DOI 10.1163/156853900501854; Lyon BE, 2003, NATURE, V422, P495, DOI 10.1038/nature01505; Lyon B, 2007, BEHAV ECOL SOCIOBIOL, V61, P455, DOI 10.1007/s00265-006-0273-2; MAGRATH RD, 1992, AUK, V109, P474; Martin-Galvez D, 2006, J EVOLUTION BIOL, V19, P543, DOI 10.1111/j.1420-9101.2005.01002.x; Martin-Vivaldi M, 2013, IBIS, V155, P140, DOI 10.1111/ibi.12000; MOKSNES A, 1991, BEHAVIOUR, V116, P64, DOI 10.1163/156853990X00365; MOKSNES A, 1989, BEHAV ECOL SOCIOBIOL, V24, P25, DOI 10.1007/BF00300114; Moskat C, 2007, ANIM COGN, V10, P377, DOI 10.1007/s10071-007-0071-x; NEW DAT, 1957, J EMBRYOL EXP MORPH, V5, P293; PAYNE RB, 1977, ECOLOGY, V58, P500, DOI 10.2307/1939000; Polacikova L, 2010, J AVIAN BIOL, V41, P111, DOI 10.1111/j.1600-048X.2010.04983.x; ROTHSTEIN SI, 1990, ANNU REV ECOL SYST, V21, P481, DOI 10.1146/annurev.es.21.110190.002405; Samas P, 2014, FRONT ZOOL, V11, DOI 10.1186/1742-9994-11-34; Samas P, 2011, ETHOLOGY, V117, P606, DOI 10.1111/j.1439-0310.2011.01917.x; Soler JJ, 1999, EVOLUTION, V53, P947, DOI 10.1111/j.1558-5646.1999.tb05388.x; Soler JJ, 2000, OECOLOGIA, V125, P309, DOI 10.1007/s004420000487; Soler M, 2002, ETHOLOGY, V108, P1093, DOI 10.1046/j.1439-0310.2002.00841.x; SOLER M, 1990, NATURE, V343, P748, DOI 10.1038/343748a0; Soler M, 2015, J AVIAN BIOL, V46, P1; Soler M, 2014, BIOL REV, V89, P688, DOI 10.1111/brv.12075; Soler M, 2012, ETHOLOGY, V118, P662, DOI 10.1111/j.1439-0310.2012.02058.x; Soler M, 2011, BEHAV ECOL SOCIOBIOL, V65, P1997, DOI 10.1007/s00265-011-1209-z; Spottiswoode CN, 2011, P ROY SOC B-BIOL SCI, V278, P3566, DOI 10.1098/rspb.2011.0401; Spottiswoode CN, 2010, P NATL ACAD SCI USA, V107, P8672, DOI 10.1073/pnas.0910486107; Stoddard MC, 2011, EVOLUTION, V65, P2004, DOI 10.1111/j.1558-5646.2011.01262.x; Stokke BG, 2008, BEHAV ECOL, V19, P612, DOI 10.1093/beheco/arn007; Stokke BG, 1999, P ROY SOC B-BIOL SCI, V266, P1483, DOI 10.1098/rspb.1999.0804; Svennungsen TO, 2010, EVOLUTION, V64, P1459, DOI 10.1111/j.1558-5646.2009.00919.x; Underwood TJ, 2006, ANIM BEHAV, V71, P409, DOI 10.1016/j.anbehav.2005.06.004	54	29	29	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135624	10.1371/journal.pone.0135624	http://dx.doi.org/10.1371/journal.pone.0135624			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295481	gold, Green Published			2022-12-26	WOS:000359926900036
J	Strom, CM; Rivera, S; Elzinga, C; Angeloni, T; Rosenthal, SH; Goos-Root, D; Siaw, M; Platt, J; Braastadt, C; Cheng, L; Ross, D; Sun, WM				Strom, Charles M.; Rivera, Steven; Elzinga, Christopher; Angeloni, Taraneh; Rosenthal, Sun Hee; Goos-Root, Dana; Siaw, Martin; Platt, Jamie; Braastadt, Cory; Cheng, Linda; Ross, David; Sun, Weimin			Development and Validation of a Next-Generation Sequencing Assay for BRCA1 and BRCA2 Variants for the Clinical Laboratory	PLOS ONE			English	Article							OVARIAN-CANCER; BREAST-CANCER; MUTATION CARRIERS; FAMILY-HISTORY; POPULATION; PREVALENCE; RISKS	The objective of this study was to design and validate a next-generation sequencing assay (NGS) to detect BRCA1 and BRCA2 mutations. We developed an assay using random shearing of genomic DNA followed by RNA bait tile hybridization and NGS sequencing on both the Illumina MiSeq and Ion Personal Gene Machine (PGM). We determined that the MiSeq Reporter software supplied with the instrument could not detect deletions greater than 9 base pairs. Therefore, we developed an alternative alignment and variant calling software, Quest Sequencing Analysis Pipeline (QSAP), that was capable of detecting large deletions and insertions. In validation studies, we used DNA from 27 stem cell lines, all with known deleterious BRCA1 or BRCA2 mutations, and DNA from 67 consented control individuals who had a total of 352 benign variants. Both the MiSeq/QSAP combination and PGM/Torrent Suite combination had 100% sensitivity for the 379 known variants in the validation series. However, the PGM/Torrent Suite combination had a lower intra-and inter-assay precision of 96.2% and 96.7%, respectively when compared to the MiSeq/QSAP combination of 100% and 99.4%, respectively. All PGM/Torrent Suite inconsistencies were false-positive variant assignments. We began commercial testing using both platforms and in the first 521 clinical samples MiSeq/QSAP had 100% sensitivity for BRCA1/2 variants, including a 64-bp deletion and a 10-bp insertion not identified by PGM/Torrent Suite, which also suffered from a high false-positive rate. Neither the MiSeq nor PGM platform with their supplied alignment and variant calling software are appropriate for a clinical laboratory BRCA sequencing test. We have developed an NGS BRCA1/2 sequencing assay, MiSeq/QSAP, with 100% analytic sensitivity and specificity in the validation set consisting of 379 variants. The MiSeq/QSAP combination has sufficient performance for use in a clinical laboratory.	[Strom, Charles M.; Rivera, Steven; Angeloni, Taraneh; Rosenthal, Sun Hee; Goos-Root, Dana; Siaw, Martin; Platt, Jamie; Cheng, Linda; Sun, Weimin] Quest Diagnost Nichols Inst, Dept Genet, San Juan Capistrano, CA 92675 USA; [Elzinga, Christopher; Braastadt, Cory] Athena Quest Diagnost, Marlborough, MA USA; [Ross, David] Celera Quest Diagnost, Alameda, CA USA	Nichols Institute	Strom, CM (corresponding author), Quest Diagnost Nichols Inst, Dept Genet, San Juan Capistrano, CA 92675 USA.	charles.m.strom@questdiagnostics.com			Quest Diagnostics	Quest Diagnostics	This research was supported by Quest Diagnostics. The specific roles of these authors are articulated in the 'author contributions' section. The authors received no specific funding for this work. Quest Diagnostics provided support in the form of salaries for all authors but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, CANC FACTS FIG 2013; American Society of Breast Surgeons, POS STAT BRCA GEN TE; [Anonymous], 2009, Obstet Gynecol, V113, P957, DOI 10.1097/AOG.0b013e3181a106d4; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Chen SN, 2007, J CLIN ONCOL, V25, P1329, DOI 10.1200/JCO.2006.09.1066; Hartman AR, 2012, CANCER-AM CANCER SOC, V118, P2787, DOI 10.1002/cncr.26576; Mavaddat N, 2013, JNCI-J NATL CANCER I, V105, P812, DOI 10.1093/jnci/djt095; Metcalfe K, 2004, J CLIN ONCOL, V22, P2328, DOI 10.1200/JCO.2004.04.033; National Comprehensive Cancer Network, 2014, NCCN CLIN PRACT GUID; Petrucelli N, 1993, GENE REV; Risch HA, 2006, JNCI-J NATL CANCER I, V98, P1694, DOI 10.1093/jnci/djj465; Robson M, 2001, CURR PROB SURG, V38, P381; Rubin SC, 1998, AM J OBSTET GYNECOL, V178, P670, DOI 10.1016/S0002-9378(98)70476-4; Whittemore AS, 1997, AM J HUM GENET, V60, P496	14	33	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136419	10.1371/journal.pone.0136419	http://dx.doi.org/10.1371/journal.pone.0136419			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295337	Green Submitted, Green Published, gold			2022-12-26	WOS:000359926900107
J	Beck, B; Cardini, F; Ladavas, E; Bertini, C				Beck, Brianna; Cardini, Flavia; Ladavas, Elisabetta; Bertini, Caterina			The Enfacement Illusion Is Not Affected by Negative Facial Expressions	PLOS ONE			English	Article							SELF-FACE RECOGNITION; NEURAL REPRESENTATIONS; TACTILE PERCEPTION; EMOTIONAL EMPATHY; OWN FACE; IDENTITY; ADAPTATION; IDENTIFICATION; PROSOPAGNOSIA; CORTICES	Enfacement is an illusion wherein synchronous visual and tactile inputs update the mental representation of one's own face to assimilate another person's face. Emotional facial expressions, serving as communicative signals, may influence enfacement by increasing the observer's motivation to understand the mental state of the expresser. Fearful expressions, in particular, might increase enfacement because they are valuable for adaptive behavior and more strongly represented in somatosensory cortex than other emotions. In the present study, a face was seen being touched at the same time as the participant's own face. This face was either neutral, fearful, or angry. Anger was chosen as an emotional control condition for fear because it is similarly negative but induces less somatosensory resonance, and requires additional knowledge (i.e., contextual information and social contingencies) to effectively guide behavior. We hypothesized that seeing a fearful face (but not an angry one) would increase enfacement because of greater somatosensory resonance. Surprisingly, neither fearful nor angry expressions modulated the degree of enfacement relative to neutral expressions. Synchronous interpersonal visuo-tactile stimulation led to assimilation of the other's face, but this assimilation was not modulated by facial expression processing. This finding suggests that dynamic, multisensory processes of self-face identification operate independently of facial expression processing.	[Beck, Brianna; Cardini, Flavia; Ladavas, Elisabetta; Bertini, Caterina] Univ Bologna, Ctr Studi & Ric Neurosci Cognit CNC, Cesena, Italy; [Beck, Brianna; Cardini, Flavia; Ladavas, Elisabetta; Bertini, Caterina] Univ Bologna, Dept Psychol, Bologna, Italy	University of Bologna; University of Bologna	Beck, B (corresponding author), UCL, Inst Cognit Neurosci, London, England.	brianna.beck@ucl.ac.uk		Beck, Brianna/0000-0002-6784-6583; Cardini, Flavia/0000-0003-4301-611X	Ministero dell'Istruzione, dell'Universita' e della Ricerca (PRIN)	Ministero dell'Istruzione, dell'Universita' e della Ricerca (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This research was supported by grants from the Ministero dell'Istruzione, dell'Universita' e della Ricerca (PRIN) to EL (http://prin.miur.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2000, J NEUROSCI, V20, P2683; Adolphs R, 1996, J NEUROSCI, V16, P7678; Apps MAJ, 2014, NEUROSCI BIOBEHAV R, V41, P85, DOI 10.1016/j.neubiorev.2013.01.029; Baudouin JY, 2000, MEMORY, V8, P285, DOI 10.1080/09658210050117717; Bobes MA, 2000, COGNITIVE BRAIN RES, V9, P249, DOI 10.1016/S0926-6410(00)00003-3; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Bufalari I, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00102; Calder AJ, 2005, NAT REV NEUROSCI, V6, P641, DOI 10.1038/nrn1724; Cardini F, 2012, EMOTION, V12, P980, DOI 10.1037/a0027351; Cardini F, 2011, J COGNITIVE NEUROSCI, V23, P503, DOI 10.1162/jocn.2010.21484; DAVIS MH, 1987, J PERS SOC PSYCHOL, V52, P126, DOI 10.1037/0022-3514.52.1.126; Devue C, 2011, CONSCIOUS COGN, V20, P40, DOI 10.1016/j.concog.2010.09.007; Duchaine BC, 2003, PERCEPTION, V32, P827, DOI 10.1068/p5067; Dummer T, 2009, PERCEPTION, V38, P271, DOI 10.1068/p5921; Eimer M, 2002, NEUROREPORT, V13, P427, DOI 10.1097/00001756-200203250-00013; Ellamil M, 2008, COGN AFFECT BEHAV NE, V8, P273, DOI 10.3758/CABN.8.3.273; Endo N., 1992, TOHOKU PSYCHOL FOLIA, V51, P37; Epley N, 2008, PERS SOC PSYCHOL B, V34, P1159, DOI 10.1177/0146167208318601; Fini C, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00165; Fox CJ, 2007, BRAIN RES, V1127, P80, DOI 10.1016/j.brainres.2006.09.104; Fox CJ, 2008, J VISION, V8, DOI 10.1167/8.3.11; Gallegos DR, 2005, BRAIN LANG, V93, P338, DOI 10.1016/j.bandl.2004.11.001; GALLUP GG, 1970, SCIENCE, V167, P86, DOI 10.1126/science.167.3914.86; GREENWALD AG, 1995, PSYCHOL REV, V102, P4, DOI 10.1037/0033-295X.102.1.4; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Humphreys K, 2007, EXP BRAIN RES, V176, P356, DOI 10.1007/s00221-006-0621-5; Keenan J. P., 2003, FACE MIRROR SEARCH O; Keenan JP, 1999, NEUROPSYCHOLOGIA, V37, P1421, DOI 10.1016/S0028-3932(99)00025-1; Kottoor TM., 1989, PSYCHOL STUD, V34, P102; Maister L, 2013, EMOTION, V13, P7, DOI 10.1037/a0030884; Maselli A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00083; Paladino MP, 2010, PSYCHOL SCI, V21, P1202, DOI 10.1177/0956797610379234; Pichon S, 2009, NEUROIMAGE, V47, P1873, DOI 10.1016/j.neuroimage.2009.03.084; Pourtois G, 2004, EUR J NEUROSCI, V20, P3507, DOI 10.1111/j.1460-9568.2004.03794.x; Sanchez-Vives MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010381; SANSONE S, 1994, PSYCHOL FR, V39, P327; Schubert TW, 2002, SELF IDENTITY, V1, P353, DOI 10.1080/152988602760328012; Schweinberger SR, 1998, J EXP PSYCHOL HUMAN, V24, P1748, DOI 10.1037/0096-1523.24.6.1748; SERGENT J, 1989, BRAIN, V112, P975, DOI 10.1093/brain/112.4.975; Sergent J., 1994, VIS COGN, V1, P349, DOI [10.1080/13506289408402305, DOI 10.1080/13506289408402305]; Serino A, 2008, PSYCHOL SCI, V19, P434, DOI 10.1111/j.1467-9280.2008.02105.x; Sforza A, 2010, SOC NEUROSCI-UK, V5, P148, DOI 10.1080/17470910903205503; Sonnby-Borgstrom M, 2002, SCAND J PSYCHOL, V43, P433, DOI 10.1111/1467-9450.00312; Spangler SM, 2010, J EXP CHILD PSYCHOL, V105, P1, DOI 10.1016/j.jecp.2009.09.003; Sui J, 2007, PSYCHOL SCI, V18, P861, DOI 10.1111/j.1467-9280.2007.01992.x; Tajadura-Jimenez A, 2012, CONSCIOUS COGN, V21, P1725, DOI 10.1016/j.concog.2012.10.004; Tong F, 1999, J EXP PSYCHOL HUMAN, V25, P1016, DOI 10.1037/0096-1523.25.4.1016; TRANEL D, 1988, NEUROLOGY, V38, P690, DOI 10.1212/WNL.38.5.690; Tsakiris M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004040; Verosky SC, 2010, NEUROIMAGE, V49, P1690, DOI 10.1016/j.neuroimage.2009.10.017; Winston JS, 2004, J NEUROPHYSIOL, V92, P1830, DOI 10.1152/jn.00155.2004	51	12	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136273	10.1371/journal.pone.0136273	http://dx.doi.org/10.1371/journal.pone.0136273			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5KH	26291532	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000359919900072
J	Chakraborty, D; Wang, TL; Andre, K; Konnert, M; Lexer, MJ; Matulla, C; Schueler, S				Chakraborty, Debojyoti; Wang, Tongli; Andre, Konrad; Konnert, Monika; Lexer, Manfred J.; Matulla, Christoph; Schueler, Silvio			Selecting Populations for Non-Analogous Climate Conditions Using Universal Response Functions: The Case of Douglas-Fir in Central Europe	PLOS ONE			English	Article							FOREST TREES; INTRASPECIFIC VARIATION; ASSISTED MIGRATION; GROWTH-RESPONSE; SEED ZONES; ADAPTATION; DROUGHT; SPRUCE; PINE; DISTRIBUTIONS	Identifying populations within tree species potentially adapted to future climatic conditions is an important requirement for reforestation and assisted migration programmes. Such populations can be identified either by empirical response functions based on correlations of quantitative traits with climate variables or by climate envelope models that compare the climate of seed sources and potential growing areas. In the present study, we analyzed the intraspecific variation in climate growth response of Douglas-fir planted within the non-analogous climate conditions of Central and continental Europe. With data from 50 common garden trials, we developed Universal Response Functions ( URF) for tree height and mean basal area and compared the growth performance of the selected best performing populations with that of populations identified through a climate envelope approach. Climate variables of the trial location were found to be stronger predictors of growth performance than climate variables of the population origin. Although the precipitation regime of the population sources varied strongly none of the precipitation related climate variables of population origin was found to be significant within the models. Overall, the URFs explained more than 88% of variation in growth performance. Populations identified by the URF models originate from western Cascades and coastal areas of Washington and Oregon and show significantly higher growth performance than populations identified by the climate envelope approach under both current and climate change scenarios. The URFs predict decreasing growth performance at low and middle elevations of the case study area, but increasing growth performance on high elevation sites. Our analysis suggests that population recommendations based on empirical approaches should be preferred and population selections by climate envelope models without considering climatic constrains of growth performance should be carefully appraised before transferring populations to planting locations with novel or dissimilar climate.	[Chakraborty, Debojyoti; Lexer, Manfred J.] Univ Nat Resources & Life Sci, Inst Silviculture, Dept Forest & Soil Sci, Vienna, Austria; [Wang, Tongli] Univ British Columbia, Dept Forest & Conservat Sci, Ctr Forest Conservat Genet, Vancouver, BC V5Z 1M9, Canada; [Andre, Konrad; Matulla, Christoph] Cent Inst Meteorol & Geodynam, Vienna, Austria; [Konnert, Monika] Bavarian Off Forest Seeding & Planting, Teisendorf, Germany; [Schueler, Silvio] Fed Res & Training Ctr Forest Nat Hazards & Lands, Dept Forest Genet, Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; University of British Columbia	Schueler, S (corresponding author), Fed Res & Training Ctr Forest Nat Hazards & Lands, Dept Forest Genet, Vienna, Austria.	silvio.schueler@bfw.gv.at	Schueler, Silvio/V-2612-2019; Chakraborty, Debojyoti/GRI-9445-2022; Wang, Tongli/AAC-8644-2020; Wang, Tongli/AAW-4427-2020	Schueler, Silvio/0000-0003-0155-5692; Wang, Tongli/0000-0002-9967-6769; Chakraborty, Debojyoti/0000-0002-7128-2688	Austrian climate research programme ACRP [B175092]	Austrian climate research programme ACRP	Austrian climate research programme ACRP, 4th Call for Proposals, Project no. B175092 https://www.klimafonds.gv.at/foerderungen/aktuelle-foerderungen/2011/austrian-climate-research-program/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams MD, 2011, TREE PHYSIOL, V31, P258, DOI 10.1093/treephys/tpr010; Aitken SN, 2008, EVOL APPL, V1, P95, DOI 10.1111/j.1752-4571.2007.00013.x; Akaike H., 1974, IEEE T AUTOMATIC CON, P19; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Andalo C, 2005, FOREST ECOL MANAG, V205, P169, DOI 10.1016/j.foreco.2004.10.045; Bansal S, 2015, GLOBAL CHANGE BIOL, V21, P947, DOI 10.1111/gcb.12719; Block K, 2013, J ADV MODEL EARTH SY, V5, P676, DOI 10.1002/jame.20041; Breda N, 2006, ANN FOREST SCI, V63, P625, DOI 10.1051/forest:2006042; Buntgen U, 2010, CLIM DYNAM, V35, P315, DOI 10.1007/s00382-009-0563-2; Burnham KP, 2002, MODEL SELECTION MULT, P149, DOI [10.1007/978-0-387-22456-5_4, DOI 10.1007/978-0-387-22456-5_4]; Carter KK, 1996, CAN J FOREST RES, V26, P1089, DOI 10.1139/x26-120; Darychuk N, 2012, CAN J FOREST RES, V42, P1530, DOI [10.1139/X2012-092, 10.1139/x2012-092]; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Eilmann B, 2013, FOREST ECOL MANAG, V302, P133, DOI 10.1016/j.foreco.2013.03.031; Hamann A, 2011, TREE GENET GENOMES, V7, P399, DOI 10.1007/s11295-010-0341-7; Hamrick JL, 2004, FOREST ECOL MANAG, V197, P323, DOI 10.1016/j.foreco.2004.05.023; Haslinger K, 2013, CLIM DYNAM, V40, P511, DOI 10.1007/s00382-012-1452-7; Hermann RK, 1999, NEW FOREST, V17, P53, DOI 10.1023/A:1006581028080; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hobbs RJ, 2006, GLOBAL ECOL BIOGEOGR, V15, P1, DOI 10.1111/j.1466-822x.2006.00212.x; Isaac-Renton MG, 2014, GLOBAL CHANGE BIOL, V20, P2607, DOI 10.1111/gcb.12604; Jacob D, 2014, REG ENVIRON CHANGE, V14, P563, DOI 10.1007/s10113-013-0499-2; Kapeller S, 2012, FOREST ECOL MANAG, V271, P46, DOI 10.1016/j.foreco.2012.01.039; Kavanagh KL, 1999, TREE PHYSIOL, V19, P31; Konig A.O., 2005, CONSERVATION MANAGEM, P275; Kopp M, 2014, EVOL APPL, V7, P169, DOI 10.1111/eva.12127; Krakowski J, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2009069; Kremer A, 2012, ECOL LETT, V15, P378, DOI 10.1111/j.1461-0248.2012.01746.x; Leites LP, 2012, ECOL APPL, V22, P154, DOI 10.1890/11-0150.1; Lesser MR, 2006, CAN J FOREST RES, V36, P1572, DOI 10.1139/X06-047; Lindner M, 2014, J ENVIRON MANAGE, V146, P69, DOI 10.1016/j.jenvman.2014.07.030; Lumley T., 2009, LEAPS REGRESSION SUB; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; Marris E., 2008, NATURE REPORTS, V2, P112, DOI DOI 10.1038/CLIMATE2008.86; Matyas C, 1996, EUPHYTICA, V92, P45, DOI 10.1007/BF00022827; MATYAS C, 1994, TREE PHYSIOL, V14, P797, DOI 10.1093/treephys/14.7-8-9.797; McKenney D, 2009, FOREST CHRON, V85, P258, DOI 10.5558/tfc85258-2; McLachlan JS, 2007, CONSERV BIOL, V21, P297, DOI 10.1111/j.1523-1739.2007.00676.x; McLane SC, 2011, ECOL APPL, V21, P776, DOI 10.1890/10-0131.1; Midgley GF, 2001, PLANT PHYSL RESPONSE; Nathan R, 2011, ECOL LETT, V14, P211, DOI 10.1111/j.1461-0248.2010.01573.x; O'Neill GA, 2008, J APPL ECOL, V45, P1040, DOI 10.1111/j.1365-2664.2008.01472.x; Ohlemuller R, 2006, GLOBAL ECOL BIOGEOGR, V15, P395, DOI 10.1111/j.1466-822X.2006.00245.x; Oney B, 2013, ECOL EVOL, V3, P437, DOI 10.1002/ece3.426; Petit RJ, 2008, SCIENCE, V320, P1450, DOI 10.1126/science.1155457; Rehfeldt GE, 1999, ECOL MONOGR, V69, P375, DOI 10.1890/0012-9615(1999)069[0375:GRTCIP]2.0.CO;2; Rehfeldt GE, 2014, FOREST ECOL MANAG, V324, P147, DOI 10.1016/j.foreco.2014.02.040; Rehfeldt GE, 2014, FOREST ECOL MANAG, V324, P126, DOI 10.1016/j.foreco.2014.02.035; Roberts DR, 2012, ECOGRAPHY, V35, P792, DOI 10.1111/j.1600-0587.2011.07147.x; Roberts DR, 2012, GLOBAL ECOL BIOGEOGR, V21, P121, DOI 10.1111/j.1466-8238.2011.00657.x; Sergent AS, 2014, ANN FOREST SCI, V71, P697, DOI 10.1007/s13595-012-0220-5; Sykes MT, 1996, J BIOGEOGR, V23, P203; Team RC, 2013, R LANGUAGE ENV STAT; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P5, DOI [10.1007/s10584-011-0148-z, 10.1007/s10584-011-0157-y]; Wang T, 2006, GLOBAL CHANGE BIOL, V12, P2404, DOI 10.1111/j.1365-2486.2006.01271.x; Wang TL, 2012, J APPL METEOROL CLIM, V51, P16, DOI 10.1175/JAMC-D-11-043.1; Wang TL, 2010, ECOL APPL, V20, P153, DOI 10.1890/08-2257.1; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104; Yang J, 2015, FOREST ECOL MANAG, V339, P34, DOI 10.1016/j.foreco.2014.12.001; Zhu K, 2012, GLOBAL CHANGE BIOL, V18, P1042, DOI 10.1111/j.1365-2486.2011.02571.x	61	38	39	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136357	10.1371/journal.pone.0136357	http://dx.doi.org/10.1371/journal.pone.0136357			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288363	Green Published, Green Submitted, gold			2022-12-26	WOS:000360018600134
J	Freire-Maia, FB; Auad, SM; de Abreu, MHNG; Sardenberg, F; Martins, MT; Paiva, SM; Pordeus, IA; Vale, MP				Freire-Maia, Fernanda Bartolomeo; Auad, Sheyla Marcia; Nogueira Guimaraes de Abreu, Mauro Henrique; Sardenberg, Fernanda; Martins, Milene Torres; Paiva, Saul Martins; Pordeus, Isabela Almeida; Vale, Miriam Pimenta			Oral Health-Related Quality of Life and Traumatic Dental Injuries in Young Permanent Incisors in Brazilian Schoolchildren: A Multilevel Approach	PLOS ONE			English	Article							PRESCHOOL-CHILDREN; DENTOALVEOLAR TRAUMA; SCHOOL-CHILDREN; SEX-DIFFERENCES; IMPACT; ADOLESCENTS; POPULATION; QUESTIONNAIRE; PERCEPTIONS; FAMILIES	Background Traumatic dental injury (TDI) during childhood may negatively impact the quality of life of children. Objective To describe the association of oral health-related quality of life (OHRQoL) and domains (oral symptons, functional limitation, emotional-and social-well-being) of children with individual and contextual variables. Methods A cross-sectional study was performed using a representative sample of 1,201 schoolchildren, 8-10 years-old, from public and private schools of Belo Horizonte, Brazil. The CPQ8-10 was used to assess OHRQoL, dichotomized in low and high impact. Sociodemographic information was collected through questionnaires to parents. Children were examined at schools, using the Andreasen criteria. Individual variables were gender, age, number of residents in home, parents/caregivers' level of education, family income, and TDI (dichotomized into without trauma/mild trauma and severe trauma). Dental caries and malocclusion were considered co-variables. Contextual variables were the Social Vulnerability Index and type of school. Ethical approval and consent forms were obtained. Data were analyzed using SPSS for Windows 19.0 and HLM 6.06, including frequency distribution, chi-squared test and multilevel approach (p < 0.05). Results The prevalence of a negative impact on OHRQoL in children with severe trauma was 55.9%. The TDI negatively impacted emotional and social domains of OHRQoL. A multilevel analysis revealed a significant difference in OHRQoL according to the type of school and showed that 16% of the total variance was due to contextual characteristics (p < 0.001; ICC = 0.16). The negative impact on OHRQoL was higher in girls (p = 0.009), younger children (p = 0.023), with severe TDI (p = 0.014), those from public schools (p = 0.017) and whose parents had a lower education level (p = 0.001). Conclusion Severe trauma impacts OHRQoL on emotional and social domains. Contextual dimensions add information to individual variability to explain higher impact, emphasizing socioeconomic inequalities.	[Freire-Maia, Fernanda Bartolomeo; Auad, Sheyla Marcia; Sardenberg, Fernanda; Martins, Milene Torres; Paiva, Saul Martins; Pordeus, Isabela Almeida; Vale, Miriam Pimenta] Univ Fed Minas Gerais, Dept Paediat Dent & Orthodont, Belo Horizonte, MG, Brazil; [Nogueira Guimaraes de Abreu, Mauro Henrique] Univ Fed Minas Gerais, Dept Community & Prevent Dent, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Freire-Maia, FB (corresponding author), Univ Fed Minas Gerais, Dept Paediat Dent & Orthodont, Belo Horizonte, MG, Brazil.	fernandabartolomeo@gmail.com	PORDEUS, ISABELA A/B-1570-2013; Auad, Sheyla/T-7290-2019; Abreu, Mauro Henrique/G-6502-2012; Paiva, Saul Martins/H-5757-2012	PORDEUS, ISABELA A/0000-0002-5902-7481; Abreu, Mauro Henrique/0000-0001-8794-5725; Paiva, Saul Martins/0000-0002-3968-1638; Auad, Sheyla/0000-0002-4572-6425	National Council for Scientific and Technological Development (CNPq); Ministry of Science and Technology; State of Minas Gerais Research Foundation (FAPEMIG), Brazilian Coordination of Higher Education (CAPES), Brazil	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); State of Minas Gerais Research Foundation (FAPEMIG), Brazilian Coordination of Higher Education (CAPES), Brazil	This study was supported by the National Council for Scientific and Technological Development (CNPq), the Ministry of Science and Technology and the State of Minas Gerais Research Foundation (FAPEMIG), Brazilian Coordination of Higher Education (CAPES), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abanto J, 2014, INT J PEDIA IN PRESS; Abanto J, 2014, COMMUNITY DENT ORAL, V42, P385, DOI 10.1111/cdoe.12099; Aldrigui JM, 2014, COMMUNITY DENT ORAL, V42, P30, DOI 10.1111/cdoe.12053; Antunes LAA, 2013, PEDIATR DENT, V35, P37; Antunes LAA, 2012, DENT TRAUMATOL, V28, P256, DOI 10.1111/j.1600-9657.2011.01094.x; Andreasen JO, 2007, TXB COLOR ATLAS TRAU, V4th; Bendo CB, 2014, INT J PAEDIATR DENT, V24, P387, DOI 10.1111/ipd.12083; Bendo CB, 2014, COMMUNITY DENT ORAL, V42, P216, DOI 10.1111/cdoe.12078; Bendo CB, 2012, INT J ENV RES PUB HE, V9, P4278, DOI 10.3390/ijerph9124278; Bendo CB, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-114; Berger TD, 2009, DENT TRAUMATOL, V25, P462, DOI 10.1111/j.1600-9657.2009.00809.x; Castro RDL, 2011, COMMUNITY DENT ORAL, V39, P336, DOI 10.1111/j.1600-0528.2010.00601.x; Cortes MID, 2002, COMMUNITY DENT ORAL, V30, P193; Dame-Teixeira N, 2013, INT J PAEDIATR DENT, V23, P266, DOI 10.1111/ipd.12002; de Paula JS, 2013, BMC ORAL HEALTH, V13, DOI 10.1186/1472-6831-13-10; Fakhruddin KS, 2008, DENT TRAUMATOL, V24, P309, DOI 10.1111/j.1600-9657.2007.00547.x; Gose M, 2013, INT J ENV RES PUB HE, V10, P5083, DOI 10.3390/ijerph10105083; Guedes RS, 2014, QUAL LIFE RES, V23, P2521, DOI 10.1007/s11136-014-0690-z; Jokovic A, 2004, PEDIATR DENT, V26, P512; Kret ME, 2012, NEUROPSYCHOLOGIA, V50, P1211, DOI 10.1016/j.neuropsychologia.2011.12.022; Kumar S, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-41; Lisboa CM, 2013, BMC ORAL HEALTH, V13, DOI 10.1186/1472-6831-13-56; Locker D, 2007, COMMUNITY DENT ORAL, V35, P348, DOI 10.1111/j.1600-0528.2006.00323.x; Malikaew Peerasak, 2003, Oral Health Prev Dent, V1, P255; Mansour ME, 2003, PEDIATRICS, V111, P1372, DOI 10.1542/peds.111.6.1372; Martins MT, 2009, EUR J PAEDIATR DENT, V10, P135; Martins MT, 2014, COMMUNITY DENT ORAL, V42, P289, DOI 10.1111/cdoe.12087; McGrath C, 2004, COMMUNITY DENT ORAL, V32, P81, DOI 10.1111/j.1600-0528.2004.00149.x; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P443, DOI 10.1136/jech.2004.023473; Moyses ST, 2003, HEALTH PROMOT INT, V18, P209, DOI 10.1093/heapro/dag016; Nahas MI, 2000, CAD CIENC SOC, V7, P75; Page LAF, 2013, INT J PAEDIATR DENT, V23, P415, DOI 10.1111/ipd.12011; Pappa E, 2009, INT J PUBLIC HEALTH, V54, P241, DOI 10.1007/s00038-009-8057-x; Patel M C, 2012, J Indian Soc Pedod Prev Dent, V30, P151, DOI 10.4103/0970-4388.99992; Pattussi MP, 2006, AM J PUBLIC HEALTH, V96, P1462, DOI 10.2105/AJPH.2005.066159; Paula JS, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-6; Peres MA, 2010, BMC ORAL HEALTH, V10, DOI 10.1186/1472-6831-10-20; Piovesan C, 2012, J PUBLIC HEALTH DENT, V72, P156, DOI 10.1111/j.1752-7325.2011.00301.x; Piovesan C, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-37; Piovesan C, 2010, QUAL LIFE RES, V19, P1359, DOI 10.1007/s11136-010-9692-7; Porritt JM, 2011, DENT TRAUMATOL, V27, P2, DOI 10.1111/j.1600-9657.2010.00943.x; Ramos-Jorge J, 2014, DENT TRAUMATOL, V30, P27, DOI 10.1111/edt.12048; Ramos-Jorge ML, 2007, DENT TRAUMATOL, V23, P114, DOI 10.1111/j.1600-9657.2005.00409.x; Sardenberg F, 2013, ANGLE ORTHOD, V83, P83, DOI 10.2319/010912-20.1; Scarpelli AC, 2013, COMMUNITY DENT ORAL, V41, P336, DOI 10.1111/cdoe.12022; Schuch HS, 2014, INT J PEDIA IN PRESS; Sellstrom E, 2006, J EPIDEMIOL COMMUN H, V60, P149, DOI 10.1136/jech.2005.036707; Siqueira MB, 2013, INT J ENV RES PUB HE, V10, P6422, DOI 10.3390/ijerph10126422; Snidjers TAB, 2012, MULTILEVEL ANAL INTR; Toprak ME, 2014, DENT TRAUMATOL, V30, P280, DOI 10.1111/edt.12092; Traebert J, 2012, DENT TRAUMATOL, V28, P423, DOI 10.1111/j.1600-9657.2012.01114.x; Viegas CM, 2014, DENT TRAUMATOL, V30, P338, DOI 10.1111/edt.12091; Viegas CM, 2012, PEDIATR DENT, V34, P300; Whittle S, 2011, BIOL PSYCHOL, V87, P319, DOI 10.1016/j.biopsycho.2011.05.003	54	41	46	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135369	10.1371/journal.pone.0135369	http://dx.doi.org/10.1371/journal.pone.0135369			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP6SN	26287386	Green Submitted, Green Published, gold			2022-12-26	WOS:000360018600045
J	Salkeld, DJ; Nieto, NC; Carbajales-Dale, P; Carbajales-Dale, M; Cinkovich, SS; Lambin, EF				Salkeld, Daniel J.; Nieto, Nathan C.; Carbajales-Dale, Patricia; Carbajales-Dale, Michael; Cinkovich, Stephanie S.; Lambin, Eric F.			Disease Risk & Landscape Attributes of Tick-Borne Borrelia Pathogens in the San Francisco Bay Area, California	PLOS ONE			English	Article							NORTHEASTERN UNITED-STATES; LYME-DISEASE; NORTHWESTERN CALIFORNIA; GRANULOCYTIC ANAPLASMOSIS; MIYAMOTOI INFECTION; HABITAT TYPE; BURGDORFERI; SPIROCHETE; DIVERSITY; TRANSMISSION	Habitat heterogeneity influences pathogen ecology by affecting vector abundance and the reservoir host communities. We investigated spatial patterns of disease risk for two human pathogens in the Borrelia genus-B. burgdorferi and B. miyamotoi-that are transmitted by the western black-legged tick, Ixodes pacificus. We collected ticks (349 nymphs, 273 adults) at 20 sites in the San Francisco Bay Area, California, USA. Tick abundance, pathogen prevalence and density of infected nymphs varied widely across sites and habitat type, though nymphal western black-legged ticks were more frequently found, and were more abundant in coast live oak forest and desert/semi-desert scrub (dominated by California sagebrush) habitats. We observed Borrelia infections in ticks at all sites where we able to collect >10 ticks. The recently recognized human pathogen, B. miyamotoi, was observed at a higher prevalence (13/349 nymphs = 3.7%, 95% CI = 2.0-6.3; 5/273 adults = 1.8%, 95% CI = 0.6-4.2) than recent studies from nearby locations (Alameda County, east of the San Francisco Bay), demonstrating that tick-borne disease risk and ecology can vary substantially at small geographic scales, with consequences for public health and disease diagnosis.	[Salkeld, Daniel J.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Salkeld, Daniel J.; Cinkovich, Stephanie S.; Lambin, Eric F.] Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA; [Nieto, Nathan C.] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA; [Carbajales-Dale, Patricia] Clemson Univ, Ctr Excellence Next Generat Comp, Clemson, SC USA; [Carbajales-Dale, Michael] Clemson Univ, Coll Engn & Sci, Clemson, SC USA; [Lambin, Eric F.] Stanford Univ, Sch Earth Energy & Environm, Stanford, CA 94305 USA	Colorado State University; Stanford University; Northern Arizona University; Clemson University; Clemson University; Stanford University	Salkeld, DJ (corresponding author), Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA.	dan.salkeld@colostate.edu	Carbajales-Dale, Michael/I-7914-2015	Carbajales-Dale, Michael/0000-0002-1568-384X; Lambin, Eric/0000-0002-0673-5257	Bay Area Lyme Foundation	Bay Area Lyme Foundation	This study was supported by a grant from the Bay Area Lyme Foundation, http://www.bayarealyme.org/, to DJS, NCN and EL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Barbour AG, 2009, AM J TROP MED HYG, V81, P1120, DOI 10.4269/ajtmh.2009.09-0208; Bay Area Open Space Council, 2011, CONS LANDS NETW SAN; Bunikis J, 2004, MICROBIOL-SGM, V150, P1741, DOI 10.1099/mic.0.26944-0; Burnham K P, 2003, MODEL SELECT MULTIMO; Chowdri HR, 2013, ANN INTERN MED, V159, P21, DOI 10.7326/0003-4819-159-1-201307020-00005; Crawley MJ, 2005, STAT INTRO USING R; Crowder CD, 2014, EMERG INFECT DIS, V20, P1678, DOI 10.3201/eid2010.131583; Eisen L, 2009, J VECTOR ECOL, V34, P81, DOI [10.1111/j.1948-7134.2009.00010.x, 10.3376/038.034.0110]; Eisen RJ, 2006, AM J TROP MED HYG, V75, P669, DOI 10.4269/ajtmh.2006.75.669; Eisen RJ, 2010, TICKS TICK-BORNE DIS, V1, P35, DOI 10.1016/j.ttbdis.2009.12.002; Fedorova N, 2014, TICKS TICK-BORNE DIS, V5, P951, DOI 10.1016/j.ttbdis.2014.07.015; Finch C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084758; Foley JE, 2009, AM J TROP MED HYG, V81, P1132, DOI 10.4269/ajtmh.2009.09-0372; Girard YA, 2009, APPL ENVIRON MICROB, V75, P7243, DOI 10.1128/AEM.01704-09; Gugliotta JL, 2013, NEW ENGL J MED, V368, P240, DOI 10.1056/NEJMoa1209039; Holden K, 2003, J MED ENTOMOL, V40, P534, DOI 10.1603/0022-2585-40.4.534; Krause PJ, 2014, EMERG INFECT DIS, V20, P1183, DOI 10.3201/eid2007.131587; Krause PJ, 2013, NEW ENGL J MED, V368, P291, DOI 10.1056/NEJMc1215469; Lane RS, 2010, TICKS TICK-BORNE DIS, V1, P159, DOI 10.1016/j.ttbdis.2010.09.004; Molloy PJ, 2015, ANN INTERN MED, V163, P91, DOI 10.7326/M15-0333; Newman EA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118146; Padgett K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110853; Platonov AE, 2011, EMERG INFECT DIS, V17, P1816, DOI 10.3201/eid1710.101474; Salkeld DJ, 2008, AM J TROP MED HYG, V79, P535, DOI 10.4269/ajtmh.2008.79.535; Salkeld DJ, 2014, TICKS TICK-BORNE DIS, V5, P790, DOI 10.1016/j.ttbdis.2014.05.002; Salkeld DJ, 2014, EMERG INFECT DIS, V20, P493, DOI 10.3201/eid2003.130668; Salkeld DJ, 2013, ECOL LETT, V16, P679, DOI 10.1111/ele.12101; Salkeld DJ, 2010, ECOLOGY, V91, P293, DOI 10.1890/08-2106.1; Scoles GA, 2001, VECTOR-BORNE ZOONOT, V1, P21, DOI 10.1089/153036601750137624; Shapiro MR, 2010, CLIN INFECT DIS, V50, P541, DOI 10.1086/649926; Taylor KR, 2013, VECTOR-BORNE ZOONOT, V13, P92, DOI 10.1089/vbz.2012.1027; Wilhelmsson P, 2010, J CLIN MICROBIOL, V48, P4169, DOI 10.1128/JCM.01061-10	33	26	26	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0134812	10.1371/journal.pone.0134812	http://dx.doi.org/10.1371/journal.pone.0134812			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288371	Green Submitted, Green Published, gold			2022-12-26	WOS:000360018600029
J	Konstantyner, T; Sesso, R; de Camargo, MF; Feltran, LD; Koch-Nogueira, PC				Konstantyner, Tulio; Sesso, Ricardo; de Camargo, Maria Fernanda; Feltran, Luciana de Santis; Koch-Nogueira, Paulo Cesar			Pediatric Chronic Dialysis in Brazil: Epidemiology and Regional Inequalities	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; RENAL REPLACEMENT THERAPY; CHILDREN; PREVALENCE	Introduction There are few reports in the literature estimating the epidemiologic characteristics of pediatric chronic dialysis. These patients have impaired physical growth, high number of comorbidities and great need for continuous attention of specialized services with high demand for complex and costly procedures. Objective The aim of this study was to estimate the incidence and prevalence rates and describe the characteristics of children and adolescents undergoing chronic dialysis treatment in a Brazilian demographic health survey. Materials and Methods A cross-sectional study was performed in a representative sample of dialysis centers (n(c) = 239) that was established from the 2011 Brazilian Nephrology Society Census (N-c = 708). We collected data encompassing the five Brazilian macro-regions. We analyzed the data from all patients under 19 years of age. The sample population consisted of 643 children and adolescents who were on chronic dialysis program anytime in 2012. Data collection was carried out in the dialysis services by means of patients' records reviews and personal interviews with the centers' leaders. Results We estimated that there were a total of 1,283 pediatric patients on chronic dialysis treatment in Brazil, resulting in a prevalence of 20.0 cases per million age-related population (pmarp) (95% CI: 14.8-25.3) and an incidence of 6.6 cases pmarp in 2012 (95% CI: 4.8-8.4). The South region had the highest prevalence and incidence rates of patients under dialysis therapy, 27.7 (95% CI: 7.3-48.1) and 11.0 (95% CI: 2.8-19.3) cases pmarp, respectively; the lowest prevalence and incidence rates were found in the North-Midwest region, 13.8 (95% CI: 6.2-21.4), and in the Northeast region, 3.8 (95% CI: 1.4-6.3) cases pmarp, respectively.	[Konstantyner, Tulio; Sesso, Ricardo; de Camargo, Maria Fernanda; Feltran, Luciana de Santis; Koch-Nogueira, Paulo Cesar] Soc Hosp Samaritano, Sao Paulo, Brazil; [Konstantyner, Tulio; Koch-Nogueira, Paulo Cesar] Univ Fed Sao Paulo, Div Pediat, Sao Paulo, Brazil; [Sesso, Ricardo] Univ Fed Sao Paulo, Div Nephrol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Konstantyner, T (corresponding author), Soc Hosp Samaritano, Sao Paulo, Brazil.	tkmed@uol.com.br	Nogueira, Paulo Cesar Koch/E-8376-2010; Feltran, Luciana S/F-2735-2013; Konstantyner, Tulio/N-1983-2013; Konstantyner, Tulio/H-3063-2019	Nogueira, Paulo Cesar Koch/0000-0002-9536-9665; Feltran, Luciana S/0000-0003-3339-0749; Konstantyner, Tulio/0000-0002-7931-9692; Konstantyner, Tulio/0000-0002-7931-9692; Sesso, Ricardo/0000-0002-1062-0073	Brazilian Ministry of Health by the 'Programa de Apoio ao Desenvolvimento Institucional do Sistema Unico de Saude - PROADI-SUS' [25000.180613/2011-11]	Brazilian Ministry of Health by the 'Programa de Apoio ao Desenvolvimento Institucional do Sistema Unico de Saude - PROADI-SUS'	'Sociedade Hospital Samaritano' received funding from the Brazilian Ministry of Health by the 'Programa de Apoio ao Desenvolvimento Institucional do Sistema Unico de Saude - PROADI-SUS', protocol number: 25000.180613/2011-11 (http://portalsaude.saude.gov.br/index.php?option=com_content&view=article&id=9538&Itemid=497). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardissino G, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.4.e382; Chadha V, 2005, ADV CHRONIC KIDNEY D, V12, P343, DOI 10.1053/j.ackd.2005.07.013; Chesnaye N, 2014, PEDIAT NEPHROL; de Araujo EM, 2009, INTERFACE-BOTUCATU, V13, P383, DOI 10.1590/S1414-32832009000400012; Garcia-Garcia G, 2015, PEDIATR NEPHROL, V30, P183, DOI 10.1007/s00467-014-2996-z; Gregg M, 2008, FIELD EPIDEMIOLOGY, V3rd; Harambat J, 2012, PEDIATR NEPHROL, V27, P363, DOI 10.1007/s00467-011-1939-1; [Interagency Network of Health Information of the Ministry of Health of Brazil (RIPSA) Brazil Ministry of Health], 2012, INT NETW HLTH INF MI; Jager KJ, 2007, KIDNEY INT, V72, P412, DOI 10.1038/sj.ki.5002341; Kirkwood B.R., 2003, ESSENTIAL MED STAT, P165; Nogueira PCK, 2011, REV ASSOC MED BRAS, V57, P443, DOI 10.1590/S0104-42302011000400020; KORN EL, 1999, WILEY S PRO STAT SUR, P1; Lewis MA, 2010, NEPHRON CLIN PRACT, V115, pC279, DOI 10.1159/000301237; Liyanage T, 2015, LANCET, V385, P1975, DOI 10.1016/S0140-6736(14)61601-9; Matas AJ, 2015, AM J TRANSPLANT, V15, DOI 10.1111/ajt.13195; McDonald SP, 2004, NEW ENGL J MED, V350, P2654, DOI 10.1056/NEJMoa031643; McTaggart S, 2008, INCIDENCE PREVALENCE, P1; North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS), 2011, 2011 ANN DIAL REP; Paim J, 2011, LANCET; Prutsch U, 2014, HIST CIENC SAUDE-MAN, V21, P219, DOI 10.1590/S0104-59702014005000005; Registry ERA-EDTA, 2010, ERA EDTA REG ANN REP; Ribeiro Patricia Tavares, 2007, Cien Saude Colet, V12, P1525, DOI 10.1590/S1413-81232007000600014; Sesso Ricardo de Castro Cintra, 2012, J Bras Nefrol, V34, P272; StataCorp, 2013, STAT STAT SOFTW REL; Stengel B, 2006, J AM SOC NEPHROL, V17, P2094, DOI 10.1681/ASN.2006060636; The ESRD Incidence Study Group, 2006, NEPHROL DIAL TRANSPL; United Nations Development Programme, 2010, ATL HUM DEV BRAZ; United States Renal Data System, 2014, 2014 ANN DAT REP EP; van der Heijden BJ, 2004, PEDIATR NEPHROL, V19, P213, DOI 10.1007/s00467-003-1376-x; Warady BA, 2007, PEDIATR NEPHROL, V22, P1999, DOI 10.1007/s00467-006-0410-1	30	20	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135649	10.1371/journal.pone.0135649	http://dx.doi.org/10.1371/journal.pone.0135649			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285019	Green Published, Green Submitted, gold			2022-12-26	WOS:000359666100053
J	Shannon, S; Vaca, C; Jia, DX; Entersz, I; Schaer, A; Carcione, J; Weaver, M; Avidar, Y; Pettit, R; Nair, M; Khan, A; Foty, RA				Shannon, Stephen; Vaca, Connan; Jia, Dongxuan; Entersz, Ildiko; Schaer, Andrew; Carcione, Jonathan; Weaver, Michael; Avidar, Yoav; Pettit, Ryan; Nair, Mohan; Khan, Atif; Foty, Ramsey A.			Dexamethasone-Mediated Activation of Fibronectin Matrix Assembly Reduces Dispersal of Primary Human Glioblastoma Cells	PLOS ONE			English	Article							CONTACT INHIBITION; STREPTOCOCCUS-PYOGENES; EMBRYONIC-TISSUES; GLIOMA-CELLS; INVASION; COHESION; GROWTH; MIGRATION; INTEGRIN; ADHESION	Despite resection and adjuvant therapy, the 5-year survival for patients with Glioblastoma multiforme (GBM) is less than 10%. This poor outcome is largely attributed to rapid tumor growth and early dispersal of cells, factors that contribute to a high recurrence rate and poor prognosis. An understanding of the cellular and molecular machinery that drive growth and dispersal is essential if we are to impact long-term survival. Our previous studies utilizing a series of immortalized GBM cell lines established a functional causation between activation of fibronectin matrix assembly (FNMA), increased tumor cohesion, and decreased dispersal. Activation of FNMA was accomplished by treatment with Dexamethasone (Dex), a drug routinely used to treat brain tumor related edema. Here, we utilize a broad range of qualitative and quantitative assays and the use of a human GBM tissue microarray and freshly-isolated primary human GBM cells grown both as conventional 2D cultures and as 3D spheroids to explore the role of Dex and FNMA in modulating various parameters that can significantly influence tumor cell dispersal. We show that the expression and processing of fibronectin in a human GBM tissue-microarray is variable, with 90% of tumors displaying some abnormality or lack in capacity to secrete fibronectin or assemble it into a matrix. We also show that low-passage primary GBM cells vary in their capacity for FNMA and that Dex treatment reactivates this process. Activation of FNMA effectively "glues" cells together and prevents cells from detaching from the primary mass. Dex treatment also significantly increases the strength of cell-ECM adhesion and decreases motility. The combination of increased cohesion and decreased motility discourages in vitro and ex vivo dispersal. By increasing cell-cell cohesion, Dex also decreases growth rate of 3D spheroids. These effects could all be reversed by an inhibitor of FNMA and by the glucocorticoid receptor antagonist, RU-486. Our results describe a new role for Dex as a suppressor of GBM dispersal and growth.	[Shannon, Stephen; Vaca, Connan; Jia, Dongxuan; Entersz, Ildiko; Schaer, Andrew; Carcione, Jonathan; Weaver, Michael; Avidar, Yoav; Pettit, Ryan; Nair, Mohan; Foty, Ramsey A.] Rutgers Robert Wood Johnson Med Sch, Dept Surg, New Brunswick, NJ 08901 USA; [Khan, Atif] Rutgers Robert Wood Johnson Med Sch, Canc Inst New Jersey, Dept Radiat Oncol, New Brunswick, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Foty, RA (corresponding author), Rutgers Robert Wood Johnson Med Sch, Dept Surg, New Brunswick, NJ 08901 USA.	fotyra@rwjms.rutgers.edu		Khan, Atif/0000-0001-8640-8530; Weaver, Michael/0000-0002-8761-3867	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM093854] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aaberg-Jessen C, 2013, INT J CLIN EXP PATHO, V6, P546; ABERCROMBIE M, 1979, NATURE, V281, P259, DOI 10.1038/281259a0; Butler CM, 2011, JOVE-J VIS EXP, DOI 10.3791/2739; Caicedo-Carvajal CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011830; Chiang HY, 2009, ARTERIOSCL THROM VAS, V29, P1074, DOI 10.1161/ATVBAHA.108.181081; Clarke J, 2010, ARCH NEUROL-CHICAGO, V67, P279, DOI 10.1001/archneurol.2010.5; Davidson PM, 2014, CELL MOL BIOENG, V7, P293, DOI 10.1007/s12195-014-0342-y; Donev K, 2010, NEUROPATH APPL NEURO, V36, P411, DOI 10.1111/j.1365-2990.2010.01078.x; Douezan S, 2011, P NATL ACAD SCI USA, V108, P7315, DOI 10.1073/pnas.1018057108; Foty RA, 1996, DEVELOPMENT, V122, P1611; FOTY RA, 1994, PHYS REV LETT, V72, P2298, DOI 10.1103/PhysRevLett.72.2298; Galante LL, 2007, J CELL BIOL, V179, P999, DOI 10.1083/jcb.200707150; Garzon-Muvdi T, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001320; HATAM A, 1983, J COMPUT ASSIST TOMO, V7, P295, DOI 10.1097/00004728-198304000-00017; Haugland HK, 1997, ANTICANCER RES, V17, P1035; Hyder CL, 2014, J CELL SCI, V127, P2161, DOI 10.1242/jcs.125062; HYNES RO, 1986, SCI AM, V254, P42, DOI 10.1038/scientificamerican0686-42; Jia DX, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-94; Jurado C, 2005, MOL BIOL CELL, V16, P507, DOI 10.1091/mbc.E04-10-0860; Kawataki T, 2007, EXP CELL RES, V313, P3819, DOI 10.1016/j.yexcr.2007.07.038; Kim SN, 2014, DEVELOPMENT, V141, P3233, DOI 10.1242/dev.106039; LEIGUARDA R, 1985, EUR NEUROL, V24, P23, DOI 10.1159/000115757; MARTZ E, 1972, J CELL PHYSIOL, V79, P189, DOI 10.1002/jcp.1040790205; Maurer LM, 2010, J BIOL CHEM, V285, P41087, DOI 10.1074/jbc.M110.153692; MCKEON RJ, 1995, EXP NEUROL, V136, P32, DOI 10.1006/exnr.1995.1081; Mehta M, 2015, MOL CANCER THER, V14, P1171, DOI 10.1158/1535-7163.MCT-14-0708; Metcalfe P., 2011, PREDICTION PHARMACOK; Nackman GB, 1998, SURGERY, V124, P353, DOI 10.1016/S0039-6060(98)70141-2; Nelson PJ, 2002, KIDNEY INT S1, V61, P99, DOI DOI 10.1046/J.1523-1755.2002.0610S1099.X; PAULUS W, 1994, J NEUROSURG, V80, P515, DOI 10.3171/jns.1994.80.3.0515; Riemenschneider MJ, 2005, AM J PATHOL, V167, P1379, DOI 10.1016/S0002-9440(10)61225-4; Robinson EE, 2004, MOL BIOL CELL, V15, P973, DOI 10.1091/mbc.E03-07-0528; Ryan PL, 2001, P NATL ACAD SCI USA, V98, P4323, DOI 10.1073/pnas.071615398; Sabari J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024810; Sampetrean O, 2011, NEOPLASIA, V13, P784, DOI 10.1593/neo.11624; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Sechler JL, 1996, J CELL BIOL, V134, P573, DOI 10.1083/jcb.134.2.573; Serres E, 2014, ONCOGENE, V33, P3451, DOI 10.1038/onc.2013.305; Shen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035236; Steinberg M, 2013, WIRES DEV BIOL; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Tomasini-Johansson BR, 2001, J BIOL CHEM, V276, P23430, DOI 10.1074/jbc.M103467200; Uhm J. H., 1999, FRONT BIOSCI, V4, P188; VECHT CJ, 1994, NEUROLOGY, V44, P675, DOI 10.1212/WNL.44.4.675; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vizirianakis IS, 2002, INT J ONCOL, V21, P135; Windler-Hart SL, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-14; Winters BS, 2005, INT J CANCER, V114, P371, DOI 10.1002/ijc.20722; Wolf K, 2003, BLOOD, V102, P3262, DOI 10.1182/blood-2002-12-3791; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616	50	25	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135951	10.1371/journal.pone.0135951	http://dx.doi.org/10.1371/journal.pone.0135951			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284619	gold, Green Published, Green Submitted			2022-12-26	WOS:000359666100090
J	Watanabe, K; Ooishi, Y; Kashino, M				Watanabe, Ken; Ooishi, Yuuki; Kashino, Makio			Sympathetic Tone Induced by High Acoustic Tempo Requires Fast Respiration	PLOS ONE			English	Article							ROSTRAL VENTROLATERAL MEDULLA; CHEMOREFLEX RESPONSE; CATECHOLAMINE LEVELS; CENTRAL NUCLEUS; BLOOD-PRESSURE; MUSIC; NEURONS; PROJECTIONS; SYSTEM; RHYTHM	Many studies have revealed the influences of music, and particularly its tempo, on the autonomic nervous system (ANS) and respiration patterns. Since there is the interaction between the ANS and the respiratory system, namely sympatho-respiratory coupling, it is possible that the effect of musical tempo on the ANS is modulated by the respiratory system. Therefore, we investigated the effects of the relationship between musical tempo and respiratory rate on the ANS. Fifty-two healthy people aged 18-35 years participated in this study. Their respiratory rates were controlled by using a silent electronic metronome and they listened to simple drum sounds with a constant tempo. We varied the respiratory rate -acoustic tempo combination. The respiratory rate was controlled at 15 or 20 cycles per minute (CPM) and the acoustic tempo was 60 or 80 beats per minute (BPM) or the environment was silent. Electrocardiograms and an elastic chest band were used to measure the heart rate and respiratory rate, respectively. The mean heart rate and heart rate variability (HRV) were regarded as indices of ANS activity. We observed a significant increase in the mean heart rate and the low (0.04-0.15 Hz) to high (0.15-0.40 Hz) frequency ratio of HRV, only when the respiratory rate was controlled at 20 CPM and the acoustic tempo was 80 BPM. We suggest that the effect of acoustic tempo on the sympathetic tone is modulated by the respiratory system.	[Watanabe, Ken; Kashino, Makio] Tokyo Inst Technol, Dept Informat Proc, Interdisciplinary Grad Sch Sci & Engn, Yokohama, Kanagawa 227, Japan; [Ooishi, Yuuki; Kashino, Makio] NTT Corp, NTT Commun Sci Labs, Human Informat Sci Lab, Atsugi, Kanagawa, Japan; [Kashino, Makio] Japan Sci & Technol Agcy, CREST, Atsugi, Kanagawa, Japan	Tokyo Institute of Technology; Nippon Telegraph & Telephone Corporation; Japan Science & Technology Agency (JST)	Watanabe, K (corresponding author), Tokyo Inst Technol, Dept Informat Proc, Interdisciplinary Grad Sch Sci & Engn, Yokohama, Kanagawa 227, Japan.	watanabe@u.ip.titech.ac.jp	nyakky, k/GXF-5548-2022	Watanabe, Ken/0000-0002-3035-1333	CREST, Japan Science and Technology Agency; NTT Corporation	CREST, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); NTT Corporation	This work was supported by CREST, Japan Science and Technology Agency to Makio Kashino. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NTT Corporation provided support in the form of salaries for authors Yuuki Ooishi and Makio Kashino, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baekey DM, 2010, RESP PHYSIOL NEUROBI, V174, P135, DOI 10.1016/j.resp.2010.09.006; Bernardi L, 2006, HEART, V92, P445, DOI 10.1136/hrt.2005.064600; Bernardi L, 2001, J HYPERTENS, V19, P2221, DOI 10.1097/00004872-200112000-00016; Bernardi L, 2009, CIRCULATION, V119, P3171, DOI 10.1161/CIRCULATIONAHA.108.806174; BORDI F, 1992, J NEUROSCI, V12, P2493; Brattico E, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00308; Camm AJ, 1996, EUR HEART J, V17, P354; Dick TE, 2009, RESP PHYSIOL NEUROBI, V168, P76, DOI 10.1016/j.resp.2009.07.009; Ellis RJ, 2010, MUSIC PERCEPT, V27, P317, DOI 10.1525/MP.2010.27.4.317; HAAS F, 1986, J APPL PHYSIOL, V61, P1185, DOI 10.1152/jappl.1986.61.3.1185; Kondo K, 2002, DIABETIC MED, V19, P359, DOI 10.1046/j.1464-5491.2002.00720.x; Kraus KS, 2012, HEARING RES, V288, P34, DOI 10.1016/j.heares.2012.02.009; Larsen PD, 2010, RESP PHYSIOL NEUROBI, V174, P111, DOI 10.1016/j.resp.2010.04.021; McCrimmon DR, 2000, CLIN EXP PHARMACOL P, V27, P126, DOI 10.1046/j.1440-1681.2000.03193.x; Moraes DJA, 2012, J NEUROPHYSIOL, V108, P610, DOI 10.1152/jn.00057.2012; Nousiainen T, 2001, CLIN SCI, V101, P601, DOI 10.1042/CS20010102; Okada K, 2009, INT HEART J, V50, P95, DOI 10.1536/ihj.50.95; PILOWSKY P, 1992, CLIN EXP PHARMACOL P, V19, P335, DOI 10.1111/j.1440-1681.1992.tb00466.x; PILOWSKY P, 1994, BRAIN RES, V633, P63, DOI 10.1016/0006-8993(94)91522-9; PILOWSKY PM, 1990, J COMP NEUROL, V301, P604, DOI 10.1002/cne.903010409; Saha S, 2005, EUR J NEUROSCI, V21, P1921, DOI 10.1111/j.1460-9568.2005.04023.x; Saha S, 2005, CLIN EXP PHARMACOL P, V32, P450, DOI 10.1111/j.1440-1681.2005.04210.x; Salimpoor VN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007487; Sammler D, 2007, PSYCHOPHYSIOLOGY, V44, P293, DOI 10.1111/j.1469-8986.2007.00497.x; Sato TG, 2012, NEUROSCI LETT, V521, P67, DOI 10.1016/j.neulet.2012.05.061; Spicuzza L, 2000, LANCET, V356, P1495, DOI 10.1016/S0140-6736(00)02881-6; Stark R, 2000, PSYCHOPHYSIOLOGY, V37, P302, DOI 10.1017/S0048577200980570; Szabo A, 1999, J SPORT MED PHYS FIT, V39, P220; Zatorre RJ, 2013, P NATL ACAD SCI USA, V110, P10430, DOI 10.1073/pnas.1301228110; Zoccal DB, 2011, CURR HYPERTENS REP, V13, P229, DOI 10.1007/s11906-011-0198-7	30	9	9	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135589	10.1371/journal.pone.0135589	http://dx.doi.org/10.1371/journal.pone.0135589			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284521	Green Published, Green Submitted, gold			2022-12-26	WOS:000359666100049
J	Wilson, ADM; Brownscombe, JW; Sullivan, B; Jain-Schlaepfer, S; Cooke, SJ				Wilson, Alexander D. M.; Brownscombe, Jacob W.; Sullivan, Brittany; Jain-Schlaepfer, Sofia; Cooke, Steven J.			Does Angling Technique Selectively Target Fishes Based on Their Behavioural Type?	PLOS ONE			English	Article							CATCH-AND-RELEASE; LARGEMOUTH BASS; LEPOMIS-MACROCHIRUS; INDUCED EVOLUTION; BLUEGILL SUNFISH; INDIVIDUAL-DIFFERENCES; PUMPKINSEED SUNFISH; ANIMAL TEMPERAMENT; HANDLING TIME; TELEOST FISH	Recently, there has been growing recognition that fish harvesting practices can have important impacts on the phenotypic distributions and diversity of natural populations through a phenomenon known as fisheries-induced evolution. Here we experimentally show that two common recreational angling techniques (active crank baits versus passive soft plastics) differentially target wild largemouth bass (Micropterus salmoides) and rock bass (Ambloplites rupestris) based on variation in their behavioural tendencies. Fish were first angled in the wild using both techniques and then brought back to the laboratory and tested for individual-level differences in common estimates of personality (refuge emergence, flight-initiation-distance, latency-to-recapture and with a net, and general activity) in an in-lake experimental arena. We found that different angling techniques appear to selectively target these species based on their boldness (as characterized by refuge emergence, a standard measure of boldness in fishes) but not other assays of personality. We also observed that body size was independently a significant predictor of personality in both species, though this varied between traits and species. Our results suggest a context-dependency for vulnerability to capture relative to behaviour in these fish species. Ascertaining the selective pressures angling practices exert on natural populations is an important area of fisheries research with significant implications for ecology, evolution, and resource management.	[Wilson, Alexander D. M.] Deakin Univ, Ctr Integrat Ecol, Sch Life & Environm Sci, Waurn Ponds, Vic 3216, Australia; [Wilson, Alexander D. M.; Brownscombe, Jacob W.; Sullivan, Brittany; Jain-Schlaepfer, Sofia; Cooke, Steven J.] Carleton Univ, Fish Ecol & Conservat Physiol Lab, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Wilson, Alexander D. M.; Brownscombe, Jacob W.; Sullivan, Brittany; Jain-Schlaepfer, Sofia; Cooke, Steven J.] Carleton Univ, Inst Environm Sci, Ottawa, ON K1S 5B6, Canada	Deakin University; Carleton University; Carleton University	Wilson, ADM (corresponding author), Deakin Univ, Ctr Integrat Ecol, Sch Life & Environm Sci, 75 Pigdons Rd, Waurn Ponds, Vic 3216, Australia.	alexander.wilson@ymail.com	Cooke, Steven J/F-4193-2010; Wilson, Alexander/B-3329-2011	Cooke, Steven J/0000-0002-5407-0659; Wilson, Alexander/0000-0002-7696-1671	Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Research Chairs program	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs program(Canada Research Chairs)	The research was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC) through discovery research grants to S.J.C. S.J.C. is also supported by the Canada Research Chairs program.	Allendorf FW, 2009, P NATL ACAD SCI USA, V106, P9987, DOI 10.1073/pnas.0901069106; Alos J, 2014, MAR ECOL PROG SER, V503, P219, DOI 10.3354/meps10745; Alos J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048030; Arlinghaus R, 2008, N AM J FISH MANAGE, V28, P123, DOI 10.1577/M06-263.1; Arlinghaus R, 2007, REV FISH SCI, V15, P75, DOI 10.1080/10641260601149432; Binder TR, 2012, T AM FISH SOC, V141, P1252, DOI 10.1080/00028487.2012.688919; Biro PA, 2008, P NATL ACAD SCI USA, V105, P2919, DOI 10.1073/pnas.0708159105; Biro PA, 2009, TRENDS ECOL EVOL, V24, P66, DOI 10.1016/j.tree.2008.11.001; Brownscombe JW, 2014, FISHERIES, V39, P251, DOI 10.1080/03632415.2014.915811; Chapman BB, 2011, ECOL LETT, V14, P871, DOI 10.1111/j.1461-0248.2011.01648.x; Coleman K, 1998, ANIM BEHAV, V56, P927, DOI 10.1006/anbe.1998.0852; Conrad JL, 2011, J FISH BIOL, V78, P395, DOI 10.1111/j.1095-8649.2010.02874.x; Cooke SJ, 2001, N AM J FISH MANAGE, V21, P333, DOI 10.1577/1548-8675(2000)020&lt;1033:EORGOT&gt;2.0.CO;2; Cooke SJ, 2007, PHYSIOL BIOCHEM ZOOL, V80, P480, DOI 10.1086/520618; Farwell M, 2009, BEHAV ECOL, V20, P913, DOI 10.1093/beheco/arp059; Gaeta JW, 2013, N AM J FISH MANAGE, V33, P606, DOI 10.1080/02755947.2013.785997; Hanson KC, 2010, CAN J ZOOL, V88, P324, DOI 10.1139/Z10-006; Harkonen L, 2014, CAN J FISH AQUAT SCI, V71, P1900, DOI 10.1139/cjfas-2014-0221; Heino M, 2002, B MAR SCI, V70, P639; Isermann DA, 2013, N AM J FISH MANAGE, V33, P344, DOI 10.1080/02755947.2013.763877; Kekalainen J, 2014, J FISH BIOL, V85, P1603, DOI 10.1111/jfb.12516; Klefoth T, 2013, FISHERIES MANAG ECOL, V20, P174, DOI 10.1111/j.1365-2400.2012.00865.x; Kortet R, 2014, BEHAV ECOL SOCIOBIOL, V68, P927, DOI 10.1007/s00265-014-1705-z; Kuparinen A, 2007, TRENDS ECOL EVOL, V22, P652, DOI 10.1016/j.tree.2007.08.011; Kyle G., 2007, Human Dimensions of Wildlife, V12, P115, DOI 10.1080/10871200701196066; Mamuneas D, 2015, BEHAV ECOL, V26, P91, DOI 10.1093/beheco/aru160; McDougall PT, 2006, ANIM CONSERV, V9, P39, DOI 10.1111/j.1469-1795.2005.00004.x; Meyer KA, 2014, N AM J FISH MANAGE, V34, P1145, DOI 10.1080/02755947.2014.951803; Mittelbach GG, 2014, CAN J FISH AQUAT SCI, V71, P927, DOI 10.1139/cjfas-2013-0558; Muoneke Maurice I., 1994, Reviews in Fisheries Science, V2, P123; Myers R, 2008, N AM J FISH MANAGE, V28, P428, DOI 10.1577/M06-265.1; Nannini MA, 2011, J FISH BIOL, V79, P1017, DOI 10.1111/j.1095-8649.2011.03079.x; Niemela PT, 2013, BEHAV ECOL, V24, P935, DOI 10.1093/beheco/art014; Philipp DP, 2009, T AM FISH SOC, V138, P189, DOI 10.1577/T06-243.1; Quinn S, 2009, CENTRARCHID FISHES D; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Redpath TD, 2010, CAN J FISH AQUAT SCI, V67, P1983, DOI 10.1139/F10-120; Riesch R, 2009, BEHAV ECOL SOCIOBIOL, V63, P1515, DOI 10.1007/s00265-009-0780-z; Siepker MJ, 2007, FISHERIES MANAG ECOL, V14, P91, DOI 10.1111/j.1365-2400.2007.00529.x; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; Thompson LA, 2008, N AM J FISH MANAGE, V28, P1059, DOI 10.1577/M07-079.1; Uusi-Heikkila S, 2008, TRENDS ECOL EVOL, V23, P419, DOI 10.1016/j.tree.2008.04.006; van Wijk SJ, 2013, FRONT ECOL ENVIRON, V11, P181, DOI 10.1890/120229; Wilson ADM, 2012, BEHAV ECOL, V23, P1316, DOI 10.1093/beheco/ars123; Wilson ADM, 2011, CAN J FISH AQUAT SCI, V68, P749, DOI 10.1139/F2011-019; Wilson ADM, 2010, BEHAV ECOL, V21, P57, DOI 10.1093/beheco/arp157; Wilson ADM, 2010, ETHOLOGY, V116, P96, DOI 10.1111/j.1439-0310.2009.01719.x; Wilson ADM, 2009, BEHAV ECOL, V20, P231, DOI 10.1093/beheco/arp018; WILSON DS, 1993, J COMP PSYCHOL, V107, P250, DOI 10.1037/0735-7036.107.3.250	50	33	33	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135848	10.1371/journal.pone.0135848	http://dx.doi.org/10.1371/journal.pone.0135848			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284779	Green Published, gold, Green Submitted			2022-12-26	WOS:000359666100075
J	Cui, B; Feng, L; Pan, ZZ; Yu, ML; Zeng, ZH; Sun, CJ; Zhao, X; Wang, Y; Cui, HX				Cui, Bo; Feng, Lei; Pan, Zhenzhong; Yu, Manli; Zeng, Zhanghua; Sun, Changjiao; Zhao, Xiang; Wang, Yan; Cui, Haixin			Evaluation of Stability and Biological Activity of Solid Nanodispersion of Lambda-Cyhalothrin	PLOS ONE			English	Article							DERMAL DELIVERY; SOLUBLE DRUGS; ORAL DELIVERY; DOSAGE FORMS; FORMULATION; NANOSUSPENSIONS; MICROEMULSION; NANOCRYSTALS; PESTICIDES; BIOAVAILABILITY	Pesticides are essential agrochemicals used to protect plants from diseases, pests and weeds. However, the formulation defects of conventional pesticides cause food toxicity and ecological environmental problems. In this study, a novel, efficient and environmentally friendly formulation of lambda-cyhalothrin, a solid nanodispersion, was successfully developed based on melt-emulsification and high-speed shearing methods. The solid nanodispersion presented excellent advantages over conventional pesticide formulations in such formulation functions as dispersibility, stability and bioavailability. The formulation is free of organic solvents, and the use of surfactant is reduced. Therefore, the application of the solid nanodispersion in crop production will improve efficacy and reduce the occurrence of both pesticide residues in food and environmental pollution from pesticides.	[Cui, Bo; Feng, Lei; Pan, Zhenzhong; Yu, Manli; Zeng, Zhanghua; Sun, Changjiao; Zhao, Xiang; Wang, Yan; Cui, Haixin] Chinese Acad Agr Sci, Inst Environm & Sustainable Dev Agr, Beijing 100193, Peoples R China; [Pan, Zhenzhong] Jilin Univ, Coll Plant Sci, Coll Nat Resources & Environm, Changchun 130023, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Environment & Sustainable Development in Agriculture, CAAS; Jilin University	Cui, HX (corresponding author), Chinese Acad Agr Sci, Inst Environm & Sustainable Dev Agr, Beijing 100193, Peoples R China.	cuihaixin@caas.cn			Major National Scientific Research Program of China [2014CB932200]; Basic Scientific Research Foundation of National non-Profit Scientific Institute of China [BSRF201406]; National 863 program of the People's Republic of China [2011AA10A201]	Major National Scientific Research Program of China; Basic Scientific Research Foundation of National non-Profit Scientific Institute of China; National 863 program of the People's Republic of China	This research was supported by Major National Scientific Research Program of China (No. 2014CB932200), Basic Scientific Research Foundation of National non-Profit Scientific Institute of China (No. BSRF201406) and National 863 program of the People's Republic of China (No. 2011AA10A201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amweg EL, 2005, ENVIRON TOXICOL CHEM, V24, P1300; Anjali CH, 2010, ECOTOX ENVIRON SAFE, V73, P1932, DOI 10.1016/j.ecoenv.2010.08.039; Bouwmeester H, 2009, REGUL TOXICOL PHARM, V53, P52, DOI 10.1016/j.yrtph.2008.10.008; Chin CP, 2012, IND ENG CHEM RES, V51, P4710, DOI 10.1021/ie201151p; Dong LF, 2013, MOD AGR, V12, P14; Dubey R, 2006, DRUG DELIV TECHNOL, V6, P65; Elek N, 2010, COLLOID SURFACE A, V372, P66, DOI 10.1016/j.colsurfa.2010.09.034; Fu Q, 2013, COLLOID SURFACE B, V109, P161, DOI 10.1016/j.colsurfb.2013.01.066; George M, 2013, EUR J PHARM SCI, V48, P142, DOI 10.1016/j.ejps.2012.10.004; Ghosh I, 2011, INT J PHARMACEUT, V409, P260, DOI 10.1016/j.ijpharm.2011.02.051; Guan HN, 2008, PESTIC BIOCHEM PHYS, V92, P83, DOI 10.1016/j.pestbp.2008.06.008; Iggland M, 2014, CHEM ENG SCI, V111, P106, DOI 10.1016/j.ces.2014.02.034; Jacobs C, 2002, PHARMACEUT RES, V19, P189, DOI 10.1023/A:1014276917363; KADOTA G, 1986, J PESTIC SCI, V11, P597; Kawakami K, 2012, ADV DRUG DELIVER REV, V64, P480, DOI 10.1016/j.addr.2011.10.009; Kesisoglou F, 2007, ADV DRUG DELIVER REV, V59, P631, DOI 10.1016/j.addr.2007.05.003; Khot LR, 2012, CROP PROT, V35, P64, DOI 10.1016/j.cropro.2012.01.007; Knoche M, 2000, PEST MANAG SCI, V56, P1005, DOI 10.1002/1526-4998(200012)56:12<1005::AID-PS188>3.0.CO;2-Y; Knowles Alan, 2008, Environmentalist, V28, P35, DOI 10.1007/s10669-007-9045-4; Kocbek P, 2006, INT J PHARMACEUT, V312, P179, DOI 10.1016/j.ijpharm.2006.01.008; Kumar RSS, 2013, ENVIRON SCI POLLUT R, V20, P2593, DOI 10.1007/s11356-012-1161-0; Le Roy Boehm A L, 2000, J Pharm Belg, V55, P40; Lee MK, 2010, INT J PHARMACEUT, V384, P173, DOI 10.1016/j.ijpharm.2009.09.041; Leuner C, 2000, EUR J PHARM BIOPHARM, V50, P47, DOI 10.1016/S0939-6411(00)00076-X; Li P, 2009, J PHARM SCI-US, V98, P1750, DOI 10.1002/jps.21547; Margni M, 2002, AGR ECOSYST ENVIRON, V93, P379, DOI 10.1016/S0167-8809(01)00336-X; Mishra PR, 2009, INT J PHARMACEUT, V371, P182, DOI 10.1016/j.ijpharm.2008.12.030; Mitri K, 2011, INT J PHARMACEUT, V420, P141, DOI 10.1016/j.ijpharm.2011.08.026; Mogul MG, 1996, RESOUR CONSERV RECY, V16, P289, DOI 10.1016/0921-3449(95)00063-1; Moore MT, 2001, AGR ECOSYST ENVIRON, V87, P309, DOI 10.1016/S0167-8809(01)00148-7; Mura P, 2002, J PHARMACEUT BIOMED, V30, P227, DOI 10.1016/S0731-7085(02)00252-2; Pan BL, 2009, VET PARASITOL, V164, P353, DOI 10.1016/j.vetpar.2009.05.030; Passerini N, 2002, EUR J PHARM SCI, V15, P71, DOI 10.1016/S0928-0987(01)00210-X; Patravale VB, 2004, J PHARM PHARMACOL, V56, P827, DOI 10.1211/0022357023691; Pereira JL, 2009, ECOTOXICOLOGY, V18, P455, DOI 10.1007/s10646-009-0300-y; Pignatello R, 2006, AAPS PHARMSCITECH, V7, DOI 10.1208/pt070127; Pratap AP, 2008, J DISPER SCI TECHNOL, V29, P1325, DOI 10.1080/01932690701866815; Qian K, 2011, MICROCHIM ACTA, V173, P51, DOI 10.1007/s00604-010-0523-x; Qian L, 2005, ENV OCCUP MED, V22, P167; Serajuddin ATM, 1999, J PHARM SCI-US, V88, P1058, DOI 10.1021/js980403l; Sharma P, 2011, INT J PHARMACEUT, V408, P138, DOI 10.1016/j.ijpharm.2011.01.032; Talekar M, 2012, EUR J PHARM SCI, V47, P824, DOI 10.1016/j.ejps.2012.09.015; Teera-Arunsiri A, 2003, J ECON ENTOMOL, V96, P292, DOI 10.1603/0022-0493-96.2.292; Van Eerdenbrugh B, 2008, INT J PHARMACEUT, V364, P64, DOI 10.1016/j.ijpharm.2008.07.023; Vilhelmsen T, 2005, INT J PHARMACEUT, V303, P132, DOI 10.1016/j.ijpharm.2005.07.012; Wang, 2012, AGROCHEMICALS, V51, P351; Wang Zhen, 2012, Chinese Journal of Pesticide Science, V14, P551, DOI 10.3969/j.issn.1008-7303.2012.05.14; Weber J, 2010, SCI TOTAL ENVIRON, V408, P2966, DOI 10.1016/j.scitotenv.2009.10.077; Wiwattanapatapee R, 2009, J AGR FOOD CHEM, V57, P11234, DOI 10.1021/jf901862z; Xu LY, 2010, BIOSYST ENG, V106, P58, DOI 10.1016/j.biosystemseng.2010.02.004; Xu RF, 2008, MOD AGR, V7, P29; Yang L., 2009, WORLD PESTICIDES, V31, P5; Yue PF, 2013, INT J PHARMACEUT, V443, P279, DOI 10.1016/j.ijpharm.2012.12.036; Zeng H, 2008, J DISPER SCI TECHNOL, V29, P358, DOI 10.1080/01932690701716085; ZhangW Qu X, 2010, J ASTM INT, V7, P1; Zhao JK, 2011, APPL CLAY SCI, V51, P460, DOI 10.1016/j.clay.2011.01.009; Zhou F, 2013, PESTIC SCI ADM, V34, P59; Zou GS, 2002, JIANGXI CHEM IND, V4, P134	58	17	22	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0135953	10.1371/journal.pone.0135953	http://dx.doi.org/10.1371/journal.pone.0135953			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26281043	gold, Green Published, Green Submitted			2022-12-26	WOS:000359664300028
J	Lehmann, C; Homann, J; Ball, AK; Blocher, R; Kleinschmidt, TK; Basavarajappa, D; Angioni, C; Ferreiros, N; Hafner, AK; Radmark, O; Proschak, E; Haeggstrom, JZ; Geisslinger, G; Parnham, MJ; Steinhilber, D; Kahnt, AS				Lehmann, Christoph; Homann, Julia; Ball, Ann-Katrin; Bloecher, Rene; Kleinschmidt, Thea K.; Basavarajappa, Devaraj; Angioni, Carlo; Ferreiros, Nerea; Haefner, Ann-Kathrin; Radmark, Olof; Proschak, Ewgenij; Haeggstrom, Jesper Z.; Geisslinger, Gerd; Parnham, Michael J.; Steinhilber, Dieter; Kahnt, Astrid Stefanie			Lipoxin and resolvin biosynthesis is dependent on 5-lipoxygenase activating protein	FASEB JOURNAL			English	Article						cytosolic phospholipase A(2 alpha); LTA(4) hydrolase; LTC4 synthase; resolution of inflammation	ARACHIDONIC-ACID; HUMAN-PLATELETS; LEUKOTRIENE A4; INFLAMMATION; NEUTROPHIL; RESOLUTION; INHIBITOR; BINDING; D1; 15-LIPOXYGENASE	Resolution of acute inflammation is an active process coordinated by proresolving lipid mediators (SPMs) such as lipoxins (LXs) and resolvins (Rvs), which are formed by the concerted action of 2 lipoxygenases (LOs). Because the exact molecular mechanisms of SPM biosynthesis are not completely understood, we aimed to investigate LX and D-type Rv formation in human leukocytes and HEK293T cells overexpressing leukotriene (LT) pathway enzymes. Activity assays in precursor (15-hydroxyeicosatetraenoic acids, 17-HDoHE)-treated granulocytes [polymorphonuclear leukocytes (PMNLs)] showed a strict dependence of LXA(4)/RvD(1) biosynthesis on cell integrity, and incubation with recombinant human 5-LO did not lead to LX or Rv formation. Pharmacologic inhibition of 5-LO activating protein (FLAP) by MK-886 inhibited LXA(4)/RvD(1) biosynthesis in precursor-treated PMNLs (drug concentration causing 50% inhibition similar to 0.3/0.2 mu M), as did knockdown of the enzyme in MM6 cells, and precursor-treated HEK293T overexpressing 5-LO produced high amounts of LXA(4) only in the presence of FLAP. In addition, inhibition of cytosolic phospholipase A(2 alpha) (cPLA(2 alpha)) interfered with LXA(4)/RvD(1) formation from exogenous precursors in PMNLs. Furthermore, inhibition of the LT synthases LTA(4) hydrolase and LTC4 synthase in PMNL/platelet coincubations augmented LXA(4) levels. These findings show that several enzymes known to be involved in the biosynthesis of proinflammatory LTs, such as FLAP and cPLA(2 alpha), also contribute to LX and Rv formation.	[Lehmann, Christoph; Geisslinger, Gerd; Parnham, Michael J.; Kahnt, Astrid Stefanie] Goethe Univ Frankfurt, Fraunhofer Inst Mol Biol & Appl Ecol, Project Grp Translat Med & Pharmacol, D-60438 Frankfurt, Germany; [Homann, Julia; Angioni, Carlo; Ferreiros, Nerea; Geisslinger, Gerd] Goethe Univ Frankfurt, Inst Clin Pharmacol, Pharmazentrum Frankfurt, D-60438 Frankfurt, Germany; [Ball, Ann-Katrin; Bloecher, Rene; Haefner, Ann-Kathrin; Proschak, Ewgenij; Steinhilber, Dieter; Kahnt, Astrid Stefanie] Goethe Univ Frankfurt, Inst Pharmaceut Chem, D-60438 Frankfurt, Germany; [Kleinschmidt, Thea K.; Basavarajappa, Devaraj; Radmark, Olof; Haeggstrom, Jesper Z.] Karolinska Inst, Dept Med Biochem & Biophys, Div Chem 2, Stockholm, Sweden	Fraunhofer Gesellschaft; Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; Karolinska Institutet	Kahnt, AS (corresponding author), Goethe Univ Frankfurt, Inst Pharmaceut Chem, Max von Laue Str 9, D-60438 Frankfurt, Germany.	kahnt@pharmchem.uni-frankfurt.de	Steinhilber, Dieter/J-3221-2012; Parnham, Michael J/D-8733-2014	Parnham, Michael J/0000-0002-7098-8451; Basavarajappa, Devaraj/0000-0003-0997-0196	Else Kroner-Fresenius Foundation; Research Training Group Translational Research Innovation-Pharma (TRIP); Landesoffensive zur Entwicklung Wissenschaftlich-Okonomischer Exzellenz (LOEWE); Schwerpunkt: Anwendungsorientierte Arzneimittelforschung [Z01, SFB 1039]; German Research Foundation (DFG); Swedish Medical Research Council	Else Kroner-Fresenius Foundation; Research Training Group Translational Research Innovation-Pharma (TRIP); Landesoffensive zur Entwicklung Wissenschaftlich-Okonomischer Exzellenz (LOEWE); Schwerpunkt: Anwendungsorientierte Arzneimittelforschung; German Research Foundation (DFG)(German Research Foundation (DFG)); Swedish Medical Research Council(Swedish Medical Research Council (SMRC))	The authors thank S. George for the purification of TGF-beta<INF>1</INF> and S. Kretschmer for the purification of WT 5-LO and editorial help. This work was supported by the Else Kroner-Fresenius Foundation, the Research Training Group Translational Research Innovation-Pharma (TRIP), the Landesoffensive zur Entwicklung Wissenschaftlich-Okonomischer Exzellenz (LOEWE), Schwerpunkt: Anwendungsorientierte Arzneimittelforschung, and Projekt Z01, Grant SFB 1039, from the German Research Foundation (DFG). The work for TK04a was financially supported by the Swedish Medical Research Council.	ABRAMOVITZ M, 1993, EUR J BIOCHEM, V215, P105, DOI 10.1111/j.1432-1033.1993.tb18012.x; ANTOINE C, 1992, BIOCHIM BIOPHYS ACTA, V1128, P139, DOI 10.1016/0005-2760(92)90299-B; Back M, 2007, CIRC RES, V100, P946, DOI 10.1161/01.RES.0000264498.60702.0d; Basavarajappa D, 2014, P NATL ACAD SCI USA, V111, P11371, DOI 10.1073/pnas.1410983111; BREZINSKI ME, 1990, P NATL ACAD SCI USA, V87, P6248, DOI 10.1073/pnas.87.16.6248; BRUNGS M, 1995, P NATL ACAD SCI USA, V92, P107, DOI 10.1073/pnas.92.1.107; CHARLESON S, 1994, EUR J PHARM-MOLEC PH, V267, P275, DOI 10.1016/0922-4106(94)90151-1; Chavis C, 1996, J EXP MED, V183, P1633, DOI 10.1084/jem.183.4.1633; EDENIUS C, 1988, BIOCHEM BIOPH RES CO, V157, P801, DOI 10.1016/S0006-291X(88)80320-6; EDENIUS C, 1988, EUR J BIOCHEM, V178, P81, DOI 10.1111/j.1432-1033.1988.tb14431.x; FIORE S, 1990, J EXP MED, V172, P1451, DOI 10.1084/jem.172.5.1451; Fredman G, 2014, P NATL ACAD SCI USA, V111, P14530, DOI 10.1073/pnas.1410851111; Homann J, 2014, J CHROMATOGR A, V1360, P150, DOI 10.1016/j.chroma.2014.07.068; Horning C, 2005, J BIOL CHEM, V280, P26913, DOI 10.1074/jbc.M500068200; Horrillo R, 2010, J IMMUNOL, V184, P3978, DOI 10.4049/jimmunol.0901355; Kaaman M, 2006, INT J OBESITY, V30, P447, DOI 10.1038/sj.ijo.0803147; Koeberle A, 2009, EUR J PHARMACOL, V608, P84, DOI 10.1016/j.ejphar.2009.02.023; Kuhn H, 2015, BBA-MOL CELL BIOL L, V1851, P308, DOI 10.1016/j.bbalip.2014.10.002; Kulkarni S, 2002, J BIOL CHEM, V277, P13167, DOI 10.1074/jbc.M112393200; LEVY BD, 1993, J CLIN INVEST, V92, P1572, DOI 10.1172/JCI116738; Levy BD, 2010, PROSTAG LEUKOTR ESS, V82, P327, DOI 10.1016/j.plefa.2010.02.003; MACLOUF JA, 1988, J BIOL CHEM, V263, P174; MANCINI JA, 1993, FEBS LETT, V318, P277, DOI 10.1016/0014-5793(93)80528-3; Mancini JA, 1998, J BIOL CHEM, V273, P32842, DOI 10.1074/jbc.273.49.32842; Michel A. A., 2008, PROTEIN EXPRES PURIF, V59, P110; Miki Y, 2013, J EXP MED, V210, P1217, DOI 10.1084/jem.20121887; Moser D, 2015, J CHEM INF MODEL, V55, P284, DOI 10.1021/ci500618u; Norris PC, 2014, P NATL ACAD SCI USA, V111, P12746, DOI 10.1073/pnas.1404372111; Petrich K, 1996, BIOCHEM J, V314, P911, DOI 10.1042/bj3140911; Radmark O, 2010, BIOCHEM BIOPH RES CO, V396, P105, DOI 10.1016/j.bbrc.2010.02.173; Rao NL, 2007, J PHARMACOL EXP THER, V321, P1154, DOI 10.1124/jpet.106.115436; Rao NL, 2010, AM J RESP CRIT CARE, V181, P899, DOI 10.1164/rccm.200807-1158OC; Recchiuti A, 2013, PROSTAG OTH LIPID M, V107, P64, DOI 10.1016/j.prostaglandins.2013.02.004; ROMANO M, 1993, BIOCHEM J, V296, P127, DOI 10.1042/bj2960127; Romano M, 2010, THESCIENTIFICWORLDJO, V10, P1048, DOI 10.1100/tsw.2010.113; ROUZER CA, 1990, J BIOL CHEM, V265, P1436; Schroder M, 2014, BBA-MOL CELL BIOL L, V1841, P1538, DOI 10.1016/j.bbalip.2014.07.022; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; SERHAN CN, 1990, J CLIN INVEST, V85, P772, DOI 10.1172/JCI114503; Sisignano M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081228; Sun YP, 2007, J BIOL CHEM, V282, P9323, DOI 10.1074/jbc.M609212200; Werz O, 2002, BLOOD, V99, P1044, DOI 10.1182/blood.V99.3.1044; Werz O, 1996, PHARMAZIE, V51, P893; Zhao L, 2004, NAT MED, V10, P966, DOI 10.1038/nm1099	45	52	53	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2015	29	12					5029	5043		10.1096/fj.15-275487	http://dx.doi.org/10.1096/fj.15-275487			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CX2JS	26289316				2022-12-26	WOS:000365523600027
J	Xu, HB; Wang, XL; Lackner, AA; Veazey, RS				Xu, Huanbin; Wang, Xiaolei; Lackner, Andrew A.; Veazey, Ronald S.			Type 3 innate lymphoid cell depletion is mediated by TLRs in lymphoid tissues of simian immunodeficiency virus-infected macaques	FASEB JOURNAL			English	Article						SIV; HIV; GALT; ILC	ARYL-HYDROCARBON RECEPTOR; TRANSCRIPTION FACTOR GATA3; NATURAL-KILLER-CELLS; ROR-GAMMA-T; INDUCER CELLS; MUCOSAL; IMMUNITY; DIFFERENTIATION; INFLAMMATION; HOMEOSTASIS	Innate lymphoid cells (ILCs) type 3, also known as lymphoid tissue inducer cells, plays a major role in both the development and remodeling of organized lymphoid tissues and the maintenance of adaptive immune responses. HIV/simian immunodeficiency virus (SIV) infection causes breakdown of intestinal barriers resulting in microbial translocation, leading to systemic immune activation and disease progression. However, the effects of HIV/SIV infection on ILC3 are unknown. Here, we analyzed ILC3 from mucosal and systemic lymphoid tissues in chronically SIV-infected macaques and uninfected controls. ILC3 cells were defined and identified in macaque lymphoid tissues as non-T, non-B (lineage-negative), c-Kit(+)IL-7R alpha(+) (CD117(+)CD127(+)) cells. These ILC3 cells highly expressed CD90 (similar to 63%) and aryl hydrocarbon receptor and produced IL-17 (similar to 63%), IL-22 (similar to 36%), and TNF-alpha (similar to 72%) but did not coexpress CD4 or NK cell markers. The intestinal ILC3 cell loss correlated with the reduction of total CD4(+) T cells and T helper (T-h) 17 and Th22 cells in the gut during SIV infection (P < 0.001). Notably, ILC3 could be induced to undergo apoptosis by microbial products through the TLR2 (lipoteichoic acid) and/or TLR4 (LPS) pathway. These findings indicated that persistent microbial translocation may result in loss of ILC3 in lymphoid tissues in SIV-infected macaques, further contributing to the HIV-induced impairment of gut-associated lymphoid tissue structure and function, especially in mucosal tissues.	[Xu, Huanbin; Wang, Xiaolei; Lackner, Andrew A.; Veazey, Ronald S.] Tulane Univ, Sch Med, Tulane Natl Primate Res Ctr, Div Comparat Pathol, Covington, LA 70433 USA	Tulane University	Xu, HB (corresponding author), Tulane Univ, Sch Med, Tulane Natl Primate Res Ctr, Div Comparat Pathol, 18703 Three Rivers Rd, Covington, LA 70433 USA.	hxu@tulane.edu; rveazey@tulane.edu	Xu, Huanbin/S-4870-2019		U.S. National Institutes of Health (NIH) [R01 AI084793, R01 AI099795, R01 DE025432]; National Center for Research Resources; Office of Research Infrastructure Programs of the NIH [OD011104-51]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099795, R01AI084793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE025432] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs of the NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Julie Bruhn and Calvin Lanclos (Division of Immunology, Tulane National Primate Research Center) for flow cytometry support and Meagan Watkins, Megan Gardner, Chanjuan Shen, and Maury Duplantis (Division of Comparative Pathology, Tulane National Primate Research Center) for technical support. This work was supported by U.S. National Institutes of Health (NIH) Grants R01 AI084793, R01 AI099795 (National Institute of Allergy and Infectious Diseases), and R01 DE025432 (National Institute of Dental and Craniofacial Research), the National Center for Research Resources, and the Office of Research Infrastructure Programs of the NIH through Grant OD011104-51. The authors declare no conflicts of interest.	Behnsen J, 2013, IMMUNITY, V39, P206, DOI 10.1016/j.immuni.2013.08.012; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Cherrier M, 2012, CURR OPIN IMMUNOL, V24, P277, DOI 10.1016/j.coi.2012.03.011; Crellin NK, 2010, IMMUNITY, V33, P752, DOI 10.1016/j.immuni.2010.10.012; Douek Daniel, 2007, Top HIV Med, V15, P114; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Estes JD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001052; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Gladiator A, 2013, J IMMUNOL, V190, P521, DOI 10.4049/jimmunol.1202924; Hepworth MR, 2014, CURR OPIN IMMUNOL, V27, P75, DOI 10.1016/j.coi.2014.01.013; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Klatt NR, 2012, MUCOSAL IMMUNOL, V5, P646, DOI 10.1038/mi.2012.38; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Lane PJL, 2009, MUCOSAL IMMUNOL, V2, P472, DOI 10.1038/mi.2009.111; Magri G, 2014, NAT IMMUNOL, V15, P354, DOI 10.1038/ni.2830; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Pearson C, 2012, TRENDS IMMUNOL, V33, P289, DOI 10.1016/j.it.2012.04.004; Pennock JL, 2004, BLOOD, V103, P2655, DOI 10.1182/blood-2003-09-3146; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Qiu J, 2013, SEMIN IMMUNOPATHOL, V35, P657, DOI 10.1007/s00281-013-0393-5; Qiu J, 2013, IMMUNITY, V39, P386, DOI 10.1016/j.immuni.2013.08.002; Reeves RK, 2010, BLOOD, V115, P4439, DOI 10.1182/blood-2010-01-265595; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Scandella E, 2008, NAT IMMUNOL, V9, P667, DOI 10.1038/ni.1605; Shin JY, 2014, J EXP MED, V211, P217, DOI 10.1084/jem.20131128; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Spencer SP, 2014, SCIENCE, V343, P432, DOI 10.1126/science.1247606; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; van de Pavert SA, 2014, NATURE, V508, P123, DOI 10.1038/nature13158; van de Pavert SA, 2010, NAT REV IMMUNOL, V10, P664, DOI 10.1038/nri2832; Webster RL, 2005, IMMUNOLOGY, V115, P206, DOI 10.1111/j.1365-2567.2005.02147.x; Withers DR, 2012, J IMMUNOL, V189, P2094, DOI 10.4049/jimmunol.1201639; Wojno EDT, 2012, CELL HOST MICROBE, V12, P445, DOI 10.1016/j.chom.2012.10.003; Xu H, 2012, MUCOSAL IMMUNOL, V5, P658, DOI 10.1038/mi.2012.39; Xu Huanbin, 2014, J AIDS Clin Res, V5; Xu HB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00085; Xu HB, 2010, J IMMUNOL, V185, P7340, DOI 10.4049/jimmunol.1001642; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003	49	30	32	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2015	29	12					5072	5080		10.1096/fj.15-276477	http://dx.doi.org/10.1096/fj.15-276477			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CX2JS	26283536	Green Published			2022-12-26	WOS:000365523600030
J	Litschko, C; Romano, MR; Pinto, V; Claus, H; Vogel, U; Berti, F; Gerardy-Schahn, R; Fiebig, T				Litschko, Christa; Romano, Maria Rosaria; Pinto, Vittoria; Claus, Heike; Vogel, Ulrich; Berti, Francesco; Gerardy-Schahn, Rita; Fiebig, Timm			The Capsule Polymerase CsIB of Neisseria meningitidis Serogroup L Catalyzes the Synthesis of a Complex Trimeric Repeating Unit Comprising Glycosidic and Phosphodiester Linkages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MENINGOCOCCAL CONJUGATE VACCINE; TRANSPORTER-DEPENDENT PATHWAYS; LIPOPOLYSACCHARIDE O-ANTIGENS; NUCLEAR-MAGNETIC-RESONANCE; 2 ACTIVE-SITES; ESCHERICHIA-COLI; PASTEURELLA-MULTOCIDA; ACTINOBACILLUS-PLEUROPNEUMONIAE; STRUCTURAL DETERMINATION; POLYSACCHARIDE ANTIGENS	Neisseria rneningitidis is a human pathogen causing bacterial meningitis and sepsis. The capsular polysaccharide surrounding N. meningitidis is a major virulence factor. The capsular polysaccharide consists of polyhexosarnine phosphates in N. meningitidis serogroups A and X. The capsule polymerases (CPs) of these serogroups are members of the Stealth protein family comprising o-hexose-1-phosphate transferases from bacterial and protozoan pathogens. CsIA, one of two putative CPs of the pathophysiologically less relevant N. meningitidis serogroup is one of the smallest known Stealth proteins and caught our attention for structure-function analyses. Because the N. meningitidis serogroup I. capsule polymer consists of a trimeric repeating unit ([-> 3)-beta-D-GUNAc-(1 -> 3)-beta-D-GlcNAc-(1 -> 3)-alpha-D-GIcNAc-(10P03Hn), we speculated that the two predicted CPs (CsIA and Cs113) work together in polymer production. Consequently, both enzymes were cloned, overexpressed, and purified as recombinant proteins. Contrary to our expectation, enzymatic testing identified CsIB to be sufficient to catalyze the synthesis of the complex trimeric N rneningitidis serogroup I. capsule polymer repeating unit. No polymerase activity was detected for CsIA, although the enzyme facilitated the hydrolysis of UDP-GIcNAc. Bioinformatics analyses identified two glycosyltransferase (GT) domains in Cs113. The N-terminal domain modeled with 100% confidence onto a number of GT-A folded proteins, whereas the C-terminal domain modeled with 100% confidence onto TagF, a GT-B folded teichoic acid polymerase from Staphylococcus epiderrnidis. Amino acid positions known to have critical catalytic functions in the template pro- teins were conserved in Cs1B, and their point mutation abolished enzyme activity. Cs113 represents an enzyme of so far unique complexity regarding both the catalyzed reaction and enzyme architecture.	[Litschko, Christa; Gerardy-Schahn, Rita; Fiebig, Timm] Hannover Med Sch, Inst Cellular Chem, Carl Neuberg Str 1, D-30625 Hannover, Germany; [Romano, Maria Rosaria; Pinto, Vittoria; Berti, Francesco] GSK Vaccines, Res, I-53100 Siena, Italy; [Claus, Heike; Vogel, Ulrich] Univ Wurzburg, Inst Hyg & Microbiol, D-97080 Wurzburg, Germany	Hannover Medical School; GlaxoSmithKline; University of Wurzburg	Fiebig, T (corresponding author), Hannover Med Sch, Inst Cellular Chem, Carl Neuberg Str 1, D-30625 Hannover, Germany.	Fiebig.Timm@mh-hannover.de		Fiebig, Timm/0000-0002-2021-7296; Litschko, Christa/0000-0001-9114-4832	LOM (impact-oriented funding) funds	LOM (impact-oriented funding) funds	This work was supported by LOM (impact-oriented funding) funds to the Institute for Cellular Chemistry. F. B., M. R. R., and V. P. are full-time employees of GSK Vaccines. There are no patents or products in development. The other authors declare that they have no conflicts of interest with the contents of this article.	Alcala B, 2002, EMERG INFECT DIS, V8, P1512, DOI 10.3201/eid0812.020081; ASHTON FE, 1983, J CLIN MICROBIOL, V17, P722, DOI 10.1128/JCM.17.5.722-727.1983; Barnett TC, 2015, CURR OPIN IMMUNOL, V36, P1, DOI 10.1016/j.coi.2015.04.002; Beddek AJ, 2009, INFECT IMMUN, V77, P2989, DOI 10.1128/IAI.00181-09; Berti F, 2012, VACCINE, V30, P6409, DOI 10.1016/j.vaccine.2012.08.021; BEYNON LM, 1991, CARBOHYD RES, V212, P219, DOI 10.1016/0008-6215(91)84059-N; BHATTACHARJEE AK, 1976, CAN J BIOCHEM CELL B, V54, P1, DOI 10.1139/o76-001; BHATTACHARJEE AK, 1975, J BIOL CHEM, V250, P1926; Bohm R, 2010, CHEMBIOCHEM, V11, P170, DOI 10.1002/cbic.200900659; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; BUNDLE DR, 1973, CARBOHYD RES, V26, P268, DOI 10.1016/S0008-6215(00)85053-3; BUNDLE DR, 1974, J BIOL CHEM, V249, P2275; Caini S, 2013, VACCINE, V31, P1597, DOI 10.1016/j.vaccine.2013.01.015; Claus H, 2009, MOL MICROBIOL, V71, P960, DOI 10.1111/j.1365-2958.2008.06580.x; DeAngelis PL, 2004, J BACTERIOL, V186, P8529, DOI 10.1128/JB.186.24.8529-8532.2004; Deangelis PL, 2003, J BIOL CHEM, V278, P35199, DOI 10.1074/jbc.M306431200; DeAngelis PL, 2002, J BIOL CHEM, V277, P7209, DOI 10.1074/jbc.M112130200; Djingarey MH, 2012, VACCINE, V30, pB40, DOI 10.1016/j.vaccine.2011.12.073; Edmond K, 2010, LANCET INFECT DIS, V10, P317, DOI 10.1016/S1473-3099(10)70048-7; Fiebig T, 2014, J BIOL CHEM, V289, P19395, DOI 10.1074/jbc.M114.575142; Fiebig T, 2014, GLYCOBIOLOGY, V24, P150, DOI 10.1093/glycob/cwt102; Freiberger F, 2007, MOL MICROBIOL, V65, P1258, DOI 10.1111/j.1365-2958.2007.05862.x; Freiberger F, 2013, CHEMBIOCHEM, V14, P1949, DOI 10.1002/cbic.201300367; Garralda ME, 2009, PEDIATR CRIT CARE ME, V10, P675, DOI 10.1097/PCC.0b013e3181ae785a; Greenfield LK, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.412577; Greenfield LK, 2012, J BIOL CHEM, V287, P35078, DOI 10.1074/jbc.M112.401000; Harrison LH, 2010, J INFECT DIS, V201, P1208, DOI 10.1086/651505; Harrison OB, 2013, EMERG INFECT DIS, V19, P566, DOI 10.3201/eid1904.111799; Hill DJ, 2010, CLIN SCI, V118, P547, DOI 10.1042/CS20090513; JENNINGS HJ, 1983, CARBOHYD RES, V112, P105, DOI 10.1016/0008-6215(83)88270-6; Jessing SG, 2008, VET MICROBIOL, V129, P350, DOI 10.1016/j.vetmic.2007.12.003; Jing W, 2003, GLYCOBIOLOGY, V13, P661, DOI 10.1093/glycob/cwg085; Kane TA, 2006, J BIOL CHEM, V281, P33192, DOI 10.1074/jbc.M606897200; Kavoosi M, 2007, BIOTECHNOL BIOENG, V98, P599, DOI 10.1002/bit.21396; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kertesz DA, 1998, J INFECT DIS, V177, P1754, DOI 10.1086/517439; Keys TG, 2014, NAT CHEM BIOL, V10, P437, DOI 10.1038/nchembio.1501; Keys TG, 2013, GLYCOBIOLOGY, V23, P613, DOI 10.1093/glycob/cwt003; Keys TG, 2012, ANAL BIOCHEM, V427, P107, DOI 10.1016/j.ab.2012.05.011; Kristiansen PA, 2013, CLIN INFECT DIS, V56, P354, DOI 10.1093/cid/cis892; LaForce FM, 2011, HEALTH AFFAIR, V30, P1049, DOI 10.1377/hlthaff.2011.0328; Lam TT, 2011, RES MICROBIOL, V162, P483, DOI 10.1016/j.resmic.2011.04.002; Liston SD, 2015, J BIOL CHEM, V290, P1075, DOI 10.1074/jbc.M114.622480; LIU TY, 1971, J BIOL CHEM, V246, P2849; Lovering AL, 2010, NAT STRUCT MOL BIOL, V17, P582, DOI 10.1038/nsmb.1819; Muindi KM, 2014, GLYCOBIOLOGY, V24, P139, DOI 10.1093/glycob/cwt091; Nadel S, 2012, ARCH DIS CHILD, V97, P993, DOI 10.1136/archdischild-2012-302036; Osawa T, 2009, BIOCHEM BIOPH RES CO, V378, P10, DOI 10.1016/j.bbrc.2008.08.121; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pace D, 2013, EXPERT OPIN BIOL TH, V13, P11, DOI 10.1517/14712598.2012.725718; PERRY MB, 1990, SERODIAG IMMUN INF D, V4, P299, DOI 10.1016/0888-0786(90)90018-J; Romanow A, 2014, J BIOL CHEM, V289, P33945, DOI 10.1074/jbc.M114.597773; Romanow A, 2013, J BIOL CHEM, V288, P11718, DOI 10.1074/jbc.M113.452276; Satola SW, 2003, INFECT IMMUN, V71, P7202, DOI 10.1128/IAI.71.12.7202-7207.2003; Schertzer JW, 2005, J BIOL CHEM, V280, P36683, DOI 10.1074/jbc.M507153200; Sethi Maya K, 2013, Methods Mol Biol, V1022, P307, DOI 10.1007/978-1-62703-465-4_23; Simoes MJ, 2009, EPIDEMIOL INFECT, V137, P161, DOI 10.1017/S0950268808001106; Sobhany M, 2008, J BIOL CHEM, V283, P32328, DOI 10.1074/jbc.M804332200; Sperisen P, 2005, PLOS COMPUT BIOL, V1, P492, DOI 10.1371/journal.pcbi.0010063; Stephens DS, 2009, VACCINE, V27, pB71, DOI 10.1016/j.vaccine.2009.04.070; Swartley JS, 1997, P NATL ACAD SCI USA, V94, P271, DOI 10.1073/pnas.94.1.271; Taha MK, 2000, LANCET, V356, P2159, DOI 10.1016/S0140-6736(00)03502-9; Trotter CL, 2004, LANCET, V364, P365, DOI 10.1016/S0140-6736(04)16725-1; Tzeng YL, 2016, CRIT REV MICROBIOL, V42, P759, DOI 10.3109/1040841X.2015.1022507; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Willis LM, 2013, P NATL ACAD SCI USA, V110, P20753, DOI 10.1073/pnas.1312637110; Willis LM, 2013, CARBOHYD RES, V378, P35, DOI 10.1016/j.carres.2013.05.007; Willis LM, 2013, P NATL ACAD SCI USA, V110, P7868, DOI 10.1073/pnas.1222317110; Xie OL, 2013, VACCINE, V31, P2852, DOI 10.1016/j.vaccine.2013.04.036; Xu ZF, 2010, J BACTERIOL, V192, P5625, DOI 10.1128/JB.00535-10; Zhu HF, 2012, J CLIN MICROBIOL, V50, P46, DOI 10.1128/JCM.00918-11	71	15	16	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24355	24366		10.1074/jbc.M115.678094	http://dx.doi.org/10.1074/jbc.M115.678094			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26286750	Green Published, hybrid			2022-12-26	WOS:000362218900024
J	Feng, DM; Chen, Z; Wang, ZW; Zhang, CL; He, KL; Guo, SY				Feng, Dongmei; Chen, Zhen; Wang, Zhiwen; Zhang, Chunlu; He, Kanglai; Guo, Shuyuan			Domain III of Bacillus thuringiensis Cry1Ie Toxin Plays an Important Role in Binding to Peritrophic Membrane of Asian Corn Borer	PLOS ONE			English	Article							PLANT-INSECT INTERACTIONS; BRUSH-BORDER MEMBRANE; CRYSTAL PROTEINS; HELIOTHIS-VIRESCENS; PLUTELLA-XYLOSTELLA; CYSTEINE PROTEASE; TOBACCO HORNWORM; AMINOPEPTIDASE-N; MANDUCA-SEXTA; RESISTANCE	The insecticidal IE648 toxin is a truncated Cry1Ie protein with increased toxicity against Asian corn borer (ACB). Cry toxins are pore-forming toxins that disrupt insect midgut cells to kill the larvae. However, the peritrophic membrane (PM) is an important barrier that Cry toxins must cross before binding to midgut cells. Previously, it was shown that Cry toxins are able to bind and accumulate in the PM of several lepidopteran insects. Binding of IE648 toxin to PM of ACB was previously reported and the goal of the current work was the identification of the binding region between Cry1Ie and the PM of ACB. Homologous competition binding assays showed that this interaction was specific. Heterologous competition binding assays performed with different fragments corresponding to domain I, domain II and domain III allowed us to identify that domain III participates in the interaction of IE648 with the PM. Specifically, peptide D3-L8 (corresponding to Cry1Ie toxin residues 607 to 616), located in an exposed loop region of domain III is probably involved in this interaction. Ligand blot assays show that IE648 interact with chitin and PM proteins with sizes of 30, 32 and 80 kDa. The fact that domain III interacts with proteins of similar molecular masses supports that this region of the toxin might be involved in PM interaction. These data provide for the first time the identification of domain III as a putative binding region between PM and 3D-Cry toxin.	[Feng, Dongmei; Chen, Zhen; Wang, Zhiwen; Zhang, Chunlu; Guo, Shuyuan] Beijing Inst Technol, Sch Life Sci, Beijing 100081, Peoples R China; [He, Kanglai] Chinese Acad Agr Sci, Inst Plant Protect, Beijing 100193, Peoples R China	Beijing Institute of Technology; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Guo, SY (corresponding author), Beijing Inst Technol, Sch Life Sci, Beijing 100081, Peoples R China.	guosy@bit.edu.cn			Natural Science Foundation of China [31171911]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China (no. 31171911 http://www.nsfc.gov.cn/). SG received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADANG MJ, 1981, CELL TISSUE RES, V218, P141; Aranda E, 1996, J INVERTEBR PATHOL, V68, P203, DOI 10.1006/jipa.1996.0087; Bolognesi R, 2008, J INSECT PHYSIOL, V54, P1413, DOI 10.1016/j.jinsphys.2008.08.002; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAVO A, 1992, J INVERTEBR PATHOL, V60, P237, DOI 10.1016/0022-2011(92)90004-N; Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006; Burton SL, 1999, J MOL BIOL, V287, P1011, DOI 10.1006/jmbi.1999.2649; Chen J, 2005, CELL TISSUE RES, V321, P123, DOI 10.1007/s00441-005-1124-6; Crickmore N, 1998, MICROBIOL MOL BIOL R, V62, P807, DOI 10.1128/MMBR.62.3.807-813.1998; de Maagd RA, 2003, ANNU REV GENET, V37, P409, DOI 10.1146/annurev.genet.37.110801.143042; DENOLF P, 1993, APPL ENVIRON MICROB, V59, P1828, DOI 10.1128/AEM.59.6.1828-1837.1993; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; Ferry N, 2004, CURR OPIN BIOTECH, V15, P155, DOI 10.1016/j.copbio.2004.01.008; GLEAVE AP, 1993, APPL ENVIRON MICROB, V59, P1683, DOI 10.1128/AEM.59.5.1683-1687.1993; Gomez I, 2006, J BIOL CHEM, V281, P34032, DOI 10.1074/jbc.M604721200; Guo SY, 2014, J INTEGR AGR, V13, P1043, DOI 10.1016/S2095-3119(13)60589-4; Guo SY, 2011, PROTEIN EXPRES PURIF, V78, P204, DOI 10.1016/j.pep.2011.03.006; Hayakawa T, 2004, FEBS LETT, V576, P331, DOI 10.1016/j.febslet.2004.09.029; HORST MN, 1983, ARCH BIOCHEM BIOPHYS, V223, P254, DOI 10.1016/0003-9861(83)90590-8; Jurat-Fuentes JL, 2003, APPL ENVIRON MICROB, V69, P5898, DOI 10.1128/AEM.69.10.5898-5906.2003; Liu XY, 2011, ARCH VIROL, V156, P1707, DOI 10.1007/s00705-011-1039-3; Liu YJ, 2004, ACTA BIOCH BIOPH SIN, V36, P309, DOI 10.1093/abbs/36.4.309; MACINTOSH SC, 1991, P NATL ACAD SCI USA, V88, P8930, DOI 10.1073/pnas.88.20.8930; Michiels K, 2010, ARCH INSECT BIOCHEM, V73, P193, DOI 10.1002/arch.20351; Mohan S, 2006, J INSECT PHYSIOL, V52, P21, DOI 10.1016/j.jinsphys.2005.08.011; Mohan S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001786; Padilla C, 2006, APPL ENVIRON MICROB, V72, P901, DOI 10.1128/AEM.72.1.901-907.2006; Rees JS, 2009, J INVERTEBR PATHOL, V100, P139, DOI 10.1016/j.jip.2009.01.002; Sayyed AH, 2005, APPL ENVIRON MICROB, V71, P6863, DOI 10.1128/AEM.71.11.6863-6869.2005; Sekar V, 1997, APPL ENVIRON MICROB, V63, P2798, DOI 10.1128/AEM.63.7.2798-2801.1997; Song FP, 2003, APPL ENVIRON MICROB, V69, P5207, DOI 10.1128/AEM.69.9.5207-5211.2003; TABASHNIK BE, 1994, P NATL ACAD SCI USA, V91, P4120, DOI 10.1073/pnas.91.10.4120; TAILOR R, 1992, MOL MICROBIOL, V6, P1211, DOI 10.1111/j.1365-2958.1992.tb01560.x; Tellam RL, 1999, INSECT BIOCHEM MOLEC, V29, P87, DOI 10.1016/S0965-1748(98)00123-4; Valaitis AP, 2013, J INVERTEBR PATHOL, V112, P1, DOI 10.1016/j.jip.2012.10.002; Wang P, 2001, ARCH INSECT BIOCHEM, V47, P110, DOI 10.1002/arch.1041; Wu YuE, 2003, Plant Protection, V29, P15; Zimoch L, 2002, CELL TISSUE RES, V308, P287, DOI 10.1007/s00441-002-0546-7	38	10	12	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136430	10.1371/journal.pone.0136430	http://dx.doi.org/10.1371/journal.pone.0136430			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295704	gold, Green Published, Green Submitted			2022-12-26	WOS:000359926900110
J	Watanabe, B; Minami, S; Ishida, H; Yoshioka, R; Nakagawa, Y; Morita, T; Hayashi, K				Watanabe, Bunta; Minami, Saki; Ishida, Hideaki; Yoshioka, Ryuzo; Nakagawa, Yoshiaki; Morita, Tsuyoshi; Hayashi, Ken'ichiro			Stereospecific Inhibitory Effects of CCG-1423 on the Cellular Events Mediated by Myocardin-Related Transcription Factor A	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CONFORMER GENERATION; NUCLEAR IMPORT; MRTF-A; EXPRESSION; MECHANISM; DYNAMICS; FIBROSIS	CCG-1423 suppresses several pathological processes including cancer cell migration, tissue fibrosis, and the development of atherosclerotic lesions. These suppressions are caused by inhibition of myocardin-related transcription factor A (MRTF-A), which is a critical factor for epithelial-mesenchymal transition (EMT). CCG-1423 can therefore be a potent inhibitor for EMT. CCG-1423 and related compounds, CCG-100602 and CCG-203971 possess similar biological activities. Although these compounds are comprised of two stereoisomers, the differences in their biological activities remain to be assessed. To address this issue, we stereoselectively synthesized optically pure isomers of these compounds and validated their biological activities. The S-isomer of CCG-1423 rather than the R-isomer exhibited modestly but significantly higher inhibitory effects on the cellular events triggered by MRTF-A activation including serum response factor-mediated gene expression and cell migration of fibroblasts and B16F10 melanoma cells. Accordingly, the S-isomer of CCG-1423 more potently blocked the serum-induced nuclear import of MRTF-A than the R-isomer. No such difference was observed in cells treated with each of two stereoisomers of CCG-100602 or CCG-203971. We previously reported that the N-terminal basic domain (NB), which functions as a nuclear localization signal of MRTF-A, is a binding site for CCG-1423. Consistent with the biological activities of two stereoisomers of CCG-1423, docking simulation demonstrated that the S-isomer of CCG-1423 was more likely to bind to NB than the R-isomer. This is a first report demonstrating the stereospecific biological activities of CCG-1423.	[Watanabe, Bunta] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan; [Minami, Saki; Nakagawa, Yoshiaki] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Kyoto 6068502, Japan; [Ishida, Hideaki] Toabo Corp Co Ltd, Chuo Ku, Osaka 5406018, Japan; [Yoshioka, Ryuzo] NAHLS Co Ltd, Nishikyo Ku, Kyoto 6158245, Japan; [Morita, Tsuyoshi; Hayashi, Ken'ichiro] Osaka Univ, Grad Sch Med, Dept RNA Biol & Neurosci, Suita, Osaka 5650871, Japan	Kyoto University; Kyoto University; Osaka University	Hayashi, K (corresponding author), Osaka Univ, Grad Sch Med, Dept RNA Biol & Neurosci, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	khayashi@nbiochem.med.osaka-u.ac.jp		Watanabe, Bunta/0000-0003-3645-5712	Ministry of Education, Science, Sports and Culture of Japan [23590332]	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan (23590332 to K. H.).	Bell JL, 2013, BEILSTEIN J ORG CHEM, V9, P966, DOI 10.3762/bjoc.9.111; Bell JL, 2013, BIOORG MED CHEM LETT, V23, P3826, DOI 10.1016/j.bmcl.2013.04.080; Elberg G, 2008, AM J PHYSIOL-RENAL, V294, pF1116, DOI 10.1152/ajprenal.00142.2007; Evelyn CR, 2007, MOL CANCER THER, V6, P2249, DOI 10.1158/1535-7163.MCT-06-0782; Evelyn CR, 2010, BIOORG MED CHEM LETT, V20, P665, DOI 10.1016/j.bmcl.2009.11.056; Hawkins PCD, 2012, J CHEM INF MODEL, V52, P2919, DOI 10.1021/ci300314k; Hawkins PCD, 2010, J CHEM INF MODEL, V50, P572, DOI 10.1021/ci100031x; Hayashi K, 2015, SCI REP-UK, V5, DOI 10.1038/srep10627; Hayashi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089016; Hayashi K, 2013, J BIOL CHEM, V288, P5743, DOI 10.1074/jbc.M112.408120; Hirano H, 2011, BIOCHEM BIOPH RES CO, V414, P373, DOI 10.1016/j.bbrc.2011.09.079; Iwasaki K, 2008, J BIOL CHEM, V283, P21230, DOI 10.1074/jbc.M710525200; Jin WZ, 2011, J CLIN INVEST, V121, P918, DOI 10.1172/JCI41940; Johnson LA, 2014, INFLAMM BOWEL DIS, V20, P154, DOI 10.1097/01.MIB.0000437615.98881.31; Kim YJ, 2014, TOXICOLOGY, V322, P23, DOI 10.1016/j.tox.2014.04.002; Li SJ, 2006, MOL CELL BIOL, V26, P5797, DOI 10.1128/MCB.00211-06; Lundquist MR, 2014, CELL, V156, P563, DOI 10.1016/j.cell.2013.12.035; McGann M, 2011, J CHEM INF MODEL, V51, P578, DOI 10.1021/ci100436p; McGann MR, 2003, BIOPOLYMERS, V68, P76, DOI 10.1002/bip.10207; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Minami T, 2012, EMBO J, V31, P4428, DOI 10.1038/emboj.2012.296; Morita T, 2007, J CELL BIOL, V179, P1027, DOI 10.1083/jcb.200708174; Nakamura S, 2010, J BIOL CHEM, V285, P37314, DOI 10.1074/jbc.M110.180786; Pawlowski R, 2010, EMBO J, V29, P3448, DOI 10.1038/emboj.2010.216; Scharenberg M. A., 2010, INT J BIOCHEM CELL B, V53, P8627; Scharenberg MA, 2010, INT J BIOCHEM CELL B, V42, P1911, DOI 10.1016/j.biocel.2010.08.014; Shin I, 2000, J ORG CHEM, V65, P7667, DOI 10.1021/jo0006573; Sisson TH, 2015, AM J PATHOL, V185, P969, DOI 10.1016/j.ajpath.2014.12.005; Small EM, 2010, CIRC RES, V107, P294, DOI 10.1161/CIRCRESAHA.110.223172; Sun Y, 2006, MOL CELL BIOL, V26, P5809, DOI 10.1128/MCB.00024-06; Weng SS, 2011, TETRAHEDRON, V67, P1640, DOI 10.1016/j.tet.2011.01.009	31	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136242	10.1371/journal.pone.0136242	http://dx.doi.org/10.1371/journal.pone.0136242			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295164	Green Published, Green Submitted, gold			2022-12-26	WOS:000359926900088
J	Bao, L; Li, T; Diao, N; Shen, YJ; Shao, LY; Zhang, Y; Lu, SH; Zhang, WH				Bao, Lei; Li, Tao; Diao, Ni; Shen, Yaojie; Shao, Lingyun; Zhang, Ying; Lu, Shuihua; Zhang, Wenhong			Fluctuating Behavior and Influential Factors in the Performance of the QuantiFERON-TB Gold In-Tube Assay in the Diagnosis of Tuberculosis	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; MYCOBACTERIUM-TUBERCULOSIS; ACTIVE TUBERCULOSIS; CHILDREN; MTB/RIF; SPOT.TB; DISEASE; LATENT	Background The QuantiFERON-TB Gold In-Tube (QFT-GIT) is a newly developed but widely used interferon-. release assay for diagnosing tuberculosis (TB). However, research has not determined whether age or the use of an immune suppressive or anti-TB treatment influences this assay's ability to detect TB. We assessed the QFT-GIT diagnostic performance for active tuberculosis (ATB) in children and adults in an endemic country and explored the effects of glucocorticoids and anti-TB therapy on the diagnostic value of the QFT-GIT. Methods A total of 60 children and 212 adults with suspected ATB were evaluated with the QFT-GIT. The association between the QFT-GIT diagnostic value and pretreatment factors was qualitatively and quantitatively assessed. Results The sensitivity of the QFT-GIT was 83.9%(95% CI 66.3%-94.6%) in children, and 73.7% (95% CI 57.8%-85.2%) in adults. Glucocorticoids affected the mitogen-stimulated response in both children and adults. In subjects undergoing glucocorticoid pretreatment, 25.0% of the children presented with false-negative QFT-GIT results, 28.6% of adults presented with indeterminate results. For subjects pre-treated with anti-TB drugs, 44.4% presented with false-negative QFT-GIT results. Conclusions The QFT-GIT has higher sensitivity and specificity in children than adults. Glucocorticoid treatment negatively impacts the diagnostic value of the QFT-GIT in all age groups. Anti-TB treatment decreases the sensitivity of the QFT-GIT. Therefore, we recommend that the QFT-GIT assay be performed before TB-specific treatment is initiated and the test should not be used on people undergoing immunosuppression treatment, regardless of their age. A quantitative analysis of the QFT-GIT could be useful for assessing and monitoring TB-specific and non-specific immunity during conversion of the disease.	[Bao, Lei; Li, Tao; Diao, Ni; Shen, Yaojie; Shao, Lingyun; Zhang, Wenhong] Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai 200433, Peoples R China; [Li, Tao; Lu, Shuihua] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Dept TB Dis, Shanghai 200433, Peoples R China; [Zhang, Ying] Johns Hopkins Univ, Dept Mol Microbiol & Immunol, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Zhang, Wenhong] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Fudan University	Lu, SH (corresponding author), Fudan Univ, Shanghai Publ Hlth Clin Ctr, Dept TB Dis, Shanghai 200433, Peoples R China.	tubercle@shaphc.org; zhangwenhong@fudan.edu.cn			National Natural Science Foundation [30901277]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This study was supported by a research grant from The National Natural Science Foundation (30901277). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashenafi S, 2013, THORAX, V68, P269, DOI 10.1136/thoraxjnl-2012-201817; Banfield S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038556; Belard E, 2011, INFLAMM BOWEL DIS, V17, P2340, DOI 10.1002/ibd.21605; Bunsow E, 2014, J INFECTION, V68, P338, DOI 10.1016/j.jinf.2013.11.012; Burl S, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0012287, 10.1371/journal.pone.0018185]; Critselis E, 2012, J PEDIATR-US, V161, P632, DOI 10.1016/j.jpeds.2012.04.007; Cruz AT, 2011, PEDIATRICS, V127, pE31, DOI 10.1542/peds.2010-1725; Detjen AK, 2007, CLIN INFECT DIS, V45, P322, DOI 10.1086/519266; Ernst JD, 2012, NAT REV IMMUNOL, V12, P581, DOI 10.1038/nri3259; Helwig U, 2012, J CROHNS COLITIS, V6, P419, DOI 10.1016/j.crohns.2011.09.011; Kobashi Y, 2008, CHEST, V133, P1196, DOI 10.1378/chest.07-1995; Ling DI, 2013, THORAX, V68, P860, DOI 10.1136/thoraxjnl-2012-203086; Organization WH, 2012, GLOB TUB CONTR WHO R; Organization WH, 2013, GLOB TUB CONTR WHO R; Rachow A, 2012, CLIN INFECT DIS, V54, P1388, DOI 10.1093/cid/cis190; Ramos JM, 2013, CLIN EXP MED, V13, P177, DOI 10.1007/s10238-012-0192-7; Rose MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037851; Sester M, 2011, EUR RESPIR J, V37, P100, DOI 10.1183/09031936.00114810; Sohn H, 2014, CLIN INFECT DIS, V58, P970, DOI 10.1093/cid/ciu022; Wang XS, 2012, J IMMUNOL, V189, P3092, DOI 10.4049/jimmunol.1200573; Yu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044944; Zhang S, 2010, CLIN VACCINE IMMUNOL, V17, P1985, DOI 10.1128/CVI.00294-10	22	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0103763	10.1371/journal.pone.0103763	http://dx.doi.org/10.1371/journal.pone.0103763			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287382	gold, Green Published, Green Submitted			2022-12-26	WOS:000360018600001
J	Cao, HX; Dong, W; Shen, HC; Xu, J; Zhu, LH; Liu, Q; Du, JJ				Cao, Hongxin; Dong, Wei; Shen, Hongchang; Xu, Jun; Zhu, Linhai; Liu, Qi; Du, Jiajun			Combinational Therapy Enhances the Effects of Anti-IGF-1R mAb Figitumumab to Target Small Cell Lung Cancer	PLOS ONE			English	Article							RECEPTOR MONOCLONAL-ANTIBODY; IGF-I; INHIBITION; GROWTH; METFORMIN; INSULIN; RESISTANCE; EFFICACY; MEK	Background Small cell lung cancer (SCLC) is a recalcitrant malignancy with distinct biologic properties. Antibody targeting therapy has been actively investigated as a new drug modality. Methods We tested the expression of IGF-1R and calculated the survival in 61 SCLC patients. We also evaluated the anti-tumor effects of anti-IGF-1R monoclonal antibody Figitumumab (CP) on SCLC, and tried two drug combinations to improve CP therapy. Results Our clinical data suggested that high IGF-1R expression was correlated with low SCLC patient survival. We then demonstrated the effect of CP was likely through IGF-1R blockage and down-regulation without IGF-1R auto-phosphorylation and PI3K/AKT activation. However, we observed elevated MEK/ERK activation upon CP treatment in SCLC cells, and this MEK/ERK activation was enhanced by beta-arrestin1 knockdown while attenuated by beta-arrestin2 knockdown. We found both MEK/ERK inhibitor and metformin could enhance CP treatment in SCLC cells. We further illustrated the additive effect of metformin was likely through promoting further IGF-1R down-regulation. Conclusion Our results highlighted the potential of anti-IGF-1R therapy and the adjuvant therapy strategy with either MEK/ERK inhibitor or metformin to target SCLC, warranting further studies.	[Cao, Hongxin; Dong, Wei; Shen, Hongchang; Xu, Jun; Zhu, Linhai; Liu, Qi; Du, Jiajun] Shandong Univ, Shandong Prov Hosp, Inst Oncol, Jinan 250100, Peoples R China; [Dong, Wei; Du, Jiajun] Shandong Univ, Shandong Prov Hosp, Dept Thorac Surg, Jinan 250100, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Du, JJ (corresponding author), Shandong Univ, Shandong Prov Hosp, Inst Oncol, Jinan 250100, Peoples R China.	jiajundusdu@gmail.com			Provincial Science and Technology Development Planning of Shandong [2012GG0021836, 2014WS0342]; National Natural Science Foundation of China [81301728]; Natural Science Foundation of Shandong Province [ZR2013HZ001]; Shandong Provincial Natural Science Fund [ZR2014HQ073]	Provincial Science and Technology Development Planning of Shandong; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Shandong Provincial Natural Science Fund(Natural Science Foundation of Shandong Province)	Funding: The work was supported by Provincial Science and Technology Development Planning of Shandong (2012GG0021836 and 2014WS0342), National Natural Science Foundation of China (81301728), Key Project of Natural Science Foundation of Shandong Province (ZR2013HZ001), and Shandong Provincial Natural Science Fund (ZR2014HQ073). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben Sahra I, 2011, CANCER RES, V71, P4366, DOI 10.1158/0008-5472.CAN-10-1769; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Cohen BD, 2005, CLIN CANCER RES, V11, P2063, DOI 10.1158/1078-0432.CCR-04-1070; D'Angelo SP, 2010, CANCER BIOL THER, V10, P1, DOI 10.4161/cbt.10.1.12045; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Flanigan SA, 2013, CLIN CANCER RES, V19, P6219, DOI 10.1158/1078-0432.CCR-13-0145; Gately K, 2011, CLIN LUNG CANCER, V12, P38, DOI 10.3816/CLC.2011.n.005; Girnita L, 2014, CELL MOL LIFE SCI, V71, P2403, DOI 10.1007/s00018-013-1514-y; Goldstraw Peter, 2007, J Thorac Oncol, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Govindan R, 2006, J CLIN ONCOL, V24, P4539, DOI 10.1200/JCO.2005.04.4859; Holt SV, 2012, BRIT J CANCER, V106, P858, DOI 10.1038/bjc.2012.8; Hu CT, 2013, CELL SIGNAL, V25, P1539, DOI 10.1016/j.cellsig.2013.03.022; Hu P, 2013, BRIT J CANCER, V109, P1609, DOI 10.1038/bjc.2013.485; Ii M, 2011, CLIN CANCER RES, V17, P5048, DOI 10.1158/1078-0432.CCR-10-3131; Iliopoulos D, 2011, CANCER RES, V71, P3196, DOI 10.1158/0008-5472.CAN-10-3471; Kurmasheva RT, 2009, CANCER RES, V69, P7662, DOI 10.1158/0008-5472.CAN-09-1693; Lund SS, 2013, DIABETOLOGIA, V56, P937, DOI 10.1007/s00125-013-2843-y; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Ma H, 2014, SCI WORLD J, DOI 10.1155/2014/230835; Magalhaes AC, 2012, BRIT J PHARMACOL, V165, P1717, DOI 10.1111/j.1476-5381.2011.01552.x; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Quinn BJ, 2013, CANCER PREV RES, V6, P801, DOI 10.1158/1940-6207.CAPR-13-0058-T; Reichert JM, 2007, NAT REV DRUG DISCOV, V6, P349, DOI 10.1038/nrd2241; Rossi A, 2008, CLIN LUNG CANCER, V9, P271, DOI 10.3816/CLC.2008.n.042; Sarfstein R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061537; Sattler M, 2003, SEMIN ONCOL, V30, P57, DOI 10.1053/sonc.2003.50019; Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; Sikka A, 2012, CELL CYCLE, V11, P1374, DOI 10.4161/cc.19798; Takahashi O, 2012, CLIN CANCER RES, V18, P1641, DOI 10.1158/1078-0432.CCR-11-2324; Teicher BA, 2014, BIOCHEM PHARMACOL, V87, P211, DOI 10.1016/j.bcp.2013.09.014; Valentinis B, 2001, J CLIN PATHOL-MOL PA, V54, P133, DOI 10.1136/mp.54.3.133; Wang SY, 2013, DIABETES CARE, V36, pE155, DOI 10.2337/dc13-0708; Zhan JB, 2013, EXPERT OPIN INV DRUG, V22, P235, DOI 10.1517/13543784.2013.750293; Zhang YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081264; Zheng HY, 2012, P NATL ACAD SCI USA, V109, P20620, DOI 10.1073/pnas.1216348110; Zhu P, 2013, CANC PREV RES PHILA; Zinn RL, 2013, MOL CANCER THER, V12, P1131, DOI 10.1158/1535-7163.MCT-12-0618	38	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135844	10.1371/journal.pone.0135844	http://dx.doi.org/10.1371/journal.pone.0135844			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287334	Green Submitted, gold, Green Published			2022-12-26	WOS:000360018600075
J	Liu, XJ; Jiang, BH; Wang, AD; Di, JB; Wang, ZZ; Chen, L; Su, XQ				Liu, Xijuan; Jiang, Beihai; Wang, Aidong; Di, Jiabo; Wang, Zaozao; Chen, Lei; Su, Xiangqian			GATA2 rs2335052 Polymorphism Predicts the Survival of Patients with Colorectal Cancer	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; COLON-CANCER; STAGE-II; GENE; EXPRESSION; TRANSCRIPTION; CHEMOTHERAPY; MUTATIONS; NPAS2	Background GATA binding protein 2 (GATA2) is a transcription factor that has essential roles in hematologic malignancies and progression of various solid tumors. Our previous studies suggested that high GATA2 expression is associated with recurrence of colorectal cancer (CRC). However, the influence of GATA2 single nucleotide polymorphisms (SNPs) on the survival of CRC remains unknown. Methods We genotyped GATA2 SNP rs2335052 using Sanger sequencing after PCR amplification, and determined GATA2 expression by immunohistochemistry in a cohort of 180 CRC patients. Kaplan-Meier survival analysis and Cox proportional hazard regression were used to analyze the association between the GATA2 rs2335052 genotypes and the clinical outcome of CRC. Results We found that there was no significant correlation between the rs2335052 genotypes and the expression of GATA2. However, the Kaplan-Meier survival analysis suggested that the carriers of the A-allele of SNP rs2335052 were significantly associated with increased risk of recurrence and reduced disease-free survival (DFS), compared with those carrying the variant genotype of GG in rs2335052 (P = 0.021). Moreover, univariate and multivariate Cox regression analyses revealed that GATA2 SNP rs2335052 was an independent risk factor for the DFS of CRC patients. Conclusion Our results demonstrated that GATA2 SNP rs2335052 is an independent predictor for prognosis of CRC patients. This raised the possibility that SNP rs2335052 may serve as a potential indicator for predicting recurrence of CRC after curative colectomy.	[Liu, Xijuan] Peking Univ, Canc Hosp & Inst, Cent Lab, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100871, Peoples R China; [Jiang, Beihai; Wang, Aidong; Di, Jiabo; Wang, Zaozao; Chen, Lei; Su, Xiangqian] Peking Univ, Canc Hosp & Inst, Dept Minimally Invas Gastrointestinal Surg, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100871, Peoples R China	Peking University; Peking University	Su, XQ (corresponding author), Peking Univ, Canc Hosp & Inst, Dept Minimally Invas Gastrointestinal Surg, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100871, Peoples R China.	suxiangqian@bjmu.edu.cn		Jiang, Beihai/0000-0002-3665-9291	National Natural Science Foundation of China [81272766, 81450028, 81470129, 81402346]; National High Technology Research and Development Program of China (863 Program) [2014AA020603]; Clinical Characteristics and Application Research of Capital (Beijing Municipal Science & Technology Commission) [Z121107001012130]; Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support [XM201309]; Peking University (PKU); Peking University [2014-MB-04]; Beijing Natural Science Foundation [7132054]; Beijing Nova Program (Beijing Municipal Science & Technology Commission) [Z111102054511075, 2011060]; Program for Excellent Talents in Beijing [2013D003034000009]; Excellent Overseas-Returnee Scholar Program (Ministry of Human Resources and Social Security); Science Foundation of Peking University Cancer Hospital Institute [2014-14]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Clinical Characteristics and Application Research of Capital (Beijing Municipal Science & Technology Commission); Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support; Peking University (PKU); Peking University(Peking University); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Nova Program (Beijing Municipal Science & Technology Commission); Program for Excellent Talents in Beijing; Excellent Overseas-Returnee Scholar Program (Ministry of Human Resources and Social Security); Science Foundation of Peking University Cancer Hospital Institute	This study was supported by the grants from the National Natural Science Foundation of China (No. 81272766, No. 81450028, No. 81470129, and No. 81402346), the National High Technology Research and Development Program of China (863 Program, No. 2014AA020603), Clinical Characteristics and Application Research of Capital (Beijing Municipal Science & Technology Commission No. Z121107001012130), Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support (No. XM201309), Peking University (PKU) 985 Special Funding for Collaborative Research with PKU Hospitals (To Xiangqian Su and Fan Bai), Seeding Grant for Medicine and Life Sciences of Peking University (2014-MB-04), Beijing Natural Science Foundation (No. 7132054), the Beijing Nova Program (Beijing Municipal Science & Technology Commission No. Z111102054511075, 2011060), Program for Excellent Talents in Beijing (No. 2013D003034000009), the Excellent Overseas-Returnee Scholar Program (Ministry of Human Resources and Social Security, to Jiabo Di), and Science Foundation of Peking University Cancer Hospital & Institute (No. 2014-14).	Benson AB, 2004, J CLIN ONCOL, V22, P3408, DOI 10.1200/JCO.2004.05.063; Bohm M, 2009, ONCOGENE, V28, P3847, DOI 10.1038/onc.2009.243; Chen L, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0498-7; Chiang YT, 2014, ONCOTARGET, V5, P451, DOI 10.18632/oncotarget.1296; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Dickinson RE, 2014, BLOOD, V123, P863, DOI 10.1182/blood-2013-07-517151; Edgen S, 2010, AJCC CANC STAGING MA; EVANS T, 1988, P NATL ACAD SCI USA, V85, P5976, DOI 10.1073/pnas.85.16.5976; Gilliland DG, 2001, CURR OPIN HEMATOL, V8, P189, DOI 10.1097/00062752-200107000-00001; Groschel S, 2014, CELL, V157, P369, DOI 10.1016/j.cell.2014.02.019; Hahn CN, 2011, NAT GENET, V43, P1012, DOI 10.1038/ng.913; Horne BD, 2009, ANN HUM GENET, V73, P551, DOI 10.1111/j.1469-1809.2009.00540.x; Jonker DJ, 2011, CLIN ONCOL-UK, V23, P314, DOI 10.1016/j.clon.2011.02.010; Kumar MS, 2012, CELL, V149, P642, DOI 10.1016/j.cell.2012.02.059; Kunicka T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101740; Kurzawski M, 2010, PARKINSONISM RELAT D, V16, P284, DOI 10.1016/j.parkreldis.2009.10.006; Li YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087505; Liu YH, 2014, GENET MOL RES, V13, P2619, DOI 10.4238/2014.April.8.4; Luesink M, 2012, BLOOD, V120, P2064, DOI 10.1182/blood-2011-12-397083; Morris M, 2007, INT J COLORECTAL DIS, V22, P887, DOI 10.1007/s00384-006-0262-y; Muiya NP, 2014, GENE, V544, P152, DOI 10.1016/j.gene.2014.04.064; Ng SC, 2013, BRIT MED BULL, V105, P29, DOI 10.1093/bmb/lds040; Pasquet M, 2013, BLOOD, V121, P822, DOI 10.1182/blood-2012-08-447367; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Steckel M, 2012, CELL RES, V22, P1227, DOI 10.1038/cr.2012.82; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; Vicente C, 2012, CRIT REV ONCOL HEMAT, V82, P1, DOI 10.1016/j.critrevonc.2011.04.007; Wang Y, 2012, HUM MOL GENET, V21, P569, DOI 10.1093/hmg/ddr491; Weiser MR, 2008, J CLIN ONCOL, V26, P380, DOI 10.1200/JCO.2007.14.1291; Weiser MR, 2011, J CLIN ONCOL, V29, P4796, DOI 10.1200/JCO.2011.36.5080; Wu DY, 2014, NUCLEIC ACIDS RES, V42, P3607, DOI 10.1093/nar/gkt1382; Xing XF, 2009, HISTOPATHOLOGY, V54, P309, DOI 10.1111/j.1365-2559.2009.03226.x; Yamada A, 2013, BREAST CANCER RES TR, V137, P773, DOI 10.1007/s10549-012-2398-5; Yi CH, 2010, BREAST CANCER RES TR, V120, P663, DOI 10.1007/s10549-009-0484-0; Yu XH, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-98; Yuan P, 2014, CANCER SCI, V105, P825, DOI 10.1111/cas.12428; Zhang SJ, 2008, P NATL ACAD SCI USA, V105, P2076, DOI 10.1073/pnas.0711824105	38	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136020	10.1371/journal.pone.0136020	http://dx.doi.org/10.1371/journal.pone.0136020			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287967	Green Published, Green Submitted, gold			2022-12-26	WOS:000360018600097
J	Mehrabian, M; Brethour, D; Wang, HS; Xi, ZR; Rogaeva, E; Schmitt-Ulms, G				Mehrabian, Mohadeseh; Brethour, Dylan; Wang, Hansen; Xi, Zhengrui; Rogaeva, Ekaterina; Schmitt-Ulms, Gerold			The Prion Protein Controls Polysialylation of Neural Cell Adhesion Molecule 1 during Cellular Morphogenesis	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; POLYSIALIC ACID SYNTHASE; OF-INTIMACY ENCODES; SYNAPTIC PLASTICITY; PSA-NCAM; SUPRACHIASMATIC NUCLEUS; NEURITE OUTGROWTH; CIRCADIAN CLOCK; ZIP FAMILY; E-CADHERIN	Despite its multi-faceted role in neurodegenerative diseases, the physiological function of the prion protein (PrP) has remained elusive. On the basis of its evolutionary relationship to ZIP metal ion transporters, we considered that PrP may contribute to the morphogenetic reprogramming of cells underlying epithelial-to-mesenchymal transitions (EMT). Consistent with this hypothesis, PrP transcription increased more than tenfold during EMT, and stable PrP-deficient cells failed to complete EMT in a mammalian cell model. A global comparative proteomics analysis identified the neural cell adhesion molecule 1 (NCAM1) as a candidate mediator of this impairment, which led to the observation that PrP-deficient cells fail to undergo NCAM1 polysialylation during EMT. Surprisingly, this defect was caused by a perturbed transcription of the polysialyltransferase ST8SIA2 gene. Proteomics data pointed toward beta-catenin as a transcriptional regulator affected in PrP-deficient cells. Indeed, pharmacological blockade or siRNA-based knockdown of beta-catenin mimicked PrP-deficiency in regards to NCAM1 polysialylation. Our data established the existence of a PrP-ST8SIA2-NCAM signaling loop, merged two mature fields of investigation and offer a simple model for explaining phenotypes linked to PrP.	[Mehrabian, Mohadeseh; Brethour, Dylan; Wang, Hansen; Xi, Zhengrui; Rogaeva, Ekaterina; Schmitt-Ulms, Gerold] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada; [Mehrabian, Mohadeseh; Brethour, Dylan; Schmitt-Ulms, Gerold] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Rogaeva, Ekaterina] Univ Toronto, Dept Med, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto	Schmitt-Ulms, G (corresponding author), Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada.	g.schmittulms@utoronto.ca	wang, hansen/I-2510-2019	wang, hansen/0000-0003-4414-3372	Canadian Institute for Health Research (CIHR); Canadian Foundation for Innovation (CFI); Ontario Trillium Scholarship (OTS); W. Garfield Weston Foundation	Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Ontario Trillium Scholarship (OTS); W. Garfield Weston Foundation	The project received support from the Canadian Institute for Health Research (CIHR) and the Canadian Foundation for Innovation (CFI). MM gratefully acknowledges support from an Ontario Trillium Scholarship (OTS). GS received generous support from the W. Garfield Weston Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; Angata K, 2004, J BIOL CHEM, V279, P32603, DOI 10.1074/jbc.M403429200; Angata K, 1997, J BIOL CHEM, V272, P7182, DOI 10.1074/jbc.272.11.7182; BASLER K, 1986, CELL, V46, P417, DOI 10.1016/0092-8674(86)90662-8; Bonfanti L, 2006, PROG NEUROBIOL, V80, P129, DOI 10.1016/j.pneurobio.2006.08.003; Bullock BP, 1998, BIOCHEMISTRY-US, V37, P3795, DOI 10.1021/bi970982t; Carratu MR, 1996, MICROSC RES TECHNIQ, V34, P489, DOI 10.1002/(SICI)1097-0029(19960815)34:6<489::AID-JEMT1>3.0.CO;2-F; Cotto E, 2005, FEBS J, V272, P500, DOI 10.1111/j.1742-4658.2004.04492.x; DAVID G, 1981, J NATL CANCER I, V67, P719; Dayon Loic, 2012, Methods Mol Biol, V893, P115, DOI 10.1007/978-1-61779-885-6_9; Drake PM, 2008, J IMMUNOL, V181, P6850, DOI 10.4049/jimmunol.181.10.6850; Drake PM, 2009, P NATL ACAD SCI USA, V106, P11995, DOI 10.1073/pnas.0905188106; ECKHARDT M, 1995, NATURE, V373, P715, DOI 10.1038/373715a0; Ehsani S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026800; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Gascon E, 2010, ADV EXP MED BIOL, V663, P127, DOI 10.1007/978-1-4419-1170-4_8; Glass JD, 2003, NEUROSCIENCE, V117, P203, DOI 10.1016/S0306-4522(02)00817-5; GLASS JD, 1994, NEUROENDOCRINOLOGY, V60, P87; Hammond MSL, 2006, J BIOL CHEM, V281, P34859, DOI 10.1074/jbc.M602568200; Herbst A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003755; HOFFMAN S, 1982, J BIOL CHEM, V257, P7720; Hu W, 2008, J NEUROL SCI, V264, P1, DOI 10.1016/j.jns.2007.06.019; Jungnickel J, 2012, GLYCOBIOLOGY, V22, P107, DOI 10.1093/glycob/cwr113; Karapetyan YE, 2013, P NATL ACAD SCI US; Kiss JZ, 2001, REV NEUROSCIENCE, V12, P297; Kocher T, 2007, NAT METHODS, V4, P807, DOI 10.1038/NMETH1093; Kochlamazashvili G, 2010, J NEUROSCI, V30, P4171, DOI 10.1523/JNEUROSCI.5806-09.2010; Kojima N, 1996, J BIOL CHEM, V271, P19457, DOI 10.1074/jbc.271.32.19457; KOJIMA N, 1995, FEBS LETT, V373, P119, DOI 10.1016/0014-5793(95)01024-9; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lehembre F, 2008, EMBO J, V27, P2603, DOI 10.1038/emboj.2008.178; Livstone MS, 2011, CURR PROTOC BIOINFOR; Malaga-Trillo E, 2009, PLOS BIOL, V7, P576, DOI 10.1371/journal.pbio.1000055; Massaro AR, 2002, NEUROL SCI, V22, P429, DOI 10.1007/s100720200001; Mathews WR, 2005, J BIOL CHEM, V280, P787, DOI 10.1074/jbc.M411308200; Mehanna A, 2009, BRAIN, V132, P1449, DOI 10.1093/brain/awp128; Mehrabian M, 2014, FRONT CELL DEV BIOL, P2; Mehrabian M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114594; Mendelsohn AR, 1999, SCIENCE, V284, P1948, DOI 10.1126/science.284.5422.1948; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Misiewicz M, 2013, J BIOL CHEM; Nicolas O, 2009, BRAIN RES REV, V61, P170, DOI 10.1016/j.brainresrev.2009.06.002; Park CH, 2005, BIOCHEM BIOPH RES CO, V328, P227, DOI 10.1016/j.bbrc.2004.12.151; Premzl M, 2003, GENE, V314, P89, DOI 10.1016/S0378-1119(03)00707-8; Prosser RA, 2003, J NEUROSCI, V23, P652, DOI 10.1523/JNEUROSCI.23-02-00652.2003; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PUCKETT C, 1991, AM J HUM GENET, V49, P320; Rutishauser D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004446; Saeki K, 1996, VIRUS GENES, V12, P15, DOI 10.1007/BF00369996; Sakudo A, 2009, CURR MED CHEM, V16, P380, DOI 10.2174/092986709787002673; Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127; Schmitt-Ulms G, 2004, NAT BIOTECHNOL, V22, P724, DOI 10.1038/nbt969; Schmitt-Ulms G, 2001, J MOL BIOL, V314, P1209, DOI 10.1006/jmbi.2000.5183; Schmitt-Ulms G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007208; Senkov O, 2006, J NEUROSCI, V26, P10888, DOI 10.1523/JNEUROSCI.0878-06.2006; Senkov O, 2012, INT J BIOCHEM CELL B, V44, P591, DOI 10.1016/j.biocel.2012.01.008; Shen HM, 1997, J NEUROSCI, V17, P5221; Shen HM, 2001, PHYSIOL BEHAV, V73, P185, DOI 10.1016/S0031-9384(01)00468-1; Steele AD, 2007, PRION, V1, P83, DOI 10.4161/pri.1.2.4346; Suzuki M, 2003, J BIOL CHEM, V278, P49459, DOI 10.1074/jbc.M308316200; THEODOSIS DT, 1991, P NATL ACAD SCI USA, V88, P5494, DOI 10.1073/pnas.88.13.5494; Unno J, 2009, INT J ONCOL, V35, P813, DOI 10.3892/ijo_00000394; Van Doren M, 2003, DEVELOPMENT, V130, P2355, DOI 10.1242/dev.00454; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Watts JC, 2007, BBA-MOL BASIS DIS, V1772, P654, DOI 10.1016/j.bbadis.2007.05.001; Watts JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000608; White JK, 2013, CELL, V154, P452, DOI 10.1016/j.cell.2013.06.022; Yamashita S, 2004, NATURE, V429, P298, DOI 10.1038/nature02545; Yook JI, 2005, J BIOL CHEM, V280, P11740, DOI 10.1074/jbc.M413878200; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	71	34	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0133741	10.1371/journal.pone.0133741	http://dx.doi.org/10.1371/journal.pone.0133741			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288071	Green Published, gold, Green Submitted			2022-12-26	WOS:000360018600009
J	Sanchez, ZM; Ribeiro, KJ; Wagner, GA				Sanchez, Zila M.; Ribeiro, Karen J.; Wagner, Gabriela A.			Binge Drinking Associations with Patrons' Risk Behaviors and Alcohol Effects after Leaving a Nightclub: Sex Differences in the "Balada com Ciencia" Portal Survey Study in Brazil	PLOS ONE			English	Article							UNITED-STATES; COLLEGE-STUDENTS; EUROPEAN CITIES; CONSUMPTION; GENDER; BARS; INTOXICATION; AGGRESSION; DEPENDENCE; NIGHTLIFE	The purpose of the present study was to investigate the potential associations of binge drinking detected at the exit of nightclubs and risk behaviors and alcohol effects just after leaving the venue in a representative sample of Brazilian nightclub patrons according to sex. For this purpose, a portal survey study called Balada com Ciencia was conducted in 2013 in the megacity of Sao Paulo, Brazil, using a two-stage cluster sampling survey design. Individual-level data were collected in 2422 subjects at the entrance and 1822 subjects at the exit of 31 nightclubs, and breath alcohol concentration (BrAC) was measured using a breathalyzer. The following day, 1222 patrons answered an online follow-up survey that included questions about risk behaviors and alcohol effects practiced just after leaving the nightclub. Weighted logistic regressions were used to analyze binge drinking associated with risk behaviors by sex. For both sexes, the most prevalent risk behaviors practiced after leaving a nightclub were drinking and driving (men=27.9%; women=20.4%), the use of illicit drugs (men=15.8%; women=9.4%) and risky sexual behavior (men=11.4%; women=6.8%). The practice of binge drinking increased the behavior of illicit drug use after leaving the nightclub by 2.54 times [95% CI: 1.26-5.09] among men who drank and increased the risk of an episode of new alcohol use by 5.80 times [95% CI: 1.50-22.44] among women who drank. Alcoholic blackouts were more prevalent among men [OR=8.92; 95% CI: 3.83-20.80] and women [OR=5.31; 95% CI: 1.68-16.84] whose BrAC was equivalent to binge drinking compared with patrons with a lower BrAC. Public policies aiming to reduce patrons' BrAC at the exit of nightclubs, such as staff training in responsible beverage service and legislation to prevent alcohol sales to drunk individuals, would be useful to protect patrons from the risk behaviors associated with binge drinking in nightclubs.	[Sanchez, Zila M.; Ribeiro, Karen J.; Wagner, Gabriela A.] Univ Fed Sao Paulo, Dept Prevent Med, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP)	Sanchez, ZM (corresponding author), Univ Fed Sao Paulo, Dept Prevent Med, Sao Paulo, Brazil.	zila.sanchez@unifesp.br	Sanchez, Zila M/F-7994-2010; Sanchez, Zila M/AAA-2369-2019	Sanchez, Zila M/0000-0002-7427-7956; Sanchez, Zila M/0000-0002-7427-7956	FAPESP (Sao Paulo State Research Foundation) [2011/51658-0]	FAPESP (Sao Paulo State Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by FAPESP (Sao Paulo State Research Foundation) - research grant to Dr. Sanchez (grant number 2011/51658-0) (http://www.bv.fapesp.br/pt/pesquisa/?sort=-data_inicio&q2=%28id_pesquisador_exact%3A106030%29+AND+%28%28situacao_exact%3A%22Em+andamento%22+AND+auxilio%3A%2A%29%29). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbey A, 2004, AGGRESS VIOLENT BEH, V9, P271, DOI 10.1016/S1359-1789(03)00011-9; ABEP (Associacao Brasileira de Empresas de Pesquisa), 2012, CRIT CLASS EC BRAS; Ammendola A, 2000, ALCOHOL ALCOHOLISM, V35, P368, DOI 10.1093/alcalc/35.4.368; Babor T.F., 2010, ALCHOL NO ORDINARY C, V2nd, DOI DOI 10.1093/ACPROF:OSO/9780199551149.003.002; Bellis MA, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-155; Blay N, 2010, PSICOTHEMA, V22, P396; Brewer RD, 2005, JAMA-J AM MED ASSOC, V294, P616, DOI 10.1001/jama.294.5.616; Calafat A, 2011, EUR J PUBLIC HEALTH, V21, P311, DOI 10.1093/eurpub/ckq141; Calafat A, 2009, ADICCIONES, V21, P387, DOI 10.20882/adicciones.226; Carlini C, 2014, DRUG ALCOHOL REV, V33, P358, DOI 10.1111/dar.12155; Castro DS, 2012, DRUG ALCOHOL DEPEN, V126, P272, DOI 10.1016/j.drugalcdep.2012.05.017; Clapp JD, 2007, EVALUATION REV, V31, P469, DOI 10.1177/0193841X07303582; Courtney KE, 2009, PSYCHOL BULL, V135, P142, DOI 10.1037/a0014414; Day AM, 2014, ADDICT BEHAV, V39, P354, DOI 10.1016/j.addbeh.2013.10.014; Duarte P, 2010, RELATORIO BRASILEIRO; Duff C, 2008, INT J DRUG POLICY, V19, P384, DOI 10.1016/j.drugpo.2007.07.003; Fernandez-Sola J, 1997, AM J CARDIOL, V80, P481; Graham K, 2004, DRUG ALCOHOL REV, V23, P31, DOI 10.1080/09595230410001645538; Graham K, 2006, ADDICTION, V101, P1569, DOI 10.1111/j.1360-0443.2006.01608.x; Graham K, 2014, DRUG ALCOHOL REV, V33, P393, DOI 10.1111/dar.12153; Grant BF, 2004, DRUG ALCOHOL DEPEN, V74, P223, DOI 10.1016/j.drugalcdep.2004.02.004; Grucza RA, 2008, ALCOHOL CLIN EXP RES, V32, P1493, DOI 10.1111/j.1530-0277.2008.00719.x; Grucza RA, 2008, ALCOHOL CLIN EXP RES, V32, P763, DOI 10.1111/j.1530-0277.2008.00635.x; Haffner HT, 2003, INT J LEGAL MED, V117, P276, DOI 10.1007/s00414-003-0384-5; Hughes K, 2014, J EPIDEMIOL COMMUN H, V68, P453, DOI 10.1136/jech-2013-203287; Hughes K, 2011, ADDICTION, V106, P37, DOI 10.1111/j.1360-0443.2010.03316.x; Kelley-Baker Tara, 2008, J Alcohol Drug Educ, V52, P46; Kerr LRFS, 2013, AIDS, V27, P427, DOI 10.1097/QAD.0b013e32835ad504; Kuntsche E, 2004, SOC SCI MED, V59, P113, DOI 10.1016/j.socscimed.2003.10.009; Lange JE, 2000, ADDICTION, V95, P521, DOI 10.1046/j.1360-0443.2000.9545214.x; Lange JE, 2001, PSYCHOL ADDICT BEHAV, V15, P310, DOI 10.1037/0893-164X.15.4.310; Laranjeira R, 2007, 1 BRAZILIAN HOUSEHOL; Laranjeira RR, 2007, BRIT MED J, V335, P735, DOI 10.1136/bmj.39360.432940.BE; Livingston M, 2007, DRUG ALCOHOL REV, V26, P557, DOI 10.1080/09595230701499191; LOFT S, 1987, SCAND J GASTROENTERO, V22, P1251, DOI 10.3109/00365528708996472; Lwanga SK, 1991, SAMPLE SIZE DETERMIN; McClatchley K, 2014, DRUG ALCOHOL REV, V33, P367, DOI 10.1111/dar.12150; Naimi TS, 2003, JAMA-J AM MED ASSOC, V289, P70, DOI 10.1001/jama.289.1.70; NIAAA, 2004, NIAAA NEWSLETTER, V3; Norstrom T, 2005, DRUG ALCOHOL REV, V24, P537, DOI 10.1080/09595230500293845; Pechansky F, 2012, REV BRAS PSIQUIATR, V34, P277, DOI 10.1016/j.rbp.2012.06.002; Perham N, 2007, ADDICTION, V102, P377, DOI 10.1111/j.1360-0443.2006.01699.x; RAO JNK, 1987, ANN STAT, V15, P385, DOI 10.1214/aos/1176350273; Rehm J, 2001, EUR ADDICT RES, V7, P138, DOI 10.1159/000050731; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Rose ME, 2010, J ADDICT MED, V4, P61, DOI 10.1097/ADM.0b013e3181e1299d; Sanchez ZM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-201; Smith GW, 2011, DRUG ALCOHOL DEPEN, V113, P222, DOI 10.1016/j.drugalcdep.2010.08.010; Testa M, 2004, J STUD ALCOHOL, V65, P320, DOI 10.15288/jsa.2004.65.320; Voas RB, 2006, EVALUATION REV, V30, P44, DOI 10.1177/0193841X05277285; Voas RB, 2013, DRUG ALCOHOL DEPEN, V132, P69, DOI 10.1016/j.drugalcdep.2013.01.014; Wechsler H, 2001, PSYCHOL ADDICT BEHAV, V15, P287, DOI 10.1037/0893-164X.15.4.287; WECHSLER H, 1995, AM J PUBLIC HEALTH, V85, P982, DOI 10.2105/AJPH.85.7.982; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Wilsnack R. W., 2005, Alcohol, gender and drinking problems: perspectives from low and middle income countries, P1; World Health Organization, 2008, GLOB BURD DIS 2004 U; Zhao GZ, 2010, TRAFFIC INJ PREV, V11, P342, DOI 10.1080/15389581003789573	57	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0133646	10.1371/journal.pone.0133646	http://dx.doi.org/10.1371/journal.pone.0133646			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP6SN	26287954	Green Published, gold, Green Submitted			2022-12-26	WOS:000360018600007
J	Sinclair, EH; Walker, WA; Thomason, JR				Sinclair, Elizabeth H.; Walker, William A.; Thomason, James R.			Body Size Regression Formulae, Proximate Composition and Energy Density of Eastern Bering Sea Mesopelagic Fish and Squid	PLOS ONE			English	Article							NORTHERN FUR SEALS; CALLORHINUS-URSINUS; OTOLITH SIZE; SOUTHERN-CALIFORNIA; MIDWATER FISHES; FORAGE FISHES; FOOD-WEB; PACIFIC; ECOLOGY; WESTERN	The ecological significance of fish and squid of the mesopelagic zone (200 m-1000 m) is evident by their pervasiveness in the diets of a broad spectrum of upper pelagic predators including other fishes and squids, seabirds and marine mammals. As diel vertical migrators, mesopelagic micronekton are recognized as an important trophic link between the deep scattering layer and upper surface waters, yet fundamental aspects of the life history and energetic contribution to the food web for most are undescribed. Here, we present newly derived regression equations for 32 species of mesopelagic fish and squid based on the relationship between body size and the size of hard parts typically used to identify prey species in predator diet studies. We describe the proximate composition and energy density of 31 species collected in the eastern Bering Sea during May 1999 and 2000. Energy values are categorized by body size as a proxy for relative age and can be cross-referenced with the derived regression equations. Data are tabularized to facilitate direct application to predator diet studies and food web models.	[Sinclair, Elizabeth H.; Walker, William A.; Thomason, James R.] NOAA, Natl Marine Fisheries Serv, Alaska Fisheries Sci Ctr, Natl Marine Mammal Lab, Seattle, WA 98115 USA	National Oceanic Atmospheric Admin (NOAA) - USA	Sinclair, EH (corresponding author), NOAA, Natl Marine Fisheries Serv, Alaska Fisheries Sci Ctr, Natl Marine Mammal Lab, Seattle, WA 98115 USA.	beth.sinclair@noaa.gov						Anderson Richard O., 1996, P447; Anderson TR, 2010, J MARINE SYST, V81, P4, DOI 10.1016/j.jmarsys.2009.12.015; Anthony JA, 2000, J EXP MAR BIOL ECOL, V248, P53, DOI 10.1016/S0022-0981(00)00159-3; AOAC, 2002, OFFICIAL METHODS ANA, Vfifteenth; ATKINSON D B, 1991, Journal of Northwest Atlantic Fishery Science, V11, P7; Aydin K, 2007, DEEP-SEA RES PT II, V54, P2501, DOI 10.1016/j.dsr2.2007.08.022; Battaglia P, 2010, SCI MAR, V74, P605, DOI 10.3989/scimar.2010.74n3605; Beamish RJ, 1999, PROG OCEANOGR, V43, P399, DOI 10.1016/S0079-6611(99)00017-8; Bilge G, 2013, ACTA ICHTHYOL PISCAT, V43, P293, DOI 10.3750/AIP2013.43.4.05; CHILDRESS JJ, 1980, MAR BIOL, V61, P27, DOI 10.1007/BF00410339; CHILDRESS JJ, 1973, DEEP-SEA RES, V20, P1093, DOI 10.1016/0011-7471(73)90023-5; Clarke M. R., 1962, Bulletin of the British Museum (Natural History) Zoology, V8, P419; Clarke M.R, 1986, HDB IDENTIFICATION C; Col LA, 2010, SC64EM2 INT WHAL COM; CROXALL JP, 1982, BRIT ANTARCTIC SURV, V55, P27; DONNELLY J, 1990, MAR BIOL, V106, P13, DOI 10.1007/BF02114670; Eder EB, 2005, MAR ECOL PROG SER, V291, P43, DOI 10.3354/meps291043; FITCH JE, 1968, J FISH RES BOARD CAN, V25, P2561, DOI 10.1139/f68-227; Fritz LW, 2005, MAR MAMMAL SCI, V21, P476, DOI 10.1111/j.1748-7692.2005.tb01245.x; Gudmundson CJ, 2006, FISH B-NOAA, V104, P445; Harvey JT, 2000, NOAA TECH REP NMFS, V150; Hidaka K, 2001, DEEP-SEA RES PT I, V48, P1923, DOI 10.1016/S0967-0637(01)00003-6; Irigoien X, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4271; Kaartvedt S, 2012, MAR ECOL PROG SER, V456, P1, DOI 10.3354/meps09785; Kubodera T., 1986, B INT N PACIF FISH C, V47, P215; Logerwell Elizabeth A., 2005, Aquatic Mammals, V31, P62, DOI 10.1578/AM.31.1.2005.62; Longenecker K, 2008, PAC SCI, V62, P533, DOI 10.2984/1534-6188(2008)62[533:RBOSAB]2.0.CO;2; LONGHURST AR, 1988, DEEP-SEA RES, V35, P881, DOI 10.1016/0198-0149(88)90065-9; Mori J, 2001, FISH RES, V52, P91, DOI 10.1016/S0165-7836(01)00233-8; Murray J, 38 FAO SIFAR, P200; O'Hea B, 2013, ACTA ICHTHYOL PISCAT, V43, P285, DOI 10.3750/AIP2013.43.4.04; OHIZUMI H, 2001, AQUABIOLOGY, V137, P626; Olsson CO, 1997, IBIS, V139, P504; Payne SA, 1999, FISH OCEANOGR, V8, P159, DOI 10.1046/j.1365-2419.1999.00097.x; Radchenko VI, 2007, RAFFLES B ZOOL, P265; Robinson C, 2010, DEEP-SEA RES PT II, V57, P1504, DOI 10.1016/j.dsr2.2010.02.018; Saila S., 1988, BASIC FISHERY SCI PR; Sinclair EH, 2008, DEEP-SEA RES PT II, V55, P1897, DOI 10.1016/j.dsr2.2008.04.031; Sinclair EH, 1999, UASGCP REP, V99, P485; Sinclair EH, 2002, DEEP-SEA RES PT II, V49, P6127, DOI 10.1016/S0967-0645(02)00337-5; Smale M.J., 1995, ICHTHYOLOGICAL MONOG; Spear LB., 2007, STUD AVIAN BIOL, V35, P1; STICKNEY DG, 1989, MAR BIOL, V103, P13, DOI 10.1007/BF00391060; Tierney M, 2002, ANTARCT SCI, V14, P225, DOI 10.1017/S0954102002000020; Van de Putte A, 2006, POLAR BIOL, V29, P1045, DOI 10.1007/s00300-006-0148-z; Van Pelt TI, 1997, COMP BIOCHEM PHYS A, V118, P1393, DOI 10.1016/S0300-9629(97)00240-5; Waessle JA, 2003, SCI MAR, V67, P233, DOI 10.3989/scimar.2003.67n2233; Walker WA, 2002, MAR MAMMAL SCI, V18, P902, DOI 10.1111/j.1748-7692.2002.tb01081.x; Wolff GA, 1984, NOAA TECH REP NMFS, V17, P50; Yonezaki S, 2011, MAMM STUDY, V36, P159; YOUNG RE, 1978, FISH B-NOAA, V76, P583	51	11	11	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0132289	10.1371/journal.pone.0132289	http://dx.doi.org/10.1371/journal.pone.0132289			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287534	Green Published, Green Submitted, gold			2022-12-26	WOS:000360018600003
J	Desrousseaux, C; Cueff, R; Aumeran, C; Garrait, G; Mailhot-Jensen, B; Traore, O; Sautou, V				Desrousseaux, Camille; Cueff, Regis; Aumeran, Claire; Garrait, Ghislain; Mailhot-Jensen, Benedicte; Traore, Ousmane; Sautou, Valerie			Fabrication of Acrylonitrile-Butadiene-Styrene Nanostructures with Anodic Alumina Oxide Templates, Characterization and Biofilm Development Test for Staphylococcus epidermidis	PLOS ONE			English	Article							BACTERIAL ADHESION; PSEUDOMONAS-AERUGINOSA; NEEDLELESS CONNECTORS; ESCHERICHIA-COLI; PORE ARRAYS; IN-VITRO; SURFACES; CELL; REPLICATION; TOPOGRAPHY	Medical devices can be contaminated by microbial biofilm which causes nosocomial infections. One of the strategies for the prevention of such microbial adhesion is to modify the biomaterials by creating micro or nanofeatures on their surface. This study aimed (1) to nanostructure acrylonitrile-butadiene-styrene (ABS), a polymer composing connectors in perfusion devices, using Anodic Alumina Oxide templates, and to control the reproducibility of this process; (2) to characterize the physico-chemical properties of the nanostructured surfaces such as wettability using captive-bubble contact angle measurement technique; (3) to test the impact of nanostructures on Staphylococcus epidermidis biofilm development. Fabrication of Anodic Alumina Oxide molds was realized by double anodization in oxalic acid. This process was reproducible. The obtained molds present hexagonally arranged 50 nm diameter pores, with a 100 nm interpore distance and a length of 100 nm. Acrylonitrile-butadiene-styrene nanostructures were successfully prepared using a polymer solution and two melt wetting methods. For all methods, the nanopicots were obtained but inside each sample their length was different. One method was selected essentially for industrial purposes and for better reproducibility results. The flat ABS surface presents a slightly hydrophilic character, which remains roughly unchanged after nanostructuration, the increasing apparent wettability observed in that case being explained by roughness effects. Also, the nanostructuration of the polymer surface does not induce any significant effect on Staphylococcus epidermidis adhesion.	[Desrousseaux, Camille; Cueff, Regis; Mailhot-Jensen, Benedicte; Sautou, Valerie] Univ Auvergne, Clermont Univ, C BIOSENSS, EA 4676, F-63000 Clermont Ferrand, France; [Desrousseaux, Camille; Aumeran, Claire; Traore, Ousmane] Univ Blaise Pascal, Clermont Univ, F-63000 Clermont Ferrand, France; [Desrousseaux, Camille; Aumeran, Claire; Traore, Ousmane] Univ Auvergne, CNRS, UMR 6023, LMGE, F-63000 Clermont Ferrand, France; [Aumeran, Claire; Traore, Ousmane] CHU Clermont Ferrand, Serv Hyg Hosp, F-63003 Clermont Ferrand, France; [Garrait, Ghislain] Univ Auvergne, Clermont Univ, CIDAM, EA 4678, F-63000 Clermont Ferrand, France; [Sautou, Valerie] CHU Clermont Ferrand, Serv Pharm, F-63003 Clermont Ferrand, France	Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Clermont Auvergne (UCA); CHU Clermont Ferrand; Universite Clermont Auvergne (UCA); CHU Clermont Ferrand	Sautou, V (corresponding author), Univ Auvergne, Clermont Univ, C BIOSENSS, EA 4676, BP 10448, F-63000 Clermont Ferrand, France.	vsautou@chu-clermontferrand.fr		MAILHOT-JENSEN, Benedicte/0000-0002-7573-9702; Ghislain, GARRAIT/0000-0001-6939-9142; SAUTOU, Valerie/0000-0002-3944-3752				Abdallah M, 2014, ARCH MICROBIOL, V196, P453, DOI 10.1007/s00203-014-0983-1; Affrossman S, 1996, MACROMOLECULES, V29, P5010, DOI 10.1021/ma9516910; An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B; Anselme K, 2010, ACTA BIOMATER, V6, P3824, DOI 10.1016/j.actbio.2010.04.001; Bico J, 2001, EUROPHYS LETT, V55, P214, DOI 10.1209/epl/i2001-00402-x; Bico J, 2002, COLLOID SURFACE A, V206, P41, DOI 10.1016/S0927-7757(02)00061-4; Bokria JG, 2002, POLYMER, V43, P3239, DOI 10.1016/S0032-3861(02)00152-0; Carman ML, 2006, BIOFOULING, V22, P11, DOI 10.1080/08927010500484854; Cheng YT, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1895487; Chernecky CC, 2013, AM J INFECT CONTROL, V41, P278, DOI 10.1016/j.ajic.2012.03.020; Choi MK, 2011, LANGMUIR, V27, P2132, DOI 10.1021/la104839a; Chung KK, 2007, BIOINTERPHASES, V2, P89, DOI 10.1116/1.2751405; Coenye T, 2010, J MICROBIOL METH, V83, P89, DOI 10.1016/j.mimet.2010.08.018; Crawford RJ, 2012, ADV COLLOID INTERFAC, V179, P142, DOI 10.1016/j.cis.2012.06.015; Dalby MJ, 2002, EXP CELL RES, V276, P1, DOI 10.1006/EXCR.2002.5498; Darmanin T, 2014, PROG POLYM SCI, V39, P656, DOI 10.1016/j.progpolymsci.2013.10.003; Desrousseaux C, 2013, J HOSP INFECT, V85, P87, DOI 10.1016/j.jhin.2013.06.015; Donlan RM, 2001, J CLIN MICROBIOL, V39, P750, DOI 10.1128/JCM.39.2.750-753.2001; Efte-khari A, NANOSTRUCTURED MAT E, P59; Ercan B, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/29/295102; Ercan B, 2011, ACTA BIOMATER, V7, P3003, DOI 10.1016/j.actbio.2011.04.002; Fu Q, 2004, J AM CHEM SOC, V126, P8904, DOI 10.1021/ja047895q; Geoghegan M, 2008, FARADAY DISCUSS, V139, P85, DOI 10.1039/b717046g; Goh C, 2005, NANO LETT, V5, P1545, DOI 10.1021/nl050704c; Grimm S, 2008, NANO LETT, V8, P1954, DOI 10.1021/nl080842c; HEITZ J, 1994, APPL PHYS A-MATER, V59, P289, DOI 10.1007/BF00348232; Hochbaum AI, 2010, NANO LETT, V10, P3717, DOI 10.1021/nl102290k; Hook AL, 2012, NAT BIOTECHNOL, V30, P868, DOI 10.1038/nbt.2316; Hui CY, 2002, LANGMUIR, V18, P1394, DOI 10.1021/la0113567; Ivanova EP, 2012, SMALL, V8, P2489, DOI 10.1002/smll.201200528; Jin L, 2015, NANOTECHNOLOGY, V26, DOI 10.1088/0957-4484/26/5/055702; Kobayashi H, 2009, CLIN ORTHOP RELAT R, V467, P1360, DOI 10.1007/s11999-008-0609-5; Lee W, 2004, LANGMUIR, V20, P7665, DOI 10.1021/la049411+; Lee W, 2002, ADV MATER, V14, P1187, DOI 10.1002/1521-4095(20020903)14:17<1187::AID-ADMA1187>3.0.CO;2-X; Lee Y, 2008, THIN SOLID FILMS, V516, P3431, DOI 10.1016/j.tsf.2007.12.131; Li AP, 1998, J APPL PHYS, V84, P6023, DOI 10.1063/1.368911; Li JY, 2012, SURF COAT TECH, V206, P2161, DOI 10.1016/j.surfcoat.2011.09.052; Martin J, 2009, LANGMUIR, V25, P1181, DOI 10.1021/la803127w; Miikkulainen V, 2008, LANGMUIR, V24, P4473, DOI 10.1021/la800285s; Mitik-Dineva N, 2009, CURR MICROBIOL, V58, P268, DOI 10.1007/s00284-008-9320-8; Onda T, 1996, LANGMUIR, V12, P2125, DOI 10.1021/la950418o; Pasquali M, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/37/375605; Peeters E, 2008, J MICROBIOL METH, V72, P157, DOI 10.1016/j.mimet.2007.11.010; Pokroy B, 2009, ADV MATER, V21, P463, DOI 10.1002/adma.200801432; Puukilainen E, 2007, LANGMUIR, V23, P7263, DOI 10.1021/la063588h; Puukilainen E, 2006, COLLOID SURFACE A, V287, P175, DOI 10.1016/j.colsurfa.2006.03.056; Quere D, 2002, PHYSICA A, V313, P32, DOI 10.1016/S0378-4371(02)01033-6; Quere D, 2008, ANNU REV MATER RES, V38, P71, DOI 10.1146/annurev.matsci.38.060407.132434; Rebollar E, 2008, BIOMATERIALS, V29, P1796, DOI 10.1016/j.biomaterials.2007.12.039; Roca-Cusachs P, 2005, LANGMUIR, V21, P5542, DOI 10.1021/la046931w; Santos RM, 2010, J APPL POLYM SCI, V116, P2005, DOI 10.1002/app.31663; Saviello D, 2014, ANAL CHIM ACTA, V843, P59, DOI 10.1016/j.aca.2014.07.021; Shibuichi S, 1996, J PHYS CHEM-US, V100, P19512, DOI 10.1021/jp9616728; Smart T, 2008, NANO TODAY, V3, P38, DOI 10.1016/S1748-0132(08)70043-4; Stormonth-Darling JM, 2014, J MICROMECH MICROENG, V24, DOI 10.1088/0960-1317/24/7/075019; Tacconelli E, 2009, J HOSP INFECT, V72, P97, DOI 10.1016/j.jhin.2008.12.012; Tan JS, 2008, J POROUS MAT, V15, P619, DOI 10.1007/s10934-007-9141-3; Tarrade J, 2014, APPL SURF SCI, V292, P782, DOI 10.1016/j.apsusc.2013.12.051; VANLOOSDRECHT MCM, 1987, APPL ENVIRON MICROB, V53, P1893, DOI 10.1128/AEM.53.8.1893-1897.1987; Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024; WIENCEK KM, 1995, J BACTERIOL, V177, P1959, DOI 10.1128/jb.177.8.1959-1966.1995; Wypych G., 2012, HDB POLYM, P3; Xu LC, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/3/035003; Xu LC, 2012, ACTA BIOMATER, V8, P72, DOI 10.1016/j.actbio.2011.08.009; Yao C, 2014, J BIOMED MATER RES A, V102, P1823, DOI 10.1002/jbm.a.34856; Yoon SH, 2014, J FOOD ENG, V131, P135, DOI 10.1016/j.jfoodeng.2014.01.031; Yu WQ, 2011, J BIOMED MATER RES B, V99B, P207, DOI 10.1002/jbm.b.31888; Zhang FX, 2010, J COLLOID INTERF SCI, V343, P109, DOI 10.1016/j.jcis.2009.11.038; Zhang Y, 2006, LANGMUIR, V22, P8595, DOI 10.1021/la061372+; Zhong P, 2010, NANO-MICRO LETT, V2, P1, DOI 10.5101/nml.v2i1.p1-5; Zhou WM, 2009, APPL SURF SCI, V255, P8019, DOI 10.1016/j.apsusc.2009.05.006	71	20	22	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135632	10.1371/journal.pone.0135632	http://dx.doi.org/10.1371/journal.pone.0135632			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284922	Green Submitted, gold, Green Published			2022-12-26	WOS:000359666100052
J	Jia, YM; Xie, YT; Wang, YJ; Han, JY; Tian, XX; Fang, WG				Jia, Yu-Mian; Xie, Yun-Tao; Wang, Ya-Jun; Han, Ji-Yuan; Tian, Xin-Xia; Fang, Wei-Gang			Association of Genetic Polymorphisms in CDH1 and CTNNB1 with Breast Cancer Susceptibility and Patients' Prognosis among Chinese Han Women	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; SINGLE-NUCLEOTIDE POLYMORPHISMS; WNT SIGNALING PATHWAY; BETA-CATENIN; E-CADHERIN; GASTRIC-CANCER; OVARIAN CARCINOMAS; MUTATIONS; RISK; POPULATION	This study aims to investigate whether the germline variants in CDH1 and CTNNB1 would affect breast cancer susceptibility and patients' prognosis among Chinese Han women using a haplotype-based association analysis. We genotyped 12 haplotype-tagging single nucleotide polymorphisms (htSNPs) in CDH1 and CTNNB1 among 1,160 BC cases and 1,336 age-matched cancer-free controls using the TaqMan (R) Genotyping Assay. For association analyses of germline variants with breast cancer susceptibility, the results showed that rs7200690, rs7198799, rs17715799, rs13689 and diplotype CGC/TGC (rs7200690 + rs12185157 + rs7198799) in CDH1 as well as rs2293303 in CTNNB1 were associated with increased breast cancer risk. In addition, the Generalized Multifactor Dimensionality Reduction (GMDR) and logistic regression analysis predicted an interaction on breast cancer risk between rs17715799 and rs13689 as well as rs13689 and menarche-FFTP (First Full-Term Pregnancy) interval. For survival analyses, the results demonstrated that the minor allele homozygotes of rs13689 and haplotype TGC in CDH1 were linked with unfavorable event-free survival of breast cancer, whereas, rs4783689 of CDH1 showed the opposite effect under dominant model. Notably, the stratified analysis revealed that rs7186053 was associated with favorable event-free survival among patients with estrogen receptor (ER)-positive, progesterone receptor (PR)-positive or lymph node metastasis negative patients. Moreover, rs7200690 and rs7198799 in CDH1 as well as rs4533622 in CTNNB1 were associated with worse event-free survival among patients with clinical stage 0-I tumors. This study indicated that the genetic polymorphisms of CDH1 and CTNNB1 were associated with breast cancer susceptibility and patients' prognosis.	[Jia, Yu-Mian; Wang, Ya-Jun; Han, Ji-Yuan; Tian, Xin-Xia; Fang, Wei-Gang] Peking Univ, Hlth Sci Ctr, Key Lab Carcinogenesis & Translat Res, Dept Pathol,Minist Educ,Sch Basic Med Sci, Beijing 100871, Peoples R China; [Jia, Yu-Mian; Wang, Ya-Jun; Han, Ji-Yuan; Tian, Xin-Xia; Fang, Wei-Gang] Peking Univ, Dept Pathol, Hosp 3, Beijing 100871, Peoples R China; [Xie, Yun-Tao] Peking Univ, Sch Oncol, Breast Ctr, Beijing Canc Hosp & Inst, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Tian, XX (corresponding author), Peking Univ, Hlth Sci Ctr, Key Lab Carcinogenesis & Translat Res, Dept Pathol,Minist Educ,Sch Basic Med Sci, Beijing 100871, Peoples R China.	tianxinxia@163.com; wgfang@bjmu.edu.cn			National Natural Science Foundation of China [81171961, 81321003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants to XXT and WGF from the National Natural Science Foundation of China (no 81171961 and No 81321003) [http://www.nsfc.gov.cn/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El-Rehim Dalia, 2009, J Egypt Natl Canc Inst, V21, P185; Alanazi MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059555; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beeghly-Fadiel A, 2010, BREAST CANCER RES TR, V121, P445, DOI 10.1007/s10549-009-0579-7; Berx G, 1995, EMBO J, V14, P6107, DOI 10.1002/j.1460-2075.1995.tb00301.x; Berx G, 2001, BREAST CANCER RES, V3, P289, DOI 10.1186/bcr309; Black Michael D, 2014, Hawaii J Med Public Health, V73, P204; Chen QH, 2013, WORLD J GASTROENTERO, V19, P909, DOI 10.3748/wjg.v19.i6.909; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Cowin P, 2005, CURR OPIN CELL BIOL, V17, P499, DOI 10.1016/j.ceb.2005.08.014; Cui Y, 2011, DNA CELL BIOL, V30, P937, DOI 10.1089/dna.2011.1257; Dapic Vesna, 2005, Cancer Control, V12, P127; De Wever O, 2008, HISTOCHEM CELL BIOL, V130, P481, DOI 10.1007/s00418-008-0464-1; Fanelli MA, 2008, CELL STRESS CHAPERON, V13, P207, DOI 10.1007/s12192-007-0007-z; Ferlay J, 2014, INT J CANC J INT CAN; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Goode EL, 2002, CANCER RES, V62, P3052; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; Han JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049296; Iwatsuki M, 2010, CANCER SCI, V101, P293, DOI 10.1111/j.1349-7006.2009.01419.x; Karabacak T, 2011, TURK J PATHOL, V27, P185, DOI 10.5146/tjpath.2011.01073; Kizildag S, 2008, J BUON, V13, P533; Lee JY, 2009, CARCINOGENESIS, V30, P1528, DOI 10.1093/carcin/bgp084; Lei HX, 2002, INT J CANCER, V98, P199, DOI 10.1002/ijc.10176; Li LC, 2000, CANCER RES, V60, P873; Li Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084489; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Masciari S, 2007, J MED GENET, V44, P726, DOI 10.1136/jmg.2007.051268; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Moreno-Bueno G, 2002, ONCOGENE, V21, P7981, DOI 10.1038/sj.onc.1205924; Mostowska A, 2014, MOL DIAGN THER, V18, P85, DOI 10.1007/s40291-013-0059-y; Nicoloso MS, 2010, CANCER RES, V70, P2789, DOI 10.1158/0008-5472.CAN-09-3541; Ruan Y, 2011, J PATHOL, V225, P535, DOI 10.1002/path.2902; Saegusa M, 2001, J PATHOL, V194, P59, DOI 10.1002/path.856; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Ting WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056196; Ueda M, 2001, BRIT J CANCER, V85, P64, DOI 10.1054/bjoc.2001.1863; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Wang H, 2012, BREAST CANCER RES TR, V136, P241, DOI 10.1007/s10549-012-2244-9; Wang SZ, 2012, MUTAGENESIS, V27, P623, DOI 10.1093/mutage/ges027; Xie ZM, 2011, CANCER-AM CANCER SOC, V117, P3112, DOI 10.1002/cncr.25876; Yu JC, 2006, J BIOMED SCI, V13, P419, DOI 10.1007/s11373-006-9069-7; Zhan Z, 2012, MOL BIOL REP, V39, P8107, DOI 10.1007/s11033-012-1658-0; Zhang XF, 2008, DIS ESOPHAGUS, V21, P21, DOI 10.1111/j.1442-2050.2007.00724.x	45	14	16	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135865	10.1371/journal.pone.0135865	http://dx.doi.org/10.1371/journal.pone.0135865			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285011	Green Published, Green Submitted, gold			2022-12-26	WOS:000359666100077
J	Sugimori, M; Hayakawa, Y; Boman, BM; Fields, JZ; Awaji, M; Kozano, H; Tamura, R; Yamamoto, S; Ogata, T; Yamada, M; Endo, S; Kurimoto, M; Kuroda, S				Sugimori, Michiya; Hayakawa, Yumiko; Boman, Bruce M.; Fields, Jeremy Z.; Awaji, Miharu; Kozano, Hiroko; Tamura, Ryoi; Yamamoto, Seiji; Ogata, Toru; Yamada, Mitsuhiko; Endo, Shunro; Kurimoto, Masanori; Kuroda, Satoshi			Discovery of Power-Law Growth in the Self-Renewal of Heterogeneous Glioma Stem Cell Populations	PLOS ONE			English	Article							TUMOR-GROWTH; CANCER; TEMOZOLOMIDE; EVOLUTION	Background Accumulating evidence indicates that cancer stem cells (CSCs) drive tumorigenesis. This suggests that CSCs should make ideal therapeutic targets. However, because CSC populations in tumors appear heterogeneous, it remains unclear how CSCs might be effectively targeted. To investigate the mechanisms by which CSC populations maintain heterogeneity during self-renewal, we established a glioma sphere (GS) forming model, to generate a population in which glioma stem cells (GSCs) become enriched. We hypothesized, based on the clonal evolution concept, that with each passage in culture, heterogeneous clonal sub-lines of GSs are generated that progressively show increased proliferative ability. Methodology/Principal Findings To test this hypothesis, we determined whether, with each passage, glioma neurosphere culture generated from four different glioma cell lines become progressively proliferative (i.e., enriched in large spheres). Rather than monitoring self-renewal, we measured heterogeneity based on neurosphere clone sizes (#cells/clone). Log-log plots of distributions of clone sizes yielded a good fit (r>0.90) to a straight line (log(% total clones) = k* log(#cells/clone)) indicating that the system follows a power-law (y = x(k)) with a specific degree exponent (k = -1.42). Repeated passaging of the total GS population showed that the same power-law was maintained over six passages (CV = -1.01 to -1.17). Surprisingly, passage of either isolated small or large subclones generated fully heterogeneous populations that retained the original power-law-dependent heterogeneity. The anti-GSC agent Temozolomide, which is well known as a standard therapy for glioblastoma multiforme (GBM), suppressed the self-renewal of clones, but it never disrupted the power-law behavior of a GS population. Conclusions/Significance Although the data above did not support the stated hypothesis, they did strongly suggest a novel mechanism that underlies CSC heterogeneity. They indicate that power-law growth governs the self-renewal of heterogeneous glioma stem cell populations. That the data always fit a power-law suggests that: (i) clone sizes follow continuous, non-random, and scale-free hierarchy; (ii) precise biologic rules that reflect self-organizing emergent behaviors govern the generation of neurospheres. That the power-law behavior and the original GS heterogeneity are maintained over multiple passages indicates that these rules are invariant. These self-organizing mechanisms very likely underlie tumor heterogeneity during tumor growth. Discovery of this power-law behavior provides a mechanism that could be targeted in the development of new, more effective, anti-cancer agents.	[Sugimori, Michiya; Awaji, Miharu; Kozano, Hiroko; Tamura, Ryoi] Toyama Univ, Dept Integrat Neurosci, Toyama, Toyama 9300194, Japan; [Hayakawa, Yumiko; Endo, Shunro; Kurimoto, Masanori; Kuroda, Satoshi] Toyama Univ, Dept Neurosurg, Toyama, Toyama 9300194, Japan; [Boman, Bruce M.] Univ Delaware, Dept Biol, Ctr Translat Canc Res, Helen F Graham Canc Ctr, Newark, DE 19711 USA; [Boman, Bruce M.] Univ Delaware, Dept Math, Ctr Translat Canc Res, Helen F Graham Canc Ctr, Newark, DE 19711 USA; [Boman, Bruce M.] Res Inst, Newark, DE 19711 USA; [Fields, Jeremy Z.] CATX Inc, Biotech Res, Gladwyne, PA 19035 USA; [Yamamoto, Seiji] Toyama Univ, Dept Pathol, Toyama, Toyama 9300194, Japan; [Ogata, Toru] NRCD Hosp, Natl Rehabil Ctr Persons Disabil, Ctr Sports Sci & Hlth Promot, Tokorozawa, Saitama 3598555, Japan; [Yamada, Mitsuhiko] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Neuropsycopharmacol, Kodaira, Tokyo 1878553, Japan	University of Toyama; University of Toyama; Helen F. Graham Cancer Center & Research Institute; University of Delaware; Helen F. Graham Cancer Center & Research Institute; University of Delaware; University of Toyama; National Center for Neurology & Psychiatry - Japan	Sugimori, M (corresponding author), Toyama Univ, Dept Integrat Neurosci, 2630 Sugitani, Toyama, Toyama 9300194, Japan.	sugimmic@med.u-toyama.ac.jp	Yamamoto, Seiji/U-8660-2018; Ogata, Toru/ADC-3560-2022; Yamada, Mitsuhiko/AAO-1107-2020	Yamamoto, Seiji/0000-0003-1007-6271; Ogata, Toru/0000-0001-9011-8640; Yamada, Mitsuhiko/0000-0002-5649-2310	Ministry of Education, Culture, Sports, Science and Technology, Japan [21591866]; Takeda Science Foundation; Uehara Memorial Foundation [201010211]; Intramural Research Grant for Neurological and Psychiatric Disorders in NCNP [24-2];  [21700379];  [23300204]; Grants-in-Aid for Scientific Research [26350992, 25293093, 25293305] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Intramural Research Grant for Neurological and Psychiatric Disorders in NCNP; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid from The Ministry of Education, Culture, Sports, Science and Technology, Japan (21591866 to M.K.); in part supported by a grant-in-aid for young scientists (B) (21700379 to M.S.); grant-in-aid (23300204 to T.O.); Takeda Science Foundation (to M.S.); the Uehara Memorial Foundation (201010211 to M.S.); Intramural Research Grant 24-2 (to M.Y.) for Neurological and Psychiatric Disorders in NCNP. The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author J.Z.F. is an emeritus scientist of CATX, Inc. and did not receive a salary from CATX, Inc. CATX, Inc. did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section. NO FUNDING WAS PROVIDED BY CATX, INC., NOT EVEN AUTHORS' SALARIES. No monetary support was provided by CATX for the study or for J.Z.F.'s salary.	Adams JM, 2008, CANCER RES, V68, P4018, DOI 10.1158/0008-5472.CAN-07-6334; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; Beier D, 2008, CANCER RES, V68, P5706, DOI 10.1158/0008-5472.CAN-07-6878; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Blanpain C, 2014, SCIENCE, V344, P1243, DOI 10.1126/science.1242281; Boman BM, 2007, CLIN PHARMACOL THER, V81, P893, DOI 10.1038/sj.clpt.6100202; Boman BM, 2008, J CLIN ONCOL, V26, P2795, DOI 10.1200/JCO.2008.17.7436; BUICK RN, 1984, CANCER RES, V44, P4909; Chen RH, 2010, CANCER CELL, V17, P362, DOI 10.1016/j.ccr.2009.12.049; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Denysenko T, 2010, CELL BIOCHEM FUNCT, V28, P343, DOI 10.1002/cbf.1666; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Dontu G, 2004, TRENDS ENDOCRIN MET, V15, P193, DOI 10.1016/j.tem.2004.05.011; Driessens G, 2012, NATURE, V488, P527, DOI 10.1038/nature11344; Egeblad M, 2010, DEV CELL, V18, P884, DOI 10.1016/j.devcel.2010.05.012; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Ishii N, 1999, BRAIN PATHOL, V9, P469, DOI 10.1111/j.1750-3639.1999.tb00536.x; Jordan CT, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000914; Jordan CT, 2009, CELL STEM CELL, V4, P203, DOI 10.1016/j.stem.2009.02.003; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Loeffler M, 2002, CELLS TISSUES ORGANS, V171, P8, DOI 10.1159/000057688; Mandelbrot BB, 1998, SCIENCE, V279, P783; Mertins SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057099; Nagao M, 2008, J CELL BIOL, V183, P1243, DOI 10.1083/jcb.200807130; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Opdenaker LM, 2009, STEM CELLS CANC PARA, P90; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Prestegarden L, 2010, CANCER RES, V70, P4274, DOI 10.1158/0008-5472.CAN-09-3904; Quintana E, 2010, CANCER CELL, V18, P510, DOI 10.1016/j.ccr.2010.10.012; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Rutka JT, 2009, J NEURO-ONCOL, V92, P261, DOI 10.1007/s11060-009-9829-0; Schafer A, 2012, NEURO-ONCOLOGY, V14, P1452, DOI 10.1093/neuonc/nos270; Setoguchi T, 2004, CELL CYCLE, V3, P414; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sugimori M, 2007, DEVELOPMENT, V134, P1617, DOI 10.1242/dev.001255; Tsuboi Y, 2009, J NEUROSURG, V110, P594, DOI 10.3171/2008.8.JNS17648; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Yu SC, 2008, CANCER LETT, V265, P124, DOI 10.1016/j.canlet.2008.02.010	45	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135760	10.1371/journal.pone.0135760	http://dx.doi.org/10.1371/journal.pone.0135760			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284929	Green Published, Green Submitted, gold			2022-12-26	WOS:000359666100068
J	Wang, BB; Gao, L; Zhang, QF; Li, AM; Deng, Y; Guo, XL				Wang, Bingbo; Gao, Lin; Zhang, Qingfang; Li, Aimin; Deng, Yue; Guo, Xingli			Diversified Control Paths: A Significant Way Disease Genes Perturb the Human Regulatory Network	PLOS ONE			English	Article							PROTEOME-SCALE MAP; AMYLOID-BETA; CONTROLLABILITY; EXPRESSION; CELL	Background The complexity of biological systems motivates us to use the underlying networks to provide deep understanding of disease etiology and the human diseases are viewed as perturbations of dynamic properties of networks. Control theory that deals with dynamic systems has been successfully used to capture systems-level knowledge in large amount of quantitative biological interactions. But from the perspective of system control, the ways by which multiple genetic factors jointly perturb a disease phenotype still remain. Results In this work, we combine tools from control theory and network science to address the diversified control paths in complex networks. Then the ways by which the disease genes perturb biological systems are identified and quantified by the control paths in a human regulatory network. Furthermore, as an application, prioritization of candidate genes is presented by use of control path analysis and gene ontology annotation for definition of similarities. We use leave-one-out cross-validation to evaluate the ability of finding the gene-disease relationship. Results have shown compatible performance with previous sophisticated works, especially in directed systems. Conclusions Our results inspire a deeper understanding of molecular mechanisms that drive pathological processes. Diversified control paths offer a basis for integrated intervention techniques which will ultimately lead to the development of novel therapeutic strategies.	[Wang, Bingbo; Gao, Lin; Zhang, Qingfang; Deng, Yue; Guo, Xingli] Xidian Univ, Sch Comp Sci & Technol, Xian, Peoples R China; [Deng, Yue] Xidian Univ, Inst Software Engn, Xian, Peoples R China; [Li, Aimin] Xian Univ Technol, Sch Comp Sci & Technol, Xian, Peoples R China	Xidian University; Xidian University; Xi'an University of Technology	Wang, BB (corresponding author), Xidian Univ, Sch Comp Sci & Technol, Xian, Peoples R China.	w_bingbo@163.com; lgao@mail.xidian.edu.cn		Li, Aimin/0000-0002-6983-2310				Agren R, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002518; Amberger J, 2009, NUCLEIC ACIDS RES, V37, pD793, DOI 10.1093/nar/gkn665; Asgari Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079397; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Backes C, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1227; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Cheng XR, 2013, J ALZHEIMERS DIS, V37, P823, DOI 10.3233/JAD-130836; Cho M, 2013, J CANCER, V4, P671, DOI 10.7150/jca.7118; Cornelius SP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2939; Cui QH, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100200; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Gao JX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6415; Hopcroft J. E., 1973, SIAM Journal on Computing, V2, P225, DOI 10.1137/0202019; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jia T, 2013, SCI REP-UK, V3, DOI 10.1038/srep02354; Kalman R. E., 1963, SIAM J CONTROL     A, V1, P152, DOI [DOI 10.1137/0301010, 10.1137/0301010]; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanekiyo T, 2013, J NEUROSCI, V33, P19276, DOI 10.1523/JNEUROSCI.3487-13.2013; Kapelko-Slowik K, 2013, POSTEP HIG MED DOSW, V67, P553, DOI 10.5604/17322693.1052449; Keller A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-552; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Kuntzer J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-367; Kuhn HW, 2005, NAV RES LOG, V52, P7, DOI 10.1002/nav.20053; Lebeck J, 2012, ACTA DIABETOL, V49, pS215, DOI 10.1007/s00592-012-0430-1; Leiserson MDM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003054; LIN CT, 1974, IEEE T AUTOMAT CONTR, VAC19, P201, DOI 10.1109/TAC.1974.1100557; Liu YY, 2013, P NATL ACAD SCI USA, V110, P2460, DOI 10.1073/pnas.1215508110; Liu YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044459; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; POLJAK S, 1990, IEEE T AUTOMAT CONTR, V35, P367, DOI 10.1109/9.50361; Rajapakse I, 2011, P NATL ACAD SCI USA, V108, P17257, DOI 10.1073/pnas.1113249108; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Ruths J, 2014, SCIENCE, V343, P1373, DOI 10.1126/science.1242063; Sun J, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.208701; Tran K, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087973, DOI 10.1371/J0URNAL.P0NE.0087973]; Vanunu O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000641; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Wang BB, 2014, SCI REP-UK, V4, DOI 10.1038/srep05399; Wang BB, 2013, EPL-EUROPHYS LETT, V101, DOI 10.1209/0295-5075/101/58003; Wang BB, 2012, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2012/04/P04011; Wang JZ, 2007, BIOINFORMATICS, V23, P1274, DOI 10.1093/bioinformatics/btm087; Wuchty S, 2014, P NATL ACAD SCI USA, V111, P7156, DOI 10.1073/pnas.1311231111; Yuan ZZ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3447; Zhao LJ, 2012, ASIAN PAC J CANCER P, V13, P3631, DOI 10.7314/APJCP.2012.13.8.3631; Zhou XZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5212	48	4	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135491	10.1371/journal.pone.0135491	http://dx.doi.org/10.1371/journal.pone.0135491			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284649	Green Published, gold, Green Submitted			2022-12-26	WOS:000359666100042
J	Yang, EJ; Ahn, S; Ryu, J; Choi, MS; Choi, S; Chong, YH; Hyun, JW; Chang, MJ; Kim, HS				Yang, Eun-Jeong; Ahn, Sangzin; Ryu, Junghwa; Choi, Moon-Seok; Choi, Shinkyu; Chong, Young Hae; Hyun, Jin-Won; Chang, Moon-Jeong; Kim, Hye-Sun			Phloroglucinol Attenuates the Cognitive Deficits of the 5XFAD Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							INDUCED CELL-DAMAGE; PAIRED HELICAL FILAMENTS; AMYLOID PLAQUE-FORMATION; PROTEIN-TAU TAU; OXIDATIVE STRESS; SYNAPTIC PLASTICITY; HYDROGEN-PEROXIDE; TRANSGENIC MICE; IN-VITRO; ANTIOXIDANT PROPERTIES	Alzheimer's disease (AD) is the most common form of dementia among the elderly. Neuritic plaques whose primary component is amyloid beta peptide (A beta) and neurofibrillary tangles which are composed of hyperphosphorylated tau, are known to be the neuropathological hallmarks of AD. In addition, impaired synaptic plasticity in neuronal networks is thought to be important mechanism underlying for the cognitive deficits observed in AD. Although various causative factors, including excitotoxicity, mitochondrial dysregulation and oxidative damage caused by A beta, are involved in early onset of AD, fundamental therapeutics that can modify the progression of this disease are not currently available. In the present study, we investigated whether phloroglucinol (1, 3, 5-trihydroxybenzene), a component of phlorotannins, which are plentiful in Ecklonia cava, a marine brown alga species, displays therapeutic activities in AD. We found that phloroglucinol attenuates the increase in reactive oxygen species (ROS) accumulation induced by oligomeric A beta(1-42) (A beta(1-42)) treatment in HT-22, hippocampal cell line. In addition, phloroglucinol was shown to ameliorate the reduction in dendritic spine density induced by A beta(1-42) treatment in rat primary hippocampal neuron cultures. We also found that the administration of phloroglucinol to the hippocampal region attenuated the impairments in cognitive dysfunction observed in 22-week-old 5XFAD (Tg6799) mice, which are used as an AD animal model. These results indicate that phloroglucinol displays therapeutic potential for AD by reducing the cellular ROS levels.	[Yang, Eun-Jeong; Ahn, Sangzin; Ryu, Junghwa; Choi, Moon-Seok; Choi, Shinkyu] Seoul Natl Univ, Coll Med, Dept Pharmacol & Biomed Sci, Seoul, South Korea; [Chong, Young Hae] Ewha Womans Univ, Sch Med, Dept Microbiol, Seoul, South Korea; [Hyun, Jin-Won] Jeju Natl Univ, Sch Med, Dept Biochem, Jeju, South Korea; [Chang, Moon-Jeong] Kookmin Univ, Dept Foods & Nutr, Coll Nat Sci, Seoul, South Korea; [Kim, Hye-Sun] Seoul Natl Univ, Coll Med, Bundang Hosp, Songnam, South Korea; [Kim, Hye-Sun] Seoul Natl Univ, Coll Med, Neurosci Res Inst, Seoul, South Korea	Seoul National University (SNU); Ewha Womans University; Jeju National University; Kookmin University; Seoul National University (SNU); Seoul National University (SNU)	Chang, MJ (corresponding author), Kookmin Univ, Dept Foods & Nutr, Coll Nat Sci, Seoul, South Korea.	cmoon@kookmin.ac.kr; hyisun@snu.ac.kr	Ryu, Junghwa/K-4034-2015; Ahn, Sangzin/E-8807-2016	Ahn, Sangzin/0000-0003-2749-0014; Choi, Moonseok/0000-0002-2816-239X	Korea Healthcare Technology R&D Project by the Ministry for Health, Welfare and Family Affairs of the Republic of Korea [HI12C0983]; National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2011-0021866]	Korea Healthcare Technology R&D Project by the Ministry for Health, Welfare and Family Affairs of the Republic of Korea; National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This work was financially supported by grants from the Korea Healthcare Technology R&D Project (HI12C0983) by the Ministry for Health, Welfare and Family Affairs of the Republic of Korea and the National Research Foundation of Korea (NRF), which is funded by the Ministry of Education, Science and Technology (grant number 2011-0021866).	Abdul HM, 2006, J NEUROCHEM, V96, P1322, DOI 10.1111/j.1471-4159.2005.03647.x; Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; Apelt J, 2004, INT J DEV NEUROSCI, V22, P475, DOI 10.1016/j.ijdevneu.2004.07.006; Arancibia S, 2008, NEUROBIOL DIS, V31, P316, DOI 10.1016/j.nbd.2008.05.012; Balboa EM, 2013, FOOD CHEM, V138, P1764, DOI 10.1016/j.foodchem.2012.11.026; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Butterfield DA, 2001, TRENDS MOL MED, V7, P548, DOI 10.1016/S1471-4914(01)02173-6; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; Devi L, 2014, NEUROBIOL AGING, V35, P2272, DOI 10.1016/j.neurobiolaging.2014.04.031; Dinamarca MC, 2006, MOL PSYCHIATR, V11, P1032, DOI 10.1038/sj.mp.4001866; Du H, 2014, BBA-MOL BASIS DIS, V1842, P2517, DOI 10.1016/j.bbadis.2013.03.004; Gabbita SP, 1999, J NEUROCHEM, V73, P1660, DOI 10.1046/j.1471-4159.1999.0731660.x; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V425, P534, DOI DOI 10.1016/J.BBRC.2012.08.020; GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Gu ZL, 2009, J BIOL CHEM, V284, P10639, DOI 10.1074/jbc.M806508200; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Hongpaisan J, 2011, J NEUROSCI, V31, P630, DOI 10.1523/JNEUROSCI.5209-10.2011; IHARA Y, 1986, J BIOCHEM-TOKYO, V99, P1807, DOI 10.1093/oxfordjournals.jbchem.a135662; Kamsler A, 2003, J NEUROSCI, V23, P269; Kang KA, 2006, J CELL BIOCHEM, V97, P609, DOI 10.1002/jcb.20668; Kang KA, 2010, CHEM-BIOL INTERACT, V185, P215, DOI 10.1016/j.cbi.2010.02.031; Katsuki H, 1997, EUR J PHARMACOL, V337, P213, DOI 10.1016/S0014-2999(97)01323-X; Kim HS, 2012, J PHARMACOL SCI, V119, P186, DOI 10.1254/jphs.12056FP; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Massaad CA, 2011, ANTIOXID REDOX SIGN, V14, P2013, DOI 10.1089/ars.2010.3208; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Matsuoka Y, 2001, NEUROSCIENCE, V104, P609, DOI 10.1016/S0306-4522(01)00115-4; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; Moon C, 2008, PHYTOTHER RES, V22, P238, DOI 10.1002/ptr.2298; Morris JK, 2014, BBA-MOL BASIS DIS, V1842, P1340, DOI 10.1016/j.bbadis.2014.04.012; Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Parajuli B, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.503; Piao MJ, 2014, INT J RADIAT BIOL, V90, P928, DOI 10.3109/09553002.2014.911990; Queguineur B, 2012, FOOD CHEM TOXICOL, V50, P2886, DOI 10.1016/j.fct.2012.05.026; Ripoli C, 2014, J NEUROSCI, V34, P12893, DOI 10.1523/JNEUROSCI.1201-14.2014; Ripoli C, 2013, NEUROBIOL AGING, V34, P1032, DOI 10.1016/j.neurobiolaging.2012.06.027; Ruszkiewicz J., 2015, NEUROCHEMISTRY INT; Ryu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071178; Segal M, 2005, NAT REV NEUROSCI, V6, P277, DOI 10.1038/nrn1649; Shrestha BR, 2006, MOL CELL NEUROSCI, V33, P274, DOI 10.1016/j.mcn.2006.07.011; Small SA, 2004, P NATL ACAD SCI USA, V101, P7181, DOI 10.1073/pnas.0400285101; Smith MA, 1998, J NEUROCHEM, V70, P2212, DOI 10.1046/j.1471-4159.1998.70052212.x; So Mi Jung, 2014, Prev Nutr Food Sci, V19, P129, DOI 10.3746/pnf.2014.19.3.129; Yuste R, 2011, NEURON, V71, P772, DOI 10.1016/j.neuron.2011.07.024; Zeng YQ, 2015, J NEUROCHEM, V133, P38, DOI 10.1111/jnc.13056	52	43	45	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135686	10.1371/journal.pone.0135686	http://dx.doi.org/10.1371/journal.pone.0135686			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284625	Green Submitted, gold, Green Published			2022-12-26	WOS:000359666100058
J	Pruller, S; Rensch, U; Meemken, D; Kaspar, H; Kopp, PA; Klein, G; Kehrenberg, C				Prueller, Sandra; Rensch, Ulrike; Meemken, Diana; Kaspar, Heike; Kopp, Peter A.; Klein, Guenter; Kehrenberg, Corinna			Antimicrobial Susceptibility of Bordetella bronchiseptica Isolates from Swine and Companion Animals and Detection of Resistance Genes	PLOS ONE			English	Article							TETRACYCLINE RESISTANCE; PASTEURELLA-MULTOCIDA; ESCHERICHIA-COLI; ANTIBIOTIC SUSCEPTIBILITY; RESPIRATORY-INFECTIONS; PATHOGENIC BACTERIA; ATROPHIC RHINITIS; BETA-LACTAMASE; PIGS; CHLORAMPHENICOL	Bordetella bronchiseptica causes infections of the respiratory tract in swine and other mammals and is a precursor for secondary infections with Pasteurella multocida. Treatment of B. bronchiseptica infections is conducted primarily with antimicrobial agents. Therefore it is essential to get an overview of the susceptibility status of these bacteria. The aim of this study was to comparatively analyse broth microdilution susceptibility testing according to CLSI recommendations with an incubation time of 16 to 20 hours and a longer incubation time of 24 hours, as recently proposed to obtain more homogenous MICs. Susceptibility testing against a panel of 22 antimicrobial agents and two fixed combinations was performed with 107 porcine isolates from different farms and regions in Germany and 43 isolates obtained from companion animals in Germany and other European countries. Isolates with increased MICs were investigated by PCR assays for the presence of resistance genes. For ampicillin, all 107 porcine isolates were classified as resistant, whereas only a single isolate was resistant to florfenicol. All isolates obtained from companion animals showed elevated MICs for beta-lactam antibiotics and demonstrated an overall low susceptibility to cephalosporines. Extension of the incubation time resulted in 1-2 dilution steps higher MIC50 values of porcine isolates for seven antimicrobial agents tested, while isolates from companion animals exhibited twofold higher MIC50/90 values only for tetracycline and cefotaxime. For three antimicrobial agents, lower MIC50 and MIC90 values were detected for both, porcine and companion animal isolates. Among the 150 isolates tested, the resistance genes bla(BOR-1) (n = 147), bla(OXA-2), (n = 4), strA and strB (n = 17), sul1 (n = 10), sul2 (n = 73), dfrA7 (n = 3) and tet(A) (n = 8) were detected and a plasmid localisation was identified for several of the resistance genes.	[Prueller, Sandra; Rensch, Ulrike; Meemken, Diana; Klein, Guenter; Kehrenberg, Corinna] Univ Vet Med Hannover, Inst Food Qual & Food Safety, D-30173 Hannover, Germany; [Kaspar, Heike] Fed Off Consumer Protect & Food Safety BVL, Berlin, Germany; [Kopp, Peter A.] Vet Med Lab GmbH, Div IDEXX Labs, Ludwigsburg, Germany	University of Veterinary Medicine Hannover, Foundation	Kehrenberg, C (corresponding author), Univ Vet Med Hannover, Inst Food Qual & Food Safety, Bischofsholer Damm 15, D-30173 Hannover, Germany.	corinna.kehrenberg@tiho-hannover.de	Klein, Günter/G-5321-2013; Kehrenberg, Corinna/GSI-9835-2022	Klein, Günter/0000-0003-1931-2701; 	Federal Ministry of Food and Agriculture (BMEL) through the German Antibiotics Resistance Strategy (DART) project [FKZ 2811HS010]; Vet Med Labor GmbH	Federal Ministry of Food and Agriculture (BMEL) through the German Antibiotics Resistance Strategy (DART) project; Vet Med Labor GmbH	This study was financially supported by the Federal Ministry of Food and Agriculture (BMEL) through the German Antibiotics Resistance Strategy (DART) project (grant number FKZ 2811HS010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Vet Med Labor GmbH provided support in the form of a salary for author PAK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the author contributions section.	Aarestrup FM, 2000, DIAGN MICR INFEC DIS, V37, P127, DOI 10.1016/S0732-8893(00)00130-9; Batchelor M, 2005, ANTIMICROB AGENTS CH, V49, P1319, DOI 10.1128/AAC.49.4.1319-1322.2005; Bert F, 2002, J ANTIMICROB CHEMOTH, V50, P11, DOI 10.1093/jac/dkf069; Bose A, 2008, CLIN MICROBIOL NEWSL, V30, P117; Brockmeier SL, 2007, VET MICROBIOL, V125, P284, DOI 10.1016/j.vetmic.2007.05.022; Brockmeier S.L., 2012, DIS SWINE, P670; Burton PJ, 1996, J VET DIAGN INVEST, V8, P464, DOI 10.1177/104063879600800411; Chalker VJ, 2003, CLIN DIAGN LAB IMMUN, V10, P352, DOI 10.1128/CDLI.10.3.352-356.2003; Chander Y, 2011, VET J, V187, P139, DOI 10.1016/j.tvjl.2009.10.013; CHIOU CS, 1995, GENE, V152, P47, DOI 10.1016/0378-1119(94)00721-4; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Clinical and Laboratory Standards Institute, 2013, VET01A4 CLSI; Dayao DAE, 2014, VET MICROBIOL, V171, P232, DOI 10.1016/j.vetmic.2014.03.014; De Briyne N, 2014, VET REC, V175, DOI 10.1136/vr.102462; DEEB BJ, 1990, J CLIN MICROBIOL, V28, P70, DOI 10.1128/JCM.28.1.70-75.1990; DeRosa DC, 2000, J VET DIAGN INVEST, V12, P541, DOI 10.1177/104063870001200608; Dunkel B, 2015, J VET EMERG CRIT CAR, V25, P89, DOI 10.1111/vec.12275; Fonseca EL, 2006, J CLIN MICROBIOL, V44, P2767, DOI 10.1128/JCM.01916-05; Frech G, 2000, J APPL MICROBIOL, V89, P633, DOI 10.1046/j.1365-2672.2000.01160.x; Frech G, 2003, J ANTIMICROB CHEMOTH, V51, P180, DOI 10.1093/jac/dkg058; Garcia-Cantu MC, 2000, EQUINE VET EDUC, V12, P45, DOI 10.1111/j.2042-3292.2000.tb01763.x; Garcia-de-la-Fuente C, 2015, DIAGN MICROBIOL INFE; GILES CJ, 1980, VET REC, V106, P25, DOI 10.1136/vr.106.2.25; GOODNOW RA, 1980, MICROBIOL REV, V44, P722, DOI 10.1128/MMBR.44.4.722-738.1980; Hansen LM, 1996, ANTIMICROB AGENTS CH, V40, P1558, DOI 10.1128/AAC.40.6.1558; Horiguchi Y, 2012, CURR TOP MICROBIOL, V361, P113, DOI 10.1007/82_2012_206; Hozbor D, 1999, RES MICROBIOL, V150, P333, DOI 10.1016/S0923-2508(99)80059-X; Kadlec K, 2005, J ANTIMICROB CHEMOTH, V56, P485, DOI 10.1093/jac/dki262; Kadlec K, 2004, ANTIMICROB AGENTS CH, V48, P4903, DOI 10.1128/AAC.48.12.4903-4906.2004; Kadlec K, 2007, J ANTIMICROB CHEMOTH, V59, P396, DOI 10.1093/jac/dkl515; Kadlec K, 2006, J ANTIMICROB CHEMOTH, V58, P225, DOI 10.1093/jac/dkl149; Karriker L. A., 2012, DIS SWINE, P106; Kehrenberg C, 2006, ANTIMICROB AGENTS CH, V50, P1156, DOI 10.1128/AAC.50.4.1156-1163.2006; Kehrenberg C, 2001, FEMS MICROBIOL LETT, V205, P283, DOI 10.1111/j.1574-6968.2001.tb10962.x; Keyes K, 2000, ANTIMICROB AGENTS CH, V44, P421, DOI 10.1128/AAC.44.2.421-424.2000; Lanz R, 2003, VET MICROBIOL, V91, P73, DOI 10.1016/S0378-1135(02)00263-8; Lartigue MF, 2005, ANTIMICROB AGENTS CH, V49, P2565, DOI 10.1128/AAC.49.6.2565-2567.2005; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; MCCANDLISH IAP, 1978, VET REC, V102, P298, DOI 10.1136/vr.102.14.293; Morrissey I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086669; MORTENSEN JE, 1989, ANTIMICROB AGENTS CH, V33, P771, DOI 10.1128/AAC.33.5.771; Perreten V, 2003, ANTIMICROB AGENTS CH, V47, P1169, DOI 10.1128/AAC.47.3.1169-1172.2003; PIJPERS A, 1989, J VET PHARMACOL THER, V12, P267, DOI 10.1111/j.1365-2885.1989.tb00670.x; Priebe S, 2003, ANTIMICROB AGENTS CH, V47, P2703, DOI 10.1128/AAC.47.8.2703-2705.2003; Pruller S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123883; Rheinwald M, 2015, VET REC, V176, P357, DOI 10.1136/vr.102694; Rhodes G, 2000, APPL ENVIRON MICROB, V66, P3883, DOI 10.1128/AEM.66.9.3883-3890.2000; ROBERTS MC, 1993, MOL CELL PROBE, V7, P387, DOI 10.1006/mcpr.1993.1057; Rose S, 2012, ANTIMICROB AGENTS CH, V56, P3664, DOI 10.1128/AAC.00266-12; Rougier S, 2006, VET MICROBIOL, V115, P192, DOI 10.1016/j.vetmic.2006.02.003; SCHOLZ P, 1989, GENE, V75, P271, DOI 10.1016/0378-1119(89)90273-4; Schwarz S, 2007, BERL MUNCH TIERARZTL, V120, P423, DOI 10.2376/0005-9366-120-423; Seydel JK, 1973, J INFECT DIS, V128, P470; Speakman AJ, 1997, VET MICROBIOL, V54, P63, DOI 10.1016/S0378-1135(96)01256-4; Speakman AJ, 2000, VET MICROBIOL, V71, P193, DOI 10.1016/S0378-1135(99)00171-6; Steinfeld A, 2012, TIERAERZTL PRAX K H, V40, P309; Stepniewska K, 2014, POL J VET SCI, V17, P71, DOI 10.2478/pjvs-2014-0009; Sundin GW, 1996, MOL ECOL, V5, P133, DOI 10.1111/j.1365-294X.1996.tb00299.x; Terry NS, 1911, J INFECT DIS, V8, P399; Viejo G, 2002, SCAND J INFECT DIS, V34, P628, DOI 10.1080/00365540210147697; WOOLFREY BF, 1991, CLIN MICROBIOL REV, V4, P243, DOI 10.1128/CMR.4.3.243-255.1991; Zhao ZQ, 2011, J VET MED SCI, V73, P103, DOI 10.1292/jvms.10-0184	62	26	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135703	10.1371/journal.pone.0135703	http://dx.doi.org/10.1371/journal.pone.0135703			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275219	Green Submitted, gold, Green Published			2022-12-26	WOS:000359493600100
J	Jen, J; Lin, LL; Chen, HT; Liao, SY; Lo, FY; Tang, YA; Su, WC; Salgia, R; Hsu, CL; Huang, HC; Juan, HF; Wang, YC				Jen, J.; Lin, L-L; Chen, H-T; Liao, S-Y; Lo, F-Y; Tang, Y-A; Su, W-C; Salgia, R.; Hsu, C-L; Huang, H-C; Juan, H-F; Wang, Y-C			Oncoprotein ZNF322A transcriptionally deregulates alpha-adducin, cyclin D1 and p53 to promote tumor growth and metastasis in lung cancer	ONCOGENE			English	Article							ZINC-FINGER PROTEIN; MARCKS-RELATED DOMAIN; KINASE-C; GASTRIC-CANCER; CELL-GROWTH; SPECTRIN; COMPLEX; PHOSPHORYLATION; IDENTIFICATION; PROGRESSION	ZNF322A encoding a classical Cys2His2 zinc finger transcription factor was previously revealed as a potential oncogene in lung cancer patients. However, the oncogenic role of ZNF322A and its underlying mechanism in lung tumorigenesis remain elusive. Here we show ZNF322A protein overexpression in 123 Asian and 74 Caucasian lung cancer patients. Multivariate Cox regression analysis indicated that ZNF322A was an independent risk factor for a poor outcome in lung cancer, corroborating the Kaplan-Meier results that patients with ZNF322A protein overexpression had significantly poorer overall survival than other patients. Overexpression of ZNF322A promoted cell proliferation and soft agar growth by prolonging cell cycle in S phase in multiple lung cell lines, including the immortalized lung cell BEAS-2B. In addition, ZNF322A overexpression enhanced cell migration and invasion, whereas knockdown of ZNF322A reduced cell growth, invasion and metastasis abilities in vitro and in vivo. Quantitative proteomic analysis revealed potential ZNF322A-regulated downstream targets, including alpha-adducin (ADD1), cyclin D1 (CCND1), and p53. Using luciferase promoter activity assay combined with site-directed mutagenesis and sequential chromatin immunoprecipitation-PCR assay, we found that ZNF322A could form a complex with c-Jun and cooperatively activate ADD1 and CCND1 but repress p53 gene transcription by recruiting differential chromatin modifiers, such as histone deacetylase 3, in an AP-1 element dependent manner. Reconstitution experiments indicated that CCND1 and p53 were important to ZNF322A-mediated promotion of cell proliferation, whereas ADD1 was necessary for ZNF322A-mediated cell migration and invasion. Our results provide compelling evidence that ZNF322A overexpression transcriptionally dysregulates genes involved in cell growth and motility therefore contributes to lung tumorigenesis and poor prognosis.	[Jen, J.; Liao, S-Y; Wang, Y-C] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, 1 Univ Rd, Tainan 701, Taiwan; [Lin, L-L; Hsu, C-L; Juan, H-F] Natl Taiwan Univ, Dept Life Sci, Inst Mol & Cellular Biol, Grad Inst Biomed Elect & Bioinformat, 1,Sec 4,Roosevelt Rd, Taipei 116, Taiwan; [Chen, H-T; Lo, F-Y; Tang, Y-A; Wang, Y-C] Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 701, Taiwan; [Su, W-C] Natl Cheng Kung Univ, Dept Internal Med, Coll Med, Tainan 701, Taiwan; [Salgia, R.] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA; [Huang, H-C] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Huang, H-C] Natl Yang Ming Univ, Ctr Syst & Synthet Biol, Taipei 112, Taiwan	National Cheng Kung University; National Taiwan University; National Cheng Kung University; National Cheng Kung University; University of Chicago; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Wang, YC (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, 1 Univ Rd, Tainan 701, Taiwan.; Juan, HF (corresponding author), Natl Taiwan Univ, Dept Life Sci, Inst Mol & Cellular Biol, Grad Inst Biomed Elect & Bioinformat, 1,Sec 4,Roosevelt Rd, Taipei 116, Taiwan.	yukijuan@ntu.edu.tw; ycw5798@mail.ncku.edu.tw	Huang, Hsuan-Cheng/C-7266-2011; Wang, Yi-Ching/J-8702-2019; Hsu, Chia-Lang/O-1458-2013	Huang, Hsuan-Cheng/0000-0002-3386-0934; Wang, Yi-Ching/0000-0002-7694-2067; Hsu, Chia-Lang/0000-0002-7447-8045; JUAN, HSUEH-FEN/0000-0003-4876-3309; Su, Wu-Chou/0000-0003-2953-4105	Taiwan Ministry of Science and Technology Grant [103-2627-B-006-007, 103-2627-B-002-002]; Taiwan Ministry of Health and Welfare Grant [MOHW103-TD-B-111-06]; Aim for the Top University Project Grant; Human Biobank, Research Center of Clinical Medicine, National Cheng Kung University Hospital	Taiwan Ministry of Science and Technology Grant; Taiwan Ministry of Health and Welfare Grant; Aim for the Top University Project Grant; Human Biobank, Research Center of Clinical Medicine, National Cheng Kung University Hospital	This work was supported by the Taiwan Ministry of Science and Technology Grant (103-2627-B-006-007; 103-2627-B-002-002), Taiwan Ministry of Health and Welfare Grant (MOHW103-TD-B-111-06) and the Aim for the Top University Project Grant. We are grateful for the support from the Human Biobank, Research Center of Clinical Medicine, National Cheng Kung University Hospital. Accession numbers: Data from proteomics was deposited in the ProteomeXchange Consortium with accession number PXD001123.	Bartek J, 2001, CURR OPIN CELL BIOL, V13, P738, DOI 10.1016/S0955-0674(00)00280-5; BENNETT V, 1988, J BIOL CHEM, V263, P5860; Chauhan S, 2013, MOL CELL, V50, P16, DOI 10.1016/j.molcel.2013.01.024; Chen CL, 2007, J CELL SCI, V120, P1157, DOI 10.1242/jcs.03408; Cheng YD, 2012, MOL CANCER RES, V10, P925, DOI 10.1158/1541-7786.MCR-11-0594; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; Cowger JJM, 2007, ONCOGENE, V26, P3378, DOI 10.1038/sj.onc.1210126; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Evans PM, 2008, ACTA BIOCH BIOPH SIN, V40, P554, DOI 10.1111/j.1745-7270.2008.00439.x; Frietze S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015082; GARDNER K, 1987, NATURE, V328, P359, DOI 10.1038/328359a0; Gocke CB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003255; Hou J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010312; Jeon BN, 2014, NUCLEIC ACIDS RES, V42, P11447, DOI 10.1093/nar/gku857; Jheon AH, 2001, J BIOL CHEM, V276, P18282, DOI 10.1074/jbc.M010885200; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kim MK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004864; Lai KP, 2014, INT J CANCER, V135, P1790, DOI 10.1002/ijc.28819; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li D, 2011, MOL CANCER RES, V9, P577, DOI 10.1158/1541-7786.MCR-10-0534; Li XL, 1998, J BIOL CHEM, V273, P19329, DOI 10.1074/jbc.273.30.19329; Li YQ, 2004, BIOCHEM BIOPH RES CO, V325, P1383, DOI 10.1016/j.bbrc.2004.10.183; Lo FY, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-235; Matsuoka Y, 1998, J CELL BIOL, V142, P485, DOI 10.1083/jcb.142.2.485; Meruvu S, 2011, J BIOL CHEM, V286, P26516, DOI 10.1074/jbc.M110.212506; Ogawa S, 2004, P NATL ACAD SCI USA, V101, P14461, DOI 10.1073/pnas.0405786101; Okayama H, 2012, CANCER RES, V72, P100, DOI 10.1158/0008-5472.CAN-11-1403; Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Selamat SA, 2012, GENOME RES, V22, P1197, DOI 10.1101/gr.132662.111; Shen Q, 2008, ONCOGENE, V27, P366, DOI 10.1038/sj.onc.1210643; Tian C, 2009, NAT CELL BIOL, V11, P580, DOI 10.1038/ncb1864; Tupler R, 2001, NATURE, V409, P832, DOI 10.1038/35057011; Wagner S, 2000, J BIOL CHEM, V275, P15685, DOI 10.1074/jbc.M910152199; Wei Z, 2009, STEM CELLS, V27, P2969, DOI 10.1002/stem.231; Yang GL, 2014, ONCOL REP, V31, P1877, DOI 10.3892/or.2014.2997; Yu J, 2013, ONCOGENE, V32, P307, DOI 10.1038/onc.2012.54; Zhang L, 2014, ONCOGENE, V33, P5491, DOI 10.1038/onc.2013.495	38	33	33	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 5	2016	35	18					2357	2369		10.1038/onc.2015.296	http://dx.doi.org/10.1038/onc.2015.296			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DM2GL	26279304	hybrid, Green Published			2022-12-26	WOS:000376165000008
J	Cai, JC; Zhao, JJ; Zhang, N; Xu, XN; Li, R; Yi, Y; Fang, LS; Zhang, L; Li, MF; Wu, JH; Zhang, H				Cai, Junchao; Zhao, JingJing; Zhang, Nu; Xu, Xiaonan; Li, Rang; Yi, Yang; Fang, Lishan; Zhang, Le; Li, Mengfeng; Wu, Jueheng; Zhang, Heng			MicroRNA-542-3p Suppresses Tumor Cell Invasion via Targeting AKT Pathway in Human Astrocytoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRIN-LINKED KINASE; HIGH-GRADE ASTROCYTOMAS; NF-KAPPA-B; GLIOBLASTOMA-MULTIFORME; BREAST-CANCER; PROGNOSTIC-SIGNIFICANCE; BETA-CATENIN; IN-VITRO; ACTIVATION; GLIOMA	The molecular mechanism underlying constitutive activation of AKT signaling, which plays essential roles in astrocytoma progression, is not fully characterized. Increasing numbers of studies have reported that microRNAs are involved in the malignant behavior of astrocytoma cells via directly targeting multiple oncogenes or tumor suppressors. Here, we found that microRNA (miR)-542-3p expression was decreased in glioblastoma cell lines and astrocytoma tissues, and reduced levels of miR-542-3p expression correlated with high histopathological grades and poor prognosis of astrocytoma patients. Exogenous miR-542-3p suppressed glioblastoma cell invasion through not only targeting AKT1 itself but also directly down-regulating its two important upstream regulators, namely, integrin-linked kinase and PIK3R1. Notably, overexpressing miR-542-3p decreased AKT1 phosphorylation and directly and indirectly repressed nuclear translocation and transactivation activity of beta-catenin to exert its anti-invasive effect. Furthermore, the miR-542-3p expression level negatively correlated with AKT activity as well as levels of integrin-linked kinase and PIK3R1 in human astrocytoma specimens. These findings suggest that miR-542-3p acts as a negative regulator in astrocytoma progression and that miR-542-3p down-regulation contributes to aberrant activation of AKT signaling, leaving open the possibility that miR-542-3p may be a potential therapeutic target for high grade astrocytoma.	[Cai, Junchao; Xu, Xiaonan; Li, Rang; Fang, Lishan; Zhang, Le; Li, Mengfeng] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Microbiol, Guangzhou, Peoples R China; [Yi, Yang] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pharmacol, Guangzhou, Peoples R China; [Cai, Junchao; Xu, Xiaonan; Li, Rang; Fang, Lishan; Zhang, Le; Li, Mengfeng; Wu, Jueheng] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou, Guangdong, Peoples R China; [Zhao, JingJing] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou 510080, Guangdong, Peoples R China; [Zhang, Nu] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurosurg, Guangzhou 510080, Guangdong, Peoples R China; [Zhang, Heng] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurosurg Intens Care Unit, Guangzhou 510080, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Wu, JH (corresponding author), Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou, Guangdong, Peoples R China.	wujh@mail.sysu.edu.cn; hengzi00@gmail.com	meng, li/GVT-2063-2022	Xu, Xiaonan/0000-0002-7366-580X	National Natural Science Foundation of China [81472351, 81001121, 81472574, 81330058, 81370072]; National Science and Technique Major Project [201305017, 2012ZX10004213, 311030]; Fundamental Research Funds for the Central Universities [11ykzd06]; Natural Science Foundation of Guangdong Province for Distinguished Young Scholars [S2013050014535]; Science and Technology Planning Project of Guangdong Province [S2012020006147]; Pearl River New Star Science and Technology Program of Guangzhou City [2013J2200022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technique Major Project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Guangdong Province for Distinguished Young Scholars; Science and Technology Planning Project of Guangdong Province; Pearl River New Star Science and Technology Program of Guangzhou City	This work was supported by the National Natural Science Foundation of China (Grants 81472351, 81001121, 81472574, 81330058, and 81370072), National Science and Technique Major Project (Grants 201305017, 2012ZX10004213, and 311030), the Fundamental Research Funds for the Central Universities (Grant 11ykzd06), the Natural Science Foundation of Guangdong Province for Distinguished Young Scholars (Grant S2013050014535), The Key Project Supported by the Science and Technology Planning Project of Guangdong Province (Grant S2012020006147), and the Pearl River New Star Science and Technology Program of Guangzhou City (Grant 2013J2200022). The authors declare that they have no potential conflicts of interest.	Antonelli M, 2012, NEUROPATHOLOGY, V32, P133, DOI 10.1111/j.1440-1789.2011.01252.x; Arko L, 2010, PHARMACOL THERAPEUT, V128, P1, DOI 10.1016/j.pharmthera.2010.04.015; Balmaceda C, 2008, CANCER-AM CANCER SOC, V112, P1139, DOI 10.1002/cncr.23167; Bleeker FE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005638; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broderick DK, 2004, CANCER RES, V64, P5048, DOI 10.1158/0008-5472.CAN-04-1170; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cortez Valerie, 2011, Front Biosci (Schol Ed), V3, P788, DOI 10.2741/s187; Edwards LA, 2008, MOL CANCER THER, V7, P59, DOI 10.1158/1535-7163.MCT-07-0329; Filipenko NR, 2005, ONCOGENE, V24, P5837, DOI 10.1038/sj.onc.1208737; Fu YC, 2009, CANCER BIOL THER, V8, P1002, DOI 10.4161/cbt.8.11.8285; Garofalo M, 2013, DRUG RESIST UPDATE, V16, P47, DOI 10.1016/j.drup.2013.05.001; Han L, 2010, BRAIN RES, V1366, P9, DOI 10.1016/j.brainres.2010.09.097; Hayes J, 2014, TRENDS MOL MED, V20, P460, DOI 10.1016/j.molmed.2014.06.005; He T, 2014, J PATHOL, V232, P499, DOI 10.1002/path.4324; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Kahlert UD, 2012, CANCER LETT, V325, P42, DOI 10.1016/j.canlet.2012.05.024; Kahn M, 2014, NAT REV DRUG DISCOV, V13, P513, DOI 10.1038/nrd4233; Kwiatkowska A, 2011, BBA-MOL CELL RES, V1813, P655, DOI 10.1016/j.bbamcr.2011.01.020; Li CX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027053; Li H, 2009, INNATE IMMUN-LONDON, V15, P143, DOI 10.1177/1753425908101509; Li J, 2008, CLIN CANCER RES, V14, P3319, DOI 10.1158/1078-0432.CCR-07-4054; Li J, 2010, INT J CANCER, V126, P1436, DOI 10.1002/ijc.24824; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Matheny RW, 2009, EXP BIOL MED, V234, P1264, DOI 10.3181/0904-MR-138; Molina JR, 2010, NEOPLASIA, V12, P453, DOI 10.1593/neo.10126; Murga C, 2002, ONCOGENE, V21, P207, DOI 10.1038/sj.onc.1205036; Oneyama C, 2012, ONCOGENE, V31, P1623, DOI 10.1038/onc.2011.367; Pu P, 2009, CANCER GENE THER, V16, P351, DOI 10.1038/cgt.2008.78; Quayle SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049466; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; Sonoda Y, 2001, CANCER RES, V61, P6674; Troussard AA, 2006, CANCER RES, V66, P393, DOI 10.1158/0008-5472.CAN-05-2304; Wang HM, 2004, LAB INVEST, V84, P941, DOI 10.1038/labinvest.3700123; Wang Y, 2008, SCAND J IMMUNOL, V68, P383, DOI 10.1111/j.1365-3083.2008.02147.x; Weber GL, 2011, ONCOTARGET, V2, P833; Williams SP, 2011, CANCER RES, V71, P5374, DOI 10.1158/0008-5472.CAN-10-3026; Yoon S, 2010, FEBS LETT, V584, P4048, DOI 10.1016/j.febslet.2010.08.025; Zhang BB, 2009, INT J CANCER, V125, P585, DOI 10.1002/ijc.24314; Zhang JX, 2010, ONCOL REP, V24, P65, DOI 10.3892/or_00000829	42	47	47	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					24678	24688		10.1074/jbc.M115.649004	http://dx.doi.org/10.1074/jbc.M115.649004			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26286747	Green Published, hybrid			2022-12-26	WOS:000362598300005
J	Yung, YL; Cheung, MY; Miao, R; Fong, YH; Li, KP; Yu, MH; Chye, ML; Wong, KB; Lam, HM				Yung, Yuk-Lin; Cheung, Ming-Yan; Miao, Rui; Fong, Yu-Hang; Li, Kwan-Pok; Yu, Mei-Hui; Chye, Mee-Len; Wong, Kam-Bo; Lam, Hon-Ming			Site-directed Mutagenesis Shows the Significance of Interactions with Phospholipids and the G-protein OsYchF1 for the Physiological Functions of the Rice GTPase-activating Protein 1 (OsGAP1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C2 DOMAIN; MEMBRANE-BINDING; ARF-GAP; EXPRESSION; IDENTIFICATION; ASSOCIATION; GENES; MODEL; BAP1	The C2 domain is one of the most diverse phospholipid-binding domains mediating cellular signaling. One group of C2-domain proteins are plant-specific and are characterized by their small sizes and simple structures. We have previously reported that a member of this group, OsGAP1, is able to alleviate salt stress and stimulate defense responses, and bind to both phospholipids and an unconventional G-protein, OsYchF1. Here we solved the crystal structure of OsGAP1 to a resolution of 1.63 angstrom. Using site-directed mutagenesis, we successfully differentiated between the clusters of surface residues that are required for binding to phospholipids versus OsYchF1, which, in turn, is critical for its role in stimulating defense responses. On the other hand, the ability to alleviate salt stress by OsGAP1 is dependent only on its ability to bind OsYchF1 and is independent of its phospholipid-binding activity.	[Yung, Yuk-Lin; Cheung, Ming-Yan; Miao, Rui; Fong, Yu-Hang; Li, Kwan-Pok; Yu, Mei-Hui; Wong, Kam-Bo; Lam, Hon-Ming] Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China; [Yung, Yuk-Lin; Cheung, Ming-Yan; Miao, Rui; Li, Kwan-Pok; Yu, Mei-Hui; Lam, Hon-Ming] Chinese Univ Hong Kong, Partner State Key Lab Agrobiotechnol, Ctr Soybean Res, Shatin, Hong Kong, Peoples R China; [Fong, Yu-Hang; Wong, Kam-Bo] Chinese Univ Hong Kong, Ctr Prot Sci & Crystallog, Shatin, Hong Kong, Peoples R China; [Miao, Rui; Chye, Mee-Len] Univ Hong Kong, Sch Biol Sci, Pokfulam, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; University of Hong Kong	Lam, HM (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Ctr Soybean Res, Partner State Key Lab Agrobiotechnol, Shatin, Hong Kong, Peoples R China.	honming@cuhk.edu.hk	Miao, Rui/AAD-4159-2020; Lam, Hon-Ming/A-9866-2008; Wong, Kam-Bo/G-4258-2013; Wong, Kam-Bo/AAU-9364-2021; Chye, Mee Len/A-2740-2010	Miao, Rui/0000-0003-0956-6310; Lam, Hon-Ming/0000-0002-6673-8740; Wong, Kam-Bo/0000-0002-6984-5373; Wong, Kam-Bo/0000-0002-6984-5373; Yung, Yuk-Lin/0000-0002-9175-2915; Chye, Mee Len/0000-0003-3505-3674	Hong Kong Research Grants Council (General Research Fund) [468013]; Hong Kong Research Grants Council (Area of Excellence) [AoE/M-05/12]	Hong Kong Research Grants Council (General Research Fund)(Hong Kong Research Grants Council); Hong Kong Research Grants Council (Area of Excellence)(Hong Kong Research Grants Council)	This work was supported by grants from the Hong Kong Research Grants Council (General Research Fund: 468013; Area of Excellence: AoE/M-05/12) (to H. M. L., K. B. W., and M. L. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bechtold N, 1998, METH MOL B, V82, P259; Bittova L, 1999, J BIOL CHEM, V274, P9665, DOI 10.1074/jbc.274.14.9665; BREARS T, 1993, PLANT PHYSIOL, V103, P1285, DOI 10.1104/pp.103.4.1285; Cheung MY, 2008, NEW PHYTOL, V179, P530, DOI 10.1111/j.1469-8137.2008.02473.x; Cheung MY, 2013, PLANT CELL ENVIRON, V36, P2008, DOI 10.1111/pce.12108; Cheung MY, 2010, J BIOL CHEM, V285, P37359, DOI 10.1074/jbc.M110.172080; Cho W, 2006, BBA-MOL CELL BIOL L, V1761, P838, DOI 10.1016/j.bbalip.2006.06.014; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fong YH, 2011, J BIOL CHEM, V286, P43241, DOI 10.1074/jbc.M111.296830; Fukuda M, 1996, J BIOL CHEM, V271, P8430, DOI 10.1074/jbc.271.14.8430; GAWLER DJ, 1995, BIOCHEM J, V307, P487, DOI 10.1042/bj3070487; Guerrero-Valero M, 2009, P NATL ACAD SCI USA, V106, P6603, DOI 10.1073/pnas.0813099106; Hallam SJ, 2002, NAT NEUROSCI, V5, P1137, DOI 10.1038/nn959; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hokanson DE, 2012, MOL BIOL CELL, V23, P701, DOI 10.1091/mbc.E11-06-0521; Jensen RB, 2000, PLANT MOL BIOL, V44, P799, DOI 10.1023/A:1026509002161; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Katagiri Fumiaki, 2002, Arabidopsis Book, V1, pe0039, DOI 10.1199/tab.0039; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; Kojima T, 1996, J BIOCHEM-TOKYO, V120, P671; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Kopka J, 1998, PLANT MOL BIOL, V36, P627, DOI 10.1023/A:1005915020760; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Leon J, 2001, J EXP BOT, V52, P1, DOI 10.1093/jexbot/52.354.1; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Meijer HJG, 2003, ANNU REV PLANT BIOL, V54, P265, DOI 10.1146/annurev.arplant.54.031902.134748; MORAN R, 1980, PLANT PHYSIOL, V65, P478, DOI 10.1104/pp.65.3.478; Msanne J, 2011, PLANTA, V234, P97, DOI 10.1007/s00425-011-1387-y; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Ochoa WF, 2001, J MOL BIOL, V311, P837, DOI 10.1006/jmbi.2001.4910; Pena V, 2008, EMBO REP, V9, P350, DOI 10.1038/embor.2008.20; Rodriguez L, 2014, PLANT CELL, V26, P4802, DOI 10.1105/tpc.114.129973; Sato M, 2003, LIFE SCI, V73, P917, DOI 10.1016/S0024-3205(03)00355-2; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Stahelin RV, 2009, J LIPID RES, V50, pS299, DOI 10.1194/jlr.R800078-JLR200; Stevens CF, 2003, NEURON, V39, P299, DOI 10.1016/S0896-6273(03)00432-X; Sutton RB, 1998, STRUCTURE, V6, P1395, DOI 10.1016/S0969-2126(98)00139-7; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wang HM, 2012, PLANT CELL ENVIRON, V35, P1932, DOI 10.1111/j.1365-3040.2012.02526.x; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Yang HJ, 2007, PLANT PHYSIOL, V145, P135, DOI 10.1104/pp.107.100800; Yang HJ, 2006, PLANT J, V48, P238, DOI 10.1111/j.1365-313X.2006.02869.x; Yang WQ, 2008, MOL PLANT, V1, P770, DOI 10.1093/mp/ssn035; Zhang DP, 2010, GENE, V469, P18, DOI 10.1016/j.gene.2010.08.006; Zhuang X, 2005, PLANT CELL ENVIRON, V28, P147, DOI 10.1111/j.1365-3040.2004.01253.x	47	8	9	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23984	23996		10.1074/jbc.M115.655639	http://dx.doi.org/10.1074/jbc.M115.655639			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26286751	Green Published, hybrid			2022-12-26	WOS:000361816500042
J	Chang, CH; Chen, SJ; Liu, CY				Chang, Chun-Hung; Chen, Shaw-Ji; Liu, Chieh-Yu			Risk of Developing Depressive Disorders following Hepatocellular Carcinoma: A Nationwide Population-Based Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; CANCER-PATIENTS; EPIDEMIOLOGY; ANXIETY; LIVER; PREVALENCE; DIAGNOSIS; RESECTION; SYMPTOMS; HRQOL	Background & Aims To evaluate the risk of depressive disorders among patients with Hepatocellular Carcinoma (HCC) using the National Health Insurance Research Database (NHIRD) in Taiwan. Methods We conducted a retrospective study of a newly diagnosed HCC cohort of 55,973 participants who were selected from the NHIRD. Patients were observed for a maximum of 6 years to determine the rates of newly onset depressive disorders, and Cox regression was used to identify the risk factors associated with depressive disorders in HCC patients. Results Of the total 55,973 HCC patients, 1,041 patients (1.86%) were diagnosed with depressive disorders during a mean (SD) follow-up period of 1.1 (1.2) years. The Cox multivariate proportional hazards analysis showed that age of 40-59 (HR 1.376, 95% CI 1.049-1.805, p = 0.021), age of 60-79 (HR 1.341, 95% CI 1.025-1.753, p = 0.032), women (HR 1.474 95% CI 1.301-1.669, p < 0.001), metastasis (HR 1.916, 95% CI 1.243-2.953, p = 0.003), and HCV (HR 1.445, 95% CI 1.231-1.697, p < 0.001) were independent risk factors for developing depressive disorders. Conclusions Our study indicated a subsequent risk of depressive disorders in patients with HCC, and the risk increased for those with female gender, aged 40 to 59, aged 60 to 79, with metastasis, or with HCV. Psychological evaluation and support are two critical issues in these HCC patients with the risk factors.	[Chang, Chun-Hung] China Med Univ Hosp, Dept Psychiat, Taichung, Taiwan; [Chang, Chun-Hung] China Med Univ, Inst Clin Med, Taichung, Taiwan; [Chen, Shaw-Ji] Mackay Mem Hosp, Dept Psychiat, Taitung Branch, Taitung, Taiwan; [Chen, Shaw-Ji] Mackay Jr Coll Med Nursing & Management, Taipei, Taiwan; [Chen, Shaw-Ji] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Liu, Chieh-Yu] Natl Taipei Univ Nursing & Hlth Sci, Inst Nursing Midwifery, Taipei, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Mackay Memorial Hospital; Mackay Junior College of Medicine, Nursing & Management; Tzu Chi University; National Taipei University of Nursing & Health Science (NTUNHS)	Liu, CY (corresponding author), Natl Taipei Univ Nursing & Hlth Sci, Inst Nursing Midwifery, Taipei, Taiwan.	b89401068@ntu.edu.tw	Liu, Chieh-Yu/AAR-9654-2021; Chang, Chun-Hung/AAT-1641-2021; Liu, Chieh-Yu/J-3789-2019	Liu, Chieh-Yu/0000-0003-3283-028X; 				Bianchi G, 2005, DIGEST LIVER DIS, V37, P593, DOI 10.1016/j.dld.2005.01.020; Boscarino JA, 2015, HEPATOLOGY, V61, P802, DOI 10.1002/hep.27422; Brintzenhofe-Szoc KM, 2009, PSYCHOSOMATICS, V50, P383, DOI 10.1176/appi.psy.50.4.383; Bromet Evelyn, 2011, BMC Med, V9, P90, DOI 10.1186/1741-7015-9-90; Cahill Bridget A, 2004, Clin J Oncol Nurs, V8, P393, DOI 10.1188/04.CJON.393-399; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Chien IC, 2007, CAN J PSYCHIAT, V52, P28, DOI 10.1177/070674370705200106; El-Serag HB, 2008, GASTROENTEROLOGY, V134, P1752, DOI 10.1053/j.gastro.2008.02.090; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Fan SY, 2010, CLIN GASTROENTEROL H, V8, P559, DOI 10.1016/j.cgh.2010.03.008; Huet PM, 2000, AM J GASTROENTEROL, V95, P760; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kaplan BJKV, 2007, KAPLAN SADOCKS SYNOP, P529; Khan NF, 2010, EUR J CANCER, V46, P3339, DOI 10.1016/j.ejca.2010.07.035; Lai SY, 2013, ABSTR APPL ANAL, DOI 10.1155/2013/838302; Lau WY, 2008, HEPATOB PANCREAT DIS, V7, P237; Mikoshiba N, 2013, PSYCHO-ONCOLOGY, V22, P2347, DOI 10.1002/pon.3300; Miovic M, 2007, CANCER-AM CANCER SOC, V110, P1665, DOI 10.1002/cncr.22980; Nardelli S, 2013, METAB BRAIN DIS, V28, P239, DOI 10.1007/s11011-012-9364-0; Palmieri VO, 2015, CLIN EXP MED, V15, P65, DOI 10.1007/s10238-013-0267-0; Pasquini M, 2006, DEPRESS ANXIETY, V23, P441, DOI 10.1002/da.20198; Perng CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088721; Poon RTP, 2001, ARCH SURG-CHICAGO, V136, P693, DOI 10.1001/archsurg.136.6.693; Raison CL, 2003, BIOL PSYCHIAT, V54, P283, DOI 10.1016/S0006-3223(03)00413-X; Satin JR, 2009, CANCER-AM CANCER SOC, V115, P5349, DOI 10.1002/cncr.24561; Shun SC, 2008, SUPPORT CARE CANCER, V16, P1059, DOI 10.1007/s00520-007-0384-y; Spiegel D, 2003, BIOL PSYCHIAT, V54, P269, DOI 10.1016/S0006-3223(03)00566-3; Tanabe G, 2001, HEPATO-GASTROENTEROL, V48, P506; Udina M, 2012, J CLIN PSYCHIAT, V73, P1128, DOI 10.4088/JCP.12r07694; WEISSMAN MM, 1977, ARCH GEN PSYCHIAT, V34, P98; Weissman MM, 1996, JAMA-J AM MED ASSOC, V276, P293, DOI 10.1001/jama.276.4.293; Wong WS, 2008, ACTA ONCOL, V47, P71, DOI 10.1080/02841860701441814	34	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135417	10.1371/journal.pone.0135417	http://dx.doi.org/10.1371/journal.pone.0135417			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295711	Green Submitted, Green Published, gold			2022-12-26	WOS:000359926900029
J	Li, J; Ding, J; Zhai, K				Li, Jie; Ding, Jie; Zhai, Kan			Detection of Human Papillomavirus DNA in Patients with Breast Tumor in China	PLOS ONE			English	Article							NO EVIDENCE; HPV INFECTION; CANCER; ASSOCIATION; CARCINOMA; VIRUS; PREVALENCE; ETIOLOGY; ABSENCE; SEQUENCES	The presence of HPV in breast tissue and the potential causal association between human papillomavirus (HPV) and breast cancer (BC) remains controversial. The aim of the present study was to compare the HPV prevalence in BC tissues, adjacent normal breast tissues and breast benign disease tissues and to investigate the possible association between HPV and breast tumor development in Chinese women. Paraffin-embedded specimens from 187 pairs of BCs including tumor and normal breast tissue adjacent to tumors and 92 breast benign lesions between June 2009 and July 2014 were investigated by nested polymerase chain reaction (PCR) and type-specific PCR, respectively. With strictly quality control, HPV positive infection was detected in three BC tissues. No HPV positive infection was detected in all normal breast tissue adjacent to tumors and benign breast tissues. Through our detailed analysis, rare HPV infection in this study suggests that HPV might not be associated with BC progression.	[Li, Jie] Capital Med Univ, Beijing Chao Yang Hosp, Dept Gen Surg, Beijing, Peoples R China; [Ding, Jie; Zhai, Kan] Capital Med Univ, Beijing Chao Yang Hosp, Med Res Ctr, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Zhai, K (corresponding author), Capital Med Univ, Beijing Chao Yang Hosp, Med Res Ctr, Beijing, Peoples R China.	kan_zhai@sina.com		Zhai, Kan/0000-0002-6495-3690				Ahangar-Oskouee M, 2014, ASIAN PAC J CANCER P, V15, P4061, DOI 10.7314/APJCP.2014.15.9.4061; Ali SHM, 2014, E MEDITERR HEALTH J, V20, P372, DOI 10.26719/2014.20.6.372; BAND V, 1990, P NATL ACAD SCI USA, V87, P463, DOI 10.1073/pnas.87.1.463; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; BRATTHAUER GL, 1992, PATHOL RES PRACT, V188, P384, DOI 10.1016/S0344-0338(11)81229-X; de Leon DC, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-26; Chaiwongkot A, 2007, ASIAN PAC J CANCER P, V8, P279; Chang P, 2012, MED ONCOL, V29, P521, DOI 10.1007/s12032-011-9945-5; Choi YL, 2007, TUMOR BIOL, V28, P327, DOI 10.1159/000124238; Czerwenka K, 1996, BREAST CANCER RES TR, V41, P51, DOI 10.1007/BF01807036; D'Souza G, 2009, J INFECT DIS, V199, P1263, DOI 10.1086/597755; Damin APS, 2004, BREAST CANCER RES TR, V84, P131, DOI 10.1023/B:BREA.0000018411.89667.0d; de Cremoux P, 2008, BREAST CANCER RES TR, V109, P55, DOI 10.1007/s10549-007-9626-4; de Villiers EM, 2005, BREAST CANCER RES, V7, pR1, DOI 10.1186/bcr940; DILONARDO A, 1992, BREAST CANCER RES TR, V21, P95, DOI 10.1007/BF01836955; Doorbar J, 2007, DIS MARKERS, V23, P297, DOI 10.1155/2007/613150; Frega A, 2012, EUR J GYNAECOL ONCOL, V33, P164; Fu L, 2015, J MED VIROL, V87, P1034, DOI 10.1002/jmv.24142; Glenn WK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048788; Gopalkrishna V, 1996, BREAST CANCER RES TR, V39, P197, DOI 10.1007/BF01806186; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; Hachana M, 2010, BREAST, V19, P541, DOI 10.1016/j.breast.2010.05.007; He Q, 2009, MOL BIOL REP, V36, P807, DOI 10.1007/s11033-008-9249-9; Hedau S, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-27; Heideman DAM, 2007, J CLIN ONCOL, V25, P4550, DOI 10.1200/JCO.2007.12.3182; Heng B, 2009, BRIT J CANCER, V101, P1345, DOI 10.1038/sj.bjc.6605282; Hobbs CGL, 2006, CLIN OTOLARYNGOL, V31, P259, DOI 10.1111/j.1749-4486.2006.01246.x; HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057; Khan NA, 2008, BRIT J CANCER, V99, P408, DOI 10.1038/sj.bjc.6604502; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Lawson JS, 2009, BRIT J CANCER, V101, P1351, DOI 10.1038/sj.bjc.6605328; Li N, 2011, BREAST CANCER RES TR, V126, P515, DOI 10.1007/s10549-010-1128-0; Liang WL, 2013, J MED VIROL, V85, P2087, DOI 10.1002/jmv.23703; Lindel K, 2007, BREAST, V16, P172, DOI 10.1016/j.breast.2006.09.001; Manzouri Leila, 2014, Adv Biomed Res, V3, P75, DOI 10.4103/2277-9175.125873; Mendizabal-Ruiz AP, 2009, BREAST CANCER RES TR, V114, P189, DOI 10.1007/s10549-008-9989-1; Mou X, 2011, J INT MED RES, V39, P1636, DOI 10.1177/147323001103900506; MUNGER K, 1989, EMBO J, V8, P4099, DOI 10.1002/j.1460-2075.1989.tb08594.x; Peng JP, 2014, J CLIN VIROL, V61, P255, DOI 10.1016/j.jcv.2014.07.010; Piana AF, 2014, VIROL J, V11, DOI 10.1186/s12985-014-0190-3; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sigaroodi A, 2012, SCI WORLD J, P1, DOI 10.1100/2012/837191; Silva RG, 2011, BREAST CANCER RES TR, V125, P261, DOI 10.1007/s10549-010-1129-z; Simoes PW, 2012, INT J GYNECOL CANCER, V22, P343, DOI 10.1097/IGC.0b013e31823c712e; Stanley MA, 2007, BIOCHEM SOC T, V35, P1456, DOI 10.1042/BST0351456; Syrjanen S, 2011, ORAL DIS, V17, P58, DOI 10.1111/j.1601-0825.2011.01792.x; Tjalma WAA, 2013, EUR J OBSTET GYN R B, V170, P45, DOI 10.1016/j.ejogrb.2013.06.027; Tsai JH, 2005, J MED VIROL, V75, P276, DOI 10.1002/jmv.20267; Vernet-Tomas M, 2015, ANTICANCER RES, V35, P851; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wang YP, 2008, ONCOL REP, V20, P333, DOI 10.3892/or_00000011; WERNESS BA, 1990, SCIENCE, V248, P76, DOI 10.1126/science.2157286; Widschwendter A, 2004, J CLIN VIROL, V31, P292, DOI 10.1016/j.jcv.2004.06.009; WREDE D, 1992, BRIT J CANCER, V65, P891, DOI 10.1038/bjc.1992.186; Yu YY, 1999, ANTICANCER RES, V19, P5057; Zhai K, 2015, J CLIN VIROL, V63, P84, DOI 10.1016/j.jcv.2014.09.014	56	26	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136050	10.1371/journal.pone.0136050	http://dx.doi.org/10.1371/journal.pone.0136050			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295705	Green Published, Green Submitted, gold			2022-12-26	WOS:000359926900065
J	Vidyasekar, P; Shyamsunder, P; Arun, R; Santhakumar, R; Kapadia, NK; Kumar, R; Verma, RS				Vidyasekar, Prasanna; Shyamsunder, Pavithra; Arun, Rajpranap; Santhakumar, Rajalakshmi; Kapadia, Nand Kishore; Kumar, Ravi; Verma, Rama Shanker			Genome Wide Expression Profiling of Cancer Cell Lines Cultured in Microgravity Reveals Significant Dysregulation of Cell Cycle and MicroRNA Gene Networks	PLOS ONE			English	Article							APOPTOSIS; PROGRESSION; MIR-21; GROWTH; OVEREXPRESSION; PROLIFERATION; CYTOSKELETON; METASTASIS; PROTEINS; PROTECTS	Zero gravity causes several changes in metabolic and functional aspects of the human body and experiments in space flight have demonstrated alterations in cancer growth and progression. This study reports the genome wide expression profiling of a colorectal cancer cell line-DLD-1, and a lymphoblast leukemic cell line-MOLT-4, under simulated microgravity in an effort to understand central processes and cellular functions that are dysregulated among both cell lines. Altered cell morphology, reduced cell viability and an aberrant cell cycle profile in comparison to their static controls were observed in both cell lines under microgravity. The process of cell cycle in DLD-1 cells was markedly affected with reduced viability, reduced colony forming ability, an apoptotic population and dysregulation of cell cycle genes, oncogenes, and cancer progression and prognostic markers. DNA microarray analysis revealed 1801 (upregulated) and 2542 (downregulated) genes (>2 fold) in DLD-1 cultures under microgravity while MOLT-4 cultures differentially expressed 349 (upregulated) and 444 (downregulated) genes (>2 fold) under microgravity. The loss in cell proliferative capacity was corroborated with the downregulation of the cell cycle process as demonstrated by functional clustering of DNA microarray data using gene ontology terms. The genome wide expression profile also showed significant dysregulation of post transcriptional gene silencing machinery and multiple microRNA host genes that are potential tumor suppressors and proto-oncogenes including MIR22HG, MIR17HG and MIR21HG. The MIR22HG, a tumor-suppressor gene was one of the highest upregulated genes in the microarray data showing a 4.4 log fold upregulation under microgravity. Real time PCR validated the dysregulation in the host gene by demonstrating a 4.18 log fold upregulation of the miR-22 microRNA. Microarray data also showed dysregulation of direct targets of miR-22, SP1, CDK6 and CCNA2.	[Vidyasekar, Prasanna; Shyamsunder, Pavithra; Arun, Rajpranap; Santhakumar, Rajalakshmi; Verma, Rama Shanker] Indian Inst Technol Madras, Dept Biotechnol, Stem Cell & Mol Biol Lab, Madras, Tamil Nadu, India; [Kapadia, Nand Kishore] Global Hosp, Dept Cardiothorac Surg, Madras, Tamil Nadu, India; [Kumar, Ravi] Fortis Malar Hosp, Dept Cardiol, Madras, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Verma, RS (corresponding author), Indian Inst Technol Madras, Dept Biotechnol, Stem Cell & Mol Biol Lab, Madras, Tamil Nadu, India.	vermars@iitm.ac.in		Verma, Rama/0000-0001-7287-7803; Arun, Raj Pranap/0000-0001-5746-4728	Defense Research Development Organization [DLS/81/48222/LSRB-189/ID/2009, DLS/81/48222/LSRB-273/SHDD/2013]	Defense Research Development Organization(Defence Research & Development Organisation (DRDO))	This work was supported by Defense Research Development Organization (DLS/81/48222/LSRB-189/ID/2009 and DLS/81/48222/LSRB-273/SH&DD/2013) to RSV. url: http://www.drdo.gov.in/drdo/boards/lsrb/fplsrb.htm	Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Augenlicht LH, 1997, CANCER RES, V57, P1769; Becker JL, 2013, NAT REV CANCER, V13, P315, DOI 10.1038/nrc3507; Behboudi A, 2006, GENE CHROMOSOME CANC, V45, P470, DOI 10.1002/gcc.20306; Belandia B, 2005, MOL CELL BIOL, V25, P1425, DOI 10.1128/MCB.25.4.1425-1436.2005; Bellone G, 2001, CANCER RES, V61, P2200; Blair A, 1997, BLOOD, V89, P3104, DOI 10.1182/blood.V89.9.3104; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Calabro L, 2003, J CELL PHYSIOL, V194, P171, DOI 10.1002/jcp.10200; Carlsson SIM, 2003, BBA-MOL CELL RES, V1642, P173, DOI 10.1016/j.bbamcr.2003.08.003; Castedo M, 2002, CELL DEATH DIFFER, V9, P1287, DOI 10.1038/sj.cdd.4401130; Chung JS, 2009, FREE RADICAL RES, V43, P729, DOI 10.1080/10715760903038432; CogoliGreuter M, 1997, ESA SP PUBL, V397, P73; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Del Poeta G, 2010, LEUKEMIA LYMPHOMA, V51, P95, DOI 10.3109/10428190903350421; Ferrarini M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071613; Gorbunova V, 2002, J BIOL CHEM, V277, P38540, DOI 10.1074/jbc.M202671200; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Habashy HO, 2010, BREAST CANCER RES TR, V119, P283, DOI 10.1007/s10549-009-0345-x; Houde C, 2004, BLOOD, V104, P3697, DOI 10.1182/blood-2003-12-4114; Huang Da Wei, 2009, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1311s27; IWAKI K, 1990, J BIOL CHEM, V265, P13809; Jhala DV, 2014, CURR CANCER DRUG TAR, V14, P394, DOI 10.2174/1568009614666140407113633; Karanu FN, 2000, J EXP MED, V192, P1365, DOI 10.1084/jem.192.9.1365; Lee SB, 2010, APOPTOSIS, V15, P204, DOI 10.1007/s10495-009-0411-1; Li MF, 2010, AAPS J, V12, P309, DOI 10.1208/s12248-010-9194-0; Liu LH, 2010, TOXICOL IN VITRO, V24, P1168, DOI 10.1016/j.tiv.2010.02.016; Liu XY, 2013, CLIN SCI, V124, P567, DOI 10.1042/CS20120240; Lu AG, 2012, WORLD J GASTROENTERO, V18, P4704, DOI 10.3748/wjg.v18.i34.4704; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; Masiello MG, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/652434; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Morabito C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/754283; Naor D, 2008, SEMIN CANCER BIOL, V18; NELSON RL, 1994, JNCI-J NATL CANCER I, V86, P455, DOI 10.1093/jnci/86.6.455; Patel JB, 2011, ONCOGENE, V30, P1290, DOI 10.1038/onc.2010.510; Pellegrinet L, 2011, GASTROENTEROLOGY, V140, P1230, DOI 10.1053/j.gastro.2011.01.005; Piazzi G, 2011, ONCOTARGET, V2, P1291; Pisanu ME, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/470253; Sasaki T, 2003, GENOMICS, V82, P323, DOI 10.1016/S0888-7543(03)00129-0; Schatten H, 2001, ACTA ASTRONAUT, V49, P399, DOI 10.1016/S0094-5765(01)00116-3; Schwarzenberg M, 1999, ADV SPACE RES, V24, P793, DOI 10.1016/S0273-1177(99)00075-7; Thangaraju M, 2009, BIOCHEM J, V417, P379, DOI 10.1042/BJ20081132; Toussaint O, 2002, BIOCHEM PHARMACOL, V64; Tremblay CS, 2008, BLOOD, V112, P2062, DOI 10.1182/blood-2008-04-152710; Tsuchiya N, 2011, CANCER RES, V71, P4628, DOI 10.1158/0008-5472.CAN-10-2475; Viallard J F, 2001, Cancer Radiother, V5, P109, DOI 10.1016/S1278-3218(01)00087-7; Wang AJ, 1997, J CANCER RES CLIN, V123, P124, DOI 10.1007/BF01269891; Xu D, 2011, J CELL BIOL, V193, P409, DOI 10.1083/jcb.201010100; Yang F, 2015, J BIOL CHEM; Yu YJ, 2013, TRANSL ONCOL, V6, P180, DOI 10.1593/tlo.12397; Zhang J, 2012, BRIT J CANCER, V107, P352, DOI 10.1038/bjc.2012.251	53	30	30	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135958	10.1371/journal.pone.0135958	http://dx.doi.org/10.1371/journal.pone.0135958			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295583	Green Published, gold, Green Submitted			2022-12-26	WOS:000359926900055
J	Li, WY; Jiang, YF; Wang, XM; Jin, JL; Qi, Y; Chi, XM; Zhang, H; Feng, XW; Niu, JQ				Li, Wanyu; Jiang, Yanfang; Wang, Xiaomei; Jin, Jinglan; Qi, Yue; Chi, Xiumei; Zhang, Hong; Feng, Xiangwei; Niu, Junqi			Natural Killer p46 Controls Hepatitis B Virus Replication and Modulates Liver Inflammation	PLOS ONE			English	Article							CELLS; INFECTION; RESPONSES; HBV; NK; EXPRESSION; INJURY; INNATE; GENES	Natural killer (NK) cells play an important role in hepatitis B virus (HBV) infection control, and are regulated by a complex network of activating and inhibitory receptors. However, NK cell activity in HBV patients remains poorly understood. The objective of this study was to investigate the phenotypic and functional characteristics of circulating NK cells in patients during different chronic hepatitis B (CHB) infection stages. We investigated NK cell phenotypes, receptor expression and function in 86 CHB patients and 20 healthy controls. NK cells were purified and NK cell subsets were characterized by flow cytometry. Cytotoxic activity (CD107a) and interferon-gamma (IFN-gamma) secretion were examined, and Natural Killer p46 (NKP46) blockade and spontaneous NK cell cytolytic activity against K562, HepG2 and HepG2.215 cell lines was studied. Activating NKp46 receptor expression was higher in inactive HBsAg carriers when compared with other groups (p = 0.008). NKp46 expression negatively correlated with HBV DNA (R = -0.253, p = 0.049) and ALT (R = -0.256, p = 0.045) levels. CD107a was higher in immune-activated groups when compared with immune-tolerant groups (p = 0.039). CD107a expression was related to viral load (p = 0.02) and HBeAg status (p = 0.024). In vitro NKp46 blockade reduced NK cell cytolytic activity against HepG2 and HepG2.215 cell lines (p = 0.02; p = 0.039). Furthermore, NK cells from high viral load CHB patients displayed significantly lower specific cytolytic activity against anti-NKp46-loaded K562 targets (p = 0.0321). No significant differences were observed in IFN-gamma secretion (p > 0.05). In conclusion, NKp46 expression regulates NK cell cytolytic function. NKp46 may moderate NK cell activity during HBV replication suppression and HBV-associated liver damage and may be critical for NK cell activity during CHB infection.	[Li, Wanyu; Jiang, Yanfang; Wang, Xiaomei; Jin, Jinglan; Qi, Yue; Chi, Xiumei; Zhang, Hong; Feng, Xiangwei; Niu, Junqi] Jilin Univ, Hosp 1, Dept Hepatol, Changchun 130021, Peoples R China	Jilin University	Niu, JQ (corresponding author), Jilin Univ, Hosp 1, Dept Hepatol, 71 Xinmin St, Changchun 130021, Peoples R China.	82232559@qq.com			National Natural Science Foundation of China [81301413]; Youth Science Foundation of the First Hospital of Jilin University [JDYY42013010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Science Foundation of the First Hospital of Jilin University	This study was supported by grants from National Natural Science Foundation of China (No. 81301413), and the Youth Science Foundation of the First Hospital of Jilin University (No. JDYY42013010).	Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Cho H, 2013, J MICROBIOL, V51, P247, DOI 10.1007/s12275-013-2522-1; Ferrari C, 2015, LIVER INT, V35, P121, DOI 10.1111/liv.12749; Fletcher SP, 2012, HEPATOLOGY, V56, P820, DOI 10.1002/hep.25730; Francesca B, 2013, IMMUNOLOGY LETT; Guy CS, 2008, J VIROL, V82, P8579, DOI 10.1128/JVI.01022-08; Heeg M, 2012, HEPATOLOGY, V56, P1197, DOI 10.1002/hep.25858; Iannello A, 2008, J LEUKOCYTE BIOL, V84, P1, DOI 10.1189/jlb.0907650; Kapoor R, 2014, FUTURE VIROL, V9, P565, DOI 10.2217/FVL.14.36; Kramer B, 2012, HEPATOLOGY, V56, P1201, DOI 10.1002/hep.25804; Li FL, 2013, GASTROENTEROLOGY, V144, P392, DOI 10.1053/j.gastro.2012.10.039; Li WY, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/138237; Li WY, 2011, LIVER INT, V31, P1118, DOI 10.1111/j.1478-3231.2011.02507.x; Lucy GM, 2012, HEPATOLOGY, V56, P1214, DOI [10.1002/hep.25771, DOI 10.1002/HEP.25771]; McMahon BJ, 2009, HEPATOLOGY, V49, pS45, DOI 10.1002/hep.22898; Micco L, 2013, J HEPATOL, V58, P225, DOI 10.1016/j.jhep.2012.09.029; Mondelli MU, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00351; Mondelli MU, 2010, EUR J CLIN INVEST, V40, P851, DOI 10.1111/j.1365-2362.2010.02332.x; Notas G, 2009, CLIN IMMUNOL, V130, P16, DOI 10.1016/j.clim.2008.08.008; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Sprengers D, 2006, J MED VIROL, V78, P561, DOI 10.1002/jmv.20576; Sun C, 2015, CELL MOL IMMUNOL, V12, P292, DOI 10.1038/cmi.2014.91; Tjwa ETTL, 2011, J HEPATOL, V54, P209, DOI 10.1016/j.jhep.2010.07.009; Webster GJM, 2004, J VIROL, V78, P5707, DOI 10.1128/JVI.78.11.5707-5719.2004; Werner JM, 2013, HEPATOLOGY, V58, P1621, DOI 10.1002/hep.26353; Wolterbeek HT, 2005, ASSAY DRUG DEV TECHN, V3, P675, DOI 10.1089/adt.2005.3.675; Zhang Z, 2011, HEPATOLOGY, V53, P73, DOI 10.1002/hep.23977; Zhao JZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049542; Zou Y, 2010, J IMMUNOL, V184, P466, DOI 10.4049/jimmunol.0900687	29	14	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135874	10.1371/journal.pone.0135874	http://dx.doi.org/10.1371/journal.pone.0135874			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291078	gold, Green Published, Green Submitted			2022-12-26	WOS:000359919900036
J	Vanderwerf, SM; Buck, DC; Wilmarth, PA; Sears, LM; David, LL; Morton, DB; Neve, KA				Vanderwerf, Scott M.; Buck, David C.; Wilmarth, Phillip A.; Sears, Leila M.; David, Larry L.; Morton, David B.; Neve, Kim A.			Role for Rab10 in Methamphetamine-Induced Behavior	PLOS ONE			English	Article							STIMULATED GLUT4 TRANSLOCATION; CANINE KIDNEY-CELLS; DROSOPHILA-MELANOGASTER; DOPAMINE-RECEPTOR; FUNCTIONAL-CHARACTERIZATION; PLASMA-MEMBRANE; NEURONS; AMPHETAMINE; TRANSPORTER; IDENTIFICATION	Lipid rafts are specialized, cholesterol-rich membrane compartments that help to organize transmembrane signaling by restricting or promoting interactions with subsets of the cellular proteome. The hypothesis driving this study was that identifying proteins whose relative abundance in rafts is altered by the abused psychostimulant methamphetamine would contribute to fully describing the pathways involved in acute and chronic effects of the drug. Using a detergent-free method for preparing rafts from rat brain striatal membranes, we identified density gradient fractions enriched in the raft protein flotillin but deficient in calnexin and the transferrin receptor, markers of non-raft membranes. Dopamine D1- and D2-like receptor binding activity was highly enriched in the raft fractions, but pretreating rats with methamphetamine ( 2 mg/kg) once or repeatedly for 11 days did not alter the distribution of the receptors. LC-MS analysis of the protein composition of raft fractions from rats treated once with methamphetamine or saline identified methamphetamine-induced changes in the relative abundance of 23 raft proteins, including the monomeric GTP-binding protein Rab10, whose abundance in rafts was decreased 2.1-fold by acute methamphetamine treatment. Decreased raft localization was associated with a selective decrease in the abundance of Rab10 in a membrane fraction that includes synaptic vesicles and endosomes. Inhibiting Rab10 activity by panneuronal expression of a dominant-negative Rab10 mutant in Drosophila melanogaster decreased methamphetamine-induced activity and mortality and decreased caffeine-stimulated activity but not mortality, whereas inhibiting Rab10 activity selectively in cholinergic neurons had no effect. These results suggest that activation and redistribution of Rab10 is critical for some of the behavioral effects of psychostimulants.	[Vanderwerf, Scott M.; Buck, David C.; Neve, Kim A.] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Vanderwerf, Scott M.; Sears, Leila M.; Morton, David B.] Oregon Hlth & Sci Univ, Dept Integrat Biosci, Portland, OR 97201 USA; [Wilmarth, Phillip A.; David, Larry L.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA; [Neve, Kim A.] VA Portland Hlth Care Syst, Res Serv, Portland, OR USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System	Neve, KA (corresponding author), Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA.	nevek@ohsu.edu		Neve, Kim/0000-0003-0109-7345	Department of Veterans Affairs [BX000810]; National Institutes of Health [R01GM105396, P30EY010572, P30CA069533]; NATIONAL CANCER INSTITUTE [P30CA069533] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY010572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105396] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by Department of Veterans Affairs (http://www.research.va.gov/) BX000810 (KAN), National Institutes of Health (https://grants.nih.gov/grants/oer.htm) R01GM105396 (DBM), P30EY010572 (LLD), and P30CA069533 (LLD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achat-Mendes C, 2012, PHARMACOL BIOCHEM BE, V101, P201, DOI 10.1016/j.pbb.2011.10.025; Babbey CM, 2006, MOL BIOL CELL, V17, P3156, DOI 10.1091/mbc.E05-08-0799; BUDNIK V, 1988, J COMP NEUROL, V268, P400, DOI 10.1002/cne.902680309; Bunzow JR, 2001, MOL PHARMACOL, V60, P1181, DOI 10.1124/mol.60.6.1181; Celver J, 2012, J NEUROCHEM, V120, P56, DOI 10.1111/j.1471-4159.2011.07559.x; Chang HY, 2006, MOL PSYCHIATR, V11, P99, DOI 10.1038/sj.mp.4001742; Chang L, 2007, ADDICTION, V102, P16, DOI 10.1111/j.1360-0443.2006.01782.x; Chen CCH, 2006, MOL BIOL CELL, V17, P1286, DOI 10.1091/mbc.E05-08-0787; Chen Y, 2009, BIOCHEM J, V422, P229, DOI 10.1042/BJ20090624; Cremona ML, 2011, NAT NEUROSCI, V14, P469, DOI 10.1038/nn.2781; Daulat AM, 2007, MOL CELL PROTEOMICS, V6, P835, DOI 10.1074/mcp.M600298-MCP200; Di Chiara G, 2007, CURR OPIN PHARMACOL, V7, P69, DOI 10.1016/j.coph.2006.11.003; Feng GP, 1996, J NEUROSCI, V16, P3925; Fisone G, 2004, CELL MOL LIFE SCI, V61, P857, DOI 10.1007/s00018-003-3269-3; Fleckenstein AE, 2007, ANNU REV PHARMACOL, V47, P681, DOI 10.1146/annurev.pharmtox.47.120505.105140; Glodowski DR, 2007, MOL BIOL CELL, V18, P4387, DOI 10.1091/mbc.E07-05-0486; GOTZES F, 1994, RECEPTOR CHANNEL, V2, P131; Greenspan RJ, 2004, FLY PUSHING; Hallett Penelope J, 2008, Curr Protoc Neurosci, VChapter 1, DOI 10.1002/0471142301.ns0116s42; Hearn MG, 2002, P NATL ACAD SCI USA, V99, P14554, DOI 10.1073/pnas.202498299; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Kaun KR, 2012, HUM GENET, V131, P959, DOI 10.1007/s00439-012-1146-6; Kong MMC, 2007, MOL PHARMACOL, V72, P1157, DOI 10.1124/mol.107.034769; Kovtun O, 2015, ACS CHEM NEUROSCI, V6, P526, DOI 10.1021/cn500202c; Lan HX, 2006, MOL PHARMACOL, V69, P185, DOI 10.1124/mol.105.017244; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Leaf DS, 1998, EXP CELL RES, V243, P39, DOI 10.1006/excr.1997.3917; Lindemann L, 2008, J PHARMACOL EXP THER, V324, P948, DOI 10.1124/jpet.107.132647; McClung C, 1998, CURR BIOL, V8, P109, DOI 10.1016/S0960-9822(98)70041-7; NECKAMEYER WS, 1993, J NEUROGENET, V8, P189, DOI 10.3109/01677069309083448; Patel H. H., 2008, V186, P167, DOI 10.1007/978-3-540-72843-6_7; Pavlos NJ, 2010, J NEUROSCI, V30, P13441, DOI 10.1523/JNEUROSCI.0907-10.2010; Pizzo AB, 2013, MOL PSYCHIATR, V18, P824, DOI 10.1038/mp.2012.82; Porzgen P, 2001, MOL PHARMACOL, V59, P83; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Sano H, 2008, BIOCHEM J, V411, P89, DOI 10.1042/BJ20071318; Sano H, 2011, J BIOL CHEM, V286, P16541, DOI 10.1074/jbc.C111.228908; Schuck S, 2007, TRAFFIC, V8, P47, DOI 10.1111/j.1600-0854.2006.00506.x; Sharma M, 2013, J BIOL CHEM, V288, P12554, DOI 10.1074/jbc.M112.443945; Sulzer D, 2011, NEURON, V69, P628, DOI 10.1016/j.neuron.2011.02.010; UNODC, 2011, AMPH ECST ATS GLOB A; Voulalas PJ, 2011, MOL CELL NEUROSCI, V46, P645, DOI 10.1016/j.mcn.2011.01.004; Wang D, 2010, P NATL ACAD SCI USA, V107, P13806, DOI 10.1073/pnas.1009428107; Wiemerslage L, 2013, J NEUROCHEM, V126, P529, DOI 10.1111/jnc.12228; Wilmarth Phillip A, 2009, J Ocul Biol Dis Infor, V2, P223; YOKEL RA, 1975, SCIENCE, V187, P547, DOI 10.1126/science.1114313; Yu PY, 2004, KIDNEY INT, V66, P2167, DOI 10.1111/j.1523-1755.2004.66007.x; Zhang JS, 2007, NAT NEUROSCI, V10, P77, DOI 10.1038/nn1816; Zhang J, 2007, GENETICS, V176, P1307, DOI 10.1534/genetics.106.066761	49	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136167	10.1371/journal.pone.0136167	http://dx.doi.org/10.1371/journal.pone.0136167			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291453	Green Submitted, gold, Green Published			2022-12-26	WOS:000359919900060
J	Ellis, DA; Wiseman, R; Jenkins, R				Ellis, David A.; Wiseman, Richard; Jenkins, Rob			Mental Representations of Weekdays	PLOS ONE			English	Article							DECISION-MAKING; UNITED-STATES; MEMORY; MONDAY; TIME; MOOD; SIMILARITY; SLEEP; MODEL; CYCLE	Keeping social appointments involves keeping track of what day it is. In practice, mismatches between apparent day and actual day are common. For example, a person might think the current day is Wednesday when in fact it is Thursday. Here we show that such mismatches are highly systematic, and can be traced to specific properties of their mental representations. In Study 1, mismatches between apparent day and actual day occurred more frequently on midweek days (Tuesday, Wednesday, and Thursday) than on other days, and were mainly due to intrusions from immediately neighboring days. In Study 2, reaction times to report the current day were fastest on Monday and Friday, and slowest midweek. In Study 3, participants generated fewer semantic associations for "Tuesday", "Wednesday" and "Thursday" than for other weekday names. Similarly, Google searches found fewer occurrences of midweek days in webpages and books. Analysis of affective norms revealed that participants' associations were strongly negative for Monday, strongly positive for Friday, and graded over the intervening days. Midweek days are confusable because their mental representations are sparse and similar. Mondays and Fridays are less confusable because their mental representations are rich and distinctive, forming two extremes along a continuum of change.	[Ellis, David A.] Lincoln Univ, Sch Psychol, Lincoln, England; [Wiseman, Richard] Univ Hertfordshire, Sch Psychol, Hatfield AL10 9AB, Herts, England; [Jenkins, Rob] Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England	University of Lincoln; University of Hertfordshire; University of York - UK	Ellis, DA (corresponding author), Lincoln Univ, Sch Psychol, Lincoln, England.	dellis@lincoln.ac.uk	Jenkins, Rob/C-5289-2008; Ellis, David/A-8322-2011	Ellis, David/0000-0001-6172-3323	ESRC studentship [ES/G017271/1]; ESRC research grant [RES-060-25-0010]	ESRC studentship(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC research grant(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research was supported by an ESRC studentship to DAE (ES/G017271/1), and an ESRC research grant to RJ (RES-060-25-0010), http://www.esrc.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JR, 1983, J VERB LEARN VERB BE, V22, P261, DOI 10.1016/S0022-5371(83)90201-3; Angie AD, 2011, COGNITION EMOTION, V25, P1393, DOI 10.1080/02699931.2010.550751; Areni CS, 2008, J APPL SOC PSYCHOL, V38, P1395, DOI 10.1111/j.1559-1816.2008.00353.x; Areni CS, 2011, PSYCHOL REP, V109, P723, DOI 10.2466/13.20.PR0.109.6.723-733; BADDELEY AD, 1968, Q J EXP PSYCHOL, V20, P249, DOI 10.1080/14640746808400159; BOWER GH, 1981, AM PSYCHOL, V36, P129, DOI 10.1037/0003-066X.36.2.129; Bradley M. M., 1999, C1 U FLOR CTR RES PS, V30, P25; Brown GDA, 2007, PSYCHOL REV, V114, P539, DOI 10.1037/0033-295X.114.3.539; Cajochen C, 2013, CURR BIOL, V23, P1485, DOI 10.1016/j.cub.2013.06.029; Chakraborty U, 2013, BIOL RHYTHM RES, P1; Colson FH., 1926, WEEK ESSAY ORIGIN DE; CRAIK FIM, 1975, J EXP PSYCHOL GEN, V104, P268, DOI 10.1037/0096-3445.104.3.268; Cross F., 1973, FINANCIAL ANALYSTS J, V29, P67, DOI 10.2469/faj.v29.n6.67; DIJK DJ, 1992, J SLEEP RES, V1, P112, DOI 10.1111/j.1365-2869.1992.tb00021.x; Eagleman DM, 2008, CURR OPIN NEUROBIOL, V18, P131, DOI 10.1016/j.conb.2008.06.002; EICH E, 1995, PSYCHOL SCI, V6, P67, DOI 10.1111/j.1467-9280.1995.tb00309.x; Ellis DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051365; Estes WK, 1997, PSYCHOL REV, V104, P148, DOI 10.1037/0033-295X.104.1.148; Foster RG, 2008, CURR BIOL, V18, pR784, DOI 10.1016/j.cub.2008.07.003; GETTY DJ, 1979, PERCEPT PSYCHOPHYS, V26, P1, DOI 10.3758/BF03199856; Golder SA, 2011, SCIENCE, V333, P1878, DOI 10.1126/science.1202775; Gregory RichardL., 2009, SEEING ILLUSIONS; Hurlstone MJ, 2014, PSYCHOL BULL, V140, P339, DOI 10.1037/a0034221; HUTTENLOCHER J, 1992, J EXP PSYCHOL GEN, V121, P313, DOI 10.1037/0096-3445.121.3.313; Huttenlocher J, 2007, J EXP PSYCHOL GEN, V136, P502, DOI 10.1037/0096-3445.136.3.502; JAFFE JF, 1989, J BANK FINANC, V13, P641, DOI 10.1016/0378-4266(89)90035-6; Johnson Helen, 2005, Health Stat Q, P13; Kamara A, 1997, J BUS, V70, P63, DOI 10.1086/209708; Kanai R, 2006, PERCEPT PSYCHOPHYS, V68, P1113, DOI 10.3758/BF03193714; Leech G, 2001, WORD FREQUENCIES WRI; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; MAIRE M, 2013, J COGN BEHAV PSYCHOT, V13, P133; MALDONADO G, 1991, SUICIDE LIFE-THREAT, V21, P174; Michel JB, 2011, SCIENCE, V331, P176, DOI 10.1126/science.1199644; Neath I, 2006, PSYCHOL LEARN MOTIV, V46, P201, DOI 10.1016/S0079-7421(06)46006-0; Pettengill G.N., 2003, Q J BUSINESS EC, V42, P3; Redelmeier DA, 1996, PAIN, V66, P3, DOI 10.1016/0304-3959(96)02994-6; Redelmeier DA, 2003, PAIN, V104, P187, DOI 10.1016/S0304-3959(03)00003-4; Rohan KJ, 2009, CURR PSYCHIATRY REV, V5, P37, DOI 10.2174/157340009787315299; Schwarz N, 2000, COGNITION EMOTION, V14, P433, DOI 10.1080/026999300402745; Spence C, 2010, CONSCIOUS COGN, V19, P364, DOI 10.1016/j.concog.2009.12.001; Tse PU, 2004, PERCEPT PSYCHOPHYS, V66, P1171, DOI 10.3758/BF03196844; TULVING E, 1970, ANNU REV PSYCHOL, V21, P437, DOI 10.1146/annurev.ps.21.020170.002253; Tulving E., 1972, ORG MEMORY, DOI DOI 10.1017/S0140525X00047257; TVERSKY A, 1977, PSYCHOL REV, V84, P327, DOI 10.1037/h0026750; Vigliocco G, 2002, COGNITION, V85, pB61, DOI 10.1016/S0010-0277(02)00107-5; WILLICH SN, 1994, CIRCULATION, V90, P87, DOI 10.1161/01.CIR.90.1.87; Zerubavel E, 1985, 7 DAY CIRCLE HIST ME	49	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0134555	10.1371/journal.pone.0134555	http://dx.doi.org/10.1371/journal.pone.0134555			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP6SN	26288194	Green Published, Green Accepted, gold			2022-12-26	WOS:000360018600026
J	Kawaguchi, T; Tsukiyama, T; Kimura, K; Matsuyama, S; Minami, N; Yamada, M; Imai, H				Kawaguchi, Takamasa; Tsukiyama, Tomoyuki; Kimura, Koji; Matsuyama, Shuichi; Minami, Naojiro; Yamada, Masayasu; Imai, Hiroshi			Generation of Naive Bovine Induced Pluripotent Stem Cells Using PiggyBac Transposition of Doxycycline-Inducible Transcription Factors	PLOS ONE			English	Article							DEFINED FACTORS; ES CELLS; FIBROBLASTS; INDUCTION; EFFICIENT; STATE; LINES; MASS; PIG; ESTABLISHMENT	Generation of pluripotent stem cells (PSCs) in large domestic animals has achieved only limited success; most of the PSCs obtained to date have been classified as primed PSCs, which possess very little capacity to produce chimeric offspring. By contrast, mouse PSCs have been classified as naive PSCs that can contribute to most of the tissues of chimeras, including germ cells. Here, we describe the generation of two different types of bovine induced pluripotent stem cells (biPSCs) from amnion cells, achieved through introduction of piggyBac vectors containing doxycycline-inducible transcription factors (Oct3/4, Sox2, Klf4, and c-Myc). One type of biPSCs, cultured in medium supplemented with knockout serum replacement (KSR), FGF2, and bovine leukemia inhibitory factor (bLIF), had a flattened morphology like human PSCs; these were classified as primed-type. The other type biPSCs, cultured in KSR, bLIF, Mek/Erk inhibitor, GSK3 inhibitor and forskolin, had a compact morphology like mouse PSCs; these were classified as naive-type. Cells could easily be switched between these two types of biPSCs by changing the culture conditions. Both types of biPSCs had strong alkaline phosphatase activity, expressed pluripotent markers (OCT3/4, NANOG, REX1, ESRR beta, STELLA, and SOCS3), and formed embryoid bodies that gave rise to differentiated cells from all three embryonic germ layers. However, only naive-type biPSCs showed the hallmarks of naive mouse PSCs, such as LIF-dependent proliferation, lack of FGF5 expression, and active XIST expression with two active X chromosomes. Furthermore, naive-type biPSCs could contribute to the inner cell mass (ICM) of host blastocysts and most tissues within chimeric embryos. This is the first report of generation of biPSCs with several characteristics similar to those of naive mouse PSCs and a demonstrated potential to contribute to chimeras.	[Kawaguchi, Takamasa; Minami, Naojiro; Yamada, Masayasu; Imai, Hiroshi] Kyoto Univ, Grad Sch Agricuture, Reprod Biol Lab, Kyoto, Japan; [Tsukiyama, Tomoyuki] Shiga Univ Med Sci, Res Ctr Anim Life Sci, Shiga, Japan	Kyoto University; Shiga University of Medical Science	Imai, H (corresponding author), Kyoto Univ, Grad Sch Agricuture, Reprod Biol Lab, Kyoto, Japan.	imai@kais.kyoto-u.ac.jp	TSUKIYAMA, Tomoyuki/AAI-3082-2020	TSUKIYAMA, Tomoyuki/0000-0002-2657-7719	Ministry of Education, Science and Culture [24380172, 26292168]	Ministry of Education, Science and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Funding: This work was supported in part by a grant from the Ministry of Education, Science and Culture to K.K. and H.I. (grant 24380172 and 26292168). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Berg DK, 2011, DEV CELL, V20, P244, DOI 10.1016/j.devcel.2011.01.003; Booth P J, 2001, Cloning Stem Cells, V3, P139, DOI 10.1089/153623001753205098; Buecker C, 2010, CELL STEM CELL, V6, P535, DOI 10.1016/j.stem.2010.05.003; Cao SB, 2009, J EXP ZOOL PART A, V311A, P368, DOI 10.1002/jez.535; Drukker M, 2006, STEM CELLS, V24, P221, DOI 10.1634/stemcells.2005-0188; Esteban MA, 2009, J BIOL CHEM, V284, P17634, DOI 10.1074/jbc.M109.008938; Ezashi T, 2009, P NATL ACAD SCI USA, V106, P10993, DOI 10.1073/pnas.0905284106; Fujishiro S, 2013, STEM CELLS DEV, V22, P473, DOI 10.1089/scd.2012.0173; Furusawa T, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.112.106641; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Hirano K, 2012, STEM CELLS DEV, V21, P1287, DOI 10.1089/scd.2011.0283; Honda A, 2010, J BIOL CHEM, V285, P31362, DOI 10.1074/jbc.M110.150540; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kinoshita M, 2014, MED BIOL, P1, DOI [10.1007/s12522-014-0199-8, DOI 10.1007/S12522-014-0199-8]; Li CL, 2009, HUM MOL GENET, V18, P4340, DOI 10.1093/hmg/ddp386; Liu HS, 2008, CELL STEM CELL, V3, P587, DOI 10.1016/j.stem.2008.10.014; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Miki T, 2005, STEM CELLS, V23, P1549, DOI 10.1634/stemcells.2004-0357; Montserrat N, 2011, J CARDIOVASC TRANSL, V4, P121, DOI 10.1007/s12265-010-9233-3; Nagata S, 2009, GENES CELLS, V14, P1395, DOI 10.1111/j.1365-2443.2009.01356.x; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Nishishita N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038389; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Ozawa M, 2012, THERIOGENOLOGY, V78, P1243, DOI 10.1016/j.theriogenology.2012.05.020; Ozawa M, 2014, STEM CELL RES, V13, P75, DOI 10.1016/j.scr.2014.04.012; PEASE S, 1990, DEV BIOL, V141, P344, DOI 10.1016/0012-1606(90)90390-5; Shimada H, 2010, MOL REPROD DEV, V77, P2, DOI 10.1002/mrd.21117; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Suemori Hirofumi, 2006, V329, P81; Sumer H, 2011, J ANIM SCI, V89, P2708, DOI 10.2527/jas.2010-3666; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Tomioka I, 2010, GENES CELLS, V15, P959, DOI 10.1111/j.1365-2443.2010.01437.x; Tsukiyama T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095329; Tsukiyama T, 2011, GENES CELLS, V16, P815, DOI 10.1111/j.1365-2443.2011.01528.x; van Oosten AL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1822; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Wu Z, 2009, J MOL CELL BIOL, V1, P46, DOI 10.1093/jmcb/mjp003; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108; Yusa K, 2009, NAT METHODS, V6, P363, DOI [10.1038/NMETH.1323, 10.1038/nmeth.1323]; Zhao HX, 2010, DIFFERENTIATION, V80, P123, DOI 10.1016/j.diff.2010.03.002	49	38	43	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135403	10.1371/journal.pone.0135403	http://dx.doi.org/10.1371/journal.pone.0135403			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287611	Green Published, gold, Green Submitted			2022-12-26	WOS:000360018600048
J	Klein, C; Terrao, M; Gil, DI; Clayton, C				Klein, Cornelia; Terrao, Monica; Gil, Diana Inchaustegui; Clayton, Christine			Polysomes of Trypanosoma brucei: Association with Initiation Factors and RNA-Binding Proteins	PLOS ONE			English	Article							TRANSLATION INITIATION; MESSENGER-RNAS; LIFE-CYCLE; GENE-EXPRESSION; POTENTIAL ROLES; COMPLEX; LEISHMANIA; HOMOLOG; STABILITY; DEPLETION	We report here the results of experiments designed to identify RNA-binding proteins that might be associated with Trypanosoma brucei polysomes. After some preliminary mass spectrometry of polysomal fractions, we investigated the distributions of selected tagged proteins using sucrose gradients and immunofluorescence. As expected, the polysomal fractions contained nearly all annotated ribosomal proteins, the translation-associated protein folding complex, and many translation factors, but also many other abundant proteins. Results suggested that cap-binding proteins EIF4E3 and EIF4E4 were associated with both free and membrane-bound polysomes. The EIF4E binding partners EIF4G4 and EIF4G3 were present but the other EIF4E and EIF4G paralogues were not detected. The dominant EIF4E in the polysomal fraction is EIF4E4 and very few polysomal mRNAs are associated with EIF4G. Thirteen potential mRNA-binding proteins were detected in the polysomes, including the known polysome-associated protein RBP42. The locations of two of the other proteins were tested after epitope tagging: RBP29 was in the nucleus and ZC3H29 was in the cytoplasm. Quantitative analyses showed that specific association of an RNA-binding protein with the polysome fraction in sucrose gradients will not be detected if the protein is in more than 25-fold molar excess over its target binding sites.	[Klein, Cornelia; Terrao, Monica; Gil, Diana Inchaustegui; Clayton, Christine] Heidelberg Univ, Zentrum Mol Biol, DKFZ ZMBH Alliance, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Clayton, C (corresponding author), Heidelberg Univ, Zentrum Mol Biol, DKFZ ZMBH Alliance, Neuenheimer Feld 282, D-69120 Heidelberg, Germany.	cclayton@zmbh.uni-heidelberg.de	Clayton, Christine/K-7700-2019		Deutsche Forschungsgemeinschaft [Cl112/16-1]; HBIGS (The Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology) graduate school - DFG	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); HBIGS (The Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology) graduate school - DFG	This study was supported by Cl112/16-1Deutsche Forschungsgemeinschaft http://www.dfg.de; Stipend from HBIGS (The Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology) graduate school (ultimately DFG-funded) http://www.hbigs.uni-heidelberg.de.	Alsford S, 2011, GENOME RES, V21, P915, DOI 10.1101/gr.115089.110; Archer SK, 2015, RNA BIOL, V12, P248, DOI 10.1080/15476286.2015.1017242; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Bonderoff JM, 2010, NUCLEIC ACIDS RES, V38, P7054, DOI 10.1093/nar/gkq566; Brecht M, 1998, MOL BIOCHEM PARASIT, V97, P189, DOI 10.1016/S0166-6851(98)00151-0; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Clayton CE, 2014, MOL BIOCHEM PARASIT, V195, P96, DOI 10.1016/j.molbiopara.2014.06.005; CLAYTON CE, 1987, J CELL BIOL, V105, P2649, DOI 10.1083/jcb.105.6.2649; Clayton C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003680; Das A, 2012, RNA, V18, P1968, DOI 10.1261/rna.033829.112; Delhi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025112; Dhalia R, 2005, MOL BIOCHEM PARASIT, V140, P23, DOI 10.1016/j.molbiopara.2004.12.001; Erben ED, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004178; Estevez AM, 2008, NUCLEIC ACIDS RES, V36, P4573, DOI 10.1093/nar/gkn406; Fadda A, 2014, MOL MICROBIOL, V94, P307, DOI 10.1111/mmi.12764; Fernandez-Moya SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048870; Freire ER, 2014, RNA, V20, P1272, DOI 10.1261/rna.045534.114; Freire ER, 2014, EUKARYOT CELL, V13, P896, DOI 10.1128/EC.00071-14; Freire ER, 2011, MOL BIOCHEM PARASIT, V176, P25, DOI 10.1016/j.molbiopara.2010.11.011; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gupta SK, 2014, RNA BIOL, V11, P715, DOI 10.4161/rna.29143; Gupta SK, 2013, NUCLEIC ACIDS RES, V41, P6577, DOI 10.1093/nar/gkt369; Gupta SK, 2013, J BIOL CHEM, V288, P4991, DOI 10.1074/jbc.M112.416578; Haanstra JR, 2008, J BIOL CHEM, V283, P2495, DOI 10.1074/jbc.M705782200; Jensen BC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-911; Jha BA, 2014, EUKARYOT CELL, V13, P664, DOI 10.1128/EC.00018-14; Kolev NG, 2014, CELL MICROBIOL, V16, P482, DOI 10.1111/cmi.12268; Kramer S, 2011, TRENDS PARASITOL, V27, P23, DOI 10.1016/j.pt.2010.06.011; Kuyumcu-Martinez NM, 2004, MOL CELL BIOL, V24, P1779, DOI 10.1128/MCB.24.4.1779-1790.2004; Luu VD, 2006, MOL BIOCHEM PARASIT, V150, P340, DOI 10.1016/j.molbiopara.2006.09.007; Michaeli S, 2011, FUTURE MICROBIOL, V6, P459, DOI [10.2217/fmb.11.20, 10.2217/FMB.11.20]; Moura DMN, 2015, RNA BIOL, V12, P305, DOI 10.1080/15476286.2015.1017233; Regmi S, 2008, MOL MICROBIOL, V70, P724, DOI 10.1111/j.1365-2958.2008.06443.x; Rezende AM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1175; Schumann Burkard G, 2013, MOL MICROBIOL; Singh A, 2014, NUCLEIC ACIDS RES, V42, P4652, DOI 10.1093/nar/gkt1416; Stern MZ, 2009, RNA, V15, P648, DOI 10.1261/rna.1230209; Urbaniak MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036619; Vasquez JJ, 2014, NUCLEIC ACIDS RES, V42, P3623, DOI 10.1093/nar/gkt1386; Voncken F, 2003, J BIOL CHEM, V278, P35299, DOI 10.1074/jbc.M301811200; Wurst M, 2012, MOL MICROBIOL, V83, P1048, DOI 10.1111/j.1365-2958.2012.07988.x; Yoffe Y, 2006, EUKARYOT CELL, V5, P1969, DOI 10.1128/EC.00230-06; Yoffe Y, 2009, NUCLEIC ACIDS RES, V37, P3243, DOI 10.1093/nar/gkp190; Zinoviev A, 2012, MOL BIOCHEM PARASIT, V185, P127, DOI 10.1016/j.molbiopara.2012.08.001; Zinoviev A, 2011, NUCLEIC ACIDS RES, V39, P8404, DOI 10.1093/nar/gkr555	45	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135973	10.1371/journal.pone.0135973	http://dx.doi.org/10.1371/journal.pone.0135973			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287607	Green Submitted, Green Published, gold			2022-12-26	WOS:000360018600093
J	Knight, BA; Shields, BM; Brook, A; Hill, A; Bhat, DS; Hattersley, AT; Yajnik, CS				Knight, Bridget Ann; Shields, Beverley M.; Brook, Adam; Hill, Anita; Bhat, Dattatray S.; Hattersley, Andrew T.; Yajnik, Chittaranjan S.			Lower Circulating B12 Is Associated with Higher Obesity and Insulin Resistance during Pregnancy in a Non-Diabetic White British Population	PLOS ONE			English	Article							MATERNAL NUTRITION; VITAMIN-B-12	Objective Vitamin B12 and folate are critical micronutrients needed to support the increased metabolic demands of pregnancy. Recent studies from India have suggested that low vitamin B12 and folate concentrations in pregnancy are associated with increased obesity; however differences in diet, antenatal vitamin supplementation, and socioeconomic status may limit the generalisability of these findings. We aimed to explore the cross-sectional relationship of circulating serum vitamin B12 and folate at 28 weeks' gestation with maternal adiposity and related biochemical markers in a white non diabetic UK obstetric cohort. Methods Anthropometry and biochemistry data was available on 995 women recruited at 28 weeks gestation to the Exeter Family Study of Childhood Health. Associations between B12 and folate with maternal BMI and other obesity-related biochemical factors (HOMA-R, fasting glucose, triglycerides, HDL and AST) were explored using regression analysis, adjusting for potential confounders (socioeconomic status, vegetarian diet, vitamin supplementation, parity, haemodilution (haematocrit)). Results Higher 28 week BMI was associated with lower circulating vitamin B12 (r = -0.25; P<0.001) and folate (r = -0.15; P<0.001). In multiple regression analysis higher 28 week BMI remained an independent predictor of lower circulating B12 (beta (95% CI) = -0.59 (-0.74, -0.44) i.e. for every 1% increase in BMI there was a 0.6% decrease in circulating B12). Other markers of adiposity/body fat metabolism (HOMA-R, triglycerides and AST) were also independently associated with circulating B12. In a similar multiple regression AST was the only independent obesity-related marker associated with serum folate (beta (95% CI) = 0.16 (0.21, 0.51)) Conclusion In conclusion, our study has replicated the previous Indian findings of associations between lower serum B12 and higher obesity and insulin resistance during pregnancy in a non-diabetic White British population. These findings may have important implications for fetal and maternal health in obese pregnancies.	[Knight, Bridget Ann; Shields, Beverley M.; Brook, Adam; Hattersley, Andrew T.] Univ Exeter, Sch Med, Exeter NIHR Clin Res Facil, Exeter, Devon, England; [Knight, Bridget Ann; Hill, Anita] Royal Devon & Exeter NHS Fdn Trust, Exeter, Devon, England; [Bhat, Dattatray S.; Yajnik, Chittaranjan S.] KEM Hosp & Res Ctr, Diabet Unit, Pune, Maharashtra, India	University of Exeter; University of Exeter	Knight, BA (corresponding author), Univ Exeter, Sch Med, Exeter NIHR Clin Res Facil, Exeter, Devon, England.	B.A.Knight@ex.ac.uk		Hattersley, Andrew/0000-0001-5620-473X; Bhat, Dattatray/0000-0001-9512-2366	South West National Health Service Research and Development; Exeter national Health Service Research and Development; Darlington Trust; National Institute for Health Research; National Institute for Health Research [NF-SI-0611-10219] Funding Source: researchfish	South West National Health Service Research and Development; Exeter national Health Service Research and Development; Darlington Trust; National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	The Exeter Family Study Of Childhood Health was funded by the South West National Health Service Research and Development, Exeter national Health Service Research and Development, and the Darlington Trust. Andrew Hattersley is an National Institute for Health Research Senior investigator and a Wellcome Trust Senior investigator. Bridget Knight held an National Health Service Research and Development Studentship. Current project was funded through the National Institute for Health Research. BS, ATH, BK are core members of the National Institute for Health Research Exeter Clinical Research Facility.	Heslehurst N, 2010, INT J OBESITY, V34, P420, DOI 10.1038/ijo.2009.250; Kimmons Joel E, 2006, MedGenMed, V8, P59; Knight B, 2006, PAEDIATR PERINAT EP, V20, P172, DOI 10.1111/j.1365-3016.2006.00701.x; Krishnaveni GV, 2009, DIABETOLOGIA, V52, P2350, DOI 10.1007/s00125-009-1499-0; Stewart CP, 2011, J NUTR, V141, P1912, DOI 10.3945/jn.111.144717; Stothard KJ, 2009, JAMA-J AM MED ASSOC, V301, P636, DOI 10.1001/jama.2009.113; Thurnham DI, 2001, HUMAN NUTR DIETETICS, P249; Vittinghoff E, 2005, STAT BIOL HEALTH, pVII; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Xanthakos SA, 2009, PEDIATR CLIN N AM, V56, P1105, DOI 10.1016/j.pcl.2009.07.002; Yajnik CS, 2008, DIABETOLOGIA, V51, P29, DOI 10.1007/s00125-007-0793-y; Yajnik CS, 2012, REV ENDOCR METAB DIS, V13, P121, DOI 10.1007/s11154-012-9214-8	12	66	69	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135268	10.1371/journal.pone.0135268	http://dx.doi.org/10.1371/journal.pone.0135268			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288227	Green Published, Green Submitted, gold			2022-12-26	WOS:000360018600042
J	Maganga, E; Smart, LR; Kalluvya, S; Kataraihya, JB; Saleh, AM; Obeid, L; Downs, JA; Fitzgerald, DW; Peck, RN				Maganga, Emmanuel; Smart, Luke R.; Kalluvya, Samuel; Kataraihya, Johannes B.; Saleh, Ahmed M.; Obeid, Lama; Downs, Jennifer A.; Fitzgerald, Daniel W.; Peck, Robert N.			Glucose Metabolism Disorders, HIV and Antiretroviral Therapy among Tanzanian Adults	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; DIABETES-MELLITUS; INSULIN SENSITIVITY; PRIMARY-CARE; LIPODYSTROPHY; PREVALENCE; AIDS; INITIATION; MARKERS	Introduction Millions of HIV-infected Africans are living longer due to long-term antiretroviral therapy (ART), yet little is known about glucose metabolism disorders in this group. We aimed to compare the prevalence of glucose metabolism disorders among HIV-infected adults on long-term ART to ART-naive adults and HIV-negative controls, hypothesizing that the odds of glucose metabolism disorders would be 2-fold greater even after adjusting for possible confounders. Methods In this cross-sectional study conducted between October 2012 and April 2013, consecutive adults (> 18 years) attending an HIV clinic in Tanzania were enrolled in 3 groups: 153 HIV-negative controls, 151 HIV-infected, ART-naive, and 150 HIV-infected on ART for >= 2 years. The primary outcome was the prevalence of glucose metabolism disorders as determined by oral glucose tolerance testing. We compared glucose metabolism disorder prevalence between each HIV group vs. the control group by Fisher's exact test and used multivariable logistic regression to determine factors associated with glucose metabolism disorders. Results HIV-infected adults on ART had a higher prevalence of glucose metabolism disorders (49/150 (32.7%) vs. 11/153 (7.2%), p<0.001) and frank diabetes mellitus (27/150 (18.0%) vs. 8/153 (5.2%), p = 0.001) than HIV-negative adults, which remained highly significant even after adjusting for age, gender, adiposity and socioeconomic status (OR = 5.72 (2.78-11.77), p<0.001). Glucose metabolism disorders were significantly associated with higher CD4+ T-cell counts. Awareness of diabetes mellitus was <25%. Conclusions HIV-infected adults on long-term ART had 5-fold greater odds of glucose metabolism disorders than HIV-negative controls but were rarely aware of their diagnosis. Intensive glucose metabolism disorder screening and education are needed in HIV clinics in sub-Saharan Africa. Further research should determine how glucose metabolism disorders might be related to immune reconstitution.	[Maganga, Emmanuel; Smart, Luke R.; Kalluvya, Samuel; Kataraihya, Johannes B.; Downs, Jennifer A.; Peck, Robert N.] Catholic Univ Hlth & Allied Sci, Dept Internal Med, Mwanza, Tanzania; [Smart, Luke R.; Kalluvya, Samuel; Kataraihya, Johannes B.; Downs, Jennifer A.; Peck, Robert N.] Bugando Med Ctr, Dept Internal Med, Mwanza, Tanzania; [Smart, Luke R.; Downs, Jennifer A.; Fitzgerald, Daniel W.; Peck, Robert N.] Weill Cornell Med Coll, Ctr Global Hlth, New York, NY USA; [Saleh, Ahmed M.; Obeid, Lama] Weill Cornell Med Coll Qatar, Doha, Qatar	Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Peck, RN (corresponding author), Catholic Univ Hlth & Allied Sci, Dept Internal Med, Mwanza, Tanzania.	rnp2002@gmail.com	Smart, Luke R./AAI-1561-2020	Smart, Luke R./0000-0003-4083-0060; Downs, Jennifer/0000-0001-9537-204X; Peck, Robert/0000-0002-4526-2480	National Institutes of Health Fogarty Foundation [TW000018]; National Institute of Allergy and Infectious Diseases [K24 AI098627]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI098627] Funding Source: NIH RePORTER	National Institutes of Health Fogarty Foundation; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by grants from the National Institutes of Health Fogarty Foundation (TW000018) and the National Institute of Allergy and Infectious Diseases (K24 AI098627). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MK, 2014, JAIDS-J ACQ IMM DEF, V67, pS27, DOI 10.1097/QAI.0000000000000256; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Awotedu K, 2010, DIABETES METAB SYND, V4, P210, DOI 10.1016/j.dsx.2010.09.002; Berhane T, 2012, PAN AFR MED J, V13; Bonfanti P, 2007, JAIDS-J ACQ IMM DEF, V45, P426, DOI 10.1097/QAI.0b013e318074ef83; Brown TT, 2005, ARCH INTERN MED, V165, P1179, DOI 10.1001/archinte.165.10.1179; Brown TT, 2005, AIDS, V19, P1375, DOI 10.1097/01.aids.0000181011.62385.91; Calza L, 2011, INT J STD AIDS, V22, P43, DOI 10.1258/ijsa.2010.010256; Carr A, 1999, LANCET, V353, P2093, DOI 10.1016/S0140-6736(98)08468-2; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Dave JA, 2011, JAIDS-J ACQ IMM DEF, V57, P284, DOI 10.1097/QAI.0b013e318221863f; Dillon DG, 2013, INT J EPIDEMIOL, V42, P1754, DOI 10.1093/ije/dyt198; Erlandson KM, 2014, AIDS, V28, P1451, DOI 10.1097/QAD.0000000000000266; Goff LM, 2003, BRIT J NUTR, V89, P365, DOI 10.1079/BJN2002789; Hattingh Z, 2009, S AFR J CLIN NUTR, V22, P22; Home P, 2006, DIABETIC MED, V23, P579; Kiage JN, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-50; Manuthu E M, 2008, East Afr Med J, V85, P10; Mbanya JCN, 2010, LANCET, V375, P2254, DOI 10.1016/S0140-6736(10)60550-8; McComsey GA, 2014, JAIDS-J ACQ IMM DEF, V65, P167, DOI 10.1097/01.qai.0000437171.00504.41; Mercier S, 2009, JAIDS-J ACQ IMM DEF, V51, P224, DOI 10.1097/QAI.0b013e31819c16f4; Msyamboza KP, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-41; Narayan KMV, 2014, JAIDS-J ACQ IMM DEF, V67, pS2, DOI 10.1097/QAI.0000000000000267; National Guidelines For the Management of HIV and AIDS, 2009, NATIONAL GUIDELINES; Ngatchou W, 2013, VASC HEALTH RISK MAN, V9, P509, DOI 10.2147/VHRM.S42350; Peck R, 2003, JAIDS-J ACQ IMM DEF, V33, P470, DOI 10.1097/00126334-200308010-00007; Peck R, 2014, LANCET GLOB HEALTH, V2, pE285, DOI 10.1016/S2214-109X(14)70033-6; Petersen M, 2014, JAIDS-J ACQ IMM DEF, V67, pS8, DOI 10.1097/QAI.0000000000000253; Priya M, 2011, DIABETES TECHNOL THE, V13, P586, DOI 10.1089/dia.2010.0218; Tanzania Commission for AIDS, 2013, TANZANIA HIV AIDS AN; Thompson V, 2011, AIDS RES HUM RETROV, V27, P785, DOI [10.1089/aid.2010.0272, 10.1089/AID.2010.0272]; UNAIDS, 2020, UNAIDS 2020 GLOB REP; World Health Organization, 2013, GLOBAL UPDATE ON HIV; World Health Organization, 2011, WHO STEPS INSTRUMENT; Zannou DM, 2009, ANTIVIR THER, V14, P371	35	46	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0134410	10.1371/journal.pone.0134410	http://dx.doi.org/10.1371/journal.pone.0134410			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287742	Green Published, gold, Green Submitted			2022-12-26	WOS:000360018600020
J	Meid, AD; Quinzler, R; Freigofas, J; Saum, KU; Schottker, B; Holleczek, B; Heider, D; Konig, HH; Brenner, H; Haefeli, WE				Meid, Andreas D.; Quinzler, Renate; Freigofas, Julia; Saum, Kai-Uwe; Schoettker, Ben; Holleczek, Bernd; Heider, Dirk; Koenig, Hans-Helmut; Brenner, Hermann; Haefeli, Walter E.			Medication Underuse in Aging Outpatients with Cardiovascular Disease: Prevalence, Determinants, and Outcomes in a Prospective Cohort Study	PLOS ONE			English	Article							OLDER-PEOPLE; ELDERLY-PATIENTS; SCREENING TOOL; ALERT DOCTORS; ALL-CAUSE; CRITERIA; POPULATION; POLYPHARMACY; PREVENTION; MORTALITY	Background Cardiovascular disease is a leading cause of death in older people, and the impact of being exposed or not exposed to preventive cardiovascular medicines is accordingly high. Underutilization of beneficial drugs is common, but prevalence estimates differ across settings, knowledge on predictors is limited, and clinical consequences are rarely investigated. Methods Using data from a prospective population-based cohort study, we assessed the prevalence, determinants, and outcomes of medication underuse based on cardiovascular criteria from Screening Tool To Alert to Right Treatment (START). Results Medication underuse was present in 69.1% of 1454 included participants (mean age 71.1 +/- 6.1 years) and was significantly associated with frailty (odds ratio: 2.11 [95% confidence interval: 1.24-3.63]), body mass index (1.03 [1.01-1.07] per kg/m(2)), and inversely with the number of prescribed drugs (0.84 [0.79-0.88] per drug). Using this information for adjustment in a follow-up evaluation (mean follow-up time 2.24 years) on cardiovascular and competing outcomes, we found no association of medication underuse with cardiovascular events (fatal and non-fatal) (hazard ratio: 1.00 [0.65-1.56]), but observed a significant association of medication underuse with competing deaths from non-cardiovascular causes (2.52 [1.01-6.30]). Conclusion Medication underuse was associated with frailty and adverse non-cardiovascular clinical outcomes. This may suggest that cardiovascular drugs were withheld because of serious co-morbidity or that concurrent illness can preclude benefit from cardiovascular prevention. In the latter case, adapted prescribing criteria should be developed and evaluated in those patients.	[Meid, Andreas D.; Quinzler, Renate; Freigofas, Julia; Haefeli, Walter E.] Heidelberg Univ, Dept Clin Pharmacol & Pharmacoepidemiol, Heidelberg, Germany; [Saum, Kai-Uwe; Schoettker, Ben; Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Holleczek, Bernd] Saarland Canc Registry, Saarbrucken, Germany; [Heider, Dirk; Koenig, Hans-Helmut] Univ Med Ctr Hamburg Eppendorf, Dept Hlth Econ & Hlth Serv Res, Hamburg Ctr Hlth Econ, Hamburg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Hamburg; University Medical Center Hamburg-Eppendorf	Haefeli, WE (corresponding author), Heidelberg Univ, Dept Clin Pharmacol & Pharmacoepidemiol, Neuenheimer Feld 410, Heidelberg, Germany.	walter.emil.haefeli@med.uni-heidelberg.de	Brenner, Hermann/ABE-6383-2020; Brenner, Hermann/B-4627-2017; Schöttker, Ben/F-8183-2014; König, Hans-Helmut/P-1211-2018; Haefeli, Walter Emil/AAJ-3024-2020	Brenner, Hermann/0000-0002-6129-1572; Brenner, Hermann/0000-0002-6129-1572; Schöttker, Ben/0000-0002-1217-4521; König, Hans-Helmut/0000-0001-5711-6862; Haefeli, Walter Emil/0000-0003-0672-6876	German Federal Ministry of Education and Research (BMBF, Berlin, Germany) [01ET0717, 01ET1004B, 01GY1320B]	German Federal Ministry of Education and Research (BMBF, Berlin, Germany)(Federal Ministry of Education & Research (BMBF))	This work was supported in part by institutional funding and ADM, RQ, and JF received funding from the German Federal Ministry of Education and Research (BMBF, Berlin, Germany) under Grant Numbers 01ET0717, 01ET1004B, and 01GY1320B. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry PJ, 2007, AGE AGEING, V36, P632, DOI 10.1093/ageing/afm118; Beer C, 2011, BRIT J CLIN PHARMACO, V71, P592, DOI 10.1111/j.1365-2125.2010.03875.x; Bohm M, 2013, AM HEART J, V166, P306, DOI 10.1016/j.ahj.2013.04.016; Byatt K, 2014, EVID BASED MED; Cherubini A, 2012, DRUG AGING, V29, P463, DOI 10.2165/11631750-000000000-00000; Cooper JA, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0484-6; Dalleur O, 2012, DRUG AGING, V29, P829, DOI 10.1007/s40266-012-0016-1; De Wilde S, 2003, LANCET, V362, P746, DOI 10.1016/S0140-6736(03)14216-X; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gallagher P, 2008, INT J CLIN PHARM TH, V46, P72; Gallagher P, 2007, J CLIN PHARM THER, V32, P113, DOI 10.1111/j.1365-2710.2007.00793.x; Gallagher PF, 2011, CLIN PHARMACOL THER, V89, P845, DOI 10.1038/clpt.2011.44; Gallagher P, 2011, EUR J CLIN PHARMACOL, V67, P1175, DOI 10.1007/s00228-011-1061-0; Galvin R, 2014, EUR J CLIN PHARM; Gaw A, 2004, INT J CLIN PRACT, V58, P777, DOI 10.1111/j.1368-5031.2004.00300.x; Glynn RJ, 2006, J CLIN EPIDEMIOL, V59, P819, DOI 10.1016/j.jclinepi.2005.12.012; Hanlon JT, 2011, J AM GERIATR SOC, V59, P1412, DOI 10.1111/j.1532-5415.2011.03522.x; Hughes CM, 2004, DRUG AGING, V21, P793, DOI 10.2165/00002512-200421120-00004; Kuijpers MAJ, 2008, BRIT J CLIN PHARMACO, V65, P130, DOI 10.1111/j.1365-2125.2007.02961.x; Liu CL, 2012, ARCH GERONTOL GERIAT, V55, P148, DOI 10.1016/j.archger.2011.07.001; Neutel CI, 2007, CAN J PUBLIC HEALTH, V98, P412, DOI 10.1007/BF03405430; Ryan C, 2009, BRIT J CLIN PHARMACO, V68, P936, DOI 10.1111/j.1365-2125.2009.03531.x; Saum KU, 2012, J AM GERIATR SOC, V60, P2110, DOI 10.1111/j.1532-5415.2012.04192.x; Schottker B, 2013, AM J CLIN NUTR, V97, P782, DOI 10.3945/ajcn.112.047712; Steinman MA, 2006, J AM GERIATR SOC, V54, P1516, DOI 10.1111/j.1532-5415.2006.00889.x; Szadkowska I, 2010, ARCH GERONTOL GERIAT, V50, P114, DOI 10.1016/j.archger.2008.12.012; Ubeda Amalia, 2012, Pharmacy Pract (Granada), V10, P83, DOI 10.4321/s1886-36552012000200004; Weiss NS, 2014, EUR J EPIDEMIOL, V29, P147, DOI 10.1007/s10654-014-9899-y; Witticke D, 2013, DRUG SAFETY, V36, P31, DOI 10.1007/s40264-012-0007-5; Zint K, 2010, PHARMACOEPIDEM DR S, V19, P1248, DOI 10.1002/pds.2031	30	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136339	10.1371/journal.pone.0136339	http://dx.doi.org/10.1371/journal.pone.0136339			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP6SN	26288222	Green Submitted, Green Published, gold			2022-12-26	WOS:000360018600132
J	Prevato, M; Ferlenghi, I; Bonci, A; Uematsu, Y; Anselmi, G; Giusti, F; Bertholet, S; Legay, F; Telford, JL; Settembre, EC; Maione, D; Cozzi, R				Prevato, Marua; Ferlenghi, Ilaria; Bonci, Alessandra; Uematsu, Yasushi; Anselmi, Giulia; Giusti, Fabiola; Bertholet, Sylvie; Legay, Francois; Telford, John Laird; Settembre, Ethan C.; Maione, Domenico; Cozzi, Roberta			Expression and Characterization of Recombinant, Tetrameric and Enzymatically Active Influenza Neuraminidase for the Setup of an Enzyme-Linked Lectin-Based Assay	PLOS ONE			English	Article							VIRUS NEURAMINIDASE; VIRAL NEURAMINIDASE; MAMMALIAN-CELLS; VACCINE ANTIGEN; HEMAGGLUTININ; PROTECTION; ANTIBODY; IMMUNIZATION; INFECTION; SYSTEM	Developing a universal influenza vaccine that induces broad spectrum and longer-term immunity has become an important potentially achievable target in influenza vaccine research and development. Hemagglutinin (HA) and neuraminidase (NA) are the two major influenza virus antigens. Although antibody responses against influenza virus are mainly directed toward HA, NA is reported to be more genetically stable; hence NA-based vaccines have the potential to be effective for longer time periods. NA-specific immunity has been shown to limit the spread of influenza virus, thus reducing disease symptoms and providing cross-protection against heterosubtypic viruses in mouse challenge experiments. The production of large quantities of highly pure and stable NA could be beneficial for the development of new antivirals, subunit-based vaccines, and novel diagnostic tools. In this study, recombinant NA (rNA) was produced in mammalian cells at high levels from both swine A/California/07/2009 (H1N1) and avian A/turkey/Turkey/01/2005 (H5N1) influenza viruses. Biochemical, structural, and immunological characterizations revealed that the soluble rNAs produced are tetrameric, enzymatically active and immunogenic, and finally they represent good alternatives to conventionally used sources of NA in the Enzyme-Linked Lectin Assay (ELLA).	[Prevato, Marua; Ferlenghi, Ilaria; Bonci, Alessandra; Uematsu, Yasushi; Anselmi, Giulia; Bertholet, Sylvie; Telford, John Laird; Maione, Domenico; Cozzi, Roberta] Novartis Vaccines & Diagnost Srl, Res Ctr, Siena, Italy; [Giusti, Fabiola] Univ Siena, Dept Life Sci, I-53100 Siena, Italy; [Legay, Francois] Novartis Vaccines & Diagnost, Vaccine Res, Basel, Switzerland; [Settembre, Ethan C.] Novartis Vaccines & Diagnost Inc, Vaccine Res, Cambridge, MA USA	Novartis; University of Siena; Novartis; Novartis	Maione, D (corresponding author), Novartis Vaccines & Diagnost Srl, Res Ctr, Siena, Italy.	domenico.maione@novartis.com	Telford, John Laird/ABG-8144-2020		Novartis Vaccines and Diagnostics	Novartis Vaccines and Diagnostics	This work was supported by internal funding from Novartis Vaccines and Diagnostics. The funder provided support in the form of salaries for authors IF AB YU SB FL JLT ECS DM RC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Air GM, 2012, INFLUENZA OTHER RESP, V6, P245, DOI 10.1111/j.1750-2659.2011.00304.x; Bosch BJ, 2010, J VIROL, V84, P10366, DOI 10.1128/JVI.01035-10; Brett IC, 2005, VIROLOGY, V339, P273, DOI 10.1016/j.virol.2005.06.006; BURMEISTER WP, 1994, J GEN VIROL, V75, P381, DOI 10.1099/0022-1317-75-2-381; Cate TR, 2010, VACCINE, V28, P2076, DOI 10.1016/j.vaccine.2009.12.041; Chen Z, 2000, VACCINE, V18, P3214, DOI 10.1016/S0264-410X(00)00149-3; Cohen M, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-321; Dalakouras T, 2006, J CHROMATOGR A, V1136, P48, DOI 10.1016/j.chroma.2006.09.067; Johansson BE, 2007, VACCINE, V25, P3062, DOI 10.1016/j.vaccine.2007.01.030; Johansson BE, 2011, EXPERT REV VACCINES, V10, P1683, DOI [10.1586/erv.11.130, 10.1586/ERV.11.130]; Jonges M, 2010, J CLIN MICROBIOL, V48, P928, DOI 10.1128/JCM.02045-09; KILBOURNE ED, 1987, INFLUENZA; LAMBRE CR, 1990, J IMMUNOL METHODS, V135, P49, DOI 10.1016/0022-1759(90)90255-T; Lawrenz M, 2010, PROTEINS, V78, P2523, DOI 10.1002/prot.22761; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Ludtke SJ, 2010, METHODS MOL BIOL, V673, P157, DOI 10.1007/978-1-60761-842-3_9; Marcelin G, 2012, REV MED VIROL, V22, P267, DOI 10.1002/rmv.1713; Martinet W, 1997, EUR J BIOCHEM, V247, P332, DOI 10.1111/j.1432-1033.1997.00332.x; MATHER KA, 1992, VIRUS RES, V26, P127, DOI 10.1016/0168-1702(92)90152-Y; Matrosovich MN, 2004, J VIROL, V78, P12665, DOI 10.1128/JVI.78.22.12665-12667.2004; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Neumann G, 2006, EMERG INFECT DIS, V12, P881, DOI 10.3201/eid1206.051336; Nivitchanyong T, 2011, J VIROL METHODS, V178, P44, DOI 10.1016/j.jviromet.2011.08.010; Organization TWH, 2014, INFL SEAS; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pica N, 2013, ANNU REV MED, V64, P189, DOI [10.1146/annurev-med-120611-145115, 10.1146/annure]; Sandbulte MR, 2009, INFLUENZA OTHER RESP, V3, P233, DOI 10.1111/j.1750-2659.2009.00094.x; Schmidt PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016284; SCHULMAN JL, 1969, P NATL ACAD SCI USA, V63, P326, DOI 10.1073/pnas.63.2.326; Sylte MJ, 2009, CURR TOP MICROBIOL, V333, P227, DOI 10.1007/978-3-540-92165-3_12; VANHEEL M, 1988, SCANNING MICROSCOPY, P295; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; WEBSTER RG, 1967, J IMMUNOL, V99, P49; WEBSTER RG, 1984, VIROLOGY, V135, P30, DOI 10.1016/0042-6822(84)90114-4; White HE, 2004, J MOL BIOL, V336, P453, DOI 10.1016/j.jmb.2003.12.015; Wohlbold TJ, 2014, VIRUSES-BASEL, V6, P2465, DOI 10.3390/v6062465; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Xu R, 2012, J VIROL, V86, P9221, DOI 10.1128/JVI.00697-12; Yongkiettrakul S, 2009, J VIROL METHODS, V156, P44, DOI 10.1016/j.jviromet.2008.10.025	39	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0135474	10.1371/journal.pone.0135474	http://dx.doi.org/10.1371/journal.pone.0135474			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26280677	Green Submitted, Green Published, gold			2022-12-26	WOS:000359664300015
J	Bahnan, W; Boettner, DR; Westermark, L; Fallman, M; Schesser, K				Bahnan, Wael; Boettner, Douglas R.; Westermark, Linda; Faellman, Maria; Schesser, Kurt			Pathogenic Yersinia Promotes Its Survival by Creating an Acidic Fluid-Accessible Compartment on the Macrophage Surface	PLOS ONE			English	Article							PLASMA-MEMBRANE; PSEUDOTUBERCULOSIS; PROTEIN; TRANSLOCATION; PESTIS; CELLS; ENTEROCOLITICA; TRAFFICKING; YOPE; AUTOPHAGOSOMES	Microbial pathogens and host immune cells each initiate events following their interaction in an attempt to drive the outcome to their respective advantage. Here we show that the bacterial pathogen Yersinia pseudotuberculosis sustains itself on the surface of a macrophage by forming acidic fluid-accessible compartments that are partially bounded by the host cell plasma membrane. These Yersinia-containing acidic compartments (YACs) are bereft of the early endosomal marker EEA1 and the lysosomal antigen LAMP1 and readily form on primary macrophages as well as macrophage-like cell lines. YAC formation requires the presence of the Yersinia virulence plasmid which encodes a type III secretion system. Unexpectedly, we found that the initial formation of YACs did not require translocation of the type III effectors into the host cell cytosol; however, the duration of YACs was markedly greater in infections using translocation-competent Y. pseudotuberculosis strains as well as strains expressing the effector YopJ. Furthermore, it was in this translocation- and YopJ-dependent phase of infection that the acidic environment was critical for Y. pseudotuberculosis survival during its interaction with macrophages. Our findings indicate that during its extracellular phase of infection Y. pseudotuberculosis initiates and then, by a separate mechanism, stabilizes the formation of a highly intricate structure on the surface of the macrophage that is disengaged from the endocytic pathway.	[Bahnan, Wael; Schesser, Kurt] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA; [Boettner, Douglas R.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Westermark, Linda; Faellman, Maria] Umea Univ, Dept Mol Biol, Umea, Sweden	University of Miami; University of Miami; Umea University	Schesser, K (corresponding author), Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA.	kschesser@med.miami.edu		Abu Kwaik, Yousef/0000-0002-2119-2078; Boettner, Douglas/0000-0002-0591-443X	National Institute of Health [RO1-AI53459, RO1-GM055796]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055796] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work received support from National Institute of Health RO1-AI53459 (KS); National Institute of Health RO1-GM055796 (DRB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopyan K, 2011, P NATL ACAD SCI USA, V108, P1639, DOI 10.1073/pnas.1013888108; Bartra S, 2001, BMC Microbiol, V1, P22, DOI 10.1186/1471-2180-1-22; BOLIN I, 1982, INFECT IMMUN, V37, P506; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Day JB, 2003, MOL MICROBIOL, V47, P807, DOI 10.1046/j.1365-2958.2003.03343.x; Edgren T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002669; Erfurth SE, 2004, INFECT IMMUN, V72, P7045, DOI 10.1128/IAI.72.12.7045-7054.2004; Fahlgren A, 2009, CELL MICROBIOL, V11, P1750, DOI 10.1111/j.1462-5822.2009.01365.x; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; GALYOV EE, 1994, J BACTERIOL, V176, P4543, DOI 10.1128/JB.176.15.4543-4548.1994; Grabenstein JP, 2006, INFECT IMMUN, V74, P3727, DOI 10.1128/IAI.00255-06; Hakansson S, 1996, EMBO J, V15, P5812, DOI 10.1002/j.1460-2075.1996.tb00968.x; Leka O, 2014, FEBS J, V281, P2115, DOI 10.1111/febs.12783; Mesaki K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019764; Montecucco C, 2001, NAT REV MOL CELL BIO, V2, P457, DOI 10.1038/35073084; Moreau K, 2010, CELL MICROBIOL, V12, P1108, DOI 10.1111/j.1462-5822.2010.01456.x; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Pujol C, 2009, INFECT IMMUN, V77, P2251, DOI 10.1128/IAI.00068-09; Ray A, 2010, J VIS EXP; Raymond B, 2013, TRENDS MICROBIOL, V21, P430, DOI 10.1016/j.tim.2013.06.008; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; SANDVIG K, 1980, J CELL BIOL, V87, P828, DOI 10.1083/jcb.87.3.828; Sarantis H, 2012, CELL HOST MICROBE, V11, P117, DOI 10.1016/j.chom.2012.01.010; Schesser K, 1996, J BACTERIOL, V178, P7227, DOI 10.1128/jb.178.24.7227-7233.1996; Siefker DT, 2014, INFECT IMMUN, V82, P762, DOI 10.1128/IAI.01489-13; Skrzypek E, 1998, MOL MICROBIOL, V30, P1051, DOI 10.1046/j.1365-2958.1998.01135.x; Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998; Trulzsch K, 2005, J IMMUNOL, V174, P4244, DOI 10.4049/jimmunol.174.7.4244; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320	29	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0133298	10.1371/journal.pone.0133298	http://dx.doi.org/10.1371/journal.pone.0133298			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275291	Green Published, Green Submitted, gold			2022-12-26	WOS:000359493600011
J	Galiullina, RA; Kasperkiewicz, P; Chichkova, NV; Szalek, A; Serebryakova, MV; Poreba, M; Drag, M; Vartapetian, AB				Galiullina, Raisa A.; Kasperkiewicz, Paulina; Chichkova, Nina V.; Szalek, Aleksandra; Serebryakova, Marina V.; Poreba, Marcin; Drag, Marcin; Vartapetian, Andrey B.			Substrate Specificity and Possible Heterologous Targets of Phytaspase, a Plant Cell Death Protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CASPASE FAMILY; GRANZYME-B; CHOLECYSTOKININ; GASTRIN; ARABIDOPSIS; METACASPASES; MEDIATORS; DISEASES; DEFENSE; DESIGN	Plants lack aspartate-specific cell death proteases homologous to animal caspases. Instead, a subtilisin-like serine-dependent plant protease named phytaspase shown to be involved in the accomplishment of programmed death of plant cells is able to hydrolyze a number of peptide-based caspase substrates. Here, we determined the substrate specificity of rice (Oryza sativa) phytaspase by using the positional scanning substrate combinatorial library approach. Phytaspase was shown to display an absolute specificity of hydrolysis after an aspartic acid residue. The preceding amino acid residues, however, significantly influence the efficiency of hydrolysis. Efficient phytaspase substrates demonstrated a remarkable preference for an aromatic amino acid residue in the P3 position. The deduced optimum phytaspase recognition motif has the sequence IWLD and is strikingly hydrophobic. The established pattern was confirmed through synthesis and kinetic analysis of cleavage of a set of optimized peptide substrates. An amino acid motif similar to the phytaspase cleavage site is shared by the human gastrointestinal peptide hormones gastrin and cholecystokinin. In agreement with the established enzyme specificity, phytaspase was shown to hydrolyze gastrin-1 and cholecystokinin at the predicted sites in vitro, thus destroying the active moieties of the hormones.	[Galiullina, Raisa A.; Chichkova, Nina V.; Serebryakova, Marina V.; Vartapetian, Andrey B.] Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow 119991, Russia; [Kasperkiewicz, Paulina; Szalek, Aleksandra; Poreba, Marcin; Drag, Marcin] Wroclaw Univ Technol, Dept Chem, Div Bioorgan Chem, PL-50370 Wroclaw, Poland	Lomonosov Moscow State University; Wroclaw University of Science & Technology	Drag, M (corresponding author), Wroclaw Univ Technol, Dept Chem, Div Bioorgan Chem, Wyb Wyspianskiego 27, PL-50370 Wroclaw, Poland.	marcin.drag@pwr.edu.pl; varta@genebee.msu.ru	Vartapetian, Andrey/B-8536-2012; Serebryakova, Marina/E-2986-2012; Chichkova, Nina/C-9994-2012	Serebryakova, Marina/0000-0002-5402-8215; 	Russian Foundation for Basic Research [14-04-00232, 14-04-00256, 14-04-91330]; National Science Centre in Poland [2011/03/B/ST5/01048]; Foundation for Polish Science; Polish Ministry of Science and Higher Education	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); National Science Centre in Poland(National Science Centre, Poland); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by Russian Foundation for Basic Research Grants 14-04-00232 (to N. V. C.) and 14-04-00256 and 14-04-91330 (to A. B. V.) and National Science Centre Grant 2011/03/B/ST5/01048 in Poland (to M. D.) and the Foundation for Polish Science. The work was also supported by a statutory activity subsidy from the Polish Ministry of Science and Higher Education for the Faculty of Chemistry at Wroclaw University of Technology. The authors declare that they have no conflicts of interest with the contents of this article.	Afonina IS, 2010, IMMUNOL REV, V235, P105, DOI 10.1111/j.0105-2896.2010.00908.x; Berna MJ, 2007, CURR TOP MED CHEM, V7, P1211; Bozhkov PV, 2005, P NATL ACAD SCI USA, V102, P14463, DOI 10.1073/pnas.0506948102; Cai YM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00041; Calatayud S, 2010, MINI-REV MED CHEM, V10, P8, DOI 10.2174/138955710791112532; Chichkova NV, 2014, RUSS J BIOORG CHEM+, V40, P606, DOI 10.1134/S1068162014060065; Chichkova NV, 2012, PHYSIOL PLANTARUM, V145, P77, DOI 10.1111/j.1399-3054.2011.01560.x; Chichkova NV, 2010, EMBO J, V29, P1149, DOI 10.1038/emboj.2010.1; Chichkova NV, 2004, PLANT CELL, V16, P157, DOI 10.1105/tpc.017889; CHICHKOVA NV, 2008, PLANT STRESS, V2, P89; Coll NS, 2010, SCIENCE, V330, P1393, DOI 10.1126/science.1194980; CRAWLEY JN, 1994, PEPTIDES, V15, P731, DOI 10.1016/0196-9781(94)90104-X; Danon A, 2000, PLANT PHYSIOL BIOCH, V38, P647, DOI 10.1016/S0981-9428(00)01178-5; Fomicheva AS, 2012, BIOCHEMISTRY-MOSCOW+, V77, P1452, DOI 10.1134/S0006297912130044; Fourmy D, 2011, GASTROENTEROLOGY, V141, P814, DOI 10.1053/j.gastro.2011.07.006; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; GREGORY H, 1964, NATURE, V204, P931, DOI 10.1038/204931a0; Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697; Hatsugai N, 2004, SCIENCE, V305, P855, DOI 10.1126/science.1099859; Hatsugai N, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00234; He R, 2008, J BIOL CHEM, V283, P774, DOI 10.1074/jbc.M704185200; Hoeberichts FA, 2003, BIOESSAYS, V25, P47, DOI 10.1002/bies.10175; Jones AM, 2001, PLANT PHYSIOL, V125, P94, DOI 10.1104/pp.125.1.94; Kasperkiewicz P, 2014, P NATL ACAD SCI USA, V111, P2518, DOI 10.1073/pnas.1318548111; Minina EA, 2014, AUTOPHAGY, V10, P926, DOI 10.4161/auto.28236; MORLEY JS, 1965, NATURE, V207, P1356, DOI 10.1038/2071356a0; Poreba M, 2014, CELL DEATH DIFFER, V21, P1482, DOI 10.1038/cdd.2014.64; Poreba M, 2014, METHODS MOL BIOL, V1133, P41, DOI 10.1007/978-1-4939-0357-3_2; Rantong G, 2015, BOTANY, V93, P193, DOI 10.1139/cjb-2014-0152; Reape TJ, 2008, J EXP BOT, V59, P435, DOI 10.1093/jxb/erm258; Reape TJ, 2010, APOPTOSIS, V15, P249, DOI 10.1007/s10495-009-0447-2; Reavy B, 2007, PLANT CELL REP, V26, P1215, DOI 10.1007/s00299-007-0335-6; Rehfeld JF, 2012, REGUL PEPTIDES, V173, P1, DOI 10.1016/j.regpep.2011.09.009; Rojo E, 2004, CURR BIOL, V14, P1897, DOI 10.1016/j.cub.2004.09.056; Schaller A, 2004, PLANTA, V220, P183, DOI 10.1007/s00425-004-1407-2; SMITH GP, 1981, SCIENCE, V213, P1036, DOI 10.1126/science.7268408; SPANARKEL M, 1983, J BIOL CHEM, V258, P6746; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Tsiatsiani L, 2011, CELL DEATH DIFFER, V18, P1279, DOI 10.1038/cdd.2011.66; Vartapetian AB, 2011, CELL DEATH DIFFER, V18, P1289, DOI 10.1038/cdd.2011.49; Walters J, 2009, BIOCHEM J, V424, P335, DOI 10.1042/BJ20090825; Watanabe N, 2011, PLANT J, V66, P969, DOI 10.1111/j.1365-313X.2011.04554.x; Williams B, 2008, MOL PLANT PATHOL, V9, P531, DOI [10.1111/j.1364-3703.2008.00473.x, 10.1111/J.1364-3703.2008.00473.X]	44	17	17	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					24806	24815		10.1074/jbc.M115.675819	http://dx.doi.org/10.1074/jbc.M115.675819			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26283788	Green Published, hybrid			2022-12-26	WOS:000362598300016
J	Soderholm, A; Guo, XH; Newton, MS; Evans, GB; Nasvall, J; Patrick, WM; Selmer, M				Soderholm, Annika; Guo, Xiaohu; Newton, Matilda S.; Evans, Gary B.; Nasvall, Joakim; Patrick, Wayne M.; Selmer, Maria			Two-step Ligand Binding in a (beta alpha)(8) Barrel Enzyme SUBSTRATE-BOUND STRUCTURES SHED NEW LIGHT ON THE CATALYTIC CYCLE OF HisA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRYPTOPHAN BIOSYNTHESIS; THERMOTOGA-MARITIMA; GENE-TRANSFER; EVOLUTION; HISTIDINE; SPECIFICITY; ISOMERASE; FOLD	HisA is a (beta alpha)(8) barrel enzyme that catalyzes the Amadori rearrangement of N'-[(5'-phosphoribosyl)formimino]-5-amino-imidazole-4-carboxamide ribonucleotide (ProFAR) to N'-((5'-phosphoribulosyl) formimino)-5-aminoimidazole-4-carboxamide-ribonucleotide (PRFAR) in the histidine biosynthesis pathway, and it is a paradigm for the study of enzyme evolution. Still, its exact catalytic mechanism has remained unclear. Here, we present crystal structures of wild type Salmonella enterica HisA (SeHisA) in its apo-state and of mutants D7N and D7N/D176A in complex with two different conformations of the labile substrate ProFAR, which was structurally visualized for the first time. Site-directed mutagenesis and kinetics demonstrated that Asp-7 acts as the catalytic base, and Asp-176 acts as the catalytic acid. The SeHisA structures with ProFAR display two different states of the long loops on the catalytic face of the structure and demonstrate that initial binding of ProFAR to the active site is independent of loop interactions. When the long loops enclose the substrate, ProFAR adopts an extended conformation where its non-reacting half is in a product-like conformation. This change is associated with shifts in a hydrogen bond network including His-47, Asp-129, Thr-171, and Ser-202, all shown to be functionally important. The closed conformation structure is highly similar to the bifunctional HisA homologue PriA in complex with PRFAR, thus proving that structure and mechanism are conserved between HisA and PriA. This study clarifies the mechanistic cycle of HisA and provides a striking example of how an enzyme and its substrate can undergo coordinated conformational changes before catalysis.	[Soderholm, Annika; Guo, Xiaohu; Selmer, Maria] Uppsala Univ, Dept Cell & Mol Biol, BMC, S-75124 Uppsala, Sweden; [Newton, Matilda S.; Patrick, Wayne M.] Univ Otago, Dept Biochem, Dunedin 9054, New Zealand; [Evans, Gary B.] Victoria Univ Wellington, Ferrier Res Inst, Lower Hutt 5046, New Zealand; [Nasvall, Joakim] Uppsala Univ, Dept Med Biochem & Microbiol, BMC, S-75123 Uppsala, Sweden	Uppsala University; University of Otago; Victoria University Wellington; Uppsala University	Patrick, WM (corresponding author), Univ Otago, Dept Biochem, POB 56, Dunedin 9054, New Zealand.	wayne.patrick@otago.ac.nz; maria.selmer@icm.uu.se	Guo, Xiaohu/N-5903-2017; Evans, Gary/B-8343-2011; Näsvall, Joakim/F-8750-2018	Evans, Gary/0000-0002-6973-2002; Näsvall, Joakim/0000-0002-6831-3105; Newton, Matilda/0000-0003-2213-3587; guo, xiaohu/0000-0001-8093-9437; Patrick, Wayne/0000-0002-2718-8053; Soderholm, Annika/0000-0003-3444-5203	Swedish Research Council; Swedish Foundation for Strategic Research; Marsden Fund; European Community [283570]; Otago Doctoral Scholarship; Rutherford Discovery Fellowship	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); European Community(European Commission); Otago Doctoral Scholarship; Rutherford Discovery Fellowship	This work was supported by grants from the Swedish Research Council and the Swedish Foundation for Strategic Research (to M.S.) and by a grant from the Marsden Fund (to W. M. P.). The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under BioStruct-X (Grant Agreement 283570). The authors declare that they have no conflicts of interest with the contents of this article.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Barona-Gomez F, 2003, EMBO REP, V4, P296, DOI 10.1038/sj.embor.embor771; BLAMEY JM, 1994, BIOCHEMISTRY-US, V33, P1000, DOI 10.1021/bi00170a019; Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096; DAVISSON VJ, 1994, J ORG CHEM, V59, P137, DOI 10.1021/jo00080a022; Due AV, 2011, P NATL ACAD SCI USA, V108, P3554, DOI 10.1073/pnas.1015996108; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; GARRICKS.L, 1970, GENETICS, V66, P231; Henn-Sax M, 2002, BIOCHEMISTRY-US, V41, P12032, DOI 10.1021/bi026092h; Hocker B, 2001, CURR OPIN BIOTECH, V12, P376, DOI 10.1016/S0958-1669(00)00230-5; Hocker B, 2001, NAT STRUCT BIOL, V8, P32; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jurgens C, 2000, P NATL ACAD SCI USA, V97, P9925, DOI 10.1073/pnas.160255397; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; KLEM TJ, 1993, BIOCHEMISTRY-US, V32, P5177, DOI 10.1021/bi00070a029; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P525, DOI 10.1016/S0076-6879(97)77029-0; Kuper J, 2005, EMBO REP, V6, P134, DOI 10.1038/sj.embor.7400330; Lang D, 2000, SCIENCE, V289, P1546, DOI 10.1126/science.289.5484.1546; Martin R. G., 1971, METHODS ENZYMOL    B, V17, P3; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6; Nasvall J, 2012, SCIENCE, V338, P384, DOI 10.1126/science.1226521; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Noda-Garcia L, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0378-1; Noda-Garcia L, 2013, MOL BIOL EVOL, V30, P2024, DOI 10.1093/molbev/mst115; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Reisinger B, 2012, PROTEIN ENG DES SEL, V25, P751, DOI 10.1093/protein/gzs080; Setiyaputra S, 2011, J MOL BIOL, V408, P291, DOI 10.1016/j.jmb.2011.02.048; Wright H, 2008, BIOCHEM BIOPH RES CO, V365, P16, DOI 10.1016/j.bbrc.2007.10.101	31	11	11	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					24657	24668		10.1074/jbc.M115.678086	http://dx.doi.org/10.1074/jbc.M115.678086			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26294764	hybrid, Green Published			2022-12-26	WOS:000362598300003
J	Kuwabara, K; Nishitsuji, K; Uchimura, K; Hung, SC; Mizuguchi, M; Nakajima, H; Mikawa, S; Kobayashi, N; Saito, H; Sakashita, N				Kuwabara, Kaori; Nishitsuji, Kazuchika; Uchimura, Kenji; Hung, Shang-Cheng; Mizuguchi, Makoto; Nakajima, Hiroyuki; Mikawa, Shiho; Kobayashi, Norihiro; Saito, Hiroyuki; Sakashita, Naomi			Cellular Interaction and Cytotoxicity of the Iowa Mutation of Apolipoprotein A-I (ApoA-I-Iowa) Amyloid Mediated by Sulfate Moieties of Heparan Sulfate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; BASEMENT-MEMBRANE; FIBRIL-FORMATION; PROTEOGLYCANS; BETA; GLYCOSAMINOGLYCANS; BINDING; PLAQUES; VARIANT; GROWTH	The single amino acid mutation G26R in human apolipoprotein A-I (apoA-I) is associated with familial amyloid polyneuropathy III. ApoA-I carrying this mutation (apoA-IIowa) forms amyloid fibrils in vitro. Heparan sulfate (HS) is a glycosaminoglycan that is abundant at the cell surface and in the extracellular matrix. Although HS and its highly sulfated domains are involved in aggregation of amyloid-beta and accumulate in cerebral amyloid plaques of patients with Alzheimer disease and mouse models of this disease, the role of HS in familial amyloid polyneuropathy III has never been addressed. Here, we used cell models to investigate the possible role of HS in the cytotoxicity of apoA-IIowa amyloid. Wild-type CHO cells, but not pgsD-677 cells, an HS-deficient CHO mutant, demonstrated uptake of apoA-IIowa amyloid after incubation with the amyloid. Addition of sulfated glycosaminoglycans to culture media prevented interaction with and cytotoxicity of apoA-IIowa amyloid to CHO cells. Elimination of cell surface HS or inhibition of HS sulfation with chemical reagents interfered with interaction of apoA-IIowa amyloid with CHO cells. We also found that cellular interaction and cytotoxicity of apoA-IIowa amyloid were significantly attenuated in CHO cells that stably expressed the human extracellular endoglucosamine 6-sulfatases HSulf-1 and HSulf-2. Our results thus suggest that cell surface HS mediates cytotoxicity of apoA-IIowa amyloid and that enzymatic remodeling of HS mitigates the cytotoxicity.	[Kuwabara, Kaori; Nishitsuji, Kazuchika; Mizuguchi, Makoto; Nakajima, Hiroyuki; Sakashita, Naomi] Univ Tokushima, Inst Biomed Sci, Dept Mol Pathol, Grad Sch, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan; [Kuwabara, Kaori; Nakajima, Hiroyuki; Mikawa, Shiho; Saito, Hiroyuki] Univ Tokushima, Inst Biomed Sci, Dept Mol Phys Pharmaceut, Grad Sch, Tokushima 7708505, Japan; [Uchimura, Kenji] Nagoya Univ, Grad Sch Med, Dept Biochem, Showa Ku, Nagoya, Aichi 4668550, Japan; [Hung, Shang-Cheng] Acad Sinica, Genom Res Ctr, Taipei 11529, Taiwan; [Kobayashi, Norihiro] Kobe Pharmaceut Univ, Dept Bioanalyt Chem, Higashinada Ku, Kobe, Hyogo 6588558, Japan	Tokushima University; Tokushima University; Nagoya University; Academia Sinica - Taiwan; Kobe Pharmaceutical University	Nishitsuji, K (corresponding author), Univ Tokushima, Inst Biomed Sci, Dept Mol Pathol, Grad Sch, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	nishitsuji@tokushima-u.ac.jp	Uchimura, Kenji/AFV-1802-2022; Uchimura, Kenji/C-9635-2014	Uchimura, Kenji/0000-0003-3009-248X; Uchimura, Kenji/0000-0003-3009-248X	Japan Society for the Promotion of Science [B-25293006, C-23590448, 26670190, B-15K19488]; Research Program for Development of Intelligent Tokushima Artificial Exosome (iTEX) from Tokushima University	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Research Program for Development of Intelligent Tokushima Artificial Exosome (iTEX) from Tokushima University	This work was supported in part by Grant-in-aid for Scientific Research B-25293006 (to H. S.), Grant C-23590448 and Grant-in-aid for Challenging Exploratory Research 26670190 (to N. S.), and Grant-in-aid for Young Scientists B-15K19488 (to K. N.) from the Japan Society for the Promotion of Science, and the Research Program for Development of Intelligent Tokushima Artificial Exosome (iTEX) from Tokushima University. The authors declare that they have no conflicts of interest with the contents of this article.	Adachi E, 2013, J BIOL CHEM, V288, P2848, DOI 10.1074/jbc.M112.428052; Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Ancsin JB, 1999, J BIOL CHEM, V274, P7172, DOI 10.1074/jbc.274.11.7172; Bernas T, 2002, CYTOMETRY, V47, P236, DOI 10.1002/cyto.10080; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Brouillette CG, 2001, BBA-MOL CELL BIOL L, V1531, P4, DOI 10.1016/S1388-1981(01)00081-6; Castillo GM, 1999, J NEUROCHEM, V72, P1681, DOI 10.1046/j.1471-4159.1999.721681.x; Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s; DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9; Dennissen MABA, 2002, J BIOL CHEM, V277, P10982, DOI 10.1074/jbc.M104852200; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; GALLAGHER JT, 1985, BIOCHEM J, V230, P665, DOI 10.1042/bj2300665; Gallagher JT, 2001, J CLIN INVEST, V108, P357, DOI 10.1172/JCI13713; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; Gomaraschi M, 2011, CLIN CHIM ACTA, V412, P1262, DOI 10.1016/j.cca.2011.03.027; Groffen AJA, 1999, NEPHROL DIAL TRANSPL, V14, P2119, DOI 10.1093/ndt/14.9.2119; Guan J, 2014, EMBO MOL MED, V6, P1493, DOI 10.15252/emmm.201404190; Horonchik L, 2005, J BIOL CHEM, V280, P17062, DOI 10.1074/jbc.M500122200; Hosono-Fukao T, 2012, AM J PATHOL, V180, P2056, DOI 10.1016/j.ajpath.2012.01.015; Hossain MM, 2010, GLYCOBIOLOGY, V20, P175, DOI 10.1093/glycob/cwp159; Valle-Delgado JJ, 2010, FASEB J, V24, P4250, DOI 10.1096/fj.09-153551; Kisilevsky R, 2007, AMYLOID, V14, P21, DOI 10.1080/13506120601116419; Kreuger J, 2003, METHOD ENZYMOL, V363, P327; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; LIDHOLT K, 1992, P NATL ACAD SCI USA, V89, P2267, DOI 10.1073/pnas.89.6.2267; McLaurin J, 1999, EUR J BIOCHEM, V266, P1101, DOI 10.1046/j.1432-1327.1999.00957.x; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Morrow JA, 1999, PROTEIN EXPRES PURIF, V16, P224, DOI 10.1006/prep.1999.1069; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Motamedi-Shad N, 2009, J BIOL CHEM, V284, P29921, DOI 10.1074/jbc.M109.018747; Nagamine S, 2012, J BIOL CHEM, V287, P9579, DOI 10.1074/jbc.M111.290262; Najjam S, 1997, CYTOKINE, V9, P1013, DOI 10.1006/cyto.1997.0246; NICHOLS WC, 1988, BIOCHEM BIOPH RES CO, V156, P762, DOI 10.1016/S0006-291X(88)80909-4; NICHOLS WC, 1990, GENOMICS, V8, P318, DOI 10.1016/0888-7543(90)90288-6; Niikura Y, 2002, J BIOCHEM, V132, P53, DOI 10.1093/oxfordjournals.jbchem.a003198; Nishitsuji K, 2011, J BIOL CHEM, V286, P6393, DOI 10.1074/jbc.M110.172106; Obici L, 2006, AMYLOID, V13, P191, DOI 10.1080/13506120600960288; Omura R, 2014, J LIPID RES, V55, P2423, DOI 10.1194/jlr.D049445; PERLMUTTER LS, 1990, BRAIN RES, V508, P13, DOI 10.1016/0006-8993(90)91111-S; Rader DJ, 2009, J LIPID RES, V50, pS189, DOI 10.1194/jlr.R800088-JLR200; Ramella NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022532; ROBINSON J, 1984, J BIOL CHEM, V259, P3818; Rops ALWMM, 2004, KIDNEY INT, V65, P768, DOI 10.1111/j.1523-1755.2004.00451.x; Rowczenio D, 2011, AM J PATHOL, V179, P1978, DOI 10.1016/j.ajpath.2011.06.024; Safaiyan F, 1999, J BIOL CHEM, V274, P36267, DOI 10.1074/jbc.274.51.36267; Saito H, 2003, J BIOL CHEM, V278, P23227, DOI 10.1074/jbc.M303365200; Sandwall E, 2010, GLYCOBIOLOGY, V20, P533, DOI 10.1093/glycob/cwp205; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; SEGREST JP, 1992, J LIPID RES, V33, P141; SNOW AD, 1989, ACTA NEUROPATHOL, V77, P337, DOI 10.1007/BF00687367; SNOW AD, 1990, AM J PATHOL, V137, P1253; SNOW AD, 1988, AM J PATHOL, V133, P456; SNOW AD, 1985, LAB INVEST, V53, P37; Sorci-Thomas MG, 2002, TRENDS CARDIOVAS MED, V12, P121, DOI 10.1016/S1050-1738(01)00163-3; Supattapone S, 2004, J MOL MED, V82, P348, DOI 10.1007/s00109-004-0534-3; Tall AR, 2008, J INTERN MED, V263, P256, DOI 10.1111/j.1365-2796.2007.01898.x; Tanaka M, 2008, BIOCHEMISTRY-US, V47, P2172, DOI 10.1021/bi702332b; Traynor CA, 2013, NEPHROLOGY, V18, P549, DOI 10.1111/nep.12108; Uchimura Kenji, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-2; VANALLEN MW, 1969, NEUROLOGY, V19, P10, DOI 10.1212/WNL.19.1.10; VIGUSHIN DM, 1994, Q J MED, V87, P149; Viviano BL, 2004, J BIOL CHEM, V279, P5604, DOI 10.1074/jbc.M310691200; Watson DJ, 1997, J BIOL CHEM, V272, P31617, DOI 10.1074/jbc.272.50.31617; YOUNG ID, 1992, ARCH PATHOL LAB MED, V116, P951; YOUNG ID, 1989, ACTA NEUROPATHOL, V78, P202, DOI 10.1007/BF00688210	67	21	22	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24210	24221		10.1074/jbc.M115.652545	http://dx.doi.org/10.1074/jbc.M115.652545			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26292220	Green Published, hybrid			2022-12-26	WOS:000362218900014
J	Chen, YZ; Sun, YR; Song, HG; Guo, ZH				Chen, Yaozong; Sun, Yueru; Song, Haigang; Guo, Zhihong			Structural Basis for the ATP-dependent Configuration of Adenylation Active Site in Bacillus subtilis o-Succinylbenzoyl-CoA Synthetase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONRIBOSOMAL PEPTIDE SYNTHETASE; FORMING ENZYME SUPERFAMILY; PROTEIN LIGASE DLTA; CRYSTAL-STRUCTURE; MENAQUINONE BIOSYNTHESIS; MUTATIONAL ANALYSIS; FIREFLY LUCIFERASE; REACTION-MECHANISM; ESCHERICHIA-COLI; IDENTIFICATION	o-Succinylbenzoyl-CoA synthetase, or MenE, is an essential adenylate-forming enzyme targeted for development of novel antibiotics in the menaquinone biosynthesis. Using its crystal structures in a ligand-free form or in complex with nucleotides, a conserved pattern is identified in the interaction between ATP and adenylating enzymes, including acyl/aryl-CoA synthetases, adenylation domains of nonribosomal peptide synthetases, and luciferases. It involves tight gripping interactions of the phosphate-binding loop (P-loop) with the ATP triphosphate moiety and an open-closed conformational change to form a compact adenylation active site. In MenE catalysis, this ATP-enzyme interaction creates a new binding site for the carboxylate substrate, allowing revelation of the determinants of substrate specificities and in-line alignment of the two substrates for backside nucleophilic substitution reaction by molecular modeling. In addition, the ATP-enzyme interaction is suggested to play a crucial catalytic role by mutation of the P-loop residues hydrogen-bonded to ATP. Moreover, the ATP-enzyme interaction has also clarified the positioning and catalytic role of a conserved lysine residue in stabilization of the transition state. These findings provide new insights into the adenylation half-reaction in the domain alteration catalytic mechanism of the adenylate-forming enzymes.	[Guo, Zhihong] Hong Kong Univ Sci & Technol, Dept Chem, Kowloon, Hong Kong, Peoples R China; Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Guo, ZH (corresponding author), Hong Kong Univ Sci & Technol, Dept Chem, Kowloon, Hong Kong, Peoples R China.	chguo@ust.hk		Guo, Zhihong/0000-0003-0374-8412; Chen, Yaozong/0000-0001-5380-2339; Sun, Yueru/0000-0002-8203-3740	Research Grants Council [GRF601413, N_HKUST621/13]; University Grants Council of Government of Hong Kong Special Administrative Region [SBI14SC05]	Research Grants Council(Hong Kong Research Grants Council); University Grants Council of Government of Hong Kong Special Administrative Region	This work was supported by Grants GRF601413 and N_HKUST621/13 from the Research Grants Council and Grant SBI14SC05 from the University Grants Council of the Government of the Hong Kong Special Administrative Region. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akerley BJ, 2002, P NATL ACAD SCI USA, V99, P966, DOI 10.1073/pnas.012602299; BERG P, 1956, J BIOL CHEM, V222, P991; Branchini BR, 2005, BIOCHEMISTRY-US, V44, P1385, DOI 10.1021/bi047903f; Branchini BR, 2000, BIOCHEMISTRY-US, V39, P5433, DOI 10.1021/bi9928804; Chang KH, 1997, BIOCHEMISTRY-US, V36, P15650, DOI 10.1021/bi971262p; Chen MJ, 2011, BIOCHEMISTRY-US, V50, P5893, DOI 10.1021/bi200376x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Drake EJ, 2006, CHEM BIOL, V13, P409, DOI 10.1016/j.chembiol.2006.02.005; Du LQ, 2008, BIOCHEMISTRY-US, V47, P11473, DOI 10.1021/bi801363b; Du Liqin, 2014, F1000Res, V3, P106, DOI 10.12688/f1000research.4097.1; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Forsyth RA, 2002, MOL MICROBIOL, V43, P1387, DOI 10.1046/j.1365-2958.2002.02832.x; GOCHT M, 1994, J BACTERIOL, V176, P2654, DOI 10.1128/JB.176.9.2654-2662.1994; Grisostomi C, 1997, BIOORG CHEM, V25, P297, DOI 10.1006/bioo.1997.1073; Gross J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-117; Gulick AM, 2004, BIOCHEMISTRY-US, V43, P8670, DOI 10.1021/bi049384m; Gulick AM, 2003, BIOCHEMISTRY-US, V42, P2866, DOI 10.1021/bi0271603; Gulick AM, 2009, ACS CHEM BIOL, V4, P811, DOI 10.1021/cb900156h; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; HAMOEN LW, 1995, MOL MICROBIOL, V15, P55, DOI 10.1111/j.1365-2958.1995.tb02220.x; Hisanaga Y, 2004, J BIOL CHEM, V279, P31717, DOI 10.1074/jbc.M400100200; Horswill AR, 2002, BIOCHEMISTRY-US, V41, P2379, DOI 10.1021/bi015647q; Jiang M, 2008, BIOCHEMISTRY-US, V47, P3426, DOI 10.1021/bi7023755; Jiang M, 2007, ORG LETT, V9, P4765, DOI 10.1021/ol702126m; Jiang M, 2007, J AM CHEM SOC, V129, P730, DOI 10.1021/ja065064+; Jiang M, 2007, BIOCHEMISTRY-US, V46, P10979, DOI 10.1021/bi700810x; Jiang M, 2010, J BIOL CHEM, V285, P30159, DOI 10.1074/jbc.M110.147702; Jiang M, 2009, BIOCHEMISTRY-US, V48, P6921, DOI 10.1021/bi900897h; Jogl G, 2004, BIOCHEMISTRY-US, V43, P1425, DOI 10.1021/bi035911a; KIM YS, 1994, BIOCHEM J, V297, P327, DOI 10.1042/bj2970327; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Kochan G, 2009, J MOL BIOL, V388, P997, DOI 10.1016/j.jmb.2009.03.064; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li H, 2007, BBA-MOL CELL BIOL L, V1771, P1246, DOI 10.1016/j.bbalip.2007.05.009; Lu XQ, 2008, BIOORG MED CHEM LETT, V18, P5963, DOI 10.1016/j.bmcl.2008.07.130; Lu XQ, 2012, CHEMBIOCHEM, V13, P129, DOI 10.1002/cbic.201100585; Marahiel MA, 1997, CHEM REV, V97, P2651, DOI 10.1021/cr960029e; May JJ, 2002, P NATL ACAD SCI USA, V99, P12120, DOI 10.1073/pnas.182156699; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MEHLER EL, 1991, PROTEIN ENG, V4, P903, DOI 10.1093/protein/4.8.903; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Nowicka B, 2010, BBA-BIOENERGETICS, V1797, P1587, DOI 10.1016/j.bbabio.2010.06.007; Osman KT, 2009, J MOL BIOL, V388, P345, DOI 10.1016/j.jmb.2009.03.040; Reger AS, 2008, BIOCHEMISTRY-US, V47, P8016, DOI 10.1021/bi800696y; Reger AS, 2007, BIOCHEMISTRY-US, V46, P6536, DOI 10.1021/bi6026506; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; SAITO M, 1995, J BIOCHEM-TOKYO, V117, P276, DOI 10.1093/jb/117.2.276; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Stuible HP, 2000, FEBS LETT, V467, P117, DOI 10.1016/S0014-5793(00)01133-9; Sun YR, 2014, J BIOL CHEM, V289, P15867, DOI 10.1074/jbc.M113.535641; Sun YR, 2012, BIOCHEMISTRY-US, V51, P4580, DOI 10.1021/bi300486j; Sundlov JA, 2012, BIOCHEMISTRY-US, V51, P6493, DOI 10.1021/bi300934s; Tian Y., 2008, THESIS U ILLINOIS CH; Tian Y, 2008, BIOCHEMISTRY-US, V47, P12434, DOI 10.1021/bi801311d; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vessey DA, 2001, BIOCHEM J, V357, P283, DOI 10.1042/0264-6021:3570283; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wu R, 2008, BIOCHEMISTRY-US, V47, P8026, DOI 10.1021/bi800698m; Yonus H, 2008, J BIOL CHEM, V283, P32484, DOI 10.1074/jbc.M800557200	68	10	11	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23971	23983		10.1074/jbc.M115.676304	http://dx.doi.org/10.1074/jbc.M115.676304			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26276389	Green Published, hybrid			2022-12-26	WOS:000361816500041
J	Lee, HY; Chen, CL; Liu, SY; Yan, YS; Chang, CJ; Chiu, CH				Lee, Hao-Yuan; Chen, Chyi-Liang; Liu, Shu-Ying; Yan, Yu-Shan; Chang, Chee-Jen; Chiu, Cheng-Hsun			Impact of Molecular Epidemiology and Reduced Susceptibility to Glycopeptides and Daptomycin on Outcomes of Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia	PLOS ONE			English	Article							MINIMUM INHIBITORY CONCENTRATION; BLOOD-STREAM INFECTIONS; RAPID IDENTIFICATION; VANCOMYCIN; MEC; THERAPY; MORTALITY; TAIWAN; RISK; ENDOCARDITIS	Background Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia was associated with high mortality, but the risk factors associated with mortality remain controversial. Methods A retrospective cohort study was designed. All patients with MRSA bacteremia admitted were screened and collected for their clinical presentations and laboratory characteristics. Minimum inhibitory concentration (MIC) and staphylococcal cassette chromosome mec (SCCmec) type of bacterial isolates were determined. Risk factors for mortality were analyzed. Results Most MRSA isolates from the 189 enrolled patients showed reduced susceptibility to antibiotics, including MIC of vancomycin >= 1.5 mg/L (79.9%), teicoplanin >= 2 mg/L (86.2%), daptomycin >= 0.38 mg/ L (73.0%) and linezolid >= 1.5 mg/ L (64.0%). MRSA with vancomycin MIC >= 1.5 mg/ L and inappropriate initial therapy were the two most important risk factors for mortality (both P < 0.05; odds ratio = 7.88 and 6.78). Hospital-associated MRSA (HAMRSA), carrying SCCmec type I, II, or III, was associated with reduced susceptibility to vancomycin, teicoplanin or daptomycin and also with higher attributable mortality (all P < 0.05). Creeping vancomycin MIC was linked to higher MIC of teicoplanin and daptomycin (both P < 0.001), but not linezolid (P = 0.759). Conclusions Giving empirical broad-spectrum antibiotics for at least 5 days to treat catheter-related infections, pneumonia, soft tissue infection and other infections was the most important risk factor for acquiring subsequent HA-MRSA infection. Choice of effective anti-MRSA agents for treating MRSA bacteremia should be based on MIC of vancomycin, teicoplanin and daptomycin. Initiation of an effective anti-MRSA agent without elevated MIC in 2 days is crucial for reducing mortality.	[Lee, Hao-Yuan; Chang, Chee-Jen; Chiu, Cheng-Hsun] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Lee, Hao-Yuan; Chen, Chyi-Liang; Chiu, Cheng-Hsun] Chang Gung Univ, Coll Med, Chang Gung Childrens Hosp, Dept Pediat, Taoyuan, Taiwan; [Lee, Hao-Yuan; Chen, Chyi-Liang; Yan, Yu-Shan; Chiu, Cheng-Hsun] Chang Gung Univ, Coll Med, Chang Gung Childrens Hosp, Mol Infect Dis Res Ctr, Taoyuan, Taiwan; [Liu, Shu-Ying; Yan, Yu-Shan] Da Yeh Univ, Dept Mol Biotechnol, Changhua, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Da Yeh University	Chiu, CH (corresponding author), Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan.	chchiu@adm.cgmh.org.tw	Chen, Chyi-Liang/GVT-1758-2022	Chen, Chyi-Liang/0000-0003-4591-0924; Chang, Chee Jen/0000-0002-7725-7555	Ministry of Science and Technology, Taiwan [97-2314-B-182A-019-MY3, 102-2314-B-182A- 023]; Chang Gung Memorial Hospital, Taiwan [CMRPG390702, CMRPG490052, CMRPG4C0031, CMRPG3E0481]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	This work was supported by grants from Ministry of Science and Technology, Executive Yuan, Taiwan (97-2314-B-182A-019-MY3 and 102-2314-B-182A- 023) and Chang Gung Memorial Hospital, Taiwan (CMRPG390702, CMRPG490052, CMRPG4C0031 and CMRPG3E0481).	Boyle-Vavra S, 2005, J CLIN MICROBIOL, V43, P4719, DOI 10.1128/JCM.43.9.4719-4730.2005; Chang HJ, 2012, J ANTIMICROB CHEMOTH, V67, P736, DOI 10.1093/jac/dkr531; Chen CJ, 2009, DIAGN MICR INFEC DIS, V65, P199, DOI 10.1016/j.diagmicrobio.2009.05.020; Chen SY, 2012, CLIN INFECT DIS, V55, P1329, DOI 10.1093/cid/cis717; Clinical and Laboratory Standards Institute, 2014, CLSI DOCUMENT M100 S; Cosgrove SE, 2005, INFECT CONT HOSP EP, V26, P166, DOI 10.1086/502522; Couderc C, 2014, CLIN INFECT DIS, V59, P206, DOI 10.1093/cid/ciu236; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Fang CT, 2006, J ANTIMICROB CHEMOTH, V57, P511, DOI 10.1093/jac/dkl006; Fowler VG, 2006, NEW ENGL J MED, V355, P653, DOI 10.1056/NEJMoa053783; Han JH, 2012, J ANTIMICROB CHEMOTH, V67, P2346, DOI 10.1093/jac/dks255; Holland TL, 2011, J INFECT DIS, V204, P329, DOI 10.1093/infdis/jir275; Holmes NE, 2013, CLIN MICROBIOL INFEC, V19, P1163, DOI 10.1111/1469-0691.12168; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Jang HC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049136; Kalil AC, 2014, JAMA-J AM MED ASSOC, V312, P1552, DOI 10.1001/jama.2014.6364; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Kullar R, 2014, CLIN INFECT DIS, V59, P1455, DOI 10.1093/cid/ciu583; Lee HY, 2014, CRIT CARE MED, V42, P1081, DOI 10.1097/CCM.0000000000000125; Lee HY, 2012, INT J ANTIMICROB AG, V40, P163, DOI 10.1016/j.ijantimicag.2012.04.018; Lodise TP, 2008, ANTIMICROB AGENTS CH, V52, P3315, DOI 10.1128/AAC.00113-08; Miller CE, 2012, CLIN INFECT DIS, V54, P591, DOI 10.1093/cid/cir858; Oliveira DC, 2002, ANTIMICROB AGENTS CH, V46, P2155, DOI 10.1128/AAC.46.7.2155-2161.2002; Paladino JA, 2014, INT J ANTIMICROB AG, V44, P557, DOI 10.1016/j.ijantimicag.2014.07.024; Paul M, 2010, J ANTIMICROB CHEMOTH, V65, P2658, DOI 10.1093/jac/dkq373; Reed SD, 2005, INFECT CONT HOSP EP, V26, P175, DOI 10.1086/502523; Tenover FC, 2007, CLIN INFECT DIS, V44, P1208, DOI 10.1086/513203; van Hal SJ, 2012, CLIN INFECT DIS, V54, P755, DOI 10.1093/cid/cir935; van Hal SJ, 2011, EUR J CLIN MICROBIOL, V30, P603, DOI 10.1007/s10096-010-1128-3; Zhang H, 2015, INT J ANTIMICROB AG, V45, P347, DOI 10.1016/j.ijantimicag.2014.12.014	30	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136171	10.1371/journal.pone.0136171	http://dx.doi.org/10.1371/journal.pone.0136171			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295150	Green Published, gold, Green Submitted			2022-12-26	WOS:000359926900079
J	Lee, HJ; Kang, SW; Byun, HS; Jeon, J; Park, KA; Kang, KD; Seo, WY; Won, MH; Seok, JH; Han, MD; Shen, HM; Hur, GM				Lee, Hyunji; Kang, Seong Wook; Byun, Hee Sun; Jeon, Juhee; Park, Kyeong Ah; Kang, Kidong; Seo, Wonhyoung; Won, Minho; Seok, Jeong Ho; Han, Man-Deuk; Shen, Han-Ming; Hur, Gang Min			Brazilin Limits Inflammatory Responses through Induction of Prosurvival Autophagy in Rheumatoid Fibroblast-Like Synoviocytes	PLOS ONE			English	Article							SYNOVIAL FIBROBLASTS; ARTHRITIS; CELLS; APOPTOSIS; IMMUNITY; DISEASE; AUTOIMMUNITY; PATHOGENESIS; SUPPRESSION; PATHWAY	Brazilin is an active compound of Caesalpinia sappan L. (Leguminosae), which possesses pro-apoptotic and anti-inflammation potentials depending on the specific cell type. However, it is largely unknown whether autophagy is implicated in the mechanism underlying its chemotherapeutic and anti-inflammatory effects in rheumatoid arthritis (RA). Here, we show that treatment of RA fibroblast-like synoviocytes (FLS) with brazilin results in enhanced level of autophagic flux, evidenced by accumulation of autophagosome and increased level of lipidated LC3 (LC3-II), which is mainly mediated by enhanced production of reactive oxygen species (ROS). Interestingly, long-term exposure of brazilin was able to restore cell survival against the cytotoxity, exclusively in RA FLS, but not in normal fibroblast. Importantly, such a restoration from brazilin-induced cytotoxity in RA FLS was completely abrogated after co-treatment with autophagy inhibitors including NH4Cl or chloroquine. Furthermore, we found that the pretreatment of RA FLS with brazilin reduced LPS- or TNF-induced NF-kappa B activation and the secretion of inflammatory cytokines in parallel with the enhanced autophagic flux. Such anti-NF-kappa B potentials of brazilin were drastically masked in RA FLS when autophagy was suppressed. These results suggest that brazilin is capable of activating autophagy exclusively in RA FLS, and such inducible autophagy promotes cell survival and limits inflammatory response.	[Lee, Hyunji; Byun, Hee Sun; Jeon, Juhee; Park, Kyeong Ah; Kang, Kidong; Seo, Wonhyoung; Won, Minho; Seok, Jeong Ho; Hur, Gang Min] Chungnam Natl Univ, Coll Med, Dept Pharmacol, Taejon, South Korea; [Kang, Seong Wook] Chungnam Natl Univ, Div Rheumatol, Dept Internal Med, Coll Med, Taejon, South Korea; [Han, Man-Deuk] Soonchunhyang Univ, Dept Biol, Asan, Chungnam, South Korea; [Shen, Han-Ming] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117595, Singapore	Chungnam National University; Chungnam National University; Soonchunhyang University; National University of Singapore	Hur, GM (corresponding author), Chungnam Natl Univ, Coll Med, Dept Pharmacol, Taejon, South Korea.	gmhur@cnu.ac.kr	JEON, Juhee/AAJ-8024-2020; SHEN, Han-Ming/B-5942-2011; Hur, Gang-min/ABF-9263-2021	SHEN, Han-Ming/0000-0001-7369-5227; Hur, Gang-min/0000-0003-4870-6574; Won, Minho/0000-0002-5873-5216; Kang, Seong Wook/0000-0002-0076-0822	National Research Foundation of Korea (NRF) - Korea government (MSIP) [2014R1A2A1A01004363, 2007-0054932]; Chungnam National University	National Research Foundation of Korea (NRF) - Korea government (MSIP); Chungnam National University	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2014R1A2A1A01004363), (No. 2007-0054932), and research fund of Chungnam National University.	An DS, 2003, HUM GENE THER, V14, P1207, DOI 10.1089/104303403322168037; Bae IK, 2005, EUR J PHARMACOL, V513, P237, DOI 10.1016/j.ejphar.2005.03.011; Bhattacharya A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00088; Brain O, 2012, INFLAMM BOWEL DIS, V18, P778, DOI 10.1002/ibd.21832; Carames B, 2012, ANN RHEUM DIS, V71, P575, DOI 10.1136/annrheumdis-2011-200557; Connor AM, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3778; Deng ZP, 2013, BIOMED CHROMATOGR, V27, P802, DOI 10.1002/bmc.2863; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Gros F, 2014, BRIT J PHARMACOL, V171, P4337, DOI 10.1111/bph.12792; Guo JY, 2013, CELL, V155, P1216, DOI 10.1016/j.cell.2013.11.019; Hoefkens E, 2013, AUTOPHAGY, V9, P2046, DOI 10.4161/auto.26337; Huang J, 2011, ANTIOXID REDOX SIGN, V14, P2215, DOI 10.1089/ars.2010.3554; Jayakumar T, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/403703; Jeon J, 2014, BIOCHEM PHARMACOL, V89, P515, DOI 10.1016/j.bcp.2014.04.004; Jung EG, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0648-x; Kenific CM, 2015, TRENDS CELL BIOL, V25, P37, DOI 10.1016/j.tcb.2014.09.001; Kim B, 2012, J AGR FOOD CHEM, V60, P9882, DOI 10.1021/jf302527p; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Lee DY, 2013, MOLECULES, V18, P2449, DOI 10.3390/molecules18022449; Lee YR, 2012, EUR J PHARMACOL, V674, P80, DOI 10.1016/j.ejphar.2011.10.016; Leech MT, 2013, CURR OPIN PHARMACOL, V13, P565, DOI 10.1016/j.coph.2013.04.001; Lefevre S, 2015, CURR PHARM DESIGN, V21, P130; Lin NY, 2013, AUTOPHAGY, V9, P1253, DOI 10.4161/auto.25467; Lin NY, 2013, ANN RHEUM DIS, V72, P761, DOI 10.1136/annrheumdis-2012-201671; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Pierdominici M, 2012, FASEB J, V26, P1400, DOI 10.1096/fj.11-194175; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Shen HM, 2012, EXP CELL RES, V318, P1304, DOI 10.1016/j.yexcr.2012.02.006; Tran Chinh N, 2005, Pathophysiology, V12, P183, DOI 10.1016/j.pathophys.2005.07.005; Turner JD, 2015, CURR OPIN RHEUMATOL, V27, P175, DOI 10.1097/BOR.0000000000000148; Wang YZ, 2011, J ETHNOPHARMACOL, V136, P271, DOI 10.1016/j.jep.2011.04.061; White E, 2010, CURR OPIN CELL BIOL, V22, P212, DOI 10.1016/j.ceb.2009.12.008; Xu K, 2013, INFLAMM RES, V62, P229, DOI 10.1007/s00011-012-0572-1; Zhang T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3062; Zhou XJ, 2012, AUTOPHAGY, V8, P1286, DOI 10.4161/auto.21212	37	22	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136122	10.1371/journal.pone.0136122	http://dx.doi.org/10.1371/journal.pone.0136122			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295477	gold, Green Published, Green Submitted			2022-12-26	WOS:000359926900072
J	Muyan, M; Gupur, G; Yasar, P; Ayaz, G; User, SD; Kazan, HH; Huang, YF				Muyan, Mesut; Gupur, Gizem; Yasar, Pelin; Ayaz, Gamze; User, Sirma Damla; Kazan, Hasan Huseyin; Huang, Yanfang			Modulation of Estrogen Response Element-Driven Gene Expressions and Cellular Proliferation with Polar Directions by Designer Transcription Regulators	PLOS ONE			English	Article							HUMAN-BREAST-CANCER; ZINC-FINGER PROTEINS; RECEPTOR-ALPHA; ER-ALPHA; ACTIVATION FUNCTIONS; REPRESSION; ESTRADIOL; BINDING; DOMAIN; CELLS	Estrogen receptor a (ER alpha), as a ligand-dependent transcription factor, mediates 17 beta-estradiol (E2) effects. ERa is a modular protein containing a DNA binding domain (DBD) and transcription activation domains (AD) located at the amino-and carboxyl-termini. The interaction of the E2-activated ERa dimer with estrogen response elements (EREs) of genes constitutes the initial step in the ERE-dependent signaling pathway necessary for alterations of cellular features. We previously constructed monomeric transcription activators, or monotransactivators, assembled from an engineered ERE-binding module (EBM) using the ER alpha-DBD and constitutively active ADs from other transcription factors. Monotransactivators modulated cell proliferation by activating and repressing ERE-driven gene expressions that simulate responses observed with E2-ER alpha. We reasoned here that integration of potent heterologous repression domains (RDs) into EBM could generate monotransrepressors that alter ERE-bearing gene expressions and cellular proliferation in directions opposite to those observed with E2-ER alpha or monotransactivators. Consistent with this, monotransrepressors suppressed reporter gene expressions that emulate the ERE-dependent signaling pathway. Moreover, a model monotransrepressor regulated DNA synthesis, cell cycle progression and proliferation of recombinant adenovirus infected ER-negative cells through decreasing as well as increasing gene expressions with polar directions compared with E2-ER alpha or monotransactivator. Our results indicate that an 'activator' or a 'repressor' possesses both transcription activating/enhancing and repressing/decreasing abilities within a chromatin context. Offering a protein engineering platform to alter signal pathway-specific gene expressions and cell growth, our approach could also be used for the development of tools for epigenetic modifications and for clinical interventions wherein multigenic de-regulations are an issue.	[Muyan, Mesut; Gupur, Gizem; Yasar, Pelin; Ayaz, Gamze; User, Sirma Damla; Kazan, Hasan Huseyin] Middle E Tech Univ, Dept Biol Sci, TR-06800 Ankara, Turkey; [Muyan, Mesut; Huang, Yanfang] Univ Rochester, Dept Biochem & Biophys, Rochester, NY 14619 USA	Middle East Technical University; University of Rochester	Muyan, M (corresponding author), Middle E Tech Univ, Dept Biol Sci, TR-06800 Ankara, Turkey.	mmuyan@metu.edu.tr	Muyan, Mesut/AAZ-4888-2020	Muyan, Mesut/0000-0003-3058-6228; Yasar, Pelin/0000-0003-3027-9842	Turkiye Bilimsel ve Teknolojik Arastirma Kurumu [TUBITAK-KBAG 212T031]; Middle East Technical University [METU-BAP-08-11-2012-125]	Turkiye Bilimsel ve Teknolojik Arastirma Kurumu(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Middle East Technical University(Middle East Technical University)	This work was supported by Turkiye Bilimsel ve Teknolojik Arastirma Kurumu, TUBITAK-KBAG 212T031, and Middle East Technical University, METU-BAP-08-11-2012-125. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUGEREAU P, 1994, MOL ENDOCRINOL, V8, P693, DOI 10.1210/me.8.6.693; Ayer DE, 1996, MOL CELL BIOL, V16, P5772; AYER DE, 1995, CELL, V80, P767, DOI 10.1016/0092-8674(95)90355-0; Bai YL, 2003, MOL ENDOCRINOL, V17, P589, DOI 10.1210/me.2002-0351; BATES SE, 1988, MOL ENDOCRINOL, V2, P543, DOI 10.1210/mend-2-6-543; Beerli RR, 2002, NAT BIOTECHNOL, V20, P135, DOI 10.1038/nbt0202-135; BERRY M, 1989, P NATL ACAD SCI USA, V86, P1218, DOI 10.1073/pnas.86.4.1218; Chen HW, 1999, CELL, V98, P675, DOI 10.1016/S0092-8674(00)80054-9; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; ElAshry D, 1996, J STEROID BIOCHEM, V59, P261, DOI 10.1016/S0960-0760(96)00118-5; Falahi F, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00022; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Frietze S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015082; Gersbach CA, 2014, ACCOUNTS CHEM RES, V47, P2309, DOI 10.1021/ar500039w; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Huang J, 2005, MOL ENDOCRINOL, V19, P2696, DOI 10.1210/me.2005-0120; Huang J, 2004, MOL CELL ENDOCRINOL, V218, P65, DOI 10.1016/j.mce.2003.12.005; Huang Jing, 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P379, DOI 10.2174/156800805774912944; Huang YF, 2011, ENDOCRINE, V39, P48, DOI 10.1007/s12020-010-9411-8; Inaoka T, 2003, J BIOL CHEM, V278, P2169, DOI 10.1074/jbc.M208722200; Juarez-Moreno K, 2013, EPIGENETICS-US, V8, P164, DOI 10.4161/epi.23503; Kasten MM, 1996, MOL CELL BIOL, V16, P4215; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Krishnamurthy M, 2011, ACS CHEM BIOL, V6, P1321, DOI 10.1021/cb200308e; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; Levenson AS, 1998, BRIT J CANCER, V78, P88, DOI 10.1038/bjc.1998.447; Li XD, 2004, MOL CELL BIOL, V24, P7681, DOI 10.1128/MCB.24.17.7681-7694.2004; Li XD, 2008, J MOL ENDOCRINOL, V40, P211, DOI 10.1677/JME-07-0156; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lupo A, 2013, CURR GENOMICS, V14, P268, DOI 10.2174/13892029113149990002; MARGOLIN JF, 1994, P NATL ACAD SCI USA, V91, P4509, DOI 10.1073/pnas.91.10.4509; Margueron R, 2003, J ENDOCRINOL, V179, P41, DOI 10.1677/joe.0.1790041; McDonnell DP, 2010, CURR OPIN PHARMACOL, V10, P620, DOI 10.1016/j.coph.2010.09.007; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; MOORE PA, 1993, MOL CELL BIOL, V13, P1666, DOI 10.1128/MCB.13.3.1666; Moosmann P, 1996, NUCLEIC ACIDS RES, V24, P4859, DOI 10.1093/nar/24.24.4859; Moosmann P, 1997, BIOL CHEM, V378, P669, DOI 10.1515/bchm.1997.378.7.669; Murakami Y, 2005, J REPROD DEVELOP, V51, P639, DOI 10.1262/jrd.17029; Mussolino C, 2012, CURR OPIN BIOTECH, V23, P644, DOI 10.1016/j.copbio.2012.01.013; Muyan M, 2001, MOL CELL ENDOCRINOL, V182, P249, DOI 10.1016/S0303-7207(01)00493-2; Norris JD, 1996, MOL ENDOCRINOL, V10, P1605, DOI 10.1210/mend.10.12.8961270; Nott SL, 2010, MOL MED, V16, P10, DOI 10.2119/molmed.2009.00107; Nott SL, 2009, J BIOL CHEM, V284, P15277, DOI 10.1074/jbc.M900365200; O'Shea JM, 2008, BIOCHEM SOC T, V36, P603, DOI 10.1042/BST0360603; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Reynolds N, 2013, DEVELOPMENT, V140, P505, DOI 10.1242/dev.083105; Sadowski I, 1988, NATURE, V335; Safe S, 2001, VITAM HORM, V62, P231, DOI 10.1016/S0083-6729(01)62006-5; Sathya G, 2002, MOL CELL ENDOCRINOL, V192, P171, DOI 10.1016/S0303-7207(01)00673-6; SCHWABE JWR, 1993, CELL, V75, P567, DOI 10.1016/0092-8674(93)90390-C; Soulez M, 2001, J MOL ENDOCRINOL, V27, P259, DOI 10.1677/jme.0.0270259; THIESEN HJ, 1991, NUCLEIC ACIDS RES, V19, P3996, DOI 10.1093/nar/19.14.3996; TRIEZENBERG SJ, 1988, GENE DEV, V2, P718, DOI 10.1101/gad.2.6.718; Yi P, 2002, MOL ENDOCRINOL, V16, P674, DOI 10.1210/me.16.4.674; Yi P, 2002, MOL ENDOCRINOL, V16, P1810, DOI 10.1210/me.2001-0323; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052	58	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136423	10.1371/journal.pone.0136423	http://dx.doi.org/10.1371/journal.pone.0136423			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295471	gold, Green Published, Green Submitted			2022-12-26	WOS:000359926900108
J	Huszthy, PC; Sakariassen, PO; Espedal, H; Brokstad, KA; Bjerkvig, R; Miletic, H				Huszthy, Peter C.; Sakariassen, Per O.; Espedal, Heidi; Brokstad, Karl A.; Bjerkvig, Rolf; Miletic, Hrvoje			Engraftment of Human Glioblastoma Cells in Immunocompetent Rats through Acquired Immunosuppression	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; GROWTH-FACTOR; EXPRESSION; MODEL; IL-6; INFILTRATION; RECRUITMENT; ACTIVATION; INHIBITOR	Transplantation of glioblastoma patient biopsy spheroids to the brain of T cell-compromised Rowett (nude) rats has been established as a representative animal model for human GBMs, with a tumor take rate close to 100%. In immunocompetent littermates however, primary human GBM tissue is invariably rejected. Here we show that after repeated passaging cycles in nude rats, human GBM spheroids are enabled to grow in the brain of immunocompetent rats. In case of engraftment, xenografts in immunocompetent rats grow progressively and host leukocytes fail to enter the tumor bed, similar to what is seen in nude animals. In contrast, rejection is associated with massive infiltration of the tumor bed by leukocytes, predominantly ED1+ microglia/macrophages, CD4+ T helper cells and CD8+ effector cells, and correlates with elevated serum levels of pro-inflammatory cytokines IL-1 beta, IL-18 and TNF-alpha. We observed that in nude rat brains, an adaptation to the host occurs after several in vivo passaging cycles, characterized by striking attenuation of microglial infiltration. Furthermore, tumor-derived chemokines that promote leukocyte migration and their entry into the CNS such as CXCL-10 and CXCL-12 are down-regulated, and the levels of TGF-beta 2 increase. We propose that through serial in vivo passaging in nude rats, human GBM cells learn to avoid and or/suppress host immunity. Such adapted GBM cells are in turn able to engraft in immunocompetent rats without signs of an inflammatory response.	[Huszthy, Peter C.; Sakariassen, Per O.; Espedal, Heidi; Bjerkvig, Rolf; Miletic, Hrvoje] Univ Bergen, Dept Biomed, KG Jebsen Brain Tumour Res Ctr, Bergen, Norway; [Huszthy, Peter C.] Univ Oslo, Natl Hosp, Dept Immunol, Ctr Immune Regulat, Oslo, Norway; [Brokstad, Karl A.] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Bjerkvig, Rolf] CRP Sante, NorLux Neurooncol Lab, Luxembourg, Luxembourg; [Miletic, Hrvoje] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway	University of Bergen; University of Oslo; National Hospital Norway; University of Bergen; Luxembourg Institute of Health; University of Bergen; Haukeland University Hospital	Huszthy, PC (corresponding author), Univ Bergen, Dept Biomed, KG Jebsen Brain Tumour Res Ctr, Bergen, Norway.	p.c.huszthy@medisin.uio.no; hrvoje.miletic@biomed.uib.no	Brokstad, Karl Albert/AAU-9639-2020; Huszthy, Peter Csaba/H-1414-2016; Brokstad, Karl Albert/N-8096-2015; Espedal, Heidi/ABE-1829-2020	Brokstad, Karl Albert/0000-0003-0593-2731; Huszthy, Peter Csaba/0000-0003-0184-8989; Brokstad, Karl Albert/0000-0003-0593-2731; Espedal, Heidi/0000-0002-0190-8999	Research Council of Norway; Norwegian Cancer Society, Helse Vest, Haukeland University Hospital; K.G. Jebsen Research Foundation; Bergen Medical Research Foundation	Research Council of Norway(Research Council of Norway); Norwegian Cancer Society, Helse Vest, Haukeland University Hospital; K.G. Jebsen Research Foundation; Bergen Medical Research Foundation	Funding was provided by the Research Council of Norway, The Norwegian Cancer Society, Helse Vest, Haukeland University Hospital, the K.G. Jebsen Research Foundation and the Bergen Medical Research Foundation.	Barker Roger A, 2004, NeuroRx, V1, P472, DOI 10.1007/BF03206631; Bedke J, 2010, MOL IMMUNOL, V47, P1047, DOI 10.1016/j.molimm.2009.11.012; BJERKVIG R, 1990, J NEUROSURG, V72, P463, DOI 10.3171/jns.1990.72.3.0463; Cascalho M, 2001, IMMUNITY, V14, P437, DOI 10.1016/S1074-7613(01)00124-8; Chang CY, 2005, J CLIN NEUROSCI, V12, P930, DOI 10.1016/j.jocn.2004.11.017; Ekdahl CT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00041; Fack F, 2015, ACTA NEUROPATHOL, V129, P115, DOI 10.1007/s00401-014-1352-5; Gabrusiewicz K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023902; GIMBRONE MA, 1989, SCIENCE, V246, P1601, DOI 10.1126/science.2688092; Gonzalez H, 2014, J NEUROIMMUNOL, V274, P1, DOI 10.1016/j.jneuroim.2014.07.012; GREENE HSN, 1953, CANCER RES, V13, P422; Hamer PCDW, 2008, ONCOGENE, V27, P2091, DOI 10.1038/sj.onc.1210850; Huszthy PC, 2005, HUM GENE THER, V16, P381, DOI 10.1089/hum.2005.16.381; Huszthy PC, 2012, NEURO-ONCOLOGY, V14, P979, DOI 10.1093/neuonc/nos135; Huszthy PC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006314; KIRSCHKE H, 1989, BIOCHEM J, V264, P467, DOI 10.1042/bj2640467; Klein RS, 2005, J VIROL, V79, P11457, DOI 10.1128/JVI.79.17.11457-11466.2005; KREMENTZ ET, 1953, CANCER, V6, P100, DOI 10.1002/1097-0142(195301)6:1<100::AID-CNCR2820060110>3.0.CO;2-H; Leveque X, 2011, CURR OPIN ORGAN TRAN, V16, P190, DOI 10.1097/MOT.0b013e32834494b5; Marshall SE, 1996, TRANSPLANTATION, V62, P1614, DOI 10.1097/00007890-199612150-00015; McCandless EE, 2008, AM J PATHOL, V172, P799, DOI 10.2353/ajpath.2008.070918; McLoughlin RM, 2005, P NATL ACAD SCI USA, V102, P9589, DOI 10.1073/pnas.0501794102; Melchior B, 2002, J NEUROSCI RES, V68, P284, DOI 10.1002/jnr.10216; Merrill JE, 1997, BRAIN BEHAV IMMUN, V11, P245, DOI 10.1006/brbi.1997.0496; Najbauer J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035150; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Rappert A, 2004, J NEUROSCI, V24, P8500, DOI 10.1523/JNEUROSCI.2451-04.2004; Revoltella RP, 2012, CYTOKINE, V57, P347, DOI 10.1016/j.cyto.2011.11.016; Roberts AB, 1998, MINER ELECTROL METAB, V24, P111, DOI 10.1159/000057358; Rolstad B, 2001, IMMUNOL REV, V184, P136, DOI 10.1034/j.1600-065x.2001.1840113.x; Sakariassen PO, 2006, P NATL ACAD SCI USA, V103, P16466, DOI 10.1073/pnas.0607668103; Souza DG, 2004, BRIT J PHARMACOL, V143, P132, DOI 10.1038/sj.bjp.0705862; STROMBLAD LG, 1982, ACTA NEUROCHIR, V65, P217, DOI 10.1007/BF01405848; Talasila KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081183; Talasila KM, 2013, ACTA NEUROPATHOL, V125, P683, DOI 10.1007/s00401-013-1101-1; Tiemessen MM, 2003, INT IMMUNOL, V15, P1495, DOI 10.1093/intimm/dxg147; UTANS U, 1995, J CLIN INVEST, V95, P2954, DOI 10.1172/JCI118003; Wang J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-465; Weissenberger J, 2004, ONCOGENE, V23, P3308, DOI 10.1038/sj.onc.1207455; Xu JG, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/187873; Yeung YT, 2013, BRIT J PHARMACOL, V168, P591, DOI 10.1111/bph.12008; Zhang LP, 2011, FASEB J, V25, P1653, DOI 10.1096/fj.10-176917	42	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136089	10.1371/journal.pone.0136089	http://dx.doi.org/10.1371/journal.pone.0136089			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291724	Green Published, gold, Green Submitted			2022-12-26	WOS:000359919900052
J	Lizarraga, F; Ceballos-Cancino, G; Espinosa, M; Vazquez-Santillan, K; Maldonado, V; Melendez-Zajgla, J				Lizarraga, Floria; Ceballos-Cancino, Gisela; Espinosa, Magali; Vazquez-Santillan, Karla; Maldonado, Vilma; Melendez-Zajgla, Jorge			Tissue Inhibitor of Metalloproteinase-4 Triggers Apoptosis in Cervical Cancer Cells	PLOS ONE			English	Article							EXPRESSION; DEATH; SMAC/DIABLO; ACTIVATION; PRO-MMP-2; RELEASE; TIMP-4; ROLES	Tissue inhibitor of metalloproteinase-4 (TIMP-4) is a member of extracellular matrix (ECM) metalloproteinases inhibitors that has pleiotropic functions. However, TIMP-4 roles in carcinogenesis are not well understood. Cell viability and flow cytometer assays were employed to evaluate cell death differences between H-Vector and H-TIMP-4 cell lines. Immunobloting and semi-quantitative RT-PCR were used to evaluate the expression of apoptosis regulators. We showed that TIMP-4 has apoptosis-sensitizing effects towards several death stimuli. Consistent with these findings, regulators of apoptosis from Inhibitors of Apoptosis Proteins (IAP), FLICE-like inhibitor proteins (FLIP) and Bcl-2 family members were modulated by TIMP-4. In addition, TIMP-4 knockdown resulted in cell survival increase after serum deprivation, as assessed by clonogenic cell analyses. This report shows that TIMP-4 regulates carcinogenesis through apoptosis activation in cervical cancer cells. Understanding TIMP-4 effects in tumorigenesis may provide clues for future therapies.	[Lizarraga, Floria; Ceballos-Cancino, Gisela; Espinosa, Magali; Vazquez-Santillan, Karla; Maldonado, Vilma; Melendez-Zajgla, Jorge] Natl Inst Genom Med, Funct Genom Lab, Basic Res Subdiv, Del Tlalpan Mexico 14610, DF, Mexico	Instituto Nacional de Medicina Genomica	Melendez-Zajgla, J (corresponding author), Natl Inst Genom Med, Funct Genom Lab, Basic Res Subdiv, Periferico Sur 4809, Del Tlalpan Mexico 14610, DF, Mexico.	jmelendez@inmegen.gob.mx	Ceballos, Gisela/AAR-2437-2021; Vazquez, Karla/ABG-7256-2020; Melendez-Zajgla, Jorge/A-5708-2008	Vazquez, Karla/0000-0003-1380-2494; 	Consejo Nacional de Ciencia y Tecnologia, conacyt.mx [1616519, 87855]	Consejo Nacional de Ciencia y Tecnologia, conacyt.mx	Consejo Nacional de Ciencia y Tecnologia, Grants 1616519, 87855, conacyt.mx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrain C, 2001, EMBO J, V20, P6627, DOI 10.1093/emboj/20.23.6627; Ahonen M, 2003, ONCOGENE, V22, P2121, DOI 10.1038/sj.onc.1206292; Bai LC, 2014, ANNU REV MED, V65, P139, DOI 10.1146/annurev-med-010713-141310; Ceballos-Cancino G, 2007, ONCOGENE, V26, P7569, DOI 10.1038/sj.onc.1210560; Celiker MY, 2001, ONCOGENE, V20, P4337, DOI 10.1038/sj.onc.1204508; Chirco R, 2006, CANCER METAST REV, V25, P99, DOI 10.1007/s10555-006-7893-x; Deryugina EI, 2001, EXP CELL RES, V263, P209, DOI 10.1006/excr.2000.5118; Espinosa M, 2012, CANCER LETT, V318, P61, DOI 10.1016/j.canlet.2011.12.002; Fulda S, 2015, SEMIN CANCER BIOL, V31, P84, DOI 10.1016/j.semcancer.2014.05.002; Groft LL, 2001, BRIT J CANCER, V85, P55, DOI 10.1054/bjoc.2001.1854; Guedez L, 1998, J CLIN INVEST, V102, P2002, DOI 10.1172/JCI2881; Guo YH, 2004, LIFE SCI, V75, P2483, DOI 10.1016/j.lfs.2004.07.007; Guzman C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092444; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hernandez-Barrantes S, 2001, BIOCHEM BIOPH RES CO, V281, P126, DOI 10.1006/bbrc.2001.4323; Jiang YF, 2002, ONCOGENE, V21, P2245, DOI 10.1038/sj.onc.1205291; Jiang YF, 2001, CANCER RES, V61, P2365; Kataoka T, 2005, CRIT REV IMMUNOL, V25, P31, DOI 10.1615/CritRevImmunol.v25.i1.30; Koyama S, 2004, DIGEST DIS SCI, V49, P1621, DOI 10.1023/B:DDAS.0000043375.35611.dd; Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263; Li XJ, 2012, CELL PHYSIOL BIOCHEM, V30, P889, DOI 10.1159/000341466; Lizarraga F, 2005, ANTICANCER RES, V25, P623; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Tong WN, 2013, AM J PHYSIOL-REG I, V304, pR613, DOI 10.1152/ajpregu.00515.2012; Tsujimoto Y, 2003, J CELL PHYSIOL, V195, P158, DOI 10.1002/jcp.10254; Tummalapalli CM, 2001, J CELL BIOCHEM, V80, P512, DOI 10.1002/1097-4644(20010315)80:4<512::AID-JCB1005>3.0.CO;2-N; Tunuguntla R, 2003, GYNECOL ONCOL, V89, P453, DOI 10.1016/S0090-8258(03)00077-5	27	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135929	10.1371/journal.pone.0135929	http://dx.doi.org/10.1371/journal.pone.0135929			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291714	Green Published, gold, Green Submitted			2022-12-26	WOS:000359919900041
J	Vaha-Ypya, H; Vasankari, T; Husu, P; Manttarl, A; Vuorimaa, T; Suni, J; Sievanen, H				Vaha-Ypya, Henri; Vasankari, Tommi; Husu, Pauliina; Manttarl, Ari; Vuorimaa, Timo; Suni, Jaana; Sievanen, Harri			Validation of Cut-Points for Evaluating the Intensity of Physical Activity with Accelerometry-Based Mean Amplitude Deviation (MAD)	PLOS ONE			English	Article							ENERGY-EXPENDITURE; WALKING; SPEED; ACCELERATION; CALIBRATION; DURATION; MODEL; WORK	Purpose Our recent study of three accelerometer brands in various ambulatory activities showed that the mean amplitude deviation (MAD) of the resultant acceleration signal performed best in separating different intensity levels and provided excellent agreement between the three devices. The objective of this study was to derive a regression model that estimates oxygen consumption (VO2) from MAD values and validate the MAD-based cut-points for light, moderate and vigorous locomotion against VO2 within a wide range of speeds. Methods 29 participants performed a pace-conducted non-stop test on a 200 m long indoor track. The initial speed was 0.6 m/s and it was increased by 0.4 m/s every 2.5 minutes until volitional exhaustion. The participants could freely decide whether they preferred to walk or run. During the test they carried a hip-mounted tri-axial accelerometer and mobile metabolic analyzer. The MAD was calculated from the raw acceleration data and compared to directly measured incident VO2. Cut-point between light and moderate activity was set to 3.0 metabolic equivalent (MET, 1 MET = 3.5 ml.kg(-1).min(-1)) and between moderate and vigorous activity to 6.0 MET as per standard use. Results The MAD and VO2 showed a very strong association. Within individuals, the range of r values was from 0.927 to 0.991 providing the mean r = 0.969. The optimal MAD cut-point for 3.0 MET was 91 mg (milligravity) and 414 mg for 6.0 MET. Conclusion The present study showed that the MAD is a valid method in terms of the VO2 within a wide range of ambulatory activities from slow walking to fast running. Being a device-independent trait, the MAD facilitates directly comparable, accurate results on the intensity of physical activity with all accelerometers providing tri-axial raw data.	[Vaha-Ypya, Henri; Vasankari, Tommi; Husu, Pauliina; Manttarl, Ari; Suni, Jaana; Sievanen, Harri] UKK Inst Hlth Promot Res, Tampere, Finland; [Vuorimaa, Timo] Haaga Helia Univ Appl Sci, Vierumaki, Finland	UKK Institute; Haaga-Helia University of Applied Sciences	Vaha-Ypya, H (corresponding author), UKK Inst Hlth Promot Res, Tampere, Finland.	henri.vaha-ypya@uta.fi	Vähä-Ypyä, Henri/AAN-1632-2021; Vähä-Ypyä, Henri/GSO-2044-2022	Husu, Pauliina/0000-0003-1502-7428	Tekes Grant [40247/12]	Tekes Grant(Finnish Funding Agency for Technology & Innovation (TEKES))	This work was supported by a Tekes Grant 40247/12 (http://www.tekes.fi/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aittasalo M, MEAN AMPLITUDE DEVIA; Bonomi AG, 2009, MED SCI SPORT EXER, V41, P1770, DOI 10.1249/MSS.0b013e3181a24536; BOUTEN CV, 1994, MED SCI SPORT EXER, V26, P1516; Cavagna GA, 2006, J EXP BIOL, V209, P4051, DOI 10.1242/jeb.02344; Crouter SE, 2008, BRIT J SPORT MED, V42, P217, DOI 10.1136/bjsm.2006.033399; CUNNINGHAM DA, 1982, J GERONTOL, V37, P560, DOI 10.1093/geronj/37.5.560; Esliger D.W., 2007, CANADIAN J PUBLIC S2, V98, P195; Fan Jerome, 2006, CJEM, V8, P19; Freedson P, 2012, MED SCI SPORT EXER, V44, pS1, DOI 10.1249/MSS.0b013e3182399b7e; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Fudge BW, 2007, MED SCI SPORT EXER, V39, P192, DOI 10.1249/01.mss.0000235884.71487.21; Gleiss AC, 2011, METHODS ECOL EVOL, V2, P23, DOI 10.1111/j.2041-210X.2010.00057.x; Halsey LG, 2008, ZOOLOGY, V111, P231, DOI 10.1016/j.zool.2007.07.011; HRELJAC A, 1993, MED SCI SPORT EXER, V25, P1158; JETTE M, 1990, CLIN CARDIOL, V13, P555, DOI 10.1002/clc.4960130809; John D, 2010, MED SCI SPORT EXER, V42, P368, DOI 10.1249/MSS.0b013e3181b3af49; Marschollek M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063522; MARTIN PE, 1992, J APPL PHYSIOL, V73, P200; McGregor SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007355; Orme M, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-34; Pasqui G, 2013, OBES REV, V14, P451, DOI [10.1111/obr.12021, DOI 10.1111/OBR.12021]; Qasem L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031187; Rowlands AV, 2007, MED SCI SPORT EXER, V39, P716, DOI 10.1249/mss.0b013e318031126c; Sentija D, 2009, INT J SPORTS MED, V30, P795, DOI 10.1055/s-0029-1237711; SHVARTZ E, 1990, AVIAT SPACE ENVIR MD, V61, P3; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; US Department of Health and Human Services, 2008, PHYS ACT GUID AM BE; Vaha-Ypya H, 2015, CLIN PHYSIOL FUNCT I, V35, P64, DOI 10.1111/cpf.12127; van Hees VT, 2014, J APPL PHYSIOL, V117, P738, DOI 10.1152/japplphysiol.00421.2014; Vanhelst J, 2009, J SPORT SCI, V27, P669, DOI 10.1080/02640410802680580; Welk GJ, 2012, MED SCI SPORT EXER, V44, pS39, DOI 10.1249/MSS.0b013e3182399d8f; WILLEMS PA, 1995, J EXP BIOL, V198, P379; Yngve A, 2003, MED SCI SPORT EXER, V35, P320, DOI 10.1249/01.MSS.0000048829.75758.A0	33	124	125	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0134813	10.1371/journal.pone.0134813	http://dx.doi.org/10.1371/journal.pone.0134813			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26292225	gold, Green Published, Green Submitted			2022-12-26	WOS:000359919900012
J	Ahlers, AA; Cotner, LA; Wolff, PJ; Mitchell, MA; Heske, EJ; Schooley, RL				Ahlers, Adam A.; Cotner, Lisa A.; Wolff, Patrick J.; Mitchell, Mark A.; Heske, Edward J.; Schooley, Robert L.			Summer Precipitation Predicts Spatial Distributions of Semiaquatic Mammals	PLOS ONE			English	Article							MINK MUSTELA-VISON; MUSKRATS ONDATRA-ZIBETHICUS; AMERICAN MINK; CLIMATE-CHANGE; HABITAT PREFERENCES; HOME RANGES; SPACE USE; OCCUPANCY; SELECTION; SURVIVAL	Climate change is predicted to increase the frequency of droughts and intensity of seasonal precipitation in many regions. Semiaquatic mammals should be vulnerable to this increased variability in precipitation, especially in human-modified landscapes where dispersal to suitable habitat or temporary refugia may be limited. Using six years of presence-absence data (2007-2012) spanning years of record-breaking drought and flood conditions, we evaluated regional occupancy dynamics of American mink (Neovison vison) and muskrats (Ondatra zibethicus) in a highly altered agroecosystem in Illinois, USA. We used noninvasive sign surveys and a multiseason occupancy modeling approach to estimate annual occupancy rates for both species and related these rates to summer precipitation. We also tracked radiomarked individuals to assess mortality risk for both species when moving in terrestrial areas. Annual model-averaged estimates of occupancy for mink and muskrat were correlated positively to summer precipitation. Mink and muskrats were widespread during a year (2008) with above-average precipitation. However, estimates of site occupancy declined substantially for mink (0.56) and especially muskrats (0.09) during the severe drought of 2012. Mink are generalist predators that probably use terrestrial habitat during droughts. However, mink had substantially greater risk of mortality away from streams. In comparison, muskrats are more restricted to aquatic habitats and likely suffered high mortality during the drought. Our patterns are striking, but a more mechanistic understanding is needed of how semiaquatic species in human-modified ecosystems will respond ecologically in situ to extreme weather events predicted by climate-change models.	[Ahlers, Adam A.; Cotner, Lisa A.; Wolff, Patrick J.; Schooley, Robert L.] Univ Illinois, Dept Nat Resources & Environm Sci, Urbana, IL 61801 USA; [Ahlers, Adam A.; Heske, Edward J.] Illinois Nat Hist Survey, Prairie Res Inst, Champaign, IL 61820 USA; [Mitchell, Mark A.] Univ Illinois, Coll Vet Med, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; Illinois Natural History Survey; University of Illinois System; University of Illinois Urbana-Champaign	Ahlers, AA (corresponding author), Kansas State Univ, Dept Hort Forestry & Recreat Resources, Manhattan, KS 66506 USA.	aahlers2@ksu.edu.edu		Ahlers, Adam/0000-0002-5699-0897	Federal Aid and Wildlife Restoration Fund [W-149-R-2]; Illinois Department of Natural Resources Furbearer Fund; Illinois Trappers Association	Federal Aid and Wildlife Restoration Fund; Illinois Department of Natural Resources Furbearer Fund; Illinois Trappers Association	Funding was provided by grants from Federal Aid and Wildlife Restoration Fund(W-149-R-2), Illinois Department of Natural Resources Furbearer Fund, and the Illinois Trappers Association.	Ahlers AA, 2010, CAN J ZOOL, V88, P1011, DOI 10.1139/Z10-069; Ahlers AA, 2011, J WILDLIFE DIS, V47, P685, DOI 10.7589/0090-3558-47.3.685; Ahlers AA, 2010, WILDLIFE BIOL, V16, P400, DOI 10.2981/10-044; Andersen DC, 2000, J MAMMAL, V81, P1087, DOI 10.1644/1545-1542(2000)081<1087:MPORSM>2.0.CO;2; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Baker DB, 2004, J AM WATER RESOUR AS, V40, P503, DOI 10.1111/j.1752-1688.2004.tb01046.x; Bellrose Frank C., 1943, JOUR MAMMAL, V24, P173, DOI 10.2307/1374798; Black A, 2009, 2008 RECORD WET STOR; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Campbell RD, 2012, GLOBAL CHANGE BIOL, V18, P2730, DOI 10.1111/j.1365-2486.2012.02739.x; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Cosentino BJ, 2011, LANDSCAPE ECOL, V26, P371, DOI 10.1007/s10980-010-9563-1; Cotner LA, 2011, J WILDLIFE MANAGE, V75, P1637, DOI 10.1002/jwmg.197; Dai AG, 2013, NAT CLIM CHANGE, V3, P52, DOI [10.1038/nclimate1633, 10.1038/NCLIMATE1633]; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Erb J, 2001, OIKOS, V93, P365, DOI 10.1034/j.1600-0706.2001.930302.x; Errington P. L., 1943, Res Bull Agric exp Stat Iowa State Coll, V320, P798; Errington PL, 1939, ECOLOGY, V20, P168, DOI 10.2307/1930738; Estay SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027766; GERELL R, 1970, OIKOS, V21, P160, DOI 10.2307/3543672; Hanski I, 2001, ECOLOGY, V82, P1505, DOI 10.1890/0012-9658(2001)082[1505:SRDAP]2.0.CO;2; Hof C, 2012, BIOL LETTERS, V8, P639, DOI 10.1098/rsbl.2012.0023; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Holmengen N, 2009, OIKOS, V118, P440, DOI 10.1111/j.1600-0706.2008.16613.x; Illinois State Water Survey, 2012, DROUGHT UPD; KINLER QJ, 1990, ESTUARIES, V13, P337, DOI 10.2307/1351925; Klamt M, 2011, GLOBAL CHANGE BIOL, V17, P3011, DOI 10.1111/j.1365-2486.2011.02472.x; Kupferberg SJ, 2012, CONSERV BIOL, V26, P513, DOI 10.1111/j.1523-1739.2012.01837.x; Lariviere Serge, 1999, Mammalian Species, V608, P1, DOI 10.2307/3504420; MacKenzie D. I., 2004, Animal Biodiversity and Conservation, V27, P461; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; Mantyka-Pringle CS, 2012, GLOBAL CHANGE BIOL, V18, P1239, DOI 10.1111/j.1365-2486.2011.02593.x; McCauley LA, 2005, ECOL APPL, V15, P1199, DOI 10.1890/04-0647; Melero Y, 2008, EUR J WILDLIFE RES, V54, P609, DOI 10.1007/s10344-008-0186-7; MESSIER F, 1990, OECOLOGIA, V84, P380, DOI 10.1007/BF00329763; Noon BR, 2012, CONSERV BIOL, V26, P432, DOI 10.1111/j.1523-1739.2012.01855.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Piha H, 2007, GLOBAL CHANGE BIOL, V13, P300, DOI 10.1111/j.1365-2486.2006.01276.x; Reynolds JC, 2004, BIOL CONSERV, V120, P533, DOI 10.1016/j.biocon.2004.03.026; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; SAS Institute Inc, 2009, SAS 9 23 SAS; Schooley RL, 2012, J WILDLIFE MANAGE, V76, P824, DOI 10.1002/jwmg.294; Schooley RL, 2009, ECOL APPL, V19, P1708, DOI 10.1890/08-2169.1; Shier CJ, 2009, J MAMMAL, V90, P897, DOI 10.1644/07-MAMM-A-410.1; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Suloway L, 1994, WETLAND RESOURCES IL; Travis JMJ, 2003, P ROY SOC B-BIOL SCI, V270, P467, DOI 10.1098/rspb.2002.2246; Trenberth KE, 2011, CLIM RES, V47, P123, DOI 10.3354/cr00953; Viljugrein H, 2001, J ANIM ECOL, V70, P671, DOI 10.1046/j.1365-2656.2001.00526.x; Virgl JA, 1997, J ZOOL, V243, P237, DOI 10.1111/j.1469-7998.1997.tb02779.x; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; Wolff PJ, 2015, WILDLIFE BIOL, V21, P9, DOI 10.2981/wlb.00031; Wuebbles D. J., 2004, Mitigation and Adaptation Strategies for Global Change, V9, P335, DOI 10.1023/B:MITI.0000038843.73424.de; Yamaguchi N, 2003, J MAMMAL, V84, P1356, DOI 10.1644/1545-1542(2003)084<1356:HPOFAM>2.0.CO;2	56	14	14	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135036	10.1371/journal.pone.0135036	http://dx.doi.org/10.1371/journal.pone.0135036			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284916	Green Submitted, Green Published, gold			2022-12-26	WOS:000359666100020
J	Kunoh, T; Wang, WX; Kobayashi, H; Matsuzaki, D; Togo, Y; Tokuyama, M; Hosoi, M; Koseki, K; Wada, S; Nagai, N; Nakamura, T; Nomura, S; Hasegawa, M; Sasaki, R; Mizukami, T				Kunoh, Tatsuki; Wang, Weixiang; Kobayashi, Hiroaki; Matsuzaki, Daisuke; Togo, Yuki; Tokuyama, Masahiro; Hosoi, Miho; Koseki, Koichi; Wada, Shu-ichi; Nagai, Nobuo; Nakamura, Toshinobu; Nomura, Shintaro; Hasegawa, Makoto; Sasaki, Ryuzo; Mizukami, Tamio			Human Dynactin-Associated Protein Transforms NIH3T3 Cells to Generate Highly Vascularized Tumors with Weak Cell-Cell Interaction	PLOS ONE			English	Article							AKT PHOSPHORYLATION; COMPLEX 2; MTOR; RICTOR; GROWTH; ACTIVATION; AKT/PKB; KINASE; RAPTOR; MICE	Human dynactin-associated protein (dynAP) is a transmembrane protein that promotes AktSer473 phosphorylation. Here, we report the oncogenic properties of dynAP. In contrast to control NIH3T3 cells expressing LacZ (NIH3T3LacZ), NIH3T3dynAP cells vigorously formed foci in two-dimensional culture, colonies on soft agar, and spheroids in anchorage-deficient three-dimensional culture. NIH3T3dynAP cells injected into nude mice produced tumors with abundant blood vessels and weak cell-cell contacts. Expression of dynAP elevated the level of rictor (an essential subunit of mTORC2) and promoted phosphorylation of FOXO3aSer253. FOXO3a is a transcriptional factor that stimulates expression of pro-apoptotic genes and phosphorylation of FOXO3a abrogates its function, resulting in promoted cell survival. Knockdown of rictor in NIH3T3dynAP cells reduced AktSer473 phosphorylation and formation of foci, colony in soft agar and spheroid, indicating that dynAP-induced activation of the mTORC2/AktSer473 pathway for cell survival contributes to cell transformation. E-cadherin and its mRNA were markedly reduced upon expression of dynAP, giving rise to cells with higher motility, which may be responsible for the weak cell-cell adhesion in tumors. Thus, dynAP could be a new oncoprotein and a target for cancer therapy.	[Kunoh, Tatsuki; Wang, Weixiang; Kobayashi, Hiroaki; Matsuzaki, Daisuke; Togo, Yuki; Tokuyama, Masahiro; Hosoi, Miho; Koseki, Koichi; Wada, Shu-ichi; Nagai, Nobuo; Nakamura, Toshinobu; Nomura, Shintaro; Hasegawa, Makoto; Sasaki, Ryuzo; Mizukami, Tamio] Nagahama Inst Biosci & Technol, Grad Sch Biosci, Nagahama, Shiga, Japan; [Sasaki, Ryuzo; Mizukami, Tamio] Frontier Pharma, Nagahama, Shiga, Japan		Mizukami, T (corresponding author), Nagahama Inst Biosci & Technol, Grad Sch Biosci, Nagahama, Shiga, Japan.	mizukami@nagahama-i-bio.ac.jp	Kunoh, Tatsuki/AAQ-7881-2021; Nakamura, Toshinobu/ABD-5906-2020; Kunoh, Tatsuki/K-7824-2019	Kunoh, Tatsuki/0000-0002-8423-2903; Nakamura, Toshinobu/0000-0003-3881-3368	JSPS KAKENHI [24300343]; Daiichi Sankyo, Inc.; Grants-in-Aid for Scientific Research [25112006, 26640063] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Daiichi Sankyo, Inc.(Daiichi Sankyo Company Limited); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI (Grant Number 24300343 to TM). This work was also supported by Daiichi Sankyo, Inc. (to RS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Bayascas JR, 2005, MOL CELL, V18, P143, DOI 10.1016/j.molcel.2005.03.020; Bozulic L, 2009, CURR OPIN CELL BIOL, V21, P256, DOI 10.1016/j.ceb.2009.02.002; BRADLEY MO, 1986, P NATL ACAD SCI USA, V83, P5277, DOI 10.1073/pnas.83.14.5277; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cornu M, 2013, CURR OPIN GENET DEV, V23, P53, DOI 10.1016/j.gde.2012.12.005; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; GREIG RG, 1985, P NATL ACAD SCI USA, V82, P3698, DOI 10.1073/pnas.82.11.3698; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017; Gupta S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081081; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hemmings BA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011189; Hietakangas V, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-282; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kunoh T, 2010, MOL CANCER THER, V9, P2934, DOI 10.1158/1535-7163.MCT-10-0730; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li WQ, 2004, J BIOL CHEM, V279, P37398, DOI 10.1074/jbc.M405730200; Liao Y, 2010, AM J TRANSL RES, V2, P19; Masri J, 2007, CANCER RES, V67, P11712, DOI 10.1158/0008-5472.CAN-07-2223; Oh WJ, 2010, EMBO J, V29, P3939, DOI 10.1038/emboj.2010.271; Oneyama C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080300; Paoli P, 2013, BBA-MOL CELL RES, V1833, P3481, DOI 10.1016/j.bbamcr.2013.06.026; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sekigawa M, 2010, J BIOMOL SCREEN, V15, P368, DOI 10.1177/1087057110363822; THORGEIRSSON UP, 1985, MOL CELL BIOL, V5, P259, DOI 10.1128/MCB.5.1.259; Uesugi A, 2011, CANCER RES, V71, P5765, DOI 10.1158/0008-5472.CAN-11-0368; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Zhang XB, 2011, BBA-MOL CELL RES, V1813, P1978, DOI 10.1016/j.bbamcr.2011.03.010; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014	34	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135836	10.1371/journal.pone.0135836	http://dx.doi.org/10.1371/journal.pone.0135836			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284361	Green Submitted, gold, Green Published			2022-12-26	WOS:000359666100072
J	Miura, H; Inoko, H; Tanaka, M; Nakaoka, H; Kimura, M; Gurumurthy, CB; Sato, M; Ohtsuka, M				Miura, Hiromi; Inoko, Hidetoshi; Tanaka, Masafumi; Nakaoka, Hirofumi; Kimura, Minoru; Gurumurthy, Channabasavaiah B.; Sato, Masahiro; Ohtsuka, Masato			Assessment of Artificial MiRNA Architectures for Higher Knockdown Efficiencies without the Undesired Effects in Mice	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; SHORT HAIRPIN RNAS; TARGETED TRANSGENESIS; PRONUCLEAR INJECTION; GENE-EXPRESSION; INTERFERENCE; PIGGYBAC; VECTORS; OVEREXPRESSION; GENERATION	RNAi-based strategies have been used for hypomorphic analyses. However, there are technical challenges to achieve robust, reproducible knockdown effect. Here we examined the artificial microRNA (amiRNA) architectures that could provide higher knockdown efficiencies. Using transient and stable transfection assays in cells, we found that simple amiRNA-expression cassettes, that did not contain a marker gene (-MG), displayed higher amiRNA expression and more efficient knockdown than those that contained a marker gene (+MG). Further, we tested this phenomenon in vivo, by analyzing amiRNA-expressing mice that were produced by the pronuclear injection-based targeted transgenesis (PITT) method. While we observed significant silencing of the target gene (eGFP) in + MG hemizygous mice, obtaining -MG amiRNA expression mice, even hemizygotes, was difficult and the animals died perinatally. We obtained only mosaic mice having both "-MG amiRNA" cells and "amiRNA low-expression" cells but they exhibited growth retardation and cataracts, and they could not transmit the -MG amiRNA allele to the next generation. Furthermore, +MG amiRNA homozygotes could not be obtained. These results suggested that excessive amiRNAs transcribed by -MG expression cassettes cause deleterious effects in mice, and the amiRNA expression level in hemizygous +MG amiRNA mice is near the upper limit, where mice can develop normally. In conclusion, the PITT-(+MG amiRNA) system demonstrated here can generate knockdown mouse models that reliably express highest and tolerable levels of amiRNAs.	[Miura, Hiromi; Inoko, Hidetoshi; Tanaka, Masafumi; Kimura, Minoru; Ohtsuka, Masato] Tokai Univ, Dept Mol Life Sci, Div Basic Med Sci & Mol Med, Sch Med, Isehara, Kanagawa 2591193, Japan; [Nakaoka, Hirofumi] Natl Inst Genet, Dept Integrated Genet, Div Human Genet, Mishima, Shizuoka 4118540, Japan; [Gurumurthy, Channabasavaiah B.] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Mouse Genome Engn Core Facil, Omaha, NE 68198 USA; [Sato, Masahiro] Kagoshima Univ, Frontier Sci Res Ctr, Sect Gene Express Regulat, Kagoshima, Kagoshima 8900065, Japan; [Ohtsuka, Masato] Tokai Univ, Inst Med Sci, Isehara, Kanagawa 2591193, Japan	Tokai University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; University of Nebraska System; University of Nebraska Medical Center; Kagoshima University; Tokai University	Ohtsuka, M (corresponding author), Tokai Univ, Dept Mol Life Sci, Div Basic Med Sci & Mol Med, Sch Med, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.	masato@is.icc.u-tokai.ac.jp	Gurumurthy, Channabasavaiah B/H-8268-2016; Gurumurthy, Channabasavaiah B/E-7205-2011	Gurumurthy, Channabasavaiah B/0000-0002-8022-4033; Sato, Masahiro/0000-0003-1334-2950; Nakaoka, Hirofumi/0000-0002-8454-1159; Ohtsuka, Masato/0000-0002-6952-4238	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [23700514, 25290035]; Tokai University School of Medicine; MEXT; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110768] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Tokai University School of Medicine; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grant-in-Aid for Young Scientists (B) (23700514) and Grant-in-Aid for Scientific Research (25290035) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and by 2011-2012 Tokai University School of Medicine, Project Research to M.O., and by MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2009-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastassiadis K, 2009, DIS MODEL MECH, V2, P508, DOI 10.1242/dmm.003087; Berger AH, 2011, NATURE, V476, P163, DOI 10.1038/nature10275; Borner K, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt836; Cadinanos J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm446; Du GW, 2006, FEBS J, V273, P5421, DOI 10.1111/j.1742-4658.2006.05534.x; Ely A, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp446; Fellmann C, 2013, CELL REP, V5, P1704, DOI 10.1016/j.celrep.2013.11.020; Gao X, 2007, PHYSIOLOGY, V22, P161, DOI 10.1152/physiol.00002.2007; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Grimm Dirk, 2011, Silence, V2, P8, DOI 10.1186/1758-907X-2-8; Grimm D, 2010, J CLIN INVEST, V120, P3106, DOI 10.1172/JCI43565; Hasuwa H, 2002, FEBS LETT, V532, P227, DOI 10.1016/S0014-5793(02)03680-3; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Hu T, 2010, MOL BIOTECHNOL, V46, P34, DOI 10.1007/s12033-010-9264-7; Kanki H, 2006, EXP ANIM TOKYO, V55, P137, DOI 10.1538/expanim.55.137; Khan AA, 2009, NAT BIOTECHNOL, V27, P549, DOI 10.1038/nbt.1543; Klein D, 2000, GENE THER, V7, P458, DOI 10.1038/sj.gt.3301112; McBride JL, 2008, P NATL ACAD SCI USA, V105, P5868, DOI 10.1073/pnas.0801775105; Mittal V, 2004, NAT REV GENET, V5, P355, DOI 10.1038/nrg1323; Miura H, 2013, ANAL BIOCHEM, V437, P29, DOI 10.1016/j.ab.2013.02.003; Nakagata N, 2011, METHODS MOL BIOL, V693, P57, DOI 10.1007/978-1-60761-974-1_4; Ohtsuka M, 2006, GENES GENET SYST, V81, P143, DOI 10.1266/ggs.81.143; Ohtsuka M, 2012, EXP ANIM TOKYO, V61, P489, DOI 10.1538/expanim.61.489; Ohtsuka M, 2012, TRANSGENIC RES, V21, P225, DOI 10.1007/s11248-011-9505-y; Ohtsuka M, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq860; Podolska K, 2011, BRIEF FUNCT GENOMICS, V10, P238, DOI 10.1093/bfgp/elr013; Premsrirut PK, 2011, CELL, V145, P145, DOI 10.1016/j.cell.2011.03.012; Qiu LH, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-77; Sato M, 2004, MOL REPROD DEV, V69, P268, DOI 10.1002/mrd.20124; Shan ZX, 2009, MOL CELL BIOCHEM, V323, P81, DOI 10.1007/s11010-008-9966-3; Sun DQ, 2006, BIOTECHNIQUES, V41, P59, DOI 10.2144/000112203; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Wong MD, 2014, DEVELOPMENT, V141, P2533, DOI 10.1242/dev.107722; Yi R, 2005, RNA, V11, P220, DOI 10.1261/rna.7233305; Yu J, 2006, GENESIS, V44, P252, DOI 10.1002/dvg.20213; Zhou HX, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni061	36	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135919	10.1371/journal.pone.0135919	http://dx.doi.org/10.1371/journal.pone.0135919			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285215	Green Submitted, Green Published, gold			2022-12-26	WOS:000359666100087
J	Zeng, CX; Wu, JS; Zhang, XZ				Zeng, Chaoxu; Wu, Jianshuang; Zhang, Xianzhou			Effects of Grazing on Above- vs. Below-Ground Biomass Allocation of Alpine Grasslands on the Northern Tibetan Plateau	PLOS ONE			English	Article							NET PRIMARY PRODUCTIVITY; PRECIPITATION GRADIENT; ENVIRONMENTAL-FACTORS; ABOVEGROUND BIOMASS; USE EFFICIENCY; CLIMATE-CHANGE; DIVERSITY; EXCLUSION; ROOT; SCALE	Biomass allocation is an essential concept for understanding above-vs. below-ground functions and for predicting the dynamics of community structure and ecosystem service under ongoing climate change. There is rare available knowledge of grazing effects on biomass allocation in multiple zonal alpine grassland types along climatic gradients across the Northern Tibetan Plateau. We collected the peak above-and below-ground biomass (AGB and BGB) values at 106 pairs of well-matched grazed vs. fenced sites during summers of 2010-2013, of which 33 pairs were subject to meadow, 52 to steppe and 21 to desert-steppe. The aboveground net primary productivity (ANPP) was represented by the peak AGB while the belowground net primary productivity (BNPP) was estimated from ANPP, the ratio of living vs. dead BGB, and the root turnover rate. Two-ways analyses of variance (ANOVA) and paired samples comparisons with t-test were applied to examine the effects of pasture managements (PMS, i.e., grazed vs. fenced) and zonal grassland types on both ANPP and BNPP. Allometric and isometric allocation hypotheses were also tested between logarithmically transformed ANPP and BNPP using standardized major axis (SMA) analyses across grazed, fenced and overall sites. In our study, a high community-dependency was observed to support the allometric biomass allocation hypothesis, in association with decreased ANPP and a decreasing-to-increasing BNPP proportions with increasing aridity across the Northern Tibetan Plateau. Grazing vs. fencing seemed to have a trivial effect on ANPP compared to the overwhelming influence of different zonal grassland types. Vegetation links above-and below-ground ecological functions through integrated meta-population adaptive strategies to the increasing severity of habitat conditions. Therefore, more detailed studies on functional diversity are essentially to achieve conservation and sustainability goals under ongoing climatic warming and intensifying human influences.	[Zeng, Chaoxu; Wu, Jianshuang; Zhang, Xianzhou] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modelling, Lhasa Plateau Ecosyst Res Stn, Beijing, Peoples R China; [Zeng, Chaoxu] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wu, Jianshuang] Free Univ Berlin, Dahlem Ctr Plant Sci, Funct Biodivers, Berlin, Germany	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Free University of Berlin	Wu, JS (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modelling, Lhasa Plateau Ecosyst Res Stn, Beijing, Peoples R China.	wujs.07s@igsnrr.ac.cn	zhang, xian/GYA-0290-2022; WU, Jianshuang/N-4694-2015	WU, Jianshuang/0000-0002-6768-8255	Strategic Priority Research Program from the Chinese Academy of Sciences (CAS) [XDB03030401]; CAS Action-Plan for West Development [KZCXZ-XB3-08]; National Natural Sciences Foundation of China [41171044, 41401070]; China Scholarship Council [201400260118]; Office of China Postdoctoral Council [20140041]	Strategic Priority Research Program from the Chinese Academy of Sciences (CAS); CAS Action-Plan for West Development; National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council); Office of China Postdoctoral Council	Xianzhou Zhang received the Strategic Priority Research Program from the Chinese Academy of Sciences (CAS, No. XDB03030401), the CAS Action-Plan for West Development (No. KZCXZ-XB3-08), and National Natural Sciences Foundation of China (No. 41171044). Jianshuang Wu received a scholarship from the China Scholarship Council (No. 201400260118), an international postdoctoral exchange fellowship program from the Office of China Postdoctoral Council (No. 20140041), and a research grant from the National Natural Sciences Foundation of China (No. 41401070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, WHOLE PLANT PERSPECT; BAZZAZ FA, 1987, BIOSCIENCE, V37, P58, DOI 10.2307/1310178; Bessler H, 2009, ECOLOGY, V90, P1520, DOI 10.1890/08-0867.1; Chen BX, 2014, AGR FOREST METEOROL, V189, P11, DOI 10.1016/j.agrformet.2014.01.002; Chen ZQ, 2012, SCI CHINA EARTH SCI, V55, P1306, DOI 10.1007/s11430-012-4389-0; Craine JM, 2001, OIKOS, V93, P274, DOI 10.1034/j.1600-0706.2001.930210.x; Evans TL, 2013, ECOHYDROLOGY, V6, P713, DOI 10.1002/eco.1292; Falster DS, 2006, MATR STANDARDIZED MA; Fan JW, 2009, J ARID ENVIRON, V73, P521, DOI 10.1016/j.jaridenv.2008.12.004; Fan JW, 2010, ENVIRON MONIT ASSESS, V170, P571, DOI 10.1007/s10661-009-1258-1; Gao YZ, 2008, PLANT SOIL, V307, P41, DOI 10.1007/s11104-008-9579-3; Gill RA, 2002, PLANT ECOL, V159, P241, DOI 10.1023/A:1015529507670; Gill RA, 2002, GLOBAL ECOL BIOGEOGR, V11, P79, DOI 10.1046/j.1466-822X.2001.00267.x; Harris RB, 2010, J ARID ENVIRON, V74, P1, DOI 10.1016/j.jaridenv.2009.06.014; Hu ZM, 2010, GLOBAL ECOL BIOGEOGR, V19, P842, DOI 10.1111/j.1466-8238.2010.00564.x; Hui DF, 2006, NEW PHYTOL, V169, P85, DOI 10.1111/j.1469-8137.2005.01569.x; Kang MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069561; KORNER C, 1987, OECOLOGIA, V74, P411, DOI 10.1007/BF00378938; Leifeld J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119184; Li XL, 2013, LAND DEGRAD DEV, V24, P72, DOI 10.1002/ldr.1108; Li XJ, 2011, ENVIRON EARTH SCI, V64, P1911, DOI 10.1007/s12665-011-1004-1; Luo WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071749; Ma WH, 2008, SCI CHINA SER C, V51, P263, DOI 10.1007/s11427-008-0029-5; Ma WH, 2010, SCI CHINA LIFE SCI, V53, P841, DOI 10.1007/s11427-010-4020-6; Ma WH, 2010, GLOBAL ECOL BIOGEOGR, V19, P233, DOI 10.1111/j.1466-8238.2009.00508.x; McNaughton SJ, 1998, ECOLOGY, V79, P587, DOI 10.1890/0012-9658(1998)079[0587:RBAPIA]2.0.CO;2; Medina-Roldan E, 2012, OECOLOGIA, V170, P159, DOI 10.1007/s00442-012-2287-y; Mokany K, 2006, GLOBAL CHANGE BIOL, V12, P84, DOI 10.1111/j.1365-2486.2005.001043.x; Muller Ivo, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P115, DOI 10.1078/1433-8319-00007; Niklas KJ, 2002, AM NAT, V159, P482, DOI 10.1086/339459; PANDEY CB, 1992, ECOLOGY, V73, P2007, DOI 10.2307/1941451; Patty L, 2010, FLORA, V205, P695, DOI 10.1016/j.flora.2009.12.039; Poorter H, 2000, AUST J PLANT PHYSIOL, V27, P595, DOI 10.1071/PP99173; Poorter H, 2012, NEW PHYTOL, V193, P30, DOI 10.1111/j.1469-8137.2011.03952.x; Pucheta E, 2004, AUSTRAL ECOL, V29, P201, DOI 10.1111/j.1442-9993.2004.01337.x; Qiu J, 2008, NATURE, V454, P393, DOI 10.1038/454393a; R Core Team, 2014, R A LANGUAGE AND ENV; Scurlock JMO, 2002, GLOBAL CHANGE BIOL, V8, P736, DOI 10.1046/j.1365-2486.2002.00512.x; Semmartin M, 2008, PLANT SOIL, V303, P177, DOI 10.1007/s11104-007-9497-9; Shi Y, 2014, BIOGEOSCIENCES, V11, P2003, DOI 10.5194/bg-11-2003-2014; Sun H. L., 2012, ACTA GEOGRAPHICA SIN, V67, P4; Sun J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108821; SUNDRIYAL R C, 1990, Tropical Ecology, V31, P84; VANDERMAAREL E, 1989, OIKOS, V56, P364, DOI 10.2307/3565622; Veen GF, 2014, OIKOS, V123, P800, DOI 10.1111/j.1600-0706.2013.01077.x; Veen GF, 2012, OECOLOGIA, V168, P511, DOI 10.1007/s00442-011-2093-y; Wang LA, 2010, SCI CHINA LIFE SCI, V53, P851, DOI 10.1007/s11427-010-4027-z; Wang LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093566; Wang Z, 2013, J VEG SCI, V24, P189, DOI 10.1111/j.1654-1103.2012.01442.x; Wu JS, 2013, J MT SCI-ENGL, V10, P1097, DOI 10.1007/s11629-013-2435-9; Wu JB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082763, 10.1371/journal.pone.0081986, 10.1371/journal.pone.0081982]; Wu JS, 2014, CHINESE SCI BULL, V59, P4332, DOI 10.1007/s11434-014-0362-y; Wu JS, 2014, ARCT ANTARCT ALP RES, V46, P419, DOI 10.1657/1938-4246-46.2.419; Wu JS, 2014, ALPINE BOT, V124, P13, DOI 10.1007/s00035-014-0125-z; Wu JS, 2013, RANGELAND ECOL MANAG, V66, P454, DOI 10.2111/REM-D-12-00051.1; Wu JianShuang, 2012, Journal of Resources and Ecology, V3, P236; Wu YB, 2011, PLANT SOIL, V338, P497, DOI 10.1007/s11104-010-0562-4; Yang YH, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043920; Yang YH, 2010, GLOBAL ECOL BIOGEOGR, V19, P268, DOI 10.1111/j.1466-8238.2009.00502.x; Yang YH, 2009, J VEG SCI, V20, P177, DOI 10.1111/j.1654-1103.2009.05566.x; Yao TD, 2012, ENVIRON DEV, V3, P52, DOI 10.1016/j.envdev.2012.04.002; Yu CQ, 2012, ENVIRON SCI TECHNOL, V46, P1979, DOI 10.1021/es2047188; [钟祥浩 Zhong Xianghao], 2010, [山地学报, Journal of Mountain Science], V28, P1; [钟祥浩 Zhong Xianhao], 2006, [山地学报, Journal of Mountain Science], V24, P129; Zhou X. M, 2001, CHINESE KOBRESIA MEA	65	59	64	17	195	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135173	10.1371/journal.pone.0135173	http://dx.doi.org/10.1371/journal.pone.0135173			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284515	gold, Green Submitted, Green Published			2022-12-26	WOS:000359666100025
J	Maghami, M; Hizam, H; Gomes, C; Hajighorbani, S; Rezaei, N				Maghami, Mohammadreza; Hizam, Hashim; Gomes, Chandima; Hajighorbani, Shahrooz; Rezaei, Nima			Evaluation of the 2013 Southeast Asian Haze on Solar Generation Performance	PLOS ONE			English	Article							AIR-POLLUTION; PHOTOVOLTAIC SYSTEMS; DUST DEPOSITION; IMPACTS; FIELD	Pollution in Southeast Asia is a major public energy problem and the cause of energy losses. A significant problem with respect to this type of pollution is that it decreases energy yield. In this study, two types of photovoltaic (PV) solar arrays were used to evaluate the effect of air pollution. The performance of two types of solar arrays were analysed in this research, namely, two units of a 1 kWp tracking flat photovoltaic (TFP) and two units of a 1 kWp fixed flat photovoltaic arrays (FFP). Data analysis was conducted on 2,190 samples at 30 min intervals from 01st June 2013, when both arrays were washed, until 30th June 2013. The performance was evaluated by using environmental data (irradiation, temperature, dust thickness, and air pollution index), power output, and energy yield. Multiple regression models were predicted in view of the environmental data and PV array output. Results showed that the fixed flat system was more affected by air pollution than the tracking flat plate. The contribution of this work is that it considers two types of photovoltaic arrays under the Southeast Asian pollution 2013.	[Maghami, Mohammadreza; Hizam, Hashim; Gomes, Chandima; Hajighorbani, Shahrooz; Rezaei, Nima] Univ Putra Malaysia, Dept Elect & Elect Engn, Serdang 43400, Selangor, Malaysia; [Maghami, Mohammadreza; Hizam, Hashim; Hajighorbani, Shahrooz; Rezaei, Nima] Univ Putra Malaysia, Ctr Adv Power & Energy Res CAPER, Serdang 43400, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia	Maghami, M (corresponding author), Univ Putra Malaysia, Dept Elect & Elect Engn, Serdang 43400, Selangor, Malaysia.	mr.maghami@gmail.com	Gomes, Chandima/S-1662-2019; Rezaei, Nima/B-4245-2008; hizam, hashim/AAF-5759-2020; Gomes, Chandima/G-4899-2010; MAGHAMI, MOHAMMADREZA/I-1304-2013	Gomes, Chandima/0000-0001-5018-8054; Rezaei, Nima/0000-0002-3836-1827; Gomes, Chandima/0000-0001-5018-8054; MAGHAMI, MOHAMMADREZA/0000-0003-1840-4823	Universiti Putra Malaysia	Universiti Putra Malaysia	This study was funded by Universiti Putra Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afroz R, 2003, ENVIRON RES, V92, P71, DOI 10.1016/S0013-9351(02)00059-2; Ahmad A., 2000, MALAYSIAN J REMOTE S, V1, P77; Asl-Soleimani E, 2001, RENEW ENERG, V24, P459, DOI 10.1016/S0960-1481(01)00029-5; Chung CE, 2003, J CLIMATE, V16, P1791, DOI 10.1175/1520-0442(2003)016<1791:SAHFRI>2.0.CO;2; El-Nashar AM, 2009, DESALINATION, V239, P66, DOI 10.1016/j.desal.2008.03.007; GOOSSENS D, 1993, SOL ENERGY, V50, P75, DOI 10.1016/0038-092X(93)90009-D; Hajiah A, 2012, INT J PHOTOENERGY, V2012, DOI 10.1155/2012/178175; Hajighorbani S, 2014, INT J PHOTOENERGY, V2014, DOI 10.1155/2014/719126; Hinds W.C., AEROSOL TECHNOLOGY P, Vsecond; Hottel H. C., 1942, T ASME, P64, DOI [10.1109/JPHOTOV.2015.2495208, DOI 10.1109/JPHOTOV.2015.2495208]; Kymakis E, 2009, ENERG CONVERS MANAGE, V50, P433, DOI 10.1016/j.enconman.2008.12.009; Maghami M, 2014, POW EN PECON 2014 IE; Maghami M, LIFE SCI J, V11; Mani M, 2010, RENEW SUST ENERG REV, V14, P3124, DOI 10.1016/j.rser.2010.07.065; Meral ME, 2011, RENEW SUST ENERG REV, V15, P2176, DOI 10.1016/j.rser.2011.01.010; Murdiyarso D., 2007, Mitigation and Adaptation Strategies for Global Change, V12, P3, DOI 10.1007/s11027-006-9055-4; Ngan M.S., 2011, APPL POW EL C IAPEC; Nie N. H., 1975, SPSS STAT PACKAGE SO, V227; PETERSON JT, 1977, SOL ENERGY, V19, P23, DOI 10.1016/0038-092X(77)90085-8; Pollutant N, 1998, CLEAN AIR, V32, P11; Razykov T, SOLAR ENERGY, V85, P1580; SHAW GE, 1993, METEOROL ATMOS PHYS, V51, P227, DOI 10.1007/BF01030496; Sheraz M, 2012, IEEE INT C POW EN; Tsoutsos T, 2005, ENERG POLICY, V33, P289, DOI 10.1016/S0301-4215(03)00241-6; Ya'acob ME, 2014, ENERG CONVERS MANAGE, V78, P8, DOI 10.1016/j.enconman.2013.10.064; You RY, 2012, AEROSOL SCI TECH, V46, P1090, DOI 10.1080/02786826.2012.695096; Youngsin C, 2004, METEOROL ATMOS PHYS, V87, P143, DOI 10.1007/s00703-003-0067-2; Zhao B, AEROSOL SCI TECHNOLO, V47, P1363	28	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135118	10.1371/journal.pone.0135118	http://dx.doi.org/10.1371/journal.pone.0135118			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275303	Green Published, gold, Green Submitted			2022-12-26	WOS:000359493600051
J	Meng, Z; Jia, LF; Gan, YH				Meng, Z.; Jia, L-F; Gan, Y-H			PTEN activation through K163 acetylation by inhibiting HDAC6 contributes to tumour inhibition	ONCOGENE			English	Article							HISTONE DEACETYLASE INHIBITORS; TRICHOSTATIN-A; MEMBRANE ASSOCIATION; PHOSPHATASE-ACTIVITY; SUPPRESSOR PTEN; PROSTATE-CANCER; PLASMA-MEMBRANE; CELL-MIGRATION; BINDING MOTIF; BREAST-CANCER	Phosphatase and tensin homologue deleted on chromosome 10 (PTEN), an important tumour-suppressor gene, is mutated, downregulated or dysfunctional in many tumours. The phosphatase activity of PTEN depends on membrane translocation (activation). As promising anti-cancer agents, histone deacetylase (HDAC) inhibitors, particularly trichostatin A (TSA), can promote PTEN membrane translocation, but the underlying mechanism remains unknown. In this study, we revealed that non-selective HDAC inhibitors, namely, TSA or suberoylanilide hydroxamic acid (SAHA), induced PTEN membrane translocation through PTEN acetylation at K163 by inhibiting HDAC6. K163 acetylation inhibited the interaction of the PTEN C-tail with the remaining part of PTEN, resulting in PTEN membrane translocation. Overexpression of wild-type PTEN, but not K163-mutated PTEN, facilitated the inhibition of cell proliferation, migration and invasion, as well as xenograft tumour growth, induced by SAHA or tubastatin A, an HDAC6-specific inhibitor. These results indicated that PTEN activation by inhibiting HDAC6 significantly contributed to tumour inhibition. Therefore, non-selective HDAC or HDAC6-specific inhibitors may be more clinically suitable to treat tumours without PTEN mutations or deletions.	[Meng, Z.; Jia, L-F; Gan, Y-H] Peking Univ, Cent Lab, Sch & Hosp Stomatol, 22 Zhongguancun Ave South, Beijing 100081, Peoples R China; [Meng, Z.; Gan, Y-H] Peking Univ, Dept Oral & Maxillofacial Surg, Sch & Hosp Stomatol, Beijing 100081, Peoples R China	Peking University; Peking University	Gan, YH (corresponding author), Peking Univ, Cent Lab, Sch & Hosp Stomatol, 22 Zhongguancun Ave South, Beijing 100081, Peoples R China.	kqyehuagan@bjmu.edu.cn			National Natural Science Foundation of China [81472764, 81271173]; China International Science and Technology Cooperation [2013DFB30360]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China International Science and Technology Cooperation	This work was supported by the National Natural Science Foundation of China (Grant No. 81472764 and 81271173) and China International Science and Technology Cooperation (Grant No. 2013DFB30360).	Altonsy MO, 2012, NUTR CANCER, V64, P1251, DOI 10.1080/01635581.2012.721156; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Butler LM, 2000, CANCER RES, V60, P5165; Chen CS, 2005, J BIOL CHEM, V280, P38879, DOI 10.1074/jbc.M505733200; Dallavalle S, 2012, BIOCHEM PHARMACOL, V84, P756, DOI 10.1016/j.bcp.2012.06.014; Das S, 2003, P NATL ACAD SCI USA, V100, P7491, DOI 10.1073/pnas.0932835100; Dekker FJ, 2009, DRUG DISCOV TODAY, V14, P942, DOI 10.1016/j.drudis.2009.06.008; Denning G, 2007, ONCOGENE, V26, P3930, DOI 10.1038/sj.onc.1210175; Donadelli M, 2003, MOL CARCINOGEN, V38, P59, DOI 10.1002/mc.10145; Duan H, 2005, MOL CELL BIOL, V25, P1608, DOI 10.1128/MCB.25.5.1608-1619.2005; Duvic M, 2007, EXPERT OPIN INV DRUG, V16, P1111, DOI 10.1517/13543784.16.7.1111; Fischle W, 1999, J BIOL CHEM, V274, P11713, DOI 10.1074/jbc.274.17.11713; Gan YH, 2009, ORAL ONCOL, V45, pE150, DOI 10.1016/j.oraloncology.2009.05.563; Georgescu MM, 2000, CANCER RES, V60, P7033; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Herold C, 2002, J HEPATOL, V36, P233, DOI 10.1016/S0168-8278(01)00257-4; Huang J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1919; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Iijima M, 2004, J BIOL CHEM, V279, P16606, DOI 10.1074/jbc.M312098200; Kim HR, 2006, EXP MOL MED, V38, P616, DOI 10.1038/emm.2006.73; Kou XX, 2013, CARCINOGENESIS, V34, P58, DOI 10.1093/carcin/bgs336; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Lee YS, 2008, CANCER RES, V68, P7561, DOI 10.1158/0008-5472.CAN-08-0188; Leslie NR, 2005, BIOCHEM SOC T, V33, P1507, DOI 10.1042/BST0331507; Li DM, 1997, CANCER RES, V57, P2124; Li DM, 1998, P NATL ACAD SCI USA, V95, P15406, DOI 10.1073/pnas.95.26.15406; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Lumb CN, 2013, BIOPHYS J, V104, P613, DOI 10.1016/j.bpj.2012.12.002; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Mei SP, 2004, INT J ONCOL, V25, P1509; Meuillet EJ, 2004, ARCH BIOCHEM BIOPHYS, V429, P123, DOI 10.1016/j.abb.2004.04.020; Oehme I, 2013, P NATL ACAD SCI USA, V110, pE2592, DOI 10.1073/pnas.1300113110; Okumura K, 2006, J BIOL CHEM, V281, P26562, DOI 10.1074/jbc.M605391200; Rahdar M, 2009, P NATL ACAD SCI USA, V106, P480, DOI 10.1073/pnas.0811212106; Saji S, 2005, ONCOGENE, V24, P4531, DOI 10.1038/sj.onc.1208646; Squarize CH, 2013, NEOPLASIA, V15, P461, DOI 10.1593/neo.121024; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Tashiro H, 1997, CANCER RES, V57, P3935; Tsao HS, 1998, ONCOGENE, V16, P3397, DOI 10.1038/sj.onc.1201881; Vazquez F, 2006, P NATL ACAD SCI USA, V103, P3633, DOI 10.1073/pnas.0510570103; Walker SM, 2004, BIOCHEM J, V379, P301, DOI 10.1042/BJ20031839; Wen SH, 2001, P NATL ACAD SCI USA, V98, P4622, DOI 10.1073/pnas.081063798; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Zhang Y, 2008, MOL CELL BIOL, V28, P1688, DOI 10.1128/MCB.01154-06	48	47	48	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 5	2016	35	18					2333	2344		10.1038/onc.2015.293	http://dx.doi.org/10.1038/onc.2015.293			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DM2GL	26279303				2022-12-26	WOS:000376165000006
J	Herremans, SC; Van Schuerbeek, P; De Raedt, R; Matthys, F; Buyl, R; De Mey, J; Baeken, C				Herremans, Sarah C.; Van Schuerbeek, Peter; De Raedt, Rudi; Matthys, Frieda; Buyl, Ronald; De Mey, Johan; Baeken, Chris			The Impact of Accelerated Right Prefrontal High-Frequency Repetitive Transcranial Magnetic Stimulation (rTMS) on Cue-Reactivity: An fMRI Study on Craving in Recently Detoxified Alcohol-Dependent Patients	PLOS ONE			English	Article							COMPULSIVE DRINKING SCALE; HF-RTMS; EMOTIONAL INFORMATION; ABSTINENT ALCOHOLICS; TALAIRACH ATLAS; CORTEX; ADDICTION; URGES; METAANALYSIS; VALIDATION	In alcohol-dependent patients craving is a difficult-to-treat phenomenon. It has been suggested that high-frequency (HF) repetitive transcranial magnetic stimulation (rTMS) may have beneficial effects. However, exactly how this application exerts its effect on the underlying craving neurocircuit is currently unclear. In an effort to induce alcohol craving and to maximize detection of HF-rTMS effects to cue-induced alcohol craving, patients were exposed to a block and event-related alcohol cue-reactivity paradigm while being scanned with fMRI. Hence, we assessed the effect of right dorsolateral prefrontal cortex (DLPFC) stimulation on cue-induced and general alcohol craving, and the related craving neurocircuit. Twenty-six recently detoxified alcohol-dependent patients were included. First, we evaluated the impact of one sham-controlled stimulation session. Second, we examined the effect of accelerated right DLPFC HF-rTMS treatment: here patients received 15 sessions in an open label accelerated design, spread over 4 consecutive days. General craving significantly decreased after 15 active HF-rTMS sessions. However, cue-induced alcohol craving was not altered. Our brain imaging results did not show that the cue-exposure affected the underlying craving neurocircuit after both one and fifteen active HF-rTMS sessions. Yet, brain activation changes after one and 15 HF-rTMS sessions, respectively, were observed in regions associated with the extended reward system and the default mode network, but only during the presentation of the event-related paradigm. Our findings indicate that accelerated HF-rTMS applied to the right DLPFC does not manifestly affect the craving neurocircuit during an alcohol-related cue-exposure, but instead it may influence the attentional network.	[Herremans, Sarah C.; Matthys, Frieda; Baeken, Chris] Vrije Univ Brussel, Dept Psychiat, Univ Ziekenhuis Brussel UZ Brussel, Brussels, Belgium; [Van Schuerbeek, Peter; De Mey, Johan] Vrije Univ Brussel, Dept Radiol, Univ Ziekenhuis Brussel UZ Brussel, Brussels, Belgium; [De Raedt, Rudi] Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium; [Buyl, Ronald] Vrije Univ Brussel, Dept Biostat & Med Informat, Brussels, Belgium; [Baeken, Chris] Univ Ghent, Dept Psychiat & Med Psychol, Univ Ziekenhuis Gent, B-9000 Ghent, Belgium	University Hospital Brussels; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Vrije Universiteit Brussel; University Hospital Brussels; Ghent University; Vrije Universiteit Brussel; Ghent University; Ghent University Hospital	Herremans, SC (corresponding author), Vrije Univ Brussel, Dept Psychiat, Univ Ziekenhuis Brussel UZ Brussel, Brussels, Belgium.	sarah.herremans@uzbrussel.be	Baeken, Chris/D-6790-2013; De Raedt, Rudi/A-3269-2012; De Raedt, Rudi/AAL-4093-2021; Buyl, Ronald/F-3862-2015; de Mey, Johan/F-3602-2011; matthys, frieda/AAW-2305-2021; de Mey, Johan/AAL-9312-2021	De Raedt, Rudi/0000-0001-6781-4808; De Raedt, Rudi/0000-0001-6781-4808; Buyl, Ronald/0000-0002-6598-9505; matthys, frieda/0000-0002-0900-1478; Van Schuerbeek, Peter/0000-0003-3647-4446; de Mey, Johan/0000-0002-3601-3212	Scientific Fund Willy Gepts [2012-03]	Scientific Fund Willy Gepts	This work was funded by Scientific Fund Willy Gepts 2012-03 (CB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaro E, 2006, BRAIN COGNITION, V60, P220, DOI 10.1016/j.bandc.2005.11.009; Amiaz R, 2009, ADDICTION, V104, P653, DOI 10.1111/j.1360-0443.2008.02448.x; ANTON RF, 1995, ALCOHOL CLIN EXP RES, V19, P92, DOI 10.1111/j.1530-0277.1995.tb01475.x; Baeken C, 2013, J AFFECT DISORDERS, V151, P625, DOI 10.1016/j.jad.2013.07.008; Bauer J, 2013, NEUROPSYCHOPHARMACOL, V38, P1401, DOI 10.1038/npp.2013.45; Beck A, 2012, ARCH GEN PSYCHIAT, V69, P842, DOI 10.1001/archgenpsychiatry.2011.2026; Bellamoli E, 2014, BEHAV NEUROL, V2014, DOI 10.1155/2014/815215; Bennett CM, 2009, SOC COGN AFFECT NEUR, V4, P417, DOI 10.1093/scan/nsp053; Berlim MT, 2013, INT J NEUROPSYCHOPH, V16, P1173, DOI 10.1017/S1461145712001691; Berridge KC, 2013, CURR OPIN NEUROBIOL, V23, P294, DOI 10.1016/j.conb.2013.01.017; BOHN MJ, 1995, ALCOHOL CLIN EXP RES, V19, P600, DOI 10.1111/j.1530-0277.1995.tb01554.x; Camprodon JA, 2007, DRUG ALCOHOL DEPEN, V86, P91, DOI 10.1016/j.drugalcdep.2006.06.002; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; De Raedt R, 2010, BIOL PSYCHOL, V85, P487, DOI 10.1016/j.biopsycho.2010.09.015; de Wildt WAJM, 2005, ALCOHOL CLIN EXP RES, V29, P509, DOI 10.1097/01.ALC.0000158844.35608.48; Di X, 2014, NEUROIMAGE, V86, P53, DOI 10.1016/j.neuroimage.2013.07.071; Drummond DC, 2002, ADDICTION, V97, P1465, DOI 10.1046/j.1360-0443.2002.00252.x; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Grall-Bronnec M, 2014, NEUROSCI BIOBEHAV R, V47, P592, DOI 10.1016/j.neubiorev.2014.10.013; Grusser SM, 2004, PSYCHOPHARMACOLOGY, V175, P296, DOI 10.1007/s00213-004-1828-4; Hayashi T, 2013, P NATL ACAD SCI USA, V110, P4422, DOI 10.1073/pnas.1212185110; Heinz A, 2003, ALCOHOL ALCOHOLISM, V38, P35, DOI 10.1093/alcalc/agg005; Heinz A, 2009, ADDICT BIOL, V14, P108, DOI 10.1111/j.1369-1600.2008.00136.x; Herremans SC, 2012, DRUG ALCOHOL DEPEN, V120, P209, DOI 10.1016/j.drugalcdep.2011.07.021; Herremans SC, 2012, PSYCHIAT DANUB, V24, pS14; Hoppner J, 2011, WORLD J BIOL PSYCHIA, V12, P57, DOI 10.3109/15622975.2011.598383; Holtzheimer PE, 2010, DEPRESS ANXIETY, V27, P960, DOI 10.1002/da.20731; Jansen JM, 2013, NEUROSCI BIOBEHAV R, V37, P2472, DOI 10.1016/j.neubiorev.2013.07.009; Jasinska AJ, 2014, NEUROSCI BIOBEHAV R, V38, P1, DOI 10.1016/j.neubiorev.2013.10.013; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Kuhn S, 2012, ADDICT BIOL, V18, P121, DOI [10.1111/j.1460-9568.2010.07590.x, DOI 10.1111/J.1460-9568.2010.07590.X]; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Langosch JM, 2012, J CLIN PSYCHOPHARM, V32, P661, DOI 10.1097/JCP.0b013e318267b586; Leyman L, 2009, PSYCHOL MED, V39, P1019, DOI 10.1017/S0033291708004431; Liu X, 2011, NEUROSCI BIOBEHAV R, V35, P1219, DOI 10.1016/j.neubiorev.2010.12.012; Lukas SE, 2013, NEUROIMAGE, V78, P176, DOI 10.1016/j.neuroimage.2013.03.055; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; MCLELLAN AT, 1980, J NERV MENT DIS, V168, P26, DOI 10.1097/00005053-198001000-00006; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Mishra BR, 2010, ADDICTION, V105, P49, DOI 10.1111/j.1360-0443.2009.02777.x; Mishra BR, 2015, J NEUROPSYCH CLIN N, V27, pE54, DOI 10.1176/appi.neuropsych.13010013; Naqvi NH, 2010, BRAIN STRUCT FUNCT, V214, P435, DOI 10.1007/s00429-010-0268-7; Paret C, 2014, NEUROIMAGE, V103, P522, DOI 10.1016/j.neuroimage.2014.08.054; Paus T, 2004, J PSYCHIATR NEUROSCI, V29, P268; Peleman K, 2010, WORLD J BIOL PSYCHIA, V11, P425, DOI [10.1080/15622970802669564, 10.3109/15622970802669564]; Politi E, 2008, AM J ADDICTION, V17, P345, DOI 10.1080/10550490802139283; Ross S, 2009, CLIN NEUROPHARMACOL, V32, P277, DOI 10.1097/WNF.0b013e3181a91655; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Rudebeck PH, 2013, NAT NEUROSCI, V16, P1140, DOI 10.1038/nn.3440; Schacht JP, 2013, ADDICT BIOL, V18, P121, DOI 10.1111/j.1369-1600.2012.00464.x; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sheffer CE, 2013, J SUBST ABUSE TREAT, V45, P206, DOI 10.1016/j.jsat.2013.01.012; SULLIVAN JT, 1989, BRIT J ADDICT, V84, P1353; Summerlin JL., 1997, NEUROIMAGE, V5, pS633, DOI DOI 10.1002/(SICI)1097-0193(1997)5:4<238:AID-HBM6>3.0.C0;2-4; Sutherland MT, 2012, NEUROIMAGE, V62, P2281, DOI 10.1016/j.neuroimage.2012.01.117; TIFFANY ST, 1990, PSYCHOL REV, V97, P147, DOI 10.1037/0033-295X.97.2.147; Tiffany ST, 2012, ANN NY ACAD SCI, V1248, P1, DOI 10.1111/j.1749-6632.2011.06298.x; Vanderhasselt MA, 2007, BRAIN RES, V1137, P111, DOI 10.1016/j.brainres.2006.12.050; Wilson SJ, 2004, NAT NEUROSCI, V7, P211, DOI 10.1038/nn1200; Yalachkov Y, 2010, BEHAV BRAIN RES, V207, P215, DOI 10.1016/j.bbr.2009.09.015	62	42	42	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136182	10.1371/journal.pone.0136182	http://dx.doi.org/10.1371/journal.pone.0136182			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295336	Green Published, Green Submitted, gold			2022-12-26	WOS:000359926900080
J	Mandel, JR; McCauley, DE				Mandel, Jennifer R.; McCauley, David E.			Pervasive Mitochondrial Sequence Heteroplasmy in Natural Populations of Wild Carrot, Daucus carota spp. carota L	PLOS ONE			English	Article							PLANT SILENE-VULGARIS; GYNODIOECIOUS PLANT; PATERNAL LEAKAGE; FERTILE CARROTS; MALE-STERILITY; SSP CAROTA; ATP9 GENES; GENOMES; RECOMBINATION; INHERITANCE	Exceptions to the generally accepted rules that plant mitochondrial genomes are strictly maternally inherited and that within-individual sequence diversity in those genomes, i.e., heteroplasmy, should be minimal are becoming increasingly apparent especially with regard to sequence-level heteroplasmy. These findings raise questions about the potential significance of such heteroplasmy for plant mitochondrial genome evolution. Still studies quantifying the amount and consequences of sequence heteroplasmy in natural populations are rare. In this study, we report pervasive sequence heteroplasmy in natural populations of wild carrot, a close relative of the cultivated crop. In order to assay directly for this heteroplasmy, we implemented a quantitative PCR assay that can detect and quantify intra-individual SNP variation in two mitochondrial genes (Cox1 and Atp9). We found heteroplasmy in >60% of all wild carrot populations surveyed and in >30% of the 140 component individuals that were genotyped. Heteroplasmy ranged from a very small proportion of the total genotype (e.g., 0.995:0.005) to near even mixtures (e.g., 0.590:0.410) in some individuals. These results have important implications for the role of intra-genomic recombination in the generation of plant mitochondrial genome genotypic novelty. The consequences of such recombination are evident in the results of this study through analysis of the degree of linkage disequilibrium (LD) between the SNP sites at the two genes studied.	[Mandel, Jennifer R.] Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA; [Mandel, Jennifer R.] Univ Memphis, W Harry Feinstone Ctr Genom Res, Memphis, TN 38152 USA; [McCauley, David E.] Vanderbilt Univ, Dept Biol Sci, VU Stn B, Nashville, TN 37235 USA	University of Memphis; University of Memphis; Vanderbilt University	Mandel, JR (corresponding author), Univ Memphis, Dept Biol Sci, 3700 Walker Ave, Memphis, TN 38152 USA.	jmandel@memphis.edu		Mandel, Jennifer/0000-0003-3539-2991	United States Department of Agriculture-National Institute of Food and Agriculture [2014-33522-21826]	United States Department of Agriculture-National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This work was supported by United States Department of Agriculture-National Institute of Food and Agriculture (http://nifa.usda.gov/) grant 2014-33522-21826 to JRM and DEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach IC, 2002, EUPHYTICA, V127, P353, DOI 10.1023/A:1020314802236; Bentley KE, 2010, GENETICS, V185, P961, DOI 10.1534/genetics.110.115360; Birky CW, 2001, ANNU REV GENET, V35, P125, DOI 10.1146/annurev.genet.35.102401.090231; BIRKY CW, 1995, P NATL ACAD SCI USA, V92, P11331, DOI 10.1073/pnas.92.25.11331; Burt A., 2006, GENES IN CONFLICT; Hauser TP, 2001, GENET RESOUR CROP EV, V48, P499, DOI 10.1023/A:1012051731933; Hedrick PW., 2009, GENETICS POPULATIONS; HUDSON RR, 1985, GENETICS, V111, P147; Mackenzie S, 1999, PLANT CELL, V11, P571, DOI 10.1105/tpc.11.4.571; Mandel JR, 2012, J HERED, V103, P418, DOI 10.1093/jhered/esr142; McCauley DE, 2008, EVOLUTION, V62, P823, DOI 10.1111/j.1558-5646.2008.00331.x; McCauley DE, 2013, NEW PHYTOL, V200, P966, DOI 10.1111/nph.12431; Pearl SA, 2009, MOL BIOL EVOL, V26, P537, DOI 10.1093/molbev/msn273; Richards A.J., 1986, PLANT BREEDING SYSTE; RONFORT J, 1995, THEOR APPL GENET, V91, P150, DOI 10.1007/BF00220872; Schnable PS, 1998, TRENDS PLANT SCI, V3, P175, DOI 10.1016/S1360-1385(98)01235-7; Sokal RR, 1995, BIOMETRY; Szklarczyk M, 2000, THEOR APPL GENET, V100, P263, DOI 10.1007/s001220050035; Szklarczyk M, 2014, THEOR APPL GENET, V127, P1689, DOI 10.1007/s00122-014-2331-x; Welch ME, 2006, GENETICS, V174, P829, DOI 10.1534/genetics.106.059246; Woloszynska M, 2010, J EXP BOT, V61, P657, DOI 10.1093/jxb/erp361	21	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136303	10.1371/journal.pone.0136303	http://dx.doi.org/10.1371/journal.pone.0136303			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295342	Green Submitted, Green Published, gold			2022-12-26	WOS:000359926900098
J	Yang, Y; Tang, BS; Weng, L; Li, N; Shen, L; Wang, J; Zuo, CT; Yan, XX; Xia, K; Guo, JF				Yang, Yang; Tang, Bei-sha; Weng, Ling; Li, Nan; Shen, Lu; Wang, Jian; Zuo, Chuan-tao; Yan, Xin-xiang; Xia, Kun; Guo, Ji-feng			Genetic Identification Is Critical for the Diagnosis of Parkinsonism: A Chinese Pedigree with Early Onset of Parkinsonism	PLOS ONE			English	Article							FRONTOTEMPORAL DEMENTIA; TAU GENE; PROTEIN-TAU; DISEASE; MUTATION; PET; DEGENERATION; NETWORK; CHROMOSOME-17; PROGRESSION	Background A number of hereditary neurological diseases display indistinguishable features at the early disease stage. Parkinsonian symptoms can be found in numerous diseases, making it difficult to get a definitive early diagnosis of primary causes for patients with onset of parkinsonism. The accurate and early diagnosis of the causes of parkinsonian patients is important for effective treatments of these patients. Methods We have identified a Chinese family (82 family members over four generations with 21 affected individuals) that manifested the characterized symptoms of parkinsonism and was initially diagnosed as Parkinson's disease. We followed up with the family for two years, during which we carried out clinical observations, Positron Emission Tomography-Computed Tomography neuroimaging analysis, and exome sequencing to correctly diagnose the case. Results During the two-year follow-up period, we performed comprehensive medical history collection, physical examination, and structural and functional neuroimaging studies of this Chinese family. We found that the patient exhibited progressive deteriorated parkinsonism with Parkinson disease-like neuropathology and also had a good response to the initial levodopa treatment. However, exome sequencing identified a missense mutation, N279K, in exon 10 of MAPT gene, verifying that the early parkinsonian symptoms in this family are caused by the genetic mutation for hereditary frontotemporal lobar dementia. Conclusions For the inherited parkinsonian patients who even show the neuropathology similar to that in Parkinson's disease and have initial response to levodopa treatment, genetic identification of the molecular basis for the disease is still required for defining the early diagnosis and correct treatment.	[Yang, Yang; Tang, Bei-sha; Weng, Ling; Li, Nan; Shen, Lu; Yan, Xin-xiang; Guo, Ji-feng] Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha 410008, Hunan, Peoples R China; [Tang, Bei-sha; Shen, Lu; Xia, Kun; Guo, Ji-feng] State Key Lab Med Genet, Changsha 410078, Hunan, Peoples R China; [Tang, Bei-sha; Li, Nan; Shen, Lu; Yan, Xin-xiang; Guo, Ji-feng] Cent S Univ, Key Lab Hunan Prov Neurodegenerat Disorders, Changsha 410008, Hunan, Peoples R China; [Tang, Bei-sha; Li, Nan; Shen, Lu; Yan, Xin-xiang; Guo, Ji-feng] Cent S Univ, Neurodegenerat Disorders Res Ctr, Changsha 410008, Hunan, Peoples R China; [Wang, Jian] Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai 200040, Peoples R China; [Zuo, Chuan-tao] Fudan Univ, Huashan Hosp, PET Ctr, Shanghai 200040, Peoples R China	Central South University; Central South University; Central South University; Fudan University; Fudan University	Guo, JF (corresponding author), Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha 410008, Hunan, Peoples R China.	guojifeng2003@163.com	XIA, KUN/AAO-3525-2020; Zuo, Chuantao/AAD-9940-2022		Major State Basic Research Development Program of China (973 Program) [2011CB510000]; National Natural Science Foundation of China [81430023, 81130021, 81171198, 81371405, 81361120404, 81300980]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Major State Basic Research Development Program of China http://www.most.gov.cn (973 Program) (grant number 2011CB510000 to Bei-sha Tang), National Natural Science Foundation of China http://www.nsfc.gov.cn/ (grant number 81430023 to Bei-sha Tang, grant number 81130021 to Bei-sha Tang, grant number 81171198 to Xin-xiang Yan, grant number 81371405 to Ji-feng Guo, grant number 81361120404 to Bei-sha Tang, grant number 81300980 to Nan Li). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcalay RN, 2010, ARCH NEUROL-CHICAGO, V67, P1116, DOI 10.1001/archneurol.2010.194; Arima K, 2000, NEUROLOGY, V54, P1787, DOI 10.1212/WNL.54.9.1787; Asanuma K, 2006, BRAIN, V129, P2667, DOI 10.1093/brain/awl162; Clark LN, 1998, P NATL ACAD SCI USA, V95, P13103, DOI 10.1073/pnas.95.22.13103; Fujioka S, 2012, NEURODEGENER DIS, V10, P257, DOI 10.1159/000334285; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; HIMMLER A, 1989, MOL CELL BIOL, V9, P1381, DOI 10.1128/MCB.9.4.1381; Huang CR, 2007, BRAIN, V130, P1834, DOI 10.1093/brain/awm086; Karimi M, 2013, ANN NEUROL, V73, P390, DOI 10.1002/ana.23798; Kim JY, 2008, MOVEMENT DISORD, V23, P207, DOI 10.1002/mds.21787; Kumar A, 2003, BRAIN, V126, P2648, DOI 10.1093/brain/awg270; Langston JW, 2006, ANN NEUROL, V59, P591, DOI 10.1002/ana.20834; Levy SF, 2005, J BIOL CHEM, V280, P13520, DOI 10.1074/jbc.M413490200; Nasrallah I, 2013, SEMIN NUCL MED, V43, P449, DOI 10.1053/j.semnuclmed.2013.06.003; Pavese N, 2009, MOVEMENT DISORD, V24, P2260, DOI 10.1002/mds.22817; Piguet O, 2011, LANCET NEUROL, V10, P162, DOI 10.1016/S1474-4422(10)70299-4; Siuda J, 2014, PARKINSONISM RELAT D, V20, P957, DOI 10.1016/j.parkreldis.2014.06.004; Soliveri P, 2003, ARCH NEUROL-CHICAGO, V60, P1454, DOI 10.1001/archneur.60.10.1454; Stamer K, 2002, J CELL BIOL, V156, P1051, DOI 10.1083/jcb.200108057; Tsuboi Y, 2002, ARCH NEUROL-CHICAGO, V59, P943, DOI 10.1001/archneur.59.6.943; Wang JL, 2011, BRAIN, V134, P3490, DOI 10.1093/brain/awr289; Wszolek ZK, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-30; Wu P, 2013, PARKINSONISM RELAT D, V19, P622, DOI 10.1016/j.parkreldis.2013.02.013; Yasuda M, 1999, NEUROLOGY, V53, P864, DOI 10.1212/WNL.53.4.864	24	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136245	10.1371/journal.pone.0136245	http://dx.doi.org/10.1371/journal.pone.0136245			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295349	gold, Green Published, Green Submitted			2022-12-26	WOS:000359926900089
J	Htun, P; Nee, J; Ploeckinger, U; Eder, K; Geisler, T; Gawaz, M; Bocksch, W; Fateh-Moghadam, S				Htun, Patrik; Nee, Jens; Ploeckinger, Ursula; Eder, Klaus; Geisler, Tobias; Gawaz, Meinrad; Bocksch, Wolfgang; Fateh-Moghadam, Suzanne			Fish-Free Diet in Patients with Phenylketonuria Is Not Associated with Early Atherosclerotic Changes and Enhanced Platelet Activation	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; POLYUNSATURATED FATTY-ACIDS; CARDIOVASCULAR RISK-FACTORS; MYOCARDIAL-INFARCTION; CONSUMPTION; MORTALITY; OMEGA-3-FATTY-ACIDS; SUPPLEMENTATION; PROGRESSION; OIL	Background and Purpose Since patients with phenylketonuria (PKU) have to follow a lifelong restriction of natural protein to lower phenylalanine-intake, they never eat fish. This diet may lead to a chronic deficit of omega-3 and omega-6 fatty acids with the risk of early atherosclerotic changes. The aim of the study was to analyse the fatty acid profile of PKU patients and to correlate the results with surrogate markers of early atherosclerotic changes [enhanced carotid intima media thickness (CIMT) and beta-stiffness index] and platelet activation. Methods In 43 PKU patients and in 58 healthy controls we prospectively examined the fatty acid profile, CIMT, beta-stiffness index and platelet activation (flow cytometric determination of markers of platelet activation). CIMT was measured bilaterally by ultrasound. CIMTmean was defined as the mean value of the sum of CIMTleft and CIMTright. Results Despite of lower HDL-cholesterol and higher triglyceride concentrations in the PKU group, there was no significant difference in the omega-6 or omega-3 fatty acid profile, CIMT, beta-stiffness index between both groups. Platelet activation was not enhanced in the PKU group. Conclusions Fish-free diet does not induce early atherosclerotic changes or enhanced platelet activation in PKU patients.	[Htun, Patrik] Zent Klinikum, Zent Notaufnahme & Med Klin 4, Augsburg, Germany; [Nee, Jens] Humboldt Univ, Charite Univ Med Campus Virchow Klinikum, Med Klin Schwerpunkt Nephrol & Intens Med, Tubingen, Germany; [Ploeckinger, Ursula] Humboldt Univ, Charite Univ Med Campus Virchow Klinikum, Interdisziplinaeres Stoffwechsel Ctr, Augsburg, Germany; [Eder, Klaus] Univ Giessen, Inst Tierernahrung & Ernahrungsphysiol, Giessen, Germany; [Geisler, Tobias; Gawaz, Meinrad; Bocksch, Wolfgang; Fateh-Moghadam, Suzanne] Univ Tubingen, Abt Kardiol & Kreislauferkrankungen, Med Klin 3, Tubingen, Germany	Humboldt University of Berlin; Humboldt University of Berlin; Justus Liebig University Giessen; Eberhard Karls University of Tubingen	Fateh-Moghadam, S (corresponding author), Univ Tubingen, Abt Kardiol & Kreislauferkrankungen, Med Klin 3, Tubingen, Germany.	suzanne.fateh-moghadam@med.uni-tuebingen.de	Geisler, Tobias/AAO-4472-2020		Charite Research Fund (Anschubfinanzierung); DFG - Klinische Forschergruppe Platelet-Basic Mechanisms and Translational Medicine [KFO274]; Deutsche Interessengemeinschaft Phenylketonurie und verwandte Stoffwechselstorungen e.V. (DIG-PKU)	Charite Research Fund (Anschubfinanzierung); DFG - Klinische Forschergruppe Platelet-Basic Mechanisms and Translational Medicine(German Research Foundation (DFG)); Deutsche Interessengemeinschaft Phenylketonurie und verwandte Stoffwechselstorungen e.V. (DIG-PKU)	This study was supported in part by grants from the Charite Research Fund (Anschubfinanzierung), by the DFG - Klinische Forschergruppe (KFO274) Platelet-Basic Mechanisms and Translational Medicine and "Deutsche Interessengemeinschaft Phenylketonurie und verwandte Stoffwechselstorungen e.V. (DIG-PKU)".	Angerer P, 2002, CARDIOVASC RES, V54, P183, DOI 10.1016/S0008-6363(02)00229-8; [Anonymous], 1985, N ENGL J MED, V313, P820; [Anonymous], 2001, METABOLIC MOL BASES, DOI DOI 10.1036/OMMBID.97; BANG HO, 1976, ACTA MED SCAND, V200, P69; Bosch J, 2012, NEW ENGL J MED, V367, P309, DOI 10.1056/NEJMoa1203859; Bowersox J, 2001, PEDIATRICS, V108, P972; BRADEN GA, 1990, CIRCULATION, V82, P178, DOI 10.1161/01.CIR.82.1.178; Bucher HC, 2002, AM J MED, V112, P298, DOI 10.1016/S0002-9343(01)01114-7; BURR ML, 1989, LANCET, V2, P757; CHETTY N, 1983, THROMB RES, V30, P619, DOI 10.1016/0049-3848(83)90270-0; Conquer JA, 1999, THROMB RES, V96, P239, DOI 10.1016/S0049-3848(99)00106-1; DOLECEK TA, 1991, WORLD REV NUTR DIET, V66, P205; EDER K, 1993, CLIN CHIM ACTA, V219, P93, DOI 10.1016/0009-8981(93)90200-N; Emoto M, 1998, DIABETES CARE, V21, P1178, DOI 10.2337/diacare.21.7.1178; Fateh-Moghadam S, 2005, ARTERIOSCL THROM VAS, V25, P1299, DOI 10.1161/01.ATV.0000165699.41301.c5; Fateh-Moghadam S, 2000, CIRCULATION, V102, P890; Fateh-Moghadam S, 2007, THROMB HAEMOSTASIS, V97, P974, DOI 10.1160/TH06-12-0725; Gawaz M, 1999, CIRCULATION, V99, P2; Hanley WB, 2004, AM J MED, V117, P590, DOI 10.1016/j.amjmed.2004.03.042; HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5; HIRAI T, 1989, CIRCULATION, V80, P78, DOI 10.1161/01.CIR.80.1.78; Hooper L, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003177.PUB2; Iannuzzi A, 2006, AM J CARDIOL, V97, P528, DOI 10.1016/j.amjcard.2005.08.072; KROMHOUT D, 1995, INT J EPIDEMIOL, V24, P340, DOI 10.1093/ije/24.2.340; KROMHOUT D, 1985, NEW ENGL J MED, V312, P1205, DOI 10.1056/NEJM198505093121901; LEAF A, 1994, CIRCULATION, V90, P2248, DOI 10.1161/01.CIR.90.5.2248; Li D, 1999, EUR J CLIN NUTR, V53, P612, DOI 10.1038/sj.ejcn.1600817; McCarty MF, 2004, MED HYPOTHESES, V63, P426, DOI 10.1016/j.mehy.2002.11.007; Mezzano D, 1999, THROMB HAEMOSTASIS, V81, P913; Mori TA, 1997, ARTERIOSCL THROM VAS, V17, P279, DOI 10.1161/01.ATV.17.2.279; MORRISON WR, 1964, J LIPID RES, V5, P600; Moseley K, 2002, J INHERIT METAB DIS, V25, P56, DOI 10.1023/A:1015142001578; Mozaffarian D, 2003, CIRCULATION, V107, P1372, DOI 10.1161/01.CIR.0000055315.79177.16; Myrup B, 2001, SCAND J CLIN LAB INV, V61, P349, DOI 10.1080/003655101316911387; Nelson GJ, 1997, LIPIDS, V32, P1129, DOI 10.1007/s11745-997-0145-6; Oomen CM, 2000, AM J EPIDEMIOL, V151, P999, DOI 10.1093/oxfordjournals.aje.a010144; PRISCO D, 1995, METABOLISM, V44, P562, DOI 10.1016/0026-0495(95)90111-6; Rodriguez BL, 1996, CIRCULATION, V94, P952, DOI 10.1161/01.CIR.94.5.952; Ruf A, 1997, BRIT J HAEMATOL, V98, P51, DOI 10.1046/j.1365-2141.1997.1502965.x; SACKS FM, 1995, J AM COLL CARDIOL, V25, P1492, DOI 10.1016/0735-1097(95)00095-L; Schoene NW, 2001, NUTRITION, V17, P793, DOI 10.1016/S0899-9007(01)00644-X; SISCOVICK DS, 1995, JAMA-J AM MED ASSOC, V274, P1363, DOI 10.1001/jama.274.17.1363; Yuan JM, 2001, AM J EPIDEMIOL, V154, P809, DOI 10.1093/aje/154.9.809	43	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135930	10.1371/journal.pone.0135930	http://dx.doi.org/10.1371/journal.pone.0135930			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291823	gold, Green Published, Green Submitted			2022-12-26	WOS:000359919900042
J	Kaltofen, T; Haase, M; Thome, UH; Laube, M				Kaltofen, Till; Haase, Melanie; Thome, Ulrich H.; Laube, Mandy			Male Sex is Associated with a Reduced Alveolar Epithelial Sodium Transport	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; ESTROGEN-RECEPTOR-BETA; LUNG LIQUID CLEARANCE; FLUID CLEARANCE; BIOPHYSICAL PROPERTIES; SURFACTANT PRODUCTION; ANDROGEN RECEPTOR; GENE-EXPRESSION; FETAL LAMB; ADULT RATS	Respiratory distress syndrome (RDS) is the most frequent pulmonary complication in preterm infants. RDS incidence differs between genders, which has been called the male disadvantage. Besides maturation of the surfactant system, Na+ transport driven alveolar fluid clearance is crucial for the prevention of RDS. Na+ transport is mediated by the epithelial Na+ channel (ENaC) and the Na,K-ATPase, therefore potential differences in their expression or activity possibly contribute to the gender imbalance observed in RDS. Fetal distal lung epithelial (FDLE) cells of rat fetuses were separated by sex and analyzed regarding expression and activity of the Na+ transporters. Ussing chamber experiments showed a higher baseline short-circuit current (I-SC) and amiloride-sensitive Delta I-SC in FDLE cells of female origin. In addition, maximal amiloride-sensitive.ISC and maximal ouabain-sensitive Delta I-SC of female cells were higher when measured in the presence of a permeabilized basolateral or apical membrane, respectively. The number of FDLE cells per fetus recoverable during cell isolation was also significantly higher in females. In addition, lung wet-to-dry weight ratio was lower in fetal and newborn female pups. Female derived FDLE cells had higher mRNA levels of the ENaC- and Na,K-ATPase subunits. Furthermore, estrogen (ER) and progesterone receptor (PR) mRNA levels were higher in female cells, which might render female cells more responsive, while concentrations of placenta-derived sex steroids do not differ between both genders during fetal life. Inhibition of ER-beta abolished the sex differences in Na+ transport and female cells were more responsive to estradiol stimulation. In conclusion, a higher alveolar Na+ transport, possibly attributable to a higher expression of hormone receptors in female FDLE cells, provides an explanation for the well known sex-related difference in RDS occurrence and outcome.	[Kaltofen, Till; Haase, Melanie; Thome, Ulrich H.; Laube, Mandy] Univ Leipzig, Ctr Pediat Res Leipzig, Div Neonatol, Hosp Children & Adolescents, D-04109 Leipzig, Germany	Leipzig University	Laube, M (corresponding author), Univ Leipzig, Ctr Pediat Res Leipzig, Div Neonatol, Hosp Children & Adolescents, D-04109 Leipzig, Germany.	mandy.laube@medizin.uni-leipzig.de		Laube, Mandy/0000-0002-7180-2858	German Research Foundation (DFG); Leipzig University	German Research Foundation (DFG)(German Research Foundation (DFG)); Leipzig University	We acknowledge support from the German Research Foundation (DFG) and Leipzig University within the program of Open Access Publishing.	Althaus M, 2011, PULM MED, V2011, DOI 10.1155/2011/830320; Altman M, 2013, PAEDIATR PERINAT EP, V27, P172, DOI 10.1111/ppe.12035; Anadkat JS, 2012, J PERINATOL, V32, P780, DOI 10.1038/jp.2011.191; Barker PM, 1997, J PEDIATR-US, V130, P373, DOI 10.1016/S0022-3476(97)70198-7; BARKER PM, 1993, AM J PHYSIOL, V265, pL512, DOI 10.1152/ajplung.1993.265.5.L512; Bastarache JA, 2011, J CRIT CARE, V26, P249, DOI 10.1016/j.jcrc.2010.06.005; Berger PJ, 1998, AM J OBSTET GYNECOL, V178, P223, DOI 10.1016/S0002-9378(98)80004-5; BLAND RD, 1982, J APPL PHYSIOL, V53, P992, DOI 10.1152/jappl.1982.53.4.992; Bostrom H, 1996, CELL, V85, P863, DOI 10.1016/S0092-8674(00)81270-2; Bresson E, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-2; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Compton DR, 2004, J MED CHEM, V47, P5872, DOI 10.1021/jm049631k; Dammann CEL, 2000, ENDOCRINOLOGY, V141, P2923, DOI 10.1210/en.141.8.2923; Dobrian A, 1999, AM J PHYSIOL-HEART C, V276, pH2159, DOI 10.1152/ajpheart.1999.276.6.H2159; Factor P, 1998, J CLIN INVEST, V102, P1421, DOI 10.1172/JCI3214; FARRELL PM, 1975, AM REV RESPIR DIS, V111, P657; FLEISHER B, 1985, OBSTET GYNECOL, V66, P327; GANDELMAN R, 1977, NATURE, V266, P722, DOI 10.1038/266722a0; Gonzalez-Arenas A, 2004, STEROIDS, V69, P351, DOI 10.1016/j.steroids.2004.03.004; Gortner L, 2013, KLIN PADIATR, V225, P64, DOI 10.1055/s-0033-1333758; Greenlee MM, 2013, AM J PHYSIOL-LUNG C, V305, pL878, DOI 10.1152/ajplung.00008.2013; Grenache DG, 2006, CLIN BIOCHEM, V39, P1, DOI 10.1016/j.clinbiochem.2005.10.008; Guo Y, 1998, AM J PHYSIOL-LUNG C, V274, pL369, DOI 10.1152/ajplung.1998.274.3.L369; HABERT R, 1984, J STEROID BIOCHEM, V21, P193, DOI 10.1016/0022-4731(84)90383-2; Helve O, 2009, NEONATOLOGY, V95, P347, DOI 10.1159/000209300; Hsu I, 2014, CARCINOGENESIS, V35, P651, DOI 10.1093/carcin/bgt348; Hume R, 2001, BIOL NEONATE, V80, P18, DOI 10.1159/000047172; Hummler E, 1996, NAT GENET, V12, P325, DOI 10.1038/ng0396-325; Icard P, 1999, AM J PHYSIOL-LUNG C, V277, pL1232, DOI 10.1152/ajplung.1999.277.6.L1232; JASSAL D, 1991, IN VITRO CELL DEV B, V27, P625; Kelly Michelle M, 2006, J Pediatr Health Care, V20, P238, DOI 10.1016/j.pedhc.2006.01.001; KERO PO, 1979, EUR J PEDIATR, V132, P7, DOI 10.1007/BF00443198; Kienitz T, 2009, HORM METAB RES, V41, P356, DOI 10.1055/s-0029-1192033; KIRK KL, 1980, NATURE, V287, P237, DOI 10.1038/287237a0; Kooijman EE, 2011, AM J PHYSIOL-LUNG C, V301, pL804, DOI 10.1152/ajplung.00445.2010; Laube M, 2011, PEDIATR RES, V69, P200, DOI 10.1203/PDR.0b013e3182070ec8; Lazrak A, 2000, AM J PHYSIOL-CELL PH, V279, pC762, DOI 10.1152/ajpcell.2000.279.3.C762; Li Y, 2011, J BIOL CHEM, V286, P32289, DOI 10.1074/jbc.M111.247825; Manno FAM, 2008, PHYSIOL BEHAV, V93, P364, DOI 10.1016/j.physbeh.2007.09.011; Massaro D, 2006, AM J PHYSIOL-LUNG C, V290, pL866, DOI 10.1152/ajplung.00396.2005; Massaro D, 2004, AM J PHYSIOL-LUNG C, V287, pL1154, DOI 10.1152/ajplung.00228.2004; Massaro GD, 1996, AM J PHYSIOL-LUNG C, V270, pL110, DOI 10.1152/ajplung.1996.270.1.L110; MASSARO GD, 1995, P NATL ACAD SCI USA, V92, P1105, DOI 10.1073/pnas.92.4.1105; Matalon S, 1999, ANNU REV PHYSIOL, V61, P627, DOI 10.1146/annurev.physiol.61.1.627; MCDONALD FJ, 1995, AM J PHYSIOL-CELL PH, V268, pC1157, DOI 10.1152/ajpcell.1995.268.5.C1157; McNicholas CM, 1997, J GEN PHYSIOL, V109, P681, DOI 10.1085/jgp.109.6.681; NIELSEN HC, 1982, J CLIN INVEST, V69, P611, DOI 10.1172/JCI110488; O'Brodovich H M, 1995, New Horiz, V3, P240; OBRODOVICH H, 1993, AM J PHYSIOL, V264, pC1137, DOI 10.1152/ajpcell.1993.264.5.C1137; OBrodovich HM, 1996, P ASSOC AM PHYSICIAN, V108, P345; OLVER RE, 1986, J PHYSIOL-LONDON, V376, P321, DOI 10.1113/jphysiol.1986.sp016156; PARKER CR, 1987, PEDIATR RES, V21, P386, DOI 10.1203/00006450-198704000-00013; Patrone C, 2003, MOL CELL BIOL, V23, P8542, DOI 10.1128/MCB.23.23.8542-8552.2003; PERKS AM, 1990, CAN J PHYSIOL PHARM, V68, P505, DOI 10.1139/y90-072; Pfister RE, 2001, J PHYSIOL-LONDON, V535, P889, DOI 10.1111/j.1469-7793.2001.00889.x; Quinkler M, 2005, HYPERTENSION, V46, P787, DOI 10.1161/01.HYP.0000184362.61744.c1; Renaud HJ, 2011, TOXICOL SCI, V124, P261, DOI 10.1093/toxsci/kfr240; Ridge KM, 1997, AM J PHYSIOL-LUNG C, V273, pL246, DOI 10.1152/ajplung.1997.273.1.L246; Roberge S, 2011, J OBSTET GYNAECOL CA, V33, P216, DOI 10.1016/S1701-2163(16)34822-8; Schmidt C, 2014, LUNG, V192, P935, DOI 10.1007/s00408-014-9640-3; Seaborn T, 2010, TRENDS ENDOCRIN MET, V21, P729, DOI 10.1016/j.tem.2010.09.001; SHANKLIN DR, 1970, J REPROD MED, V5, P53; Shao RJ, 2006, J ENDOCRINOL, V190, P857, DOI 10.1677/joe.1.06896; Simard M, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-25; Sweezey N, 1998, AM J PHYSIOL-CELL PH, V274, pC379, DOI 10.1152/ajpcell.1998.274.2.C379; Thame U, 2001, AM J RESP CELL MOL, V24, P245, DOI 10.1165/ajrcmb.24.3.3994; Thome UH, 2003, AM J PHYSIOL-LUNG C, V284, pL376, DOI 10.1152/ajplung.00218.2002; TORDAY JS, 1990, ENDOCRINOLOGY, V126, P3240, DOI 10.1210/endo-126-6-3240; TORDAY JS, 1987, EXP LUNG RES, V12, P1, DOI 10.3109/01902148709068811; Trotter A, 2006, PEDIATR RES, V60, P60, DOI 10.1203/01.pdr.0000220360.77567.d8; Ware LB, 2001, AM J RESP CRIT CARE, V163, P1376, DOI 10.1164/ajrccm.163.6.2004035; WEISZ J, 1980, ENDOCRINOLOGY, V106, P306, DOI 10.1210/endo-106-1-306; Yin J, 2014, CELL PHYSIOL BIOCHEM, V33, P1681, DOI 10.1159/000362951; Yusef YR, 2014, PHYSL REP, V2, P5	74	27	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136178	10.1371/journal.pone.0136178	http://dx.doi.org/10.1371/journal.pone.0136178			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291531	Green Submitted, gold, Green Published			2022-12-26	WOS:000359919900061
J	Pelosi, B; Pratelli, M; Migliarini, S; Pacini, G; Pasqualetti, M				Pelosi, Barbara; Pratelli, Marta; Migliarini, Sara; Pacini, Giulia; Pasqualetti, Massimo			Generation of a Tph2 Conditional Knockout Mouse Line for Time- and Tissue-Specific Depletion of Brain Serotonin	PLOS ONE			English	Article							HUMAN TRYPTOPHAN-HYDROXYLASE; AGGRESSIVE-BEHAVIOR; RECEPTOR; CRE; TRANSPORTER; EXPRESSION; NOREPINEPHRINE; DELETION; ANXIETY; EMBRYOGENESIS	Serotonin has been gaining increasing attention during the last two decades due to the dual function of this monoamine as key regulator during critical developmental events and as neurotransmitter. Importantly, unbalanced serotonergic levels during critical temporal phases might contribute to the onset of neuropsychiatric disorders, such as schizophrenia and autism. Despite increasing evidences from both animal models and human genetic studies have underpinned the importance of serotonin homeostasis maintenance during central nervous system development and adulthood, the precise role of this molecule in time-specific activities is only beginning to be elucidated. Serotonin synthesis is a 2-step process, the first step of which is mediated by the rate-limiting activity of Tph enzymes, belonging to the family of aromatic amino acid hydroxylases and existing in two isoforms, Tph1 and Tph2, responsible for the production of peripheral and brain serotonin, respectively. In the present study, we generated and validated a conditional knockout mouse line, Tph2(flox/flox), in which brain serotonin can be effectively ablated with time specificity. We demonstrated that the Cre-mediated excision of the third exon of Tph2 gene results in the production of a Tph2(null) allele in which we observed the near-complete loss of brain serotonin, as well as the growth defects and perinatal lethality observed in serotonin conventional knockouts. We also revealed that in mice harbouring the Tph2null allele, but not in wild-types, two distinct Tph2 mRNA isoforms are present, namely Tph2 Delta 3 and Tph2 Delta 3 Delta 4, with the latter showing an in-frame deletion of amino acids 84-178 and coding a protein that could potentially retain non-negligible enzymatic activity. As we could not detect Tph1 expression in the raphe, we made the hypothesis that the Tph2 Delta 3 Delta 4 isoform can be at the origin of the residual, sub-threshold amount of serotonin detected in the brain of Tph2(null/null) mice. Finally, we set up a tamoxifen administration protocol that allows an efficient, time-specific inactivation of brain serotonin synthesis. On the whole, we generated a suitable genetic tool to investigate how serotonin depletion impacts on time-specific events during central nervous system development and adulthood life.	[Pelosi, Barbara; Pratelli, Marta; Migliarini, Sara; Pacini, Giulia; Pasqualetti, Massimo] Univ Pisa, Unit Cell & Dev Biol, Dept Biol, I-56127 Pisa, Italy; [Pasqualetti, Massimo] Ist Italiano Tecnol, Ctr Neurosci & Cognit Syst UniTn, I-38068 Rovereto, TN, Italy	University of Pisa; Istituto Italiano di Tecnologia - IIT	Pasqualetti, M (corresponding author), Univ Pisa, Unit Cell & Dev Biol, Dept Biol, SS 12 Abetone & Brennero 4, I-56127 Pisa, Italy.	massimo.pasqualetti@unipi.it	Pratelli, Marta/GWQ-6324-2022	Pelosi, Barbara/0000-0002-2829-2979; Pasqualetti, Massimo/0000-0002-0844-8139; Migliarini, Sara/0000-0003-2741-269X	Italian Ministry of Education, University and Research (MIUR) [200894SYW2]; Toscana Life Sciences Foundation [0108]; Norvegian Research Council; University of Pisa; Regional Program; European Social Fund	Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Toscana Life Sciences Foundation; Norvegian Research Council; University of Pisa; Regional Program; European Social Fund(European Social Fund (ESF))	This work was supported by Italian Ministry of Education, University and Research (MIUR) (Prin 2008, 200894SYW2), Toscana Life Sciences Foundation (Orphan 0108 program) and Norvegian Research Council to M. Pasqualetti. BP, M. Pratelli and GP were supported by PhD program from University of Pisa. SM was supported by Regional Program and European Social Fund.	Alenina N, 2009, P NATL ACAD SCI USA, V106, P10332, DOI 10.1073/pnas.0810793106; Bengel D, 1999, MOL PSYCHIATR, V4, P463, DOI 10.1038/sj.mp.4000550; BLAKELY RD, 1991, NATURE, V354, P66, DOI 10.1038/354066a0; Bonnin A, 2011, NATURE, V472, P347, DOI 10.1038/nature09972; Brust P, 2000, J NEUROCHEM, V74, P1241; Buznikov GA, 2001, CELL TISSUE RES, V305, P177, DOI 10.1007/s004410100408; Carkaci-Salli N, 2006, J BIOL CHEM, V281, P28105, DOI 10.1074/jbc.M602817200; Cases O, 1996, NEURON, V16, P297, DOI 10.1016/S0896-6273(00)80048-3; CASES O, 1995, SCIENCE, V268, P1763, DOI 10.1126/science.7792602; Chugani DC, 1999, ANN NEUROL, V45, P287, DOI 10.1002/1531-8249(199903)45:3<287::AID-ANA3>3.0.CO;2-9; Compan V, 2004, J NEUROSCI, V24, P412, DOI 10.1523/JNEUROSCI.2806-03.2004; Cote F, 2003, P NATL ACAD SCI USA, V100, P13525, DOI 10.1073/pnas.2233056100; Cote F, 2007, P NATL ACAD SCI USA, V104, P329, DOI 10.1073/pnas.0606722104; Dahlstroem A., 1964, ACTA PHYSL SCAND S, V232, P231; Daubert EA, 2010, TRENDS NEUROSCI, V33, P424, DOI 10.1016/j.tins.2010.05.005; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Feil Susanne, 2009, V530, P343, DOI 10.1007/978-1-59745-471-1_18; Fernandez SP, 2012, NEUROPHARMACOLOGY, V62, P144, DOI 10.1016/j.neuropharm.2011.08.049; Fitzpatrick PF, 1999, ANNU REV BIOCHEM, V68, P355, DOI 10.1146/annurev.biochem.68.1.355; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Glaser S, 2005, NAT GENET, V37, P1187, DOI 10.1038/ng1668; Gutknecht L, 2008, J NEURAL TRANSM, V115, P1127, DOI 10.1007/s00702-008-0096-6; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hendricks TJ, 2003, NEURON, V37, P233, DOI 10.1016/S0896-6273(02)01167-4; Hull EM, 2004, PHYSIOL BEHAV, V83, P291, DOI 10.1016/j.physbeh.2004.08.018; Kim JY, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-48; Knobelman DA, 2001, J PHARMACOL EXP THER, V298, P1092; Kriegebaum C, 2010, NEUROCHEM INT, V57, P512, DOI 10.1016/j.neuint.2010.06.015; Lane HY, 2008, J PSYCHIATR NEUROSCI, V33, P47; LAUDER JM, 1993, TRENDS NEUROSCI, V16, P233, DOI 10.1016/0166-2236(93)90162-F; Lesch KP, 2012, NEURON, V76, P175, DOI 10.1016/j.neuron.2012.09.013; LIDOV HGW, 1982, BRAIN RES BULL, V9, P559, DOI 10.1016/0361-9230(82)90164-2; Lucki I, 1998, BIOL PSYCHIAT, V44, P151, DOI 10.1016/S0006-3223(98)00139-5; MANN JJ, 1990, ANN NY ACAD SCI, V600, P476, DOI 10.1111/j.1749-6632.1990.tb16903.x; Martinez A, 2001, CURR MED CHEM, V8, P1077, DOI 10.2174/0929867013372616; McKinney JA, 2009, HUM MUTAT, V30, P787, DOI 10.1002/humu.20956; Metzger D, 2001, METHODS, V24, P71, DOI 10.1006/meth.2001.1159; Migliarini S, 2013, MOL PSYCHIATR, V18, P1106, DOI 10.1038/mp.2012.128; Mijimolle N, 2005, CANCER CELL, V7, P313, DOI 10.1016/j.ccr.2005.03.004; Mockus SM, 1997, BBA-PROTEIN STRUCT M, V1342, P132, DOI 10.1016/S0167-4838(97)00069-1; Morin LP, 1999, ANN MED, V31, P12, DOI 10.3109/07853899909019259; Mosienko V, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0003-6; Mosienko V, 2015, BEHAV BRAIN RES, V277, P78, DOI 10.1016/j.bbr.2014.06.005; Murthy S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6524; Nakamura K, 2006, J NEUROSCI, V26, P530, DOI 10.1523/JNEUROSCI.1835-05.2006; Neal KB, 2009, J PHYSIOL-LONDON, V587, P567, DOI 10.1113/jphysiol.2008.160416; Pasqualetti M, 2002, GENESIS, V32, P109, DOI 10.1002/gene.10053; Patel PD, 2004, BIOL PSYCHIAT, V55, P428, DOI 10.1016/j.biopsych.2003.09.002; Pelosi B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104318; Persico AM, 2001, J NEUROSCI, V21, P6862, DOI 10.1523/JNEUROSCI.21-17-06862.2001; Ramboz S, 1998, P NATL ACAD SCI USA, V95, P14476, DOI 10.1073/pnas.95.24.14476; Ramoz N, 2007, EXPERT OPIN PHARMACO, V8, P2029, DOI 10.1517/14656566.8.13.2029; REITER RJ, 1991, ENDOCR REV, V12, P151, DOI 10.1210/edrv-12-2-151; Ren SY, 2002, GENESIS, V32, P105, DOI 10.1002/gene.10052; Riccio O, 2012, CEREB CORTEX, V22, P86, DOI 10.1093/cercor/bhr086; Ringrose L, 1999, EMBO J, V18, P6630, DOI 10.1093/emboj/18.23.6630; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Ruhe HG, 2007, MOL PSYCHIATR, V12, P331, DOI 10.1038/sj.mp.4001949; SAUDOU F, 1994, SCIENCE, V265, P1875, DOI 10.1126/science.8091214; Savelieva KV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003301; Skjaerven L, 2001, STRUCTURE FUNCTION R; Sodhi MSK, 2004, INT REV NEUROBIOL, V59, P111; STEIN PL, 1994, GENE DEV, V8, P1999, DOI 10.1101/gad.8.17.1999; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; Tenner K, 2007, J NEUROCHEM, V102, P1887, DOI 10.1111/j.1471-4159.2007.04664.x; Wakayama K, 2002, NEUROSCI RES, V44, P173, DOI 10.1016/S0168-0102(02)00120-7; WALLACE JA, 1983, BRAIN RES BULL, V10, P459, DOI 10.1016/0361-9230(83)90144-2; Walther DJ, 2003, BIOCHEM PHARMACOL, V66, P1673, DOI 10.1016/S0006-2952(03)00556-2; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Whitaker-Azmitia PM, 2001, BRAIN RES BULL, V56, P479, DOI 10.1016/S0361-9230(01)00615-3; Wu Q, 2012, NATURE, V483, P594, DOI 10.1038/nature10899; Yadav VK, 2009, CELL, V138, P976, DOI 10.1016/j.cell.2009.06.051; Yang SH, 2009, TRANSGENIC RES, V18, P483, DOI 10.1007/s11248-008-9237-9; YANG XJ, 1994, P NATL ACAD SCI USA, V91, P6659, DOI 10.1073/pnas.91.14.6659; Zhao ZQ, 2006, J NEUROSCI, V26, P12781, DOI 10.1523/JNEUROSCI.4143-06.2006	75	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136422	10.1371/journal.pone.0136422	http://dx.doi.org/10.1371/journal.pone.0136422			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291320	gold, Green Published, Green Submitted			2022-12-26	WOS:000359919900081
J	Yang, PL; Huang, GS; Tsai, CS; Lou, MF				Yang, Pei-Lin; Huang, Guey-Shiun; Tsai, Chien-Sung; Lou, Meei-Fang			Sleep Quality and Emotional Correlates in Taiwanese Coronary Artery Bypass Graft Patients 1 Week and 1 Month after Hospital Discharge: A Repeated Descriptive Correlational Study	PLOS ONE			English	Article							CARDIAC-SURGERY; CANCER-PATIENTS; BREAST-CANCER; DEPRESSION; ANXIETY; PATTERNS; INSOMNIA; THERAPY; ASSOCIATIONS; PREDICTORS	Background Poor sleep quality is a common health problem for coronary artery bypass graft patients, however few studies have evaluated sleep quality during the period immediately following hospital discharge. Purpose The aim of this study was to investigate changes in sleep quality and emotional correlates in coronary artery bypass graft patients in Taiwan at 1 week and 1 month after hospital discharge. Methods We used a descriptive correlational design for this study. One week after discharge, 87 patients who had undergone coronary artery bypass surgery completed two structured questionnaires: the Pittsburgh Sleep Quality Index and the Hospital Anxiety and Depression Scale. Three weeks later (1 month after discharge) the patients completed the surveys again. Pearson correlations, t-tests, ANOVA and linear multiple regression analysis were used to analyze the data. Results A majority of the participants had poor sleep quality at 1 week (82.8%) and 1 month (66.7%) post-hospitalization, based on the global score of the Pittsburgh Sleep Quality Index. Despite poor sleep quality at both time-points the sleep quality at 1 month was significantly better than at 1-week post hospitalization. Poorer sleep quality correlated with older age, poorer heart function, anxiety and depression. The majority of participants had normal levels of anxiety at 1 week (69.0%) and 1 month (88.5%) as measured by the Hospital Anxiety and Depression Scale. However, some level of depression was seen at 1 week (78.1%) and 1 month (59.7%). Depression was a significant predictor of sleep quality at 1 week; at 1 month after hospital discharge both anxiety and depression were significant predictors of sleep quality. Conclusion Sleep quality, anxiety and depression all significantly improved 1 month after hospital discharge. However, more than half of the participants continued to have poor sleep quality and some level of depression. Health care personnel should be encouraged to assess sleep and emotional status in patients after coronary artery bypass surgery and offer them appropriate management strategies to improve sleep and reduce anxiety and depression.	[Yang, Pei-Lin] Natl Def Med Ctr, Sch Nursing, Taipei, Taiwan; [Huang, Guey-Shiun; Lou, Meei-Fang] Natl Taiwan Univ, Coll Med, Sch Nursing, Taipei 10764, Taiwan; [Tsai, Chien-Sung] Tri Serv Gen Hosp, Natl Def Med Ctr, Taipei, Taiwan; [Tsai, Chien-Sung] Natl Def Med Ctr, Sch Med, Taipei, Taiwan	National Defense Medical Center; National Taiwan University; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center	Lou, MF (corresponding author), Natl Taiwan Univ, Coll Med, Sch Nursing, Taipei 10764, Taiwan.	mfalou@ntu.edu.tw	Yang, Pei-Lin/GPP-2641-2022	HUANG, GUEY-SHIUN/0000-0003-2170-0084; LOU, MEEI-FANG/0000-0001-6574-8050	Tri-Service-Hospital, Taipei, Taiwan [TSGH-C100-164]	Tri-Service-Hospital, Taipei, Taiwan	This study was supported by the support grant from Tri-Service-Hospital, Taipei, Taiwan (TSGH-C100-164), which made this study possible. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON EA, 1987, J CONSULT CLIN PSYCH, V55, P513, DOI 10.1037/0022-006X.55.4.513; Andrew MJ, 2000, J PSYCHOSOM RES, V48, P537, DOI 10.1016/S0022-3999(00)00089-1; [Anonymous], AUST CRIT CARE; Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011; Brummett BH, 2006, HEALTH PSYCHOL, V25, P220, DOI 10.1037/0278-6133.25.2.220; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chen P.Y., 1999, FORMOSAN J MED, V3, P373; Chocron S, 2013, ANN THORAC SURG, V95, P1609, DOI 10.1016/j.athoracsur.2013.02.035; Edell-Gustaffson UM, 2002, J ADV NURS, V37, P414, DOI 10.1046/j.1365-2648.2002.02106.x; Edell-Gustafsson UM, 1999, J ADV NURS, V29, P1213, DOI 10.1046/j.1365-2648.1999.01006.x; Edell-Gustafsson UM, 1999, SCAND J CARING SCI, V13, P137, DOI 10.1080/02839319950162697; Fang CS, 2007, J EVIDENCE BASED NUR, V3, P54; Fleming L, 2014, PSYCHO-ONCOLOGY, V23, P679, DOI 10.1002/pon.3468; Fortier-Brochu E, 2014, SLEEP, V37, P1789, DOI 10.5665/sleep.4172; Foulk MA, 2014, J GERONTOL SOC WORK, V57, P498, DOI 10.1080/01634372.2013.869787; Gregory AM, 2005, J ABNORM CHILD PSYCH, V33, P157, DOI 10.1007/s10802-005-1824-0; Haimov I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061390; Hedges C, 2008, AM J CRIT CARE, V17, P133; Johansson I, 2010, EUR J CARDIOVASC NUR, V9, P175, DOI 10.1016/j.ejcnurse.2009.12.003; Kim KH, 2009, JOGNN-J OBST GYN NEO, V38, P344, DOI 10.1111/j.1552-6909.2009.01029.x; KNAPPSPOONER C, 1992, HEART LUNG, V21, P342; Lawlor DA, 2001, BMJ-BRIT MED J, V322, P763, DOI 10.1136/bmj.322.7289.763; Lemma Seblewengel, 2012, Sleep Disord, V2012, P583510, DOI 10.1155/2012/583510; Liang SY., 1998, THESIS NATL YANG MIN; Liao WC, 2011, J NURS RES, V19, P275, DOI 10.1097/JNR.0b013e318236cf68; Liou HL, 2004, TZU CHI N J, V3, P61; Maslow AH, 1943, PSYCHOL REV, V50, P370, DOI 10.1037/h0054346; McNeely ML, 2006, CAN MED ASSOC J, V175, P34, DOI 10.1503/cmaj.051073; Ministry of Health and Welfare, 2014, 2013 STAT CAUS DEATH; MOORE SM, 1994, APPL NURS RES, V7, P170, DOI 10.1016/0897-1897(94)90023-X; Nieveen JL, 2008, HEART LUNG, V37, P17, DOI 10.1016/j.hrtlng.2006.12.002; Peric V, 2008, J CARDIAC SURG, V23, P648, DOI 10.1111/j.1540-8191.2008.00667.x; Proyer RT, 2014, AGING MENT HEALTH, V18, P997, DOI 10.1080/13607863.2014.899978; Redeker N S, 1993, Clin Nurs Res, V2, P148, DOI 10.1177/105477389300200205; Redeker N.S., 2008, SLEEP QUAL LIFE CLIN, P367; Redeker Nancy S, 2002, J Cardiovasc Nurs, V17, P56; Redeker NS, 2004, RES NURS HEALTH, V27, P217, DOI 10.1002/nur.20023; Redeker NS, 2004, NURS RES, V53, P154, DOI 10.1097/00006199-200405000-00002; Redeker NS, 1996, APPL NURS RES, V9, P115, DOI 10.1016/S0897-1897(96)80206-0; Rymaszewska J, 2003, EUR PSYCHIAT, V18, P155, DOI 10.1016/S0924-9338(03)00052-X; Sampson B K, 1998, Dimens Crit Care Nurs, V17, P158, DOI 10.1097/00003465-199805000-00009; Savard J, 2005, J CLIN ONCOL, V23, P6083, DOI 10.1200/JCO.2005.09.548; Schaefer K M, 1996, Prog Cardiovasc Nurs, V11, P5; Schulz PS, 2011, APPL NURS RES, V24, P65, DOI 10.1016/j.apnr.2009.03.001; Shiao HC., 2008, THESIS NATL TAIWAN U; Tsai PS, 2005, QUAL LIFE RES, V14, P1943, DOI 10.1007/s11136-005-4346-x; Tully PJ, 2012, J GERIATR CARDIOL, V9, P197, DOI 10.3724/SP.J.1263.2011.12221; Tzeng YJ, 2007, THESIS CHUNG SHAN ME; Utriyaprasit Ketsarin, 2005, J Transcult Nurs, V16, P97, DOI 10.1177/1043659604273548; WATSON D, 1995, J ABNORM PSYCHOL, V104, P3, DOI 10.1037/0021-843X.104.1.3; Wells RD, 2004, PSYCHOSOM MED, V66, P692, DOI 10.1097/01.psy.0000140002.84288.e1; Wu Y, 2002, FORMOSAN J MED, V6, P288; Yilmaz H, 2007, CIRC J, V71, P1506, DOI 10.1253/circj.71.1506; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	54	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136431	10.1371/journal.pone.0136431	http://dx.doi.org/10.1371/journal.pone.0136431			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5KH	26291524	Green Submitted, Green Published, gold			2022-12-26	WOS:000359919900083
J	Paez, UAH; Romero, IAG; Restrepo, SR; Gutierrez, FAA; Castano, DM				Hurtado Paez, Uriel Alonso; Garcia Romero, Ibonne Aydee; Restrepo, Silvia Restrepo; Aristizabal Gutierrez, Fabio Ancizar; Montoya Castano, Dolly			Assembly and Analysis of Differential Transcriptome Responses of Hevea brasiliensis on Interaction with Microcyclus ulei	PLOS ONE			English	Article							RNA-SEQ DATA; DISEASE RESISTANCE; MOLECULAR MARKERS; REFERENCE GENOME; GENE-EXPRESSION; GENERATION; QUANTIFICATION; ANNOTATION; PATHWAYS; SEQUENCE	Natural rubber (Hevea brasiliensis) is a tropical tree used commercially for the production of latex, from which 40,000 products are generated. The fungus Microcyclus ulei infects this tree, causing South American leaf blight (SALB) disease. This disease causes developmental delays and significant crop losses, thereby decreasing the production of latex. Currently several groups are working on obtaining clones of rubber tree with durable resistance to SALB through the use of extensive molecular biology techniques. In this study, we used a secondary clone that was resistant to M. ulei isolate GCL012. This clone, FX 3864 was obtained by crossing between clones PB 86 and B 38 (H. brasiliensis x H. brasiliensis). RNA-Seq high-throughput sequencing technology was used to analyze the differential expression of the FX 3864 clone transcriptome at 0 and 48 h post infection (hpi) with the M. ulei isolate GCL012. A total of 158,134,220 reads were assembled using the de novo assembly strategy to generate 90,775 contigs with an N50 of 1672. Using a reference-based assembly, 76,278 contigs were generated with an N50 of 1324. We identified 86 differentially expressed genes associated with the defense response of FX 3864 to GCL012. Seven putative genes members of the AP2/ERF ethylene (ET)-dependent superfamily were found to be down-regulated. An increase in salicylic acid (SA) was associated with the up-regulation of three genes involved in cell wall synthesis and remodeling, as well as in the down-regulation of the putative gene CPR5. The defense response of FX 3864 against the GCL012 isolate was associated with the antagonistic SA, ET and jasmonic acid (JA) pathways. These responses are characteristic of plant resistance to biotrophic pathogens.	[Hurtado Paez, Uriel Alonso; Garcia Romero, Ibonne Aydee; Aristizabal Gutierrez, Fabio Ancizar] Univ Nacl Colombia, Inst Biotecnol, Lab Caracterizac Mol, Bogota, Colombia; [Restrepo, Silvia Restrepo] Univ Los Andes, Lab Micol & Fitopatol, Bogota, Colombia; [Hurtado Paez, Uriel Alonso; Garcia Romero, Ibonne Aydee; Aristizabal Gutierrez, Fabio Ancizar; Montoya Castano, Dolly] Univ Nacl Colombia, Inst Biotecnol, Grp Bioproc & Bioprospecc, Bogota, Colombia	Universidad Nacional de Colombia; Universidad de los Andes (Colombia); Universidad Nacional de Colombia	Paez, UAH (corresponding author), Univ Nacl Colombia, Inst Biotecnol, Lab Caracterizac Mol, Bogota, Colombia.	uahurtadop@unal.edu.co	Aristizabal, Fabio A./AAG-8356-2020; Montoya, Dolly/N-4986-2016	Montoya, Dolly/0000-0001-7891-5452; Restrepo, Silvia/0000-0001-9016-1040; Aristizabal, Fabio/0000-0002-6405-7079; Garcia-Romero, Ibonne Aydee/0000-0002-8834-0899	Administratice Department of Science, Technology and Innovation-Colciencias [110152128525]	Administratice Department of Science, Technology and Innovation-Colciencias	Funding provided by Administratice Department of Science, Technology and Innovation-Colciencias, www.colciencias.gov.co, grant number: 110152128525, DMC received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrews S., 2012, FASTQC QUALITY CONTR; Avrova AO, 2003, FUNGAL GENET BIOL, V40, P4, DOI 10.1016/S1087-1845(03)00063-X; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Barbazuk WB, 2008, GENOME RES, V18, P1381, DOI 10.1101/gr.053678.106; Bowling SA, 1997, PLANT CELL, V9, P1573, DOI 10.1105/tpc.9.9.1573; Castellanos OF, 2009, AGENA PROSPECTIVA IN; Cazypedia, 2015, CARB ACT ENZ GLYC HY; CCC. Confederacion Colombiana de Caucho, 2013, CENS NAC CAUCH 2011; Chan AP, 2010, NAT BIOTECHNOL, V28, P951, DOI 10.1038/nbt.1674; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Duan JL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-392; Fan HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059997; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Flors V, 2007, PLANT J, V52, P1027, DOI 10.1111/j.1365-313X.2007.03299.x; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Garcia D, 2011, PHYSIOL MOL PLANT P, V76, P126, DOI 10.1016/j.pmpp.2011.07.006; Garcia IA, 2012, ESTUDIO INTERACCION; García Ibonne A., 2011, Rev. colomb. biotecnol, V13, P144; Gibbons JG, 2009, MOL BIOL EVOL, V26, P2731, DOI 10.1093/molbev/msp188; Gordon A, 2012, FASTX TOOLKIT SHORT; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gutterson N, 2004, CURR OPIN PLANT BIOL, V7, P465, DOI 10.1016/j.pbi.2004.04.007; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Harvey AJ, 2000, PROTEINS, V41, P257, DOI 10.1002/1097-0134(20001101)41:2<257::AID-PROT100>3.0.CO;2-C; IRSG. International Rubber Statistical Group, 2014, INT RUBB STAT GROUP, P68; Junqueira NTV, 1989, FITOPATOL BRAS, V14, P147; Junqueira NTV., 1984, REV CERES, V31, P322; Kingston RE, 2010, PREPARATION ANAL RNA, DOI [10.1002/0471142727.mb0400s89, DOI 10.1002/0471142727.MB0400S89]; Langford MH, 1945, TECH B USDA, P1; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; LIEBEREI R, 1983, J RUBBER RES I MALAY, V31, P227; Lieberei R, 2007, ANN BOT-LONDON, V100, P1125, DOI 10.1093/aob/mcm133; Lodha TD, 2012, MOL BIOTECHNOL, V50, P87, DOI 10.1007/s12033-011-9418-2; Lorenzo O, 2003, PLANT CELL, V15, P165, DOI 10.1105/tpc.007468; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Mattos C. R. R., 2003, Fitopatologia Brasileira, V28, P502, DOI 10.1590/S0100-41582003000500006; Nongpiur R, 2012, PLANT SIGNAL BEHAV, V7, P1230, DOI 10.4161/psb.21516; Papanicolaou A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-447; Perazza D, 2011, PLANT PHYSIOL, V157, P1232, DOI 10.1104/pp.111.179804; Rahman A.Y.A., 2013, BMC GENOMICS, V2013, P14; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Salgado LR, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-236; Schmieder R, 2012, BIOINFORMATICS, V28, P433, DOI 10.1093/bioinformatics/btr669; Seyednasrollah F, 2015, BRIEF BIOINFORM, V16, P59, DOI 10.1093/bib/bbt086; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Van Belleghem SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042605; Van der Does D, 2013, PLANT CELL, V25, P744, DOI 10.1105/tpc.112.108548; Varghese YA, 1997, PLANT BREEDING, V116, P47, DOI 10.1111/j.1439-0523.1997.tb00973.x; Venu RC, 2007, MOL GENET GENOMICS, V278, P421, DOI 10.1007/s00438-007-0260-y; Vorwerk S, 2004, TRENDS PLANT SCI, V9, P203, DOI 10.1016/j.tplants.2004.02.005; Ward JA, 2012, AM J BOT, V99, P267, DOI 10.3732/ajb.1100334; Xu L, 2011, J PHYTOPATHOL, V159, P606, DOI 10.1111/j.1439-0434.2011.01813.x	59	11	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0134837	10.1371/journal.pone.0134837	http://dx.doi.org/10.1371/journal.pone.0134837			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287380	Green Published, gold			2022-12-26	WOS:000360018600030
J	Abdallah, HM; Reuland, EA; Wintermans, BB; al Naiemi, N; Koek, A; Abdelwahab, AM; Ammar, AM; Mohamed, AA; Vandenbroucke-Grauls, CMJE				Abdallah, H. M.; Reuland, E. A.; Wintermans, B. B.; al Naiemi, N.; Koek, A.; Abdelwahab, A. M.; Ammar, A. M.; Mohamed, A. A.; Vandenbroucke-Grauls, C. M. J. E.			Extended-Spectrum beta-Lactamases and/or Carbapenemases-Producing Enterobacteriaceae Isolated from Retail Chicken Meat in Zagazig, Egypt	PLOS ONE			English	Article							REAL-TIME PCR; ESCHERICHIA-COLI; CTX-M; STAPHYLOCOCCUS-AUREUS; KLEBSIELLA-PNEUMONIAE; RESISTANCE GENES; HIGH PREVALENCE; EMERGENCE; POULTRY; ANTIBIOTICS	Objectives The aim of the present study was to determine the prevalence and to characterize extended-spectrum beta-lactamases-and/or carbapenemases-producing Enterobacteriaceae among Enterobacteriaceae isolated from retail chicken meat in Zagazig, Egypt. Methods One hundred and six Enterobacteriaceae isolates were collected from retail chicken meat samples purchased in Zagazig, Egypt in 2013. Species identification was done by MALDI-TOF MS. Screening for ESBL-E was performed by inoculation of isolates recovered from meat samples onto the EbSA (Cepheid Benelux, Apeldoorn, the Netherlands) selective screening agar. ESBL production was confirmed by combination disc diffusion test with clavulanic acid (Rosco, Taastrup, Denmark). Carbapenemases production was confirmed with double disk synergy tests. Resistance genes were characterized by PCR with specific primers for TEM, SHV, and CTX-M and carbapenemases (KPC, NDM, OXA-48, IMP and VIM). PCR products of CTX-M genes were purified and sequenced. Phylogenetic grouping of E. coli was performed by a PCR-based method. Results Of these 106 isolates 69 (65.09%) were ESBL producers. Twelve (11.32%) of these isolates were also phenotypically class B carbapenemases producer. TEM genes were detected in 61 (57.55%) isolates. 49 (46.23%) isolates harbored CTX-M genes, and 25 (23.58%) carried genes of the SHV family. All CPE belonged to the NDM group. The predominant CTX-M sequence type was CTX-M-15 (89.80%). The majority (80%) of the ESBL-EC belonged to low virulence phylogroups A and B1. Conclusions This is the first study from Egypt reporting high rates of ESBLs and carbapenemases (65.09% and 11.32%, respectively) in Enterobacteriaceae isolated from retail chicken meat. These results raise serious concerns about public health and food safety as retail meat could serve as a reservoir for these resistant bacteria which could be transferred to humans through the food chain.	[Abdallah, H. M.; Reuland, E. A.; Wintermans, B. B.; al Naiemi, N.; Koek, A.; Vandenbroucke-Grauls, C. M. J. E.] Vrije Univ Amsterdam Med Ctr, Med Microbiol & Infect Control, Amsterdam, Netherlands; [al Naiemi, N.] Lab Med Microbiol & Publ Hlth, Hengelo, Netherlands; [al Naiemi, N.] Ziekenhuisgroep Twente, Microbiol & Infect Control, Amsterdam, Netherlands; [Abdelwahab, A. M.; Ammar, A. M.; Mohamed, A. A.] Zagazig Univ, Fac Vet Med, Dept Bacteriol Mycol & Immunol, Zagazig, Egypt	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Egyptian Knowledge Bank (EKB); Zagazig University	Abdallah, HM (corresponding author), Vrije Univ Amsterdam Med Ctr, Med Microbiol & Infect Control, Amsterdam, Netherlands.	bactine_ho@yahoo.com	Vandenbroucke-Grauls, Christina/AAO-7953-2020	Vandenbroucke-Grauls, Christina/0000-0003-2074-1597; abdallah, Hossam/0000-0003-0384-7322	Egyptian high education ministry; VU medical center, the Netherlands	Egyptian high education ministry(Ministry of Higher Education & Scientific Research (MHESR)); VU medical center, the Netherlands	The research is funded by the joint supervision mission between Egyptian high education ministry and VU medical center, the Netherlands.	Abdelaziz MO, 2013, J GLOB ANTIMICROB RE, V1, P213, DOI 10.1016/j.jgar.2013.06.003; Al Naiemi N, 2009, EUR J CLIN MICROBIOL, V28, P989, DOI 10.1007/s10096-009-0714-8; Al Naiemi N, NVMM GUIDELINE LAB D; Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Ben-Ami R, 2009, CLIN INFECT DIS, V49, P682, DOI 10.1086/604713; Blaak H, 2014, APPL ENVIRON MICROB, V80, P239, DOI 10.1128/AEM.02616-13; Borjesson S, 2013, APPL ENVIRON MICROB, V79, P2463, DOI 10.1128/AEM.03893-12; Bouchillon SK, 2004, INT J ANTIMICROB AG, V24, P119, DOI 10.1016/j.ijantimicag.2004.01.010; Campos CB, 2014, INT J MED MICROBIOL, V304, P678, DOI 10.1016/j.ijmm.2014.04.012; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; CLSI, 2014, PERF STAND ANT; Coleman K, 2011, CURR OPIN MICROBIOL, V14, P550, DOI 10.1016/j.mib.2011.07.026; Cox NA, 2010, J FOOD PROTECT, V73, P976, DOI 10.4315/0362-028X-73.5.976; De Medici D, 2003, APPL ENVIRON MICROB, V69, P3456, DOI 10.1128/AEM.69.6.3456-3461.2003; Doi Y, 2010, CLIN MICROBIOL INFEC, V16, P33, DOI 10.1111/j.1469-0691.2009.03001.x; Essack SY, 2001, PHARM RES-DORDR, V18, P1391, DOI 10.1023/A:1012272403776; Fischer J, 2013, J ANTIMICROB CHEMOTH, V68, P478, DOI 10.1093/jac/dks393; Guerra B, 2014, VET MICROBIOL, V171, P290, DOI 10.1016/j.vetmic.2014.02.001; Hughes LA, 2013, EQUINE VET J, V45, P141, DOI 10.1111/j.2042-3306.2012.00602.x; Kluytmans JAJW, 2013, CLIN INFECT DIS, V56, P478, DOI 10.1093/cid/cis929; Kola A, 2012, J ANTIMICROB CHEMOTH, V67, P2631, DOI 10.1093/jac/dks295; Leverstein-van Hall MA, 2011, CLIN MICROBIOL INFEC, V17, P873, DOI 10.1111/j.1469-0691.2011.03497.x; Livermore DM, 2005, J ANTIMICROB CHEMOTH, V56, P451, DOI 10.1093/jac/dki239; Mulvey MR, 2003, J CLIN MICROBIOL, V41, P460, DOI 10.1128/JCM.41.1.460-462.2003; Naas T, 2007, ANTIMICROB AGENTS CH, V51, P223, DOI 10.1128/AAC.00611-06; Olesen I, 2004, MICROB DRUG RESIST, V10, P334, DOI 10.1089/mdr.2004.10.334; Overdevest I, 2011, EMERG INFECT DIS, V17, P1216, DOI 10.3201/eid1707.110209; Pasteran F, 2009, J CLIN MICROBIOL, V47, P1631, DOI 10.1128/JCM.00130-09; Poirel L, 2011, J ANTIMICROB CHEMOTH, V66, P2781, DOI 10.1093/jac/dkr384; Poirel L, 2011, DIAGN MICR INFEC DIS, V70, P119, DOI 10.1016/j.diagmicrobio.2010.12.002; Poole K, 2004, CELL MOL LIFE SCI, V61, P2200, DOI 10.1007/s00018-004-4060-9; Randall LP, 2011, J ANTIMICROB CHEMOTH, V66, P86, DOI 10.1093/jac/dkq396; Rawat D, 2010, J GLOB INFECT DIS, V2, P263, DOI 10.4103/0974-777X.68531; Schaumburg F, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0286-3; Seiffert SN, 2013, ANTIMICROB AGENTS CH, V57, P6406, DOI 10.1128/AAC.01773-13; Shahcheraghi F, 2013, MICROB DRUG RESIST, V19, P30, DOI 10.1089/mdr.2012.0078; Sonnevend A, 2013, J MED MICROBIOL, V62, P1044, DOI 10.1099/jmm.0.059014-0; Tsakris A, 2009, J CLIN MICROBIOL, V47, P362, DOI 10.1128/JCM.01922-08; Wang LJ, 2012, ANN CLIN MICROB ANTI, V11, DOI 10.1186/1476-0711-11-9; Weill FX, 2004, J CLIN MICROBIOL, V42, P2432, DOI 10.1128/JCM.42.6.2432-2437.2004	40	48	51	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0136052	10.1371/journal.pone.0136052	http://dx.doi.org/10.1371/journal.pone.0136052			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284654	Green Published, gold, Green Submitted			2022-12-26	WOS:000359666100098
J	Motbainor, A; Worku, A; Kumie, A				Motbainor, Achenef; Worku, Alemayehu; Kumie, Abera			Stunting Is Associated with Food Diversity while Wasting with Food Insecurity among Underfive Children in East and West Gojjam Zones of Amhara Region, Ethiopia	PLOS ONE			English	Article								Background Food insecurity has detrimental effects in protecting child undernutrition. This study sought to determine the level of child undernutrition and its association with food insecurity. Methods A community based comparative cross-sectional study design involving multistage sampling technique was implemented from 24th of May to 20th of July 2013. Using two population proportion formula, a total of 4110 randomly selected households were included in the study. Availability of the productive safety net programme was used for grouping the study areas. A multiple linear regression model was used to assess the association between food insecurity and child malnutrition. Clustering effects of localities were controlled during analysis. Results Stunting (37.5%), underweight (22.0%) and wasting (17.1%) were observed in East Gojjam zone, while 38.3% stunting, 22.5% underweight, and 18.6% wasting for the West Gojjam zone. Food insecurity was significantly associated with wasting (beta = -0.108, P < 0.05). Food diversity and number of meals the child ate per day significantly associated with stunting (beta = 0.039, P < 0.01) and underweight (beta = 0.035, P < 0.05) respectively. Residential area was the significant predictor of all indices. Conclusion The magnitude of child undernutrition was found to be very high in the study areas. Food insecurity was the significant determinant of wasting. Food diversity and number of meals the child ate per day were the significant determinants of stunting and underweight respectively. Child nutrition intervention strategies should take into account food security, dietary diversity, and carefully specified with regard to residential locations. Addressing food insecurity is of paramount importance.	[Motbainor, Achenef; Worku, Alemayehu; Kumie, Abera] Univ Addis Ababa, Coll Hlth Sci, Sch Publ Hlth, Addis Ababa, Ethiopia	Addis Ababa University	Motbainor, A (corresponding author), Univ Addis Ababa, Coll Hlth Sci, Sch Publ Hlth, Addis Ababa, Ethiopia.	motbainor2@gmail.com	Kumie, Abera/AAC-8537-2022	Motbainor, Achenef/0000-0001-7620-5780	Addis Ababa University	Addis Ababa University	This study was funded by Addis Ababa University, School of Public Health who provide money for data collection. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali D, 2013, J NUTR, V143, P2015, DOI 10.3945/jn.113.175182; [Anonymous], 2013, STATE FOOD INSECURIT; [Anonymous], 2005, MAN MEAS INT MALN MO; Belachew T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-604; Coates J., 2007, FOOD NUTR TECHNICAL, DOI 10.1007/s13398-014-0173-7.2; Demissie S., 2013, SCI J PUBLIC HLTH, V1, P175, DOI [10.11648/j.sjph.20130104.12, DOI 10.11648/J.SJPH.20130104.12]; Derseh B., 2014, OALIB, V01, P1; Development ABoFaE, 2014, POP SIZ SEX AG GROUP; Endale Worku, 2014, BMC Res Notes, V7, P130, DOI 10.1186/1756-0500-7-130; Ethiopia FDRo, 2008, NAT NUTR STRAT ADD A; Furness BW, 2004, PUBLIC HEALTH NUTR, V7, P791, DOI 10.1079/PHN2004608; Gebre GG, 2012, INTERDISCIP DESCR CO, V10, P159; Ghattas H., 2014, FOOD SECURITY NUTR C; Gilberto K, 2012, PLOS ONE, V7, P1, DOI [10.1371/journal.pone.0045747, DOI 10.1371/J0URNAL.P0NE.0045747]; Gudina E, 2014, BMC PEDIAT, V14; Hasan M.M., 2013, J FOOD SECURITY, V1, P52; International CSAEaI, 2012, ETH DEM HLTH SURV 20; Isanaka S, 2007, J NUTR, V137, P2747, DOI 10.1093/jn/137.12.2747; Jesmin A, 2011, J HEALTH POPUL NUTR, V29, P494; Kandala NB, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-261; Keino S, 2014, AGR FOOD SECUR, V3, P2, DOI [10.1186/2048-7010-3-2, DOI 10.1186/2048-7010-3-2]; Lutter CK, 2011, PEDIATRICS, V128, pE1418, DOI 10.1542/peds.2011-1392; Masresha T, 2013, PAN AFRICAN MED J, V14, DOI 10.11604/pamj.2013.14.75.1630; Mercedes d.O., 1997, WHO GLOBAL DATABASE; Nguyen Ngoc Hien, 2009, Pakistan Journal of Nutrition, V8, P958; Noreen W, 2011, STAT CANADA HLTH REP, V22; Oluwole SI., 2012, J MED MED SCI, V3, P005; Osei A, 2010, FOOD NUTR BULL, V31, P483, DOI 10.1177/156482651003100402; Paudel R, 2012, Kathmandu Univ Med J (KUMJ), V10, P18; Rachel S, 2006, ETHIOPIA PRODUCTIVE; Saha KK, 2009, PUBLIC HEALTH NUTR, V12, P1556, DOI 10.1017/S1368980009004765; Santos Leonardo Pozza dos, 2013, Rev. bras. epidemiol., V16, P984, DOI 10.1590/S1415-790X2013000400018; Sarah C-B, 2013, TARGETING FOOD SECUR; Seligman HK, 2010, J NUTR, V140, P304, DOI 10.3945/jn.109.112573; Shaibu MO, 2013, J POPULATION RES, V12; Solomon Amsalu, 2008, Ethiopian Journal of Health Development, V22, P21; State AR, 2002, STRAT PLAN SUST DEV; Stephanie P, 2012, POPULATION HLTH METR, V10; Teshome B, 2009, ETHIOP J HEALTH DEV, V23, P98; Willows ND, 2009, PUBLIC HEALTH NUTR, V12, P1150, DOI 10.1017/S1368980008004345; Wondimagegn ZT, 2014, CURR RES NUTR FOOD S, V2, P88, DOI 10.12944/CRNFSJ.2.2.05; Zipporah NB, 2014, J NUTR METABOLISM, V2014	42	61	62	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0133542	10.1371/journal.pone.0133542	http://dx.doi.org/10.1371/journal.pone.0133542			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285047	Green Published, gold, Green Submitted			2022-12-26	WOS:000359666100005
J	Oshoma, CE; Greetham, D; Louis, EJ; Smart, KA; Phister, TG; Powell, C; Du, CY				Oshoma, Cyprian E.; Greetham, Darren; Louis, Edward J.; Smart, Katherine A.; Phister, Trevor G.; Powell, Chris; Du, Chenyu			Screening of Non- Saccharomyces cerevisiae Strains for Tolerance to Formic Acid in Bioethanol Fermentation	PLOS ONE			English	Article							ACETIC-ACID; PHENOTYPIC CHARACTERIZATION; ETHANOL PRODUCTIVITY; YEAST; INHIBITORS; GROWTH; GLYCOGEN; TREHALOSE; IDENTIFICATION; ADAPTATION	Formic acid is one of the major inhibitory compounds present in hydrolysates derived from lignocellulosic materials, the presence of which can significantly hamper the efficiency of converting available sugars into bioethanol. This study investigated the potential for screening formic acid tolerance in non-Saccharomyces cerevisiae yeast strains, which could be used for the development of advanced generation bioethanol processes. Spot plate and phenotypic microarray methods were used to screen the formic acid tolerance of 7 non-Saccharomyces cerevisiae yeasts. S. kudriavzeii IFO1802 and S. arboricolus 2.3319 displayed a higher formic acid tolerance when compared to other strains in the study. Strain S. arboricolus 2.3319 was selected for further investigation due to its genetic variability among the Saccharomyces species as related to Saccharomyces cerevisiae and availability of two sibling strains: S. arboricolus 2.3317 and 2.3318 in the lab. The tolerance of S. arboricolus strains (2.3317, 2.3318 and 2.3319) to formic acid was further investigated by lab-scale fermentation analysis, and compared with S. cerevisiae NCYC2592. S. arboricolus 2.3319 demonstrated improved formic acid tolerance and a similar bioethanol synthesis capacity to S. cerevisiae NCYC2592, while S. arboricolus 2.3317 and 2.3318 exhibited an overall inferior performance. Metabolite analysis indicated that S. arboricolus strain 2.3319 accumulated comparatively high concentrations of glycerol and glycogen, which may have contributed to its ability to tolerate high levels of formic acid.	[Oshoma, Cyprian E.; Greetham, Darren; Powell, Chris; Du, Chenyu] Univ Nottingham, Sch Biosci, Loughborough, Leics, England; [Louis, Edward J.] Univ Leicester, Ctr Genet Architecture Complex Traits, Leicester, Leics, England; [Smart, Katherine A.] SAB Miller PLC, Surrey, England; [Phister, Trevor G.] PepsiCo Int Beaumont Pk, Leicester, Leics, England; [Du, Chenyu] Univ Huddersfield, Sch Appl Sci, Huddersfield HD1 3DH, W Yorkshire, England	University of Nottingham; University of Leicester; Anheuser-Busch InBev; SABMiller; PepsiCo; University of Huddersfield	Du, CY (corresponding author), Univ Nottingham, Sch Biosci, Bioenergy & Brewing Sci Bldg, Loughborough, Leics, England.	C.du@hud.ac.uk	Powell, Chris/Y-2298-2019; Louis, Edward/B-7920-2008	Powell, Chris/0000-0001-9524-8137; Louis, Edward/0000-0003-1157-3608; Oshoma, Cyprian/0000-0002-1063-6286; Du, Chenyu/0000-0002-8216-0504	Biotechnology and Biological Sciences Research Council (BBSRC), under the programme of Lignocellulosic Conversion to Ethanol (LACE) [BB/G01616X/1]; Educational Trust Fund from the University of Benin, Benin City, Nigeria for Cyprian Oshoma's PhD scholarship; SAB Miller PLC; PepsiCo Int.; Biotechnology and Biological Sciences Research Council [BB/G01616X/1, BB/L022508/1] Funding Source: researchfish; BBSRC [BB/L022508/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC), under the programme of Lignocellulosic Conversion to Ethanol (LACE)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Educational Trust Fund from the University of Benin, Benin City, Nigeria for Cyprian Oshoma's PhD scholarship; SAB Miller PLC; PepsiCo Int.; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Biotechnology and Biological Sciences Research Council (BBSRC), under the programme of Lignocellulosic Conversion to Ethanol (LACE) (BB/G01616X/1, www.bbsrc.ac.uk). The authors also thank the financial support provided by Educational Trust Fund from the University of Benin, Benin City, Nigeria for Cyprian Oshoma's PhD scholarship. SAB Miller PLC and PepsiCo Int. provided support in the form of salaries for authors KAS and TGP, respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. KAS and TGP moved to SABMiller and PepsiCo, during this project, after which they were not involved in any further research. The specific roles of these authors are articulated in the 'author contributions' section.	Almeida JRM, 2009, BIORESOURCE TECHNOL, V100, P3674, DOI 10.1016/j.biortech.2009.02.057; Almeida JRM, 2007, J CHEM TECHNOL BIOT, V82, P340, DOI 10.1002/jctb.1676; Barber AR, 2000, J IND MICROBIOL BIOT, V25, P104, DOI 10.1038/sj.jim.7000031; Bauer BE, 2003, EUR J BIOCHEM, V270, P3189, DOI 10.1046/j.1432-1033.2003.03701.x; Bochner BR, 2009, FEMS MICROBIOL REV, V33, P191, DOI 10.1111/j.1574-6976.2008.00149.x; Casey E, 2010, FEMS YEAST RES, V10, P385, DOI 10.1111/j.1567-1364.2010.00623.x; Chandel A. K., 2007, Biotechnology and Molecular Biology Reviews, V2, P014; Deshpande PS, 2011, J I BREWING, V117, P113, DOI 10.1002/j.2050-0416.2011.tb00451.x; Francois J, 2001, FEMS MICROBIOL REV, V25, P125, DOI 10.1016/S0168-6445(00)00059-0; Fujita Y, 2002, APPL ENVIRON MICROB, V68, P5136, DOI 10.1128/AEM.68.10.5136-5141.2002; Greetham D, 2014, J IND MICROBIOL BIOT; Hasunuma T, 2012, BIOTECHNOL ADV, V30, P1207, DOI 10.1016/j.biotechadv.2011.10.011; Hasunuma T, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-2; Hasunuma T, 2011, APPL MICROBIOL BIOT, V90, P997, DOI 10.1007/s00253-011-3085-x; Homann OR, 2005, PLOS GENET, V1, P715, DOI 10.1371/journal.pgen.0010080; Huang HZ, 2011, BIORESOURCE TECHNOL, V102, P7486, DOI 10.1016/j.biortech.2011.05.008; Ivanova V., 2011, INT REV CHEM ENG, V3, P289, DOI [10.48550/arXiv.1105.0619, DOI 10.48550/ARXIV.1105.0619]; Keating JD, 2006, BIOTECHNOL BIOENG, V93, P1196, DOI 10.1002/bit.20838; Larsson S, 1999, ENZYME MICROB TECH, V24, P151, DOI 10.1016/S0141-0229(98)00101-X; Liti G, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-69; Martin C, 2002, WORLD J MICROB BIOT, V18, P857, DOI 10.1023/A:1021258708507; Naumov GI, 2010, ANTON LEEUW INT J G, V98, P1, DOI 10.1007/s10482-010-9441-5; Palmqvist E, 2000, BIORESOURCE TECHNOL, V74, P25, DOI 10.1016/S0960-8524(99)00161-3; Palmqvist E, 1999, BIOTECHNOL BIOENG, V63, P46, DOI 10.1002/(SICI)1097-0290(19990405)63:1<46::AID-BIT5>3.0.CO;2-J; Palmqvist E, 2000, BIORESOURCE TECHNOL, V74, P17, DOI 10.1016/S0960-8524(99)00160-1; Pampulha ME, 2000, FEMS MICROBIOL LETT, V184, P69, DOI 10.1016/S0378-1097(00)00022-7; Parrou JL, 1997, ANAL BIOCHEM, V248, P186, DOI 10.1006/abio.1997.2138; SAMI M, 1994, J FERMENT BIOENG, V78, P212, DOI 10.1016/0922-338X(94)90292-5; Samokhvalov VA, 2004, MICROBIOLOGY+, V73, P378, DOI 10.1023/B:MICI.0000036979.96786.78; Somani A, 2012, J AM SOC BREW CHEM, V70, P123, DOI 10.1094/ASBCJ-2012-0427-01; Sun WL, 2010, AFR J MICROBIOL RES, V4, P1105; Sun Y, 2002, BIORESOURCE TECHNOL, V83, P1, DOI 10.1016/S0960-8524(01)00212-7; Taherzadeh MJ, 1999, J BIOSCI BIOENG, V87, P169, DOI 10.1016/S1389-1723(99)89007-0; Taherzadeh MJ, 1997, CHEM ENG SCI, V52, P2653, DOI 10.1016/S0009-2509(97)00080-8; Taherzadeh MJ, 2000, APPL MICROBIOL BIOT, V53, P701, DOI 10.1007/s002530000328; Taherzadeh MJ, 2000, BIOTECHNOL BIOENG, V69, P330, DOI [10.1002/1097-0290(20000805)69:3<330::AID-BIT11>3.0.CO;2-Q, 10.1002/1097-0290(20000805)69:3&lt;330::AID-BIT11&gt;3.0.CO;2-Q]; Tomas-Pejo E, 2010, J IND MICROBIOL BIOT, V37, P1211, DOI 10.1007/s10295-010-0768-8; van Maris AJA, 2006, ANTON LEEUW INT J G, V90, P391, DOI 10.1007/s10482-006-9085-7; van Wyk JPH, 2001, TRENDS BIOTECHNOL, V19, P172, DOI 10.1016/S0167-7799(01)01601-8; VERDUYN C, 1992, YEAST, V8, P501, DOI 10.1002/yea.320080703; Walker G.M., 1998, YEAST PHYSL BIOTECHN; Wang SA, 2008, INT J SYST EVOL MICR, V58, P510, DOI 10.1099/ijs.0.65331-0; Wikandari R., 2010, AGR J, V5, P105, DOI DOI 10.3923/aj.2010.105.109; Wimalasena TT, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-47; Zheng DQ, 2011, BIORESOURCE TECHNOL, V102, P3020, DOI 10.1016/j.biortech.2010.09.122	45	10	11	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135626	10.1371/journal.pone.0135626	http://dx.doi.org/10.1371/journal.pone.0135626			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284784	Green Published, Green Accepted, gold			2022-12-26	WOS:000359666100051
J	Zhao, JN; Zhang, XX; He, XC; Yang, GR; Zhang, XQ; Xin, WG; Li, HC				Zhao, Jiang-nan; Zhang, Xian-xin; He, Xiao-chun; Yang, Guo-ru; Zhang, Xiao-qi; Xin, Wen-gen; Li, Huai-chen			Multidrug-Resistant Tuberculosis in Patients with Chronic Obstructive Pulmonary Disease in China	PLOS ONE			English	Article							RISK-FACTORS; DRUG-RESISTANCE; PREVALENCE	Background Relatively little is known about the specific relationship and impact from chronic obstructive pulmonary disease (COPD) on multidrug-resistant tuberculsosis (MDR-TB). Methods We conducted a retrospective study included patients aged >= 40 years with a confirmed pulmonary TB at three tertiary hospitals (Shandong, China) between January 2011 and October 2014. Univariable and multivariable analyses were performed to identify the relationship of MDR-TB and COPD. Results A total of 2164 patients aged >= 40 years with available results of drug susceptibility test (DST) and medical records were screened for this study: 268 patients with discharge diagnosis of COPD and 1896 patients without COPD. Overall, 14.2% of patients with COPD and 8.5% patients without COPD were MDR-TB. The rate of MDR-TB were significantly higher in patients with COPD (P<0.05). Migrant (odds ratios (OR) 1.32, 95% confidence interval (CI) 1.02-1.72), previous anti-TB treatment (OR 4.58, 95% CI 1.69-12.42), cavity (OR 2.33, 95% CI 1.14-4.75), and GOLD stage (OR 1.86, 95% CI 1.01-2.93) were the independent predictors for MDR-TB among patients with COPD. Conclusions MDR-TB occurs more frequently in patients with underlying COPD, especially those with being migrant, previous anti-TB therapy, cavity and severe airway obstruction.	[Zhao, Jiang-nan; He, Xiao-chun; Li, Huai-chen] Shandong Univ, Prov Hosp, Dept Resp Med, Jinan 250100, Peoples R China; [Zhang, Xian-xin] Shandong Prov Chest Hosp, Dept Resp Med, Jinan, Peoples R China; [Yang, Guo-ru] Chest Specially Hosp Weifang, Dept Resp Med, Weifang, Peoples R China; [Zhang, Xiao-qi; Xin, Wen-gen] Chest Specially Hosp Weifang, Dept TB Med, Weifang, Peoples R China	Shandong University; Shandong University	Li, HC (corresponding author), Shandong Univ, Prov Hosp, Dept Resp Med, Jinan 250100, Peoples R China.	zjn911016@126.com			Science and Technology Development plan of Shandong Province [2009GG10002054]	Science and Technology Development plan of Shandong Province	This work was supported by a Science and Technology Development plan of Shandong Province (Grant Number: 2009GG10002054). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, GUID SURV DRUG RES T; Arevalo M, 1996, EUR RESPIR J, V9, P274, DOI 10.1183/09031936.96.09020274; Bastos ML, 2014, CLIN INFECT DIS, V59, P1364, DOI 10.1093/cid/ciu619; Caminero JA, 2010, INT J TUBERC LUNG D, V14, P382; Chakrabarti Biswajit, 2007, Int J Chron Obstruct Pulmon Dis, V2, P263; Daley CL, 2014, CLIN INFECT DIS, V59, P1064, DOI 10.1093/cid/ciu578; Faustini A, 2006, THORAX, V61, P158, DOI 10.1136/thx.2005.045963; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Gunther G, 2015, EMERG INFECT DIS; Hnizdo E, 2000, THORAX, V55, P32, DOI 10.1136/thorax.55.1.32; Inghammar M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010138; Kim JH, 2013, CHEST, V143, P1018, DOI 10.1378/chest.12-1225; Kiran B, 2010, ARCH MED SCI, V6, P77, DOI 10.5114/aoms.2010.13511; Kliiman K, 2009, EUR RESPIR J, V33, P1085, DOI 10.1183/09031936.00155708; Lam KBH, 2010, CHEST, V137, P593, DOI 10.1378/chest.09-1435; Lee CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037978; Leimane V, 2005, LANCET, V365, P318, DOI 10.1016/S0140-6736(05)17786-1; Liang LB, 2012, THORAX, V67, P632, DOI 10.1136/thoraxjnl-2011-200018; Liu CH, 2011, RESPIROLOGY, V16, P918, DOI 10.1111/j.1440-1843.2011.01990.x; Long R, 2009, CLIN INFECT DIS, V48, P1354, DOI 10.1086/598196; Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Ruddy M, 2005, THORAX, V60, P130, DOI 10.1136/thx.2004.026922; Sharma SK, 2003, INFECT GENET EVOL, V3, P183, DOI 10.1016/S1567-1348(03)00086-8; Shen X, 2009, INT J TUBERC LUNG D, V13, P253; Temple B, 2008, CLIN INFECT DIS, V47, P1126, DOI 10.1086/592252; World Health Organization, 2011, GUID PROGR MAN DRUG; World Health Organization, 2014, GLOB TUB REP; Zhao YL, 2012, NEW ENGL J MED, V366, P2161, DOI 10.1056/NEJMoa1108789; Zhong N, 2007, AM J RESP CRIT CARE, V176, P753, DOI 10.1164/rccm.200612-1749OC	30	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135205	10.1371/journal.pone.0135205	http://dx.doi.org/10.1371/journal.pone.0135205			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284920	Green Published, Green Submitted, gold			2022-12-26	WOS:000359666100028
J	Liu, ZY; Li, XL; Wang, ZL; Sun, QZ				Liu, Zhiying; Li, Xiliang; Wang, Zongli; Sun, Qizhong			Contrasting Strategies of Alfalfa Stem Elongation in Response to Fall Dormancy in Early Growth Stage: The Tradeoff between Internode Length and Internode Number	PLOS ONE			English	Article							WINTER HARDINESS; CYTOCHROME-P450 MONOOXYGENASE; STELLARIA-LONGIPES; ROOT PHYSIOLOGY; NUTRITIVE-VALUE; LIGHT QUALITY; LEAF; GIBBERELLINS; TISSUES; TRAITS	Fall dormancy (FD) in alfalfa (Medicago sativa L.) can be described using 11 FD ratings, is widely used as an important indicator of stress resistance, productive performance and spring growth. However, the contrasting growth strategies in internode length and internode number in alfalfa cultivars with different FD rating are poorly understood. Here, a growth chamber study was conducted to investigate the effect of FD on plant height, aboveground biomass, internode length, and internode number in alfalfa individuals in the early growth stages. In order to simulate the alfalfa growth environment in the early stage, 11 alfalfa cultivars with FD ratings from one to 11 were chosen and seeded at the greenhouse, and then were transplanted into an artificial growth chamber. The experimental design was a randomized complete block in a split-plot arrangement with three replicates. Plant height, above-ground biomass, internode length, and internode number were measured in early growth stage in all individuals. Our findings showed that plant height and the aboveground biomass of alfalfa did not significantly differ among 11 different FD rated cultivars. Also, internode length and internode number positively affected plant height and the aboveground biomass of alfalfa individuals and the average internode length significantly increased with increasing FD rating. However, internode number tended to sharply decline when the FD rating increased. Moreover, there were no correlations, slightly negative correlations, and strongly negative correlations between internode length and internode number in alfalfa individuals among the three scales, including within-FD ratings, within-FD categories and inter-FD ratings, respectively. Therefore, our results highlighted that contrasting growth strategies in stem elongation were adopted by alfalfa with different FD ratings in the early growth stage. Alfalfa cultivars with a high FD rating have longer internodes, whereas more dormant alfalfa cultivars have a larger number of internodes. There were tradeoffs between internode length and internode number in response to FD in alfalfa, which reflected certain scale-dependence.	[Liu, Zhiying; Li, Xiliang; Wang, Zongli; Sun, Qizhong] Chinese Acad Agr Sci, Inst Grassland Res, Hohhot, Peoples R China; [Liu, Zhiying; Li, Xiliang] Chinese Acad Agr Sci, Grad Sch, Beijing, Peoples R China; [Wang, Zongli] Minist Agr, Dept Anim Husb, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Grassland Research, CAAS; Chinese Academy of Agricultural Sciences; Graduate School, CAAS; Ministry of Agriculture & Rural Affairs	Sun, QZ (corresponding author), Chinese Acad Agr Sci, Inst Grassland Res, Hohhot, Peoples R China.	sunqz@126.com			China Agriculture Research System [CARS-35]; Agricultural Science and Technology Innovation Program of CAAS [CAAS-ASTIP-IGR 2015-02]	China Agriculture Research System; Agricultural Science and Technology Innovation Program of CAAS	This research was supported by the China Agriculture Research System (CARS-35) and the Agricultural Science and Technology Innovation Program of CAAS (CAAS-ASTIP-IGR 2015-02).	Anderson Edgar, 1944, ANN MISSOURI BOT GARD, V31, P241, DOI 10.2307/2394288; Barillot R, 2014, ANN BOT-LONDON, V114, P725, DOI 10.1093/aob/mcu099; Brock MT, 2010, MOL ECOL, V19, P1187, DOI 10.1111/j.1365-294X.2010.04538.x; BROWN LG, 1990, AGRON J, V82, P267, DOI 10.2134/agronj1990.00021962008200020018x; Brummer EC, 2000, CROP SCI, V40, P971, DOI 10.2135/cropsci2000.404971x; Brummer EC, 2002, AGRON J, V94, P782; Buck-Sorlin GH, 2005, NEW PHYTOL, V166, P859, DOI 10.1111/j.1469-8137.2005.01324.x; Cici SZH, 2008, ANN BOT-LONDON, V101, P1311, DOI 10.1093/aob/mcn040; Cunningham SM, 2003, CROP SCI, V43, P562, DOI 10.2135/cropsci2003.0562; Cunningham SM, 2001, CROP SCI, V41, P1091, DOI 10.2135/cropsci2001.4141091x; de Saint Germain A, 2013, PLANT PHYSIOL, V163, P1012, DOI 10.1104/pp.113.220541; Dong C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023942; Engels FM, 2005, ANIM FEED SCI TECH, V120, P309, DOI 10.1016/j.anifeedsci.2005.03.003; Engels FM, 1998, ANN BOT-LONDON, V82, P561, DOI 10.1006/anbo.1998.0705; Haagenson DM, 2003, CROP SCI, V43, P1441, DOI 10.2135/cropsci2003.1441; Hedden P, 1997, ANNU REV PLANT PHYS, V48, P431, DOI 10.1146/annurev.arplant.48.1.431; HEICHEL GH, 1990, CROP SCI, V30, P1123, DOI 10.2135/cropsci1990.0011183X003000050033x; INGRAM TJ, 1987, PLANT PHYSIOL, V83, P1048, DOI 10.1104/pp.83.4.1048; JONES FR, 1950, AGRON J, V42, P432, DOI 10.2134/agronj1950.00021962004200090003x; Jung HG, 2006, CROP SCI, V46, P2054, DOI 10.2135/cropsci2005.12.0470; Jung HG, 2002, CROP SCI, V42, P524, DOI 10.2135/cropsci2002.0524; Kallenbach RL, 2002, AGRON J, V94, P1094, DOI 10.2134/agronj2002.1094; KAUFMAN PB, 1976, PLANT PHYSIOL, V58, P131, DOI 10.1104/pp.58.2.131; Kurepin LV, 2007, J EXP BOT, V58, P2145, DOI 10.1093/jxb/erm068; Kurepin LV, 2006, PLANT CELL ENVIRON, V29, P1319, DOI 10.1111/j.1365-3040.2006.01512.x; Kurepin LV, 2006, PLANT CELL ENVIRON, V29, P647, DOI 10.1111/j.1365-3040.2005.01443.x; Lauriault L.M., 2009, FORAGE GRAZINGLANDS, V7, P1, DOI [10.1094/fg-2009-0508-01-rs, DOI 10.1094/FG-2009-0508-01-RS]; Lemerle D, 2001, AUST J AGR RES, V52, P527, DOI 10.1071/AR00056; Luo AD, 2006, PLANT CELL PHYSIOL, V47, P181, DOI 10.1093/pcp/pci233; Malinowski DP, 2007, AGRON J, V99, P621, DOI 10.2134/agronj2006.0056; Marquez-Ortiz J. J., 1999, Crop Science, V39, P38; PERRY LJ, 1974, CROP SCI, V14, P693, DOI 10.2135/cropsci1974.0011183X001400050025x; Retta A, 2000, AGRON J, V92, P225, DOI 10.1007/s100870050026; Rimi F, 2014, AGRON J, V106, P1258, DOI 10.2134/agronj13.0495; Rimi F, 2012, AGRON J, V104, P415, DOI 10.2134/agronj2011.0222; Rimi F, 2010, AGRON J, V102, P1578, DOI 10.2134/agronj2010.0193; Sheaffer CC, 2000, AGRON J, V92, P733, DOI 10.2134/agronj2000.924733x; SHERIDAN KP, 1968, CROP SCI, V8, P289, DOI 10.2135/cropsci1968.0011183X00080003008x; SPRAGUE M. A., 1941, JOUR AMER SOC AGRON, V33, P437; SPRAY C, 1984, PLANTA, V160, P464, DOI 10.1007/BF00429764; Teuber L.R., 1998, STANDARD TESTS CHARA, pA; Vandenbussche F, 2005, CURR OPIN PLANT BIOL, V8, P462, DOI 10.1016/j.pbi.2005.07.007; Ventroni LM, 2010, FIELD CROP RES, V119, P252, DOI 10.1016/j.fcr.2010.07.015; VOLENEC JJ, 1985, CROP SCI, V25, P822, DOI 10.2135/cropsci1985.0011183X002500050023x; Wang CZ, 2009, AGRON J, V101, P1146, DOI 10.2134/agronj2009.0026; Wang ChengZhang, 2006, Acta Prataculturae Sinica, V15, P30; Weishaar MA, 2005, CROP SCI, V45, P60, DOI 10.2135/cropsci2005.0060; Williams R. W., 1996, Proceedings of the 8th Australian Agronomy Conference, Toowoomba, Queensland, Australia, 30 January-2 February, 1996., P586; Woodman HE, 1935, J AGR SCI, V25, P578, DOI 10.1017/S0021859600019675; Yoshida S, 1981, FUNDAMENTALS RICE CR; Zhu YY, 2006, PLANT CELL, V18, P442, DOI 10.1105/tpc.105.038455	51	7	9	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0135934	10.1371/journal.pone.0135934	http://dx.doi.org/10.1371/journal.pone.0135934			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26281014	gold, Green Published, Green Submitted			2022-12-26	WOS:000359664300027
J	Akasheva, DU; Plokhova, EV; Tkacheva, ON; Strazhesko, ID; Dudinskaya, EN; Kruglikova, AS; Pykhtina, VS; Brailova, NV; Pokshubina, IA; Sharashkina, NV; Agaltsov, MV; Skvortsov, D; Boytsov, SA				Akasheva, Dariga U.; Plokhova, Ekaterina V.; Tkacheva, Olga N.; Strazhesko, Irina D.; Dudinskaya, Ekaterina N.; Kruglikova, Anna S.; Pykhtina, Valentina S.; Brailova, Natalia V.; Pokshubina, Inna A.; Sharashkina, Natalia V.; Agaltsov, Mikhail V.; Skvortsov, Dmitry; Boytsov, Sergey A.			Age-Related Left Ventricular Changes and Their Association with Leukocyte Telomere Length in Healthy People	PLOS ONE			English	Article							DIASTOLIC FUNCTION; HEART-FAILURE; CARDIOVASCULAR-DISEASE; SYSTOLIC FUNCTION; ATHEROSCLEROSIS; CARDIOMYOCYTE; PARAMETERS; ATTRITION; HUMANS; TISSUE	Introduction With advancing age the left ventricle (LV) undergoes structural and functional changes, thereby creating the substrate for the development of diseases. One possible mechanism of the ageing heart is a cellular senescence. Leukocyte telomere length (LTL) is a marker of replicative ageing. The purpose of this study was to evaluate the structure and function of the LV in people of different ages free of cardiovascular diseases (CVD) and regular drug medication and to assess their relationship with LTL. We hypothesized that age-related changes in LV myocardium are associated with telomere length. Methods The study population consisted of 150 healthy, non-obese volunteers aged 28 to 78 years without history of CVD, significant deviations by 12-lead electrocardiogram and negative exercise test (treadmill stress test). All the participants underwent standardized transthoracic echocardiography using an available system (iE33; Philips). The LTL was measured by real-time quantitative polymerase chain reaction. We determined the relative ratio of telomere repeat copy number (T) to single-copy gene copy number (S). Results In the older people there was a higher wall thickness than in the younger (1.03 +/- 0.09 vs. 0.88 +/- 0.10, p<0.01), whereas LV mass index was comparable between them (85.8 +/- 15. 40 vs. 83.1 +/- 11.8, p = 0.20). There was a decrease in LV dimensions with advancing age (p<0.001). Older subjects had impairment in LV relaxation. LTL was associated with decreased E/A, Em/Am ratio (beta = -0.323, p = 0.0001) after adjusting for age, sex and risk factors. There is no relation between the LTL and the structure of LV. Conclusions Our data suggest that the ageing process leads to changes in LV structure and diastolic function and is linked with a phenotype of concentric LV remodeling. Telomere attrition is associated with age-related LV diastolic dysfunction. Telomere length appears to be a biomarker of myocardial ageing.	[Akasheva, Dariga U.; Plokhova, Ekaterina V.; Tkacheva, Olga N.; Strazhesko, Irina D.; Dudinskaya, Ekaterina N.; Kruglikova, Anna S.; Pykhtina, Valentina S.; Brailova, Natalia V.; Pokshubina, Inna A.; Sharashkina, Natalia V.; Agaltsov, Mikhail V.; Boytsov, Sergey A.] Natl Res Ctr Prevent Med, Dept Study Ageing & Prevent Age Associated Dis, Moscow, Russia; [Skvortsov, Dmitry] Moscow MV Lomonosov State Univ, Dept Chem, Moscow, Russia	National Medical Research Center for Therapy & Preventive Medicine; Lomonosov Moscow State University	Plokhova, EV (corresponding author), Natl Res Ctr Prevent Med, Dept Study Ageing & Prevent Age Associated Dis, Moscow, Russia.	ekaterina.naydenko@gmail.com	Tkacheva, Olga/M-4510-2014; Dudinskaya, Ekaterina/H-3281-2013; Boytsov, Sergey A/M-4486-2014; Drapkina, Oksana/AAE-5376-2021; Boytsov, Sergey/AAK-5354-2021; Strazhesko, Irina/AAD-9390-2019; Skvortsov, Dmitry A/D-3738-2015; Akasheva, Dariga U/K-2764-2017	Tkacheva, Olga/0000-0002-4193-688X; Dudinskaya, Ekaterina/0000-0001-7891-6850; Boytsov, Sergey A/0000-0001-6998-8406; Drapkina, Oksana/0000-0002-4453-8430; Boytsov, Sergey/0000-0001-6998-8406; Akasheva, Dariga U/0000-0003-0694-7062; Skvortsov, Dmitry/0000-0001-8336-8596; Plokhova, Ekaterina/0000-0001-9869-2153				Bekaert S, 2005, ANTICANCER RES, V25, P3011; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bernhard D, 2008, GERONTOLOGY, V54, P24, DOI 10.1159/000113503; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chahal NS, 2010, EUR J ECHOCARDIOGR, V11, P51, DOI 10.1093/ejechocard/jep164; Cheng S, 2009, CIRC-CARDIOVASC IMAG, V2, P191, DOI 10.1161/CIRCIMAGING.108.819938; Collerton J, 2007, EUR HEART J, V28, P172, DOI 10.1093/eurheartj/ehl437; Daniali L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2602; Denil SLIJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115071; Ganau A, 1995, J HYPERTENS, V13, P1818; Gates PE, 2003, EUR HEART J, V24, P2213, DOI 10.1016/j.ehj.2003.09.026; Hastings R, 2004, EXP GERONTOL, V39, P855, DOI 10.1016/j.exger.2004.02.003; Kawel N, 2012, CIRC-CARDIOVASC IMAG, V5, P500, DOI 10.1161/CIRCIMAGING.112.973560; Kitzman DW, 2001, AM J CARDIOL, V87, P413, DOI 10.1016/S0002-9149(00)01393-X; Leri A, 2003, EMBO J, V22, P131, DOI 10.1093/emboj/cdg013; Munagala VK, 2003, J AM SOC ECHOCARDIOG, V16, P1049, DOI 10.1016/S0894-7317(03)00516-9; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Nilsson PM, 2013, TRANSL RES, V162, P371, DOI 10.1016/j.trsl.2013.05.004; OLIVETTI G, 1991, CIRC RES, V68, P1560, DOI 10.1161/01.RES.68.6.1560; Ruan QY, 2005, EXP PHYSIOL, V90, P527, DOI 10.1113/expphysiol.2005.030007; Serrano AL, 2004, CIRC RES, V94, P575, DOI 10.1161/01.RES.0000122141.18795.9C; Solomon Scott D., 2006, CIRCULATION, V113, pe396; Strait JB, 2012, HEART FAIL CLIN, V8, P143, DOI 10.1016/j.hfc.2011.08.011; Takubo K, 2010, GERIATR GERONTOL INT, V10, pS197, DOI 10.1111/j.1447-0594.2010.00605.x; Terai M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02401; Vasan RS, 2009, CIRCULATION, V120, P1195, DOI 10.1161/CIRCULATIONAHA.109.853895	26	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135883	10.1371/journal.pone.0135883	http://dx.doi.org/10.1371/journal.pone.0135883			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275065	Green Published, gold, Green Submitted			2022-12-26	WOS:000359493600128
J	Hajarnis, SS; Patel, V; Aboudehen, K; Attanasio, M; Cobo-Stark, P; Pontoglio, M; Igarashi, P				Hajarnis, Sachin S.; Patel, Vishal; Aboudehen, Karam; Attanasio, Massimo; Cobo-Stark, Patricia; Pontoglio, Marco; Igarashi, Peter			Transcription Factor Hepatocyte Nuclear Factor-1 beta (HNF-1 beta) Regulates MicroRNA-200 Expression through a Long Noncoding RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYCYSTIC KIDNEY-DISEASE; EPITHELIAL-MESENCHYMAL TRANSITION; TISSUE-SPECIFIC EXPRESSION; DNA METHYLATION; MIR-200 FAMILY; FUNCTIONAL POLYCYSTIN-1; HUMAN GENOME; RENAL CYSTS; GENE; PKD1	The transcription factor hepatocyte nuclear factor-1 beta (HNF-1 beta) regulates tissue-specific gene expression in the kidney and other epithelial organs. Mutations of HNF-1 beta produce kidney cysts, and previous studies have shown that HNF-1 beta regulates the transcription of cystic disease genes, including Pkd2 and Pkhd1. Here, we combined chromatin immunoprecipitation and next-generation sequencing (ChIP-Seq) with microarray analysis to identify microRNAs (miRNAs) that are directly regulated by HNF-1 beta in renal epithelial cells. These studies identified members of the epithelial-specific miR-200 family (miR-200b/200a/429) as novel transcriptional targets of HNF-1 beta. HNF-1 beta binds to two evolutionarily conserved sites located 28 kb upstream to miR-200b. Luciferase reporter assays showed that the HNF-1 beta binding sites were located within a promoter that was active in renal epithelial cells. Mutations of the HNF-1 beta binding sites abolished promoter activity. RT-PCR analysis revealed that a long noncoding RNA (lncRNA) is transcribed from the promoter and encodes the miR-200 cluster. Inhibition of the lncRNA with siRNAs decreased the levels of miR-200 but did not affect expression of the Ttll10 host gene. The expression of the lncRNA and miR-200 was decreased in kidneys from HNF-1 beta knock-out mice and renal epithelial cells expressing dominant-negative mutant HNF-1 beta. The expression of miR-200 targets, Zeb2 and Pkd1, was increased in HNF-1 beta knock-out kidneys and in cells expressing mutant HNF-1 beta. Overexpression of miR-200 decreased the expression of Zeb2 and Pkd1 in HNF-1 beta mutant cells. These studies reveal a novel pathway whereby HNF-1 beta directly contributes to the control of miRNAs that are involved in epithelial-mesenchymal transition and cystic kidney disease.	[Hajarnis, Sachin S.; Patel, Vishal; Aboudehen, Karam; Attanasio, Massimo; Cobo-Stark, Patricia; Igarashi, Peter] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Igarashi, Peter] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Pontoglio, Marco] Univ Paris 05, Inst Cochin, CNRS UMR 8104, INSERM U1016,Dept Genet & Dev, F-75014 Paris, France	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Igarashi, P (corresponding author), Univ Minnesota, Sch Med, Dept Med, 420 Delaware St SE,MMC 194, Minneapolis, MN 55455 USA.	igarashi@umn.edu	Regan, Clinton/E-6250-2012; Patel, Vishal/GMW-7076-2022	Patel, Vishal/0000-0003-2875-4659; Cobo-Stark, Patricia/0000-0002-8113-6211; Igarashi, Peter/0000-0001-8698-1185; aboudehen, karam/0000-0003-4975-464X; Attanasio, Massimo/0000-0002-1278-3650	National Institutes of Health [UL1TR001105]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090326, R01DK102572, T32DK007257, K08DK084311, R37DK042921, P30DK079328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Chao Xing and Mohammed Kanchwala in the McDermott Bioinformatics Core at UT Southwestern (National Institutes of Health Grant UL1TR001105) for assistance with data analysis.	Alvarez ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077468; Bai Y, 2002, AM J PHYSIOL-RENAL, V283, pF839, DOI 10.1152/ajprenal.00128.2002; Ballarino M, 2015, MOL CELL BIOL, V35, P728, DOI 10.1128/MCB.01394-14; Bingham C, 2004, NEPHROL DIAL TRANSPL, V19, P2703, DOI 10.1093/ndt/gfh348; Boutet A, 2006, EMBO J, V25, P5603, DOI 10.1038/sj.emboj.7601421; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Cano A, 2008, TRENDS CELL BIOL, V18, P357, DOI 10.1016/j.tcb.2008.05.005; Cheret C, 2002, J MOL BIOL, V322, P929, DOI 10.1016/S0022-2836(02)00816-1; Coffinier C, 1999, MECH DEVELOP, V89, P211, DOI 10.1016/S0925-4773(99)00221-X; DESIMONE V, 1991, EMBO J, V10, P1435, DOI 10.1002/j.1460-2075.1991.tb07664.x; Dey BK, 2014, GENE DEV, V28, P491, DOI 10.1101/gad.234419.113; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Duns G, 2013, GENE CHROMOSOME CANC, V52, P165, DOI 10.1002/gcc.22016; Flynn RA, 2014, CELL STEM CELL, V14, P752, DOI 10.1016/j.stem.2014.05.014; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gresh L, 2004, EMBO J, V23, P1657, DOI 10.1038/sj.emboj.7600160; Hiesberger T, 2004, J CLIN INVEST, V113, P814, DOI 10.1172/JCI200420083; Hiesberger T, 2005, J BIOL CHEM, V280, P10578, DOI 10.1074/jbc.M414121200; Hopp K, 2012, J CLIN INVEST, V122, P4257, DOI 10.1172/JCI64313; Igarashi P, 1996, J BIOL CHEM, V271, P9666, DOI 10.1074/jbc.271.16.9666; Jin L, 2012, J PHARMACOL EXP THER, V340, P648, DOI 10.1124/jpet.111.187161; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kikuchi R, 2007, MOL PHARMACOL, V72, P1619, DOI 10.1124/mol.107.039701; Kikuchi R, 2006, MOL PHARMACOL, V70, P887, DOI 10.1124/mol.106.025494; Knouf EC, 2012, NUCLEIC ACIDS RES, V40, P499, DOI 10.1093/nar/gkr731; Kolesnikoff N, 2014, J BIOL CHEM, V289, P11194, DOI 10.1074/jbc.M113.529172; Kurbegovic A, 2010, HUM MOL GENET, V19, P1174, DOI 10.1093/hmg/ddp588; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Legnini I, 2014, MOL CELL, V53, P506, DOI 10.1016/j.molcel.2013.12.012; Lin S, 2014, P NATL ACAD SCI USA, V111, P17224, DOI 10.1073/pnas.1413624111; Lokmane L, 2010, DEVELOPMENT, V137, P347, DOI 10.1242/dev.042226; Ma ZD, 2007, P NATL ACAD SCI USA, V104, P20386, DOI 10.1073/pnas.0705957104; Marques AC, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-11-r131; Massa F, 2013, DEVELOPMENT, V140, P886, DOI 10.1242/dev.086546; MENDEL DB, 1991, GENE DEV, V5, P1042, DOI 10.1101/gad.5.6.1042; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; OTT MO, 1991, MECH DEVELOP, V36, P47, DOI 10.1016/0925-4773(91)90071-D; Pandey P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-624; Patel V, 2013, P NATL ACAD SCI USA, V110, P10765, DOI 10.1073/pnas.1301693110; Patel V, 2012, J AM SOC NEPHROL, V23, P1941, DOI 10.1681/ASN.2012030321; Pieraccioli M, 2013, CELL CYCLE, V12, P2309, DOI 10.4161/cc.25405; Pontoglio M, 1996, CELL, V84, P575, DOI 10.1016/S0092-8674(00)81033-8; Pritchard L, 2000, HUM MOL GENET, V9, P2617, DOI 10.1093/hmg/9.18.2617; Rebouissou S, 2005, HUM MOL GENET, V14, P603, DOI 10.1093/hmg/ddi057; Rossetti S, 2009, KIDNEY INT, V75, P848, DOI 10.1038/ki.2008.686; Saji T, 2008, J PHARMACOL EXP THER, V324, P784, DOI 10.1124/jpet.107.128249; Spaderna Simone, 2009, Gastroenterology, V136, P1835, DOI 10.1053/j.gastro.2009.03.009; Sun ZX, 2001, GENE DEV, V15, P3217, DOI 10.1101/gad946701; Thivierge C, 2006, MOL CELL BIOL, V26, P1538, DOI 10.1128/MCB.26.4.1538-1548.2006; Vandewalle C, 2005, NUCLEIC ACIDS RES, V33, P6566, DOI 10.1093/nar/gki965; Wild W, 2000, P NATL ACAD SCI USA, V97, P4695, DOI 10.1073/pnas.080010897; Yoshino H, 2013, J HUM GENET, V58, P508, DOI 10.1038/jhg.2013.31; Zhang YL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000414	54	38	39	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					24793	24805		10.1074/jbc.M115.670646	http://dx.doi.org/10.1074/jbc.M115.670646			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26292219	Green Published, hybrid			2022-12-26	WOS:000362598300015
J	da Cunha, MGMCM; Zia, S; Arcolino, FO; Carlon, MS; Beckmann, DV; Pippi, NL; Graca, DL; Levtchenko, E; Deprest, J; Toelen, J				Carvalho Mori da Cunha, Marina Gabriela Monteiro; Zia, Silvia; Arcolino, Fanny Oliveira; Carlon, Marianne Sylvia; Beckmann, Diego Vilibaldo; Pippi, Ney Luis; Graca, Dominguita Luhers; Levtchenko, Elena; Deprest, Jan; Toelen, Jaan			Amniotic Fluid Derived Stem Cells with a Renal Progenitor Phenotype Inhibit Interstitial Fibrosis in Renal Ischemia and Reperfusion Injury in Rats	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; MESENCHYMAL STROMAL CELLS; CADHERIN GENE PROMOTER; ISCHEMIA/REPERFUSION INJURY; IN-VITRO; HEME OXYGENASE-1; GRAFT FUNCTION; CONTRIBUTE; REPAIR; TRANSPLANTATION	Objectives Mesenchymal stem cells derived from human amniotic fluid (hAFSCs) are a promising source for cellular therapy, especially for renal disorders, as a subpopulation is derived from the fetal urinary tract. The purpose of this study was to evaluate if hAFSCs with a renal progenitor phenotype demonstrate a nephroprotective effect in acute ischemia reperfusion (I/R) model and prevent late stage fibrosis. Methods A total of 45 male 12-wk-old Wistar rats were divided into three equal groups;: rats subjected to I/R injury and treated with Chang Medium, rats subjected to I/R injury and treated with hAFSCs and sham-operated animals. In the first part of this study, hAFSCs that highly expressed CD24, CD117, SIX2 and PAX2 were isolated and characterized. In the second part, renal I/R injury was induced in male rats and cellular treatment was performed 6 hours later via arterial injection. Functional and histological analyses were performed 24 hours, 48 hours and 2 months after treatment using serum creatinine, urine protein to creatinine ratio, inflammatory and regeneration markers and histomorphometric analysis of the kidney. Statistical analysis was performed by analysis of variance followed by the Tukey's test for multiple comparisons or by nonparametric Kruskal-Wallis followed by Dunn. Statistical significance level was defined as p<0.05. Results hAFSCs treatment resulted in significantly reduced serum creatinine level at 24 hours, less tubular necrosis, less hyaline cast formation, higher proliferation index, less inflammatory cell infiltration and less myofibroblasts at 48h. The treated group had less fibrosis and proteinuria at 2 months after injury. Conclusion hAFSCs contain a renal progenitor cell subpopulation that has a nephroprotective effect when delivered intra-arterially in rats with renal I/R injury, and reduces interstitial fibrosis on long term follow-up.	[Carvalho Mori da Cunha, Marina Gabriela Monteiro; Zia, Silvia; Deprest, Jan; Toelen, Jaan] Katholieke Univ Leuven, Dept Dev & Regenerat, Organ Syst Cluster, Fetal Therapy Grp,Grp Biomed Sci, Leuven, Belgium; [Carvalho Mori da Cunha, Marina Gabriela Monteiro; Beckmann, Diego Vilibaldo; Pippi, Ney Luis; Graca, Dominguita Luhers] Univ Fed Santa Maria, Expt Vet Surg Lab, BR-97119900 Santa Maria, RS, Brazil; [Arcolino, Fanny Oliveira; Levtchenko, Elena] Katholieke Univ Leuven, Dept Dev & Regenerat, Organ Syst Cluster, Lab Pediat Nephrol,Grp Biomed Sci, Leuven, Belgium; [Carlon, Marianne Sylvia] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Lab Mol Virol & Gene Therapy, Grp Biomed Sci, Leuven, Belgium; [Deprest, Jan] Univ Hosp Leuven, Dept Obstet & Gynecol, Leuven, Belgium; [Levtchenko, Elena; Toelen, Jaan] Univ Hosp Leuven, Dept Pediat, Leuven, Belgium	KU Leuven; Universidade Federal de Santa Maria (UFSM); KU Leuven; KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven	Toelen, J (corresponding author), Katholieke Univ Leuven, Dept Dev & Regenerat, Organ Syst Cluster, Fetal Therapy Grp,Grp Biomed Sci, Leuven, Belgium.	jaan.toelen@uzleuven.be	Levtchenko, Elena/AAO-7125-2020; da Cunha, Marina Gabriela Monteiro Carvalho Mori/AAH-8673-2019; Carlon, Marianne/AAY-3211-2020; Arcolino, Fanny Oliveira/L-2367-2018	da Cunha, Marina Gabriela Monteiro Carvalho Mori/0000-0001-6658-7797; Carlon, Marianne/0000-0002-8263-0350; Arcolino, Fanny Oliveira/0000-0003-2207-9699; Deprest, Jan/0000-0002-4920-945X	Agency for Innovation by Science and technology (IWT)-Vlaanderen; European Commission grant of Diagnostic Molecular Imaging (DIMI) [LSHB11 CT-2005-512146]; In vivo Molecular Imaging Research (IMIR) program from the KU Leuven	Agency for Innovation by Science and technology (IWT)-Vlaanderen(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); European Commission grant of Diagnostic Molecular Imaging (DIMI); In vivo Molecular Imaging Research (IMIR) program from the KU Leuven	Research was funded by the Agency for Innovation by Science and technology (IWT)-Vlaanderen, by the European Commission grant of Diagnostic Molecular Imaging (DIMI) (LSHB11 CT-2005-512146) and by the In vivo Molecular Imaging Research (IMIR) program from the KU Leuven. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam TV, 2003, KIDNEY INT, V63, P134, DOI 10.1046/j.1523-1755.2003.00737.x; Bai Y, 2002, AM J PHYSIOL-RENAL, V283, pF839, DOI 10.1152/ajprenal.00128.2002; Baulier E, 2014, STEM CELL TRANSL MED, V3, P809, DOI 10.5966/sctm.2013-0186; Bayrak O, 2008, WORLD J UROL, V26, P285, DOI 10.1007/s00345-008-0253-4; Bi B, 2007, J AM SOC NEPHROL, V18, P2486, DOI 10.1681/ASN.2007020140; Bieback K, 2010, TISSUE ENG PT A, V16, P3467, DOI [10.1089/ten.tea.2009.0727, 10.1089/ten.TEA.2009.0727]; Bonventre JV, 2009, J AM SOC NEPHROL, V20, P927, DOI 10.1681/ASN.2009030322; Brady PD, 2014, GENET MED, V16, P469, DOI 10.1038/gim.2013.168; Bucaloiu ID, 2012, KIDNEY INT, V81, P477, DOI 10.1038/ki.2011.405; Cai JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092347; Cantaluppi V, 2012, KIDNEY INT, V82, P412, DOI 10.1038/ki.2012.105; da Cunha MGMCM, 2013, EUR SURG RES, V51, P58, DOI 10.1159/000354389; Chen J, 2008, KIDNEY INT, V74, P879, DOI 10.1038/ki.2008.304; Da Sacco S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081812; Da Sacco S, 2011, CURR OPIN ORGAN TRAN, V16, P101, DOI 10.1097/MOT.0b013e3283424f6e; Da Sacco S, 2010, J UROLOGY, V183, P1193, DOI 10.1016/j.juro.2009.11.006; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; Dobreva MP, 2010, INT J DEV BIOL, V54, P761, DOI 10.1387/ijdb.092935md; Du T, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt215; Du T, 2012, CYTOTHERAPY, V14, P1215, DOI 10.3109/14653249.2012.711471; Duffield JS, 2005, KIDNEY INT, V68, P1956, DOI 10.1111/j.1523-1755.2005.00629.x; Duplomb L, 2007, STEM CELLS, V25, P544, DOI 10.1634/stemcells.2006-0395; Feng Z, 2010, NEPHROL DIAL TRANSPL, V25, P3874, DOI 10.1093/ndt/gfq603; Geng YQ, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt469; GILBERT WM, 1993, SEMIN PERINATOL, V17, P150; Giraud S, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/532127; Glenn Justin D, 2014, World J Stem Cells, V6, P526, DOI 10.4252/wjsc.v6.i5.526; Griffin MD, 2010, HUM GENE THER, V21, P1641, DOI 10.1089/hum.2010.156; Hara Y, 2011, TRANSPL INT, V24, P1112, DOI 10.1111/j.1432-2277.2011.01328.x; Hauser PV, 2010, AM J PATHOL, V177, P2011, DOI 10.2353/ajpath.2010.091245; Herrera MB, 2004, INT J MOL MED, V14, P1035; HEUKESHOVEN J, 1985, J CHROMATOGR, V326, P91, DOI 10.1016/S0021-9673(01)87434-3; Humphreys BD, 2008, ANNU REV MED, V59, P311, DOI 10.1146/annurev.med.59.061506.154239; Jang HR, 2009, J MOL MED, V87, P859, DOI 10.1007/s00109-009-0491-y; Kaviani A, 2001, J PEDIATR SURG, V36, P1662, DOI 10.1053/jpsu.2001.27945; Kortekaas KA, 2013, INFLAMM RES, V62, P53, DOI 10.1007/s00011-012-0550-7; Kotsch K, 2007, ANTIOXID REDOX SIGN, V9, P2049, DOI 10.1089/ars.2007.1801; Kreidberg JA, 2010, ORGANOGENESIS, V6, P61, DOI 10.4161/org.6.2.11928; Krolewski AS, 2014, DIABETES CARE, V37, P226, DOI 10.2337/dc13-0985; Lam AQ, 2014, J AM SOC NEPHROL, V25, P1211, DOI 10.1681/ASN.2013080831; Lameire NH, 2013, LANCET, V382, P170, DOI 10.1016/S0140-6736(13)60647-9; Lassailly F, 2010, BLOOD, V115, P5347, DOI 10.1182/blood-2009-05-224030; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Lee S, 2011, J AM SOC NEPHROL, V22, P317, DOI 10.1681/ASN.2009060615; Li L, 2007, J AM SOC NEPHROL, V18, P3067, DOI 10.1681/ASN.2007030284; Li P, 2013, STEM CELLS DEV, V22, P340, DOI 10.1089/scd.2012.0357; Lin FM, 2003, J AM SOC NEPHROL, V14, P1188, DOI 10.1097/01.ASN.0000061595.28546.A0; Liu MC, 2008, J AM SOC NEPHROL, V19, P1360, DOI 10.1681/ASN.2007080901; Mitka M, 2001, JAMA-J AM MED ASSOC, V286, P2083, DOI 10.1001/jama.286.17.2083; Moncada S, 1997, ANN NY ACAD SCI, V811, P60, DOI 10.1111/j.1749-6632.1997.tb51989.x; Morigi M, 2008, STEM CELLS, V26, P2075, DOI 10.1634/stemcells.2007-0795; Morigi M, 2010, STEM CELLS, V28, P513, DOI 10.1002/stem.293; Morizane R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064843; Ojo AO, 1997, TRANSPLANTATION, V63, P968, DOI 10.1097/00007890-199704150-00011; Perin L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009357; Pratschke J, 2001, TRANSPLANT P, V33, P693, DOI 10.1016/S0041-1345(00)02207-7; Prusa AR, 2004, AM J OBSTET GYNECOL, V191, P309, DOI 10.1016/j.ajog.2003.12.014; Prusa AR, 2003, HUM REPROD, V18, P1489, DOI 10.1093/humrep/deg279; Reinders MEJ, 2013, STEM CELL TRANSL MED, V2, P107, DOI 10.5966/sctm.2012-0114; Reis LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044092; Ricardo SD, 2008, J CLIN INVEST, V118, P3522, DOI 10.1172/JCI36150; Saenz-Morales D, 2010, KIDNEY INT, V77, P781, DOI 10.1038/ki.2010.10; Salahudeen AK, 2004, J INVEST MED, V52, P296, DOI 10.1136/jim-52-05-28; Schrier RW, 2004, J CLIN INVEST, V114, P5, DOI 10.1172/JC1200422353; Schroppell B, 2014, KIDNEY INT, V86, P251, DOI 10.1038/ki.2014.18; Sekiya I, 2002, P NATL ACAD SCI USA, V99, P4397, DOI 10.1073/pnas.052716199; Semedo P, 2007, TRANSPL P, V39, P421, DOI 10.1016/j.transproceed.2007.01.036; Singbartl K, 2012, KIDNEY INT, V81, P819, DOI 10.1038/ki.2011.339; Tan JM, 2012, JAMA-J AM MED ASSOC, V307, P1169, DOI 10.1001/jama.2012.316; Togel F, 2008, AM J PHYSIOL-RENAL, V295, pF315, DOI 10.1152/ajprenal.00098.2008; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; Turgut F, 2008, INT UROL NEPHROL, V40, P453, DOI [10.1007/s11255-008-9365-4, 10.1007/s11255-008-9445-5]; Underwood Mark A, 2005, J Perinatol, V25, P341, DOI 10.1038/sj.jp.7211290; Wald R, 2012, AM J MED, V125, P585, DOI 10.1016/j.amjmed.2012.01.016; Warnock DG, 2005, J AM SOC NEPHROL, V16, P3149, DOI 10.1681/ASN.2005090934; Whyte DA, 1999, AM J PHYSIOL-RENAL, V277, pF587, DOI 10.1152/ajprenal.1999.277.4.F587; Yamashita T, 2012, FASEB J, V26, P1559, DOI 10.1096/fj.11-183194; Yuan L, 2011, AM J PHYSIOL-RENAL, V300, pF207, DOI 10.1152/ajprenal.00073.2010; Zarjou A, 2011, AM J PHYSIOL-RENAL, V300, pF254, DOI 10.1152/ajprenal.00594.2010; Zia S, 2013, PRENATAL DIAG, V33, P921, DOI 10.1002/pd.4162; Zonta S, 2010, TRANSPL P, V42, P1336, DOI 10.1016/j.transproceed.2010.03.081	81	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136145	10.1371/journal.pone.0136145	http://dx.doi.org/10.1371/journal.pone.0136145			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295710	gold, Green Published, Green Submitted			2022-12-26	WOS:000359926900074
J	Jiang, F; Chen, ZY; Bi, H; Ekure, E; Su, BB; Wu, HR; Huang, YF; Zhang, B; Jiang, J				Jiang, Feng; Chen, Zheyi; Bi, Hua; Ekure, Edgar; Su, Binbin; Wu, Haoran; Huang, Yifei; Zhang, Bin; Jiang, Jun			Association between Ocular Sensory Dominance and Refractive Error Asymmetry	PLOS ONE			English	Article							CONVERGENCE EYE-MOVEMENTS; SPHERICAL/ASTIGMATIC ANISOMETROPIA; INTEROCULAR SUPPRESSION; MONOVISION PSEUDOPHAKIA; PATIENT SATISFACTION; DYNAMIC ASYMMETRIES; CONTACT-LENS; SEX ANALYSIS; MYOPIA; INDIVIDUALS	Purpose To investigate the association between ocular sensory dominance and interocular refractive error difference (IRED). Methods A total of 219 subjects were recruited. The refractive errors were determined by objective refraction with a fixation target located 6 meters away. 176 subjects were myopic, with 83 being anisometropic (IRED >= 0.75 D). 43 subjects were hyperopic, with 22 being anisometropic. Sensory dominance was measured with a continuous flashing technique with the tested eye viewing a Gabor increasing in contrast and the fellow eye viewing a Mondrian noise decreasing in contrast. The log ratio of Mondrian to Gabor's contrasts was recorded when a subject just detected the tilting direction of the Gabor during each trial. T-test was used to compare the 50 values collected from each eye, and the t-value was used as a subject's ocular dominance index (ODI) to quantify the degree of ocular dominance. A subject with ODI >= 2 (p < 0.05) had clear dominance and the eye with larger mean ratio was the dominant one. Otherwise, a subject had an unclear dominance. Results The anisometropic subjects had stronger ocular dominance in comparison to non-anisometropic subjects (rank-sum test, p < 0.01 for both myopic and hyperopic subjects). In anisometropic subjects with clear dominance, the amplitude of the anisometropia was correlated with ODI values (R = 0.42, p < 0.01 in myopic anisometropic subjects; R = 0.62, p < 0.01 in hyperopic anisometropic subjects). Moreover, the dominant eyes were more myopic in myopic anisometropic subjects (sign-test, p < 0.05) and less hyperopic in hyperopic anisometropic subjects (sign-test, p < 0.05). Conclusion The degree of ocular sensory dominance is associated with interocular refractive error difference.	[Jiang, Feng; Huang, Yifei] Chinese PLA, Sch Med, Beijing, Peoples R China; [Jiang, Feng] Jinling Hosp, Dept Ophthalmol, Nanjing, Jiangsu, Peoples R China; [Chen, Zheyi; Su, Binbin; Wu, Haoran; Zhang, Bin; Jiang, Jun] Wenzhou Med Univ, Hosp Eye, Wenzhou, Peoples R China; [Bi, Hua; Ekure, Edgar; Zhang, Bin] Nova SE Univ, Coll Optometry, Davie, FL USA	Wenzhou Medical University; Nova Southeastern University	Zhang, B (corresponding author), Wenzhou Med Univ, Hosp Eye, Wenzhou, Peoples R China.	bz52@nova.edu; jjhsj@hotmail.com	Huang, Yifei/ABE-4692-2020; Zhang, Bin/GOH-1376-2022; Huang, Yifei/ABE-7566-2020; bi, huaqiang/GYJ-5005-2022	Huang, Yifei/0000-0002-7089-6426; Wu, Haoran/0000-0002-2248-3547				Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Braun EHP, 2008, OPHTHALMOLOGY, V115, P1196, DOI 10.1016/j.ophtha.2007.09.018; Cheng CY, 2004, INVEST OPHTH VIS SCI, V45, P2856, DOI 10.1167/iovs.03-0878; Chia A, 2007, INVEST OPHTH VIS SCI, V48, P3533, DOI 10.1167/iovs.06-1489; Evans BJW, 2007, OPHTHAL PHYSL OPT, V27, P417, DOI 10.1111/j.1475-1313.2007.00488.x; Fink WH, 1938, ARCH OPHTHALMOL-CHIC, V19, P555, DOI 10.1001/archopht.1938.00850160081005; Greenbaum S, 2002, J CATARACT REFR SURG, V28, P1439, DOI 10.1016/S0886-3350(02)01218-X; Gupta N, 2009, OPTOMETRY VISION SCI, V86, P98; Handa T, 2004, J CATARACT REFR SURG, V30, P769, DOI 10.1016/j.jcrs.2003.07.013; Hom M M, 1999, J Am Optom Assoc, V70, P117; Horng JL, 1998, VISION RES, V38, P2761, DOI 10.1016/S0042-6989(97)00453-7; Ito M, 2013, J REFRACT SURG, V29, P717, DOI 10.3928/1081597X-20130813-02; Kawata H, 2001, JPN J OPHTHALMOL, V45, P437, DOI 10.1016/S0021-5155(01)00405-1; Linke SJ, 2012, INVEST OPHTH VIS SCI, V53, P5362, DOI 10.1167/iovs.11-8781; Linke SJ, 2011, INVEST OPHTH VIS SCI, V52, P9166, DOI 10.1167/iovs.11-8131; Mapp AP, 2003, PERCEPT PSYCHOPHYS, V65, P310, DOI 10.3758/BF03194802; MONEY J, 1972, Q J EXP PSYCHOL, V24, P454, DOI 10.1080/14640747208400305; Morgan PB, 2011, CONTACT LENS ANTERIO, V34, P223, DOI 10.1016/j.clae.2011.08.001; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PORAC C, 1976, PSYCHOL BULL, V83, P880, DOI 10.1037/0033-2909.83.5.880; Reiss M R, 1997, Laterality, V2, P7, DOI 10.1080/135765097397602; Schaeffel F, 2013, OPHTHAL PHYSL OPT, V33, P362, DOI 10.1111/opo.12058; SENGPIEL F, 1994, J NEUROSCI, V14, P6855; Sridhar D, 2011, VISION RES, V51, P1075, DOI 10.1016/j.visres.2011.02.023; Wallman J, 2004, NEURON, V43, P447, DOI 10.1016/j.neuron.2004.08.008; Wildsoet CE, 2003, CURR EYE RES, V27, P371, DOI 10.1076/ceyr.27.6.371.18188; Wright KW, 1999, J CATARACT REFR SURG, V25, P177, DOI 10.1016/S0886-3350(99)80123-0; Yang E, 2010, INVEST OPHTH VIS SCI, V51, P588, DOI 10.1167/iovs.08-3076; Yang ZK, 2008, INVEST OPHTH VIS SCI, V49, P4779, DOI 10.1167/iovs.07-1616; Zhang FX, 2011, J CATARACT REFR SURG, V37, P853, DOI 10.1016/j.jcrs.2010.12.041	30	18	23	5	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136222	10.1371/journal.pone.0136222	http://dx.doi.org/10.1371/journal.pone.0136222			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295803	gold, Green Published, Green Submitted			2022-12-26	WOS:000359926900084
J	Wood, HE; Marlin, N; Mudway, IS; Bremner, SA; Cross, L; Dundas, I; Grieve, A; Grigg, J; Jamaludin, JB; Kelly, FJ; Lee, T; Sheikh, A; Walton, R; Griffiths, CJ				Wood, Helen E.; Marlin, Nadine; Mudway, Ian S.; Bremner, Stephen A.; Cross, Louise; Dundas, Isobel; Grieve, Andrew; Grigg, Jonathan; Jamaludin, Jeenath B.; Kelly, Frank J.; Lee, Tak; Sheikh, Aziz; Walton, Robert; Griffiths, Christopher J.			Effects of Air Pollution and the Introduction of the London Low Emission Zone on the Prevalence of Respiratory and Allergic Symptoms in Schoolchildren in East London: A Sequential Cross-Sectional Study	PLOS ONE			English	Article							PRESCHOOL-CHILDREN; CHILDHOOD ISAAC; ASTHMA; EXPOSURE; HEALTH; ECZEMA; PATY; UK	The adverse effects of traffic-related air pollution on children's respiratory health have been widely reported, but few studies have evaluated the impact of traffic-control policies designed to reduce urban air pollution. We assessed associations between traffic-related air pollutants and respiratory/allergic symptoms amongst 8-9 year-old schoolchildren living within the London Low Emission Zone (LEZ). Information on respiratory/allergic symptoms was obtained using a parent-completed questionnaire and linked to modelled annual air pollutant concentrations based on the residential address of each child, using a multivariable mixed effects logistic regression analysis. Exposure to traffic-related air pollutants was associated with current rhinitis: NOx (OR 1.01, 95% CI 1.00-1.02), NO2 (1.03, 1.00-1.06), PM10 (1.16, 1.04-1.28) and PM2.5 (1.38, 1.08-1.78), all per mu g/m(3) of pollutant, but not with other respiratory/allergic symptoms. The LEZ did not reduce ambient air pollution levels, or affect the prevalence of respiratory/allergic symptoms over the period studied. These data confirm the previous association between traffic-related air pollutant exposures and symptoms of current rhinitis. Importantly, the London LEZ has not significantly improved air quality within the city, or the respiratory health of the resident population in its first three years of operation. This highlights the need for more robust measures to reduce traffic emissions.	[Wood, Helen E.; Mudway, Ian S.; Grieve, Andrew; Jamaludin, Jeenath B.] Kings Coll London, MRC PHE Ctr Environm & Hlth, London WC2R 2LS, England; [Marlin, Nadine; Bremner, Stephen A.; Cross, Louise; Walton, Robert; Griffiths, Christopher J.] Queen Mary Univ London, Blizard Inst, Asthma UK Ctr Appl Asthma Res, Ctr Primary Care & Publ Hlth, London, England; [Dundas, Isobel; Grigg, Jonathan] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, London, England; [Jamaludin, Jeenath B.] Univ Sains Malaysia, Inst Res Mol Med INFORMM, Kelantan, Malaysia; [Lee, Tak] Kings Coll London, MRC & Asthma UK Ctr Allerg Mech Asthma, London WC2R 2LS, England; [Lee, Tak] HK Sanat & Hosp, Allergy Ctr, Hong Kong, Hong Kong, Peoples R China; [Sheikh, Aziz] Univ Edinburgh, Ctr Populat Hlth Sci, Allergy & Resp Res Grp, Edinburgh, Midlothian, Scotland; [Sheikh, Aziz] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gen Internal Med & Primary Care, Boston, MA 02115 USA	University of London; King's College London; University of London; Queen Mary University London; University of London; Queen Mary University London; Universiti Sains Malaysia; University of London; King's College London; University of Edinburgh; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Mudway, IS (corresponding author), Kings Coll London, MRC PHE Ctr Environm & Hlth, London WC2R 2LS, England.	ian.mudway@kcl.ac.uk	Kelly, Frank J/C-6125-2009; Lee, Tak/AAA-9526-2020; Bremner, Stephen/R-4038-2016; Kelly, Frank/ABG-3411-2021	Kelly, Frank J/0000-0003-2558-8392; Lee, Tak/0000-0002-7554-4059; Bremner, Stephen/0000-0003-0790-7070; Kelly, Frank/0000-0003-2558-8392; Mudway, Ian/0000-0003-1239-5014; Walton, Robert/0000-0001-7700-1907; Grigg, Jonathan/0000-0003-3109-6028; Marlin, Nadine/0000-0002-2841-4825; Sheikh, Aziz/0000-0001-7022-3056	National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London; Dr. and Mrs. Lee Iu Cheung Fund; Hackney Primary Care Trust (PCT); Medical Research Council [G1000758, MC_U190092710, G1000758B, MR/K007017/1, MR/L01341X/1, MR/K010727/1] Funding Source: researchfish; National Institute for Health Research [RP-PG-0609-10181] Funding Source: researchfish; Natural Environment Research Council [NE/I008039/1] Funding Source: researchfish; Asthma UK [AUK-AC-2012-01] Funding Source: researchfish; MRC [MR/K010727/1, MC_U190092710, MR/L01341X/1, MR/K007017/1] Funding Source: UKRI; NERC [NE/I008039/1] Funding Source: UKRI	National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London; Dr. and Mrs. Lee Iu Cheung Fund; Hackney Primary Care Trust (PCT); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Asthma UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was funded/supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London, Dr. and Mrs. Lee Iu Cheung Fund, and Hackney Primary Care Trust (PCT). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson HR, 2010, OCCUP ENVIRON MED, V67, P293, DOI 10.1136/oem.2009.048785; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Austin JB, 1999, ARCH DIS CHILD, V81, P225, DOI 10.1136/adc.81.3.225; Beevers SD, 2013, J EXPO SCI ENV EPID, V23, P647, DOI 10.1038/jes.2013.6; Boezen HM, 1999, LANCET, V353, P874, DOI 10.1016/S0140-6736(98)06311-9; Brunekreef B, 2009, ENVIRON HEALTH PERSP, V117, P1791, DOI 10.1289/ehp.0800467; Cames Michel, 2013, Environmental Sciences Europe, V25, P15, DOI 10.1186/2190-4715-25-15; Carslaw DC, 2011, ATMOS ENVIRON, V45, P7053, DOI 10.1016/j.atmosenv.2011.09.063; Carslaw DC, 2011, DEFRA URBAN MODEL EV, V1; Cesaroni G, 2012, OCCUP ENVIRON MED, V69, P133, DOI 10.1136/oem.2010.063750; Dales R, 2009, J OCCUP ENVIRON MED, V51, P654, DOI 10.1097/JOM.0b013e3181a0363c; Department for Communities and Local Government, ENGL IND DEPR 2010 2; Environmental Research Group KsCL, LOND AIR; Green DC, 2009, ATMOS ENVIRON, V43, P2132, DOI 10.1016/j.atmosenv.2009.01.024; HEI Panel on the Health Effects of Traffic-Related Air Pollution, 2010, TRAFF REL AIR POLL C; HENDERSON FW, 1989, AM REV RESPIR DIS, V140, P197, DOI 10.1164/ajrccm/140.1.197; Hoek G, 2012, EUR RESPIR J, V40, P538, DOI 10.1183/09031936.00002611; Janssen NAH, 2003, ENVIRON HEALTH PERSP, V111, P1512, DOI 10.1289/ehp.6243; Kaur B, 1998, BRIT MED J, V316, P118; Kelly F, 2011, LONDON LOW EMISSION; Office for National Statistics, 2012, POP EST ENGL WAL MID; Oosterlee A, 1996, OCCUP ENVIRON MED, V53, P241, DOI 10.1136/oem.53.4.241; Pattenden S, 2006, OCCUP ENVIRON MED, V63, P828, DOI 10.1136/oem.2006.025213; Penard-Morand C, 2010, EUR RESPIR J, V36, P33, DOI 10.1183/09031936.00116109; Transport for London (TfL), 2008, LOND LOW EM ZON IMP; van der Zee SC, 1999, OCCUP ENVIRON MED, V56, P802, DOI 10.1136/oem.56.12.802; Weiland Stephan K., 1994, Annals of Epidemiology, V4, P243; WHO, 2006, INDIAN J MED RES; WJST M, 1993, BRIT MED J, V307, P596, DOI 10.1136/bmj.307.6904.596; Zuraimi MS, 2011, PEDIAT ALLERG IMM-UK, V22, pe112, DOI 10.1111/j.1399-3038.2010.00992.x	30	26	27	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0109121	10.1371/journal.pone.0109121	http://dx.doi.org/10.1371/journal.pone.0109121			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295579	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000359926900001
J	Kovacs, L; Kezer, FL; Tozser, J; Szenci, O; Poti, P; Pajor, F				Kovacs, Levente; Kezer, Fruzsina Luca; Tozser, Janos; Szenci, Otto; Poti, Peter; Pajor, Ferenc			Heart Rate and Heart Rate Variability in Dairy Cows with Different Temperament and Behavioural Reactivity to Humans	PLOS ONE			English	Article							COPING STYLES; MILK-YIELD; ANIMALS; AVOIDANCE; WELFARE; STRESS; CATTLE; PIGS; FEAR; RESPONSES	From the 1990s, extensive research was started on the physiological aspects of individual traits in animals. Previous research has established two extreme (proactive and reactive) coping styles in several animal species, but the means of reactivity with the autonomic nervous system (ANS) activity has not yet been investigated in cattle. The aim of this study was the characterization of cardiac autonomic activity under different conditions in cows with different individual characteristics. For this purpose, we investigated heart rate and ANS-related heart rate variability (HRV) parameters of dairy cows (N = 282) on smaller-and larger-scale farms grouped by (1) temperament and (2) behavioural reactivity to humans (BRH). Animals with high BRH scores were defined as impulsive, while animals with low BRH scores were defined as reserved. Cardiac parameters were calculated for undisturbed lying (baseline) and for milking bouts, the latter with the presence of an unfamiliar person (stressful situation). Sympathetic tone was higher, while vagal activity was lower in temperamental cows than in calm animals during rest both on smaller-and larger-scale farms. During milking, HRV parameters were indicative of a higher sympathetic and a lower vagal activity of temperamental cows as compared to calm ones in farms of both sizes. Basal heart rate did not differ between BRH groups either on smaller-or larger-scale farms. Differences between basal ANS activity of impulsive and reserved cows reflected a higher resting vagal and lower sympathetic activity of reserved animals compared to impulsive ones both on smaller-and larger-scale farms. There was no difference either in heart rate or in HRV parameters between groups during milking neither in smaller-nor in larger-scale farms. These two groupings allowed to draw possible parallels between personality and cardiac autonomic activity during both rest and milking in dairy cows. Heart rate and HRV seem to be useful for characterisation of physiological differences related to temperament and BRH.	[Kovacs, Levente; Kezer, Fruzsina Luca; Tozser, Janos; Szenci, Otto] MTA SZIE Large Anim Clin Res Grp, Ullo Dora Major, Hungary; [Kovacs, Levente; Kezer, Fruzsina Luca; Poti, Peter; Pajor, Ferenc] Szent Istvan Univ, Fac Agr & Environm Sci, Inst Anim Husb, Godollo, Hungary; [Szenci, Otto] Szent Istvan Univ, Fac Vet Sci, Dept & Clin Reprod, Budapest, Hungary	Hungarian University of Agriculture & Life Sciences; Hungarian University of Agriculture & Life Sciences	Kovacs, L (corresponding author), MTA SZIE Large Anim Clin Res Grp, Ullo Dora Major, Hungary.	Kovacs.Levente@mkk.szie.hu	Ferenc, Pajor/AAK-1498-2020	Ferenc, Pajor/0000-0003-1501-0968	Research Centre of Excellence [9878/2015/FEKUT]	Research Centre of Excellence	Funding was provided by Research Centre of Excellence - 9878/2015/FEKUT project, http://kih.gov.hu/nemzeti. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk K, 2013, LIVEST SCI, V154, P1, DOI 10.1016/j.livsci.2013.01.016; Bolhuis JE, 2003, PHYSIOL BEHAV, V79, P289, DOI 10.1016/S0031-9384(03)00090-8; Burrow H. M., 1997, Animal Breeding Abstracts, V65, P477; Camm AJ, 1996, CIRCULATION, V93, P1043; Cannon WB., BODILY CHANGES PAIN, DOI [10.1037/10013-000, DOI 10.1037/10013-000]; Carere C, 2013, INT COMP BIOL, V53, P873; Coppens CM, 2010, PHILOS T R SOC B, V365, P4021, DOI 10.1098/rstb.2010.0217; Curley KO, 2008, HORM BEHAV, V53, P20, DOI 10.1016/j.yhbeh.2007.08.005; Dodzi MS, 2011, APPL ANIM BEHAV SCI, V133, P11, DOI 10.1016/j.applanim.2011.04.014; Engel B. T., 1972, S PHYS EM PSYCH ILLN, P57; FOKKEMA DS, 1995, PHYSIOL BEHAV, V57, P857, DOI 10.1016/0031-9384(94)00333-Z; Forkman B, 2007, PHYSIOL BEHAV, V92, P340, DOI 10.1016/j.physbeh.2007.03.016; Frondelius L, 2005, PHYSIOL BEHAV, V139, P437; Gygax L, 2008, APPL ANIM BEHAV SCI, V109, P167, DOI 10.1016/j.applanim.2007.03.010; Hagen K, 2005, PHYSIOL BEHAV, V85, P195, DOI 10.1016/j.physbeh.2005.03.019; Koolhaas JM, 2008, BRAIN BEHAV IMMUN, V22, P662, DOI 10.1016/j.bbi.2007.11.006; Koolhaas JM, 2010, FRONT NEUROENDOCRIN, V31, P307, DOI 10.1016/j.yfrne.2010.04.001; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Korte SM, 1999, PHYSIOL BEHAV, V65, P649; Kovacs L, 2014, J DAIRY SCI, V97, P6955, DOI 10.3168/jds.2014-8327; Kovacs L, 2014, ANIMAL, V8, P316, DOI 10.1017/S1751731113002140; Kovacs L, 2013, J DAIRY SCI, V96, P7743, DOI 10.3168/jds.2013-7030; Lazarus RS, 1966, PSYCHOSOCIAL STRESS; MANTECA X, 1993, ANIM WELFARE, V2, P247; Marchant-Forde RM, 2004, PHYSIOL BEHAV, V80, P449, DOI 10.1016/j.physbeh.2003.09.007; Mohr E, 2002, PHYSIOL BEHAV, V75, P251, DOI 10.1016/S0031-9384(01)00651-5; Munksgaard L, 1997, J DAIRY SCI, V80, P1106, DOI 10.3168/jds.S0022-0302(97)76036-3; Munksgaard L, 2001, APPL ANIM BEHAV SCI, V73, P15, DOI 10.1016/S0168-1591(01)00119-8; Ndou SP, 2011, AFR J BIOTECHNOL, V10, P1049; Phillips C, 2002, CATTLE BEHAV WELFARE; Piccione G, 2005, RES VET SCI, V79, P155, DOI 10.1016/j.rvsc.2004.11.010; Porges SW, 2003, PHYSIOL BEHAV, V79, P503, DOI 10.1016/S0031-9384(03)00156-2; Reimert I, 2014, PHYSIOL BEHAV, V129, P221, DOI 10.1016/j.physbeh.2014.02.059; Rousing T, 2006, LIVEST SCI, V101, P219, DOI 10.1016/j.livprodsci.2005.11.013; Ruis MAW, 2001, APPL ANIM BEHAV SCI, V70, P201, DOI 10.1016/S0168-1591(00)00150-7; Sgoifo A, 1997, AM J PHYSIOL-HEART C, V273, pH1754, DOI 10.1152/ajpheart.1997.273.4.H1754; Steimer T, 2005, NEUROSCI BIOBEHAV R, V29, P99, DOI 10.1016/j.neubiorev.2004.07.002; Strelau J, 1987, EUR J PERSONALITY, V1, P107, DOI DOI 10.1002/PER.2410010205; Sutherland MA, 2012, PHYSIOL BEHAV, V107, P329, DOI 10.1016/j.physbeh.2012.07.013; Tarvainen MP, 2014, COMPUT METH PROG BIO, V113, P210, DOI 10.1016/j.cmpb.2013.07.024; Valance D, 2007, GENES BRAIN BEHAV, V6, P339, DOI 10.1111/j.1601-183X.2006.00262.x; Visser EK, 2002, PHYSIOL BEHAV, V76, P289, DOI 10.1016/S0031-9384(02)00698-4; Visser EK, 2001, APPL ANIM BEHAV SCI, V74, P241, DOI 10.1016/S0168-1591(01)00177-0; von Borell E, 2007, PHYSIOL BEHAV, V92, P293, DOI 10.1016/j.physbeh.2007.01.007; Waiblinger S, 2004, APPL ANIM BEHAV SCI, V85, P31, DOI 10.1016/j.applanim.2003.07.002; Waiblinger S, 2006, APPL ANIM BEHAV SCI, V101, P185, DOI 10.1016/j.applanim.2006.02.001; WECHSLER B, 1995, APPL ANIM BEHAV SCI, V43, P123, DOI 10.1016/0168-1591(95)00557-9; Welfare Quality<(R)>, 2009, ASS PROT CATTL; Zuckerman M., 2005, PSYCHOBIOLOGY PERSON	49	16	17	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136294	10.1371/journal.pone.0136294	http://dx.doi.org/10.1371/journal.pone.0136294			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291979	gold, Green Published, Green Submitted			2022-12-26	WOS:000359919900076
J	Sanchez-Alavez, M; Nguyen, W; Mori, S; Moroncini, G; Viader, A; Nomura, DK; Cravatt, BF; Conti, B				Sanchez-Alavez, Manuel; Nguyen, William; Mori, Simone; Moroncini, Gianluca; Viader, Andreu; Nomura, Daniel K.; Cravatt, Benjamin F.; Conti, Bruno			Monoacylglycerol Lipase Regulates Fever Response	PLOS ONE			English	Article							PROSTAGLANDIN EP3 RECEPTOR; LIPOPOLYSACCHARIDE-INDUCED FEVER; BRAIN ENDOTHELIAL-CELLS; ACID AMIDE HYDROLASE; FEBRILE RESPONSE; ALZHEIMERS-DISEASE; RAT HYPOTHALAMUS; MICE; CYCLOOXYGENASE-2; NEURONS	Cyclooxygenase inhibitors such as ibuprofen have been used for decades to control fever through reducing the levels of the pyrogenic lipid transmitter prostaglandin E2 (PGE2). Historically, phospholipases have been considered to be the primary generator of the arachidonic acid (AA) precursor pool for generating PGE2 and other eicosanoids. However, recent studies have demonstrated that monoacyglycerol lipase (MAGL), through hydrolysis of the endocannabinoid 2-arachidonoylglycerol, provides a major source of AA for PGE2 synthesis in the mammalian brain under basal and neuroinflammatory states. We show here that either genetic or pharmacological ablation of MAGL leads to significantly reduced fever responses in both centrally or peripherally-administered lipopolysaccharide or interleukin-1 beta-induced fever models in mice. We also show that a cannabinoid CB1 receptor antagonist does not attenuate these anti-pyrogenic effects of MAGL inhibitors. Thus, much like traditional nonsteroidal anti-inflammatory drugs, MAGL inhibitors can control fever, but appear to do so through restricted control over prostaglandin production in the nervous system.	[Sanchez-Alavez, Manuel; Nguyen, William; Mori, Simone; Viader, Andreu; Cravatt, Benjamin F.; Conti, Bruno] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Moroncini, Gianluca] Univ Politecn Marche, Dipartimento Sci Clin & Mol, Ancona, Italy; [Nomura, Daniel K.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA	Scripps Research Institute; Marche Polytechnic University; University of California System; University of California Berkeley	Conti, B (corresponding author), Scripps Res Inst, Dept Physiol Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	bconti@scripps.edu	; MORONCINI, Gianluca/K-6021-2016	Mori, Simone/0000-0002-0793-7045; Conti, Bruno/0000-0002-9185-5201; MORONCINI, Gianluca/0000-0002-0380-0105; Sanchez-Alavez, Manuel/0000-0002-8164-8452	NIH [DA032933, CA172667, GM109315, NS085155]; NATIONAL CANCER INSTITUTE [R01CA172667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113894, K01GM109315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA032933] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the NIH grants DA032933 (B.F.C.), CA172667 (D.K.N.), GM109315 (A.V.), and NS085155 (B.C.).	BELL RL, 1979, P NATL ACAD SCI USA, V76, P3238, DOI 10.1073/pnas.76.7.3238; BROEKMAN MJ, 1986, J LIPID RES, V27, P884; Buczynski MW, 2009, J LIPID RES, V50, P1015, DOI 10.1194/jlr.R900004-JLR200; Chen RQ, 2012, CELL REP, V2, P1329, DOI 10.1016/j.celrep.2012.09.030; Conti B, 2006, SCIENCE, V314, P825, DOI 10.1126/science.1132191; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; DINARELLO CA, 1974, J EXP MED, V139, P1369, DOI 10.1084/jem.139.6.1369; Elmquist JK, 1997, TRENDS NEUROSCI, V20, P565, DOI 10.1016/S0166-2236(97)01138-7; Gao Y, 2010, J NEUROSCI, V30, P2017, DOI 10.1523/JNEUROSCI.5693-09.2010; Hruba L, 2015, J PHARMACOL EXP THER, V353, P261, DOI 10.1124/jpet.115.222836; Hsu KL, 2012, NAT CHEM BIOL, V8, P999, DOI [10.1038/NCHEMBIO.1105, 10.1038/nchembio.1105]; Kohnz RA, 2014, CHEM SOC REV, V43, P6859, DOI 10.1039/c4cs00047a; Lazarus M, 2007, NAT NEUROSCI, V10, P1131, DOI 10.1038/nn1949; Li S, 2001, BRAIN RES, V910, P163, DOI 10.1016/S0006-8993(01)02707-X; Long JZ, 2009, P NATL ACAD SCI USA, V106, P20270, DOI 10.1073/pnas.0909411106; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Matsumura K, 1998, J NEUROSCI, V18, P6279; Morrison SF, 2011, FRONT BIOSCI-LANDMRK, V16, P74, DOI 10.2741/3677; Mulvihill MM, 2013, LIFE SCI, V92, P492, DOI 10.1016/j.lfs.2012.10.025; Nakamura K, 2000, J COMP NEUROL, V421, P543, DOI 10.1002/(SICI)1096-9861(20000612)421:4<543::AID-CNE6>3.0.CO;2-3; Nakamura K, 2004, J NEUROSCI, V24, P5370, DOI 10.1523/JNEUROSCI.1219-04.2004; Nakamura K, 1999, NEUROSCI LETT, V260, P117, DOI 10.1016/S0304-3940(98)00962-8; Nakamura Y, 2005, EUR J NEUROSCI, V22, P3137, DOI 10.1111/j.1460-9568.2005.04515.x; Nirodi CS, 2004, P NATL ACAD SCI USA, V101, P1840, DOI 10.1073/pnas.0303950101; Nomura DK, 2011, SCIENCE, V334, P809, DOI 10.1126/science.1209200; Oka T, 2003, J PHYSIOL-LONDON, V551, P945, DOI 10.1113/jphysiol.2003.048140; Piro JR, 2012, CELL REP, V1, P617, DOI 10.1016/j.celrep.2012.05.001; Ranels HJ, 2003, BRAIN RES, V964, P42, DOI 10.1016/S0006-8993(02)04063-5; Rosenberger TA, 2003, J LIPID RES, V44, P109, DOI 10.1194/jlr.M200298-JLR200; Sanchez-Alavez M, 2006, P NATL ACAD SCI USA, V103, P2904, DOI 10.1073/pnas.0510960103; Sanchez-Alavez M, 2007, BRAIN RES, V1158, P71, DOI 10.1016/j.brainres.2007.05.010; Sanchez-Alavez M, 2010, DIABETES, V59, P43, DOI 10.2337/db09-1128; Scammell TE, 1996, J NEUROSCI, V16, P6246; SCHOENER EP, 1976, BRAIN RES, V117, P157, DOI 10.1016/0006-8993(76)90567-9; Steiner AA, 2011, J PHYSIOL-LONDON, V589, P2415, DOI 10.1113/jphysiol.2010.202465; STITT JT, 1973, J PHYSIOL-LONDON, V232, P163, DOI 10.1113/jphysiol.1973.sp010262; Ushikubi F, 1998, NATURE, V395, P281, DOI 10.1038/26233; WILLIAMS JW, 1977, BRAIN RES, V120, P251, DOI 10.1016/0006-8993(77)90904-0; Wise LE, 2012, ACS CHEM NEUROSCI, V3, P369, DOI 10.1021/cn200130s; Yamagata K, 2001, J NEUROSCI, V21, P2669, DOI 10.1523/JNEUROSCI.21-08-02669.2001; Zhang YH, 2003, J COMP NEUROL, V463, P3, DOI 10.1002/cne.10743; Zorriila EP, 2007, P NATL ACAD SCI USA, V104, P11097, DOI 10.1073/pnas.0611523104	42	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0134437	10.1371/journal.pone.0134437	http://dx.doi.org/10.1371/journal.pone.0134437			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287872	gold, Green Published, Green Submitted			2022-12-26	WOS:000360018600021
J	Tranchida, F; Shintu, L; Rakotoniaina, Z; Tchiakpe, L; Deyris, V; Hiol, A; Caldarelli, S				Tranchida, Fabrice; Shintu, Laetitia; Rakotoniaina, Zo; Tchiakpe, Leopold; Deyris, Valerie; Hiol, Abel; Caldarelli, Stefano			Metabolomic and Lipidomic Analysis of Serum Samples following Curcuma longa Extract Supplementation in High-Fructose and Saturated Fat Fed Rats	PLOS ONE			English	Article							INDUCED INSULIN-RESISTANCE; SKELETAL-MUSCLE; ACID-CONCENTRATIONS; ETHANOL-METABOLISM; DIABETES-MELLITUS; MEMBRANE-FLUIDITY; PROTEIN-SYNTHESIS; LIVER; OBESE; GLUCOSE	We explored, using nuclear magnetic resonance (NMR) metabolomics and fatty acids profiling, the effects of a common nutritional complement, Curcuma longa, at a nutritionally relevant dose with human use, administered in conjunction with an unbalanced diet. Indeed, traditional food supplements have been long used to counter metabolic impairments induced by unbalanced diets. Here, rats were fed either a standard diet, a high level of fructose and saturated fatty acid (HFS) diet, a diet common to western countries and that certainly contributes to the epidemic of insulin resistance (IR) syndrome, or a HFS diet with a Curcuma longa extract (1% of curcuminoids in the extract) for ten weeks. Orthogonal projections to latent structures discriminant analysis (OPLS-DA) on the serum NMR profiles and fatty acid composition (determined by GC/MS) showed a clear discrimination between HFS groups and controls. This discrimination involved metabolites such as glucose, amino acids, pyruvate, creatine, phosphocholine/glycerophosphocholine, ketone bodies and glycoproteins as well as an increase of monounsaturated fatty acids (MUFAs) and a decrease of n-6 and n-3 polyunsaturated fatty acids (PUFAs). Although the administration of Curcuma longa did not prevent the observed increase of glucose, triglycerides, cholesterol and insulin levels, discriminating metabolites were observed between groups fed HFS alone or with addition of a Curcuma longa extract, namely some MUFA and n-3 PUFA, glycoproteins, glutamine, and methanol, suggesting that curcuminoids may act respectively on the fatty acid metabolism, the hexosamine biosynthesis pathway and alcohol oxidation. Curcuma longa extract supplementation appears to be beneficial in these metabolic pathways in rats. This metabolomic approach highlights important serum metabolites that could help in understanding further the metabolic mechanisms leading to IR.	[Tranchida, Fabrice; Shintu, Laetitia; Rakotoniaina, Zo; Deyris, Valerie; Caldarelli, Stefano] Aix Marseille Univ, CNRS, ISm2, Cent Marseille,UMR 7313, Marseille, France; [Tchiakpe, Leopold] Aix Marseille Univ, Lab Nutr Dietet, Fac Pharm, Marseille, France; [Hiol, Abel] Univ La Reunion, CIRAD, ESIROI, UMR QualiSud, St Denis, France; [Caldarelli, Stefano] CNRS, Inst Chim Subst Nat, UPR 2301, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; CIRAD; University of La Reunion; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay	Tranchida, F (corresponding author), Aix Marseille Univ, CNRS, ISm2, Cent Marseille,UMR 7313, Marseille, France.	fabrice.tranchida@univ-amu.fr; laetitia.shintu@univ-amu.fr	Stefano, Caldaralli/B-2750-2017; shintu, laetitia/B-6293-2009	Stefano, Caldaralli/0000-0001-9008-9392; shintu, laetitia/0000-0003-2730-121X				Araujo CAC, 2001, MEM I OSWALDO CRUZ, V96, P723, DOI 10.1590/S0074-02762001000500026; Astrup A, 2000, Obes Rev, V1, P57, DOI 10.1046/j.1467-789x.2000.00013.x; AXELROD J, 1965, SCIENCE, V150, P892, DOI 10.1126/science.150.3698.892; Balkau B, 2002, DIABETES METAB, V28, P364; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; Binder E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074705; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; BRENNER RR, 1966, J BIOL CHEM, V241, P5213; Candiloros H, 1996, J CLIN ENDOCR METAB, V81, P2912, DOI 10.1210/jc.81.8.2912; CASTELLINO P, 1987, J CLIN INVEST, V80, P1784, DOI 10.1172/JCI113272; Cazzola R, 2004, J LIPID RES, V45, P1846, DOI 10.1194/jlr.M300509-JLR200; Clore JN, 2000, METABOLISM, V49, P232, DOI 10.1016/S0026-0495(00)91455-0; D'Angelo G, 2005, HYPERTENSION, V46, P806, DOI 10.1161/01.HYP.0000182697.39687.34; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Evans JL, 2003, DIABETES, V52, P1, DOI 10.2337/diabetes.52.1.1; Faure P, 1997, J NUTR, V127, P103, DOI 10.1093/jn/127.1.103; FUKUDA N, 1982, J BIOL CHEM, V257, P4066; Ghafoorunissa, 2005, J NUTR, V135, P2634, DOI 10.1093/jn/135.11.2634; Girard A, 2005, NUTRITION, V21, P240, DOI 10.1016/j.nut.2004.04.022; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; Gupta SC, 2013, AAPS J, V15, P195, DOI 10.1208/s12248-012-9432-8; Haffner HT, 1998, INT J LEGAL MED, V111, P27; HANDLER JA, 1988, FEBS LETT, V238, P139, DOI 10.1016/0014-5793(88)80243-6; Havel PJ, 2005, NUTR REV, V63, P133, DOI [10.1301/nr.2005.may.133-157, 10.1111/j.1753-4887.2005.tb00132.x]; He QH, 2012, J NUTR BIOCHEM, V23, P133, DOI 10.1016/j.jnutbio.2010.11.007; HIRANO T, 1989, AM J PHYSIOL, V256, pE559, DOI 10.1152/ajpendo.1989.256.4.E559; Huang DJ, 2002, J AGR FOOD CHEM, V50, P4437, DOI 10.1021/jf0201529; Joint Expert Committee on Food Additives, 2004, WHO TECHN REP SER, V922; JULIA P, 1987, EUR J BIOCHEM, V162, P179, DOI 10.1111/j.1432-1033.1987.tb10559.x; Katsanos CS, 2009, J CLIN ENDOCR METAB, V94, P2984, DOI 10.1210/jc.2008-2686; Kawashima H, 1996, BIOSCI BIOTECH BIOCH, V60, P108, DOI 10.1271/bbb.60.108; Kim HJ, 2011, J PROTEOME RES, V10, P722, DOI 10.1021/pr100892r; KORNFELD S, 1964, P NATL ACAD SCI USA, V52, P371, DOI 10.1073/pnas.52.2.371; Le KA, 2009, AM J CLIN NUTR, V89, P1760, DOI 10.3945/ajcn.2008.27336; Lin SH, 2011, MOL BIOSYST, V7, P1537, DOI 10.1039/c0mb00246a; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Mahendran Y, 2013, DIABETES, V62, P3618, DOI 10.2337/db12-1363; Malik VS, 2006, AM J CLIN NUTR, V84, P274; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; Masood A, 2005, J LIPID RES, V46, P2299, DOI 10.1194/jlr.D500022-JLR200; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Na LX, 2011, NUTR METAB CARDIOVAS, V21, P526, DOI 10.1016/j.numecd.2009.11.009; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Newman JC, 2014, TRENDS ENDOCRIN MET, V25, P42, DOI 10.1016/j.tem.2013.09.002; Neyrinck AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081252; Pari L, 2007, PLANT FOOD HUM NUTR, V62, P25, DOI 10.1007/s11130-006-0037-1; PATIL TN, 1971, INDIAN J EXP BIOL, V9, P167; Patti ME, 1999, DIABETES, V48, P1562, DOI 10.2337/diabetes.48.8.1562; Pongchaidecha A, 2009, NUTRITION, V25, P870, DOI 10.1016/j.nut.2009.02.001; Qin LQ, 2011, J NUTR, V141, P249, DOI 10.3945/jn.110.128520; Rippe JM, 2013, ADV NUTR, V4, P236, DOI 10.3945/an.112.002824; Sasaki H, 2011, BIOL PHARM BULL, V34, P660, DOI 10.1248/bpb.34.660; SCHNEIDER WJ, 1978, EUR J BIOCHEM, V85, P181, DOI 10.1111/j.1432-1033.1978.tb12226.x; SCHOLZ R, 1976, EUR J BIOCHEM, V63, P449, DOI 10.1111/j.1432-1033.1976.tb10247.x; SENSI M, 1993, DIABETOLOGIA, V36, P797, DOI 10.1007/BF00400352; Seo KI, 2008, MOL NUTR FOOD RES, V52, P995, DOI 10.1002/mnfr.200700184; Sestili P, 2011, AMINO ACIDS, V40, P1385, DOI 10.1007/s00726-011-0875-5; Shearer J, 2008, DIABETES OBES METAB, V10, P950, DOI 10.1111/j.1463-1326.2007.00837.x; Sreejayan N, 1997, INT J PHARM, V151, P127, DOI 10.1016/S0378-5173(97)04900-4; Stumvoll M, 1996, DIABETES, V45, P863, DOI 10.2337/diabetes.45.7.863; Taghibiglou C, 2002, J BIOL CHEM, V277, P793, DOI 10.1074/jbc.M106737200; TEPHLY TR, 1991, LIFE SCI, V48, P1031, DOI 10.1016/0024-3205(91)90504-5; Thresher JS, 2000, AM J PHYSIOL-REG I, V279, pR1334, DOI 10.1152/ajpregu.2000.279.4.R1334; TONG P, 1995, LANCET, V345, P357, DOI 10.1016/S0140-6736(95)90343-7; Tranchida F, 2012, J ZHEJIANG UNIV-SC B, V13, P307, DOI 10.1631/jzus.B1100090; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Tsai J, 2009, AM J PHYSIOL-GASTR L, V296, pG1287, DOI 10.1152/ajpgi.90540.2008; TYGSTRUP N, 1965, J CLIN INVEST, V44, P817, DOI 10.1172/JCI105194; WOODS HG, 1970, BIOCHEM J, V119, P501, DOI 10.1042/bj1190501; ZEISEL SH, 1994, ANNU REV NUTR, V14, P269, DOI 10.1146/annurev.nu.14.070194.001413; Zhang XY, 2009, J PROTEOME RES, V8, P5188, DOI 10.1021/pr900524z	72	17	18	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135948	10.1371/journal.pone.0135948	http://dx.doi.org/10.1371/journal.pone.0135948			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288372	Green Published, gold, Green Submitted			2022-12-26	WOS:000360018600089
J	Jung, HM; Lee, JS; Lairson, DR; Kim, Y				Jung, Hye-Min; Lee, Jin-Seok; Lairson, David R.; Kim, Yoon			The Effect of National Cancer Screening on Disparity Reduction in Cancer Stage at Diagnosis by Income Level	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; HEALTH; KOREA; PREVALENCE; MORTALITY	Background Early detection of cancer is an effective and efficient cancer management strategy. In South Korea, the National Health Insurance administers the National Cancer Screening Program to its beneficiaries. We examined the impact of the National Cancer Screening Program on socioeconomic disparities in cancer stage at diagnosis. Methods Cancer patients registered in the Korean Central Cancer Registry from January 1, 2010 to December 31, 2010 with a diagnosis of gastric cancer (n = 22,470), colon cancer (n = 16,323), breast cancer (n = 10,076), or uterine cervical cancer (n = 2,447) were included. Income level was divided into three groups according to their monthly contribution of National Health Insurance. We employed absolute (age-standardized prevalence rate, slope index of inequality) and relative (relative index of inequality) measures to separately examine social disparities among participants and non-participants of the National Cancer Screening Program in terms of the early-stage rate. Results Age-standardized prevalence rates of early-stage by income group were always higher in participants than in non-participants. Furthermore, the age-standardized prevalence rate of early-stage in the low income group of the participants was also higher than that of the high income group of the non-participants. The sizes of disparities (both slope index of inequality and relative index of inequality) are smaller in participants compared to non-participants. Conclusion National Cancer Screening Program participation reduced income disparity in cancer stage at diagnosis. Population-based cancer screening programs can be used as an effective measure to reduce income disparity in cancer care.	[Jung, Hye-Min; Lee, Jin-Seok; Kim, Yoon] Seoul Natl Univ, Coll Med, Dept Hlth Policy & Management, Seoul, South Korea; [Lee, Jin-Seok; Kim, Yoon] Seoul Natl Univ, Med Res Ctr, Inst Hlth Policy & Management, Seoul, South Korea; [Lairson, David R.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Houston, TX 77030 USA	Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU); Seoul National University (SNU); University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Lee, JS (corresponding author), Seoul Natl Univ, Coll Med, Dept Hlth Policy & Management, Seoul, South Korea.	phealth@snu.ac.kr		Jung, Hyemin/0000-0001-7339-7983	Ministry of Health and Welfare, Republic of Korea	Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	Funding for this work was provided by the Ministry of Health and Welfare, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand S, 2001, CHALLENGING INEQUITI, P49; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Bretthauer M, 2013, BRIT J SURG, V100, P55, DOI 10.1002/bjs.8995; Cho HJ, 2013, J KOREAN MED ASSOC, V56, P184, DOI 10.5124/jkma.2013.56.3.184; Clegg LX, 2009, CANCER CAUSE CONTROL, V20, P417, DOI 10.1007/s10552-008-9256-0; Gross CP, 2006, JAMA-J AM MED ASSOC, V296, P2815, DOI 10.1001/jama.296.23.2815; Halpern MT, 2008, LANCET ONCOL, V9, P222, DOI 10.1016/S1470-2045(08)70032-9; Jung KW, 2014, CANCER RES TREAT, V46, P109, DOI 10.4143/crt.2014.46.2.109; Lee HY, 2010, CANCER EPIDEM BIOMAR, V19, P1919, DOI 10.1158/1055-9965.EPI-09-1308; Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1; Sassi F, 2006, AM J PUBLIC HEALTH, V96, P2165, DOI 10.2105/AJPH.2005.071761; Schwartz KL, 2003, CANCER CAUSE CONTROL, V14, P761, DOI 10.1023/A:1026321923883; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Swan J, 2003, CANCER, V97, P1528, DOI 10.1002/cncr.11208; von Karsa L., 2008, CANC SCREENING EUROP; World Health Organization, 2007, CANC CONTR KNOWL ACT	16	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0136036	10.1371/journal.pone.0136036	http://dx.doi.org/10.1371/journal.pone.0136036			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP1VY	26284526	gold, Green Submitted, Green Published			2022-12-26	WOS:000359666100097
J	Ding, D; Wang, M; Su, DF; Hong, CJ; Li, XR; Yang, YO; Zhang, Y; Hu, G; Ling, WH				Ding, Ding; Wang, Min; Su, Dongfang; Hong, Changjiang; Li, Xinrui; Yang, Yunou; Zhang, Yuan; Hu, Gang; Ling, Wenhua			Body Mass Index, High-Sensitivity C-Reactive Protein and Mortality in Chinese with Coronary Artery Disease	PLOS ONE			English	Article							ELEVATION MYOCARDIAL-INFARCTION; PRACTICE GUIDELINES COMMITTEE; AMERICAN-HEART-ASSOCIATION; CARDIOVASCULAR-DISEASE; DIALYSIS PATIENTS; OBESITY PARADOX; RISK-FACTOR; TASK-FORCE; INFLAMMATION; OUTCOMES	Background To investigate single and joint associations of body mass index (BMI) and serum high-sensitivity C-reactive protein (hsCRP) with death. Methods The study included 1871 coronary artery disease (CAD) patients aged 40-85 year-old recruited from 2008 to 2011. Cox regression models were used to estimate the association of BMI and hsCRP with mortality. The data was analyzed in 2014. Results During 3.1 years follow-up, 141 deaths were recorded, 110 died of cardiovascular disease (CVD). After adjustment of major CVD risk factors, there was a J-shaped association between BMI and all-cause and CVD mortality, and a positive association between hsCRP and mortality. The J-shaped association of BMI with mortality was present among patients who never smoked or with elevated hsCRP (>= 3.0 mg/L). Compared with overweight (BMI 24-27.9 kg/m(2)) patients with normal hsCRP (<3.0 mg/L), obese patients (BMI >= 28 kg/m(2)) with elevated hsCRP had a 3.41-fold risk of all-cause mortality (95% CI 1.49-7.80) and a 3.50-fold risk of CVD mortality (1.40-8.75), lean patients (BMI<24 kg/m(2)) with elevated hsCRP concentration had a 2.54-fold risk of all-cause mortality (1.36-4.74) and a 2.36-fold risk of CVD mortality (1.19-4.70). Conclusions The association pattern between baseline BMI and mortality changed among different baseline hsCRP concentrations, indicating that low-grade inflammation may be related to BMI and secondary prognosis of CAD.	[Ding, Ding; Wang, Min; Su, Dongfang; Li, Xinrui; Yang, Yunou; Ling, Wenhua] Sun Yat Sen Univ, Sch Publ Hlth, Dept Nutr, Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou 510275, Guangdong, Peoples R China; [Hong, Changjiang; Zhang, Yuan; Hu, Gang] Guangzhou Mil Command Peoples Liberat Army, Gen Hosp, Dept Cardiol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Hu, G (corresponding author), Pennington Biomed Res Ctr, Chron Dis Epidemiol Lab, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	gang.hu@pbrc.edu; lingwh@mail.sysu.edu.cn	Hu, Gang/N-1971-2017; Hu, Gang/V-7947-2019	Hu, Gang/0000-0002-6172-8017; Hu, Gang/0000-0002-6172-8017	Key Project of National Natural Science Fund, China [81130052]; China Scholarship Council	Key Project of National Natural Science Fund, China; China Scholarship Council(China Scholarship Council)	This work was supported by the Key Project of National Natural Science Fund [grant number 81130052], China (http://www.nsfc.gov.cn/) to WL. DD is supported by a Scholarship from the China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeras O, 2013, EUR HEART J, V34, P345, DOI 10.1093/eurheartj/ehs217; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Bergstrom J, 1998, AM J KIDNEY DIS, V32, P834, DOI 10.1016/S0272-6386(98)70148-9; Braunwald E, 2000, CIRCULATION, V102, P1193, DOI 10.1161/01.CIR.102.10.1193; Das SR, 2011, J AM COLL CARDIOL, V58, P2642, DOI 10.1016/j.jacc.2011.09.030; DEGOULET P, 1982, NEPHRON, V31, P103, DOI 10.1159/000182627; Ding D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120633; Ding D, 2014, DIABETES CARE, V37, P546, DOI 10.2337/dc13-1387; Ferrero-Miliani L, 2007, CLIN EXP IMMUNOL, V147, P227, DOI 10.1111/j.1365-2249.2006.03261.x; FLORES EA, 1989, J CLIN INVEST, V83, P1614, DOI 10.1172/JCI114059; Gibbons RJ, 1999, CIRCULATION, V99, P2829, DOI 10.1161/01.CIR.99.21.2829; Gurm HS, 2002, J AM COLL CARDIOL, V39, P834, DOI 10.1016/S0735-1097(02)01687-X; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Kalantar-Zadeh K, 2001, AM J KIDNEY DIS, V38, P1343, DOI 10.1053/ajkd.2001.29250; Kalantar-Zadeh K, 2007, CURR OPIN CLIN NUTR, V10, P433, DOI 10.1097/MCO.0b013e3281a30594; Kaysen GA, 2000, NEPHROL DIAL TRANSPL, V15, P1521, DOI 10.1093/ndt/15.10.1521; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Kennedy LMA, 2005, J AM COLL CARDIOL, V45, P156, DOI 10.1016/j.jacc.2004.10.001; Lagrand WK, 1999, CIRCULATION, V100, P96, DOI 10.1161/01.CIR.100.1.96; McCarthy DO, 2000, RES NURS HEALTH, V23, P222, DOI 10.1002/1098-240X(200006)23:3<222::AID-NUR6>3.0.CO;2-3; McEwen LN, 2012, DIABETES CARE, V35, P1301, DOI 10.2337/dc11-2281; Motie M, 2014, EXP THER MED, V8, P181, DOI 10.3892/etm.2014.1673; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Oreopoulos A, 2008, AM HEART J, V156, P13, DOI 10.1016/j.ahj.2008.02.014; Oreopoulos A, 2009, EUR HEART J, V30, P2584, DOI 10.1093/eurheartj/ehp288; Organization WH, 2009, GLOB HLTH RISKS MORT; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Poston WSC, 2004, INT J OBESITY, V28, P1011, DOI 10.1038/sj.ijo.0802703; Romero-Corral A, 2006, LANCET, V368, P666, DOI 10.1016/S0140-6736(06)69251-9; Sabatine MS, 2007, CIRCULATION, V115, P1528, DOI 10.1161/CIRCULATIONAHA.106.649939; Uretsky S, 2007, AM J MED, V120, P863, DOI 10.1016/j.amjmed.2007.05.011; Voeikov VL, 2006, J ALTERN COMPLEM MED, V12, P111, DOI 10.1089/acm.2006.12.111; Wong JS, 1999, KIDNEY INT, V55, P2515, DOI 10.1046/j.1523-1755.1999.00464.x	34	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0135713	10.1371/journal.pone.0135713	http://dx.doi.org/10.1371/journal.pone.0135713			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26280165	Green Submitted, gold, Green Published			2022-12-26	WOS:000359664300020
J	Meng, FY; Wu, H				Meng, Fanyong; Wu, Hao			Indoor Air Pollution by Methylsiloxane in Household and Automobile Settings	PLOS ONE			English	Article							LINEAR SILOXANES; CYCLIC SILOXANES; PERSONAL-CARE; WATER; SOIL; D5	This study examines characteristics of atmospheric methylsiloxane pollution in indoor settings where interior renovation/redecoration is being undertaken, in addition to ordinary family homes and inside family cars. Concentrations of atmospheric methylsiloxane in these locations were approximately one order of magnitude higher than that in outdoor areas. The average indoor concentration of methylsiloxane where renovation was being undertaken was 9.4 mu g/m(3), which is slightly higher than that in an ordinary family home (7.88 mu g/m(3)), while samples from family cars showed lower concentration (3.10 mu g/m(3)). The indoor atmospheric concentration during renovation/redecoration work was significantly positively correlated with the duration of the work. The structure of atmospheric methylsiloxane pollution is basically the same in these three venues. The concentration of annulus siloxane was much higher than that of linear compounds (85% of the total methylsiloxane concentrations). Household dust in average family homes showed total methylsiloxane concentration of 9.5 mu g/m(3) (average); the structure mainly consisted of linear siloxane (approximately 98% of total concentration), thereby differing from that of atmospheric methylsiloxane pollution. The comparatively high concentration of methylsiloxane in these three venues indicates that interior renovation and decoration work, and even travelling in cars, can involve exposure to more serious siloxane contamination during everyday activities.	[Meng, Fanyong; Wu, Hao] Beihang Univ, Sch Econ & Management, Beijing 100191, Peoples R China	Beihang University	Meng, FY (corresponding author), Beihang Univ, Sch Econ & Management, Beijing 100191, Peoples R China.	meng_fy@sohu.com; by0081wuhao@hotmail.com			China Recycle Economy Research Center, Beihang University	China Recycle Economy Research Center, Beihang University	This study was supported by the China Recycle Economy Research Center, Beihang University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borga K, 2012, ENVIRON SCI TECHNOL, V46, P6347, DOI 10.1021/es300875d; He B, 2003, TOXICOL APPL PHARM, V192, P254, DOI 10.1016/S0041-008X(03)00282-5; Horii Y, 2008, ARCH ENVIRON CON TOX, V55, P701, DOI 10.1007/s00244-008-9172-z; Kaj L., 2005, SILOXANES NORDIC ENV; Kierkegaard A, 2011, ENVIRON SCI TECHNOL, V45, P5936, DOI 10.1021/es200707r; Lu Y, 2011, ENVIRON POLLUT, V159, P3522, DOI 10.1016/j.envpol.2011.08.015; Lu Y, 2010, ENVIRON SCI TECHNOL, V44, P6081, DOI 10.1021/es101368n; McGoldrick DJ, 2014, ENVIRON POLLUT, V186, P141, DOI 10.1016/j.envpol.2013.12.003; Shields HC, 1996, INDOOR AIR, V6, P2, DOI 10.1111/j.1600-0668.1996.t01-3-00002.x; Surita SC, 2014, SCI TOTAL ENVIRON, V468, P46, DOI 10.1016/j.scitotenv.2013.08.006; Velicogna J, 2012, CHEMOSPHERE, V87, P77, DOI 10.1016/j.chemosphere.2011.11.064; Wang DG, 2013, CHEMOSPHERE, V93, P766, DOI 10.1016/j.chemosphere.2012.10.047; Xu L, 2013, WATER RES, V47, P715, DOI 10.1016/j.watres.2012.10.046; Xu L, 2012, ENVIRON SCI TECHNOL, V46, P11718, DOI 10.1021/es3023368	14	3	5	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0135509	10.1371/journal.pone.0135509	http://dx.doi.org/10.1371/journal.pone.0135509			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26280831	Green Published, gold, Green Submitted			2022-12-26	WOS:000359664300016
J	Zhai, H; Lu, SX; Wu, HY; Zhang, YP; Zhang, XZ; Yang, JY; Wang, YY; Yang, G; Qiu, HM; Cui, TT; Xia, ZJ				Zhai, Hong; Lu, Shixiang; Wu, Hongyan; Zhang, Yupeng; Zhang, Xingzheng; Yang, Jiayin; Wang, Yaying; Yang, Guang; Qiu, Hongmei; Cui, Tingting; Xia, Zhengjun			Diurnal Expression Pattern, Allelic Variation, and Association Analysis Reveal Functional Features of the E1 Gene in Control of Photoperiodic Flowering in Soybean	PLOS ONE			English	Article							MAP-BASED CLONING; MATURITY LOCI; L MERRILL; TIME; INSENSITIVITY; INHERITANCE; RESPONSES; GIGANTEA; PLANT; E3	Although four maturity genes, E1 to E4, in soybean have been successfully cloned, their functional mechanisms and the regulatory network of photoperiodic flowering remain to be elucidated. In this study, we investigated how the diurnal expression pattern of the E1 gene is related to photoperiodic length; and to what extent allelic variation in the B3-like domain of the E1 gene is associated with flowering time phenotype. The bimodal expression of the E1 gene peaked first at around 2 hours after dawn in long-day condition. The basal expression level of E1 was enhanced by the long light phase, and decreased by duration of dark. We identified a 5bp (3 SNP and 2-bp deletion) mutation, referred to an e1-b3a, which occurs in the middle of B3 domain of the E1 gene in the early flowering cultivar Yanhuang 3. Subcellular localization analysis showed that the putative truncated e1-b3a protein was predominately distributed in nuclei, indicating the distribution pattern of e1-b3a was similar to that of E1, but not to that of e1-as. Furthermore, genetic analysis demonstrated allelic variations at the E1 locus significantly underlay flowering time in three F-2 populations. Taken together, we can conclude the legume specific E1 gene confers some special features in photoperiodic control of flowering in soybean. Further characterization of the E1 gene will extend our understanding of the soybean flowering pathway in soybean.	[Zhai, Hong; Lu, Shixiang; Wu, Hongyan; Zhang, Yupeng; Zhang, Xingzheng; Wang, Yaying; Yang, Guang; Cui, Tingting; Xia, Zhengjun] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Soybean Mol Design Breeding, Harbin, Peoples R China; [Lu, Shixiang; Zhang, Yupeng; Zhang, Xingzheng; Wang, Yaying] Univ Chinese Acad Sci, Beijing, Peoples R China; [Yang, Jiayin] Huaiyin Inst Agr Sci Xuhuai Reg Jiangsu, Huaian, Peoples R China; [Qiu, Hongmei] Jilin Acad Agr Sci, Soybean Res Inst, Changchun, Peoples R China	Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Jiangsu Academy of Agricultural Sciences; Jilin Academy of Agricultural Sciences	Xia, ZJ (corresponding author), Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Soybean Mol Design Breeding, Harbin, Peoples R China.	xiazhj@iga.ac.cn			National Natural Science of China [31430065, 31471518, 31271742, 31301338]; Chinese Academy of Sciences [XDA08010105, KZCX 2-EW-303]; National Science and Technology Ministry of China [2011BAD35B06-2]	National Natural Science of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); National Science and Technology Ministry of China	This work was supported by the State Key Program (31430065) and Programs (31471518, 31271742, and 31301338) from National Natural Science of China; by Programs (XDA08010105, Hundred Talents Program, and KZCX 2-EW-303) from Chinese Academy of Sciences; by Program (2011BAD35B06-2) from National Science and Technology Ministry of China.	Abe J, 2003, CROP SCI, V43, P1300, DOI 10.2135/cropsci2003.1300; Bendix C, 2015, MOL PLANT, V8, P1135, DOI 10.1016/j.molp.2015.03.003; BERNARD RL, 1971, CROP SCI, V11, P242, DOI 10.2135/cropsci1971.0011183X001100020022x; Bonato ER, 1999, GENET MOL BIOL, V22, P229, DOI 10.1590/S1415-47571999000200016; Buzzell R. I., 1980, SOYBEAN GENETICS NEW, V7, P26, DOI DOI 10.1093/JHERED/ESP113; BUZZELL RI, 1971, CAN J GENET CYTOL, V13, P703, DOI 10.1139/g71-100; Cober ER, 2010, CROP SCI, V50, P524, DOI 10.2135/cropsci2009.04.0174; Cober ER, 1996, CROP SCI, V36, P601, DOI 10.2135/cropsci1996.0011183X003600030013x; Cober ER, 1996, CROP SCI, V36, P606, DOI 10.2135/cropsci1996.0011183X003600030014x; Cober ER, 2001, CROP SCI, V41, P698, DOI 10.2135/cropsci2001.413698x; FEHR WR, 1971, CROP SCI, V11, P929, DOI 10.2135/cropsci1971.0011183X001100060051x; Garner WW, 1923, J AGRIC RES, V23, P0871; Garner WW., 1920, J AGR RES, VXVII, P553; Kawasaki S, 2000, J PLANT RES, V113, P497, DOI 10.1007/PL00013960; Kong FJ, 2014, CROP SCI, V54, P2529, DOI 10.2135/cropsci2014.03.0228; Kong FJ, 2010, PLANT PHYSIOL, V154, P1220, DOI 10.1104/pp.110.160796; Liu B, 2008, GENETICS, V180, P995, DOI 10.1534/genetics.108.092742; Liu BH, 2010, J HERED, V101, P251, DOI 10.1093/jhered/esp113; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MCBLAIN BA, 1987, CROP SCI, V27, P1127, DOI 10.2135/cropsci1987.0011183X002700060008x; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Owen FV, 1927, GENETICS, V12, P519; RAY JD, 1995, CROP SCI, V35, P1001, DOI 10.2135/cropsci1995.0011183X003500040012x; Thakare D, 2011, PLANTA, V234, P933, DOI 10.1007/s00425-011-1450-8; Thakare D, 2010, PLANTA, V231, P951, DOI 10.1007/s00425-010-1100-6; Tsubokura Y, 2014, ANN BOT-LONDON, V113, P429, DOI 10.1093/aob/mct269; UPADHYAY AP, 1994, ANN BOT-LONDON, V74, P87, DOI [10.1006/anbo.1994.1097, 10.1093/aob/74.1.87]; Watanabe S, 2011, GENETICS, V188, P395, DOI 10.1534/genetics.110.125062; Watanabe S, 2009, GENETICS, V182, P1251, DOI 10.1534/genetics.108.098772; Xia Z, 2007, DNA RES, V14, P257, DOI 10.1093/dnares/dsm027; Xia ZJ, 2012, P NATL ACAD SCI USA, V109, pE2155, DOI 10.1073/pnas.1117982109; Xie QG, 2015, P NATL ACAD SCI USA, V112, P3829, DOI 10.1073/pnas.1421803112; Xu ML, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-91; Zhai H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097636; Zhou ZK, 2015, NAT BIOTECHNOL, V33, P408, DOI 10.1038/nbt.3096	35	19	21	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135909	10.1371/journal.pone.0135909	http://dx.doi.org/10.1371/journal.pone.0135909			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275311	Green Published, gold, Green Submitted			2022-12-26	WOS:000359493600131
J	Thakur, RS; Basavaraju, S; Khanduja, JS; Muniyappa, K; Nagaraju, G				Thakur, Roshan Singh; Basavaraju, Shivakumar; Khanduja, Jasbeer Singh; Muniyappa, K.; Nagaraju, Ganesh			Mycobacterium tuberculosis RecG Protein but Not RuvAB or RecA Protein Is Efficient at Remodeling the Stalled Replication Forks IMPLICATIONS FOR MULTIPLE MECHANISMS OF REPLICATION RESTART IN MYCOBACTERIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; DNA-BINDING PROTEIN; HOMOLOGOUS RECOMBINATION; HOLLIDAY-JUNCTIONS; BRANCH MIGRATION; GENOME STABILITY; ATPASE ACTIVITY; LAGGING-STRAND; FANCONI-ANEMIA; SMEGMATIS RECA	Aberrant DNA replication, defects in the protection, and restart of stalled replication forks are major causes of genome instability in all organisms. Replication fork reversal is emerging as an evolutionarily conserved physiological response for restart of stalled forks. Escherichia coli RecG, RuvAB, and RecA proteins have been shown to reverse the model replication fork structures in vitro. However, the pathways and the mechanisms by which Mycobacterium tuberculosis, a slow growing human pathogen, responds to different types of replication stress and DNA damage are unclear. Here, we show that M. tuberculosis RecG rescues E. coli Delta recG cells from replicative stress. The purified M. tuberculosis RecG (MtRecG) and RuvAB(MtRuvAB) proteins catalyze fork reversal of model replication fork structures with and without a leading strand single-stranded DNA gap. Interestingly, single-stranded DNA-binding protein suppresses the MtRecG- and MtRuvAB-mediated fork reversal with substrates that contain lagging strand gap. Notably, our comparative studies with fork structures containing template damage and template switching mechanism of lesion bypass reveal that MtRecG but not MtRuvAB or MtRecA is proficient in driving the fork reversal. Finally, unlike MtRuvAB, we find that MtRecG drives efficient reversal of forks when fork structures are tightly bound by protein. These results provide direct evidence and valuable insights into the underlying mechanism of MtRecG-catalyzed replication fork remodeling and restart pathways in vivo.	[Thakur, Roshan Singh; Basavaraju, Shivakumar; Khanduja, Jasbeer Singh; Muniyappa, K.; Nagaraju, Ganesh] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Nagaraju, G (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	nganesh@biochem.iisc.ernet.in		Thakur, Roshan/0000-0001-5284-4975	Department of Atomic Energy [2010/37B/40/BRNS/1437, 37(1)/14/52/2014-BRNS/1620]; DBT-IISc Partnership Program [DBT/BF/PR/INS/IISc/2011-12]; Center of Excellence and Innovation program of the Department of Biotechnology, New Delhi; Council of Scientific and Industrial Research fellowship	Department of Atomic Energy(Department of Atomic Energy (DAE)); DBT-IISc Partnership Program; Center of Excellence and Innovation program of the Department of Biotechnology, New Delhi; Council of Scientific and Industrial Research fellowship(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by in part Department of Atomic Energy Grants 2010/37B/40/BRNS/1437 and 37(1)/14/52/2014-BRNS/1620 and DBT-IISc Partnership Program Grant DBT/BF/PR/INS/IISc/2011-12 and by the Center of Excellence and Innovation program of the Department of Biotechnology, New Delhi (to the K. M. laboratory). The authors declare that they have no conflicts of interest with the contents of this article.r Supported through a Council of Scientific and Industrial Research fellowship.	Abd Wahab S, 2013, J BIOL CHEM, V288, P26397, DOI 10.1074/jbc.M113.500223; Ambur OH, 2009, FEMS MICROBIOL REV, V33, P453, DOI 10.1111/j.1574-6976.2009.00173.x; Atkinson J, 2009, NUCLEIC ACIDS RES, V37, P3475, DOI 10.1093/nar/gkp244; Baharoglu Z, 2006, EMBO J, V25, P596, DOI 10.1038/sj.emboj.7600941; Baharoglu Z, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000012; Berti M, 2013, NAT STRUCT MOL BIOL, V20, P347, DOI 10.1038/nsmb.2501; Betous R, 2013, CELL REP, V3, P1958, DOI 10.1016/j.celrep.2013.05.002; Bianco PR, 2015, PROG BIOPHYS MOL BIO, V117, P166, DOI 10.1016/j.pbiomolbio.2015.01.001; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Bugreev DV, 2011, NUCLEIC ACIDS RES, V39, P2153, DOI 10.1093/nar/gkq1139; Buss JA, 2008, NUCLEIC ACIDS RES, V36, P7029, DOI 10.1093/nar/gkn795; Courcelle J, 2003, SCIENCE, V299, P1064, DOI 10.1126/science.1081328; Cox MM, 2007, NAT REV MOL CELL BIO, V8, P127, DOI 10.1038/nrm2099; Cox MM, 2001, ANNU REV GENET, V35, P53, DOI 10.1146/annurev.genet.35.102401.090016; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Cox MM, 2000, PROG NUCLEIC ACID RE, V63, P311, DOI 10.1016/S0079-6603(08)60726-6; Donaldson JR, 2004, GENETICS, V166, P1631, DOI 10.1534/genetics.166.4.1631; Eggleston AK, 1997, CELL, V89, P607, DOI 10.1016/S0092-8674(00)80242-1; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Ganesh N, 2003, PROTEINS, V53, P6, DOI 10.1002/prot.10433; Ganesh N, 2003, BIOCHEMISTRY-US, V42, P7216, DOI 10.1021/bi0340548; Gorna AE, 2010, CLIN SCI, V119, P187, DOI 10.1042/CS20100041; Gupta S, 2014, J BIOL CHEM, V289, P28376, DOI 10.1074/jbc.M114.587881; Gupta S, 2014, J BIOL CHEM, V289, P28388, DOI 10.1074/jbc.M114.587907; Harmon FG, 2001, J BIOL CHEM, V276, P232, DOI 10.1074/jbc.M006555200; Heller RC, 2005, J BIOL CHEM, V280, P34143, DOI 10.1074/jbc.M507224200; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; Khanduja JS, 2009, BIOCHEMISTRY-US, V48, P27, DOI 10.1021/bi8016526; Khanduja JS, 2012, J BIOL CHEM, V287, P1345, DOI 10.1074/jbc.M111.304741; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Kreuzer KN, 2005, ANNU REV MICROBIOL, V59, P43, DOI 10.1146/annurev.micro.59.030804.121255; Kumar RA, 1996, BIOCHEMISTRY-US, V35, P1793, DOI 10.1021/bi9517751; Kurthkoti K, 2012, MECH AGEING DEV, V133, P138, DOI 10.1016/j.mad.2011.09.003; Kurthkoti K, 2011, TUBERCULOSIS, V91, P533, DOI 10.1016/j.tube.2011.06.005; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Kuzminov A, 2001, P NATL ACAD SCI USA, V98, P8461, DOI 10.1073/pnas.151260698; Le Masson M, 2008, MOL MICROBIOL, V70, P537, DOI 10.1111/j.1365-2958.2008.06431.x; Lienhardt C, 2012, NAT REV MICROBIOL, V10, P407, DOI 10.1038/nrmicro2797; LLOYD RG, 1991, J BACTERIOL, V173, P6837, DOI 10.1128/jb.173.21.6837-6843.1991; LLOYD RG, 1991, J BACTERIOL, V173, P1004, DOI 10.1128/jb.173.3.1004-1011.1991; LLOYD RG, 1991, J BACTERIOL, V173, P5414, DOI 10.1128/jb.173.17.5414-5418.1991; LOHMAN TM, 1986, BIOCHEMISTRY-US, V25, P21, DOI 10.1021/bi00349a004; Mahdi AA, 2003, EMBO J, V22, P724, DOI 10.1093/emboj/cdg043; Manosas M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3368; Manosas M, 2012, SCIENCE, V338, P1217, DOI 10.1126/science.1225437; MARIANS KJ, 1992, ANNU REV BIOCHEM, V61, P673, DOI 10.1146/annurev.bi.61.070192.003325; McGlynn P, 2000, CELL, V101, P35, DOI 10.1016/S0092-8674(00)80621-2; McGlynn P, 2002, NAT REV MOL CELL BIO, V3, P859, DOI 10.1038/nrm951; McGlynn P, 2004, CURR OPIN GENET DEV, V14, P107, DOI 10.1016/j.gde.2004.01.001; McGlynn P, 2001, P NATL ACAD SCI USA, V98, P8227, DOI 10.1073/pnas.111008698; McGlynn P, 2001, P NATL ACAD SCI USA, V98, P8235, DOI 10.1073/pnas.121007798; McGlynn P, 2001, J BIOL CHEM, V276, P41938, DOI 10.1074/jbc.M107945200; MEYER RR, 1990, MICROBIOL REV, V54, P342, DOI 10.1128/MMBR.54.4.342-380.1990; Michel B, 2004, P NATL ACAD SCI USA, V101, P12783, DOI 10.1073/pnas.0401586101; Michel B, 2001, P NATL ACAD SCI USA, V98, P8181, DOI 10.1073/pnas.111008798; Michel B, 2007, DNA REPAIR, V6, P967, DOI 10.1016/j.dnarep.2007.02.016; Muniyappa K, 2000, MICROBIOL-UK, V146, P2093, DOI 10.1099/00221287-146-9-2093; Nagaraju G, 2007, DNA REPAIR, V6, P1018, DOI 10.1016/j.dnarep.2007.02.020; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Neelsen KJ, 2015, NAT REV MOL CELL BIO, V16, P207, DOI 10.1038/nrm3935; Rachman H, 2006, INFECT IMMUN, V74, P1233, DOI 10.1128/IAI.74.2.1233-1242.2006; Ralf C, 2006, J BIOL CHEM, V281, P22839, DOI 10.1074/jbc.M604268200; Rawal P, 2006, GENOME RES, V16, P644, DOI 10.1101/gr.4508806; Reddy MS, 2001, J BIOL CHEM, V276, P45959, DOI 10.1074/jbc.M103523200; Robu ME, 2001, P NATL ACAD SCI USA, V98, P8211, DOI 10.1073/pnas.131022698; Rudolph CJ, 2010, DNA REPAIR, V9, P210, DOI 10.1016/j.dnarep.2009.12.014; San Filippo J, 2006, J BIOL CHEM, V281, P11649, DOI 10.1074/jbc.M601249200; Saravanan M, 2004, NUCLEIC ACIDS RES, V32, P6129, DOI 10.1093/nar/gkh951; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Seigneur M, 2000, MOL MICROBIOL, V38, P565, DOI 10.1046/j.1365-2958.2000.02152.x; SHURVINTON CE, 1982, MOL GEN GENET, V185, P352, DOI 10.1007/BF00330811; Singleton MR, 2001, CELL, V107, P79, DOI 10.1016/S0092-8674(01)00501-3; Slocum SL, 2007, J MOL BIOL, V367, P647, DOI 10.1016/j.jmb.2007.01.007; Sommers JA, 2014, J BIOL CHEM, V289, P19928, DOI 10.1074/jbc.M113.542456; Somyajit K, 2010, CARCINOGENESIS, V31, P2031, DOI 10.1093/carcin/bgq210; Sun ZQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep09625; Sung P, 2003, J BIOL CHEM, V278, P42729, DOI 10.1074/jbc.R300027200; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Syeda AH, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016550; Thakur RS, 2013, FEBS J, V280, P1841, DOI 10.1111/febs.12208; Thakur RS, 2014, J BIOL CHEM, V289, P25112, DOI 10.1074/jbc.M114.563569; van Gool AJ, 1998, EMBO J, V17, P1838, DOI 10.1093/emboj/17.6.1838; Warner DF, 2006, CLIN MICROBIOL REV, V19, P558, DOI 10.1128/CMR.00060-05; West SC, 1997, ANNU REV GENET, V31, P213, DOI 10.1146/annurev.genet.31.1.213; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; WHITBY MC, 1993, CELL, V75, P341, DOI 10.1016/0092-8674(93)80075-P; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Yeeles JTP, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012815; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897	90	9	9	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24119	24139		10.1074/jbc.M115.671164	http://dx.doi.org/10.1074/jbc.M115.671164			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26276393	hybrid, Green Published			2022-12-26	WOS:000362218900007
J	Ceschin, J; Hurlimann, HC; Saint-Marc, C; Albrecht, D; Violo, T; Moenner, M; Daignan-Fornier, B; Pinson, B				Ceschin, Johanna; Huerlimann, Hans Caspar; Saint-Marc, Christelle; Albrecht, Delphine; Violo, Typhaine; Moenner, Michel; Daignan-Fornier, Bertrand; Pinson, Benoit			Disruption of Nucleotide Homeostasis by the Antiproliferative Drug 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside Monophosphate (AICAR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; PURINE INTERMEDIATE; YEAST; PURIFICATION; ERYTHROCYTES; ACCUMULATION; INHIBITION; GLYCOLYSIS; PHOSPHATE; RIBOSIDE	5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside monophosphate (AICAR) is a natural metabolite with potent anti-proliferative and low energy mimetic properties. At high concentration, AICAR is toxic for yeast and mammalian cells, but the molecular basis of this toxicity is poorly understood. Here, we report the identification of yeast purine salvage pathway mutants that are synthetically lethal with AICAR accumulation. Genetic suppression revealed that this synthetic lethality is in part due to low expression of adenine phosphoribosyl transferase under high AICAR conditions. In addition, metabolite profiling points to the AICAR/NTP balance as crucial for optimal utilization of glucose as a carbon source. Indeed, we found that AICAR toxicity in yeast and human cells is alleviated when glucose is replaced by an alternative carbon source. Together, our metabolic analyses unveil the AICAR/NTP balance as a major factor of AICAR antiproliferative effects.	[Ceschin, Johanna; Huerlimann, Hans Caspar; Saint-Marc, Christelle; Albrecht, Delphine; Violo, Typhaine; Moenner, Michel; Daignan-Fornier, Bertrand; Pinson, Benoit] Univ Bordeaux, F-33077 Bordeaux, France; [Ceschin, Johanna; Huerlimann, Hans Caspar; Saint-Marc, Christelle; Albrecht, Delphine; Violo, Typhaine; Moenner, Michel; Daignan-Fornier, Bertrand; Pinson, Benoit] CNRS, Inst Biochim & Genet Cellulaires, UMR 5095, F-33077 Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Daignan-Fornier, B (corresponding author), CNRS, Inst Biochim & Genet Cellulaires, UMR 5095, 1 Rue C St Saens CS 61390, F-33077 Bordeaux, France.	b.daignan-fornier@ibgc.cnrs.fr		ceschin, johanna/0000-0001-7771-531X; albrecht, delphine/0000-0002-8026-3251; DOUILLET, Delphine/0000-0002-9529-1255; Pinson, Benoit/0000-0003-2936-9058	Association de la Recherche contre le Cancer [SFI-2012-120-5915]; Ligue contre le Cancer Project LARGE	Association de la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Ligue contre le Cancer Project LARGE	This work was supported by Association de la Recherche contre le Cancer Grant SFI-2012-120-5915 (to B. D.-F.) and Ligue contre le Cancer Project LARGE (to M.M.). The authors declare that they have no conflicts of interest with the contents of this article.	Alfonzo JD, 1997, BBA-PROTEIN STRUCT M, V1341, P173, DOI 10.1016/S0167-4838(97)00068-X; Breton A, 2008, GENETICS, V178, P815, DOI 10.1534/genetics.107.083295; Ceballos-Picot I, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-014-0219-0; Ceschin J, 2014, J BIOL CHEM, V289, P16844, DOI 10.1074/jbc.M114.551192; Daignan-Fornier B, 2012, METABOLITES, V2, DOI 10.3390/metabo2020292; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Gauthier S, 2008, MOL MICROBIOL, V68, P1583, DOI 10.1111/j.1365-2958.2008.06261.x; Guetsova ML, 1997, GENETICS, V147, P383; Guetsova ML, 1999, J BACTERIOL, V181, P2984, DOI 10.1128/JB.181.9.2984-2986.1999; Guigas B, 2006, DIABETES, V55, P865, DOI 10.2337/diabetes.55.04.06.db05-1178; Hurlimann HC, 2011, J BIOL CHEM, V286, P30994, DOI 10.1074/jbc.M111.262659; JAVAUX F, 1995, BIOCHEM J, V305, P913, DOI 10.1042/bj3050913; KNUDSEN RC, 1972, J BACTERIOL, V112, P569, DOI 10.1128/JB.112.1.569-575.1972; KONRAD M, 1988, J BIOL CHEM, V263, P19468; Liu XN, 2014, P NATL ACAD SCI USA, V111, pE435, DOI 10.1073/pnas.1311121111; Mayer FV, 2011, CELL METAB, V14, P707, DOI 10.1016/j.cmet.2011.09.009; MERKLER DJ, 1989, J BIOL CHEM, V264, P21422; Pinson B, 2009, GENE DEV, V23, P1399, DOI 10.1101/gad.521809; Rebora K, 2005, GENETICS, V170, P61, DOI 10.1534/genetics.104.039396; Rebora K, 2001, MOL CELL BIOL, V21, P7901, DOI 10.1128/MCB.21.23.7901-7912.2001; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; Saint-Marc C, 2009, GENETICS, V183, P529, DOI 10.1534/genetics.109.105858; Sherman F., 1986, METHODS YEAST GENETI; SIDI Y, 1985, J CLIN INVEST, V76, P2416, DOI 10.1172/JCI112255; Szijgyarto Z, 2011, SCIENCE, V334, P802, DOI 10.1126/science.1211908; Tang YC, 2011, CELL, V144, P499, DOI 10.1016/j.cell.2011.01.017; Tibbetts AS, 1997, ARCH BIOCHEM BIOPHYS, V340, P195, DOI 10.1006/abbi.1997.9919; Vincent EE, 2015, ONCOGENE, V34, P3627, DOI 10.1038/onc.2014.301; VINCENT MF, 1992, BIOCHEM J, V281, P267, DOI 10.1042/bj2810267	29	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23947	23959		10.1074/jbc.M115.656017	http://dx.doi.org/10.1074/jbc.M115.656017			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26283791	Green Published, hybrid			2022-12-26	WOS:000361816500039
J	Dohn, LH; Pappot, H; Iversen, BR; Illemann, M; Hoyer-Hansen, G; Christensen, IJ; Thind, P; Salling, L; von der Maase, H; Laerum, OD				Dohn, Line Hammer; Pappot, Helle; Iversen, Benedikte Richter; Illemann, Martin; Hoyer-Hansen, Gunilla; Christensen, Ib Jarle; Thind, Peter; Salling, Lisbeth; von der Maase, Hans; Laerum, Ole Didrik			uPAR Expression Pattern in Patients with Urothelial Carcinoma of the Bladder - Possible Clinical Implications	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR RECEPTOR; TUMOR-ASSOCIATED MACROPHAGES; LIBERATED DOMAIN I; UROKINASE RECEPTOR; CLEAVED FORMS; COLON-CANCER; CELLS; PLASMA; INHIBITOR; SURVIVAL	The objective of the present study was to confirm the expression and localisation pattern of the urokinase-type plasminogen activator receptor (uPAR) focusing on its possible clinical relevance in patients with urothelial neoplasia of the bladder. uPAR is a central molecule in tissue remodelling during cancer invasion and metastasis and is an established prognostic marker in various cancer diseases other than bladder cancer. Formalin-fixed and paraffin-embedded tumour-tissue blocks from 186 patients treated with radical cystectomy were analysed. uPAR expression was scored as either negative or positive as well as by the actual score. Separate scores were obtained for cancer cells, macrophages and myofibroblasts at the invasive front and in tumour core. We were able to confirm, in an independent patient cohort, the tissue expression and localisation pattern of uPAR as investigated by Immunohistochemistry as well as a significant association between uPAR positivity and increasing tumour stage and tumour grade. This demonstrates the robustness of our previous and current findings. In addition the association between uPAR positive myofibroblasts and poor survival was reproduced. The highest hazard ratios for survival were seen for uPAR positive myofibroblasts both at the invasive front and in tumour core. Evaluating uPAR expression by the actual score showed a significant association between uPAR positive myofibroblasts in tumour core and an increased risk of cancer specific mortality. Our investigations have generated new and valuable biological information about the cell types being involved in tumour invasion and progression through the plasminogen activation system.	[Dohn, Line Hammer; Pappot, Helle; von der Maase, Hans] Rigshosp, Dept Oncol, DK-2100 Copenhagen, Denmark; [Dohn, Line Hammer; Illemann, Martin; Hoyer-Hansen, Gunilla; Christensen, Ib Jarle; Laerum, Ole Didrik] Rigshosp, Finsen Lab, DK-2100 Copenhagen, Denmark; [Iversen, Benedikte Richter] Rigshosp, Dept Pathol, DK-2100 Copenhagen, Denmark; [Illemann, Martin; Hoyer-Hansen, Gunilla; Christensen, Ib Jarle; Laerum, Ole Didrik] Univ Copenhagen, BRIC, Copenhagen, Denmark; [Thind, Peter; Salling, Lisbeth] Rigshosp, Dept Urol, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen	Dohn, LH (corresponding author), Rigshosp, Dept Oncol, DK-2100 Copenhagen, Denmark.	line.hammer.dohn@regionh.dk	Illemann, Martin/M-7361-2015; Pappot, Helle/ADY-3530-2022		Oncological Research Foundation at Department of Oncology at Rigshospitalet; Dansk Kraeftforsknings Fond; Merchant Georg Bjorkner and wife Ellen Bjorkner Foundation; Harboe Foundation	Oncological Research Foundation at Department of Oncology at Rigshospitalet; Dansk Kraeftforsknings Fond; Merchant Georg Bjorkner and wife Ellen Bjorkner Foundation; Harboe Foundation	This study was funded by the Oncological Research Foundation at Department of Oncology at Rigshospitalet, Dansk Kraeftforsknings Fond, Merchant Georg Bjorkner and wife Ellen Bjorkner Foundation, and The Harboe Foundation. Grant numbers and URLs are not available for any of the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasi CE, 2013, APMIS, V121, P189, DOI 10.1111/j.1600-0463.2012.02955.x; Almasi CE, 2011, PROSTATE, V71, P899, DOI 10.1002/pros.21306; Almasi CE, 2011, LUNG CANCER, V74, P510, DOI 10.1016/j.lungcan.2011.05.008; Alpizar-Alpizar W, 2012, INT J CANCER, V131, pE329, DOI 10.1002/ijc.26417; Alpizar-Alpizar W, 2010, INT J CANCER, V126, P405, DOI 10.1002/ijc.24755; Altman DG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001216; Bhuvarahamurthy V, 2004, ONCOL REP, V12, P909; Casella R, 2002, CANCER, V95, P2494, DOI 10.1002/cncr.10989; Dano K, 2005, THROMB HAEMOSTASIS, V93, P676, DOI 10.1160/TH05-01-0054; Dohn LH, 2015, UROL ONCOL; EBLE JN, 2004, TUMOURS URINARY SYST, P90; Ecke TH, 2005, ANTICANCER RES, V25, P635; Gakis G, 2012, BJU INT, V110, P233, DOI 10.1111/j.1464-410X.2011.10839.x; Grunnet M, 2014, CLIN BIOCHEM, V47, P599, DOI 10.1016/j.clinbiochem.2014.01.030; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Henic E, 2008, CLIN CANCER RES, V14, P5785, DOI 10.1158/1078-0432.CCR-08-0096; Illemann M, 2014, CANCER MED-US, V3, P855, DOI 10.1002/cam4.242; Illemann M, 2009, INT J CANCER, V124, P1860, DOI 10.1002/ijc.24166; Janicke F, 2001, J NATL CANCER I, V93, P913, DOI 10.1093/jnci/93.12.913; Kamat AM, 2013, EUR UROL, V63, P4, DOI 10.1016/j.eururo.2012.09.057; Kotzsch M, 2010, HISTOPATHOLOGY, V57, P461, DOI 10.1111/j.1365-2559.2010.03644.x; Laerum OD, 2012, INT J CANCER, V131, P558, DOI 10.1002/ijc.26382; Mantovani A, 2013, ARTERIOSCL THROM VAS, V33, P1478, DOI 10.1161/ATVBAHA.113.300168; Morrow DA, 2007, CIRCULATION, V115, P949, DOI 10.1161/CIRCULATIONAHA.106.683110; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Nielsen BS, 2007, INT J CANCER, V120, P2086, DOI 10.1002/ijc.22340; PLESNER T, 1994, BLOOD, V83, P808; Punt CJA, 2007, JNCI-J NATL CANCER I, V99, P998, DOI 10.1093/jnci/djm024; RONNE E, 1995, BREAST CANCER RES TR, V33, P199, DOI 10.1007/BF00665944; Shariat SF, 2003, J UROLOGY, V170, P2244, DOI 10.1097/01.ju.0000090965.71697.37; Shariat SF, 2010, UROL ONCOL-SEMIN ORI, V28, P389, DOI 10.1016/j.urolonc.2010.02.011; Sidaway P, 2015, NAT REV UROL, V12; Sobin LH, 2009, TNM CLASSIFICATION M, P262; STERNBERG C, 2014, LANCET ONCOL; Thurison T, 2010, CLIN CHEM, V56, P1636, DOI 10.1373/clinchem.2010.144410; Usher PA, 2005, INT J CANCER, V113, P870, DOI 10.1002/ijc.20665; Witjes JA, 2014, EUR UROL, V65, P778, DOI 10.1016/j.eururo.2013.11.046	37	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135824	10.1371/journal.pone.0135824	http://dx.doi.org/10.1371/journal.pone.0135824			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26292086	Green Published, gold, Green Submitted			2022-12-26	WOS:000359919900033
J	Dorazio, RM; Connor, EF; Askins, RA				Dorazio, Robert M.; Connor, Edward F.; Askins, Robert A.			Estimating the Effects of Habitat and Biological Interactions in an Avian Community	PLOS ONE			English	Article							HETEROSPECIFIC ATTRACTION; CENSUS-DATA; COMPETITION; ABUNDANCE; MODELS; FOREST; DIVERSITY; COOCCURRENCE; COEFFICIENTS; SCALE	We used repeated sightings of individual birds encountered in community-level surveys to investigate the relative roles of habitat and biological interactions in determining the distribution and abundance of each species. To analyze these data, we developed a multispecies N-mixture model that allowed estimation of both positive and negative correlations between abundances of different species while also estimating the effects of habitat and the effects of errors in detection of each species. Using a combination of single-and multispecies N-mixture modeling, we examined for each species whether our measures of habitat were sufficient to account for the variation in encounter histories of individual birds or whether other habitat variables or interactions with other species needed to be considered. In the community that we studied, habitat appeared to be more influential than biological interactions in determining the distribution and abundance of most avian species. Our results lend support to the hypothesis that abundances of forest specialists are negatively affected by forest fragmentation. Our results also suggest that many species were associated with particular types of vegetation as measured by structural attributes of the forests. The abundances of 6 of the 73 species observed in our study were strongly correlated. These species included large birds (American Crow (Corvus brachyrhynchos) and Red-winged Blackbird (Agelaius phoeniceus)) that forage on the ground in open habitats and small birds (Red-eyed Vireo (Vireo olivaceus), House Wren (Troglodytes aedon), Hooded Warbler (Setophaga citrina), and Prairie Warbler (Setophaga discolor)) that are associated with dense shrub cover. Species abundances were positively correlated within each size group and negatively correlated between groups. Except for the American Crow, which preys on eggs and nestlings of small song birds, none of the other 5 species is known to display direct interactions, so we suspect that the correlations may have been associated with species-specific responses to habitat components not adequately measured by our covariates.	[Dorazio, Robert M.] US Geol Survey, Southeast Ecol Sci Ctr, Gainesville, FL 32653 USA; [Connor, Edward F.] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA; [Askins, Robert A.] Connecticut Coll, Dept Biol, New London, CT 06320 USA	United States Department of the Interior; United States Geological Survey; California State University System; San Francisco State University; Connecticut College	Dorazio, RM (corresponding author), US Geol Survey, Southeast Ecol Sci Ctr, Gainesville, FL 32653 USA.	bdorazio@usgs.gov			National Institute for Mathematical and Biological Synthesis (NIMBIOS); National Science Foundation; U.S. Department of Homeland Security; U.S. Department of Agriculture through NSF [EF-0832858]; Nature Conservancy; Connecticut College Arboretum; Div Of Biological Infrastructure [1300426] Funding Source: National Science Foundation	National Institute for Mathematical and Biological Synthesis (NIMBIOS)(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); National Science Foundation(National Science Foundation (NSF)); U.S. Department of Homeland Security(United States Department of Homeland Security (DHS)); U.S. Department of Agriculture through NSF(National Science Foundation (NSF)); Nature Conservancy; Connecticut College Arboretum; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Institute for Mathematical and Biological Synthesis (NIMBIOS), which was sponsored by the National Science Foundation, the U.S. Department of Homeland Security, and the U.S. Department of Agriculture through NSF Award \#EF-0832858. The field research was funded by the Nature Conservancy and the Connecticut College Arboretum.	AITCHISON J, 1989, BIOMETRIKA, V76, P643; ANDREWARTHA HG, 1954, DISTRIBUTION ABUNDAN; ASKINS RA, 1987, BIOL CONSERV, V39, P129, DOI 10.1016/0006-3207(87)90030-9; Barnagaud JY, 2014, ECOLOGY, V95, P78, DOI 10.1890/13-0791.1; Chandler RB, 2013, CONSERV BIOL, V27, P785, DOI 10.1111/cobi.12046; Chen GK, 2013, J ECOL, V101, P183, DOI 10.1111/1365-2745.12021; Cimprich DA, 2000, BIRDS N AM ONLINE; Clark JS, 2014, ECOL APPL, V24, P990, DOI 10.1890/13-1015.1; CLAYTON DG, 1993, INT J EPIDEMIOL, V22, P1193, DOI 10.1093/ije/22.6.1193; Clements FE, 1905, RES METHODS ECOLOGY; CONNOR EF, 1979, ECOLOGY, V60, P1132, DOI 10.2307/1936961; DeGraaf R.M., 2001, UPNE; DEGRAAF RM, 1985, ENVIRON MANAGE, V9, P493, DOI 10.1007/BF01867324; Dellinger R., 2012, BIRDS N AM ONLINE, DOI [10.2173/bna.261, DOI 10.2173/BNA.261]; Diamond J.M., 1975, P342; Dorazio RM, 2006, ECOLOGY, V87, P842, DOI 10.1890/0012-9658(2006)87[842:ESRAAB]2.0.CO;2; Dorazio RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094323; Dorazio RM, 2011, BIODIVERSITY LOSS IN A CHANGING PLANET, P277; Fox BJ, 1996, OIKOS, V77, P291, DOI 10.2307/3546068; Freemark Kathryn E., 1995, P381; Geyer CJ, 2011, CH CRC HANDB MOD STA, P3; Gleason H. A, 1917, B TORREY BOTANICAL C, V44, P463, DOI DOI 10.2307/2479596; HOLT RD, 1987, OIKOS, V48, P110, DOI 10.2307/3565696; Holyoak M, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P1; Iknayan KJ, 2014, TRENDS ECOL EVOL, V29, P97, DOI 10.1016/j.tree.2013.10.012; Lack D., 1954, P343; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; MONKKONEN M, 1990, OECOLOGIA, V85, P218, DOI 10.1007/BF00319404; Ovaskainen O, 2011, ECOLOGY, V92, P289, DOI 10.1890/10-1251.1; Ovaskainen O, 2010, ECOLOGY, V91, P2514, DOI 10.1890/10-0173.1; Paciorek CJ, 2010, STAT SCI, V25, P107, DOI 10.1214/10-STS326; Pollock LJ, 2014, METHODS ECOL EVOL, V5, P397, DOI 10.1111/2041-210X.12180; R Core Team, 2013, R LANG ENV STAT COMP; Ritchie EG, 2009, J ANIM ECOL, V78, P724, DOI 10.1111/j.1365-2656.2008.01520.x; Royle JA, 2006, J AGR BIOL ENVIR ST, V11, P249, DOI 10.1198/108571106X129153; Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x; Sebastian-Gonzalez E, 2010, P ROY SOC B-BIOL SCI, V277, P2983, DOI 10.1098/rspb.2010.0244; Shenbrot G, 2002, OIKOS, V99, P47, DOI 10.1034/j.1600-0706.2002.990105.x; Smith HS, 1935, J ECON ENTOMOL, V28, P873, DOI 10.1093/jee/28.6.873; STAMPS JA, 1988, AM NAT, V131, P329, DOI 10.1086/284793; Thompson FR, 2002, STUD AVIAN BIOL-SER, P8; WHITTAKER RH, 1956, ECOL MONOGR, V26, P1, DOI 10.2307/1943577; WIENS JA, 1977, AM SCI, V65, P590; Wisz MS, 2013, BIOL REV, V88, P15, DOI 10.1111/j.1469-185X.2012.00235.x; Yamaura Y, 2012, BIODIVERS CONSERV, V21, P1365, DOI 10.1007/s10531-012-0244-z; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4; Zipkin EF, 2010, BIOL CONSERV, V143, P479, DOI 10.1016/j.biocon.2009.11.016	47	18	18	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135987	10.1371/journal.pone.0135987	http://dx.doi.org/10.1371/journal.pone.0135987			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287671	gold, Green Published, Green Submitted			2022-12-26	WOS:000360018600094
J	McGregor, H; Legge, S; Jones, ME; Johnson, CN				McGregor, Hugh; Legge, Sarah; Jones, Menna E.; Johnson, Christopher N.			Feral Cats Are Better Killers in Open Habitats, Revealed by Animal-Borne Video	PLOS ONE			English	Article							SMALL MAMMALS; PREDATION RISK; FELIS-CATUS; HOUSE CATS; AUSTRALIA; DECLINE; EXTINCTION; FIRE; WILDLIFE; SAVANNA	One of the key gaps in understanding the impacts of predation by small mammalian predators on prey is how habitat structure affects the hunting success of small predators, such as feral cats. These effects are poorly understood due to the difficulty of observing actual hunting behaviours. We attached collar-mounted video cameras to feral cats living in a tropical savanna environment in northern Australia, and measured variation in hunting success among different microhabitats (open areas, dense grass and complex rocks). From 89 hours of footage, we recorded 101 hunting events, of which 32 were successful. Of these kills, 28% were not eaten. Hunting success was highly dependent on microhabitat structure surrounding prey, increasing from 17% in habitats with dense grass or complex rocks to 70% in open areas. This research shows that habitat structure has a profound influence on the impacts of small predators on their prey. This has broad implications for management of vegetation and disturbance processes (like fire and grazing) in areas where feral cats threaten native fauna. Maintaining complex vegetation cover can reduce predation rates of small prey species from feral cat predation.	[McGregor, Hugh; Legge, Sarah] Mornington Wildlife Sanctuary, Australian Wildlife Conservancy, Derby, WA 6728, Australia; [McGregor, Hugh; Jones, Menna E.; Johnson, Christopher N.] Univ Tasmania, Sch Biol Sci, Hobart, Tas 7001, Australia	University of Tasmania	McGregor, H (corresponding author), Mornington Wildlife Sanctuary, Australian Wildlife Conservancy, PMB 925, Derby, WA 6728, Australia.	hugh.mcgregor@australianwildlife.org	Johnson, Christopher/J-7894-2014; Legge, Sarah/GYE-1554-2022; McGregor, Hugh W/T-2283-2017; Legge, Sarah/AAB-7229-2019	Johnson, Christopher/0000-0002-9719-3771; McGregor, Hugh W/0000-0003-3255-9282; Legge, Sarah/0000-0001-6968-2781; Jones, Menna/0000-0001-7558-9022	Australian Wildlife Conservancy; Australian Research Council; Western Australian Department of Parks and Wildlife (Kimberley Science and Conservation Strategy)	Australian Wildlife Conservancy; Australian Research Council(Australian Research Council); Western Australian Department of Parks and Wildlife (Kimberley Science and Conservation Strategy)	This research was funded by supporters of the Australian Wildlife Conservancy, the Australian Research Council, and the Western Australian Department of Parks and Wildlife (Kimberley Science and Conservation Strategy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barratt DG, 1998, WILDLIFE RES, V25, P475, DOI 10.1071/WR97026; Brook LA, 2012, J APPL ECOL, V49, P1278, DOI 10.1111/j.1365-2664.2012.02207.x; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; Burbidge AA, 2002, J BIOGEOGR, V29, P465, DOI 10.1046/j.1365-2699.2002.00699.x; Conner LM, 2011, J WILDLIFE MANAGE, V75, P938, DOI 10.1002/jwmg.110; Coughlin CE, 2014, WILDLIFE RES, V41, P606, DOI 10.1071/WR14160; Denny E., 2010, REV CAT ECOLOGY MANA; Doherty TS, 2015, J BIOGEOGR, V42, P964, DOI 10.1111/jbi.12469; Firth RSC, 2010, BIOL CONSERV, V143, P1193, DOI 10.1016/j.biocon.2010.02.027; Fisher DO, 2014, GLOBAL ECOL BIOGEOGR, V23, P181, DOI 10.1111/geb.12088; Fitzgerald B. Mike, 2000, P151; Frank ASK, 2014, J APPL ECOL, V51, P1486, DOI 10.1111/1365-2664.12323; GITTLEMAN JL, 1985, OECOLOGIA, V67, P540, DOI 10.1007/BF00790026; Gorini L, 2012, MAMMAL REV, V42, P55, DOI 10.1111/j.1365-2907.2011.00189.x; Griffiths AD, 2015, BIOL CONSERV, V186, P337, DOI 10.1016/j.biocon.2015.03.021; Griffiths AD, 2014, INT J WILDLAND FIRE, V23, P1034, DOI 10.1071/WF14026; Hebblewhite M, 2005, OIKOS, V111, P101, DOI 10.1111/j.0030-1299.2005.13858.x; HOBBS RJ, 1992, CONSERV BIOL, V6, P324, DOI 10.1046/j.1523-1739.1992.06030324.x; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Hopcraft JGC, 2005, J ANIM ECOL, V74, P559, DOI 10.1111/j.1365-2656.2005.00955.x; Johnson C, 2006, AUSTR MAMMAL EXTINCT; KONECNY MJ, 1987, OIKOS, V50, P24, DOI 10.2307/3565398; Leahy L, 2015, AMPLIFIED P IN PRESS; Legge S, 2011, AUSTRAL ECOL, V36, P791, DOI 10.1111/j.1442-9993.2010.02218.x; Lone K, 2014, OIKOS, V123, P641, DOI 10.1111/j.1600-0706.2013.00938.x; Loss SR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2380; Loyd KAT, 2013, BIOL CONSERV, V160, P183, DOI 10.1016/j.biocon.2013.01.008; Martin GR, 1996, WILDLIFE RES, V23, P475, DOI 10.1071/WR9960475; Mattisson J, 2011, BIOL CONSERV, V144, P3009, DOI 10.1016/j.biocon.2011.09.004; McGregor HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109097; McGregor HW, 2015, WILDLIFE RE IN PRESS; Medina FM, 2011, GLOBAL CHANGE BIOL, V17, P3503, DOI 10.1111/j.1365-2486.2011.02464.x; Moil RJ, 2007, TRENDS ECOL EVOL, V22, P660, DOI 10.1016/j.tree.2007.09.007; Oakwood M, 2000, AUST J ZOOL, V48, P519, DOI 10.1071/ZO00028; Orsdol KG, 1984, AFR J ECOL, V22, P79; PANAMAN R, 1981, Z TIERPSYCHOL, V56, P59; Pardon LG, 2003, J ANIM ECOL, V72, P106, DOI 10.1046/j.1365-2656.2003.00686.x; Peck DR, 2008, ANIM CONSERV, V11, P65, DOI 10.1111/j.1469-1795.2007.00153.x; R Core Team, 2018, R LANG ENV STAT COMP; Schooley RL, 1996, CAN J ZOOL, V74, P157, DOI 10.1139/z96-020; Sinclair E. A., 1996, Australian Mammalogy, V19, P69; Smith AP, 1996, BIOL CONSERV, V77, P243, DOI 10.1016/0006-3207(96)00002-X; TOLAND B R, 1987, Journal of Raptor Research, V21, P14; Williams CR, 2000, J HERPETOL, V34, P431, DOI 10.2307/1565367; Woinarski JCZ, 2015, P NATL ACAD SCI USA, V112, P4531, DOI 10.1073/pnas.1417301112; Woinarski JCZ, 2011, CONSERV LETT, V4, P192, DOI 10.1111/j.1755-263X.2011.00164.x; Woods M, 2003, MAMMAL REV, V33, P174, DOI 10.1046/j.1365-2907.2003.00017.x	47	130	135	3	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0133915	10.1371/journal.pone.0133915	http://dx.doi.org/10.1371/journal.pone.0133915			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288224	gold, Green Published, Green Submitted			2022-12-26	WOS:000360018600012
J	Michel, ES; Demarais, S; Strickland, BK; Belant, JL				Michel, Eric S.; Demarais, Stephen; Strickland, Bronson K.; Belant, Jerrold L.			Contrasting the Effects of Maternal and Behavioral Characteristics on Fawn Birth Mass in White-Tailed Deer	PLOS ONE			English	Article							FEMALE MOUNTAIN GOATS; DOMINANCE HIERARCHIES; REPRODUCTIVE SUCCESS; TERRITORY SIZE; PATH MODELS; SOCIAL RANK; BODY-SIZE; AGE; SELECTION; GROWTH	Maternal care influences offspring quality and can improve a mother's inclusive fitness. However, improved fitness may only occur when offspring quality (i.e., offspring birth mass) persists throughout life and enhances survival and/or reproductive success. Although maternal body mass, age, and social rank have been shown to influence offspring birth mass, the inter-dependence among these variables makes identifying causation problematic. We established that fawn birth mass was related to adult body mass for captive male and female white-tailed deer (Odocoileus virginianus), thus maternal care should improve offspring fitness. We then used path analysis to identify which maternal characteristic(s) most influenced fawn birth mass of captive female white-tailed deer. Maternal age, body mass and social rank had varying effects on fawn birth mass. Maternal body mass displayed the strongest direct effect on fawn birth mass, followed by maternal age and social rank. Maternal body mass had a greater effect on social rank than age. The direct path between social rank and fawn birth mass may indicate dominance as an underlying mechanism. Our results suggest that heavier mothers could use dominance to improve access to resources, resulting in increased fitness through production of heavier offspring.	[Michel, Eric S.; Demarais, Stephen; Strickland, Bronson K.] Mississippi State Univ, Dept Wildlife Fisheries & Aquaculture, Forest & Wildlife Res Ctr, Deer Ecol & Management Lab, Mississippi State, MS 39762 USA; [Belant, Jerrold L.] Mississippi State Univ, Carnivore Ecol Lab, Forest & Wildlife Res Ctr, Mississippi State, MS 39762 USA	Mississippi State University; Mississippi State University	Michel, ES (corresponding author), Mississippi State Univ, Dept Wildlife Fisheries & Aquaculture, Forest & Wildlife Res Ctr, Deer Ecol & Management Lab, Mississippi State, MS 39762 USA.	esm120@msstate.edu	Belant, Jerrold/HDM-7749-2022		Federal Aid in Wildlife Restoration Fund [W-48-61]	Federal Aid in Wildlife Restoration Fund	Our project was supported by the Federal Aid in Wildlife Restoration Fund under project number W-48-61. State wildlife agency employees helped with data collection.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Andersen R, 2000, J ANIM ECOL, V69, P672, DOI 10.1046/j.1365-2656.2000.00425.x; APPLEBY MC, 1980, BEHAVIOUR, V74, P294, DOI 10.1163/156853980X00519; ARMSTRONG RA, 1950, AM MIDL NAT, V43, P650, DOI 10.2307/2421857; Benton TG, 2008, J ANIM ECOL, V77, P1038, DOI 10.1111/j.1365-2656.2008.01434.x; Berkeley SA, 2004, ECOLOGY, V85, P1258, DOI 10.1890/03-0706; Biro PA, 2014, J ANIM ECOL, V83, P1186, DOI 10.1111/1365-2656.12210; Burnham K. P., 1998, MODEL SELECTION INFE; Ceacero F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032780; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; CLUTTONBROCK TH, 1976, Z TIERPSYCHOL, V41, P202; CLUTTONBROCK TH, 1986, ANIM BEHAV, V34, P460, DOI 10.1016/S0003-3472(86)80115-4; CLUTTONBROCK TH, 1984, NATURE, V308, P358, DOI 10.1038/308358a0; Coltman DW, 2002, P ROY SOC B-BIOL SCI, V269, P165, DOI 10.1098/rspb.2001.1851; Cote SD, 2001, ANIM BEHAV, V62, P173, DOI 10.1006/anbe.2001.1719; Cote SD, 2000, BEHAVIOUR, V137, P1541, DOI 10.1163/156853900502718; Dahle B, 2006, J ZOOL, V269, P273, DOI 10.1111/j.1469-7998.2006.00127.x; De Vries H, 1998, ANIM BEHAV, V55, P827, DOI 10.1006/anbe.1997.0708; Demarais S., 2000, ECOLOGY MANAGEMENT L, P601; DEVRIES H, 1995, ANIM BEHAV, V50, P1375, DOI 10.1016/0003-3472(95)80053-0; Ditchkoff SS, 2011, BIOLOGY AND MANAGEMENT OF WHITE-TAILED DEER, P43; Donohue RN, 2013, J WILDLIFE MANAGE, V77, P1401, DOI 10.1002/jwmg.606; Feder C, 2008, OECOLOGIA, V156, P773, DOI 10.1007/s00442-008-1035-9; Festa-Bianchet M, 2000, BEHAV ECOL, V11, P633, DOI 10.1093/beheco/11.6.633; French AR, 2005, BIOTROPICA, V37, P96, DOI 10.1111/j.1744-7429.2005.04051.x; Gaillard JM, 2000, P ROY SOC B-BIOL SCI, V267, P471, DOI 10.1098/rspb.2000.1024; GREEN WCH, 1991, OECOLOGIA, V86, P521, DOI 10.1007/BF00318318; Hamel S, 2009, J ANIM ECOL, V78, P143, DOI 10.1111/j.1365-2656.2008.01459.x; Hewison AJM, 1999, TRENDS ECOL EVOL, V14, P229, DOI 10.1016/S0169-5347(99)01592-X; Iossa G, 2008, J MAMMAL, V89, P1481, DOI 10.1644/07-MAMM-A-405.1; Isaac JL, 2005, BIOL LETTERS, V1, P271, DOI 10.1098/rsbl.2005.0326; Killen SS, 2011, J ANIM ECOL, V80, P1024, DOI 10.1111/j.1365-2656.2011.01844.x; Kreeger T.J., 1996, HDB WILDLIFE CHEM IM; MATTINGLY DK, 1982, ECOLOGY, V63, P183, DOI 10.2307/1937043; MAUTZ W W, 1978, Wildlife Society Bulletin, V6, P88; Miller BF, 2004, J WILDLIFE DIS, V40, P533, DOI 10.7589/0090-3558-40.3.533; Mitchell R.J., 2001, DESIGN ANAL ECOLOGIC, P217; Monteith KL, 2009, J MAMMAL, V90, P651, DOI 10.1644/08-MAMM-A-191R1.1; OZOGA JJ, 1986, J WILDLIFE MANAGE, V50, P480, DOI 10.2307/3801110; OZOGA JJ, 1972, J WILDLIFE MANAGE, V36, P861, DOI 10.2307/3799441; Palomares F, 1998, J ANIM ECOL, V67, P967, DOI 10.1046/j.1365-2656.1998.6760967.x; Pekins PJ, 1998, CAN J ZOOL, V76, P1091, DOI 10.1139/cjz-76-6-1091; Reale D, 2000, ANIM BEHAV, V60, P589, DOI 10.1006/anbe.2000.1530; Reale D, 2003, ANIM BEHAV, V65, P463, DOI 10.1006/anbe.2003.2100; Robinson MR, 2006, EVOLUTION, V60, P2168, DOI 10.1111/j.0014-3820.2006.tb01854.x; SCHOENER TW, 1983, AM NAT, V121, P608, DOI 10.1086/284090; Schumacker R. E, 2004, BEGINNERS GUIDE STRU, V2nd, DOI DOI 10.4135/9781412973380.N17; Sempere AJ, 1998, EUROPEAN ROE DEER: THE BIOLOGY OF SUCCESS, P161; Shipley B, 2003, STRUCT EQU MODELING, V10, P214, DOI 10.1207/S15328007SEM1002_3; Shipley B., 2000, CAUSE AND CORRELATIO; Shipley B, 2000, STRUCT EQU MODELING, V7, P206, DOI 10.1207/S15328007SEM0702_4; Shipley B, 2013, ECOLOGY, V94, P560, DOI 10.1890/12-0976.1; Shipley B, 2009, ECOLOGY, V90, P363, DOI 10.1890/08-1034.1; Solberg EJ, 2008, OECOLOGIA; Stearns S., 1992, EVOLUTION LIFE HIST; Steiger S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1225; Strickland BK, 2000, J WILDLIFE MANAGE, V64, P903, DOI 10.2307/3803198; Taillon J, 2007, ANIM BEHAV, V74, P265, DOI 10.1016/j.anbehav.2006.11.018; Thomas DW, 2007, FUNCT ECOL, V21, P947, DOI 10.1111/j.1365-2435.2007.01301.x; VERME LJ, 1989, J MAMMAL, V70, P438, DOI 10.2307/1381538; Vogel ER, 2005, BEHAV ECOL SOCIOBIOL, V58, P333, DOI 10.1007/s00265-005-0960-4	61	10	11	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136034	10.1371/journal.pone.0136034	http://dx.doi.org/10.1371/journal.pone.0136034			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288141	Green Submitted, Green Published, gold			2022-12-26	WOS:000360018600100
J	Sanchez-Veliz, R; Carmona, MJ; Otsuki, DA; Freitas, C; Benicio, A; Negri, EM; Malbouisson, LM				Sanchez-Veliz, Rodrigo; Carmona, Maria Jose; Otsuki, Denise Aya; Freitas, Claudia; Benicio, Anderson; Negri, Elnara Marcia; Malbouisson, Luiz Marcelo			Impact of Cardiopulmonary Bypass on Respiratory Mucociliary Function in an Experimental Porcine Model	PLOS ONE			English	Article							TRACHEAL MUCOUS VELOCITY; BRONCHIAL TRANSECTION; MUCUS CLEARANCE; LUNG INJURY; TRANSPORT; ATELECTASIS; ANESTHESIA; RESPONSES; MANNITOL	Background The impact of cardiac surgery using cardiopulmonary bypass (CPB) on the respiratory mucociliary function is unknown. This study evaluated the effects of CPB and interruption of mechanical ventilation on the respiratory mucociliary system. Methods Twenty-two pigs were randomly assigned to the control (n = 10) or CPB group (n = 12). After the induction of anesthesia, a tracheostomy was performed, and tracheal tissue samples were excised (T0) from both groups. All animals underwent thoracotomy. In the CPB group, an aorto-bicaval CPB was installed and maintained for 90 minutes. During the CPB, mechanical ventilation was interrupted, and the tracheal tube was disconnected. A second tracheal tissue sample was obtained 180 minutes after the tracheostomy (T180). Mucus samples were collected from the trachea using a bronchoscope at T0, T90 and T180. Ciliary beat frequency (CBF) and in situ mucociliary transport (MCT) were studied in ex vivo tracheal epithelium. Mucus viscosity (MV) was assessed using a cone-plate viscometer. Qualitative tracheal histological analysis was performed at T180 tissue samples. Results CBF decreased in the CPB group (13.1 +/- 1.9 Hz vs. 11.1 +/- 2.1 Hz, p < 0.05) but not in the control group (13.1 +/- 1 Hz vs. 13 +/- 2.9 Hz). At T90, viscosity was increased in the CPB group compared to the control (p < 0.05). No significant differences were observed in in situ MCT. Tracheal histology in the CPB group showed areas of ciliated epithelium loss, submucosal edema and infiltration of inflammatory cells. Conclusion CPB acutely contributed to alterations in tracheal mucocilliary function.	[Sanchez-Veliz, Rodrigo; Carmona, Maria Jose; Otsuki, Denise Aya; Freitas, Claudia; Malbouisson, Luiz Marcelo] Univ Sao Paulo, Sch Med, Lab Anesthesiol LIM08, Sao Paulo, Brazil; [Benicio, Anderson] Univ Sao Paulo, Sch Med, Cardiac Surg Div, Heart Inst InCor, Sao Paulo, Brazil; [Negri, Elnara Marcia] Univ Sao Paulo, Sch Med, Expt Air Pollut Lab, Dept Pathol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Malbouisson, LM (corresponding author), Univ Sao Paulo, Sch Med, Lab Anesthesiol LIM08, Sao Paulo, Brazil.	luiz.malbouisson@hc.fm.usp.br	Benício, Anderson/O-6002-2015; Negri, Elnara M/F-3643-2019; CARMONA, MARIA JOSÉ CARVALHO/G-3653-2014; Sa Malbouisson, Luiz Marcelo/F-4819-2012	Benício, Anderson/0000-0002-6273-3416; Negri, Elnara M/0000-0002-6428-6066; CARMONA, MARIA JOSÉ CARVALHO/0000-0002-3031-2924; Sa Malbouisson, Luiz Marcelo/0000-0002-3261-5603	Conselho Nacional de Pesquisa e Desenvolvimento (CNPq), Brazil [478485/2004-2]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP, Sao Paulo, Brazil [07/52127-3]	Conselho Nacional de Pesquisa e Desenvolvimento (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP, Sao Paulo, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Funding: This study was supported by a grant from Conselho Nacional de Pesquisa e Desenvolvimento (CNPq - Grant 478485/2004-2), Brazil. Rodrigo Sanchez-Veliz received a scholarship from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP (Process 07/52127-3), Sao Paulo, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertini-Yagi CS, 2005, RESP PHYSIOL NEUROBI, V145, P101, DOI 10.1016/j.resp.2004.08.010; Asimakopoulos G, 1999, ANN THORAC SURG, V68, P1107, DOI 10.1016/S0003-4975(99)00781-X; Beaver BV, 2001, J AM VET MED ASSOC, V218, P669, DOI 10.2460/javma.2001.218.669; BURKE AM, 1981, J NEUROSURG, V55, P550, DOI 10.3171/jns.1981.55.4.0550; BUTLER J, 1993, J THORAC CARDIOV SUR, V105, P25, DOI 10.1016/S0022-5223(19)33843-7; Carney DE, 1999, CIRCULATION, V100, P400, DOI 10.1161/01.CIR.100.4.400; Chilvers M A, 2000, Paediatr Respir Rev, V1, P27, DOI 10.1053/prrv.2000.0009; HIRSCH JA, 1975, J APPL PHYSIOL, V39, P242; HOLT JP, 1968, AM J PHYSIOL, V215, P704, DOI 10.1152/ajplegacy.1968.215.3.704; Houtmeyers E, 1999, EUR RESPIR J, V13, P1177, DOI 10.1034/j.1399-3003.1999.13e39.x; HUBER AR, 1989, J CLIN INVEST, V83, P1122, DOI 10.1172/JCI113992; HUBER AR, 1991, SCIENCE, V254, P99, DOI 10.1126/science.1718038; Keller C, 1998, ANESTH ANALG, V86, P1280, DOI 10.1097/00000539-199806000-00028; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; KOLFF W J, 1958, Cleve Clin Q, V25, P65; KONRAD F, 1992, CHEST, V102, P1377, DOI 10.1378/chest.102.5.1377; LANDA JF, 1975, J APPL PHYSIOL, V38, P946, DOI 10.1152/jappl.1975.38.5.946; LAURENZI GA, 1968, NEW ENGL J MED, V279, P333, DOI 10.1056/NEJM196808152790701; Magnusson L, 1997, ANESTHESIOLOGY, V87, P1153, DOI 10.1097/00000542-199711000-00020; Massoudy P, 1999, Eur J Med Res, V4, P178; Massoudy P, 2001, CHEST, V119, P31, DOI 10.1378/chest.119.1.31; Ng CSH, 2002, CHEST, V121, P1269, DOI 10.1378/chest.121.4.1269; Pazetti R, 2008, ANN THORAC SURG, V85, P1925, DOI 10.1016/j.athoracsur.2008.02.084; Piccin VS, 2011, INTENS CARE MED, V37, P132, DOI 10.1007/s00134-010-2056-5; Rivero DHRF, 2001, CHEST, V119, P1510, DOI 10.1378/chest.119.5.1510; Robinson M, 1999, EUR RESPIR J, V14, P678, DOI 10.1034/j.1399-3003.1999.14c30.x; Rothen HU, 1999, BRIT J ANAESTH, V82, P551, DOI 10.1093/bja/82.4.551; SACKNER MA, 1975, CHEST, V68, P774, DOI 10.1378/chest.68.6.774; Schlensak C, 2001, EUR J CARDIO-THORAC, V19, P326, DOI 10.1016/S1010-7940(01)00581-4; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Travis SM, 1999, AM J RESP CELL MOL, V20, P872, DOI 10.1165/ajrcmb.20.5.3572; Wan S, 1996, J THORAC CARDIOV SUR, V111, P469, DOI 10.1016/S0022-5223(96)70458-0; Wan S, 1997, CHEST, V112, P676, DOI 10.1378/chest.112.3.676; YENMEZ K, 1988, TURKISH J PEDIATR, V30, P123	34	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135564	10.1371/journal.pone.0135564	http://dx.doi.org/10.1371/journal.pone.0135564			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288020	Green Published, gold, Green Submitted			2022-12-26	WOS:000360018600053
J	Rego, FDMGR; Caldas, RAA; Kurachi, C; Bagnato, VS; de Araujo, MT				Martins Gomes Rego Filho, Francisco de Assis; Alencar Caldas, Romualdo Arthur; Kurachi, Cristina; Bagnato, Vanderlei Salvador; de Araujo, Maria Tereza			Possibility for the Conjugated Use of Photodynamic Therapy and Electrosurgical Devices	PLOS ONE			English	Article							YAG LASER; SKIN; ACID; MICRODERMABRASION; ENHANCEMENT; DELIVERY	Because tissue optics limits the treated volume during anti-tumor Photodynamic Therapy (PDT), its conjugation with prior tissue debulking has been suggested clinically. In this context, the conjugation of radiofrequency ablation and PDT has already been demonstrated. However, the basic principles that enable the success of these protocols have not been discussed. This proof-of-principle study analyzes the possibility of conjugating electrosurgery (ES) and PDT, analyzing different sequences of photosensitizer (PS) administration in an animal model. The animals were distributed over five groups: ES, PS+Light, PS+ES, ES +PS+Light and PS+ES+Light. The PS Photogem was administered systemically. An electrosurgical unit (480 kHz) was used to remove a portion of the liver, leaving a plane surface for PDT illumination (630 nm, 150 J/cm(2)). Fluorescence was collected during the stages of the experiment to monitor the PS accumulation. After 30 hours, histological processing was performed. The fluorescence spectra revealed strong Photogem emission in both administration sequences (ES+PS; PS+ES), and little PS bleach after ES was observed. The maximum necrosis depth was observed for the PS+ES+Light group-(716 +/- 75) mu m-higher than its respective control group (160 +/- 28) mu m, proving successful conjugation. Histological features from ES and PDT on both conjugation sequences were observed. Pre-photosensitized tissue presented decreased ES-related thermal damage. A simple physical hypothesis, based on the Joule effect and the tissue electrical conductivity, was proposed to support these findings. In conclusion, the results successfully demonstrated the possibility of conjugating ES and PDT in a single protocol.	[Martins Gomes Rego Filho, Francisco de Assis; de Araujo, Maria Tereza] Univ Fed Alagoas, Inst Fis, Maceio, Alagoas, Brazil; [Alencar Caldas, Romualdo Arthur] Univ Fed Alagoas, Hosp Univ HUPAA, Maceio, Alagoas, Brazil; [Kurachi, Cristina; Bagnato, Vanderlei Salvador] Univ Sao Paulo, Inst Fis Sao Carlos, BR-01498 Sao Carlos, SP, Brazil	Universidade Federal de Alagoas; Universidade Federal de Alagoas; Universidade de Sao Paulo	Rego, FDMGR (corresponding author), Univ Fed Alagoas, Inst Fis, Maceio, Alagoas, Brazil.	francisco.rego@fis.ufal.br	Kurachi, Cristina/G-3731-2012; Bagnato, Vanderlei S/C-3133-2012; de Assis Martins Gomes Rego Filho, Francisco/P-7703-2014	de Assis Martins Gomes Rego Filho, Francisco/0000-0002-4968-9916; INCT de Optica Basica e Aplicada as Ciencias da Vida (CNPq), CePOF (FAPESP)/0000-0002-6403-4037; Bagnato, Vanderlei Salvador/0000-0003-4833-239X	CAPES; CNPq; FAPESP; FINEP	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FINEP(Financiadora de Inovacao e Pesquisa (Finep))	Financial support and scholarships provided by CAPES, CNPq, FAPESP and FINEP. The funders did not participate on the experimental design, data collection and analysis, manuscript preparation or any decision related to the publication process.	Brown DB, 2005, J VASC INTERV RADIOL, V16, P597, DOI 10.1097/01.RVI.0000156097.63027.7B; Buttemere CR, 2004, J BIOMED OPT, V9, P1018, DOI 10.1117/1.1779627; Carruth JAS, 1986, MED LASERS SCI CLIN, P51; Castano AP, 2006, NAT REV CANCER, V6, P535, DOI 10.1038/nrc1894; Ceilley RI, 2006, INT J DERMATOL, V45, P489, DOI 10.1111/j.1365-4632.2006.02673.x; Cushing H., 1928, SURG GYNECOL OBSTET, V47, P751; Dougherty TJ, 1998, JNCI-J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889; Fang JY, 2004, BRIT J DERMATOL, V151, P132, DOI 10.1111/j.1365-2133.2004.06051.x; Ferraz RCMC, 2009, PHOTOMED LASER SURG, V27, P93, DOI 10.1089/pho.2007.2207; Ferreira J, 2004, LASER PHYS, V14, P209; Gao S, 2003, CHIN OPT LETT, V2, P160; Karakullukcu B, 2011, PHOTODIAGN PHOTODYN, V8, P264, DOI 10.1016/j.pdpdt.2011.03.340; Korbelik M, 2006, LASER SURG MED, V38, P500, DOI 10.1002/lsm.20337; KROSL G, 1995, BRIT J CANCER, V71, P549, DOI 10.1038/bjc.1995.108; Lee WR, 2006, DERMATOL SURG, V32, P1013, DOI 10.1111/j.1524-4725.2006.32224.x; Lencioni R, 2010, HEPATOLOGY, V52, P762, DOI 10.1002/hep.23725; Lins E. C., 2009, World Congress on Medical Physics and Biomedical Engineering. World Congress 2009. Diagnostic and Therapeutic Instrumentation, Clinical Engineering, P714, DOI 10.1007/978-3-642-03885-3_198; Livraghi T, 1999, RADIOLOGY, V210, P655, DOI 10.1148/radiology.210.3.r99fe40655; MacCormack Mollie A, 2006, Adv Dermatol, V22, P219, DOI 10.1016/j.yadr.2006.09.008; Masilamani V, 2004, J LUMIN, V109, P143, DOI 10.1016/j.jlumin.2004.02.001; Mcintyre WJ, 2007, AM FAM PHYSICIAN, V76, P667; Medtech Insight, 2007, A606 MEDT INS LLC DI, P1; Melo CAS, 2004, J PHOTOCH PHOTOBIO B, V73, P183, DOI 10.1016/j.jphotobiol.2003.11.005; Melo CAS, 2001, J CLIN LASER MED SUR, V19, P175, DOI 10.1089/104454701316918925; Nicolodelli G, 2014, J BIOPHOTONICS, V7, P631, DOI 10.1002/jbio.201300024; Olson JM, 2012, DERMATOL CLIN, V30, P153, DOI 10.1016/j.det.2011.08.011; Palanker D, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/12/123022; Pearce JA, 1986, ELECTROSURGERY; POPE AJ, 1991, BRIT J UROL, V68, P1, DOI 10.1111/j.1464-410X.1991.tb15246.x; Rego RF, 2013, LASER PHYS, V23, DOI 10.1088/1054-660X/23/7/075603; Rego FG, 2011, PROC SPIE, V8092, DOI 10.1117/12.889688; Shen SC, 2006, J PHARM SCI-US, V95, P929, DOI 10.1002/jps.20577; Shokrollahi K, 2013, ANN PLAS SURG, V70, P1, DOI 10.1097/SAP.0b013e31827ed58e; Shokrollahi Kayvan, 2009, Cases J, V2, P7920, DOI 10.4076/1757-1626-2-7920; Sietses C, 2001, SURG ENDOSC-ULTRAS, V15, P69, DOI 10.1007/s004640010061; Smucler R, 2008, LASER SURG MED, V40, P153, DOI 10.1002/lsm.20606; Sokolov VV, 1994, P SOC PHOTO-OPT INS, V2325, P367; Souza CS, 2007, DERMATOL SURG, V33, P194, DOI 10.1111/j.1524-4725.2006.33038.x; Sun JH, 2002, PHOTOCH PHOTOBIO SCI, V1, P690, DOI 10.1039/b204254a; Thissen MRTM, 2000, BRIT J DERMATOL, V142, P338, DOI 10.1046/j.1365-2133.2000.03404.x; Whitaker IS, 2007, ANN PLAS SURG, V59, P484, DOI 10.1097/SAP.0b013e3180338536	41	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0136194	10.1371/journal.pone.0136194	http://dx.doi.org/10.1371/journal.pone.0136194			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284935	gold, Green Published, Green Submitted			2022-12-26	WOS:000359666100108
J	Mittag, F; Romer, M; Zell, A				Mittag, Florian; Roemer, Michael; Zell, Andreas			Influence of Feature Encoding and Choice of Classifier on Disease Risk Prediction in Genome-Wide Association Studies	PLOS ONE			English	Article							GENETIC RISK; GWAS; VARIANTS; CANCER; TESTS; SCORE	Various attempts have been made to predict the individual disease risk based on genotype data from genome-wide association studies (GWAS). However, most studies only investigated one or two classification algorithms and feature encoding schemes. In this study, we applied seven different classification algorithms on GWAS case-control data sets for seven different diseases to create models for disease risk prediction. Further, we used three different encoding schemes for the genotypes of single nucleotide polymorphisms (SNPs) and investigated their influence on the predictive performance of these models. Our study suggests that an additive encoding of the SNP data should be the preferred encoding scheme, as it proved to yield the best predictive performances for all algorithms and data sets. Furthermore, our results showed that the differences between most state-of-the-art classification algorithms are not statistically significant. Consequently, we recommend to prefer algorithms with simple models like the linear support vector machine (SVM) as they allow for better subsequent interpretation without significant loss of accuracy.	[Mittag, Florian; Roemer, Michael; Zell, Andreas] Univ Tubingen, Cognit Syst Grp, Tubingen, Germany	Eberhard Karls University of Tubingen	Mittag, F (corresponding author), Univ Tubingen, Cognit Syst Grp, Tubingen, Germany.	florian.mittag@uni-tuebingen.de		Mittag, Florian/0000-0002-6472-0221	program for medical genome research; Federal Ministry of Education and Research (BMBF) [01GS08134]; Deutsche Forschungsgemeinschaft; University of Tubingen	program for medical genome research; Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Tubingen	This study was funded by the program for medical genome research with financial support from the Federal Ministry of Education and Research (BMBF, http://www.bmbf.de/) under the support code 01GS08134 (recipient AZ). The authors also acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of University of Tubingen.	Barnett GC, 2009, NAT REV CANCER, V9, P134, DOI 10.1038/nrc2587; Beekman M, 2010, P NATL ACAD SCI USA, V107, P18046, DOI 10.1073/pnas.1003540107; Botta V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093379; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cantor RM, 2010, AM J HUM GENET, V86, P6, DOI 10.1016/j.ajhg.2009.11.017; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cohen S, 2010, MOL CELL, V37, P451, DOI 10.1016/j.molcel.2010.02.006; Conde L, 2013, AM J HUM GENET, V92, P126, DOI 10.1016/j.ajhg.2012.11.009; Conover WJ, 1999, PRACTICAL NONPARAMET, V22; Cosgun E, 2011, BIOINFORMATICS, V27, P1384, DOI 10.1093/bioinformatics/btr159; Costafreda SG, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-18; Demsar J, 2006, J MACH LEARN RES, V7, P1; Depeursinge A, 2010, J DIGIT IMAGING, V23, P18, DOI 10.1007/s10278-008-9158-4; Derrac J, 2011, SWARM EVOL COMPUT, V1, P3, DOI 10.1016/j.swevo.2011.02.002; Franken H, 2011, LECT N BIOINFORMAT, V7036, P121, DOI 10.1007/978-3-642-24855-9_11; Frayling TM, 2014, DIABETES, V63, P1836, DOI 10.2337/db14-0130; Friedman M, 1937, J AM STAT ASSOC, V32, P675, DOI 10.2307/2279372; Goh CL, 2012, J INTERN MED, V271, P353, DOI 10.1111/j.1365-2796.2012.02511.x; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hannum G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000782; Henckaerts L, 2009, CLIN GASTROENTEROL H, V7, P972, DOI 10.1016/j.cgh.2009.05.001; Hertz DL, 2012, BREAST CANCER RES TR, V134, P401, DOI 10.1007/s10549-012-2054-0; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; IMAN RL, 1980, COMMUN STAT A-THEOR, V9, P571, DOI 10.1080/03610928008827904; James M, 1986, CLASSIFICATION ALGOR, V6; Loley C, 2011, HUM HERED, V71, P23, DOI 10.1159/000323768; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Miller DJ, 2009, BIOINFORMATICS, V25, P2478, DOI 10.1093/bioinformatics/btp435; Mittag F, 2012, HUM MUTAT, V33, P1708, DOI 10.1002/humu.22161; Morrison AC, 2007, AM J EPIDEMIOL, V166, P28, DOI 10.1093/aje/kwm060; Mosley JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081503; Nalls MA, 2011, LANCET, V377, P641, DOI 10.1016/S0140-6736(10)62345-8; Nemenyi P., 1963, DISTRIBUTION FREE MU; Pirooznia M, 2012, PSYCHIAT GENET, V22, P55, DOI 10.1097/YPG.0b013e32834dc40d; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi QB, 2012, DIABETES, V61, P745, DOI 10.2337/db11-1254; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; SHAFFER JP, 1986, J AM STAT ASSOC, V81, P826, DOI 10.2307/2289016; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Smola AJ, 1998, NEURAL NETWORKS, V11, P637, DOI 10.1016/S0893-6080(98)00032-X; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wan XA, 2010, AM J HUM GENET, V87, P325, DOI 10.1016/j.ajhg.2010.07.021; Wei Z, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000678; Wise AL, 2013, AM J HUM GENET, V92, P643, DOI 10.1016/j.ajhg.2013.03.017; Wolpert DH, 1996, NEURAL COMPUT, V8, P1391, DOI 10.1162/neco.1996.8.7.1391; Wray NR, 2007, GENOME RES, V17, P1520, DOI 10.1101/gr.6665407	50	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135832	10.1371/journal.pone.0135832	http://dx.doi.org/10.1371/journal.pone.0135832			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285210	gold, Green Submitted, Green Published			2022-12-26	WOS:000359666100071
J	Chaplin, AV; Efimov, BA; Smeianov, VV; Kafarskaia, LI; Pikina, AP; Shkoporov, AN				Chaplin, Andrei V.; Efimov, Boris A.; Smeianov, Vladimir V.; Kafarskaia, Lyudmila I.; Pikina, Alla P.; Shkoporov, Andrei N.			Intraspecies Genomic Diversity and Long-Term Persistence of Bifidobacterium longum	PLOS ONE			English	Article							SUBSP INFANTIS; PAN-GENOME; MOLECULAR CHARACTERIZATION; SEQUENCE-ANALYSIS; MILK UTILIZATION; STRAINS; PLASMIDS; REVEALS; IDENTIFICATION; CONSTRUCTION	Members of genus Bifidobacterium are Gram-positive bacteria, representing a large part of the human infant microbiota and moderately common in adults. However, our knowledge about their diversity, intraspecific phylogeny and long-term persistence in humans is still limited. Bifidobacterium longum is generally considered to be the most common and prevalent species in the intestinal microbiota. In this work we studied whole genome sequences of 28 strains of B. longum, including 8 sequences described in this paper. Part of these strains were isolated from healthy children during a long observation period (up to 10 years between isolation from the same patient). The three known subspecies (longum, infantis and suis) could be clearly divided using sequence-based phylogenetic methods, gene content and the average nucleotide identity. The profiles of glycoside hydrolase genes reflected the different ecological specializations of these three subspecies. The high impact of horizontal gene transfer on genomic diversity was observed, which is possibly due to a large number of prophages and rapidly spreading plasmids. The pan-genome characteristics of the subspecies longum corresponded to the open pan-genome model. While the major part of the strain-specific genetic loci represented transposons and phage-derived regions, a large number of cell envelope synthesis genes were also observed within this category, representing high variability of cell surface molecules. We observed the cases of isolation of high genetically similar strains of B. longum from the same patients after long periods of time, however, we didn't succeed in the isolation of genetically identical bacteria: a fact, reflecting the high plasticity of microbiota in children.	[Chaplin, Andrei V.; Efimov, Boris A.; Kafarskaia, Lyudmila I.; Pikina, Alla P.; Shkoporov, Andrei N.] Pirogov Russian Natl Res Med Univ, Microbiol & Virol Dept, Moscow, Russia; [Smeianov, Vladimir V.] North Caucasus State Acad Humanities & Technol, Inst Med, Dept Nat Sci, Cherkessk, Russia	Pirogov Russian National Research Medical University	Chaplin, AV (corresponding author), Pirogov Russian Natl Res Med Univ, Microbiol & Virol Dept, Moscow, Russia.	chaplin.andr@gmail.com	Smeianov, Vladimir/U-9585-2019; Shkoporov, Andrey/AAA-3043-2020; Chaplin, Andrei/AAL-7487-2020; Efimov, Boris/B-8114-2019	Chaplin, Andrei/0000-0003-1377-7153; Smeianov, Vladimir/0000-0002-8950-9684; Shkoporov, Andrey/0000-0002-5547-8672				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Biavati B, 2000, ANN MICROBIOL, V50, P117; Bottacini F, 2014, APPL ENV MICROBIOL; Bottacini F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-170; Briner AE, 2014, APPL ENVIRON MICROB, V80, P994, DOI 10.1128/AEM.03015-13; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Martinez FAC, 2013, BIOTECHNOL ADV, V31, P482, DOI 10.1016/j.biotechadv.2013.01.010; Corneau N, 2004, PLASMID, V51, P87, DOI 10.1016/j.plasmid.2003.12.003; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; De Maayer P, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-404; Deletoile A, 2010, RES MICROBIOL, V161, P82, DOI 10.1016/j.resmic.2009.12.006; Delgado S, 2008, J APPL MICROBIOL, V104, P1119, DOI 10.1111/j.1365-2672.2007.03642.x; Deng XY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-500; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Donati C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r107; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Foroni E, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S16; Frost LS, 2005, NAT REV MICROBIOL, V3, P722, DOI 10.1038/nrmicro1235; Fujita K, 2014, APPL ENVIRON MICROB, V80, P4577, DOI 10.1128/AEM.00802-14; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Fushinobu S, 2010, BIOSCI BIOTECH BIOCH, V74, P2374, DOI 10.1271/bbb.100494; Garrido D, 2012, ADV NUTR, V3, p415S, DOI 10.3945/an.111.001586; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Guglielmetti S, 2007, APPL MICROBIOL BIOT, V74, P1053, DOI 10.1007/s00253-006-0755-1; Ham JS, 2011, J BACTERIOL, V193, P5044, DOI 10.1128/JB.05620-11; Hao YL, 2011, J BACTERIOL, V193, P787, DOI 10.1128/JB.01213-10; Ishikawa E, 2013, J BIOSCI BIOENG, V116, P265, DOI 10.1016/j.jbiosc.2013.02.010; Ito T, 2014, BIOCHEM BIOPH RES CO, V447, P32, DOI 10.1016/j.bbrc.2014.03.096; Ivanov D, 2006, J BIOL CHEM, V281, P17246, DOI 10.1074/jbc.M601678200; Khokhlova EV, 2012, MICROBIOL IMMUNOL, V56, P27, DOI 10.1111/j.1348-0421.2011.00398.x; Kim GB, 2005, BIOTECHNOL LETT, V27, P817, DOI 10.1007/s10529-005-6717-3; Klijn A, 2005, FEMS MICROBIOL REV, V29, P491, DOI 10.1016/j.femsre.2005.04.010; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee JH, 2006, APPL ENVIRON MICROB, V72, P527, DOI 10.1128/AEM.72.1.527-535.2006; Lee JH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-247; Lee JH, 2011, APPL ENVIRON MICROB, V77, P5879, DOI 10.1128/AEM.00571-11; Lee JH, 2010, MICROBIOL MOL BIOL R, V74, P378, DOI 10.1128/MMBR.00004-10; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liu GJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-775; LoCascio RG, 2010, APPL ENVIRON MICROB, V76, P7373, DOI 10.1128/AEM.00675-10; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Matamoros S, 2011, J MICROBIOL METH, V87, P378, DOI 10.1016/j.mimet.2011.10.005; Matsuki T, 1999, APPL ENVIRON MICROB, V65, P4506; Mattarelli P, 2008, INT J SYST EVOL MICR, V58, P767, DOI 10.1099/ijs.0.65319-0; Maughan Heather, 2009, PLoS One, V4, pe5854, DOI 10.1371/journal.pone.0005854; Medina M, 2007, CLIN EXP IMMUNOL, V150, P531, DOI 10.1111/j.1365-2249.2007.03522.x; Menard O, 2010, APPL ENVIRON MICROB, V76, P2846, DOI 10.1128/AEM.01714-09; Milani C, 2014, APPL ENVIRON MICROB, V80, P6290, DOI 10.1128/AEM.02308-14; Miyauchi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079735; Monzingo AF, 2007, J MOL BIOL, V366, P165, DOI 10.1016/j.jmb.2006.11.031; Moon GS, 2009, J MICROBIOL BIOTECHN, V19, P403, DOI 10.4014/jmb.0806.378; Motherway MO, 2011, P NATL ACAD SCI USA, V108, P11217, DOI 10.1073/pnas.1105380108; Park BH, 2010, GLYCOBIOLOGY, V20, P1574, DOI 10.1093/glycob/cwq106; Pokusaeva K, 2011, GENES NUTR, V6, P285, DOI 10.1007/s12263-010-0206-6; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Ringel-Kulka T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064315; Roberts RJ, 2010, NUCLEIC ACIDS RES, V38, pD234, DOI 10.1093/nar/gkp874; Russell JA, 2009, EVOLUTION, V63, P624, DOI 10.1111/j.1558-5646.2008.00579.x; Said HM, 2013, AM J PHYSIOL-GASTR L, V305, pG601, DOI 10.1152/ajpgi.00231.2013; Sakata S, 2002, INT J SYST EVOL MICR, V52, P1945, DOI [10.1099/ijs.0.02221-0, 10.1099/00207713-52-6-1945]; Schell MA, 2002, P NATL ACAD SCI USA, V99, P14422, DOI 10.1073/pnas.212527599; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; SGORBATI B, 1982, J GEN MICROBIOL, V128, P2121; Shkoporov AN, 2008, B EXP BIOL MED+, V146, P782, DOI 10.1007/s10517-009-0423-4; Shkoporov A. N., 2006, Vestnik Rossiiskoi Akademii Meditsinskikh Nauk, P45; Shkoporov AN, 2013, GENOME ANNOUNC, V1; Shkoporov AN, 2008, PLASMID, V60, P136, DOI 10.1016/j.plasmid.2008.06.005; Shkoporov AN, 2008, BIOSCI BIOTECH BIOCH, V72, P742, DOI 10.1271/bbb.70628; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; STAHL M, 1990, INT J SYST BACTERIOL, V40, P189, DOI 10.1099/00207713-40-2-189; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Tettelin H, 2008, CURR OPIN MICROBIOL, V11, P472, DOI 10.1016/j.mib.2008.09.006; Turroni F, 2014, APPL ENVIRON MICROB, V80, P730, DOI 10.1128/AEM.03313-13; Turroni F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036957; Turroni F, 2010, APPL ENVIRON MICROB, V76, P3206, DOI 10.1128/AEM.02938-09; Turroni F, 2009, APPL ENVIRON MICROB, V75, P1534, DOI 10.1128/AEM.02216-08; Varani AM, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r30; Ventura M, 2009, APPL ENVIRON MICROB, V75, P6929, DOI 10.1128/AEM.01112-09; Viborg AH, 2014, GLYCOBIOLOGY, V24, P208, DOI 10.1093/glycob/cwt104; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; Wei YX, 2010, J BACTERIOL, V192, P4076, DOI 10.1128/JB.00538-10; Yang Y-S, 1998, [No title captured], Patent No. 5711977; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485; Zhurina D, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.01084-13	87	29	29	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135658	10.1371/journal.pone.0135658	http://dx.doi.org/10.1371/journal.pone.0135658			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275230	Green Published, gold, Green Submitted			2022-12-26	WOS:000359493600090
J	Cokic, VP; Mossuz, P; Han, J; Socoro, N; Beleslin-Cokic, BB; Mitrovic, O; Suboticki, T; Diklic, M; Lekovic, D; Gotic, M; Puri, RK; Noguchi, CT; Schechter, AN				Cokic, Vladan P.; Mossuz, Pascal; Han, Jing; Socoro, Nuria; Beleslin-Cokic, Bojana B.; Mitrovic, Olivera; Suboticki, Tijana; Diklic, Milos; Lekovic, Danijela; Gotic, Mirjana; Puri, Raj K.; Noguchi, Constance Tom; Schechter, Alan N.			Microarray and Proteomic Analyses of Myeloproliferative Neoplasms with a Highlight on the mTOR Signaling Pathway	PLOS ONE			English	Article							GENE-EXPRESSION; POLYCYTHEMIA-VERA; ESSENTIAL THROMBOCYTHEMIA; MAMMALIAN TARGET; BREAST-CANCER; MEGAKARYOCYTE PROGENITORS; HEMATOPOIETIC STEM; RHEB GTPASE; CELLS; PROLIFERATION	The gene and protein expression profiles in myeloproliferative neoplasms (MPNs) may reveal gene and protein markers of a potential clinical relevance in diagnosis, treatment and prediction of response to therapy. Using cDNA microarray analysis of 25,100 unique genes, we studied the gene expression profile of CD34(+) cells and granulocytes obtained from peripheral blood of subjects with essential thrombocythemia (ET), polycythemia vera (PV) and primary myelofibrosis (PMF). The microarray analyses of the CD34(+) cells and granulocytes were performed from 20 de novo MPN subjects: JAK2 positive ET, PV, PMF subjects, and JAK2 negative ET/PMF subjects. The granulocytes for proteomic studies were pooled in 4 groups: PV with JAK2 mutant allele burden above 80%, ET with JAK2 mutation, PMF with JAK2 mutation and ET/PMF with no JAK2 mutation. The number of differentially regulated genes was about two fold larger in CD34(+) cells compared to granulocytes. Thirty-six genes (including RUNX1, TNFRSF19) were persistently highly expressed, while 42 genes (including FOXD4, PDE4A) were underexpressed both in CD34(+) cells and granulocytes. Using proteomic studies, significant up-regulation was observed for MAPK and PI3K/AKT signaling regulators that control myeloid cell apoptosis and proliferation: RAC2, MNDA, S100A8/9, CORO1A, and GNAI2. When the status of the mTOR signaling pathway related genes was analyzed, PI3K/AKT regulators were preferentially up-regulated in CD34(+) cells of MPNs, with down-regulated major components of the protein complex EIF4F. Molecular profiling of CD34(+) cells and granulocytes of MPN determined gene expression patterns beyond their recognized function in disease pathogenesis that included dominant up-regulation of PI3K/AKT signaling.	[Cokic, Vladan P.; Mitrovic, Olivera; Suboticki, Tijana; Diklic, Milos] Univ Belgrade, Inst Med Res, Belgrade, Serbia; [Mossuz, Pascal] CHU Grenoble, Inst Biol & Pathol, Dept Hematol, F-38043 Grenoble, France; [Han, Jing; Puri, Raj K.] US FDA, Tumor Vaccines & Biotechnol Branch, Div Cellular & Gene Therapies, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA; [Socoro, Nuria] Fac Med Grenoble, Lab TIMC IMAG, Grenoble, France; [Beleslin-Cokic, Bojana B.] Clin Ctr Serbia, Clin Endocrinol Diabet & Dis Metab, Belgrade, Serbia; [Lekovic, Danijela; Gotic, Mirjana] Clin Ctr Serbia, Clin Hematol, Belgrade, Serbia; [Gotic, Mirjana] Univ Belgrade, Fac Med, Belgrade, Serbia; [Noguchi, Constance Tom; Schechter, Alan N.] Natl Inst Diabet & Digest & Kidney Dis, Mol Med Branch, NIH, Bethesda, MD USA	University of Belgrade; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); US Food & Drug Administration (FDA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Clinical Centre of Serbia; Clinical Centre of Serbia; University of Belgrade; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Cokic, VP (corresponding author), Univ Belgrade, Inst Med Res, Belgrade, Serbia.	vl@imi.bg.ac.rs	Subotički, Tijana/ABE-3583-2021; Ajtić, Olivera Mitrović/AAS-4741-2021	Lekovic, Danijela/0000-0002-6194-8298; Diklic, Milos/0000-0003-1171-5186; Cokic, Vladan/0000-0002-0362-1449; Suboticki, Tijana/0000-0002-5132-8319	Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health; Serbian Ministry of Education, Science and Technological Development [175053]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK025016, ZIADK025021] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Serbian Ministry of Education, Science and Technological Development; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases and the National Institutes of Health and by a grant from the Serbian Ministry of Education, Science and Technological Development [175053].	Bartalucci N, 2013, J CELL MOL MED, V17, P1385, DOI 10.1111/jcmm.12162; Bogani C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054826; Britschgi A, 2012, CANCER CELL, V22, P796, DOI 10.1016/j.ccr.2012.10.023; Cazzola M, 2014, BLOOD, V123, P3714, DOI 10.1182/blood-2014-03-530865; Chow S, 2006, EXP HEMATOL, V34, P1183, DOI 10.1016/j.exphem.2006.05.002; Cokic VP, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-116; Dai CH, 2005, EXP HEMATOL, V33, P152, DOI 10.1016/j.exphem.2004.10.017; Dong ZW, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-17; Drayer AL, 2006, STEM CELLS, V24, P105, DOI 10.1634/stemcells.2005-0062; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Fiskus W, 2013, MOL CANCER THER, V12, P577, DOI 10.1158/1535-7163.MCT-12-0862; Gallardo M, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-142; Geest CR, 2009, HAEMATOL-HEMATOL J, V94, P901, DOI 10.3324/haematol.13766; Goerttler PS, 2005, BRIT J HAEMATOL, V129, P138, DOI 10.1111/j.1365-2141.2005.05416.x; Grimwade LF, 2009, BRIT J HAEMATOL, V147, P495, DOI 10.1111/j.1365-2141.2009.07870.x; Guglielmelli P, 2007, STEM CELLS, V25, P165, DOI 10.1634/stemcells.2006-0351; Guglielmelli P, 2011, BLOOD, V118, P2069, DOI 10.1182/blood-2011-01-330563; Hasselbalch HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085567; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jones LC, 2005, STEM CELLS, V23, P631, DOI 10.1634/stemcells.2004-0131; Kralovics R, 2005, BLOOD, V106, P3374, DOI 10.1182/blood-2005-05-1889; Martin TD, 2014, MOL CELL, V53, P209, DOI 10.1016/j.molcel.2013.12.004; Mossuz P, 2008, EXP HEMATOL, V36, P1642, DOI 10.1016/j.exphem.2008.07.013; Nagao T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084746; Pellagatti A, 2003, CANCER RES, V63, P3940; Puigdecanet E, 2008, LEUKEMIA, V22, P1368, DOI 10.1038/leu.2008.112; Raslova H, 2006, BLOOD, V107, P2303, DOI 10.1182/blood-2005-07-3005; Rojo F, 2014, CANCER EPIDEM BIOMAR, V23, P288, DOI 10.1158/1055-9965.EPI-13-0761; Schwernmers S, 2007, EXP HEMATOL, V35, P1695, DOI 10.1016/j.exphem.2007.07.004; Skov V, 2012, EXP HEMATOL, V40, P771, DOI 10.1016/j.exphem.2012.05.011; Steelman LS, 2008, LEUKEMIA, V22, P686, DOI 10.1038/leu.2008.26; Steidl U, 2005, ANN NY ACAD SCI, V1044, P94, DOI 10.1196/annals.1349.013; Tasian SK, 2012, BLOOD, V120, P833, DOI 10.1182/blood-2011-12-389932; Tenedini E, 2004, BLOOD, V104, P3126, DOI 10.1182/blood-2003-07-2597; Tokunaga E, 2008, CURR CANCER DRUG TAR, V8, P27, DOI 10.2174/156800908783497140; Uniacke J, 2014, CANCER RES, V74, P1379, DOI 10.1158/0008-5472.CAN-13-2278; Vainchenker W, 2013, ONCOGENE, V32, P2601, DOI 10.1038/onc.2012.347; Vicari L, 2012, BRIT J HAEMATOL, V159, P237, DOI 10.1111/j.1365-2141.2012.09246.x; Yang XL, 2014, ONCOTARGETS THER, V7, P1033, DOI 10.2147/OTT.S63145; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105	41	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135463	10.1371/journal.pone.0135463	http://dx.doi.org/10.1371/journal.pone.0135463			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275051	Green Published, Green Submitted, gold			2022-12-26	WOS:000359493600068
J	Marques, ARA; Aten, J; Ottenhoff, R; van Roomen, CPAA; Moro, DH; Claessen, N; Veloz, MFV; Zhou, KK; Lin, ZM; Mirzaian, M; Boot, RG; De Zeeuw, CI; Overkleeft, HS; Yildiz, Y; Aerts, JMFG				Marques, Andre R. A.; Aten, Jan; Ottenhoff, Roelof; van Roomen, Cindy P. A. A.; Moro, Daniela Herrera; Claessen, Nike; Veloz, Maria Fernanda Vinueza; Zhou, Kuikui; Lin, Zhanmin; Mirzaian, Mina; Boot, Rolf G.; De Zeeuw, Chris I.; Overkleeft, Herman S.; Yildiz, Yildiz; Aerts, Johannes M. F. G.			Reducing GBA2 Activity Ameliorates Neuropathology in Niemann-Pick Type C Mice	PLOS ONE			English	Article							NONLYSOSOMAL GLUCOSYLCERAMIDASE; N-BUTYLDEOXYNOJIRIMYCIN; STORAGE DISORDER; IN-SITU; DISEASE; GLUCOCEREBROSIDASE; DEFICIENCY; INHIBITORS; CHOLESTEROL; METABOLISM	The enzyme glucocerebrosidase (GBA) hydrolyses glucosylceramide (GlcCer) in lysosomes. Markedly reduced GBA activity is associated with severe manifestations of Gaucher disease including neurological involvement. Mutations in the GBA gene have recently also been identified as major genetic risk factor for Parkinsonism. Disturbed metabolism of GlcCer may therefore play a role in neuropathology. Besides lysosomal GBA, cells also contain a non-lysosomal glucosylceramidase (GBA2). Given that the two beta-glucosidases share substrates, we speculated that over-activity of GBA2 during severe GBA impairment might influence neuropathology. This hypothesis was studied in Niemann-Pick type C (Npc1(-/-)) mice showing secondary deficiency in GBA in various tissues. Here we report that GBA2 activity is indeed increased in the brain of Npc1(-/-) mice. We found that GBA2 is particularly abundant in Purkinje cells (PCs), one of the most affected neuronal populations in NPC disease. Inhibiting GBA2 in Npc1(-/-) mice with a brain-permeable low nanomolar inhibitor significantly improved motor coordination and extended lifespan in the absence of correction in cholesterol and ganglioside abnormalities. This trend was recapitulated, although not to full extent, by introducing a genetic loss of GBA2 in Npc1(-/-) mice. Our findings point to GBA2 activity as therapeutic target in NPC.	[Marques, Andre R. A.; Ottenhoff, Roelof; van Roomen, Cindy P. A. A.; Moro, Daniela Herrera; Mirzaian, Mina; Boot, Rolf G.; Aerts, Johannes M. F. G.] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; [Aten, Jan; Claessen, Nike] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Veloz, Maria Fernanda Vinueza; Zhou, Kuikui; Lin, Zhanmin; De Zeeuw, Chris I.] Erasmus MC, Dept Neurosci, NL-3000 CA Rotterdam, Netherlands; [De Zeeuw, Chris I.] Royal Dutch Acad Arts & Sci, Netherlands Inst Neurosci, NL-1105 BA Amsterdam, Netherlands; [Overkleeft, Herman S.; Aerts, Johannes M. F. G.] Leiden Univ, Leiden Inst Chem, NL-2300 RA Leiden, Netherlands; [Yildiz, Yildiz] Hosp Bregenz, Dept Internal Med, A-6900 Bregenz, Austria	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Leiden University; Leiden University - Excl LUMC	Aerts, JMFG (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.m.f.g.aerts@lic.leidenuniv.nl	Marques, André R. A./Q-3892-2018; Aerts, Johannes/A-1028-2009	Marques, André R. A./0000-0001-9674-3017; Aerts, Johannes/0000-0001-8168-2565; Mirzaian, Mina/0000-0001-9404-2903; Aten, Jan/0000-0002-0997-6777; Herrera Moro Chao, Daniela/0000-0001-8406-1377; Overkleeft, Herman/0000-0001-6976-7005; Boot, Rolf/0000-0002-7031-3390	ERC-EU [294775, 290836]	ERC-EU	Chris I. De Zeeuw was supported by the ERC-advanced (294775) programs of the EU. Johannes Aerts and Herman Overkleeft were supported by the ERC-advanced (290836) program of the EU.	Aerts JM, 2003, PHILOS T R SOC B, V358, P905, DOI 10.1098/rstb.2003.1273; Apps R, 2009, NAT REV NEUROSCI, V10, P670, DOI 10.1038/nrn2698; Ashe KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021758; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boot RG, 2007, J BIOL CHEM, V282, P1305, DOI 10.1074/jbc.M610544200; BRADY RO, 1965, BIOCHEM BIOPH RES CO, V18, P221, DOI 10.1016/0006-291X(65)90743-6; Burke DG, 2013, J INHERIT METAB DIS, V36, P869, DOI 10.1007/s10545-012-9561-3; Cox T, 2000, LANCET, V355, P1481, DOI 10.1016/S0140-6736(00)02161-9; De Zeeuw CI, 2011, NAT REV NEUROSCI, V12, P327, DOI 10.1038/nrn3011; Dekker N, 2011, BLOOD, V118, pE118, DOI 10.1182/blood-2011-05-352971; Elleder M, 2006, J INHERIT METAB DIS, V29, P707, DOI 10.1007/s10545-006-0411-z; FOLCH J, 1957, J BIOL CHEM, V226, P497; Groener JEM, 2007, CLIN CHEM, V53, P742, DOI 10.1373/clinchem.2006.079012; Hopfner F, 2013, MOVEMENT DISORD, V28, P538, DOI 10.1002/mds.25349; Kallemeijn WW, 2012, ANGEW CHEM INT EDIT, V51, P12529, DOI 10.1002/anie.201207771; Korschen HG, 2013, J BIOL CHEM, V288, P3381, DOI 10.1074/jbc.M112.414714; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Mistry PK, 2014, P NATL ACAD SCI USA, V111, P4934, DOI 10.1073/pnas.1400768111; Nalls MA, 2013, JAMA NEUROL, V70, P727, DOI 10.1001/jamaneurol.2013.1925; Nietupski JB, 2012, MOL GENET METAB, V105, P621, DOI 10.1016/j.ymgme.2012.01.020; Overkleeft HS, 1998, J BIOL CHEM, V273, P26522, DOI 10.1074/jbc.273.41.26522; Parra J, 2011, BIOCHEM BIOPH RES CO, V413, P400, DOI 10.1016/j.bbrc.2011.08.096; Patterson MC, 2007, LANCET NEUROL, V6, P765, DOI 10.1016/S1474-4422(07)70194-1; PENTCHEV PG, 1980, BIOCHIM BIOPHYS ACTA, V619, P669, DOI 10.1016/0005-2760(80)90116-2; PLATT FM, 1994, J BIOL CHEM, V269, P8362; Salvioli R, 2004, J BIOL CHEM, V279, P17674, DOI 10.1074/jbc.M313517200; Sarkar S, 2013, CELL REP, V5, P1302, DOI 10.1016/j.celrep.2013.10.042; Sarna JR, 2003, J COMP NEUROL, V456, P279, DOI 10.1002/cne.10522; Sleat DE, 2004, P NATL ACAD SCI USA, V101, P5886, DOI 10.1073/pnas.0308456101; Sorli SC, 2013, FASEB J, V27, P489, DOI 10.1096/fj.12-215152; Van Der Giessen RS, 2008, NEURON, V58, P599, DOI 10.1016/j.neuron.2008.03.016; van der Loos CM, 2010, J HISTOTECHNOL, V33, P31, DOI 10.1179/his.2010.33.1.31; Vanier MT, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-16; VANIER MT, 1983, BIOCHIM BIOPHYS ACTA, V750, P178, DOI 10.1016/0005-2760(83)90218-7; VANWEELY S, 1993, BIOCHIM BIOPHYS ACTA, V1181, P55, DOI 10.1016/0925-4439(93)90090-N; Veloz MFV, 2012, GENES BRAIN BEHAV, V11, P325, DOI 10.1111/j.1601-183X.2011.00763.x; Veloz MFV, 2015, BRAIN STRUCT FUNCT, V220, P3513, DOI 10.1007/s00429-014-0870-1; Vlugt KGVD, 2008, CLIN CHIM ACTA, V389, P109, DOI 10.1016/j.cca.2007.12.001; Wennekes T, 2007, J ORG CHEM, V72, P1088, DOI 10.1021/jo061280p; Witte MD, 2010, NAT CHEM BIOL, V6, P907, DOI 10.1038/NCHEMBIO.466; Yildiz Y, 2006, J CLIN INVEST, V116, P2985, DOI 10.1172/JCI29224; Yildiz Y, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-151; Zervas M, 2001, CURR BIOL, V11, P1283, DOI 10.1016/S0960-9822(01)00396-7	43	39	40	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135889	10.1371/journal.pone.0135889	http://dx.doi.org/10.1371/journal.pone.0135889			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275242	Green Published, Green Submitted, gold			2022-12-26	WOS:000359493600130
J	Babaian, A; Romanish, MT; Gagnier, L; Kuo, LY; Karimi, MM; Steidl, C; Mager, DL				Babaian, A.; Romanish, M. T.; Gagnier, L.; Kuo, L. Y.; Karimi, M. M.; Steidl, C.; Mager, D. L.			Onco-exaptation of an endogenous retroviral LTR drives IRF5 expression in Hodgkin lymphoma	ONCOGENE			English	Article							TRANSPOSABLE ELEMENTS; GENES; ISOFORM; TRANSCRIPTS; PROMOTERS; ALIGNMENT; BIOLOGY	The transcription factor interferon regulatory factor 5 (IRF5) is upregulated in Hodgkin lymphoma (HL) and is a key regulator of the aberrant transcriptome characteristic of this disease. Here we show that IRF5 upregulation in HL is driven by transcriptional activation of a normally dormant endogenous retroviral LOR1a long terminal repeat (LTR) upstream of IRF5. Specifically, through screening of RNA-sequencing libraries, we detected LTR-IRF5 chimeric transcripts in multiple HL cell lines but not in normal B-cell controls. In HL, the LTR was in an open and hypomethylated epigenetic state, and we further show the LTR is the site of transcriptional initiation. Among HL cell lines, usage of the LTR promoter strongly correlates with overall levels of IRF5 mRNA and protein, indicating that LTR transcriptional awakening is a major contributor to IRF5 upregulation in HL. Taken together, oncogenic IRF5 overexpression in HL is the result of a specific LTR transcriptional activation. We propose that such LTR derepression is a distinct mechanism of oncogene activation ('onco-exaptation'), and that such a mechanism warrants further investigation in molecular and cancer research.	[Babaian, A.; Romanish, M. T.; Gagnier, L.; Kuo, L. Y.; Mager, D. L.] British Columbia Canc Agcy, Terry Fox Lab, 675 West 10th Ave, Vancouver, BC V5Z 1L3, Canada; [Babaian, A.; Romanish, M. T.; Gagnier, L.; Karimi, M. M.; Mager, D. L.] Univ British Columbia, Dept Med Genet, Vancouver, BC V5Z 1M9, Canada; [Karimi, M. M.] Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada; [Steidl, C.] British Columbia Canc Agcy, Dept Lymphoid Canc Res, Vancouver, BC V5Z 1L3, Canada; [Steidl, C.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada	British Columbia Cancer Agency; University of British Columbia; University of British Columbia; British Columbia Cancer Agency; University of British Columbia	Mager, DL (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, 675 West 10th Ave, Vancouver, BC V5Z 1L3, Canada.; Steidl, C (corresponding author), British Columbia Canc Agcy, Ctr Lymphoid Canc, 675 West 10th Ave, Vancouver, BC V5Z 1L3, Canada.	CSteidl@bccancer.bc.ca; dmager@bccrc.ca		Mager, Dixie/0000-0002-5955-2550; Karimi, Mohammad Mahdi/0000-0001-5017-1252; Babaian, Artem/0000-0002-4315-6262	Leukemia and Lymphoma Society of Canada; British Columbia Cancer Agency; Natural Sciences and Engineering Research Council of Canada; Michael Smith Foundation for Health Research (MSFHR); MSFHR	Leukemia and Lymphoma Society of Canada; British Columbia Cancer Agency; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); MSFHR(Michael Smith Foundation for Health Research)	This work was supported by a grant from the Leukemia and Lymphoma Society of Canada to DM and CS, with core support provided by the British Columbia Cancer Agency. AB is supported by a studentship award from the Natural Sciences and Engineering Research Council of Canada, MMK is supported by a postdoctoral fellowship from the Michael Smith Foundation for Health Research (MSFHR) and CS is supported by a scholarship award from MSFHR.	Chiaromonte F, 2002, Pac Symp Biocomput, P115; Clark DN, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00360; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; De Smet Charles, 2010, Epigenetics, V5, P206; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Hur K, 2014, GUT, V63, P635, DOI 10.1136/gutjnl-2012-304219; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kapusta A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003470; Karimi MM, 2011, CELL STEM CELL, V8, P676, DOI 10.1016/j.stem.2011.04.004; Kelley D, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r107; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kreher S, 2014, P NATL ACAD SCI USA, V111, pE4513, DOI 10.1073/pnas.1406985111; Lamprecht B, 2010, NAT MED, V16, P571, DOI 10.1038/nm.2129; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lazzari E, 2014, CLIN IMMUNOL, V153, P343, DOI 10.1016/j.clim.2014.06.001; Liu Y, 2014, LEUKEMIA, V28, P2248, DOI 10.1038/leu.2014.201; Lock FE, 2014, P NATL ACAD SCI USA, V111, pE3534, DOI 10.1073/pnas.1405507111; Mancl ME, 2005, J BIOL CHEM, V280, P21078, DOI 10.1074/jbc.M500543200; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; PANGANIBAN AT, 1985, CELL, V42, P5, DOI 10.1016/S0092-8674(85)80092-1; Rebollo R, 2012, ANNU REV GENET, V46, P21, DOI 10.1146/annurev-genet-110711-155621; Rebollo R, 2012, MOBILE DNA-UK, V3, DOI 10.1186/1759-8753-3-9; Rebollo R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002301; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Romanish MT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005761; Roullet MR, 2007, EXPERT REV MOL DIAGN, V7, P805, DOI 10.1586/14737159.7.6.805; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; St Laurent G, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r73; Steidl C, 2012, BLOOD, V120, P3530, DOI 10.1182/blood-2012-06-439570; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Weber B, 2010, ONCOGENE, V29, P5775, DOI 10.1038/onc.2010.227; Wolff EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000917; Xie MC, 2013, NAT GENET, V45, P836, DOI 10.1038/ng.2649	35	44	45	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 12	2016	35	19					2542	2546		10.1038/onc.2015.308	http://dx.doi.org/10.1038/onc.2015.308			5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DM2GQ	26279299				2022-12-26	WOS:000376165500012
J	Yamaoka, H; Tachibanaki, S; Kawamura, S				Yamaoka, Hiromi; Tachibanaki, Shuji; Kawamura, Satoru			Dephosphorylation during Bleach and Regeneration of Visual Pigment in Carp Rod and Cone Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTORECEPTOR DARK-ADAPTATION; RHODOPSIN PHOSPHORYLATION; MULTIPLE PHOSPHORYLATION; LIGHT ADAPTATION; IN-VIVO; ARRESTIN; CELLS; TRANSDUCIN; RETINA; PHOTOTRANSDUCTION	On absorption of light by vertebrate visual pigment, the chromophore, 11-cis retinal, is isomerized to all-trans retinal to activate the phototransduction cascade, which leads to a hyperpolarizing light response. Activated pigment is inactivated by phosphorylation on the protein moiety, opsin. Isomerized alltrans retinal is ultimately released from opsin, and the pigment is regenerated by binding to 11-cis retinal. In this pigment regeneration cycle, the phosphates incorporated should be removed in order that the pigment regains the capability of activating the phototransduction cascade. However, it is not clear yet how pigment dephosphorylation takes place in the regeneration cycle. First in this study, we tried to estimate the dephosphorylation activity in living carp rods and cones and found that the activity, which is present mainly in the cytoplasm in both rods and cones, is three times higher in cones than in rods. Second, we examined at which stage the dephosphorylation takes place; before or after the release of all-trans retinal, during pigment regeneration, or alter pigment regeneration. For this purpose we prepared three types of phosphorylated substrates in purified carp rod and cone membranes: phosphorylated bleaching intermediate, phosphorylated opsin, and phosphorylated and regenerated pigment. We also examined the effect of pigment regeneration on the dephosphorylation. The results showed that the dephosphorylation does not show substrate preference in the regeneration cycle and suggested that the dephosphorylation takes place constantly. The results also suggest that, under bright light, some of the regenerated visual pigment remains phosphorylated to reduce the light sensitivity in cones.	[Yamaoka, Hiromi; Tachibanaki, Shuji; Kawamura, Satoru] Osaka Univ, Grad Sch Frontier Biosci, Yamada Oka 1-3, Suita, Osaka 5650871, Japan; [Tachibanaki, Shuji; Kawamura, Satoru] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Kawamura, S (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Yamada Oka 1-3, Suita, Osaka 5650871, Japan.	kawamura@fbs.osaka-u.ac.jp		Kawamura, Satoru/0000-0003-2070-5940	Japan Society for the Promotion of Science [23227002, 24570085]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Japan Society for the Promotion of Science Grants 23227002 (to S. K.) and 24570085 (to S. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Ala-Laurila P, 2009, J BIOL CHEM, V284, P16492, DOI 10.1074/jbc.M109.004697; ARMSTRONG CG, 1995, J CELL SCI, V108, P3367; Arshavsky VY, 2002, TRENDS NEUROSCI, V25, P124, DOI 10.1016/S0166-2236(00)02094-4; Brown BM, 2002, BIOCHEMISTRY-US, V41, P13526, DOI 10.1021/bi0204490; BROWN PK, 1963, J CELL BIOL, V19, P79, DOI 10.1083/jcb.19.1.79; BURKHARDT DA, 1994, J NEUROSCI, V14, P1091, DOI 10.1523/JNEUROSCI.14-03-01091.1994; Gurevich VV, 2011, PROG RETIN EYE RES, V30, P405, DOI 10.1016/j.preteyeres.2011.07.002; JONES GJ, 1989, P NATL ACAD SCI USA, V86, P9606, DOI 10.1073/pnas.86.23.9606; KAWAMURA S, 1993, NATURE, V362, P855, DOI 10.1038/362855a0; Kawamura S., 2014, VERTEBRATE PHOTORECE, P23; KELLEHER DJ, 1988, MOL PHARMACOL, V34, P452; Kennedy MJ, 2004, NEURON, V41, P915, DOI 10.1016/S0896-6273(04)00086-8; Kennedy MJ, 2001, NEURON, V31, P87, DOI 10.1016/S0896-6273(01)00340-3; KUHN H, 1974, NATURE, V250, P588, DOI 10.1038/250588a0; Kutuzov MA, 1996, EUR J BIOCHEM, V238, P613, DOI 10.1111/j.1432-1033.1996.0613w.x; Lee KA, 2010, BIOCHEMISTRY-US, V49, P2454, DOI 10.1021/bi1001085; Mata NL, 2002, NEURON, V36, P69, DOI 10.1016/S0896-6273(02)00912-1; Miyazono S, 2008, P NATL ACAD SCI USA, V105, P16051, DOI 10.1073/pnas.0806593105; OHGURO H, 1993, BIOCHEMISTRY-US, V32, P5718, DOI 10.1021/bi00072a030; OHGURO H, 1995, J BIOL CHEM, V270, P14259, DOI 10.1074/jbc.270.24.14259; OKANO T, 1989, BIOCHEMISTRY-US, V28, P8848, DOI 10.1021/bi00448a025; PALCZEWSKI K, 1989, BIOCHEMISTRY-US, V28, P415, DOI 10.1021/bi00428a001; PALCZEWSKI K, 1989, J BIOL CHEM, V264, P15770; Peet JA, 2004, J CELL SCI, V117, P3049, DOI 10.1242/jcs.01167; Peskin James C., 1942, JOUR GEN PHYSIOL, V26, P27, DOI 10.1085/jgp.26.1.27; Tachibanaki S, 2005, P NATL ACAD SCI USA, V102, P9329, DOI 10.1073/pnas.0501875102; Tachibanaki S, 2001, P NATL ACAD SCI USA, V98, P14044, DOI 10.1073/pnas.241396898; Tachibanaki S, 2012, J BIOL CHEM, V287, P41186, DOI 10.1074/jbc.M112.403717; Tang PH, 2013, PROG RETIN EYE RES, V32, P48, DOI 10.1016/j.preteyeres.2012.09.002; TAYLOR JW, 1969, VISION RES, V9, P443, DOI 10.1016/0042-6989(69)90133-3; Tomizuka J, 2015, J BIOL CHEM, V290, P9399, DOI 10.1074/jbc.M114.634543; WILDEN U, 1995, BIOCHEMISTRY-US, V34, P1446, DOI 10.1021/bi00004a040; Yau KW, 2009, CELL, V139, P246, DOI 10.1016/j.cell.2009.09.029	33	6	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24381	24390		10.1074/jbc.M115.674101	http://dx.doi.org/10.1074/jbc.M115.674101			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26286749	hybrid, Green Published			2022-12-26	WOS:000362218900026
J	Lei, WW; Guo, XF; Fu, SH; Feng, Y; Nie, K; Song, JD; Li, Y; Ma, XJ; Liang, GD; Zhou, HN				Lei, Wenwen; Guo, Xiaofang; Fu, Shihong; Feng, Yun; Nie, Kai; Song, Jingdong; Li, Yang; Ma, Xuejun; Liang, Guodong; Zhou, Hongning			Isolation of Tibet orbivirus, TIBOV, from Culicoides Collected in Yunnan, China	PLOS ONE			English	Article							VIRUS; MOSQUITOS; CELLS; BORNE	We isolated a novel virus strain (YN12246) from Culicoides spp. specimens collected at the China-Laos-Myanmar border in southern Yunnan Province. This virus had a cytopathic effect (CPE) on both insect cells (C6/36) and mammalian cells (BHK-21). Electron microscopy revealed the structure of the virions to be spherical with a diameter of 75 nm. Polyacrylamide gel analysis demonstrated that the viral genome consisted of 10 segments of double-stranded RNA (dsRNA), with a distribution pattern of 3-3-3-1. The coding sequences of 9 genome segments of YN12246 (Seg1, Seg3-Seg10) were obtained by high-throughput sequencing and Sanger sequencing. Comparisons of conserved genome segments 1 and 3 (Seg1 and Seg3), encoding the polymerase-VP1 and sub-core T2 protein, respectively, showed that YN12246 groups with the Culicoides-borne orbiviruses. The highest levels of sequence identity were detected between YN12246 and Tibet orbivirus (TIBOV), indicating that they belong to the same virus species (with amino acid identity of 98.8% and 96.4% for the polymerase and T2 protein, respectively). The data presented here confirm that YN12246 is a member of the TIBOV species, which was first isolated from mosquitoes in 2009. This is the first report of the isolation of TIBOV from Culicoides.	[Lei, Wenwen; Fu, Shihong; Nie, Kai; Song, Jingdong; Li, Yang; Ma, Xuejun; Liang, Guodong] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Lei, Wenwen; Fu, Shihong; Liang, Guodong] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China; [Guo, Xiaofang; Zhou, Hongning] Yunnan Inst Parasit Dis, Puer, Yunnan, Peoples R China; [Feng, Yun] Yunnan Prov Ctr Virus & Rickettsia Res, Yunnan Inst Endem Dis Control & Prevent, Dali, Yunnan, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Yunnan Institute for Endemic Disease Control & Prevention	Liang, GD (corresponding author), Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	gdliang@hotmail.com; zhhn@yipd.org	Nie, Kai/L-5389-2019	li, yang/0000-0001-8771-7044	National Natural Science Foundation of China [81290342]; Ministry of Science and Technology, China [2011CB504702]; State Key Laboratory for Infectious Disease Prevention and Control [2014SKLID103]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology, China(Ministry of Science and Technology, China); State Key Laboratory for Infectious Disease Prevention and Control	This work was supported by grants from National Natural Science Foundation of China (81290342), The Ministry of Science and Technology, China (2011CB504702) and Development Grant of State Key Laboratory for Infectious Disease Prevention and Control (2014SKLID103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attoui H, 2006, J GEN VIROL, V87, P199, DOI 10.1099/vir.0.81294-0; Attoui H, 2005, J GEN VIROL, V86, P3409, DOI 10.1099/vir.0.81258-0; Attoui H, 2001, J GEN VIROL, V82, P795, DOI 10.1099/0022-1317-82-4-795; Attoui H, 2011, FAMILY REOVIRIDAE, P541; Attoui H, 2009, BIOL ANIM INFECT, P23, DOI 10.1016/B978-012369368-6.50007-1; Attoui H, 2009, VIROLOGY, V394, P298, DOI 10.1016/j.virol.2009.08.032; Belaganahalli MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031911; Belaganahalli MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023605; BREMER C W, 1976, Onderstepoort Journal of Veterinary Research, V43, P193; Karabatsos N., 1985, INT CATALOGUE ARBOVI; Li MH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001231; Li MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088738; LIBIKOVA H, 1978, MED MICROBIOL IMMUN, V166, P255, DOI 10.1007/BF02121159; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Mertens P P C, 2004, Vet Ital, V40, P426; Mertens PPC., 2005, VIRUS TAXONOMY, P466; Mertens PPC, 1999, ENCY VIROLOGY, V2nd, P1043; MOSS SR, 1992, J GEN VIROL, V73, P2585, DOI 10.1099/0022-1317-73-10-2585; Pfeffer M, 1997, AM J TROP MED HYG, V57, P709, DOI 10.4269/ajtmh.1997.57.709; Sun Xiao-hong, 2009, Chinese Journal of Virology, V25, P173; Wang JL, 2011, AM J TROP MED HYG, V84, P738, DOI 10.4269/ajtmh.2011.10-0294; Zhai Y, 2010, J GEN VIROL, V91, P2836, DOI 10.1099/vir.0.024794-0	22	17	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136257	10.1371/journal.pone.0136257	http://dx.doi.org/10.1371/journal.pone.0136257			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295700	Green Submitted, gold, Green Published			2022-12-26	WOS:000359926900092
J	Yao, SH; Wang, T; Shen, WM; Pan, SM; Chong, YW; Ding, F				Yao, Shihong; Wang, Tao; Shen, Weiming; Pan, Shaoming; Chong, Yanwen; Ding, Fei			Feature Selection and Pedestrian Detection Based on Sparse Representation	PLOS ONE			English	Article							PROJECTIONS; RECOGNITION	Pedestrian detection have been currently devoted to the extraction of effective pedestrian features, which has become one of the obstacles in pedestrian detection application according to the variety of pedestrian features and their large dimension. Based on the theoretical analysis of six frequently-used features, SIFT, SURF, Haar, HOG, LBP and LSS, and their comparison with experimental results, this paper screens out the sparse feature subsets via sparse representation to investigate whether the sparse subsets have the same description abilities and the most stable features. When any two of the six features are fused, the fusion feature is sparsely represented to obtain its important components. Sparse subsets of the fusion features can be rapidly generated by avoiding calculation of the corresponding index of dimension numbers of these feature descriptors; thus, the calculation speed of the feature dimension reduction is improved and the pedestrian detection time is reduced. Experimental results show that sparse feature subsets are capable of keeping the important components of these six feature descriptors. The sparse features of HOG and LSS possess the same description ability and consume less time compared with their full features. The ratios of the sparse feature subsets of HOG and LSS to their full sets are the highest among the six, and thus these two features can be used to best describe the characteristics of the pedestrian and the sparse feature subsets of the combination of HOG-LSS show better distinguishing ability and parsimony.	[Yao, Shihong; Wang, Tao; Shen, Weiming; Pan, Shaoming; Chong, Yanwen] Wuhan Univ, State Key Lab Informat Engn Surveying Mapping & R, Wuhan 430072, Peoples R China; [Ding, Fei] Shanghai Inst Satellite Engn, Informat Proc & Commun Technol Lab, Shanghai, Peoples R China	Wuhan University	Chong, YW (corresponding author), Wuhan Univ, State Key Lab Informat Engn Surveying Mapping & R, Wuhan 430072, Peoples R China.	ywchong@whu.edu.cn	Shen, Weiming/B-7400-2013	Shen, Weiming/0000-0001-5204-7992	Foundation Research Funds for the Central Universities [204201kf0242, 204201kf0263]; National Natural Science Foundation of China [41271398]; Natural Science Foundation of Hubei Province of China [2012FFB04204]; Shanghai Aerospace Science and Technology Innovation Fund Projects [SAST201425]	Foundation Research Funds for the Central Universities; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province of China(Natural Science Foundation of Hubei Province); Shanghai Aerospace Science and Technology Innovation Fund Projects	This paper was supported by the Foundation Research Funds for the Central Universities (204201kf0242, SMP, 204201kf0263, YWC), National Natural Science Foundation of China (41271398, SMP), Natural Science Foundation of Hubei Province of China (2012FFB04204), and Shanghai Aerospace Science and Technology Innovation Fund Projects (SAST201425, YWC). YWC had a role in study design, data analysis and decision to publish. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bay H, 2006, LECT NOTES COMPUT SC, V3951, P404, DOI 10.1007/11744023_32; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P489, DOI 10.1109/TIT.2005.862083; Chong YW, 2012, COMM COM INF SC, V304, P280; Dalal N, 2005, PROC CVPR IEEE, P886, DOI 10.1109/cvpr.2005.177; Dollar P, 2012, IEEE T PATTERN ANAL, V34, P743, DOI 10.1109/TPAMI.2011.155; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; FELZENSZWALB PF, 2010, PROC CVPR IEEE, P2241, DOI DOI 10.1109/CVPR.2010.5539906; Forman G., 2003, Journal of Machine Learning Research, V3, P1289, DOI 10.1162/153244303322753670; Freeman W. T., 1995, INT WORKSH AUT FAC G, V12, P296; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Huang YZ, 2008, PROC CVPR IEEE, P2000; Kittipanya-Ngam P, 2011, LECT NOTES COMPUT SC, V6468, P143; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Labusch K, 2008, IEEE T NEURAL NETWOR, V19, P1985, DOI 10.1109/TNN.2008.2005830; Liu J, 2012, NEURAL COMPUT APPL, V21, P1827, DOI 10.1007/s00521-010-0519-9; Liu JN, 2012, OPT COMMUN, V285, P2549, DOI 10.1016/j.optcom.2012.01.065; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Maji Subhransu, 2008, CVPR, DOI DOI 10.1109/CVPR.2008.4587630; Ojala T, 1996, PATTERN RECOGN, V29, P51, DOI 10.1016/0031-3203(95)00067-4; Omidiran D, 2010, J MACH LEARN RES, V11, P2361; Qiao LS, 2010, PATTERN RECOGN, V43, P331, DOI 10.1016/j.patcog.2009.05.005; Rodriguez-Lujan I, 2010, J MACH LEARN RES, V11, P1491; Sabzmeydani P, 2007, P IEEE C COMP VIS PA, P1; Shechtman E, 2007, IEEE C COMP VIS PATT, P1, DOI DOI 10.1109/CVPR.2007.383198; Song L., 2007, P 24 INT C MACHINE L, P823, DOI [10.1145/1273496.1273600, DOI 10.1145/1273496.1273600]; Tuv E, 2009, J MACH LEARN RES, V10, P1341; Viola P, 2001, PROC CVPR IEEE, P511, DOI 10.1109/cvpr.2001.990517; Viola P, 2004, INT J COMPUT VISION, V57, P137, DOI 10.1023/B:VISI.0000013087.49260.fb; Walk S, 2010, PROC CVPR IEEE, P1030, DOI 10.1109/CVPR.2010.5540102; Wang XY, 2009, IEEE I CONF COMP VIS, P32, DOI 10.1109/iccv.2009.5459207; Wright J, 2009, IEEE T PATTERN ANAL, V31, P210, DOI 10.1109/TPAMI.2008.79; Wu B. Q., 2008, 2008 AS PAC MICR C M, P1, DOI [DOI 10.1109/GLOCOM.2008.ECP.519, 10.1109/APMC.2008.4958141, DOI 10.1109/APMC.2008.4958141]; Wu XD, 2013, IEEE T PATTERN ANAL, V35, P1178, DOI 10.1109/TPAMI.2012.197; Xia H, 2012, J COMPUT INF SYST, V8, P425; Xin  Y., 2011, P 3 INT WORKSH INT S, P1, DOI DOI 10.1109/ISA.2011; Yao SH, 2015, NEUROCOMPUTING, V151, P1006, DOI 10.1016/j.neucom.2014.08.080; Yu L, 2004, J MACH LEARN RES, V5, P1205; Zhang T, 2009, J MACH LEARN RES, V10, P555; Zhao P, 2006, J MACH LEARN RES, V7, P2541	39	12	12	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0134242	10.1371/journal.pone.0134242	http://dx.doi.org/10.1371/journal.pone.0134242			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295480	gold, Green Published, Green Submitted			2022-12-26	WOS:000359926900009
J	Sanchez, C; Horcajada, MN; Scalfo, FM; Ameye, L; Offord, E; Henrotin, Y				Sanchez, Christelle; Horcajada, Marie-Noelle; Scalfo, Fanny Membrez; Ameye, Laurent; Offord, Elizabeth; Henrotin, Yves			Carnosol Inhibits Pro-Inflammatory and Catabolic Mediators of Cartilage Breakdown in Human Osteoarthritic Chondrocytes and Mediates Cross-Talk between Subchondral Bone Osteoblasts and Chondrocytes	PLOS ONE			English	Article							ARTICULAR CHONDROCYTES; ONCOSTATIN-M; INTERLEUKIN-6; TRANSCRIPTION; PATHWAY; ANTIOXIDANT; EXPRESSION; AGGRECAN; ROSEMARY; CELLS	Aim The aim of this work was to evaluate the effects of carnosol, a rosemary polyphenol, on pro-inflammatory and catabolic mediators of cartilage breakdown in chondrocytes and via bone-cartilage crosstalk. Materials and Methods Osteoarthritic (OA) human chondrocytes were cultured in alginate beads for 4 days in presence or absence of carnosol (6 nM to 9 mu M). The production of aggrecan, matrix metalloproteinase (MMP)-3, tissue inhibitor of metalloproteinase (TIMP)-1, interleukin (IL)-6 and nitric oxide (NO) and the expression of type II collagen and ADAMTS-4 and -5 were analyzed. Human osteoblasts from sclerotic (SC) or non-sclerotic (NSC) subchondral bone were cultured for 3 days in presence or absence of carnosol before co-culture with chondrocytes. Chondrocyte gene expression was analyzed after 4 days of co-culture. Results In chondrocytes, type II collagen expression was significantly enhanced in the presence of 3 mu M carnosol (p = 0.008). MMP-3, IL-6, NO production and ADAMTS-4 expression were down-regulated in a concentration-dependent manner by carnosol (p<0.01). TIMP-1 production was slightly increased at 3 mu M (p = 0.02) and ADAMTS-5 expression was decreased from 0.2 to 9 mu M carnosol (p<0.05). IL-6 and PGE(2) production was reduced in the presence of carnosol in both SC and NSC osteoblasts while alkaline phosphatase activity was not changed. In co-culture experiments preincubation of NSC and SC osteoblasts wih carnosol resulted in similar effects to incubation with anti-IL-6 antibody, namely a significant increase in aggrecan and decrease in MMP-3, ADAMTS-4 and -5 gene expression by chondrocytes. Conclusions Carnosol showed potent inhibition of pro-inflammatory and catabolic mediators of cartilage breakdown in chondrocytes. Inhibition of matrix degradation and enhancement of formation was observed in chondrocytes cocultured with subchondral osteoblasts preincubated with carnosol indicating a cross-talk between these two cellular compartments, potentially mediated via inhibition of IL-6 in osteoblasts as similar results were obtained with anti-IL-6 antibody.	[Sanchez, Christelle; Henrotin, Yves] Univ Liege, Bone & Cartilage Res Unit, Arthropole Liege, Liege, Belgium; [Horcajada, Marie-Noelle; Scalfo, Fanny Membrez; Ameye, Laurent; Offord, Elizabeth] Nestle Res Ctr, Nutr & Hlth, CH-1000 Lausanne, Switzerland; [Henrotin, Yves] Princess Paola Hosp, Phys Therapy & Rehabil Dept, Marche En Famenne, Belgium	University of Liege; Nestle SA	Henrotin, Y (corresponding author), Univ Liege, Bone & Cartilage Res Unit, Arthropole Liege, Liege, Belgium.	yhenrotin@ulg.ac.be		Henrotin, Yves/0000-0003-1073-449X; sanchez, christelle/0000-0002-1005-8172	Nestec; Nestle	Nestec(European CommissionEuropean Commission Joint Research Centre); Nestle(Nestle SA)	This project received a grant from Nestec. Nestec chose the compounds and doses evaluated in this study. Yves Henrotin who is the head of BCRU, received the funding. The funders also participated in study design, decision to publish and preparation of the manuscript preparation. Nestle provided support in the form of salaries for authors MNH, FMS, LA and EO, but did not have role in the data collection and analysis.	GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Guevremont M, 2003, J BONE MINER RES, V18, P1073, DOI 10.1359/jbmr.2003.18.6.1073; Hilal G, 1998, ARTHRITIS RHEUM, V41, P891, DOI 10.1002/1529-0131(199805)41:5<891::AID-ART17>3.0.CO;2-X; Huang SC, 2005, BIOCHEM PHARMACOL, V69, P221, DOI 10.1016/j.bcp.2004.09.019; Jiang J, 2005, BIOCHEM BIOPH RES CO, V338, P762, DOI 10.1016/j.bbrc.2005.10.025; Johnson JJ, 2011, CANCER LETT, V305, P1, DOI 10.1016/j.canlet.2011.02.005; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; Legendre F, 2003, J BIOL CHEM, V278, P2903, DOI 10.1074/jbc.M110773200; Liu-Bryan R, 2015, NAT REV RHEUMATOL, V11, P35, DOI 10.1038/nrrheum.2014.162; Lo AH, 2002, CARCINOGENESIS, V23, P983, DOI 10.1093/carcin/23.6.983; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Lopez-Jimenez A, 2013, EUR J NUTR, V52, P85, DOI 10.1007/s00394-011-0289-x; Martel-Pelletier J, 1999, OSTEOARTHRITIS CLIN, P156, DOI DOI 10.1007/978-3-642-60026-5_9; Martin D, 2004, J BIOL CHEM, V279, P8919, DOI 10.1074/jbc.M309660200; Massicotte F, 2002, OSTEOARTHR CARTILAGE, V10, P491, DOI 10.1053/joca.2002.0528; NIETFELD JJ, 1990, ARTHRITIS RHEUM, V33, P1695, DOI 10.1002/art.1780331113; OFFORD E, 2004, OXIDAT STRESS DIS, P457; Pesesse L, 2011, JOINT BONE SPINE, V78, P144, DOI 10.1016/j.jbspin.2010.07.001; Prasadam I, 2012, J RHEUMATOL, V39, P621, DOI 10.3899/jrheum.110777; Vaquero MR, 2013, MOL NUTR FOOD RES, V57, P1834, DOI 10.1002/mnfr.201300052; Sanchez C, 2005, OSTEOARTHR CARTILAGE, V13, P988, DOI 10.1016/j.joca.2005.07.012; Sanchez C, 2005, OSTEOARTHR CARTILAGE, V13, P979, DOI 10.1016/j.joca.2005.03.008; Sanchez C, 2004, OSTEOARTHR CARTILAGE, V12, P801, DOI 10.1016/j.joca.2004.06.011; Sanchez C, 2003, BIOCHEM PHARMACOL, V65, P377, DOI 10.1016/S0006-2952(02)01485-5; Sanchez C, 2008, ARTHRITIS RHEUM-US, V58, P442, DOI 10.1002/art.23159; SERTEYN D, 1988, VET RES COMMUN, V12, P219, DOI 10.1007/BF00362803; Subbaramaiah K, 2002, CANCER RES, V62, P2522; Takaki I, 2008, J MED FOOD, V11, P741, DOI 10.1089/jmf.2007.0524	28	22	25	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136118	10.1371/journal.pone.0136118	http://dx.doi.org/10.1371/journal.pone.0136118			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26292290	gold, Green Submitted, Green Published			2022-12-26	WOS:000359919900057
J	Bonaccorsi-Riani, E; Danger, R; Lozano, JJ; Martinez-Picola, M; Kodela, E; Mas-Malavila, R; Bruguera, M; Collins, HL; Hider, RC; Martinez-Llordella, M; Sanchez-Fueyo, A				Bonaccorsi-Riani, Eliano; Danger, Richard; Lozano, Juan Jose; Martinez-Picola, Marta; Kodela, Elisavet; Mas-Malavila, Roser; Bruguera, Miquel; Collins, Helen L.; Hider, Robert C.; Martinez-Llordella, Marc; Sanchez-Fueyo, Alberto			Iron Deficiency Impairs Intra-Hepatic Lymphocyte Mediated Immune Response	PLOS ONE			English	Article							KILLER T-CELLS; LIVER-INJURY; CONCANAVALIN-A; MICE; EXPRESSION; TOLERANCE; TRANSPLANTATION; ACTIVATION; MECHANISMS; HEPATITIS	Hepatic expression of iron homeostasis genes and serum iron parameters predict the success of immunosuppression withdrawal following clinical liver transplantation, a phenomenon known as spontaneous operational tolerance. In experimental animal models, spontaneous liver allograft tolerance is established through a process that requires intrahepatic lymphocyte activation and deletion. Our aim was to determine if changes in systemic iron status regulate intra-hepatic lymphocyte responses. We used a murine model of lymphocyte-mediated acute liver inflammation induced by Concanavalin A (ConA) injection employing mice fed with an iron-deficient (IrDef) or an iron-balanced diet (IrRepl). While the mild iron deficiency induced by the IrDef diet did not significantly modify the steady state immune cell repertoire and systemic cytokine levels, it significantly dampened inflammatory liver damage after ConA challenge. These findings were associated with a marked decrease in T cell and NKT cell activation following ConA injection in IrDef mice. The decreased liver injury observed in IrDef mice was independent from changes in the gut microflora, and was replicated employing an iron specific chelator that did not modify intrahepatic hepcidin secretion. Furthermore, low-dose iron chelation markedly impaired the activation of isolated T cells in vitro. All together, these results suggest that small changes in iron homeostasis can have a major effect in the regulation of intra-hepatic lymphocyte mediated responses.	[Bonaccorsi-Riani, Eliano; Danger, Richard; Kodela, Elisavet; Mas-Malavila, Roser; Martinez-Llordella, Marc; Sanchez-Fueyo, Alberto] Kings Coll London Univ, Kings Coll Hosp, Div Transplantat Immunol & Mucosal Biol,Dept Live, Med Res Council MRC,Ctr Transplantat,Fac Life Sci, London, England; [Lozano, Juan Jose; Martinez-Picola, Marta; Bruguera, Miquel] Hosp Clin Barcelona, Liver Unit, Barcelona, Spain; [Lozano, Juan Jose; Martinez-Picola, Marta; Bruguera, Miquel] Hosp Clin Barcelona, CIBEREHD, Bioinformat Platform, Barcelona, Spain; [Collins, Helen L.] Kings Coll London, Dept Immunobiol, Div Immunol Infect & Inflammatory Dis, Fac Life Sci & Med, London WC2R 2LS, England; [Hider, Robert C.] Kings Coll London, Inst Pharmaceut Sci, Fac Life Sci & Med, London WC2R 2LS, England	King's College Hospital NHS Foundation Trust; King's College Hospital; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; University of London; King's College London; University of London; King's College London	Sanchez-Fueyo, A (corresponding author), Kings Coll London Univ, Kings Coll Hosp, Div Transplantat Immunol & Mucosal Biol,Dept Live, Med Res Council MRC,Ctr Transplantat,Fac Life Sci, Denmark Hill, London, England.	sanchez_fueyo@kcl.ac.uk	RIANI, ELIANO BONACCORSI/J-4542-2019	Hider, Robert/0000-0003-1330-5797; Sanchez-Fueyo, Alberto/0000-0002-8316-3504; Lozano, Juan Jose/0000-0001-7613-3908; Danger, Richard/0000-0002-5058-795X	Medical Research Council (MRC) Centre for Transplantation, King's College London, UK - MRC [MR/J006742/1]; National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London; MRC [MR/L008890/1] Funding Source: UKRI; Medical Research Council [MR/L008890/1, MR/J006742/1] Funding Source: researchfish	Medical Research Council (MRC) Centre for Transplantation, King's College London, UK - MRC; National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Institute of Liver Studies (KCL) is supported by the Medical Research Council (MRC) Centre for Transplantation, King's College London, UK (transplantation.kcl.ac.uk) - MRC grant no. MR/J006742/1 and by the National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek JH, 2011, BBA-GENE REGUL MECH, V1809, P262, DOI 10.1016/j.bbagrm.2011.04.010; Benitez C, 2013, HEPATOLOGY, V58, P1824, DOI 10.1002/hep.26426; Benseler V, 2007, SEMIN LIVER DIS, V27, P194, DOI 10.1055/s-2007-979471; Bjorkholm B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006958; Bohne F, 2012, J CLIN INVEST, V122, P368, DOI 10.1172/JCI59411; Chen JN, 2014, SCI REP-UK, V4, DOI 10.1038/srep07259; Corbitt N, 2013, AM J PATHOL, V182, P180, DOI 10.1016/j.ajpath.2012.09.010; Crispe IN, 2003, NAT REV IMMUNOL, V3, P51, DOI 10.1038/nri981; De Domenico I, 2010, J CLIN INVEST, V120, P2395, DOI 10.1172/JCI42011; Evstatiev R, 2014, AM J HEMATOL, V89, P524, DOI 10.1002/ajh.23682; Fakih S, 2009, J PHARM SCI-US, V98, P2212, DOI 10.1002/jps.21583; Ganz T, 2013, PHYSIOL REV, V93, P1721, DOI 10.1152/physrev.00008.2013; Grant SM, 2003, J NUTR, V133, P2635, DOI 10.1093/jn/133.8.2635; HOFFBRAND AV, 1976, BRIT J HAEMATOL, V33, P517, DOI 10.1111/j.1365-2141.1976.tb03570.x; Ikeda Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089355; Imaizumi T, 2015, NEUROSCI RES, V94, P10, DOI 10.1016/j.neures.2015.01.001; Klein C, 2005, J CLIN INVEST, V115, P860, DOI 10.1172/JCI200523640; Kusters S, 1996, GASTROENTEROLOGY, V111, P462, DOI 10.1053/gast.1996.v111.pm8690213; KUVIBIDILA S, 1991, AM J CLIN NUTR, V54, P944, DOI 10.1093/ajcn/54.5.944; Kuvibidila SR, 1998, J NUTR, V128, P1077, DOI 10.1093/jn/128.7.1077; Li W, 2008, AM J TRANSPLANT, V8, P1639, DOI 10.1111/j.1600-6143.2008.02300.x; LUCAS JJ, 1995, BLOOD, V86, P2268, DOI 10.1182/blood.V86.6.2268.bloodjournal8662268; Minamiyama Y, 2010, AM J PHYSIOL-ENDOC M, V298, pE1140, DOI 10.1152/ajpendo.00620.2009; MIZUHARA H, 1994, J EXP MED, V179, P1529, DOI 10.1084/jem.179.5.1529; Nairz M, 2009, CELL MICROBIOL, V11, P1365, DOI 10.1111/j.1462-5822.2009.01337.x; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Oexle H, 2003, J LEUKOCYTE BIOL, V74, P287, DOI 10.1189/jlb.0802420; Otogawa K, 2008, AM J PHYSIOL-REG I, V294, pR311, DOI 10.1152/ajpregu.00735.2007; Pagani A, 2011, BLOOD, V118, P736, DOI 10.1182/blood-2011-02-337212; Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109; Sass G, 2002, CYTOKINE, V19, P115, DOI 10.1006/cyto.2002.1948; Sato T, 2011, HEPATOL RES, V41, P660, DOI 10.1111/j.1872-034X.2011.00821.x; Tiegs G., 1992, CLIN INVESTIGATOR, V90, P196, DOI DOI 10.1172/JCI115836; Tompkins GR, 2001, CURR MICROBIOL, V43, P38, DOI 10.1007/s002840010257; Wang HX, 2012, WORLD J GASTROENTERO, V18, P119, DOI 10.3748/wjg.v18.i2.119; Wang LJ, 2009, J CLIN INVEST, V119, P3322, DOI 10.1172/JCI39939; Wilson MT, 2003, P NATL ACAD SCI USA, V100, P10913, DOI 10.1073/pnas.1833166100	37	33	33	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136106	10.1371/journal.pone.0136106	http://dx.doi.org/10.1371/journal.pone.0136106			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287688	gold, Green Published			2022-12-26	WOS:000360018600109
J	Gilbert, CC; Steininger, CM; Kibii, JM; Berger, LR				Gilbert, Christopher C.; Steininger, Christine M.; Kibii, Job M.; Berger, Lee R.			Papio Cranium from the Hominin-Bearing Site of Malapa: Implications for the Evolution of Modern Baboon Cranial Morphology and South African Plio-Pleistocene Biochronology	PLOS ONE			English	Article							AUSTRALOPITHECUS-SEDIBA; FOSSIL CERCOPITHECIDAE; AFAR REGION; PHYLOGEOGRAPHY; STERKFONTEIN; SYSTEMATICS; ASSEMBLAGE; PHYLOGENY; AGE	A new partial cranium (UW 88-886) of the Plio-Pleistocene baboon Papio angusticeps from Malapa is identified, described and discussed. UW 88-886 represents the only non-hominin primate yet recovered from Malapa and is important both in the context of baboon evolution as well as South African hominin site biochronology. The new specimen may represent the first appearance of modern baboon anatomy and coincides almost perfectly with molecular divergence date estimates for the origin of the modern P. hamadryas radiation. The fact that the Malapa specimen is dated between similar to 2.026-2.36 million years ago (Ma) also has implications for the biochronology of other South African Plio-Pleistocene sites where P. angusticeps is found.	[Gilbert, Christopher C.] CUNY Hunter Coll, Dept Anthropol, New York, NY 10065 USA; [Gilbert, Christopher C.] CUNY, Grad Ctr, PhD Programs Anthropol & Biol, New York, NY 10016 USA; [Gilbert, Christopher C.] New York Consortium Evolutionary Primatol, New York, NY USA; [Steininger, Christine M.; Kibii, Job M.; Berger, Lee R.] Univ Witwatersrand, Evolutionary Studies Inst, ZA-2050 Johannesburg, Johannesburg, South Africa	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; University of Witwatersrand	Gilbert, CC (corresponding author), CUNY Hunter Coll, Dept Anthropol, 695 Pk Ave, New York, NY 10065 USA.	cgilbert@hunter.cuny.edu	Berger, Lee Rogers/AAC-3484-2020; Steininger, Christoph/U-8815-2019	Berger, Lee Rogers/0000-0002-0367-7629; Steininger, Christoph/0000-0003-3500-7205; Gilbert, Christopher/0000-0001-8768-3171; Steininger, Christine/0000-0002-9082-0672	National Geographic Society; National Research Foundation of South Africa; Lyda Hill Foundation; DST-NRF Centre of Excellence in Palaeosciences; Gauteng Provincial Government; Department of Arts and Culture of South Africa; Hunter College; Wenner-Gren Foundation	National Geographic Society(National Geographic Society); National Research Foundation of South Africa(National Research Foundation - South Africa); Lyda Hill Foundation; DST-NRF Centre of Excellence in Palaeosciences; Gauteng Provincial Government; Department of Arts and Culture of South Africa; Hunter College; Wenner-Gren Foundation	Funding for the Malapa project was generously provided by the National Geographic Society, the National Research Foundation of South Africa, the Lyda Hill Foundation, the DST-NRF Centre of Excellence in Palaeosciences, the Gauteng Provincial Government and the Department of Arts and Culture of South Africa. Funding for CCG was generously provided by Hunter College and the Wenner-Gren Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JW, 2013, J HUM EVOL, V64, P693, DOI 10.1016/j.jhevol.2013.02.009; Alemseged Z, 2000, CR ACAD SCI II A, V331, P549, DOI 10.1016/S1251-8050(00)01450-6; BEHRENSMEYER AK, 1978, PALEOBIOLOGY, V4, P150, DOI 10.1017/S0094837300005820; Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; BERGER LR, 1993, AM J PHYS ANTHROPOL, V92, P107, DOI 10.1002/ajpa.1330920109; Berger LR, 2002, AM J PHYS ANTHROPOL, V119, P192, DOI 10.1002/ajpa.10156; BROWN FH, 1985, ANCESTORS HARD EVIDE, P82; Brugal JP, 2003, CR PALEVOL, V2, P675, DOI 10.1016/j.crpv.2003.09.028; Carlson KJ, 2011, SCIENCE, V333, P1402, DOI 10.1126/science.1203922; Churchill SE, 2013, SCIENCE, V340, DOI 10.1126/science.1233477; de Ruiter DJ, 2013, SCIENCE, V340, DOI 10.1126/science.1232997; Delson E., 1988, P317; Delson E., 1984, Courier Forschungsinstitut Senckenberg, V69, P199; Delson Eric, 2000, Anthropological Papers of the American Museum of Natural History, V83, P1; DeSilva JM, 2013, SCIENCE, V340, DOI 10.1126/science.1232999; Dirks PHGM, 2010, SCIENCE, V328, P205, DOI 10.1126/science.1184950; EISENHART WL, 1974, THESIS HARVARD COLL; Freedman L., 1957, Annals of the Transvaal Museum, V23, P121; Frost SR, 2003, ANAT REC PART A, V275A, P1048, DOI 10.1002/ar.a.10112; Frost SR, 2007, J HUM EVOL, V53, P227, DOI 10.1016/j.jhevol.2007.02.003; Frost SR, 2007, AM J PHYS ANTHROPOL, V134, P460, DOI 10.1002/ajpa.20688; Gilbert CC, 2013, AM J PHYS ANTHROPOL, V150, P129; Gilbert CC, 2013, J HUM EVOL, V64, P399, DOI 10.1016/j.jhevol.2013.01.013; Granger DE, 2015, NATURE, V522, P85, DOI 10.1038/nature14268; Harrison T, 2011, VERTEBR PALEOBIOL PA, P83, DOI 10.1007/978-90-481-9962-4_6; Hartstone-Rose Adam, 2013, Transactions of the Royal Society of South Africa, V68, P1, DOI 10.1080/0035919X.2012.748698; Heaton JL., 2006, THESIS INDIANA U BLO; Herries AIR, 2014, S AFR J SCI, V110, P40, DOI 10.1590/sajs.2014/20130102; Herries Andy I.R., 2013, P21; Herries AIR, 2009, QUATERN INT, V202, P14, DOI 10.1016/j.quaint.2008.05.017; Irish JD, 2013, SCIENCE, V340, DOI 10.1126/science.1233062; JABLONSKI N. G., 2008, KOOBI FORA RES PROJE, V6, P397; Jablonski NG, 2002, CAM S BIO EVOL ANTHR, V33, P255; Keyser AW, 2000, S AFR J SCI, V96, P193; Kibii JM, 2011, SCIENCE, V333, P1407, DOI 10.1126/science.1202521; Kivell TL, 2011, SCIENCE, V333, P1411, DOI 10.1126/science.1202625; Kuhn BF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026940; Leakey M.G., 1976, Fossil Vertebr Afr, V4, P121; Leakey M.G., 1987, P91; McKee Jeffrey K., 1993, Palaeontologia Africana, V30, P43; MCKEE JK, 1994, INT J PRIMATOL, V15, P823, DOI 10.1007/BF02736070; MCKEE JK, 1995, AM J PHYS ANTHROPOL, V96, P235, DOI 10.1002/ajpa.1330960303; Newman TK, 2004, AM J PHYS ANTHROPOL, V124, P17, DOI 10.1002/ajpa.10340; Pickering R, 2011, SCIENCE, V333, P1421, DOI 10.1126/science.1203697; Remane A, 1925, WISSENSCHAFTLICHE ER, V2, P83; Schmid P, 2013, SCIENCE, V340, DOI 10.1126/science.1234598; SZALAY F. S., 1979, EVOLUTIONARY HIST PR; Wildman DE, 2004, MOL PHYLOGENET EVOL, V32, P287, DOI 10.1016/j.ympev.2003.12.014; Williams BA, 2012, AM J PHYS ANTHROPOL, V149, P1, DOI 10.1002/ajpa.22093; Williams SA, 2013, SCIENCE, V340, DOI 10.1126/science.1232996; Zinner D, 2013, AM J PHYS ANTHROPOL, V150, P133, DOI 10.1002/ajpa.22185; Zinner D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-83; Zipfel B, 2011, SCIENCE, V333, P1417, DOI 10.1126/science.1202703	53	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0133361	10.1371/journal.pone.0133361	http://dx.doi.org/10.1371/journal.pone.0133361			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287673	Green Published, gold			2022-12-26	WOS:000360018600005
J	Gomez-Grau, M; Garrido, E; Cozar, M; Rodriguez-Sureda, V; Dominguez, C; Arenas, C; Gatti, RA; Cormand, B; Grinberg, D; Vilageliu, L				Gomez-Grau, Marta; Garrido, Elena; Cozar, Monica; Rodriguez-Sureda, Victor; Dominguez, Carmen; Arenas, Concepcion; Gatti, Richard A.; Cormand, Bru; Grinberg, Daniel; Vilageliu, Lluisa			Evaluation of Aminoglycoside and Non-Aminoglycoside Compounds for Stop-Codon Readthrough Therapy in Four Lysosomal Storage Diseases	PLOS ONE			English	Article							MAROTEAUX-LAMY-SYNDROME; MPS I-H; READ-THROUGH; NONSENSE MUTATIONS; SUPPRESSION; IDENTIFICATION; GENE; GENTAMICIN; SPANISH; STRATEGIES	Nonsense mutations are quite prevalent in inherited diseases. Readthrough drugs could provide a therapeutic option for any disease caused by this type of mutation. Geneticin (G418) and gentamicin were among the first to be described. Novel compounds have been generated, but only a few have shown improved results. PTC124 is the only compound to have reached clinical trials. Here we first investigated the readthrough effects of gentamicin on fibroblasts from one patient with Sanfilippo B, one with Sanfilippo C, and one with Maroteaux-Lamy. We found that ARSB activity (Maroteaux-Lamy case) resulted in an increase of 2-3 folds and that the amount of this enzyme within the lysosomes was also increased, after treatment. Since the other two cases (Sanfilippo B and Sanfilippo C) did not respond to gentamicin, the treatments were extended with the use of geneticin and five non-aminoglycoside (PTC124, RTC13, RTC14, BZ6 and BZ16) readthrough compounds (RTCs). No recovery was observed at the enzyme activity level. However, mRNA recovery was observed in both cases, nearly a two-fold increase for Sanfilippo B fibroblasts with G418 and around 1.5 fold increase for Sanfilippo C cells with RTC14 and PTC124. Afterwards, some of the products were assessed through in vitro analyses for seven mutations in genes responsible for those diseases and, also, for Niemann-Pick A/B. Using the coupled transcription/translation system (TNT), the best results were obtained for SMPD1 mutations with G418, reaching a 35% recovery at 0.25 mu g/ml, for the p.W168X mutation. The use of COS cells transfected with mutant cDNAs gave positive results for most of the mutations with some of the drugs, although to a different extent. The higher enzyme activity recovery, of around two-fold increase, was found for gentamicin on the ARSB p.W146X mutation. Our results are promising and consistent with those of other groups. Further studies of novel compounds are necessary to find those with more consistent efficacy and fewer toxic effects.	[Gomez-Grau, Marta; Garrido, Elena; Cozar, Monica; Cormand, Bru; Grinberg, Daniel; Vilageliu, Lluisa] Univ Barcelona, Fac Biol, Dept Genet, IBUB,CIBERER, Barcelona, Spain; [Rodriguez-Sureda, Victor; Dominguez, Carmen] Hosp Univ Vall dHebron, CIBERER, CIBBIM Nanomed, VHIR, Barcelona, Spain; [Arenas, Concepcion] Univ Barcelona, Fac Biol, Dept Estadist, Barcelona, Spain; [Gatti, Richard A.] David Geffen UCLA Sch Med, Dept Pathol & Lab Med, Los Angeles, CA USA; [Gatti, Richard A.] David Geffen UCLA Sch Med, Dept Human Genet, Los Angeles, CA USA	CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Grinberg, D (corresponding author), Univ Barcelona, Fac Biol, Dept Genet, IBUB,CIBERER, Barcelona, Spain.	dgrinberg@ub.edu	Grinberg, Daniel/F-3641-2010; Arenas, Concepcion/H-5579-2015; Cormand, Bru/H-5338-2015	Grinberg, Daniel/0000-0001-9859-2590; Arenas, Concepcion/0000-0002-6489-4934; Cormand, Bru/0000-0001-5318-4382	Spanish Ministry of Science and Innovation [SAF2010-17589, SAF2011-25431]; Catalan Government [2009SGR971]; Jonah's Just Begun-Foundation; Jonah's Just Begun-Foundation to Cure Sanfilippo Inc. (USA); Association Sanfilippo Sud (France); Fundacion Stop Sanfilippo (Spain); Asociacion MPS Espana (Spain); APRAT (A-T, France); A-T Ease (A-T, New York, USA); BioMarin; University of Barcelona (APIF)	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Catalan Government; Jonah's Just Begun-Foundation; Jonah's Just Begun-Foundation to Cure Sanfilippo Inc. (USA); Association Sanfilippo Sud (France); Fundacion Stop Sanfilippo (Spain); Asociacion MPS Espana (Spain); APRAT (A-T, France); A-T Ease (A-T, New York, USA); BioMarin; University of Barcelona (APIF)	Funding: This study was partially funded by grants from the Spanish Ministry of Science and Innovation (SAF2010-17589, SAF2011-25431) and from the Catalan Government (2009SGR971), and by financial support from 'patient-support' associations, such as Jonah's Just Begun-Foundation to Cure Sanfilippo Inc. (USA), Association Sanfilippo Sud (France), Fundacion Stop Sanfilippo (Spain), Asociacion MPS Espana (Spain), APRAT (A-T, France), and A-T Ease (A-T, New York, USA). RAG was partially supported by a Sponsored Research Grant for readthrough drug development from BioMarin. MGG was supported by a grant from the University of Barcelona (APIF).	Allamand V, 2008, J GENE MED, V10, P217, DOI 10.1002/jgm.1140; Bartolomeo R, 2013, J INHERIT METAB DIS, V36, P363, DOI 10.1007/s10545-012-9521-y; Barton-Davis ER, 1999, J CLIN INVEST, V104, P375, DOI 10.1172/JCI7866; Bellais S, 2010, EUR J HUM GENET, V18, P130, DOI 10.1038/ejhg.2009.122; Bidou L, 2004, GENE THER, V11, P619, DOI 10.1038/sj.gt.3302211; Bidou L, 2012, TRENDS MOL MED, V18, P679, DOI 10.1016/j.molmed.2012.09.008; Bordeira-Carrico R, 2012, TRENDS MOL MED, V18, P667, DOI 10.1016/j.molmed.2012.09.004; Boustany RMN, 2013, NAT REV NEUROL, V9, P583, DOI 10.1038/nrneurol.2013.163; Brooks DA, 2006, TRENDS MOL MED, V12, P367, DOI 10.1016/j.molmed.2006.06.001; Buck NE, 2009, MOL GENET METAB, V97, P244, DOI 10.1016/j.ymgme.2009.04.004; Coll MJ, 2001, J INHERIT METAB DIS, V24, P83, DOI 10.1023/A:1005627311402; de Winter JCF, 2013, PRACTICAL ASSESSMENT, V18, P1; Dranchak PK, 2011, J CELL BIOCHEM, V112, P1250, DOI 10.1002/jcb.22979; Du LT, 2013, MOL THER, V21, P1653, DOI 10.1038/mt.2013.150; Du LT, 2009, J EXP MED, V206, P2285, DOI 10.1084/jem.20081940; Du M, 2008, P NATL ACAD SCI USA, V105, P2064, DOI 10.1073/pnas.0711795105; Du M, 2006, J MOL MED, V84, P573, DOI 10.1007/s00109-006-0045-5; Fan XL, 2006, AM J HUM GENET, V79, P738, DOI 10.1086/508068; Finkel RS, 2010, J CHILD NEUROL, V25, P1158, DOI 10.1177/0883073810371129; Floquet C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002608; Floquet C, 2011, NUCLEIC ACIDS RES, V39, P3350, DOI 10.1093/nar/gkq1277; Garrido E, 2008, MOL GENET METAB, V94, P305, DOI 10.1016/j.ymgme.2008.02.012; Garrido E, 2007, MOL GENET METAB, V92, P122, DOI 10.1016/j.ymgme.2007.06.002; Gatti RA, 2012, ANN NY ACAD SCI, V1250, P33, DOI 10.1111/j.1749-6632.2012.06467.x; Goldmann T, 2011, HUM GENE THER, V22, P537, DOI 10.1089/hum.2010.067; Gregory-Evans CY, 2014, J CLIN INVEST, V124, P111, DOI 10.1172/JCI70462; Gunn G, 2014, MOL GENET METAB, V111, P374, DOI 10.1016/j.ymgme.2013.12.007; Hein LK, 2004, J MOL BIOL, V338, P453, DOI 10.1016/j.jmb.2004.03.012; Howard M, 1996, NAT MED, V2, P467, DOI 10.1038/nm0496-467; Howard MT, 2000, ANN NEUROL, V48, P164, DOI 10.1002/1531-8249(200008)48:2<164::AID-ANA5>3.3.CO;2-2; Hrebicek M, 2006, AM J HUM GENET, V79, P807, DOI 10.1086/508294; Jung ME, 2011, BIOORG MED CHEM LETT, V21, P5842, DOI 10.1016/j.bmcl.2011.07.107; Kayali R, 2012, HUM MOL GENET, V21, P4007, DOI 10.1093/hmg/dds223; Keeling KM, 2014, ANNU REV GENOM HUM G, V15, P371, DOI 10.1146/annurev-genom-091212-153527; Keeling KM, 2001, HUM MOL GENET, V10, P291, DOI 10.1093/hmg/10.3.291; KLEIN U, 1978, P NATL ACAD SCI USA, V75, P5185, DOI 10.1073/pnas.75.10.5185; Kuschal C, 2013, P NATL ACAD SCI USA, V110, P19483, DOI 10.1073/pnas.1312088110; Lai CH, 2004, P NATL ACAD SCI USA, V101, P15676, DOI 10.1073/pnas.0405155101; Lee HLR, 2012, PHARMACOL THERAPEUT, V136, P227, DOI 10.1016/j.pharmthera.2012.07.007; Manuvakhova M, 2000, RNA, V6, P1044, DOI 10.1017/S1355838200000716; Matalonga L, 2014, J INHERIT METAB DIS, V37, P439, DOI 10.1007/s10545-013-9668-1; Matos L, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0180-y; Mattis VB, 2006, HUM GENET, V120, P589, DOI 10.1007/s00439-006-0245-7; McElroy SP, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001593; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; Nudelman I, 2010, BIOORGAN MED CHEM, V18, P3735, DOI 10.1016/j.bmc.2010.03.060; Nudelman I, 2009, J MED CHEM, V52, P2836, DOI 10.1021/jm801640k; Ouesleti S, 2011, CLIN CHIM ACTA, V412, P2326, DOI 10.1016/j.cca.2011.08.032; Peltz SW, 2013, ANNU REV MED, V64, P407, DOI 10.1146/annurev-med-120611-144851; Rodriguez-Pascau L, 2009, HUM MUTAT, V30, P1117, DOI 10.1002/humu.21018; Ruijter GJG, 2008, MOL GENET METAB, V93, P104, DOI 10.1016/j.ymgme.2007.09.011; Sanchez-Alcudia R, 2012, HUM MUTAT, V33, P973, DOI 10.1002/humu.22047; SCHUCHMAN EH, 1995, HUM MUTAT, V6, P352, DOI 10.1002/humu.1380060412; Schuchman EH, 2001, METABOLIC MOL BASES, V3, P3589; Tan L, 2011, J INHERIT METAB DIS, V34, P443, DOI 10.1007/s10545-010-9265-5; Villani GRD, 1999, BBA-MOL BASIS DIS, V1453, P185, DOI 10.1016/S0925-4439(98)00099-4; Voskoboeva E. Yu., 2000, Genetika, V36, P837; Wang D, 2012, MOL GENET METAB, V105, P116, DOI 10.1016/j.ymgme.2011.10.005; Welch EM, 2007, NATURE, V447, P87, DOI 10.1038/nature05756	59	23	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135873	10.1371/journal.pone.0135873	http://dx.doi.org/10.1371/journal.pone.0135873			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287674	Green Submitted, gold, Green Published			2022-12-26	WOS:000360018600079
J	Mai, M; Wang, K; Huber, G; Kirby, M; Shattuck, MD; O'Hern, CS				Mai, Manuel; Wang, Kun; Huber, Greg; Kirby, Michael; Shattuck, Mark D.; O'Hern, Corey S.			Outcome Prediction in Mathematical Models of Immune Response to Infection	PLOS ONE			English	Article							ACUTE INFLAMMATORY RESPONSE; A VIRUS-INFECTION; DYNAMICS IN-VIVO; HIV-1 INFECTION; TUBERCULOSIS; INNATE; MEMORY	Clinicians need to predict patient outcomes with high accuracy as early as possible after disease inception. In this manuscript, we show that patient-to-patient variability sets a fundamental limit on outcome prediction accuracy for a general class of mathematical models for the immune response to infection. However, accuracy can be increased at the expense of delayed prognosis. We investigate several systems of ordinary differential equations (ODEs) that model the host immune response to a pathogen load. Advantages of systems of ODEs for investigating the immune response to infection include the ability to collect data on large numbers of 'virtual patients', each with a given set of model parameters, and obtain many time points during the course of the infection. We implement patient-to-patient variability v in the ODE models by randomly selecting the model parameters from distributions with coefficients of variation v that are centered on physiological values. We use logistic regression with one-versus-all classification to predict the discrete steady-state outcomes of the system. We find that the prediction algorithm achieves near 100% accuracy for v = 0, and the accuracy decreases with increasing v for all ODE models studied. The fact that multiple steady-state outcomes can be obtained for a given initial condition, i.e. the basins of attraction overlap in the space of initial conditions, limits the prediction accuracy for v > 0. Increasing the elapsed time of the variables used to train and test the classifier, increases the prediction accuracy, while adding explicit external noise to the ODE models decreases the prediction accuracy. Our results quantify the competition between early prognosis and high prediction accuracy that is frequently encountered by clinicians.	[Mai, Manuel; O'Hern, Corey S.] Yale Univ, Dept Phys, New Haven, CT 06520 USA; [Wang, Kun; Kirby, Michael] Colorado State Univ, Dept Math, Ft Collins, CO 80523 USA; [Wang, Kun; Shattuck, Mark D.; O'Hern, Corey S.] Yale Univ, Dept Mech Engn & Mat Sci, New Haven, CT USA; [Huber, Greg] Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA; [Kirby, Michael] Colorado State Univ, Dept Comp Sci, Ft Collins, CO 80523 USA; [Shattuck, Mark D.] CUNY, Benjamin Levich Inst, New York, NY 10021 USA; [Shattuck, Mark D.] CUNY, Dept Phys, New York, NY 10021 USA; [O'Hern, Corey S.] Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA; [O'Hern, Corey S.] Yale Univ, Grad Program Computat Biol & Bioinformat, New Haven, CT USA	Yale University; Colorado State University; Yale University; University of California System; University of California Santa Barbara; Colorado State University; City University of New York (CUNY) System; City University of New York (CUNY) System; Yale University; Yale University	Mai, M (corresponding author), Yale Univ, Dept Phys, New Haven, CT 06520 USA.	manuel.mai@yale.edu	Shattuck, Mark D/F-5680-2015; O'Hern, Corey/I-3459-2014	Shattuck, Mark D/0000-0001-8473-2505; O'Hern, Corey/0000-0002-8272-5640	DARPA (Space and Naval Warfare System Center Pacific) [N66001-11-1-4184]; National Science Foundation [NSF PHY11-25915]; Yale University; Infectious Disease Supercluster, Colorado State University; NSF [CNS-0821132]	DARPA (Space and Naval Warfare System Center Pacific); National Science Foundation(National Science Foundation (NSF)); Yale University; Infectious Disease Supercluster, Colorado State University; NSF(National Science Foundation (NSF))	Funding: This work was partially supported by DARPA (Space and Naval Warfare System Center Pacific, http://www.darpa.mil) under award number N66001-11-1-4184 (M.S., M.K., G.H., and C.O.) and partially supported by the National Science Foundation Grant (www.nsf.gov) No. NSF PHY11-25915 (M.S., C.O., and G.H.). Additional support for this work was provided by Yale University (www.yale.edu) (M.M.) and the Infectious Disease Supercluster, Colorado State University, 2012 seed grant (http://infectiousdisease.colostate.edu/pages/clusters.aspx) (K.W. and M.K.). This work also benefited from the facilities and staff of the Yale University Faculty of Arts and Sciences High Performance Computing Center and NSF Grant No. CNS-0821132 that partially funded acquisition of the computational facilities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belz GT, 2002, J VIROL, V76, P12388, DOI 10.1128/JVI.76.23.12388-12393.2002; BOCHAROV GA, 1994, J THEOR BIOL, V167, P323, DOI 10.1006/jtbi.1994.1074; Callaway DS, 2002, B MATH BIOL, V64, P29, DOI 10.1006/bulm.2001.0266; CastilloChavez C, 1997, J MATH BIOL, V35, P629, DOI 10.1007/s002850050069; Day J, 2006, J THEOR BIOL, V242, P237, DOI 10.1016/j.jtbi.2006.02.015; Dowdy DW, 2006, AIDS, V20, P751, DOI 10.1097/01.aids.0000216376.07185.cc; Guidotti LG, 2001, ANNU REV IMMUNOL, V19, P65, DOI 10.1146/annurev.immunol.19.1.65; Hancioglu B, 2007, J THEOR BIOL, V246, P70, DOI 10.1016/j.jtbi.2006.12.015; Hastie T., 2009, UNSUPERVISED LEARNIN; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Klipp E, 2005, SYSTEMS BIOLOGY IN PRACTICE: CONCEPTS, IMPLEMENTATION AND APPLICATION, P1, DOI 10.1002/3527603603; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Nelson PW, 2002, MATH BIOSCI, V179, P73, DOI 10.1016/S0025-5564(02)00099-8; O'Hara S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-832; Perelson AS, 1999, SIAM REV, V41, P3, DOI 10.1137/S0036144598335107; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Perelson AS, 2002, NAT REV IMMUNOL, V2, P28, DOI 10.1038/nri700; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; Reynolds A, 2006, J THEOR BIOL, V242, P220, DOI 10.1016/j.jtbi.2006.02.016; Serdobova I, 2006, AM J PUBLIC HEALTH, V96, P1554, DOI 10.2105/AJPH.2005.074583; Vodovotz Y, 2009, MATH BIOSCI, V217, P1, DOI 10.1016/j.mbs.2008.07.013; Vodovotz Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000014; Wang K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082700; Webb GF, 2005, P NATL ACAD SCI USA, V102, P13343, DOI 10.1073/pnas.0504053102; Wetterstrand K.A., DNA SEQUENCING COSTS; Wodarz D, 2002, BIOESSAYS, V24, P1178, DOI 10.1002/bies.10196; Young D, 2008, NAT REV MICROBIOL, V6, P520, DOI 10.1038/nrmicro1919	28	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135861	10.1371/journal.pone.0135861	http://dx.doi.org/10.1371/journal.pone.0135861			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287609	Green Submitted, gold, Green Published			2022-12-26	WOS:000360018600078
J	Schnitzler, F; Friedrich, M; Stallhofer, J; Schonermarck, U; Fischereder, M; Habicht, A; Karbalai, N; Wolf, C; Angelberger, M; Olszak, T; Beigel, F; Tillack, C; Goke, B; Zachoval, R; Denk, G; Guba, M; Rust, C; Gruner, N; Brand, S				Schnitzler, Fabian; Friedrich, Matthias; Stallhofer, Johannes; Schoenermarck, Ulf; Fischereder, Michael; Habicht, Antje; Karbalai, Nazanin; Wolf, Christiane; Angelberger, Marianne; Olszak, Torsten; Beigel, Florian; Tillack, Cornelia; Goeke, Burkhard; Zachoval, Reinhart; Denk, Gerald; Guba, Markus; Rust, Christian; Gruener, Norbert; Brand, Stephan			Solid Organ Transplantation in Patients with Inflammatory Bowel Diseases (IBD): Analysis of Transplantation Outcome and IBD Activity in a Large Single Center Cohort	PLOS ONE			English	Article							PRIMARY SCLEROSING CHOLANGITIS; ORTHOTOPIC LIVER-TRANSPLANTATION; HEMOLYTIC-UREMIC SYNDROME; ULCERATIVE-COLITIS; CLINICAL-COURSE; KIDNEY-TRANSPLANTATION; CROHNS-DISEASE; RISK-FACTORS; CASE SERIES; IMMUNOSUPPRESSION	Background Currently, limited data of the outcome of inflammatory bowel disease (IBD) in patients after solid organ transplantation (SOT) are available. We aimed to analyze effects of SOT on the IBD course in a large IBD patient cohort. Methods Clinical data from 1537 IBD patients were analyzed for patients who underwent SOT (n = 31) between July 2002 and May 2014. Sub-analyses included SOT outcome parameters, IBD activity before and after SOT, and efficacy of IBD treatment. Results 4.74% of patients with ulcerative colitis (UC) and 0.84% of patients with Crohn's disease (CD) underwent SOT (p = 2.69 x 10(-6), UC vs. CD). 77.4% of patients with SOT underwent liver transplantation (LTx) with tacrolimus-based immunosuppressive therapy after SOT. All LTx were due to primary sclerosing cholangitis (PSC) or PSC overlap syndromes. Six patients (19.4%) required renal transplantation and one patient (3.2%) heart transplantation. A survival rate of 83.9% after a median follow-up period of 103 months was observed. Before SOT, 65.0% of patients were in clinical remission and 5 patients received immunosuppressive therapy (16.1%). After SOT, 61.0% of patients were in remission (p = 1.00 vs. before SOT) and 29.0% required IBD-specific immunosuppressive or anti-TNF therapy (p = 0.54 vs. before SOT). 42.9% of patients with worsening of IBD after SOT were at higher risk of needing steroid therapy for increased IBD activity (p = 0.03; relative risk (RR): 10.29; 95% CI 1.26-84.06). Four patients (13.0%) needed anti-TNF therapy after SOT (response rate 75%). Conclusions SOT was more common in UC patients due to the higher prevalence of PSC-related liver cirrhosis in UC. Despite mainly tacrolimus-based immunosuppressive regimens, outcome of SOT and IBD was excellent in this cohort. In this SOT cohort, concomitant immunosuppressive therapy due to IBD was well tolerated.	[Schnitzler, Fabian; Friedrich, Matthias; Stallhofer, Johannes; Angelberger, Marianne; Olszak, Torsten; Beigel, Florian; Tillack, Cornelia; Goeke, Burkhard; Denk, Gerald; Gruener, Norbert; Brand, Stephan] Univ Munich, Dept Med Grosshadern 2, Munich, Germany; [Friedrich, Matthias] Univ Munich, Dept Prevent Dent & Periodontol, Munich, Germany; [Schoenermarck, Ulf; Fischereder, Michael] Univ Munich, Dept Med Nephrol Grosshadern 4, Munich, Germany; [Fischereder, Michael; Habicht, Antje; Zachoval, Reinhart; Denk, Gerald; Guba, Markus; Gruener, Norbert] Univ Munich, Transplantat Ctr Grosshadern, Munich, Germany; [Karbalai, Nazanin; Wolf, Christiane] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Guba, Markus] Univ Munich, Dept Surg Grosshadern, Munich, Germany; [Rust, Christian] Hosp Barmherzige Bruder, Dept Gastroenterol, Munich, Germany	University of Munich; University of Munich; University of Munich; University of Munich; Max Planck Society; University of Munich	Brand, S (corresponding author), Univ Munich, Dept Med Grosshadern 2, Munich, Germany.	stephan.brand@med.uni-muenchen.de	Mirza-Schreiber, Nazanin/AAD-1563-2022; Schönermarck, Ulf/AAE-6590-2020; Mirza-Schreiber, Nazanin/AAD-1558-2022; Zachoval, Roman/Q-6488-2016; Guba, Markus/M-4309-2019	Mirza-Schreiber, Nazanin/0000-0003-0836-8267; Zachoval, Roman/0000-0003-0906-269X; Schonermarck, Ulf/0000-0002-3266-9791; Stallhofer, Johannes/0000-0001-8698-6103	Deutsche Forschungsgemeinschaft (DFG) [BR1912/6-1, OL/324-1]; Else-Kroner-Fresenius-Stiftung (Else Kroner-Exzellenzstipendium) [2010_EKES.32]; DFG [BE 4490/2-1]; Ludwig-Maximilians-University Munich	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Else-Kroner-Fresenius-Stiftung (Else Kroner-Exzellenzstipendium); DFG(German Research Foundation (DFG)); Ludwig-Maximilians-University Munich	Funding: S. Brand was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) (BR1912/6-1) and the Else-Kroner-Fresenius-Stiftung (Else Kroner-Exzellenzstipendium 2010_EKES.32). F. Beigel was supported by DFG (BE 4490/2-1). C. Tillack was supported by a grant of Ludwig-Maximilians-University Munich (FoFoLe program). T. Olszak was supported by a grant from Deutsche Forschungsgemeinschaft (DFG, OL/324-1) and by a grant from the Ludwig-Maximilians-University Munich (FoFoLe program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambruzs JM, 2014, CLIN J AM SOC NEPHRO, V9, P265, DOI 10.2215/CJN.04660513; Azevedo P, 2013, TRANSPL P, V45, P1084, DOI 10.1016/j.transproceed.2013.03.008; Befeler AS, 1998, TRANSPLANTATION, V65, P393, DOI 10.1097/00007890-199802150-00017; Bergquist A, 2002, J HEPATOL, V36, P321, DOI 10.1016/S0168-8278(01)00288-4; Boonstra K, 2012, INFLAMM BOWEL DIS, V18, P2270, DOI 10.1002/ibd.22938; BROOME U, 1995, HEPATOLOGY, V22, P1404, DOI 10.1016/0270-9139(95)90144-2; Broome U, 2006, SEMIN LIVER DIS, V26, P31, DOI 10.1055/s-2006-933561; Cholongitas E, 2007, LIVER TRANSPLANT, V13, P552, DOI 10.1002/lt.21077; Dvorchik I, 2002, HEPATOLOGY, V35, P380, DOI 10.1053/jhep.2002.30695; Eaton JE, 2013, GASTROENTEROLOGY, V145, P521, DOI 10.1053/j.gastro.2013.06.052; El-Nachef N, 2010, AM J GASTROENTEROL, V105, P1210, DOI 10.1038/ajg.2010.33; GAVALER JS, 1991, DIGEST DIS SCI, V36, P321, DOI 10.1007/BF01318204; Gheith O, 2010, TRANSPL INFECT DIS, V12, P164, DOI 10.1111/j.1399-3062.2009.00474.x; Gizard E, 2014, ALIMENT PHARM THER, V40, P3, DOI 10.1111/apt.12794; Ha C, 2009, AM J GASTROENTEROL, V104, P1445, DOI 10.1038/ajg.2009.81; Haagsma EB, 2003, ALIMENT PHARM THER, V18, P33, DOI 10.1046/j.1365-2036.2003.01613.x; Ho GT, 2005, EUR J GASTROEN HEPAT, V17, P1379, DOI 10.1097/00042737-200512000-00018; Hueppelshaeuser R, 2012, PEDIATR NEPHROL, V27, P1103, DOI 10.1007/s00467-012-2126-8; Indriolo A, 2013, ALIMENT PHARM THER, V37, P840, DOI 10.1111/apt.12256; Indriolo A, 2014, WORLD J GASTROENTERO, V20, P3525, DOI 10.3748/wjg.v20.i13.3525; Joo M, 2009, AM J SURG PATHOL, V33, P854, DOI 10.1097/PAS.0b013e318196d018; Jorgensen KK, 2013, CLIN GASTROENTEROL H, V11, P517, DOI 10.1016/j.cgh.2012.12.027; Jorgensen KK, 2012, INFLAMM BOWEL DIS, V18, P536, DOI 10.1002/ibd.21699; Joshi D, 2013, LIVER INT, V33, P53, DOI 10.1111/j.1478-3231.2011.02677.x; Kaplan BS, 1998, J AM SOC NEPHROL, V9, P1126; Lal S, 2007, EUR J GASTROEN HEPAT, V19, P277, DOI 10.1097/MEG.0b013e3280116ccc; Lewis B, 2013, INFLAMM BOWEL DIS, V19, P1846, DOI 10.1097/MIB.0b013e31828a661e; Loftus EV, 2005, GUT, V54, P91, DOI 10.1136/gut.2004.046615; Lundqvist K, 1997, DIS COLON RECTUM, V40, P451, DOI 10.1007/BF02258391; MacLean AR, 2003, DIS COLON RECTUM, V46, P1124, DOI 10.1007/s10350-004-7291-9; McAlister VC, 2006, AM J TRANSPLANT, V6, P1578, DOI 10.1111/j.1600-6143.2006.01360.x; Mohabbat AB, 2012, ALIMENT PHARM THER, V36, P569, DOI 10.1111/j.1365-2036.2012.05217.x; Moncrief KJ, 2010, CAN J GASTROENTEROL, V24, P40, DOI 10.1155/2010/830291; Navaneethan U, 2012, ALIMENT PHARM THER, V35, P1054, DOI 10.1111/j.1365-2036.2012.05067.x; O'Toole A, 2012, CLIN GASTROENTEROL H, V10, P439, DOI 10.1016/j.cgh.2011.11.010; Oikonomou K, 2011, INFLAMM BOWEL DIS, V17, P1034, DOI 10.1002/ibd.21468; OLSSON R, 1991, GASTROENTEROLOGY, V100, P1319; Papatheodoridis GV, 1998, GUT, V43, P639, DOI 10.1136/gut.43.5.639; Parameswaran S, 2011, Indian J Nephrol, V21, P120, DOI 10.4103/0971-4065.78063; Peraldi MN, 1997, NEPHROL DIAL TRANSPL, V12, P2744, DOI 10.1093/ndt/12.12.2744; Primas C, 2013, J CROHNS COLITIS, V7, P630, DOI DOI 10.1016/J.CR0HNS.2013.05.001; Reinisch W, 2008, AM J GASTROENTEROL, V103, P2284, DOI 10.1111/j.1572-0241.2008.02024.x; Rust C, 2011, GUT, V60, P1165, DOI 10.1136/gut.2011.240309; Saldeen K, 1999, SCAND J GASTROENTERO, V34, P535, DOI 10.1080/003655299750026308; Sandhu A, 2012, ALIMENT PHARM THER, V36, P159, DOI 10.1111/j.1365-2036.2012.05141.x; Sano H, 2011, J HEPATO-BIL-PAN SCI, V18, P154, DOI 10.1007/s00534-010-0319-8; Sattianayagam PT, 2013, DIGEST DIS SCI, V58, P1689, DOI 10.1007/s10620-012-2549-x; Shaked A, 1992, ANN SURG, V215, P4; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Singh S, 2013, AM J GASTROENTEROL, V108, P1417, DOI 10.1038/ajg.2013.163; Soetikno RM, 2002, GASTROINTEST ENDOSC, V56, P48, DOI 10.1067/mge.2002.125367; Sokol H, 2008, WORLD J GASTROENTERO, V14, P3497, DOI 10.3748/wjg.14.3497; STEPHENS J, 1993, TRANSPLANT P, V25, P1122; Temme J, 2010, TRANSPL P, V42, P3880, DOI 10.1016/j.transproceed.2010.08.044; Van de Vrie W, 2003, EUR J GASTROEN HEPAT, V15, P657, DOI 10.1097/00042737-200306000-00013; Verdonka RC, 2006, AM J TRANSPLANT, V6, P1422, DOI 10.1111/j.1600-6143.2006.01333.x; Yanai H, 2015, J CROHNS COLITIS, V9, P177, DOI 10.1093/ecco-jcc/jju013	57	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135807	10.1371/journal.pone.0135807	http://dx.doi.org/10.1371/journal.pone.0135807			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288187	Green Published, Green Submitted, gold			2022-12-26	WOS:000360018600071
J	Ban, SS; Pressey, RL; Graham, NAJ				Ban, Stephen S.; Pressey, Robert L.; Graham, Nicholas A. J.			Assessing the Effectiveness of Local Management of Coral Reefs Using Expert Opinion and Spatial Bayesian Modeling	PLOS ONE			English	Article							GREAT-BARRIER-REEF; MARINE PROTECTED AREAS; CLIMATE-CHANGE; MULTIPLE STRESSORS; BELIEF NETWORK; WATER-QUALITY; PHASE-SHIFTS; CONSERVATION; RESILIENCE; NUTRIENT	Multiple stressors are an increasing concern in the management and conservation of ecosystems, and have been identified as a key gap in research. Coral reefs are one example of an ecosystem where management of local stressors may be a way of mitigating or delaying the effects of climate change. Predicting how multiple stressors interact, particularly in a spatially explicit fashion, is a difficult challenge. Here we use a combination of an expert-elicited Bayesian network (BN) and spatial environmental data to examine how hypothetical scenarios of climate change and local management would result in different outcomes for coral reefs on the Great Barrier Reef (GBR), Australia. Parameterizing our BN using the mean responses from our experts resulted in predictions of limited efficacy of local management in combating the effects of climate change. However, there was considerable variability in expert responses and uncertainty was high. Many reefs within the central GBR appear to be at risk of further decline based on the pessimistic opinions of our expert pool. Further parameterization of the model as more data and knowledge become available could improve predictive power. Our approach serves as a starting point for subsequent work that can fine-tune parameters and explore uncertainties in predictions of responses to management.	[Ban, Stephen S.; Pressey, Robert L.; Graham, Nicholas A. J.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia	James Cook University	Ban, SS (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	Stephen.ban@gmail.com	Graham, Nicholas AJ/C-8360-2014	Graham, Nicholas AJ/0000-0002-0304-7467	Australian Postgraduate Award	Australian Postgraduate Award(Australian Government)	This study was supported by Australian Postgraduate Award.	Allison GW, 1998, ECOL APPL, V8, pS79, DOI 10.1890/1051-0761(1998)8[S79:MRANBN]2.0.CO;2; Alvarez-Romero JG, 2013, J ENVIRON MANAGE, V119, P194, DOI 10.1016/j.jenvman.2013.01.036; Ban NC, 2012, CONSERV BIOL, V26, P799, DOI 10.1111/j.1523-1739.2012.01894.x; Ban SS, 2014, GLOBAL ENVIRON CHANG, V27, P64, DOI 10.1016/j.gloenvcha.2014.04.018; Bansal S, 2013, TREE PHYSIOL, V33, P451, DOI 10.1093/treephys/tpt019; BARRETT GW, 1976, BIOSCIENCE, V26, P192, DOI 10.2307/1297248; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bos AR, 2013, OCEAN COAST MANAGE, V71, P116, DOI 10.1016/j.ocecoaman.2012.09.011; Brodie JE, 2012, MAR POLLUT BULL, V65, P81, DOI 10.1016/j.marpolbul.2011.12.012; Brodie J, 2012, ESTUAR COAST SHELF S, V104, P1, DOI 10.1016/j.ecss.2012.03.012; Brown CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065765; Burgman MA, 2013, DIVERS DISTRIB, V19, P485, DOI 10.1111/ddi.12060; Cain J., 2001, PLANNING IMPROVEMENT; Camerer CF, 1997, RES JUDGMENT DECISIO; Carilli JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006324; Chin A, 2012, MAR ECOL PROG SER, V460, P115, DOI 10.3354/meps09722; Clark JS, 2005, ECOL LETT, V8, P2, DOI 10.1111/j.1461-0248.2004.00702.x; Cote IM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000438; Darling ES, 2010, CONSERV LETT, V3, P122, DOI 10.1111/j.1755-263X.2009.00089.x; Day J, 2000, P 9 INT COR REEF S B; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; DPI F, 2012, ANN STAT REP 2011 CO; Drescher M, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00415.1; Fabricius KE, 2008, LIMNOL OCEANOGR, V53, P690, DOI 10.4319/lo.2008.53.2.0690; Faugier J, 1997, J ADV NURS, V26, P790, DOI 10.1046/j.1365-2648.1997.00371.x; Fernandes L, 2005, CONSERV BIOL, V19, P1733, DOI 10.1111/j.1523-1739.2005.00302.x; Folt CL, 1999, LIMNOL OCEANOGR, V44, P864, DOI 10.4319/lo.1999.44.3_part_2.0864; GOEDEN GB, 1982, BIOL CONSERV, V22, P273, DOI 10.1016/0006-3207(82)90022-2; GOREAU TJ, 1994, AMBIO, V23, P176; Graham NAJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003039; Graham NAJ, 2013, FRONT ECOL ENVIRON, V11, P541, DOI 10.1890/120305; Great Barrier Reef Marine Park Authority, 2013, ZON PERM PLANS 2013; Grech A, 2010, AQUAT CONSERV, V20, P437, DOI 10.1002/aqc.1107; Halpern BS, 2008, OCEAN COAST MANAGE, V51, P203, DOI 10.1016/j.ocecoaman.2007.08.002; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Haynes D, 2007, ENVIRON MANAGE, V40, P993, DOI 10.1007/s00267-007-9009-y; Hecky RE, 2010, FRESHWATER BIOL, V55, P19, DOI 10.1111/j.1365-2427.2009.02374.x; Holmes G, 2010, ECOL MODEL, V221, P1173, DOI 10.1016/j.ecolmodel.2010.01.010; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; HUSS WR, 1988, INT J FORECASTING, V4, P377, DOI 10.1016/0169-2070(88)90105-7; Kininmonth S, 2010, ECOL MODEL, V221, P2870, DOI 10.1016/j.ecolmodel.2010.08.042; Knapp KR, 2010, B AM METEOROL SOC, V91, P363, DOI 10.1175/2009BAMS2755.1; Kujala H, 2013, CONSERV LETT, V6, P73, DOI 10.1111/j.1755-263X.2012.00299.x; Landis WG, 2013, ENVIRON TOXICOL CHEM, V32, P79, DOI 10.1002/etc.2047; Leigh GM, 2014, QUEENSLAND DEPARTMEN; Lewis SE, 2009, ENVIRON POLLUT, V157, P2470, DOI 10.1016/j.envpol.2009.03.006; Lindenmayer DB, 2010, P NATL ACAD SCI USA, V107, P21957, DOI 10.1073/pnas.1015696107; MacNeil MA, 2010, GLOBAL ECOL BIOGEOGR, V19, P412, DOI 10.1111/j.1466-8238.2009.00515.x; Mantyka-Pringle CS, 2014, J APPL ECOL, V51, P572, DOI 10.1111/1365-2664.12236; Marcot BG, 2006, ECOLOGY SOC, V11; Marcot BG, 2006, CAN J FOREST RES, V36, P3063, DOI 10.1139/X06-135; Martin TG, 2012, CONSERV BIOL, V26, P29, DOI 10.1111/j.1523-1739.2011.01806.x; Maynard JA, 2010, CORAL REEFS, V29, P381, DOI 10.1007/s00338-010-0603-8; McClanahan TR, 2006, CURR BIOL, V16, P1408, DOI 10.1016/j.cub.2006.05.062; McCook LJ, 2010, P NATL ACAD SCI USA, V107, P18278, DOI 10.1073/pnas.0909335107; Meesters EH, 1998, CONSERV BIOL, V12, P957, DOI 10.1046/j.1523-1739.1998.96421.x; Melbourne-Thomas J, 2011, ENVIRON MODELL SOFTW, V26, P66, DOI 10.1016/j.envsoft.2010.03.033; Mumby PJ, 2008, TRENDS ECOL EVOL, V23, P555, DOI 10.1016/j.tree.2008.06.011; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; NOAA (National Oceanic and Atmospheric Administration), 2012, NOAAS INT ASS PROGR; Norsys Software Corporation, 1992, NET; Osborne K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017516; Page CA, 2009, DIS AQUAT ORGAN, V87, P135, DOI 10.3354/dao02112; Palmer M, 2011, MAR ECOL PROG SER, V430, P87, DOI 10.3354/meps09109; Payo DA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2660; Peterson GD, 2003, CONSERV BIOL, V17, P358, DOI 10.1046/j.1523-1739.2003.01491.x; Possingham HP, 2005, ECOSYSTEM FUNCTION IN HETEROGENEOUS LANDSCAPES, P389, DOI 10.1007/0-387-24091-8_19; Pressey R, 2007, TRENDS ECOL EVOL; Przeslawski R, 2005, GLOBAL CHANGE BIOL, V11, P515, DOI 10.1111/j.1365-2486.2005.00918.x; Riegl B, 2009, ANN NY ACAD SCI, V1162, P136, DOI 10.1111/j.1749-6632.2009.04493.x; ROBERTS CM, 1995, CONSERV BIOL, V9, P988, DOI 10.1046/j.1523-1739.1995.9051332.x-i1; Russell BD, 2009, GLOBAL CHANGE BIOL, V15, P2153, DOI 10.1111/j.1365-2486.2009.01886.x; Salbu B, 2005, J ENVIRON MONITOR, V7, P539, DOI 10.1039/b506220a; Schroeder T, 2012, MAR POLLUT BULL, V65, P210, DOI 10.1016/j.marpolbul.2012.02.022; Smith CS, 2007, BIOL CONSERV, V139, P333, DOI 10.1016/j.biocon.2007.06.025; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Speirs-Bridge A, 2010, RISK ANAL, V30, P512, DOI 10.1111/j.1539-6924.2009.01337.x; Stelzenmuller V, 2011, MAR ECOL PROG SER, V441, P197, DOI 10.3354/meps09354; Stelzenmuller V, 2010, MAR POLLUT BULL, V60, P1743, DOI 10.1016/j.marpolbul.2010.06.024; Swart RJ, 2004, GLOBAL ENVIRON CHANG, V14, P137, DOI 10.1016/j.gloenvcha.2003.10.002; Thomas CR, 2008, BAYESIAN BELIEF NETW; van Nes EH, 2005, ECOLOGY, V86, P1797, DOI 10.1890/04-0550; Vinebrooke RD, 2004, OIKOS, V104, P451, DOI 10.1111/j.0030-1299.2004.13255.x; Wooldridge S, 2007, MARINE TROPICAL SCI, P21; Wooldridge S, 2006, MAR POLLUT BULL, V52, P1467, DOI 10.1016/j.marpolbul.2006.05.009; Wootton JT, 2005, ANNU REV ECOL EVOL S, V36, P419, DOI 10.1146/annurev.ecolsys.36.091704.175535	86	22	23	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135465	10.1371/journal.pone.0135465	http://dx.doi.org/10.1371/journal.pone.0135465			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284372	Green Published, gold, Green Accepted			2022-12-26	WOS:000359666100040
J	Hsieh, CH; Chung, RH; Lee, WJ; Lin, MW; Chuang, LM; Quertermous, T; Assimes, T; Hung, YJ; Yu, YW				Hsieh, Chang-Hsun; Chung, Ren-Hua; Lee, Wen-Jane; Lin, Ming-Wei; Chuang, Lee-Ming; Quertermous, Thomas; Assimes, Themistocles; Hung, Yi-Jen; Yu, Ya-Wen			Effect of Common Genetic Variants of Growth Arrest-Specific 6 Gene on Insulin Resistance, Obesity and Type 2 Diabetes in an Asian Population	PLOS ONE			English	Article							TYROSINE KINASE RECEPTOR; ADIPOSE-TISSUE DEVELOPMENT; GAS6 GENE; PROTEIN-S; ASSOCIATION; INFLAMMATION; AXL; GLUCOSE; MICE; ADIPOGENESIS	Objectives Growth arrest-specific 6 (Gas6), a vitamin K-dependent protein, has been implicated in systemic inflammation, obesity, and insulin resistance (IR). Data from recent studies suggest that polymorphisms in the Gas6 gene are associated with cardiovascular disorders and type 2 diabetes (T2D). However, the association of Gas6 gene variants with obesity, IR, and T2D development has not been explored. Materials and Methods Four common single nucleotide polymorphisms (SNPs) in the Gas6 gene were genotyped in 984 participants from the Stanford Asia-Pacific Program for Hypertension and Insulin Resistance (SAPPHIRe) family cohort. An insulin suppression test was performed to determine IR based on steady-state plasma glucose (SSPG). Associations between IR indices and obesity, and SNP genotypes, based on previously-reported data for this cohort (Phase I), were analyzed. In the present follow-up study (Phase II), the effects of gene variants of Gas6 on the progression to T2D were explored in individuals who were free of T2D in Phase I. The mean follow-up period for Phase II was 5.7 years. Results The mean age of the study population in Phase I was 49.5 years and 16.7% of individuals developed T2D during follow-up. After adjusting for covariates, three SNPs (rs8191973, rs8197974, and rs7323932) were found to be associated with SSPG levels (p = 0.007, p = 0.03, and p = 0.011, respectively). This association remained significant after multiple testing and showed a significant interaction with physical activity for SNP rs8191973. However, no other significant correlations were observed between Gas6 polymorphisms and other indices of IR or obesity. A specific haplotype, AACG (from rs8191974, rs7323932, rs7331124, and rs8191973), was positively associated with SSPG levels (p = 0.0098). None of the polymorphisms were associated with an increased risk of T2D development. Conclusions Our results suggest that Gas6 gene variants are associated with IR, although their effects on subsequent progression to T2D were minimal in this prospective Asian cohort.	[Hsieh, Chang-Hsun; Hung, Yi-Jen] Triserv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Div Endocrinol & Metab, Taipei, Taiwan; [Chung, Ren-Hua; Yu, Ya-Wen] Natl Hlth Res Inst, Div Biostat & Bioinformat, Inst Populat Hlth Sci, Miaoli Country, Taiwan; [Lee, Wen-Jane; Lin, Ming-Wei] Taichung Vet Gen Hosp, Dept Med Educ & Res, Taichung, Taiwan; [Lin, Ming-Wei] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Chuang, Lee-Ming] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Chuang, Lee-Ming] Natl Taiwan Univ, Grad Inst Prevent Med, Sch Publ Hlth, Taipei 10764, Taiwan; [Quertermous, Thomas; Assimes, Themistocles] Stanford Univ, Dept Med, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA; [Quertermous, Thomas; Assimes, Themistocles] Stanford Univ, Stanford Cardiovasc Inst, Stanford, CA 94305 USA	National Defense Medical Center; Tri-Service General Hospital; National Health Research Institutes - Taiwan; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Stanford University; Stanford University	Hsieh, CH (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Div Endocrinol & Metab, Taipei, Taiwan.	10324peter@gmail.com	Chung, Ren-Hua/AAB-8364-2019; Chuang, Lee-Ming/AAF-3324-2019; Assimes, Themistocles Leonard/D-9696-2015	Assimes, Themistocles Leonard/0000-0003-2349-0009; CHUANG, LEE-MING/0000-0003-0978-2662; Quertermous, Thomas/0000-0002-7645-9067	Tri-Service General Hospital [TSGH-C101-119, TSGH-C102-117]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK107437] Funding Source: NIH RePORTER	Tri-Service General Hospital; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The present study was supported by grants from the Tri-Service General Hospital (TSGH-C101-119 and TSGH-C102-117).	Ader H., 2008, ADVISING RES METHODS, P271; Alciato F, 2010, J LEUKOCYTE BIOL, V87, P869, DOI 10.1189/jlb.0909610; Augustine KA, 1999, J CELL PHYSIOL, V181, P433, DOI 10.1002/(SICI)1097-4652(199912)181:3<433::AID-JCP7>3.0.CO;2-Y; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Bellosta P, 1997, ONCOGENE, V15, P2387, DOI 10.1038/sj.onc.1201419; Blostein MD, 2011, J THROMB THROMBOLYS, V32, P272, DOI 10.1007/s11239-011-0597-2; Chang YC, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-58; Chung RH, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-199; Ekman C, 2010, CLIN BIOCHEM, V43, P110, DOI 10.1016/j.clinbiochem.2009.07.025; Fourcot A, 2011, AM J PHYSIOL-GASTR L, V300, pG1043, DOI 10.1152/ajpgi.00311.2010; GODOWSKI PJ, 1995, CELL, V82, P355, DOI 10.1016/0092-8674(95)90424-7; Hsiao FC, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/674069; Hsiao FC, 2013, J CLIN ENDOCR METAB, V98, pE267, DOI 10.1210/jc.2012-3179; Hung YJ, 2010, DIABETES CARE, V33, P1840, DOI 10.2337/dc09-1073; Hwu CM, 2004, BLOOD PRESSURE, V13, P355, DOI 10.1080/08037050410004828; Jiang L, 2009, AM J CLIN PATHOL, V131, P738, DOI 10.1309/AJCP3CX3AUVRBHCF; Lange C, 2004, AM J HUM GENET, V74, P367, DOI 10.1086/381563; Laurance S, 2012, ADV NUTR, V3, P196, DOI 10.3945/an.111.001826; Lee CH, 2012, DIABETES RES CLIN PR, V95, P201, DOI 10.1016/j.diabres.2011.09.013; Lijnen HR, 2011, J PHARMACOL EXP THER, V337, P457, DOI 10.1124/jpet.110.178046; Luna A, 2007, BIOINFORMATICS, V23, P774, DOI 10.1093/bioinformatics/btl657; MANFIOLETTI G, 1993, MOL CELL BIOL, V13, P4976, DOI 10.1128/MCB.13.8.4976; Maquoi E, 2005, ARTERIOSCL THROM VAS, V25, P1002, DOI 10.1161/01.ATV.0000160611.68791.c6; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Munoz X, 2004, HUM MUTAT, V23, P506, DOI 10.1002/humu.20025; Munoz X, 2007, THROMB HAEMOSTASIS, V98, P406, DOI 10.1160/TH06-12-0681; Nagata K, 1996, J BIOL CHEM, V271, P30022, DOI 10.1074/jbc.271.47.30022; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Scroyen I, 2012, OBESITY, V20, P1168, DOI 10.1038/oby.2011.399; SHEN SW, 1970, J CLIN INVEST, V49, P2151, DOI 10.1172/JCI106433; Son BK, 2006, CIRC RES, V98, P1024, DOI 10.1161/01.RES.0000218859.90970.8d; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Wu KD, 2002, HYPERTENS RES, V25, P529	34	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135681	10.1371/journal.pone.0135681	http://dx.doi.org/10.1371/journal.pone.0135681			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284522	Green Published, Green Submitted, gold			2022-12-26	WOS:000359666100057
J	Liu, JH; Zhang, XQ; Zhang, W; Gu, GJ; Wang, PJ				Liu, Jianhui; Zhang, Xiaoqing; Zhang, Wei; Gu, Guojun; Wang, Peijun			Effects of Sevoflurane on Young Male Adult C57BL/6 Mice Spatial Cognition	PLOS ONE			English	Article							EXTRASYNAPTIC NMDA RECEPTORS; NITROUS OXIDE ANESTHESIA; IN-VIVO; SYNAPTIC PLASTICITY; RAT BRAIN; AGED RATS; MEMORY; ISOFLURANE; EXPOSURE; ENHANCEMENT	Inhalation anesthetics are reported to affect cognition in both animals and humans. The influence of inhalation anesthetics in learning and memory are contradictory. We therefore investigated the effects of sevoflurane anesthesia with different durations on cognitive performance and the levels of NMDA receptor subunit NR2B, phosphorylated ERK1/2 (p-ERK1/2) and activated caspase3 in mouse hippocampus. We anaesthetized eight-week old male C57BL/6 mice with 2.5% sevoflurane for durations ranging from one to four hours. Non-anaesthetized mice served as controls. Mice exposed to sevoflurane for one to three hours showed improved performance, whereas mice with exposure up to four hours displayed similar behavioral performance as control group. NR2B was increased both at 24h and at two weeks post sevoflurane exposure in all groups. The p-ERK1/2: total ERK1/2 ratio increased at 24h in all anesthesia groups. The ratio remained elevated at two weeks in groups with two- to four-hour exposure. Activated caspase3 was detected elevated at 24h in groups with two- to four-hour exposure. The elevated trend of activated caspase3 was still detectable at two weeks in groups with three- to four-hour exposure. At two weeks post anesthesia, the typical morphology associated with apoptotic cells was observed in the hippocampus of mice exposed to four hours of sevoflurane. Our results indicate that 2.5% sevoflurane exposure for one to three hours improved spatial cognitive performance in young adult mice. The cognitive improvement might be related to the increase of NR2B, the p-ERK1/2: total ERK1/2 ratio in hippocampus. However, exposure to sevoflurane for four hours caused neurotoxicity due to caspase3 activation and apoptosis.	[Liu, Jianhui; Zhang, Xiaoqing] Tongji Univ, Tongji Hosp, Dept Anesthesiol, Shanghai 200092, Peoples R China; [Zhang, Wei; Gu, Guojun; Wang, Peijun] Tongji Univ, Tongji Hosp, Dept Med Image, Shanghai 200092, Peoples R China	Tongji University; Tongji University	Wang, PJ (corresponding author), Tongji Univ, Tongji Hosp, Dept Med Image, Shanghai 200092, Peoples R China.	peijunwang1246@163.com			National Nature Science Foundation of China [81200934]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Nature Science Foundation of China awarded to PJ Wang (81200934). The funder had roles in data collection and analysis, decision to publish, or preparation of the manuscript.	Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; Alkire MT, 2008, P NATL ACAD SCI USA, V105, P1722, DOI 10.1073/pnas.0711651105; Bibb JA, 2010, J NEUROSCI, V30, P14987, DOI 10.1523/JNEUROSCI.4419-10.2010; Collingridge GL, 2013, NEUROPHARMACOLOGY, V64, P13, DOI 10.1016/j.neuropharm.2012.06.051; Culley DJ, 2004, ANESTH ANALG, V99, P1393, DOI 10.1213/01.ANE.0000135408.14319.CC; Culley DJ, 2004, ANESTHESIOLOGY, V100, P309, DOI 10.1097/00000542-200402000-00020; Culley DJ, 2003, ANESTH ANALG, V96, P1004, DOI 10.1213/01.ANE.0000052712.67573.12; Edwards DA, 2010, ANESTHESIOLOGY, V112, P567, DOI 10.1097/ALN.0b013e3181cf9138; Fang F, 2012, NEUROSCI BULL, V28, P499, DOI 10.1007/s12264-012-1260-4; Feng X, 2012, BRIT J ANAESTH, V109, P225, DOI 10.1093/bja/aes121; Gibert S, 2012, ANESTHESIOLOGY, V117, P1253, DOI 10.1097/ALN.0b013e318273e272; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Haseneder R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064732; Ivanov A, 2006, J PHYSIOL-LONDON, V572, P789, DOI 10.1113/jphysiol.2006.105510; JARRARD LE, 1993, BEHAV NEURAL BIOL, V60, P9, DOI 10.1016/0163-1047(93)90664-4; KOMATSU H, 1993, ANESTH ANALG, V76, P609; Leveille F, 2008, FASEB J, V22, P4258, DOI 10.1096/fj.08-107268; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Mao LM, 2004, EUR J NEUROSCI, V19, P1207, DOI 10.1111/j.1460-9568.2004.03223.x; Morgado-Bernal I, 2011, NEUROSCIENCE, V176, P12, DOI 10.1016/j.neuroscience.2010.12.056; Rammes G, 2009, NEUROPHARMACOLOGY, V56, P626, DOI 10.1016/j.neuropharm.2008.11.002; Sakai EM, 2005, PHARMACOTHERAPY, V25, P1773, DOI 10.1592/phco.2005.25.12.1773; Satomoto M, 2009, ANESTHESIOLOGY, V110, P628, DOI 10.1097/ALN.0b013e3181974fa2; Sava A, 2012, NEUROPHARMACOLOGY, V62, P925, DOI 10.1016/j.neuropharm.2011.09.025; Selcher JC, 1999, LEARN MEMORY, V6, P478, DOI 10.1101/lm.6.5.478; Sgambato V, 1998, J NEUROSCI, V18, P214; Solt K, 2007, CURR OPIN ANESTHESIO, V20, P300, DOI 10.1097/ACO.0b013e32816678a5; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Wang WY, 2016, MOL NEUROBIOL, V53, P216, DOI 10.1007/s12035-014-9005-1; Williams JM, 1998, MOL BRAIN RES, V60, P21, DOI 10.1016/S0169-328X(98)00154-5; Xie ZC, 2006, ANESTHESIOLOGY, V104, P988, DOI 10.1097/00000542-200605000-00015; Xie ZC, 2008, ANN NEUROL, V64, P618, DOI 10.1002/ana.21548; Young C, 2005, NEUROBIOL DIS, V20, P608, DOI 10.1016/j.nbd.2005.04.014; Zhang XG, 2008, NEUROSCI LETT, V447, P109, DOI 10.1016/j.neulet.2008.09.083; Zhou M, 2006, J NEUROSCI, V26, P2956, DOI 10.1523/JNEUROSCI.4299-05.2006	37	18	21	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0134217	10.1371/journal.pone.0134217	http://dx.doi.org/10.1371/journal.pone.0134217			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285216	Green Published, gold, Green Submitted			2022-12-26	WOS:000359666100007
J	Tardivo, JP; Baptista, MS; Correa, JA; Adami, F; Pinhal, MAS				Tardivo, Joao Paulo; Baptista, Mauricio S.; Correa, Joao Antonio; Adami, Fernando; Silva Pinhal, Maria Aparecida			Development of the Tardivo Algorithm to Predict Amputation Risk of Diabetic Foot	PLOS ONE			English	Article							PERIPHERAL ARTERIAL-DISEASE; OSTEOMYELITIS; MANAGEMENT; SEVERITY; SURGERY; ULCERS; FOCUS; SCORE; CARE	Diabetes is a chronic disease that affects almost 19% of the elderly population in Brazil and similar percentages around the world. Amputation of lower limbs in diabetic patients who present foot complications is a common occurrence with a significant reduction of life quality, and heavy costs on the health system. Unfortunately, there is no easy protocol to define the conditions that should be considered to proceed to amputation. The main objective of the present study is to create a simple prognostic score to evaluate the diabetic foot, which is called Tardivo Algorithm. Calculation of the score is based on three main factors: Wagner classification, signs of peripheral arterial disease (PAD), which is evaluated by using Peripheral Arterial Disease Classification, and the location of ulcers. The final score is obtained by multiplying the value of the individual factors. Patients with good peripheral vascularization received a value of 1, while clinical signs of ischemia received a value of 2 (PAD 2). Ulcer location was defined as forefoot, midfoot and hind foot. The conservative treatment used in patients with scores below 12 was based on a recently developed Photodynamic Therapy (PDT) protocol. 85.5% of these patients presented a good outcome and avoided amputation. The results showed that scores 12 or higher represented a significantly higher probability of amputation (Odds ratio and logistic regression-IC 95%, 12.2-1886.5). The Tardivo algorithm is a simple prognostic score for the diabetic foot, easily accessible by physicians. It helps to determine the amputation risk and the best treatment, whether it is conservative or surgical management.	[Tardivo, Joao Paulo; Correa, Joao Antonio; Adami, Fernando; Silva Pinhal, Maria Aparecida] Fac Med ABC, Santo Andre, SP, Brazil; [Tardivo, Joao Paulo] Fac Med ABC, Ctr Treatment Diabet Feet, Santo Andre, SP, Brazil; [Baptista, Mauricio S.] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, SP, Brazil	Faculdade de Medicina do ABC; Faculdade de Medicina do ABC; Universidade de Sao Paulo	Baptista, MS (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, SP, Brazil.	baptista@iq.usp.br	Adami, Fernando/D-3855-2012; Baptista, Mauricio S/AAO-5749-2021; Baptista, Mauricio S/A-5140-2008; Pinhal, Maria Aparecida Silva/J-1797-2012	Adami, Fernando/0000-0003-1918-3364; Baptista, Mauricio S/0000-0001-7079-7666; Baptista, Mauricio S/0000-0001-7079-7666; Pinhal, Maria Aparecida Silva/0000-0003-4001-1663	FAPESP [12/50680-5, 13/07937-8]; CNPq [303016/2007-8]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by FAPESP (grants 12/50680-5 and 13/07937-8) who provided funds to buy equipments and reagents and CNPq (grant 303016/2007-8) provides funds for the activity of MASP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albayati MA, 2013, MED CLIN N AM, V97, P821, DOI 10.1016/j.mcna.2013.03.009; [Anonymous], NATIONAL DIABETES ST; Apelqvist J, 2011, J VASC SURG, V53, P1582, DOI 10.1016/j.jvs.2011.02.006; Barberan J, 2010, ENFERM INFEC MICR CL, V28, P680, DOI 10.1016/j.eimc.2009.12.017; Beckert S, 2006, DIABETES CARE, V29, P988, DOI 10.2337/dc05-2431; Bisland SK, 2006, PHOTOCH PHOTOBIO SCI, V5, P31, DOI 10.1039/b507082a; Brechow A, 2013, THER ADV ENDOCRINOL, V4, P83, DOI 10.1177/2042018813489719; Chung J, 2015, J VASC SURG, V61, P162, DOI 10.1016/j.jvs.2014.05.101; Elgzyri T, 2014, EUR J VASC ENDOVASC, V48, P440, DOI 10.1016/j.ejvs.2014.06.041; Goodney PP, 2014, JAMA SURG, V149, P34, DOI 10.1001/jamasurg.2013.4277; Henke PK, 2005, ANN SURG, V241, P885, DOI 10.1097/01.sla.0000164172.28918.3f; Jeffcoate WJ, 2011, DIABETOLOGIA, V54, P991, DOI 10.1007/s00125-011-2075-y; Lipsky BA, 2011, DIABETES CARE, V34, P1695, DOI 10.2337/dc11-0331; Lowe J, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001814; Maisch T, 2009, MINI-REV MED CHEM, V9, P974, DOI 10.2174/138955709788681582; Mills JL, 2014, J VASC SURG, V59, P220, DOI 10.1016/j.jvs.2013.08.003; Prompers L, 2008, DIABETOLOGIA, V51, P747, DOI 10.1007/s00125-008-0940-0; Tardivo JP, 2009, PHOTOMED LASER SURG, V27, P145, DOI 10.1089/pho.2008.2252; Tardivo JP, 2014, PHOTODIAGN PHOTODYN, V11, P342, DOI 10.1016/j.pdpdt.2014.04.007; Tardivo JP, 2012, PHOTODYNAMIC THERAPY, P121; Trignano E, 2016, MICROSURG, V36, P37, DOI 10.1002/micr.22378; Wainwright M, 1998, J ANTIMICROB CHEMOTH, V42, P13, DOI 10.1093/jac/42.1.13; Wukich DK, 2013, DIABETES CARE, V36, P2862, DOI 10.2337/dc12-2712	23	8	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0135707	10.1371/journal.pone.0135707	http://dx.doi.org/10.1371/journal.pone.0135707			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26281044	Green Published, Green Submitted, gold			2022-12-26	WOS:000359664300019
J	Andrey, DO; Jousselin, A; Villanueva, M; Renzoni, A; Monod, A; Barras, C; Rodriguez, N; Kelley, WL				Andrey, Diego O.; Jousselin, Ambre; Villanueva, Maite; Renzoni, Adriana; Monod, Antoinette; Barras, Christine; Rodriguez, Natalia; Kelley, William L.			Impact of the Regulators SigB, Rot, SarA and sarS on the Toxic Shock Tst Promoter and TSST-1 Expression in Staphylococcus aureus	PLOS ONE			English	Article							VIRULENCE-DETERMINANT EXPRESSION; FIBRONECTIN-BINDING PROTEINS; GLOBAL REGULATION; GENE-EXPRESSION; SIGNAL-TRANSDUCTION; ALPHA-HEMOLYSIN; PATHOGENICITY ISLANDS; ENVIRONMENTAL-FACTORS; NASAL COLONIZATION; 2-COMPONENT SYSTEM	Staphylococcus aureus is an important pathogen manifesting virulence through diverse disease forms, ranging from acute skin infections to life-threatening bacteremia or systemic toxic shock syndromes. In the latter case, the prototypical superantigen is TSST-1 (Toxic Shock Syndrome Toxin 1), encoded by tst(H), and carried on a mobile genetic element that is not present in all S. aureus strains. Transcriptional regulation of tst is only partially understood. In this study, we dissected the role of sarA, sarS (sarH1), RNAIII, rot, and the alternative stress sigma factor sigB (sigma(B)). By examining tst promoter regulation predominantly in the context of its native sequence within the SaPI1 pathogenicity island of strain RN4282, we discovered that sB emerged as a particularly important tst regulator. We did not detect a consensus sigma(B) site within the tst promoter, and thus the effect of sigma(B) is likely indirect. We found that sigma(B) strongly repressed the expression of the toxin via at least two distinct regulatory pathways dependent upon sarA and agr. Furthermore rot, a member of SarA family, was shown to repress tst expression when overexpressed, although its deletion had no consistent measurable effect. We could not find any detectable effect of sarS, either by deletion or overexpression, suggesting that this regulator plays a minimal role in TSST-1 expression except when combined with disruption of sarA. Collectively, our results extend our understanding of complex multifactorial regulation of tst, revealing several layers of negative regulation. In addition to environmental stimuli thought to impact TSST-1 production, these findings support a model whereby sporadic mutation in a few key negative regulators can profoundly affect and enhance TSST-1 expression.	[Andrey, Diego O.; Renzoni, Adriana; Monod, Antoinette; Barras, Christine] Univ Hosp Geneva, Infect Dis Serv, CH-1211 Geneva 14, Switzerland; [Andrey, Diego O.; Jousselin, Ambre; Villanueva, Maite; Renzoni, Adriana; Monod, Antoinette; Barras, Christine; Rodriguez, Natalia; Kelley, William L.] Med Sch Geneva, CH-1211 Geneva 14, Switzerland; [Jousselin, Ambre; Villanueva, Maite; Rodriguez, Natalia; Kelley, William L.] Univ Hosp Geneva, Dept Microbiol & Mol Med, CH-1211 Geneva 14, Switzerland	University of Geneva; University of Geneva; University of Geneva	Kelley, WL (corresponding author), Univ Hosp Geneva, Infect Dis Serv, 4 Rue Gabrielle Perret Gentil, CH-1211 Geneva 14, Switzerland.	william.kelley@unige.ch	Villanueva, Maite/AAA-9550-2020	Villanueva, Maite/0000-0002-3894-0060; jousselin, ambre/0000-0001-7003-5426; Renzoni, Adriana/0000-0002-4897-5208; ANDREY, Diego/0000-0003-3247-9274	Swiss National Science Foundation [3100A0-120428, 310030-146540]; Swiss Academy of Medical Sciences via the F. Hoffmann-La Roche Research Foundation; Swiss Society of Infections Diseases; University Hospital and Medical School of Geneva; Canton of Geneva	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Academy of Medical Sciences via the F. Hoffmann-La Roche Research Foundation; Swiss Society of Infections Diseases; University Hospital and Medical School of Geneva; Canton of Geneva	This work was supported by grants from the Swiss National Science Foundation 3100A0-120428 and 310030-146540 (to WLK), an MD-PhD thesis doctoral training grant from the Swiss Academy of Medical Sciences via the F. Hoffmann-La Roche Research Foundation (to DOA), a fellowship grant from the Swiss Society of Infections Diseases (to NR), the University Hospital and Medical School of Geneva, and the Canton of Geneva.	Andrey DO, 2010, J BACTERIOL, V192, P6077, DOI 10.1128/JB.00146-10; Tormo-Mas MA, 2010, NATURE, V465, P779, DOI 10.1038/nature09065; Baek KT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077122; Ballal A, 2009, MICROBIOL-SGM, V155, P2342, DOI 10.1099/mic.0.027417-0; Benson MA, 2012, J BACTERIOL, V194, P4355, DOI 10.1128/JB.00706-12; Bischoff M, 2004, J BACTERIOL, V186, P4085, DOI 10.1128/JB.186.13.4085-4099.2004; Bischoff M, 2001, J BACTERIOL, V183, P5171, DOI 10.1128/JB.183.17.5171-5179.2001; Bisognano C, 2004, J BIOL CHEM, V279, P9064, DOI 10.1074/jbc.M309836200; Blevins JS, 2002, INFECT IMMUN, V70, P470, DOI 10.1128/IAI.70.2.470-480.2002; Boisset S, 2007, GENE DEV, V21, P1353, DOI 10.1101/gad.423507; Bronner S, 2004, FEMS MICROBIOL REV, V28, P183, DOI 10.1016/j.femsre.2003.09.003; Burnside K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011071; Chan PF, 1998, J BACTERIOL, V180, P6232; Chan PF, 1998, MICROBIOL-SGM, V144, P2469, DOI 10.1099/00221287-144-9-2469; Chen PR, 2009, MOL MICROBIOL, V71, P198, DOI 10.1111/j.1365-2958.2008.06518.x; Cheung AL, 2001, INFECT IMMUN, V69, P2448, DOI 10.1128/IAI.69.4.2448-2455.2001; CHEUNG AL, 1994, J BACTERIOL, V176, P580, DOI 10.1128/jb.176.3.580-585.1994; CHEUNG AL, 1992, P NATL ACAD SCI USA, V89, P6462, DOI 10.1073/pnas.89.14.6462; Cheung AL, 1999, INFECT IMMUN, V67, P1331, DOI 10.1128/IAI.67.3.1331-1337.1999; Cheung AL, 2004, FEMS IMMUNOL MED MIC, V40, P1, DOI 10.1016/S0928-8244(03)00309-2; Cheung AL, 2008, INT J BIOCHEM CELL B, V40, P355, DOI 10.1016/j.biocel.2007.10.032; Chien YT, 1999, J BIOL CHEM, V274, P37169, DOI 10.1074/jbc.274.52.37169; Didier JP, 2010, FEMS MICROBIOL LETT, V306, P30, DOI 10.1111/j.1574-6968.2010.01930.x; Felden B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002006; Foster TJ, 2009, VET DERMATOL, V20, P456, DOI 10.1111/j.1365-3164.2009.00825.x; GAVENTA S, 1989, REV INFECT DIS, V11, pS28; Geisinger E, 2006, MOL MICROBIOL, V61, P1038, DOI 10.1111/j.1365-2958.2006.05292.x; Geissmann T, 2009, NUCLEIC ACIDS RES, V37, P7239, DOI 10.1093/nar/gkp668; Gertz S, 2000, J BACTERIOL, V182, P6983, DOI 10.1128/JB.182.24.6983-6991.2000; Giachino P, 2001, J BACTERIOL, V183, P1843, DOI 10.1128/JB.183.6.1843-1852.2001; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; HALDENWANG WG, 1995, MICROBIOL REV, V59, P1; Heinrichs JH, 1996, J BACTERIOL, V178, P418, DOI 10.1128/jb.178.2.418-423.1996; Herbert S, 2010, INFECT IMMUN, V78, P2877, DOI 10.1128/IAI.00088-10; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Jelsbak L, 2010, INT J MED MICROBIOL, V300, P229, DOI 10.1016/j.ijmm.2009.07.003; Karlsson A, 2001, INFECT IMMUN, V69, P4742, DOI 10.1128/IAI.69.8.4742-4748.2001; Karlsson-Kanth A, 2006, INT J MED MICROBIOL, V296, P229, DOI 10.1016/j.ijmm.2006.01.067; KASS EH, 1989, REV INFECT DIS, V11, pS167; Kass EH, 1989, REV INFECT DIS SUPPL, V11, pS73; Kimber I, 2013, TOXICOL SCI, V134, P49, DOI 10.1093/toxsci/kft099; KIYOTA H, 1989, J INFECT DIS, V160, P1061, DOI 10.1093/infdis/160.6.1061; Koch G, 2014, CELL, V158, P1060, DOI 10.1016/j.cell.2014.06.046; KREISWIRTH BN, 1984, SURV SYN PATHOL RES, V3, P73; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; KREISWIRTH BN, 1989, REV INFECT DIS, V11, pS83; Kullik I, 1997, ARCH MICROBIOL, V167, P151, DOI 10.1007/s002030050428; Lamy B, 2012, EUR J CLIN MICROBIOL, V31, P1279, DOI 10.1007/s10096-011-1441-5; Lappin E, 2009, LANCET INFECT DIS, V9, P281, DOI 10.1016/S1473-3099(09)70066-0; Leiba J, 2012, J BIOL CHEM, V287, P43607, DOI 10.1074/jbc.M112.418913; Li JR, 2011, P NATL ACAD SCI USA, V108, P3360, DOI 10.1073/pnas.1017431108; Liang XD, 2005, J BACTERIOL, V187, P5486, DOI 10.1128/JB.187.15.5486-5492.2005; Lindsay JA, 2006, J BACTERIOL, V188, P669, DOI 10.1128/JB.188.2.669-676.2006; Lindsay JA, 1998, MOL MICROBIOL, V29, P527, DOI 10.1046/j.1365-2958.1998.00947.x; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Maiques E, 2006, J BACTERIOL, V188, P2726, DOI 10.1128/JB.188.7.2726-2729.2006; Manna AC, 1998, J BACTERIOL, V180, P3828, DOI 10.1128/JB.180.15.3828-3836.1998; McCallum N, 2004, J BACTERIOL, V186, P2966, DOI 10.1128/JB.186.10.2966-2972.2004; McCormick JK, 2001, ANNU REV MICROBIOL, V55, P77, DOI 10.1146/annurev.micro.55.1.77; McNamara PJ, 2009, ANTIMICROB AGENTS CH, V53, P1898, DOI 10.1128/AAC.01293-08; McNamara PJ, 2000, J BACTERIOL, V182, P3197, DOI 10.1128/JB.182.11.3197-3203.2000; Megevand C, 2010, CLIN MICROBIOL INFEC, V16, P1414, DOI 10.1111/j.1469-0691.2009.03090.x; Meier S, 2007, INFECT IMMUN, V75, P4562, DOI 10.1128/IAI.00392-07; MILLS JT, 1986, INFECT IMMUN, V53, P663, DOI 10.1128/IAI.53.3.663-670.1986; Mir-Sanchis I, 2012, MOL MICROBIOL, V85, P833, DOI 10.1111/j.1365-2958.2012.08145.x; Nagao M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-52; Nielsen JS, 2011, ARCH MICROBIOL, V193, P23, DOI 10.1007/s00203-010-0641-1; Novick RP, 2010, NAT REV MICROBIOL, V8, P541, DOI 10.1038/nrmicro2393; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; Novick RP, 2003, PLASMID, V49, P93, DOI 10.1016/S0147-619X(02)00157-9; Ohlsen K, 2010, INT J MED MICROBIOL, V300, P137, DOI 10.1016/j.ijmm.2009.08.016; Oscarsson J, 2005, INT J MED MICROBIOL, V295, P253, DOI 10.1016/j.ijmm.2005.05.003; Oscarsson J, 2006, J BACTERIOL, V188, P8526, DOI 10.1128/JB.00866-06; Parsonnet J, 2005, J CLIN MICROBIOL, V43, P4628, DOI 10.1128/JCM.43.9.4628-4634.2005; Pragman AA, 2004, J BACTERIOL, V186, P2430, DOI 10.1128/JB.186.8.2430-2438.2004; Pragman AA, 2007, BIOCHEMISTRY-US, V46, P314, DOI 10.1021/bi0603266; Quoc PHT, 2007, INFECT IMMUN, V75, P1079, DOI 10.1128/IAI.01143-06; Ram G, 2012, P NATL ACAD SCI USA, V109, P16300, DOI 10.1073/pnas.1204615109; RECSEI P, 1986, MOL GEN GENET, V202, P58, DOI 10.1007/BF00330517; Renzoni A, 2004, ANTIMICROB AGENTS CH, V48, P2958, DOI 10.1128/AAC.48.8.2958-2965.2004; Renzoni A, 2009, ANTIMICROB AGENTS CH, V53, P903, DOI 10.1128/AAC.01287-08; Reyes D, 2011, J BACTERIOL, V193, P6020, DOI 10.1128/JB.05436-11; Rooijakkers SHM, 2005, TRENDS MICROBIOL, V13, P596, DOI 10.1016/j.tim.2005.10.002; Said-Salim B, 2003, J BACTERIOL, V185, P610, DOI 10.1128/JB.185.2.610-619.2003; SARAFIAN SK, 1987, J MED MICROBIOL, V24, P75, DOI 10.1099/00222615-24-1-75; Schlievert PM, 2007, BIOCHEMISTRY-US, V46, P14349, DOI 10.1021/bi701202w; Schlievert PM, 2013, ANTIMICROB AGENTS CH, V57, P5432, DOI 10.1128/AAC.01279-13; SCHLIEVERT PM, 1984, J INFECT DIS, V149, P471, DOI 10.1093/infdis/149.3.471; Schmidt KA, 2003, INFECT IMMUN, V71, P5139, DOI 10.1128/IAI.71.9.5139-5148.2003; Schulthess B, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-17; Schulthess B, 2011, J BACTERIOL, V193, P4954, DOI 10.1128/JB.05362-11; Seidl K, 2008, INFECT IMMUN, V76, P5093, DOI 10.1128/IAI.00724-08; Somerville GA, 2009, MICROBIOL MOL BIOL R, V73, P233, DOI 10.1128/MMBR.00005-09; Spaan AN, 2013, ANNU REV MICROBIOL, V67, P629, DOI 10.1146/annurev-micro-092412-155746; Stevens DL, 2007, J INFECT DIS, V195, P202, DOI 10.1086/510396; Subedi A, 2007, MICROBIOL-SGM, V153, P3235, DOI 10.1099/mic.0.2007/006932-0; Sun F, 2010, J BACTERIOL, V192, P2111, DOI 10.1128/JB.01524-09; TAYLOR D, 1989, REV INFECT DIS, V11, pS151; Tegmark K, 2000, MOL MICROBIOL, V37, P398, DOI 10.1046/j.1365-2958.2000.02003.x; Ubeda C, 2005, MOL MICROBIOL, V56, P836, DOI 10.1111/j.1365-2958.2005.04584.x; Ubeda C, 2008, MOL MICROBIOL, V67, P493, DOI 10.1111/j.1365-2958.2007.06027.x; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; Vaudaux P, 2002, INFECT IMMUN, V70, P5428, DOI 10.1128/IAI.70.10.5428-5437.2002; Vojtov N, 2002, P NATL ACAD SCI USA, V99, P10102, DOI 10.1073/pnas.152152499; Weinrick B, 2004, J BACTERIOL, V186, P8407, DOI 10.1128/JB.186.24.8407-8423.2004; Yarwood JM, 2000, J CLIN MICROBIOL, V38, P1797, DOI 10.1128/JCM.38.5.1797-1803.2000; Yarwood JM, 2001, J BACTERIOL, V183, P1113, DOI 10.1128/JB.183.4.1113-1123.2001; Zielinska AK, 2011, J BACTERIOL, V193, P2948, DOI 10.1128/JB.01517-10	108	24	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135579	10.1371/journal.pone.0135579	http://dx.doi.org/10.1371/journal.pone.0135579			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275216	Green Published, gold, Green Submitted			2022-12-26	WOS:000359493600080
J	Shershakova, N; Bashkatova, E; Babakhin, A; Andreev, S; Nikonova, A; Shilovsky, I; Kamyshnikov, O; Buzuk, A; Elisyutina, O; Fedenko, E; Khaitov, M				Shershakova, Nadezda; Bashkatova, Elena; Babakhin, Alexander; Andreev, Sergey; Nikonova, Alexandra; Shilovsky, Igor; Kamyshnikov, Oleg; Buzuk, Andrey; Elisyutina, Olga; Fedenko, Elena; Khaitov, Musa			Allergen-Specific Immunotherapy with Monomeric Allergoid in a Mouse Model of Atopic Dermatitis	PLOS ONE			English	Article							BOVINE SERUM-ALBUMIN; EPICUTANEOUS SENSITIZATION; LYSINE SUCCINYLATION; AIRWAY INFLAMMATION; PROTEINS; IL-17; SKIN; MECHANISMS; EXPOSURE; EFFICACY	Atopic dermatitis (AD) is a widespread and difficult to treat allergic skin disease and is a tough challenge for healthcare. In this study, we investigated whether allergen-specific immunotherapy (ASIT) with a monomeric allergoid obtained by succinylation of ovalbumin (sOVA) is effective in a mouse model of atopic dermatitis. An experimental model of AD was reproduced by epicutaneous sensitization with ovalbumin (OVA). ASIT was performed with subcutaneous (SC) administration of increasing doses of OVA or sOVA. The levels of anti-OVA antibodies, as well as cytokines, were detected by ELISA. Skin samples from patch areas were taken for histologic examination. ASIT with either OVA or sOVA resulted in a reduction of both the anti-OVA IgE level and the IgG1/IgG2a ratio. Moreover, ASIT with sOVA increased the IFN-gamma level in supernatants after splenocyte stimulation with OVA. Histologic analysis of skin samples from the sites of allergen application showed that ASIT improved the histologic picture by decreasing allergic inflammation in comparison with untreated mice. These data suggest that ASIT with a succinylated allergen represents promising approach for the treatment of AD.	[Shershakova, Nadezda; Bashkatova, Elena; Babakhin, Alexander; Andreev, Sergey; Nikonova, Alexandra; Shilovsky, Igor; Kamyshnikov, Oleg; Khaitov, Musa] Fed Med Biol Agcy Russia, Natl Res Ctr, Dept Nanobiomed Technol, Inst Immunol, Moscow, Russia; [Elisyutina, Olga; Fedenko, Elena] Fed Med Biol Agcy Russia, Natl Res Ctr, Dept Skin Allergol & Immunopathol, Inst Immunol, Moscow, Russia; [Buzuk, Andrey] Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, London, England	NRC Institute of Immunology FMBA of Russia; NRC Institute of Immunology FMBA of Russia; Imperial College London	Shershakova, N (corresponding author), Fed Med Biol Agcy Russia, Natl Res Ctr, Dept Nanobiomed Technol, Inst Immunol, Moscow, Russia.	nn.shershakova@nrcii.ru; sm.andreev@nrcii.ru; mr.khaitov@nrcii.ru	Khaitov, Musa R/L-3369-2017; Elisyutina, Olga/S-2549-2016; Shershakova, Nadezda/AAW-8734-2020; Fedenko, Elena S./P-6912-2015; Baraboshkina, Elena/G-6848-2017; Khaitov, Musa/AAC-1516-2021; Fedenko, Elena/AAH-9814-2020; Nikonova, Alexandra/A-4206-2014	Khaitov, Musa R/0000-0003-4961-9640; Elisyutina, Olga/0000-0002-4609-2591; Shershakova, Nadezda/0000-0001-6444-6499; Fedenko, Elena S./0000-0003-3358-5087; Khaitov, Musa/0000-0003-4961-9640; Fedenko, Elena/0000-0003-3358-5087; Nikonova, Alexandra/0000-0001-9610-0935	Ministry of Science and Education of the Russian Federation, Federal target program "Research and development on priority directions of scientific-technological complex of Russia" [14.604.21.0059, RFMEFI60414X0059]	Ministry of Science and Education of the Russian Federation, Federal target program "Research and development on priority directions of scientific-technological complex of Russia"	This work was supported by the Ministry of Science and Education of the Russian Federation, the Federal target program "Research and development on priority directions of scientific-technological complex of Russia in 2014 - 2020" (agreement 14.604.21.0059, the unique identifier RFMEFI60414X0059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalberse RC, 2011, ALLERGY, V66, P1261, DOI 10.1111/j.1398-9995.2011.02656.x; Akdis CA, 2000, INT ARCH ALLERGY IMM, V121, P261, DOI 10.1159/000024352; Akdis CA, 2012, NAT MED, V18, P736, DOI 10.1038/nm.2754; ANDREEV SM, 1986, BIOORG KHIM+, V12, P725; ANDREEV SM, 1987, BIOORG KHIM+, V13, P696; Arkwright PD, 2013, J ALLER CL IMM-PRACT, V1, P142, DOI 10.1016/j.jaip.2012.09.002; Babakhin A.A., 2011, IMMUNOPHARMACOGENOMI, V7, P17; Babakhin A.A., 2011, IMMUNOFARMAKOGENOMIK, V11, P3; BABAKHIN AA, 1995, ALLERGY PROC, V16, P261, DOI 10.2500/108854195778702620; Bae JM, 2013, J ALLERGY CLIN IMMUN, V132, P110, DOI 10.1016/j.jaci.2013.02.044; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Bieber T, 2010, ANN DERMATOL, V22, P125, DOI 10.5021/ad.2010.22.2.125; Bieber T, 2009, CURR ALLERGY ASTHM R, V9, P291, DOI 10.1007/s11882-009-0041-2; Bonness S, 2007, CURR OPIN ALLERGY CL, V7, P382, DOI 10.1097/ACI.0b013e3282a643c3; Bussmann C, 2007, CLIN EXP ALLERGY, V37, P1277, DOI 10.1111/j.1365-2222.2007.02783.x; Calderon M.A., 2012, CLIN TRANSL ALLERGY, V2, P1, DOI DOI 10.1186/2045-7022-2-20; CHANG TS, 1978, INT J PEPT PROT RES, V11, P65; Compalati E, 2012, CURR OPIN ALLERGY CL, V12, P427, DOI 10.1097/ACI.0b013e328354e540; Darsow U, 2011, CURR ALLERGY ASTHM R, V11, P277, DOI 10.1007/s11882-011-0194-7; Dioszeghy V, 2011, J IMMUNOL, V186, P5629, DOI 10.4049/jimmunol.1003134; Gushchin I. S., 1997, Russ J Immunol, V2, P111; HABEEB AFS, 1966, ANAL BIOCHEM, V14, P328, DOI 10.1016/0003-2697(66)90275-2; He R, 2007, P NATL ACAD SCI USA, V104, P15817, DOI 10.1073/pnas.0706942104; He R, 2009, J ALLERGY CLIN IMMUN, V124, P761, DOI 10.1016/j.jaci.2009.07.040; Jutel M, 2011, ALLERGY, V66, P725, DOI 10.1111/j.1398-9995.2011.02589.x; Kezic S, 2014, FRONT BIOSCI-LANDMRK, V19, P541, DOI 10.2741/4225; Khaitov M.R., 2004, ROSSIYSKIY ALLERGOLO, V1, P73; Kushak RI, 1987, IZVESTIA ACAD NAUK L, V7, P74; Liu ZX, 2014, NUCLEIC ACIDS RES, V42, pD531, DOI 10.1093/nar/gkt1093; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; MISTRELLO G, 1994, IMMUNOL LETT, V40, P31, DOI 10.1016/0165-2478(94)90202-X; Mosges R, 2010, ACTA DERMATOVEN ALP, V19, P3; Mondoulet L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031967; Nakatsukasa H, 2009, J HEALTH SCI, V55, P516, DOI 10.1248/jhs.55.516; Noon L, 1911, LANCET, V1, P1572; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Passalacqua G, 1998, LANCET, V351, P629, DOI 10.1016/S0140-6736(97)07055-4; Ring J, 2012, J EUR ACAD DERMATOL, V26, P1176, DOI 10.1111/j.1468-3083.2012.04636.x; Shershakova N.N., 2011, PHYSL PATHOLOGIYA IM, V18, P3; Silva CJSM, 2004, FOOD TECHNOL BIOTECH, V42, P51; Spergel JM, 1998, J CLIN INVEST, V101, P1614, DOI 10.1172/JCI1647; TAYYAB S, 1986, J BIOCHEM, V100, P1125, DOI 10.1093/oxfordjournals.jbchem.a121816; Toda M, 2003, J ALLERGY CLIN IMMUN, V111, P875, DOI 10.1067/mai.2003.1414; Weinert BT, 2013, CELL REP, V4, P842, DOI 10.1016/j.celrep.2013.07.024; Wollenberg A, 2012, ANN DERMATOL, V24, P253, DOI 10.5021/ad.2012.24.3.253; Yu JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039032; Zhang ZH, 2011, NAT CHEM BIOL, V7, P58, DOI [10.1038/nchembio.495, 10.1038/NCHEMBIO.495]	47	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135070	10.1371/journal.pone.0135070	http://dx.doi.org/10.1371/journal.pone.0135070			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275152	Green Published, gold, Green Submitted			2022-12-26	WOS:000359493600049
J	Kegulian, NC; Sankhagowit, S; Apostolidou, M; Jayasinghe, SA; Malmstadt, N; Butler, PC; Langen, R				Kegulian, Natalie C.; Sankhagowit, Shalene; Apostolidou, Melania; Jayasinghe, Sajith A.; Malmstadt, Noah; Butler, Peter C.; Langen, Ralf			Membrane Curvature-sensing and Curvature-inducing Activity of Islet Amyloid Polypeptide and Its Implications for Membrane Disruption	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-BAR DOMAIN; ALPHA-SYNUCLEIN OLIGOMERS; AMPHIPATHIC HELICES; LIPID-BILAYERS; ANTIMICROBIAL PEPTIDE; HUMAN AMYLIN; MECHANISM; ENDOPHILIN; TOXICITY; PROTEINS	Islet amyloid polypeptide (IAPP) is a 37-amino acid amyloid protein intimately associated with pancreatic islet beta-cell dysfunction and death in type II diabetes. In this study, we combine spectroscopic methods and microscopy to investigate alpha-helical IAPP-membrane interactions. Using light scattering and fluorescence microscopy, we observe that larger vesicles become smaller upon treatment with human or rat IAPP. Electron microscopy shows the formation of various highly curved structures such as tubules or smaller vesicles in a membrane-remodeling process, and spectrofluorometric detection of vesicle leakage shows disruption of membrane integrity. This effect is stronger for human IAPP than for the less toxic rat IAPP. From CD spectra in the presence of different-sized vesicles, we also uncover the membrane curvature-sensing ability of IAPP and find that it transitions from inducing to sensing membrane curvature when lipid negative charge is decreased. Our in vivo EM images of immunogold-labeled rat IAPP and human IAPP show both forms to localize to mitochondrial cristae, which contain not only locally curved membranes but also phosphatidylethanolamine and cardiolipin, lipids with high spontaneous negative curvature. Disruption of membrane integrity by induction of membrane curvature could apply more broadly to other amyloid proteins and be responsible for membrane damage observed in other amyloid diseases as well.	[Kegulian, Natalie C.; Apostolidou, Melania; Jayasinghe, Sajith A.; Langen, Ralf] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Sankhagowit, Shalene; Malmstadt, Noah] Univ So Calif, Mork Family Dept Chem Engn & Mat Sci, Los Angeles, CA 90089 USA; [Butler, Peter C.] Univ Calif Los Angeles, David Geffen Sch Med, Larry Hillblom Islet Res Ctr, Los Angeles, CA 90095 USA	University of Southern California; University of Southern California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Langen, R (corresponding author), Zilkha Neurogenet Inst, Dept Biochem & Mol Biol, 1501 San Pablo St,ZNI 119, Los Angeles, CA 90089 USA.	langen@usc.edu	Kegulian, Natalie/AAF-1086-2022; Malmstadt, Noah/GQA-6198-2022; Regan, Clinton/E-6250-2012; Kegulian, Natalie/AFF-8981-2022	butler, peter/0000-0002-2981-8979; Kegulian, Natalie/0000-0002-8574-1099	National Institutes of Health [G027936, GM063915, 1R01GM093279, 5T32GM067587-10]; NIDDK [DK-059579]; National Science Foundation [CMMI-1068212]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067587, R01GM063915, R01GM093279] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants G027936 and GM063915 (to R. L.) and 1R01GM093279 (to N. M.) and Grant DK-059579 from the NIDDK (to P. C. B.). This work was also supported by National Science Foundation Award CMMI-1068212 (to N. M.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by National Institutes of Health Predoctoral Training Grant 5T32GM067587-10.	Allende D, 2005, BIOPHYS J, V88, P1828, DOI 10.1529/biophysj.104.049817; Almeida PF, 2009, BIOCHEMISTRY-US, V48, P8083, DOI 10.1021/bi900914g; Ambroso MR, 2014, P NATL ACAD SCI USA, V111, P6982, DOI 10.1073/pnas.1402233111; ANGELOVA MI, 1992, PROG COLL POL SCI S, V89, P127; Apostolidou M, 2008, J BIOL CHEM, V283, P17205, DOI 10.1074/jbc.M801383200; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Bertelsen K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047745; Bhatia VK, 2009, EMBO J, V28, P3303, DOI 10.1038/emboj.2009.261; Boassa D, 2013, J NEUROSCI, V33, P2605, DOI 10.1523/JNEUROSCI.2898-12.2013; Bram Yaron, 2014, Sci Rep, V4, P4267, DOI 10.1038/srep04267; Brender JR, 2008, J AM CHEM SOC, V130, P6424, DOI 10.1021/ja710484d; Brender JR, 2007, BBA-BIOMEMBRANES, V1768, P2026, DOI 10.1016/j.bbamem.2007.07.001; Brender JR, 2013, PHYS CHEM CHEM PHYS, V15, P8908, DOI 10.1039/c3cp44696d; Brender JR, 2011, BIOPHYS J, V100, P685, DOI 10.1016/j.bpj.2010.09.070; Brender JR, 2008, BIOCHEMISTRY-US, V47, P12680, DOI 10.1021/bi801427c; Burke KA, 2013, BBA-BIOMEMBRANES, V1828, P1953, DOI 10.1016/j.bbamem.2013.04.025; BUTLER PC, 1990, DIABETES, V39, P752, DOI 10.2337/diabetes.39.6.752; Caillon L, 2013, BBA-BIOMEMBRANES, V1828, P2091, DOI 10.1016/j.bbamem.2013.05.014; Campelo F, 2008, BIOPHYS J, V95, P2325, DOI 10.1529/biophysj.108.133173; Cao P, 2013, P NATL ACAD SCI USA, V110, P19279, DOI 10.1073/pnas.1305517110; Chang WK, 2008, BBA-BIOMEMBRANES, V1778, P2430, DOI 10.1016/j.bbamem.2008.06.016; COOPER GJS, 1987, P NATL ACAD SCI USA, V84, P8628, DOI 10.1073/pnas.84.23.8628; Cui HS, 2013, BIOPHYS J, V104, P404, DOI 10.1016/j.bpj.2012.12.006; Cui HS, 2011, BIOPHYS J, V100, P1271, DOI 10.1016/j.bpj.2011.01.036; Daum G, 1997, PROG LIPID RES, V36, P103, DOI 10.1016/S0163-7827(97)00006-4; Der-Sarkissian A, 2003, J BIOL CHEM, V278, P37530, DOI 10.1074/jbc.M305266200; Engel MFM, 2008, P NATL ACAD SCI USA, V105, P6033, DOI 10.1073/pnas.0708354105; Frey TG, 2002, BBA-BIOENERGETICS, V1555, P196, DOI 10.1016/S0005-2728(02)00278-5; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Gazit E, 1996, J MOL BIOL, V258, P860, DOI 10.1006/jmbi.1996.0293; Gennis R. B., 1989, BIOMEMBRANE, P80; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; Green JD, 2004, J MOL BIOL, V342, P877, DOI 10.1016/j.jmb.2004.07.052; Gurlo T, 2010, AM J PATHOL, V176, P861, DOI 10.2353/ajpath.2010.090532; Heyl DL, 2010, INT J PEPT RES THER, V16, P43, DOI 10.1007/s10989-010-9202-3; Horvath SE, 2013, PROG LIPID RES, V52, P590, DOI 10.1016/j.plipres.2013.07.002; Janson J, 1996, P NATL ACAD SCI USA, V93, P7283, DOI 10.1073/pnas.93.14.7283; Janson J, 1999, DIABETES, V48, P491, DOI 10.2337/diabetes.48.3.491; Jao CC, 2010, J BIOL CHEM, V285, P20164, DOI 10.1074/jbc.M110.127811; Jao CC, 2008, P NATL ACAD SCI USA, V105, P19666, DOI 10.1073/pnas.0807826105; Jayasinghe SA, 2005, BIOCHEMISTRY-US, V44, P12113, DOI 10.1021/bi050840w; Jayasinghe SA, 2007, BBA-BIOMEMBRANES, V1768, P2002, DOI 10.1016/j.bbamem.2007.01.022; Knight JD, 2004, J MOL BIOL, V341, P1175, DOI 10.1016/j.jmb.2004.06.086; Knight JD, 2006, BIOCHEMISTRY-US, V45, P9496, DOI 10.1021/bi060579z; Kumar S, 2015, CHEM BIOL, V22, P369, DOI 10.1016/j.chembiol.2015.01.006; Langham AA, 2008, J AM CHEM SOC, V130, P4338, DOI 10.1021/ja0780380; Last NB, 2013, P NATL ACAD SCI USA, V110, P6382, DOI 10.1073/pnas.1219059110; Last NB, 2011, P NATL ACAD SCI USA, V108, P9460, DOI 10.1073/pnas.1102356108; Low C, 2008, BIOPHYS J, V95, P4315, DOI 10.1529/biophysj.108.134155; Madsen KL, 2010, FEBS LETT, V584, P1848, DOI 10.1016/j.febslet.2010.01.053; Magzoub M, 2012, FASEB J, V26, P1228, DOI 10.1096/fj.11-194613; MATSUZAKI K, 1995, BIOCHEMISTRY-US, V34, P6521, DOI 10.1021/bi00019a033; Mizuno N, 2012, J BIOL CHEM, V287, P29301, DOI 10.1074/jbc.M112.365817; Nanga RPR, 2011, BBA-BIOMEMBRANES, V1808, P2337, DOI 10.1016/j.bbamem.2011.06.012; OBRIEN TD, 1994, DIABETES, V43, P329, DOI 10.2337/diabetes.43.2.329; Oren Z, 1998, BIOPOLYMERS, V47, P451; Ouberai MM, 2013, J BIOL CHEM, V288, P20883, DOI 10.1074/jbc.M113.478297; Pandey AP, 2011, J PHYS CHEM B, V115, P5886, DOI 10.1021/jp1121917; Pannuzzo M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02781; Patil SM, 2009, J BIOL CHEM, V284, P11982, DOI 10.1074/jbc.M809085200; Perkins G, 1997, J STRUCT BIOL, V119, P260, DOI 10.1006/jsbi.1997.3885; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pranke IM, 2011, J CELL BIOL, V194, P88, DOI 10.1083/jcb.201011118; Relini A, 2014, ADV COLLOID INTERFAC, V207, P81, DOI 10.1016/j.cis.2013.10.015; RUSTENBECK I, 1994, LIPIDS, V29, P685, DOI 10.1007/BF02538912; Sato H, 2006, BBA-BIOMEMBRANES, V1758, P1245, DOI 10.1016/j.bbamem.2006.02.021; Sengupta D, 2008, BBA-BIOMEMBRANES, V1778, P2308, DOI 10.1016/j.bbamem.2008.06.007; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Smith PES, 2009, J AM CHEM SOC, V131, P4470, DOI 10.1021/ja809002a; Sparr E, 2004, FEBS LETT, V577, P117, DOI 10.1016/j.febslet.2004.09.075; Stefanovic AND, 2014, FEBS J, V281, P2838, DOI 10.1111/febs.12824; Terzi E, 1997, BIOCHEMISTRY-US, V36, P14845, DOI 10.1021/bi971843e; Thapa A, 2013, LANGMUIR, V29, P11713, DOI 10.1021/la4020459; Varkey J, 2013, J BIOL CHEM, V288, P17620, DOI 10.1074/jbc.M113.476697; Varkey J, 2010, J BIOL CHEM, V285, P32486, DOI 10.1074/jbc.M110.139576; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P5036, DOI 10.1073/pnas.87.13.5036; Williamson JA, 2007, PROTEIN SCI, V16, P110, DOI 10.1110/ps.062486907; Woods SC, 2006, PHILOS T R SOC B, V361, P1219, DOI 10.1098/rstb.2006.1858; Xu WX, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.051922; Zerbes RM, 2012, BIOL CHEM, V393, P1247, DOI 10.1515/hsz-2012-0239; Zhang SP, 2014, FASEB J, V28, P5083, DOI 10.1096/fj.14-251744; Zhu M, 2003, J BIOL CHEM, V278, P40186, DOI 10.1074/jbc.M305326200; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	83	28	28	1	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2015	290	43					25782	25793		10.1074/jbc.M115.659797	http://dx.doi.org/10.1074/jbc.M115.659797			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU4VA	26283787	Green Published, hybrid			2022-12-26	WOS:000363527300001
J	Li, W; Cheng, JM; Yu, KL; Epstein, HE; Guo, L; Jing, GH; Zhao, J; Du, GZ				Li, Wei; Cheng, Ji-Min; Yu, Kai-Liang; Epstein, Howard E.; Guo, Liang; Jing, Guang-Hua; Zhao, Jie; Du, Guo-Zhen			Plant Functional Diversity Can Be Independent of Species Diversity: Observations Based on the Impact of 4-Yrs of Nitrogen and Phosphorus Additions in an Alpine Meadow	PLOS ONE			English	Article							TRAIT CONVERGENCE; BIODIVERSITY LOSS; FIELD EXPERIMENT; COMMUNITY; PRODUCTIVITY; COMPETITION; DIVERGENCE; RICHNESS; STABILITY; RESPONSES	Past studies have widely documented the decrease in species diversity in response to addition of nutrients, however functional diversity is often independent from species diversity. In this study, we conducted a field experiment to examine the effect of nitrogen and phosphorus fertilization ((NH4)(2) HPO4) at 0, 15, 30 and 60 g m(-2) yr(-1) (F0, F15, F30 and F60) after 4 years of continuous fertilization on functional diversity and species diversity, and its relationship with productivity in an alpine meadow community on the Tibetan Plateau. To this purpose, three community-weighted mean trait values (specific leaf area, SLA; mature plant height, MPH; and seed size, SS) for 30 common species in each fertilization level were determined; three components of functional diversity (functional richness, FRic; functional evenness, FEve; and Rao's index of quadratic entropy, FRao) were quantified. Our results showed that: (i) species diversity sharply decreased, but functional diversity remained stable with fertilization; (ii) community-weighted mean traits (SLA and MPH) had a significant increase along the fertilization level; (iii) aboveground biomass was not correlated with functional diversity, but it was significantly correlated with species diversity and MPH. Our results suggest that decreases in species diversity due to fertilization do not result in corresponding changes in functional diversity. Functional identity of species may be more important than functional diversity in influencing aboveground productivity in this alpine meadow community, and our results also support the mass ratio hypothesis; that is, the traits of the dominant species influenced the community biomass production.	[Li, Wei; Cheng, Ji-Min; Guo, Liang] Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling 712100, Peoples R China; [Li, Wei; Cheng, Ji-Min; Guo, Liang; Jing, Guang-Hua] Chinese Acad Sci, Inst Soil & Water Conservat, Yangling 712100, Peoples R China; [Li, Wei; Cheng, Ji-Min; Guo, Liang; Jing, Guang-Hua] Minist Water Resource, Yangling 712100, Peoples R China; [Yu, Kai-Liang; Epstein, Howard E.] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22904 USA; [Zhao, Jie] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Peoples R China; [Du, Guo-Zhen] Lanzhou Univ, Sch Life Sci, Lanzhou 730000, Peoples R China	Northwest A&F University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; University of Virginia; Northwest A&F University - China; Lanzhou University	Li, W (corresponding author), Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling 712100, Peoples R China.	liwei2013@nwsuaf.edu.cn			Key Program of National Natural Science Foundation of China [40930533]; Natural Science Foundation of China [41230852]; Key Program of Chinese Academy of Sciences [KJZD-EW-TZ-G10]; Northwest A F University [Z109021107, Z109021307, QN2013070]; West Light Foundation of Chinese Academy of Sciences [K318021305]; China Scholarship Council	Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program of Chinese Academy of Sciences(Chinese Academy of Sciences); Northwest A F University; West Light Foundation of Chinese Academy of Sciences(Chinese Academy of Sciences); China Scholarship Council(China Scholarship Council)	This study was supported by Key Program of National Natural Science Foundation of China (40930533), Natural Science Foundation of China (41230852), Key Program of Chinese Academy of Sciences (KJZD-EW-TZ-G10), Northwest A & F University (Z109021107, Z109021307, QN2013070), West Light Foundation of Chinese Academy of Sciences (K318021305) and the China Scholarship Council.	Ackerly DD, 2007, ECOL LETT, V10, P135, DOI 10.1111/j.1461-0248.2006.01006.x; Casanoves F, 2011, METHODS ECOL EVOL, V2, P233, DOI 10.1111/j.2041-210X.2010.00082.x; Chalcraft DR, 2008, ECOLOGY, V89, P2165, DOI 10.1890/07-0971.1; Clark CM, 2008, NATURE, V451, P712, DOI 10.1038/nature06503; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Cornwell WK, 2006, ECOLOGY, V87, P1465, DOI 10.1890/0012-9658(2006)87[1465:ATTFHF]2.0.CO;2; Crist TO, 2003, AM NAT, V162, P734, DOI 10.1086/378901; de Bello F, 2006, ECOGRAPHY, V29, P801, DOI 10.1111/j.2006.0906-7590.04683.x; de Bello F, 2011, METHODS ECOL EVOL, V2, P163, DOI 10.1111/j.2041-210X.2010.00071.x; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Dickson TL, 2014, ECOLOGY, V95, P2443, DOI 10.1890/13-1875.1; Du MY, 2004, GLOBAL PLANET CHANGE, V41, P241, DOI 10.1016/j.gloplacha.2004.01.010; Fargione J, 2007, P ROY SOC B-BIOL SCI, V274, P871, DOI 10.1098/rspb.2006.0351; Flynn DFB, 2011, ECOLOGY, V92, P1573, DOI 10.1890/10-1245.1; Fukami T, 2005, ECOL LETT, V8, P1283, DOI 10.1111/j.1461-0248.2005.00829.x; Garnier E, 2004, ECOLOGY, V85, P2630, DOI 10.1890/03-0799; Gillman LN, 2006, ECOLOGY, V87, P1234, DOI 10.1890/0012-9658(2006)87[1234:TIOPOT]2.0.CO;2; Gough L, 2000, OIKOS, V89, P428, DOI 10.1034/j.1600-0706.2000.890302.x; Grime JP, 2006, J VEG SCI, V17, P255, DOI 10.1111/j.1654-1103.2006.tb02444.x; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Harpole WS, 2007, NATURE, V446, P791, DOI 10.1038/nature05684; Hautier Y, 2009, SCIENCE, V324, P636, DOI 10.1126/science.1169640; Isbell F, 2013, P NATL ACAD SCI USA, V110, P11911, DOI 10.1073/pnas.1310880110; Isbell FI, 2009, ECOL LETT, V12, P443, DOI 10.1111/j.1461-0248.2009.01299.x; Jiang L, 2009, J ECOL, V97, P603, DOI 10.1111/j.1365-2745.2009.01503.x; Klein JA, 2007, ECOL APPL, V17, P541, DOI 10.1890/05-0685; Laughlin DC, 2011, J ECOL, V99, P1091, DOI 10.1111/j.1365-2745.2011.01856.x; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; Li W, 2011, J PLANT ECOL, V4, P138, DOI 10.1093/jpe/rtq031; Luo YJ, 2006, J VEG SCI, V17, P417, DOI 10.1658/1100-9233(2006)17[417:IOATAF]2.0.CO;2; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; Mason NWH, 2011, J ECOL, V99, P788, DOI 10.1111/j.1365-2745.2011.01801.x; Mason NWH, 2005, OIKOS, V111, P112, DOI 10.1111/j.0030-1299.2005.13886.x; Mayfield MM, 2010, GLOBAL ECOL BIOGEOGR, V19, P423, DOI 10.1111/j.1466-8238.2010.00532.x; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Mokany K, 2008, J ECOL, V96, P884, DOI 10.1111/j.1365-2745.2008.01395.x; Mouchet MA, 2010, FUNCT ECOL, V24, P867, DOI 10.1111/j.1365-2435.2010.01695.x; Naeem S, 1998, CONSERV BIOL, V12, P39, DOI 10.1046/j.1523-1739.1998.96379.x; Niu KC, 2008, BASIC APPL ECOL, V9, P485, DOI 10.1016/j.baae.2007.06.015; Pakeman RJ, 2011, J ECOL, V99, P1143, DOI 10.1111/j.1365-2745.2011.01853.x; Rajaniemi TK, 2003, J ECOL, V91, P407, DOI 10.1046/j.1365-2745.2003.00768.x; Ricotta C, 2005, ACTA BIOTHEOR, V53, P29, DOI 10.1007/s10441-005-7001-6; Roscher C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036760; Schmid B, 2004, BASIC APPL ECOL, V5, P535, DOI 10.1016/j.baae.2004.07.001; Schumacher J, 2009, OIKOS, V118, P1659, DOI 10.1111/j.1600-0706.2009.17711.x; Shipley B, 2006, SCIENCE, V314, P812, DOI 10.1126/science.1131344; Silvertown J, 2006, J ECOL, V94, P801, DOI 10.1111/j.1365-2745.2006.01145.x; Silvertown J, 2006, ECOLOGY, V87, pS39, DOI 10.1890/0012-9658(2006)87[39:PATHOO]2.0.CO;2; Stevens MHH, 1999, J ECOL, V87, P490, DOI 10.1046/j.1365-2745.1999.00374.x; Suding KN, 2005, P NATL ACAD SCI USA, V102, P4387, DOI 10.1073/pnas.0408648102; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1; Westoby M, 1998, PLANT SOIL, V199, P213, DOI 10.1023/A:1004327224729; Yang HJ, 2012, ECOL LETT, V15, P619, DOI 10.1111/j.1461-0248.2012.01778.x	56	18	23	12	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136040	10.1371/journal.pone.0136040	http://dx.doi.org/10.1371/journal.pone.0136040			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295345	Green Published, gold, Green Submitted			2022-12-26	WOS:000359926900062
J	Penaluna, BE; Dunham, JB; Railsback, SF; Arismendi, I; Johnson, SL; Bilby, RE; Safeeq, M; Skaugset, AE				Penaluna, Brooke E.; Dunham, Jason B.; Railsback, Steve F.; Arismendi, Ivan; Johnson, Sherri L.; Bilby, Robert E.; Safeeq, Mohammad; Skaugset, Arne E.			Local Variability Mediates Vulnerability of Trout Populations to Land Use and Climate Change	PLOS ONE			English	Article							LONG-TERM TRENDS; CUTTHROAT TROUT; STREAM TEMPERATURES; SPECIES ABUNDANCE; FOREST HARVEST; CHANGE IMPACTS; MODELS; RESPONSES; HABITAT; CREEK	Land use and climate change occur simultaneously around the globe. Fully understanding their separate and combined effects requires a mechanistic understanding at the local scale where their effects are ultimately realized. Here we applied an individual-based model of fish population dynamics to evaluate the role of local stream variability in modifying responses of Coastal Cutthroat Trout (Oncorhynchus clarkii clarkii) to scenarios simulating identical changes in temperature and stream flows linked to forest harvest, climate change, and their combined effects over six decades. We parameterized the model for four neighboring streams located in a forested headwater catchment in northwestern Oregon, USA with multi-year, daily measurements of stream temperature, flow, and turbidity (20072011), and field measurements of both instream habitat structure and three years of annual trout population estimates. Model simulations revealed that variability in habitat conditions among streams (depth, available habitat) mediated the effects of forest harvest and climate change. Net effects for most simulated trout responses were different from or less than the sum of their separate scenarios. In some cases, forest harvest countered the effects of climate change through increased summer flow. Climate change most strongly influenced trout (earlier fry emergence, reductions in biomass of older trout, increased biomass of young-of-year), but these changes did not consistently translate into reductions in biomass over time. Forest harvest, in contrast, produced fewer and less consistent responses in trout. Earlier fry emergence driven by climate change was the most consistent simulated response, whereas survival, growth, and biomass were inconsistent. Overall our findings indicate a host of local processes can strongly influence how populations respond to broad scale effects of land use and climate change.	[Penaluna, Brooke E.; Johnson, Sherri L.] US Forest Serv, Pacific NW Res Stn, Corvallis, OR 97331 USA; [Penaluna, Brooke E.; Arismendi, Ivan] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; [Dunham, Jason B.] US Geol Survey, Forest Rangeland Ecosyst Sci Ctr, Corvallis Res Grp, Corvallis, OR 97331 USA; [Railsback, Steve F.] Lang Railsback & Associates, Arcata, CA 95521 USA; [Bilby, Robert E.] Weyerhaeuser Co, Federal Way, WA 98063 USA; [Safeeq, Mohammad] Univ Calif Merced, Sierra Nevada Res Inst, Merced, CA 95343 USA; [Skaugset, Arne E.] Oregon State Univ, Dept Forest Engn, Corvallis, OR 97331 USA	United States Department of Agriculture (USDA); United States Forest Service; Oregon State University; United States Department of the Interior; United States Geological Survey; University of California System; University of California Merced; Oregon State University	Penaluna, BE (corresponding author), US Forest Serv, Pacific NW Res Stn, 3200 SW Jefferson Way, Corvallis, OR 97331 USA.	Brooke.Penaluna@oregonstate.edu	Arismendi, Ivan/B-3144-2010	Arismendi, Ivan/0000-0002-8774-9350; Railsback, Steven/0000-0002-5923-9847	EPA Science to Achieve Results STAR Grant; J Frances Allen Scholarship through American Fisheries Society; Watersheds Research Cooperative at Oregon State University; US Geological Survey Forest and Rangeland Ecosystem Science Center; PNW Research Station; US Forest Service	EPA Science to Achieve Results STAR Grant; J Frances Allen Scholarship through American Fisheries Society; Watersheds Research Cooperative at Oregon State University; US Geological Survey Forest and Rangeland Ecosystem Science Center(United States Geological Survey); PNW Research Station; US Forest Service(United States Department of Agriculture (USDA)United States Forest Service)	BEP was funded by an EPA Science to Achieve Results STAR Grant and J Frances Allen Scholarship through American Fisheries Society. Additional funding support came from the Watersheds Research Cooperative at Oregon State University, US Geological Survey Forest and Rangeland Ecosystem Science Center, and the PNW Research Station with US Forest Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arismendi I, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051448; BAUER DF, 1972, J AM STAT ASSOC, V67, P687, DOI 10.2307/2284469; Berger AM, 2009, CAN J FISH AQUAT SCI, V66, P613, DOI 10.1139/F09-029; BETHKE RW, 1995, ECOL APPL, V5, P588, DOI 10.2307/1941969; Bisson Peter A., 2008, V199, P259; Black BA, 2014, SCIENCE, V345, P1498, DOI 10.1126/science.1253209; Bunnell DB, 2010, OECOLOGIA, V162, P641, DOI 10.1007/s00442-009-1487-6; Clavero M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018581; Crozier LG, 2008, GLOBAL CHANGE BIOL, V14, P236, DOI 10.1111/j.1365-2486.2007.01497.x; Darling ES, 2008, ECOL LETT, V11, P1278, DOI 10.1111/j.1461-0248.2008.01243.x; Daufresne M, 2009, P NATL ACAD SCI USA, V106, P12788, DOI 10.1073/pnas.0902080106; Esterby SR, 1996, HYDROL PROCESS, V10, P127; Gaillard JM, 2013, ECOL LETT, V16, P48, DOI 10.1111/ele.12059; Gregory Stanley V., 2008, V199, P237; Groom JD, 2011, FOREST ECOL MANAG, V262, P1618, DOI 10.1016/j.foreco.2011.07.012; Hall J.D., 2004, P365; Hamed KH, 1998, J HYDROL, V204, P182, DOI 10.1016/S0022-1694(97)00125-X; Hartman G. F., 1990, CANADIAN B FISHERIES, V223; Harvey BC, 1998, CAN J FISH AQUAT SCI, V55, P1902, DOI 10.1139/cjfas-55-8-1902; Harvey BC, 2006, T AM FISH SOC, V135, P998, DOI 10.1577/T05-233.1; Harvey BC, 2014, N AM J FISH MANAGE, V34, P247, DOI 10.1080/02755947.2013.860062; Harvey BC, 2014, ENVIRON BIOL FISH, V97, P615, DOI 10.1007/s10641-013-0186-7; HIRSCH RM, 1982, WATER RESOUR RES, V18, P107, DOI 10.1029/WR018i001p00107; Hof C, 2011, NATURE, V480, P516, DOI 10.1038/nature10650; Hollander M., 1973, NONPARAMETRIC STAT M; HOLTBY LB, 1989, CAN J FISH AQUAT SCI, V46, P1396, DOI 10.1139/f89-179; Hsieh CH, 2009, GLOBAL CHANGE BIOL, V15, P2137, DOI 10.1111/j.1365-2486.2009.01875.x; Jarema SI, 2009, GLOBAL CHANGE BIOL, V15, P508, DOI 10.1111/j.1365-2486.2008.01732.x; Jeffress MR, 2013, ECOL APPL, V23, P864, DOI 10.1890/12-0979.1; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Johnson SL, 2000, CAN J FISH AQUAT SCI, V57, P30, DOI 10.1139/cjfas-57-S2-30; Jones JA, 2004, WATER RESOUR RES, V40, P1; Kearney MR, 2010, CONSERV LETT, V3, P203, DOI 10.1111/j.1755-263X.2010.00097.x; Kendall M, 1975, MULTIVARIATE ANAL; Lande R., 2003, OXFORD SERIES ECOLOG; Leach JA, 2012, AQUAT SCI, V74, P427, DOI 10.1007/s00027-011-0238-z; Lemoine N, 2007, CONSERV BIOL, V21, P495, DOI 10.1111/j.1523-1739.2006.00633.x; Livneh B, 2013, J CLIMATE, V26, P9384, DOI 10.1175/JCLI-D-12-00508.1; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Mann HB, 1945, ECONOMETRICA, V13, P245, DOI 10.2307/1907187; Meyers EM, 2010, T AM FISH SOC, V139, P1657, DOI 10.1577/T09-192.1; Moore RD, 2005, J AM WATER RESOUR AS, V41, P763, DOI 10.1111/j.1752-1688.2005.tb04463.x; Overland JE, 2010, J MARINE SYST, V79, P305, DOI 10.1016/j.jmarsys.2008.12.009; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Penaluna BE, 2015, CAN J FISH AQUAT SCI, V72, P893, DOI 10.1139/cjfas-2014-0377; Pollock MM, 2009, J AM WATER RESOUR AS, V45, P141, DOI 10.1111/j.1752-1688.2008.00266.x; Potter KA, 2013, GLOBAL CHANGE BIOL, V19, P2932, DOI [10.1111/, 10.1111/gcb.12257]; R Development Core Team, 2012, R LANG ENV STAT COMP; Railsback S.F., 2009, PSWGTR218 USDA FOR S; Railsback S.F., 2011, INSTREAM INDIVIDUAL; Railsback S.F., 2001, GEN TECHNICAL REPORT; Railsback SF, 2002, ECOLOGY, V83, P1817, DOI 10.2307/3071767; Railsback SF, 2014, P NATL ACAD SCI USA, V111, P6109, DOI 10.1073/pnas.1320957111; Railsback Steven F., 2002, Natural Resource Modeling, V15, P83; Renwick AR, 2012, DIVERS DISTRIB, V18, P121, DOI 10.1111/j.1472-4642.2011.00827.x; Roni P, 2015, CAN J FISH AQUAT SCI, V72, P466, DOI 10.1139/cjfas-2014-0344; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Safeeq M, 2013, HYDROL PROCESS, V27, P655, DOI 10.1002/hyp.9628; Santander Meteorology Group, 2013, FUME PACK SET FUNCT; Sheridan JA, 2011, NAT CLIM CHANGE, V1, P401, DOI 10.1038/NCLIMATE1259; Steel EA, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00255.1; Surfleet CG, 2013, WEST J APPL FOR, V28, P13, DOI 10.5849/wjaf.11-038; Thackeray SJ, 2010, GLOBAL CHANGE BIOL, V16, P3304, DOI 10.1111/j.1365-2486.2010.02165.x; VANHORNE B, 1983, J WILDLIFE MANAGE, V47, P893; Walther GR, 2010, PHILOS T R SOC B, V365, P2019, DOI 10.1098/rstb.2010.0021; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Warren DR, 2012, GLOBAL CHANGE BIOL, V18, P1804, DOI 10.1111/j.1365-2486.2012.02670.x; Wenger SJ, 2013, GLOBAL CHANGE BIOL, V19, P3343, DOI 10.1111/gcb.12294; Wenger SJ, 2011, P NATL ACAD SCI USA, V108, P14175, DOI 10.1073/pnas.1103097108; Wigington PJ, 2013, J AM WATER RESOUR AS, V49, P163, DOI 10.1111/jawr.12009; Winkel W, 1997, J AVIAN BIOL, V28, P187, DOI 10.2307/3677313; Wu H, 2012, WATER RESOUR RES; Yue S, 2004, WATER RESOUR MANAG, V18, P201, DOI 10.1023/B:WARM.0000043140.61082.60	74	27	28	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135334	10.1371/journal.pone.0135334	http://dx.doi.org/10.1371/journal.pone.0135334			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295478	Green Published, gold			2022-12-26	WOS:000359926900027
J	Zhu, WJ; Xu, BH				Zhu, Wenjie; Xu, Binghe			Association of Pretreatment Anemia with Pathological Response and Survival of Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Population-Based Study	PLOS ONE			English	Article							HEMOGLOBIN LEVELS; TREATMENT RESISTANCE; RADIATION-THERAPY; PROGNOSTIC-FACTOR; TUMOR HYPOXIA; CELLS; IMPACT; ERYTHROPOIETIN; CARCINOMA; OUTCOMES	Background Anemia related to adjuvant chemotherapy might predict compromised survival in patients with breast cancer. The present population-based study was to investigate the correlation of pretreatment anemia with pathological response and long-term prognosis of breast cancer patients receiving neoadjuvant chemotherapy (NCT). Methods From 1999 to 2011, a total of 655 patients with operable or locally advanced breast cancer who underwent NCT before definitive surgery were reviewed. The patients were subdivided into anemic (baseline hemoglobin (Hb)<12.0g/dL) and non-anemic (Hb >= 12.0g/dL) groups. Comparison was made between anemic and non-anemic groups concerning the rate of pathological complete response (pCR), relapse-free survival (RFS), overall survival (OS) and cancer-specific survival (CSS). Logistic and Cox regression models were utilized to determine the predictive value of pretreatment anemia in outcomes of patients undergoing NCT. Results 166 women (25.3%) were anemic before treatment. Patients in the anemic group were less likely to achieve pCR in NCT than their non-anemic counterparts (odds ratio (OR) 0.428, 95% confidence interval (CI) 0.198-0.927, p = 0.031). Patients with baseline anemia displayed inferior 10-year RFS (59.1% vs 66.0%, p = 0.022 by log-rank), OS (75.3% vs 90.9%, p <0.001) and CSS (82.4% vs 94.4%, p<0.001) compared with those without. After adjustment for confounders, pretreatment anemia was demonstrated to correlate with elevated risk of relapse (hazard ratio (HR) 1.453, 95% CI 1.077-1.962, p = 0.015), cancer-specific mortality (HR 2.961, 95% CI 1.679-5.222, p<0.001) and all-cause mortality (HR 2.873, 95% CI 1.757-4.699, p<0.001). Conclusions Pretreatment anemia was associated with worse pathological response to NCT as well as survival status in breast cancer. Further studies are warranted to identify optimal interventions and improve the prognosis of this subgroup.	[Xu, Binghe] Chinese Acad Med Sci, Dept Med Oncol, Canc Hosp, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Xu, BH (corresponding author), Chinese Acad Med Sci, Dept Med Oncol, Canc Hosp, Beijing 100730, Peoples R China.	bhxu@hotmail.com						Aapro M, 2015, ANN ONCOL, V26, P688, DOI 10.1093/annonc/mdu579; Beresford MJ, 2006, CLIN ONCOL-UK, V18, P453, DOI 10.1016/j.clon.2006.04.006; Boehm DU, 2007, ANTICANCER RES, V27, P1223; Bottini A, 2003, BRIT J CANCER, V89, P977, DOI 10.1038/sj.bjc.6601216; Caro JJ, 2001, CANCER-AM CANCER SOC, V91, P2214, DOI 10.1002/1097-0142(20010615)91:12<2214::AID-CNCR1251>3.0.CO;2-P; Dubsky P, 2008, CLIN CANCER RES, V14, P2082, DOI 10.1158/1078-0432.CCR-07-2068; DUNPHY EP, 1989, INT J RADIAT ONCOL, V16, P1173, DOI 10.1016/0360-3016(89)90277-0; Feldmann HJ, 2001, LUNG CANCER S1, V33, P77; Flamant L, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-391; Flamant L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-191; Gilreath JA, 2014, AM J HEMATOL, V89, P203, DOI 10.1002/ajh.23628; Green SL, 1998, CANCER J SCI AM, V4, P218; Grogan M, 1999, CANCER, V86, P1528, DOI 10.1002/(SICI)1097-0142(19991015)86:8<1528::AID-CNCR20>3.0.CO;2-E; Harrison LB, 2002, ONCOLOGIST, V7, P492, DOI 10.1634/theoncologist.7-6-492; Hedley BD, 2011, CLIN CANCER RES, V17, P6151, DOI 10.1158/1078-0432.CCR-10-3298; Henke M, 2004, STRAHLENTHER ONKOL, V180, P45, DOI 10.1007/s00066-004-1123-7; Hu Kenneth, 2005, Curr Treat Options Oncol, V6, P31, DOI 10.1007/s11864-005-0011-4; Kamby C, 1999, CLIN ONCOL-UK, V11, P156, DOI 10.1053/clon.1999.9033; Khorana AA, 2008, ARCH INTERN MED, V168, P2377, DOI 10.1001/archinte.168.21.2377; Knight K, 2004, AM J MED, V116, P11, DOI 10.1016/j.amjmed.2003.12.008; Matthews NE, 2001, J NATL CANCER I, V93, P1879, DOI 10.1093/jnci/93.24.1879; PAN SS, 1981, MOL PHARMACOL, V19, P184; Rodgers GM, 2012, J NATL COMPR CANC NE, V10, P628, DOI 10.6004/jnccn.2012.0064; Sullivan R, 2008, MOL CANCER THER, V7, P1961, DOI 10.1158/1535-7163.MCT-08-0198; Thompson CA, 2006, BRIT J HAEMATOL, V135, P405, DOI 10.1111/j.1365-2141.2006.06295.x; Todaro M, 2013, CANCER RES, V73, P6393, DOI 10.1158/0008-5472.CAN-13-0248; Vaupel P, 2001, MED ONCOL, V18, P243, DOI 10.1385/MO:18:4:243; Vaupel P, 2005, TRANSFUS CLIN BIOL, V12, P5, DOI 10.1016/j.tracli.2004.11.005; Wilson J, 2007, HEALTH TECHNOL ASSES, V11, P1; Zhang YJ, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-844	30	10	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136268	10.1371/journal.pone.0136268	http://dx.doi.org/10.1371/journal.pone.0136268			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291454	gold, Green Published, Green Submitted			2022-12-26	WOS:000359919900071
J	Davis, AJ; Phillips, ML; Doherty, PF				Davis, Amy J.; Phillips, Michael L.; Doherty, Paul F., Jr.			Nest Success of Gunnison Sage-Grouse in Colorado, USA	PLOS ONE			English	Article							CENTROCERCUS-UROPHASIANUS; HABITAT SELECTION; SITE SELECTION; MONO COUNTY; PREDATION; SURVIVAL	Gunnison Sage-Grouse (Centrocercus minimus) is a species of concern for which little demographic information exists. To help fill this information gap, we investigated factors affecting nest success in two populations of Gunnison Sage-Grouse. We assessed the relative effects of (1) vegetation characteristics (e.g., shrub height, shrub cover, grass cover, and grass height), (2) temporal factors (e.g., year, timing of incubation initiation, and nest age), (3) precipitation, and (4) age of the nesting female (yearling or adult) on nest success rates. We found 177 nests in the Gunnison Basin population (that contains 85-90% of the species) from 2005-2010 and 20 nests in the San Miguel population (that contains < 10% of the species) from 2007-2010. Temporal factors had the greatest impact on nest success compared to vegetation characteristics, precipitation, and female age. Nest success varied considerably among years ranging from 4.0%-60.2% in Gunnison Basin and from 12.9%51.9% in San Miguel. Nests that were initiated earlier in the breeding season had higher nest success (at least one egg hatches). Daily nest survival rates decreased during the course of incubation. None of the vegetation characteristics we examined were strongly related to nest success.	[Davis, Amy J.; Doherty, Paul F., Jr.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Phillips, Michael L.] Colorado Pk & Wildlife, Ft Collins, CO USA	Colorado State University	Davis, AJ (corresponding author), US Anim & Plant Hlth Inspect Serv, USDA, Ft Collins, CO 80521 USA.	Amy.J.Davis@aphis.usda.gov			Colorado State University	Colorado State University	Colorado Parks and Wildlife funded the research with support from Colorado State University.	Aldridge CL, 2012, J WILDLIFE MANAGE, V76, P391, DOI 10.1002/jwmg.268; Aldridge CL, 2002, J WILDLIFE MANAGE, V66, P433, DOI 10.2307/3803176; Apa A.D., 2004, HABITAT USE MO UNPUB; Barbieri MM, 2004, ANN STAT, V32, P870, DOI 10.1214/009053604000000238; Beck T. D. I., 1975, SEX AGE DETERMINATIO; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CANFIELD R. H., 1941, JOUR FOREST, V39, P388; Coates PS, 2008, CONDOR, V110, P627, DOI 10.1525/cond.2008.8579; CONNELLY JW, 1993, CONDOR, V95, P1041, DOI 10.2307/1369443; Connelly JW, 2000, WILDLIFE SOC B, V28, P967; Connelly JW, 2011, STUDIES AVIAN BIOL, V38; Conover MR, 2010, CONDOR, V112, P331, DOI 10.1525/cond.2010.090172; Crete M, 2003, CAN J ZOOL, V81, P1808, DOI 10.1139/Z03-182; Dalke P. D., 1963, Journal of Wildlife Management, V27, P811; DAUBENMIRE R., 1959, NORTHWEST SCI, V33, P43; Davis, 2012, THESIS COLORADO STAT; Dinkins JB, 2012, AUK, V129, P600, DOI 10.1525/auk.2012.12009; Dinsmore SJ, 2002, ECOLOGY, V83, P3476, DOI 10.1890/0012-9658(2002)083[3476:ATFMAN]2.0.CO;2; Doherty KE, 2014, WILDLIFE BIOL, V20, P320, DOI 10.2981/wlb.00004; Doherty PF, 2012, J ORNITHOL, V152, pS317, DOI 10.1007/s10336-010-0598-5; GIESEN K M, 1982, Wildlife Society Bulletin, V10, P224; GREGG MA, 1994, J WILDLIFE MANAGE, V58, P162, DOI 10.2307/3809563; Gunnison Sage-Grouse Rangewide Steering Committee, 2005, GUNN SAG GROUS RENG; Hagen CA, 2007, WILDLIFE BIOL, V13, P42, DOI 10.2981/0909-6396(2007)13[42:AMOGSC]2.0.CO;2; Herman-Brunson KM, 2009, WILDLIFE BIOL, V15, P395, DOI 10.2981/09-005; HINES JE, 1983, J WILDLIFE MANAGE, V47, P1063, DOI 10.2307/3808165; Holloran MJ, 2005, J WILDLIFE MANAGE, V69, P638, DOI 10.2193/0022-541X(2005)069[0638:GSNHSA]2.0.CO;2; HUPP JW, 1989, J WILDLIFE MANAGE, V53, P823, DOI 10.2307/3809220; Johnson HE, 2010, ECOL APPL, V20, P1753, DOI 10.1890/09-1107.1; Kolada EJ, 2009, J WILDLIFE MANAGE, V73, P1341, DOI 10.2193/2008-339; Kolada EJ, 2009, J WILDLIFE MANAGE, V73, P1333, DOI 10.2193/2008-338; Mabille G, 2010, POPUL ECOL, V52, P537, DOI 10.1007/s10144-010-0198-5; MARTIN TE, 1995, ECOL MONOGR, V65, P101, DOI 10.2307/2937160; Miller R, 2011, ECOLOGY CONSERVATION; Moynahan BJ, 2007, J WILDLIFE MANAGE, V71, P1773, DOI 10.2193/2005-386; Nams VO, 1990, LOCATE; National Oceanic and Atmospheric Administration, 2012, CLIM DAT ANN SUMM CO, P110; Patterson BR, 1998, CAN J ZOOL, V76, P1885, DOI 10.1139/cjz-76-10-1885; Popham GP, 2003, WILDLIFE BIOL, V9, P327, DOI 10.2981/wlb.2003.021; Powell LA, 2007, CONDOR, V109, P949, DOI 10.1650/0010-5422(2007)109[949:AVODPU]2.0.CO;2; Randa LA, 2009, J MAMMAL, V90, P594, DOI 10.1644/08-MAMM-A-092R1.1; ROBINSON SK, 1995, SCIENCE, V267, P1987, DOI 10.1126/science.267.5206.1987; Schroeder MA, 2004, CONDOR, V106, P363, DOI 10.1650/7425; Stiver JA, 2007, POLYGYNY EFFECTIVE P; Stiver JR, 2008, BIOL CONSERV, V141, P472, DOI 10.1016/j.biocon.2007.10.018; Sveum CM, 1998, J RANGE MANAGE, V51, P265, DOI 10.2307/4003409; U.S. Fish and Wildlife Service, 2014, THREAT STAT GUNN SAG; WAKKINEN WL, 1992, WILDLIFE SOC B, V20, P425; WALLESTAD R, 1974, J WILDLIFE MANAGE, V38, P630, DOI 10.2307/3800029; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Winter M, 2005, J WILDLIFE MANAGE, V69, P185, DOI 10.2193/0022-541X(2005)069&lt;0185:VIVEOD&gt;2.0.CO;2; Wisdom MJ, 1997, J WILDLIFE MANAGE, V61, P302, DOI 10.2307/3802585; Young JR, 1994, THESIS PURDUE U W LA	53	6	6	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136310	10.1371/journal.pone.0136310	http://dx.doi.org/10.1371/journal.pone.0136310			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287996	Green Published, gold, Green Submitted			2022-12-26	WOS:000360018600128
J	Raghu, A; Praveen, D; Peiris, D; Tarassenko, L; Clifford, G				Raghu, Arvind; Praveen, Devarsetty; Peiris, David; Tarassenko, Lionel; Clifford, Gari			Implications of Cardiovascular Disease Risk Assessment Using the WHO/ISH Risk Prediction Charts in Rural India	PLOS ONE			English	Article							SELECTION	Cardiovascular disease (CVD) risk in India is currently assessed using the World Health Organization/International Society for Hypertension (WHO/ISH) risk prediction charts since no population-specific models exist. The WHO/ISH risk prediction charts have two versions -one with total cholesterol as a predictor (the high information (HI) model) and the other without (the low information (LI) model). However, information on the WHO/ISH risk prediction charts including guidance on which version to use and when, as well as relative performance of the LI and HI models, is limited. This article aims to, firstly, quantify the relative performance of the LI and HI WHO/ISH risk prediction (for WHO-South East Asian Region D) using data from rural India. Secondly, we propose a pre-screening (simplified) point-of-care (POC) test to identify patients who are likely to benefit from a total cholesterol (TC) test, and subsequently when the LI model is preferential to HI model. Analysis was performed using cross-sectional data from rural Andhra Pradesh collected in 2005 with recorded blood cholesterol measurements (N = 1066). CVD risk was computed using both LI and HI models, and high risk individuals who needed treatment(T-HR) were subsequently identified based on clinical guidelines. Model development for the POC assessment of a TC test was performed through three machine learning techniques: Support Vector Machine (SVM), Regularised Logistic Regression (RLR), and Random Forests (RF) along with a feature selection process. Disagreement in CVD risk predicted by LI and HI WHO/ISH models was 14.5% (n = 155; p<0.01) overall and comprised 36 clinically relevant T-HR patients (31% of patients identified as T-HR by using either model). Using two patient-specific parameters (age, systolic blood pressure), our POC assessment can pre-determine the benefit of TC testing and choose the appropriate risk model (out-of-sample AUCs: RF-0.85, SVM-0.84, RLR: 0.82 and maximum sensitivity-98%). The identification of patients benefitting from a TC test for CVD risk stratification can aid planning for resource-allocation and save costs for large-scale screening programmes.	[Raghu, Arvind; Tarassenko, Lionel] Univ Oxford, Dept Engn Sci, Inst Biomed Engn, Oxford OX1 3PJ, England; [Praveen, Devarsetty] George Inst Global Hlth, Hyderabad, Andhra Pradesh, India; [Praveen, Devarsetty] Univ Sydney, Sydney, NSW 2006, Australia; [Peiris, David] George Inst Global Hlth, Sydney, NSW, Australia; [Clifford, Gari] Emory Univ, Atlanta, GA 30322 USA; [Clifford, Gari] Georgia Inst Technol, Atlanta, GA 30332 USA	University of Oxford; University of Sydney; George Institute for Global Health; University of Sydney; Emory University; University System of Georgia; Georgia Institute of Technology	Raghu, A (corresponding author), Univ Oxford, Dept Engn Sci, Inst Biomed Engn, Parks Rd, Oxford OX1 3PJ, England.	arvind.raghu@eng.ox.ac.uk	Clifford, Gari/GRJ-0376-2022; Praveen, Devarsetty/K-8729-2014	Clifford, Gari/0000-0002-5709-201X; Peiris, David/0000-0002-6898-3870; Praveen, Devarsetty/0000-0002-0973-943X	Wellcome Trust/EPSRC Oxford Centre for Excellence in Medical Engineering [WT 088877/Z/09/Z]; University of Oxford; Centre for Affordable Healthcare Technology; Australian Agency for International Development (AusAID); NHMRC post-doctoral fellowship [1054754]	Wellcome Trust/EPSRC Oxford Centre for Excellence in Medical Engineering(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); University of Oxford; Centre for Affordable Healthcare Technology; Australian Agency for International Development (AusAID)(Australian Aid (AusAID)); NHMRC post-doctoral fellowship(National Health and Medical Research Council (NHMRC) of Australia)	Arvind Raghu is funded by the Wellcome Trust/EPSRC Oxford Centre for Excellence in Medical Engineering (grant number WT 088877/Z/09/Z), University of Oxford and the Centre for Affordable Healthcare Technology through a donation from ARM. Devarsetty Praveen is supported by the Australian Agency for International Development (AusAID). David Peiris is supported by a NHMRC post-doctoral fellowship (ID 1054754). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 1996, OUT OF BAG ESTIMATIO; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chauhan S, 2013, INT J SCI RES PUBLIC, V3, P212; Chow C, 2007, INT J CARDIOL, V116, P180, DOI 10.1016/j.ijcard.2006.03.043; Chow CK, 2008, ATHEROSCLEROSIS, V196, P943, DOI 10.1016/j.atherosclerosis.2007.02.027; Cooney MT, 2010, CIRCULATION, V122, P300, DOI 10.1161/CIRCULATIONAHA.109.852756; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Director General of Health Services Ministry of Health and Family Welfare Government of India, 2009, MIN HLTH FAM WELF GO; Goyal A, 2006, INDIAN J MED RES, V124, P235; Gupta R, 2012, J HUM HYPERTENS, V26, P585, DOI 10.1038/jhh.2011.79; Hussain SM, 2013, ASSESSMENT CARDIOVAS, V2013; International Institute for Population Sciences, 2007, NAT FAM HLTH SURV 3; Ministry of Health and Family Welfare Government of India, 2009, NAT PROGR PREV CONTR; National Institute of Health Fogarty International Centre, 2011, NEWS ART RED GUESSW; Pednekar MS, 2009, AM J HYPERTENS, V22, P1076, DOI 10.1038/ajh.2009.131; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Praveen D, 2014, JMIR MHEALTH UHEALTH, V2, DOI 10.2196/mhealth.3568; Rodriguez-Galiano VF, 2012, ISPRS J PHOTOGRAMM, V67, P93, DOI 10.1016/j.isprsjprs.2011.11.002; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; WHO, HLTH FIN; World Bank, 2013, WORLD BANK GROUP IMPACT EVALUATIONS: RELEVANCE AND EFFECTIVENESS, P1, DOI 10.1596/978-0-8213-9717-6; World Health Organization, 2008, The global burden of disease: 2004 update; World Health Organization/International Society for Hypertension, 2011, POCK GUID ASS MAN CA; Xing JC, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r113	26	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0133618	10.1371/journal.pone.0133618	http://dx.doi.org/10.1371/journal.pone.0133618			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287807	Green Submitted, Green Published, gold			2022-12-26	WOS:000360018600006
J	Rashtak, S; Khaleghi, S; Marietta, EV; Pittelkow, MR; Larson, JJ; Lahr, BD; Murray, JA				Rashtak, Shadi; Khaleghi, Shahryar; Marietta, Eric V.; Pittelkow, Mark R.; Larson, Joseph J.; Lahr, Brian D.; Murray, Joseph A.			Isotretinoin Exposure and Risk of Celiac Disease	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; T-CELLS; IMMUNE-RESPONSES; POPULATION; PREVALENCE	Background Isotretinoin (13-cis retinoic acid) is a metabolite of vitamin A and has anti-inflammatory and immunoregulatory effects; however, a recent publication by DePaolo et al. demonstrated that in the presence of IL-15, retinoic acid can act as an adjuvant and promote inflammation against dietary proteins. Objective To evaluate the risk of overt and latent celiac disease (CD) among users of isotretinoin. Material and Methods Medical records of patients from 1995 to 2011 who had a mention of isotretinoin in their records (N = 8393) were searched for CD diagnosis using ICD-09CM codes. Isotretinoin exposure was compared across overt CD patients and their age-and gender-matched controls from the same pool. To evaluate the risk of latent CD with isotretinoin exposure, patients were overlapped with a community-based list of patients with waste serum samples that were tested for CD serology, excluding those with overt CD (2006-2011). Isotretinoin exposure was defined as the use of isotretinoin prior to CD diagnosis or serology. Results Of 8393 patients, 25 had a confirmed CD diagnosis. Compared to matched controls (N = 75), isotretinoin exposure was not significantly different between overt CD patients versus controls (36% versus 39%, respectively; P = 0.712). Likewise, latent CD defined as positive serology was not statistically different between isotretinoin exposed (N = 506) versus non-exposed (N = 571) groups (1.8% versus 1.4%, respectively; P = 0.474). Conclusions There was no association between isotretinoin use and risk of either overt or latent CD.	[Rashtak, Shadi; Marietta, Eric V.; Pittelkow, Mark R.] Mayo Clin, Dept Dermatol, Rochester, MN USA; [Khaleghi, Shahryar; Marietta, Eric V.; Murray, Joseph A.] Mayo Clin, Dept Gastroenterol & Hepatol, Rochester, MN USA; [Marietta, Eric V.; Murray, Joseph A.] Mayo Clin, Dept Immunol, Rochester, MN USA; [Larson, Joseph J.; Lahr, Brian D.] Mayo Clin, Dept Biomed Stat & Informat, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Murray, JA (corresponding author), Mayo Clin, Dept Gastroenterol & Hepatol, Rochester, MN USA.	murray.joseph@mayo.edu			National Institutes of Health [DK057982]; Mayo Clinic	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic	Funding: This study was funded by the National Institutes of Health, grant number DK057982 (Dr. Murray) and the Mayo Clinic.	Alhusayen RO, 2013, J INVEST DERMATOL, V133, P907, DOI 10.1038/jid.2012.387; Bernstein CN, 2009, AM J GASTROENTEROL, V104, P2774, DOI 10.1038/ajg.2009.417; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Crockett SD, 2010, AM J GASTROENTEROL, V105, P1986, DOI 10.1038/ajg.2010.124; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; De Palma G, 2010, J LEUKOCYTE BIOL, V87, P765, DOI 10.1189/jlb.0709471; DePaolo RW, 2011, NATURE, V471, P220, DOI 10.1038/nature09849; Etminan M, 2013, JAMA DERMATOL, V149, P216, DOI 10.1001/jamadermatol.2013.1344; Godfrey JD, 2010, GASTROENTEROLOGY, V139, P763, DOI 10.1053/j.gastro.2010.05.041; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Holtmann MH, 2004, GUT, V53, P1065, DOI 10.1136/gut.2003.038232; Iwata M, 2003, INT IMMUNOL, V15, P1017, DOI 10.1093/intimm/dxg101; Kratzer W, 2013, WORLD J GASTROENTERO, V19, P2612, DOI 10.3748/wjg.v19.i17.2612; Maiuri L, 2000, GASTROENTEROLOGY, V119, P996, DOI 10.1053/gast.2000.18149; Marild K, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-109; Mention JJ, 2003, GASTROENTEROLOGY, V125, P730, DOI 10.1016/S0016-5085(03)01047-3; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Rashtak S, 2014, JAMA DERMATOL, V150, P1322, DOI 10.1001/jamadermatol.2014.1540; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Rubio-Tapia A, 2012, AM J GASTROENTEROL, V107, P1538, DOI 10.1038/ajg.2012.219; Sanz Y, 2011, INT REV IMMUNOL, V30, P207, DOI 10.3109/08830185.2011.599084; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Zhu YF, 2013, BIOMED ENVIRON SCI, V26, P774, DOI 10.3967/0895-3988.2013.09.010	24	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135881	10.1371/journal.pone.0135881	http://dx.doi.org/10.1371/journal.pone.0135881			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287738	Green Submitted, Green Published, gold			2022-12-26	WOS:000360018600080
J	Sun, JH; Nie, CH; Zhang, YL; Zhou, GH; Ai, J; Zhou, TY; Zhu, TY; Zhang, AB; Wang, WL; Zheng, SS				Sun, Jun-Hui; Nie, Chun-Hui; Zhang, Yue-Lin; Zhou, Guan-Hui; Ai, Jing; Zhou, Tan-Yang; Zhu, Tong-Yin; Zhang, Ai-Bin; Wang, Wei-Lin; Zheng, Shu-Sen			Transcatheter Arterial Embolization Alone for Giant Hepatic Hemangioma	PLOS ONE			English	Article							CAVERNOUS HEMANGIOMA; LIVER HEMANGIOMAS; HEPATOCELLULAR-CARCINOMA; CT FINDINGS; RESECTION; PINGYANGMYCIN; TUMORS; CHEMOEMBOLIZATION; ASSOCIATION; ULTRASOUND	Giant hepatic hemangioma is a benign liver condition that may be treated using surgery. We studied the digital subtraction angiographic (DSA) characteristics of giant hepatic hemangioma, and the effectiveness of transcatheter arterial embolization (TAE) alone for its treatment. This was a retrospective study of 27 patients diagnosed with giant hepatic hemangioma and treated with TAE alone (using lipiodol mixed with pingyangmycin) at the Division of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, Zhejiang University, between January 2010 and March 2013. The feeding arteries were identified using DSA. All patients were followed up for between three weeks and 12 months. Changes in tumor diameter and symptoms were observed. The 27 patients included had giant hepatic hemangiomas ranging from 5.3 to 24.5 cm (mean, 11.24 +/- 5.08 cm) in the right (n = 13), left (n = 1) or both (n = 13) lobes. Preoperative hepatic angiography showed multiple abnormal vascular lakes in the early phase, known as the " early leaving but late returning, hanging nut on a twig" sign. On the day after TAE, hepatic transaminase levels were increased (ALT: 22.69 +/- 17.95 to 94.88 +/- 210.32 U/L; ALT: 24.00 +/- 12.37 to 99.70 +/- 211.54 U/L; both P<0.05), but not total bilirubin. Six patients complained of abdominal pain, and 12 experienced transient fever. In the months after TAE, tumor size decreased (baseline: 11.24 +/- 5.08; 3 months: 8.95 +/- 4.33; 6 months: 7.60 +/- 3.90 cm; P<0.05), and the patients' condition improved. These results indicated that TAE was effective and safe for treating giant hepatic hemangioma. TAE may be a useful alternative to surgery for the treatment of hepatic hemangioma.	[Sun, Jun-Hui; Nie, Chun-Hui; Zhang, Yue-Lin; Zhou, Guan-Hui; Zhou, Tan-Yang; Zhu, Tong-Yin; Zhang, Ai-Bin; Wang, Wei-Lin; Zheng, Shu-Sen] Zhejiang Univ, Sch Med, Hepatobiliary & Pancreat Intervent Treatment Ctr, Div Hepatobiliary & Pancreat Surg,Affiliated Hosp, Hangzhou 310003, Zhejiang, Peoples R China; [Ai, Jing] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Ophthalmol,Binjiang Branch, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Zheng, SS (corresponding author), Zhejiang Univ, Sch Med, Hepatobiliary & Pancreat Intervent Treatment Ctr, Div Hepatobiliary & Pancreat Surg,Affiliated Hosp, Hangzhou 310003, Zhejiang, Peoples R China.	medscisjh@126.com			National Clinical Key Subject Construction Project; National Natural Science Foundation of China [81371658]; Zhejiang Provincial Natural Science Foundation of China [LQ14H120001, Y2110183]; Medical Health Fund of Zhejiang Province [2013KYB097]	National Clinical Key Subject Construction Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Medical Health Fund of Zhejiang Province	This study was supported by the National Clinical Key Subject Construction Project (General Surgery), the National Natural Science Foundation of China (No. 81371658), Zhejiang Provincial Natural Science Foundation of China (No. LQ14H120001 and NO.Y2110183), and Medical Health Fund of Zhejiang Province (No. 2013KYB097).	Akamatsu Nobuhisa, 2010, J Med Case Rep, V4, P283, DOI 10.1186/1752-1947-4-283; Anderson SW, 2009, RADIOGRAPHICS, V29, P211, DOI 10.1148/rg.291085099; BELLI L, 1992, SURG GYNECOL OBSTET, V174, P474; Duxbury MS, 2010, DIGEST SURG, V27, P7, DOI 10.1159/000268108; FARGES O, 1995, WORLD J SURG, V19, P19, DOI 10.1007/BF00316974; GANDOLFI L, 1991, GUT, V32, P677, DOI 10.1136/gut.32.6.677; Gedaly R, 1999, ARCH SURG-CHICAGO, V134, P407, DOI 10.1001/archsurg.134.4.407; GRAHAM E, 1993, OBSTET GYNECOL, V81, P813; Ho Hui-Yu, 2012, Chang Gung Med J, V35, P70; Hochwald S N, 2000, HPB Surg, V11, P413, DOI 10.1155/2000/25954; Hoekstra LT, 2013, EXPERT REV GASTROENT, V7, P263, DOI [10.1586/egh.13.10, 10.1586/EGH.13.10]; Hou J, 2011, INT J ORAL MAX SURG, V40, P1246, DOI 10.1016/j.ijom.2011.07.906; Huang YD, 2014, EXP THER MED, V7, P473, DOI 10.3892/etm.2013.1428; Jain Vaibhav, 2010, Saudi J Gastroenterol, V16, P116, DOI 10.4103/1319-3767.61240; Jang HJ, 2003, AM J ROENTGENOL, V180, P135, DOI 10.2214/ajr.180.1.1800135; Jangjoo Ali, 2010, Acta Med Iran, V48, P419; JOHN TG, 1994, ANN SURG, V220, P711, DOI 10.1097/00000658-199412000-00002; Kaido T, 2003, NEW ENGL J MED, V349, pE19, DOI 10.1056/ENEJMicm010097; Kim GE, 2006, LIVER INT, V26, P334, DOI 10.1111/j.1478-3231.2005.01226.x; Kim JT, 2009, J NEUROIMAGING, V19, P394, DOI 10.1111/j.1552-6569.2009.00380.x; KRISTIDIS P, 1991, J PAEDIATR CHILD H, V27, P57, DOI 10.1111/j.1440-1754.1991.tb00348.x; Lee MG, 1996, J COMPUT ASSIST TOMO, V20, P905, DOI 10.1097/00004728-199611000-00007; Lehmann FS, 1999, J HEPATOL, V30, P951, DOI 10.1016/S0168-8278(99)80152-4; Lerner SM, 2004, ARCH SURG-CHICAGO, V139, P818, DOI 10.1001/archsurg.139.8.818; Lupinacci RM, 2011, G CHIR, V32, P469; Mahajan D, 2008, J HEPATOL, V49, P867, DOI 10.1016/j.jhep.2008.06.028; MCFARLAND EG, 1994, RADIOLOGY, V193, P43, DOI 10.1148/radiology.193.1.8090920; Ozden I, 2000, ARCH SURG-CHICAGO, V135, P978, DOI 10.1001/archsurg.135.8.978; Perkins AB, 2000, J CLIN ULTRASOUND, V28, P159, DOI 10.1002/(SICI)1097-0096(200005)28:4<159::AID-JCU1>3.0.CO;2-B; SAEGUSA T, 1995, INTERNAL MED, V34, P207, DOI 10.2169/internalmedicine.34.207; Seo HI, 2009, WORLD J GASTROENTERO, V15, P3437, DOI 10.3748/wjg.15.3437; TRASTEK VF, 1983, AM J SURG, V145, P49, DOI 10.1016/0002-9610(83)90165-4; Unal E, 2011, EXP CLIN TRANSPLANT, V9, P344; Wang ZJ, 2012, J CLIN PATHOL, V65, P146, DOI 10.1136/jclinpath-2011-200365; Yamashita Y, 1997, RADIOLOGY, V203, P121, DOI 10.1148/radiology.203.1.9122378; Yu JS, 2001, RADIOLOGY, V221, P429, DOI 10.1148/radiol.2212010339; Yue H, 2013, BRIT J OPHTHALMOL, V97, P739, DOI 10.1136/bjophthalmol-2012-302900; Zeng QG, 2004, CARDIOVASC INTER RAD, V27, P481; Zhou JX, 2013, WORLD J GASTROENTERO, V19, P2974, DOI 10.3748/wjg.v19.i19.2974	39	30	38	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135158	10.1371/journal.pone.0135158	http://dx.doi.org/10.1371/journal.pone.0135158			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287964	Green Published, gold, Green Submitted			2022-12-26	WOS:000360018600037
J	Fusco, F; D'Anzeo, G; Henneges, C; Rossi, A; Buttner, H; Nickel, JC				Fusco, Ferdinando; D'Anzeo, Gianluca; Henneges, Carsten; Rossi, Andrea; Buettner, Hartwig; Nickel, J. Curtis			Predictors of Individual Response to Placebo or Tadalafil 5mg among Men with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Integrated Clinical Data Mining Analysis	PLOS ONE			English	Article							ERECTILE DYSFUNCTION; HEALTH-STATUS; IMPACT INDEX; POOLED DATA; QUESTIONNAIRES; MANAGEMENT	Background A significant percentage of patients with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) achieve clinically meaningful improvement when receiving placebo or tadalafil 5mg once daily. However, individual patient characteristics associated with treatment response are unknown. Methods This integrated clinical data mining analysis was designed to identify factors associated with a clinically meaningful response to placebo or tadalafil 5mg once daily in an individual patient with LUTS-BPH. Analyses were performed on pooled data from four randomized, placebo-controlled, double-blind, clinical studies, including about 1,500 patients, from which 107 baseline characteristics were selected and 8 response criteria. The split set evaluation method (1,000 repeats) was used to estimate prediction accuracy, with the database randomly split into training and test subsets. Logistic Regression (LR), Decision Tree (DT), Support Vector Machine (SVM) and Random Forest (RF) models were then generated on the training subset and used to predict response in the test subset. Prediction models were generated for placebo and tadalafil 5mg once daily Receiver Operating Curve (ROC) analysis was used to select optimal prediction models lying on the ROC surface. Findings International Prostate Symptom Score (IPSS) baseline group (mild/moderate vs. severe) for active treatment and placebo achieved the highest combined sensitivity and specificity of 70% and similar to 50% for all analyses, respectively. This was below the sensitivity and specificity threshold of 80% that would enable reliable allocation of an individual patient to either the responder or non-responder group Conclusions This extensive clinical data mining study in LUTS-BPH did not identify baseline clinical or demographic characteristics that were sufficiently predictive of an individual patient response to placebo or once daily tadalafil 5mg. However, the study reaffirms the efficacy of tadalalfil 5mg once daily in the treatment of LUTS-BPH in the majority of patients and the importance of evaluating individual patient need in selecting the most appropriate treatment.	[Fusco, Ferdinando] Univ Naples Federico II, Urol Clin, Naples, Italy; [D'Anzeo, Gianluca; Rossi, Andrea] Eli Lilly Italy SpA, Sesto Fiorentino, FI, Italy; [Henneges, Carsten; Buettner, Hartwig] Lilly Deutschland GmbH, Bad Homburg, Germany; [Nickel, J. Curtis] Queens Univ, Dept Urol, Kingston, ON, Canada	University of Naples Federico II; Eli Lilly; Eli Lilly; Lilly Deutschland GmbH; Queens University - Canada	Henneges, C (corresponding author), Lilly Deutschland GmbH, Bad Homburg, Germany.	henneges_carsten@lilly.com	Rossi, Andrea/AAT-1759-2021	Rossi, Andrea/0000-0003-4019-4412; Fusco, Ferdinando/0000-0002-5158-5526	Eli Lilly and Company	Eli Lilly and Company(Eli Lilly)	This work was funded by Eli Lilly and Company. The funders were involved in the study design, data collection and analysis, decision to publish and preparation of the manuscript.	AUA Practice Guidelines Committee, 2010, AUA GUID MAN BEN PRO; Barry MJ, 2013, J UROLOGY, V189, P987, DOI 10.1016/j.juro.2012.08.257; BARRY MJ, 1995, MED CARE, V33, pAS145; BARRY MJ, 1992, J UROLOGY, V148, P1549, DOI 10.1016/S0022-5347(17)36966-5; BARRY MJ, 1995, J UROLOGY, V154, P1770, DOI 10.1016/S0022-5347(01)66780-6; Bechara A, 2014, J SEX MED, V11, P498, DOI 10.1111/jsm.12386; Bender R, 1997, J ROY COLL PHYS LOND, V31, P546; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 1993, CLASSIFICATION REGRE; Brock G, 2013, BJU INT, V112, P990, DOI 10.1111/bju.12251; Brock GB, 2014, J UROLOGY, V191, P405, DOI 10.1016/j.juro.2013.09.057; Chapple CR, 2015, EUR UROL, V67, P114, DOI 10.1016/j.eururo.2014.08.072; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; de Vet HC, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-54; Egerdie RB, 2012, J SEX MED, V9, P271, DOI 10.1111/j.1743-6109.2011.02504.x; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Gacci M, 2012, EUR UROL, V61, P994, DOI 10.1016/j.eururo.2012.02.033; Godman B, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-179; Govorov A, 2014, CENT EUR J UROL, V67, P167, DOI 10.5173/ceju.2014.02.art10; Gravas S, 2014, GUIDELINES MANAGEMEN; Hoffmann TC, 2014, JAMA-J AM MED ASSOC, V312, P1295, DOI 10.1001/jama.2014.10186; Homma Y, 1996, Int J Urol, V3, P267, DOI 10.1111/j.1442-2042.1996.tb00532.x; Iavindrasana J, 2009, Yearb Med Inform, P121; Kaplan Steven A, 2005, Rev Urol, V7 Suppl 7, pS34; Lepor Herbert, 2004, Rev Urol, V6 Suppl 1, pS8; McVary KT, 2011, J UROLOGY, V185, P1793, DOI 10.1016/j.juro.2011.01.074; Meyer D, PACKAGE E1071 MISC F; Nickel JC, 2015, BJU INT, V115, P815, DOI 10.1111/bju.12926; Oelke M, 2014, J UROLOGY, DOI [10.1016/j.juro.2014.11.094, DOI 10.1016/J.JUR0.2014.11.094]; Oelke M, 2012, EUR UROL, V61, P917, DOI 10.1016/j.eururo.2012.01.013; Park NC, 2014, SIGNIFICANCE TESTOST; Podgorelec Vili, 2002, J Med Syst, V26, P445, DOI 10.1023/A:1016409317640; Porst H, 2013, UROLOGY, V82, P667, DOI 10.1016/j.urology.2013.05.005; Porst H, 2013, J SEX MED, V10, P2044, DOI 10.1111/jsm.12212; Porst H, 2011, EUR UROL, V60, P1105, DOI 10.1016/j.eururo.2011.08.005; Roehrborn CG, 2008, J UROLOGY, V180, P1228, DOI 10.1016/j.juro.2008.06.079; Roehrborn CG, 2014, J UROLOGY, V191, P1045, DOI 10.1016/j.juro.2013.10.074; Roehrborn Claus G, 2008, Rev Urol, V10, P14; Rosen R, 2003, EUR UROL, V44, P637, DOI 10.1016/j.eururo.2003.08.015; Therneau T. M., 2012, RPART RECURSIVE PART; Um YH, 2014, NEUROENDOCRINOL LETT, V35, P116; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Viktrup L, 2012, BMC UROL, V12, DOI 10.1186/1471-2490-12-30; Yang YJ, 2014, J KOREAN MED SCI, V29, P1145, DOI 10.3346/jkms.2014.29.8.1145	44	3	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135484	10.1371/journal.pone.0135484	http://dx.doi.org/10.1371/journal.pone.0135484			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284523	Green Published, gold, Green Submitted			2022-12-26	WOS:000359666100041
J	Soonthornchai, W; Chaiyapechara, S; Jarayabhand, P; Soderhall, K; Jiravanichpaisal, P				Soonthornchai, Wipasiri; Chaiyapechara, Sage; Jarayabhand, Padermsak; Soderhall, Kenneth; Jiravanichpaisal, Pikul			Interaction of Vibrio spp. with the Inner Surface of the Digestive Tract of Penaeus monodon	PLOS ONE			English	Article							HOST-MICROBIAL INTERACTIONS; SHRIMP SICYONIA-INGENTIS; CHITIN-BINDING PROTEINS; PACIFIC WHITE SHRIMP; REAL-TIME PCR; LITOPENAEUS-VANNAMEI; INTESTINAL MICROFLORA; PERITROPHIC MEMBRANE; RELATIVE ABUNDANCE; MARINE-BACTERIA	Several species of Vibrio are the causative agent of gastroenteritis in humans. In aquaculture, Vibrio harveyi (Vh) and V. parahaemolyticus (Vp) have long been considered as shrimp pathogens in freshwater, brackish and marine environments. Here we show by using scanning electron microscopy (SEM) that Penaeus monodon orally inoculated with each of these two pathogens via an Artemia diet had numerous bacteria attached randomly across the stomach surface, in single and in large biofilm-like clusters 6 h post-infection. A subsequent marked proliferation in the number of V. harveyi within the biofilm-like formations resulted in the development of infections in the stomach, the upper and middle midgut, but neither in the posterior midgut nor the hindgut. SEM also revealed the induced production of peritrichous pili-like structures by the Vp attaching to the stomach lining, whilst only a single polar fibre was seen forming an apparent physical bridge between Vh and the host's epithelium. In contrast to these observations, no such adherences or linkages were seen when trials were conducted with non-pathogenic Vibrio spp. or with Micrococcus luteus, with no obvious resultant changes to the host's gut surface. In naive shrimp, the hindgut was found to be a favorable site for bacteria notably curved, short-rod shaped bacteria which probably belong to Vibrio spp. Data from the current study suggests that pathogens of P. monodon must be able to colonize the digestive tract, particularly the stomach, where chitin is present, and then they use an array of virulent factors and enzymes to infect their host resulting in disease. Oral infection is a better way of mimicking natural routes of infection; investigating the host-bacteria interactions occurring in the digestive tract may lead to new strategies for the prevention or control of bacterial infections in penaeids.	[Soonthornchai, Wipasiri] Chulalongkorn Univ, Program Biotechnol, Fac Sci, Bangkok 10330, Thailand; [Chaiyapechara, Sage; Jiravanichpaisal, Pikul] NSTDA, Aquat Mol Genet & Biotechnol Lab, Natl Ctr Genet Engn & Biotechnol BIOTEC, Klongluang 12120, Pathumthani, Thailand; [Jarayabhand, Padermsak] Chulalongkorn Univ, Grad Sch, Interdisciplinary Grad Program Maritime Adm, Bangkok 10330, Thailand; [Soderhall, Kenneth; Jiravanichpaisal, Pikul] Uppsala Univ, Dept Comparat Physiol, SE-75236 Uppsala, Sweden; [Jiravanichpaisal, Pikul] Fish Vet Grp Asia Ltd, Bangkok 10210, Thailand	Chulalongkorn University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Chulalongkorn University; Uppsala University	Chaiyapechara, S (corresponding author), NSTDA, Aquat Mol Genet & Biotechnol Lab, Natl Ctr Genet Engn & Biotechnol BIOTEC, 113 Paholyothin Rd,Klong 1, Klongluang 12120, Pathumthani, Thailand.	sage.cha@biotec.or.th		Chaiyapechara, Sage/0000-0002-6836-2759	Institute for the Promotion of the Teaching Science and Technology of Thailand (IPST) in the Development and Promotion of Science and Technology Talents Project (DPST); National Center for Genetic Engineering and Biotechnology (BIOTEC) [P-14-50570]	Institute for the Promotion of the Teaching Science and Technology of Thailand (IPST) in the Development and Promotion of Science and Technology Talents Project (DPST); National Center for Genetic Engineering and Biotechnology (BIOTEC)	The project received funding support from (1) the Institute for the Promotion of the Teaching Science and Technology of Thailand (IPST) in the Development and Promotion of Science and Technology Talents Project (DPST) for Ms. Wipasiri Soonthornchai's tuition, research, and stipends, and (2) National Center for Genetic Engineering and Biotechnology (BIOTEC) (Project# P-14-50570) for the detection of pathogenic Vibrio using specific PCR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin B, 2006, THESCIENTIFICWORLDJO, V6, P931, DOI 10.1100/tsw.2006.181; AVTSYN A P, 1986, Byulleten' Eksperimental'noi Biologii i Meditsiny, V102, P342; BASSLER BL, 1991, J BIOL CHEM, V266, P24268; Bignell D.E., 1989, INVERTEBRATE MICROBI, P205; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Bry L, 1996, SCIENCE, V273, P1380, DOI 10.1126/science.273.5280.1380; Ceccaldi Hubert J., 1998, Reviews in Fisheries Science, V6, P13, DOI 10.1080/10641269891314177; Chaiyapechara S, 2012, MICROB ECOL, V63, P938, DOI 10.1007/s00248-011-9936-2; Coenye T, 2003, FEMS MICROBIOL LETT, V228, P45, DOI 10.1016/S0378-1097(03)00717-1; Collins SM, 2012, NAT REV MICROBIOL, V10, P735, DOI 10.1038/nrmicro2876; Corbari L, 2012, CR BIOL, V335, P142, DOI 10.1016/j.crvi.2011.12.005; CRAWFORD CS, 1983, INT J INSECT MORPHOL, V12, P301, DOI 10.1016/0020-7322(83)90025-9; Defoirdt T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003603; Dempsey AC, 1989, CRUSTACEANA, V56, P266; Drobne Damjana, 1995, Acta Microbiologica et Immunologica Hungarica, V42, P45; Epis S, 2013, TICKS TICK-BORNE DIS, V4, P39, DOI 10.1016/j.ttbdis.2012.06.005; Farzanfar A, 2006, FEMS IMMUNOL MED MIC, V48, P149, DOI 10.1111/j.1574-695X.2006.00116.x; Fegatella F, 1998, APPL ENVIRON MICROB, V64, P4433; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; Fogel GB, 1999, MICROB ECOL, V38, P93, DOI 10.1007/s002489900162; GILDEMEISTER OS, 1994, GLYCOCONJUGATE J, V11, P518, DOI 10.1007/BF00731302; Gode-Potratz CJ, 2011, MOL MICROBIOL, V79, P240, DOI 10.1111/j.1365-2958.2010.07445.x; HARRIS JM, 1993, MICROB ECOL, V25, P195, DOI 10.1007/BF00171889; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; HUQ A, 1986, APPL ENVIRON MICROB, V52, P586, DOI 10.1128/AEM.52.3.586-588.1986; HUSEBYE E, 1994, DIGEST DIS SCI, V39, P946, DOI 10.1007/BF02087542; ISHIMARU K, 1995, INT J SYST BACTERIOL, V45, P134, DOI 10.1099/00207713-45-1-134; Jiravanichpaisal P., 1994, Journal of Aquatic Animal Health, V6, P27, DOI 10.1577/1548-8667(1994)006&lt;0027:HBAPOV&gt;2.3.CO;2; Johnson CN, 2008, J WORLD AQUACULT SOC, V39, P251, DOI 10.1111/j.1749-7345.2008.00155.x; Jonson Ann-Beth, 2005, V12, P67, DOI 10.1159/000081690; Joshi J, 2014, AQUACULTURE, V428, P297, DOI 10.1016/j.aquaculture.2014.03.030; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Keyhani NO, 1999, BBA-GEN SUBJECTS, V1473, P108, DOI 10.1016/S0304-4165(99)00172-5; Koga R, 2009, APPL ENTOMOL ZOOL, V44, P281, DOI 10.1303/aez.2009.281; KRAXBERGERBEATTY T, 1990, J FISH DIS, V13, P557, DOI 10.1111/j.1365-2761.1990.tb00819.x; Kuraishi T, 2011, P NATL ACAD SCI USA, V108, P15966, DOI 10.1073/pnas.1105994108; Lau WWY, 2002, MICROBIAL ECOL, V43, P455, DOI 10.1007/s00248-001-1043-3; LAVILLAPITOGO CR, 1990, AQUACULTURE, V91, P1, DOI 10.1016/0044-8486(90)90173-K; Lee SY, 2001, J IMMUNOL, V166, P7319, DOI 10.4049/jimmunol.166.12.7319; Li P, 2007, J NUTR, V137, P2763, DOI 10.1093/jn/137.12.2763; Lightner D.V., 1983, CRC HDB MARICULTURE, P289; Lightner DV, 1990, DISEASES OF CRUSTACE; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Martin GG, 2006, BIOL BULL-US, V211, P275, DOI 10.2307/4134549; Martin GG, 2004, DIS AQUAT ORGAN, V60, P21, DOI 10.3354/dao060021; McCarter Linda, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P51; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Mohan CV, 2012, FHS AFS, V10, P1; MONTGOMERY MT, 1994, APPL ENVIRON MICROB, V60, P4284, DOI 10.1128/AEM.60.12.4284-4288.1994; MONTGOMERY MT, 1993, APPL ENVIRON MICROB, V59, P373, DOI 10.1128/AEM.59.2.373-379.1993; Moss SM, 2000, J WORLD AQUACULT SOC, V31, P255, DOI 10.1111/j.1749-7345.2000.tb00361.x; NAGASAWA S, 1987, P JPN ACAD B-PHYS, V63, P33, DOI 10.2183/pjab.63.33; Nayduch D, 2005, INVERTEBR BIOL, V124, P74, DOI 10.1111/j.1744-7410.2005.1241-09.x; Nordstrom JL, 2007, APPL ENVIRON MICROB, V73, P5840, DOI 10.1128/AEM.00460-07; Ofek I, 2003, BACTERIAL ADHESION T; Oxley APA, 2002, J APPL MICROBIOL, V93, P214, DOI 10.1046/j.1365-2672.2002.01673.x; Peters W, 1992, PERITROPHIC MEMBRANE; Pinn EH, 1999, MAR BIOL, V133, P103, DOI 10.1007/s002270050448; Rawls JF, 2004, P NATL ACAD SCI USA, V101, P4596, DOI 10.1073/pnas.0400706101; Rendon MA, 2007, P NATL ACAD SCI USA, V104, P10637, DOI 10.1073/pnas.0704104104; Rengpipat S, 2003, DIS AQUAT ORGAN, V55, P169, DOI 10.3354/dao055169; Ringo E, 1999, AQUAC RES, V30, P73, DOI 10.1046/j.1365-2109.1999.00302.x; Rungrassamee W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091853; Rungrassamee W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060802; Shakibazadeh S, 2009, ANN MICROBIOL, V59, P425, DOI 10.1007/BF03175126; Soonthornchai W, 2010, DEV COMP IMMUNOL, V34, P19, DOI 10.1016/j.dci.2009.07.007; Sousa L, 2006, BIOCELL, V30, P287; Stappenbeck TS, 2002, P NATL ACAD SCI USA, V99, P15451, DOI 10.1073/pnas.202604299; Sung HH, 1999, J EXP MAR BIOL ECOL, V236, P261, DOI 10.1016/S0022-0981(98)00206-8; Thaithongnum S, 2006, AQUACULTURE, V261, P1, DOI 10.1016/j.aquaculture.2006.07.001; Theethakaew C, 2013, APPL ENVIRON MICROB, V79, P2358, DOI 10.1128/AEM.03067-12; Uribe A, 1997, SCAND J GASTROENTERO, V32, P691, DOI 10.3109/00365529708996520; Vaseeharan B, 2003, MICROBIOL RES, V158, P299, DOI 10.1078/0944-5013-00208; Venkateswaran K, 1998, APPL ENVIRON MICROB, V64, P681; Wang P, 1998, J INVERTEBR PATHOL, V72, P57, DOI 10.1006/jipa.1998.4759; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0	78	50	50	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135783	10.1371/journal.pone.0135783	http://dx.doi.org/10.1371/journal.pone.0135783			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285030	Green Published, gold, Green Submitted			2022-12-26	WOS:000359666100069
J	Umemura, S; Imai, S; Mimura, A; Fujiwara, M; Ebihara, S				Umemura, Shoya; Imai, Saki; Mimura, Ayumi; Fujiwara, Mari; Ebihara, Shizufumi			Impaired Maternal Behavior in Usp46 Mutant Mice: A Model for Trans-Generational Transmission of Maternal Care	PLOS ONE			English	Article							RECEPTOR SUBUNIT EXPRESSION; PARENTAL BEHAVIOR; LATER ADOPTIONS; SEXUAL-ABUSE; CHILD-ABUSE; INBRED MICE; STRESS; MALTREATMENT; RAT; MECHANISMS	Usp46 mutant mice (congenic strain on a B6 genetic background; MT mice) have a low weaning rate and display poor maternal behavior compared to C57BL/6J mice (B6 mice). Based on these observations, we examined how maternal behavior is shaped by cross-fostering and in-fostering MT and B6 mice. The experiments consisted of six groups: B6 mice fostered by their biological mother (B6-CO); MT mice fostered by their biological mother (MT-CO); B6 mice fostered by a different B6 mother (B6-IF); MT mice fostered by a different MT mother (MT-IF); B6 mice fostered by an MT mother (B6-CF); and MT mice fostered by a B6 mother (MT-CF). Maternal behavior was assessed using the pup-retrieval test in adult female offspring, and four parameters, time nursing pups in the nest, time sniffing or licking pups, rearing behavior, and latency to retrieve pups, were measured. Cross-fostering significantly reduced time spent nursing and sniffing/licking pup, and increased the number of instances of rearing in the B6-CF group, and improved three parameters of maternal behaviors (nursing, rearing and latency) in the MT-CF group. These results indicate that the level of maternal care is transmitted to their pups and proper maternal behaviors can be shaped if adequate postpartum maternal care is given, even in genetically vulnerable mice. However, the offspring's genotype may also influence the development of maternal behaviors in adulthood. Thus, MT mice may prove useful as a model for trans-generational transmission of maternal care, and these findings may provide insight into the mechanisms of maltreating behaviors in human child abuse.	[Umemura, Shoya; Imai, Saki; Mimura, Ayumi; Fujiwara, Mari; Ebihara, Shizufumi] Nagoya Univ, Grad Sch Bioagr Sci, Div Biomodeling, Nagoya, Aichi 4648601, Japan	Nagoya University	Ebihara, S (corresponding author), Kwansei Gakuin Univ, Sch Sci & Technol, Dept Biomed Chem, 2-1 Gakuen, Sanda, Hyogo 6691337, Japan.	ebihara@kwansei.ac.jp			JSPS KAKENHI [22658093, 25292186]; Life Science Foundation of Japan; Takeda Science Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Life Science Foundation of Japan(Life Science Foundation of Japan); Takeda Science Foundation(Takeda Science Foundation (TSF))	This research was supported by JSPS KAKENHI (Grant Number 22658093, 25292186), Life Science Foundation of Japan and Takeda Science Foundation to S.E.	Barbazanges A, 1996, J NEUROSCI, V16, P7783; BARTH RP, 1983, SOC SERV REV, V57, P477, DOI 10.1086/644120; Bebbington PE, 2004, BRIT J PSYCHIAT, V185, P220, DOI 10.1192/bjp.185.3.220; Berlin LJ, 2011, CHILD DEV, V82, P162, DOI 10.1111/j.1467-8624.2010.01547.x; Caldji C, 2004, NEUROPSYCHOPHARMACOL, V29, P1344, DOI 10.1038/sj.npp.1300436; Caldji C, 2003, NEUROPSYCHOPHARMACOL, V28, P1950, DOI 10.1038/sj.npp.1300237; Champagne FA, 2008, FRONT NEUROENDOCRIN, V29, P386, DOI 10.1016/j.yfrne.2008.03.003; Cicchetti D, 2006, DEV PSYCHOPATHOL, V18, P623, DOI 10.1017/S0954579406060329; Curley JP, 2010, BEHAV GENET, V40, P220, DOI 10.1007/s10519-010-9334-4; Darnaudery M, 2004, BEHAV NEUROSCI, V118, P590, DOI 10.1037/0735-7044.118.3.590; EGELAND B, 1988, CHILD DEV, V59, P1080, DOI 10.1111/j.1467-8624.1988.tb03260.x; Fluke JD, 1999, CHILD ABUSE NEGLECT, V23, P633, DOI 10.1016/S0145-2134(99)00039-3; Francis D, 1999, SCIENCE, V286, P1155, DOI 10.1126/science.286.5442.1155; Francis DD, 2003, NAT NEUROSCI, V6, P445, DOI 10.1038/nn1038; Freyd JJ, 2005, SCIENCE, V308, P501, DOI 10.1126/science.1108066; Imai S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058566; Imai S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039084; Kaffman A, 2007, J CHILD PSYCHOL PSYC, V48, P224, DOI 10.1111/j.1469-7610.2007.01730.x; Kuroda KO, 2007, MOL CELL NEUROSCI, V36, P121, DOI 10.1016/j.mcn.2007.05.010; Kuroda KO, 2011, PROG NEURO-PSYCHOPH, V35, P1205, DOI 10.1016/j.pnpbp.2011.02.008; Lu LL, 2009, BEHAV BRAIN RES, V198, P172, DOI 10.1016/j.bbr.2008.10.031; Maguire J, 2008, NEURON, V59, P207, DOI 10.1016/j.neuron.2008.06.019; Meaney MJ, 2010, CHILD DEV, V81, P41, DOI 10.1111/j.1467-8624.2009.01381.x; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; Mullen PE, 1996, CHILD ABUSE NEGLECT, V20, P7, DOI 10.1016/0145-2134(95)00112-3; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Pears KC, 2001, CHILD ABUSE NEGLECT, V25, P1439, DOI 10.1016/S0145-2134(01)00286-1; Priebe K, 2005, DEV PSYCHOBIOL, V47, P398, DOI 10.1002/dev.20098; Schury K, 2012, ANN NY ACAD SCI, V1262, P93, DOI 10.1111/j.1749-6632.2012.06617.x; Shoji H, 2009, DEV PSYCHOBIOL, V51, P345, DOI 10.1002/dev.20375; Tomida S, 2009, NAT GENET, V41, P688, DOI 10.1038/ng.344; TRIVERS RL, 1974, AM ZOOL, V14, P249; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Zhang TY, 2010, J NEUROSCI, V30, P13130, DOI 10.1523/JNEUROSCI.1039-10.2010	34	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0136016	10.1371/journal.pone.0136016	http://dx.doi.org/10.1371/journal.pone.0136016			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284364	Green Published, gold, Green Submitted			2022-12-26	WOS:000359666100096
J	Wang, M; Yang, JX; Wang, ZW; Lu, SF				Wang, Min; Yang, Jinxiu; Wang, Zhiwei; Lu, Shuangfang			Nanometer-Scale Pore Characteristics of Lacustrine Shale, Songliao Basin, NE China	PLOS ONE			English	Article							TIGHT GAS-RESERVOIR; SOIL ORGANIC-MATTER; BARNETT SHALE; ELECTRON-MICROSCOPY; MERCURY INTRUSION; THERMAL MATURITY; NORTHEAST CHINA; SURFACE-AREA; ALBANY SHALE; BLACK SHALES	In shale, liquid hydrocarbons are accumulated mainly in nanometer-scale pores or fractures, so the pore types and PSDs (pore size distributions) play a major role in the shale oil occurrence (free or absorbed state), amount of oil, and flow features. The pore types and PSDs of marine shale have been well studied; however, research on lacustrine shale is rare, especially for shale in the oil generation window, although lacustrine shale is deposited widely around the world. To investigate the relationship between nanometer-scale pores and oil occurrence in the lacustrine shale, 10 lacustrine shale core samples from Songliao Basin, NE China were analyzed. Analyses of these samples included geochemical measurements, SEM (scanning electron microscope) observations, low pressure CO2 and N-2 adsorption, and high-pressure mercury injection experiments. Analysis results indicate that: (1) Pore types in the lacustrine shale include inter-matrix pores, intergranular pores, organic matter pores, and dissolution pores, and these pores are dominated by mesopores and micropores; (2) There is no apparent correlation between pore volumes and clay content, however, a weak negative correlation is present between total pore volume and carbonate content; (3) Pores in lacustrine shale are well developed when the organic matter maturity (Ro) is >1.0% and the pore volume is positively correlated with the TOC (total organic carbon) content. The statistical results suggest that oil in lacustrine shale mainly occurs in pores with diameters larger than 40 nm. However, more research is needed to determine whether this minimum pore diameter for oil occurrence in lacustrine shale is widely applicable.	[Wang, Min; Yang, Jinxiu; Wang, Zhiwei; Lu, Shuangfang] China Univ Petr East China, RIUP & RE, Qingdao 266580, Shandong, Peoples R China; [Wang, Min] CSIRO Energy Flagship, N Ryde, NSW 2113, Australia	China University of Petroleum; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Lu, SF (corresponding author), China Univ Petr East China, RIUP & RE, Qingdao 266580, Shandong, Peoples R China.	lushuangfang@upc.edu.cn		LU, Shuangfang/0000-0002-0758-4075; WANG, MIN/0000-0003-4611-2684	"the Fundamental Research Funds for the Central Universities" [14CX05017A, 13CX05013A]; Natural Science Foundation of China [41402110, 41330313, 41172134, U1262106]; China National Petroleum Corporation Innovation Foundation [2011D-5006-0101]	"the Fundamental Research Funds for the Central Universities"(Fundamental Research Funds for the Central Universities); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China National Petroleum Corporation Innovation Foundation	This study was supported by grants from "the Fundamental Research Funds for the Central Universities" (14CX05017A, 13CX05013A), the Natural Science Foundation of China (41402110, 41330313, 41172134, U1262106) and the China National Petroleum Corporation Innovation Foundation (2011D-5006-0101).	Ambrose RJ, 2012, 131772 SPE; BARRETT EP, 1951, J AM CHEM SOC, V73, P373, DOI 10.1021/ja01145a126; BRALOWER TJ, 1994, PALAIOS, V9, P335, DOI 10.2307/3515055; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; Bustin RM, 2008, SPE SHAL GAS PROD C, DOI [10.2118/119892-MS, DOI 10.2118/119892-MS]; Cai YD, 2013, FUEL, V103, P258, DOI 10.1016/j.fuel.2012.06.055; Chalmers GR, 2012, AAPG BULL, V96, P1099, DOI 10.1306/10171111052; Chalmers GRL, 2007, INT J COAL GEOL, V70, P223, DOI 10.1016/j.coal.2006.05.001; Chalmers GRL, 2012, MAR PETROL GEOL, V38, P53, DOI 10.1016/j.marpetgeo.2012.08.004; Clarkson CR, 2013, FUEL, V103, P606, DOI 10.1016/j.fuel.2012.06.119; Clarkson CR, 2012, FUEL, V95, P371, DOI 10.1016/j.fuel.2011.12.010; Curtis ME, 2012, INT J COAL GEOL, V103, P26, DOI 10.1016/j.coal.2012.08.004; deJonge H, 1996, ENVIRON SCI TECHNOL, V30, P408, DOI 10.1021/es950043t; DUBININ MM, 1980, J COLLOID INTERF SCI, V75, P34, DOI 10.1016/0021-9797(80)90346-X; Fathi E, 2012, 146821 SPE; Feng ZQ, 2010, BASIN RES, V22, P79, DOI 10.1111/j.1365-2117.2009.00445.x; Fishman NS, 2012, INT J COAL GEOL, V103, P32, DOI 10.1016/j.coal.2012.07.012; Gao R.Q., 1997, FORMATION CONDITIONS, P104; Gong YY, 2014, MAR POLLUT BULL, V79, P16, DOI 10.1016/j.marpolbul.2013.12.024; Gregg S.J., 1982, ADSORPTION SURFACE A, V2nd, P303, DOI [10.1002/bbpc.19820861019, DOI 10.1002/BBPC.19820861019]; Groen JC, 2003, MICROPOR MESOPOR MAT, V60, P1, DOI 10.1016/S1387-1811(03)00339-1; Heath JE, 2011, GEOSPHERE, V7, P429, DOI 10.1130/GES00619.1; Javadpour F, 2009, J CAN PETROL TECHNOL, V48, P16, DOI 10.2118/09-08-16-DA; JENKYNS HC, 1980, J GEOL SOC LONDON, V137, P171, DOI 10.1144/gsjgs.137.2.0171; Kuila U., 2011, 146869 SPE; Loucks RG, 2012, AAPG BULL, V96, P1071, DOI 10.1306/08171111061; Loucks RG, 2009, J SEDIMENT RES, V79, P848, DOI 10.2110/jsr.2009.092; Mastalerz M, 2013, AAPG BULL, V97, P1621, DOI 10.1306/04011312194; Mastalerz M, 2012, ENERG FUEL, V26, P5109, DOI 10.1021/ef300735t; Melnichenko YB, 2012, FUEL, V91, P200, DOI 10.1016/j.fuel.2011.06.026; Milliken KL, 2013, AAPG BULL, V97, P177, DOI 10.1306/07231212048; Nelson PH, 2009, AAPG BULL, V93, P329, DOI 10.1306/10240808059; Pignatello JJ, 2006, ENVIRON SCI TECHNOL, V40, P7757, DOI 10.1021/es061307m; Ran Y, 2013, J ENVIRON QUAL, V42, P806, DOI 10.2134/jeq2012.0286; Reed RM, 2014, INT J COAL GEOL, V127, P111, DOI 10.1016/j.coal.2013.11.012; Rippen D, 2013, ORG GEOCHEM, V63, P18, DOI 10.1016/j.orggeochem.2013.07.013; Romero-Sarmiento MF, 2014, ORG GEOCHEM, V71, P7, DOI 10.1016/j.orggeochem.2014.03.008; Schmitt M, 2013, MAR PETROL GEOL, V39, P138, DOI 10.1016/j.marpetgeo.2012.09.001; Sing K., 1985, PURE APPL CHEM, V5714, P603, DOI DOI 10.1351/PAC198557040603; Strapoc D, 2010, AAPG BULL, V94, P1713, DOI 10.1306/06301009197; Tian H, 2013, MAR PETROL GEOL, V48, P8, DOI 10.1016/j.marpetgeo.2013.07.008; Wang M, 2011, MAR PETROL GEOL, V28, P1714, DOI 10.1016/j.marpetgeo.2011.07.004; Wang Y, 2014, ENERG FUEL, V28, P945, DOI 10.1021/ef402159e; Xing BS, 1997, ENVIRON SCI TECHNOL, V31, P792, DOI 10.1021/es960481f; [姚军 Yao Jun], 2013, [中国科学. 物理学, 力学, 天文学, Scientia Sinica Physica, Mechanica & Astronomica], V43, P1527; Zeng L, 2010, OIL GAS IND STANDARD; Zhang TW, 2012, ORG GEOCHEM, V47, P120, DOI 10.1016/j.orggeochem.2012.03.012; [朱如凯 Zhu Rukai], 2013, [古地理学报, Journal of Palaeogeography], V15, P615; Zou CN, 2011, ACTA PETROL SIN, V27, P1857	49	24	23	7	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135252	10.1371/journal.pone.0135252	http://dx.doi.org/10.1371/journal.pone.0135252			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285123	Green Submitted, gold, Green Published			2022-12-26	WOS:000359666100030
J	Yoshioka, K; Oda, A; Notsu, C; Ohtsuka, T; Kawai, Y; Suzuki, S; Nakamura, T; Mabuchi, Y; Matsuzaki, Y; Goitsuka, R				Yoshioka, Kentaro; Oda, Akihisa; Notsu, Chihiro; Ohtsuka, Takafumi; Kawai, Yasuhiro; Suzuki, Sadafumi; Nakamura, Takuro; Mabuchi, Yo; Matsuzaki, Yumi; Goitsuka, Ryo			Loss of the Homeodomain Transcription Factor Prep1 Perturbs Adult Hematopoiesis in the Bone Marrow	PLOS ONE			English	Article							STEM-CELLS; MEIS1; PKNOX1; PBX; HOX; PROTEIN; MICE; GENE; DNA; RECEPTOR	Prep1, a TALE-family homeodomain transcription factor, has been demonstrated to play a critical role in embryonic hematopoiesis, as its insufficiency caused late embryonic lethality associated with defective hematopoiesis and angiogenesis. In the present study, we generated hematopoietic- and endothelial cell-specific Prep1-deficient mice and demonstrated that expression of Prep1 in the hematopoietic cell compartment is not essential for either embryonic or adult hematopoiesis, although its absence causes significant hematopoietic abnormalities in the adult bone marrow. Loss of Prep1 promotes cell cycling of hematopoietic stem/progenitor cells (HSPC), leading to the expansion of the HSPC pool. Prep1 deficiency also results in the accumulation of lineage-committed progenitors, increased monocyte/macrophage differentiation and arrested erythroid maturation. Maturation of T cells and B cells is also perturbed in Prep-deficient mice. These findings provide novel insight into the pleiotropic roles of Prep1 in adult hematopoiesis that were unrecognized in previous studies using germline Prep1 hypomorphic mice.	[Yoshioka, Kentaro; Oda, Akihisa; Notsu, Chihiro; Ohtsuka, Takafumi; Kawai, Yasuhiro; Goitsuka, Ryo] Tokyo Univ Sci, Res Inst Biomed Sci, Div Dev & Aging, Noda, Chiba 278, Japan; [Suzuki, Sadafumi] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 160, Japan; [Nakamura, Takuro] Japanese Fdn Canc Res, Inst Canc, Div Carcinogenesis, Koto Ku, Tokyo 170, Japan; [Mabuchi, Yo] Tokyo Med & Dent Univ, Grad Sch Hlth Care Sci, Dept Biochem & Biophys, Bunkyo Ku, Tokyo, Japan; [Matsuzaki, Yumi] Shimane Univ, Fac Med, Dept Canc Biol, Izumo, Shimane, Japan	Tokyo University of Science; Keio University; Japanese Foundation for Cancer Research; Tokyo Medical & Dental University (TMDU); Shimane University	Goitsuka, R (corresponding author), Tokyo Univ Sci, Res Inst Biomed Sci, Div Dev & Aging, Noda, Chiba 278, Japan.	ryogoi@rs.noda.tus.ac.jp	Mabuchi, Yo/L-1535-2013	Mabuchi, Yo/0000-0001-8008-3966; Matsuzaki, Yumi/0000-0002-3729-2997	Ministry of Education, Culture, Sports, Science, and Technology of Japan [25111513, 25292194, 15H01163]; Grants-in-Aid for Scientific Research [26660259] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work has been supported by Grant-in-Aid for Scientific Research (25111513, 25292194 and 15H01163 to R. G.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Arata Y, 2006, DEV CELL, V11, P105, DOI 10.1016/j.devcel.2006.04.020; Ariki R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087646; Bauer A, 1999, GENE DEV, V13, P2996, DOI 10.1101/gad.13.22.2996; Berthelsen J, 1998, GENOMICS, V47, P323, DOI 10.1006/geno.1997.5086; Berthelsen J, 1998, EMBO J, V17, P1434, DOI 10.1093/emboj/17.5.1434; Broudy VC, 1996, BLOOD, V88, P75; Carbe C, 2012, DEV BIOL, V363, P320, DOI 10.1016/j.ydbio.2011.12.038; Chen HM, 1997, GENOMICS, V41, P193, DOI 10.1006/geno.1997.4632; Crist RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023665; Dardaei L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096711; Dardaei L, 2014, P NATL ACAD SCI USA, V111, pE896, DOI 10.1073/pnas.1321200111; Di Rosa P, 2007, DEV BIOL, V311, P324, DOI 10.1016/j.ydbio.2007.08.031; Fernandez-Diaz LC, 2010, DEVELOPMENT, V137, P3393, DOI 10.1242/dev.050567; Ferretti E, 1999, MECH DEVELOP, V83, P53, DOI 10.1016/S0925-4773(99)00031-3; Ferretti E, 2006, MOL CELL BIOL, V26, P5650, DOI 10.1128/MCB.00313-06; Ficara F, 2008, CELL STEM CELL, V2, P484, DOI 10.1016/j.stem.2008.03.004; Ficara F, 2013, J CELL SCI, V126, P3181, DOI 10.1242/jcs.125435; Fognani C, 2002, NUCLEIC ACIDS RES, V30, P2043, DOI 10.1093/nar/30.9.2043; Imoto I, 2001, BIOCHEM BIOPH RES CO, V287, P270, DOI 10.1006/bbrc.2001.5578; Iotti G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048353; Kanki H, 2006, EXP ANIM TOKYO, V55, P137, DOI 10.1538/expanim.55.137; Kanzleiter T, 2014, MOL CELL BIOL, V34, P290, DOI 10.1128/MCB.01232-13; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Knoepfler PS, 1997, P NATL ACAD SCI USA, V94, P14553, DOI 10.1073/pnas.94.26.14553; Kocabas F, 2012, BLOOD, V120, P4963, DOI 10.1182/blood-2012-05-432260; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; Krosl J, 2003, NAT MED, V9, P1428, DOI 10.1038/nm951; Longobardi E, 2014, DEV DYNAM, V243, P59, DOI 10.1002/dvdy.24016; Longobardi E, 2010, MOL ONCOL, V4, P126, DOI 10.1016/j.molonc.2010.01.001; Micali N, 2009, MOL CELL BIOL, V29, P1143, DOI 10.1128/MCB.01273-08; Modica L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107916; Noro B, 2006, GENE DEV, V20, P1636, DOI 10.1101/gad.1412606; Okada Y, 2003, BLOOD, V101, P4748, DOI 10.1182/blood-2002-02-0380; Okada Y, 2003, BIOCHEM BIOPH RES CO, V305, P155, DOI 10.1016/S0006-291X(03)00718-6; Oriente F, 2013, DIABETOLOGIA, V56, P2713, DOI 10.1007/s00125-013-3053-3; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Penkov D, 2005, MOL CELL BIOL, V25, P10768, DOI 10.1128/MCB.25.24.10768-10781.2005; Penkov D, 2013, CELL REP, V3, P1321, DOI 10.1016/j.celrep.2013.03.029; Piper DE, 1999, CELL, V96, P587, DOI 10.1016/S0092-8674(00)80662-5; Rieckhof GE, 1997, CELL, V91, P171, DOI 10.1016/S0092-8674(00)80400-6; Rowan S, 2010, GENE DEV, V24, P980, DOI 10.1101/gad.1890410; Ryoo HD, 1999, DEVELOPMENT, V126, P5137; Satoh T, 2013, NATURE, V495, P524, DOI 10.1038/nature11930; Thorsteinsdottir U, 2001, MOL CELL BIOL, V21, P224, DOI 10.1128/MCB.21.1.224-234.2001; Unnisa Z, 2012, BLOOD, V120, P4973, DOI 10.1182/blood-2012-06-435800; Vanden Berghe T, 2015, IMMUNITY, V43, P200, DOI 10.1016/j.immuni.2015.06.011; Wu MF, 2007, CELL STEM CELL, V1, P541, DOI 10.1016/j.stem.2007.08.009; Yang Y, 2000, J BIOL CHEM, V275, P20734, DOI 10.1074/jbc.M908382199; Zeddies S, 2014, HAEMATOLOGICA, V99, P1555, DOI 10.3324/haematol.2014.106567	50	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0136107	10.1371/journal.pone.0136107	http://dx.doi.org/10.1371/journal.pone.0136107			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285139	gold, Green Published, Green Submitted			2022-12-26	WOS:000359666100102
J	Huang, CD; Liu, QQ; Heerink, N; Stomph, T; Li, BS; Liu, RL; Zhang, HY; Wang, C; Li, XL; Zhang, CC; van der Werf, W; Zhang, FS				Huang, Chengdong; Liu, Quanqing; Heerink, Nico; Stomph, TjeerdJan; Li, Baoshen; Liu, Ruili; Zhang, Hongyan; Wang, Chong; Li, Xiaolin; Zhang, Chaochun; van der Werf, Wopke; Zhang, Fusuo			Economic Performance and Sustainability of a Novel Intercropping System on the North China Plain	PLOS ONE			English	Article							REDUCING ENVIRONMENTAL RISK; NUTRIENT-USE EFFICIENCY; FOOD SECURITY; CROP PRODUCTIVITY; N MANAGEMENT; RESOURCE USE; AGRICULTURE; COMPETITION; FERTILIZER; DIVERSITY	Double cropping of wheat and maize is common on the North China Plain, but it provides limited income to rural households due to the small farm sizes in the region. Local farmers in Quzhou County have therefore innovated their production system by integration of watermelon as a companion cash crop into the system. We examine the economic performance and sustainability of this novel intercropping system using crop yield data from 2010 to 2012 and farm household survey data collected in 2012. Our results show that the gross margin of the intercropping system exceeded that of the double cropping system by more than 50% in 2012. Labor use in the intercropping system was more than three times that in double cropping. The lower returns per labor hour in intercropping, however, exceeded the average off-farm wage in the region by a significant margin. Nutrient surpluses and irrigation water use are significant larger under the intercropping system. We conclude that the novel wheat-maize/watermelon intercropping system contributes to rural poverty alleviation and household-level food security, by raising farm incomes and generating more employment, but needs further improvement to enhance its sustainability.	[Huang, Chengdong; Li, Baoshen; Liu, Ruili; Zhang, Hongyan; Wang, Chong; Li, Xiaolin; Zhang, Chaochun; Zhang, Fusuo] China Agr Univ, Ctr Resources Environm & Food Secur, Beijing 100094, Peoples R China; [Liu, Quanqing] Hebei Acad Agr & Forestry Sci, Inst Agr Resources Environm, Shijiazhuang, Peoples R China; [Heerink, Nico] Wageningen Univ, Dev Econ Grp, NL-6700 AP Wageningen, Netherlands; [Stomph, TjeerdJan; van der Werf, Wopke] Wageningen Univ, Ctr Crop Syst Anal, NL-6700 AP Wageningen, Netherlands	China Agricultural University; Hebei Academy of Agricultural & Forestry Sciences; Wageningen University & Research; Wageningen University & Research	Zhang, CC (corresponding author), China Agr Univ, Ctr Resources Environm & Food Secur, Beijing 100094, Peoples R China.	zhangcc@cau.edu.cn	Heerink, Nico/AAA-2045-2020; Huang, Chengdong/T-6146-2017; Zhang, Fusuo/AAV-4517-2021; Stomph, Tjeerd-Jan/AAU-2582-2021; van der Werf, Wopke/A-2557-2009	Heerink, Nico/0000-0002-9911-3501; Huang, Chengdong/0000-0003-4992-4485; van der Werf, Wopke/0000-0002-5506-4699; Stomph, Tjeerd Jan/0000-0001-5984-1523	National Natural Science Foundation of China [31210103906]; Innovative Group Grant of the National Science Foundation of China [31421092]; Chinese National Basic Research Program [2015CB150400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovative Group Grant of the National Science Foundation of China; Chinese National Basic Research Program(National Basic Research Program of China)	This work received financial supports from the National Natural Science Foundation of China (NO. 31210103906) and the Innovative Group Grant of the National Science Foundation of China (31421092) and the Chinese National Basic Research Program (2015CB150400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen Q, 2004, NUTR CYCL AGROECOSYS, V69, P51, DOI 10.1023/B:FRES.0000025293.99199.ff; Chen XP, 2011, P NATL ACAD SCI USA, V108, P6399, DOI 10.1073/pnas.1101419108; Chen XP, 2014, NATURE, V514, P486, DOI 10.1038/nature13609; Cui ZL, 2008, FIELD CROP RES, V105, P48, DOI 10.1016/j.fcr.2007.07.008; Cui ZL, 2013, ENVIRON SCI TECHNOL, V47, P6015, DOI 10.1021/es4003026; Dawe D, 2012, GLOB FOOD SECUR-AGR, V1, P127, DOI 10.1016/j.gfs.2012.09.001; Fan MS, 2012, J EXP BOT, V63, P13, DOI 10.1093/jxb/err248; Fan SG, 2005, AGR ECON-BLACKWELL, V32, P135, DOI 10.1111/j.0169-5150.2004.00019.x; Feike T, 2010, RENEW AGR FOOD SYST, V25, P272, DOI 10.1017/S1742170510000293; Gale HF, 2013, USDA ERS ECONOMIC RE; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; IMAM SA, 1990, FIELD CROP RES, V25, P111, DOI 10.1016/0378-4290(90)90076-N; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; Khan S, 2009, AGR WATER MANAGE, V96, P349, DOI 10.1016/j.agwat.2008.09.022; Knorzer H, 2009, CLIMATE CHANGE, INTERCROPPING, PEST CONTROL AND BENEFICIAL MICROORGANISMS, P13, DOI 10.1007/978-90-481-2716-0_3; Koninklijke Nederlandse Akademie van Wetenschappen (KNAW), 2003, GEDR GEBR SOONSG WET; Lester GE, 2005, J AM SOC HORTIC SCI, V130, P649, DOI 10.21273/JASHS.130.4.649; Li CY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008049; Li L, 2007, P NATL ACAD SCI USA, V104, P11192, DOI 10.1073/pnas.0704591104; Lithourgidis AS, 2011, EUR J AGRON, V34, P287, DOI 10.1016/j.eja.2011.02.007; Liu XJ, 2013, NATURE, V494, P459, DOI 10.1038/nature11917; National Bureau of Statistics of China, 2013, CHIN CIT STAT YB 201; NJOROGE JM, 1993, EXP AGR, V29, P373, DOI 10.1017/S0014479700020937; Nosengo N, 2003, NATURE, V425, P894, DOI 10.1038/425894a; Piesse J, 2009, FOOD POLICY, V34, P119, DOI 10.1016/j.foodpol.2009.01.001; Qu FT, 2011, CHINA ECON REV, V22, P444, DOI 10.1016/j.chieco.2010.08.005; Shen JB, 2013, GLOB FOOD SECUR-AGR, V2, P1, DOI 10.1016/j.gfs.2012.12.004; Shi XP, 2011, CHINA ECON REV, V22, P524, DOI 10.1016/j.chieco.2010.08.003; Statistical Bureau of Quzhou County, 2010, QUZH STAT YB; Statistical Bureau of Quzhou County, 2012, QUZH STAT YB; Sun QP, 2011, AGR WATER MANAGE, V98, P808, DOI 10.1016/j.agwat.2010.12.007; Tsimba R, 2013, FIELD CROP RES, V150, P145, DOI 10.1016/j.fcr.2013.05.021; Tsubo M, 2005, FIELD CROP RES, V93, P10, DOI 10.1016/j.fcr.2004.09.002; van Asten PJA, 2011, AGR SYST, V104, P326, DOI 10.1016/j.agsy.2010.12.004; Vandermeer J.H., 1989, ECOLOGY INTERCROPPIN, DOI [10.1017/CBO9780511623523, DOI 10.1017/CBO9780511623523]; Vereniging van Samenwerkende Nederlandse Universiteiten (VSNU), 2014, NED GEDR WET PRINC G; Wang SQ, 2009, J GEOGR SCI, V19, P175, DOI 10.1007/s11442-009-0175-0; WILLEY RW, 1990, AGR WATER MANAGE, V17, P215, DOI 10.1016/0378-3774(90)90069-B; WILLEY RW, 1980, EXP AGR, V16, P117, DOI 10.1017/S0014479700010802; Zhang FS, 2003, PLANT SOIL, V248, P305, DOI 10.1023/A:1022352229863; Zhang FS, 2013, NATURE, V497, P33, DOI 10.1038/497033a; Zhang FS, 2011, J ENVIRON QUAL, V40, P1051, DOI 10.2134/jeq2010.0292; Zhang L, 2008, FIELD CROP RES, V107, P29, DOI 10.1016/j.fcr.2007.12.014; Zhang WF, 2013, P NATL ACAD SCI USA, V110, P8375, DOI 10.1073/pnas.1210447110; Zhao JM, 2014, CAN J AGR ECON, V62, P307, DOI 10.1111/cjag.12033	46	27	29	2	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135518	10.1371/journal.pone.0135518	http://dx.doi.org/10.1371/journal.pone.0135518			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO9KD	26275297	Green Published, gold, Green Submitted			2022-12-26	WOS:000359493600071
J	Latchney, SE; Jiang, YD; Petrik, DP; Eisch, AJ; Hsieh, J				Latchney, Sarah E.; Jiang, Yindi; Petrik, David P.; Eisch, Amelia J.; Hsieh, Jenny			Inducible knockout of Mef2a, -c, and -d from nestin-expressing stem/progenitor cells and their progeny unexpectedly uncouples neurogenesis and dendritogenesis in vivo	FASEB JOURNAL			English	Article						hippocampus; dentate gyrus; transcription factor; transgenic mouse; doublecortin	ENHANCER FACTOR 2C; TRANSCRIPTION FACTOR; ADULT NEUROGENESIS; STRUCTURAL PLASTICITY; NEURONAL-ACTIVITY; GENE-EXPRESSION; SITE; MATURATION; SYNAPSES; PROMOTER	Myocyte enhancer factor (Mef)-2 transcription factors are implicated in activity-dependent neuronal processes during development, but the role of MEF2 in neural stem/progenitor cells (NSPCs) in the adult brain is unknown. We used a transgenic mouse in which Mef2a, -c, and -d were inducibly deleted in adult nestin-expressing NSPCs and their progeny. Recombined cells in the hippocampal granule cell layer were visualized and quantified by yellow fluorescent protein (YFP) expression. In control mice, postmitotic neurons expressed Mef2a, -c, and -d, whereas type 1 stem cells and proliferating progenitors did not. Based on this expression, we hypothesized that Mef2a, -c, and -d deletion in adult nestin-expressing NSPCs and their progeny would result in fewer mature neurons. Control mice revealed an increase in YFP+ neurons and dendrite formation over time. Contrary to our hypothesis, inducible Mef2 KO mice also displayed an increase in YFP+ neurons over time-but with significantly stunted dendrites-suggesting an uncoupling of neuron survival and dendritogenesis. We also found non-cell-autonomous effects after Mef2a, -c, and -d deletion. These in vivo findings indicate a surprising functional role for Mef2a, -c, and -d in cell-and non-cell-autonomous control of adult hippocampal neurogenesis that is distinct from its role during development.	[Latchney, Sarah E.; Petrik, David P.; Eisch, Amelia J.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Jiang, Yindi; Hsieh, Jenny] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Eisch, AJ (corresponding author), Univ Texas SW Med Ctr Dallas, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	amelia.eisch@utsouthwestern.edu; jenny.hsieh@utsouthwestern.edu	Latchney, Sarah/AAQ-2957-2021; Latchney, Sarah/M-4740-2019	Latchney, Sarah/0000-0002-4070-1165; Eisch, Amelia/0000-0001-6476-5385; Petrik, David/0000-0003-3026-0770	U.S. National Institutes of Health (NIH) National Institute on Drug Abuse [016765, 023555]; NIH National Institute of Mental Health [107945]; U.S. National Aeronautics and Space Administration [NNX12AB55G, NNX15AE09G]; NIH National Institute on Aging [032383, 041815]; NIH National Institute of Neurological Disorders and Stroke [076775, 038572, 081203]; Welch Foundation [I-1660]; Texas Institute for Brain Injury and Repair; NIH National Institute on Drug Abuse [T32DA00722]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH107945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K02AG041815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016765, K02DA023555, T32DA007290] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute on Drug Abuse; NIH National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); U.S. National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); NIH National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Welch Foundation(The Welch Foundation); Texas Institute for Brain Injury and Repair; NIH National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank Dr. E. Olson (University of Texas Southwestern Medical Center, Dallas, TX, USA) for providing the Mef2a<SUP>f/f</SUP>, Mef2c<SUP>f/f</SUP>, and Mef2d<SUP>f/f</SUP> mice. This work was funded by grants from the U.S. National Institutes of Health (NIH) National Institute on Drug Abuse (016765, 023555), the NIH National Institute of Mental Health (107945), the U.S. National Aeronautics and Space Administration (NNX12AB55G, NNX15AE09G) (all to A.J.E.), and grants from the NIH National Institute on Aging (032383, 041815), the NIH National Institute of Neurological Disorders and Stroke (076775, 038572, 081203), the Welch Foundation (I-1660), and the Texas Institute for Brain Injury and Repair (all to J.H.). S.E.L. was supported by an institutional training grant from NIH National Institute on Drug Abuse (T32DA00722; Principle Investigator, A.J.E.).	Ables JL, 2010, J NEUROSCI, V30, P10484, DOI 10.1523/JNEUROSCI.4721-09.2010; Aguirre A, 2004, J NEUROSCI, V24, P10530, DOI 10.1523/JNEUROSCI.3572-04.2004; Akhtar MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034863; ANDRES V, 1995, J BIOL CHEM, V270, P23246, DOI 10.1074/jbc.270.40.23246; Arisi GM, 2007, BRAIN RES, V1165, P126, DOI 10.1016/j.brainres.2007.06.037; Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; Barbosa AC, 2008, P NATL ACAD SCI USA, V105, P9391, DOI 10.1073/pnas.0802679105; Barkis WB, 2010, P NATL ACAD SCI USA, V107, P22302, DOI 10.1073/pnas.1008775108; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Bosch M, 2012, CURR OPIN NEUROBIOL, V22, P383, DOI 10.1016/j.conb.2011.09.002; Brewer GJ, 2007, NAT PROTOC, V2, P1490, DOI 10.1038/nprot.2007.207; Chancey JH, 2014, J NEUROSCI, V34, P2349, DOI 10.1523/JNEUROSCI.3620-13.2014; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; Cole CJ, 2012, NAT NEUROSCI, V15, P1255, DOI 10.1038/nn.3189; EDMONDSON DG, 1994, DEVELOPMENT, V120, P1251; Eisch AJ, 2000, P NATL ACAD SCI USA, V97, P7579, DOI 10.1073/pnas.120552597; Fietz SA, 2011, CURR OPIN NEUROBIOL, V21, P23, DOI 10.1016/j.conb.2010.10.002; Fiore R, 2009, EMBO J, V28, P697, DOI 10.1038/emboj.2009.10; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Gao ZL, 2009, NAT NEUROSCI, V12, P1090, DOI 10.1038/nn.2385; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Jayatissa MN, 2009, BRAIN RES, V1290, P133, DOI 10.1016/j.brainres.2009.07.001; Kannangara TS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103155; Kempermann G, 1997, P NATL ACAD SCI USA, V94, P10409, DOI 10.1073/pnas.94.19.10409; Kessels MM, 2011, EUR J CELL BIOL, V90, P926, DOI 10.1016/j.ejcb.2010.08.011; Kim Y, 2008, J CLIN INVEST, V118, P124, DOI 10.1172/JCI33255; Korets-Smith E, 2004, GENESIS, V40, P131, DOI 10.1002/gene.20074; Krainc D, 1998, J BIOL CHEM, V273, P26218, DOI 10.1074/jbc.273.40.26218; Krebs J, 2011, FRONT NEUROSCI-SWITZ, V5, DOI [10.3389/fnins.2011.00106, 10.3389/fnins.2011.00107]; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Li H, 2008, P NATL ACAD SCI USA, V105, P9397, DOI 10.1073/pnas.0802876105; Li Z, 2008, J NEUROSCI, V28, P6557, DOI 10.1523/JNEUROSCI.0134-08.2008; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; LYONS GE, 1995, J NEUROSCI, V15, P5727, DOI 10.1523/jneurosci.15-08-05727.1995; Mandyam CD, 2004, J NEUROSCI RES, V76, P783, DOI 10.1002/jnr.20090; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Ninkovic J, 2013, BIOESSAYS, V35, P242, DOI 10.1002/bies.201200108; PAKKENBERG B, 1988, J MICROSC-OXFORD, V150, P1, DOI 10.1111/j.1365-2818.1988.tb04582.x; Petrik D, 2012, FASEB J, V26, P3148, DOI 10.1096/fj.11-201426; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Pulipparacharuvil S, 2008, NEURON, V59, P621, DOI 10.1016/j.neuron.2008.06.020; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Simo S, 2012, GENE DEV, V26, P1653, DOI 10.1101/gad.199034.112; Song J, 2013, NAT NEUROSCI, V16, P1728, DOI 10.1038/nn.3572; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tian XY, 2010, MOL CELL NEUROSCI, V44, P94, DOI 10.1016/j.mcn.2010.01.012; Turrigiano G, 2007, CURR OPIN NEUROBIOL, V17, P318, DOI 10.1016/j.conb.2007.04.004; Vetere G, 2011, P NATL ACAD SCI USA, V108, P8456, DOI 10.1073/pnas.1016275108; Vivar C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2101; WEST MJ, 1990, J COMP NEUROL, V296, P1, DOI 10.1002/cne.902960102; Yamaguchi M, 2000, NEUROREPORT, V11, P1991, DOI 10.1097/00001756-200006260-00037; Yau SY, 2014, CELL TRANSPLANT, V23, P471, DOI 10.3727/096368914X678283; Yau SY, 2011, CELL TRANSPLANT, V20, P99, DOI 10.3727/096368910X532846; Zang T, 2013, MOL CELL NEUROSCI, V56, P39, DOI 10.1016/j.mcn.2013.03.002	58	15	15	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2015	29	12					5059	5071		10.1096/fj.15-275651	http://dx.doi.org/10.1096/fj.15-275651			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CX2JS	26286136	Green Published			2022-12-26	WOS:000365523600029
J	Yu, X; Guan, PP; Guo, JW; Wang, Y; Cao, LL; Xu, GB; Konstantopoulos, K; Wang, ZY; Wang, P				Yu, Xin; Guan, Pei-Pei; Guo, Jing-Wen; Wang, Yue; Cao, Long-Long; Xu, Guo-Biao; Konstantopoulos, Konstantinos; Wang, Zhan-You; Wang, Pu			By suppressing the expression of anterior pharynx-defective-1 alpha and-1 beta and inhibiting the aggregation of beta-amyloid protein, magnesium ions inhibit the cognitive decline of amyloid precursor protein/presenilin 1 transgenic mice	FASEB JOURNAL			English	Article						ERK1/2; magnesium-L-threonate; PPAR gamma; cerebrospinal fluid; Alzheimer's disease	DISEASE MOUSE MODEL; ALZHEIMERS-DISEASE; BRAIN MAGNESIUM; SYNAPTIC PLASTICITY; BEHAVIORAL DEFICITS; CHONDROCYTES; IMPAIRMENT; CORTEX; NEUROINFLAMMATION; ELEVATION	Alzheimer's disease (AD) is associated with a magnesium ion (Mg2+) deficit in the serum or brain. However, the mechanisms regulating the roles of Mg2+ in the pathologic condition of AD remain unknown. We studied whether brain Mg2+ can decrease beta-amyloid (Ab) deposition and ameliorate the cognitive decline in a model of AD, the APPswe/PS1DE9 transgenic (Tg) mouse. We used a recently developed compound, magnesium-L-threonate (MgT), for a treatment that resulted in enhanced clearance of Ab in an anterior pharynx-defective (APH)-1 alpha/-1 beta-dependent manner. To further explore how MgT treatment inhibits cognitive decline in APP/PS1 Tg mice, the critical molecules for amyloid precursor protein (APP) cleavage and signaling pathways were investigated. In neurons, ERK1/2 and PPAR gamma signaling pathways were activated by MgT treatment, which in turn suppressed (by >80%) the expression of APH-1 alpha/-1 beta, which is responsible for the deposition of Ab and potentially contributes to the memory deficit that occurs in AD. More important, A beta oligomers in the cerebrospinal fluid (CSF) further promoted the expression of APH-1 alpha/-1 beta (by >2.5-fold), which enhances the gamma-cleavage of APP and Ab deposition during AD progression. These findings provide new insights into the mechanisms of AD progression and are instrumental for developing better strategies to combat the disease.	[Yu, Xin; Guan, Pei-Pei; Guo, Jing-Wen; Wang, Yue; Cao, Long-Long; Xu, Guo-Biao; Wang, Zhan-You; Wang, Pu] Northeastern Univ, Coll Life & Hlth Sci, Shenyang 110819, Peoples R China; [Konstantopoulos, Konstantinos] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA; [Konstantopoulos, Konstantinos] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Konstantopoulos, Konstantinos] Johns Hopkins Univ, Johns Hopkins Inst NanoBioTechnol, Baltimore, MD USA; [Konstantopoulos, Konstantinos] Johns Hopkins Univ, Johns Hopkins Phys Sci Oncol Ctr, Baltimore, MD USA; [Konstantopoulos, Konstantinos] Johns Hopkins Univ, Ctr Canc Nanotechnol Excellence, Baltimore, MD USA	Northeastern University - China; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Wang, P (corresponding author), Northeastern Univ, Coll Life & Hlth Sci, 3-11 Wenhua Rd, Shenyang 110819, Peoples R China.	wangzy@mail.neu.edu.cn; wangpu@mail.neu.edu.cn		Wang, Zhan-You/0000-0003-0807-9916	Natural Science Foundation of China [31300777, 31371091]; Fundamental Research Funds of China [N142004002, N130120002, N141008001/7, N120820001]; Liaoning Provincial Talent Support Program [LJQ2013029]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds of China; Liaoning Provincial Talent Support Program	The authors thank Dr. J.-Y. Li for kindly providing brain samples from human donors with AD, and A. C. McCourt for critical reading and linguistic revision of the manuscript. This work was supported in part or in whole by Grants 31300777 and 31371091 from the Natural Science Foundation of China; Grants N142004002, N130120002, N141008001/7, and N120820001 from the Fundamental Research Funds of China; and Grant LJQ2013029 from the Liaoning Provincial Talent Support Program. The authors declare no conflicts of interest.	Abumaria N, 2011, J NEUROSCI, V31, P14871, DOI 10.1523/JNEUROSCI.3782-11.2011; Andrasi E, 2005, J ALZHEIMERS DIS, V7, P273; de Oliveira LDB, 2011, ARQ NEURO-PSIQUIAT, V69, P349, DOI 10.1590/S0004-282X2011000300016; Cheng B, 2014, MICROB PATHOGENESIS, V69-70, P1, DOI 10.1016/j.micpath.2014.03.001; Cilliler AE, 2007, GERONTOLOGY, V53, P419, DOI 10.1159/000110873; Cornett CR, 1998, NEUROTOXICOLOGY, V19, P339; Corsonello A, 2001, MAGNESIUM RES, V14, P273; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; EHMANN WD, 1986, NEUROTOXICOLOGY, V7, P197; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Hamaguchi T, 2012, ACTA NEUROPATHOL, V123, P31, DOI 10.1007/s00401-011-0912-1; Hoane MR, 2003, BRAIN RES BULL, V60, P105, DOI 10.1016/S0361-9230(03)00022-4; Huang CY, 2010, CHINESE J PHYSIOL, V53, P299, DOI 10.4077/CJP.2010.AMK063; Ikari A, 2010, LIFE SCI, V86, P766, DOI 10.1016/j.lfs.2010.03.016; Kummer MP, 2015, MOL NEUROBIOL, V51, P661, DOI 10.1007/s12035-014-8743-4; LAI YL, 1983, J APPL PHYSIOL, V54, P1754, DOI 10.1152/jappl.1983.54.6.1754; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Li ST, 2000, NEUROSCI LETT, V283, P141, DOI 10.1016/S0304-3940(00)00938-1; Li W, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0065-y; Lin XL, 2014, DNA CELL BIOL, V33, P514, DOI 10.1089/dna.2013.2290; Liu L, 2004, NEUROBIOL DIS, V17, P516, DOI 10.1016/j.nbd.2004.08.005; Lopez-Gonzalez I, 2015, J NEUROPATH EXP NEUR, V74, P319, DOI 10.1097/NEN.0000000000000176; Miyashita T, 2012, NEURON, V74, P887, DOI 10.1016/j.neuron.2012.03.039; Mo JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116802; Morales-Corraliza J, 2013, NEUROBIOL AGING, V34, P137, DOI 10.1016/j.neurobiolaging.2012.04.007; Nenov MN, 2014, J NEUROSCI, V34, P1028, DOI 10.1523/JNEUROSCI.3413-13.2014; Piermartiri TCB, 2010, EXP NEUROL, V226, P274, DOI 10.1016/j.expneurol.2010.08.030; Prakash A, 2014, NEUROTOX RES, V25, P335, DOI 10.1007/s12640-013-9437-9; Shoghi-Jadid K, 2002, AM J GERIAT PSYCHIAT, V10, P24, DOI 10.1176/appi.ajgp.10.1.24; Slutsky I, 2010, NEURON, V65, P165, DOI 10.1016/j.neuron.2009.12.026; SQUADRITO F, 1990, JPN J PHARMACOL, V53, P495, DOI 10.1254/jjp.53.495; Wang P, 2013, FASEB J, V27, P4664, DOI 10.1096/fj.13-234542; Wang P, 2012, J BIOL CHEM, V287, P31877, DOI 10.1074/jbc.M112.362731; Wang P, 2011, FASEB J, V25, P3401, DOI 10.1096/fj.11-184861; Wang P, 2010, J BIOL CHEM, V285, P24793, DOI 10.1074/jbc.M110.110320; Wang P, 2010, AM J PHYSIOL-CELL PH, V298, pC1445, DOI 10.1152/ajpcell.00508.2009; Wang X, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-46; Xu SJ, 2014, J ALZHEIMERS DIS, V39, P239, DOI 10.3233/JAD-130680; Xu ZP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108645; Yaksh TL, 1999, SPINAL DRUG DELIVERY, P216	40	22	23	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2015	29	12					5044	5058		10.1096/fj.15-275578	http://dx.doi.org/10.1096/fj.15-275578			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CX2JS	26293690				2022-12-26	WOS:000365523600028
J	Newman, PA; Rubincam, C; Slack, C; Essack, Z; Chakrapani, V; Chuang, DM; Tepjan, S; Shunmugam, M; Roungprakhon, S; Logie, C; Koen, J; Lindegger, G				Newman, Peter A.; Rubincam, Clara; Slack, Catherine; Essack, Zaynab; Chakrapani, Venkatesan; Chuang, Deng-Min; Tepjan, Suchon; Shunmugam, Murali; Roungprakhon, Surachet; Logie, Carmen; Koen, Jennifer; Lindegger, Graham			Towards a Science of Community Stakeholder Engagement in Biomedical HIV Prevention Trials: An Embedded Four-Country Case Study	PLOS ONE			English	Article							CIVIL-SOCIETY PERSPECTIVES; VACCINE TRIALS; CLINICAL-TRIALS; DOUBLE-BLIND; EFFICACY TRIALS; HEALTH RESEARCH; GLOBAL HEALTH; MISCONCEPTION; RISK; INTERVENTION	Objectives Broad international guidelines and studies in the context of individual clinical trials highlight the centrality of community stakeholder engagement in conducting ethically rigorous HIV prevention trials. We explored and identified challenges and facilitators for community stakeholder engagement in biomedical HIV prevention trials in diverse global settings. Our aim was to assess and deepen the empirical foundation for priorities included in the GPP guidelines and to highlight challenges in implementation that may merit further attention in subsequent GPP iterations. Methods From 2008-2012 we conducted an embedded, multiple case study centered in Thailand, India, South Africa and Canada. We conducted in-depth interviews and focus groups with respondents from different trial-related subsystems: civil society organization representatives, community advocates, service providers, clinical trialists/researchers, former trial participants, and key HIV risk populations. Interviews/focus groups were recorded, and coded using thematic content analysis. After intra-case analyses, we conducted cross-case analysis to contrast and synthesize themes and sub-themes across cases. Lastly, we applied the case study findings to explore and assess UNAIDS/AVAC GPP guidelines and the GPP Blueprint for Stakeholder Engagement. Results Across settings, we identified three cross-cutting themes as essential to community stakeholder engagement: trial literacy, including lexicon challenges and misconceptions that imperil sound communication; mistrust due to historical exploitation; and participatory processes: engaging early; considering the breadth of "community"; and, developing appropriate stakeholder roles. Site-specific challenges arose in resource-limited settings and settings where trials were halted. Conclusions This multiple case study revealed common themes underlying community stakeholder engagement across four country settings that largely mirror GPP goals and the GPP Blueprint, as well as highlighting challenges in the implementation of important guidelines. GPP guidance documents could be strengthened through greater focus on: identifying and addressing the community-specific roots of mistrust and its impact on trial literacy activities; achieving and evaluating representativeness in community stakeholder groups; and addressing the impact of power and funding streams on meaningful engagement and independent decision-making.	[Newman, Peter A.; Rubincam, Clara; Chuang, Deng-Min; Tepjan, Suchon; Logie, Carmen] Univ Toronto, Factor Inwentash Fac Social Work, Toronto, ON, Canada; [Slack, Catherine; Essack, Zaynab; Koen, Jennifer; Lindegger, Graham] Univ KwaZulu Natal, Sch Appl Human Sci, HIV AIDS Vaccines Eth Grp, Pietermaritzburg, South Africa; [Chakrapani, Venkatesan; Shunmugam, Murali] Ctr Sexual & Hlth Res & Policy C SHaRP, Madras, Tamil Nadu, India; [Roungprakhon, Surachet] Rajamangala Univ Technol Phra Nakhon, Fac Sci & Technol, Bangkok, Thailand	University of Toronto; University of Kwazulu Natal; Rajamangala University of Technology Phra Nakhon	Newman, PA (corresponding author), Univ Toronto, Factor Inwentash Fac Social Work, Toronto, ON, Canada.	p.newman@utoronto.ca	Essack, Zaynab/P-3253-2019; Newman, Peter A/P-7056-2019; Chakrapani, Venkatesan/P-8056-2014; chuang, deng-min/AAP-5207-2020	Essack, Zaynab/0000-0002-8867-3415; Newman, Peter A/0000-0003-0444-5915; Chakrapani, Venkatesan/0000-0001-9998-9135; chuang, deng-min/0000-0001-6824-2792	Canadian Institutes of Health Research [THA-118570, MOP-102512]; Social Sciences and Humanities Research Council [861080042]; Canada Research Chairs Program; Canada Foundation for Innovation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Social Sciences and Humanities Research Council(Social Sciences and Humanities Research Council of Canada (SSHRC)); Canada Research Chairs Program(Canada Research Chairs); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This research was supported in part by grants from: Canadian Institutes of Health Research (THA-118570; PAN, GL, VC) http://www.cihr-irsc.gc.ca, Canadian Institutes of Health Research (MOP-102512; PAN, VC) http://www.cihr-irsc.gc.ca, Social Sciences and Humanities Research Council (861080042; PAN) http://www.sshrc-crsh.gc.ca, Canada Research Chairs Program (PAN) http://www.chairs-chaires.gc.ca, and Canada Foundation for Innovation (PAN) www.innovation.ca.	ABDOOL KQ, 2010, SCIENCE, V329, P1168, DOI DOI 10.1126/SCIENCE.1193748; Allen M, 2008, SOC SCI MED, V66, P945, DOI 10.1016/j.socscimed.2007.10.019; Allman D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100058; [Anonymous], 2011, GOOD PART PRACT GUID; AVAC, 2014, GPP BLUEPR STAK ENG; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Burnard P, 2008, BR DENT J, V204, P249; Burt RS, 2005, BROKERAGE CLOSURE IN; Chakrapani V, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-731; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Cooper CJ, 2010, JAMA-J AM MED ASSOC, V304, P275, DOI 10.1001/jama.2010.926; Creswell JW, 2000, THEOR PRACT, V39, P124, DOI 10.1207/s15430421tip3903_2; Delany-Moretlwe S, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-S1-S8; Duerr A, 2012, J INFECT DIS, V206, P258, DOI 10.1093/infdis/jis342; Essack Z, 2012, AIDS CARE, V24, P1249, DOI 10.1080/09540121.2012.656566; Fonsart J, 2014, 20 INT AIDS C JUL 20; Francis DP, 2003, AIDS, V17, P147, DOI 10.1097/00002030-200301240-00003; Godfrey C, 2014, JAIDS-J ACQ IMM DEF, V65, pS1, DOI 10.1097/QAI.0000000000000032; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gray GE, 2011, LANCET INFECT DIS, V11, P507, DOI 10.1016/S1473-3099(11)70098-6; Harriott RE, 1983, ED RES, V12, P14; Henderson GE, 2007, PLOS MED, V4, P1735, DOI 10.1371/journal.pmed.0040324; Horwood J, 2007, LANCET INFECT DIS, V7, P183, DOI 10.1016/S1473-3099(07)70039-7; Jewkes R, 1996, SOC SCI MED, V43, P555, DOI 10.1016/0277-9536(95)00439-4; Kagan JM, 2012, PROG COMM HLTH PARTN, V6, P311, DOI 10.1353/cpr.2012.0034; Kegeles SM, 2006, AIDS EDUC PREV, V18, P560, DOI 10.1521/aeap.2006.18.6.560; King KF, 2014, BMC MED ETHICS, V15, DOI 10.1186/1472-6939-15-84; Koblin BA, 2000, J ACQ IMMUN DEF SYND, V24, P451, DOI 10.1097/00126334-200008150-00010; Koen J, 2013, DEV WORLD BIOETH, V13, P138, DOI 10.1111/j.1471-8847.2012.00338.x; Kolopack PA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003713; Lally M, 2014, J ADOLESCENT HEALTH, V55, P254, DOI 10.1016/j.jadohealth.2014.01.006; Lavery JV, 2010, TRENDS PARASITOL, V26, P279, DOI 10.1016/j.pt.2010.02.009; Mack N, 2013, OPEN ACCESS J CLIN T, V5, P127, DOI 10.2147/OAJCT.S45717; Mack N, 2010, J EMPIR RES HUM RES, V5, P3, DOI 10.1525/jer.2010.5.2.3; MacQueen KM, 2015, BMC MED ETHICS, V16, DOI 10.1186/s12910-015-0033-9; MacQueen KM, 2012, STAKEHOLDER ENGAGEME; Marsh V, 2008, SOC SCI MED, V67, P721, DOI 10.1016/j.socscimed.2008.02.007; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; McGrory E., 2009, RES RASHOMON LESSONS; Merriam S. B., 1998, QUALITATIVE RES GUID; Nakibinge S, 2009, TROP MED INT HEALTH, V14, P190, DOI 10.1111/j.1365-3156.2008.02207.x; Namwat C, 2007, AIDS VACC AUG 20 23; National AIDS Control Organisation, 2012, HIV SENT SURV 2012 1; Newman PA, 2012, GLOB PUBLIC HEALTH, V7, P87, DOI 10.1080/17441692.2010.549139; Newman PA, 2006, LANCET, V367, P302, DOI 10.1016/S0140-6736(06)68067-7; Newman PA, 2008, VACCINE, V26, P1091, DOI 10.1016/j.vaccine.2007.12.016; Newman PA, 2014, EXPERT REV VACCINES, V13, P1553, DOI 10.1586/14760584.2014.953484; Newman PA, 2014, VACCINE, V32, P5854, DOI 10.1016/j.vaccine.2014.08.043; Newman PA, 2012, EXPERT REV VACCINES, V11, P1, DOI [10.1586/erv.11.162, 10.1586/ERV.11.162]; Newman PA, 2011, AM J PUBLIC HEALTH, V101, P1749, DOI 10.2105/AJPH.2011.300208; Participants in the Community Engagement and Consent Workshop  Kilifi Kenya  March 2011, 2013, J Empir Res Hum Res Ethics, V8, P1, DOI 10.1525/jer.2013.8.4.1; Ragin DF, 2008, SOC SCI MED, V66, P1379, DOI 10.1016/j.socscimed.2007.10.022; Rautenbach C, 2015, J EMPIR RES HUM RES, V10, P151, DOI 10.1177/1556264615575509; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Singh JA, 2005, PLOS MED, V2, P824, DOI 10.1371/journal.pmed.0020234; Slevin KW, 2008, COMMUNITY ENGAGEMENT, P14; Strauss A., 1998, BASICS QUALITATIVE R; The Wellcome Trust, 2011, COMM ENG UND MICR IN; Tindana P, 2015, BMC MED ETHICS, V16, DOI 10.1186/s12910-015-0014-z; Tindana PO, 2007, PLOS MED, V4, P1451, DOI 10.1371/journal.pmed.0040273; Ukpong M., 2009, ORAL TENOFOVIR CONTR; UNAIDS, 2013, THAIL HIV AIDS EST; UNAIDS AVAC, 2007, GOOD PART PRACT GUID; *UNAIDS WHO, 2007, ETH CONS BIOM HIV PR; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; Van Damme L, 2008, NEW ENGL J MED, V359, P463, DOI 10.1056/NEJMoa0707957; Yin R.K., 2009, CASE STUDY RES DESIG, V4th ed., DOI [10.33524/cjar.v14i1.73, DOI 10.33524/CJAR.V14I1.73]; Yin R. K., 2012, APPL CASE STUDY RES, V3rd	68	44	44	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135937	10.1371/journal.pone.0135937	http://dx.doi.org/10.1371/journal.pone.0135937			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5MR	26295159	Green Published, Green Submitted, gold			2022-12-26	WOS:000359926900052
J	Vinette, V; Placet, M; Arguin, G; Gendron, FP				Vinette, Valerie; Placet, Morgane; Arguin, Guillaume; Gendron, Fernand-Pierre			Multidrug Resistance-Associated Protein 2 Expression Is Upregulated by Adenosine 5 '-Triphosphate in Colorectal Cancer Cells and Enhances Their Survival to Chemotherapeutic Drugs	PLOS ONE			English	Article							ATP-BINDING CASSETTE; EXTRACELLULAR ATP; COLON-CANCER; PURINERGIC RECEPTORS; SIGNALING PATHWAYS; EPITHELIAL-CELLS; GENE-EXPRESSION; INFLAMMATION; MRP2; TRANSPORT	Extracellular adenosine 5'-triphosphate (ATP) is a signaling molecule that induces a plethora of effects ranging from the regulation of cell proliferation to modulation of cancerous cell behavior. In colorectal cancer, ATP was reported to stimulate epithelial cell proliferation and possibly promote resistance to anti-cancer treatments. However, the exact role of this danger-signaling molecule on cancerous intestinal epithelial cells (IECs) in response to chemotherapeutic agents remains unknown. To address how ATP may influence the response of cancerous IECs to chemotherapeutic agents, we used Caco-2 cells, which display enterocyte-like features, to determine the effect of ATP on the expression of multidrug resistance-associated protein 2 (MRP2). Gene and protein expression were determined by quantitative real-time PCR (qRT-PCR) and Western blotting. Resistance to etoposide, cisplatin and doxorubicin was determined by MTT assays in response to ATP stimulation of Caco-2 cells and in cells for which MRP2 expression was down-regulated by shRNA. ATP increased the expression of MRP2 at both the mRNA and protein levels. MRP2 expression involved an ATP-dependent stimulation of the MEK/ERK signaling pathway that was associated with an increase in relative resistance of Caco-2 cells to etoposide. Abolition of MRP2 expression using shRNA significantly reduced the protective effect of MRP2 toward etoposide as well as to cisplatin and doxorubicin. This study describes the mechanism by which ATP may contribute to the chemoresistance of cancerous IECs in colorectal cancer. Given the heterogeneity of colorectal adenocarcinoma responses to anti-cancer drugs, these findings call for further study to understand the role of P2 receptors in cancer drug therapy and to develop novel therapies aimed at regulating P2 receptor activity.	[Vinette, Valerie; Placet, Morgane; Arguin, Guillaume; Gendron, Fernand-Pierre] Univ Sherbrooke, Dept Anat & Cell Biol, Fac Med & Sci Sante, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke	Gendron, FP (corresponding author), Univ Sherbrooke, Dept Anat & Cell Biol, Fac Med & Sci Sante, Pavillon Rech Appl Canc, Sherbrooke, PQ J1K 2R1, Canada.	Fernand-P.Gendron@USherbrooke.ca	Gendron, Fernand-Pierre/AAN-2965-2021		Canadian Institutes of Health Research [MOP-286567]; FRQS	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); FRQS	This research was supported by a Canadian Institutes of Health Research operating grant (MOP-286567) to F.P.G. F.P.G. is a member of the FRQS-funded "Centre de Recherche du Centre hospitalier universitaire de Sherbrooke".	Agteresch HJ, 2003, ANTI-CANCER DRUG, V14, P639, DOI 10.1097/00001813-200309000-00009; Akhtar R, 2014, WORLD J GASTRO ONCOL, V6, P177, DOI 10.4251/wjgo.v6.i6.177; Amin R, 2013, AM J PHYSIOL-CELL PH, V305, pC78, DOI 10.1152/ajpcell.00339.2012; Amiri F, 2013, EUR J PHARMACOL, V718, P34, DOI 10.1016/j.ejphar.2013.09.020; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Bergamin LS, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/959848; Bourzac JF, 2013, J CELL PHYSIOL, V228, P120, DOI 10.1002/jcp.24111; Burnstock G, 2013, PURINERG SIGNAL, V9, P541, DOI 10.1007/s11302-013-9381-4; Buzzi N, 2010, BBA-GEN SUBJECTS, V1800, P946, DOI 10.1016/j.bbagen.2010.05.009; Chang SJ, 2008, CELL SIGNAL, V20, P1248, DOI 10.1016/j.cellsig.2008.02.011; Colombo V, 2011, CANCER CHEMOTH PHARM, V67, P369, DOI 10.1007/s00280-010-1335-8; Coolen EJCM, 2011, BRIT J NUTR, V105, P357, DOI 10.1017/S0007114510003570; Cui YH, 1999, MOL PHARMACOL, V55, P929; Degagne E, 2013, J CELL PHYSIOL, V228, P99, DOI 10.1002/jcp.24109; Degagne E, 2012, FEBS J, V279, P2957, DOI 10.1111/j.1742-4658.2012.08676.x; Degagne E, 2009, J IMMUNOL, V183, P4521, DOI 10.4049/jimmunol.0803977; Deli T, 2008, PATHOL ONCOL RES, V14, P219, DOI 10.1007/s12253-008-9071-7; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Di Virgilio F, 2012, CANCER RES, V72, P5441, DOI 10.1158/0008-5472.CAN-12-1600; Di Virgilio F, 2009, PURINERG SIGNAL, V5, P251, DOI 10.1007/s11302-009-9145-3; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Fujita K, 2008, BIOL PHARM BULL, V31, P2137, DOI 10.1248/bpb.31.2137; Galluzzi L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.428; Ghanem E, 2005, BRIT J PHARMACOL, V146, P364, DOI 10.1038/sj.bjp.0706353; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Grbic DM, 2008, J IMMUNOL, V180, P2659, DOI 10.4049/jimmunol.180.4.2659; Grbic DM, 2012, INFLAMM BOWEL DIS, V18, P1456, DOI 10.1002/ibd.21931; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Harden TK, 2010, ACTA PHYSIOL, V199, P149, DOI 10.1111/j.1748-1716.2010.02116.x; Hinoshita E, 2000, CLIN CANCER RES, V6, P2401; Hlavata I, 2012, MUTAGENESIS, V27, P187, DOI 10.1093/mutage/ger075; Hopfner M, 1998, BIOCHEM BIOPH RES CO, V251, P811, DOI 10.1006/bbrc.1998.9555; Huang TT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041383; Jacobson KA, 2012, PURINERG SIGNAL, V8, P419, DOI 10.1007/s11302-012-9294-7; Jakubikova J, 2005, BIOCHEM PHARMACOL, V69, P1543, DOI 10.1016/j.bcp.2005.03.015; Jedlitschky G, 2006, EXPERT OPIN DRUG MET, V2, P351, DOI 10.1517/17425255.2.3.351; Jensen NF, 2015, MOL ONCOL; Kim HS, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/527534; Kruh GD, 2003, ONCOGENE, V22, P7537, DOI 10.1038/sj.onc.1206953; Kukulski F, 2005, Purinergic Signal, V1, P193, DOI 10.1007/s11302-005-6217-x; Leipziger J, 2003, AM J PHYSIOL-RENAL, V284, pF419, DOI 10.1152/ajprenal.00075.2002; MARKS DC, 1992, LEUKEMIA RES, V16, P1165, DOI 10.1016/0145-2126(92)90114-M; North RA, 2013, MOL PHARMACOL, V83, P759, DOI 10.1124/mol.112.083758; Nussbaum N, 2015, CURR ONCOL REP, V17, DOI 10.1007/s11912-014-0434-9; Nylund G., 2007, Autonomic & Autacoid Pharmacology, V27, P79, DOI 10.1111/j.1474-8673.2007.00389.x; Pellegatti P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002599; Schafer R, 2003, AM J PHYSIOL-LUNG C, V285, pL376, DOI 10.1152/ajplung.00447.2002; Shabbir M, 2008, BJU INT, V101, P106, DOI 10.1111/j.1464-410X.2007.07286.x; Swennen ELR, 2010, CHEM-BIOL INTERACT, V184, P338, DOI 10.1016/j.cbi.2010.02.011; Takai E, 2012, J CELL SCI, V125, P5051, DOI 10.1242/jcs.104976; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Tremblay E, 2006, J CELL BIOCHEM, V99, P1175, DOI 10.1002/jcb.21015; von Kugelgen I, 2011, ADV PHARMACOL, V61, P373, DOI 10.1016/B978-0-12-385526-8.00012-6; Wagstaff SC, 2000, CARCINOGENESIS, V21, P2175, DOI 10.1093/carcin/21.12.2175; Watson AJM, 2011, DIGEST DIS, V29, P222, DOI 10.1159/000323926; Wink MR, 2003, CANCER LETT, V198, P211, DOI 10.1016/S0304-3835(03)00308-2; Xiao Z, 2012, ANAT REC, V295, P2122, DOI 10.1002/ar.22552; Xing Y, 2014, J DIGEST DIS, V15, P246, DOI 10.1111/1751-2980.12131; Yaguchi T, 2010, CELL PHYSIOL BIOCHEM, V26, P125, DOI 10.1159/000320518; Yamasaki M, 2011, BRIT J CANCER, V104, P707, DOI 10.1038/sj.bjc.6606071; Yang Youyun, 2011, Int J Biochem Mol Biol, V2, P89; Zhang Y, 2010, CANCER LETT, V293, P189, DOI 10.1016/j.canlet.2010.01.010	62	20	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136080	10.1371/journal.pone.0136080	http://dx.doi.org/10.1371/journal.pone.0136080			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295158	Green Submitted, Green Published, gold			2022-12-26	WOS:000359926900070
J	Xie, CY; Wu, X; Li, J; Fan, ZY; Long, CM; Liu, HN; Even, PC; Blachier, F; Yin, YL				Xie, Chunyan; Wu, Xin; Li, Jun; Fan, Zhiyong; Long, Cimin; Liu, Hongnan; Even, Patrick Christian; Blachier, Francois; Yin, Yulong			Effects of the Sequence of Isocaloric Meals with Different Protein Contents on Plasma Biochemical Indexes in Pigs	PLOS ONE			English	Article							AMINO-ACIDS; CIRCADIAN CLOCK; ENERGY-INTAKE; DIETARY SUPPLEMENTATION; INSULIN RESPONSES; LOW-CARBOHYDRATE; GLYCEMIC CONTROL; EXPRESSION; GLUCAGON; METABOLISM	Nutrient composition and pattern of food intake may play a significant role in weight gain. The aim of this study was to document the effects of a daily 3-meal pattern with isocaloric diets containing different dietary protein contents on growth performance and different plasma biochemical indexes including amino acid plasma concentration in castrated male pigs. Then, 21 DLY (DurocxLandracexYorkshire) pigs aged 60 days were assigned randomly into 3 groups: a control group (crude protein, CP 18.1%), a group receiving high then basal and then low CP meals (High-Low group) and a group receiving low then basal and then high CP meal (Low-High group) for 40 days with pigs being feed-restricted. On day 40, after 12 h fasting, blood samples were obtained for analysis. The results showed that the insulin/glucagon ratio was lower in the High-Low group (P<0.05) when compared with the control group. Compared with the control group, the average daily gain of pigs from the High-Low group increased by 14.10% (P = 0.046). Compared with the control group, serum gamma-glutamyl transferase (GGT) decreased significantly (P<0.05) in both the High-Low and Low-High groups. Plasma concentrations of branched-chain amino acids (BCAA: valine, isoleucine and leucine) increased in the Low-High group (P<0.05) when compared with the control group; and plasma methionine and serine decreased in both the two experimental groups (P<0.05). Compared with the High-Low group, all the BCAA increased significantly (P<0.05) in the Low-High group. These findings suggest that the sequence and quantity of alimentary protein intake affect the insulin/glucagon ratio, as well as amino acid concentrations including BCAA, methionine and serine. It is proposed that meal pattern with pigs receiving high then basal and then low CP meals daily may help to improve the weight gain of pigs.	[Xie, Chunyan; Wu, Xin; Li, Jun; Long, Cimin; Liu, Hongnan; Yin, Yulong] Chinese Acad Sci, Inst Subtrop Agr, Hunan Prov Engn Res Ctr Healthy Livestock, Key Lab Agroecol Proc Subtrop Reg, Changsha 410125, Hunan, Peoples R China; [Wu, Xin; Fan, Zhiyong; Long, Cimin] Hunan Agr Univ, Coll Anim Sci & Technol, Changsha 410128, Hunan, Peoples R China; [Yin, Yulong] Hunan Normal Univ, Sch Life Sci, Changsha 41008, Hunan, Peoples R China; [Even, Patrick Christian; Blachier, Francois] INRA, AgroParisTech, Nutr Physiol & Ingest Behav, UMR 914, Paris, France	Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS; Hunan Agricultural University; Hunan Normal University; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Wu, X (corresponding author), Chinese Acad Sci, Inst Subtrop Agr, Hunan Prov Engn Res Ctr Healthy Livestock, Key Lab Agroecol Proc Subtrop Reg, Changsha 410125, Hunan, Peoples R China.	wuxin@isa.ac.cn; yinyulong@isa.ac.cn			NSFC [31110103909]; National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2012BAD39B00]; Chinese Academy of Sciences and Knowledge Innovation Project [CXJQ120113-1]; Chinese Academy of Sciences President's International Fellowship Initiative Grant [2015VBA009, 2013T2S0014]; China Postdoctoral Science Foundation [2014M552022]	NSFC(National Natural Science Foundation of China (NSFC)); National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); Chinese Academy of Sciences and Knowledge Innovation Project(Knowledge Innovation Program of the Chinese Academy of Sciences); Chinese Academy of Sciences President's International Fellowship Initiative Grant; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This paper was jointly supported by grants from the NSFC (31110103909), the National Key Technology Research and Development Program of the Ministry of Science and Technology of China (2012BAD39B00), Chinese Academy of Sciences and Knowledge Innovation Project (CXJQ120113-1), Chinese Academy of Sciences President's International Fellowship Initiative Grant (No. 2015VBA009, 2013T2S0014), China Postdoctoral Science Foundation funded project (2014M552022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADIBI SA, 1976, METABOLISM, V25, P1287, DOI 10.1016/S0026-0495(76)80012-1; AHMED M, 1980, AM J CLIN NUTR, V33, P1917, DOI 10.1093/ajcn/33.9.1917; Arble DM, 2009, OBESITY, V17, P2100, DOI 10.1038/oby.2009.264; Blouet C, 2006, J NUTR, V136, P1849, DOI 10.1093/jn/136.7.1849; Bowen J, 2006, J CLIN ENDOCR METAB, V91, P1477, DOI 10.1210/jc.2005-1856; Calbet JAL, 2002, J NUTR, V132, P2174, DOI 10.1093/jn/132.8.2174; Deng J, 2010, J ANIM PHYSIOL AN N, V94, P220, DOI 10.1111/j.1439-0396.2008.00902.x; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; FERNSTROM JD, 1979, AM J CLIN NUTR, V32, P1912, DOI 10.1093/ajcn/32.9.1912; Froy O, 2007, FRONT NEUROENDOCRIN, V28, P61, DOI 10.1016/j.yfrne.2007.03.001; Froy O, 2010, ENDOCR REV, V31, P1, DOI 10.1210/er.2009-0014; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Huang RL, 2005, POULTRY SCI, V84, P1383, DOI 10.1093/ps/84.9.1383; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lee SY, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/578693; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; MUNRO HN, 1963, NUTR DIETA, V5, P298; NASSET ES, 1979, J NUTR, V109, P621, DOI 10.1093/jn/109.4.621; Nishioka M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062929; Oike Hideaki, 2014, Curr Nutr Rep, V3, P204; Oishi K, 2012, CHRONOBIOL INT, V29, P799, DOI 10.3109/07420528.2012.699127; Oosterman JE, 2014, AM J PHYSL REGUL INT; Panda S, 2004, J BIOL RHYTHM, V19, P374, DOI 10.1177/0748730404269008; Pereira M, 2011, J NUTR, V141, P163, DOI 10.3945/jn.109.114405; PERET J, 1981, J NUTR, V111, P1173, DOI 10.1093/jn/111.7.1173; Pomar C, 2014, ANIMAL, V8, P704, DOI 10.1017/S1751731114000408; Raben A, 2003, AM J CLIN NUTR, V77, P91, DOI 10.1093/ajcn/77.1.91; Ranawana V, 2013, ADV FOOD NUTR RES, V70, P1, DOI 10.1016/B978-0-12-416555-7.00001-1; Ren WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088335; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Riggio O, 1989, Recenti Prog Med, V80, P591; ROMON M, 1993, AM J CLIN NUTR, V57, P476, DOI 10.1093/ajcn/57.4.476; Suryawan A, 2008, AM J PHYSIOL-ENDOC M, V295, pE868, DOI 10.1152/ajpendo.90314.2008; Tang ZR, 2005, DOMEST ANIM ENDOCRIN, V28, P430, DOI 10.1016/j.domaniend.2005.02.003; TIEDGEN M, 1980, J NUTR, V110, P876, DOI 10.1093/jn/110.5.876; Tovar AR, 2002, AM J PHYSIOL-ENDOC M, V283, pE1016, DOI 10.1152/ajpendo.00398.2001; Tsai PJ, 2000, J FORMOS MED ASSOC, V99, P151; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; van Loon LJC, 2000, AM J CLIN NUTR, V72, P96; Wu X, 2010, AMINO ACIDS, V39, P831, DOI 10.1007/s00726-010-0538-y; Xiao H, 2015, J ANIM SCI, V93, P1114, DOI 10.2527/jas.2014-8229; Yin FG, 2010, BRIT J NUTR, V103, P1404, DOI 10.1017/S0007114509993321; Yin J, 2015, RSC ADV, V5, P15479, DOI 10.1039/c4ra13557a; Yin J, 2014, AMINO ACIDS, V46, P883, DOI 10.1007/s00726-013-1643-5; YIN YL, 1993, ANIM FEED SCI TECH, V42, P297, DOI 10.1016/0377-8401(93)90106-T; Yin YL, 2010, AMINO ACIDS, V39, P1581, DOI 10.1007/s00726-010-0577-4; Yin YL, 2010, AMINO ACIDS, V39, P1477, DOI 10.1007/s00726-010-0612-5; Zhou J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056072	48	17	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0125640	10.1371/journal.pone.0125640	http://dx.doi.org/10.1371/journal.pone.0125640			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295708	Green Published, Green Submitted, gold			2022-12-26	WOS:000359926900002
J	den Besten, G; Gerding, A; van Dijk, TH; Ciapaite, J; Bleeker, A; van Eunen, K; Havinga, R; Groen, AK; Reijngoud, DJ; Bakker, BM				den Besten, Gijs; Gerding, Albert; van Dijk, Theo H.; Ciapaite, Jolita; Bleeker, Aycha; van Eunen, Karen; Havinga, Rick; Groen, Albert K.; Reijngoud, Dirk-Jan; Bakker, Barbara M.			Protection against the Metabolic Syndrome by Guar Gum-Derived Short-Chain Fatty Acids Depends on Peroxisome Proliferator-Activated Receptor. and Glucagon-Like Peptide-1	PLOS ONE			English	Article							INSULIN SENSITIVITY; DIETARY FIBER; BODY-WEIGHT; GLUCOSE; MICROBIOTA; OBESITY; STIMULATION; NUTRITION; GLP-1; TERM	The dietary fiber guar gum has beneficial effects on obesity, hyperglycemia and hypercholesterolemia in both humans and rodents. The major products of colonic fermentation of dietary fiber, the short-chain fatty acids (SCFAs), have been suggested to play an important role. Recently, we showed that SCFAs protect against the metabolic syndrome via a signaling cascade that involves peroxisome proliferator-activated receptor (PPAR). repression and AMP-activated protein kinase (AMPK) activation. In this study we investigated the molecular mechanism via which the dietary fiber guar gum protects against the metabolic syndrome. C57Bl/6J mice were fed a high-fat diet supplemented with 0% or 10% of the fiber guar gum for 12 weeks and effects on lipid and glucose metabolism were studied. We demonstrate that, like SCFAs, also guar gum protects against high-fat diet-induced metabolic abnormalities by PPAR. repression, subsequently increasing mitochondrial uncoupling protein 2 expression and AMP/ATP ratio, leading to the activation of AMPK and culminating in enhanced oxidative metabolism in both liver and adipose tissue. Moreover, guar gum markedly increased peripheral glucose clearance, possibly mediated by the SCFA-induced colonic hormone glucagon-like peptide-1. Overall, this study provides novel molecular insights into the beneficial effects of guar gum on the metabolic syndrome and strengthens the potential role of guar gum as a dietary-fiber intervention.	[den Besten, Gijs; Gerding, Albert; Ciapaite, Jolita; Bleeker, Aycha; van Eunen, Karen; Havinga, Rick; Groen, Albert K.; Reijngoud, Dirk-Jan; Bakker, Barbara M.] Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Dept Pediat & Syst Biol,Ctr Energy Metab & Ageing, Groningen, Netherlands; [van Dijk, Theo H.; Groen, Albert K.; Reijngoud, Dirk-Jan] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands; [den Besten, Gijs; van Eunen, Karen; Groen, Albert K.; Reijngoud, Dirk-Jan; Bakker, Barbara M.] Netherlands Consortium Syst Biol, Amsterdam, Netherlands; [Bleeker, Aycha; van Eunen, Karen; Groen, Albert K.; Reijngoud, Dirk-Jan; Bakker, Barbara M.] Top Inst Food & Nutr, NL-6700 AN Wageningen, Netherlands	University of Groningen; University of Groningen; Top Institute Food & Nutrition	Bakker, BM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Dept Pediat & Syst Biol,Ctr Energy Metab & Ageing, Groningen, Netherlands.	B.M.Bakker01@umcg.nl	van Dijk, Theo/H-6436-2013	Bakker, Barbara/0000-0001-6274-3633; Ciapaite, Jolita/0000-0001-8761-9233; Reijngoud, Dirk-Jan/0000-0003-1157-4491	Netherlands Genomics Initiative via the Netherlands Consortium for Systems Biology from NWO/ZonMw [91108004]; Top Institute Food and Nutrition; Rosalind Franklin fellowship from the University of Groningen	Netherlands Genomics Initiative via the Netherlands Consortium for Systems Biology from NWO/ZonMw; Top Institute Food and Nutrition; Rosalind Franklin fellowship from the University of Groningen	This work was funded by the Netherlands Genomics Initiative via the Netherlands Consortium for Systems Biology (91108004) from NWO/ZonMw. KVE and AB are currently receiving an unrestricted research grant from Top Institute Food and Nutrition. BMB was supported by a Rosalind Franklin fellowship from the University of Groningen.	Barrera JG, 2011, NAT REV ENDOCRINOL, V7, P507, DOI 10.1038/nrendo.2011.77; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Bingham SA, 2003, LANCET, V361, P1496, DOI 10.1016/S0140-6736(03)13174-1; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Burcelin R, 2001, DIABETES, V50, P1720, DOI 10.2337/diabetes.50.8.1720; Cannon Barbara, 2008, V456, P109, DOI 10.1007/978-1-59745-245-8_8; Carling D, 2011, NAT CHEM BIOL, V7, P512, DOI [10.1038/nchembio.610, 10.1038/NCHEMBIO.610]; Cicero AFG, 2010, MEDITERR J NUTR META, V3, P47, DOI 10.1007/s12349-009-0056-1; Claus SP, 2011, MBIO, V2, DOI 10.1128/mBio.00271-10; DALESSIO DA, 1994, J CLIN INVEST, V93, P2263, DOI 10.1172/JCI117225; Dall'Alba V, 2013, BRIT J NUTR, V110, P1601, DOI 10.1017/S0007114513001025; den Besten G, 2015, DIABETES, V64, P2398, DOI 10.2337/db14-1213; den Besten G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107392; den Besten G, 2013, AM J PHYSIOL-GASTR L, V305, pG900, DOI 10.1152/ajpgi.00265.2013; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; EBELING P, 1988, AM J CLIN NUTR, V48, P98, DOI 10.1093/ajcn/48.1.98; Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156; Foretz M, 1998, J BIOL CHEM, V273, P14767, DOI 10.1074/jbc.273.24.14767; Freeland KR, 2010, BRIT J NUTR, V103, P460, DOI 10.1017/S0007114509991863; Galisteo M, 2008, J NUTR BIOCHEM, V19, P71, DOI 10.1016/j.jnutbio.2007.02.009; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; Gnaiger E, 2000, LIFE IN THE COLD, P431; Grefhorst A, 2005, AM J PHYSIOL-ENDOC M, V289, pE829, DOI 10.1152/ajpendo.00165.2005; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Holmes E, 2012, CELL METAB, V16, P559, DOI 10.1016/j.cmet.2012.10.007; Institute-of-Medicine, 2005, DIET REF INT EN CARB, P339; Ionut V, 2005, DIABETOLOGIA, V48, P967, DOI 10.1007/s00125-005-1709-3; KROTKIEWSKI M, 1984, BRIT J NUTR, V52, P97, DOI 10.1079/BJN19840075; Kuznetsov AV, 1998, OROBOROS BIOENERG NE, V3, P1; LANDIN K, 1992, AM J CLIN NUTR, V56, P1061, DOI 10.1093/ajcn/56.6.1061; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Leclerc I, 1998, FEBS LETT, V431, P180, DOI 10.1016/S0014-5793(98)00745-5; Lin HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035240; Meier JJ, 2012, NAT REV ENDOCRINOL, V8, P728, DOI 10.1038/nrendo.2012.140; Mildaziene V, 2002, TOXICOL SCI, V65, P220, DOI 10.1093/toxsci/65.2.220; Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808; Misra A, 2010, J AM COLL NUTR, V29, p289S, DOI 10.1080/07315724.2010.10719844; Murphy KG, 2006, NATURE, V444, P854, DOI 10.1038/nature05484; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Oosterveer MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006066; Papathanasopoulos A, 2010, GASTROENTEROLOGY, V138, P65, DOI 10.1053/j.gastro.2009.11.045; SMITH U, 1982, ATHEROSCLEROSIS, V45, P1, DOI 10.1016/0021-9150(82)90166-6; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; UUSITUPA M, 1989, AM J CLIN NUTR, V49, P345, DOI 10.1093/ajcn/49.2.345; van den Hoek AM, 2004, DIABETES, V53, P1949, DOI 10.2337/diabetes.53.8.1949	47	75	76	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136364	10.1371/journal.pone.0136364	http://dx.doi.org/10.1371/journal.pone.0136364			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26292284	Green Submitted, Green Published, gold			2022-12-26	WOS:000359919900079
J	Neumann, AJ; Gardner, OFW; Williams, R; Alini, M; Archer, CW; Stoddart, MJ				Neumann, Alexander J.; Gardner, Oliver F. W.; Williams, Rebecca; Alini, Mauro; Archer, Charles W.; Stoddart, Martin J.			Human Articular Cartilage Progenitor Cells Are Responsive to Mechanical Stimulation and Adenoviral-Mediated Overexpression of Bone-Morphogenetic Protein 2	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; FIBRIN-POLYURETHANE COMPOSITES; IN-VITRO CHONDROGENESIS; DYNAMIC COMPRESSION; GENE-EXPRESSION; MARROW; DIFFERENTIATION; CULTURE; REPAIR; TRANSPLANTATION	Articular cartilage progenitor cells (ACPCs) represent a new and potentially powerful alternative cell source to commonly used cell sources for cartilage repair, such as chondrocytes and bone-marrow derived mesenchymal stem cells (MSCs). This is particularly due to the apparent resistance of ACPCs to hypertrophy. The current study opted to investigate whether human ACPCs (hACPCs) are responsive towards mechanical stimulation and/or adenoviral-mediated overexpression of bone morphogenetic protein 2 (BMP-2). hACPCs were cultured in fibrin-polyurethane composite scaffolds. Cells were cultured in a defined chondro-permissive medium, lacking exogenous growth factors. Constructs were cultured, for 7 or 28 days, under free-swelling conditions or with the application of complex mechanical stimulation, using a custom built bioreactor that is able to generate joint-like movements. Outcome parameters were quantification of BMP-2 and transforming growth factor beta 1 (TGF-beta 1) concentration within the cell culture medium, biochemical and gene expression analyses, histology and immunohistochemistry. The application of mechanical stimulation alone resulted in the initiation of chondrogenesis, demonstrating the cells are mechanoresponsive. This was evidenced by increased GAG production, lack of expression of hypertrophic markers and a promising gene expression profile (significant up-regulation of cartilaginous marker genes, specifically collagen type II, accompanied by no increase in the hypertrophic marker collagen type X or the osteogenic marker alkaline phosphatase). To further investigate the resistance of ACPCs to hypertrophy, overexpression of a factor associated with hypertrophic differentiation, BMP-2, was investigated. A novel, three-dimensional, transduction protocol was used to transduce cells with an adenovirus coding for BMP-2. Over-expression of BMP-2, independent of load, led to an increase in markers associated with hypertropy. Taken together ACPCs represent a potential alterative cell source for cartilage tissue engineering applications.	[Neumann, Alexander J.; Gardner, Oliver F. W.; Alini, Mauro; Stoddart, Martin J.] AO Fdn, AO Res Inst Davos, CH-7270 Davos, Switzerland; [Neumann, Alexander J.; Gardner, Oliver F. W.; Williams, Rebecca] Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Archer, Charles W.] Swansea Univ, Swansea Sch Med, Swansea SA2 8PP, W Glam, Wales	Cardiff University; Swansea University	Stoddart, MJ (corresponding author), AO Fdn, AO Res Inst Davos, Clavadelerstr 8, CH-7270 Davos, Switzerland.	martin.stoddart@aofoundation.org	Stoddart, Martin J/E-3240-2013; Alini, Mauro/AAG-7961-2020	Stoddart, Martin J/0000-0002-9538-1517; Williams, Rebecca/0000-0003-2168-7369	AO Foundation	AO Foundation	This work was supported by AO Foundation.	Barry F, 2001, EXP CELL RES, V268, P189, DOI 10.1006/excr.2001.5278; Bosnakovski D, 2006, JPN J VET RES, V53, P127; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Cucchiarini M, 2014, Eur Cell Mater, V27, P12; Dowthwaite GP, 2004, J CELL SCI, V117, P889, DOI 10.1242/jcs.00912; Estes BT, 2004, CURR TOP DEV BIOL, V60, P91; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Fortier LA, 2011, CLIN ORTHOP RELAT R, V469, P2706, DOI 10.1007/s11999-011-1857-3; Freyria AM, 2012, INJURY, V43, P259, DOI 10.1016/j.injury.2011.05.035; Gaissmaier C, 2008, INJURY, V39, pS88, DOI 10.1016/j.injury.2008.01.035; Gorna K, 2002, J BIOMED MATER RES, V60, P592, DOI 10.1002/jbm.10100; Grad S, 2011, CLIN ORTHOP RELAT R, V469, P2764, DOI 10.1007/s11999-011-1819-9; Hayes AJ, 2008, J HISTOCHEM CYTOCHEM, V56, P125, DOI 10.1369/jhc.7A7320.2007; HOMMINGA GN, 1990, J BONE JOINT SURG BR, V72, P1003, DOI 10.1302/0301-620X.72B6.2246280; Johnstone B, 2013, EUR CELLS MATER, V25, P248, DOI 10.22203/eCM.v025a18; Kelly DJ, 2010, BIRTH DEFECTS RES C, V90, P75, DOI 10.1002/bdrc.20173; Khan IM, 2009, OSTEOARTHR CARTILAGE, V17, P518, DOI 10.1016/j.joca.2008.08.002; Kisiday JD, 2008, J ORTHOP RES, V26, P322, DOI 10.1002/jor.20508; Kupcsik L, 2010, TISSUE ENG PT A, V16, P1845, DOI [10.1089/ten.tea.2009.0531, 10.1089/ten.TEA.2009.0531]; Kupcsik L, 2009, TISSUE ENG PT A, V15, P2309, DOI 10.1089/ten.tea.2008.0400; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; Leijten J, 2014, P NATL ACAD SCI USA, V111, P13954, DOI 10.1073/pnas.1410977111; Li Z, 2009, J CELL MOL MED; Li Z, 2010, TISSUE ENG PT A, V16, P575, DOI [10.1089/ten.tea.2009.0262, 10.1089/ten.TEA.2009.0262]; Li Z, 2010, J CELL MOL MED, V14, P1338, DOI 10.1111/j.1582-4934.2009.00780.x; Li Z, 2009, TISSUE ENG PT A, V15, P1729, DOI 10.1089/ten.tea.2008.0247; Madry H, 2011, DTSCH ARZTEBL INT, V108, P669, DOI 10.3238/arztebl.2011.0669; Majumdar MK, 2001, J CELL PHYSIOL, V189, P275, DOI 10.1002/jcp.10025; McCarthy HE, 2012, VET J, V192, P345, DOI 10.1016/j.tvjl.2011.08.036; Neumann AJ, 2013, TISSUE ENG PT A, V19, P1285, DOI [10.1089/ten.tea.2012.0411, 10.1089/ten.TEA.2012.0411]; Neumann AJ, 2013, MOL BIOTECHNOL, V53, P207, DOI 10.1007/s12033-012-9522-y; Palmer GD, 2005, MOL THER, V12, P219, DOI 10.1016/j.ymthe.2005.03.024; Pelttari K, 2006, ARTHRITIS RHEUM-US, V54, P3254, DOI 10.1002/art.22136; Sailor LZ, 1996, J ORTHOPAED RES, V14, P937, DOI 10.1002/jor.1100140614; Salzmann GM, 2009, TISSUE ENG PT A, V15, P2513, DOI 10.1089/ten.tea.2008.0479; Schatti O, 2011, EUR CELLS MATER, V22, P214, DOI 10.22203/eCM.v022a17; Schumann D, 2006, BIO-MED MATER ENG, V16, pS37; Steadman J Richard, 2002, J Knee Surg, V15, P170; Steinert AF, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2822; Szerb I, 2005, BULL HOSP JT DIS, V63, P54; Toh WS, 2007, STEM CELLS, V25, P950, DOI 10.1634/stemcells.2006-0326; Williams R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013246; Wimmer MA, 2004, TISSUE ENG, V10, P1436, DOI 10.1089/1076327042500454; Yoo JU, 1998, J BONE JOINT SURG AM, V80A, P1745, DOI 10.2106/00004623-199812000-00004	44	31	35	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136229	10.1371/journal.pone.0136229	http://dx.doi.org/10.1371/journal.pone.0136229			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26292283	Green Published, gold, Green Submitted			2022-12-26	WOS:000359919900068
J	Wright, LS; Pinilla, I; Saha, J; Clermont, JM; Lien, JS; Borys, KD; Capowski, EE; Phillips, MJ; Gamm, DM				Wright, Lynda S.; Pinilla, Isabel; Saha, Jishnu; Clermont, Joshua M.; Lien, Jessica S.; Borys, Katarzyna D.; Capowski, Elizabeth E.; Phillips, M. Joseph; Gamm, David M.			VSX2 and ASCL1 Are Indicators of Neurogenic Competence in Human Retinal Progenitor Cultures	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; NON-SYNDROMIC MICROPHTHALMIA/ANOPHTHALMIA; VESICLE-LIKE STRUCTURES; HOMEOBOX GENE CHX10; IN-VITRO EXPANSION; TRANSCRIPTION FACTORS; NEURAL RETINA; PHOTORECEPTOR DIFFERENTIATION; FATE DETERMINATION; MAMMALIAN RETINA	Three dimensional (3D) culture techniques are frequently used for CNS tissue modeling and organoid production, including generation of retina-like tissues. A proposed advantage of these 3D systems is their potential to more closely approximate in vivo cellular microenvironments, which could translate into improved manufacture and/or maintenance of neuronal populations. Visual System Homeobox 2 (VSX2) labels all multipotent retinal progenitor cells (RPCs) and is known to play important roles in retinal development. In contrast, the proneural transcription factor Acheate scute-like 1 (ASCL1) is expressed transiently in a subset of RPCs, but is required for the production of most retinal neurons. Therefore, we asked whether the presence of VSX2 and ASCL1 could gauge neurogenic potential in 3D retinal cultures derived from human prenatal tissue or ES cells (hESCs). Short term prenatal 3D retinal cultures displayed multiple characteristics of human RPCs (hRPCs) found in situ, including robust expression of VSX2. Upon initiation of hRPC differentiation, there was a small increase in co-labeling of VSX2+cells with ASCL1, along with a modest increase in the number of PKC alpha+neurons. However, 3D prenatal retinal cultures lost expression of VSX2 and ASCL1 over time while concurrently becoming refractory to neuronal differentiation. Conversely, 3D optic vesicles derived from hESCs (hESC-OVs) maintained a robust VSX2+ hRPC population that could spontaneously co-express ASCL1 and generate photoreceptors and other retinal neurons for an extended period of time. These results show that VSX2 and ASCL1 can serve as markers for neurogenic potential in cultured hRPCs. Furthermore, unlike hESC-OVs, maintenance of 3D structure does not independently convey an advantage in the culture of prenatal hRPCs, further illustrating differences in the survival and differentiation requirements of hRPCs extracted from native tissue vs. those generated entirely in vitro.	[Wright, Lynda S.; Saha, Jishnu; Clermont, Joshua M.; Lien, Jessica S.; Borys, Katarzyna D.; Capowski, Elizabeth E.; Phillips, M. Joseph; Gamm, David M.] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Wright, Lynda S.; Phillips, M. Joseph; Gamm, David M.] Univ Wisconsin, McPherson Eye Res Inst, Madison, WI USA; [Pinilla, Isabel] Lozano Blesa Univ Hosp, Dept Ophthalmol, Zaragoza, Spain; [Pinilla, Isabel] Aragones Hlth Sci Inst, Zaragoza, Spain; [Clermont, Joshua M.] New England Coll Optometry, Boston, MA USA; [Gamm, David M.] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Lozano Blesa University Clinical Hospital; University of Wisconsin System; University of Wisconsin Madison	Gamm, DM (corresponding author), Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA.	dgamm@wisc.edu		Pinilla, Isabel/0000-0003-0349-9997	National Institutes of Health [R01EY21218, P30HD03352]; Foundation Fighting Blindness Wynn-Gund Translational Research Acceleration Program [TA-RM-1013-0610-UWI-WG]; Retina Research Foundation-Kathryn and Latimer Murfee Chair; Retina Research Foundation-Emmet A. Humble Distinguished Directorship; McPherson Eye Research Institute-Sandra Lemke Trout Chair in Eye Research; David and Nancy Walsh Family Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY021218] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness Wynn-Gund Translational Research Acceleration Program; Retina Research Foundation-Kathryn and Latimer Murfee Chair; Retina Research Foundation-Emmet A. Humble Distinguished Directorship; McPherson Eye Research Institute-Sandra Lemke Trout Chair in Eye Research; David and Nancy Walsh Family Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health grant numbers R01EY21218 (DG) and P30HD03352; the Foundation Fighting Blindness Wynn-Gund Translational Research Acceleration Program grant TA-RM-1013-0610-UWI-WG (www.blindness.org) (DG); the Retina Research Foundation-Kathryn and Latimer Murfee Chair (retinaresearchfnd.org) (DG); the Retina Research Foundation-Emmet A. Humble Distinguished Directorship (DG); the McPherson Eye Research Institute-Sandra Lemke Trout Chair in Eye Research https://vision.wisc.edu) (DG); and the David and Nancy Walsh Family Fund (DG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aftab U, 2009, EXP EYE RES, V89, P301, DOI 10.1016/j.exer.2009.03.025; Agathocleous M, 2009, ANNU REV CELL DEV BI, V25, P45, DOI 10.1146/annurev.cellbio.042308.113259; Assawachananont J, 2014, STEM CELL REP, V2, P662, DOI 10.1016/j.stemcr.2014.03.011; Bae SK, 2000, DEVELOPMENT, V127, P2933; Bar-Yosef U, 2004, HUM GENET, V115, P302, DOI 10.1007/s00439-004-1154-2; Baranov PY, 2014, TISSUE ENG PT A, V20, P1465, DOI [10.1089/ten.tea.2013.0361, 10.1089/ten.TEA.2013.0361]; Bhardwaj RD, 2006, P NATL ACAD SCI USA, V103, P12564, DOI 10.1073/pnas.0605177103; Boije H, 2014, CURR OPIN NEUROBIOL, V27, P68, DOI 10.1016/j.conb.2014.02.014; Boucherie C, 2013, STEM CELLS, V31, P408, DOI 10.1002/stem.1268; Bozanic D, 2004, ANAT EMBRYOL, V208, P381, DOI 10.1007/s00429-004-0410-5; Brzezinski JA, 2011, DEVELOPMENT, V138, P3519, DOI 10.1242/dev.064006; Burmeister M, 1996, NAT GENET, V12, P376, DOI 10.1038/ng0496-376; Carpenter MK, 1999, EXP NEUROL, V158, P265, DOI 10.1006/exnr.1999.7098; Castro DS, 2011, GENE DEV, V25, P930, DOI 10.1101/gad.627811; Chanda S, 2014, STEM CELL REP, V3, P282, DOI 10.1016/j.stemcr.2014.05.020; Chow RL, 2001, ANNU REV CELL DEV BI, V17, P255, DOI 10.1146/annurev.cellbio.17.1.255; Czekaj M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041798; Dyer MA, 2001, NAT REV NEUROSCI, V2, P333, DOI 10.1038/35072555; Eiraku M, 2012, CURR OPIN NEUROBIOL, V22, P768, DOI 10.1016/j.conb.2012.02.005; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Endl E, 2000, EXP CELL RES, V257, P231, DOI 10.1006/excr.2000.4888; Faiyaz-Ul-Haque M, 2007, CLIN GENET, V72, P164, DOI 10.1111/j.1399-0004.2007.00846.x; Gamm DM, 2008, INVEST OPHTH VIS SCI, V49, P788, DOI 10.1167/iovs.07-0777; Gamm DM, 2008, STEM CELLS, V26, P3182, DOI 10.1634/stemcells.2008-0300; Gamm DM, 2005, ANN NY ACAD SCI, V1049, P107, DOI 10.1196/annals.1334.011; Gonzalez-Cordero A, 2013, NAT BIOTECHNOL, V31, P741, DOI 10.1038/nbt.2643; Haverkamp S, 2003, VISUAL NEUROSCI, V20, P589, DOI 10.1017/S0952523803206015; Horsford DJ, 2005, DEVELOPMENT, V132, P177, DOI 10.1242/dev.01571; Hufnagel RB, 2010, DEV BIOL, V340, P490, DOI 10.1016/j.ydbio.2010.02.002; Jakovcevski I, 2011, CEREB CORTEX, V21, P1771, DOI 10.1093/cercor/bhq245; Jasoni CL, 1996, J COMP NEUROL, V369, P319; KELLEY MW, 1995, INVEST OPHTH VIS SCI, V36, P1280; Kim EJ, 2008, MOL CELL NEUROSCI, V38, P595, DOI 10.1016/j.mcn.2008.05.008; Kim EJ, 2007, J NEUROSCI, V27, P12764, DOI 10.1523/JNEUROSCI.3178-07.2007; Klassen H, 2004, J NEUROSCI RES, V77, P334, DOI 10.1002/jnr.20183; KOLB H, 1993, VISUAL NEUROSCI, V10, P341, DOI 10.1017/S0952523800003734; Lamba DA, 2006, P NATL ACAD SCI USA, V103, P12769, DOI 10.1073/pnas.0601990103; Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125; Layer PG, 2002, TRENDS NEUROSCI, V25, P131, DOI 10.1016/S0166-2236(00)02036-1; Liang L, 2008, EXP EYE RES, V86, P541, DOI 10.1016/j.exer.2007.03.004; LINBERG KA, 1990, VISUAL NEUROSCI, V5, P43, DOI 10.1017/S0952523800000067; LIU ISC, 1994, NEURON, V13, P377, DOI 10.1016/0896-6273(94)90354-9; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Livne-Bar I, 2006, P NATL ACAD SCI USA, V103, P4988, DOI 10.1073/pnas.0600083103; Lund AW, 2009, TISSUE ENG PART B-RE, V15, P371, DOI [10.1089/ten.teb.2009.0270, 10.1089/ten.TEB.2009.0270]; Ma WX, 2006, MOL CELL NEUROSCI, V31, P463, DOI 10.1016/j.mcn.2005.10.018; Mansergh FC, 2010, EXP EYE RES, V91, P500, DOI 10.1016/j.exer.2010.07.003; Meyer JS, 2011, STEM CELLS, V29, P1206, DOI 10.1002/stem.674; Meyer JS, 2009, P NATL ACAD SCI USA, V106, P16698, DOI 10.1073/pnas.0905245106; Morrow EM, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-2; Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009; Nelson BR, 2008, DEV DYNAM, V237, P1565, DOI 10.1002/dvdy.21550; Nelson BR, 2009, DEV DYNAM, V238, P2163, DOI 10.1002/dvdy.21848; Nistor G, 2005, J NEUROSCI METH, V190, P63; Ohsawa R, 2008, BRAIN RES, V1192, P90, DOI 10.1016/j.brainres.2007.04.014; ORAHILLY R, 1975, EXP EYE RES, V21, P93, DOI 10.1016/0014-4835(75)90075-5; Osakada F, 2008, NAT BIOTECHNOL, V26, P215, DOI 10.1038/nbt1384; Percin EF, 2000, NAT GENET, V25, P397, DOI 10.1038/78071; Perron M, 2000, CELL MOL LIFE SCI, V57, P215, DOI 10.1007/PL00000685; Phillips MJ, 2014, STEM CELLS, V32, P1480, DOI 10.1002/stem.1667; Phillips MJ, 2012, INVEST OPHTH VIS SCI, V53, P2007, DOI 10.1167/iovs.11-9313; Pinilla I, 2007, EXP EYE RES, V85, P381, DOI 10.1016/j.exer.2007.06.002; Pollak J, 2013, DEVELOPMENT, V140, P2619, DOI 10.1242/dev.091355; RAKIC P, 1985, SCIENCE, V227, P1054, DOI 10.1126/science.3975601; Rapaport DH, 2004, J COMP NEUROL, V474, P304, DOI 10.1002/cne.20134; Raposo AASF, 2015, CELL REP, V10, P1544, DOI 10.1016/j.celrep.2015.02.025; RHODES RH, 1979, AM J ANAT, V154, P195, DOI 10.1002/aja.1001540206; Ringuette R, 2014, INVEST OPHTH VIS SCI, V55, P43, DOI 10.1167/iovs.13-12592; Rowan S, 2004, DEVELOPMENT, V131, P5139, DOI 10.1242/dev.01300; Sasai Y, 2012, DEVELOPMENT, V139, P4111, DOI 10.1242/dev.079590; Sharma RK, 2007, BRAIN RES, V1176, P11, DOI 10.1016/j.brainres.2007.07.090; Smirnov E B, 2004, Neurosci Behav Physiol, V34, P643, DOI 10.1023/B:NEAB.0000028299.76009.1c; Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5; Vasconcelos FF, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00412; Wapinski OL, 2013, CELL, V155, P621, DOI 10.1016/j.cell.2013.09.028; West EL, 2012, STEM CELLS, V30, P1424, DOI 10.1002/stem.1123; Wong LL, 2009, DEVELOPMENT, V136, P1707, DOI 10.1242/dev.027607; Wright LS, 2003, J NEUROCHEM, V86, P179, DOI 10.1046/j.1471-4159.2003.01826.x; Wright LS, 2006, EXP CELL RES, V312, P2107, DOI 10.1016/j.yexcr.2006.03.012; Yang P, 2002, EXP NEUROL, V177, P326, DOI 10.1006/exnr.2002.7955; Zhong XF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5047; Zhu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054552	82	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135830	10.1371/journal.pone.0135830	http://dx.doi.org/10.1371/journal.pone.0135830			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26292211	Green Published, gold, Green Submitted			2022-12-26	WOS:000359919900034
J	Alonso, C; Raynor, PC; Davies, PR; Torremorell, M				Alonso, Carmen; Raynor, Peter C.; Davies, Peter R.; Torremorell, Montserrat			Concentration, Size Distribution, and Infectivity of Airborne Particles Carrying Swine Viruses	PLOS ONE			English	Article							PORCINE-EPIDEMIC-DIARRHEA; RESPIRATORY SYNDROME VIRUS; INFLUENZA-A-VIRUS; MOUTH-DISEASE; TRANSMISSION; QUANTIFICATION; TRANSPORT; AEROSOLS; PRRSV; PIGS	When pathogens become airborne, they travel associated with particles of different size and composition. Particle size determines the distance across which pathogens can be transported, as well as the site of deposition and the survivability of the pathogen. Despite the importance of this information, the size distribution of particles bearing viruses emitted by infectious animals remains unknown. In this study we characterized the concentration and size distribution of inhalable particles that transport influenza A virus (IAV), porcine reproductive and respiratory syndrome virus (PRRSV), and porcine epidemic diarrhea virus (PEDV) generated by acutely infected pigs and assessed virus viability for each particle size range. Aerosols from experimentally infected pigs were sampled for 24 days using an Andersen cascade impactor able to separate particles by size (ranging from 0.4 to 10 micrometer (mu m) in diameter). Air samples collected for the first 9, 20 and the last 3 days of the study were analyzed for IAV, PRRSV and PEDV, respectively, using quantitative reverse transcription polymerase chain reaction (RT-PCR) and quantified as geometric mean copies/m(3) within each size range. IAV was detected in all particle size ranges in quantities ranging from 5.5x10(2) (in particles ranging from 1.1 to 2.1 mu m) to 4.3x105 RNA copies/m(3) in the largest particles (9.0-10.0 mu m). PRRSV was detected in all size ranges except particles between 0.7 and 2.1 mu m in quantities ranging from 6x10(2) (0.4-0.7 mu m) to 5.1x10(4) RNA copies/m(3) (9.0-10.0 mu m). PEDV, an enteric virus, was detected in all particle sizes and in higher quantities than IAV and PRRSV (p < 0.0001) ranging from 1.3x106 (0.4-0.7 mu m) to 3.5x10(8) RNA copies/m(3) (9.0-10.0 mu m). Infectious status was demonstrated for the 3 viruses, and in the case of IAV and PRRSV, viruses were isolated from particles larger than 2.1 mu m. In summary, our results indicated that airborne PEDV, IAV and PRRSV can be found in a wide range of particle sizes. However, virus viability is particle size dependent.	[Alonso, Carmen; Davies, Peter R.; Torremorell, Montserrat] Univ Minnesota Twin Cities, Coll Vet Med, Dept Vet Populat Med, St Paul, MN USA; [Raynor, Peter C.] Univ Minnesota Twin Cities, Sch Publ Hlth, Div Environm Hlth Sci, St Paul, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Torremorell, M (corresponding author), Univ Minnesota Twin Cities, Coll Vet Med, Dept Vet Populat Med, St Paul, MN USA.	torr0033@umn.edu			Agricultural Experimental Extension Project [MIN-62-106 MT]	Agricultural Experimental Extension Project	Funding: Funding for this study was provided by Agricultural Experimental Extension Project, project number MIN-62-106 MT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso C, 2014, VET RES, V45, DOI 10.1186/s13567-014-0073-z; Alonso C, 2013, PREV VET MED, V112, P109, DOI 10.1016/j.prevetmed.2013.06.001; Appert J, 2012, AEROSOL SCI TECH, V46, P249, DOI 10.1080/02786826.2011.619224; AUSTIN E, 1979, AM IND HYG ASSOC J, V40, P1055, DOI 10.1080/15298667991430703; Bahnson P, 1994, ENZOOTIC PNEUMONIA S; Blachere FM, 2009, CLIN INFECT DIS, V48, P438, DOI 10.1086/596478; Bonifait L, 2015, CLIN INFECT DIS, V61, P299, DOI 10.1093/cid/civ321; Brookes SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009068; Cho JG, 2006, AM J VET RES, V67, P489, DOI 10.2460/ajvr.67.3.489; Corzo CA, 2014, TRANSBOUND EMERG DIS, V61, P28, DOI 10.1111/j.1865-1682.2012.01367.x; Dee S, 2010, VIRUS RES, V154, P177, DOI 10.1016/j.virusres.2010.07.022; Dee S, 2009, VET RES, V40, DOI 10.1051/vetres/2009022; Detmer SE, 2011, J VET DIAGN INVEST, V23, P241, DOI 10.1177/104063871102300207; DONALDSON AI, 1983, VET REC, V113, P490, DOI 10.1136/vr.113.21.490; DONALDSON AI, 1987, RES VET SCI, V43, P339, DOI 10.1016/S0034-5288(18)30804-X; Fabian P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002691; Gloster J, 2007, VET J, V174, P42, DOI 10.1016/j.tvjl.2006.05.020; HOFMANN M, 1988, J CLIN MICROBIOL, V26, P2235, DOI 10.1128/JCM.26.11.2235-2239.1988; HYSLOP NSG, 1971, J AM VET MED ASSOC, V159, P1500; Koster F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033118; Lindsley W, 2010, CLIN INFECT DIS, V50; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Mengeling WL, 1996, VET MICROBIOL, V49, P105, DOI 10.1016/0378-1135(95)00173-5; MILLER WS, 1967, P SOC EXP BIOL MED, V125, P222, DOI 10.3181/00379727-125-32054; Milton DK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003205; Mubareka S, 2009, J INFECT DIS, V199, P858, DOI 10.1086/597073; Otake S, 2010, VET MICROBIOL, V145, P198, DOI 10.1016/j.vetmic.2010.03.028; Park JE, 2014, VIRUS RES, V191, P143, DOI 10.1016/j.virusres.2014.07.038; Romagosa A, 2012, INFLUENZA OTHER RESP, V6, P110, DOI 10.1111/j.1750-2659.2011.00276.x; ROSSOW KD, 1994, J VET DIAGN INVEST, V6, P3, DOI 10.1177/104063879400600102; Sattler T, 2014, VET RES, V10; Slomka MJ, 2010, INFLUENZA OTHER RESP, V4, P277, DOI 10.1111/j.1750-2659.2010.00149.x; Stevenson GW, 2013, J VET DIAGN INVEST, V25, P649, DOI 10.1177/1040638713501675; Stilianakis NI, 2010, J R SOC INTERFACE, V7, P1355, DOI 10.1098/rsif.2010.0026; Tseng CC, 2010, J ENVIRON HEALTH, V73, P22; Vincent AL, 2010, INFLUENZA OTHER RESP, V4, P53, DOI 10.1111/j.1750-2659.2009.00121.x; Xie X, 2007, INDOOR AIR, V17, P211, DOI 10.1111/j.1600-0668.2007.00469.x; Yang W, 2011, J R SOC INTERFACE, V8, P1176, DOI 10.1098/rsif.2010.0686; Zuo ZL, 2013, AEROSOL SCI TECH, V47, P373, DOI 10.1080/02786826.2012.754841	39	70	72	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135675	10.1371/journal.pone.0135675	http://dx.doi.org/10.1371/journal.pone.0135675			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287616	Green Published, gold, Green Submitted			2022-12-26	WOS:000360018600063
J	Ludovico, O; Carella, M; Bisceglia, L; Basile, G; Mastroianno, S; Palena, A; De Cosmo, S; Copetti, M; Prudente, S; Trischitta, V				Ludovico, Ornella; Carella, Massimo; Bisceglia, Luigi; Basile, Giorgio; Mastroianno, Sandra; Palena, Antonio; De Cosmo, Salvatore; Copetti, Massimiliano; Prudente, Sabrina; Trischitta, Vincenzo			Identification and Clinical Characterization of Adult Patients with Multigenerational Diabetes Mellitus	PLOS ONE			English	Article							MUTATIONS; YOUNG	Background Some patients diagnosed as having type 2 diabetes mellitus (T2DM) are, instead, affected by multigenerational diabetes whose clinical characteristics are mostly undefined. Objective 1. To identify among patients who had been previously defined as affected by T2DM those, in fact, affected by multigenerational diabetes; 2. After excluding patients carrying the most common MODY genes and mitochondrial mutations, we compared clinical features of remaining patients with those of patients with T2DM. Methods Among 2,583 consecutive adult patients who had been defined as affected by T2DM, we looked for those with diabetes in >= 3 consecutive generations. All probands were screened for mutations in six MODY genes (HNF4A, GCK, HNF1A, PDX1, HNF1B and NeuroD1) and for the A3243G mitochondrial mutation. After excluding patients with mutations in one of such genes, we compared clinical features of the remaining 67 patients (2.6% of the whole initial sample) affected by multigenerational "familial diabetes of the adulthood" (FDA) and of their diabetic relatives (n = 63) to those with T2DM (n = 1,028) by generalized hierarchical linear models followed by pairwise comparisons. Results Age, age at diagnosis, proportion of hypertension (all p<0.001), and waist circumference (p<0.05) were lower in FDA than T2DM. Nonetheless, the two groups had similar age-adjusted incidence rate of all-cause mortality. Conclusions Beside younger age at diagnosis, FDA patients show lower waist circumference and reduced proportion of hypertension as compared to those with T2DM; despite such reduced potential cardiovascular risk factors, FDA patients did not show a reduced mortality risk than patients with T2DM.	[Ludovico, Ornella; Palena, Antonio] IRCCS Casa Sollievo Sofferenza, Endocrine Clin Unit, San Giovanni Rotondo, Italy; [Carella, Massimo; Bisceglia, Luigi] IRCCS Casa Sollievo Sofferenza, Med Genet Unit, San Giovanni Rotondo, Italy; [Basile, Giorgio; Prudente, Sabrina; Trischitta, Vincenzo] IRCCS Casa Sollievo Sofferenza, Mendel Lab, San Giovanni Rotondo, Italy; [Basile, Giorgio; Trischitta, Vincenzo] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [Mastroianno, Sandra] IRCCS Casa Sollievo Sofferenza, Unit Cardiol, San Giovanni Rotondo, Italy; [De Cosmo, Salvatore] IRCCS Casa Sollievo Sofferenza, Med Unit, San Giovanni Rotondo, Italy; [Copetti, Massimiliano] IRCCS Casa Sollievo Sofferenza, Unit Biostat, San Giovanni Rotondo, Italy; [Trischitta, Vincenzo] IRCCS Casa Sollievo Sofferenza, Res Unit Diabet & Endocrine Dis, San Giovanni Rotondo, Italy	IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; Sapienza University Rome; IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza	Prudente, S (corresponding author), IRCCS Casa Sollievo Sofferenza, Mendel Lab, San Giovanni Rotondo, Italy.	s.prudente@css-mendel.it; vincenzo.trischitta@uniroma1.it	Copetti, Massimiliano/K-3186-2016; Basile, Giorgio/AAD-2202-2022; Bisceglia, Luigi/B-8720-2017; Trischitta, Vincenzo/K-1487-2016; COPETTI, MASSIMILIANO/AAG-1473-2021; Prudente, Sabrina/H-2886-2016; De Cosmo, Salvatore/J-7420-2016; Carella, Massimo/A-2804-2014	Copetti, Massimiliano/0000-0002-7960-5947; Basile, Giorgio/0000-0001-9900-4922; Bisceglia, Luigi/0000-0001-5367-8518; Trischitta, Vincenzo/0000-0003-1174-127X; COPETTI, MASSIMILIANO/0000-0002-7960-5947; Prudente, Sabrina/0000-0001-9220-8981; De Cosmo, Salvatore/0000-0001-8787-8286; Carella, Massimo/0000-0002-6830-6829; Mastroianno, Sandra/0000-0001-6898-4657	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	Funding: This work was supported by the Italian Ministry of Health (Ricerca Corrente 2013 and 2014 to SP and VT).	Biggin A, 2005, MOL GENET METAB, V84, P61, DOI 10.1016/j.ymgme.2004.09.011; De Cosmo S, 2013, DIABETES CARE, V36, P2830, DOI 10.2337/dc12-1906; Doria A, 1999, DIABETES CARE, V22, P253, DOI 10.2337/diacare.22.2.253; Ellard S, 2013, DIABETOLOGIA, V56, P1958, DOI 10.1007/s00125-013-2962-5; Fajans SS, 2011, DIABETES CARE, V34, P1878, DOI 10.2337/dc11-0035; Prudente S, 2015, AM J HUM GENET, V97, P177, DOI 10.1016/j.ajhg.2015.05.011; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Tuomi T, 2014, LANCET, V383, P1084, DOI 10.1016/S0140-6736(13)62219-9; Vaxillaire M, 2008, ENDOCR REV, V29, P254, DOI 10.1210/er.2007-0024; Weng J, 2001, DIABETOLOGIA, V44, P249, DOI 10.1007/s001250051608	10	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135855	10.1371/journal.pone.0135855	http://dx.doi.org/10.1371/journal.pone.0135855			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287533	Green Submitted, Green Published, gold			2022-12-26	WOS:000360018600077
J	Sinclair, LI; Button, KS; Munafo, MR; Day, INM; Lewis, G				Sinclair, Lindsey I.; Button, Katherine S.; Munafo, Marcus R.; Day, Ian N. M.; Lewis, Glyn			Possible Association of APOE Genotype with Working Memory in Young Adults	PLOS ONE			English	Article							APOLIPOPROTEIN-E POLYMORPHISM; ALZHEIMERS-DISEASE; HEAD-INJURY; EPSILON-4; HEALTHY; ALLELE; ATTENTION; PROTEIN; BENEFIT; TASKS	Background Possession of the epsilon 4 allele of the Apolipoprotein E (APOE) gene is associated with an increased risk of Alzheimer's disease. Early adult life effects of epsilon 4 are less well understood. Working memory has been relatively little studied (compared to episodic memory) in relation to APOE genotype despite its importance in cognitive functioning. Our hypothesis was that epsilon 4 would lead to an impairment in working memory in young adults. Methods We studied working memory using a computerised n-back task in the Avon Longitudinal Study of Parents and Children (ALSPAC) at age 18. Data was available for 1049-1927 participants and for the 2- and 3-back versions of the task. Using multiple and multi-level regression controlling for important confounders we examined the association between APOE genotype on accuracy and reaction times. Results There was no evidence of a genotype effect on accuracy when the two difficulty levels were examined separately. There was some evidence to support a deleterious effect of the epsilon 4 allele on n-back accuracy in the multi-level regression. There was weak evidence that the epsilon 22 group were less accurate but the numbers were very low in this group. The epsilon 34 group had faster reaction times than the reference epsilon 33 group in all adjusted analyses but the epsilon 44 group were only faster in the 3-back condition in multi-level analyses. Conclusions There was no evidence of benefit in epsilon 4 carriers, but there was some evidence of a detrimental effect on working memory in this large study.	[Sinclair, Lindsey I.; Button, Katherine S.; Day, Ian N. M.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Munafo, Marcus R.] Univ Bristol, MRC Integrat Epidemiol Unit IEU, Bristol, Avon, England; [Lewis, Glyn] UCL, Div Psychiat, London, England; [Munafo, Marcus R.] Univ Bristol, Sch Expt Psychol, UK Ctr Tobacco & Alcohol Studies, Bristol, Avon, England	University of Bristol; University of Bristol; University of London; University College London; University of Bristol	Sinclair, LI (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol, Avon, England.	lindsey.sinclair@bristol.ac.uk	Lewis, Glyn/E-9944-2012; Munafo, Marcus/AAE-2306-2020	Lewis, Glyn/0000-0001-5205-8245; Munafo, Marcus/0000-0002-4049-993X; Button, Katherine/0000-0003-4332-8789	Wellcome Trust [084268/Z/07/Z, 096114/Z/11/Z]; British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Medical Research Council; National Institute for Health Research; UK Clinical Research Collaboration; National Institute for Health Research School for Primary Care Research (NIHR SPCR); MRC [MC_UU_12013/6] Funding Source: UKRI; Medical Research Council [MC_UU_12013/6, MC_PC_15018] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); UK Clinical Research Collaboration; National Institute for Health Research School for Primary Care Research (NIHR SPCR); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding: This publication was supported by the Wellcome Trust (084268/Z/07/Z). LS is supported by a research training fellowship from the Wellcome Trust (096114/Z/11/Z). MRM is a member of the UK Centre for Tobacco Control Studies, a UKCRC Public Health Research: Centre of Excellence. Funding from British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, and the National Institute for Health Research, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. KSB is funded by the National Institute for Health Research School for Primary Care Research (NIHR SPCR). The NIHR SPCR is a partnership between the Universities of Birmingham, Bristol, Keele, Manchester, Nottingham, Oxford, Southampton and University College London. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi MR, 2006, CLIN CHEM, V52, P1420, DOI 10.1373/clinchem.2006.067082; Alexander DM, 2007, BIOL PSYCHOL, V75, P229, DOI 10.1016/j.biopsycho.2007.03.001; Backman L, 2005, NEUROPSYCHOLOGY, V19, P520, DOI 10.1037/0894-4105.19.4.520; Belleville S, 2007, NEUROPSYCHOLOGY, V21, P458, DOI 10.1037/0894-4105.21.4.458; Berlau DJ, 2009, NEUROLOGY, V72, P829, DOI 10.1212/01.wnl.0000343853.00346.a4; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Bunce D, 2011, NEUROPSYCHOLOGIA, V49, P1693, DOI 10.1016/j.neuropsychologia.2011.02.042; Caselli RJ, 2010, NEUROSCI LETT, V473, P168, DOI 10.1016/j.neulet.2010.02.016; Chen CJ, 2013, AM J NEURORADIOL, V34, P1197, DOI 10.3174/ajnr.A3369; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Deary IJ, 2004, PSYCHOL AGING, V19, P367, DOI 10.1037/0882-7974.19.2.367; Deary IJ, 2002, NATURE, V418, P932, DOI 10.1038/418932a; Deeny SP, 2008, BIOL PSYCHOL, V78, P179, DOI 10.1016/j.biopsycho.2008.02.007; Dietschy JM, 2004, J LIPID RES, V45, P1375, DOI 10.1194/jlr.R400004-JLR200; Ennis S, 2006, ANN HUM GENET, V70, P170, DOI 10.1111/j.1529-8817.2005.00220.x; Ensembl, 2012, ENSEMBL GENOME BROWS; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Fraser A, 2013, INT J EPIDEMIOL, V42, P97, DOI 10.1093/ije/dys066; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Greenwood PM, 2005, NEUROPSYCHOLOGY, V19, P199, DOI 10.1037/0894-4105.19.2.199; Hubacek JA, 2001, NEUROPSYCHOBIOLOGY, V43, P200, DOI 10.1159/000054890; Mahley RW, 2012, J MED CHEM, V55, P8997, DOI 10.1021/jm3008618; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Millar K, 2003, J NEUROL NEUROSUR PS, V74, P1047, DOI 10.1136/jnnp.74.8.1047; Mondadori CRA, 2007, CEREB CORTEX, V17, P1934, DOI 10.1093/cercor/bhl103; Mumford SE, 1999, ARCH DIS CHILD-FETAL, V81, pF146, DOI 10.1136/fn.81.2.F146; O'Hara R, 2008, J PSYCHIATR RES, V42, P199, DOI 10.1016/j.jpsychires.2006.12.001; Ohm TG, 1999, ACTA NEUROPATHOL, V98, P273, DOI 10.1007/s004010051080; Reinvang I, 2010, NEUROPSYCHOLOGIA, V48, P566, DOI 10.1016/j.neuropsychologia.2009.10.018; Rusted JM, 2013, NEUROIMAGE, V65, P364, DOI 10.1016/j.neuroimage.2012.10.010; Scarmeas N, 2005, J NEUROL NEUROSUR PS, V76, P1440, DOI 10.1136/jnnp.2004.053645; Smith EE, 1997, COGNITIVE PSYCHOL, V33, P5, DOI 10.1006/cogp.1997.0658; TALBOT C, 1994, LANCET, V343, P1432, DOI 10.1016/S0140-6736(94)92557-7; Taylor AE, 2011, BIOL PSYCHIAT, V70, P152, DOI 10.1016/j.biopsych.2010.10.033; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Trachtenberg AJ, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.11.011; Turic D, 2001, NEUROSCI LETT, V299, P97, DOI 10.1016/S0304-3940(00)01789-4; Wardle MC, 2013, NEUROPSYCHOPHARMACOL, V38, P1253, DOI 10.1038/npp.2013.24; WEISGRABER KH, 1981, J BIOL CHEM, V256, P9077; White F, 2001, NEUROBIOL DIS, V8, P611, DOI 10.1006/nbdi.2001.0401; Zacho J, 2008, NEW ENGL J MED, V359, P1897, DOI 10.1056/NEJMoa0707402; Zhong N, 2009, CURR ALZHEIMER RES, V6, P415, DOI 10.2174/156720509789207921	48	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135894	10.1371/journal.pone.0135894	http://dx.doi.org/10.1371/journal.pone.0135894			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287823	Green Submitted, gold, Green Published			2022-12-26	WOS:000360018600081
J	Wang, R; Guo, SL; Li, NN; Li, RJ; Zhang, YJ; Jiang, JS; Wang, ZQ; Liu, QF; Wu, DF; Sun, QQ; Du, LL; Zhao, M				Wang, Rui; Guo, Shengli; Li, Nana; Li, Rujian; Zhang, Yanjun; Jiang, Jishao; Wang, Zhiqi; Liu, Qingfang; Wu, Defeng; Sun, Qiqi; Du, Lanlan; Zhao, Man			Phosphorus Accumulation and Sorption in Calcareous Soil under Long-Term Fertilization	PLOS ONE			English	Article							MITIGATION OPTIONS; MANURE; SATURATION; CHINA; AGRICULTURE; ADSORPTION; AVAILABILITY; MANAGEMENT; INDEXES; RISK	Application of phosphorus (P) fertilizers to P-deficient soils can also result in P accumulation. In this study, soil P status and P uptake by apple trees were investigated in 5-, 10-, and 15-year-old orchards in the semi-arid Loess Plateau, China, and subset soils with different soil P statuses (14-90 Olsen-P mg kg(-1)) were selected to evaluate the characteristic P adsorption. Due to the low P-use efficiency (4-6%), total soil P increased from 540 mg kg(-1) to 904 mg kg(-1), Olsen-P ranged from 3.4 mg kg(-1) to 30.7 mg kg(-1), and CaCl2-P increased from less than 0.1 mg kg(-1) to 0.66 mg kg(-1) under continuous P fertilization. The P sorption isotherms for each apple orchard were found to fit the Langmuir isotherm model (R-2 = 0.91-0.98). K (binding energy) and Q(m) (P sorption maximum) decreased, whereas DPS (degree of phosphorus sorption) increased with increasing P concentration. CaCl2-P increased significantly with the increase of Olsen-P, especially above the change point of 46.1 mg kg(-1). Application of surplus P could result in P enrichment in P-deficient soil which has high P fixation capacity, thus posing a significant environmental risk.	[Wang, Rui; Guo, Shengli; Liu, Qingfang; Wu, Defeng; Zhao, Man] Northwest A&F Univ, Coll Resources & Environm, Yangling 712100, Shaanxi, Peoples R China; [Guo, Shengli; Li, Nana; Li, Rujian; Zhang, Yanjun; Wang, Zhiqi; Du, Lanlan] Northwest A&F Univ, Inst Soil & Water Conservat, Yangling 712100, Shaanxi, Peoples R China; [Jiang, Jishao; Sun, Qiqi] Chinese Acad Sci, Inst Soil & Water Conservat, Yangling 712100, Shaanxi, Peoples R China; [Jiang, Jishao; Sun, Qiqi] Minist Water Resource, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Northwest A&F University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS	Guo, SL (corresponding author), Northwest A&F Univ, Coll Resources & Environm, Yangling 712100, Shaanxi, Peoples R China.	slguo@ms.iswc.ac.cn			Chinese Academy of Sciences [XDA05050504]; Non-profit Research Foundation for Agriculture [201203039]	Chinese Academy of Sciences(Chinese Academy of Sciences); Non-profit Research Foundation for Agriculture	This work is supported by the "Strategic Priority Research Program-Climate Change: Carbon Budget and Related Issues" of the Chinese Academy of Sciences (Grant No. XDA05050504), and the Non-profit Research Foundation for Agriculture (No. 201203039).	Allen BL, 2006, SOIL SCI SOC AM J, V70, P454, DOI 10.2136/sssaj2005.0031; Bai ZH, 2013, PLANT SOIL, V372, P27, DOI 10.1007/s11104-013-1696-y; Beauchemin S, 1999, CAN J SOIL SCI, V79, P615, DOI 10.4141/S98-087; Bolland MDA, 2003, AUST J SOIL RES, V41, P1369, DOI 10.1071/SR02098; Casson JP, 2006, J ENVIRON QUAL, V35, P2212, DOI 10.2134/jeq2006.0085; Djodjic F, 2005, SOIL USE MANAGE, V21, P94, DOI [10.1079/SUM2005305, 10.1111/j.1475-2743.2005.tb00413.x]; Eghball B, 1996, J ENVIRON QUAL, V25, P1339, DOI 10.2134/jeq1996.00472425002500060024x; Fan HZ, 2006, GROWTH NUTR UPTAKE U; Guo SL, 2008, PEDOSPHERE, V18, P248, DOI 10.1016/S1002-0160(08)60014-4; Guo ShengLi, 2005, Plant Nutrition and Fertilizer Science, V11, P33; HECKRATH G, 1995, J ENVIRON QUAL, V24, P904, DOI 10.2134/jeq1995.00472425002400050018x; Hooda PS, 2001, ADV ENVIRON RES, V5, P13, DOI 10.1016/S1093-0191(00)00037-X; Jordan C, 2000, SOIL USE MANAGE, V16, P27, DOI 10.1111/j.1475-2743.2000.tb00168.x; Kronvang B, 2009, J ENVIRON QUAL, V38, P1924, DOI 10.2134/jeq2009.0051; Kyllingsbaek A, 2007, NUTR CYCL AGROECOSYS, V79, P267, DOI 10.1007/s10705-007-9114-6; [来璐 Lai Lu], 2003, [水土保持研究, Research of Soil and Water Conservation], V10, P68; [李亚星 Li Yaxing], 2013, [水土保持学报, Journal of Soil and Water Conservation], V27, P98; Lu R. K., 1996, CHINESE J SOIL SCI, V27, P193; Lu SC, 2012, J PLANT NUTR, V35, P1509, DOI 10.1080/01904167.2012.689911; Maguire RO, 2009, J ENVIRON QUAL, V38, P1989, DOI 10.2134/jeq2007.0659; Mejias JH, 2013, GEODERMA, V207, P49, DOI 10.1016/j.geoderma.2013.04.030; MOZAFFARI M, 1994, SOIL SCI, V157, P97, DOI 10.1097/00010694-199402000-00005; Murphy J., 1962, ANAL CHIM ACTA, V27, P31, DOI [DOI 10.1016/S0003-2670(00)88444-5, 10.1016/S0003-2670(00)88444-5]; NAIR PS, 1984, J ENVIRON QUAL, V13, P591, DOI 10.2134/jeq1984.00472425001300040016x; OLSEN STERLING R., 1957, SOIL SCI SOC AMER PROC, V21, P144; Pautler MC, 2000, SOIL SCI SOC AM J, V64, P765, DOI 10.2136/sssaj2000.642765x; Peng L, 1998, ACTA AGRIC BOREALI O, V7, P104; Pothig R, 2010, ENVIRON SCI POLLUT R, V17, P497, DOI 10.1007/s11356-009-0230-5; Rubaek GH, 2013, GEODERMA, V209, P241, DOI 10.1016/j.geoderma.2013.06.022; Sattari SZ, 2012, P NATL ACAD SCI USA, V109, P6348, DOI 10.1073/pnas.1113675109; Sharpley AN, 1996, SOIL SCI SOC AM J, V60, P1459, DOI 10.2136/sssaj1996.03615995006000050025x; Skopp J, 2009, J CHEM EDUC, V86, P1341, DOI 10.1021/ed086p1341; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; WERNER W, 1995, WATER SCI TECHNOL, V31, P87, DOI 10.1016/0273-1223(95)00360-Y; Whalen JK, 2002, COMMUN SOIL SCI PLAN, V33, P1011, DOI 10.1081/CSS-120003870; Whalen JK, 2001, J ENVIRON QUAL, V30, P229, DOI 10.2134/jeq2001.301229x; Withers PJA, 2001, SOIL USE MANAGE, V17, P139, DOI 10.1079/SUM200181; Wu FQ, 2008, NUTR CYCL AGROECOSYS, V81, P95, DOI 10.1007/s10705-007-9155-x; Xin LJ, 2012, J GEOGR SCI, V22, P643, DOI 10.1007/s11442-012-0953-y; ZHU XA, 1983, GEODERMA, V29, P237, DOI 10.1016/0016-7061(83)90090-3; ZHU XM, 1989, SOILS AGR LOESS PLAT, P286	41	23	26	2	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135160	10.1371/journal.pone.0135160	http://dx.doi.org/10.1371/journal.pone.0135160			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288011	Green Submitted, gold, Green Published			2022-12-26	WOS:000360018600038
J	Miller, MA; O'Leary, CJ; Allen, PD; Crane, BT				Miller, Mark A.; O'Leary, Catherine J.; Allen, Paul D.; Crane, Benjamin T.			Human Vection Perception Using Inertial Nulling and Certainty Estimation: The Effect of Migraine History	PLOS ONE			English	Article							SELF-MOTION PERCEPTION; VISUAL-VESTIBULAR INTERACTIONS; ROOM TILT ILLUSION; OPTIC-FLOW; OPTOKINETIC NYSTAGMUS; VELOCITY STORAGE; SICKNESS; TRANSLATION; MODULATION; VISION	Vection is an illusory perception of self-motion that can occur when visual motion fills the majority of the visual field. This study examines the effect of the duration of visual field movement (VFM) on the perceived strength of self-motion using an inertial nulling (IN) and a magnitude estimation technique based on the certainty that motion occurred (certainty estimation, CE). These techniques were then used to investigate the association between migraine diagnosis and the strength of perceived vection. Visual star-field stimuli consistent with either looming or receding motion were presented for 1, 4, 8 or 16s. Subjects reported the perceived direction of self-motion during the final 1s of the stimulus. For the IN method, an inertial nulling motion was delivered during this final 1s of the visual stimulus, and subjects reported the direction of perceived self-motion during this final second. The magnitude of inertial motion was varied adaptively to determine the point of subjective equality (PSE) at which forward or backward responses were equally likely. For the CE trials the same range of VFM was used but without inertial motion and subjects rated their certainty of motion on a scale of 0-100. PSE determined with the IN technique depended on direction and duration of visual motion and the CE technique showed greater certainty of perceived vection with longer VFM duration. A strong correlation between CE and IN techniques was present for the 8s stimulus. There was appreciable between-subject variation in both CE and IN techniques and migraine was associated with significantly increased perception of self-motion by CE and IN at 8 and 16s. Together, these results suggest that vection may be measured by both CE and IN techniques with good correlation. The results also suggest that susceptibility to vection may be higher in subjects with a history of migraine.	[Miller, Mark A.; O'Leary, Catherine J.] Univ Rochester, Sch Med & Dent, Rochester, NY 14642 USA; [Allen, Paul D.; Crane, Benjamin T.] Univ Rochester, Dept Otolaryngol, Rochester, NY 14642 USA; [Crane, Benjamin T.] Univ Rochester, Dept Bioengn, Rochester, NY 14642 USA; [Allen, Paul D.; Crane, Benjamin T.] Univ Rochester, Dept Neurobiol & Anat, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester	Crane, BT (corresponding author), Univ Rochester, Dept Otolaryngol, 601 Elmwood Ave,Box 629, Rochester, NY 14642 USA.	Benjamin_Crane@urmc.rochester.edu			United States National Institute of Health, National Institute of Deafness and Communicative Disorders (NIDCD) [K23 DC011298, P30 DC005409, T32 DC009974]; Triological Society; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K23DC011298, P30DC005409, R01DC013580] Funding Source: NIH RePORTER	United States National Institute of Health, National Institute of Deafness and Communicative Disorders (NIDCD); Triological Society; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by a grant from the United States National Institute of Health, National Institute of Deafness and Communicative Disorders (NIDCD K23 DC011298, P30 DC005409, and T32 DC009974). Support was also provided by a Triological Society Career Scientist Award (to BTC). All funders had a roll in study design, data collection, analysis, and preparation of the manuscript.	ANDERSEN GJ, 1985, J EXP PSYCHOL HUMAN, V11, P122, DOI 10.1037/0096-1523.11.2.122; Angelaki DE, 2008, ANNU REV NEUROSCI, V31, P125, DOI 10.1146/annurev.neuro.31.060407.125555; [Anonymous], 2004, CEPHALALGIA S1, V24, P9; Arjona A, 2002, NEUROLOGIA, V17, P338; AU YN, 2007, J NEUROPHYSIOL, V97, P1100; BERTHOZ A, 1975, EXP BRAIN RES, V23, P471; Bertolini G, 2011, J NEUROPHYSIOL, V105, P209, DOI 10.1152/jn.00154.2010; Bubka A, 2008, PERCEPTION, V37, P704, DOI 10.1068/p5781; Bubka A, 2010, PERCEPTION, V39, P627, DOI 10.1068/p6315; Butler JS, 2011, SEEING PERCEIVING, V24, P453, DOI 10.1163/187847511X588070; CARPENTERSMITH TR, 1995, PERCEPT PSYCHOPHYS, V57, P35, DOI 10.3758/BF03211848; CARPENTERSMITH TR, 1992, ANN NY ACAD SCI, V656, P817, DOI 10.1111/j.1749-6632.1992.tb25262.x; COHEN B, 1981, ANN NY ACAD SCI, V374, P421, DOI 10.1111/j.1749-6632.1981.tb30888.x; Crane BT, 2013, EXP BRAIN RES, V224, P165, DOI 10.1007/s00221-012-3299-x; Crane BT, 2012, EXP BRAIN RES, V219, P477, DOI 10.1007/s00221-012-3105-9; Cuturi LF, 2014, CURR BIOL, V24, P2817, DOI 10.1016/j.cub.2014.10.015; DeAngelis G.C., 2012, NEURAL BASES MULTISE, P1; Dominguez JML, 2007, NEUROLOGIA, V22, P58; Drummond PD, 2005, HEADACHE, V45, P653, DOI 10.1111/j.1526-4610.2005.05132.x; Fetsch CR, 2010, EUR J NEUROSCI, V31, P1721, DOI 10.1111/j.1460-9568.2010.07207.x; Flanagan MB, 2002, AVIAT SPACE ENVIR MD, V73, P1067; Furman Joseph M, 2012, Continuum (Minneap Minn), V18, P1102, DOI 10.1212/01.CON.0000421621.18407.96; GESCHEIDER GA, 1988, ANNU REV PSYCHOL, V39, P169, DOI 10.1146/annurev.psych.39.1.169; Grunfeld E, 1998, BRAIN RES BULL, V47, P433, DOI 10.1016/S0361-9230(98)00099-9; Hettinger L J, 1990, Mil Psychol, V2, P171, DOI 10.1207/s15327876mp0203_4; Hu SQ, 1997, AVIAT SPACE ENVIR MD, V68, P306; HUANG JK, 1987, AVIAT SPACE ENVIR MD, V58, P1197; Jeong SH, 2010, J NEUROL, V257, P905, DOI 10.1007/s00415-009-5435-5; Ji JTT, 2009, HUM FACTORS, V51, P739, DOI 10.1177/0018720809349708; KAYAN A, 1984, BRAIN, V107, P1123, DOI 10.1093/brain/107.4.1123; Keshavarz B, 2014, EXP BRAIN RES, V232, P827, DOI 10.1007/s00221-013-3793-9; Kitazaki M, 2003, PERCEPTION, V32, P475, DOI 10.1068/p5037; KURITZKY A, 1981, HEADACHE, V21, P227, DOI 10.1111/j.1526-4610.1981.hed2105227.x; LARISH JF, 1990, J EXP PSYCHOL HUMAN, V16, P295, DOI 10.1037/0096-1523.16.2.295; Lempert T, 2012, J VESTIBUL RES-EQUIL, V22, P167, DOI 10.3233/VES-2012-0453; Nakamura S, 2013, PERCEPTION, V42, P153, DOI 10.1068/p7321; Nakamura S, 2010, PERCEPTION, V39, P320, DOI 10.1068/p6534; Neuhauser H, 2001, NEUROLOGY, V56, P436, DOI 10.1212/WNL.56.4.436; OHMI M, 1988, PERCEPTION, V17, P5, DOI 10.1068/p170005; Palmisano S, 2002, PERCEPTION, V31, P463, DOI 10.1068/p3321; Roditi RE, 2012, EXP BRAIN RES, V219, P369, DOI 10.1007/s00221-012-3099-3; Roditi RE, 2012, JARO-J ASSOC RES OTO, V13, P381, DOI 10.1007/s10162-012-0318-3; Seno T, 2012, PERCEPTION, V41, P577, DOI 10.1068/p7184; Seno T, 2011, VISION RES, V51, P2499, DOI 10.1016/j.visres.2011.10.007; Seno T, 2010, SEEING PERCEIVING, V23, P273, DOI 10.1163/187847510X532667; Sharon JD, 2014, LARYNGOSCOPE, V124, P969, DOI 10.1002/lary.24285; STERN RM, 1990, AVIAT SPACE ENVIR MD, V61, P712; STEWART WF, 1992, JAMA-J AM MED ASSOC, V267, P64, DOI 10.1001/jama.267.1.64; TEGHTSOONIAN R, 1981, ACTA PSYCHOL, V49, P83, DOI 10.1016/0001-6918(81)90034-2; Webb NA, 2002, AVIAT SPACE ENVIR MD, V73, P351; ZACHARIAS GL, 1981, EXP BRAIN RES, V41, P159	51	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0135335	10.1371/journal.pone.0135335	http://dx.doi.org/10.1371/journal.pone.0135335			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26280172	Green Published, gold, Green Submitted			2022-12-26	WOS:000359664300011
J	Siddiqui, MF; Reza, AW; Kanesan, J				Siddiqui, Muhammad Faisal; Reza, Ahmed Wasif; Kanesan, Jeevan			An Automated and Intelligent Medical Decision Support System for Brain MRI Scans Classification	PLOS ONE			English	Article							PRINCIPAL COMPONENT ANALYSIS; VECTOR MACHINE; IMAGE CLASSIFICATION; SELECTION	A wide interest has been observed in the medical health care applications that interpret neuroimaging scans by machine learning systems. This research proposes an intelligent, automatic, accurate, and robust classification technique to classify the human brain magnetic resonance image (MRI) as normal or abnormal, to cater down the human error during identifying the diseases in brain MRIs. In this study, fast discrete wavelet transform (DWT), principal component analysis (PCA), and least squares support vector machine (LS-SVM) are used as basic components. Firstly, fast DWT is employed to extract the salient features of brain MRI, followed by PCA, which reduces the dimensions of the features. These reduced feature vectors also shrink the memory storage consumption by 99.5%. At last, an advanced classification technique based on LS-SVM is applied to brain MR image classification using reduced features. For improving the efficiency, LS-SVM is used with non-linear radial basis function (RBF) kernel. The proposed algorithm intelligently determines the optimized values of the hyper-parameters of the RBF kernel and also applied k-fold stratified cross validation to enhance the generalization of the system. The method was tested by 340 patients' benchmark datasets of T1-weighted and T2-weighted scans. From the analysis of experimental results and performance comparisons, it is observed that the proposed medical decision support system outperformed all other modern classifiers and achieves 100% accuracy rate (specificity/sensitivity 100%/100%). Furthermore, in terms of computation time, the proposed technique is significantly faster than the recent well-known methods, and it improves the efficiency by 71%, 3%, and 4% on feature extraction stage, feature reduction stage, and classification stage, respectively. These results indicate that the proposed well-trained machine learning system has the potential to make accurate predictions about brain abnormalities from the individual subjects, therefore, it can be used as a significant tool in clinical practice.	[Siddiqui, Muhammad Faisal; Reza, Ahmed Wasif; Kanesan, Jeevan] Univ Malaya, Dept Elect Engn, Fac Engn, Kuala Lumpur, Malaysia	Universiti Malaya	Reza, AW (corresponding author), Univ Malaya, Dept Elect Engn, Fac Engn, Kuala Lumpur, Malaysia.	wasif@um.edu.my	KANESAN, JEEVAN/B-8707-2010; Reza, Ahmed Wasif/ABE-5779-2020	KANESAN, JEEVAN/0000-0001-9949-3105; 	University of Malaya [RG286-14AFR]	University of Malaya(Universiti Malaya)	This research work is supported by the University of Malaya Research Grant (UMRG) scheme (RG286-14AFR). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cawley GC, 2004, NEURAL NETWORKS, V17, P1467, DOI 10.1016/j.neunet.2004.07.002; Chaplot S, 2006, BIOMED SIGNAL PROCES, V1, P86, DOI 10.1016/j.bspc.2006.05.002; Chen GC, 2013, IEEE COMPUT INTELL M, V8, P33, DOI 10.1109/MCI.2012.2228592; Chu W, 2005, IEEE T NEURAL NETWOR, V16, P498, DOI 10.1109/TNN.2004.841785; Das S, 2013, PROG ELECTROMAGN RES, V137, P1, DOI 10.2528/PIER13010105; Duan K, 2003, NEUROCOMPUTING, V51, P41, DOI 10.1016/S0925-2312(02)00601-X; Duda RO, 2001, PATTERN CLASSIFICATI, V2nd, P20; El-Dahshan ESA, 2010, DIGIT SIGNAL PROCESS, V20, P433, DOI 10.1016/j.dsp.2009.07.002; Faisal A, 2013, J MED SYST, V37, DOI 10.1007/s10916-013-9938-3; Guo XC, 2006, LECT NOTES COMPUT SC, V4233, P1138; Kloppel S, 2008, BRAIN, V131, P2969, DOI 10.1093/brain/awn239; Kumar P., 2012, INT J COMPUTER APPL, V53, P25; Lendasse A, 2005, LECT NOTES COMPUT SC, V3697, P625; Lustig M, 2008, IEEE SIGNAL PROC MAG, V25, P72, DOI 10.1109/MSP.2007.914728; Magalhaes F, 2013, LECT NOTES COMPUT SC, V7950, P758, DOI 10.1007/978-3-642-39094-4_87; Maitra M, 2006, BIOMED SIGNAL PROCES, V1, P299, DOI 10.1016/j.bspc.2006.12.001; Maji P, 2007, ICCTA 2007: INTERNATIONAL CONFERENCE ON COMPUTING: THEORY AND APPLICATIONS, PROCEEDINGS, P372; Matoug S, 2012, J PHYS C SERIES; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McRobbie D. W., 2006, MRI PICTURE PROTON; Mwangi B, 2012, BRAIN, V135, P1508, DOI 10.1093/brain/aws084; Patil NS, 2005, CHEM ENG RES DES, V83, P1030, DOI 10.1205/cherd.03144; Prasad PV., 2006, MAGNETIC RESONANCE I; Scapaticci R., 2012, Progress In Electromagnetics Research B, V40, P305; Sengur A, 2008, COMPUT BIOL MED, V38, P329, DOI 10.1016/j.compbiomed.2007.11.004; Suykens JAK, 1999, NEURAL PROCESS LETT, V9, P293, DOI 10.1023/A:1018628609742; van Gestel T, 2004, MACH LEARN, V54, P5, DOI 10.1023/B:MACH.0000008082.80494.e0; Vapnik V.N., 1995, NATURE STAT LEARNING; Wang FF, 2011, PROG ELECTROM RES LE, V23, P119, DOI 10.2528/PIERL11031106; Westbrook C, 2013, HDB MRI TECHNIQUE; Zhang W, 2009, 5 INT C NAT COMP 200; Zhang Y, 2012, PROG ELECTROMAGN RES, V130, P369, DOI 10.2528/PIER12061410; Zhang Y, 2011, PROG ELECTROMAGN RES, V116, P65, DOI 10.2528/PIER11031709; Zhang Y, 2010, PROG ELECTROMAGN RES, V109, P325, DOI 10.2528/PIER10090105; Zhang YD, 2011, SENSORS-BASEL, V11, P4721, DOI 10.3390/s110504721; Zhang YD, 2011, EXPERT SYST APPL, V38, P10049, DOI 10.1016/j.eswa.2011.02.012	36	38	38	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0135875	10.1371/journal.pone.0135875	http://dx.doi.org/10.1371/journal.pone.0135875			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26280918	Green Published, Green Submitted, gold			2022-12-26	WOS:000359664300026
J	Kempuraj, D; Thangavel, R; Yang, E; Pattani, S; Zaheer, S; Santillan, DA; Santillan, MK; Zaheer, A				Kempuraj, Duraisamy; Thangavel, Ramasamy; Yang, Evert; Pattani, Sagar; Zaheer, Smita; Santillan, Donna A.; Santillan, Mark K.; Zaheer, Asgar			Dopaminergic Toxin 1-Methyl-4-Phenylpyridinium, Proteins alpha-Synuclein and Glia Maturation Factor Activate Mast Cells and Release Inflammatory Mediators	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; VASOACTIVE-INTESTINAL-PEPTIDE; PARKINSONS-DISEASE; FACTOR-BETA; FACTOR OVEREXPRESSION; ASTROCYTES; EXPRESSION; MICROGLIA; NEUROINFLAMMATION; MODEL	Parkinson's disease (PD) is characterized by the presence of Lewy bodies and degeneration of dopaminergic neurons. 1-methyl-4-phenylpyridinium (MPP+), a metabolite of neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and Lewy body component alpha-synuclein activates glia in PD pathogenesis. Mast cells and glia maturation factor (GMF) are implicated in neuroinflammatory conditions including Multiple Sclerosis. However, the role of mast cells in PD is not yet known. We have analyzed the effect of recombinant GMF, MPP+, alpha-synuclein and interleukin-33 (IL-33) on mouse bone marrow-derived cultured mast cells (BMMCs), human umbilical cord blood-derived cultured mast cells (hCBMCs) and mouse brain-derived cultured astrocytes by quantifying cytokines/chemokines released using ELISA or by detecting the expression of co-stimulatory molecules CD40 and CD40L by flow cytometry. GMF significantly released chemokine (C-C motif) ligand 2 (CCL2) from BMMCs but its release was reduced in BMMCs from GMF knockout mice. GMF, alpha-synuclein and MPP+ released IL-1 beta, beta-hexosaminidase from BMMCs, and IL-8 from hCBMCs. GMF released CCL5, and IL-33- induced the expression of GMF from hCBMCs. Novel GMF expression was detected in hCBMCs and BMMCs by immunocytochemistry. GMF released tumor necrosis factor-alpha (TNF-alpha) from mouse astrocytes, and this release was greater in BMMC-astrocyte coculture than in individual cultures. Flow cytometry results showed increased IL-33 expression by GMF and MPP+, and GMF-induced CD40 expression in astrocytes. Proinflammatory mediator release by GMF, MPP+ and alpha-synuclein, as well as GMF expression by mast cells indicate a potential therapeutic target for neurodegenerative diseases including PD.	[Kempuraj, Duraisamy; Thangavel, Ramasamy; Zaheer, Asgar] Vet Affairs Hlth Care Syst, Iowa City, IA USA; [Kempuraj, Duraisamy; Thangavel, Ramasamy; Yang, Evert; Pattani, Sagar; Zaheer, Smita; Zaheer, Asgar] Univ Iowa Hosp & Clin, Dept Neurol, Carver Coll Med, Iowa City, IA 52242 USA; [Santillan, Donna A.; Santillan, Mark K.] Univ Iowa Hosp & Clin, Dept Obstet & Gynecol, Carver Coll Med, Iowa City, IA 52242 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Iowa; University of Iowa	Zaheer, A (corresponding author), Vet Affairs Hlth Care Syst, Iowa City, IA USA.	asgar-zaheer@uiowa.edu	duraisamy, kempuraj/R-3043-2019; Duraisamy, Kempuraj/AAC-5638-2022	Santillan, Donna/0000-0002-6180-9714; Santillan, Mark/0000-0002-3991-8017	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development [BX002477-01]; National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke [NS073670]; Reproductive Scientist Development Program [HD000849, RR024980]; CSTA [U54TR001013]; University of Iowa Carver College of Medicine; Department of Obstetrics Gynecology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000849] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [U54TR001013] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073670] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002477] Funding Source: NIH RePORTER	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development(US Department of Veterans Affairs); National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Reproductive Scientist Development Program; CSTA; University of Iowa Carver College of Medicine; Department of Obstetrics Gynecology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	This material is based upon work supported, in part, by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development (BX002477-01, AZ), and by the National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke Grant NS073670 (AZ), and the Reproductive Scientist Development Program HD000849, RR024980 (MS) and CSTA U54TR001013. The Maternal Fetal Tissue Bank at the University of Iowa is supported by the University of Iowa Carver College of Medicine and Department of Obstetrics & Gynecology.	Alexandrakis M, 2003, EUR J HAEMATOL, V71, P448, DOI 10.1046/j.0902-4441.2003.00167.x; Bennett JL, 2009, J IMMUNOL, V182, P5507, DOI 10.4049/jimmunol.0801485; Beraud D, 2013, J NEUROIMMUNE PHARM, V8, P94, DOI 10.1007/s11481-012-9401-0; Brahmachari S, 2009, J IMMUNOL, V183, P5917, DOI 10.4049/jimmunol.0803336; Chikahisa S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078434; Czlonkowska A, 1996, NEURODEGENERATION, V5, P137, DOI 10.1006/neur.1996.0020; Duran R, 2010, MOVEMENT DISORD, V25, P489, DOI 10.1002/mds.22928; Enoksson M, 2011, J IMMUNOL, V186, P2523, DOI 10.4049/jimmunol.1003383; Freeman JG, 2001, J NEUROIMMUNOL, V119, P231, DOI 10.1016/S0165-5728(01)00384-8; Fukuishi N, 2014, J IMMUNOL, V193, P1886, DOI 10.4049/jimmunol.1302520; Hirsch Etienne C, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS210, DOI 10.1016/S1353-8020(11)70065-7; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; HOSLI L, 1984, NEUROSCI LETT, V48, P287, DOI 10.1016/0304-3940(84)90052-1; Hsu LJ, 2000, AM J PATHOL, V157, P401, DOI 10.1016/S0002-9440(10)64553-1; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Kalia LV, 2013, ANN NEUROL, V73, P155, DOI 10.1002/ana.23746; KAPLAN R, 1991, J NEUROCHEM, V57, P483, DOI 10.1111/j.1471-4159.1991.tb03777.x; Karagkouni A, 2013, AUTOIMMUN REV, V12, P947, DOI 10.1016/j.autrev.2013.02.006; Kempuraj D, 1999, BLOOD, V93, P3338, DOI 10.1182/blood.V93.10.3338.410k05_3338_3346; Kempuraj D, 2013, J NEUROIMMUNE PHARM, V8, P643, DOI 10.1007/s11481-013-9439-7; Kempuraj D, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-20; Khan MM, 2014, J MOL NEUROSCI, V53, P590, DOI 10.1007/s12031-013-0225-z; Kim DY, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-25; Kim DY, 2010, J IMMUNOL, V185, P273, DOI 10.4049/jimmunol.1000991; Korkmaz OT, 2010, J MOL NEUROSCI, V41, P278, DOI 10.1007/s12031-009-9307-3; Lee EJ, 2010, J IMMUNOL, V185, P615, DOI 10.4049/jimmunol.0903480; Lee HJ, 2010, OXID MED CELL LONGEV, V3, P283, DOI 10.4161/oxim.3.4.12809; LIM R, 1989, P NATL ACAD SCI USA, V86, P3901, DOI 10.1073/pnas.86.10.3901; Lim R, 2004, BRAIN RES, V1024, P225, DOI 10.1016/j.brainres.2004.08.003; LIM R, 1991, ADV EXP MED BIOL, V296, P161; LIM RM, 1990, FASEB J, V4, P3360, DOI 10.1096/fasebj.4.15.2253851; Marx CE, 2001, BIOL PSYCHIAT, V50, P743, DOI 10.1016/S0006-3223(01)01209-4; Mekori YA, 2000, IMMUNOL REV, V173, P131, DOI 10.1034/j.1600-065X.2000.917305.x; Moulin D, 2007, CYTOKINE, V40, P216, DOI 10.1016/j.cyto.2007.09.013; Nelissen S, 2013, ACTA NEUROPATHOL, V125, P637, DOI 10.1007/s00401-013-1092-y; Radinger Madeleine, 2010, Curr Protoc Immunol, VChapter 7, DOI 10.1002/0471142735.im0737s90; Roodveldt C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013481; Ryan BJ, 2014, FREE RADICAL BIO MED, V67, P58, DOI 10.1016/j.freeradbiomed.2013.10.008; Saito T, 2005, NEUROMOL MED, V7, P79, DOI 10.1385/NMM:7:1-2:079; Santillan MK, 2014, EUR J OBSTET GYN R B, V179, P94, DOI 10.1016/j.ejogrb.2014.05.023; Sayed BA, 2011, J IMMUNOL, V186, P3294, DOI 10.4049/jimmunol.1003574; Sayed BA, 2010, J IMMUNOL, V184, P6891, DOI 10.4049/jimmunol.1000126; Secor VH, 2000, J EXP MED, V191, P813, DOI 10.1084/jem.191.5.813; SEELDRAYERS PA, 1992, J NEUROIMMUNOL, V36, P239, DOI 10.1016/0165-5728(92)90056-Q; Silver R, 2013, TRENDS NEUROSCI, V36, P513, DOI 10.1016/j.tins.2013.06.001; Silverman AJ, 2000, J NEUROSCI, V20, P401, DOI 10.1523/JNEUROSCI.20-01-00401.2000; Sismanopoulos N, 2012, CURR PHARM DESIGN, V18, P2261, DOI 10.2174/138161212800165997; Skaper SD, 2014, CNS NEUROL DISORD-DR, V13, P1654; Skaper SD, 2014, IMMUNOLOGY, V141, P314, DOI 10.1111/imm.12170; Skaper SD, 2013, MOL NEUROBIOL, V48, P340, DOI 10.1007/s12035-013-8487-6; Skaper SD, 2012, PHILOS T R SOC B, V367, P3312, DOI 10.1098/rstb.2011.0391; Skaper SD, 2012, FASEB J, V26, P3103, DOI 10.1096/fj.11-197194; Tagen M, 2009, J IMMUNOL, V183, P6313, DOI 10.4049/jimmunol.0803422; Tanzola MB, 2003, J IMMUNOL, V171, P4385, DOI 10.4049/jimmunol.171.8.4385; Thangavel R, 2012, NEUROPATH APPL NEURO, V38, P572, DOI 10.1111/j.1365-2990.2011.01232.x; Theoharides TC, 2012, BBA-MOL BASIS DIS, V1822, P21, DOI 10.1016/j.bbadis.2010.12.014; Theoharides TC, 2010, P NATL ACAD SCI USA, V107, P4448, DOI 10.1073/pnas.1000803107; Tore F, 2009, CURR PHARM DESIGN, V15, P3433, DOI 10.2174/138161209789105036; Trudler D, 2015, J NEURAL TRANSM; Tuncel N, 2005, PEPTIDES, V26, P827, DOI 10.1016/j.peptides.2004.12.019; Tung HY, 2014, J INTERF CYTOK RES, V34, P141, DOI 10.1089/jir.2012.0066; Walker ME, 2012, BBA-MOL BASIS DIS, V1822, P57, DOI 10.1016/j.bbadis.2011.02.009; WANG BR, 1992, BRAIN RES, V591, P1, DOI 10.1016/0006-8993(92)90971-B; Xiong Z, 2014, J ALZHEIMERS DIS, V40, P297, DOI 10.3233/JAD-132081; Yasuoka S, 2011, BRAIN RES, V1385, P8, DOI 10.1016/j.brainres.2011.02.045; ZAHEER A, 1993, J NEUROCHEM, V60, P914, DOI 10.1111/j.1471-4159.1993.tb03237.x; Zaheer A, 2001, NEUROCHEM RES, V26, P1293, DOI 10.1023/A:1014241300179; Zaheer A, 2002, BIOCHEM BIOPH RES CO, V294, P238, DOI 10.1016/S0006-291X(02)00467-9; Zaheer A, 2008, BRAIN RES, V1208, P192, DOI 10.1016/j.brainres.2008.02.093; Zaheer A, 2008, BRAIN RES, V1190, P206, DOI 10.1016/j.brainres.2007.11.011; Zaheer A, 2007, J NEUROCHEM, V101, P364, DOI 10.1111/j.1471-4159.2006.04385.x; Zaheer S, 2011, NEUROSCIENCE, V194, P227, DOI 10.1016/j.neuroscience.2011.07.069; Zaltieri M., 2015, PARKINSONS DIS-US, V2015, DOI [DOI 10.1155/2015/108029, 10.1155/2015/108029]; Zhang S, 2012, CELL PHYSIOL BIOCHEM, V29, P931, DOI 10.1159/000171029	74	26	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135776	10.1371/journal.pone.0135776	http://dx.doi.org/10.1371/journal.pone.0135776			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275153	Green Published, Green Submitted, gold			2022-12-26	WOS:000359493600109
J	Orozco-Davila, D; Adriano-Anaya, MD; Quintero-Fong, L; Salvador-Figueroa, M				Orozco-Davila, Dina; de Lourdes Adriano-Anaya, Maria; Quintero-Fong, Luis; Salvador-Figueroa, Miguel			Sterility and Sexual Competitiveness of Tapachula-7 Anastrepha ludens Males Irradiated at Different Doses	PLOS ONE			English	Article							MEDITERRANEAN FRUIT-FLIES; MATING PERFORMANCE; GAMMA-RADIATION; DIPTERA; TEPHRITIDAE; FLY; COMPATIBILITY; ERADICATION; RELEASE	A genetic sexing strain of Anastrepha ludens (Loew), Tapachula-7, was developed by the Mexican Program Against Fruit Flies to produce and release only males in programs where the sterile insect technique (SIT) is applied. Currently, breeding are found at a massive scale, and it is necessary to determine the optimum irradiation dose that releases sterile males with minimum damage to their sexual competitiveness. Under laboratory and field conditions, we evaluated the effects of gamma irradiation at doses of 0, 20, 40, 60 and 80 Gy on the sexual competitiveness of males, the induction of sterility in wild females and offspring survivorship. The results of the study indicate that irradiation doses have a significant effect on the sexual behavior of males. A reduction of mating capacity was inversely proportional to the irradiation dose of males. It is estimated that a dose of 60 Gy can induce more than 99% sterility in wild females. In all treatments, the degree of offspring fertility was correlated with the irradiation dose of the parents. In conclusion, the results of the study indicate that a dose of 60 Gy can be applied in sterile insect technique release programs. The application of this dose in the new genetic sexing strain of A. ludens is discussed.	[Orozco-Davila, Dina; Quintero-Fong, Luis] Programa Moscafrut, Metapa De Dominguez, Chiapas, Mexico; [de Lourdes Adriano-Anaya, Maria; Salvador-Figueroa, Miguel] Univ Autonoma Chiapas, Ctr Biociencias, Tapachula, Chiapas, Mexico	Universidad Autonoma de Chiapas	Quintero-Fong, L (corresponding author), Programa Moscafrut, Metapa De Dominguez, Chiapas, Mexico.	jose.quintero@iica-moscafrut.org.mx	Orozco-Davila, Dina/AAJ-2862-2021; Orozco-Davila, Dina/B-4050-2016; Orozco-Davila, Dina/B-3236-2016; Quintero, Jose Luis/B-6213-2013; Orozco-Davila, Dina/T-5369-2019	Orozco-Davila, Dina/0000-0002-6806-0945; Orozco-Davila, Dina/0000-0002-6806-0945; Quintero, Jose Luis/0000-0002-2066-9524; Adriano-Anaya, Lourdes/0000-0002-4356-5429	Programa Nacional Moscas de la fruta SAGARPA-IICA	Programa Nacional Moscas de la fruta SAGARPA-IICA	This research was funded and supported by the Programa Nacional Moscas de la fruta SAGARPA-IICA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allinghi A, 2007, FLA ENTOMOL, V90, P96, DOI 10.1653/0015-4040(2007)90[96:IOSIAF]2.0.CO;2; Aluja M, 2000, FRUIT FLIES (TEPHRITIDAE): PHYLOGENY AND EVOLUTION OF BEHAVIOR, P375; Bakri A, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P233, DOI 10.1007/1-4020-4051-2_9; Barry JD, 2003, J ECON ENTOMOL, V96, P615, DOI 10.1603/0022-0493-96.3.615; Calkins C.O., 1985, Folia Entomologica Mexicana, P205; CALKINS CO, 1994, FRUIT FLIES AND THE STERILE INSECT TECHNIQUE, P85; CALKINS CO, 1989, J APPL ENTOMOL, V108, P401, DOI 10.1111/j.1439-0418.1989.tb00474.x; CALKINS CO, 1983, FLA ENTOMOL, V66, P512, DOI 10.2307/3494025; Calkins CO, 1988, S MOD INS CONTR NUCL, P299; Cunningham R. T., 1980, Citrograph, V65, P63; Dominiak BC, 2003, AUST J EXP AGR, V43, P519, DOI 10.1071/EA01146; Enkerlin D, 1982, STERILE INSECT TECHN, P323; FAO/IAEA/USDA, 2019, PROD QUAL CONTR STER; Favret E., 1995, Mendeliana, V11, P69; Gutiurrez JM., 2010, MOSCAS FRUTA FUNDAME, P3; Hendrichs J, 2002, FLA ENTOMOL, V85, P1, DOI 10.1653/0015-4040(2002)085[0001:MASITP]2.0.CO;2; HOOPER G H S, 1975, Journal of the Australian Entomological Society, V14, P81; Hooper GHS., 1989, WORLD CROP PESTS A, P153; Klassen W, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P39, DOI 10.1007/1-4020-4051-2_2; KNIPLING EF, 1955, J ECON ENTOMOL, V48, P459, DOI 10.1093/jee/48.4.459; Kuba H, 1996, FRUIT FLY PESTS, P543; Lux SA, 2002, FLA ENTOMOL, V85, P102, DOI 10.1653/0015-4040(2002)085[0102:EOIOTC]2.0.CO;2; Meza JS, 2005, J ECON ENTOMOL, V98, P1930, DOI 10.1603/0022-0493-98.6.1930; Meza-Hernandez JS, 2006, J ECON ENTOMOL, V99, P1979, DOI 10.1603/0022-0493-99.6.1979; Orozco D, 2012, 8 M WORK GROUP FRUIT; Orozco D, 2013, J ECON ENTOMOL, V106, P735, DOI 10.1603/EC12441; Ramirez E, 2012, 8 M WORK GROUP FRUIT; RHODE RH, 1961, J ECON ENTOMOL, V54, P202, DOI 10.1093/jee/54.1.202; Robinson AS, 2002, MUTAT RES-REV MUTAT, V511, P113, DOI 10.1016/S1383-5742(02)00006-6; Rull J, 2007, J ECON ENTOMOL, V100, P1153, DOI 10.1603/0022-0493(2007)100[1153:IOALDT]2.0.CO;2; Rull J, 2014, INT J TROP INSECT SC, V34, pS28, DOI 10.1017/S174275841400006X; SEO ST, 1990, J ECON ENTOMOL, V83, P1948, DOI 10.1093/jee/83.5.1949; Zepeda-Cisneros CS, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-S2-S1; TOLEDO J, 1993, FRUIT FLIES, P301; Toledo J, 2004, J ECON ENTOMOL, V97, P383, DOI 10.1603/0022-0493-97.2.383; WALDER JM, 1992, FLA ENTOMOL, V75, P267, DOI 10.2307/3495629; Walder JMM, 1993, SCI AGR, V50, P157, DOI DOI 10.1590/S0103-90161993000200001; Zar J.H., 2010, BIOSTAT ANAL	38	24	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135759	10.1371/journal.pone.0135759	http://dx.doi.org/10.1371/journal.pone.0135759			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274926	gold, Green Published, Green Submitted			2022-12-26	WOS:000359493600107
J	Tang, CX; Ji, XY; Wu, L; Xiong, Y				Tang, Chenxiang; Ji, Xiaoyun; Wu, Li; Xiong, Yong			Impaired dNTPase Activity of SAMHD1 by Phosphomimetic Mutation of Thr-592	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AICARDI-GOUTIERES SYNDROME; RESTRICTION FACTOR SAMHD1; HIV-1 REVERSE TRANSCRIPTION; ACID BINDING-PROTEIN; INFECTION; PHOSPHORYLATION; REPLICATION; CELL; MACROPHAGES; INHIBITION	SAMHD1 is a cellular protein that plays key roles in HIV-1 restriction and regulation of cellular dNTP levels. Mutations in SAMHD1 are also implicated in the pathogenesis of chronic lymphocytic leukemia and Aicardi-Goutieres syndrome. The anti-HIV-1 activity of SAMHD1 is negatively modulated by phosphorylation at residue Thr-592. The mechanism underlying the effect of phosphorylation on anti-HIV-1 activity remains unclear. SAMHD1 forms tetramers that possess deoxyribonucleotide triphosphate triphosphohydrolase (dNTPase) activity, which is allosterically controlled by the combined action of GTP and all four dNTPs. Here we demonstrate that the phosphomimetic mutation T592E reduces the stability of the SAMHD1 tetramer and the dNTPase activity of the enzyme. To better understand the underlying mechanisms, we determined the crystal structures of SAMHD1 variants T592E and T592V. Although the neutral substitution T592V does not perturb the structure, the charged T592E induces large conformational changes, likely triggered by electrostatic repulsion from a distinct negatively charged environment surrounding Thr-592. The phosphomimetic mutation results in a significant decrease in the population of active SAMHD1 tetramers, and hence the dNTPase activity is substantially decreased. These results provide a mechanistic understanding of how SAMHD1 phosphorylation at residue Thr-592 may modulate its cellular and antiviral functions.	[Tang, Chenxiang; Ji, Xiaoyun; Xiong, Yong] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Wu, Li] Ohio State Univ, Ctr Retrovirus Res, Dept Vet Biosci, Columbus, OH 43210 USA; [Wu, Li] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA	Yale University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Xiong, Y (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.	yong.xiong@yale.edu	Regan, Clinton/E-6250-2012; Wu, Li/ABB-2813-2020; Wu, Li/E-4330-2011	Wu, Li/0000-0002-5468-2487; Wu, Li/0000-0002-5468-2487; Ji, Xiaoyun/0000-0002-0801-8825	National Institutes of Health [AI102778, AI120845, AI104483]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104483, K99AI120845, R01AI102778] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grants AI102778 (to Y. X.), AI120845 (to X. J.), and AI104483 (to L. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Amie SM, 2013, J BIOL CHEM, V288, P25001, DOI 10.1074/jbc.C113.493619; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Beloglazova N, 2013, J BIOL CHEM, V288, P8101, DOI 10.1074/jbc.M112.431148; Berger A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002425; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Clifford R, 2014, BLOOD, V123, P1021, DOI 10.1182/blood-2013-04-490847; Cribier A, 2013, CELL REP, V3, P1036, DOI 10.1016/j.celrep.2013.03.017; Davidson MB, 2012, EMBO J, V31, P895, DOI 10.1038/emboj.2011.485; Descours B, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-87; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franzolin E, 2013, P NATL ACAD SCI USA, V110, P14272, DOI 10.1073/pnas.1312033110; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Goncalves A, 2012, HUM MUTAT, V33, P1116, DOI 10.1002/humu.22087; Gramberg T, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-26; Hansen EC, 2014, P NATL ACAD SCI USA, V111, pE1843, DOI 10.1073/pnas.1401706111; HOL WGJ, 1985, PROG BIOPHYS MOL BIO, V45, P149, DOI 10.1016/0079-6107(85)90001-X; Hollenbaugh JA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003481; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Ji XY, 2014, P NATL ACAD SCI USA, V111, pE4305, DOI 10.1073/pnas.1412289111; Ji XY, 2013, NAT STRUCT MOL BIOL, V20, P1304, DOI 10.1038/nsmb.2692; Kim ET, 2013, J VIROL, V87, P12949, DOI 10.1128/JVI.02291-13; Kretschmer S, 2015, ANN RHEUM DIS, V74, DOI 10.1136/annrheumdis-2013-204845; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Li N, 2000, IMMUNOL LETT, V74, P221, DOI 10.1016/S0165-2478(00)00276-5; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Pauls E, 2014, AIDS, V28, P2213, DOI 10.1097/QAD.0000000000000399; Pauls E, 2014, J IMMUNOL, V193, P1988, DOI 10.4049/jimmunol.1400873; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Ryoo J, 2014, NAT MED, V20, P936, DOI 10.1038/nm.3626; Seamon KJ, 2015, NUCLEIC ACIDS RES, V43, P6486, DOI 10.1093/nar/gkv633; St Gelais C, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-105; Stillman B, 2013, P NATL ACAD SCI USA, V110, P14120, DOI 10.1073/pnas.1312901110; STUART DI, 1979, J MOL BIOL, V134, P109, DOI 10.1016/0022-2836(79)90416-9; Sze A, 2013, J MOL BIOL, V425, P4981, DOI 10.1016/j.jmb.2013.10.022; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Welbourn S, 2013, J VIROL, V87, P11516, DOI 10.1128/JVI.01642-13; White TE, 2013, CELL HOST MICROBE, V13, P441, DOI 10.1016/j.chom.2013.03.005; White TE, 2013, VIROLOGY, V436, P81, DOI 10.1016/j.virol.2012.10.029; Yan JP, 2015, J BIOL CHEM, V290, P13279, DOI 10.1074/jbc.M115.646588; Yan JP, 2013, J BIOL CHEM, V288, P10406, DOI 10.1074/jbc.M112.443796; Zhu CF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3722	44	61	64	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 30	2015	290	44					26352	26359		10.1074/jbc.M115.677435	http://dx.doi.org/10.1074/jbc.M115.677435			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CW2AO	26294762	Green Published, hybrid			2022-12-26	WOS:000364793600001
J	Wells, ML; Hicks, SN; Perera, L; Blackshear, PJ				Wells, Melissa L.; Hicks, Stephanie N.; Perera, Lalith; Blackshear, Perry J.			Functional Equivalence of an Evolutionarily Conserved RNA Binding Module	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEINS; AU-RICH ELEMENT; MESSENGER-RNA; SCHIZOSACCHAROMYCES-POMBE; POSTTRANSCRIPTIONAL REGULATION; TRISTETRAPROLIN FAMILY; DEGRADATION; DOMAIN; DESTABILIZATION; DEADENYLATION	Members of the tristetraprolin (TIP) family of proteins participate in the regulation of mRNA turnover after initially binding to AU-rich elements in target mRNAs. Related proteins from most groups of eukaryotes contain a conserved tandem zinc finger (TZF) domain consisting of two closely spaced, similar CCCH zinc fingers that form the primary RNA binding domain. There is considerable sequence variation within the 'ern, domains from different family members within a single organism and from different organisms, raising questions about sequence-specific effects on RNA binding and decay promotion. We hypothesized that TZF domains from evolutionarily distant species are functionally interchangeable. The single family member expressed in the fission yeast Schizosaccharomyces pombe, Zfsl, promotes the turnover of several dozen transcripts, some of which are involved in cell-cell interactions. Using knockin techniques, we replaced the 'ern, domain of S. pornbe Zfsl with the equivalent domains from human TTP and the single family member proteins expressed in the silkworm Bombyx mori, the pathogenic yeast Candida mondii, and the plant Chromolaena odorata. We found that the TZF domains from these widely disparate species could completely substitute for the native S. pornbe TZF domain, as determined by measurement of target transcript levels and the flocculation phenotype characteristic of Zfs1 deletion. Recombinant TZF domain peptides from several of these species bound to an AU-rich RNA oligonucleotide with comparably high affinity. We conclude that the TZF domains from TTP family members in these evolutionarily widely divergent species are functionally interchangeable in mRNA binding and decay.	[Wells, Melissa L.; Hicks, Stephanie N.; Blackshear, Perry J.] NIEHS, Signal Transduct Lab, NIH, Res Triangle Pk, NC 27709 USA; [Perera, Lalith] NIEHS, Genome Integr & Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Blackshear, Perry J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Blackshear, Perry J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Duke University; Duke University	Blackshear, PJ (corresponding author), NIEHS, F1-13,111 Alexander Dr, Res Triangle Pk, NC 27709 USA.	black009@niehs.nih.gov	Blackshear, Perry J./C-6206-2019; Perera, Lalith/ABB-9995-2021; perera, Lalith/B-6879-2012	Blackshear, Perry J./0000-0002-9561-8529; perera, Lalith/0000-0003-0823-1631	NIEHS/National Institutes of Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES043010, ZIAES090080] Funding Source: NIH RePORTER	NIEHS/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported, in whole or in part, by the intramural research program of the NIEHS/National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article.	Blackshear PJ, 2014, J INTERF CYTOK RES, V34, P297, DOI 10.1089/jir.2013.0150; Blackshear PJ, 2003, J BIOL CHEM, V278, P19947, DOI 10.1074/jbc.M301290200; Brewer BY, 2004, J BIOL CHEM, V279, P27870, DOI 10.1074/jbc.M402551200; Brooks SA, 2013, BBA-GENE REGUL MECH, V1829, P666, DOI 10.1016/j.bbagrm.2013.02.003; Case D.A., 2022, AMBER; Choi YJ, 2014, J BIOL CHEM, V289, P35042, DOI 10.1074/jbc.M114.593491; Ciais D, 2013, CELL MOL LIFE SCI, V70, P2031, DOI 10.1007/s00018-012-1150-y; Cuthbertson BJ, 2008, J BIOL CHEM, V283, P2586, DOI 10.1074/jbc.M707154200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fabian MR, 2013, NAT STRUCT MOL BIOL, V20, P735, DOI 10.1038/nsmb.2572; Funakoshi M, 2009, YEAST, V26, P185, DOI 10.1002/yea.1658; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Hudson BP, 2004, NAT STRUCT MOL BIOL, V11, P257, DOI 10.1038/nsmb738; KANOH J, 1995, MOL BIOL CELL, V6, P1185, DOI 10.1091/mbc.6.9.1185; Kedar VP, 2012, J BIOL CHEM, V287, P5459, DOI 10.1074/jbc.M111.312652; Lai WS, 2014, J BIOL CHEM, V289, P565, DOI 10.1074/jbc.M113.466326; Lai WS, 2000, J BIOL CHEM, V275, P17827, DOI 10.1074/jbc.M001696200; Lai WS, 2005, J BIOL CHEM, V280, P34365, DOI 10.1074/jbc.M506757200; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lai WS, 2002, J BIOL CHEM, V277, P9606, DOI 10.1074/jbc.M110395200; Moon AF, 2010, PROTEIN SCI, V19, P901, DOI 10.1002/pro.368; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; Sandler H, 2011, NUCLEIC ACIDS RES, V39, P4373, DOI 10.1093/nar/gkr011; TAYLOR GA, 1991, NUCLEIC ACIDS RES, V19, P3454, DOI 10.1093/nar/19.12.3454; Wells ML, 2015, MOL MICROBIOL, V95, P1036, DOI 10.1111/mmi.12913; Wells ML, 2012, MOL CELL BIOL, V32, P4206, DOI 10.1128/MCB.00325-12	27	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24413	24423		10.1074/jbc.M115.673012	http://dx.doi.org/10.1074/jbc.M115.673012			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26292216	Green Published, hybrid			2022-12-26	WOS:000362218900029
J	Remacle, AG; Kumar, S; Motamedchaboki, K; Cieplak, P; Hullugundi, S; Dolkas, J; Shubayev, VI; Strongin, AY				Remacle, Albert G.; Kumar, Sonu; Motamedchaboki, Khatereh; Cieplak, Piotr; Hullugundi, Swathi; Dolkas, Jennifer; Shubayev, Veronica I.; Strongin, Alex Y.			Matrix Metalloproteinase (MMP) Proteolysis of the Extracellular Loop of Voltage-gated Sodium Channels and Potential Alterations in Pain Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDE LIBRARIES; CHANNELOPATHIES; INSENSITIVITY; MUTATIONS; TARGETS	Congenital insensitivity to pain (CIP) or congenital analgesia is a rare monogenic hereditary condition. This disorder is characterized by the inability to perceive any form of pain. Nonsense mutations in Nav. 1.7, the main pain signaling voltage-gated sodium channel, lead to its truncations and, consequently, to the inactivation of the channel functionality. However, a non-truncating homozygously inherited missense mutation in a Bedouin family with CIP (Nav1.7-R907Q) has also been reported. Based on our currently acquired in-depth knowledge of matrix metalloproteinase (MMP) cleavage preferences, we developed the specialized software that predicts the presence of the MMP cleavage sites in the peptide sequences. According to our in silico predictions, the peptide sequence of the exposed extracellular unstructured region linking the S5-S6 transmembrane segments in the DII domain of the human Nav1.7 sodium channel is highly sensitive to MMP-9 proteolysis. Intriguingly, the CIP R907Q mutation overlaps with the predicted MMP-9 cleavage site sequence. Using MMP-9 proteolysis of the wild-type, CIP, and control peptides followed by mass spectrometry of the digests, we demonstrated that the mutant sequence is several-fold more sensitive to MMP-9 proteolysis relative to the wild type. Because of the substantial level of sequence homology among sodium channels, our data also implicate MMP proteolysis in regulating the cell surface levels of the Nav1.7, Nav1.6, and Nav1.8 channels, but not Nav1.9. It is likely that the aberrantly accelerated MMP-9 proteolysis during neurogenesis is a biochemical rational for the functional inactivation in Nav1.7 and that the enhanced cleavage of the Nav1.7-R907Q mutant is a cause of CIP in the Bedouin family.	[Remacle, Albert G.; Kumar, Sonu; Motamedchaboki, Khatereh; Cieplak, Piotr; Strongin, Alex Y.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Hullugundi, Swathi; Dolkas, Jennifer; Shubayev, Veronica I.] Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92093 USA; [Hullugundi, Swathi; Dolkas, Jennifer; Shubayev, Veronica I.] Vet Affairs San Diego Healthcare Syst, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Strongin, AY (corresponding author), Sanford Burnham Med Res Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	strongin@sanfordburnham.org	Strongin, Alex/R-6609-2019; Hullugundi, Swathi/I-6281-2019; Kumar, Sonu/GZA-9110-2022; Kumar, Sonu/AAH-2962-2019; Regan, Clinton/E-6250-2012; Kumar, Sonu/AAA-1746-2019	Strongin, Alex/0000-0003-3765-3016; Kumar, Sonu/0000-0003-0423-2880; hullugundi, swathi/0000-0003-0697-9988	National Institutes of Health [R01 DE022757, RO1 CA157328, R01 GM098835]; Department of Veterans Affairs [5I01BX000638]; NATIONAL CANCER INSTITUTE [R01CA157328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098835] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000638] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	The work was supported, in whole or in part, by National Institutes of Health Grants R01 DE022757 (to V. I. S. and A. Y. S.), RO1 CA157328 (to A. Y. S.) and R01 GM098835 (to P. C.). The work was also supported by Department of Veterans Affairs Merit Review Award 5I01BX000638 (to V. I. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Bennett DLH, 2014, LANCET NEUROL, V13, P587, DOI 10.1016/S1474-4422(14)70024-9; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Brouwer BA, 2014, J PERIPHER NERV SYST, V19, P53, DOI 10.1111/jns5.12071; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Cox JJ, 2010, HUM MUTAT, V31, pE1670, DOI 10.1002/humu.21325; Dib-Hajj SD, 2013, NAT REV NEUROSCI, V14, P49, DOI 10.1038/nrn3404; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Ethell IM, 2007, J NEUROSCI RES, V85, P2813, DOI 10.1002/jnr.21273; Gingras J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105895; Goldberg YP, 2007, CLIN GENET, V71, P311, DOI 10.1111/j.1399-0004.2007.00790.x; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Kim Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033664; Kukreja M, 2015, CHEM BIOL, V22, P1122, DOI 10.1016/j.chembiol.2015.07.008; Lee JH, 2014, CELL, V157, P1393, DOI 10.1016/j.cell.2014.03.064; Liu HQ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-119; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Prudova A, 2010, MOL CELL PROTEOMICS, V9, P894, DOI 10.1074/mcp.M000050-MCP201; Ratnikov BI, 2014, P NATL ACAD SCI USA, V111, pE4148, DOI 10.1073/pnas.1406134111; Ruiz MD, 2015, J MED CHEM, V58, P7093, DOI 10.1021/jm501981g; Schilling O, 2008, NAT BIOTECHNOL, V26, P685, DOI 10.1038/nbt1408; Schilling O, 2007, CURR OPIN CHEM BIOL, V11, P36, DOI 10.1016/j.cbpa.2006.11.037; Schilling O, 2010, NAT METHODS, V7, P508, DOI [10.1038/NMETH.1467, 10.1038/nmeth.1467]; Smith ESJ, 2011, SCIENCE, V334, P1557, DOI 10.1126/science.1213760; ToledoAral JJ, 1997, P NATL ACAD SCI USA, V94, P1527, DOI 10.1073/pnas.94.4.1527; Tsai CJ, 2013, J MOL BIOL, V425, P4074, DOI 10.1016/j.jmb.2013.06.036; Turk BE, 2001, NAT BIOTECHNOL, V19, P661, DOI 10.1038/90273; Vandooren J, 2013, CRIT REV BIOCHEM MOL, V48, P222, DOI 10.3109/10409238.2013.770819; Vandooren J, 2013, NAT METHODS, V10, P211, DOI [10.1038/NMETH.2371, 10.1038/nmeth.2371]; Waxman SG, 2014, LANCET NEUROL, V13, P1152, DOI 10.1016/S1474-4422(14)70150-4	30	10	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					22939	22944		10.1074/jbc.C115.671107	http://dx.doi.org/10.1074/jbc.C115.671107			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26283785	hybrid, Green Published			2022-12-26	WOS:000361685500007
J	Carroll, JB; Deik, A; Fossale, E; Weston, RM; Guide, JR; Arjomand, J; Kwak, S; Clish, CB; MacDonald, ME				Carroll, Jeffrey B.; Deik, Amy; Fossale, Elisa; Weston, Rory M.; Guide, Jolene R.; Arjomand, Jamshid; Kwak, Seung; Clish, Clary B.; MacDonald, Marcy E.			Hdh(Q111) Mice Exhibit Tissue Specific Metabolite Profiles that Include Striatal Lipid Accumulation	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; HEPATIC MITOCHONDRIAL DYSFUNCTION; HUNTINGTONS-DISEASE; ENERGY HOMEOSTASIS; WEIGHT-LOSS; EXPRESSION; PATHWAY; PHOSPHOETHANOLAMINE; RESPIRATION; IMPAIRMENT	The HTT CAG expansion mutation causes Huntington's Disease and is associated with a wide range of cellular consequences, including altered metabolism. The mutant allele is expressed widely, in all tissues, but the striatum and cortex are especially vulnerable to its effects. To more fully understand this tissue-specificity, early in the disease process, we asked whether the metabolic impact of the mutant CAG expanded allele in heterozygous B6.HdhQ(111/+) mice would be common across tissues, or whether tissues would have tissue-specific responses and whether such changes may be affected by diet. Specifically, we cross-sectionally examined steady state metabolite concentrations from a range of tissues (plasma, brown adipose tissue, cerebellum, striatum, liver, white adipose tissue), using an established liquid chromatography-mass spectrometry pipeline, from cohorts of 8 month old mutant and wild-type littermate mice that were fed one of two different high-fat diets. The differential response to diet highlighted a proportion of metabolites in all tissues, ranging from 3% (7/219) in the striatum to 12% (25/212) in white adipose tissue. By contrast, the mutant CAG-expanded allele primarily affected brain metabolites, with 14% (30/219) of metabolites significantly altered, compared to wild-type, in striatum and 11% (25/224) in the cerebellum. In general, diet and the CAG-expanded allele both elicited metabolite changes that were predominantly tissue-specific and non-overlapping, with evidence for mutation-by-diet interaction in peripheral tissues most affected by diet. Machine-learning approaches highlighted the accumulation of diverse lipid species as the most genotype-predictive metabolite changes in the striatum. Validation experiments in cell culture demonstrated that lipid accumulation was also a defining feature of mutant Hdh(Q111) striatal progenitor cells. Thus, metabolite-level responses to the CAG expansion mutation in vivo were tissue specific and most evident in brain, where the striatum featured signature accumulation of a set of lipids including sphingomyelin, phosphatidylcholine, cholesterol ester and triglyceride species. Importantly, in the presence of the CAG mutation, metabolite changes were unmasked in peripheral tissues by an interaction with dietary fat, implying that the design of studies to discover metabolic changes in HD mutation carriers should include metabolic perturbations.	[Carroll, Jeffrey B.; Fossale, Elisa; Guide, Jolene R.; MacDonald, Marcy E.] Harvard Univ, Sch Med, Dept Neurol, Ctr Human Genet Res,Massachusetts Gen Hosp, Boston, MA 02115 USA; [Carroll, Jeffrey B.; Weston, Rory M.] Western Washington Univ, Dept Psychol, Behav Neurosci Program, Bellingham, WA 98225 USA; [Deik, Amy; Fossale, Elisa; Clish, Clary B.; MacDonald, Marcy E.] Broad Inst Harvard & MIT, Cambridge, MA USA; [Arjomand, Jamshid; Kwak, Seung] CHDI Fdn Inc, Princeton, NJ USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Western Washington University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Carroll, JB (corresponding author), Harvard Univ, Sch Med, Dept Neurol, Ctr Human Genet Res,Massachusetts Gen Hosp, Boston, MA 02115 USA.	jeff.carroll@wwu.edu	Clish, Clary B/ABB-9374-2021; Clish, Clary/AAB-7124-2019	Clish, Clary B/0000-0001-8259-9245; Weston, Rory/0000-0001-6117-0204	National Institute of Health [MEM: NS32765]; CHDI Foundation Inc. (MEM); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032765] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CHDI Foundation Inc. (MEM); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding for this work was provided by the National Institute of Health (MEM: NS32765); CHDI Foundation Inc. (MEM). CHDI Foundation is also the employer of two authors (JA and SK). Beyond their intellectual contributions to the design of the study, foundation staff did not play a role in the data analysis, primary figure or manuscript drafting, or the decision to publish this manuscript.	ALAVI A, 1986, SEMIN NUCL MED, V16, P2, DOI 10.1016/S0001-2998(86)80002-2; Aziz NA, 2008, NEUROLOGY, V71, P1506, DOI 10.1212/01.wnl.0000334276.09729.0e; Aziz NA, 2010, J NEUROL NEUROSUR PS, V81, P1233, DOI 10.1136/jnnp.2009.191833; Aziz NA, 2008, J NEUROL, V255, P1872, DOI 10.1007/s00415-009-0062-8; BEAL MF, 1992, ANN NEUROL, V31, P119, DOI 10.1002/ana.410310202; Bjorkqvist M, 2008, J EXP MED, V205, P1869, DOI 10.1084/jem.20080178; Chaturvedi RK, 2010, HUM MOL GENET, V19, P3190, DOI 10.1093/hmg/ddq229; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; de Graaf RA, 2009, J NEUROCHEM, V109, P494, DOI 10.1111/j.1471-4159.2009.05967.x; ELLISON DW, 1987, BRAIN RES, V417, P389, DOI 10.1016/0006-8993(87)90471-9; Giralt A, 2012, HUM MOL GENET, V21, P1203, DOI 10.1093/hmg/ddr552; Gohil VM, 2013, J BIOL CHEM, V288, P35387, DOI 10.1074/jbc.M113.489237; Gohil VM, 2011, HUM MOL GENET, V20, P294, DOI 10.1093/hmg/ddq464; Gohil VM, 2010, NAT BIOTECHNOL, V28, P249, DOI 10.1038/nbt.1606; Guo X, 2013, J CLIN INVEST, V123, P5371, DOI 10.1172/JCI70911; HAYDEN MR, 1986, NEUROLOGY, V36, P888, DOI 10.1212/WNL.36.7.888; He FS, 1995, NEUROLOGY, V45, P2178, DOI 10.1212/WNL.45.12.2178; HEISS WD, 1986, NEUROPSYCHOLOGIA, V24, P141, DOI 10.1016/0028-3932(86)90048-5; Holter SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080923; Hoffmann R, 2014, MOVEMENT DISORD, V29, P831, DOI 10.1002/mds.25862; Jacobsen JC, 2011, HUM MOL GENET, V20, P2846, DOI 10.1093/hmg/ddr195; Ji JG, 2012, LANCET ONCOL, V13, P642, DOI 10.1016/S1470-2045(12)70132-8; Jin YH, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-10; KUWERT T, 1990, BRAIN, V113, P1405, DOI 10.1093/brain/113.5.1405; Lee JM, 2007, PLOS GENET, V3, P1397, DOI 10.1371/journal.pgen.0030135; Lloret A, 2006, HUM MOL GENET, V15, P2015, DOI 10.1093/hmg/ddl125; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Marder K, 2009, NEUROLOGY, V73, P385, DOI 10.1212/WNL.0b013e3181b04aa2; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; Menzies FM, 2011, CURR OPIN CELL BIOL, V23, P190, DOI 10.1016/j.ceb.2010.10.010; Mochel F, 2012, J BIOL CHEM, V287, P1361, DOI 10.1074/jbc.M111.309849; Powers WJ, 2007, P NATL ACAD SCI USA, V104, P2945, DOI 10.1073/pnas.0609833104; Ramos EM, 2015, MAMM GENOME, V26, P119, DOI 10.1007/s00335-014-9552-9; Rhee EP, 2011, J CLIN INVEST, V121, P1402, DOI 10.1172/JCI44442; Rosas HD, 2003, NEUROLOGY, V60, P1615, DOI 10.1212/01.WNL.0000065888.88988.6E; Ross CA, 2014, NAT REV NEUROL, V10, P204, DOI 10.1038/nrneurol.2014.24; Seong IS, 2005, HUM MOL GENET, V14, P2871, DOI 10.1093/hmg/ddi319; Shaham O, 2010, P NATL ACAD SCI USA, V107, P1571, DOI 10.1073/pnas.0906039107; Shirendeb UP, 2012, HUM MOL GENET, V21, P406, DOI 10.1093/hmg/ddr475; Singh R, 2009, J CLIN INVEST, V119, P3329, DOI 10.1172/JCI39228; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Song WJ, 2011, NAT MED, V17, P377, DOI 10.1038/nm.2313; Stuwe SH, 2013, NEUROLOGY, V80, P743, DOI 10.1212/WNL.0b013e318282514e; Tang CC, 2013, J CLIN INVEST, V123, P4076, DOI 10.1172/JCI69411; Tian L, 2005, P NATL ACAD SCI USA, V102, P13544, DOI 10.1073/pnas.0506577102; Tkac I, 2007, J NEUROCHEM, V100, P1397, DOI 10.1111/j.1471-4159.2006.04323.x; Trager U, 2014, BRAIN, V137, P819, DOI 10.1093/brain/awt355; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Trushina E, 2006, HUM MOL GENET, V15, P3578, DOI 10.1093/hmg/ddl434; Valenza M, 2005, J NEUROSCI, V25, P9932, DOI 10.1523/JNEUROSCI.3355-05.2005; Van Raamsdonk JM, 2006, HUM MOL GENET, V15, P1513, DOI 10.1093/hmg/ddl072; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; YOUNG AB, 1986, ANN NEUROL, V20, P296, DOI 10.1002/ana.410200305; Zheng SQ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000838; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009	58	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0134465	10.1371/journal.pone.0134465	http://dx.doi.org/10.1371/journal.pone.0134465			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295712	Green Published, Green Submitted, gold			2022-12-26	WOS:000359926900011
J	Zhuo, Z; Lamont, SJ; Lee, WR; Abasht, B				Zhuo, Zhu; Lamont, Susan J.; Lee, William R.; Abasht, Behnam			RNA-Seq Analysis of Abdominal Fat Reveals Differences between Modern Commercial Broiler Chickens with High and Low Feed Efficiencies	PLOS ONE			English	Article							STEAROYL-COA DESATURASE; ADIPOSE-TISSUE; GENE-EXPRESSION; IN-VIVO; CHOLESTEROL-METABOLISM; GALLUS-DOMESTICUS; BODY-COMPOSITION; WEIGHT-GAIN; LIPOGENESIS; DIFFERENTIATION	For economic and environmental reasons, chickens with superior feed efficiency (FE) are preferred in the broiler chicken industry. High FE (HFE) chickens typically have reduced abdominal fat, the major adipose tissue in chickens. In addition to its function of energy storage, adipose tissue is a metabolically active organ that also possesses endocrine and immune regulatory functions. It plays a central role in maintaining energy homeostasis. Comprehensive understanding of the gene expression in the adipose tissue and the biological basis of FE are of significance to optimize selection and breeding strategies. Through gene expression profiling of abdominal fat from high and low FE (LFE) commercial broiler chickens, the present study aimed to characterize the differences of gene expression between HFE and LFE chickens. mRNA-seq analysis was carried out on the total RNA of abdominal fat from 10 HFE and 12 LFE commercial broiler chickens, and 1.48 billion of 75-base sequence reads were generated in total. On average, 11,565 genes were expressed (> 5 reads/gene/sample) in the abdominal fat tissue, of which 286 genes were differentially expressed (DE) at q (False Discover Rate) < 0.05 and fold change > 1.3 between HFE and LFE chickens. Expression levels from RNA-seq were confirmed with the NanoString nCounter analysis system. Functional analysis showed that the DE genes were significantly (p < 0.01) enriched in lipid metabolism, coagulation, and immune regulation pathways. Specifically, the LFE chickens had higher expression of lipid synthesis genes and lower expression of triglyceride hydrolysis and cholesterol transport genes. In conclusion, our study reveals the overall differences of gene expression in the abdominal fat from HFE and LFE chickens, and the results suggest that the divergent expression of lipid metabolism genes represents the major differences.	[Zhuo, Zhu; Abasht, Behnam] Univ Delaware, Dept Anim & Food Sci, Newark, DE 19711 USA; [Lamont, Susan J.] Iowa State Univ, Dept Anim Sci, Ames, IA USA; [Lee, William R.] Maple Leaf Farms Inc, Leesburg, IN USA	University of Delaware; Iowa State University	Abasht, B (corresponding author), Univ Delaware, Dept Anim & Food Sci, Newark, DE 19711 USA.	abasht@udel.edu	z, z/GXZ-4805-2022; Z, Z/AEN-2153-2022; z, z/HHN-3970-2022		Delaware Bioscience Center for Advanced Technology; Heritage Breeders, LLC; Maple Leaf Farms, Inc.	Delaware Bioscience Center for Advanced Technology; Heritage Breeders, LLC; Maple Leaf Farms, Inc.	This work was funded by Delaware Bioscience Center for Advanced Technology and Heritage Breeders, LLC. Phenotypic data were collected at Heritage Breeders, LLC. Maple Leaf Farms, Inc. provided support in the form of salaries for author William R. Lee, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Birsoy K, 2008, P NATL ACAD SCI USA, V105, P12985, DOI 10.1073/pnas.0805621105; Bottje W, 2013, J ANIM SCI, V91, P1582, DOI 10.2527/jas.2012-5787; Bottje WG, 2012, POULTRY SCI, V91, P2576, DOI 10.3382/ps.2012-02204; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; CARTWRIGHT AL, 1991, J NUTR, V121, P1486, DOI 10.1093/jn/121.9.1486; Daval S, 2000, GENET SEL EVOL, V32, P521, DOI 10.1051/gse:2000134; De Verdal H, 2010, 9 WORLD C GEN APPL L, P1; DeLuca DS, 2012, BIOINFORMATICS, V28, P1530, DOI 10.1093/bioinformatics/bts196; DOUAIRE M, 1992, POULTRY SCI, V71, P1911, DOI 10.3382/ps.0711911; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gong Y, 2006, CELL METAB, V3, P15, DOI 10.1016/j.cmet.2005.11.014; GRIFFIN HD, 1992, J NUTR, V122, P363, DOI 10.1093/jn/122.2.363; Hausman GJ, 2014, ADIPOCYTE, V3, P297, DOI 10.4161/adip.29252; Heinemann FS, 2003, PROSTAG LEUKOTR ESS, V68, P123, DOI 10.1016/S0952-3278(02)00262-4; HOOD RL, 1982, POULTRY SCI, V61, P117, DOI 10.3382/ps.0610117; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Ji B, 2014, PHYSIOL GENOMICS, V46, P315, DOI 10.1152/physiolgenomics.00163.2013; Ji B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-441; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kong BW, 2011, POULTRY SCI, V90, P2535, DOI 10.3382/ps.2011-01435; KOVANEN PT, 1975, J LIPID RES, V16, P211; KRAUSE BR, 1984, J LIPID RES, V25, P97; LEVEILLE GA, 1968, P SOC EXP BIOL MED, V128, P398; Li JH, 2014, J BIOL CHEM, V289, P747, DOI 10.1074/jbc.M113.534172; Li JP, 2003, P NATL ACAD SCI USA, V100, P9476, DOI 10.1073/pnas.1133426100; MacLaren RE, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-3; Man WC, 2006, J LIPID RES, V47, P1928, DOI 10.1194/jlr.M600172-JLR200; Mathews ST, 2002, DIABETES, V51, P2450, DOI 10.2337/diabetes.51.8.2450; Miyazaki M, 2000, J BIOL CHEM, V275, P30132, DOI 10.1074/jbc.M005488200; Mohamed-Ali V, 1998, INT J OBESITY, V22, P1145, DOI 10.1038/sj.ijo.0800770; Mori T, 2005, J BIOL CHEM, V280, P12867, DOI 10.1074/jbc.M410515200; Mutryn MF, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1623-0; OHEA EK, 1968, COMP BIOCHEM PHYSIOL, V26, P111, DOI 10.1016/0010-406X(68)90317-4; PYM RAE, 1979, BRIT POULTRY SCI, V20, P87, DOI 10.1080/00071667908416552; Resnyk CW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-557; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Sato K, 2009, ANIM SCI J, V80, P322, DOI 10.1111/j.1740-0929.2009.00639.x; SHRAGO E, 1976, AM J CLIN NUTR, V29, P540, DOI 10.1093/ajcn/29.5.540; Simon J., 1988, Leanness in domestic birds: genetic, metabolic and hormonal aspects., P258; SIMON J, 1989, Critical Reviews in Poultry Biology, V2, P121; THOMAS CH, 1958, POULTRY SCI, V37, P862, DOI 10.3382/ps.0370862; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Wang HB, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-193; WASHBURN KW, 1975, J NUTR, V105, P1311, DOI 10.1093/jn/105.10.1311; Wu Y, 2010, MECH DEVELOP, V127, P183, DOI 10.1016/j.mod.2009.12.003; Yoo W, 2010, BIOCHEM BIOPH RES CO, V397, P170, DOI 10.1016/j.bbrc.2010.05.067; Zannis VI, 2006, J MOL MED, V84, P276, DOI 10.1007/s00109-005-0030-4; Zhou N, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1364-0	50	41	41	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135810	10.1371/journal.pone.0135810	http://dx.doi.org/10.1371/journal.pone.0135810			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295149	gold, Green Submitted, Green Published			2022-12-26	WOS:000359926900043
J	Taborda, NA; Gonzalez, SM; Alvarez, CM; Correa, LA; Montoya, CJ; Rugeles, MT				Andrea Taborda, Natalia; Milena Gonzalez, Sandra; Mauricio Alvarez, Cristiam; Alfonso Correa, Luis; Julio Montoya, Carlos; Teresa Rugeles, Maria			Higher Frequency of NK and CD4(+) T-Cells in Mucosa and Potent Cytotoxic Response in HIV Controllers	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; ELITE CONTROLLERS; IMMUNE ACTIVATION; GRANZYME-B; CENTRAL MEMORY; INFECTION; DISEASE; EXPRESSION; DEPLETION; PROGRESSION	HIV infection induces immune alterations, mainly in gut mucosa, where the main target cells reside. However, the evolution of the infection is variable among infected individuals, as evidenced by HIV controllers who exhibit low or undetectable viral load in the absence of treatment. The aim of this study was to evaluate the frequency, phenotype and activity of T and NK cells in peripheral blood and gut mucosa in a cohort of Colombian HIV controllers. Blood and gut biopsies were included. The frequency and the activation status of T and NK cells were performed by flow cytometry. In addition, Gag-stimulated CD8(+) T-cells and cytokine-stimulated NK cells were tested for cytotoxic activity. Finally, microbial translocation was measured by plasma lipopolysaccharide quantification. Compared with HIV-progressors, HIV controllers exhibited higher frequency of CD4(+) T and NK cells, and lower expression of activation molecules in blood and mucosal immune cells, as well as lower microbial translocation. An increased production of molecules associated with cytotoxic activity of CD8(+) T-cells in blood and mucosa and a higher percentage of polyfunctional CD8(+) T cells in blood were also observed in HIV controllers. In addition, an increased activity of NK cells was observed in blood. These findings suggest that HIV controllers have a potent immune response, mainly mediated by cytotoxic cells that control HIV replication, which contribute to reducing alterations at the gut mucosa.	[Andrea Taborda, Natalia; Milena Gonzalez, Sandra; Julio Montoya, Carlos; Teresa Rugeles, Maria] Univ Antioquia, UdeA, Fac Med, Grp Inmunovirol, Medellin, Colombia; [Mauricio Alvarez, Cristiam] Univ Antioquia, UdeA, Fac Med, Grp Inmunol Celular & Inmunogenet, Medellin, Colombia; [Alfonso Correa, Luis] Univ Antioquia, UdeA, Fac Med, Secc Dermatol,Dept Med Interna, Medellin, Colombia; [Alfonso Correa, Luis] Obra Congregac Mariana, Lab Clin VID, Lab Patol, Medellin, Colombia	Universidad de Antioquia; Universidad de Antioquia; Universidad de Antioquia	Rugeles, MT (corresponding author), Univ Antioquia, UdeA, Fac Med, Grp Inmunovirol, Medellin, Colombia.	maria.rugeles@udea.edu.co		Taborda, Natalia/0000-0002-6169-0119; Rugeles, Maria T./0000-0001-7855-1409; Taborda Vanegas, Natalia Andrea/0000-0001-6085-855X	CODI-Universidad de Antioquia convocatoria mediana cuantia; Estrategia para Sostenibilidad de Grupos Universidad de Antioquia; CIHR IID&GH Program of the University of Manitoba, Canada; Colciencias "Convocatoria Nacional 511 para el estudio de Doctorado en Colombia ano"	CODI-Universidad de Antioquia convocatoria mediana cuantia; Estrategia para Sostenibilidad de Grupos Universidad de Antioquia; CIHR IID&GH Program of the University of Manitoba, Canada; Colciencias "Convocatoria Nacional 511 para el estudio de Doctorado en Colombia ano"	This investigation was financially supported by CODI-Universidad de Antioquia convocatoria mediana cuantia 2011; Estrategia para Sostenibilidad de Grupos 2014-2015 Universidad de Antioquia; CIHR IID&GH Program of the University of Manitoba, Canada; Natalia Taborda received a scholarship from Colciencias "Convocatoria Nacional 511 para el estudio de Doctorado en Colombia ano 2010".	Alter G, 2007, J IMMUNOL, V178, P7658, DOI 10.4049/jimmunol.178.12.7658; Baker BM, 2009, EXPERT OPIN BIOL TH, V9, P55, DOI [10.1517/14712590802571928, 10.1517/14712590802571928 ]; Belyakov IM, 2012, CURR TOP MICROBIOL, V354, P157, DOI 10.1007/82_2010_119; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Brunetta E, 2010, J LEUKOCYTE BIOL, V88, P1119, DOI 10.1189/jlb.0410225; Critchfield JW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003577; Duvall MG, 2008, EUR J IMMUNOL, V38, P350, DOI 10.1002/eji.200737768; Ferre AL, 2010, J VIROL, V84, P11020, DOI 10.1128/JVI.00980-10; Ferre AL, 2009, BLOOD, V113, P3978, DOI 10.1182/blood-2008-10-182709; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Hendel H, 1996, BIOMED PHARMACOTHER, V50, P480, DOI 10.1016/S0753-3322(97)89278-5; Hong HS, 2010, J VIROL, V84, P1183, DOI 10.1128/JVI.01675-09; Jaspan HB, 2003, EXP MOL PATHOL, V74, P13, DOI 10.1016/S0014-4800(03)80003-5; Jost S, 2012, MICROBES INFECT, V14, P904, DOI 10.1016/j.micinf.2012.05.001; Kelleher AD, 2001, J EXP MED, V193, P375, DOI 10.1084/jem.193.3.375; Kottilil S, 2003, J INFECT DIS, V187, P1038, DOI 10.1086/368222; Kottilil S, 2006, J IMMUNOL, V176, P1107, DOI 10.4049/jimmunol.176.2.1107; Kuri-Cervantes L, 2014, J LEUKOCYTE BIOL, V96, P7, DOI 10.1189/jlb.0913514; Lord SJ, 2003, IMMUNOL REV, V193, P31, DOI 10.1034/j.1600-065X.2003.00044.x; Rueda CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030307; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Mela CM, 2007, AIDS, V21, P2177, DOI 10.1097/QAD.0b013e3282f08b72; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Mothe B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029717; Naranbhai V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053251; Ndhlovu ZM, 2012, J VIROL, V86, P6959, DOI 10.1128/JVI.00531-12; Nielsen N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031959; Owen RE, 2010, AIDS, V24, P1095, DOI 10.1097/QAD.0b013e3283377a1e; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Potter SJ, 2007, J VIROL, V81, P13904, DOI 10.1128/JVI.01401-07; Ranasinghe C, 2007, J IMMUNOL, V178, P2370, DOI 10.4049/jimmunol.178.4.2370; Reeves RK, 2010, BLOOD, V115, P4439, DOI 10.1182/blood-2010-01-265595; Reitano KN, 2009, AIDS RES HUM RETROV, V25, P1029, DOI 10.1089/aid.2008.0311; Sankaran S, 2005, P NATL ACAD SCI USA, V102, P9860, DOI 10.1073/pnas.0503463102; Sips M, 2012, MUCOSAL IMMUNOL, V5, P30, DOI 10.1038/mi.2011.40; Taborda NA, 2015, J ACQUIR IMMUNE DEFI; Taborda NA, 2012, JAIDS-J ACQ IMM DEF, V60, P12, DOI 10.1097/QAI.0b013e31824876ca; Turk G, 2013, J VIROL, V87, P7445, DOI 10.1128/JVI.00865-13; Wong AHW, 2010, AIDS RES HUM RETROV, V26, P459, DOI 10.1089/aid.2009.0176; Yan JY, 2013, J VIROL, V87, P5170, DOI 10.1128/JVI.02379-12; Yang OO, 2005, VIROLOGY, V332, P16, DOI 10.1016/j.virol.2004.11.028	44	14	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136292	10.1371/journal.pone.0136292	http://dx.doi.org/10.1371/journal.pone.0136292			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291824	gold, Green Submitted, Green Published			2022-12-26	WOS:000359919900075
J	McCormick, N; Bhole, V; Lacaille, D; Avina-Zubieta, JA				McCormick, Natalie; Bhole, Vidula; Lacaille, Diane; Avina-Zubieta, J. Antonio			Validity of Diagnostic Codes for Acute Stroke in Administrative Databases: A Systematic Review	PLOS ONE			English	Review							ACUTE ISCHEMIC-STROKE; HOSPITAL DISCHARGE REGISTER; BRAIN ATTACK SURVEILLANCE; ACUTE TREATMENT COSTS; CASE-FATALITY; ICD-9 CODES; INTERNATIONAL-CLASSIFICATION; INTRACEREBRAL HEMORRHAGE; INTRACRANIAL HEMORRHAGE; CEREBROVASCULAR EVENTS	Objective To conduct a systematic review of studies reporting on the validity of International Classification of Diseases (ICD) codes for identifying stroke in administrative data. Methods MEDLINE and EMBASE were searched (inception to February 2015) for studies: (a) Using administrative data to identify stroke; or (b) Evaluating the validity of stroke codes in administrative data; and (c) Reporting validation statistics (sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), or Kappa scores) for stroke, or data sufficient for their calculation. Additional articles were located by hand search (up to February 2015) of original papers. Studies solely evaluating codes for transient ischaemic attack were excluded. Data were extracted by two independent reviewers; article quality was assessed using the Quality Assessment of Diagnostic Accuracy Studies tool. Results Seventy-seven studies published from 1976-2015 were included. The sensitivity of ICD-9 430-438/ICD-10 I60-I69 for any cerebrovascular disease was >= 82% in most [>= 50%] studies, and specificity and NPV were both >= 95%. The PPV of these codes for any cerebrovascular disease was >= 81% in most studies, while the PPV specifically for acute stroke was >= 68%. In at least 50% of studies, PPVs were >= 93% for subarachnoid haemorrhage (ICD-9 430/ICD-10 I60), 89% for intracerebral haemorrhage (ICD-9 431/ICD-10 I61), and 82% for ischaemic stroke (ICD-9 434/ICD-10 I63 or ICD-9 434&436). For in-hospital deaths, sensitivity was 55%. For cerebrovascular disease or acute stroke as a cause-of-death on death certificates, sensitivity was >= 71% in most studies while PPV was >= 87%. Conclusions While most cases of prevalent cerebrovascular disease can be detected using 430-438/I60-I69 collectively, acute stroke must be defined using more specific codes. Most in-hospital deaths and death certificates with stroke as a cause-of-death correspond to true stroke deaths. Linking vital statistics and hospitalization data may improve the ascertainment of fatal stroke.	[McCormick, Natalie] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada; [McCormick, Natalie; Bhole, Vidula; Lacaille, Diane; Avina-Zubieta, J. Antonio] Arthrit Res Canada, Richmond, BC, Canada; [Lacaille, Diane; Avina-Zubieta, J. Antonio] Univ British Columbia, Dept Med, Div Rheumatol, Vancouver, BC, Canada; [Lacaille, Diane; Avina-Zubieta, J. Antonio] CANRAD Network, Cardiovasc Comm, Richmond, BC, Canada	University of British Columbia; Arthritis Research Canada; University of British Columbia	Avina-Zubieta, JA (corresponding author), Arthrit Res Canada, Richmond, BC, Canada.	azubieta@arthritisresearch.ca		McCormick, Natalie/0000-0002-4147-8348	Canadian Arthritis Network; Canadian Institutes of Health Research; Arthritis Society of Canada; Michael Smith Foundation for Health Research	Canadian Arthritis Network; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Arthritis Society of Canada; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This study was funded by the Canadian Arthritis Network (http://www.canradnetwork.ca). Natalie McCormick is supported by a Doctoral Research Award from the Canadian Institutes of Health Research. J. Antonio Avina-Zubieta held a salary award from the Canadian Arthritis Network and The Arthritis Society of Canada. He is currently the British Columbia Lupus Society Scholar and holds a Scholar Award from the Michael Smith Foundation for Health Research. Diane Lacaille holds the Mary Pack Chair in Arthritis Research from UBC and The Arthritis Society of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboa-Eboule C, 2013, J NEUROL, V260, P605, DOI 10.1007/s00415-012-6686-0; Agrawal N, 2009, STROKE, V40, P3415, DOI 10.1161/STROKEAHA.109.564633; Andrade SE, 2012, PHARMACOEPIDEM DR S, V21, P100, DOI 10.1002/pds.2312; Appelros P, 2011, ACTA NEUROL SCAND, V123, P289, DOI 10.1111/j.1600-0404.2010.01402.x; Appelros P, 2014, CEREBROVASC DIS, V37, P22, DOI 10.1159/000356346; Arnason T, 2006, THROMB RES, V118, P253, DOI 10.1016/j.thromres.2005.06.015; Asi T, 2011, CLIN NEUROL NEUROSUR, V113, P111, DOI 10.1016/j.clineuro.2010.09.014; Barber C, 2013, ARTHRIT CARE RES, V65, P1343, DOI 10.1002/acr.21959; Benesch C, 1997, NEUROLOGY, V49, P660, DOI 10.1212/WNL.49.3.660; Bernatsky S, 2013, J RHEUMATOL, V40, P66, DOI 10.3899/jrheum.120835; Birman-Deych E, 2005, MED CARE, V43, P480, DOI 10.1097/01.mlr.0000160417.39497.a9; BLOTH B, 1976, ACTA MED SCAND, V200, P281; Borzecki AM, 2004, AM J MED QUAL, V19, P201, DOI 10.1177/106286060401900504; Broderick J, 1998, STROKE, V29, P415, DOI 10.1161/01.STR.29.2.415; Brown DL, 2007, AM J EPIDEMIOL, V165, P591, DOI 10.1093/aje/kwk042; Chen GM, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-5; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Christensen MC, 2009, ACTA NEUROL SCAND, V119, P246, DOI 10.1111/j.1600-0404.2008.01094.x; Christensen MC, 2008, NEUROEPIDEMIOLOGY, V30, P239, DOI 10.1159/000128323; Christensen MC, 2009, NEUROEPIDEMIOLOGY, V32, P142, DOI 10.1159/000184747; Davenport R J, 1996, Health Bull (Edinb), V54, P402; Demant MN, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-156; Derby CA, 2000, STROKE, V31, P875, DOI 10.1161/01.STR.31.4.875; Derby CA, 2001, STROKE, V32, P1487, DOI 10.1161/01.STR.32.7.1487; Dodel RC, 2004, VALUE HEALTH, V7, P144, DOI 10.1111/j.1524-4733.2004.72314.x; Ellekjaer H, 1999, STROKE, V30, P56, DOI 10.1161/01.STR.30.1.56; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Gaist D, 2000, BRIT MED J, V320, P141, DOI 10.1136/bmj.320.7228.141; Ghia D, 2010, NEUROEPIDEMIOLOGY, V35, P53, DOI 10.1159/000310338; Gioldasis G, 2008, ACTA NEUROL SCAND, V118, P268, DOI 10.1111/j.1600-0404.2008.01014.x; Goldstein LB, 1998, STROKE, V29, P1602, DOI 10.1161/01.STR.29.8.1602; Golomb MR, 2006, NEUROLOGY, V67, P2053, DOI 10.1212/01.wnl.0000247281.98094.e2; Goulart AC, 2012, J STROKE CEREBROVASC, V21, P832, DOI 10.1016/j.jstrokecerebrovasdis.2011.04.017; Haesebaert J, 2013, STROKE, V44, P1770, DOI 10.1161/STROKEAHA.113.001300; Hasan M, 1995, INT J QUAL HEALTH C, V7, P407, DOI 10.1093/intqhc/7.4.407; Heckbert SR, 2004, AM J EPIDEMIOL, V160, P1152, DOI 10.1093/aje/kwh314; Henderson T, 2006, MED CARE, V44, P1011, DOI 10.1097/01.mlr.0000228018.48783.34; Hennessy DA, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-99; Holick CN, 2009, J CLIN PSYCHOPHARM, V29, P453, DOI 10.1097/JCP.0b013e3181b2b828; Holloway RG, 1996, NEUROLOGY, V46, P854; Hsieh CY, 2015, J FORMOS MED ASSOC, V114, P254, DOI 10.1016/j.jfma.2013.09.009; Hudson M, 2013, J CLIN EPIDEMIOL, V66, P278, DOI 10.1016/j.jclinepi.2012.10.004; Humphries KH, 2000, J CLIN EPIDEMIOL, V53, P343, DOI 10.1016/S0895-4356(99)00188-2; ISO H, 1990, AM J EPIDEMIOL, V132, P993, DOI 10.1093/oxfordjournals.aje.a115742; Ives Diane G., 1995, Annals of Epidemiology, V5, P278, DOI 10.1016/1047-2797(94)00093-9; Johnsen SP, 2002, J CLIN EPIDEMIOL, V55, P602, DOI 10.1016/S0895-4356(02)00391-8; Jones SA, 2014, STROKE, V45, P3219, DOI 10.1161/STROKEAHA.114.006316; Kirkman MA, 2009, ACTA NEUROL BELG, V109, P114; Klatsky AL, 2005, NEUROEPIDEMIOLOGY, V25, P26, DOI 10.1159/000085310; Kokotailo RA, 2005, STROKE, V36, P1776, DOI 10.1161/01.STR.0000174293.17959.a1; Koster M, 2013, NEUROEPIDEMIOLOGY, V40, P240, DOI 10.1159/000345953; Krarup LH, 2007, NEUROEPIDEMIOLOGY, V28, P150, DOI 10.1159/000102143; Kumamaru H, 2014, CIRC-CARDIOVASC QUAL, V7, P611, DOI 10.1161/CIRCOUTCOMES.113.000743; Lakshminarayan K, 2014, STROKE, V45, P815, DOI 10.1161/STROKEAHA.113.003408; Lakshminarayan K, 2009, AM J EPIDEMIOL, V169, P1070, DOI 10.1093/aje/kwp029; Lambert L, 2012, CAN J CARDIOL, V28, P162, DOI 10.1016/j.cjca.2011.10.005; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee DS, 2005, MED CARE, V43, P182, DOI 10.1097/00005650-200502000-00012; Lee WC, 2007, ADV THER, V24, P258, DOI 10.1007/BF02849893; Lee WC, 2007, CEREBROVASC DIS, V23, P57, DOI 10.1159/000096542; LEIBSON CL, 1994, STROKE, V25, P2348, DOI 10.1161/01.STR.25.12.2348; Lentine KL, 2009, CLIN J AM SOC NEPHRO, V4, P1213, DOI 10.2215/CJN.00670109; Leone MA, 2004, NEUROL SCI, V25, P281, DOI 10.1007/s10072-004-0355-8; Leong A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075256; Leppala JM, 1999, EUR J EPIDEMIOL, V15, P155, DOI 10.1023/A:1007504310431; Levy AR, 1999, CAN J CARDIOL, V15, P1277; LINDBLAD U, 1993, SCAND J SOC MED, V21, P3, DOI 10.1177/140349489302100102; Liu LY, 1999, CEREBROVASC DIS, V9, P224, DOI 10.1159/000015960; Mayo N, 1993, CAN J CARDIOL SD, V9, p121D; McCormick N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104519; McCormick N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092286; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Newton KM, 1999, J CLIN EPIDEMIOL, V52, P199, DOI 10.1016/S0895-4356(98)00161-9; Olson KL, 2014, AM J MANAG CARE, V20, pE27; Palmieri L, 2007, CEREBROVASC DIS, V24, P530, DOI 10.1159/000110423; Phillips S, 1993, CAN J CARDIOL SD, V9, p124D; Piriyawat P, 2002, AM J EPIDEMIOL, V156, P1062, DOI 10.1093/aje/kwf152; Ramalle-Gomara E, 2013, NEUROEPIDEMIOLOGY, V41, P185, DOI 10.1159/000354626; Rampatige R, 2013, HEALTH INF MANAG J, V42, P20, DOI 10.1177/183335831304200302; Rao C, 2007, INT J EPIDEMIOL, V36, P642, DOI 10.1093/ije/dym003; Reed SD, 2001, NEUROLOGY, V57, P305, DOI 10.1212/WNL.57.2.305; REGGIO A, 1995, ITAL J NEUROL SCI, V16, P567, DOI 10.1007/BF02282916; Reker DM, 2001, J REHABIL RES DEV, V38, P281; Rinaldi R, 2003, NEUROL SCI, V24, P65, DOI 10.1007/s100720300074; Rosamond WD, 1999, STROKE, V30, P736, DOI 10.1161/01.STR.30.4.736; Rossnagel K, 2005, EUR J NEUROL, V12, P862, DOI 10.1111/j.1468-1331.2005.01091.x; Rournie CL, 2008, PHARMACOEPIDEM DR S, V17, P20, DOI 10.1002/pds.1518; Sacco RL, 2013, STROKE, V44, P2064, DOI 10.1161/STR.0b013e318296aeca; Saka O, 2009, AGE AGEING, V38, P27, DOI 10.1093/ageing/afn281; SARTI C, 1994, J CLIN EPIDEMIOL, V47, P1259, DOI 10.1016/0895-4356(94)90131-7; SHAHAR E, 1995, STROKE, V26, P1; Singh B, 2012, MAYO CLIN PROC, V87, P817, DOI 10.1016/j.mayocp.2012.04.015; Sinha S, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-74; Skolarus LE, 2014, STROKE, V45, P224, DOI 10.1161/STROKEAHA.113.002874; So L, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-161; Soo Martin, 2014, BMC Res Notes, V7, P253, DOI 10.1186/1756-0500-7-253; Spolaore P, 2005, STROKE, V36, P1031, DOI 10.1161/01.STR.0000160755.94884.4a; Sprigg N, 2013, STROKE, V44, P3458, DOI 10.1161/STROKEAHA.113.002201; STEGMAYR B, 1992, NEUROEPIDEMIOLOGY, V11, P204, DOI 10.1159/000110933; Sun Y, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-133; SZCZESNIEWSKA D, 1990, REV EPIDEMIOL SANTE, V38, P435; Thigpen JL, 2015, CIRC-CARDIOVASC QUAL, V8, P8, DOI 10.1161/CIRCOUTCOMES.113.000371; Tirschwell DL, 2002, STROKE, V33, P2465, DOI 10.1161/01.STR.0000032240.28636.BD; Tolonen H, 2007, EUR J CARDIOV PREV R, V14, P380, DOI 10.1097/01.hjr.0000239466.26132.f2; Tu K, 2013, CAN J CARDIOL, V29, P1388, DOI 10.1016/j.cjca.2013.07.676; Vagal A, 2014, STROKE, V45, P1029, DOI 10.1161/STROKEAHA.113.004332; Wahl PM, 2010, PHARMACOEPIDEM DR S, V19, P596, DOI 10.1002/pds.1924; Wang GJ, 2014, J STROKE CEREBROVASC, V23, P861, DOI 10.1016/j.jstrokecerebrovasdis.2013.07.017; Wei JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013041; Weinfeld, 1981, STROKE S1, V12, pI13; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Widdifield J, 2013, ARTHRIT CARE RES, V65, P1490, DOI 10.1002/acr.21993; Wildenschild C, 2014, CLIN EPIDEMIOL, V6, P27, DOI 10.2147/CLEP.S50449; Wu CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112257; Yoneda Y, 2005, HEALTH POLICY, V73, P202, DOI 10.1016/j.healthpol.2004.11.016	116	230	230	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135834	10.1371/journal.pone.0135834	http://dx.doi.org/10.1371/journal.pone.0135834			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5KH	26292280	gold, Green Submitted, Green Published			2022-12-26	WOS:000359919900035
J	Aleng, NA; Sung, YY; MacRae, TH; Abd Wahid, ME				Aleng, Nor Afiqah; Sung, Yeong Yik; MacRae, Thomas H.; Abd Wahid, Mohd Effendy			Non-Lethal Heat Shock of the Asian Green Mussel, Perna viridis, Promotes Hsp70 Synthesis, Induces Thermotolerance and Protects Against Vibrio Infection	PLOS ONE			English	Article							PACIFIC OYSTER; CRASSOSTREA-VIRGINICA; ARGOPECTEN-IRRADIANS; ARTEMIA-FRANCISCANA; MOLECULAR-CLONING; GENE-EXPRESSION; CDNA CLONING; PROTEINS; RESISTANCE; CHALLENGE	Mild heat stress promotes thermotolerance and protection against several different stresses in aquatic animals, consequences correlated with the accumulation of heat shock protein 70 (Hsp70). The purpose of this study was to determine if non-lethal heat shock (NLHS) of the Asian green mussel, Perna viridis, an aquatic species of commercial value, promoted the production of Hsp70 and enhanced its resistance to stresses. Initially, the LT50 and LHT for P. viridis were determined to be 42 degrees C and 44 degrees C, respectively, with no heat shock induced death of mussels at 40 degrees C or less. Immunoprobing of western blots revealed augmentation of constitutive (PvHsp70-1) and inducible (PvHsp70-2) Hsp70 in tissue from adductor muscle, foot, gill and mantel of P. viridis exposed to 38 degrees C for 30 min followed by 6 h recovery, NLHS conditions for this organism. Characterization by liquid chromatography-tandem mass spectrometry (LC-MS/MS) revealed that PvHsp70-1 and PvHsp70-2 respectively corresponded most closely to Hsp70 from P. viridis and Mytilus galloprovincialis. Priming of adult mussels with NLHS promoted thermotolerance and increased resistance to V. alginolyticus. The induction of Hsp70 in parallel with enhanced thermotolerance and improved protection against V. alginolyticus, suggests Hsp70 functions in P. viridis as a molecular chaperone and as a stimulator of the immune system.	[Aleng, Nor Afiqah; Sung, Yeong Yik; Abd Wahid, Mohd Effendy] Univ Malaysia Terengganu, Inst Marine Biotechnol, Kuala Terengganu 21030, Malaysia; [Sung, Yeong Yik; Abd Wahid, Mohd Effendy] Univ Malaysia Terengganu, Sch Fisheries & Aquaculture Sci, Kuala Terengganu 21030, Malaysia; [MacRae, Thomas H.] Dalhousie Univ, Dept Biol, Halifax, NS B3H 4R2, Canada	Universiti Malaysia Terengganu; Universiti Malaysia Terengganu; Dalhousie University	Sung, YY (corresponding author), Univ Malaysia Terengganu, Inst Marine Biotechnol, Kuala Terengganu 21030, Malaysia.	yeong@umt.edu.my; effendy@umt.edu.my	Afiqah-Aleng, Nor/AAK-6912-2020; Wahid, Mohd Effendy Abd/M-9901-2018; Sung, Yeong Yik/AAA-2654-2020	Afiqah-Aleng, Nor/0000-0003-0919-5126; Wahid, Mohd Effendy Abd/0000-0002-4685-7048; Sung, Yeong Yik/0000-0001-5897-9037	E-Science Fund from Ministry of Science, Technology and Innovation (MOSTI), Malaysia [04-01-12-SS0109]; ERGS from Ministry of Education, Malaysia [55090]; Natural Sciences and Engineering Research Council	E-Science Fund from Ministry of Science, Technology and Innovation (MOSTI), Malaysia; ERGS from Ministry of Education, Malaysia; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding: Funded by E-Science Fund No: 04-01-12-SS0109 from the Ministry of Science, Technology and Innovation (MOSTI), Malaysia to MEAW (www.mosti.gov.my), ERGS No. 55090 from the Ministry of Education, Malaysia(www.moe.gov.my) to YYS, and Natural Sciences and Engineering Research Council Discovery Grant to THM.	Arkush KD, 2008, ACTA ZOOL-STOCKHOLM, V89, P331, DOI 10.1111/j.1463-6395.2008.00321.x; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Bahrndorff S, 2009, FUNCT ECOL, V23, P233, DOI 10.1111/j.1365-2435.2009.01541.x; Balakrishnan K, 2006, CELL STRESS CHAPERON, V11, P44, DOI 10.1379/CSC-136R1.1; Biusing R., 2001, ASSESSMENT COASTAL F; Bringans S, 2008, PROTEOMICS, V8, P1081, DOI 10.1002/pmic.200700948; Brown HM, 2004, J SHELLFISH RES, V23, P135; Brun NT, 2009, J EXP MAR BIOL ECOL, V371, P77, DOI 10.1016/j.jembe.2009.01.006; Campisi J, 2003, J APPL PHYSIOL, V94, P43, DOI 10.1152/japplphysiol.00681.2002; CHATTERJI A, 1984, AQUACULTURE, V40, P47, DOI 10.1016/0044-8486(84)90215-1; Chen HS, 2006, J ENDOCRINOL, V190, P433, DOI 10.1677/joe.1.06692; Clegg JS, 1998, MOL MAR BIOL BIOTECH, V7, P21; Clegg JS, 2000, J EXP MAR BIOL ECOL, V252, P85, DOI 10.1016/S0022-0981(00)00239-2; de la Vega E, 2006, AQUACULTURE, V253, P82, DOI 10.1016/j.aquaculture.2005.07.041; De Vos KJ, 2008, ANNU REV NEUROSCI, V31, P151, DOI 10.1146/annurev.neuro.31.061307.090711; Ellis RP, 2015, J EXP MAR BIOL ECOL, V462, P83, DOI 10.1016/j.jembe.2014.10.015; Encomio VG, 2007, DIS AQUAT ORGAN, V76, P251, DOI 10.3354/dao076251; Fabbri E., 2008, ISJ, V5, P135; FAO, FIGIS TIM SER QUER A; Gong WJ, 2006, GENETICS, V172, P275, DOI 10.1534/genetics.105.048793; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hooper C, 2007, FISH SHELLFISH IMMUN, V22, P363, DOI 10.1016/j.fsi.2006.06.009; HUPPERT HW, 1980, MAR ECOL PROG SER, V3, P113, DOI 10.3354/meps003113; Johnson JD, 2006, J LEUKOCYTE BIOL, V79, P425, DOI 10.1189/jlb.0905523; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Meimaridou E, 2009, J MOL ENDOCRINOL, V42, P1, DOI 10.1677/JME-08-0116; Nair M, 2003, AQUAC RES, V34, P1037; Loc NH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073199; Park K, 2015, FISH SHELLFISH IMMUN, V42, P233, DOI 10.1016/j.fsi.2014.10.036; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Perrigault M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-377; Piano A, 2002, CELL STRESS CHAPERON, V7, P250, DOI 10.1379/1466-1268(2002)007<0250:HEITSO>2.0.CO;2; Pockley AG, 2008, TRENDS BIOCHEM SCI, V33, P71, DOI 10.1016/j.tibs.2007.10.005; Qiu LM, 2007, FISH SHELLFISH IMMUN, V22, P451, DOI 10.1016/j.fsi.2006.05.003; Richards GP, 2015, APPL ENVIRON MICROB, V81, P292, DOI 10.1128/AEM.02930-14; Roberts RJ, 2010, J FISH DIS, V33, P789, DOI 10.1111/j.1365-2761.2010.01183.x; Sallih K. B., 2005, MUSSEL FARMING STATE; Sayuthi S, 1993, P AQ WORKSH SEAFDEC, P57; Scott MA, 2003, J EXP BIOL, V206, P303, DOI 10.1242/jeb.00107; Shamseldin AA, 1997, J SHELLFISH RES, V16, P487; Singh V, 2006, P NATL ACAD SCI USA, V103, P13092, DOI 10.1073/pnas.0604050103; Song LS, 2006, FISH SHELLFISH IMMUN, V21, P335, DOI 10.1016/j.fsi.2005.12.011; Song LS, 2010, ADV EXP MED BIOL, V708, P44; Sung YY, 2007, FISH SHELLFISH IMMUN, V22, P318, DOI 10.1016/j.fsi.2006.05.008; Sung YY, 2011, REV AQUACULT, V3, P120, DOI 10.1111/j.1753-5131.2011.01049.x; Sung YT, 2014, ADV MECH ENG, DOI 10.1155/2014/349078; Sung YY, 2014, MAR SCI RES DEV, V4, pe126; Sung YY., 2011, J AQUACUL RES DEV, V2, P006, DOI [10.4172/2155-9546, DOI 10.4172/2155-9546.S2-006, DOI 10.4172/2155-9546]; Tanguy A, 2004, GENE, V338, P121, DOI 10.1016/j.gene.2004.05.019; Toyohara H, 2005, FISHERIES SCI, V71, P327, DOI 10.1111/j.1444-2906.2005.00968.x; Trivedi V, 2010, INT J PHARM SCI REV, V2, P57; Vabulas RM, 2002, J BIOL CHEM, V277, P15107, DOI 10.1074/jbc.M111204200; Wang YJ, 2011, MAR POLLUT BULL, V63, P201, DOI 10.1016/j.marpolbul.2011.05.035; Wu XW, 2014, GENE, V543, P275, DOI 10.1016/j.gene.2013.11.103; Yue X, 2011, FISH SHELLFISH IMMUN, V30, P791, DOI 10.1016/j.fsi.2010.12.027	55	20	22	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135603	10.1371/journal.pone.0135603	http://dx.doi.org/10.1371/journal.pone.0135603			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288319	Green Submitted, Green Published, gold			2022-12-26	WOS:000360018600058
J	Bae, JH; Shin, DS; Lee, SC; Hwang, IC				Bae, Jeong Hun; Shin, Doo Sup; Lee, Sung Chul; Hwang, In Cheol			Sodium Intake and Socioeconomic Status as Risk Factors for Development of Age-Related Cataracts: The Korea National Health and Nutrition Examination Survey	PLOS ONE			English	Article							LONG-TERM INCIDENCE; LENS OPACITIES; BLOOD-PRESSURE; SMOKING; PREVALENCE; HYPERTENSION; ASSOCIATION; PROGRESSION; EXCRETION; DISEASE	Purpose Cataract is a very prevalent ocular disorder, and environmental risk factors for age-related cataracts have been widely investigated. We aimed to evaluate an association of dietary sodium intake and socioeconomic factors with the development of age-related cataracts. Methods A cross-sectional case-control study based on the 2008-2011 Korea National Health and Nutrition Examination Survey. Dietary sodium intake was estimated using urinary sodium to creatinine ratio (U[Na+]/Cr). Results Among a total 12,693 participants, 2,687 (21.1%) had cataracts and 10,006 patients without cataracts served as controls. The prevalence of cataracts increased with age and quartiles of U[Na+]/Cr (p for trend < 0.001). Multivariate logistic regression analyses revealed that factors related to the development of cataracts were age >= 50 years (adjusted odds ratio [aOR] 15.34, 95% confidence interval [CI] 13.31-17.69), low income (aOR 1.85, 95% CI 1.64-2.09), low educational attainment (aOR 1.76, 95% CI 1.57-1.96), and high sodium intake (U[Na+]/Cr > 16.4 mmol/mmol; aOR 1.29, 95% CI 1.16-1.44). In a subgroup analysis, a robust effect on cataracts across U[Na+]/Cr quartiles was observed in patients >= 50 years of age (aOR 1.11, 95% CI 1.04-1.18), though not in younger patients (aOR 1.06, 95% CI 0.96-1.17). Conclusions Our results suggest that high sodium intake and low socioeconomic status may affect the development of cataracts, and that a low-salt diet could be helpful for the prevention of cataracts in an older population. Furthermore, efforts to close gaps in health services due to socioeconomic factors may contribute to a reduction in the prevalence of cataracts.	[Bae, Jeong Hun] Sungkyunkwan Univ, Sch Med, Dept Ophthalmol, Kangbuk Samsung Hosp, Seoul, South Korea; [Shin, Doo Sup] Seoul Natl Univ Hosp, Dept Educ & Res, Seoul 110744, South Korea; [Bae, Jeong Hun; Lee, Sung Chul] Yonsei Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Hwang, In Cheol] Gachon Univ, Gil Med Ctr, Dept Family Med, Inchon, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU); Seoul National University Hospital; Yonsei University; Yonsei University Health System; Gachon University	Hwang, IC (corresponding author), Gachon Univ, Gil Med Ctr, Dept Family Med, Inchon, South Korea.	spfe0211@gmail.com		Shin, Doosup/0000-0003-4960-5732	Senior-Friendly Product R&D program - Ministry of Health & Welfare thorough the Korea Health Industry Development Institute [HI14C1435]	Senior-Friendly Product R&D program - Ministry of Health & Welfare thorough the Korea Health Industry Development Institute	This study was supported by the Senior-Friendly Product R&D program funded by the Ministry of Health & Welfare thorough the Korea Health Industry Development Institute (HI14C1435, http://www.khidi.or.kr/eps). ICH received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasiov PA, 2008, BRIT J OPHTHALMOL, V92, P1169, DOI 10.1136/bjo.2008.139725; Bentley B, 2006, J CARDIOVASC NURS, V21, P63, DOI 10.1097/00005082-200601000-00012; Choi JA, 2014, INVEST OPHTH VIS SCI, V55, P2041, DOI [10.1167/iovs.13-12853, 10.1167/IOVS.13-12853]; Choi YJ, 2009, DIABETES CARE, V32, P2016, DOI 10.2337/dc08-2228; Christopher-Stine L, 2004, J RHEUMATOL, V31, P1557; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P487; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Cumming RG, 2000, OPHTHALMOLOGY, V107, P450, DOI 10.1016/S0161-6420(99)00024-X; Cumming RG, 2000, AM J EPIDEMIOL, V151, P624, DOI 10.1093/oxfordjournals.aje.a010251; Dandona R, 2001, BRIT J OPHTHALMOL, V85, P1484, DOI 10.1136/bjo.85.12.1484; Deaton A, 2003, SOC SCI MED, V56, P1139, DOI 10.1016/S0277-9536(02)00115-6; EDERER F, 1981, AM J OPHTHALMOL, V91, P381, DOI 10.1016/0002-9394(81)90293-2; GLYNN RJ, 1995, ARCH OPHTHALMOL-CHIC, V113, P1131, DOI 10.1001/archopht.1995.01100090057023; Hiller R, 2003, OPHTHALMOLOGY, V110, P578, DOI 10.1016/S0161-6420(02)01762-1; JAHN CE, 1986, OPHTHALMIC RES, V18, P112, DOI 10.1159/000265424; Kanthan GL, 2011, ACTA OPHTHALMOL, V89, pE434, DOI 10.1111/j.1755-3768.2011.02149.x; Kim TN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094189; Klein BEK, 1998, AM J OPHTHALMOL, V126, P782, DOI 10.1016/S0002-9394(98)00280-3; KLEIN R, 1994, OPHTHALMOLOGY, V101, P1969; Krishnaiah S, 2005, INVEST OPHTH VIS SCI, V46, P58, DOI 10.1167/iovs.04-0089; Lee SG, 2013, CLIN CHIM ACTA, V424, P168, DOI 10.1016/j.cca.2013.05.027; LESKE MC, 1983, AM J EPIDEMIOL, V118, P152, DOI 10.1093/oxfordjournals.aje.a113625; Mann SJ, 2010, J CLIN HYPERTENS, V12, P174, DOI 10.1111/j.1751-7176.2009.00241.x; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Miglior S, 1989, Dev Ophthalmol, V17, P158; Mirsamadi Mansour, 2004, Int J Med Sci, V1, P165; Miyaki K, 2013, INT J ENV RES PUB HE, V10, P980, DOI 10.3390/ijerph10030980; Rhee MY, 2014, NUTRIENTS, V6, P2360, DOI 10.3390/nu6062360; RODRIGUEZSARGENT C, 1989, INVEST OPHTH VIS SCI, V30, P2356; RODRIGUEZSARGENT C, 1987, HYPERTENSION, V9, P304, DOI 10.1161/01.HYP.9.3.304; Seah SKL, 2002, OPHTHALMOLOGY, V109, P2058, DOI 10.1016/S0161-6420(02)01221-6; Tan JSL, 2008, OPHTHAL EPIDEMIOL, V15, P155, DOI 10.1080/09286580701840362; Tavani A, 1996, ANN EPIDEMIOL, V6, P41, DOI 10.1016/1047-2797(95)00099-2; WEST S, 1989, ARCH OPHTHALMOL-CHIC, V107, P1166, DOI 10.1001/archopht.1989.01070020232031; Wu RY, 2010, ARCH OPHTHALMOL-CHIC, V128, P1029, DOI 10.1001/archophthalmol.2010.147; Yoon Kyung-Chul, 2011, Korean J Ophthalmol, V25, P421, DOI 10.3341/kjo.2011.25.6.421	37	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136218	10.1371/journal.pone.0136218	http://dx.doi.org/10.1371/journal.pone.0136218			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287670	gold, Green Published, Green Submitted			2022-12-26	WOS:000360018600124
J	Orand, A; Gupta, A; Shih, W; Presson, AP; Hammer, C; Niesler, B; Heendeniya, N; Mayer, EA; Chang, L				Orand, Alexa; Gupta, Arpana; Shih, Wendy; Presson, Angela P.; Hammer, Christian; Niesler, Beate; Heendeniya, Nuwanthi; Mayer, Emeran A.; Chang, Lin			Catecholaminergic Gene Polymorphisms Are Associated with GI Symptoms and Morphological Brain Changes in Irritable Bowel Syndrome	PLOS ONE			English	Article							ADVERSE LIFE EVENTS; GRAY-MATTER VOLUME; CHRONIC PAIN; SOMATOSENSORY CORTEX; STRESS; ABUSE; INVENTORY; THICKNESS; PREVALENCE; PERCEPTION	Background Genetic and environmental factors contribute to the pathophysiology of irritable bowel syndrome (IBS). In particular, early adverse life events (EALs) and the catecholaminergic system have been implicated. Aims To investigate whether catecholaminergic SNPs with or without interacting with EALs are associated with: 1) a diagnosis of IBS, 2) IBS symptoms and 3) morphological alterations in brain regions associated with somatosensory, viscerosensory, and interoceptive processes. Methods In 277 IBS and 382 healthy control subjects (HCs), 11 SNPs in genes of the catecholaminergic signaling pathway were genotyped. A subset (121 IBS, 209 HCs) underwent structural brain imaging (magnetic resonance imaging [MRI]). Logistic and linear regressions evaluated each SNP separately and their interactions with EALs in predicting IBS and GI symptom severity, respectively. General linear models determined grey matter (GM) alterations from the SNPs and EALs that were predictive of IBS. Results 1) Diagnosis: There were no statistically significant associations between the SNPs and IBS status with or without the interaction with EAL after adjusting for multiple comparisons. 2) Symptoms: GI symptom severity was associated with ADRA1D rs1556832 (P = 0.010). 3) Brain morphometry: In IBS, the homozygous genotype of the major ADRA1D allele was associated with GM increases in somatosensory regions (FDR q = 0.022), left precentral gyrus (q = 0.045), and right hippocampus (q = 0.009). In individuals with increasing sexual abuse scores, the ADRA beta 2 SNP was associated with GM changes in the left posterior insula (q = 0.004) and left putamen volume (q = 0.029). Conclusion In IBS, catecholaminergic SNPs are associated with symptom severity and morphological changes in brain regions concerned with sensory processing and modulation and affect regulation. Thus, certain adrenergic receptor genes may facilitate or worsen IBS symptoms.	[Orand, Alexa; Gupta, Arpana; Heendeniya, Nuwanthi; Mayer, Emeran A.; Chang, Lin] Univ Calif Los Angeles, David Geffen Sch Med, Oppenheimer Ctr Neurobiol Stress, Los Angeles, CA 90095 USA; [Shih, Wendy; Presson, Angela P.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biostat, Los Angeles, CA 90095 USA; [Presson, Angela P.] Univ Utah, Dept Internal Med, Div Epidemiol, Salt Lake City, UT 84112 USA; [Hammer, Christian; Niesler, Beate] Heidelberg Univ, Dept Human Mol Genet, Inst Human Genet, Heidelberg, Germany	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Utah System of Higher Education; University of Utah; Ruprecht Karls University Heidelberg	Chang, L (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Oppenheimer Ctr Neurobiol Stress, Los Angeles, CA 90095 USA.	linchang@mednet.ucla.edu	Chang, Lin/AAI-4333-2021; Hammer, Christian/C-5827-2014	Chang, Lin/0000-0001-6800-2967; Hammer, Christian/0000-0003-4548-7548	Medical Faculty University of Heidelberg [P50 DK064539, RO1 DK048351, P30 DK041301]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR033176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK064539, P30DK041301, R01DK048351] Funding Source: NIH RePORTER	Medical Faculty University of Heidelberg; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding: The work was supported by P50 DK064539 (EAM), RO1 DK048351 (EAM), P30 DK041301, Medical Faculty University of Heidelberg (BN).	[Anonymous], 1997, FED REG; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Arborelius L, 2007, NEUROSCIENCE, V145, P738, DOI 10.1016/j.neuroscience.2006.12.007; Benjamini Y, 2000, J EDUC BEHAV STAT, V25, P60, DOI 10.3102/10769986025001060; Benjamini Y, 2006, BIOMETRIKA, V93, P491, DOI 10.1093/biomet/93.3.491; Berman S, 2012, NEUROIMAGE, V63, P1854, DOI 10.1016/j.neuroimage.2012.08.028; Blankstein U, 2010, GASTROENTEROLOGY, V138, P1783, DOI 10.1053/j.gastro.2009.12.043; Bradford K, 2012, CLIN GASTROENTEROL H, V10, P385, DOI 10.1016/j.cgh.2011.12.018; Bremner JD, 2007, J NERV MENT DIS, V195, P211, DOI 10.1097/01.nmd.0000243824.84651.6c; Camilleri M, 2013, NEUROGASTROENT MOTIL, V25, P458, DOI 10.1111/nmo.12132; Camilleri M, 2013, AM J PHYSIOL-GASTR L, V304, pG553, DOI 10.1152/ajpgi.00376.2012; Chang L, 2011, GASTROENTEROLOGY, V140, P761, DOI 10.1053/j.gastro.2011.01.032; Cheng P, 2013, NEUROGASTROENT MOTIL, V25, pE650, DOI 10.1111/nmo.12177; Chung MK, 2005, LECT NOTES COMPUT SC, V3565, P627; DaSilva AFM, 2007, NEUROLOGY, V69, P1990, DOI 10.1212/01.wnl.0000291618.32247.2d; Davidson RJ, 2012, NAT NEUROSCI, V15, P689, DOI 10.1038/nn.3093; Diatchenko L, 2006, PAIN, V125, P216, DOI 10.1016/j.pain.2006.05.024; Diatchenko L, 2006, PAIN, V123, P226, DOI 10.1016/j.pain.2006.04.015; Diatchenko L, 2006, AM J MED GENET B, V141B, P449, DOI 10.1002/ajmg.b.30324; Dickhaus B, 2003, AM J GASTROENTEROL, V98, P135; Dina OA, 2001, EUR J NEUROSCI, V13, P2227, DOI 10.1046/j.0953-816x.2001.01614.x; Drossman DA, 2011, AM J GASTROENTEROL, V106, P14, DOI 10.1038/ajg.2010.453; Drossman DA, 2006, GASTROENTEROLOGY, V130, P1377, DOI 10.1053/j.gastro.2006.03.008; Elsenbruch S, 2014, PAIN, V155, P244, DOI 10.1016/j.pain.2013.09.027; Erpelding N, 2012, PAIN, V153, P1602, DOI 10.1016/j.pain.2012.03.012; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Gupta A, 2014, PSYCHOSOM MED, V76, P404, DOI 10.1097/PSY.0000000000000089; Gustin SM, 2012, J NEUROSCI, V32, P14874, DOI 10.1523/JNEUROSCI.1733-12.2012; Heitkemper M, 2001, DIGEST DIS SCI, V46, P1276, DOI 10.1023/A:1010671514618; Ibeakanma C, 2011, GASTROENTEROLOGY, V141, P2098, DOI 10.1053/j.gastro.2011.08.006; Ishizuka O, 2013, INT J UROL, V20, P73, DOI 10.1111/j.1442-2042.2012.03223.x; Iwata N, 1998, PSYCHOL REP, V82, P651, DOI 10.2466/PR0.82.2.651-656; Jiang ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073932; Khasar SG, 1999, J NEUROPHYSIOL, V81, P1104, DOI 10.1152/jn.1999.81.3.1104; Kilpatrick LA, 2011, GASTROENTEROLOGY, V140, P1943, DOI 10.1053/j.gastro.2011.03.011; Kitayama N, 2006, J AFFECT DISORDERS, V90, P171, DOI 10.1016/j.jad.2005.11.006; Korner A, 2008, PSYCHOTHER PSYCH MED, V58, P238, DOI 10.1055/s-2007-986199; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Kvetnansky R, 2009, PHYSIOL REV, V89, P535, DOI 10.1152/physrev.00042.2006; Labus JS, 2014, PAIN, V155, P137, DOI 10.1016/j.pain.2013.09.020; Labus JS, 2004, ALIMENT PHARM THER, V20, P89, DOI 10.1111/j.1365-2036.2004.02007.x; Leung K, 2010, THESIS U CALIFORNIA; Leung KT, 2008, LECT NOTES COMPUT SC, V5069, P612; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; LONGSTRETH GF, 1993, DIGEST DIS SCI, V38, P1581, DOI 10.1007/BF01303163; May A, 2008, PAIN, V137, P7, DOI 10.1016/j.pain.2008.02.034; May A, 2011, NEUROSCIENTIST, V17, P209, DOI 10.1177/1073858410396220; Mayer EA, 2001, AM J PHYSIOL-GASTR L, V280, pG519, DOI 10.1152/ajpgi.2001.280.4.G519; McCrory E, 2012, J ROY SOC MED, V105, P151, DOI 10.1258/jrsm.2011.110222; McCrory E, 2010, J CHILD PSYCHOL PSYC, V51, P1079, DOI 10.1111/j.1469-7610.2010.02271.x; Moayedi M, 2011, NEUROIMAGE, V55, P277, DOI 10.1016/j.neuroimage.2010.12.013; Moseley GL, 2012, NEUROREHAB NEURAL RE, V26, P646, DOI 10.1177/1545968311433209; Rodriguez-Raecke R, 2009, J NEUROSCI, V29, P13746, DOI 10.1523/JNEUROSCI.3687-09.2009; Schmulson M, 1999, AM J GASTROENTEROL, V94, P2929, DOI 10.1111/j.1572-0241.1999.01440.x; Shattuck DW, 2008, NEUROIMAGE, V39, P1064, DOI 10.1016/j.neuroimage.2007.09.031; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Shi YG, 2011, LECT NOTES COMPUT SC, V6892, P327, DOI 10.1007/978-3-642-23629-7_40; Su AM, 2014, NEUROGASTROENT MOTIL, V26, P36, DOI 10.1111/nmo.12220; Sugaya K, 2002, NEUROSCI LETT, V328, P74, DOI 10.1016/S0304-3940(02)00459-7; Sugaya K, 2002, J UROLOGY, V168, P2668, DOI 10.1016/S0022-5347(05)64241-3; Tillisch K, 2005, GUT, V54, P1396, DOI 10.1136/gut.2004.058685; Tomoda A, 2009, NEUROIMAGE, V47, pT66, DOI 10.1016/j.neuroimage.2009.03.005; Ung H, 2012, MULTIVARIATE CLASSIF; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Weniger G, 2008, ACTA PSYCHIAT SCAND, V118, P281, DOI 10.1111/j.1600-0447.2008.01246.x; Wilson S, 2004, BRIT J GEN PRACT, V54, P495; Wouters MM, 2012, NEUROGASTROENT MOTIL, V24, DOI 10.1111/j.1365-2982.2012.01919.x; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	69	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135910	10.1371/journal.pone.0135910	http://dx.doi.org/10.1371/journal.pone.0135910			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288143	Green Published, gold, Green Submitted			2022-12-26	WOS:000360018600085
J	Shoeb, M; Singh, BR; Mobin, M; Afreen, G; Khan, W; Naqvi, AH				Shoeb, Mohd; Singh, Braj Raj; Mobin, Mohammad; Afreen, Gul; Khan, Wasi; Naqvi, Alim H.			Kinetic Study on Mutagenic Chemical Degradation through Three Pot Synthesiszed Graphene@ZnO Nanocomposite	PLOS ONE			English	Article							PHOTOCATALYTIC DEGRADATION; OXIDE NANOCOMPOSITE; CDS NANOPARTICLES; FACILE SYNTHESIS; METHYLENE-BLUE; REDUCTION; COMPOSITES; FABRICATION; CELLS; PARTICLES	The study was taken up with the objective to synthesize graphene-zinc oxide nano particles (NPs) nanocomposite (Gr@ZnO-Nc) via In-situ synthesis method. The structural, optical, thermal, electrical and photocatalytic properties of the synthesized Gr@ZnO-Nc were studied. The characterization data confirmed that the ZnO NPs were successfully incorporated into the graphene sheets. Further, TGA/DTA results exhibited an enhanced thermal stability of the Gr@ZnO-Nc compared with the graphene. The Gr@ZnO-Nc, graphene sheets were uniformly wrapped by ZnO NPs, which can protect graphene and delay their oxidation in air. The synthesized Gr@ZnO-Nc was used for the efficient photodegradation of a carcinogenic methyl orange (MO) dye. The results exhibited promising photodegradation of the MO dye under UV light irradiation through the production of reactive oxygen species (ROS). The promising effect of Gr@ZnO-Nc on the photodegradation properties was conferred by the large surface area which increased adsorption capacity, and the strong electron transfer ability. Thus, it is encouraging to conclude that the synthesized Gr@ZnO-Nc has environmental significance with its utility in remediation in the hazardous MO dye.	[Shoeb, Mohd; Singh, Braj Raj; Khan, Wasi; Naqvi, Alim H.] Aligarh Muslim Univ, Ctr Excellence Mat Sci Nanomat, Dept Appl Phys, ZH Coll Engn & Tech, Aligarh, Uttar Pradesh, India; [Shoeb, Mohd; Mobin, Mohammad] Aligarh Muslim Univ, Dept Appl Chem, ZH Coll Engn & Tech, Aligarh, Uttar Pradesh, India; [Afreen, Gul] Indian Inst Technol Delhi, Dept Chem Engn, Delhi, India	Aligarh Muslim University; Zakir Husain College Of Engineering & Technology; Aligarh Muslim University; Zakir Husain College Of Engineering & Technology; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	Singh, BR (corresponding author), Aligarh Muslim Univ, Ctr Excellence Mat Sci Nanomat, Dept Appl Phys, ZH Coll Engn & Tech, Aligarh, Uttar Pradesh, India.	brajviro@gmail.com	Mobin, Mohammad/AAX-6438-2021; Shoeb, Mohd/B-4206-2014; , Mobin/D-1273-2014	Mobin, Mohammad/0000-0003-4829-7491; Shoeb, Mohd/0000-0003-0582-7034; , Mobin/0000-0003-1940-3822				Akhavan O, 2011, CARBON, V49, P11, DOI 10.1016/j.carbon.2010.08.030; An XQ, 2011, RSC ADV, V1, P1426, DOI 10.1039/c1ra00382h; Ansari SA, 2012, MATER SCI ENG B-ADV, V177, P428, DOI 10.1016/j.mseb.2012.01.022; Azarang M, 2014, J APPL PHYS, V116, DOI 10.1063/1.4894141; Chen D, 2013, ENERG ENVIRON SCI, V6, P1362, DOI 10.1039/c3ee23586f; Chen Z, 2013, CRYSTENGCOMM, V15, P3022, DOI 10.1039/c3ce27021a; Chu DW, 2010, LANGMUIR, V26, P2811, DOI 10.1021/la902866a; Chua CK, 2014, CHEM SOC REV, V43, P291, DOI 10.1039/c3cs60303b; CHUNG KT, 1981, APPL ENVIRON MICROB, V42, P641, DOI 10.1128/AEM.42.4.641-648.1981; Dreyer DR, 2010, CHEM SOC REV, V39, P228, DOI 10.1039/b917103g; Dutta S, 2005, PHYS STATUS SOLIDI A, V202, P1172, DOI 10.1002/pssa.200406932; Dwivedi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111289; Fan HG, 2012, CATAL COMMUN, V29, P29, DOI 10.1016/j.catcom.2012.09.013; Fan XB, 2008, ADV MATER, V20, P4490, DOI 10.1002/adma.200801306; Gedamu D, 2014, ADV MATER, V26, P1541, DOI 10.1002/adma.201304363; Hilder M, 2012, PHYS CHEM CHEM PHYS, V14, P14034, DOI 10.1039/c2cp42385e; Hong Y, 2013, J MATER CHEM A, V1, P5700, DOI 10.1039/c3ta10218a; Huang X, 2012, CHEM SOC REV, V41, P666, DOI 10.1039/c1cs15078b; Ji QM, 2010, ANGEW CHEM INT EDIT, V49, P9737, DOI 10.1002/anie.201004929; Ji YZ, 2013, MAT SCI ENG C-MATER, V33, P3811, DOI 10.1016/j.msec.2013.05.016; Jin X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106991; Jin X, 2013, ADV MATER, V25, P1342, DOI 10.1002/adma.201203849; Kavitha MK, 2013, J MATER CHEM C, V1, P3669, DOI 10.1039/c3tc30323c; Khan JA, 2014, CR CHIM, V17, P91, DOI 10.1016/j.crci.2013.08.006; Khan JA, 2013, SPECTROCHIM ACTA A, V109, P313, DOI 10.1016/j.saa.2013.03.011; Khenfouch M, 2012, OPT MATER, V34, P1320, DOI 10.1016/j.optmat.2012.02.005; Kim YK, 2012, ACS APPL MATER INTER, V4, P6545, DOI 10.1021/am301658p; Lai Q, 2012, AIP ADV, V2, DOI 10.1063/1.4747817; Leng WH, 2005, J PHYS CHEM B, V109, P15008, DOI 10.1021/jp051821z; Li BJ, 2011, J MATER CHEM, V21, P3346, DOI 10.1039/c0jm03253k; Li BX, 2012, J COLLOID INTERF SCI, V377, P114, DOI 10.1016/j.jcis.2012.03.060; Liu Q, 2009, ADV FUNCT MATER, V19, P894, DOI 10.1002/adfm.200800954; Liu XJ, 2012, CHEM ENG J, V183, P238, DOI 10.1016/j.cej.2011.12.068; Loh KP, 2010, J MATER CHEM, V20, P2277, DOI 10.1039/b920539j; Lu K, 2012, CHINESE SCI BULL, V57, P1223, DOI 10.1007/s11434-012-4986-5; Luo QP, 2012, J PHYS CHEM C, V116, P8111, DOI 10.1021/jp2113329; Lv T, 2012, CATAL SCI TECHNOL, V2, P2297, DOI 10.1039/c2cy20023f; Lv X, 2009, SMALL, V5, P1682, DOI 10.1002/smll.200900044; Marcano DC, 2010, ACS NANO, V4, P4806, DOI 10.1021/nn1006368; Mecklenburg M, 2012, ADV MATER, V24, P3486, DOI 10.1002/adma.201200491; Mishra YK, 2012, J APPL PHYS, V112, DOI 10.1063/1.4752469; Mishra YK, 2014, KONA POWDER PART J, P92; Nethravathi C, 2008, CARBON, V46, P1994, DOI 10.1016/j.carbon.2008.08.013; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Papavlassopoulos H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084983; Pawar RC, 2014, APPL CATAL B-ENVIRON, V144, P57, DOI 10.1016/j.apcatb.2013.06.022; Pawar RC, 2013, MATER CHEM PHYS, V141, P686, DOI 10.1016/j.matchemphys.2013.05.062; Pawar RC, 2013, CURR APPL PHYS, V13, pS50, DOI 10.1016/j.cap.2012.12.031; Peng WC, 2013, NANO RES, V6, P286, DOI 10.1007/s12274-013-0306-x; Rao RAK, 2014, J ENVIRON CHEM ENG, V2, P199, DOI 10.1016/j.jece.2013.12.011; Rosi NL, 2005, CHEM REV, V105, P1547, DOI 10.1021/cr030067f; Roy P, 2013, ENVIRON SCI TECHNOL, V47, P6688, DOI 10.1021/es400422k; Saravanakumar B, 2013, MATER RES BULL, V48, P878, DOI 10.1016/j.materresbull.2012.11.048; Shoeb M, 2013, ADV NAT SCI-NANOSCI, V4, DOI 10.1088/2043-6262/4/3/035015; Siddique YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080944; Singh BR, 2012, BIOMATERIALS, V33, P5753, DOI 10.1016/j.biomaterials.2012.04.045; Singh S, 2014, J MOL STRUCT, V1056, P194, DOI 10.1016/j.molstruc.2013.10.020; Song M, 2012, J NANOMATER, V2012, DOI 10.1155/2012/135138; Upadhyay RK, 2014, RSC ADV, V4, P3823, DOI 10.1039/c3ra45013a; Wahab R, 2013, COLLOID SURFACE B, V111, P211, DOI 10.1016/j.colsurfb.2013.06.003; Wahab R, 2012, J BIOMED NANOTECHNOL, V8, P424, DOI 10.1166/jbn.2012.1448; Wahab R, 2011, CHEM ENG J, V175, P450, DOI 10.1016/j.cej.2011.09.055; Wang LX, 2013, DALTON T, V42, P8070, DOI 10.1039/c3dt50333j; Wang X, 2008, NANO LETT, V8, P323, DOI 10.1021/nl072838r; Wu JL, 2010, APPL SURF SCI, V256, P2826, DOI 10.1016/j.apsusc.2009.11.034; Xiong P, 2012, J MATER CHEM, V22, P17485, DOI 10.1039/c2jm31522j; Xu TG, 2011, APPL CATAL B-ENVIRON, V101, P382, DOI 10.1016/j.apcatb.2010.10.007; Xu YX, 2008, J AM CHEM SOC, V130, P5856, DOI 10.1021/ja800745y; Yan DH, 2009, J PHYS CHEM B, V113, P6047, DOI 10.1021/jp808805w; Yang HF, 2009, J MATER CHEM, V19, P4632, DOI 10.1039/b901421g; Yang L, 2013, J APPL PHYS, V113; Yang Y, 2011, APPL SURF SCI, V257, P8950, DOI 10.1016/j.apsusc.2011.05.070; Yavari F, 2010, SMALL, V6, P2535, DOI 10.1002/smll.201001384; Zhang H, 2010, ACS NANO, V4, P380, DOI 10.1021/nn901221k; Zhang L, 2013, PHYSICA E, V47, P279, DOI 10.1016/j.physe.2012.10.008; Zhang Q, 2012, J MATER CHEM, V22, P11778, DOI 10.1039/c2jm31401k; Zhang W, 2009, APPL CATAL A-GEN, V371, P1, DOI 10.1016/j.apcata.2009.09.038; Zhang YP, 2011, PROG NAT SCI-MATER, V21, P467, DOI 10.1016/S1002-0071(12)60084-7; Zhang YJ, 2012, CHINESE SCI BULL, V57, P3086, DOI 10.1007/s11434-012-5333-6; Zhang ZY, 2013, ACS APPL MATER INTER, V5, P2227, DOI 10.1021/am303299r; Zheng Q, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/45/455103	81	31	31	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135055	10.1371/journal.pone.0135055	http://dx.doi.org/10.1371/journal.pone.0135055			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287672	Green Submitted, Green Published, gold			2022-12-26	WOS:000360018600034
J	Sola-Villa, D; Dilme, JF; Rodriguez, C; Soto, B; Vila, L; Escudero, JR; Martinez-Gonzalez, J; Camacho, M				Sola-Villa, David; Dilme, Jaime-Felix; Rodriguez, Cristina; Soto, Begona; Vila, Luis; Escudero, Jose-Roman; Martinez-Gonzalez, Jose; Camacho, Mercedes			Expression and Cellular Localization of 15-Hydroxy-Prostaglandin-Dehydrogenase in Abdominal Aortic Aneurysm	PLOS ONE			English	Article							PROSTAGLANDIN E-2 SYNTHESIS; SMOOTH-MUSCLE-CELLS; I-SYNTHASE ACTIVITY; ENDOTHELIAL-CELLS; 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE; CYCLOOXYGENASE-2 EXPRESSION; THROMBOXANE A(2); SUPPRESSOR; DEPENDS; PGE(2)	PGE(2) has been implicated in abdominal aortic aneurysm (AAA) associated hypervascularization. PGE(2)-metabolism involves 15-hydroxyprostaglandin-dehydrogenase (15-PGDH) the expression of which in AAA is unknown. The aim of this study was to examine the expression and cell distribution of 15-PGDH in AAA. Here, we show that 15-PGDH mRNA levels were significantly higher in aorta samples from patients undergoing AAA repair than in those from healthy multiorgan donors. Consequently, the ratio of metabolized PGE(2) secreted by aortic samples was significantly higher in AAA. AAA production of total PGE(2) and PGE(2) metabolites correlated positively with PGI(2) production, while the percentage of metabolized PGE(2) correlated negatively with the total amount of PGE(2) and with PGI(2). Transcript levels of 15-PGDH were statistically associated with leukocyte markers but did not correlate with microvascular endothelial cell markers. Immunohistochemistry revealed 15-PGDH in the areas of leukocyte infiltration in AAA samples, mainly associated with CD45-positive cells, but not in normal aorta samples. We provide new data concerning 15-PGDH expression in human AAA, showing that 15-PGDH is upregulated in AAA and mainly expressed in infiltrating leukocytes. Our data suggest that microvasculature was not involved in PGE(2) catabolism, reinforcing the potential role of microvasculature derived PGE(2) in AAA-associated hypervascularization.	[Sola-Villa, David] Autonomous Univ Barcelona, Inst Biomed Res II B St Pau, Barcelona, Spain; [Dilme, Jaime-Felix; Soto, Begona; Vila, Luis; Escudero, Jose-Roman; Camacho, Mercedes] Inst Biomed Res II B St Pau, Angiol Vasc Biol & Inflammat Lab, Barcelona, Spain; [Dilme, Jaime-Felix; Soto, Begona; Escudero, Jose-Roman] Inst Biomed Res II B St Pau, Dept Vasc Surg, Barcelona, Spain; [Rodriguez, Cristina; Martinez-Gonzalez, Jose] Inst Biomed Res II B St Pau, Cardiovasc Res Ctr CSIC ICCC, Barcelona, Spain	Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Catala de Ciencies Cardiovasculars (ICCC)	Camacho, M (corresponding author), Inst Biomed Res II B St Pau, Angiol Vasc Biol & Inflammat Lab, Barcelona, Spain.	mcamacho@santpau.cat	Rodriguez, Cristina/D-3099-2011; Dilme, Jaime/AAB-6994-2019	Rodriguez, Cristina/0000-0002-6472-5647; Martinez-Gonzalez, Jose/0000-0002-3894-7166; Camacho, Mercedes/0000-0001-5970-3294	Spanish Ministry of Economy and Competiveness [SAF2010-21392, SAF2013-46707-R, SAF2012-40127]; Instituto de Salud Carlos III [PI12/01952, RD12/0042/0051, RD12/0042/0053]; Fondo Europeo de Desarrollo Regional (FEDER), a way to make Europe	Spanish Ministry of Economy and Competiveness(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fondo Europeo de Desarrollo Regional (FEDER), a way to make Europe	This work was supported by grants SAF2010-21392 (LV), SAF2013-46707-R (LV, MC), SAF2012-40127 (JM-G) from the Spanish Ministry of Economy and Competiveness, PI12/01952 (CR) and Red de Investigacion Cardiovascular RD12/0042/0051 (LV) and RD12/0042/0053 (JM-G) from the Instituto de Salud Carlos III. The study was cofunded by Fondo Europeo de Desarrollo Regional (FEDER), a way to make Europe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGGARD E, 1971, ACTA PHYSIOL SCAND, V81, P396, DOI 10.1111/j.1748-1716.1971.tb04914.x; Bishop-Bailey D, 2006, ARTERIOSCL THROM VAS, V26, P956, DOI 10.1161/01.ATV.0000219672.68024.bc; Bru A, 2009, TUMOUR CELL LINES HT; Camacho M, 1998, CIRC RES, V83, P353, DOI 10.1161/01.RES.83.4.353; Camacho M, 2007, J THROMB HAEMOST, V5, P1411, DOI 10.1111/j.1538-7836.2007.02555.x; Camacho M, 2000, THROMB RES, V99, P155, DOI 10.1016/S0049-3848(00)00241-3; Camacho M, 2015, J PATHOL, V235, P125, DOI 10.1002/path.4453; Camacho M, 2013, J LIPID RES, V54, P3506, DOI 10.1194/jlr.M042481; Casos K, 2011, MICROVASC RES, V81, P261, DOI 10.1016/j.mvr.2011.01.006; Chapple KS, 2007, ANN VASC SURG, V21, P61, DOI 10.1016/j.avsg.2006.10.008; Cheuk BLY, 2007, INT J MOL MED, V20, P391; Choke E, 2006, ARTERIOSCL THROM VAS, V26, P2077, DOI 10.1161/01.ATV.0000234944.22509.f9; Salvado MD, 2009, ARTERIOSCL THROM VAS, V29, P1131, DOI 10.1161/ATVBAHA.109.188540; Gitlin JM, 2007, CARDIOVASC RES, V73, P227, DOI 10.1016/j.cardiores.2006.10.015; HERRON GS, 1991, ARTERIOSCLER THROMB, V11, P1667, DOI 10.1161/01.ATV.11.6.1667; Holmes DR, 1997, J VASC SURG, V25, P810, DOI 10.1016/S0741-5214(97)70210-6; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Myung SJ, 2006, P NATL ACAD SCI USA, V103, P12098, DOI 10.1073/pnas.0603235103; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Nordon IM, 2011, NAT REV CARDIOL, V8, P92, DOI 10.1038/nrcardio.2010.180; Paik DC, 2004, EXP MOL MED, V36, P524, DOI 10.1038/emm.2004.67; Sola-Villa D, 2006, KIDNEY INT, V70, P1935, DOI 10.1038/sj.ki.5001948; Soler M, 2000, CIRC RES, V87, P504; Tai HH, 2002, PROSTAG OTH LIPID M, V68-9, P483, DOI 10.1016/S0090-6980(02)00050-3; Vila L, 2004, MED RES REV, V24, P399, DOI 10.1002/med.10065; Walton LJ, 1999, CIRCULATION, V100, P48, DOI 10.1161/01.CIR.100.1.48; Wang M, 2008, CIRCULATION, V117, P1302, DOI 10.1161/CIRCULATIONAHA.107.731398; Wolf I, 2006, CANCER RES, V66, P7818, DOI 10.1158/0008-5472.CAN-05-4368	28	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136201	10.1371/journal.pone.0136201	http://dx.doi.org/10.1371/journal.pone.0136201			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287481	Green Published, Green Submitted, gold			2022-12-26	WOS:000360018600121
J	Bill, J; Buesing, L; Habenschuss, S; Nessler, B; Maass, W; Legenstein, R				Bill, Johannes; Buesing, Lars; Habenschuss, Stefan; Nessler, Bernhard; Maass, Wolfgang; Legenstein, Robert			Distributed Bayesian Computation and Self-Organized Learning in Sheets of Spiking Neurons with Local Lateral Inhibition	PLOS ONE			English	Article							EXCITATORY NEURONS; VISUAL-CORTEX; CONNECTIONS; MODEL; ORIENTATION; SPECIFICITY; INTEGRATION; PLASTICITY; NETWORKS; DYNAMICS	During the last decade, Bayesian probability theory has emerged as a framework in cognitive science and neuroscience for describing perception, reasoning and learning of mammals. However, our understanding of how probabilistic computations could be organized in the brain, and how the observed connectivity structure of cortical microcircuits supports these calculations, is rudimentary at best. In this study, we investigate statistical inference and self-organized learning in a spatially extended spiking network model, that accommodates both local competitive and large-scale associative aspects of neural information processing, under a unified Bayesian account. Specifically, we show how the spiking dynamics of a recurrent network with lateral excitation and local inhibition in response to distributed spiking input, can be understood as sampling from a variational posterior distribution of a well-defined implicit probabilistic model. This interpretation further permits a rigorous analytical treatment of experience-dependent plasticity on the network level. Using machine learning theory, we derive update rules for neuron and synapse parameters which equate with Hebbian synaptic and homeostatic intrinsic plasticity rules in a neural implementation. In computer simulations, we demonstrate that the interplay of these plasticity rules leads to the emergence of probabilistic local experts that form distributed assemblies of similarly tuned cells communicating through lateral excitatory connections. The resulting sparse distributed spike code of a well-adapted network carries compressed information on salient input features combined with prior experience on correlations among them. Our theory predicts that the emergence of such efficient representations benefits from network architectures in which the range of local inhibition matches the spatial extent of pyramidal cells that share common afferent input.	[Bill, Johannes; Habenschuss, Stefan; Maass, Wolfgang; Legenstein, Robert] Graz Univ Technol, Inst Theoret Comp Sci, Graz, Austria; [Buesing, Lars] Columbia Univ, Dept Stat, New York, NY USA; [Nessler, Bernhard] Frankfurt Inst Adv Studies, Frankfurt, Germany	Graz University of Technology; Columbia University	Bill, J (corresponding author), Graz Univ Technol, Inst Theoret Comp Sci, Graz, Austria.	bill.scientific@gmail.com		Legenstein, Robert/0000-0002-8724-5507	CHIST-ERAERA-Net (Project FWF) [I753-N23]; European Union project [FP7-269921, FP7-237955]; Austrian Science Fund (FWF) [I 753] Funding Source: researchfish	CHIST-ERAERA-Net (Project FWF)(Austrian Science Fund (FWF)); European Union project(European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was written under partial support of CHIST-ERAERA-Net (Project FWF # I753-N23, PNEUMA) and the European Union projects # FP7-269921 (BrainScaleS) and # FP7-237955 (FACETSITN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesnik H, 2010, NATURE, V464, P1155, DOI 10.1038/nature08935; Angelaki DE, 2009, CURR OPIN NEUROBIOL, V19, P452, DOI 10.1016/j.conb.2009.06.008; [Anonymous], ARXIV13113211; [Anonymous], 1989, ANALOG VLSI IMPLEMEN; Avermann M, 2012, J NEUROPHYSIOL, V107, P3116, DOI 10.1152/jn.00917.2011; Berkes P, 2011, SCIENCE, V331, P83, DOI 10.1126/science.1195870; Berniker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012686; Bill J, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00412; Bishop C. M, 2006, PATTERN RECOGNITION; Bosking WH, 1997, J NEUROSCI, V17, P2112; Buesing L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002211; Carreira-Perpinan M.A., 2005, P ARTIFICIAL INTELLI, VR5:, P33; CHUA LO, 1971, IEEE T CIRCUITS SYST, VCT18, P507, DOI 10.1109/TCT.1971.1083337; Deneve S., 2005, ADV NEURAL INFORM PR, V17, P353; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Ecker AS, 2010, SCIENCE, V327, P584, DOI 10.1126/science.1179867; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Fiser J, 2010, TRENDS COGN SCI, V14, P119, DOI 10.1016/j.tics.2010.01.003; Ganchev J., 2008, P C NEUR INF PROC SY, P569; Gentet LJ, 2010, NEURON; Goodman ND, 2008, COGNITIVE SCI, V32, P108, DOI 10.1080/03640210701802071; Habenschuss S, 2013, PLOS COMPUTATIONAL B, V9, DOI [10.1371/journal.pcbi.1003311, DOI 10.1371/J0URNAL.PCBI.1003311]; Habenschuss S, 2012, ADV NEURAL INFORM PR, V25, P782; Habenschuss S, 2013, NEURAL COMPUT, V25, P1371, DOI 10.1162/NECO_a_00446; Haider B, 2013, NATURE, V493, P97, DOI 10.1038/nature11665; Hinton G. E., 1986, PARALLEL DISTRIBUTED, V1, DOI DOI 10.1234/12345678; Hinton GE, 2002, NEURAL COMPUT, V14, P1771, DOI 10.1162/089976602760128018; Hyvarinen A, 2002, NIPS; Hyvarinen A, 2006, NEURAL COMPUT, V18, P2283, DOI 10.1162/neco.2006.18.10.2283; Indiveri G, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/38/384010; Johansson C, 2006, LECT NOTES COMPUT SC, V3853, P265; Jolivet R, 2006, J COMPUT NEUROSCI, V21, P35, DOI 10.1007/s10827-006-7074-5; Kappel D, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003511; Kerlin AM, 2010, NEURON; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Lansner A., 1989, International Journal of Neural Systems, V1, P77, DOI 10.1142/S0129065789000499; Lansner A, 2003, THEOR BIOSCI, V122, P19, DOI 10.1078/1431-7613-00072; Lansner A, 2009, TRENDS NEUROSCIENCES; Lansner A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073776; Legenstein R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003859; Liu ZW, 2010, J NEUROSCI, V30, P8671, DOI 10.1523/JNEUROSCI.1409-10.2010; Lochmann T, 2011, CURR OPIN NEUROBIOL, V21, P774, DOI 10.1016/j.conb.2011.05.018; Lundqvist M, 2006, NETWORK-COMP NEURAL, V17, P253, DOI 10.1080/09548980600774619; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Mateo C, 2011, CURR BIOL, V21, P1593, DOI 10.1016/j.cub.2011.08.028; Mayr C., 2012, ADV NEURAL INF PROCE, V25, P1700; Moreno-Bote R, 2014, PLOS COMPUT BIOL, V10, DOI [10.1371/journal.pcbi.1003522, DOI 10.1371/J0URNAL.PCBI.1003522]; Moreno-Bote R, 2011, P NATL ACAD SCI USA, V108, P12491, DOI 10.1073/pnas.1101430108; Neal RM, 1998, NATO ADV SCI I D-BEH, V89, P355; Nessler B, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003037; Orban G, 2008, P NATL ACAD SCI USA, V105, P2745, DOI 10.1073/pnas.0708424105; Pecevski D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002294; Petersen CCH, 2013, NEURON, V78, P28, DOI 10.1016/j.neuron.2013.03.020; Peyrache A, 2009, NAT NEUROSCI, V12, P919, DOI 10.1038/nn.2337; Pouget A, 2013, NAT NEUROSCI, V16, P1170, DOI 10.1038/nn.3495; Poulet JF, 2012, TRENDS NEUROSCIENCES; Querlioz D, 2011, 2011 INTERNATIONAL JOINT CONFERENCE ON NEURAL NETWORKS (IJCNN), P1775, DOI 10.1109/IJCNN.2011.6033439; Rao R. P. N., 2004, P ADV NEUR INF PROC, P1113; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; RAO RPN, 2007, BAYESIAN BRAIN PROBA, P239; Runyan CA, 2010, NEURON; Salakhutdinov R., 2009, ARTIF INTELL, P1; Sato M.-A., 1999, FAST LEARNING ON LIN; Savin C, 2014, ADV NEURAL INF PROCE, P2024; Schemmel J, 2006, IEEE IJCNN, P1; Schemmel J, 2008, IEEE IJCNN, P431, DOI 10.1109/IJCNN.2008.4633828; Serrano-Gotarredona T, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00002; Smith SL, 2010, NAT NEUROSCI, V13, P1144, DOI 10.1038/nn.2620; Snider GS, 2008, 2008 IEEE INTERNATIONAL SYMPOSIUM ON NANOSCALE ARCHITECTURES, P85, DOI 10.1109/NANOARCH.2008.4585796; Sohya K, 2007, J NEUROSCI, V27, P2145, DOI 10.1523/JNEUROSCI.4641-06.2007; Steimer A, 2009, NEURAL COMPUT, V21, P2502, DOI 10.1162/neco.2009.08-08-837; Stepanyants A, 2009, P NATL ACAD SCI USA, V106, P3555, DOI 10.1073/pnas.0810390106; Strukov DB, 2008, NATURE, V453, P80, DOI 10.1038/nature06932; Sundareswara R, 2008, J VISION, V8, DOI 10.1167/8.5.12; Suri M, 2013, IEEE T ELECTRON DEV, V60, P2402, DOI 10.1109/TED.2013.2263000; Teglas E, 2011, SCIENCE, V332, P1054, DOI 10.1126/science.1196404; Tenenbaum JB, 2011, SCIENCE, V331, P1279, DOI 10.1126/science.1192788; Tononi G, 2014, NEURON, V81, P12, DOI 10.1016/j.neuron.2013.12.025; Tully Philip J, 2014, Front Synaptic Neurosci, V6, P8, DOI 10.3389/fnsyn.2014.00008; van Rossum G., 1995, CENTRUM WISKUNDE INF; Yang JJS, 2013, NAT NANOTECHNOL, V8, P13, DOI [10.1038/nnano.2012.240, 10.1038/NNANO.2012.240]; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565; Zariwala HA, 2011, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00162; Zemel RS, 1998, NEURAL COMPUT, V10, P403, DOI 10.1162/089976698300017818	86	5	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0134356	10.1371/journal.pone.0134356	http://dx.doi.org/10.1371/journal.pone.0134356			51	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284370	Green Published, Green Submitted, gold			2022-12-26	WOS:000359666100008
J	Dueregger, A; Schopf, B; Eder, T; Hofer, J; Gnaiger, E; Aufinger, A; Kenner, L; Perktold, B; Ramoner, R; Klocker, H; Eder, IE				Dueregger, Andrea; Schoepf, Bernd; Eder, Theresa; Hoefer, Julia; Gnaiger, Erich; Aufinger, Astrid; Kenner, Lukas; Perktold, Bernhard; Ramoner, Reinhold; Klocker, Helmut; Eder, Iris E.			Differential Utilization of Dietary Fatty Acids in Benign and Malignant Cells of the Prostate	PLOS ONE			English	Article							CANCER-CELLS; KETOGENIC DIET; LOW-CARBOHYDRATE; SMALL BIOPSIES; METABOLISM; PROGRESSION; GLUCOSE; GROWTH; ZINC; DEHYDROGENASE	Tumor cells adapt via metabolic reprogramming to meet elevated energy demands due to continuous proliferation, for example by switching to alternative energy sources. Nutrients such as glucose, fatty acids, ketone bodies and amino acids may be utilized as preferred substrates to fulfill increased energy requirements. In this study we investigated the metabolic characteristics of benign and cancer cells of the prostate with respect to their utilization of medium chain (MCTs) and long chain triglycerides (LCTs) under standard and glucose-starved culture conditions by assessing cell viability, glycolytic activity, mitochondrial respiration, the expression of genes encoding key metabolic enzymes as well as mitochondrial mass and mtDNA content. We report that BE prostate cells (RWPE-1) have a higher competence to utilize fatty acids as energy source than PCa cells (LNCaP, ABL, PC3) as shown not only by increased cell viability upon fatty acid supplementation but also by an increased beta-oxidation of fatty acids, although the base-line respiration was 2-fold higher in prostate cancer cells. Moreover, BE RWPE-1 cells were found to compensate for glucose starvation in the presence of fatty acids. Of notice, these findings were confirmed in vivo by showing that PCa tissue has a lower capacity in oxidizing fatty acids than benign prostate. Collectively, these metabolic differences between benign and prostate cancer cells and especially their differential utilization of fatty acids could be exploited to establish novel diagnostic and therapeutic strategies.	[Dueregger, Andrea; Eder, Theresa; Hoefer, Julia; Klocker, Helmut; Eder, Iris E.] Med Univ Innsbruck, Dept Urol, Div Expt Urol, A-6020 Innsbruck, Austria; [Dueregger, Andrea; Schoepf, Bernd; Klocker, Helmut] Oncotyrol GmbH, Ctr Personalized Med, Innsbruck, Austria; [Schoepf, Bernd] Med Univ Innsbruck, Dept Med Genet Mol & Clin Pharmacol, Div Genet Epidemiol, A-6020 Innsbruck, Austria; [Schoepf, Bernd; Gnaiger, Erich] Oroboros Instruments, High Resolut Respirometry, Innsbruck, Austria; [Aufinger, Astrid; Kenner, Lukas] Med Univ Vienna, Clin Inst Pathol, Vienna, Austria; [Perktold, Bernhard; Ramoner, Reinhold] FHG Zentrum Gesundheitsberufe Tirol GmbH, Diatol, Innsbruck, Austria; [Gnaiger, Erich] Med Univ Innsbruck, D Swarovski Res Lab, Dept Gen & Transplant Surg, A-6020 Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Vienna; Medical University of Innsbruck	Eder, IE (corresponding author), Med Univ Innsbruck, Dept Urol, Div Expt Urol, A-6020 Innsbruck, Austria.	iris.eder@i-med.ac.at	Klocker, Helmut/AAI-7130-2020	Kenner, Lukas/0000-0003-2184-1338; Hoefer, Julia/0000-0003-1138-3134; Gnaiger, Erich/0000-0003-3647-5895; Eder, Iris/0000-0003-3716-0027	Competence Center Oncotyrol within the scope of the Austrian Competence Centers for Excellent Technologies program [2.3.3, 2.1.5]; Austrian Cancer Aid Tyrol; autonomous province Bozen [37/40.3]; Oroboros Instruments and Oncotyrol GmbH	Competence Center Oncotyrol within the scope of the Austrian Competence Centers for Excellent Technologies program; Austrian Cancer Aid Tyrol; autonomous province Bozen; Oroboros Instruments and Oncotyrol GmbH	This work was supported by the Competence Center Oncotyrol (grant numbers: 2.3.3 and 2.1.5) within the scope of the Austrian Competence Centers for Excellent Technologies program conducted by the Austrian Research Promotion Agency (FFG). In addition, the study was partly funded by a category B research funding from the Austrian Cancer Aid Tyrol and the autonomous province Bozen (grant number: 37/40.3). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Oroboros Instruments and Oncotyrol GmbH provided support in the form of salaries for authors [AD, BS, EG], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acham-Roschitz B, 2009, MOL GENET METAB, V98, P300, DOI 10.1016/j.ymgme.2009.06.012; BABSON AL, 1973, CLIN CHEM, V19, P766; BAGGETTO LG, 1992, BIOCHIMIE, V74, P959, DOI 10.1016/0300-9084(92)90016-8; Barfeld SJ, 2014, ENDOCR-RELAT CANCER, V21, pT57, DOI 10.1530/ERC-13-0515; Barrientos A., 2009, CURR PROTOC HUM GENE, V19, P13, DOI DOI 10.1002/0471142905.HG1903S63; Bossy-Wetzel E, 2003, CURR OPIN CELL BIOL, V15, P706, DOI 10.1016/j.ceb.2003.10.015; Bracarda S, 2011, BJU INT, V107, P13, DOI 10.1111/j.1464-410X.2010.10036.x; Bu H, 2013, FEBS J, V280, P1249, DOI 10.1111/febs.12118; CARROLL JJ, 1970, BIOCHEM MED METAB B, V4, P171, DOI 10.1016/0006-2944(70)90093-1; Champ CE, 2014, J NEURO-ONCOL, V117, P125, DOI 10.1007/s11060-014-1362-0; Christensen CE, 2014, J BIOL CHEM, V289, P2344, DOI 10.1074/jbc.M113.498626; Chua ME, 2012, PROSTATE CANCER, V2012, DOI 10.1155/2012/826254; Cohen MB, 2009, J CELL BIOCHEM, V106, P363, DOI 10.1002/jcb.22022; Cook CC, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.141; Costello LC, 2005, MITOCHONDRION, V5, P143, DOI 10.1016/j.mito.2005.02.001; Costello LC, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-17; Culig Z, 1999, BRIT J CANCER, V81, P242, DOI 10.1038/sj.bjc.6690684; Dasgupta S, 2015, J CLIN INVEST, V125, P1174, DOI 10.1172/JCI76029; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Dueregger A, 2013, PHYTOMEDICINE, V20, P1306, DOI 10.1016/j.phymed.2013.07.009; Eser PO, 2013, MOL CLIN ONCOL, V1, P444, DOI 10.3892/mco.2013.76; FRIEDMAN MI, 1990, AM J PHYSIOL, V258, pR216, DOI 10.1152/ajpregu.1990.258.1.R216; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Ghosh SK, 2010, CANCER RES, V70, P6119, DOI 10.1158/0008-5472.CAN-10-1008; Gnaiger E, 2000, P NATL ACAD SCI USA, V97, P11080, DOI 10.1073/pnas.97.20.11080; Grupp K, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-145; Hayes JH, 2014, JAMA-J AM MED ASSOC, V311, P1143, DOI 10.1001/jama.2014.2085; Higgins LH, 2009, BBA-BIOENERGETICS, V1787, P1433, DOI 10.1016/j.bbabio.2009.06.003; Higuchi M, 2006, ONCOGENE, V25, P1437, DOI 10.1038/sj.onc.1209190; Ho VW, 2011, CANCER RES, V71, P4484, DOI 10.1158/0008-5472.CAN-10-3973; Huebner SM, 2014, J NUTR, V144, P177, DOI 10.3945/jn.113.182550; JOHNSON RC, 1990, AM J CLIN NUTR, V52, P502, DOI 10.1093/ajcn/52.3.502; Kim JL, 2014, ASIAN PAC J CANCER P, V15, P433, DOI 10.7314/APJCP.2014.15.1.433; Klement RJ, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-75; Kolonel LN, 1999, JNCI-J NATL CANCER I, V91, P414, DOI 10.1093/jnci/91.5.414; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Kuznetsov AV, 2002, ANAL BIOCHEM, V305, P186, DOI 10.1006/abio.2002.5658; Laffel L, 1999, DIABETES-METAB RES, V15, P412, DOI 10.1002/(SICI)1520-7560(199911/12)15:6<412::AID-DMRR72>3.0.CO;2-8; Larsson SC, 2004, AM J CLIN NUTR, V79, P935; LETELLIER T, 1992, PEDIATR RES, V32, P17, DOI 10.1203/00006450-199207000-00004; Liu Y, 2006, PROSTATE CANCER P D, V9, P230, DOI 10.1038/sj.pcan.4500879; Liu YY, 2010, ANTICANCER RES, V30, P369; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOPASCHUK GD, 1994, J BIOL CHEM, V269, P25871; MILLER WR, 1990, J STEROID BIOCHEM, V37, P317, DOI 10.1016/0960-0760(90)90480-9; Mizumachi T, 2008, PROSTATE, V68, P408, DOI 10.1002/pros.20697; Naito A, 2008, CANCER SCI, V99, P1584, DOI 10.1111/j.1349-7006.2008.00879.x; Otto C, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-122; Paoli A, 2013, EUR J CLIN NUTR, V67, P789, DOI 10.1038/ejcn.2013.116; Pelser C, 2013, CANCER EPIDEM BIOMAR, V22, P697, DOI 10.1158/1055-9965.EPI-12-1196-T; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; Pinthus JH, 2007, PROSTATE, V67, P1330, DOI 10.1002/pros.20609; Sakharkar MK, 2013, PPAR RES, V2013, DOI 10.1155/2013/109285; Sampson N, 2013, IN VITRO MODEL SYSTE; Sampson N, 2011, MOL ENDOCRINOL, V25, P503, DOI 10.1210/me.2010-0340; Schmidt M, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-54; Seyfried TN, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-7; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Upadhyay M, 2013, PHARMACOL THERAPEUT, V137, P318, DOI 10.1016/j.pharmthera.2012.11.003; WARBURG O, 1956, SCIENCE, V124, P269; Zadra G, 2013, BBA-MOL CELL BIOL L, V1831, P1518, DOI 10.1016/j.bbalip.2013.03.010; Zhang Y, 2013, CANCER BIOL THER, V14, P81, DOI 10.4161/cbt.22958; Zhang YF, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-204; Zheng J, 2012, ONCOL LETT, V4, P1151, DOI 10.3892/ol.2012.928	65	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135704	10.1371/journal.pone.0135704	http://dx.doi.org/10.1371/journal.pone.0135704			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285134	Green Published, Green Submitted, gold			2022-12-26	WOS:000359666100062
J	Lorkova, L; Scigelova, M; Arrey, TN; Vit, O; Pospisilova, J; Doktorova, E; Klanova, M; Alam, M; Vockova, P; Maswabi, B; Klener, P; Petrak, J				Lorkova, Lucie; Scigelova, Michaela; Arrey, Tabiwang Ndipanquang; Vit, Ondrej; Pospisilova, Jana; Doktorova, Eliska; Klanova, Magdalena; Alam, Mahmudul; Vockova, Petra; Maswabi, Bokang; Klener, Pavel, Jr.; Petrak, Jiri			Detailed Functional and Proteomic Characterization of Fludarabine Resistance in Mantle Cell Lymphoma Cells	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; MOLECULAR PATHOGENESIS; REPLICATION STRESS; TYROSINE KINASE; IN-VIVO; B-CELLS; CHEMORESISTANCE; MECHANISMS; CLADRIBINE; EXPRESSION	Mantle cell lymphoma (MCL) is a chronically relapsing aggressive type of B-cell non-Hodgkin lymphoma considered incurable by currently used treatment approaches. Fludarabine is a purine analog clinically still widely used in the therapy of relapsed MCL. Molecular mechanisms of fludarabine resistance have not, however, been studied in the setting of MCL so far. We therefore derived fludarabine-resistant MCL cells (Mino/FR) and performed their detailed functional and proteomic characterization compared to the original fludarabine sensitive cells (Mino). We demonstrated that Mino/FR were highly cross-resistant to other antinucleosides (cytarabine, cladribine, gemcitabine) and to an inhibitor of Bruton tyrosine kinase (BTK) ibrutinib. Sensitivity to other types of anti-lymphoma agents was altered only mildly (methotrexate, doxorubicin, bortezomib) or remained unaffacted (cisplatin, bendamustine). The detailed proteomic analysis of Mino/FR compared to Mino cells unveiled over 300 differentially expressed proteins. Mino/FR were characterized by the marked downregulation of deoxycytidine kinase (dCK) and BTK (thus explaining the observed crossresistance to antinucleosides and ibrutinib), but also by the upregulation of several enzymes of de novo nucleotide synthesis, as well as the up-regulation of the numerous proteins of DNA repair and replication. The significant upregulation of the key antiapoptotic protein Bcl-2 in Mino/FR cells was associated with the markedly increased sensitivity of the fludarabine-resistant MCL cells to Bcl-2-specific inhibitor ABT199 compared to fludarabine-sensitive cells. Our data thus demonstrate that a detailed molecular analysis of drug-resistant tumor cells can indeed open a way to personalized therapy of resistant malignancies.	[Lorkova, Lucie; Vit, Ondrej; Pospisilova, Jana; Doktorova, Eliska; Klanova, Magdalena; Alam, Mahmudul; Vockova, Petra; Maswabi, Bokang; Klener, Pavel, Jr.; Petrak, Jiri] Charles Univ Prague, Fac Med 1, Inst Pathol Physiol, Prague, Czech Republic; [Scigelova, Michaela; Arrey, Tabiwang Ndipanquang] Thermo Fisher Sci, Bremen, Germany; [Klanova, Magdalena; Vockova, Petra; Klener, Pavel, Jr.] Gen Univ Hosp, Dept Med 1, Dept Hematol, Prague, Czech Republic; [Klanova, Magdalena; Vockova, Petra; Klener, Pavel, Jr.] Charles Univ Prague, Prague, Czech Republic; [Petrak, Jiri] Inst Hematol & Blood Transfus, CR-12820 Prague, Czech Republic	Charles University Prague; Thermo Fisher Scientific; General University Hospital Prague; Charles University Prague; Institute of Hematology Prague	Petrak, J (corresponding author), Charles Univ Prague, Fac Med 1, Inst Pathol Physiol, Prague, Czech Republic.	jpetr@lf1.cuni.cz	Klener, Pavel/AAA-2789-2021; Klener, Pavel/F-7185-2017; Doktorová, Eliska/I-9719-2017; Petrak, Jiri/I-8950-2017; Vočková, Petra/H-3557-2017; Klanova, Magdalena/AAG-9785-2021; Alam, Mahmudul/AAX-4097-2020; Vit, Ondrej/I-8905-2017	Klener, Pavel/0000-0001-7786-9378; Doktorová, Eliska/0000-0001-9230-0972; Petrak, Jiri/0000-0002-8695-4803; Vočková, Petra/0000-0001-9968-6054; Klanova, Magdalena/0000-0003-3526-8114; Alam, Mahmudul/0000-0002-3464-4125; Vit, Ondrej/0000-0002-7941-0699; Maswabi, Bokang/0000-0003-4699-5392; Pospisilova, Jana/0000-0001-6020-1048	ministry of health of CR [IGA-MZ NT13201-4, NT12248-5, 15-32961A, 15-27757A]; Minsitry of Education, Youth and Sports of the Czech Republic [PRVOUK P24/LF1/3, PRVOUK P27/LF1/1, UNCE 204021, SVV-2013-260033]; Charles University [GAUK 700712 253284, 595912]; Czech Science Foundation [15-02986S, 14-19590S, 15-14200S]; BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences; Charles University in Vestec from the ERDF [CZ.1.05/1.1.00/02.0109]	ministry of health of CR; Minsitry of Education, Youth and Sports of the Czech Republic; Charles University; Czech Science Foundation(Grant Agency of the Czech Republic); BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences; Charles University in Vestec from the ERDF	The work was supported by The ministry of health of CR (www.mzcr.cz) via grants: IGA-MZ NT13201-4 (PK), NT12248-5 (JP), 15-32961A (JP) and 15-27757A (PK). The work was also supported by the Minsitry of Education, Youth and Sports of the Czech Republic (www.msmt.cz) via institutional grants PRVOUK P24/LF1/3 (JP) and PRVOUK P27/LF1/1(PK), UNCE 204021 (PK) and SVV-2013-260033 (JP) and grants from Charles University (www.cuni.cz) GAUK 700712 253284 (OV) and 595912 (BM) and from the Czech Science Foundation (www.gacr.cz) grants 15-02986S (PK), 14-19590S (PK) and 15-14200S (JP). The project was also supported by BIOCEV - Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University in Vestec (CZ.1.05/1.1.00/02.0109), from the ERDF (www.biocev.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Harbi S, 2011, BLOOD, V118, P3579, DOI 10.1182/blood-2011-03-340364; ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9; Austen B, 2007, J CLIN ONCOL, V25, P5448, DOI 10.1200/JCO.2007.11.2649; Austin WR, 2012, J EXP MED, V209, P2215, DOI 10.1084/jem.20121061; Bai L, 1998, J CANCER RES CLIN, V124, P367, DOI 10.1007/s004320050185; Brosch M, 2009, J PROTEOME RES, V8, P3176, DOI 10.1021/pr800982s; Cinar M, 2013, LEUKEMIA RES, V37, P1271, DOI 10.1016/j.leukres.2013.07.028; Constantinou A, 2012, CHROMOSOMA, V121, P21, DOI 10.1007/s00412-011-0349-2; CYSTER JG, 1995, IMMUNITY, V2, P13, DOI 10.1016/1074-7613(95)90075-6; de Campos-Nebel M, 2008, MUTAT RES-FUND MOL M, V646, P8, DOI 10.1016/j.mrfmmm.2008.08.013; de la Fuente MT, 2003, BIOCHEM BIOPH RES CO, V311, P708, DOI 10.1016/j.bbrc.2003.10.054; Dreyling M, 2013, LEUKEMIA LYMPHOMA, V54, P699, DOI 10.3109/10428194.2012.733882; Florczyk U, 2011, CANCER LETT, V300, P40, DOI 10.1016/j.canlet.2010.09.003; Forstpointner R, 2004, BLOOD, V104, P3064, DOI 10.1182/blood-2004-04-1323; Gandhi V, 2002, CLIN PHARMACOKINET, V41, P93, DOI 10.2165/00003088-200241020-00002; Heale JT, 2006, MOL CELL, V21, P837, DOI 10.1016/j.molcel.2006.01.036; Jares P, 2012, J CLIN INVEST, V122, P3416, DOI 10.1172/JCI61272; Kim SS, 2013, BIOCHEM BIOPH RES CO, V440, P658, DOI 10.1016/j.bbrc.2013.09.120; Klanova M, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-159; Kluin-Nelemans HC, 2012, NEW ENGL J MED, V367, P520, DOI 10.1056/NEJMoa1200920; Lai R, 2002, LEUKEMIA RES, V26, P849, DOI 10.1016/S0145-2126(02)00013-9; Li P, 2014, MOL BIOL CELL, V25, P2934, DOI 10.1091/mbc.E14-05-0957; Lin TS, 2010, J CLIN ONCOL, V28, P418, DOI 10.1200/JCO.2009.24.1570; Lotfi K, 1999, CLIN CANCER RES, V5, P2438; Mackey JR, 2005, BLOOD, V105, P767, DOI 10.1182/blood-2004-03-1046; Mansson E, 2003, BIOCHEM PHARMACOL, V65, P237, DOI 10.1016/S0006-2952(02)01484-3; Mansson E, 1999, CANCER RES, V59, P5956; Messina M, 2014, BLOOD, V123, P2378, DOI 10.1182/blood-2013-10-534271; Moussay E, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-115; Mraz M, 2015, EUR J HAEMATOL; NATSUMEDA Y, 1984, CANCER RES, V44, P2475; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Qin TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023372; Reed JC, 1997, SEMIN HEMATOL, V34, P9; Reed JC, 1996, J CLIN INVEST, V97, P2403, DOI 10.1172/JCI118684; Reiman T, 2002, LEUKEMIA, V16, P1886, DOI 10.1038/sj.leu.2402579; Rossi D, 2012, BLOOD, V119, P2854, DOI 10.1182/blood-2011-12-395673; Saba N, 2014, CURR OPIN HEMATOL, V21, P350, DOI 10.1097/MOH.0000000000000057; Satterthwaite AB, 2000, IMMUNOL REV, V175, P120, DOI 10.1034/j.1600-065X.2000.017504.x; Sharma A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.155; Sharma A, 2014, MOL CANCER RES, V12, P1205, DOI 10.1158/1541-7786.MCR-14-0124; Smith SC, 2014, NUCLEIC ACIDS RES, V42, P11517, DOI 10.1093/nar/gku840; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; TEW KD, 1994, CANCER RES, V54, P4313; Vie N, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-14; Wang ML, 2013, NEW ENGL J MED, V369, P507, DOI 10.1056/NEJMoa1306220; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Yao P, 2013, EMBO MOL MED, V5, P332, DOI 10.1002/emmm.201100626; Zenz T, 2009, BLOOD, V114, P2589, DOI 10.1182/blood-2009-05-224071	50	8	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135314	10.1371/journal.pone.0135314	http://dx.doi.org/10.1371/journal.pone.0135314			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285204	gold, Green Published			2022-12-26	WOS:000359666100031
J	Costantini, D; Goutte, A; Barbraud, C; Faivre, B; Sorci, G; Weimerskirch, H; Delord, K; Chastel, O				Costantini, David; Goutte, Aurelie; Barbraud, Christophe; Faivre, Bruno; Sorci, Gabriele; Weimerskirch, Henri; Delord, Karine; Chastel, Olivier			Demographic Responses to Oxidative Stress and Inflammation in the Wandering Albatross (Diomedea exulans)	PLOS ONE			English	Article							RECAPTURE MODELS; REPRODUCTION; SURVIVAL; MULTIEVENT; UNCERTAIN; COSTS; CARE	One of the major challenges in ecological research is the elucidation of physiological mechanisms that underlie the demographic traits of wild animals. We have assessed whether a marker of plasma oxidative stress (TBARS) and plasma haptoglobin (protein of the acute inflammatory phase response) measured at time t predict five demographic parameters (survival rate, return rate to the breeding colony, breeding probability, hatching and fledging success) in sexually mature wandering albatrosses over the next four years (Diomedea exulans) using a five-year individual-based dataset. Non-breeder males, but not females, having higher TBARS at time t had reduced future breeding probabilities; haptoglobin was not related to breeding probability. Neither TBARS nor haptoglobin predicted future hatching or fledging success. Haptoglobin had a marginally positive effect on female survival rate, while TBARS had a marginally negative effect on return rate. Our findings do not support the role for oxidative stress as a constraint of future reproductive success in the albatross. However, our data point to a potential mechanism underlying some aspects of reproductive senescence and survival. Our results also highlight that the study of the consequences of oxidative stress should consider the life-cycle stage of an individual and its reproductive history.	[Costantini, David] Univ Antwerp, Dept Biol, B-2610 Antwerp, Belgium; [Costantini, David] Univ Glasgow, IBAHCM, Glasgow, Lanark, Scotland; [Goutte, Aurelie; Barbraud, Christophe; Weimerskirch, Henri; Delord, Karine; Chastel, Olivier] Univ La Rochelle, CEBC, CNRS, UMR7372, F-79360 La Rochelle, France; [Goutte, Aurelie] Univ Paris 06, EPHE, CNRS, UMR 7619, F-75005 Paris, France; [Faivre, Bruno; Sorci, Gabriele] Univ Bourgogne, UMR CNRS Biogeosci 6282, F-21000 Dijon, France	University of Antwerp; University of Glasgow; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite; Universite de Bourgogne	Costantini, D (corresponding author), Univ Antwerp, Dept Biol, Univ Pl 1, B-2610 Antwerp, Belgium.	david.costantini@uantwerpen.be	Weimerskirch, Henri/F-5562-2013; Goutte, Aurelie/F-7572-2017; Barbraud, Christophe/A-5870-2012; Weimerskirch, Henri/K-7306-2019	Barbraud, Christophe/0000-0003-0146-212X; Weimerskirch, Henri/0000-0002-0457-586X; Goutte, Aurelie/0000-0001-8322-5843; Sorci, Gabriele/0000-0002-0799-3995; Costantini, David/0000-0002-8140-8790	French Polar Institute (IPEV), Terres Australes et Antarctiques Francaises, Zone Atelier de Recherches sur l'Environnement Antarctique et Subantarctique (CNRS-INEE) [109]; Agence Nationale de la Recherche (ANR STRESS OX AGE)	French Polar Institute (IPEV), Terres Australes et Antarctiques Francaises, Zone Atelier de Recherches sur l'Environnement Antarctique et Subantarctique (CNRS-INEE); Agence Nationale de la Recherche (ANR STRESS OX AGE)(French National Research Agency (ANR))	This project was supported by the French Polar Institute (IPEV, program 109, H.W.), Terres Australes et Antarctiques Francaises, Zone Atelier de Recherches sur l'Environnement Antarctique et Subantarctique (CNRS-INEE). B.F. and G.S. received financial support from the Agence Nationale de la Recherche (ANR STRESS OX & AGE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1982, ESTIMATION ANIMAL AB; Barbraud C, 2012, J ORNITHOL, V152, pS605, DOI 10.1007/s10336-011-0686-1; Beaulieu M, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot004; Beaulieu M, 2011, FUNCT ECOL, V25, P577, DOI 10.1111/j.1365-2435.2010.01825.x; Bergeron P, 2011, FUNCT ECOL, V25, P1063, DOI 10.1111/j.1365-2435.2011.01868.x; Bize P, 2008, ECOLOGY, V89, P2584, DOI 10.1890/07-1135.1; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cam E, 1998, ECOLOGY, V79, P2917, DOI 10.1890/0012-9658(1998)079[2917:AANPPT]2.0.CO;2; Noguera JC, 2012, BIOL LETTERS, V8, P61, DOI 10.1098/rsbl.2011.0756; Choquet R, 2009, ENVIRON ECOL STAT SE, V3, P845, DOI 10.1007/978-0-387-78151-8_39; Choquet R, 2009, ECOGRAPHY, V32, P1071, DOI 10.1111/j.1600-0587.2009.05968.x; Costantini D., 2014, OXIDATIVE STRESS HOR; Costantini D, 2015, CONSERV PHYSIOL, V3, DOI 10.1093/conphys/cov024; Costantini D, 2014, OECOLOGIA, V175, P1107, DOI 10.1007/s00442-014-2975-x; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Goutte A, 2011, BIOL LETTERS, V7, P790, DOI 10.1098/rsbl.2011.0196; Hunter CM, 2009, MODELING DEMOGRAPHIC, P324; Jelena A, 2013, J PHYSIOL BIOCHEM, V69, P45, DOI 10.1007/s13105-012-0186-7; Lebreton JD, 2002, J APPL STAT, V29, P353, DOI 10.1080/02664760120108638; Lecomte VJ, 2010, P NATL ACAD SCI USA, V107, P6370, DOI 10.1073/pnas.0911181107; Losdat S, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0888; Newton I, 2010, POPULATION ECOLOGY R; Pardo D, 2013, OECOLOGIA, V173, P1283, DOI 10.1007/s00442-013-2704-x; Pardo D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060389; Pradel R, 2005, BIOMETRICS, V61, P442, DOI 10.1111/j.1541-0420.2005.00318.x; Saino N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019593; Santos ESA, 2012, J EVOLUTION BIOL, V25, P1911, DOI 10.1111/j.1420-9101.2012.02569.x; Sorci G, 2009, PHILOS T R SOC B, V364, P71, DOI 10.1098/rstb.2008.0151; Stier A, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-37; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; Wegmann M, 2015, PHYSIOL BEHAV, V141, P127, DOI 10.1016/j.physbeh.2015.01.017; Weimerskirch H, 1997, BIOL CONSERV, V79, P257, DOI 10.1016/S0006-3207(96)00084-5; Weimerskirch H, 1999, P 22 INT ORN C DURB, P1178	33	18	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0133967	10.1371/journal.pone.0133967	http://dx.doi.org/10.1371/journal.pone.0133967			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275171	Green Published, gold			2022-12-26	WOS:000359493600019
J	Shin, DH; Kim, EJ; Kim, SJ; Park, JY; Oh, J				Shin, Dong Ho; Kim, Eun Jung; Kim, Soo Jin; Park, Ji-Young; Oh, Jieun			Delta Neutrophil Index as a Marker for Differential Diagnosis between Acute Graft Pyelonephritis and Acute Graft Rejection	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CRITICALLY-ILL PATIENTS; MYCOPHENOLATE-MOFETIL; RENAL-TRANSPLANTATION; INFECTION; KIDNEY; SEPSIS; PROCALCITONIN; BACTERIURIA	Introduction The delta neutrophil index (DNI) is the fraction of circulating immature granulocytes, which reflect infectious and/or septic condition. Acute graft pyelonephritis (AGPN) versus acute graft rejection is a frequently encountered diagnostic and therapeutic dilemma in kidney transplant recipients, but little is known about the clinical usefulness of DNI value in the differentiation of the two conditions. Material & Methods A total of 90 episodes of AGPN or acute graft rejection were evaluated at the Kangdong Sacred Heart Hospital between 2008 and 2014. We performed retrospective analysis of demographic, clinical, and laboratory parameters data. Receiver operating curves (ROC) and multivariate logistic regression were conducted to ascertain the utility of DNI in discriminating between AGPN and acute graft rejection. Results AGPN group had significantly higher DNI values than acute graft rejection group (2.9% vs. 1.9%, P < 0.001). The area under the ROC curve for DNI value to discriminate between AGPN and acute graft rejection was 0.85 (95% confidence interval [CI]; 0.76-0.92, P < 0.001). A DNI value of 2.7% was selected as the cut-off value for AGPN, and kidney transplant recipients with a DNI value >= 2.7% were found to be at a higher risk of infection than those with a DNI < 2.7% (odd ratio [OR] 40.50; 95% CI 8.68-189.08; P < 0.001). In a multivariate logistic regression analysis, DNI was a significant independent factor for predicting AGPN after adjusting age, sex, log WBC count, log neutorphil count, log lymphocyte count, CRP concentration, and procalcitonin concentration (OR 4.32; 95% CI 1.81-10.34, P < 0.001). Conclusions This study showed that DNI was an effective marker to differentiate between AGPN and acute graft rejection. Thus, these finding suggest that DNI may be a useful marker in the management of these patients.	[Shin, Dong Ho; Kim, Eun Jung; Kim, Soo Jin; Oh, Jieun] Hallym Univ, Kangdong Sacred Heart Hosp, Dept Internal Med, Seoul, South Korea; [Park, Ji-Young] Hallym Univ, Kangdong Sacred Heart Hosp, Dept Lab Med, Seoul, South Korea; [Oh, Jieun] Hallym Univ, Hallym Kidney Res Inst, Kangdong Sacred Heart Hosp, Dept Internal Med, Seoul, South Korea	Hallym University; Hallym University; Hallym University	Oh, J (corresponding author), Hallym Univ, Kangdong Sacred Heart Hosp, Dept Internal Med, Seoul, South Korea.	jieunmd@gmail.com	Oh, Jieun/ABA-4669-2020	Oh, Jieun/0000-0001-9429-9602				Abbott KC, 2004, AM J KIDNEY DIS, V44, P353, DOI 10.1053/j.ajkd.2004.04.040; Ansari-Lari MA, 2003, AM J CLIN PATHOL, V120, P795, DOI 10.1309/LT30BV9UJJV9CFHQ; Arnon S, 2008, CURR OPIN INFECT DIS, V21, P223, DOI 10.1097/QCO.0b013e3282fa15dd; Berthoux F, 2000, NEPHROL DIAL TRANSPL, V15, P2, DOI 10.1093/ndt/15.suppl_7.2; Chuang P, 2005, CLIN TRANSPLANT, V19, P230, DOI 10.1111/j.1399-0012.2005.00327.x; Cornbleet PJ, 2002, CLIN LAB MED, V22, P101, DOI 10.1016/S0272-2712(03)00069-6; DUTCHER TF, 1984, CLIN LAB MED, V4, P71; Fortun J, 2010, TRANSPL INFECT DIS, V12, P397, DOI 10.1111/j.1399-3062.2010.00526.x; Giral M, 2002, KIDNEY INT, V61, P1880, DOI 10.1046/j.1523-1755.2002.00323.x; Hammer S, 2000, INTENS CARE MED, V26, pS182, DOI 10.1007/BF02900735; Harbarth S, 2001, AM J RESP CRIT CARE, V164, P396, DOI 10.1164/ajrccm.164.3.2009052; Herzum I, 2008, CURR MED CHEM, V15, P581, DOI 10.2174/092986708783769704; Hooton TM, 2013, NEW ENGL J MED, V369, P1883, DOI 10.1056/NEJMoa1302186; HyunNahm C, 2008, ANN CLIN LAB SCI, V38, P241; KASS EH, 1962, ANN INTERN MED, V56, P46, DOI 10.7326/0003-4819-56-1-46; Kibe S, 2011, J ANTIMICROB CHEMOTH, V66, pII33, DOI 10.1093/jac/dkq523; Maes BD, 2004, KIDNEY INT, V65, P1842, DOI 10.1111/j.1523-1755.2004.00588.x; Ng PC, 1997, ARCH DIS CHILD-FETAL, V77, pF221, DOI 10.1136/fn.77.3.F221; Nigro KG, 2005, AM J CLIN PATHOL, V123, P618, DOI 10.1309/73H7K7UBW816PBJJ; NORDEN CW, 1968, ANNU REV MED, V19, P431, DOI 10.1146/annurev.me.19.020168.002243; Oghumu S, 2014, TRANSPLANTATION, V97, P559, DOI 10.1097/01.TP.0000441322.95539.b3; Park BH, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-299; Pethig K, 2004, J HEART LUNG TRANSPL, V23, P61, DOI 10.1016/S1053-2498(03)00097-4; Pyo JY, 2013, LUPUS, V22, P1102, DOI 10.1177/0961203313499957; Rubin RH, 1981, CLIN APPROACH INFECT, P629; Seebach JD, 1997, AM J CLIN PATHOL, V107, P582; Senthilnayagam B, 2012, PATHOLOG RES INT, V2012, DOI [10.1155/2012/483670, DOI 10.1155/2012/483670]; SHOENFELD Y, 1981, AM J MED, V71, P773, DOI 10.1016/0002-9343(81)90363-6; Their M, 2002, PEDIATR TRANSPLANT, V6, P153, DOI 10.1034/j.1399-3046.2002.01071.x; Wong BM, 2007, TRANSPLANTATION, V83, P48, DOI 10.1097/01.tp.0000248864.21574.92	30	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135819	10.1371/journal.pone.0135819	http://dx.doi.org/10.1371/journal.pone.0135819			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275220	gold, Green Submitted, Green Published			2022-12-26	WOS:000359493600120
J	Fan, L; Peng, G; Sahgal, N; Fazli, L; Gleave, M; Zhang, Y; Hussain, A; Qi, J				Fan, L.; Peng, G.; Sahgal, N.; Fazli, L.; Gleave, M.; Zhang, Y.; Hussain, A.; Qi, J.			Regulation of c-Myc expression by the histone demethylase JMJD1A is essential for prostate cancer cell growth and survival	ONCOGENE			English	Article							ANDROGEN RECEPTOR; TUMOR-SUPPRESSOR; UBIQUITIN LIGASE; GENE-EXPRESSION; STEM-CELLS; TRANSCRIPTION; PROLIFERATION; JHDM2A; OVEREXPRESSION; PROGRESSION	The histone demethylase JMJD1A, which controls gene expression by epigenetic regulation of H3K9 methylation marks, functions in diverse activities, including spermatogenesis, metabolism and stem cell self-renewal and differentiation. Here, we found that JMJD1A knockdown in prostate cancer cells antagonizes their proliferation and survival. Profiling array analyses revealed that JMJD1A-dependent genes function in cellular growth, proliferation and survival, and implicated that the c-Myc transcriptional network is deregulated following JMJD1A inhibition. Biochemical analyses confirmed that JMJD1A enhances c-Myc transcriptional activity by upregulating c-Myc expression levels. Mechanistically, JMJD1A activity promoted recruitment of androgen receptor (AR) to the c-Myc gene enhancer and induced H3K9 demethylation, increasing AR-dependent transcription of c-Myc mRNA. In parallel, we found that JMJD1A regulated c-Myc stability, likely by inhibiting HUWE1, an E3 ubiquitin ligase known to target degradation of several substrates including c-Myc. JMJD1A (wild type or mutant lacking histone demethylase activity) bound to HUWE1, attenuated HUWE1-dependent ubiquitination and subsequent degradation of c-Myc, increasing c-Myc protein levels. Furthermore, c-Myc knockdown in prostate cancer cells phenocopied effects of JMJD1A knockdown, and c-Myc re-expression in JMJD1A-knockdown cells partially rescued prostate cancer cell growth in vitro and in vivo. c-Myc protein levels were positively correlated with those of JMJD1A in a subset of human prostate cancer specimens. Collectively, our findings identify a critical role for JMJD1A in regulating proliferation and survival of prostate cancer cells by controlling c-Myc expression at transcriptional and post-translational levels.	[Fan, L.; Peng, G.; Zhang, Y.; Hussain, A.; Qi, J.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Fan, L.; Peng, G.; Hussain, A.; Qi, J.] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Fan, L.; Peng, G.; Hussain, A.; Qi, J.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Sahgal, N.] Queen Mary Univ London, Barts Canc Inst, Ctr Mol Oncol, London, England; [Fazli, L.; Gleave, M.] Univ British Columbia, Vancouver Prostate Ctr, Vancouver, BC V5Z 1M9, Canada; [Zhang, Y.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Hussain, A.] Baltimore VA Med Ctr, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of London; Queen Mary University London; University of British Columbia; University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center	Qi, J (corresponding author), Univ Maryland, Dept Biochem & Mol Biol, Marlene & Stewart Greenebaum Canc Ctr, Sch Med, 655W Baltimore St, Baltimore, MD 21201 USA.	jqi@som.umaryland.edu		qi, jianfei/0000-0001-7884-7656; Zhang, Yuji/0000-0002-5429-6762; Gleave, Martin/0000-0003-4235-0167	NCI [CA154888]; Merit Review Award Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [R00CA154888, K99CA154888] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Merit Review Award Department of Veterans Affairs; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support by NCI Grant CA154888 (to JQ) and a Merit Review Award Department of Veterans Affairs (to AH) is gratefully acknowledged.	Bush A, 1998, GENE DEV, V12, P3797, DOI 10.1101/gad.12.24.3797; Cai CM, 2011, CANCER CELL, V20, P457, DOI 10.1016/j.ccr.2011.09.001; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Chen SY, 2006, ONCOGENE, V25, P7212, DOI 10.1038/sj.onc.1209705; Cho HJ, 2014, CANCER DISCOV, V4, P318, DOI 10.1158/2159-8290.CD-13-0346; Civenni G, 2013, CANCER RES, V73, P6816, DOI 10.1158/0008-5472.CAN-13-0615; Conzen SD, 2000, MOL CELL BIOL, V20, P6008, DOI 10.1128/MCB.20.16.6008-6018.2000; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Gao LN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063563; Gil J, 2005, CANCER RES, V65, P2179, DOI 10.1158/0008-5472.CAN-03-4030; Goda S, 2013, J BIOL CHEM, V288, P36948, DOI 10.1074/jbc.M113.492595; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Gurel B, 2008, MODERN PATHOL, V21, P1156, DOI 10.1038/modpathol.2008.111; Hawksworth D, 2010, PROSTATE CANCER P D, V13, P311, DOI 10.1038/pcan.2010.31; Herkert Barbara, 2010, Genes Cancer, V1, P580, DOI 10.1177/1947601910379012; Inoue S, 2013, GENE DEV, V27, P1101, DOI 10.1101/gad.214577.113; Kim J, 2012, ONCOGENE, V31, P322, DOI 10.1038/onc.2011.236; Koh Cheryl M, 2010, Genes Cancer, V1, P617, DOI 10.1177/1947601910379132; Krieg AJ, 2010, MOL CELL BIOL, V30, P344, DOI 10.1128/MCB.00444-09; Kuroki S, 2013, SCIENCE, V341, P1106, DOI 10.1126/science.1239864; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Mimura I, 2012, MOL CELL BIOL, V32, P3018, DOI 10.1128/MCB.06643-11; Okada Y, 2007, NATURE, V450, P119, DOI 10.1038/nature06236; Osawa T, 2013, CANCER RES, V73, P3019, DOI 10.1158/0008-5472.CAN-12-3231; Ouyang X, 2008, CANCER RES, V68, P2132, DOI 10.1158/0008-5472.CAN-07-6055; Parimi V, 2014, AM J CLIN EXP UROL, V2, P273; Park SJ, 2013, BIOCHEM BIOPH RES CO, V434, P722, DOI 10.1016/j.bbrc.2013.03.091; Parrish JK, 2015, ONCOGENE, V34, P257, DOI 10.1038/onc.2013.541; Qi JF, 2010, CANCER CELL, V18, P23, DOI 10.1016/j.ccr.2010.05.024; Rajasekhar VK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1159; Rye MB, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-50; Sharma NL, 2013, CANCER CELL, V23, P35, DOI 10.1016/j.ccr.2012.11.010; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sotelo J, 2010, P NATL ACAD SCI USA, V107, P3001, DOI 10.1073/pnas.0906067107; Tao SF, 2014, MOL BIOL REP, V41, P6291, DOI 10.1007/s11033-014-3511-0; Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tee AE, 2014, ONCOTARGET, V5, P1793, DOI 10.18632/oncotarget.1785; Vaughan L, 2015, CELL REP, V10, P88, DOI 10.1016/j.celrep.2014.12.012; Wang JQ, 2012, CANCER RES, V72, P4765, DOI 10.1158/0008-5472.CAN-12-0820; Wang LZ, 2009, CANCER CELL, V16, P336, DOI 10.1016/j.ccr.2009.08.016; Wang XZ, 2014, BIOCHEM BIOPH RES CO, V444, P549, DOI 10.1016/j.bbrc.2014.01.075; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Yu CY, 2011, IN VIVO, V25, P69; Zhao XD, 2008, NAT CELL BIOL, V10, P643, DOI 10.1038/ncb1727; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009; Zhou ZF, 1997, J BIOL CHEM, V272, P8227, DOI 10.1074/jbc.272.13.8227	48	67	69	2	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 12	2016	35	19					2441	2452		10.1038/onc.2015.309	http://dx.doi.org/10.1038/onc.2015.309			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DM2GQ	26279298	Green Accepted			2022-12-26	WOS:000376165500003
J	Sunaguchi, N; Yuasa, T; Hirano, S; Gupta, R; Ando, M				Sunaguchi, Naoki; Yuasa, Tetsuya; Hirano, Shin-ichi; Gupta, Rajiv; Ando, Masami			In Vitro Validation of an Artefact Suppression Algorithm in X-Ray Phase-Contrast Computed Tomography	PLOS ONE			English	Article							DARK-FIELD; RECONSTRUCTION	X-ray phase-contrast tomography can significantly increase the contrast-resolution of conventional attenuation-contrast imaging, especially for soft-tissue structures that have very similar attenuation. Just as in attenuation-based tomography, phase contrast tomography requires a linear dependence of aggregate beam direction on the incremental direction alteration caused by individual voxels along the path of the X-ray beam. Dense objects such as calcifications in biological specimens violate this condition. There are extensive beam deflection artefacts in the vicinity of such structures because they result in large distortion of wave front due to the large difference of refractive index; for such large changes in beam direction, the transmittance of the silicon analyzer crystal saturates and is no longer linearly dependent on the angle of refraction. This paper describes a method by which these effects can be overcome and excellent soft-tissue contrast of phase tomography can be preserved in the vicinity of such artefact-producing structures.	[Sunaguchi, Naoki] Gunma Univ, Grad Sch Engn, Kiryu, Gunma, Japan; [Yuasa, Tetsuya] Yamagata Univ, Grad Sch Engn & Sci, Yonezawa, Yamagata, Japan; [Hirano, Shin-ichi] Mercian Cleantec Corp, Fujisawa, Kanagawa, Japan; [Hirano, Shin-ichi] MiZ Corp, Kamakura, Kanagawa, Japan; [Gupta, Rajiv] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Gupta, Rajiv] Harvard Univ, Sch Med, Boston, MA USA; [Ando, Masami] Tokyo Univ Sci, Res Inst Sci & Technol, Noda, Chiba 278, Japan	Gunma University; Yamagata University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Tokyo University of Science	Sunaguchi, N (corresponding author), Gunma Univ, Grad Sch Engn, Kiryu, Gunma, Japan.				KEK [2008S2-002, 2014G-002]; Japanese Ministry of Education Science and Culture [23602002, 26350494, 26750142]; Mercian Cleantec Corporation; MiZ Corporation	KEK(High Energy Accelerator Research Organization (KEK)); Japanese Ministry of Education Science and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mercian Cleantec Corporation; MiZ Corporation	The experiment was performed under the auspices of KEK (2008S2-002, 2014G-002). This work was funded by the Japanese Ministry of Education Science and Culture (TY #23602002, TY #26350494, NS #26750142)https://www.jsps.go.jp/j-grantsinaid/. At the time of the study Mercian Cleantec Corporation and MiZ Corporation provided support in the form of a salary for author SH but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ando M, 2002, JPN J APPL PHYS 2, V41, pL1016, DOI 10.1143/JJAP.41.L1016; Ando M, 2014, EUR RADIOL, V24, P423, DOI 10.1007/s00330-013-3021-9; BONSE U, 1965, APPL PHYS LETT, V6, P155, DOI 10.1063/1.1754212; Chapman D, 1997, PHYS MED BIOL, V42, P2015, DOI 10.1088/0031-9155/42/11/001; FIENUP JR, 1978, OPT LETT, V3, P27, DOI 10.1364/OL.3.000027; Ge YS, 2014, OPT EXPRESS, V22, P14246, DOI 10.1364/OE.22.014246; Intl Commission on Radiation, 1992, 46 ICRU; Kak A.V., 1988, PRINCIPLES COMPUTERI, DOI DOI 10.1137/1.9780898719277.CH7; Kashyap YS, 2008, APPL RADIAT ISOTOPES, V66, P1083, DOI 10.1016/j.apradiso.2007.12.008; Keyrilainen J, 2010, ACTA RADIOL, V51, P866, DOI 10.3109/02841851.2010.504742; Momose A, 2003, JPN J APPL PHYS 2, V42, pL866, DOI 10.1143/JJAP.42.L866; Paganin D., 2006, COHERENT XRAY OPTICS, DOI 10.1093/acprof:oso/9780198567288.001.0001; PAPOULIS A, 1975, IEEE T CIRCUITS SYST, V22, P735, DOI 10.1109/TCS.1975.1084118; Pfeiffer F, 2006, NAT PHYS, V2, P258, DOI 10.1038/nphys265; RUDIN LI, 1992, PHYSICA D, V60, P259, DOI 10.1016/0167-2789(92)90242-F; Sunaguchi N, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4824075; Sunaguchi N, 2011, OPT LETT, V36, P391, DOI 10.1364/OL.36.000391; Tapfer A, 2012, P NATL ACAD SCI USA, V109, P15691, DOI 10.1073/pnas.1207503109; Wen H, 2008, IEEE T MED IMAGING, V27, P997, DOI 10.1109/TMI.2007.912393; Wilkins SW, 1996, NATURE, V384, P335, DOI 10.1038/384335a0; Zhou W, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4890281	21	5	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135654	10.1371/journal.pone.0135654	http://dx.doi.org/10.1371/journal.pone.0135654			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295713	Green Published, Green Submitted, gold			2022-12-26	WOS:000359926900038
J	Fujisawa, TX; Jung, M; Kojima, M; Saito, DN; Kosaka, H; Tomoda, A				Fujisawa, Takashi X.; Jung, Minyoung; Kojima, Masahiko; Saito, Daisuke N.; Kosaka, Hirotaka; Tomoda, Akemi			Neural Basis of Psychological Growth following Adverse Experiences: A Resting-State Functional MRI Study	PLOS ONE			English	Article							DEFAULT MODE NETWORK; POSTTRAUMATIC-STRESS-DISORDER; ROSTRAL PREFRONTAL CORTEX; PARIETAL CORTEX; EPISODIC MEMORY; WORKING-MEMORY; CONNECTIVITY; BRAIN; INFORMATION; DEPRESSION	Over the past decade, research on the aftereffects of stressful or traumatic events has emphasized the negative outcomes from these experiences. However, the positive outcomes deriving from adversity are increasingly being examined, and such positive changes are described as posttraumatic growth (PTG). To investigate the relationship between basal whole-brain functional connectivity and PTG, we employed resting-state functional magnetic resonance imaging and analyzed the neural networks using independent component analysis in a sample of 33 healthy controls. Correlations were calculated between the network connectivity strength and the Posttraumatic Growth Inventory (PTGI) score. There were positive associations between the PTGI scores and brain activation in the rostral prefrontal cortex and superior parietal lobule (SPL) within the left central executive network (CEN) (respectively, r = 0.41, p < 0.001; r = 0.49, p < 0.001). Individuals with higher psychological growth following adverse experiences had stronger activation in prospective or working memory areas within the executive function network than did individuals with lower psychological growth (r = 0.40, p < 0.001). Moreover, we found that individuals with higher PTG demonstrated stronger connectivity between the SPL and supramarginal gyrus (SMG). The SMG is one of the brain regions associated with the ability to reason about the mental states of others, otherwise known as mentalizing. These findings suggest that individuals with higher psychological growth may have stronger functional connectivity between memory functions within the CEN and social functioning in the SMG, and that their better sociality may result from using more memory for mentalizing during their daily social interactions.	[Fujisawa, Takashi X.; Jung, Minyoung; Saito, Daisuke N.; Kosaka, Hirotaka; Tomoda, Akemi] Univ Fukui, Res Ctr Child Mental Dev, Fukui 910, Japan; [Fujisawa, Takashi X.; Jung, Minyoung; Kojima, Masahiko; Saito, Daisuke N.; Kosaka, Hirotaka; Tomoda, Akemi] Univ Fukui, United Grad Sch Child Dev, Div Dev Higher Brain Funct, Fukui 910, Japan; [Saito, Daisuke N.] Univ Fukui, Biomed Imaging Res Ctr, Fukui 910, Japan; [Kosaka, Hirotaka] Univ Fukui, Fac Med Sci, Dept Neuropsychiat, Fukui 910, Japan	University of Fukui; University of Fukui; University of Fukui; University of Fukui	Tomoda, A (corresponding author), Univ Fukui, Res Ctr Child Mental Dev, Fukui 910, Japan.	atomoda@u-fukui.ac.jp	Kosaka, Hirotaka/AFG-5500-2022; Fujisawa, Takashi/Z-4461-2019	Kosaka, Hirotaka/0000-0003-2210-5025; Jung, Minyoung/0000-0001-9188-0549	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan (KAKENHI) [24300149, 25560386]; Center of Developmental Education and Research (CORDER) [2509]; Grants-in-Aid for Scientific Research [25560386] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Center of Developmental Education and Research (CORDER); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research (B) and Challenging Exploratory Research from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan (KAKENHI, https://www.jsps.go.jp/english/index.html, grant numbers 24300149 and 25560386 to Akemi Tomoda) and by a grant from Center of Developmental Education and Research (CORDER, http://www.coder.or.jp/index.html) in Japan (grant number 2509 to Takashi X. Fujisawa). There are no conflicts of interest, including any financial, personal, or other relationships with persons or organizations, for any author related to the work described in this article.	Abu-Akel A, 2011, NEUROPSYCHOLOGIA, V49, P2971, DOI 10.1016/j.neuropsychologia.2011.07.012; Allen JG, 2006, COPING TRAUMA HOPE U; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Asukai N, 2002, J NERV MENT DIS, V190, P175, DOI 10.1097/00005053-200203000-00006; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Benoit RG, 2012, CEREB CORTEX, V22, P1876, DOI 10.1093/cercor/bhr264; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bryant RA, 2000, J ABNORM PSYCHOL, V109, P341, DOI 10.1037/0021-843X.109.2.341; Cabeza R, 2008, NAT REV NEUROSCI, V9, P613, DOI 10.1038/nrn2459; Calhoun LG, 2000, J TRAUMA STRESS, V13, P521, DOI 10.1023/A:1007745627077; CRICK F, 1995, NATURE, V375, P121, DOI 10.1038/375121a0; Daniels JK, 2010, J PSYCHIATR NEUROSCI, V35, P258, DOI 10.1503/jpn.090010; DAVIDSON RJ, 1990, J PERS SOC PSYCHOL, V58, P330, DOI 10.1037/0022-3514.58.2.330; Dekel S, 2012, PSYCHOL TRAUMA-US, V4, P94, DOI 10.1037/a0021865; Dickstein DP, 2010, BIOL PSYCHIAT, V68, P839, DOI 10.1016/j.biopsych.2010.06.029; Ellis J., 1996, PROSPECTIVE MEMORY T, P1; Eren-Kocak E, 2014, J NERV MENT DIS, V202, P859, DOI 10.1097/NMD.0000000000000211; First M. B., 1997, STRUCTURED CLIN INTE; First MB, 2002, STRUCTURED CLIN INTE; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Gilbert SJ, 2007, SOC COGN AFFECT NEUR, V2, P217, DOI 10.1093/scan/nsm014; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hull AM, 2002, BRIT J PSYCHIAT, V181, P102; Jung M, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-35; Koenigs M, 2009, J NEUROSCI, V29, P14980, DOI 10.1523/JNEUROSCI.3706-09.2009; Lewis GJ, 2014, SOC COGN AFFECT NEUR, V9, P615, DOI 10.1093/scan/nst032; Liao HY, 2012, BRAIN IMAGING BEHAV, V6, P397, DOI 10.1007/s11682-012-9154-7; McDaniel MA., 2007, PROSPECTIVE MEMORY O, DOI [10.4135/9781452225913, DOI 10.4135/9781452225913]; Morris BA, 2012, SUPPORT CARE CANCER, V20, P749, DOI 10.1007/s00520-011-1143-7; O'Donnell ML, 2007, BEHAV RES THER, V45, P601, DOI 10.1016/j.brat.2006.03.015; Polak AR, 2012, J AFFECT DISORDERS, V141, P11, DOI 10.1016/j.jad.2012.01.001; Qiu YW, 2011, RADIOLOGY, V261, P551, DOI 10.1148/radiol.11102466; Rabe S, 2006, J CONSULT CLIN PSYCH, V74, P880, DOI 10.1037/0022-006X.74.5.880; Raichle ME, 2011, BRAIN CONNECT, V1, P3, DOI 10.1089/brain.2011.0019; Satterthwaite TD, 2013, NEUROIMAGE, V64, P240, DOI 10.1016/j.neuroimage.2012.08.052; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sestieri C, 2011, J NEUROSCI, V31, P4407, DOI 10.1523/JNEUROSCI.3335-10.2011; Shakespeare-Finch J, 2014, J ANXIETY DISORD, V28, P223, DOI 10.1016/j.janxdis.2013.10.005; Shakespeare-Finch J, 2010, J LOSS TRAUMA, V15, P69, DOI 10.1080/15325020903373151; Taku K, 2007, ANXIETY STRESS COPIN, V20, P353, DOI 10.1080/10615800701295007; Taku K, 2009, ANXIETY STRESS COPIN, V22, P129, DOI 10.1080/10615800802317841; Tedeschi R.G., 1995, TRAUMA TRANSFORMATIO, V1st; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; Uddin LQ, 2013, JAMA PSYCHIAT, V70, P869, DOI 10.1001/jamapsychiatry.2013.104; Uddin LQ, 2011, J NEUROSCI, V31, P18578, DOI 10.1523/JNEUROSCI.4465-11.2011; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; Urry HL, 2004, PSYCHOL SCI, V15, P367, DOI 10.1111/j.0956-7976.2004.00686.x; Veer IM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00041; Vranceanu AM, 2007, CHILD ABUSE NEGLECT, V31, P71, DOI 10.1016/j.chiabu.2006.04.010; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Weber DL, 2005, PSYCHIAT RES-NEUROIM, V140, P27, DOI 10.1016/j.pscychresns.2005.07.003; Weiss D. S., 2007, ASSESSING PSYCHOL TR, P219, DOI [10.1007/978-0-387-70990-1_10, DOI 10.1007/978-0-387-70990-1_10]; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yonemoto T, 2009, ANTICANCER RES, V29, P4287	62	15	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136427	10.1371/journal.pone.0136427	http://dx.doi.org/10.1371/journal.pone.0136427			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291449	gold, Green Submitted, Green Published			2022-12-26	WOS:000359919900082
J	Wang, H; Gao, JE; Li, XH; Zhang, SL; Wang, HJ				Wang, Hong; Gao, Jian-en; Li, Xing-hua; Zhang, Shao-long; Wang, Hong-jie			Nitrate Accumulation and Leaching in Surface and Ground Water Based on Simulated Rainfall Experiments	PLOS ONE			English	Article							KINETIC-ENERGY RELATIONSHIPS; FLOW SYSTEM; AGRICULTURE; POLLUTION; NITROGEN; RECHARGE; MANAGEMENT; INTENSITY; CHINA; PRECIPITATION	To evaluate the process of nitrate accumulation and leaching in surface and ground water, we conducted simulated rainfall experiments. The experiments were performed in areas of 5.3 m(2) with bare slopes of 3 degrees that were treated with two nitrogen fertilizer inputs, high (22.5 g/m(2) NH4NO3) and control (no fertilizer), and subjected to 2 hours of rainfall, with. From the 1st to the 7th experiments, the same content of fertilizer mixed with soil was uniformly applied to the soil surface at 10 minutes before rainfall, and no fertilizer was applied for the 8th through 12th experiments. Initially, the time-series nitrate concentration in the surface flow quickly increased, and then it rapidly decreased and gradually stabilized at a low level during the fertilizer experiments. The nitrogen loss in the surface flow primarily occurred during the first 18.6 minutes of rainfall. For the continuous fertilizer experiments, the mean nitrate concentrations in the groundwater flow remained at less than 10 mg/L before the 5th experiment, and after the 7th experiment, these nitrate concentrations were greater than 10 mg/L throughout the process. The time-series process of the changing concentration in the groundwater flow exhibited the same parabolic trend for each fertilizer experiment. However, the time at which the nitrate concentration began to change lagged behind the start time of groundwater flow by approximately 0.94 hours on average. The experiments were also performed with no fertilizer. In these experiments, the mean nitrate concentration of groundwater initially increased continuously, and then, the process exhibited the same parabolic trend as the results of the fertilization experiments. The nitrate concentration decreased in the subsequent experiments. Eight days after the 12 rainfall experiments, 50.53% of the total nitrate applied remained in the experimental soil. Nitrate residues mainly existed at the surface and in the bottom soil layers, which represents a potentially more dangerous pollution scenario for surface and ground water. The surface and subsurface flow would enter into and contaminate water bodies, thus threatening the water environment.	[Wang, Hong; Gao, Jian-en] Chinese Acad Sci, Inst Soil & Water Conservat, Yangling, Shaanxi Provinc, Peoples R China; [Wang, Hong; Gao, Jian-en] Minist Water Resources, Yangling, Shaanxi Provinc, Peoples R China; [Gao, Jian-en] Northwest A&F Univ, Inst Soil & Water Conservat, Yangling, Shaanxi Provinc, Peoples R China; [Wang, Hong] Univ Chinese Acad Sci, Beijing, Peoples R China; [Gao, Jian-en; Li, Xing-hua; Zhang, Shao-long; Wang, Hong-jie] Northwest A&F Univ, Coll Water Resources & Architectural Engn, Yangling, Shaanxi Provinc, Peoples R China	Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Ministry of Water Resources; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Northwest A&F University - China; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Northwest A&F University - China	Gao, JE (corresponding author), Chinese Acad Sci, Inst Soil & Water Conservat, Yangling, Shaanxi Provinc, Peoples R China.	gaojianen@126.com			Natural Science Foundation of China [41371276, 51309194]; National Technology Support Project [2011BAD31B05]; Science and Technology Project of Shaanxi Province [2013KTDZ03-03-01]; Subject of National Science and Technology Major Project [2009ZX07212-002-003-02]; Knowledge Innovation Project of Institute of Soil and Water Conservation, CAS MWR [A315021304]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Technology Support Project; Science and Technology Project of Shaanxi Province; Subject of National Science and Technology Major Project; Knowledge Innovation Project of Institute of Soil and Water Conservation, CAS MWR	This paper was supported by Natural Science Foundation of China (41371276, 51309194), by National Technology Support Project (2011BAD31B05), by Science and Technology Project of Shaanxi Province (2013KTDZ03-03-01), by the Subject of National Science and Technology Major Project (2009ZX07212-002-003-02) and by Knowledge Innovation Project of Institute of Soil and Water Conservation, CAS & MWR (A315021304).	Addiscott T.M., 1991, FARMING FERTILIZERS; Almasri MN, 2004, J HYDROL, V295, P225, DOI 10.1016/j.jhydrol.2004.03.013; Archna, 2012, E-J CHEM, V9, P1667, DOI 10.1155/2012/154616; Ator S.W., 1997, NITRATE SELECTED PES; Bakhsh A, 2000, T ASAE, V43, P69, DOI 10.13031/2013.2689; Bengtson RL, 1984, T AM SOC AGR ENG, V27; Boers PCM, 1996, WATER SCI TECHNOL, V33, P183, DOI 10.1016/0273-1223(96)00229-6; Cerda A, 1997, SOIL TECHNOL, V11, P163, DOI 10.1016/S0933-3630(96)00135-3; Chen J, 2005, HYDROGEOL J, V13, P481, DOI 10.1007/s10040-004-0321-9; Chen XiaoMin, 2001, China Environmental Science, V21, P481; CORTAS NK, 1990, CLIN CHEM, V36, P1440; Dourson M, 1991, NATO ASI SER G, V30, P477; Dragon K, 2013, ENVIRON EARTH SCI, V68, P2099, DOI 10.1007/s12665-012-1895-5; Eigel J.D., 1983, EFFECT RAINFALL ENER; EIGEL JD, 1983, T ASAE, V26, P1079; Elrashidi MA, 2015, COMMUN SOIL SCI PLAN, V46, P16, DOI 10.1080/00103624.2014.956883; EPAU, 1996, DRINK WAT REG HLTH A; Fan J, 2010, CAN J SOIL SCI, V90, P429, DOI 10.4141/CJSS09105; [冯绍元 Feng Shaoyuan], 2010, [灌溉排水学报, Journal of Irrigation and Drainage], V29, P11; Fennessy MS, 1997, CRIT REV ENV SCI TEC, V27, P285, DOI 10.1080/10643389709388502; Groves SJ, 2004, SOIL USE MANAGE, V20, P96, DOI 10.1079/SUM2003229; Hall MD, 2001, J AM WATER RESOUR AS, V37, P139, DOI 10.1111/j.1752-1688.2001.tb05481.x; HALLBERG GR, 1987, RURAL GROUNDWATER CO; Hanson C., 2002, NITRATE CONCENTRATIO; Heathwaite AL, 1996, HYDROL PROCESS, V10, P263, DOI 10.1002/(SICI)1099-1085(199602)10:2&lt;263::AID-HYP441&gt;3.0.CO;2-K; Hu CX, 1993, CHINESE J SOIL SCI, V24, P118; Huang M. X., 2001, SOIL ENV SCI, V10, P6; Hudak PF, 2000, J HYDROL, V228, P37, DOI 10.1016/S0022-1694(99)00206-1; Hunag RH, 2004, STUDY SIMULATING EXP; Kaufmann V, 2014, J CONTAM HYDROL, V160, P53, DOI 10.1016/j.jconhyd.2014.02.005; KINNELL PIA, 1981, SOIL SCI SOC AM J, V45, P153, DOI 10.2136/sssaj1981.03615995004500010033x; Kronvang B, 1996, WATER SCI TECHNOL, V33, P81, DOI 10.1016/0273-1223(96)00217-X; LEE YW, 1992, J WATER RES PL-ASCE, V118, P151, DOI 10.1061/(ASCE)0733-9496(1992)118:2(151); Liang XQ, 2011, PHYS CHEM EARTH, V36, P395, DOI 10.1016/j.pce.2010.03.017; Line DE, 1998, WATER ENVIRON RES, V70, P895, DOI 10.2175/106143098X134514; Liu BZ, 1997, THE SOIL EROSION; Meisinger JJ, 2002, J SOIL WATER CONSERV, V57, P485; Misiti TM, 2011, WATER RES, V45, P5587, DOI 10.1016/j.watres.2011.08.019; Narula KK, 2013, SCI TOTAL ENVIRON, V468, pS102, DOI 10.1016/j.scitotenv.2013.01.022; Neal C, 2000, SCI TOTAL ENVIRON, V251, P5, DOI 10.1016/S0048-9697(00)00410-1; Neal C, 2000, SCI TOTAL ENVIRON, V251, P441, DOI 10.1016/S0048-9697(00)00398-3; Nolan BT, 2002, ENVIRON SCI TECHNOL, V36, P2138, DOI 10.1021/es0113854; Randall GW, 1997, J ENVIRON QUAL, V26, P1240, DOI 10.2134/jeq1997.00472425002600050007x; RANDALL GW, 1995, J ENVIRON QUAL, V24, P360, DOI 10.2134/jeq1995.00472425002400020020x; Rodvang SJ, 2001, HYDROGEOL J, V9, P44; SAFFIGNA PG, 1977, GROUND WATER, V15, P170, DOI 10.1111/j.1745-6584.1977.tb03162.x; Sanford W, 2002, HYDROGEOL J, V10, P110, DOI 10.1007/s10040-001-0173-5; SCHEPERS JS, 1991, MANAGING NITROGEN FOR GROUNDWATER QUALITY AND FARM PROFITABILITY, P125; Sha RD, 1997, CORPUS SHAYUQING; Sha YQ, 1956, SEDIMENT RES, V1, P1; Shu R.J., 2006, SCI SOIL WATER CONSE, V4, P65; SPALDING RF, 1993, J ENVIRON QUAL, V22, P392, DOI 10.2134/jeq1993.00472425002200030002x; van Dijk AIJM, 2002, J HYDROL, V261, P1, DOI 10.1016/S0022-1694(02)00020-3; Wang H, 2015, CATENA, V127, P80, DOI 10.1016/j.catena.2014.12.014; Wang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079103; Wang HY, 2010, AGR WATER MANAGE, V97, P1646, DOI 10.1016/j.agwat.2010.05.022; Wang SL, 2008, MODELING NITROGEN TR; Wang WK., 2006, GROUNDWATER ENV EVOL; Wang Z, 2014, AGR WATER MANAGE, V142, P19, DOI 10.1016/j.agwat.2014.04.013; WISCHMEIER WALTER H., 1958, TRANS AMER GEOPHYS UNION, V39, P285; Wolfe AH, 2002, AMBIO, V31, P120, DOI 10.1639/0044-7447(2002)031[0120:RNAHHA]2.0.CO;2; Wriedt G, 2007, J HYDROL, V343, P154, DOI 10.1016/j.jhydrol.2007.06.010; WYLIE BK, 1995, WATER RESOUR BULL, V31, P399; [谢红梅 Xie Hongmei], 2003, [生态环境, Ecology and Environment], V12, P349; Yakovlev V, 2015, APPL GEOCHEM, V53, P71, DOI 10.1016/j.apgeochem.2014.12.009; Yi X., 1993, AGROENVIRONMENTAL PR, V12, P250; Zhang Qingzhong, 2002, Yingyong Shengtai Xuebao, V13, P233; Zhang W. L., 1995, PLANT NUTR FERTILIZE, V1, P80; Zhang WL, 1996, AGR ECOSYST ENVIRON, V59, P223, DOI 10.1016/0167-8809(96)01052-3; Zhang X., 2000, ACTA GEOGRAPHICAL SI, V55, P617	70	29	30	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136274	10.1371/journal.pone.0136274	http://dx.doi.org/10.1371/journal.pone.0136274			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291616	Green Published, gold, Green Submitted			2022-12-26	WOS:000359919900073
J	Liu, ZY; Liu, J; Li, L; Nie, D; Tao, QL; Wu, J; Fan, JJ; Lin, C; Zhao, SW; Ju, DW				Liu, Zhongyu; Liu, Jun; Li, Li; Nie, Dan; Tao, Qilei; Wu, Jian; Fan, Jiajun; Lin, Chen; Zhao, Shuwei; Ju, Dianwen			Inhibition of Autophagy Potentiated the Antitumor Effect of Nedaplatin in Cisplatin-Resistant Nasopharyngeal Carcinoma Cells	PLOS ONE			English	Article							OVARIAN-CANCER CELLS; PLATINUM COMPLEXES; INDUCED APOPTOSIS; ROS GENERATION; STEM-CELLS; THERAPY; CHEMORADIOTHERAPY; CHEMOTHERAPY; RADIOTHERAPY; ACTIVATION	Nedaplatin, a cisplatin analog, was developed to reduce the toxicity of cisplatin, whereas it can be cross-resistant with cisplatin in some circumstances. This study aimed to investigate the role of autophagy in nedaplatin induced cell death in cisplatin-resistant nasopharyngeal carcinoma cells. Here, we showed that HNE1/DDP and CNE2/DDP cells were resistant to nedaplatin-induced cell death with reduced apoptotic activity. Nedaplatin treatment resulted in autophagosome accumulation and increased expression of LC3-II, indicating the induction of autophagy by nedaplatin in HNE1/DDP and CNE2/DDP cells. Inhibition of autophagy by Bafilomycin A1 (Baf A1) and 3-Methyladenine (3-MA) remarkably enhanced the antitumor efficacy of nedaplatin in HNE1/DDP and CNE2/DDP cells, suggesting that the resistance to nedaplatin-induced cell death was caused by enhanced autophagy in nedaplatin-resistant NPC cells. Additionally, Baf A1 enhanced reactive oxygen species (ROS) generation and apoptosis induced by nedaplatin in HNE1/DDP cells. Mechanistically, nedaplatin treatment caused activation of ERK1/2 and suppression of Akt/mTOR signaling pathways. While inhibition of ERK1/2 by MEK1/2 inhibitor, U0126, could reduce the expression of LC3-II in nedaplatin-resistant NPC cells. Furthermore, suppression of ROS could inhibit nedaplatin-induced ERK activation in HNE1/DDP cells, indicating that ROS and ERK were involved in nedaplatin-induced autophagy. Together, these findings suggested that autophagy played a cytoprotective role in nedaplatin-induced cytotoxicity of HNE1/DDP and CNE2/DDP cells. Furthermore, our results highlighted a potential approach to restore the sensitivity of cisplatin-resistant nasopharyngeal cancer cells to nedaplatin in combination with autophagy inhibitors.	[Liu, Zhongyu; Li, Li; Tao, Qilei; Wu, Jian; Lin, Chen; Zhao, Shuwei] Second Mil Med Univ, Changzheng Hosp, Dept Otolaryngol Head & Neck Surg, Shanghai, Peoples R China; [Liu, Jun] W Virginia Univ, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA; [Nie, Dan] Tradit Chinese Med Hosp Guangdong Prov, Dept Otolaryngol, Guangzhou, Guangdong, Peoples R China; [Fan, Jiajun; Ju, Dianwen] Fudan Univ, Sch Pharm, Dept Biosynth, Shanghai 200433, Peoples R China	Naval Medical University; West Virginia University; Guangzhou University of Chinese Medicine; Fudan University	Zhao, SW (corresponding author), Second Mil Med Univ, Changzheng Hosp, Dept Otolaryngol Head & Neck Surg, Shanghai, Peoples R China.	zhaoshw@live.cn; dianwenju@fudan.edu.cn			National Key Basic Research Program of China [2015CB931800]; Shanghai Science and Technology Commission [13431900303]; Shanghai Health and Family Planning Commission [2013012]	National Key Basic Research Program of China(National Basic Research Program of China); Shanghai Science and Technology Commission(Science & Technology Commission of Shanghai Municipality (STCSM)Shanghai Science & Technology Committee); Shanghai Health and Family Planning Commission	This study was supported by funds from National Key Basic Research Program of China (2015CB931800), Shanghai Science and Technology Commission (13431900303); and Shanghai Health and Family Planning Commission (2013012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sarraf M, 1998, J CLIN ONCOL, V16, P1310, DOI 10.1200/JCO.1998.16.4.1310; Alberto ME, 2009, J PHYS CHEM B, V113, P14473, DOI 10.1021/jp9056835; ALSARRAF M, 1990, J CLIN ONCOL, V8, P1342, DOI 10.1200/JCO.1990.8.8.1342; Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Bhogal RH, 2012, AUTOPHAGY, V8, P545, DOI 10.4161/auto.19012; Bhutia SK, 2013, ADV CANCER RES, V118, P61, DOI 10.1016/B978-0-12-407173-5.00003-0; Botta G, 2012, HUM GENE THER, V23, P623, DOI 10.1089/hum.2011.120; Chen YQ, 2008, AUTOPHAGY, V4, P246, DOI 10.4161/auto.5432; Corcelle E, 2007, AUTOPHAGY, V3, P57, DOI 10.4161/auto.3424; Friesen C, 1999, LEUKEMIA, V13, P1854, DOI 10.1038/sj.leu.2401333; Friesen C, 1997, LEUKEMIA, V11, P1833, DOI 10.1038/sj.leu.2400827; FUKUDA M, 1995, ANTICANCER RES, V15, P393; Guan JL, 2013, AUTOPHAGY, V9, P830, DOI 10.4161/auto.24132; Guo XL, 2012, CANCER LETT, V320, P171, DOI 10.1016/j.canlet.2012.03.002; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Hou J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.338; Jia WH, 2012, SEMIN CANCER BIOL, V22, P117, DOI 10.1016/j.semcancer.2012.01.009; Kano G, 2013, J ALLERGY CLIN IMMUN, V132, P437, DOI 10.1016/j.jaci.2013.03.024; Kawai Y, 2005, BIOL PHARM BULL, V28, P1385, DOI 10.1248/bpb.28.1385; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kong DJ, 2012, BIOMED PHARMACOTHER, V66, P271, DOI 10.1016/j.biopha.2011.12.002; Lebwohl D, 1998, EUR J CANCER, V34, P1522, DOI 10.1016/S0959-8049(98)00224-X; Lee AWM, 2012, SEMIN RADIAT ONCOL, V22, P233, DOI 10.1016/j.semradonc.2012.03.008; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Ma XH, 2014, J CLIN INVEST, V124, P1406, DOI 10.1172/JCI70454; Marullo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081162; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; O'Donovan TR, 2011, AUTOPHAGY, V7, P509, DOI 10.4161/auto.7.5.15066; Ouyang L, 2012, CELL PROLIFERAT, V45, P487, DOI 10.1111/j.1365-2184.2012.00845.x; Peng PJ, 2013, CANCER CHEMOTH PHARM, V72, P323, DOI 10.1007/s00280-013-2203-0; Rosenfeldt MT, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001306; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Saiki S, 2011, AUTOPHAGY, V7, P176, DOI 10.4161/auto.7.2.14074; SASAKI Y, 1989, CANCER CHEMOTH PHARM, V23, P243, DOI 10.1007/BF00451649; Sciarretta S, 2014, AUTOPHAGY, V10, P699, DOI 10.4161/auto.27955; Shinojima N, 2007, AUTOPHAGY, V3, P635, DOI 10.4161/auto.4916; Sirichanchuen B, 2012, MOL CELL BIOCHEM, V364, P11, DOI 10.1007/s11010-011-1199-1; Son Yong, 2011, J Signal Transduct, V2011, P792639, DOI 10.1155/2011/792639; Tonino SH, 2011, ONCOGENE, V30, P701, DOI 10.1038/onc.2010.441; Wan XB, 2010, AUTOPHAGY, V6, P395, DOI 10.4161/auto.6.3.11303; Wangpaichitr Medhi, 2009, Cancers (Basel), V1, P23; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Xu JH, 2014, HEAD NECK-J SCI SPEC, V36, P1474, DOI 10.1002/hed.23487; Yu H, 2011, EUR J CANCER, V47, P1585, DOI 10.1016/j.ejca.2011.01.019; Zheng JJ, 2010, JPN J CLIN ONCOL, V40, P425, DOI 10.1093/jjco/hyp183	46	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135236	10.1371/journal.pone.0135236	http://dx.doi.org/10.1371/journal.pone.0135236			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288183	Green Published, gold, Green Submitted			2022-12-26	WOS:000360018600041
J	Ramanoel, S; Kauffmann, L; Cousin, E; Dojat, M; Peyrin, C				Ramanoel, Stephen; Kauffmann, Louise; Cousin, Emilie; Dojat, Michel; Peyrin, Carole			Age-Related Differences in Spatial Frequency Processing during Scene Categorization	PLOS ONE			English	Article							CONTRAST SENSITIVITY DECLINE; TO-FINE CATEGORIZATION; MACULAR DEGENERATION; GLOBAL PRECEDENCE; VISUAL SCENES; RECOGNITION; CORTEX; PREVALENCE; STATISTICS; ATTENTION	Visual analysis of real-life scenes starts with the parallel extraction of different visual elementary features at different spatial frequencies. The global shape of the scene is mainly contained in low spatial frequencies (LSF), and the edges and borders of objects are mainly contained in high spatial frequencies (HSF). The present fMRI study investigates the effect of age on the spatial frequency processing in scenes. Young and elderly participants performed a categorization task (indoor vs. outdoor) on LSF and HSF scenes. Behavioral results revealed performance degradation for elderly participants only when categorizing HSF scenes. At the cortical level, young participants exhibited retinotopic organization of spatial frequency processing, characterized by medial activation in the anterior part of the occipital lobe for LSF scenes (compared to HSF), and the lateral activation in the posterior part of the occipital lobe for HSF scenes (compared to LSF). Elderly participants showed activation only in the anterior part of the occipital lobe for LSF scenes (compared to HSF), but not significant activation for HSF (compared to LSF). Furthermore, a ROI analysis revealed that the parahippocampal place area, a scene-selective region, was less activated for HSF than LSF for elderly participants only. Comparison between groups revealed greater activation of the right inferior occipital gyrus in young participants than in elderly participants for HSF. Activation of temporo-parietal regions was greater in elderly participants irrespective of spatial frequencies. The present findings indicate a specific low-contrasted HSF deficit for normal elderly people, in association with an occipito-temporal cortex dysfunction, and a functional reorganization of the categorization of filtered scenes.	[Ramanoel, Stephen; Kauffmann, Louise; Cousin, Emilie; Peyrin, Carole] Univ Grenoble Alpes, LPNC, F-38000 Grenoble, France; [Ramanoel, Stephen; Kauffmann, Louise; Cousin, Emilie; Peyrin, Carole] CNRS, LPNC, F-38000 Grenoble, France; [Ramanoel, Stephen; Dojat, Michel] Univ Grenoble Alpes, GIN, F-38000 Grenoble, France; [Cousin, Emilie] UMS IRMaGe, F-38000 Grenoble, France; [Dojat, Michel] INSERM U836, GIN, F-38000 Grenoble, France	Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CEA; Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Peyrin, C (corresponding author), Univ Grenoble Alpes, LPNC, F-38000 Grenoble, France.	carole.peyrin@upmf-grenoble.fr	Dojat, Michel/G-7758-2011; Ramanoel, Stephen/AAB-5080-2022	Dojat, Michel/0000-0003-2747-6845; Ramanoel, Stephen/0000-0003-4735-1097; Peyrin, Carole/0000-0001-7792-092X	Agence Nationale pour la Recherche [ANR-12-JHS2-0002-01 RECOR]; French program "Investissement d'Avenir" [ANR-11-INBS-0006]	Agence Nationale pour la Recherche(French National Research Agency (ANR)); French program "Investissement d'Avenir"(French National Research Agency (ANR))	This work was supported by Agence Nationale pour la Recherche grant ANR-12-JHS2-0002-01 RECOR. Grenoble MRI facility IRMaGE was partly funded by the French program "Investissement d'Avenir" run by the "Agence Nationale pour la Recherche": Grant "Infrastructure d'Avenir en Biologie Sante" (ANR-11-INBS-0006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams S, 2003, HUM BRAIN MAPP, V20, P29, DOI 10.1002/hbm.10126; Aminoff E, 2007, CEREB CORTEX, V17, P1493, DOI 10.1093/cercor/bhl078; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; BADCOCK JC, 1990, PERCEPTION, V19, P617, DOI 10.1068/p190617; Bar M, 2008, J NEUROSCI, V28, P8539, DOI 10.1523/JNEUROSCI.0987-08.2008; Bex PJ, 2002, J OPT SOC AM A, V19, P1096, DOI 10.1364/JOSAA.19.001096; BREITMEYER B, 1975, VISION RES, V15, P411, DOI 10.1016/0042-6989(75)90090-5; Brewer Alyssa A, 2012, Health (Irvine Calif), V4, P695; Brewer AA, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00074; BROWN B, 1993, OPTOMETRY VISION SCI, V70, P45, DOI 10.1097/00006324-199301000-00009; Bruyer R, 2000, EXP AGING RES, V26, P285, DOI 10.1080/036107300750015705; Bullier J, 2001, BRAIN RES REV, V36, P96, DOI 10.1016/S0165-0173(01)00085-6; Cabeza R, 2002, CURRENT OPINION NEUR, V13, P415; Crossland MD, 2008, INVEST OPHTH VIS SCI, V49, P3734, DOI 10.1167/iovs.07-1621; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; de Fockert JW, 2009, BRAIN RES, V1282, P67, DOI 10.1016/j.brainres.2009.05.060; Downing PE, 2006, CEREB CORTEX, V16, P1453, DOI 10.1093/cercor/bhj086; ELLIOTT D, 1990, VISION RES, V30, P541, DOI 10.1016/0042-6989(90)90066-T; ELLIOTT DB, 1987, OPHTHAL PHYSL OPT, V7, P415, DOI 10.1111/j.1475-1313.1987.tb00771.x; ELLIOTT DB, 1995, OPTOMETRY VISION SCI, V72, P186, DOI 10.1097/00006324-199503000-00006; Elliott SL, 2010, J VISION, V10, DOI 10.1167/10.4.4; Epstein R, 2003, NEURON, V37, P865, DOI 10.1016/S0896-6273(03)00117-X; Epstein R, 1999, NEURON, V23, P115, DOI 10.1016/S0896-6273(00)80758-8; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Epstein RA, 2005, VIS COGN, V12, P954, DOI 10.1080/13506280444000607; Epstein RA, 2007, J NEUROPHYSIOL, V97, P3670, DOI 10.1152/jn.00003.2007; Epstein RA, 2010, CEREB CORTEX, V20, P294, DOI 10.1093/cercor/bhp099; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Friedman L, 1998, BRAIN LANG, V64, P231, DOI 10.1006/brln.1998.1953; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Geerligs L, 2014, NEUROIMAGE, V91, P52, DOI 10.1016/j.neuroimage.2014.01.029; Gerlach C, 2000, NEUROPSYCHOLOGIA, V38, P1693, DOI 10.1016/S0028-3932(00)00082-8; GINSBURG AP, 1986, HDB PERCEPTION HUMAN, V2, P1; GITTINGS NS, 1986, EXP GERONTOL, V21, P423, DOI 10.1016/0531-5565(86)90047-1; Glascher J, 2008, CONTRAST WEIGH UNPUB; Guyader N, 2004, CR BIOL, V327, P313, DOI 10.1016/j.crvi.2004.02.006; Hardy JL, 2005, J OPT SOC AM A, V22, P49, DOI 10.1364/JOSAA.22.000049; Haring AE, 2013, BRAIN RES, V1499, P69, DOI 10.1016/j.brainres.2013.01.003; Henriksson L, 2008, J VISION, V8, DOI 10.1167/8.10.5; HIGGINS KE, 1988, J OPT SOC AM A, V5, P2173, DOI 10.1364/JOSAA.5.002173; Hughes HC, 1996, J COGNITIVE NEUROSCI, V8, P197, DOI 10.1162/jocn.1996.8.3.197; Kauffmann L, 2015, NEUROIMAGE, V112, P86, DOI 10.1016/j.neuroimage.2015.02.058; Kauffmann L, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00037; Klein R, 2011, ARCH OPHTHALMOL-CHIC, V129, P75, DOI 10.1001/archophthalmol.2010.318; LAMB MR, 1993, PERCEPT PSYCHOPHYS, V54, P773, DOI 10.3758/BF03211802; Lemaitre H, 2005, NEUROIMAGE, V26, P900, DOI 10.1016/j.neuroimage.2005.02.042; Lux S, 2008, CORTEX, V44, P21, DOI 10.1016/j.cortex.2005.08.001; Marchand WR, 2011, NEUROIMAGE, V55, P194, DOI 10.1016/j.neuroimage.2010.12.030; Mummery CJ, 1998, J COGNITIVE NEUROSCI, V10, P766, DOI 10.1162/089892998563059; Musel B, 2014, J COGNITIVE NEUROSCI, V26, P2287, DOI 10.1162/jocn_a_00643; Musel B, 2013, J COGNITIVE NEUROSCI, V25, P1315, DOI 10.1162/jocn_a_00397; Musel B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038493; Musel B, 2011, VISUAL NEUROSCI, V28, P529, DOI 10.1017/S0952523811000435; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; Oken BS, 1999, J GERIATR PSYCH NEUR, V12, P76, DOI 10.1177/089198879901200207; OWSLEY C, 1983, VISION RES, V23, P689, DOI 10.1016/0042-6989(83)90210-9; Owsley C, 2011, VISION RES, V51, P1610, DOI 10.1016/j.visres.2010.10.020; Palmer S, 1993, UNDERSTANDING VISION, P39; Park D. C., 1999, COGNITIVE AGING PRIM; Park DC, 2002, PSYCHOL AGING, V17, P299, DOI 10.1037//0882-7974.17.2.299; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Parker DM, 1996, J EXP PSYCHOL HUMAN, V22, P1448, DOI 10.1037/0096-1523.22.6.1448; Peyrin C, 2004, NEUROIMAGE, V23, P698, DOI 10.1016/j.neuroimage.2004.06.020; Peyrin C, 2010, J COGNITIVE NEUROSCI, V22, P2768, DOI 10.1162/jocn.2010.21424; Pokorny J, 1997, J OPT SOC AM A, V14, P2477, DOI 10.1364/JOSAA.14.002477; Rajimehr R, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000608; Rosenholtz R, 2007, J VISION, V7, DOI 10.1167/7.2.17; Roux F, 2001, BRAIN COGNITION, V46, P383, DOI 10.1006/brcg.2001.1296; Rubin GS, 1997, INVEST OPHTH VIS SCI, V38, P557; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Sasaki Y, 2001, P NATL ACAD SCI USA, V98, P2077, DOI 10.1073/pnas.98.4.2077; SCHYNS PG, 1994, PSYCHOL SCI, V5, P195, DOI 10.1111/j.1467-9280.1994.tb00500.x; SEKULER R, 1980, SCIENCE, V209, P1255, DOI 10.1126/science.7403884; SHULMAN GL, 1986, PERCEPTION, V15, P259, DOI 10.1068/p150259; Staudinger MR, 2011, CORTEX, V47, P854, DOI 10.1016/j.cortex.2010.08.001; Szlyk JP, 2009, INVEST OPHTH VIS SCI, V50, P4487, DOI 10.1167/iovs.08-2258; Talairach J., 1988, COPLANAR STEREOTAXIC; Thioux M, 2005, COGNITIVE BRAIN RES, V24, P284, DOI 10.1016/j.cogbrainres.2005.02.009; Torralba A, 2003, NETWORK-COMP NEURAL, V14, P391, DOI 10.1088/0954-898X/14/3/302; Van Essen David C., 1995, P383; Viggiano MP, 2006, ARCH GERONTOL GERIAT, V42, P329, DOI 10.1016/j.archger.2005.08.003; VINGERLING JR, 1995, OPHTHALMOLOGY, V102, P205; Willenbockel V, 2010, J EXP PSYCHOL HUMAN, V36, P122, DOI 10.1037/a0016465	85	16	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0134554	10.1371/journal.pone.0134554	http://dx.doi.org/10.1371/journal.pone.0134554			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288146	Green Published, Green Submitted, gold			2022-12-26	WOS:000360018600025
J	Wang, ZW; Katsaros, D; Shen, Y; Fu, YY; Canuto, EM; Benedetto, C; Lu, LG; Chu, WM; Risch, HA; Yu, H				Wang, Zhanwei; Katsaros, Dionyssios; Shen, Yi; Fu, Yuanyuan; Canuto, Emilie Marion; Benedetto, Chiara; Lu, Lingeng; Chu, Wen-Ming; Risch, Harvey A.; Yu, Herbert			Biological and Clinical Significance of MAD2L1 and BUB1, Genes Frequently Appearing in Expression Signatures for Breast Cancer Prognosis	PLOS ONE			English	Article							MITOTIC CHECKPOINT GENES; CHROMOSOMAL INSTABILITY; CELL-PROLIFERATION; BIOINFORMATICS; ANEUPLOIDY; OVEREXPRESSION; INACTIVATION; METASTASIS; RECURRENCE; POPULATION	To investigate the biologic relevance and clinical implication of genes involved in multiple gene expression signatures for breast cancer prognosis, we identified 16 published gene expression signatures, and selected two genes, MAD2L1 and BUB1. These genes appeared in 5 signatures and were involved in cell-cycle regulation. We analyzed the expression of these genes in relation to tumor features and disease outcomes. In vitro experiments were also performed in two breast cancer cell lines, MDA-MB-231 and MDA-MB-468, to assess cell proliferation, migration and invasion after knocking down the expression of these genes. High expression of these genes was found to be associated with aggressive tumors and poor disease-free survival of 203 breast cancer patients in our study, and the association with survival was confirmed in an online database consisting of 914 patients. In vitro experiments demonstrated that lowering the expression of these genes by siRNAs reduced tumor cell growth and inhibited cell migration and invasion. Our investigation suggests that MAD2L1 and BUB1 may play important roles in breast cancer progression, and measuring the expression of these genes may assist the prediction of breast cancer prognosis.	[Wang, Zhanwei; Shen, Yi; Fu, Yuanyuan; Yu, Herbert] Univ Hawaii, Ctr Canc, Canc Epidemiol Program, Honolulu, HI 96822 USA; [Katsaros, Dionyssios; Canuto, Emilie Marion; Benedetto, Chiara] Azienda Osped Univ Citta Salute, Gynecol Oncol, Dept Surg Sci, Turin, Italy; [Lu, Lingeng; Risch, Harvey A.] Yale Univ, Sch Publ Hlth, Dept Chron Dis Epidemiol, New Haven, CT USA; [Chu, Wen-Ming] Univ Hawaii, Ctr Canc, Canc Biol Program, Honolulu, HI 96822 USA	Cancer Research Center of Hawaii; University of Hawaii System; A.O.U. Citta della Salute e della Scienza di Torino; Yale University; Cancer Research Center of Hawaii; University of Hawaii System	Yu, H (corresponding author), Univ Hawaii, Ctr Canc, Canc Epidemiol Program, Honolulu, HI 96822 USA.	hyu@cc.hawaii.edu	wang, zhanwei/AAR-4978-2020; wang, zhanwei/F-9958-2016		NATIONAL CANCER INSTITUTE [P30CA071789] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA071789] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Bian Y, 2014, P NATL ACAD SCI USA, V111, P1628, DOI 10.1073/pnas.1315588111; Boidot R, 2008, GENE CHROMOSOME CANC, V47, P299, DOI 10.1002/gcc.20533; Cardoso F, 2008, J CLIN ONCOL, V26, P729, DOI 10.1200/JCO.2007.14.3222; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Colak D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063204; Collins K, 1997, P NATL ACAD SCI USA, V94, P2776, DOI 10.1073/pnas.94.7.2776; Dai HY, 2005, CANCER RES, V65, P4059, DOI 10.1158/0008-5472.CAN-04-3953; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Filipits M, 2011, CLIN CANCER RES, V17, P6012, DOI 10.1158/1078-0432.CCR-11-0926; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gordon DJ, 2012, NAT REV GENET, V13, P189, DOI 10.1038/nrg3123; Grabsch H, 2003, J PATHOL, V200, P16, DOI 10.1002/path.1324; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hempen PM, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9120; Hernando E, 2004, NATURE, V430, P797, DOI 10.1038/nature02820; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Li Y, 1996, SCIENCE, V274, P246, DOI 10.1126/science.274.5285.246; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Mannelqvist M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098787; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Mu L, 2012, BREAST CANCER RES TR, V133, P321, DOI 10.1007/s10549-012-1952-5; Nyati S, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005379; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Polyak K, 2007, J CLIN INVEST, V117, P3155, DOI 10.1172/JCI33295; Pulverer B, 2004, NAT CELL BIOL, V6, P806, DOI 10.1038/ncb0904-806; Reyal F, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2192; Ricke RM, 2011, J CELL BIOL, V193, P1049, DOI 10.1083/jcb.201012035; Ringner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017911; Schvartzman JM, 2010, NAT REV CANCER, V10, P102, DOI 10.1038/nrc2781; Shichiri M, 2002, CANCER RES, V62, P13; Shigeishi H, 2001, PATHOBIOLOGY, V69, P24, DOI 10.1159/000048754; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Sparano JA, 2008, J CLIN ONCOL, V26, P721, DOI [10.1200/JCO.2007.15.1068, 10.1200/JCO.2008.16.7528]; Taylor SS, 2004, CHROMOSOME RES, V12, P599, DOI 10.1023/B:CHRO.0000036610.78380.51; Terunuma A, 2014, J CLIN INVEST, V124, P398, DOI 10.1172/JCI71180; Thorner AR, 2009, ONCOGENE, V28, P742, DOI 10.1038/onc.2008.430; van Vliet MH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-375; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Yin ZQ, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/1756-9966-33-49; Yoon CH, 2012, J BIOL CHEM, V287, P19516, DOI 10.1074/jbc.M111.337428; Yuan BB, 2006, CLIN CANCER RES, V12, P405, DOI 10.1158/1078-0432.CCR-05-0903	53	34	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136246	10.1371/journal.pone.0136246	http://dx.doi.org/10.1371/journal.pone.0136246			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287798	Green Submitted, Green Published, gold			2022-12-26	WOS:000360018600126
J	Yi, SY; Tuot, S; Chhoun, P; Pal, K; Tith, K; Brody, C				Yi, Siyan; Tuot, Sovannary; Chhoun, Pheak; Pal, Khuondyla; Tith, Khimuy; Brody, Carinne			Factors Associated with Inconsistent Condom Use among Men Who Have Sex with Men in Cambodia	PLOS ONE			English	Article							UNPROTECTED ANAL INTERCOURSE; HIV-POSITIVE MEN; UNITED-STATES; HONG-KONG; RISK BEHAVIOR; CHINESE MEN; PREVENTION; PARTNERS; INFECTIONS; PREVALENCE	Background Compared to the general population, men who have sex with men (MSM) are at greater risk for HIV and less understood due to their more hidden and stigmatized nature. Moreover, the discrepancy in findings in the literature merits further investigations in MSM populations from different cultures and settings. We therefore conducted this study to explore factors associated with inconsistent condom use among high-risk MSM in Cambodia. Methods This cross-sectional study was conducted in 2014 among 367 MSM randomly selected from Battembang and Siem Reap using a two-stage cluster sampling method. A structured questionnaire was used for face-to-face interviews to collect information on characteristics of respondents, HIV testing history, self-perception of HIV risk, substance use, sexual behaviors, mental disorders, and HIV knowledge. Multivariable logistic regression analysis was performed to identify factors independently associated with inconsistent condom use. Results On average, 62.3% of respondents reported that they always used condoms over the past three months. The rates varied with types of sexual partners; the proportion of respondents who reported always using condoms was 55.1%, 64.2%, 75.9%, 73.0%, 78.1%, and 70.3%, for sexual partners who were girlfriends, boyfriends, female sex workers, male sex workers, female clients, or male clients, respectively. After adjustment, inconsistent condom use was significantly associated with age of >= 25 (AOR = 1.77, 95% CI = 1.09-2.86), self-rated quality of life as good or very good (AOR = 4.37, 95% CI = 1.79-5.67), self-perception of higher HIV risk compared to the general population (AOR = 2.37, 95% CI = 1.35-4.17), illicit drug use in the past three months (AOR = 5.76, 95% CI = 1.65-10.09), and reported consistent lubricant use when selling anal sex to men in the past three months (AOR = 2.85, 95% CI = 1.07-8.12). Conclusions We found risky sexual behaviors to be considerably high among MSM in this study, especially among those who used illicit drugs or were older than 25. HIV education and social marketing should be expanded and specifically designed for MSM to better educate on the increased risk of HIV with unprotected anal sex and illicit drug use as risk factors, and the importance of the use of both condoms and lubricant during anal intercourse.	[Yi, Siyan; Tuot, Sovannary; Chhoun, Pheak; Pal, Khuondyla; Tith, Khimuy] KHANA, Res Ctr, Phnom Penh, Cambodia; [Yi, Siyan; Brody, Carinne] Touro Univ Calif, Ctr Global Hlth Res, Publ Hlth Program, Vallejo, CA USA	Touro University California	Yi, SY (corresponding author), KHANA, Res Ctr, Phnom Penh, Cambodia.	siyan@doctor.com	Chhoun, Pheak/AAR-3361-2021	Chhoun, Pheak/0000-0001-6369-0190; Brody, Carinne/0000-0001-9376-5528	United States Agency for International Development (USAID)	United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	Data used for this analysis were collected as part of an impact evaluation study of the Sustainable Action against HIV and AIDS in Communities (SAHACOM) which was funded by the United States Agency for International Development (USAID). However, the authors received no specific finding for this work.	Aho J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099591; Altman D, 2012, LANCET, V380, P439, DOI 10.1016/S0140-6736(12)60920-9; [Anonymous], 1994, PREVENTING AIDS THEO; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Balan IC, 2009, AIDS EDUC PREV, V21, P14, DOI 10.1521/aeap.2009.21.1.14; Baral S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004997; Baral SD, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.4.18768; Barron-Limon S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-433; Bell David C, 2003, Clin Lab Sci, V16, P20; Beyrer C, 2013, AIDS, V27, P2665, DOI 10.1097/01.aids.0000432449.30239.fe; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Cai Y, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-205; Carey MP, 2002, AIDS EDUC PREV, V14, P172, DOI 10.1521/aeap.14.2.172.23902; Centers for Disease Control and Prevention (CDC), 2013, COND STDS FACTSH PUB; Chen SY, 2003, AIDS, V17, P942, DOI 10.1097/00002030-200304110-00031; Clark Holie, 2012, Morbidity and Mortality Weekly Report, V61, P962; Deshpande S, 2015, GLOB PUBLIC HEALTH, V10, P103, DOI 10.1080/17441692.2014.972968; Goldberg D.P., 1988, USERS GUIDE GEN HLTH; Goldberg D.P, 1972, DETECTION PSYCHIAT I; Goldberg DP, 1998, PSYCHOL MED, V28, P915, DOI 10.1017/S0033291798006874; Havlir D, 2012, NEW ENGL J MED, V367, P685, DOI 10.1056/NEJMp1207138; Hirshfield S, 2004, AIDS CARE, V16, P1036, DOI 10.1080/09540120412331292525; Hubach RD, 2015, AIDS EDUC PREV, V27, P72, DOI 10.1521/aeap.2015.27.1.72; Jin FY, 2010, AIDS, V24, P907, DOI 10.1097/QAD.0b013e3283372d90; Lau JTF, 2013, AIDS BEHAV, V17, P1395, DOI 10.1007/s10461-012-0244-8; Lau JTF, 2012, AIDS CARE, V24, P59, DOI 10.1080/09540121.2011.592813; Levy ME, 2014, AIDS BEHAV, V18, P972, DOI 10.1007/s10461-014-0719-x; Li DL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119977; Liu KL, 2010, BROS KHMER BEHAV RIS; Mansergh G, 2006, AIDS BEHAV, V10, P743, DOI 10.1007/s10461-006-9108-4; Margolis AD, 2014, SEX TRANSM DIS, V41, P749, DOI 10.1097/OLQ.0000000000000206; Ministry of Education Youth and Sports (MEYS), 2012, EX LIF EXP HIV RISKS; National Center for HIV/ AIDS, 2013, BEH SENT SURV BSS 20; National Institute of Public Health National Institute of Statistics and ORC Macro, 2010, CAMB DEM HLTH SURV 2; Nelson LE, 2015, RES NURS HEALTH, V38, P194, DOI 10.1002/nur.21650; Nelson LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115504; Ramanathan S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-827; Rogers RW., 1997, HDB HLTH BEHAV RES P, P113; Semple S, 2009, AM J ADDICTION, V18, P65, DOI 10.1080/10550490802544466; Smith DK, 2015, JAIDS-J ACQ IMM DEF, V68, P337, DOI 10.1097/QAI.0000000000000461; Trapence G, 2012, LANCET, V380, P400, DOI 10.1016/S0140-6736(12)60834-4; Tuot S., 2013, MIDTERM REV SUSTAINA; UNAIDS, 2012, GLOBAL REPORT UNAIDS; Vun MC, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18905; World Health Organization (WHO), 2010, COND HIV PREV; Xu JJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0642-9; Yi S, 2015, INT J TROP DIS HLTH, V5, P37; Yi S, 2014, GLOB J MED PUBLIC HL, V3, P1; Yi SY, 2015, BMC INFECT DIS, V15, DOI [10.1186/s12879-015-0954-4, 10.1186/s12889-015-2096-4]; Yi SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121461; Yi SY, 2011, J SUBST USE, V16, P14, DOI 10.3109/14659890903531261; Yi SY, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-477; Yi SY, 2009, AIDS CARE, V21, P529, DOI 10.1080/09540120802270268; Zhang H, 2015, ARCH SEX BEHAV, V44, P375, DOI 10.1007/s10508-014-0396-x; ZUCKERMAN M, 1978, J CONSULT CLIN PSYCH, V46, P139, DOI 10.1037/0022-006X.46.1.139	56	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136114	10.1371/journal.pone.0136114	http://dx.doi.org/10.1371/journal.pone.0136114			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP6SN	26287731	gold, Green Published, Green Submitted			2022-12-26	WOS:000360018600110
J	Almeida, D; Maldonado, E; Vasconcelos, V; Antunes, A				Almeida, Daniela; Maldonado, Emanuel; Vasconcelos, Vitor; Antunes, Agostinho			Adaptation of the Mitochondrial Genome in Cephalopods: Enhancing Proton Translocation Channels and the Subunit Interactions	PLOS ONE			English	Article							AMINO-ACID SITES; DETECTING POSITIVE SELECTION; CYTOCHROME-C-OXIDASE; HEREDITARY OPTIC NEUROPATHY; NADH-QUINONE OXIDOREDUCTASE; PHYLOGENETIC ANALYSIS; COMPLEX-I; ND6 GENE; STATISTICAL-METHODS; CODON-SUBSTITUTION	Mitochondrial protein-coding genes (mt genes) encode subunits forming complexes of crucial cellular pathways, including those involved in the vital process of oxidative phosphorylation (OXPHOS). Despite the vital role of the mitochondrial genome (mt genome) in the survival of organisms, little is known with respect to its adaptive implications within marine invertebrates. The molluscan Class Cephalopoda is represented by a marine group of species known to occupy contrasting environments ranging from the intertidal to the deep sea, having distinct metabolic requirements, varied body shapes and highly advanced visual and nervous systems that make them highly competitive and successful worldwide predators. Thus, cephalopods are valuable models for testing natural selection acting on their mitochondrial subunits (mt subunits). Here, we used concatenated mt genes from 17 fully sequenced mt genomes of diverse cephalopod species to generate a robust mitochondrial phylogeny for the Class Cephalopoda. We followed an integrative approach considering several branches of interest-covering cephalopods with distinct morphologies, metabolic rates and habitats-to identify sites under positive selection and localize them in the respective protein alignment and/or tridimensional structure of the mt subunits. Our results revealed significant adaptive variation in several mt subunits involved in the energy production pathway of cephalopods: ND5 and ND6 from Complex I, CYTB from Complex III, COX2 and COX3 from Complex IV, and in ATP8 from Complex V. Furthermore, we identified relevant sites involved in protein-interactions, lining proton translocation channels, as well as disease/deficiencies related sites in the aforementioned complexes. A particular case, revealed by this study, is the involvement of some positively selected sites, found in Octopoda lineage in lining proton translocation channels (site 74 from ND5) and in interactions between subunits (site 507 from ND5) of Complex I.	[Almeida, Daniela; Maldonado, Emanuel; Vasconcelos, Vitor; Antunes, Agostinho] Univ Porto, Interdisciplinary Ctr Marine & Environm Res, CIIMAR CIMAR, P-4100 Oporto, Portugal; [Almeida, Daniela; Vasconcelos, Vitor; Antunes, Agostinho] Univ Porto, Fac Sci, Dept Biol, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto	Antunes, A (corresponding author), Univ Porto, Interdisciplinary Ctr Marine & Environm Res, CIIMAR CIMAR, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	aantunes@ciimar.up.pt	Almeida, Daniela/D-1956-2019; Maldonado, Emanuel/X-1620-2019; Vasconcelos, Vitor/A-8933-2008	Almeida, Daniela/0000-0002-9874-933X; Maldonado, Emanuel/0000-0002-0084-6116; Vasconcelos, Vitor/0000-0003-3585-2417; Antunes, Agostinho/0000-0002-1328-1732	Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BD/79766/2011]; European Regional Development Fund (ERDF) through the COMPETE-Operational Competitiveness Programme; FCT [PEst-C/MAR/LA0015/2013, PTDC/AAC-AMB/121301/2010 (FCOMP-01-0124-FEDER-019490)]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); European Regional Development Fund (ERDF) through the COMPETE-Operational Competitiveness Programme; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	DA was funded by a PhD grant (SFRH/BD/79766/2011) from Fundacao para a Ciencia e a Tecnologia (FCT). AA was partially supported by the European Regional Development Fund (ERDF) through the COMPETE-Operational Competitiveness Programme and national funds through FCT under the projects PEst-C/MAR/LA0015/2013 and PTDC/AAC-AMB/121301/2010 (FCOMP-01-0124-FEDER-019490).	Akasaki T, 2006, MOL PHYLOGENET EVOL, V38, P648, DOI 10.1016/j.ympev.2005.10.018; Albertin CB, 2012, STAND GENOMIC SCI, V7, P175, DOI 10.4056/sigs.3136559; Allcock AL, 2011, ZOOL J LINN SOC-LOND, V161, P573, DOI 10.1111/j.1096-3642.2010.00656.x; Alnajjar KS, 2014, BIOCHEMISTRY-US, V53, P496, DOI 10.1021/bi401535q; Anisimova M, 2002, MOL BIOL EVOL, V19, P950, DOI 10.1093/oxfordjournals.molbev.a004152; Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945; [Anonymous], TRACER V1 6; Arends A, 2001, COMP BIOCHEM PHYS A, V130, P105, DOI 10.1016/S1095-6433(01)00371-3; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bertin G, 2006, BIOCHIMIE, V88, P1549, DOI 10.1016/j.biochi.2006.10.001; Blier PU, 2001, TRENDS GENET, V17, P400, DOI 10.1016/S0168-9525(01)02338-1; Bonaccorso FJ, 2003, J COMP PHYSIOL B, V173, P43, DOI 10.1007/s00360-002-0308-6; BROWN MD, 1992, GENETICS, V130, P163; Carelli V, 1999, ANN NEUROL, V45, P320, DOI 10.1002/1531-8249(199903)45:3<320::AID-ANA7>3.0.CO;2-L; Chinnery PF, 2001, BRAIN, V124, P209, DOI 10.1093/brain/124.1.209; da Fonseca RR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-119; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Meo PD, 2012, NUCLEIC ACIDS RES, V40, pD1168, DOI 10.1093/nar/gkr1144; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; DeVries DD, 1996, AM J HUM GENET, V58, P703; Ding KY, 2005, MOL BIOL EVOL, V22, P148, DOI 10.1093/molbev/msh266; DOnorio de Meo P, 2011, MITOZOA DB CASPUR201, P10; Dowling DK, 2008, TRENDS ECOL EVOL, V23, P546, DOI 10.1016/j.tree.2008.05.011; Drummond AJ., 2011, GENEIOUS PRO 5 4; Drummond DA, 2009, NAT REV GENET, V10, P715, DOI 10.1038/nrg2662; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Efremov RG, 2011, NATURE, V476, P414, DOI 10.1038/nature10330; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Fontanillas P, 2005, MOL ECOL, V14, P661, DOI 10.1111/j.1365-294X.2004.02414.x; Foote AD, 2011, BIOL LETTERS, V7, P116, DOI 10.1098/rsbl.2010.0638; Garvin MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024127; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Horvath R, 2002, J MED GENET, V39, P812, DOI 10.1136/jmg.39.11.812; Huang LS, 2005, J MOL BIOL, V351, P573, DOI 10.1016/j.jmb.2005.05.053; Janssens TKS, 2009, INSECT SCI, V16, P3, DOI 10.1111/j.1744-7917.2009.00249.x; Kao MC, 2005, BIOCHEMISTRY-US, V44, P3562, DOI 10.1021/bi0476477; Kirby DM, 2000, ANN NEUROL, V48, P102, DOI 10.1002/1531-8249(200007)48:1<102::AID-ANA15>3.3.CO;2-D; Korsloot A., 2004, Environmental stress and cellular response in arthropods; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lindgren AR, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-129; Lupi R, 2010, MITOCHONDRION, V10, P192, DOI 10.1016/j.mito.2010.01.004; Maldonado E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096243; Marechal A, 2012, BBA-BIOENERGETICS, V1817, P620, DOI 10.1016/j.bbabio.2011.08.011; MarineBio, 2012, VAMP SQUIDS VAMP INF; Mathiesen C, 2002, BBA-BIOENERGETICS, V1556, P121, DOI 10.1016/S0005-2728(02)00343-2; Mayorov V, 2005, ANN NEUROL, V58, P807, DOI 10.1002/ana.20669; McClellan DA, 2005, MOL BIOL EVOL, V22, P437, DOI 10.1093/molbev/msi028; McClellan DA, 2001, MOL BIOL EVOL, V18, P917, DOI 10.1093/oxfordjournals.molbev.a003892; McNab BK, 2000, NATURE, V407, P584, DOI 10.1038/35036695; Meikejohn KA, 2014, MOL PHYLOGENET EVOL, V78, P314, DOI 10.1016/j.ympev.2014.06.003; Melo-Ferreira J, 2014, GENOME BIOL EVOL, V6, P886, DOI 10.1093/gbe/evu059; Meunier B, 2013, BBA-BIOENERGETICS, V1827, P1346, DOI 10.1016/j.bbabio.2012.11.015; Michel J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017420; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Nakamaru-Ogiso E, 2010, J BIOL CHEM, V285, P39070, DOI 10.1074/jbc.M110.157826; Nateewathana A, 1998, P SEAFDEC SEM FISH R, P76; Nielsen R, 1998, GENETICS, V148, P929; Patsi J, 2008, BIOCHEM J, V409, P129, DOI 10.1042/BJ20070866; Phillips MJ, 2004, MOL BIOL EVOL, V21, P1455, DOI 10.1093/molbev/msh137; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Rahman S, 1999, AM J HUM GENET, V65, P1030, DOI 10.1086/302590; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schrodinger L., 2020, PYMOL; Scott GR, 2011, MOL BIOL EVOL, V28, P351, DOI 10.1093/molbev/msq205; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Strugnell J, 2005, MOL PHYLOGENET EVOL, V37, P426, DOI 10.1016/j.ympev.2005.03.020; Suzuki Y, 2002, MOL BIOL EVOL, V19, P1865, DOI 10.1093/oxfordjournals.molbev.a004010; Suzuki Y, 2001, MOL BIOL EVOL, V18, P2179, DOI 10.1093/oxfordjournals.molbev.a003764; Swanson WJ, 2003, MOL BIOL EVOL, V20, P18, DOI 10.1093/oxfordjournals.molbev.a004233; Valentino ML, 2002, ANN NEUROL, V51, P774, DOI 10.1002/ana.10193; Wenz T, 2007, J BIOL CHEM, V282, P3977, DOI 10.1074/jbc.M606482200; Wissinger B, 1997, BIOCHEM BIOPH RES CO, V234, P511, DOI 10.1006/bbrc.1997.6660; Wong WSW, 2004, GENETICS, V168, P1041, DOI 10.1534/genetics.104.031153; Woolley S, 2003, BIOINFORMATICS, V19, P671, DOI 10.1093/bioinformatics/btg043; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1998, J MOL EVOL, V46, P409, DOI 10.1007/PL00006320; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2008, MOL BIOL EVOL, V25, P568, DOI 10.1093/molbev/msm284; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	88	12	13	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135405	10.1371/journal.pone.0135405	http://dx.doi.org/10.1371/journal.pone.0135405			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285039	Green Published, gold, Green Submitted			2022-12-26	WOS:000359666100037
J	Bouklata, N; Supply, P; Jaouhari, S; Charof, R; Seghrouchni, F; Sadki, K; El Achhab, Y; Nejjari, C; Filali-Maltouf, A; Lahlou, O; El Aouad, R				Bouklata, Nada; Supply, Philip; Jaouhari, Sanae; Charof, Reda; Seghrouchni, Fouad; Sadki, Khalid; El Achhab, Youness; Nejjari, Chakib; Filali-Maltouf, Abdelkarim; Lahlou, Ouafae; El Aouad, Rajae			Molecular Typing of Mycobacterium Tuberculosis Complex by 24-Locus Based MIRU-VNTR Typing in Conjunction with Spoligotyping to Assess Genetic Diversity of Strains Circulating in Morocco	PLOS ONE			English	Article							POPULATION-STRUCTURE; CASABLANCA; DATABASE; EPIDEMIOLOGY; POLYMORPHISM; GENOTYPES; FAMILY; AREA	Background Standard 24-locus Mycobacterial Interspersed Repetitive Unit Variable Number Tandem Repeat (MIRU-VNTR) typing allows to get an improved resolution power for tracing TB transmission and predicting different strain (sub) lineages in a community. Methodology During 2010-2012, a total of 168 Mycobacterium tuberculosis Complex (MTBC) isolates were collected by cluster sampling from 10 different Moroccan cities, and centralized by the National Reference Laboratory of Tuberculosis over the study period. All isolates were genotyped using spoligotyping, and a subset of 75 was genotyped using 24-locus based MIRU-VNTR typing, followed by first line drug susceptibility testing. Corresponding strain lineages were predicted using MIRU-VNTRplus database. Principal Findings Spoligotyping resulted in 137 isolates in 18 clusters (2-50 isolates per cluster: clustering rate of 81.54%) corresponding to a SIT number in the SITVIT database, while 31(18.45%) patterns were unique of which 10 were labelled as "unknown" according to the same database. The most prevalent spoligotype family was LAM; (n = 81 or 48.24% of isolates, dominated by SIT42, n = 49), followed by Haarlem (23.80%), T superfamily (15.47%), > Beijing (2.97%), > U clade (2.38%) and S clade (1.19%). Subsequent 24-Locus MIRU-VNTR typing identified 64 unique types and 11 isolates in 5 clusters (2 to 3isolates per cluster), substantially reducing clusters defined by spoligotyping only. The single cluster of three isolates corresponded to two previously treated MDR-TB cases and one new MDR-TB case known to be contact a same index case and belonging to a same family, albeit residing in 3 different administrative regions. MIRU-VNTR loci 4052, 802, 2996, 2163b, 3690, 1955, 424, 2531, 2401 and 960 were highly discriminative in our setting (HGDI > 0.6). Conclusions 24-locus MIRU-VNTR typing can substantially improve the resolution of large clusters initially defined by spoligotyping alone and predominating in Morocco, and could therefore be used to better study tuberculosis transmission in a population-based, multi-year sample context.	[Bouklata, Nada; Jaouhari, Sanae; Charof, Reda; Lahlou, Ouafae] Natl Inst Hyg, Natl TB Reference Lab, Rabat, Morocco; [Supply, Philip] INSERM, U1018, F-59045 Lille, France; [Supply, Philip] Inst Pasteur, Ctr Immunol & Biol Parasitaire, CNRS, UMR8204, F-59019 Lille, France; [Supply, Philip] Inst Pasteur, CIIL, Lille, France; [Supply, Philip] Univ Lille, Lille, France; [Bouklata, Nada; Sadki, Khalid; Filali-Maltouf, Abdelkarim] Univ Mohammed 5, Lab Microbiol & Mol Biol, Fac Sci, Rabat, Morocco; [El Achhab, Youness; Nejjari, Chakib] Sidi Mohamed Ben Abdillah Univ, Fac Med & Pharm Fes, Dept Epidemiol & Publ Hlth, Fes, Morocco; [El Aouad, Rajae] Univ Mohamed VI Sci & Hlth, Sch Publ Hlth & Management Syst Hlth, Casablanca, Morocco; [Supply, Philip] Genoscreen, Lille, France; [Seghrouchni, Fouad] Natl Inst Hyg, Dept Immunol, Lab Cell Immunol, Rabat, Morocco	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Mohammed V University in Rabat; Sidi Mohamed Ben Abdellah University of Fez; Mohammed VI University of Health Sciences (UM6SS)	Bouklata, N (corresponding author), Natl Inst Hyg, Natl TB Reference Lab, Rabat, Morocco.	bouklatanada@gmail.com	EL ACHHAB, Youness/V-5153-2019; Filali-Maltouf, Abdelkarim/AAD-3681-2022; Supply, Philip/A-9580-2019	EL ACHHAB, Youness/0000-0002-2527-2518; Filali-Maltouf, Abdelkarim/0000-0002-2727-3389; Supply, Philip/0000-0003-3690-3853; SADKI, khalid/0000-0002-9224-5050; EL AOUAD, Rajae/0000-0002-2686-6924	Academie Hassan II des Sciences [1169]; Euro Mediterranean Network against Tuberculosis, European Commission	Academie Hassan II des Sciences; Euro Mediterranean Network against Tuberculosis, European Commission	The work performed was funded by Academie Hassan II des Sciences (grant number 1169). The collaboration with Institut Pasteur de Lille France was financed through the Euro Mediterranean Network against Tuberculosis, European Commission, 7th Framework program (EUMEDNETvsTB; http://www.eumednet-tb.org/index. html). However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Author Philip Supply is a Consultant for Genoscreen. Genoscreen provided support in the form of consultancy fee for author PS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abitbol M, 2009, HIST MAROC, P756; Al Hajoj S, 2010, ANN THORAC MED, V5, P149, DOI 10.4103/1817-1737.65045; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P1398, DOI 10.1128/JCM.02089-07; [Anonymous], GLOB TUB CONTR WHO R; Baker L, 2004, EMERG INFECT DIS, V10, P1568, DOI 10.3201/eid1009.040046; Bidovec-Stojkovic U, 2011, RESP MED, V105, pS67, DOI 10.1016/S0954-6111(11)70014-2; Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Chaoui I, 2014, INFECT GENET EVOL, V21, P463, DOI 10.1016/j.meegid.2013.05.023; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; David H, 1987, METHODES LAB MYCOBAC; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Diraa O, 2005, INT J TUBERC LUNG D, V9, P1294; Dou HY, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-170; ElBaghdadi J, 1997, B SOC PATHOL EXOT, V90, P156; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; Glynn JR, 2006, EMERG INFECT DIS, V12, P736, DOI 10.3201/eid1205.050400; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Lahlou O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047113; Maes M, 2008, TUBERCULOSIS, V88, P490, DOI 10.1016/j.tube.2008.04.003; Martins MC, 2013, INFECT GENET EVOL, V14, P39, DOI 10.1016/j.meegid.2012.10.015; Merker M, 2015, NAT GENET, V47, P242, DOI 10.1038/ng.3195; Niemann S, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a021188; Niobe-Eyangoh SN, 2004, J CLIN MICROBIOL, V42, P5029, DOI 10.1128/JCM.42.11.5029-5035.2004; Oelemann MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018256; Perez-Lago L, 2014, J INFECT DIS, V209, P98, DOI 10.1093/infdis/jit439; Qiao L, 2011, BMC INFECT DIS; Rastogi N., 2007, TUBERCULOSIS 2007 BA, V2007, P53; Roetzer A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001387; Shamputa IC, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-99; Soini H, 2000, J CLIN MICROBIOL, V38, P669, DOI 10.1128/JCM.38.2.669-676.2000; Sola C, 2003, INFECT GENET EVOL, V3, P125, DOI 10.1016/S1567-1348(03)00011-X; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Tazi L, 2004, J CLIN MICROBIOL, V42, P461, DOI 10.1128/JCM.42.1.461-466.2004; Tazi L, 2007, INFECT GENET EVOL, V7, P636, DOI 10.1016/j.meegid.2007.06.005; Valcheva V, 2008, J CLIN MICROBIOL, V46, P1014, DOI 10.1128/JCM.01841-07; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234, DOI 10.1128/JCM.33.12.3234-3238.1995; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; Warren RM, 2004, J CLIN MICROBIOL, V42, P5774, DOI 10.1128/JCM.42.12.5774-5782.2004; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; World Health Organization Geneva, 2014, GLOB TUB CONTR WHO R	46	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135695	10.1371/journal.pone.0135695	http://dx.doi.org/10.1371/journal.pone.0135695			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285026	Green Submitted, gold, Green Published			2022-12-26	WOS:000359666100061
J	Ptatscheck, C; Traunspurger, W				Ptatscheck, Christoph; Traunspurger, Walter			Meio- and Macrofaunal Communities in Artificial Water-Filled Tree Holes: Effects of Seasonality, Physical and Chemical Parameters, and Availability of Food Resources	PLOS ONE			English	Article							SECONDARY PRODUCTION; BOTTOM-UP; MEIOFAUNA; MOSQUITO; PRODUCTIVITY; POPULATIONS; DISPERSAL; DYNAMICS; LAKES; COLONIZATION	Objectives In this study we investigated the dynamics of meiofaunal and macrofaunal communities in artificial water-filled tree holes. The abundances and, for the first time, biomasses and secondary production rates of these communities were examined. The experimental set-up consisted of 300 brown plastic cups placed in temperate mixed forests and sampled five times over a period of 16 months to determine the impact of (i) seasonal events, (ii) physicochemical parameters, and (iii) food resources on the tree hole metazoans. Outcomes Metazoan organisms, especially the meiofauna (rotifers and nematodes) occupied nearly all of the cups (> 99%) throughout the year. Between 55% and 99% of themetazoan community was represented by rotifers (max. 557,000 individuals 100 cm(-2)) and nematodes (max. 58,000 individuals 100 cm(-2)). Diptera taxa, particularly Dasyhelea sp. (max. 256 individuals 100 cm(-2)) dominated the macrofaunal community. Macrofauna accounted for the majority of the metazoan biomass, with a mean dry weight of 5,800 mu g 100 cm(-2) and an annual production rate of 20,400 mu g C 100 cm(-2), whereas for meiofauna mean biomass and annual production were 100 mu g 100 cm(-2) and 5,300 mu g C 100 cm(-2), respectively. The macrofaunal taxa tended to show more fluctuating population dynamic while the meiofaunal dynamic was rather low with partly asynchronous development. Seasonality (average temperature and rain intervals) had a significant impact on both meiofauna and macrofauna. Furthermore, bottom-up control (chlorophyll-a and organic carbon), mainly attributable to algae, was a significant factor that shaped the metazoan communities. In contrast, physicochemical water parameters had no evident influence. 23.7% of organism density distribution was explained by redundancy analysis (RDA) indicating a high dynamic and asynchrony of the systems.	[Ptatscheck, Christoph; Traunspurger, Walter] Univ Bielefeld, Anim Ecol, D-33615 Bielefeld, Germany	University of Bielefeld	Ptatscheck, C (corresponding author), Univ Bielefeld, Anim Ecol, Konsequenz 45, D-33615 Bielefeld, Germany.	christoph.ptatscheck@uni-bielefeld.de		Ptatscheck, Christoph/0000-0002-2079-4130	German Federal Environmental Foundation (DBU)	German Federal Environmental Foundation (DBU)	The study was supported by the German Federal Environmental Foundation (DBU; https://www.dbu.de/). The authors acknowledge support for the Article Processing Charge by the Deutsche Forschungsgemeinschaft and the Open Access Publication Fund of Bielefeld University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RS, 1980, HYDROBIOLOGIA, V70, P257, DOI 10.1007/BF00016768; Andrassy I., 1956, Archivum Zoologicum Budapest, V2, P1; Benke AC, 1999, J N AM BENTHOL SOC, V18, P308, DOI 10.2307/1468447; Bergtold M, 2005, J N AM BENTHOL SOC, V24, P321, DOI 10.1899/03-038.1; BRADSHAW WE, 1988, OECOLOGIA, V74, P507, DOI 10.1007/BF00380047; Brouard O, 2012, FRESHWATER BIOL, V57, P815, DOI 10.1111/j.1365-2427.2012.02749.x; Brouard O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020129; Butkas KJ, 2011, AQUAT SCI, V73, P153, DOI 10.1007/s00027-010-0168-1; Caceres CE, 2002, OECOLOGIA, V131, P402, DOI 10.1007/s00442-002-0897-5; CARPENTER SR, 1982, OECOLOGIA, V53, P1, DOI 10.1007/BF00377128; Devetter Miloslav, 2004, Acta Societatis Zoologicae Bohemicae, V68, P161; Dezerald O, 2014, HYDROBIOLOGIA, V723, P77, DOI 10.1007/s10750-013-1464-2; Dolbeth M, 2012, CAN J FISH AQUAT SCI, V69, P1230, DOI 10.1139/F2012-050; Feller R.J., 1988, P181; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Foit K, 2012, AQUAT TOXICOL, V109, P243, DOI 10.1016/j.aquatox.2011.09.013; Fontaneto Diego, 2004, P121; Frankland PF, 1886, P R SOC LONDON, V40, P509; Frisch D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040205; Herzig A., 1984, FUNDAMENTAL REQUIREM; JACKSON JM, 1991, HYDROBIOLOGIA, V209, P59, DOI 10.1007/BF00006718; JENKINS B, 1992, OIKOS, V65, P249, DOI 10.2307/3545016; Jocque M, 2014, HYDROBIOLOGIA, V730, P153, DOI 10.1007/s10750-014-1831-7; Kitching R.L., 2000, FOOD WEBS CONTAINER, DOI [10.1017/CBO9780511542107, DOI 10.1017/CBO9780511542107]; Kitching RL, 2001, ANNU REV ENTOMOL, V46, P729, DOI 10.1146/annurev.ento.46.1.729; KITCHING RL, 1971, J ANIM ECOL, V40, P281, DOI 10.2307/3247; Kutikova LA, 2003, BIOL BULL+, V30, P271, DOI 10.1023/A:1023811929889; Macia A, 2000, OECOLOGIA, V125, P55, DOI 10.1007/PL00008891; MAGUIRE B, 1963, ECOL MONOGR, V33, P161, DOI 10.2307/1948560; Marino NAC, 2011, HYDROBIOLOGIA, V678, P191, DOI 10.1007/s10750-011-0848-4; McSorley R, 2003, FLA ENTOMOL, V86, P138, DOI 10.1653/0015-4040(2003)086[0138:AONTEE]2.0.CO;2; Michiels IC, 2004, NEMATOLOGY, V6, P655, DOI 10.1163/1568541042843568; Muschiol D, 2009, AQUAT ECOL, V43, P235, DOI 10.1007/s10452-008-9202-y; NALEPA TF, 1983, J GREAT LAKES RES, V9, P530, DOI 10.1016/S0380-1330(83)71926-X; Paradise Christopher J., 2008, BMC Ecology, V8, P22, DOI 10.1186/1472-6785-8-22; PIMM SL, 1987, OIKOS, V50, P302, DOI 10.2307/3565490; PLANTE C, 1989, CAN J FISH AQUAT SCI, V46, P1489, DOI 10.1139/f89-191; Ptatscheck C, 2014, AQUAT ECOL, V48, P285, DOI 10.1007/s10452-014-9483-2; Ptatscheck C, 2015, HYDROBIOLOGIA, V757, P143, DOI 10.1007/s10750-015-2246-9; Ricci C, 2005, INTEGR COMP BIOL, V45, P759, DOI 10.1093/icb/45.5.759; Ristau K, 2012, FRESHWATER BIOL, V57, P824, DOI 10.1111/j.1365-2427.2012.02750.x; Schmid PE, 1997, FRESHWATER BIOL, V38, P67, DOI 10.1046/j.1365-2427.1997.00197.x; Schmid-Araya JM, 2000, FRESHWATER BIOL, V44, P149, DOI 10.1046/j.1365-2427.2000.00594.x; Schmidl J, 2008, HYDROBIOLOGIA, V598, P285, DOI 10.1007/s10750-007-9163-5; Schroeder F, 2012, FUND APPL LIMNOL, V181, P143, DOI 10.1127/1863-9135/2012/0332; SOTA T, 1994, RES POPUL ECOL, V36, P93, DOI 10.1007/BF02515090; Srivastava DS, 1998, AM NAT, V152, P510, DOI 10.1086/286187; Stead TK, 2005, LIMNOL OCEANOGR, V50, P398, DOI 10.4319/lo.2005.50.1.0398; Stich HB, 2005, ARCH HYDROBIOL, V162, P111, DOI 10.1127/0003-9136/2005/0162-0111; ter Braak CJF, 1994, ECOSCIENCE, V1, P127, DOI 10.1080/11956860.1994.11682237; Tod SP, 2009, LIMNOL OCEANOGR, V54, P450, DOI 10.4319/lo.2009.54.2.0450; Traunspurger W, 2000, FRESHWATER BIOL, V44, P29, DOI 10.1046/j.1365-2427.2000.00585.x; Traunspurger W, 2012, FUND APPL LIMNOL, V180, P233, DOI 10.1127/1863-9135/2012/0144; Vanschoenwinkel B, 2008, OIKOS, V117, P125, DOI 10.1111/j.2007.0030-1299.16349.x; WALKER ED, 1991, ECOLOGY, V72, P1529, DOI 10.2307/1940953; WHARTON DA, 1995, BIOL REV, V70, P161, DOI 10.1111/j.1469-185X.1995.tb01442.x; Yanoviak SP, 2005, METH ECOL, P168, DOI 10.1002/9780470750513.ch8; Yanoviak SP, 2001, FLA ENTOMOL, V84, P265, DOI 10.2307/3496178; Yee DA, 2007, OECOLOGIA, V153, P153, DOI 10.1007/s00442-007-0707-1	59	15	15	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0133447	10.1371/journal.pone.0133447	http://dx.doi.org/10.1371/journal.pone.0133447			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284811	gold, Green Published, Green Submitted			2022-12-26	WOS:000359666100003
J	Roubalova, L; Vosahlikova, M; Brejchova, J; Sykora, J; Rudajev, V; Svoboda, P				Roubalova, Lenka; Vosahlikova, Miroslava; Brejchova, Jana; Sykora, Jan; Rudajev, Vladimir; Svoboda, Petr			High Efficacy but Low Potency of delta-Opioid Receptor-G Protein Coupling in Brij-58-Treated, Low-Density Plasma Membrane Fragments	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; RESONANCE ENERGY-TRANSFER; BETA-ADRENERGIC-RECEPTOR; A2 ADENOSINE RECEPTORS; LIPID RAFTS; BIOLOGICAL-MEMBRANES; SIGNAL-TRANSDUCTION; ADENYLYL-CYCLASE; CAVEOLAE MICRODOMAINS; CARDIAC MYOCYTES	Principal Findings HEK293 cells stably expressing PTX-insensitive delta-opioid receptor-Gi1 alpha ((CI)-I-351) fusion protein were homogenized, treated with low concentrations of non-ionic detergent Brij-58 at 0 degrees C and fractionated by flotation in sucrose density gradient. In optimum range of detergent concentrations (0.025-0.05% w/v), Brij-58-treated, low-density membranes exhibited 2-3fold higher efficacy of DADLE-stimulated, high-affinity [P-32]GTPase and [S-35]GTP.S binding than membranes of the same density prepared in the absence of detergent. The potency of agonist DADLE response was significantly decreased. At high detergent concentrations (>0.1%), the functional coupling between delta-opioid receptors and G proteins was completely diminished. The same detergent effects were measured in plasma membranes isolated from PTX-treated cells. Therefore, the effect of Brij-58 on delta-opioid receptor-G protein coupling was not restricted to the covalently bound G(i)1 alpha within delta-opioid receptor-G(i)1 alpha fusion protein, but it was also valid for PTX-sensitive G proteins of G(i)/G(o) family endogenously expressed in HEK293 cells. Characterization of the direct effect of Brij-58 on the hydrophobic interior of isolated plasma membranes by steady-state anisotropy of diphenylhexatriene (DPH) fluorescence indicated a marked increase of membrane fluidity. The time-resolved analysis of decay of DPH fluorescence by the "wobble in cone" model of DPH motion in the membrane indicated that the exposure to the increasing concentrations of Brij-58 led to a decreased order and higher motional freedom of the dye. Summary Limited perturbation of plasma membrane integrity by low concentrations of non-ionic detergent Brij-58 results in alteration of delta-OR-G protein coupling. Maximum G protein-response to agonist stimulation (efficacy) is increased; affinity of response (potency) is decreased. The total degradation plasma membrane structure at high detergent concentrations results in diminution of functional coupling between delta-opioid receptors and G proteins.	[Roubalova, Lenka; Vosahlikova, Miroslava; Brejchova, Jana; Svoboda, Petr] Acad Sci Czech Republ, Inst Physiol, Dept Biomath, Prague, Czech Republic; [Sykora, Jan] Acad Sci Czech Republ, J Heyrovsky Inst Phys Chem, Dept Biophys Chem, Prague, Czech Republic; [Rudajev, Vladimir] Acad Sci Czech Republ, Inst Physiol, Dept Neurochem, Prague, Czech Republic	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Czech Academy of Sciences; J. Heyrovsky Institute of Physical Chemistry of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences	Svoboda, P (corresponding author), Acad Sci Czech Republ, Inst Physiol, Dept Biomath, Prague, Czech Republic.	svobodap@biomed.cas.cz	Rudajev, Vladimir/T-3851-2019; Sykora, Jan/F-5179-2014; Rudajev, Vladimir/C-3356-2012; Svoboda, Petr/C-2619-2012; Roubalova, Lenka/C-2628-2012; Brejchova, Jana/L-9368-2015; Vosahlikova, Miroslava/G-3022-2014	Svoboda, Petr/0000-0002-3076-4672; Roubalova, Lenka/0000-0002-0603-7184; Brejchova, Jana/0000-0002-2126-6671; Vosahlikova, Miroslava/0000-0003-4832-7953	Grant Agency of the Czech Republic [P207/12/0919]; Institute of Physiology, Academy of Sciences of the Czech Republic [RVO:67985823]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Institute of Physiology, Academy of Sciences of the Czech Republic	This work was supported by the Grant Agency of the Czech Republic (P207/12/0919) and from institutional project of the Institute of Physiology, Academy of Sciences of the Czech Republic (RVO:67985823). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Alves ID, 2005, BIOCHEMISTRY-US, V44, P9168, DOI 10.1021/bi050207a; Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Bourova L, 2003, J NEUROCHEM, V85, P34, DOI 10.1046/j.1471-4159.2003.01667.x; Brejchova J, 2011, BBA-BIOMEMBRANES, V1808, P2819, DOI 10.1016/j.bbamem.2011.08.010; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Brown DA, 1997, BIOCHEM BIOPH RES CO, V240, P1, DOI 10.1006/bbrc.1997.7575; Brown DA, 1998, J MEMBRANE BIOL, V164, P103, DOI 10.1007/s002329900397; Cvejic S, 1997, J BIOL CHEM, V272, P26959, DOI 10.1074/jbc.272.43.26959; De Luca A, 2000, J CELL BIOCHEM, V77, P529, DOI 10.1002/(SICI)1097-4644(20000615)77:4<529::AID-JCB2>3.0.CO;2-X; Dessy C, 2000, EMBO J, V19, P4272, DOI 10.1093/emboj/19.16.4272; deWeerd WFC, 1997, J BIOL CHEM, V272, P17858, DOI 10.1074/jbc.272.28.17858; Epand RF, 2006, BIOCHEMISTRY-US, V45, P6105, DOI 10.1021/bi060245+; Epand RM, 2005, J MOL BIOL, V345, P339, DOI 10.1016/j.jmb.2004.10.064; Feron O, 1997, J BIOL CHEM, V272, P17744, DOI 10.1074/jbc.272.28.17744; George SR, 2000, J BIOL CHEM, V275, P26128, DOI 10.1074/jbc.M000345200; Gomes I, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0007.2000; GROSS W, 1991, MOL PHARMACOL, V39, P524; Harder T, 1997, CURR OPIN CELL BIOL, V9, P534, DOI 10.1016/S0955-0674(97)80030-0; He L, 2002, CELL, V108, P271, DOI 10.1016/S0092-8674(02)00613-X; Huang P, 2007, BIOCHEM PHARMACOL, V73, P534, DOI 10.1016/j.bcp.2006.10.032; Jensen MO, 2004, BBA-BIOMEMBRANES, V1666, P205, DOI 10.1016/j.bbamem.2004.06.009; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; KAWATO S, 1977, BIOCHEMISTRY-US, V16, P2319, DOI 10.1021/bi00630a002; KINOSITA K, 1982, BIOPHYS J, V37, P461, DOI 10.1016/S0006-3495(82)84692-4; Lasley RD, 2000, J BIOL CHEM, V275, P4417, DOI 10.1074/jbc.275.6.4417; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Lisanti Michael P., 1994, Trends in Cell Biology, V4, P231, DOI 10.1016/0962-8924(94)90114-7; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; Lohse MJ, 2010, CURR OPIN PHARMACOL, V10, P53, DOI 10.1016/j.coph.2009.10.007; LOHSE MJ, 1991, MOL PHARMACOL, V39, P517; London E, 2000, BBA-BIOMEMBRANES, V1508, P182, DOI 10.1016/S0304-4157(00)00007-1; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; McVey M, 2001, J BIOL CHEM, V276, P14092, DOI 10.1074/jbc.M008902200; Moffett S, 2000, J BIOL CHEM, V275, P2191, DOI 10.1074/jbc.275.3.2191; Monastyrskaya K, 2005, J BIOL CHEM, V280, P7135, DOI 10.1074/jbc.M405806200; Moon HE, 2001, NEUROPHARMACOLOGY, V41, P321, DOI 10.1016/S0028-3908(01)00076-4; Moravcova Z, 2004, BBA-MOL CELL RES, V1691, P51, DOI 10.1016/j.bbamcr.2003.12.004; Murthy KS, 2000, J BIOL CHEM, V275, P30211, DOI 10.1074/jbc.M002194200; Neubig RR, 1998, SEMIN NEUROSCI, V9, P189, DOI 10.1006/smns.1997.0117; NEUBIG RR, 1994, FASEB J, V8, P939, DOI 10.1096/fasebj.8.12.8088459; Oh P, 2001, MOL BIOL CELL, V12, P685, DOI 10.1091/mbc.12.3.685; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Ostrom RS, 2000, J PHARMACOL EXP THER, V294, P407; Ostrom RS, 2004, BRIT J PHARMACOL, V143, P235, DOI 10.1038/sj.bjp.0705930; Ostrom RS, 2001, J BIOL CHEM, V276, P42063, DOI 10.1074/jbc.M105348200; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; Ramsay D, 2002, BIOCHEM J, V365, P429, DOI 10.1042/BJ20020251; Remmers AE, 2000, EUR J PHARMACOL, V396, P67, DOI 10.1016/S0014-2999(00)00212-0; Rybin VO, 2003, MOL PHARMACOL, V63, P1338, DOI 10.1124/mol.63.6.1338; Rybin VO, 2000, J BIOL CHEM, V275, P41447, DOI 10.1074/jbc.M006951200; Sabourin T, 2002, MOL PHARMACOL, V61, P546, DOI 10.1124/mol.61.3.546; Salamon Z, 2000, BIOPHYS J, V79, P2463, DOI 10.1016/S0006-3495(00)76489-7; SARGIACOMO M, 1993, J CELL BIOL, V122, P789, DOI 10.1083/jcb.122.4.789; Savi P, 2006, P NATL ACAD SCI USA, V103, P11069, DOI 10.1073/pnas.0510446103; Schwencke C, 1999, J CELL BIOCHEM, V75, P64, DOI 10.1002/(SICI)1097-4644(19991001)75:1<64::AID-JCB7>3.0.CO;2-L; Shaul PW, 1998, AM J PHYSIOL-LUNG C, V275, pL843, DOI 10.1152/ajplung.1998.275.5.L843; SHINITZKY M, 1976, BIOCHIM BIOPHYS ACTA, V433, P133, DOI 10.1016/0005-2736(76)90183-8; SHINITZKY M, 1978, BIOCHIM BIOPHYS ACTA, V515, P367, DOI 10.1016/0304-4157(78)90010-2; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Smart EJ, 1999, MOL CELL BIOL, V19, P7289; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Song KS, 1996, J BIOL CHEM, V271, P15160, DOI 10.1074/jbc.271.25.15160; Steinberg SF, 2001, ANNU REV PHARMACOL, V41, P751, DOI 10.1146/annurev.pharmtox.41.1.751; STICKLE D, 1993, MOL PHARMACOL, V43, P397; Stickle D, 1996, BBA-MOL CELL RES, V1310, P242, DOI 10.1016/0167-4889(95)00147-6; Stohr J, 2004, DEV BRAIN RES, V151, P67, DOI 10.1016/j.devbrainres.2004.03.014; Sykora J, 2009, BBA-BIOMEMBRANES, V1788, P324, DOI 10.1016/j.bbamem.2008.11.008; TOLKOVSKY AM, 1978, BIOCHEMISTRY-US, V17, P3795, DOI 10.1021/bi00611a020; Ushio-Fukai M, 2001, J BIOL CHEM, V276, P48269, DOI 10.1074/jbc.M105901200; Xu W, 2006, J PHARMACOL EXP THER, V317, P1295, DOI 10.1124/jpet.105.099507; Zhao H, 2006, MOL PHARMACOL, V69, P1421, DOI 10.1124/mol.105.020024; Zheng H, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-6	77	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135664	10.1371/journal.pone.0135664	http://dx.doi.org/10.1371/journal.pone.0135664			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285205	Green Published, gold, Green Submitted			2022-12-26	WOS:000359666100055
J	Shimokawabe, A; Yamaura, Y; Akasaka, T; Sato, T; Shida, Y; Yamanaka, S; Nakamura, F				Shimokawabe, Ayuma; Yamaura, Yuichi; Akasaka, Takumi; Sato, Tomonori; Shida, Yuichiro; Yamanaka, Satoshi; Nakamura, Futoshi			The Distribution of Cool Spots as Microrefugia in a Mountainous Area	PLOS ONE			English	Article							CLIMATE-CHANGE; SCALE; PROJECTIONS; CAPACITY; IMPACTS; REFUGIA; FUTURE; MODELS; MAXENT	It has recently been proposed that microrefugia played an important role in species survival during past climate change events. However, the current distributions of microrefugia remain largely unknown. Wind-hole sites are areas affected by preferential flows of cool air generated in interstitial spaces created by rock fragments or colluvia. Alpine plant species occurring in lowland wind-hole sites isolated from alpine zones may be relicts of the last glacial period. Hokkaido, northern Japan, is known to contain many wind-hole sites in which alpine plant species can occur. Here we surveyed 55 wind-hole sites in the Kitami region, eastern Hokkaido, and observed two alpine plant species (lingonberry, Vaccinium vitis-idaea, and Labrador tea, Rhododendron groenlandicum ssp. diversipilosum var. diversipilosum) in 14 wind-hole sites. Statistical modeling showed that wind-hole sites are likely to occur in areas with high maximum slope angles and volcanic rock cover, and concave surfaces. Our predictions of wind-hole site distributions suggest that such topographic conditions are common in our study area, and that many undiscovered wind-hole sites exist. Ignoring microhabitats may greatly underestimate species distributions in topographically complex regions, and dispersed cool spots may also function as stepping stones and temporal habitats for cold-adapted species. Because these localized unique habitats usually occur in economically unproductive sites, identifying and protecting potential microrefugia (cool spots) would be a robust and cost-effective mitigation of climate change impacts.	[Shimokawabe, Ayuma; Yamaura, Yuichi; Akasaka, Takumi; Shida, Yuichiro; Yamanaka, Satoshi; Nakamura, Futoshi] Hokkaido Univ, Grad Sch Agr, Div Environm Resources, Sapporo, Hokkaido, Japan; [Sato, Tomonori] Hokkaido Univ, Fac Environm Earth Sci, Sapporo, Hokkaido, Japan; [Yamaura, Yuichi] Forestry & Forest Prod Res Inst, Dept Forest Vegetat, Tsukuba, Ibaraki 305, Japan; [Akasaka, Takumi] Obihiro Univ Agr & Vet Med, Lab Wildlife Ecol, Obihiro, Hokkaido 080, Japan	Hokkaido University; Hokkaido University; Forestry & Forest Products Research Institute - Japan; Obihiro University of Agriculture & Veterinary Medicine	Yamaura, Y (corresponding author), Hokkaido Univ, Grad Sch Agr, Div Environm Resources, Sapporo, Hokkaido, Japan.	yamaura@ffpri.affrc.go.jp	Sato, Tomonori/GOP-2277-2022; Sato, Tomonori/A-3415-2012; Yamaura, Yuichi/A-3638-2012; Nakamura, Futoshi/A-6696-2012	Sato, Tomonori/0000-0001-6541-742X; Sato, Tomonori/0000-0001-6541-742X; Yamaura, Yuichi/0000-0001-9355-4413; Nakamura, Futoshi/0000-0003-4351-2578	Japan Science Society [26-542]; JSPS KAKENHI [23248021, 23780153]	Japan Science Society; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	AS was supported by A Sasakawa Scientific Research Grant from the Japan Science Society, no. 26-542. AS YY TA YS SY FN were supported by JSPS KAKENHI Grant no. 23248021, and YY was supported by JSPS KAKENHI Grant no. 23780153. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashcroft MB, 2012, GLOBAL CHANGE BIOL, V18, P1866, DOI 10.1111/j.1365-2486.2012.02661.x; Ashcroft MB, 2010, J BIOGEOGR, V37, P1407, DOI 10.1111/j.1365-2699.2010.02300.x; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Botkin DB, 2007, BIOSCIENCE, V57, P227, DOI 10.1641/B570306; Chandler R, 2013, MAXLIKE MODEL SPECIE; deMaynadier Phillip, 1997, P68; Dobrowski SZ, 2011, GLOBAL CHANGE BIOL, V17, P1022, DOI 10.1111/j.1365-2486.2010.02263.x; Franklin J, 2013, GLOBAL CHANGE BIOL, V19, P473, DOI 10.1111/gcb.12051; Gillingham PK, 2012, DIVERS DISTRIB, V18, P990, DOI 10.1111/j.1472-4642.2012.00933.x; Guillera-Arroita G, 2014, METHODS ECOL EVOL, V5, P1192, DOI 10.1111/2041-210X.12252; Hannah L, 2014, TRENDS ECOL EVOL, V29, P390, DOI 10.1016/j.tree.2014.04.006; Hastie T, 2013, ECOGRAPHY, V36, P864, DOI 10.1111/j.1600-0587.2013.00321.x; He FL, 2011, NATURE, V473, P368, DOI 10.1038/nature09985; Higa M, 2015, DIVERS DISTRIB, V21, P46, DOI 10.1111/ddi.12255; Hjort J, 2015, CONSERV BIOL, V29, P630, DOI 10.1111/cobi.12510; Keppel G, 2015, FRONT ECOL ENVIRON, V13, P106, DOI 10.1890/140055; Lindenmayer D.B., 2002, CONSERVING FOREST BI; Lundquist JD, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD009879; Luoto M, 2008, GLOBAL CHANGE BIOL, V14, P483, DOI 10.1111/j.1365-2486.2007.01527.x; Merow C, 2014, METHODS ECOL EVOL, V5, P215, DOI 10.1111/2041-210X.12152; Mosblech NAS, 2011, J BIOGEOGR, V38, P419, DOI 10.1111/j.1365-2699.2010.02436.x; Pearson RG, 2006, TRENDS ECOL EVOL, V21, P111, DOI 10.1016/j.tree.2005.11.022; R Core Team, 2012, R LANG ENV STAT COMP; Randin CF, 2009, GLOBAL CHANGE BIOL, V15, P1557, DOI 10.1111/j.1365-2486.2008.01766.x; Royle JA, 2012, METHODS ECOL EVOL, V3, P545, DOI 10.1111/j.2041-210X.2011.00182.x; Rull V, 2009, J BIOGEOGR, V36, P481, DOI 10.1111/j.1365-2699.2008.02023.x; Ruzicka Vlastimil, 1999, Decheniana Beihefte, V37, P141; Sasaki H., 1986, Ecological Review, V21, P21; Sato K., 1995, BULL HIGAS TAISET MU, V17, P107; Sato Ken, 1993, Japanese Journal of Ecology (Sendai), V43, P91; Sawada Y, 2003, GEOMORPHOLOGY, V52, P121, DOI 10.1016/S0169-555X(02)00252-0; Shiboi T, 1975, MEM KITAMI I TECHN, V7, P163; Shiboi T, 1974, MEM KITAMI I TECHN, V5, P213; Shiboi T, 1980, KITAMI DAIGAKU RONSH, V3, P141; Shimizu C, 2004, KOMAZAWA GEOGRAPHY, V40, P121; Storlie C, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0576; Tanaka HL, 2000, J METEOROL SOC JPN, V78, P611, DOI 10.2151/jmsj1965.78.5_611; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Trivedi MR, 2008, GLOBAL CHANGE BIOL, V14, P1089, DOI 10.1111/j.1365-2486.2008.01553.x; Willis KJ, 2009, SCIENCE, V326, P806, DOI 10.1126/science.1178838	41	6	6	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135732	10.1371/journal.pone.0135732	http://dx.doi.org/10.1371/journal.pone.0135732			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285206	Green Published, gold, Green Submitted			2022-12-26	WOS:000359666100063
J	Xu, D; You, X; Wang, ZG; Zeng, QY; Xu, JH; Jiang, LD; Gong, L; Wu, FQ; Gu, JR; Tao, Y; Chen, JW; Zhao, JL; Li, MT; Zhao, Y; Zeng, XF				Xu, Dong; You, Xin; Wang, Zhengang; Zeng, Qingyu; Xu, Jianhua; Jiang, Lindi; Gong, Lu; Wu, Fengqi; Gu, Jieruo; Tao, Yi; Chen, Jinwei; Zhao, Jiuliang; Li, Mengtao; Zhao, Yan; Zeng, Xiaofeng		CSTAR	Chinese Systemic Lupus Erythematosus Treatment and Research Group Registry VI: Effect of Cigarette Smoking on the Clinical Phenotype of Chinese Patients with Systemic Lupus Erythematosus	PLOS ONE			English	Article							PRIMARY RENAL-DISEASE; ALCOHOL-CONSUMPTION; CUTANEOUS LUPUS; AUTOANTIBODY PRODUCTION; RISK; ASSOCIATION; FAILURE; COHORT; POPULATION; NEPHRITIS	Objectives Our study aimed to investigate the effect of cigarette smoking on the clinical phenotype of patients registered in the Chinese Systemic Lupus Erythematosus (SLE) Treatment and Research (CSTAR) group registry database, the first online registry of Chinese patients with SLE. Methods A prospective cross-sectional study of Chinese SLE patients was conducted using the CSTAR. Our case-control analysis was performed on age-and gender-matched subjects to explore the potential effect of cigarette smoking on the clinical manifestation of SLE. Results Smokers comprised 8.9% (65/730) of patients, and the ratio of females/males was 19/46. Thirty-nine patients were current smokers, and 26 were ex-smokers. Data showed significant differences between smokers and nonsmokers in the following areas: nephropathy (58.5% vs. 39.2%; p = 0.003), microscopic hematuria (30.8% vs. 19.1%; p = 0.025), proteinuria (53.8% vs. 34.4%; p = 0.002), and SLE Disease Activity Index(DAI) scores (12.38 +/- 8.95 vs. 9.83 +/- 6.81; p = 0.028). After adjusting for age and gender, significant differences between smokers and nonsmokers were found with photosensitivity (35.9% vs. 18%; p = 0.006), nephropathy (59.4% vs. 39.8%; p = 0.011), and proteinuria (54.7% vs. 35.2%). Although smokers tended to have greater disease severity compared with nonsmokers (SLEDAI scores: 12.58 +/- 8.89 vs. 10.5 +/- 7.09), the difference was not significant (p = 0.081). Conclusions Cigarette smoking triggers the development and exacerbation of SLE, especially with respect to renal involvement. Chinese smokers with SLE should be advised to discontinue cigarette use.	[Xu, Dong; You, Xin; Zhao, Jiuliang; Li, Mengtao; Zhao, Yan; Zeng, Xiaofeng] Beijing Union Med Coll Hosp, Peking Union Med Coll, Dept Rheumatol, Beijing 100730, Peoples R China; [Xu, Dong; You, Xin; Zhao, Jiuliang; Li, Mengtao; Zhao, Yan; Zeng, Xiaofeng] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Xu, Dong; You, Xin; Zhao, Jiuliang; Li, Mengtao; Zhao, Yan; Zeng, Xiaofeng] Minist Educ, Key Lab Rheumatol & Clin Immunol, Beijing 100730, Peoples R China; [Wang, Zhengang] Capital Med Univ, Beijing Tongren Hosp, Dept Rheumatol, Beijing 100730, Peoples R China; [Zeng, Qingyu] Shantou Univ, Coll Med, Affiliated Hosp 1, Dept Rheumatol, Shantou 515041, Peoples R China; [Xu, Jianhua] Anhui Med Univ, Affiliated Hosp 1, Dept Rheumatol, Hefei 230022, Peoples R China; [Jiang, Lindi] Fudan Univ, Zhongshan Hosp, Dept Rheumatol, Shanghai 200032, Peoples R China; [Gong, Lu] Tianjing Med Univ, Gen Hosp, Dept Rheumatol, Tianjin 300052, Peoples R China; [Wu, Fengqi] Capital Inst Pediat, Dept Rheumatol, Beijing 100020, Peoples R China; [Gu, Jieruo] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Rheumatol, Guangzhou 510630, Guangdong, Peoples R China; [Tao, Yi] Guangzhou Med Univ, Affiliated Hosp 2, Dept Rheumatol, Guangzhou 510120, Guangdong, Peoples R China; [Chen, Jinwei] Cent S Univ, Xiangya Hosp 2, Dept Rheumatol, Changsha 410011, Hunan, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Capital Medical University; Shantou University; Anhui Medical University; Fudan University; Tianjin Medical University; Capital Institute of Pediatrics (CIP); Sun Yat Sen University; Guangzhou Medical University; Central South University	Zeng, XF (corresponding author), Beijing Union Med Coll Hosp, Peking Union Med Coll, Dept Rheumatol, 1 Shuaifuyuan, Beijing 100730, Peoples R China.	xiaofeng.zeng@cstar.org.cn	Xu, Huji/AAB-2902-2021; meng, li/GVT-2063-2022; Jiuliang, Zhao/AAW-5669-2020	Xu, Huji/0000-0002-8588-118X; Jiuliang, Zhao/0000-0001-9308-2858; Zhang, Fengxiao/0000-0002-5109-4196	Chinese National Key Technology R&D Program, Ministry of Science and Technology [2008BAI59B02]; Chinese National High Technology Research and Development Program, Ministry of Science and Technology [2012AA02A513]	Chinese National Key Technology R&D Program, Ministry of Science and Technology; Chinese National High Technology Research and Development Program, Ministry of Science and Technology(National High Technology Research and Development Program of China)	This work was funded by the Chinese National Key Technology R&D Program, Ministry of Science and Technology (2008BAI59B02), and the Chinese National High Technology Research and Development Program, Ministry of Science and Technology (2012AA02A513), both received by XFZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaya-Amaya J, 2013, AUTOIMMUN DIS, V2013, DOI 10.1155/2013/794383; Bourre-Tessier J, 2013, ARTHRIT CARE RES, V65, P1275, DOI 10.1002/acr.21966; Costenbader KH, 2006, LUPUS, V15, P737, DOI 10.1177/0961203306069344; Costenbader KH, 2004, ARTHRITIS RHEUM-US, V50, P849, DOI 10.1002/art.20049; Ekblom-Kullberg S, 2013, CLIN RHEUMATOL, V32, P1219, DOI 10.1007/s10067-013-2224-4; Formica MK, 2003, J RHEUMATOL, V30, P1222; Freemer MM, 2006, ANN RHEUM DIS, V65, P581, DOI 10.1136/ard.2005.039438; Gallego H, 1999, CUTIS, V63, P231; Ghaussy NO, 2003, J RHEUMATOL, V30, P1215; Ghaussy NO, 2001, J RHEUMATOL, V28, P2449; Gustafsson JT, CIGARETTE SMOKING AN; Halimi JM, 2000, NEPHROL DIAL TRANSPL, V15, P938, DOI 10.1093/ndt/15.7.938; Halimi JM, 2000, KIDNEY INT, V58, P1285, DOI 10.1046/j.1523-1755.2000.00284.x; Hardy CJ, 1998, ANN RHEUM DIS, V57, P451, DOI 10.1136/ard.57.8.451; Harel-Meir M, 2007, NAT CLIN PRACT RHEUM, V3, P707, DOI 10.1038/ncprheum0655; Ho KT, 2005, RHEUMATOLOGY, V44, P1303, DOI 10.1093/rheumatology/kei014; Jewell ML, 2000, J AM ACAD DERMATOL, V42, P983, DOI 10.1016/S0190-9622(00)90290-1; June RR, 2013, JCR-J CLIN RHEUMATOL, V19, P367, DOI 10.1097/RHU.0000000000000017; Kiyohara C, 2012, J RHEUMATOL, V39, P1363, DOI 10.3899/jrheum.111609; Leroux G, 2007, ANN RHEUM DIS, V66, P1547, DOI 10.1136/ard.2007.072587; Li M, 2013, LUPUS, V22, P1192, DOI 10.1177/0961203313499086; MCALINDON T, 1993, ANN RHEUM DIS, V52, P720, DOI 10.1136/ard.52.10.720; Mont MA, 1997, J RHEUMATOL, V24, P654; Moraes-Fontes Maria Francisca, 2012, ISRN Rheumatol, V2012, P989218, DOI 10.5402/2012/989218; Orth SR, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000018401.82863.FD; Orth SR, 2001, TOHOKU J EXP MED, V194, P1, DOI 10.1620/tjem.194.1; Orth SR, 1998, KIDNEY INT, V54, P926, DOI 10.1046/j.1523-1755.1998.00067.x; Orth SR, 1997, KIDNEY INT, V51, P1669, DOI 10.1038/ki.1997.232; Piette EW, 2011, J INVEST DERMATOL, V131, pS86; Rahman P, J RHEUMATOL, V25, P1716; Rubin RL, 2005, TOXICOL SCI, V87, P86, DOI 10.1093/toxsci/kfi217; SanchezGuerrero J, 1996, ARTHRITIS RHEUM, V39, P657, DOI 10.1002/art.1780390418; Schiffl H, 2002, J NEPHROL, V15, P270; Simard JF, 2009, LUPUS, V18, P431, DOI 10.1177/0961203308098186; Stengel B, 2000, KIDNEY INT, V57, P2519, DOI 10.1016/S0085-2538(15)47011-5; Susanne Ekblom-Kullberg, 2014, RHEUMATOL INT, V34, P341, DOI [10.1007/s00296-013-2889-7, DOI 10.1007/S00296-013-2889-7]; Takvorian SU, 2014, LUPUS, V23, P537, DOI 10.1177/0961203313501400; Turchin I, 2009, J RHEUMATOL, V36, P2691, DOI 10.3899/jrheum.090403; WARD MM, 1992, ARCH INTERN MED, V152, P2082, DOI 10.1001/archinte.152.10.2082; Washio Masakazu, 2006, Mod Rheumatol, V16, P143; Young KA, 2014, LUPUS, V23, P360, DOI 10.1177/0961203314520838	41	10	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0134451	10.1371/journal.pone.0134451	http://dx.doi.org/10.1371/journal.pone.0134451			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26280671	Green Published, gold, Green Submitted			2022-12-26	WOS:000359664300006
J	Yang, WL; Liu, Y; Slovik, KJ; Wu, JC; Duncan, SA; Rader, DJ; Morrisey, EE				Yang, Wenli; Liu, Ying; Slovik, Katherine J.; Wu, Joseph C.; Duncan, Stephen A.; Rader, Daniel J.; Morrisey, Edward E.			Generation of iPSCs as a Pooled Culture Using Magnetic Activated Cell Sorting of Newly Reprogrammed Cells	PLOS ONE			English	Article							INTRAPATIENT VARIATIONS; DIFFERENTIATION	Although significant advancement has been made in the induced pluripotent stem cell (iPSC) field, current methods for iPSC derivation are labor intensive and costly. These methods involve manual selection, expansion, and characterization of multiple clones for each reprogrammed cell sample and therefore significantly hampers the feasibility of studies where a large number of iPSCs need to be derived. To develop higher throughput iPSC reprogramming methods, we generated iPSCs as a pooled culture using rigorous cell surface pluripotent marker selection with TRA-1-60 or SSEA4 antibodies followed by Magnetic Activated Cell Sorting (MACS). We observed that pool-selected cells are similar or identical to clonally derived iPSC lines from the same donor by all criteria examined, including stable expression of endogenous pluripotency genes, normal karyotype, loss of exogenous reprogramming factors, and in vitro spontaneous and lineage directed differentiation potential. This strategy can be generalized for iPSC generation using both integrating and non-integrating reprogramming methods. Our studies provide an attractive alternative to clonal derivation of iPSCs using rigorously selected cell pools and is amenable to automation.	[Yang, Wenli; Liu, Ying; Slovik, Katherine J.; Morrisey, Edward E.] Univ Penn, Inst Regenerat Med, Philadelphia, PA 19104 USA; [Yang, Wenli; Liu, Ying; Slovik, Katherine J.; Rader, Daniel J.; Morrisey, Edward E.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Morrisey, Edward E.] Univ Penn, Dept Cell & Dev Biol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Rader, Daniel J.] Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA 19104 USA; [Rader, Daniel J.; Morrisey, Edward E.] Univ Penn, Cardiovasc Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; [Wu, Joseph C.] Stanford Univ, Dept Med, Sch Med, Div Cardiol, Stanford, CA 94305 USA; [Wu, Joseph C.] Stanford Univ, Sch Med, Stanford Cardiovasc Inst, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Duncan, Stephen A.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Program Regenerat Med & Stem Cell Biol, Milwaukee, WI 53226 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Stanford University; Stanford University; Medical College of Wisconsin	Yang, WL (corresponding author), Univ Penn, Inst Regenerat Med, Philadelphia, PA 19104 USA.	wenliyan@mail.med.upenn.edu; emorrise@mail.med.upenn.edu	Wu, Joseph/H-1067-2013	Wu, Joseph/0000-0002-6068-8041; Duncan, Stephen/0000-0002-2507-7827	National Institutes of Health [U01-HG006398, U01-HL099776]; Health Research Formula Fund HRFF - Pennsylvania Department of Health [554248]; Institute for Regenerative Medicine of the University of Pennsylvania; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099776] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006398] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Health Research Formula Fund HRFF - Pennsylvania Department of Health; Institute for Regenerative Medicine of the University of Pennsylvania; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by National Institutes of Health grants U01-HG006398 to EEM, DJR and SAD, and U01-HL099776 to JCW; by a Health Research Formula Fund HRFF 554248 sponsored by the Pennsylvania Department of Health; and by the Institute for Regenerative Medicine of the University of Pennsylvania. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Cahan P, 2013, NAT REV MOL CELL BIO, V14, P357, DOI 10.1038/nrm3584; Cayo MA, 2012, HEPATOLOGY, V56, P2163, DOI 10.1002/hep.25871; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chou BK, 2015, STEM CELL TRANSL MED, V4, P320, DOI 10.5966/sctm.2014-0214; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Gu MX, 2015, EUR HEART J, V36, P806, DOI 10.1093/eurheartj/ehu411; Inoue H, 2014, EMBO J, V33, P409, DOI 10.1002/embj.201387098; Kahler DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059867; Li Q, 2013, PREP BIOCHEM BIOTECH, V43, P197, DOI 10.1080/10826068.2012.719846; Liang GY, 2013, CELL STEM CELL, V13, P149, DOI 10.1016/j.stem.2013.07.001; Mallanna Sunil K, 2013, Curr Protoc Stem Cell Biol, V26, DOI 10.1002/9780470151808.sc01g04s26; Mills JA, 2013, BLOOD, V122, P2047, DOI 10.1182/blood-2013-02-484444; Narsinh KH, 2011, J CLIN INVEST, V121, P1217, DOI 10.1172/JCI44635; Nasu A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053771; Noto Fallon K, 2014, BMC Res Notes, V7, P437, DOI 10.1186/1756-0500-7-437; Sgodda M, 2013, MOL THER, V21, P5, DOI 10.1038/mt.2012.273; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Singh VK, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00002; Somers A, 2010, STEM CELLS, V28, P1728, DOI 10.1002/stem.495; Sommer AG, 2012, JOVE-J VIS EXP, DOI 10.3791/4327; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thatava T, 2013, MOL THER, V21, P228, DOI 10.1038/mt.2012.245; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Valamehr B, 2012, SCI REP-UK, V2, DOI 10.1038/srep00213; Willmann CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065324; Yang W., 2012, IPSC REPROGRAMMING H; Zhou HY, 2015, STEM CELL REV REP, V11, P652, DOI 10.1007/s12015-015-9586-8	28	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0134995	10.1371/journal.pone.0134995	http://dx.doi.org/10.1371/journal.pone.0134995			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26281015	Green Submitted, gold, Green Published			2022-12-26	WOS:000359664300009
J	Bottino-Rojas, V; Talyuli, OAC; Jupatanakul, N; Sim, S; Dimopoulos, G; Venancio, TM; Bahia, AC; Sorgine, MH; Oliveira, PL; Paiva-Silva, GO				Bottino-Rojas, Vanessa; Talyuli, Octavio A. C.; Jupatanakul, Natapong; Sim, Shuzhen; Dimopoulos, George; Venancio, Thiago M.; Bahia, Ana C.; Sorgine, Marcos H.; Oliveira, Pedro L.; Paiva-Silva, Gabriela O.			Heme Signaling Impacts Global Gene Expression, Immunity and Dengue Virus Infectivity in Aedes aegypti	PLOS ONE			English	Article							GENOME-WIDE; BLOOD MEAL; VECTOR; MIDGUT; INSECT; CELLS; PROTEIN; DETOXIFICATION; MITOCHONDRIA; PROTECTION	Blood-feeding mosquitoes are exposed to high levels of heme, the product of hemoglobin degradation. Heme is a pro-oxidant that influences a variety of cellular processes. We performed a global analysis of heme-regulated Aedes aegypti (yellow fever mosquito) transcriptional changes to better understand influence on mosquito physiology at the molecular level. We observed an iron-and reactive oxygen species (ROS)-independent signaling induced by heme that comprised genes related to redox metabolism. By modulating the abundance of these transcripts, heme possibly acts as a danger signaling molecule. Furthermore, heme triggered critical changes in the expression of energy metabolism and immune response genes, altering the susceptibility towards bacteria and dengue virus. These findings seem to have implications on the adaptation of mosquitoes to hematophagy and consequently on their ability to transmit diseases. Altogether, these results may also contribute to the understanding of heme cell biology in eukaryotic cells.	[Bottino-Rojas, Vanessa; Talyuli, Octavio A. C.; Bahia, Ana C.; Sorgine, Marcos H.; Oliveira, Pedro L.; Paiva-Silva, Gabriela O.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, BR-21941902 Rio De Janeiro, Brazil; [Bahia, Ana C.; Sorgine, Marcos H.; Oliveira, Pedro L.; Paiva-Silva, Gabriela O.] INCT EM, Rio De Janeiro, Brazil; [Jupatanakul, Natapong; Sim, Shuzhen; Dimopoulos, George] Johns Hopkins Univ, W Harry Feinstone Dept Mol Microbiol & Immunol, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Sim, Shuzhen] Genome Inst Singapore, Singapore 138672, Singapore; [Venancio, Thiago M.] Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, BR-28013602 Campos Dos Goytacazes, Brazil	Universidade Federal do Rio de Janeiro; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Universidade Estadual do Norte Fluminense	Paiva-Silva, GO (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, BR-21941902 Rio De Janeiro, Brazil.	gosilva@bioqmed.ufrj.br	Jupatanakul, Natapong/GPF-9058-2022; Nascimento, Ana Cristina Bahia/G-2372-2015; Bottino-Rojas, Vanessa/AAX-2172-2020; Venancio, Thiago M/B-5003-2011; L. Oliveira, Pedro/A-9438-2010	Jupatanakul, Natapong/0000-0003-2326-4255; Nascimento, Ana Cristina Bahia/0000-0002-4584-1888; Bottino-Rojas, Vanessa/0000-0001-8019-9942; Venancio, Thiago M/0000-0002-2215-8082; Talyuli Cunha, Octavio Augusto/0000-0002-7026-463X; L. Oliveira, Pedro/0000-0003-0307-354X	FAPERJ; CNPq; National Institutes of Health/National Institute of Allergy and Infectious Disease [R21AI090188, R01AI101431, R01AI061576]; Agency for Science, Technology and Research (A*STAR), Singapore; Royal Thai Government fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI090188, R01AI061576, R01AI101431] Funding Source: NIH RePORTER	FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institutes of Health/National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR)); Royal Thai Government fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by: FAPERJ, CNPq, National Institutes of Health/National Institute of Allergy and Infectious Disease grants R21AI090188, R01AI101431, R01AI061576, a fellowship from the Agency for Science, Technology and Research (A*STAR), Singapore to SS, a Royal Thai Government fellowship to NJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoedo ND, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022264; Bonizzoni M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-82; Castello PR, 2007, J BIOL CHEM, V282, P14186, DOI 10.1074/jbc.M700827200; Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618; Cosgrove JB, 1996, MED VET ENTOMOL, V10, P260, DOI 10.1111/j.1365-2915.1996.tb00740.x; Cruz J, 2012, MOL CELL ENDOCRINOL, V349, P262, DOI 10.1016/j.mce.2011.11.006; DANSAPETRETSKI M, 1995, J BIOL CHEM, V270, P10893, DOI 10.1074/jbc.270.18.10893; Devenport M, 2006, BIOCHEMISTRY-US, V45, P9540, DOI 10.1021/bi0605991; Fallon AM, 2001, INSECT BIOCHEM MOLEC, V31, P263, DOI 10.1016/S0965-1748(00)00146-6; Barletta ABF, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-148; Gao Y, 1999, INSECT MOL BIOL, V8, P311, DOI 10.1046/j.1365-2583.1999.83119.x; Gentile C, 2005, MEM I OSWALDO CRUZ, V100, P645; Girardot F, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-74; Goncalves RLS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007854; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009; GRACE TDC, 1966, NATURE, V211, P366, DOI 10.1038/211366a0; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; HAMILTON SD, 1984, CLIN CHEM, V30, P226; Hamza I, 2012, BBA-MOL CELL RES, V1823, P1617, DOI 10.1016/j.bbamcr.2012.04.009; Heiss EH, 2013, REDOX BIOL, V1, P359, DOI 10.1016/j.redox.2013.06.001; Jones DP, 2006, ANTIOXID REDOX SIGN, V8, P1865, DOI 10.1089/ars.2006.8.1865; KOGAN PH, 1990, J MED ENTOMOL, V27, P709, DOI 10.1093/jmedent/27.4.709; Korolnek T, 2014, CELL METAB, V19, P1008, DOI 10.1016/j.cmet.2014.03.030; Kruger A, 2011, ANTIOXID REDOX SIGN, V15, P311, DOI 10.1089/ars.2010.3797; Kumar S, 2004, J BIOL CHEM, V279, P53475, DOI 10.1074/jbc.M409905200; Larsen R, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00077; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lumjuan N, 2007, INSECT BIOCHEM MOLEC, V37, P1026, DOI 10.1016/j.ibmb.2007.05.018; Molina-Cruz A, 2008, J BIOL CHEM, V283, P3217, DOI 10.1074/jbc.M705873200; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Oliveira JHM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001320; Oliveira MF, 1999, NATURE, V400, P517, DOI 10.1038/22910; Oliveira PL, 2002, FEBS LETT, V525, P3, DOI 10.1016/S0014-5793(02)03026-0; Paes MC, 2001, ARCH INSECT BIOCHEM, V48, P63, DOI 10.1002/arch.1058; Paiva-Silva GO, 2006, P NATL ACAD SCI USA, V103, P8030, DOI 10.1073/pnas.0602224103; Pakpour N, 2013, MICROBES INFECT, V15, P243, DOI 10.1016/j.micinf.2013.01.003; Pereira LOR, 2007, BIOCHEMISTRY-US, V46, P6822, DOI 10.1021/bi700011d; Porto BN, 2007, J BIOL CHEM, V282, P24430, DOI 10.1074/jbc.M703570200; Price DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022573; Ramirez JL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001561; Sanders HR, 2003, INSECT BIOCHEM MOLEC, V33, P1105, DOI 10.1016/S0965-1748(03)00124-3; SCHMITT TH, 1993, ARCH BIOCHEM BIOPHYS, V307, P96, DOI 10.1006/abbi.1993.1566; Severance S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001044; Sim S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002295; Tsiftsoglou AS, 2006, PHARMACOL THERAPEUT, V111, P327, DOI 10.1016/j.pharmthera.2005.10.017; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Weber AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034745; Wegiel B, 2014, ANTIOXID REDOX SIGN, V20, P1709, DOI 10.1089/ars.2013.5667; Wijayanti N, 2004, CURR MED CHEM, V11, P981, DOI 10.2174/0929867043455521; Wu JM, 2006, NUCLEIC ACIDS RES, V34, pW720, DOI 10.1093/nar/gkl167; Zou S, 2000, P NATL ACAD SCI USA, V97, P13726, DOI 10.1073/pnas.260496697	53	38	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135985	10.1371/journal.pone.0135985	http://dx.doi.org/10.1371/journal.pone.0135985			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275150	Green Published, gold, Green Submitted			2022-12-26	WOS:000359493600139
J	Garland, HG; Kimbro, DL				Garland, Hanna G.; Kimbro, David L.			Drought Increases Consumer Pressure on Oyster Reefs in Florida, USA	PLOS ONE			English	Article							ECOSYSTEM; ESTUARIES; SALINITY; DYNAMICS; IMPACTS; ECOLOGY	Coastal economies and ecosystems have historically depended on oyster reefs, but this habitat has declined globally by 85% because of anthropogenic activities. In a Florida estuary, we investigated the cause of newly reported losses of oysters. We found that the oyster reefs have deteriorated from north to south and that this deterioration was positively correlated with the abundance of carnivorous conchs and water salinity. In experiments across these gradients, oysters survived regardless of salinity if conchs were excluded. After determining that conchs were the proximal cause of oyster loss, we tested whether elevated water salinity was linked to conch abundance either by increasing conch growth and survivorship or by decreasing the abundance of a predator of conchs. In field experiments across a salinity gradient, we failed to detect spatial variation in predation on conchs or in conch growth and survivorship. A laboratory experiment, however, demonstrated the role of salinity by showing that conch larvae failed to survive at low salinities. Because this estuary's salinity increased in 2006 in response to reduced inputs of freshwater, we concluded that the ultimate cause of oyster decline was an increase in salinity. According to records from 2002 to 2012, oyster harvests have remained steady in the northernmost estuaries of this ecoregion (characterized by high reef biomass, low salinity, and low conch abundance) but have declined in the southernmost estuaries (characterized by lower reef biomass, increases in salinity, and increases in conch abundance). Oyster conservation in this ecoregion, which is probably one of the few that still support viable oyster populations, may be undermined by drought-induced increases in salinity causing an increased abundance of carnivorous conchs.	[Garland, Hanna G.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Kimbro, David L.] Northeastern Univ, Ctr Marine Sci, Dept Marine & Environm Sci, Nahant, MA 01908 USA	State University System of Florida; Florida State University; Northeastern University	Kimbro, DL (corresponding author), Northeastern Univ, Ctr Marine Sci, Dept Marine & Environm Sci, Nahant, MA 01908 USA.	d.kimbro@neu.edu			National Science Foundation [1338372]; National Park Service [P11AT51041]; North Carolina and Florida SeaGrant [2011-R/MG-1107]	National Science Foundation(National Science Foundation (NSF)); National Park Service; North Carolina and Florida SeaGrant	Funding provided by National Science Foundation (award #1338372 to DLK), National Park Service (Task agreement # P11AT51041 to DLK) and North Carolina and Florida SeaGrant (award # 2011-R/MG-1107 to HGG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri AH, 2012, ECOLOGY, V93, P1402, DOI 10.1890/11-1314.1; Anderegg WRL, 2012, P NATL ACAD SCI USA, V109, P233, DOI 10.1073/pnas.1107891109; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Beck MW, 2011, BIOSCIENCE, V61, P107, DOI 10.1525/bio.2011.61.2.5; Beschta RL, 2009, BIOL CONSERV, V142, P2401, DOI 10.1016/j.biocon.2009.06.015; Blasius B, 1999, NATURE, V399, P354, DOI 10.1038/20676; Boettiger C, 2013, THEOR ECOL-NETH, V6, P255, DOI 10.1007/s12080-013-0192-6; Brodie J, 2005, MAR POLLUT BULL, V51, P266, DOI 10.1016/j.marpolbul.2004.10.035; BROWN KM, 1992, J EXP MAR BIOL ECOL, V160, P67, DOI 10.1016/0022-0981(92)90111-M; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Burnham K. P., 2002, MODEL SELECTION AND; Byers JE, 2015, LIMNOL OCEANOGR, DOI [10.1002/lno.10073, DOI 10.1002/LN0.10073]; Choler P, 2001, ECOLOGY, V82, P3295, DOI 10.1890/0012-9658(2001)082[3295:FACOGI]2.0.CO;2; Crain CM, 2004, ECOLOGY, V85, P2539, DOI 10.1890/03-0745; Dayton P.K., 1972, P C CONSERVATION PRO, P81; Ellison AM, 2005, FRONT ECOL ENVIRON, V3, P479, DOI 10.1890/1540-9295(2005)003[0479:LOFSCF]2.0.CO;2; Ermgassen PSEZ, 2012, P ROY SOC B-BIOL SCI, V279, P3393, DOI 10.1098/rspb.2012.0313; ESTES JA, 1974, SCIENCE, V185, P1058, DOI 10.1126/science.185.4156.1058; GARTON D, 1980, BIOL BULL, V158, P49, DOI 10.2307/1540757; Grabowski JH, 2012, BIOSCIENCE, V62, P900, DOI 10.1525/bio.2012.62.10.10; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; HATHAWAY RALPH R., 1961, BULL MARINE SCI GULF AND CARIBBEAN, V11, P45; Hayes KA, 2009, J BIOGEOGR, V36, P28, DOI 10.1111/j.1365-2699.2008.01966.x; HECK KL, 1995, J EXP MAR BIOL ECOL, V189, P205, DOI 10.1016/0022-0981(95)00012-G; Hoffman GE, 2001, BIOL BULL, V291, P374; HOFMANN EE, 1995, J SHELLFISH RES, V14, P121; Kimbro DL, 2014, ECOL LETT, V17, P845, DOI 10.1111/ele.12293; Kimbro DL, 2012, ECOLOGY, V93, P334, DOI 10.1890/11-0596.1; Kimbro DL, 2009, OECOLOGIA, V160, P563, DOI 10.1007/s00442-009-1322-0; Kirby MX, 2000, PALAIOS, V15, P132, DOI 10.2307/3515499; Largier JL, 1997, ESTUAR COAST SHELF S, V45, P789, DOI 10.1006/ecss.1997.0279; Livingston RJ, 2000, ESTUAR COAST SHELF S, V50, P655, DOI 10.1006/ecss.1999.0597; Loftin JL, 1987, THESIS, V101; Lord JP, 2012, MAR BIOL, V159, P1177, DOI 10.1007/s00227-012-1896-7; MCLAREN BE, 1994, SCIENCE, V266, P1555, DOI 10.1126/science.266.5190.1555; MEADE RH, 1969, J SEDIMENT PETROL, V39, P222; MENZEL R. WINSTON, 1958, BULL MARINE SCI GULF AND CARIBBEAN, V8, P125; PAINE RT, 1963, ECOLOGY, V44, P63, DOI 10.2307/1933181; Petes LE, 2012, ECOL EVOL, V2, P1712, DOI 10.1002/ece3.291; Pollack JB, 2011, ESTUAR COAST, V34, P187, DOI 10.1007/s12237-010-9338-6; Robinson EM, 2014, AQUAT BIOL, V20, P111, DOI 10.3354/ab00549; Sheng YP, 2008, J COASTAL RES, P9, DOI 10.2112/SI55-002.1; SIH A, 1987, THEOR POPUL BIOL, V31, P1, DOI 10.1016/0040-5809(87)90019-0; Silliman BR, 2013, ANNU REV ECOL EVOL S, V44, P503, DOI 10.1146/annurev-ecolsys-110512-135753; Silliman BR, 2012, P NATL ACAD SCI USA, V109, P11234, DOI 10.1073/pnas.1204922109; Trenberth KE, 2007, J HYDROMETEOROL, V8, P758, DOI 10.1175/JHM600.1; USGCRP (U.S. Global Change Research Program), 2009, GLOBAL CLIMATE CHANG; Waldbusser GG, 2013, ECOLOGY, V94, P895, DOI 10.1890/12-1179.1; Walter C., 2013, APALACHICOLA BAY OYS; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985; WILBER TP, 1982, J CRUSTACEAN BIOL, V2, P588, DOI 10.2307/1548099	51	19	21	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0125095	10.1371/journal.pone.0125095	http://dx.doi.org/10.1371/journal.pone.0125095			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275296	gold, Green Submitted, Green Published			2022-12-26	WOS:000359493600001
J	Jiao, Y; Ma, S; Li, J; Shan, LQ; Wang, YJ; Tian, M; Yang, YW; Sun, JL; Ban, JH; Chen, JH				Jiao, Yang; Ma, Sai; Li, Jing; Shan, Lequn; Wang, Yingjie; Tian, Min; Yang, Yanwei; Sun, Jinlong; Ban, Jinghao; Chen, Jihua			N-Acetyl Cysteine (NAC)-Directed Detoxification of Methacryloxylethyl Cetyl Ammonium Chloride (DMAE-CB)	PLOS ONE			English	Article							CATIONIC ANTIBACTERIAL MONOMER; DENTAL RESIN MONOMERS; 2-HYDROXYETHYL METHACRYLATE; OXIDATIVE STRESS; ADDUCT FORMATION; IN-VITRO; GLUTATHIONE; CYTOTOXICITY; APOPTOSIS; TOXICITY	Methacryloxylethyl cetyl ammonium chloride (DMAE-CB) is a polymerizable antibacterial monomer and has been proved as an effective strategy to achieve bioactive bonding with reliable bacterial inhibitory effects. However, the toxicity of DMAE-CB may hamper its wide application in clinical situations. Thus, this study was designed to investigate the toxicity of DMAE-CB and explore the possible protective effects of N-acetyl cysteine (NAC). High performance liquid chromatography (HPLC) and liquid chromatography-mass spectrometry (LC-MS) analysis showed that chemical binding of NAC and DMAE-CB occurred in a time dependent manner. Pre-incubation of fourty-eight hours is required for adequate reaction between DMAE-CB and NAC. DMAE-CB reduced human dental pulp cells (hDPCs) viability in a dose-dependent manner. The toxic effects of DMAE-CB were accompanied by increased reactive oxygen species (ROS) level and reduced glutathione (GSH) content. NAC alleviated DMAE-CB-induced oxidative stress. Annexin V/Propidium Iodide (PI) staining and Hoechst 33342 staining indicated that DMAE-CB induced apoptosis. Collapsed mitochondrial membrane potential (MMP) and activation of caspase-3 were also observed after DMAE-CB treatment. NAC rescued hDPCs from DMAE-CB-induced apoptosis, accompanied by lower level of MMP loss and caspase-3 activity. This study assists to elucidate the mechanism underlying the cytotoxic effects of DMAE-CB and provides theoretical supports for the searching of effective strategies to reduce toxicity of quaternary ammonium dental monomers.	[Jiao, Yang; Ma, Sai; Tian, Min; Yang, Yanwei; Sun, Jinlong; Ban, Jinghao; Chen, Jihua] Fourth Mil Med Univ, State Key Lab Mil Stomatol, Dept Prosthodont, Sch Stomatol, Xian 710032, Peoples R China; [Li, Jing] Fourth Mil Med Univ, Dept Orthopaed Oncol, Xijing Hosp, Xian 710032, Peoples R China; [Shan, Lequn] Fourth Mil Med Univ, Dept Orthopaed Surg, Tangdu Hosp, Xian 710032, Peoples R China; [Wang, Yingjie] Fourth Mil Med Univ, Sch Stomatol, Dept Gen & Emergency, State Key Lab Mil Stomatol, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Chen, JH (corresponding author), Fourth Mil Med Univ, State Key Lab Mil Stomatol, Dept Prosthodont, Sch Stomatol, Xian 710032, Peoples R China.	jhchen@fmmu.edu.cn	SUN, JIN/GPX-9641-2022	Chen, Ji-hua/0000-0002-1151-0693	National Nature Science Foundation of China [81130078, 81300927]; Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) [IRT13051]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This study was financially supported by grant 81130078 (principal investigator JC) and grant 81300927 (principal investigator SM) from the National Nature Science Foundation of China, and Program No. IRT13051 from the Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Eckhardt A, 2010, DENT MATER, V26, P232, DOI 10.1016/j.dental.2009.10.005; GREIM H, 1995, CHEMOSPHERE, V31, P2637, DOI 10.1016/0045-6535(95)00136-V; IMAZATO S, 1994, J DENT RES, V73, P1437, DOI 10.1177/00220345940730080701; Inacio AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019850; Jiao Y, 2015, PEERJ, V3, DOI 10.7717/peerj.868; Jimbo A, 2003, EXP CELL RES, V283, P156, DOI 10.1016/S0014-4827(02)00033-2; Kitagawa R, 2014, J DENT RES, V93, P1277, DOI 10.1177/0022034514549808; Krifka S, 2013, BIOMATERIALS, V34, P4555, DOI 10.1016/j.biomaterials.2013.03.019; Krifka S, 2012, BIOMATERIALS, V33, P5177, DOI 10.1016/j.biomaterials.2012.04.013; Lefeuvre M, 2004, J DENT RES, V83, P914, DOI 10.1177/154405910408301205; Li F, 2009, J DENT RES, V88, P372, DOI 10.1177/0022034509334499; Li F, 2011, J AM DENT ASSOC, V142, P184, DOI 10.14219/jada.archive.2011.0062; Ma S, 2013, DENT MATER, V29, P1219, DOI 10.1016/j.dental.2013.09.008; Ma S, 2011, BRAZ J MED BIOL RES, V44, P1125, DOI [10.1590/S0100-879X2011007500130, 10.1590/S0100-879X2011001100008]; Marcotte L, 2005, J COLLOID INTERF SCI, V292, P219, DOI 10.1016/j.jcis.2005.05.060; Nocca G, 2007, J DENT, V35, P187, DOI 10.1016/j.jdent.2006.07.008; Nocca G, 2011, DENT MATER, V27, pE87, DOI 10.1016/j.dental.2011.01.002; Nocca G, 2010, BIOMATERIALS, V31, P2508, DOI 10.1016/j.biomaterials.2009.12.015; Ramp U, 2003, BRIT J CANCER, V88, P1800, DOI 10.1038/sj.bjc.6600984; Sai M., 2011, BRAZ J MED BIOL RES, V44, P1125; Samuelsen JT, 2011, J BIOMED MATER RES A, V96A, P395, DOI 10.1002/jbm.a.32993; Schweikl H, 2006, J DENT RES, V85, P870, DOI 10.1177/154405910608501001; Schweikl H, 2014, BIOMATERIALS, V35, P2890, DOI 10.1016/j.biomaterials.2013.12.044; Spagnuolo G, 2013, DENT MATER, V29, pE153, DOI 10.1016/j.dental.2013.04.023; Stanislawski L, 2003, J BIOMED MATER RES A, V66A, P476, DOI 10.1002/jbm.a.10600; Suski JM, 2012, METHODS MOL BIOL, V810, P183, DOI 10.1007/978-1-61779-382-0_12; Walther UI, 2004, ARCH ORAL BIOL, V49, P125, DOI 10.1016/j.archoralbio.2003.08.008; Xiao YH, 2009, J BIOMED MATER RES B, V90B, P813, DOI 10.1002/jbm.b.31350; Zhang K, 2013, J DENT, V41, P464, DOI 10.1016/j.jdent.2013.02.001	29	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135815	10.1371/journal.pone.0135815	http://dx.doi.org/10.1371/journal.pone.0135815			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274909	Green Published, gold, Green Submitted			2022-12-26	WOS:000359493600117
J	Liu, SZ; Jiang, LG; Zhong, T; Kong, SH; Zheng, RB; Kong, FY; Zhang, C; Zhang, L; An, LG				Liu, Shuzhen; Jiang, Ligang; Zhong, Tao; Kong, Shuhui; Zheng, Rongbin; Kong, Fengyun; Zhang, Cong; Zhang, Lei; An, Liguo			Effect of Acrylamide on Oocyte Nuclear Maturation and Cumulus Cells Apoptosis in Mouse In Vitro	PLOS ONE			English	Article							DEVELOPMENTAL COMPETENCE; GRANULOSA-CELLS; CHROMOSOME CONGRESSION; MICROTUBULE DYNAMICS; ACTIVIN RECEPTOR; BOVINE OOCYTES; GERM-CELLS; EXPOSURE; COMPLEXES; MICE	Acrylamide (ACR) is a chemical compound with severe neurotoxicity, genotoxicity, carcinogenicity and reproductive toxicity. Recent studies showed that ACR impairs the function of reproductive organs, e.g., epididymis and testes. In vitro maturation of mouse oocyte is a sensitive assay to identify potential chemical hazard to female fertility. The aim of this study was to evaluate the adverse effects of ACR on the nuclear maturation and cumulus cells apoptosis of mouse oocytes in vitro. Cumulus-oocyte complexes were incubated in a maturation medium containing 0, 5, 10 and 20 mu M of ACR. Chromosome alignment and spindle morphology of oocytes was determined by immunofluorescence and confocal microscopy. Our results showed that oocytes exposed to different doses of ACR in vitro were associated with a significant decrease of oocyte maturation, significant increase of chromosome misalignment rate, occurrence of abnormal spindle configurations, and the inhibition of oocyte parthenogenetic activation. Furthermore, apoptosis of cumulus cells was determined by TUNEL and CASPASE-3 assay. Results showed that apoptosis in cumulus cells was enhanced and the expression of CASPASE-3 was increased after cumulus-oocyte complexes were exposed to ACR. Therefore, ACR may affect the nuclear maturation of oocytes via the apoptosis of cumulus cells in vitro.	[Liu, Shuzhen; Zhong, Tao; Kong, Shuhui; Zheng, Rongbin; Zhang, Cong; Zhang, Lei; An, Liguo] Shandong Normal Univ, Coll Life Sci, Key Lab Anim Resistance Res, Jinan, Peoples R China; [Jiang, Ligang] Shandong Univ, Qilu Hosp, Ctr Reprod Med, Jinan 250100, Peoples R China; [Kong, Fengyun] Shandong Univ Tradit Chinese Med, Hosp Affiliated 2, Reprod Med Ctr, Jinan, Shandong, Peoples R China	Shandong Normal University; Shandong University; Shandong University of Traditional Chinese Medicine	Liu, SZ (corresponding author), Shandong Normal Univ, Coll Life Sci, Key Lab Anim Resistance Res, Jinan, Peoples R China.	shuzhen26@163.com; anlg@sdnu.edu.cn			National Nature Science Foundation of China [31101068]; National Undergraduate Training Programs for Innovation and Entrepreneurship [201310445095 12]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Undergraduate Training Programs for Innovation and Entrepreneurship	This study was supported by the National Nature Science Foundation of China (Grant number 31101068) and National Undergraduate Training Programs for Innovation and Entrepreneurship (number 201310445095 12).	Antonio C, 2000, CELL, V102, P425, DOI 10.1016/S0092-8674(00)00048-9; Appeltant R, 2015, THERIOGENOLOGY, V83, P567, DOI 10.1016/j.theriogenology.2014.10.026; Avazeri N, 2006, BIOCHIMIE, V88, P1823, DOI 10.1016/j.biochi.2006.04.011; Brevini TAL, 2005, REPROD DOMEST ANIM, V40, P291, DOI 10.1111/j.1439-0531.2005.00592.x; Can A, 2000, MOL HUM REPROD, V6, P154, DOI 10.1093/molehr/6.2.154; Channing C P, 1980, Int Rev Physiol, V22, P117; Claus A, 2008, J CEREAL SCI, V47, P118, DOI 10.1016/j.jcs.2007.06.016; Coticchio G, 2015, HUM REPROD UPDATE, V21, P427, DOI 10.1093/humupd/dmv011; De la Fuente R, 2001, DEV BIOL, V229, P224, DOI 10.1006/dbio.2000.9947; DEARFIELD KL, 1995, MUTAT RES-FUND MOL M, V330, P71, DOI 10.1016/0027-5107(95)00037-J; DENG H, 1993, INT ARCH OCC ENV HEA, V65, P53, DOI 10.1007/BF00586059; Downs SM, 2015, REPROD FERT DEVELOP, V27, P572, DOI 10.1071/RD14343; Duan X, 2015, SCI REP-UK, V5, DOI 10.1038/srep11562; Eichenlaub-Ritter U, 2007, BIOL REPROD, V76, P784, DOI 10.1095/biolreprod.106.055111; El-Sayyad HI, 2011, NUTRITION, V27, P343, DOI 10.1016/j.nut.2010.11.005; Exon J H, 2006, J Toxicol Environ Health B Crit Rev, V9, P397, DOI 10.1080/10937400600681430; Fabritius AS, 2011, CURR OPIN CELL BIOL, V23, P78, DOI 10.1016/j.ceb.2010.07.008; Favor J, 2005, MUTAT RES-GEN TOX EN, V580, P21, DOI 10.1016/j.mrgentox.2004.09.010; Fennell TR, 2006, TOXICOL SCI, V93, P256, DOI 10.1093/toxsci/kfl069; FRIEDMAN MA, 1995, FUND APPL TOXICOL, V27, P95, DOI 10.1006/faat.1995.1112; Gandolfi TALB, 2001, THERIOGENOLOGY, V55, P1255, DOI 10.1016/S0093-691X(01)00481-2; GOTOH Y, 1991, NATURE, V349, P251, DOI 10.1038/349251a0; Grossman D, 2012, CELL BIOL TOXICOL, V28, P383, DOI 10.1007/s10565-012-9230-1; Guan HB, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0046-9; Ha AN, 2015, REPROD DOMEST ANIM, V50, P292, DOI 10.1111/rda.12487; Hall B. K., 2008, FINS LIMBS EVOLUTION; HE FS, 1989, SCAND J WORK ENV HEA, V15, P125, DOI 10.5271/sjweh.1878; Hogervorst JG, 2008, AM J CLIN NUTR, V87, P1428, DOI 10.1093/ajcn/87.5.1428; Holland N, 1999, REPROD TOXICOL, V13, P167, DOI 10.1016/S0890-6238(99)00011-8; Host E, 2002, FERTIL STERIL, V77, P511, DOI 10.1016/S0015-0282(01)03006-0; Hu Y, 2001, HUM REPROD, V16, P737, DOI 10.1093/humrep/16.4.737; Izadyar F, 1998, MOL REPROD DEV, V49, P186, DOI 10.1002/(SICI)1098-2795(199802)49:2&lt;186::AID-MRD9&gt;3.0.CO;2-L; Ju JC, 2005, THERIOGENOLOGY, V64, P1677, DOI 10.1016/j.theriogenology.2005.03.025; Konings EJM, 2003, FOOD CHEM TOXICOL, V41, P1569, DOI 10.1016/S0278-6915(03)00187-X; Lee KS, 2001, J ASSIST REPROD GEN, V18, P490, DOI 10.1023/A:1016649026353; Lenart P, 2005, NATURE, V436, P812, DOI 10.1038/nature03810; Lenie S, 2008, MUTAT RES-GEN TOX EN, V651, P71, DOI 10.1016/j.mrgentox.2007.10.017; Li R, 2000, BIOL REPROD, V63, P839, DOI 10.1095/biolreprod63.3.839; Liu SZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102064; LOPACHIN RM, 1994, NEUROTOXICOLOGY, V15, P247; MARLOWE C, 1986, TOXICOL APPL PHARM, V86, P457, DOI 10.1016/0041-008X(86)90373-X; Mattioli Mauro, 1994, Zygote, V2, P347; Matzuk MM, 2002, SCIENCE, V296, P2178, DOI 10.1126/science.1071965; Mehri S, 2012, CELL MOL NEUROBIOL, V32, P227, DOI 10.1007/s10571-011-9752-8; Meo SC, 2005, THERIOGENOLOGY, V63, P2089, DOI 10.1016/j.theriogenology.2004.08.012; Mottram DS, 2002, NATURE, V419, P448, DOI 10.1038/419448a; Pedreschi F, 2004, LEBENSM-WISS TECHNOL, V37, P679, DOI 10.1016/j.lwt.2004.03.001; Pocar P, 2005, REPRODUCTION, V130, P857, DOI 10.1530/rep.1.00761; Rossi G, 2006, REPROD TOXICOL, V22, P51, DOI 10.1016/j.reprotox.2005.11.005; Saraste A, 2000, CARDIOVASC RES, V45, P528, DOI 10.1016/S0008-6363(99)00384-3; Sidis Y, 1998, BIOL REPROD, V59, P807, DOI 10.1095/biolreprod59.4.807; Sutton ML, 2003, HUM REPROD UPDATE, V9, P35, DOI 10.1093/humupd/dmg009; Tanghe S, 2002, MOL REPROD DEV, V61, P414, DOI 10.1002/mrd.10102; Tareke E, 2002, J AGR FOOD CHEM, V50, P4998, DOI 10.1021/jf020302f; Tatemoto H, 2000, BIOL REPROD, V63, P805, DOI 10.1095/biolreprod63.3.805; TILSON HA, 1981, NEUROBEH TOXICOL TER, V3, P445; TSUDA H, 1993, MUTAGENESIS, V8, P23, DOI 10.1093/mutage/8.1.23; Tyl RW, 2000, REPROD TOXICOL, V14, P147, DOI 10.1016/S0890-6238(00)00066-6; VANDERHYDEN BC, 1990, DEV BIOL, V140, P307, DOI 10.1016/0012-1606(90)90081-S; VERDE F, 1990, NATURE, V343, P233, DOI 10.1038/343233a0; Wang Wei-Hua, 2002, Cloning and Stem Cells, V4, P269, DOI 10.1089/15362300260339557; Wei QW, 2014, REPROD TOXICOL, V46, P121, DOI 10.1016/j.reprotox.2014.03.007; Yokoo M, 2004, INT REV CYTOL, V235, P251, DOI 10.1016/S0074-7696(04)35006-0; Yuan YQ, 2005, THERIOGENOLOGY, V63, P2147, DOI 10.1016/j.theriogenology.2004.09.054; Zenzes Maria Teresa, 2004, Tob Induc Dis, V2, P151, DOI 10.1186/1617-9625-2-3-151	65	14	15	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135818	10.1371/journal.pone.0135818	http://dx.doi.org/10.1371/journal.pone.0135818			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275143	Green Submitted, gold, Green Published			2022-12-26	WOS:000359493600119
J	O'Connell, RP; Musa, H; Gomez, MS; Avula, UM; Herron, TJ; Kalifa, J; Anumonwo, JMB				O'Connell, Ryan P.; Musa, Hassan; Gomez, Mario San Martin; Avula, Uma Mahesh; Herron, Todd J.; Kalifa, Jerome; Anumonwo, Justus M. B.			Free Fatty Acid Effects on the Atrial Myocardium: Membrane Ionic Currents Are Remodeled by the Disruption of T-Tubular Architecture	PLOS ONE			English	Article							MOUSE VENTRICULAR MYOCYTES; CARDIOVASCULAR HEALTH; ADIPOSE-TISSUE; FIBRILLATION; HEART; CALCIUM; OBESITY; STRESS; PLASMA; GROWTH	Background Epicardial adiposity and plasma levels of free fatty acids (FFAs) are elevated in atrial fibrillation, heart failure and obesity, with potentially detrimental effects on myocardial function. As major components of epicardial fat, FFAs may be abnormally regulated, with a potential to detrimentally modulate electro-mechanical function. The cellular mechanisms underlying such effects of FFAs are unknown. Objective To determine the mechanisms underlying electrophysiological effects of palmitic (PA), stearic (SA) and oleic (OA) FFAs on sheep atrial myocytes. Methods We used electrophysiological techniques, numerical simulations, biochemistry and optical imaging to examine the effects of acutely (<= 15 min), short-term (4-6 hour) or 24-hour application of individual FFAs (10 mu M) on isolated ovine left atrial myocytes (LAMs). Results Acute and short-term incubation in FFAs resulted in no differences in passive or active properties of isolated left atrial myocytes (LAMs). 24-hour application had differential effects depending on the FFA. PA did not affect cellular passive properties but shortened (p<0.05) action potential duration at 30% repolarization (APD(30)). APD(50) and APD(80) were unchanged. SA had no effect on resting membrane potential but reduced membrane capacitance by 15% (p<0.05), and abbreviated APD at all values measured (p <= 0.001). OA did not significantly affect passive or active properties of LAMs. Measurement of the major voltage-gated ion channels in SA treated LAMs showed a similar to 60% reduction (p<0.01) of the L-type calcium current (ICa-L) and similar to 30% reduction (p<0.05) in the transient outward potassium current (I-TO). A human atrial cell model recapitulated SA effects on APD. Optical imaging showed that SA incubated for 24 hours altered t-tubular structure in isolated cells (p<0.0001). Conclusions SA disrupts t-tubular architecture and remodels properties of membrane ionic currents in sheep atrial myocytes, with potential implications in arrhythmogenesis.	[O'Connell, Ryan P.; Musa, Hassan; Gomez, Mario San Martin; Avula, Uma Mahesh; Herron, Todd J.; Kalifa, Jerome; Anumonwo, Justus M. B.] Univ Michigan, Sch Med, Dept Internal Med, Ctr Arrhythmia Res, Ann Arbor, MI 48109 USA; [O'Connell, Ryan P.; Herron, Todd J.; Anumonwo, Justus M. B.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Anumonwo, JMB (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Ctr Arrhythmia Res, Ann Arbor, MI 48109 USA.	anumonwo@med.umich.edu	Musa, Hassan/AAQ-1548-2021; Avula, Uma Mahesh/B-8047-2014	Avula, Uma Mahesh/0000-0002-4786-3722	American Heart Association [12PRE1205004312]; National Institutes of Health [1RO1-GM-076608]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL124319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076608] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	American Heart Association awarded predoctoral fellowship 12PRE1205004312 (to ROC) and National Institutes of Health 1RO1-GM-076608 (to JMBA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed HS, 2013, HEART RHYTHM, V10, P90, DOI 10.1016/j.hrthm.2012.08.043; Al Chekakie MO, 2010, J AM COLL CARDIOL, V56, P784, DOI 10.1016/j.jacc.2010.03.071; ANUMONWO JMB, 1990, J PHYSIOL-LONDON, V425, P145, DOI 10.1113/jphysiol.1990.sp018097; Barber MC, 2000, J ANIM SCI, V78, P62; Campbell DL, 1996, J GEN PHYSIOL, V108, P277, DOI 10.1085/jgp.108.4.277; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Cheng LF, 2011, AM J PHYSIOL-HEART C, V301, pH1984, DOI 10.1152/ajpheart.00304.2011; Dhamoon AS, 2004, CIRC RES, V94, P1332, DOI 10.1161/01.RES.0000128408.66946.67; Dibb KM, 2009, CIRC-HEART FAIL, V2, P482, DOI 10.1161/CIRCHEARTFAILURE.109.852228; Djousse L, 2013, CIRC-HEART FAIL, V6, P964, DOI 10.1161/CIRCHEARTFAILURE.113.000521; Doolan GK, 2002, FASEB J, V16, P1662, DOI 10.1096/fj.02-0084fje; Dublin S, 2006, ARCH INTERN MED, V166, P2322, DOI 10.1001/archinte.166.21.2322; EMKEN EA, 1994, AM J CLIN NUTR, V60, p1023S, DOI 10.1093/ajcn/60.6.1023S; Frisk M, 2014, AM J PHYSIOL-HEART C, V307, pH609, DOI 10.1152/ajpheart.00295.2014; Gong D., 2003, CURR OPIN ENDOCRINOL, V10, P115, DOI [10.1097/00060793-200304000-00004, DOI 10.1097/00060793-200304000-00004]; Grandi E, 2011, CIRC RES, V109, P1055, DOI 10.1161/CIRCRESAHA.111.253955; Graner M, 2013, J CLIN ENDOCR METAB, V98, P1189, DOI 10.1210/jc.2012-3190; Haim TE, 2010, J MOL CELL CARDIOL, V48, P395, DOI 10.1016/j.yjmcc.2009.10.004; Hendrickson SC, 1997, MOL CELL BIOCHEM, V166, P85, DOI 10.1023/A:1006886601825; Hong TT, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000312; ISENBERG G, 1982, PFLUG ARCH EUR J PHY, V395, P6, DOI 10.1007/BF00584963; KANG JX, 1995, P NATL ACAD SCI USA, V92, P3997, DOI 10.1073/pnas.92.9.3997; Khawaja O, 2012, AM J CARDIOL, V110, P212, DOI 10.1016/j.amjcard.2012.03.010; Kim JY, 2010, J PROTEOME RES, V9, P4368, DOI 10.1021/pr100101p; Leaf A, 2001, EUR HEART J SUPPL, V3, pD98, DOI 10.1016/S1520-765X(01)90127-0; Lemieux H, 2011, MITOCHONDRION, V11, P97, DOI 10.1016/j.mito.2010.07.014; Lenaerts I, 2009, CIRC RES, V105, P876, DOI 10.1161/CIRCRESAHA.109.206276; Lin YK, 2014, INT J CARDIOL, V176, P191, DOI 10.1016/j.ijcard.2014.07.004; Lin YK, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0293-1; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; Louch WE, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/503906; Lyon AR, 2009, P NATL ACAD SCI USA, V106, P6854, DOI 10.1073/pnas.0809777106; Maan A, 2013, J INNOVATIONS CARDIA, V4, P1077; Marshall C, 2007, BIOCHEM BIOPH RES CO, V356, P756, DOI 10.1016/j.bbrc.2007.03.047; Martins RP, 2014, CIRCULATION, V129, P1472, DOI 10.1161/CIRCULATIONAHA.113.004742; Moench I, 2013, EXP PHYSIOL, V98, P1164, DOI 10.1113/expphysiol.2013.072470; Musa H, 2013, HEART RHYTHM OFFICIA; Musa H, 2013, HEART RHYTHM, V10, P1044, DOI 10.1016/j.hrthm.2013.03.014; Pantanowitz L, 2001, HEART, V85, P253, DOI 10.1136/heart.85.3.253; Patel SP, 2005, J PHYSIOL-LONDON, V569, P7, DOI 10.1113/jphysiol.2005.086223; Rennison JH, 2009, CIRC-ARRHYTHMIA ELEC, V2, P460, DOI 10.1161/CIRCEP.109.880773; Ricci E, 2006, OBESITY, V14, P778, DOI 10.1038/oby.2006.90; RICHIERI GV, 1995, J LIPID RES, V36, P229; Riquelme CA, 2011, SCIENCE, V334, P528, DOI 10.1126/science.1210558; Sacks HS, 2007, AM HEART J, V153, P907, DOI 10.1016/j.ahj.2007.03.019; Sun H, 2006, CIRC RES, V98, P1390, DOI 10.1161/01.RES.0000223321.34482.8c; SUZUKI T, 1968, TOHOKU J EXP MED, V95, P271, DOI 10.1620/tjem.95.271; Vaidyanathan R, 2010, J BIOL CHEM; Vaidyanathan R, 2013, HEART RHYTHM, V10, P80, DOI 10.1016/j.hrthm.2012.10.002; van Oort RJ, 2011, CIRCULATION, V123, P979, DOI 10.1161/CIRCULATIONAHA.110.006437; Veiga-Lopez A, 2013, ENDOCRINOLOGY, V154, P1731, DOI 10.1210/en.2012-2145; Xu HD, 1999, J GEN PHYSIOL, V113, P661, DOI 10.1085/jgp.113.5.661	52	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0133052	10.1371/journal.pone.0133052	http://dx.doi.org/10.1371/journal.pone.0133052			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274906	gold, Green Published, Green Submitted			2022-12-26	WOS:000359493600007
J	Chang, HHY; Watanabe, G; Lieber, MR				Chang, Howard H. Y.; Watanabe, Go; Lieber, Michael R.			Unifying the DNA End-processing Roles of the Artemis Nuclease KU-DEPENDENT ARTEMIS RESECTION AT BLUNT DNA ENDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMBINED IMMUNE-DEFICIENCY; CODING JOINT FORMATION; V(D)J RECOMBINATION; PROTEIN-KINASE; ENDONUCLEASE ACTIVITY; BREAK REPAIR; PKCS; CELLS; MECHANISM; HAIRPINS	Artemis is a member of the metallo-beta-lactamase protein family of nucleases. It is essential in vertebrates because, during V(D)J recombination, the RAG complex generates hairpins when it creates the double strand breaks at V, D, and J segments, and Artemis is required to open the hairpins so that they can be joined. Artemis is a diverse endo-and exonuclease, and creating a unified model for its wide range of nuclease properties has been challenging. Here we show that Artemis resects iteratively into blunt DNA ends with an efficiency that reflects the AT-richness of the DNA end. GC-rich ends are not cut by Artemis alone because of a requirement for DNA end breathing (and confirmed using fixed pseudo-Y structures). All DNA ends are cut when both the DNA-dependent protein kinase catalytic subunit and Ku accompany Artemis but not when Ku is omitted. These are the first biochemical data demonstrating a Ku dependence of Artemis action on DNA ends of any configuration. The action of Artemis at blunt DNA ends is slower than at overhangs, consistent with a requirement for a slow DNA end breathing step preceding the cut. The AT sequence dependence, the order of strand cutting, the length of the cuts, and the Ku-dependence of Artemis action at blunt ends can be reconciled with the other nucleolytic properties of both Artemis and Artemis DNA-PKcs in a model incorporating DNA end breathing of blunt ends to form transient single to double strand boundaries that have structural similarities to hairpins and fixed 5' and 3' overhangs.	[Lieber, Michael R.] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Pathol, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Biol Sci, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Mol Microbiol, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Immunol, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California	Lieber, MR (corresponding author), Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Pathol, Los Angeles, CA 90033 USA.	lieber@usc.edu	Regan, Clinton/E-6250-2012	Lieber, Michael/0000-0001-8809-0909; Lieber, Michael/0000-0003-3700-6345	National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health (to M. R. L.). The authors declare that they have no conflicts of interest with the contents of this article.	BLOMMERS MJJ, 1989, BIOCHEMISTRY-US, V28, P7491, DOI 10.1021/bi00444a049; Dominski Z, 2007, CRIT REV BIOCHEM MOL, V42, P67, DOI 10.1080/10409230701279118; Gauss GH, 1996, MOL CELL BIOL, V16, P258; Goodarzi AA, 2004, DNA REPAIR, V3, P753, DOI 10.1016/j.dnarep.2004.03.041; Goodarzi AA, 2006, EMBO J, V25, P3880, DOI 10.1038/sj.emboj.7601255; Gu JF, 2007, NUCLEIC ACIDS RES, V35, P5755, DOI 10.1093/nar/gkm579; Gu JF, 2010, DNA REPAIR, V9, P429, DOI 10.1016/j.dnarep.2010.01.001; Huang Y, 2009, J EXP MED, V206, P893, DOI 10.1084/jem.20082396; Kulesza P, 1998, NUCLEIC ACIDS RES, V26, P3944, DOI 10.1093/nar/26.17.3944; Kurosawa A, 2008, DNA CELL BIOL, V27, P55, DOI 10.1089/dna.2007.0649; Li SC, 2014, J BIOL CHEM, V289, P7825, DOI 10.1074/jbc.M113.544874; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Lieber MR, 2004, NAT REV MOL CELL BIO, V5, P69, DOI 10.1038/nrm1281; LIEBER MR, 1988, CELL, V55, P7, DOI 10.1016/0092-8674(88)90004-9; Lu H, 2008, MOL CELL, V31, P485, DOI 10.1016/j.molcel.2008.05.029; Ma YM, 2005, DNA REPAIR, V4, P845, DOI 10.1016/j.dnarep.2005.04.013; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; MARTIN GM, 1985, ISRAEL J MED SCI, V21, P296; Moshous D, 2001, CELL, V105, P177, DOI 10.1016/S0092-8674(01)00309-9; Niewolik D, 2006, J BIOL CHEM, V281, P33900, DOI 10.1074/jbc.M606023200; Pannicke U, 2004, EMBO J, V23, P1987, DOI 10.1038/sj.emboj.7600206; Povirk Lawrence F, 2012, ISRN Mol Biol, V2012, DOI 10.5402/2012/345805; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Rooney S, 2003, J EXP MED, V197, P553, DOI 10.1084/jem.20021891; Rooney S, 2002, MOL CELL, V10, P1379, DOI 10.1016/S1097-2765(02)00755-4; Touvrey C, 2008, MOL IMMUNOL, V45, P3383, DOI 10.1016/j.molimm.2008.04.004; Tsai AG, 2009, J BIOL CHEM, V284, P7157, DOI 10.1074/jbc.M806866200; West RB, 1998, MOL CELL BIOL, V18, P5908, DOI 10.1128/MCB.18.10.5908; Yannone SM, 2008, NUCLEIC ACIDS RES, V36, P3354, DOI 10.1093/nar/gkn205	30	33	34	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24036	24050		10.1074/jbc.M115.680900	http://dx.doi.org/10.1074/jbc.M115.680900			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26276388	Green Published, hybrid			2022-12-26	WOS:000362218900001
J	Echevarria, D; Gutfraind, A; Boodram, B; Major, M; Del Valle, S; Cotler, SJ; Dahari, H				Echevarria, Desarae; Gutfraind, Alexander; Boodram, Basmattee; Major, Marian; Del Valle, Sara; Cotler, Scott J.; Dahari, Harel			Mathematical Modeling of Hepatitis C Prevalence Reduction with Antiviral Treatment Scale-Up in Persons Who Inject Drugs in Metropolitan Chicago	PLOS ONE			English	Article							VIRUS-INFECTION; UNITED-STATES; YOUNG-ADULTS; USERS; RISK; HIV; PEOPLE; MASSACHUSETTS; TRANSMISSION; RESTORATION	Background/Aim New direct-acting antivirals (DAAs) provide an opportunity to combat hepatitis C virus (HCV) infection in persons who inject drugs (PWID). Here we use a mathematical model to predict the impact of a DAA-treatment scale-up on HCV prevalence among PWID and the estimated cost in metropolitan Chicago. Methods To estimate the HCV antibody and HCV-RNA (chronic infection) prevalence among the metropolitan Chicago PWID population, we used empirical data from three large epidemiological studies. Cost of DAAs is assumed $50,000 per person. Results Approximately 32,000 PWID reside in metropolitan Chicago with an estimated HCV-RNA prevalence of 47% or 15,040 cases. Approximately 22,000 PWID (69% of the total PWID population) attend harm reduction (HR) programs, such as syringe exchange programs, and have an estimated HCV-RNA prevalence of 30%. There are about 11,000 young PWID (<30 years old) with an estimated HCV-RNA prevalence of 10% (PWID in these two subpopulations overlap). The model suggests that the following treatment scale-up is needed to reduce the baseline HCV-RNA prevalence by one-half over 10 years of treatment [cost per year, min-max in millions]: 35 per 1,000 [$50-$77] in the overall PWID population, 19 per 1,000 [$20-$26] for persons in HR programs, and 5 per 1,000 [$3-$4] for young PWID. Conclusions Treatment scale-up could dramatically reduce the prevalence of chronic HCV infection among PWID in Chicago, who are the main reservoir for on-going HCV transmission. Focusing treatment on PWID attending HR programs and/or young PWID could have a significant impact on HCV prevalence in these subpopulations at an attainable cost.	[Echevarria, Desarae; Gutfraind, Alexander; Cotler, Scott J.; Dahari, Harel] Loyola Univ Chicago, Med Ctr, Program Expt & Theoret Modeling, Div Hepatol,Dept Med, Maywood, IL 60526 USA; [Gutfraind, Alexander; Boodram, Basmattee] Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL USA; [Major, Marian] US FDA, Div Viral Prod, Ctr Biol Evaluat & Res, Silver Spring, MD USA; [Del Valle, Sara] Los Alamos Natl Lab, Energy & Infrastruct Anal Grp, Los Alamos, NM USA; [Dahari, Harel] Los Alamos Natl Lab, Theoret & Biophys Grp, Los Alamos, NM USA	Loyola University Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Food & Drug Administration (FDA); United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory	Dahari, H (corresponding author), Loyola Univ Chicago, Med Ctr, Program Expt & Theoret Modeling, Div Hepatol,Dept Med, Maywood, IL 60526 USA.	hdahari@lumc.edu	Del Valle, Sara/AAG-5148-2021	Del Valle, Sara/0000-0002-0159-1952	NIH [P20-GM103452, R01-AI078881]; U.S. Department of Energy [DE-AC52-06NA25396]; UIC Award of Excellence; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103452, P30GM110907] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy(United States Department of Energy (DOE)); UIC Award of Excellence; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by NIH grants P20-GM103452 and R01-AI078881, the U.S. Department of Energy contract DE-AC52-06NA25396 and UIC Award of Excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hakeem MS, 2010, J VIROL, V84, P10429, DOI 10.1128/JVI.01094-10; Amon JJ, 2008, CLIN INFECT DIS, V46, P1852, DOI 10.1086/588297; [Anonymous], 2014, PRIOR AUTH SOV OTH M; Armstrong GL, 2000, HEPATOLOGY, V31, P777, DOI 10.1002/hep.510310332; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Aspinall EJ, 2013, CLIN INFECT DIS, V57, pS80, DOI 10.1093/cid/cit306; Boodram B, 2010, DRUG ALCOHOL DEPEN, V111, P136, DOI 10.1016/j.drugalcdep.2010.04.003; Boodram B, 2011, DRUG ALCOHOL DEPEN, V119, P166, DOI 10.1016/j.drugalcdep.2011.06.005; Booth RE, 2006, DRUG ALCOHOL DEPEN, V82, pS49, DOI 10.1016/S0376-8716(06)80009-8; Broz D, 2008, DRUG ALCOHOL DEPEN, V94, P221, DOI 10.1016/j.drugalcdep.2007.11.020; Broz D, 2014, MMWR SURVEILL SUMM, V63, P1; Bruggmann P, 2013, HEPATOLOGY, V58, P1523, DOI 10.1002/hep.26539; CDC. Centers for Disease Control and Prevention, 2012, VIR HEP DRUG US; Centers for Disease Control and Prevention, 2010, MMWR MORBIDITY AND M, V60, P1457; Centers for Disease Control and Prevention (CDC), 2012, MMWR Morb Mortal Wkly Rep, V61, P133; Church D., 2011, Morbidity and Mortality Weekly Report, V60, P1457; Cousien A, 2015, J VIRAL HEPATITIS, V22, P213, DOI 10.1111/jvh.12337; Dahari H, 2010, GASTROENTEROLOGY, V139, P965, DOI 10.1053/j.gastro.2010.05.077; Delwart E, 2012, J INFECT DIS, V205, P875, DOI 10.1093/infdis/jir862; Dimova RB, 2013, CLIN INFECT DIS, V56, P806, DOI 10.1093/cid/cis1007; Feinstone SM, 2012, CLIN INFECT DIS, V55, pS25, DOI 10.1093/cid/cis362; Garfein RS, 2007, DRUG ALCOHOL DEPEN, V91, pS4, DOI 10.1016/j.drugalcdep.2007.05.007; Golub ET, 2007, DRUG ALCOHOL DEPEN, V91, pS30, DOI 10.1016/j.drugalcdep.2007.02.013; Grebely J, 2008, DRUG ALCOHOL DEPEN, V93, P141, DOI 10.1016/j.drugalcdep.2007.09.008; Hahn JA, 2010, ADDICTION, V105, P1254, DOI 10.1111/j.1360-0443.2010.02949.x; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Heckathorn DD, 1997, SOC PROBL, V44, P25; Hellard M, 2014, HEPATOLOGY, V60, P1861, DOI 10.1002/hep.27403; Hill A, 2014, SCIENCE, V345, P141, DOI 10.1126/science.1257737; Hill A, 2014, CLIN INFECT DIS, V58, P928, DOI 10.1093/cid/ciu012; Kohli A, 2015, LANCET, V385, P1107, DOI 10.1016/S0140-6736(14)61228-9; Leuchner L., 2008, Morbidity and Mortality Weekly Report, V57, P517; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lum PJ, 2005, SUBST USE MISUSE, V40, P1681, DOI 10.1080/10826080500222834; Major ME, 2004, HEPATOLOGY, V39, P1709, DOI 10.1002/hep.20239; Martin NK, 2013, HEPATOLOGY, V58, P1598, DOI 10.1002/hep.26431; Martin NK, 2012, HEPATOLOGY, V55, P49, DOI 10.1002/hep.24656; Martin NK, 2011, J HEPATOL, V54, P1137, DOI 10.1016/j.jhep.2010.08.029; Mehta SH, 2002, LANCET, V359, P1478, DOI 10.1016/S0140-6736(02)08435-0; Mehta SH, 2008, J COMMUN HEALTH, V33, P126, DOI 10.1007/s10900-007-9083-3; Missale G, 2012, GUT, V61, P1076, DOI 10.1136/gutjnl-2011-300515; Netski DM, 2005, CLIN INFECT DIS, V41, P667, DOI 10.1086/432478; Onofrey Shauna, 2011, Morbidity and Mortality Weekly Report, V60, P537; Osburn WO, 2010, GASTROENTEROLOGY, V138, P315, DOI 10.1053/j.gastro.2009.09.017; Page K, 2013, CLIN INFECT DIS, V56, P405, DOI 10.1093/cid/cis921; Page K, 2009, J INFECT DIS, V200, P1216, DOI 10.1086/605947; Rondinelli AJ, 2009, DRUG ALCOHOL DEPEN, V104, P167, DOI 10.1016/j.drugalcdep.2009.05.013; Sacks-Davis R, 2015, J INFECT DIS, V212, P1407, DOI 10.1093/infdis/jiv220; Shiffman ML, 2014, CURR OPIN GASTROEN, V30, P217, DOI 10.1097/MOG.0000000000000062; Sidharthan S, 2014, HEPATOL INT, V8, pS452, DOI 10.1007/s12072-013-9494-4; Spiller MW, 2015, MMWR-MORBID MORTAL W, V64, P270; Tempalski B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064789; Thorpe LE, 2002, AM J EPIDEMIOL, V155, P645, DOI 10.1093/aje/155.7.645; Williams IT, 2011, ARCH INTERN MED, V171, P242, DOI 10.1001/archinternmed.2010.511	54	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135901	10.1371/journal.pone.0135901	http://dx.doi.org/10.1371/journal.pone.0135901			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295805	Green Published, Green Submitted, gold			2022-12-26	WOS:000359926900048
J	Ghosh, A; Ratha, BN; Gayen, N; Mroue, KH; Kar, RK; Mandal, AK; Bhunia, A				Ghosh, Anirban; Ratha, Bhisma Narayan; Gayen, Nilanjan; Mroue, Kamal H.; Kar, Rajiv K.; Mandal, Atin K.; Bhunia, Anirban			Biophysical Characterization of Essential Phosphorylation at the Flexible C-Terminal Region of C-Raf with 14-3-3 zeta Protein	PLOS ONE			English	Article							TRANSFER DIFFERENCE NMR; STRUCTURAL BASIS; TARGETING RAF; CAUSE NOONAN; MEK KINASE; ACTIVATION; BINDING; 14-3-3-PROTEINS; MUTATIONS; LIGAND	Phosphorylation at the C-terminal flexible region of the C-Raf protein plays an important role in regulating its biological activity. Auto-phosphorylation at serine 621 (S621) in this region maintains C-Raf stability and activity. This phosphorylation mediates the interaction between C-Raf and scaffold protein 14-3-3 zeta to activate the downstream MEK kinase pathway. In this study, we have defined the interaction of C-terminal peptide sequence of C-Raf with 14-3-3 zeta protein and determined the possible structural adaptation of this region. Biophysical elucidation of the interaction was carried out using phosphopeptide (residue number 615-630) in the presence of 14-3-3 zeta protein. Using isothermal titration calorimetry (ITC), a high binding affinity with micro-molar range was found to exist between the peptide and 14-3-3 zeta protein, whereas the non-phosphorylated peptide did not show any appreciable binding affinity. Further interaction details were investigated using several biophysical techniques such as circular dichroism (CD), fluorescence, and nuclear magnetic resonance (NMR) spectroscopy, in addition to molecular modeling. This study provides the molecular basis for C-Raf C-terminal-derived phosphopeptide interaction with 14-3-3 zeta protein as well as structural insights responsible for phosphorylated S621-mediated 14-3-3 zeta binding at an atomic resolution.	[Ghosh, Anirban; Ratha, Bhisma Narayan; Kar, Rajiv K.; Bhunia, Anirban] Bose Inst, Dept Biophys, Kolkata 700054, India; [Gayen, Nilanjan; Mandal, Atin K.] Bose Inst, Dept Mol Med, Kolkata 700054, India; [Mroue, Kamal H.] Univ Michigan, Biophys, Ann Arbor, MI 48109 USA; [Mroue, Kamal H.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA	Department of Science & Technology (India); Bose Institute; Department of Science & Technology (India); Bose Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Mandal, AK (corresponding author), Bose Inst, Dept Mol Med, P-1-12 CIT Scheme VII M, Kolkata 700054, India.	mandalak@jcbose.ac.in; bhunia@jcbose.ac.in	RATHA, BHISMA NARAYAN/ABF-1767-2020; Ghosh, Anirban/S-9315-2017; Kar, Rajiv Kumar/O-5939-2018	RATHA, BHISMA NARAYAN/0000-0002-0829-1637; Ghosh, Anirban/0000-0001-9837-3339; Bhunia, Anirban/0000-0002-8752-2842; Kar, Rajiv Kumar/0000-0003-4629-5863; Mroue, Kamal/0000-0002-4737-6529	Bose Institute, Kolkata, India	Bose Institute, Kolkata, India(Department of Science & Technology (India))	This research was supported by Bose Institute, Kolkata, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham D, 2000, J BIOL CHEM, V275, P22300, DOI 10.1074/jbc.M003259200; Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; ALTER GM, 1983, J BIOL CHEM, V258, P4966; Banerjee V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072318; Banks JL, 2005, J COMPUT CHEM, V26, P1752, DOI 10.1002/jcc.20292; Bera S, 2015, J COLLOID INTERF SCI, V452, P148, DOI 10.1016/j.jcis.2015.04.031; Bhattacharjya S, 1997, BIOPOLYMERS, V41, P251, DOI 10.1002/(SICI)1097-0282(199703)41:3<251::AID-BIP2>3.0.CO;2-R; Bhunia A, 2012, DRUG DISCOV TODAY, V17, P505, DOI 10.1016/j.drudis.2011.12.016; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; CONKLIN DS, 1995, P NATL ACAD SCI USA, V92, P7892, DOI 10.1073/pnas.92.17.7892; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dhandapany PS, 2014, NAT GENET, V46, P635, DOI 10.1038/ng.2963; Dhillon AS, 2009, CELL SIGNAL, V21, P1645, DOI 10.1016/j.cellsig.2009.07.001; Dhillon AS, 2002, EMBO J, V21, P64, DOI 10.1093/emboj/21.1.64; DiMauro MA, 2014, BIOCHEMISTRY-US, V53, P7269, DOI 10.1021/bi501004y; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Dumaz N, 2003, J BIOL CHEM, V278, P29819, DOI 10.1074/jbc.C300182200; Fanger GR, 1998, J BIOL CHEM, V273, P3476, DOI 10.1074/jbc.273.6.3476; FANTL WJ, 1994, NATURE, V371, P612, DOI 10.1038/371612a0; Fischer A, 2009, J BIOL CHEM, V284, P3183, DOI 10.1074/jbc.M804795200; FREED E, 1994, SCIENCE, V265, P1713, DOI 10.1126/science.8085158; FU H, 1994, SCIENCE, V266, P126, DOI 10.1126/science.7939632; Gardino AK, 2006, SEMINARS CANC BIOL; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; GARDNER AM, 1994, MOL BIOL CELL, V5, P193, DOI 10.1091/mbc.5.2.193; Ghosh A, 2014, CHEMMEDCHEM, V9, P2059, DOI 10.1002/cmdc.201402238; Ghosh A, 2014, CHEMMEDCHEM, V9, P2052, DOI 10.1002/cmdc.201402215; Ghosh A, 2014, MOL BIOSYST, V10, P1596, DOI 10.1039/c4mb00111g; Grammatikakis N, 1999, MOL CELL BIOL, V19, P1661; Hekman M, 2004, J BIOL CHEM, V279, P14074, DOI 10.1074/jbc.M309620200; Hermeking H, 2006, SEMIN CANCER BIOL, V16, P183, DOI 10.1016/j.semcancer.2006.03.002; Holderfield M, 2014, NAT REV CANCER, V14, P455, DOI 10.1038/nrc3760; Honda R, 1997, BIOCHEM BIOPH RES CO, V230, P262, DOI 10.1006/bbrc.1996.5933; JELINEK T, 1994, MOL CELL BIOL, V14, P8212, DOI 10.1128/MCB.14.12.8212; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kar RK, 2013, SAR QSAR ENVIRON RES, V24, P215, DOI 10.1080/1062936X.2013.765912; Killoran RC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123934; Kubicek M, 2002, J BIOL CHEM, V277, P7913, DOI 10.1074/jbc.M108733200; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE, V3rd; LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; Liu YC, 1996, J BIOL CHEM, V271, P14591, DOI 10.1074/jbc.271.24.14591; Mashiach E, 2010, PROTEINS, V78, P3197, DOI 10.1002/prot.22790; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; Meyer B, 2003, ANGEW CHEM INT EDIT, V42, P864, DOI 10.1002/anie.200390233; MICHAUD NR, 1995, MOL CELL BIOL, V15, P3390; Mischak H, 1996, MOL CELL BIOL, V16, P5409; Moelling K, 2002, J BIOL CHEM, V277, P31099, DOI 10.1074/jbc.M111974200; Molzan M, 2013, ACS CHEM BIOL, V8, P1869, DOI 10.1021/cb4003464; Molzan M, 2010, MOL CELL BIOL, V30, P4698, DOI 10.1128/MCB.01636-09; MORRISON DK, 1993, J BIOL CHEM, V268, P17309; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; NI F, 1994, ACCOUNTS CHEM RES, V27, P257, DOI 10.1021/ar00045a001; Noble C, 2008, MOL CELL, V31, P862, DOI 10.1016/j.molcel.2008.08.026; Obsil T, 2011, SEMIN CELL DEV BIOL, V22, P663, DOI 10.1016/j.semcdb.2011.09.001; Pandit B, 2007, NAT GENET, V39, P1007, DOI 10.1038/ng2073; Rajagopalan S, 2010, NUCLEIC ACIDS RES, V38, P893, DOI 10.1093/nar/gkp1041; Rapp UR, 2006, CANCER CELL, V9, P9, DOI 10.1016/j.ccr.2005.12.022; Razzaque MA, 2007, NAT GENET, V39, P1013, DOI 10.1038/ng2078; Reyniers L, 2014, J NEUROCHEM, V131, P239, DOI 10.1111/jnc.12798; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; ROSS PD, 1981, BIOCHEMISTRY-US, V20, P3096, DOI 10.1021/bi00514a017; Roy S, 1998, MOL CELL BIOL, V18, P3947, DOI 10.1128/MCB.18.7.3947; Saravanan R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072718; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; SCHULTE TW, 1995, J BIOL CHEM, V270, P24585, DOI 10.1074/jbc.270.41.24585; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; Thorson JA, 1998, MOL CELL BIOL, V18, P5229, DOI 10.1128/MCB.18.9.5229; Tzivion G, 1998, NATURE, V394, P88, DOI 10.1038/27938; WARTMANN M, 1994, J BIOL CHEM, V269, P6695; Waterman MJF, 1998, NAT GENET, V19, P175, DOI 10.1038/542; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yip-Schneider MT, 2000, BIOCHEM J, V351, P151, DOI 10.1042/0264-6021:3510151; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	77	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135976	10.1371/journal.pone.0135976	http://dx.doi.org/10.1371/journal.pone.0135976			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295714	Green Published, gold, Green Submitted			2022-12-26	WOS:000359926900056
J	Sun, HL; Qi, C; Niu, Y; Kang, TF; Wei, YX; Jin, G; Dong, XZ; Wang, CH; Zhu, W				Sun, Hongliu; Qi, Cai; Niu, Yu; Kang, Tengfei; Wei, Yongxin; Jin, Gang; Dong, Xianzhi; Wang, Chunhua; Zhu, Wei			Detection of Cytomegalovirus Antibodies Using a Biosensor Based on Imaging Ellipsometry	PLOS ONE			English	Article							OFF-NULL ELLIPSOMETRY; IGG AVIDITY; INFECTION; DIAGNOSIS; IMMUNOGLOBULIN; VISUALIZATION; IMMUNOASSAY; SURFACE; ASSAYS	Background Cytomegalovirus (CMV) is the most common infectious cause of mental disability in new-borns in developed countries. There is an urgent need to establish an early detection and high-throughput screening method for CMV infection using portable detection devices. Methods An antibody analysis method is reported for the detection and identification of CMV antibodies in serum using a biosensor based on high spatial resolution imaging ellipsometry (BIE). CMV antigen (CMV-3A) was immobilized on silicon wafers and used to capture CMV antibodies in serum. An antibody against human immunoglobulin G (anti-IgG) was used to confirm the IgG antibody against CMV captured by the CMV-3A. Results Our results show that this assay is rapid and specific for the identification of IgG antibody against CMV. Further, patient serum was quantitatively assessed using the standard curve method, and the quantitative results were in agreement with the enzyme-linked immunosorbent assay. The CMV antibody detection sensitivity of BIE reached 0.01 IU/mL. Conclusions This novel biosensor may be a valuable diagnostic tool for analysis of IgG antibody against CMV during CMV infection screening.	[Sun, Hongliu; Wang, Chunhua] Binzhou Med Univ, Sch Pharmaceut Sci, Yantai, Peoples R China; [Qi, Cai] Chinese Acad Inspect & Quarantine, Inst Equipment Technol, Beijing 3, Peoples R China; [Niu, Yu; Kang, Tengfei; Jin, Gang] Chinese Acad Sci, Inst Mech, Beijing 100080 15, Peoples R China; [Wei, Yongxin] Beijing Inspect & Quarantine Testing Ctr, Food Lab, Beijing 6, Peoples R China; [Dong, Xianzhi] Chinese Acad Sci, Inst Biophys, Beijing 100080 15, Peoples R China; [Zhu, Wei] Shandong Acad Med Sci, Inst Radiat Med, Jinan 18877, Peoples R China	Binzhou Medical University; Chinese Academy of Inspection & Quarantine; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Biophysics, CAS; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Zhu, W (corresponding author), Shandong Acad Med Sci, Inst Radiat Med, Jinan 18877, Peoples R China.	fsszw@163.com	Niu, Yu/C-2876-2012	Niu, Yu/0000-0003-2380-1006	Yantai Science and Technology Development Fund [2012128]; Youth Backbone Teacher Fund of Binzhou Medical University; National Natural Science Fund [81202516]; Shandong Province Natural Science Fund [ZR2013HL039]; Science and technology development plan of Shandong Academy of Medical Sciences [2014-08]; Special Fund for Agro-scientific Research in the Public Interest [201303045]; National Key Scientific Instrument and Equipment Development Project of China [2012YQ090197]; National Basic Research Program (Project 973) of China [2009CB320300]; National Basic Research Program of China [2009CB320302]; National High Technology Research Development Program of China [2008AA02Z419]; International Science & Technology Cooperation Program of China [2012DFG31880]; Projects of Sino-Portugal ST Cooperation; National Natural Science Foundation of China [21305147]; Instrument Developing Project of the Chinese Academy of Sciences [KJCX2-YW-M04, KJCX2-YW-M03]	Yantai Science and Technology Development Fund; Youth Backbone Teacher Fund of Binzhou Medical University; National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Shandong Province Natural Science Fund; Science and technology development plan of Shandong Academy of Medical Sciences; Special Fund for Agro-scientific Research in the Public Interest; National Key Scientific Instrument and Equipment Development Project of China; National Basic Research Program (Project 973) of China(National Basic Research Program of China); National Basic Research Program of China(National Basic Research Program of China); National High Technology Research Development Program of China(National High Technology Research and Development Program of China); International Science & Technology Cooperation Program of China; Projects of Sino-Portugal ST Cooperation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Instrument Developing Project of the Chinese Academy of Sciences	The authors' laboratory work is supported by grants from the Yantai Science and Technology Development Fund (2012128), the Youth Backbone Teacher Fund of Binzhou Medical University, the National Natural Science Fund (81202516), the Shandong Province Natural Science Fund (ZR2013HL039), Science and technology development plan of Shandong Academy of Medical Sciences (2014-08), the Special Fund for Agro-scientific Research in the Public Interest (201303045), the National Key Scientific Instrument and Equipment Development Project of China (2012YQ090197), the National Basic Research Program (Project 973) of China (2009CB320300), the National Basic Research Program of China (2009CB320302), the National High Technology Research Development Program of China (2008AA02Z419), the International Science & Technology Cooperation Program of China (2012DFG31880), the Projects of Sino-Portugal S&T Cooperation 2010-2015, the National Natural Science Foundation of China (21305147) and the Instrument Developing Project of the Chinese Academy of Sciences (KJCX2-YW-M04, KJCX2-YW-M03).	Aabye MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039228; Adler SP, 2013, CLIN INFECT DIS, V57, pS189, DOI 10.1093/cid/cit585; ARWIN H, 1993, J COLLOID INTERF SCI, V156, P377, DOI 10.1006/jcis.1993.1125; Baalawi F, 2010, PATHOLOGY, V42, P578, DOI 10.3109/00313025.2010.508778; Breda G, 2013, PATHOG GLOB HEALTH, V107, P312, DOI 10.1179/2047773213Y.0000000114; Chen YY, 2007, APPL OPTICS, V46, P8475, DOI 10.1364/AO.46.008475; Essa S, 2000, CLIN TRANSPLANT, V14, P147, DOI 10.1034/j.1399-0012.2000.140208.x; Feron D, 2013, ANAL BIOCHEM, V433, P202, DOI 10.1016/j.ab.2012.10.012; FREEDMAN D, 1991, STATISTICS; GrangeotKeros L, 1997, J INFECT DIS, V175, P944, DOI 10.1086/513996; Han Feng, 2013, Maternal and Child Health Care of China, V28, P4738; Jin G, 2011, THIN SOLID FILMS, V519, P2750, DOI 10.1016/j.tsf.2010.12.175; Jin G, 1996, REV SCI INSTRUM, V67, P2930, DOI 10.1063/1.1147074; JIN G, 1995, ANAL BIOCHEM, V232, P69, DOI 10.1006/abio.1995.9959; Kaneko M, 2013, J PERINATOL, V33, P831, DOI 10.1038/jp.2013.87; Lazzarotto T, 1997, CLIN DIAGN LAB IMMUN, V4, P469, DOI 10.1128/CDLI.4.4.469-473.1997; Lazzarotto T, 2008, J CLIN VIROL, V41, P192, DOI 10.1016/j.jcv.2007.10.015; Liu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073842; Novak Z, 2008, J CLIN MICROBIOL, V46, P882, DOI 10.1128/JCM.01079-07; Ogawa-Goto K, 2003, J VIROL, V77, P8541, DOI 10.1128/JVI.77.15.8541-8547.2003; Qi C, 2009, J VIRAL HEPATITIS, V16, P822, DOI 10.1111/j.1365-2893.2009.01123.x; Qi C, 2011, BIOSENSORS FOR HEALT; Qi C, 2006, BIOMED MICRODEVICES, V8, P247, DOI 10.1007/s10544-006-8305-2; Qi C, 2014, SCI REP-UK, V4, DOI 10.1038/srep05341; Qi C, 2010, BIOSENS BIOELECTRON, V25, P1530, DOI 10.1016/j.bios.2009.10.030; Rajasekariah H, 2013, J MED VIROL, V85, P315, DOI 10.1002/jmv.23471; Revello MG, 2012, EUR J CLIN MICROBIOL, V31, P3331, DOI 10.1007/s10096-012-1700-0; Revello Maria Grazia, 2008, Expert Opin Med Diagn, V2, P547, DOI 10.1517/17530059.2.5.547; Revello MG, 2002, CLIN MICROBIOL REV, V15, P680, DOI 10.1128/CMR.15.4.680-715.2002; Ross SA, 2010, J INFECT DIS, V201, P386, DOI 10.1086/649903; Stenberg M., 1983, Journal de Physique Colloque, V44, P83, DOI 10.1051/jphyscol:19831017; Wang W, 2013, ANAL CHEM, V85, P4446, DOI 10.1021/ac303783j; Wang ZH, 2003, J BIOCHEM BIOPH METH, V57, P203, DOI 10.1016/S0165-022X(03)00109-X; Wang ZH, 2006, ELECTROPHORESIS, V27, P4078, DOI 10.1002/elps.200500956; Zhang HG, 2005, CLIN CHEM, V51, P1038, DOI 10.1373/clinchem.2004.043240	35	7	7	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136253	10.1371/journal.pone.0136253	http://dx.doi.org/10.1371/journal.pone.0136253			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295458	Green Submitted, gold, Green Published			2022-12-26	WOS:000359926900090
J	Pallesen, KJ; Bailey, CJ; Brattico, E; Gjedde, A; Palva, JM; Palva, S				Pallesen, Karen Johanne; Bailey, Christopher J.; Brattico, Elvira; Gjedde, Albert; Palva, J. Matias; Palva, Satu			Experience Drives Synchronization: The phase and Amplitude Dynamics of Neural Oscillations to Musical Chords Are Differentially Modulated by Musical Expertise	PLOS ONE			English	Article							GAMMA-BAND ACTIVITY; PRIMARY AUDITORY-CORTEX; SHORT-TERM-MEMORY; PITCH PERCEPTION; AWAKE MONKEY; NEURONAL OSCILLATIONS; MISMATCH NEGATIVITY; TEMPORAL DYNAMICS; EVOKED-POTENTIALS; CORTICAL ACTIVITY	Musical expertise is associated with structural and functional changes in the brain that underlie facilitated auditory perception. We investigated whether the phase locking (PL) and amplitude modulations (AM) of neuronal oscillations in response to musical chords are correlated with musical expertise and whether they reflect the prototypicality of chords in Western tonal music. To this aim, we recorded magnetoencephalography (MEG) while musicians and non-musicians were presented with common prototypical major and minor chords, and with uncommon, non-prototypical dissonant and mistuned chords, while watching a silenced movie. We then analyzed the PL and AM of ongoing oscillations in the theta (4-8 Hz) alpha (8-14 Hz), beta- (14-30 Hz) and gamma- (30-80 Hz) bands to these chords. We found that musical expertise was associated with strengthened PL of ongoing oscillations to chords over a wide frequency range during the first 300 ms from stimulus onset, as opposed to increased alpha-band AM to chords over temporal MEG channels. In musicians, the gamma- band PL was strongest to non-prototypical compared to other chords, while in non-musicians PL was strongest to minor chords. In both musicians and non-musicians the long-latency (> 200 ms) gamma-band PL was also sensitive to chord identity, and particularly to the amplitude modulations (beats) of the dissonant chord. These findings suggest that musical expertise modulates oscillation PL to musical chords and that the strength of these modulations is dependent on chord prototypicality.	[Pallesen, Karen Johanne; Gjedde, Albert] Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark; [Pallesen, Karen Johanne] Aarhus Univ Hosp, Res Clin Funct Disorders & Psychosomat, DK-8000 Aarhus, Denmark; [Pallesen, Karen Johanne; Bailey, Christopher J.; Gjedde, Albert] Aarhus Univ, Ctr Funct Integrat Neurosci, Aarhus, Denmark; [Brattico, Elvira] Univ Helsinki, Helsinki Coll Adv Studies, Helsinki, Finland; [Brattico, Elvira] Univ Helsinki, Inst Behav Sci, Cognit Brain Res Unit, Helsinki, Finland; [Gjedde, Albert] Aarhus Univ Hosp, Pathophysiol & Expt Tomog Ctr, DK-8000 Aarhus, Denmark; [Palva, J. Matias; Palva, Satu] Univ Helsinki, Ctr Neurosci, Helsinki, Finland; [Palva, Satu] Univ Helsinki, Cent Hosp, HUS Med Imaging Ctr, BioMag Lab, Helsinki, Finland	University of Copenhagen; Aarhus University; Aarhus University; University of Helsinki; University of Helsinki; Aarhus University; University of Helsinki; Hyvinkaan Sairaala; University of Helsinki; Helsinki University Central Hospital	Pallesen, KJ (corresponding author), Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark.	karepall@rm.dk	Palva, Matias/D-5837-2013; Palva, Satu/D-7400-2013; Brattico, Elvira/M-1455-2019; Palva, Satu/AAH-6938-2020; Gjedde, Albert/U-3751-2019; Gjedde, Albert/I-2452-2019	Palva, Satu/0000-0001-9496-7391; Gjedde, Albert/0000-0002-3756-7401; Brattico, Elvira/0000-0003-0676-6464; Palva, J. Matias/0000-0003-1885-2749; Bailey, Christopher/0000-0003-3318-3344	Academy of Finland [133673, 1126967, 266402, 253130, 256472]; Helsinki University Research Grants [490083, 788/51/2010]	Academy of Finland(Academy of Finland); Helsinki University Research Grants	This work was supported by the Academy of Finland, http://www.aka.fi/en-GB/A/ project numbers 133673, 1126967, 266402 (SP), and 253130, and 256472 ( MP); The Helsinki University Research Grants, http://www.helsinki.fi/tiedesaatio/english/index.htm, project numbers 490083 and 788/51/2010 (SP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken SJ, 2008, EAR HEARING, V29, P139, DOI 10.1097/AUD.0b013e31816453dc; Anaki D, 2007, NEUROIMAGE, V37, P1407, DOI 10.1016/j.neuroimage.2007.05.054; Anderson S, 2010, J NEUROSCI, V30, P4922, DOI 10.1523/JNEUROSCI.0107-10.2010; Bailey JA, 2010, EXP BRAIN RES, V204, P91, DOI 10.1007/s00221-010-2299-y; Becker R, 2008, NEUROIMAGE, V39, P707, DOI 10.1016/j.neuroimage.2007.09.016; Ben-Ari Y, 2001, TRENDS NEUROSCI, V24, P353, DOI 10.1016/S0166-2236(00)01813-0; Bendor D, 2010, J NEUROPHYSIOL, V103, P1809, DOI 10.1152/jn.00281.2009; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Besle J, 2011, J NEUROSCI, V31, P3176, DOI 10.1523/JNEUROSCI.4518-10.2011; Bidelman GM, 2011, J COGNITIVE NEUROSCI, V23, P425, DOI 10.1162/jocn.2009.21362; Bosnyak DJ, 2004, CEREB CORTEX, V14, P1088, DOI 10.1093/cercor/bhh068; Brattico E, 2003, NEUROREPORT, V14, P2489, DOI 10.1097/00001756-200312190-00039; Brattico E, 2013, PSYCHOPHYSIOLOGY, V50, P653, DOI 10.1111/psyp.12049; Brattico E, 2009, J COGNITIVE NEUROSCI, V21, P2230, DOI 10.1162/jocn.2008.21144; Brugge JF, 2009, J NEUROPHYSIOL, V102, P2358, DOI 10.1152/jn.91346.2008; Cousineau M, 2012, P NATL ACAD SCI USA, V109, P19858, DOI 10.1073/pnas.1207989109; Dellacherie D, 2011, PSYCHOPHYSIOLOGY, V48, P337, DOI 10.1111/j.1469-8986.2010.01075.x; ERICSSON KA, 1993, PSYCHOL REV, V100, P363, DOI 10.1037/0033-295X.100.3.363; Fellinger R, 2011, BRAIN RES BULL, V85, P417, DOI 10.1016/j.brainresbull.2011.03.025; Fiebach CJ, 2005, J NEUROSCI, V25, P3414, DOI 10.1523/JNEUROSCI.4107-04.2005; Fishman YI, 2000, J ACOUST SOC AM, V108, P247, DOI 10.1121/1.429461; Fishman YI, 2001, J NEUROPHYSIOL, V86, P2761, DOI 10.1152/jn.2001.86.6.2761; Fishman YI, 2000, J ACOUST SOC AM, V108, P235, DOI 10.1121/1.429460; GALAMBOS R, 1981, P NATL ACAD SCI-BIOL, V78, P2643, DOI 10.1073/pnas.78.4.2643; Gander RE, 2010, HEARING RES, V269, P81, DOI 10.1016/j.heares.2010.07.001; Garrido MI, 2009, CLIN NEUROPHYSIOL, V120, P453, DOI 10.1016/j.clinph.2008.11.029; Gill KZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008144; Gruber T, 2002, COGNITIVE BRAIN RES, V13, P377, DOI 10.1016/S0926-6410(01)00130-6; Gutschalk A, 1999, CLIN NEUROPHYSIOL, V110, P856, DOI 10.1016/S1388-2457(99)00019-X; Helmholtz HLF, 1954, SENSATIONS TONE; Herholz SC, 2012, NEURON, V76, P486, DOI 10.1016/j.neuron.2012.10.011; Herrmann CS, 2004, TRENDS COGN SCI, V8, P347, DOI 10.1016/j.tics.2004.06.006; Honkanen R, 2015, CEREB CORTEX, V25, P3788, DOI 10.1093/cercor/bhu263; Hyde KL, 2009, J NEUROSCI, V29, P3019, DOI 10.1523/JNEUROSCI.5118-08.2009; Joris PX, 2004, PHYSIOL REV, V84, P541, DOI 10.1152/physrev.00029.2003; Kaiser J, 2006, NEUROIMAGE, V30, P1376, DOI 10.1016/j.neuroimage.2005.10.042; Kaiser J, 2008, CEREB CORTEX, V18, P2286, DOI 10.1093/cercor/bhm251; Kaiser J, 2007, CEREB CORTEX, V17, P2258, DOI 10.1093/cercor/bhl134; Kaiser J, 2009, NEUROIMAGE, V44, P257, DOI 10.1016/j.neuroimage.2008.08.018; Keil A, 2010, BRAIN RES, V1313, P172, DOI 10.1016/j.brainres.2009.12.006; Koelsch S, 2001, NEUROREPORT, V12, P1385, DOI 10.1097/00001756-200105250-00019; Kraus N, 2010, NAT REV NEUROSCI, V11, P599, DOI 10.1038/nrn2882; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Kuriki S, 2006, J NEUROSCI, V26, P4046, DOI 10.1523/JNEUROSCI.3907-05.2006; Lachaux JP, 2005, NEUROIMAGE, V25, P491, DOI 10.1016/j.neuroimage.2004.11.052; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Lu T, 2001, NAT NEUROSCI, V4, P1131, DOI 10.1038/nn737; Luo H, 2007, NEURON, V54, P1001, DOI 10.1016/j.neuron.2007.06.004; Luo H, 2013, CURR BIOL, V23, P968, DOI 10.1016/j.cub.2013.04.031; Martinovic J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003781; Menning H, 2000, NEUROREPORT, V11, P817, DOI 10.1097/00001756-200003200-00032; Musacchia G, 2008, HEARING RES, V241, P34, DOI 10.1016/j.heares.2008.04.013; Musacchia G, 2007, P NATL ACAD SCI USA, V104, P15894, DOI 10.1073/pnas.0701498104; NAATANEN R, 1995, EAR HEARING, V16, P6; Ott CGM, 2013, NEUROREPORT, V24, P445, DOI 10.1097/WNR.0b013e328360abdb; Pallesen KJ, 2005, ANN NY ACAD SCI, V1060, P450, DOI 10.1196/annals.1360.047; Pallesen KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011120; Pallesen KJ, 2009, J COGNITIVE NEUROSCI, V21, P1065, DOI 10.1162/jocn.2009.21086; Palva S, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-04-j0003.2002; Palva S, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00204; Pantev C, 1998, NATURE, V392, P811, DOI 10.1038/33918; Pantev C, 2011, NEUROSCI BIOBEHAV R, V35, P2140, DOI 10.1016/j.neubiorev.2011.06.010; Patel AD, 2000, NATURE, V404, P80, DOI 10.1038/35003577; Patel AD, 2001, NAT NEUROSCI, V4, P839, DOI 10.1038/90557; Perfetti B, 2011, J NEUROSCI, V31, P14810, DOI 10.1523/JNEUROSCI.1319-11.2011; Plomin R, 2014, INTELLIGENCE, V45, P46, DOI 10.1016/j.intell.2013.06.008; PLOMP R, 1965, J ACOUST SOC AM, V38, P548, DOI 10.1121/1.1909741; Poeppel D, 2003, SPEECH COMMUN, V41, P245, DOI 10.1016/S0167-6393(02)00107-3; Ruiz MH, 2009, HUM BRAIN MAPP, V30, P1207, DOI 10.1002/hbm.20584; Schellenberg EG, 1996, PSYCHOL SCI, V7, P272, DOI 10.1111/j.1467-9280.1996.tb00373.x; Schneider P, 2002, NAT NEUROSCI, V5, P688, DOI 10.1038/nn871; SHACKLETON TM, 1994, J ACOUST SOC AM, V95, P3529, DOI 10.1121/1.409970; Shahin A, 2003, J NEUROSCI, V23, P5545; Shahin AJ, 2008, NEUROIMAGE, V41, P113, DOI 10.1016/j.neuroimage.2008.01.067; Simonton DK, 2014, INTELLIGENCE, V45, P66, DOI 10.1016/j.intell.2013.04.007; SINGER W, 1995, SCIENCE, V270, P758, DOI 10.1126/science.270.5237.758; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Singer W, 2009, COGN NEURODYNAMICS, V3, P189, DOI 10.1007/s11571-009-9087-z; SINKKONEN J, 1995, J NEUROSCI METH, V56, P99, DOI 10.1016/0165-0270(94)00111-S; SPIEGEL MF, 1984, J ACOUST SOC AM, V76, P1690, DOI 10.1121/1.391605; Steinschneider M, 1998, J ACOUST SOC AM, V104, P2935, DOI 10.1121/1.423877; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; TERHARDT E, 1978, PERCEPT PSYCHOPHYS, V23, P483, DOI 10.3758/BF03199523; van Wassenhove V, 2007, J NEUROSCI, V27, P2663, DOI 10.1523/JNEUROSCI.4844-06.2007; Vidal JR, 2006, J COGNITIVE NEUROSCI, V18, P1850, DOI 10.1162/jocn.2006.18.11.1850; Widmann A, 2007, CEREB CORTEX, V17, P2696, DOI 10.1093/cercor/bhl178; Womelsdorf T, 2007, CURR OPIN NEUROBIOL, V17, P154, DOI 10.1016/j.conb.2007.02.002; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7; Zatorre RJ, 2008, PHILOS T R SOC B, V363, P1087, DOI 10.1098/rstb.2007.2161; Zatorre RJ, 2013, SCIENCE, V342, P585, DOI 10.1126/science.1238414; Zentner MR, 1998, INFANT BEHAV DEV, V21, P483, DOI 10.1016/S0163-6383(98)90021-2; Zentner MR, 1996, NATURE, V383, P29, DOI 10.1038/383029a0; Zion-Golumbic E, 2008, NEUROIMAGE, V39, P1980, DOI 10.1016/j.neuroimage.2007.10.025; Zion-Golumbic E, 2007, CEREB CORTEX, V17, P1741, DOI 10.1093/cercor/bhl100	95	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0134211	10.1371/journal.pone.0134211	http://dx.doi.org/10.1371/journal.pone.0134211			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5KH	26291324	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000359919900004
J	Prior, JC; Naess, M; Langhammer, A; Forsmo, S				Prior, Jerilynn C.; Naess, Marit; Langhammer, Arnulf; Forsmo, Siri			Ovulation Prevalence in Women with Spontaneous Normal-Length Menstrual Cycles - A Population-Based Cohort from HUNT3, Norway	PLOS ONE			English	Article							COGNITIVE DIETARY RESTRAINT; PREMENOPAUSAL WOMEN; PROGESTERONE LEVELS; SERUM PROGESTERONE; EARLY-PREGNANCY; URINARY; DISTURBANCES; CORTISOL; RISK; CONFIRMATION	Background Ovulatory menstrual cycles are essential for women's fertility and needed to prevent bone loss. There is a medical/ cultural expectation that clinically normal menstrual cycles are inevitably ovulatory. Currently within the general population it is unknown the proportion of regular, normal-length menstrual cycles that are ovulatory. Thus, the objective of this study was to determine the population point prevalence of ovulation in premenopausal, normally menstruating women. The null hypothesis was that such cycles are ovulatory. Methods This is a single-cycle, cross-sectional, population-based study-a sub-study of the HUNT3 health study in the semi-rural county (Nord Trondelag) in mid-Norway. Participants included >3,700 spontaneously (no hormonal contraception) menstruating women, primarily Caucasian, ages 20-49.9 from that county. Participation rate was 51.9%. All reported the date previous flow started. A single, random serum progesterone level was considered ovulatory if >= 9.54 nmol/L on cycle days 14 to -3 days before usual cycle length (CL). Results Ovulation was assessed in 3,168 women mean age 41.7 (interquartile range, [IQR] 36.8 to 45.5), cycle length 28 days (d) (IQR 28 to 28) and body mass index (BMI) 26.3 kg/m2 (95% CI 26.1 to 26.4). Parity was 95.6%, 30% smoked, 61.3% exercised regularly and 18% were obese. 1,545 women with a serum progesterone level on cycle days 14 to -3 were presumed to be in the luteal phase. Of these, 63.3% of women had an ovulatory cycle (n = 978) and 37% (n = 567) were anovulatory. Women with/without ovulation did not differ in age, BMI, cycle day, menarche age, cigarette use, physical activity, % obesity or self-reported health. There were minimal differences in parity (96.7% vs. 94.5%, P = 0.04) and major differences in progesterone level (24.5 vs. 3.8 nmol/L, P = 0.001). Conclusion Anovulation in a random population occurs in over a third of clinically normal menstrual cycles.	[Prior, Jerilynn C.; Forsmo, Siri] Univ British Columbia, Ctr Menstrual Cycle & Ovulat Res, Vancouver, BC V5Z 1M9, Canada; [Prior, Jerilynn C.] Univ British Columbia, Dept Med, Div Endocrinol, Vancouver, BC, Canada; [Prior, Jerilynn C.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Prior, Jerilynn C.] Vancouver Coastal Hlth Res Inst, Vancouver, BC, Canada; [Naess, Marit; Langhammer, Arnulf] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, HUNT Res Ctr, Levanger, Norway; [Forsmo, Siri] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway	University of British Columbia; University of British Columbia; University of British Columbia; Vancouver Coastal Health Research Institute; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Prior, JC (corresponding author), Univ British Columbia, Ctr Menstrual Cycle & Ovulat Res, Vancouver, BC V5Z 1M9, Canada.	Jerilynn.prior@ubc.ca			Canadian Institutes for Health Research under the International Opportunities Programme [80033]	Canadian Institutes for Health Research under the International Opportunities Programme(Canadian Institutes of Health Research (CIHR))	The authors appreciate that The Nord-Trondelag Health Study (The HUNT Study) involves collaboration between the HUNT Research Centre (Faculty of Medicine, Norwegian University of Science and Technology, NTNU), the Nord-Trondelag County Council, the Central Norway Health Authority, and the Norwegian Institute of Public Health. This ovulation point prevalence study's hormonal analyses were funded (2005) by the Canadian Institutes for Health Research under the International Opportunities Programme (Grant # 80033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arck PC, 2008, REPROD BIOMED ONLINE, V17, P101, DOI 10.1016/S1472-6483(10)60300-8; Bedford JL, 2010, J CLIN ENDOCR METAB, V95, P3291, DOI 10.1210/jc.2009-2497; Bedford JL, 2009, EUR J OBSTET GYN R B, V146, P76, DOI 10.1016/j.ejogrb.2009.05.001; Brown JB, 2011, HUM REPROD UPDATE, V17, P141, DOI 10.1093/humupd/dmq040; De Souza MJ, 2010, HUM REPROD, V25, P491, DOI 10.1093/humrep/dep411; Gorgels WJMJ, 1997, J CLIN EPIDEMIOL, V50, P275, DOI 10.1016/S0895-4356(96)00367-8; GRATTAROLA R, 1964, CANCER, V17, P1119, DOI 10.1002/1097-0142(196409)17:9<1119::AID-CNCR2820170904>3.0.CO;2-1; Harlow SD, 2012, CLIMACTERIC, V15, P105, DOI [10.3109/13697137.2011.650656, 10.1016/j.fertnstert.2012.01.128, 10.1210/jc.2011-3362, 10.1097/gme.0b013e31824d8f40]; ISRAEL R, 1972, AM J OBSTET GYNECOL, V112, P1043, DOI 10.1016/0002-9378(72)90178-0; Kharazmi E, 2011, HEART, V97, P49, DOI 10.1136/hrt.2010.202226; Klein JD, 2006, PEDIATRICS, V118, P2245, DOI 10.1542/peds.2006-2481; Krokstad S, 2013, INT J EPIDEMIOL, V42, P968, DOI 10.1093/ije/dys095; Li DN, 2014, EPIDEMIOL REV, V36, P137, DOI 10.1093/epirev/mxt012; MACDONALD PC, 1991, ENDOCR REV, V12, P372, DOI 10.1210/edrv-12-4-372; Malcolm CE, 2003, OBSTET GYNECOL, V102, P317, DOI 10.1016/S0029-7844(03)00527-1; McLean JA, 2001, AM J CLIN NUTR, V73, P7; Mumford SL, 2011, HUM REPROD, V26, P423, DOI 10.1093/humrep/deq322; Naess M, 2011, THESIS U TROMSO UIT; Nepomnaschy PA, 2006, P NATL ACAD SCI USA, V103, P3938, DOI 10.1073/pnas.0511183103; O'Connor KA, 2006, HUM REPROD, V21, P1442, DOI 10.1093/humrep/dei497; O'Connor KA, 2009, MENOPAUSE, V16, P1178, DOI 10.1097/gme.0b013e3181aa192d; Prior J. C., 2014, J RESTORATIVE MED, V3, P85; PRIOR JC, 1990, NEW ENGL J MED, V323, P1221, DOI 10.1056/NEJM199011013231801; PRIOR JC, 1990, CLIN INVEST MED, V13, P123; Santoro N, 2003, AM J PHYSIOL-ENDOC M, V284, pE521, DOI 10.1152/ajpendo.00381.2002; Seifert-Klauss V, 2010, J OSTEOPOROS, V2010, DOI 10.4061/2010/845180; Selye H, 1939, ENDOCRINOLOGY, V25, P615, DOI 10.1210/endo-25-4-615; SHEPARD MK, 1977, FERTIL STERIL, V28, P541; Shepard R.J, 1978, PHUSICALACTIVITY AGI; Sowers M, 1998, J BONE MINER RES, V13, P1191, DOI 10.1359/jbmr.1998.13.7.1191; Vitzthum VJ, 2009, YEARB PHYS ANTHROPOL, V52, P95, DOI 10.1002/ajpa.21195; Vitzthum VJ, 2009, AM J HUM BIOL, V21, P548, DOI 10.1002/ajhb.20936; Vitzthum VJ, 2004, P NATL ACAD SCI USA, V101, P1443, DOI 10.1073/pnas.0302640101; Vitzthum VJ, 2002, HUM REPROD, V17, P1906, DOI 10.1093/humrep/17.7.1906; Vollman RF, 1977, MAJOR PROBLEMS OBSTE, V7, P11; Waller K, 1996, J CLIN ENDOCR METAB, V81, P663, DOI 10.1210/jc.81.2.663; Weiss G, 2004, JAMA-J AM MED ASSOC, V292, P2991, DOI 10.1001/jama.292.24.2991; Williams NI, 2007, AM J PHYSIOL-ENDOC M, V293, pE270, DOI 10.1152/ajpendo.00108.2007; World Health Organization Task Force, 1985, INT J FERTIL, V30, P18; Xu WH, 2004, INT J CANCER, V108, P613, DOI 10.1002/ijc.11598	40	44	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0134473	10.1371/journal.pone.0134473	http://dx.doi.org/10.1371/journal.pone.0134473			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291617	Green Published, gold, Green Submitted			2022-12-26	WOS:000359919900007
J	Sinha, R; Samaddar, S; De, RK				Sinha, Rituparna; Samaddar, Sandip; De, Rajat K.			CNV-CH: A Convex Hull Based Segmentation Approach to Detect Copy Number Variations (CNV) Using Next-Generation Sequencing Data	PLOS ONE			English	Article								Copy number variation (CNV) is a form of structural alteration in the mammalian DNA sequence, which are associated with many complex neurological diseases as well as cancer. The development of next generation sequencing (NGS) technology provides us a new dimension towards detection of genomic locations with copy number variations. Here we develop an algorithm for detecting CNVs, which is based on depth of coverage data generated by NGS technology. In this work, we have used a novel way to represent the read count data as a two dimensional geometrical point. A key aspect of detecting the regions with CNVs, is to devise a proper segmentation algorithm that will distinguish the genomic locations having a significant difference in read count data. We have designed a new segmentation approach in this context, using convex hull algorithm on the geometrical representation of read count data. To our knowledge, most algorithms have used a single distribution model of read count data, but here in our approach, we have considered the read count data to follow two different distribution models independently, which adds to the robustness of detection of CNVs. In addition, our algorithm calls CNVs based on the multiple sample analysis approach resulting in a low false discovery rate with high precision.	[Sinha, Rituparna] Heritage Inst Technol, Dept Informat Technol, Kolkata, W Bengal, India; [Samaddar, Sandip] Heritage Inst Technol, Dept Comp Sci & Engn, Kolkata, W Bengal, India; [De, Rajat K.] Indian Stat Inst, Machine Intelligence Unit, Kolkata, W Bengal, India	Heritage Institute of Technology (HITK); Heritage Institute of Technology (HITK); Indian Statistical Institute; Indian Statistical Institute Kolkata	De, RK (corresponding author), Indian Stat Inst, Machine Intelligence Unit, Kolkata, W Bengal, India.	rajat@isical.ac.in						Benjamini Y ST, 2012, NUCLEIC ACIDS RES, P41; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Buysse K, 2009, EUR J MED GENET, V52, P398, DOI 10.1016/j.ejmg.2009.09.002; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Carter NP, 2007, NAT GENET, V39, pS16, DOI 10.1038/ng2028; Goon AM, 1968, FUNDAMENTALS STAT; Ivakhno S, 2010, BIOINFORMATICS, V26, P3051, DOI 10.1093/bioinformatics/btq587; Junbo D, 2013, BMC BIOINFORMATICS, V14, P1471; Klambauer G, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks003; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Magi A, 2012, BIOINFORMATICS, V28, P470, DOI 10.1093/bioinformatics/btr707; Magi A, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr068; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Min Z, 2013, BMC BIOINFORMATICS, P14; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Szatkiewicz JP, 2013, NUCLEIC ACIDS RES, V41, P1519, DOI 10.1093/nar/gks1363; THOMAS H, 1990, INTRO ALGORITHMS; Wang ZY, 2013, J COMPUT BIOL, V20, P224, DOI 10.1089/cmb.2012.0258; Yoon ST, 2009, GENOME RES, V19, P1586, DOI 10.1101/gr.092981.109; Zhang QY, 2010, BIOINFORMATICS, V26, P464, DOI 10.1093/bioinformatics/btp708	24	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135895	10.1371/journal.pone.0135895	http://dx.doi.org/10.1371/journal.pone.0135895			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291322	Green Published, gold			2022-12-26	WOS:000359919900037
J	Derkow, K; Kruger, C; Dembny, P; Lehnardt, S				Derkow, Katja; Krueger, Christina; Dembny, Paul; Lehnardt, Seija			Microglia Induce Neurotoxic IL-17+gamma delta T Cells Dependent on TLR2, TLR4, and TLR9 Activation	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; GAMMA-DELTA; IL-17 PRODUCTION; INNATE IMMUNITY; PIVOTAL ROLE; RECEPTOR; PROMOTE; PATHOGENESIS; EXPRESSION; RESPONSES	Background Interleukin-17 (IL-17) acts as a key regulator in central nervous system (CNS) inflammation. gamma delta T cells are an important innate source of IL-17. Both IL-17+gamma delta T cells and microglia, the major resident immune cells of the brain, are involved in various CNS disorders such as multiple sclerosis and stroke. Also, activation of Toll-like receptor (TLR) signaling pathways contributes to CNS damage. However, the mechanisms underlying the regulation and interaction of these cellular and molecular components remain unclear. Objective In this study, we investigated the crosstalk between gamma delta T cells and microglia activated by TLRs in the context of neuronal damage. To this end, co-cultures of IL-17+ gamma delta T cells, neurons, and microglia were analyzed by immunocytochemistry, flow cytometry, ELISA and multiplex immunoassays. Results We report here that IL-17+ gamma delta T cells but not naive gamma delta T cells induce a dose-and time-dependent decrease of neuronal viability in vitro. While direct stimulation of gamma delta T cells with various TLR ligands did not result in up-regulation of CD69, CD25, or in IL-17 secretion, supernatants of microglia stimulated by ligands specific for TLR2, TLR4, TLR7, or TLR9 induced activation of gamma delta T cells through IL-1 beta and IL-23, as indicated by up-regulation of CD69 and CD25 and by secretion of vast amounts of IL-17. This effect was dependent on the TLR adaptor myeloid differentiation primary response gene 88 (MyD88) expressed by both gamma delta T cells and microglia, but did not require the expression of TLRs by gamma delta T cells. Similarly to cytokine-primed IL-17+ gamma delta T cells, IL-17+ gamma delta T cells induced by supernatants derived from TLR-activated microglia also caused neurotoxicity in vitro. While these neurotoxic effects required stimulation of TLR2, TLR4, or TLR9 in microglia, neuronal injury mediated by bone marrow-derived macrophages did not require TLR signaling. Neurotoxicity mediated by IL-17+ gamma delta T cells required a direct cell-cell contact between T cells and neurons. Conclusion Taken together, these results point to a crucial role for microglia activated through TLRs in polarization of gamma delta T cells towards neurotoxic IL-17+ gamma delta T cells.	[Derkow, Katja; Krueger, Christina; Dembny, Paul; Lehnardt, Seija] Charite, Dept Neurol, D-13353 Berlin, Germany; [Lehnardt, Seija] Charite, Cluster Excellence NeuroCure, D-13353 Berlin, Germany; [Lehnardt, Seija] Charite, Inst Cell Biol & Neurobiol, Ctr Anat, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Derkow, K (corresponding author), Charite, Dept Neurol, D-13353 Berlin, Germany.	katja.derkow@charite.de	Lehnardt, Seija/AAA-4113-2022		Deutsche Forschungsgemeinschaft [SFB TRR-43, NeuroCure Exc 257]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding: This research was supported by Deutsche Forschungsgemeinschaft (http://www.dfg.de/index.jsp) SFB TRR-43 and NeuroCure Exc 257 (to SL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Cameron JS, 2007, J NEUROSCI, V27, P13033, DOI 10.1523/JNEUROSCI.4290-06.2007; Carding SR, 2002, NAT REV IMMUNOL, V2, P336, DOI 10.1038/nri797; Chang J, 2013, P NATL ACAD SCI USA, V110, P2270, DOI 10.1073/pnas.1206048110; Chen ZH, 2016, J NEUROCHEM, V136, P10, DOI 10.1111/jnc.13062; Chien YH, 2014, ANNU REV IMMUNOL, V32, P121, DOI 10.1146/annurev-immunol-032713-120216; Das S, 2008, J NEUROIMMUNOL, V195, P60, DOI 10.1016/j.jneuroim.2008.01.009; Esen N, 2006, J IMMUNOL, V176, P6802, DOI 10.4049/jimmunol.176.11.6802; Fang H, 2010, FEMS IMMUNOL MED MIC, V59, P71, DOI 10.1111/j.1574-695X.2010.00663.x; GARMAN RD, 1986, CELL, V45, P733, DOI 10.1016/0092-8674(86)90787-7; Gelderblom M, 2012, BLOOD, V120, P3793, DOI 10.1182/blood-2012-02-412726; Hanamsagar R, 2011, J NEUROCHEM, V119, P736, DOI 10.1111/j.1471-4159.2011.07481.x; Heil F, 2003, EUR J IMMUNOL, V33, P2987, DOI 10.1002/eji.200324238; Hu MH, 2014, CLIN EXP IMMUNOL, V175, P268, DOI 10.1111/cei.12219; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Kang ZH, 2013, NAT NEUROSCI, V16, P1401, DOI 10.1038/nn.3505; Kaul D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037767; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Lalor SJ, 2011, J IMMUNOL, V186, P5738, DOI 10.4049/jimmunol.1003597; Lee J, 2003, P NATL ACAD SCI USA, V100, P6646, DOI 10.1073/pnas.0631696100; Lehmann SM, 2012, J IMMUNOL, V189, P1448, DOI 10.4049/jimmunol.1201078; Lehmann SM, 2012, NAT NEUROSCI, V15, P827, DOI 10.1038/nn.3113; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Liblau RS, 2013, TRENDS NEUROSCI, V36, P315, DOI 10.1016/j.tins.2013.01.008; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; Manzanero S, 2012, METHODS MOL BIOL, V844, P177, DOI 10.1007/978-1-61779-527-5_12; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; McCandless EE, 2009, J IMMUNOL, V183, P613, DOI 10.4049/jimmunol.0802258; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Miller NM, 2013, ASN NEURO, V5, DOI 10.1042/AN20120087; O'Neill L, 2000, BIOCHEM SOC T, V28, P557, DOI 10.1042/bst0280557; Odyniec A, 2004, J IMMUNOL, V173, P682, DOI 10.4049/jimmunol.173.1.682; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Petermann F, 2010, IMMUNITY, V33, P351, DOI 10.1016/j.immuni.2010.08.013; Price AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039750; Reynolds JM, 2013, TRENDS IMMUNOL, V34, P511, DOI 10.1016/j.it.2013.06.003; Reynolds JM, 2012, P NATL ACAD SCI USA, V109, P13064, DOI 10.1073/pnas.1120585109; Reynolds JM, 2010, IMMUNITY, V32, P692, DOI 10.1016/j.immuni.2010.04.010; Ribot JC, 2010, J IMMUNOL, V185, P6421, DOI 10.4049/jimmunol.1002283; Schirmer L, 2013, JAMA NEUROL, V70, P345, DOI 10.1001/2013.jamaneurol.409; Schon MP, 2006, J INVEST DERMATOL, V126, P1338, DOI 10.1038/sj.jid.5700286; Schwacha MG, 2014, INNATE IMMUN-LONDON, V20, P261, DOI 10.1177/1753425913488969; Schwacha MG, 2008, CYTOKINE, V44, P328, DOI 10.1016/j.cyto.2008.09.001; SELMAJ K, 1991, P NATL ACAD SCI USA, V88, P6452, DOI 10.1073/pnas.88.15.6452; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Siffrin V, 2010, IMMUNITY, V33, P424, DOI 10.1016/j.immuni.2010.08.018; Sonobe Y, 2005, BRAIN RES, V1040, P202, DOI 10.1016/j.brainres.2005.01.100; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Wang DD, 2009, J NEUROIMMUNOL, V212, P17, DOI 10.1016/j.jneuroim.2009.04.007; Wang WW, 2008, GLIA, V56, P241, DOI 10.1002/glia.20609; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; WUCHERPFENNIG KW, 1992, P NATL ACAD SCI USA, V89, P4588, DOI 10.1073/pnas.89.10.4588; Zhang JX, 2013, 2013 IEEE WIRELESS COMMUNICATIONS AND NETWORKING CONFERENCE WORKSHOPS (WCNCW), P1, DOI [10.1109/WCNCW.2013.6533305, 10.1109/PLASMA.2013.6633336]; Zimmermann J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057307	57	40	40	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135898	10.1371/journal.pone.0135898	http://dx.doi.org/10.1371/journal.pone.0135898			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288016	Green Submitted, Green Published, gold			2022-12-26	WOS:000360018600083
J	Felt, W; Selinger, JC; Donelan, JM; Remy, CD				Felt, Wyatt; Selinger, Jessica C.; Donelan, J. Maxwell; Remy, C. David			"Body-In-The-Loop": Optimizing Device Parameters Using Measures of Instantaneous Energetic Cost	PLOS ONE			English	Article							HUMAN WALKING; ALIGNMENT; GAIT	This paper demonstrates methods for the online optimization of assistive robotic devices such as powered prostheses, orthoses and exoskeletons. Our algorithms estimate the value of a physiological objective in real-time (with a body "in-the-loop") and use this information to identify optimal device parameters. To handle sensor data that are noisy and dynamically delayed, we rely on a combination of dynamic estimation and response surface identification. We evaluated three algorithms (Steady-State Cost Mapping, Instantaneous Cost Mapping, and Instantaneous Cost Gradient Search) with eight healthy human subjects. Steady-State Cost Mapping is an established technique that fits a cubic polynomial to averages of steady-state measures at different parameter settings. The optimal parameter value is determined from the polynomial fit. Using a continuous sweep over a range of parameters and taking into account measurement dynamics, Instantaneous Cost Mapping identifies a cubic polynomial more quickly. Instantaneous Cost Gradient Search uses a similar technique to iteratively approach the optimal parameter value using estimates of the local gradient. To evaluate these methods in a simple and repeatable way, we prescribed step frequency via a metronome and optimized this frequency to minimize metabolic energetic cost. This use of step frequency allows a comparison of our results to established techniques and enables others to replicate our methods. Our results show that all three methods achieve similar accuracy in estimating optimal step frequency. For all methods, the average error between the predicted minima and the subjects' preferred step frequencies was less than 1% with a standard deviation between 4% and 5%. Using Instantaneous Cost Mapping, we were able to reduce subject walking-time from over an hour to less than 10 minutes. While, for a single parameter, the Instantaneous Cost Gradient Search is not much faster than Steady-State Cost Mapping, the Instantaneous Cost Gradient Search extends favorably to multi-dimensional parameter spaces.	[Felt, Wyatt; Remy, C. David] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA; [Selinger, Jessica C.; Donelan, J. Maxwell] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada	University of Michigan System; University of Michigan; Simon Fraser University	Remy, CD (corresponding author), Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA.	cdremy@umich.edu.edu	Felt, Wyatt/AAC-4207-2019	Felt, Wyatt/0000-0003-3968-1889; Remy, C David/0000-0002-4072-8034	MCubed program at the University of Michigan; U.S. Army Research Office [W911NF-13-1-0268]; Natural Sciences and Engineering Research Council of Canada; Vanier Canadian Graduate Scholarship; National Science Foundation Graduate Research Fellowship [DGE 1256260]	MCubed program at the University of Michigan; U.S. Army Research Office; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Vanier Canadian Graduate Scholarship; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF))	Funding for the work of the RAMlab came through the MCubed program at the University of Michigan (CDR) (http://mcubed.umich.edu/projects/reducing-effort-through-augmented-lower-limb-prostheses). Funding for the work done by the Locomotion Lab was supported by: U.S. Army Research Office Grant #W911NF-13-1-0268 (JMD) (www.aro.army.mil), Natural Sciences and Engineering Research Council of Canada, Discovery Grant (JMD), and Vanier Canadian Graduate Scholarship (JCS) (http://www.nserc-crsng.gc.ca/). This material is based upon work supported by the National Science Foundation Graduate Research Fellowship (WF) under Grant No. DGE 1256260. Any opinion, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertram JEA, 2005, J EXP BIOL, V208, P979, DOI 10.1242/jeb.01498; Bhatnagar S, 2013, LECT NOTES CONTROL I, P434, DOI [10.1007/978-1-4471-4285-0_10, DOI 10.1007/978-1-4471-4285-0_10]; BiOM Personal Bionics, T2 PROD BROCH; Boone DA, 2012, J REHABIL RES DEV, V49, P843, DOI 10.1682/JRRD.2011.08.0143; Collins SH, 2015, NATURE, V522, P212, DOI 10.1038/nature14288; Dollar AM, 2008, IEEE T ROBOT, V24, P144, DOI 10.1109/TRO.2008.915453; Donelan JM, 2004, J BIOMECH, V37, P827, DOI 10.1016/j.jbiomech.2003.06.002; Felt W, INSTANTANEUOS COST M; Galle S, 2014, 2D PARAMETER SWEEP B; Isermann R, 2011, IDENTIFICATION OF DYNAMIC SYSTEMS: AN INTRODUCTION WITH APPLICATIONS, P1, DOI 10.1007/978-3-540-78879-9; Israel JF, 2006, PHYS THER, V86, P1466, DOI 10.2522/ptj.20050266; Kobayashi T, 2015, PROSTHET ORTHOT INT, V39, P512, DOI 10.1177/0309364614545421; LAMARRA N, 1987, J APPL PHYSIOL, V62, P2003, DOI 10.1152/jappl.1987.62.5.2003; Lawrence G., 2002, P 19 C UNC ART INT, P354; Lawson BE, 2013, IEEE INT CONF ROBOT, P3888, DOI 10.1109/ICRA.2013.6631124; Malcolm P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056137; McLean J.A., 2007, ANIMAL HUMAN CALORIM; MYERS J, 1990, J APPL PHYSIOL, V68, P404, DOI 10.1152/jappl.1990.68.1.404; Myers R. H., 2009, RESPONSE SURFACE MET, V705; Olkin I, 1960, CONTRIBUTIONS PROBAB; RALSTON H J, 1958, Int Z Angew Physiol, V17, P277; Sawicki GS, 2009, J EXP BIOL, V212, P32, DOI 10.1242/jeb.017277; Schmalz T, 2002, GAIT POSTURE, V16, P255, DOI 10.1016/S0966-6362(02)00008-5; Selinger JC, 2014, J APPL PHYSIOL, V117, P1406, DOI 10.1152/japplphysiol.00445.2014; Snaterse M, 2011, J APPL PHYSIOL, V110, P1682, DOI 10.1152/japplphysiol.00536.2010; Sup F, 2008, INT J ROBOT RES, V27, P263, DOI 10.1177/0278364907084588; Umberger BR, 2007, J EXP BIOL, V210, P3255, DOI 10.1242/jeb.000950; Zahedi M S, 1986, J Rehabil Res Dev, V23, P2; Zelik KE, 2011, IEEE T NEUR SYS REH, V19, P411, DOI 10.1109/TNSRE.2011.2159018	29	67	67	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135342	10.1371/journal.pone.0135342	http://dx.doi.org/10.1371/journal.pone.0135342			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288361	Green Published, Green Submitted, gold			2022-12-26	WOS:000360018600044
J	Wu, CY; Lin, YW; Kuo, CH; Liu, WH; Tai, HF; Pan, CH; Chen, YT; Hsiao, PW; Chan, CH; Chang, CC; Liu, CC; Chow, YH; Chen, JR				Wu, Chia-Ying; Lin, Yi-Wen; Kuo, Chia-Ho; Liu, Wan-Hsin; Tai, Hsiu-Fen; Pan, Chien-Hung; Chen, Yung-Tsung; Hsiao, Pei-Wen; Chan, Chi-Hsien; Chang, Ching-Chuan; Liu, Chung-Cheng; Chow, Yen-Hung; Chen, Juine-Ruey			Inactivated Enterovirus 71 Vaccine Produced by 200-L Scale Serum-Free Microcarrier Bioreactor System Provides Cross-Protective Efficacy in Human SCARB2 Transgenic Mouse	PLOS ONE			English	Article							COXSACKIEVIRUS A16; NEUTRALIZING ANTIBODIES; MOUTH-DISEASE; STRAIN; HAND; MICE; FOOT; IMMUNIZATION; INFECTIONS; SELECTION	Epidemics and outbreaks caused by infections of several subgenotypes of EV71 and other serotypes of coxsackie A viruses have raised serious public health concerns in the Asia-Pacific region. These concerns highlight the urgent need to develop a scalable manufacturing platform for producing an effective and sufficient quantity of vaccines against deadly enteroviruses. In this report, we present a platform for the large-scale production of a vaccine based on the inactivated EV71(E59-B4) virus. The viruses were produced in Vero cells in a 200 L bioreactor with serum-free medium, and the viral titer reached 10(7) TCID50/mL 10 days after infection when using an MOI of 10(-4). The EV71 virus particles were harvested and purified by sucrose density gradient centrifugation. Fractions containing viral particles were pooled based on ELISA and SDS-PAGE. TEM was used to characterize the morphologies of the viral particles. To evaluate the cross-protective efficacy of the EV71 vaccine, the pooled antigens were combined with squalene-based adjuvant (AddaVAX) or aluminum phosphate (AlPO4) and tested in human SCARB2 transgenic (Tg) mice. The Tg mice immunized with either the AddaVAX- or AlPO4-adjuvanted EV71 vaccine were fully protected from challenges by the subgenotype C2 and C4 viruses, and surviving animals did not show any degree of neurological paralysis symptoms or muscle damage. Vaccine treatments significantly reduced virus antigen presented in the central nervous system of Tg mice and alleviated the virus-associated inflammatory response. These results strongly suggest that this preparation results in an efficacious vaccine and that the microcarrier/bioreactor platform offers a superior alternative to the previously described roller-bottle system.	[Wu, Chia-Ying; Kuo, Chia-Ho; Liu, Wan-Hsin; Tai, Hsiu-Fen; Pan, Chien-Hung; Chen, Yung-Tsung; Chan, Chi-Hsien; Chang, Ching-Chuan; Liu, Chung-Cheng; Chen, Juine-Ruey] Adimmune Corp, Taichung, Taiwan; [Lin, Yi-Wen; Chow, Yen-Hung] Natl Hlth Res Inst, Inst Infect Dis & Vaccinol, Zhunan, Miaoli County, Taiwan; [Hsiao, Pei-Wen] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan; [Liu, Chung-Cheng] Enimmune Corp, Taichung, Taiwan; [Chow, Yen-Hung] China Med Univ, Grad Inst Immunol, Taichung, Taiwan	National Health Research Institutes - Taiwan; Academia Sinica - Taiwan; China Medical University Taiwan	Chow, YH (corresponding author), Natl Hlth Res Inst, Inst Infect Dis & Vaccinol, Zhunan, Miaoli County, Taiwan.	choeyenh@nhri.org.tw; JR_Chen@adimmune.com.tw	Hsiao, Pei-Wen/V-5653-2018	Hsiao, Pei-Wen/0000-0002-3589-6754	Adimmune Corporation; Enimmune Corporation; Ministry of Economic Affairs, Taiwan [101-EC-17-A-20-I1-0054]	Adimmune Corporation; Enimmune Corporation; Ministry of Economic Affairs, Taiwan(Ministry of Economic Affairs, Taiwan)	This study was supported by funds from Adimmune Corporation, Enimmune Corporation and the Ministry of Economic Affairs, Taiwan (grant no. 101-EC-17-A-20-I1-0054). Enimmune is a subsidiary of Adimmune Corp. Coauthors CYW, CHK, WHL, HFT, CHP, YTC, CHC, CCC, CCL and JRC are all employees of Adimmune Corporation. CCL is also serving as acting general manager of Enimmune Corporation. The parties provided the financial support in the form of salaries for authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Butler M, 2000, BIOTECHNOL PROGR, V16, P854, DOI 10.1021/bp000110+; Cai YC, 2014, VACCINE, V32, P2406, DOI 10.1016/j.vaccine.2014.03.012; Cai YC, 2013, VACCINE, V31, P2215, DOI 10.1016/j.vaccine.2013.03.007; Chang JY, 2012, VACCINE, V30, P703, DOI 10.1016/j.vaccine.2011.11.087; Chong P, 2014, CLIN INFECT DIS OFFI; Chong P, 2012, HUM VACC IMMUNOTHER, V8, P1775, DOI 10.4161/hv.21739; Chong P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049973; Chou AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079783; Chou AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034834; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; Khong WX, 2012, J VIROL; Lee MS, 2010, EXPERT REV VACCINES, V9, P149, DOI [10.1586/erv.09.152, 10.1586/ERV.09.152]; Li JX, 2014, EXPERT REV VACCINES, V13, P609, DOI 10.1586/14760584.2014.897617; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Li RC, 2014, NEW ENGL J MED, V370, P829, DOI 10.1056/NEJMoa1303224; Liang ZL, 2013, HUM VACC IMMUNOTHER, V9, P1701, DOI 10.4161/hv.24949; Lin CW, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/670506; Lin TY, 2003, CLIN INFECT DIS, V36, P269, DOI 10.1086/345905; Lin YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057591; Liu CC, 2007, VACCINE, V25, P19, DOI 10.1016/j.vaccine.2006.06.083; Liu CC, 2014, VACCINE, V32, P6177, DOI 10.1016/j.vaccine.2014.08.064; Liu CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106756; Liu CC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020005, 10.1371/journal.pone.0021464]; Mao QY, 2010, CHINESE MED J-PEKING, V123, P1679, DOI 10.3760/cma.j.issn.0366-6999.2010.13.012; Mao QY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079599; Mao QY, 2014, HUM VACC IMMUNOTHER, V10, P360, DOI 10.4161/hv.27087; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sabanathan S, 2014, J EPIDEMIOL COMMUN H, V68, P500, DOI 10.1136/jech-2014-203836; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Tee KK, 2010, J VIROL, V84, P3339, DOI 10.1128/JVI.01019-09; Wang SM, 2003, J INFECT DIS, V188, P564, DOI 10.1086/376998; Wang YF, 2004, J VIROL, V78, P7916, DOI 10.1128/JVI.78.15.7916-7924.2004; Weng KF, 2010, MICROBES INFECT, V12, P505, DOI 10.1016/j.micinf.2010.03.006; Wu CN, 2001, VACCINE, V20, P895, DOI 10.1016/S0264-410X(01)00385-1; Wu SC, 2004, VACCINE, V22, P3858, DOI 10.1016/j.vaccine.2004.05.037; Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6; Xu J, 2010, VACCINE, V28, P3516, DOI 10.1016/j.vaccine.2010.03.003; Yan XF, 2012, SCAND J INFECT DIS, V44, P297, DOI 10.3109/00365548.2011.634433; Yip Cyril C Y, 2013, Emerg Health Threats J, V6, P19780, DOI 10.3402/ehtj.v6i0.19780; Zhang Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059086, 10.1371/journal.pone.0056341]; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhu FC, 2013, LANCET, V381, P2024, DOI 10.1016/S0140-6736(13)61049-1; Zhu FC, 2014, NEW ENGL J MED, V370, P818, DOI 10.1056/NEJMoa1304923	46	22	27	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136420	10.1371/journal.pone.0136420	http://dx.doi.org/10.1371/journal.pone.0136420			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287531	Green Published, Green Submitted, gold			2022-12-26	WOS:000360018600137
J	Barbone, D; Follo, C; Echeverry, N; Gerbaudo, VH; Klabatsa, A; Bueno, R; Felley-Bosco, E; Broaddus, VC				Barbone, Dario; Follo, Carlo; Echeverry, Nohemy; Gerbaudo, Victor H.; Klabatsa, Astero; Bueno, Raphael; Felley-Bosco, Emanuela; Broaddus, V. Courtney			Autophagy Correlates with the Therapeutic Responsiveness of Malignant Pleural Mesothelioma in 3D Models	PLOS ONE			English	Article							3-KINASE/MAMMALIAN TARGET; APOPTOTIC RESISTANCE; INHIBITOR GDC-0980; KINASE INHIBITOR; LUNG-CANCER; MTOR; PATHWAY; PROTEINS; SURVIVAL; BCL-2	Malignant pleural mesothelioma is a highly chemoresistant solid tumor. We have studied this apoptotic resistance using in vitro and ex vivo three-dimensional models, which acquire a high level of chemoresistance that can be reduced by PI3K/mTOR inhibitors. Here, we investigate the activity of GDC-0980, a novel dual PI3K/mTOR inhibitor, which has been proposed to be effective in mesothelioma. In this work, we aimed to identify mechanisms and markers of efficacy for GDC-0980 by utilizing 3D models of mesothelioma, both in vitro multicellular spheroids and ex vivo tumor fragment spheroids grown from patient tumor samples. We found that a subset of mesothelioma spheroids is sensitive to GDC-0980 alone and to its combination with chemotherapy. Unexpectedly, this sensitivity did not correlate with the activation of the Akt/mTOR pathway. Instead, sensitivity to GDC-0980 correlated with the presence of constitutive ATG13 puncta, a feature of autophagy, a cellular program that supports cells under stress. In tumor fragment spheroids grown from 21 tumors, we also found a subset (n = 11) that was sensitive to GDC-0980, a sensitivity that also correlated with the presence of ATG13 puncta. Interference with autophagy by siRNA of ATG7, an essential autophagic protein, increased the response to chemotherapy, but only in the sensitive multicellular spheroids. In the spheroids resistant to GDC-0980, autophagy appeared to play no role. In summary, we show that GDC-0980 is effective in mesothelioma 3D models that display ATG13 puncta, and that blockade of autophagy increases their response to chemotherapy. For the first time, we show a role for autophagy in the response to chemotherapy of 3D models of mesothelioma and propose ATG13 as a potential biomarker of the therapeutic responsiveness of mesothelioma.	[Barbone, Dario; Follo, Carlo; Broaddus, V. Courtney] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div Pulm & Crit Care Med, San Francisco, CA 94110 USA; [Echeverry, Nohemy; Felley-Bosco, Emanuela] Univ Zurich Hosp, Clin Oncol, CH-8044 Zurich, Switzerland; [Gerbaudo, Victor H.] Brigham & Womens Hosp, Dept Radiol, Div Nucl Med & Mol Imaging, Boston, MA 02115 USA; [Klabatsa, Astero] Kings Coll London, Dept Res Oncol, London, England; [Bueno, Raphael] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Surg, Boston, MA 02115 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of Zurich; University Zurich Hospital; Harvard University; Brigham & Women's Hospital; University of London; King's College London; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Barbone, D (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div Pulm & Crit Care Med, San Francisco, CA 94110 USA.	dario.barbone@ucsf.edu	Felley-Bosco, Emanuela/E-7484-2017; Klampatsa, Astero/AAK-4419-2020	Felley-Bosco, Emanuela/0000-0002-3408-0294; Klampatsa, Astero/0000-0003-0572-502X; Follo, Carlo/0000-0001-9711-2655	Mesothelioma Applied Research Foundation Grant [255458]; Simmons Mesothelioma Foundation - Simmons Fellowship in Mesothelioma Research; Swiss National Science Foundation; Baugarten Foundation	Mesothelioma Applied Research Foundation Grant; Simmons Mesothelioma Foundation - Simmons Fellowship in Mesothelioma Research; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Baugarten Foundation	This work was supported by Mesothelioma Applied Research Foundation Grant 255458 to DB (http://www.curemeso.org). Additional funding was provided by the Simmons Mesothelioma Foundation - Simmons Fellowship in Mesothelioma Research to CF (http://www.simmonsmesotheliomafoundation.org/). Further support was provided by the Swiss National Science Foundation and Baugarten Foundation grants to EFB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abayasiriwardana KS, 2007, MOL CANCER THER, V6, P2766, DOI 10.1158/1535-7163.MCT-07-0278; Alemu EA, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.378109; Alers S, 2014, AUTOPHAGY, V10, P944, DOI 10.4161/auto.28987; Alers S, 2011, AUTOPHAGY, V7, P1424, DOI 10.4161/auto.7.12.18027; Alifrangis CC, 2014, MOL ONCOL, V8, P1112, DOI 10.1016/j.molonc.2014.05.014; Altomare DA, 2005, ONCOGENE, V24, P6080, DOI 10.1038/sj.onc.1208744; Barbone D, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.58; Barbone D, 2008, J BIOL CHEM, V283, P13021, DOI 10.1074/jbc.M709698200; Barbone D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052753; Barthel A, 1999, J BIOL CHEM, V274, P20281, DOI 10.1074/jbc.274.29.20281; Battisti S, 2012, AM J RESP CELL MOL, V46, P498, DOI 10.1165/rcmb.2011-0195OC; Broaddus VC, 2005, J BIOL CHEM, V280, P12486, DOI 10.1074/jbc.M408190200; Cacciotti P, 2005, CANCER RES, V65, P5256, DOI 10.1158/0008-5472.CAN-05-0127; Cedres S, 2012, LUNG CANCER, V77, P192, DOI 10.1016/j.lungcan.2012.02.022; Chan EY, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.284pe51; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]; Claerhout S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039400; Fan QW, 2006, CANCER CELL, V9, P341, DOI 10.1016/j.ccr.2006.03.029; Fischer B, 2012, LUNG CANCER, V78, P23, DOI 10.1016/j.lungcan.2012.07.005; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Green DR, 2014, CELL, V157, P65, DOI 10.1016/j.cell.2014.02.049; Gump JM, 2014, NAT CELL BIOL, V16, P47, DOI 10.1038/ncb2886; Guo J, 2013, ONCOGENE, V32, P151, DOI 10.1038/onc.2012.39; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HARASAWA R, 1993, RES MICROBIOL, V144, P489, DOI 10.1016/0923-2508(93)90057-9; Hartley D, 2002, J CELL BIOCHEM, V85, P304, DOI 10.1002/jcb.10135; Hippert MM, 2006, CANCER RES, V66, P9349, DOI 10.1158/0008-5472.CAN-06-1597; Hoda MA, 2011, J THORAC ONCOL, V6, P852, DOI 10.1097/JTO.0b013e31820e1a25; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kanteti R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105919; Klabatsa A, 2014, EUR J NUCL MED MOL I, V41, P276, DOI 10.1007/s00259-013-2561-1; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Li JR, 2013, TOXICOL LETT, V220, P267, DOI 10.1016/j.toxlet.2013.04.021; METCALF RA, 1992, CANCER RES, V52, P2610; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Narasimhan SR, 1998, AM J PHYSIOL-LUNG C, V275, pL165, DOI 10.1152/ajplung.1998.275.1.L165; POPESCU NC, 1988, CANCER RES, V48, P142; Ramos-Nino ME, 2008, AM J RESP CELL MOL, V38, P209, DOI 10.1165/rcmb.2007-0206OC; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; Salphati L, 2012, DRUG METAB DISPOS, V40, P1785, DOI 10.1124/dmd.112.046052; Sartore-Bianchi A, 2007, CLIN CANCER RES, V13, P5942, DOI 10.1158/1078-0432.CCR-07-0536; Satoh M, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-19; SMYTHE WR, 1994, ANN THORAC SURG, V57, P1395, DOI 10.1016/0003-4975(94)90090-6; Sutherlin DP, 2011, J MED CHEM, V54, P7579, DOI 10.1021/jm2009327; Suzuki H, 2014, STRUCTURE, V22, P47, DOI 10.1016/j.str.2013.09.023; Suzuki Y, 2009, MOL MED REP, V2, P181, DOI 10.3892/mmr_00000081; Tang JY, 2014, BIOCHEM BIOPH RES CO, V453, P533, DOI 10.1016/j.bbrc.2014.09.115; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Wallin JJ, 2011, MOL CANCER THER, V10, P2426, DOI 10.1158/1535-7163.MCT-11-0446; Watson PM, 2008, AM J RESP CELL MOL, V38, P671, DOI 10.1165/rcmb.2007-0205OC; Watzka SB, 2011, EUR J CARDIO-THORAC, V39, P180, DOI 10.1016/j.ejcts.2010.05.007; Wilson SM, 2008, AM J RESP CELL MOL, V39, P576, DOI 10.1165/rcmb.2007-0460OC; Yang TM, 2009, AM J RESP CELL MOL, V41, P14, DOI 10.1165/rcmb.2008-0320OC; Zhou S, 2014, BRIT J CANCER, V110, P2479, DOI 10.1038/bjc.2014.220	55	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0134825	10.1371/journal.pone.0134825	http://dx.doi.org/10.1371/journal.pone.0134825			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284517	Green Submitted, gold, Green Published			2022-12-26	WOS:000359666100017
J	Lebeau, J; Wesselingh, RA; Van Dyck, H				Lebeau, Julie; Wesselingh, Renate A.; Van Dyck, Hans			Butterfly Density and Behaviour in Uncut Hay Meadow Strips: Behavioural Ecological Consequences of an Agri-Environmental Scheme	PLOS ONE			English	Article							CENTAUREA-SCABIOSA L; NECTAR AMINO-ACIDS; MANIOLA-JURTINA; LIFE-HISTORY; NIGRA L; CONSERVATION; GRASSLANDS; DIVERSITY; BIODIVERSITY; POLLINATORS	Sparing zones from mowing has been proposed, and applied, to improve local conditions for survival and reproduction of insects in hay meadows. However, little is known about the efficiency of refuge zones and the consequences for local populations. We studied population densities of butterflies before and after mowing in the refuge zone of 15 meadows in 2009 and 2011. We also studied the behaviour of the meadow brown (Maniola jurtina) comparing nectar use, interactions and flights in the refuge zone before and after mowing. Densities of grassland butterflies in this zone doubled on average after mowing. The density of females of M. jurtina increased on average fourfold, while males showed a more modest increase. In line with the idea of increased scramble competition in the refuge zone after mowing, M. jurtina increased the time spent on nectar feeding, the preferred nectar source was visited more frequently, and females made more use of non-preferred nectar sources. Maniola jurtina did not interact more with conspecifics after mowing, but interactions lasted longer. Flight tracks did not change in linearity, but were faster and shorter after mowing. After mowing, only a part of the local grassland butterflies moved to the uncut refuge zone. The resulting concentration effect alters the time allocated to different activities, nectar use and movements. These aspects have been largely ignored for agri-environmental schemes and grassland management in nature reserves and raise questions about optimal quantities and quality of uncut refuge sites for efficient conservation of grassland arthropods in agricultural landscapes.	[Lebeau, Julie; Wesselingh, Renate A.; Van Dyck, Hans] UCL, Biodivers Res Ctr, Earth & Life Inst, B-1348 Louvain, Belgium	Universite Catholique Louvain	Van Dyck, H (corresponding author), UCL, Biodivers Res Ctr, Earth & Life Inst, Croix Sud 4-5,Box L7-07-04, B-1348 Louvain, Belgium.	hans.vandyck@uclouvain.be	Wesselingh, Renate A./F-4240-2011	Wesselingh, Renate A./0000-0003-0241-2255				Aviron S, 2007, AGR ECOSYST ENVIRON, V122, P295, DOI 10.1016/j.agee.2006.12.035; Aviron S, 2011, RESTOR ECOL, V19, P500, DOI 10.1111/j.1526-100X.2010.00649.x; Balmer O, 2000, CONSERV BIOL, V14, P746, DOI 10.1046/j.1523-1739.2000.98612.x; Berwaerts K, 2004, OECOLOGIA, V141, P536, DOI 10.1007/s00442-004-1661-9; Blake RJ, 2011, J INSECT CONSERV, V15, P221, DOI 10.1007/s10841-010-9339-6; BOGGS CL, 1993, ECOLOGY, V74, P433, DOI 10.2307/1939305; BRAKEFIELD PM, 1982, J ANIM ECOL, V51, P713, DOI 10.2307/4000; Braschler B, 2009, ECOL ENTOMOL, V34, P321, DOI 10.1111/j.1365-2311.2008.01080.x; Buri P, 2013, AGR ECOSYST ENVIRON, V181, P22, DOI 10.1016/j.agee.2013.09.003; Butler SJ, 2007, SCIENCE, V315, P381, DOI 10.1126/science.1136607; Carvell C, 2007, J APPL ECOL, V44, P29, DOI 10.1111/j.1365-2664.2006.01249.x; Cizek O, 2012, J INSECT CONSERV, V16, P215, DOI 10.1007/s10841-011-9407-6; Cowley MJR, 2001, J ANIM ECOL, V70, P410, DOI 10.1046/j.1365-2656.2001.00508.x; Croxton PJ, 2005, BIOL CONSERV, V121, P579, DOI 10.1016/j.biocon.2004.06.008; Dahlstrom A., 2008, Environment and History, V14, P385, DOI 10.3197/096734008X333572; DAVIES NB, 1978, ANIM BEHAV, V26, P138, DOI 10.1016/0003-3472(78)90013-1; Delattre T, 2013, AGR ECOSYST ENVIRON, V166, P102, DOI 10.1016/j.agee.2011.06.018; Delattre T, 2010, OIKOS, V119, P1900, DOI 10.1111/j.1600-0706.2010.18615.x; Dover JW, 2010, J INSECT CONSERV, V14, P413, DOI 10.1007/s10841-010-9267-5; Dover JW, 1997, AGR ECOSYST ENVIRON, V63, P31, DOI 10.1016/S0167-8809(96)01120-6; Dover JW, 1996, J APPL ECOL, V33, P723, DOI 10.2307/2404943; Erhardt A, 1998, OECOLOGIA, V117, P536, DOI 10.1007/s004420050690; Feber RE, 1996, J APPL ECOL, V33, P1191, DOI 10.2307/2404698; Field RG, 2006, BIODIVERS CONSERV, V16, P465; Hirsch M, 2003, AGR ECOSYST ENVIRON, V98, P331, DOI 10.1016/S0167-8809(03)00093-8; Hossain Z, 2002, J APPL ECOL, V39, P445, DOI 10.1046/j.1365-2664.2002.00729.x; Humbert JY, 2010, J APPL ENTOMOL, V134, P592, DOI 10.1111/j.1439-0418.2009.01503.x; Humbert JY, 2012, BIOL CONSERV, V152, P96, DOI 10.1016/j.biocon.2012.03.015; Humbert JY, 2009, AGR ECOSYST ENVIRON, V130, P1, DOI 10.1016/j.agee.2008.11.014; Jervis MA, 2005, TRENDS ECOL EVOL, V20, P585, DOI 10.1016/j.tree.2005.08.015; Johst K, 2006, J APPL ECOL, V43, P333, DOI 10.1111/j.1365-2664.2006.01125.x; Kohler F, 2008, J APPL ECOL, V45, P753, DOI 10.1111/j.1365-2664.2007.01394.x; Kulfan J, 2012, POL J ECOL, V60, P601; LACK AJ, 1982, NEW PHYTOL, V91, P309, DOI 10.1111/j.1469-8137.1982.tb03315.x; LACK AJ, 1982, NEW PHYTOL, V91, P321, DOI 10.1111/j.1469-8137.1982.tb03316.x; Littlewood NA, 2012, INSECT CONSERV DIVER, V5, P1, DOI 10.1111/j.1752-4598.2011.00174.x; Meek B, 2002, BIOL CONSERV, V106, P259, DOI 10.1016/S0006-3207(01)00252-X; Merckx T, 2002, J INSECT BEHAV, V15, P541, DOI 10.1023/A:1016385301634; Mevi-Schutz J, 2005, AM NAT, V165, P411, DOI 10.1086/429150; O'Brien DM, 2004, OIKOS, V105, P279, DOI 10.1111/j.0030-1299.2004.13012.x; Ockinger E, 2007, J APPL ECOL, V44, P50, DOI 10.1111/j.1365-2664.2006.01250.x; ODENDAAL FJ, 1989, OECOLOGIA, V78, P283, DOI 10.1007/BF00377167; Ouin A, 2004, AGR ECOSYST ENVIRON, V103, P473, DOI 10.1016/j.agee.2003.11.003; POLLARD E, 1994, MONITORING BUTTERFLI; Pryke SR, 2001, BIOL CONSERV, V101, P85, DOI 10.1016/S0006-3207(01)00042-8; Pywell RF, 2004, BIOL CONSERV, V118, P313, DOI 10.1016/j.biocon.2003.09.011; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Robinson RA, 2002, J APPL ECOL, V39, P157, DOI 10.1046/j.1365-2664.2002.00695.x; Sang A, 2011, INSECT CONSERV DIVER, V4, P257, DOI 10.1111/j.1752-4598.2011.00134.x; SAS, 2012, SAS STAT 12 1 US GUI; Schneider C, 2003, ECOL ENTOMOL, V28, P219, DOI 10.1046/j.1365-2311.2003.00494.x; Schultz CB, 1999, OECOLOGIA, V119, P231, DOI 10.1007/s004420050781; Tallowin JRB, 2005, GRASS FORAGE SCI, V60, P225, DOI 10.1111/j.1365-2494.2005.00470.x; Thorbek P, 2004, J APPL ECOL, V41, P526, DOI 10.1111/j.0021-8901.2004.00913.x; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Valtonen A., 2006, Animal Biodiversity and Conservation, V29, P133; Van Dyck H, 2010, ANIM BEHAV, V80, P621, DOI 10.1016/j.anbehav.2010.06.021; van Swaay C, 2006, J INSECT CONSERV, V10, P189, DOI 10.1007/s10841-006-6293-4; Van Swaay CAM, 2013, EUROPEAN GRASSLAND B, P1; Venables WN., 2002, MODERN APPL STAT S 4; Vickery JA, 2001, J APPL ECOL, V38, P647, DOI 10.1046/j.1365-2664.2001.00626.x; WallisDeVries MF, 2002, BIOL CONSERV, V104, P265, DOI 10.1016/S0006-3207(01)00191-4; WICKMAN PO, 1988, ZOOL J LINN SOC-LOND, V93, P357, DOI 10.1111/j.1096-3642.1988.tb01367.x; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08	64	16	17	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0134945	10.1371/journal.pone.0134945	http://dx.doi.org/10.1371/journal.pone.0134945			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284618	Green Submitted, Green Published, gold			2022-12-26	WOS:000359666100018
J	Lee, S; Kim, JE; Hong, SH; Lee, AY; Park, EJ; Seo, HW; Chae, C; Doble, P; Bishop, D; Cho, MH				Lee, Somin; Kim, Ji-Eun; Hong, Seong-Ho; Lee, Ah-Young; Park, Eun-Jung; Seo, Hwi Won; Chae, Chanhee; Doble, Philip; Bishop, David; Cho, Myung-Haing			High Inorganic Phosphate Intake Promotes Tumorigenesis at Early Stages in a Mouse Model of Lung Cancer	PLOS ONE			English	Article							DIETARY PHOSPHORUS; TRANSLATION INITIATION; PROTEIN TRANSLATION; CELL-CYCLE; ANGIOGENESIS; METABOLISM; APOPTOSIS; AUTOPHAGY; GROWTH; MTOR	Inorganic phosphate (Pi) is required by all living organisms for the development of organs such as bone, muscle, brain, and lungs, regulating the expression of several critical genes as well as signal transduction. However, little is known about the effects of prolonged dietary Pi consumption on lung cancer progression. This study investigated the effects of a high-phosphate diet (HPD) in a mouse model of adenocarcinoma. K-ras(LA1) mice were fed a normal diet (0.3% Pi) or an HPD (1% Pi) for 1, 2, or 4 months. Mice were then sacrificed and subjected to inductively coupled plasma mass/optical emission spectrometry and laser ablation inductively coupled plasma mass-spectrometry analyses, western blot analysis, histopathological, immunohistochemical, and immunocytochemical analyses to evaluate tumor formation and progression (including cell proliferation, angiogenesis, and apoptosis), changes in ion levels and metabolism, autophagy, epithelial-to-mesenchymal transition, and protein translation in the lungs. An HPD accelerated tumorigenesis, as evidenced by increased adenoma and adenocarcinoma rates as well as tumor size. However, after 4 months of the HPD, cell proliferation was arrested, and marked increases in liver and lung ion levels and in energy production via the tricarboxylic acid cycle in the liver were observed, which were accompanied by increased autophagy and decreased angiogenesis and apoptosis. These results indicate that an HPD initially promotes but later inhibits lung cancer progression because of metabolic adaptation leading to tumor cell quiescence. Moreover, the results suggest that carefully regulated Pi consumption are effective in lung cancer prevention.	[Lee, Somin; Kim, Ji-Eun; Hong, Seong-Ho; Lee, Ah-Young; Cho, Myung-Haing] Seoul Natl Univ, Res Inst Vet Sci, PLUSProgram Creat Vet Sci Res BK21, Toxicol Lab, Seoul 151742, South Korea; [Lee, Somin; Kim, Ji-Eun; Hong, Seong-Ho; Lee, Ah-Young; Cho, Myung-Haing] Seoul Natl Univ, Coll Vet Med, Seoul 151742, South Korea; [Cho, Myung-Haing] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Suwon 443270, South Korea; [Park, Eun-Jung] Ajou Univ, Dept Mol Sci & Technol, Suwon 443749, South Korea; [Seo, Hwi Won; Chae, Chanhee] Seoul Natl Univ, Coll Vet Med, Pathol Lab, Seoul 151742, South Korea; [Doble, Philip; Bishop, David] Univ Technol Sydney, Dept Chem & Forens Sci, Elemental Bioimaging Facil, Sydney, NSW 2007, Australia; [Lee, Somin; Cho, Myung-Haing] Seoul Natl Univ, Grad Grp Tumor Biol, Seoul 151742, South Korea; [Cho, Myung-Haing] Seoul Natl Univ, Adv Inst Convergence Technol, Suwon 443270, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Ajou University; Seoul National University (SNU); University of Technology Sydney; Seoul National University (SNU); Seoul National University (SNU)	Cho, MH (corresponding author), Seoul Natl Univ, Res Inst Vet Sci, PLUSProgram Creat Vet Sci Res BK21, Toxicol Lab, Seoul 151742, South Korea.	mchotox@snu.ac.kr	Cho, Myung-Haing/B-7362-2014; Doble, Philip/A-8812-2012; Park, Eun-Jung/Y-4427-2019; Bishop, David P/F-2891-2019; Kim, Ji-Eun/AAL-8406-2021	Cho, Myung-Haing/0000-0002-3993-2011; Doble, Philip/0000-0002-8472-1301; Bishop, David P/0000-0002-6533-4410; Kim, Ji-Eun/0000-0002-3643-2177; Chae, Chanhee/0000-0002-0190-1957	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2012M3A9C4048819]; Research Institute for Veterinary Science, Seoul National University; Kenelec Scientific as part of the Linkage Projects program [LP100200254]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; Research Institute for Veterinary Science, Seoul National University; Kenelec Scientific as part of the Linkage Projects program	Part of this work is supported by the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2012M3A9C4048819). M.H. Cho was also partially supported by the Research Institute for Veterinary Science, Seoul National University. LA-IPC-MS experiments were performed with support from the Australian Research Council, Agilent Technologies, and Kenelec Scientific as part of the Linkage Projects program (LP100200254). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnuthan G, 2002, ONCOGENE, V21, P7839, DOI 10.1038/sj.onc.1205983; Beck GR, 2003, J CELL BIOCHEM, V90, P234, DOI 10.1002/jcb.10622; CALVO MS, 1993, J NUTR, V123, P1627, DOI 10.1093/jn/123.9.1627; Chang SH, 2006, AM J RESP CELL MOL, V35, P528, DOI 10.1165/rcmb.2005-0477OC; Chang SH, 2013, J TOXICOL SCI, V38, P823; Ducker GS, 2014, ONCOGENE, V33, P1590, DOI 10.1038/onc.2013.92; Fujimura K, 2012, NUCLEIC ACIDS RES, V40, P8099, DOI 10.1093/nar/gks566; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Hinnebusch AG, 2012, MOL CELL, V46, P717, DOI 10.1016/j.molcel.2012.06.001; Hong SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077121; Hsieh AC, 2010, CANCER CELL, V17, P249, DOI 10.1016/j.ccr.2010.01.021; Hu YL, 2012, CANCER RES, V72, P1773, DOI 10.1158/0008-5472.CAN-11-3831; HUNTINGTON GB, 1990, REPROD NUTR DEV, V30, P35, DOI 10.1051/rnd:19900103; Israelsen WJ, 2010, CELL, V143, P669, DOI 10.1016/j.cell.2010.11.010; Jin H, 2006, TOXICOL SCI, V90, P221, DOI 10.1093/toxsci/kfj066; Jin H, 2009, AM J RESP CRIT CARE, V179, P59, DOI 10.1164/rccm.200802-306OC; Jin H, 2007, TOXICOL SCI, V100, P215, DOI 10.1093/toxsci/kfm202; Katiyar SK, 2005, MOL CANCER THER, V4, P207; Kenific CM, 2010, CURR OPIN CELL BIOL, V22, P241, DOI 10.1016/j.ceb.2009.10.008; Krasko A, 2002, DNA CELL BIOL, V21, P67, DOI 10.1089/10445490252810320; Ku JH, 2012, UROL ONCOL-SEMIN ORI, V30, P562, DOI 10.1016/j.urolonc.2010.06.001; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Lampila LE, 2013, ANN NY ACAD SCI, V1301, P37, DOI 10.1111/nyas.12230; Landriscina M, 2009, ANTIOXID REDOX SIGN, V11, P2701, DOI 10.1089/ars.2009.2692; Lear J, 2012, ANAL CHEM, V84, P6707, DOI 10.1021/ac301156f; Liao D, 2007, CANCER METAST REV, V26, P281, DOI 10.1007/s10555-007-9066-y; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Nikoletopoulou V, 2013, BBA-MOL CELL RES, V1833, P3448, DOI 10.1016/j.bbamcr.2013.06.001; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; REEVES PG, 1993, J NUTR, V123, P1923, DOI 10.1093/jn/123.11.1923; Shuto E, 2009, J AM SOC NEPHROL, V20, P1504, DOI 10.1681/ASN.2008101106; Singh RP, 2006, J NATL CANCER I, V98, P846, DOI 10.1093/jnci/djj231; Sosa MS, 2013, ADV EXP MED BIOL, V734, P73, DOI 10.1007/978-1-4614-1445-2_5; STEVENS RG, 1994, INT J CANCER, V56, P364, DOI 10.1002/ijc.2910560312; Takeda E, 2004, J CELL MOL MED, V8, P191, DOI 10.1111/j.1582-4934.2004.tb00274.x; Takeda E, 2012, NUTR REV, V70, P311, DOI 10.1111/j.1753-4887.2012.00473.x; Torti SV, 2013, NAT REV CANCER, V13, P342, DOI 10.1038/nrc3495; Tuquet C, 2000, CELL BIOL TOXICOL, V16, P207, DOI 10.1023/A:1007695308257; Untergasser G, 2000, BIOCHEM BIOPH RES CO, V279, P607, DOI 10.1006/bbrc.2000.3975; Valcourt JR, 2012, CELL CYCLE, V11, P1680, DOI 10.4161/cc.19879; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271; Wulaningsih W, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-257; Xu CX, 2008, AM J PHYSIOL-GASTR L, V295, pG654, DOI 10.1152/ajpgi.90213.2008; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	47	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135582	10.1371/journal.pone.0135582	http://dx.doi.org/10.1371/journal.pone.0135582			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285136	gold, Green Submitted, Green Published			2022-12-26	WOS:000359666100046
J	Park, JI; Bae, E; Kim, YL; Kang, SW; Yang, CW; Kim, NH; Lee, JP; Kim, DK; Joo, KW; Kim, YS; Lee, H				Park, Ji In; Bae, Eunjin; Kim, Yong-Lim; Kang, Shin-Wook; Yang, Chul Woo; Kim, Nam-Ho; Lee, Jung Pyo; Kim, Dong Ki; Joo, Kwon Wook; Kim, Yon Su; Lee, Hajeong			Glycemic Control and Mortality in Diabetic Patients Undergoing Dialysis Focusing on the Effects of Age and Dialysis Type: A Prospective Cohort Study in Korea	PLOS ONE			English	Article							INTENSIVE GLUCOSE CONTROL; FOLLOW-UP; HEMODIALYSIS; SURVIVAL; HEMOGLOBIN; OUTCOMES; THERAPY; DEATH	Background Active glycemic control has been proven to delay the onset and slow the progression of diabetic retinopathy, nephropathy, and neuropathy in diabetic patients, but the optimal level is obscure in end-stage renal disease. In this study, we evaluated the effect of hemoglobin A1c (HbA1c) on mortality of diabetic patients on dialysis, focusing on age and dialysis type. Methods Of 3,302 patients enrolled in the prospective cohort for end-stage renal disease in Korea between August 2008 and October 2013, 1,239 diabetic patients who had been diagnosed with diabetes or having HbA1c >= 6.5% at the time of enrollment were analyzed. Age was categorized as <55, 55-64 and >= 65 years old. Age, sex, modified Charlson comorbidity index, hemoglobin, primary renal disease, body mass index, and dialysis duration were adjusted. Results A total of 873 patients received hemodialysis (HD) and 366 underwent peritoneal dialysis (PD). During the mean follow-up of 19.1 months, 141 patients died. Patients with poor glucose control (HbA1c >= 8%) showed worse survival than patients with HbA1c<8% (hazard ratio [HR], 2.2; 95% confidence interval [CI], 1.48-3.29; P<0.001). Subgroup analysis divided by age revealed that HbA1c >= 8% was a predictor of mortality in age <55 (HR, 4.3; 95% CI, 1.78-10.41; P = 0.001) and age 55-64 groups (HR, 3.3; 95% CI, 1.56-7.05; P = 0.002), but not in age >= 65 group. Combining dialysis type and age, poor glucose control negatively affected survival only in age < 55 group among HD patients, but it was significant in age < 55 and age 55-64 groups in PD patients. Deaths from infection were more prevalent in the PD group, and poor glucose control tended to correlate with more deaths from infection in PD patients (P = 0.050). Conclusions In this study, the effect of glycemic control differed according to age and dialysis type in diabetic patients. Thus, the target of glycemic control should be customized; further observational studies may strengthen the clinical relevance.	[Park, Ji In] Kangwon Natl Univ, Dept Internal Med, Coll Med, Chunchon, South Korea; [Park, Ji In; Bae, Eunjin; Kim, Yong-Lim; Kang, Shin-Wook; Yang, Chul Woo; Kim, Nam-Ho; Lee, Jung Pyo; Kim, Dong Ki; Joo, Kwon Wook; Kim, Yon Su; Lee, Hajeong] Clin Res Ctr End Stage Renal Dis Korea, Daegu, South Korea; [Bae, Eunjin; Kim, Dong Ki; Joo, Kwon Wook; Kim, Yon Su; Lee, Hajeong] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Kim, Yong-Lim] Kyungpook Natl Univ, Dept Internal Med, Sch Med, Daegu, South Korea; [Kang, Shin-Wook] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Yang, Chul Woo] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Nam-Ho] Chonnam Natl Univ, Dept Internal Med, Sch Med, Gwangju, South Korea; [Lee, Jung Pyo] Seoul Natl Univ, Dept Internal Med, Boramae Med Ctr, Seoul, South Korea	Kangwon National University; Seoul National University (SNU); Kyungpook National University; Yonsei University; Yonsei University Health System; Catholic University of Korea; Chonnam National University; Seoul National University (SNU); Seoul National University Hospital	Lee, H (corresponding author), Clin Res Ctr End Stage Renal Dis Korea, Daegu, South Korea.	mdhjlee@gmail.com	Kim, Dong Ki/J-5389-2012	Kim, Dong Ki/0000-0002-5195-7852; Park, Ji In/0000-0003-4662-3759	Korea Healthcare Technology RD Project; Ministry of Health and Welfare, Republic of Korea [HI10C2020]	Korea Healthcare Technology RD Project; Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (HI10C2020). Clinical research center for end-stage renal disease received the funding, and the leader of the center is YLK. The "Ministry of Health and Welfare" URL is: http://www.mw.go.kr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler A, 2014, DIABETES CARE, V37, P1304, DOI 10.2337/dc13-0553; American Diabetes Association, 2015, Diabetes Care, V38 Suppl, pS67, DOI 10.2337/dc15-S013; [Anonymous], 2015, DIABETES CARE, V38, pS33, DOI 10.2337/dc15-S009; Bolton K, 2005, AM J KIDNEY DIS, V45, pS7, DOI 10.1053/j.ajkd.2005.01.016; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Collins Allan J, 2014, Am J Kidney Dis, V63, pA7, DOI 10.1053/j.ajkd.2013.11.001; Currie CJ, 2010, LANCET, V375, P481, DOI 10.1016/S0140-6736(09)61969-3; Duong U, 2011, CLIN J AM SOC NEPHRO, V6, P1041, DOI 10.2215/CJN.08921010; Hemmelgarn BR, 2003, AM J KIDNEY DIS, V42, P125, DOI 10.1016/S0272-6386(03)00415-3; Hill CJ, 2014, AM J KIDNEY DIS, V63, P84, DOI 10.1053/j.ajkd.2013.06.020; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Huang ES, 2011, DIABETES CARE, V34, P1329, DOI 10.2337/dc10-2377; Jin Dong Chan, 2011, Korean Journal of Internal Medicine, V26, P123, DOI 10.3904/kjim.2011.26.2.123; Kim TN, 2010, DIABETES CARE, V33, P1497, DOI 10.2337/dc09-2310; Kirkman MS, 2012, J AM GERIATR SOC, V60, P2342, DOI 10.1111/jgs.12035; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Marron B, 2008, KIDNEY INT, V73, pS42, DOI 10.1038/sj.ki.5002600; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Oomichi T, 2006, DIABETES CARE, V29, P1496, DOI 10.2337/dc05-1887; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Perkovic V, 2013, KIDNEY INT, V83, P517, DOI 10.1038/ki.2012.401; Ramirez SPB, 2012, DIABETES CARE, V35, P2527, DOI 10.2337/dc12-0573; Ricks J, 2012, DIABETES, V61, P708, DOI 10.2337/db11-1015; Sekercioglu N, 2012, INT UROL NEPHROL, V44, P1861, DOI 10.1007/s11255-012-0180-6; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Wu MS, 1999, PERITONEAL DIALYSIS; Yoo DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030072; Yu CC, 1997, PERITON DIALYSIS INT, V17, P262; Zoungas S, 2014, NEW ENGL J MED, V371, P1392, DOI 10.1056/NEJMoa1407963	30	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0136085	10.1371/journal.pone.0136085	http://dx.doi.org/10.1371/journal.pone.0136085			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285034	Green Published, Green Submitted, gold			2022-12-26	WOS:000359666100101
J	Pfleging, J; Stucheli, M; Iovita, R; Buchli, J				Pfleging, Johannes; Stuecheli, Marius; Iovita, Radu; Buchli, Jonas			Dynamic Monitoring Reveals Motor Task Characteristics in Prehistoric Technical Gestures	PLOS ONE			English	Article							STONE; MICROWEAR	Reconstructing ancient technical gestures associated with simple tool actions is crucial for understanding the co-evolution of the human forelimb and its associated control-related cognitive functions on the one hand, and of the human technological arsenal on the other hand. Although the topic of gesture is an old one in Paleolithic archaeology and in anthropology in general, very few studies have taken advantage of the new technologies from the science of kinematics in order to improve replicative experimental protocols. Recent work in paleoanthropology has shown the potential of monitored replicative experiments to reconstruct tool-use-related motions through the study of fossil bones, but so far comparatively little has been done to examine the dynamics of the tool itself. In this paper, we demonstrate that we can statistically differentiate gestures used in a simple scraping task through dynamic monitoring. Dynamics combines kinematics (position, orientation, and speed) with contact mechanical parameters (force and torque). Taken together, these parameters are important because they play a role in the formation of a visible archaeological signature, use-wear. We present our new affordable, yet precise methodology for measuring the dynamics of a simple hide-scraping task, carried out using a pull-to (PT) and a push-away (PA) gesture. A strain gage force sensor combined with a visual tag tracking system records force, torque, as well as position and orientation of hafted flint stone tools. The set-up allows switching between two tool configurations, one with distal and the other one with perpendicular hafting of the scrapers, to allow for ethnographically plausible reconstructions. The data show statistically significant differences between the two gestures: scraping away from the body (PA) generates higher shearing forces, but requires greater hand torque. Moreover, most benchmarks associated with the PA gesture are more highly variable than in the PT gesture. These results demonstrate that different gestures used in 'common' prehistoric tasks can be distinguished quantitatively based on their dynamic parameters. Future research needs to assess our ability to reconstruct these parameters from observed use-wear patterns.	[Pfleging, Johannes; Buchli, Jonas] ETH, Agile & Dexterous Robot Lab, Zurich, Switzerland; [Stuecheli, Marius] ETH, Prod Dev Grp Zurich, Zurich, Switzerland; [Iovita, Radu] RGZM, MONREPOS Archaeol Res Ctr & Museum, Neuwied, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Leibniz-Forschungsinstitut fur Archaologie (RGZM)	Pfleging, J (corresponding author), ETH, Agile & Dexterous Robot Lab, Zurich, Switzerland.	pfleginj@ethz.ch; iovita@rgzm.de	Iovita, Radu/B-9580-2015	Iovita, Radu/0000-0001-9531-1159	Swiss National Science Foundation through a Professorship Award; NCCR robotics by Research Grant of ETH Zurich [ETH-36 14-1, ETH-22 13-2]; MONREPOS Archaeological Research Centre of the Romisch-Germanisches Zentralmuseum (RGZM)	Swiss National Science Foundation through a Professorship Award; NCCR robotics by Research Grant of ETH Zurich; MONREPOS Archaeological Research Centre of the Romisch-Germanisches Zentralmuseum (RGZM)	This research has been supported by the Swiss National Science Foundation through a Professorship Award to Jonas Buchli (www.snf.ch) and the NCCR robotics (www.nccrrobotics.ch, JP and JB), by Research Grants of ETH Zurich (www.ethz.ch), ETH-36 14-1 (JB/JP) and ETH-22 13-2 (MS). Radu Iovita thanks the MONREPOS Archaeological Research Centre of the Romisch-Germanisches Zentralmuseum (RGZM, www.rgzm.de) for supporting this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PC, 2006, J ARCHAEOL SCI, V33, P1559, DOI 10.1016/j.jas.2006.02.011; Barcelo Alvarez JA, 2008, PREHISTORIC TECHNOLO, P63; Beyries S., 2008, PREHISTORIC TECHNOLO, P21; CHRISTENSEN M, 1992, NUCL INSTRUM METH B, V64, P488, DOI 10.1016/0168-583X(92)95521-R; Cooper HM, 1954, MAT CULTURE AUSTR AB; Evans AA, 2005, J ARCHAEOL SCI, V32, P1733, DOI 10.1016/j.jas.2005.06.010; Gallagher J. P., 1977, J FIELD ARCHAEOL, V4, P407, DOI [DOI 10.2307/529396, 10.2307/529396]; Gendel P.A., 1982, STUDIA PRAEHISTORICA, V2, P251; Gonzalez-Urquijo J, 2015, MAN ARCHAEOL METH, P27, DOI 10.1007/978-3-319-08257-8_3; Hardy BL, 2008, J HUM EVOL, V54, P648, DOI 10.1016/j.jhevol.2007.10.003; Key AJM, 2013, LITHIC TECHNOL, V38, P32, DOI 10.1179/0197726113Z.0000000001; KNUTSSON K, 1984, ARCHAEOMETRY, V26, P49, DOI 10.1111/j.1475-4754.1984.tb00317.x; Lemonnier Pierre, 1992, ELEMENTS ANTHR TECHN, V88; Leroi-Gourhan A., 1964, GESTE PAROLE TECHNIQ; Mauss M., 1935, J PSYCHOL, V32, P271; Morrow JE., 1997, LITHIC TECHNOL, V22, P70, DOI [10.1080/01977261.1997.11754534, DOI 10.1080/01977261.1997.11754534]; Nissen K., 1974, TEBIWA, V17, P67; Odell G.H., 1980, J FIELD ARCHAEOL, V7, P87, DOI DOI 10.1179/009346980791505545; Odell G.H., 1981, J FIELD ARCHAEOL, V8, P197; ODELL GH, 1994, J ANTHROPOL ARCHAEOL, V13, P51, DOI 10.1006/jaar.1994.1004; Olson Edwin, 2011, 2011 IEEE International Conference on Robotics and Automation, P3400; Rots V, 2004, J ARCHAEOL SCI, V31, P1287, DOI 10.1016/j.jas.2004.02.009; Sahle Y, 2012, AFR ARCHAEOL REV, V29, P383, DOI 10.1007/s10437-012-9114-z; Schlanger N, 1996, CAMB ARCHAEOL J, V6, P231, DOI DOI 10.1017/S0959774300001724; Schmitt D, 2003, J ARCHAEOL SCI, V30, P103, DOI 10.1006/jasc.2001.0814; Seeman MF, 2013, AM ANTIQUITY, V78, P407, DOI 10.7183/0002-7316.78.3.407; Semenov S., 1964, PREHISTORIC TECHNOLO; Shaw CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040349; Shea J., 1992, EVOL ANTHROPOL, V1, P143, DOI DOI 10.1002/EVAN.1360010407; Shott MJ, 2007, J ARCHAEOL SCI, V34, P1016, DOI 10.1016/j.jas.2006.09.009; Sigaut F., 1991, COUTEAU NE SERT PAS, P21; Skinner MM, 2015, SCIENCE, V347, P395, DOI 10.1126/science.1261735; Smit Z, 1999, NUCL INSTRUM METH B, V150, P565, DOI 10.1016/S0168-583X(98)00941-0; Takase K., 2010, ASIAN PERSPECT, V49, P363, DOI [10.1353/asi.2010.0013, DOI 10.1353/ASI.2010.0013]; Tomenchuk J., 1985, THESIS U TORONTO; Tora Belkin KW, 2006, WOMAN TOOLMAKER HIDE; Unrath G, 1984, EARLY MAN NEWS, P117; Williams EM, 2012, J HUM EVOL, V62, P520, DOI 10.1016/j.jhevol.2012.02.005	38	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0134570	10.1371/journal.pone.0134570	http://dx.doi.org/10.1371/journal.pone.0134570			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP1VY	26284785	Green Published, gold, Green Submitted			2022-12-26	WOS:000359666100011
J	Sanderman, J; Reseigh, J; Wurst, M; Young, MA; Austin, J				Sanderman, Jonathan; Reseigh, Jodie; Wurst, Michael; Young, Mary-Anne; Austin, Jenet			Impacts of Rotational Grazing on Soil Carbon in Native Grass-Based Pastures in Southern Australia	PLOS ONE			English	Article							ORGANIC-CARBON; PATCH DYNAMICS; LAND-USE; MANAGEMENT; STOCKS; SEQUESTRATION; PARAMETERS; VEGETATION; FRACTIONS; CLIMATE	Rotational grazing management strategies have been promoted as a way to improve the sustainability of native grass-based pasture systems. From disturbance ecology theory, rotational grazing relative to continuous grazing can increase pasture productivity by allowing vegetation to recover after short intense grazing periods. This project sought to assess whether soil organic carbon (SOC) stocks would also increase with adoption of rotational grazing management. Twelve pairs of rotationally and continuously grazed paddocks were sampled across a rainfall gradient in South Australia. Pasture productivity approximated as the normalized difference vegetation index (NDVI) was on average no different between management categories, but when the data from all sites were aggregated as log response ratios (rotational/continuous) a significant positive trend of increasing NDVI under rotational grazing relative to continuous grazing was found (R-2 = 0.52). Mean SOC stocks (0-30 cm) were 48.3 Mg C ha(-1) with a range of 20-80 Mg C ha-1 across the study area with no differences between grazing management categories. SOC stocks were well correlated with rainfall and temperature (multiple linear regression R-2 = 0.61). After removing the influence of climate on SOC stocks, the management variables, rest periods, stocking rate and grazing days, were found to be significantly correlated with SOC, explaining 22% of the variance in SOC, but there were still no clear differences in SOC stocks at paired sites. We suggest three reasons for the lack of SOC response. First, changes in plant productivity and turnover in low-medium rainfall regions due to changes in grazing management are small and slow, so we would only expect at best small incremental changes in SOC stocks. This is compounded by the inherent variability within and between paddocks making detection of a small real change difficult on short timescales. Lastly, the management data suggests that there is a gradation in implementation of rotational grazing and the use of two fixed categories (i.e. rotational v. continuous) may not be the most appropriate method of comparing diverse management styles.	[Sanderman, Jonathan] CSIRO Sustainable Agr Flagship, Urrbrae, SA, Australia; [Reseigh, Jodie; Wurst, Michael; Young, Mary-Anne] Rural Solut SA, Primary Ind & Regions South Australia, Adelaide, SA, Australia; [Austin, Jenet] CSIRO Land & Water Flagship, Black Mountain, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Sanderman, J (corresponding author), Woods Hole Res Ctr, Falmouth, MA 02540 USA.	jsanderman@whrc.org	Austin, Jenet/F-8476-2013	Austin, Jenet/0000-0002-9421-0388; Sanderman, Jonathan/0000-0002-3215-1706	Australian Department of Agriculture, CSIRO Sustainable Agriculture Flagship and Rural Solutions South Australia	Australian Department of Agriculture, CSIRO Sustainable Agriculture Flagship and Rural Solutions South Australia	This project was supported by funding from the Australian Department of Agriculture, CSIRO Sustainable Agriculture Flagship and Rural Solutions South Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DE, 2013, SOIL RES, V51, P695, DOI 10.1071/SR13041; Amundson R, 2001, ANNU REV EARTH PL SC, V29, P535, DOI 10.1146/annurev.earth.29.1.535; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2011, 1 2 SRTM DERIVED DIG; Badini O, 2007, AGR SYST, V94, P87, DOI 10.1016/j.agsy.2005.09.010; Bai G, 2013, MYCORRHIZA, V23, P289, DOI 10.1007/s00572-012-0468-5; Baldock JA, 2013, SOIL RES, V51, P577, DOI 10.1071/SR13077; Baldock JA, 2013, SOIL RES, V51, P561, DOI 10.1071/SR12374; Baldock JA, 2011, HDB SOIL SCI; Briske DD, 2008, RANGELAND ECOL MANAG, V61, P3, DOI 10.2111/06-159R.1; BROUGHAM R. W., 1959, NEW ZEALAND JOUR AGRIC RES, V2, P1232; Chan KY, 2010, AUST J SOIL RES, V48, P7, DOI 10.1071/SR09092; Chappell A, 2012, GLOBAL CHANGE BIOL, V18, P2081, DOI 10.1111/j.1365-2486.2012.02682.x; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Conant RT, 2003, BIOL FERT SOILS, V38, P386, DOI 10.1007/s00374-003-0652-z; Conant RT, 2001, ECOL APPL, V11, P343, DOI 10.1890/1051-0761(2001)011[0343:GMACIG]2.0.CO;2; Cotrufo MF, 2013, GLOBAL CHANGE BIOL, V19, P988, DOI 10.1111/gcb.12113; Dorrough J, 2004, AUST J AGR RES, V55, P279, DOI 10.1071/AR03024; Earl J. M., 1996, Rangeland Journal, V18, P327, DOI 10.1071/RJ9960327; Fitzgerald D, 2000, PROGRAZIER AUTUMN, P14; Gifford RM, 2003, GLOBAL CHANGE BIOL, V9, P1507, DOI 10.1046/j.1365-2486.2003.00677.x; Hedges LV, 1999, ECOLOGY, V80, P1150, DOI 10.2307/177062; Isbell R.F., 2002, AUSTR SOIL CLASSIFIC; Janik LJ, 2006, PREDICT VER 6 0 MIR; Kahn LP, 2010, RANGELAND J, V32, P379, DOI 10.1071/RJ10003; Kemp DR, 2000, AUST J EXP AGR, V40, P343, DOI 10.1071/EA99001; King EA, 2013, NORMALIZED DIFFERENC; Kirschbaum MUF, 2000, BIOGEOCHEMISTRY, V48, P21, DOI 10.1023/A:1006238902976; Lal R, 2006, LAND DEGRAD DEV, V17, P197, DOI 10.1002/ldr.696; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Legendre P., 2012, NUMERICAL ECOLOGY; LEIGH JH, 1978, AUST J EXP AGR, V18, P381, DOI 10.1071/EA9780381; Lodge G. M., 1985, AUST RANGELAND J, V7, P6; Lodge GM, 1997, NSW AGR TECHNICAL B; Loveland P, 2003, SOIL TILL RES, V70, P1, DOI 10.1016/S0167-1987(02)00139-3; Macdonald LM, 2013, SOIL RES, V51, P738, DOI 10.1071/SR13156; Mcsherry ME, 2013, GLOBAL CHANGE BIOL, V19, P1347, DOI 10.1111/gcb.12144; NASA Land Processes Distributed Active Archive Center LP DAAC, 2013, NASA LAND PROC DISTR; Paget M. J., 2008, 004 CSIRO; Queensland Government, 2014, SILO CLIM DAT STAT Q; Rayment G.E., 2011, SOIL CHEM METHODS AU; Reseigh J, 2004, THESIS U NEW ENGLAND; Sanderman J, 2013, 1 FIELD LAB METH CSI; Sanderman J, 2014, DATA COLLECTION, DOI [10.4225/08/53B0EC7D91D4B, DOI 10.4225/08/53B0EC7D91D4B]; Sanderman J, 2014, 53 FTRG AUSTR DEP AG; Sanford P, 2003, AUST J EXP AGR, V43, P945, DOI 10.1071/EA02209; Sanjari G, 2009, AUST J SOIL RES, V47, P796, DOI 10.1071/SR09032; Smith P, 2004, EUR J AGRON, V20, P229, DOI 10.1016/j.eja.2003.08.002; Soil Survey Staff, 2009, USDA HDB, P436; State Herbarium of South Australia, 2014, EL FLOR S AUSTR; Teague R, 2013, J ENVIRON MANAGE, V128, P699, DOI 10.1016/j.jenvman.2013.05.064; Teague WR, 2011, AGR ECOSYST ENVIRON, V141, P310, DOI 10.1016/j.agee.2011.03.009; Teague WR, 2010, AGR ECOSYST ENVIRON, V137, P113, DOI 10.1016/j.agee.2010.01.010; Teague WR, 2003, J ARID ENVIRON, V53, P211, DOI 10.1006/jare.2002.1036; Teague WR, 2004, J ARID ENVIRON, V58, P97, DOI 10.1016/S0140-1963(03)00122-8; Wilson BR, 2013, SOIL RES, V51, P668, DOI 10.1071/SR12376; Xu B, 2008, INT J REMOTE SENS, V29, P5313, DOI 10.1080/01431160802036276	58	33	35	4	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0136157	10.1371/journal.pone.0136157	http://dx.doi.org/10.1371/journal.pone.0136157			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284658	gold, Green Submitted, Green Published			2022-12-26	WOS:000359666100106
J	Scott, JC; Shah, N; Porco, T; Flood, J				Scott, James C.; Shah, Neha; Porco, Travis; Flood, Jennifer			Cost Resulting from Anti-Tuberculosis Drug Shortages in the United States: A Hypothetical Cohort Study	PLOS ONE			English	Article							RESISTANT TUBERCULOSIS; ADVERSE EVENTS; MDR-TB; SAFETY; REGIMENS; RIFAMPIN	Background From 2012 through 2014, the United States experienced acute shortages and price escalations of several first-line anti-tuberculosis (TB) medications. Because secondary TB drug regimens are longer and adverse events occur more frequently with them, we sought to conservatively estimate the cost, to patients and the health care system, of TB treatment and medication adverse events from alternative regimens during drug shortages. Methods We assessed the cost of treatment for TB disease in the absence of isoniazid (INH), rifampin (RIF), or pyrazinamide (PZA), or both INH and RIF. We simulated adverse events based on published probabilities using a monthly discrete-time stochastic model. For total costs, we summed costs of medications, routine testing, and treatment of adverse events using procedural terminology codes. We report average cost ratios of TB treatment during drug shortages to standard TB treatment. Results The cost ratio of TB treatment without INH, RIF, or PZA to standard treatment was 1.7 (Range: 1.2, 2.3), 4.9 (Range: 3.2, 7.3), and 1.1 (Range: 0.7, 1.7) times higher, respectively. Without both INH and RIF, the cost ratio was 18.6 (Range: 10.0, 39.0) times higher. When the prices for INH, RIF and PZA were increased, the cost for standard treatment increased by a factor of 2.7 (Range: 1.9, 3.0). The percentage of patients experiencing at least one adverse event while taking standard therapy was 3.9% (Range: 1.3%, 11.8%). This percentage increased to 51.5%(Range: 20.1%, 83.8%) when RIF was unavailable, and increased to 82.5% (Range: 41.2%, 98.5%) when both INH and RIF were unavailable. Conclusions Our conservative model illustrates that an interruption in first-line anti-TB medications leads to appreciable additional costs and adverse events for patients. The availability of these drugs in the United States should be ensured. Models that incorporate the effectiveness of alternative regimens, delays in treatment initiation, and TB transmission can provide broader perspectives on the impact of drug shortages.	[Scott, James C.] Colby Coll, Dept Math & Stat, Waterville, ME 04901 USA; [Scott, James C.; Porco, Travis] Francis I Proctor Fdn, San Francisco, CA USA; [Shah, Neha; Flood, Jennifer] Calif Dept Hlth TB Control Branch, Richmond, CA 94804 USA; [Shah, Neha] Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA; [Porco, Travis] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	Colby College; California Department of Public Health; Centers for Disease Control & Prevention - USA; University of California System; University of California San Francisco	Shah, N (corresponding author), Calif Dept Hlth TB Control Branch, Richmond, CA 94804 USA.	nshah6@cdc.gov			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM087728] Funding Source: NIH RePORTER; NIGMS NIH HHS [U01-GM087728, U01 GM087728] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 2013, REP TUB US; [Anonymous], 2012, CURR PROC TERM CPT 2; Ball P, 2004, CLIN THER, V26, P940, DOI 10.1016/S0149-2918(04)90170-1; Cattamanchi A, 2009, CLIN INFECT DIS, V48, P179, DOI 10.1086/595689; Centers for Disease Control and Prevention, 2003, MMWR, V52; Centers for Disease Control and Prevention (CDC), 2012, MMWR Morb Mortal Wkly Rep, V61, P1029; COX H, 2012, INT J TUBERC LUNG D, V16, P447, DOI DOI 10.5588/IJTLD.11.0451; Curry International Tuberculosis Center, 2012, TUB DRUG INF GUID; FOX W, 1999, INT J TUBERC LUNG S2, V3, pS231; Francis J., 2008, DRUG RESISTANT TUBER; Holland DP, 2009, AM J RESP CRIT CARE, V179, P1055, DOI 10.1164/rccm.200901-0153OC; Hwang TJ, 2013, INT J TUBERC LUNG D, V17, P1257, DOI 10.5588/ijtld.12.0863; Kanouse J, 2014, NAT TUB CONTR ASS AN; Khaliq Y, 2003, CLIN INFECT DIS, V36, P1404, DOI 10.1086/375078; Law S, 2014, EUR RESPIR J, V43, P566, DOI 10.1183/09031936.00005613; Martinez E, 1999, MEDICINE, V78, P361, DOI 10.1097/00005792-199911000-00001; Menzies D, 2008, ANN INTERN MED, V149, P689, DOI 10.7326/0003-4819-149-10-200811180-00003; Modongo C, 2012, INT J TUBERC LUNG D, V16, P1561, DOI 10.5588/ijtld.12.0403; Nathanson E, 2004, INT J TUBERC LUNG D, V8, P1382; National Tuberculosis Controllers Association, 2014, NAT TUB CONT ASS ANN; Peloquin C, 2004, CHEST, V126, P1722, DOI 10.1378/chest.126.6.1722; Peloquin CA, 2004, CLIN INFECT DIS, V38, P1538, DOI 10.1086/420742; Porco TC, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-157; R Development Core Team, 2014, R LANG ENV STAT COMP; Saukkonen JJ, 2006, AM J RESP CRIT CARE, V174, P935, DOI 10.1164/rccm.200510-1666ST; Scott Bentley T., 2011, US ORGAN TISSUE TRAN; Seaworth BJ, 2013, MMWR-MORBID MORTAL W, V62, P23; Sotgiu G, 2012, EUR RESPIR J, V40, P1430, DOI 10.1183/09031936.00022912; STEELE MA, 1988, CHEST, V94, P845, DOI 10.1378/chest.94.4.845; Sterling TR, 2011, NEW ENGL J MED, V365, P2155, DOI 10.1056/NEJMoa1104875; SWAI OB, 1988, TUBERCLE, V69, P5, DOI 10.1016/0041-3879(88)90035-9; Warkentin J, 2013, MMWR-MORBID MORTAL W, V62, P398; World Health Organization, 2011, WHO PUBLIC ASSESSMEN	33	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0134597	10.1371/journal.pone.0134597	http://dx.doi.org/10.1371/journal.pone.0134597			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284924	Green Published, gold			2022-12-26	WOS:000359666100012
J	Tripathy, D; Choudhary, A; Banerjee, UC; Singh, IP; Chatterjee, A				Tripathy, Debabrata; Choudhary, Alka; Banerjee, Uttam Chand; Singh, Inder Pal; Chatterjee, Anupam			Induction of Apoptosis and Reduction of Endogenous Glutathione Level by the Ethyl-Acetate Soluble Fraction of the Methanol Extract of the Roots of Potentilla fulgens in Cancer Cells	PLOS ONE			English	Article							GAMMA-GLUTAMYLCYSTEINE SYNTHETASE; NATURAL-PRODUCTS; URSOLIC ACID; ANTIOXIDANT; MODULATION; PREVENTION; TUMORS; DRUGS; MICE	Potentilla fulgens root traditionally used as a folk remedy in Meghalaya, India. However, systematic evaluation of its anticancer efficacy was limited. We investigated the anticancer potentials of the various extracts prepared by partitioning of the methanol extract of the root with the aim to discover major contributing factors from the most effective fractions. Methanol extract of P. fulgens roots (PRE) was prepared by maceration which was subsequently fractionated into hexane, ethyl-acetate (EA) and n-butanol soluble fractions. Various assays (clonogenic assay, Flow cytometry analysis, western blot, semiquantitative RT-PCR and the level of endogenous glutathione) were used to evaluate different parameters, such as Cell survivability, PARP-1 proteolysis, expression pattern of anti-apoptotic and.-glutamylcysteine synthetase heavy subunit (GCSC) genes in both MCF-7 and U87 cancer cell lines. Since the EA-fraction showed most efficient growth inhibitory effect, it was further purified and a total of nine compounds and some monomeric and dimeric flavan-3-ols were identified and characterized. Three compounds viz., epicatechin (EC), gallic acid (GA) and ursolic acid (UA) were taken on the basis of their higher yield and 10 mu g/ml of each was mixed together. The concentration used in this study for PRE, EA-and Hex-fraction was 100 mu g/ml, which was higher than the IC50 value. Apoptotic cell death in the PRE, EA-fraction and EC+GA+UA treated cancer cell cultures was significantly greater than in normal cells due to suppression of anti-apoptotic protein Bcl2 following treatment. Depletion of glutathione by downregulating GCSC was also observed. Induction of apoptosis and lowering the level of glutathione are considered to be positive activity for an anticancer agent. Therefore, modulation of GSH concentration in tumor cells by PRE and its EA-fraction opened up the possibility of a new therapeutic approach because these plant products are not harmful to normal cells and may regulate the tumor cellular response to different anticancer treatments. Thus, it would be interesting to examine efficacy of these plant products or EA-fraction in human cancer treatment.	[Tripathy, Debabrata; Chatterjee, Anupam] North Eastern Hill Univ, Dept Biotechnol & Bioinformat, Mol Genet Lab, Shillong 793022, Meghalaya, India; [Choudhary, Alka; Banerjee, Uttam Chand] Natl Inst Pharmaceut Educ & Res, Dept Pharmaceut Technol Biotechnol, Sect 67, Sas Nagar 160062, Punjab, India; [Singh, Inder Pal] Natl Inst Pharmaceut Educ & Res, Dept Nat Prod, Sect 67, Sas Nagar 160062, Punjab, India	North Eastern Hill University; National Institute of Pharmaceutical Education & Research (NIPER); National Institute of Pharmaceutical Education & Research, S.A.S. Nagar (Mohali); National Institute of Pharmaceutical Education & Research (NIPER); National Institute of Pharmaceutical Education & Research, S.A.S. Nagar (Mohali)	Chatterjee, A (corresponding author), North Eastern Hill Univ, Dept Biotechnol & Bioinformat, Mol Genet Lab, Shillong 793022, Meghalaya, India.	chatterjeeanupam@hotmail.com		Tripathy, Debabrata/0000-0003-1081-2232; Banerjee, uttam Chand/0000-0002-7363-4042	DBT, Govt. of India [BT/59/NE/TBP/2010]; DBT fellowship; DST-Inspire fellowship [IF 120044]	DBT, Govt. of India(Department of Biotechnology (DBT) India); DBT fellowship; DST-Inspire fellowship	This work was supported by DBT, Govt. of India (BT/59/NE/TBP/2010) to AC, UCB, and IPS; DBT fellowship and DST-Inspire fellowship (IF 120044) to Alka Choudhary; DBT-fellowship to DT.	Akerboom T P, 1981, Methods Enzymol, V77, P373; Amin ARMR, 2009, J CLIN ONCOL, V27, P2712, DOI 10.1200/JCO.2008.20.6235; Chattopadhyay A, 1999, INT J RADIAT BIOL, V75, P1283, DOI 10.1080/095530099139449; Choudhary A, 2015, PHYTOCHEM ANALYSIS, V26, P161, DOI 10.1002/pca.2547; Choudhary A, 2013, FITOTERAPIA, V91, P290, DOI 10.1016/j.fitote.2013.09.008; Circu ML, 2012, BBA-MOL CELL RES, V1823, P1767, DOI 10.1016/j.bbamcr.2012.06.019; Coseri S, 2009, MINI-REV MED CHEM, V9, P560, DOI 10.2174/138955709788167592; De Angel RE, 2010, NUTR CANCER, V62, P1074, DOI 10.1080/01635581.2010.492092; Elbaz HA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088322; ESTRELA JM, 1995, NAT MED, V1, P84, DOI 10.1038/nm0195-84; Estrela JM, 2006, CRIT REV CL LAB SCI, V43, P143, DOI 10.1080/10408360500523878; Fang Y, 2012, J BIOL CHEM, V287, P35234, DOI 10.1074/jbc.M112.389494; Franco R, 2009, CELL DEATH DIFFER, V16, P1303, DOI 10.1038/cdd.2009.107; Franklin CC, 2009, MOL ASPECTS MED, V30, P86, DOI 10.1016/j.mam.2008.08.009; Gamcsik MP, 2012, BIOMARKERS, V17, P671, DOI 10.3109/1354750X.2012.715672; Griffith OW, 1999, ADV ENZYMOL RAMB, V73, P209, DOI 10.1002/9780470123195.ch7; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Ishige K, 2001, FREE RADICAL BIO MED, V30, P433, DOI 10.1016/S0891-5849(00)00498-6; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Jenny Marcel, 2005, J Carcinog, V4, P15, DOI 10.1186/1477-3163-4-15; Jew S, 2009, J MED FOOD, V12, P925, DOI 10.1089/jmf.2008.0268; Lauterburg Bernhard H, 2002, Am J Ther, V9, P225, DOI 10.1097/00045391-200205000-00008; Lauthier F, 2000, ANTI-CANCER DRUG, V11, P737; Lu Y, 2010, EUR J PHARMACOL, V641, P102, DOI 10.1016/j.ejphar.2010.05.043; Myhrstad MCW, 2002, FREE RADICAL BIO MED, V32, P386, DOI 10.1016/S0891-5849(01)00812-7; Newman DJ, 2008, J MED CHEM, V51, P2589, DOI 10.1021/jm0704090; Ortega Angel L, 2011, Cancers (Basel), V3, P1285, DOI 10.3390/cancers3011285; POOT M, 1995, J CELL PHYSIOL, V163, P555, DOI 10.1002/jcp.1041630316; Prasad S, 2011, J BIOL CHEM, V286, P5546, DOI 10.1074/jbc.M110.183699; Radhika M, 2012, J COMPLEMENTARY INTE, V9, P1; Ramos AA, 2010, MUTAT RES-FUND MOL M, V692, P6, DOI 10.1016/j.mrfmmm.2010.07.004; Rosangkima G., 2004, Indian Journal of Experimental Biology, V42, P981; Safarzadeh E, 2014, ADV PHARM BULL, V4, P421, DOI 10.5681/apb.2014.062; Shushunov S, 2009, J MED FOOD, V12, P1173, DOI 10.1089/jmf.2008.0281; Siegelin MD, 2008, MOL CANCER THER, V7, P3566, DOI 10.1158/1535-7163.MCT-08-0236; Soldani C, 2001, EXP CELL RES, V269, P193, DOI 10.1006/excr.2001.5293; Syiem D, 2002, J ETHNOPHARMACOL, V83, P55, DOI 10.1016/S0378-8741(02)00190-3; Thayyullathil F, 2011, BIOCHEM BIOPH RES CO, V411, P1, DOI 10.1016/j.bbrc.2011.05.156; Tomczyk M, 2010, MOLECULES, V15, P4639, DOI 10.3390/molecules15074639; Tomczyk M, 2009, J ETHNOPHARMACOL, V122, P184, DOI 10.1016/j.jep.2008.12.022; Verma S, 2013, ENVIRON TOXICOL PHAR, V35, P473, DOI 10.1016/j.etap.2013.02.011; Wang SS, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-321; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zamzami N, 2005, CELL DEATH DIFFER, V12, P1478, DOI 10.1038/sj.cdd.4401682; Zhao YL, 2008, PHYTOMEDICINE, V15, P253, DOI 10.1016/j.phymed.2008.01.005	45	9	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135890	10.1371/journal.pone.0135890	http://dx.doi.org/10.1371/journal.pone.0135890			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284809	Green Published, Green Submitted, gold			2022-12-26	WOS:000359666100083
J	Tabana, H; Nkonki, L; Hongoro, C; Doherty, T; Ekstrom, AM; Naik, R; Zembe-Mkabile, W; Jackson, D; Thorson, A				Tabana, Hanani; Nkonki, Lungiswa; Hongoro, Charles; Doherty, Tanya; Ekstrom, Anna Mia; Naik, Reshma; Zembe-Mkabile, Wanga; Jackson, Debra; Thorson, Anna			A Cost-Effectiveness Analysis of a Home-Based HIV Counselling and Testing Intervention versus the Standard (Facility Based) HIV Testing Strategy in Rural South Africa	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; HEALTH; TRANSMISSION; ACCEPTABILITY; CARE	Introduction There is growing evidence concerning the acceptability and feasibility of home-based HIV testing. However, less is known about the cost-effectiveness of the approach yet it is a critical component to guide decisions about scaling up access to HIV testing. This study examined the cost-effectiveness of a home-based HIV testing intervention in rural South Africa. Methods Two alternatives: clinic and home-based HIV counselling and testing were compared. Costs were analysed from a provider's perspective for the period of January to December 2010. The outcome, HIV counselling and testing (HCT) uptake was obtained from the Good Start home-based HIV counselling and testing (HBHCT) cluster randomised control trial undertaken in KwaZulu-Natal province. Cost-effectiveness was estimated for a target population of 22,099 versus 23,864 people for intervention and control communities respectively. Average costs were calculated as the cost per client tested, while cost-effectiveness was calculated as the cost per additional client tested through HBHCT. Results Based on effectiveness of 37% in the intervention (HBHCT) arm compared to 16% in control arm, home based testing costs US$29 compared to US$38 per person for clinic HCT. The incremental cost effectiveness per client tested using HBHCT was $19. Conclusions HBHCT was less costly and more effective. Home- based HCT could present a cost- effective alternative for rural 'hard to reach' populations depending on affordability by the health system, and should be considered as part of community outreach programs.	[Tabana, Hanani; Doherty, Tanya; Naik, Reshma; Zembe-Mkabile, Wanga] Med Res Council South Africa, Hlth Syst Res Unit, Cape Town, South Africa; [Tabana, Hanani; Ekstrom, Anna Mia; Thorson, Anna] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Tabana, Hanani; Doherty, Tanya; Jackson, Debra] Univ Western Cape, Sch Publ Hlth, Cape Town, South Africa; [Ekstrom, Anna Mia; Thorson, Anna] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden; [Nkonki, Lungiswa] Univ Stellenbosch, Div Community Hlth, Fac Hlth Sci, Cape Town, South Africa; [Naik, Reshma] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA; [Naik, Reshma] Populat Reference Bur, Washington, DC USA; [Hongoro, Charles] Human Sci Res Council, Populat Hlth Hlth Syst & Innovat, Pretoria, South Africa	Karolinska Institutet; University of the Western Cape; Karolinska Institutet; Karolinska University Hospital; Stellenbosch University; Boston University; Human Sciences Research Council-South Africa	Tabana, H (corresponding author), Med Res Council South Africa, Hlth Syst Res Unit, Cape Town, South Africa.	htabana@uwc.ac.za	Tabana, Hanani/AAJ-5361-2020; Nkonki, Lungiswa/AAA-8613-2021; Mo, Xiumei/C-9340-2013; Tabana, Hanani/AAP-8143-2020	Tabana, Hanani/0000-0003-1576-2238; Tabana, Hanani/0000-0003-1576-2238; Thorson, Anna/0000-0002-8703-6561; Zembe-Mkabile, Wanga/0000-0003-4106-4513; Nkonki, Lungiswa/0000-0003-2011-5844; Hongoro, Charles/0000-0002-9715-4940; Jackson, Debra/0000-0003-3307-632X	South African Medical Research Council	South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was financed using funds from the South African Medical Research Council. The institution had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam T, 2007, COSTIT SOFTWARE 2007; [Anonymous], 2011, PROV GUID IMPL 3 STR; [Anonymous], 2007, METHODS EC EVALUATIO; Baron P, 2011, PHASA NEWSLETTE 1115; Bateganya MH, 2007, COCHRANE DATABASE SY, P4; Bateganya MH, 2007, COCHRANE DB SYST REV, P4; Bhattacharyya K, 2001, COMMUNITY HLTH WORKE; Borgdorff MW, 2002, B WORLD HEALTH ORGAN, V80, P217; Callaghan M, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-8; Costing Guidelines for HIV Prevention Strategies, 2000, COST GUID HIV PREV S; De Cock KM, 2003, LANCET, V362, P1847, DOI 10.1016/S0140-6736(03)14906-9; Doherty T, 2013, BMJ-BRIT MED J, V346, P1; Fylkesnes K, 2004, TROP MED INT HEALTH, V9, P566, DOI 10.1111/j.1365-3156.2004.01231.x; Galarraga O, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-S1-S5; Jha P, 2001, SCIENCE, V292, P224, DOI 10.1126/science.1058187; Johns B, 2005, HEALTH POLICY PLANN, V20, P1, DOI 10.1093/heapol/czi001; Lugada E, 2010, JAIDS-J ACQ IMM DEF, V55, P245, DOI 10.1097/QAI.0b013e3181e9e069; Marseille E, 2002, COST EFFECTIVENESS H; Matovu JKB, 2007, TROP MED INT HEALTH, V12, P1315, DOI 10.1111/j.1365-3156.2007.01923.x; Mayosi BM, 2012, LANCET, V380, P2029, DOI 10.1016/S0140-6736(12)61814-5; McCord GC, 2013, B WORLD HEALTH ORGAN, V91, P244, DOI 10.2471/BLT.12.109660; Menzies N, 2009, AIDS, V23, P395, DOI 10.1097/QAD.0b013e328321e40b; Mulogo EM, 2013, AFR HEALTH SCI, V13, P423, DOI 10.4314/ahs.v13i2.32; Naik R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-824; Negin J, 2009, TROP MED INT HEALTH, V14, P849, DOI 10.1111/j.1365-3156.2009.02304.x; Sabapathy K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001351; Shisana O, 2014, S AFRICAN NATL HIV P; Statistics South Africa, 2011, STAT S AFR; Sweat M, 2000, LANCET, V356, P113, DOI 10.1016/S0140-6736(00)02447-8; Tabana H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066390; Tabana H, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-73; Thielman NM, 2006, AM J PUBLIC HEALTH, V96, P114, DOI 10.2105/AJPH.2004.056796; Tumwesigye E, 2010, AIDS PATIENT CARE ST, V24, P735, DOI 10.1089/apc.2010.0096; UMzimkhulu Local Municipality, 2010, INT DEV PLAN 2009 20	34	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135048	10.1371/journal.pone.0135048	http://dx.doi.org/10.1371/journal.pone.0135048			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CO9KD	26275059	gold, Green Published			2022-12-26	WOS:000359493600048
J	Wang, YN; Wang, H; Hay, AJ; Zhong, ZT; Zhu, J; Kan, BA				Wang, Yuning; Wang, Hui; Hay, Amanda J.; Zhong, Zengtao; Zhu, Jun; Kan, Biao			Functional RelBE-Family Toxin-Antitoxin Pairs Affect Biofilm Maturation and Intestine Colonization in Vibrio cholerae	PLOS ONE			English	Article							VIRULENCE GENE-EXPRESSION; ESCHERICHIA-COLI; F-PLASMID; SYSTEMS; MUTAGENESIS; CLONING; RESISTANCE; SEQUENCE; LOCUS; PHD	Toxin-antitoxin (TA) systems are small genetic elements that typically encode a stable toxin and its labile antitoxin. These cognate pairs are abundant in prokaryotes and have been shown to regulate various cellular functions. Vibrio cholerae, a human pathogen that is the causative agent of cholera, harbors at least thirteen TA loci. While functional HigBA, ParDE have been shown to stabilize plasmids and Phd/Doc to mediate cell death in V. cholerae, the function of seven RelBE-family TA systems is not understood. In this study we investigated the function of the RelBE TA systems in V. cholerae physiology and found that six of the seven relBE loci encoded functional toxins in E. coli. Deletion analyses of each relBE locus indicate that RelBE systems are involved in biofilm formation and reactive oxygen species (ROS) resistance. Interestingly, all seven relBE loci are induced under the standard virulence induction conditions and two of the relBE mutants displayed a colonization defect, which was not due to an effect on virulence gene expression. Although further studies are needed to characterize the mechanism of action, our study reveals that RelBE systems are important for V. cholerae physiology.	[Wang, Yuning; Wang, Hui; Zhong, Zengtao; Zhu, Jun] Nanjing Agr Univ, Dept Microbiol, Nanjing, Jiangsu, Peoples R China; [Wang, Yuning; Kan, Biao] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China; [Wang, Yuning; Hay, Amanda J.; Zhu, Jun] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kan, Biao] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China	Nanjing Agricultural University; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; University of Pennsylvania; Pennsylvania Medicine; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Zhu, J (corresponding author), Nanjing Agr Univ, Dept Microbiol, Nanjing, Jiangsu, Peoples R China.	jun_zhu@njau.edu.cn; kanbiao@icdc.cn	Zhong, Zengtao/E-2533-2016; Zhu, Jun/A-1324-2007		NIH/NIAID R01 grant [AI080654]; Priority Project of State Key Laboratory for Infectious Disease Prevention and Control [2014SKLID101]; 973 project [2015CB5542000]; NSFC [81371763]; China Scholarship Council; NSF GRFP fellowship [DGE-1321851]	NIH/NIAID R01 grant; Priority Project of State Key Laboratory for Infectious Disease Prevention and Control; 973 project(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council); NSF GRFP fellowship(National Science Foundation (NSF)NSF - Office of the Director (OD))	This study is supported by an NIH/NIAID R01 grant (AI080654), the Priority Project of State Key Laboratory for Infectious Disease Prevention and Control (2014SKLID101), a 973 project (2015CB5542000), and an NSFC grant (81371763). Y.W. is also supported by a fellowship from China Scholarship Council, and A.J.H. is supported by an NSF GRFP fellowship (DGE-1321851). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Christensen-Dalsgaard M, 2006, MOL MICROBIOL, V62, P397, DOI 10.1111/j.1365-2958.2006.05385.x; Christensen-Dalsgaard M, 2010, MOL MICROBIOL, V75, P333, DOI 10.1111/j.1365-2958.2009.06969.x; Clark CA, 1997, MOL MICROBIOL, V26, P1137; De la Cruz MA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003827; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; Gardel CL, 1996, INFECT IMMUN, V64, P2246, DOI 10.1128/IAI.64.6.2246-2255.1996; GERDES K, 1986, P NATL ACAD SCI USA, V83, P3116, DOI 10.1073/pnas.83.10.3116; Gerdes K, 2000, J BACTERIOL, V182, P561, DOI 10.1128/JB.182.3.561-572.2000; Gotfredsen M, 1998, MOL MICROBIOL, V29, P1065, DOI 10.1046/j.1365-2958.1998.00993.x; Gronlund H, 1999, J MOL BIOL, V285, P1401, DOI 10.1006/jmbi.1998.2416; Guerout AM, 2013, J BACTERIOL, V195, P2270, DOI 10.1128/JB.01389-12; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; HIGGINS DE, 1994, MOL MICROBIOL, V14, P17, DOI 10.1111/j.1365-2958.1994.tb01263.x; Iqbal N, 2015, J BACTERIOL, V197, P2150, DOI 10.1128/JB.00108-15; IWANAGA M, 1986, MICROBIOL IMMUNOL, V30, P1075, DOI 10.1111/j.1348-0421.1986.tb03037.x; JAFFE A, 1985, J BACTERIOL, V163, P841; Joelsson A, 2006, INFECT IMMUN, V74, P1141, DOI 10.1128/IAI.74.2.1141-1147.2006; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Karaolis DKR, 1998, P NATL ACAD SCI USA, V95, P3134, DOI 10.1073/pnas.95.6.3134; Khlebnikov A, 2001, MICROBIOL-SGM, V147, P3241, DOI 10.1099/00221287-147-12-3241; Kim YH, 2009, J BACTERIOL, V191, P1258, DOI 10.1128/JB.01465-08; LEHNHERR H, 1993, J MOL BIOL, V233, P414, DOI 10.1006/jmbi.1993.1521; Liu Z, 2011, P NATL ACAD SCI USA, V108, P810, DOI 10.1073/pnas.1014640108; Matson JS, 2007, INFECT IMMUN, V75, P5542, DOI 10.1128/IAI.01094-07; Mazel D, 1998, SCIENCE, V280, P605, DOI 10.1126/science.280.5363.605; MENARD R, 1993, J BACTERIOL, V175, P5899; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; MOYED HS, 1986, J BACTERIOL, V166, P399, DOI 10.1128/jb.166.2.399-403.1986; Norton JP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002954; OGURA T, 1983, P NATL ACAD SCI-BIOL, V80, P4784, DOI 10.1073/pnas.80.15.4784; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Provenzano D, 2000, P NATL ACAD SCI USA, V97, P10220, DOI 10.1073/pnas.170219997; PULLINGER GD, 1992, MOL MICROBIOL, V6, P1631, DOI 10.1111/j.1365-2958.1992.tb00888.x; Ramage HR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000767; RHINE JA, 1994, MOL MICROBIOL, V13, P1013, DOI 10.1111/j.1365-2958.1994.tb00492.x; ROBERTS RC, 1992, J BACTERIOL, V174, P8119, DOI 10.1128/JB.174.24.8119-8132.1992; Schuster CF, 2013, FEMS MICROBIOL LETT, V340, P73, DOI 10.1111/1574-6968.12074; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Slattery A, 2013, J BACTERIOL, V195, P647, DOI 10.1128/JB.01397-12; SZYBALSKI W, 1952, J BACTERIOL, V64, P489, DOI 10.1128/JB.64.4.489-499.1952; Tian QB, 1996, BIOCHEM BIOPH RES CO, V220, P280, DOI 10.1006/bbrc.1996.0396; Van Melderen L, 2010, CURR OPIN MICROBIOL, V13, P781, DOI 10.1016/j.mib.2010.10.006; Wang HK, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029452, 10.1371/journal.pone.0041330, 10.1371/journal.pone.0038619]; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412; Yang MH, 2013, P NATL ACAD SCI USA, V110, P2348, DOI 10.1073/pnas.1218039110; Yildiz FH, 2009, TRENDS MICROBIOL, V17, P109, DOI 10.1016/j.tim.2008.12.004; Yuan J, 2011, J BACTERIOL, V193, P611, DOI 10.1128/JB.01185-10; Zhu J, 2003, DEV CELL, V5, P647, DOI 10.1016/S1534-5807(03)00295-8; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	50	31	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135696	10.1371/journal.pone.0135696	http://dx.doi.org/10.1371/journal.pone.0135696			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275048	Green Published, gold, Green Submitted			2022-12-26	WOS:000359493600098
J	Hijazi, A; Guan, HY; Cernea, M; Yang, KP				Hijazi, Ayten; Guan, Haiyan; Cernea, Maria; Yang, Kaiping			Prenatal exposure to bisphenol A disrupts mouse fetal lung development	FASEB JOURNAL			English	Article						endocrine-disrupting chemical; environmental exposure; lung maturation; glucocorticoid signaling	RESPIRATORY-DISTRESS; CELL-PROLIFERATION; GENE; DIFFERENTIATION; EXPRESSION; INFLAMMATION; MATURATION; WHEEZE; ASTHMA; ALTERS	Developmental exposure to bisphenol A (BPA) is associated with lung dysfunction and diseases. However, it is unknown if this association has a fetal origin. The present study addressed this important question by examining the effects of BPA on fetal lung development. BPA was administered to pregnant mice via diet from embryonic day (E) 7.5 to E18.5. Fetal lungs were analyzed at E18.5 for changes in structure and expression of key molecular markers of lung maturation. Our main findings were as follows: BPA severely retards fetal lung maturation, as evidenced by diminished alveolar airspace (15% of control) and thickened septa, hallmarks of lung immaturity; this immaturity is characterized by aberrant alveolar epithelial type I cell differentiation because expression of the type I cell marker, aquaporin 5, but not type II cell markers, is dramatically reduced (16% of control); and the effects of BPA are likely mediated through the glucocorticoid signaling pathway because the expression of epithelial sodium channel gamma and glutathione peroxidase, 2 well-known glucocorticoid target genes, is down-regulated in BPA-exposed fetal lungs, and, importantly, maternal dexamethasone administration rescues the lung immaturity phenotype. Taken together, these findings demonstrate that BPA disrupts fetal lung maturation, thus suggesting a fetal origin for BPA-induced lung diseases.	Univ Western Ontario, Dept Obstet & Gynaecol, Childrens Hlth Res Inst, London, ON, Canada; Univ Western Ontario, Dept Physiol & Pharmacol, Childrens Hlth Res Inst, London, ON, Canada; Univ Western Ontario, Lawson Hlth Res Inst, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Yang, KP (corresponding author), Childrens Hlth Res Inst, Victoria Res Labs, Room A5-132,800 Commissioners Rd East, Victoria, ON N6C 2V5, Canada.	kyang@uwo.ca			Canadian Institutes of Health Research [MOP-79484]; Children's Health Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Children's Health Foundation	The authors thank F. Beier, D. Hardy, S. Gill, F. Possmayer, and R. Tirona (Western University, London, ON, Canada) for helpful discussions. This work was supported by the Canadian Institutes of Health Research (Operating Grant MOP-79484), and M.C. was the recipient of a postdoctoral fellowship from Children's Health Foundation.	BARLOW SM, 1974, J ENDOCRINOL, V60, P473, DOI 10.1677/joe.0.0600473; Bauer SM, 2012, TOXICOL SCI, V130, P82, DOI 10.1093/toxsci/kfs227; Bird AD, 2007, J PHYSIOL-LONDON, V585, P187, DOI 10.1113/jphysiol.2007.136796; Bouwman P, 2000, EMBO J, V19, P655, DOI 10.1093/emboj/19.4.655; Calhoun KC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085894; Chapalamadugu KC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089096; COLE TJ, 1995, GENE DEV, V9, P1608, DOI 10.1101/gad.9.13.1608; Cole TJ, 2004, AM J RESP CELL MOL, V30, P613, DOI 10.1165/rcmb.2003-0236OC; Compernolle V, 2002, NAT MED, V8, P702, DOI 10.1038/nm721; De Coster S, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/713696; Divakaran K, 2014, TOXICOL SCI, V141, P292, DOI 10.1093/toxsci/kfu126; Dolinoy DC, 2007, P NATL ACAD SCI USA, V104, P13056, DOI 10.1073/pnas.0703739104; Donohue KM, 2013, J ALLERGY CLIN IMMUN, V131, P736, DOI 10.1016/j.jaci.2012.12.1573; Elsworth JD, 2013, NEUROTOXICOLOGY, V35, P113, DOI 10.1016/j.neuro.2013.01.001; Erden ES, 2014, EUR REV MED PHARMACO, V18, P3477; Gerona RR, 2013, ENVIRON SCI TECHNOL, V47, P12477, DOI 10.1021/es402764d; Golub MS, 2010, BIRTH DEFECTS RES B, V89, P441, DOI 10.1002/bdrb.20275; Grier David G, 2004, Treat Respir Med, V3, P295, DOI 10.2165/00151829-200403050-00004; Im SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058511; IRIS, 2012, 80057 IRIS CASRN; Kim KN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111383; Klinger S, 2009, P NATL ACAD SCI USA, V106, P16710, DOI 10.1073/pnas.0900919106; Kreda SM, 2001, AM J RESP CELL MOL, V24, P224, DOI 10.1165/ajrcmb.24.3.4367; Lee MD, 1997, CHEST, V111, pS111, DOI 10.1378/chest.111.6_Supplement.111S; Martis PC, 2006, DEVELOPMENT, V133, P1155, DOI 10.1242/dev.02273; Mendelson CR, 2000, ANNU REV PHYSIOL, V62, P875, DOI 10.1146/annurev.physiol.62.1.875; Midoro-Horiuti T, 2010, ENVIRON HEALTH PERSP, V118, P273, DOI 10.1289/ehp.0901259; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; MUGLIA L, 1995, NATURE, V373, P427, DOI 10.1038/373427a0; Nakajima Y, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-8; Nishikawa M, 2010, ENVIRON HEALTH PERSP, V118, P1196, DOI 10.1289/ehp.0901575; O'Brien E, 2014, J DEV ORIG HLTH DIS, V5, P121, DOI 10.1017/S204017441400004X; Padmanabhan V, 2008, J PERINATOL, V28, P258, DOI 10.1038/sj.jp.7211913; Pei LM, 2011, NAT MED, V17, P1466, DOI 10.1038/nm.2450; Peretz J, 2014, ENVIRON HEALTH PERSP, V122, P775, DOI 10.1289/ehp.1307728; Ramirez MI, 2003, DEV BIOL, V256, P61, DOI 10.1016/S0012-1606(02)00098-2; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Rochester JR, 2013, REPROD TOXICOL, V42, P132, DOI 10.1016/j.reprotox.2013.08.008; Roelofs MJE, 2015, TOXICOLOGY, V329, P10, DOI 10.1016/j.tox.2015.01.003; Saini Y, 2008, J BIOL CHEM, V283, P33650, DOI 10.1074/jbc.M805927200; Schonfelder G, 2002, ENVIRON HEALTH PERSP, V110, pA703, DOI 10.1289/ehp.021100703; Schug TT, 2011, J STEROID BIOCHEM, V127, P204, DOI 10.1016/j.jsbmb.2011.08.007; Selvaratnam J, 2013, AM J PHYSIOL-ENDOC M, V305, pE727, DOI 10.1152/ajpendo.00157.2013; Spanier AJ, 2014, JAMA PEDIATR, V168, P1131, DOI 10.1001/jamapediatrics.2014.1397; Spanier AJ, 2014, J PEDIATR-US, V164, P1403, DOI 10.1016/j.jpeds.2014.02.026; Spanier AJ, 2012, ENVIRON HEALTH PERSP, V120, P916, DOI 10.1289/ehp.1104175; Stahlhut RW, 2009, ENVIRON HEALTH PERSP, V117, P784, DOI 10.1289/ehp.0800376; Susiarjo M, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030005; Taylor JA, 2011, ENVIRON HEALTH PERSP, V119, P422, DOI 10.1289/ehp.1002514; Tharp AP, 2012, P NATL ACAD SCI USA, V109, P8190, DOI 10.1073/pnas.1120488109; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Veiga-Lopez A, 2013, ENDOCRINOLOGY, V154, P1873, DOI 10.1210/en.2012-2129; Wadia PR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063902; WEAVER TE, 1991, BIOCHEM J, V273, P249, DOI 10.1042/bj2730249; Wolstenholme JT, 2012, ENDOCRINOLOGY, V153, P3828, DOI 10.1210/en.2012-1195; Yang HH, 2002, DEVELOPMENT, V129, P2233; Zhang PM, 1999, GENE DEV, V13, P213, DOI 10.1101/gad.13.2.213	57	24	24	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2015	29	12					4968	4977		10.1096/fj.15-270942	http://dx.doi.org/10.1096/fj.15-270942			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CX2JS	26283537				2022-12-26	WOS:000365523600022
J	Effelsberg, D; Cruz-Zaragoza, LD; Tonillo, J; Schliebs, W; Erdmann, R				Effelsberg, Daniel; Cruz-Zaragoza, Luis Daniel; Tonillo, Jason; Schliebs, Wolfgang; Erdmann, Ralf			Role of Pex21p for Piggyback Import of Gpd1p and Pnc1p into Peroxisomes of Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PTS1 RECEPTOR PEX5P; PROTEIN IMPORT; TARGETING SIGNAL; GLYCEROL-3-PHOSPHATE DEHYDROGENASE; SUBCELLULAR-DISTRIBUTION; 3-OXOACYL-COA THIOLASE; YARROWIA-LIPOLYTICA; YEAST; PATHWAY; PEX7P	Proteins designated for peroxisomal protein import harbor one of two common peroxisomal targeting signals (PTS). In the yeast Saccharomyces cerevisiae, theoleate-induced PTS2-dependent import of the thiolase Fox3p into peroxisomes is conducted by the soluble import receptor Pex7p in cooperation with the auxiliary Pex18p, one of two supposedly redundant PTS2 co-receptors. Here, we report on a novel function for the co-receptor Pex21p, which cannot be fulfilled by Pex18p. The data establish Pex21p as a general co-receptor in PTS2-dependent protein import, whereas Pex18p is especially important for oleate-induced import of PTS2 proteins. The glycerol-producing PTS2 protein glycerol-3-phosphate dehydrogenase Gpd1p shows a tripartite localization in peroxisomes, in the cytosol, and in the nucleus under osmotic stress conditions. We show the following: (i) Pex21p is required for peroxisomal import of Gpd1p as well as a key enzyme of the NAD(+) salvage pathway, Pnc1p; (ii) Pnc1p, a nicotinamidase without functional PTS2, is co-imported into peroxisomes by piggyback transport via Gpd1p. Moreover, the specific transport of these two enzymes into peroxisomes suggests a novel regulatory role for peroxisomes under various stress conditions.	[Effelsberg, Daniel; Cruz-Zaragoza, Luis Daniel; Schliebs, Wolfgang; Erdmann, Ralf] Ruhr Univ Bochum, Inst Biochem & Pathobiochem, Abt Syst Biochem, D-44780 Bochum, Germany; [Tonillo, Jason] Ruhr Univ Bochum, Med Proteomctr, Abt Syst Biochem, D-44780 Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Erdmann, R (corresponding author), Ruhr Univ Bochum, Inst Biochem & Pathobiochem, Abt Syst Biochem, D-44780 Bochum, Germany.	ralf.erdmann@rub.de		Cruz-Zaragoza, Luis Daniel/0000-0001-9568-0245; Schliebs, Wolfgang/0000-0003-2762-3403	Deutsche Forschungsgemeinschaft Grant [FOR1905]; Marie Curie Initial Training Networks (PerFuMe) [316723]	Deutsche Forschungsgemeinschaft Grant(German Research Foundation (DFG)); Marie Curie Initial Training Networks (PerFuMe)	This work was supported by Deutsche Forschungsgemeinschaft Grant FOR1905 (to R. E.). This work was also supported by a grant from the Marie Curie Initial Training Networks (316723, PerFuMe) (to L.D.C.). The authors declare that they have no conflicts of interest with the contents of this article.	Agne B, 2003, MOL CELL, V11, P635, DOI 10.1016/S1097-2765(03)00062-5; Albertini M, 1997, CELL, V89, P83, DOI 10.1016/S0092-8674(00)80185-3; ALBERTYN J, 1994, MOL CELL BIOL, V14, P4135, DOI 10.1128/MCB.14.6.4135; Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; BIGL M, 1994, BIOL CHEM H-S, V375, P153, DOI 10.1515/bchm3.1994.375.3.153; Birschmann I, 2003, MOL BIOL CELL, V14, P2226, DOI 10.1091/mbc.E02-11-0752; Blobel F, 1996, EUR J BIOCHEM, V240, P468, DOI 10.1111/j.1432-1033.1996.0468h.x; Bottger G, 2000, MOL BIOL CELL, V11, P3963, DOI 10.1091/mbc.11.11.3963; Braverman N, 1998, HUM MOL GENET, V7, P1195, DOI 10.1093/hmg/7.8.1195; Brocard C, 2006, BBA-MOL CELL RES, V1763, P1565, DOI 10.1016/j.bbamcr.2006.08.022; Cramer J., 2015, SUBCELLULAR FRACTION, P97; Dodt G, 1996, J CELL BIOL, V135, P1763, DOI 10.1083/jcb.135.6.1763; Einwachter H, 2001, EMBO REP, V2, P1035, DOI 10.1093/embo-reports/kve228; ERDMANN R, 1994, YEAST, V10, P1173, DOI 10.1002/yea.320100905; ERDMANN R, 1989, P NATL ACAD SCI USA, V86, P5419, DOI 10.1073/pnas.86.14.5419; Flynn CR, 1998, PLANT J, V16, P709, DOI 10.1046/j.1365-313x.1998.00344.x; Girzalsky W, 1999, J CELL BIOL, V144, P1151, DOI 10.1083/jcb.144.6.1151; GLOVER JR, 1994, P NATL ACAD SCI USA, V91, P10541, DOI 10.1073/pnas.91.22.10541; Grunau S, 2009, TRAFFIC, V10, P451, DOI [10.1111/j.1600-0854.2009.00876.x, 10.1111/j.1600-0854.2008.00876.x]; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Harlow E., 1988, ANTIBODIES LAB MANUA, P469; Jelinsky SA, 1999, P NATL ACAD SCI USA, V96, P1486, DOI 10.1073/pnas.96.4.1486; Jung S, 2010, J BIOL CHEM, V285, P6739, DOI 10.1074/jbc.M109.058552; Karpichev IV, 1998, MOL CELL BIOL, V18, P6560, DOI 10.1128/MCB.18.11.6560; Kim PK, 2015, J MOL BIOL, V427, P1176, DOI 10.1016/j.jmb.2015.02.005; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kuravi K, 2006, J CELL SCI, V119, P3994, DOI 10.1242/jcs.03166; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Lazarow PB, 2006, BBA-MOL CELL RES, V1763, P1599, DOI 10.1016/j.bbamcr.2006.08.011; Lee JR, 2006, PLANT J, V47, P457, DOI 10.1111/j.1365-313X.2006.02797.x; Leon S, 2006, J CELL BIOL, V172, P67, DOI 10.1083/jcb.200508096; Liu XQ, 2012, CURR OPIN CELL BIOL, V24, P484, DOI 10.1016/j.ceb.2012.05.003; MARZIOCH M, 1994, EMBO J, V13, P4908, DOI 10.1002/j.1460-2075.1994.tb06818.x; Matsumura T, 2000, J BIOL CHEM, V275, P21715, DOI 10.1074/jbc.M000721200; Meinecke M, 2010, NAT CELL BIOL, V12, P273, DOI 10.1038/ncb2027; O'Rourke SM, 2004, MOL BIOL CELL, V15, P532, DOI 10.1091/mbc.E03-07-0521; Okumoto K, 2014, J BIOL CHEM, V289, P14089, DOI 10.1074/jbc.M113.527937; Otzen M, 2005, J CELL SCI, V118, P3409, DOI 10.1242/jcs.02463; Padden J, 2014, MOL CELL PROTEOMICS, V13, P2661, DOI 10.1074/mcp.M113.034942; Pan DQ, 2013, NAT STRUCT MOL BIOL, V20, P987, DOI 10.1038/nsmb.2618; Platta HW, 2007, J CELL BIOL, V177, P197, DOI 10.1083/jcb.200611012; Platta HW, 2005, NAT CELL BIOL, V7, P817, DOI 10.1038/ncb1281; Purdue PE, 1998, J CELL BIOL, V143, P1859; ROSE MD, 1989, CELL, V57, P1211, DOI 10.1016/0092-8674(89)90058-5; Schafer A, 2004, MOL CELL BIOL, V24, P8895, DOI 10.1128/MCB.24.20.8895-8906.2004; Schliebs W, 2006, BBA-MOL CELL RES, V1763, P1605, DOI 10.1016/j.bbamcr.2006.08.051; Schliebs W, 2010, NAT REV MOL CELL BIO, V11, P885, DOI 10.1038/nrm3008; Schroetter A, 2012, MOL CELL PROTEOMICS, V11, P1274, DOI 10.1074/mcp.M112.019364; Sichting M, 2003, MOL BIOL CELL, V14, P810, DOI 10.1091/mbc.E02-08-0539; Smith JJ, 2001, J BIOL CHEM, V276, P1618, DOI 10.1074/jbc.M005072200; Stein K, 2002, MOL CELL BIOL, V22, P6056, DOI 10.1128/MCB.22.17.6056-6069.2002; Valadi A, 2004, J BIOL CHEM, V279, P39677, DOI 10.1074/jbc.M403310200; VANDERLEIJ I, 1993, P NATL ACAD SCI USA, V90, P11782, DOI 10.1073/pnas.90.24.11782; VEENHUIS M, 1987, YEAST, V3, P77, DOI 10.1002/yea.320030204; Vendrell A, 2011, EMBO REP, V12, P1062, DOI 10.1038/embor.2011.154; Yang XD, 2001, EUR J CELL BIOL, V80, P126, DOI 10.1078/0171-9335-00144	57	30	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 16	2015	290	42					25333	25342		10.1074/jbc.M115.653451	http://dx.doi.org/10.1074/jbc.M115.653451			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT6ZO	26276932	hybrid, Green Published			2022-12-26	WOS:000362962800012
J	Wu, ML; Puddifoot, CA; Taylor, P; Joiner, WJ				Wu, Meilin; Puddifoot, Clare A.; Taylor, Palmer; Joiner, William J.			Mechanisms of Inhibition and Potentiation of alpha 4132 Nicotinic Acetylcholine Receptors by Members of the Ly6 Protein Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED UP-REGULATION; VENTRAL TEGMENTAL AREA; SMOKING-CESSATION; PHARMACOLOGICAL CHAPERONE; ENDOPLASMIC-RETICULUM; CHOLINERGIC-RECEPTOR; PARKINSONS-DISEASE; CRYSTAL-STRUCTURE; PROTOTOXIN LYNX1; PARTIAL AGONIST	alpha 4 beta 2 nicotinic acetylcholine receptors (nAChRs) are abundantly expressed throughout the central nervous system and are thought to be the primary target of nicotine, the main addictive substance in cigarette smoking. Understanding the mechanisms by which these receptors are regulated may assist in developing compounds to selectively interfere with nicotine addiction. Here we report previously unrecognized modulatory properties of members of the Ly6 protein family on a402 nAChRs. Using a FRET-based Ca2+ flux assay, we found that the maximum response of alpha 4 beta 2 receptors to agonist was strongly inhibited by Ly6h and Lynx2 but potentiated by Ly6g6e. The mechanisms underlying these opposing effects appear to be fundamentally distinct. Receptor inhibition by Lynx2 was accompanied by suppression of a4132 expression at the cell surface, even when assays were preceded by chronic exposure of cells to an established chaperone, nicotine. Receptor inhibition by I,ynx2 also was resistant to pretreatment with extracellular phospholipase C, which cleaves lipid moieties like those that attach Ly6 proteins to the plasma membrane. In contrast, potentiation of a4/32 activity by Ly6g6e was readily reversible by pretreatment with phospholipase C. Potentiation was also accompanied by slowing of receptor desensitization and an increase in peak currents. Collectively our data support roles for Lynx2 and Ly6g6e in intracellular trafficking and allosteric potentiation of alpha 4 beta 2 nAChRs, respectively.	[Wu, Meilin; Puddifoot, Clare A.; Taylor, Palmer; Joiner, William J.] Univ Calif San Diego, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Taylor, Palmer; Joiner, William J.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Taylor, Palmer; Joiner, William J.] Univ Calif San Diego, Neurosci Grad Program, La Jolla, CA 92093 USA; [Joiner, William J.] Univ Calif San Diego, Ctr Circadian Biol, La Jolla, CA 92093 USA; [Taylor, Palmer] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Joiner, WJ (corresponding author), Univ Calif San Diego, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	wjoiner@ucsd.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [R01 NS072431, RO1 GM18360]; Whitehall Foundation [WF20110560]; PhRMA Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM018360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072431] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehall Foundation; PhRMA Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant R01 NS072431, Whitehall Foundation Grant WF20110560, and a PhRMA Foundation Research Starter Grant (to W. J. J.), and by National Institutes of Health Grant RO1 GM18360 (to P. T.). The authors declare that they have no conflict of interest with the contents of this article.	Adermann K, 1999, PROTEIN SCI, V8, P810, DOI 10.1110/ps.8.4.810; Arredondo J, 2006, J CELL PHYSIOL, V208, P238, DOI 10.1002/jcp.20661; Auerbach A, 1998, J GEN PHYSIOL, V112, P181, DOI 10.1085/jgp.112.2.181; Azam L, 2007, NEUROSCIENCE, V144, P1347, DOI 10.1016/j.neuroscience.2006.11.011; BENWELL MEM, 1988, J NEUROCHEM, V50, P1243, DOI 10.1111/j.1471-4159.1988.tb10600.x; Biala G, 2010, N-S ARCH PHARMACOL, V381, P361, DOI 10.1007/s00210-010-0498-5; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; Breese CR, 1997, J PHARMACOL EXP THER, V282, P7; Coe JW, 2005, J MED CHEM, V48, P3474, DOI 10.1021/jm050069n; Cohen C, 2003, J PHARMACOL EXP THER, V306, P407, DOI 10.1124/jpet.103.049262; Conroy WG, 1998, MOL PHARMACOL, V53, P392, DOI 10.1124/mol.53.3.392; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; Darsow T, 2005, J BIOL CHEM, V280, P18311, DOI 10.1074/jbc.M501157200; Darvas M, 2009, EUR NEUROPSYCHOPHARM, V19, P670, DOI 10.1016/j.euroneuro.2009.03.007; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; FLORES CM, 1992, MOL PHARMACOL, V41, P31; Galat A, 2008, FEBS J, V275, P3207, DOI 10.1111/j.1742-4658.2008.06473.x; Gotti C, 2009, BIOCHEM PHARMACOL, V78, P703, DOI 10.1016/j.bcp.2009.05.024; Govind AP, 2012, J NEUROSCI, V32, P2227, DOI 10.1523/JNEUROSCI.5438-11.2012; Huang S, 2013, BIOCHEM J, V454, P303, DOI 10.1042/BJ20130636; Ibanez-Tallon I, 2002, NEURON, V33, P893, DOI 10.1016/S0896-6273(02)00632-3; Koh K, 2008, SCIENCE, V321, P372, DOI 10.1126/science.1155942; Kuryatov A, 2005, MOL PHARMACOL, V68, P1839, DOI 10.1124/mol.105.012419; Lester HA, 2009, AAPS J, V11, P167, DOI 10.1208/s12248-009-9090-7; Liu Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055886; Lorenz R, 2014, ACTA NEUROL SCAND, V130, P164, DOI 10.1111/ane.12259; Lyukmanova EN, 2011, J BIOL CHEM, V286, P10618, DOI 10.1074/jbc.M110.189100; MARKS MJ, 1983, J PHARMACOL EXP THER, V226, P817; Miwa JM, 2006, NEURON, V51, P587, DOI 10.1016/j.neuron.2006.07.025; Morishita H, 2010, SCIENCE, V330, P1238, DOI 10.1126/science.1195320; Nashmi R, 2003, J NEUROSCI, V23, P11554; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; Nichols WA, 2014, J BIOL CHEM, V289, P31423, DOI 10.1074/jbc.M114.573667; Paradiso KG, 2003, J PHYSIOL-LONDON, V553, P857, DOI 10.1113/jphysiol.2003.053447; Perez X. A., MOL PHARM, V78, P971; Perry DC, 1999, J PHARMACOL EXP THER, V289, P1545; Picciotto MR, 2008, FRONT BIOSCI-LANDMRK, V13, P492, DOI 10.2741/2695; Picciotto MR, 2008, PROG NEUROBIOL, V84, P329, DOI 10.1016/j.pneurobio.2007.12.005; Pons S, 2008, J NEUROSCI, V28, P12318, DOI 10.1523/JNEUROSCI.3918-08.2008; Puddifoot CA, 2015, J NEUROSCI, V35, P3420, DOI 10.1523/JNEUROSCI.3630-14.2015; Quik M, 2007, TRENDS PHARMACOL SCI, V28, P229, DOI 10.1016/j.tips.2007.03.001; Quik M, 2013, NEUROPHARMACOLOGY, V71, P191, DOI 10.1016/j.neuropharm.2013.03.038; Rollema H, 2007, NEUROPHARMACOLOGY, V52, P985, DOI 10.1016/j.neuropharm.2006.10.016; Sallette J, 2005, NEURON, V46, P595, DOI 10.1016/j.neuron.2005.03.029; SCHWARTZ RD, 1983, SCIENCE, V220, P214, DOI 10.1126/science.6828889; Srinivasan R, 2012, MOL PHARMACOL, V81, P759, DOI 10.1124/mol.112.077792; Srinivasan R, 2011, J GEN PHYSIOL, V137, P59, DOI 10.1085/jgp.201010532; Tekinay AB, 2009, P NATL ACAD SCI USA, V106, P4477, DOI 10.1073/pnas.0813109106; Tsetlin VI, 2015, TRENDS PHARMACOL SCI, V36, P109, DOI 10.1016/j.tips.2014.11.003; Vallejo YF, 2005, J NEUROSCI, V25, P5563, DOI 10.1523/JNEUROSCI.5240-04.2005; Whiteaker P, 2006, J COMP NEUROL, V499, P1016, DOI 10.1002/cne.21181; WHITING PJ, 1988, J NEUROSCI, V8, P3395; Wu ML, 2008, J CLIN INVEST, V118, P2076, DOI 10.1172/JCI33715; Wu ML, 2014, CURR BIOL, V24, P621, DOI 10.1016/j.cub.2014.02.026; Xiao C, 2009, J NEUROSCI, V29, P12428, DOI 10.1523/JNEUROSCI.2939-09.2009; Yamauchi JG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016519; Yang KC, 2009, J PHYSIOL-LONDON, V587, P345, DOI 10.1113/jphysiol.2008.162743; Zoli M, 1998, J NEUROSCI, V18, P4461	58	26	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24509	24518		10.1074/jbc.M115.647248	http://dx.doi.org/10.1074/jbc.M115.647248			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26276394	hybrid, Green Published			2022-12-26	WOS:000362218900036
J	Aenishaenslin, C; Gern, L; Michel, P; Ravel, A; Hongoh, V; Waaub, JP; Milord, F; Belanger, D				Aenishaenslin, Cecile; Gern, Lise; Michel, Pascal; Ravel, Andre; Hongoh, Valerie; Waaub, Jean-Philippe; Milord, Francois; Belanger, Denise			Adaptation and Evaluation of a Multi-Criteria Decision Analysis Model for Lyme Disease Prevention	PLOS ONE			English	Article							IXODES-SCAPULARIS ACARI; TICK-BORNE DISEASES; REDUCED ABUNDANCE; PUBLIC-HEALTH; NORTH-AMERICA; IXODIDAE; BORRELIOSIS; RISK; EUROPE; DEER	Designing preventive programs relevant to vector-borne diseases such as Lyme disease (LD) can be complex given the need to include multiple issues and perspectives into prioritizing public health actions. A multi-criteria decision aid (MCDA) model was previously used to rank interventions for LD prevention in Quebec, Canada, where the disease is emerging. The aim of the current study was to adapt and evaluate the decision model constructed in Quebec under a different epidemiological context, in Switzerland, where LD has been endemic for the last thirty years. The model adaptation was undertaken with a group of Swiss stakeholders using a participatory approach. The PROMETHEE method was used for multi-criteria analysis. Key elements and results of the MCDA model are described and contrasted with the Quebec model. All criteria and most interventions of the MCDA model developed for LD prevention in Quebec were directly transferable to the Swiss context. Four new decision criteria were added, and the list of proposed interventions was modified. Based on the overall group ranking, interventions targeting human populations were prioritized in the Swiss model, with the top ranked action being the implementation of a large communication campaign. The addition of criteria did not significantly alter the intervention rankings, but increased the capacity of the model to discriminate between highest and lowest ranked interventions. The current study suggests that beyond the specificity of the MCDA models developed for Quebec and Switzerland, their general structure captures the fundamental and common issues that characterize the complexity of vector-borne disease prevention. These results should encourage public health organizations to adapt, use and share MCDA models as an effective and functional approach to enable the integration of multiple perspectives and considerations in the prevention and control of complex public health issues such as Lyme disease or other vector- borne and zoonotic diseases.	[Aenishaenslin, Cecile; Michel, Pascal; Hongoh, Valerie; Belanger, Denise] Univ Montreal, Fac Med Vet, Res Grp Epidemiol Zoonoses & Publ Hlth, St Hyacinthe, PQ J2S 7C6, Canada; [Michel, Pascal] Publ Hlth Agcy Canada, Lab Foodborne Zoonoses, St Hyacinthe, PQ, Canada; [Gern, Lise] Univ Neuchatel, Inst Biol, Lab Ecopidemiol, CH-2000 Neuchatel, Switzerland; [Milord, Francois] Inst Natl Sante Publ Quebec, Longueuil, PQ, Canada; [Waaub, Jean-Philippe] Grp Res Decis Anal GERAD, Montreal, PQ, Canada; [Aenishaenslin, Cecile; Ravel, Andre; Hongoh, Valerie; Belanger, Denise] Univ Montreal, Fac Med Vet, Dept Pathol & Microbiol, St Hyacinthe, PQ J2S 7C6, Canada	Universite de Montreal; Public Health Agency of Canada; University of Neuchatel; Institut national de sante publique du Quebec (INSPQ); Universite de Montreal; Universite de Montreal	Aenishaenslin, C (corresponding author), Univ Montreal, Fac Med Vet, Res Grp Epidemiol Zoonoses & Publ Hlth, St Hyacinthe, PQ J2S 7C6, Canada.	cecile.aenishaenslin@umontreal.ca		Aenishaenslin, Cecile/0000-0002-8594-4945	Fonds de la recherche du Quebec; 4P Training program in health promotion, prevention and public policy; Ministere de l'Education, des Loisirs et des Sports du Quebec	Fonds de la recherche du Quebec; 4P Training program in health promotion, prevention and public policy; Ministere de l'Education, des Loisirs et des Sports du Quebec	This work was supported by Fonds de la recherche du Quebec: Doctoral grant for CA (http://www.frqs.gouv.qc.ca/); the 4P Training program in health promotion, prevention and public policy: Doctoral grant for CA (http://www.santepop.qc.ca/en/4p-training-program); and Ministere de l'Education, des Loisirs et des Sports du Quebec: Mobility grant for CA (http://www.education.gouv.qc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aenishaenslin C, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-897; Behzadian M, 2010, EUR J OPER RES, V200, P198, DOI 10.1016/j.ejor.2009.01.021; BRANS JP, 1986, EUR J OPER RES, V24, P228, DOI 10.1016/0377-2217(86)90044-5; Brei B, 2009, VECTOR-BORNE ZOONOT, V9, P423, DOI 10.1089/vbz.2008.0150; Brownstein John S., 2005, EcoHealth, V2, P38, DOI 10.1007/s10393-004-0139-x; Brownstein JS, 2005, OECOLOGIA, V146, P469, DOI 10.1007/s00442-005-0251-9; C, 2013, CDC PROV EST AM DIAG; Daltroy LH, 2007, HEALTH EDUC BEHAV, V34, P531, DOI 10.1177/1090198106294646; DANIELS TJ, 1993, J MED ENTOMOL, V30, P1043, DOI 10.1093/jmedent/30.6.1043; DANIELS TJ, 1991, J MED ENTOMOL, V28, P537, DOI 10.1093/jmedent/28.4.537; DEBLINGER RD, 1993, J MED ENTOMOL, V30, P144, DOI 10.1093/jmedent/30.1.144; Dolan MC, 2004, J MED ENTOMOL, V41, P1043, DOI 10.1603/0022-2585-41.6.1043; Gage KL, 2008, AM J PREV MED, V35, P436, DOI 10.1016/j.amepre.2008.08.030; Guitouni A, 1998, EUR J OPER RES, V109, P501, DOI 10.1016/S0377-2217(98)00073-3; Hayez Q, 2012, IGI GLOBAL, P1; MARESCHAL B, 1988, EUR J OPER RES, V34, P69, DOI 10.1016/0377-2217(88)90456-0; Mareschal P., 1994, INVESTIGATION OPERAT, V4, P107; Marsh K, 2013, J PUBLIC HEALTH-UK, V35, P460, DOI 10.1093/pubmed/fds099; Montibeller G, 2005, OPERATIONAL RES SOC, P17; Mowbray F, 2012, VECTOR-BORNE ZOONOT, V12, P817, DOI 10.1089/vbz.2011.0774; Ogden N H, 2008, Can Commun Dis Rep, V34, P1; Ogden NH, 2008, CAN FAM PHYSICIAN, V54, P1381; Piesman J, 2004, PARASITOLOGY, V129, pS191, DOI 10.1017/S0031182003004694; Piesman J, 2008, ANNU REV ENTOMOL, V53, P323, DOI 10.1146/annurev.ento.53.103106.093429; Piesman J, 2006, INT J MED MICROBIOL, V296, P17, DOI 10.1016/j.ijmm.2005.11.007; Poland GA, 2001, MAYO CLIN PROC, V76, P713, DOI 10.4065/76.7.713; Poland GA, 2001, VACCINE, V19, P2303, DOI 10.1016/S0264-410X(00)00520-X; Randolph SE, 2001, PHILOS T R SOC B, V356, P1045, DOI 10.1098/rstb.2001.0893; Randolph SE, 2004, INT J MED MICROBIOL, V293, P5, DOI 10.1016/S1433-1128(04)80004-4; Roy B., 1985, METHODOLOGIE MULTICR; Schulze TL, 2009, VECTOR-BORNE ZOONOT, V9, P389, DOI 10.1089/vbz.2008.0160; Shen AK, 2011, CLIN INFECT DIS, V52, pS247, DOI 10.1093/cid/ciq115; Solberg VB, 2003, J VECTOR ECOL, V28, P117; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; Swiss Federal Public Health Office, 2011, B OFF FED SANT PUBL, P895; Vilas VJD, 2013, PATHOG GLOB HEALTH, V107, P340, DOI 10.1179/2047773213Y.0000000122; WHO, 2006, LYM BORR EUR INFL CL; Zinsstag J, 2005, LANCET, V366, P2142, DOI 10.1016/S0140-6736(05)67731-8	38	9	9	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135171	10.1371/journal.pone.0135171	http://dx.doi.org/10.1371/journal.pone.0135171			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295344	Green Submitted, Green Published, gold			2022-12-26	WOS:000359926900017
J	Rocha, MC; de Godoy, KF; de Castro, PA; Hori, JI; Bom, VLP; Brown, NA; da Cunha, AF; Goldman, GH; Malavazi, I				Rocha, Marina Campos; de Godoy, Krissia Franco; de Castro, Patrcia Alves; Hori, Juliana Issa; Pedro Bom, Vinicius Leite; Brown, Neil Andrew; da Cunha, Anderson Ferreira; Goldman, Gustavo Henrique; Malavazi, Iran			The Aspergillus fumigatus pkcA(G579R) Mutant Is Defective in the Activation of the Cell Wall Integrity Pathway but Is Dispensable for Virulence in a Neutropenic Mouse Infection Model	PLOS ONE			English	Article							PROTEIN-KINASE-C; YEAST SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS-RESPONSE; CRYPTOCOCCUS-NEOFORMANS; SIGNALING PATHWAY; POLARIZED GROWTH; INVASIVE ASPERGILLOSIS; CALCOFLUOR WHITE; CANDIDA-ALBICANS; NIKKOMYCIN-Z	Aspergillus fumigatus is an opportunistic human pathogen, which causes the life-threatening disease, invasive pulmonary aspergillosis. In fungi, cell wall homeostasis is controlled by the conserved Cell Wall Integrity (CWI) pathway. In A. fumigatus this signaling cascade is partially characterized, but the mechanisms by which it is activated are not fully elucidated. In this study we investigated the role of protein kinase C (PkcA) in this signaling cascade. Our results suggest that pkcA is an essential gene and is activated in response to cell wall stress. Subsequently, we constructed and analyzed a non-essential A. fumigatus pkcA(G579R) mutant, carrying a Gly579Arg substitution in the PkcA C1B regulatory domain. The pkcAG579R mutation has a reduced activation of the downstream Mitogen-Activated Protein Kinase, MpkA, resulting in the altered expression of genes encoding cell wall-related proteins, markers of endoplasmic reticulum stress and the unfolded protein response. Furthermore, PkcA(G579R) is involved in the formation of proper conidial architecture and protection to oxidative damage. The pkcA(G579R) mutant elicits increased production of TNF-alpha and phagocytosis but it has no impact on virulence in a murine model of invasive pulmonary aspergillosis. These results highlight the importance of PkcA to the CWI pathway but also indicated that additional regulatory circuits may be involved in the biosynthesis and/or reinforcement of the A. fumigatus cell wall during infection.	[Rocha, Marina Campos; de Godoy, Krissia Franco; da Cunha, Anderson Ferreira; Malavazi, Iran] Univ Fed Sao Carlos, Ctr Ciencias Biol & Saude, Dept Genet Evolucao, Sao Paulo, Brazil; [de Castro, Patrcia Alves; Pedro Bom, Vinicius Leite; Goldman, Gustavo Henrique] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Dept Ciencias Farmaceut, Sao Paulo, Brazil; [Hori, Juliana Issa] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Farmacol, Sao Paulo, Brazil; [Brown, Neil Andrew] Rothamsted Res, Dept Plant Biol & Crop Sci, Harpenden, Herts, England; [Goldman, Gustavo Henrique] Lab Nacl Ciencia & Tecnol Bioetanol, Sao Paulo, Brazil	Universidade Federal de Sao Carlos; Universidade de Sao Paulo; Universidade de Sao Paulo; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Malavazi, I (corresponding author), Univ Fed Sao Carlos, Ctr Ciencias Biol & Saude, Dept Genet Evolucao, Sao Paulo, Brazil.	imalavazi@ufscar.br	da Cunha, Anderson Ferreira/M-9038-2019; Hori, Juliana I/L-2302-2016; da Cunha, Anderson Ferreira/B-7931-2012; Malavazi, Iran/E-4132-2013; Goldman, Gustavo Henrique/F-1848-2013; Campos Rocha, Marina/P-7337-2015; Hori, Juliana Issa/D-3486-2014	da Cunha, Anderson Ferreira/0000-0003-3485-5659; Malavazi, Iran/0000-0002-4526-4961; Goldman, Gustavo Henrique/0000-0002-2986-350X; Brown, Neil/0000-0002-3555-5765; Campos Rocha, Marina/0000-0003-4988-7629; Hori, Juliana Issa/0000-0002-5421-3728; Leite Pedro Bom, Vinicius/0000-0002-3083-2524	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP [2009/53546-5]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq [485478/2011-0]; BBSRC [BBS/E/C/00005192] Funding Source: UKRI	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP (http://www.fapesp.br/en/), grant number: 2009/53546-5 to IM; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq (http://www.cnpq.br), grant number 485478/2011-0) to IM.	Abad A, 2010, REV IBEROAM MICOL, V27, P155, DOI 10.1016/j.riam.2010.10.003; Aimanianda V, 2009, NATURE, V460, P1117, DOI 10.1038/nature08264; Aquino-Pinero E, 2002, MED MYCOL, V40, P185, DOI 10.1080/714031095; Arellano M, 1999, J CELL SCI, V112, P3569; Beauvais A, 2005, APPL ENVIRON MICROB, V71, P1531, DOI 10.1128/AEM.71.3.1531-1538.2005; Beauvais A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003716; BELL RM, 1991, J BIOL CHEM, V266, P4661; Brown NA, 2014, MOL MICROBIOL, V94, P1103, DOI 10.1111/mmi.12820; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97; Cheon SA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002177; Cocheme HM, 2008, J BIOL CHEM, V283, P1786, DOI 10.1074/jbc.M708597200; Colabardini AC, 2010, MOL MICROBIOL, V78, P1259, DOI 10.1111/j.1365-2958.2010.07403.x; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Corbalan-Garcia S, 2006, BBA-MOL CELL BIOL L, V1761, P633, DOI 10.1016/j.bbalip.2006.04.015; Damveld RA, 2005, MOL MICROBIOL, V58, P305, DOI 10.1111/j.1365-2958.2005.04827.x; Damveld RA, 2005, FUNGAL GENET BIOL, V42, P165, DOI 10.1016/j.fgb.2004.11.006; de Nobel H, 2000, MICROBIOL-SGM, V146, P2121, DOI 10.1099/00221287-146-9-2121; Dichtl K, 2015, MOL MICROBIOL, V95, P458, DOI 10.1111/mmi.12877; Dichtl K, 2012, MOL MICROBIOL, V83, P506, DOI 10.1111/j.1365-2958.2011.07946.x; Dinamarco TM, 2012, EUKARYOT CELL, V11, P518, DOI 10.1128/EC.00016-12; Dirr F, 2010, INT J MED MICROBIOL, V300, P496, DOI 10.1016/j.ijmm.2010.03.001; Do JH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-306; Feng XZ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002330; Ferreira MED, 2006, EUKARYOT CELL, V5, P207, DOI 10.1128/EC.5.1.207-211.2006; Fujioka T, 2007, EUKARYOT CELL, V6, P1497, DOI 10.1128/EC.00281-06; Gastebois A, 2009, FUTURE MICROBIOL, V4, P583, DOI 10.2217/FMB.09.29; GAUGHRAN JP, 1994, J BACTERIOL, V176, P5857, DOI 10.1128/JB.176.18.5857-5860.1994; Gerik KJ, 2008, EUKARYOT CELL, V7, P1685, DOI 10.1128/EC.00146-08; Gersuk GM, 2006, J IMMUNOL, V176, P3717, DOI 10.4049/jimmunol.176.6.3717; Graham LM, 2006, J IMMUNOL METHODS, V314, P164, DOI 10.1016/j.jim.2006.05.013; Gravelat FN, 2010, CELL MICROBIOL, V12, P473, DOI 10.1111/j.1462-5822.2009.01408.x; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2; Henry C, 2012, EUKARYOT CELL, V11, P26, DOI 10.1128/EC.05270-11; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V172, P993, DOI 10.1016/0006-291X(90)91544-3; Herrmann M, 2006, APPL ENVIRON MICROB, V72, P2957, DOI 10.1128/AEM.72.4.2957-2970.2006; Heung LJ, 2005, J BIOL CHEM, V280, P28547, DOI 10.1074/jbc.M503404200; Heung LJ, 2004, J BIOL CHEM, V279, P21144, DOI 10.1074/jbc.M312995200; Hill TW, 2006, MYCOLOGIA, V98, P399, DOI 10.3852/mycologia.98.3.399; Hohl TM, 2005, PLOS PATHOG, V1, P232, DOI 10.1371/journal.ppat.0010030; Hurley JH, 1997, PROTEIN SCI, V6, P477; Ichinomiya M, 2007, BIOSCI BIOTECH BIOCH, V71, P2787, DOI 10.1271/bbb.70409; Ingham CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035478; IRIE K, 1993, MOL CELL BIOL, V13, P3076, DOI 10.1128/MCB.13.5.3076; Jacoby JJ, 1997, FEBS LETT, V417, P219, DOI 10.1016/S0014-5793(97)01287-8; Jung US, 1999, MOL MICROBIOL, V34, P1049, DOI 10.1046/j.1365-2958.1999.01667.x; Kafer E, 1977, Adv Genet, V19, P33, DOI 10.1016/S0065-2660(08)60245-X; Ketela T, 1999, J BACTERIOL, V181, P3330, DOI 10.1128/JB.181.11.3330-3340.1999; Khatun R, 2011, FUNGAL GENET BIOL, V48, P465, DOI 10.1016/j.fgb.2010.11.002; Krishnan K, 2014, VIRULENCE, V5, P334, DOI 10.4161/viru.26571; KRIVJANSKY V, 1994, FEMS MICROBIOL LETT, V120, P87; Kuranda K, 2006, MOL MICROBIOL, V61, P1147, DOI 10.1111/j.1365-2958.2006.05300.x; Kwon-Chung KJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003743; LaFayette SL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001069; Latge JP, 2010, CELL MICROBIOL, V12, P863, DOI 10.1111/j.1462-5822.2010.01474.x; LEE KS, 1992, MOL CELL BIOL, V12, P172, DOI 10.1128/MCB.12.1.172; Levin DE, 2011, GENETICS, V189, P1145, DOI 10.1534/genetics.111.128264; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malavazi I, 2014, BRIEF FUNCT GENOMICS, V13, P456, DOI 10.1093/bfgp/elu027; Malavazi Iran, 2012, Methods Mol Biol, V845, P99, DOI 10.1007/978-1-61779-539-8_7; Marim FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015263; Martin H, 2000, J BIOL CHEM, V275, P1511, DOI 10.1074/jbc.275.2.1511; Maubon D, 2006, FUNGAL GENET BIOL, V43, P366, DOI 10.1016/j.fgb.2006.01.006; Mech F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019591; Mehrad B, 1999, J IMMUNOL, V162, P1633; Mellado E, 2003, FUNGAL GENET BIOL, V38, P98, DOI 10.1016/S1087-1845(02)00516-9; Miyazaki T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003160; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; OSMANI SA, 1987, J CELL BIOL, V104, P1495, DOI 10.1083/jcb.104.6.1495; Pakula TM, 2003, J BIOL CHEM, V278, P45011, DOI 10.1074/jbc.M302372200; Paravicini G, 1996, YEAST, V12, P741, DOI 10.1002/(SICI)1097-0061(19960630)12:8<741::AID-YEA967>3.0.CO;2-G; Bom VLP, 2015, EUKARYOT CELL, V14, P728, DOI 10.1128/EC.00008-15; Perlin DS, 2011, FUTURE MICROBIOL, V6, P441, DOI [10.2217/fmb.11.19, 10.2217/FMB.11.19]; Rajavel M, 1999, MOL CELL BIOL, V19, P3969; Ram AFJ, 2006, NAT PROTOC, V1, P2253, DOI 10.1038/nprot.2006.397; Richie DL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000258; Ronen R, 2007, CURR GENET, V51, P321, DOI 10.1007/s00294-007-0129-y; Sambrook J., 2001, MOL CLONING LAB MANU; Schmitz HP, 2003, CURR GENET, V43, P245, DOI 10.1007/s00294-003-0403-6; Schmitz HP, 2001, J MOL BIOL, V311, P1, DOI 10.1006/jmbi.2001.4848; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Segal BH, 2009, NEW ENGL J MED, V360, P1870, DOI 10.1056/NEJMra0808853; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Taramelli D, 1996, J MED VET MYCOL, V34, P49; Teepe AG, 2007, FUNGAL GENET BIOL, V44, P554, DOI 10.1016/j.fgb.2006.10.001; Thon M, 2007, J BIOL CHEM, V282, P27259, DOI 10.1074/jbc.M704298200; Valiante V, 2008, FUNGAL GENET BIOL, V45, P618, DOI 10.1016/j.fgb.2007.09.006; Valiante V, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00325; Valiante V, 2009, FUNGAL GENET BIOL, V46, P909, DOI 10.1016/j.fgb.2009.08.005; Verna J, 1997, P NATL ACAD SCI USA, V94, P13804, DOI 10.1073/pnas.94.25.13804; Verwer PEB, 2012, ANTIMICROB AGENTS CH, V56, P1595, DOI 10.1128/AAC.05323-11; Castro FAV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003999; Walker LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000040; Wallace MA, 2005, CHEM RES TOXICOL, V18, P1279, DOI 10.1021/tx050050n; Walsh TJ, 2008, CLIN INFECT DIS, V46, P327, DOI 10.1086/525258; WATANABE Y, 1995, MOL CELL BIOL, V15, P5740; Watanabe Y, 1997, MOL CELL BIOL, V17, P2615, DOI 10.1128/MCB.17.5.2615; Werner JL, 2009, J IMMUNOL, V182, P4938, DOI 10.4049/jimmunol.0804250; Wimalasena TT, 2008, FUNGAL GENET BIOL, V45, P1235, DOI 10.1016/j.fgb.2008.06.001; Winkelstroter LK, 2015, MOL MICROBIOL, V96, P42, DOI 10.1111/mmi.12919; Yang CF, 2003, TRENDS PHARMACOL SCI, V24, P602, DOI 10.1016/j.tips.2003.09.003	102	38	40	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135195	10.1371/journal.pone.0135195	http://dx.doi.org/10.1371/journal.pone.0135195			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295576	gold, Green Submitted, Green Published			2022-12-26	WOS:000359926900019
J	Spillane, DR; Wang, DY; Newbigging, S; Wang, YD; Shi, CX; Cho, HR; Shimizu, H; Gramolini, A; Liu, MY; Wen, XY				Spillane, David R.; Wang, Ding Yan; Newbigging, Susan; Wang, Youdong; Shi, Chang-Xin; Cho, Hae-Ra; Shimizu, Hiroki; Gramolini, Anthony; Liu, Mingyao; Wen, Xiao-Yan			Chromosome Condensation 1-Like (Chc1L) Is a Novel Tumor Suppressor Involved in Development of Histiocyte-Rich Neoplasms	PLOS ONE			English	Article							HISTIOCYTIC/DENDRITIC CELL SARCOMAS; CHRONIC LYMPHOCYTIC-LEUKEMIA; FOLLICULAR LYMPHOMA; GENE REARRANGEMENTS; CLONAL RELATIONSHIP; MULTIPLE-MYELOMA; PROSTATE-CANCER; MICE; TRANSDIFFERENTIATION; EXPRESSION	Human chromosomal region 13q14 is a deletion hotspot in prostate cancer, multiple myeloma, and chronic lymphocytic leukemia. This region is believed to host multiple tumor suppressors. Chromosome Condensation 1-like (CHC1L) is located at 13q14, and found within the smallest common region of loss of heterozygosity in prostate cancer. Decreased expression of CHC1L is linked to pathogenesis and progression of both prostate cancer and multiple myeloma. However, there is no direct evidence for CHC1L's putative tumor suppressing role in current literature. Presently, we describe the generation and characterization of Chc1L knockout mice. Chc1L(-/-) mice do not develop cancer at a young age, but bone marrow and spleen cells from 8-12 week-old mice display an exaggerated proliferative response. By approximately two years of age, knockout and heterozygote mice have a markedly increased incidence of tumorigenesis compared to wild-type controls, with tumors occurring mainly in the spleen, mesenteric lymph nodes, liver and intestinal tract. Histopathological analysis found that most heterozygote and knockout mice succumb to either Histiocytic Sarcoma or Histiocyte-Associated Lymphoma. Our study suggests that Chc1L is involved in suppression of these two histiocyte-rich neoplasms in mice and supports clinical data suggesting that CHC1L loss of function is an important step in the pathogenesis of cancers containing 13q14 deletion.	[Spillane, David R.; Wang, Youdong; Wen, Xiao-Yan] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr Biomed Sci, Toronto, ON M5B 1W8, Canada; [Spillane, David R.; Shi, Chang-Xin; Liu, Mingyao; Wen, Xiao-Yan] Univ Toronto, Dept Med, Toronto, ON, Canada; [Spillane, David R.; Shi, Chang-Xin; Liu, Mingyao; Wen, Xiao-Yan] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Wang, Ding Yan; Gramolini, Anthony; Liu, Mingyao; Wen, Xiao-Yan] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Newbigging, Susan] Univ Toronto, Mt Sinai Hosp, Toronto Ctr Phenogen, Ctr Modeling Human Dis,Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Cho, Hae-Ra; Shimizu, Hiroki; Liu, Mingyao] Univ Hlth Network, Toronto Gen Res Inst, Latner Thorac Surg Res Labs, Toronto, ON, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Wen, XY (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr Biomed Sci, 30 Bond St, Toronto, ON M5B 1W8, Canada.	x.wen@utoronto.ca		Liu, Mingyao/0000-0002-9188-8417; Wen, Xiao-Yan/0000-0001-6728-0025	Multiple Myeloma Research Foundation (MMRF)	Multiple Myeloma Research Foundation (MMRF)	This work is funded by a grant from the Multiple Myeloma Research Foundation (MMRF) to XYW (http://www.themmrf.org/).	BAUER SR, 1986, J IMMUNOL, V136, P4695; Been RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097280; Carrasco DR, 2006, CANCER CELL, V9, P379, DOI 10.1016/j.ccr.2006.03.028; Chen W, 2009, AM J SURG PATHOL, V33, P863, DOI 10.1097/PAS.0b013e31819287b8; Clarke PR, 2008, NAT REV MOL CELL BIO, V9, P464, DOI 10.1038/nrm2410; Cooney KA, 1996, CANCER RES, V56, P1142; Della Porta M, 2003, EUR J HAEMATOL, V70, P315; Devilder MC, 1998, GENOMICS, V54, P99, DOI 10.1006/geno.1998.5498; Dewald GW, 2003, BRIT J HAEMATOL, V121, P287, DOI 10.1046/j.1365-2141.2003.04265.x; Elnenaei MO, 2003, GENE CHROMOSOME CANC, V36, P99, DOI 10.1002/gcc.10140; Feldman AL, 2008, BLOOD, V111, P5433, DOI 10.1182/blood-2007-11-124792; Fonseca Rafael, 2004, Cancer Research, V64, P1546, DOI 10.1158/0008-5472.CAN-03-2876; Gertz MA, 2004, HEMATOLOGIC MALIGNAN; Hao X, 2010, VET PATHOL, V47, P434, DOI 10.1177/0300985810363705; Hedan B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-201; JaffeES HN, 2001, PATHOLOGY GENETICS T, P273; Lacroix-Triki M, 2003, TOXICOL PATHOL, V31, P304, DOI 10.1080/01926230390204342; Latil A, 2002, INT J CANCER, V99, P689, DOI 10.1002/ijc.10393; Legartova S, 2010, NEOPLASMA, V57, P482, DOI 10.4149/neo_2010_05_482; Leroux D, 2002, BLOOD, V99, P4154, DOI 10.1182/blood.V99.11.4154; Li ZX, 2007, ANN NY ACAD SCI, V1106, P95, DOI 10.1196/annals.1392.003; Lund AH, 2002, NAT GENET, V32, P160, DOI 10.1038/ng956; Martin-Caballero J, 2001, CANCER RES, V61, P6234; Mashima R, 2010, LAB INVEST, V90, P1357, DOI 10.1038/labinvest.2010.121; Mashima R, 2009, IMMUNOL REV, V232, P273, DOI 10.1111/j.1600-065X.2009.00844.x; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Ohnishi K, 2012, J CLIN EXP HEMATOP, V52, P171, DOI 10.3960/jslrt.52.171; Ouillette P, 2008, CANCER RES, V68, P1012, DOI 10.1158/0008-5472.CAN-07-3105; Plafker KS, 2009, BIOCHEMISTRY-US, V48, P3527, DOI 10.1021/bi801971m; Vincent SD, 2005, DEVELOPMENT, V132, P1315, DOI 10.1242/dev.01711; Wang ED, 2011, AM J SURG PATHOL, V35, P457, DOI 10.1097/PAS.0b013e3182098799; Wang ED, 2010, LEUKEMIA LYMPHOMA, V51, P802, DOI 10.3109/10428191003699845; Wang JK, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037647, 10.1371/journal.pone.0030209, 10.1371/journal.pone.0047127, 10.1371/journal.pone.0051808]; Zeng WF, 2011, J CUTAN PATHOL, V38, P999, DOI 10.1111/j.1600-0560.2011.01769.x; Zhang D, 2009, INT J HEMATOL, V89, P529, DOI 10.1007/s12185-009-0300-y	35	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135755	10.1371/journal.pone.0135755	http://dx.doi.org/10.1371/journal.pone.0135755			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291700	Green Submitted, Green Published, gold			2022-12-26	WOS:000359919900030
J	Oktem-Okullu, S; Tiftikci, A; Saruc, M; Cicek, B; Vardareli, E; Tozun, N; Kocagoz, T; Sezerman, U; Yavuz, AS; Sayi-Yazgan, A				Oktem-Okullu, Sinem; Tiftikci, Arzu; Saruc, Murat; Cicek, Bahattin; Vardareli, Eser; Tozun, Nurdan; Kocagoz, Tanil; Sezerman, Ugur; Yavuz, Ahmet Sinan; Sayi-Yazgan, Ayca			Multiplex-PCR-Based Screening and Computational Modeling of Virulence Factors and T-Cell Mediated Immunity in Helicobacter pylori Infections for Accurate Clinical Diagnosis	PLOS ONE			English	Article							VACUOLATING CYTOTOXIN ALLELES; GASTRITIS; ASSOCIATION; LYMPHOCYTES; PHENOTYPE; SEQUENCE; MUCOSA; ANTRUM; GENES; GAMMA	The outcome of H. pylori infection is closely related with bacteria's virulence factors and host immune response. The association between T cells and H. pylori infection has been identified, but the effects of the nine major H. pylori specific virulence factors; cagA, vacA, oipA, babA, hpaA, napA, dupA, ureA, ureB on T cell response in H. pylori infected patients have not been fully elucidated. We developed a multiplex-PCR assay to detect nine H. pylori virulence genes with in a three PCR reactions. Also, the expression levels of Th1, Th17 and Treg cell specific cytokines and transcription factors were detected by using qRT-PCR assays. Furthermore, a novel expert derived model is developed to identify set of factors and rules that can distinguish the ulcer patients from gastritis patients. Within all virulence factors that we tested, we identified a correlation between the presence of napA virulence gene and ulcer disease as a first data. Additionally, a positive correlation between the H. pylori dupA virulence factor and IFN-gamma, and H. pylori babA virulence factor and IL-17 was detected in gastritis and ulcer patients respectively. By using computer-based models, clinical outcomes of a patients infected with H. pylori can be predicted by screening the patient's H. pylori vacA m1/m2, ureA and cagA status and IFN-gamma (Th1), IL-17 (Th17), and FOXP3 (Treg) expression levels. Herein, we report, for the first time, the relationship between H. pylori virulence factors and host immune responses for diagnostic prediction of gastric diseases using computer-based models.	[Oktem-Okullu, Sinem; Sayi-Yazgan, Ayca] Istanbul Tech Univ, Dept Mol Biol & Genet, TR-80626 Istanbul, Turkey; [Oktem-Okullu, Sinem; Kocagoz, Tanil] Acibadem Univ, Sch Med, Dept Med Microbiol, Istanbul, Turkey; [Tiftikci, Arzu; Saruc, Murat; Cicek, Bahattin; Vardareli, Eser; Tozun, Nurdan] Acibadem Univ, Sch Med, Dept Internal Med, Istanbul, Turkey; [Tiftikci, Arzu; Saruc, Murat; Cicek, Bahattin; Vardareli, Eser; Tozun, Nurdan] Acibadem Hosp Grp, Dept Gastroenterol, Istanbul, Turkey; [Sezerman, Ugur] Acibadem Univ, Sch Med, Dept Biostat & Med Informat, Istanbul, Turkey; [Yavuz, Ahmet Sinan] Sabanci Univ, Fac Engn & Nat Sci, Mol Biol Genet & Bioengn Program, Istanbul, Turkey	Istanbul Technical University; Acibadem University; Acibadem University; Acibadem Hospitals Group; Acibadem University; Sabanci University	Sayi-Yazgan, A (corresponding author), Istanbul Tech Univ, Dept Mol Biol & Genet, TR-80626 Istanbul, Turkey.	sayi@itu.edu.tr	oktem-okullu, sinem/D-2480-2015; SEZERMAN, OSMAN U/X-6441-2018; Saruc, Murat/W-9868-2018; Yazgan, Ayca Sayi/C-4733-2016; Tozun, Nurdan/D-6984-2015	oktem-okullu, sinem/0000-0002-2255-0930; Saruc, Murat/0000-0002-9541-0381; Yazgan, Ayca Sayi/0000-0002-9015-8244; Yavuz, Ahmet Sinan/0000-0003-4069-6105; Sezerman, Osman Ugur/0000-0003-0905-6783	Istanbul Technical University [36243]	Istanbul Technical University(Istanbul Technical University)	The financial support of this work was provided by Istanbul Technical University through Scientific Research Project Funds with the grant number 36243.	Abdollahi H, 2013, JUNDISHAPUR J MICROB, V6, DOI 10.5812/jjm.4739; Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; ATHERTON JC, 1995, J BIOL CHEM, V270, P17771, DOI 10.1074/jbc.270.30.17771; Atherton JC, 1999, J CLIN MICROBIOL, V37, P2979, DOI 10.1128/JCM.37.9.2979-2982.1999; Auja SJ, 2007, SEMIN IMMUNOL, V19, P377, DOI 10.1016/j.smim.2007.10.009; Bamford KB, 1998, GASTROENTEROLOGY, V114, P482, DOI 10.1016/S0016-5085(98)70531-1; Blaser MJ, 2004, J CLIN INVEST, V113, P321, DOI [10.1172/JCI200420925, 10.1172/JCI20925]; Correa Pelayo, 2004, Gastric Cancer, V7, P9, DOI 10.1007/s10120-003-0265-0; Dundon WG, 2001, INT J MED MICROBIOL, V290, P647, DOI 10.1016/S1438-4221(01)80002-3; Eaton KA, 2001, J IMMUNOL, V166, P7456, DOI 10.4049/jimmunol.166.12.7456; Frenck RW, 2003, MICROBES INFECT, V5, P705, DOI 10.1016/S1286-4579(03)00112-6; Fu S, 2004, AM J TRANSPLANT, V4, P1614, DOI 10.1111/j.1600-6143.2004.00566.x; Hussein NR, 2010, J INFECT DIS, V202, P261, DOI 10.1086/653587; Kaebisch R, 2014, J IMMUNOL, V192, P316, DOI 10.4049/jimmunol.1302476; KARTTUNEN R, 1995, GUT, V36, P341, DOI 10.1136/gut.36.3.341; Lima VP, 2010, INT J INFECT DIS, V14, pE613, DOI 10.1016/j.ijid.2009.09.006; Ohno T, 2011, J INFECT DIS, V203, P726, DOI 10.1093/infdis/jiq090; Pavithran Keechilat, 2002, Gastric Cancer, V5, P240, DOI 10.1007/s101200200042; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Smythies LE, 2000, J IMMUNOL, V165, P1022, DOI 10.4049/jimmunol.165.2.1022; Sommer F, 1998, INFECT IMMUN, V66, P5543, DOI 10.1128/IAI.66.11.5543-5546.1998; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823	23	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136212	10.1371/journal.pone.0136212	http://dx.doi.org/10.1371/journal.pone.0136212			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287606	gold, Green Published, Green Submitted			2022-12-26	WOS:000360018600123
J	Zhao, ZJ; Hou, XD; Yin, XX; Li, YY; Duan, R; Boyce, BF; Yao, ZQ				Zhao, Zhijun; Hou, Xiaodong; Yin, Xiaoxiang; Li, Yanyun; Duan, Rong; Boyce, Brendan F.; Yao, Zhenqiang			TNF Induction of NF-kappa B RelB Enhances RANKL-Induced Osteoclastogenesis by Promoting Inflammatory Macrophage Differentiation but also Limits It through Suppression of NFATc1 Expression	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; MEDIATED JOINT DESTRUCTION; RHEUMATOID-ARTHRITIS; STROMAL CELLS; UP-REGULATION; BONE-MARROW; RECEPTOR; TRANSCRIPTION; DISEASE; MICE	TNF induces bone loss in common bone diseases by promoting osteoclast formation directly and indirectly, but it also limits osteoclast formation by inducing expression of NF-kappa B p100. Osteoclast precursors (OCPs) are derived from M1 (inflammatory) and M2 (resident) macrophages. However, it is not known if TNF stimulates or limits osteoclast formation through regulation of M1 or M2 differentiation or if RelB, a partner of p100, is involved. To investigate these questions, we treated bone marrow cells (BMCs) with M-CSF alone or in combination with TNF to enrich for OCPs, which we called M-OCPs and T-OCPs, respectively. We found that TNF switched CD11b(+)F4/80(+)M(-)OCPs from Ly6C-Gr1-M2 to Ly6C(+)Gr1-CD11c(+) and Ly6C-Gr1-CD11c(+)M1 cells. RANKL induced osteoclast formation from both Ly6C(+)Gr1(-) and Ly6C-Gr1-T-OCPs, but only from Ly6C(+)Gr1(-)M-OCPs, which formed significantly fewer osteoclasts than T-OCPs. Importantly, Ly6C(+)Gr1-cells from both M-and T-OCPs have increased expression of the M1 marker genes, iNOS, TNF, IL-1 beta and TGF beta 1, compared to Ly6C(-)Gr1(-) cells, and Ly6C(-)Gr1(-) cells from T-OCPs also have increased expression of iNOS and TGF beta 1 compared to cells from M-OCPs. Both RANKL and TNF increased RelB mRNA expression. TNF significantly increased RelB protein levels, but RANKL did not because it also induced RelB proteasomal degradation. TNF inhibited RANKL-induced NFATc1 mRNA expression and osteoclast formation from M-OCPs, but not from T-OCPs, and it did not induce Ly6C(+)Gr1(-)CD11c(+) or Ly6C(-)Gr1(-)CD11c(+)M1 macrophages from RelB-/- MCs. Furthermore, overexpression of RelB in M-OCPs reduced RANKL-induced osteoclast formation and NFATc1 mRNA expression, but it increased TNF-induced OC formation without affecting NFATc1 levels. Thus, TNF induction of RelB directly mediates terminal osteoclast differentiation independent of NFATc1 and limits RANKL-induced osteoclastogenesis by inhibiting NFATc1 activation. However, the dominant role of TNF is to expand the OCP pool by switching the differentiation of M-CSF-induced M2 to M1 macrophages with enhanced osteoclast forming potential. Strategies to degrade RelB could prevent TNF-induced M2/M1 switching and reduce osteoclast formation.	[Zhao, Zhijun; Hou, Xiaodong; Yin, Xiaoxiang] Henan Univ, Affiliated Hosp 1, Dept Med Imaging, Kaifeng 475001, Henan, Peoples R China; [Hou, Xiaodong; Yin, Xiaoxiang; Li, Yanyun; Duan, Rong; Boyce, Brendan F.; Yao, Zhenqiang] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [Hou, Xiaodong; Yin, Xiaoxiang; Li, Yanyun; Duan, Rong; Boyce, Brendan F.; Yao, Zhenqiang] Ctr Musculoskeletal Res, Rochester, NY 14642 USA	Henan University; University of Rochester	Yao, ZQ (corresponding author), Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Box 626,Room 1-2105,601 Elmwood Ave, Rochester, NY 14642 USA.	zhenqiang_yao@urmc.rochester.edu			National Natural Science Foundation of China [81373191]; National Institute for Arthritis, Musculoskeletal and Skin Diseases [AR43510, P30AR061307]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043510, P30AR061307] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institute for Arthritis, Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funding: This work was funded by National Natural Science Foundation of China 81373191 to ZY, National Institute for Arthritis, Musculoskeletal and Skin Diseases AR43510 to BFB, and P30AR061307 pilot grant (from Edward M. Schwarz) to ZY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amer Y, 2004, J CELL BIOCHEM, V93, P980, DOI 10.1002/jcb.20197; BURKLY L, 1995, NATURE, V373, P531, DOI 10.1038/373531a0; Comstock KL, 1998, J MOL CELL CARDIOL, V30, P2761, DOI 10.1006/jmcc.1998.0851; Elewaut D, 2003, J EXP MED, V197, P1623, DOI 10.1084/jem.20030141; Ferrari-Lacraz S, 2011, OSTEOPOROSIS INT, V22, P435, DOI 10.1007/s00198-010-1326-y; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2007, EUR J IMMUNOL, V37, pS9, DOI 10.1002/eji.200737638; Hah YS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087733; Hodge JM, 2007, J CELL BIOCHEM, V102, P759, DOI 10.1002/jcb.21331; Hyrich KL, 2006, RHEUMATOLOGY, V45, P1558, DOI 10.1093/rheumatology/kel149; Jackson SH, 2002, EXP HEMATOL, V30, P430, DOI 10.1016/S0301-472X(02)00792-0; Jeganathan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104498; Kaneki H, 2006, J BIOL CHEM, V281, P4326, DOI 10.1074/jbc.M509430200; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; Kiebala M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011875, 10.1371/journal.pone.0013102]; Kim N, 2005, J EXP MED, V202, P589, DOI 10.1084/jem.20050978; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; Kono Y, 2014, BIOL PHARM BULL, V37, P137, DOI 10.1248/bpb.b13-00659; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Leuschner F, 2011, NAT BIOTECHNOL, V29, P1005, DOI 10.1038/nbt.1989; Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566; Li J, 2012, CURR RHEUMATOL REP, V14, P445, DOI 10.1007/s11926-012-0272-4; Li J, 2012, ARTHRITIS RHEUM-US, V64, P1098, DOI 10.1002/art.33423; Madge LA, 2011, CELL CYCLE, V10, P6, DOI 10.4161/cc.10.1.14291; Marienfeld R, 2003, J BIOL CHEM, V278, P19852, DOI 10.1074/jbc.M301945200; MARKS SC, 1985, BONE, V6, P451, DOI 10.1016/8756-3282(85)90223-6; Mizoguchi T, 2009, J CELL BIOL, V184, P541, DOI 10.1083/jcb.200806139; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Overgaard M, 2009, J MOL BIOL, V394, P183, DOI 10.1016/j.jmb.2009.09.006; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; Redlich K, 2002, J CLIN INVEST, V110, P1419, DOI 10.1172/JCI200215582; Redlich K, 2002, ARTHRITIS RHEUM, V46, P785, DOI 10.1002/art.10097; Schmid MA, 2010, IMMUNOL REV, V234, P32, DOI 10.1111/j.0105-2896.2009.00877.x; Sierra-Filardi E, 2010, IMMUNOBIOLOGY, V215, P788, DOI 10.1016/j.imbio.2010.05.020; Smith AM, 2009, J EXP MED, V206, P1883, DOI 10.1084/jem.20091233; Storheim K, 2014, ANN RHEUM DIS, V73, P949, DOI 10.1136/annrheumdis-2014-205327; Sun SC, 2012, IMMUNOL REV, V246, P125, DOI 10.1111/j.1600-065X.2011.01088.x; Symmons DPM, 2006, LUPUS, V15, P122, DOI 10.1191/0961203306lu2278rr; Takai H, 1998, J BIOL CHEM, V273, P27091, DOI 10.1074/jbc.273.42.27091; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2007, ANN NY ACAD SCI, V1116, P227, DOI 10.1196/annals.1402.071; Tang Simon Y, 2013, Bonekey Rep, V2, P255, DOI 10.1038/bonekey.2012.255; Vaira S, 2008, P NATL ACAD SCI USA, V105, P3897, DOI 10.1073/pnas.0708576105; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Wei S, 2005, J CLIN INVEST, V115, P282, DOI 10.1172/JCI200523394; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yamashita T, 2007, J BIOL CHEM, V282, P18245, DOI 10.1074/jbc.M610701200; Yao ZQ, 2008, J BIOL CHEM, V283, P9917, DOI 10.1074/jbc.M706415200; Yao ZQ, 2014, J BONE MINER RES, V29, P866, DOI 10.1002/jbmr.2108; Yao ZQ, 2009, J CLIN INVEST, V119, P3024, DOI 10.1172/JCI38716; Yao ZQ, 2006, J BIOL CHEM, V281, P11846, DOI 10.1074/jbc.M512624200; Yona S, 2010, CURR OPIN HEMATOL, V17, P53, DOI 10.1097/MOH.0b013e3283324f80; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; Zhang YH, 2001, J BIOL CHEM, V276, P563, DOI 10.1074/jbc.M008198200; Zhao BH, 2012, J EXP MED, V209, P319, DOI 10.1084/jem.20111566; Zhao BH, 2009, NAT MED, V15, P1066, DOI 10.1038/nm.2007	62	12	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135728	10.1371/journal.pone.0135728	http://dx.doi.org/10.1371/journal.pone.0135728			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287732	Green Published, Green Submitted, gold			2022-12-26	WOS:000360018600065
J	Albuquerque, RV; Malcher, NS; Amado, LL; Coleman, MD; dos Santos, DC; Borges, RS; Valente, SAS; Valente, VC; Monteiro, MC				Albuquerque, Rosyana V.; Malcher, Nivea S.; Amado, Lilian L.; Coleman, Michael D.; dos Santos, Danielle C.; Borges, Rosivaldo Sa; Valente, Sebastiao Aldo S.; Valente, Vera C.; Monteiro, Marta Chagas			In Vitro Protective Effect and Antioxidant Mechanism of Resveratrol Induced by Dapsone Hydroxylamine in Human Cells	PLOS ONE			English	Article							INDUCED HEMOLYTIC-ANEMIA; ALPHA-LIPOIC ACID; OXIDATIVE STRESS; HUMAN ERYTHROCYTES; METHYLENE-BLUE; DNA-DAMAGE; INDUCED METHEMOGLOBINEMIA; TRANS-RESVERATROL; SODIUM ARSENITE; LEPROSY	Dapsone (DDS) hydroxylamine metabolites cause oxidative stress-linked adverse effects in patients, such as methemoglobin formation and DNA damage. This study evaluated the ameliorating effect of the antioxidant resveratrol (RSV) on DDS hydroxylamine (DDS-NHOH) mediated toxicity in vitro using human erythrocytes and lymphocytes. The antioxidant mechanism was also studied using in-silico methods. In addition, RSV provided intracellular protection by inhibiting DNA damage in human lymphocytes induced by DDS-NHOH. However, whilst pretreatment with RSV (10-1000 mu M significantly attenuated DDS-NHOH-induced methemoglobinemia, but it was not only significantly less effective than methylene blue (MET), but also post-treatment with RSV did not reverse methemoglobin formation, contrarily to that observed with MET. DDS-NHOH inhibited catalase (CAT) activity and reactive oxygen species (ROS) generation, but did not alter superoxide dismutase (SOD) activity in erythrocytes. Pretreatment with RSV did not alter these antioxidant enzymes activities in erythrocytes treated with DDS-NHOH. Theoretical calculations using density functional theory methods showed that DDS-NHOH has a pro-oxidant effect, whereas RSV and MET have antioxidant effect on ROS. The effect on methemoglobinemia reversion for MET was significantly higher than that of RSV. These data suggest that the pretreatment with resveratrol may decrease heme-iron oxidation and DNA damage through reduction of ROS generated in cells during DDS therapy.	[Albuquerque, Rosyana V.; Borges, Rosivaldo Sa; Monteiro, Marta Chagas] Univ Fed Para UFPA, Fac Farm, Programa Posgrad Ciencias Farmaceut, BR-66075110 Belem, PA, Brazil; [Malcher, Nivea S.; dos Santos, Danielle C.] Univ Fed Para UFPA, Fac Farm, BR-66075110 Belem, PA, Brazil; [Amado, Lilian L.] Univ Fed Para UFPA, Inst Ciencias Biol, BR-66075110 Belem, PA, Brazil; [Coleman, Michael D.] Aston Univ, Sch Life & Hlth Sci, Mech Drug Tox Grp, Birmingham B4 7ET, W Midlands, England; [Valente, Sebastiao Aldo S.; Valente, Vera C.] Inst Evandro Chagas, Secao Parasitol, SVS, MS, Ananindeua, Para, Brazil	Universidade Federal do Para; Universidade Federal do Para; Universidade Federal do Para; Aston University; Instituto Evandro Chagas	Monteiro, MC (corresponding author), Univ Fed Para UFPA, Fac Farm, Programa Posgrad Ciencias Farmaceut, Rua Augusto Correa 01, BR-66075110 Belem, PA, Brazil.	martachagas2@yahoo.com.br	Borges, Rosivaldo/U-3039-2019; Monteiro, Marta C./F-6575-2010; Borges, Rosivaldo RSB/K-4807-2016; Coleman, Michael Damian/AAD-5503-2019; Amado, Lílian Lund/I-1320-2012	Borges, Rosivaldo/0000-0003-4072-7573; Monteiro, Marta C./0000-0002-3328-5650; Amado, Lilian Lund/0000-0001-7693-8191; Coleman, MIchael D/0000-0002-5510-6852	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); CAPES; FAPESPA; Federal University of Para/PA; CNPq	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESPA(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA)); Federal University of Para/PA; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), CAPES, FAPESPA and Federal University of Para/PA. MCM was the recipient of fellowships from CNPq.	Adrian M, 2012, FITOTERAPIA, V83, P1345, DOI 10.1016/j.fitote.2012.04.004; Aebi H, 1984, Methods Enzymol, V105, P121; Aeschlimann C, 1996, DRUG METAB DISPOS, V24, P1336; Almeida L, 2009, MOL NUTR FOOD RES, V53, pS7, DOI 10.1002/mnfr.200800177; Aly FAE, 2002, MUTAT RES-GEN TOX EN, V518, P1, DOI 10.1016/S1383-5718(02)00037-2; ANDERSON D, 1994, MUTAT RES, V307, P261, DOI 10.1016/0027-5107(94)90300-X; Banerjee T, 2004, BRIT J HAEMATOL, V124, P391, DOI 10.1046/j.1365-2141.2003.04781.x; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BEIGUELMAN B, 1975, INT J LEPROSY, V43, P41; Bergamaschi MM, 2011, FOOD CHEM TOXICOL, V49, P1638, DOI 10.1016/j.fct.2011.03.025; Bertelli AAA, 2009, J CARDIOVASC PHARM, V54, P468, DOI 10.1097/FJC.0b013e3181bfaff3; Bhullar KS, 2015, BBA-MOL BASIS DIS, V1852, P1209, DOI 10.1016/j.bbadis.2015.01.012; Bode LM, 2013, AM J CLIN NUTR, V97, P295, DOI 10.3945/ajcn.112.049379; Bordin L, 2010, BRIT J PHARMACOL, V161, P1186, DOI 10.1111/j.1476-5381.2010.00962.x; Borges RS, 2013, J COMPUT THEOR NANOS, V10, P2029, DOI 10.1166/jctn.2013.3165; BOYS SF, 1970, MOL PHYS, V19, P553, DOI 10.1080/00268977000101561; Bukowska B, 2000, CELL BIOL INT, V24, P705, DOI 10.1006/cbir.2000.0553; Cao J, 2013, INT J MOL SCI, V14, P17525, DOI 10.3390/ijms140917525; Chen B, 2015, CHEM SOC REV, V44, P5246, DOI 10.1039/c4cs00373j; Chen CZ, 2013, BIOL TRACE ELEM RES, V155, P119, DOI 10.1007/s12011-013-9757-x; Chen CZ, 2013, FOOD CHEM TOXICOL, V59, P8, DOI 10.1016/j.fct.2013.05.030; Coleman MD, 2003, ENVIRON TOXICOL PHAR, V14, P121, DOI 10.1016/S1382-6689(03)00048-6; Coleman MD, 1996, DRUG SAFETY, V14, P394, DOI 10.2165/00002018-199614060-00005; COLEMAN MD, 1993, BRIT J DERMATOL, V129, P507, DOI 10.1111/j.1365-2133.1993.tb00476.x; DeFedericis HC, 2006, RADIAT RES, V165, P445, DOI 10.1667/RR3533.1; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Evelo C T, 1998, Blood Cells Mol Dis, V24, P280, DOI 10.1006/bcmd.1998.0194; Fernandez-Mar MI, 2012, FOOD CHEM, V130, P797, DOI 10.1016/j.foodchem.2011.08.023; Freitas LRS, 2014, TROP MED INT HEALTH, V19, P1216, DOI 10.1111/tmi.12362; Frisch M.J., 2009, GAUSSIAN 09 LINUX VE; Furian AF, 2007, NEUROCHEM INT, V50, P164, DOI 10.1016/j.neuint.2006.07.012; Gandhi G, 2004, MUTAGENESIS, V19, P483, DOI 10.1093/mutage/geh061; Ganesan S, 2010, J APPL TOXICOL, V30, P271, DOI 10.1002/jat.1493; Gitika B, 2006, FREE RADICAL RES, V40, P95, DOI 10.1080/10715760500335447; GOLLAPUDI BB, 1995, MUTAT RES LETT, V347, P97; Gomes A, 2005, J BIOCHEM BIOPH METH, V65, P45, DOI 10.1016/j.jbbm.2005.10.003; GROSSMAN S, 1995, J PHARMACOL EXP THER, V273, P870; HACKEL C, 1985, INT J LEPROSY, V53, P533; Hare GMT, 2013, REDOX BIOL, V1, P65, DOI 10.1016/j.redox.2012.12.003; HARIHARA.PC, 1973, THEOR CHIM ACTA, V28, P213, DOI 10.1007/BF00533485; Harikumar KB, 2008, CELL CYCLE, V7, P1020, DOI 10.4161/cc.7.8.5740; HEGESH E, 1970, CLIN CHIM ACTA, V30, P679, DOI 10.1016/0009-8981(70)90260-3; ISRAILI ZH, 1973, J PHARMACOL EXP THER, V187, P138; JOENJE H, 1989, MUTAT RES, V219, P193, DOI 10.1016/0921-8734(89)90001-5; Jung U, 2001, FREE RADICAL BIO MED, V31, P479, DOI 10.1016/S0891-5849(01)00604-9; Kalaiselvi K, 2002, MUTAGENESIS, V17, P309, DOI 10.1093/mutage/17.4.309; Kasai H, 1997, MUTAT RES-REV MUTAT, V387, P147, DOI 10.1016/S1383-5742(97)00035-5; Kluger N, 2011, MED MALADIES INFECT, V41, P115, DOI 10.1016/j.medmal.2010.09.013; Kovacic P, 2014, J APPL TOXICOL, V34, P825, DOI 10.1002/jat.3005; Kulkarni SS, 2015, BBA-MOL BASIS DIS, V1852, P1114, DOI 10.1016/j.bbadis.2014.10.005; Lastoria JC, 2014, AN BRAS DERMATOL, V89, P205, DOI 10.1590/abd1806-4841.20142450; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Li HG, 2012, NITRIC OXIDE-BIOL CH, V26, P102, DOI 10.1016/j.niox.2011.12.006; Lisovskaya IL, 2009, CHEM-BIOL INTERACT, V180, P433, DOI 10.1016/j.cbi.2009.04.003; Lu Z, 2007, J FLUORESC, V17, P580, DOI 10.1007/s10895-007-0220-2; Mahal HS, 2006, RES CHEM INTERMEDIAT, V32, P59, DOI 10.1163/156856706775012941; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MCMILLAN DC, 1995, J PHARMACOL EXP THER, V274, P540; MIEHLICH B, 1989, CHEM PHYS LETT, V157, P200, DOI 10.1016/0009-2614(89)87234-3; Miyazaki R, 2008, ARTERIOSCL THROM VAS, V28, P1263, DOI 10.1161/ATVBAHA.108.166991; Mukherjee S, 2010, DOSE-RESPONSE, V8, P478, DOI 10.2203/dose-response.09-015.Mukherjee; Mukherjee S, 2009, FREE RADICAL BIO MED, V46, P573, DOI 10.1016/j.freeradbiomed.2008.11.005; Myhre O, 2003, BIOCHEM PHARMACOL, V65, P1575, DOI 10.1016/S0006-2952(03)00083-2; Nakagawa H, 2001, J CANCER RES CLIN, V127, P258, DOI 10.1007/s004320000190; Ng BKW, 2010, PSYCHOSOMATICS, V51, P194, DOI 10.1176/appi.psy.51.3.194; Oliveira FR, 2014, J BRAZIL CHEM SOC, V25, P1770, DOI 10.5935/0103-5053.20140168; Oz M, 2011, MED RES REV, V31, P93, DOI 10.1002/med.20177; Pandey KB, 2010, PHYTOTHER RES, V24, pS11, DOI 10.1002/ptr.2853; Pandey KB, 2009, APPL PHYSIOL NUTR ME, V34, P1093, DOI 10.1139/H09-115; Poulsen MM, 2015, BBA-MOL BASIS DIS, V1852, P1124, DOI 10.1016/j.bbadis.2014.12.024; Pritchard SM, 2011, J CELL MOL MED, V15, P1621, DOI 10.1111/j.1582-4934.2011.01273.x; Qadri SM, 2009, LIFE SCI, V85, P33, DOI 10.1016/j.lfs.2009.04.015; Queiroz AN, 2009, EUR J MED CHEM, V44, P1644, DOI 10.1016/j.ejmech.2008.09.023; Ramis MR, 2015, MECH AGEING DEV, V146, P28, DOI 10.1016/j.mad.2015.03.008; Rashid K, 2013, FOOD CHEM TOXICOL, V62, P584, DOI 10.1016/j.fct.2013.09.026; Reilly TP, 1998, BIOCHEM PHARMACOL, V55, P803, DOI 10.1016/S0006-2952(97)00547-9; REIMER DL, 1994, GENOMICS, V21, P325, DOI 10.1006/geno.1994.1273; RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9; Riedel W, 2003, MOL CELL BIOCHEM, V247, P83, DOI 10.1023/A:1024142400835; Rifkind JM, 2004, ANTIOXID REDOX SIGN, V6, P657, DOI 10.1089/152308604773934422; SALARIS SC, 1991, BIOCHEM PHARMACOL, V42, P499, DOI 10.1016/0006-2952(91)90311-R; Sanches LAT, 2007, REV SOC BRAS MED TRO, V40, P541, DOI 10.1590/S0037-86822007000500010; Schalcher TR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085712; Schiff DE, 2006, J PEDIAT HEMATOL ONC, V28, P395, DOI 10.1097/00043426-200606000-00015; Signorelli P, 2005, J NUTR BIOCHEM, V16, P449, DOI 10.1016/j.jnutbio.2005.01.017; Singh CK, 2015, BBA-MOL BASIS DIS, V1852, P1178, DOI 10.1016/j.bbadis.2014.11.004; Tedesco I, 2000, J NUTR BIOCHEM, V11, P114, DOI 10.1016/S0955-2863(99)00080-7; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; Umbreit J, 2007, AM J HEMATOL, V82, P134, DOI 10.1002/ajh.20738; Vidavalur Ramesh, 2006, Exp Clin Cardiol, V11, P217; Vijayaraghavan R, 2005, EUR J CLIN NUTR, V59, P1121, DOI 10.1038/sj.ejcn.1602221; Vyas PA, 2005, BIOCHEM PHARMACOL, V70, P275, DOI 10.1016/j.bcp.2005.04.023; Walker JG, 2009, J NEURO-ONCOL, V94, P149, DOI 10.1007/s11060-009-9813-8; World Health Organization, 2012, WKLY EPIDEMIOL REC, V87, P317; Zhu YI, 2001, J AM ACAD DERMATOL, V45, P420, DOI 10.1067/mjd.2001.114733; ZUIDEMA J, 1986, CLIN PHARMACOKINET, V11, P299, DOI 10.2165/00003088-198611040-00003	96	32	33	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0134768	10.1371/journal.pone.0134768	http://dx.doi.org/10.1371/journal.pone.0134768			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284371	gold, Green Accepted, Green Published			2022-12-26	WOS:000359666100016
J	Dabo, AJ; Cummins, N; Eden, E; Geraghty, P				Dabo, Abdoulaye J.; Cummins, Neville; Eden, Edward; Geraghty, Patrick			Matrix Metalloproteinase 9 Exerts Antiviral Activity against Respiratory Syncytial Virus	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE; AIRWAY INFLAMMATION; LUNG; NEUTROPHIL; INFECTION; MMP-9; CELLS; GELATINASE; ACTIVATION; EXPRESSION	Increased lung levels of matrix metalloproteinase 9 (MMP9) are frequently observed during respiratory syncytial virus (RSV) infection and elevated MMP9 concentrations are associated with severe disease. However little is known of the functional role of MMP9 during lung infection with RSV. To determine whether MMP9 exerted direct antiviral potential, active MMP9 was incubated with RSV, which showed that MMP9 directly prevented RSV infectivity to airway epithelial cells. Using knockout mice the effect of the loss of Mmp9 expression was examined during RSV infection to demonstrate MMP9's role in viral clearance and disease progression. Seven days following RSV infection, Mmp9(-/-) mice displayed substantial weight loss, increased RSV-induced airway hyperresponsiveness (AHR) and reduced clearance of RSV from the lungs compared to wild type mice. Although total bronchoalveolar lavage fluid (BALF) cell counts were similar in both groups, neutrophil recruitment to the lungs during RSV infection was significantly reduced in Mmp9(-/-) mice. Reduced neutrophil recruitment coincided with diminished RANTES, IL-1 beta, SCF, G-CSF expression and p38 phosphorylation. Induction of p38 signaling was required for RANTES and G-CSF expression during RSV infection in airway epithelial cells. Therefore, MMP9 in RSV lung infection significantly enhances neutrophil recruitment, cytokine production and viral clearance while reducing AHR.	[Dabo, Abdoulaye J.; Cummins, Neville; Eden, Edward; Geraghty, Patrick] Mt Sinai Hlth Syst, Mt Sinai St Lukes Med Ctr, Div Pulm Crit Care & Sleep Med, New York, NY 10019 USA	Icahn School of Medicine at Mount Sinai; Mount Sinai St. Luke's	Geraghty, P (corresponding author), Mt Sinai Hlth Syst, Mt Sinai St Lukes Med Ctr, Div Pulm Crit Care & Sleep Med, New York, NY 10019 USA.	pgeraghty@chpnet.org		Geraghty, Patrick/0000-0003-1647-5505	Flight Attendant Medical Research Institute [YCSA 113380]	Flight Attendant Medical Research Institute	This work was supported by a grant made available to P.G. (Flight Attendant Medical Research Institute (famri.org/); YCSA 113380). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson JJ, 2003, AM J RESP CELL MOL, V28, P12, DOI 10.1165/rcmb.2002-0166TR; Balamayooran G, 2012, J IMMUNOL, V189, P5849, DOI 10.4049/jimmunol.1200585; BORREGAARD N, 1995, BLOOD, V85, P812, DOI 10.1182/blood.V85.3.812.bloodjournal853812; Bradley LM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002641; Castilow EM, 2008, J IMMUNOL, V180, P2376, DOI 10.4049/jimmunol.180.4.2376; Cataldo DD, 2002, AM J PATHOL, V161, P491, DOI 10.1016/S0002-9440(10)64205-8; Chakrabarti S, 2006, J LEUKOCYTE BIOL, V79, P214, DOI 10.1189/jlb.0605353; Ellerbroek SM, 2001, CANCER RES, V61, P1855; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Foronjy RF, 2015, MUCOSAL IMMUNOL, V8, P161, DOI 10.1038/mi.2014.54; Foronjy R, 2008, AM J PHYSIOL-LUNG C, V294, pL1149, DOI 10.1152/ajplung.00481.2007; Foronjy RF, 2014, BMC IMMUNOL, V15, DOI 10.1186/s12865-014-0041-4; Foronjy RF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090567; Fricke J, 2013, J VIROL, V87, P1333, DOI 10.1128/JVI.02263-12; Fridman R, 2003, CANCER METAST REV, V22, P153, DOI 10.1023/A:1023091214123; Geraghty P, 2014, AM J RESP CELL MOL, V50, P559, DOI 10.1165/rcmb.2013-0258OC; Geraghty P, 2013, AM J RESP CELL MOL, V49, P721, DOI 10.1165/rcmb.2013-0026OC; Hol J, 2010, J LEUKOCYTE BIOL, V87, P501, DOI 10.1189/jlb.0809532; Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST; ICHIHARA M, 1994, INT J HEMATOL, V59, P81; Julovi SM, 2011, J ORTHOP RES, V29, P258, DOI 10.1002/jor.21216; Kanbe N, 1999, EUR J IMMUNOL, V29, P2645; Khan AI, 2004, J IMMUNOL, V173, P7594, DOI 10.4049/jimmunol.173.12.7594; Khokha R, 2013, NAT REV IMMUNOL, V13, P649, DOI 10.1038/nri3499; Kinyanjui MW, 2013, J IMMUNOL, V190, P3859, DOI 10.4049/jimmunol.1200506; Kong MYF, 2014, EUR RESPIR J, V43, P1086, DOI 10.1183/09031936.00105613; KUNKEL SL, 1991, EXP LUNG RES, V17, P17, DOI 10.3109/01902149109063278; Lee YH, 2013, VIRUS RES, V178, P411, DOI 10.1016/j.virusres.2013.09.011; Leigh R, 2004, AM J RESP CRIT CARE, V170, P851, DOI 10.1164/rccm.200311-1488OC; Lemjabbar H, 1999, AM J RESP CELL MOL, V20, P903, DOI 10.1165/ajrcmb.20.5.3260; Lepidi S, 2001, J VASC SURG, V34, P1111, DOI 10.1067/mva.2001.119401; Li W, 2007, CHINESE MED J-PEKING, V120, P5, DOI 10.1097/00029330-200701010-00002; Lin M, 2008, AM J PATHOL, V173, P144, DOI 10.2353/ajpath.2008.080081; Long XR, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0176-8; Louhelainen N, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-13; Luplertlop N, 2008, JPN J INFECT DIS, V61, P298; Malik M, 2007, J IMMUNOL, V178, P1013, DOI 10.4049/jimmunol.178.2.1013; Marchant D, 2010, J VIROL, V84, P11359, DOI 10.1128/JVI.00804-10; Marchant DJ, 2014, NAT MED, V20, P497, DOI 10.1038/nm.3508; McCurdy LH, 2003, J VIROL, V77, P1747, DOI 10.1128/JVI.77.3.1747-1756.2003; McGovern TK, 2015, AM J RESP CELL MOL, V52, P513, DOI 10.1165/rcmb.2013-0430OC; McMillan SJ, 2004, J IMMUNOL, V172, P2586, DOI 10.4049/jimmunol.172.4.2586; McNamara PS, 2003, ARCH DIS CHILD, V88, P922, DOI 10.1136/adc.88.10.922; McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200; Mehra D, 2010, AM J PHYSIOL-LUNG C, V298, pL189, DOI 10.1152/ajplung.00042.2009; Ng HH, 2012, EXP MOL PATHOL, V92, P287, DOI 10.1016/j.yexmp.2012.03.003; Olson MW, 1998, J BIOL CHEM, V273, P10672, DOI 10.1074/jbc.273.17.10672; Oshita Y, 2003, THORAX, V58, P757, DOI 10.1136/thorax.58.9.757; Overbeek SA, 2011, EUR J PHARMACOL, V668, P428, DOI 10.1016/j.ejphar.2011.03.022; Page K, 2009, J IMMUNOL, V183, P3400, DOI 10.4049/jimmunol.0900838; Pan ZZ, 2000, AM J PHYSIOL-LUNG C, V279, pL658, DOI 10.1152/ajplung.2000.279.4.L658; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; Ringshausen I, 2004, LEUKEMIA, V18, P1964, DOI 10.1038/sj.leu.2403544; Tester AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000312; Van den Steen PE, 2003, EUR J BIOCHEM, V270, P3739, DOI 10.1046/j.1432-1033.2003.03760.x; Ventura I, 2014, ALLERGY, V69, P898, DOI 10.1111/all.12414; Weathington NM, 2006, NAT MED, V12, P317, DOI 10.1038/nm1361; Yabluchanskiy A, 2013, PHYSIOLOGY, V28, P391, DOI 10.1152/physiol.00029.2013; Yasui K, 2005, PEDIATR INT, V47, P190, DOI 10.1111/j.1442-200x.2005.02039.x; Yeo SJ, 2002, ARCH VIROL, V147, P229, DOI 10.1007/s705-002-8316-1; Yu Q, 1999, GENE DEV, V13, P35, DOI 10.1101/gad.13.1.35; Zhang LQ, 2002, J VIROL, V76, P5654, DOI 10.1128/JVI.76.11.5654-5666.2002	63	15	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135970	10.1371/journal.pone.0135970	http://dx.doi.org/10.1371/journal.pone.0135970			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284919	Green Published, gold, Green Submitted			2022-12-26	WOS:000359666100092
J	Zazzo, A; Lebon, M; Quiles, A; Reiche, I; Vigne, JD				Zazzo, Antoine; Lebon, Matthieu; Quiles, Anita; Reiche, Ina; Vigne, Jean-Denis			Direct Dating and Physico-Chemical Analyses Cast Doubts on the Coexistence of Humans and Dwarf Hippos in Cyprus	PLOS ONE			English	Article							BONE APATITE; CALCINED BONES; MASTODON IVORY; ORIGIN; TRANSFORMATION; LIGHT	In the Mediterranean, the island dwarf megafaunas became extinct around the end of the Pleistocene, during a period of rapid and global climate change. In Cyprus, this coincided with the first human presence on the island, as attested by the rock shelter of Akrotiri-Aetok-remnos where an Epipaleolithic anthropogenic layer (stratum 2) was found overlying a massive accumulation of pygmy hippopotamus (Phanourios minor (Desmarest, 1822)) [Boekschoten and Sondaar, 1972] bones (stratum 4). The relationship between the two layers is highly controversial and the role played by humans in hippo extinction remains fiercely debated. Here, we provide new, direct radiocarbon and physico-chemical analyses on calcined bones which elucidates the complex depositional history of the assemblage. Bone turquoise was identified using micro-PIXE analysis and depth-profiling together with Vis spectroscopy, demonstrating that these bones were not freshly burned. Bayesian modeling of the radiocarbon dates indicates that stratum 4 accumulated during the first half of the 13th mill cal BP and that calcination occurred several hundred years later. We conclude that accumulation occurred naturally during the beginning of the Younger Dryas and that Epipalaeolithic visitors subsequently used the bones as fuel, starting from the mid-13th mill cal BP. At that time, dwarf hippos were probably already extinct or at least highly endangered. Our results shed new light on the possible causes of hippo extinction, on the subsequent introduction of the wild boar and on the earliest occupation of the island by humans.	[Zazzo, Antoine; Vigne, Jean-Denis] Museum Natl Hist Nat, CNRS, Unite Mixte Rech Archeozool Archeobot Soc Prat &, F-75005 Paris, France; [Lebon, Matthieu] Museum Natl Hist Nat, CNRS, Unite Mixte Rech Hist Nat Homme Prehist 7194, F-75005 Paris, France; [Quiles, Anita] Inst Francais Archeol Orientale, Pole Archeometrie, Cairo 11441, Egypt; [Reiche, Ina] Sorbonne Univ, Univ Paris 06, Unite Mixte Rech 8220, Lab Archeol Mol & Struct,CNRS, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Zazzo, A (corresponding author), Museum Natl Hist Nat, CNRS, Unite Mixte Rech Archeozool Archeobot Soc Prat &, CP 56,55 Rue Buffon, F-75005 Paris, France.	zazzo@mnhn.fr	zazzo, Antoine/H-1697-2011; Reiche, Ina/AAQ-3897-2020	zazzo, Antoine/0000-0001-7608-2207; Quiles, Anita/0000-0002-2933-4472	MNHN (ATM Biodiversite actuelle et passee); Ministry of higher education (PNRCC OsiRis); SEEG "Limassol" of the CNRS	MNHN (ATM Biodiversite actuelle et passee); Ministry of higher education (PNRCC OsiRis); SEEG "Limassol" of the CNRS	This work was funded by the MNHN (ATM Biodiversite actuelle et passee), grant to AZ; the Ministry of higher education (PNRCC OsiRis) grant to IR; the SEEG "Limassol" of the CNRS, grant to JDV. These grants have no specific number. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammerman AJ, 2005, WORLD ARCHAEOL, V37, P533, DOI 10.1080/00438240500404359; Athanassiou A., 2007, P 11 INT C ATH GREEC, V40, P201, DOI DOI 10.12681/BGSG.16514; Bennett JL, 1999, J ARCHAEOL SCI, V26, P1, DOI 10.1006/jasc.1998.0283; Binford L, 2000, AM ANTIQUITY, V65, P771, DOI 10.2307/2694435; Blondel Jacques, 1993, P135; BOEKSCHOTEN G. J., 1972, P KONINKLIJKE NEDE B, V75, P306; Bromage Timothy G., 2002, BAR International Series, V1095, P420; Brook BW, 2004, J BIOGEOGR, V31, P517, DOI 10.1046/j.1365-2699.2003.01028.x; Bunimovitz S., 1996, J MEDITERR ARCHAEOL, V9, P85; Calligaro T, 2004, NUCL INSTRUM METH B, V226, P29, DOI 10.1016/j.nimb.2004.04.176; Carvalho ML, 2008, X-RAY SPECTROM, V37, P32, DOI 10.1002/xrs.1006; Castel Jean-Christophe, 2010, Revue de Paleobiologie, V29, P411; Castro W, 2010, FORENSIC SCI INT, V195, P17, DOI 10.1016/j.forsciint.2009.10.029; Coumont M-P, 2006, AVENS PIEGES FAIBLE, P181; Cucchi T, 2006, ZOOTAXA, P1; Habelitz S, 2001, J MATER SCI, V36, P4131, DOI 10.1023/A:1017996217452; Hadjisterkotis E, 2008, EUR J WILDLIFE RES, V54, P122, DOI 10.1007/s10344-007-0121-3; Held SO, 1989, COLONIZATION CYCLES, V1, P1; Huls CM, 2010, RADIOCARBON, V52, P587; Knapp AB, 2010, J WORLD PREHIST, V23, P79, DOI 10.1007/s10963-010-9034-2; Koch PL, 2006, ANNU REV ECOL EVOL S, V37, P215, DOI 10.1146/annurev.ecolsys.34.011802.132415; Lanting JN, 2001, RADIOCARBON, V43, P249; Lebon M, 2010, J ARCHAEOL SCI, V37, P2265, DOI 10.1016/j.jas.2010.03.024; Martin P.S., 1984, P354; MAXWELL JA, 1989, NUCL INSTRUM METH B, V43, P218, DOI 10.1016/0168-583X(89)90042-6; Olsen Sandra L., 1999, FAUNAL EXTINCTION IS, P230; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Reese, 1995, PLEISTOCENE VERTEBRA; Reese D., 1999, FAUNAL EXTINCTION IS, P161; Reiche I, 2000, SOLID STATE SCI, V2, P625, DOI 10.1016/S1293-2558(00)01067-0; Reiche I, 2001, AM MINERAL, V86, P1519; Reiche I, 2008, HETEROGENEITES COMPO; Reiche I, 2008, J ANAL ATOM SPECTROM, V23, P799, DOI 10.1039/b717442j; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Simmons AH, 2013, EURASIAN PREHISTORY, V10, P139; Simmons AH, 1997, GEOARCHAEOLOGY, V12, P567; Simmons AH, 1999, FAUNAL EXTINCTION IS, p[i, 1]; Simmons AH, 1999, FAUNAL EXTINCTION IS, P283; Simmons A, 2007, WORLD ARCHAEOL, V39, P475, DOI 10.1080/00438240701676169; Snoeck C, 2014, RADIOCARBON, V56, P591, DOI 10.2458/56.17454; Van Strydonck M, 2010, RADIOCARBON, V52, P578; Vigne J-D, 2013, EURASIAN PREHISTORY, V10, P157; Vigne JD, 2009, P NATL ACAD SCI USA, V106, P16135, DOI 10.1073/pnas.0905015106; Wasse A, 2007, MARGINS SW ASIA CYPR, P43; WEINER S, 1990, J ARCHAEOL SCI, V17, P187, DOI 10.1016/0305-4403(90)90058-D; Wigand P., 1999, FAUNAL EXTINCTION IS, P193; Zazzo A, 2011, PALAEOGEOGR PALAEOCL, V310, P52, DOI 10.1016/j.palaeo.2010.12.004; Zazzo A, 2013, RADIOCARBON, V55, P1409, DOI 10.1017/S0033822200048347; Zazzo A, 2012, RADIOCARBON, V54, P855, DOI 10.1017/S0033822200047500	49	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0134429	10.1371/journal.pone.0134429	http://dx.doi.org/10.1371/journal.pone.0134429			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284623	Green Published, gold, Green Submitted			2022-12-26	WOS:000359666100010
J	Lee, SSJ; Lin, HH; Tsai, HC; Su, IJ; Yang, CH; Sun, HY; Hung, CC; Sy, CL; Wu, KS; Chen, JK; Chen, YS; Fang, CT				Lee, Susan Shin-Jung; Lin, Hsi-Hsun; Tsai, Hung-Chin; Su, Ih-Jen; Yang, Chin-Hui; Sun, Hsin-Yun; Hung, Chien-Chin; Sy, Cheng-Len; Wu, Kuan-Sheng; Chen, Jui-Kuang; Chen, Yao-Shen; Fang, Chi-Tai			A Clinical Algorithm to Identify HIV Patients at High Risk for Incident Active Tuberculosis: A Prospective 5-Year Cohort Study	PLOS ONE			English	Article							ISONIAZID PREVENTIVE THERAPY; GAMMA RELEASE ASSAYS; QUANTIFERON-TB GOLD; RIO-DE-JANEIRO; ANTIRETROVIRAL THERAPY; INFECTED PATIENTS; SKIN-TEST; DOUBLE-BLIND; PREVALENCE; DIAGNOSIS	Background Predicting the risk of tuberculosis (TB) in people living with HIV (PLHIV) using a single test is currently not possible. We aimed to develop and validate a clinical algorithm, using baseline CD4 cell counts, HIV viral load (pVL), and interferon-gamma release assay (IGRA), to identify PLHIV who are at high risk for incident active TB in low-to-moderate TB burden settings where highly active antiretroviral therapy (HAART) is routinely provided. Materials and Methods A prospective, 5-year, cohort study of adult PLHIV was conducted from 2006 to 2012 in two hospitals in Taiwan. HAART was initiated based on contemporary guidelines (CD4 count < = 350/mu L). Cox regression was used to identify the predictors of active TB and to construct the algorithm. The validation cohorts included 1455 HIV-infected individuals from previous published studies. Area under the receiver operating characteristic (ROC) curve was calculated. Results Seventeen of 772 participants developed active TB during a median follow-up period of 5.21 years. Baseline CD4 < 350/mu L or pVL >= 100,000/mL was a predictor of active TB (adjusted HR 4.87, 95% CI 1.49-15.90, P = 0.009). A positive baseline IGRA predicted TB in patients with baseline CD4 >= 350/mu L and pVL < 100,000/mL (adjusted HR 6.09, 95% CI 1.52-24.40, P = 0.01). Compared with an IGRA-alone strategy, the algorithm improved the sensitivity from 37.5% to 76.5%, the negative predictive value from 98.5% to 99.2%. Compared with an untargeted strategy, the algorithm spared 468 (60.6%) from unnecessary TB preventive treatment. Area under the ROC curve was 0.692 (95% CI: 0.587-0.798) for the study cohort and 0.792 (95% CI: 0.776-0.808) and 0.766 in the 2 validation cohorts. Conclusions A validated algorithm incorporating the baseline CD4 cell count, HIV viral load, and IGRA status can be used to guide targeted TB preventive treatment in PLHIV in low-to-moderate TB burden settings where HAART is routinely provided to all PLHIV. The implementation of this algorithm will avoid unnecessary exposure of low-risk patients to drug toxicity and simultaneously, reduce the burden of universal treatment on the healthcare system.	[Lee, Susan Shin-Jung; Tsai, Hung-Chin; Sy, Cheng-Len; Wu, Kuan-Sheng; Chen, Jui-Kuang; Chen, Yao-Shen] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei 112, Taiwan; [Lee, Susan Shin-Jung; Tsai, Hung-Chin; Sy, Cheng-Len; Wu, Kuan-Sheng; Chen, Jui-Kuang; Chen, Yao-Shen] Kaohsiung Vet Gen Hosp, Dept Internal Med, Infect Dis Sect, Kaohsiung 813, Taiwan; [Lee, Susan Shin-Jung; Fang, Chi-Tai] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 100, Taiwan; [Lin, Hsi-Hsun] I Shou Univ, E Da Hosp, Dept Infect Control & Internal Med, Kaohsiung, Taiwan; [Lin, Hsi-Hsun] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan; [Su, Ih-Jen] Natl Hlth Res Inst, Zhu Nan, Taiwan; [Yang, Chin-Hui] Minist Hlth & Welf, Ctr Dis Control, Taipei, Taiwan; [Yang, Chin-Hui] Taipei Med Univ, Taipei Med Univ Hosp, Dept Internal Med, Div Infect Dis, Taipei, Taiwan; [Sun, Hsin-Yun; Hung, Chien-Chin; Fang, Chi-Tai] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Internal Med, Div Infect Dis, Taipei 100, Taiwan; [Sun, Hsin-Yun; Hung, Chien-Chin; Fang, Chi-Tai] Natl Taiwan Univ, Coll Publ Hlth, Taipei 100, Taiwan	National Yang Ming Chiao Tung University; Kaohsiung Veterans General Hospital; National Taiwan University; E-Da Hospital; I Shou University; National Yang Ming Chiao Tung University; National Health Research Institutes - Taiwan; Centers For Disease Control - Taiwan; Taipei Medical University; Taipei Medical University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Fang, CT (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Room 535,17 Xu Zhou Rd, Taipei 100, Taiwan.	fangct@ntu.edu.tw	Fang, Chi-Tai/P-2908-2016	Fang, Chi-Tai/0000-0002-7380-1699; SUN, HSIN-YUN/0000-0003-0074-7721	Kaohsiung Veterans General Hospital [VGHKS101-032, VGHKS97-066]; National Science Council of Taiwan [NSC100-2314-B-010-039, NSC102-2314-B-010-017]; National Health Research Institute, Taiwan [NHRI-99A1-PDCO-0710101]	Kaohsiung Veterans General Hospital; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan)	This work was supported by grants from Kaohsiung Veterans General Hospital [VGHKS101-032 and VGHKS97-066], the National Science Council of Taiwan [NSC100-2314-B-010-039 and NSC102-2314-B-010-017] and the National Health Research Institute, Taiwan [NHRI-99A1-PDCO-0710101]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Aichelburg MC, 2009, CLIN INFECT DIS, V48, P954, DOI 10.1086/597351; Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3; [Anonymous], 2002, J Microbiol Immunol Infect, V35, P207; [Anonymous], 2011, GUID INT TUB CAS FIN; Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; Cattamanchi A, 2011, JAIDS-J ACQ IMM DEF, V56, P230, DOI 10.1097/QAI.0b013e31820b07ab; Centers for Disease Control R. O. C. (Taiwan), 2014, TAIW TUB CONTR REP 2; Chan PC, 2012, INT J TUBERC LUNG D, V16, P633, DOI 10.5588/ijtld.11.0504; Chan PC, 2014, AM J RESP CRIT CARE, V189, P203, DOI 10.1164/rccm.201305-0863OC; Chan PC, 2013, THORAX, V68, P263, DOI 10.1136/thoraxjnl-2012-202208; Cobelens FG, 2006, CLIN INFECT DIS, V43, P634, DOI 10.1086/506432; Cohn DL, 2000, AM J RESP CRIT CARE, V161, pS221; Costagliola D, 2005, CLIN INFECT DIS, V41, P1772, DOI 10.1086/498315; Diel R, 2011, EUR RESPIR J, V37, P88, DOI 10.1183/09031936.00115110; Diel R, 2008, AM J RESP CRIT CARE, V177, P1164, DOI 10.1164/rccm.200711-1613OC; Diel R, 2012, CHEST, V142, P63, DOI 10.1378/chest.11-3157; Durovni B, 2013, LANCET INFECT DIS, V13, P852, DOI 10.1016/S1473-3099(13)70187-7; Elzi L, 2007, CLIN INFECT DIS, V44, P94, DOI 10.1086/510080; Golub JE, 2007, AIDS, V21, P1441, DOI 10.1097/QAD.0b013e328216f441; Golub JE, 2009, AIDS, V23, P1446, DOI 10.1097/QAD.0b013e32832d53fc; Gupta A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034156; Havlir DV, 2008, JAMA-J AM MED ASSOC, V300, P423, DOI 10.1001/jama.300.4.423; Janis EM, 1996, AM J MED, V100, P186, DOI 10.1016/S0002-9343(97)89457-0; Jonnalagadda S, 2010, J INFECT DIS, V202, P1826, DOI 10.1086/657411; Lawn SD, 2005, AIDS, V19, P2109, DOI 10.1097/01.aids.0000194808.20035.c1; Mahomed H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017984; McMullen SE, 2014, CLIN INFECT DIS, V58, P1260, DOI 10.1093/cid/ciu119; Ramos JM, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-169; Rangaka MX, 2014, LANCET, V384, P682, DOI 10.1016/S0140-6736(14)60162-8; Rangaka MX, 2013, LANCET INFECT DIS, V13, P825, DOI 10.1016/S1473-3099(13)70218-4; Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3; Santin M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032482; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; Stephan C, 2008, AIDS, V22, P2471, DOI 10.1097/QAD.0b013e3283188415; Sultan B, 2013, INT J STD AIDS, V24, P775, DOI 10.1177/0956462413486459; Sun HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125260; Suthar AB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001270; Tedla Z, 2014, CHEST, DOI [10.1378/chest.1314-0215, DOI 10.1378/CHEST.1314-0215]; Van Rie A, 2011, JAIDS-J ACQ IMM DEF, V56, P349, DOI 10.1097/QAI.0b013e3181f9fb39; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Yang CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073069	41	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0135801	10.1371/journal.pone.0135801	http://dx.doi.org/10.1371/journal.pone.0135801			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26280669	Green Submitted, gold, Green Published			2022-12-26	WOS:000359664300024
J	Peltier, J; Shaw, HA; Couchman, EC; Dawson, LF; Yu, L; Choudhary, JS; Kaever, V; Wren, BW; Fairweather, NF				Peltier, Johann; Shaw, Helen A.; Couchman, Edward C.; Dawson, Lisa F.; Yu, Lu; Choudhary, Jyoti S.; Kaever, Volkhard; Wren, Brendan W.; Fairweather, Neil F.			Cyclic diGMP Regulates Production of Sortase Substrates of Clostridium difficile and Their Surface Exposure through Zmpl Protease-mediated Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-POSITIVE BACTERIA; DI-GMP; CELL-WALL; MOLECULAR CHARACTERIZATION; LISTERIA-MONOCYTOGENES; EHRLICHIA-CHAFFEENSIS; BACILLUS-SUBTILIS; TOXIN PRODUCTION; CROSS-LINKS; PROTEINS	In Gram-positive pathogens, surface proteins may be covalently anchored to the bacterial peptidoglycan by sortase, a cysteine transpeptidase enzyme. In contrast to other Grain-positive bacteria, only one single sortase enzyme, SrtB, is conserved between strains of Clostridium difficile. Sortase-mediated peptidase activity has been reported in vitro, and seven potential substrates have been identified. Here, we demonstrate the functionality of sortase in C. difficile. We identify two sortase-anchored proteins, the putative adhesins CD2831 and CD3246, and determine the cell wall anchor structure of CD2831. The C-terminal PPKTG sorting motif of CD2831 is cleaved between the threonine and glycine residues, and the carboxyl group of threonine is amide-linked to the side chain amino group of diaminopimelic acid within the peptidoglycan peptide stem. We show that CD28:31 protein levels are elevated in the presence of high intracellular cyclic diGMP (c-diGMP) concentrations, in agreement with the control of CD2831 expression by a c-diGMP-dependent type II riboswitch. Low c-diGMP levels induce the release of CD2831 and presumably CD3246 from the surface of cells. This regulation is mediated by proteolytic cleavage of CD2831 and CD3246 by the zinc metalloprotease ZmpI, whose expression is controlled by a type I c-diGMP riboswitch. These data reveal a novel regulatory mechanism for expression of two sortase substrates by the secondary messenger c-diGMP, on which surface anchoring is dependent.	[Peltier, Johann; Shaw, Helen A.; Couchman, Edward C.; Fairweather, Neil F.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ctr Mol Bacteriol & Infect, London SW7 2AZ, England; [Dawson, Lisa F.; Wren, Brendan W.] London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, London WC1 7HT, England; [Yu, Lu; Choudhary, Jyoti S.] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Kaever, Volkhard] Hannover Med Sch, Res Core Unit Metabol, D-30625 Hannover, Germany	Imperial College London; University of London; London School of Hygiene & Tropical Medicine; Wellcome Trust Sanger Institute; Hannover Medical School	Fairweather, NF (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, South Kensington Campus, London SW7 2AZ, England.	n.fairweather@imperial.ac.uk	Kaever, Volkhard/G-3280-2013; Choudhary, Jyoti/S-1232-2017; Peltier, Johann/Q-2001-2017	Choudhary, Jyoti/0000-0003-0881-5477; Peltier, Johann/0000-0003-3207-9465; Fairweather, Neil/0000-0002-3224-0207	European Community [PIEF-GA-2011-302561-DIFFISORT]; Medical Research Council; Biotechnology and Biological Sciences Research Council CASE studentship; Wellcome Trust [079643/Z/06/Z]; Biotechnology and Biological Sciences Research Council [1100199] Funding Source: researchfish; Medical Research Council [G0800170, G1000214] Funding Source: researchfish; MRC [G1000214, G0800170] Funding Source: UKRI	European Community(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council CASE studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by a Marie Curie Intra-European Fellowship within the 7th European Community Framework Program Grant PIEF-GA-2011-302561-DIFFISORT (to J. P.) and Medical Research Council funding (to B. W.). The authors declare that they have no conflicts of interest with the contents of this article.r Recipient of a Biotechnology and Biological Sciences Research Council CASE studentship (to N. F. F.).r Supported by Wellcome Trust Grant 079643/Z/06/Z.	Barbut F, 2007, INFECT CONT HOSP EP, V28, P131, DOI 10.1086/511794; Bierne H, 2004, J BACTERIOL, V186, P1972, DOI 10.1128/JB.186.7.1972-1982.2004; Bierne H, 2012, CURR OPIN MICROBIOL, V15, P715, DOI 10.1016/j.mib.2012.10.010; Bordeleau E, 2015, J BACTERIOL, V197, P819, DOI 10.1128/JB.02340-14; Bordeleau E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002039; Bruck S, 2011, J BACTERIOL, V193, P4425, DOI 10.1128/JB.01154-10; Burhenne Heike, 2013, Methods Mol Biol, V1016, P27, DOI 10.1007/978-1-62703-441-8_3; Cafardi V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081306; Cartman ST, 2012, APPL ENVIRON MICROB, V78, P4683, DOI 10.1128/AEM.00249-12; Cartman ST, 2010, APPL ENVIRON MICROB, V76, P1103, DOI 10.1128/AEM.02525-09; Chambers CJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep09449; Chen AGY, 2011, RNA, V17, P1967, DOI 10.1261/rna.2757311; Dapa T, 2013, J BACTERIOL, V195, P545, DOI 10.1128/JB.01980-12; Deakin LJ, 2012, INFECT IMMUN, V80, P2704, DOI 10.1128/IAI.00147-12; Deivanayagam CCS, 2000, STRUCTURE, V8, P67, DOI 10.1016/S0969-2126(00)00081-2; Deneve C, 2009, INT J ANTIMICROB AG, V33, pS24, DOI 10.1016/S0924-8579(09)70012-3; Deshpande A, 2013, J ANTIMICROB CHEMOTH, V68, P1951, DOI 10.1093/jac/dkt129; Donahue EH, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0219-1; Fagan RP, 2011, J BIOL CHEM, V286, P27483, DOI 10.1074/jbc.M111.263889; Gao XH, 2014, APPL ENVIRON MICROB, V80, P6167, DOI 10.1128/AEM.01638-14; Gupta A, 2014, INFECT DRUG RESIST, V7, P63, DOI 10.2147/IDR.S46780; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Hensbergen PJ, 2014, MOL CELL PROTEOMICS, V13, P1231, DOI 10.1074/mcp.M113.034728; Kang HJ, 2011, TRENDS BIOCHEM SCI, V36, P227, DOI 10.1016/j.tibs.2010.09.007; Kline KA, 2009, CELL HOST MICROBE, V5, P580, DOI 10.1016/j.chom.2009.05.011; Kumagai Y, 2011, INFECT IMMUN, V79, P3905, DOI 10.1128/IAI.05320-11; Kumagai Y, 2010, J BACTERIOL, V192, P4122, DOI 10.1128/JB.00132-10; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee ER, 2010, SCIENCE, V329, P845, DOI 10.1126/science.1190713; Leffler DA, 2015, NEW ENGL J MED, V372, P1539, DOI 10.1056/NEJMra1403772; Marraffini LA, 2005, J BIOL CHEM, V280, P16263, DOI 10.1074/jbc.M500071200; Mayer MJ, 2008, J BACTERIOL, V190, P6734, DOI 10.1128/JB.00686-08; Mayer MJ, 2011, J BACTERIOL, V193, P5477, DOI 10.1128/JB.00439-11; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; McKee RW, 2013, J BACTERIOL, V195, P5174, DOI 10.1128/JB.00501-13; Navarro MVAS, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000588; Newell PD, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000587; Pallen MJ, 2001, TRENDS MICROBIOL, V9, P97, DOI 10.1016/S0966-842X(01)01956-4; Peltier J, 2011, J BIOL CHEM, V286, P29053, DOI 10.1074/jbc.M111.259150; Peniche AG, 2013, CURR OPIN INFECT DIS, V26, P447, DOI 10.1097/01.qco.0000433318.82618.c6; Purcell EB, 2012, J BACTERIOL, V194, P3307, DOI 10.1128/JB.00100-12; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Schneewind O, 2012, PHILOS T R SOC B, V367, P1123, DOI 10.1098/rstb.2011.0210; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Smith TJ, 2000, MICROBIOL-UK, V146, P249, DOI 10.1099/00221287-146-2-249; Sondermann H, 2012, CURR OPIN MICROBIOL, V15, P140, DOI 10.1016/j.mib.2011.12.008; Soutourina OA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003493; Spirig T, 2011, MOL MICROBIOL, V82, P1044, DOI 10.1111/j.1365-2958.2011.07887.x; Valiente E, 2014, CLIN MICROBIOL INFEC, V20, P396, DOI 10.1111/1469-0691.12619; van Leeuwen HC, 2014, FEBS LETT, V588, P4325, DOI 10.1016/j.febslet.2014.09.041; Yan WJ, 2010, MICROBIOL RES, V165, P87, DOI 10.1016/j.micres.2008.10.001	51	45	46	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24453	24469		10.1074/jbc.M115.665091	http://dx.doi.org/10.1074/jbc.M115.665091			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26283789	Green Accepted, hybrid, Green Published			2022-12-26	WOS:000362218900032
J	Dong, YD; Liu, DL; Hu, Y; Ma, XL				Dong, Yaodong; Liu, Dongliang; Hu, Yue; Ma, Xiulan			NaHS Protects Cochlear Hair Cells from Gentamicin-Induced Ototoxicity by Inhibiting the Mitochondrial Apoptosis Pathway	PLOS ONE			English	Article							HYDROGEN-SULFIDE ELICITS; SMALL-INTESTINE ROLE; INNER-EAR; ANTIINFLAMMATORY PHENOTYPE; OXIDATIVE STRESS; IN-VITRO; DEATH; CHANNELS; MECHANOTRANSDUCTION; AMINOGLYCOSIDES	Aminoglycoside antibiotics such as gentamicin could cause ototoxicity in mammalians, by inducing oxidative stress and apoptosis in sensory hair cells of the cochlea. Sodium hydrosulfide (NaHS) is reported to alleviate oxidative stress and apoptosis, but its role in protecting aminoglycoside-induced hearing loss is unclear. In this study, we investigated the antioxidant and anti-apoptosis effect of NaHS in in vitro cultured House Ear Institute-Organ of Corti 1 (HEI-OC1) cells and isolated mouse cochlea. Results from cultured HEI-OC1 cells and cochlea consistently indicated that NaHS exhibited protective effects from gentamicin-induced ototoxicity, evident by maintained cell viability, hair cell number and cochlear morphology, reduced reactive oxygen species production and mitochondrial depolarization, as well as apoptosis activation of the intrinsic pathway. Moreover, in the isolated cochlear culture, NaHS was also demonstrated to protect the explant from gentamicin-induced mechanotransduction loss. Our study using multiple in vitro models revealed for the first time, the potential of NaHS as a therapeutic agent in protecting against aminoglycoside-induced hearing loss.	[Dong, Yaodong; Liu, Dongliang; Hu, Yue; Ma, Xiulan] China Med Univ, Shengjing Hosp, Dept Otol, Shenyang 110004, Peoples R China	China Medical University	Ma, XL (corresponding author), China Med Univ, Shengjing Hosp, Dept Otol, Shenyang 110004, Peoples R China.	maxl1@sj-hospital.org			Natural Science foundation of Liaoning province [201402019]	Natural Science foundation of Liaoning province(Natural Science Foundation of Liaoning Province)	This work was supported by Natural Science foundation of Liaoning province (201402019).	Abi-Hachem Ralph N, 2010, Recent Pat CNS Drug Discov, V5, P147; Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Avanzato D, 2014, CELL PHYSIOL BIOCHEM, V33, P1205, DOI 10.1159/000358690; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bodmer D, 2008, SWISS MED WKLY, V138, P708, DOI /aop/smw-aop12260; Borg E, 2002, HEARING RES, V172, P10, DOI 10.1016/S0378-5955(02)00284-8; Bratton SB, 2001, EMBO J, V20, P998, DOI 10.1093/emboj/20.5.998; Chen P, 2002, DEVELOPMENT, V129, P2495; Choung YH, 2009, NEUROSCIENCE, V161, P214, DOI 10.1016/j.neuroscience.2009.02.085; Coffin AB, 2013, JARO-J ASSOC RES OTO, V14, P645, DOI 10.1007/s10162-013-0404-1; Dehne N, 2002, HEARING RES, V169, P47, DOI 10.1016/S0378-5955(02)00338-6; Doetzlhofer A, 2009, DEV CELL, V16, P58, DOI 10.1016/j.devcel.2008.11.008; Durante-Mangoni E, 2009, INT J ANTIMICROB AG, V33, P201, DOI 10.1016/j.ijantimicag.2008.09.001; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hirose K, 1997, HEARING RES, V104, P1, DOI 10.1016/S0378-5955(96)00169-4; Hobbie SN, 2008, P NATL ACAD SCI USA, V105, P20888, DOI 10.1073/pnas.0811258106; Kalinec GM, 2003, AUDIOL NEURO-OTOL, V8, P177, DOI 10.1159/000071059; Kawashima Y, 2011, J CLIN INVEST, V121, P4796, DOI 10.1172/JCI60405; Kumar B, 2008, CANCER RES, V68, P1777, DOI 10.1158/0008-5472.CAN-07-5259; Lumpkin EA, 2003, GENE EXPR PATTERNS, V3, P389, DOI 10.1016/S1567-133X(03)00089-9; Mangiardi DA, 2004, J COMP NEUROL, V475, P1, DOI 10.1002/cne.20129; Marcotti W, 2005, J PHYSIOL-LONDON, V567, P505, DOI 10.1113/jphysiol.2005.085951; Minamishima S, 2009, CIRCULATION, V120, P888, DOI 10.1161/CIRCULATIONAHA.108.833491; Mingeot-Leclercq MP, 1999, ANTIMICROB AGENTS CH, V43, P727, DOI 10.1128/AAC.43.4.727; Pan BF, 2013, NEURON, V79, P504, DOI 10.1016/j.neuron.2013.06.019; Romand R, 1997, EUR J CELL BIOL, V74, P138; Roy S, 2000, J EXP MED, V192, pF21, DOI 10.1084/jem.192.8.F21; Rybak LP, 2007, HEARING RES, V226, P157, DOI 10.1016/j.heares.2006.09.015; Sinha K, 2013, ARCH TOXICOL, V87, P1157, DOI 10.1007/s00204-013-1034-4; TABLAN OC, 1984, J INFECT DIS, V149, P257, DOI 10.1093/infdis/149.2.257; Zuidema MY, 2011, AM J PHYSIOL-HEART C, V301, pH888, DOI 10.1152/ajpheart.00432.2010; Zuidema MY, 2010, AM J PHYSIOL-HEART C, V299, pH1554, DOI 10.1152/ajpheart.01229.2009	33	13	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136051	10.1371/journal.pone.0136051	http://dx.doi.org/10.1371/journal.pone.0136051			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295804	Green Published, gold, Green Submitted			2022-12-26	WOS:000359926900066
J	Meng, JR; Liu, PP; Zhu, LL; Zou, CW; Li, JQ; Chen, BS				Meng, Jiaorong; Liu, Pingping; Zhu, Liling; Zou, Chengwu; Li, Jieqiu; Chen, Baoshan			Complete Genome Sequence of Mulberry Vein Banding Associated Virus, a New Tospovirus Infecting Mulberry	PLOS ONE			English	Article							CHLOROTIC-SPOT-VIRUS; RINGSPOT-VIRUS; MOLECULAR CHARACTERIZATION; TOMATO; PROTEIN; RNA; ISOLATE; IDENTIFICATION; MOVEMENT; CHINA	Mulberry vein banding associated virus (MVBaV) that infects mulberry plants with typical vein banding symptoms had been identified as a tentative species of the genus Tospovirus based on the homology of N gene sequence to those of tospoviruses. In this study, the complete sequence of the tripartite RNA genome of MVBaV was determined and analyzed. The L RNA has 8905 nucleotides (nt) and encodes the putative RNA-dependent RNA polymerase (RdRp) of 2877 aa amino acids (aa) in the viral complementary (vc) strand. The RdRp of MVBaV shares the highest aa sequence identity (85.9%) with that of Watermelon silver mottle virus (WSMoV), and contains conserved motifs shared with those of the species of the genus Tospovirus. The M RNA contains 4731 nt and codes in ambisense arrangement for the NSm protein of 309 aa in the sense strand and the Gn/Gc glycoprotein precursor (GP) of 1,124 aa in the vc strand. The NSm and GP of MVBaV share the highest aa sequence identities with those of Capsicum chlorosis virus (CaCV) and Groundnut bud necrosis virus (GBNV) (83.2% and 84.3%, respectively). The S RNA is 3294 nt in length and contains two open reading frames (ORFs) in an ambisense coding strategy, encoding a 439-aa non-structural protein (NSs) and the 277-aa nucleocapsid protein (N), respectively. The NSs and N also share the highest aa sequence identity (71.1% and 74.4%, respectively) with those of CaCV. Phylogenetic analysis of the RdRp, NSm, GP, NSs, and N proteins showed that MVBaV is most closely related to CaCV and GBNV and that these proteins cluster with those of the WSMoV serogroup, and that MVBaV seems to be a species bridging the two subgroups within the WSMoV serogroup of tospoviruses in evolutionary aspect, suggesting that MVBaV represents a distinct tospovirus. Analysis of S RNA sequence uncovered the highly conserved 5'-/3'-ends and the coding regions, and the variable region of IGR with divergent patterns among MVBaV isolates.	[Meng, Jiaorong; Liu, Pingping; Zhu, Liling; Zou, Chengwu; Li, Jieqiu] Guangxi Univ, Coll Agr, Nanning 530004, Peoples R China; [Meng, Jiaorong; Chen, Baoshan] Guangxi Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning 530004, Peoples R China; [Meng, Jiaorong; Chen, Baoshan] Minist Educ China Microbial & Plant Genet Engn, Key Lab, Nanning, Peoples R China	Guangxi University; Guangxi University	Chen, BS (corresponding author), Guangxi Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning 530004, Peoples R China.	chenyaoj@gxu.edu.cn	Zou, Chengwu/GXW-2438-2022		Natural Science Foundation of Guangxi Province [2011GXNSFD018019, 2014GXNSFAA118085]; Key Laboratory of Ministry of Education of China [JB1301]	Natural Science Foundation of Guangxi Province(National Natural Science Foundation of Guangxi Province); Key Laboratory of Ministry of Education of China(Ministry of Education, China)	This work was partially supported by grants from the Natural Science Foundation of Guangxi Province (2011GXNSFD018019, 2014GXNSFAA118085), and the Key Laboratory of Ministry of Education of China for Microbial and Plant Genetic Engineering (JB1301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen TC, 2012, PLANT PATHOL, V61, P183, DOI 10.1111/j.1365-3059.2011.02484.x; Chen TC, 2013, VIRUS GENES, V46, P487, DOI 10.1007/s11262-013-0880-8; Chen TC, 2010, ARCH VIROL, V155, P1085, DOI 10.1007/s00705-010-0688-y; de Oliveira AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038634; de Oliveira AS, 2011, VIRUS GENES, V43, P385, DOI 10.1007/s11262-011-0639-z; de Ronde D, 2014, MOL PLANT PATHOL, V15, P185, DOI 10.1111/mpp.12082; De Ronde D, 2013, MOL PLANT PATHOL, V14, P405, DOI 10.1111/mpp.12016; Dong JH, 2013, VIRUS GENES, V46, P567, DOI 10.1007/s11262-012-0873-z; Dong JH, 2008, ARCH VIROL, V153, P855, DOI 10.1007/s00705-008-0054-5; Dullemans AM, 2015, ARCH VIROL, V160, P605, DOI 10.1007/s00705-014-2282-1; Hedil M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106027; Hu ZZ, 2011, ARCH VIROL, V156, P1905, DOI 10.1007/s00705-011-1078-9; Jones DR, 2005, EUR J PLANT PATHOL, V113, P119, DOI 10.1007/s10658-005-2334-1; Kang YC, 2014, EUR J PLANT PATHOL, V140, P815, DOI 10.1007/s10658-014-0511-9; Kayvan Etebari, 2004, Entomologia Sinica, V11, P243, DOI 10.1111/j.1744-7917.2004.tb00421.x; Khatabi B, 2012, EUR J PLANT PATHOL, V133, P783, DOI 10.1007/s10658-012-9969-5; Kikkert M, 1997, J GEN VIROL, V78, P1755, DOI 10.1099/0022-1317-78-7-1755; King AMQ, 2011, VIRUS TAXONOMY, P725; Li W, 2009, VIROLOGY, V390, P110, DOI 10.1016/j.virol.2009.04.027; Lian S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063380; Lokesh B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009757; Margaria P, 2014, ARCH VIROL, V159, P3149, DOI 10.1007/s00705-014-2166-4; Meng JR, 2013, PLANT DIS, V97, P1001, DOI 10.1094/PDIS-08-12-0792-PDN; Montero-Astua M, 2014, MOL PLANT MICROBE IN, V27, P296, DOI 10.1094/MPMI-09-13-0287-FI; Pappu HR, 2009, VIRUS RES, V141, P219, DOI 10.1016/j.virusres.2009.01.009; Quito-Avila DF, 2014, EUR J PLANT PATHOL, V140, P193, DOI 10.1007/s10658-014-0454-1; Rao XQ, 2013, VIRUS GENES, V46, P576, DOI 10.1007/s11262-013-0885-3; Reitz SR, 2011, AGR SCI CHINA, V10, P867, DOI 10.1016/S1671-2927(11)60073-4; Seepiban C, 2011, ARCH VIROL, V156, P263, DOI 10.1007/s00705-010-0856-0; Shimomoto Y, 2014, J GEN PLANT PATHOL, V80, P169, DOI 10.1007/s10327-014-0503-9; Silva MS, 2001, ARCH VIROL, V146, P1267, DOI 10.1007/s007050170090; Singh P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099370; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Torres R, 2012, ARCH VIROL, V157, P609, DOI 10.1007/s00705-011-1217-3; TSUCHIZAKI T, 1971, Annals of the Phytopathological Society of Japan, V37, P266; TSUCHIZAKI T, 1976, Annals of the Phytopathological Society of Japan, V42, P304, DOI 10.3186/jjphytopath.42.304; Webster CG, 2015, PHYTOPATHOLOGY, V105, P388, DOI 10.1094/PHYTO-06-14-0172-R; Webster CG, 2011, VIROLOGY, V413, P216, DOI 10.1016/j.virol.2011.02.011; Whitfield AE, 2005, ANNU REV PHYTOPATHOL, V43, P459, DOI 10.1146/annurev.phyto.43.040204.140017; Whitfield AE, 2004, J VIROL, V78, P13197, DOI 10.1128/JVI.78.23.13197-13206.2004; Xu Y, 2014, ARCH VIROL, V159, P2805, DOI 10.1007/s00705-014-2100-9; Xu Y, 2013, ARCH VIROL, V158, P2597, DOI 10.1007/s00705-013-1756-x; Yin YQ, 2014, MATH PROBL ENG, V2014, DOI 10.1155/2014/201421; Zhai Y, 2014, ARCH VIROL, V159, P1499, DOI 10.1007/s00705-013-1928-8; Zhou J, 2011, VIRUS GENES, V43, P289, DOI 10.1007/s11262-011-0621-9	45	15	20	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136196	10.1371/journal.pone.0136196	http://dx.doi.org/10.1371/journal.pone.0136196			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291718	Green Published, Green Submitted, gold			2022-12-26	WOS:000359919900063
J	Zhang, SY; Shi, CH; Mao, CY; Song, B; Hou, HM; Wu, J; Liu, XJ; Luo, HY; Sun, SL; Xu, YM				Zhang, Shuyu; Shi, Changhe; Mao, Chengyuan; Song, Bo; Hou, Haiman; Wu, Jun; Liu, Xinjing; Luo, Haiyang; Sun, Shilei; Xu, Yuming			Plasma Homocysteine, Vitamin B12 and Folate Levels in Multiple System Atrophy: A Case-Control Study	PLOS ONE			English	Article							PARKINSONS-DISEASE; DNA-DAMAGE; EXCITOTOXICITY; NEUROTOXICITY; METAANALYSIS; DEFICIENCY; SURVIVAL; NEURONS; RISK	Background Multiple system atrophy (MSA) is a neurodegenerative disease, and its pathological hallmark is the accumulation of alpha-synuclein proteins. Homocysteine (Hcy) is an intermediate amino acid generated during the metabolism of methionine. Hcy may contribute to the pathogenesis of neurodegenerative disorders. Vitamin B12 and folate are cofactors necessary for the methylation of homocysteine. Methods This study compared the levels of serum Hcy, vitamin B12 and folate in patients with MSA with those in healthy people to reveal the possible association between MSA and plasma levels of Hcy, vitamin B12 and folate. We enrolled 161 patients with MSA and 161 healthy people in this study. The association between MSA and the levels of Hcy, vitamin B12 and folate were analyzed using binary logistic regression. Results The mean level of Hcy in patients with MSA was significantly higher than that in healthy controls (16.23 +/- 8.09 umol/l vs 14.04 +/- 4.25 umol/l, p < 0.05). After adjusting for age, sex and medical history, the odds ratio for Hcy was 1.07 (95% CI = 1.01-1.13, p < 0.05) for patients with MSA. Vitamin B12 and folate levels were not significantly different between patients with MSA and controls. Conclusion Our data suggest that higher levels of Hcy may be associated with an increased risk for MSA.	[Zhang, Shuyu; Shi, Changhe; Mao, Chengyuan; Song, Bo; Hou, Haiman; Wu, Jun; Liu, Xinjing; Luo, Haiyang; Sun, Shilei; Xu, Yuming] Zhengzhou Univ, Affiliated Hosp 1, Dept Neurol, Zhengzhou 450052, Henan, Peoples R China	Zhengzhou University	Xu, YM (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Neurol, Zhengzhou 450052, Henan, Peoples R China.	xuyuming@zzu.edu.cn			National Natural Science Foundation of China [81471158, U1404311]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grant 81471158 from the National Natural Science Foundation of China (to Dr. Yu-ming Xu) and grant U1404311 from the National Natural Science Foundation of China (to Dr. Chang-he Shi).	BenShlomo Y, 1997, NEUROLOGY, V48, P384, DOI 10.1212/WNL.48.2.384; Chen H, 2015, CURR ALZHEIMER RES, V12, P88, DOI 10.2174/1567205012666141218144035; Fanciulli A, 2015, NEW ENGL J MED, V372, P249, DOI 10.1056/NEJMra1311488; Geser F, 2006, MOVEMENT DISORD, V21, P179, DOI 10.1002/mds.20678; Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15; Ho PI, 2002, J NEUROSCI RES, V70, P694, DOI 10.1002/jnr.10416; Jellinger KA, 2014, MOVEMENT DISORD, V29, P1720, DOI 10.1002/mds.26052; Kiely AP, 2013, ACTA NEUROPATHOL, V125, P753, DOI 10.1007/s00401-013-1096-7; Kim WK, 1999, NEUROSCI LETT, V265, P99, DOI 10.1016/S0304-3940(99)00212-8; Kruman II, 2000, J NEUROSCI, V20, P6920, DOI 10.1523/JNEUROSCI.20-18-06920.2000; Lachner C, 2012, J NEUROPSYCH CLIN N, V24, P5, DOI 10.1176/appi.neuropsych.11020052; Lendinez AM, 2014, CLIN LAB, V60, P1579, DOI 10.7754/Clin.Lab.2013.130914; Liu YY, 2011, J MOL CELL BIOL, V3, P239, DOI 10.1093/jmcb/mjr011; Macedo D, 2015, HUM MOL GENET, V24, P1717, DOI 10.1093/hmg/ddu585; Madenci G, 2012, NEUROCHEM RES, V37, P1436, DOI 10.1007/s11064-012-0729-x; Mattson MP, 2003, TRENDS NEUROSCI, V26, P137, DOI 10.1016/S0166-2236(03)00032-8; McCann H, 2014, PARKINSONISM RELAT D, V20, P62, DOI DOI 10.1016/S1353-8020(13)70017-8; Refsum H, 2004, CLIN CHEM, V50, P3, DOI 10.1373/clinchem.2003.021634; Sakuta H, 2005, CLIN NUTR, V24, P244, DOI 10.1016/j.clnu.2004.10.006; Scholz SW, 2009, ANN NEUROL, V65, P610, DOI 10.1002/ana.21685; Schrag A, 1999, LANCET, V354, P1771, DOI 10.1016/S0140-6736(99)04137-9; Schrag A, 2008, MOVEMENT DISORD, V23, P294, DOI 10.1002/mds.21839; Smith AD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012244; Vaes BLT, 2009, CALCIFIED TISSUE INT, V84, P413, DOI 10.1007/s00223-009-9244-8; Voutilainen S, 1999, ARTERIOSCL THROM VAS, V19, P1263, DOI 10.1161/01.ATV.19.5.1263; Zhang DF, 2014, MOVEMENT DISORD, V29, P819, DOI 10.1002/mds.25863	26	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136468	10.1371/journal.pone.0136468	http://dx.doi.org/10.1371/journal.pone.0136468			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291976	Green Submitted, Green Published, gold			2022-12-26	WOS:000359919900087
J	Hermans, S; Horsburgh, CR; Wood, R				Hermans, Sabine; Horsburgh, C. Robert, Jr.; Wood, Robin			A Century of Tuberculosis Epidemiology in the Northern and Southern Hemisphere: The Differential Impact of Control Interventions	PLOS ONE			English	Article							NEW-YORK-CITY; HISTORICAL DECLINES; ENGLAND; AFRICA; WALES; INFECTION; LONDON	Background Cape Town has one of the highest TB burdens of any city in the world. In 1900 the City of Cape Town, New York City and London had high mortality of tuberculosis (TB). Throughout the 20th century contemporaneous public health measures including screening, diagnosis and treatment were implemented in all three settings. Mandatory notification of TB and vital status enabled comparison of disease burden trajectories. Methods TB mortality, notification and case fatality rates were calculated from 1912 to 2012 using annual TB notifications, TB death certifications and population estimates. Notification rates were stratified by age and in Cape Town by HIV status (from 2009 onwards). Results Pre-chemotherapy, TB mortality and notification rates declined steadily in New York and London but remained high in Cape Town. Following introduction of combination chemotherapy, mean annual case fatality dropped from 45-60% to below 10% in all three settings. Mortality and notification rates subsequently declined, although Cape Town notifications did not decline as far as those in New York or London and returned to pre-chemotherapy levels by 1980. The proportional contribution of childhood TB diminished in New York and London but remained high in Cape Town. The advent of the Cape Town HIV-epidemic in the 1990s was associated with a further two-fold increase in incidence. In 2012, notification rates among HIV-negatives remained at pre-chemotherapy levels. Conclusions TB control was achieved in New York and London but failed in Cape Town. The TB disease burden trajectories started diverging before the availability of combination chemotherapy in 1952 and further diverged following the HIV epidemic in 1990. Chemotherapy impacted case fatality but not transmission, evidenced by on-going high childhood TB rates. Currently endemic TB results from high on-going transmission, which has been exacerbated by the HIV epidemic. TB control will require reducing transmission, which is inexorably linked to prevailing socio-economic factors.	[Hermans, Sabine; Wood, Robin] Univ Cape Town, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa; [Hermans, Sabine] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, Amsterdam Inst Global Hlth & Dev, NL-1105 AZ Amsterdam, Netherlands; [Hermans, Sabine] Makerere Univ, Coll Hlth Sci, Sch Med, Dept Internal Med, Kampala, Uganda; [Horsburgh, C. Robert, Jr.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Wood, Robin] Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa; [Wood, Robin] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, London WC1, England	University of Cape Town; University of Amsterdam; Academic Medical Center Amsterdam; Makerere University; Boston University; University of Cape Town; University of London; London School of Hygiene & Tropical Medicine	Hermans, S (corresponding author), Univ Cape Town, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa.	sabine.hermans@hiv-research.org.za		Hermans, Sabine/0000-0001-5146-2932; Horsburgh, C./0000-0001-6838-7895	European Union [PIOF-GA-2012-332311]; Swiss National Science Foundation [PBSKP3_145774]; National Institutes of Health [R01AI058736-02, R01AI093269-02, U01AI069924-02, U01A1069519, U01AI100805]; South African Medical Research Council [MRC-RFA-UFSP-01-2013/CCAMP]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI100805, R37AI093269, R01AI058736, R01AI093269, U01AI069924] Funding Source: NIH RePORTER	European Union(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the European Union [Marie Curie International Outgoing Fellowship for Career Development PIOF-GA-2012-332311 to SH], the Swiss National Science Foundation [PBSKP3_145774 to SH], the National Institutes of Health [R01AI058736-02, R01AI093269-02, U01AI069924-02 and U01A1069519 to RW, U01AI100805 to CRH], and the South African Medical Research Council [MRC-RFA-UFSP-01-2013/CCAMP to RW]. The funding bodies had no role in study design, data analysis, or write-up.	Actuarial Society of South Africa, 2008, AIDS DEM MOD 2008; Albertyn AA, 1965, J S AFR VET ASSOC, V36, P33; Anderson SR, 2007, THORAX, V62, P162, DOI 10.1136/thx.2006.058313; [Anonymous], 1982, PUBL HLTH ENGL; Atkins P., 2000, FOOD SCI POLICY REGU; [Bureau of Tuberculosis Control New York City Department of Health and Mental Hygiene], 1900, BUR TUB CONTR ANN SU; [City of Cape Town Medical Officer of Health], 2012, ANN REP 1904 1994; Compendium of population health indicators, 1993, MORT TUB IND STAND R; Davies RPO, 1999, INT J TUBERC LUNG D, V3, P1051; Department for Environment Food and Rural Affairs, 2011, BOV TB DIS ITS EP HI; Drolet G, 1952, HALF CENTURY PROGR T; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Fox W, 1999, INT J TUBERC LUNG D, V3, pS231; FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406; Grange JM, 2001, INT J TUBERC LUNG D, V5, P208; Gurney Champion S, 1936, BRIT MED J, V2, P740; Hayward AC, 2000, EMERG INFECT DIS, V6, P12; LERNER BH, 1993, AM J PUBLIC HEALTH, V83, P758, DOI 10.2105/AJPH.83.5.758; Macaraig M, 2014, NEW ENGL J MED, V370, P2362, DOI 10.1056/NEJMp1402147; MCKEOWN T, 1962, POP STUD-J DEMOG, V16, P94, DOI 10.2307/2173119; Medical Officer of Health London, 1848, ANN REP; [Ministry of Health England & Wales Chief Medical Officer], 1950, ANN REP; National Department of Health, 2011, NAT ANT SENT HIV SYP; New York City Department of Health and Mental Hygiene, 2014, EPIQUERY NYC INT HLT; New York Department of Health, 2005, BRIEF HIST CAMP TUB; Office for National Statistics, 2012, 2011 CENS POP HOUS E; Office for Population Censuses and Surveys, 1974, OPCS MON DH5 MORT ST; Office for Population Censuses and Surveys, 1974, OPCS MON MB2 COMM DI; Provincial Administration of the Western Cape Provincial Region City of Cape Town, 2004, CAP TOWN TB CONTR PR; Provincial Government of the Western Cape, 2002, MIGR STUD W CAP 2001; Public Health England, 2013, TURB LOND ANN REV 20; Registrar-General, 1965, STAT REV ENGL WAL; Roy Sukhendu, 2012, J Indian Med Assoc, V110, P728; Statistics South Africa, 2014, MORT CAUS DEATH S AF; Statistics South Africa, 2002, MID POP EST 2002 201; Strategic Development Information and GIS Department City of Cape Town, 2011, CAP TOWN OV CENS 201; United Nations Department of Economic and Social Affairs Population Division, 1952, MAN 1 METH EST TOT P; United Nations Human Settlements Programme, 2012, STAT WORLDS CIT 2012; United States Census Bureau, 2002, DEM TRENDS 20 CENT; United States Census Bureau, 2005, NEW YORK RAC HOSP OR; [University of Portsmouth Great Britain Historical GIS Project], 2014, VIS BRIT TIM 2014; US Census Bureau, 2010, 2010 CENS; vanHarmelen J, 1997, AIDS, V11, P81, DOI 10.1097/00002030-199701000-00012; Vynnycky E, 1999, INT J EPIDEMIOL, V28, P327, DOI 10.1093/ije/28.2.327; Vynnycky E, 1997, INT J TUBERC LUNG D, V1, P389; Walker ARP, 2001, J R SOC PROMO HEALTH, V121, P85, DOI 10.1177/146642400112100208; WILSON LG, 1990, J HIST MED ALL SCI, V45, P366, DOI 10.1093/jhmas/45.3.366; Wood R, 2010, INT J TUBERC LUNG D, V14, P406; Wood R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025098; World Health Organization, 2014, REP GLOB TUB CONTR; World Health Organization, 1987, WEEKLY EPIDEMIOLOGIC	51	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135179	10.1371/journal.pone.0135179	http://dx.doi.org/10.1371/journal.pone.0135179			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288079	Green Published, Green Submitted, gold			2022-12-26	WOS:000360018600039
J	Petit, C; Le Ru, B; Dupas, S; Frerot, B; Ahuya, P; Kaiser-Arnauld, L; Harry, M; Calatayud, PA				Petit, Christophe; Le Ru, Bruno; Dupas, Stephane; Frerot, Brigitte; Ahuya, Peter; Kaiser-Arnauld, Laure; Harry, Myriam; Calatayud, Paul-Andre			Influence of Dietary Experience on the Induction of Preference of Adult Moths and Larvae for a New Olfactory Cue	PLOS ONE			English	Article							LEPIDOPTERAN STEM BORERS; TRICHOPLUSIA-NI; HOST-SELECTION; BUSSEOLA-FUSCA; OVIPOSITION; NOCTUIDAE; RESPONSES; PLANTS; MAIZE; SPECIALIST	In Lepidoptera, host plant selection is first conditioned by oviposition site preference of adult females followed by feeding site preference of larvae. Dietary experience to plant volatile cues can induce larval and adult host plant preference. We investigated how the parent's and self-experience induce host preference in adult females and larvae of three lepidopteran stem borer species with different host plant ranges, namely the polyphagous Sesamia nonagrioides, the oligophagous Busseola fusca and the monophagous Busseola nairobica, and whether this induction can be linked to a neurophysiological phenotypic plasticity. The three species were conditioned to artificial diet enriched with vanillin from the neonate larvae to the adult stage during two generations. Thereafter, two-choice tests on both larvae and adults using a Y-tube olfactometer and electrophysiological (electroantennography [EAG] recordings) experiments on adults were carried out. In the polyphagous species, the induction of preference for a new olfactory cue (vanillin) by females and 3rd instar larvae was determined by parents' and self-experiences, without any modification of the sensitivity of the females antennae. No preference induction was found in the oligophagous and monophagous species. Our results suggest that lepidopteran stem borers may acquire preferences for new olfactory cues from the larval to the adult stage as described by Hopkins' host selection principle (HHSP), neo-Hopkins' principle, and the concept of 'chemical legacy.'	[Petit, Christophe; Le Ru, Bruno; Ahuya, Peter; Calatayud, Paul-Andre] African Insect Sci Food & Hlth, ICIPE, Inst Rech Dev, Noctuid Stem Borer Biodivers Team, Nairobi, Kenya; [Petit, Christophe; Le Ru, Bruno; Dupas, Stephane; Kaiser-Arnauld, Laure; Harry, Myriam; Calatayud, Paul-Andre] CNRS, Inst Rech Dev, Evolut Genomes Comportement & Ecol, UMR 247, Gif Sur Yvette, France; [Petit, Christophe; Le Ru, Bruno; Dupas, Stephane; Kaiser-Arnauld, Laure; Harry, Myriam; Calatayud, Paul-Andre] Univ Paris 11, Orsay, France; [Frerot, Brigitte] INRA, Inst Ecol & Sci Environm Paris, UMR 1392, Versailles, France	Institut de Recherche pour le Developpement (IRD); International Centre of Insect Physiology & Ecology (ICIPE); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Universite Paris Saclay; Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Petit, C (corresponding author), African Insect Sci Food & Hlth, ICIPE, Inst Rech Dev, Noctuid Stem Borer Biodivers Team, Nairobi, Kenya.	christophepetit86@gmail.com	HARRY, Myriam/AAF-1530-2019; Calatayud, Paul-andre/AAG-8117-2020; LE RU, BRUNO/C-5862-2011; Le Ru, bruno/K-3480-2016; Paul-André, Calatayud/K-3282-2019	Calatayud, Paul-andre/0000-0002-9482-4646; Le Ru, bruno/0000-0002-4208-3727; 				Akhtar Y, 2003, J CHEM ECOL, V29, P1853, DOI 10.1023/A:1024802328458; Anderson P, 2014, PLANT CELL ENVIRON, V37, P1826, DOI 10.1111/pce.12342; Anderson P, 2013, ANIM BEHAV, V85, P1169, DOI 10.1016/j.anbehav.2013.03.002; ATKINSON PR, 1980, J ENTOMOL SOC S AFR, V43, P171; Barron AB, 2001, J INSECT BEHAV, V14, P725, DOI 10.1023/A:1013033332535; Berdegue M, 1998, ENTOMOL EXP APPL, V89, P57, DOI 10.1023/A:1003464102518; Bernays E. A., 1994, Host-plant selection by phytophagous insects.; Bernays EA, 2001, ANNU REV ENTOMOL, V46, P703, DOI 10.1146/annurev.ento.46.1.703; Calatayud PA, 2014, ENTOMOL EXP APPL, V152, P72, DOI 10.1111/eea.12201; Chakraborty TS, 2009, J NEUROGENET, V23, P210, DOI 10.1080/01677060802491559; Chow JK, 2005, CHEMOECOLOGY, V15, P129, DOI 10.1007/s00049-005-0304-x; CORBET SA, 1985, ECOL ENTOMOL, V10, P143, DOI 10.1111/j.1365-2311.1985.tb00543.x; Cunningham JP, 1998, ANIM BEHAV, V55, P227, DOI 10.1006/anbe.1997.0600; DICKENS JC, 1984, J CHEM ECOL, V10, P1759, DOI 10.1007/BF00987360; Felix AE, 2013, ANN SOC ENTOMOL FR, V49, P345, DOI 10.1080/00379271.2013.863040; Hopkins AD, 1916, USDA PROGRAM WORK 19, P353; Hora KH, 2005, ENTOMOL EXP APPL, V115, P271, DOI 10.1111/j.1570-7458.2005.00287.x; JAENIKE J, 1983, OECOLOGIA, V58, P320, DOI 10.1007/BF00385230; Le Ru BP, 2006, B ENTOMOL RES, V96, P555, DOI [10.1079/BER2006457, 10.1017/BER2006457]; Le Ru BP, 2006, ANN SOC ENTOMOL FR, V42, P353, DOI 10.1080/00379271.2006.10697467; Ledon-Rettig CC, 2013, BEHAV ECOL, V24, P311, DOI 10.1093/beheco/ars145; Moolman J, 2014, J APPL ENTOMOL, V138, P52, DOI 10.1111/jen.12085; Ndemah R, 2007, J APPL ENTOMOL, V131, P658, DOI 10.1111/j.1439-0418.2007.01219.x; NgiSong AJ, 1996, J CHEM ECOL, V22, P307, DOI 10.1007/BF02055101; Ong'amo G. O, 2009, DIVERSITY ECOLOGY PO; Ong'amo GO, 2006, ANN SOC ENTOMOL FR, V42, P171, DOI 10.1080/00379271.2006.10700620; ONYANGO FO, 1994, ENTOMOL EXP APPL, V73, P139, DOI 10.1007/BF02383419; Roessingh P, 2007, J COMP PHYSIOL A, V193, P635, DOI 10.1007/s00359-007-0218-x; Schoonhoven L. M., 2005, Insect-plant biology; TRAYNIER RMM, 1984, PHYSIOL ENTOMOL, V9, P465, DOI 10.1111/j.1365-3032.1984.tb00789.x; Youngson NA, 2008, ANNU REV GENOM HUM G, V9, P233, DOI 10.1146/annurev.genom.9.081307.164445; Zhang PJ, 2007, J CHEM ECOL, V33, P1528, DOI 10.1007/s10886-007-9325-y	32	18	19	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136169	10.1371/journal.pone.0136169	http://dx.doi.org/10.1371/journal.pone.0136169			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288070	Green Published, gold, Green Submitted			2022-12-26	WOS:000360018600114
J	Pandey, P; Sui, M; Li, MY; Zhang, QZ; Kim, ES; Lee, J				Pandey, Puran; Sui, Mao; Li, Ming-Yu; Zhang, Quanzhen; Kim, Eun-Soo; Lee, Jihoon			Systematic Study on the Self-Assembled Hexagonal Au Voids, Nano-Clusters and Nanoparticles on GaN (0001)	PLOS ONE			English	Article							AGGLOMERATION BEHAVIOR; FABRICATION; FILMS; TEMPERATURE; MORPHOLOGY; NANOWIRES; EVOLUTION; DROPLETS; GROWTH	Au nano-clusters and nanoparticles (NPs) have been widely utilized in various electronic, optoelectronic, and bio-medical applications due to their great potentials. The size, density and configuration of Au NPs play a vital role in the performance of these devices. In this paper, we present a systematic study on the self-assembled hexagonal Au voids, nano-clusters and NPs fabricated on GaN (0001) by the variation of annealing temperature and deposition amount. At relatively low annealing temperatures between 400 and 600 degrees C, the fabrication of hexagonal shaped Au voids and Au nano-clusters are observed and discussed based on the diffusion limited aggregation model. The size and density of voids and nano-clusters can systematically be controlled. The self-assembled Au NPs are fabricated at comparatively high temperatures from 650 to 800 degrees C based on the Volmer-Weber growth model and also the size and density can be tuned accordingly. The results are symmetrically analyzed and discussed in conjunction with the diffusion theory and thermodynamics by utilizing AFM and SEM images, EDS maps and spectra, FFT power spectra, cross-sectional line-profiles and size and density plots.	[Pandey, Puran; Sui, Mao; Li, Ming-Yu; Zhang, Quanzhen; Kim, Eun-Soo; Lee, Jihoon] Kwangwoon Univ, Coll Elect & Informat, Seoul, South Korea; [Lee, Jihoon] Univ Arkansas, Inst Nanoscale Sci & Engn, Fayetteville, AR 72701 USA	Kwangwoon University; University of Arkansas System; University of Arkansas Fayetteville	Lee, J (corresponding author), Kwangwoon Univ, Coll Elect & Informat, Seoul, South Korea.	jihoonleenano@gmail.com	/B-7688-2019; Li, Ming-Yu/AAH-6879-2020; Pandey, Puran/AFR-7802-2022	/0000-0002-8768-8586; Li, Ming-Yu/0000-0003-4812-8604; Pandey, Puran/0000-0002-4993-2066; Lee, Jihoon/0000-0002-0508-486X	National Research Foundation (NRF) of Korea [2011-0030821, 2013R1A1A1007118]; Kwangwoon University	National Research Foundation (NRF) of Korea(National Research Foundation of Korea); Kwangwoon University	Financial support from the National Research Foundation (NRF) of Korea (no. 2011-0030821 and 2013R1A1A1007118), and in part by the research grant of Kwangwoon University in 2015 is gratefully acknowledged.	Abraham DB, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/16002; AbuWaar ZY, 2006, NANOTECHNOLOGY, V17, P4037, DOI 10.1088/0957-4484/17/16/007; Baker CO, 2011, ACS NANO, V5, P3469, DOI 10.1021/nn200992w; Chen XQ, 2013, SOL ENERG MAT SOL C, V111, P1, DOI 10.1016/j.solmat.2012.12.016; Dahiya AS, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-379; Dong YJ, 2009, NANO LETT, V9, P2183, DOI 10.1021/nl900858v; Dowdy R, 2012, IEEE ELECTR DEVICE L, V33, P522, DOI 10.1109/LED.2012.2186115; Gholampour M, 2014, MATER LETT, V120, P136, DOI 10.1016/j.matlet.2014.01.062; Glasner K, 2009, EUR J APPL MATH, V20, P1, DOI 10.1017/S0956792508007559; Huang XH, 2010, J ADV RES, V1, P13, DOI 10.1016/j.jare.2010.02.002; Jacopin G, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.014101; Jensen MCR, 2008, J PHYS CHEM C, V112, P16953, DOI 10.1021/jp804492h; Jessen GH, 2003, IEEE ELECTR DEVICE L, V24, P677, DOI 10.1109/LED.2003.818816; Kawamura M, 2005, MICROELECTRON ENG, V82, P277, DOI 10.1016/j.mee.2005.07.035; Kim BJ, 2014, NANO LETT, V14, P4554, DOI 10.1021/nl501582q; Kuznetsov AI, 2011, ACS NANO, V5, P4843, DOI 10.1021/nn2009112; Kwon JY, 2003, J APPL PHYS, V93, P3270, DOI 10.1063/1.1556178; Lee JM, 2007, MAT SCI ENG A-STRUCT, V449, P769, DOI 10.1016/j.msea.2006.02.403; Li MY, 2014, NANOSCALE RES LETT, V9, P1, DOI 10.1186/1556-276X-9-407; Li MY, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-113; Liu CY, 2011, SCRIPTA MATER, V64, P533, DOI 10.1016/j.scriptamat.2010.11.036; Mishra UK, 2008, P IEEE, V96, P287, DOI 10.1109/JPROC.2007.911060; Obi D, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/44/445008; Petrov I, 2003, J VAC SCI TECHNOL A, V21, pS117, DOI 10.1116/1.1601610; Qiao LF, 2011, APPL ENERG, V88, P848, DOI 10.1016/j.apenergy.2010.09.021; Ruffino F, 2014, J APPL PHYS, V115, DOI 10.1063/1.4866876; Sahoo P, 2013, J MATER CHEM C, V1, P7237, DOI 10.1039/c3tc31494d; Salomon D, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-61; Strobel S, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/50/505301; Sugawara K, 2008, VACUUM, V83, P610, DOI 10.1016/j.vacuum.2008.04.029; Sui M, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-436; Sui M, 2014, CRYSTENGCOMM, V16, P4390, DOI 10.1039/c4ce00210e; Sui M, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-525; Sun W, 2013, J PHYS CHEM C, V117, P19234, DOI 10.1021/jp406294t; Takahashi K, 2007, WIDE BANDGAP SEMICON, P393; Wang CM, 2005, J APPL PHYS, V98, DOI 10.1063/1.2130890; WITTEN TA, 1981, PHYS REV LETT, V47, P1400, DOI 10.1103/PhysRevLett.47.1400; YAO JH, 1993, PHYS REV B, V47, P14110, DOI 10.1103/PhysRevB.47.14110; Yu HZ, 2014, ACTA MATER, V67, P189, DOI 10.1016/j.actamat.2013.12.031; Zhou HQ, 2010, J AM CHEM SOC, V132, P944, DOI 10.1021/ja909228n; Zhu HW, 2014, BIOMED MICRODEVICES, V16, P479, DOI 10.1007/s10544-014-9850-8	41	12	12	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0134637	10.1371/journal.pone.0134637	http://dx.doi.org/10.1371/journal.pone.0134637			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285135	Green Published, gold, Green Submitted			2022-12-26	WOS:000359666100014
J	Nygaard, GO; Celius, EG; Benavent, SAD; Sowa, P; Gustavsen, MW; Fjell, AM; Landro, NI; Walhovd, KB; Harbo, HF				Nygaard, Gro O.; Celius, Elisabeth G.; Benavent, Sigrid A. de Rodez; Sowa, Piotr; Gustavsen, Marte W.; Fjell, Anders M.; Landro, Nils I.; Walhovd, Kristine B.; Harbo, Hanne F.			A Longitudinal Study of Disability, Cognition and Gray Matter Atrophy in Early Multiple Sclerosis Patients According to Evidence of Disease Activity	PLOS ONE			English	Article							NATALIZUMAB; PROGRESSION; THERAPY; RESERVE	New treatment options may make "no evidence of disease activity" (NEDA: no relapses or disability progression and no new/enlarging MRI lesions, as opposed to "evidence of disease activity" (EDA) with at least one of the former), an achievable goal in relapsing-remitting multiple sclerosis (RRMS). The objective of the present study was to determine whether early RRMS patients with EDA at one-year follow-up had different disability, cognition, treatment and gray matter (GM) atrophy rates from NEDA patients and healthy controls (HC). RRMS patients (mean age 34 years, mean disease duration 2.2 years) were examined at baseline and one-year follow-up with neurological (n = 72), neuropsychological (n = 56) and structural MRI (n = 57) examinations. Matched HC (n = 61) were retested after three years. EDA was found in 46% of RRMS patients at follow-up. EDA patients used more first line and less second line disease modifying treatment than NEDA (p = 0.004). While the patients groups had similar disability levels at baseline, they differed in disability at follow-up (p = 0.010); EDA patients progressed (EDSS: 1.8-2.2, p = 0.010), while NEDA patients improved (EDSS: 2.0-1.7, p<0.001). Cognitive function was stable in both patient groups. Subcortical GM atrophy rates were higher in EDA patients than HC (p<0.001). These results support the relevance of NEDA as outcome in RRMS and indicate that pathological neuro-degeneration in RRMS mainly occur in patients with evidence of disease activity.	[Nygaard, Gro O.; Celius, Elisabeth G.; Gustavsen, Marte W.; Harbo, Hanne F.] Univ Oslo, Oslo Univ Hosp, Dept Neurol, Oslo, Norway; [Nygaard, Gro O.; Celius, Elisabeth G.; Benavent, Sigrid A. de Rodez; Sowa, Piotr; Gustavsen, Marte W.; Harbo, Hanne F.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Benavent, Sigrid A. de Rodez] Univ Oslo, Dept Ophthalmol, Oslo Univ Hosp, Oslo, Norway; [Sowa, Piotr] Univ Oslo, Dept Radiol, Oslo Univ Hosp, Oslo, Norway; [Fjell, Anders M.; Landro, Nils I.; Walhovd, Kristine B.] Univ Oslo, Dept Psychol, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Nygaard, GO (corresponding author), Univ Oslo, Oslo Univ Hosp, Dept Neurol, Oslo, Norway.	g.o.nygaard@medisin.uio.no	Celius, Elisabeth Gulowsen/S-1387-2019	Celius, Elisabeth Gulowsen/0000-0002-9127-6488	South-Eastern Health Authorities of Norway [2011059]; Odd Fellows Foundation for Multiple Sclerosis Research	South-Eastern Health Authorities of Norway; Odd Fellows Foundation for Multiple Sclerosis Research	This work was funded by the South-Eastern Health Authorities of Norway (grant number 2011059, entitled 'Genetic risk factors and MRI and clinical outcome in MS') and a research grant from the Odd Fellows Foundation for Multiple Sclerosis Research. This funding was external to our organization. The first author received a PhD scholarship from the former, and the research assistants who performed neuropsychological testing of the patients were supported by the latter grant, both of which were administered by Oslo University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato MP, 2013, NEUROLOGY, V80, P1728, DOI 10.1212/WNL.0b013e3182918c6f; Bakshi R, 2008, ARCH NEUROL-CHICAGO, V65, P1449, DOI 10.1001/archneur.65.11.1449; Battaglini M, 2012, HUM BRAIN MAPP, V33, P2062, DOI 10.1002/hbm.21344; Beck AT, 1996, MANUAL FOR THE BECK; Benedict RH, 1997, BVMT R BRIEF VISUOSP; Bevan CJ, 2014, JAMA NEUROL, V71, P269, DOI 10.1001/jamaneurol.2013.5486; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Cifelli A, 2002, ANN NEUROL, V52, P650, DOI 10.1002/ana.10326; Cohen JA, 2012, LANCET NEUROL, V11, P467, DOI 10.1016/S1474-4422(12)70059-5; Cutter GR, 1999, BRAIN, V122, P871, DOI 10.1093/brain/122.5.871; De Stefano N, 2014, CNS DRUGS, V28, P147, DOI 10.1007/s40263-014-0140-z; Delis DC, 2000, CALIFORNIA VERBAL LE, DOI DOI 10.1016/j.schres.2003.09.011; Geurts JJG, 2012, LANCET NEUROL, V11, P1082, DOI 10.1016/S1474-4422(12)70230-2; Giovannoni G, 2011, LANCET NEUROL, V10, P329, DOI 10.1016/S1474-4422(11)70023-0; Havrdova E, 2009, LANCET NEUROL, V8, P254, DOI 10.1016/S1474-4422(09)70021-3; Kappos L, 2009, LANCET NEUROL, V8, P987, DOI 10.1016/S1474-4422(09)70237-6; Karussis D, 2006, EUR J NEUROL, V13, P61, DOI 10.1111/j.1468-1331.2006.01147.x; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Lublin FD, 2013, ANN NEUROL, V73, P327, DOI 10.1002/ana.23863; Myhr K-M, 2011, NASJONALE FAGLIGE RE; Nash RA, 2015, JAMA NEUROL, V72, P159, DOI 10.1001/jamaneurol.2014.3780; Nygaard GO, 2015, MULT SCLER J, V21, P402, DOI 10.1177/1352458514543811; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Popescu V, 2013, J NEUROL NEUROSUR PS, V84, P1082, DOI 10.1136/jnnp-2012-304094; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Reuter M, 2010, NEUROIMAGE, V53, P1181, DOI 10.1016/j.neuroimage.2010.07.020; Rotstein DL, 2015, JAMA NEUROL, V72, P152, DOI 10.1001/jamaneurol.2014.3537; Sastre-Garriga J, 2015, MULT SCLER J, V21, P749, DOI 10.1177/1352458514556300; Shirani A, 2012, JAMA; Smith A., 1982, SYMBOL DIGIT MODALIT; Sormani MP, 2013, MULT SCLER J, V19, P605, DOI 10.1177/1352458512460605; Sumowski JF, 2014, NEUROLOGY, V82, P1776, DOI 10.1212/WNL.0000000000000433; Tedeholm H, 2013, MULT SCLER J, V19, P765, DOI 10.1177/1352458512463764; Tremlett H, 2012, MULT SCLER J, V18, P1412, DOI 10.1177/1352458512439119; Van Schependom J, 2015, MULT SCLER J, V21, P83, DOI 10.1177/1352458514537012; Vidal-Jordana A, 2013, MULT SCLER J, V19, P1175, DOI 10.1177/1352458512473190; Vrenken H, 2013, J NEUROL, V260, P2458, DOI 10.1007/s00415-012-6762-5; Walhovd KB, 2013, NEUROBIOLOGY OF AGIN; Wegner C, 2006, NEUROLOGY, V67, P960, DOI 10.1212/01.wnl.0000237551.26858.39; Zivadinov R, 2008, NEUROLOGY, V71, P136, DOI 10.1212/01.wnl.0000316810.01120.05	40	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0135974	10.1371/journal.pone.0135974	http://dx.doi.org/10.1371/journal.pone.0135974			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26280173	Green Published, gold			2022-12-26	WOS:000359664300029
J	Chien, MY; Chen, LC; Chen, YC; Sheu, MT; Tsai, YC; Ho, HO; Su, CH; Liu, DZ				Chien, Mei-Yin; Chen, Ling-Chun; Chen, Ying-Chen; Sheu, Ming-Thau; Tsai, Ya-Chi; Ho, Hsiu-O; Su, Ching-Hua; Liu, Der-Zen			Mycelial Mattress from a Sporangia Formation-Delayed Mutant of Rhizopus stolonifer as Wound Healing-Enhancing Biomaterial	PLOS ONE			English	Article							FUNGAL MYCELIA; KERATINOCYTE PROLIFERATION; SKIN SUBSTITUTES; CHITOSAN; CHITIN; METALLOPROTEINASES; INHIBITORS	A mycelial mattress of Rhizopus stolonifer obtained from a liquid static culture was utilized for wound dressing and biomedical use. Following screening of mutants induced by UV radiation, F6, exhibiting delayed sporangium formation was selected because its sporangium maturation exhibited a 5-day delay without significant loss of mycelial weight compared to the wild type. The sporangium-free mycelial mattress from the sporangiospore culture of F6 was treated with 1N sodium hydroxide NaOH at 85 degrees C for 2 h to produce a sponge-like membrane named Rhizochitin. The trifluoroacetic acid hydrolysate of Rhizochitin contained 36% N-acetylglucosamine and 53% hexose respectively detected by the Elson-Morgen and phenol-sulfuric acid methods. Results indicated the wound area in rats covered with Rhizochitin was 40% less than that of the uncovered group. Rhizochitin decreased the expression of PDGF in the proliferation stage, increased the expression of TGF-beta in the inflammation and proliferation stages, and increased the expression of VEGF in the inflammation and proliferation stages. Rhizochitin inhibited secretion of matrix metalloproteinase-9 on days 1, 7, 9, and 12 and matrix metalloproteinase-2 on days 3, 7, 9, and 12. It was concluded that Rhizochitin has beneficial properties of biocompatible, biodegradable, and wound healing.	[Chien, Mei-Yin] Taipei Med Univ, Sch Dent, Coll Oral Med, Taipei, Taiwan; [Chen, Ling-Chun; Chen, Ying-Chen; Sheu, Ming-Thau; Ho, Hsiu-O] Taipei Med Univ, Sch Pharm, Coll Pharm, Taipei, Taiwan; [Sheu, Ming-Thau] Taipei Med Univ Hosp, Clin Res Ctr, Taipei, Taiwan; [Sheu, Ming-Thau] Taipei Med Univ Hosp, Tradit Herbal Med Res Ctr, Taipei, Taiwan; [Tsai, Ya-Chi; Liu, Der-Zen] Taipei Med Univ, Grad Inst Biomed Mat & Tissue Engn, Coll Oral Med, Taipei, Taiwan; [Su, Ching-Hua] Taipei Med Univ, Sch Med, Dept Microbiol & Immunol, Coll Med, Taipei, Taiwan; [Liu, Der-Zen] Hsuan Chuang Univ, Ctr Gen Educ, Hsinchu, Taiwan; [Chien, Mei-Yin] Ko Da Pharmaceut Co, Taoyuan, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Hsuan Chuang University	Liu, DZ (corresponding author), Taipei Med Univ, Grad Inst Biomed Mat & Tissue Engn, Coll Oral Med, Taipei, Taiwan.	tonyliu@tmu.edu.tw			Center of Excellence for Clinical Trials and Research in Neuroscience [DOH 100-TD-B-111-003]; Ministry of Science and Technology of ROC [NSC 100-2320-B-038-004-MY3]; Ko Da Pharmaceutical Co., Taoyuan, Taiwan	Center of Excellence for Clinical Trials and Research in Neuroscience; Ministry of Science and Technology of ROC; Ko Da Pharmaceutical Co., Taoyuan, Taiwan	Financial funding from the Center of Excellence for Clinical Trials and Research in Neuroscience (DOH 100-TD-B-111-003) and Ministry of Science and Technology of ROC (NSC 100-2320-B-038-004-MY3) is highly appreciated. Ko Da Pharmaceutical Co., Taoyuan, Taiwan provided support in the form of salaries for author MYC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baik WY, 2002, BIORESOURCE TECHNOL, V81, P167, DOI 10.1016/S0960-8524(01)00148-1; Chen C, 1999, WOUND REPAIR REGEN, V7, P486, DOI 10.1046/j.1524-475X.1999.00486.x; Chittoria R. K., 2012, J SOC WOUND CARE RES, V5, P2; Ferreira JA, 2012, BIORESOURCE TECHNOLO; Francesko A, 2011, ADV BIOCHEM ENG BIOT, V125, P1, DOI [10.10007/10_2010_93, 10.1007/10_2010_93]; Franco RA, 2013, J BIOMATER APPL, V27, P605, DOI 10.1177/0885328211416527; Gibson D., 2009, WOUNDS INT, V1, P1; Gill SE, 2008, INT J BIOCHEM CELL B, V40, P1334, DOI 10.1016/j.biocel.2007.10.024; Hung WS, 2004, J BIOMED MATER RES B, V70B, P122, DOI 10.1002/jbm.b.30028; Jayakumar R, 2011, INT J MOL SCI, V12, P1876, DOI 10.3390/ijms12031876; Kennedy JF, 1994, CARBOHYDRATE ANALYSI; Moussa S, 2011, INT J BIOL MACROMOL, V48, P736, DOI 10.1016/j.ijbiomac.2011.02.022; Rodriguez X, 2004, BIOINORGANIC CHEMIST, P1, DOI [10.1155/S1565363304000019, DOI 10.1155/S1565363304000019]; Senevirathne M, 2012, ADV FOOD NUTR RES, V65, P495, DOI 10.1016/B978-0-12-416003-3.00032-9; Shahidi F, 1999, TRENDS FOOD SCI TECH, V10, P37, DOI 10.1016/S0924-2244(99)00017-5; Snoek-van Beurden PAM, 2005, BIOTECHNIQUES, V38, P73, DOI 10.2144/05381RV01; Srinivasan A, 2010, BIORESOURCE TECHNOL, V101, P6594, DOI 10.1016/j.biortech.2010.03.079; Su CH, 2005, J BIOMED MATER RES A, V72A, P220, DOI 10.1002/jbm.a.30235; Su CH, 1997, BIOMATERIALS, V18, P1169, DOI 10.1016/S0142-9612(97)00048-3; Su CH, 1999, BIOMATERIALS, V20, P61, DOI 10.1016/S0142-9612(98)00139-2; Tayel AA, 2010, INT J BIOL MACROMOL, V47, P454, DOI 10.1016/j.ijbiomac.2010.06.011; Tayel AA, 2010, INT J BIOL MACROMOL, V47, P10, DOI 10.1016/j.ijbiomac.2010.04.005; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Wu T, 2005, J AGR FOOD CHEM, V53, P3888, DOI 10.1021/jf048202s; Zamani A, 2013, BIOTECHNOLOGY ADVANC; Zamani A, 2010, INT J MOL SCI, V11, P2976, DOI 10.3390/ijms11082976; Zhang JL, 2010, MAR DRUGS, V8, P1962, DOI 10.3390/md8071962	27	4	4	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0134090	10.1371/journal.pone.0134090	http://dx.doi.org/10.1371/journal.pone.0134090			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275241	Green Published, Green Submitted, gold			2022-12-26	WOS:000359493600020
J	Fan, YF; Geren, IN; Dong, JB; Lou, JL; Wen, WH; Conrad, F; Smith, TJ; Smith, LA; Ho, MF; Pires-Alves, M; Wilson, BA; Marks, JD				Fan, Yongfeng; Geren, Isin N.; Dong, Jianbo; Lou, Jianlong; Wen, Weihua; Conrad, Fraser; Smith, Theresa J.; Smith, Leonard A.; Ho, Mengfei; Pires-Alves, Melissa; Wilson, Brenda A.; Marks, James D.			Monoclonal Antibodies Targeting the Alpha-Exosite of Botulinum Neurotoxin Serotype/A Inhibit Catalytic Activity	PLOS ONE			English	Article							MOTOR-NERVE TERMINALS; TOXIN TYPE-A; LIGHT-CHAIN; HEAVY-CHAIN; CLOSTRIDIAL NEUROTOXINS; MOLECULAR EVOLUTION; STRUCTURAL INSIGHT; CRYSTAL-STRUCTURE; PROTEIN-RECEPTOR; IMMUNE GLOBULIN	The paralytic disease botulism is caused by botulinum neurotoxins (BoNT), multi-domain proteins containing a zinc endopeptidase that cleaves the cognate SNARE protein, thereby blocking acetylcholine neurotransmitter release. Antitoxins currently used to treat botulism neutralize circulating BoNT but cannot enter, bind to or neutralize BoNT that has already entered the neuron. The light chain endopeptidase domain (LC) of BoNT serotype A (BoNT/A) was targeted for generation of monoclonal antibodies (mAbs) that could reverse paralysis resulting from intoxication by BoNT/A. Single-chain variable fragment (scFv) libraries from immunized humans and mice were displayed on the surface of yeast, and 19 BoNT/A LC-specific mAbs were isolated by using fluorescence-activated cell sorting (FACS). Affinities of the mAbs for BoNT/A LC ranged from a K-D value of 9.0x10(-11) M to 3.53x10(-8) M(mean K-D 5.38x10(-9) M and median K-D 1.53x10(-9) M), as determined by flow cytometry analysis. Eleven mAbs inhibited BoNT/A LC catalytic activity with IC50 values ranging from 8.3 similar to 73x10(-9) M. The fine epitopes of selected mAbs were also mapped by alanine-scanning mutagenesis, revealing that the inhibitory mAbs bound the alpha-exosite region remote from the BoNT/A LC catalytic center. The results provide mAbs that could prove useful for intracellular reversal of paralysis post-intoxication and further define epitopes that could be targeted by small molecule inhibitors.	[Fan, Yongfeng; Geren, Isin N.; Dong, Jianbo; Lou, Jianlong; Wen, Weihua; Conrad, Fraser; Marks, James D.] Univ Calif San Francisco, Dept Anesthesia, San Francisco, CA 94143 USA; [Smith, Theresa J.] US Army Med Inst Infect Dis, Mol & Translat Sci Div, Ft Detrick, MD USA; [Smith, Leonard A.] US Army Med Inst Infect Dis, Med Countermeasures Technol, US Army Med Res & Mat Command, Ft Detrick, MD USA; [Ho, Mengfei; Pires-Alves, Melissa; Wilson, Brenda A.] Univ Illinois, Dept Microbiol, Urbana, IL USA	University of California System; University of California San Francisco; United States Department of Defense; United States Army; University of Illinois System; University of Illinois Urbana-Champaign	Marks, JD (corresponding author), Univ Calif San Francisco, Dept Anesthesia, San Francisco, CA 94143 USA.	jim.marks@ucsf.edu	Ho, Mengfei/Q-6844-2019; Geren, Isin/AAG-7281-2019	Ho, Mengfei/0000-0002-8315-8158; Geren, Isin/0000-0001-7777-1450	NIH/NIAID [U01 AI056493, R21/R33 AI101504, U01 AI075502, U54 AI0571530]; DTRA [HDTRA1-07-C-0030]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101504, U01AI056493, R33AI101504, U01AI075502] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); DTRA(United States Department of DefenseDefense Threat Reduction Agency); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded in part by NIH/NIAID under Cooperative Agreement U01 AI056493 (to JDM), DTRA contract HDTRA1-07-C-0030 (to JDM), NIH/NIAID R21/R33 AI101504 (to BAW), NIH/NIAID U01 AI075502 (to BAW), and NIH/NIAID subcontract under U54 AI0571530 (to BAW). Opinions, interpretations, conclusions, and recommendations are those of the authors and not necessarily endorsed by the U.S. Army, the National Institute of Allergy and Infectious Diseases, or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekar SP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003023; Arnon SS, 2006, NEW ENGL J MED, V354, P462, DOI 10.1056/NEJMoa051926; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Barash JR, 2014, J INFECT DIS, V209, P183, DOI 10.1093/infdis/jit449; BLACK RE, 1980, AM J MED, V69, P567, DOI 10.1016/0002-9343(80)90469-6; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; BLAUSTEIN RO, 1987, FEBS LETT, V226, P115, DOI 10.1016/0014-5793(87)80562-8; Bradbury A, 2004, PHAGE ANTIBODY LIB; Breidenbach MA, 2004, NATURE, V432, P925, DOI 10.1038/nature03123; Brunger AT, 2007, PLOS PATHOG, V3, P1191, DOI 10.1371/journal.ppat.0030113; Burnett JC, 2007, J BIOL CHEM, V282, P5004, DOI 10.1074/jbc.M608166200; Chai Q, 2006, NATURE, V444, P1096, DOI 10.1038/nature05411; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Dickerson TJ, 2006, ACS CHEM BIOL, V1, P359, DOI 10.1021/cb600179d; DOLLY JO, 1984, NATURE, V307, P457, DOI 10.1038/307457a0; Dong JB, 2010, J MOL BIOL, V397, P1106, DOI 10.1016/j.jmb.2010.01.070; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Dover N, 2014, J INFECT DIS, V209, P192, DOI 10.1093/infdis/jit450; Edupuganti OP, 2012, FEBS J, V279, P2555, DOI 10.1111/j.1742-4658.2012.08638.x; Farrow B, 2015, ANGEW CHEM INT ED EN; Fischer A, 2007, P NATL ACAD SCI USA, V104, P10447, DOI 10.1073/pnas.0700046104; Fischer A, 2009, P NATL ACAD SCI USA, V106, P1330, DOI 10.1073/pnas.0812839106; FRANZ DR, 1993, BOTULINUM AND TETANUS NEUROTOXINS, P473; Garcia-Rodriguez C, 2007, NAT BIOTECHNOL, V25, P107, DOI 10.1038/nbt1269; Hall YHJ, 2004, J IMMUNOL METHODS, V288, P55, DOI 10.1016/j.jim.2004.02.011; Hayes ME, 2006, GENE THER, V13, P646, DOI 10.1038/sj.gt.3302699; Hibbs RG, 1996, CLIN INFECT DIS, V23, P337, DOI 10.1093/clinids/23.2.337; Ho MF, 2012, PROTEIN SCI, V21, P318, DOI 10.1002/pro.2017; Ho MF, 2011, PROTEIN ENG DES SEL, V24, P247, DOI 10.1093/protein/gzq093; Hu X, 2014, J COMPUT AID MOL DES, V28, P765, DOI 10.1007/s10822-014-9758-7; Jensen MJ, 2003, TOXICON, V41, P691, DOI 10.1016/S0041-0101(03)00042-4; Jin RS, 2006, NATURE, V444, P1092, DOI 10.1038/nature05387; Kalb SR, 2015, ANAL CHEM, V87, P3911, DOI 10.1021/ac504716v; KRIEGLSTEIN KG, 1994, J PROTEIN CHEM, V13, P49, DOI 10.1007/BF01891992; Lacy DB, 1999, J MOL BIOL, V291, P1091, DOI 10.1006/jmbi.1999.2945; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; Levy R, 2007, J MOL BIOL, V365, P196, DOI 10.1016/j.jmb.2006.09.084; Mahrhold S, 2006, FEBS LETT, V580, P2011, DOI 10.1016/j.febslet.2006.02.074; Marks James D, 2004, Anesthesiol Clin North Am, V22, P509, DOI 10.1016/j.atc.2004.05.010; MARKS JD, 1991, J MOL BIOL, V222, P581, DOI 10.1016/0022-2836(91)90498-U; Miethe S, 2014, MABS-AUSTIN, V6, P446, DOI 10.4161/mabs.27773; Montecucco C, 2004, TRENDS MICROBIOL, V12, P442, DOI 10.1016/j.tim.2004.08.002; Muller J, 2009, CHEM BIOL, V16, P442, DOI 10.1016/j.chembiol.2009.03.007; Nowakowski A, 2002, P NATL ACAD SCI USA, V99, P11346, DOI 10.1073/pnas.172229899; Park JG, 2006, BIOORGAN MED CHEM, V14, P395, DOI 10.1016/j.bmc.2005.08.018; Pires-Alves M, 2009, TOXICON, V53, P392, DOI 10.1016/j.toxicon.2008.12.016; Ravichandran E, 2006, J PHARMACOL EXP THER, V318, P1343, DOI 10.1124/jpet.106.104661; Razai A, 2005, J MOL BIOL, V351, P158, DOI 10.1016/j.jmb.2005.06.003; Schechter R, 2000, LANCET, V355, P237, DOI 10.1016/S0140-6736(05)72119-X; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; SCHIAVO G, 1993, FEBS LETT, V335, P99, DOI 10.1016/0014-5793(93)80448-4; Segelke B, 2004, P NATL ACAD SCI USA, V101, P6888, DOI 10.1073/pnas.0400584101; Sheets MD, 1998, P NATL ACAD SCI USA, V95, P6157, DOI 10.1073/pnas.95.11.6157; SIMPSON LL, 1980, J PHARMACOL EXP THER, V212, P16; Stenmark P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000129; Takahashi T, 2009, VACCINE, V27, P2616, DOI 10.1016/j.vaccine.2009.02.051; Wilson BA, 2014, CURR TOP MED CHEM, V14, P2081, DOI 10.2174/1568026614666141022094517; Wu Y, 2007, P NATL ACAD SCI USA, V104, P19784, DOI 10.1073/pnas.0708251104	58	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135306	10.1371/journal.pone.0135306	http://dx.doi.org/10.1371/journal.pone.0135306			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275214	Green Published, gold, Green Submitted			2022-12-26	WOS:000359493600060
J	Maeda, T; Babazono, A; Nishi, T; Yasui, M; Matsuda, S; Fushimi, K; Fujimori, K				Maeda, Toshiki; Babazono, Akira; Nishi, Takumi; Yasui, Midori; Matsuda, Shinya; Fushimi, Kiyohide; Fujimori, Kenji			The Impact of Opportunistic Infections on Clinical Outcome and Healthcare Resource Uses for Adult T Cell Leukaemia	PLOS ONE			English	Article							ORGAN TRANSPLANT RECIPIENTS; FUNGAL-INFECTION; LYMPHOMA; COMPLICATIONS; GUIDELINES; ASSOCIATION; MANAGEMENT; MORTALITY; THERAPY; SOCIETY	We examined the impact of opportunistic infections on in-hospital mortality, hospital length of stay (LOS), and the total cost (TC) among adult T-cell leukaemia (ATL) patients. In this retrospective cohort study, we identified 3712 patients with ATL using national hospital administrative data. Analysed opportunistic infections included Aspergillus spp., Candida spp., cytomegalovirus (CMV), herpes simplex virus (HSV), pneumocystis pneumonia (PCP), tuberculosis, varicella zoster virus (VZV), Cryptococcus spp., nontuberculous mycobacteria, and Strongyloides spp. Multilevel logistic regression analysis for in-hospital mortality and a multilevel linear regression analysis for LOS and TC were employed to determine the impact of opportunistic infections on clinical outcomes and healthcare resources. We found ATL patients infected with CMV had significantly higher in-hospital mortality (adjusted odds ratio (AOR) 2.29 [1.50-3.49] p < 0.001), longer LOS (coefficient (B): 0.13 [0.06-0.20] p < 0.001) and higher TC (B: 0.25 [0.17-0.32] p < 0.001) than those without CMV. Those with CAN and PCP were associated with a lower in-hospital mortality rate (AOR 0.72 [0.53-0.98] p = 0.035 and 0.54[0.41-0.73] p < 0.001, respectively) than their infections. VZV was associated with longer LOS (B: 0.13 [0.06-0.19] p < 0.001), while aspergillosis, HSV, or VZV infections were associated with higher TC (B: 0.16 [0.07-0.24] p < 0.001, 0.12 [0.02-0.23] p = 0.025, and 0.17 [0.10-0.24] p < 0.001, respectively). Our findings reveal that CMV infection is a major determinant of poor prognosis in patients affected by ATL.	[Maeda, Toshiki; Babazono, Akira; Nishi, Takumi; Yasui, Midori] Kyushu Univ, Dept Healthcare Adm & Management, Grad Sch Healthcare Sci, Fukuoka 812, Japan; [Matsuda, Shinya] Univ Occupat & Environm Hlth, Dept Prevent Med & Community Hlth, Fukuoka, Japan; Tokyo Med & Dent Univ, Dept Hlth Policy & Informat, Grad Sch Med, Tokyo, Japan; [Fujimori, Kenji] Tohoku Univ, Dept Hlth Adm & Policy, Sendai, Miyagi 980, Japan	Kyushu University; University of Occupational & Environmental Health - Japan; Tokyo Medical & Dental University (TMDU)	Maeda, T (corresponding author), Kyushu Univ, Dept Healthcare Adm & Management, Grad Sch Healthcare Sci, Fukuoka 812, Japan.	toshikimaeda1216@gmail.com		Matsuda, Shinya/0000-0002-8472-8909; Nishi, Takumi/0000-0003-2560-6765				Abbott K C, 2001, Transpl Infect Dis, V3, P203, DOI 10.1034/j.1399-3062.2001.30404.x; Fishman JA, 1998, NEW ENGL J MED, V338, P1741, DOI 10.1056/NEJM199806113382407; Fujiwara H, 2000, J MED VIROL, V62, P140, DOI 10.1002/1096-9071(200010)62:2&lt;140::AID-JMV3&gt;3.0.CO;2-X; FUNAI N, 1995, ACTA HAEMATOL-BASEL, V93, P25; GILL PS, 1995, NEW ENGL J MED, V332, P1744, DOI 10.1056/NEJM199506293322603; Gourishankar S, 2004, AM J TRANSPLANT, V4, P108, DOI 10.1046/j.1600-6143.2003.00287.x; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hishizawa M, 2010, BLOOD, V116, P1369, DOI 10.1182/blood-2009-10-247510; Itonaga H, 2013, BIOL BLOOD MARROW TR, V19, P607, DOI 10.1016/j.bbmt.2013.01.011; Katsuya H, 2012, J CLIN ONCOL, V30, P1635, DOI 10.1200/JCO.2011.38.2101; Khera N, 2012, BLOOD, V120, P1545, DOI 10.1182/blood-2012-05-426783; Kuwabara K, 2008, HEALTH POLICY, V85, P196, DOI 10.1016/j.healthpol.2007.07.015; Lee SJ, 2000, J CLIN ONCOL, V18, P64, DOI 10.1200/JCO.2000.18.1.64; Lindenauer PK, 2005, NEW ENGL J MED, V353, P349, DOI 10.1056/NEJMoa041895; Maeda T, 2014, BRIT J HAEMATOL, P1; Masaki A, 2013, J IMMUNOL, V191, P135, DOI 10.4049/jimmunol.1202692; Matsuda S., 2008, Eurohealth, V14, P25; Matsuda S., 2007, JPN J SOC SEC POLICY, V6, P43; Matsuoka M, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-27; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; Ministerio de Sanidad, 2014, PLAN DESC ATM ESTR 2, P1; Nichols WG, 2002, J INFECT DIS, V185, P273, DOI 10.1086/338624; Pappas PG, 2010, CLIN INFECT DIS, V50, P1101, DOI 10.1086/651262; Penack O, 2011, ANN ONCOL, V22, P1019, DOI 10.1093/annonc/mdq442; Pergam SA, 2009, AM J TRANSPLANT, V9, pS108, DOI 10.1111/j.1600-6143.2009.02901.x; Rabkin JM, 2000, AM J SURG, V179, P426, DOI 10.1016/S0002-9610(00)00366-4; SHIMOYAMA M, 1991, BRIT J HAEMATOL, V79, P428, DOI 10.1111/j.1365-2141.1991.tb08051.x; SHIMOYAMA M, 1991, LEUKEMIA RES, V15, P81; Stocchi R, 1999, HAEMATOLOGICA, V84, P71; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; SUZUMIYA J, 1993, LEUKEMIA LYMPHOMA, V11, P281, DOI 10.3109/10428199309087005; Svahn BM, 2012, BONE MARROW TRANSPL, V47, P706, DOI 10.1038/bmt.2011.162; Tomblyn M, 2009, BIOL BLOOD MARROW TR, V15, P1143, DOI 10.1016/j.bbmt.2009.06.019; Tsukasaki K, 2007, J CLIN ONCOL, V25, P5458, DOI 10.1200/JCO.2007.11.9958; Tsukasaki K, 2009, J CLIN ONCOL, V27, P453, DOI 10.1200/JCO.2008.18.2428; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Wang EHZ, 2012, TRANSPL INFECT DIS, V14, P519, DOI 10.1111/j.1399-3062.2012.00740.x	37	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135042	10.1371/journal.pone.0135042	http://dx.doi.org/10.1371/journal.pone.0135042			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274925	Green Published, Green Submitted, gold			2022-12-26	WOS:000359493600047
J	Tasiou, V; Hiber, M; Steenpass, L				Tasiou, Vasiliki; Hiber, Michaela; Steenpass, Laura			A Mouse Model for Imprinting of the Human Retinoblastoma Gene	PLOS ONE			English	Article							DE-NOVO METHYLATION; CPG ISLANDS; EVOLUTION; IDENTIFICATION; ORIGIN; TRANSCRIPTION; ACQUISITION; EXPRESSION; REVEALS; DEFENSE	The human RB1 gene is imprinted due to integration of the PPP1R26P1 pseudogene into intron 2. PPP1R26P1 harbors the gametic differentially methylated region of the RB1 gene, CpG85, which is methylated in the female germ line. The paternally unmethylated CpG85 acts as promoter for the alternative transcript 2B of RB1, which interferes with expression of full-length RB1 in cis. In mice, PPP1R26P1 is not present in the Rb1 gene and Rb1 is not imprinted. Assuming that the mechanisms responsible for genomic imprinting are conserved, we investigated if imprinting of mouse Rb1 can be induced by transferring human PPP1R26P1 into mouse Rb1. We generated humanized Rb1_PPP1R26P1 knock-in mice that pass human PPP1R26P1 through the mouse germ line. We found that the function of unmethylated CpG85 as promoter for an alternative Rb1 transcript and as cis-repressor of the main Rb1 transcript is maintained in mouse tissues. However, CpG85 is not recognized as a gametic differentially methylated region in the mouse germ line. DNA methylation at CpG85 is acquired only in tissues of neuroectodermal origin, independent of parental transmission of PPP1R26P1. Absence of CpG85 methylation in oocytes and sperm implies a failure of imprint methylation establishment in the germ line. Our results indicate that site-specific integration of a proven human gametic differentially methylated region is not sufficient for acquisition of DNA methylation in the mouse germ line, even if promoter function of the element is maintained. This suggests a considerable dependency of DNA methylation induction on the surrounding sequence. However, our model is suited to determine the cellular function of the alternative Rb1 transcript.	[Tasiou, Vasiliki; Hiber, Michaela; Steenpass, Laura] Univ Duisburg Essen, Univ Hosp Essen, Inst Human Genet, Essen, Germany	University of Duisburg Essen	Steenpass, L (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Inst Human Genet, Essen, Germany.	laura.steenpass@uni-due.de			Deutsche Forschungsgemeinschaft [STE1987/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	LS received funding for this study from the Deutsche Forschungsgemeinschaft, grant number STE1987/4-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anwar SL, 2014, J PATHOL, V233, P392, DOI 10.1002/path.4376; Babak T, 2008, CURR BIOL, V18, P1735, DOI 10.1016/j.cub.2008.09.044; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Barlow DP, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018382; BARLOW DP, 1993, SCIENCE, V260, P309, DOI 10.1126/science.8469984; Baubec T, 2015, NATURE, V520, P243, DOI 10.1038/nature14176; Benavente CA, 2015, ANNU REV PATHOL-MECH, V10, P547, DOI 10.1146/annurev-pathol-012414-040259; Beygo J, 2011, MOL SYNDROMOL, V2, P53, DOI 10.1159/000335545; CHAILLET JR, 1994, MUTAT RES, V307, P441, DOI 10.1016/0027-5107(94)90255-0; Choi JD, 2005, MOL CELL BIOL, V25, P5514, DOI 10.1128/MCB.25.13.5514-5522.2005; Chotalia M, 2009, GENE DEV, V23, P105, DOI 10.1101/gad.495809; Ciccone DN, 2009, NATURE, V461, P415, DOI 10.1038/nature08315; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; Court F, 2014, GENOME RES, V24, P554, DOI 10.1101/gr.164913.113; Cowley M, 2010, BRIEF FUNCT GENOMICS, V9, P340, DOI 10.1093/bfgp/elq015; Deininger PL, 2002, GENOME RES, V12, P1455, DOI 10.1101/gr.282402; Dhayalan A, 2010, J BIOL CHEM, V285, P26114, DOI 10.1074/jbc.M109.089433; Edwards CA, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-157; Hanna CW, 2014, HEREDITY, V113, P176, DOI 10.1038/hdy.2014.54; Henckel A, 2012, EMBO J, V31, P606, DOI 10.1038/emboj.2011.425; Illingworth RS, 2009, FEBS LETT, V583, P1713, DOI 10.1016/j.febslet.2009.04.012; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Kanber D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081502; Kanber D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000790; KELSEY G, 2013, BIOL SCI, V368, P10336, DOI DOI 10.1098/RSTB.2011.0336; Kuehnen P, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002543; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; Lewis MW, 2015, P NATL ACAD SCI USA, V112, P6871, DOI 10.1073/pnas.1411261111; Lonfat N, 2013, P NATL ACAD SCI USA, V110, P11946, DOI 10.1073/pnas.1310704110; Markel P, 1997, NAT GENET, V17, P280, DOI 10.1038/ng1197-280; Matzke MA, 2000, PLANT MOL BIOL, V43, P401, DOI 10.1023/A:1006484806925; McCole RB, 2008, EPIGENETICS-US, V3, P258, DOI 10.4161/epi.3.5.7052; McDonald JF, 2005, CYTOGENET GENOME RES, V110, P242, DOI 10.1159/000084958; Nabetani A, 1997, MOL CELL BIOL, V17, P789, DOI 10.1128/MCB.17.2.789; Ohshima K, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-r74; Okae H, 2012, HUM MOL GENET, V21, P548, DOI 10.1093/hmg/ddr488; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Peters J, 2014, NAT REV GENET, V15, P517, DOI 10.1038/nrg3766; Proudhon C, 2012, MOL CELL, V47, P909, DOI 10.1016/j.molcel.2012.07.010; Rademacher K, 2014, GENOME BIOL EVOL, V6, P1579, DOI 10.1093/gbe/evu125; Rahmann S, 2013, PEER J PREPRINTS, DOI [10.7287/peerj.preprints.122v2, DOI 10.7287/PEERJ.PREPRINTS.122V2]; Regha K, 2006, CYTOGENET GENOME RES, V113, P165, DOI 10.1159/000090829; RUBIN CM, 1994, NUCLEIC ACIDS RES, V22, P5121, DOI 10.1093/nar/22.23.5121; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schulz R, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl461; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Smith EY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002422; Smith RJ, 2003, GENOME RES, V13, P558, DOI 10.1101/gr.781503; Steenpass L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074159; Suzuki S, 2011, GENOME BIOL EVOL, V3, P1276, DOI 10.1093/gbe/evr104; Wang L, 2014, CELL, V157, P979, DOI 10.1016/j.cell.2014.04.017; Wood AJ, 2007, PLOS GENET, V3, P192, DOI 10.1371/journal.pgen.0030020; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Zhang JK, 2004, CELL CYCLE, V3, P952; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	57	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0134672	10.1371/journal.pone.0134672	http://dx.doi.org/10.1371/journal.pone.0134672			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275142	Green Submitted, Green Published, gold			2022-12-26	WOS:000359493600039
J	Balzano, D; Fawal, MA; Velazquez, JV; Santiveri, CM; Yang, J; Pastor, J; Campos-Olivas, R; Djouder, N; Lietha, D				Balzano, Deborah; Fawal, Mohannad-Ali; Velazquez, Jose V.; Santiveri, Clara M.; Yang, Joshua; Pastor, Joaquin; Campos-Olivas, Ramon; Djouder, Nabil; Lietha, Daniel			Alternative Activation Mechanisms of Protein Kinase B Trigger Distinct Downstream Signaling Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; HYDROPHOBIC MOTIF PHOSPHORYLATION; FOCAL ADHESION KINASE; RICTOR-MTOR COMPLEX; PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE; BINDING POCKET; DNA-PK; AKT; PDK1; INHIBITOR	Protein kinase B (PKB/Akt) is an important mediator of signals that control various cellular processes including cell survival, growth, proliferation, and metabolism. PKB promotes these processes by phosphorylating many cellular targets, which trigger distinct downstream signaling events. However, how PKB is able to selectively target its substrates to induce specific cellular functions remains elusive. Here we perform a systematic study to dissect mechanisms that regulate intrinsic kinase activity versus mechanisms that specifically regulate activity toward specific substrates. We demonstrate that activation loop phosphorylation and the C-terminal hydrophobic motif are essential for high PKB activity in general. On the other hand, we identify membrane targeting, which for decades has been regarded as an essential step in PKB activation, as a mechanism mainly affecting substrate selectivity. Further, we show that PKB activity in cells can be triggered independently of PI3K by initial hydrophobic motif phosphorylation, presumably through a mechanism analogous to other AGC kinases. Importantly, different modes of PKB activation result in phosphorylation of distinct downstream targets. Our data indicate that specific mechanisms have evolved for signaling nodes, like PKB, to select between various downstream events. Targeting such mechanisms selectively could facilitate the development of therapeutics that might limit toxic side effects.	[Balzano, Deborah; Velazquez, Jose V.; Yang, Joshua; Lietha, Daniel] Spanish Natl Canc Res Ctr, Struct Biol & Biocomp Programme, Cell Signalling & Adhes Grp, E-28029 Madrid, Spain; [Fawal, Mohannad-Ali; Djouder, Nabil] Spanish Natl Canc Res Ctr, Canc Cell Biol Programme, Growth Factors Nutrients & Cancer Grp, E-28029 Madrid, Spain; [Santiveri, Clara M.; Campos-Olivas, Ramon] Spanish Natl Canc Res Ctr, Struct Biol & Biocomp Programme, Spect & Nucl Magnet Resonance Unit, E-28029 Madrid, Spain; [Pastor, Joaquin] Spanish Natl Canc Res Ctr, Expt Therapeut Programme, E-28029 Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO)	Lietha, D (corresponding author), Spanish Natl Canc Res Ctr, Struct Biol & Biocomp Programme, Cell Signalling & Adhes Grp, Calle Melchor Fernandez Almagro 3, E-28029 Madrid, Spain.	dlietha@cnio.es	Djouder, Nabil/E-4135-2015; Lietha, Daniel/L-8041-2014; Yang, Joshua Young Cynming/P-6447-2018; Lietha, Daniel/AAD-1952-2022; Campos-Olivas, Ramón/L-9173-2014; Fernandez, Joaquin Pastor/I-4567-2015	Djouder, Nabil/0000-0001-8423-1030; Lietha, Daniel/0000-0002-6133-6486; Yang, Joshua Young Cynming/0000-0003-2410-7817; Lietha, Daniel/0000-0002-6133-6486; Campos-Olivas, Ramón/0000-0002-5743-2221; Fernandez, Joaquin Pastor/0000-0003-0553-8021; Santiveri, Clara M./0000-0001-6095-7224; FAWAL, Mohamad-Ali/0000-0002-2460-0882	Spanish Ministry of Economy and Competitiveness [BFU2010-15923, SAF2010-18518]; Comunidad Autonoma de Madrid [S2010/BMD-2457]; National Cancer Research Centre; La Caixa Foundation; Caja Navara postdoctoral fellowship; Sever Ochoa funds; Spanish Ramon y Cajal fellowship; Ramon y Cajal Program [RYC-2010-06948]; Volkswagen Foundation [Az: 86 416-1]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Comunidad Autonoma de Madrid(Comunidad de Madrid); National Cancer Research Centre; La Caixa Foundation(La Caixa Foundation); Caja Navara postdoctoral fellowship; Sever Ochoa funds; Spanish Ramon y Cajal fellowship(Spanish Government); Ramon y Cajal Program(Spanish Government); Volkswagen Foundation(Volkswagen)	This work was supported by Spanish Ministry of Economy and Competitiveness Grants BFU2010-15923 (to D. L) and SAF2010-18518 (to N. D.), Comunidad Autonoma de Madrid Grant S2010/BMD-2457 (to D. L and R. C.-O.), and by the National Cancer Research Centre. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by an international Ph.D. fellowship from the La Caixa Foundation.; Supported by a Caja Navara postdoctoral fellowship and by Sever Ochoa funds.; Recipient of the Spanish Ramon y Cajal fellowship.; Recipient of Ramon y Cajal Program Award RYC-2010-06948 and Volkswagen Foundation Award Az: 86 416-1. To whom correspondence should be addressed: Cell Signalling and Adhesion Group, Structural Biology and Rio computing Programme, Spanish National Cancer Research Centre, Calle Melchor Fernandez Almagro, 3, E-28029, Madrid, Spain. Tel.: 34-917-328-000, Ext. 3090; Fax: 34-912-246-976; E-mail: dlietha@cnio.es.	Alessi DR, 1997, CURR BIOL, V7, P776, DOI 10.1016/S0960-9822(06)00336-8; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Ananthanarayanan B, 2007, J BIOL CHEM, V282, P36634, DOI 10.1074/jbc.M706227200; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Bayascas JR, 2008, MOL CELL BIOL, V28, P3258, DOI 10.1128/MCB.02032-07; Bayascas JR, 2006, J BIOL CHEM, V281, P28772, DOI 10.1074/jbc.M606789200; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Bozulic L, 2008, MOL CELL, V30, P203, DOI 10.1016/j.molcel.2008.02.024; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Cai XM, 2008, MOL CELL BIOL, V28, P201, DOI 10.1128/MCB.01324-07; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; Cheung M, 2013, CURR CANCER DRUG TAR, V13, P234, DOI 10.2174/1568009611313030002; Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575; Dummler B, 2007, BIOCHEM SOC T, V35, P231, DOI 10.1042/BST0350231; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Frodin M, 2002, EMBO J, V21, P5396, DOI 10.1093/emboj/cdf551; Gan XQ, 2011, J BIOL CHEM, V286, P10998, DOI 10.1074/jbc.M110.195016; Granda TG, 2013, INVEST NEW DRUG, V31, P66, DOI 10.1007/s10637-012-9835-5; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; Kohn AD, 1996, J BIOL CHEM, V271, P21920, DOI 10.1074/jbc.271.36.21920; KOHN AD, 1995, EMBO J, V14, P4288, DOI 10.1002/j.1460-2075.1995.tb00103.x; Kunkel MT, 2005, J BIOL CHEM, V280, P5581, DOI 10.1074/jbc.M411534200; Leahy JJJ, 2004, BIOORG MED CHEM LETT, V14, P6083, DOI 10.1016/j.bmcl.2004.09.060; Lietha D, 2007, CELL, V129, P1177, DOI 10.1016/j.cell.2007.05.041; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Gonzalez SM, 2012, BIOORG MED CHEM LETT, V22, P3460, DOI 10.1016/j.bmcl.2012.03.090; Milburn CC, 2003, BIOCHEM J, V375, P531, DOI 10.1042/BJ20031229; Najafov A, 2012, BIOCHEM J, V448, P285, DOI 10.1042/BJ20121287; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Waugh C, 2009, MOL CELL BIOL, V29, P5952, DOI 10.1128/MCB.00585-09; Wu WI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012913; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Yang ZZ, 2004, BIOCHEM SOC T, V32, P350, DOI 10.1042/BST0320350; Zhou XY, 2014, CELL CYCLE, V13, P3164, DOI 10.4161/15384101.2014.962954; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014; Zurashvili T, 2013, MOL CELL BIOL, V33, P1027, DOI 10.1128/MCB.01052-12	42	12	14	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					24975	24985		10.1074/jbc.M115.651570	http://dx.doi.org/10.1074/jbc.M115.651570			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26286748	Green Published, hybrid			2022-12-26	WOS:000362598300028
J	Hwang, MH; Li, XJ; Kim, JE; Jeong, SY; Lee, SW; Lee, J; Ahn, BC				Hwang, Mi-Hye; Li, Xiu Juan; Kim, Jung Eun; Jeong, Shin Young; Lee, Sang-Woo; Lee, Jaetae; Ahn, Byeong-Cheol			Potential Therapeutic Effect of Natural Killer Cells on Doxorubicin-Resistant Breast Cancer Cells In Vitro	PLOS ONE			English	Article							NK CELLS; CELLULAR IMMUNOTHERAPY; LINE; LEUKOCYTES; THERAPIES; OVARIAN	Objective The aim of this study was to explore the therapeutic effect of natural killer (NK) cells on human doxorubicin-sensitive and resistant breast adenocarcinoma. Methods Human doxorubicin-sensitive and resistant breast cancer cell lines (MCF-7 and MCF-7/ADR) were tagged with renilla luciferase (Rluc) (MCF-7/RC and MCF-7/ADR/RC). NK cells were tagged with enhanced firefly luciferase (effluc) using a recombinant retrovirus transfection (NKF). Expression of Rluc, effluc, and NK cell surface markers CD16, CD56 as well as death receptors, DR4 and DR5, were assessed by using flow cytometry. In vitro cytotoxic effect of NK to MCF-7 and MCF-7/ADR was measured and in vivo bioluminescence imaging was also performed to visualize MCF-7/RC, MCF-7/ADR, and NKF in an animal model. Results NK92-MI, MCF-7, and MCF-7/ADR cells were successfully labeled with Rluc or effluc. Both the target breast cancer cells (with Rluc) and therapeutic NK cells (with effluc) were noninvasively visualized in nude mice. Doxorubicin-resistant breast cancer cells (MCF-7/ADR) presented a higher expression of DR5 and were more sensitive to NK cells compared with doxorubicin-sensitive breast cancer cells (MCF-7). Conclusion The results of present study suggest that NK cell therapy has a therapeutic effect on doxorubicin-sensitive and resistant breast cancer cells.	[Hwang, Mi-Hye; Li, Xiu Juan; Kim, Jung Eun; Jeong, Shin Young; Lee, Sang-Woo; Lee, Jaetae; Ahn, Byeong-Cheol] Kyungpook Natl Univ, Sch Med, Dept Nucl Med, Daegu, South Korea	Kyungpook National University	Ahn, BC (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Nucl Med, Daegu, South Korea.	abc2000@knu.ac.kr	Lee, Jaetae/ABF-3980-2020; Lee, Jaetae/AAR-3317-2021; li, xiu/GXV-1745-2022		Medical Cluster R & D Support Project through the Daegu-Gyengbuk Medical Innovation Foundation (DGMIF) - Ministry of Health & Welfare, Republic of Korea [HT13C0002]; National Nuclear R&D Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012M2A2A7014020, NRF-2009-0078234]; Korea Healthcare Technology R & D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [A111345]	Medical Cluster R & D Support Project through the Daegu-Gyengbuk Medical Innovation Foundation (DGMIF) - Ministry of Health & Welfare, Republic of Korea; National Nuclear R&D Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; Korea Healthcare Technology R & D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea	This research was supported by a grant from the Medical Cluster R & D Support Project through the Daegu-Gyengbuk Medical Innovation Foundation (DGMIF: http://www.dgmif.re.kr/main.htm), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HT13C0002), BCA received the funding. Grants from the National Nuclear R&D Program through the National Research Foundation of Korea (NRF: www.nrf.re.kr) funded by the Ministry of Education, Science and Technology (No. 2012M2A2A7014020, NRF-2009-0078234), JL received the funding. Grants from the Korea Healthcare Technology R & D Project, Ministry for Health, Welfare & Family Affairs (www.mw.go.kr), Republic of Korea (A111345), SWL received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachanova V, 2010, CANCER IMMUNOL IMMUN, V59, P1739, DOI 10.1007/s00262-010-0896-z; Cao X., 2014, MOL PHARM; El-Gazzar A, 2010, MOL CANCER THER, V9, P1007, DOI 10.1158/1535-7163.MCT-09-0933; Eun Kim Jung, 2014, NUCL MED MOL IMAGING, DOI [10.1007/s13139-014-0309-x, DOI 10.1007/S13139-014-0309-X]; Gambhir SS, 1999, P NATL ACAD SCI USA, V96, P2333, DOI 10.1073/pnas.96.5.2333; Geller MA, 2011, CYTOTHERAPY, V13, P98, DOI 10.3109/14653249.2010.515582; Germano S, 2009, CURR CANCER DRUG TAR, V9, P398, DOI 10.2174/156800909788166529; Herberman RB, 2012, NATURAL CELL MEDIATE; Hoffman RM, 2006, NAT PROTOC, V1, P928, DOI 10.1038/nprot.2006.119; Kim HW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070194; Kim JA, 2008, CANCER LETT, V268, P225, DOI 10.1016/j.canlet.2008.03.050; Lanier LL, 2008, NAT REV IMMUNOL, V8, P259, DOI 10.1038/nri2276; Mitchell MJ, 2015, EXPERT OPIN DRUG DEL, V12, P375, DOI 10.1517/17425247.2015.966684; Mitchell MJ, 2014, P NATL ACAD SCI USA, V111, P930, DOI 10.1073/pnas.1316312111; Pachynski RK, 2012, J EXP MED, V209, P1427, DOI 10.1084/jem.20112124; Rehemtulla A, 2000, NEOPLASIA, V2, P491, DOI 10.1038/sj.neo.7900121; Roberti MP, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00375; Screpanti V, 2005, MOL IMMUNOL, V42, P495, DOI 10.1016/j.molimm.2004.07.033; Takeda K, 2007, ONCOGENE, V26, P3745, DOI 10.1038/sj.onc.1210374; Tam YK, 1999, HUM GENE THER, V10, P1359, DOI 10.1089/10430349950018030; TAYLOR CW, 1991, BRIT J CANCER, V63, P923, DOI 10.1038/bjc.1991.202; Terme M, 2008, NAT IMMUNOL, V9, P486, DOI 10.1038/ni1580; Tonn T, 2001, J HEMATOTH STEM CELL, V10, P535, DOI 10.1089/15258160152509145; Trapani JA, 2002, NAT REV IMMUNOL, V2, P735, DOI 10.1038/nri911; Yan Y, 1998, CLIN CANCER RES, V4, P2859; Yu P, 2014, ACTA BIOMATER; Zamai L, 2007, J IMMUNOL, V178, P4011, DOI 10.4049/jimmunol.178.7.4011	27	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136209	10.1371/journal.pone.0136209	http://dx.doi.org/10.1371/journal.pone.0136209			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295571	Green Submitted, Green Published, gold			2022-12-26	WOS:000359926900082
J	Lacraz, G; Rouleau, AJ; Couture, V; Sollrald, T; Drouin, G; Veillette, N; Grandbois, M; Grenier, G				Lacraz, Gregory; Rouleau, Andre-Jean; Couture, Vanessa; Soellrald, Thomas; Drouin, Genevieve; Veillette, Noemie; Grandbois, Michel; Grenier, Guillaume			Increased Stiffness in Aged Skeletal Muscle Impairs Muscle Progenitor Cell Proliferative Activity	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; STEM-CELL; SATELLITE CELL; EXTRACELLULAR-MATRIX; SELF-RENEWAL; REVERSIBLE QUIESCENCE; CONNECTIVE-TISSUE; ADULT MYOGENESIS; NICHE; REGENERATION	Background Skeletal muscle aging is associated with a decreased regenerative potential due to the loss of function of endogenous stem cells or myogenic progenitor cells (MPCs). Aged skeletal muscle is characterized by the deposition of extracellular matrix (ECM), which in turn influences the biomechanical properties of myofibers by increasing their stiffness. Since the stiffness of the MPC microenvironment directly impacts MPC function, we hypothesized that the increase in muscle stiffness that occurs with aging impairs the behavior of MPCs, ultimately leading to a decrease in regenerative potential. Results We showed that freshly isolated individual myofibers from aged mouse muscles contain fewer MPCs overall than myofibers from adult muscles, with fewer quiescent MPCs and more proliferative and differentiating MPCs. We observed alterations in cultured MPC behavior in aged animals, where the proliferation and differentiation of MPCs were lower and higher, respectively. These alterations were not linked to the intrinsic properties of aged myofibers, as shown by the similar values for the cumulative population-doubling values and fusion indexes. However, atomic force microscopy (AFM) indentation experiments revealed a nearly 4-fold increase in the stiffness of the MPC microenvironment. We further showed that the increase in stiffness is associated with alterations to muscle ECM, including the accumulation of collagen, which was correlated with higher hydroxyproline and advanced glycation end-product content. Lastly, we recapitulated the impaired MPC behavior observed in aging using a hydrogel substrate that mimics the stiffness of myofibers. Conclusions These findings provide novel evidence that the low regenerative potential of aged skeletal muscle is independent of intrinsic MPC properties but is related to the increase in the stiffness of the MPC microenvironment.	[Lacraz, Gregory; Rouleau, Andre-Jean; Couture, Vanessa; Drouin, Genevieve; Veillette, Noemie; Grandbois, Michel; Grenier, Guillaume] Univ Sherbrooke, CRCHUS, Sherbrooke, PQ J1K 2R1, Canada; [Soellrald, Thomas] Univ Sherbrooke, Fac Engn, Dept Elect & Comp Engn, Sherbrooke, PQ J1K 2R1, Canada; [Grandbois, Michel] Univ Sherbrooke, Fac Med, Dept Pharmacol, Sherbrooke, PQ J1H 5N4, Canada; [Grenier, Guillaume] Univ Sherbrooke, Fac Med, Dept Orthoped Surg, Sherbrooke, PQ, Canada	University of Sherbrooke; University of Sherbrooke; University of Sherbrooke; University of Sherbrooke	Grenier, G (corresponding author), Univ Sherbrooke, CRCHUS, Sherbrooke, PQ J1K 2R1, Canada.	guillaume.grenier@usherbrooke.ca			Canadian Institutes of Health Research (CIHR) [MOP - 110966]; Canada Foundation for Innovation (CFI); Fonds de Recherche Quebec-Sante (FRQS); CIHR; FRQS	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Fonds de Recherche Quebec-Sante (FRQS); CIHR(Canadian Institutes of Health Research (CIHR)); FRQS	This work was supported by grants from the Canadian Institutes of Health Research (CIHR, http://www.cihr-irsc.gc.ca/) (MOP - 110966), the Canada Foundation for Innovation (CFI), and the Fonds de Recherche Quebec-Sante (FRQS). GL received a scholarship from CIHR. GG received a New Investigator Award from FRQS.	ALNAQEEB MA, 1984, J ANAT, V139, P677; Bentzinger CF, 2014, NAT MED, V20, P234, DOI 10.1038/nm.3499; BILODEAU GG, 1992, J APPL MECH-T ASME, V59, P519, DOI 10.1115/1.2893754; Boirie Y, 2009, J NUTR HEALTH AGING, V13, P717, DOI 10.1007/s12603-009-0203-x; Boonen KJM, 2009, AM J PHYSIOL-CELL PH, V296, pC1338, DOI 10.1152/ajpcell.00015.2009; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Calve S, 2010, DEV BIOL, V344, P259, DOI 10.1016/j.ydbio.2010.05.007; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Cornelison DDW, 2004, GENE DEV, V18, P2231, DOI 10.1101/gad.1214204; Cosgrove BD, 2009, DIFFERENTIATION, V78, P185, DOI 10.1016/j.diff.2009.08.004; Cretu Alexandra, 2010, J Vis Exp, DOI 10.3791/2089; Crick SL, 2007, BIOMECH MODEL MECHAN, V6, P199, DOI 10.1007/S10237-006-0046-x; Cuerrier CM, 2009, PFLUG ARCH EUR J PHY, V457, P1361, DOI 10.1007/s00424-008-0596-0; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; EDWARDS CA, 1980, CLIN CHIM ACTA, V104, P161, DOI 10.1016/0009-8981(80)90192-8; Garcia-Prat L, 2013, FEBS J, V280, P4051, DOI 10.1111/febs.12221; Gattazzo F, 2014, BBA-GEN SUBJECTS, V1840, P2506, DOI 10.1016/j.bbagen.2014.01.010; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Gosselin LE, 1998, J APPL PHYSIOL, V85, P1011; Grenier G, 2003, IN VITRO CELL DEV-AN, V39, P131; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Haus JM, 2007, J APPL PHYSIOL, V103, P2068, DOI 10.1152/japplphysiol.00670.2007; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013; Liu L, 2011, J CELL BIOL, V193, P257, DOI 10.1083/jcb.201010131; Mann CJ, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-21; Meregalli M, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00048; Meyer GA, 2011, J BIOMECH, V44, P771, DOI 10.1016/j.jbiomech.2010.10.044; Motohashi N, 2014, FRONTIERS CELL DEV B, V2; NEUMAN RE, 1950, J BIOL CHEM, V186, P549; Olguin HC, 2007, J CELL BIOL, V177, P769, DOI 10.1083/jcb.200608122; Pisconti A, 2010, J CELL BIOL, V190, P427, DOI 10.1083/jcb.201003081; Prado LG, 2005, J GEN PHYSIOL, V126, P461, DOI 10.1085/jgp.200509364; ROWE RWD, 1981, TISSUE CELL, V13, P681, DOI 10.1016/S0040-8166(81)80005-5; Scime A, 2010, MECH AGEING DEV, V131, P9, DOI 10.1016/j.mad.2009.11.001; Serrano AL, 2011, CURR TOP DEV BIOL, V96, P167, DOI 10.1016/B978-0-12-385940-2.00007-3; Shea KL, 2010, CELL STEM CELL, V6, P117, DOI 10.1016/j.stem.2009.12.015; Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013; Trensz F, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0030-1; Trensz F, 2011, STEM CELLS BIOL REG, P197, DOI 10.1007/978-1-61779-322-6_10; Trensz F, 2010, AM J PHYSIOL-CELL PH, V299, pC939, DOI 10.1152/ajpcell.00253.2010; Tse J.R., 2010, CURR PROTOC CELL BIO, V10, pUnit, DOI [DOI 10.1002/0471143030.CB1016S47, 10.1002/0471143030.cb1016s47]; Wen JH, 2014, NAT MATER, V13, P979, DOI [10.1038/NMAT4051, 10.1038/nmat4051]; Wood LK, 2014, J APPL PHYSIOL, V117, P363, DOI 10.1152/japplphysiol.00256.2014; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	47	77	80	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136217	10.1371/journal.pone.0136217	http://dx.doi.org/10.1371/journal.pone.0136217			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295702	gold, Green Published			2022-12-26	WOS:000359926900083
J	Manley, R; Harrup, LE; Veronesi, E; Stubbins, F; Stoner, J; Gubbins, S; Wilson, A; Batten, C; Koenraadt, CJM; Henstock, M; Barber, J; Carpenter, S				Manley, Robyn; Harrup, Lara E.; Veronesi, Eva; Stubbins, Francesca; Stoner, Jo; Gubbins, Simon; Wilson, Anthony; Batten, Carrie; Koenraadt, Constantianus J. M.; Henstock, Mark; Barber, James; Carpenter, Simon			Testing of UK Populations of Culex pipiens L. for Schmallenberg Virus Vector Competence and Their Colonization	PLOS ONE			English	Article							WEST-NILE-VIRUS; COMPLEX; TRANSMISSION; MOSQUITOS; DIPTERA; IDENTIFICATION; ARBOVIRUSES; CULICIDAE; OUTBREAK; EUROPE	Background Schmallenberg virus (SBV), an arboviral pathogen of ruminants, emerged in northern Europe during 2011 and has subsequently spread across a vast geographic area. While Culicoides biting midges (Diptera: Ceratopogonidae) have been identified as a biological transmission agent of SBV, the role of mosquitoes (Diptera: Culicidae) as potential vectors has not been defined beyond small-scale field collections in affected areas. Culex pipiens L. are one of the most widespread mosquitoes in northern Europe; they are present on farms across the region and have previously been implicated as vectors of several other arboviruses. We assessed the ability of three colony lines of Cx. pipiens, originating from geographically diverse field populations, to become fully infected by SBV using semi-quantitative real-time RT-PCR (sqPCR). Findings Two colony lines of Cx. pipiens were created in the UK ('Brookwood' and 'Caldbeck') from field collections of larvae and pupae and characterised using genetic markers. A third strain of Cx. pipiens from CVI Wageningen, The Netherlands, was also screened during experiments. Intrathoracic inoculation of the Brookwood line resulted in infections after 14 days that were characterised by high levels of RNA throughout individuals, but which demonstrated indirect evidence of salivary gland barriers. Feeding of 322 individuals across the three colony lines on a membrane based infection system resulted in no evidence of full dissemination of SBV, although infections did occur in a small proportion of Cx. pipiens from each line. Conclusions/Significance This study established two novel lines of Cx. pipiens mosquitoes of UK origin in the laboratory and subsequently tested their competence for SBV. Schmallenberg virus replication and dissemination was restricted, demonstrating that Cx. pipiens is unlikely to be an epidemiologically important vector of the virus in northern Europe.	[Manley, Robyn; Harrup, Lara E.; Veronesi, Eva; Stubbins, Francesca; Stoner, Jo; Gubbins, Simon; Wilson, Anthony; Batten, Carrie; Henstock, Mark; Barber, James; Carpenter, Simon] Pirbright Inst, Vector Borne Viral Dis Programme, Pirbright, Surrey, England; [Koenraadt, Constantianus J. M.] WUR, Entomol Lab, Wageningen, Netherlands	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; Wageningen University & Research	Carpenter, S (corresponding author), Pirbright Inst, Vector Borne Viral Dis Programme, Pirbright, Surrey, England.	simon.carpenter@pirbright.ac.uk	Carpenter, Simon T/C-2718-2013	Carpenter, Simon T/0000-0001-5775-045X; Batten, Carrie/0000-0003-4274-7375; Gubbins, Simon/0000-0003-0538-4173; Harrup, Lara/0000-0001-8828-7349; Wilson, Anthony/0000-0002-2000-2914; Veronesi, Eva/0000-0003-3411-7891; Koenraadt, Constantianus/0000-0001-7861-8781	Defra grant [SE: 0542]; BBSRC grant [BBS/E/I/00001445]; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001701, BBS/E/I/00001445] Funding Source: researchfish; BBSRC [BBS/E/I/00001445, BBS/E/I/00001701] Funding Source: UKRI	Defra grant; BBSRC grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Studies were financially supported by Defra grant SE: 0542 and BBSRC grant: BBS/E/I/00001445.	Bahnck CM, 2006, AM J TROP MED HYG, V75, P251, DOI 10.4269/ajtmh.2006.75.2.0750251; Balenghien T, 2014, PREV VET MED, V116, P360, DOI 10.1016/j.prevetmed.2014.03.007; Becker N, 2010, MOSQUITOES THEIR CON, P43, DOI DOI 10.1007/978-3-540-92874-4_4; Becker N, 2012, J AM MOSQUITO CONTR, V28, P53, DOI 10.2987/8756-971X-28.4s.53; Bilk S, 2012, VET MICROBIOL, V159, P236, DOI 10.1016/j.vetmic.2012.03.035; Carpenter S, 2009, TRENDS MICROBIOL, V17, P172, DOI 10.1016/j.tim.2009.01.001; Ciota AT, 2013, PARASITE VECTOR, V6, P4; Danabalan R, 2012, J AM MOSQUITO CONTR, V28, P68, DOI 10.2987/8756-971X-28.0.68; De Regge N, 2012, TRANSBOUND EMERG DIS, V59, P471, DOI 10.1111/tbed.12000; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elbers ARW, 2013, EMERG INFECT DIS, V19, P106, DOI 10.3201/eid1901.121054; Farajollahi A, 2011, INFECT GENET EVOL, V11, P1577, DOI 10.1016/j.meegid.2011.08.013; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fritz ML, 2015, MED VET ENTOMOL, V29, P115, DOI 10.1111/mve.12096; Gomes B, 2013, INFECT GENET EVOL, V16, P218, DOI 10.1016/j.meegid.2013.02.006; Gomes B, 2012, J AM MOSQUITO CONTR, V28, P75, DOI 10.2987/8756-971X-28.4s.75; Harbach RE, 2012, J AM MOSQUITO CONTR, V28, P10, DOI 10.2987/8756-971X-28.4.10; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hesson JC, 2011, VECTOR-BORNE ZOONOT, V11, P1383, DOI 10.1089/vbz.2011.0630; Hoch A.L., 1987, Bulletin of the Pan American Health Organization, V21, P55; Hoffmann B, 2012, EMERG INFECT DIS, V18, P469, DOI 10.3201/eid1803.111905; Hoffmann B, 2009, EMERG INFECT DIS, V15, P1481, DOI 10.3201/eid1509.090562; Koenraadt CJM, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-77; Kuno G, 2005, CLIN MICROBIOL REV, V18, P608, DOI 10.1128/CMR.18.4.608-637.2005; Mackenzie-Impoinvil L, 2015, MED VET ENTOMOL, V29, P1, DOI 10.1111/mve.12083; Medlock JM, 2005, MED VET ENTOMOL, V19, P2, DOI 10.1111/j.0269-283X.2005.00547.x; Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814; Medlock Jolyon M., 2011, European Mosquito Bulletin, V29, P38; MELLOR PS, 1980, ANN TROP MED PARASIT, V74, P463, DOI 10.1080/00034983.1980.11687368; Mellor PS, 2000, J COMP PATHOL, V123, P231, DOI 10.1053/jcpa.2000.0434; PINHEIRO FP, 1982, SCIENCE, V215, P1251, DOI 10.1126/science.6800036; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Richards SL, 2010, AM J TROP MED HYG, V83, P126, DOI 10.4269/ajtmh.2010.09-0776; Scholte EJ, 2014, MED VET ENTOMOL, V28, P110, DOI 10.1111/mve.12010; Shaikevich E. V., 2007, European Mosquito Bulletin, P25; Smith JL, 2004, AM J TROP MED HYG, V70, P339, DOI 10.4269/ajtmh.2004.70.339; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TURELL MJ, 1984, SCIENCE, V225, P1039, DOI 10.1126/science.6474165; Veronesi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057747; Wernike K, 2014, PARASITE VECTOR, V7, P6	41	23	23	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0134453	10.1371/journal.pone.0134453	http://dx.doi.org/10.1371/journal.pone.0134453			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291533	Green Published, gold, Green Accepted			2022-12-26	WOS:000359919900006
J	Zhi, HY; Dai, J; Liu, JL; Zhu, JQ; Newman, DK; Gao, CJ; Newman, PJ				Zhi, Huiying; Dai, Jing; Liu, Junling; Zhu, Jieqing; Newman, Debra K.; Gao, Cunji; Newman, Peter J.			Platelet Activation and Thrombus Formation over IgG Immune Complexes Requires Integrin alpha IIb beta 3 and Lyn Kinase	PLOS ONE			English	Article							FC-GAMMA-RIIA; SRC FAMILY KINASES; TYROSINE PHOSPHORYLATION; RHEUMATOID-ARTHRITIS; SEQUENTIAL PHOSPHORYLATION; ADHESION; RECEPTOR; PROTEIN; IDENTIFICATION; ROLES	IgG immune complexes contribute to the etiology and pathogenesis of numerous autoimmune disorders, including heparin-induced thrombocytopenia, systemic lupus erythematosus, rheumatoid-and collagen-induced arthritis, and chronic glomerulonephritis. Patients suffering from immune complex-related disorders are known to be susceptible to plateletmediated thrombotic events. Though the role of the Fc receptor, Fc gamma RIIa, in initiating platelet activation is well understood, the role of the major platelet adhesion receptor, integrin alpha IIb beta 3, in amplifying platelet activation and mediating adhesion and aggregation downstream of encountering IgG immune complexes is poorly understood. The goal of this investigation was to gain a better understanding of the relative roles of these two receptor systems in immune complex-mediated thrombotic complications. Human platelets, and mouse platelets genetically engineered to differentially express Fc gamma RIIa and alpha IIb beta 3, were allowed to interact with IgG-coated surfaces under both static and flow conditions, and their ability to spread and form thrombi evaluated in the presence and absence of clinically-used fibrinogen receptor antagonists. Although binding of IgG immune complexes to Fc gamma RIIa was sufficient for platelet adhesion and initial signal transduction events, platelet spreading and thrombus formation over IgG-coated surfaces showed an absolute requirement for alpha IIb beta 3 and its ligands. Tyrosine kinases Lyn and Syk were found to play key roles in IgGinduced platelet activation events. Taken together, our data suggest a complex functional interplay between Fc gamma RIIa, Lyn, and alpha IIb beta 3 in immune complex-induced platelet activation. Future studies may be warranted to determine whether patients suffering from immune complex disorders might benefit from treatment with anti-alpha IIb beta 3-directed therapeutics.	[Zhi, Huiying; Zhu, Jieqing; Newman, Debra K.; Gao, Cunji; Newman, Peter J.] BloodCtr Wisconsin, Blood Res Inst, Milwaukee, WI 53233 USA; [Dai, Jing] Shanghai Jiao Tong Univ, Sch Med, Ruijing Hosp, Shanghai 200030, Peoples R China; [Liu, Junling] Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Tumor Microenvironm & Inflammat, Dept Biochem & Mol Cell Biol, Shanghai 200030, Peoples R China; [Zhu, Jieqing] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Newman, Debra K.] Med Coll Wisconsin, Dept Microbiol, Milwaukee, WI 53226 USA; [Newman, Debra K.; Newman, Peter J.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Gao, Cunji] Zhejiang Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Chron Dis Res Inst, Hangzhou 310003, Zhejiang, Peoples R China; [Newman, Peter J.] Med Coll Wisconsin, Dept Cell Biol, Milwaukee, WI 53226 USA	Versiti Blood Center of Wisconsin; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Zhejiang University; Medical College of Wisconsin	Newman, PJ (corresponding author), BloodCtr Wisconsin, Blood Res Inst, Milwaukee, WI 53233 USA.	peter.newman@bcw.edu			National Natural Science Foundation of China [81270586]; Heart, Lung, and Blood Institute of the National Institutes of Health [HL-44612]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL044612, R56HL122985] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Natural Science Foundation of China #81270586 (to CG) and by the Heart, Lung, and Blood Institute of the National Institutes of Health #HL-44612 (to DKN and PJN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Aringer M, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4126; Arman M, 2014, BLOOD; Bisoendial RJ, 2010, SEMIN THROMB HEMOST, V36, P452, DOI 10.1055/s-0030-1254054; Bodin S, 2003, THROMB HAEMOSTASIS, V89, P318, DOI 10.1055/s-0037-1613449; Boylan B, 2008, BLOOD, V112, P2780, DOI 10.1182/blood-2008-02-142125; CHACKO GW, 1994, J BIOL CHEM, V269, P32435; CLARK EA, 1994, J BIOL CHEM, V269, P28859; Fernandez M, 2007, ARTHRITIS RHEUM, V56, P614, DOI 10.1002/art.22376; Geahlen RL, 2014, TRENDS PHARMACOL SCI, V35, P414, DOI 10.1016/j.tips.2014.05.007; Gomez-Puerta JA, 2011, NAT REV RHEUMATOL, V7, P134, DOI 10.1038/nrrheum.2011.8; Gratacap MP, 1998, J BIOL CHEM, V273, P24314, DOI 10.1074/jbc.273.38.24314; Greinacher A, 2009, J THROMB HAEMOST, V7, P9, DOI 10.1111/j.1538-7836.2009.03385.x; HAIMOVICH B, 1993, J BIOL CHEM, V268, P15868; Hantgan RR, 2003, J BIOL CHEM, V278, P3417, DOI 10.1074/jbc.M208869200; Hitchcock IS, 2008, BLOOD, V111, P596, DOI 10.1182/blood-2007-05-089680; HUANG MM, 1992, J BIOL CHEM, V267, P5467; Ibarrola I, 1997, BBA-MOL CELL RES, V1357, P348, DOI 10.1016/S0167-4889(97)00034-7; KAPLAN KB, 1994, EMBO J, V13, P4745, DOI 10.1002/j.1460-2075.1994.tb06800.x; KARAS SP, 1982, BLOOD, V60, P1277; KORNBERG L, 1992, J BIOL CHEM, V267, P23439; LEGRAND C, 1989, BLOOD, V73, P1226; Lewis JE, 2013, DISCOV MED, V15, P85; Li ZY, 2010, J BIOL CHEM, V285, P12559, DOI 10.1074/jbc.M109.098756; Lowell CA, 1996, J CELL BIOL, V133, P895, DOI 10.1083/jcb.133.4.895; Mameli A, 2009, CLIN EXP RHEUMATOL, V27, P846; McKenzie SE, 1999, J IMMUNOL, V162, P4311; Mewar D, 2006, BIOMED PHARMACOTHER, V60, P648, DOI 10.1016/j.biopha.2006.09.002; Michel M, 2002, BRIT J HAEMATOL, V119, P354, DOI 10.1046/j.1365-2141.2002.03817.x; Ming ZY, 2011, BLOOD, V117, P3903, DOI 10.1182/blood-2010-09-304816; Mitrugno A, 2014, BLOOD, V123, P249, DOI 10.1182/blood-2013-03-492447; MOVAT HZ, 1965, P SOC EXP BIOL MED, V120, P232; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; Paddock C, 2011, BLOOD, V117, P6012, DOI 10.1182/blood-2010-11-317867; Palatinus A, 2009, SEMIN THROMB HEMOST, V35, P621, DOI 10.1055/s-0029-1242716; PELLETIER AJ, 1995, J BIOL CHEM, V270, P18133, DOI 10.1074/jbc.270.30.18133; Ragab A, 2007, BLOOD, V110, P2466, DOI 10.1182/blood-2007-02-075432; Reddy KB, 2008, J CELL SCI, V121, P1641, DOI 10.1242/jcs.014076; Reilly MP, 2011, BLOOD, V117, P2241, DOI 10.1182/blood-2010-03-274969; ROSENFELD SI, 1985, J CLIN INVEST, V76, P2317, DOI 10.1172/JCI112242; Ruzzene M, 1996, BIOCHEMISTRY-US, V35, P5327, DOI 10.1021/bi9528614; Severin S, 2012, J THROMB HAEMOST, V10, P1631, DOI 10.1111/j.1538-7836.2012.04814.x; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Su XY, 2008, BLOOD, V112, P592, DOI 10.1182/blood-2007-09-110437; Tourdot BE, 2013, BIOCHEMISTRY-US, V52, P2597, DOI 10.1021/bi301461t; VANDENHERIKOUDIJK IE, 1995, BLOOD, V85, P2202, DOI 10.1182/blood.V85.8.2202.bloodjournal8582202; Xiong Y, 2006, BIOCHEMISTRY-US, V45, P8721, DOI 10.1021/bi060529u; Zhi HY, 2013, BLOOD, V121, P1858, DOI 10.1182/blood-2012-07-443325; Zhu JQ, 2007, J BIOL CHEM, V282, P11914, DOI 10.1074/jbc.M700249200	49	22	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135738	10.1371/journal.pone.0135738	http://dx.doi.org/10.1371/journal.pone.0135738			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291522	Green Submitted, Green Published, gold			2022-12-26	WOS:000359919900028
J	Ambreen, H; Kumar, S; Variath, MT; Joshi, G; Bali, S; Agarwal, M; Kumar, A; Jagannath, A; Goel, S				Ambreen, Heena; Kumar, Shivendra; Variath, Murali Tottekkad; Joshi, Gopal; Bali, Sapinder; Agarwal, Manu; Kumar, Amar; Jagannath, Arun; Goel, Shailendra			Development of Genomic Microsatellite Markers in Carthamus tinctorius L. (Safflower) Using Next Generation Sequencing and Assessment of Their Cross-Species Transferability and Utility for Diversity Analysis	PLOS ONE			English	Article							GENETIC DIVERSITY; SSR MARKERS; TRANSCRIPTOME; REPEATS; LOCI; DNA; IDENTIFICATION; AMPLIFICATION; POLYMORPHISM; GERMPLASM	Background Safflower (Carthamus tinctorius L.), an Asteraceae member, yields high quality edible oil rich in unsaturated fatty acids and is resilient to dry conditions. The crop holds tremendous potential for improvement through concerted molecular breeding programs due to the availability of significant genetic and phenotypic diversity. Genomic resources that could facilitate such breeding programs remain largely underdeveloped in the crop. The present study was initiated to develop a large set of novel microsatellite markers for safflower using next generation sequencing. Principal Findings Low throughput genome sequencing of safflower was performed using Illumina paired end technology providing similar to 3.5X coverage of the genome. Analysis of sequencing data allowed identification of 23,067 regions harboring perfect microsatellite loci. The safflower genome was found to be rich in dinucleotide repeats followed by tri-, tetra-, penta- and hexa-nucleotides. Primer pairs were designed for 5,716 novel microsatellite sequences with repeat length >= 20 bases and optimal flanking regions. A subset of 325 microsatellite loci was tested for amplification, of which 294 loci produced robust amplification. The validated primers were used for assessment of 23 safflower accessions belonging to diverse agro-climatic zones of the world leading to identification of 93 polymorphic primers (31.6%). The numbers of observed alleles at each locus ranged from two to four and mean polymorphism information content was found to be 0.3075. The polymorphic primers were tested for cross-species transferability on nine wild relatives of cultivated safflower. All primers except one showed amplification in at least two wild species while 25 primers amplified across all the nine species. The UPGMA dendrogram clustered C. tinctorius accessions and wild species separately into two major groups. The proposed progenitor species of safflower, C. oxyacantha and C. palaestinus were genetically closer to cultivated safflower and formed a distinct cluster. The cluster analysis also distinguished diploid and tetraploid wild species of safflower. Conclusion Next generation sequencing of safflower genome generated a large set of microsatellite markers. The novel markers developed in this study will add to the existing repertoire of markers and can be used for diversity analysis, synteny studies, construction of linkage maps and marker-assisted selection.	[Ambreen, Heena; Kumar, Shivendra; Variath, Murali Tottekkad; Joshi, Gopal; Bali, Sapinder; Agarwal, Manu; Kumar, Amar; Jagannath, Arun; Goel, Shailendra] Univ Delhi, Dept Bot, Delhi 110007, India	University of Delhi	Jagannath, A (corresponding author), Univ Delhi, Dept Bot, Delhi 110007, India.	jagannatharun@yahoo.co.in; shailendragoel@gmail.com	Bali, Sapinder/AAR-7019-2021	Goel, Shailendra/0000-0002-8731-8892; AGARWAL, MANU/0000-0003-4241-5055	Delhi University-Department of Science and Technology, Government of India [Dean(R)/2009/868]; University Grants Commission, India [/JRF/AA/208/2010-11]	Delhi University-Department of Science and Technology, Government of India; University Grants Commission, India(University Grants Commission, India)	Funding: This work was supported by Delhi University-Department of Science and Technology grant, Government of India to SG, AJ, AK and MA, and grant no. Dean(R)/2009/868. HA was supported by a research fellowship from University Grants Commission, India, grant no. Sch.No./JRF/AA/208/2010-11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; [Anonymous], 1991, MOL TECHNIQUES TAXON; ASHRI A, 1960, AGRON J, V52, P11, DOI 10.2134/agronj1960.00021962005200010004x; ASHRI A, 1971, EUPHYTICA, V20, P410, DOI 10.1007/BF00035666; Bali S, 2013, MOL BREEDING, V32, P735, DOI 10.1007/s11032-013-9902-4; Cardle L, 2000, GENETICS, V156, P847; Carlsson AS, 2014, BIOCATAL AGRIC BIOTE, V3, P58, DOI 10.1016/j.bcab.2013.12.007; Chapman MA, 2009, THEOR APPL GENET, V120, P85, DOI 10.1007/s00122-009-1161-8; Chen TW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S9; Collard BCY, 2005, EUPHYTICA, V142, P169, DOI 10.1007/s10681-005-1681-5; Dajue L, 1996, SAFFLOWER CARTHAMUS, V7; Dutta S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-17; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Flider FJ, 2013, LIPID TECHNOL, V25, P27; Garcia-Moreno MJ, 2010, EUPHYTICA, V175, P145, DOI 10.1007/s10681-010-0139-6; Garnatje T, 2006, ANN BOT-LONDON, V97, P461, DOI 10.1093/aob/mcj050; Golkar P., 2014, Australian Journal of Crop Science, V8, P1079; Hamdan YAS, 2011, PLANT BREEDING, V130, P237, DOI 10.1111/j.1439-0523.2010.01826.x; Heesacker A, 2008, THEOR APPL GENET, V117, P1021, DOI 10.1007/s00122-008-0841-0; Huang DN, 2014, MOL ECOL RESOUR, V14, P569, DOI 10.1111/1755-0998.12197; Huang LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038653; Ilkilic C, 2011, FUEL PROCESS TECHNOL, V92, P356, DOI 10.1016/j.fuproc.2010.09.028; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jin L, 1996, P NATL ACAD SCI USA, V93, P15285, DOI 10.1073/pnas.93.26.15285; Johnson RC, 2007, CROP SCI, V47, P1728, DOI 10.2135/cropsci2006.12.0757; Kalia RK, 2011, EUPHYTICA, V177, P309, DOI 10.1007/s10681-010-0286-9; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kumar S, 2015, PLANT MOL BIOL REP, V33, P1299, DOI 10.1007/s11105-014-0828-8; Lee GA, 2014, MOL ECOL RESOUR, V14, P69, DOI 10.1111/1755-0998.12146; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Majidi MM, 2011, AUST J CROP SCI, V5, P1055; McPherson MA, 2009, TRANSGENIC RES, V18, P281, DOI 10.1007/s11248-008-9217-0; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Naresh V, 2009, EUPHYTICA, V170, P347, DOI 10.1007/s10681-009-9995-3; Nimbkar N, 2008, P 7 INT SAFFL C WAGG; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Peakall R, 1998, MOL BIOL EVOL, V15, P1275, DOI 10.1093/oxfordjournals.molbev.a025856; Pearl SA, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-43; Peng S, 2008, BIOCHEM SYST ECOL, V36, P531, DOI 10.1016/j.bse.2008.03.010; Perrier X., 2006, DARWIN SOFTWARE; Perry DJ, 2004, THEOR APPL GENET, V109, P55, DOI 10.1007/s00122-004-1597-9; Pootakham W, 2012, PLANT BREEDING, V131, P555, DOI 10.1111/j.1439-0523.2012.01982.x; Powell W, 1996, TRENDS PLANT SCI, V1, P215, DOI 10.1016/1360-1385(96)86898-1; QUELLER DC, 1993, TRENDS ECOL EVOL, V8, P285, DOI 10.1016/0169-5347(93)90256-O; Ross MG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r51; Sabzalian MR, 2010, CROP PROT, V29, P550, DOI 10.1016/j.cropro.2009.12.013; Sehgal D, 2008, GENOME, V51, P638, DOI 10.1139/G08-049; Sehgal D, 2009, GENETICA, V135, P457, DOI 10.1007/s10709-008-9292-4; Song QJ, 2005, THEOR APPL GENET, V110, P550, DOI 10.1007/s00122-004-1871-x; Squirrell J, 2003, MOL ECOL, V12, P1339, DOI 10.1046/j.1365-294X.2003.01825.x; Tangphatsornruang S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-137; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Varshney Rajeev K., 2007, P207, DOI 10.1007/978-1-4020-6297-1_10; Velasco L, 2005, PLANT BREEDING, V124, P459, DOI 10.1111/j.1439-0523.2005.01150.x; Wang HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062293; Wang HX, 2012, PLANT CELL REP, V31, P2047, DOI 10.1007/s00299-012-1315-z; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Weiss E.A., 1983, OILSEED CROPS, P216; Whitton J, 1997, MOL BIOL EVOL, V14, P204, DOI 10.1093/oxfordjournals.molbev.a025755; Yang T, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-65; Yang YX, 2007, GENET RESOUR CROP EV, V54, P1043, DOI 10.1007/s10722-006-9192-3; You FM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-253; Zalapa JE, 2012, AM J BOT, V99, P193, DOI 10.3732/ajb.1100394; Zane L, 2002, MOL ECOL, V11, P1, DOI 10.1046/j.0962-1083.2001.01418.x; Zhu W, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-286	68	28	30	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135443	10.1371/journal.pone.0135443	http://dx.doi.org/10.1371/journal.pone.0135443			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287743	gold, Green Published, Green Submitted			2022-12-26	WOS:000360018600050
J	Bunaciu, RP; Jensen, HA; MacDonald, RJ; LaTocha, DH; Varner, JD; Yen, A				Bunaciu, Rodica P.; Jensen, Holly A.; MacDonald, Robert J.; LaTocha, Dorian H.; Varner, Jeffrey D.; Yen, Andrew			6-Formylindolo(3,2-b)Carbazole (FICZ) Modulates the Signalsome Responsible for RA-Induced Differentiation of HL-60 Myeloblastic Leukemia Cells	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; JUVENILE MYELOMONOCYTIC LEUKEMIA; ACID-INDUCED DIFFERENTIATION; INDUCED BLR1 EXPRESSION; TRANS-RETINOIC ACID; ACUTE MYELOID-LEUKEMIA; C-CBL; GRANULOCYTIC DIFFERENTIATION; CD38 EXPRESSION; SURFACE ANTIGEN	6-Formylindolo(3,2-b) carbazole (FICZ) is a photoproduct of tryptophan and an endogenous high affinity ligand for aryl hydrocarbon receptor (AhR). It was previously reported that, in patient-derived HL-60 myeloblastic leukemia cells, retinoic acid (RA)-induced differentiation is driven by a signalsome containing c-Cbl and AhR. FICZ enhances RA-induced differentiation, assessed by expression of the membrane differentiation markers CD38 and CD11b, cell cycle arrest and the functional differentiation marker, inducible oxidative metabolism. Moreover, FICZ augments the expression of a number of the members of the RA-induced signalsome, such as c-Cbl, Vav1, Slp76, PI3K, and the Src family kinases Fgr and Lyn. Pursuing the molecular signaling responsible for RA-induced differentiation, we characterized, using FRET and clustering analysis, associations of key molecules thought to drive differentiation. Here we report that, assayed by FRET, AhR interacts with c-Cbl upon FICZ plus RA-induced differentiation, whereas AhR constitutively interacts with Cbl-b. Moreover, correlation analysis based on the flow cytometric assessment of differentiation markers and western blot detection of signaling factors reveal that Cbl-b, p-p38a and pT390-GSK3 beta, are not correlated with other known RA-induced signaling components or with a phenotypic outcome. We note that FICZ plus RA elicited signaling responses that were not typical of RA alone, but may represent alternative differentiation-driving pathways. In clusters of signaling molecules seminal to cell differentiation, FICZ co-administered with RA augments type and intensity of the dynamic changes induced by RA. Our data suggest relevance for FICZ in differentiation-induction therapy. The mechanism of action includes modulation of a SFK and MAPK centered signalsome and c-Cbl-AhR association.	[Bunaciu, Rodica P.; Jensen, Holly A.; MacDonald, Robert J.; Yen, Andrew] Cornell Univ, Dept Biomed Sci, Ithaca, NY 14853 USA; [Jensen, Holly A.; Varner, Jeffrey D.] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA; [LaTocha, Dorian H.; Yen, Andrew] Cornell Univ, Flow Cytometry Core Facil, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University	Yen, A (corresponding author), Cornell Univ, Dept Biomed Sci, Ithaca, NY 14853 USA.	ay13@cornell.edu		Bunaciu, Rodica/0000-0002-3101-0928	NIH [R01 CA033505, R01 CA152870]; NIH/PS-OC [3U54CA143876]; NYSTEM NY Dept. Health [C026718]; Cornell Vertebrate Genomics (VERGE); National Science Foundation [CBET-0846876]; NATIONAL CANCER INSTITUTE [R01CA033505, R01CA152870, U54CA143876] Funding Source: NIH RePORTER; Directorate For Engineering [0846876] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/PS-OC; NYSTEM NY Dept. Health; Cornell Vertebrate Genomics (VERGE); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	Funding: R01 CA033505, R01 CA152870 from NIH (AY) and 3U54CA143876 NIH/PS-OC (Shuler/AY/RPB), C026718 NYSTEM NY Dept. Health (AY), Cornell Vertebrate Genomics (VERGE) (RPB) and CBET-0846876 from National Science Foundation (JDV/HAJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT BD, 1989, TOXICOL APPL PHARM, V99, P287, DOI 10.1016/0041-008X(89)90011-2; ABBOTT BD, 1989, TERATOLOGY, V40, P533, DOI 10.1002/tera.1420400602; Arany I, 2004, AM J PHYSIOL-RENAL, V287, pF543, DOI 10.1152/ajprenal.00112.2004; Battle TE, 2000, EXP CELL RES, V254, P287, DOI 10.1006/excr.1999.4766; Battle TE, 2001, EUR J CELL BIOL, V80, P59, DOI 10.1078/0171-9335-00141; Brooks SC, 1996, BLOOD, V87, P227; Bunaciu RP, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-39; Bunaciu RP, 2011, CANCER RES, V71, P2371, DOI 10.1158/0008-5472.CAN-10-2299; Bunaciu RP, 2015, CURRENT PHARM REPORT, DOI [10.1007/s40495-015-0036-8, DOI 10.1007/S40495-015-0036-8]; BUSQUE L, 1995, BLOOD, V85, P21, DOI 10.1182/blood.V85.1.21.bloodjournal85121; Cambier N, 2001, Hematol J, V2, P97, DOI 10.1038/sj.thj.6200099; Chen GQ, 1996, LEUKEMIA, V10, P825; Chen WL, 2014, BLOOD, V124, P1645, DOI 10.1182/blood-2014-02-554204; Cheng J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8209; CLEGHON V, 1994, J BIOL CHEM, V269, P17749; COMIC M, 1994, LEUKEMIA, V8, P914; Congleton J, 2012, LEUKEMIA, V26, P1180, DOI 10.1038/leu.2011.390; Congleton J, 2014, CELL SIGNAL, V26, P1589, DOI 10.1016/j.cellsig.2014.03.021; COURTNEY KD, 1971, TOXICOL APPL PHARM, V20, P396, DOI 10.1016/0041-008X(71)90282-1; COUTURE LA, 1990, TERATOLOGY, V42, P619, DOI 10.1002/tera.1420420606; Daver N, 2015, BRIT J HAEMATOL, V168, P646, DOI 10.1111/bjh.13189; Douer D, 2013, LEUKEMIA RES, V37, P795, DOI 10.1016/j.leukres.2013.03.001; Efficace F, 2014, J CLIN ONCOL, V32, P3406, DOI 10.1200/JCO.2014.55.3453; Fernandes MS, 2010, J BIOL CHEM, V285, P32596, DOI 10.1074/jbc.M110.106161; Finsinger P, 2015, ANN HEMATOL, V94, P195, DOI 10.1007/s00277-014-2197-7; Fritz H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021107; Geil WM, 2013, FEBS J; Gilbert S.F., 2010, DEV BIOL; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; GRATAS C, 1993, LEUKEMIA, V7, P1156; Hong HY, 2001, DIFFERENTIATION, V68, P55, DOI 10.1046/j.1432-0436.2001.068001055.x; Huang BT, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0233-z; Jacobs H, 2011, ENVIRON HEALTH PERSP, V119, P1590, DOI 10.1289/ehp.1003075; Kishimoto H, 1998, J BIOL CHEM, V273, P15429, DOI 10.1074/jbc.273.25.15429; Kontani K, 1996, J BIOL CHEM, V271, P1534; Lamkin TJ, 2006, J CELL BIOCHEM, V97, P1328, DOI 10.1002/jcb.20745; Lo-Coco F, 2014, CURR HEMATOL MALIG R, V9, P138, DOI 10.1007/s11899-014-0206-5; Loh ML, 2011, BRIT J HAEMATOL, V152, P677, DOI 10.1111/j.1365-2141.2010.08525.x; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Marchisio M, 1998, BIOCHEM BIOPH RES CO, V253, P346, DOI 10.1006/bbrc.1998.9787; Maschan M, 2014, PEDIATR BLOOD CANCER, V61, P1871, DOI 10.1002/pbc.25013; Mehta K, 1997, BLOOD, V89, P3607, DOI 10.1182/blood.V89.10.3607.3607_3607_3614; Melander F, 2003, BIOCHEM J, V370, P687, DOI 10.1042/BJ20021201; Moro M, 2015, J THORACIC ONCOLOGY; Munshi CB, 2002, J BIOL CHEM, V277, P49453, DOI 10.1074/jbc.M209313200; Niemeyer CM, 2010, NAT GENET, V42, P794, DOI 10.1038/ng.641; NILSSON B, 1984, BRIT J HAEMATOL, V57, P365, DOI 10.1111/j.1365-2141.1984.tb02910.x; Oberg M, 2005, TOXICOL SCI, V85, P935, DOI 10.1093/toxsci/kfi154; Puga A, 2005, BIOCHEM PHARMACOL, V69, P199, DOI 10.1016/j.bcp.2004.06.043; Reiterer G, 2007, CANCER RES, V67, P7765, DOI 10.1158/0008-5472.CAN-07-0014; Shen MQ, 2008, CANCER RES, V68, P8761, DOI 10.1158/0008-5472.CAN-08-1058; Shen MQ, 2011, LEUKEMIA LYMPHOMA, V52, P2372, DOI 10.3109/10428194.2011.603449; Shen MQ, 2009, J BIOL CHEM, V284, P25664, DOI 10.1074/jbc.M109.014241; Shiba N, 2010, LEUKEMIA, V24, P1090, DOI 10.1038/leu.2010.49; Smith J, 2009, EXP CELL RES, V315, P2241, DOI 10.1016/j.yexcr.2009.03.004; Stockinger B, 2014, ANNU REV IMMUNOL, V32, P403, DOI 10.1146/annurev-immunol-032713-120245; Veselits M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089792; Visani G, 2001, LEUKEMIA, V15, P1696, DOI 10.1038/sj.leu.2402266; Wang JR, 2008, J BIOL CHEM, V283, P4375, DOI 10.1074/jbc.M708471200; Wang JR, 2004, MOL CELL BIOL, V24, P2423, DOI 10.1128/MCB.24.6.2423-2443.2004; Wei YD, 2000, ARCH BIOCHEM BIOPHYS, V383, P99, DOI 10.1006/abbi.2000.2037; Welch H, 1997, ONCOGENE, V15, P2021, DOI 10.1038/sj.onc.1201356; Werner B, 2014, CANCER RES, V74, P5386, DOI 10.1158/0008-5472.CAN-14-1210; Werner S, 2015, CANCER DISCOV, V5, P506, DOI 10.1158/2159-8290.CD-14-1042; WILLIAMS NG, 1992, P NATL ACAD SCI USA, V89, P2922, DOI 10.1073/pnas.89.7.2922; Wincent E, 2009, J BIOL CHEM, V284, P2690, DOI 10.1074/jbc.M808321200; Yamada T, 2014, J CRANIO MAXILL SURG, V42, P1, DOI 10.1016/j.jcms.2013.01.024; Yang CM, 2013, BIOCHEM PHARMACOL, V85, P1115, DOI 10.1016/j.bcp.2013.01.013; Yen A, 2006, EUR J CELL BIOL, V85, P117, DOI 10.1016/j.ejcb.2005.09.020; Yen A, 2000, IN VITRO CELL DEV-AN, V36, P249; YEN A, 1994, EUR J CELL BIOL, V65, P103; Yen A, 1998, CANCER RES, V58, P3163	72	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135668	10.1371/journal.pone.0135668	http://dx.doi.org/10.1371/journal.pone.0135668			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287494	Green Published, gold, Green Submitted			2022-12-26	WOS:000360018600061
J	Feng, YF; Guo, H; Yuan, F; Shen, MQ				Feng, Yi-fan; Guo, Hua; Yuan, Fei; Shen, Min-qian			Lipopolysaccharide Promotes Choroidal Neovascularization by Up-Regulation of CXCR4 and CXCR7 Expression in Choroid Endothelial Cell	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; MACULAR DEGENERATION; CHLAMYDIA-PNEUMONIAE; TUBE FORMATION; FACTOR-I; MIGRATION; TLR4; PROLIFERATION; PATHOGENESIS; INFLAMMATION	Stromal cell-derived factor-1 (SDF-1) has been confirmed to participate in the formation of choroidal neovascularization (CNV) via its two receptors: CXC chemokine receptors 4 (CXCR4) and CXCR7. Previous studies have indicated that the activation of Toll-like receptors (TLRs) by lipopolysaccharide (LPS) might elevate CXCR4 and/or CXCR7 expression in tumor cells, enhancing the response to SDF-1 to promote invasion and cell dissemination. However, the impact of LPS on the CXCR4 and CXCR7 expression in endothelial cells and subsequent pathological angiogenesis formation remains to be elucidated. The present study shows that LPS enhanced the CXCR4 and CXCR7 expression via activation of the TLR4 pathway in choroid-retinal endothelial (RF/6A) cells. In addition, the transcriptional regulation of CXCR4 and CXCR7 by LPS was found to be mediated by phosphorylation of the extracellular signal-related kinase (ERK) 1/2 and activation of nuclear factor kappa B (NF-kappa B) signaling pathways, which were blocked by ERK-or NF-kappa B-specific inhibitors. Furthermore, the increased CXCR4 and CXCR7 expression resulted in increased SDF-1induced RF/6A cells proliferation, migration and tube formation. In vivo, LPS-treated rat had significantly higher mRNA levels of CXCR4 and CXCR7 expression and lager laser-induced CNV area than vehicle-treated rat. SDF-1 blockade with a neutralizing antibody attenuated the progression of CNV in LPS-treated rat after a single intravitreal injection. Altogether, these results demonstrated that LPS might influence CNV formation by enhancing CXCR7 and CXCR7 expression in endothelial cells, possibly providing a new perspective for the treatment of CNV-associated diseases.	[Feng, Yi-fan; Guo, Hua; Yuan, Fei; Shen, Min-qian] Fudan Univ, Dept Ophthalmol, Zhongshan Hosp, Shanghai 200433, Peoples R China	Fudan University	Yuan, F (corresponding author), Fudan Univ, Dept Ophthalmol, Zhongshan Hosp, Shanghai 200433, Peoples R China.	yuanfeiyk@163.com			National Nature Science Foundation of China [81470637]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from the National Nature Science Foundation of China (no. 81470637, http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustin AJ, 2009, EXPERT OPIN THER TAR, V13, P641, DOI 10.1517/14728220902942322; Berkowitz BA, 1998, INVEST OPHTH VIS SCI, V39, P391; Campos M, 2006, INVEST OPHTH VIS SCI, V47, P5163, DOI 10.1167/iovs.06-0156; Dai XZ, 2011, J CELL MOL MED, V15, P1299, DOI 10.1111/j.1582-4934.2011.01301.x; Donoso LA, 2006, SURV OPHTHALMOL, V51, P137, DOI 10.1016/j.survophthal.2005.12.001; Edelman JL, 2000, EXP EYE RES, V71, P523, DOI 10.1006/exer.2000.0907; Elner SG, 2005, INVEST OPHTH VIS SCI, V46, P4627, DOI 10.1167/iovs.05-0658; Feng YF, 2014, MOL CELL BIOCH; Franitza S, 2002, EUR J IMMUNOL, V32, P193, DOI 10.1002/1521-4141(200201)32:1<193::AID-IMMU193>3.0.CO;2-H; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P532; Fujimoto T, 2010, INVEST OPHTH VIS SCI, V51, P4694, DOI 10.1167/iovs.09-4464; Izumi-Nagai K, 2007, AM J PATHOL, V170, P2149, DOI 10.2353/ajpath.2007.061018; Jin J, 2013, MOL CELL BIOCHEM, V381, P267, DOI 10.1007/s11010-013-1710-y; Jin J, 2013, OPHTHALMIC RES, V50, P6, DOI 10.1159/000348532; Kindzelskii AL, 2004, J GEN PHYSIOL, V124, P139, DOI 10.1085/jgp.200409062; Kumar MV, 2004, J NEUROIMMUNOL, V153, P7, DOI 10.1016/j.jneuroim.2004.04.018; Lee E, 2010, INVEST OPHTH VIS SCI, V51, P3666, DOI 10.1167/iovs.09-3802; Li DM, 2014, J DENT, V42, P1327, DOI 10.1016/j.jdent.2014.07.007; Liu HB, 2010, BIOCHEM BIOPH RES CO, V401, P509, DOI 10.1016/j.bbrc.2010.09.076; LOU DA, 1987, IN VITRO CELL DEV B, V23, P75, DOI 10.1007/BF02623586; Matsumura N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039890; Miao H, 2012, MOL VIS, V18, P574; Miller DM, 2004, AM J OPHTHALMOL, V138, P323, DOI 10.1016/j.ajo.2004.03.018; Niu N, 2013, INVEST OPHTH VIS SCI, V54, P7045, DOI 10.1167/iovs.13-12531; Otsuka H, 2010, AM J PATHOL, V177, P2268, DOI 10.2353/ajpath.2010.100134; Robman L, 2005, AM J EPIDEMIOL, V161, P1013, DOI 10.1093/aje/kwi130; Sabroe I, 2003, J IMMUNOL, V171, P1630, DOI 10.4049/jimmunol.171.4.1630; Suzuki M, 2014, BRIT J OPHTHALMOL, V98, P1186, DOI 10.1136/bjophthalmol-2013-304670; Takabayashi T, 2009, ORAL ONCOL, V45, P968, DOI 10.1016/j.oraloncology.2009.06.006; Tarnowski M, 2010, MOL CANCER RES, V8, P1, DOI 10.1158/1541-7786.MCR-09-0259; Tong HP, 2006, CLIN BIOCHEM, V39, P267, DOI 10.1016/j.clinbiochem.2005.11.013; Wang XB, 2008, BIOCHEM BIOPH RES CO, V371, P283, DOI 10.1016/j.bbrc.2008.04.055; Wong TY, 2006, BRIT J OPHTHALMOL, V90, P506, DOI 10.1136/bjo.2005.083733; Xu HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027399; Zhang ZX, 2011, CURR EYE RES, V36, P838, DOI 10.3109/02713683.2011.593107	35	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136175	10.1371/journal.pone.0136175	http://dx.doi.org/10.1371/journal.pone.0136175			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288180	gold, Green Published, Green Submitted			2022-12-26	WOS:000360018600116
J	Fritz, HK; Gustafsson, A; Ljungberg, B; Ceder, Y; Axelson, H; Dahlback, B				Fritz, Helena K.; Gustafsson, Anna; Ljungberg, Borje; Ceder, Yvonne; Axelson, Hakan; Dahlback, Bjorn			The Axl-Regulating Tumor Suppressor miR-34a Is Increased in ccRCC but Does Not Correlate with Axl mRNA or Axl Protein Levels	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; GENE-EXPRESSION; CANCER; MICRORNAS; OVEREXPRESSION; PROLIFERATION; THERAPY; TARGETS; UPDATE; FAMILY	High expression of the receptor tyrosine kinase Axl is associated with poor prognosis in patients with Renal Cell Carcinoma (RCC), the most common malignancy of the kidney. The miR-34a has been shown to directly regulate Axl in cancer cells. The miR-34a is a mediator of p53-dependent tumor suppression, and low expression of miR-34a has been associated with worse prognosis in several cancers. Our aim was to elucidate whether miR-34a or the other members of the miR-34 family (miR-34b/c) regulate Axl in RCC.	[Fritz, Helena K.; Gustafsson, Anna; Dahlback, Bjorn] Lund Univ, Dept Translat Med, Sect Clin Chem, Univ Hosp Malmo, Malmo, Sweden; [Ljungberg, Borje] Umea Univ, Dept Surg & Perioperat Sci, Umea, Sweden; [Ljungberg, Borje] Umea Univ, Dept Urol, Umea, Sweden; [Ljungberg, Borje] Umea Univ, Dept Androl, Umea, Sweden; [Ceder, Yvonne; Axelson, Hakan] Lund Univ, Dept Lab Med, Div Translat Canc Res, Lund, Sweden	Lund University; Skane University Hospital; Umea University; Umea University; Umea University; Lund University	Dahlback, B (corresponding author), Lund Univ, Dept Translat Med, Sect Clin Chem, Univ Hosp Malmo, Malmo, Sweden.			Ljungberg, Borje/0000-0002-4121-3753; Ceder, Yvonne/0000-0002-8705-8293; Dahlback, Bjorn/0000-0003-1546-0328	Swedish Cancer Foundation; Swedish Research Council; University Hospital Malmo Cancer Research Foundation	Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); University Hospital Malmo Cancer Research Foundation	The work was supported by Swedish Cancer Foundation, Swedish Research Council grant, and University Hospital Malmo Cancer Research Foundation.	Abe H, 2013, INT J UROL, V20, P944, DOI 10.1111/iju.12187; Arvey A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.24; Axelrod H, 2014, ONCOTARGET, V5, P1, DOI 10.18632/oncotarget.2422; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Boysen J, 2014, LEUKEMIA, V28, P451, DOI 10.1038/leu.2013.298; Brand TM, 2014, CANCER RES, V74, P5152, DOI 10.1158/0008-5472.CAN-14-0294; Chung BI, 2003, DNA CELL BIOL, V22, P533, DOI 10.1089/10445490360708946; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Concepcion CP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002797; Dutta KK, 2007, CANCER SCI, V98, P1845, DOI 10.1111/j.1349-7006.2007.00619.x; Escudier B, 2012, NAT REV CLIN ONCOL, V9, P327, DOI 10.1038/nrclinonc.2012.59; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fritz HKM, 2014, EUR J CANCER, V50, P1758, DOI 10.1016/j.ejca.2014.03.281; Graham DK, 2014, NAT REV CANCER, V14, P769, DOI 10.1038/nrc3847; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Gustafsson A, 2009, CLIN CANCER RES, V15, P4742, DOI 10.1158/1078-0432.CCR-08-2514; Hagman Z, 2010, INT J CANCER, V127, P2768, DOI 10.1002/ijc.25269; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Huang Y, 2009, EJSO-EUR J SURG ONC, V35, P1119, DOI 10.1016/j.ejso.2009.04.010; Jain AK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002859; Juan D, 2010, UROLOGY, V75, P835, DOI 10.1016/j.urology.2009.10.033; Kaller M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010462; Lenburg ME, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-31; Liu HQ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-51; Ljungberg B, 2010, EUR UROL, V58, P398, DOI 10.1016/j.eururo.2010.06.032; Long D, 2007, NAT STRUCT MOL BIOL, V14, P287, DOI 10.1038/nsmb1226; Lopez-Beltran A, 2009, INT J UROL, V16, P432, DOI 10.1111/j.1442-2042.2009.02302.x; Mackiewicz M, 2011, BREAST CANCER RES TR, V130, P663, DOI 10.1007/s10549-011-1690-0; Mudduluru G, 2011, ONCOGENE, V30, P2888, DOI 10.1038/onc.2011.13; Muller J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6712; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Paccez JD, 2014, INT J CANCER, V134, P1024, DOI 10.1002/ijc.28246; Sotillo E, 2011, ONCOGENE, V30, P2587, DOI 10.1038/onc.2010.634; Thorstenson A, 2014, SCAND J UROL, V48, P231, DOI 10.3109/21681805.2013.864698; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vogt M, 2011, VIRCHOWS ARCH, V458, P313, DOI 10.1007/s00428-010-1030-5; Walesky C, 2013, HEPATOLOGY, V57, P2480, DOI 10.1002/hep.26251; Wang ZY, 2013, BBA-GENE REGUL MECH, V1829, P436, DOI 10.1016/j.bbagrm.2012.12.009; Weikert S, 2010, WORLD J UROL, V28, P247, DOI 10.1007/s00345-010-0555-1; Wirsing A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027438; Yu G, 2014, J UROLOGY, V192, P1229, DOI 10.1016/j.juro.2014.05.094	42	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135991	10.1371/journal.pone.0135991	http://dx.doi.org/10.1371/journal.pone.0135991			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287733	gold, Green Published, Green Submitted			2022-12-26	WOS:000360018600095
J	Zheng, Y; Godar, SP; Litovsky, RY				Zheng, Yi; Godar, Shelly P.; Litovsky, Ruth Y.			Development of Sound Localization Strategies in Children with Bilateral Cochlear Implants	PLOS ONE			English	Article							MINIMUM AUDIBLE ANGLE; AUDITORY SPACE; BARN OWL; SPEECH-INTELLIGIBILITY; SENSITIVE PERIOD; TIME DIFFERENCES; SPATIAL RELEASE; NEURAL CIRCUITS; HEARING; CORTEX	Localizing sounds in our environment is one of the fundamental perceptual abilities that enable humans to communicate, and to remain safe. Because the acoustic cues necessary for computing source locations consist of differences between the two ears in signal intensity and arrival time, sound localization is fairly poor when a single ear is available. In adults who become deaf and are fitted with cochlear implants (CIs) sound localization is known to improve when bilateral CIs (BiCIs) are used compared to when a single CI is used. The aim of the present study was to investigate the emergence of spatial hearing sensitivity in children who use BiCIs, with a particular focus on the development of behavioral localization patterns when stimuli are presented in free-field horizontal acoustic space. A new analysis was implemented to quantify patterns observed in children for mapping acoustic space to a spatially relevant perceptual representation. Children with normal hearing were found to distribute their responses in a manner that demonstrated high spatial sensitivity. In contrast, children with BiCIs tended to classify sound source locations to the left and right; with increased bilateral hearing experience, they developed a perceptual map of space that was better aligned with the acoustic space. The results indicate experience-dependent refinement of spatial hearing skills in children with CIs. Localization strategies appear to undergo transitions from sound source categorization strategies to more fine-grained location identification strategies. This may provide evidence for neural plasticity, with implications for training of spatial hearing ability in CI users.	[Zheng, Yi; Godar, Shelly P.; Litovsky, Ruth Y.] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison	Litovsky, RY (corresponding author), Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA.	Litovsky@waisman.wisc.edu			National Institutes of Health [5R01-DC008365, 2P30-HD003352]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008365] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funding: This work was supported by National Institutes of Health, Grant 5R01-DC008365, 2P30-HD003352 http://www.nih.gov.	Brown CA, 2014, EAR HEARING, V35, P580, DOI 10.1097/AUD.0000000000000044; Dahmen JC, 2010, NEURON, V66, P937, DOI 10.1016/j.neuron.2010.05.018; Gordon KA, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00719; Gordon KA, 2013, BRAIN, V136, P1609, DOI 10.1093/brain/awt052; Grieco-Calub TM, 2012, EAR HEARING, V33, P561, DOI 10.1097/AUD.0b013e31824c7801; Grieco-Calub TM, 2010, EAR HEARING, V31, P645, DOI 10.1097/AUD.0b013e3181e50a1d; Hartmann WM, 1998, J ACOUST SOC AM, V104, P3546, DOI 10.1121/1.423936; JEFFRESS LA, 1948, J COMP PHYSIOL PSYCH, V41, P35, DOI 10.1037/h0061495; Johnstone PM, 2006, J ACOUST SOC AM, V120, P2177, DOI 10.1121/1.2225416; Jones H, 2014, TRENDS HEAR IN PRESS; Joris PX, 1998, NEURON, V21, P1235, DOI 10.1016/S0896-6273(00)80643-1; Kacelnik O, 2006, PLOS BIOL, V4, P627, DOI 10.1371/journal.pbio.0040071; Kan A, 2015, HEARING RES, V322, P127, DOI 10.1016/j.heares.2014.08.005; Keating P, 2014, EUR J NEUROSCI, V39, P197, DOI 10.1111/ejn.12402; King AJ, 2000, P NATL ACAD SCI USA, V97, P11821, DOI 10.1073/pnas.97.22.11821; King AJ, 2011, NEUROSCI BIOBEHAV R, V35, P2129, DOI 10.1016/j.neubiorev.2011.03.008; KNUDSEN EI, 1984, J NEUROSCI, V4, P1001; Knudsen EI, 1996, NATURE, V383, P428, DOI 10.1038/383428a0; KNUDSEN EI, 1993, J NEUROSCI, V13, P2837; Kral Andrej, 2006, Adv Otorhinolaryngol, V64, P89, DOI 10.1159/000094647; Kral A, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00093; Kral A, 2013, BRAIN, V136, P180, DOI 10.1093/brain/aws305; Kral A, 2012, TRENDS NEUROSCI, V35, P111, DOI 10.1016/j.tins.2011.09.004; Kumpik DP, 2010, J NEUROSCI, V30, P4883, DOI 10.1523/JNEUROSCI.5488-09.2010; Laback B, 2004, EAR HEARING, V25, P488, DOI 10.1097/01.aud.0000145124.85517.e8; Litovsky RY, 2012, J AM ACAD AUDIOL, V23, P476, DOI 10.3766/jaaa.23.6.9; Litovsky RY, 2009, EAR HEARING, V30, P419, DOI 10.1097/AUD.0b013e3181a165be; Litovsky RY, 2006, EAR HEARING, V27, P43, DOI 10.1097/01.aud.0000194515.28023.4b; Litovsky RY, 2004, ARCH OTOLARYNGOL, V130, P648, DOI 10.1001/archotol.130.5.648; Litovsky RY, 1997, J ACOUST SOC AM, V102, P1739, DOI 10.1121/1.420106; Litovsky RY, 2011, COCHLEAR IMPLANTS IN; Lomber SG, 2001, J COMP NEUROL, V441, P44, DOI 10.1002/cne.1396; Majdak P, 2006, J ACOUST SOC AM, V120, P2190, DOI 10.1121/1.2258390; MASINO T, 1990, NATURE, V345, P434, DOI 10.1038/345434a0; McAlpine D, 2001, NAT NEUROSCI, V4, P396, DOI 10.1038/86049; MILLS AW, 1958, J ACOUST SOC AM, V30, P237, DOI 10.1121/1.1909553; Misurelli SM, 2012, J ACOUST SOC AM, V132, P380, DOI 10.1121/1.4725760; Nakamoto KT, 2008, J NEUROPHYSIOL, V99, P2347, DOI 10.1152/jn.01326.2007; Salminen NH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007600; Sharma A, 2007, INT J AUDIOL, V46, P494, DOI 10.1080/14992020701524836; Sharma Anu, 2002, Ear and Hearing, V23, P532, DOI 10.1097/00003446-200212000-00004; Stecker GC, 2005, PLOS BIOL, V3, P520, DOI 10.1371/journal.pbio.0030078; Van Deun L, 2010, AUDIOL NEURO-OTOL, V15, P7, DOI 10.1159/000218358; van Hoesel RJM, 2003, J ACOUST SOC AM, V113, P1617, DOI 10.1121/1.1539520; WHITFIELD IC, 1972, J NEUROPHYSIOL, V35, P718, DOI 10.1152/jn.1972.35.5.718; Wright BA, 2006, INT J AUDIOL, V45, pS92, DOI 10.1080/14992020600783004	46	29	29	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135790	10.1371/journal.pone.0135790	http://dx.doi.org/10.1371/journal.pone.0135790			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288142	gold, Green Published, Green Submitted			2022-12-26	WOS:000360018600070
J	Zoratti, L; Jaakola, L; Haggman, H; Giongo, L				Zoratti, Laura; Jaakola, Laura; Haeggman, Hely; Giongo, Lara			Modification of Sunlight Radiation through Colored Photo-Selective Nets Affects Anthocyanin Profile in Vaccinium spp. Berries	PLOS ONE			English	Article							PHENOLIC-COMPOUNDS; ANTIOXIDANT CAPACITY; WILD POPULATIONS; FRUIT-QUALITY; MYRTILLUS L.; BIOSYNTHESIS; BLUEBERRY; TEMPERATURE; BILBERRY; PHOTORECEPTORS	Objectives In recent years, the interest on the effects of the specific wavelengths of the light spectrum on growth and metabolism of plants has been increasing markedly. The present study covers the effect of modified sunlight conditions on the accumulation of anthocyanin pigments in two Vaccinium species: the European wild bilberry (V. myrtillus L.) and the cultivated high-bush blueberry (V. corymbosum L.). Methods The two Vaccinium species were grown in the same test field in the Alps of Trentino (Northern Italy) under modified light environment. The modification of sunlight radiation was carried out in field, through the use of colored photo-selective nets throughout the berry ripening during two consecutive growing seasons. The anthocyanin profile was then assessed in berries at ripeness. Results The results indicated that the light responses of the two Vaccinium species studied were different. Although both studied species are shade-adapted plants, 90% shading of sunlight radiation was beneficial only for bilberry plants, which accumulated the highest content of anthocyanins in both seasons. The same condition, instead, was not favorable for blueberries, whose maturation was delayed for at least two weeks, and anthocyanin accumulation was significantly decreased compared to berries grown under sunlight conditions. Moreover, the growing season had strong influence on the anthocyanin accumulation in both species, in relation to temperature flow and sunlight spectra composition during the berry ripening period. Conclusions Our results suggest that the use of colored photo-selective nets may be a complementary agricultural practice for cultivation of Vaccinium species. However, further studies are needed to analyze the effect of the light spectra modifications to other nutritional properties, and to elucidate the molecular mechanisms behind the detected differences between the two relative Vaccinium species.	[Zoratti, Laura; Haeggman, Hely] Univ Oulu, Genet & Physiol Unit, Oulu, Finland; [Jaakola, Laura] UiT Arctic Univ Norway, Dept Arctic & Marine Biol, Climate Lab, Tromso, Norway; [Jaakola, Laura] NIBIO Holt, Norwegian Inst Bioecon Res, Tromso, Norway; [Zoratti, Laura; Giongo, Lara] Edmund Mach Fdn, Genom & Biol Fruit Crop Dept, Res & Innovat Ctr, Trento, Italy	University of Oulu; UiT The Arctic University of Tromso; Norwegian Institute of Bioeconomy Research; Fondazione Edmund Mach	Zoratti, L (corresponding author), Univ Oulu, Genet & Physiol Unit, Oulu, Finland.	laura.zoratti@oulu.fi	Jaakola, Laura/AAA-4437-2021		Fondazione Edmund Mach, Applied Rosaceous Genomics research group (Italy)	Fondazione Edmund Mach, Applied Rosaceous Genomics research group (Italy)	This work was supported by funding granted to LG from the Fondazione Edmund Mach, Applied Rosaceous Genomics research group (Italy) (http://www.fmach.it/eng/CRI/general-info/organisation/Genomics-and-Biology-of-Fruit-Crop/Applied-Rosaceous-Genomics).	Aung T, 2014, J JPN SOC HORTIC SCI, V83, P273, DOI 10.2503/jjshs1.CH-110; Bouly JP, 2007, J BIOL CHEM, V282, P9383, DOI 10.1074/jbc.M609842200; Cheng JH, 2015, J AGR SCI TECH-IRAN, V17, P157; Ehlenfeldt MK, 2001, J AGR FOOD CHEM, V49, P2222, DOI 10.1021/jf0013656; Eichholz I., 2015, PROCESSING IMPACT AC, P173; Giacalone M, 2015, BIOACTIVE NUTRACEUTICALS AND DIETARY SUPPLEMENTS IN NEUROLOGICAL AND BRAIN DISEASE: PREVENTION AND THERAPY, P17, DOI 10.1016/B978-0-12-411462-3.00002-3; Giongo L, 2013, POSTHARVEST BIOL TEC, V76, P34, DOI 10.1016/j.postharvbio.2012.09.004; Giovanelli G, 2009, FOOD CHEM, V112, P903, DOI 10.1016/j.foodchem.2008.06.066; Gough E. R., 1993, HIGHBUSH BLUEBERRY I, P288; Jaakola L, 2013, TRENDS PLANT SCI, V18, P477, DOI 10.1016/j.tplants.2013.06.003; Jovancevic M, 2011, J MED PLANTS RES, V5, P910; Kadomura-Ishikawa Y, 2013, J PLANT RES, V126, P847, DOI 10.1007/s10265-013-0582-2; Kondo S, 2014, J PLANT PHYSIOL, V171, P823, DOI 10.1016/j.jplph.2014.01.001; Koyama K, 2012, PHYTOCHEMISTRY, V78, P54, DOI 10.1016/j.phytochem.2012.02.026; Kuhn N, 2014, J EXP BOT, V65, P4543, DOI 10.1093/jxb/ert395; Li XY, 2012, GENE, V511, P54, DOI 10.1016/j.gene.2012.09.021; Lin-Wang K, 2011, PLANT CELL ENVIRON, V34, P1176, DOI 10.1111/j.1365-3040.2011.02316.x; Liu HT, 2011, TRENDS PLANT SCI, V16, P684, DOI 10.1016/j.tplants.2011.09.002; Lobos GA, 2013, SCI HORTIC-AMSTERDAM, V153, P143, DOI 10.1016/j.scienta.2013.02.012; Moze S, 2011, J AGR FOOD CHEM, V59, P6998, DOI 10.1021/jf200765n; Nestby R, 2009, ACTA HORTIC, V838, P67; Norberto S, 2013, J FUNCT FOODS, V5, P1518, DOI 10.1016/j.jff.2013.08.015; Ordidge M, 2010, FOOD CHEM, V119, P1224, DOI 10.1016/j.foodchem.2009.08.039; Parlane S, 2006, FOREST ECOL MANAG, V222, P272, DOI 10.1016/j.foreco.2005.10.032; Prior RL, 1998, J AGR FOOD CHEM, V46, P2686, DOI 10.1021/jf980145d; Retamales JB, 2008, ACTA HORTIC, V770, P193; Rieger G, 2008, J AGR FOOD CHEM, V56, P9080, DOI 10.1021/jf801104e; Riihinen K, 2008, FOOD CHEM, V110, P156, DOI 10.1016/j.foodchem.2008.01.057; Rodriguez-Mateos A, 2012, J AGR FOOD CHEM, V60, P5772, DOI 10.1021/jf203812w; Routray W, 2011, COMPR REV FOOD SCI F, V10, P303, DOI 10.1111/j.1541-4337.2011.00164.x; Rowland LJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-46; Shahak Y, 2008, ACTA HORTIC, V770, P161; Stagnari F, 2014, J SCI FOOD AGR, V94, P713, DOI 10.1002/jsfa.6312; Steyn W. J., 2009, P85, DOI 10.1007/978-0-387-77335-3_4; Tarara JM, 2008, AM J ENOL VITICULT, V59, P235; Ubi BE, 2006, PLANT SCI, V170, P571, DOI 10.1016/j.plantsci.2005.10.009; Uleberg E, 2012, J AGR FOOD CHEM, V60, P10406, DOI 10.1021/jf302924m; Gonzalez CV, 2015, PHYTOCHEMISTRY, V110, P46, DOI 10.1016/j.phytochem.2014.11.018; Wang CY, 2009, FOOD CHEM, V117, P426, DOI 10.1016/j.foodchem.2009.04.037; Yamane T, 2006, AM J ENOL VITICULT, V57, P54; Zoratti L, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0377-1; Zoratti L, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00534	42	32	32	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135935	10.1371/journal.pone.0135935	http://dx.doi.org/10.1371/journal.pone.0135935			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288240	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000360018600087
J	Baracz, SJ; Everett, NA; Cornish, JL				Baracz, Sarah Jane; Everett, Nicholas Adams; Cornish, Jennifer Louise			The Involvement of Oxytocin in the Subthalamic Nucleus on Relapse to Methamphetamine-Seeking Behaviour	PLOS ONE			English	Article							CONDITIONED PLACE PREFERENCE; MEDIAL PREFRONTAL CORTEX; ADMINISTERED OXYTOCIN; ACCUMBENS CORE; BINDING-SITES; DOPAMINE; VASOPRESSIN; REWARD; COCAINE; BRAIN	The psychostimulant methamphetamine (METH) is an addictive drug of abuse. The neuropeptide oxytocin has been shown to modulate METH-related reward and METH-seeking behaviour. Recent findings implicated the subthalamic nucleus (STh) as a key brain region in oxytocin modulation of METH-induced reward. However, it is unclear if oxytocin acts in this region to attenuate relapse to METH-seeking behaviour, and if this action is through the oxytocin receptor. We aimed to determine whether oxytocin pretreatment administered into the STh would reduce reinstatement to METH use in rats experienced at METH self-administration, and if this could be reversed by the co-administration of the oxytocin receptor antagonist desGly-NH2,d(CH2)5[D-Tyr2,Thr4]OVT. Male Sprague Dawley rats underwent surgery to implant an intravenous jugular vein catheter and bilateral microinjection cannulae into the STh under isoflourane anaesthesia. Rats were then trained to self-administer intravenous METH (0.1 mg/kg/infusion) by lever press during 2-hour sessions under a fixed ratio 1 schedule for 20 days. Following extinction of lever press activity, the effect of microinjecting saline, oxytocin (0.2 pmol, 0.6 pmol, 1.8 pmol, 3.6 pmol) or co-administration of oxytocin (3.6 pmol) and desGly-NH2,d(CH2)5[D-Tyr(2),Thr(4)]OVT (3 nmol) into the STh (200 nl/side) was examined on METH-primed reinstatement (1 mg/kg; i.p.). We found that local administration of the highest oxytocin dose (3.6 pmol) into the STh decreased METH-induced reinstatement and desGly-NH2,d(CH2)5[ D-Tyr2,Thr4]OVT had a non-specific effect on lever press activity. These findings highlight that oxytocin modulation of the STh is an important modulator of relapse to METH abuse.	[Baracz, Sarah Jane; Everett, Nicholas Adams; Cornish, Jennifer Louise] Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia	Macquarie University	Cornish, JL (corresponding author), Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia.	Jennifer.cornish@mq.edu.au	Baracz, Sarah Jane/K-4860-2019	Everett, Nicholas/0000-0001-9226-6153; Baracz, Sarah/0000-0002-9938-1936; Cornish, Jennifer/0000-0002-9754-8069	Macquarie University; Australian Postgraduate Award	Macquarie University; Australian Postgraduate Award(Australian Government)	Research was supported by internal funding from Macquarie University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Miss Sarah Baracz is the recipient of an Australian Postgraduate Award.	ADAN RAH, 1995, ENDOCRINOLOGY, V136, P4022, DOI 10.1210/en.136.9.4022; Baracz SJ, 2013, HORM BEHAV, V63, P370, DOI 10.1016/j.yhbeh.2012.12.003; Baracz SJ, 2012, BEHAV BRAIN RES, V228, P185, DOI 10.1016/j.bbr.2011.11.038; Baracz SJ, ADDICTION BIOL; Baskerville TA, 2010, CNS NEUROSCI THER, V16, pe92, DOI 10.1111/j.1755-5949.2010.00154.x; Baunez C, 2005, NAT NEUROSCI, V8, P484, DOI 10.1038/nn1429; Caldwell HK, 2008, PROG NEUROBIOL, V84, P1, DOI 10.1016/j.pneurobio.2007.10.007; Carson DS, 2010, ADDICT BIOL, V15, P448, DOI 10.1111/j.1369-1600.2010.00247.x; Carson DS, 2010, NEUROPHARMACOLOGY, V58, P38, DOI 10.1016/j.neuropharm.2009.06.018; Chan W.Y., 2003, EXP PHYSL S, V85S, P7; Chudasama Y, 2003, J NEUROSCI, V23, P5477; Ciketic S, 2012, J SUBST USE, V17, P363, DOI 10.3109/14659891.2011.592900; Cox BM, 2013, PSYCHONEUROENDOCRINO, V38, P2343, DOI 10.1016/j.psyneuen.2013.05.005; Cui SS, 2001, J NEUROSCI, V21, P9867, DOI 10.1523/JNEUROSCI.21-24-09867.2001; Darbaky Y, 2005, NEUROREPORT, V16, P1241, DOI 10.1097/00001756-200508010-00022; Dyer KR, 2005, AUST PSYCHOL, V40, P96, DOI 10.1080/00050060500094647; Field A, 2009, DISCOVERING STATISTI; Figueira RJ, 2008, BEHAV NEUROSCI, V122, P618, DOI 10.1037/0735-7044.122.3.618; FREUNDMERCIER MJ, 1988, NEUROSCIENCE, V26, P261, DOI 10.1016/0306-4522(88)90143-1; Gong WH, 1997, PROG NEURO-PSYCHOPH, V21, P839, DOI 10.1016/S0278-5846(97)00084-5; Harris D, 2000, AM J ADDICTION, V9, P28; Hicks C, 2014, BRIT J PHARMACOL, V171, P2868, DOI 10.1111/bph.12613; KOOB GF, 1992, TRENDS PHARMACOL SCI, V13, P177, DOI 10.1016/0165-6147(92)90060-J; KOVACS GL, 1985, NEUROPHARMACOLOGY, V24, P413, DOI 10.1016/0028-3908(85)90026-7; KOVACS GL, 1990, NEUROPHARMACOLOGY, V29, P365, DOI 10.1016/0028-3908(90)90095-9; Lardeux S, 2008, NEUROPSYCHOPHARMACOL, V33, P634, DOI 10.1038/sj.npp.1301432; Lardeux S, 2013, J NEUROPHYSIOL, V110, P1497, DOI 10.1152/jn.00160.2013; Lardeux S, 2009, J NEUROPHYSIOL, V102, P2526, DOI 10.1152/jn.91009.2008; Lintas A, 2012, BRAIN RES, V1434, P142, DOI 10.1016/j.brainres.2011.09.005; Manning M, 2008, PROG BRAIN RES, V170, P473, DOI 10.1016/S0079-6123(08)00437-8; McCann UD, 1998, J NEUROSCI, V18, P8417; McGregor IS, 2008, BRIT J PHARMACOL, V154, P358, DOI 10.1038/bjp.2008.132; McGregor IS, 2012, HORM BEHAV, V61, P331, DOI 10.1016/j.yhbeh.2011.12.001; Meredith CW, 2005, HARVARD REV PSYCHIAT, V13, P141, DOI 10.1080/10673220591003605; Motbey CP, 2013, J PSYCHOPHARMACOL, V27, P823, DOI 10.1177/0269881113490325; Ornstein TJ, 2000, NEUROPSYCHOPHARMACOL, V23, P113, DOI 10.1016/S0893-133X(00)00097-X; PARENT A, 1995, BRAIN RES REV, V20, P128, DOI 10.1016/0165-0173(94)00008-D; PHILLIPS AG, 1984, BRAIN RES BULL, V12, P195, DOI 10.1016/0361-9230(84)90189-8; PONTIERI FE, 1990, PSYCHOPHARMACOLOGY, V102, P175, DOI 10.1007/BF02245919; Qi J, 2008, N-S ARCH PHARMACOL, V376, P441, DOI 10.1007/s00210-007-0245-8; Qi J, 2009, NEUROPHARMACOLOGY, V56, P856, DOI 10.1016/j.neuropharm.2009.01.010; Ramos L, 2013, NEUROPSYCHOPHARMACOL, V38, P2249, DOI 10.1038/npp.2013.125; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Rouaud T, 2010, P NATL ACAD SCI USA, V107, P1196, DOI 10.1073/pnas.0908189107; SARNYAI Z, 1992, NEUROPEPTIDES, V23, P27, DOI 10.1016/0143-4179(92)90006-I; Shen KZ, 2000, J PHYSIOL-LONDON, V525, P331, DOI 10.1111/j.1469-7793.2000.00331.x; Shirley DG, 2011, NEPHRON PHYSIOL, V117, pP21, DOI 10.1159/000320290; Smith Y, 1998, NEUROSCIENCE, V86, P353; Song ZM, 2014, PSYCHONEUROENDOCRINO, V50, P14, DOI 10.1016/j.psyneuen.2014.08.005; TRIBOLLET E, 1988, BRAIN RES, V442, P105, DOI 10.1016/0006-8993(88)91437-0; Turnipseed SD, 2003, J EMERG MED, V24, P369, DOI 10.1016/S0736-4679(03)00031-3; United Nations Office on Drugs and Crime, 2010, WORLD DRUG REPORT; UVNASMOBERG K, 1994, PHARMACOL BIOCHEM BE, V49, P101, DOI 10.1016/0091-3057(94)90462-6; Volkow ND, 2001, AM J PSYCHIAT, V158, P377, DOI 10.1176/appi.ajp.158.3.377; Watson C, 1997, THE RAT BRAIN ATLAS; Westover AN, 2007, ARCHIVES OF GENERAL, P64; Yang J, 2011, PEPTIDES, V32, P2104, DOI 10.1016/j.peptides.2011.08.021; You ZD, 2000, NEUROREPORT, V11, P3113, DOI 10.1097/00001756-200009280-00015; Zanos P, 2014, PHARMACOL BIOCHEM BE, V119, P72, DOI 10.1016/j.pbb.2013.05.009	59	28	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0136132	10.1371/journal.pone.0136132	http://dx.doi.org/10.1371/journal.pone.0136132			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284529	Green Submitted, Green Published, gold			2022-12-26	WOS:000359666100105
J	Bowman, JS; Ducklow, HW				Bowman, Jeff S.; Ducklow, Hugh W.			Microbial Communities Can Be Described by Metabolic Structure: A General Framework and Application to a Seasonally Variable, Depth-Stratified Microbial Community from the Coastal West Antarctic Peninsula	PLOS ONE			English	Article							SEA-ICE; BACTERIAL; BACTERIOPLANKTON; PHYLOGENY; DIVERSITY; ALIGNMENT; GENOMICS; DATABASE; SUMMER; WINTER	Taxonomic marker gene studies, such as the 16S rRNA gene, have been used to successfully explore microbial diversity in a variety of marine, terrestrial, and host environments. For some of these environments long term sampling programs are beginning to build a historical record of microbial community structure. Although these 16S rRNA gene datasets do not intrinsically provide information on microbial metabolism or ecosystem function, this information can be developed by identifying metabolisms associated with related, phenotyped strains. Here we introduce the concept of metabolic inference; the systematic prediction of metabolism from phylogeny, and describe a complete pipeline for predicting the metabolic pathways likely to be found in a collection of 16S rRNA gene phylotypes. This framework includes a mechanism for assigning confidence to each metabolic inference that is based on a novel method for evaluating genomic plasticity. We applied this framework to 16S rRNA gene libraries from the West Antarctic Peninsula marine environment, including surface and deep summer samples and surface winter samples. Using statistical methods commonly applied to community ecology data we found that metabolic structure differed between summer surface and winter and deep samples, comparable to an analysis of community structure by 16S rRNA gene phylotypes. While taxonomic variance between samples was primarily driven by low abundance taxa, metabolic variance was attributable to both high and low abundance pathways. This suggests that clades with a high degree of functional redundancy can occupy distinct adjacent niches. Overall our findings demonstrate that inferred metabolism can be used in place of taxonomy to describe the structure of microbial communities. Coupling metabolic inference with targeted metagenomics and an improved collection of completed genomes could be a powerful way to analyze microbial communities in a high-throughput manner that provides direct access to metabolic and ecosystem function.	[Bowman, Jeff S.; Ducklow, Hugh W.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Bowman, Jeff S.] Blue Marble Space Inst Sci, Seattle, WA USA	Columbia University	Bowman, JS (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.	bowmanjs@ldeo.columbia.edu		Bowman, Jeff/0000-0002-8811-6280	National Science Foundation Division of Polar Programs [1440435, 1340886]; Directorate For Geosciences [1440435] Funding Source: National Science Foundation	National Science Foundation Division of Polar Programs(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding provided by National Science Foundation Division of Polar Programs, http://www.nsf.gov/div/index.jsp?div=PLR, grant number 1440435 to HWD and National Science Foundation Division of Polar Programs, http://www.nsf.gov/div/index.jsp?div=PLR, grant number 1340886 to HWD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bowman JS, 2014, FEMS MICROBIOL ECOL, V89, P376, DOI 10.1111/1574-6941.12331; Bowman JS, 2012, ISME J, V6, P11, DOI 10.1038/ismej.2011.76; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caro-Quintero A, 2012, ENVIRON MICROBIOL, V14, P347, DOI 10.1111/j.1462-2920.2011.02668.x; Caspi R, 2014, NUCLEIC ACIDS RES, V42, pD459, DOI 10.1093/nar/gkt1103; CHAO A, 1984, SCAND J STAT, V11, P265; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Coenye T, 2003, FEMS MICROBIOL LETT, V228, P45, DOI 10.1016/S0378-1097(03)00717-1; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Ducklow HW, 2013, OCEANOGRAPHY, V26, P190, DOI 10.5670/oceanog.2013.62; Ghiglione JF, 2012, ENVIRON MICROBIOL, V14, P617, DOI 10.1111/j.1462-2920.2011.02601.x; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Grzymski JJ, 2012, ISME J, V6, P1901, DOI 10.1038/ismej.2012.31; Iverson V, 2012, SCIENCE, V335, P587, DOI 10.1126/science.1212665; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karp PD, 2010, BRIEF BIOINFORM, V11, P40, DOI 10.1093/bib/bbp043; Karsenti E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001177; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Luria CM, 2014, AQUAT MICROB ECOL, V73, P107, DOI 10.3354/ame01703; Martens K, 2005, HYDROBIOLOGIA, V542, P27, DOI 10.1007/s10750-005-0892-z; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; McCarren J, 2010, P NATL ACAD SCI USA, V107, P16420, DOI 10.1073/pnas.1010732107; Michotey V, 1997, MAR ECOL PROG SER, V160, P47, DOI 10.3354/meps160047; Montes-Hugo M, 2009, SCIENCE, V323, P1470, DOI 10.1126/science.1164533; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Okuda S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2203; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Qi J, 2004, J MOL EVOL, V58, P1, DOI 10.1007/s00239-003-2493-7; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Roling WFM, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00125; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schomburg I, 2004, NUCLEIC ACIDS RES, V32, pD431, DOI 10.1093/nar/gkh081; Shemesh Y, 2004, ENVIRON MICROBIOL, V6, P12, DOI 10.1046/j.1462-2920.2003.00530.x; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Steinle L, 2015, NAT GEOSCI, V8, P378, DOI [10.1038/NGEO2420, 10.1038/ngeo2420]; Team RC, 2014, R LANG ENV STAT COMP; Teeling H, 2012, SCIENCE, V336, P608, DOI 10.1126/science.1218344; Vollmers J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063422; Wietz M, 2015, ENVIRON MICROBIOL, V17, P3822, DOI 10.1111/1462-2920.12842	43	88	92	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135868	10.1371/journal.pone.0135868	http://dx.doi.org/10.1371/journal.pone.0135868			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285202	Green Published, Green Submitted, gold			2022-12-26	WOS:000359666100079
J	Alos, J; Puiggros, A; Diaz-Gil, C; Palmer, M; Rossello, R; Arlinghaus, R				Alos, Josep; Puiggros, Antoni; Diaz-Gil, Carlos; Palmer, Miquel; Rossello, Rosario; Arlinghaus, Robert			Empirical Evidence for Species-Specific Export of Fish Naivete from a No-Take Marine Protected Area in a Coastal Recreational Hook and Line Fishery	PLOS ONE			English	Article							ANGLING CATCH RATES; RESERVES; VULNERABILITY; SPILLOVER; BEHAVIOR; TROUT; POPULATIONS; IMPACTS; EXPLOITATION; CONSERVATION	No-take marine protected areas (MPAs) are assumed to enhance fisheries catch via the "spillover" effect, where biomass is exported to adjacent exploited areas. Recent studies in spearfishing fisheries suggest that the spillover of gear-naive individuals from protected to unprotected sites increases catch rates outside the boundaries of MPAs. Whether this is a widespread phenomenon that also holds for other gear types and species is unknown. In this study, we tested if the distance to a Mediterranean MPA predicted the degree of vulnerability to hook and line in four small-bodied coastal fish species. With the assistance of underwater video recording, we investigated the interaction effect of the distance to the boundary of an MPA and species type relative to the latency time to ingest a natural bait, which was considered as a surrogate of fish naivete or vulnerability to fishing. Vulnerability to angling increased (i.e., latency time decreased) within and near the boundary of an MPA for an intrinsically highly catchable species (Serranus scriba), while it remained constant for an intrinsically uncatchable control species (Chromis chromis). While all of the individuals of S. scriba observed within the MPA and surrounding areas were in essence captured by angling gear, only one fifth of individuals in the far locations were captured. This supports the potential for the spillover of gear-naive and consequently more vulnerable fish from no-take MPAs. Two other species initially characterized as intermediately catchable (Coris julis and Diplodus annularis) also had a shorter latency time in the vicinity of an MPA, but for these two cases the trend was not statistically significant. Overall, our results suggest that an MPA-induced naivete effect may not be universal and may be confined to only intrinsically highly catchable fish species. This fact emphasizes the importance of considering the behavioural dimension when predicting the outcomes of MPAs, otherwise the effective contribution may be smaller than predicted for certain highly catchable species such as S. scriba.	[Alos, Josep; Arlinghaus, Robert] Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Biol & Ecol Fishes, Muggelseedamm 310, D-12587 Berlin, Germany; [Puiggros, Antoni; Diaz-Gil, Carlos; Palmer, Miquel; Rossello, Rosario] IMEDEA CSIC UIB, Inst Mediterraneo Estudios Avanzados, Esporles 07190, Illes Balears, Spain; [Diaz-Gil, Carlos] LIMIA Balear Govt, Lab Invest Marines & Aqicultura, Port Dandratx, Illes Balears, Spain; [Arlinghaus, Robert] Humboldt Univ, Div Integrat Fisheries Management, Fac Life Sci, D-10155 Berlin, Germany; [Arlinghaus, Robert] Humboldt Univ, Integrat Res Inst Transformat Human Environm Syst, D-10155 Berlin, Germany	Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; Humboldt University of Berlin; Humboldt University of Berlin	Alos, J (corresponding author), Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Biol & Ecol Fishes, Muggelseedamm 310, Muggelseedamm 310, D-12587 Berlin, Germany.	alos@igb-berlin.de	Arlinghaus, Robert/E-3340-2010; Díaz Gil, Carlos/H-2454-2017; Arlinghaus, Robert/J-6171-2019; Palmer, Miquel/E-3561-2013	Arlinghaus, Robert/0000-0003-2861-527X; Díaz Gil, Carlos/0000-0003-4095-1559; Alos, Josep/0000-0003-4385-9539; Miquel, Palmer/0000-0002-7875-3673	Marie Curie Post-Doc grant (Project Fish&Fishers, FP7-PEOPLE-IEF) [327160]; B-Types project through Leibniz Competition [SAW-2013-IGB-2]; FPI-INIA grant; REC2 [CTM2011-23835]	Marie Curie Post-Doc grant (Project Fish&Fishers, FP7-PEOPLE-IEF); B-Types project through Leibniz Competition; FPI-INIA grant; REC2	This study was funded through a Marie Curie Post-Doc grant (Project Fish&Fishers, FP7-PEOPLE-2012-IEF, grant #327160, https://www.facebook.com/pages/FishFishers-Research-Project/985161008176055). JA and RA received additional funding from the B-Types project funded through Leibniz Competition (grant #SAW-2013-IGB-2, http://www.b-types.igb-berlin.de/). CDG was funded by FPI-INIA-2012 grant and MP and CDG by the research project REC2 (grant#CTM2011-23835). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abesamis RA, 2014, REV FISH BIOL FISHER, V24, P1033, DOI 10.1007/s11160-014-9362-x; Alos J, 2009, J APPL ICHTHYOL, V25, P565, DOI 10.1111/j.1439-0426.2009.01272.x; Alos J, 2015, CAN J FISH AQUAT SCI, V72, P217, DOI 10.1139/cjfas-2014-0183; Alos J, 2014, MAR ECOL PROG SER, V503, P219, DOI 10.3354/meps10745; Alos J, 2013, FISH RES, V137, P88, DOI 10.1016/j.fishres.2012.09.007; Alos J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048030; Ariyomo TO, 2013, BEHAV GENET, V43, P161, DOI 10.1007/s10519-013-9585-y; Arlinghaus R, 2008, FISH RES, V92, P53, DOI 10.1016/j.fishres.2007.12.012; Arlinghaus R, 2006, N AM J FISH MANAGE, V26, P592, DOI 10.1577/M04-220.1; Askey PJ, 2006, N AM J FISH MANAGE, V26, P1020, DOI 10.1577/M06-035.1; Bellier E, 2013, ECOL INFORM, V18, P188, DOI 10.1016/j.ecoinf.2013.09.004; BEUKEMA JJ, 1970, J FISH BIOL, V2, P155, DOI 10.1111/j.1095-8649.1970.tb03268.x; Biro PA, 2008, TRENDS ECOL EVOL, V23, P361, DOI 10.1016/j.tree.2008.04.003; Biro PA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2283; Bohnsack JA, 2011, B MAR SCI, V87, P939, DOI 10.5343/bms.2010.1072; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Botsford LW, 2003, ECOL APPL, V13, pS25; Cardona L, 2007, SCI MAR, V71, P811, DOI 10.3989/scimar.2007.71n4811; Carter AJ, 2012, ANIM BEHAV, V83, P1051, DOI 10.1016/j.anbehav.2012.01.033; Cerda M, 2010, FISH RES, V101, P146, DOI 10.1016/j.fishres.2009.09.016; COBLE DW, 1985, CAN J FISH AQUAT SCI, V42, P791, DOI 10.1139/f85-101; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; Conrad JL, 2011, J FISH BIOL, V78, P395, DOI 10.1111/j.1095-8649.2010.02874.x; Cote IM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094248; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Cox SP, 2002, N AM J FISH MANAGE, V22, P21, DOI 10.1577/1548-8675(2002)022&lt;0021:MEIRFA&gt;2.0.CO;2; Crawley M.J., 2007, R BOOK; Deudero S, 2004, MAR BIOL, V145, P971, DOI 10.1007/s00227-004-1374-y; Dingemanse NJ, 2013, J ANIM ECOL, V82, P39, DOI 10.1111/1365-2656.12013; Dochtermann NA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2201; Donaldson MR, 2011, FISHERIES, V36, P385, DOI 10.1080/03632415.2011.597672; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Emslie MJ, 2015, CURR BIOL, V25, P983, DOI 10.1016/j.cub.2015.01.073; Font T, 2014, REV FISH SCI AQUAC, V22, P73, DOI 10.1080/10641262.2013.823907; Forcada A, 2009, MAR ECOL PROG SER, V379, P197, DOI 10.3354/meps07892; Francour P, 2001, AQUAT CONSERV, V11, P155, DOI 10.1002/aqc.442; Fujitani ML, 2012, ECOL APPL, V22, P597, DOI 10.1890/11-0603.1; Gell FR, 2003, TRENDS ECOL EVOL, V18, P448, DOI 10.1016/S0169-5347(03)00189-7; Godo OR, 1997, ICES J MAR SCI, V54, P273, DOI 10.1006/jmsc.1996.0167; Guidetti P, 2008, J MAR BIOL ASSOC UK, V88, P625, DOI 10.1017/S0025315408000933; Halpern BS, 2014, NATURE, V506, P167, DOI 10.1038/nature13053; Halpern BS, 2009, ENVIRON CONSERV, V36, P268, DOI 10.1017/S0376892910000032; Harkonen L, 2014, CAN J FISH AQUAT SCI, V71, P1900, DOI 10.1139/cjfas-2014-0221; Harrison HB, 2012, CURR BIOL, V22, P1023, DOI 10.1016/j.cub.2012.04.008; Hastings A, 2003, ECOL APPL, V13, pS65; Hilborn R, 2004, OCEAN COAST MANAGE, V47, P197, DOI 10.1016/j.ocecoaman.2004.04.001; HILBORN R, 1992; Hougaard P, 1999, BIOMETRICS, V55, P13, DOI 10.1111/j.0006-341X.1999.00013.x; Januchowski-Hartley FA, 2015, BIOL CONSERV, V182, P8, DOI 10.1016/j.biocon.2014.11.024; Januchowski-Hartley FA, 2013, ECOL LETT, V16, P191, DOI 10.1111/ele.12028; Januchowski-Hartley FA, 2012, MAR ECOL PROG SER, V469, P113, DOI 10.3354/meps09971; Januchowski-Hartley FA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022761; Karpouzi VS, 2003, J FISH BIOL, V62, P1353, DOI 10.1046/j.1095-8649.2003.00118.x; Klefoth T, 2011, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2011072; Klefoth T, 2013, FISHERIES MANAGEMENT, V20, P12; Klefoth T, 2012, BEHAV ECOL SOCIOBIOL, V66, P547, DOI 10.1007/s00265-011-1303-2; Kuparinen A, 2010, FISH RES, V105, P111, DOI 10.1016/j.fishres.2010.03.011; Letessier TB, 2015, J EXP MAR BIOL ECOL, V466, P120, DOI 10.1016/j.jembe.2015.02.013; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; LOKKEBORG S, 1989, CAN J FISH AQUAT SCI, V46, P1478, DOI 10.1139/f89-189; March D, 2014, FISH RES, V154, P63, DOI 10.1016/j.fishres.2014.01.020; Mittelbach GG, 2014, CAN J FISH AQUAT SCI, V71, P927, DOI 10.1139/cjfas-2013-0558; Moland E, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2679; Morales-Nin B, 2005, ICES J MAR SCI, V62, P727, DOI 10.1016/j.icesjms.2005.01.022; Olsen EM, 2012, ECOLOGY EVOLUTION, V2, P13; Paukert CP, 2001, FISHERIES, V26, P6, DOI 10.1577/1548-8446(2001)026&lt;0006:AOONPR&gt;2.0.CO;2; Perez-Ruzafa A, 2008, J NAT CONSERV, V16, P234, DOI 10.1016/j.jnc.2008.09.003; Philipp DP, 2009, T AM FISH SOC, V138, P189, DOI 10.1577/T06-243.1; Pine WE, 2009, FISHERIES, V34, P165, DOI 10.1577/1548-8446-34.4.165; Pinnegar JK, 2000, OECOLOGIA, V122, P399, DOI 10.1007/s004420050046; Pitcher T, 1993, PREDATION RISK FEEDI, P716; Planes S, 2009, P NATL ACAD SCI USA, V106, P5693, DOI 10.1073/pnas.0808007106; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RAAT A J P, 1985, Aquaculture and Fisheries Management, V16, P171, DOI 10.1111/j.1365-2109.1985.tb00305.x; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; Russ GR, 2004, OECOLOGIA, V138, P622, DOI 10.1007/s00442-003-1456-4; Seytre C, 2014, MAR FRESHWATER RES, V65, P244, DOI 10.1071/MF13080; Stelzenmuller V, 2008, MAR POLLUT BULL, V56, P2018, DOI 10.1016/j.marpolbul.2008.08.006; Sutter DAH, 2012, P NATL ACAD SCI USA, V109, P20960, DOI 10.1073/pnas.1212536109; van Poorten BT, 2005, N AM J FISH MANAGE, V25, P329, DOI 10.1577/M03-225.1; Villegas-Rios D, 2014, MAR ECOL PROG SER, V515, P239, DOI 10.3354/meps11018; Ward HGM, 2013, CAN J FISH AQUAT SCI, V70, P1542, DOI 10.1139/cjfas-2013-0264; Watson JR, 2011, ECOLOGY, V92, P1193, DOI 10.1890/10-1436.1	84	22	22	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135348	10.1371/journal.pone.0135348	http://dx.doi.org/10.1371/journal.pone.0135348			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275290	Green Published, Green Submitted, gold			2022-12-26	WOS:000359493600061
J	Kirov, JV; Adkisson, M; Nava, AJ; Cipollone, A; Willis, B; Engelhard, EK; Lloyd, KCK; de Jong, P; West, DB				Kirov, Julia V.; Adkisson, Michael; Nava, A. J.; Cipollone, Andreana; Willis, Brandon; Engelhard, Eric K.; Lloyd, K. C. Kent; de Jong, Pieter; West, David B.			Reporter Gene Silencing in Targeted Mouse Mutants Is Associated with Promoter CpG Island Methylation	PLOS ONE			English	Article							BODY-SPECIFIC METHYLATION; DNA METHYLATION; TRANSGENE EXPRESSION; X-CHROMOSOME; IN-VIVO; GENOME; TRANSCRIPTION; RESOURCE; INACTIVATION; LANDSCAPE	Targeted mutations in mouse disrupt local chromatin structure and may lead to unanticipated local effects. We evaluated targeted gene promoter silencing in a group of six mutants carrying the tm1a Knockout Mouse Project allele containing both a LacZ reporter gene driven by the native promoter and a neo selection cassette. Messenger RNA levels of the reporter gene and targeted gene were assessed by qRT-PCR, and methylation of the promoter CpG islands and LacZ coding sequence were evaluated by sequencing of bisulfite-treated DNA. Mutants were stratified by LacZ staining into presumed Silenced and Expressed reporter genes. Silenced mutants had reduced relative quantities LacZ mRNA and greater CpG Island methylation compared with the Expressed mutant group. Within the silenced group, LacZ coding sequence methylation was significantly and positively correlated with CpG Island methylation, while promoter CpG methylation was only weakly correlated with LacZ gene mRNA. The results support the conclusion that there is promoter silencing in a subset of mutants carrying the tm1a allele. The features of targeted genes which promote local silencing when targeted remain unknown.	[Kirov, Julia V.; Adkisson, Michael; Nava, A. J.; de Jong, Pieter; West, David B.] CHORI, Oakland, CA 94609 USA; [Cipollone, Andreana; Willis, Brandon; Engelhard, Eric K.; Lloyd, K. C. Kent] Univ Calif Davis, Mouse Biol Program, Davis, CA 95616 USA	Children's Hospital Oakland Research Institute; University of California System; University of California Davis	West, DB (corresponding author), CHORI, Oakland, CA 94609 USA.	dwest@chori.org			National Health Institutes [U42OD011175, U54HG006364, U01HG004080]; Children's Hospital Oakland Research Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006364, U01HG004080] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [U42OD011175] Funding Source: NIH RePORTER	National Health Institutes(National Health Research Institutes - Taiwan); Children's Hospital Oakland Research Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by U42OD011175 National Health Institutes DBW KCKL; U54HG006364 National Health Institutes DBW KCKL; U01HG004080 National Health Institutes PdJ; grant from the Children's Hospital Oakland Research Foundation DBW.	Aran D, 2011, HUM MOL GENET, V20, P670, DOI 10.1093/hmg/ddq513; Ayadi A, 2012, MAMM GENOME, V23, P600, DOI 10.1007/s00335-012-9418-y; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Birling Marie-Christine, 2009, Methods Mol Biol, V561, P245, DOI 10.1007/978-1-60327-019-9_16; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chevalier-Mariette C, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r53; Ciavatta D, 2006, P NATL ACAD SCI USA, V103, P9958, DOI 10.1073/pnas.0603754103; Cotton AM, 2015, HUM MOL GENET, V24, P1528, DOI 10.1093/hmg/ddu564; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Furst RW, 2012, J STEROID BIOCHEM, V130, P96, DOI 10.1016/j.jsbmb.2012.01.009; Galy B, 2004, RNA, V10, P1019, DOI 10.1261/rna.7220704; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; Gates H, 2011, METHODS, V53, P394, DOI 10.1016/j.ymeth.2010.12.017; Hadjantonakis Anna-Katerina, 2008, V461, P111, DOI 10.1007/978-1-60327-483-8_8; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Herbst F, 2012, MOL THER, V20, P1014, DOI 10.1038/mt.2012.46; Hyvarinen J, 2010, J BIOL CHEM, V285, P13646, DOI 10.1074/jbc.M109.084855; Illingworth RS, 2009, FEBS LETT, V583, P1713, DOI 10.1016/j.febslet.2009.04.012; Jjingo D, 2012, ONCOTARGET, V3, P462, DOI 10.18632/oncotarget.497; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lettice LA, 2002, P NATL ACAD SCI USA, V99, P7548, DOI 10.1073/pnas.112212199; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lloyd KCK, 2011, ANN NY ACAD SCI, V1245, P24, DOI 10.1111/j.1749-6632.2011.06311.x; MacDonald WA, 2014, MOL REPROD DEV, V81, P126, DOI 10.1002/mrd.22220; Maguire S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091807; Masser DR, 2013, EPIGENET CHROMATIN, V6, P33, DOI DOI 10.1186/1756-8935-6-33; Medvedeva YA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-119; Meier ID, 2010, FASEB J, V24, P1714, DOI 10.1096/fj.09-140749; Olson EN, 1996, CELL, V85, P1, DOI 10.1016/S0092-8674(00)81073-9; Rosser JM, 2010, GENE, V456, P15, DOI 10.1016/j.gene.2010.02.005; Ryder E, 2013, MAMM GENOME, V24, P286, DOI 10.1007/s00335-013-9467-x; Scacheri PC, 2001, GENESIS, V30, P259, DOI 10.1002/gene.1072; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tajima S, 2006, J BIOCHEM, V139, P705, DOI 10.1093/jb/mvj075; Voss AK, 1998, DEV DYNAM, V212, P171, DOI 10.1002/(SICI)1097-0177(199806)212:2<171::AID-AJA3>3.0.CO;2-E; Voss AK, 1998, DEV DYNAM, V212, P258; West DB, 2015, GENOME IN PRESS 0115; Whitelaw E, 2001, NAT GENET, V27, P361, DOI 10.1038/86850; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Zuniga AE, 2004, GENE DEV, V18, P1553, DOI 10.1101/gad.299904	47	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0134155	10.1371/journal.pone.0134155	http://dx.doi.org/10.1371/journal.pone.0134155			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275310	Green Published, gold, Green Submitted			2022-12-26	WOS:000359493600021
J	Zhu, CJ; Hua, F; Zhu, XL; Li, M; Wang, HX; Yu, XM; Li, Y				Zhu, Chuan-jiang; Hua, Fang; Zhu, Xiao-lu; Li, Meng; Wang, Hong-xu; Yu, Xiao-ming; Li, Yan			Stereoselective Regulation of P-gp Activity by Clausenamide Enantiomers in Caco-2, KB/KBv and Brain Microvessel Endothelial Cells	PLOS ONE			English	Article							TISSUE DISTRIBUTION; PROTEIN EXPRESSION; CYTOCHROME-P450 3A; GLYCOPROTEIN; RHODAMINE-123; METABOLISM; MONOLAYERS; SUBSTRATE; TRANSPORT; BINDING	The (-)- and (+)-clausenamide (CLA) enantiomers have different pharmacokinetic effects in animals, but their association with putative stereoselective regulation of P-glycoprotein (P-gp) remains unclear. Using three cells expressing P-gp-Caco-2, KBv and rat brain micro-vessel endothelial cells(RBMEC), this study investigated the association of CLA enantiomers with P-gp. The results showed that the rhodamine 123 (Rh123) accumulation, an indicator of P-gp activity, in Caco-2, KBv and RBMECs was increased by (-) CLA (1 or 5 mu mol/L) at 8.2%-28.5%, but reduced by (+) CLA at 11.7%-25.9%, showing stereoselectivity in their regulation of P-gp activity. Following co-treatment of these cells with each CLA enantiomer and verapamil as a P-gp inhibitor, the (+)-isomer clearly antagonized the inhibitory effects of verapamil on P-gp efflux, whereas the (-)-isomer had slightly synergistic or additive effects. When higher concentrations (5 or 10 mu mol/L) of CLA enantiomers were added, the stimulatory effects of the (+)-isomer were converted into inhibitory ones, leading to an enhanced intracellular uptake of Rh123 by 24.5%-58.2%; but (-)-isomer kept its inhibition to P-gp activity, causing 30.0%-63.0% increase in the Rh123 uptake. The biphasic effects of (+) CLA were confirmed by CLA uptake in the Caco-2 cells. (+) CLA at 1 mu mol/L had significantly lower intracellular uptake than (-) CLA with a ratio[(-)/(+)] of 2.593, which was decreased to 2.167 and 1.893 after CLA concentrations increased to 2.5 and 5 mu mol/L. Besides, in the non-induced KB cells, (+) CLA(5 mu mol/L) upregulated P-gp expression at 54.5% relative to vehicle control, and decreased Rh123 accumulation by 28.2%, while (-) CLA(5 mu mol/L) downregulated P-gp expression at 15.9% and increased Rh123 accumulation by 18.0%. These results suggested that (-) CLA could be a P-gp inhibitor and (+) CLA could be a modulator with concentration-dependent biphasic effects on P-gp activity, which may result in drug-drug interactions when combined with other P-gp substrate drugs.	[Zhu, Chuan-jiang; Hua, Fang; Zhu, Xiao-lu; Li, Meng; Wang, Hong-xu; Yu, Xiao-ming; Li, Yan] Chinese Acad Med Sci, Inst Mat Med, Beijing 100050, Peoples R China; [Zhu, Chuan-jiang; Hua, Fang; Zhu, Xiao-lu; Li, Meng; Wang, Hong-xu; Yu, Xiao-ming; Li, Yan] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhu, Chuan-jiang; Li, Yan] Beijing Key Lab Nonclin Drug Metab & PK PD Study, Beijing, Peoples R China; [Zhu, Chuan-jiang] Beijing Key Lab New Drug Mech & Pharmacol Evaluat, Beijing, Peoples R China; [Yu, Xiao-ming] Beijing Key Lab Act Subst Discovery & Druggabil E, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zhu, CJ (corresponding author), Chinese Acad Med Sci, Inst Mat Med, Beijing 100050, Peoples R China.	zhucj@imm.ac.cn	meng, li/GVT-2063-2022; Zhu, Xiao/AAV-2637-2021		National Natural Science Foundation of China [30873117]; Major Scientific and Technological Special Project for "Significant New Drugs Creation" [2009ZX09501-018, 2009ZX09301-003-51, 2012ZX09301-002-001-002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Scientific and Technological Special Project for "Significant New Drugs Creation"	This work was supported by the grants from the National Natural Science Foundation of China (30873117, http://www.nsfc.gov.cn/, CJZ), and the Major Scientific and Technological Special Project for "Significant New Drugs Creation" (http://www.most.gov.cn/; 2009ZX09501-018, CJZ, XMY; 2009ZX09301-003-51, CJZ, YL; 2012ZX09301-002-001-002, CJZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmeier CJ, 2011, BIOPHARM DRUG DISPOS, V32, P233, DOI 10.1002/bdd.753; Chen Y, 2009, J PHARMACOL EXP THER, V330, P956, DOI 10.1124/jpet.109.154781; Duan Wenzhen, 1998, Yaoxue Xuebao, V33, P259; Duan WZ, 1998, ACTA PHARMACOL SIN, V19, P332; Fontaine M, 1996, LIFE SCI, V59, P1521, DOI 10.1016/0024-3205(96)00483-3; Glaeser H, 2011, HANDB EXP PHARMACOL, V201, P285, DOI 10.1007/978-3-642-14541-4_7; Hochman JH, 2000, J PHARMACOL EXP THER, V292, P310; Iwanaga K, 2011, BIOL PHARM BULL, V34, P1246, DOI 10.1248/bpb.34.1246; Karwatsky J, 2003, BIOCHEMISTRY-US, V42, P12163, DOI 10.1021/bi034149+; Kirby B, 2006, J CLIN PHARMACOL, V46, P1313, DOI 10.1177/0091270006292625; Kondratov RV, 2001, P NATL ACAD SCI USA, V98, P14078, DOI 10.1073/pnas.241314798; Litman T, 1997, BBA-MOL BASIS DIS, V1361, P169, DOI 10.1016/S0925-4439(97)00027-6; Liu Shaolin, 1998, Yaoxue Xuebao, V33, P254; Liu ShaoLin, 1999, Acta Pharmaceutica Sinica, V34, P325; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Meyer RP, 2007, CURR DRUG METAB, V8, P297, DOI 10.2174/138920007780655478; Qian ZY, 1999, CHIN J CELL BIOL, V21, P42; Rao EC, 1994, ACTA PHARMACOL SIN, V29, P502; Sachs-Barrable K, 2007, J PHARM PHARM SCI, V10, P319; Schuetz EG, 1996, MOL PHARMACOL, V49, P311; Shen SJ, 2007, CHIRALITY, V19, P485, DOI 10.1002/chir.20400; Swed A, 2009, MOL PHARMACEUT, V6, P1883, DOI 10.1021/mp900170y; Tang FX, 2004, J PHARM SCI-US, V93, P1185, DOI 10.1002/jps.20046; Tian Y, 2012, ACTA PHARM SIN B, V2, P168, DOI 10.1016/j.apsb.2012.02.005; WACHER VJ, 1995, MOL CARCINOGEN, V13, P129, DOI 10.1002/mc.2940130302; YANG M-H, 1987, Yaoxue Xuebao, V22, P33; YANG MH, 1987, ACTA CHIM SINICA, V45, P1170; Yumoto R, 1999, J PHARMACOL EXP THER, V289, P149; Zhang XH, 1994, ACTA PHARMACOL SINIC, V29, P246; Zhang Y, 2010, CANCER CHEMOTH PHARM, V66, P851, DOI 10.1007/s00280-009-1229-9; Zhu CJ, 2009, CHIRALITY, V21, P402, DOI 10.1002/chir.20623; Zhu CJ, 2013, EUR J PHARM SCI, V49, P761, DOI 10.1016/j.ejps.2013.04.033; Zhu CJ, 2003, CHIRALITY, V15, P668, DOI 10.1002/chir.10278; Zhu CJ, 2003, CHIRALITY, V15, P448, DOI 10.1002/chir.10228	34	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135866	10.1371/journal.pone.0135866	http://dx.doi.org/10.1371/journal.pone.0135866			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295572	Green Published, gold, Green Submitted			2022-12-26	WOS:000359926900046
J	Liu, XC; Lian, W; Zhang, LJ; Feng, XC; Gao, Y; Li, SX; Liu, C; Cheng, Y; Yang, L; Wang, XJ; Chen, L; Wang, RQ; Chai, J; Chen, WS				Liu, Xiao-cong; Lian, Wei; Zhang, Liang-jun; Feng, Xin-chan; Gao, Yu; Li, Shao-xue; Liu, Chang; Cheng, Ying; Yang, Long; Wang, Xiao-Juan; Chen, Lei; Wang, Rong-quan; Chai, Jin; Chen, Wen-sheng			Interleukin-18 Down-Regulates Multidrug Resistance-Associated Protein 2 Expression through Farnesoid X Receptor Associated with Nuclear Factor Kappa B and Yin Yang 1 in Human Hepatoma HepG2 Cells	PLOS ONE			English	Article							PRIMARY BILIARY-CIRRHOSIS; BILE-ACID TRANSPORTERS; NECROSIS-FACTOR-ALPHA; OBSTRUCTIVE CHOLESTASIS; LIVER-INJURY; RAT-LIVER; MRP2; MECHANISMS; PATHWAY; GENES	Multidrug resistance-associated protein 2 (MRP2) plays an important role in bile acid metabolism by transporting toxic organic anion conjugates, including conjugated bilirubin, glutathione, sulfate, and multifarious drugs. MRP2 expression is reduced in cholestatic patients and rodents. However, the molecular mechanism of MRP2 down-regulation remains elusive. In this report, we treated human hepatoma HepG2 cells with interleukin-18 (IL-18) and measured the expression of MRP2, nuclear factor kappa B (NF-kappa B), farnesoid X receptor (FXR), and the transcription factor Yin Yang 1 (YY1) by quantitative real-time quantitative polymerase chain reaction (PCR) and western blotting. We found that expression of MRP2 was repressed by IL-18 at both the mRNA and protein levels in a dose-and time-dependent manner. Furthermore, the activated NF-kappa B pathway increased YY1 and reduced FXR. These changes were all attenuated in HepG2 cells with knockdown of the NF-kappa B subunit, p65. The reduced expression of FXR and MRP2 in HepG2 cells that had been caused by IL-18 treatment was also attenuated by YY1 knockdown. We further observed significantly elevated IL-18, NF-kappa B, and YY1 expression and decreased FXR and MRP2 expression in bile duct-ligated Sprague Dawley rat livers. Chromatin immunoprecipitation assays also showed that FXR bound to the promoter region in MRP2 was less abundant in liver extracts from bile duct-ligated rats than sham-operated rats. Our findings indicate that IL-18 down-regulates MRP2 expression through the nuclear receptor FXR in HepG2 cells, and may be mediated by NF-kappa B and YY1.	[Liu, Xiao-cong; Lian, Wei; Zhang, Liang-jun; Feng, Xin-chan; Gao, Yu; Li, Shao-xue; Liu, Chang; Cheng, Ying; Yang, Long; Chen, Lei; Wang, Rong-quan; Chai, Jin; Chen, Wen-sheng] Third Mil Med Univ, Dept Gastroenterol, Southwest Hosp, Chongqing, Peoples R China; [Liu, Xiao-cong] Chengdu Mil Gen Hosp, Dept Gastroenterol, Chengdu, Sichuan, Peoples R China; [Wang, Xiao-Juan] Chengdu Mil Gen Hosp, Dept Burn & Plast Surg, Chengdu, Sichuan, Peoples R China	Army Medical University	Chen, WS (corresponding author), Third Mil Med Univ, Dept Gastroenterol, Southwest Hosp, Chongqing, Peoples R China.	wenshengchen@hotmail.com	Zhang, Liang/GWM-6088-2022	Wang, Rongquan/0000-0001-5307-0086; Chai, Jin/0000-0002-8543-4566	National Natural Science Foundation of China [81170430, 81370560, 81470850, 81470880, 81101427]; Chongqing Natural Science Foundation of China [CSTC 2012jjB0079]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing Natural Science Foundation of China	This work was supported by National Natural Science Foundation of China (81170430 to W.S. Chen, 81370560 to W.S. Chen, 81470850 to L Chen, 81470880 to J Chai and 81101427 to X.J. Wang) and Chongqing Natural Science Foundation of China (CSTC 2012jjB0079 to W.S. Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chai J, 2012, HEPATOLOGY, V55, P1485, DOI 10.1002/hep.24801; Chen HL, 2008, PEDIATR RES, V63, P667, DOI 10.1203/PDR.0b013e318170a6b5; Cherrington NJ, 2013, AM J PHYSIOL-GASTR L, V304, pG48, DOI 10.1152/ajpgi.00317.2012; Dawiskiba Janusz, 2002, HPB (Oxford), V4, P11, DOI 10.1080/136518202753598681; Denson LA, 2000, J BIOL CHEM, V275, P8835, DOI 10.1074/jbc.275.12.8835; El-Sayed IH, 2003, CLIN CHIM ACTA, V336, P123, DOI 10.1016/S0009-8981(03)00336-X; Geier A, 2003, HEPATOLOGY, V38, P345, DOI 10.1053/jhep.2003.50317; Grube M, 2005, DRUG METAB DISPOS, V33, P31, DOI 10.1124/dmd.104.001560; Halilbasic E, 2013, J HEPATOL, V58, P155, DOI 10.1016/j.jhep.2012.08.002; Jedlitschky G, 2006, EXPERT OPIN DRUG MET, V2, P351, DOI 10.1517/17425255.2.3.351; Jin Ping, 2011, Zhonghua Fu Chan Ke Za Zhi, V46, P329; Kast HR, 2002, J BIOL CHEM, V277, P2908, DOI 10.1074/jbc.M109326200; Keppler D, 1996, Prog Liver Dis, V14, P55; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; Kojima H, 1998, BIOCHEM BIOPH RES CO, V244, P183, DOI 10.1006/bbrc.1998.8236; Kubitz R, 1999, GASTROENTEROLOGY, V116, P401, DOI 10.1016/S0016-5085(99)70138-1; Kullak-Ublick GA, 2002, HEPATOL RES, V23, P78, DOI 10.1016/S1386-6346(01)00159-0; Lickteig AJ, 2007, DRUG METAB DISPOS, V35, P402, DOI 10.1124/dmd.106.012138; Lu Y, 2014, GUT, V63, P170, DOI 10.1136/gutjnl-2012-303150; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Martinez-Paniagua MA, 2012, MOL CANCER THER, V11, P572, DOI 10.1158/1535-7163.MCT-11-0635; Matsumoto S, 1997, BIOCHEM BIOPH RES CO, V234, P454, DOI 10.1006/bbrc.1997.6665; Russell DW, 1999, CELL, V97, P539, DOI 10.1016/S0092-8674(00)80763-1; Shoda J, 2001, AM J GASTROENTEROL, V96, P3368; Siewert E, 2004, BIOCHEM BIOPH RES CO, V322, P232, DOI 10.1016/j.bbrc.2004.07.102; Sun PY, 2014, PHARMACOL REP, V66, P311, DOI 10.1016/j.pharep.2014.02.013; Thomas MJ, 1999, GENE, V236, P197, DOI 10.1016/S0378-1119(99)00261-9; Trauner M, 1997, GASTROENTEROLOGY, V113, P255, DOI 10.1016/S0016-5085(97)70103-3; Trauner M, 2005, J CLIN GASTROENTEROL, V39, pS111, DOI 10.1097/01.mcg.0000155551.37266.26; Trauner M, 1998, NEW ENGL J MED, V339, P1217, DOI 10.1056/NEJM199810223391707; Wang HT, 2007, MOL CELL BIOL, V27, P4374, DOI 10.1128/MCB.02020-06; Wen X, 2014, AM J PATHOL, V184, P1299, DOI 10.1016/j.ajpath.2014.01.025; Yamada T, 2005, LANGENBECK ARCH SURG, V390, P421, DOI 10.1007/s00423-005-0564-5; Yamamoto N, 2008, INT J MOL MED, V22, P43; Yamano T, 2000, CLIN EXP IMMUNOL, V122, P227, DOI 10.1046/j.1365-2249.2000.01356.x; Zhang JH, 2014, GENE, V537, P230, DOI 10.1016/j.gene.2013.12.062; Zollner G, 2001, HEPATOLOGY, V33, P633, DOI 10.1053/jhep.2001.22646	38	3	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136215	10.1371/journal.pone.0136215	http://dx.doi.org/10.1371/journal.pone.0136215			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26292095	Green Submitted, Green Published, gold			2022-12-26	WOS:000359919900066
J	Ma, LB; Liu, XY; Wang, FM; He, XY; Chen, S; Li, WD				Ma, LiBing; Liu, Xiyu; Wang, FengMei; He, XiaoYing; Chen, Shan; Li, Wenda			Different Donor Cell Culture Methods Can Influence the Developmental Ability of Cloned Sheep Embryos	PLOS ONE			English	Article							SERUM STARVATION; NUCLEAR TRANSFER; CONTACT INHIBITION; CYCLE SYNCHRONIZATION; IN-VITRO; DEPENDENT INHIBITION; FIBROBLAST CELLS; BOVINE EMBRYOS; GRANULOSA; OOCYTES	It was proposed that arresting nuclear donor cells in G0/G1 phase facilitates the development of embryos that are derived from somatic cell nuclear transfer (SCNT). Full confluency or serum starvation is commonly used to arrest in vitro cultured somatic cells in G0/G1 phase. However, it is controversial as to whether these two methods have the same efficiency in arresting somatic cells in G0/G1 phase. Moreover, it is unclear whether the cloned embryos have comparable developmental ability after somatic cells are subjected to one of these methods and then used as nuclear donors in SCNT. In the present study, in vitro cultured sheep skin fibroblasts were divided into four groups: (1) cultured to 70-80% confluency (control group), (2) cultured to full confluency, (3) starved in low serum medium for 4 d, or (4) cultured to full confluency and then further starved for 4 d. Flow cytometry was used to assay the percentage of fibroblasts in G0/G1 phase, and cell counting was used to assay the viability of the fibroblasts. Then, real-time reverse transcription PCR was used to determine the levels of expression of several cell cycle-related genes. Subsequently, the four groups of fibroblasts were separately used as nuclear donors in SCNT, and the developmental ability and the quality of the cloned embryos were compared. The results showed that the percentage of fibroblasts in G0/G1 phase, the viability of fibroblasts, and the expression levels of cell cycle-related genes was different among the four groups of fibroblasts. Moreover, the quality of the cloned embryos was comparable after these four groups of fibroblasts were separately used as nuclear donors in SCNT. However, cloned embryos derived from fibroblasts that were cultured to full confluency combined with serum starvation had the highest developmental ability. The results of the present study indicate that there are synergistic effects of full confluency and serum starvation on arresting fibroblasts in G0/G1 phase, and the short-term treatment of nuclear donor cells with these two methods could improve the efficiency of SCNT.	[Ma, LiBing; Liu, Xiyu; He, XiaoYing; Chen, Shan; Li, Wenda] Inner Mongolia Univ Sci & Technol, Sch Math Phys & Biol Engn, Baotou, Inner Mongolia, Peoples R China; [Wang, FengMei] Baotou Light Ind Vocat Tech Coll, Baotou, Inner Mongolia, Peoples R China	Inner Mongolia University of Science & Technology	Ma, LB (corresponding author), Inner Mongolia Univ Sci & Technol, Sch Math Phys & Biol Engn, Baotou, Inner Mongolia, Peoples R China.	mlb-xn2004@163.com			National Natural Science Foundation of China [31160245]; Natural Science Foundation of Inner Mongolia Autonomous Region of China [2012MS0503]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Inner Mongolia Autonomous Region of China	This work was funded by National Natural Science Foundation of China, grant number 31160245; National Natural Science Foundation of China (http://www.nsfc.gov.cn/), to Ma LiBing; and Natural Science Foundation of Inner Mongolia Autonomous Region of China, grant number 2012MS0503 (http://www.nmkjt.gov.cn/), to He XiaoYing.	Arat S, 2001, MOL REPROD DEV, V60, P20, DOI 10.1002/mrd.1057; Bhojwani S, 2007, THERIOGENOLOGY, V67, P341, DOI 10.1016/j.theriogenology.2006.08.006; Campbell K H, 1996, Rev Reprod, V1, P40, DOI 10.1530/ror.0.0010040; Chiu A, 2007, BLOOD, V109, P729, DOI 10.1182/blood-2006-04-015958; Coller HA, 2006, PLOS BIOL, V4, P329, DOI 10.1371/journal.pbio.0040083; Cooper S, 2003, FASEB J, V17, P333, DOI 10.1096/fj.02-0352rev; Curto M, 2007, J CELL BIOL, V177, P893, DOI 10.1083/jcb.200703010; Dalman A, 2010, REPROD DOMEST ANIM, V45, pE46, DOI 10.1111/j.1439-0531.2009.01520.x; de Barros FRO, 2010, REPROD DOMEST ANIM, V45, P38, DOI 10.1111/j.1439-0531.2008.01201.x; Galli C, 2003, NATURE, V424, P635, DOI 10.1038/424635a; Golpour M, 2014, INT J MOL CELL MED, V3, P74; Gos M, 2005, CELL PROLIFERAT, V38, P107, DOI 10.1111/j.1365-2184.2005.00334.x; GUSTINCICH S, 1993, CELL GROWTH DIFFER, V4, P753; Hayes O, 2005, ANIM REPROD SCI, V87, P181, DOI 10.1016/j.anireprosci.2004.11.011; Hua S, 2007, CLONING STEM CELLS, V9, P237, DOI 10.1089/clo.2006.0020; Iuso D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051317; Khammanit R, 2008, THERIOGENOLOGY, V70, P27, DOI 10.1016/j.theriogenology.2008.02.015; Kim JH, 2011, J CELL SCI, V124, P1280, DOI 10.1242/jcs.078394; Kim MK, 2007, CLONING STEM CELLS, V9, P130, DOI 10.1089/clo.2006.0034; LEVINE EM, 1965, P NATL ACAD SCI USA, V53, P350, DOI 10.1073/pnas.53.2.350; Ma LB, 2014, INDIAN J ANIM RES, V48, P221, DOI 10.5958/j.0976-0555.48.3.047; Ma LB, 2008, MOL REPROD DEV, V75, P33, DOI 10.1002/mrd.20736; Ma LB, 2014, ZYGOTE, V22, P540, DOI 10.1017/S0967199413000129; Ma LB, 2014, ANIM CELLS SYST, V18, P161, DOI 10.1080/19768354.2014.927397; Moulavi F, 2013, REPRODUCTION, V145, P345, DOI 10.1530/REP-12-0318; Rickert RC, 2011, IMMUNOL REV, V244, P115, DOI 10.1111/j.1600-065X.2011.01067.x; Sanchez E, 2012, BRIT J HAEMATOL, V158, P727, DOI 10.1111/j.1365-2141.2012.09241.x; Shin JS, 2008, INT J ONCOL, V32, P435; Sung LY, 2006, NAT GENET, V38, P1323, DOI 10.1038/ng1895; Swat A, 2009, MOL CELL BIOL, V29, P3332, DOI 10.1128/MCB.01955-08; Wani NA, 2010, BIOL REPROD, V82, P373, DOI 10.1095/biolreprod.109.081083; Wells DN, 2003, THERIOGENOLOGY, V59, P45, DOI 10.1016/S0093-691X(02)01273-6; Wen BQ, 2014, THERIOGENOLOGY, V81, P332, DOI 10.1016/j.theriogenology.2013.09.032; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wittayarat M, 2013, REPROD DOMEST ANIM, V48, P305, DOI 10.1111/j.1439-0531.2012.02149.x; Zimmermann O, 2006, J VASC RES, V43, P157, DOI 10.1159/000090945	36	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135344	10.1371/journal.pone.0135344	http://dx.doi.org/10.1371/journal.pone.0135344			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291536	Green Published, Green Submitted, gold			2022-12-26	WOS:000359919900017
J	Yang, XP; Hu, HJ; Yu, DZ; Sun, ZH; He, XJ; Zhang, JG; Chen, QL; Tian, R; Fan, J				Yang, Xiaoping; Hu, Hongju; Yu, Dazhao; Sun, Zhonghai; He, Xiujuan; Zhang, Jingguo; Chen, Qiliang; Tian, Rui; Fan, Jing			Candidate Resistant Genes of Sand Pear (Pyrus pyrifolia Nakai) to Alternaria alternata Revealed by Transcriptome Sequencing	PLOS ONE			English	Article							JAPANESE PEAR; IDENTIFICATION; VARIABILITY; RIN4	Pear black spot (PBS) disease, which is caused by Alternaria alternata (Aa), is one of the most serious diseases affecting sand pear (Pyrus pyrifolia Nakai) cultivation worldwide. To investigate the defense mechanisms of sand pear in response to Aa, the transcriptome of a sand pear germplasm with differential resistance to Aa was analyzed using Illumina paired-end sequencing. Four libraries derived from PBS-resistant and PBS-susceptible sand pear leaves were characterized through inoculation or mock-inoculation. In total, 20.5 Gbp of sequence data and 101,632,565 reads were generated, representing 44717 genes. Approximately 66% of the genes or sequenced reads could be aligned to the pear reference genome. A large number (5213) of differentially expressed genes related to PBS resistance were obtained; 34 microsatellites were detected in these genes, and 28 genes were found to be closely related to PBS resistance. Using a transcriptome analysis in response to PBS inoculation and comparison analysis to the PHI database, 4 genes (Pbr039001, Pbr001627, Pbr025080 and Pbr023112) were considered to be promising candidates for sand pear resistance to PBS. This study provides insight into changes in the transcriptome of sand pear in response to PBS infection, and the findings have improved our understanding of the resistance mechanism of sand pear to PBS and will facilitate future gene discovery and functional genome studies of sand pear.	[Yang, Xiaoping; Yu, Dazhao] Wuhan Univ, Sch Life Sci, Wuhan 430072, Hubei, Peoples R China; [Yang, Xiaoping; Hu, Hongju; Sun, Zhonghai; He, Xiujuan; Zhang, Jingguo; Chen, Qiliang; Tian, Rui; Fan, Jing] Hubei Acad Agr Sci, Res Inst Fruit & Tea, Wuhan 430064, Hubei, Peoples R China; [Yu, Dazhao] Hubei Lab Crop Dis Insect Pests & Weeds Control, Wuhan 430064, Hubei, Peoples R China	Wuhan University; Hubei Academy of Agricultural Sciences	Yu, DZ (corresponding author), Wuhan Univ, Sch Life Sci, Wuhan 430072, Hubei, Peoples R China.	dazhaoyu@china.com; hbfruit@126.com			Ministry of Science and Technology of China [2011AA100206]; Construction of Modern Agricultural Industry Technology System [nycytx-29-23]; Hubei Agricultural Science and Technology Innovation Fund [2011-620-005-003-01]; Young Scientist Foundation of Hubei Academy of Agricultural Sciences [2013NKYJJ14]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Construction of Modern Agricultural Industry Technology System; Hubei Agricultural Science and Technology Innovation Fund; Young Scientist Foundation of Hubei Academy of Agricultural Sciences	This research was financially supported by the Ministry of Science and Technology of China (no. 2011AA100206), The Construction of Modern Agricultural Industry Technology System (no. nycytx-29-23), Hubei Agricultural Science and Technology Innovation Fund (no. 2011-620-005-003-01), and Young Scientist Foundation of Hubei Academy of Agricultural Sciences (no. 2013NKYJJ14).	Bao L, 2008, SCI HORTIC-AMSTERDAM, V116, P374, DOI 10.1016/j.scienta.2008.02.008; Bassil N, 2010, GENET RESOUR CROP EV, V57, P357, DOI 10.1007/s10722-009-9474-7; Demirbas A, 2001, CROP SCI, V41, P1220, DOI 10.2135/cropsci2001.4141220x; Donald TM, 2002, THEOR APPL GENET, V104, P610, DOI 10.1007/s00122-001-0768-1; Dondini L, 2004, MOL BREEDING, V14, P407, DOI 10.1007/s11032-004-0505-y; Faize Mohamed, 2007, Journal of General Plant Pathology, V73, P104, DOI 10.1007/s10327-006-0330-8; Gururani MA, 2012, PHYSIOL MOL PLANT P, V78, P51, DOI 10.1016/j.pmpp.2012.01.002; Hou L, 2013, J INTEGR AGR, V12, P2197, DOI 10.1016/S2095-3119(13)60293-2; Kaneyoshi J, 2001, PLANT CELL REP, V20, P622, DOI 10.1007/s002990100380; Karasov TL, 2014, CURR OPIN PLANT BIOL, V18, P24, DOI 10.1016/j.pbi.2013.12.003; Katula-Debreceni D, 2010, SCI HORTIC-AMSTERDAM, V126, P448, DOI 10.1016/j.scienta.2010.08.012; Ke XW, 2014, FUNGAL GENET BIOL, V68, P31, DOI 10.1016/j.fgb.2014.04.004; Knight SC, 1997, ANNU REV PHYTOPATHOL, V35, P349, DOI 10.1146/annurev.phyto.35.1.349; Krajaejun T, 2014, FUNGAL BIOL, P31; Lei CL, 2013, CROP J, V1, P2, DOI 10.1016/j.cj.2013.07.007; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Liu J, 2011, CELL HOST MICROBE, V9, P137, DOI 10.1016/j.chom.2011.01.010; Liu MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046766; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mackey D, 2002, CELL, V108, P743, DOI 10.1016/S0092-8674(02)00661-X; Reis RF, 2007, SCI HORTIC-AMSTERDAM, V113, P336, DOI 10.1016/j.scienta.2007.04.005; Sanzani SM, 2010, POSTHARVEST BIOL TEC, V56, P1, DOI 10.1016/j.postharvbio.2009.11.010; Shan JW, 2013, GENOMICS, V102, P388, DOI 10.1016/j.ygeno.2013.07.001; Terakami S, 2006, THEOR APPL GENET, V113, P743, DOI 10.1007/s00122-006-0344-9; Terakami S, 2009, J JPN SOC HORTIC SCI, V78, P417, DOI 10.2503/jjshs1.78.417; Wolko L, 2010, GENET RESOUR CROP EV, V57, P801, DOI 10.1007/s10722-010-9587-z; Wu J, 2013, GENOME RES, V23, P396, DOI 10.1101/gr.144311.112; Wu Tao, 2012, African Journal of Agricultural Research, V7, P3701; Zhang HL, 2011, SCI HORTIC-AMSTERDAM, V127, P282, DOI 10.1016/j.scienta.2010.10.016; Zhang JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-90; Zou D, 2013, GENOMICS, V102, P57, DOI 10.1016/j.ygeno.2013.02.014	31	17	19	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135046	10.1371/journal.pone.0135046	http://dx.doi.org/10.1371/journal.pone.0135046			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26292286	Green Submitted, Green Published, gold			2022-12-26	WOS:000359919900013
J	Horng, JL; Chao, PL; Chen, PY; Shih, TH; Lin, LY				Horng, Jiun-Lin; Chao, Pei-Lin; Chen, Po-Yen; Shih, Tin-Han; Lin, Li-Yih			Aquaporin 1 Is Involved in Acid Secretion by Ionocytes of Zebrafish Embryos through Facilitating CO2 Transport	PLOS ONE			English	Article							ATPASE-RICH CELLS; KILLIFISH FUNDULUS-HETEROCLITUS; RELATIVE CO2/NH3 SELECTIVITIES; DEPENDENT SODIUM UPTAKE; AMMONIA EXCRETION; MOLECULAR-MECHANISMS; SEAWATER ACCLIMATION; CARBONIC-ANHYDRASE; XENOPUS OOCYTES; BASE REGULATION	Mammalian aquaporin 1 (AQP1) is well known to function as a membrane channel for H2O and CO2 transport. Zebrafish AQP1a.1 (the homologue of mammalian AQP1) was recently identified in ionocytes of embryos; however its role in ionocytes is still unclear. In this study, we hypothesized that zebrafish AQP1a.1 is involved in the acid secretion by ionocytes through facilitating H2O and CO2 diffusion. A real-time PCR showed that mRNA levels of AQP1a.1 in embryos were induced by exposure to 1% CO2 hypercapnia for 3 days. In situ hybridization and immunohistochemistry showed that the AQP1a. 1 transcript was highly expressed by acid-secreting ionocytes, i.e., H+-ATPase-rich (HR) cells. A scanning ion-selective electrode technique (SIET) was applied to analyze CO2-induced H+ secretion by individual ionocytes in embryos. H+ secretion by HR cells remarkably increased after a transient loading of CO2 (1% for 10 min). AQP1a.1 knockdown with morpholino oligonucleotides decreased the H+ secretion of HR cells by about half and limited the CO2 stimulated increase. In addition, exposure to an AQP inhibitor (PCMB) for 10 min also suppressed CO2-induced H+ secretion. Results from this study support our hypothesis and provide in vivo evidence of the physiological role of AQP1 in CO2 transport.	[Horng, Jiun-Lin] Taipei Med Univ, Coll Med, Sch Med, Dept Anat & Cell Biol, Taipei, Taiwan; [Chao, Pei-Lin; Chen, Po-Yen; Shih, Tin-Han; Lin, Li-Yih] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan	Taipei Medical University; National Taiwan Normal University	Lin, LY (corresponding author), Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan.	linly@ntnu.edu.tw			Ministry of Science and Technology of Taiwan [101-2311-B-003 -004 -MY3]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the grant (101-2311-B-003 -004 -MY3) of the Ministry of Science and Technology of Taiwan.	Boron WF, 2006, J AM SOC NEPHROL, V17, P2368, DOI 10.1681/ASN.2006060620; Chen LM, 2010, AM J PHYSIOL-REG I, V299, pR1163, DOI 10.1152/ajpregu.00319.2010; Choi YJ, 2013, COMP BIOCHEM PHYS A, V165, P228, DOI 10.1016/j.cbpa.2013.03.013; Cutler CP, 2007, COMP BIOCHEM PHYS A, V148, P82, DOI 10.1016/j.cbpa.2006.09.022; Dymowska AK, 2012, RESP PHYSIOL NEUROBI, V184, P282, DOI 10.1016/j.resp.2012.08.025; Endeward V, 2006, FASEB J, V20, P1974, DOI 10.1096/fj.04-3300com; Geyer RR, 2013, AM J PHYSIOL-CELL PH, V304, pC985, DOI 10.1152/ajpcell.00033.2013; Giffard-Mena I, 2007, COMP BIOCHEM PHYS A, V148, P430, DOI 10.1016/j.cbpa.2007.06.002; Gilmour KM, 2009, J EXP BIOL, V212, P1647, DOI 10.1242/jeb.029181; Hamm LL, 2008, SELDIN GIEBSCHS KIDN; Herrera M, 2007, AM J PHYSIOL-RENAL, V292, pF1443, DOI 10.1152/ajprenal.00353.2006; Herrera M, 2006, HYPERTENSION, V48, P157, DOI 10.1161/01.HYP.0000223652.29338.77; Herrera M, 2011, PFLUG ARCH EUR J PHY, V462, P623, DOI 10.1007/s00424-011-1002-x; Hirano Y, 2010, BIOPHYS J, V98, P1512, DOI 10.1016/j.bpj.2009.12.4310; Holm LM, 2005, PFLUG ARCH EUR J PHY, V450, P415, DOI 10.1007/s00424-005-1399-1; Horng JL, 2007, AM J PHYSIOL-REG I, V292, pR2068, DOI 10.1152/ajpregu.00578.2006; Horng JL, 2009, AM J PHYSIOL-CELL PH, V296, pC682, DOI 10.1152/ajpcell.00576.2008; Hwang P.P., 2013, PHYSL FISHES; Hwang PP, 2011, AM J PHYSIOL-REG I, V301, pR28, DOI 10.1152/ajpregu.00047.2011; Ip YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061163; Ishibashi K, 2009, CLIN EXP NEPHROL, V13, P107, DOI 10.1007/s10157-008-0118-6; Jung D, 2012, TOXICOL SCI, V127, P101, DOI 10.1093/toxsci/kfs078; Katoh F, 2003, J EXP BIOL, V206, P793, DOI 10.1242/jeb.00159; Kim YK, 2014, COMP BIOCHEM PHYS A, V171, P1, DOI 10.1016/j.cbpa.2014.01.012; Kwong RWM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070764; Lee YC, 2011, AM J PHYSIOL-CELL PH, V300, pC295, DOI 10.1152/ajpcell.00263.2010; Lignot JH, 2002, J EXP BIOL, V205, P2653; Lin LY, 2013, AM J PHYSIOL-CELL PH, V305, pC1060, DOI 10.1152/ajpcell.00077.2013; Lin LY, 2006, AM J PHYSIOL-CELL PH, V290, pC371, DOI 10.1152/ajpcell.00281.2005; Lin TY, 2008, AM J PHYSIOL-CELL PH, V294, pC1250, DOI 10.1152/ajpcell.00021.2008; Liu ST, 2013, AM J PHYSIOL-REG I, V305, pR242, DOI 10.1152/ajpregu.00047.2013; Musa-Aziz R, 2009, P NATL ACAD SCI USA, V106, P5406, DOI 10.1073/pnas.0813231106; Nakhoul NL, 1998, AM J PHYSIOL-CELL PH, V274, pC543, DOI 10.1152/ajpcell.1998.274.2.C543; Prasad GVR, 1998, J BIOL CHEM, V273, P33123, DOI 10.1074/jbc.273.50.33123; Shih TH, 2013, AM J PHYSIOL-REG I, V304, pR1130, DOI 10.1152/ajpregu.00550.2012; Shih TH, 2012, AM J PHYSIOL-REG I, V302, pR84, DOI 10.1152/ajpregu.00318.2011; Shih TH, 2008, AM J PHYSIOL-CELL PH, V295, pC1625, DOI 10.1152/ajpcell.00255.2008; Tingaud-Sequeira A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-38; Tipsmark CK, 2010, J EXP BIOL, V213, P368, DOI 10.1242/jeb.034785; Tse WKF, 2006, BIOCHEM BIOPH RES CO, V346, P1181, DOI 10.1016/j.bbrc.2006.06.028; Wagner CA, 2009, PFLUG ARCH EUR J PHY, V458, P137, DOI 10.1007/s00424-009-0657-z; Weihrauch D, 2009, J EXP BIOL, V212, P1716, DOI 10.1242/jeb.024851; Wu SC, 2010, AM J PHYSIOL-CELL PH, V298, pC237, DOI 10.1152/ajpcell.00373.2009	43	16	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136440	10.1371/journal.pone.0136440	http://dx.doi.org/10.1371/journal.pone.0136440			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287615	Green Submitted, gold, Green Published			2022-12-26	WOS:000360018600138
J	Ustav, M; Castaneda, FR; Reinson, T; Mannik, A; Ustav, M				Ustav, Mart, Jr.; Castaneda, Fernando Rodriguez; Reinson, Tormi; Maennik, Andres; Ustav, Mart			Human Papillomavirus Type 18 cis-Elements Crucial for Segregation and Latency	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; E2 BINDING-SITES; BOVINE PAPILLOMAVIRUS; EPISOMAL MAINTENANCE; VIRAL-GENOME; TRANSCRIPTIONAL ACTIVATION; MUTATIONAL ANALYSIS; TERMINAL DOMAIN; REPLICATION; PROTEIN	Stable maintenance replication is characteristic of the latency phase of HPV infection, during which the viral genomes are actively maintained as extrachromosomal genetic elements in infected proliferating basal keratinocytes. Active replication in the S-phase and segregation of the genome into daughter cells in mitosis are required for stable maintenance replication. Most of our knowledge about papillomavirus genome segregation has come from studies of bovine papillomavirus type 1 (BPV-1), which have demonstrated that the E2 protein cooperates with cellular trans-factors and that E2 binding sites act as cis-regulatory elements in the viral genome that are essential for the segregation process. However, the genomic organization of the regulatory region in HPVs, and the properties of the viral proteins are different from those of their BPV-1 counterparts. We have designed a segregation assay for HPV-18 and used it to demonstrate that the E2 protein performs segregation in combination with at least two E2 binding sites. The cooperative binding of the E2 protein to two E2 binding sites is a major determinant of HPV-18 genome segregation, as demonstrated by the change in spacing between adjacent binding sites #1 and #2 in the HPV-18 Upstream Regulatory Region (URR). Duplication or triplication of the natural 4 bp 5'-CGGG-3' spacer between the E2 binding sites increased the cooperative binding of the E2 molecules as well as E2-dependent segregation. Removal of any spacing between these sites eliminated cooperative binding of the E2 protein and disabled segregation of the URR and HPV-18 genome. Transfer of these configurations of the E2 binding sites into viral genomes confirmed the role of the E2 protein and binding sites #1 and #2 in the segregation process. Additional analysis demonstrated that these sites also play an important role in the transcriptional regulation of viral gene expression from different HPV-18 promoters.	[Ustav, Mart, Jr.; Castaneda, Fernando Rodriguez; Reinson, Tormi; Ustav, Mart] Univ Tartu, Inst Technol, EE-50090 Tartu, Estonia; [Maennik, Andres; Ustav, Mart] Icosagen Cell Factory OU, Tartu, Estonia; [Ustav, Mart] Estonian Acad Sci, EE-200103 Tallinn, Estonia	University of Tartu; Estonian Academy of Sciences	Ustav, M (corresponding author), Univ Tartu, Inst Technol, Ulikooli 18, EE-50090 Tartu, Estonia.	mart.ustav@ut.ee	Ustav, Mart/G-6484-2017		Estonian Research Council [SF0180175A, SF0180175B]; Center of Excellence in Chemical Biology - European Regional Development Fund [3.2.0101.08-0017]; Estonian Science Foundation [9385, 9467]; Enterprise Estonia (EAS) Project [EU42266]; IUT of the Estonian Ministry of Education and Research [20-27]	Estonian Research Council(Estonian Research Council); Center of Excellence in Chemical Biology - European Regional Development Fund; Estonian Science Foundation; Enterprise Estonia (EAS) Project; IUT of the Estonian Ministry of Education and Research	Funding: This work was supported by targeted financing to projects SF0180175A and SF0180175B by the Estonian Research Council; by the Center of Excellence in Chemical Biology (3.2.0101.08-0017) financed by the European Regional Development Fund; by research grants 9385 and 9467 from the Estonian Science Foundation; by Enterprise Estonia (EAS) Project EU42266; and by institutional research funding IUT(20-27) of the Estonian Ministry of Education and Research. The funders had no role in the study design, data collection and analysis, the decision to publish, or the preparation of the manuscript.	Abbate EA, 2006, MOL CELL, V24, P877, DOI 10.1016/j.molcel.2006.11.002; Abroi A, 2004, J VIROL, V78, P2100, DOI 10.1128/JVI.78.4.2100-2113.2004; Ballestas ME, 2001, J VIROL, V75, P3250, DOI 10.1128/JVI.75.7.3250-3258.2001; Baxter MK, 2005, J VIROL, V79, P4806, DOI 10.1128/JVI.79.8.4806-4818.2005; BOCHKAREV A, 1995, CELL, V83, P39, DOI 10.1016/0092-8674(95)90232-5; CESARMAN E, 1995, BLOOD, V86, P2708, DOI 10.1182/blood.V86.7.2708.bloodjournal8672708; Chaiwongkot A, 2013, INT J CANCER, V132, P2087, DOI 10.1002/ijc.27906; Chang SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110882; CHIANG CM, 1992, P NATL ACAD SCI USA, V89, P5799, DOI 10.1073/pnas.89.13.5799; Collins CM, 2002, ADV CANCER RES, V84, P155, DOI 10.1016/S0065-230X(02)84005-2; Cotter MA, 2001, VIROLOGY, V291, P241, DOI 10.1006/viro.2001.1202; Dao LD, 2006, J VIROL, V80, P4792, DOI 10.1128/JVI.80.10.4792-4800.2006; Donaldson MM, 2007, J VIROL, V81, P4338, DOI 10.1128/JVI.02353-06; Fradet-Turcotte A, 2011, J VIROL, V85, P8996, DOI 10.1128/JVI.00542-11; Geimanen J, 2011, J VIROL, V85, P3315, DOI 10.1128/JVI.01985-10; Gillison ML, 2004, LANCET, V363, P1488, DOI 10.1016/S0140-6736(04)16194-1; GIRI I, 1988, EMBO J, V7, P2823, DOI 10.1002/j.1460-2075.1988.tb03138.x; Grm HS, 2005, ONCOGENE, V24, P5149, DOI 10.1038/sj.onc.1208701; Helfer CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077994; Ilves I, 2006, J VIROL, V80, P3660, DOI 10.1128/JVI.80.7.3660-3665.2006; Ilves I, 1999, J VIROL, V73, P4404, DOI 10.1128/JVI.73.5.4404-4412.1999; Johannsen E, 2013, VIROLOGY, V445, P205, DOI 10.1016/j.virol.2013.07.016; Kadaja M, 2007, EMBO J, V26, P2180, DOI 10.1038/sj.emboj.7601665; Kim SS, 2000, J BIOL CHEM, V275, P31245, DOI 10.1074/jbc.M004541200; Klueevsek K, 2007, VIROLOGY, V360, P191, DOI 10.1016/j.virol.2006.10.018; Kurg R, 2010, VIROLOGY, V408, P159, DOI 10.1016/j.virol.2010.09.010; LORINCZ AT, 1992, OBSTET GYNECOL, V79, P328, DOI 10.1097/00006250-199203000-00002; MCBRIDE AA, 1988, EMBO J, V7, P533, DOI 10.1002/j.1460-2075.1988.tb02842.x; MCBRIDE AA, 1989, P NATL ACAD SCI USA, V86, P510, DOI 10.1073/pnas.86.2.510; McPhillips MG, 2006, J VIROL, V80, P9530, DOI 10.1128/JVI.01105-06; McPhillips MG, 2005, J VIROL, V79, P8920, DOI 10.1128/JVI.79.14.8920-8932.2005; Nanbo A, 2007, EMBO J, V26, P4252, DOI 10.1038/sj.emboj.7601853; Oliveira JG, 2006, P NATL ACAD SCI USA, V103, P1047, DOI 10.1073/pnas.0507624103; Orav M, 2013, J VIROL, V87, P12051, DOI 10.1128/JVI.01798-13; Parish JL, 2006, MOL CELL, V24, P867, DOI 10.1016/j.molcel.2006.11.005; Piirsoo M, 1996, EMBO J, V15, P1; Poddar A, 2009, J VIROL, V83, P640, DOI 10.1128/JVI.01936-08; Reinson T, 2013, J VIROL, V87, P951, DOI 10.1128/JVI.01943-12; ROMANCZUK H, 1990, J VIROL, V64, P2849, DOI 10.1128/JVI.64.6.2849-2859.1990; Sakakibara N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003777; Sakakibara N, 2011, J VIROL, V85, P8981, DOI 10.1128/JVI.00541-11; Sanchez IE, 2008, NUCLEIC ACIDS RES, V36, P756, DOI 10.1093/nar/gkm1104; Sankovski E, 2014, J VIROL, V88, P961, DOI 10.1128/JVI.01841-13; Schepers A, 2001, EMBO J, V20, P4588, DOI 10.1093/emboj/20.16.4588; Schmiedeskamp MR, 2006, ANN PHARMACOTHER, V40, P1344, DOI 10.1345/aph.1G723; Sears J, 2003, J VIROL, V77, P11767, DOI 10.1128/JVI.77.21.11767-11780.2003; Sekhar V, 2010, J VIROL, V84, P543, DOI 10.1128/JVI.01908-09; SENEAR DF, 1991, J BIOL CHEM, V266, P13661; Siddiqui MAA, 2006, DRUGS, V66, P1263, DOI 10.2165/00003495-200666090-00008; Silla T, 2010, J VIROL, V84, P11175, DOI 10.1128/JVI.01366-10; SPALHOLZ BA, 1988, J VIROL, V62, P3143, DOI 10.1128/JVI.62.9.3143-3150.1988; TAN SH, 1994, J VIROL, V68, P6411, DOI 10.1128/JVI.68.10.6411-6420.1994; Toots M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116151; USTAV M, 1991, EMBO J, V10, P4321, DOI 10.1002/j.1460-2075.1991.tb05010.x; Vinokurova S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024451; Voitenleitner C, 2002, J VIROL, V76, P3440, DOI 10.1128/JVI.76.7.3440-3451.2002; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wang HK, 2009, GENE DEV, V23, P181, DOI 10.1101/gad.1735109; Wang X, 2013, J VIROL, V87, P3871, DOI 10.1128/JVI.03068-12; Wu H, 2002, J VIROL, V76, P2480, DOI 10.1128/JVI.76.5.2480-2490.2002; YATES JL, 1991, J VIROL, V65, P483, DOI 10.1128/JVI.65.1.483-488.1991; Ye FC, 2004, J VIROL, V78, P11121, DOI 10.1128/JVI.78.20.11121-11129.2004; You J, 2004, CELL, V117, P349, DOI 10.1016/S0092-8674(04)00402-7; You JX, 2010, BBA-GENE REGUL MECH, V1799, P192, DOI 10.1016/j.bbagrm.2009.09.009; Yu T, 2007, J VIROL, V81, P1736, DOI 10.1128/JVI.01638-06	65	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135770	10.1371/journal.pone.0135770	http://dx.doi.org/10.1371/journal.pone.0135770			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288015	Green Published, gold, Green Submitted			2022-12-26	WOS:000360018600068
J	Adler, C; Haelterman, E; Barlow, P; Marchant, A; Levy, J; Goetghebuer, T				Adler, Catherine; Haelterman, Edwige; Barlow, Patricia; Marchant, Arnaud; Levy, Jack; Goetghebuer, Tessa			Severe Infections in HIV-Exposed Uninfected Infants Born in a European Country	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; INCREASED RISK; 1ST YEAR; CHILDREN; DISEASE; MORBIDITY; MORTALITY; SURVEILLANCE; TRANSMISSION; PNEUMONIA	Background Several studies indicate that HIV-exposed uninfected (HEU) children have a high infectious morbidity. We previously reported an increased incidence of group B streptococcus (GBS) infections in HEU infants born in Belgium. Methods This study was undertaken to evaluate the incidence and risk factors of all cause severe infections in HEU infants born in Belgium between 1985 and 2006, including the pre-antiretroviral (ARV) prophylaxis era (1985 to 1994). The medical charts of 537 HEU infants followed in a single center were reviewed. Results The incidence rate of severe infections during the first year of life was 16.8/100 HEU infant-years. The rates of invasive S. pneumoniae (0.62/100 infant-years) and GBS infections (1.05/100 infant-years) were, respectively, 4 and 13-fold higher in HEU infants than in the general infant population. Preterm birth was a risk factor for severe infections in the neonatal period (aOR = 21.34, 95% CI: 7.12-63.93) and post-neonatal period (aHR = 3.00, 95% CI: 1.53-5.88). As compared to the pre-ARV prophylaxis era, infants born in the ARV prophylaxis era (i.e., after April 1994) had a greater risk of severe infections (aHR = 2.93; 95% CI: 1.07-8.05). This risk excess was present in those who received ARV prophylaxis (aHR 2.01, 95% CI 0.72-5.65) and also in those born in the ARV prophylaxis era who did not benefit from ARV prophylaxis as a result of poor access to antenatal care or lack of compliance (aHR 3.06, 95% CI 0.88-10.66). Conclusions In HEU infants born in an industrialized country, preterm birth and being born during the ARV prophylaxis era were risk factors of severe infections throughout the first year of life. These observations have important implications for the clinical management of HIV-infected mothers and their infants.	[Adler, Catherine; Levy, Jack; Goetghebuer, Tessa] St Pierre Univ Hosp, Dept Pediat, Brussels, Belgium; [Haelterman, Edwige] ImmuneHealth, Clin Invest Unit, Gosselies, Belgium; [Barlow, Patricia] St Pierre Univ Hosp, Dept Obstet, Brussels, Belgium; [Marchant, Arnaud] Univ Libre Bruxelles, Inst Med Immunol, Gosselies, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles	Levy, J (corresponding author), St Pierre Univ Hosp, Dept Pediat, Brussels, Belgium.	jack_levy@stpierre-bru.be			Kids Foundation, Belgium; Smiles Foundation, Belgium	Kids Foundation, Belgium; Smiles Foundation, Belgium	Dr C. Adler benefited from research grants from the Kids Foundation, Belgium. Dr. A. Marchant is a senior associate at the Fonds National de la Recherche Scientifique (FNRS), Belgium. This study was supported by the Smiles Foundation, Belgium.	[Anonymous], 2002, JAMA, V287, P1106; Casimir GJA, 2010, SHOCK, V33, P258, DOI 10.1097/SHK.0b013e3181b2b36b; Chougnet C, 2000, J INFECT DIS, V181, P1590, DOI 10.1086/315458; Clerici M, 2000, BLOOD, V96, P3866, DOI 10.1182/blood.V96.12.3866.h8003866_3866_3871; CSS, 2003, RECOMMANDATIONS DU C, P7721; Cutland CL, 2015, EMERG INFECT DIS, V21, P638, DOI 10.3201/eid2104.141562; Cutland CL, 2012, PEDIATRICS, V130, pE581, DOI 10.1542/peds.2011-1548; Epalza C, 2010, PEDIATRICS, V126, pE631, DOI 10.1542/peds.2010-0183; Filteau S, 2009, TROP MED INT HEALTH, V14, P276, DOI 10.1111/j.1365-3156.2009.02220.x; Giaquinto C, 2005, CLIN INFECT DIS, V40, P458, DOI 10.1086/427287; Giaquinto C, 2004, AIDS, V18, P2009, DOI 10.1097/00002030-200410210-00005; Goetghebuer T, 2009, EUR J PEDIATR, V168, P79, DOI 10.1007/s00431-008-0717-y; Hainaut M, 2009, J PEDIAT BELGE, V11, P70; Heidari S, 2011, JAIDS-J ACQ IMM DEF, V57, P290, DOI 10.1097/QAI.0b013e318221c56a; Heresi GP, 1997, CLIN INFECT DIS, V25, P739, DOI 10.1086/516938; Houweling LMA, 2013, J PEDIATR-US, V163, P61, DOI 10.1016/j.jpeds.2012.12.014; Hviid A, 2007, AM J EPIDEMIOL, V165, P756, DOI 10.1093/aje/kwk064; Knapp KM, 2012, PEDIATR INFECT DIS J, V31, P164, DOI 10.1097/INF.0b013e318235c7aa; Koyanagi A, 2011, PEDIATR INFECT DIS J, V30, P45, DOI 10.1097/INF.0b013e3181ecbf7e; Kuhn L, 2005, CLIN INFECT DIS, V41, P1654, DOI 10.1086/498029; Kuhn L, 2002, CLIN INFECT DIS, V34, P267, DOI 10.1086/338153; Le Chenadec J, 2003, AIDS, V17, P2053, DOI 10.1097/00002030-200309260-00006; Leroy Ch. VLV, 2013, DONNEES PERINATATLES; Marinda E, 2007, PEDIATR INFECT DIS J, V26, P519, DOI 10.1097/01.inf.0000264527.69954.4c; McNally LM, 2007, LANCET, V369, P1440, DOI 10.1016/S0140-6736(07)60670-9; Minsart AF, 2013, EUR J PUBLIC HEALTH, V23, P269, DOI 10.1093/eurpub/cks032; Mussi-Pinhata MM, 2007, PEDIATRICS, V119, pE694, DOI 10.1542/peds.2006-1856; Mussi-Pinhata MM, 2010, INT J INFECT DIS, V14, pE176, DOI 10.1016/j.ijid.2010.01.006; Nielsen SD, 2001, BLOOD, V98, P398, DOI 10.1182/blood.V98.2.398; Pacheco SE, 2006, J INFECT DIS, V194, P1089, DOI 10.1086/507645; Paul ME, 2005, PEDIATR INFECT DIS J, V24, P46, DOI 10.1097/01.inf.0000148879.83854.7e; Slogrove AL, 2010, J TROP PEDIATRICS, V56, P75, DOI 10.1093/tropej/fmp057; Slogrove A, 2012, J TROP PEDIATRICS, V58, P505, DOI 10.1093/tropej/fms019; Taron-Brocard C, 2014, CLIN INFECT DIS; THEA DM, 1993, NEW ENGL J MED, V329, P1696, DOI 10.1056/NEJM199312023292304; Vergison A, 2006, PEDIATRICS, V118, pE801, DOI 10.1542/peds.2005-3195; Victora CG, 2000, LANCET, V355, P451, DOI 10.1016/S0140-6736(00)82011-5; von Mollendorf C, 2015, CLIN INFECT DIS; WEINHOLD KJ, 1989, J IMMUNOL, V142, P3091	39	34	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135375	10.1371/journal.pone.0135375	http://dx.doi.org/10.1371/journal.pone.0135375			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284528	Green Published, Green Submitted, gold			2022-12-26	WOS:000359666100033
J	Tang, YT; Ji, YH; Ye, XF; Wang, XF; Cai, L; Xu, JM; Lu, Y				Tang, Yating; Ji, Yinghong; Ye, Xiaofang; Wang, Xiaofeng; Cai, Lei; Xu, Jianming; Lu, Yi			The Association of Outdoor Activity and Age-Related Cataract in a Rural Population of Taizhou Eye Study: Phase 1 Report	PLOS ONE			English	Article							BLUE MOUNTAINS EYE; BEAVER DAM EYE; HORMONE REPLACEMENT THERAPY; MIXED LENS OPACITIES; ANGELES-LATINO-EYE; RISK-FACTORS; CORTICAL CATARACT; 10-YEAR INCIDENCE; NUCLEAR CATARACT; LIGHT EXPOSURE	Purpose To study the relationship between outdoor activity and risk of age-related cataract (ARC) in a rural population of Taizhou Eye Study (phrase 1 report). Method A population-based, cross-sectional study of 2006 eligible rural adults (>= 45 years old) from Taizhou Eye Study was conducted from Jul. to Sep. 2012. Participants underwent detailed ophthalmologic examinations including uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), intraocular pressure (IOP), slit lamp and fundus examinations as well as questionnaires about previous outdoor activity and sunlight protection methods. ARC was recorded by LOCS. classification system. The prevalence of cortical, nuclear and posterior subcapsular cataract were assessed separately for the risk factors and its association with outdoor activity. Results Of all 2006 eligible participants, 883 (44.0%) adults were diagnosed with ARC. The prevalence rates of cortical, nuclear and posterior subcapsular cataract per person were 41.4%, 30.4% and 1.5%, respectively. Women had a higher tendency of nuclear and cortical cataract than men (OR = 1.559, 95% CI 1.204-2.019 and OR = 1.862, 95% CI 1.456-2.380, respectively). Adults with high myopia had a higher prevalence of nuclear cataract than adults without that (OR = 2.528, 95% CI 1.055-6.062). Multivariable logistic regression revealed that age was risk factor of nuclear (OR = 1.190, 95% CI 1.167-1.213) and cortical (OR = 1.203, 95% CI 1.181-1.226) cataract; eyes with fundus diseases was risk factor of posterior subcapsular cataract (OR = 6.529, 95% CI 2.512-16.970). Outdoor activity was an independent risk factor of cortical cataract (OR = 1.043, 95% CI 1.004-1.083). The risk of cortical cataract increased 4.3% (95% CI 0.4%-8.3%) when outdoor activity time increased every one hour. Furthermore, the risk of cortical cataract increased 1.1% (95% CI 0.1%-2.0%) when cumulative UV-B exposure time increased every one year. Conclusion Outdoor activity was an independent risk factor for cortical cataract, but was not risk factor for nuclear and posterior subcapsular cataract. The risk of cortical cataract increased 4.3% when outdoor activity time increased every one hour. In addition, the risk of cortical cataract increased 1.1% (95% CI 0.1%-2.0%) when cumulative UV-B exposure time increased every one year.	[Tang, Yating; Ji, Yinghong; Cai, Lei; Lu, Yi] Fudan Univ, Eye & ENT Hosp, Dept Ophthalmol, Shanghai 200433, Peoples R China; [Tang, Yating; Ji, Yinghong; Cai, Lei; Lu, Yi] Minist Hlth, Myopia Key Lab, Shanghai, Peoples R China; [Tang, Yating; Ji, Yinghong; Cai, Lei; Lu, Yi] Visual Impairment & Reconstruct Key Lab Shanghai, Shanghai, Peoples R China; [Ye, Xiaofang] Fudan Univ, Shanghai 200433, Peoples R China; [Ye, Xiaofang; Xu, Jianming] Pudong Meteorol Serv, Shanghai Key Lab Meteorol & Hlth, Shanghai, Peoples R China; [Wang, Xiaofeng] Fudan Univ, State Key Lab Genet Engn, Collaborat Innovat Ctr Genet & Dev, Sch Life Sci, Shanghai 200433, Peoples R China; [Wang, Xiaofeng] Fudan Univ, MOE Key Lab Contemporary Anthropol, Collaborat Innovat Ctr Genet & Dev, Sch Life Sci, Shanghai 200433, Peoples R China; [Wang, Xiaofeng] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Wang, Xiaofeng] Fudan Taizhou Inst Hlth Sci, Taizhou, Jiangsu, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University; Fudan University	Lu, Y (corresponding author), Fudan Univ, Eye & ENT Hosp, Dept Ophthalmol, 83 Fenyang Rd, Shanghai 200433, Peoples R China.	luyieent@126.com			Shanghai Science and Technology Commission [11231200602]; Key Projects in the National Science & Technology Pillar Program [2011BAI09B00]; New One Hundred People's Plan of Shanghai Health Bureau [XBR2011056]; Visual Impairment and Reconstruction Key Laboratory of Shanghai [12DZ2260500];  [NSFC81270989];  [81300745]	Shanghai Science and Technology Commission(Science & Technology Commission of Shanghai Municipality (STCSM)Shanghai Science & Technology Committee); Key Projects in the National Science & Technology Pillar Program; New One Hundred People's Plan of Shanghai Health Bureau; Visual Impairment and Reconstruction Key Laboratory of Shanghai; ; 	The work was supported by grants for Natural Science Foundation of China (NSFC81270989 and 81300745), Shanghai Science and Technology Commission (11231200602), Key Projects in the National Science & Technology Pillar Program (2011BAI09B00), New One Hundred People's Plan of Shanghai Health Bureau (XBR2011056) and Visual Impairment and Reconstruction Key Laboratory of Shanghai (12DZ2260500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, LANCET, V372, P1273, DOI [10.1016/S0140-6736(08)61348-3, 10.1016/S0140-6736(08)61527-5]; Brian G, 2001, B WORLD HEALTH ORGAN, V79, P249; Cheng C Y, 2000, Zhonghua Yi Xue Za Zhi (Taipei), V63, P641; China national committee on aging office, 2014, PROSP CHIN ELD NEXT; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; Congdon NG, 2001, BRIT J OPHTHALMOL, V85, P516, DOI 10.1136/bjo.85.5.516; CRUICKSHANKS KJ, 1992, AM J PUBLIC HEALTH, V82, P1658, DOI 10.2105/AJPH.82.12.1658; Delcourt C, 2000, ARCH OPHTHALMOL-CHIC, V118, P385, DOI 10.1001/archopht.118.3.385; Delcourt C, 2003, OPHTHALMOLOGY, V110, P2318, DOI 10.1016/S0161-6420(03)00713-9; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Freeman EE, 2001, ARCH OPHTHALMOL-CHIC, V119, P1687; HIRVELA H, 1995, OPHTHALMOLOGY, V102, P108; Holekamp NM, 2005, AM J OPHTHALMOL, V139, P302, DOI 10.1016/j.ajo.2004.09.046; HU TS, 1989, ARCH OPHTHALMOL-CHIC, V107, P666, DOI 10.1001/archopht.1989.01070010684027; Huang WY, 2012, INVEST OPHTH VIS SCI, V53, P7936, DOI 10.1167/iovs.12-10903; JAVITT JC, 1994, DOC OPHTHALMOL, V88, P307, DOI 10.1007/BF01203684; Ji Y, 2014, MOL CELL BIOCH; Kanthan GL, 2008, OPHTHALMOLOGY, V115, P808, DOI 10.1016/j.ophtha.2007.07.008; Kanthan GL, 2014, CLIN EXP OPHTHALMOL, V42, P347, DOI 10.1111/ceo.12206; Klein B E, 1999, Ophthalmic Epidemiol, V6, P247; Klein BEK, 2008, OPHTHALMOLOGY, V115, P477, DOI 10.1016/j.ophtha.2007.11.024; Klein BEK, 2000, AM J OPHTHALMOL, V130, P322, DOI 10.1016/S0002-9394(00)00474-8; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1128; Koo E, 2013, OPHTHAL EPIDEMIOL, V20, P71, DOI 10.3109/09286586.2012.759598; Lai KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078647; Li EY, 2013, OPHTHALMOLOGY, V120, P2176, DOI 10.1016/j.ophtha.2013.04.003; Liang YB, 2008, OPHTHALMOLOGY, V115, P1965, DOI 10.1016/j.ophtha.2008.05.030; Lindblad BE, 2010, OPHTHALMOLOGY, V117, P424, DOI 10.1016/j.ophtha.2009.07.046; Mahdi AM, 2014, INVEST OPHTH VIS SCI, V55, P2642, DOI 10.1167/iovs.12-10303; McCarty CA, 1996, B WORLD HEALTH ORGAN, V74, P353; Na KS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096461; Navarro EJ, 2007, EUR J OPHTHALMOL, V17, P29; PALMQUIST BM, 1984, BRIT J OPHTHALMOL, V68, P113, DOI 10.1136/bjo.68.2.113; Prokofyeva E, 2013, ACTA OPHTHALMOL, V91, P395, DOI 10.1111/j.1755-3768.2012.02444.x; Richter GM, 2012, OPHTHALMOLOGY, V119, P2040, DOI 10.1016/j.ophtha.2012.05.001; Richter GM, 2012, OPHTHALMOLOGY, V119, P547, DOI 10.1016/j.ophtha.2011.09.005; Richter GM, 2009, OPHTHALMOLOGY, V116, P2327, DOI 10.1016/j.ophtha.2009.05.040; Sasaki H, 2003, INVEST OPHTH VIS SCI, V44, P4210, DOI 10.1167/iovs.01-1221; Sperduto RD, 2001, OPHTHALMOLOGY, V108, P1400; Tang Y, 2015, OPHTHALMOLOGY; Tsai SY, 2003, OPHTHALMOLOGY, V110, P1089, DOI 10.1016/S0161-6420(03)00243-4; Wang XF, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-223; Wong TY, 2001, INVEST OPHTH VIS SCI, V42, P1449; Wu RY, 2010, ARCH OPHTHALMOL-CHIC, V128, P1029, DOI 10.1001/archophthalmol.2010.147; Xu L, 2006, OPHTHALMOLOGY, V113, P747, DOI 10.1016/j.ophtha.2006.01.026; Younan C, 2002, AM J EPIDEMIOL, V155, P997, DOI 10.1093/aje/155.11.997; Zhang JS, 2011, OPHTHALMOLOGY, V118, P711, DOI 10.1016/j.ophtha.2010.08.021; Zhao JL, 2010, OPHTHALMOLOGY, V117, P409, DOI 10.1016/j.ophtha.2009.11.023; Zhou Q, 2007, OPHTHAL EPIDEMIOL, V14, P399, DOI 10.1080/09286580701331974	49	21	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135870	10.1371/journal.pone.0135870	http://dx.doi.org/10.1371/journal.pone.0135870			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284359	gold, Green Published, Green Submitted			2022-12-26	WOS:000359666100080
J	Todor, H; Gooding, J; Ilkayeva, OR; Schmid, AK				Todor, Horia; Gooding, Jessica; Ilkayeva, Olga R.; Schmid, Amy K.			Dynamic Metabolite Profiling in an Archaeon Connects Transcriptional Regulation to Metabolic Consequences	PLOS ONE			English	Article							HALOBACTERIUM-SALINARUM; HALOFERAX-VOLCANII; PATHWAYS; PURIFICATION; PHOSPHATE; GROWTH; TRMB	Previous work demonstrated that the TrmB transcription factor is responsible for regulating the expression of many enzyme-coding genes in the hypersaline-adapted archaeon Halobacterium salinarum via a direct interaction with a cis-regulatory sequence in their promoters. This interaction is abolished in the presence of glucose. Although much is known about the effects of TrmB at the transcriptional level, it remains unclear whether and to what extent changes in mRNA levels directly affect metabolite levels. In order to address this question, here we performed a high-resolution metabolite profiling time course during a change in nutrients using a combination of targeted and untargeted methods in wild-type and Delta trmB strain backgrounds. We found that TrmB-mediated transcriptional changes resulted in widespread and significant changes to metabolite levels across the metabolic network. Additionally, the pattern of growth complementation using various purines suggests that the mis-regulation of gluconeogenesis in the Delta trmB mutant strain in the absence of glucose results in low phosphoribosylpyrophosphate (PRPP) levels. We confirmed these low PRPP levels using a quantitative mass spectrometric technique and found that they are associated with a metabolic block in de novo purine synthesis, which is partially responsible for the growth defect of the Delta trmB mutant strain in the absence of glucose. In conclusion, we show how transcriptional regulation of metabolism affects metabolite levels and ultimately, phenotypes.	[Todor, Horia; Schmid, Amy K.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Gooding, Jessica; Ilkayeva, Olga R.] Duke Univ, Med Ctr, Dept Pharmacol, Sarah W Stedman Nutr & Metab Ctr,Duke Mol Physiol, Durham, NC 27710 USA; [Gooding, Jessica; Ilkayeva, Olga R.] Duke Univ, Med Ctr, Dept Canc Biol & Med, Sarah W Stedman Nutr & Metab Ctr,Duke Mol Physiol, Durham, NC USA; [Schmid, Amy K.] Duke Univ, Univ Program Genet & Genom, Durham, NC USA; [Schmid, Amy K.] Duke Univ, Ctr Syst Biol, Durham, NC USA	Duke University; Duke University; Duke University; Duke University; Duke University	Schmid, AK (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	amy.schmid@duke.edu			National Science Foundation [MCB-1052290, MCB-1417750]; Duke University; National Institutes of Health [K01-GM109320-02]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K01GM109320] Funding Source: NIH RePORTER; Direct For Biological Sciences [1417750] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Duke University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This material is based upon work supported by the National Science Foundation (nsf.gov) under grant numbers MCB-1052290 and MCB-1417750 to AKS, by Duke University (duke.edu) startup funds to AKS, and by the National Institutes of Health (nih.gov) under grant number K01-GM109320-02 to JG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht E, 2014, METABOLOMICS, V10, P141, DOI 10.1007/s11306-013-0565-2; Cho BK, 2011, NUCLEIC ACIDS RES, V39, P6456, DOI 10.1093/nar/gkr307; Cunchillos C, 2005, MOL BIOL EVOL, V22, P1, DOI 10.1093/molbev/msh253; DEMEDICIS E, 1982, BIOCHIM BIOPHYS ACTA, V708, P57, DOI 10.1016/0167-4838(82)90203-5; Esser D, 2012, J PROTEOME RES, V11, P4823, DOI 10.1021/pr300190k; Ferrara CT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000034; GOCHNAUER MB, 1969, CAN J MICROBIOL, V15, P1157, DOI 10.1139/m69-211; Gonzalez O, 2008, MOL BIOSYST, V4, P148, DOI 10.1039/b715203e; Gonzalez O, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000332; Jensen MV, 2006, J BIOL CHEM, V281, P22342, DOI 10.1074/jbc.M604350200; Kanai T, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703424200; Krug M, 2013, PROTEIN SCI, V22, P800, DOI 10.1002/pro.2263; Lee SJ, 2003, J BIOL CHEM, V278, P983, DOI 10.1074/jbc.M210236200; LEICHT W, 1978, BIOCHEMISTRY-US, V17, P4004, DOI 10.1021/bi00612a020; Malki L, 2009, J BACTERIOL, V191, P5196, DOI 10.1128/JB.00297-09; NEWTON GL, 1985, J BACTERIOL, V161, P438, DOI 10.1128/JB.161.1.438-441.1985; Ng WV, 2000, P NATL ACAD SCI USA, V97, P12176, DOI 10.1073/pnas.190337797; ORLOWSKI M, 1970, P NATL ACAD SCI USA, V67, P1248, DOI 10.1073/pnas.67.3.1248; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; Peck RF, 2000, MOL MICROBIOL, V35, P667, DOI 10.1046/j.1365-2958.2000.01739.x; Pickl A, 2015, FEBS LETT, V589, P1105, DOI 10.1016/j.febslet.2015.03.026; Pinson B, 2009, GENE DEV, V23, P1399, DOI 10.1101/gad.521809; Schmid AK, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.40; Severina L. O., 1990, ARCH MICROBIOL, V155, P131, DOI DOI 10.1007/BF00248606; Siebers B, 2005, CURR OPIN MICROBIOL, V8, P695, DOI 10.1016/j.mib.2005.10.014; Sinha RA, 2014, HEPATOLOGY, V59, P1366, DOI 10.1002/hep.26667; SONAWAT HM, 1990, BIOCHEM BIOPH RES CO, V173, P358, DOI 10.1016/S0006-291X(05)81065-4; Stuer-Lauridsen B, 1998, J BACTERIOL, V180, P457, DOI 10.1128/JB.180.3.457-463.1998; Todor H, 2014, MOL MICROBIOL, V93, P1172, DOI 10.1111/mmi.12726; Todor H, 2013, NUCLEIC ACIDS RES, V41, P8546, DOI 10.1093/nar/gkt659; Villas-Boas SG, 2005, YEAST, V22, P1155, DOI 10.1002/yea.1308	31	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135693	10.1371/journal.pone.0135693	http://dx.doi.org/10.1371/journal.pone.0135693			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284786	Green Submitted, Green Published, gold			2022-12-26	WOS:000359666100059
J	Ahn, SH; Kim, J; Min, HJ; Chung, HJ; Hong, JM; Lee, JG; Kim, CH; Cho, HJ				Ahn, Sang Hyeon; Kim, Jinna; Min, Hyun Jin; Chung, Hyo Jin; Hong, Jae Min; Lee, Jeung-Gweon; Kim, Chang-Hoon; Cho, Hyung-Ju			Tongue Volume Influences Lowest Oxygen Saturation but Not Apnea-Hypopnea Index in Obstructive Sleep Apnea	PLOS ONE			English	Article							UPPER AIRWAY; CEPHALOMETRIC ANALYSIS; OBESE; FAT; HYPERTENSION; MORPHOLOGY; DISORDERS; NONOBESE; ADULTS; RATIO	Objectives The aim of this study was to identify correlations between sleep apnea severity and tongue volume or posterior airway space measured via three-dimensional reconstruction of volumetric computerized tomography (CT) images in patients with obstructive sleep apnea (OSA) for use in predicting OSA severity and in surgical treatment. We also assessed associations between tongue volume and Mallampati score. Methods Snoring/OSA male patients (n = 64) who underwent polysomnography, cephalometry, and CT scans were enrolled in this retrospective study. OSA was diagnosed when the apneahypopnea index (AHI) was greater than 5 (mild 5-14; moderate 15-29; severe>30). The patients were also categorized into the normal-mild group (n = 22) and the moderate-severe group (n = 42). Using volumetric CT images with the three-dimensional reconstruction technique, the volume of the tongue, posterior airway space volume, and intra-mandibular space were measured. The volumes, polysomnographic parameters, and physical examination findings were compared, and independent factors that are related to OSA were analysed. Results No associations between tongue volume or posterior airway space and the AHI were observed. However, multivariate linear analyses showed that tongue volume had significantly negative association with lowest O-2 saturation (r = 0.365, p = 0.027). High BMI was related to an increase in tongue volume. Modified Mallampati scores showed borderline significant positive correlations with absolute tongue volume (r = 0.251, p = 0.046) and standardized tongue volume (absolute tongue volume / intramandibular area; r = 0.266, p = 0.034). Between the normal-mild and moderate-severe groups, absolute tongue volumes were not different, although the standardized tongue volume in the moderate-severe group was significantly higher. Conclusion Absolute tongue volume showed stronger associations with lowest O-2 saturation during sleep than with the severity of AHI. We also found that high BMI was a relevant factor for an increase in absolute tongue volume and modified Mallampati grading was a useful physical examination to predict tongue size.	[Ahn, Sang Hyeon; Chung, Hyo Jin; Hong, Jae Min; Lee, Jeung-Gweon; Kim, Chang-Hoon; Cho, Hyung-Ju] Yonsei Univ, Coll Med, Severance Hosp, Dept Otorhinolaryngol, Seoul, South Korea; [Kim, Jinna] Yonsei Univ, Coll Med, Severance Hosp, Dept Radiol, Seoul, South Korea; [Min, Hyun Jin] Chung Ang Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul 156756, South Korea; [Kim, Chang-Hoon; Cho, Hyung-Ju] Yonsei Univ, Coll Med, Airway Mucus Inst, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Chung Ang University; Chung Ang University Hospital; Yonsei University; Yonsei University Health System	Kim, CH (corresponding author), Yonsei Univ, Coll Med, Severance Hosp, Dept Otorhinolaryngol, Seoul, South Korea.	entman@yuhs.ac; hyungjucho@yuhs.ac	Chung-ang, HyunJin/AAO-9395-2020; Kim, Chang-Hoon/D-7205-2016	Kim, Chang-Hoon/0000-0003-1238-6396; Cho, Hyung-Ju/0000-0002-2851-3225; Kim, Jinna/0000-0002-9978-4356; Ahn, Sang Hyeon/0000-0002-2389-0005	Basic Science Research Program through the National Research Foundation of Korea(NRF) - Ministry of Education [2012R1A1A2042476]; Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning [2013M3A9D5072551]; Yonsei University Future-leading Research Initiative [2014-22-0131]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology [NRF-2013R1A1A1010151]	Basic Science Research Program through the National Research Foundation of Korea(NRF) - Ministry of Education; Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning; Yonsei University Future-leading Research Initiative; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology	This research was supported by Basic Science Research Program through the National Research Foundation of Korea(NRF) funded by the Ministry of Education(2012R1A1A2042476) to C.H. Kim. This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Ministry of Science, ICT & Future Planning (2013M3A9D5072551) to C.H. Kim. This research was supported (in part) by the Yonsei University Future-leading Research Initiative of 2014 (2014-22-0131) to C.H. Kim. This research was supported by a grant from the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science, and Technology (NRF-2013R1A1A1010151) to H.J. Cho. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brennick MJ, 2014, SLEEP, V37, P1095, DOI 10.5665/sleep.3768; Brennick MJ, 2009, AM J RESP CRIT CARE, V179, P158, DOI 10.1164/rccm.200809-1435OC; Chi L, 2011, EUR RESPIR J, V38, P348, DOI 10.1183/09031936.00119210; Faria AC, 2013, SLEEP BREATH, V17, P395, DOI 10.1007/s11325-012-0707-1; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; Friedman M, 1999, LARYNGOSCOPE, V109, P1901, DOI 10.1097/00005537-199912000-00002; Friedman M, 2002, OTOLARYNG HEAD NECK, V127, P13, DOI 10.1067/mhn.2002.126477; Ha JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081590; Iida-Kondo Chisato, 2006, Journal of Medical and Dental Sciences, V53, P119; KALES A, 1985, J CHRON DIS, V38, P427, DOI 10.1016/0021-9681(85)90138-9; Kim AM, 2014, SLEEP, V37, P1639, DOI 10.5665/sleep.4072; Lee RWW, 2010, SLEEP, V33, P1249, DOI 10.1093/sleep/33.9.1249; Lee RWW, 2010, SLEEP, V33, P1075, DOI 10.1093/sleep/33.8.1075; LOWE AA, 1986, AM J ORTHOD DENTOFAC, V90, P484, DOI 10.1016/0889-5406(86)90108-3; LOWE AA, 1986, AM J ORTHOD DENTOFAC, V90, P364, DOI 10.1016/0889-5406(86)90002-8; LYBERG T, 1989, J LARYNGOL OTOL, V103, P287, DOI 10.1017/S0022215100108734; Min HJ, 2014, YONSEI MED J, V55, P1310, DOI 10.3349/ymj.2014.55.5.1310; Nashi N, 2007, LARYNGOSCOPE, V117, P1467, DOI 10.1097/MLG.0b013e318068b566; Ogawa T, 2005, ST HEAL T, V111, P365; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Punjabi NM, 2005, J APPL PHYSIOL, V99, P1998, DOI 10.1152/japplphysiol.00695.2005; Sakakibara H, 1999, EUR RESPIR J, V13, P403, DOI 10.1183/09031936.99.13240399; Schwab RJ, 2003, AM J RESP CRIT CARE, V168, P522, DOI 10.1164/rccm.200208-866OC; Shigeta Y, 2011, ORAL SURG ORAL MED O, V111, P239, DOI 10.1016/j.tripleo.2010.10.013; Tsuiki S, 2008, ANESTHESIOLOGY, V108, P1009, DOI 10.1097/ALN.0b013e318173f103; Vicini C, 2014, HEAD NECK-J SCI SPEC, V36, P77, DOI 10.1002/hed.23271; Welch KC, 2002, SLEEP, V25, P532, DOI 10.1093/sleep/25.5.530; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; Young T, 2008, SLEEP, V31, P1071; Yu XJ, 2003, CHEST, V124, P212, DOI 10.1378/chest.124.1.212	30	20	21	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0135796	10.1371/journal.pone.0135796	http://dx.doi.org/10.1371/journal.pone.0135796			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26280546	gold, Green Published, Green Submitted			2022-12-26	WOS:000359664300023
J	Lee, KN; Chirwa, S				Lee, Kiera-Nicole; Chirwa, Sanika			Blocking Dopaminergic Signaling Soon after Learning Impairs Memory Consolidation in Guinea Pigs	PLOS ONE			English	Article							LONG-TERM POTENTIATION; TIME-DEPENDENT REORGANIZATION; SPATIAL WORKING-MEMORY; HIPPOCAMPAL-FORMATION; PREFRONTAL CORTEX; LOCUS-COERULEUS; NORADRENERGIC NEURONS; RECOGNITION MEMORY; D-1/D-5 RECEPTORS; CA1 REGION	Formation of episodic memories (i.e. remembered experiences) requires a process called consolidation which involves communication between the neocortex and hippocampus. However, the neuromodulatory mechanisms underlying this neocortico-hippocampal communication are poorly understood. Here, we examined the involvement of dopamine D1 receptors (D1R) and D2 receptors (D2R) mediated signaling on memory consolidation using the Novel Object Recognition (NOR) test. We conducted the tests in male Hartley guinea pigs and cognitive behaviors were assessed in customized Phenotyper home cages utilizing Ethovision XT software from Noldus enabled for the 3-point detection system (nose, center of the body, and rear). We found that acute intraperitoneal injections of either 0.25 mg/kg SCH23390 to block D1Rs or 1.0 mg/kg sulpiride to block D2Rs soon after acquisition (which involved familiarization to two similar objects) attenuated subsequent discrimination for novel objects when tested after 5-hours in the NOR test. By contrast guinea pigs treated with saline showed robust discrimination for novel objects indicating normal operational processes undergirding memory consolidation. The data suggests that involvement of dopaminergic signaling is a key post-acquisition factor in modulating memory consolidation in guinea pigs.	[Lee, Kiera-Nicole; Chirwa, Sanika] Meharry Med Coll, Dept Neurosci & Pharmacol, Nashville, TN 37208 USA; [Chirwa, Sanika] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37203 USA	Meharry Medical College; Vanderbilt University	Chirwa, S (corresponding author), Meharry Med Coll, Dept Neurosci & Pharmacol, 1005 DB Todd Blvd, Nashville, TN 37208 USA.	schirwa@mmc.edu			National Institutes of Health [R24 DA021471, R25 GM059994, T32 NS061201]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM059994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS061201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R24DA021471] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007586] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by the National Institutes of Health research grant R24 DA021471, and training grants R25 GM059994, T32 NS061201. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TA, 2013, P NATL ACAD SCI USA, V110, P10379, DOI 10.1073/pnas.1301199110; ANCILL RJ, 1956, J PHYSIOL-LONDON, V132, P469, DOI 10.1113/jphysiol.1956.sp005539; Balderas I, 2013, HIPPOCAMPUS, V23, P873, DOI 10.1002/hipo.22143; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; Born J, 2012, PSYCHOL RES-PSYCH FO, V76, P192, DOI 10.1007/s00426-011-0335-6; Bouret S, 2002, EUR J NEUROSCI, V16, P2371, DOI 10.1046/j.1460-9568.2002.02413.x; Bourne JA, 2001, CNS DRUG REV, V7, P399; Broadbent NJ, 2010, LEARN MEMORY, V17, P794, DOI 10.1101/lm.1650110; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; Chen ZX, 1996, RECEPTOR CHANNEL, V4, P1; Chirwa S, 2005, BRAIN RES BULL, V64, P433, DOI 10.1016/j.brainresbull.2004.09.012; Ciliax BJ, 2000, SYNAPSE, V37, P125, DOI 10.1002/1098-2396(200008)37:2<125::AID-SYN7>3.0.CO;2-7; Clark RE, 2000, J NEUROSCI, V20, P8853; DAGOSTIN.R, 1973, BIOMETRIKA, V60, P613, DOI 10.1093/biomet/60.3.613; Debiec J, 2006, ANN NY ACAD SCI, V1071, P521, DOI 10.1196/annals.1364.056; Depue BE, 2012, NEUROSCI BIOBEHAV R, V36, P1382, DOI 10.1016/j.neubiorev.2012.02.012; Dere E, 2006, NEUROSCI BIOBEHAV R, V30, P1206, DOI 10.1016/j.neubiorev.2006.09.005; Dudai Y, 2012, ANNU REV NEUROSCI, V35, P227, DOI 10.1146/annurev-neuro-062111-150500; Eichenbaum H, 2012, COGNITIVE NEUROSCIEN; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Eschenko O, 2008, CEREB CORTEX, V18, P2596, DOI 10.1093/cercor/bhn020; Eschenko O, 2012, CEREB CORTEX, V22, P426, DOI 10.1093/cercor/bhr121; Frank MJ, 2006, BEHAV NEUROSCI, V120, P497, DOI 10.1037/0735-7044.120.3.497; FREY U, 1991, NEUROSCI LETT, V129, P111, DOI 10.1016/0304-3940(91)90732-9; Furini CRG, 2014, BEHAV BRAIN RES, V271, P212, DOI 10.1016/j.bbr.2014.06.027; Gasbarri A, 1997, PROG NEURO-PSYCHOPH, V21, P1, DOI 10.1016/S0278-5846(96)00157-1; Haist F, 2001, NAT NEUROSCI, V4, P1139, DOI 10.1038/nn739; Harley CW, 2007, PROG BRAIN RES, V163, P299, DOI 10.1016/S0079-6123(07)63018-0; Hars B, 2014, LEARN MEMORY, V13, P515; Hasselmo ME, 2004, PROG BRAIN RES, V145, P207, DOI 10.1016/S0079-6123(03)45015-2; Hollnagel JO, 2014, NEUROSCI LETT, V574, P15, DOI 10.1016/j.neulet.2014.04.045; Horvitz JC, 1997, BRAIN RES, V759, P251, DOI 10.1016/S0006-8993(97)00265-5; HUANG YY, 1995, P NATL ACAD SCI USA, V92, P2446, DOI 10.1073/pnas.92.7.2446; Jenkins TA, 2004, NEUROSCIENCE, V124, P43, DOI 10.1016/j.neuroscience.2003.11.024; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; Khan ZU, 2000, NEUROSCIENCE, V100, P689, DOI 10.1016/S0306-4522(00)00274-8; Komorowski RW, 2013, J NEUROSCI, V33, P8079, DOI 10.1523/JNEUROSCI.5458-12.2013; Lai ECC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089795; Lai ECC, 2013, SCHIZOPHRENIA BULL, V39, P673, DOI 10.1093/schbul/sbs002; Lee KN, 2014, SYNAPSE, V68, P221, DOI 10.1002/syn.21731; Lemon N, 2006, J NEUROSCI, V26, P7723, DOI 10.1523/JNEUROSCI.1454-06.2006; Li M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/810548; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; LJUNGBERG T, 1992, J NEUROPHYSIOL, V67, P145, DOI 10.1152/jn.1992.67.1.145; Manago F, 2009, LEARN MEMORY, V16, P46, DOI 10.1101/lm.1177509; Marzo A, 2009, CURR NEUROPHARMACOL, V7, P286, DOI 10.2174/157015909790031193; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; MCCORMICK DA, 1991, PROG BRAIN RES, V88, P293; McGaugh JL, 2009, PSYCHOPHARMACOLOGY, V202, P3, DOI 10.1007/s00213-008-1285-6; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; McKenzie S, 2011, NEURON, V71, P224, DOI 10.1016/j.neuron.2011.06.037; Mehta MA, 2003, NEUROIMAGE, V20, P1982, DOI 10.1016/j.neuroimage.2003.08.007; Mehta MA, 2004, PSYCHOPHARMACOLOGY, V176, P331, DOI 10.1007/s00213-004-1899-2; Mehta MA, 2008, PSYCHOPHARMACOLOGY, V196, P157, DOI 10.1007/s00213-007-0947-0; Muzzio IA, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000140; O'Keefe J., 1978, HIPPOCAMPUS COGNITIV, V3; Otmakhova NA, 1996, J NEUROSCI, V16, P7478; Preston AR, 2013, CURR BIOL, V23, pR764, DOI 10.1016/j.cub.2013.05.041; Przybyslawski J, 1997, BEHAV BRAIN RES, V84, P241, DOI 10.1016/S0166-4328(96)00153-2; Przybyslawski J, 1999, J NEUROSCI, V19, P6623; Remondes M, 2004, NATURE, V431, P699, DOI 10.1038/nature02965; Robinson Susan W., 1997, P137; Rossato JI, 2013, NEUROBIOL LEARN MEM, V106, P66, DOI 10.1016/j.nlm.2013.07.012; Roullet P, 1998, NEURAL PLAST, V6, P63, DOI 10.1155/NP.1998.63; Rowland DC, 2011, P NATL ACAD SCI USA, V108, P14654, DOI 10.1073/pnas.1105445108; Sara SJ, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00185; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SEEMAN P, 1994, TRENDS PHARMACOL SCI, V15, P264, DOI 10.1016/0165-6147(94)90323-9; STEINFELS GF, 1983, BRAIN RES, V277, P150, DOI 10.1016/0006-8993(83)90917-4; Swanson-Park JL, 1996, NEUROSCIENCE, V92, P485; Szpunar KK, 2009, SCHOLARPEDIA, V4, P3332, DOI DOI 10.4249/SCH0LARPEDIA.3332; Takashima A, 2006, P NATL ACAD SCI USA, V103, P756, DOI 10.1073/pnas.0507774103; Takehara K, 2003, J NEUROSCI, V23, P9897; TOBLER I, 1993, AM J PHYSIOL, V264, pR1125, DOI 10.1152/ajpregu.1993.264.6.R1125; Tronel S, 2004, LEARN MEMORY, V11, P453, DOI 10.1101/lm.74504; Ul Haq R, 2012, HIPPOCAMPUS, V22, P516, DOI 10.1002/hipo.20918; Wang SH, 2010, ANNU REV PSYCHOL, V61, P49, DOI 10.1146/annurev.psych.093008.100523; Williams S, 2006, NEUROSCI LETT, V402, P46, DOI 10.1016/j.neulet.2006.03.075; ZOLAMORGAN SM, 1990, SCIENCE, V250, P288, DOI 10.1126/science.2218534	80	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135578	10.1371/journal.pone.0135578	http://dx.doi.org/10.1371/journal.pone.0135578			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275140	gold, Green Published, Green Submitted			2022-12-26	WOS:000359493600079
J	Kruiswijk, F; Hasenfuss, SC; Sivapatham, R; Baar, MP; Putavet, D; Naipal, KAT; van den Broek, NJF; Kruit, W; van der Spek, PJ; van Gent, DC; Brenkman, AB; Campisi, J; Burgering, BMT; Hoeijmakers, JHJ; de Keizer, PLJ				Kruiswijk, F.; Hasenfuss, S. C.; Sivapatham, R.; Baar, M. P.; Putavet, D.; Naipal, K. A. T.; van den Broek, N. J. F.; Kruit, W.; van der Spek, P. J.; van Gent, D. C.; Brenkman, A. B.; Campisi, J.; Burgering, B. M. T.; Hoeijmakers, J. H. J.; de Keizer, P. L. J.			Targeted inhibition of metastatic melanoma through interference with Pin1-FOXM1 signaling	ONCOGENE			English	Article							MEK INHIBITION; TRANSCRIPTION FACTORS; IMPROVED SURVIVAL; MITOTIC PROGRAM; BRAF; FOXM1; EXPRESSION; GENE; RESISTANCE; PHOSPHORYLATION	Melanoma is the most lethal form of skin cancer and successful treatment of metastatic melanoma remains challenging. BRAF/MEK inhibitors only show a temporary benefit due to rapid occurrence of resistance, whereas immunotherapy is mainly effective in selected subsets of patients. Thus, there is a need to identify new targets to improve treatment of metastatic melanoma. To this extent, we searched for markers that are elevated in melanoma and are under regulation of potentially druggable enzymes. Here, we show that the pro-proliferative transcription factor FOXM1 is elevated and activated in malignant melanoma. FOXM1 activity correlated with expression of the enzyme Pin1, which we found to be indicative of a poor prognosis. In functional experiments, Pin1 proved to be a main regulator of FOXM1 activity through MEK-dependent physical regulation during the cell cycle. The Pin1-FOXM1 interaction was enhanced by BRAF(V600E), the driver oncogene in the majority of melanomas, and in extrapolation of the correlation data, interference with\Pin1 in BRAF(V600E)-driven metastatic melanoma cells impaired both FOXM1 activity and cell survival. Importantly, cell-permeable Pin1-FOXM1-blocking peptides repressed the proliferation of melanoma cells in freshly isolated human metastatic melanoma ex vivo and in three-dimensional-cultured patient-derived melanoids. When combined with the BRAF(V600) Einhibitor PLX4032 a robust repression in melanoid viability was obtained, establishing preclinical value of patient-derived melanoids for prognostic use of drug sensitivity and further underscoring the beneficial effect of Pin1-FOXM1 inhibitory peptides as anti-melanoma drugs. These proof-of-concept results provide a starting point for development of therapeutic Pin1-FOXM1 inhibitors to target metastatic melanoma.	[Kruiswijk, F.; Hasenfuss, S. C.; van den Broek, N. J. F.; Brenkman, A. B.; Burgering, B. M. T.; de Keizer, P. L. J.] Univ Med Ctr, Ctr Mol Med, Mol Canc Res, Utrecht, Netherlands; [Sivapatham, R.; Campisi, J.; de Keizer, P. L. J.] Buck Inst Res Aging, Novato, CA USA; [Baar, M. P.; Putavet, D.; Naipal, K. A. T.; van Gent, D. C.; Hoeijmakers, J. H. J.; de Keizer, P. L. J.] Erasmus MC, Dept Genet, Wytemaweg 80,POB 2040, NL-3000 CA Rotterdam, Netherlands; [Kruit, W.] Erasmus MC, Dept Med Oncol, Rotterdam, Netherlands; [van der Spek, P. J.] Erasmus MC, Dept Bioinformat, Rotterdam, Netherlands; [Brenkman, A. B.] Univ Med Ctr, Dept Metab & Endocrine Dis, Utrecht, Netherlands; [Campisi, J.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA	Utrecht University; Utrecht University Medical Center; Buck Institute for Research on Aging; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	de Keizer, PLJ (corresponding author), Erasmus MC, Dept Genet, Wytemaweg 80,POB 2040, NL-3000 CA Rotterdam, Netherlands.	p.dekeizer@erasmusmc.nl	de+Keizer, Peter/AAD-5320-2020; Sivapatham, Renuka/AAS-3650-2020; Hoeijmakers, Jan/AAX-6972-2021	de+Keizer, Peter/0000-0002-6948-925X; Sivapatham, Renuka/0000-0003-0309-3671; van Gent, Dik C./0000-0003-1473-8148; Naipal, Kishan/0000-0001-8267-8218	NIH [R37-AG009909]; NIH/NIA [AG-17242-02]; KNAW; ERC; FP7 framework [HEALTH-F2-2010-259893]; Dutch Cancer Society [Buit-4649]; EMCR [2014-7141]; Erasmus Medical Center Rotterdam: EMC fellowship; CGC; NATIONAL INSTITUTE ON AGING [R37AG009909, P01AG017242] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); KNAW; ERC(European Research Council (ERC)European Commission); FP7 framework; Dutch Cancer Society(KWF Kankerbestrijding); EMCR; Erasmus Medical Center Rotterdam: EMC fellowship; CGC; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to gratefully acknowledge Dr Richard Marais for material from BRAF<SUP>V600E-</SUP>inducible mice, Dr Hugo Snippert and Dr Rene Overmeer for advice on organoid culture and Dr Jamila Laoukili and Dr Rene Medema for general advice on FOXM1 signaling. This work has been supported by grants from the NIH: R37-AG009909 (JC), CGC (BB), NIH/NIA: AG-17242-02 (JC/JH), KNAW (JH), ERC (JH), FP7 framework HEALTH-F2-2010-259893 (JH), the Dutch Cancer Society: Buit-4649 (PDK), EMCR 2014-7141 (PDK) and the Erasmus Medical Center Rotterdam: 2013 EMC fellowship (PDK).	Alcala AM, 2012, CLIN CANCER RES, V18, P33, DOI 10.1158/1078-0432.CCR-11-0997; Alvarez B, 2001, NATURE, V413, P744, DOI 10.1038/35099574; Anders L, 2011, CANCER CELL, V20, P620, DOI 10.1016/j.ccr.2011.10.001; Aytes A, 2014, CANCER CELL, V25, P638, DOI 10.1016/j.ccr.2014.03.017; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Bogunovic D, 2009, P NATL ACAD SCI USA, V106, P20429, DOI 10.1073/pnas.0905139106; Bonny C, 2001, DIABETES, V50, P77, DOI 10.2337/diabetes.50.1.77; Brenkman AB, 2008, CANCER RES, V68, P7597, DOI 10.1158/0008-5472.CAN-08-1059; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Damsky WE, 2014, ONCOGENE, V33, P2413, DOI 10.1038/onc.2013.194; Damsky WE, 2010, PIGM CELL MELANOMA R, V23, P853, DOI 10.1111/j.1755-148X.2010.00777.x; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Das Thakur M, 2013, NATURE, V494, P251, DOI 10.1038/nature11814; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; de Keizer PLJ, 2010, CANCER RES, V70, P8526, DOI 10.1158/0008-5472.CAN-10-1563; Dhomen N, 2009, HEMATOL ONCOL CLIN N, V23, P529, DOI 10.1016/j.hoc.2009.04.001; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; Down CF, 2012, BBA-GENE REGUL MECH, V1819, P855, DOI 10.1016/j.bbagrm.2012.03.008; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Geurts-Giele WRR, 2014, J PATHOL, V234, P548, DOI 10.1002/path.4419; Gusarova GA, 2007, J CLIN INVEST, V117, P99, DOI 10.1172/JCI27527; Halasi M, 2009, CELL CYCLE, V8, P1966, DOI 10.4161/cc.8.12.8708; Hatzivassiliou G, 2013, NATURE, V501, P232, DOI 10.1038/nature12441; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Jones AT, 2012, J CONTROL RELEASE, V161, P582, DOI 10.1016/j.jconrel.2012.04.003; Korver W, 1997, NUCLEIC ACIDS RES, V25, P1715, DOI 10.1093/nar/25.9.1715; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Li XX, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-204; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Ma RYM, 2005, J CELL SCI, V118, P795, DOI 10.1242/jcs.01657; Maser RS, 2007, NATURE, V447, P966, DOI 10.1038/nature05886; Naipal KAT, 2014, CLIN CANCER RES, V20, P4816, DOI 10.1158/1078-0432.CCR-14-0571; Nakamura A, 2013, CANCER RES, V73, P7043, DOI 10.1158/0008-5472.CAN-13-1825; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Poulikakos PI, 2011, CANCER CELL, V19, P11, DOI 10.1016/j.ccr.2011.01.008; Raychaudhuri P, 2011, CANCER RES, V71, P4329, DOI 10.1158/0008-5472.CAN-11-0640; REED JA, 1995, CANCER RES, V55, P2713; Riker AI, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-13; Smith AP, 2005, CANCER BIOL THER, V4, P1018, DOI 10.4161/cbt.4.9.2165; Solit D, 2010, NATURE, V468, P902, DOI 10.1038/468902a; Talantov D, 2005, CLIN CANCER RES, V11, P7234, DOI 10.1158/1078-0432.CCR-05-0683; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P639, DOI 10.1038/77929; Wagle N, 2014, CANCER DISCOV, V4, P61, DOI 10.1158/2159-8290.CD-13-0631; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Walker GJ, 2011, PIGM CELL MELANOMA R, V24, P1158, DOI 10.1111/j.1755-148X.2011.00923.x; Xu L, 2008, MOL CANCER RES, V6, P760, DOI 10.1158/1541-7786.MCR-07-0344; Zhang N, 2012, CLIN CANCER RES, V18, P5961, DOI 10.1158/1078-0432.CCR-12-0039	47	36	37	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 28	2016	35	17					2166	2177		10.1038/onc.2015.282	http://dx.doi.org/10.1038/onc.2015.282			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DK5UK	26279295	Green Published, hybrid, Green Accepted, Green Submitted			2022-12-26	WOS:000374986000003
J	Noda, A; Suemori, H; Hirai, Y; Hamasaki, K; Kodama, Y; Mitani, H; Landes, RD; Nakamura, N				Noda, Asao; Suemori, Hirofumi; Hirai, Yuko; Hamasaki, Kanya; Kodama, Yoshiaki; Mitani, Hiroshi; Landes, Reid D.; Nakamura, Nori			Creation of Mice Bearing a Partial Duplication of HPRT Gene Marked with a GFP Gene and Detection of Revertant Cells In Situ as GFP-Positive Somatic Cells	PLOS ONE			English	Article							EYED UNSTABLE MUTATION; INTRACHROMOSOMAL HOMOLOGOUS RECOMBINATION; BLOOD T-LYMPHOCYTES; SMALL-INTESTINE; STEM-CELLS; CHROMOSOME TRANSLOCATIONS; GAMMA-RADIATION; DIRECT REPEAT; ANEUPLOIDY; MOSAICISM	It is becoming clear that apparently normal somatic cells accumulate mutations. Such accumulations or propagations of mutant cells are thought to be related to certain diseases such as cancer. To better understand the nature of somatic mutations, we developed a mouse model that enables in vivo detection of rare genetically altered cells via GFP positive cells. The mouse model carries a partial duplication of 3' portion of X-chromosomal HPRT gene and a GFP gene at the end of the last exon. In addition, although HPRT gene expression was thought ubiquitous, the expression level was found insufficient in vivo to make the revertant cells detectable by GFP positivity. To overcome the problem, we replaced the natural HPRT-gene promoter with a CAG promoter. In such animals, termed HPRT-dup-GFP mouse, losing one duplicated segment by crossover between the two sister chromatids or within a single molecule of DNA reactivates gene function, producing hybrid HPRT-GFP proteins which, in turn, cause the revertant cells to be detected as GFP-positive cells in various tissues. Frequencies of green mutant cells were measured using fixed and frozen sections (liver and pancreas), fixed whole mount (small intestine), or by means of flow cytometry (unfixed splenocytes). The results showed that the frequencies varied extensively among individuals as well as among tissues. X-ray exposure (3 Gy) increased the frequency moderately (similar to 2 times) in the liver and small intestine. Further, in two animals out of 278 examined, some solid tissues showed too many GFP-positive cells to score (termed extreme jackpot mutation). Present results illustrated a complex nature of somatic mutations occurring in vivo. While the HPRT-dup-GFP mouse may have a potential for detecting tissue-specific environmental mutagens, large inter-individual variations of mutant cell frequency cause the results unstable and hence have to be reduced. This future challenge will likely involve lowering the background mutation frequency, thus reducing inter-individual variation.	[Noda, Asao; Hirai, Yuko; Hamasaki, Kanya; Kodama, Yoshiaki; Nakamura, Nori] Radiat Effects Res Fdn, Dept Genet, Minami Ku, Hiroshima 7320815, Japan; [Suemori, Hirofumi] Kyoto Univ, Lab Embryon Stem Cell Res, Stem Cell Res Ctr, Inst Frontier Med Sci,Sakyo Ku, Kyoto 6068507, Japan; [Mitani, Hiroshi] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba 2778562, Japan; [Landes, Reid D.] Radiat Effects Res Fdn, Dept Stat, Minami Ku, Hiroshima 7320815, Japan	Radiation Effects Research Foundation - Japan; Kyoto University; University of Tokyo; Radiation Effects Research Foundation - Japan	Noda, A (corresponding author), Radiat Effects Res Fdn, Dept Genet, Minami Ku, 5-2 Hijiyama Pk, Hiroshima 7320815, Japan.	asnoda@rerf.or.jp		Noda, Asao/0000-0002-9029-9813	DOE grant (National Academy of Sciences, United States) [DE-HS0000031]; MEXT grant (Japanese Ministry of Health, Labour and Welfare) [s21001003, s25220102]; Central Research Institute of Electronic Industry grant; Japan Chemical Industry Association LRI grant	DOE grant (National Academy of Sciences, United States); MEXT grant (Japanese Ministry of Health, Labour and Welfare); Central Research Institute of Electronic Industry grant; Japan Chemical Industry Association LRI grant	Funding provided by DOE Award DE-HS0000031 (National Academy of Sciences, United States) to AN, YH, KH, YK, RDL, NN, MEXT grant (Japanese Ministry of Health, Labour and Welfare) s21001003, s25220102 to AN, HM, Central Research Institute of Electronic Industry grant to AN and Japan Chemical Industry Association LRI grant to AN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views of the authors do not necessarily reflect those of the two governments.	ABRUZZO MA, 1985, CYTOGENET CELL GENET, V39, P275, DOI 10.1159/000132157; Aubrecht J, 1999, CARCINOGENESIS, V20, P2229, DOI 10.1093/carcin/20.12.2229; Baker DJ, 2013, NAT CELL BIOL, V15, P96, DOI 10.1038/ncb2643; Baker DJ, 2010, CELL CYCLE, V9, P1711, DOI 10.4161/cc.9.9.11314; Barber RC, 2006, MUTAT RES-FUND MOL M, V598, P50, DOI 10.1016/j.mrfmmm.2006.01.009; Barker N, 2010, CELL STEM CELL, V7, P656, DOI 10.1016/j.stem.2010.11.016; Bertrand P, 1997, ONCOGENE, V14, P1117, DOI 10.1038/sj.onc.1200931; Bishop AJR, 2000, CANCER RES, V60, P395; Bourdeaut F, 2010, J MED GENET, V47, P859, DOI 10.1136/jmg.2009.075374; Bushman DM, 2013, SEMIN CELL DEV BIOL, V24, P357, DOI 10.1016/j.semcdb.2013.02.003; De S, 2011, TRENDS GENET, V27, P217, DOI 10.1016/j.tig.2011.03.002; Faggioli F, 2012, HUM MOL GENET, V21, P5246, DOI 10.1093/hmg/dds375; Frank SA, 2010, P NATL ACAD SCI USA, V107, P1725, DOI 10.1073/pnas.0909343106; GONDO Y, 1993, P NATL ACAD SCI USA, V90, P297, DOI 10.1073/pnas.90.1.297; Greaves MF, 2003, NAT REV CANCER, V3, P639, DOI 10.1038/nrc1164; Hanks S, 2004, NAT GENET, V36, P1159, DOI 10.1038/ng1449; Hendricks CA, 2003, P NATL ACAD SCI USA, V100, P6325, DOI 10.1073/pnas.1232231100; Hinkley DV, 1997, BOOTSTRAP METHODS TH, P582, DOI [10.1017/CBO9780511802843, DOI 10.1017/CBO9780511802843]; HIRAI Y, 1995, MUTAT RES-FUND MOL M, V329, P183, DOI 10.1016/0027-5107(95)00044-J; Hulten MA, 2010, CURR GENOMICS, V11, P409, DOI 10.2174/138920210793176056; IANNACCONE PM, 1987, INT J CANCER, V39, P778, DOI 10.1002/ijc.2910390621; Kass EM, 2013, P NATL ACAD SCI USA, V110, P5564, DOI 10.1073/pnas.1216824110; Knouse KA, 2014, P NATL ACAD SCI USA, V111, P13409, DOI 10.1073/pnas.1415287111; KUSHIRO J, 1992, MUTAT RES, V272, P17, DOI 10.1016/0165-1161(92)90005-7; LI YQ, 1994, J CELL SCI, V107, P3271; Mekeel KL, 1997, ONCOGENE, V14, P1847, DOI 10.1038/sj.onc.1201143; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Nakano M, 2004, RADIAT RES, V161, P273, DOI 10.1667/RR3133; Noda A, 2011, MUTAT RES-GEN TOX EN, V721, P101, DOI 10.1016/j.mrgentox.2010.12.010; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; PARK HS, 1995, AM J PATHOL, V147, P1416; POTTEN CS, 1987, VIRCHOWS ARCH B, V53, P227, DOI 10.1007/BF02890247; Prochazkova K, 2009, AM J MED GENET A, V149A, P206, DOI 10.1002/ajmg.a.32574; Rodriguez-Santiago B, 2010, AM J HUM GENET, V87, P129, DOI 10.1016/j.ajhg.2010.06.002; Schiestl RH, 1997, P NATL ACAD SCI USA, V94, P4576, DOI 10.1073/pnas.94.9.4576; SCHIESTL RH, 1994, SCIENCE, V266, P1573, DOI 10.1126/science.7985029; SCHMIDT GH, 1988, DEVELOPMENT, V103, P785; SCHONBERG S, 1984, AM J HUM GENET, V36, P387; Shao CS, 2001, NAT GENET, V28, P169, DOI 10.1038/88897; Sukup-Jackson MR, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004299; Tang JCY, 2013, CELL, V154, P928, DOI 10.1016/j.cell.2013.07.021; Tichy ED, 2010, STEM CELLS DEV, V19, P1699, DOI 10.1089/scd.2010.0058; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; Torres EM, 2008, GENETICS, V179, P737, DOI 10.1534/genetics.108.090878; Tucker JD, 1998, MUTAT RES-FUND MOL M, V400, P321, DOI 10.1016/S0027-5107(98)00048-7; Wiktor-Brown DM, 2006, P NATL ACAD SCI USA, V103, P11862, DOI 10.1073/pnas.0604943103; Wiktor-Brown DM, 2011, DNA REPAIR, V10, P1294, DOI 10.1016/j.dnarep.2011.09.009; WINTON DJ, 1989, MUTAGENESIS, V4, P404, DOI 10.1093/mutage/4.5.404; WINTON DJ, 1988, NATURE, V333, P463, DOI 10.1038/333463a0; Yurov YB, 2009, MOL CYTOGENET, V2, DOI 10.1186/1755-8166-2-23	50	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136041	10.1371/journal.pone.0136041	http://dx.doi.org/10.1371/journal.pone.0136041			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295470	Green Submitted, Green Published, gold			2022-12-26	WOS:000359926900063
J	Shen, LY; Luo, J; Du, JJ; Liu, CD; Wu, XQ; Pu, Q; Fu, YH; Tang, QZ; Liu, YR; Li, Q; Yang, RL; Li, XW; Tang, GQ; Jiang, YZ; Li, MZ; Zhang, SH; Zhu, L				Shen, Linyuan; Luo, Jia; Du, Jingjing; Liu, Chendong; Wu, Xiaoqian; Pu, Qiang; Fu, Yuhua; Tang, Qianzi; Liu, Yuanrui; Li, Qiang; Yang, Runlin; Li, Xuewei; Tang, Guoqing; Jiang, Yanzhi; Li, Mingzhou; Zhang, Shunhua; Zhu, Li			Transcriptome Analysis of Liangshan Pig Muscle Development at the Growth Curve Inflection Point and Asymptotic Stages Using Digital Gene Expression Profiling	PLOS ONE			English	Article							FATTY-ACID; SKELETAL-MUSCLE; MEAT QUALITY; CARCASS CHARACTERISTICS; INITIATION-FACTORS; INTRAMUSCULAR FAT; FEED-INTAKE; PERFORMANCE; WEIGHT; VCAM-1	Animal growth curves can provide essential information for animal breeders to optimize feeding and management strategies. However, the genetic mechanism underlying the phenotypic differentiation between the inflection point and asymptotic stages of the growth curve is not well characterized. Here, we employed Liangshan pigs in stages of growth at the inflection point (under inflection point: UIP) and the two asymptotic stages (before the inflection point: BIP, after the inflection point: AIP) as models to survey global gene expression in the longissimus dorsi muscle using digital gene expression (DGE) tag profiling. We found Liangshan pigs reached maximum growth rate (UIP) at 163.6 days of age and a weight of 134.6 kg. The DGE libraries generated 117 million reads of 5.89 gigabases in length. 21,331, 20,996 and 20,139 expressed transcripts were identified BIP, UIP and AIP, respectively. Among them, we identified 757 differentially expressed genes (DEGs) between BIP and UIP, and 271 DEGs between AIP and UIP. An enrichment analysis of DEGs proved the immune system was strengthened in the AIP stage. Energy metabolism rate, global transcriptional activity and bone development intensity were highest UIP. Meat from Liangshan pigs had the highest intramuscular fat content and most favorable fatty acid composition in the AIP. Three hundred eighty (27.70%) specific expression genes were highly enriched in QTL regions for growth and meat quality traits. This study completed a comprehensive analysis of diverse genetic mechanisms underlying the inflection point and asymptotic stages of growth. Our findings will serve as an important resource in the understanding of animal growth and development in indigenous pig breeds.	[Shen, Linyuan; Luo, Jia; Du, Jingjing; Liu, Chendong; Wu, Xiaoqian; Pu, Qiang; Tang, Qianzi; Yang, Runlin; Li, Xuewei; Tang, Guoqing; Li, Mingzhou; Zhang, Shunhua; Zhu, Li] Sichuan Agr Univ, Coll Anim Sci & Technol, Chengdu, Sichuan, Peoples R China; [Fu, Yuhua] Huazhong Agr Univ, Minist Educ, Key Lab Agr Anim Genet Breeding & Reprod, Wuhan, Peoples R China; [Fu, Yuhua] Huazhong Agr Univ, Key Lab Swine Genet, Wuhan, Peoples R China; [Yang, Runlin] Mabian Gold Liangshan Agr Dev Co Ltd, Chengdu, Sichuan, Peoples R China; [Jiang, Yanzhi] Sichuan Agr Univ, Dept Biol, Coll Life & Sci, Chengdu, Sichuan, Peoples R China; [Li, Qiang] Sichuan Prov Gen Stn Anim Husb, Chengdu, Sichuan, Peoples R China; [Liu, Yuanrui] LC Sci, Hangzhou, Zhejiang, Peoples R China	Sichuan Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University; Sichuan Agricultural University	Zhang, SH (corresponding author), Sichuan Agr Univ, Coll Anim Sci & Technol, Chengdu, Sichuan, Peoples R China.	zhangsh1919@163.com; zhuli7508@163.com	Du, Jingjing/X-4006-2019	Shen, Linyuan/0000-0001-6072-3268; Li, Mingzhou/0000-0001-8681-7684	Sichuan Sci & Tech Support Program [2013NZ0041]; earmarked fund for China Agriculture Research System [CARS-36-485 05B]; Chinese National Sci & Tech Support Program [2013BAD20B07]; International Science & Technology Cooperation Program of China [2014DFA31260]; Mabian Gold Liangshan Agricultural Development Co., Ltd.; LC Sciences	Sichuan Sci & Tech Support Program; earmarked fund for China Agriculture Research System; Chinese National Sci & Tech Support Program; International Science & Technology Cooperation Program of China; Mabian Gold Liangshan Agricultural Development Co., Ltd.; LC Sciences	The study was supported by the Sichuan Sci & Tech Support Program (No. 2013NZ0041), the earmarked fund for China Agriculture Research System (No. CARS-36-485 05B), the Chinese National Sci & Tech Support Program (No. 2013BAD20B07), and International Science & Technology Cooperation Program of China (2014DFA31260). Mabian Gold Liangshan Agricultural Development Co., Ltd. provided support in the form of a salary for author RY, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. LC Sciences provided support in the form of a salary for author YL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ai HS, 2015, NAT GENET, V47, P217, DOI 10.1038/ng.3199; Asano K, 2000, GENE DEV, V14, P2534, DOI 10.1101/gad.831800; Balooch G, 2005, P NATL ACAD SCI USA, V102, P18813, DOI 10.1073/pnas.0507417102; Bermejo JL, 2003, LIVEST PROD SCI, V82, P15, DOI 10.1016/S0301-6226(03)00005-8; Brossard L, 2009, ANIMAL, V3, P1114, DOI 10.1017/S1751731109004546; Cao Y, 1998, GENOMICS, V49, P327, DOI 10.1006/geno.1998.5268; Cho HP, 1999, J BIOL CHEM, V274, P37335, DOI 10.1074/jbc.274.52.37335; CONAWAY RC, 1993, ANNU REV BIOCHEM, V62, P161; Cook-Mills JM, 2002, MOL IMMUNOL, V39, P499, DOI 10.1016/S0161-5890(02)00206-7; de Lange CFM, 2001, CAN J ANIM SCI, V81, P1, DOI 10.4141/A00-006; Edelson BT, 2006, BLOOD, V107, P143, DOI 10.1182/blood-2005-06-2218; ELICES MJ, 1990, CELL, V60, P577, DOI 10.1016/0092-8674(90)90661-W; Enser M, 2001, OILS FATS ANIMAL CAR, V2, P77; Feng CG, 2000, J IMMUNOL, V164, P4853, DOI 10.4049/jimmunol.164.9.4853; Gerbens F, 2001, J ANIM SCI, V79, P347; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; Green DM, 2003, J SCI FOOD AGR, V83, P1150, DOI 10.1002/jsfa.1519; Guantes R, 2015, GENOME RES, V25, P633, DOI 10.1101/gr.178426.114; Hanawa T, 1997, J BIOMED MATER RES, V36, P131, DOI 10.1002/(SICI)1097-4636(199707)36:1<131::AID-JBM16>3.0.CO;2-L; Jiang YZ, 2011, ANIMAL, V5, P1485, DOI 10.1017/S1751731111000425; Kebreab E, 2007, J ANIM SCI, V85, P2498, DOI 10.2527/jas.2006-738; Kim CW, 2010, P NATL ACAD SCI USA, V107, P9626, DOI 10.1073/pnas.1001292107; KINGSLEY MCS, 1979, CAN J ZOOL, V57, P1020, DOI 10.1139/z79-130; Kishore U, 2000, IMMUNOPHARMACOLOGY, V49, P159, DOI 10.1016/S0162-3109(00)80301-X; Kohn F, 2007, J ANIM SCI, V85, P84, DOI 10.2527/jas.2006-271; Kourtidis A, 2010, CANCER RES, V70, P1783, DOI 10.1158/0008-5472.CAN-09-1550; KRIETER J, 1989, J ANIM BREED GENET, V106, P300, DOI 10.1111/j.1439-0388.1989.tb00244.x; Laing NG, 2009, HUM MUTAT, V30, P1267, DOI 10.1002/humu.21059; Lam SH, 2004, DEV COMP IMMUNOL, V28, P9, DOI 10.1016/S0145-305X(03)00103-4; Langelier MF, 2001, J BIOL CHEM, V276, P38652, DOI 10.1074/jbc.M106422200; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Li X, 2010, MOL BIOL REP, V37, P3931, DOI 10.1007/s11033-010-0050-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LU PW, 1994, J BONE MINER RES, V9, P1451; Mandal A, 2011, COMPUT STAT DATA AN, V55, P1086, DOI 10.1016/j.csda.2010.09.003; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; McDaneld TG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-77; Mottram DS, 1998, FOOD CHEM, V62, P415, DOI 10.1016/S0308-8146(98)00076-4; Nayak A, 2012, INNATE IMMUN-LONDON, V18, P350, DOI 10.1177/1753425910396252; Nesetrilova H, 2005, CZECH J ANIM SCI, V50, P347, DOI 10.17221/4176-CJAS; Pas M. F. W. te, 2005, Archiv fur Tierzucht, V48, P141; Pas MFWT, 2005, J MUSCLE RES CELL M, V26, P157, DOI 10.1007/s10974-005-7004-6; Qiao Yong, 2007, Journal of Genetics and Genomics, V34, P909, DOI 10.1016/S1673-8527(07)60102-7; Richard D, 2009, CELL MOL LIFE SCI, V66, P3277, DOI 10.1007/s00018-009-0085-4; Shen LY, 2014, ANIM SCI J, V85, P770, DOI 10.1111/asj.12207; Sonck E, 2009, VET IMMUNOL IMMUNOP, V130, P131, DOI 10.1016/j.vetimm.2009.01.010; Strathe AB, 2010, J ANIM SCI, V88, P638, DOI 10.2527/jas.2009-1822; SUZUKI H, 1990, J BIOL CHEM, V265, P8681; Tang ZL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r115; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang JY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-273; Wang T, 2013, INT J BIOL SCI, V9, P550, DOI 10.7150/ijbs.6257; Watanabe Akira, 2004, Animal Science Journal, V75, P361, DOI 10.1111/j.1740-0929.2004.00198.x; Weatherup RN, 1998, ANIM SCI, V67, P591, DOI 10.1017/S1357729800033038; Wood JD, 2004, MEAT SCI, V66, P21, DOI 10.1016/S0309-1740(03)00022-6; Xiao RJ, 1999, ANIM FEED SCI TECH, V79, P119, DOI 10.1016/S0377-8401(98)00282-X; Xu YJ, 2012, J PROTEOMICS, V75, P2093, DOI 10.1016/j.jprot.2012.01.013; Yang HJ, 2005, MEAT SCI, V71, P670, DOI 10.1016/j.meatsci.2005.05.019; Zhao X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019774, 10.1371/journal.pone.0021739]; Zhou HT, 2010, DEV COMP IMMUNOL, V34, P246, DOI 10.1016/j.dci.2009.11.002	60	15	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135978	10.1371/journal.pone.0135978	http://dx.doi.org/10.1371/journal.pone.0135978			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26292092	Green Submitted, Green Published, gold			2022-12-26	WOS:000359919900044
J	Tillack, K; Aboutalebi, H; Kramer, ER				Tillack, Karsten; Aboutalebi, Helia; Kramer, Edgar R.			An Efficient and Versatile System for Visualization and Genetic Modification of Dopaminergic Neurons in Transgenic Mice	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; HYDROXYLASE MESSENGER-RNA; CENTRAL-NERVOUS-SYSTEM; EMBRYONIC STEM-CELLS; TYROSINE-HYDROXYLASE; CRE RECOMBINASE; CATECHOLAMINERGIC NEURONS; CONDITIONAL EXPRESSION; PARKINSONS-DISEASE; LATERAL HABENULA	Background & Aims The brain dopaminergic (DA) system is involved in fine tuning many behaviors and several human diseases are associated with pathological alterations of the DA system such as Parkinson's disease (PD) and drug addiction. Because of its complex network integration, detailed analyses of physiological and pathophysiological conditions are only possible in a whole organism with a sophisticated tool box for visualization and functional modification. Methods & Results Here, we have generated transgenic mice expressing the tetracycline-regulated transactivator (tTA) or the reverse tetracycline-regulated transactivator (rtTA) under control of the tyrosine hydroxylase (TH) promoter, TH-tTA (tet-OFF) and TH-rtTA (tet-ON) mice, to visualize and genetically modify DA neurons. We show their tight regulation and efficient use to overexpress proteins under the control of tet-responsive elements or to delete genes of interest with tet-responsive Cre. In combination with mice encoding tet-responsive luciferase, we visualized the DA system in living mice progressively over time. Conclusion These experiments establish TH-tTA and TH-rtTA mice as a powerful tool to generate and monitor mouse models for DA system diseases.	[Tillack, Karsten; Aboutalebi, Helia; Kramer, Edgar R.] Univ Med Ctr Hamburg Eppendorf, Ctr Mol Neurobiol, Dev & Maintenance Nervous Syst, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Kramer, ER (corresponding author), Univ Med Ctr Hamburg Eppendorf, Ctr Mol Neurobiol, Dev & Maintenance Nervous Syst, Hamburg, Germany.	kramer@zmnh.uni-hamburg.de	Kramer, Edgar/A-9288-2012	Kramer, Edgar/0000-0002-4882-4143	German Research Foundation (DFG) [KR 3529/4-1]; town of Hamburg (Lexi)	German Research Foundation (DFG)(German Research Foundation (DFG)); town of Hamburg (Lexi)	This study was supported by grants from the German Research Foundation (DFG KR 3529/4-1 to ERK) and the town of Hamburg (Lexi to ERK).	Asmus SE, 2008, BRAIN RES, V1222, P95, DOI 10.1016/j.brainres.2008.05.053; Backman CM, 2006, GENESIS, V44, P383, DOI 10.1002/dvg.20228; Baker H, 2003, CELL MOL NEUROBIOL, V23, P507, DOI 10.1023/A:1025015928129; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Brockschniedier D, 2006, GENESIS, V44, P322, DOI 10.1002/dvg.20218; Cagniard B, 2006, NEURON, V51, P541, DOI 10.1016/j.neuron.2006.07.026; Chinta SJ, 2007, J NEUROSCI, V27, P13997, DOI 10.1523/JNEUROSCI.3885-07.2007; DIPORZIO U, 1990, INT J DEV NEUROSCI, V8, P523; Donaldson AE, 2005, MOL CELL NEUROSCI, V30, P108, DOI 10.1016/j.mcn.2005.06.004; Duty S, 2011, BRIT J PHARMACOL, V164, P1357, DOI 10.1111/j.1476-5381.2011.01426.x; Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103; Engblom D, 2008, NEURON, V59, P497, DOI 10.1016/j.neuron.2008.07.010; Evans MS, 2014, NAT METHODS, V11, P393, DOI [10.1038/NMETH.2839, 10.1038/nmeth.2839]; Forni PE, 2006, J NEUROSCI, V26, P9593, DOI 10.1523/JNEUROSCI.2815-06.2006; FUJII T, 1994, NEUROSCI LETT, V165, P161, DOI 10.1016/0304-3940(94)90734-X; Gardaneh M, 2004, MOL BRAIN RES, V126, P173, DOI 10.1016/j.molbrainres.2004.04.008; Gelman DM, 2003, GENESIS, V36, P196, DOI 10.1002/gene.10217; Gingrich JR, 1998, ANNU REV NEUROSCI, V21, P377, DOI 10.1146/annurev.neuro.21.1.377; Golden JP, 2013, J NEUROSCI, V 33, P17095, DOI 10.1523/JNEUROSCI.0890-13.2013; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Guggenhuber S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015707; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; KAWANO H, 1995, DEV BRAIN RES, V86, P101, DOI 10.1016/0165-3806(95)00018-9; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Kramer ER, 2007, PLOS BIOL, V5, P616, DOI 10.1371/journal.pbio.0050039; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Lammel S, 2015, NEURON, V85, P429, DOI 10.1016/j.neuron.2014.12.036; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lin X, 2012, J NEUROSCI, V32, P9248, DOI 10.1523/JNEUROSCI.1731-12.2012; Lindeberg J, 2004, GENESIS, V40, P67, DOI 10.1002/gene.20065; Loening AM, 2007, NAT METHODS, V4, P641, DOI 10.1038/NMETH1070; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Masuda M, 2011, EUR J NEUROSCI, V34, P1355, DOI 10.1111/j.1460-9568.2011.07873.x; Matsuda W, 2009, J NEUROSCI, V29, P444, DOI 10.1523/JNEUROSCI.4029-08.2009; MIN N, 1994, MOL BRAIN RES, V27, P281, DOI 10.1016/0169-328X(94)90011-6; Oyer JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004832; Parlato R, 2006, GENESIS, V44, P454, DOI 10.1002/dvg.20236; Qiu HY, 2008, GENESIS, V46, P324, DOI 10.1002/dvg.20399; Root DH, 2014, NAT NEUROSCI, V17, P1543, DOI 10.1038/nn.3823; Root DH, 2014, J NEUROSCI, V34, P13906, DOI 10.1523/JNEUROSCI.2029-14.2014; Rotolo T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004099; SATOH J, 1990, DEV BRAIN RES, V53, P1, DOI 10.1016/0165-3806(90)90119-J; Savitt JM, 2005, J NEUROSCI, V25, P6721, DOI 10.1523/JNEUROSCI.0760-05.2005; Sawamoto K, 2001, P NATL ACAD SCI USA, V98, P6423, DOI 10.1073/pnas.111152398; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; Schonig K, 2013, TRANSGENIC RES, V22, P251, DOI 10.1007/s11248-012-9660-9; Schonig K, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf134; Shevtsova Z, 2005, EXP PHYSIOL, V90, P53, DOI 10.1113/expphysiol.2004.028159; Smedemark-Margulies N, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00018; Smidt MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042641; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stamatakis AM, 2013, NEURON, V80, P1039, DOI 10.1016/j.neuron.2013.08.023; Stuber GD, 2015, NEURON, V85, P439, DOI 10.1016/j.neuron.2014.12.034; Takebayashi H, 2008, GENESIS, V46, P775, DOI 10.1002/dvg.20461; Tanaka KF, 2012, CELL REP, V2, P397, DOI 10.1016/j.celrep.2012.06.011; Traykova-Brauch M, 2008, NAT MED, V14, P979, DOI 10.1038/nm.1865; Wurst W, 2010, DOPAMINE HDB, P141; Xie W, 1999, ONCOGENE, V18, P3593, DOI 10.1038/sj.onc.1202673; Zhao SL, 2004, EUR J NEUROSCI, V19, P1133, DOI 10.1111/j.1460-9568.2004.03206.x; ZHOU QY, 1995, NATURE, V374, P640, DOI 10.1038/374640a0; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0; Zhou WB, 2009, STEM CELLS, V27, P2952, DOI 10.1002/stem.216; Zhu PX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000533; Zhuang XX, 2005, J NEUROSCI METH, V143, P27, DOI 10.1016/j.jneumeth.2004.09.020	64	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136203	10.1371/journal.pone.0136203	http://dx.doi.org/10.1371/journal.pone.0136203			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291828	Green Published, gold, Green Submitted			2022-12-26	WOS:000359919900064
J	Xu, JQ; Hu, HX; Chen, B; Yue, RC; Zhou, Z; Liu, Y; Zhang, S; Xu, L; Wang, H; Yu, ZP				Xu, Jiqian; Hu, Houxiang; Chen, Bin; Yue, Rongchuan; Zhou, Zhou; Liu, Yin; Zhang, Shuang; Xu, Lei; Wang, Huan; Yu, Zhengping			Lycopene Protects against Hypoxia/Reoxygenation Injury by Alleviating ER Stress Induced Apoptosis in Neonatal Mouse Cardiomyocytes	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; ISCHEMIA-REPERFUSION INJURY; ACUTE MYOCARDIAL-INFARCTION; OXIDATIVE STRESS; ISCHEMIA/REPERFUSION-INJURY; CARDIOVASCULAR-DISEASE; BETA-CAROTENE; CELL-CYCLE; HEART; INHIBITION	Endoplasmic reticulum (ER) stress induced apoptosis plays a pivotal role in myocardial ischemia/reperfusion (I/R)-injury. Inhibiting ER stress is a major therapeutic target/strategy in treating cardiovascular diseases. Our previous studies revealed that lycopene exhibits great pharmacological potential in protecting against the I/R-injury in vitro and vivo, but whether attenuation of ER stress (and) or ER stress-induced apoptosis contributes to the effects remains unclear. In the present study, using neonatal mouse cardiomyocytes to establish an in vitro model of hypoxia/reoxygenation (H/R) to mimic myocardium I/R in vivo, we aimed to explore the hypothesis that lycopene could alleviate the ER stress and ER stress-induced apoptosis in H/R-injury. We observed that lycopene alleviated the H/R injury as revealed by improving cell viability and reducing apoptosis, suppressed reactive oxygen species (ROS) generation and improved the phosphorylated AMPK expression, attenuated ER stress as evidenced by decreasing the expression of GRP78, ATF6 mRNA, sXbp-1 mRNA, eIF2 alpha mRNA and eIF2 alpha phosphorylation, alleviated ER stress-induced apoptosis as manifested by reducing CHOP/GADD153 expression, the ratio of Bax/Bcl-2, caspase-12 and caspase-3 activity in H/R-treated cardiomyocytes. Thapsigargin (TG) is a potent ER stress inducer and used to elicit ER stress of cardiomyocytes. Our results showed that lycopene was able to prevent TG-induced ER stress as reflected by attenuating the protein expression of GRP78 and CHOP/GADD153 compared to TG group, significantly improve TG-caused a loss of cell viability and decrease apoptosis in TG-treated cardiomyocytes. These results suggest that the protective effects of lycopene on H/R-injury are, at least in part, through alleviating ER stress and ER stress-induced apoptosis in neonatal mouse cardiomyocytes.	[Xu, Jiqian; Hu, Houxiang; Yue, Rongchuan; Zhang, Shuang; Xu, Lei; Wang, Huan] Affiliated Hosp, North Sichuan Med Coll, Dept Cardiol, Nanchong 637000, Sichuan, Peoples R China; [Xu, Jiqian; Chen, Bin] Affiliated Hosp, North Sichuan Med Coll, Dept Anesthesiol, Nanchong 637000, Sichuan, Peoples R China; [Zhou, Zhou; Yu, Zhengping] Third Mil Med Univ, Dept Occupat Hlth, Chongqing 400038, Peoples R China; [Liu, Yin] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada	North Sichuan Medical University; North Sichuan Medical University; Army Medical University; Western University (University of Western Ontario)	Hu, HX (corresponding author), Affiliated Hosp, North Sichuan Med Coll, Dept Cardiol, Nanchong 637000, Sichuan, Peoples R China.	hhxiang17@163.com; chenbin8703@163.com			National Natural Science Foundation of China [NSFC 81070101]; Applied Basic Research Programs of Sichuan Provincial Science and Education Department [12ZA060, 15ZB0200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Applied Basic Research Programs of Sichuan Provincial Science and Education Department	This work was supported by grants from the National Natural Science Foundation of China (NSFC 81070101) and the Applied Basic Research Programs of Sichuan Provincial Science and Education Department (12ZA060 and 15ZB0200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agca CA, 2012, PHARM BIOL, V50, P1513, DOI 10.3109/13880209.2012.688057; Bansal P, 2006, MOL CELL BIOCHEM, V289, P1, DOI 10.1007/s11010-006-9141-7; Bian YF, 2011, J INVEST MED, V59, P921, DOI 10.2310/JIM.0b013e318216ad04; Cao HP, 2013, IN VITRO CELL DEV-AN, V49, P759, DOI 10.1007/s11626-013-9671-8; Chen Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091793; Crnkovic S, 2012, FREE RADICAL BIO MED, V52, P1786, DOI 10.1016/j.freeradbiomed.2012.02.036; Csordas G, 2009, BBA-BIOENERGETICS, V1787, P1352, DOI 10.1016/j.bbabio.2009.06.004; Das S, 2005, FREE RADICAL RES, V39, P449, DOI 10.1080/10715760500053685; Ekelof S, 2014, CARDIOVASC DRUG THER, V28, P173, DOI 10.1007/s10557-014-6511-3; Fonseca ACRG, 2013, BBA-MOL BASIS DIS, V1832, P2191, DOI 10.1016/j.bbadis.2013.08.007; Fujita K, 2013, NEUROCHEM RES, V38, P461, DOI 10.1007/s11064-012-0952-5; Gao X, 2012, BASIC CLIN PHARMACOL, V111, P14, DOI 10.1111/j.1742-7843.2011.00854.x; Groenendyk J, 2010, CIRC RES, V107, P1185, DOI 10.1161/CIRCRESAHA.110.227033; Guo LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070565; Gupta P, 2013, BIOCHEM BIOPH RES CO, V434, P479, DOI 10.1016/j.bbrc.2013.03.099; Hardy B, 2010, J MOL MED, V88, P1157, DOI 10.1007/s00109-010-0657-7; Heusch G, 2013, LANCET, V381, P166, DOI 10.1016/S0140-6736(12)60916-7; Karppi J, 2013, ATHEROSCLEROSIS, V226, P172, DOI 10.1016/j.atherosclerosis.2012.10.077; Karppi J, 2012, EUR J PUBLIC HEALTH, V22, P835, DOI 10.1093/eurpub/ckr174; Kim Y, 2010, BRAIN RES, V1317, P13, DOI 10.1016/j.brainres.2009.12.062; Levitsky S, 2006, CIRCULATION, V114, pI339, DOI 10.1161/CIRCULATIONAHA.105.001685; Levonen AL, 2008, CIRCULATION, V117, P2142, DOI 10.1161/CIRCULATIONAHA.107.718585; Liu BM, 2012, FREE RADICAL BIO MED, V53, P183, DOI 10.1016/j.freeradbiomed.2012.04.015; Martindale JJ, 2006, CIRC RES, V98, P1186, DOI 10.1161/01.RES.0000220643.65941.8d; Minamino T, 2010, CIRC RES, V107, P1071, DOI 10.1161/CIRCRESAHA.110.227819; Miyazaki Y, 2011, ARTERIOSCL THROM VAS, V31, P1124, DOI 10.1161/ATVBAHA.111.224519; Neuber C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098893; Oerlemans MIFJ, 2013, INT J CARDIOL, V165, P410, DOI 10.1016/j.ijcard.2012.03.055; Soares NDP, 2013, NUTR CANCER, V65, P1076, DOI 10.1080/01635581.2013.812225; Pi HF, 2013, AUTOPHAGY, V9, P1780, DOI 10.4161/auto.25665; Pierre N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065061; Qiu B, 2013, BIOCHEM BIOPH RES CO, V436, P655, DOI 10.1016/j.bbrc.2013.05.142; Qiu X, 2013, CANCER PREV RES, V6, P419, DOI 10.1158/1940-6207.CAPR-12-0364; Song P, 2012, FREE RADICAL BIO MED, V52, P1607, DOI 10.1016/j.freeradbiomed.2012.01.025; Takeshima M, 2014, CANCER SCI, V105, P252, DOI 10.1111/cas.12349; Tao JP, 2011, AM J PHYSIOL-HEART C, V301, pH1471, DOI 10.1152/ajpheart.00097.2011; Terai K, 2005, MOL CELL BIOL, V25, P9554, DOI 10.1128/MCB.25.21.9554-9575.2005; Tsutsumi YM, 2007, LIFE SCI, V81, P1223, DOI 10.1016/j.lfs.2007.08.031; Upaganlawar Aman, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P345, DOI 10.1016/S2221-1691(12)60054-9; Wu CX, 2013, NEUROSCI LETT, V546, P57, DOI 10.1016/j.neulet.2013.04.060; Wu XD, 2013, APOPTOSIS, V18, P85, DOI 10.1007/s10495-012-0766-6; Yadavilli S, 2007, TOXICOL IN VITRO, V21, P1429, DOI 10.1016/j.tiv.2007.06.007; Yeh CH, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/130636; Yi F, 2013, NEUROCHEM RES, V38, P1747, DOI 10.1007/s11064-013-1079-z; Yue RC, 2015, J CELL PHYSIOL, V230, P2128, DOI 10.1002/jcp.24941; Yue RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050778; Zhang GG, 2013, PEPTIDES, V48, P156, DOI 10.1016/j.peptides.2013.08.015; Zhu XY, 2013, J ETHNOPHARMACOL, V150, P672, DOI 10.1016/j.jep.2013.09.044	48	47	48	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136443	10.1371/journal.pone.0136443	http://dx.doi.org/10.1371/journal.pone.0136443			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291709	Green Published, Green Submitted, gold			2022-12-26	WOS:000359919900085
J	Medlock, AE; Shiferaw, MT; Marcero, JR; Vashisht, AA; Wohlschlegel, JA; Phillips, JD; Dailey, HA				Medlock, Amy E.; Shiferaw, Mesafint T.; Marcero, Jason R.; Vashisht, Ajay A.; Wohlschlegel, James A.; Phillips, John D.; Dailey, Harry A.			Identification of the Mitochondrial Heme Metabolism Complex	PLOS ONE			English	Article							LINKED SIDEROBLASTIC ANEMIA; ERYTHROID CELL-DIFFERENTIATION; SUCCINYL-COA SYNTHETASE; SYNTHASE MESSENGER-RNA; PORPHOBILINOGEN DEAMINASE; ERYTHROLEUKEMIA-CELLS; IN-SITU; ABC-ME; IRON; ENZYME	Heme is an essential cofactor for most organisms and all metazoans. While the individual enzymes involved in synthesis and utilization of heme are fairly well known, less is known about the intracellular trafficking of porphyrins and heme, or regulation of heme biosynthesis via protein complexes. To better understand this process we have undertaken a study of macromolecular assemblies associated with heme synthesis. Herein we have utilized mass spectrometry with coimmunoprecipitation of tagged enzymes of the heme biosynthetic pathway in a developing erythroid cell culture model to identify putative protein partners. The validity of these data obtained in the tagged protein system is confirmed by normal porphyrin/heme production by the engineered cells. Data obtained are consistent with the presence of a mitochondrial heme metabolism complex which minimally consists of ferrochelatase, protoporphyrinogen oxidase and aminolevulinic acid synthase-2. Additional proteins involved in iron and intermediary metabolism as well as mitochondrial transporters were identified as potential partners in this complex. The data are consistent with the known location of protein components and support a model of transient protein-protein interactions within a dynamic protein complex.	[Medlock, Amy E.; Shiferaw, Mesafint T.; Marcero, Jason R.; Dailey, Harry A.] Univ Georgia, Biomed & Hlth Sci Inst, Athens, GA 30602 USA; [Medlock, Amy E.; Shiferaw, Mesafint T.; Marcero, Jason R.; Dailey, Harry A.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Dailey, Harry A.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Medlock, Amy E.; Shiferaw, Mesafint T.] Univ Georgia, GRU UGA Med Partnership, Athens, GA 30602 USA; [Phillips, John D.] Univ Utah, Sch Med, Dept Med, Div Hematol, Salt Lake City, UT USA; [Vashisht, Ajay A.; Wohlschlegel, James A.] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90024 USA; [Vashisht, Ajay A.; Wohlschlegel, James A.] Univ Calif Los Angeles, Inst Genom & Prote, Los Angeles, CA USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Utah System of Higher Education; University of Utah; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Medlock, AE (corresponding author), Univ Georgia, Biomed & Hlth Sci Inst, Athens, GA 30602 USA.	medlock@uga.edu		Medlock, Amy/0000-0001-9402-3593	American Heart Association [12GRNT12080123]; National Institutes of Health [DK096051, GM089778, DK020503, DK083909]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK096051, R56DK020503, R01DK020503, U54DK083909, R37DK020503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089778] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: The research was supported by an American Heart Association (http://www.heart.org) grant 12GRNT12080123 (to A.E.M.) and National Institutes of Health (http://www.nih.gov) grants DK096051 (to H.A.D.), GM089778 (to J.A.W.), DK020503 and DK083909 (to J.D.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003070; Barman-Aksozen J, 2013, BLOOD CELL MOL DIS, V51, P151, DOI 10.1016/j.bcmd.2013.05.008; Bayeva M, 2013, CIRC RES, V113, P279, DOI 10.1161/CIRCRESAHA.113.301552; Bekri S, 2000, BLOOD, V96, P3256; Besur S, 2014, METABOLITES, V4, P977, DOI 10.3390/metabo4040977; BHASKER CR, 1993, J BIOL CHEM, V268, P12699; Bishop DF, 2012, J BIOL CHEM, V287, P28943, DOI 10.1074/jbc.M111.306423; BISHOP DF, 1990, GENOMICS, V7, P207, DOI 10.1016/0888-7543(90)90542-3; Burden AE, 1999, BBA-PROTEIN STRUCT M, V1435, P191, DOI 10.1016/S0167-4838(99)00196-X; Campanella ME, 2005, P NATL ACAD SCI USA, V102, P2402, DOI 10.1073/pnas.0409741102; Cardalda CA, 1997, ARCH BIOCHEM BIOPHYS, V347, P69, DOI 10.1006/abbi.1997.0310; Castellana M, 2014, NAT BIOTECHNOL, V32, P1011, DOI 10.1038/nbt.3018; Chen CY, 2012, BBA-MOL CELL RES, V1823, P1459, DOI 10.1016/j.bbamcr.2012.01.003; Chen W, 2010, BLOOD, V116, P628, DOI 10.1182/blood-2009-12-259614; Chen W, 2009, P NATL ACAD SCI USA, V106, P16263, DOI 10.1073/pnas.0904519106; CHEUNG CW, 1989, J BIOL CHEM, V264, P4038; CONDER LH, 1991, BIOCHEM J, V275, P321, DOI 10.1042/bj2750321; De March M, 2014, J INORG BIOCHEM, V135, P58, DOI 10.1016/j.jinorgbio.2014.02.015; Deery E, 2012, NAT CHEM BIOL, V8, P933, DOI [10.1038/NCHEMBIO.1086, 10.1038/nchembio.1086]; DEYBACH JC, 1985, EUR J BIOCHEM, V149, P431, DOI 10.1111/j.1432-1033.1985.tb08943.x; ELDER GH, 1978, BIOCHEM J, V172, P345, DOI 10.1042/bj1720345; FERREIRA GC, 1988, J BIOL CHEM, V263, P3835; Furuyama K, 2000, J CLIN INVEST, V105, P757, DOI 10.1172/JCI6816; Gill R, 2009, BIOCHEM J, V420, P17, DOI 10.1042/BJ20082077; GRANDCHAMP B, 1978, BIOCHEM J, V176, P97, DOI 10.1042/bj1760097; Hamdi A, 2014, BLOOD, V124, DOI 10.1182/blood.V124.21.4023.4023; Hamza I, 2012, BBA-MOL CELL RES, V1823, P1617, DOI 10.1016/j.bbamcr.2012.04.009; HRADILEK A, 1992, J CELL PHYSIOL, V150, P327, DOI 10.1002/jcp.1041500216; Jorgensen K, 2005, CURR OPIN PLANT BIOL, V8, P280, DOI 10.1016/j.pbi.2005.03.014; Kabe Y, 2006, J BIOL CHEM, V281, P31729, DOI 10.1074/jbc.M604729200; Koch M, 2004, EMBO J, V23, P1720, DOI 10.1038/sj.emboj.7600189; LAKEBULLOCK H, 1993, MOL CELL BIOL, V13, P7122, DOI 10.1128/MCB.13.11.7122; Leighton J, 1998, METHOD ENZYMOL, V292, P776; Liesa M, 2012, BBA-MOL CELL RES, V1823, P1945, DOI 10.1016/j.bbamcr.2012.07.013; Medlock A, 2007, P NATL ACAD SCI USA, V104, P1789, DOI 10.1073/pnas.0606144104; Medlock AE, 2007, J MOL BIOL, V373, P1006, DOI 10.1016/j.jmb.2007.08.040; Medlock Amy E., 2009, P116, DOI 10.1007/978-0-387-78518-9_7; MELEFORS O, 1993, J BIOL CHEM, V268, P5974; OHTA Y, 1976, P NATL ACAD SCI USA, V73, P1232, DOI 10.1073/pnas.73.4.1232; Orchard S, 2014, NUCLEIC ACIDS RES, V42, pD358, DOI 10.1093/nar/gkt1115; Pondarre C, 2007, BLOOD, V109, P3567, DOI 10.1182/blood-2006-04-015768; PROULX KL, 1993, PROTEIN SCI, V2, P1092, DOI 10.1002/pro.5560020703; Qin XH, 2011, FASEB J, V25, P653, DOI 10.1096/fj.10-170811; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; Richardson DR, 2010, P NATL ACAD SCI USA, V107, P10775, DOI 10.1073/pnas.0912925107; Richardson DR, 1996, BLOOD, V87, P3477, DOI 10.1182/blood.V87.8.3477.bloodjournal8783477; ROBINSON JB, 1985, J BIOL CHEM, V260, P800; RUTHERFORD T, 1979, P NATL ACAD SCI USA, V76, P833, DOI 10.1073/pnas.76.2.833; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Sheftel AD, 2007, BLOOD, V110, P125, DOI 10.1182/blood-2007-01-068148; Shirihai OS, 2000, EMBO J, V19, P2492, DOI 10.1093/emboj/19.11.2492; SINGER D, 1974, P NATL ACAD SCI USA, V71, P2668, DOI 10.1073/pnas.71.7.2668; Spector DL, 1999, INSTITUTE OF EXPERIM, V1, P411; SRERE PA, 1985, TRENDS BIOCHEM SCI, V10, P109, DOI 10.1016/0968-0004(85)90266-X; SRERE PA, 1994, BIOCHEM SOC T, V22, P446, DOI 10.1042/bst0220446; Stehling O, 2012, SCIENCE, V337, P195, DOI 10.1126/science.1219723; Taketani S, 2003, BLOOD, V101, P3274, DOI 10.1182/blood-2002-04-1212; Tang LL, 2012, BRIT J HAEMATOL, V157, P151, DOI 10.1111/j.1365-2141.2011.08936.x; TSAI SF, 1987, J BIOL CHEM, V262, P1268; WARD JH, 1982, J BIOL CHEM, V257, P317; Whatley SD, 2008, AM J HUM GENET, V83, P408, DOI 10.1016/j.ajhg.2008.08.003; Woo AJ, 2008, MOL CELL BIOL, V28, P2675, DOI 10.1128/MCB.01945-07; Woodard SI, 2000, ARCH BIOCHEM BIOPHYS, V384, P375, DOI 10.1006/abbi.2000.2069; Yamamoto M, 2014, MOL CELL BIOL, V34, P1077, DOI 10.1128/MCB.00865-13; Yien YY, 2014, J CLIN INVEST, V124, P4294, DOI 10.1172/JCI76979; YOUNG SP, 1990, BIOCHEM J, V265, P587, DOI 10.1042/bj2650587; Zhang AS, 2005, BLOOD, V105, P368, DOI 10.1182/blood-2004-06-2226	67	64	64	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135896	10.1371/journal.pone.0135896	http://dx.doi.org/10.1371/journal.pone.0135896			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287972	Green Published, gold, Green Submitted			2022-12-26	WOS:000360018600082
J	Tung-Thompson, G; Libera, DA; Koch, KL; de los Reyes, FL; Jaykus, LA				Tung-Thompson, Grace; Libera, Dominic A.; Koch, Kenneth L.; de los Reyes, Francis L., III; Jaykus, Lee-Ann			Aerosolization of a Human Norovirus Surrogate, Bacteriophage MS2, during Simulated Vomiting	PLOS ONE			English	Article							NORWALK VIRUS; AIRBORNE TRANSMISSION; ARTIFICIAL SALIVA; ENTERIC VIRUSES; UNITED-STATES; GASTROENTERITIS; CONTAMINATION; ENVIRONMENT; INFECTION; OUTBREAKS	Human noroviruses (NoV) are the leading cause of acute gastroenteritis worldwide. Epidemiological studies of outbreaks have suggested that vomiting facilitates transmission of human NoV, but there have been no laboratory-based studies characterizing the degree of NoV release during a vomiting event. The purpose of this work was to demonstrate that virus aerosolization occurs in a simulated vomiting event, and to estimate the amount of virus that is released in those aerosols. A simulated vomiting device was constructed at one-quarter scale of the human body following similitude principles. Simulated vomitus matrices at low (6.24 mPa*s) and high (177.5 mPa*s) viscosities were inoculated with low (10(8) PFU/mL) and high (10(10) PFU/mL) concentrations of bacteriophage MS2 and placed in the artificial "stomach" of the device, which was then subjected to scaled physiologically relevant pressures associated with vomiting. Bio aerosols were captured using an SKC Biosampler. In low viscosity artificial vomitus, there were notable differences between recovered aerosolized MS2 as a function of pressure (i.e., greater aerosolization with increased pressure), although this was not always statistically significant. This relationship disappeared when using high viscosity simulated vomitus. The amount of MS2 aerosolized as a percent of total virus "vomited" ranged from 7.2 x 10(-5) to 2.67 x 10(-2) (which corresponded to a range of 36 to 13,350 PFU total). To our knowledge, this is the first study to document and measure aerosolization of a NoV surrogate in a similitude-based physical model. This has implications for better understanding the transmission dynamics of human NoV and for risk modeling purposes, both of which can help in designing effective infection control measures.	[Tung-Thompson, Grace; Jaykus, Lee-Ann] N Carolina State Univ, Dept Food Bioproc & Nutr Sci, Raleigh, NC 27695 USA; [Libera, Dominic A.; de los Reyes, Francis L., III] N Carolina State Univ, Dept Civil Construct & Environm Engn, Raleigh, NC 27695 USA; [Koch, Kenneth L.] Wake Forest Univ, Bowman Gray Sch Med, Gastroenterol Sect, Winston Salem, NC 27157 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Wake Forest University; Wake Forest Baptist Medical Center	de los Reyes, FL (corresponding author), N Carolina State Univ, Dept Civil Construct & Environm Engn, Raleigh, NC 27695 USA.	fldelosr@ncsu.edu	de los Reyes, Francis/AAL-7909-2020; de los Reyes, Francis/E-6780-2011	de los Reyes, Francis/0000-0002-3593-0932; de los Reyes, Francis/0000-0002-3593-0932	USDA-CSREES National Integrated Food Safety Initiative (NIFSI) project [2011-51110-31020]; Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture [2011-68003-30395]	USDA-CSREES National Integrated Food Safety Initiative (NIFSI) project; Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture	This project was supported by the USDA-CSREES National Integrated Food Safety Initiative (NIFSI) project #2011-51110-31020 (http://www.nifa.usda.gov/nea/food/in_focus/safety_if_national.html). Partial support was also provided by Agriculture and Food Research Initiative Competitive Grant no. 2011-68003-30395 from the USDA National Institute of Food and Agriculture (http://www.nifa.usda.gov/funding/rfas/afri.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Atmar RL, 2008, EMERG INFECT DIS, V14, P1553, DOI 10.3201/eid1410.080117; Atmar RL, 2014, J INFECT DIS, V209, P1016, DOI 10.1093/infdis/jit620; Badman L, 2001, WATER MATTERS PROPOS, P43; Beggs CB, 2003, INDOOR BUILT ENVIRON, V12, P9, DOI 10.1177/1420326X03012001002; Beggs CB, 2000, INDOOR BUILT ENVIRON, V9, P241, DOI 10.1159/000057517; Bonifait L, 2015, CLIN INFECT DIS, V61, P299, DOI 10.1093/cid/civ321; CAUL EO, 1994, LANCET, V343, P1240, DOI 10.1016/S0140-6736(94)92146-6; Cheesbrough JS, 2000, EPIDEMIOL INFECT, V125, P93, DOI 10.1017/S095026889900432X; Dawson DJ, 2005, J APPL MICROBIOL, V98, P203, DOI 10.1111/j.1365-2672.2004.02439.x; Dijkstra PU, 1999, J ORAL REHABILITATIO; Eames I, 2009, J R SOC INTERFACE, V6, pS697, DOI 10.1098/rsif.2009.0407.focus; Fabian P, 2009, INDOOR AIR, V19, P433, DOI 10.1111/j.1600-0668.2009.00609.x; Fox R.W., 2004, INTRO FLUID MECH; Gallimore CI, 2008, J CLIN MICROBIOL, V46, P3112, DOI 10.1128/JCM.00400-08; Gralton J, 2011, J INFECTION, V62, P1, DOI 10.1016/j.jinf.2010.11.010; GREENBERG HB, 1979, LANCET, V1, P55; Hall AJ, 2013, EMERG INFECT DIS, V19, P1305, DOI 10.3201/eid1908.130482; Harris JP, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003060; Hogan CJ, 2005, J APPL MICROBIOL, V99, P1422, DOI 10.1111/j.1365-2672.2005.02720.x; Iqbal A, 2008, SURG ENDOSC, V22, P2571, DOI 10.1007/s00464-008-0080-0; Isakbaeva ET, 2005, EMERG INFECT DIS, V11, P154, DOI 10.3201/eid1101.040434; Koch KL, 2006, THERAPY DIGESTIVE DI, P1003; Kotwal G, 2014, CURR OPIN VIROL, V4, P37, DOI 10.1016/j.coviro.2013.12.003; Kuo Braden, 2006, GI MOTILITY ONLINE, DOI DOI 10.1038/GIMO6; Leith DE, 1986, INDOOR AIR, DOI [10.1002/cphy.cp030320.31, DOI 10.1002/CPHY.CP030320.31]; Lindsley WG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015100; Lopman B, 2012, CURR OPIN VIROL, V2, P96, DOI 10.1016/j.coviro.2011.11.005; MAILLARD JY, 1994, APPL ENVIRON MICROB, V60, P2205, DOI 10.1128/AEM.60.6.2205-2206.1994; Makison Booth Catherine, 2014, J Infect Prev, V15, P176, DOI 10.1177/1757177414545390; Marks PJ, 2000, EPIDEMIOL INFECT, V124, P481, DOI 10.1017/S0950268899003805; Nazaroff WW, 2011, INDOOR AIR, V21, P353, DOI 10.1111/j.1600-0668.2011.00735.x; Papineni R S, 1997, J Aerosol Med, V10, P105, DOI 10.1089/jam.1997.10.105; Sarkar A, 2009, FOOD HYDROCOLLOID, V23, P1270, DOI 10.1016/j.foodhyd.2008.09.008; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101; Su XW, 2011, APPL ENVIRON MICROB, V77, P3982, DOI 10.1128/AEM.00193-11; Teunis PFM, 2008, J MED VIROL, V80, P1468, DOI 10.1002/jmv.21237; Todd ECD, 2008, J FOOD PROTECT, V71, P2582, DOI 10.4315/0362-028X-71.12.2582; Tseng CC, 2005, J AEROSOL SCI, V36, P593, DOI 10.1016/j.jaerosci.2004.12.004; Turgeon N, 2014, APPL ENVIRON MICROB, V80, P4242, DOI 10.1128/AEM.00767-14; Utrup LJ, 2004, EXP BIOL MED, V229, P345, DOI 10.1177/153537020422900409; Verreault D, 2008, MICROBIOL MOL BIOL R, V72, P413, DOI 10.1128/MMBR.00002-08; Zuo ZL, 2014, APPL ENVIRON MICROB, V80, P2796, DOI 10.1128/AEM.00056-14	42	33	33	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0134277	10.1371/journal.pone.0134277	http://dx.doi.org/10.1371/journal.pone.0134277			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287612	Green Submitted, Green Published, gold			2022-12-26	WOS:000360018600018
J	Amber-Vitos, O; Kucherenko, N; Nachliel, E; Gutman, M; Tsfadia, Y				Amber-Vitos, Ortal; Kucherenko, Nataly; Nachliel, Esther; Gutman, Menachem; Tsfadia, Yossi			The Interaction of FABP with Kap alpha	PLOS ONE			English	Article							NUCLEAR-LOCALIZATION SIGNAL; FATTY-ACID-BINDING; IMPORTIN-ALPHA; STRUCTURAL BASIS; PROTEIN-BINDING; PPAR-GAMMA; RECEPTOR; NLS; SIMULATIONS; ACTIVATION	Gene-activating lipophilic compounds are carried into the nucleus when loaded on fatty-acid-binding proteins (FABP). Some of these proteins are recognized by the alpha-Karyopherin (Kap alpha) through its nuclear localization signal (NLS) consisting of three positive residues that are not in a continuous sequence. The Importin system can distinguish between FABP loaded with activating and non-activating compounds. In the present study, we introduced molecular dynamics as a tool for clarifying the mechanism by which FABP4, loaded with activating ligand (linoleate) is recognized by Kapa. In the first phase, we simulated the complex between Kap alpha(Delta IBB) (termed "Armadillo") that was crystallized with two NLS hepta-peptides. The trajectory revealed that the crystal-structure orientation of the peptides is rapidly lost and new interactions dominate. Though, the NLS sequence of FABP4 is cryptic, since the functional residues are not in direct sequence, implicating more than one possible conformation. Therefore, four possible docked conformations were generated, in which the NLS of FABP4 is interacting with either the major or the minor sites of Kap alpha, and the N -> C vectors are parallel or anti-parallel. Out of these four basic starting positions, only the FABP4-minor site complex exhibited a large number of contact points. In this complex, the FABP interacts with the minor and the major sites, suppressing the self-inhibitory interaction of the Kap alpha, rendering it free to react with Kap beta. Finally, we propose that the transportable conformation generated an extended hydrophobic domain which expanded out of the boundary of the FABP4, allowing the loaded linoleate to partially migrate out of the FABP into a joint complex in which the Kapa contributes part of a combined binding pocket.	[Amber-Vitos, Ortal; Kucherenko, Nataly; Nachliel, Esther; Gutman, Menachem; Tsfadia, Yossi] Tel Aviv Univ, Dept Biochem & Mol Biol, IL-69978 Tel Aviv, Israel	Tel Aviv University	Tsfadia, Y (corresponding author), Tel Aviv Univ, Dept Biochem & Mol Biol, IL-69978 Tel Aviv, Israel.	YossiT@tauex.tau.ac.il						Armstrong EH, 2014, J BIOL CHEM; Ayers SD, 2007, BIOCHEMISTRY-US, V46, P6744, DOI 10.1021/bi700047a; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barish GD, 2006, J CLIN INVEST, V116, P590, DOI 10.1172/JCI27955; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Boulikas Teni, 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P193; Castelein H, 1997, BIOCHEM BIOPH RES CO, V233, P91, DOI 10.1006/bbrc.1997.6395; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Chang CW, 2012, PLANT CELL, V24, P5074, DOI 10.1105/tpc.112.104422; Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014; Darnell SJ, 2008, NUCLEIC ACIDS RES, V36, pW265, DOI 10.1093/nar/gkn346; Daura X, 1999, PROTEINS, V36, P542, DOI 10.1002/(SICI)1097-0134(19990901)36:4<542::AID-PROT17>3.0.CO;2-M; David CC, 2014, METHODS MOL BIOL, V1084, P193, DOI 10.1007/978-1-62703-658-0_11; Duhovny D, 2002, LECT NOTES COMPUT SC, V2452, P185; Dukuzumuremyi JM, 2000, J BIOL CHEM, V275, P35281, DOI 10.1074/jbc.M003009200; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Evans RM, 2005, MOL ENDOCRINOL, V19, P1429, DOI 10.1210/me.2005-0046; Fontes MRM, 2005, BBA-PROTEINS PROTEOM, V1750, P9, DOI 10.1016/j.bbapap.2005.03.014; Ge Q, 2011, J BIOL CHEM, V286, P28119, DOI 10.1074/jbc.M111.237016; Gillilan RE, 2007, J MOL BIOL, V372, P1246, DOI 10.1016/j.jmb.2007.07.040; Glatz J.F.C., 2014, PROSTAGLANDINS LEUKO; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Huang H, 2014, FEBS J, V281, P2266, DOI 10.1111/febs.12780; Konecny R, 2012, COMPUTATIONAL SCIENC, V5; Kruger DM, 2013, NUCLEIC ACIDS RES, V41, pW340, DOI 10.1093/nar/gkt292; London N, 2010, STRUCTURE, V18, P188, DOI 10.1016/j.str.2009.11.012; Lott K, 2011, J BIOL CHEM, V286, P28160, DOI 10.1074/jbc.M111.228007; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Moise AR, 2007, BIOCHEMISTRY-US, V46, P4449, DOI 10.1021/bi7003069; Morgan E, 2010, INVOLVEMENT FATTY AC, V2010; Motojima K, 1997, BIOCHEM BIOPH RES CO, V230, P155, DOI 10.1006/bbrc.1996.5906; Noy N, 2007, BIOCHEMISTRY-US, V46, P13461, DOI 10.1021/bi7018699; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Pedraza L, 1997, NEURON, V18, P579, DOI 10.1016/S0896-6273(00)80299-8; Pfleger C, 2013, J COMPUT CHEM, V34, P220, DOI 10.1002/jcc.23122; Plutzky J, 2011, CIRC RES, V108, P1002, DOI 10.1161/CIRCRESAHA.110.226860; RICHIERI GV, 1995, J BIOL CHEM, V270, P15076, DOI 10.1074/jbc.270.25.15076; Roman N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082038; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Sessler RJ, 2005, MOL CELL, V18, P343, DOI 10.1016/j.molcel.2005.03.026; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Unni S, 2011, J COMPUT CHEM, V32, P1488, DOI 10.1002/jcc.21720	45	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0132138	10.1371/journal.pone.0132138	http://dx.doi.org/10.1371/journal.pone.0132138			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284534	gold, Green Submitted, Green Published			2022-12-26	WOS:000359666100001
J	Juan-Mateu, J; Gonzalez-Quereda, L; Rodriguez, MJ; Baena, M; Verdura, E; Nascimento, A; Ortez, C; Baiget, M; Gallano, P				Juan-Mateu, Jonas; Gonzalez-Quereda, Lidia; Rodriguez, Maria Jose; Baena, Manel; Verdura, Edgard; Nascimento, Andres; Ortez, Carlos; Baiget, Montserrat; Gallano, Pia			DMD Mutations in 576 Dystrophinopathy Families: A Step Forward in Genotype-Phenotype Correlations	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; SPECTRIN-LIKE REPEATS; ACTIN-BINDING DOMAIN; BETA-DYSTROGLYCAN; MISSENSE MUTATIONS; POINT MUTATIONS; ZZ DOMAIN; GENOMIC DISORDERS; REFERRAL CENTER; GENE	Recent advances in molecular therapies for Duchenne muscular dystrophy (DMD) require precise genetic diagnosis because most therapeutic strategies are mutation-specific. To understand more about the genotype-phenotype correlations of the DMD gene we performed a comprehensive analysis of the DMD mutational spectrum in a large series of families. Here we provide the clinical, pathological and genetic features of 576 dystrophinopathy patients. DMD gene analysis was performed using the MLPA technique and whole gene sequencing in blood DNA and muscle cDNA. The impact of the DNA variants on mRNA splicing and protein functionality was evaluated by in silico analysis using computational algorithms. DMD mutations were detected in 576 unrelated dystrophinopathy families by combining the analysis of exonic copies and the analysis of small mutations. We found that 471 of these mutations were large intragenic rearrangements. Of these, 406 (70.5%) were exonic deletions, 64 (11.1%) were exonic duplications, and one was a deletion/duplication complex rearrangement (0.2%). Small mutations were identified in 105 cases (18.2%), most being nonsense/frameshift types (75.2%). Mutations in splice sites, however, were relatively frequent (20%). In total, 276 mutations were identified, 85 of which have not been previously described. The diagnostic algorithm used proved to be accurate for the molecular diagnosis of dystrophinopathies. The reading frame rule was fulfilled in 90.4% of DMD patients and in 82.4% of Becker muscular dystrophy patients (BMD), with significant differences between the mutation types. We found that 58% of DMD patients would be included in single exon-exon skipping trials, 63% from strategies directed against multiexon-skipping exons 45 to 55, and 14% from PTC therapy. A detailed analysis of missense mutations provided valuable information about their impact on the protein structure.	[Juan-Mateu, Jonas; Gonzalez-Quereda, Lidia; Baiget, Montserrat; Gallano, Pia] Hosp Santa Creu & Sant Pau, Dept Genet, CIBERER U705, Barcelona, Spain; [Rodriguez, Maria Jose; Baena, Manel; Verdura, Edgard] Hosp Santa Creu & Sant Pau, Dept Genet, Barcelona, Spain; [Nascimento, Andres; Ortez, Carlos] Hosp St Joan de Deu, Neuromuscular Unit, Esplugas de Llobregat, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital of Santa Creu i Sant Pau; Hospital of Santa Creu i Sant Pau	Gallano, P (corresponding author), Hosp Santa Creu & Sant Pau, Dept Genet, CIBERER U705, Barcelona, Spain.	pgallano@santpau.cat	Gonzalez, Lidia/E-7669-2013	Gonzalez, Lidia/0000-0003-0715-6414; Juan-Mateu, Jonas/0000-0001-9749-6441; Ortez Gonzalez, Carlos Ignacio/0000-0001-8187-8103; Verdura, Edgard/0000-0003-3856-2060	Instituto de Salud Carlos III [PI 11/02586]; FEDER	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); FEDER(European Commission)	The study is sponsored through a governmental grant of the Instituto de Salud Carlos III (PI 11/02586) which is co-funded by FEDER.	Aartsma-Rus A, 2006, MUSCLE NERVE, V34, P135, DOI 10.1002/mus.20586; Acsadi G, 2012, J BIOL CHEM, V287, P18153, DOI 10.1074/jbc.M111.284521; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Amann KJ, 1998, J BIOL CHEM, V273, P28419, DOI 10.1074/jbc.273.43.28419; Becker Kristin, 2003, Hum Mutat, V21, P651, DOI 10.1002/humu.9143; BEGGS AH, 1990, HUM GENET, V86, P45; Bennett RR, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-17; Bhasin N, 2005, J MOL BIOL, V352, P795, DOI 10.1016/j.jmb.2005.07.064; Bhosle RC, 2006, BIOCHEM BIOPH RES CO, V346, P768, DOI 10.1016/j.bbrc.2006.05.192; Bladen CL, 2015, HUM MUTAT, V36, P395, DOI 10.1002/humu.22758; Broderick MJF, 2005, ADV PROTEIN CHEM, V70, P203, DOI 10.1016/S0065-3233(04)70007-8; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; Deburgrave N, 2007, HUM MUTAT, V28, P183, DOI 10.1002/humu.20422; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Desguerre I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004347; DeWolf C, 1997, BIOPHYS J, V72, P2599, DOI 10.1016/S0006-3495(97)78903-3; Dolinsky Luciana C B, 2003, Methods Mol Biol, V217, P165; Emanuel BS, 2001, NAT REV GENET, V2, P791, DOI 10.1038/35093500; ENGLAND SB, 1990, NATURE, V343, P180, DOI 10.1038/343180a0; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Ferlini A, 1998, AM J HUM GENET, V63, P436, DOI 10.1086/301952; Flanigan KM, 2009, HUM MUTAT, V30, P1657, DOI 10.1002/humu.21114; Flanigan KM, 2003, AM J HUM GENET, V72, P931, DOI 10.1086/374176; GRIMM T, 1994, J MED GENET, V31, P183, DOI 10.1136/jmg.31.3.183; Gualandi F, 2006, GENE, V370, P26, DOI 10.1016/j.gene.2005.11.002; Gurvich OL, 2009, HUM MUTAT, V30, P633, DOI 10.1002/humu.20913; Hamed SA, 2006, AM J MED GENET B, V141B, P44, DOI 10.1002/ajmg.b.30234; Harper SQ, 2002, HUM MOL GENET, V11, P1807, DOI 10.1093/hmg/11.16.1807; Helleday T, 2003, MUTAT RES-FUND MOL M, V532, P103, DOI 10.1016/j.mrfmmm.2003.08.013; Henderson DM, 2010, P NATL ACAD SCI USA, V107, P9632, DOI 10.1073/pnas.1001517107; Hnia K, 2007, BIOCHEM J, V401, P667, DOI 10.1042/BJ20061051; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hofstra RMW, 2004, HUM MUTAT, V23, P57, DOI 10.1002/humu.10283; HU XY, 1991, EMBO J, V10, P2471, DOI 10.1002/j.1460-2075.1991.tb07786.x; HU XY, 1990, AM J HUM GENET, V46, P682; Huang X, 2000, NAT STRUCT BIOL, V7, P634, DOI 10.1038/77923; Ishikawa-Sakurai M, 2004, HUM MOL GENET, V13, P693, DOI 10.1093/hmg/ddh087; Ji YG, 2000, GENOME RES, V10, P597, DOI 10.1101/gr.10.5.597; Juan-Mateu J, 2012, CLIN GENET, V82, P574, DOI 10.1111/j.1399-0004.2011.01814.x; Juan-Mateu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059916; JUNG D, 1995, J BIOL CHEM, V270, P27305, DOI 10.1074/jbc.270.45.27305; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; Kondrashov AS, 2003, HUM MUTAT, V21, P12, DOI 10.1002/humu.10147; Krawczak M, 1998, AM J HUM GENET, V63, P474, DOI 10.1086/301965; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lai Y, 2009, J CLIN INVEST, V119, P624, DOI 10.1172/JCI36612; Legardinier S, 2009, J BIOL CHEM, V284, P8822, DOI 10.1074/jbc.M805846200; Legge GB, 2004, J MOL BIOL, V343, P1081, DOI 10.1016/j.jmb.2004.08.087; Legrand B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023819; Mendell JR, 2001, NEUROLOGY, V57, P645, DOI 10.1212/WNL.57.4.645; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Miller LA, 2006, BIRTH DEFECTS RES A, V76, P793, DOI 10.1002/bdra.20279; Moizard MP, 2000, EUR J HUM GENET, V8, P552, DOI 10.1038/sj.ejhg.5200488; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; Norwood FLM, 2000, STRUCTURE, V8, P481, DOI 10.1016/S0969-2126(00)00132-5; Ponting CP, 1996, PROTEIN SCI, V5, P2353, DOI 10.1002/pro.5560051122; PRIOR TW, 1993, NAT GENET, V4, P357, DOI 10.1038/ng0893-357; Rybakova IN, 2006, J BIOL CHEM, V281, P9996, DOI 10.1074/jbc.M513121200; Sakamoto M, 2002, BIOCHEM BIOPH RES CO, V293, P1265, DOI 10.1016/S0006-291X(02)00362-5; Schwartz M, 2004, GENET TEST, V8, P361, DOI 10.1089/gte.2004.8.361; Sedlackova J, 2009, NEUROMUSCULAR DISORD, V19, P749, DOI 10.1016/j.nmd.2009.08.011; Shaffer LG, 2000, ANNU REV GENET, V34, P297, DOI 10.1146/annurev.genet.34.1.297; Singh SM, 2010, P NATL ACAD SCI USA, V107, P15069, DOI 10.1073/pnas.1008818107; SOMMER SS, 1995, TRENDS GENET, V11, P141, DOI 10.1016/S0168-9525(00)89028-9; Stankiewicz P, 2002, CURR OPIN GENET DEV, V12, P312, DOI 10.1016/S0959-437X(02)00304-0; SUZUKI A, 1992, FEBS LETT, V308, P154, DOI 10.1016/0014-5793(92)81265-N; Takeshima Y, 2010, J HUM GENET, V55, P379, DOI 10.1038/jhg.2010.49; Tokarz SA, 1998, MOL GENET METAB, V65, P272, DOI 10.1006/mgme.1998.2763; Tuffery-Giraud S, 2004, NEUROMUSCULAR DISORD, V14, P650, DOI 10.1016/j.nmd.2004.05.002; Tuffery-Giraud S, 2009, HUM MUTAT, V30, P934, DOI 10.1002/humu.20976; White S, 2002, AM J HUM GENET, V71, P365, DOI 10.1086/341942; White SJ, 2006, CYTOGENET GENOME RES, V115, P240, DOI 10.1159/000095920; WINNARD AV, 1995, AM J HUM GENET, V56, P158; Yamashita K, 2010, BIOCHEM BIOPH RES CO, V391, P812, DOI 10.1016/j.bbrc.2009.11.144; Zhong Min, 2006, Nan Fang Yi Ke Da Xue Xue Bao, V26, P757	78	70	80	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135189	10.1371/journal.pone.0135189	http://dx.doi.org/10.1371/journal.pone.0135189			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284620	Green Published, Green Submitted, gold			2022-12-26	WOS:000359666100026
J	Sakata, R; Kabutomori, R; Okano, K; Mitsui, H; Takemura, A; Miwa, T; Yamamoto, H; Okano, T				Sakata, Rie; Kabutomori, Ryo; Okano, Keiko; Mitsui, Hiromasa; Takemura, Akihiro; Miwa, Tetsuya; Yamamoto, Hiroyuki; Okano, Toshiyuki			Rhodopsin in the Dark Hot Sea: Molecular Analysis of Rhodopsin in a Snailfish, Careproctus rhodomelas, Living near the Deep-Sea Hydrothermal Vent	PLOS ONE			English	Article							CONE VISUAL PIGMENTS; PHOTOSENSITIVE PIGMENTS; BOVINE RHODOPSIN; COTTOID FISH; LAKE BAIKAL; ROD; SHRIMP; OPSIN; BIOLUMINESCENCE; EXPRESSION	Visual systems in deep-sea fishes have been previously studied from a photobiological aspect; however, those of deep-sea fish inhabiting the hydrothermal vents are far less understood due to sampling difficulties. In this study, we analyzed the visual pigment of a deep-sea snailfish, Careproctus rhodomelas, discovered and collected only near the hydrothermal vents of oceans around Japan. Proteins were solubilized from the C. rhodomelas eyeball and subjected to spectroscopic analysis, which revealed the presence of a pigment characterized by an absorption maximum (lambda(max)) at 480 nm. Immunoblot analysis of the ocular protein showed a rhodopsin-like immunoreactivity. We also isolated a retinal cDNA encoding the entire coding sequence of putative C. rhodomelas rhodopsin (CrRh). HEK293EBNA cells were transfected with the CrRh cDNA and the proteins extracted from the cells were subjected to spectroscopic analysis. The recombinant CrRh showed the absorption maximum at 480 nm in the presence of 11-cis retinal. Comparison of the results from the eyeball extract and the recombinant CrRh strongly suggests that CrRh has an A(1)-based 11-cis-retinal chromophore and works as a photoreceptor in the C. rhodomelas retina, and hence that C. rhodomelas responds to dim blue light much the same as other deep-sea fishes. Because hydrothermal vent is a huge supply of viable food, C. rhodomelas likely do not need to participate diel vertical migration and may recognize the bioluminescence produced by aquatic animals living near the hydrothermal vents.	[Sakata, Rie; Kabutomori, Ryo; Okano, Keiko; Mitsui, Hiromasa; Okano, Toshiyuki] Waseda Univ TWIns, Grad Sch Adv Sci & Engn, Dept Elect Engn & Biosci, Tokyo, Japan; [Takemura, Akihiro] Univ Ryukyus, Dept Chem Biol & Marine Sci, Fac Sci, Nishihara, Okinawa 90301, Japan; [Miwa, Tetsuya] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Marine Technol Dev Dept, Marine Technol & Engn Ctr, Yokosuka, Kanagawa, Japan; [Yamamoto, Hiroyuki] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Environm Impact Assessment Res Grp, Res & Dev Ctr Submarine Resources, Yokosuka, Kanagawa, Japan	Waseda University; University of the Ryukyus; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Okano, T (corresponding author), Waseda Univ TWIns, Grad Sch Adv Sci & Engn, Dept Elect Engn & Biosci, Tokyo, Japan.	okano@waseda.jp		Okano, Toshiyuki/0000-0001-6740-6265	Ministry of Education, Culture, Sports, Science and Technology (MEXT); Research Foundation for Opto-Science and Technology; Japanese Society for the Promotion of Science (JSPS) of Japan [23248033, 24657109, 26650024]	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Foundation for Opto-Science and Technology; Japanese Society for the Promotion of Science (JSPS) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was partially supported by the Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), the Research Foundation for Opto-Science and Technology, and the Japanese Society for the Promotion of Science (JSPS, No. 23248033, 24657109, 26650024, Core-to-Core Program, A. Advanced Research Networks) of Japan awarded to TO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOWMAKER JK, 1994, VISION RES, V34, P591, DOI 10.1016/0042-6989(94)90015-9; BOWMAKER JK, 1988, J COMP PHYSIOL A, V163, P685, DOI 10.1007/BF00603853; COHEN GB, 1993, BIOCHEMISTRY-US, V32, P6111, DOI 10.1021/bi00074a024; CORLISS JB, 1979, SCIENCE, V203, P1073, DOI 10.1126/science.203.4385.1073; CRESCITELLI F, 1985, J COMP PHYSIOL A, V157, P323, DOI 10.1007/BF00618122; DENTON EJ, 1957, J MAR BIOL ASSOC UK, V36, P651, DOI 10.1017/S0025315400025911; Douglas RH, 1999, VISION RES, V39, P2817, DOI 10.1016/S0042-6989(98)00332-0; Douglas RH, 1997, J FISH BIOL, V50, P68; DOUGLAS RH, 1995, J COMP PHYSIOL A, V177, P111; Douglas RH, 1998, PROG RETIN EYE RES, V17, P597, DOI 10.1016/S1350-9462(98)00002-0; DRATZ EA, 1983, TRENDS BIOCHEM SCI, V8, P128, DOI 10.1016/0968-0004(83)90235-9; DUNTLEY SQ, 1963, J OPT SOC AM, V53, P214, DOI 10.1364/JOSA.53.000214; FITE KV, 1973, VISION RES, V13, P219, DOI 10.1016/0042-6989(73)90101-6; Gilbert C. H., 1912, P US NAT MUS, V42, P351; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; GRASSLE JF, 1985, SCIENCE, V229, P713, DOI 10.1126/science.229.4715.713; Hasegawa EI, 2008, J FISH BIOL, V72, P937, DOI 10.1111/j.1095-8649.2007.01772.x; HERRING PJ, 1983, PROC R SOC SER B-BIO, V220, P183, DOI 10.1098/rspb.1983.0095; Hisatomi O, 1997, PHOTOCHEM PHOTOBIOL, V66, P792, DOI 10.1111/j.1751-1097.1997.tb03226.x; Hope AJ, 1997, P ROY SOC B-BIOL SCI, V264, P155, DOI 10.1098/rspb.1997.0023; Hunt DM, 2001, J EXP BIOL, V204, P3333; Hunt DM, 1996, VISION RES, V36, P1217, DOI 10.1016/0042-6989(95)00228-6; Jinks RN, 2002, NATURE, V420, P68, DOI 10.1038/nature01144; JOHNSON RL, 1993, BIOCHEMISTRY-US, V32, P208, DOI 10.1021/bi00052a027; KARNIK SS, 1990, J BIOL CHEM, V265, P17520; Kawamura S, 2008, COMP BIOCHEM PHYS A, V150, P369, DOI 10.1016/j.cbpa.2008.04.600; KOJIMA D, 1992, P NATL ACAD SCI USA, V89, P6841, DOI 10.1073/pnas.89.15.6841; Morel A, 2007, LIMNOL OCEANOGR, V52, P217, DOI 10.4319/lo.2007.52.1.0217; MUNZ FW, 1958, J PHYSIOL-LONDON, V140, P220, DOI 10.1113/jphysiol.1958.sp005929; Okano K, 2000, J EXP ZOOL, V286, P136, DOI 10.1002/(SICI)1097-010X(20000201)286:2<136::AID-JEZ5>3.0.CO;2-X; OKANO T, 1989, BIOCHEMISTRY-US, V28, P8848, DOI 10.1021/bi00448a025; OKANO T, 1994, NATURE, V372, P94, DOI 10.1038/372094a0; OKANO T, 1992, P NATL ACAD SCI USA, V89, P5932, DOI 10.1073/pnas.89.13.5932; OVCHINNIKOV YA, 1988, FEBS LETT, V230, P1, DOI 10.1016/0014-5793(88)80628-8; PARTRIDGE JC, 1989, J COMP PHYSIOL A, V164, P513, DOI 10.1007/BF00610445; PARTRIDGE JC, 1988, J COMP PHYSIOL A, V162, P543, DOI 10.1007/BF00612519; PELLI DG, 1989, NATURE, V337, P460, DOI 10.1038/337460a0; Robison BH, 2004, J EXP MAR BIOL ECOL, V300, P253, DOI 10.1016/j.jembe.2004.01.012; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; Takemura A, 2010, J FISH BIOL, V77, P1709, DOI 10.1111/j.1095-8649.2010.02789.x; Takemura A, 2008, CRUISE REPORT NATSUS; Tokuda G, 2008, MAR ECOL-EVOL PERSP, V29, P106, DOI 10.1111/j.1439-0485.2007.00211.x; VanDover CL, 1996, GEOPHYS RES LETT, V23, P2049, DOI 10.1029/96GL02151; VANDOVER CL, 1989, NATURE, V337, P458, DOI 10.1038/337458a0; Wada Y, 1998, FEBS LETT, V424, P53, DOI 10.1016/S0014-5793(98)00138-0; WIDDER EA, 1983, BIOL BULL, V165, P791, DOI 10.2307/1541479; Yokoyama S, 2007, PHOTOCHEM PHOTOBIOL, V83, P236, DOI 10.1562/2006-06-19-RA-939	47	5	6	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135888	10.1371/journal.pone.0135888	http://dx.doi.org/10.1371/journal.pone.0135888			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275172	gold, Green Published, Green Submitted			2022-12-26	WOS:000359493600129
J	Zhang, S; Chung, WC; Xu, K				Zhang, S.; Chung, W-C; Xu, K.			Lunatic Fringe is a potent tumor suppressor in Kras-initiated pancreatic cancer	ONCOGENE			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; DUCTAL ADENOCARCINOMA; PROGENITOR CELLS; NOTCH; EXPRESSION; PROGRESSION; PATHWAY; NEOPLASIA; PROSTATE	Notch controls pancreatic differentiation during development and is reactivated in pancreatic cancer. In recent years, the importance of Notch signaling in pancreatic tumorigenesis has become increasingly evident; however, it remains unclear how Notch activities are regulated in this context. Here we report differential regulation of Notch receptors by Lunatic Fringe (Lfng), which encodes an O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase known to modify epidermal growth factor repeats in the Notch extracellular domain, during pathogenesis of Kras-induced pancreatic ductal adenocarcinoma (PDAC). We show that Lfng is uniquely expressed in a subset of acinar cells in the adult pancreas. Deletion of Lfng in the Kras(LSL-G12D/+); Pdx1-Cre mouse model caused increased activation of Notch3 throughout PDAC initiation and progression, and Notch1 after the onset of disease, associated with marked upregulation of Notch target gene Hes1. Deletion of Lfng also resulted in accumulation of Aldh1-positive cell population. We found that loss of Lfng significantly accelerated Kras-initiated PDAC development and shortened survival of the PDAC mice. Interestingly, Lfng-deficient tumors showed a propensity for a poorly differentiated state with features of epithelial-tomesenchymal transition. Likewise, knockdown of LFNG in human PDAC cell lines caused elevated Notch activation, associated with either accelerated cell proliferation or expanded Aldh1-positive cell population. Deletion of Lfng resulted in downregulation of Tgfb1, Tgfb2 and Tgfbr2 expression in the wild-type pancreas at all ages examined, and in the Kras(LSL-G12D/+); Pdx1-Cre pancreas after PDAC onset, as well as reduced phospho-Smad2 levels in pancreatic tumors. We provide evidence that Lfng regulates transforming growth factor (TGF)-beta-signaling through Notch-mediated transcriptional repression of TGF-beta pathway genes. Taken together, our results reveal a potent tumor-suppressive function for Lfng and crosstalk between Notch and TGF-beta pathways in the pancreas, which provides new insight into initiation of PDAC and signals involved in disease progression.	[Zhang, S.; Chung, W-C; Xu, K.] Univ Mississippi, Med Ctr, Inst Canc, 2500 North State St, Jackson, MS 39216 USA; [Zhang, S.] Cent S Univ, State Key Lab Med Genet, Changsha, Hunan, Peoples R China; [Zhang, S.] Cent S Univ, Sch Life Sci, Changsha, Hunan, Peoples R China; [Xu, K.] Univ Mississippi, Med Ctr, Dept Neurobiol & Anat Sci, Jackson, MS 39216 USA	University of Mississippi; University of Mississippi Medical Center; Central South University; Central South University; University of Mississippi; University of Mississippi Medical Center	Xu, K (corresponding author), Univ Mississippi, Med Ctr, Inst Canc, 2500 North State St, Jackson, MS 39216 USA.	kxu@umc.edu			NIH [R21CA175136]; UMMC Cancer Institute; NATIONAL CANCER INSTITUTE [R21CA175136] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UMMC Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors are thankful to Sean Egan and Tom Gridley for providing mouse strains. We also thank Sean Egan for critical reading of the manuscript. This work was supported in part by NIH grant R21CA175136 and by start-up funds from UMMC Cancer Institute to KX.	Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Avila JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052133; Bardeesy N, 2006, GENE DEV, V20, P3130, DOI 10.1101/gad.1478706; Baumgart A, 2014, ONCOGENE, V34, P578; Court H, 2013, J CLIN INVEST, V123, P4681, DOI 10.1172/JCI65764; De Waele E, 2014, PANCREAS, V43, P1083, DOI 10.1097/MPA.0000000000000154; Doucas H, 2008, J SURG ONCOL, V97, P63, DOI 10.1002/jso.20894; Ellenrieder V, 2001, INT J CANCER, V93, P204, DOI 10.1002/ijc.1330; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Han LF, 2014, CANCER RES, V74, P6509, DOI 10.1158/0008-5472.CAN-14-0816; Hanlon L, 2010, CANCER RES, V70, P4280, DOI 10.1158/0008-5472.CAN-09-4645; Hezel AF, 2012, CANCER RES, V72, P4840, DOI 10.1158/0008-5472.CAN-12-0634; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Ijichi H, 2006, GENE DEV, V20, P3147, DOI 10.1101/gad.1475506; Ischenko I, 2014, P NATL ACAD SCI USA, V111, P3466, DOI 10.1073/pnas.1319911111; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jean-Paul D, 2008, P NATL ACAD SCI USA, V105, P18907, DOI 10.1073/pnas.0810111105; Kopinke D, 2012, DEV BIOL, V362, P57, DOI 10.1016/j.ydbio.2011.11.010; Kopp JL, 2012, CANCER CELL, V22, P737, DOI 10.1016/j.ccr.2012.10.025; Leung L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084366; Liu H, 2009, CIRC RES, V104, P466, DOI 10.1161/CIRCRESAHA.108.184846; Maniati E, 2011, J CLIN INVEST, V121, P4685, DOI 10.1172/JCI45797; Mann CD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051119; Mazur PK, 2010, P NATL ACAD SCI USA, V107, P13438, DOI 10.1073/pnas.1002423107; Misra K, 2014, DEVELOPMENT, V141, P187, DOI 10.1242/dev.092536; Miyamoto Y, 2003, CANCER CELL, V3, P565, DOI 10.1016/S1535-6108(03)00140-5; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Ohnuki H, 2014, CANCER RES, V74, P2038, DOI 10.1158/0008-5472.CAN-13-3118; Principe DR, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt369; Rovira M, 2010, P NATL ACAD SCI USA, V107, P75, DOI 10.1073/pnas.0912589107; Ryan DP, 2014, NEW ENGL J MED, V371, P1039, DOI 10.1056/NEJMra1404198; Schiavone M, 2014, DIS MODEL MECH, V7, P883, DOI 10.1242/dmm.014969; Shih HP, 2012, DEVELOPMENT, V139, P2488, DOI 10.1242/dev.078634; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Svensson P, 2009, MOL CELL BIOL, V29, P2129, DOI 10.1128/MCB.01644-08; Ungefroren H, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-67; Valdez JM, 2012, CELL STEM CELL, V11, P676, DOI 10.1016/j.stem.2012.07.003; Vo K, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-138; Xie MJ, 2002, PANCREAS, V25, P234, DOI 10.1097/00006676-200210000-00004; Xu KL, 2012, CANCER CELL, V21, P626, DOI 10.1016/j.ccr.2012.03.041; Xu KL, 2010, AM J PHYSIOL-LUNG C, V298, pL45, DOI 10.1152/ajplung.90550.2008; Yen WC, 2015, CLIN CANCER RES, V21, P2084, DOI 10.1158/1078-0432.CCR-14-2808; Yu XB, 2006, STEM CELLS, V24, P876, DOI 10.1634/stemcells.2005-0598; Zhang NA, 1998, NATURE, V394, P374, DOI 10.1038/28625; Zhang SB, 2014, NEOPLASIA, V16, P158, DOI 10.1593/neo.131870	46	25	25	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 12	2016	35	19					2485	2495		10.1038/onc.2015.306	http://dx.doi.org/10.1038/onc.2015.306			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DM2GQ	26279302				2022-12-26	WOS:000376165500007
J	Hughes-Fulford, M; Chang, TT; Martinez, EM; Li, CF				Hughes-Fulford, Millie; Chang, Tammy T.; Martinez, Emily M.; Li, Chai-Fei			Spaceflight alters expression of microRNA during T-cell activation	FASEB JOURNAL			English	Article						gene expression; microgravity; epigenetics; immune response	EPSTEIN-BARR-VIRUS; IMMUNE-RESPONSES; GENE-EXPRESSION; RHEUMATOID-ARTHRITIS; PERIPHERAL-BLOOD; SPACE-FLIGHT; MICROGRAVITY; MIR-21; OVEREXPRESSION; PROLIFERATION	Altered immune function has been demonstrated in astronauts during spaceflights dating back to Apollo and Skylab; this could be a major barrier to long-term space exploration. We tested the hypothesis that spaceflight causes changes inmicroRNA (miRNA) expression. Human leukocytes were stimulated with mitogens on board the International Space Station using an onboard normal gravity control. Bioinformatics showed that miR-21 was significantly up-regulated 2-fold during early T-cell activation in normal gravity, and gene expression was suppressed under microgravity. This was confirmed using quantitative real-time PCR (n = 4). This is the first report that spaceflight regulates miRNA expression. Global microarray analysis showed significant (P < 0.05) suppression of 85 genes under microgravity conditions compared to normal gravity samples. EGR3, FASLG, BTG2, SPRY2, and TAGAP are biologically confirmed targets and are co-up-regulated with miR-21. These genes share common promoter regions with pre-mir-21; as the miR-21 matures and accumulates, it most likely will inhibit translation of its target genes and limit the immune response. These data suggest that gravity regulates T-cell activation not only by transcription promotion but also by blocking translation via noncoding RNA mechanisms. Moreover, this study suggests that T-cell activation itself may induce a sequence of gene expressions that is self-limited bymiR-21.	[Hughes-Fulford, Millie] San Francisco Dept Vet Affairs Med Ctr, Div Metab, Dept Med, Hughes Fulford Lab, San Francisco, CA USA; [Hughes-Fulford, Millie; Martinez, Emily M.; Li, Chai-Fei] Univ Calif San Francisco, Northern Calif Inst Res & Educ, San Francisco, CA 94143 USA; [Hughes-Fulford, Millie] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Chang, Tammy T.] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA	Northern California Institute for Research & Education; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Hughes-Fulford, M (corresponding author), Hughes Fulford Lab, MC 151F,4150 Clement St, San Francisco, CA 94121 USA.	milliehf@gmail.com		Hughes-Fulford, Millie/0000-0002-0756-068X	U.S. Veterans Affairs Biomedical Laboratory Research and Development Merit Review award; U.S. NASA Award [NCC2-1361]; NASA Award [NNX09AH21G]; CASIS; U.S. National Institutes of Health National Institute on Aging [5UH3AG037628]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK093708, P30DK026743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [UH3AG037628] Funding Source: NIH RePORTER	U.S. Veterans Affairs Biomedical Laboratory Research and Development Merit Review award; U.S. NASA Award; NASA Award; CASIS; U.S. National Institutes of Health National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a U.S. Veterans Affairs Biomedical Laboratory Research and Development Merit Review award to M.H.F., U.S. NASA Award NCC2-1361, NASA Award NNX09AH21G, CASIS, and primarily by U.S. National Institutes of Health National Institute on Aging Grant 5UH3AG037628.	Akkad DA, 2015, NEUROGENETICS, V16, P161, DOI 10.1007/s10048-015-0438-0; Ando Y, 2013, J AUTOIMMUN, V41, P111, DOI 10.1016/j.jaut.2012.12.013; Baumjohann D, 2013, NAT REV IMMUNOL, V13, P666, DOI 10.1038/nri3494; Berry C., 1975, BIOMEDICAL RESULTS A, P43; Boonyaratanakornkit JB, 2005, FASEB J, V19, P2020, DOI 10.1096/fj.05-3778fje; Carissimi C, 2014, BIOCHIMIE, V107, P319, DOI 10.1016/j.biochi.2014.09.021; Chang TT, 2012, J LEUKOCYTE BIOL, V92, P1133, DOI 10.1189/jlb.0312157; Chen R, 2011, GENES IMMUN, V12, P314, DOI 10.1038/gene.2011.8; Chusorn P, 2013, TUMOR BIOL, V34, P1579, DOI 10.1007/s13277-013-0688-0; COGOLI A, 1993, J LEUKOCYTE BIOL, V53, P569, DOI 10.1002/jlb.53.5.569; Cogoli A, 1997, Gravit Space Biol Bull, V10, P5; Contreras J, 2012, LEUKEMIA, V26, P404, DOI 10.1038/leu.2011.356; Crucian BE, 2000, J INTERF CYTOK RES, V20, P547, DOI 10.1089/10799900050044741; Fujita S, 2008, J MOL BIOL, V378, P492, DOI 10.1016/j.jmb.2008.03.015; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hughes-Fulford M, 2005, CELL SIGNAL, V17, P1111, DOI 10.1016/j.cellsig.2004.12.016; Kimsey S., 1977, BIOMEDICAL RESULTS S, P249; KONSTANT.IV, 1973, KOSM BIOL AVIAK MED+, V7, P35; Lu TX, 2011, J IMMUNOL, V187, P3362, DOI 10.4049/jimmunol.1101235; Martinez EM, 2015, AM J PHYSIOL-REG I, V308, pR480, DOI 10.1152/ajpregu.00449.2014; Ottoboni L, 2013, NEUROLOGY, V81, P1891, DOI 10.1212/01.wnl.0000436612.66328.8a; Payne DA, 1999, AVIAT SPACE ENVIR MD, V70, P1211; Pippia P, 1996, J BIOTECHNOL, V47, P215, DOI 10.1016/0168-1656(96)01387-9; Prasad P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031584; Qin XY, 2012, ONCOL LETT, V4, P1290, DOI 10.3892/ol.2012.896; Sayed D, 2008, MOL BIOL CELL, V19, P3272, DOI 10.1091/mbc.E08-02-0159; Stowe RP, 2011, J MED VIROL, V83, P1071, DOI 10.1002/jmv.22079; Stowe RP, 2001, AVIAT SPACE ENVIR MD, V72, P884; Talotta F, 2009, ONCOGENE, V28, P73, DOI 10.1038/onc.2008.370; Terra R, 2008, INT IMMUNOL, V20, P317, DOI 10.1093/intimm/dxm152; Viatte S, 2013, J RHEUMATOL, V40, P144, DOI 10.3899/jrheum.121034; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pD153, DOI 10.1093/nar/gku1215; Wang JH, 2015, MOL MED REP, V12, P1810, DOI 10.3892/mmr.2015.3567	33	32	36	2	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2015	29	12					4893	4900		10.1096/fj.15-277392	http://dx.doi.org/10.1096/fj.15-277392			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CX2JS	26276131	Green Published			2022-12-26	WOS:000365523600015
J	Jules, J; Wang, SQ; Shi, ZQ; Liu, JZ; Wei, S; Feng, X				Jules, Joel; Wang, Shunqing; Shi, Zhenqi; Liu, Jianzhong; Wei, Shi; Feng, Xu			The IVVY Motif and Tumor Necrosis Factor Receptor-associated Factor (TRAF) Sites in the Cytoplasmic Domain of the Receptor Activator of Nuclear Factor kappa B (RANK) Cooperate to Induce Osteoclastogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TNF-ALPHA; OSTEOPROTEGERIN LIGAND; BONE-RESORPTION; FAMILY-MEMBERS; DIFFERENTIATION; INTERLEUKIN-1; IDENTIFICATION; SUPERFAMILY; MACROPHAGES; ARTHRITIS	Receptor activator of NF-kappa B (RANK) activation by RANK ligand (RANKL) mediates osteoclastogenesis by recruiting TNF receptor-associated factors (TRAFs) via three cytoplasmic motifs (motif 1, PFQEP(369-373); motif 2, PVQEET(559-564); and motif 3, PVQEQG(604-609)) to activate the NF-kappa B and MAPK signaling pathways. RANK also has a TRAF-independent motif (IVVY535-538), which is dispensable for the activation of TRAF-induced signaling pathways but essential for osteoclast lineage commitment by inducing the expression of nuclear factor of activated T-cells c1 (NFATc1) to regulate osteoclast gene expression. Notably, TNF/IL-1-mediated osteoclastogenesis requires RANK ligand assistance, and the IVVY motif is also critical for TNF/IL-1-mediated osteoclastogenesis by rendering osteoclast genes responsive to these two cytokines. Here we show that the two types of RANK cytoplasmic motifs have to be on the same RANK molecule to mediate osteoclastogenesis, suggesting a functional cooperation between them. Subsequent osteoclastogenesis assays with TNF or IL-1 revealed that, although all three TRAF motifs play roles in TNF/IL-1-mediated osteoclastogenesis, motifs 2 and 3 are more potent than motif 1. Accordingly, inactivation of motifs 2 and 3 blocks TNF/IL-1-mediated osteoclastogenesis. Mechanistically, double mutation of motifs 2 and 3, similar to inactivation of the IVVY motif, abrogates the expression of nuclear factor of activated T-cells c1 and osteoclast genes in assays reflecting RANK-initiated and TNF/IL-1-mediated osteoclastogenesis. In contrast, double inactivation of motifs 2 and 3 did not affect the ability of RANK to activate the NF-kappa B and MAPK signaling pathways. Collectively, these results indicate that the RANK IVVY motif cooperates with the TRAF-binding motifs to promote osteoclastogenesis, which provides novel insights into the molecular mechanism of RANK signaling in osteoclastogenesis.	[Jules, Joel; Wang, Shunqing; Shi, Zhenqi; Liu, Jianzhong; Wei, Shi; Feng, Xu] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Wang, Shunqing] Guangzhou Med Univ, Guangzhou Peoples Hosp 1, Dept Hematol, Guangzhou 510180, Guangdong, Peoples R China	University of Alabama System; University of Alabama Birmingham; Guangzhou Medical University	Feng, X (corresponding author), Univ Alabama Birmingham, Dept Pathol, 1670 Univ Blvd,Volker Hall G019E, Birmingham, AL 35294 USA.	xufeng@uab.edu			NIAMS/National Institutes of Health [AR47830]; NIAMS [AR47830]; Research and Education Foundation of the American College of Rheumatology; National Natural Science Foundation of China [3087110, 80171939]; Guangzhou Science and Technology Program [11C33150710]; Guangzhou Medical Science and Technology Project [201102A212024]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311, R01AR047830] Funding Source: NIH RePORTER	NIAMS/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Research and Education Foundation of the American College of Rheumatology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangzhou Science and Technology Program; Guangzhou Medical Science and Technology Project; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by NIAMS/National Institutes of Health Grant AR47830 (to X. F.) and a NIAMS graduate research supplement to Grant AR47830 (to J. J.). This work was also supported by a Within Our Reach innovative basic research grant from the Research and Education Foundation of the American College of Rheumatology (to X. F.), Grants 3087110 and 80171939 from the National Natural Science Foundation of China (to S. Wang), Grant 11C33150710 from the Guangzhou Science and Technology Program (to S. Wang), and Grant 201102A212024 from the Guangzhou Medical Science and Technology Project (to S. Wang). The authors declare that they have no conflicts of interest with the contents of this article.	Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Armstrong AP, 2002, J BIOL CHEM, V277, P44347, DOI 10.1074/jbc.M202009200; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Beyaert R, 1998, CYTOKINES, P335, DOI 10.1016/B978-012498340-3/50025-7; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Choi HK, 2013, CELL RES, V23, P524, DOI 10.1038/cr.2013.33; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Feng X, 2005, GENE, V350, P1, DOI 10.1016/j.gene.2005.01.014; Feng X, 2001, J CLIN INVEST, V107, P1137, DOI 10.1172/JCI12040; Feng X, 2011, ANNU REV PATHOL-MECH, V6, P121, DOI 10.1146/annurev-pathol-011110-130203; Galibert L, 1998, J BIOL CHEM, V273, P34120, DOI 10.1074/jbc.273.51.34120; Graves DT, 2003, J PERIODONTOL, V74, P391, DOI 10.1902/jop.2003.74.3.391; Guerrini MM, 2008, AM J HUM GENET, V83, P64, DOI 10.1016/j.ajhg.2008.06.015; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Inoue J, 2000, EXP CELL RES, V254, P14, DOI 10.1006/excr.1999.4733; Jules J, 2012, J BIOL CHEM, V287, P15728, DOI 10.1074/jbc.M111.296228; Jules J, 2010, J BIOL CHEM, V285, P37427, DOI 10.1074/jbc.M110.149484; Kim H, 2009, J CLIN INVEST, V119, P813, DOI 10.1172/JCI36809; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Li P, 2004, J BONE MINER RES, V19, P207, DOI 10.1359/JBMR.0301233; Liu W, 2005, J BIOL CHEM, V280, P43064, DOI 10.1074/jbc.M509006200; Liu W, 2004, J BIOL CHEM, V279, P54759, DOI 10.1074/jbc.M404687200; Ma T, 2004, CYTOKINE, V26, P138, DOI 10.1016/j.cyto.2004.02.001; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Pacifici R, 1998, ENDOCRINOLOGY, V139, P2659, DOI 10.1210/en.139.6.2659; Ross FP, 2005, IMMUNOL REV, V208, P88, DOI 10.1111/j.0105-2896.2005.00331.x; Strand V, 2004, RHEUMATOLOGY, V43, P10, DOI 10.1093/rheumatology/keh202; Taguchi Y, 2009, GENES CELLS, V14, P1331, DOI 10.1111/j.1365-2443.2009.01351.x; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Teitelbaum SL, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1857; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Wei S, 2005, J CLIN INVEST, V115, P282, DOI 10.1172/JCI200523394; Xu DR, 2006, J BIOL CHEM, V281, P4678, DOI 10.1074/jbc.M510383200; Xu DR, 2004, BIOCHEM J, V383, P219, DOI 10.1042/BJ20040961	36	15	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	2015	290	39					23738	23750		10.1074/jbc.M115.667535	http://dx.doi.org/10.1074/jbc.M115.667535			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS1IF	26276390	Green Published, hybrid			2022-12-26	WOS:000361816500022
J	Ogutu, JO; Owen-Smith, N; Piepho, HP; Dublin, HT				Ogutu, Joseph O.; Owen-Smith, Norman; Piepho, Hans-Peter; Dublin, Holly T.			How Rainfall Variation Influences Reproductive Patterns of African Savanna Ungulates in an Equatorial Region Where Photoperiod Variation Is Absent	PLOS ONE			English	Article							PHENOLOGY; SEASONALITY; VEGETATION; DYNAMICS; POPULATION; SYNCHRONY; RUMINANTS	In high temperate latitudes, ungulates generally give birth within a narrow time window when conditions are optimal for offspring survival in spring or early summer, and use changing photoperiod to time conceptions so as to anticipate these conditions. However, in low tropical latitudes day length variation is minimal, and rainfall variation makes the seasonal cycle less predictable. Nevertheless, several ungulate species retain narrow birth peaks under such conditions, while others show births spread quite widely through the year. We investigated how within-year and between-year variation in rainfall influenced the reproductive timing of four ungulate species showing these contrasting patterns in the Masai Mara region of Kenya. All four species exhibited birth peaks during the putative optimal period in the early wet season. For hartebeest and impala, the birth peak was diffuse and offspring were born throughout the year. In contrast, topi and warthog showed a narrow seasonal concentration of births, with conceptions suppressed once monthly rainfall fell below a threshold level. High rainfall in the previous season and high early rains in the current year enhanced survival into the juvenile stage for all the species except impala. Our findings reveal how rainfall variation affecting grass growth and hence herbivore nutrition can govern the reproductive phenology of ungulates in tropical latitudes where day length variation is minimal. The underlying mechanism seems to be the suppression of conceptions once nutritional gains become insufficient. Through responding proximally to within-year variation in rainfall, tropical savanna ungulates are less likely to be affected adversely by the consequences of global warming for vegetation phenology than northern ungulates showing more rigid photoperiodic control over reproductive timing.	[Ogutu, Joseph O.] Int Livestock Res Inst, Nairobi 00100, Kenya; [Ogutu, Joseph O.; Piepho, Hans-Peter] Univ Hohenheim, Inst Crop Sci, D-70599 Stuttgart, Germany; [Owen-Smith, Norman] Univ Witwatersrand, Sch Anim Plant & Environm Sci, Ctr African Ecol, ZA-2050 Johannesburg, South Africa; [Dublin, Holly T.] Wasaa Conservat Ctr, IUCN ESARO, Nairobi 00200, Kenya	CGIAR; International Livestock Research Institute (ILRI); University Hohenheim; University of Witwatersrand	Ogutu, JO (corresponding author), Int Livestock Res Inst, POB 30709, Nairobi 00100, Kenya.	jogutu2007@gmail.com	Owen-Smith, Norman/ABI-5113-2020	Piepho, Hans-Peter/0000-0001-7813-2992; Owen-Smith, Norman/0000-0001-8429-1201; Ogutu, Joseph O/0000-0002-7379-0387	World Wide Fund for Nature-East Africa Program (WWF-EARPO); Friends of Conservation (FOC); WWF-US; WWF-Sweden; Darwin Initiative (DICE); University of British Columbia; United States Fish and Wildlife Service; Kenya Wildlife Service; Cottar's Camp; Kichwa Tembo; Keekorok Lodge/Balloon Safaris; Kerr and Downey Safaris; National Science Foundation (NSF) [BCS 0709671, DEB-0342820]; Belgian government [DGIC BEL011]; International Livestock Research Institute (ILRI); University of Hohenheim, Biostatistics Unit; German Research Found (DFG) [OG 83/1-1]	World Wide Fund for Nature-East Africa Program (WWF-EARPO); Friends of Conservation (FOC); WWF-US; WWF-Sweden; Darwin Initiative (DICE); University of British Columbia; United States Fish and Wildlife Service(US Fish & Wildlife Service); Kenya Wildlife Service; Cottar's Camp; Kichwa Tembo; Keekorok Lodge/Balloon Safaris; Kerr and Downey Safaris; National Science Foundation (NSF)(National Science Foundation (NSF)); Belgian government; International Livestock Research Institute (ILRI)(CGIAR); University of Hohenheim, Biostatistics Unit; German Research Found (DFG)	The monitoring was funded by the World Wide Fund for Nature-East Africa Program (WWF-EARPO) and Friends of Conservation (FOC). The program also received financial, material or logistical support from WWF-US, WWF-Sweden, the Darwin Initiative (DICE), the University of British Columbia, United States Fish and Wildlife Service, Kenya Wildlife Service, Cottar's Camp, Kichwa Tembo, Keekorok Lodge/Balloon Safaris and Kerr and Downey Safaris. Data analysis and writing were partially supported by the National Science Foundation (NSF) through Grant Nos: BCS 0709671 and DEB-0342820 and a grant from the Belgian government (DGIC BEL011) to the International Livestock Research Institute. JO was supported by the International Livestock Research Institute (ILRI), the University of Hohenheim, Biostatistics Unit and a grant from the German Research Found (DFG, Research Grant # OG 83/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrestani FS, 2012, OIKOS, V121, P1300, DOI 10.1111/j.1600-0706.2011.20244.x; Allan RP, 2008, SCIENCE, V321, P1481, DOI 10.1126/science.1160787; ANDERSON JL, 1979, MAMMAL REV, V9, P33, DOI 10.1111/j.1365-2907.1979.tb00230.x; ANSELL W. F. H., 1960, PROC ZOOL SOC LONDON, V134, P251; Ansell W. F. H., 1963, Puku Occasional Papers of the Department of Game and Fisheries Northern Rhodesia, V1, P9; BOUTTON TW, 1988, AFR J ECOL, V26, P103, DOI 10.1111/j.1365-2028.1988.tb00961.x; BOUTTON TW, 1988, AFR J ECOL, V26, P89, DOI 10.1111/j.1365-2028.1988.tb00960.x; Brown O. E., 1936, Journal of Mammalogy, V17, P10, DOI 10.2307/1374541; Child G., 1964, Arnoldia, V1, P1; Child G, 1968, 2563 FAO PA; Clough G., 1969, Journal of Reproduction and Fertility Suppl, VNo.6, P323; ESTES R D, 1974, Proceedings of the Academy of Natural Sciences of Philadelphia, V126, P73; ESTES R D, 1976, East African Wildlife Journal, V14, P135; ESTES RD, BEHAV GUIDE AFRICAN; Fairall N., 1968, AFR ZOOL, V3, P180; Gosling L. M., 1969, Journal of Reproduction and Fertility Suppl, VNo. 6, P265; HALL-MARTIN A J, 1975, East African Wildlife Journal, V13, P237; Knoop MC, 2006, AFR J ECOL, V44, P228, DOI 10.1111/j.1365-2028.2006.00637.x; Laws R.M., 1975, ELEPHANTS THEIR HABI; Moe SR, 2007, J ZOOL, V273, P237, DOI 10.1111/j.1469-7998.2007.00319.x; Moss CJ, 2001, J ZOOL, V255, P145, DOI 10.1017/S0952836901001212; MURRAY MG, 1982, Z TIERPSYCHOL, V59, P319; Oftedal O.T., 1985, P215; Ogutu JO, 2008, J ANIM ECOL, V77, P814, DOI 10.1111/j.1365-2656.2008.01392.x; Ogutu JO, 2008, AFR J ECOL, V46, P132, DOI 10.1111/j.1365-2028.2007.00821.x; Ogutu JO, 2009, J ZOOL, V278, P1, DOI 10.1111/j.1469-7998.2008.00536.x; Ogutu JO, 2014, WILDLIFE RES, V41, P323, DOI 10.1071/WR13211; Ogutu JO, 2013, WILDLIFE RES, V40, P698, DOI 10.1071/WR13117; Ogutu JO, 2011, POPUL ECOL, V53, P195, DOI 10.1007/s10144-010-0223-8; Ogutu JO, 2010, POPUL ECOL, V52, P89, DOI 10.1007/s10144-009-0163-3; Owen-Smith N, 2013, ECOGRAPHY, V36, P256, DOI 10.1111/j.1600-0587.2012.00156.x; Owen-Smith R.N., 1988, MEGAHERBIVORES INFLU, DOI [10.1017/CBO9780511565441, DOI 10.1017/CBO9780511565441]; Owen-Smith RN., 2002, ADAPTIVE HERBIVORE E, VStudent; Post E, 2008, PHILOS T R SOC B, V363, P2369, DOI 10.1098/rstb.2007.2207; RUTBERG AT, 1987, AM NAT, V130, P692, DOI 10.1086/284739; SEKULIC R, 1978, E AFR WILDL J, V16, P177; Sinclair ARE, 2000, ECOLOGY, V81, P2100, DOI 10.1890/0012-9658(2000)081[2100:WDPASO]2.0.CO;2; SKINNER J D, 1974, Journal of the Southern African Wildlife Management Association, V4, P15; Skinner J.D., 1973, Journal Reprod Fert, V19, P101; Skinner J. D., 2002, Transactions of the Royal Society of South Africa, V57, P25; Skinner J.D., 2005, MAMMALS SO AFRICAN S, DOI DOI 10.1017/CBO9781107340992; SPINAGE CA, 1969, J REPROD FERTIL, V18, P445, DOI 10.1530/jrf.0.0180445; Wilson D. E., 1977, WILDL MONOGR, V54; Wilson V. J., 1969, Arnoldia Bulawayo, V4, P1; Wittemyer G, 2007, ECOGRAPHY, V30, P42, DOI 10.1111/j.2006.0906-7590.04900.x; Zerbe P, 2012, BIOL REV, V87, P965, DOI 10.1111/j.1469-185X.2012.00238.x	46	15	15	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0133744	10.1371/journal.pone.0133744	http://dx.doi.org/10.1371/journal.pone.0133744			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295154	Green Submitted, Green Published, gold			2022-12-26	WOS:000359926900007
J	Sun, Y; Sun, L				Sun, Yun; Sun, Li			CsBAFF, a Teleost B Cell Activating Factor, Promotes Pathogen-Induced Innate Immunity and Vaccine-Induced Adaptive Immunity	PLOS ONE			English	Article							TURBOT SCOPHTHALMUS-MAXIMUS; NECROSIS-FACTOR FAMILY; TNF13B BAFF GENE; T-CELL; LYMPHOCYTE STIMULATOR; MOLECULAR-CLONING; BIOACTIVITY CHARACTERIZATION; BIOINFORMATICS ANALYSIS; CYNOGLOSSUS-SEMILAEVIS; FUNCTIONAL-ANALYSIS	B cell activating factor (BAFF) is a member of the tumor necrosis factor family that is known to play an important role in B cell activation, proliferation, and differentiation in mammals. However, studies of BAFF in teleosts are very limited and its function, in particular that under in vivo conditions, is essentially unknown. In this study, we conducted in vivo as well as in vitro functional analyses of a BAFF homologue (CsBAFF) from the teleost fish tongue sole (Cynoglossus semilaevis). CsBAFF is composed of 261 residues and shares moderate sequence identities with known BAFFs of other teleosts. CsBAFF expression was most abundant in immune organs and was upregulated during bacterial infection. Purified recombinant CsBAFF (rCsBAFF) bound to tongue sole lymphocytes and promoted cellular proliferation and survival. The results of an in vivo study showed that CsBAFF overexpression in tongue sole significantly enhanced macrophage activation and reduced bacterial infection in fish tissues, whereas knockdown of CsBAFF expression resulted in increased bacterial dissemination and colonization in fish tissues. Furthermore, vaccination studies showed that CsBAFF enhanced the immunoprotection of a DNA vaccine and augmented the production of specific serum antibodies. Taken together, these results provide the first in vivo evidence to indicate that teleost BAFF is an immunostimulator that significantly contributes to the innate antibacterial immune response and vaccine-induced adaptive immune response.	[Sun, Yun; Sun, Li] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao 266071, Peoples R China; [Sun, Yun] Hainan Univ, Coll Marine Sci, State Key Lab Breeding Base Sustainable Exploitat, Haikou 570228, Peoples R China; [Sun, Li] Qingdao Natl Oceanog Lab, Funct Lab Marine Biol & Biotechnol, Qingdao, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Hainan University	Sun, L (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao 266071, Peoples R China.	lsun@qdio.ac.cn			China Postdoctoral Science Foundation [2014M550377]; Science and Technology Development Plan of Shandong Province [2014GHY115001]; Taishan Scholar Program of Shandong Province	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Science and Technology Development Plan of Shandong Province; Taishan Scholar Program of Shandong Province	This work was supported by the grants from China Postdoctoral Science Foundation (2014M550377), Science and Technology Development Plan of Shandong Province (2014GHY115001), and Taishan Scholar Program of Shandong Province.	Ai HX, 2011, FISH SHELLFISH IMMUN, V30, P1265, DOI 10.1016/j.fsi.2011.03.020; Bertram EM, 2002, J IMMUNOL, V168, P3777, DOI 10.4049/jimmunol.168.8.3777; Bossen C, 2006, SEMIN IMMUNOL, V18, P263, DOI 10.1016/j.smim.2006.04.006; Boule MW, 2004, J EXP MED, V199, P1631, DOI 10.1084/jem.20031942; Castigli E, 2005, J EXP MED, V201, P35, DOI 10.1084/jem.20032000; Cella M, 1996, J EXP MED, V184, P747, DOI 10.1084/jem.184.2.747; Chang SK, 2006, BLOOD, V108, P2687, DOI 10.1182/blood-2005-12-017319; Chang SK, 2008, J IMMUNOL, V180, P7394, DOI 10.4049/jimmunol.180.11.7394; Cheema GS, 2001, ARTHRITIS RHEUM-US, V44, P1313, DOI 10.1002/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S; Chen C, 2013, FISH SHELLFISH IMMUN, V35, P1677, DOI 10.1016/j.fsi.2013.08.020; Cui XW, 2012, INT IMMUNOPHARMACOL, V12, P34, DOI 10.1016/j.intimp.2011.10.009; Diaz-de-Durana Y, 2006, BLOOD, V107, P594, DOI 10.1182/blood-2004-12-4708; Dickinson GS, 2014, INFECT IMMUN, V82, P453, DOI 10.1128/IAI.01147-13; Elgueta R, 2010, IMMUNOL REV, V236, P139, DOI 10.1111/j.1600-065X.2010.00924.x; Groom J, 2002, J CLIN INVEST, V109, P59, DOI 10.1172/JCI200214121; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Gross JA, 2001, IMMUNITY, V15, P289, DOI 10.1016/S1074-7613(01)00183-2; Guan ZB, 2007, DEV COMP IMMUNOL, V31, P1211, DOI 10.1016/j.dci.2007.03.006; Guan ZB, 2007, CYTOKINE, V39, P192, DOI 10.1016/j.cyto.2007.07.190; Jeon ST, 2010, IMMUNOL CELL BIOL, V88, P148, DOI 10.1038/icb.2009.75; Jiao XD, 2009, VACCINE, V27, P5195, DOI 10.1016/j.vaccine.2009.06.071; Kanagavelu SK, 2012, VACCINE, V30, P691, DOI 10.1016/j.vaccine.2011.11.088; Karpusas M, 2002, J MOL BIOL, V315, P1145, DOI 10.1006/jmbi.2001.5296; Katsenelson N, 2007, EUR J IMMUNOL, V37, P1785, DOI 10.1002/eji.200636800; Kim MY, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.4; Li MF, 2013, FISH SHELLFISH IMMUN, V35, P2026, DOI 10.1016/j.fsi.2013.10.013; Li MF, 2013, DEV COMP IMMUNOL, V41, P514, DOI 10.1016/j.dci.2013.07.022; Liang ZN, 2010, FISH SHELLFISH IMMUN, V29, P233, DOI 10.1016/j.fsi.2010.03.006; Liu CS, 2010, VACCINE, V28, P4153, DOI 10.1016/j.vaccine.2010.04.016; Long H, 2014, FISH SHELLFISH IMMUN, V37, P66, DOI 10.1016/j.fsi.2014.01.013; Mackay F, 2003, ANNU REV IMMUNOL, V21, P231, DOI 10.1146/annurev.immunol.21.120601.141152; Mackay F, 2007, CURR OPIN IMMUNOL, V19, P327, DOI 10.1016/j.coi.2007.04.008; Mackay F, 2006, SEMIN IMMUNOL, V18, P284, DOI 10.1016/j.smim.2006.04.005; Mackay F, 2006, SEMIN IMMUNOL, V18, P261, DOI 10.1016/j.smim.2006.07.003; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; MILLER DJ, 1992, EUR J IMMUNOL, V22, P373, DOI 10.1002/eji.1830220213; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Nardelli B, 2001, BLOOD, V97, P198, DOI 10.1182/blood.V97.1.198; Ng LG, 2005, MOL IMMUNOL, V42, P763, DOI 10.1016/j.molimm.2004.06.041; Ng LG, 2004, J IMMUNOL, V173, P807, DOI 10.4049/jimmunol.173.2.807; Qiu R, 2013, FISH SHELLFISH IMMUN, V34, P810, DOI 10.1016/j.fsi.2012.12.016; Rolink AG, 2002, EUR J IMMUNOL, V32, P2004, DOI 10.1002/1521-4141(200207)32:7<2004::AID-IMMU2004>3.0.CO;2-5; Salinas I, 2011, DEV COMP IMMUNOL, V35, P1346, DOI 10.1016/j.dci.2011.11.009; Sasaki Y, 2004, J IMMUNOL, V173, P2245, DOI 10.4049/jimmunol.173.4.2245; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Shen YF, 2011, VET IMMUNOL IMMUNOP, V142, P133, DOI 10.1016/j.vetimm.2011.04.014; Shu HB, 1999, J LEUKOCYTE BIOL, V65, P680, DOI 10.1002/jlb.65.5.680; Shulga-Morskaya S, 2004, J IMMUNOL, V173, P2331, DOI 10.4049/jimmunol.173.4.2331; Sun Y, 2011, FISH SHELLFISH IMMUN, V30, P273, DOI 10.1016/j.fsi.2010.10.020; Tertilt C, 2009, INFECT IMMUN, V77, P3044, DOI 10.1128/IAI.00927-08; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; Treml LS, 2007, J IMMUNOL, V178, P7531, DOI 10.4049/jimmunol.178.12.7531; Tribouley C, 1999, BIOL CHEM, V380, P1443, DOI 10.1515/BC.1999.186; Wiens GD, 2010, FISH SHELLFISH IMMUN, V29, P639, DOI 10.1016/j.fsi.2010.06.010; Xiao W, 2014, MOL IMMUNOL, V59, P64, DOI 10.1016/j.molimm.2014.01.005; You FT, 2012, INT IMMUNOPHARMACOL, V12, P433, DOI 10.1016/j.intimp.2011.12.018; Yu G, 2000, NAT IMMUNOL, V1, P252, DOI 10.1038/79802; Zhang J, 2001, J IMMUNOL, V166, P6, DOI 10.4049/jimmunol.166.1.6; Zhang M, 2008, MICROBIOL-SGM, V154, P2060, DOI 10.1099/mic.0.2008/017343-0; Zheng WJ, 2010, FISH SHELLFISH IMMUN, V29, P305, DOI 10.1016/j.fsi.2010.04.008; Zhou ZX, 2015, DEV COMP IMMUNOL, V49, P113, DOI 10.1016/j.dci.2014.11.018	62	30	30	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136015	10.1371/journal.pone.0136015	http://dx.doi.org/10.1371/journal.pone.0136015			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295165	Green Published, Green Submitted, gold			2022-12-26	WOS:000359926900061
J	Bi, K; Yang, J; Wang, L; Gu, Y; Zhan, B; Zhu, XP				Bi, Kuo; Yang, Jing; Wang, Lei; Gu, Yuan; Zhan, Bin; Zhu, Xinping			Partially Protective Immunity Induced by a 20 kDa Protein Secreted by Trichinella spiralis Stichocytes	PLOS ONE			English	Article							SERINE-PROTEASE; HUMAN TRICHINOSIS; RAPID EXPULSION; MICE; IDENTIFICATION; INFECTIONS; EXPRESSION; ANTIGENS; VACCINES; CLONING	Background Trichinella spiralis infection induces protective immunity against re-infection in animal models. Identification of the antigens eliciting acquired immunity during infection is important for vaccine development against Trichinella infection and immunodiagnosis. Methods and Findings The T. spiralis adult cDNA library was immunoscreened with sera from pigs experimentally infected with 20,000 infective T. spiralis larvae. Total 43 positive clones encoding for 28 proteins were identified; one of the immunodominant proteins was 20 kDa Ts-ES-1 secreted by Trichinella stichocytes and existing in the excretory/secretory (ES) products of T. spiralis adult and muscle larval worms. Ts-ES-1 contains 172 amino acids with a typical signal peptide in the first 20 amino acids. The expression of Ts-ES-1 was detected in both the adult and muscle larval stages at the mRNA and protein expression levels. Mice immunized with recombinant Ts-ES-1 (rTs-ES-1) formulated with ISA50v2 adjuvant exhibited a significant worm reduction in both the adult worm (27%) and muscle larvae burden (42.1%) after a challenge with T. spiralis compared to the adjuvant control group (p<0.01). The rTs-ES-1-induced protection was associated with a high level of specific anti-Ts-ES-1 IgG antibodies and a Th1/Th2 mixed immune response. Conclusion The newly identified rTs-ES-1 is an immunodominant protein secreted by Trichinella stichocytes during natural infection and enables to the induction of partial protective immunity in vaccinated mice against Trichinella infection. Therefore, rTs-ES-1 is a potential candidate for vaccine development against trichinellosis.	[Bi, Kuo; Yang, Jing; Wang, Lei; Gu, Yuan; Zhu, Xinping] Capital Med Univ, Dept Parasitol, Sch Basic Med Sci, Beijing, Peoples R China; [Wang, Lei] Capital Med Univ, Beijing Friendship Hosp, Beijing, Peoples R China; [Zhan, Bin] Baylor Coll Med, Dept Pediat, Natl Sch Trop Med, Houston, TX 77030 USA	Capital Medical University; Capital Medical University; Baylor College of Medicine	Zhu, XP (corresponding author), Capital Med Univ, Dept Parasitol, Sch Basic Med Sci, Beijing, Peoples R China.	zhuxping@ccmu.edu.cn		Wolf, Nathaniel/0000-0001-6567-2447	National Natural Science Foundation of China [81171598, 81371837, 81201313]; National Science and Technology Major Project [2012ZX10004220-012]; Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions [IDHT20140212]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project; Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions	This study was supported by grants from the National Natural Science Foundation of China (81171598, 81371837, 81201313), the National Science and Technology Major Project (2012ZX10004220-012), and the Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions (IDHT20140212). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALIZADEH H, 1982, INT J PARASITOL, V12, P65, DOI 10.1016/0020-7519(82)90097-2; APPLETON JA, 1988, IMMUNOLOGY, V65, P487; Bai X, 2012, PARASITOL RES, V110, P2481, DOI 10.1007/s00436-011-2789-2; Bell RG, 1998, ADV PARASIT, V41, P149, DOI 10.1016/S0065-308X(08)60424-8; Blum LK, 2009, J IMMUNOL, V183, P5816, DOI 10.4049/jimmunol.0900944; Bruschi F., 2002, ENDOCRINE METABOLIC, V2, P269; Cao XD, 2014, EXP PARASITOL, V146, P43, DOI 10.1016/j.exppara.2014.09.004; Chen XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049913; Cui J, 2011, ACTA TROP, V118, P1, DOI 10.1016/j.actatropica.2011.02.005; Cui J, 2015, ACTA TROP, V142, P57, DOI 10.1016/j.actatropica.2014.10.017; Dea-Ayuela MA, 2000, FOLIA PARASIT, V47, P172, DOI 10.14411/fp.2000.034; Dea-Ayuela MA, 2006, VACCINE, V24, P2772, DOI 10.1016/j.vaccine.2006.01.006; DESPOMMIER DD, 1976, J PARASITOL, V62, P775, DOI 10.2307/3278960; Deville S, 2005, VET PARASITOL, V132, P75, DOI 10.1016/j.vetpar.2005.05.029; Dixon H, 2008, PARASITE IMMUNOL, V30, P454, DOI 10.1111/j.1365-3024.2008.01035.x; Dorny P, 2009, VET PARASITOL, V163, P196, DOI 10.1016/j.vetpar.2009.05.026; Dupouy-Camet J, 2000, VET PARASITOL, V93, P191, DOI 10.1016/S0304-4017(00)00341-1; Dupouy-Camet J, 2009, VET PARASITOL, V159, P194, DOI 10.1016/j.vetpar.2008.10.064; El Ridi R, 2013, J PARASITOL, V99, P194, DOI 10.1645/GE-3186.1; Fang L, 2014, VACCINE, V32, P4412, DOI 10.1016/j.vaccine.2014.06.055; Feng S, 2013, J PARASITOL, V99, P426, DOI 10.1645/12-46.1; Gajadhar AA, 2009, VET PARASITOL, V159, P197, DOI 10.1016/j.vetpar.2008.10.063; Gottstein B, 2009, CLIN MICROBIOL REV, V22, P127, DOI 10.1128/CMR.00026-08; Gour JK, 2012, EXP PARASITOL, V132, P355, DOI 10.1016/j.exppara.2012.04.022; Gu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077238; Haffner A, 1998, EXP PARASITOL, V90, P26, DOI 10.1006/expr.1998.4313; Harnett W, 2014, MOL BIOCHEM PARASIT, V195, P130, DOI 10.1016/j.molbiopara.2014.03.007; Hussaarts L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00499; KARANU FN, 1993, EXP PARASITOL, V77, P362, DOI 10.1006/expr.1993.1093; Kolodziej-Sobocinska M, 2006, EXP PARASITOL, V112, P52, DOI 10.1016/j.exppara.2005.09.004; Li LG, 2015, ACTA TROP, V146, P25, DOI 10.1016/j.actatropica.2015.02.020; Li X, 2013, PARASITOL RES, V112, P3229, DOI 10.1007/s00436-013-3500-6; Loukas A, 2006, LANCET INFECT DIS, V6, P733, DOI 10.1016/S1473-3099(06)70630-2; McManus DP, 2008, CLIN MICROBIOL REV, V21, P225, DOI 10.1128/CMR.00046-07; McVay C, 2000, INFECT IMMUN, V68, P1912, DOI 10.1128/IAI.68.4.1912-1918.2000; Mulvenna J, 2009, MOL CELL PROTEOMICS, V8, P109, DOI 10.1074/mcp.M800206-MCP200; Murrell KD, 2011, EMERG INFECT DIS, V17, P2194, DOI 10.3201/eid1712.110896; MURRELL KD, 1985, EXP PARASITOL, V59, P347, DOI 10.1016/0014-4894(85)90090-6; Nagano I, 2001, J HELMINTHOL, V75, P273; Oeser K, 2015, MUCOSAL IMMUNOL, V8, P672, DOI 10.1038/mi.2014.101; Onah Denis Nnabuike, 2000, Korean Journal of Parasitology, V38, P209, DOI 10.3347/kjp.2000.38.4.209; Ortega-Pierres G, 2015, J HELMINTHOL, P1; Pecaut MJ, 2000, COMPARATIVE MED, V50, P595; Pozio E, 2007, VET PARASITOL, V149, P3, DOI 10.1016/j.vetpar.2007.07.002; REASON AJ, 1994, GLYCOBIOLOGY, V4, P593, DOI 10.1093/glycob/4.5.593; RUSSELL DA, 1984, J PARASITOL, V70, P593, DOI 10.2307/3281412; Scales HE, 2007, PARASITE IMMUNOL, V29, P81, DOI 10.1111/j.1365-3024.2006.00920.x; Singh PK, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/590281; TAKAHASHI Y, 1992, J PARASITOL, V78, P518, DOI 10.2307/3283656; Wang B, 2013, EXP PARASITOL, V134, P148, DOI 10.1016/j.exppara.2013.03.004; WATANABE N, 1988, P NATL ACAD SCI USA, V85, P4460, DOI 10.1073/pnas.85.12.4460; Wei JF, 2011, VACCINE, V29, P3162, DOI 10.1016/j.vaccine.2011.02.072; White RR, 2012, VIRULENCE, V3, P668, DOI 10.4161/viru.22832; Williamson AL, 2006, INFECT IMMUN, V74, P961, DOI 10.1128/IAI.74.2.961-967.2006; Yang J, 2008, BIOCHEM BIOPH RES CO, V365, P528, DOI 10.1016/j.bbrc.2007.11.012; Yang XD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096454; Yang YP, 2010, VACCINE, V28, P2735, DOI 10.1016/j.vaccine.2010.01.026; Zhang YL, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-246; Zocevic A, 2011, PARASITOLOGY, V138, P463, DOI 10.1017/S0031182010001526	59	19	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136189	10.1371/journal.pone.0136189	http://dx.doi.org/10.1371/journal.pone.0136189			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288365	Green Submitted, gold, Green Published			2022-12-26	WOS:000360018600119
J	McBurney, MI; Yu, EA; Ciappio, ED; Bird, JK; Eggersdorfer, M; Mehta, S				McBurney, Michael I.; Yu, Elaine A.; Ciappio, Eric D.; Bird, Julia K.; Eggersdorfer, Manfred; Mehta, Saurabh			Suboptimal Serum alpha-Tocopherol Concentrations Observed among Younger Adults and Those Depending Exclusively upon Food Sources, NHANES 2003-2006(1-3)	PLOS ONE			English	Article							VITAMIN-E; OXIDATIVE STRESS; GAMMA-TOCOPHEROL; MAJOR DEPRESSION; BETA-CAROTENE; DISEASE; SUPPLEMENTATION; METAANALYSIS; WOMEN; ANTIOXIDANTS	Vitamin E is an essential nutrient for human health, with an established function as a lipidsoluble antioxidant that protects cell membranes from free radical damage. Low vitamin E status has been linked to multiple health outcomes, including total mortality. With vitamin E being identified as a 'shortfall nutrient' because >90% of American adults are not consuming recommended amounts of vitamin E, we aimed to determine the prevalence of both clinical vitamin E deficiency (serum alpha-tocopherol concentration < 12 mu mol/L) and failure to meet a criterion of vitamin E adequacy, serum alpha-tocopherol concentration of 30 mu mol/L, based on the Estimated Average Requirement (EAR) and lowest mortality rate in the Alpha-Tocopherol Beta-Carotene (ATBC) study. The most recent nationally-representative cross-sectional data (2003-2006) among non-institutionalized US citizens with available serum concentrations of alpha-tocopherol from the National Health and Nutrition Examination Survey (NHANES); Centers for Disease Control and Prevention were analyzed. Serum alpha-tocopherol distributions were compared between those reporting consumption of food without supplement use (FOOD) and food and supplement use (FOOD+DS) by sex, age, and race/ethnicity. Only 1% of the US population is clinically deficient. FOOD consumers have lower average alpha-tocopherol levels (24.9 +/- 0.2 mu mol/L) than FOOD+DS users (33.7 +/- 0.3 mu mol/L), even when adjusted for total cholesterol. Using a criterion of adequacy of 30 mu mol/L, 87% of persons 20-30y and 43% of those 51+y had inadequate vitamin E status (p<0.01). A significant greater prevalence of FOOD compared to FOOD+DS users did not meet the criterion of adequacy which was based on the EAR and low ATBC mortality rate consistently across age, sex, and race/ethnic groups. The prevalence of inadequate vitamin E levels is significantly higher among non-users of dietary supplements. With declining usage of vitamin E supplements, the population should be monitored for changes in vitamin E status and related health outcomes.	[McBurney, Michael I.; Ciappio, Eric D.] DSM Nutr Prod, Parsippany, NJ 07054 USA; [Yu, Elaine A.; Mehta, Saurabh] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Bird, Julia K.] DSM Nutr Prod, Delft, Netherlands; [Eggersdorfer, Manfred] DSM Nutr Prod, Kaiseraugst, Switzerland	DSM NV; Cornell University; DSM NV; DSM NV	McBurney, MI (corresponding author), DSM Nutr Prod, Parsippany, NJ 07054 USA.	Michael.McBurney@dsm.com	McBurney, Michael I./AAB-6850-2019; Mehta, Saurabh/L-8490-2017; Bird, Julia K./I-3044-2019	McBurney, Michael I./0000-0003-4511-6034; Mehta, Saurabh/0000-0003-3788-0665; Bird, Julia K./0000-0001-6015-3576; Yu, Elaine A./0000-0003-2433-9562	DSM Nutritional Products	DSM Nutritional Products	Funding: This statistical analysis of data collected by the Centers for Disease Control (CDC) (http://www.cdc.gov/nutritionreport/faq.html) was supported by DSM Nutritional Products, a manufacturer of vitamin E. MM, EC, JB and ME are employees of DSM Nutritional Products. DSM Nutritional Products provided support in the form of salaries for authors MM, EC, JB, and ME and as an unencumbered gift to Cornell University that was used to support EY as a graduate research assistant, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abner Erin L, 2011, Curr Aging Sci, V4, P158; AITKEN RJ, 1987, J REPROD FERTIL, V81, P459; Almbro M, 2011, ECOL LETT, V14, P891, DOI 10.1111/j.1461-0248.2011.01653.x; Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501; [Anonymous], NCHS LAB PROC MAN; Bailey RL, 2012, J PEDIATR-US, V161, P837, DOI 10.1016/j.jpeds.2012.05.009; Bailey RL, 2011, J NUTR, V141, P261, DOI 10.3945/jn.110.133025; Benedetti S, 2012, REPROD BIOMED ONLINE, V25, P300, DOI 10.1016/j.rbmo.2012.05.011; Beydoun MA, 2013, BRIT J NUTR, V109, P1714, DOI 10.1017/S0007114512003467; Biesalski HK, 2010, NUTRIENTS, V2, P929, DOI 10.3390/nu2090929; Biesalski HK, 1997, CLIN NUTR, V16, P151, DOI 10.1016/S0261-5614(97)80245-2; Center for Disease Control, 2012, 2 NAT REP BIOCH IND; Chai WW, 2014, J AM COLL NUTR, V33, P192, DOI 10.1080/07315724.2013.862490; Cicek N, 2012, J ASSIST REPROD GEN, V29, P325, DOI 10.1007/s10815-012-9714-1; Dysken MW, 2014, ALZHEIMERS DEMENT, V10, P36, DOI 10.1016/j.jalz.2013.01.014; Ford ES, 2006, AM J CLIN NUTR, V84, P375; Fulgoni VL, 2011, J NUTR, V141, P1847, DOI 10.3945/jn.111.142257; Gahche Jamie, 2011, NCHS Data Brief, P1; Geva E, 1996, FERTIL STERIL, V66, P430, DOI 10.1016/S0015-0282(16)58514-8; Han Sung Nim, 2006, Expert Rev Clin Immunol, V2, P561, DOI 10.1586/1744666X.2.4.561; Heaney RP, 2014, NUTR REV, V72, P48, DOI 10.1111/nure.12090; HHS/USDA, 2015, SCI REP 2015 DIET GU; Khalil A, 2011, EXP GERONTOL, V46, P475, DOI 10.1016/j.exger.2011.02.002; Kim HJ, 2014, J ACAD NUTR DIET; Lappe JM, 2012, DERM-ENDOCRINOL, V4, P95, DOI 10.4161/derm.19833; Lebold KM, 2012, AM J CLIN NUTR, V96, P801, DOI 10.3945/ajcn.112.038620; Levy AP, 2004, DIABETES CARE, V27, P925, DOI 10.2337/diacare.27.4.925; Maes M, 2000, J AFFECT DISORDERS, V58, P241, DOI 10.1016/S0165-0327(99)00121-4; Mangialasche F, 2013, J INTERN MED, V273, P602, DOI 10.1111/joim.12037; Menezo Y, 2014, ADV EXP MED BIOL, V791, P173, DOI 10.1007/978-1-4614-7783-9_11; Michaelsson K, 2014, AM J CLIN NUTR, V99, P107, DOI 10.3945/ajcn.113.064691; Miller ER, 2005, ANN INTERN MED, V142, P37, DOI 10.7326/0003-4819-142-1-200501040-00110; National Academies Press, 2000, DIETARY REFERENCE IN; NHLBI N, 2005, NIH PUBLICATION, V05-3290; Niki E, 2012, ANN NUTR METAB, V61, P207, DOI 10.1159/000343106; Owen AJ, 2005, EUR J CLIN NUTR, V59, P304, DOI 10.1038/sj.ejcn.1602072; Ozkaya MO, 2010, FERTIL STERIL, V94, P2465, DOI 10.1016/j.fertnstert.2010.01.066; Pae M, 2012, AGING DIS, V3, P91; Peter S, 2013, INT J VITAM NUTR RES, V83, P129, DOI 10.1024/0300-9831/a000153; Pfeiffer CM, 2013, J NUTR, V143, p938S, DOI 10.3945/jn.112.172858; Ruder EH, 2008, HUM REPROD UPDATE, V14, P345, DOI 10.1093/humupd/dmn011; Schleicher RL, 2013, J NUTR, V143, p966S, DOI 10.3945/jn.112.172965; Schmid TE, 2012, FERTIL STERIL, V98, P1130, DOI 10.1016/j.fertnstert.2012.07.1126; Siddiqui IA, 2013, BIOMARK MED, V7, P229, DOI [10.2217/BMM.12.109, 10.2217/bmm.12.109]; THURNHAM DI, 1986, ANN CLIN BIOCHEM, V23, P514, DOI 10.1177/000456328602300505; Traber MG, 2008, CURR OPIN LIPIDOL, V19, P30, DOI 10.1097/MOL.0b013e3282f2dab6; Traber MG, 2011, FREE RADICAL BIO MED, V51, P1000, DOI 10.1016/j.freeradbiomed.2011.05.017; Vardi M, 2012, EUR J INTERN MED, V23, P628, DOI 10.1016/j.ejim.2012.04.009; Weinstein SJ, 2007, CANCER EPIDEM BIOMAR, V16, P1253, DOI 10.1158/1055-9965.EPI-06-1084; Wright ME, 2006, AM J CLIN NUTR, V84, P1200, DOI 10.1093/ajcn/84.5.1200; Zhao Y, 2014, BRIT J NUTR, V112, P1575, DOI 10.1017/S0007114514002438	51	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135510	10.1371/journal.pone.0135510	http://dx.doi.org/10.1371/journal.pone.0135510			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287975	gold, Green Submitted, Green Published			2022-12-26	WOS:000360018600052
J	Schuler, E; Larsson, M; Parris, TZ; Johansson, ME; Helou, K; Forssell-Aronsson, E				Schuler, Emil; Larsson, Maria; Parris, Toshima Z.; Johansson, Martin E.; Helou, Khalil; Forssell-Aronsson, Eva			Potential Biomarkers for Radiation-Induced Renal Toxicity following Lu-177-Octreotate Administration in Mice	PLOS ONE			English	Article							RECEPTOR RADIONUCLIDE THERAPY; GENE-EXPRESSION; RADIOLABELED SOMATOSTATIN; TRANSCRIPTIONAL RESPONSE; NEUROENDOCRINE TUMORS; PROTEIN BIOMARKERS; MOUSE-TISSUES; DOSE-RATE; EXPOSURE; RENOGRAPHY	The kidneys are one of the main dose-limiting organs in peptide receptor radionuclide therapy and due to large inter-individual variations in renal toxicity, biomarkers are urgently needed in order to optimize therapy and reduce renal tissue damage. The aim of this study was to investigate the transcriptional, functional, and morphological effects on renal tissue after Lu-177-octreotate administration in normal mice, and to identify biomarkers for radiation induced renal toxicity. Methods C57BL/6N mice were i.v. injected with 0, 30, 60, 90, 120, or 150 MBq Lu-177-octreotate (0, 16, 29, 40, 48, and 54 Gy to the kidneys). At 4, 8, and 12 months after administration, radiation-induced effects were evaluated in relation to (a) global transcriptional variations in kidney tissues, (b) morphological changes in the kidneys, (c) changes in white and red blood cell count as well as blood levels of urea, and (d) changes in renal function using Tc-99m-DTPA/Tc-99m-DMSA scintigraphy. Results In general, the highest number of differentially regulated transcripts was observed at 12 months after administration. The Cdkn1a, C3, Dbp, Lcn2, and Per2 genes displayed a distinct dose-dependent regulation, with increased expression level with increasing absorbed dose. Ifng, Tnf, and Il1B were identified as primary up-stream regulators of the recurrently regulated transcripts. Furthermore, previously proposed biomarkers for kidney injury and radiation damage were also observed. The functional investigation revealed reduced excretion of Tc-99m-DTPA after 150 MBq, an increased uptake of Tc-99m-DMSA at all dose levels compared with the controls, and markedly increased urea level in blood after 150 MBq at 12 months. Conclusion Distinct dose-response relationships were found for several of the regulated transcripts. The Cdkn1a, Dbp, Lcn2, and Per2 genes are proposed as biomarkers for Lu-177-octreotate exposure of kidney. Correlations to functional and morphological effects further confirm applicability of these genes as markers of radiation damage in kidney tissue.	[Schuler, Emil; Larsson, Maria; Forssell-Aronsson, Eva] Univ Gothenburg, Sahlgrenska Univ Hosp, Sahlgrenska Canc Ctr, Dept Radiat Phys,Inst Clin Sci,Sahlgrenska Acad, Gothenburg, Sweden; [Parris, Toshima Z.; Helou, Khalil] Univ Gothenburg, Sahlgrenska Univ Hosp, Sahlgrenska Canc Ctr, Dept Oncol,Inst Clin Sci,Sahlgrenska Acad, Gothenburg, Sweden; [Johansson, Martin E.] Lund Univ, Dept Lab Med, SUS Malmo, Malmo, Sweden; [Forssell-Aronsson, Eva] Sahlgrens Univ Hosp, Dept Med Phys & Med Bioengn, Gothenburg, Sweden	Sahlgrenska University Hospital; University of Gothenburg; Sahlgrenska University Hospital; University of Gothenburg; Lund University; Sahlgrenska University Hospital	Schuler, E (corresponding author), Univ Gothenburg, Sahlgrenska Univ Hosp, Sahlgrenska Canc Ctr, Dept Radiat Phys,Inst Clin Sci,Sahlgrenska Acad, Gothenburg, Sweden.	emil.schuler@gu.se	Parris, Toshima/Q-5427-2018	Parris, Toshima/0000-0003-0834-5540; Forssell-Aronsson, Eva/0000-0002-7558-4368	Swedish Research Council [21073]; Swedish Cancer Society [3427]; BioCARE - a National Strategic Research Program at the University of Gothenburg; Swedish Radiation Safety Authority; King Gustav V Jubilee Clinic Cancer Research Foundation; Sahlgrenska University Hospital; Assar Gabrielsson Cancer Research Foundation; Lions Cancerfond Vast; Adlerbertska Research Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); BioCARE - a National Strategic Research Program at the University of Gothenburg; Swedish Radiation Safety Authority; King Gustav V Jubilee Clinic Cancer Research Foundation; Sahlgrenska University Hospital; Assar Gabrielsson Cancer Research Foundation; Lions Cancerfond Vast; Adlerbertska Research Foundation	This study was supported by grants from the Swedish Research Council (grant no. 21073), the Swedish Cancer Society (grant no. 3427), BioCARE - a National Strategic Research Program at the University of Gothenburg, the Swedish Radiation Safety Authority, the King Gustav V Jubilee Clinic Cancer Research Foundation, the Sahlgrenska University Hospital Research Funds, the Assar Gabrielsson Cancer Research Foundation, the Lions Cancerfond Vast, and the Adlerbertska Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiyanti Sri S, 2012, Acta Med Indones, V44, P246; Assadi M, 2008, INT UROL NEPHROL, V40, P1059, DOI 10.1007/s11255-008-9446-4; Barone R, 2005, J NUCL MED, V46, p99S; Bodei L, 2014, EUR J NUCL MED MOL I; Bodei L, 2008, EUR J NUCL MED MOL I, V35, P1847, DOI 10.1007/s00259-008-0778-1; Bolch WE, 2009, J NUCL MED, V50, P477, DOI 10.2967/jnumed.108.056036; Chaudhry MA, 2008, J BIOMED SCI, V15, P557, DOI 10.1007/s11373-008-9253-z; Cruz Dinna N, 2010, Congest Heart Fail, V16 Suppl 1, pS25, DOI 10.1111/j.1751-7133.2010.00163.x; Daniel GB, 1999, VET RADIOL ULTRASOUN, V40, P572, DOI 10.1111/j.1740-8261.1999.tb00883.x; Filiano AN, 2011, RADIAT RES, V176, P49, DOI 10.1667/RR2419.1; Forrer F, 2007, CANCER BIOTHER RADIO, V22, P40, DOI 10.1089/cbr.2006.353; Forssell-Aronsson E, 2004, ACTA ONCOL, V43, P436, DOI 10.1080/02841860410030670; Forssell-Aronsson EB, 2000, J NUCL MED, V41, P636; Forssell-Aronsson E, 2013, NEUROENDOCRINOLOGY, V97, P86, DOI 10.1159/000336086; Han WK, 2002, KIDNEY INT, V62, P237, DOI 10.1046/j.1523-1755.2002.00433.x; Hecht S, 2010, CAN VET J, V51, P1360; Hewitt SM, 2004, J AM SOC NEPHROL, V15, P1677, DOI 10.1097/01.ASN.0000129114.92265.32; Hoffmann D, 2010, TOXICOL SCI, V116, P8, DOI 10.1093/toxsci/kfq029; Khan S, 2011, J NUCL MED, V52, P1361, DOI 10.2967/jnumed.111.087932; Langen B, 2015, EJNMMI RES, V5, P1, DOI 10.1186/s13550-014-0078-7; Langen B, 2013, J NUCL MED, V54, P990, DOI 10.2967/jnumed.112.114462; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Marchetti F, 2006, INT J RADIAT BIOL, V82, P605, DOI 10.1080/09553000600930103; McBride WH, 2004, RADIAT RES, V162, P1, DOI 10.1667/RR3196; Melis M, 2005, EUR J NUCL MED MOL I, V32, P1136, DOI 10.1007/s00259-005-1793-0; Melis M, 2007, NUCL MED BIOL, V34, P633, DOI 10.1016/j.nucmedbio.2007.05.002; Melis M, 2010, J NUCL MED, V51, P1962, DOI 10.2967/jnumed.110.080143; Miller WH, 2005, CANCER BIOTHER RADIO, V20, P436, DOI 10.1089/cbr.2005.20.436; Narvaez-Sanchez R, 2008, CLIN BIOCHEM, V41, P498, DOI 10.1016/j.clinbiochem.2008.01.022; Nickolas TL, 2008, CURR OPIN NEPHROL HY, V17, P127, DOI 10.1097/MNH.0b013e3282f4e525; Pajonk F, 2001, RADIOTHER ONCOL, V59, P203, DOI 10.1016/S0167-8140(01)00311-5; Perco P, 2006, EUR J CLIN INVEST, V36, P753, DOI 10.1111/j.1365-2362.2006.01729.x; Medeiros FSR, 2009, TRANSPL INT, V22, P323, DOI 10.1111/j.1432-2277.2008.00799.x; Ritchie G, 2008, PEDIATR RADIOL, V38, P857, DOI 10.1007/s00247-008-0908-8; Rudqvist N, 2015, NUCL MED BIOL, V42, P263, DOI 10.1016/j.nucmedbio.2014.11.006; Rudqvist N, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-32; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuler E, 2015, ACTA ONCOL, P1; Schuler E, 2014, NUCL MED BIOL, V41, P825, DOI 10.1016/j.nucmedbio.2014.07.010; Schuler E, 2014, NUCL MED BIOL, V41, P238, DOI 10.1016/j.nucmedbio.2013.12.001; Snyder AR, 2004, CANCER METAST REV, V23, P259, DOI 10.1023/B:CANC.0000031765.17886.fa; Svensson J, 2012, NUCL MED BIOL, V39, P756, DOI 10.1016/j.nucmedbio.2012.02.003; Sward C, 2010, WORLD J SURG, V34, P1368, DOI 10.1007/s00268-009-0387-6; Thomas C, 2009, DTSCH ARZTEBL INT, V106, P849, DOI 10.3238/arztebl.2009.0849; Vaidya VS, 2008, ANNU REV PHARMACOL, V48, P463, DOI 10.1146/annurev.pharmtox.48.113006.094615; Vegt E, 2010, J NUCL MED, V51, P1049, DOI 10.2967/jnumed.110.075101; Weyer K, 2013, J NUCL MED, V54, P159, DOI 10.2967/jnumed.112.110528	47	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136204	10.1371/journal.pone.0136204	http://dx.doi.org/10.1371/journal.pone.0136204			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287527	Green Published, gold, Green Submitted			2022-12-26	WOS:000360018600122
J	Zhou, SH; Shi, ZY; Cui, M; Li, JL; Ma, Z; Shi, YY; Zheng, ZJ; Zhang, FC; Jin, TB; Geng, TT; Chen, C; Guo, YL; Zhou, JP; Huang, S; Guo, XL; Gao, L; Gong, PY; Gao, XC; Zhang, KJ				Zhou, Shaohe; Shi, Zhangyan; Cui, Meng; Li, Junlin; Ma, Zhe; Shi, Yuanyu; Zheng, Zijian; Zhang, Fuchang; Jin, Tianbo; Geng, Tingting; Chen, Chao; Guo, Yale; Zhou, Jianping; Huang, Shaoping; Guo, Xingli; Gao, Lin; Gong, Pingyuan; Gao, Xiaocai; Zhang, Kejin			A New Role for LOC101928437 in Non-Syndromic Intellectual Disability: Findings from a Family-Based Association Test	PLOS ONE			English	Article							MENTAL-RETARDATION; UNIFIED APPROACH; POPULATION; BINDING; GENES	Non-syndromic intellectual disability (NSID) is mental retardation in persons of normal physical appearance who have no recognisable features apart from obvious deficits in intellectual functioning and adaptive ability; however, its genetic etiology of most patients has remained unknown. The main purpose of this study was to fine map and identify specific causal gene(s) by genotyping a NSID family cohort using a panel of markers encompassing a target region reported in a previous work. A total of 139 families including probands, parents and relatives were included in the household survey, clinical examinations and intelligence tests, recruited from the Qinba mountain region of Shannxi province, western China. A collection of 34 tagged single nucleotide polymorphisms (tSNPs) spanning five microsatellite marker (STR) loci were genotyped using an iPLEX Gold assay. The association between tSNPs and patients was analyzed by family-based association testing (FBAT) and haplotype analysis (HBAT). Four markers (rs5974392, rs12164331, rs5929554 and rs3116911) in a block that showed strong linkage disequilibrium within the first three introns of the LOC101928437 locus were found to be significantly associated with NSID (all P<0.01) by the FBAT method for a single marker in additive, dominant and recessive models. The results of haplotype tests of this block also revealed a significant association with NSID (all P<0.05) using 2-window and larger HBAT analyses. These results suggest that LOC101928437 is a novel candidate gene for NSID in Han Chinese individuals of the Qinba region of China. Although the biological function of the gene has not been well studied, knowledge about this gene will provide insights that will increase our understanding of NSID development.	[Zhou, Shaohe; Shi, Zhangyan; Li, Junlin; Ma, Zhe; Shi, Yuanyu; Zhang, Fuchang; Gao, Xiaocai; Zhang, Kejin] NW Univ Xian, Inst Populat & Hlth, Coll Life Sci, Minist Educ,Key Lab Resource Biol & Biotechnol We, Xian 710069, Peoples R China; [Cui, Meng] Xian Inst Mental Hlth, Xian, Peoples R China; [Zheng, Zijian; Zhang, Fuchang; Gao, Xiaocai] NW Univ Xian, Inst Applicat Psychol, Coll Publ Management, Xian 710069, Peoples R China; [Jin, Tianbo; Geng, Tingting; Chen, Chao] NW Univ Xian, Sch Life Sci, Xian 710069, Shaanxi, Peoples R China; [Jin, Tianbo; Geng, Tingting; Chen, Chao] Natl Engn Res Ctr Miniaturized Detect Syst, Xian, Shaanxi, Peoples R China; [Guo, Yale; Zhou, Jianping; Huang, Shaoping] Xi An Jiao Tong Univ, Affiliated Hosp 2, Xian, Peoples R China; [Guo, Xingli; Gao, Lin] Xidian Univ, Sch Comp Sci & Technol, Xian, Shaanxi, Peoples R China; [Gong, Pingyuan] Henan Univ Sci & Technol, Lab Med Mol Biol, Luoyang, Peoples R China	Northwest University Xi'an; Northwest University Xi'an; Northwest University Xi'an; Xi'an Jiaotong University; Xidian University; Henan University of Science & Technology	Gao, XC (corresponding author), NW Univ Xian, Inst Populat & Hlth, Coll Life Sci, Minist Educ,Key Lab Resource Biol & Biotechnol We, Xian 710069, Peoples R China.	gaoxc@nwu.edu.cn; zhangkj@nwu.edu.cn	Zhang, Kejin/A-4205-2015	Zhang, Kejin/0000-0002-4980-1736; Li, Junlin/0000-0002-3204-6420; Geng, Tingting/0000-0003-2309-7637	Natural Science Foundation of China [31340028, 31371327, 31100899]; NWU Graduate Innovation and Creativity Funds [201410697124]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NWU Graduate Innovation and Creativity Funds	Funding: This study was supported by grants from the Natural Science Foundation of China (No. 31340028) to Kejin Zhang, (No. 31371327) to Junlin Li and (No. 31100899) to Zhangyan Shi, and NWU Graduate Innovation and Creativity Funds (No. 201410697124) to Shaohe Zhou. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Delbridge ML, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-65; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gabriel Stacey, 2009, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0212s60; Gecz J, 2009, TRENDS GENET, V25, P308, DOI 10.1016/j.tig.2009.05.002; Gong Y., 1993, WECHSLER INTELLIGENC; Gong Y, 1989, ADULT MENTAL HANDICA; Gong YX., 1992, CHINESE WECHSLER YOU; Gong YX, 1992, MANUAL CHINESE REVIS; Gremer L, 2010, HUM MOL GENET, V19, P790, DOI 10.1093/hmg/ddp548; He Y, 2008, ANN HUM GENET, V72, P801, DOI 10.1111/j.1469-1809.2008.00465.x; Kaufman L, 2010, J NEURODEV DISORD, V2, P182, DOI 10.1007/s11689-010-9055-2; Kelly SM, 2014, RNA, V20, P681, DOI 10.1261/rna.043984.113; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Lake SL, 2000, AM J HUM GENET, V67, P1515, DOI 10.1086/316895; Leonard H, 2002, MENT RETARD DEV D R, V8, P117, DOI 10.1002/mrdd.10031; Longo-Guess CM, 2005, P NATL ACAD SCI USA, V102, P7894, DOI 10.1073/pnas.0500760102; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Piton A, 2013, AM J HUM GENET, V93, P368, DOI 10.1016/j.ajhg.2013.06.013; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; Raymond FL, 2006, HUM MOL GENET, V15, pR110, DOI 10.1093/hmg/ddl189; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Vink JM, 2002, BIOL PSYCHOL, V61, P53, DOI 10.1016/S0301-0511(02)00052-2; Visser R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049229; Wang D, 2007, CHINESE J CLIN PSYCH, V15, P6; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Zechner U, 2001, TRENDS GENET, V17, P697, DOI 10.1016/S0168-9525(01)02446-5; Zhang KJ, 2009, PSYCHIAT GENET, V19, P27, DOI 10.1097/YPG.0b013e3283121d05; ZUO Q, 1988, ADAPTIVE SCALE INFAN	31	2	2	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135669	10.1371/journal.pone.0135669	http://dx.doi.org/10.1371/journal.pone.0135669			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287547	Green Published, Green Submitted, gold			2022-12-26	WOS:000360018600062
J	Gimblet, C; Loesche, MA; Carvalho, L; Carvalho, EM; Grice, EA; Artis, D; Scott, P				Gimblet, Ciara; Loesche, Michael A.; Carvalho, Lucas; Carvalho, Edgar M.; Grice, Elizabeth A.; Artis, David; Scott, Phillip			IL-22 Protects against Tissue Damage during Cutaneous Leishmaniasis	PLOS ONE			English	Article							HOST-DEFENSE; KERATINOCYTE MIGRATION; CELLS; INFLAMMATION; INNATE; DIFFERENTIATION; INTERLEUKIN-22; EXPRESSION; IMMUNITY; SEVERITY	Cutaneous leishmaniasis is a disease characterized by ulcerating skin lesions, the resolution of which requires an effective, but regulated, immune response that limits parasite growth without causing permanent tissue damage. While mechanisms that control the parasites have been well studied, the factors regulating immunopathologic responses are less well understood. IL-22, a member of the IL-10 family of cytokines, can contribute to wound healing, but in other instances promotes pathology. Here we investigated the role of IL-22 during leishmania infection, and found that IL-22 limits leishmania-induced pathology when a certain threshold of damage is induced by a high dose of parasites. Il22(-/-) mice developed more severe disease than wild-type mice, with significantly more pathology at the site of infection, and in some cases permanent loss of tissue. The increased inflammation was not due to an increased parasite burden, but rather was associated with the loss of a wound healing phenotype in keratinocytes. Taken together, these studies demonstrate that during cutaneous leishmaniasis, IL-22 can play a previously unappreciated role in controlling leishmania-induced immunopathology.	[Gimblet, Ciara; Scott, Phillip] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Loesche, Michael A.; Grice, Elizabeth A.] Univ Penn, Perelman Sch Med, Dept Dermatol, Philadelphia, PA 19104 USA; [Carvalho, Lucas; Carvalho, Edgar M.] Univ Fed Bahia, Serv Imunol, Salvador, BA, Brazil; [Carvalho, Lucas; Carvalho, Edgar M.] Inst Nacl Ciencias & Tecnol Doencas Trop, Salvador, BA, Brazil; [Carvalho, Lucas; Carvalho, Edgar M.] Univ Fed Bahia, Inst Ciencias Saude, Salvador, BA, Brazil; [Artis, David] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Universidade Federal da Bahia; Universidade Federal da Bahia; University of Pennsylvania; Pennsylvania Medicine	Scott, P (corresponding author), Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA.	pscott@vet.upenn.edu	Carvalho, Lucas/AAP-1844-2020	Loesche, Michael/0000-0003-0737-0138; Grice, Elizabeth/0000-0003-3939-2200; Artis, David/0000-0002-1753-4100; Gimblet-Ochineg, Ciara/0000-0002-7699-9645	National Institutes of Health [RO1AI106842 (PS), AR060873 (EAG)]; Tropical Medicine Research Center [AI30639, T32AI753216]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106842, F31AI114227, P50AI030639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007465, R00AR060873] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tropical Medicine Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded by National Institutes of Health, RO1AI106842 (PS), AR060873 (EAG), Tropical Medicine Research Centers AI30639 (EMC), and T32AI753216 (CG). All funders played a role in the study design, data collection and analysis, decision to publish, and/or preparation of the manuscript.	Antonelli LRV, 2005, IMMUNOL LETT, V101, P226, DOI 10.1016/j.imlet.2005.06.004; Aujla SJ, 2009, J MOL MED, V87, P451, DOI 10.1007/s00109-009-0448-1; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Bacellar O, 2002, INFECT IMMUN, V70, P6734, DOI 10.1128/IAI.70.12.6734-6740.2002; Bafica A, 2003, INT J DERMATOL, V42, P203, DOI 10.1046/j.1365-4362.2003.01868.x; Baldwin T, 2007, PARASITE IMMUNOL, V29, P501, DOI 10.1111/j.1365-3024.2007.00969.x; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Brosch S, 2014, J INVEST DERMATOL; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carlsen ED, 2015, J INNATE IMMUN; Carta S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00123; Crosby EJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003970; da Silva Santos C, 2014, J INVEST DERMATOL; de Moura TR, 2005, INFECT IMMUN, V73, P5827, DOI 10.1128/IAI.73.9.5827-5834.2005; de Oliveira CI, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00145; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elso C, 2004, GENES IMMUN, V5, P188, DOI 10.1038/sj.gene.6364056; Elso CM, GENES; Faria DR, 2005, INFECT IMMUN, V73, P7853, DOI 10.1128/IAI.73.12.7853-7859.2005; Fernandez-Figueroa EA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001533; Gaze ST, 2006, SCAND J IMMUNOL, V63, P70, DOI 10.1111/j.1365-3083.2005.01707.x; Ghosh K, 2013, J INFECT DIS, V207, P1016, DOI 10.1093/infdis/jis771; Gonzalez-Lombana C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003243; Guilloteau K, 2010, J IMMUNOL; Hannigan GD, 2014, J ORTHOP RES, V32, P597, DOI 10.1002/jor.22578; Kedzierski L, 2010, J GLOB INFECT DIS, V2, P177, DOI 10.4103/0974-777X.62881; Kostka SL, 2009, J IMMUNOL, V182, P3039, DOI 10.4049/jimmunol.0713598; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Ma HL, 2008, J CLIN INVEST, V118, P597, DOI 10.1172/JCI33263; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Mcgee HM, 2013, J INVEST DERMATOL, V133, P1321, DOI 10.1038/jid.2012.463; Naik S, 2012, SCIENCE, V337, P1115, DOI 10.1126/science.1225152; Novais FO, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003504; Novais FO, 2014, J INVEST DERMATOL; Pantelyushin S, 2012, J CLIN INVEST, V122, P2252, DOI 10.1172/JCI61862; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Pitta MGR, 2009, J CLIN INVEST, V119, P2379, DOI 10.1172/JCI38813; Radaeva S, 2004, HEPATOLOGY, V39, P1332, DOI 10.1002/hep.20184; REED SG, 1986, AM J TROP MED HYG, V35, P79, DOI 10.4269/ajtmh.1986.35.79; Rotty JD, 2012, J CELL BIOL, V197, P381, DOI 10.1083/jcb.201107078; Sa SM, 2007, J IMMUNOL, V178, P2229, DOI 10.4049/jimmunol.178.4.2229; Sertorio M, 2015, HEPATOLOGY, V61, P1321, DOI 10.1002/hep.27629; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Sonnenberg GF, 2010, J EXP MED, V207, P1293, DOI 10.1084/jem.20092054; Spath GF, 2001, EXP PARASITOL, V99, P97, DOI 10.1006/expr.2001.4656; Sun DP, 2013, CYTOKINE, V62, P360, DOI 10.1016/j.cyto.2013.03.017; Svensson M, 2004, IMMUNITY, V21, P805, DOI 10.1016/j.immuni.2004.10.012; Taube C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021799; Usui ML, 2008, J HISTOCHEM CYTOCHEM, V56, P687, DOI 10.1369/jhc.2008.951194; Usui ML, 2005, WOUND REPAIR REGEN, V13, P468, DOI 10.1111/j.1067-1927.2005.00067.x; Van Belle AB, 2012, J IMMUNOL, V188, P462, DOI 10.4049/jimmunol.1102224; Vogl T, 2004, BLOOD, V104, P4260, DOI 10.1182/blood-2004-02-0446; Voronov E, 2010, INT IMMUNOL, V22, P245, DOI 10.1093/intimm/dxq006; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WANG ZE, 1994, J EXP MED, V179, P1367, DOI 10.1084/jem.179.4.1367; Wawersik MJ, 2001, MOL BIOL CELL, V12, P3439, DOI 10.1091/mbc.12.11.3439; Wilson MS, 2010, J IMMUNOL, V184, P4378, DOI 10.4049/jimmunol.0903416; Wolk K, 2002, J IMMUNOL, V168, P5397, DOI 10.4049/jimmunol.168.11.5397; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Xu WF, 2001, P NATL ACAD SCI USA, V98, P9511, DOI 10.1073/pnas.171303198; Xu X, 2014, J IMMUNOL, V192, P1778, DOI 10.4049/jimmunol.1300039; Zaph C, 2004, NAT MED, V10, P1104, DOI 10.1038/nm1108; Zenewicz LA, 2013, J IMMUNOL, V190, P5306, DOI 10.4049/jimmunol.1300016; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	68	23	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0134698	10.1371/journal.pone.0134698	http://dx.doi.org/10.1371/journal.pone.0134698			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285207	Green Published, gold, Green Submitted			2022-12-26	WOS:000359666100015
J	Okoche, D; Asiimwe, BB; Katabazi, FA; Kato, L; Najjuka, CF				Okoche, Deogratius; Asiimwe, Benon B.; Katabazi, Fred Ashaba; Kato, Laban; Najjuka, Christine F.			Prevalence and Characterization of Carbapenem-Resistant Enterobacteriaceae Isolated from Mulago National Referral Hospital, Uganda	PLOS ONE			English	Article							MODIFIED HODGE TEST; KLEBSIELLA-PNEUMONIAE; SPREAD	Introduction Carbapenemases have increasingly been reported in enterobacteriaceae worldwide. Most carbapenemases are plasmid encoded hence resistance can easily spread. Carbapenem-resistant enterobacteriaceae are reported to cause mortality in up to 50% of patients who acquire bloodstream infections. We set out to determine the burden of carbapenem resistance as well as establish genes encoding for carbapenemases in enterobacteriaceae clinical isolates obtained from Mulago National Referral Hospital, Uganda. Methods This was a cross-sectional study with a total of 196 clinical isolates previously collected from pus swabs, urine, blood, sputum, tracheal aspirates, cervical swabs, endomentrial aspirates, rectal swabs, Vaginal swabs, ear swabs, products of conception, wound biopsy and amniotic fluid. All isolates were subjected to phenotypic carbapenemase screening using Boronic acid-based inhibition, Modified Hodge and EDTA double combined disk test. In addition, all the isolates were subjected to PCR assay to confirm presence of carbapenemase encoding genes. Results The study found carbapenemase prevalence of 22.4%(44/196) in the isolates using phenotypic tests, with the genotypic prevalence slightly higher at 28.6% (56/196). Over all, the most prevalent gene was blaVIM (21,10.7%), followed by blaOXA-48 (19, 9.7%), blaIMP (12, 6.1%), blaKPC (10, 5.1%) and blaNDM-1 (5, 2.6%). Among 56 isolates positive for 67 carbapenemase encoding genes, Klebsiella pneumonia was the species with the highest number (52.2%). Most 32/67(47.7%) of these resistance genes were in bacteria isolated from pus swabs. Conclusion There is a high prevalence of carbapenemases and carbapenem-resistance encoding genes among third generation cephalosporins resistant Enterobacteriaceae in Uganda, indicating a danger of limited treatment options in this setting in the near future.	[Okoche, Deogratius; Asiimwe, Benon B.; Katabazi, Fred Ashaba; Kato, Laban; Najjuka, Christine F.] Makerere Univ, Coll Hlth Sci, Dept Med Microbiol, Kampala, Uganda	Makerere University	Najjuka, CF (corresponding author), Makerere Univ, Coll Hlth Sci, Dept Med Microbiol, Kampala, Uganda.	najjukafc@gmail.com			BBA	BBA	DO was a student supported by BBA. The authors received no specific funding for this work.	Bratu S, 2005, ARCH INTERN MED, V165, P1430, DOI 10.1001/archinte.165.12.1430; Brink AJ, 2012, J CLIN MICROBIOL, V50, P525, DOI 10.1128/JCM.05956-11; Carvalhaes CG, 2010, J ANTIMICROB CHEMOTH, V65, P249, DOI 10.1093/jac/dkp431; Cockerill FR, 2011, CLSI PERFORMANCE STA; Coetzee J., 2011, Southern African Journal of Epidemiology & Infection, V26, P239; Doumith M, 2009, J ANTIMICROB CHEMOTH, V63, P659, DOI 10.1093/jac/dkp029; Ehrhard I, 2014, BUNDESGESUNDHEITSBLA, V57, P406, DOI 10.1007/s00103-013-1914-z; El Wartiti MA, 2012, INT ARAB J ANTIMICRO, V2, P1, DOI [10.3823/718, DOI 10.3823/718]; Girlich D, 2012, J CLIN MICROBIOL, V50, P477, DOI 10.1128/JCM.05247-11; Gwimile JJ, 2012, PAN AFR MED J, V12; Hu L, 2014, EPIDEMIOL INFECT, V142, P1972, DOI 10.1017/S0950268813002975; Huang TD, 2014, J ANTIMICROB CHEMOTH, V69, P445, DOI 10.1093/jac/dkt367; Karuniawati Anis, 2013, Acta Med Indones, V45, P101; Khosravi Y, 2012, SCI WORLD J, DOI 10.1100/2012/654939; KNOTHE H, 1983, INFECTION, V11, P315, DOI 10.1007/BF01641355; Miriagou V, 2010, CLIN MICROBIOL INFEC, V16, P112, DOI 10.1111/j.1469-0691.2009.03116.x; Miro E, 2013, EUR J CLIN MICROBIOL, V32, P253, DOI 10.1007/s10096-012-1737-0; Moquet O, 2011, EMERG INFECT DIS, V17, P143, DOI [10.3201/eid1701.100224, 10.3201/eid1701.100244]; Mukonzo JK, 2013, J MULTIDISCIP HEALTH, V6, P303, DOI 10.2147/JMDH.S49075; Mushi MF, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/303104; Nagdeo Neena V., 2012, CHRONICLES OF YOUNG, V3, P292; Nordmann P, 2012, CLIN MICROBIOL INFEC, V18, P432, DOI 10.1111/j.1469-0691.2012.03815.x; Nordmann P, 2012, TRENDS MOL MED, V18, P263, DOI 10.1016/j.molmed.2012.03.003; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Pasteran F, 2009, J CLIN MICROBIOL, V47, P1631, DOI 10.1128/JCM.00130-09; Paterson DL, 2006, AM J MED, V119, pS20, DOI 10.1016/j.amjmed.2006.03.013; Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P934, DOI 10.1128/AAC.01247-10; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Spyros Pournaras, 2010, J ANTIMICROB CHEMOTH, P1; Tian BY, 2012, MBIO, V3, DOI 10.1128/mBio.00377-12; Tsakris A, 2008, J ANTIMICROB CHEMOTH, V62, P1257, DOI 10.1093/jac/dkn364; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09; Yusuf I., 2012, BAJOPAS, V5, P84	33	63	70	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135745	10.1371/journal.pone.0135745	http://dx.doi.org/10.1371/journal.pone.0135745			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284519	Green Published, Green Submitted, gold			2022-12-26	WOS:000359666100065
J	Palma, G; Tedeschi, E; Borrelli, P; Cocozza, S; Russo, C; Liu, SF; Ye, YQ; Comerci, M; Alfano, B; Salvatore, M; Haacke, EM; Mancini, M				Palma, Giuseppe; Tedeschi, Enrico; Borrelli, Pasquale; Cocozza, Sirio; Russo, Carmela; Liu, Saifeng; Ye, Yongquan; Comerci, Marco; Alfano, Bruno; Salvatore, Marco; Haacke, E. Mark; Mancini, Marcello			A Novel Multiparametric Approach to 3D Quantitative MRI of the Brain	PLOS ONE			English	Article							T-1; TISSUE; QUANTIFICATION; RELAXOMETRY; RELAXATION; TIME	Magnetic Resonance properties of tissues can be quantified in several respects: relaxation processes, density of imaged nuclei, magnetism of environmental molecules, etc. In this paper, we propose a new comprehensive approach to obtain 3D high resolution quantitative maps of arbitrary body districts, mainly focusing on the brain. The theory presented makes it possible to map longitudinal (R-1), pure transverse (R-2) and free induction decay (R-2*) rates, along with proton density (PD) and magnetic susceptibility (chi), from a set of fast acquisition sequences in steady-state that are highly insensitive to flow phenomena. A novel denoising scheme is described and applied to the acquired datasets to enhance the signal to noise ratio of the derived maps and an information theory approach compensates for biases from radio frequency (RF) inhomogeneities, if no direct measure of the RF field is available. Finally, the results obtained on sample brain scans of healthy controls and multiple sclerosis patients are presented and discussed.	[Palma, Giuseppe; Comerci, Marco; Alfano, Bruno; Mancini, Marcello] CNR, Inst Biostruct & Bioimaging, Naples, Italy; [Tedeschi, Enrico; Cocozza, Sirio; Russo, Carmela] Univ Naples Federico II, Dept Adv Biomed Sci, Naples, Italy; [Borrelli, Pasquale; Salvatore, Marco] IRCCS SDN, Naples, Italy; [Liu, Saifeng] MRI Inst Biomed Res, Waterloo, ON, Canada; [Ye, Yongquan; Haacke, E. Mark] Wayne State Univ, Dept Radiol, Detroit, MI USA; [Haacke, E. Mark] MRI Inst Biomed Res, Detroit, MI USA	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); University of Naples Federico II; IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN); Wayne State University	Palma, G (corresponding author), CNR, Inst Biostruct & Bioimaging, Naples, Italy.	giuseppe.palma@ibb.cnr.it	Russo, Carmela/AAA-3193-2022; Borrelli, Pasquale/H-7493-2016; Palma, Giuseppe/GXV-0228-2022; Palma, Giuseppe/AAX-1413-2020; Tedeschi, Enrico/AAN-7112-2020; Cocozza, Sirio/ABD-1161-2020; Borrelli, Pasquale/N-4880-2019; Liu, Saifeng/I-1242-2019; Salvatore, Marco/K-8083-2016	Borrelli, Pasquale/0000-0002-9299-9661; Palma, Giuseppe/0000-0002-0210-268X; Tedeschi, Enrico/0000-0002-0511-0132; Cocozza, Sirio/0000-0002-0300-5160; Borrelli, Pasquale/0000-0002-9299-9661; Salvatore, Marco/0000-0001-9734-7702; Alfano, Bruno/0000-0002-7315-3628; Russo, Carmela/0000-0003-1855-7571; Liu, Saifeng/0000-0002-3642-8282	Italian Ministry of Education, University and Research (MIUR), within the PRIN framework [2010XE5L2R]; Canadian Institutes of Health Research (CIHR)/Heart and Stroke Foundation of Canada (HSFC) Synchrotron Medical Imaging Team Grant [CIF 99472]	Italian Ministry of Education, University and Research (MIUR), within the PRIN framework(Ministry of Education, Universities and Research (MIUR)); Canadian Institutes of Health Research (CIHR)/Heart and Stroke Foundation of Canada (HSFC) Synchrotron Medical Imaging Team Grant(Canadian Institutes of Health Research (CIHR))	This study has been supported by the Italian Ministry of Education, University and Research (MIUR), within the PRIN framework (2010XE5L2R) and by the Canadian Institutes of Health Research (CIHR)/Heart and Stroke Foundation of Canada (HSFC) Synchrotron Medical Imaging Team Grant #CIF 99472.	Abdul-Rahman HS, 2007, APPL OPTICS, V46, P6623, DOI 10.1364/AO.46.006623; Bjork M, 2011, EUR SIGNAL PR CONF, P1000; Bjork M, 2014, MAGN RESON MED, V72, P880, DOI 10.1002/mrm.24986; Bonnier G, 2014, ANN CLIN TRANSL NEUR, V1, P423, DOI 10.1002/acn3.68; Borrelli Pasquale, 2014, 2014 IEEE International Conference on Acoustics, Speech and Signal Processing (ICASSP), P1230, DOI 10.1109/ICASSP.2014.6853793; Borrelli P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126835; Brown RW, 2014, MAGNETIC RESONANCE I, DOI 10.1002/9781118633953.ch18; Chavhan GB, 2008, RADIOGRAPHICS, V28, P1147, DOI 10.1148/rg.284075031; Deoni SCL, 2005, MAGN RESON MED, V53, P237, DOI 10.1002/mrm.20314; Deoni SCL, 2003, MAGNET RESON MED, V49, P515, DOI 10.1002/mrm.10407; Deoni Sean C L, 2010, Top Magn Reson Imaging, V21, P101, DOI 10.1097/RMR.0b013e31821e56d8; Deoni SCL, 2009, J MAGN RESON IMAGING, V30, P411, DOI 10.1002/jmri.21849; Deoni SCL, 2008, MAGN RESON MED, V60, P1372, DOI 10.1002/mrm.21704; Draganski B, 2011, NEUROIMAGE, V55, P1423, DOI 10.1016/j.neuroimage.2011.01.052; Haacke EM, 2015, MAGN RESON IMAGING, V33, P1, DOI 10.1016/j.mri.2014.09.004; Haacke EM, 2011, SUSCEPTIBILITY WEIGH; Hanicke W, 2003, MAGN RESON MED, V49, P771, DOI 10.1002/mrm.10410; Heule R, 2014, NMR BIOMED, V27, P1037, DOI 10.1002/nbm.3152; Heule R, 2014, MAGN RESON MED, V71, P230, DOI 10.1002/mrm.24659; Li L, 2001, J MAGN RESON, V148, P442, DOI 10.1006/jmre.2000.2267; Neeb H, 2012, NEUROIMAGE-CLIN, V1, P121, DOI 10.1016/j.nicl.2012.09.013; Neema M, 2009, NEUROIMAGE, V46, P633, DOI 10.1016/j.neuroimage.2009.03.001; Palma G, 2012, US Patent App, Patent No. [13/409,953, 13409953]; Palma G, 2013, FED CONF COMPUT SCI, P495; Schweser F, 2011, NEUROIMAGE, V54, P2789, DOI 10.1016/j.neuroimage.2010.10.070; Sirignano C, 2012, EUR C RADIOLOGY; Soscia E, 2011, EUR C RADIOLOGY; Stanisz GJ, 2005, MAGNET RESON MED, V54, P507, DOI 10.1002/mrm.20605; Tofts P, 2005, QUANTITATIVE MRI BRA; Warnties JBM, 2008, MAGN RESON MED, V60, P320, DOI 10.1002/mrm.21635; Warntjes JBM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070864; Weiskopf N, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00095; West JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066212; Wright PJ, 2008, MAGN RESON MATER PHY, V21, P121, DOI 10.1007/s10334-008-0104-8; ZUR Y, 1990, MAGNET RESON MED, V16, P444, DOI 10.1002/mrm.1910160311	35	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0134963	10.1371/journal.pone.0134963	http://dx.doi.org/10.1371/journal.pone.0134963			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284778	Green Submitted, Green Published, gold			2022-12-26	WOS:000359666100019
J	Chieffo, D; Brogna, C; Berardinelli, A; D'Angelo, G; Mallardi, M; D'Amico, A; Alfieri, P; Mercuri, E; Pane, M				Chieffo, Daniela; Brogna, Claudia; Berardinelli, Angela; D'Angelo, Grazia; Mallardi, Maria; D'Amico, Adele; Alfieri, Paolo; Mercuri, Eugenio; Pane, Marika			Early Neurodevelopmental Findings Predict School Age Cognitive Abilities in Duchenne Muscular Dystrophy: A Longitudinal Study	PLOS ONE			English	Article							MENTAL RETARDATION; BOYS; INTELLIGENCE; ASSOCIATION; DISORDER	Objective Neurodevelopmental and cognitive difficulties are known to occur frequently in boys with Duchenne muscular dystrophy but so far none of the published studies have reported both early neurodevelopmental assessments and cognitive tests in the same cohort. The aim of the present longitudinal study was to establish the correlation between early neurodevelopmental assessments performed in preschool boys and the cognitive scales performed at school age or later. Methods We performed cognitive tests at school age (mean age 5.7 year +/- 1.7 SD) (69 months+ 19 SD) in a cohort of Duchenne boys, previously assessed using the Griffiths scales before the age of 4 years (mean age when the Griffiths scales were performed 30 months +/- 8.9 SD). Results The range of total Developmental quotients on the Griffiths ranged between 56 and 116 (mean 89 +/- 15.6 SD). The total Intelligence Quotients on the Wechsler scales ranged between 35 and 119 (mean 87 +/- 17.2 SD). There was a significant correlation between the findings on the two scales. P = <0.0001. When we subdivided the cohort according to site of mutations, there was a difference between boys with mutations upstream exon 44 and those with mutations in exon 44-45 affecting Dp140 on both Developmental and Intelligence Quotient (p 0.01 and p 0,003 respectively). Conclusions Our results confirm that Duchenne boys tend to slightly underperform on both neurodevelopmental and cognitive assessments. Early neurodevelopmental findings correlated with the cognitive results obtained at school age with a clear concordance between subscales exploring similar domains on the two scales.	[Chieffo, Daniela; Brogna, Claudia; Mallardi, Maria; Mercuri, Eugenio; Pane, Marika] Univ Cattolica Sacro Cuore, Dept Paediat Neurol, Rome, Italy; [Berardinelli, Angela] C Mondino Fdn, Child Neurol & Psychiat Unit, Pavia, Italy; [D'Angelo, Grazia] IRCCS Eugenio Medea, Bosisio Parini, Italy; [D'Amico, Adele] Bambino Gesu Pediat Hosp, Unit Neuromuscular & Neurodegenerat Disorders, Dept Neurosci, Rome, Italy; [Alfieri, Paolo] Bambino Gesu Pediat Hosp, Child & Adolescence Neuropsychiat Unit, Dept Neurosci, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Fondazione Casimiro Mondino; IRCCS Eugenio Medea; IRCCS Bambino Gesu; IRCCS Bambino Gesu	Mercuri, E (corresponding author), Univ Cattolica Sacro Cuore, Dept Paediat Neurol, Rome, Italy.	mercuri@rm.unicatt.it	Berardinelli, angela/AAA-9496-2019; d'amico, adele/J-9203-2016; Mercuri, Eugenio/G-1351-2015; D'Angelo, Maria Grazia/K-4685-2016; BROGNA, Claudia/K-9759-2016	d'amico, adele/0000-0003-2438-2624; Mercuri, Eugenio/0000-0002-9851-5365; berardinelli, angela/0000-0002-4645-8055; Pane, Marika/0000-0002-4851-6124; D'Angelo, Maria Grazia/0000-0003-1241-4350; BROGNA, Claudia/0000-0002-9526-6367	Telethon UILDM grant [GUP 11002]	Telethon UILDM grant(Fondazione Telethon)	The study is supported by Telethon UILDM grant (GUP 11002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN JE, 1960, AM J DIS CHILD, V100, P208, DOI 10.1001/archpedi.1960.04020040210008; COHEN HJ, 1968, DEV MED CHILD NEUROL, V10, P754; Connolly AM, 2014, PEDIATR NEUROL, V50, P557, DOI 10.1016/j.pediatrneurol.2014.02.006; Cotton S, 2001, DEV MED CHILD NEUROL, V43, P497, DOI 10.1017/S0012162201000913; Cotton SM, 2005, DEV MED CHILD NEUROL, V47, P257, DOI 10.1017/S0012162205000496; Cyrulnik SE, 2007, J PEDIAT, V150, P456; Cyrulnik SE, 2008, NEUROSCI BIOBEHAV R, V32, P486, DOI 10.1016/j.neubiorev.2007.09.001; DORMAN C, 1988, DEV MED CHILD NEUROL, V30, P316, DOI 10.1111/j.1469-8749.1988.tb14556.x; DUBOWITZ V, 1965, ARCH DIS CHILD, V40, P296, DOI 10.1136/adc.40.211.296; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; Griffiths R., 1996, GRIFFITHS MENTAL DEV; Griffiths R, 1984, ABILITIES YOUNG CHIL, P21; Hinton VJ, 2007, J AUTISM DEV DISORD, V37, P1925, DOI 10.1007/s10803-006-0325-5; Hinton V J, 2004, Learn Disabil Res Pract, V19, P146, DOI 10.1111/j.1540-5826.2004.00098.x; Hinton VJ, 2000, NEUROLOGY, V54, P2127, DOI 10.1212/WNL.54.11.2127; LEIBOWITZ D, 1981, DEV MED CHILD NEUROL, V23, P577; Magri F, 2011, J NEUROL, V258, P1610, DOI 10.1007/s00415-011-5979-z; MILLER G, 1993, PEDIATR NEUROL, V9, P3, DOI 10.1016/0887-8994(93)90002-T; Muntoni F, 2003, DUCHENNE MUSCULAR DY; Pane M, 2013, NEUROMUSCULAR DISORD, V23, P451, DOI 10.1016/j.nmd.2013.02.012; Pane M, 2012, J PEDIATR-US, V161, P705, DOI 10.1016/j.jpeds.2012.03.020; Picone L, 2006, WISC 3 WECHSL INT SC; [Primary Scale of Intelligence Wechsler Preschool], 1989, WECHSL PRESCH PRIM S; PROSSER EJ, 1969, ARCH DIS CHILD, V44, P221, DOI 10.1136/adc.44.234.221; Ricotti V, 2011, DEV MED CHILD NEUROL, V53, P12, DOI 10.1111/j.1469-8749.2010.03836.x; Sivo S, 2014, NEUROMUSCUL DISORD; Snow WM, 2013, NEUROSCI BIOBEHAV R, V37, P743, DOI 10.1016/j.neubiorev.2013.03.016; Wechsler D, 1991, WISC 3 WECHSL INT SC; WORDEN DK, 1962, PEDIATRICS, V29, P968	29	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0133214	10.1371/journal.pone.0133214	http://dx.doi.org/10.1371/journal.pone.0133214			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275215	Green Submitted, gold, Green Published			2022-12-26	WOS:000359493600010
J	Virard, F; Cousty, S; Cambus, JP; Valentin, A; Kemoun, P; Clement, F				Virard, Francois; Cousty, Sarah; Cambus, Jean-Pierre; Valentin, Alexis; Kemoun, Philippe; Clement, Franck			Cold Atmospheric Plasma Induces a Predominantly Necrotic Cell Death via the Microenvironment	PLOS ONE			English	Article							DIELECTRIC BARRIER DISCHARGE; REACTIVE OXYGEN; APOPTOSIS; DNA	Introduction Cold plasma is a partially ionized gas generated by an electric field at atmospheric pressure that was initially used in medicine for decontamination and sterilization of inert surfaces. There is currently growing interest in using cold plasma for more direct medical applications, mainly due to the possibility of tuning it to obtain selective biological effects in absence of toxicity for surrounding normal tissues,. While the therapeutic potential of cold plasma in chronic wound, blood coagulation, and cancer treatment is beginning to be documented, information on plasma/cell interaction is so far limited and controversial. Methods and Results Using normal primary human fibroblast cultures isolated from oral tissue, we sought to decipher the effects on cell behavior of a proprietary cold plasma device generating guided ionization waves carried by helium. In this model, cold plasma treatment induces a predominantly necrotic cell death. Interestingly, death is not triggered by a direct interaction of the cold plasma with cells, but rather via a transient modification in the microenvironment. We show that modification of the microenvironment redox status suppresses treatment toxicity and protects cells from death. Moreover, necrosis is not accidental and seems to be an active response to an environmental cue, as its execution can be inhibited to rescue cells. Conclusion These observations will need to be taken into account when studying in vitro plasma/cell interaction and may have implications for the design and future evaluation of the efficacy and safety of this new treatment strategy.	[Virard, Francois] Univ Lyon 1, Ctr Rech Cancerol Lyon, UCBL, UMR5286,CNRS,INSERM, F-69365 Lyon, France; [Virard, Francois] Univ Lyon 1, Fac Odontol Lyon, F-69365 Lyon, France; [Cousty, Sarah; Kemoun, Philippe] Univ Toulouse 3, Fac Chirurg Dentaire Toulouse, F-31062 Toulouse, France; [Cousty, Sarah; Cambus, Jean-Pierre; Valentin, Alexis; Kemoun, Philippe] CHU Toulouse, Toulouse, France; [Cambus, Jean-Pierre] Hop Rangueil, Lab Hematol, TSA 50032, Toulouse, France; [Valentin, Alexis] Univ Toulouse 3, Fac Pharm, UMR IRD UPS PHARMA DEV 152, F-31062 Toulouse, France; [Clement, Franck] Univ Pau & Pays Adour, LCABIE IPREM, UMR 5254, Pau, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Pau et des Pays de l'Adour	Kemoun, P (corresponding author), Univ Toulouse 3, Fac Chirurg Dentaire Toulouse, F-31062 Toulouse, France.	philippe.kemoun@univ-tlse3.fr	VIRARD, francois/Y-1839-2019; Cousty, Sarah/AGZ-6395-2022; Valentin, Alexis/I-6821-2015	VIRARD, francois/0000-0001-7570-1088; Cousty, Sarah/0000-0003-4077-2796; Valentin, Alexis/0000-0002-2133-112X; KEMOUN, PHILIPPE/0000-0001-7373-2657	French National Research Agency [ANR-10-BLAN-0950, ANR-12-BSV5-0006]; ANR	French National Research Agency(French National Research Agency (ANR)); ANR(French National Research Agency (ANR))	The French National Research Agency 1 - PLASMAVIV ANR-10-BLAN-0950 http://www.agence-nationale-recherche.fr/en/anr-funded-project/?tx_lwmsuivibilan_pi2%5BCODE%5D=ANR-10-BLAN-0950 Understanding of the interaction mechanisms between plasma produced atomic nitrogen and living matter FC UPPA-IPREM : LCABIE UNIVERSITE DE PAU ET DES PAYS DE L'ADOUR 2- PLASMINF ANR-12-BSV5-0006 http://www.agence-nationale-recherche.fr/en/anr-funded-project/?tx_lwmsuivibilan_pi2%5BCODE%5D=ANR-12-BSV5-0006 Plasma gas for infectious diseases and inflammation FC; AV ANR funded project Calls for proposals Bookmark & Share Blanc - SVSE 5 - Physique, chimie du vivant et innovations biotechnologiques (Blanc SVSE 5) Edition 2012 PlasmInf Plasma gas for infectious diseases and inflammation Use of a physic process, plasma gas, for the treatment of infectious diseases The use of plasma gas (physical process without toxic chemical inputs) for the treatment of inflammatory or infectious diseases is here studied to understand its mechanisms of action on infectious targets. Understanding its mechanisms should allow for this very new process in medicine, a controlled tool. plasma gas as a treatment without chemical inputs PLASMINF aims to analyze the interactions and modes of action of bio-compatible plasma models on living targets. Understanding how plasma at the cellular level is expected in order to extend their applications to various diseases and, in some cases, opening the possibility to get rid of expensive chemical treatments, potentially toxic, or low effective because the development of resistance of some bacteria or cells. The potential gains in terms of savings are difficult to quantify so far, but it seems reasonable to assume that physical technique, potentially minimally invasive will greatly reduce some adverse effects of chemotherapy currently used in medicine Activity of plasma on cellular targets The purpose, here is to understand, through the use of techniques of cellular biology (imaging) and molecular biology (amplification of some mesengers) cellular and nuclear changes induced in the cells by the plasma gas. This understanding should guide the response of the body, depending on the desired effects (inflammation or repair) with a non-intrusive process, the plasma gas Resultats Undeveloped, the project was initiated six months ago. Perspectives Undeveloped Productions scientifiques et brevets undeveloped PARTENAIRES Pharma-DEV UMR 152 IRD-UPS Pharmacochimie et pharmacologie pour le developpement IPREM / UMR 5254 / LCABIE Universite de Pau et des Pays de l'Adour The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Ahn HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086173; Aichelmann-Reidy ME, 2008, J PERIODONTOL, V79, P387, DOI 10.1902/jop.2008.060521 ; Bedner E, 2001, CYTOMETRY, V43, P38, DOI 10.1002/1097-0320(20010101)43:1<38::AID-CYTO1017>3.0.CO;2-S; Boeuf JP, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/1/015201; Chang JW, 2014, ARCH BIOCHEM BIOPHYS, V545, P133, DOI 10.1016/j.abb.2014.01.022; Chapple ILC, 2007, PERIODONTOL 2000, V43, P160, DOI 10.1111/j.1600-0757.2006.00178.x; Dobrynin D, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115020; Dudek D, 2007, J PHYS D APPL PHYS, V40, P7367, DOI 10.1088/0022-3727/40/23/017; Foster B L, 2005, Orthod Craniofac Res, V8, P285, DOI 10.1111/j.1601-6343.2005.00351.x; Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154; Fridman G, 2007, PLASMA CHEM PLASMA P, V27, P163, DOI 10.1007/s11090-007-9048-4; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Gazeli K, 2015, J APPL PHYS, V117, DOI 10.1063/1.4914035; Gazeli K, 2013, PLASMA SOURCES SCI T, V22, DOI 10.1088/0963-0252/22/2/025020; Gazeli K., 2012, 19 INT C GAS DISCH T, V38; Hong YC, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2400078; Jarrige J, 2010, PLASMA SOURCES SCI T, V19, DOI 10.1088/0963-0252/19/6/065005; Joh HM, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4742742; Kalghatgi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016270; Kang SU, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.33; Kemoun P, 2011, BIOMATERIALS, V32, P7375, DOI 10.1016/j.biomaterials.2011.06.043; Kieft IE, 2006, IEEE T PLASMA SCI, V34, P1331, DOI 10.1109/TPS.2006.876511; Kim SJ, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3462293; Kroemer G, 2013, ANNU REV IMMUNOL, V31, P51, DOI 10.1146/annurev-immunol-032712-100008; Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001; Laroussi M, 2004, J APPL PHYS, V96, P3028, DOI 10.1063/1.1777392; Lee HJ, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115026; Lockshin RA, 2001, NAT REV MOL CELL BIO, V2, P545, DOI 10.1038/35080097; Lu X, 2014, PHYS REP, V540, P123, DOI 10.1016/j.physrep.2014.02.006; Lu XP, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2912524; Lunov O, 2014, SCI REP-UK, V4, DOI 10.1038/srep07129; Ma YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091947; Marchetti C, 2002, HUM REPROD, V17, P1257, DOI 10.1093/humrep/17.5.1257; Mericam-Bourdet N, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/5/055207; Panngom K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.168; Reuter S, 2012, PLASMA SOURCES SCI T, V21, DOI 10.1088/0963-0252/21/3/034015; Robert E, 2012, PLASMA SOURCES SCI T, V21, DOI 10.1088/0963-0252/21/3/034017; Ryu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066231; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Srivastava N, 2011, IEEE T PLASMA SCI, V39, P918, DOI 10.1109/TPS.2010.2101618; Stoffels E, 2003, J PHYS D APPL PHYS, V36, P2908, DOI 10.1088/0022-3727/36/23/007; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; van Gils CAJ, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/17/175203; Vandamme M, 2012, INT J CANCER, V130, P2185, DOI 10.1002/ijc.26252; Vanden Berghe T, 2014, NAT REV MOL CELL BIO, V15, P134, DOI 10.1038/nrm3737; Walsh JL, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2817965; Weltmann KD, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/19/194008; Xiong Q, 2013, PLASMA SOURCES SCI T, V22, DOI 10.1088/0963-0252/22/1/015011; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	49	38	38	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0133120	10.1371/journal.pone.0133120	http://dx.doi.org/10.1371/journal.pone.0133120			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275141	gold, Green Published, Green Submitted			2022-12-26	WOS:000359493600009
J	Jakobson, CM; Kim, EY; Slininger, MF; Chien, A; Tullman-Ercek, D				Jakobson, Christopher M.; Kim, Edward Y.; Slininger, Marilyn F.; Chien, Alex; Tullman-Ercek, Danielle			Localization of Proteins to the 1,2-Propanediol Utilization Microcompartment by Non-native Signal Sequences Is Mediated by a Common Hydrophobic Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTERICA SEROVAR TYPHIMURIUM; IMPROVED CATALYTIC EFFICIENCY; BACTERIAL MICROCOMPARTMENT; SALMONELLA-TYPHIMURIUM; TRANSCRIPTIONAL ACTIVATOR; ETHANOLAMINE UTILIZATION; SHELL PROTEINS; EUT OPERON; DEGRADATION; ENZYMES	Various bacteria localize metabolic pathways to proteinaceous organelles known as bacterial microcompartments (MCPs), enabling the metabolism of carbon sources to enhance survival and pathogenicity in the gut. There is considerable interest in exploiting bacterial MC:Ps for metabolic engineering applications, but little is known about the interactions between MCP signal sequences and the protein shells of different MCP systems. We found that the N-terminal sequences from the ethanolamine utilization (Eut) and glycyl radical-generating protein NICPs are able to target reporter proteins to the 1,2-propanediol utilization (Pdu) MCP, and that this localization is mediated by a conserved hydrophobic residue motif. Recapitulation of this motif by the addition of a single amino acid conferred targeting function on an N-terminal sequence from the ethanol utilization MCP system that previously did not act as a Pdu signal sequence. Moreover, the Pdu-localized signal sequences competed with native Pdu targeting sequences for encapsulation in the Pdu MCP. Salmonella enterica natively possesses both the Pdu and Eut operons, and our results suggest that Eut proteins might be localized to the Pdu MCP in vivo. We further demonstrate that S. enterica I,T2 retained the ability to grow on 1,2propanediol as the sole carbon source when a Pdu enzyme was replaced with its Eut homolog. Although the relevance of this finding to the native system remains to be explored, we show that the Pdu-localized signal sequences described herein allow control over the ratio of heterologous proteins encapsulated within Pdu MCPs.	[Jakobson, Christopher M.; Kim, Edward Y.; Slininger, Marilyn F.; Tullman-Ercek, Danielle] Univ Calif Berkeley, Dept Chem & Biomol Engn, 116 Gilman Hall, Berkeley, CA 94720 USA; [Chien, Alex] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Tullman-Ercek, D (corresponding author), Univ Calif Berkeley, Dept Chem & Biomol Engn, 116 Gilman Hall, Berkeley, CA 94720 USA.	dtercek@berkeley.edu	Tullman-Ercek, Danielle/L-2792-2016		National Science Foundation [1150567]; Army Research Office [W911NF-15-1-0144]; University of California Berkeley; Direct For Biological Sciences [1150567] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Army Research Office; University of California Berkeley(University of California System); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grant 1150567 (to C. M. J., E. Y. K., M. F. S., and D. T.-E.), Army Research Office Grant W911NF-15-1-0144 (to D. T.-E.), and a University of California Berkeley fellowship (to C. M. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Aussignargues Clement, 2015, Commun Integr Biol, V8, pe1039755, DOI 10.1080/19420889.2015.1039755; Axen SD, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003898; Bertin Y, 2011, ENVIRON MICROBIOL, V13, P365, DOI 10.1111/j.1462-2920.2010.02334.x; BOBIK TA, 1992, J BACTERIOL, V174, P2253, DOI 10.1128/JB.174.7.2253-2266.1992; Bobik TA, 1999, J BACTERIOL, V181, P5967, DOI 10.1128/JB.181.19.5967-5975.1999; CHEN P, 1995, J BACTERIOL, V177, P5401, DOI 10.1128/jb.177.19.5401-5410.1995; Cheng SQ, 2011, J BACTERIOL, V193, P1385, DOI 10.1128/JB.01473-10; Choudhary S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033342; Chowdhury C, 2015, P NATL ACAD SCI USA, V112, P2990, DOI 10.1073/pnas.1423672112; Conrado RJ, 2007, METAB ENG, V9, P355, DOI 10.1016/j.ymben.2007.05.002; Conrado RJ, 2012, NUCLEIC ACIDS RES, V40, P1879, DOI 10.1093/nar/gkr888; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Datta S, 2006, GENE, V379, P109, DOI 10.1016/j.gene.2006.04.018; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Erbilgin O, 2014, APPL ENVIRON MICROB, V80, P2193, DOI 10.1128/AEM.03887-13; Fan CG, 2012, P NATL ACAD SCI USA, V109, P14995, DOI 10.1073/pnas.1207516109; Fan CG, 2011, J BACTERIOL, V193, P5623, DOI 10.1128/JB.05661-11; Fan CG, 2010, P NATL ACAD SCI USA, V107, P7509, DOI 10.1073/pnas.0913199107; Heldt D, 2009, BIOCHEM J, V423, P199, DOI 10.1042/BJ20090780; Huseby DL, 2013, J BACTERIOL, V195, P2864, DOI 10.1128/JB.02179-12; Jorda J, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004067; Jorda J, 2013, PROTEIN SCI, V22, P179, DOI 10.1002/pro.2196; Kerfeld CA, 2015, TRENDS MICROBIOL, V23, P22, DOI 10.1016/j.tim.2014.10.003; Kim EY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113814; Kim EY, 2014, BIOTECHNOL J, V9, P348, DOI 10.1002/biot.201300391; Kofoid E, 1999, J BACTERIOL, V181, P5317, DOI 10.1128/JB.181.17.5317-5329.1999; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lassila JK, 2014, J MOL BIOL, V426, P2217, DOI 10.1016/j.jmb.2014.02.025; Lawrence AD, 2014, ACS SYNTH BIOL, V3, P454, DOI 10.1021/sb4001118; Leal NA, 2003, ARCH MICROBIOL, V180, P353, DOI 10.1007/s00203-003-0601-0; Lee H, 2012, METAB ENG, V14, P242, DOI 10.1016/j.ymben.2011.09.003; Pang A, 2014, J BIOL CHEM, V289, P22377, DOI 10.1074/jbc.M114.569285; Pang A, 2012, ACTA CRYSTALLOGR D, V68, P1642, DOI 10.1107/S0907444912039315; Rondon MR, 1996, J BACTERIOL, V178, P2196, DOI 10.1128/jb.178.8.2196-2203.1996; ROOF DM, 1992, J BACTERIOL, V174, P6634, DOI 10.1128/JB.174.20.6634-6643.1992; Sachdeva G, 2014, NUCLEIC ACIDS RES, V42, P9493, DOI 10.1093/nar/gku617; Sampson EM, 2008, J BACTERIOL, V190, P2966, DOI 10.1128/JB.01925-07; SHEPPARD DE, 1994, J BACTERIOL, V176, P1287, DOI 10.1128/jb.176.5.1287-1296.1994; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sinha S, 2012, J BACTERIOL, V194, P1912, DOI 10.1128/JB.06529-11; Srikumar S, 2011, APPL ENVIRON MICROB, V77, P281, DOI 10.1128/AEM.01403-10; Temme K, 2008, J MOL BIOL, V377, P47, DOI 10.1016/j.jmb.2007.12.044; Thompson MC, 2014, ACTA CRYSTALLOGR F, V70, P1584, DOI 10.1107/S2053230X1402158X	45	35	37	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24519	24533		10.1074/jbc.M115.651919	http://dx.doi.org/10.1074/jbc.M115.651919			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26283792	Green Published, hybrid			2022-12-26	WOS:000362218900037
J	Guo, YW; Wu, YQ; Anderson, JA; Moss, JQ; Zhu, L				Guo, Yuanwen; Wu, Yanqi; Anderson, Jeff A.; Moss, Justin Q.; Zhu, Lan			Disomic Inheritance and Segregation Distortion of SSR Markers in Two Populations of Cynodon dactylon (L.) Pers. var. dactylon	PLOS ONE			English	Article							LINKAGE MAP; DIVERSITY; AFLP	Common bermudagrass [C. dactylon (L.) Pers. var. dactylon] is economically and environmentally the most important member among Cynodon species because of its extensive use for turf, forage and soil erosion control in the world. However, information regarding the inheritance within the taxon is limited. Accordingly, the objective of this study was to determine qualitative inheritance mode in common bermudagrass. Two tetraploid (2n = 4x = 36), first-generation selfed (S1) populations, 228 progenies of 'Zebra' and 273 from A12359, were analyzed for segregation with 21 and 12 simple sequence repeat (SSR) markers, respectively. It is concluded that the inheritance mode of tetraploid bermudagrass was complete or near complete disomic. It is evident that the two bermudagrass parents had an allotetraploid genome with two distinct subgenomes since 33 SSR primer pairs amplified 34 loci, each having two alleles. Severe transmission ratio distortions occurred in the Zebra population while less so in the A12359 population. The findings of disomic inheritance and segregation ratio distortion in common bermudagrass is significant in subsequent linkage map construction, quantitative trait locus mapping and marker-assisted selection in the species.	[Guo, Yuanwen; Wu, Yanqi] Oklahoma State Univ, Dept Plant & Soil Sci, Stillwater, OK 74078 USA; [Anderson, Jeff A.; Moss, Justin Q.] Oklahoma State Univ, Dept Hort & Landscape Architecture, Stillwater, OK 74078 USA; [Zhu, Lan] Oklahoma State Univ, Dept Stat, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma State University System; Oklahoma State University - Stillwater	Wu, YQ (corresponding author), Oklahoma State Univ, Dept Plant & Soil Sci, Stillwater, OK 74078 USA.	yanqi.wu@okstate.edu	Wu, Yanqi/N-8180-2016; Moss, Justin Quetone/ABF-7404-2020	Moss, Justin Quetone/0000-0002-6758-3488; Wu, Yanqi/0000-0003-0802-6881	United States Golf Association; United States Department of Agriculture Specialty Crops Research Initiative (SCRI) award [2010-51181-21064]; China Scholarship Council	United States Golf Association; United States Department of Agriculture Specialty Crops Research Initiative (SCRI) award; China Scholarship Council(China Scholarship Council)	This research was sponsored by the United States Golf Association, United States Department of Agriculture Specialty Crops Research Initiative (SCRI) award 2010-51181-21064, and China Scholarship Council.	Andru S, 2011, THEOR APPL GENET, V123, P77, DOI 10.1007/s00122-011-1568-x; Bethel CM, 2006, THEOR APPL GENET, V112, P727, DOI 10.1007/s00122-005-0177-y; Burnham CR, 1962, DISCUSSIONS CYTOGENE, P215; BURTON GW, 1947, J AM SOC AGRON, V39, P551; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Clayton WD, 1986, GENERA GRAMINUM GRAS, P411; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; FORBES IAN, 1963, CROP SCI, V3, P75, DOI 10.2135/cropsci1963.0011183X000300010023x; Gulsen O, 2009, THEOR APPL GENET, V118, P1309, DOI 10.1007/s00122-009-0982-9; HANNA WW, 1977, CROP SCI, V17, P243, DOI 10.2135/cropsci1977.0011183X001700020003x; HARLAN J. R., 1970, Herbage Abstracts, V40, P233; HARLAN JR, 1969, CROP SCI, V9, P774, DOI 10.2135/cropsci1969.0011183X000900060031x; HARLAN JR, 1970, CROP SCI, V10, P288, DOI 10.2135/cropsci1970.0011183X001000030023x; HARLAN JR, 1969, AM J BOT, V56, P944, DOI 10.2307/2440636; Harris-Shultz KR, 2010, J AM SOC HORTIC SCI, V135, P511, DOI 10.21273/JASHS.135.6.511; Hurcombe R., 1947, JOUR S AFRICAN BOT, V13, P107; Jewell MC, 2012, CROP SCI, V52, P879, DOI 10.2135/cropsci2011.09.0497; JOHNSTON RA, 1975, CROP SCI, V15, P445, DOI 10.2135/cropsci1975.0011183X001500030050x; Kang SY, 2008, MOL CELLS, V25, P163; Liu LL, 2013, MOL BREEDING, V32, P923, DOI 10.1007/s11032-013-9921-1; Liu LL, 2012, BIOENERG RES, V5, P662, DOI 10.1007/s12155-011-9173-z; Liu LL, 2012, G3-GENES GENOM GENET, V2, P357, DOI 10.1534/g3.111.001503; LYTTLE TW, 1991, ANNU REV GENET, V25, P511, DOI 10.1146/annurev.ge.25.120191.002455; Okada M, 2010, GENETICS, V185, P745, DOI 10.1534/genetics.110.113910; Preacher K.J., 2001, CALCULATION CHI SQUA; Taliaferro C.M., 1997, PERS INT TURFGRASS S, V8, P393; TALIAFERRO CM, 1995, CROP SCI, V35, P327, DOI 10.2135/cropsci1995.0011183X003500020006x; Taliaferro CM, 2004, WARM SEASON C4 GRASS; Tan CC, 2012, MOL BREEDING, V29, P23, DOI 10.1007/s11032-010-9521-2; Wu YQ, 2006, CROP SCI, V46, P917, DOI 10.2135/cropsci2005.08.0256	30	14	15	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136332	10.1371/journal.pone.0136332	http://dx.doi.org/10.1371/journal.pone.0136332			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295707	Green Published, gold, Green Submitted			2022-12-26	WOS:000359926900101
J	Huang, LB; Li, XF; Nguyen, TAH				Huang, Longbin; Li, Xiaofang; Nguyen, Tuan A. H.			Extremely High Phosphate Sorption Capacity in Cu-Pb-Zn Mine Tailings	PLOS ONE			English	Article							PHOSPHORUS SORPTION; EXTRACTABLE FE; SOILS; DITHIONITE; AL; ADSORPTION; MAGHEMITE	Elevated inorganic phosphate (Pi) concentrations in pore water of amended tailings under direct revegetation may cause toxicity in some native woody species but not native forbs or herb species, all of which are key constituents in target native plant communities for phytostabilizing base metal mine tailings. As a result, Pi sorption capacity has been quantified by a conventional batch procedure in three types of base metal mine tailings sampled from two copper (Cu)-lead (Pb)-zinc (Zn) mines, as the basis for Pi-fertiliser addition. It was found that the Pi-sorption capacity in the tailings and local soil was extremely high, far higher than highly weathered agricultural soils in literature, but similar to those of volcanic ash soils. The Langmuir P-sorption maximum was up to 7.72, 4.12, 4.02 and 3.62 mg P g(-1) tailings, in the fresh tailings of mixed Cu-Pb-Zn streams (MIMTD7), the weathered tailings of mixed Cu-Pb-Zn streams (MIMTD5), EHM-TD (fresh Cu-stream, high magnetite content) and local soil (weathered shale and schist), respectively. Physicochemical factors highly correlated with the high Pi-sorption in the tailings were fine particle distribution, oxalate and dithionite-citrate-bicarbonate extractable Fe (Fe-O and Fe-d), oxalate-extractable Al and Mn, and the levels of soluble Cd and Zn, and total S and Fe. Large amounts of amorphous Fe oxides and oxyhydroxides may have been formed from the oxidation of pyritic materials and redox cycles of Fe-minerals (such as pyrite (FeS2), ankerite (Ca(Fe Mg)(CO3)(2) and siderite (FeCO3), as indicated by the extractable Fe-O values. The likely formation of sparingly soluble Zn-phosphate in the Pb-Zn tailings containing high levels of Zn (from sphalerite ((Zn, Fe) S, ZnS, (Zn, Cd) S)) may substantially lower soluble Zn levels in the tailings through high rates of Pi-fertiliser addition. As a result, the possibility of P-toxicity in native plant species caused by the addition of soluble phosphate fertilizers would be minimal.	[Huang, Longbin; Li, Xiaofang; Nguyen, Tuan A. H.] Univ Queensland, Sustainable Minerals Inst, Ctr Mined Land Rehabil, Brisbane, Qld 4072, Australia	University of Queensland	Huang, LB (corresponding author), Univ Queensland, Sustainable Minerals Inst, Ctr Mined Land Rehabil, Brisbane, Qld 4072, Australia.	l.huang@uq.edu.au	Nguyen, Tuan/I-8179-2012	Nguyen, Tuan/0000-0002-3024-2081; , Longbin Huang/0000-0001-5024-0107	Xstrata Copper Ltd	Xstrata Copper Ltd	The present study was funded by Mount Isa Mines, Glencore Ltd (formerly Xstrata Copper Ltd) within a tailings phytostabilization program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auxtero E, 2008, GEODERMA, V144, P535, DOI 10.1016/j.geoderma.2008.01.008; BARBER TM, 2002, PHOSPHATE ADSORPTION; BARROW NJ, 1978, J SOIL SCI, V29, P447, DOI 10.1111/j.1365-2389.1978.tb00794.x; COLE CV, 1953, SOIL SCI SOC AM PRO, V17, P352, DOI 10.2136/sssaj1953.03615995001700040013x; Davey KJ, 2008, FULL VALUE RECOVERY; Dobbie KE, 2005, SOIL USE MANAGE, V21, P231, DOI 10.1079/SUM2005314; Dold B, 2002, CHEM GEOL, V189, P135, DOI 10.1016/S0009-2541(02)00044-X; Dzombak D.A., 1990, SURFACE COMPLEXATION, P416; Forsyth B, 2011, 7 AUSTR WORKSH AC ME, P105; Forsyth BJT., 2011, UNDERSTANDING LONG T, V1, P301; FREEMAN JS, 1981, J SOIL SCI, V32, P75, DOI 10.1111/j.1365-2389.1981.tb01687.x; Hartikainen SH, 2008, APPL GEOCHEM, V23, P2716, DOI 10.1016/j.apgeochem.2008.06.004; Hassan NM, 2007, WATER AIR SOIL POLL, V178, P323, DOI 10.1007/s11270-006-9201-3; Holford ICR, 1997, AUST J SOIL RES, V35, P227, DOI 10.1071/S96047; HOLFORD ICR, 1982, AUST J SOIL RES, V20, P233, DOI 10.1071/SR9820233; HOLMGREN GG, 1967, SOIL SCI SOC AM PRO, V31, P210, DOI 10.2136/sssaj1967.03615995003100020020x; Huang L., 2011, 2 INT SEM ENV ISS MI, P31; Huang LB, 2012, ANN BOT-LONDON, V110, P223, DOI 10.1093/aob/mcs115; Lambers H, 2010, PLANT SOIL, V334, P11, DOI 10.1007/s11104-010-0444-9; Lottermoser BG, 2010, MINE WASTES: CHARACTERIZATION, TREATMENT AND ENVIRONMENTAL IMPACTS, P1, DOI 10.1007/978-3-642-12419-8_1; MAHANEY WC, 1994, CATENA, V21, P27, DOI 10.1016/0341-8162(94)90029-9; Marschner H., 2006, MINERAL NUTR HIGHER; McGowen SL, 2001, J ENVIRON QUAL, V30, P493, DOI 10.2134/jeq2001.302493x; MCKEAGUE JA, 1966, CAN J SOIL SCI, V46, P13, DOI 10.4141/cjss66-003; Mendez Monica O., 2008, Reviews in Environmental Science and Bio/Technology, V7, P47, DOI 10.1007/s11157-007-9125-4; Merry RH, 1999, SITE DATA SOIL PROFI; O'Loughlin EJ, 2013, ENVIRON SCI TECHNOL, V47, P9157, DOI 10.1021/es400627j; PARFITT RL, 1988, AUST J SOIL RES, V26, P121, DOI 10.1071/SR9880121; PING CL, 1986, COMMUN SOIL SCI PLAN, V17, P299, DOI 10.1080/00103628609367714; Prietzel J, 2007, EUR J SOIL SCI, V58, P1027, DOI 10.1111/j.1365-2389.2006.00882.x; Rayment G.E., 2011, SOIL CHEM METHODS AU; Redwan M, 2012, SCI TOTAL ENVIRON, V414, P480, DOI 10.1016/j.scitotenv.2011.10.038; Ryan MH, 2009, ANN BOT-LONDON, V103, P901, DOI 10.1093/aob/mcp021; Services E., 1984, SOIL CLASS HILT MOUN; SINGER MJ, 1995, CLAY CLAY MINER, V43, P1, DOI 10.1346/CCMN.1995.0430101; SINGH B, 1991, AUST J SOIL RES, V29, P603, DOI 10.1071/SR9910603; Sjarif S, 1990, SOME CHARACTERISTICS; TORRENT J, 1987, SOIL SCI SOC AM J, V51, P78, DOI 10.2136/sssaj1987.03615995005100010016x; Wisawapipat W, 2009, GEODERMA, V153, P408, DOI 10.1016/j.geoderma.2009.09.005; Zachara JM, 2002, GEOMICROBIOL J, V19, P179, DOI 10.1080/01490450252864271	40	12	12	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135364	10.1371/journal.pone.0135364	http://dx.doi.org/10.1371/journal.pone.0135364			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295582	Green Published, gold, Green Submitted			2022-12-26	WOS:000359926900028
J	Adams, AJ; LaBonte, JP; Ball, ML; Richards-Hrdlicka, KL; Toothman, MH; Briggs, CJ				Adams, Andrea J.; LaBonte, John P.; Ball, Morgan L.; Richards-Hrdlicka, Kathryn L.; Toothman, Mary H.; Briggs, Cheryl J.			DNA Extraction Method Affects the Detection of a Fungal Pathogen in Formalin-Fixed Specimens Using qPCR	PLOS ONE			English	Article							EMERGING INFECTIOUS-DISEASE; AMPHIBIAN CHYTRID FUNGUS; BATRACHOCHYTRIUM-DENDROBATIDIS; KILLING FUNGUS; CHYTRIDIOMYCOSIS; DYNAMICS; BIODIVERSITY; EXTINCTION; DECLINES; ENDEMISM	Museum collections provide indispensable repositories for obtaining information about the historical presence of disease in wildlife populations. The pathogenic amphibian chytrid fungus Batrachochytrium dendrobatidis (Bd) has played a significant role in global amphibian declines, and examining preserved specimens for Bd can improve our understanding of its emergence and spread. Quantitative PCR (qPCR) enables Bd detection with minimal disturbance to amphibian skin and is significantly more sensitive to detecting Bd than histology; therefore, developing effective qPCR methodologies for detecting Bd DNA in formalin-fixed specimens can provide an efficient and effective approach to examining historical Bd emergence and prevalence. Techniques for detecting Bd in museum specimens have not been evaluated for their effectiveness in control specimens that mimic the conditions of animals most likely to be encountered in museums, including those with low pathogen loads. We used American bullfrogs (Lithobates catesbeianus) of known infection status to evaluate the success of qPCR to detect Bd in formalin-fixed specimens after three years of ethanol storage. Our objectives were to compare the most commonly used DNA extraction method for Bd (PrepMan, PM) to Macherey-Nagel DNA FFPE (MN), test optimizations for Bd detection with PM, and provide recommendations for maximizing Bd detection. We found that successful detection is relatively high (80-90%) when Bd loads before formalin fixation are high, regardless of the extraction method used; however, at lower infection levels, detection probabilities were significantly reduced. The MN DNA extraction method increased Bd detection by as much as 50% at moderate infection levels. Our results indicate that, for animals characterized by lower pathogen loads (i.e., those most commonly encountered in museum collections), current methods may underestimate the proportion of Bd-infected amphibians. Those extracting DNA from archived museum specimens should ensure that the techniques they are using are known to provide high-quality throughput DNA for later analysis.	[Adams, Andrea J.; LaBonte, John P.; Toothman, Mary H.; Briggs, Cheryl J.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Ball, Morgan L.] Wildlands Conservat Sci, Lompoc, CA USA; [Richards-Hrdlicka, Kathryn L.] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA	University of California System; University of California Santa Barbara; Yale University	Adams, AJ (corresponding author), Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.	andrea.adams@lifesci.ucsb.edu	Adams, Andrea/C-4092-2015; Adams, Andrea/AAH-3580-2021	Adams, Andrea/0000-0001-5609-6150; Adams, Andrea/0000-0001-5609-6150	National Science Foundation Ecology of Infectious Disease [EF-0723563]; Robert and Patricia Switzer Foundation; Vandenberg Air Force Base	National Science Foundation Ecology of Infectious Disease(National Science Foundation (NSF)); Robert and Patricia Switzer Foundation; Vandenberg Air Force Base	Funding was provided by the National Science Foundation Ecology of Infectious Disease grant #EF-0723563 (awarded to CJB, http://www.nsf.gov/), the Robert and Patricia Switzer Foundation (fellowship awarded to AJA, http://www.switzernetwork.org/), and Vandenberg Air Force Base (awarded to JPL, http://www.vandenberg.af.mil/). None of the funders played any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annis SL, 2004, J WILDLIFE DIS, V40, P420, DOI 10.7589/0090-3558-40.3.420; Avila-Arcos MC, 2013, MOL BIOL EVOL, V30, P299, DOI 10.1093/molbev/mss223; Barta JL, 2014, J ARCHAEOL SCI, V46, P281, DOI 10.1016/j.jas.2014.03.030; Berger L, 2005, DIS AQUAT ORGAN, V68, P47, DOI 10.3354/dao068047; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Berger L., 1999, ZOOS PRINT J, V15, P184, DOI DOI 10.11609/JOTT.ZPJ.15.1.184-90; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Bucklin A, 2004, MOL PHYLOGENET EVOL, V30, P879, DOI 10.1016/j.ympev.2003.11.002; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P9502, DOI 10.1073/pnas.1105538108; Daszak P, 2004, HERPETOL J, V14, P201; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Fong JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115656; Gardner JL, 2011, TRENDS ECOL EVOL, V26, P285, DOI 10.1016/j.tree.2011.03.005; Garland S, 2010, DIS AQUAT ORGAN, V92, P113, DOI 10.3354/dao02053; Green DE, 2002, ANN NY ACAD SCI, V969, P323, DOI 10.1111/j.1749-6632.2002.tb04400.x; Heard M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023150; Hewson I, 2014, P NATL ACAD SCI USA, V111, P17278, DOI 10.1073/pnas.1416625111; Huss M, 2013, ECOHEALTH, V10, P339, DOI 10.1007/s10393-013-0895-6; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; James TY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000458; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Kinney VC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016708; Kosch TA, 2013, MOL ECOL RESOUR, V13, P230, DOI 10.1111/1755-0998.12041; Kriger KM, 2006, DIS AQUAT ORGAN, V71, P141, DOI 10.3354/dao071141; Lips KR, 2008, PLOS BIOL, V6, P441, DOI 10.1371/journal.pbio.0060072; Lips KR, 2011, P NATL ACAD SCI USA, V108, P9323, DOI 10.1073/pnas.1107246108; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; McDiarmid R.W., 1994, MEASURING MONITORING, P289; Mendelson JR, 2006, SCIENCE, V313, P48, DOI 10.1126/science.1128396; Mendelson JR, 2014, S AM J HERPETOL, V9, P151, DOI 10.2994/SAJH-D-14-00021.1; Morehouse EA, 2003, MOL ECOL, V12, P395, DOI 10.1046/j.1365-294X.2003.01732.x; Morgan JAT, 2007, P NATL ACAD SCI USA, V104, P13845, DOI 10.1073/pnas.0701838104; Muletz C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103728; Muths E, 2003, BIOL CONSERV, V110, P357, DOI 10.1016/S0006-3207(02)00239-2; Carnaval ACOD, 2006, ECOHEALTH, V3, P41, DOI 10.1007/s10393-005-0008-2; Olson DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056802; Ouellet M, 2005, CONSERV BIOL, V19, P1431, DOI 10.1111/j.1523-1739.2005.00108.x; Padgett-Flohr GE., 2009, THESIS; Padgett-Flohr GE, 2009, DIS AQUAT ORGAN, V83, P1, DOI 10.3354/dao02003; Pessier AP, 1999, J VET DIAGN INVEST, V11, P194, DOI 10.1177/104063879901100219; Piovia-Scott J, 2015, ISME J, V9, P1570, DOI 10.1038/ismej.2014.241; Popa Oana Paula, 2007, Travaux du Museum National d'Histoire Naturelle Grigore Antipa, V50, P527; PORTER RD, 1969, SCIENCE, V165, P199, DOI 10.1126/science.165.3889.199; R Core Team, 2012, R A LANGUAGE AND ENV; Rachowicz LJ, 2006, ECOLOGY, V87, P1671, DOI 10.1890/0012-9658(2006)87[1671:EIDAAP]2.0.CO;2; Reeder NMM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033567; Richards-Hrdlicka KL, 2012, METHODS ECOL EVOL, V3, P842, DOI 10.1111/j.2041-210X.2012.00228.x; Rocha LA, 2014, SCIENCE, V344, P814, DOI 10.1126/science.344.6186.814; Rodriguez D, 2014, MOL ECOL, V23, P774, DOI 10.1111/mec.12615; Savage AE, 2011, BIOL CONSERV, V144, P1910, DOI 10.1016/j.biocon.2011.03.018; Simmons JE, 2002, HERPETOLOGICAL CIRCU, P153; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Soto-Azat C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079862; Soto-Azat C, 2010, DIVERS DISTRIB, V16, P126, DOI 10.1111/j.1472-4642.2009.00618.x; Talley BL, 2015, BIOL CONSERV, V182, P254, DOI 10.1016/j.biocon.2014.12.007; Vredenburg VT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063791; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Wandeler P, 2007, TRENDS ECOL EVOL, V22, P634, DOI 10.1016/j.tree.2007.08.017; Weinstein SB, 2009, COPEIA, P653, DOI 10.1643/CH-08-180; Weldon C, 2004, EMERG INFECT DIS, V10, P2100, DOI 10.3201/eid1012.030804; Wyatt KB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003602; Zhu W, 2014, ECOHEALTH, V11, P241, DOI 10.1007/s10393-013-0894-7	64	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135389	10.1371/journal.pone.0135389	http://dx.doi.org/10.1371/journal.pone.0135389			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291624	Green Submitted, Green Published, gold			2022-12-26	WOS:000359919900018
J	Butovskaya, ML; Lazebny, OE; Vasilyev, VA; Dronova, DA; Karelin, DV; Mabulla, AZP; Shibalev, DV; Shackelford, TK; Fink, B; Ryskov, AP				Butovskaya, Marina L.; Lazebny, Oleg E.; Vasilyev, Vasiliy A.; Dronova, Daria A.; Karelin, Dmitri V.; Mabulla, Audax Z. P.; Shibalev, Dmitri V.; Shackelford, Todd K.; Fink, Bernhard; Ryskov, Alexey P.			Androgen Receptor Gene Polymorphism, Aggression, and Reproduction in Tanzanian Foragers and Pastoralists	PLOS ONE			English	Article							HUNTER-GATHERERS; PERSONALITY-TRAITS; DATOGA PASTORALISTS; REPEAT POLYMORPHISM; TESTOSTERONE LEVELS; AFRICAN FORAGERS; MATE PREFERENCES; MEN; HADZA; CAG	The androgen receptor (AR) gene polymorphism in humans is linked to aggression and may also be linked to reproduction. Here we report associations between AR gene polymorphism and aggression and reproduction in two small-scale societies in northern Tanzania (Africa)-the Hadza (monogamous foragers) and the Datoga (polygynous pastoralists). We secured self-reports of aggression and assessed genetic polymorphism of the number of CAG repeats for the AR gene for 210 Hadza men and 229 Datoga men (aged 17-70 years). We conducted structural equation modeling to identify links between AR gene polymorphism, aggression, and number of children born, and included age and ethnicity as covariates. Fewer AR CAG repeats predicted greater aggression, and Datoga men reported more aggression than did Hadza men. In addition, aggression mediated the identified negative relationship between CAG repeats and number of children born.	[Butovskaya, Marina L.; Dronova, Daria A.] Russian Acad Sci, Inst Ethnol & Anthropol, Dept Cross Cultural Psychol & Human Ethol, Moscow, Russia; [Lazebny, Oleg E.] Russian Acad Sci, Dept Evolutionary & Dev Genet, Koltzov Inst Dev Biol, Moscow, Russia; [Vasilyev, Vasiliy A.; Shibalev, Dmitri V.; Ryskov, Alexey P.] Russian Acad Sci, Inst Gene Biol, Dept Genome Org, Moscow, Russia; [Karelin, Dmitri V.] Moscow MV Lomonosov State Univ, Fac Biol, Moscow, Russia; [Mabulla, Audax Z. P.] Univ Dar Es Salaam, Coll Arts & Social Sci, Dept Archaeol, Dar Es Salaam, Tanzania; [Shackelford, Todd K.] Oakland Univ, Dept Psychol, Rochester, MI 48063 USA; [Fink, Bernhard] Univ Gottingen, Inst Psychol, D-37073 Gottingen, Germany	Russian Academy of Sciences; N.N. Miklukho-Maklai Institute of Ethnology & Anthropology; Russian Academy of Sciences; Koltzov Institute of Developmental Biology of the Russian Academy of Sciences; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; Lomonosov Moscow State University; University of Dar es Salaam; Oakland University; University of Gottingen	Lazebny, OE (corresponding author), Russian Acad Sci, Dept Evolutionary & Dev Genet, Koltzov Inst Dev Biol, Moscow, Russia.	oelazebny@gmail.com	Fink, Bernhard/G-7312-2011; Vasilyev, Vasily/AAO-5336-2021; Mabulla, Audax ZP/ABE-2455-2020; Shackelford, Todd K./T-6243-2017; Butovskaya, Marina/E-2368-2016; Karelin, Dmitriy/AAE-5169-2019; Karelin, Dmitry/AAK-9470-2020; Lazebny, Oleg/R-9208-2016; Dronova, Daria/V-2150-2019; Ryskov, Alexey/F-1179-2016	Fink, Bernhard/0000-0003-2739-5236; Shackelford, Todd K./0000-0001-8101-4292; Butovskaya, Marina/0000-0002-5528-0519; Karelin, Dmitry/0000-0001-5778-3163; Lazebny, Oleg/0000-0003-3136-0415; Dronova, Daria/0000-0002-2735-6248; Ryskov, Alexey/0000-0002-4159-0671	Russian Foundation for Humanities [12-01-00032-MLB]; Russian Foundation for Basic Research [13-06-00393-MLB, 12-04-31869-APR, 13-04-00858-APR]; Research Program of Russian Academy of Sciences 'Molecular and Cell Biology'-APR; President RF Program [5233.2012.4-APR, 2501.2014.4-APR]	Russian Foundation for Humanities; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Research Program of Russian Academy of Sciences 'Molecular and Cell Biology'-APR; President RF Program	This work was supported by the Russian Foundation for Humanities-12-01-00032-MLB, the Russian Foundation for Basic Research-13-06-00393-MLB, the Russian Foundation for Basic Research-12-04-31869-APR, the Russian Foundation for Basic Research-13-04-00858-APR, the Research Program of Russian Academy of Sciences 'Molecular and Cell Biology'-APR, the President RF Program-5233.2012.4-APR, and the President RF Program-2501.2014.4-APR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluja A, 2011, PSYCHIAT GENET, V21, P229, DOI 10.1097/YPG.0b013e328345465e; Apicella CL, 2007, BIOL LETTERS, V3, P682, DOI 10.1098/rsbl.2007.0410; Apicella CL, 2009, P ROY SOC B-BIOL SCI, V276, P1077, DOI 10.1098/rspb.2008.1542; Archer J, 2007, PERS INDIV DIFFER, V43, P627, DOI 10.1016/j.paid.2007.01.005; Archer J, 2009, BEHAV BRAIN SCI, V32, P249, DOI 10.1017/S0140525X09990951; Bachu A., 1996, WORKING PAPER SERIES; Boehm C, 1999, HUM NATURE-INT BIOS, V10, P205, DOI 10.1007/s12110-999-1003-z; Bogaert V, 2009, EUR J ENDOCRINOL, V161, P171, DOI 10.1530/EJE-09-0123; BRISLIN RW, 1970, J CROSS CULT PSYCHOL, V1, P185, DOI 10.1177/135910457000100301; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Buss D.M., 2006, EVOLUTION SOCIAL PSY, P263; Butovskaia M. L., 2011, ANTHROPOLOGY SOCIAL, P365; [Бутовская Марина Львовна Butovskaya M.L.], 2011, [Этнографическое обозрение, Ethnographic Review, Etnograficheskoe obozrenie], P85; Butovskaya M.L., 2013, WAR PEACE HUMAN NATU, P278, DOI [DOI 10.1093/ACPROF:OSO/9780199858996.003.0014, 10.1093/acprof:oso/9780199858996.003.0014]; Butovskaya ML, 2013, SCI REP-UK, V3, DOI 10.1038/srep03148; Butovskaya ML, 2012, J AGGRESS CONFL PEAC, V4, P28, DOI 10.1108/17596591211192975; Butovskaya ML, 2012, BEHAV GENET, V42, P647, DOI 10.1007/s10519-012-9533-2; Butovskaya ML, 2010, J AGGRESS CONFL PEAC, V2, P17, DOI 10.5042/jacpr.2010.0002; Campbell BC, 2009, INT J ANDROL, V32, P140, DOI 10.1111/j.1365-2605.2007.00825.x; CHAMBERLAIN NL, 1994, NUCLEIC ACIDS RES, V22, P3181, DOI 10.1093/nar/22.15.3181; Chapman D.W., 1979, EDUC EVAL POLICY AN, V1, P71, DOI [10.3102/01623737001003071, DOI 10.3102/01623737001003071]; Craig IW, 2009, HUM GENET, V126, P101, DOI 10.1007/s00439-009-0695-9; Daly M, 2001, Nebr Symp Motiv, V47, P1; Daly M, 1990, Hum Nat, V1, P81, DOI 10.1007/BF02692147; Daly M, 1988, HOMICIDE HAWTHORNE; Fouts HN, 2008, CROSS-CULT RES, V42, P290, DOI 10.1177/1069397108317484; Fry D. P, 2004, WAR HUMAN POTENTIAL; Gettler LT, 2011, P NATL ACAD SCI USA, V108, P16194, DOI 10.1073/pnas.1105403108; Gray PB, 2006, P ROY SOC B-BIOL SCI, V273, P333, DOI 10.1098/rspb.2005.3311; Gray Peter B., 2010, FATHERHOOD EVOLUTION; Grundy E, 2008, AM J EPIDEMIOL, V167, P271, DOI 10.1093/aje/kwm295; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Hewlett BS, 1993, INTIMATE FATHERS NAT; Holmberg AR, 1969, NOMADS LONG BOW SIRI; Irons W, 1979, EVOLUTIONARY BIOL HU, P256; Jonsson EG, 2001, PSYCHIAT GENET, V11, P19, DOI 10.1097/00041444-200103000-00004; KNAUFT BM, 1991, CURR ANTHROPOL, V32, P391, DOI 10.1086/203975; Lachance J, 2012, CELL, V150, P457, DOI 10.1016/j.cell.2012.07.009; LANE C., 1996, PASTURES LOST BARABA; Loehlin JC, 2005, PERS INDIV DIFFER, V39, P661, DOI 10.1016/j.paid.2005.02.016; Low B., 2000, WHY SEX MATTRES DARW; Manning JT, 2008, FINGER BOOK; Marlowe F., 2002, ETHNICITY HUNTER GAT, P247; Marlowe F., 2010, HADZA HUNTER GATHERE, DOI DOI 10.1152/physiol.00027.2018; Marlowe FW, 2012, J HUM EVOL, V63, P834, DOI 10.1016/j.jhevol.2012.09.004; Marlowe FW, 2004, HUM NATURE-INT BIOS, V15, P365, DOI 10.1007/s12110-004-1014-8; Marlowe FW, 2003, EVOL HUM BEHAV, V24, P217, DOI 10.1016/S1090-5138(03)00014-X; Marlowe FW, 2003, CROSS-CULT RES, V37, P282, DOI 10.1177/1069397103254008; Mulder MB, 2007, EVOL HUM BEHAV, V28, P299, DOI 10.1016/j.evolhumbehav.2007.05.009; Muller MN, 2009, P ROY SOC B-BIOL SCI, V276, P347, DOI 10.1098/rspb.2008.1028; Pisanski K, 2013, CROSS-CULT RES, V47, P162, DOI 10.1177/1069397112471806; Rajender S, 2008, INT J LEGAL MED, V122, P367, DOI 10.1007/s00414-008-0225-7; Sear R, 2002, DEMOGRAPHY, V39, P43, DOI 10.1353/dem.2002.0010; Sear R, 2008, EVOL HUM BEHAV, V29, P1, DOI 10.1016/j.evolhumbehav.2007.10.001; Sear R, 2009, BIOL LETTERS, V5, P606, DOI 10.1098/rsbl.2009.0342; Shibalev DV, 2013, RUSS J GENET+, V49, P1258, DOI 10.1134/S1022795413120119; Sorokowski P, 2012, BODY IMAGE, V9, P510, DOI 10.1016/j.bodyim.2012.07.002; Tomikawa M., 1978, SENRI ETHOLOGICAL ST, V1, P1; TURKE PW, 1985, ETHOL SOCIOBIOL, V6, P79, DOI 10.1016/0162-3095(85)90001-9; Westberg L, 2009, J PSYCHIATR NEUROSCI, V34, P205; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134; WOODBURN J, 1982, MAN, V17, P431, DOI 10.2307/2801707; Woodburn J, 1988, HUNTERS GATHERERS, V1, P43	63	31	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136208	10.1371/journal.pone.0136208	http://dx.doi.org/10.1371/journal.pone.0136208			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291982	gold, Green Published, Green Submitted			2022-12-26	WOS:000359919900065
J	Groten, K; Pahari, NT; Xu, SQ; van Doorn, MM; Baldwin, IT				Groten, Karin; Pahari, Nabin T.; Xu, Shuqing; van Doorn, Maja Miloradovic; Baldwin, Ian T.			Virus-Induced Gene Silencing Using Tobacco Rattle Virus as a Tool to Study the Interaction between Nicotiana attenuata and Rhizophagus irregularis	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGUS; PHOSPHATE TRANSPORTER GENES; GERMIN-LIKE PROTEINS; MEDICAGO-TRUNCATULA; GLOMUS-INTRARADICES; TRANSCRIPTION FACTOR; EXPRESSION PATTERNS; CORTICAL-CELLS; PLANT; SYMBIOSIS	Most land plants live in a symbiotic association with arbuscular mycorrhizal fungi (AMF) that belong to the phylum Glomeromycota. Although a number of plant genes involved in the plant-AMF interactions have been identified by analyzing mutants, the ability to rapidly manipulate gene expression to study the potential functions of new candidate genes remains unrealized. We analyzed changes in gene expression of wild tobacco roots (Nicotiana attenuata) after infection with mycorrhizal fungi (Rhizophagus irregularis) by serial analysis of gene expression (SuperSAGE) combined with next generation sequencing, and established a virus-induced gene-silencing protocol to study the function of candidate genes in the interaction. From 92,434 SuperSAGE Tag sequences, 32,808 (35%) matched with our in-house Nicotiana attenuata transcriptome database and 3,698 (4%) matched to Rhizophagus genes. In total, 11,194 Tags showed a significant change in expression (p<0.05, >2-fold change) after infection. When comparing the functions of highly up-regulated annotated Tags in this study with those of two previous large-scale gene expression studies, 18 gene functions were found to be up-regulated in all three studies mainly playing roles related to phytohormone metabolism, catabolism and defense. To validate the function of identified candidate genes, we used the technique of virus-induced gene silencing (VIGS) to silence the expression of three putative N. attenuata genes: germin-like protein, indole-3-acetic acid-amido synthetase GH3.9 and, as a proof-of-principle, calcium and calmodulin- dependent protein kinase (CCaMK). The silencing of the three plant genes in roots was successful, but only CCaMK silencing had a significant effect on the interaction with R. irregularis. Interestingly, when a highly activated inoculum was used for plant inoculation, the effect of CCaMK silencing on fungal colonization was masked, probably due to transcomplementation. This study demonstrates that large-scale gene expression studies across different species induce of a core set of genes of similar functions. However, additional factors seem to influence the overall pattern of gene expression, resulting in high variability among independent studies with different hosts. We conclude that VIGS is a powerful tool with which to investigate the function of genes involved in plant-AMF interactions but that inoculum strength can strongly influence the outcome of the interaction.	[Groten, Karin; Pahari, Nabin T.; Xu, Shuqing; van Doorn, Maja Miloradovic; Baldwin, Ian T.] Max Planck Inst Chem Ecol, Dept Mol Ecol, D-07745 Jena, Germany	Max Planck Society	Groten, K (corresponding author), Max Planck Inst Sci Human Hist, Kahlaische Str 10, D-07745 Jena, Germany.	groten@shh.mpg.de	Groten, Karin/B-2883-2018; Xu, Shuqing/AAL-6634-2021; Baldwin, Ian T/K-1809-2013; Groten, Karin/H-9652-2015	Groten, Karin/0000-0003-0177-8810; Xu, Shuqing/0000-0001-7010-4604; Groten, Karin/0000-0003-0177-8810; Baldwin, Ian/0000-0001-5371-2974	Max Planck Society; Global Research Lab Program from the National Research Foundation of Korea [2012055546]; Swiss National Science Foundation [PEBZP3-142886]; Marie Curie Intra-European Fellowships (IEF) [328935]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Global Research Lab Program from the National Research Foundation of Korea(National Research Foundation of Korea); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Marie Curie Intra-European Fellowships (IEF)(European Commission)	Funding by the Max Planck Society, the Global Research Lab Program (2012055546) from the National Research Foundation of Korea, the Swiss National Science Foundation (Project number PEBZP3-142886 to SX), and the Marie Curie Intra-European Fellowships (IEF) (Project Number 328935 to SX) is gratefully acknowledged.	Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; Allen JW, 2009, PLANT PHYSIOL, V149, P549, DOI 10.1104/pp.108.129866; Allen MF, 2009, NEW PHYTOL, V182, P290, DOI 10.1111/j.1469-8137.2009.02815.x; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Balestrini R, 2007, MOL PLANT MICROBE IN, V20, P1055, DOI 10.1094/MPMI-20-9-1055; Balzer S, 2011, BIOINFORMATICS, V27, pI304, DOI 10.1093/bioinformatics/btr251; Bapaume L, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00223; Belmondo S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00436; Bernier F, 2001, PLANT PHYSIOL BIOCH, V39, P545, DOI 10.1016/S0981-9428(01)01285-2; Besserer A, 2006, PLOS BIOL, V4, P1239, DOI 10.1371/journal.pbio.0040226; Brechenmacher L, 2004, MYCORRHIZA, V14, P253, DOI 10.1007/s00572-003-0263-4; Breuillin F, 2010, PLANT J, V64, P1002, DOI 10.1111/j.1365-313X.2010.04385.x; Brigneti G, 1998, EMBO J, V17, P6739, DOI 10.1093/emboj/17.22.6739; Campanella JJ, 2008, J PLANT GROWTH REGUL, V27, P26, DOI 10.1007/s00344-007-9027-2; Chen AQ, 2007, NEW PHYTOL, V173, P817, DOI 10.1111/j.1469-8137.2006.01962.x; Chen CY, 2007, PLANT PHYSIOL, V145, P1619, DOI 10.1104/pp.107.109876; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Conrath U, 2006, MOL PLANT MICROBE IN, V19, P1062, DOI 10.1094/MPMI-19-1062; Czaja LF, 2012, PLANT PHYSIOL, V159, P1671, DOI 10.1104/pp.112.195990; Ding XH, 2008, PLANT CELL, V20, P228, DOI 10.1105/tpc.107.055657; Doll J, 2003, PLANT CELL PHYSIOL, V44, P1208, DOI 10.1093/pcp/pcg153; Dunwell JM, 2008, CRIT REV PLANT SCI, V27, P342, DOI 10.1080/07352680802333938; Etemadi M, 2014, PLANT PHYSIOL, V166, P281, DOI 10.1104/pp.114.246595; Feddermann N, 2008, PLANTA, V227, P671, DOI 10.1007/s00425-007-0649-1; Fiorilli V, 2013, PLANTA, V237, P1267, DOI 10.1007/s00425-013-1842-z; Fiorilli V, 2009, NEW PHYTOL, V184, P975, DOI 10.1111/j.1469-8137.2009.03031.x; Fitze D, 2005, J PLANT PHYSIOL, V162, P1210, DOI 10.1016/j.jplph.2005.01.014; Floss DS, 2013, P NATL ACAD SCI USA, V110, pE5025, DOI 10.1073/pnas.1308973110; Foo E, 2013, J PLANT PHYSIOL, V170, P523, DOI 10.1016/j.jplph.2012.11.002; Galis I, 2012, VIRUS INDUCED GENE S, P109; Gase K, 2012, PLANT ECOL DIVERS, V5, P485, DOI 10.1080/17550874.2012.754797; Gaude N, 2012, PLANT J, V69, P510, DOI 10.1111/j.1365-313X.2011.04810.x; Genre A, 2005, PLANT CELL, V17, P3489, DOI 10.1105/tpc.105.035410; Genre A, 2008, PLANT CELL, V20, P1407, DOI 10.1105/tpc.108.059014; Gerlach N, 2015, PLANT CELL IN PRESS; Gilardoni PA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-66; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Gomez SK, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-10; Gronlund M, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-28; Groten K, 2015, PLANT CELL IN PRESS; Groth M, 2010, PLANT CELL, V22, P2509, DOI 10.1105/tpc.109.069807; Grunwald U, 2009, PLANTA, V229, P1023, DOI 10.1007/s00425-008-0877-z; Guether M, 2009, NEW PHYTOL, V182, P200, DOI 10.1111/j.1469-8137.2008.02725.x; Guimil S, 2005, P NATL ACAD SCI USA, V102, P8066, DOI 10.1073/pnas.0502999102; Gutjahr C, 2014, CURR OPIN PLANT BIOL, V20, P26, DOI 10.1016/j.pbi.2014.04.003; Hamiaux C, 2012, CURR BIOL, V22, P2032, DOI 10.1016/j.cub.2012.08.007; Helber N, 2011, PLANT CELL, V23, P3812, DOI 10.1105/tpc.111.089813; Hogekamp C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-306; Hogekamp C, 2011, PLANT PHYSIOL, V157, P2023, DOI 10.1104/pp.111.186635; Hohnjec N, 2005, PLANT PHYSIOL, V137, P1283, DOI 10.1104/pp.104.056572; Ivanov S, 2012, P NATL ACAD SCI USA, V109, P8316, DOI 10.1073/pnas.1200407109; Jassbi AR, 2008, PLANT PHYSIOL, V146, P974, DOI 10.1104/pp.107.108811; Javot H, 2007, P NATL ACAD SCI USA, V104, P1720, DOI 10.1073/pnas.0608136104; Jung SC, 2012, J CHEM ECOL, V38, P651, DOI 10.1007/s10886-012-0134-6; Kistner C, 2005, PLANT CELL, V17, P2217, DOI 10.1105/tpc.105.032714; Kistner C, 2005, LOTUS JAPONICUS HANDBOOK, P123, DOI 10.1007/1-4020-3735-X_9; Kloppholz S, 2011, CURR BIOL, V21, P1204, DOI 10.1016/j.cub.2011.06.044; Koricheva J, 2009, ECOLOGY, V90, P2088, DOI 10.1890/08-1555.1; Kruger M, 2012, NEW PHYTOL, V193, P970, DOI 10.1111/j.1469-8137.2011.03962.x; Krugel T, 2002, CHEMOECOLOGY, V12, P177, DOI 10.1007/PL00012666; Kumar P, 2014, P NATL ACAD SCI USA, V111, P1245, DOI 10.1073/pnas.1314848111; Kumar P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031347; Lanfranco L, 1999, NEW PHYTOL, V142, P347, DOI 10.1046/j.1469-8137.1999.00393.x; Laparre J, 2014, MOL PLANT, V7, P554, DOI 10.1093/mp/sst136; Levy J, 2004, SCIENCE, V303, P1361, DOI 10.1126/science.1093038; Liao D, 2014, PLANT CELL PHYSL, P1; Liu JY, 2007, PLANT J, V50, P529, DOI 10.1111/j.1365-313X.2007.03069.x; Liu JY, 2003, PLANT CELL, V15, P2106, DOI 10.1105/tpc.014183; Maillet F, 2011, NATURE, V469, P58, DOI 10.1038/nature09622; Matsumura H, 2003, P NATL ACAD SCI USA, V100, P15718, DOI 10.1073/pnas.2536670100; MCGONIGLE TP, 1990, NEW PHYTOL, V115, P495, DOI 10.1111/j.1469-8137.1990.tb00476.x; Meldau S, 2012, ANN BOT-LONDON, V110, P1503, DOI 10.1093/aob/mcs212; Middleton PH, 2007, PLANT CELL, V19, P1221, DOI 10.1105/tpc.106.048264; Parniske M, 2008, NAT REV MICROBIOL, V6, P763, DOI 10.1038/nrmicro1987; Perez-Sancho J, 2015, PLANT PHYSIOL, V168, P132, DOI 10.1104/pp.15.00260; Plackett ARG, 2012, PLANT CELL, V24, P941, DOI 10.1105/tpc.111.095109; Ratcliff F, 2001, PLANT J, V25, P237, DOI 10.1046/j.0960-7412.2000.00942.x; Riedel T, 2008, PLANT CELL ENVIRON, V31, P1203, DOI 10.1111/j.1365-3040.2008.01827.x; Ruzicka D, 2013, PLANT GENOME-US, V6, DOI 10.3835/plantgenome2012.06.0007; Saedler R, 2004, J EXP BOT, V55, P151, DOI 10.1093/jxb/erh004; Santhanam R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094710; Schmitz AM, 2014, J INTEGR PLANT BIOL, V56, P250, DOI 10.1111/jipb.12155; Schussler A, 2001, MYCOL RES, V105, P1413, DOI 10.1017/S0953756201005196; Schweiger R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4886; Seddas PMA, 2009, MOL PLANT MICROBE IN, V22, P341, DOI 10.1094/MPMI-22-3-0341; Seo PJ, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-101; Singh S, 2012, CURR OPIN PLANT BIOL, V15, P444, DOI 10.1016/j.pbi.2012.04.002; Smith FA, 2013, PLANT SOIL, V363, P7, DOI 10.1007/s11104-012-1583-y; Soanes DM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002514; Steinkellner S, 2007, MOLECULES, V12, P1290, DOI 10.3390/12071290; Tamayo E, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00547; Tisserant E, 2012, NEW PHYTOL, V193, P755, DOI 10.1111/j.1469-8137.2011.03948.x; Tisserant E, 2013, P NATL ACAD SCI USA, V110, P20117, DOI 10.1073/pnas.1313452110; Veiga RSL, 2013, PLANT CELL ENVIRON, V36, P1926, DOI 10.1111/pce.12102; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Veresoglou SD, 2012, TRENDS ECOL EVOL, V27, P588, DOI 10.1016/j.tree.2012.08.002; Voinnet O, 2001, TRENDS GENET, V17, P449, DOI 10.1016/S0168-9525(01)02367-8; Willmann M, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00533; Wulf A, 2003, MOL PLANT MICROBE IN, V16, P306, DOI 10.1094/MPMI.2003.16.4.306; Yang DH, 2012, PLANT PHYSIOL, V159, P1591, DOI 10.1104/pp.112.199018; Zhang Q, 2010, PLANT CELL, V22, P1483, DOI 10.1105/tpc.110.074955	102	8	10	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136234	10.1371/journal.pone.0136234	http://dx.doi.org/10.1371/journal.pone.0136234			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291081	Green Published, gold, Green Submitted			2022-12-26	WOS:000359919900069
J	Tanno, LK; Kerr, DS; dos Santos, B; Talib, LL; Yamaguti, C; Rodrigues, H; Gattaz, WF; Kalil, J				Tanno, Luciana Kase; Kerr, Daniel Shikanai; dos Santos, Bernardo; Talib, Leda Leme; Yamaguti, Celia; Rodrigues, Helcio; Gattaz, Wagner Farid; Kalil, Jorge			The Absence of CYP3A5*3 Is a Protective Factor to Anticonvulsants Hypersensitivity Reactions: A Case-Control Study in Brazilian Subjects	PLOS ONE			English	Article							STEVENS-JOHNSON-SYNDROME; MICROSOMAL EPOXIDE HYDROLASE; CARBAMAZEPINE; PHENOTYPE; EXPRESSION; VARIANTS; EPILEPSY	Although aromatic anticonvulsants are usually well tolerated, they can cause cutaneous adverse drug reactions in up to 10% of patients. The clinical manifestations of the antiepileptics-induced hypersensitivity reactions (AHR) vary from mild skin rashes to severe cutaneous drug adverse reactions which are related to high mortality and significant morbidity. Genetic polymorphisms in cytochrome P450 genes are associated with altered enzymatic activity and may contribute to the risk of AHR. Here we present a case-control study in which we genotyped SNPs of CYP2C19, 2C9 and 3A5 of 55 individuals with varying severities of AHR, 83 tolerant, and 366 healthy control subjects from Sao Paulo, Brazil. Clinical characterization was based on standardized scoring systems and drug patch test. All in vivo investigation followed the ENDA (European Network of Drug Allergy) recommendations. Genotype was determined by real time PCR using peripheral blood DNA as a template. Of all 504 subjects, 65% were females, 45% self-identified as Afro-American, 38% as Caucasian and 17% as having non-African mixed ascendancy. Amongst 55 subjects with AHR, 44 had severe cutaneous drug adverse reactions. Of the 46 drug patch tests performed, 29 (63%) were positive. We found a strong association between the absence of CYP3A5*3 and tolerant subjects when compared to AHR (p = 0.0002, OR = 5.28 [CI95% 2.09-14.84]). None of our groups presented positive association with CYP2C19 and 2C9 polymorphisms, however, both SNPs contributed to separation of cases and tolerants in a Classification and Regression Tree. Our findings indicate that drug metabolism genes can contribute in the tolerability of antiepileptics. CYP3A5*3 is the most prevalent CYP3A5 allele associated with reduced enzymatic function. The current study provides evidence that normal CYP3A5 activity might be a protective factor to aromatic antiepileptics-induced hypersensitivity reactions in Brazilian subjects.	[Tanno, Luciana Kase; Kalil, Jorge] Univ Sao Paulo, Clin Immunol & Allergy Div, Sao Paulo, Brazil; [Kerr, Daniel Shikanai; Talib, Leda Leme; Gattaz, Wagner Farid] Univ Sao Paulo, Inst Psychiat, Lab Neurosci LIM 27, Sao Paulo, Brazil; [Yamaguti, Celia; Rodrigues, Helcio; Kalil, Jorge] Univ Sao Paulo, Clin Immunol & Allergy Div, Lab Immunol LIM 19, Sao Paulo, Brazil; [dos Santos, Bernardo] Univ Sao Paulo, Sch Nursing, Sao Paulo, Brazil; [Kerr, Daniel Shikanai; Talib, Leda Leme; Gattaz, Wagner Farid] Univ Sao Paulo, Ctr Interdisciplinary Res Appl Neurosci NAPNA, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Tanno, LK (corresponding author), Univ Sao Paulo, Clin Immunol & Allergy Div, Sao Paulo, Brazil.	luciana.tanno@gmail.com	Tanno, Luciana Kase/J-9981-2014; Talib, Leda/AAJ-4669-2021; KALIL, JORGE/C-8029-2012	Tanno, Luciana Kase/0000-0003-3236-1225; Talib, Leda/0000-0001-5866-1993; KALIL, JORGE/0000-0001-8415-4274	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/22748-1]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work received funding from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - http://fapesp.br/) under the grant number 2011/22748-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auquier-Dunant A, 2002, ARCH DERMATOL, V138, P1019, DOI 10.1001/archderm.138.8.1019; Barbaud A, 2013, BRIT J DERMATOL, V168, P555, DOI 10.1111/bjd.12125; Baron JM, 2008, CURR MED CHEM, V15, P2258, DOI 10.2174/092986708785747535; Brockow K, 2013, ALLERGY, V68, P702, DOI 10.1111/all.12142; Demoly P, 2014, ALLERGY, V69, P420, DOI 10.1111/all.12350; Edwards SGM, 1999, POSTGRAD MED J, V75, P680, DOI 10.1136/pgmj.75.889.680; GAEDIGK A, 1994, PHARMACOGENETICS, V4, P142, DOI 10.1097/00008571-199406000-00005; Goldstein JA, 1997, PHARMACOGENETICS, V7, P59, DOI 10.1097/00008571-199702000-00008; Gonzalez-Galarza FF, 2015, NUCLEIC ACIDS RES, V43, pD784, DOI 10.1093/nar/gku1166; GREEN VJ, 1995, BIOCHEM PHARMACOL, V50, P1353, DOI 10.1016/0006-2952(95)02009-8; Hung SL, 2006, PHARMACOGENET GENOM, V16, P297, DOI 10.1097/01.fpc.0000199500.46842.4a; Hustert E, 2001, PHARMACOGENETICS, V11, P773, DOI 10.1097/00008571-200112000-00005; LAITINEN J, 1994, BIOTECHNIQUES, V17, P316; Lee AY, 2003, CONTACT DERMATITIS, V48, P137, DOI 10.1034/j.1600-0536.2003.00065.x; LERTRATANANGKOON K, 1982, DRUG METAB DISPOS, V10, P1; Lonjou C, 2006, PHARMACOGENOMICS J, V6, P265, DOI 10.1038/sj.tpj.6500356; Madden S, 1996, DRUG METAB DISPOS, V24, P469; Marson AG, 2007, LANCET, V369, P1016, DOI 10.1016/S0140-6736(07)60461-9; McCormack M, 2011, NEW ENGL J MED, V364, P1134, DOI 10.1056/NEJMoa1013297; Mockenhaupt M, 2014, INCLUSION CRITERIA; Naisbitt DJ, 2003, MOL PHARMACOL, V63, P732, DOI 10.1124/mol.63.3.732; Nishimura M, 2003, YAKUGAKU ZASSHI, V123, P369; Ozawa Shogo, 2004, Drug Metab Pharmacokinet, V19, P83, DOI 10.2133/dmpk.19.83; Pena SDJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017063; Pirmohamed M, 2011, CLIN PHARMACOL THER, V89, P896, DOI 10.1038/clpt.2011.79; Posadas SJ, 2007, CLIN EXP ALLERGY, V37, P989, DOI 10.1111/j.1365-2222.2007.02742.x; ROUJEAU JC, 1994, NEW ENGL J MED, V331, P1272, DOI 10.1056/NEJM199411103311906; ROUJEAU JC, 1995, NEW ENGL J MED, V333, P1600, DOI 10.1056/NEJM199512143332404; Santiago F, 2010, CONTACT DERMATITIS, V62, P47, DOI 10.1111/j.1600-0536.2009.01659.x; Sim Sarah C., 2010, Human Genomics, V4, P278; SPIELBERG SP, 1981, J PHARMACOL EXP THER, V217, P386; Suarez-Kurtz G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083472; Thorn CF, 2012, PHARMACOGENET GENOM, V22, P466, DOI 10.1097/FPC.0b013e32834aeedb; Thorn CF, 2011, PHARMACOGENET GENOM, V21, P440, DOI 10.1097/FPC.0b013e32833ffb56; Wiffen PJ, 2011, COCHRANE DATABASE SY; Wu Y, 2006, J ALLERGY CLIN IMMUN, V118, P233, DOI 10.1016/j.jaci.2006.03.005; Xie HG, 2002, ADV DRUG DELIVER REV, V54, P1257, DOI 10.1016/S0169-409X(02)00076-5	37	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136141	10.1371/journal.pone.0136141	http://dx.doi.org/10.1371/journal.pone.0136141			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291084	Green Published, gold, Green Submitted			2022-12-26	WOS:000359919900058
J	Zhao, Q; Li, Y; Tan, BB; Fan, LQ; Yang, PG; Tian, Y				Zhao, Qun; Li, Yong; Tan, Bi-bo; Fan, Li-qiao; Yang, Pei-gang; Tian, Yuan			HIF-1 alpha Induces Multidrug Resistance in Gastric Cancer Cells by Inducing MiR-27a	PLOS ONE			English	Article							DRUG-RESISTANCE; DOWN-REGULATION; EXPRESSION; SURGERY; CHEMORESISTANCE; PROLIFERATION; CHEMOTHERAPY; METASTASIS; INHIBITION; HIF1-ALPHA	This study aimed to determine the correlation between HIF-1 alpha and miR-27a expression and to evaluate the effect of inhibition of HIF-1 alpha expression on miR-27a expression and drug resistance in gastric cancer (GC). In the present study, real time-PCR and Western blot were performed to detect the expression of HIF-1 alpha in GC tissues and cell lines. Then, OCUM-2MD3/L-OHP cells were transfected with HIF-1 alpha-siRNA, a miR-27a mimic or pcDNA-HIF-1 alpha, and cell survival was determined via the MTT assay. The expression of HIF-1 alpha, miR-27a, and MDR-related genes was measured via real time-PCR and Western blot. ChIP and dual luciferase activity assays were performed to assess the transcriptional regulation of HIF-1 alpha and miR-27a. The results revealed that transfection with HIF-1 alpha-siRNA markedly decreased the levels of miR-27a, resulting in dramatically enhanced inhibition of the proliferation rate of OCUM-2MD3/L-OHP cells. Compared to non-transfected cells, the survival rate was significantly reduced in the cells transfected with HIF-1 alpha-siRNA after treatment with L-OHP. The cell survival rate was significantly increased in OCUM-2MD3/L-OHP cells transfected with the miR-27a mimic, whereas HIF-1 alpha overexpression did not result in any clear change in cell survival. The results of the dual luciferase activity assay demonstrated that HIF-1 alpha enhances the transcriptional activity of the miR27a promoter in cells transfected with a reporter plasmid containing the upstream promoter region of miR27a together with pcDNA-HIF-1 alpha. ChIP analysis suggested that HIF-1 alpha directly binds to the promoter region of miR27a. Inhibition of HIF-1 alpha or miR27a expression decreased MDR1/P-gp, LRP, and Bcl-2 expression in OCUM-2MD3/L-OHP cells. Thus, we found that HIF-1 alpha is closely associated with MDR in GC and that HIF-1 alpha may suppress MDR1/P-gp, LRP and Bcl-2 expression by inhibiting miR-27a expression.	[Zhao, Qun; Li, Yong; Tan, Bi-bo; Fan, Li-qiao; Yang, Pei-gang; Tian, Yuan] Hebei Med Univ, Affiliated Hosp 4, Dept Gen Surg, Shijiazhuang, Peoples R China	Hebei Medical University	Li, Y (corresponding author), Hebei Med Univ, Affiliated Hosp 4, Dept Gen Surg, Shijiazhuang, Peoples R China.	li_yong_hbth@126.com			Provincial Natural Science Foundation of Hebei Province [H2013206311]	Provincial Natural Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province)	This work was supported by the following grant: The Provincial Natural Science Foundation of Hebei Province (No. H2013206311 to Qun Zhao).	Pereira KMA, 2013, ONCOL LETT, V6, P311, DOI 10.3892/ol.2013.1371; Carbajo-Pescador S, 2013, BRIT J CANCER, V109, P83, DOI 10.1038/bjc.2013.285; Chen CT, 2012, MOL CANCER THER, V11, P660, DOI 10.1158/1535-7163.MCT-11-0754; Cheng JC, 2013, CANCER LETT, V329, P197, DOI 10.1016/j.canlet.2012.10.029; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; D'Ugo D, 2009, LANCET ONCOL, V10, P191, DOI 10.1016/S1470-2045(09)70021-X; Gravalos C, 2008, ANN ONCOL, V19, P1523, DOI 10.1093/annonc/mdn169; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Katanoda K, 2013, JPN J CLIN ONCOL, V43, P492, DOI 10.1093/jjco/hyt038; Kulshreshtha R, 2008, CELL DEATH DIFFER, V15, P667, DOI 10.1038/sj.cdd.4402310; Li DW, 2013, ASIAN PAC J CANCER P, V14, P4853, DOI 10.7314/APJCP.2013.14.8.4853; Li Y, 2012, TUMORI J, V98, P516, DOI 10.1700/1146.12648; Li Zhi-min, 2010, Zhonghua Fu Chan Ke Za Zhi, V45, P372; Liu Wei, 2012, Int J Biochem Mol Biol, V3, P165; Liu YB, 2012, CARCINOGENESIS, V33, P1187, DOI 10.1093/carcin/bgs142; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Min LF, 2012, MOL MED REP, V5, P228, DOI 10.3892/mmr.2011.604; Miyake S, 2013, INT J ONCOL, V43, P1431, DOI 10.3892/ijo.2013.2068; Montagner M, 2012, NATURE, V487, P380, DOI 10.1038/nature11207; Naito Y, 2012, DIGESTION, V86, P94, DOI 10.1159/000339342; Nakamura J, 2009, ONCOL REP, V22, P693, DOI 10.3892/or_00000489; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Roukos D, 2009, ANN SURG ONCOL, V16, P795, DOI 10.1245/s10434-009-0317-8; Sandhu S, 2011, SEMIN ONCOL, V38, P781, DOI 10.1053/j.seminoncol.2011.08.007; Sermeus A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047519; Sun FQ, 2012, ONCOL LETT, V4, P156, DOI 10.3892/ol.2012.681; Tong Y, 2013, FEBS LETT, V587, P2530, DOI 10.1016/j.febslet.2013.06.017; Wang C, 2008, J BIOCHEM, V144, P313, DOI 10.1093/jb/mvn068; Wei H, 2013, EUR REV MED PHARMACO, V17, P436; Xia LM, 2012, CARCINOGENESIS, V33, P2250, DOI 10.1093/carcin/bgs249; Xu K, 2013, MOL CARCINOGEN, V52, P70, DOI 10.1002/mc.21832; Yashiro M, 1996, CLIN EXP METASTAS, V14, P43, DOI 10.1007/BF00157685; Zhao XH, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-55; Zhu H, 2012, CHINESE MED J-PEKING, V125, P1095, DOI 10.3760/cma.j.issn.0366-6999.2012.06.024	36	44	49	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0132746	10.1371/journal.pone.0132746	http://dx.doi.org/10.1371/journal.pone.0132746			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26292288	Green Published, Green Submitted, gold			2022-12-26	WOS:000359919900002
J	Al-Asmari, AK; Albalawi, SM; Athar, MT; Khan, AQ; Al-Shahrani, H; Islam, M				Al-Asmari, Abdulrahman Khazim; Albalawi, Sulaiman Mansour; Athar, Md Tanwir; Khan, Abdul Quaiyoom; Al-Shahrani, Hamoud; Islam, Mozaffarul			Moringa oleifera as an Anti-Cancer Agent against Breast and Colorectal Cancer Cell Lines	PLOS ONE			English	Article							MOLECULAR-MECHANISMS; SAUDI-ARABIA; D-ALLOSE; EUGENOL; APOPTOSIS; CURCUMIN; HEALTH; PHYTOCHEMICALS; ISOTHIOCYANATE	In this study we investigated the anti-cancer effect of Moringa oleifera leaves, bark and seed extracts. When tested against MDA-MB-231 and HCT-8 cancer cell lines, the extracts of leaves and bark showed remarkable anti-cancer properties while surprisingly, seed extracts exhibited hardly any such properties. Cell survival was significantly low in both cells lines when treated with leaves and bark extracts. Furthermore, a striking reduction (about 70-90%) in colony formation as well as cell motility was observed upon treatment with leaves and bark. Additionally, apoptosis assay performed on these treated breast and colorectal cancer lines showed a remarkable increase in the number of apoptotic cells; with a 7 fold increase in MD-MB-231 to an increase of several fold in colorectal cancer cell lines. However, no significant apoptotic cells were detected upon seeds extract treatment. Moreover, the cell cycle distribution showed a G2/M enrichment (about 2-3 fold) indicating that these extracts effectively arrest the cell progression at the G2/M phase. The GC-MS analyses of these extracts revealed numerous known anti-cancer compounds, namely eugenol, isopropyl isothiocynate, D-allose, and hexadeconoic acid ethyl ester, all of which possess long chain hydrocarbons, sugar moiety and an aromatic ring. This suggests that the anticancer properties of Moringa oleifera could be attributed to the bioactive compounds present in the extracts from this plant. This is a novel study because no report has yet been cited on the effectiveness of Moringa extracts obtained in the locally grown environment as an anti-cancer agent against breast and colorectal cancers. Our study is the first of its kind to evaluate the anti-malignant properties of Moringa not only in leaves but also in bark. These findings suggest that both the leaf and bark extracts of Moringa collected from the Saudi Arabian region possess anti-cancer activity that can be used to develop new drugs for treatment of breast and colorectal cancers.	[Al-Asmari, Abdulrahman Khazim; Albalawi, Sulaiman Mansour; Athar, Md Tanwir; Khan, Abdul Quaiyoom; Al-Shahrani, Hamoud; Islam, Mozaffarul] Prince Sultan Mil Med City, Res Ctr, Riyadh 11159, Saudi Arabia	Prince Sultan Military Medical City	Al-Asmari, AK (corresponding author), Prince Sultan Mil Med City, Res Ctr, Riyadh 11159, Saudi Arabia.	abdulrahman.alasmari@gmail.com			Prince Sultan Military Medical City	Prince Sultan Military Medical City	Funding: This work was funded by Prince Sultan Military Medical City. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACS, 2013, BREAST CANC FACTS FI, P1; Aggarwal BB, 2007, ADV EXP MED BIOL, V595, P1; Aja P, 2014, ADV LIFE SCI TECHNOL, V24, P73; Al-Sharif I, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-600; Alaklabi A, 2014, SAUDI J BIOL SCI; Alghamdi IG, 2013, BREAST CANCER-TARGET, V5, P103, DOI 10.2147/BCTT.S50750; American Cancer Society (ACS), 2014, COL CANC FACTS FIG, P1; Berkovich L, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-212; Bhuvaneswari V., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P627, DOI 10.2174/156801105774574667; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Craig W, 1999, CAN J DIET PRACT RES, V60, P78; Craig WJ, 1997, J AM DIET ASSOC, V97, pS199, DOI 10.1016/S0002-8223(97)00765-7; Emmanuel S.A., 2014, AM J ETHNOMED, V1, P346; Ferreira Paulo Michel Pinheiro, 2014, PHARM THERAPEUTICS; FOLKMAN J, 1982, ANN NY ACAD SCI, V401, P212, DOI 10.1111/j.1749-6632.1982.tb25720.x; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Garg AK, 2005, ANTIOXID REDOX SIGN, V7, P1630, DOI 10.1089/ars.2005.7.1630; Gaurisankar Sa, 2010, Al Ameen Journal of Medical Sciences, V3, P21; Ghosh R, 2005, J BIOL CHEM, V280, P5812, DOI 10.1074/jbc.M411429200; Ghosh R, 2009, J STEROID BIOCHEM, V113, P25, DOI 10.1016/j.jsbmb.2008.11.002; Harada H, 2002, ANTICANCER RES, V22, P2587; Islam M, 2000, EXP EYE RES, V70, P261, DOI 10.1006/exer.1999.0783; Islam M, 2013, ORAL ONCOL, V49, P778, DOI 10.1016/j.oraloncology.2013.04.003; Islam M, 2009, MOL CANCER RES, V7, P1771, DOI 10.1158/1541-7786.MCR-08-0512; Jung IL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095492; Kalkunte S, 2006, J EXP THER ONCOL, V5, P287; Kaur G, 2010, MOL CARCINOGEN, V49, P290, DOI 10.1002/mc.20601; Kong KW, 2010, MOLECULES, V15, P959, DOI 10.3390/molecules15020959; Lacroix M, 2006, ENDOCR-RELAT CANCER, V13, P293, DOI 10.1677/erc.1.01172; Leone A, 2015, INT J MOL SCI, V16, P12791, DOI 10.3390/ijms160612791; MANIGAUHA, 2010, DRUG INVENTION TODAY, V2; Manikandan P, 2011, INVEST NEW DRUG, V29, P110, DOI 10.1007/s10637-009-9345-2; Manikandan P, 2010, LIFE SCI, V86, P936, DOI 10.1016/j.lfs.2010.04.010; Mann J, 2002, NAT REV CANCER, V2, P143, DOI 10.1038/nrc723; Matsuda H, 2007, EUR J PHARMACOL, V561, P172, DOI 10.1016/j.ejphar.2006.12.040; Mbikay M., 2012, FRONT PHARMACOL, P3; Mosli MH, 2012, ASIAN PAC J CANCER P, V13, P3809, DOI 10.7314/APJCP.2012.13.8.3809; Olson ME, 2002, SYST BOT, V27, P55; Pal D, 2010, J DERMATOL SCI, V59, P31, DOI 10.1016/j.jdermsci.2010.04.013; Park BS, 2005, APOPTOSIS, V10, P193, DOI 10.1007/s10495-005-6074-7; Pisano M, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-8; Rao AVR, 2000, J AM COLL NUTR, V19, P563, DOI 10.1080/07315724.2000.10718953; Razis AFA, 2014, ASIAN PAC J CANCER P, V15, P8571, DOI 10.7314/APJCP.2014.15.20.8571; Shanmugam MK, 2015, MOLECULES, V20, P2728, DOI 10.3390/molecules20022728; Shehzad A, 2013, BIOFACTORS, V39, P27, DOI 10.1002/biof.1065; Shin SH, 2007, J KOR ASSOC ORAL MAX, V32, P20; Shishodia S, 2013, BIOFACTORS, V39, P37, DOI 10.1002/biof.1041; Sui L, 2005, INT J ONCOL, V27, P907; Tiloke C, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-226; Trejo-Solis C, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/705121; Vermeulen SJ, 1998, CANCER GENET CYTOGEN, V107, P76, DOI 10.1016/S0165-4608(98)00081-8; Yamaguchi F, 2008, INT J ONCOL, V32, P377; Yoo CB, 2005, CANCER LETT, V225, P41, DOI 10.1016/j.canlet.2004.11.018; Yuan Peng, 2008, Chinese Journal of Natural Medicines, V6, P325, DOI 10.3724/SP.J.1009.2008.00325; 김규천, 2006, Anatomy and Cell Biology, V39, P245	55	143	150	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135814	10.1371/journal.pone.0135814	http://dx.doi.org/10.1371/journal.pone.0135814			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288313	Green Published, gold, Green Submitted			2022-12-26	WOS:000360018600073
J	Lee, SH; Kim, JS; Ravichandran, K; Gil, HW; Song, HY; Hong, SY				Lee, Sun-hyo; Kim, Jin-sun; Ravichandran, Kameswaran; Gil, Hyo-Wook; Song, Ho-yeon; Hong, Sae-yong			P-Glycoprotein Induction Ameliorates Colistin Induced Nephrotoxicity in Cultured Human Proximal Tubular Cells	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; AUTOPHAGY; APOPTOSIS; EXPRESSION; DEATH; TRANSPORTER; POLYMYXINS; PROTEINS; MODEL	The pathogenesis of colistin induced nephrotoxicity is poorly understood. Currently there are no effective therapeutic or prophylactic agents available. This study was aimed to determine the mechanism of colistin induced nephrotoxicity and to determine whether P-glycoprotein (P-gp) induction could prevent colistin induced nephrotoxicity. Colistin induced cell toxicity in cultured human proximal tubular cells in both dose and time dependent manner. Colistin provoked ROS in a dose dependent manner as measured by DCF-DA. To investigate apoptosis, caspase 3/7 activity was determined. Caspase 3/7 activity was increased dose dependently (25, 50, 100 mu g/ml) at 6 h. Autophagosome formation was assessed by measuring LC3-II/LC3-I ratio. The ratio of LC3-II to LC3-I was increased at 2 h (25 mu g/ml). Suppression of autophagosome formation increased colistin induced nephrotoxicity. The expression of P-gp and the cell toxicity was determined in colistin with or without dexamethasone (P-gp inducer) and verapamil (selective P-gp inhibitor). Colistin itself suppressed the expression of P-gp. P-gp expression and activity decreased colistin induced nephrotoxicity with dexamethasone treatment. In addition induced P-gp transporter was shown to improve the efflux effect on colistin treated HK2 cell line, which was demonstrated by calcein-AM fluorescence accumulation assay. The increased activity could be blocked by N-acetylcysteine. In conclusion, colistin induces nephrotoxicity by suppressing P-gp. Induction of P-gp could ameliorate colistin induced nephrotoxicity by decreasing apoptosis.	[Lee, Sun-hyo; Kim, Jin-sun; Gil, Hyo-Wook; Hong, Sae-yong] Soonchunhyang Univ, Cheonan Hosp, Dept Internal Med, Cheonan, South Korea; [Ravichandran, Kameswaran] Univ Colorado Denver, Div Renal Dis & Hypertens, Aurora, CO USA; [Song, Ho-yeon] Soonchunhyang Univ, Dept Microbiol, Coll Med, Cheonan, South Korea	Soonchunhyang University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Soonchunhyang University	Gil, HW (corresponding author), Soonchunhyang Univ, Cheonan Hosp, Dept Internal Med, Cheonan, South Korea.	hwgil@schmc.ac.kr	RAVICHANDRAN, KAMESWARAN/Y-6920-2019; Song, Ho-Yeon/G-7168-2016	RAVICHANDRAN, KAMESWARAN/0000-0002-0596-2044; hong, saeyong/0000-0001-7854-3871	Soonchunghyang University [20130622]	Soonchunghyang University	Soonchunghyang University Research fund (No. 20130622). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergen PJ, 2006, ANTIMICROB AGENTS CH, V50, P1953, DOI 10.1128/AAC.00035-06; Dai CS, 2014, ANTIMICROB AGENTS CH, V58, P4075, DOI 10.1128/AAC.00070-14; del Moral RG, 1998, EXP NEPHROL, V6, P89; Demeule M, 1999, FEBS LETT, V442, P208, DOI 10.1016/S0014-5793(98)01663-9; Eadon MT, 2013, PHYSIOL GENOMICS, V45, P877, DOI 10.1152/physiolgenomics.00076.2013; Falagas ME, 2006, CRIT CARE, V10, DOI 10.1186/cc3995; Ghlissi Z, 2013, RENAL FAILURE, V35, P1130, DOI 10.3109/0886022X.2013.815091; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; Gozuacik D, 2007, CURR TOP DEV BIOL, V78, P217, DOI 10.1016/S0070-2153(06)78006-1; Kim YH, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-60; Ko HJ, 2011, NEPHRON CLIN PRACT, V117, pC284, DOI 10.1159/000320746; Kundu M, 2008, ANNU REV PATHOL-MECH, V3, P427, DOI 10.1146/annurev.pathmechdis.2.010506.091842; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Li J, 2006, LANCET INFECT DIS, V6, P589, DOI 10.1016/S1473-3099(06)70580-1; Li L, 2010, AM J PATHOL, V176, P1767, DOI 10.2353/ajpath.2010.090345; Livingston MJ, 2014, SEMIN NEPHROL, V34, P17, DOI 10.1016/j.semnephrol.2013.11.004; Ma Z, 2009, ANTIMICROB AGENTS CH, V53, P2857, DOI 10.1128/AAC.00030-09; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Ozyilmaz E, 2011, INTENS CARE MED, V37, P141, DOI 10.1007/s00134-010-2038-7; Paglin S, 2001, CANCER RES, V61, P439; Phe K, 2014, ANTIMICROB AGENTS CH, V58, P2740, DOI 10.1128/AAC.02476-13; Romiti N, 2002, TOXICOL APPL PHARM, V183, P83, DOI 10.1006/taap.2002.9461; Taipalensuu J, 2001, J PHARMACOL EXP THER, V299, P164; Wang LT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079814; Yang C, 2008, AM J PHYSIOL-RENAL, V294, pF777, DOI 10.1152/ajprenal.00590.2007; Yousef JM, 2012, J ANTIMICROB CHEMOTH, V67, P452, DOI 10.1093/jac/dkr483; Yousef JM, 2011, ANTIMICROB AGENTS CH, V55, P4044, DOI 10.1128/AAC.00328-11; Yun B, 2015, J ANTIMICROB CHEMOTH, V70, P827, DOI 10.1093/jac/dku441; Zhang XH, 2014, J IMMUNOL, V193, P2405, DOI 10.4049/jimmunol.1302798	30	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136075	10.1371/journal.pone.0136075	http://dx.doi.org/10.1371/journal.pone.0136075			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287374	Green Submitted, Green Published, gold			2022-12-26	WOS:000360018600105
J	Perogamvros, L; Aberg, K; Gex-Fabry, M; Perrig, S; Cloninger, CR; Schwartz, S				Perogamvros, Lampros; Aberg, Kristoffer; Gex-Fabry, Marianne; Perrig, Stephen; Cloninger, C. Robert; Schwartz, Sophie			Increased Reward-Related Behaviors during Sleep and Wakefulness in Sleepwalking and Idiopathic Nightmares	PLOS ONE			English	Article							CYCLIC ALTERNATING PATTERN; NOVELTY-SEEKING; DREAM CONTENT; REM-SLEEP; PERSONALITY PROFILES; BAD DREAMS; WAKE-LIKE; DISORDER; FREQUENCY; TEMPERAMENT	Background We previously suggested that abnormal sleep behaviors, i.e., as found in parasomnias, may often be the expression of increased activity of the reward system during sleep. Because nightmares and sleepwalking predominate during REM and NREM sleep respectively, we tested here whether exploratory excitability, a waking personality trait reflecting high activity within the mesolimbic dopaminergic (ML-DA) system, may be associated with specific changes in REM and NREM sleep patterns in these two sleep disorders. Methods Twenty-four unmedicated patients with parasomnia (12 with chronic sleepwalking and 12 with idiopathic nightmares) and no psychiatric comorbidities were studied. Each patient spent one night of sleep monitored by polysomnography. The Temperament and Character Inventory (TCI) was administered to all patients and healthy controls from the Geneva population (n = 293). Results Sleepwalkers were more anxious than patients with idiopathic nightmares (Spielberger Trait anxiety/STAI-T), but the patient groups did not differ on any personality dimension as estimated by the TCI. Compared to controls, parasomnia patients (sleepwalkers together with patients with idiopathic nightmares) scored higher on the Novelty Seeking (NS) TCI scale and in particular on the exploratory excitability/curiosity (NS1) subscale, and lower on the Self-directedness (SD) TCI scale, suggesting a general increase in reward sensitivity and impulsivity. Furthermore, parasomnia patients tended to worry about social separation persistently, as indicated by greater anticipatory worry (HA1) and dependence on social attachment (RD3). Moreover, exploratory excitability (NS1) correlated positively with the severity of parasomnia (i.e., the frequency of self-reported occurrences of nightmares and sleepwalking), and with time spent in REM sleep in patients with nightmares. Conclusions These results suggest that patients with parasomnia might share common waking personality traits associated to reward-related brain functions. They also provide further support to the notion that reward-seeking networks are active during human sleep.	[Perogamvros, Lampros; Gex-Fabry, Marianne; Perrig, Stephen] Univ Hosp Geneva, Dept Psychiat, Geneva, Switzerland; [Perogamvros, Lampros; Aberg, Kristoffer; Schwartz, Sophie] Univ Geneva, Dept Neurosci, Geneva, Switzerland; [Perogamvros, Lampros] Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA; [Aberg, Kristoffer; Schwartz, Sophie] Univ Geneva, Swiss Ctr Affect Sci, Geneva, Switzerland; [Cloninger, C. Robert] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA	University of Geneva; University of Geneva; University of Wisconsin System; University of Wisconsin Madison; University of Geneva; Washington University (WUSTL)	Perogamvros, L (corresponding author), Univ Hosp Geneva, Dept Psychiat, Geneva, Switzerland.	lambros.pero@gmail.com	Aberg, Kristoffer/F-1040-2018; Perogamvros, Lampros/AAC-4931-2019; Cloninger, Claude/F-5357-2012	Aberg, Kristoffer/0000-0002-0970-400X; Cloninger, Claude/0000-0003-3096-4807; Schwartz, Sophie/0000-0001-7718-4053	Swiss National Science Foundation [320030_135653]; National Center of Competence in Research (NCCR) Affective Sciences - Swiss National Science Foundation [51NF40-104897]; BIAL Foundation [225/12]; Boninchi Foundation; Swiss Branch of the Anthropedia Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center of Competence in Research (NCCR) Affective Sciences - Swiss National Science Foundation; BIAL Foundation(Bial Foundation); Boninchi Foundation; Swiss Branch of the Anthropedia Foundation	This work was supported by the Swiss National Science Foundation (No 320030_135653) to SS, the National Center of Competence in Research (NCCR) Affective Sciences financed by the Swiss National Science Foundation (No 51NF40-104897) to SS, the BIAL Foundation (No 225/12) to SS, and a grant from the Boninchi Foundation to SS. CC is supported by the Swiss Branch of the Anthropedia Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abler B, 2006, NEUROIMAGE, V31, P790, DOI 10.1016/j.neuroimage.2006.01.001; American Academy of Sleep Medicine, 2005, DIAGN COD MAN; American Academy of Sleep Medicine, 2014, INT CLASS SLEEP DIS, V3rd; Bassetti C, 2000, LANCET, V356, P484, DOI 10.1016/S0140-6736(00)02561-7; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Blagrove M, 2004, J SLEEP RES, V13, P129, DOI 10.1111/j.1365-2869.2004.00394.x; BONKALO A, 1974, PSYCHIAT QUART, V48, P400, DOI 10.1007/BF01562162; Bonnet MH, 2007, J CLIN SLEEP MED, V3, P271; Bravo-Ortiz M, 2013, SLEEP MED S1, V14, P297; Brion A, 2012, SLEEP MED, V13, P1094, DOI 10.1016/j.sleep.2012.06.012; Cartwright R, 2005, SLEEPWALKING HOBOKEN; Chivers L, 1999, PERS INDIV DIFFER, V27, P843, DOI 10.1016/S0191-8869(99)00033-1; Cloninger C Robert, 2011, Int J Pers Cent Med, V1, P43; Cloninger CR, 2012, J AFFECT DISORDERS, V136, P758, DOI 10.1016/j.jad.2011.09.046; Cloninger CR, 2009, AUST NZ J PSYCHIAT, V43, P994, DOI 10.3109/00048670903270506; CLONINGER CR, 1987, ARCH GEN PSYCHIAT, V44, P573; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; CLONINGER CR, 1986, PSYCHIAT DEV, V4, P167; Ebstein RP, 1997, MOL PSYCHIATR, V2, P381, DOI 10.1038/sj.mp.4000315; Fantini ML, 2005, NEUROLOGY, V65, P1010, DOI 10.1212/01.wnl.0000179346.39655.e0; Farmer A, 2003, ARCH GEN PSYCHIAT, V60, P490, DOI 10.1001/archpsyc.60.5.490; Feld GB, 2014, J COGNITIVE NEUROSCI, V26, P2310, DOI 10.1162/jocn_a_00629; Giesbrecht T, 2004, PERS INDIV DIFFER, V37, P1341, DOI 10.1016/j.paid.2004.01.004; Guilleminault C, 2006, SLEEP MED, V7, P163, DOI 10.1016/j.sleep.2005.12.006; Guilleminault C, 2005, BRAIN, V128, P1062, DOI 10.1093/brain/awh481; Guilleminault C, 2001, J PSYCHOSOM RES, V51, P411, DOI 10.1016/S0022-3999(01)00187-8; Guilleminault C, 2006, SLEEP, V29, P14; HARTMANN E, 1989, PSYCHIAT J U OTTAWA, V14, P557; Howell D. C., 2013, STAT METHODS PSYCHOL; Hublin C, 1997, NEUROLOGY, V48, P177, DOI 10.1212/WNL.48.1.177; Hublin C, 1999, AM J MED GENET, V88, P329, DOI 10.1002/(SICI)1096-8628(19990820)88:4<329::AID-AJMG8>3.0.CO;2-E; Iber C., 2007, AASM MANUAL SCORING; Krebs RM, 2009, BIOL PSYCHIAT, V65, P103, DOI 10.1016/j.biopsych.2008.08.019; Kryger MH., 2011, PRINCIPLES PRACTICE; Labelle MA, 2013, SLEEP MED, V14, P1348, DOI 10.1016/j.sleep.2013.05.023; Lancee J, 2010, SLEEP BIOL RHYTHMS, V8, P187, DOI 10.1111/j.1479-8425.2010.00447.x; Lansink CS, 2008, J NEUROSCI, V28, P6372, DOI 10.1523/JNEUROSCI.1054-08.2008; Levin R, 2002, SLEEP, V25, P205; Leyton M, 2002, NEUROPSYCHOPHARMACOL, V27, P1027, DOI 10.1016/S0893-133X(02)00366-4; Licis AK, 2011, NEUROLOGY, V76, P49, DOI 10.1212/WNL.0b013e318203e964; Lopez R, 2013, SLEEP, V36, P345, DOI 10.5665/sleep.2446; Mahowald MW, 2011, CURR TOP MED CHEM, V11, P2392; McNamara P, 2001, J SLEEP RES, V10, P117, DOI 10.1046/j.1365-2869.2001.00244.x; McNamara P, 2011, ATTACH HUM DEV, V13, P141, DOI 10.1080/14616734.2011.553999; Mwenge B, 2013, SLEEP MED, V14, P1226, DOI 10.1016/j.sleep.2013.04.027; Nielsen T, 2007, SLEEP MED REV, V11, P295, DOI 10.1016/j.smrv.2007.03.004; Nobili L, 2011, NEUROIMAGE, V58, P612, DOI 10.1016/j.neuroimage.2011.06.032; Ohayon MM, 1999, J CLIN PSYCHIAT, V60, P268, DOI 10.4088/JCP.v60n0413; Oudiette D, 2009, SLEEP, V32, P1621, DOI 10.1093/sleep/32.12.1621; Panksepp J., 1998, AFFECTIVE NEUROSCIEN; Park JH, 2012, PSYCHIAT RES, V197, P275, DOI 10.1016/j.psychres.2011.09.018; Perogamvros L, 2012, FRONT NEUROL, V3, DOI 10.3389/fneur.2012.00168; Perogamvros L, 2012, NEUROSCI BIOBEHAV R, V36, P1934, DOI 10.1016/j.neubiorev.2012.05.010; Perroud N, 2013, J AFFECT DISORDERS, V146, P246, DOI 10.1016/j.jad.2012.09.012; Preisig M, 1999, EUR ARCH PSY CLIN N, V249, P174, DOI 10.1007/s004060050084; Revonsuo A, 2000, BEHAV BRAIN SCI, V23, P877, DOI 10.1017/S0140525X00004015; Robert G, 2014, SLEEP, V37, P409, DOI 10.5665/sleep.3426; Saurat MT, 2011, CONSCIOUS COGN, V20, P1425, DOI 10.1016/j.concog.2011.05.015; Schmidt RE, 2008, BEHAV SLEEP MED, V6, P178, DOI 10.1080/15402000802162570; Schredl M, 2003, EUR ARCH PSY CLIN N, V253, P241, DOI 10.1007/s00406-003-0438-1; Schredl M, 2003, CONSCIOUS COGN, V12, P298, DOI 10.1016/S1053-8100(02)00072-7; Schredl M, 1999, DREAMING, V9, P257, DOI 10.1023/A:1021336103535; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Simor P, 2014, J SLEEP RES, V23, P70; Simor P, 2013, BIOL PSYCHOL, V94, P592, DOI 10.1016/j.biopsycho.2013.05.022; Simor P, 2013, SLEEP, V36, P413, DOI 10.5665/sleep.2462; Simor P, 2011, SCAND J PSYCHOL, V52, P369, DOI 10.1111/j.1467-9450.2011.00888.x; Small DM, 2003, NEUROIMAGE, V18, P633, DOI 10.1016/S1053-8119(02)00012-5; Smith MJ, 2008, SCHIZOPHR RES, V104, P198, DOI 10.1016/j.schres.2008.06.025; Solms M, 2000, BEHAV BRAIN SCI, V23, P843, DOI 10.1017/S0140525X00003988; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Spoormaker VI, 2006, SLEEP MED REV, V10, P19, DOI 10.1016/j.smrv.2005.06.001; Terzaghi M, 2009, SLEEP, V32, P409, DOI 10.1093/sleep/32.3.409; Voss U, 2011, CONSCIOUS COGN, V20, P673, DOI 10.1016/j.concog.2010.10.020; Winkelman John W, 2011, Handb Clin Neurol, V98, P577, DOI 10.1016/B978-0-444-52006-7.00037-X; Zadra A, 2006, SLEEP, V29, pA269; Zadra A, 2000, J ABNORM PSYCHOL, V109, P273, DOI 10.1037/0021-843X.109.2.273; Zadra A, 2013, LANCET NEUROL, V12, P285, DOI 10.1016/S1474-4422(12)70322-8; Zald DH, 2008, J NEUROSCI, V28, P14372, DOI 10.1523/JNEUROSCI.2423-08.2008	79	9	9	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0134504	10.1371/journal.pone.0134504	http://dx.doi.org/10.1371/journal.pone.0134504			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP6SN	26287974	Green Published, Green Submitted, gold			2022-12-26	WOS:000360018600022
J	Xiang, JJ; Hansen, A; Pisaniello, D; Bi, P				Xiang, Jianjun; Hansen, Alana; Pisaniello, Dino; Bi, Peng			Perceptions of Workplace Heat Exposure and Controls among Occupational Hygienists and Relevant Specialists in Australia	PLOS ONE			English	Article							FARM-WORKERS; ILLNESS; HEALTH; MIGRANT; PREVENTION; EXHAUSTION; SAFETY; ISSUES; IMPACT; INDEX	With warmer weather projections, workplace heat exposure is presenting a growing challenge to workers' health and safety. Occupational hygienists are the specialist group conducting measurements and providing advice on heat stress management to industry. In order to provide insights into hygienists perceptions on workplace heat exposure, current and future preparedness for extreme heat, and barriers to possible heat adaptation strategies, a self-administered questionnaire survey was conducted during a national conference of the Australian Institute of Occupational Hygienists. Nearly 90% of the 180 respondents were at least moderately concerned about extreme heat and 19% were dissatisfied with current heat stress prevention measures. Barriers recognized by the participants were lack of awareness (68%), insufficient training (56%), unsatisfactory management commitment (52%), and low compliance with prevention policies (40%). The findings suggest a need to refine occupational heat management and prevention strategies.	[Xiang, Jianjun; Hansen, Alana; Pisaniello, Dino; Bi, Peng] Univ Adelaide, Sch Publ Hlth, Adelaide, SA, Australia; [Xiang, Jianjun] Fujian Prov Ctr Dis Control & Prevent, Dept Publ Hlth Preparedness & Response, Fuzhou, Fujian, Peoples R China	University of Adelaide	Bi, P (corresponding author), Univ Adelaide, Sch Publ Hlth, Adelaide, SA, Australia.	peng.bi@adelaide.edu.au		Xiang, Jianjun/0000-0002-6862-2696; Pisaniello, Dino/0000-0002-4156-0608; Bi, Peng/0000-0002-3238-3427				Balakrishnan K, 2010, GLOBAL HEALTH ACTION, V3, DOI 10.3402/gha.v3i0.5635; Commonwealth Scientific and Industrial Research Organisation (CSIRO) & Bureau of Meteorology, 2014, STAT CLIM 2014; Corleto RD, 2013, GUIDE MANAGING HEAT; Crowe J, 2009, GLOBAL HEALTH ACTION, V2, P71, DOI 10.3402/gha.v2i0.2062; Crowe J, 2010, GLOBAL HEALTH ACTION, V3, DOI 10.3402/gha.v3i0.5619; Cutforth P, 2013, WORKERS DEATH LINKED; Donoghue AM, 2000, OCCUP MED-OXFORD, V50, P259, DOI 10.1093/occmed/50.4.259; Donoghue AM, 2000, OCCUP ENVIRON MED, V57, P165, DOI 10.1136/oem.57.3.165; Fleischer NL, 2013, AM J PREV MED, V44, P199, DOI 10.1016/j.amepre.2012.10.020; Forbes CF, 2010, INT J BIOMETEOROL, V52, P1; [Forestry Mining and Energy Union (CFMEU) Australian Construction], 2012, INCL WEATH HEAT POL; Government of Western Australia, 2009, DEATH QUEENSL WORK P; Gubernot DM, 2014, INT J BIOMETEOROL, V58, P1779, DOI 10.1007/s00484-013-0752-x; Gun RT, 1987, STUDIES HEAT STRESS; Hanna EG, 2011, ASIA-PAC J PUBLIC HE, V23, p14S, DOI 10.1177/1010539510391457; Hansen E, 2003, J HEALTH CARE POOR U, V14, P153, DOI 10.1177/1049208903014002001; Hyatt OM, 2010, GLOBAL HEALTH ACTION, V3, DOI 10.3402/gha.v3i0.5715; Kjellstrom T, 2011, HOTHAPS PROGRAM CLIM; Kjellstrom T, 2013, IND HEALTH, V51, P56, DOI 10.2486/indhealth.2012-0174; Kjellstrom T, 2009, GLOBAL HEALTH ACTION, V2, P81, DOI 10.3402/gha.v2i0.2082; Lam M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1004; Maeda T, 2006, J OCCUP HEALTH, V48, P223, DOI 10.1539/joh.48.223; Mares P, 2005, 2 FUT AUSTR COUNTR T; Mathee A, 2010, GLOBAL HEALTH ACTION, V3, DOI 10.3402/gha.v3i0.5612; Mckean B, 2010, BRICKLAYER DIES HEAT; Miller V, 2007, J OCCUP HLTH SAF AUS, V23, P79; Mirabelli MC, 2010, AM J PREV MED, V39, P468, DOI 10.1016/j.amepre.2010.07.008; MOBED K, 1992, WESTERN J MED, V157, P367; Nevarez J, 2013, J OCCUP ENVIRON HYG, V10, pD67, DOI 10.1080/15459624.2013.784177; Oosthuizen J, 2012, GLOBAL WARMING HEAT, P289, DOI [10.5772/34794, DOI 10.5772/34794]; Quandt SA, 2013, AM J PUBLIC HEALTH, V103, pE24, DOI 10.2105/AJPH.2012.301135; Riley K, 2012, NEW SOLUT, V22, P297, DOI 10.2190/NS.22.3.e; Safe Work Australia, 2011, MOD COD PRACT MAN WO; Schulte PA, 2009, J OCCUP ENVIRON HYG, V6, P542, DOI 10.1080/15459620903066008; Singh S, 2015, HEALTH PROMOT INT, V30, P239, DOI 10.1093/heapro/dat027; Stoecklin-Marois M, 2013, IND HEALTH, V51, P47, DOI 10.2486/indhealth.2012-0128; Storey K, 2001, AUST GEOGR, V32, P133, DOI 10.1080/00049180120066616; The US Department of Labor, 2011, CAMPAIGN TO PREVENT; Tongco M. D. C., 2007, Ethnobotany Research and Applications, V5, P147; Xiang J, 2013, IND HLTH, V52, P91; Xiang JJ, 2014, ENVIRON RES, V133, P90, DOI 10.1016/j.envres.2014.04.042; Xiang JJ, 2014, OCCUP ENVIRON MED, V71, P246, DOI 10.1136/oemed-2013-101584	42	28	29	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135040	10.1371/journal.pone.0135040	http://dx.doi.org/10.1371/journal.pone.0135040			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP6SN	26287608	Green Published, gold, Green Submitted			2022-12-26	WOS:000360018600033
J	Mia, S; Federico, G; Feger, M; Pakladok, T; Meissner, A; Voelkl, J; Groene, HJ; Alesutan, I; Lang, F				Mia, Sobuj; Federico, Giuseppina; Feger, Martina; Pakladok, Tatsiana; Meissner, Adrian; Voelkl, Jakob; Groene, Hermann-Josef; Alesutan, Ioana; Lang, Florian			Impact of AMP-Activated Protein Kinase alpha 1 Deficiency on Tissue Injury following Unilateral Ureteral Obstruction	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CHRONIC KIDNEY-DISEASE; NF-KAPPA-B; TGF-BETA; RENAL FIBROSIS; MYOCARDIAL-INFARCTION; SKELETAL-MUSCLE; ANGIOTENSIN-II; TAK1; PATHWAY	Background AMP-activated protein kinase (Ampk) is a sensor of the cellular energy status and a powerful regulator of metabolism. Activation of Ampk was previously shown to participate in monocyte-to-fibroblast transition and matrix protein production in renal tissue. Thus, the present study explored whether the catalytic Ampk alpha 1 isoform participates in the regulation of the renal fibrotic response following unilateral ureteral obstruction (UUO). Methods UUO was induced in gene-targeted mice lacking functional Ampk alpha 1 (Ampk alpha 1(-/-)) and in corresponding wild-type mice (Ampk alpha 1(+/+)). In the obstructed kidney and, for comparison, in the non-obstructed control kidney, quantitative RT-PCR, Western blotting and immunostaining were employed to determine transcript levels and protein abundance, respectively. Results In Ampk alpha 1(+/+) mice, UUO significantly up-regulated the protein abundance of the Ampka1 isoform, but significantly down-regulated the Ampk alpha 2 isoform in renal tissue. Phosphorylated Ampka protein levels were significantly increased in obstructed kidney tissue of Ampk alpha 1(+/+) mice but not of Ampk alpha 1(-/-) mice. Renal expression of a-smooth muscle actin was increased following UUO, an effect again less pronounced in Ampk alpha 1(-/-) mice than in Ampk alpha 1(+/+) mice. Histological analysis did not reveal a profound effect of Ampk alpha 1 deficiency on collagen 1 protein deposition. UUO significantly increased phosphorylated and total Tgf-beta-activated kinase 1 (Tak1) protein, as well as transcript levels of Tak1-downstream targets c-Fos, Il6, Pai1 and Snai1 in Ampk alpha 1(+/+) mice, effects again significantly ameliorated in Ampk alpha 1(-/-) mice. Moreover, Ampk alpha 1 deficiency inhibited the UUO-induced mRNA expression of Cd206, a marker of M2 macrophages and of Cxcl16, a pro-fibrotic chemokine associated with myeloid fibroblast formation. The effects of Ampk alpha 1 deficiency during UUO were, however, paralleled by increased tubular injury and apoptosis. Conclusions Renal obstruction induces an isoform shift from Ampk alpha 2 towards Ampk alpha 1, which contributes to the signaling involved in cell survival and fibrosis.	[Mia, Sobuj; Feger, Martina; Pakladok, Tatsiana; Meissner, Adrian; Voelkl, Jakob; Alesutan, Ioana; Lang, Florian] Univ Tubingen, Dept Physiol, D-72076 Tubingen, Germany; [Federico, Giuseppina; Groene, Hermann-Josef] German Canc Res Ctr, Dept Cellular & Mol Pathol, D-69120 Heidelberg, Germany	Eberhard Karls University of Tubingen; Helmholtz Association; German Cancer Research Center (DKFZ)	Lang, F (corresponding author), Univ Tubingen, Dept Physiol, Gmelinstr 5, D-72076 Tubingen, Germany.	florian.lang@uni-tuebingen.de	Voelkl, Jakob/T-4298-2019; Mia, Sobuj/P-5425-2017		Deutsche Forschungsgemeinschaft [GK 1302]; IZKF-Nachwuchsgruppe of the Medical Faculty of the University of Tubingen [1889-0-0]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); IZKF-Nachwuchsgruppe of the Medical Faculty of the University of Tubingen	The funders, Deutsche Forschungsgemeinschaft (GK 1302 / URL: http://www.dfg.de/) and IZKF-Nachwuchsgruppe of the Medical Faculty of the University of Tubingen (No. 1889-0-0/ URL: http://www.acrc-gu.de/izkf_tuebingen.php?first = izkf) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bair AM, 2009, J BIOL CHEM, V284, P563, DOI 10.1074/jbc.M803984200; Bascands JL, 2005, KIDNEY INT, V68, P925, DOI 10.1111/j.1523-1755.2005.00486.x; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Carling David, 2007, Novartis Found Symp, V286, P72; Chen G, 2011, J AM SOC NEPHROL, V22, P1876, DOI 10.1681/ASN.2010080881; Chen KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106554; Chen ZY, 2013, MOL CELL BIOCHEM, V377, P35, DOI 10.1007/s11010-013-1568-z; Cheng JZ, 2010, KIDNEY INT, V78, P668, DOI 10.1038/ki.2010.214; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Choi ME, 2012, SEMIN NEPHROL, V32, P244, DOI 10.1016/j.semnephrol.2012.04.003; Cieslik KA, 2013, J MOL CELL CARDIOL, V63, P26, DOI 10.1016/j.yjmcc.2013.07.005; Cieslik KA, 2011, AM J PATHOL, V179, P1792, DOI 10.1016/j.ajpath.2011.06.022; Dai YB, 2011, J AM SOC NEPHROL, V22, P890, DOI 10.1681/ASN.2010080890; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Evans AM, 2005, J BIOL CHEM, V280, P41504, DOI 10.1074/jbc.M510040200; Foller M, 2009, FASEB J, V23, P1072, DOI 10.1096/fj.08-121772; Grgic I, 2012, PEDIATR NEPHROL, V27, P183, DOI 10.1007/s00467-011-1772-6; Guo F, 2013, J INVEST DERMATOL, V133, P1646, DOI 10.1038/jid.2013.28; Gusarova GA, 2009, MOL CELL BIOL, V29, P3455, DOI 10.1128/MCB.00054-09; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hattori Y, 2006, HYPERTENSION, V47, P265, DOI 10.1161/01.HYP.0000198425.21604.aa; He JH, 2013, CLIN EXP NEPHROL, V17, P488, DOI 10.1007/s10157-013-0781-0; Herrero-Martin G, 2009, EMBO J, V28, P677, DOI 10.1038/emboj.2009.8; Horman Sandrine, 2012, Curr Heart Fail Rep, V9, P164, DOI 10.1007/s11897-012-0102-z; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; Kim M, 2012, J MOL CELL CARDIOL, V52, P1066, DOI 10.1016/j.yjmcc.2012.01.016; Kim SY, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.95; Kriz W, 2011, J CLIN INVEST, V121, P468, DOI 10.1172/JCI44595; Lee JH, 2013, AM J PHYSIOL-RENAL, V304, pF686, DOI 10.1152/ajprenal.00148.2012; Liang Y, 2014, BRIT J PHARMACOL, V171, P498, DOI 10.1111/bph.12482; Liu XN, 2014, P NATL ACAD SCI USA, V111, pE435, DOI 10.1073/pnas.1311121111; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Lokmic Z, 2012, INT REV CEL MOL BIO, V296, P139, DOI 10.1016/B978-0-12-394307-1.00003-5; Ma FY, 2011, AM J PHYSIOL-RENAL, V300, pF1410, DOI 10.1152/ajprenal.00018.2011; Ma YG, 2013, CIRC RES, V112, P675, DOI 10.1161/CIRCRESAHA.111.300502; Mcgee SL, 2008, FRONT BIOSCI-LANDMRK, V13, P3022, DOI 10.2741/2907; Mishra R, 2008, J BIOL CHEM, V283, P10461, DOI 10.1074/jbc.M800902200; Noppe G, 2014, J MOL CELL CARDIOL, V74, P32, DOI 10.1016/j.yjmcc.2014.04.018; Pan BX, 2015, CELL PHYSIOL BIOCHEM, V35, P1062, DOI 10.1159/000373932; Qin SF, 2008, J BIOL CHEM, V283, P6744, DOI 10.1074/jbc.M708848200; Roca H, 2009, J BIOL CHEM, V284, P34342, DOI 10.1074/jbc.M109.042671; Samarakoon R, 2012, CELL TISSUE RES, V347, P117, DOI 10.1007/s00441-011-1181-y; Sasaki Y, 2001, J BIOL CHEM, V276, P29943, DOI 10.1074/jbc.M104230200; Shen YY, 2007, NEPHROL DIAL TRANSPL, V22, P171, DOI 10.1093/ndt/gfl552; Silverstein DM, 2003, KIDNEY INT, V64, P25, DOI 10.1046/j.1523-1755.2003.00067.x; Steinberg GR, 2009, APPL PHYSIOL NUTR ME, V34, P315, DOI 10.1139/H09-009; Strippoli R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031492; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Viollet B, 2010, CRIT REV BIOCHEM MOL, V45, P276, DOI 10.3109/10409238.2010.488215; Voelkl J, 2013, KIDNEY BLOOD PRESS R, V38, P156, DOI 10.1159/000355763; Wang SX, 2010, CIRC RES, V106, P1117, DOI 10.1161/CIRCRESAHA.109.212530; Winder WW, 2007, CELL BIOCHEM BIOPHYS, V47, P332, DOI 10.1007/s12013-007-0008-7; Winder WW, 2000, J APPL PHYSIOL, V88, P2219, DOI 10.1152/jappl.2000.88.6.2219; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Xie M, 2006, P NATL ACAD SCI USA, V103, P17378, DOI 10.1073/pnas.0604708103; Xiong M, 2012, AM J PHYSIOL-RENAL, V303, pF1107, DOI 10.1152/ajprenal.00151.2012; Xu X, 2014, HYPERTENSION, V63, P723, DOI 10.1161/HYPERTENSIONAHA.113.02619; Yanagita M, 2012, NEPHROL DIAL TRANSPL, V27, P3686, DOI 10.1093/ndt/gfs381; Yang J, 2013, J AM SOC NEPHROL, V24, P1644, DOI 10.1681/ASN.2013030217; Yu Y, 2008, J BIOL CHEM, V283, P24497, DOI 10.1074/jbc.M802825200; Zaha VG, 2012, CIRC RES, V111, P800, DOI 10.1161/CIRCRESAHA.111.255505; Zhang F, 2009, AM J PHYSIOL-CELL PH, V296, pC346, DOI 10.1152/ajpcell.00444.2008	63	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135235	10.1371/journal.pone.0135235	http://dx.doi.org/10.1371/journal.pone.0135235			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285014	Green Submitted, Green Published, gold			2022-12-26	WOS:000359666100029
J	Rajkumar, H; Ramagoni, RK; Anchoju, VC; Vankudavath, RN; Syed, AUZ				Rajkumar, Hemalatha; Ramagoni, Ramesh Kumar; Anchoju, Vijayendra Chary; Vankudavath, Raju Naik; Syed, Arshi Uz Zaman			De Novo Transcriptome Analysis of Allium cepa L. (Onion) Bulb to Identify Allergens and Epitopes	PLOS ONE			English	Article							EXPRESSED SEQUENCE TAGS; CONTACT-DERMATITIS; IGE	Allium cepa (onion) is a diploid plant with one of the largest nuclear genomes among all diploids. Onion is an example of an under-researched crop which has a complex heterozygous genome. There are no allergenic proteins and genomic data available for onions. This study was conducted to establish a transcriptome catalogue of onion bulb that will enable us to study onion related genes involved in medicinal use and allergies. Transcriptome dataset generated from onion bulb using the Illumina HiSeq 2000 technology showed a total of 99,074,309 high quality raw reads (similar to 20 Gb). Based on sequence homology onion genes were categorized into 49 different functional groups. Most of the genes however, were classified under 'unknown' in all three gene ontology categories. Of the categorized genes, 61.2% showed metabolic functions followed by cellular components such as binding, cellular processes; catalytic activity and cell part. With BLASTx top hit analysis, a total of 2,511 homologous allergenic sequences were found, which had 37-100% similarity with 46 different types of allergens existing in the database. From the 46 contigs or allergens, 521 B-cell linear epitopes were identified using BepiPred linear epitope prediction tool. This is the first comprehensive insight into the transcriptome of onion bulb tissue using the NGS technology, which can be used to map IgE epitopes and prediction of structures and functions of various proteins.	[Rajkumar, Hemalatha; Ramagoni, Ramesh Kumar; Anchoju, Vijayendra Chary] Indian Council Med Res, Natl Inst Nutr, Dept Microbiol & Immunol, Hyderabad 500007, Telangana State, India; [Vankudavath, Raju Naik] Indian Council Med Res, Natl Inst Nutr, Biomed Informat Ctr, Hyderabad 500007, Telangana State, India; [Syed, Arshi Uz Zaman] Nucleome Informat Pvt Ltd, Hyderabad 500049, Telangana State, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN); Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN)	Rajkumar, H (corresponding author), Indian Council Med Res, Natl Inst Nutr, Dept Microbiol & Immunol, Jamai Osmania Po, Hyderabad 500007, Telangana State, India.	rhemalathanin@gmail.com	Rajunaik, Vankudavath/GPX-0362-2022; Naik Raju, Vankudavath/Q-7148-2017	Rajunaik, Vankudavath/0000-0002-5601-0633; Naik Raju, Vankudavath/0000-0001-8514-1889	Department of Biotechnology, Ministry of science and technology [BT/PR-11489/FNS/20/391/2008]; National Institute of Nutrition, ICMR; Nucleome Informatics Pvt. Ltd.	Department of Biotechnology, Ministry of science and technology; National Institute of Nutrition, ICMR(Indian Council of Medical Research (ICMR)); Nucleome Informatics Pvt. Ltd.	The authors acknowledge the Department of Biotechnology, Ministry of science and technology for funding the study (Grant no. BT/PR-11489/FNS/20/391/2008). The authors thank the National Institute of Nutrition, ICMR for supporting this work. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Nucleome Informatics Pvt. Ltd., provided support in the form of a salary for author Syed Arshi Uz Zaman, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the author contribution section.	Accelrys Software Inc, 2013, DISCOVERY STUDIO MOD; [Anonymous], ALL AB ON; Arena A, 2000, Allergol Immunopathol (Madr), V28, P287; Arochena L, 2012, J INVEST ALLERG CLIN, V22, P441; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Asero R, 2001, J ALLERGY CLIN IMMUN, V108, P309, DOI 10.1067/mai.2001.116983; Asero R, 2007, MOL NUTR FOOD RES, V51, P135, DOI 10.1002/mnfr.200600132; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BLEUMINK E, 1972, BRIT J DERMATOL, V87, P6, DOI 10.1111/j.1365-2133.1972.tb05089.x; Block E., 2010, GARLIC OTHER ALLIUMS; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; BRUIJNZEELKOOMEN C, 1995, ALLERGY, V50, P623, DOI 10.1111/j.1398-9995.1995.tb02579.x; Chinnappareddy LRD, 2013, CZECH J GENET PLANT, V49, P131, DOI 10.17221/111/2013-CJGPB; Collins LJ, 2008, GENOME INFORM SER, V21, P3; Enrique E, 2007, ANN ALLERG ASTHMA IM, V98, P202, DOI 10.1016/S1081-1206(10)60700-4; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Fullwood MJ, 2009, GENOME RES, V19, P521, DOI 10.1101/gr.074906.107; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Gonzalez CA, 2006, INT J CANCER, V118, P2559, DOI 10.1002/ijc.21678; Hamilton RG, 2010, IMMUNOL RES, V47, P273, DOI 10.1007/s12026-009-8160-3; HOST A, 1990, ALLERGY, V45, P587, DOI 10.1111/j.1398-9995.1990.tb00944.x; Ivanciuc O, 2003, NUCLEIC ACIDS RES, V31, P359, DOI 10.1093/nar/gkg010; Kuhl JC, 2004, PLANT CELL, V16, P114, DOI 10.1105/tpc.017202; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; LEVITT M, 1978, BIOCHEMISTRY-US, V17, P4277, DOI 10.1021/bi00613a026; Li XQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088339; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Mari A, 2002, INT ARCH ALLERGY IMM, V129, P286, DOI 10.1159/000067591; Mari A, 2009, CURR ALLERGY ASTHM R, V9, P376, DOI 10.1007/s11882-009-0055-9; McCallum J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-168; Moneret-Vautrin D A, 2002, Allerg Immunol (Paris), V34, P135; Moyle Mignon, 2004, Australas J Dermatol, V45, P223, DOI 10.1111/j.1440-0960.2004.00102.x; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013; Parkinson John, 2009, V533, P1, DOI 10.1007/978-1-60327-136-3_1; Radauer C, 2007, J ALLERGY CLIN IMMUN, V120, P518, DOI 10.1016/j.jaci.2007.07.024; Ricroch A, 2005, GENOME, V48, P511, DOI 10.1139/G05-017; Rowan BA, 2011, DEV CELL, V21, P65, DOI 10.1016/j.devcel.2011.05.021; Sampson HA, 2004, J ALLERGY CLIN IMMUN, V113, P805, DOI 10.1016/j.jaci.2004.03.014; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Shek LPC, 2005, ALLERGY, V60, P912, DOI 10.1111/j.1398-9995.2005.00705.x; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V125, pS116, DOI 10.1016/j.jaci.2009.08.028; Smarda P, 2014, P NATL ACAD SCI USA, V111, pE4096, DOI 10.1073/pnas.1321152111; Toledo-Silva G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070781; Turktas M, 2015, TURK J AGRIC FOR, V39, P361, DOI 10.3906/tar-1409-93; VALDIVIESO R, 1994, J ALLERGY CLIN IMMUN, V94, P928, DOI 10.1016/0091-6749(94)90161-9; Vijayendra CA, 2012, INT J PHARM PHARM SC, V4, P175; Vinogradov AE, 2003, NUCLEIC ACIDS RES, V31, P1838, DOI 10.1093/nar/gkg296; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	50	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135387	10.1371/journal.pone.0135387	http://dx.doi.org/10.1371/journal.pone.0135387			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284934	Green Published, gold, Green Submitted			2022-12-26	WOS:000359666100036
J	Ward, BA				Ward, Ben A.			Temperature-Correlated Changes in Phytoplankton Community Structure Are Restricted to Polar Waters	PLOS ONE			English	Article							SOUTHERN-OCEAN; SIZE STRUCTURE; CHLOROPHYLL; ECOSYSTEMS; PRODUCTIVITY; LIMITATION; ATLANTIC; PIGMENTS; MARINE; GROWTH	Globally distributed observations of size-fractionated chlorophyll a and temperature were used to incorporate temperature dependence into an existing semi-empirical model of phytoplankton community size structure. The additional temperature-dependent term significantly increased the model's ability to both reproduce and predict observations of chlorophyll a size-fractionation at temperatures below 2 degrees C. The most notable improvements were in the smallest (picoplankton) size-class, for which overall model fit was more than doubled, and predictive skill was increased by approximately 40%. The model was subsequently applied to generate global maps for three phytoplankton size classes, on the basis of satellite-derived estimates of surface chlorophyll a and sea surface temperature. Polar waters were associated with marked decline in the chlorophyll a biomass of the smallest cells, relative to lower latitude waters of equivalent total chlorophyll a. In the same regions a complementary increase was seen in the chlorophyll a biomass of larger size classes. These findings suggest that a warming and stratifying ocean will see a poleward expansion of the habitat range of the smallest phytoplankton, with the possible displacement of some larger groups that currently dominate. There was no evidence of a strong temperature dependence in tropical or sub-tropical regions, suggesting that future direct temperature effects on community structure at lower latitudes may be small.	[Ward, Ben A.] Inst Univ Europeen Mer, Lab Sci Environm Marin, Plouzane, France; [Ward, Ben A.] Univ Bristol, Sch Geog Sci, Bristol, Avon, England	Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); University of Bristol	Ward, BA (corresponding author), Inst Univ Europeen Mer, Lab Sci Environm Marin, Pl Nicolas Copernic, Plouzane, France.	b.a.ward@bristol.ac.uk	Ward, Ben/I-4776-2012	Ward, Ben/0000-0003-1290-8270	"Laboratoire d'Excellence" LabexMER [ANR-10-LABX-19]; French government under the program "Investissements d'Avenir"; Regional Council of Brittany (SAD programme); European Research Council "PALEOGENiE" project [ERC-2013-CoG-617313]	"Laboratoire d'Excellence" LabexMER; French government under the program "Investissements d'Avenir"(French National Research Agency (ANR)); Regional Council of Brittany (SAD programme)(Region Bretagne); European Research Council "PALEOGENiE" project	This work was supported by the "Laboratoire d'Excellence" LabexMER (ANR-10-LABX-19), co-funded by a grant from the French government under the program "Investissements d'Avenir", and by a grant from the Regional Council of Brittany (SAD programme). Support through the European Research Council "PALEOGENiE" project (ERC-2013-CoG-617313) is also gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG RA, 1994, LIMNOL OCEANOGR, V39, P597, DOI 10.4319/lo.1994.39.3.0597; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Brewin RJW, 2014, J GEOPHYS RES-OCEANS, V119; Brewin RJW, 2010, ECOL MODEL, V221, P1472, DOI 10.1016/j.ecolmodel.2010.02.014; Cermeno P, 2006, ESTUAR COAST SHELF S, V67, P251, DOI 10.1016/j.ecss.2005.11.027; Clarke A, 2008, DEEP-SEA RES PT II, V55, P1988, DOI 10.1016/j.dsr2.2008.04.035; CUSHING DH, 1989, J PLANKTON RES, V11, P1, DOI 10.1093/plankt/11.1.1; Devred E, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC002880; Dierssen HM, 2010, P NATL ACAD SCI USA, V107, P17073, DOI 10.1073/pnas.0913800107; Edwards KF, 2012, LIMNOL OCEANOGR, V57, P554, DOI 10.4319/lo.2012.57.2.0554; Fiala M, 1998, J MARINE SYST, V17, P179, DOI 10.1016/S0924-7963(98)00037-2; Flombaum P., 2013, P NATL ACAD SCI US, DOI 10.1073/pnas.1307701110; Froneman PW, 2004, DEEP-SEA RES PT II, V51, P2715, DOI 10.1016/j.dsr2.2002.09.001; Froneman PW, 2001, J PLANKTON RES, V23, P611, DOI 10.1093/plankt/23.6.611; Henson SA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046735; Hirata T, 2011, BIOGEOSCIENCES, V8, P311, DOI 10.5194/bg-8-311-2011; Imai K, 2002, DEEP-SEA RES PT II, V49, P5395, DOI 10.1016/S0967-0645(02)00198-4; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Kostadinov TS, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2009JC005303; Lara-Lara JR, 2005, CIENC MAR, V31, P11, DOI 10.7773/cm.v31i11.82; Latasa M, 1998, DEEP-SEA RES PT II, V45, P2133, DOI 10.1016/S0967-0645(98)00066-6; Li WKW, 2009, SCIENCE, V326, P539, DOI 10.1126/science.1179798; Litchman E, 2009, P NATL ACAD SCI USA, V106, P2665, DOI 10.1073/pnas.0810891106; Maranon E, 2001, MAR ECOL PROG SER, V216, P43, DOI 10.3354/meps216043; Maranon E, 2015, LIMNOLOGY OCEANOGRAP; Maranon E, 2015, MAR SCI, V7; Maranon E, 2012, LIMNOL OCEANOGR, V57, P1266, DOI 10.4319/lo.2012.57.5.1266; Moran XAG, 2015, LIMNOLOGY OCEANOGRAP; Moran XAG, 2010, GLOBAL CHANGE BIOL, V16, P1137, DOI 10.1111/j.1365-2486.2009.01960.x; Mouw CB, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2010JC006337; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Roy S, 2013, REMOTE SENS ENVIRON, V139, P185, DOI 10.1016/j.rse.2013.08.004; Sathyendranath S, 2001, INT J REMOTE SENS, V22, P249, DOI 10.1080/014311601449925; SMETACEK VS, 1985, MAR BIOL, V84, P239, DOI 10.1007/BF00392493; Smith RC, 2000, J GEOPHYS RES, V105, P26, DOI [10.1029/, DOI 10.1029/1999JC000296]; Sosik HM, 2002, DEEP-SEA RES PT I, V49, P1195, DOI 10.1016/S0967-0637(02)00015-8; THINGSTAD TF, 1990, MAR ECOL PROG SER, V63, P261, DOI 10.3354/meps063261; Tsuda A, 2003, SCIENCE, V300, P958, DOI 10.1126/science.1082000; Uitz J, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003207	39	38	38	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135581	10.1371/journal.pone.0135581	http://dx.doi.org/10.1371/journal.pone.0135581			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285028	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000359666100045
J	Zheng, J; Wu, WL; Liu, YP; Xiang, Z; Liu, M; Chan, KH; Lau, SY; Lam, KT; To, KKW; Chan, JFW; Li, LJ; Chen, HL; Lau, L; Yuen, KY; Tu, WW				Zheng, Jian; Wu, Wai-Lan; Liu, Yinping; Xiang, Zheng; Liu, Ming; Chan, Kwok-Hung; Lau, Siu-Ying; Lam, Kwok-Tai; To, Kelvin Kai-Wang; Chan, Jasper Fuk-Woo; Li, Lanjuan; Chen, Honglin; Lau, Lung; Yuen, Kwok-Yung; Tu, Wenwei			The Therapeutic Effect of Pamidronate on Lethal Avian Influenza A H7N9 Virus Infected Humanized Mice	PLOS ONE			English	Article							DELTA-T-CELLS; MOUSE MODELS; ORIGIN	A novel avian influenza virus H7N9 infection occurred among human populations since 2013. Although the lack of sustained human-to-human transmission limited the epidemics caused by H7N9, the late presentation of most patients and the emergence of neuraminidase-resistant strains made the development of novel antiviral strategy against H7N9 in urgent demands. In this study, we evaluated the potential of pamidronate, a pharmacological phosphoantigen that can specifically boost human V delta 2-T-cell, on treating H7N9 virus-infected humanized mice. Our results showed that intraperitoneal injection of pamidronate could potently decrease the morbidity and mortality of H7N9-infected mice through controlling both viral replication and inflammation in affected lungs. More importantly, pamidronate treatment starting from 3 days after infection could still significantly ameliorate the severity of diseases in infected mice and improve their survival chance, whereas orally oseltamivir treatment starting at the same time showed no therapeutic effects. As for the mechanisms underlying pamidronate-based therapy, our in vitro data demonstrated that its antiviral effects were partly mediated by IFN-gamma secreted from human V delta 2-T cells. Meanwhile, human V delta 2-T cells could directly kill virus-infected host cells in a perforin-, granzyme B- and CD137-dependent manner. As pamidronate has been used for osteoporosis treatment for more than 20 years, pamidronate-based therapy represents for a safe and readily available option for clinical trials to treat H7N9 infection.	[Zheng, Jian; Liu, Yinping; Xiang, Zheng; Lam, Kwok-Tai; Lau, Lung; Tu, Wenwei] Univ Hong Kong, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China; [Wu, Wai-Lan; Chan, Kwok-Hung; Lau, Siu-Ying; To, Kelvin Kai-Wang; Chan, Jasper Fuk-Woo; Chen, Honglin; Yuen, Kwok-Yung] Univ Hong Kong, Dept Microbiol, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Liu, Ming] Guangzhou Med Univ, Guangzhou Inst Resp Dis, Guangzhou, Guangdong, Peoples R China; [Li, Lanjuan] Zhejiang Univ, Coll Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China	University of Hong Kong; University of Hong Kong; Guangzhou Medical University; Zhejiang University	Tu, WW (corresponding author), Univ Hong Kong, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China.	wwtu@hku.hk	To, Kelvin/AAV-7007-2020; Chen, Honglin/C-4224-2009; Chan, Kwok Hung/ABD-5399-2021; Chan, Jasper F. W./D-8007-2013; Lau, Yu Lung/C-4322-2009	To, Kelvin/0000-0002-1921-5824; Chen, Honglin/0000-0001-5108-8338; Chan, Jasper F. W./0000-0001-6336-6657; Yuen, Kwok-yung/0000-0002-2083-1552; Lau, Yu Lung/0000-0002-4780-0289	General Research Fund, Research Grants Council of Hong Kong [HKU 780113M]; Area of Excellence program on Influenza of Hong Kong SAR, China [AoE/M-12/06]	General Research Fund, Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Area of Excellence program on Influenza of Hong Kong SAR, China	This work was supported in part by General Research Fund, Research Grants Council of Hong Kong (HKU 780113M), Area of Excellence program on Influenza (AoE/M-12/06) of Hong Kong SAR, China, and Dr. Richard YH Yu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bantia S, 2011, ANTIVIR RES, V90, P17, DOI 10.1016/j.antiviral.2011.02.001; Beck BH, 2010, BREAST CANCER RES TR, V122, P135, DOI 10.1007/s10549-009-0527-6; Belser JA, 2007, J INFECT DIS, V196, P1493, DOI 10.1086/522609; Bonneville M, 2006, CURR OPIN IMMUNOL, V18, P539, DOI 10.1016/j.coi.2006.07.002; Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; Chan-Tack KM, 2009, NEW ENGL J MED, V361, P1713, DOI 10.1056/NEJMc0905290; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Cheng VCC, 2012, CLIN MICROBIOL REV, V25, P223, DOI 10.1128/CMR.05012-11; Dharan NJ, 2009, JAMA-J AM MED ASSOC, V301, P1034, DOI 10.1001/jama.2009.294; Ebell Mark H, 2014, Evid Based Med, V19, P211, DOI 10.1136/ebmed-2014-110033; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Hu YW, 2013, LANCET, V381, P2273, DOI 10.1016/S0140-6736(13)61125-3; Hung IFN, 2011, CLIN INFECT DIS, V52, P447, DOI 10.1093/cid/ciq106; Jiang Q, 2008, BLOOD, V112, P2858, DOI 10.1182/blood-2008-03-145946; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1; Luke TC, 2006, ANN INTERN MED, V145, P599, DOI 10.7326/0003-4819-145-8-200610170-00139; Mao Huawei, 2014, Virologica Sinica, V29, P170, DOI 10.1007/s12250-014-3473-3; Mok CKP, 2013, MBIO, V4, DOI 10.1128/mBio.00362-13; Pearson T, 2008, CURR TOP MICROBIOL, V324, P25; Peiris JSM, 2009, EUR J IMMUNOL, V39, P2946, DOI 10.1002/eji.200939911; Poccia F, 2005, IMMUNOL LETT, V100, P14, DOI 10.1016/j.imlet.2005.06.025; Qin G, 2012, J INFECT DIS, V205, P1646, DOI 10.1093/infdis/jis253; Qin G, 2011, J VIROL, V85, P10109, DOI 10.1128/JVI.05341-11; Qin G, 2009, J INFECT DIS, V200, P858, DOI 10.1086/605413; Tu WW, 2011, J EXP MED, V208, P1511, DOI 10.1084/jem.20110226; Viasus D, 2011, J INFECTION, V62, P193, DOI 10.1016/j.jinf.2011.01.014; Wang LS, 2001, J CLIN INVEST, V108, P1349, DOI 10.1172/JCI13584; WHO, MAP EP CURV CONF HUM; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; Zheng BJ, 2008, P NATL ACAD SCI USA, V105, P8091, DOI 10.1073/pnas.0711942105; Zheng J, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004943; Zheng J, 2013, CELL MOL IMMUNOL, V10, P50, DOI 10.1038/cmi.2012.43; Zhirnov OP, 2011, ANTIVIR RES, V92, P27, DOI 10.1016/j.antiviral.2011.07.014; Zhu H, 2013, SCIENCE, V341, P183, DOI 10.1126/science.1239844	36	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135999	10.1371/journal.pone.0135999	http://dx.doi.org/10.1371/journal.pone.0135999			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285203	Green Published, Green Submitted, gold			2022-12-26	WOS:000359666100095
J	Cong, XJ; Campomanes, P; Kless, A; Schapitz, I; Wagener, M; Koch, T; Carloni, P				Cong, Xiaojing; Campomanes, Pablo; Kless, Achim; Schapitz, Inga; Wagener, Markus; Koch, Thomas; Carloni, Paolo			Structural Determinants for the Binding of Morphinan Agonists to the mu-Opioid Receptor	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; FREE-ENERGY; FUNCTIONAL SELECTIVITY; CRYSTAL-STRUCTURE; LIGAND-BINDING; FORCE-FIELD; VALIDATION; ACTIVATION; PROTEINS; RECOGNITION	Atomistic descriptions of the mu-opioid receptor (mu OR) noncovalently binding with two of its prototypical morphinan agonists, morphine (MOP) and hydromorphone (HMP), are investigated using molecular dynamics (MD) simulations. Subtle differences between the binding modes and hydration properties of MOP and HMP emerge from the calculations. Alchemical free energy perturbation calculations show qualitative agreement with in vitro experiments performed in this work: indeed, the binding free energy difference between MOP and HMP computed by forward and backward alchemical transformation is 1.2 +/- 1.1 and 0.8 +/- 0.8 kcal/mol, respectively, to be compared with 0.4 +/- 0.3 kcal/mol from experiment. Comparison with an MD simulation of mu OR covalently bound with the antagonist beta-funaltrexamine hints to agonist-induced conformational changes associated with an early event of the receptor's activation: a shift of the transmembrane helix 6 relative to the transmembrane helix 3 and a consequent loss of the key R165-T279 interhelical hydrogen bond. This finding is consistent with a previous proposal suggesting that the R165-T279 hydrogen bond between these two helices indicates an inactive receptor conformation.	[Cong, Xiaojing; Campomanes, Pablo; Carloni, Paolo] German Res Sch Simulat Sci GmbH, Lab Computat Biophys, D-52425 Julich, Germany; [Cong, Xiaojing; Campomanes, Pablo; Carloni, Paolo] Forschungszentrum Julich, IAS, Computat Biomed Sect IAS 5, D-52425 Julich, Germany; [Cong, Xiaojing; Campomanes, Pablo; Carloni, Paolo] Forschungszentrum Julich, INM, Computat Biomed Sect INM 9, D-52425 Julich, Germany; [Kless, Achim; Schapitz, Inga; Wagener, Markus; Koch, Thomas] Grunenthal GmbH, Grunenthal Innovat, D-52078 Aachen, Germany	Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; Grunenthal Group	Carloni, P (corresponding author), German Res Sch Simulat Sci GmbH, Lab Computat Biophys, D-52425 Julich, Germany.	p.carloni@fz-juelich.de	Campomanes, Pablo/E-1068-2014; Kless, Achim/B-8341-2014	Campomanes, Pablo/0000-0001-9229-8323; Kless, Achim/0000-0001-8301-5934; Carloni, Paolo/0000-0002-9010-0149	European Union [604102]; Grunenthal GmbH	European Union(European Commission); Grunenthal GmbH	This work has been funded by the European Union Seventh Framework Programme (FP7/2007-2013, http://ec.europa.eu/research/fp7) under Grant Agreement N. 604102 (the Human Brain Project) to P. Carloni. The in vitro data were provided by Grunenthal GmbH through research collaboration without additional financial support. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Grunenthal GmbH provided support in the form of salaries for authors [AK, IS, MW and TK] but did not have any additional role in the study design, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ANDERSEN HC, 1980, J CHEM PHYS, V72, P2384, DOI 10.1063/1.439486; AQVIST J, 1990, J PHYS CHEM-US, V94, P8021, DOI 10.1021/j100384a009; Bailey CP, 2005, CURR OPIN PHARMACOL, V5, P60, DOI 10.1016/j.coph.2004.08.012; BROWNSTEIN MJ, 1993, P NATL ACAD SCI USA, V90, P5391, DOI 10.1073/pnas.90.12.5391; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Christie MJ, 2008, BRIT J PHARMACOL, V154, P384, DOI 10.1038/bjp.2008.100; Darden T, 1999, STRUCT FOLD DES, V7, pR55, DOI 10.1016/S0969-2126(99)80033-1; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; DeWire SM, 2013, J PHARMACOL EXP THER, V344, P708, DOI 10.1124/jpet.112.201616; Dreborg S, 2008, P NATL ACAD SCI USA, V105, P15487, DOI 10.1073/pnas.0805590105; Frisch G. W., 2013, GAUSSIAN 09; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Huang P, 2001, BIOCHEMISTRY-US, V40, P13501, DOI 10.1021/bi010917q; Jambeck JPM, 2012, J CHEM THEORY COMPUT, V8, P2938, DOI 10.1021/ct300342n; Jambeck JPM, 2012, J PHYS CHEM B, V116, P3164, DOI 10.1021/jp212503e; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kenakin T, 2011, J PHARMACOL EXP THER, V336, P296, DOI 10.1124/jpet.110.173948; Kirkwood JG, 1935, J CHEM PHYS, V3, P300, DOI 10.1063/1.1749657; Kuehn BM, 2007, JAMA-J AM MED ASSOC, V297, P1306, DOI 10.1001/jama.297.12.1306; Labute P, 2008, J COMPUT CHEM, V29, P1693, DOI 10.1002/jcc.20933; Labute P, 2009, PROTEINS, V75, P187, DOI 10.1002/prot.22234; Lamberts JT, 2013, CURR PHARM DESIGN, V19, P7333; Lau AY, 2007, STRUCTURE, V15, P1203, DOI 10.1016/j.str.2007.07.015; Lau AY, 2011, NAT STRUCT MOL BIOL, V18, P283, DOI 10.1038/nsmb.2010; Law PY, 2013, TRENDS BIOCHEM SCI, V38, P275, DOI 10.1016/j.tibs.2013.03.003; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; LORD JAH, 1977, NATURE, V267, P495, DOI 10.1038/267495a0; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Mansour A, 1997, J NEUROCHEM, V68, P344, DOI 10.1046/j.1471-4159.1997.68010344.x; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; MOLLEREAU C, 1994, FEBS LETT, V341, P33, DOI 10.1016/0014-5793(94)80235-1; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rominger DH, 2014, CURR OPIN PHARMACOL, V16, P108, DOI 10.1016/j.coph.2014.04.002; Ross S, 2009, CLIN NEUROPHARMACOL, V32, P269, DOI 10.1097/WNF.0b013e3181a9163c; Schmidt TH, 2012, J CHEM INF MODEL, V52, P2657, DOI [10.1021/ci3000453, 10.1021/ci30006531]; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Serohijos AWR, 2011, STRUCTURE, V19, P1683, DOI 10.1016/j.str.2011.08.003; Spetea M, 2013, CURR PHARM DESIGN, V19, P7415; Stevens RC, 2013, NAT REV DRUG DISCOV, V12, P25, DOI 10.1038/nrd3859; SURRATT CK, 1994, J BIOL CHEM, V269, P20548; Suwa M, 2011, PHARMACEUTICALS, V4, P652, DOI 10.3390/ph4040652; TATTRIE NH, 1968, CAN J BIOCHEM CELL B, V46, P819, DOI 10.1139/o68-124; Tehan BG, 2014, PHARMACOL THERAPEUT, V143, P51, DOI 10.1016/j.pharmthera.2014.02.004; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Weichenberger CX, 2007, NUCLEIC ACIDS RES, V35, pW403, DOI 10.1093/nar/gkm263; Yuan SG, 2013, ANGEW CHEM INT EDIT, V52, P10112, DOI 10.1002/anie.201302244; Zhang L, 1996, PROTEINS, V24, P433, DOI 10.1002/(SICI)1097-0134(199604)24:4<433::AID-PROT3>3.0.CO;2-F; Zhou L, 2014, CURR OPIN CELL BIOL, V27, P102, DOI 10.1016/j.ceb.2013.11.010	57	16	17	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0135998	10.1371/journal.pone.0135998	http://dx.doi.org/10.1371/journal.pone.0135998			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26280453	gold, Green Published, Green Submitted			2022-12-26	WOS:000359664300031
J	Escobar-Camacho, D; Barriga, R; Ron, SR				Escobar-Camacho, Daniel; Barriga, Ramiro; Ron, Santiago R.			Discovering Hidden Diversity of Characins (Teleostei: Characiformes) in Ecuador's Yasuni National Park	PLOS ONE			English	Article							ASTYANAX-FASCIATUS TELEOSTEI; 6TH MASS EXTINCTION; CRYPTIC DIVERSITY; OSTARIOPHYSI CHARACIFORMES; MOLECULAR-IDENTIFICATION; SPECIES-COMPLEX; FISH; PHYLOGENY; GYMNOTIFORMES; CONSERVATION	Background Management and conservation of biodiversity requires adequate species inventories. The Yasuni National Park is one of the most diverse regions on Earth and recent studies of terrestrial vertebrates, based on genetic evidence, have shown high levels of cryptic and undescribed diversity. Few genetic studies have been carried out in freshwater fishes from western Amazonia. Thus, in contrast with terrestrial vertebrates, their content of cryptic diversity remains unknown. In this study, we carried out genetic and morphological analyses on characin fishes at Yasuni National Park, in eastern Ecuador. Our goal was to identify cryptic diversity among one of the most speciose fish families in the Amazon region. This is the first time that genetic evidence has been used to assess the species content of the Napo Basin, one of the richest regions in vertebrate diversity. Results Phylogenetic analyses of partial mitochondrial 16S ribosomal RNA gene (similar to 600 pb) DNA sequences from 232 specimens of the family Characidae and its closest groups revealed eight candidate new species among 33 species sampled, representing a 24% increase in species number. Analyses of external morphology allowed us to confirm the species status of six of the candidate species. Conclusions Our results show high levels of cryptic diversity in Amazonian characins. If this group is representative of other Amazonian fish, our results would imply that the species richness of the Amazonian ichthyofauna is highly underestimated. Molecular methods are a necessary tool to obtain more realistic inventories of Neotropical freshwater fishes.	[Escobar-Camacho, Daniel; Ron, Santiago R.] Pontificia Univ Catolica Ecuador, Escuela Biol, Museo Zool, Quito, Pichincha, Ecuador; [Escobar-Camacho, Daniel; Barriga, Ramiro] Escuela Politec Nacl, Museo Ictiol, Museo Hist Nat Gustavo Orces, Inst Ciencias Biol, Quito, Pichincha, Ecuador	Pontificia Universidad Catolica del Ecuador; Escuela Politecnica Nacional Ecuador	Ron, SR (corresponding author), Pontificia Univ Catolica Ecuador, Escuela Biol, Museo Zool, Quito, Pichincha, Ecuador.	santiago.r.ron@gmail.com	Ron, Santiago/J-4203-2019	Ron, Santiago/0000-0001-6300-9350	Secretaria Nacional de Educacion Superior, Ciencia, Tecnologia e Innovacion del Ecuador SENESCYT [PI-C08-0000470]; Pontificia Universidad Catolica del Ecuador of the Direccion General Academica (DGA) department	Secretaria Nacional de Educacion Superior, Ciencia, Tecnologia e Innovacion del Ecuador SENESCYT; Pontificia Universidad Catolica del Ecuador of the Direccion General Academica (DGA) department	This study was supported by grants from the Secretaria Nacional de Educacion Superior, Ciencia, Tecnologia e Innovacion del Ecuador SENESCYT (PI-C08-0000470) http://www.educacionsuperior.gob.ec/, for SRR; and a grant from Pontificia Universidad Catolica del Ecuador of the Direccion General Academica (DGA) department for SRR, http://www.puce.edu.ec/portal/content/Cont%C3%A1ctenos/1?link = oln30.redirect. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe KT, 2013, MOL PHYLOGENET EVOL, V69, P1209, DOI 10.1016/j.ympev.2013.07.005; Albert JS, 2011, ANIMALS-BASEL, V1, P205, DOI 10.3390/ani1020205; Albert JS, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P3; Antonelli A, 2011, TAXON, V60, P403, DOI 10.1002/tax.602010; Ardura A, 2010, FOOD RES INT, V43, P1549, DOI 10.1016/j.foodres.2010.03.016; Ardura A, 2010, BIOL CONSERV, V143, P1438, DOI 10.1016/j.biocon.2010.03.019; Balian EV, 2008, HYDROBIOLOGIA, V595, P627, DOI 10.1007/s10750-007-9246-3; Barletta M, 2010, J FISH BIOL, V76, P2118, DOI 10.1111/j.1095-8649.2010.02684.x; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Barriga R. S., 2012, REV POLITECNICA, V30, P83, DOI DOI 10.5962/BHL.TITLE.67474; Bass MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008767; Basset Y, 2012, SCIENCE, V338, P1481, DOI 10.1126/science.1226727; Bergmann PJ, 2007, ZOOL J LINN SOC-LOND, V149, P339; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Calcagnotto D, 2005, MOL PHYLOGENET EVOL, V36, P135, DOI 10.1016/j.ympev.2005.01.004; Casciotta J, 2012, ZOOTAXA, P39; Clare EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022648; Cooke GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048800; Cooke GM, 2012, J BIOGEOGR, V39, P724, DOI 10.1111/j.1365-2699.2011.02635.x; Craig M. T., 2009, Endangered Species Research, V7, P167, DOI 10.3354/esr00117; Di Finizio A, 2007, EUR FOOD RES TECHNOL, V225, P337, DOI 10.1007/s00217-006-0420-z; Elmer KR, 2008, ZOOTAXA, P11, DOI 10.11646/zootaxa.1784.1.2; Eschmeyer WN, 2014, FAMILY SUBFAMILY CHA, P1; Ferreira-Neto M, 2012, COMP CYTOGENET, V6, P29, DOI 10.3897/CompCytogen.v6i1.2151; Finer M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002932; Fink W.L., 1974, Smithsonian Contributions to Zoology, VNo. 172, P1; Fink WL, 1983, B MUSEUM COMP ZOOL, V150, P386; Fouquet A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001109; Fouquet A, 2007, MOL PHYLOGENET EVOL, V43, P567, DOI 10.1016/j.ympev.2006.12.006; Funk WC, 2012, P ROY SOC B-BIOL SCI, V279, P1806, DOI 10.1098/rspb.2011.1653; Garcia-Davilla C, 2013, GENETICA, V141, P347, DOI 10.1007/s10709-013-9734-5; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Javonillo R, 2010, MOL PHYLOGENET EVOL, V54, P498, DOI 10.1016/j.ympev.2009.08.026; Jenkins CN, 2013, P NATL ACAD SCI USA, V110, pE2602, DOI 10.1073/pnas.1302251110; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kavalco KF, 2009, GENET MOL BIOL, V32, P477, DOI 10.1590/S1415-47572009005000055; Kochzius M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012620; Kon T, 2007, MOL PHYLOGENET EVOL, V44, P53, DOI 10.1016/j.ympev.2006.12.007; Kullander S.O., 2003, CHECK LIST FRESHWATE, P605; Lakra WS, 2009, MOL BIOL REP, V36, P831, DOI 10.1007/s11033-008-9252-1; Leary S, 2013, EUTHANASIA ANIMALS; Littmann MW, 2001, P ACAD NAT SCI PHILA, V151, P87, DOI 10.1635/0097-3157(2001)151[0087:ANCSOS]2.0.CO;2; Lundberg JG, 2000, ANN MO BOT GARD, V87, P26, DOI 10.2307/2666207; Maddison WP., 2008, EVOLUTION, V62, P1103; Marcos Mirande J, 2009, Cladistics, V25, P574, DOI 10.1111/j.1096-0031.2009.00262.x; Mirande JM, 2010, NEOTROP ICHTHYOL, V8, P385, DOI 10.1590/S1679-62252010000300001; Mariguela TC, 2013, J ZOOL SYST EVOL RES, V51, P327, DOI 10.1111/jzs.12025; Medrado AS, 2008, GENET MOL BIOL, V31, P208, DOI 10.1590/S1415-47572008000200007; Milhomem SSR, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-75; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Murray SW, 2012, MOL PHYLOGENET EVOL, V62, P597, DOI 10.1016/j.ympev.2011.10.021; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nagamachi CY, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-28; Nakayama C, 2001, COPEIA, P866; Nelson JS, 2006, FISHES WORLD; Oberdorff Thierry, 2011, International Journal of Ecology, V2011, DOI 10.1155/2011/967631; Oliveira C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-275; Ornelas-Garcia Claudia Patricia, 2008, BMC Evol Biol, V8, P340, DOI 10.1186/1471-2148-8-340; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Palumbi S, 1991, SIMPLE FOOLS GUIDE P; Pazza Rubens, 2003, Cytologia (Tokyo), V68, P159, DOI 10.1508/cytologia.68.159; Peces Barriga R., 2011, PECES FAUNA GUIYERO, P145; Pereira LHG, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-20; Pereira LHG, 2011, MITOCHONDR DNA, V22, P71, DOI 10.3109/19401736.2010.532213; Piggott MP, 2011, BIOL J LINN SOC, V102, P391, DOI 10.1111/j.1095-8312.2010.01571.x; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, 2014, MOL EVOLUTION PHYLOG; Rheindt FE, 2013, BIOL J LINN SOC, V108, P889, DOI 10.1111/j.1095-8312.2012.02036.x; Schneider CH, 2012, J FISH BIOL, V81, P1210, DOI 10.1111/j.1095-8649.2012.03403.x; Silva DD, 2008, MICRON, V39, P1251, DOI 10.1016/j.micron.2008.04.001; Teletchea F, 2009, REV FISH BIOL FISHER, V19, P265, DOI 10.1007/s11160-009-9107-4; Tisseuil C, 2013, J ANIM ECOL, V82, P365, DOI 10.1111/1365-2656.12018; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Ward RD, 2009, MOL ECOL RESOUR, V9, P1077, DOI 10.1111/j.1755-0998.2009.02541.x; Zhang J, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-405; Zwickl D. J, 2006, GENETIC ALGORITHM AP	79	7	7	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135569	10.1371/journal.pone.0135569	http://dx.doi.org/10.1371/journal.pone.0135569			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275041	Green Published, gold, Green Submitted			2022-12-26	WOS:000359493600078
J	Nadrah, K; Beck, TC; Pereira, JP				Nadrah, Kristina; Beck, Thomas C.; Pereira, Joao P.			Immature B Cell Egress from Bone Marrow Is SOCS3 Independent	PLOS ONE			English	Article							WHIM-SYNDROME; UP-REGULATION; RECEPTOR INTERNALIZATION; BETA-ARRESTIN; CXCR4; CHEMOKINE; MIGRATION; RESPONSES; PHOSPHORYLATION; RESPONSIVENESS	Suppressor of cytokine signaling (SOCS)-3 has been suggested to regulate CXCR4 signaling in a variety of human cell lines. In mice, conditional SOCS3 inactivation in hematopoietic cells including B-lineage lymphocytes has been reported to exacerbate CXCR4-signaling and focal adhesion kinase phosphorylation, which resulted in altered immature B cell distribution in bone marrow (BM) due to sustained alpha 4 beta 1 integrin-mediated adhesion to the extracellular matrix. However, a recent study examining conditional SOCS3 deletion specifically in B-lineage cells failed to detect significant roles in B-lineage cell retention in BM. In this study we carefully examined the role played by SOCS3 in CXCR4 signaling in developing B cell subsets. We show that in mice conditionally deficient in SOCS3 exclusively in B cells (Socs3(fl/fl) Mb1(cre/+)) there was no detectable difference in B cell development in BM and in periphery. We show that SOCS3 deficient and sufficient immature B cell subsets are similarly distributed between BM parenchyma and sinusoids, and are equally competent at exiting BM into peripheral blood. Furthermore, we found no significant differences in CXCR4 desensitization upon ligand exposure in developing B lymphocyte subsets. Consequently, SOCS3-deficient and sufficient B-lineage cell migration towards CXCL12 in vitro was undistinguishable, and B-lineage cell amoeboid motility within BM parenchyma was also unaffected by SOCS3-deficiency. Thus we conclude that SOCS3 has no detectable influence on biological processes known to be controlled by CXCR4 signaling.	[Nadrah, Kristina; Beck, Thomas C.; Pereira, Joao P.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA	Yale University	Pereira, JP (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.	joao.pereira@yale.edu	Nadrah, Kristina/L-9779-2016	Beck, Thomas/0000-0002-8860-5850; Pereira, Joao/0000-0002-5694-4938	National Institutes of Health [R56AI098996, RO1AI113040]; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI113040, R56AI098996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR053495] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	These studies were funded by the National Institutes of Health (grants no. R56AI098996 and RO1AI113040). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allende ML, 2010, J EXP MED, V207, P1113, DOI 10.1084/jem.20092210; Balabanian K, 2008, J CLIN INVEST, V118, P1074, DOI 10.1172/JCI33187; BATTEN SJ, 1984, J IMMUNOL METHODS, V72, P381, DOI 10.1016/0022-1759(84)90007-3; Beck TC, 2014, J EXP MED, V211, P2567, DOI 10.1084/jem.20140457; Beltman JB, 2009, NAT REV IMMUNOL, V9, P789, DOI 10.1038/nri2638; CHAFFIN KE, 1991, EUR J IMMUNOL, V21, P2565, DOI 10.1002/eji.1830211038; Cheng ZJ, 2000, J BIOL CHEM, V275, P2479, DOI 10.1074/jbc.275.4.2479; Cronshaw DG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015397; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; Donovan EE, 2010, EUR J IMMUNOL, V40, P688, DOI 10.1002/eji.200939858; Fedyk ER, 1999, J LEUKOCYTE BIOL, V66, P667, DOI 10.1002/jlb.66.4.667; Ganju RK, 1998, J BIOL CHEM, V273, P23169, DOI 10.1074/jbc.273.36.23169; Garzon R, 2004, J BIOL CHEM, V279, P44460, DOI 10.1074/jbc.M408010200; Gorlin RJ, 2000, AM J MED GENET, V91, P368, DOI 10.1002/(SICI)1096-8628(20000424)91:5<368::AID-AJMG10>3.0.CO;2-9; Gray EE, 2013, NAT IMMUNOL, V14, P584, DOI 10.1038/ni.2585; Haribabu B, 1997, J BIOL CHEM, V272, P28726, DOI 10.1074/jbc.272.45.28726; Hernandez PA, 2003, NAT GENET, V34, P70, DOI 10.1038/ng1149; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Honczarenko M, 1999, BLOOD, V94, P2990, DOI 10.1182/blood.V94.9.2990.421k36_2990_2998; Jones SA, 2011, J IMMUNOL, V187, P6318, DOI 10.4049/jimmunol.1102057; Krishnaswamy JK, 2015, P NATL ACAD SCI USA, V112, P3056, DOI 10.1073/pnas.1501554112; Lagane B, 2008, BLOOD, V112, P34, DOI 10.1182/blood-2007-07-102103; Le Y, 2007, IMMUNITY, V27, P811, DOI 10.1016/j.immuni.2007.09.011; Liu Q, 2012, BLOOD, V120, P181, DOI 10.1182/blood-2011-12-395608; Mazo IB, 1998, J EXP MED, V188, P465, DOI 10.1084/jem.188.3.465; McDermott DH, 2014, BLOOD, V123, P2308, DOI 10.1182/blood-2013-09-527226; Moriguchi M, 2005, J BIOL CHEM, V280, P17408, DOI 10.1074/jbc.M414219200; Nagasawa T, 2006, NAT REV IMMUNOL, V6, P107, DOI 10.1038/nri1780; Orsini MJ, 1999, J BIOL CHEM, V274, P31076, DOI 10.1074/jbc.274.43.31076; Pello OM, 2006, BLOOD, V108, P3928, DOI 10.1182/blood-2006-02-006353; Pereira JP, 2009, NAT IMMUNOL, V10, P403, DOI 10.1038/ni.1710; Pereira JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009277; Soriano SF, 2002, J EXP MED, V196, P311, DOI 10.1084/jem.20012041; Soriano SF, 2003, EUR J IMMUNOL, V33, P1328, DOI 10.1002/eji.200323897; Vila-Coro AJ, 1999, FASEB J, V13, P1699, DOI 10.1096/fasebj.13.13.1699; Zhang XF, 2001, BLOOD, V97, P3342, DOI 10.1182/blood.V97.11.3342	36	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0136061	10.1371/journal.pone.0136061	http://dx.doi.org/10.1371/journal.pone.0136061			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274929	Green Submitted, gold, Green Published			2022-12-26	WOS:000359493600147
J	Gkouskou, KK; Ioannou, M; Pavlopoulos, GA; Georgila, K; Siganou, A; Nikolaidis, G; Kanellis, DC; Moore, S; Papadakis, KA; Kardassis, D; Iliopoulos, I; McDyer, FA; Drakos, E; Eliopoulos, AG				Gkouskou, K. K.; Ioannou, M.; Pavlopoulos, G. A.; Georgila, K.; Siganou, A.; Nikolaidis, G.; Kanellis, D. C.; Moore, S.; Papadakis, K. A.; Kardassis, D.; Iliopoulos, I.; McDyer, F. A.; Drakos, E.; Eliopoulos, A. G.			Apolipoprotein A-I inhibits experimental colitis and colitis-propelled carcinogenesis	ONCOGENE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; TUMOR-DEVELOPMENT; MIMETIC PEPTIDES; MOUSE MODELS; COLON-CANCER; PROGRESSION; MICE; IL-6; EXPRESSION	In both humans with long-standing ulcerative colitis and mouse models of colitis-associated carcinogenesis (CAC), tumors develop predominantly in the distal part of the large intestine but the biological basis of this intriguing pathology remains unknown. Herein we report intrinsic differences in gene expression between proximal and distal colon in the mouse, which are augmented during dextran sodium sulfate (DSS)/azoxymethane (AOM)-induced CAC. Functional enrichment of differentially expressed genes identified discrete biological pathways operating in proximal vs distal intestine and revealed a cluster of genes involved in lipid metabolism to be associated with the disease-resistant proximal colon. Guided by this finding, we have further interrogated the expression and function of one of these genes, apolipoprotein A-I (ApoA-I), a major component of high-density lipoprotein. We show that ApoA-I is expressed at higher levels in the proximal compared with the distal part of the colon and its ablation in mice results in exaggerated DSS-induced colitis and disruption of epithelial architecture in larger areas of the large intestine. Conversely, treatment with an ApoA-I mimetic peptide ameliorated the phenotypic, histopathological and inflammatory manifestations of the disease. Genetic interference with ApoA-I levels in vivo impacted on the number, size and distribution of AOM/DSS-induced colon tumors. Mechanistically, ApoA-I was found to modulate signal transducer and activator of transcription 3 (STAT3) and nuclear factor-kappa B activation in response to the bacterial product lipopolysaccharide with concomitant impairment in the production of the pathogenic cytokine interleukin-6. Collectively, these data demonstrate a novel protective role for ApoA-I in colitis and CAC and unravel an unprecedented link between lipid metabolic processes and intestinal pathologies.	[Gkouskou, K. K.; Georgila, K.; Siganou, A.; Nikolaidis, G.; Kanellis, D. C.; Eliopoulos, A. G.] Univ Crete, Sch Med, Mol & Cellular Biol Lab, Div Basic Sci, Iraklion 71003, Crete, Greece; [Ioannou, M.; Kardassis, D.; Eliopoulos, A. G.] Fdn Res & Technol Hellas FORTH, Inst Mol Biol & Biotechnol, Iraklion, Greece; [Pavlopoulos, G. A.; Iliopoulos, I.] Univ Crete, Sch Med, Div Basic Sci, Bioinformat & Computat Biol Lab, Iraklion 71003, Crete, Greece; [Moore, S.; McDyer, F. A.] Almac Diagnost, Craigavon, North Ireland; [Papadakis, K. A.] Univ Crete, Sch Med, Dept Gastroenterol, Iraklion 71003, Crete, Greece; [Papadakis, K. A.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA; [Kardassis, D.] Univ Crete, Sch Med, Div Basic Sci, Lab Biochem, Iraklion 71003, Crete, Greece; [Drakos, E.] Univ Crete, Sch Med, Dept Pathol, Iraklion 71003, Crete, Greece	University of Crete; University of Crete; University of Crete; Mayo Clinic; University of Crete; University of Crete	Eliopoulos, AG (corresponding author), Univ Crete, Sch Med, Mol & Cellular Biol Lab, Div Basic Sci, Iraklion 71003, Crete, Greece.	eliopag@med.uoc.gr	Gkouskou, Kalliopi/AAY-4666-2021; Kanellis, Dimitrios/AHB-0318-2022; Pavlopoulos, Georgios A./L-7544-2017; ELIOPOULOS, ARISTIDES/R-9449-2018; ELIOPOULOS, ARISTIDES/ABI-6632-2020	Kanellis, Dimitrios/0000-0001-8690-2010; Pavlopoulos, Georgios A./0000-0002-4577-8276; ELIOPOULOS, ARISTIDES/0000-0002-6403-6761; ELIOPOULOS, ARISTIDES/0000-0002-6403-6761	European Commission (EC) [223151]; Almac Diagnostics; EC [285948]	European Commission (EC)(European CommissionEuropean Commission Joint Research Centre); Almac Diagnostics; EC(European CommissionEuropean Commission Joint Research Centre)	We thank Dimitra Vyrla (University of Crete Medical School), Triantafyllos Liloglou (University of Liverpool) and Maria Denis (Biomedcode Hellas SA) for helpful discussions. This work was supported by the European Commission (EC) research program Inflammation and Cancer Research in Europe (INFLA-CARE; EC contract number 223151) to AGE and Almac Diagnostics and the EC REGPOT support program Translational Potential (TransPOT; EC contract number 285948) to AGE, KP, II and DK.	Basque JR, 1998, J CELL BIOCHEM, V70, P354, DOI 10.1002/(SICI)1097-4644(19980901)70:3<354::AID-JCB9>3.3.CO;2-8; Becker C, 2004, IMMUNITY, V21, P491, DOI 10.1016/j.immuni.2004.07.020; Bernstein CN, 2001, CANCER-AM CANCER SOC, V91, P854, DOI 10.1002/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z; Bersudsky M, 2014, GUT, V63, P598, DOI 10.1136/gutjnl-2012-303329; Bollrath J, 2009, EMBO REP, V10, P1314, DOI 10.1038/embor.2009.243; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Bonn V, 2002, ATHEROSCLEROSIS, V163, P59; Brunham LR, 2006, J CLIN INVEST, V116, P1052, DOI 10.1172/JCI27352; CHOI PM, 1993, GASTROENTEROLOGY, V104, P666, DOI 10.1016/0016-5085(93)90455-L; COOPER HS, 1993, LAB INVEST, V69, P238; Cooper HS, 2000, CARCINOGENESIS, V21, P757, DOI 10.1093/carcin/21.4.757; Danese S, 2010, ONCOGENE, V29, P3313, DOI 10.1038/onc.2010.109; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; Do RQ, 2014, EMBO MOL MED, V6, P1215, DOI 10.15252/emmm.201404000; Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526; Eyking A, 2011, GASTROENTEROLOGY, V141, P2154, DOI 10.1053/j.gastro.2011.08.043; Fukata M, 2007, GASTROENTEROLOGY, V133, P1869, DOI 10.1053/j.gastro.2007.09.008; Gkirtzimanaki K, 2013, P NATL ACAD SCI USA, V110, pE1470, DOI 10.1073/pnas.1215938110; Gkouskou KK, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00028; Goldstone R, 2012, INFLAMM BOWEL DIS, V18, P832, DOI 10.1002/ibd.21809; Goldstone R, 2011, GASTROINTEST ENDOSC, V74, P1087, DOI 10.1016/j.gie.2011.06.028; Greenhill CJ, 2011, J IMMUNOL, V186, P1199, DOI 10.4049/jimmunol.1002971; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Gupta H, 2005, CIRC RES, V97, P236, DOI 10.1161/01.RES.0000176530.66400.48; Gupta J, 2014, CANCER CELL, V25, P484, DOI 10.1016/j.ccr.2014.02.019; Haberman Y, 2014, J CLIN INVEST, V124, P3617, DOI 10.1172/JCI75436; Haghpassand M, 2001, J CLIN INVEST, V108, P1315, DOI 10.1172/JCI200112810; Kanagarajan N, 2008, INFLAMM RES, V57, P34, DOI 10.1007/s00011-007-6177-4; Laroui H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032084; Ma J, 2004, ACTA BIOCH BIOPH SIN, V36, P419, DOI 10.1093/abbs/36.6.419; Mahler M, 1998, AM J PHYSIOL-GASTR L, V274, pG544, DOI 10.1152/ajpgi.1998.274.3.G544; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; MILLER JCE, 1983, P NATL ACAD SCI-BIOL, V80, P1511, DOI 10.1073/pnas.80.6.1511; Mudter J, 2007, INFLAMM BOWEL DIS, V13, P1016, DOI 10.1002/ibd.20148; Navab M, 2005, CIRC RES, V97, P1085, DOI 10.1161/01.RES.0000194558.86099.ba; Navab M, 2005, ARTERIOSCL THROM VAS, V25, P1426, DOI 10.1161/01.ATV.0000167412.98221.1a; Navab M, 2002, CIRCULATION, V105, P290, DOI 10.1161/hc0302.103711; Navab M, 2006, NAT CLIN PRACT CARD, V3, P540, DOI 10.1038/ncpcardio0661; Neufert C, 2007, NAT PROTOC, V2, P1998, DOI 10.1038/nprot.2007.279; Okayasu I, 1996, GUT, V39, P87, DOI 10.1136/gut.39.1.87; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Ou JS, 2005, CIRC RES, V97, P1190, DOI 10.1161/01.RES.0000190634.60042.cb; Poynter JN, 2005, NEW ENGL J MED, V352, P2184, DOI 10.1056/NEJMoa043792; Ramasamy I, 2014, CLIN CHEM LAB MED, V52, P1695, DOI 10.1515/cclm-2013-0358; Rubin DC, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00107; Smythies LE, 2010, AM J PHYSIOL-CELL PH, V298, pC1538, DOI 10.1152/ajpcell.00467.2009; Su F, 2012, MOL CANCER THER, V11, P1311, DOI 10.1158/1535-7163.MCT-11-0905; Su F, 2010, P NATL ACAD SCI USA, V107, P19997, DOI 10.1073/pnas.1009010107; Toft NJ, 1999, P NATL ACAD SCI USA, V96, P3911, DOI 10.1073/pnas.96.7.3911; van Duijnhoven FJB, 2011, GUT, V60, P1094, DOI 10.1136/gut.2010.225011; Williams KL, 2001, GASTROENTEROLOGY, V120, P925, DOI 10.1053/gast.2001.22470; WU AL, 1979, J BIOL CHEM, V254, P7316; Yan YT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006073	53	31	31	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 12	2016	35	19					2496	2505		10.1038/onc.2015.307	http://dx.doi.org/10.1038/onc.2015.307			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DM2GQ	26279300	Bronze			2022-12-26	WOS:000376165500008
J	Namgaladze, D; Snodgrass, RG; Angioni, C; Grossmann, N; Dehne, N; Geisslinger, G; Brune, B				Namgaladze, Dmitry; Snodgrass, Ryan G.; Angioni, Carlo; Grossmann, Nina; Dehne, Nathalie; Geisslinger, Gerd; Bruene, Bernhard			AMP-activated Protein Kinase Suppresses Arachidonate 15-Lipoxygenase Expression in Interleukin 4-polarized Human Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; ALTERNATIVE ACTIVATION; INSULIN-RESISTANCE; KAPPA-B; INFLAMMATION; 12/15-LIPOXYGENASE; PPAR; DIFFERENTIATION; IL-4; POLARIZATION	Macrophages respond to the Th2 cytokine 11,-4 with elevated expression of arachidonate 15-lipoxygenase (ALOX15). Although IL-4 signaling elicits anti-inflammatory responses, 15-lipoxygenase may either support or inhibit inflammatory processes in a context-dependent manner. AMP-activated protein kinase (AMPK) is a metabolic sensor/regulator that supports an anti-inflammatory macrophage phenotype. How AMPK activation is linked to IL-4-elicited gene signatures remains unexplored. Using primary human macrophages stimulated with IL-4, we observed elevated ALOX15 mRNA and protein expression, which was attenuated by AMPK activation. AMPK activators, e.g. phenformin and aminoimidazole-4-carboxamide 1-0D-ribofuranoside inhibited IL-4-evoked activation of STAT3 while leaving activation of STAT6 and induction of typical IL-4responsive genes intact. In addition, phenformin prevented IL-4-induced association of STAT6 and Lys-9 acetylation of histone H3 at the AL0X15 promoter. Activating AMPK abolished cellular production of 15-lipoxygenase arachidonic acid metabolites in IL-4-stimulated macrophages, which was mimicked by AI,OX15 knockdown. Finally, pretreatment of macrophages with IL-4 for 48 h increased the mRNA expression of the proinflammatory cytokines IL-6, IL-12, CXCL9, and CXCI,10 induced by subsequent stimulation with lipopolysaccharide. This response was attenuated by inhibition of AI,OX15 or activation of AMPK during incubation with IL-4. In conclusion, limiting ALOX15 expression by AMPK may promote an anti-inflammatory phenotype of IL-4-stimulated human macrophages.	[Namgaladze, Dmitry; Snodgrass, Ryan G.; Grossmann, Nina; Dehne, Nathalie; Bruene, Bernhard] Goethe Univ Frankfurt, Fac Med, Inst Biochem 1, Theodor Stern Kai 7, D-60590 Frankfurt, Germany; [Angioni, Carlo; Geisslinger, Gerd] Goethe Univ Frankfurt, Inst Clin Pharmacol, Pharmazentrum Frankfurt, D-60590 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Brune, B (corresponding author), Goethe Univ Frankfurt, Fac Med, Inst Biochem 1, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	b.bruene@biochem.uni-frankfurt.de	Snodgrass, Ryan G./AAH-5110-2021; Snodgrass, Ryan G/U-1031-2018	Snodgrass, Ryan G./0000-0001-9896-5297; Snodgrass, Ryan G/0000-0001-9896-5297	Deutsche Forschungsgemeinschaft [NA429/2-1, SFB 1039]; Else Kroner Fresenius Foundation (TRIP)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Else Kroner Fresenius Foundation (TRIP)	This study was supported by Deutsche Forschungsgemeinschaft Grants NA429/2-1 and SFB 1039 Teilprojekt A05, B04, and Z01 and by the Else Kroner Fresenius Foundation (TRIP). The authors declare that they have no conflicts of interest with the contents of this article.	Bhattacharjee A, 2013, FREE RADICAL BIO MED, V54, P1, DOI 10.1016/j.freeradbiomed.2012.10.553; Biswas SK, 2006, BLOOD, V107, P2112, DOI 10.1182/blood-2005-01-0428; Buckley CD, 2014, IMMUNITY, V40, P315, DOI 10.1016/j.immuni.2014.02.009; Chaitidis P, 2005, CYTOKINE, V30, P366, DOI 10.1016/j.cyto.2005.02.004; Cole BK, 2013, PROSTAG OTH LIPID M, V104, P84, DOI 10.1016/j.prostaglandins.2012.07.004; CONRAD DJ, 1992, P NATL ACAD SCI USA, V89, P217, DOI 10.1073/pnas.89.1.217; Conrad M, 2010, P NATL ACAD SCI USA, V107, P15774, DOI 10.1073/pnas.1007909107; Danielsson KN, 2008, ATHEROSCLEROSIS, V199, P34, DOI 10.1016/j.atherosclerosis.2007.10.027; Dioszeghy V, 2008, J IMMUNOL, V181, P6514, DOI 10.4049/jimmunol.181.9.6514; El Chartouni C, 2010, IMMUNOBIOLOGY, V215, P780, DOI 10.1016/j.imbio.2010.05.032; Galic S, 2011, J CLIN INVEST, V121, P4903, DOI 10.1172/JCI58577; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Hamilton SR, 2001, FEBS LETT, V500, P163, DOI 10.1016/S0014-5793(01)02602-3; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; HART PH, 1989, P NATL ACAD SCI USA, V86, P3803, DOI 10.1073/pnas.86.10.3803; Huang JT, 1999, NATURE, V400, P378, DOI 10.1038/22572; Ivanov I, 2010, ARCH BIOCHEM BIOPHYS, V503, P161, DOI 10.1016/j.abb.2010.08.016; Jenkins Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081870; Kronke G, 2009, J IMMUNOL, V183, P3383, DOI 10.4049/jimmunol.0900327; Kuhn H, 2015, BBA-MOL CELL BIOL L, V1851, P308, DOI 10.1016/j.bbalip.2014.10.002; Kundumani-Sridharan V, 2013, J BIOL CHEM, V288, P15830, DOI 10.1074/jbc.M113.453290; Li J, 2013, ARTERIOSCL THROM VAS, V33, P971, DOI 10.1161/ATVBAHA.113.301335; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martinez FO, 2013, BLOOD, V121, pE57, DOI 10.1182/blood-2012-06-436212; Meares GP, 2013, J IMMUNOL, V190, P372, DOI 10.4049/jimmunol.1202390; Middleton MK, 2006, J IMMUNOL, V176, P265, DOI 10.4049/jimmunol.176.1.265; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mounier R, 2013, CELL METAB, V18, P251, DOI 10.1016/j.cmet.2013.06.017; Namgaladze D, 2013, CARDIOVASC RES, V98, P479, DOI 10.1093/cvr/cvt073; Naruhn S, 2010, MOL PHARMACOL, V77, P171, DOI 10.1124/mol.109.060541; Nerstedt A, 2010, DIABETOLOGIA, V53, P2406, DOI 10.1007/s00125-010-1856-z; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Rydberg EK, 2004, ARTERIOSCL THROM VAS, V24, P2040, DOI 10.1161/01.ATV.0000144951.08072.0b; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Shankaranarayanan P, 2001, J BIOL CHEM, V276, P42753, DOI 10.1074/jbc.M102626200; SLOANE DL, 1991, NATURE, V354, P149, DOI 10.1038/354149a0; Szanto A, 2010, IMMUNITY, V33, P699, DOI 10.1016/j.immuni.2010.11.009; Uderhardt S, 2012, J MOL MED, V90, P1247, DOI 10.1007/s00109-012-0954-4; Van Dyken SJ, 2013, ANNU REV IMMUNOL, V31, P317, DOI 10.1146/annurev-immunol-032712-095906; Varin A, 2010, BLOOD, V115, P353, DOI 10.1182/blood-2009-08-236711; Vasamsetti SB, 2015, DIABETES, V64, P2028, DOI 10.2337/db14-1225; Wuest SJA, 2012, ATHEROSCLEROSIS, V225, P121, DOI 10.1016/j.atherosclerosis.2012.07.022; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Yang ZG, 2010, J BIOL CHEM, V285, P19051, DOI 10.1074/jbc.M110.123620; Zhang Y, 2011, ARTERIOSCL THROM VAS, V31, P2897, DOI 10.1161/ATVBAHA.111.237453	46	26	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24484	24494		10.1074/jbc.M115.678243	http://dx.doi.org/10.1074/jbc.M115.678243			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26276392	Green Published, hybrid			2022-12-26	WOS:000362218900034
J	Gentsch, K; Grandjean, D; Scherer, KR				Gentsch, Kornelia; Grandjean, Didier; Scherer, Klaus R.			Appraisals Generate Specific Configurations of Facial Muscle Movements in a Gambling Task: Evidence for the Component Process Model of Emotion	PLOS ONE			English	Article							CONGENITALLY BLIND; GOAL CONDUCIVENESS; ILLUSORY CONTROL; EXPRESSION; PLEASANTNESS; SURPRISE; CHANCE; DRIVEN; ARCHITECTURE; MECHANISMS	Scherer's Component Process Model provides a theoretical framework for research on the production mechanism of emotion and facial emotional expression. The model predicts that appraisal results drive facial expressions, which unfold sequentially and cumulatively over time. In two experiments, we examined facial muscle activity changes (via facial electromyography recordings over the corrugator, cheek, and frontalis regions) in response to events in a gambling task. These events were experimentally manipulated feedback stimuli which presented simultaneous information directly affecting goal conduciveness (gambling outcome: win, loss, or break-even) and power appraisals (Experiment 1 and 2), as well as control appraisal (Experiment 2). We repeatedly found main effects of goal conduciveness (starting similar to 600 ms), and power appraisals (starting similar to 800 ms after feedback onset). Control appraisal main effects were inconclusive. Interaction effects of goal conduciveness and power appraisals were obtained in both experiments (Experiment 1: over the corrugator and cheek regions; Experiment 2: over the frontalis region) suggesting amplified goal conduciveness effects when power was high in contrast to invariant goal conduciveness effects when power was low. Also an interaction of goal conduciveness and control appraisals was found over the cheek region, showing differential goal conduciveness effects when control was high and invariant effects when control was low. These interaction effects suggest that the appraisal of having sufficient control or power affects facial responses towards gambling outcomes. The result pattern suggests that corrugator and frontalis regions are primarily related to cognitive operations that process motivational pertinence, whereas the cheek region would be more influenced by coping implications. Our results provide first evidence demonstrating that cognitive-evaluative mechanisms related to goal conduciveness, control, and power appraisals affect facial expressions dynamically over time, immediately after an event is perceived. In addition, our results provide further indications for the chronography of appraisal-driven facial movements and the underlying cognitive processes.	[Gentsch, Kornelia; Grandjean, Didier; Scherer, Klaus R.] Univ Geneva, Swiss Ctr Affect Sci CISA, Geneva, Switzerland; [Gentsch, Kornelia; Grandjean, Didier] Univ Geneva, Dept Psychol, Neurosci Emot & Affect Dynam Lab NEAD, Geneva, Switzerland	University of Geneva; University of Geneva	Gentsch, K (corresponding author), Univ Geneva, Swiss Ctr Affect Sci CISA, Geneva, Switzerland.	kornelia.gentsch@yahoo.de	Gentsch, Kornelia/HHZ-4638-2022	Grandjean, Didier/0000-0001-6125-4520	ERC Advanced Grant in the European Community's 7th Framework Programme [230331]; National Center of Competence in Research (NCCR) Affective Sciences - Swiss National Science Foundation [51NF40-104897]	ERC Advanced Grant in the European Community's 7th Framework Programme; National Center of Competence in Research (NCCR) Affective Sciences - Swiss National Science Foundation	This article is part of the PhD project of Kornelia Gentsch. The research was funded by an ERC Advanced Grant in the European Community's 7th Framework Programme under grant agreement 230331-PROPEREMO (Production and perception of emotion: an affective sciences approach) to Klaus Scherer and by the National Center of Competence in Research (NCCR) Affective Sciences financed by the Swiss National Science Foundation (51NF40-104897) and hosted by the University of Geneva.	Aue T, 2008, BIOL PSYCHOL, V79, P158, DOI 10.1016/j.biopsycho.2008.04.004; Aue T, 2007, BIOL PSYCHOL, V74, P347, DOI 10.1016/j.biopsycho.2006.09.001; Baker TE, 2011, BIOL PSYCHOL, V87, P25, DOI 10.1016/j.biopsycho.2011.01.010; Biner PM, 1998, MOTIV EMOTION, V22, P277, DOI 10.1023/A:1021300306318; Darwin C., 1998, EXPRESS EMOT MAN, V3rd; Delplanque S, 2009, EMOTION, V9, P316, DOI 10.1037/a0015369; DIMBERG U, 1990, BIOL PSYCHOL, V31, P137, DOI 10.1016/0301-0511(90)90013-M; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; Ekman P., 2002, MANUAL INVESTIGATORS; Ellsworth P.C., 1991, INT REV STUDIES EMOT, P143; Ellsworth PC, 2003, SER AFFECTIVE SCI, P572; Fernandez-Dols JM, 2013, EMOT REV, V5, P3, DOI 10.1177/1754073912457209; FRIDLUND AJ, 1986, PSYCHOPHYSIOLOGY, V23, P567, DOI 10.1111/j.1469-8986.1986.tb00676.x; Galati D, 2001, INT J BEHAV DEV, V25, P268, DOI 10.1080/01650250042000393; Galati D, 1997, J PERS SOC PSYCHOL, V73, P1363, DOI 10.1037/0022-3514.73.6.1363; Gentsch K, 2013, PSYCHOPHYSIOLOGY, V50, P1010, DOI 10.1111/psyp.12079; GRAMMER K, 1988, ETHOLOGY, V77, P279; Grandjean D, 2008, EMOTION, V8, P341, DOI 10.1037/1528-3542.8.3.341; Grandjean D, 2008, CONSCIOUS COGN, V17, P484, DOI 10.1016/j.concog.2008.03.019; IZARD CE, 1994, PSYCHOL BULL, V115, P288, DOI 10.1037/0033-2909.115.2.288; James W., 1894, PSYCHOL REV, V1, P516, DOI DOI 10.1037/H0065078; Johnson DDP, 2011, NATURE, V477, P317, DOI 10.1038/nature10384; Kappas A, 1999, COGNITION EMOTION, V13, P119, DOI 10.1080/026999399379401; Lanctot N, 2007, EMOTION, V7, P207, DOI 10.1037/1528-3542.7.1.207; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; LANGER EJ, 1975, J PERS SOC PSYCHOL, V32, P311, DOI 10.1037/0022-3514.32.2.311; LANGER EJ, 1975, J PERS SOC PSYCHOL, V32, P951, DOI 10.1037/0022-3514.32.6.951; LAZARUS RS, 1991, AM PSYCHOL, V46, P819, DOI 10.1037/0003-066X.46.8.819; Moors A, 2013, EMOT REV, V5, P132, DOI 10.1177/1754073912463601; Nelson NL, 2013, EMOT REV, V5, P8, DOI 10.1177/1754073912457227; Nieuwenhuis S, 2004, NEUROSCI BIOBEHAV R, V28, P441, DOI 10.1016/j.neubiorev.2004.05.003; Peleg G, 2009, ISR J ECOL EVOL, V55, P11, DOI 10.1560/IJEE.55.1.11; POPE LK, 1994, COGNITION EMOTION, V8, P65, DOI 10.1080/02699939408408929; Reisenzein R, 2006, J PERS SOC PSYCHOL, V91, P295, DOI 10.1037/0022-3514.91.2.295; RINN WE, 1984, PSYCHOL BULL, V95, P52, DOI 10.1037/0033-2909.95.1.52; Roseman I.J., 2001, APPRAISAL PROCESSES, P3, DOI DOI 10.1080/02699939108411034; Roseman I.J., 1984, REV PERSONAL SOC PSY, V5, P11; RUSSELL JA, 1994, PSYCHOL BULL, V115, P102, DOI 10.1037/0033-2909.115.1.102; Scherer K.R., 2001, APPRAISAL PROCESSES, DOI DOI 10.1016/S0166-4115(08)62387-0; Scherer K.R., 1984, APPROACHES EMOTION, P293; Scherer KR, 2007, EMOTION, V7, P113, DOI 10.1037/1528-3542.7.1.113; Scherer KR, 2013, EMOT REV, V5, P47, DOI 10.1177/1754073912451504; Scherer KR, 2009, COGNITION EMOTION, V23, P1307, DOI 10.1080/02699930902928969; Scherer KR, 2004, EMOTION, V4, P389, DOI 10.1037/1528-3542.4.4.389; Scherer KR., 1987, GENEVA STUDIES EMOTI, V1, P1, DOI DOI 10.1080/02699930902928969; Schutzwohl A, 2012, EVOL HUM BEHAV, V33, P657, DOI 10.1016/j.evolhumbehav.2012.04.003; SCHWARTZ GE, 1980, PSYCHOPHYSIOLOGY, V17, P75, DOI 10.1111/j.1469-8986.1980.tb02463.x; SMITH CA, 1989, J PERS SOC PSYCHOL, V56, P339, DOI 10.1037/0022-3514.56.3.339; SMITH CA, 1985, J PERS SOC PSYCHOL, V48, P813, DOI 10.1037/0022-3514.48.4.813; Susskind JM, 2008, NAT NEUROSCI, V11, P843, DOI 10.1038/nn.2138; van Peer JM, 2014, EMOTION, V14, P51, DOI 10.1037/a0034566; van Reekum CM, 2000, THESIS U GENEVA; Wohl MJA, 2002, PERS SOC PSYCHOL B, V28, P1388, DOI 10.1177/014616702236870	53	13	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135837	10.1371/journal.pone.0135837	http://dx.doi.org/10.1371/journal.pone.0135837			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5MR	26295338	gold, Green Submitted, Green Published			2022-12-26	WOS:000359926900044
J	Zhang, R; Cao, PJ; Yang, ZZ; Wang, ZZ; Wu, JL; Chen, Y; Pan, Y				Zhang, Rui; Cao, Peijuan; Yang, Zhongzhou; Wang, Zhenzhen; Wu, Jiu-Lin; Chen, Yan; Pan, Yi			Heparan Sulfate Biosynthesis Enzyme, Ext1, Contributes to Outflow Tract Development of Mouse Heart via Modulation of FGF Signaling	PLOS ONE			English	Article							CARDIAC NEURAL CREST; ARTERIAL POLE; EXTRACELLULAR-MATRIX; VALVE DEVELOPMENT; PHARYNGEAL ARCH; 2ND HEART; CELLS; MUTANT; FIELD; MICE	Glycosaminoglycans are important regulators of multiple signaling pathways. As a major constituent of the heart extracellular matrix, glycosaminoglycans are implicated in cardiac morphogenesis through interactions with different signaling morphogens. Ext1 is a glycosyltransferase responsible for heparan sulfate synthesis. Here, we evaluate the function of Ext1 in heart development by analyzing Ext1 hypomorphic mutant and conditional knockout mice. Outflow tract alignment is sensitive to the dosage of Ext1. Deletion of Ext1 in the mesoderm induces a cardiac phenotype similar to that of a mutant with conditional deletion of UDP-glucose dehydrogenase, a key enzyme responsible for synthesis of all glycosaminoglycans. The outflow tract defect in conditional Ext1 knockout(Ext1(f/f):Mesp1Cre) mice is attributable to the reduced contribution of second heart field and neural crest cells. Ext1 deletion leads to downregulation of FGF signaling in the pharyngeal mesoderm. Exogenous FGF8 ameliorates the defects in the outflow tract and pharyngeal explants. In addition, Ext1 expression in second heart field and neural crest cells is required for outflow tract remodeling. Our results collectively indicate that Ext1 is crucial for outflow tract formation in distinct progenitor cells, and heparan sulfate modulates FGF signaling during early heart development.	[Zhang, Rui; Cao, Peijuan; Wang, Zhenzhen; Chen, Yan; Pan, Yi] Univ Chinese Acad Sci, Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci,Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Yang, Zhongzhou] Nanjing Univ, MOE Key Lab Model Anim Dis Study, Model Anim Res Ctr, Nanjing 210008, Jiangsu, Peoples R China; [Wu, Jiu-Lin] Fuzhou Univ, Inst Biomed & Pharmaceut Technol, Fuzhou 350002, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Nanjing University; Fuzhou University	Chen, Y (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci, Key Lab Nutr & Metab, Inst Nutr Sci,Shanghai Inst Biol Sci, Shanghai, Peoples R China.	ychen3@sibs.ac.cn; ypan@sibs.ac.cn			Ministry of Science and Technology of China [2012CB524900, 2010CB529506]; National Natural Science Foundation of China [81130077, 81390350, 81321062]; Natural Science Foundation of Shanghai [14ZR1446500]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai)	This work was supported by research grants from the Ministry of Science and Technology of China (2012CB524900 to Y.C. and 2010CB529506 to Y.P. and Z.W.), the National Natural Science Foundation of China (81130077, 81390350 and 81321062 to Y.C.), and the Natural Science Foundation of Shanghai 14ZR1446500 to Y.P.).	Abu-Issa R, 2002, DEVELOPMENT, V129, P4613; Brade T, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a013847; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Camenisch TD, 2002, NAT MED, V8, P850, DOI 10.1038/nm742; Campione M, 2001, DEV BIOL, V231, P252, DOI 10.1006/dbio.2000.0133; Costell M, 2002, CIRC RES, V91, P158, DOI 10.1161/01.RES.0000026056.81424.DA; Dyer LA, 2009, DEV BIOL, V336, P137, DOI 10.1016/j.ydbio.2009.10.009; Franco D, 1999, ANAT RECORD, V254, P135; Frank DU, 2002, DEVELOPMENT, V129, P4591; Garcia-Garcia MJ, 2003, CELL, V114, P727, DOI 10.1016/S0092-8674(03)00715-3; Guo CS, 2011, J CLIN INVEST, V121, P1585, DOI 10.1172/JCI44630; Hatano S, 2012, GLYCOBIOLOGY, V22, P1268, DOI 10.1093/glycob/cws095; Hutson MR, 2007, SEMIN CELL DEV BIOL, V18, P101, DOI 10.1016/j.semcdb.2006.12.004; Hutson MR, 2006, DEV BIOL, V295, P486, DOI 10.1016/j.ydbio.2006.02.052; Hyde AS, 2012, J BIOL CHEM, V287, P32708, DOI 10.1074/jbc.M112.395202; Iwamoto R, 2010, DEVELOPMENT, V137, P2205, DOI 10.1242/dev.048926; Kitajima S, 2006, DEV DYNAM, V235, P395, DOI 10.1002/dvdy.20640; Liao J, 2008, DEV BIOL, V316, P524, DOI 10.1016/j.ydbio.2008.01.037; Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798; Lincoln J, 2007, DEV BIOL, V305, P120, DOI 10.1016/j.ydbio.2007.02.002; LITTLE CD, 1995, EXPERIENTIA, V51, P873, DOI 10.1007/BF01921738; Liu W, 2004, P NATL ACAD SCI USA, V101, P4489, DOI 10.1073/pnas.0308466101; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; Mesbah K, 2008, CIRC RES, V103, P743, DOI 10.1161/CIRCRESAHA.108.172858; Mjaatvedt CH, 1998, DEV BIOL, V202, P56, DOI 10.1006/dbio.1998.9001; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Ng A, 2009, DEV BIOL, V335, P208, DOI 10.1016/j.ydbio.2009.08.029; Olson EN, 1996, CELL, V85, P1, DOI 10.1016/S0092-8674(00)81073-9; Pan Y, 2006, DEVELOPMENT, V133, P4933, DOI 10.1242/dev.02679; Pan Y, 2014, MATRIX BIOL, V35, P253, DOI 10.1016/j.matbio.2013.10.013; Park EJ, 2008, DEVELOPMENT, V135, P3599, DOI 10.1242/dev.025437; Pellegrini L, 2001, CURR OPIN STRUC BIOL, V11, P629, DOI 10.1016/S0959-440X(00)00258-X; Princivalle M, 2002, INT J DEV BIOL, V46, P267; Qu XX, 2012, DEVELOPMENT, V139, P2730, DOI 10.1242/dev.079236; Saga Y, 1999, DEVELOPMENT, V126, P3437; Sasisekharan R, 2006, ANNU REV BIOMED ENG, V8, P181, DOI 10.1146/annurev.bioeng.8.061505.095745; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Tirosh-Finkel L, 2006, DEVELOPMENT, V133, P1943, DOI 10.1242/dev.02365; Vincentz JW, 2008, DEV DYNAM, V237, P3809, DOI 10.1002/dvdy.21803; Waldo KL, 2005, DEV BIOL, V281, P66, DOI 10.1016/j.ydbio.2005.02.011; Walsh EC, 2001, SCIENCE, V293, P1670, DOI 10.1126/science.293.5535.1670; WASHINGTON SI, 2005, DEV BIOL, V283, P357, DOI DOI 10.1016/J.YDBI0.2005.04.029; Watanabe Y, 2010, CIRC RES, V106, P495, DOI 10.1161/CIRCRESAHA.109.201665; Wurdak H, 2006, BIOESSAYS, V28, P1078, DOI 10.1002/bies.20484; Yamamura H, 1997, DEV BIOL, V186, P58, DOI 10.1006/dbio.1997.8559; Yue XP, 2004, GLYCOBIOLOGY, V14, P745, DOI 10.1093/glycob/cwh083	47	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136518	10.1371/journal.pone.0136518	http://dx.doi.org/10.1371/journal.pone.0136518			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295701	Green Published, gold, Green Submitted			2022-12-26	WOS:000359926900119
J	Feigin, VL; Krishnamurthi, RV; Barker-Collo, S; McPherson, KM; Barber, PA; Parag, V; Arroll, B; Bennett, DA; Tobias, M; Jones, A; Witt, E; Brown, P; Abbott, M; Bhattacharjee, R; Rush, E; Suh, FM; Theadom, A; Rathnasabapathy, Y; Ao, BT; Parmar, PG; Anderson, C; Bonita, R				Feigin, Valery L.; Krishnamurthi, Rita V.; Barker-Collo, Suzanne; McPherson, Kathryn M.; Barber, P. Alan; Parag, Varsha; Arroll, Bruce; Bennett, Derrick A.; Tobias, Martin; Jones, Amy; Witt, Emma; Brown, Paul; Abbott, Max; Bhattacharjee, Rohit; Rush, Elaine; Suh, Flora Minsun; Theadom, Alice; Rathnasabapathy, Yogini; Ao, Braden Te; Parmar, Priya G.; Anderson, Craig; Bonita, Ruth		ARCOS IV Grp	30-Year Trends in Stroke Rates and Outcome in Auckland, New Zealand (1981-2012): A Multi-Ethnic Population-Based Series of Studies	PLOS ONE			English	Article							CASE-FATALITY RATES; REGIONAL COMMUNITY STROKE; RISK-FACTORS; SUBARACHNOID HEMORRHAGE; ETHNIC DISPARITIES; GLOBAL BURDEN; ATRIAL-FIBRILLATION; CEREBROVASCULAR-DISEASE; CARDIOVASCULAR-DISEASE; HEALTH DISPARITIES	Background Insufficient data exist on population-based trends in morbidity and mortality to determine the success of prevention strategies and improvements in health care delivery in stroke. The aim of this study was to determine trends in incidence and outcome (1-year mortality, 28-day case-fatality) in relation to management and risk factors for stroke in the multi-ethnic population of Auckland, New Zealand (NZ) over 30-years. Methods Four stroke incidence population-based register studies were undertaken in adult residents (aged >= 15 years) of Auckland NZ in 1981-1982, 1991-1992, 2002-2003 and 2011-2012. All used standard World Health Organization (WHO) diagnostic criteria and multiple overlapping sources of case-ascertainment for hospitalised and non-hospitalised, fatal and non-fatal, new stroke events. Ethnicity was consistently self-identified into four major groups. Crude and age-adjusted (WHO world population standard) annual incidence and mortality with corresponding 95% confidence intervals (CI) were calculated per 100,000 people, assuming a Poisson distribution. Results 5400 new stroke patients were registered in four 12 month recruitment phases over the 30-year study period; 79% were NZ/European, 6% Maori, 8% Pacific people, and 7% were of Asian or other origin. Overall stroke incidence and 1-year mortality decreased by 23% (95% CI 5%-31%) and 62% (95% CI 36%-86%), respectively, from 1981 to 2012. Whilst stroke incidence and mortality declined across all groups in NZ from 1991, Maori and Pacific groups had the slowest rate of decline and continue to experience stroke at a significantly younger age (mean ages 60 and 62 years, respectively) compared with NZ/Europeans (mean age 75 years). There was also a decline in 28-day stroke case fatality (overall by 14%, 95% CI 11%-17%) across all ethnic groups from 1981 to 2012. However, there were significant increases in the frequencies of pre-morbid hypertension, myocardial infarction, and diabetes mellitus, but a reduction in frequency of current smoking among stroke patients. Conclusions In this unique temporal series of studies spanning 30 years, stroke incidence, early case-fatality and 1-year mortality have declined, but ethnic disparities in risk and outcome for stroke persisted suggesting that primary stroke prevention remains crucial to reducing the burden of this disease.	[Feigin, Valery L.; Krishnamurthi, Rita V.; Jones, Amy; Witt, Emma; Brown, Paul; Abbott, Max; Bhattacharjee, Rohit; Rush, Elaine; Theadom, Alice; Ao, Braden Te; Parmar, Priya G.] Auckland Univ Technol, Auckland, New Zealand; [Barker-Collo, Suzanne; Barber, P. Alan; Parag, Varsha; Arroll, Bruce; Bonita, Ruth] Univ Auckland, Auckland 1, New Zealand; [McPherson, Kathryn M.] Hlth Res Council New Zealand, Auckland, New Zealand; [Bennett, Derrick A.] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England; [Tobias, Martin] Minist Hlth, Publ Hlth Intelligence, Wellington, New Zealand; [Brown, Paul] Univ Calif Merced, Merced, CA USA; [Suh, Flora Minsun] Univ Queensland, Brisbane, Qld, Australia; [Rathnasabapathy, Yogini] North Shore Hosp, Waitemata Dist Hlth Board, Auckland, New Zealand; [Anderson, Craig] Univ Sydney, Camperdown, NSW, Australia	Auckland University of Technology; University of Auckland; University of Oxford; University of California System; University of California Merced; University of Queensland; University of Sydney	Feigin, VL (corresponding author), Auckland Univ Technol, Auckland, New Zealand.	valery.feigin@aut.ac.nz	Krishnamurthi, Rita/AAU-7841-2021; , Bennett/O-7998-2019; Rush, Elaine/AAQ-9992-2021; Feigin, Valery/AAF-2313-2019; Bennett, Derrick/AAH-1220-2022; Bennett, Derrick/AFL-9254-2022	Krishnamurthi, Rita/0000-0003-0869-2083; Rush, Elaine/0000-0001-7713-6203; Bennett, Derrick/0000-0002-9170-8447; Bennett, Derrick/0000-0002-9170-8447; Parmar, Priya/0000-0001-6001-9326; Anderson, Craig/0000-0002-7248-4863; Barber, P Alan/0000-0003-2469-9023; McPherson, Kathryn/0000-0003-1240-8882; Te Ao, Braden/0000-0002-1050-200X; Feigin, Valery L./0000-0002-6372-1740; McPherson, Kath/0000-0003-0487-8497	Health Research Council of New Zealand [10/458]	Health Research Council of New Zealand(Health Research Council of New Zealand)	Support was provided by grant number 10/458 from the Health Research Council of New Zealand [http://www.hrc.govt.nz]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad O. B., 2000, GPE DISCUSSION PAPER, V31; AHO K, 1980, B WORLD HEALTH ORGAN, V58, P113; Albers GW, 2011, STROKE, V42, P2645, DOI 10.1161/STROKEAHA.111.618850; Alberti KGMM, 2013, NAT REV ENDOCRINOL, V9, P258, DOI 10.1038/nrendo.2013.54; Anand SS, 2000, LANCET, V356, P279, DOI 10.1016/S0140-6736(00)02502-2; Anderson CS, 2005, STROKE, V36, P2087, DOI 10.1161/01.STR.0000181079.42690.bf; [Anonymous], 2004, ETHN DAT PROT HLTH D; [Anonymous], 2007, LANCET, V369, P247; Bell C, 1996, NEW ZEAL MED J, V109, P66; Benatru I, 2006, STROKE, V37, P1674, DOI 10.1161/01.STR.0000226979.56456.a8; Blakely T, 2005, SOC SCI MED, V61, P2233, DOI 10.1016/j.socscimed.2005.02.011; BONITA R, 1983, STROKE, V14, P342, DOI 10.1161/01.STR.14.3.342; Bonita R, 1997, STROKE, V28, P758, DOI 10.1161/01.STR.28.4.758; BONITA R, 1993, LANCET, V342, P1470, DOI 10.1016/0140-6736(93)92938-P; BONITA R, 1995, INT J EPIDEMIOL, V24, P535, DOI 10.1093/ije/24.3.535; BONITA R, 1984, AM J EPIDEMIOL, V120, P236, DOI 10.1093/oxfordjournals.aje.a113885; BONITA R, 1995, STROKE, V26, P541, DOI 10.1161/01.STR.26.4.541; Briggs ADM, 2013, BMJ-BRIT MED J, P347; Carter K, 2006, STROKE, V37, P56, DOI 10.1161/01.STR.0000195131.23077.85; CASPER M, 1992, AM J PUBLIC HEALTH, V82, P1600, DOI 10.2105/AJPH.82.12.1600; Chroinin DN, 2011, STROKE, V42, P1021, DOI 10.1161/STROKEAHA.110.596734; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Corbin DOC, 2004, STROKE, V35, P1254, DOI 10.1161/01.STR.0000127371.24658.df; Corso G, 2009, NEUROEPIDEMIOLOGY, V32, P186, DOI 10.1159/000195688; de Rooij NK, 2007, J NEUROL NEUROSUR PS, V78, P1365, DOI 10.1136/jnnp.2007.117655; Diaz KM, 2014, HYPERTENSION, V64, P465, DOI 10.1161/HYPERTENSIONAHA.114.03565; Dundas R, 2001, ETHNIC HEALTH, V6, P95, DOI 10.1080/13557850120068423; Dyall L, 2006, N Z MED J, V119; Dyall L, 2008, SOC POLICY J NZ, P178; Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; Ezzati M, 2013, NEW ENGL J MED, V369, P954, DOI 10.1056/NEJMra1203528; Feigin V, 2006, LANCET NEUROL, V5, P130, DOI 10.1016/S1474-4422(05)70325-2; Feigin V, 2005, STROKE, V36, P1360, DOI 10.1161/01.STR.0000170710.95689.41; Feigin VL, 2007, INT J STROKE, V2, P208, DOI 10.1111/j.1747-4949.2007.00140.x; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Feigin VL, 2014, INT J STROKE, V9, P61, DOI 10.1111/ijs.12117; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Fink J, 2006, N Z MED J, V119, P1; Fisher A, 2014, J STROKE CEREBROVASC, V23, P759, DOI 10.1016/j.jstrokecerebrovasdis.2013.06.035; FRASER GE, 1978, INT J EPIDEMIOL, V7, P277, DOI 10.1093/ije/7.3.277; Friberg L, 2014, STROKE; Gulliford MC, 2010, J NEUROL NEUROSUR PS, V81, P416, DOI 10.1136/jnnp.2009.193136; Gunarathne A, 2008, J HUM HYPERTENS, V22, P18, DOI 10.1038/sj.jhh.1002265; Hajat C, 2001, STROKE, V32, P37, DOI 10.1161/01.STR.32.1.37; Hallstrom B, 2008, STROKE, V39, P10, DOI 10.1161/STROKEAHA.107.491779; Hannon N, 2011, STROKE, V42, P2503, DOI 10.1161/STROKEAHA.110.602235; Harris R, 2006, LANCET, V367, P2005, DOI 10.1016/S0140-6736(06)68890-9; Harwood M, 2000, STROKE, V31, P2517, DOI 10.1161/01.STR.31.10.2517; Health. Mo, 2012, HLTH NZ AD 2011 12 K; Health Mo, 2013, MORTALITY DEMOGRAPHI; Health Mo, 2013, HLTH LOSS NZ REP NZ; Heuschmann PU, 2008, STROKE, V39, P2204, DOI 10.1161/STROKEAHA.107.507285; Hook EB, 1995, EPIDEMIOL REV, V17, P243, DOI 10.1093/oxfordjournals.epirev.a036192; Howard G, 2013, STROKE, V44, P1282, DOI 10.1161/STROKEAHA.111.000529; Howard G, 2011, STROKE, V42, P3369, DOI 10.1161/STROKEAHA.111.625277; Inagawa T, 2001, STROKE, V32, P1499, DOI 10.1161/01.STR.32.7.1499; Islam SM, 2008, STROKE, V39, P776, DOI 10.1161/STROKEAHA.107.493643; KAPLAN GA, 1993, CIRCULATION, V88, P1973, DOI 10.1161/01.CIR.88.4.1973; Kawachi I, 2005, HEALTH AFFAIR, V24, P343, DOI 10.1377/hlthaff.24.2.343; Kissela BM, 2012, NEUROLOGY, V79, P1781, DOI 10.1212/WNL.0b013e318270401d; Kita Y, 2009, INT J STROKE, V4, P241, DOI 10.1111/j.1747-4949.2009.00293.x; Kleindorfer DO, 2010, STROKE, V41, P1326, DOI 10.1161/STROKEAHA.109.575043; Koton S, 2014, JAMA-J AM MED ASSOC, V312, P259, DOI 10.1001/jama.2014.7692; Krishnamurthi R, 2014, INT J STROKE, V9, P140, DOI 10.1111/ijs.12108; Krishnamurthi RV, 2013, LANCET GLOB HEALTH, V1, pE259, DOI 10.1016/S2214-109X(13)70089-5; Kwon JW, 2013, WORLD NEUROSURG, V79, P499, DOI 10.1016/j.wneu.2012.07.032; Leyden JM, 2013, STROKE, V44, P1226, DOI 10.1161/STROKEAHA.113.675140; Macpherson KJ, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-38; Manobianca G, 2010, EUR J NEUROL, V17, P1148, DOI 10.1111/j.1468-1331.2010.02983.x; McGruder HF, 2004, STROKE, V35, P1557, DOI 10.1161/01.STR.0000130427.84114.50; McLean RM, 2013, NZ MED J, V126; McPherson KM, 2003, BRIT MED J, V327, P443, DOI 10.1136/bmj.327.7412.443; Mo Health, 2010, TAT KAH MAOR HLTH CH; Mozaffarian D, 2014, NEW ENGL J MED, V371, P624, DOI 10.1056/NEJMoa1304127; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Napier AD, 2014, LANCET, V384, P1607, DOI 10.1016/S0140-6736(14)61603-2; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Palm F, 2010, STROKE, V41, P1865, DOI 10.1161/STROKEAHA.110.592642; Rastenyte D, 2006, SCAND J PUBLIC HEALT, V34, P488, DOI 10.1080/14034940600551640; Rothwell PM, 2005, LANCET, V366, P1773, DOI 10.1016/S0140-6736(05)67702-1; Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2; Sacco RL, 2001, STROKE, V32, P1725, DOI 10.1161/01.STR.32.8.1725; SACCO RL, 1995, NEUROLOGY, V45, P659, DOI 10.1212/WNL.45.4.659; Sacco RL, 1998, AM J EPIDEMIOL, V147, P259, DOI 10.1093/oxfordjournals.aje.a009445; SAKURAI Y, 1995, TOHOKU J EXP MED, V177, P89, DOI 10.1620/tjem.177.89; SPRAFKA JM, 1994, DIABETIC MED, V11, P678, DOI 10.1111/j.1464-5491.1994.tb00332.x; Statistics New Zealand, 2014, NZ CENS 2013; Stroke Foundation of New Zealand and New Zealand Guidelines Group, 2010, NZ CLIN GUID STROK M; Strong K, 2007, LANCET NEUROL, V6, P182, DOI 10.1016/S1474-4422(07)70031-5; Sudlow CLM, 1996, STROKE, V27, P550, DOI 10.1161/01.STR.27.3.550; Syme PD, 2005, STROKE, V36, P1837, DOI 10.1161/01.STR.0000177873.82478.1c; Talelli Penelope, 2008, Ther Adv Cardiovasc Dis, V2, P387, DOI 10.1177/1753944708093411; Tilling K, 2001, INT J EPIDEMIOL, V30, P1351, DOI 10.1093/ije/30.6.1351; Tobias M, 2007, AUST NZ J PUBL HEAL, V31, P520, DOI 10.1111/j.1753-6405.2007.00136.x; Vaartjes IP, STROKE; Vibo R, 2005, STROKE, V36, P2544, DOI 10.1161/01.STR.0000189633.33623.69; Waxman A., 2004, Development (London), V47, P75, DOI 10.1057/palgrave.development.1100032; Wieberdink RG, 2012, EUR J EPIDEMIOL, V27, P287, DOI 10.1007/s10654-012-9673-y; Ziegler PD, 2012, AM J CARDIOL, V110, P1309, DOI 10.1016/j.amjcard.2012.06.034	99	67	68	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0134609	10.1371/journal.pone.0134609	http://dx.doi.org/10.1371/journal.pone.0134609			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5KH	26291829	Green Published, gold, Green Submitted			2022-12-26	WOS:000359919900009
J	Schulz, K; Frahm, J; Kersten, S; Meyer, U; Rehage, J; Piechotta, M; Meyerholz, M; Breves, G; Reiche, D; Sauerwein, H; Danicke, S				Schulz, Kirsten; Frahm, Jana; Kersten, Susanne; Meyer, Ulrich; Rehage, Juergen; Piechotta, Marion; Meyerholz, Maria; Breves, Gerhard; Reiche, Dania; Sauerwein, Helga; Daenicke, Sven			Effects of Inhibiting Dipeptidyl Peptidase-4 (DPP4) in Cows with Subclinical Ketosis	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; LACTATING DAIRY-COWS; FATTY LIVER; PLASMA-CONCENTRATIONS; INSULIN-RESISTANCE; GUT PEPTIDES; EXPRESSION; ACIDS; PERFORMANCE; HAPTOGLOBIN	The inhibition of dipeptidyl peptidase-4 (DPP4) via specific inhibitors is known to result in improved glucose tolerance and insulin sensitivity and decreased accumulation of hepatic fat in type II diabetic human patients. The metabolic situation of dairy cows can easily be compared to the status of human diabetes and non-alcoholic fatty liver. For both, insulin sensitivity is reduced, while hepatic fat accumulation increases, characterized by high levels of non-esterified fatty acids (NEFA) and ketone bodies. Therefore, in the present study, a DPP4 inhibitor was employed (BI 14332) for the first time in cows. In a first investigation BI 14332 treatment (intravenous injection at dosages of up to 3 mg/kg body weight) was well tolerated in healthy lactating pluriparous cows (n = 6) with a significant inhibition of DPP4 in plasma and liver. Further testing included primi- and pluriparous lactating cows suffering from subclinical ketosis (beta-hydroxybutyrate concentrations in serum > 1.2 mM; n = 12). The intension was to offer effects of DPP4 inhibition during comprehensive lipomobilisation and hepatosteatosis. The cows of subclinical ketosis were evenly allocated to either the treatment group (daily injections, 0.3 mg BI 14332/kg body weight, 7 days) or the control group. Under condition of subclinical ketosis, the impact of DPP4 inhibition via BI 14332 was less, as in particular beta-hydroxybutyrate and the hepatic lipid content remained unaffected, but NEFA and triglyceride concentrations were decreased after treatment. Owing to lower NEFA, the revised quantitative insulin sensitivity check index (surrogate marker for insulin sensitivity) increased. Therefore, a positive influence on energy metabolism might be quite possible. Minor impacts on immune-modulating variables were limited to the lymphocyte CD4(+)/CD8(+) ratio for which a trend to decreased values in treated versus control animals was noted. In sum, the DPP4 inhibition in cows did not affect glycaemic control like it is shown in humans, but was able to impact hyperlipemia, as NEFA and TG decreased.	[Schulz, Kirsten; Frahm, Jana; Kersten, Susanne; Meyer, Ulrich; Daenicke, Sven] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Inst Anim Nutr, Braunschweig, Germany; [Rehage, Juergen; Piechotta, Marion; Meyerholz, Maria] Univ Vet Med Hannover, Clin Cattle, Hannover, Germany; [Breves, Gerhard] Univ Vet Med Hannover, Dept Physiol, Hannover, Germany; [Reiche, Dania] Boehringer Ingelheim Vetmed, Ingelheim, Germany; [Sauerwein, Helga] Univ Bonn, Inst Anim Sci, Physiol & Hyg Unit, Bonn, Germany	Friedrich Loeffler Institute; University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; Boehringer Ingelheim; University of Bonn	Frahm, J (corresponding author), Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Inst Anim Nutr, Braunschweig, Germany.	jana.frahm@fli.bund.de	Sauerwein, Helga/R-8242-2019; Breves, Gerhard/ABI-1315-2020		Boehringer Ingelheim Vetmedica GmbH	Boehringer Ingelheim Vetmedica GmbH(Boehringer Ingelheim)	Boehringer Ingelheim Vetmedica GmbH (www.vetmedica.de) funded the present study. Represented by Dr. Dania Reiche, Boehringer Ingelheim Vetmedica GmbH was involved in study design and data Analysis. Furthermore, Boehringer Ingelheim Vetmedica GmbH granted the decision to publish the present manuscript.	Anz D, 2014, DIABETES OBES METAB, V16, P569, DOI 10.1111/dom.12246; Asai K, 1998, VET IMMUNOL IMMUNOP, V65, P51, DOI 10.1016/S0165-2427(98)00176-7; Bell AW, 1997, J MAMMARY GLAND BIOL, V2, P265, DOI 10.1023/A:1026336505343; Ben-Shlomo S, 2011, J HEPATOL, V54, P1214, DOI 10.1016/j.jhep.2010.09.032; Bobe G, 2004, J DAIRY SCI, V87, P3105, DOI 10.3168/jds.S0022-0302(04)73446-3; Bradford BJ, 2008, J DAIRY SCI, V91, P1443, DOI 10.3168/jds.2007-0670; Connor EE, 2010, J DAIRY SCI, V93, P5167, DOI 10.3168/jds.2010-3205; Deacon CF, 2004, HORM METAB RES, V36, P761, DOI 10.1055/s-2004-826160; Dirksen G., 2012, BOVINE INTERNAL DIS; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Duffield T, 2000, VET CLIN N AM-FOOD A, V16, P231, DOI 10.1016/S0749-0720(15)30103-1; EDMONSON AJ, 1989, J DAIRY SCI, V72, P68, DOI 10.3168/jds.S0022-0302(89)79081-0; Fathi E, 2013, INT J RECENT SCI RES, V4, P842; Flatt PR, 2008, FRONT BIOSCI-LANDMRK, V13, P3648, DOI 10.2741/2956; Frey H, 2009, LEHRBUCH PHARMAKOLOG; Gorrell MD, 2001, SCAND J IMMUNOL, V54, P249, DOI 10.1046/j.1365-3083.2001.00984.x; Hachenberg S, 2007, J ANIM SCI, V85, P1923, DOI 10.2527/jas.2006-480; Hiss S, 2004, J DAIRY SCI, V87, P3778, DOI 10.3168/jds.S0022-0302(04)73516-X; Holtenius P, 2007, ACTA VET SCAND, V49, DOI 10.1186/1751-0147-49-29; HOVE K, 1978, J DAIRY SCI, V61, P1407, DOI 10.3168/jds.S0022-0302(78)83742-4; Huttner S, 2008, J CLIN PHARMACOL, V48, P1171, DOI 10.1177/0091270008323753; Larsen M, 2010, J DAIRY SCI, V93, P5729, DOI 10.3168/jds.2010-3258; McArt JAA, 2013, VET J, V198, P560, DOI 10.1016/j.tvjl.2013.08.011; Mehrzad J, 2008, J DAIRY RES, V75, P457, DOI 10.1017/S0022029908003439; MUNOZ E, 1992, IMMUNOLOGY, V77, P43; Ohtsuka H, 2001, J VET MED SCI, V63, P1021, DOI 10.1292/jvms.63.1021; Pezeshki A, 2012, J DAIRY SCI, V95, P5089, DOI 10.3168/jds.2011-5311; Relling AE, 2008, DOMEST ANIM ENDOCRIN, V35, P35, DOI 10.1016/j.domaniend.2008.01.005; Saremi B, 2012, VET IMMUNOL IMMUNOP, V146, P201, DOI 10.1016/j.vetimm.2012.03.011; Saremi B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086211; *SAS I, 2004, SAS STAT 9 1 US GUID, V1; Schulz K, 2015, ARCH ANIM NUTR, V69, P113, DOI 10.1080/1745039X.2015.1013666; Schulz K, 2014, J DAIRY RES, V81, P257, DOI 10.1017/S0022029914000107; Starke A, 2010, J ANIM SCI, V88, P2741, DOI 10.2527/jas.2009-2599; StatSoft I., 2011, STATISTICA WIND OP S; Stelter K, 2013, ARCH ANIM NUTR, V67, P461, DOI 10.1080/1745039X.2013.858897; Taylor-Edwards CC, 2010, DOMEST ANIM ENDOCRIN, V39, P181, DOI 10.1016/j.domaniend.2010.05.002; Tilg H, 2008, TRENDS ENDOCRIN MET, V19, P371, DOI 10.1016/j.tem.2008.08.005; Toutain PL, 2004, J VET PHARMACOL THER, V27, P415, DOI 10.1111/j.1365-2885.2004.00605.x; Toutain PL, 2004, J VET PHARMACOL THER, V27, P427, DOI 10.1111/j.1365-2885.2004.00600.x; White JR., 2008, CLIN DIABETES, V26, P53, DOI [DOI 10.2337/DIACLIN.26.2.53, 10.2337/diaclin.26.2.53]	41	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136078	10.1371/journal.pone.0136078	http://dx.doi.org/10.1371/journal.pone.0136078			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291537	Green Published, gold, Green Submitted			2022-12-26	WOS:000359919900050
J	Talundzic, E; Chenet, SM; Goldman, IF; Patel, DS; Nelson, JA; Plucinski, MM; Barnwell, JW; Udhayakumar, V				Talundzic, Eldin; Chenet, Stella M.; Goldman, Ira F.; Patel, Dhruviben S.; Nelson, Julia A.; Plucinski, Mateusz M.; Barnwell, John W.; Udhayakumar, Venkatachalam			Genetic Analysis and Species Specific Amplification of the Artemisinin Resistance-Associated Kelch Propeller Domain in P. falciparum and P-vivax	PLOS ONE			English	Article							REAL-TIME PCR; WESTERN CAMBODIA; SOUTHEAST-ASIA; MALARIA; CLEARANCE; PROVINCE	Plasmodium falciparum resistance to artemisinin has emerged in the Greater Mekong Sub-region and now poses a threat to malaria control and prevention. Recent work has identified mutations in the kelch propeller domain of the P. falciparum K13 gene to be associated artemisinin resistance as defined by delayed parasite clearance and ex vivo ring stage survival assays. Species specific primers for the two most prevalent human malaria species, P. falciparum and P. vivax, were designed and tested on multiple parasite isolates including human, rodent, and non-humans primate Plasmodium species. The new protocol described here using the species specific primers only amplified their respective species, P. falciparum and P. vivax, and did not cross react with any of the other human malaria Plasmodium species. We provide an improved species specific PCR and sequencing protocol that could be effectively used in areas where both P. falciparum and P. vivax are circulating. To design this improved protocol, the kelch gene was analyzed and compared among different species of Plasmodium. The kelch propeller domain was found to be highly conserved across the mammalian Plasmodium species.	[Talundzic, Eldin; Chenet, Stella M.; Goldman, Ira F.; Patel, Dhruviben S.; Plucinski, Mateusz M.; Barnwell, John W.; Udhayakumar, Venkatachalam] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Parasit Dis & Malaria, Atlanta, GA 30329 USA; [Talundzic, Eldin; Nelson, Julia A.] Atlanta Res & Educ Fdn, VA Med Ctr, Decatur, GA USA; [Plucinski, Mateusz M.] Presidents Malaria Initiat, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System	Talundzic, E (corresponding author), Ctr Dis Control & Prevent, Ctr Global Hlth, Div Parasit Dis & Malaria, 1600 Clifton Rd,Mail Stop D-67, Atlanta, GA 30329 USA.	etalundzic@cdc.gov	Chenet, Stella M/H-6001-2018	Chenet, Stella M/0000-0002-5305-0664; Plucinski, Mateusz/0000-0002-7322-4625	CDC Advanced Molecular Detection Initiative; Atlanta Research and Education Foundation; American Society of Microbiology postdoctoral fellowship	CDC Advanced Molecular Detection Initiative; Atlanta Research and Education Foundation; American Society of Microbiology postdoctoral fellowship	The authors acknowledge funding support from the CDC Advanced Molecular Detection Initiative. ET is supported by the Atlanta Research and Education Foundation and SMC by the American Society of Microbiology postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaratunga C, 2012, LANCET INFECT DIS, V12, P851, DOI 10.1016/S1473-3099(12)70181-0; [Anonymous], J INFECT DIS; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Bosman P, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-394; Carrara VI, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001398; Collins W.E, 1971, PRIMATE MALARIAS, P366; Cui LW, 2012, ACTA TROP, V121, P227, DOI 10.1016/j.actatropica.2011.02.016; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Douglas NM, 2010, LANCET INFECT DIS, V10, P405, DOI 10.1016/S1473-3099(10)70079-7; Gogtay N, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008492.pub3; Kamau E., 2014, J INFECT DIS; Khim N, 2014, EMERG INFECT DIS, V20, P1637, DOI 10.3201/eid2010.140411; Lucchi NW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056677; Mangold KA, 2005, J CLIN MICROBIOL, V43, P2435, DOI 10.1128/JCM.43.5.2435-2440.2005; Mohon A, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-431; Na-Bangchang K, 2007, TOHOKU J EXP MED, V211, P99, DOI 10.1620/tjem.211.99; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; Plucinski M.M., 2014, ANTIMICROB AGENTS CH; Popovici J, 2015, ANTIMICROB AGENTS CH, V59, P730, DOI 10.1128/AAC.03908-14; Sattabongkot J, 2004, TRENDS PARASITOL, V20, P192, DOI 10.1016/j.pt.2004.02.001; Takala-Harrison S, 2013, P NATL ACAD SCI USA, V110, P240, DOI 10.1073/pnas.1211205110; Talundzic E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004789; Talundzic E, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-31; Taylor SM, 2014, J INFECT DIS; Wellems TE, 2001, J INFECT DIS, V184, P770, DOI 10.1086/322858; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2020, REP ANT DRUG EFF RES; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813; Yang Z, 2012, J STRUCT BIOL, V179, P269, DOI 10.1016/j.jsb.2011.09.006	31	34	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136099	10.1371/journal.pone.0136099	http://dx.doi.org/10.1371/journal.pone.0136099			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26292024	Green Submitted, Green Published, gold			2022-12-26	WOS:000359919900054
J	Hussein, MA; Shrestha, E; Ouimet, M; Barrett, TJ; Leone, S; Moore, KJ; Herault, Y; Fisher, EA; Garabedian, MJ				Hussein, Maryem A.; Shrestha, Elina; Ouimet, Mireille; Barrett, Tessa J.; Leone, Sarah; Moore, Kathryn J.; Herault, Yann; Fisher, Edward A.; Garabedian, Michael J.			LXR-Mediated ABCA1 Expression and Function Are Modulated by High Glucose and PRMT2	PLOS ONE			English	Article							DEPENDENT DIABETES-MELLITUS; CHOLESTEROL EFFLUX; NUCLEAR RECEPTOR; ARGININE METHYLTRANSFERASE; GENE-EXPRESSION; RISK-FACTORS; X RECEPTOR; PROTEIN; ATHEROSCLEROSIS; METHYLATION	High cholesterol and diabetes are major risk factors for atherosclerosis. Regression of atherosclerosis is mediated in part by the Liver X Receptor (LXR) through the induction of genes involved in cholesterol transport and efflux. In the context of diabetes, regression of atherosclerosis is impaired. We proposed that changes in glucose levels modulate LXR-dependent gene expression. Using a mouse macrophage cell line (RAW 264.7) and primary bone marrow derived macrophages (BMDMs) cultured in normal or diabetes relevant high glucose conditions we found that high glucose inhibits the LXR-dependent expression of ATP-binding cassette transporter A1 (ABCA1), but not ABCG1. To probe for this mechanism, we surveyed the expression of a host of chromatin-modifying enzymes and found that Protein Arginine Methyltransferase 2 (PRMT2) was reduced in high compared to normal glucose conditions. Importantly, ABCA1 expression and ABCA1-mediated cholesterol efflux were reduced in Prmt2(-/-) compared to wild type BMDMs. Monocytes from diabetic mice also showed decreased expression of Prmt2 compared to non-diabetic counterparts. Thus, PRMT2 represents a glucose-sensitive factor that plays a role in LXR-mediated ABCA1-dependent cholesterol efflux and lends insight to the presence of increased atherosclerosis in diabetic patients.	[Hussein, Maryem A.; Shrestha, Elina; Leone, Sarah; Garabedian, Michael J.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Ouimet, Mireille; Barrett, Tessa J.; Moore, Kathryn J.; Fisher, Edward A.] NYU, Sch Med, Dept Med, New York, NY USA; [Herault, Yann] Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; [Herault, Yann] CNRS, UMR7104, Illkirch Graffenstaden, France; [Herault, Yann] INSERM, U964, Illkirch Graffenstaden, France; [Herault, Yann] Univ Strasbourg, Illkirch Graffenstaden, France; [Herault, Yann] ICS, F-67404 Illkirch Graffenstaden, France	New York University; New York University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Garabedian, MJ (corresponding author), NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.	michael.garabedian@nyumc.org	Herault, Yann/B-5500-2012; Moore, Kathryn/ABE-6416-2020; Fisher, Edward/ABE-7469-2020	Herault, Yann/0000-0001-7049-6900; Moore, Kathryn/0000-0003-2505-2547; Fisher, Edward/0000-0001-9802-143X; Barrett, Tessa/0000-0003-0751-1578	National Institutes of Health [T32AI07180, T32GM007238, R01DK095684, R01HL117226, T32 GM007308]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007238, T32GM007308] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (www.NIH.gov) grants T32AI07180 (MAH), T32GM007238 (ES), R01DK095684 (TB and EAF), R01HL117226 (MJG and EAF). T32 GM007308 (MAH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander CM, 2003, DIABETES, V52, P1210, DOI 10.2337/diabetes.52.5.1210; Barrero MJ, 2006, MOL CELL, V24, P233, DOI 10.1016/j.molcel.2006.09.020; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Brasacchio D, 2009, DIABETES, V58, P1229, DOI 10.2337/db08-1666; Breslow JL, 1996, SCIENCE, V272, P685, DOI 10.1126/science.272.5262.685; Chait A, 2009, J LIPID RES, V50, pS335, DOI 10.1194/jlr.R800059-JLR200; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Costet P, 2000, J BIOL CHEM, V275, P28240; DORMAN JS, 1985, DIABETES CARE, V8, P54, DOI 10.2337/diacare.8.1.S54; El-Osta A, 2008, J EXP MED, V205, P2409, DOI 10.1084/jem.20081188; Feig JE, 2011, CIRCULATION, V123, P989, DOI 10.1161/CIRCULATIONAHA.110.984146; Feig JE, 2010, J CLIN INVEST, V120, P4415, DOI 10.1172/JCI38911; Fox CS, 2004, JAMA-J AM MED ASSOC, V292, P2495, DOI 10.1001/jama.292.20.2495; Gabbi C, 2014, BIOCHEM BIOPH RES CO, V446, P647, DOI 10.1016/j.bbrc.2013.11.077; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Iwasaki H, 2010, CIRC RES, V107, P992, DOI 10.1161/CIRCRESAHA.110.225326; Jakobsson T, 2009, MOL CELL, V34, P510, DOI 10.1016/j.molcel.2009.05.006; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Jansson D, 2008, P NATL ACAD SCI USA, V105, P10161, DOI 10.1073/pnas.0800796105; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kannel W B, 1979, Diabetes Care, V2, P120, DOI 10.2337/diacare.2.2.120; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Lakowski TM, 2009, BIOCHEM J, V421, P253, DOI 10.1042/BJ20090268; Le DD, 2012, CURR OPIN CHEM BIOL, V16, P507, DOI 10.1016/j.cbpa.2012.09.014; Le Goff W, 2006, ARTERIOSCL THROM VAS, V26, P527, DOI 10.1161/01.ATV.0000201042.00725.84; LIKE AA, 1976, SCIENCE, V193, P415, DOI 10.1126/science.180605; Mazzone T, 2008, LANCET, V371, P1800, DOI 10.1016/S0140-6736(08)60768-0; Meyer R, 2007, J STEROID BIOCHEM, V107, P1, DOI 10.1016/j.jsbmb.2007.05.006; Miao F, 2013, PHYSIOL GENOMICS, V45, P287, DOI 10.1152/physiolgenomics.00001.2013; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; Moreno PR, 2000, CIRCULATION, V102, P2180; Murphy AJ, 2011, J CLIN INVEST, V121, P4138, DOI 10.1172/JCI57559; Parathath S, 2011, DIABETES, V60, P1759, DOI 10.2337/db10-0778; Qi C, 2002, J BIOL CHEM, V277, P28624, DOI 10.1074/jbc.M201053200; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Schwartz K, 2000, BIOCHEM BIOPH RES CO, V274, P794, DOI 10.1006/bbrc.2000.3243; SMITHIES O, 1995, P NATL ACAD SCI USA, V92, P5266, DOI 10.1073/pnas.92.12.5266; Sparrow CP, 2002, J BIOL CHEM, V277, P10021, DOI 10.1074/jbc.M108225200; TEBOUL M, 1995, P NATL ACAD SCI USA, V92, P2096, DOI 10.1073/pnas.92.6.2096; Torra IP, 2008, MOL CELL BIOL, V28, P2626, DOI 10.1128/MCB.01575-07; Turner RC, 1998, BMJ-BRIT MED J, V316, P823, DOI 10.1136/bmj.316.7134.823; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Yoshimoto T, 2006, EXP CELL RES, V312, P2040, DOI 10.1016/j.yexcr.2006.03.001; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	48	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135218	10.1371/journal.pone.0135218	http://dx.doi.org/10.1371/journal.pone.0135218			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288135	Green Published, gold, Green Submitted			2022-12-26	WOS:000360018600040
J	Lakestani, N; Donaldson, ML				Lakestani, Nelly; Donaldson, Morag L.			Dog Bite Prevention: Effect of a Short Educational Intervention for Preschool Children	PLOS ONE			English	Article							BEHAVIOR; PERCEPTION; OWNERSHIP; INJURIES; PROGRAM	This study aimed to investigate whether preschool children can learn how to interpret dogs' behaviours, with the purpose of helping avoid dog bites. Three-to five-year-old children (N = 70) were tested on their ability to answer questions about dogs' emotional states before and after participating in either an educational intervention about dog behaviour (intervention group) or an activity about wild animals (control group). Children who had received training about dog behaviour (intervention group) were significantly better at judging the dogs' emotional states after the intervention compared to before. The frequency with which they referred to relevant behaviours in justifying their judgements also increased significantly. In contrast, the control group's performance did not differ significantly between the two testing times. These results indicate that preschool children can be taught how to correctly interpret dogs' behaviours. This implies that incorporating such training into prevention programmes may contribute to reducing dog bite incidents.	[Lakestani, Nelly] Univ Andres Bello, Escuela Med Vet, Fac Ecol & Recursos Nat, Santiago, Chile; [Donaldson, Morag L.] Univ Edinburgh, Sch Philosophy Psychol & Language Sci, Edinburgh, Midlothian, Scotland	Universidad Andres Bello; University of Edinburgh	Lakestani, N (corresponding author), Univ Andres Bello, Escuela Med Vet, Fac Ecol & Recursos Nat, Santiago, Chile.	nelly.lakestani@unab.cl						AMPOFOBOATENG K, 1991, BRIT J PSYCHOL, V82, P487, DOI 10.1111/j.2044-8295.1991.tb02415.x; AVMA, 2012, US PET OWN STAT DEM; Beard R.M., 2013, OUTLINE PIAGETS DEV, DOI [10.4324/9780203715765, DOI 10.4324/9780203715765]; BECK AM, 1985, PUBLIC HEALTH REP, V100, P315; Bernardo LM, 2002, PEDIATR EMERG CARE, V18, P247, DOI 10.1097/00006565-200206000-00024; Chapman S, 2000, BRIT MED J, V320, P1512, DOI 10.1136/bmj.320.7248.1512; De Keuster T, 2006, VET J, V172, P482, DOI 10.1016/j.tvjl.2005.04.024; Gilchrist J, 2008, INJURY PREV, V14, P296, DOI 10.1136/ip.2007.016220; GRIEVE R, 1985, BRIT J DEV PSYCHOL, V3, P385, DOI 10.1111/j.2044-835X.1985.tb00990.x; Guy NC, 2001, APPL ANIM BEHAV SCI, V74, P43, DOI 10.1016/S0168-1591(01)00155-1; Hill R, 2000, BRIT J DEV PSYCHOL, V18, P103, DOI 10.1348/026151000165607; Kahn A, 2004, EUR J PEDIATR, V163, P424, DOI 10.1007/s00431-004-1456-3; Kahn A, 2003, EUR J PEDIATR, V162, P254, DOI 10.1007/s00431-002-1130-6; Lakestani N.N., 2007, THESIS U EDINBURGH E; Lakestani NN, 2014, ANTHROZOOS, V27, P65, DOI 10.2752/175303714X13837396326413; Love M, 2001, J AM VET MED ASSOC, V219, P446, DOI 10.2460/javma.2001.219.446; Meints K, 2009, J PEDIATR PSYCHOL, V34, P1084, DOI 10.1093/jpepsy/jsp053; Mendez Gallart R, 2002, An Esp Pediatr, V56, P425; Murray JK, 2010, VET REC, V166, P163, DOI 10.1136/vr.b4712; Ozanne-Smith J, 2001, Inj Prev, V7, P321, DOI 10.1136/ip.7.4.321; Peak Karen, 2002, J Emerg Nurs, V28, P450, DOI 10.1067/men.2002.128404; Poresky RH, 1996, ANTHROZOOS, V9, P159, DOI 10.2752/089279396787001437; Reisner IR, 2011, INJURY PREV, V17, P348, DOI 10.1136/ip.2010.029868; Sacks J J, 1996, Inj Prev, V2, P52, DOI 10.1136/ip.2.1.52; Savino F, 2002, Minerva Pediatr, V54, P237; Schwebel DC, 2012, J PEDIATR PSYCHOL, V37, P272, DOI 10.1093/jpepsy/jsr102; Shen JB, 2013, INT J ENV RES PUB HE, V10, P950, DOI 10.3390/ijerph10030950; Spiegel IB, 2000, ANTHROZOOS, V13, P164, DOI 10.2752/089279300786999789; Thompson B, 2005, COMP CONT EDUC PRACT, V27, P328; VANHOUTTE BA, 1995, J APPL DEV PSYCHOL, V16, P463, DOI 10.1016/0193-3973(95)90030-6; Westgarth C, 2010, INT J ENV RES PUB HE, V7, P3704, DOI 10.3390/ijerph7103704; Wilson F, 2003, J COMMUNITY PSYCHOL, V31, P75, DOI 10.1002/jcop.10038	32	27	27	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0134319	10.1371/journal.pone.0134319	http://dx.doi.org/10.1371/journal.pone.0134319			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP6SN	26287686	Green Published, Green Submitted, gold			2022-12-26	WOS:000360018600019
J	Linsuwanon, P; Poovorawan, Y; Li, LL; Deng, XT; Vongpunsawad, S; Delwart, E				Linsuwanon, Piyada; Poovorawan, Yong; Li, Linlin; Deng, Xutao; Vongpunsawad, Sompong; Delwart, Eric			The Fecal Virome of Children with Hand, Foot, and Mouth Disease that Tested PCR Negative for Pathogenic Enteroviruses	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; HUMAN RHINOVIRUS C; COXSACKIEVIRUS A6; GENETIC DIVERSITY; ENTERIC VIRUSES; HUMAN BOCAVIRUS; SAFFOLD VIRUS; STOOL SAMPLES; 71 INFECTION; ASTROVIRUS	Hand, foot, and mouth disease (HFMD) affects infant and young children. A viral metagenomic approach was used to identify the eukaryotic viruses in fecal samples from 29 Thai children with clinical diagnosis of HFMD collected during the 2012 outbreak. These children had previously tested negative by PCR for enterovirus 71 and coxsackievirus A16 and A6. Deep sequencing revealed nine virus families: Picornaviridae, Astroviridae, Parvoviridae, Caliciviridae, Paramyxoviridae, Adenoviridae, Reoviridae, Picobirnaviridae, and Polyomaviridae. The highest number of viral sequences belonged to human rhinovirus C, astrovirus-MLB2, and coxsackievirus A21. Our study provides an overview of virus community and highlights a broad diversity of viruses found in feces from children with HFMD.	[Linsuwanon, Piyada; Poovorawan, Yong; Vongpunsawad, Sompong] Chulalongkorn Univ, Ctr Excellence Clin Virol, Bangkok, Thailand; [Li, Linlin; Deng, Xutao; Delwart, Eric] Blood Syst Res Inst, San Francisco, CA USA; [Li, Linlin; Deng, Xutao; Delwart, Eric] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	Chulalongkorn University; Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco	Poovorawan, Y (corresponding author), Chulalongkorn Univ, Ctr Excellence Clin Virol, Bangkok, Thailand.	yong.p@chula.ac.th	ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022; Ibrahim, Essam Hassan/G-1960-2018; Linsuwanon, Piyada/AAS-7642-2020	Ibrahim, Essam Hassan/0000-0003-0130-2257; vongpunsawad, sompong/0000-0001-7520-8728; Poovorawan, Yong/0000-0002-2337-6807	Ratchadaphiseksomphot Endowment Fund; Blood Systems Research Institute (BSRI), NIH [R01 HL083254, R01HL105770]; Research Chair Grant National Science and Technology Development Agency (NSTDA); National Research University Project, Office of Higher Education Commission [HR1155A, WCU-001, 007-HR-57]; Centenary Academic Development Project, Integrated Innovation Academic Center; Chulalongkorn University Centenary Academic Development Project [CU56-HR01]; Outstanding Professor of the Thailand Research Fund [DPG5480002]; MK Restaurant Company Limited; Siam Cement Pcl; King Chulalongkorn Memorial Hospital Thai Red Cross Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105770, R01HL083254] Funding Source: NIH RePORTER	Ratchadaphiseksomphot Endowment Fund; Blood Systems Research Institute (BSRI), NIH; Research Chair Grant National Science and Technology Development Agency (NSTDA); National Research University Project, Office of Higher Education Commission; Centenary Academic Development Project, Integrated Innovation Academic Center; Chulalongkorn University Centenary Academic Development Project; Outstanding Professor of the Thailand Research Fund; MK Restaurant Company Limited; Siam Cement Pcl; King Chulalongkorn Memorial Hospital Thai Red Cross Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding: This project described was supported by the Ratchadaphiseksomphot Endowment Fund to Dr. Piyada Linsuwanon; The Blood Systems Research Institute (BSRI), NIH R01 HL083254 and NIH R01HL105770 to Dr. Eric Delwart; The Research Chair Grant National Science and Technology Development Agency (NSTDA); the National Research University Project, Office of Higher Education Commission (HR1155A, WCU-001, 007-HR-57); the Centenary Academic Development Project, Integrated Innovation Academic Center; Chulalongkorn University Centenary Academic Development Project (CU56-HR01); the Outstanding Professor of the Thailand Research Fund (DPG5480002); MK Restaurant Company Limited and The Siam Cement Pcl; and King Chulalongkorn Memorial Hospital Thai Red Cross Society to Professor Yong Poovorawan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EJ, 2004, LANCET INFECT DIS, V4, P91, DOI 10.1016/S1473-3099(04)00928-4; Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; Berciaud S, 2012, J CLIN VIROL, V54, P302, DOI 10.1016/j.jcv.2012.04.009; Blinkova O, 2009, J VIROL, V83, P4631, DOI 10.1128/JVI.02085-08; Blomqvist S, 2002, J CLIN MICROBIOL, V40, P4218, DOI 10.1128/JCM.40.11.4218-4223.2002; Blomqvist S, 2010, J CLIN VIROL, V48, P49, DOI 10.1016/j.jcv.2010.02.002; Blomstrom AL, 2010, J CLIN MICROBIOL, V48, P4392, DOI 10.1128/JCM.01040-10; Bouzalas IG, 2014, J CLIN MICROBIOL, V52, P3318, DOI 10.1128/JCM.01195-14; Cardosa MJ, 1999, LANCET, V354, P987, DOI 10.1016/S0140-6736(98)11032-2; Chang L, 2007, NEW ENGL J MED, V356, P1226, DOI 10.1056/NEJMoa065954; Chang LY, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e88; Chang LY, 1999, PEDIATR INFECT DIS J, V18, P1092, DOI 10.1097/00006454-199912000-00013; Chen SY, 2013, PEDIATR INFECT DIS J, V32, P1335, DOI 10.1097/INF.0b013e3182a5f5b6; Chhabra P, 2013, J INFECT DIS, V208, P790, DOI 10.1093/infdis/jit254; Chiu CY, 2008, P NATL ACAD SCI USA, V105, P14124, DOI 10.1073/pnas.0805968105; Cotmore SF, 2014, ARCH VIROL, V159, P1239, DOI 10.1007/s00705-013-1914-1; De Gascun CF, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/373579; Delwart E, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003146; Delwart EL, 2007, REV MED VIROL, V17, P115, DOI 10.1002/rmv.532; Downing C, 2014, J CLIN VIROL, V60, P381, DOI 10.1016/j.jcv.2014.04.023; Drexler JF, 2010, J GEN VIROL, V91, P1418, DOI 10.1099/vir.0.018887-0; Dropulic LK, 2008, BONE MARROW TRANSPL, V41, P11, DOI 10.1038/sj.bmt.1705886; Edwards MR, 2012, NAT REV MICROBIOL, V10, P459, DOI 10.1038/nrmicro2801; Finkbeiner SR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000011; Finkbeiner SR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-161; Finkbeiner SR, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-117; Gopalkrishna V, 2012, J MED MICROBIOL, V61, P420, DOI 10.1099/jmm.0.036400-0; Greninger AL, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-82; GROHMANN GS, 1993, NEW ENGL J MED, V329, P14, DOI 10.1056/NEJM199307013290103; Hall AJ, 2014, MMWR-MORBID MORTAL W, V63, P491; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Harvala H, 2012, J MED VIROL, V84, P536, DOI 10.1002/jmv.23203; He B, 2013, PLOS ONE, V8, DOI [10.1371/annotation/68f77773-a2a0-4bfe-b5e6-950dc30b79f9, DOI 10.1371/ANNOTATION/68F77773-A2A0-4BFE-B5E6-950DC30B79F9]; He YQ, 2013, J CLIN MICROBIOL, V51, P3560, DOI 10.1128/JCM.01231-13; Himeda T, 2012, J VIROL, V86, P1292, DOI 10.1128/JVI.06087-11; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Holtz LR, 2014, CLIN VACCINE IMMUNOL, V21, P908, DOI 10.1128/CVI.00100-14; Holtz LR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028647; Honkanen H, 2013, J CLIN VIROL, V56, P250, DOI 10.1016/j.jcv.2012.11.020; Hu YF, 2012, J VIROL, V86, P10901, DOI 10.1128/JVI.01808-12; Huang SW, 2009, J CLIN MICROBIOL, V47, P3653, DOI 10.1128/JCM.00630-09; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; Kapoor A, 2009, J GEN VIROL, V90, P2965, DOI 10.1099/vir.0.014449-0; Kapoor A, 2010, J INFECT DIS, V201, P1633, DOI 10.1086/652416; Kapusinszky B, 2012, J CLIN MICROBIOL, V50, P3427, DOI 10.1128/JCM.01589-12; Khetsuriani N, 2006, MMWR-MORBID MORTAL W, V55, P1; Kim GY, 2004, CLIN GASTROENTEROL H, V2, P175, DOI 10.1016/S1542-3565(03)00316-1; King D, 2013, MMWR-MORBID MORTAL W, V62, P637; Kistler A, 2007, J INFECT DIS, V196, P817, DOI 10.1086/520816; Kreuter JD, 2011, ARCH PATHOL LAB MED, V135, P793, DOI 10.1043/2010-0174-CR.1; Kung YA, 2014, EXPERT OPIN BIOL TH, V14, P1455, DOI 10.1517/14712598.2014.935330; Lau SKP, 2012, J CLIN VIROL, V53, P290, DOI 10.1016/j.jcv.2012.01.008; Lau SKP, 2009, J INFECT DIS, V200, P1096, DOI 10.1086/605697; Ledford RM, 2004, J VIROL, V78, P3663, DOI 10.1128/JVI.78.7.3663-3674.2004; Lee HF, 2014, J CHILD NEUROL, V29, P1283, DOI 10.1177/0883073813516193; Li LL, 2013, EMERG INFECT DIS, V19, P1385, DOI 10.3201/eid1909.130682; Li RC, 2014, NEW ENGL J MED, V370, P829, DOI 10.1056/NEJMoa1303224; Linsuwanon P, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-16; Linsuwanon P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035190; Linsuwanon P, 2009, J INFECTION, V59, P115, DOI 10.1016/j.jinf.2009.05.009; Lukashev AN, 2014, J GEN VIROL, V95, P868, DOI 10.1099/vir.0.060004-0; Ma XM, 2006, J CLIN MICROBIOL, V44, P1132, DOI 10.1128/JCM.44.3.1132-1134.2006; Martinez M, 2014, INFECT GENET EVOL, V27, P402, DOI 10.1016/j.meegid.2014.08.015; McIntyre CL, 2013, J GEN VIROL, V94, P1791, DOI 10.1099/vir.0.053686-0; McIntyre CL, 2010, J VIROL, V84, P10297, DOI 10.1128/JVI.00962-10; McIntyre Mary G., 2012, Morbidity and Mortality Weekly Report, V61, P213; McMinn P, 2001, CLIN INFECT DIS, V32, P236, DOI 10.1086/318454; Meijer A, 2012, VIROLOGY, V423, P49, DOI 10.1016/j.virol.2011.11.021; Minot S, 2011, GENOME RES, V21, P1616, DOI 10.1101/gr.122705.111; Mirand A, 2012, CLIN MICROBIOL INFEC, V18, pE110, DOI 10.1111/j.1469-0691.2012.03789.x; Mori D, 2013, EMERG INFECT DIS, V19, P1859, DOI 10.3201/eid1911.121548; Naeem A, 2014, J GEN VIROL, V95, P1945, DOI 10.1099/vir.0.066498-0; Nakamura S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004219; Nielsen ACY, 2013, J CLIN VIROL, V57, P239, DOI 10.1016/j.jcv.2013.03.015; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Onozuka D, 2011, SCI TOTAL ENVIRON, V410, P119, DOI 10.1016/j.scitotenv.2011.09.055; Ooi MH, 2010, LANCET NEUROL, V9, P1097, DOI 10.1016/S1474-4422(10)70209-X; Opanda SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102866; Palmenberg AC, 2009, SCIENCE, V324, P55, DOI 10.1126/science.1165557; Petrogiannis-Haliotis T, 2001, NEW ENGL J MED, V345, P1250, DOI 10.1056/NEJMoa010319; Podin Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-180; Puenpa J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098888; Puenpa J, 2013, EMERG INFECT DIS, V19, P641, DOI 10.3201/eid1904.121666; Quan PL, 2010, EMERG INFECT DIS, V16, P918, DOI 10.3201/eid1606.091536; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Rovida F, 2013, DIAGN MICR INFEC DIS, V77, P231, DOI 10.1016/j.diagmicrobio.2013.07.020; Samphutthanon R, 2014, INT J ENV RES PUB HE, V11, P312, DOI 10.3390/ijerph110100312; Savolainen-Kopra C, 2013, J MED VIROL, V85, P1466, DOI 10.1002/jmv.23593; Schibler M, 2012, J GEN VIROL, V93, P93, DOI 10.1099/vir.0.035808-0; SCHIEBLE JH, 1967, AM J EPIDEMIOL, V85, P297, DOI 10.1093/oxfordjournals.aje.a120693; Sigurs N, 2000, AM J RESP CRIT CARE, V161, P1501, DOI 10.1164/ajrccm.161.5.9906076; Tapparel C, 2013, INFECT GENET EVOL, V14, P282, DOI 10.1016/j.meegid.2012.10.016; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Tian HF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084233; Tokarz R, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-288; van Leeuwen M, 2010, J CLIN MICROBIOL, V48, P1787, DOI 10.1128/JCM.02452-09; Vanchiere JA, 2005, J INFECT DIS, V192, P658, DOI 10.1086/432076; Vanchiere JA, 2009, J CLIN MICROBIOL, V47, P2388, DOI 10.1128/JCM.02472-08; Victoria JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08; Wong ASY, 2009, BONE MARROW TRANSPL, V43, P43, DOI 10.1038/bmt.2008.266; Wu JM, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e26; Wurzel DF, 2014, CLIN INFECT DIS, V59, P34, DOI 10.1093/cid/ciu225; Xiang ZC, 2012, EMERG INFECT DIS, V18, P821, DOI 10.3201/eid1805.111376; Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6; Yozwiak NL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001485; Zhang XA, 2015, SCI REP-UK, V5, DOI 10.1038/srep07704; Zhang XA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-606; Zhu FC, 2014, NEW ENGL J MED, V370, P818, DOI 10.1056/NEJMoa1304923	108	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135573	10.1371/journal.pone.0135573	http://dx.doi.org/10.1371/journal.pone.0135573			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288145	gold, Green Submitted, Green Published			2022-12-26	WOS:000360018600055
J	Zhang, P; Guo, ZY; Wu, Y; Hu, RL; Du, J; He, XS; Jiao, XY; Zhu, XF				Zhang, Peng; Guo, Zhiyong; Wu, Ying; Hu, Ronglin; Du, Jun; He, Xiaoshun; Jiao, Xingyuan; Zhu, Xiaofeng			Histone Deacetylase Inhibitors Inhibit the Proliferation of Gallbladder Carcinoma Cells by Suppressing AKT/mTOR Signaling	PLOS ONE			English	Article							CANCER-THERAPY; MTOR; PATHWAY; SAHA; TRANSLATION; RESECTION; GROWTH; PTEN	Gallbladder carcinoma is an aggressive malignancy with high mortality mainly due to the limited potential for curative resection and its resistance to chemotherapeutic agents. Here, we show that the histone deacetylase inhibitors (HDACIs) trichostatin-A (TSA) and suberoylanilide hydroxamic acid (SAHA) reduce the proliferation and induce apoptosis of gallbladder carcinoma cells by suppressing the AKT/mammalian target of rapamycin (mTOR) signaling. Gallbladder carcinoma SGC-996 cells were treated with different concentrations of TSA and SAHA for different lengths of time. Cell proliferation and morphology were assessed with MTT assay and microscopy, respectively. Cell cycle distribution and cell apoptosis were analyzed with flow cytometry. Western blotting was used to detect the proteins related to apoptosis, cell cycle, and the AKT/mTOR signaling pathway. Our data showed that TSA and SAHA reduced SGC-996 cell viability and arrested cell cycle at the G1 phase in a dose-and time-dependent manner. TSA and SAHA promoted apoptosis of SGC-996 cells, down-regulated the expression of cyclin D1, c-Myc and Bmi1, and decreased the phosphorylation of AKT, mTOR p70S6K1, S6 and 4E-BP1. Additionally, the mTOR inhibitor rapamycin further reduced the cell viability of TSA-and SAHA-treated SGC-996 cells and the phosphorylation of mTOR, whereas the mTOR activator 1,2-dioctanoyl-sn-glycero-3-phosphate (C8-PA) exerted the opposite influence. Our results demonstrate that histone deacetylase inhibitors (HDACIs) suppress the proliferation of gallbladder carcinoma cell via inhibition of AKT/mTOR signaling. These findings offer a mechanistic rationale for the application of HDACIs in gallbladder carcinoma treatment.	[Zhang, Peng; Guo, Zhiyong; Hu, Ronglin; He, Xiaoshun; Jiao, Xingyuan; Zhu, Xiaofeng] Sun Yat Sen Univ, Organ Transplant Ctr, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Wu, Ying] Sun Yat Sen Univ, Dept Biostat, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Du, Jun] Sun Yat Sen Univ, Sch Pharmaceut Sci, Dept Microbial & Biochem Pharm, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Jiao, XY (corresponding author), Sun Yat Sen Univ, Organ Transplant Ctr, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China.	jiaoxingyuan@hotmail.com; 740803277@qq.com			National Natural Science Foundation of China [81270531, 81071984]; Natural Science Foundation of Guangdong Province of China [2009B030801371]; Specialized Research Fund for the Doctoral Thesis Program of Higher Education in China [20120171110073]; Guangdong Provincial Key Laboratory Construction Projection on Organ Donation and Transplant Immunology [2013A061401007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province of China(National Natural Science Foundation of Guangdong Province); Specialized Research Fund for the Doctoral Thesis Program of Higher Education in China; Guangdong Provincial Key Laboratory Construction Projection on Organ Donation and Transplant Immunology	This study was supported by grants from the National Natural Science Foundation of China (No. 81270531 and 81071984), the Natural Science Foundation of Guangdong Province of China (No. 2009B030801371), the Specialized Research Fund for the Doctoral Thesis Program of Higher Education in China (No. 20120171110073) and the Guangdong Provincial Key Laboratory Construction Projection on Organ Donation and Transplant Immunology (No. 2013A061401007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andren-Sandberg A, 2014, CURR OPIN GASTROEN, V30, P326, DOI 10.1097/MOG.0000000000000068; Bajbouj K, 2012, J NEURO-ONCOL, V107, P503, DOI 10.1007/s11060-011-0791-2; Bartlett DL, 1996, ANN SURG, V224, P639, DOI 10.1097/00000658-199611000-00008; Batra Y, 2005, J GASTROEN HEPATOL, V20, P309, DOI 10.1111/j.1440-1746.2005.03576.x; Batty N, 2009, CANCER LETT, V280, P192, DOI 10.1016/j.canlet.2009.03.013; Bhalla KN, 2005, J CLIN ONCOL, V23, P3971, DOI 10.1200/JCO.2005.16.600; Bjornsti MA, 2004, CANCER CELL, V5, P519, DOI 10.1016/j.ccr.2004.05.027; Burgess A, 2004, ONCOGENE, V23, P6693, DOI 10.1038/sj.onc.1207893; Butte JM, 2011, J AM COLL SURGEONS, V212, P50, DOI 10.1016/j.jamcollsurg.2010.09.009; Carnero A, 2010, CURR PHARM DESIGN, V16, P34, DOI 10.2174/138161210789941865; Chao OS, 2014, MOL CANC RES; Coburn NG, 2008, J AM COLL SURGEONS, V207, P371, DOI 10.1016/j.jamcollsurg.2008.02.031; Czito BG, 2005, INT J RADIAT ONCOL, V62, P1030, DOI 10.1016/j.ijrobp.2004.12.059; Duvic M, 2007, BIOL-TARGETS THER, V1, P377; Ellis L, 2013, ONCOTARGET, V4, P2225, DOI 10.18632/oncotarget.1314; Erlich RB, 2012, BRIT J CANCER, V106, P107, DOI 10.1038/bjc.2011.495; Gupta M, 2009, BLOOD, V114, P2926, DOI 10.1182/blood-2009-05-220889; Hahnen E, 2008, EXPERT OPIN INV DRUG, V17, P169, DOI 10.1517/13543784.17.2.169; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Huang S, 2003, CURR OPIN PHARMACOL, V3, P371, DOI 10.1016/S1471-4892(03)00071-7; Huang WJ, 2011, J ETHNOPHARMACOL, V136, P156, DOI 10.1016/j.jep.2011.04.034; Kawamata N, 2007, BLOOD, V110, P2667, DOI 10.1182/blood-2005-11-026344; Kitamura T, 2012, J HEPATOL, V57, P84, DOI 10.1016/j.jhep.2012.01.018; Lin W, 2012, CANCER LETT, V314, P127, DOI 10.1016/j.canlet.2011.09.004; Monneret C, 2007, ANTI-CANCER DRUG, V18, P363, DOI 10.1097/CAD.0b013e328012a5db; Mwakwari SC, 2010, CURR TOP MED CHEM, V10, P1423; Nishioka C, 2008, LEUKEMIA, V22, P2159, DOI 10.1038/leu.2008.243; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yamaguchi J, 2010, CANCER SCI, V101, P355, DOI 10.1111/j.1349-7006.2009.01387.x; Zaytseva YY, 2012, CANCER LETT, V319, P1, DOI 10.1016/j.canlet.2012.01.005; Zhang P, 2013, ONCOL REP, V29, P269, DOI 10.3892/or.2012.2073	32	20	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136193	10.1371/journal.pone.0136193	http://dx.doi.org/10.1371/journal.pone.0136193			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287365	Green Published, Green Submitted, gold			2022-12-26	WOS:000360018600120
J	Cai, YP; Chen, L; Liu, XJ; Sun, S; Wu, CX; Jiang, BJ; Han, TF; Hou, WS				Cai, Yupeng; Chen, Li; Liu, Xiujie; Sun, Shi; Wu, Cunxiang; Jiang, Bingjun; Han, Tianfu; Hou, Wensheng			CRISPR/Cas9-Mediated Genome Editing in Soybean Hairy Roots	PLOS ONE			English	Article							CRISPR-CAS SYSTEM; TARGETED MUTAGENESIS; AGROBACTERIUM-RHIZOGENES; HOMOLOGOUS RECOMBINATION; MEDIATED TRANSFORMATION; GLYCINE-MAX; GUIDE RNA; PLANTS; GENE; RICE	As a new technology for gene editing, the CRISPR (clustered regularly interspaced short palindromic repeat)/Cas (CRISPR-associated) system has been rapidly and widely used for genome engineering in various organisms. In the present study, we successfully applied type II CRISPR/Cas9 system to generate and estimate genome editing in the desired target genes in soybean (Glycine max (L.) Merrill.). The single-guide RNA (sgRNA) and Cas9 cassettes were assembled on one vector to improve transformation efficiency, and we designed a sgRNA that targeted a transgene (bar) and six sgRNAs that targeted different sites of two endogenous soybean genes (GmFEI2 and GmSHR). The targeted DNA mutations were detected in soybean hairy roots. The results demonstrated that this customized CRISPR/Cas9 system shared the same efficiency for both endogenous and exogenous genes in soybean hairy roots. We also performed experiments to detect the potential of CRISPR/Cas9 system to simultaneously edit two endogenous soybean genes using only one customized sgRNA. Overall, generating and detecting the CRISPR/Cas9-mediated genome modifications in target genes of soybean hairy roots could rapidly assess the efficiency of each target loci. The target sites with higher efficiencies can be used for regular soybean transformation. Furthermore, this method provides a powerful tool for root-specific functional genomics studies in soybean.	[Cai, Yupeng; Chen, Li; Liu, Xiujie; Sun, Shi; Wu, Cunxiang; Jiang, Bingjun; Han, Tianfu; Hou, Wensheng] Chinese Acad Agr Sci, Key Lab Soybean Biol Beijing, Inst Crop Sci, Minist Agr, Beijing 100081, Peoples R China; [Cai, Yupeng; Chen, Li; Liu, Xiujie; Hou, Wensheng] Chinese Acad Agr Sci, Inst Crop Sci, Natl Ctr Transgen Res Plants, Beijing 100081, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Hou, WS (corresponding author), Chinese Acad Agr Sci, Key Lab Soybean Biol Beijing, Inst Crop Sci, Minist Agr, Beijing 100081, Peoples R China.	houwensheng@caas.cn	Jiang, Bingjun/GWQ-4354-2022		Major Science and Technology Projects of China [2014ZX08010-004]; CAAS (Chinese Academy of Agriculture Sciences) Innovation Project	Major Science and Technology Projects of China; CAAS (Chinese Academy of Agriculture Sciences) Innovation Project	This work was supported by Major Science and Technology Projects of China (2014ZX08010-004) and the CAAS (Chinese Academy of Agriculture Sciences) Innovation Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEVAN MW, 1982, ANNU REV GENET, V16, P357, DOI 10.1146/annurev.ge.16.120182.002041; Cao D, 2011, PLANT CELL TISS ORG, V107, P541, DOI 10.1007/s11240-011-0005-9; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Curtin SJ, 2011, PLANT PHYSIOL, V156, P466, DOI 10.1104/pp.111.172981; Feng ZY, 2014, P NATL ACAD SCI USA, V111, P4632, DOI 10.1073/pnas.1400822111; Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Jacobs TB, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0131-2; Jian B, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-78; Jiang WZ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt780; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Lei Y, 2014, MOL PLANT, V7, P1494, DOI 10.1093/mp/ssu044; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Liang Z, 2014, J GENET GENOMICS, V41, P63, DOI 10.1016/j.jgg.2013.12.001; Meyer JDF, 2009, PLANT PHYSIOL, V150, P295, DOI 10.1104/pp.108.134551; Miao J, 2013, CELL RES, V23, P1233, DOI 10.1038/cr.2013.123; Nakano M, 2014, PLANT CELL PHYSIOL, V55, P1763, DOI 10.1093/pcp/pcu107; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Olhoft PM, 2006, METH MOL B, V343, P385; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064; Schlueter JA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-330; Shan QW, 2014, NAT PROTOC, V9, P2395, DOI 10.1038/nprot.2014.157; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Taylor CG, 2006, METH MOL B, V343, P155; Upadhyay SK, 2013, G3-GENES GENOM GENET, V3, P2233, DOI 10.1534/g3.113.008847; Wang GL, 2008, PLANT CELL REP, V27, P1177, DOI 10.1007/s00299-008-0535-8; Xie KB, 2013, MOL PLANT, V6, P1975, DOI 10.1093/mp/sst119; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y; Xu RF, 2014, RICE, V7, DOI 10.1186/s12284-014-0005-6; Zhou HB, 2014, NUCLEIC ACIDS RES, V42, P10903, DOI 10.1093/nar/gku806	32	120	140	4	147	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0136064	10.1371/journal.pone.0136064	http://dx.doi.org/10.1371/journal.pone.0136064			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284791	gold, Green Submitted, Green Published			2022-12-26	WOS:000359666100099
J	Khan, W; Aguilar, C; Kiddle, SJ; Doyle, O; Thambisetty, M; Muehlboeck, S; Sattlecker, M; Newhouse, S; Lovestone, S; Dobson, R; Giampietro, V; Westman, E; Simmons, A				Khan, Wasim; Aguilar, Carlos; Kiddle, Steven J.; Doyle, Orla; Thambisetty, Madhav; Muehlboeck, Sebastian; Sattlecker, Martina; Newhouse, Stephen; Lovestone, Simon; Dobson, Richard; Giampietro, Vincent; Westman, Eric; Simmons, Andrew		Alzheimer's Dis Neuroimaging Initi	A Subset of Cerebrospinal Fluid Proteins from a Multi-Analyte Panel Associated with Brain Atrophy, Disease Classification and Prediction in Alzheimer's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; ACID-BINDING PROTEIN; CHROMOGRANIN-A; CSF BIOMARKERS; MCI PATIENTS; MRI MEASURES; PATTERNS; NEURODEGENERATION; ADNI	In this exploratory neuroimaging-proteomic study, we aimed to identify CSF proteins associated with AD and test their prognostic ability for disease classification and MCI to AD conversion prediction. Our study sample consisted of 295 subjects with CSF multi-analyte panel data and MRI at baseline downloaded from ADNI. Firstly, we tested the statistical effects of CSF proteins (n = 83) to measures of brain atrophy, CSF biomarkers, ApoE genotype and cognitive decline. We found that several proteins (primarily CgA and FABP) were related to either brain atrophy or CSF biomarkers. In relation to ApoE genotype, a unique biochemical profile characterised by low CSF levels of Apo E was evident in epsilon 4 carriers compared to epsilon 3 carriers. In an exploratory analysis, 3/83 proteins (SGOT, MCP-1, IL6r) were also found to be mildly associated with cognitive decline in MCI subjects over a 4-year period. Future studies are warranted to establish the validity of these proteins as prognostic factors for cognitive decline. For disease classification, a subset of proteins (n = 24) combined with MRI measurements and CSF biomarkers achieved an accuracy of 95.1% (Sensitivity 87.7%; Specificity 94.3%; AUC 0.95) and accurately detected 94.1% of MCI subjects progressing to AD at 12 months. The subset of proteins included FABP, CgA, MMP-2, and PPP as strong predictors in the model. Our findings suggest that the marker of panel of proteins identified here may be important candidates for improving the earlier detection of AD. Further targeted proteomic and longitudinal studies would be required to validate these findings with more generalisability.	[Khan, Wasim; Kiddle, Steven J.; Doyle, Orla; Muehlboeck, Sebastian; Sattlecker, Martina; Newhouse, Stephen; Dobson, Richard; Giampietro, Vincent; Westman, Eric; Simmons, Andrew] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England; [Khan, Wasim; Kiddle, Steven J.; Muehlboeck, Sebastian; Sattlecker, Martina; Newhouse, Stephen; Dobson, Richard; Simmons, Andrew] NIHR Biomed Res Ctr Mental Hlth, London, England; [Khan, Wasim; Muehlboeck, Sebastian; Dobson, Richard; Simmons, Andrew] NIHR Biomed Res Unit Dementia, London, England; [Aguilar, Carlos; Westman, Eric] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Thambisetty, Madhav] NIA, Lab Behav Neurosci, NIH, Baltimore, MD 21224 USA; [Lovestone, Simon] Univ Oxford, Dept Psychiat, Oxford, England	University of London; King's College London; University of London; King's College London; Karolinska Institutet; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Oxford	Khan, W (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England.	wasim.khan@kcl.ac.uk	Aguilar, Carlos/AAQ-9837-2021; Simmons, Andrew/B-8848-2008; Westman, Eric/H-5771-2011; Giampietro, Vincent P/D-1279-2011; dobson, richard/C-9269-2011	Aguilar, Carlos/0000-0003-4321-2516; Simmons, Andrew/0000-0003-2306-5811; Westman, Eric/0000-0002-3115-2977; Giampietro, Vincent P/0000-0002-9381-8201; Lovestone, Simon/0000-0003-0473-4565; Doyle, Orla/0000-0002-6964-0140; Kiddle, Steven/0000-0003-4350-7437; dobson, richard/0000-0003-4224-9245; Newhouse, Stephen/0000-0002-1843-9842; Khan, Wasim/0000-0002-4489-4945	ADNI from National Institutes of Health [U01 393 AG024904]; NIHR Biomedical Research Centre for Mental Health; NIHR Biomedical Research Unit for Dementia at the South London and Maudsley NHS Foundation Trust; Institute of Psychiatry, Kings College London; Alzheimer's Research UK; National Institutes of Health [P30 AG010129, K01 AG030514]; Dana Foundation; MRC [MR/L011859/1] Funding Source: UKRI; Alzheimers Research UK [ART-PG2010-4] Funding Source: researchfish; Medical Research Council [MR/L011859/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10053] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000200, P30AG010129, P50AG005146, K01AG030514] Funding Source: NIH RePORTER	ADNI from National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIHR Biomedical Research Centre for Mental Health(National Institute for Health Research (NIHR)); NIHR Biomedical Research Unit for Dementia at the South London and Maudsley NHS Foundation Trust; Institute of Psychiatry, Kings College London(General Electric); Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Data collection and sharing for this project were funded by the ADNI (grant U01 393 AG024904 from the National Institutes of Health). This study was supported by funds from the NIHR Biomedical Research Centre for Mental Health and NIHR Biomedical Research Unit for Dementia at the South London and Maudsley NHS Foundation Trust and Institute of Psychiatry, Kings College London, and Alzheimer's Research UK. This research was also supported by grants P30 AG010129 and K01 AG030514 from the National Institutes of Health and by the Dana Foundation.	Aguilar C, 2013, PSYCHIAT RES-NEUROIM, V212, P89, DOI 10.1016/j.pscychresns.2012.11.005; Apostolova LG, 2010, NEUROBIOL AGING, V31, P1284, DOI 10.1016/j.neurobiolaging.2010.05.003; Blennow K, 2003, LANCET NEUROL, V2, P605, DOI 10.1016/S1474-4422(03)00530-1; BLENNOW K, 1995, DEMENTIA, V6, P306, DOI 10.1159/000106963; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chiasserini D, 2010, J ALZHEIMERS DIS, V22, P1281, DOI 10.3233/JAD-2010-101293; Craig-Schapiro R, 2010, BIOL PSYCHIAT, V68, P903, DOI 10.1016/j.biopsych.2010.08.025; Cui Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021896; Davatzikos C, 2010, NEUROBIOL AGING; Davatzikos C, 2009, BRAIN, V132, P2026, DOI 10.1093/brain/awp091; Desikan RS, 2009, BRAIN, V132, P2048, DOI 10.1093/brain/awp123; Fagan AM, 2012, BIOMARK MED, V6, P455, DOI [10.2217/bmm.12.42, 10.2217/BMM.12.42]; Fan Y, 2008, NEUROIMAGE, V39, P1731, DOI 10.1016/j.neuroimage.2007.10.031; Fox NC, 1996, BRAIN, V119, P2001, DOI 10.1093/brain/119.6.2001; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Hsu C.-W., 2010, PRACTICAL GUIDE SUPP; Hu WT, 2012, NEUROLOGY, V79, P897, DOI 10.1212/WNL.0b013e318266fa70; Hu WT, 2010, ACTA NEUROPATHOL, V119, P669, DOI 10.1007/s00401-010-0667-0; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Jack CR, 2014, LANCET NEUROL, V13, P997, DOI 10.1016/S1474-4422(14)70194-2; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jing Z, 2005, NEUROBIOL AGING, V26, P207, DOI 10.1016/j.neurobiolaging.2004.03.012; Mattsson N, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.69; Mattsson N, 2014, NEUROBIOL AGING, V35, P614, DOI 10.1016/j.neurobiolaging.2013.08.027; Mattsson N, 2009, JAMA-J AM MED ASSOC, V302, P385, DOI 10.1001/jama.2009.1064; Misra C, 2009, NEUROIMAGE, V44, P1415, DOI 10.1016/j.neuroimage.2008.10.031; Olsson B, 2013, J ALZHEIMERS DIS, V34, P673, DOI 10.3233/JAD-121384; Paterson RW, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.58; Perrin RJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016032, 10.1371/journal.pone.0018850]; Scholkopf B., 2002, LEARNING KERNELS; Shaw LM, 2007, NAT REV DRUG DISCOV, V6, P295, DOI 10.1038/nrd2176; Shaw LM, 2011, ACTA NEUROPATHOL, V121, P597, DOI 10.1007/s00401-011-0808-0; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Simmons A, 2011, INT J GERIATR PSYCH, V26, P75, DOI 10.1002/gps.2491; Simmons A, 2009, ANN NY ACAD SCI, V1180, P47, DOI 10.1111/j.1749-6632.2009.05063.x; Soares HD, 2012, ARCH NEUROL-CHICAGO, V69, P1310, DOI 10.1001/archneurol.2012.1070; Taylor DL, 2002, J NEUROCHEM, V82, P1179, DOI 10.1046/j.1471-4159.2002.01062.x; Trojanowski JQ, 2010, ALZHEIMERS DEMENT, V6, P230, DOI 10.1016/j.jalz.2010.03.008; Vemuri P, 2009, NEUROLOGY, V73, P294, DOI 10.1212/WNL.0b013e3181af79fb; Villemagne VL, 2013, LANCET NEUROL, V12, P357, DOI 10.1016/S1474-4422(13)70044-9; Weiner MW, 2010, ALZHEIMERS DEMENT, V6, P202, DOI 10.1016/j.jalz.2010.03.007; Westman E, 2013, BRAIN TOPOGR, V26, P9, DOI 10.1007/s10548-012-0246-x; Westman E, 2012, NEUROIMAGE, V62, P229, DOI 10.1016/j.neuroimage.2012.04.056; Westman E, 2011, NEUROIMAGE, V58, P818, DOI 10.1016/j.neuroimage.2011.06.065; Westman E, 2011, NEUROIMAGE, V54, P1178, DOI 10.1016/j.neuroimage.2010.08.044; Zhang DQ, 2011, NEUROIMAGE, V55, P856, DOI 10.1016/j.neuroimage.2011.01.008	47	17	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0134368	10.1371/journal.pone.0134368	http://dx.doi.org/10.1371/journal.pone.0134368			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284520	Green Submitted, Green Published, gold			2022-12-26	WOS:000359666100009
J	McDonald, LM; Griffin, HJ; Angeli, A; Torkamani, M; Georgiev, D; Jahanshahi, M				McDonald, Louise M.; Griffin, Harry J.; Angeli, Aikaterini; Torkamani, Mariam; Georgiev, Dejan; Jahanshahi, Marjan			Motivational Modulation of Self-Initiated and Externally Triggered Movement Speed Induced by Threat of Shock: Experimental Evidence for Paradoxical Kinesis in Parkinson's Disease	PLOS ONE			English	Article							MOTOR URGENCY; TIME; INVENTORY; BRAIN; DEPRESSION; DOPAMINE; ANXIETY	Background Paradoxical kinesis has been observed in bradykinetic people with Parkinson's disease. Paradoxical kinesis occurs in situations where an individual is strongly motivated or influenced by relevant external cues. Our aim was to induce paradoxical kinesis in the laboratory. We tested whether the motivation of avoiding a mild electric shock was sufficient to induce paradoxical kinesis in externally-triggered and self-initiated conditions in people with Parkinson's disease tested on medication and in age-matched controls. Methods Participants completed a shock avoidance behavioural paradigm in which half of the trials could result in a mild electric shock if the participant did not move fast enough. Half of the trials of each type were self-initiated and half were externally-triggered. The criterion for avoiding shock was a maximum movement time, adjusted according to each participant's performance on previous trials using a staircase tracking procedure. Results On trials with threat of shock, both patients with Parkinson's disease and controls had faster movement times compared to no potential shock trials, in both self-initiated and externally-triggered conditions. The magnitude of improvement of movement time from no potential shock to potential shock trials was positively correlated with anxiety ratings. Conclusions When motivated to avoid mild electric shock, patients with Parkinson's disease, similar to healthy controls, showed significant speeding of movement execution. This was observed in both self-initiated and externally-triggered versions of the task. Nevertheless, in the ET condition the improvement of reaction times induced by motivation to avoid shocks was greater for the PD patients than controls, highlighting the value of external cues for movement initiation in PD patients. The magnitude of improvement from the no potential shock to the potential shock trials was associated with the threat-induced anxiety. This demonstration of paradoxical kinesis in the laboratory under both self-initiated and externally-triggered conditions has implications for motivational and attentional enhancement of movement speed in Parkinson's disease.	[McDonald, Louise M.; Griffin, Harry J.; Angeli, Aikaterini; Torkamani, Mariam; Georgiev, Dejan; Jahanshahi, Marjan] UCL Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London, England	University of London; University College London	Jahanshahi, M (corresponding author), UCL Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London, England.	m.jahanshah@ucl.ac.uk		Georgiev, Dejan/0000-0003-1832-3441	European Commission Ambient Assisted Living Programme; Parkinson's UK; Medical Research Council (MRC) grant	European Commission Ambient Assisted Living Programme; Parkinson's UK(Parkinson's UK); Medical Research Council (MRC) grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	LMM and MT were funded by a grant from the European Commission Ambient Assisted Living Programme. HJG was funded by a project grant from Parkinson's UK, and DG was funded by a Medical Research Council (MRC) grant.	AUERBACH SM, 1974, J GENET PSYCHOL, V124, P187, DOI 10.1080/00221325.1974.10532280; Ballanger B, 2008, J NEUROL NEUROSUR PS, V79, P1110, DOI 10.1136/jnnp.2007.141689; Ballanger B, 2006, MOVEMENT DISORD, V21, P1490, DOI 10.1002/mds.20987; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Bonanni L, 2010, NEUROL SCI, V31, P751, DOI 10.1007/s10072-010-0403-5; Chase HW, 2011, J COGNITIVE NEUROSCI, V23, P936, DOI 10.1162/jocn.2010.21456; Clark J, 2006, CAN ADRENALINE HELP; Crucian GP, 2001, NEUROLOGY, V56, P159, DOI 10.1212/WNL.56.2.159; Droit-Volet S, 2007, TRENDS COGN SCI, V11, P504, DOI 10.1016/j.tics.2007.09.008; FitzGerald M.J.T., 2011, CLIN NEUROANATOMY NE; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GLICKSTEIN M, 1991, TRENDS NEUROSCI, V14, P480, DOI 10.1016/0166-2236(91)90055-Y; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Hall AJ, 1927, LANCET NEUROL, V12, P1009; Hanakawa T, 1999, ANN NEUROL, V45, P329, DOI 10.1002/1531-8249(199903)45:3<329::AID-ANA8>3.0.CO;2-S; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Hughes A, 1992, J NEUROL NEUROSUR PS, V66, P181, DOI DOI 10.1136/JNNP.55.3.181; JAHANSHAHI M, 1995, BRAIN, V118, P913, DOI 10.1093/brain/118.4.913; JAHANSHAHI M, 1992, BRAIN, V115, P539, DOI 10.1093/brain/115.2.539; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Kojovic M, 2014, J NEUROL, V261, P1080, DOI 10.1007/s00415-014-7315-x; LEVIN BE, 1988, J NEUROL NEUROSUR PS, V51, P1401, DOI 10.1136/jnnp.51.11.1401; LINDMAN R, 1975, SCAND J PSYCHOL, V16, P65, DOI 10.1111/j.1467-9450.1975.tb00165.x; Luria A.R, 1932, NATURE HUMAN CONFLIC; Majsak MJ, 2008, EXP NEUROL, V210, P479, DOI 10.1016/j.expneurol.2007.11.023; Mazzoni P, 2007, J NEUROSCI, V27, P7105, DOI 10.1523/JNEUROSCI.0264-07.2007; Mir P, 2011, EXP BRAIN RES, V209, P551, DOI 10.1007/s00221-011-2583-5; Morris ME, 1996, BRAIN, V119, P551, DOI 10.1093/brain/119.2.551; Moustafa AA, 2008, J NEUROSCI, V28, P12294, DOI 10.1523/JNEUROSCI.3116-08.2008; Niv Y, 2007, PSYCHOPHARMACOLOGY, V191, P507, DOI 10.1007/s00213-006-0502-4; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pessiglione M, 2007, SCIENCE, V316, P904, DOI 10.1126/science.1140459; Purdon-Martin J, 1967, BASAL GANGLIA POSTUR; Rahman S, 2008, MOVEMENT DISORD, V23, P1428, DOI 10.1002/mds.21667; Robinson OJ, 2011, COGN AFFECT BEHAV NE, V11, P217, DOI 10.3758/s13415-011-0030-5; Sacks O, 1991, AWAKENINGS; Schmidt L, 2009, J NEUROSCI, V29, P9450, DOI 10.1523/JNEUROSCI.1951-09.2009; Shiner T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047138; Siegert RJ, 2002, J CLIN EXP NEUROPSYC, V24, P146, DOI 10.1076/jcen.24.2.146.991; Souques A, 1921, REV NEUROL, V37, P559, DOI DOI 10.1002/MDS.20281; Thobois S, 2007, NEUROIMAGE, V37, P243, DOI 10.1016/j.neuroimage.2007.04.049	42	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135149	10.1371/journal.pone.0135149	http://dx.doi.org/10.1371/journal.pone.0135149			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP1VY	26284366	Green Published, Green Submitted, gold			2022-12-26	WOS:000359666100024
J	Reijnierse, EM; Trappenburg, MC; Leter, MJ; Blauw, GJ; de van der Schueren, MAE; Meskers, CGM; Maier, AB				Reijnierse, Esmee M.; Trappenburg, Marijke C.; Leter, Morena J.; Blauw, Gerard Jan; de van der Schueren, Marian A. E.; Meskers, Carel G. M.; Maier, Andrea B.			The Association between Parameters of Malnutrition and Diagnostic Measures of Sarcopenia in Geriatric Outpatients	PLOS ONE			English	Article							LOWER-EXTREMITY PERFORMANCE; BODY-COMPOSITION; MUSCLE MASS; PHYSICAL PERFORMANCE; FUNCTIONAL IMPAIRMENT; OLDER PERSONS; LEAN MASS; WOMEN; CONSENSUS; STRENGTH	Objectives Diagnostic criteria for sarcopenia include measures of muscle mass, muscle strength and physical performance. Consensus on the definition of sarcopenia has not been reached yet. To improve insight into the most clinically valid definition of sarcopenia, this study aimed to compare the association between parameters of malnutrition, as a risk factor in sarcopenia, and diagnostic measures of sarcopenia in geriatric outpatients. Material and Methods This study is based on data from a cross-sectional study conducted in a geriatric outpatient clinic including 185 geriatric outpatients (mean age 82 years). Parameters of malnutrition included risk of malnutrition (assessed by the Short Nutritional Assessment Questionnaire), loss of appetite, unintentional weight loss and underweight (body mass index <22 kg/m(2)). Diagnostic measures of sarcopenia included relative musclemass (lean mass and appendicular lean mass [ALM] as percentages), absolute muscle mass (total lean mass and ALM/height(2)), handgrip strength and walking speed. All diagnostic measures of sarcopenia were standardized. Associations between parameters of malnutrition (independent variables) and diagnostic measures of sarcopenia (dependent variables) were analysed using multivariate linear regression models adjusted for age, body mass, fat mass and height in separate models. Results None of the parameters of malnutrition was consistently associated with diagnostic measures of sarcopenia. The strongest associations were found for both relative and absolute muscle mass; less stronger associations were found for muscle strength and physical performance. Underweight (p = < 0.001) and unintentional weight loss (p = 0.031) were most strongly associated with higher lean mass percentage after adjusting for age. Loss of appetite (p = 0.003) and underweight (p = 0.021) were most strongly associated with lower total lean mass after adjusting for age and fat mass. Conclusion Parameters of malnutrition relate differently to diagnostic measures of sarcopenia in geriatric outpatients. The association between parameters of malnutrition and diagnostic measures of sarcopenia was strongest for both relative and absolute muscle mass, while less strong associations were found with muscle strength and physical performance.	[Reijnierse, Esmee M.; Trappenburg, Marijke C.; Leter, Morena J.; Maier, Andrea B.] Vrije Univ Amsterdam Med Ctr, Sect Gerontol & Geriatr, Dept Internal Med, Amsterdam, Netherlands; [Trappenburg, Marijke C.] Amstelland Hosp, Dept Internal Med, Amstelveen, Netherlands; [Blauw, Gerard Jan] Leiden Univ Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [Blauw, Gerard Jan] Bronovo Hosp, Dept Geriatr, The Hague, Netherlands; [de van der Schueren, Marian A. E.] Vrije Univ Amsterdam Med Ctr, Sect Nutr & Dietet, Dept Internal Med, Amsterdam, Netherlands; [de van der Schueren, Marian A. E.] HAN Univ Appl Sci, Fac Hlth & Social Studies, Dept Nutr Sports & Hlth, Nijmegen, Netherlands; [Meskers, Carel G. M.] Vrije Univ Amsterdam Med Ctr, Dept Rehabil Med, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Leiden University; Leiden University Medical Center (LUMC); Haaglanden Medical Center; Bronovo Hospital; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Maier, AB (corresponding author), Vrije Univ Amsterdam Med Ctr, Sect Gerontol & Geriatr, Dept Internal Med, Amsterdam, Netherlands.	a.maier@vumc.nl	Blauw, Gerard/GWD-1079-2022; Maier, Andrea B./Q-5548-2019; Blauw, Gerard/AAW-7904-2021; Maier, Andrea/W-7060-2019; de van der Schueren, Marian A.E./AAM-5713-2021	Maier, Andrea/0000-0001-7206-1724; de van der Schueren, Marian A.E./0000-0001-5693-0811; Reijnierse, Esmee M./0000-0002-4197-4800; Meskers, Carel/0000-0002-5056-5611	MYOAGE [HEALTH-2007-2.4.5-10]; Dutch Technology Foundation STW, Netherlands Organization for Scientific Research; Ministry of Economic Affairs, Agriculture, and Innovation	MYOAGE; Dutch Technology Foundation STW, Netherlands Organization for Scientific Research; Ministry of Economic Affairs, Agriculture, and Innovation	This study was supported by the seventh framework program MYOAGE (HEALTH-2007-2.4.5-10), and by the Dutch Technology Foundation STW, which is part of the Netherlands Organization for Scientific Research, and partly funded by the Ministry of Economic Affairs, Agriculture, and Innovation.	Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Baumgartner RN, 1995, J GERONTOL A-BIOL, V50, P307; Bijlsma AY, 2014, AGE, V36, P275, DOI 10.1007/s11357-013-9556-5; Bijlsma AY, 2013, AGE, V35, P2367, DOI 10.1007/s11357-013-9516-0; Bijlsma AY, 2013, OSTEOPOROSIS INT, V24, P2681, DOI 10.1007/s00198-013-2376-8; Bijlsma AY, 2013, AGE, V35, P871, DOI 10.1007/s11357-012-9384-z; Bijlsma AY, 2013, J AM MED DIR ASSOC, V14, P493, DOI 10.1016/j.jamda.2013.02.001; Boirie Y, 2014, MECH AGEING DEV, V136, P76, DOI 10.1016/j.mad.2014.01.008; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Delmonico MJ, 2007, J AM GERIATR SOC, V55, P769, DOI 10.1111/j.1532-5415.2007.01140.x; Estrada M, 2007, J AM GERIATR SOC, V55, P1712, DOI 10.1111/j.1532-5415.2007.01436.x; Ferreira RS, 2013, GERIATR NURS, V34, P465, DOI 10.1016/j.gerinurse.2013.07.013; Fielding RA, 2011, J AM MED DIR ASSOC, V12, P249, DOI 10.1016/j.jamda.2011.01.003; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Guerra RS, 2015, JPEN-PARENTER ENTER, V39, P322, DOI 10.1177/0148607113514113; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Houston DK, 2008, AM J CLIN NUTR, V87, P150, DOI 10.1093/ajcn/87.1.150; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Kruizenga HM, 2005, CLIN NUTR, V24, P75, DOI 10.1016/j.clnu.2004.07.015; Landi F, 2010, J AM MED DIR ASSOC, V11, P268, DOI 10.1016/j.jamda.2009.12.088; Lebrun CEI, 2006, MENOPAUSE, V13, P474, DOI 10.1097/01.gme.0000222331.23478.ec; Ling CHY, 2011, CLIN NUTR, V30, P610, DOI 10.1016/j.clnu.2011.04.001; Martone AM, 2013, NUTRIENTS, V5, P4126, DOI 10.3390/nu5104126; Morley JE, 2011, J AM MED DIR ASSOC, V12, P403, DOI 10.1016/j.jamda.2011.04.014; Muscaritoli M, 2010, CLIN NUTR, V29, P154, DOI 10.1016/j.clnu.2009.12.004; Newman AB, 2005, AM J CLIN NUTR, V82, P872, DOI 10.1093/ajcn/82.4.872; Rosenberg IH, 1997, J NUTR, V127, P990, DOI DOI 10.1016/J.CGER.2011.03.003; Schilp J, 2011, NED TIJDSCHR EVID BA, V9, P18; Sergi G, 2002, J GERONTOL A-BIOL, V57, pM302, DOI 10.1093/gerona/57.5.M302; Studenski SA, 2014, J GERONTOL A-BIOL, V69, P547, DOI 10.1093/gerona/glu010; Tolea MI, 2010, J GERONTOL B-PSYCHOL, V65, P174, DOI 10.1093/geronb/gbp130; van Bokhorst-de van der Schueren MAE, 2013, CLIN NUTR, V32, P1007, DOI 10.1016/j.clnu.2013.05.007; Vasunilashorn S, 2009, J GERONTOL A-BIOL, V64, P223, DOI 10.1093/gerona/gln022; Visser M, 2005, J GERONTOL A-BIOL, V60, P324, DOI 10.1093/gerona/60.3.324; Visser M, 2002, J AM GERIATR SOC, V50, P897, DOI 10.1046/j.1532-5415.2002.50217.x; Welch AA, 2014, P NUTR SOC, V73, P16, DOI 10.1017/S0029665113003698; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	38	39	40	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135933	10.1371/journal.pone.0135933	http://dx.doi.org/10.1371/journal.pone.0135933			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284368	Green Published, gold			2022-12-26	WOS:000359666100088
J	Zheng, R; Yao, CW; Jin, H; Zhu, L; Zhang, Q; Deng, W				Zheng, Ran; Yao, Chuanwei; Jin, Hai; Zhu, Lei; Zhang, Qin; Deng, Wei			Parallel Key Frame Extraction for Surveillance Video Service in a Smart City	PLOS ONE			English	Article								Surveillance video service (SVS) is one of the most important services provided in a smart city. It is very important for the utilization of SVS to provide design efficient surveillance video analysis techniques. Key frame extraction is a simple yet effective technique to achieve this goal. In surveillance video applications, key frames are typically used to summarize important video content. It is very important and essential to extract key frames accurately and efficiently. A novel approach is proposed to extract key frames from traffic surveillance videos based on GPU (graphics processing units) to ensure high efficiency and accuracy. For the determination of key frames, motion is a more salient feature in presenting actions or events, especially in surveillance videos. The motion feature is extracted in GPU to reduce running time. It is also smoothed to reduce noise, and the frames with local maxima of motion information are selected as the final key frames. The experimental results show that this approach can extract key frames more accurately and efficiently compared with several other methods.	[Zheng, Ran; Yao, Chuanwei; Jin, Hai; Zhu, Lei; Zhang, Qin; Deng, Wei] Huazhong Univ Sci & Technol, Serv Comp Technol & Syst Lab, Cluster & Grid Comp Lab, Sch Comp Sci & Technol, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology	Jin, H (corresponding author), Huazhong Univ Sci & Technol, Serv Comp Technol & Syst Lab, Cluster & Grid Comp Lab, Sch Comp Sci & Technol, Wuhan 430074, Hubei, Peoples R China.	hjin@hust.edu.cn		Zhu, Lei/0000-0002-2993-7142	National 863 Basic Research Program of China [2012AA01A306]; National Natural Science Foundation of China [61133008]	National 863 Basic Research Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National 863 Basic Research Program of China under grant No. 2012AA01A306, and the National Natural Science Foundation of China, under grant No. 61133008.	Bhatt HS, 2014, IEEE T INF FOREN SEC, V9, P1056, DOI 10.1109/TIFS.2014.2318433; Chang J, 2009, INT C METH MOD COMP, P1; Chen WN, 2008, 2008 IEEE INTERNATIONAL CONFERENCE ON MULTIMEDIA AND EXPO, VOLS 1-4, P697; Gao XB, 2009, PATTERN RECOGN LETT, V30, P140, DOI 10.1016/j.patrec.2008.02.009; Goyette N., 2012, 2012 IEEE Computer Society Conference on Computer Vision and Pattern Recognition Workshops (CVPR Workshops), DOI 10.1109/CVPRW.2012.6238919; Hu WM, 2011, IEEE T SYST MAN CY C, V41, P797, DOI 10.1109/TSMCC.2011.2109710; Kehoe P, 2007, P 8 INT WORKSH IM AN, P15; Kuanar SK, 2013, J VIS COMMUN IMAGE R, V24, P1212, DOI 10.1016/j.jvcir.2013.08.003; Liu YX, 2009, INT PARALL DISTRIB P, P74; Merrill DG, 2010, PACT 2010: PROCEEDINGS OF THE NINETEENTH INTERNATIONAL CONFERENCE ON PARALLEL ARCHITECTURES AND COMPILATION TECHNIQUES, P545, DOI 10.1145/1854273.1854344; Omidyeganeh M., 2010, Proceedings of the 2010 IEEE Workshop on Signal Processing Systems (SiPS 2010), P128, DOI 10.1109/SIPS.2010.5624775; Patel BV., 2012, INT J UBICOMP, V3, P13, DOI [10.5121/iju.2012.3202, DOI 10.5121/IJU.2012.3202]; Quast K, 2010, VISAPP 2010: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON COMPUTER VISION THEORY AND APPLICATIONS, VOL 1, P413; Ran Zheng, 2015, CAMPUS ROAD SURVEILL, DOI [http://dx.doi.org/10.6084/m9.figshare.1500802, DOI 10.6084/M9.FIGSHARE.1500802]; Sun ZH, 2008, 2008 FOURTH INTERNATIONAL CONFERENCE ON INTELLIGENT INFORMATION HIDING AND MULTIMEDIA SIGNAL PROCESSING, PROCEEDINGS, P196, DOI 10.1109/IIH-MSP.2008.245; Truong BT, 2007, ACM T MULTIM COMPUT, V3, DOI 10.1145/1198302.1198305; Yang Y, 2011, P AM MATH SOC, V139, P3171, DOI 10.1090/S0002-9939-2011-10735-4; Zhang H. J., 1993, MULTIMEDIA SYSTEMS, V1, P10, DOI DOI 10.1007/BF01210504; Zhang HJ, 1977, PATTERN RECOGN, V30, P643	19	7	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135694	10.1371/journal.pone.0135694	http://dx.doi.org/10.1371/journal.pone.0135694			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284923	Green Published, Green Submitted, gold			2022-12-26	WOS:000359666100060
J	Matthews, Q; Isabelle, M; Harder, SJ; Smazynski, J; Beckham, W; Brolo, AG; Jirasek, A; Lum, JJ				Matthews, Quinn; Isabelle, Martin; Harder, Samantha J.; Smazynski, Julian; Beckham, Wayne; Brolo, Alexandre G.; Jirasek, Andrew; Lum, Julian J.			Radiation-Induced Glycogen Accumulation Detected by Single Cell Raman Spectroscopy Is Associated with Radioresistance that Can Be Reversed by Metformin	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; ACTIVATED PROTEIN-KINASE; CANCER-CELLS; IONIZING-RADIATION; IN-VITRO; AMPK; INHIBITION; CYCLE; LINES; METABOLISM	Altered cellular metabolism is a hallmark of tumor cells and contributes to a host of properties associated with resistance to radiotherapy. Detection of radiation-induced biochemical changes can reveal unique metabolic pathways affecting radiosensitivity that may serve as attractive therapeutic targets. Using clinically relevant doses of radiation, we performed label-free single cell Raman spectroscopy on a series of human cancer cell lines and detected radiation-induced accumulation of intracellular glycogen. The increase in glycogen post-irradiation was highest in lung (H460) and breast (MCF7) tumor cells compared to prostate (LNCaP) tumor cells. In response to radiation, the appearance of this glycogen signature correlated with radiation resistance. Moreover, the buildup of glycogen was linked to the phosphorylation of GSK-3 beta, a canonical modulator of cell survival following radiation exposure and a key regulator of glycogen metabolism. When MCF7 cells were irradiated in the presence of the anti-diabetic drug metformin, there was a significant decrease in the amount of radiation-induced glycogen. The suppression of glycogen by metformin following radiation was associated with increased radiosensitivity. In contrast to MCF7 cells, metformin had minimal effects on both the level of glycogen in H460 cells following radiation and radiosensitivity. Our data demonstrate a novel approach of spectral monitoring by Raman spectroscopy to assess changes in the levels of intracellular glycogen as a potential marker and resistance mechanism to radiation therapy.	[Matthews, Quinn; Isabelle, Martin; Lum, Julian J.] BC Canc Agcy, Trev & Joyce Deeley Res Ctr, Victoria, BC, Canada; [Isabelle, Martin; Harder, Samantha J.; Beckham, Wayne] Univ Victoria, Dept Phys & Astron, Victoria, BC, Canada; [Smazynski, Julian; Lum, Julian J.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada; [Matthews, Quinn; Beckham, Wayne] BC Canc Agcy, Dept Med Phys, Victoria, BC, Canada; [Brolo, Alexandre G.] Univ Victoria, Dept Chem, Victoria, BC, Canada; [Jirasek, Andrew] Univ British Columbia Okanagan, Math Stat Phys & Comp Sci, Kelowna, BC, Canada	British Columbia Cancer Agency; University of Victoria; University of Victoria; British Columbia Cancer Agency; University of Victoria; University of British Columbia; University of British Columbia Okanagan	Jirasek, A (corresponding author), Univ British Columbia Okanagan, Math Stat Phys & Comp Sci, Kelowna, BC, Canada.	andrew.jirasek@ubc.ca; jjlum@bccancer.bc.ca	Matthews, Quinn/A-2568-2013	Matthews, Quinn/0000-0001-6512-7000; Multhoff, Gabriele/0000-0002-2616-3137; Lum, Julian/0000-0002-5624-3541; Jirasek, Andrew/0000-0003-0844-2092	Canadian Institutes for Health Research [258926]; Cancer Research Society; Western Economic Diversification Fund; Canada Foundation for Innovations; British Columbia Knowledge Development Fund; Michael Smith Foundation for Health Research & Provincial Health Services Authority Post-doctoral Fellowship Award [STPDF03250(11-1)B]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Cancer Research Society; Western Economic Diversification Fund; Canada Foundation for Innovations(Canada Foundation for Innovation); British Columbia Knowledge Development Fund; Michael Smith Foundation for Health Research & Provincial Health Services Authority Post-doctoral Fellowship Award	The authors are grateful for funding from Canadian Institutes for Health Research (258926, JJL, AGB, AJ), Cancer Research Society (JJL), Western Economic Diversification Fund (AGB), Canada Foundation for Innovations and British Columbia Knowledge Development Fund (AGB), Michael Smith Foundation for Health Research & Provincial Health Services Authority Post-doctoral Fellowship Award (STPDF03250(11-1) B, QM),	Ben Sahra I, 2011, CANCER RES, V71, P4366, DOI 10.1158/0008-5472.CAN-10-1769; Chan JW, 2009, ANAL CHEM, V81, P1324, DOI 10.1021/ac801665m; Cheng KW, 2012, EMBO MOL MED, V4, P125, DOI 10.1002/emmm.201100193; Crow P, 2005, BRIT J CANCER, V92, P2166, DOI 10.1038/sj.bjc.6602638; Fasih A, 2014, RADIAT RES, V182, P50, DOI 10.1667/RR13568.1; Favaro E, 2012, CELL METAB, V16, P751, DOI 10.1016/j.cmet.2012.10.017; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Gartel AL, 2003, ONCOL RES, V13, P405; Harder SJ, 2015, APPL SPECTROSC, V69, P193, DOI 10.1366/14-07561; Jiang XY, 2014, INT J RADIAT ONCOL, V89, P714, DOI 10.1016/j.ijrobp.2014.04.018; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Konorov SO, 2011, ANAL CHEM, V83, P6254, DOI 10.1021/ac201581e; Lai SL, 2007, J BIOMEDICAL SCI, P64; Li HW, 2014, ONCOL REP, V32, P2596, DOI 10.3892/or.2014.3485; Liu JF, 2012, ONCOL REP, V28, P1406, DOI 10.3892/or.2012.1932; Mahoney CL, 2009, BRIT J CANCER, V100, P370, DOI 10.1038/sj.bjc.6604886; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Matthews Q, 2011, PHYS MED BIOL, V56, P6839, DOI 10.1088/0031-9155/56/21/006; Matthews Q, 2011, PHYS MED BIOL, V56, P19, DOI 10.1088/0031-9155/56/1/002; Matthews Q, 2010, APPL SPECTROSC, V64, P871, DOI 10.1366/000370210792080966; Miller RA, 2010, J CLIN INVEST, V120, P2267, DOI 10.1172/JCI43661; Miyashita K, 2009, CLIN CANCER RES, V15, P887, DOI 10.1158/1078-0432.CCR-08-0760; Neugebauer U, 2010, J BIOPHOTONICS, V3, P579, DOI 10.1002/jbio.201000020; Oshima Y, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3316296; Pascut FC, 2013, BBA-GEN SUBJECTS, V1830, P3517, DOI 10.1016/j.bbagen.2013.01.030; Pelletier J, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00018; ROUSSET M, 1980, JNCI-J NATL CANCER I, V65, P885; Sanli T, 2014, CANCER BIOL THER, V15, P156, DOI 10.4161/cbt.26726; Sanli T, 2012, RADIOTHER ONCOL, V102, P459, DOI 10.1016/j.radonc.2011.11.014; Sanli T, 2010, INT J RADIAT ONCOL, V78, P221, DOI 10.1016/j.ijrobp.2010.03.005; Sarfstein R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061537; Shimura T, 2011, J RADIAT RES, V52, P539, DOI 10.1269/jrr.11098; Skinner HD, 2013, ACTA ONCOL, V52, P1002, DOI 10.3109/0284186X.2012.718096; Skjoth IHE, 2006, INT J ONCOL, V28, P217; Song CW, 2012, SCI REP-UK, V2, DOI 10.1038/srep00362; Spalding AC, 2010, NEOPLASIA, V12, P357, DOI 10.1593/neo.92112; Storozhuk Y, 2013, BRIT J CANCER, V108, P2021, DOI 10.1038/bjc.2013.187; Takahashi S, 1999, J GASTROENTEROL, V34, P474, DOI 10.1007/s005350050299; Thotala DK, 2012, CELL DEATH DIFFER, V19, P387, DOI 10.1038/cdd.2011.94; Townsend KN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082406; Wang J, 2015, CELL BIOCH BIOPHYSIC; Witney TH, 2014, CANCER RES, V74, P1319, DOI 10.1158/0008-5472.CAN-13-2768; Zannella VE, 2011, RADIOTHER ONCOL, V99, P293, DOI 10.1016/j.radonc.2011.05.049	43	24	26	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0135356	10.1371/journal.pone.0135356	http://dx.doi.org/10.1371/journal.pone.0135356			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26280348	Green Published, gold, Green Submitted			2022-12-26	WOS:000359664300012
J	Gao, F; Mei, JY; Sun, JP; Wang, J; Yang, EF; Hussain, A				Gao, Fei; Mei, Jingyuan; Sun, Jinping; Wang, Jun; Yang, Erfu; Hussain, Amir			A Novel Classification Algorithm Based on Incremental Semi-Supervised Support Vector Machine	PLOS ONE			English	Article							ENSEMBLE; SVM	For current computational intelligence techniques, a major challenge is how to learn new concepts in changing environment. Traditional learning schemes could not adequately address this problem due to a lack of dynamic data selection mechanism. In this paper, inspired by human learning process, a novel classification algorithm based on incremental semi-supervised support vector machine (SVM) is proposed. Through the analysis of prediction confidence of samples and data distribution in a changing environment, a "softstart" approach, a data selection mechanism and a data cleaning mechanism are designed, which complete the construction of our incremental semi-supervised learning system. Noticeably, with the ingenious design procedure of our proposed algorithm, the computation complexity is reduced effectively. In addition, for the possible appearance of some new labeled samples in the learning process, a detailed analysis is also carried out. The results show that our algorithm does not rely on the model of sample distribution, has an extremely low rate of introducing wrong semi-labeled samples and can effectively make use of the unlabeled samples to enrich the knowledge system of classifier and improve the accuracy rate. Moreover, our method also has outstanding generalization performance and the ability to overcome the concept drift in a changing environment.	[Gao, Fei; Mei, Jingyuan; Sun, Jinping; Wang, Jun] Beihang Univ, Sch Elect & Informat Engn, Beijing 100191, Peoples R China; [Yang, Erfu] Univ Strathclyde, Dept Design Manufacture & Engn Management, Space Mechatron Syst Technol Lab, Glasgow G1 1XJ, Lanark, Scotland; [Hussain, Amir] Univ Stirling, Sch Nat Sci, Cognit Signal Image & Control Proc Res Lab, Stirling FK9 4LA, Scotland	Beihang University; University of Strathclyde; University of Stirling	Mei, JY (corresponding author), Beihang Univ, Sch Elect & Informat Engn, Beijing 100191, Peoples R China.	347068642@qq.com	Yang, Erfu/N-2673-2016; SUN, JIN/GPX-9641-2022; Hussain, Amir/AAG-6299-2020	Yang, Erfu/0000-0003-1813-5950; Hussain, Amir/0000-0002-8080-082X	National Natural Science Foundation of China [61071139, 61471019, 61171122]; Royal Society of Edinburgh (RSE); National Natural Science Foundation of China (NNSFC) [61211130210]; Beihang University; RSE-NNSFC joint project [61211130309]; Anhui University, China; Engineering and Physical Sciences Research Council [EP/I009310/1] Funding Source: researchfish; EPSRC [EP/I009310/1] Funding Source: UKRI	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Royal Society of Edinburgh (RSE); National Natural Science Foundation of China (NNSFC)(National Natural Science Foundation of China (NSFC)); Beihang University; RSE-NNSFC joint project; Anhui University, China(Anhui University); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This research is supported by the National Natural Science Foundation of China, No. 61071139, No. 61471019 and No. 61171122, the Royal Society of Edinburgh (RSE), and The National Natural Science Foundation of China (NNSFC) under the RSE-NNSFC joint project (2012-2014) [grant number 61211130210] with Beihang University. This research is also funded, in part, by the RSE-NNSFC joint project (2012-2014) [grant number 61211130309] with Anhui University, China; URL: http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list.	[Anonymous], GEOSC REM SENS S IGA; Baluja S., 1998, PROBABILISTIC MODELI; Bruzzone L, 2009, IEEE T GEOSCI REMOTE, V47, P2142, DOI 10.1109/TGRS.2008.2011983; Cauwenberghs G, 2001, ADV NEUR IN, V13, P409; Cheng SX, 2007, PATTERN RECOGN, V40, P964, DOI 10.1016/j.patcog.2006.06.016; Chia-Feng J, 2014, FUZZY SYSTEMS IEEE T, V22, P324; COPPOCK HW, 1962, SCIENCE, V135, P318, DOI 10.1126/science.135.3500.318; Diehl CP, 2003, NEUR NETW 2003 P INT; Domeniconi Carlotta, 2001, DAT MIN 2001 ICDM 20; Emara W, 2007, DAT MIN WORKSH 2007; Erdem Z, 2005, LECT NOTES COMPUT SC, V3541, P246; Erdem Z, 2005, LECT NOTES COMPUT SC, V3697, P607; Fujino A, 1999, P NAT C ART INT 2005; Jianzhao Q, 2006, PATT REC 2006 ICPR 2; Jin-Long A, 2003, MACH LEARN CYB 2003; Jun J, 2008, ED TECHN TRAIN 2008; Laskov P, 2006, J MACH LEARN RES, V7, P1909; Maulik U, 2013, IEEE T BIO-MED ENG, V60, P1111, DOI 10.1109/TBME.2012.2225622; Minku LL, 2010, IEEE T KNOWL DATA EN, V22, P730, DOI 10.1109/TKDE.2009.156; Mitra P, 2000, PATT REC 2000 P 15 I; Nigam K, 2000, MACH LEARN, V39, P103, DOI 10.1023/A:1007692713085; Rong X, 2000, TOOLS ART INT 2000 I; Srinivas U, 2014, IEEE T AERO ELEC SYS, V50, P591, DOI 10.1109/TAES.2013.120340; Syed N, 1999, P 5 ACM SIGKDD INT C; Syed N.A., 1999, INCREMENTAL LEARNING; Vapnik V.N., 1995, NATURE STAT LEARNING; Widmer G., 1993, MACHINE LEARNING ECM; Zhu X, 2008, COMPUTER SCI, V2, P3	28	4	4	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135709	10.1371/journal.pone.0135709	http://dx.doi.org/10.1371/journal.pone.0135709			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275294	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000359493600101
J	Higashide, T; Ohkubo, S; Sugiyama, K				Higashide, Tomomi; Ohkubo, Shinji; Sugiyama, Kazuhisa			Long-Term Outcomes and Prognostic Factors of Trabeculectomy following Intraocular Bevacizumab Injection for Neovascular Glaucoma	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; AHMED VALVE IMPLANTATION; INTRAVITREAL BEVACIZUMAB; MITOMYCIN-C; INTRACAMERAL BEVACIZUMAB; IRIS NEOVASCULARIZATION; MOLTENO IMPLANT; EFFICACY; TUBE	Purpose To evaluate long-term outcomes and identify prognostic factors of trabeculectomy following intraocular bevacizumab injection for neovascular glaucoma. Methods Sixty-one eyes of 54 patients with neovascular glaucoma treated by trabeculectomy following intraocular bevacizumab injection were consecutively enrolled. Surgical success criteria were sufficient intraocular pressure (IOP) reduction (IOP <= 21 mmHg, >= 20% IOP reduction, no additional medications or glaucoma surgeries) without devastating complications (loss of light perception, phthisis bulbi, and endophthalmitis) or significant hypotony (IOP <= 5 mmHg continued >= 6 months and until the last follow-up visit or hypotony requiring intervention). Kaplan-Meier survival curves and Cox regression analysis were used to examine success rates and risk factors for surgical outcomes. Results The follow-up period after trabeculectomy was 45.0 +/- 22.2 months (mean +/- standard deviation). Surgical success rate was 86.9 +/- 4.3% (+/- standard error), 74.0 +/- 6.1%, and 51.3 +/- 8.6% at 1, 3, and 5 years. Multivariate Cox regression analysis identified two risk factors; lower preoperative IOP (<= 30 mmHg) for surgical failure and hypotony [hazard ratio (HR), 2.92, 6.64; 95% confidence interval (CI), 1.22 to 7.03, 1.47 to 30.0; P = 0.018, 0.014, respectively], and vitrectomy after trabeculectomy for surgical failure with or without hypotony criteria (HR, 2.32, 4.06; 95% CI, 1.02 to 5.28, 1.30 to 12.7; P = 0.045, 0.016, respectively). Conclusions The long-term outcomes of trabeculectomy following intraocular bevacizumab injection for neovascular glaucoma were favorable. Lower baseline IOP was associated with development of significant hypotony, while additional vitrectomy was related to insufficient IOP reduction.	[Higashide, Tomomi; Ohkubo, Shinji; Sugiyama, Kazuhisa] Kanazawa Univ, Dept Ophthalmol & Visual Sci, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan	Kanazawa University	Higashide, T (corresponding author), Kanazawa Univ, Dept Ophthalmol & Visual Sci, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan.	eyetomo@med.kanazawa-u.ac.jp		Shukla, Deepak/0000-0002-3039-6953				AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Al Obeidan SA, 2008, EUR J OPHTHALMOL, V18, P758, DOI 10.1177/112067210801800516; BENSON MT, 1990, BRIT J OPHTHALMOL, V74, P103, DOI 10.1136/bjo.74.2.103; Bindlish R, 2002, OPHTHALMOLOGY, V109, P1336, DOI 10.1016/S0161-6420(02)01069-2; Chen CH, 2010, J OCUL PHARMACOL TH, V26, P111, DOI 10.1089/jop.2009.0055; Davidorf FH, 2006, RETINA-J RET VIT DIS, V26, P354, DOI 10.1097/00006982-200603000-00017; Every SG, 2006, ARCH OPHTHALMOL-CHIC, V124, P355, DOI 10.1001/archopht.124.3.355; Gedde SJ, 2012, AM J OPHTHALMOL, V153, P789, DOI 10.1016/j.ajo.2011.10.026; Gedde SJ, 2009, AM J OPHTHALMOL, V148, P670, DOI 10.1016/j.ajo.2009.06.018; Grisanti S, 2006, AM J OPHTHALMOL, V142, P158, DOI 10.1016/j.ajo.2006.02.045; Gupta V, 2009, EUR J OPHTHALMOL, V19, P435, DOI 10.1177/112067210901900318; Hyung S M, 2001, Korean J Ophthalmol, V15, P98; Iliev ME, 2006, AM J OPHTHALMOL, V142, P1054, DOI 10.1016/j.ajo.2006.06.066; Jamil AL, 2007, AM J OPHTHALMOL, V143, P141, DOI 10.1016/j.ajo.2006.10.024; Kang JY, 2014, INT OPHTHALMOL, V34, P793, DOI 10.1007/s10792-013-9875-7; Kim YG, 2009, J GLAUCOMA, V18, P443, DOI 10.1097/IJG.0b013e3181895e5c; Kirwan JF, 2013, OPHTHALMOLOGY, V120, P2532, DOI 10.1016/j.ophtha.2013.07.049; Kiuchi Y, 2006, OPHTHALMOLOGICA, V220, P383, DOI 10.1159/000095865; Kobayashi S, 2015, J GLAUCOMA; Kunikata H, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/306814; Mahdy RA, 2013, J GLAUCOMA, V22, P768, DOI 10.1097/IJG.0b013e318259aec4; Mandal Anil K., 2002, Indian Journal of Ophthalmology, V50, P287; Miki A, 2011, EYE, V25, P658, DOI 10.1038/eye.2011.58; Nakatake S, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-55; Netland PA, 2010, J GLAUCOMA, V19, P581, DOI 10.1097/IJG.0b013e3181ca7f7f; Saito Y, 2010, AM J OPHTHALMOL, V149, P964, DOI 10.1016/j.ajo.2010.01.008; Saito Y, 2010, ACTA OPHTHALMOL, V88, P96, DOI 10.1111/j.1755-3768.2009.01648.x; Sevim MS, 2013, OPHTHALMOLOGICA, V229, P94, DOI 10.1159/000345490; Shaarawy TM, 2009, GUIDELINES DESIGN RE, P15; Simha A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007920.pub2; Sivak-Callcott JA, 2001, OPHTHALMOLOGY, V108, P1767, DOI 10.1016/S0161-6420(01)00775-8; Takihara Y, 2011, J GLAUCOMA, V20, P196, DOI 10.1097/IJG.0b013e3181d9ce12; Takihara Y, 2009, AM J OPHTHALMOL, V147, P912, DOI 10.1016/j.ajo.2008.11.015; Teixeira SH, 2012, J GLAUCOMA, V21, P342, DOI 10.1097/IJG.0b013e31820d7e4e; Tolentino MJ, 1996, ARCH OPHTHALMOL-CHIC, V114, P964, DOI 10.1001/archopht.1996.01100140172010; TSAI JC, 1995, OPHTHALMOLOGY, V102, P887, DOI 10.1016/S0161-6420(95)30938-4; Wakabayashi T, 2008, OPHTHALMOLOGY, V115, P1571, DOI 10.1016/j.ophtha.2008.02.026; Yalvac IS, 2007, EYE, V21, P65, DOI 10.1038/sj.eye.6702125; Yildirim N, 2009, J GLAUCOMA, V18, P192, DOI 10.1097/IJG.0b013e31817d235c; Zhang HT, 2014, INT J OPHTHALMOL-CHI, V7, P837, DOI 10.3980/j.issn.2222-3959.2014.05.18; Zhou MW, 2013, CHINESE MED J-PEKING, V126, P1412, DOI 10.3760/cma.j.issn.0366-6999.20130011	41	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135766	10.1371/journal.pone.0135766	http://dx.doi.org/10.1371/journal.pone.0135766			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275060	gold, Green Submitted, Green Published			2022-12-26	WOS:000359493600108
J	Li, X; Liang, Q; Liu, W; Zhang, N; Xu, L; Zhang, X; Zhang, J; Sung, JJY; Yu, J				Li, X.; Liang, Q.; Liu, W.; Zhang, N.; Xu, L.; Zhang, X.; Zhang, J.; Sung, J. J. Y.; Yu, J.			Ras association domain family member 10 suppresses gastric cancer growth by cooperating with GSTP1 to regulate JNK/c-Jun/AP-1 pathway	ONCOGENE			English	Article							FUNCTIONAL TUMOR-SUPPRESSOR; CELL-CYCLE PROGRESSION; C-JUN; EPIGENETIC INACTIVATION; TRANSCRIPTION; RASSF10; METHYLATION; PROTEIN; GENE; AP-1	The Ras association domain family (RASSF) encodes several members with tumor-suppressive potentials. We aimed to investigate the biological function and clinical implication of RASSF10 in gastric cancer (GC). We found that RASSF10 was silenced in six of seven GC cell lines and in primary GC tissues, but was highly expressed in normal gastric tissues. The silence of RASSAF10 was mediated by promoter methylation as evaluated by bisulfite genomic sequencing. RASSF10 expression could be restored by demethylation treatment. A negative correlation between methylation and mRNA expression of RASSF10 was observed in 223 gastric samples of The Cancer Genome Atlas study (P<0.0001). Re-expression of RASSF10 in GC cell lines (AGS and MKN45) significantly suppressed cell viability, colony formation, migration and invasion, reduced cells in S phase, accumulated cells in G2 phase and induced cell apoptosis in vitro, and inhibited tumorigenicity in nude mice. These were confirmed by decreased expression of proliferation markers (proliferating cell nuclear antigen, p-CDC2 and p-CDC25) and increased apoptotic cascades (cleaved caspases-9, -8, -3 and cleaved poly (ADP-ribose) polymerase). Conversely, RASSF10 knockdown in normal gastric cell line yielded an opposing effect. Co-immunoprecipitation combined with mass spectrometry analyses were performed to reveal the downstream effectors of RASSF10. The result revealed that glutathione S-transferase Pi 1 (GSTP1) was a direct cooperator of RASSF10. The tumor-suppressive effect of RASSF10 was partially mediated by cooperating with GSTP1 to deregulate Jun N-terminal kinase (JNK)/c-Jun/AP-1 pathway. Importantly, RASSF10 methylation was detected in 56.6% (98/173) of primary GCs and is an independent risk factor for poor survival of GC patients (P = 0.001). In conclusions, RASSF10 functions as a tumor suppressor by cooperating with GSTP1 to deregulate JNK/c-Jun/AP-1 pathway in GC. Promoter methylation of RASSF10 is associated with poor survival of GC patients.	[Li, X.; Liang, Q.; Xu, L.; Zhang, X.; Zhang, J.; Sung, J. J. Y.; Yu, J.] Chinese Univ Hong Kong, CUHK Shenzhen Res Inst, Li Ka Shing Inst Hlth Sci, Institute Digest Dis,Dept Med & Therapeut,State K, Shatin, Hong Kong, Peoples R China; [Li, X.] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Liu, W.] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Gastroenterol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, N.; Xu, L.] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Gastroenterol, Guangzhou 510275, Guangdong, Peoples R China	Chinese University of Hong Kong; State Key Lab Oncology South China; Sun Yat Sen University; Zhejiang University; Sun Yat Sen University	Yu, J (corresponding author), Chinese Univ Hong Kong, Inst Digest Dis, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China.	junyu@cuhk.edu.hk	Li, Xiao-xing/B-9114-2008; Liang, Qiaoyi Jessie/G-9612-2019; ZHANG, Xiang/N-7918-2015; Sung, Joseph J. Y./R-3203-2018; Yu, Jun/D-8569-2015; ZHANG, Jingwan/AIC-2560-2022	Li, Xiao-xing/0000-0001-8791-7505; Liang, Qiaoyi Jessie/0000-0001-8496-3442; ZHANG, Xiang/0000-0002-3222-5824; Sung, Joseph J. Y./0000-0003-3125-5199; Yu, Jun/0000-0001-5008-2153; ZHANG, Jingwan/0000-0002-0344-3398	Natural Science Foundation of China (NSFC) [81201963, 81372600]; China 863 Program [2012AA02A504]; Shenzhen Municipal Science and Technology RD fund [JCYJ20130401151108652]; Pearl River SAMP;T Nova Program of Guangzhou [201506010050]; Shenzhen Virtual University Park Support Scheme; Natural Science Foundation of China (NSFC) [81201963, 81372600]; China 863 Program [2012AA02A504]; Shenzhen Municipal Science and Technology RD fund [JCYJ20130401151108652]; Pearl River SAMP;T Nova Program of Guangzhou [201506010050]; Shenzhen Virtual University Park Support Scheme	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); China 863 Program(National High Technology Research and Development Program of China); Shenzhen Municipal Science and Technology RD fund; Pearl River SAMP;T Nova Program of Guangzhou; Shenzhen Virtual University Park Support Scheme; Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); China 863 Program(National High Technology Research and Development Program of China); Shenzhen Municipal Science and Technology RD fund; Pearl River SAMP;T Nova Program of Guangzhou; Shenzhen Virtual University Park Support Scheme	This project was supported by research funds of Natural Science Foundation of China (NSFC) (81201963 and 81372600), a China 863 Program (2012AA02A504), Shenzhen Municipal Science and Technology R&D fund (JCYJ20130401151108652), Pearl River S&T Nova Program of Guangzhou (201506010050) and Shenzhen Virtual University Park Support Scheme to CUHK Shenzhen Research Institute. The results shown here are in part based on data generated by the TCGA Research Network: http://cancergenome.nih.gov/.	Adler V, 1999, EMBO J, V18, P1321, DOI 10.1093/emboj/18.5.1321; Cayrol C, 1998, ONCOGENE, V16, P311, DOI 10.1038/sj.onc.1201543; CELIS JE, 1988, ARCH BIOL MED EXP, V21, P417; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Hesson LB, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-42; Kim GD, 2002, EMBO J, V21, P4183, DOI 10.1093/emboj/cdf401; Lee JG, 2013, FOOD CHEM TOXICOL, V55, P214, DOI 10.1016/j.fct.2012.12.026; Li X, 2012, ONCOGENE, V31, P3419, DOI 10.1038/onc.2011.511; Li X, 2014, CANCER LETT, V348, P146, DOI 10.1016/j.canlet.2014.03.017; Li ZH, 2014, ONCOL REP, V31, P1661, DOI 10.3892/or.2014.3039; Liu WL, 2011, HEPATOLOGY, V53, P843, DOI 10.1002/hep.24124; Liu YM, 2002, ONCOGENE, V21, P7680, DOI 10.1038/sj.onc.1205883; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Otani K, 2013, EXPERT REV MOL DIAGN, V13, P445, DOI [10.1586/ERM.13.32, 10.1586/erm.13.32]; Ozanne BW, 2007, ONCOGENE, V26, P1, DOI 10.1038/sj.onc.1209759; Richter AM, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.18; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Shen Q, 2008, ONCOGENE, V27, P366, DOI 10.1038/sj.onc.1210643; Takai Daiya, 2003, In Silico Biology, V3, P235; Tao Q, 2002, HUM MOL GENET, V11, P2091, DOI 10.1093/hmg/11.18.2091; Tomita H, 2011, GASTROENTEROLOGY, V140, P879, DOI 10.1053/j.gastro.2010.11.037; Ushijima T, 1997, P NATL ACAD SCI USA, V94, P2284, DOI 10.1073/pnas.94.6.2284; Volodko N, 2014, FEBS LETT, V588, P2671, DOI 10.1016/j.febslet.2014.02.041; Wang SY, 2013, GUT, V62, P833, DOI 10.1136/gutjnl-2011-301776; Wang T, 2001, J BIOL CHEM, V276, P20999, DOI 10.1074/jbc.M101355200; Wei ZR, 2013, BIOCHEM BIOPH RES CO, V432, P632, DOI 10.1016/j.bbrc.2013.02.033; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188; Xu LX, 2012, GUT, V61, P977, DOI 10.1136/gutjnl-2011-300411; Ying JM, 2005, CLIN CANCER RES, V11, P6442, DOI 10.1158/1078-0432.CCR-05-0267; Yu J, 2013, ONCOGENE, V32, P307, DOI 10.1038/onc.2012.54; Yu J, 2009, GASTROENTEROLOGY, V136, P640, DOI 10.1053/j.gastro.2008.10.050; Zhang Y, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-145	35	22	22	0	17	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 12	2016	35	19					2453	2464		10.1038/onc.2015.300	http://dx.doi.org/10.1038/onc.2015.300			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DM2GQ	26279301				2022-12-26	WOS:000376165500004
J	Lovas, S; Het, DZZ; Liu, HZ; Tang, J; Pecka, JL; Hatfield, MPD; Beiser, KW				Lovas, Sandor; Het, David Z. Z.; Liu, Huizhan; Tang, Jie; Pecka, Jason L.; Hatfield, Marcus P. D.; Beiser, Kirk W.			Glutamate Transporter Homolog-based Model Predicts That Anion-pi Interaction Is the Mechanism for the Voltage-dependent Response of Prestin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER HAIR CELL; PROTEIN SECONDARY STRUCTURE; LATERAL MEMBRANE; MOTOR PROTEIN; ELECTROMOTILITY; SUPERFAMILY; RECOGNITION; SIMULATION; DOMAINS; PATTERN	Prestin is the motor protein of cochlear outer hair cells. Its unique capability to perform direct, rapid, and reciprocal electromechanical conversion depends on membrane potential and interaction with intracellular anions. How prestin senses the voltage change and interacts with anions are still unknown. Our three-dimensional model of prestin using molecular dynamics simulations predicts that prestin contains eight transmembrane-spanning segments and two helical re-entry loops and that tyrosyl residues are the structural specialization of the molecule for the unique function of prestin. Using site-directed mutagenesis and electrophysiological techniques, we confirmed that residues Tyr(367), Tyr(486), Tyran, and Tyr(501) contribute to anion binding, interacting with intracellular anions through novel anion-Tr interactions. Such weak interactions, sensitive to voltage and mechanical stimulation, confer prestin with a unique capability to perform electromechanical and mechano-electric conversions with exquisite sensitivity. This novel mechanism is completely different from all known mechanisms seen in ion channels, transporters, and motor proteins.	[Lovas, Sandor; Het, David Z. Z.; Liu, Huizhan; Tang, Jie; Pecka, Jason L.; Hatfield, Marcus P. D.; Beiser, Kirk W.] Creighton Univ, Sch Med, Dept Biomed Sci, 2500 Calif Plaza, Omaha, NE 68178 USA	Creighton University	Lovas, S (corresponding author), Creighton Univ, Sch Med, Dept Biomed Sci, 2500 Calif Plaza, Omaha, NE 68178 USA.	slovas@creighton.edu; davidhe@creighton.edu; kirkbeisel@creighton.edu	Tang, Jie/GNW-2318-2022	He (he zhi zhou), Zhi-Zhou/0000-0001-8383-9634; Tang, Jie/0000-0001-7882-4462	National Institutes of Health from the NIDCD [R01 DC 004696]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004696] Funding Source: NIH RePORTER	National Institutes of Health from the NIDCD; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DC 004696 from the NIDCD (to D. Z. Z. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Ashmore J. F., 1989, COCHLEAR MECH, P107; Bai JP, 2009, BIOPHYS J, V96, P3179, DOI 10.1016/j.bpj.2008.12.3948; Bowers K. J., 2006, P 2006 ACM IEEE C SU, P43, DOI DOI 10.1145/1188455.1188544; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; Chang AB, 2004, MOL MEMBR BIOL, V21, P171, DOI 10.1080/09687680410001720830; Chourasia M, 2011, INT J BIOL MACROMOL, V48, P540, DOI 10.1016/j.ijbiomac.2011.01.008; Csontos J, 2008, J COMPUT CHEM, V29, P1344, DOI 10.1002/jcc.20898; Dallos P, 2002, NAT REV MOL CELL BIO, V3, P104, DOI 10.1038/nrm730; Dallos P, 2008, NEURON, V58, P333, DOI 10.1016/j.neuron.2008.02.028; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; Dong XX, 2000, BIOPHYS J, V79, P1876, DOI 10.1016/S0006-3495(00)76437-X; Fisher JAN, 2012, NEURON, V76, P989, DOI 10.1016/j.neuron.2012.09.031; Frontera A, 2011, ANGEW CHEM INT EDIT, V50, P9564, DOI 10.1002/anie.201100208; GALE JE, 1994, P ROY SOC B-BIOL SCI, V255, P243, DOI 10.1098/rspb.1994.0035; Gorbunov D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4622; Hallworth R, 2012, J NEUROPHYSIOL, V107, P5, DOI 10.1152/jn.00728.2011; He DZZ, 2014, HEARING RES, V311, P25, DOI 10.1016/j.heares.2013.12.002; He DZZ, 2010, CYTOSKELETON, V67, P43, DOI 10.1002/cm.20423; Homma K, 2013, J BIOL CHEM, V288, P2452, DOI 10.1074/jbc.M112.411579; Illergard K, 2009, PROTEINS, V77, P499, DOI 10.1002/prot.22458; Jones GJ, 2013, J PHYS CHEM B, V117, P3315, DOI 10.1021/jp400345s; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Lippert RA, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2431176; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Lobley A, 2009, BIOINFORMATICS, V25, P1761, DOI 10.1093/bioinformatics/btp302; Lovas S., 2011, P 22 AM PEPT S AM PE, P120; Lu FR, 2011, NATURE, V472, P243, DOI 10.1038/nature09885; Mount DB, 2004, PFLUG ARCH EUR J PHY, V447, P710, DOI 10.1007/s00424-003-1090-3; Naider Fred, 2007, V386, P95, DOI 10.1007/978-1-59745-430-8_4; Nishio M, 2014, PHYS CHEM CHEM PHYS, V16, P12648, DOI 10.1039/c4cp00099d; Ohana E, 2011, J GEN PHYSIOL, V137, P239, DOI 10.1085/jgp.201010531; Ohana E, 2009, J PHYSIOL-LONDON, V587, P2179, DOI 10.1113/jphysiol.2008.164863; Okoruwa OE, 2008, EVOL DEV, V10, P300, DOI 10.1111/j.1525-142X.2008.00239.x; Oliver D, 2001, SCIENCE, V292, P2340, DOI 10.1126/science.1060939; Palermo NY, 2012, J PEPT SCI, V18, P252, DOI 10.1002/psc.2393; Philip V, 2011, BIOCHEMISTRY-US, V50, P2939, DOI 10.1021/bi200066k; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Robertazzi A, 2011, CRYSTENGCOMM, V13, P3293, DOI 10.1039/c0ce00819b; Rybalchenko V, 2003, BIOPHYSICS OF THE COCHLEA: FROM MOLECULES TO MODELS, P116, DOI 10.1142/9789812704931_0015; SANTOS-SACCHI J, 1989, J NEUROSCI, V9, P2954; Santos-Sacchi J, 2001, J PHYSIOL-LONDON, V531, P661, DOI 10.1111/j.1469-7793.2001.0661h.x; Schaechinger TJ, 2011, EMBO J, V30, P2793, DOI 10.1038/emboj.2011.202; Shrivastava IH, 2008, J BIOL CHEM, V283, P28680, DOI 10.1074/jbc.M800889200; Song L, 2010, BIOPHYS J, V98, P371, DOI 10.1016/j.bpj.2009.10.027; Sousounis K, 2012, HUM GENOMICS, V6, DOI 10.1186/1479-7364-6-10; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; SZENDREI GI, 1994, EUR J BIOCHEM, V226, P917, DOI 10.1111/j.1432-1033.1994.t01-1-00917.x; Tan XD, 2012, J CELL SCI, V125, P1039, DOI 10.1242/jcs.097337; Tan XD, 2011, J NEUROPHYSIOL, V105, P36, DOI 10.1152/jn.00234.2010; Tang J, 2011, J BIOL CHEM, V286, P31014, DOI 10.1074/jbc.M111.259564; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Vastermark A, 2014, PROTEINS, V82, P336, DOI 10.1002/prot.24401; Vastermark A, 2014, PROTEINS, V82, P2797, DOI 10.1002/prot.24643; Wang X, 2010, BRAIN RES, V1333, P28, DOI 10.1016/j.brainres.2010.03.070; Wong FH, 2012, J MOL MICROB BIOTECH, V22, P105, DOI 10.1159/000338542; Yamaguchi T, 2010, J MOL BIOL, V397, P179, DOI 10.1016/j.jmb.2010.01.027; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009; Zheng J, 2001, NEUROREPORT, V12, P1929, DOI 10.1097/00001756-200107030-00032	61	8	8	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24326	24339		10.1074/jbc.M115.649962	http://dx.doi.org/10.1074/jbc.M115.649962			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26283790	Green Published, hybrid			2022-12-26	WOS:000362218900022
J	Jiang, L; Chen, J; Wang, P; Ren, QQ; Yuan, J; Qian, CJ; Hua, XH; Guo, ZC; Zhang, L; Yang, JK; Wang, Y; Zhang, Q; Ding, HW; Bi, D; Zhang, ZM; Wang, QQ; Chen, DS; Kan, XZ				Jiang, Lan; Chen, Juan; Wang, Ping; Ren, Qiongqiong; Yuan, Jian; Qian, Chaoju; Hua, Xinghong; Guo, Zhichun; Zhang, Lei; Yang, Jianke; Wang, Ying; Zhang, Qin; Ding, Hengwu; Bi, De; Zhang, Zongmeng; Wang, Qingqing; Chen, Dongsheng; Kan, Xianzhao			The Mitochondrial Genomes of Aquila fasciata and Buteo lagopus (Aves, Accipitriformes): Sequence, Structure and Phylogenetic Analyses	PLOS ONE			English	Article							PSEUDO-CONTROL REGIONS; OLD-WORLD VULTURES; EVOLUTIONARY HISTORY; NUCLEOTIDE-SEQUENCES; GENUS; BIRDS; EAGLES; PASSERIFORMES; EMBERIZIDAE; DIVERSITY	The family Accipitridae is one of the largest groups of non-passerine birds, including 68 genera and 243 species globally distributed. In the present study, we determined the complete mitochondrial sequences of two species of accipitrid, namely Aquila fasciata and Buteo lagopus, and conducted a comparative mitogenome analysis across the family. The mitogenome length of A. fasciata and B. lagopus are 18,513 and 18,559 bp with an A + T content of 54.2% and 55.0%, respectively. For both the two accipitrid birds mtDNAs, obvious positive AT-skew and negative GC-skew biases were detected for all 12 PCGs encoded by the H strand, whereas the reverse was found in MT-ND6 encoded by the L strand. One extra nucleotide'C'is present at the position 174 of MT-ND3 gene of A. fasciata, which is not observed at that of B. lagopus. Six conserved sequence boxes in the Domain II, named boxes F, E, D, C, CSBa, and CSBb, respectively, were recognized in the CRs of A. fasciata and B. lagopus. Rates and patterns of mitochondrial gene evolution within Accipitridae were also estimated. The highest dN/dS was detected for the MT-ATP8 gene (0.32493) among Accipitridae, while the lowest for the MT-CO1 gene (0.01415). Mitophylogenetic analysis supported the robust monophyly of Accipitriformes, and Cathartidae was basal to the balance of the order. Moreover, we performed phylogenetic analyses using two other data sets (two mitochondrial loci, and combined nuclear and mitochondrial loci). Our results indicate that the subfamily Aquilinae and all currently polytypic genera of this subfamily are monophyletic. These two novel mtDNA data will be useful in refining the phylogenetic relationships and evolutionary processes of Accipitriformes.	[Jiang, Lan; Chen, Juan; Wang, Ping; Ren, Qiongqiong; Guo, Zhichun; Zhang, Lei; Wang, Ying; Zhang, Qin; Ding, Hengwu; Bi, De; Zhang, Zongmeng; Wang, Qingqing; Chen, Dongsheng; Kan, Xianzhao] Anhui Normal Univ, Coll Life Sci, Inst Bioinformat, Wuhu, Anhui, Peoples R China; [Jiang, Lan; Kan, Xianzhao] Prov Key Lab Conservat & Exploitat Res Biol Resou, Wuhu, Anhui, Peoples R China; [Yuan, Jian] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Qian, Chaoju] Chinese Acad Sci, Key Lab Stress Physiol & Ecol Cold & Arid Reg, Dept Ecol & Agr Res, Cold & Arid Reg Environm & Engn Res Inst, Lanzhou, Gansu, Peoples R China; [Hua, Xinghong] Ningguo Museum Nat Hist, Ningguo, Anhui, Peoples R China; [Yang, Jianke] Wannan Med Coll, Dept Med Biol, Wuhu, Anhui, Peoples R China	Anhui Normal University; Peking University; Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; Wannan Medical College	Kan, XZ (corresponding author), Anhui Normal Univ, Coll Life Sci, Inst Bioinformat, Wuhu, Anhui, Peoples R China.	xianzhao@ahnu.edu.cn	Kan, Xianzhao/AAA-5050-2021	Kan, Xianzhao/0000-0002-9225-407X; Zhang, Zongmeng/0000-0002-4144-6901; Yuan, Jian/0000-0002-1896-2561	Key Programme of Natural Science Foundation of the Anhui Higher Education Institutions [KJ2013A127]; Anhui Provincial Natural Science Foundation [1308085MC38]	Key Programme of Natural Science Foundation of the Anhui Higher Education Institutions; Anhui Provincial Natural Science Foundation(Natural Science Foundation of Anhui Province)	This work was funded by (1) the Key Programme of Natural Science Foundation of the Anhui Higher Education Institutions (no. KJ2013A127), Special to Prof. XK (website: http://202.38.95.119/Srmis/login.aspx), and (2) the Anhui Provincial Natural Science Foundation (no. 1308085MC38), Special to Prof. XK (website: http://www.ahinfo.gov.cn/zrkxjj/index.htm).	AMADON D, 1988, Proceedings of the Western Foundation of Vertebrate Zoology, V3, P295; Asai S, 2006, BIRD CONSERV INT, V16, P113, DOI 10.1017/S0959270906000050; Asai Shigeki, 2008, Ornithological Science, V7, P143, DOI 10.2326/1347-0558-7.2.143; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Beckenbach AT, 2005, J MOL EVOL, V60, P141, DOI 10.1007/s00239-004-0178-5; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; Burleigh JG, 2015, MOL PHYLOGENET EVOL, V84, P53, DOI 10.1016/j.ympev.2014.12.003; Cadahia L, 2009, J EXP ZOOL PART B, V312B, P171, DOI 10.1002/jez.b.21282; Chesser RT, 2010, AUK, V127, P726, DOI 10.1525/auk.2010.127.3.726; Clements JF, 2014, EBIRD CLEMENTS CHECK; CRACRAFT J, 1981, AUK, V98, P681; del Hoyo J, 1994, HDB BIRDS WORLD, V2, P434; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Doyle JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095599; Gibb GC, 2007, MOL BIOL EVOL, V24, P269, DOI 10.1093/molbev/msl158; Gill F., 2015, IOC WORLD BIRD LIST; Grant JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-202; Gray KA, 2015, NUCLEIC ACIDS RES, V43, pD1079, DOI 10.1093/nar/gku1071; Gregory Steven M.S., 2012, Bulletin of the British Ornithologists' Club, V132, P135; Griffiths CS, 2007, J AVIAN BIOL, V38, P587, DOI 10.1111/j.2007.0908-8857.03971.x; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Haring E, 2007, J ZOOL SYST EVOL RES, V45, P353, DOI 10.1111/j.1439-0469.2007.00410.x; Haring E, 2001, MOL BIOL EVOL, V18, P1892, DOI 10.1093/oxfordjournals.molbev.a003730; Helbig AJ, 2005, MOL PHYLOGENET EVOL, V35, P147, DOI 10.1016/j.ympev.2004.10.003; Higdon JW, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-216; Jarvis ED, 2014, SCIENCE, V346, P1320, DOI 10.1126/science.1253451; JOLLIE M, 1977, Evolutionary Theory, V2, P115; Kan XZ, 2010, GENET MOL RES, V9, P1625, DOI 10.4238/vol9-3gmr898; Kan XZ, 2010, GENET MOL RES, V9, P1234, DOI 10.4238/vol9-2gmr853; Kan XZ, 2010, GENET MOL RES, V9, P1204, DOI 10.4238/vol9-2gmr820; Kan XZ, 2013, MITOCHONDR DNA, V24, P648, DOI 10.3109/19401736.2013.772165; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; KONIG C, 1982, J ORNITHOL, V123, P259, DOI 10.1007/BF01644360; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Lepage D., 2014, PETERS CHECK LIST BI; Lerner HRL, 2005, MOL PHYLOGENET EVOL, V37, P327, DOI 10.1016/j.ympev.2005.04.010; Li XJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1234-9; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Livezey BC, 2001, NETH J ZOOL, V51, P179, DOI 10.1163/156854201750385145; Livezey BC, 2007, ZOOL J LINN SOC-LOND, V149, P1, DOI 10.1111/j.1096-3642.2006.00293.x; Mahmood MT, 2014, GENOME BIOL EVOL, V6, P326, DOI 10.1093/gbe/evu016; Marshall HD, 2013, GENE, V517, P37, DOI 10.1016/j.gene.2012.12.093; Mayr G, 2003, CLADISTICS, V19, P527, DOI [10.1016/j.cladistics.2003.10.003, 10.1111/j.1096-0031.2003.tb00387.x]; Mindell DP, 1998, MOL BIOL EVOL, V15, P1568, DOI 10.1093/oxfordjournals.molbev.a025884; Nagy Jeno, 2014, Ornis Hungarica, V22, P15; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Ong PS, 2011, MOL ECOL RESOUR, V11, P245, DOI 10.1111/j.1755-0998.2010.02928.x; Peng QK, 2014, MITOCHONDRIAL DNA; Ren QQ, 2016, MITOCHONDRIAL DNA A, V27, P375, DOI 10.3109/19401736.2014.895993; Ren QQ, 2014, J GENET, V93, P699, DOI 10.1007/s12041-014-0428-2; Riesing MJ, 2003, MOL PHYLOGENET EVOL, V27, P328, DOI 10.1016/S1055-7903(02)00450-5; Russell RD, 2008, J MOL EVOL, V67, P682, DOI 10.1007/s00239-008-9179-0; Sambrook J., 2001, MOL CLONING LAB MANU; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Seibold I, 1995, PHILOS T ROY SOC B, V350, P163, DOI 10.1098/rstb.1995.0150; Sibley CG, 1990, DISTRIBUTION TAXONOM; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Slack KE, 2007, MOL PHYLOGENET EVOL, V42, P1, DOI 10.1016/j.ympev.2006.06.002; Song XH, 2015, BIOCHEM SYST ECOL, V58, P75, DOI 10.1016/j.bse.2014.10.013; STAMATAKIS A., 2006, P 20 IEEE INT PAR DI, DOI DOI 10.1109/IPDPS.2006.1639535; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vali U, 2002, MOL ECOL, V11, P2189, DOI 10.1046/j.1365-294X.2002.01578.x; Wells D. R., 2012, Bulletin of the British Ornithologists' Club, V132, P70; Wink M, 1995, Z NATURFORSCH C, V50, P868; Wink Michael, 2004, P483; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064; Zhang H, 2014, MITOCHONDRIAL DNA; Zhang LQ, 2012, MOL BIOL REP, V39, P8315, DOI 10.1007/s11033-012-1681-1	73	18	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136297	10.1371/journal.pone.0136297	http://dx.doi.org/10.1371/journal.pone.0136297			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295156	Green Published, Green Submitted, gold			2022-12-26	WOS:000359926900097
J	Cho, GJ; Kim, LY; Sung, YN; Kim, JA; Hwang, SY; Hong, HR; Hong, SC; Oh, MJ; Kim, HJ				Cho, Geum Joon; Kim, Log Young; Sung, Ye Na; Kim, Jee Ae; Hwang, Soon Young; Hong, Hye-Ri; Hong, Soon-Cheol; Oh, Min-Jeong; Kim, Hai-Joong			Secular Trends of Gestational Diabetes Mellitus and Changes in Its Risk Factors	PLOS ONE			English	Article							INCREASING PREVALENCE; GLUCOSE-TOLERANCE; OBESITY; WOMEN; PREGNANCY; COHORT; ASSOCIATION; POPULATION; CARPENTER; DIAGNOSIS	Objective The aim of this study was to evaluate the secular trends of incidence of gestational diabetes mellitus (GDM) and insulin treatment for GDM in a Korean population and to determine the factors that contribute to the trends in the incidence of GDM. Study Design We used data collected by the Health Insurance Review & Assessment Service of Korea and analyzed data from women who had given birth from 2006 to 2010. We evaluated the trends in the incidence of GDM and GDM requiring insulin treatment and the changes in risk factors. Results There were 1,824,913 births during the study period, which included 129,666 cases of GDM, an incidence of 7.11% over this period. The incidence of GDM increased from 3.86% in 2007 to 11.83% in 2010, with a continuous increase after adjustment for age. However, the number of GDM cases that required insulin treatment decreased significantly from 13.87% in 2007 to 5.94% in 2010. The proportion of patients who were at an older age and multiparity, 2 GDM risk factors, increased during the study period. Conclusions In Korea, the incidence of GDM, especially mild GDM, increased dramatically during the period from 2006 to 2010. Further efforts are needed to monitor this trend and to identify associated factors.	[Cho, Geum Joon; Hong, Soon-Cheol; Oh, Min-Jeong; Kim, Hai-Joong] Korea Univ, Coll Med, Dept Obstet & Gynecol, Seoul 136705, South Korea; [Kim, Log Young; Sung, Ye Na; Kim, Jee Ae] Hlth Insurance Review & Assessment Serv Korea, Seoul, South Korea; [Hwang, Soon Young] Korea Univ, Coll Med, Dept Biostat, Seoul 136705, South Korea; [Hong, Hye-Ri] Kyung Hee Univ, Dept Obstet & Gynecol, Sch Med, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Kyung Hee University	Oh, MJ (corresponding author), Korea Univ, Coll Med, Dept Obstet & Gynecol, Seoul 136705, South Korea.	mjohmd@korea.ac.kr	Rhim, Sonny H./W-9532-2019; Hong, Soon Cheol/F-6614-2013	Hong, Soon Cheol/0000-0003-2102-7555	Korea Academy of Medical Sciences	Korea Academy of Medical Sciences	This study was supported by a 2013-Grant from Korea Academy of Medical Sciences.	Albrecht SS, 2010, DIABETES CARE, V33, P768, DOI 10.2337/dc09-1801; American College of Obstetricians and Gynecologists Committee on Practice Bulletins--Obstetrics, 2001, Obstet Gynecol, V98, P525; American Diabetes Association, 2002, AM DIABETES ASS DIAB, V25, ps94, DOI DOI 10.2337/DIACARE.25.2007.S94); Anna V, 2008, DIABETES CARE, V31, P2288, DOI 10.2337/dc08-1038; Ben-Haroush A, 2004, DIABETIC MED, V21, P103, DOI 10.1046/j.1464-5491.2003.00985.x; Chen YZ, 2009, POPUL HEALTH MANAG, V12, P165, DOI 10.1089/pop.2009.12303; Cheng YW, 2009, OBSTET GYNECOL, V114, P326, DOI 10.1097/AOG.0b013e3181ae8d85; Choi NK, 2010, PHARMACOEPIDEM DR S, V19, P238, DOI 10.1002/pds.1902; Choi SK, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-6; Chon SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114972; Chu SY, 2007, DIABETES CARE, V30, P2070, DOI 10.2337/dc06-2559a; Chu SY, 2009, PREV MED, V49, P265, DOI 10.1016/j.ypmed.2009.07.001; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973; Dabelea D, 2005, DIABETES CARE, V28, P579, DOI 10.2337/diacare.28.3.579; Davenport MH, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-85; Dempsey JC, 2004, AM J EPIDEMIOL, V159, P663, DOI 10.1093/aje/kwh091; England LJ, 2004, AM J EPIDEMIOL, V160, P1205, DOI 10.1093/aje/kwh340; Ferrara A, 2004, OBSTET GYNECOL, V103, P526, DOI 10.1097/01.AOG.0000113623.18286.20; Ferrara A, 2002, DIABETES CARE, V25, P1625, DOI 10.2337/diacare.25.9.1625; Ferrara A, 2007, DIABETES CARE, V30, pS141, DOI 10.2337/dc07-s206; Genuth S, 2003, DIABETES CARE, V26, P3160; JANG HC, 1995, INT J GYNECOL OBSTET, V51, P115, DOI 10.1016/0020-7292(95)02524-G; Kim JY, 2006, CONSTRUCTION NATL SU; Kim SY, 2007, OBESITY, V15, P986, DOI 10.1038/oby.2007.621; Lee AJ, 2007, DIABETES CARE, V30, P878, DOI 10.2337/dc06-1816; Lee SY, 2007, DIABETES RES CLIN PR, V75, P72, DOI 10.1016/j.diabres.2006.04.013; Metzger BE, 1998, DIABETES CARE, V21, pB161; Murgia C, 2006, DIABETES CARE, V29, P1713, DOI 10.2337/dc06-0635; Oh SW, 2004, OBES RES, V12, P2031, DOI 10.1038/oby.2004.254; Park S, 2013, EUR J CLIN NUTR, V67, P196, DOI 10.1038/ejcn.2012.207; Radesky JS, 2008, PAEDIATR PERINAT EP, V22, P47, DOI 10.1111/j.1365-3016.2007.00899.x; Rhee SY, 2013, KOREAN J INTERN MED, V28, P29, DOI 10.3904/kjim.2013.28.1.29; Ricart W, 2005, DIABETOLOGIA, V48, P1135, DOI 10.1007/s00125-005-1756-9; Savitz DA, 2008, BJOG-INT J OBSTET GY, V115, P969, DOI 10.1111/j.1471-0528.2008.01763.x; Schmidt MI, 2001, DIABETES CARE, V24, P1151, DOI 10.2337/diacare.24.7.1151; Sella T, 2013, J MATERN-FETAL NEO M, V26, P412, DOI 10.3109/14767058.2012.733761; Sendag F, 2001, J REPROD MED, V46, P1057; WHITE P, 1949, AM J MED, V7, P609, DOI 10.1016/0002-9343(49)90382-4; Wong VW, 2012, DIABETIC MED, V29, P366, DOI 10.1111/j.1464-5491.2011.03439.x; Wong VW, 2011, AUST NZ J OBSTET GYN, V51, P432, DOI 10.1111/j.1479-828X.2011.01329.x; Zhang F, 2011, DIABETIC MED, V28, P652, DOI 10.1111/j.1464-5491.2010.03205.x	42	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136017	10.1371/journal.pone.0136017	http://dx.doi.org/10.1371/journal.pone.0136017			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26292282	Green Submitted, Green Published, gold			2022-12-26	WOS:000359919900046
J	Kaplovitch, E; Gomes, T; Camacho, X; Dhalla, IA; Mamdani, MM; Juurlink, DN				Kaplovitch, Eric; Gomes, Tara; Camacho, Ximena; Dhalla, Irfan A.; Mamdani, Muhammad M.; Juurlink, David N.			Sex Differences in Dose Escalation and Overdose Death during Chronic Opioid Therapy: A Population-Based Cohort Study	PLOS ONE			English	Article							CHRONIC NONCANCER PAIN; UNITED-STATES; PRESCRIPTION OPIOIDS; NONMALIGNANT PAIN; TRENDS; GENDER; RISK; METAANALYSIS; ANALGESICS; MORTALITY	Background The use of opioids for noncancer pain is widespread, and more than 16,000 die of opioid-related causes in the United States annually. The patients at greatest risk of death are those receiving high doses of opioids. Whether sex influences the risk of dose escalation or opioid-related mortality is unknown. Methods and Findings We conducted a cohort study using healthcare records of 32,499 individuals aged 15 to 64 who commenced chronic opioid therapy for noncancer pain between April 1, 1997 and December 31, 2010 in Ontario, Canada. Patients were followed from their first opioid prescription until discontinuation of therapy, death from any cause or the end of the study period. Among patients receiving chronic opioid therapy, 589 (1.8%) escalated to high dose therapy and n = 59 (0.2%) died of opioid-related causes while on treatment. After multivariable adjustment, men were more likely than women to escalate to high-dose opioid therapy ( adjusted hazard ratio 1.44; 95% confidence interval 1.21 to 1.70) and twice as likely to die of opioid-related causes (adjusted hazard ratio 2.04; 95% confidence interval 1.18 to 3.53). These associations were maintained in a secondary analysis of 285,520 individuals receiving any opioid regardless of the duration of therapy. Conclusions Men are at higher risk than women for escalation to high-dose opioid therapy and death from opioid-related causes. Both outcomes were more common than anticipated.	[Kaplovitch, Eric; Dhalla, Irfan A.; Juurlink, David N.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Gomes, Tara; Camacho, Ximena; Dhalla, Irfan A.; Mamdani, Muhammad M.; Juurlink, David N.] Inst Clin Evaluat Sci, Chron Dis & Pharmacotherapy Res Program, Toronto, ON, Canada; [Gomes, Tara; Mamdani, Muhammad M.] Univ Toronto, Dept Pharm, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto	Juurlink, DN (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.	david.juurlink@ices.on.ca		Gomes, Tara/0000-0002-1468-1965	Ontario Ministry of Health and Long-Term Care (MOHLTC) Drug Innovation Fund; Institute for Clinical Evaluative Sciences (ICES) - Ontario MOHLTC	Ontario Ministry of Health and Long-Term Care (MOHLTC) Drug Innovation Fund; Institute for Clinical Evaluative Sciences (ICES) - Ontario MOHLTC	This study was supported by a grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC) Drug Innovation Fund and the Institute for Clinical Evaluative Sciences (ICES), a non-profit research institute sponsored by the Ontario MOHLTC. The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], US MED US REV 2011; Back SE, 2010, ADDICT BEHAV, V35, P1001, DOI 10.1016/j.addbeh.2010.06.018; Back SE, 2009, CLIN J PAIN, V25, P477, DOI 10.1097/AJP.0b013e31819c2c2f; Boudreau D, 2009, PHARMACOEPIDEM DR S, V18, P1166, DOI 10.1002/pds.1833; Campbell CI, 2010, AM J PUBLIC HEALTH, V100, P2541, DOI 10.2105/AJPH.2009.180646; Caudill-Slosberg MA, 2004, PAIN, V109, P514, DOI 10.1016/j.pain.2004.03.006; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chou R, 2009, J PAIN, V10, P147, DOI 10.1016/j.jpain.2008.10.007; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Dhalla IA, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5142; Dhalla IA, 2009, CAN MED ASSOC J, V181, P891, DOI 10.1503/cmaj.090784; Fillingim RB, 2009, J PAIN, V10, P447, DOI 10.1016/j.jpain.2008.12.001; Furlan AD, 2006, CAN MED ASSOC J, V174, P1589, DOI 10.1503/cmaj.051528; Gomes T, 2013, JAMA INTERN MED, V173, P196, DOI 10.1001/2013.jamainternmed.733; Gomes Tara, 2011, Open Med, V5, pe13; Gomes T, 2011, ARCH INTERN MED, V171, P686, DOI 10.1001/archinternmed.2011.117; Green CR, 2003, J PAIN, V4, P29, DOI 10.1054/jpai.2003.5; Hall AJ, 2008, JAMA-J AM MED ASSOC, V300, P2613, DOI 10.1001/jama.2008.802; Hall S, 2006, J CLIN EPIDEMIOL, V59, P67, DOI 10.1016/j.jclinepi.2005.05.001; Han Huijun, 2013, J Opioid Manag, V9, P129, DOI 10.5055/jom.2012.0154; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Jamison RN, 2010, J PAIN, V11, P312, DOI 10.1016/j.jpain.2009.07.016; Joynt M, 2013, J GEN INTERN MED; Kissin I, 2013, J PAIN RES, V6, P513, DOI [10.2147/JPR.S47182, 10.2147/JPR.S47162]; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67; Mamdani M, 2005, BMJ-BRIT MED J, V330, P960, DOI 10.1136/bmj.330.7497.960; National Opioid Use Guideline Group (NOUGG), 2010, CAN GUID SAF EFF US; Nelson LS, 2012, JAMA-J AM MED ASSOC, V308, P457, DOI 10.1001/jama.2012.8165; Noble M, 2008, J PAIN SYMPTOM MANAG, V35, P214, DOI 10.1016/j.jpainsymman.2007.03.015; Paulozzi Leonard J., 2012, Morbidity and Mortality Weekly Report, V61, P493; Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P1487; Pletcher MJ, 2008, JAMA-J AM MED ASSOC, V299, P70, DOI 10.1001/jama.2007.64; PORTENOY RK, 1986, PAIN, V25, P171, DOI 10.1016/0304-3959(86)90091-6; Sadowski CA, 2009, J POPUL THER CLIN PH, V16, pE322; Spiller H, 2009, J ADDICT DIS, V28, P130, DOI 10.1080/10550880902772431; Sullivan MD, 2008, PAIN, V138, P440, DOI 10.1016/j.pain.2008.04.027; Von Korff M, 2011, ANN INTERN MED, V155, P325, DOI 10.7326/0003-4819-155-5-201109060-00011; Warner Margaret, 2011, NCHS Data Brief, P1; Wisniewski AM, 2008, J ADDICT DIS, V27, P1, DOI 10.1300/J069v27n01_01; YOLA M, 1994, J CLIN EPIDEMIOL, V47, P731, DOI 10.1016/0895-4356(94)90170-8	40	97	98	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0134550	10.1371/journal.pone.0134550	http://dx.doi.org/10.1371/journal.pone.0134550			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5KH	26291716	Green Published, gold			2022-12-26	WOS:000359919900008
J	Li, GC; Wang, JZ; Hu, WG; Zhang, Z				Li, Guichao; Wang, Jiazhou; Hu, Weigang; Zhang, Zhen			Radiation-Induced Liver Injury in Three-Dimensional Conformal Radiation Therapy (3D-CRT) for Postoperative or Locoregional Recurrent Gastric Cancer: Risk Factors and Dose Limitations	PLOS ONE			English	Article							COMPLICATION PROBABILITY MODEL; HEPATOCELLULAR-CARCINOMA; PARALLEL-ARCHITECTURE; NORMAL-TISSUES; DISEASE; RADIOTHERAPY; IRRADIATION; TOLERANCE; PREDICTION	Purpose This study examined the status of radiation-induced liver injury in adjuvant or palliative gastric cancer radiation therapy (RT), identified risk factors of radiation-induced liver injury in gastric cancer RT, analysed the dose-volume effects of liver injury, and developed a liver dose limitation reference for gastric cancer RT. Methods and Materials Data for 56 post-operative gastric cancer patients and 6 locoregional recurrent gastric cancer patients treated with three-dimensional conformal radiation therapy (3D-CRT) or intensity-modulated radiation therapy (IMRT) from Sep 2007 to Sep 2009 were analysed. Forty patients (65%) were administered concurrent chemotherapy. Pre- and post-radiation chemotherapy were given to 61 patients and 43 patients, respectively. The radiation dose was 45-50.4 Gy in 25-28 fractions. Clinical parameters, including gender, age, hepatic B virus status, concurrent chemotherapy, and the total number of chemotherapy cycles, were included in the analysis. Univariate analyses with a non-parametric rank test (Mann-Whitney test) and logistic regression test and a multivariate analysis using a logistic regression test were completed. We also analysed the correlation between RT and the changes in serum chemistry parameters [including total bilirubin, (TB), direct bilirubin (D-TB), alkaline phosphatase (ALP), alanine aminotransferase (ALT), aspartate aminotransferase (AST) and serum albumin (ALB)] after RT. Results The Child-Pugh grade progressed from grade A to grade B after radiotherapy in 10 patients. A total of 16 cases of classic radiation-induced liver disease (RILD) were observed, and 2 patients had both Child-Pugh grade progression and classic RILD. No cases of non-classic radiation liver injury occurred in the study population. Among the tested clinical parameters, the total number of chemotherapy cycles correlated with liver function injury. V35 and ALP levels were significant predictive factors for radiation liver injury. Conclusions In 3D-CRT for gastric cancer patients, radiation-induced liver injury may occur and affect the overall treatment plan. The total number of chemotherapy cycles correlated with liver function injury, and V35 and ALP are significant predictive factors for radiation-induced liver injury. Our dose limitation reference for liver protection is feasible.	[Zhang, Zhen] Fudan Univ, Dept Radiat Oncol, Shanghai Canc Ctr, Shanghai 200433, Peoples R China; Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Zhang, Z (corresponding author), Fudan Univ, Dept Radiat Oncol, Shanghai Canc Ctr, Shanghai 200433, Peoples R China.	zhenzhang6@163.com						Bockbrader M, 2009, EXPERT REV ANTICANC, V9, P637, DOI 10.1586/ERA.09.16; Cheng JCH, 2005, INT J RADIAT ONCOL, V62, P1150, DOI 10.1016/j.ijrobp.2004.12.031; Cheng JCH, 2002, INT J RADIAT ONCOL, V54, P156, DOI 10.1016/S0360-3016(02)02915-2; Cunningham D, 2008, NEW ENGL J MED, V358, P36, DOI 10.1056/NEJMoa073149; Dawson LA, 2005, SEMIN RADIAT ONCOL, V15, P279, DOI 10.1016/j.semradonc.2005.04.005; Dawson LA, 2001, INT J RADIAT ONCOL, V51, P1410, DOI 10.1016/S0360-3016(01)02653-0; Dawson LA, 2001, SEMIN RADIAT ONCOL, V11, P240, DOI 10.1053/srao.2001.23485; Dawson LA, 2002, INT J RADIAT ONCOL, V53, P810, DOI 10.1016/S0360-3016(02)02846-8; JACKSON A, 1993, MED PHYS, V20, P613, DOI 10.1118/1.597056; Kang Y., 2006, ASCO, V24, DOI [10.1200/jco.2006.24.18_suppl.lba4018, DOI 10.1200/JCO.2006.24.18_SUPPL.LBA4018]; Kim TH, 2007, INT J RADIAT ONCOL, V67, P225, DOI 10.1016/j.ijrobp.2006.08.015; Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI 10.1016/S1470-2045(08)70035-4; Liang SX, 2006, INT J RADIAT ONCOL, V65, P426, DOI 10.1016/j.ijrobp.2005.12.031; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Ohara K, 1997, INT J RADIAT ONCOL, V38, P367, DOI 10.1016/S0360-3016(96)00587-1; Pan CC, 2010, INT J RADIAT ONCOL, V76, pS94, DOI 10.1016/j.ijrobp.2009.06.092; Tai A, 2009, INT J RADIAT ONCOL, V74, P283, DOI 10.1016/j.ijrobp.2008.11.029; Xu ZY, 2006, INT J RADIAT ONCOL, V65, P189, DOI 10.1016/j.ijrobp.2005.11.034; Yorke ED, 2001, SEMIN RADIAT ONCOL, V11, P197, DOI 10.1053/srao.2001.23478; YORKE ED, 1993, RADIOTHER ONCOL, V26, P226, DOI 10.1016/0167-8140(93)90264-9; Zhu J, 2006, JPN J CLIN ONCOL, V36, P783, DOI 10.1093/jjco/hyl117	21	11	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136288	10.1371/journal.pone.0136288	http://dx.doi.org/10.1371/journal.pone.0136288			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291715	Green Published, gold, Green Submitted			2022-12-26	WOS:000359919900074
J	Rohde, RA; Muller, RA				Rohde, Robert A.; Muller, Richard A.			Air Pollution in China: Mapping of Concentrations and Sources	PLOS ONE			English	Article							PARTICULATE MATTER; GLOBAL BURDEN; NO X; MORTALITY; AEROSOL; EMISSIONS; EXPOSURE; DISEASE	China has recently made available hourly air pollution data from over 1500 sites, including airborne particulate matter (PM), SO2, NO2, and O-3. We apply Kriging interpolation to four months of data to derive pollution maps for eastern China. Consistent with prior findings, the greatest pollution occurs in the east, but significant levels are widespread across northern and central China and are not limited to major cities or geologic basins. Sources of pollution are widespread, but are particularly intense in a northeast corridor that extends from near Shanghai to north of Beijing. During our analysis period, 92% of the population of China experienced > 120 hours of unhealthy air (US EPA standard), and 38% experienced average concentrations that were unhealthy. China's population-weighted average exposure to PM2.5 was 52 mu g/m(3). The observed air pollution is calculated to contribute to 1.6 million deaths/year in China [0.7-2.2 million deaths/year at 95% confidence], roughly 17% of all deaths in China.	[Rohde, Robert A.; Muller, Richard A.] Berkeley Earth, Berkeley, CA 94720 USA; [Muller, Richard A.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Rohde, RA (corresponding author), Berkeley Earth, Berkeley, CA 94720 USA.	robert@berkeleyearth.org; rich@berkeleyearth.org			Berkeley Earth	Berkeley Earth	The authors received support from Berkeley Earth, a 501c3 non-profit, whose website is http://www.berkeleyearth.org. There was no directed funding for this project, and no funders were involved in the design, execution, or reporting of this study.	Battelle Memorial Institute Center for International Earth Science Information Network-CIESIN-Columbia University, 2013, GLOB ANN AV PM2 5 GR, DOI [10.7927/H4H41PB4, DOI 10.7927/H4H41PB4]; Beelen R, 2014, LANCET, V383, P785, DOI 10.1016/S0140-6736(13)62158-3; Boys BL, 2014, ENVIRON SCI TECHNOL, V48, P11109, DOI 10.1021/es502113p; Burnett RT, 2014, ENVIRON HEALTH PERSP, V122, P397, DOI 10.1289/ehp.1307049; Cai H, 2012, ANLESD122; Chen YY, 2013, P NATL ACAD SCI USA, V110, P12936, DOI 10.1073/pnas.1300018110; Davidson CI, 2005, AEROSOL SCI TECH, V39, P737, DOI 10.1080/02786820500191348; de Sherbinin A, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/8/084013; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Environmental Protection Agency, 2014, AIR QUAL IND GUID AI; Government of China, 2012, 30952012 GB GOV CHIN; Hoek G, 2012, ENV HLTH, V12, P43; Huffman G J, 2011, REAL TIME TRMM MULTI; Huffman GJ, 2007, J HYDROMETEOROL, V8, P38, DOI 10.1175/JHM560.1; Krige D.G, 1951, J S AFR I MIN METALL, V52, P201, DOI DOI 10.2307/3006914; Lei Y, 2011, ATMOS CHEM PHYS, V11, P931, DOI 10.5194/acp-11-931-2011; Liu XH, 2010, ATMOS ENVIRON, V44, P2415, DOI 10.1016/j.atmosenv.2010.03.035; Lu Z, 2011, ATMOS CHEM PHYS, V11, P9839, DOI 10.5194/acp-11-9839-2011; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; NOAA/NCEP, 2012, GLOB FOR SYST GFS AT; O'Keefe B., 2013, HEI ANN C 2012; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Rohde R., 2013, GEOINF GEOSTAL OVERV, V1, P1, DOI [10.4172/2327-4581.1000103, DOI 10.4172/2327-4581.1000103]; Schabenberger O., 2004, STAT METHODS SPATIAL; Shi Y, 2014, J ZHEJIANG UNIV-SC A, V15, P454, DOI 10.1631/jzus.A1300379; Song WZ, 2014, REMOTE SENS ENVIRON, V154, P1, DOI 10.1016/j.rse.2014.08.008; US Energy Information Agency, 1998, DOEEIA056098; van Donkelaar A, 2015, ENV HLTH PERSPECT, DOI [10.1289/ehp.1408646, DOI 10.1289/EHP.1408646]; Wang J, 2010, REMOTE SENS ENVIRON, V114, P2575, DOI 10.1016/j.rse.2010.05.034; World Health Organization, 2012, BURD DIS JOINT EFF H; World Health Organization (WHO), 2014, WHOHISHSIGHE20147; Yang A, 2012, GLOBAL COAL RISK ASS; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1; Zhang Q, 2012, CHINESE SCI BULL, V57, P2857, DOI 10.1007/s11434-012-5015-4; Zhang WJ, 2006, BIOMED ENVIRON SCI, V19, P461	35	470	485	28	339	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135749	10.1371/journal.pone.0135749	http://dx.doi.org/10.1371/journal.pone.0135749			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291610	Green Submitted, gold, Green Published			2022-12-26	WOS:000359919900029
J	Yazaki, K; Kuroda, K; Nakano, T; Kitao, M; Tobita, H; Ogasa, MY; Ishida, A				Yazaki, Kenichi; Kuroda, Katsushi; Nakano, Takashi; Kitao, Mitsutoshi; Tobita, Hiroyuki; Ogasa, Mayumi Y.; Ishida, Atsushi			Recovery of Physiological Traits in Saplings of Invasive Bischofia Tree Compared with Three Species Native to the Bonin Islands under Successive Drought and Irrigation Cycles	PLOS ONE			English	Article							CRYOSCANNING ELECTRON-MICROSCOPY; WOOD DENSITY; HYDRAULIC EFFICIENCY; ECOLOGICAL SIGNIFICANCE; XYLEM CAVITATION; WATER TRANSPORT; EMBOLISM REPAIR; LEAF; SAFETY; FOREST	Partial leaf shedding induced by hydraulic failure under prolonged drought can prevent excess water consumption, resulting in delayed recovery of carbon productivity following rainfall. To understand the manner of water use of invasive species in oceanic island forests under a fluctuating water regime, leaf shedding, multiple physiological traits, and the progress of embolism in the stem xylem under repeated drought-irrigation cycles were examined in the potted saplings of an invasive species, Bischofia javanica Blume, and three endemic native species, Schima mertensiana (Sieb. Et Zucc,) Koitz., Hibiscus glaber Matsum, and Distylium lepidotum Nakai, from the Bonin Islands, Japan. The progress of xylem embolism was observed by cryo-scanning electron microscopy. The samples exhibited different processes of water saving and drought tolerance based on the different combinations of partial leaf shedding involved in embolized conduits following repeated de-rehydration. Predawn leaf water potential largely decreased with each successive drought-irrigation cycle for all tree species, except for B. javanica. B. javanica shed leaves conspicuously under drought and showed responsive stomatal conductance to VPD, which contributed to recover leaf gas exchange in the remaining leaves, following a restored water supply. In contrast, native tree species did not completely recover photosynthetic rates during the repeated drought-irrigation cycles. H. glaber and D. lepidotum preserved water in vessels and adjusted leaf osmotic rates but did not actively shed leaves. S. mertensiana exhibited partial leaf shedding during the first cycle with an osmotic adjustment, but they showed less responsive stomatal conductance to VPD. Our data indicate that invasive B. javanica saplings can effectively use water supplied suddenly under drought conditions. We predict that fluctuating precipitation in the future may change tree distributions even in mesic or moist sites in the Bonin Islands.	[Yazaki, Kenichi; Kitao, Mitsutoshi; Tobita, Hiroyuki; Ogasa, Mayumi Y.] FFPRI, Dept Plant Ecol, Tsukuba, Ibaraki 3058687, Japan; [Kuroda, Katsushi] FFPRI, Dept Wood Properties, Tsukuba, Ibaraki 3058687, Japan; [Nakano, Takashi] Mt Fuji Res Inst, Div Nat Environm Sci, Fujiyoshida, Yamanashi 4030005, Japan; [Ishida, Atsushi] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan	Forestry & Forest Products Research Institute - Japan; Forestry & Forest Products Research Institute - Japan; Kyoto University	Yazaki, K (corresponding author), FFPRI, Dept Plant Ecol, Tsukuba, Ibaraki 3058687, Japan.	kyazaki@ffpri.affrc.go.jp		Y. Ogasa, Mayumi/0000-0002-3814-4937; Ishida, Atsushi/0000-0003-0620-5819	Japan's Ministry of Education, Culture, Sports, Science and Technology [19780129, 23780190, 14360091, 24370009, 26660125]	Japan's Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Grants-in-Aid (19780129, 23780190 to KY, 14360091, 24370009, 26660125 to AT) from Japan's Ministry of Education, Culture, Sports, Science and Technology (http://www.jsps.go.jp/english/e-grants/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackman CJ, 2009, PLANT CELL ENVIRON, V32, P1584, DOI 10.1111/j.1365-3040.2009.02023.x; Brodersen CR, 2010, PLANT PHYSIOL, V154, P1088, DOI 10.1104/pp.110.162396; Bucci SJ, 2004, TREE PHYSIOL, V24, P891, DOI 10.1093/treephys/24.8.891; Charra-Vaskou K, 2012, TREE PHYSIOL, V32, P1161, DOI 10.1093/treephys/tps071; Chesson P, 2004, OECOLOGIA, V141, P236, DOI 10.1007/s00442-004-1551-1; Cochard H, 2000, PLANT PHYSIOL, V124, P1191, DOI 10.1104/pp.124.3.1191; Cochard H, 2013, ANN FOREST SCI, V70, P659, DOI 10.1007/s13595-013-0317-5; Delzon S, 2014, NEW PHYTOL, V203, P355, DOI 10.1111/nph.12798; Engelbrecht BMJ, 2005, TREES-STRUCT FUNCT, V19, P312, DOI 10.1007/s00468-004-0393-0; Field C.B., 2012, MANAGING RISKS EXTRE; Fukuda K, 2007, TREE PHYSIOL, V27, P969, DOI 10.1093/treephys/27.7.969; Hacke UG, 2003, PLANT CELL ENVIRON, V26, P303, DOI 10.1046/j.1365-3040.2003.00962.x; Hacke UG, 2001, PERSPECT PLANT ECOL, V4, P97, DOI 10.1078/1433-8319-00017; Hacke UG, 2006, TREE PHYSIOL, V26, P689, DOI 10.1093/treephys/26.6.689; Holbrook NM, 1999, PLANT PHYSIOL, V120, P7, DOI 10.1104/pp.120.1.7; Hukin D, 2005, J EXP BOT, V56, P2003, DOI 10.1093/jxb/eri198; Ishida A, 2009, OGASAWARA RES, V34, P1; Ishida A, 2008, OECOLOGIA, V156, P193, DOI 10.1007/s00442-008-0965-6; Ishida A, 2010, TREE PHYSIOL, V30, P935, DOI 10.1093/treephys/tpq025; Johnson DM, 2012, PLANT SCI, V195, P48, DOI 10.1016/j.plantsci.2012.06.010; Maherali H, 2004, ECOLOGY, V85, P2184, DOI 10.1890/02-0538; Markesteijn L, 2011, PLANT CELL ENVIRON, V34, P137, DOI 10.1111/j.1365-3040.2010.02231.x; Martinez-Cabrera HI, 2009, AM J BOT, V96, P1388, DOI 10.3732/ajb.0800237; Mayr S, 2014, PLANT PHYSIOL, V164, P1731, DOI 10.1104/pp.114.236646; McCulloh KA, 2011, OECOLOGIA, V167, P27, DOI 10.1007/s00442-011-1973-5; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; McDowell NG, 2013, NEW PHYTOL, V200, P304, DOI 10.1111/nph.12465; Meinzer FC, 2008, TREE PHYSIOL, V28, P1609, DOI 10.1093/treephys/28.11.1609; Meinzer FC, 2013, TREE PHYSIOL, V33, P331, DOI 10.1093/treephys/tpt022; Mencuccini M, 2003, PLANT CELL ENVIRON, V26, P163, DOI 10.1046/j.1365-3040.2003.00991.x; Mishio M., 1992, FUNCTIONAL PLANT BIO, V19, P539; Nardini A, 2011, PLANT SCI, V180, P604, DOI 10.1016/j.plantsci.2010.12.011; Oren R, 1999, PLANT CELL ENVIRON, V22, P1515, DOI 10.1046/j.1365-3040.1999.00513.x; Osone Y, 2014, J PLANT RES, V127, P315, DOI 10.1007/s10265-013-0609-8; Pittermann J, 2006, PLANT CELL ENVIRON, V29, P1618, DOI 10.1111/j.1365-3040.2006.01539.x; Pittermann J, 2010, PLANT PHYSIOL, V153, P1919, DOI 10.1104/pp.110.158824; Preston KA, 2006, NEW PHYTOL, V170, P807, DOI 10.1111/j.1469-8137.2006.01712.x; Santiago LS, 2004, OECOLOGIA, V140, P543, DOI 10.1007/s00442-004-1624-1; SHIMIZU Y, 1991, Pacific Science, V45, P28; SOBRADO MA, 1993, OECOLOGIA, V96, P19, DOI 10.1007/BF00318025; Torres-Ruiz JM, 2015, PLANT PHYSIOL, V167, P40, DOI 10.1104/pp.114.249706; TYREE MT, 1993, PLANT CELL ENVIRON, V16, P879, DOI 10.1111/j.1365-3040.1993.tb00511.x; Tyree MT, 1999, PLANT PHYSIOL, V120, P11, DOI 10.1104/pp.120.1.11; Utsumi Y, 1998, PLANT PHYSIOL, V117, P1463, DOI 10.1104/pp.117.4.1463; Wheeler JK, 2013, PLANT CELL ENVIRON, V36, P1938, DOI 10.1111/pce.12139; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Yamashita N, 2000, OECOLOGIA, V125, P412, DOI 10.1007/s004420000475; Yamashita N, 2002, ANN BOT-LONDON, V90, P599, DOI 10.1093/aob/mcf231; Yamashita N, 2002, PLANT CELL ENVIRON, V25, P1341, DOI 10.1046/j.1365-3040.2002.00907.x; Yazaki K, 2010, TREE PHYSIOL, V30, P597, DOI 10.1093/treephys/tpq010; Zanne AE, 2006, FUNCT ECOL, V20, P200, DOI 10.1111/j.1365-2435.2006.01101.x	52	16	16	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135117	10.1371/journal.pone.0135117	http://dx.doi.org/10.1371/journal.pone.0135117			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291326	Green Published, Green Submitted, gold			2022-12-26	WOS:000359919900015
J	Bracis, C; Gurarie, E; Van Moorter, B; Goodwin, RA				Bracis, Chloe; Gurarie, Eliezer; Van Moorter, Bram; Goodwin, R. Andrew			Memory Effects on Movement Behavior in Animal Foraging	PLOS ONE			English	Article							SPATIAL MEMORY; HOME RANGES; MODELS; SEAGRASS; MECHANISMS; SELECTION; HABITATS; ECOLOGY; MAP	An individual's choices are shaped by its experience, a fundamental property of behavior important to understanding complex processes. Learning and memory are observed across many taxa and can drive behaviors, including foraging behavior. To explore the conditions under which memory provides an advantage, we present a continuous-space, continuous-time model of animal movement that incorporates learning and memory. Using simulation models, we evaluate the benefit memory provides across several types of landscapes with variable-quality resources and compare the memory model within a nested hierarchy of simpler models (behavioral switching and random walk). We find that memory almost always leads to improved foraging success, but that this effect is most marked in landscapes containing sparse, contiguous patches of high-value resources that regenerate relatively fast and are located in an otherwise devoid landscape. In these cases, there is a large payoff for finding a resource patch, due to size, value, or locational difficulty. While memory-informed search is difficult to differentiate from other factors using solely movement data, our results suggest that disproportionate spatial use of higher value areas, higher consumption rates, and consumption variability all point to memory influencing the movement direction of animals in certain ecosystems.	[Bracis, Chloe] Univ Washington, Quantitat Ecol & Resource Management, Seattle, WA 98195 USA; [Bracis, Chloe] Senckenberg Gesell Nat Forsch, Senckenberg Biodivers & Climate Res Ctr BiK F, Frankfurt, Main, Germany; [Bracis, Chloe] Goethe Univ Frankfurt, D-60054 Frankfurt, Main, Germany; [Gurarie, Eliezer] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Van Moorter, Bram] Norwegian Univ Sci & Technol, Ctr Conservat Biol, N-7034 Trondheim, Norway; [Van Moorter, Bram] Norwegian Inst Nat Res NINA, Trondheim, Norway; [Goodwin, R. Andrew] US Army Engineer Res & Dev Ctr, Environm Lab, Portland, OR USA	University of Washington; University of Washington Seattle; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Goethe University Frankfurt; University System of Maryland; University of Maryland College Park; Norwegian University of Science & Technology (NTNU); Norwegian Institute Nature Research; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC)	Bracis, C (corresponding author), Univ Washington, Quantitat Ecol & Resource Management, Seattle, WA 98195 USA.	cbracis@uw.edu	Gurarie, Eliezer/AGI-0958-2022; Goodwin, R. Andrew/ABG-5799-2020	Gurarie, Eliezer/0000-0002-8666-9674; Goodwin, R. Andrew/0000-0002-6846-0287; Van Moorter, Bram/0000-0002-3196-1993	U.S. Army Engineer Research and Development Center (ERDC); Cold Regions Research and Engineering Laboratory; AT24 Program; Geospatial Research and Engineering Program; ERDC BAA; ERDC Construction Engineering Research Laboratory; National Science Foundation [ABI-1062411]; Norwegian Research Council	U.S. Army Engineer Research and Development Center (ERDC)(United States Department of DefenseUnited States Army); Cold Regions Research and Engineering Laboratory; AT24 Program; Geospatial Research and Engineering Program; ERDC BAA; ERDC Construction Engineering Research Laboratory; National Science Foundation(National Science Foundation (NSF)); Norwegian Research Council(Research Council of NorwayEuropean Commission)	Research was conducted under sponsorship of the U.S. Army Engineer Research and Development Center (ERDC, http://www.erdc.usace.army.mil), Cold Regions Research and Engineering Laboratory, AT24 and Geospatial Research and Engineering Programs (Bert Davis, Randy Hill). C.B. was partially funded through an ERDC BAA awarded to James Anderson, University of Washington. R.G. was partially funded through the ERDC Construction Engineering Research Laboratory, Military Ranges and Lands Program (Alan Anderson). E.G. was partially funded by National Science Foundation (http://www.nsf.gov) grant ABI-1062411. B.M. was funded by Norwegian Research Council's (http://www.forskningsradet.no) PredClim grant to B.-E. Saether. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson James J., 2002, Natural Resource Modeling, V15, P55; Anderson JJ, 2010, P 32 ANN C COGN SCI; Aragones LV, 2006, OECOLOGIA, V149, P635, DOI 10.1007/s00442-006-0477-1; Avgar T, 2015, J ANIM ECOL, V84, P1059, DOI 10.1111/1365-2656.12357; Avgar T, 2013, ECOL MODEL, V251, P158, DOI 10.1016/j.ecolmodel.2012.12.002; Bailey DW, 1996, J RANGE MANAGE, V49, P386, DOI 10.2307/4002919; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett DA, 2006, INT J GEOGR INF SCI, V20, P1039, DOI 10.1080/13658810600830806; Boyer D, 2012, J R SOC INTERFACE, V9, P842, DOI 10.1098/rsif.2011.0582; Boyer D, 2010, PHILOS T R SOC A, V368, P5645, DOI 10.1098/rsta.2010.0275; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Butcher J.C., 2008, NUMERICAL METHODS OR, DOI DOI 10.1002/9780470753767; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Codling EA, 2005, J THEOR BIOL, V233, P573, DOI 10.1016/j.jtbi.2004.11.008; COURANT R, 1967, IBM J RES DEV, V11, P215, DOI 10.1147/rd.112.0215; Cruse H, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002009; Eliassen S, 2009, AM NAT, V174, P478, DOI 10.1086/605370; Esposito S, 2010, ECOL MODEL, V221, P1283, DOI 10.1016/j.ecolmodel.2010.01.009; Fagan WF, 2013, ECOL LETT, V16, P1316, DOI 10.1111/ele.12165; Gautestad AO, 2011, J THEOR BIOL, V287, P26, DOI 10.1016/j.jtbi.2011.07.010; Gautestad AO, 2010, ECOL MODEL, V221, P2741, DOI 10.1016/j.ecolmodel.2010.08.014; Gil M, 2009, J EXP BIOL, V212, P2830, DOI 10.1242/jeb.032623; Goodwin RA, 2014, P NATL ACAD SCI USA, V111, P5277, DOI 10.1073/pnas.1311874111; GORDON IJ, 1989, OECOLOGIA, V79, P383, DOI 10.1007/BF00384318; Grove M, 2013, MATH BIOSCI, V242, P25, DOI 10.1016/j.mbs.2012.11.011; Gurarie E, 2013, THEOR ECOL-NETH, V6, P189, DOI 10.1007/s12080-012-0170-4; Gurarie E, 2011, AM NAT, V178, P113, DOI 10.1086/660285; Hollander M., 2014, NONPARAMETRIC STAT M, V3rd ed.; Hothorn T, 2006, AM STAT, V60, P257, DOI 10.1198/000313006X118430; Hothorn T, 2008, J STAT SOFTW, V28, P1; Humston R, 2004, T AM FISH SOC, V133, P1304, DOI 10.1577/T03-040.1; Johnson DS, 2008, BIOMETRICS, V64, P968, DOI 10.1111/j.1541-0420.2007.00943.x; Kacelnik A., 1987, Quantitative Analyses of Behavior, V6, P63; KAMIL AC, 1985, ANNU REV PSYCHOL, V36, P141, DOI 10.1146/annurev.ps.36.020185.001041; Kolling N, 2012, SCIENCE, V336, P95, DOI 10.1126/science.1216930; Lima SL, 2002, TRENDS ECOL EVOL, V17, P70, DOI 10.1016/S0169-5347(01)02393-X; McClintock BT, 2014, MOV ECOL, V2, DOI 10.1186/s40462-014-0021-6; McNamara JM, 2013, SCIENCE, V340, P1084, DOI 10.1126/science.1230599; Menzel R, 2005, P NATL ACAD SCI USA, V102, P3040, DOI 10.1073/pnas.0408550102; Morales JM, 2004, ECOLOGY, V85, P2436, DOI 10.1890/03-0269; Morales JM, 2010, PHILOS T R SOC B, V365, P2289, DOI 10.1098/rstb.2010.0082; Mueller T, 2008, J APPL ECOL, V45, P649, DOI 10.1111/j.1365-2664.2007.01371.x; Mueller T, 2011, THEOR ECOL-NETH, V4, P341, DOI 10.1007/s12080-010-0081-1; Nabe-Nielsen J, 2013, OIKOS, V122, P1307, DOI 10.1111/j.1600-0706.2013.00069.x; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Olson KA, 2010, J ARID ENVIRON, V74, P1435, DOI 10.1016/j.jaridenv.2010.05.022; Oom SP, 2004, ECOL COMPLEX, V1, P299, DOI 10.1016/j.ecocom.2004.06.003; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Poldrack RA, 2003, NEUROPSYCHOLOGIA, V41, P245, DOI 10.1016/S0028-3932(02)00157-4; PREEN A, 1995, MAR ECOL PROG SER, V124, P201, DOI 10.3354/meps124201; PREEN A, 1995, WILDLIFE RES, V22, P507, DOI 10.1071/WR9950507; R Core Team, 2021, R LANGUAGE ENV STAT; REESE ES, 1989, ENVIRON BIOL FISH, V25, P79, DOI 10.1007/BF00002202; Regular PM, 2013, ANIM BEHAV, V86, P545, DOI 10.1016/j.anbehav.2013.06.008; Schlather M, 2014, R PACKAGE VERSION 3; Sheppard JK, 2007, ESTUAR COAST SHELF S, V71, P117, DOI 10.1016/j.ecss.2006.07.006; Shettleworth SJ, 2001, ANIM BEHAV, V61, P277, DOI 10.1006/anbe.2000.1606; Smouse PE, 2010, PHILOS T R SOC B, V365, P2201, DOI 10.1098/rstb.2010.0078; Spencer WD, 2012, J MAMMAL, V93, P929, DOI 10.1644/12-MAMM-S-061.1; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; Turchin Peter, 1998; TURNER MG, 1993, ECOL MODEL, V69, P163, DOI 10.1016/0304-3800(93)90026-O; Van Moorter B, 2013, ECOGRAPHY, V36, P323, DOI 10.1111/j.1600-0587.2012.07291.x; Van Moorter B, 2009, OIKOS, V118, P641, DOI 10.1111/j.1600-0706.2008.17003.x; Vincenot CE, 2015, ECOL COMPLEX, V22, P139, DOI 10.1016/j.ecocom.2015.03.004; Watkins KS, 2013, ECOL MODEL, V250, P214, DOI 10.1016/j.ecolmodel.2012.11.011	67	53	53	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136057	10.1371/journal.pone.0136057	http://dx.doi.org/10.1371/journal.pone.0136057			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288228	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000360018600102
J	Kornblatt, JA; Quiros, V; Kornblatt, MJ				Kornblatt, Jack A.; Quiros, Veronica; Kornblatt, M. Judith			The Energetics of Streptococcal Enolase Octamer Formation: The Quantitative Contributions of the Last Eight Amino Acids at the Carboxy-Terminus	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; SIZE-DISTRIBUTION ANALYSIS; GROUP-A STREPTOCOCCI; CRYSTAL-STRUCTURE; YEAST ENOLASE; ANALYTICAL ULTRACENTRIFUGATION; PLASMINOGEN-BINDING; AQUEOUS-SOLUTION; SURFACE ENOLASE; DIMERIC ENZYME	The enolase produced by Streptococcus pyogenes is a homo-octamer whose overall shape resembles that of a donut. The octamer is best described as a tetramer of dimers. As such, it contains two types of interfaces. The first is common to almost all enolases as most enolases that have been studied are dimers. The second is unique to the octamers and includes residues near the carboxy-terminus. The primary sequence of the enolase contains 435 residues with an added 19 as an N-terminal hexahistine tag. We have systematically truncated the carboxy-terminus, individually removing the first 8 residues. This gave rise to a series of eight structures containing respectively, 435, 434, 433, 432, 431, 430, 429 and 427 residues. The truncations cause the protein to gradually dissociate from octamers to enzymatically inactive monomers with very small amounts of intermediate tetramers and dimers. We have evaluated the contributions of the missing residues to the monomer/octamer equilibrium using a combination of analytical ultracentrifugation and activity assays. For the dissociation reaction, octramer double left arrow double right arrow 8 monomer truncation of all eight C-terminal residues resulted in a diminution in the standard Gibbs energy of dissociation of about 59 kJ/mole of octamer relative to the full length protein. Considering that this change is spread over eight subunits, this translates to a change in standard Gibbs interaction energy of less than 8 kJ/mole of monomer distributed over the eight monomers. The resulting proteins, containing 434, 433, 432, 431, 430, 429 and 427 residues per monomer, showed intermediate free energies of dissociation. Finally, three other mutations were introduced into our reference protein to establish how they influenced the equilibrium. The main importance of this work is it shows that for homo-multimeric proteins a small change in the standard Gibbs interaction energy between subunits can have major physiological effects.	[Kornblatt, Jack A.] Concordia Univ, Dept Biol, Ctr Struct & Funct Genom, Montreal, PQ H3G 1M8, Canada; [Quiros, Veronica] Concordia Univ, Dept Biol, Montreal, PQ H3G 1M8, Canada; [Kornblatt, M. Judith] Concordia Univ, Dept Chem & Biochem, Montreal, PQ H3G 1M8, Canada	Concordia University - Canada; Concordia University - Canada; Concordia University - Canada	Kornblatt, JA (corresponding author), Concordia Univ, Dept Biol, Ctr Struct & Funct Genom, 1455 De Maisonneuve Blvd W, Montreal, PQ H3G 1M8, Canada.	jack.kornblatt@concordia.ca		kornblatt, jack/0000-0002-9802-8321	Natural Sciences and Engineering Research Council (Canada) [9988]	Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding: Funding was provided by Natural Sciences and Engineering Research Council (Canada) Grant Number 9988 jak, http://www.nserc-crsng.gc.ca/.	Attali C, 2008, INFECT IMMUN, V76, P5350, DOI 10.1128/IAI.00184-08; Bergmann S, 2013, INT J MED MICROBIOL, V303, P452, DOI 10.1016/j.ijmm.2013.06.002; Chaussee MA, 2008, ARCH MICROBIOL, V189, P27, DOI 10.1007/s00203-007-0290-1; Cork AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121764; Cork AJ, 2009, J BIOL CHEM, V284, P17129, DOI 10.1074/jbc.M109.004317; Dall'Acqua W, 1998, BIOCHEMISTRY-US, V37, P7981, DOI 10.1021/bi980148j; Derbise A, 2004, INFECT IMMUN, V72, P94, DOI 10.1128/IAI.72.1.94-105.2004; Ehinger S, 2004, J MOL BIOL, V343, P997, DOI 10.1016/j.jmb.2004.08.088; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Gerstein M, 1996, P NATL ACAD SCI USA, V93, P10167, DOI 10.1073/pnas.93.19.10167; Gerstein M, 1999, SCIENCE, V285, P1682, DOI 10.1126/science.285.5434.1682; GUTTE B, 1971, J BIOL CHEM, V246, P1922; HARPAZ Y, 1994, STRUCTURE, V2, P641, DOI 10.1016/S0969-2126(00)00065-4; HAYASHI R, 1973, J BIOL CHEM, V248, P3889; HEATH WF, 1986, P NATL ACAD SCI USA, V83, P6367, DOI 10.1073/pnas.83.17.6367; HODGES RS, 1975, J BIOL CHEM, V250, P1231; Karbassi F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008810; KORNBLATT J, 1982, EUR J BIOCHEM, V128, P577; Kornblatt JA, 2005, BIOCHEMISTRY-US, V44, P13122, DOI 10.1021/bi050895y; Kornblatt MJ, 2004, EUR J BIOCHEM, V271, P3897, DOI 10.1111/j.1432-1033.2004.04326.x; KORNBLATT MJ, 1987, ARCH BIOCHEM BIOPHYS, V252, P277, DOI 10.1016/0003-9861(87)90032-4; Kornblatt MJ, 1996, EUR J BIOCHEM, V236, P78, DOI 10.1111/j.1432-1033.1996.00078.x; Kornblatt MJ, 1998, EUR J BIOCHEM, V251, P775, DOI 10.1046/j.1432-1327.1998.2510775.x; KORNBLATT MJ, 1993, ARCH BIOCHEM BIOPHYS, V306, P495, DOI 10.1006/abbi.1993.1542; LIN MC, 1972, J BIOL CHEM, V247, P4768; Lottenberg Richard, 1994, Trends in Microbiology, V2, P20, DOI 10.1016/0966-842X(94)90340-9; Martin TW, 1999, NAT STRUCT BIOL, V6, P403, DOI 10.1038/8195; OTTING G, 1991, SCIENCE, V254, P974, DOI 10.1126/science.1948083; PALADINI AA, 1981, BIOCHEMISTRY-US, V20, P2587, DOI 10.1021/bi00512a034; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; PANCHOLI V, 1992, J EXP MED, V176, P415, DOI 10.1084/jem.176.2.415; Perica T, 2014, SCIENCE, V346, DOI 10.1126/science.1254346; Perica T, 2012, P NATL ACAD SCI USA, V109, P8127, DOI 10.1073/pnas.1120028109; POULOS TL, 1987, J MOL BIOL, V195, P687, DOI 10.1016/0022-2836(87)90190-2; POULOS TL, 1986, BIOCHEMISTRY-US, V25, P5314, DOI 10.1021/bi00366a049; PRIVALOV PL, 1974, J MOL BIOL, V86, P665, DOI 10.1016/0022-2836(74)90188-0; Roche J, 2013, J AM CHEM SOC, V135, P14610, DOI 10.1021/ja406682e; Schottel BL, 2008, CHEM SOC REV, V37, P68, DOI 10.1039/b614208g; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schwartz ML, 2009, J CELL BIOL, V185, P535, DOI 10.1083/jcb.200811082; Sims PA, 2005, J MOL CATAL B-ENZYM, V32, P77, DOI 10.1016/j.molcatb.2004.10.002; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; TIMASHEFF SN, 1992, BIOCHEMISTRY-US, V31, P9857, DOI 10.1021/bi00156a001; Tsatsaronis JA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004266; UNSON CG, 1995, J BIOL CHEM, V270, P27720, DOI 10.1074/jbc.270.46.27720; van Holde K.E., 1998, PRINCIPLES PHYS BIOC, Vsecond; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; WUTHRICH K, 1992, FARADAY DISCUSS, V93, P35, DOI 10.1039/fd9929300035; Zhao SP, 2008, FEBS J, V275, P97, DOI 10.1111/j.1742-4658.2007.06177.x	50	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135754	10.1371/journal.pone.0135754	http://dx.doi.org/10.1371/journal.pone.0135754			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287818	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000360018600066
J	Navanesan, S; Wahab, NA; Manickam, S; Sim, KS				Navanesan, Suerialoasan; Wahab, Norhanom Abdul; Manickam, Sugumaran; Sim, Kae Shin			Leptospermum flavescens Constituent-LF1 Causes Cell Death through the Induction of Cell Cycle Arrest and Apoptosis in Human Lung Carcinoma Cells	PLOS ONE			English	Article							ANTITUMOR-ACTIVITY; CANCER; PROLIFERATION; CASPASE-3; SMOKING; ASSAY	Leptospermum flavescens Sm. (Myrtaceae), locally known as 'Senna makki' is a smallish tree that is widespread and recorded to naturally occur in the montane regions above 900 m a.s.l from Burma to Australia. Although the species is recorded to be used traditionally to treat various ailments, there is limited data on biological and chemical investigations of L. flavescens. The aim of the present study was to investigate and understand the ability of L. flavescens in inducing cell death in lung cancer cells. The cytotoxic potentials of the extraction yields (methanol, hexane, ethyl acetate and water extracts as wells as a semi pure fraction, LF1) were evaluated against two human non-small cell lung carcinoma cell lines (A549 and NCI-H1299) using the MTT assay. LF1 showed the greatest cytotoxic effect against both cell lines with IC50 values of 7.12 +/- 0.07 and 9.62 +/- 0.50 mu g/ml respectively. LF1 treated cells showed a sub-G1 region in the cell cycle analysis and also caused the presence of apoptotic morphologies in cells stained with acridine orange and ethidium bromide. Treatment with LF1 manifested an apoptotic population in cells that were evaluated using the Annexin V/propidium iodide assay. Increasing dosage of LF1 caused a rise in the presence of activated caspase-3 enzymes in treated cells. Blockage of cell cycle progression was also observed in LF1-treated cells. These findings suggest that LF1 induces apoptosis and cell cycle arrest in treated lung cancer cells. Further studies are being conducted to isolate and identify the active compound as well to better understand the mechanism involved in inducing cell death.	[Navanesan, Suerialoasan; Sim, Kae Shin] Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur, Malaysia; [Wahab, Norhanom Abdul] Univ Malaya, Div Biol, Ctr Fdn Studies Sci, Kuala Lumpur, Malaysia; [Manickam, Sugumaran] Univ Malaya, Fac Sci, Inst Biol Sci, Rimba Ilmu Bot Garden, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Sim, KS (corresponding author), Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur, Malaysia.	simkaeshin@um.edu.my	SIM, KAE SHIN/B-9780-2010; NAVANESAN, SUERIALOASAN/AAK-5297-2020; Manickam, Sugumaran/B-5268-2010	Manickam, Sugumaran/0000-0003-3125-767X	University of Malaya [RG082-13BIO, FP006-2013A]	University of Malaya(Universiti Malaya)	This work was supported by research funding from University of Malaya Research Grant (UMRG), RG082-13BIO and Fundamental Research Grant Scheme (FRGS), FP006-2013A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARENDS MJ, 1990, AM J PATHOL, V136, P593; Ariffin SHZ, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-6; Bartucci M, 2012, CELL DEATH DIFFER, V19, P768, DOI 10.1038/cdd.2011.170; Baskic D, 2006, CELL BIOL INT, V30, P924, DOI 10.1016/j.cellbi.2006.06.016; Batugal PA, 2004, MED PLANTS RES ASIA, VI; Bi XL, 2014, EUR J PHARMACOL, V742, P145, DOI 10.1016/j.ejphar.2014.08.032; Catelinois O, 2006, ENVIRON HEALTH PERSP, V114, P1361, DOI 10.1289/ehp.9070; Collins LG, 2007, AM FAM PHYSICIAN, V75, P56; Cullen SP, 2009, CELL DEATH DIFFER, V16, P935, DOI 10.1038/cdd.2009.59; Dela Cruz CS, 2011, CLIN CHEST MED, V32, P605, DOI 10.1016/j.ccm.2011.09.001; Demuner AJ, 2011, MOLECULES, V16, P1181, DOI 10.3390/molecules16021181; FADOK VA, 1992, J IMMUNOL, V148, P2207; Gorlova OY, 2007, INT J CANCER, V121, P111, DOI 10.1002/ijc.22615; HIGGINS CF, 1994, CELL, V79, P393, DOI 10.1016/0092-8674(94)90248-8; Hseu YC, 2014, J ETHNOPHARMACOL, V153, P499, DOI 10.1016/j.jep.2014.03.012; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jeruc J, 2006, AM J KIDNEY DIS, V48, P410, DOI 10.1053/j.ajkd.2006.05.019; Kabir Z, 2007, Ir Med J, V100, P367; Kajstura M, 2007, CYTOM PART A, V71A, P125, DOI 10.1002/cyto.a.20357; Khazir J, 2013, J ASIAN NAT PROD RES, V15, P764, DOI 10.1080/10286020.2013.798314; King RJB, 2006, CANC BIOL; Li L, 2012, CANCER CELL INT, V12, DOI 10.1186/1475-2867-12-49; Mahavorasirikul W, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-55; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; PARKIN DM, 1994, INT J CANCER, V59, P494, DOI 10.1002/ijc.2910590411; Parrish Amanda B, 2013, Cold Spring Harb Perspect Biol, V5, DOI 10.1101/cshperspect.a008672; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Ribble D, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-12; Sachithanandan A, 2012, Med J Malaysia, V67, P3; Sancho-Martinez SM, 2011, TOXICOL SCI, V122, P73, DOI 10.1093/toxsci/kfr098; Song GB, 2006, COLLOID SURFACE B, V48, P1, DOI 10.1016/j.colsurfb.2005.12.012; Stark R, 1981, BOOK APHRODISIACS; VANDELOOSDRECHT AA, 1994, J IMMUNOL METHODS, V174, P311, DOI 10.1016/0022-1759(94)90034-5; Vermes I, 2000, J IMMUNOL METHODS, V243, P167, DOI 10.1016/S0022-1759(00)00233-7	34	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135995	10.1371/journal.pone.0135995	http://dx.doi.org/10.1371/journal.pone.0135995			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287817	gold, Green Published, Green Submitted			2022-12-26	WOS:000360018600096
J	Rubiano-Labrador, C; Bland, C; Miotello, G; Armengaud, J; Baena, S				Rubiano-Labrador, Carolina; Bland, Celine; Miotello, Guylaine; Armengaud, Jean; Baena, Sandra			Salt Stress Induced Changes in the Exoproteome of the Halotolerant Bacterium Tistlia consotensis Deciphered by Proteogenomics	PLOS ONE			English	Article							MODERATELY HALOPHILIC BACTERIUM; PROTEIN SECRETION; MASS-SPECTROMETRY; LIGAND-BINDING; PROTEOMICS; TOLERANCE; BIOSYNTHESIS; TRANSDUCTION; PEPTIDES; GENOMICS	The ability of bacteria to adapt to external osmotic changes is fundamental for their survival. Halotolerant microorganisms, such as Tistlia consotensis, have to cope with continuous fluctuations in the salinity of their natural environments which require effective adaptation strategies against salt stress. Changes of extracellular protein profiles from Tistlia consotensis in conditions of low and high salinities were monitored by proteogenomics using a bacterial draft genome. At low salinity, we detected greater amounts of the HpnM protein which is involved in the biosynthesis of hopanoids. This may represent a novel, and previously unreported, strategy by halotolerant microorganisms to prevent the entry of water into the cell under conditions of low salinity. At high salinity, proteins associated with osmosensing, exclusion of Na+ and transport of compatible solutes, such as glycine betaine or proline are abundant. We also found that, probably in response to the high salt concentration, T. consotensis activated the synthesis of flagella and triggered a chemotactic response neither of which were observed at the salt concentration which is optimal for growth. Our study demonstrates that the exoproteome is an appropriate indicator of adaptive response of T. consotensis to changes in salinity because it allowed the identification of key proteins within its osmoadaptive mechanism that had not previously been detected in its cell proteome.	[Rubiano-Labrador, Carolina; Baena, Sandra] Pontificia Univ Javeriana, Dept Biol, Unidad Saneamiento Biotecnol Ambiental, Bogota, DC, Colombia; [Rubiano-Labrador, Carolina; Baena, Sandra] GeBiX, Colombian Ctr Genom & Bioinformat Extreme Environ, Bogota, DC, Colombia; [Bland, Celine; Miotello, Guylaine; Armengaud, Jean] CEA, DSV, IBEB, SBTN,Lab Biochim Syst Perturb, F-30207 Bagnols Sur Ceze, France	Pontificia Universidad Javeriana; CEA	Baena, S (corresponding author), Pontificia Univ Javeriana, Dept Biol, Unidad Saneamiento Biotecnol Ambiental, POB 56710, Bogota, DC, Colombia.	baena@javeriana.edu.co	Baena, Sandra/AAF-8165-2019	ARMENGAUD, Jean/0000-0003-1589-445X; Rubiano Labrador, Carolina/0000-0001-9064-3680; Baena, Sandra/0000-0001-5377-9079; Miotello, Guylaine/0000-0002-2398-1249	Commissariat al'Energie Atomique et aux Energies Alternatives (C. E.A. Lab Biochim SystemPerturb, France); Pontificia Universidad Javeriana (Colombia); Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS, Colombia); Colombian Center for Genomics and Bioinformatics of Extreme Environments (GeBiX, Colombia); ECOS-NORD bilateralprogram; MAVDT [56]	Commissariat al'Energie Atomique et aux Energies Alternatives (C. E.A. Lab Biochim SystemPerturb, France); Pontificia Universidad Javeriana (Colombia); Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS, Colombia)(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Colombian Center for Genomics and Bioinformatics of Extreme Environments (GeBiX, Colombia); ECOS-NORD bilateralprogram; MAVDT	The authors thank the Commissariat al'Energie Atomique et aux Energies Alternatives (C. E.A. Lab Biochim SystemPerturb, France), Pontificia Universidad Javeriana (Colombia), Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS, Colombia), Colombian Center for Genomics and Bioinformatics of Extreme Environments (GeBiX, Colombia), and the ECOS-NORD bilateralprogram for financial support. This work was carried out under MAVDT Research Permit Resolution No. 0168, 2009 and MAVDT Contract No. 56, 2013 for Access to Genetic Resources.	Armengaud J, 2013, ENVIRON MICROBIOL, V15, P12, DOI 10.1111/j.1462-2920.2012.02811.x; Armengaud J, 2012, EXPERT REV PROTEOMIC, V9, P561, DOI [10.1586/epr.12.52, 10.1586/EPR.12.52]; Ashby MK, 2004, FEMS MICROBIOL LETT, V231, P277, DOI 10.1016/S0378-1097(04)00004-7; Averhoff B, 2010, RES MICROBIOL, V161, P506, DOI 10.1016/j.resmic.2010.05.006; Bagos PG, 2008, J PROTEOME RES, V7, P5082, DOI 10.1021/pr800162c; Bendtsen JD, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-58; BERRY AM, 1993, P NATL ACAD SCI USA, V90, P6091, DOI 10.1073/pnas.90.13.6091; Breed J, 2001, ACTA CRYSTALLOGR D, V57, P448, DOI 10.1107/S0907444901000397; Carvalho PC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-316; Christie-Oleza JA, 2012, ISME J, V6, P124, DOI 10.1038/ismej.2011.86; Christie-Oleza JA, 2010, MAR DRUGS, V8, P2223, DOI 10.3390/md8082223; Clair G, 2010, MOL CELLULAR PROTEOM; Dalbey RE, 2012, FEMS MICROBIOL REV, V36, P1023, DOI 10.1111/j.1574-6976.2012.00327.x; de Carvalho CCCR, 2010, MAR DRUGS, V8, P705, DOI 10.3390/md8030705; de Groot A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000434; Dedieu A, 2011, J BIOL CHEM, V286, P259, DOI 10.1074/jbc.M110.159483; Derr P, 2006, J MOL BIOL, V355, P923, DOI 10.1016/j.jmb.2005.11.025; Diaz-Cardenas C, 2010, INT J SYST EVOL MICR, V60, P1437, DOI 10.1099/ijs.0.010926-0; Diaz-Cardenas C, 2011, THESIS PONTIFICIA U; Dupierris V, 2009, BIOINFORMATICS, V25, P1980, DOI 10.1093/bioinformatics/btp301; Galperin MY, 2010, MOL BIOSYST, V6, P721, DOI 10.1039/b908047c; Gul N, 2013, MOL MEMBR BIOL, V30, P138, DOI 10.3109/09687688.2012.754060; Hahne H, 2010, J BACTERIOL, V192, P870, DOI 10.1128/JB.01106-09; Harrison JP, 2013, TRENDS MICROBIOL, V21, P204, DOI 10.1016/j.tim.2013.01.006; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; HORBACH S, 1991, FEMS MICROBIOL LETT, V79, P347, DOI 10.1016/0378-1097(91)90110-V; Jung K, 2012, CURR OPIN MICROBIOL, V15, P118, DOI 10.1016/j.mib.2011.11.009; Kim K, 1998, J BACTERIOL, V180, P3692, DOI 10.1128/JB.180.14.3692-3696.1998; Kokoeva MV, 2002, EMBO J, V21, P2312, DOI 10.1093/emboj/21.10.2312; Koster M, 2000, INT J MED MICROBIOL, V290, P325; Kramer R, 2010, CHEM REC, V10, P217, DOI 10.1002/tcr.201000005; Kramer R, 2009, AMINO ACIDS, V37, P487, DOI 10.1007/s00726-009-0271-6; Krell T, 2011, ENVIRON MICROBIOL, V13, P1115, DOI 10.1111/j.1462-2920.2010.02383.x; Lacal J, 2010, ENVIRON MICROBIOL, V12, P2873, DOI 10.1111/j.1462-2920.2010.02325.x; Lopes MS, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-92; Magnus M, 2012, BBA-PROTEINS PROTEOM, V1824, P1425, DOI 10.1016/j.bbapap.2012.05.018; Moran MA, 2007, APPL ENVIRON MICROB, V73, P4559, DOI 10.1128/AEM.02580-06; Morris RM, 2010, ISME J, V4, P673, DOI 10.1038/ismej.2010.4; Muddiman D, 2010, ANAL BIOANAL CHEM, V398, P377, DOI 10.1007/s00216-010-3955-6; Mulligan C, 2011, FEMS MICROBIOL REV, V35, P68, DOI 10.1111/j.1574-6976.2010.00236.x; Penn K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-86; PORALLA K, 1984, FEMS MICROBIOL LETT, V23, P253; Poralla K, 2000, FEMS MICROBIOL LETT, V189, P93, DOI 10.1111/j.1574-6968.2000.tb09212.x; Pumirat P, 2009, BBA-PROTEINS PROTEOM, V1794, P898, DOI 10.1016/j.bbapap.2009.01.011; Roessler M, 2002, J BACTERIOL, V184, P6207, DOI 10.1128/JB.184.22.6207-6215.2002; Rubiano-Labrador C, 2014, J PROTEOMICS, V97, P36, DOI 10.1016/j.jprot.2013.05.020; Saum SH, 2007, J BACTERIOL, V189, P6968, DOI 10.1128/JB.00775-07; Schmerk CL, 2011, J BACTERIOL, V193, P6712, DOI 10.1128/JB.05979-11; Shinya R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067377; Takami H, 2002, NUCLEIC ACIDS RES, V30, P3927, DOI 10.1093/nar/gkf526; Tsuzuki M, 2011, APPL ENVIRON MICROB, V77, P7551, DOI 10.1128/AEM.05463-11; WALMSLEY AR, 1992, J BIOL CHEM, V267, P8064; Welander PV, 2009, J BACTERIOL, V191, P6145, DOI 10.1128/JB.00460-09; Wuichet K, 2010, CURR OPIN MICROBIOL, V13, P219, DOI 10.1016/j.mib.2009.12.011; Zhang WJ, 2012, J MOL BIOL, V416, P558, DOI 10.1016/j.jmb.2011.12.065; Zivanovic Y, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r70	56	24	24	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135065	10.1371/journal.pone.0135065	http://dx.doi.org/10.1371/journal.pone.0135065			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287734	Green Published, gold, Green Submitted			2022-12-26	WOS:000360018600035
J	Traver, S; Scalici, E; Mullet, T; Molinari, N; Vincens, C; Anahory, T; Hamamah, S				Traver, Sabine; Scalici, Elodie; Mullet, Tiffany; Molinari, Nicolas; Vincens, Claire; Anahory, Tal; Hamamah, Samir			Cell-free DNA in Human Follicular Microenvironment: New Prognostic Biomarker to Predict in vitro Fertilization Outcomes	PLOS ONE			English	Article							HUMAN CUMULUS CELLS; FREE NUCLEIC-ACIDS; CONTROLLED OVARIAN STIMULATION; ANTI-MULLERIAN HORMONE; EMBRYO CULTURE-MEDIUM; ANTIMULLERIAN HORMONE; MITOCHONDRIAL-DNA; GENE-EXPRESSION; GNRH ANTAGONIST; PREGNANCY	Cell-free DNA (cfDNA) fragments, detected in blood and in other biological fluids, are released from apoptotic and/or necrotic cells. CfDNA is currently used as biomarker for the detection of many diseases such as some cancers and gynecological and obstetrics disorders. In this study, we investigated if cfDNA levels in follicular fluid (FF) samples from in vitro fertilization (IVF) patients, could be related to their ovarian reserve status, controlled ovarian stimulation (COS) protocols and IVF outcomes. Therefore, 117 FF samples were collected from women (n = 117) undergoing IVF/Intra-cytoplasmic sperm injection (ICSI) procedure and cfDNA concentration was quantified by ALU-quantitative PCR. We found that cfDNA level was significantly higher in FF samples from patients with ovarian reserve disorders (low functional ovarian reserve or polycystic ovary syndrome) than from patients with normal ovarian reserve (2.7 +/- 2.7 ng/mu l versus 1.7 +/- 2.3 ng/mu l, respectively, p = 0.03). Likewise, FF cfDNA levels were significant more elevated in women who received long ovarian stimulation (>10 days) or high total dose of gonadotropins (>= 3000 IU/l) than in women who received short stimulation duration (7-10 days) or total dose of gonadotropins < 3000 IU/l (2.4 +/- 2.8 ng/mu l versus 1.5 +/- 1.9 ng/mu l, p = 0.008; 2.2 +/- 2.3 ng/mu l versus 1.5 +/- 2.1 ng/mu l, p = 0.01, respectively). Finally, FF cfDNA level was an independent and significant predictive factor for pregnancy outcome (adjusted odds ratio = 0.69 [0.5; 0.96], p = 0.03). In multivariate analysis, the Receiving Operator Curve (ROC) analysis showed that the performance of FF cfDNA in predicting clinical pregnancy reached 0.73 [0.66-0.87] with 88% specificity and 60% sensitivity. CfDNA might constitute a promising biomarker of follicular micro-environment quality which could be used to predict IVF prognosis and to enhance female infertility management.	[Traver, Sabine; Scalici, Elodie; Hamamah, Samir] St Eloi Hosp, CHU Montpellier, Inst Regenerat Med & Biotherapy, INSERM,U1203, Montpellier, France; [Scalici, Elodie; Mullet, Tiffany; Hamamah, Samir] Univ Montpellier I, UFR Med, Montpellier, France; [Scalici, Elodie; Mullet, Tiffany; Vincens, Claire; Anahory, Tal; Hamamah, Samir] CHU Montpellier, Arnaud de Villeneuve Hosp, ART PGD Dept, Montpellier, France; [Molinari, Nicolas] CHRU, DIM, UMR 1049, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier	Hamamah, S (corresponding author), St Eloi Hosp, CHU Montpellier, Inst Regenerat Med & Biotherapy, INSERM,U1203, Montpellier, France.	s-hamamah@chu-montpellier.fr	HAMAMAH, Samir/AAC-4156-2019; molinari, nicolas/Y-9681-2019		University Hospital of Montpellier; Ferring Pharmaceuticals	University Hospital of Montpellier; Ferring Pharmaceuticals(Ferring Pharmaceuticals)	This study was funded with partial financial support from the University Hospital of Montpellier and Ferring Pharmaceuticals. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assou S, 2008, MOL HUM REPROD, V14, P711, DOI 10.1093/molehr/gan067; Assou S, 2010, MOL HUM REPROD, V16, P531, DOI 10.1093/molehr/gaq032; Baka S, 2006, REPROD BIOMED ONLINE, V12, P500, DOI 10.1016/S1472-6483(10)62005-6; Broekmans FJ, 2014, HUM REPROD, V29, P1688, DOI 10.1093/humrep/deu090; Broer SL, 2009, FERTIL STERIL, V91, P705, DOI 10.1016/j.fertnstert.2007.12.013; BURKI E, 1948, OPHTHALMOLOGICA, V115, P241; Carpintero Nayara Lopez, 2014, J Hum Reprod Sci, V7, P187, DOI 10.4103/0974-1208.142479; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Chiba H, 1997, GYNECOL OBSTET INVES, V43, P171, DOI 10.1159/000291848; Czamanski-Cohen J, 2014, ARCH WOMEN MENT HLTH, V17, P251, DOI 10.1007/s00737-013-0407-2; Czamanski-Cohen J, 2013, REPROD BIOMED ONLINE, V26, P36, DOI 10.1016/j.rbmo.2012.09.018; Dewailly D, 2014, HUM REPROD UPDATE, V20, P370, DOI 10.1093/humupd/dmt062; Ficicioglu C, 2014, GYNECOL ENDOCRINOL, V30, P372, DOI 10.3109/09513590.2014.887064; Franks S, 2008, HUM REPROD UPDATE, V14, P367, DOI 10.1093/humupd/dmn015; Gardner DK, 2000, FERTIL STERIL, V73, P1155, DOI 10.1016/S0015-0282(00)00518-5; Gebhardt KM, 2011, FERTIL STERIL, V96, P47, DOI 10.1016/j.fertnstert.2011.04.033; Goodarzi MO, 2011, NAT REV ENDOCRINOL, V7, P219, DOI 10.1038/nrendo.2010.217; Iager AE, 2013, FERTIL STERIL, V99, P745, DOI 10.1016/j.fertnstert.2012.10.041; Jayaprakasan K, 2010, FERTIL STERIL, V93, P855, DOI 10.1016/j.fertnstert.2008.10.042; Krisher R.L., 2004, J ANIM SCI, V82, pE14, DOI 10.2527/2004.8213_supplE14x; La Marca A, 2014, HUM REPROD UPDATE, V20, P124, DOI 10.1093/humupd/dmt037; La Marca A, 2012, CURR PHARM BIOTECHNO, V13, P398, DOI 10.2174/138920112799361972; Lavorato HL, 2012, EUR J OBSTET GYN R B, V165, P61, DOI 10.1016/j.ejogrb.2012.07.014; Ledee N, 2013, HUM REPROD, V28, P406, DOI 10.1093/humrep/des354; Liu S, 2011, REPROD FERT DEVELOP, V23, P990, DOI 10.1071/RD11079; Lynch CD, 2014, HUM REPROD, V29, P1067, DOI 10.1093/humrep/deu032; Mendoza C, 2002, HUM REPROD, V17, P1017, DOI 10.1093/humrep/17.4.1017; Nardo LG, 2009, FERTIL STERIL, V92, P1586, DOI 10.1016/j.fertnstert.2008.08.127; Nelson SM, 2013, FERTIL STERIL, V99, P963, DOI 10.1016/j.fertnstert.2012.11.051; Ni XR, 2015, REPROD SCI, V22, P271, DOI 10.1177/1933719114549852; Ralla B, 2014, CRIT REV CL LAB SCI, V51, pA2, DOI 10.3109/10408363.2014.914888; Revelli A, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-40; Rodgers RJ, 2010, BIOL REPROD, V82, P1021, DOI 10.1095/biolreprod.109.082941; Scalici E, 2014, HUM REPROD, V29, P2661, DOI 10.1093/humrep/deu238; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Seifer DB, 1996, FERTIL STERIL, V66, P593, DOI 10.1016/S0015-0282(16)58573-2; Spencer S J, 1996, Obstet Gynecol Surv, V51, P314, DOI 10.1097/00006254-199605000-00023; Stigliani S, 2014, MOL HUM REPROD, V20, P1238, DOI 10.1093/molehr/gau086; Stigliani S, 2013, HUM REPROD, V28, P2652, DOI 10.1093/humrep/det314; Swarup V, 2007, FEBS LETT, V581, P795, DOI 10.1016/j.febslet.2007.01.051; Tal R, 2015, FERTIL STERIL, V103, P119, DOI 10.1016/j.fertnstert.2014.09.041; Traver S, 2014, HUM REPROD UPDATE, V20, P905, DOI 10.1093/humupd/dmu031; Umetani N, 2006, CLIN CHEM, V52, P1062, DOI 10.1373/clinchem.2006.068577; Uyar A, 2013, FERTIL STERIL, V99, P979, DOI 10.1016/j.fertnstert.2013.01.129; van Montfoort APA, 2008, MOL HUM REPROD, V14, P157, DOI 10.1093/molehr/gam088; Vital Reyes V S, 2001, Ginecol Obstet Mex, V69, P101; Lan VTN, 2013, REPROD BIOMED ONLINE, V27, P390, DOI 10.1016/j.rbmo.2013.07.008; Wathlet S, 2012, FERTIL STERIL, V98, P432, DOI 10.1016/j.fertnstert.2012.05.007; Xu XF, 2015, REPROD SCI, V22, P173, DOI 10.1177/1933719114536471; Yanaihara A, 2007, FERTIL STERIL, V87, P279, DOI 10.1016/j.fertnstert.2006.06.025; Younis JS, 2005, FERTIL STERIL, V83, P504, DOI 10.1016/j.fertnstert.2004.09.021	51	19	21	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136172	10.1371/journal.pone.0136172	http://dx.doi.org/10.1371/journal.pone.0136172			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288130	Green Published, gold, Green Submitted			2022-12-26	WOS:000360018600115
J	Mei, SY; Xin, JX; Liu, Y; Zhang, Y; Liang, X; Su, XM; Yan, H; Huang, YG; Yang, RC				Mei, Shiyue; Xin, Jiaxuan; Liu, Yu; Zhang, Yuan; Liang, Xue; Su, Xiaomin; Yan, Hui; Huang, Yugang; Yang, Rongcun			MicroRNA-200c Promotes Suppressive Potential of Myeloid-Derived Suppressor Cells by Modulating PTEN and FOG2 Expression	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; T-CELL; DENDRITIC CELLS; GM-CSF; CANCER; DIFFERENTIATION; ACCUMULATION; INFLAMMATION; MECHANISMS; INTERLEUKIN-10	Myeloid-derived suppressor cells (MDSCs) constitute one of the major populations that potently suppress anti-tumor immune responses and favor tumor growth in tumor microenvironment. However, the mechanism(s) regulating the differentiation and suppressive function of tumor-associated MDSCs remain(s) unclear. Here, we identified a microRNA-200c (miR-200c), whose expression was dramatically induced by tumor-derived factors. Meanwhile, we also demonstrated that GM-CSF was a main inducer of miR-200c in tumor environment, and miR-200c in turn promoted the expansion and immune suppressive activity of MDSCs via targeting phosphatase and tensin homolog (PTEN) and friend of Gata 2 (FOG2), which can lead to STAT3 and PI3K/Akt activation. Finally, we examined in vivo suppressive function of miR-200c transfected MDSCs and found that miR-200c could remarkably promote tumor growth via modifying MDSCs. Thus, GM-CSF induced miR200c in tumor environment plays a critical role in governing the expansion and functions of tumor-associated MDSCs and serves as a potential target in immunotherapy against tumor.	[Mei, Shiyue; Xin, Jiaxuan; Liu, Yu; Zhang, Yuan; Liang, Xue; Su, Xiaomin; Yan, Hui; Huang, Yugang; Yang, Rongcun] Nankai Univ, Sch Med, Dept Immunol, Tianjin 300071, Peoples R China; [Yang, Rongcun] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Yang, Rongcun] Nankai Univ, Minist Educ, Key Lab Bioact Mat, Tianjin 300071, Peoples R China	Nankai University; Nankai University; Nankai University	Yang, RC (corresponding author), Nankai Univ, Sch Med, Dept Immunol, Tianjin 300071, Peoples R China.	ryang@nankai.edu.cn			NSFC [31470876, 91029736, 91442111]; ISF-NSFC program [31461143010]; Ministry of Science and Technology grant (863 program) [2008AA02Z129]; National Key Scientific Program [2011CB964902]; Program for Changjiang Scholars and Innovative Research Team in University [IRT13023]; State Key Laboratory of Medicinal Chemical Biology	NSFC(National Natural Science Foundation of China (NSFC)); ISF-NSFC program; Ministry of Science and Technology grant (863 program); National Key Scientific Program; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); State Key Laboratory of Medicinal Chemical Biology	This research was supported by NSFC grants 31470876, 91029736, 91442111 and ISF-NSFC program 31461143010, a Ministry of Science and Technology grant (863 program, 2008AA02Z129), the National Key Scientific Program (2011CB964902) the Program for Changjiang Scholars and Innovative Research Team in University (No. IRT13023) and State Key Laboratory of Medicinal Chemical Biology.	Bayne LJ, 2012, CANCER CELL, V21, P822, DOI 10.1016/j.ccr.2012.04.025; Cheng PY, 2008, J EXP MED, V205, P2235, DOI 10.1084/jem.20080132; Chomarat P, 2000, NAT IMMUNOL, V1, P510, DOI 10.1038/82763; Condamine T, 2011, TRENDS IMMUNOL, V32, P19, DOI 10.1016/j.it.2010.10.002; Dolcetti L, 2010, EUR J IMMUNOL, V40, P22, DOI 10.1002/eji.200939903; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Goddard S, 2004, AM J PATHOL, V164, P511, DOI 10.1016/S0002-9440(10)63141-0; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Kono K, 1996, EUR J IMMUNOL, V26, P1308, DOI 10.1002/eji.1830260620; Kusmartsev S, 2004, J IMMUNOL, V172, P989, DOI 10.4049/jimmunol.172.2.989; Kusmartsev S, 2006, CANCER METAST REV, V25, P323, DOI 10.1007/s10555-006-9002-6; Lechner MG, 2010, J IMMUNOL, V185, P2273, DOI 10.4049/jimmunol.1000901; Li LM, 2014, J IMMUNOL, V192, P1034, DOI 10.4049/jimmunol.1301309; Liu QF, 2011, INT J CANCER, V129, P2662, DOI 10.1002/ijc.25921; Liu Y, 2012, J IMMUNOL, V188, P5500, DOI 10.4049/jimmunol.1103505; Lutz MB, 2000, EUR J IMMUNOL, V30, P1813, DOI 10.1002/1521-4141(200007)30:7<1813::AID-IMMU1813>3.0.CO;2-8; Mandruzzato S, 2009, J IMMUNOL, V182, P6562, DOI 10.4049/jimmunol.0803831; Marigo I, 2010, IMMUNITY, V32, P790, DOI 10.1016/j.immuni.2010.05.010; Min SP, 2013, J IMMUNOL, V190, P2437, DOI 10.4049/jimmunol.1202282; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Obermajer N, 2011, CANCER RES, V71, P7463, DOI 10.1158/0008-5472.CAN-11-2449; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Otsuji M, 1996, P NATL ACAD SCI USA, V93, P13119, DOI 10.1073/pnas.93.23.13119; PAK AS, 1995, CLIN CANCER RES, V1, P95; Peranzoni E, 2010, CURR OPIN IMMUNOL, V22, P238, DOI 10.1016/j.coi.2010.01.021; Petriv OI, 2010, P NATL ACAD SCI USA, V107, P15443, DOI 10.1073/pnas.1009320107; PISA P, 1992, P NATL ACAD SCI USA, V89, P7708, DOI 10.1073/pnas.89.16.7708; Pylayeva-Gupta Y, 2012, CANCER CELL, V21, P836, DOI 10.1016/j.ccr.2012.04.024; Rauh MJ, 2005, IMMUNITY, V23, P361, DOI 10.1016/j.immuni.2005.09.003; Rodriguez PC, 2002, J BIOL CHEM, V277, P21123, DOI 10.1074/jbc.M110675200; Sade-Feldman M, 2013, IMMUNITY, V38, P541, DOI 10.1016/j.immuni.2013.02.007; Serafini P, 2004, CANCER RES, V64, P6337, DOI 10.1158/0008-5472.CAN-04-0757; Serafini P, 2006, SEMIN CANCER BIOL, V16, P53, DOI 10.1016/j.semcancer.2005.07.005; Sinha P, 2007, CANCER RES, V67, P4507, DOI 10.1158/0008-5472.CAN-06-4174; Sonda N, 2013, IMMUNITY, V38, P1236, DOI 10.1016/j.immuni.2013.06.004; Yang RC, 2004, J VIROL, V78, P11152, DOI 10.1128/JVI.78.20.11152-11160.2004; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhang MM, 2011, J IMMUNOL, V186, P4716, DOI 10.4049/jimmunol.1002989; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104	43	34	35	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135867	10.1371/journal.pone.0135867	http://dx.doi.org/10.1371/journal.pone.0135867			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285119	Green Published, Green Submitted, gold			2022-12-26	WOS:000359666100078
J	Shang, XF; Luo, ZL; Wang, XD; Jaeblon, T; Marymont, JV; Dong, YF				Shang, Xifu; Luo, Zhengliang; Wang, Xudong; Jaeblon, Todd; Marymont, John V.; Dong, Yufeng			Deletion of RBPJK in Mesenchymal Stem Cells Enhances Osteogenic Activity by Up-Regulation of BMP Signaling	PLOS ONE			English	Article							BONE-MARROW; STROMAL CELLS; GROWTH-FACTOR; DIFFERENTIATION	Recently we have demonstrated the importance of RBPjk-dependent Notch signaling in the regulation of mesenchymal stem cell (MSC) differentiation during skeletogenesis both in vivo and in vitro. Here we further performed RBPJK loss-of-function experiments to demonstrate for the first time that RBPJK deficient MSC shows enhanced differentiation and osteogenesis acts via up-regulation of the BMP signaling. In the present study, we first compared the spontaneous and osteogenic differentiation in normal and recombination signal binding protein for immunoglobulin kappa J region (RBPJK) deficient human bone marrow-derived mesenchymal stem cells (MSCs). It was found that RBPJK highly expressed in fresh isolated MSCs and its expression was progressing down-regulated during spontaneous differentiation and even greater in osteogenic media inducted differentiation. Deletion of RBPJK in MSCs not only enhances cell spontaneous differentiation, but also significantly accelerates condition media inducted osteogenic differentiation by showing enhanced alkaline phosphatase (ALP) activity, Alizarin red staining, gene expression of Runx2, Osteopontin (OPN), Type I collagen (COL1a1) in culture. Additionally, BMP signaling responsive reporter activity and phosphor-smad1/5/8 expression were also significantly increased upon removal of RBPJK in MSCs. These data proved that inhibition of Notch signaling in MSCs promotes cell osteogenic differentiation by up-regulation of BMP signaling, and RBPJK deficient MSC maybe a better cell population for cell-based bone tissue engineering.	[Shang, Xifu; Luo, Zhengliang] Anhui Prov Hosp, Dept Orthopaed Surg, Hefei, Anhui, Peoples R China; [Wang, Xudong] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Oral & Craniomaxillofacial Surg, Shanghai 200030, Peoples R China; [Jaeblon, Todd; Marymont, John V.; Dong, Yufeng] Louisiana State Univ, Hlth Sci Ctr, Dept Orthopaed Surg, Shreveport, LA 71105 USA	Shanghai Jiao Tong University; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Dong, YF (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Orthopaed Surg, Shreveport, LA 71105 USA.	ydong@lsuhsc.edu			NIH/NIAMS [AR063803]; Department of Orthopedic Surgery at LSUHSC-Shreveport; China Anhui Province [1503062022]; Natural Science Foundation of China [81271122]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR063803] Funding Source: NIH RePORTER	NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Department of Orthopedic Surgery at LSUHSC-Shreveport; China Anhui Province; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by the following grants: NIH/NIAMS R21 grant (AR063803) to YD, Start-up funds from Department of Orthopedic Surgery at LSUHSC-Shreveport to YD, Foreign scientific cooperation grant from China Anhui Province (Grant No. 1503062022) to XS, the Natural Science Foundation of China (Grant No. 81271122) to XW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah BM, 2008, GENE THER, V15, P109, DOI 10.1038/sj.gt.3303067; Augello A, 2010, HUM GENE THER, V21, P1226, DOI 10.1089/hum.2010.173; Bai Y, 2013, BIOTECHNOL LETT, V35, P301, DOI 10.1007/s10529-012-1084-3; Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P81, DOI 10.1002/term.74; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; BRUDER SP, 1994, J CELL BIOCHEM, V56, P283, DOI 10.1002/jcb.240560303; Bruder SP, 1998, CLIN ORTHOP RELAT R, pS247; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Chang CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105705; Chen XD, 2004, FASEB J, V18, P948, DOI 10.1096/fj.03-0899com; D'Alimonte I, 2013, STEM CELL RES, V11, P611, DOI 10.1016/j.scr.2013.04.002; Desiderio V, 2013, J CELL PHYSIOL, V228, P1762, DOI 10.1002/jcp.24336; Dong Y, 2014, STEM CELLS TRANSLATI; Dong YF, 2007, MOL ENDOCRINOL, V21, P2805, DOI 10.1210/me.2007-0199; Dong YF, 2010, DEVELOPMENT, V137, P1461, DOI 10.1242/dev.042911; FRIEDENSTEIN A, 1971, TRANSPLANTATION, V12, P99, DOI 10.1097/00007890-197108000-00001; Giuliani N, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/312501; Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716; Horn P, 2008, CYTOTHERAPY, V10, P676, DOI 10.1080/14653240802398845; Karanu FN, 2000, J EXP MED, V192, P1365, DOI 10.1084/jem.192.9.1365; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; La Noce M, 2014, J DENT, V42, P761, DOI 10.1016/j.jdent.2014.02.018; Lee MW, 2004, BIOCHEM BIOPH RES CO, V320, P273, DOI 10.1016/j.bbrc.2004.04.206; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; Oliveira MS, 2015, WORLD J STEM CELLS, V7, P769, DOI 10.4252/wjsc.v7.i4.769; Osyczka AM, 2005, ENDOCRINOLOGY, V146, P3428, DOI 10.1210/en.2005-0303; Rodriguez IA, 2012, INT J BIOMATER, V2012, DOI 10.1155/2012/159484; Ulrich H, 2015, STEM CELL REV REP, V11, P474, DOI 10.1007/s12015-014-9556-6; Wang JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074255; Yang XD, 2007, AM J RESP CELL MOL, V37, P598, DOI 10.1165/rcmb.2006-0360OC	30	9	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135971	10.1371/journal.pone.0135971	http://dx.doi.org/10.1371/journal.pone.0135971			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285013	Green Published, gold, Green Submitted			2022-12-26	WOS:000359666100093
J	Bhandaru, M; Martinka, M; McElwee, KJ; Rotte, A				Bhandaru, Madhuri; Martinka, Magdalena; McElwee, Kevin J.; Rotte, Anand			Prognostic Significance of Nuclear Phospho-ATM Expression in Melanoma	PLOS ONE			English	Article							ATAXIA-TELANGIECTASIA GENE; DNA-DAMAGE RESPONSE; KINASE-ACTIVITY; IONIZING-RADIATION; REPAIR PATHWAY; BREAST-CANCER; CELLS; PROTEIN; P53; INHIBITION	UV radiation induced genomic instability is one of the leading causes for melanoma. Phosphorylation of Ataxia Telangiectasia Mutated (ATM) is one of the initial events that follow DNA damage. Phospho-ATM (p-ATM) plays a key role in the activation of DNA repair and several oncogenic pathways as well as in the maintenance of genomic integrity. The present study was therefore performed to understand the significance of p-ATM in melanoma progression and to correlate it with patient prognosis. Tissue microarray and immunohistochemical analysis were employed to study the expression of p-ATM in melanoma patients. A total of 366 melanoma patients (230 primary melanoma and 136 metastatic melanoma) were used for the study. Chi-square test, Kaplan-Meier, univariate and multivariate Cox regression analysis were used to elucidate the prognostic significance of p-ATM expression. Results revealed that both loss of, and gain in, p-ATM expression were associated with progression of melanoma from normal nevi to metastatic melanoma. Patients whose samples showed negative or strong p-ATM staining had significantly worse 5-year survival compared to patients who had weak to moderate expression. Loss of p-ATM expression was associated with relatively better 5-year survival, but the corresponding 10-year survival curve almost overlapped with that of strong p-ATM expression. p-ATM expression was found to be an independent prognostic factor for 5-year but not for 10-year patient survival. In conclusion our findings show that loss of p-ATM expression and gain-in p-ATM expression are indicators of worse melanoma patient survival.	[Bhandaru, Madhuri; McElwee, Kevin J.; Rotte, Anand] Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 1M9, Canada; [Martinka, Magdalena] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [McElwee, Kevin J.] Replicel Inc, Vancouver, BC, Canada	University of British Columbia; University of British Columbia	Bhandaru, M (corresponding author), Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 1M9, Canada.	madhuribhandaru@gmail.com; anand.rotte@gmail.com	Rotte, Anand/H-4774-2019	Rotte, Anand/0000-0002-3452-7068; McElwee, Kevin/0000-0003-1020-3832	grants from Canadian Institutes of Health Research (CIHR) [CCI-117958, MOP-93810, MOP-110974]; Canadian Dermatology Foundation (CDF); Replicel Life Sciences Inc.	grants from Canadian Institutes of Health Research (CIHR); Canadian Dermatology Foundation (CDF); Replicel Life Sciences Inc.	MB & AR were supported by grants from Canadian Institutes of Health Research (CIHR; CCI-117958, MOP-93810, MOP-110974) and KJM was supported by the Canadian Dermatology Foundation (CDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. KJM is affiliated to Replicel Life Sciences Inc. Replicel Life Sciences Inc. provided support in the form of consulting fees for author KJM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "author contributions" section.	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Batey MA, 2013, MOL CANCER THER, V12, P959, DOI 10.1158/1535-7163.MCT-12-0707; Battu A, 2011, NUCLEIC ACIDS RES, V39, P7931, DOI 10.1093/nar/gkr523; Bhandaru M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-398; Bhandaru M, 2014, PIGM CELL MELANOMA R, V27, P366, DOI 10.1111/pcmr.12212; Biddlestone-Thorpe L, 2013, CLIN CANCER RES, V19, P3189, DOI 10.1158/1078-0432.CCR-12-3408; Camp RL, 2004, CLIN CANCER RES, V10, P7252, DOI 10.1158/1078-0432.CCR-04-0713; Chen G, 1996, J BIOL CHEM, V271, P33693, DOI 10.1074/jbc.271.52.33693; Chen GD, 2012, J INVEST DERMATOL, V132, P2632, DOI 10.1038/jid.2012.193; Cheng YB, 2013, CANCER METAST REV, V32, P567, DOI 10.1007/s10555-013-9433-9; Chou WC, 2015, CARCINOGENESIS, V36, P832, DOI 10.1093/carcin/bgv079; Dianov GL, 2015, REF MISMAT, V112, P3997, DOI 10.1073/pnas.141SG31112; Eich M, 2013, MOL CANCER THER, V12, P2529, DOI 10.1158/1535-7163.MCT-13-0136; Gao Y, 2011, CARCINOGENESIS, V32, P882, DOI 10.1093/carcin/bgr071; Gonzaga Evelyn R, 2009, Am J Clin Dermatol, V10 Suppl 1, P19, DOI 10.2165/0128071-200910001-00004; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Ivanov VN, 2009, CANCER RES, V69, P3510, DOI 10.1158/0008-5472.CAN-08-3883; Bin K, 2008, MUTAT RES-FUND MOL M, V638, P17, DOI 10.1016/j.mrfmmm.2007.08.013; Khalil HS, 2012, EXP BIOL MED, V237, P622, DOI 10.1258/ebm.2012.011378; Kim H, 2014, CLIN CANCER RES, V20, P1865, DOI 10.1158/1078-0432.CCR-13-1239; Kim HS, 2013, PATHOBIOLOGY, V80, P127, DOI 10.1159/000346034; Lee HE, 2013, PATHOBIOLOGY, V81, P25, DOI 10.1159/000351072; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Lin H, 2009, CLIN CANCER RES, V15, P6404, DOI 10.1158/1078-0432.CCR-09-1135; McKinnon PJ, 2004, EMBO REP, V5, P772, DOI 10.1038/sj.embor.7400210; Mhawech- Fauceglia P, 2014, GYNECOL ONCOL, V132, P593, DOI [10. 1016/ j. ygyno. 2014. 02. 002, DOI 10.1016/J.YGYN0.2014.02.002]; Moschos SJ, 2009, CANCER BIOL THER, V8, P1815, DOI 10.4161/cbt.8.19.9435; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Perlman Susan, 2003, Semin Pediatr Neurol, V10, P173, DOI 10.1016/S1071-9091(03)00026-3; Prokopcova J, 2007, BREAST CANCER RES TR, V104, P121, DOI 10.1007/s10549-006-9406-6; Ray A, 2013, DNA REPAIR, V12, P273, DOI 10.1016/j.dnarep.2013.01.003; REMMELE W, 1987, PATHOLOGE, V8, P138; Roesch A, 2007, CANCER EPIDEM BIOMAR, V16, P2486, DOI 10.1158/1055-9965.EPI-07-0224; Rondeau S, 2015, BRIT J CANCER, V112, P1059, DOI 10.1038/bjc.2015.60; Roossink F, 2012, INT J CANCER, V131, P2056, DOI 10.1002/ijc.27488; Rotte A, 2015, CANCER METAST REV, V34, P115, DOI 10.1007/s10555-014-9542-0; Rotte A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075405; Rustgi AK, 2014, REF MISMAT, V28, P1, DOI 10.1101/gad.228452.113; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Shen L, 2014, REF MISMAT, V9, DOI 10.1371/]ournal.pone.0096911; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Shin JU, 2012, TUMOR BIOL, V33, P1645, DOI 10.1007/s13277-012-0420-5; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Smith GCM, 1999, MOL CELL BIOL, V19, P6076; Smith GCM, 1999, P NATL ACAD SCI USA, V96, P11134, DOI 10.1073/pnas.96.20.11134; Stagni V, 2014, INT J MOL SCI, V15, P5388, DOI 10.3390/ijms15045388; Stankovic T, 1998, REF MISMAT, V62, P334, DOI 10.1086/301706; Thorstenson YR, 2003, CANCER RES, V63, P3325; Wakasugi M, 2014, J BIOL CHEM, V289, P28730, DOI 10.1074/jbc.M114.589747; Wang JZ, 2006, AM J PHYSIOL-RENAL, V291, pF1300, DOI 10.1152/ajprenal.00509.2005; Wong RPC, 2012, PIGM CELL MELANOMA R, V25, DOI 10.1111/j.1755-148X.2011.00948.x; Yu GZ, 2004, PANCREAS, V28, P421, DOI 10.1097/00006676-200405000-00011; Zhang GH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045037; Zhang ZZ, 2011, CANCER-AM CANCER SOC, V117, P2719, DOI 10.1002/cncr.25838	54	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0134678	10.1371/journal.pone.0134678	http://dx.doi.org/10.1371/journal.pone.0134678			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275218	gold, Green Submitted, Green Published			2022-12-26	WOS:000359493600040
J	Chen, BJ; Litvin, O; Ungar, L; Pe'er, D				Chen, Bo-Juen; Litvin, Oren; Ungar, Lyle; Pe'er, Dana			Context Sensitive Modeling of Cancer Drug Sensitivity	PLOS ONE			English	Article							GENE-EXPRESSION; BREAST-CANCER; INDUCED APOPTOSIS; STEM-CELLS; KAPPA-B; INSULIN; INHIBITION; PACLITAXEL; SELECTION; PATHWAYS	Recent screening of drug sensitivity in large panels of cancer cell lines provides a valuable resource towards developing algorithms that predict drug response. Since more samples provide increased statistical power, most approaches to prediction of drug sensitivity pool multiple cancer types together without distinction. However, pan-cancer results can be misleading due to the confounding effects of tissues or cancer subtypes. On the other hand, independent analysis for each cancer-type is hampered by small sample size. To balance this trade-off, we present CHER (Contextual Heterogeneity Enabled Regression), an algorithm that builds predictive models for drug sensitivity by selecting predictive genomic features and deciding which ones should-and should not-be shared across different cancers, tissues and drugs. CHER provides significantly more accurate models of drug sensitivity than comparable elastic-net-based models. Moreover, CHER provides better insight into the underlying biological processes by finding a sparse set of shared and type-specific genomic features.	[Chen, Bo-Juen] Columbia Univ, Dept Biomed Informat, New York, NY 10032 USA; [Chen, Bo-Juen; Litvin, Oren; Pe'er, Dana] Columbia Univ, Dept Biol Sci, Dept Syst Biol, New York, NY 10027 USA; [Ungar, Lyle] Univ Penn, Comp & Informat Sci, Philadelphia, PA 19104 USA	Columbia University; Columbia University; University of Pennsylvania	Pe'er, D (corresponding author), Columbia Univ, Dept Biol Sci, Dept Syst Biol, New York, NY 10027 USA.	dpeer@biology.columbia.edu			Stand Up To Cancer Innovative Research Grant [IRG08]; National Institutes of Health [R01CA164729]; National Centers for Biomedical Computing Grant [1U54CA121852-01A1]; NATIONAL CANCER INSTITUTE [U54CA121852, R01CA164729] Funding Source: NIH RePORTER	Stand Up To Cancer Innovative Research Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Centers for Biomedical Computing Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by Stand Up To Cancer Innovative Research Grant (IRG08), National Institutes of Health (R01CA164729) and National Centers for Biomedical Computing Grant 1U54CA121852-01A1. D.P. holds a Packard Fellowship for Science and Engineering.	Ahmad S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04483; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Altelaar AFM, 2013, NAT REV GENET, V14, P35, DOI 10.1038/nrg3356; Bacus SS, 2001, ONCOGENE, V20, P147, DOI 10.1038/sj.onc.1204062; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bava SV, 2011, INT J BIOCHEM CELL B, V43, P331, DOI 10.1016/j.biocel.2010.09.011; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bermudez O, 2010, AM J PHYSIOL-CELL PH, V299, pC189, DOI 10.1152/ajpcell.00347.2009; Bickel P.J., 1977, MATH STAT; Bielen A, 2012, P NATL ACAD SCI USA, V109, pE1267, DOI 10.1073/pnas.1105034109; Bissell MJ, 2005, CANCER CELL, V7, P17, DOI 10.1016/j.ccr.2004.12.013; Boldt S, 2002, CARCINOGENESIS, V23, P1831, DOI 10.1093/carcin/23.11.1831; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Calzone FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055135; Chen BJ, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.69; Chi DDJ, 1997, AM J PATHOL, V150, P2143; Costello JC, 2014, NAT BIOTECHNOL, V32, P1202, DOI 10.1038/nbt.2877; Cover TM, 2012, ELEMENTS INFORM THEO, DOI DOI 10.1002/047174882X; Dhillon PS, 2011, J MACH LEARN RES, V12, P525; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Ebi H, 2013, P NATL ACAD SCI USA, V110, P21124, DOI 10.1073/pnas.1314124110; Flanigan SA, 2010, CLIN CANCER RES, V16, P5436, DOI 10.1158/1078-0432.CCR-10-2054; Frankild S, DISEASES DIS GENE AS; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Fu JY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002431; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Goto Y, 2012, INVEST NEW DRUG, V30, P1548, DOI 10.1007/s10637-011-9715-4; Gu L, 2008, LEUKEMIA, V22, P730, DOI 10.1038/leu.2008.11; Gualberto A, 2011, BRIT J CANCER, V104, P68, DOI 10.1038/sj.bjc.6605972; Hamilton A, 2006, LEUKEMIA, V20, P1035, DOI 10.1038/sj.leu.2404189; Heiser LM, 2012, P NATL ACAD SCI USA, V109, P2724, DOI 10.1073/pnas.1018854108; Hubbell E, 2002, BIOINFORMATICS, V18, P1585, DOI 10.1093/bioinformatics/18.12.1585; Klinger S, 2008, DIABETES, V57, P584, DOI 10.2337/db07-1414; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kojima K, 2005, BLOOD, V106, P3150, DOI 10.1182/blood-2005-02-0553; Kopetz S, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.3534; Kutalik Z, 2008, NAT BIOTECHNOL, V26, P531, DOI 10.1038/nbt1397; Lee SY, 2011, J PATHOL, V223, P15, DOI 10.1002/path.2766; Mabuchi S, 2004, CLIN CANCER RES, V10, P7645, DOI 10.1158/1078-0432.CCR-04-0958; McLeod HL, 2013, SCIENCE, V339, P1563, DOI 10.1126/science.1234139; Nguyen DM, 2004, J THORAC CARDIOV SUR, V127, P365, DOI 10.1016/j.jtcvs.2003.09.033; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Patel NM, 2000, ONCOGENE, V19, P4159, DOI 10.1038/sj.onc.1203768; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Price AL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001317; Prickett TD, 2012, CLIN CANCER RES, V18, P4240, DOI 10.1158/1078-0432.CCR-11-1217; Rad R, 2013, CANCER CELL, V24, P15, DOI 10.1016/j.ccr.2013.05.014; Raina R, 2006, P 23 INT C MACH LEAR; Rissanen J, 1999, COMPUT J, V42, P260, DOI 10.1093/comjnl/42.4.260; RISSANEN J, 1978, AUTOMATICA, V14, P465, DOI 10.1016/0005-1098(78)90005-5; Sattler M, 1998, LEUKEMIA, V12, P637, DOI 10.1038/sj.leu.2401010; Spiliotaki M, 2011, LUNG CANCER, V73, P158, DOI 10.1016/j.lungcan.2010.11.010; Tang J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003226; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wolff EM, 2010, CANCER RES, V70, P8169, DOI 10.1158/0008-5472.CAN-10-1335; Yin D, 2005, NEUROL RES, V27, P27, DOI 10.1179/016164105X18151; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	59	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0133850	10.1371/journal.pone.0133850	http://dx.doi.org/10.1371/journal.pone.0133850			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274927	Green Published, Green Submitted, gold			2022-12-26	WOS:000359493600017
J	James, AD; Patel, W; Butt, Z; Adiamah, M; Dakhel, R; Latif, A; Uggenti, C; Swanton, E; Imamura, H; Siriwardena, AK; Bruce, JIE				James, Andrew D.; Patel, Waseema; Butt, Zohra; Adiamah, Magretta; Dakhel, Raga; Latif, Ayse; Uggenti, Carolina; Swanton, Eileithyia; Imamura, Hiromi; Siriwardena, Ajith K.; Bruce, Jason I. E.			The Plasma Membrane Calcium Pump in Pancreatic Cancer Cells Exhibiting the Warburg Effect Relies on Glycolytic ATP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH AEROBIC GLYCOLYSIS; HEPATOMA-CELLS; OXIDATIVE-PHOSPHORYLATION; ENERGY-METABOLISM; TUMOR-CELLS; MITOCHONDRIA; 3-BROMOPYRUVATE; GLUTAMINE; PHOSPHATIDYLSERINE; CA2+-ATPASE	Evidence suggests that the plasma membrane Ca2+-ATPase (PMCA), which is critical for maintaining a low intracellular Ca2+ concentration ([Ca2+](i)), utilizes glycolytically derived ATP in pancreatic ductal adenocarcinoma (PDAC) and that inhibition of glycolysis in PDAC cell lines results in ATP depletion, PMCAinhibition, and an irreversible [Ca2+](i) overload. We explored whether this is a specific weakness of highly glycolytic PDAC by shifting PDAC cell (MIA PaCa-2 and PANC-1) metabolism from a highly glycolytic phenotype toward mitochondrial metabolism and assessing the effects of mitochondrial versus glycolytic inhibitors on ATP depletion, PMCA inhibition, and [Ca2+](i) overload. The highly glycolytic phenotype of these cells was first reversed by depriving MIA PaCa-2 and PANC-1 cells of glucose and supplementing with alpha-ketoisocaproate or galactose. These culture conditions resulted in a significant decrease in both glycolytic flux and proliferation rate, and conferred resistance to ATP depletion by glycolytic inhibition while sensitizing cells to mitochondrial inhibition. Moreover, in direct contrast to cells exhibiting a high glycolytic rate, glycolytic inhibition had no effect on PMCA activity and resting [Ca2+](i) in alpha-ketoisocaproateand galactose-cultured cells, suggesting that the glycolytic dependence of the PMCA is a specific vulnerability of PDAC cells exhibiting the Warburg phenotype.	[James, Andrew D.; Patel, Waseema; Butt, Zohra; Adiamah, Magretta; Dakhel, Raga; Swanton, Eileithyia; Bruce, Jason I. E.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Latif, Ayse] Univ Manchester, Manchester Pharm Sch, Manchester M13 9PT, Lancs, England; [Uggenti, Carolina] Univ Manchester, Fac Med & Human Sci, Manchester M13 9PT, Lancs, England; [Imamura, Hiromi] Kyoto Univ, Hakubi Ctr Adv Res, Kyoto 6068501, Japan; [Imamura, Hiromi] Kyoto Univ, Grad Sch Biostudies, Kyoto 6068501, Japan; [Siriwardena, Ajith K.] Manchester Royal Infirm, Hepatobiliary Surg Unit, Manchester M13 9NT, Lancs, England	University of Manchester; University of Manchester; University of Manchester; Kyoto University; Kyoto University; University of Manchester	Bruce, JIE (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9NT, Lancs, England.	jason.bruce@manchester.ac.uk	Uggenti, Carolina/G-9145-2017; Imamura, Hiromi/AAD-5109-2019; Latif, A/U-4241-2019	Uggenti, Carolina/0000-0003-2673-5120; Imamura, Hiromi/0000-0002-1896-0443; Latif, A/0000-0002-7245-8729; Swanton, Eileithyia/0000-0002-3299-4228; James, Andrew/0000-0002-2432-5948	Pancreatic Cancer Research Fund; Central Manchester Foundation Trust/National Institutes of Health Research Manchester Biological Research Centre pump priming fund; Biotechnology and Biological Sciences Research Council; AstraZeneca plc; Central Manchester Healthcare Trust Strategic Investment Fund project; RP Fighting Blindness Ph.D studentship; Grants-in-Aid for Scientific Research [26291027] Funding Source: KAKEN	Pancreatic Cancer Research Fund; Central Manchester Foundation Trust/National Institutes of Health Research Manchester Biological Research Centre pump priming fund; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); AstraZeneca plc(AstraZeneca); Central Manchester Healthcare Trust Strategic Investment Fund project; RP Fighting Blindness Ph.D studentship; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Pancreatic Cancer Research Fund research grant (to J. I. E. B.) and a Central Manchester Foundation Trust/National Institutes of Health Research Manchester Biological Research Centre pump priming fund (to A. K. S. and J. I. E. B.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Biotechnology and Biological Sciences Research Council and AstraZeneca plc CASE Ph.D. studentship.; Supported by a Central Manchester Healthcare Trust Strategic Investment Fund project grant to Prof. Ian Stratford and Dr. Emma Crosbie.; Supported by RP Fighting Blindness Ph.D studentship.	Amin Z, 2006, CLIN RADIOL, V61, P996, DOI 10.1016/j.crad.2006.07.005; Baggaley EM, 2008, AM J PHYSIOL-CELL PH, V295, pC1247, DOI 10.1152/ajpcell.00083.2008; Bellance N, 2009, INT J BIOCHEM CELL B, V41, P2566, DOI 10.1016/j.biocel.2009.08.012; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Busk M, 2008, INT J CANCER, V122, P2726, DOI 10.1002/ijc.23449; BUSTAMANTE E, 1977, P NATL ACAD SCI USA, V74, P3735, DOI 10.1073/pnas.74.9.3735; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Campanella ME, 2005, P NATL ACAD SCI USA, V102, P2402, DOI 10.1073/pnas.0409741102; Chaika NV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032996; Chen Z, 2009, BBA-BIOENERGETICS, V1787, P553, DOI 10.1016/j.bbabio.2009.03.003; Echarte MM, 2007, BIOCHEMISTRY-US, V46, P1034, DOI 10.1021/bi061857x; Frezza C, 2009, SEMIN CANCER BIOL, V19, P4, DOI 10.1016/j.semcancer.2008.11.008; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Guillaumond F, 2013, P NATL ACAD SCI USA, V110, P3919, DOI 10.1073/pnas.1219555110; Guppy M, 2002, BIOCHEM BIOPH RES CO, V299, P676, DOI 10.1016/S0006-291X(02)02710-9; HARDIN CD, 1992, J GEN PHYSIOL, V99, P21, DOI 10.1085/jgp.99.1.21; HUTTON JC, 1979, BIOCHEM J, V184, P291, DOI 10.1042/bj1840291; Ihrlund LS, 2008, MOL ONCOL, V2, P94, DOI 10.1016/j.molonc.2008.01.003; Kim JS, 2008, J BIOENERG BIOMEMBR, V40, P607, DOI 10.1007/s10863-008-9188-0; Le A, 2012, CLIN CANCER RES, V18, P4285, DOI 10.1158/1078-0432.CCR-12-0041; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; MALAISSE WJ, 1981, BIOCHIM BIOPHYS ACTA, V677, P39, DOI 10.1016/0304-4165(81)90143-4; Marroquin LD, 2007, TOXICOL SCI, V97, P539, DOI 10.1093/toxsci/kfm052; Martin M, 1998, J BIOENERG BIOMEMBR, V30, P565, DOI 10.1023/A:1020584517588; Nakano M, 2011, ACS CHEM BIOL, V6, P709, DOI 10.1021/cb100313n; NAKASHIMA RA, 1984, CANCER RES, V44, P5702; NODA C, 1974, J BIOCHEM-TOKYO, V76, P1123; PAUL RJ, 1989, FASEB J, V3, P2298, DOI 10.1096/fasebj.3.11.2528493; Puchulu-Campanella E, 2013, J BIOL CHEM, V288, P848, DOI 10.1074/jbc.M112.428573; Rodriguez-Enriquez S, 2008, J CELL PHYSIOL, V216, P189, DOI 10.1002/jcp.21392; Rodriguez-Enriquez S, 2006, TOXICOL APPL PHARM, V215, P208, DOI 10.1016/j.taap.2006.02.005; ROSSI JPFC, 1989, BIOCHIM BIOPHYS ACTA, V996, P153, DOI 10.1016/0167-4838(89)90241-0; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; Semenza GL, 2008, J CLIN INVEST, V118, P3835, DOI 10.1172/JCI37373; Shukla SK, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-18; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Xu RH, 2005, LEUKEMIA, V19, P2153, DOI 10.1038/sj.leu.2403968; Zhang J, 2009, CELL CALCIUM, V45, P177, DOI [10.1016/j.ceca.2008.09.002, 10.3778/j.issn.1002-8331.2009.04.050]; Zhou WD, 2012, J PROTEOME RES, V11, P554, DOI 10.1021/pr2009274; Zu XL, 2004, BIOCHEM BIOPH RES CO, V313, P459, DOI 10.1016/j.bbrc.2003.11.136	42	26	27	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					24760	24771		10.1074/jbc.M115.668707	http://dx.doi.org/10.1074/jbc.M115.668707			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26294767	Green Published, hybrid			2022-12-26	WOS:000362598300012
J	Srinivasan, S; Schiemer, J; Zhang, XW; Chishti, AH; Le Breton, GC				Srinivasan, Subhashini; Schiemer, James; Zhang, Xiaowei; Chishti, Athar H.; Le Breton, Guy C.			G alpha(13) Switch Region 2 Binds to the Talin Head Domain and Activates alpha IIb beta 3 Integrin in Human Platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G-PROTEINS; MONOCLONAL-ANTIBODIES; CYTOPLASMIC TAILS; BLOOD-PLATELETS; SHAPE CHANGE; SUBUNIT; IDENTIFICATION; ADHESION; PROTEASE; CALCIUM	Even though GPCR signaling in human platelets is directly involved in hemostasis and thrombus formation, the sequence of events by which G protein activation leads to alpha IIb beta 3 integrin activation (inside-out signaling) is not clearly defined. We previously demonstrated that a conformationally sensitive domain of one G protein, i.e. G alpha(13) switch region 1 (G alpha(13)SR1), can directly participate in the platelet inside-out signaling process. Interestingly however, the dependence on G alpha(13)SR1 signaling was limited to PAR1 receptors, and did not involve signaling through other important platelet GPCRs. Based on the limited scope of this involvement, and the known importance of G(13) in hemostasis and thrombosis, the present study examined whether signaling through another switch region of G(13), i.e. G alpha(13) switch region 2 (G alpha(13)SR2) may represent a more global mechanism of platelet activation. Using multiple experimental approaches, our results demonstrate that G alpha(13)SR2 forms a bimolecular complex with the head domain of talin and thereby promotes beta 3 integrin activation. Moreover, additional studies provided evidence that G alpha(13)SR2 is not constitutively associated with talin in unactivated platelets, but becomes bound to talin in response to elevated intraplatelet calcium levels. Collectively, these findings provide evidence for a novel paradigm of inside-out signaling in platelets, whereby beta 3 integrin activation involves the direct binding of the talin head domain to the switch region 2 sequence of the G alpha(13) subunit.	[Srinivasan, Subhashini; Zhang, Xiaowei; Le Breton, Guy C.] Univ Illinois, Dept Pharmacol, Coll Med, Chicago, IL 60612 USA; [Schiemer, James; Chishti, Athar H.] Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Dept Dev Mol & Chem Biol,Program Cellular & Mol P, Boston, MA 02111 USA; [Schiemer, James; Chishti, Athar H.] Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Dept Dev Mol & Chem Biol,Program Pharmacol & Micr, Boston, MA 02111 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Tufts University; Tufts University	Le Breton, GC (corresponding author), Univ Illinois, Dept Mol Pharmacol, Coll Med, 835 South Wolcott Ave,MC 868, Chicago, IL 60612 USA.	gcl@uic.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [HL24530-29, HL089517]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089517, R01HL024530] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grant HL24530-29 (to G. C. L.), HL089517 (to A. H. C.), and grant-in-aid from the American Heart Association (to A. H. C.). The authors declare that they have no conflicts of interest with the contents of this article.	BAI Y, 1984, BLOOD, V64, P139; Bledzka K, 2010, J BIOL CHEM, V285, P30370, DOI 10.1074/jbc.C110.134247; BRACE LD, 1985, AM J PHYSIOL, V249, pH1, DOI 10.1152/ajpheart.1985.249.1.H1; Brass LF, 1997, THROMB HAEMOSTASIS, V78, P581; BURRIDGE K, 1983, J CELL BIOL, V97, P359, DOI 10.1083/jcb.97.2.359; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Djellas Y, 1999, J BIOL CHEM, V274, P14325, DOI 10.1074/jbc.274.20.14325; FOX JEB, 1983, CELL MOTIL CYTOSKEL, V3, P579, DOI 10.1002/cm.970030524; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; Galvagni F, 2010, CIRC RES, V106, P1839, DOI 10.1161/CIRCRESAHA.109.206326; GERRARD JM, 1974, AM J PATHOL, V77, P151; Gong HX, 2010, SCIENCE, V327, P340, DOI 10.1126/science.1174779; Huang JS, 2007, J BIOL CHEM, V282, P10210, DOI 10.1074/jbc.M605678200; Jin JG, 1998, J BIOL CHEM, V273, P2030, DOI 10.1074/jbc.273.4.2030; Kahn ML, 1999, J CLIN INVEST, V103, P879, DOI 10.1172/JCI6042; KIM SO, 1992, BIOCHEM PHARMACOL, V43, P313; Kuchay SM, 2007, CURR OPIN HEMATOL, V14, P249, DOI 10.1097/MOH.0b013e3280ef68f8; LAMBRIGHT DG, 1994, NATURE, V369, P621, DOI 10.1038/369621a0; Ma YQ, 2006, BIOCHEMISTRY-US, V45, P6656, DOI 10.1021/bi060279h; MICHAL F, 1971, NATURE-NEW BIOL, V231, P220, DOI 10.1038/newbio231220a0; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; Moers A, 2003, NAT MED, V9, P1418, DOI 10.1038/nm943; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Offermanns S, 1997, SCIENCE, V275, P533, DOI 10.1126/science.275.5299.533; Patil S, 1999, J BIOL CHEM, V274, P28575, DOI 10.1074/jbc.274.40.28575; PHILLIPS DR, 1987, ANN NY ACAD SCI, V509, P177, DOI 10.1111/j.1749-6632.1987.tb30994.x; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; SHATTIL SJ, 1987, BLOOD, V70, P307; Shen B, 2013, NATURE, V503, P131, DOI 10.1038/nature12613; Sonde J., 1994, NATURE, V217, P503; Southgate EL, 2008, J IMMUNOL, V181, P1429, DOI 10.4049/jimmunol.181.2.1429; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Yan B, 2001, J BIOL CHEM, V276, P28164, DOI 10.1074/jbc.M104161200	34	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					25129	25139		10.1074/jbc.M115.650978	http://dx.doi.org/10.1074/jbc.M115.650978			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26292217	Green Published, hybrid			2022-12-26	WOS:000362598300040
J	Wen, JH; Wen, H; Gibson-Corley, KN; Glenn, KA				Wen, John H.; Wen, Hsiang; Gibson-Corley, Katherine N.; Glenn, Kevin A.			FBG1 Is the Final Arbitrator of A1AT-Z Degradation	PLOS ONE			English	Article							MUTANT ALPHA(1)-ANTITRYPSIN Z; ENDOPLASMIC-RETICULUM; ALPHA-1-ANTITRYPSIN DEFICIENCY; UBIQUITIN LIGASE; LIVER-DISEASE; DEUBIQUITINATING ENZYME; NEUTROPHIL LIPOCALIN; REGULATES AUTOPHAGY; Z-VARIANT; PROTEIN	Alpha-1 antitrypsin deficiency is the leading cause of childhood liver failure and one of the most common lethal genetic diseases. The disease-causing mutant A1AT-Z fails to fold correctly and accumulates in the endoplasmic reticulum (ER) of the liver, resulting in hepatic fibrosis and hepatocellular carcinoma in a subset of patients. Furthermore, A1AT-Z sequestration in hepatocytes leads to a reduction in A1AT secretion into the serum, causing panacinar emphysema in adults. The purpose of this work was to elucidate the details by which A1AT-Z is degraded in hepatic cell lines. We identified the ubiquitin ligase FBG1, which has been previously shown to degrade proteins by both the ubiquitin proteasome pathway and autophagy, as being key to A1AT-Z degradation. Using chemical and genetic approaches we show that FBG1 degrades A1AT-Z through both the ubiquitin proteasome system and autophagy. Overexpression of FBG1 decreases the half-life of A1AT-Z and knocking down FBG1 in a hepatic cell line, and in mice results in an increase in ATAT. Finally, we show that FBG1 degrades A1AT-Z through a Beclin1-dependent arm of autophagy. In our model, FBG1 acts as a safety ubiquitin ligase, whose function is to re-ubiquitinate ER proteins that have previously undergone de-ubiquitination to ensure they are degraded.	[Wen, John H.] Yale Univ, New Haven, CT 06520 USA; [Wen, Hsiang; Glenn, Kevin A.] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Gibson-Corley, Katherine N.] Univ Iowa, Dept Pathol, Carver Coll Med, Iowa City, IA 52242 USA; [Glenn, Kevin A.] VA Med Ctr, Iowa City, IA USA	Yale University; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Glenn, KA (corresponding author), Yale Univ, New Haven, CT 06520 USA.	kevin-glenn@uiowa.edu		Glenn, Kevin/0000-0002-6941-9649; Gibson-Corley, Katherine/0000-0002-1846-1580	Veteran Affairs Research Career Development Award	Veteran Affairs Research Career Development Award	Veteran Affairs Research Career Development Award to KAG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Thoracic Soc European Respir, 2003, AM J RESP CRIT CARE, V168, P818, DOI 10.1164/rccm.168.7.818; Ballar P, 2011, INT J BIOCHEM CELL B, V43, P613, DOI 10.1016/j.biocel.2010.12.021; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bartlett BJ, 2011, AUTOPHAGY, V7, P572, DOI 10.4161/auto.7.6.14943; Bouchecareilh M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.404707; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; Chang JW, 2011, J NEUROCHEM, V116, P659, DOI 10.1111/j.1471-4159.2010.07158.x; Choi CH, 2012, BIOCHEM BIOPH RES CO, V418, P759, DOI 10.1016/j.bbrc.2012.01.095; Chu AS, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/459823; Claessen JHL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090204; Claessen JHL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028542; Claessen JHL, 2012, TRENDS CELL BIOL, V22, P22, DOI 10.1016/j.tcb.2011.09.010; Comunale MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012419; Cooper GR, 1997, BIOCHEM J, V325, P601, DOI 10.1042/bj3250601; Crosas B, 2006, CELL, V127, P1401, DOI 10.1016/j.cell.2006.09.051; Ernst R, 2009, MOL CELL, V36, P28, DOI 10.1016/j.molcel.2009.09.016; Fairbanks KD, 2008, AM J GASTROENTEROL, V103, P2136, DOI 10.1111/j.1572-0241.2008.01955.x; Fujita E, 2007, HUM MOL GENET, V16, P618, DOI 10.1093/hmg/ddm002; Gelling CL, 2012, GENETICS, V192, P889, DOI 10.1534/genetics.112.143487; Glenn KA, 2008, J BIOL CHEM, V283, P12717, DOI 10.1074/jbc.M709508200; GOKAL PK, 1986, J BIOL CHEM, V261, P2536; Gordon KL, 2012, NEUROSCIENCE, V224, P160, DOI 10.1016/j.neuroscience.2012.08.023; Grishchuk Y, 2011, AUTOPHAGY, V7, P1115, DOI 10.4161/auto.7.10.16608; Haspel J, 2011, AUTOPHAGY, V7, P629, DOI 10.4161/auto.7.6.15100; Hassink GC, 2009, EMBO REP, V10, P755, DOI 10.1038/embor.2009.69; Hidvegi T, 2011, METHOD ENZYMOL, V499, P33, DOI [10.1016/B978-0-12-386471-0.00003-1, 10.1016/13978-0-12-386471-0.00003-1]; Hidvegi T, 2010, SCIENCE, V329, P229, DOI 10.1126/science.1190354; Jaber N, 2012, P NATL ACAD SCI USA, V109, P2003, DOI 10.1073/pnas.1112848109; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Jones SA, 2013, IMMUNOL CELL BIOL, V91, P250, DOI 10.1038/icb.2012.82; Juenemann Katrin, 2012, Int J Cell Biol, V2012, P189794, DOI 10.1155/2012/189794; Kamimoto T, 2006, J BIOL CHEM, V281, P4467, DOI 10.1074/jbc.M509409200; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kaushal S, 2010, EXP BIOL MED, V235, P700, DOI 10.1258/ebm.2010.009297; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Kruse KB, 2006, MOL BIOL CELL, V17, P203, DOI 10.1091/mbc.e04-09-0779; Lawless MW, 2004, J IMMUNOL, V172, P5722, DOI 10.4049/jimmunol.172.9.5722; Le Fourn V, 2009, CELL MOL LIFE SCI, V66, P1434, DOI 10.1007/s00018-009-9038-1; Lomas DJ, 1995, LANCET, V346, pS20, DOI 10.1016/0140-6736(95)90019-5; Mallinger A, 2012, BIOCHEM BIOPH RES CO, V418, P44, DOI 10.1016/j.bbrc.2011.12.109; Motoi Y, 2014, ACS CHEM NEUROSCI, V5, P434, DOI 10.1021/cn500056q; Nelson DR, 2012, CLIN GASTROENTEROL H, V10, P575, DOI 10.1016/j.cgh.2011.12.028; Nelson RF, 2007, J NEUROSCI, V27, P5163, DOI 10.1523/JNEUROSCI.0206-07.2007; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; Perlmutter DH, 2007, HEPATOLOGY, V45, P1313, DOI 10.1002/hep.21628; Perlmutter DH, 2006, AUTOPHAGY, V2, P258, DOI 10.4161/auto.2882; Qu DF, 1996, J BIOL CHEM, V271, P22791, DOI 10.1074/jbc.271.37.22791; Renna M, 2010, J BIOL CHEM, V285, P11061, DOI 10.1074/jbc.R109.072181; SAMANDARI T, 1993, PROTEIN SCI, V2, P1400, DOI 10.1002/pro.5560020905; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Schmidt BZ, 2005, AM J PHYSIOL-GASTR L, V289, pG444, DOI 10.1152/ajpgi.00237.2004; Shen YX, 2006, BIOCHEM BIOPH RES CO, V349, P1285, DOI 10.1016/j.bbrc.2006.08.173; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Smith SE, 2011, J BIOL CHEM, V286, P41563, DOI 10.1074/jbc.M111.280073; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Sveger T, 1998, PEDIATR RES, V44, P939, DOI 10.1203/00006450-199812000-00019; Sveger T, 2003, SCAND J CLIN LAB INV, V63, P89, DOI 10.1080/00365510310000961; SVEGER T, 1995, HEPATOLOGY, V22, P514, DOI 10.1002/hep.1840220221; SVEGER T, 1976, NEW ENGL J MED, V294, P1316, DOI 10.1056/NEJM197606102942404; SVEGER T, 1984, J PEDIATR-US, V104, P91, DOI 10.1016/S0022-3476(84)80599-5; SVEGER T, 1994, ACTA PAEDIATR, V83, P18, DOI 10.1111/j.1651-2227.1994.tb13201.x; SVEGER T, 1978, PEDIATRICS, V62, P22; Sveger T, 1997, ACTA PAEDIATR, V86, P37, DOI 10.1111/j.1651-2227.1997.tb08828.x; SVEGER T, 1988, ACTA PAEDIATR SCAND, V77, P847, DOI 10.1111/j.1651-2227.1988.tb10767.x; Tassa A, 2003, BIOCHEM J, V376, P577, DOI 10.1042/BJ20030826; Teckman JH, 2000, AM J PHYSIOL-GASTR L, V279, pG961, DOI 10.1152/ajpgi.2000.279.5.G961; Teckman JH, 2002, AM J PHYSIOL-GASTR L, V283, pG1156, DOI 10.1152/ajpgi.00041.2002; Teckman JH, 2000, AM J PHYSIOL-GASTR L, V278, pG39, DOI 10.1152/ajpgi.2000.278.1.G39; Teckman JH, 2001, J BIOL CHEM, V276, P44865, DOI 10.1074/jbc.M103703200; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang HP, 2011, MOL CELL BIOCHEM, V346, P137, DOI 10.1007/s11010-010-0600-9; Wang QY, 2006, J CELL BIOL, V174, P963, DOI 10.1083/jcb.200605100; Wen H, 2014, INT J BIOCH RES REV; Wen H, 2010, CELL CYCLE, V9, P4506, DOI 10.4161/cc.9.22.13743; Werner ED, 1996, P NATL ACAD SCI USA, V93, P13797, DOI 10.1073/pnas.93.24.13797; Wu Y, 2003, P NATL ACAD SCI USA, V100, P8229, DOI 10.1073/pnas.1430537100; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Zhou CH, 2012, ACTA BIOCH BIOPH SIN, V44, P815, DOI 10.1093/abbs/gms064	78	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135591	10.1371/journal.pone.0135591	http://dx.doi.org/10.1371/journal.pone.0135591			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295339	Green Submitted, Green Published, gold			2022-12-26	WOS:000359926900035
J	Cody, EM; Reagan, AJ; Mitchell, L; Dodds, PS; Danforth, CM				Cody, Emily M.; Reagan, Andrew J.; Mitchell, Lewis; Dodds, Peter Sheridan; Danforth, Christopher M.			Climate Change Sentiment on Twitter: An Unsolicited Public Opinion Poll	PLOS ONE			English	Article							SOCIAL MEDIA; MASS-MEDIA; BELIEF; WEATHER	The consequences of anthropogenic climate change are extensively debated through scientific papers, newspaper articles, and blogs. Newspaper articles may lack accuracy, while the severity of findings in scientific papers may be too opaque for the public to understand. Social media, however, is a forum where individuals of diverse backgrounds can share their thoughts and opinions. As consumption shifts from old media to new, Twitter has become a valuable resource for analyzing current events and headline news. In this research, we analyze tweets containing the word "climate" collected between September 2008 and July 2014. Through use of a previously developed sentiment measurement tool called the Hedonometer, we determine how collective sentiment varies in response to climate change news, events, and natural disasters. We find that natural disasters, climate bills, and oil-drilling can contribute to a decrease in happiness while climate rallies, a book release, and a green ideas contest can contribute to an increase in happiness. Words uncovered by our analysis suggest that responses to climate change news are predominately from climate change activists rather than climate change deniers, indicating that Twitter is a valuable resource for the spread of climate change awareness.	[Cody, Emily M.; Reagan, Andrew J.; Dodds, Peter Sheridan; Danforth, Christopher M.] Univ Vermont, Computat Story Lab, Burlington, VT 05401 USA; [Cody, Emily M.; Reagan, Andrew J.; Dodds, Peter Sheridan; Danforth, Christopher M.] Univ Vermont, Vermont Complex Syst Ctr, Burlington, VT 05401 USA; [Cody, Emily M.; Reagan, Andrew J.; Dodds, Peter Sheridan; Danforth, Christopher M.] Univ Vermont, Dept Math & Stat, Burlington, VT 05401 USA; [Mitchell, Lewis] Univ Adelaide, Sch Math Sci, Adelaide, SA 5005, Australia	University of Vermont; University of Vermont; University of Vermont; University of Adelaide	Cody, EM (corresponding author), 16 Colchester Ave, Burlington, VT 05401 USA.	Emily.Cody@uvm.edu	Mitchell, Lewis/U-8250-2019; Mitchell, Lewis/W-1312-2018; Dodds, Peter/C-9119-2014	Mitchell, Lewis/0000-0001-8191-1997; Mitchell, Lewis/0000-0001-8191-1997; Dodds, Peter/0000-0003-1973-8614	National Science Foundation (NSF) grant [DMS-0940271]; NSF CAREER Award [0846668]; Direct For Mathematical & Physical Scien [0940271] Funding Source: National Science Foundation	National Science Foundation (NSF) grant(National Science Foundation (NSF)); NSF CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The authors are grateful for the computational resources provided by the Vermont Advanced Computing Core which is supported by the Vermont Complex Systems Center. CMD, AJR, EMC, and LM were supported by National Science Foundation (NSF) grant DMS-0940271 to the Mathematics & Climate Research Network. PSD was supported by NSF CAREER Award #0846668.	An X., 2014, KDD; Aramaki E., 2011, P C EMPIRICAL METHOD, P1568, DOI DOI 10.1016/J.DEUGALCDEP.2015.07.1199; Barros V, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, pIX; Bliss CA, 2012, J COMPUT SCI-NETH, V3, P388, DOI 10.1016/j.jocs.2012.05.001; Boykoff M. T., 2011, MAKING SENSE MEDIA R; Boykoff MT, 2007, GEOFORUM, V38, P1190, DOI 10.1016/j.geoforum.2007.01.008; Dodds PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026752; Everett, 1996, AGENDA SETTING, V6; Field C.B., 2012, MANAGING RISKS EXTRE; Fischer EM, 2015, NAT CLIM CHANGE, V5, P560, DOI 10.1038/nclimate2617; Hamilton LC, 2013, WEATHER CLIM SOC, V5, P112, DOI 10.1175/WCAS-D-12-00048.1; Howe PD, 2015, NAT CLIM CHANGE, V5, P596, DOI 10.1038/nclimate2583; Huber D.G., 2011, EXTREME WEATHER CLIM; Kirilenko AP, 2015, GLOBAL ENVIRON CHANG, V30, P92, DOI 10.1016/j.gloenvcha.2014.11.003; Kloumann IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029484; Kryvasheyeu Y, 2015, NOWCASTING DIS UNPUB; Kwak H., 2010, PROC 19 INT C WORLD, P591, DOI 10.1145/1772690.1772751; Leiserowitz A., 2013, CLIMATE CHANGE AM MI; Li Y, 2011, PSYCHOL SCI, V22, P454, DOI 10.1177/0956797611400913; Lin Y.R., 2013, P 22 INT C WORLD WID, P737, DOI DOI 10.1145/2488388.2488453; Lin YR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094093; MacKay D., 2008, SUSTAINABLE ENERGY H; Mann M.E., 2006, EOS, V87, P233, DOI 10.1029/2006EO240001; Mitchell L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064417; Paul M.J., 2011, P 5 INT AAAI C WEBL, P265; Phan TQ, 2015, P NATL ACAD SCI USA, V112, P6595, DOI 10.1073/pnas.1404770112; Ripberger JT, 2014, WEATHER CLIM SOC, V6, P520, DOI 10.1175/WCAS-D-13-00028.1; Sakaki T., 2010, P 19 INT C WORLD WID, P851, DOI [10.1145/1772690.1772777, DOI 10.1145/1772690.1772777, 10.1145/1772690.1772777.]; Schuldt J. P., 2011, PUBLIC OPIN QUART; Twain M, 1980, M TWAINS NOTEBOOKS J, V8; Williams HTP, 2015, GLOBAL ENVIRON CHANG, V32, P126, DOI 10.1016/j.gloenvcha.2015.03.006; Wilson KM., 1995, MASS COMMUNICATION R, V22, P75; Zaval L, 2014, NAT CLIM CHANGE, V4, P143, DOI 10.1038/NCLIMATE2093; Zimmerman M., 2009, EOS T AM GEOPHYS UN, V99, P22, DOI DOI 10.1029/2009EO030002	36	115	117	5	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136092	10.1371/journal.pone.0136092	http://dx.doi.org/10.1371/journal.pone.0136092			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5KH	26291877	Green Published, Green Submitted, gold			2022-12-26	WOS:000359919900053
J	Karita, E; Price, MA; Lakhi, S; Kilembe, W; Kamali, A; Ruzagira, E; Hunter, E; Farmer, P; Allen, S; Stevens, G; Chetty, P; Welsh, S; Yang, A; Gilmour, J; Fast, P				Karita, Etienne; Price, Matt A.; Lakhi, Shabir; Kilembe, William; Kamali, Anatoli; Ruzagira, Eugene; Hunter, Eric; Farmer, Paul; Allen, Susan; Stevens, Gwynn; Chetty, Paramesh; Welsh, Sabrina; Yang, Annie; Gilmour, Jill; Fast, Pat		IAVI Africa HIV Prevention	High Transmitter CD4+T-Cell Count Shortly after the Time of Transmission in a Study of African Serodiscordant Couples	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ANTIRETROVIRAL THERAPY; DISCORDANT COUPLES; PREVENT TRANSMISSION; VIRAL LOAD; HIV; DECLINE; ZAMBIA; INITIATION; INFECTION	Background 2013 WHO guidelines recommend starting ART at CD4+ T-cell counts <= 500 cells/mu L. We present the T-cell counts from adult Africans with HIV shortly following transmission to their sexual partners. Methods HIV-discordant couples in Zambia, Uganda and Rwanda were followed prospectively and received couples counseling and condoms. HIV uninfected partners were tested for HIV at least quarterly and HIV-infected partners received HIV care and referral for ART per national guidelines. Upon diagnosis of incident HIV infection in the previously HIV-uninfected partner, a blood sample was collected from both partners to measure CD4+ T-cells and perform viral linkage. The estimated date of infection (EDI) of the incident case was calculated based on testing history. EDI was unknown for suspected transmitting partners. Results From 2006-2011, 4,705 HIV-discordant couples were enrolled in this cohort, and 443 cases of incident HIV infection were documented. Virus linkage analysis was performed in 374 transmission pairs, and 273 (73%) transmissions were linked genetically. CD4 counts in the transmitting partner were measured a median of 56 days after EDI (mean:90.5, min:10, max:396). The median CD4 count was 339 cells/mu l (mean:386.4, min:15,max:1,434), and the proportion of partners with a CD4+ T-cell count above 500/mu l was 25% (95% CI:21, 31). Conclusions In our cohort of discordant couples, 73% of HIV transmissions occurred within the relationship, and the transmitter CD4+ T-cell count shortly after the transmission event was frequently higher than the WHO 2013 ART-initiation guidelines.	[Karita, Etienne; Hunter, Eric] Projet San Francisco, Kigali, Rwanda; [Price, Matt A.; Welsh, Sabrina; Yang, Annie; Fast, Pat] IAVI, New York, NY 10004 USA; [Lakhi, Shabir; Kilembe, William; Hunter, Eric] Zambia Emory HIV Res Project, Lusaka, Ndola & Kitwe, Zambia; [Kamali, Anatoli; Ruzagira, Eugene] Uganda Virus Res Inst, MRC, Masaka, Uganda; [Kamali, Anatoli; Ruzagira, Eugene] Uganda Virus Res Inst, MRC, Entebbe, Uganda; [Hunter, Eric; Farmer, Paul] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Allen, Susan] Emory Univ, Sch Med, Atlanta, GA USA; [Stevens, Gwynn; Chetty, Paramesh; Gilmour, Jill] IAVI, Human Immunol Lab, London, England; [Price, Matt A.] UCSF Dept Epidemiol & Biostat, San Francisco, CA USA	International AIDS Vaccine Initiative; Uganda Virus Research Institute; Emory University; Emory University; International AIDS Vaccine Initiative	Price, MA (corresponding author), IAVI, New York, NY 10004 USA.	mprice@iavi.org	Price, Matt/AAK-6881-2021	Price, Matt/0000-0002-2918-1373; Ruzagira, Eugene/0000-0002-7291-1693	Bill & Melinda Gates Foundation; Ministry of Foreign Affairs of Denmark; Irish Aid; Ministry of Finance of Japan; Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation (NORAD); United Kingdom Department for International Development (DFID); United States Agency for International Development (USAID); American people through USAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064060, R37AI051231] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Ministry of Foreign Affairs of Denmark; Irish Aid(CGIAR); Ministry of Finance of Japan; Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation (NORAD)(CGIAR); United Kingdom Department for International Development (DFID); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); American people through USAID(United States Agency for International Development (USAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	IAVI's work is made possible by generous support from many donors including: the Bill & Melinda Gates Foundation; the Ministry of Foreign Affairs of Denmark; Irish Aid; the Ministry of Finance of Japan; the Ministry of Foreign Affairs of the Netherlands; the Norwegian Agency for Development Cooperation (NORAD); the United Kingdom Department for International Development (DFID), and the United States Agency for International Development (USAID). The full list of IAVI donors is available at www.iavi.org. This study is made possible by the generous support of the American people through USAID. None of the funders had a role in study design, data collection, decision to publish, or preparation of the manuscript.	Allen S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-349; Amornkul PN, 2013, AIDS, V27, P2775, DOI 10.1097/QAD.0000000000000012; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Baeten JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001888; Campbell MS, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016986, 10.1371/journal.pone.0018283]; Chomba E, 2008, JAIDS-J ACQ IMM DEF, V47, P108, DOI 10.1097/QAI.0b013e31815b2d67; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cohen MS, 2010, CLIN INFECT DIS, V50, pS85, DOI 10.1086/651478; Czaicki N, 2012, PROGR CHALLENGES INT; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; El-Sadr WM, 2011, AIDS, V25, P2295, DOI 10.1097/QAD.0b013e32834c4c22; Eshleman SH, 2011, J INFECT DIS, V204, P1918, DOI 10.1093/infdis/jir651; Fabiani M, 1998, J ACQ IMMUN DEF SYND, V18, P514, DOI 10.1097/00042560-199808150-00015; Fast PE, 2013, LANCET, V382, P1778, DOI 10.1016/S0140-6736(13)62539-8; Graham SM, 2007, AIDS, V21, P501, DOI 10.1097/QAD.0b013e32801424bd; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Kamali A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116100; Kiwanuka N, 2010, JAIDS-J ACQ IMM DEF, V54, P180, DOI 10.1097/QAI.0b013e3181c98fc0; Matovu JKB, 2010, CURR HIV RES, V8, P430, DOI 10.2174/157016210793499303; Mulissa Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013268; Price MA, 2011, AIDS RES HUM RETROV, V27, P5, DOI 10.1089/aid.2010.0030; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Trask SA, 2002, J VIROL, V76, P397, DOI 10.1128/JVI.76.1.397-405.2002; UNAIDS, 2012, GLOB AIDS EP FACTS F; Urassa W, 2004, AIDS, V18, P433, DOI 10.1097/00002030-200402200-00009; Vernazza PL, 2000, AIDS, V14, P117, DOI 10.1097/00002030-200001280-00006; WHO UNICEF UNAIDS, 2013, PROGR CHALL INT CVCT; World Health Organization, 2013, CREAT AFR HIV CLIN R; Wubshet M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059197	30	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0134438	10.1371/journal.pone.0134438	http://dx.doi.org/10.1371/journal.pone.0134438			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291456	Green Published, Green Submitted, gold			2022-12-26	WOS:000359919900005
J	Toth, Z				Toth, Zoltan			Context-Dependent Plastic Response during Egg-Laying in a Widespread Newt Species	PLOS ONE			English	Article							PREDATOR-INDUCED PLASTICITY; PHENOTYPIC PLASTICITY; BEHAVIORAL PLASTICITY; MATERNAL INVESTMENT; WRAPPING BEHAVIOR; NATURAL-SELECTION; FITNESS COSTS; SMOOTH NEWTS; T-HELVETICUS; SIZE	Previous research on predator-induced phenotypic plasticity mostly focused on responses in morphology, developmental time and/or behaviour during early life stages, but the potential significance of anticipatory parental responses has been investigated less often. In this study I examined behavioural and maternal responses of gravid female smooth newts, Lissotriton vulgaris, in the presence of chemical cues originating from invertebrate predators, Acilius sulcatus water beetles and Aeshna cyanea dragonfly larvae. More specifically, I tested the extent of oviposition preference, plasticity in egg-wrapping behaviour and plasticity in egg size when females had the possibility to lay eggs at oviposition sites with and without predator cues during overnight trials. I found that individuals did not avoid laying eggs in the environment with predator cues; however, individuals that deposited eggs into both environments adjusted the size of the laid eggs to the perceived environment. Females deposited larger eggs earlier in the season but egg size decreased with time in the absence of predator cues, whereas individuals laid eggs of average size throughout the investigated reproductive period when such cues were present. Also, egg size was found to be positively related to hatching success. Individuals did not adjust their wrapping behaviour to the presence of predator cues, but females differed in the extent of egg-wrapping between ponds. Females' body mass and tail depth were also different between ponds, whereas their body size was positively associated with egg size. According to these results, female smooth newts have the potential to exhibit activational plasticity and invest differently into eggs depending on temporal and environmental factors. Such an anticipatory response may contribute to the success of this caudate species under a wide range of predator regimes at its natural breeding habitats.	Hungarian Acad Sci, Agr Res Ctr, Inst Plant Protect, Lendulet Evolutionary Ecol Res Grp, Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research	Toth, Z (corresponding author), Hungarian Acad Sci, Agr Res Ctr, Inst Plant Protect, Lendulet Evolutionary Ecol Res Grp, Budapest, Hungary.	toth.zoltan@agrar.mta.hu		Toth, Zoltan/0000-0002-2634-8393	Hungarian Scientific Research Fund [PD108938]; Postdoctoral Research Programme of the Hungarian Academy of Sciences [SZ-029/2013]; "Lendulet" Programme of the Hungarian Academy of Sciences [LP2012-24/2012]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Postdoctoral Research Programme of the Hungarian Academy of Sciences; "Lendulet" Programme of the Hungarian Academy of Sciences	This study was financially supported by a grant of the Hungarian Scientific Research Fund to ZT (www.otka.hu, PD108938). During the study, ZT was also supported by the Postdoctoral Research Programme of the Hungarian Academy of Sciences (www.mta.hu, SZ-029/2013) and the "Lendulet" Programme of the Hungarian Academy of Sciences (LP2012-24/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abjornsson K, 2004, ECOLOGY, V85, P1859, DOI 10.1890/03-0074; Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Agrawal AA, 1999, NATURE, V401, P60, DOI 10.1038/43425; Alekseev V, 2001, NATURE, V414, P899, DOI 10.1038/414899a; Allen RM, 2008, AM NAT, V171, P225, DOI 10.1086/524952; American Public Health Association, 1985, WATER WASTEWATER STA; Arntzen JW, 2009, IUCN 2012 IUCN RED L; BELL G, 1977, ECOL MONOGR, V47, P279, DOI 10.2307/1942518; Berrigan D., 2004, PHENOTYPIC PLASTICIT, P82; Bestion E, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0701; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bronmark C, 2000, OIKOS, V88, P103, DOI 10.1034/j.1600-0706.2000.880112.x; Bronmark C, 1998, ECOLOGY AND EVOLUTION OF INDUCIBLE DEFENSES, P203; Bronmark C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021773; Burgess SC, 2014, OIKOS, V123, P769, DOI 10.1111/oik.01235; Coslovsky M, 2012, GEN COMP ENDOCR, V176, P211, DOI 10.1016/j.ygcen.2012.01.013; Dingemanse NJ, 2013, ANIM BEHAV, V85, P1031, DOI 10.1016/j.anbehav.2012.12.032; Ezard THG, 2014, FUNCT ECOL, V28, P693, DOI 10.1111/1365-2435.12207; Faraway J.J., 2006, C&H TEXT STAT SCI, P59; Gasc J. P., 1997, COLLECTION PATRIMOIN; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Giesing ER, 2011, P ROY SOC B-BIOL SCI, V278, P1753, DOI 10.1098/rspb.2010.1819; GOULDEN CE, 1987, OECOLOGIA, V72, P28, DOI 10.1007/BF00385040; Hettyey A, 2011, J EVOLUTION BIOL, V24, P1007, DOI 10.1111/j.1420-9101.2011.02233.x; Hettyey A, 2010, OIKOS, V119, P1814, DOI 10.1111/j.1600-0706.2010.18563.x; Huizinga M, 2009, J EVOLUTION BIOL, V22, P1860, DOI 10.1111/j.1420-9101.2009.01799.x; Jehle R, 2007, BIOLOGY LETT, V3, P526, DOI 10.1098/rsbl.2007.0311; KAPLAN RH, 1992, ECOLOGY, V73, P280, DOI 10.2307/1938739; Kaplan RH, 2006, EVOLUTION, V60, P142; Kaplan RH, 1997, HERPETOLOGICA, V53, P149; Kasumovic MM, 2013, ANIM BEHAV, V85, P1049, DOI 10.1016/j.anbehav.2013.02.009; Kats LB, 1998, ECOSCIENCE, V5, P361, DOI 10.1080/11956860.1998.11682468; Kurdikova V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023842; Laurila A, 2004, OIKOS, V107, P90, DOI 10.1111/j.0030-1299.2004.13126.x; Lind MI, 2011, EVOLUTION, V65, P684, DOI 10.1111/j.1558-5646.2010.01122.x; Loman J, 2002, J ZOOL, V257, P93, DOI 10.1017/S0952836902000687; Manenti R, 2013, J ZOOL, V289, P182, DOI 10.1111/j.1469-7998.2012.00976.x; Marco A, 2001, ANIM BEHAV, V61, P639, DOI 10.1006/anbe.2000.1632; Marshall DJ, 2007, OIKOS, V116, P1957, DOI 10.1111/j.2007.0030-1299.16203.x; Martin RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009117; MCGINLEY MA, 1987, AM NAT, V130, P370, DOI 10.1086/284716; MIAUD C, 1994, COPEIA, P535; MIAUD C, 1993, J ZOOL, V231, P575, DOI 10.1111/j.1469-7998.1993.tb01939.x; Michimae H, 2012, J EVOLUTION BIOL, V25, P1331, DOI 10.1111/j.1420-9101.2012.02523.x; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Nollert A., 1992, AMPHIBIEN EUROPAS BE; Norris KM, 2005, ETHOLOGY, V111, P357, DOI 10.1111/j.1439-0310.2005.01071.x; Orizaola G, 2003, HERPETOL J, V13, P189; Orizaola G, 2003, HERPETOL J, V13, P121; Ortiz-Santaliestra ME, 2007, AQUAT TOXICOL, V85, P251, DOI 10.1016/j.aquatox.2007.09.008; PARKER GA, 1986, AM NAT, V128, P573, DOI 10.1086/284589; Pfennig DW, 2010, TRENDS ECOL EVOL, V25, P459, DOI 10.1016/j.tree.2010.05.006; Pigliucci M., 2001, SYN ECO EVO; R Core Team, R LANG ENV STAT COMP; Rasanen K, 2007, FUNCT ECOL, V21, P408, DOI 10.1111/j.1365-2435.2007.01246.x; Relyea RA, 2004, ECOLOGY, V85, P172, DOI 10.1890/03-0169; Relyea RA, 2001, ECOLOGY, V82, P523, DOI 10.1890/0012-9658(2001)082[0523:MABPOL]2.0.CO;2; Rieger JF, 2004, ECOLOGY, V85, P2094, DOI 10.1890/04-0156; Schmidt BR, 2005, J EVOLUTION BIOL, V18, P415, DOI 10.1111/j.1420-9101.2004.00822.x; Schmidt Peter, 2006, P139; Segers FHID, 2012, P ROY SOC B-BIOL SCI, V279, P1241, DOI 10.1098/rspb.2011.1290; Segers FHID, 2011, FUNCT ECOL, V25, P166, DOI 10.1111/j.1365-2435.2010.01790.x; SEMLITSCH RD, 1988, ECOLOGY, V69, P184, DOI 10.2307/1943173; Sih Andrew, 2004, P112; Snell-Rood EC, 2013, ANIM BEHAV, V85, P1004, DOI 10.1016/j.anbehav.2012.12.031; Sultan SE, 2002, AM NAT, V160, P271, DOI 10.1086/341015; TEMPLETON AR, 1978, THEOR POPUL BIOL, V13, P340, DOI 10.1016/0040-5809(78)90050-3; Tollrian Ralph, 1999, P177; Toth Z, 2011, J ZOOL, V284, P46, DOI 10.1111/j.1469-7998.2010.00781.x; Toth Z, 2011, AMPHIBIA-REPTILIA, V32, P77, DOI 10.1163/017353710X543001; Uller T, 2013, J EVOLUTION BIOL, V26, P2161, DOI 10.1111/jeb.12212; Van Buskirk J, 1999, OIKOS, V85, P31, DOI 10.2307/3546789; Van Buskirk J, 2002, EVOLUTION, V56, P361; Van Buskirk J, 2001, J EVOLUTION BIOL, V14, P482, DOI 10.1046/j.1420-9101.2001.00282.x; Van Buskirk J, 1997, EVOLUTION, V51, P1983, DOI 10.1111/j.1558-5646.1997.tb05119.x; Van Buskirk J, 2000, ECOLOGY, V81, P3009, DOI 10.1890/0012-9658(2000)081[3009:PIPPIL]2.0.CO;2; VERRELL PA, 1986, J HERPETOL, V20, P416, DOI 10.2307/1564504; Walsh MR, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2205; WARD D, 1981, COPEIA, P724; Weddeling K, 2004, HERPETOL J, V14, P1; Weitere M, 2004, MOL ECOL, V13, P1665, DOI 10.1111/j.1365-294X.2004.02155.x; Wells KD, 2007, ECOLOGY BEHAV AMPHIB, P499; West-Eberhard Mary Jane, 2003, pi; WESTEBERHARD MJ, 1989, ANNU REV ECOL SYST, V20, P249, DOI 10.1146/annurev.es.20.110189.001341; Wilson RS, 2005, FUNCT ECOL, V19, P238, DOI 10.1111/j.1365-2435.2005.00958.x	85	4	4	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136044	10.1371/journal.pone.0136044	http://dx.doi.org/10.1371/journal.pone.0136044			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291328	Green Published, gold, Green Accepted			2022-12-26	WOS:000359919900048
J	Cincotta, A; Yans, J; Godefroit, P; Garcia, G; Dejax, J; Benammi, M; Amico, S; Valentin, X				Cincotta, Aude; Yans, Johan; Godefroit, Pascal; Garcia, Geraldine; Dejax, Jean; Benammi, Mouloud; Amico, Sauveur; Valentin, Xavier			Integrated Paleoenvironmental Reconstruction and Taphonomy of a Unique Upper Cretaceous Vertebrate-Bearing Locality (Velaux, Southeastern France)	PLOS ONE			English	Article							PROVENCE BASIN; LATE EOCENE; FACIES; LACUSTRINE; REASSESSMENT; DINOSAURS; EGGSHELLS; LIMESTONE; PATTERNS; DEPOSITS	The Velaux-La Bastide Neuve fossil-bearing site (Bouches-du-Rhone, France) has yielded a diverse vertebrate assemblage dominated by dinosaurs, including the titanosaur Atsinganosaurus velauciensis. We here provide a complete inventory of vertebrate fossils collected during two large-scale field campaigns. Numerous crocodilian teeth occur together with complete skulls. Pterosaur, hybodont shark and fish elements are also represented but uncommon. Magnetostratigraphic analyses associated with biostratigraphic data from dinosaur eggshell and charophytes suggest a Late Campanian age for the locality. Lithologic and taphonomic studies, associated with microfacies and palynofacies analyses, indicate a fluvial setting of moderate energy with broad floodplain. Palynomorphs are quite rare; only three taxa of pollen grains occur: a bisaccate taxon, a second form probably belonging to the Normapolles complex, and another tricolporate taxon. Despite the good state of preservation, these taxa are generally difficult to identify, since they are scarce and have a very minute size. Most of the vertebrate remains are well preserved and suggest transport of the carcasses over short distances before accumulation in channel and overbank facies, together with reworked Aptian grains of glauconite, followed by a rapid burial. The bones accumulated in three thin layers that differ by their depositional modes and their taphonomic histories. Numerous calcareous and iron oxides-rich paleosols developed on the floodplain, suggesting an alternating dry and humid climate in the region during the Late Campanian.	[Cincotta, Aude; Yans, Johan] Univ Namur, Dept Geol, NaGRIDD, Namur, Belgium; [Cincotta, Aude; Godefroit, Pascal] Royal Belgian Inst Nat Sci, Directorate Earth & Hist Life, Brussels, Belgium; [Garcia, Geraldine; Benammi, Mouloud; Valentin, Xavier] Univ Poitiers, Inst Paleoprimatol Paleontol Humaine Evolut & Pal, UMR 7262, TSA 51106, Poitiers, France; [Dejax, Jean] Univ Paris 06, CNRS, Sorbonne Univ, CR2P,UMR 7207,MNHN, Paris, France; [Amico, Sauveur] Conseil Gen Bouches du Rhone, Hotel Dept, Direct Environm, Marseille, France; [Valentin, Xavier] Palaios Assoc, Valdivienne, France	University of Namur; Royal Belgian Institute of Natural Sciences; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Poitiers; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Cincotta, A (corresponding author), Univ Namur, Dept Geol, NaGRIDD, Namur, Belgium.	aude.cincotta@unamur.be			'Fond National pour la Recherche Scientifique' (FNRS)	'Fond National pour la Recherche Scientifique' (FNRS)(Fonds de la Recherche Scientifique - FNRS)	AC disposes of a FRIA grant provided by the 'Fond National pour la Recherche Scientifique' (FNRS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain R, 2003, CR PALEVOL, V2, P27, DOI 10.1016/S1631-0683(03)00002-2; Armenteros I, 1997, PALAEOGEOGR PALAEOCL, V128, P111, DOI 10.1016/S0031-0182(96)00108-3; Behrensmeyer A. K., 2007, BONEBEDS GENESIS ANA; Blasco R, 2008, J ARCHAEOL SCI, V35, P1605, DOI 10.1016/j.jas.2007.11.007; Brierley GJ, 1997, SEDIMENT GEOL, V114, P1, DOI 10.1016/S0037-0738(97)00114-0; Brown SAE, 2012, CRETACEOUS RES, V36, P162, DOI 10.1016/j.cretres.2012.02.008; CLARK J, 1967, Fieldiana Geology Memoirs, V5, P1; Cojan I, 2003, PALAEOGEOGR PALAEOCL, V191, P111, DOI 10.1016/S0031-0182(02)00655-7; Csiki Z, 2010, PALAEOGEOGR PALAEOCL, V293, P375, DOI 10.1016/j.palaeo.2009.10.013; Cuny G, 2012, BERNISSART DINOSAURS, P629; deBroin FD, 1996, CR ACAD SCI II A, V323, P729; Delfino M, 2008, J VERTEBR PALEONTOL, V28, P111, DOI 10.1671/0272-4634(2008)28[111:ACSOAP]2.0.CO;2; do Nascimento DR, 2015, SEDIMENT GEOL, V316, P1, DOI 10.1016/j.sedgeo.2014.11.002; Dominguez-Rodrigo M, 2014, J ARCHAEOL SCI, V41, P44, DOI 10.1016/j.jas.2013.07.025; Eberth DA, 2005, LIFE O PAST, P501; Eberth DA, 2005, LIFE O PAST, P453; Faith JT, 2006, J ARCHAEOL SCI, V33, P1718, DOI 10.1016/j.jas.2006.03.004; Fiorillo A.R., 1988, ROCKY MT GEOL, V26, P57; FIORILLO AR, 1991, PALAEOGEOGR PALAEOCL, V88, P157, DOI 10.1016/0031-0182(91)90062-V; FIORILLO AR, 1991, PALAEOGEOGR PALAEOCL, V81, P281, DOI 10.1016/0031-0182(91)90151-G; Garcia G, 2001, PALAEOGEOGR PALAEOCL, V169, P153, DOI 10.1016/S0031-0182(01)00215-2; Garcia G, 2010, B SOC GEOL FR, V181, P269, DOI 10.2113/gssgfbull.181.3.269; Ghosh P, 2006, SEDIMENT GEOL, V191, P3, DOI 10.1016/j.sedgeo.2006.01.002; Gradstein F, 2012, GEOLOGIC TIME SCALE, P435; Guyonnet-Benaize C, 2010, J GEODYN, V50, P81, DOI 10.1016/j.jog.2010.03.003; Kabanov P, 2008, SEDIMENT GEOL, V205, P81; Kos AM, 2003, J ARCHAEOL SCI, V30, P781, DOI 10.1016/S0305-4403(02)00252-2; Marmi J, 2012, CRETACEOUS RES, V35, P133, DOI 10.1016/j.cretres.2011.12.004; Marmi J, 2009, CRETACEOUS RES, V30, P1307, DOI 10.1016/j.cretres.2009.07.008; Murru M, 2003, CR GEOSCI, V335, P227, DOI 10.1016/S1631-0713(03)00029-4; Nichols GJ, 2007, SEDIMENT GEOL, V195, P75, DOI 10.1016/j.sedgeo.2006.07.004; Pimentel NL, 1996, SEDIMENT GEOL, V105, P1, DOI 10.1016/0037-0738(96)00034-6; PLAZIAT JC, 1981, PALAEOGEOGR PALAEOCL, V36, P263, DOI 10.1016/0031-0182(81)90110-3; Schnyder J, 2009, PALAEOGEOGR PALAEOCL, V281, P79, DOI 10.1016/j.palaeo.2009.07.014; Scott AC, 2000, PALAEOGEOGR PALAEOCL, V164, P1, DOI 10.1016/S0031-0182(00)00168-1; SMOOT JP, 1991, PALAEOGEOGR PALAEOCL, V84, P369, DOI 10.1016/0031-0182(91)90055-V; Srivastava P, 2006, PALAEOGEOGR PALAEOCL, V239, P241, DOI 10.1016/j.palaeo.2006.01.012; STEIGER RH, 1977, EARTH PLANET SC LETT, V36, P359, DOI 10.1016/0012-821X(77)90060-7; STEWART DJ, 1981, SEDIMENTOLOGY, V28, P1, DOI 10.1111/j.1365-3091.1981.tb01658.x; Tabuce R, 2013, ZOOL J LINN SOC-LOND, V169, P653, DOI 10.1111/zoj.12074; Thouand E, 2004, THESIS U POITIERS; Tofalo OR, 2010, J S AM EARTH SCI, V29, P665, DOI 10.1016/j.jsames.2009.09.002; Turkmen I, 2007, J ASIAN EARTH SCI, V30, P181, DOI 10.1016/j.jseaes.2006.08.006; Valentin Xavier, 2012, P582; Vedrine S, 2007, FACIES, V53, P535, DOI 10.1007/s10347-007-0114-4; Vila B, 2012, PALAEOGEOGR PALAEOCL, V350, P19, DOI 10.1016/j.palaeo.2012.06.008; Viseras C, 2006, PALAEOGEOGR PALAEOCL, V242, P139, DOI 10.1016/j.palaeo.2006.05.013; WESTPHAL M, 1989, EARTH PLANET SC LETT, V94, P143, DOI 10.1016/0012-821X(89)90090-3; Wright VP, 1997, SEDIMENT GEOL, V114, P81, DOI 10.1016/S0037-0738(97)00059-6; Wright VP, 1992, DEV SEDIMENTOL, V47, P591, DOI DOI 10.1016/S0070-4571(08)70574-0	50	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0134231	10.1371/journal.pone.0134231	http://dx.doi.org/10.1371/journal.pone.0134231			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287486	Green Published, gold			2022-12-26	WOS:000360018600016
J	Morand-Ferron, J; Hamblin, S; Cole, EF; Aplin, LM; Quinn, JL				Morand-Ferron, Julie; Hamblin, Steven; Cole, Ella F.; Aplin, Lucy M.; Quinn, John L.			Taking the Operant Paradigm into the Field: Associative Learning in Wild Great Tits	PLOS ONE			English	Article							PROBLEM-SOLVING PERFORMANCE; MIXED-SPECIES FLOCKS; INDIVIDUAL VARIATION; BEHAVIORAL FLEXIBILITY; COGNITIVE PERFORMANCE; PERSONALITY; EVOLUTION; MONKEYS; MEMORY; BLUE	Associative learning is essential for resource acquisition, predator avoidance and reproduction in a wide diversity of species, and is therefore a key target for evolutionary and comparative cognition research. Automated operant devices can greatly enhance the study of associative learning and yet their use has been mainly restricted to laboratory conditions. We developed a portable, weatherproof, battery-operated operant device and conducted the first fully automated colour-associative learning experiment using free-ranging individuals in the wild. We used the device to run a colour discrimination task in a monitored population of tits (Paridae). Over two winter months, 80 individuals from four species recorded a total of 5,128 trials. Great tits (Parus major) were more likely than other species to visit the devices and engage in trials, but there were no sex or personality biases in the sample of great tits landing at the devices and registering key pecks. Juveniles were more likely than adults to visit the devices and to register trials. Individuals that were successful at solving a novel technical problem in captivity (lever-pulling) learned faster than non-solvers when at the operant devices in the wild, suggesting cross-contextual consistency in learning performance in very different tasks. There was no significant effect of personality or sex on learning rate, but juveniles' choice accuracy tended to improve at a faster rate than adults. We discuss how customisable automated operant devices, such as the one described here, could prove to be a powerful tool in evolutionary ecology studies of cognitive traits, especially among inquisitive species such as great tits.	[Morand-Ferron, Julie] Univ Ottawa, Dept Biol, Ottawa, ON, Canada; [Morand-Ferron, Julie; Cole, Ella F.; Aplin, Lucy M.; Quinn, John L.] Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England; [Hamblin, Steven] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Quinn, John L.] Natl Univ Ireland Univ Coll Cork, Sch Biol Earth & Environm Sci, Cork, Ireland	University of Ottawa; University of Oxford; University of New South Wales Sydney; University College Cork	Morand-Ferron, J (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON, Canada.	jmf@uottawa.ca; j.quinn@ucc.ie	Morand-Ferron, Julie/AAW-7022-2021	Morand-Ferron, Julie/0000-0001-5186-7710	Natural Environment Research Council [NE/I017208/1]; Leverhulme grant [RPG-265]; NERC grant [NE/I017208/1]; Natural Sciences and Engineering Research Council Discovery grant [435596-2013]; BBSRC [BB/L006081/1] Funding Source: UKRI; NERC [NE/K006274/1, NE/I017208/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L006081/1] Funding Source: researchfish; Natural Environment Research Council [NE/K006274/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Leverhulme grant; NERC grant(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Sciences and Engineering Research Council Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by a Natural Environment Research Council grant (NE/I017208/1) to JLQ, and EFC was funded by a Leverhulme grant (RPG-265) (http://www.leverhulme.ac.uk/) to JLQ. JMF was funded by a NERC grant (NE/I017208/1) and a Natural Sciences and Engineering Research Council Discovery grant (435596-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aplin LM, 2013, ECOL LETT, V16, P1365, DOI 10.1111/ele.12181; Aplin LM, 2012, P ROY SOC B-BIOL SCI, V279, P4199, DOI 10.1098/rspb.2012.1591; Aplin LM, 2015, NATURE, V518, P538, DOI 10.1038/nature13998; Aplin LM, 2013, ANIM BEHAV, V85, P1225, DOI 10.1016/j.anbehav.2013.03.009; Auguie B, 2017, GRIDEXTRA MISCELLANE; BAUM WM, 1974, SCIENCE, V185, P78, DOI 10.1126/science.185.4145.78; Benson-Amram S, 2013, ANIM BEHAV, V85, P349, DOI 10.1016/j.anbehav.2012.11.003; Biro PA, 2009, TRENDS ECOL EVOL, V24, P66, DOI 10.1016/j.tree.2008.11.001; Boisvert MJ, 2000, PHYSIOL BEHAV, V71, P147, DOI 10.1016/S0031-9384(00)00317-6; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bond AB, 2007, J COMP PSYCHOL, V121, P372, DOI 10.1037/0735-7036.121.4.372; Bonte E, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00188; Bonter DN, 2011, J FIELD ORNITHOL, V82, P1, DOI 10.1111/j.1557-9263.2010.00302.x; Boogert NJ, 2008, ANIM BEHAV, V75, P1509, DOI 10.1016/j.anbehav.2007.09.033; Boogert NJ, 2010, BEHAV PROCESS, V85, P135, DOI 10.1016/j.beproc.2010.06.020; Cole EF, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0178; Cole EF, 2012, CURR BIOL, V22, P1808, DOI 10.1016/j.cub.2012.07.051; Cole EF, 2012, P ROY SOC B-BIOL SCI, V279, P1168, DOI 10.1098/rspb.2011.1539; Cole EF, 2011, ANIM BEHAV, V81, P491, DOI 10.1016/j.anbehav.2010.11.025; Dickinson A, 2012, PHILOS T R SOC B, V367, P2733, DOI 10.1098/rstb.2012.0220; Drea CM, 1999, P NATL ACAD SCI USA, V96, P12965, DOI 10.1073/pnas.96.22.12965; Fagot J, 2010, BEHAV RES METHODS, V42, P507, DOI 10.3758/BRM.42.2.507; Farine DR, 2012, ANIM BEHAV, V84, P1271, DOI 10.1016/j.anbehav.2012.08.008; Ferrari MCO, 2011, ANIM COGN, V14, P309, DOI 10.1007/s10071-010-0363-4; Galef BG, 2004, LEARN BEHAV, V32, P53; Galef BG, 2001, ANIM BEHAV, V61, P3, DOI 10.1006/anbe.2000.1557; Ginsburg S, 2010, J THEOR BIOL, V266, P11, DOI 10.1016/j.jtbi.2010.06.017; Gosler A, 1993, GREAT TIT; Greenlees MJ, 2010, BEHAV ECOL, V21, P966, DOI 10.1093/beheco/arq095; Griffin AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084907; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P137, DOI 10.1016/j.neubiorev.2004.06.010; Guenther A, 2014, J COMP PSYCHOL, V128, P74, DOI 10.1037/a0033678; Guillette LM, 2009, BEHAV PROCESS, V82, P265, DOI 10.1016/j.beproc.2009.07.005; Ham AD, 2006, BEHAV ECOL SOCIOBIOL, V60, P482, DOI 10.1007/s00265-006-0190-4; HEALY SD, 1995, Q J EXP PSYCHOL-B, V48, P179; Heyes C, 2012, PHILOS T R SOC B, V367, P2695, DOI 10.1098/rstb.2012.0217; Hoffman AM, 2007, BEHAV RES METHODS, V39, P776, DOI 10.3758/BF03192968; HOLLIS KL, 1989, J COMP PSYCHOL, V103, P115, DOI 10.1037/0735-7036.103.2.115; Hoppitt W, 2008, ADV STUD BEHAV, V38, P105, DOI 10.1016/S0065-3454(08)00003-X; Hurly TA, 1996, ANIM BEHAV, V51, P1149; Ings TC, 2009, BEHAV ECOL SOCIOBIOL, V63, P1207, DOI 10.1007/s00265-009-0731-8; Isden J, 2013, ANIM BEHAV, V86, P829, DOI 10.1016/j.anbehav.2013.07.024; Kendal RL, 2010, LEARN BEHAV, V38, P187, DOI 10.3758/LB.38.3.187; Krause J, 2013, TRENDS ECOL EVOL, V28, P541, DOI 10.1016/j.tree.2013.06.002; Lihoreau Mathieu, 2013, Commun Integr Biol, V6, pe22701, DOI 10.4161/cib.22701; Lihoreau M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001392; Lipp HP, 2001, NEUROSCI BIOBEHAV R, V25, P83, DOI 10.1016/S0149-7634(00)00050-6; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Marchetti C, 2000, ANIM BEHAV, V60, P131, DOI 10.1006/anbe.2000.1443; Biondi LM, 2010, ANIM COGN, V13, P701, DOI 10.1007/s10071-010-0319-8; Marshall RES, 2012, ANIM BEHAV, V83, P1163, DOI 10.1016/j.anbehav.2012.02.003; Marzluff JM, 2010, ANIM BEHAV, V79, P699, DOI 10.1016/j.anbehav.2009.12.022; Matechou E, 2015, ECOLOGY, V96, P1641, DOI 10.1890/14-0886.1; Morand-Ferron J, 1967, ANIM BEHAV, V200468, P1267; Morand-Ferron J, 2016, BIOL REV, V91, P367, DOI 10.1111/brv.12174; Morand-Ferron J, 2011, BEHAV ECOL, V22, P1241, DOI 10.1093/beheco/arr120; Morand-Ferron J, 2011, P NATL ACAD SCI USA, V108, P15898, DOI 10.1073/pnas.1111560108; MORGAN MJ, 1976, PERCEPTION, V5, P57, DOI 10.1068/p050057; Nachev V, 2012, ANIM COGN, V15, P393, DOI 10.1007/s10071-011-0465-7; Overington SE, 2011, BEHAV PROCESS, V87, P274, DOI 10.1016/j.beproc.2011.06.002; Papini MR, 2002, PSYCHOL REV, V109, P186, DOI 10.1037//0033-295X.109.1.186; Patrick SC, 2012, P ROY SOC B-BIOL SCI, V279, P1724, DOI 10.1098/rspb.2011.1820; Paur J, 2011, ANIM BEHAV, V82, P825, DOI 10.1016/j.anbehav.2011.07.017; Perrins C.M., 1979, BRIT TITS; Pinheiro J, 2001, MIXED EFFECTS MODELS; Psorakis I, 2012, J R SOC INTERFACE, V9, P3055, DOI 10.1098/rsif.2012.0223; Quinn JL, 2012, P ROY SOC B-BIOL SCI, V279, P1919, DOI 10.1098/rspb.2011.2227; Quinn JL, 2014, BEHAV ECOL, V25, P1297, DOI 10.1093/beheco/aru141; Quinn JL, 2011, J ANIM ECOL, V80, P918, DOI 10.1111/j.1365-2656.2011.01835.x; Quinn JL, 2009, J ANIM ECOL, V78, P1203, DOI 10.1111/j.1365-2656.2009.01585.x; Raine NE, 2008, P R SOC B, V275, P803, DOI 10.1098/rspb.2007.1652; Reader SM, 2003, ANIM BIOL, V53, P147, DOI 10.1163/157075603769700340; Roth TC, 2010, P ROY SOC B-BIOL SCI, V277, P3187, DOI 10.1098/rspb.2010.0630; Rowe C, 2014, BEHAV ECOL, V25, P1287, DOI 10.1093/beheco/aru090; SASVARI L, 1979, ANIM BEHAV, V27, P767, DOI 10.1016/0003-3472(79)90012-5; SASVARI L, 1992, ANIM BEHAV, V43, P289, DOI 10.1016/S0003-3472(05)80224-6; Schielzeth H, 2009, BEHAV ECOL, V20, P416, DOI 10.1093/beheco/arn145; SCHULER W, 1992, ADV STUD BEHAV, V21, P111, DOI 10.1016/S0065-3454(08)60143-6; Schwarz S, 2010, BEHAV ECOL SOCIOBIOL, V64, P2033, DOI 10.1007/s00265-010-1016-y; Shettleworth S.J., 2009, COGNITION EVOLUTION; Skinner BF, 1932, J GEN PSYCHOL, V6, P38, DOI 10.1080/00221309.1932.9711853; Steurer MM, 2012, BEHAV RES METHODS, V44, P909, DOI 10.3758/s13428-012-0198-9; Stuber EF, 2013, BEHAV ECOL, V24, P1092, DOI 10.1093/beheco/art035; Svadova K, 2009, ANIM BEHAV, V77, P327, DOI 10.1016/j.anbehav.2008.09.034; Svensson L., 1992, IDENTIFICATION GUIDE; Thornton A, 2012, PHILOS T R SOC B, V367, P2773, DOI 10.1098/rstb.2012.0214; Titulaer M, 2012, ANIM BEHAV, V83, P723, DOI 10.1016/j.anbehav.2011.12.020; Toxopeus IB, 2005, BEHAVIOUR, V142, P1269, DOI 10.1163/156853905774539373; VERBEEK MEM, 1994, ANIM BEHAV, V48, P1113, DOI 10.1006/anbe.1994.1344; Webster SJ, 2001, ANIM BEHAV, V62, P23, DOI 10.1006/anbe.2000.1725; WILSON DS, 1993, J COMP PSYCHOL, V107, P250, DOI 10.1037/0735-7036.107.3.250	91	46	46	3	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0133821	10.1371/journal.pone.0133821	http://dx.doi.org/10.1371/journal.pone.0133821			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288131	Green Published, gold, Green Submitted			2022-12-26	WOS:000360018600010
J	Konar, M; Beernink, PT; Granoff, DM				Konar, Monica; Beernink, Peter T.; Granoff, Dan M.			A Newly-Identified Polymorphism in Rhesus Macaque Complement Factor H Modulates Binding Affinity for Meningococcal FHbp	PLOS ONE			English	Article							NEISSERIA-MENINGITIDIS; PROTEIN; IMMUNOGENICITY	Background Two meningococcal serogroup B vaccines contain Factor H binding protein (FHbp). Binding of Factor H (FH) to FHbp was thought to be specific for human or chimpanzee FH. However, in a previous study an amino acid polymorphism in rhesus macaque FH domain 6, tyrosine at position 352 (Y352) was associated with high binding to FHbp, whereas histidine at position 352 (H352) was associated with low binding. Methods and Results Here we report that a second FH polymorphism at position 360 also affects macaque FH binding. Of 43 macaques, 11 had high FH binding and 32 had low binding. As in our previous study, all 11 animals with high binding had Y352, and 24 with low binding had H352. However the remaining eight with low FH binding had Y352, which was predicted to yield high binding. All eight had S360 instead of P360. Thus, three allelic variants at positions 352 and 360 affect macaque FH binding to FHbp: HP (low), YS (low), and YP (high). We measured binding affinity of each FH sequence type to FHbp by surface plasmon resonance. Two animals with high binding types (YS/YP and HP/YP) had dissociation constants (K-D) of 10.4 and 18.2 nM, respectively, which were similar to human FH (19.8 nM). Two macaques with low binding (HP/HP and HP/YS) had K-D values approximately five-fold higher (100.3 and 99.5 nM, respectively). A third macaque with low binding (YS/YS) had a K-D value too high to be measured. Conclusions Macaques have at least three allelic variants encoding FH with different affinities for FHbp (five genotypic combinations of these variants). Since in previous studies binding of FH to FHbp vaccines decreased protective antibody responses, our data will aid in selection of macaques with FH binding that is similar to humans for further investigation of FHbp vaccine immunogenicity.	[Konar, Monica; Beernink, Peter T.; Granoff, Dan M.] UCSF Benioff Childrens Hosp Oakland, Ctr Immunobiol & Vaccine Dev, Oakland, CA 94609 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Granoff, DM (corresponding author), UCSF Benioff Childrens Hosp Oakland, Ctr Immunobiol & Vaccine Dev, Oakland, CA 94609 USA.	dgranoff@chori.org		Konar, Monica/0000-0002-8312-9699	Public Health Service grants from the National Institute of Allergy and Infectious Diseases, NIH [R01 AI 046464, AI 099125, AI 114701]; California National Primate Research Center [OD011107]; National Institute of Heart, Lung and Blood, NIH [R25 HL125451]; Research Facilities Improvement Program from the National Center for Research Resources, NIH [C06 RR016226]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR016226] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R25HL125451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046464, R01AI099125, R01AI114701] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107] Funding Source: NIH RePORTER	Public Health Service grants from the National Institute of Allergy and Infectious Diseases, NIH; California National Primate Research Center; National Institute of Heart, Lung and Blood, NIH; Research Facilities Improvement Program from the National Center for Research Resources, NIH; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Public Health Service grants R01 AI 046464 (to D.M.G.), AI 099125 (to P.T.B.), and AI 114701 (D.M.G. and P.T.B.) from the National Institute of Allergy and Infectious Diseases, NIH, and OD011107 from the California National Primate Research Center (P.T.B. and D.M.G.). Additional support came from the National Institute of Heart, Lung and Blood, NIH grant R25 HL125451. The work at Children's Hospital Oakland Research Institute (CHORI) was performed in a facility funded by Research Facilities Improvement Program grant number C06 RR016226 from the National Center for Research Resources, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beernink PT, 2008, INFECT IMMUN, V76, P2568, DOI 10.1128/IAI.00033-08; Beernink PT, 2014, CLIN VACCINE IMMUNOL, V21, P1505, DOI 10.1128/CVI.00517-14; Beernink PT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002688; Beernink PT, 2011, J IMMUNOL, V186, P3606, DOI 10.4049/jimmunol.1003470; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Committee for the Update of the Guide for the Care and Use of Laboratory Animals Institute for Laboratory Animal Research Division on Earth and Life Studies National Research Council of the National Academies, 2011, GUIDE FOR THE CARE A; Costa I, 2014, MBIO, V5, DOI 10.1128/mBio.01625-14; Granoff DM, 2015, J INFECT DIS, V212, P784, DOI 10.1093/infdis/jiv081; Granoff DM, 2013, CLIN VACCINE IMMUNOL, V20, P1099, DOI 10.1128/CVI.00260-13; Granoff DM, 2009, INFECT IMMUN, V77, P764, DOI 10.1128/IAI.01191-08; Granoff DM, 2014, MICROBE, V9, P321; Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501; Rossi R, 2013, VACCINE, V31, P5451, DOI 10.1016/j.vaccine.2013.08.099; Schneider MC, 2006, J IMMUNOL, V176, P7566, DOI 10.4049/jimmunol.176.12.7566; Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769; van der Veen S, 2014, INFECT IMMUN, V82, P1157, DOI 10.1128/IAI.01183-13	16	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135996	10.1371/journal.pone.0135996	http://dx.doi.org/10.1371/journal.pone.0135996			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285122	Green Submitted, Green Published, gold			2022-12-26	WOS:000359666100094
J	Pfalzer, AC; Nesbeth, PDC; Parnell, LD; Iyer, LK; Liu, ZH; Kane, AV; Chen, CYO; Tai, AK; Bowman, TA; Obin, MS; Mason, JB; Greenberg, AS; Choi, SW; Selhub, J; Paul, L; Crott, JW				Pfalzer, Anna C.; Nesbeth, Paula-Dene C.; Parnell, Laurence D.; Iyer, Lakshmanan K.; Liu, Zhenhua; Kane, Anne V.; Chen, C-Y. Oliver; Tai, Albert K.; Bowman, Thomas A.; Obin, Martin S.; Mason, Joel B.; Greenberg, Andrew S.; Choi, Sang-Woon; Selhub, Jacob; Paul, Ligi; Crott, Jimmy W.			Diet- and Genetically-Induced Obesity Differentially Affect the Fecal Microbiome and Metabolome in Apc(1638N) Mice	PLOS ONE			English	Article							EXPERIMENTAL MURINE COLITIS; GUT MICROBIOME; ADENOSINE; CANCER; INFLAMMATION; TUMORIGENESIS; MECHANISMS; PATTERNS; INCREASE; MUTATION	Obesity is a risk factor for colorectal cancer (CRC), and alterations in the colonic microbiome and metabolome may be mechanistically involved in this relationship. The relative contribution of diet and obesity per se are unclear. We compared the effect of diet-and genetically-induced obesity on the intestinal microbiome and metabolome in a mouse model of CRC. Apc(1638N) mice were made obese by either high fat (HF) feeding or the presence of the Lepr(db/db) (DbDb) mutation. Intestinal tumors were quantified and stool microbiome and metabolome were profiled. Genetic obesity, and to a lesser extent HF feeding, promoted intestinal tumorigenesis. Each induced distinct microbial patterns: taxa enriched in HF were mostly Firmicutes (6 of 8) while those enriched in DbDb were split between Firmicutes (7 of 12) and Proteobacteria (5 of 12). Parabecteroides distasonis was lower in tumor-bearing mice and its abundance was inversely associated with colonic Il1b production (p<0.05). HF and genetic obesity altered the abundance of 49 and 40 fecal metabolites respectively, with 5 in common. Of these 5, adenosine was also lower in obese and in tumor-bearing mice (p<0.05) and its concentration was inversely associated with colonic Il1b and Tnf production (p<0.05). HF and genetic obesity differentially alter the intestinal microbiome and metabolome. A depletion of adenosine and P. distasonis in tumor-bearing mice could play a mechanistic role in tumor formation. Adenosine and P. distasonis have previously been shown to be anti-inflammatory in the colon and we postulate their reduction could promote tumorigenesis by de-repressing inflammation.	[Pfalzer, Anna C.; Nesbeth, Paula-Dene C.; Parnell, Laurence D.; Liu, Zhenhua; Kane, Anne V.; Chen, C-Y. Oliver; Bowman, Thomas A.; Obin, Martin S.; Mason, Joel B.; Greenberg, Andrew S.; Choi, Sang-Woon; Selhub, Jacob; Paul, Ligi; Crott, Jimmy W.] Tufts Univ, Canc Cluster, USDA, Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Pfalzer, Anna C.; Nesbeth, Paula-Dene C.; Liu, Zhenhua; Chen, C-Y. Oliver; Obin, Martin S.; Mason, Joel B.; Greenberg, Andrew S.; Selhub, Jacob; Paul, Ligi; Crott, Jimmy W.] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; [Parnell, Laurence D.] Tufts Univ, ARS, USDA, Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Iyer, Lakshmanan K.] Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA; [Liu, Zhenhua] Univ Massachusetts, Dept Nutr, Amherst, MA 01003 USA; [Kane, Anne V.] Tufts Med Ctr, Phoenix Lab, Boston, MA USA; [Tai, Albert K.] Tufts Univ, Sch Med, Genom Core, Boston, MA 02111 USA; [Choi, Sang-Woon] CHA Univ, Sch Med, Seoul, South Korea	Tufts University; United States Department of Agriculture (USDA); Tufts University; Tufts University; United States Department of Agriculture (USDA); Tufts University; University of Massachusetts System; University of Massachusetts Amherst; Tufts Medical Center; Tufts University; Pochon Cha University	Crott, JW (corresponding author), Tufts Univ, Canc Cluster, USDA, Human Nutr Res Ctr Aging, Boston, MA 02111 USA.	jimmy.crott@tufts.edu	Bowman, Thomas/I-4649-2013	Bowman, Thomas/0000-0002-9591-7561	Agricultural Research Service of the United States Department of Agriculture [58-1950-0-014, 58-1950-4-003]; National Institutes of Health [RO1 DK098606, RO1 DKO98606 02S1, 5UO1 ES020958, RO3 ES022710, P30 DK046200]; Prevent Cancer Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK046200, R01DK098606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R03ES022710, U01ES020958] Funding Source: NIH RePORTER	Agricultural Research Service of the United States Department of Agriculture(United States Department of Agriculture (USDA)USDA Agricultural Research Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Prevent Cancer Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was funded by the Agricultural Research Service of the United States Department of Agriculture, Cooperative Agreements #58-1950-0-014 and #58-1950-4-003, the National Institutes of Health RO1 DK098606, RO1 DKO98606 02S1, 5UO1 ES020958, RO3 ES022710, P30 DK046200 (ASG), and the Prevent Cancer Foundation (JBM).	Ahn J, 2013, JNCI-J NATL CANCER I, V105, P1907, DOI 10.1093/jnci/djt300; Aleman JO, 2014, GASTROENTEROLOGY, V146, P357, DOI 10.1053/j.gastro.2013.11.051; Antonioli L, 2007, J PHARMACOL EXP THER, V322, P435, DOI 10.1124/jpet.107.122762; Antonioli L, 2013, NAT REV CANCER, V13, P842, DOI 10.1038/nrc3613; Antonioli L, 2010, J PHARMACOL EXP THER, V335, P434, DOI 10.1124/jpet.110.171223; Baxter NT, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-20; Brown JB, 2008, INFLAMM BOWEL DIS, V14, P880, DOI 10.1002/ibd.20410; Burghoff S, 2013, ARCH PHYSIOL BIOCHEM, V119, P39, DOI 10.3109/13813455.2012.755547; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Daniel H, 2014, ISME J, V8, P295, DOI 10.1038/ismej.2013.155; DeHaven CD, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-9; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Finucane MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084689; Flores MBS, 2012, GASTROENTEROLOGY, V143, P741, DOI 10.1053/j.gastro.2012.05.045; FODDE R, 1994, P NATL ACAD SCI USA, V91, P8969, DOI 10.1073/pnas.91.19.8969; Frick JS, 2009, J IMMUNOL, V182, P4957, DOI 10.4049/jimmunol.0801324; Friedman DJ, 2009, P NATL ACAD SCI USA, V106, P16788, DOI 10.1073/pnas.0902869106; Gravaghi C, 2008, INT J OBESITY, V32, P1716, DOI 10.1038/ijo.2008.149; Hausler SFM, 2014, AM J TRANSL RES, V6, P129; Huffman DM, 2013, CANCER PREV RES, V6, P177, DOI 10.1158/1940-6207.CAPR-12-0414; HUMMEL KP, 1966, SCIENCE, V153, P1127, DOI 10.1126/science.153.3740.1127; Kverka M, 2011, CLIN EXP IMMUNOL, V163, P250, DOI 10.1111/j.1365-2249.2010.04286.x; Liu ZH, 2011, FASEB J, V25, P3136, DOI 10.1096/fj.11-184143; Mabley J, 2003, EUR J PHARMACOL, V466, P323, DOI 10.1016/S0014-2999(03)01570-X; Mane J, 2009, J NUTR, V139, P603, DOI 10.3945/jn.108.101170; McCoy AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053653; Muller-Haegele S, 2014, EXPERT REV CLIN IMMU, V10, P897, DOI 10.1586/1744666X.2014.915739; Odashima M, 2005, GASTROENTEROLOGY, V129, P26, DOI 10.1053/j.gastro.2005.05.032; Ohta T, 2009, TOXICOL PATHOL, V37, P521, DOI 10.1177/0192623309336152; R Core Team, 2021, R LANGUAGE ENV STAT; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shen XJ, 2010, GUT MICROBES, V1, P138, DOI 10.4161/gmic.1.3.12360; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Siegmund B, 2001, J PHARMACOL EXP THER, V296, P99; Siegmund B, 2001, P NATL ACAD SCI USA, V98, P13249, DOI 10.1073/pnas.231473998; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Wang TT, 2012, ISME J, V6, P320, DOI 10.1038/ismej.2011.109; Weir TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070803; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yehuda-Shnaidman E, 2012, OBES REV, V13, P1083, DOI 10.1111/j.1467-789X.2012.01024.x; Zackular JP, 2013, MBIO, V4, DOI 10.1128/mBio.00692-13; Zitomersky NL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063686	49	34	37	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135758	10.1371/journal.pone.0135758	http://dx.doi.org/10.1371/journal.pone.0135758			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284788	Green Published, gold, Green Submitted			2022-12-26	WOS:000359666100067
J	Qu, DF; Weygant, N; May, R; Chandrakesan, P; Madhoun, M; Ali, N; Sureban, SM; An, GY; Schlosser, MJ; Houchen, CW				Qu, Dongfeng; Weygant, Nathaniel; May, Randal; Chandrakesan, Parthasarathy; Madhoun, Mohammad; Ali, Naushad; Sureban, Sripathi M.; An, Guangyu; Schlosser, Michael J.; Houchen, Courtney W.			Ablation of Doublecortin-Like Kinase 1 in the Colonic Epithelium Exacerbates Dextran Sulfate Sodium-Induced Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; RADIATION-INJURY; PATHOGENESIS; INFILTRATION; BARRIER; REPAIR; CRYPT	Doublecortin-like kinase 1 (Dclk1), a microtubule-associated kinase, marks the fifth lineage of intestinal epithelial cells called tuft cells that function as tumor stem cells in Apc mutant models of colon cancer. In order to determine the role of Dclk1 in dextran sulfate sodium (DSS) induced colonic inflammation both intestinal epithelial specific Dclk1 deficient (Villin(Cre);Dclk1(f/f)) and control (Dclk1f/f) mice were fed 3% DSS in drinking water for 9 days, allowed to recover for 2 days, and killed. The clinical and histological features of DSS-induced colitis were scored and immunohistochemical, gene expression, pro-inflammatory cytokines/chemokines, and immunoblotting analyses were used to examine epithelial barrier integrity, inflammation, and stem and tuft cell features. In DSS-induced colitis, Villin(Cre);Dclk1(f/f) mice demonstrated exacerbated injury including higher clinical colitis scores, increased epithelial barrier permeability, higher levels of pro-inflammatory cytokines and chemokines, decreased levels of Lgr5, and dysregulated Wnt/b-Catenin pathway genes. These results suggest that Dclk1 plays an important role in regulating colonic inflammatory response and colonic epithelial integrity.	[Qu, Dongfeng; Weygant, Nathaniel; May, Randal; Chandrakesan, Parthasarathy; Madhoun, Mohammad; Ali, Naushad; Sureban, Sripathi M.; An, Guangyu; Houchen, Courtney W.] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK 73104 USA; [Qu, Dongfeng; May, Randal; Sureban, Sripathi M.; Houchen, Courtney W.] Dept Vet Affairs Med Ctr, Oklahoma City, OK 73104 USA; [Qu, Dongfeng; Chandrakesan, Parthasarathy; Ali, Naushad; Sureban, Sripathi M.; Houchen, Courtney W.] Peggy & Charles Stephenson Oklahoma Canc Ctr, Oklahoma City, OK 73104 USA; [An, Guangyu] Capitol Med Univ, Beijing Chaoyang Hosp, Dept Oncol, Beijing 100020, Peoples R China; [Schlosser, Michael J.; Houchen, Courtney W.] COARE Biotechnol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Capital Medical University	Houchen, CW (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK 73104 USA.	Courtney-houchen@ouhsc.edu	Sureban, Sripathi/Q-8232-2019; Chandrakesan, Parthasarathy/AAB-9136-2020	Sureban, Sripathi/0000-0001-5476-9593; Weygant, Nathaniel/0000-0001-7861-6532; Chandrakesan, Parthasarathy/0000-0002-7587-9553; Ali, Naushad/0000-0002-0058-7396	National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Allergy and Infectious Diseases [NIH U01 DK-085508]; Veterans Affairs Merit Award [1I01BX001952]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK085508] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001952] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs Merit Award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This research was performed as a project of the Intestinal Stem Cell Consortium; a collaborative research project funded by the National Institute of Diabetes and Digestive and Kidney Diseases and the National Institute of Allergy and Infectious Diseases (NIH U01 DK-085508 to CWH) and also funded by a Veterans Affairs Merit Award (1I01BX001952) to CWH. COARE Biotechnology provided support in the form of salaries for MJS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "author contributions" section.	Atreya I, 2008, J INTERN MED, V263, P591, DOI 10.1111/j.1365-2796.2008.01953.x; Clayburgh DR, 2004, LAB INVEST, V84, P282, DOI 10.1038/labinvest.3700050; Dignass AU, 2004, ALIMENT PHARM THER, V20, P9, DOI 10.1111/j.1365-2036.2004.02047.x; GORDON JI, 1994, CURR OPIN CELL BIOL, V6, P795, DOI 10.1016/0955-0674(94)90047-7; GRISHAM MB, 1986, AM J PHYSIOL, V251, pG567, DOI 10.1152/ajpgi.1986.251.4.G567; Hering NA, 2012, J PHYSIOL-LONDON, V590, P1035, DOI 10.1113/jphysiol.2011.224568; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kim ER, 2014, WORLD J GASTROENTERO, V20, P9872, DOI 10.3748/wjg.v20.i29.9872; Koch S, 2012, ANNU REV PATHOL-MECH, V7, P35, DOI 10.1146/annurev-pathol-011811-120905; Koelink PJ, 2014, GUT, V63, P578, DOI 10.1136/gutjnl-2012-303252; Koo BK, 2014, GASTROENTEROLOGY, V147, P289, DOI 10.1053/j.gastro.2014.05.007; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; May R, 2008, STEM CELLS, V26, P630, DOI 10.1634/stemcells.2007-0621; May R, 2014, STEM CELLS, V32, P822, DOI 10.1002/stem.1566; May R, 2009, STEM CELLS, V27, P2571, DOI 10.1002/stem.193; Nakanishi Y, 2013, NAT GENET, V45, P98, DOI 10.1038/ng.2481; Perse M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/718617; Qu DF, 2014, AM J PHYSIOL-GASTR L, V306, pG404, DOI 10.1152/ajpgi.00088.2013; Wallace JL, 2006, THESCIENTIFICWORLDJO, V6, P577, DOI 10.1100/tsw.2006.122; Westphalen CB, 2014, J CLIN INVEST; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	22	39	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0134212	10.1371/journal.pone.0134212	http://dx.doi.org/10.1371/journal.pone.0134212			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285154	Green Submitted, Green Published, gold			2022-12-26	WOS:000359666100006
J	Versypt, ANF; Arendt, PD; Pack, DW; Braatz, RD				Versypt, Ashlee N. Ford; Arendt, Paul D.; Pack, Daniel W.; Braatz, Richard D.			Derivation of an Analytical Solution to a Reaction-Diffusion Model for Autocatalytic Degradation and Erosion in Polymer Microspheres	PLOS ONE			English	Article							DRUG-DELIVERY SYSTEMS; HYDROLYTIC DEGRADATION; ALIPHATIC POLYESTERS; PLGA MICROSPHERES; RELEASE; ACID); MATRICES	A mathematical reaction-diffusion model is defined to describe the gradual decomposition of polymer microspheres composed of poly(D, L-lactic-co-glycolic acid) (PLGA) that are used for pharmaceutical drug delivery over extended periods of time. The partial differential equation (PDE) model treats simultaneous first-order generation due to chemical reaction and diffusion of reaction products in spherical geometry to capture the microsphere-size-dependent effects of autocatalysis on PLGA erosion that occurs when the microspheres are exposed to aqueous media such as biological fluids. The model is solved analytically for the concentration of the autocatalytic carboxylic acid end groups of the polymer chains that comprise the microspheres as a function of radial position and time. The analytical solution for the reaction and transport of the autocatalytic chemical species is useful for predicting the conditions under which drug release from PLGA microspheres transitions from diffusion-controlled to erosion-controlled release, for understanding the dynamic coupling between the PLGA degradation and erosion mechanisms, and for designing drug release particles. The model is the first to provide an analytical prediction for the dynamics and spatial heterogeneities of PLGA degradation and erosion within a spherical particle. The analytical solution is applicable to other spherical systems with simultaneous diffusive transport and first-order generation by reaction.	[Versypt, Ashlee N. Ford; Arendt, Paul D.; Pack, Daniel W.; Braatz, Richard D.] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; [Versypt, Ashlee N. Ford; Braatz, Richard D.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Pack, Daniel W.] Univ Kentucky, Dept Chem & Mat Engn, Lexington, KY USA; [Pack, Daniel W.] Univ Kentucky, Dept Pharmaceut Sci, Lexington, KY USA	University of Illinois System; University of Illinois Urbana-Champaign; Massachusetts Institute of Technology (MIT); University of Kentucky; University of Kentucky	Braatz, RD (corresponding author), Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA.	braatz@mit.edu	Versypt, Ashlee Ford/H-1274-2012; Braatz, Richard D/I-6725-2015; Ford Versypt, Ashlee/AAY-8953-2020	Versypt, Ashlee Ford/0000-0001-9059-5703; Braatz, Richard D/0000-0003-4304-3484; Ford Versypt, Ashlee/0000-0001-9059-5703	National Institutes of Health [NIBIB 5RO1EB005181]; National Science Foundation [0426328]; U.S. Department of Energy Computational Science Graduate Fellowship Program of the Office of Science; National Nuclear Security Administration in the Department of Energy [DE-FG02-97ER25308]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005181] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); U.S. Department of Energy Computational Science Graduate Fellowship Program of the Office of Science; National Nuclear Security Administration in the Department of Energy(National Nuclear Security Administration); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The authors acknowledge the support of the National Institutes of Health (NIBIB 5RO1EB005181) and the National Science Foundation (Grant #0426328). A. N. Ford Versypt acknowledges the support of the U.S. Department of Energy Computational Science Graduate Fellowship Program of the Office of Science and National Nuclear Security Administration in the Department of Energy under contract DE-FG02-97ER25308.	Antheunis H, 2010, BIOMACROMOLECULES, V11, P1118, DOI 10.1021/bm100125b; Batycky RP, 1997, J PHARM SCI, V86, P1464, DOI 10.1021/js9604117; Berkland C, 2002, J CONTROL RELEASE, V82, P137, DOI 10.1016/S0168-3659(02)00136-0; Berkland C, 2007, J PHARM SCI-US, V96, P1176, DOI 10.1002/jps.20948; Crank J., 1975, MATH DIFFUSION; Deen, 1998, ANAL TRANSPORT PHENO; Edlund U, 2002, ADV POLYM SCI, V157, P67; Edwards CH., 2004, DIFF EQUAT+; Estey T, 2006, J PHARM SCI-US, V95, P1626, DOI 10.1002/jps.20625; Ford Versypt AN, 2012, THESIS U ILLINOIS UR; Freiberg S, 2004, INT J PHARMACEUT, V282, P1, DOI 10.1016/j.ijpharm.2004.04.013; Fu K, 2000, PHARM RES-DORDR, V17, P100, DOI 10.1023/A:1007582911958; Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3; GRIZZI I, 1995, BIOMATERIALS, V16, P305, DOI 10.1016/0142-9612(95)93258-F; Haberman R, 2004, APPL PARTIAL DIFFERE; Klose D, 2008, INT J PHARMACEUT, V354, P95, DOI 10.1016/j.ijpharm.2007.10.030; Kulkarni A, 2007, SURF INTERFACE ANAL, V39, P740, DOI 10.1002/sia.2580; Lao LL, 2011, INT J PHARMACEUT, V418, P28, DOI 10.1016/j.ijpharm.2010.12.020; Lyu S, 2005, J POLYM SCI POL PHYS, V43, P383, DOI 10.1002/polb.20340; PITT CG, 1995, J CONTROL RELEASE, V33, P391, DOI 10.1016/0168-3659(94)00113-9; Raman C, 2005, J CONTROL RELEASE, V103, P149, DOI 10.1016/j.jconrel.2004.11.012; Sackett CK, 2011, INT J PHARMACEUT, V418, P104, DOI 10.1016/j.ijpharm.2010.11.048; Schiesser W. E., 1991, NUMERICAL METHOD LIN; Schiesser W. E., 2013, PARTIAL DIFFERENTIAL; Scott Fogler H., 2006, ELEMENTS CHEM REACTI; Siepmann J, 2005, BIOMACROMOLECULES, V6, P2312, DOI 10.1021/bm050228k; Siepmann J, 2001, ADV DRUG DELIVER REV, V48, P229, DOI 10.1016/S0169-409X(01)00116-8; Sinha VR, 2003, J CONTROL RELEASE, V90, P261, DOI 10.1016/S0168-3659(03)00194-9; Tzafriri AR, 2000, J CONTROL RELEASE, V63, P69, DOI 10.1016/S0168-3659(99)00174-1; van Nostrum CF, 2004, POLYMER, V45, P6779, DOI 10.1016/j.polymer.2004.08.001; Varde NK, 2004, EXPERT OPIN BIOL TH, V4, P35, DOI 10.1517/eobt.4.1.35.25256; Versypt ANF, 2013, J CONTROL RELEASE, V165, P29, DOI 10.1016/j.jconrel.2012.10.015; Vert M, 1997, ANGEW MAKROMOL CHEM, V247, P239, DOI 10.1002/apmc.1997.052470116; Wang Y, 2008, BIOMATERIALS, V29, P3393, DOI 10.1016/j.biomaterials.2008.04.042	34	12	12	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135506	10.1371/journal.pone.0135506	http://dx.doi.org/10.1371/journal.pone.0135506			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284787	gold, Green Published, Green Submitted			2022-12-26	WOS:000359666100043
J	Abubakari, A; Kynast-Wolf, G; Jahn, A				Abubakari, Abdulai; Kynast-Wolf, Gisela; Jahn, Albrecht			Maternal Determinants of Birth Weight in Northern Ghana	PLOS ONE			English	Article							PREPREGNANCY WEIGHT; FETAL ORIGINS; UNITED-STATES; PREGNANCY; GAIN; OBESITY; OUTCOMES; RISK; MACROSOMIA; MANAGEMENT	Objectives Weight at birth is usually considered as an indicator of the health status of a given society. As a result this study was designed to investigate the association between birth weight and maternal factors such as gestational weight gain, pre-pregnancy BMI and socio-economic status in Northern Ghana. Methods The study was a facility-based cross-sectional survey conducted in two districts in the Northern region of Ghana. These districts were purposively sampled to represent a mix of urban, peri-urban and rural population. The current study included 419 mother-infant pairs who delivered at term (37-42 weeks). Mother's height, pre-pregnancy weight and weight changes were generated from the antenatal records. Questionnaires were administered to establish socio-economic and demographic information of respondents. Maternal factors associated with birth weight were examined using multiple and univariate regressions. Results The mothers were generally well nourished before conception (Underweight 3.82%, Normal 57.76%, Overweight 25.06% and Obesity 13.37%) but approximately half of them could not gain adequate weight according to Institute of Medicine recommendations (Low weight gain 49.64%, Adequate weight gain 42.96% and Excessive weight gain 7.40%). Infants whose mothers had excess weight gain were 431g (95% CI 18-444) heavier compared to those whose mothers gained normal weight, while those whose mothers gained less were 479g (95% CI -682-(-276) lighter. Infants of mothers who were overweight and obese before conception were 246g (95% CI 87-405) and 595g (95% CI 375-815) respectively heavier than those of normal mothers, whereas those whose mothers were underweight were 305g (95% CI -565 -(-44) lighter. The mean birth weight observed was 2.98 +/- 0.68 kg. Conclusion Our findings show that pre-pregnancy body mass index and weight gain during pregnancy influence birth weight. Therefore, emphasis should be placed on counseling and assisting pregnant women to stay within the recommended weight gain ranges.	[Abubakari, Abdulai; Kynast-Wolf, Gisela; Jahn, Albrecht] Univ Dev Studies, Sch Allied Hlth Sci, Community Nutr Dept, Tamale, Ghana; [Abubakari, Abdulai] Heidelberg Univ, Fac Med, Inst Publ Hlth, D-69115 Heidelberg, Germany	University for Development Studies; Ruprecht Karls University Heidelberg	Abubakari, A (corresponding author), Univ Dev Studies, Sch Allied Hlth Sci, Community Nutr Dept, Tamale, Ghana.	abubakariabdulai@yahoo.com						Abrams B, 2000, AM J CLIN NUTR, V71, p1233S, DOI 10.1093/ajcn/71.5.1233s; Addo V, 2011, GHANA MED J, V44, P64; Allen LH, 2004, WHAT WORKS REV EFFIC; Amin Nurul, 1993, Indian Journal of Pediatrics, V60, P269, DOI 10.1007/BF02822189; ANDERSON GD, 1984, AM J OBSTET GYNECOL, V150, P236, DOI 10.1016/S0002-9378(84)90358-2; Appiah CA., 2014, INT J CLIN NUTR, V2, P60, DOI [10.12691/ijcn-2-3-3, DOI 10.12691/IJCN-2-3-3, https://doi.org/10.12691/ijcn-2-3-3]; Arendas K, 2008, J OBSTET GYNAECOL CA, V30, P477, DOI 10.1016/S1701-2163(16)32863-8; Bailey BA, 2009, J RURAL HEALTH, V25, P141, DOI 10.1111/j.1748-0361.2009.00210.x; Bale JR, 2003, IMPROVING BIRTH OUTC; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Bish CL, 2009, MATERN CHILD HLTH J, V13, P286, DOI 10.1007/s10995-008-0349-x; Boerma JT, 1996, B WORLD HEALTH ORGAN, V74, P209; Boulet S L, 2004, J Obstet Gynaecol, V24, P622; Boulet SL, 2003, AM J OBSTET GYNECOL, V188, P1372, DOI 10.1067/mob.2003.302; Bracero LA, 1998, GYNECOL OBSTET INVES, V46, P9, DOI 10.1159/000009988; Clausen T, 2005, EUR J ENDOCRINOL, V153, P887, DOI 10.1530/eje.1.02034; Dake Fidelia AA, 2012, J PUBLIC HLTH, V3; De-Graft Aikins A., 2011, FATNESS MATERNAL BOD; DeVader SR, 2007, OBSTET GYNECOL, V110, P745, DOI 10.1097/01.AOG.0000284451.37882.85; Dietz P., 2009, AM J OBSTET GYNECOL, V53, pe1; Dubois L, 2006, PEDIATR INT, V48, P470, DOI 10.1111/j.1442-200X.2006.02256.x; EKBLAD U, 1992, INT J GYNECOL OBSTET, V39, P277, DOI 10.1016/0020-7292(92)90258-K; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Fosu M. O., 2013, Journal of Biology, Agriculture and Healthcare, V3, P205; Gluckman PD, 1993, PERINATAL PEDIATRIC; Godfrey K M, 2001, Public Health Nutr, V4, P611; Grange A., 2006, PAED ASS NIG C JOS N; Guoyao W, 2004, J NUTR, P2169; Hedderson MM, 2006, OBSTET GYNECOL, V108, P1153, DOI 10.1097/01.AOG.0000242568.75785.68; Institute of Medicine Nutrition During Pregnancy, 1990, WEIGHT GAIN 1; Institute of Medicine Nutrition During Pregnancy, 1990, NUTR SUPPL 2; Johansson K, 2007, OBES RES CLIN PRACT, V1, P243, DOI 10.1016/j.orcp.2007.09.001; Kac Gilberto, 2005, J. Pediatr. (Rio J.), V81, P47, DOI [10.2223/JPED.1282, 10.1590/S0021-75572005000100010]; Kelly A, 1996, INT J GYNECOL OBSTET, V53, P219, DOI 10.1016/0020-7292(96)02652-5; Konan ER, 2010, EPIDEMIOLOGY ADIPOSI; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Kramer MS, 2003, J NUTR, V133, p1592S, DOI 10.1093/jn/133.5.1592S; KRAMER MS, 1990, PEDIATRICS, V86, P18; Kramer MS, 1987, OFFICIAL J AM ACAD P; Kumar R, 1987, 10 WHO, V10; Kumari AS, 2001, INT J GYNECOL OBSTET; LAWOYIN TO, 1991, J TROP PEDIATRICS, V37, P166, DOI 10.1093/tropej/37.4.166; Marsoosi V, 2004, INT J GYNECOL OBSTET, V87, P36, DOI 10.1016/j.ijgo.2004.06.002; May R, 2007, AM J HUM BIOL, V19, P305, DOI 10.1002/ajhb.20572; MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204; Muller O, 2009, MATERNAL AND CHILD HEALTH: GLOBAL CHALLENGES, PROGRAMS AND POLICIES, P287, DOI 10.1007/b106524_16; Munim S, 2012, JCPSP-J COLL PHYSICI, V22, P694, DOI 11.2012/JCPSP.694698; Obed Sa, 2006, Ghana Med J, V40, P8; OHLIN A, 1990, INT J OBESITY, V14, P159; Oken E, 2003, OBES RES, V11, P496, DOI 10.1038/oby.2003.69; Orskou J, 2003, OBSTET GYNECOL, V102, P115, DOI 10.1016/S0029-7844(03)00402-2; Parsons TJ, 1999, INT J OBESITY, V23, pS1; Popkin BM, 2005, PUBLIC HEALTH NUTR, V8, P724, DOI 10.1079/PHN2005776; Popkin BM, 1998, PUBLIC HEALTH NUTR, P1; RANSOMEKUTI O, 1985, ACTA PAEDIATR SCAND, P95; Rasmussen KM, 2009, I MED WEIGHT GAIN DU; Saaka M, 2012, INT J CHILD HEALTH N, V1, P148, DOI 10.6000/1929-4247.2012.01.02.6; Sacks DA, 2000, OBSTET GYNECOL SURV, V55, P229, DOI 10.1097/00006254-200004000-00022; Samaras TT, 2003, J NATL MED ASSOC, V95, P1170; Shin D, 2014, MATERN CHILD HLTH J, V18, P1667, DOI 10.1007/s10995-013-1407-6; Simas TAM, 2012, J WOMENS HEALTH, V21, P410, DOI 10.1089/jwh.2011.2810; Stotland NE, 2006, OBSTET GYNECOL, V108, P635, DOI 10.1097/01.AOG.0000228960.16678.bd; Suitor CW, 1997, MATERNAL WEIGHT GAIN; Sukalich S, 2006, AM J OBSTET GYNECOL, V195, P851, DOI 10.1016/j.ajog.2006.06.070; Tayie F., 2004, AFR J FOOD AGR NUTR, V4; The Vanuatu National Statistics Office, 2009, NAT POP HOUS CENS AN, V2; United Nations Administrative Committee on Coordination Subcommittee on Nutrition, 2000, NUTR THROUGH LIF CYC; VARMA TR, 1984, INT J GYNECOL OBSTET, V22, P161, DOI 10.1016/0020-7292(84)90031-6; Voigt M, 2007, Z Geburtshilfe Neonatol, V211, P191, DOI 10.1055/s-2007-981327; Wax JR, 2009, CURR OPIN OBSTET GYN, V21, P117, DOI 10.1097/GCO.0b013e328328d3c7; WHO/UNICEF, 2004, LOW BIRTH WEIGHT COU	71	23	23	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0135641	10.1371/journal.pone.0135641	http://dx.doi.org/10.1371/journal.pone.0135641			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26281013	gold, Green Published, Green Submitted			2022-12-26	WOS:000359664300018
J	Deng, YP; Yang, M; Xu, F; Zhang, Q; Zhao, Q; Yu, HT; Li, DF; Zhang, G; Lu, AP; Cho, K; Teng, FK; Wu, P; Wang, LL; Wu, WY; Liu, X; Guo, DA; Jiang, BH				Deng, Yanping; Yang, Min; Xu, Feng; Zhang, Qian; Zhao, Qun; Yu, Haitao; Li, Defang; Zhang, Ge; Lu, Aiping; Cho, Kenka; Teng, Fukang; Wu, Peng; Wang, Linlin; Wu, Wanying; Liu, Xuan; Guo, De-an; Jiang, Baohong			Combined Salvianolic Acid B and Ginsenoside Rg1 Exerts Cardioprotection against Ischemia/Reperfusion Injury in Rats	PLOS ONE			English	Article							HEART; COMBINATION; ACTIVATION; MECHANISMS; CELLS	Lack of pharmacological strategies in clinics restricts the patient prognosis with myocardial ischemia/reperfusion (I/R) injury. The aim of this study was to evaluate the cardioprotection of combined salvianolic acid B (SalB) and ginsenoside Rg1 (Rg1) against myocardial I/R injury and further investigate the underlying mechanism. I/R injury was induced by coronary artery ligation for Wistar male rats and hypoxia/reoxygenation injury was induced on H9c2 cells. Firstly, the best ratio between SalB and Rg1 was set as 2: 5 based on their effects on heart function detected by hemodynamic measurement. Then SalB-Rg1 (2: 5) was found to maintain mitochondrial membrane potential and resist apoptosis and necrosis in H9c2 cell with hypoxia/reoxygenation injury. Companying with same dose of SalB or Rg1 only, SalB-Rg1 showed more significant effects on down-regulation of myocardial infarct size, maintenance of myocardium structure, improvement on cardiac function, decrease of cytokine secretion including TNF-alpha, IL-1 beta, RANTES and sVCAM-1. Finally, the SalB-Rg1 improved the viability of cardiac myocytes other than cardiac fibroblasts in rats with I/R injury using flow cytometry. Our results revealed that SalB-Rg1 was a promising strategy to prevent myocardial I/R injury.	[Deng, Yanping; Yang, Min; Zhao, Qun; Yu, Haitao; Teng, Fukang; Wu, Peng; Wang, Linlin; Wu, Wanying; Liu, Xuan; Guo, De-an; Jiang, Baohong] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China; [Xu, Feng; Zhao, Qun; Teng, Fukang; Wu, Peng] Shenyang Pharmaceut Univ, Shenyang 110016, Peoples R China; [Zhang, Qian] Fudan Univ, Sch Pharm, Dept Med Chem, Shanghai 200237, Peoples R China; [Li, Defang; Zhang, Ge; Lu, Aiping] Hong Kong Baptist Univ, Sch Chinese Med, Inst Adv Translat Med Bone & Joint Dis, Hong Kong, Hong Kong, Peoples R China; [Cho, Kenka] Takarazuka Univ Med & Hlth Care, Takarazuka, Hyogo 6660162, Japan	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shenyang Pharmaceutical University; Fudan University; Hong Kong Baptist University	Jiang, BH (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Haike Rd 501, Shanghai 201203, Peoples R China.	jiangbh@simm.ac.cn	zhou, ju/M-3255-2017; Zhang, Ge/K-9118-2019	Zhang, Ge/0000-0002-7807-7695; Li, Defang/0000-0003-4151-9151	National Science & Technology Major Project for "Key New Drug Creation and Manufacturing Program" [2013ZX09103002-024]; National Natural Science Foundation of China [81173587]; Shanghai Science and Technology Development Foundation [14401900900]; Croucher Foundation [CAS14201]; State Key Laboratory of Drug Research [SIMM1501KF-01]	National Science & Technology Major Project for "Key New Drug Creation and Manufacturing Program"; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Development Foundation; Croucher Foundation; State Key Laboratory of Drug Research	This work was supported by National Science & Technology Major Project for "Key New Drug Creation and Manufacturing Program" (2013ZX09103002-024), National Natural Science Foundation of China Grants (81173587), and Shanghai Science and Technology Development Foundation (14401900900). This work was also partially supported by the Croucher Foundation (CAS14201) and the State Key Laboratory of Drug Research (SIMM1501KF-01).	Arslan F, 2010, CIRCULATION, V121, P80, DOI 10.1161/CIRCULATIONAHA.109.880187; Banerjee I, 2007, AM J PHYSIOL-HEART C, V293, pH1883, DOI 10.1152/ajpheart.00514.2007; Betgem RP, 2015, NAT REV CARDIOL, V12, P156, DOI 10.1038/nrcardio.2014.188; Crea F, 2015, ATHEROSCLEROSIS, V241, P157, DOI 10.1016/j.atherosclerosis.2015.04.802; Deng YP, 2015, J CHIN MED ASSOC, V78, P114, DOI 10.1016/j.jcma.2014.10.001; Diaz RJ, 2013, CARDIOVASC RES, V98, P411, DOI 10.1093/cvr/cvt056; Feng GM, 2012, EUR J NUTR, V51, P987, DOI 10.1007/s00394-011-0278-0; Guo J, 2013, ATHEROSCLEROSIS, V231, P384, DOI 10.1016/j.atherosclerosis.2013.10.003; Homma T, 2013, J MOL CELL CARDIOL, V62, P179, DOI 10.1016/j.yjmcc.2013.06.004; Kassiri Z, 2009, J BIOL CHEM, V284, P29893, DOI 10.1074/jbc.M109.028449; Poh KK, 2014, EUR J CLIN PHARMACOL, V70, P527, DOI 10.1007/s00228-014-1650-9; Moran AE, 2014, CIRCULATION, V129, P1483, DOI 10.1161/CIRCULATIONAHA.113.004042; Morrison A, 2011, BIOCHEM PHARMACOL, V82, P195, DOI 10.1016/j.bcp.2011.04.004; Rodrigues SF, 2010, CARDIOVASC RES, V87, P291, DOI 10.1093/cvr/cvq090; Seif AA, 2013, J PHYSIOL BIOCHEM, V69, P937, DOI 10.1007/s13105-013-0272-5; Suzuki YJ, 2003, ANTIOXID REDOX SIGN, V5, P741, DOI 10.1089/152308603770380043; Wang YH, 2011, PHYTOMEDICINE, V19, P13, DOI 10.1016/j.phymed.2011.06.024; Wei YH, 2007, J PHARMACEUT BIOMED, V45, P775, DOI 10.1016/j.jpba.2007.07.013; Wu B, 2014, CLIN EXP IMMUNOL, V176, P438, DOI 10.1111/cei.12284; Xu H, 2014, DRUG METAB DISPOS, V42, P274, DOI 10.1124/dmd.113.053694; Xu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024036; Yue QX, 2012, J ETHNOPHARMACOL, V141, P659, DOI 10.1016/j.jep.2011.08.044; Zhang P, 2012, AM J PHYSIOL-HEART C, V303, pH1385, DOI 10.1152/ajpheart.01167.2011; Zhou Q, 2014, THROMB RES, V133, P57, DOI 10.1016/j.thromres.2013.10.032	24	46	52	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0135435	10.1371/journal.pone.0135435	http://dx.doi.org/10.1371/journal.pone.0135435			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26280455	Green Submitted, Green Published, gold			2022-12-26	WOS:000359664300013
J	Kim, SY; Sim, S; Kim, SG; Choi, HG				Kim, So Young; Sim, Songyong; Kim, Sung-Gyun; Choi, Hyo Geun			Sleep Deprivation Is Associated with Bicycle Accidents and Slip and Fall Injuries in Korean Adolescents	PLOS ONE			English	Article							TRAUMATIC DENTAL INJURIES; DURATION; RISK; RECOMMENDATIONS; PREVALENCE; CHILDREN; SAFETY; AGE	Objective This study sought to evaluate associations between sleep time and bicycle accidents, falls under various circumstances, and dental injuries in adolescents. Methods A total of 61,696 participants ranging from 12 to 18 years of age who completed the Korea Youth Risk Behavior Web-based Survey (KYRBWS) in 2013 were enrolled in this study. Bicycle riding accidents were analyzed for 17,232 bicycle-riding participants. Data were collected regarding the weekday sleep duration for the most recent 7 days, which was categorized as < 5.5 h, 5.5-6.5 h, 6.5-7.5 h, or >= 7.5 h per day, and the incidence of bicycle accidents, slips and falls under various circumstances, and dental injuries in the most recent 12 months. Adjusted odds ratios (aORs) were calculated among sleep groups for bicycle accidents, slips and falls, and dental injuries using simple and multiple logistic regression analyses with complex sampling. Results Bicycle riding accidents and slips and falls in classrooms, corridors, the ground, toilets, stairs, and other unspecified situations showed positive correlations with sleep deprivation. Comparisons of groups with >= 7.5 h sleep, < 5.5 h, 5.5-6.5 h sleep, and 6.5-7.5 h sleep revealed increased associations with slips and falls under various circumstances. In particular, the aORs were higher in the groups with less sleep (aOR of the 5.5 h group > the 5.5-6.5 h group > the 6.5-7.5 h group). There was no significant relationship between sleep deprivation and dental injury. Conclusions This study demonstrated that sleep deprivation among Korean adolescents was associated with bicycle accidents and falls at home and school. Thus, adequate sleep may be needed to prevent accidents and falls.	[Kim, So Young] Seoul Natl Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Kim, So Young] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Sim, Songyong] Hallym Univ, Dept Stat, Chunchon, South Korea; [Kim, Sung-Gyun] Hallym Univ, Coll Med, Dept Internal Med, Anyang, South Korea; [Choi, Hyo Geun] Hallym Univ, Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea	Seoul National University (SNU); Seoul National University (SNU); Hallym University; Hallym University; Hallym University	Choi, HG (corresponding author), Hallym Univ, Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea.	pupen@naver.com	Choi, Hyo Geun/K-4461-2019	Choi, Hyo Geun/0000-0003-1655-9549	Hallym University Sacred Heart Hospital [HURF-2014-58, HURF-2015-3]	Hallym University Sacred Heart Hospital	This study was supported by a Research Grant funded by Hallym University Sacred Heart Hospital (HURF-2014-58 and HURF-2015-3).	Adams SK, 2013, HEALTH SERV INSIGHTS, V6, P99, DOI 10.4137/HSI.S11083; Arora T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072406; Ayas NT, 2003, DIABETES CARE, V26, P380, DOI 10.2337/diacare.26.2.380; Bae Jisuk, 2010, J Prev Med Public Health, V43, P403, DOI 10.3961/jpmph.2010.43.5.403; Bae Jisuk, 2010, J Prev Med Public Health, V43, P396, DOI 10.3961/jpmph.2010.43.5.396; Bastone EB, 2000, AUST DENT J, V45, P2, DOI 10.1111/j.1834-7819.2000.tb00234.x; Cain N, 2010, SLEEP MED, V11, P735, DOI 10.1016/j.sleep.2010.02.006; Chen MC, 2012, J SLEEP RES, V21, P68, DOI 10.1111/j.1365-2869.2011.00934.x; Connor J, 2001, ACCIDENT ANAL PREV, V33, P31, DOI 10.1016/S0001-4575(00)00013-0; Daniel LC, 2012, ANN ALLERG ASTHMA IM, V109, P41, DOI 10.1016/j.anai.2012.05.015; Davis AL, 2013, J ADOLESCENT HEALTH, V53, P785, DOI 10.1016/j.jadohealth.2013.07.008; Garbarino S, 2001, SLEEP, V24, P203; Gillberg M, 1996, SLEEP, V19, P570, DOI 10.1093/sleep/19.7.570; Hirshkowitz M, 2015, SLEEP HEALTH, V1, P40, DOI 10.1016/j.sleh.2014.12.010; Hoffrage U, 2003, J EXP PSYCHOL-APPL, V9, P249, DOI 10.1037/1076-898X.9.4.249; Howland RH, 2011, J PSYCHOSOC NURS MEN, V49, P17, DOI 10.3928/02793695-20101208-01; Killgore WDS, 2006, J SLEEP RES, V15, P7, DOI 10.1111/j.1365-2869.2006.00487.x; Knutson KL, 2010, BEST PRACT RES CL EN, V24, P731, DOI 10.1016/j.beem.2010.07.001; Lund HG, 2010, J ADOLESCENT HEALTH, V46, P124, DOI 10.1016/j.jadohealth.2009.06.016; Matricciani LA, 2012, PEDIATRICS, V129, P548, DOI 10.1542/peds.2011-2039; Matthews KA, 2012, SLEEP, V35, P1353, DOI 10.5665/sleep.2112; Mercer PW, 1998, J ADOLESCENT HEALTH, V23, P259, DOI 10.1016/S1054-139X(98)00037-8; Milewski MD, 2014, J PEDIATR ORTHOPED, V34, P129, DOI 10.1097/BPO.0000000000000151; O'Brien Erin M, 2005, Behav Sleep Med, V3, P113, DOI 10.1207/s15402010bsm0303_1; Owens Judith A, 2005, Behav Sleep Med, V3, P18, DOI 10.1207/s15402010bsm0301_4; Owens JA, 2012, PEDIATRICS, V129, P987, DOI 10.1542/peds.2012-0755A; Paavonen EJ, 2009, PEDIATRICS, V123, pE857, DOI 10.1542/peds.2008-2164; Philip P, 2004, J SLEEP RES, V13, P105, DOI 10.1111/j.1365-2869.2004.00399.x; Philip P, 2006, SLEEP MED REV, V10, P347, DOI 10.1016/j.smrv.2006.04.002; Philip P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114102; Ravishankar TL, 2010, CHIN J DENT RES, V13, P57; Rowe R, 2007, J CHILD PSYCHOL PSYC, V48, P71, DOI 10.1111/j.1469-7610.2006.01674.x; Soriano EP, 2007, DENT TRAUMATOL, V23, P232, DOI 10.1111/j.1600-9657.2005.00426.x; Thornley S, 2014, NEW ZEAL MED J, V127, P32; Valent F, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.2.e23; Yang CK, 2005, PEDIATRICS, V115, P250, DOI 10.1542/peds.2004-0815G	36	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0135753	10.1371/journal.pone.0135753	http://dx.doi.org/10.1371/journal.pone.0135753			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP1VK	26280345	Green Submitted, Green Published, gold			2022-12-26	WOS:000359664300021
J	Noiret, L; Baigent, S; Jalan, R; Thomas, SR				Noiret, Lorette; Baigent, Stephen; Jalan, Rajiv; Thomas, S. Randall			Mathematical Model of Ammonia Handling in the Rat Renal Medulla	PLOS ONE			English	Article							THICK ASCENDING LIMB; RH C GLYCOPROTEIN; NA+-K+-ATPASE; COLLECTING DUCT; METABOLIC-ACIDOSIS; NA+-K+-2CL(-) COTRANSPORTER; JUXTAMEDULLARY NEPHRON; BICARBONATE TRANSPORT; CHRONIC HYPERKALEMIA; POTASSIUM SECRETION	The kidney is one of the main organs that produces ammonia and release it into the circulation. Under normal conditions, between 30 and 50% of the ammonia produced in the kidney is excreted in the urine, the rest being absorbed into the systemic circulation via the renal vein. In acidosis and in some pathological conditions, the proportion of urinary excretion can increase to 70% of the ammonia produced in the kidney. Mechanisms regulating the balance between urinary excretion and renal vein release are not fully understood. We developed a mathematical model that reflects current thinking about renal ammonia handling in order to investigate the role of each tubular segment and identify some of the components which might control this balance. The model treats the movements of water, sodium chloride, urea, NH3 and NH4+, and non-reabsorbable solute in an idealized renal medulla of the rat at steady state. A parameter study was performed to identify the transport parameters and microenvironmental conditions that most affect the rate of urinary ammonia excretion. Our results suggest that urinary ammonia excretion is mainly determined by those parameters that affect ammonia recycling in the loops of Henle. In particular, our results suggest a critical role for interstitial pH in the outer medulla and for luminal pH along the inner medullary collecting ducts.	[Noiret, Lorette; Baigent, Stephen] UCL, CoMPLEX, London, England; [Baigent, Stephen] UCL, Math, London, England; [Jalan, Rajiv] UCL, Sch Med, Inst Hepatol, London W1N 8AA, England; [Thomas, S. Randall] Univ Paris 11, CNRS, IR4M UMR8081, F-91405 Orsay, France	University of London; University College London; University of London; University College London; University of London; University College London; UCL Medical School; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Saclay	Noiret, L (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol, Boston, MA 02138 USA.	noiret.lorette@mgh.harvard.edu			Engineering and Physical Sciences Research Council through the UCL CoMPLEX doctoral training centre; Virtual Physiological Human - Network of Excellence (EU) [23920]	Engineering and Physical Sciences Research Council through the UCL CoMPLEX doctoral training centre; Virtual Physiological Human - Network of Excellence (EU)	This work was supported by the Engineering and Physical Sciences Research Council through the UCL CoMPLEX doctoral training centre and by the following grant: The Virtual Physiological Human - Network of Excellence (EU FP7, grant 23920, http://cordis.europa.eu/fp7/ict/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Hossain S, 2011, AM J PHYSIOL-RENAL, V301, pF969, DOI 10.1152/ajprenal.00010.2011; Attmane-Elakeb A, 1998, J BIOL CHEM, V273, P33681, DOI 10.1074/jbc.273.50.33681; Attmane-Elakeb A, 2001, AMERICAN JOURNAL OF, V280; BATTILANA CA, 1978, J CLIN INVEST, V62, P1093, DOI 10.1172/JCI109215; Bishop JM, 2013, AM J PHYSIOL-RENAL, V304, pF422, DOI 10.1152/ajprenal.00301.2012; Biver S, 2008, NATURE, V456, P339, DOI 10.1038/nature07518; BUERKERT J, 1983, AM J PHYSIOL, V244, pF442, DOI 10.1152/ajprenal.1983.244.4.F442; BUERKERT J, 1982, J CLIN INVEST, V70, P1, DOI 10.1172/JCI110581; DEJONG CHC, 1993, J CLIN INVEST, V92, P2834, DOI 10.1172/JCI116903; DEJONG CHC, 1993, GUT, V34, P1112, DOI 10.1136/gut.34.8.1112; DUBOSE TD, 1992, J CLIN INVEST, V90, P1443, DOI 10.1172/JCI116011; DUBOSE TD, 1991, J AM SOC NEPHROL, V1, P1193; DUBOSE TD, 1983, AM J PHYSIOL, V244, pF497, DOI 10.1152/ajprenal.1983.244.5.F497; DUBOSE TD, 1991, AM J PHYSIOL, V260, pF680, DOI 10.1152/ajprenal.1991.260.5.F680; Eladari D, 2002, J AM SOC NEPHROL, V13, P1999, DOI 10.1097/01.ASN.0000025280.02386.9D; FERGUSON EB, 1951, J PHYSIOL-LONDON, V112, P420, DOI 10.1113/jphysiol.1951.sp004539; FLESSNER MF, 1991, AM J PHYSIOL, V260, pF264, DOI 10.1152/ajprenal.1991.260.2.F264; FLESSNER MF, 1993, AM J PHYSIOL, V264, pF837, DOI 10.1152/ajprenal.1993.264.5.F837; FLESSNER MF, 1992, AM J PHYSIOL, V262, pF1, DOI 10.1152/ajprenal.1992.262.1.F1; Garibotto G, 2009, METAB BRAIN DIS, V24, P159, DOI 10.1007/s11011-008-9121-6; GARVIN JL, 1988, AM J PHYSIOL, V255, pF56; Garvin JL, 1987, THE AMERICAN JOURNAL, V252; GOOD DW, 1985, AM J PHYSIOL, V248, pF459, DOI 10.1152/ajprenal.1985.248.4.F459; GOOD DW, 1984, J CLIN INVEST, V73, P602, DOI 10.1172/JCI111250; GOOD DW, 1987, J CLIN INVEST, V80, P1358, DOI 10.1172/JCI113213; GOOD DW, 1988, AM J PHYSIOL, V255, pF78, DOI 10.1152/ajprenal.1988.255.1.F78; GRABER ML, 1981, AM J PHYSIOL, V241, pF669, DOI 10.1152/ajprenal.1981.241.6.F669; Han KH, 2011, AM J PHYSIOL-RENAL, V301, pF823, DOI 10.1152/ajprenal.00266.2011; Hervy S, 2003, AMERICAN JOURNAL OF, V284; Houillier P, 2012, AM J PHYSIOL-RENAL, V302, pF293, DOI 10.1152/ajprenal.00307.2011; JAMISON RL, 1976, KIDNEY INT, V9, P323, DOI 10.1038/ki.1976.38; JAMISON RL, 1982, URINARY CONCENTRATIN; JEN JF, 1994, B MATH BIOL, V56, P491, DOI 10.1007/BF02460468; KERSTING U, 1994, PFLUG ARCH EUR J PHY, V426, P354, DOI 10.1007/BF00374794; KINNE R, 1986, J MEMBRANE BIOL, V94, P279, DOI 10.1007/BF01869723; KNEPPER MA, 1977, KIDNEY INT, V12, P313, DOI 10.1038/ki.1977.118; KRIZ W, 1967, Z ZELLFORSCH MIK ANA, V82, P495, DOI 10.1007/BF00337120; Kuramochi G, 1996, PFLUG ARCH EUR J PHY, V432, P1062, DOI 10.1007/s004240050235; Kuramochi G, 1997, PFLUG ARCH EUR J PHY, V434, P392, DOI 10.1007/s004240050412; KURTZ I, 1986, AM J PHYSIOL, V250, pF497, DOI 10.1152/ajprenal.1986.250.3.F497; Lee HW, 2013, AM J PHYSIOL-RENAL, V304, pF410, DOI 10.1152/ajprenal.00300.2012; Lee HW, 2009, AM J PHYSIOL-RENAL, V296, pF1364, DOI 10.1152/ajprenal.90667.2008; LEONARD E, 1955, AM J PHYSIOL, V182, P131, DOI 10.1152/ajplegacy.1955.182.1.131; LEVINE DZ, 1991, J CLIN INVEST, V87, P1513, DOI 10.1172/JCI115161; MALNIC G, 1966, AM J PHYSIOL, V211, P529, DOI 10.1152/ajplegacy.1966.211.3.529; Mejia Raymond, 1993, American Journal of Physiology, V264, pF397; OWEN EE, 1962, J CLIN INVEST, V41, P1139, DOI 10.1172/JCI104566; Pannabecker TL, 2004, AMERICAN JOURNAL OF, V286; Paredes A, 2006, AM J PHYSIOL-RENAL, V290, pF1094, DOI 10.1152/ajprenal.00071.2005; SAJO IM, 1981, KIDNEY INT, V20, P353, DOI 10.1038/ki.1981.146; SIMON E, 1985, J CLIN INVEST, V76, P855, DOI 10.1172/JCI112043; Stephenson JL, 1974, PROCEEDINGS OF THE N, V71, P1618, DOI [10.1073/pnas.71.5.1618, DOI 10.1073/PNAS.71.5.1618]; Stephenson JL, 1992, HANDBOOK OF PHYSIOLO, V2; STERN L, 1985, KIDNEY INT, V27, P652, DOI 10.1038/ki.1985.60; Stettner P, 2013, P NATL ACAD SCI USA, V110, P9998, DOI 10.1073/pnas.1217775110; Sufit CR, 1983, THE AMERICAN JOURNAL, V245; Tannehill-Gregg SH, 2009, TOXICOL PATHOL, V37, P293, DOI 10.1177/0192623309332990; TANNEN RL, 1977, KIDNEY INT, V11, P453, DOI 10.1038/ki.1977.63; Thomas SR, 1995, THE AMERICAN JOURNAL, V269; TIZIANELLO A, 1980, J CLIN INVEST, V65, P1162, DOI 10.1172/JCI109771; TIZIANELLO A, 1982, CONTRIB NEPHROL, V31, P40; TIZIANELLO A, 1991, KIDNEY INT, V40, P772, DOI 10.1038/ki.1991.274; Verlander JW, 2003, AM J PHYSIOL-RENAL, V284, pF323, DOI 10.1152/ajprenal.00050.2002; Wagner CA, 2009, PFLUG ARCH EUR J PHY, V458, P137, DOI 10.1007/s00424-009-0657-z; Wall SM, 1999, AM J PHYSIOL-RENAL, V277, pF866, DOI 10.1152/ajprenal.1999.277.6.F866; Wall SM, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134827; WALL SM, 1994, AM J PHYSIOL-RENAL, V267, pF660, DOI 10.1152/ajprenal.1994.267.4.F660; Weiner ID, 2011, AM J PHYSIOL-RENAL, V300, pF11, DOI 10.1152/ajprenal.00554.2010; Weinstein AM, 2015, AM J PHYSIOL-RENAL, V308, pF1076, DOI 10.1152/ajprenal.00504.2014; Weinstein AM, 2010, AM J PHYSIOL-RENAL, V298, pF543, DOI 10.1152/ajprenal.00232.2009; Weinstein AM, 2002, AM J PHYSIOL-RENAL, V283, pF1237, DOI 10.1152/ajprenal.00162.2002; WILCOX CS, 1984, AM J PHYSIOL, V247, pF506, DOI 10.1152/ajprenal.1984.247.3.F506; Zhai XY, 2007, J AM SOC NEPHROL, V18, P2937, DOI 10.1681/ASN.2007010056	73	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0134477	10.1371/journal.pone.0134477	http://dx.doi.org/10.1371/journal.pone.0134477			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26280830	Green Published, gold			2022-12-26	WOS:000359664300007
J	Pan, T; Wang, H; Hu, CC; Sun, ZL; Zhu, XX; Meng, T; Meng, XX; Zhang, BW				Pan, Tao; Wang, Hui; Hu, Chaochao; Sun, Zhonglou; Zhu, Xiaoxue; Meng, Tao; Meng, Xiuxiang; Zhang, Baowei			Species Delimitation in the Genus Moschus (Ruminantia: Moschidae) and Its High-Plateau Origin	PLOS ONE			English	Article							COMPLETE MITOCHONDRIAL GENOME; EAST-ASIAN MONSOON; MUSK DEER; TIBETAN PLATEAU; COMPREHENSIVE ANALYSIS; PHYLOGENETIC ANALYSIS; GENETIC CONSEQUENCES; CYTOCHROME-B; UPLIFT; DNA	The authenticity of controversial species is a significant challenge for systematic biologists. Moschidae is a small family of musk deer in the Artiodactyla, composing only one genus, Moschus. Historically, the number of species in the Moschidae family has been debated. Presently, most musk deer species were restricted in the Tibetan Plateau and surrounding/adjacent areas, which implied that the evolution of Moschus might have been punctuated by the uplift of the Tibetan Plateau. In this study, we aimed to determine the evolutionary history and delimit the species in Moschus by exploring the complete mitochondrial genome (mtDNA) and other mitochondrial gene. Our study demonstrated that six species, M. leucogaster, M. fuscus, M. moschiferus, M. berezovskii, M. chrysogaster and M. anhuiensis, were authentic species in the genus Moschus. Phylogenetic analysis and molecular dating showed that the ancestor of the present Moschidae originates from Tibetan Plateau which suggested that the evolution of Moschus was prompted by the most intense orogenic movement of the Tibetan Plateau during the Pliocene age, and alternating glacial-interglacial geological eras.	[Pan, Tao; Wang, Hui; Sun, Zhonglou; Zhu, Xiaoxue; Zhang, Baowei] Anhui Univ, Sch Life Sci, Anhui Key Lab Ecoengn & Biotech, Hefei 230601, Anhui, Peoples R China; [Hu, Chaochao] Nanjing Normal Univ, Sch Life Sci, Nanjing 230039, Jiangsu, Peoples R China; [Meng, Tao] Guangxi Forest Inventory & Planning Inst, Nanning 530011, Guangxi, Peoples R China; [Meng, Xiuxiang] Renmin Univ China, Sch Environm & Nat Resources, Beijing 100872, Peoples R China	Anhui University; Nanjing Normal University; Renmin University of China	Zhang, BW (corresponding author), Anhui Univ, Sch Life Sci, Anhui Key Lab Ecoengn & Biotech, Hefei 230601, Anhui, Peoples R China.	zhangbw@ahu.edu.cn			The wild populations investigation and habitat assessment project of Moschus anhuiensis; The field patrol and habitat protected project of Moschus anhuiensis, (Anhui Nature Reserve Management Station) [20132014]; Foundation for Young and Key Teachers Project of Anhui University [02203104/04]; Endangerment mechanism and habitat assessment project of forest musk deer (Guangxi) [2014GXNSFAA118122]	The wild populations investigation and habitat assessment project of Moschus anhuiensis; The field patrol and habitat protected project of Moschus anhuiensis, (Anhui Nature Reserve Management Station); Foundation for Young and Key Teachers Project of Anhui University; Endangerment mechanism and habitat assessment project of forest musk deer (Guangxi)	This project was funded by The wild populations investigation and habitat assessment project of Moschus anhuiensis (The second land survey of wild animal resources investigation project, 2014-2015, Baowei ZHANG), The field patrol and habitat protected project of Moschus anhuiensis, (Anhui Nature Reserve Management Station, 20132014, Baowei ZHANG) and Foundation for Young and Key Teachers Project of Anhui University (02203104/04, Baowei ZHANG), Endangerment mechanism and habitat assessment project of forest musk deer (Guangxi, 2014GXNSFAA118122, Tao MENG). The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper. All projects came from Baowei ZHANG support the study design, data collection and analysis and decision to publish. The project came from Tao MENG support the preparation of the manuscript and data collection and analysis.	Achilli A, 2008, CURR BIOL, V18, pR157, DOI 10.1016/j.cub.2008.01.019; Agnarsson I, 2008, MOL PHYLOGENET EVOL, V48, P964, DOI 10.1016/j.ympev.2008.05.046; An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1; Anderson S, 1981, SEQUENCE AND ORGANIZ; [Anonymous], 2001, PRIMER V5; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; Burland T G, 2000, Methods Mol Biol, V132, P71; Cao MM, 2012, MOL PHYLOGENET EVOL, V65, P823, DOI 10.1016/j.ympev.2012.08.004; Chung SL, 1998, NATURE, V394, P769, DOI 10.1038/29511; Davies TJ, 2011, PHILOS T R SOC B, V366, P2526, DOI 10.1098/rstb.2011.0018; DEGIORGI C, 1989, CELL BIOPHYS, V14, P67, DOI 10.1007/BF02797392; Deng T, 2011, SCIENCE, V333, P1285, DOI 10.1126/science.1206594; Drummond A.J., 2007, TRACER VERSION 15; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Feng H, 2012, ACTA AGRICULTURAE BO, V8, P3; Flerov C, 1929, YEARBOOK OF THE ZOOL, V31, P1; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Gibb GC, 2007, MOL BIOL EVOL, V24, P269, DOI 10.1093/molbev/msl158; Gray J.E., 1821, LONDON MED REPOSITOR, V15, P296; GROVES C P, 1986, Acta Theriologica Sinica, V6, P101; Groves Colin P., 1995, Acta Theriologica Sinica, V15, P181; GRUBB P, 1982, Saeugetierkundliche Mitteilungen, V30, P127; Hassanin A, 2012, CR BIOL, V335, P32, DOI 10.1016/j.crvi.2011.11.002; Hassanin A, 2009, J MOL EVOL, V68, P293, DOI 10.1007/s00239-009-9208-7; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hiendleder S, 1998, J MOL EVOL, V47, P441, DOI 10.1007/PL00006401; Hodgson BH, 1839, J ASIATIC SOC BENGAL, V7, P202; Hua X, 2013, AM NAT, V182, P1, DOI 10.1086/670690; HUELSENBECK J, 2005, MRBAYES VERSION 3 1; Jang KH, 2010, MITOCHONDR DNA, V21, P65, DOI 10.3109/19401736.2010.490834; Jin YT, 2014, MOL PHYLOGENET EVOL, V71, P288, DOI 10.1016/j.ympev.2013.11.004; Li M, 1999, CHINESE SCI BULL, V44, P719, DOI 10.1007/BF02909711; Li ZX, 1981, ZOOL RES, V2, P7; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lin YH, 2002, GENE, V294, P119, DOI 10.1016/S0378-1119(02)00695-9; Linnaeus C., 1758, SYSTEMA NATURAE, V1; Liu JQ, 2006, MOL PHYLOGENET EVOL, V38, P31, DOI 10.1016/j.ympev.2005.09.010; Liu XD, 2002, PALAEOGEOGR PALAEOCL, V183, P223, DOI 10.1016/S0031-0182(01)00488-6; Lu B, 2014, MOL PHYLOGENET EVOL, V73, P40, DOI 10.1016/j.ympev.2014.01.008; Nylander J, 2003, MRMODELTEST 1 0 B A; Pan GT, 2012, J ASIAN EARTH SCI, V53, P3, DOI 10.1016/j.jseaes.2011.12.018; Parham JF, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-11; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Peng HY, 2009, J NAT HIST, V43, P1219, DOI 10.1080/00222930902767458; Qiang XK, 2001, EARTH PLANET SC LETT, V187, P83, DOI 10.1016/S0012-821X(01)00281-3; Rambaut A., 2010, TREEANNOTATOR VERSIO; Rambaut A., 2009, FIGTREE VERSION 1 3; Rannala B, 2003, GENETICS, V164, P1645; Saccone C, 1999, GENE, V238, P195, DOI 10.1016/S0378-1119(99)00270-X; Sambrook J, 1989, MOLECULAR CLONING CO; Sanchez IM, 2011, J VERTEBR PALEONTOL, V31, P1397, DOI 10.1080/02724634.2011.618155; Sheng H.L., 1992, THE DEER IN CHINA; Sheng HL, 2007, THE MUSK DEER IN CHI; Sokolov VE, 1997, IZV AKAD NAUK BIOL+, P677; Sowerby A. de C., 1925, China Journal of Science and Arts, V3, P651; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Su B, 1999, MOL PHYLOGENET EVOL, V12, P241, DOI 10.1006/mpev.1999.0616; Su Bing, 2001, Zoological Research, V22, P169; Swofford DL., 2001, PAUP PHYLOGENETIC AN; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vislobokova IA, 2009, PALEONTOL J+, V43, P326, DOI 10.1134/S0031030109030125; Wang H, 2013, MITOCHONDR DNA, V24, P487, DOI 10.3109/19401736.2013.770499; Wang Q., 1982, Acta Theriologica Sinica, V2, P133; Wang XM, 2013, PALAEOGEOGR PALAEOCL, V374, P81, DOI 10.1016/j.palaeo.2013.01.007; Wang XM, 2003, AM MUS NOVIT, P1; Wang Y. X., 2003, COMPLETE CHECKLIST M; Willis KJ, 2002, SCIENCE, V295, P1245, DOI 10.1126/science.1067335; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yan F, 2013, MOL ECOL, V22, P1120, DOI 10.1111/mec.12153; Yang CZ, 2015, MITOCHONDR DNA, V26, P605, DOI 10.3109/19401736.2014.880887; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Yao YG, 2008, J MED GENET, V45, P769, DOI 10.1136/jmg.2008.059782; Zhang DF, 2000, ENVIRON GEOL, V39, P1352, DOI 10.1007/s002540000174; Zhang JQ, 2004, JOURNAL OF CHINA WES, V25, P251; Zhang PZ, 2004, GEOLOGY, V32, P809, DOI 10.1130/G20554.1; Zhou YJ, 2004, FOLIA ZOOL, V53, P129; Zhu XX, 2013, MITOCHONDR DNA, V24, P205, DOI 10.3109/19401736.2012.744985	83	23	25	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0134183	10.1371/journal.pone.0134183	http://dx.doi.org/10.1371/journal.pone.0134183			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26280166	gold, Green Published, Green Submitted			2022-12-26	WOS:000359664300002
J	Hoeflinger, JL; Kashtanov, DO; Cox, SB; Dowd, SE; Jouni, ZE; Donovan, SM; Miller, MJ				Hoeflinger, Jennifer L.; Kashtanov, Dimitri O.; Cox, Stephen B.; Dowd, Scot E.; Jouni, Zeina E.; Donovan, Sharon M.; Miller, Michael J.			Characterization of the Intestinal Lactobacilli Community following Galactooligosaccharides and Polydextrose Supplementation in the Neonatal Piglet	PLOS ONE			English	Article							HUMAN-MILK OLIGOSACCHARIDES; INULIN-TYPE PREBIOTICS; BOVINE-MILK; INFANT FORMULA; MICROBIOTA; IDENTIFICATION; DIVERSITY; NUTRITION; SEQUENCES; DIGESTION	Recently, prebiotic supplementation of infant formula has become common practice; however the impact on the intestinal microbiota has not been completely elucidated. In this study, neonatal piglets were randomized to: formula (FORM, n = 8), formula supplemented with 2 g/L each galactooligosaccharides (GOS) and polydextrose (PDX, F+GP, n = 9) or a sow-reared (SOW, n = 12) reference group for 19 days. The ileal (IL) and ascending colon (AC) microbiota were characterized using culture-dependent and -independent methods. 16S amplicon sequencing identified no differences at the genera level in the IL. Interestingly, six genera in the AC were significantly different between FORM and F+GP (P<0.05): Lactobacillus, Ruminococcus, Parabacteroides, Oscillospira, Hydrogenoanaerobacterium and Catabacter. In particular, the relative abundance of AC Lactobacillus was higher (P = 0.04) in F+GP as compared to FORM. Culture-dependent analysis of the IL and AC lactobacilli communities of FORM and F+GP revealed a Lactobacillus spp. composition similar to 16S amplicon sequencing. Additional analysis demonstrated individual Lactobacillus isolates were unable to ferment PDX. Conversely, a majority of lactobacilli isolates could ferment GOS, regardless of piglet diet. In addition, the ability of lactobacilli isolates to ferment the longer chain GOS fragments (DP 3 or greater), which are expected to be present in the distal intestine, was not different between FORM and F+GP. In conclusion, prebiotic supplementation of formula impacted the AC microbiota; however, direct utilization of GOS or PDX does not lead to an increase in Lactobacillus spp.	[Hoeflinger, Jennifer L.; Donovan, Sharon M.; Miller, Michael J.] Univ Illinois, Dept Food Sci & Human Nutr Sci, Urbana, IL 61801 USA; [Kashtanov, Dimitri O.; Donovan, Sharon M.; Miller, Michael J.] Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA; [Dowd, Scot E.; Jouni, Zeina E.] Res & Testing Lab, Lubbock, TX 79407 USA; [Jouni, Zeina E.] Mead Johnson Nutr, Evansville, IN 47712 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Miller, MJ (corresponding author), Univ Illinois, Dept Food Sci & Human Nutr Sci, 905 S Goodwin Ave, Urbana, IL 61801 USA.	mille216@illinois.edu	Dowd, Scot E/M-5386-2017; Donovan, Sharon/AAY-6787-2020	Dowd, Scot E/0000-0002-6296-1427; Hoeflinger, Jennifer/0000-0002-3342-3611; Miller, Michael/0000-0001-8579-1080	Mead Johnson Nutrition; Research and Testing Laboratory; Molecular Research LP	Mead Johnson Nutrition; Research and Testing Laboratory; Molecular Research LP	This study was funded by Mead Johnson Nutrition who had a role in the study design. They had a limited role in the decision to publish and preparation of the manuscript but had no role in the collection and analysis of data. Mead Johnson Nutrition provided support in the form of a salary for author ZEJ, but did not have any additional role in the data collection and analysis. The specific role of this author is articulated in the 'author contributions' section. Research and Testing Laboratory and Molecular Research LP provided support in the form of salaries for authors SBC and SED, respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Aufreiter S, 2011, J NUTR, V141, P366, DOI 10.3945/jn.110.135343; Barry KA, 2009, J ANIM SCI, V87, P3244, DOI 10.2527/jas.2008-1659; BETTELHEIM KA, 1974, J HYG-CAMBRIDGE, V72, P67, DOI 10.1017/S0022172400023226; Blaiotta G, 2008, APPL ENVIRON MICROB, V74, P208, DOI 10.1128/AEM.01711-07; Bode L, 2009, NUTR REV, V67, pS183, DOI 10.1111/j.1753-4887.2009.00239.x; Boehm G, 2002, ARCH DIS CHILD-FETAL, V86, P178, DOI 10.1136/fn.86.3.F178; BROOK I, 1979, PEDIATRICS, V63, P451; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Collins SM, 2009, GASTROENTEROLOGY, V136, P2003, DOI 10.1053/j.gastro.2009.01.075; Coppa G V, 2006, Dig Liver Dis, V38 Suppl 2, pS291; Cummings JH, 2002, BRIT J NUTR, V87, pS145, DOI 10.1079/BJN/2002530; Cummings JH, 2001, AM J CLIN NUTR, V73, p415S, DOI 10.1093/ajcn/73.2.415s; Davis LMG, 2010, INT J FOOD MICROBIOL, V144, P285, DOI 10.1016/j.ijfoodmicro.2010.10.007; Davis LMG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025200; Domeneghini C, 2006, HISTOL HISTOPATHOL, V21, P273, DOI 10.14670/HH-21.273; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Dowd SF, 2008, FOODBORNE PATHOG DIS, V5, P459, DOI 10.1089/fpd.2008.0107; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Eshach Adiv Orly, 2004, Pediatr Endocrinol Rev, V2, P216; Fava F, 2007, BRIT J NUTR, V98, P123, DOI 10.1017/S0007114507691818; Garrido D, 2013, FOOD MICROBIOL, V33, P262, DOI 10.1016/j.fm.2012.10.003; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; Gopal Pramod K., 2000, British Journal of Nutrition, V84, pS69; Harmsen HJM, 2000, J PEDIATR GASTR NUTR, V30, P61, DOI 10.1097/00005176-200001000-00019; Herfel TM, 2009, FOOD CHEM TOXICOL, V47, P1530, DOI 10.1016/j.fct.2009.03.039; Herfel TM, 2011, J NUTR, V141, P2139, DOI 10.3945/jn.111.143727; Hunt KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021313; Ishak HD, 2011, MICROB ECOL, V61, P821, DOI 10.1007/s00248-010-9793-4; KARLSSON FH, 2011, MICROB ECOL, V61, P473, DOI DOI 10.1007/s00248-010-9796-1; Kelly G, 2009, ALTERN MED REV, V14, P36; Kelly G, 2008, ALTERN MED REV, V13, P315; Kingma SDK, 2011, J NUTR, V141, P1023, DOI 10.3945/jn.110.135517; Konstantinov SR, 2004, APPL ENVIRON MICROB, V70, P3821, DOI 10.1128/AEM.70.7.3821-3830.2004; Konstantinov SR, 2003, FEMS MICROBIOL ECOL, V43, P225, DOI 10.1111/j.1574-6941.2003.tb01062.x; Korhonen JM, 2007, J APPL MICROBIOL, V103, P2496, DOI 10.1111/j.1365-2672.2007.03483.x; Kunz C, 2000, ANNU REV NUTR, V20, P699, DOI 10.1146/annurev.nutr.20.1.699; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Lau K, 2011, J IMMUNOL, V186, P3538, DOI 10.4049/jimmunol.1001864; Li M, 2012, J NUTR, V142, P681, DOI 10.3945/jn.111.154427; Louis P, 2007, APPL ENVIRON MICROB, V73, P2009, DOI 10.1128/AEM.02561-06; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; MACFARLANE GT, 1992, FEMS MICROBIOL ECOL, V101, P81, DOI 10.1111/j.1574-6968.1992.tb05764.x; MACFARLANE GT, 1986, J GEN MICROBIOL, V132, P1647; Martin-Sosa S, 2003, J DAIRY SCI, V86, P52, DOI 10.3168/jds.S0022-0302(03)73583-8; Monaco MH, 2011, J PEDIATR GASTR NUTR, V52, P210, DOI 10.1097/MPG.0b013e3181ffcaee; Mountzouris KC, 2002, BRIT J NUTR, V87, P405, DOI 10.1079/BJN2002563; Muir HE, 1996, J ANIM SCI, V74, P1641; Nakamura N, 2009, APPL ENVIRON MICROB, V75, P1121, DOI 10.1128/AEM.02359-07; Odle J, 2014, ANNU REV ANIM BIOSCI, V2, P419, DOI 10.1146/annurev-animal-022513-114158; Oksanen J., 2022, VEGAN COMMUNITY ECOL; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rao S, 2009, ARCH PEDIAT ADOL MED, V163, P755, DOI 10.1001/archpediatrics.2009.94; Ribeiro TC, 2011, J PEDIATR GASTROENTE; Roberfroid MB, 2007, J NUTR, V137, p2493S, DOI 10.1093/jn/137.11.2493S; Roberts DW, 2010, LABDSV ORDINATION AN, V1, P4; Roesch LFW, 2009, ISME J, V3, P536, DOI 10.1038/ismej.2009.5; Salvini F, 2011, J NUTR, V141, P1335, DOI 10.3945/jn.110.136747; Sanders ME, 2010, GUT MICROBES, V1, P164, DOI 10.4161/gmic.1.3.12127; Sangild PT, 2013, J ANIM SCI, V91, P4713, DOI 10.2527/jas.2013-6359; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Scalabrin DMF, 2012, J PEDIATR GASTR NUTR, V54, P343, DOI 10.1097/MPG.0b013e318237ed95; Schaub M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0013115, 10.1371/journal.pone.0015046]; Smiricky-Tjardes MR, 2003, J ANIM SCI, V81, P2535; Thompson CL, 2008, ISME J, V2, P739, DOI 10.1038/ismej.2008.29; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Valladares R, 2013, FASEB J, V27, P1711, DOI 10.1096/fj.12-223339; Valladares R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010507; Veereman-Wauters G, 2011, J PEDIATR GASTR NUTR, V52, P763, DOI 10.1097/MPG.0b013e3182139f39; Walter J, 2008, APPL ENVIRON MICROB, V74, P4985, DOI 10.1128/AEM.00753-08; Wang M, 2013, J NUTR, V143, P795, DOI 10.3945/jn.112.173096; Warnes GR, 2015, GPLOTS VARIOUS R PRO; Yang JL, 2011, CLIN INVEST MED, V34, pE254; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Ziegler E, 2007, J PEDIATR GASTR NUTR, V44, P359, DOI 10.1097/MPG.0b013e31802fca8c	77	15	15	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135494	10.1371/journal.pone.0135494	http://dx.doi.org/10.1371/journal.pone.0135494			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275147	Green Published, gold, Green Submitted			2022-12-26	WOS:000359493600069
J	Gong, Z; Martin-Garcia, JM; Daskalova, SM; Craciunescu, FM; Song, LS; Dorner, K; Hansen, DT; Yang, JH; LaBaer, J; Hogue, BG; Mor, TS; Fromme, P				Gong, Zhen; Martin-Garcia, Jose M.; Daskalova, Sasha M.; Craciunescu, Felicia M.; Song, Lusheng; Doerner, Katerina; Hansen, Debra T.; Yang, Jay-How; LaBaer, Joshua; Hogue, Brenda G.; Mor, Tsafrir S.; Fromme, Petra			Biophysical Characterization of a Vaccine Candidate against HIV-1: The Transmembrane and Membrane Proximal Domains of HIV-1 gp41 as a Maltose Binding Protein Fusion	PLOS ONE			English	Article							CIRCULAR-DICHROISM SPECTRA; IMMUNODEFICIENCY-VIRUS TYPE-1; BROADLY NEUTRALIZING ANTIBODIES; C-TERMINAL TAIL; ENVELOPE GLYCOPROTEIN; SECONDARY STRUCTURE; EPITHELIAL TRANSCYTOSIS; LIGHT-SCATTERING; EXTERNAL REGION; SPANNING DOMAIN	The membrane proximal region (MPR, residues 649-683) and transmembrane domain (TMD, residues 684-705) of the gp41 subunit of HIV-1's envelope protein are highly conserved and are important in viral mucosal transmission, virus attachment and membrane fusion with target cells. Several structures of the trimeric membrane proximal external region (residues 662-683) of MPR have been reported at the atomic level; however, the atomic structure of the TMD still remains unknown. To elucidate the structure of both MPR and TMD, we expressed the region spanning both domains, MPR-TM (residues 649-705), in Escherichia coli as a fusion protein with maltose binding protein (MBP). MPR-TM was initially fused to the C-terminus of MBP via a 42 aa-long linker containing a TEV protease recognition site (MBP-linker-MPR-TM). Biophysical characterization indicated that the purified MBP-linker-MPR-TM protein was a monodisperse and stable candidate for crystallization. However, crystals of the MBP-linker-MPR-TM protein could not be obtained in extensive crystallization screens. It is possible that the 42 residue-long linker between MBP and MPR-TM was interfering with crystal formation. To test this hypothesis, the 42 residue-long linker was replaced with three alanine residues. The fusion protein, MBP-AAA-MPR-TM, was similarly purified and characterized. Significantly, both the MBP-linker-MPR-TM and MBP-AAA-MPR-TM proteins strongly interacted with broadly neutralizing monoclonal antibodies 2F5 and 4E10. With epitopes accessible to the broadly neutralizing antibodies, these MBP/MPR-TM recombinant proteins may be in immunologically relevant conformations that mimic a pre-hairpin intermediate of gp41.	[Gong, Zhen; Martin-Garcia, Jose M.; Daskalova, Sasha M.; Doerner, Katerina; Hansen, Debra T.; Yang, Jay-How; LaBaer, Joshua; Fromme, Petra] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Gong, Zhen; Martin-Garcia, Jose M.; Craciunescu, Felicia M.; Doerner, Katerina; Hansen, Debra T.; Yang, Jay-How; Hogue, Brenda G.; Fromme, Petra] Arizona State Univ, Biodesign Inst, Ctr Appl Struct Discovery, Tempe, AZ 85287 USA; [Daskalova, Sasha M.; Hogue, Brenda G.; Mor, Tsafrir S.] Arizona State Univ, Biodesign Inst, Ctr Infect Dis & Vaccinol, Tempe, AZ 85287 USA; [Craciunescu, Felicia M.; Hansen, Debra T.] Arizona State Univ, Biodesign Inst, Ctr Innovat Med, Tempe, AZ 85287 USA; [Song, Lusheng; LaBaer, Joshua] Arizona State Univ, Biodesign Inst, Virginia G Piper Ctr Personalized Diagnost, Tempe, AZ 85287 USA; [Hogue, Brenda G.; Mor, Tsafrir S.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Mor, TS (corresponding author), Arizona State Univ, Biodesign Inst, Ctr Infect Dis & Vaccinol, Tempe, AZ 85287 USA.	tsafrir.mor@asu.edu; pfromme@asu.edu	MARTIN GARCIA, JOSE MANUEL/AAB-6838-2020; Garcia, Jose Manuel Martin/V-2043-2018; MARTIN GARCIA, JOSE MANUEL/GQA-3160-2022; Gong, Zhen/A-6932-2016	MARTIN GARCIA, JOSE MANUEL/0000-0002-4558-3858; Garcia, Jose Manuel Martin/0000-0002-4558-3858; MARTIN GARCIA, JOSE MANUEL/0000-0002-4558-3858; Hogue, Brenda/0000-0002-4545-9208; Hansen, Debra T./0000-0003-4395-8297	PSI: Biology program within the National Institute of General Medical Sciences' Protein Structure Initiative (National Institutes of Health) [U54GM094599]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094599] Funding Source: NIH RePORTER	PSI: Biology program within the National Institute of General Medical Sciences' Protein Structure Initiative (National Institutes of Health); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by PSI: Biology program within the National Institute of General Medical Sciences' Protein Structure Initiative (National Institutes of Health grant number U54GM094599) to PF, TSM, BGH, JL.	Alfsen A, 2002, J BIOL CHEM, V277, P25649, DOI 10.1074/jbc.M200554200; Alfsen A, 2001, J IMMUNOL, V166, P6257, DOI 10.4049/jimmunol.166.10.6257; Andrew P, 2006, ESTIMATION OF MOLECU, P1; Bomsel M, 2011, IMMUNITY, V34, P269, DOI 10.1016/j.immuni.2011.01.015; Buzon V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000880; Center RJ, 1998, PROTEIN SCI, V7, P1612, DOI 10.1002/pro.5560070715; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; CHU B, 1970, ANNU REV PHYS CHEM, V21, P145, DOI 10.1146/annurev.pc.21.100170.001045; Cohen T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001085; COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1; Devito C, 2000, J IMMUNOL, V165, P5170, DOI 10.4049/jimmunol.165.9.5170; Do BH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089906; Frey G, 2008, P NATL ACAD SCI USA, V105, P3739, DOI 10.1073/pnas.0800255105; GABUZDA D, 1991, J ACQ IMMUN DEF SYND, V4, P34; Gong Z, 2014, PROTEIN SCI, V23, P1607, DOI 10.1002/pro.2540; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Hamilton MD, 2007, NUCLEIC ACIDS RES, V35, P143, DOI 10.1093/nar/gkl1015; Hollier MJ, 2005, VIROLOGY, V337, P284, DOI 10.1016/j.virol.2005.04.015; Hoo CM, 2008, J NANOPART RES, V10, P89, DOI 10.1007/s11051-008-9435-7; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Ke W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039168; KENNEDY RC, 1986, SCIENCE, V231, P1556, DOI 10.1126/science.3006246; Kobe B, 1999, P NATL ACAD SCI USA, V96, P4319, DOI 10.1073/pnas.96.8.4319; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; Mao YD, 2013, P NATL ACAD SCI USA, V110, P12438, DOI 10.1073/pnas.1307382110; Nguyen MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089038; Miyauchi K, 2005, J VIROL, V79, P4720, DOI 10.1128/JVI.79.8.4720-4729.2005; Moon AF, 2010, PROTEIN SCI, V19, P901, DOI 10.1002/pro.368; Newstead S, 2008, PROTEIN SCI, V17, P466, DOI 10.1110/ps.073263108; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Proteau Ariane, 2010, Curr Protoc Protein Sci, VChapter 17, DOI 10.1002/0471140864.ps1710s61; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; PURTSCHER M, 1994, AIDS RES HUM RETROV, V10, P1651, DOI 10.1089/aid.1994.10.1651; Puryear WB, 2013, ADV EXP MED BIOL, V762, P131, DOI 10.1007/978-1-4614-4433-6_5; Raran-Kurussi S, 2014, BIOTECHNOL BIOENG, V111, P2407, DOI 10.1002/bit.25317; Reardon PN, 2014, P NATL ACAD SCI USA, V111, P1391, DOI 10.1073/pnas.1309842111; Reuven EM, 2012, BIOCHEMISTRY-US, V51, P2867, DOI 10.1021/bi201721r; Roosild TP, 2005, SCIENCE, V307, P1317, DOI 10.1126/science.1106392; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scott J.E., 2004, ASSAY GUIDANCE MANUA; Seiler CY, 2014, NUCLEIC ACIDS RES, V42, pD1253, DOI 10.1093/nar/gkt1060; Shang L, 2008, J VIROL, V82, P5417, DOI 10.1128/JVI.02666-07; Shen RZ, 2011, AM J REPROD IMMUNOL, V65, P261, DOI 10.1111/j.1600-0897.2010.00939.x; Shi WX, 2010, J BIOL CHEM, V285, P24290, DOI 10.1074/jbc.M110.111351; Smyth DR, 2003, PROTEIN SCI, V12, P1313, DOI 10.1110/ps.0243403; SPURLINO JC, 1991, J BIOL CHEM, V266, P5202; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Steckbeck JD, 2013, J GEN VIROL, V94, P1, DOI 10.1099/vir.0.046508-0; Tan MHE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074359; Thao Sandy, 2004, Journal of Structural and Functional Genomics, V5, P267, DOI 10.1007/s10969-004-7148-4; Tropea Joseph E., 2009, V498, P297, DOI 10.1007/978-1-59745-196-3_19; Tudor D, 2009, MUCOSAL IMMUNOL, V2, P412, DOI 10.1038/mi.2009.89; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	59	4	4	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136507	10.1371/journal.pone.0136507	http://dx.doi.org/10.1371/journal.pone.0136507			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295457	Green Published, gold, Green Submitted			2022-12-26	WOS:000359926900117
J	Hachicho, N; Reithel, S; Miltner, A; Heipieper, HJ; Kuster, E; Luckenbach, T				Hachicho, Nancy; Reithel, Sarah; Miltner, Anja; Heipieper, Hermann J.; Kuester, Eberhard; Luckenbach, Till			Body Mass Parameters, Lipid Profiles and Protein Contents of Zebrafish Embryos and Effects of 2,4-Dinitrophenol Exposure	PLOS ONE			English	Article							COD GADUS-MACROCEPHALUS; FATTY-ACID COMPOSITION; DANIO-RERIO; SUBSTITUTED PHENOLS; CARASSIUS-AURATUS; DEVELOPING EGGS; RISK-ASSESSMENT; UNFED LARVAE; MARINE FISH; NEW-MODEL	Morphology and physiology of fish embryos undergo dramatic changes during their development until the onset of feeding, supplied only by endogenous yolk reserves. For obtaining an insight how these restructuring processes are reflected by body mass related parameters, dry weights (dw), contents of the elements carbon and nitrogen and lipid and protein levels were quantified in different stages within the first four days of embryo development of the zebrafish (Danio rerio). The data show age dependent changes in tissue composition. Dry weights decreased significantly from 79 mu gdw/egg at 0hours post fertilization (hpf) to 61 mu gdw/egg after 96 hpf. The amounts of total carbon fluctuated between 460 mg g(-1) and 540 mg g(-1) dw, nitrogen was at about 100 mg g(-1) dw and total fatty acids were between 48-73 mg g(-1) dw. In contrast to these parameters that remained relatively constant, the protein content, which was 240 mg g(-1) at 0 hpf, showed an overall increase of about 40%. Comparisons of intact eggs and dechorionated embryos at stages prior to hatching (24, 30, 48 hpf) showed that the differences seen for dry weight and for carbon and nitrogen contents became smaller at more advanced stages, consistent with transition of material from the chorion to embryo tissue. Further, we determined the effect of 2,4-dinitrophenol at a subacutely toxic concentration (14 mu M, LC10) as a model chemical challenge on the examined body mass related parameters. The compound caused significant decreases in phospholipid and glycolipid fatty acid contents along with a decrease in the phospholipid fatty acid unsaturation index. No major changes were observed for the other examined parameters. Lipidomic studies as performed here may thus be useful for determining subacute effects of lipophilic organic compounds on lipid metabolism and on cellular membranes of zebrafish embryos.	[Hachicho, Nancy; Miltner, Anja; Heipieper, Hermann J.] UFZ Helmholtz Ctr Environm Res, Dept Environm Biotechnol, D-04318 Leipzig, Germany; [Reithel, Sarah; Kuester, Eberhard; Luckenbach, Till] UFZ Helmholtz Ctr Environm Res, Dept Bioanalyt Ecotoxicol, D-04318 Leipzig, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Luckenbach, T (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Bioanalyt Ecotoxicol, Permoserstr 15, D-04318 Leipzig, Germany.	till.luckenbach@ufz.de	Heipieper, Hermann/D-1864-2010; Luckenbach, Till/G-6482-2015	Heipieper, Hermann/0000-0002-3723-9600; Luckenbach, Till/0000-0001-6204-1033; Miltner, Anja/0000-0001-9317-0487; Kuster, Eberhard/0000-0002-6062-2755	UFZ - Helmholtz Centre of Environmental Research [POF II-U45]	UFZ - Helmholtz Centre of Environmental Research	This work was supported by UFZ - Helmholtz Centre of Environmental Research (POF II-U45) to NH, SR, AM, HJH, EK, and TL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belanger SE, 2013, ENVIRON TOXICOL CHEM, V32, P1768, DOI 10.1002/etc.2244; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bonsignorio D, 1996, ZYGOTE, V4, P101, DOI 10.1017/S0967199400002975; Braasch I, 2015, J EXP ZOOL PART B, V324, P316, DOI 10.1002/jez.b.22589; Braun MH, 2009, AM J PHYSIOL-RENAL, V296, pF994, DOI 10.1152/ajprenal.90656.2008; COSSINS AR, 1978, P NATL ACAD SCI USA, V75, P2040, DOI 10.1073/pnas.75.4.2040; COTELLI F, 1988, J ULTRA MOL STRUCT R, V99, P70, DOI 10.1016/0889-1605(88)90034-1; COUTURE P, 1995, J MEMBRANE BIOL, V148, P27; Czamanski M, 2011, MAR BIOL, V158, P2847, DOI 10.1007/s00227-011-1783-7; Dantas MC, 2007, J FISH BIOL, V70, P100, DOI 10.1111/j.1095-8649.2006.01277.x; DEY I, 1993, P NATL ACAD SCI USA, V90, P7498, DOI 10.1073/pnas.90.16.7498; EHRLICH KF, 1975, COMP BIOCHEM PHYS B, V51, P25, DOI 10.1016/0305-0491(75)90354-5; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Escher BI, 1996, ENVIRON SCI TECHNOL, V30, P260, DOI 10.1021/es9503084; Farkas T, 2001, AQUAC RES, V32, P645, DOI 10.1046/j.1365-2109.2001.00600.x; Finn RN, 2007, BIOL REPROD, V76, P926, DOI 10.1095/biolreprod.106.059766; Flynn EJ, 2009, J LIPID RES, V50, P1641, DOI 10.1194/jlr.M800590-JLR200; FRASER AJ, 1988, MAR BIOL, V99, P307, DOI 10.1007/BF02112122; Frazer JK, 2009, LEUKEMIA, V23, P1825, DOI 10.1038/leu.2009.116; Goldsmith P, 2004, CURR OPIN PHARMACOL, V4, P504, DOI 10.1016/j.coph.2004.04.005; GREEN DE, 1966, J LIPID RES, V7, P587; Haque S, 2014, ZEBRAFISH, V11, P499, DOI 10.1089/zeb.2014.0994; Hill AJ, 2005, TOXICOL SCI, V86, P6, DOI 10.1093/toxsci/kfi110; Holtta-Vuori M, 2010, BIOCHEM J, V429, P235, DOI 10.1042/BJ20100293; JONES D. B., 1931, U.S. Dept. Agric., Circular; Kamler E, 2008, REV FISH BIOL FISHER, V18, P143, DOI 10.1007/s11160-007-9070-x; Kaszycki P, 2013, APPL MICROBIOL BIOT, V97, P5555, DOI 10.1007/s00253-013-4796-y; Kim DH, 2006, IEEE T NANOBIOSCI, V5, P89, DOI 10.1109/TNB.2006.875054; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kluver N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029063; Krishnan Kannan, 2009, ECOTOXICOLOGY MODELI, P145, DOI [10.1007/978-1-4419-0197-2_6, DOI 10.1007/978-1-4419-0197-2_6]; KROES J, 1972, BIOCHIM BIOPHYS ACTA, V274, P71, DOI 10.1016/0005-2736(72)90281-7; Kuster E, 2005, AQUAT TOXICOL, V75, P76, DOI 10.1016/j.aquatox.2005.07.005; Ladam F, 2014, METHODS MOL BIOL, V1196, P133, DOI 10.1007/978-1-4939-1242-1_9; Lammer E, 2009, COMP BIOCHEM PHYS C, V149, P196, DOI 10.1016/j.cbpc.2008.11.006; Langheinrich U, 2003, BIOESSAYS, V25, P904, DOI 10.1002/bies.10326; Laurel BJ, 2012, MAR BIOL, V159, P2025, DOI 10.1007/s00227-012-1989-3; Laurel BJ, 2010, MAR BIOL, V157, P1713, DOI 10.1007/s00227-010-1445-1; MACFARLANE RB, 1995, J EXP BIOL, V198, P1197; MERTZ W, 1981, SCIENCE, V213, P1332, DOI 10.1126/science.7022654; Miyares RL, 2014, DIS MODEL MECH, V7, P915, DOI 10.1242/dmm.015800; Mommsen T.P., 1988, P347; MORRISON WR, 1964, J LIPID RES, V5, P600; Mukhopadhyay Tapas, 2007, J Oleo Sci, V56, P399; Mushtaq MY, 2014, PLANTA MED, V80, P1227, DOI 10.1055/s-0034-1382878; Nagel R, 2002, ALTEX-ALTERN TIEREXP, V19, P38; Nunes C, 2008, J ENVIRON BIOL, V29, P733; Oberemm A, 2000, LAB ANIMAL, V29, P32; OECD, 2013, OECD TEST 236 FISH E; PALMEIRA CM, 1994, TOXICOL APPL PHARM, V127, P50, DOI 10.1006/taap.1994.1138; Pelster Bernd, 2008, P91; Petersen GI, 1998, ENVIRON TOXICOL CHEM, V17, P1385, DOI 10.1002/etc.5620170724; PETERSON GL, 1979, ANAL BIOCHEM, V100, P201, DOI 10.1016/0003-2697(79)90222-7; Pilati A, 2007, OIKOS, V116, P1663, DOI 10.1111/j.2007.0030-1299.15970.x; RAINUZZO JR, 1992, COMP BIOCHEM PHYS B, V103, P21, DOI 10.1016/0305-0491(92)90407-I; Rao P. G. P., 2013, International Food Research Journal, V20, P275; Ronnestad I, 1999, AQUACULTURE, V177, P201, DOI 10.1016/S0044-8486(99)00082-4; Rossmeisl M, 2000, FASEB J, V14, P1793, DOI 10.1096/fj.99-0965com; Sarasquete C, 2002, HISTOL HISTOPATHOL, V17, P775, DOI 10.14670/HH-17.775; Scholz S, 2008, ENVIRON SCI POLLUT R, V15, P394, DOI 10.1007/s11356-008-0018-z; Scholz S, 2013, REGUL TOXICOL PHARM, V67, P506, DOI 10.1016/j.yrtph.2013.10.003; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SINENSKY M, 1974, P NATL ACAD SCI USA, V71, P522, DOI 10.1073/pnas.71.2.522; SPECTOR AA, 1985, J LIPID RES, V26, P1015; Stackley KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025652; Sterner RW, 2000, ECOLOGY, V81, P127, DOI 10.1890/0012-9658(2000)081[0127:CNAPSO]2.0.CO;2; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; TOCHER DR, 1985, LIPIDS, V20, P84, DOI 10.1007/BF02534213; TOCHER DR, 1984, LIPIDS, V19, P492, DOI 10.1007/BF02534481; WATANABE T, 1994, AQUACULTURE, V124, P223, DOI 10.1016/0044-8486(94)90386-7; Webb KJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r81; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; WIEGAND MD, 1991, FISH PHYSIOL BIOCHEM, V9, P199, DOI 10.1007/BF02265141	73	37	37	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0134755	10.1371/journal.pone.0134755	http://dx.doi.org/10.1371/journal.pone.0134755			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26292096	Green Submitted, Green Published, gold			2022-12-26	WOS:000359919900011
J	Momen, B; Behling, SJ; Lawrence, GB; Sullivan, JH				Momen, Bahram; Behling, Shawna J.; Lawrence, Greg B.; Sullivan, Joseph H.			Photosynthetic and Growth Response of Sugar Maple (Acer saccharum Marsh.) Mature Trees and Seedlings to Calcium, Magnesium, and Nitrogen Additions in the Catskill Mountains, NY, USA	PLOS ONE			English	Article							ACIDIC DEPOSITION; EXPERIMENTAL FOREST; SOIL ACIDIFICATION; ALLEGHENY PLATEAU; CROWN VIGOR; NUTRITION; DECLINE; STRESS; SATURATION; ECOSYSTEM	Decline of sugar maple in North American forests has been attributed to changes in soil calcium (Ca) and nitrogen (N) by acidic precipitation. Although N is an essential and usually a limiting factor in forests, atmospheric N deposition may cause N-saturation leading to loss of soil Ca. Such changes can affect carbon gain and growth of sugar maple trees and seedlings. We applied a 2(2) factorial arrangement of N and dolomitic limestone containing Ca and Magnesium (Mg) to 12 forest plots in the Catskill Mountain region of NY, USA. To quantify the short-term effects, we measured photosynthetic-light responses of sugar maple mature trees and seedlings two or three times during two summers. We estimated maximum net photosynthesis (An-max) and its related light intensity (PAR at An-max), apparent quantum efficiency (A(qe)), and light compensation point (LCP). To quantify the long-term effects, we measured basal area of living mature trees before and 4 and 8 years after treatment applications. Soil and foliar chemistry variables were also measured. Dolomitic limestone increased Ca, Mg, and pH in the soil Oe horizon. Mg was increased in the B horizon when comparing the plots receiving N with those receiving CaMg. In mature trees, foliar Ca and Mg concentrations were higher in the CaMg and N+CaMg plots than in the reference or N plots; foliar Ca concentration was higher in the N+CaMg plots compared with the CaMg plots, foliar Mg was higher in the CaMg plots than the N+CaMg plots; An-max was maximized due to N+CaMg treatment; A(qe) decreased by N addition; and PAR at An-max increased by N or CaMg treatments alone, but the increase was maximized by their combination. No treatment effect was detected on basal areas of living mature trees four or eight years after treatment applications. In seedlings, An-max was increased by N+CaMg addition. The reference plots had an open herbaceous layer, but the plots receiving N had a dense monoculture of common woodfern in the forest floor, which can impede seedling survival.	[Momen, Bahram] Univ Maryland, Environm Sci & Technol Dept, College Pk, MD 20742 USA; [Behling, Shawna J.; Sullivan, Joseph H.] Univ Maryland, Plant Sci & Landscape Architecture Dept, College Pk, MD 20742 USA; [Lawrence, Greg B.] US Geol Survey, New York Water Sci Ctr, Troy, NY USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; United States Department of the Interior; United States Geological Survey	Momen, B (corresponding author), Univ Maryland, Environm Sci & Technol Dept, College Pk, MD 20742 USA.	bmomen@umd.edu	Sullivan, Joe H./AAC-2195-2020	Sullivan, Joe H./0000-0002-2082-0343; Behling, Shawn/0000-0001-5537-3603	GBL through USGS	GBL through USGS	SJB received Research Assistantship from the University of Maryland, College Park when working on this project. Travel and treatment applications expenses were provided by GBL through USGS internal funds.	ADAMS CM, 1992, CAN J FOREST RES, V22, P1489, DOI 10.1139/x92-199; Bailey SW, 2005, SOIL SCI SOC AM J, V69, P681, DOI 10.2136/sssaj2004.0057; Bernacchi CJ, 2003, NEW PHYTOL, V159, P609, DOI 10.1046/j.1469-8137.2003.00850.x; Catovsky S, 2002, ECOL APPL, V12, P1056, DOI 10.1890/1051-0761(2002)012[1056:NAIROT]2.0.CO;2; Clark RB, 2000, J PLANT NUTR, V23, P867, DOI 10.1080/01904160009382068; Dijkstra FA, 2002, ECOSYSTEMS, V5, P385, DOI 10.1007/s10021-001-0082-4; Driscoll CT, 2001, BIOSCIENCE, V51, P180, DOI 10.1641/0006-3568(2001)051[0180:ADITNU]2.0.CO;2; Duchesne L, 2005, FOREST ECOL MANAG, V208, P223, DOI 10.1016/j.foreco.2004.12.003; Duchesne L, 2002, J ENVIRON QUAL, V31, P1676, DOI 10.2134/jeq2002.1676; Eallonardo AS, 2006, THESIS STATE U NEW Y; Elvir JA, 2010, ENVIRON MONIT ASSESS, V171, P129, DOI 10.1007/s10661-010-1523-3; FAHEY TJ, 1994, J ECOL, V82, P533, DOI 10.2307/2261262; Hallett RA, 2006, CAN J FOREST RES, V36, P2235, DOI 10.1139/X06-120; Heijne B, 1996, PLANT SOIL, V179, P197, DOI 10.1007/BF00009329; Horsley SB, 2000, CAN J FOREST RES, V30, P1365, DOI 10.1139/cjfr-30-9-1365; Hotopp KP, 2002, SOUTHEAST NAT, V1, P27, DOI 10.1656/1528-7092(2002)001[0027:LSASCI]2.0.CO;2; Huggett BA, 2007, CAN J FOREST RES, V37, P1692, DOI 10.1139/X07-042; Hurd TM, 1998, CAN J FOREST RES, V28, P799, DOI 10.1139/cjfr-28-6-799; Johnson AH, 2008, SOIL SCI SOC AM J, V72, P1824, DOI 10.2136/sssaj2006.0407; Jones ME, 2011, ARTHROPOD-PLANT INTE, V5, P163, DOI 10.1007/s11829-011-9125-8; Juice SM, 2006, ECOLOGY, V87, P1267, DOI 10.1890/0012-9658(2006)87[1267:ROSMTC]2.0.CO;2; KOLB TE, 1993, CAN J FOREST RES, V23, P2395, DOI 10.1139/x93-296; Lange OL, 1986, TREES-STRUCT FUNCT, V1, P70, DOI 10.1007/BF00197027; Lawrence GB, 1999, ECOL APPL, V9, P1059, DOI 10.1890/1051-0761(1999)009[1059:SCSATR]2.0.CO;2; Lawrence GB, 2000, BIOGEOCHEMISTRY, V50, P21, DOI 10.1023/A:1006332230890; LIU G, 1994, PLANT SOIL, V160, P79, DOI 10.1007/BF00150348; Long RP, 2009, ECOL APPL, V19, P1454, DOI 10.1890/08-1535.1; Long RP, 1997, CAN J FOREST RES, V27, P1560, DOI 10.1139/cjfr-27-10-1560; Lovett GM, 2000, ECOL APPL, V10, P73, DOI 10.1890/1051-0761(2000)010[0073:NSARIF]2.0.CO;2; Magill AH, 2000, ECOSYSTEMS, V3, P238, DOI 10.1007/s100210000023; Markewitz D, 1998, SOIL SCI SOC AM J, V62, P1428, DOI 10.2136/sssaj1998.03615995006200050040x; McLaughlin S, 1999, WATER AIR SOIL POLL, V116, P151, DOI 10.1023/A:1005215112743; Monson RK, 2007, PHILOS T R SOC A, V365, P1677, DOI 10.1098/rsta.2007.2038; Moore JD, 2006, CAN J FOREST RES, V36, P1834, DOI 10.1139/X06-081; Murdoch PS, 1993, AIR SOIL POLLUT, V67, P365; OUIMET R, 1995, CAN J SOIL SCI, V75, P169, DOI 10.4141/cjss95-024; Peek MS, 2002, OECOLOGIA, V132, P175, DOI 10.1007/s00442-002-0954-0; Schabenberger O., 2002, CONT STAT MODELS PLA; Shaffer, 1990, HDB METHODS ACID DEP; Siemion J, 2014, HYDROL PROCESS, V28, P3615, DOI 10.1002/hyp.9903; Sullivan TJ, 2013, ENVIRON SCI TECHNOL, V47, P12687, DOI 10.1021/es401864w; Talhelm AF, 2011, ECOL APPL, V21, P2413, DOI 10.1890/10-2076.1; Thomas G. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P159; Tissue DT, 2002, TREE PHYSIOL, V22, P1157, DOI 10.1093/treephys/22.15-16.1157; Warby RAF, 2009, SOIL SCI SOC AM J, V73, P274, DOI 10.2136/sssaj2007.0016; Wargo PM, 2002, CAN J FOREST RES, V32, P629, DOI [10.1139/x02-008, 10.1139/X02-008]; Warren JM, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plu074; Wilmot TR, 1996, FOREST ECOL MANAG, V84, P123, DOI 10.1016/0378-1127(96)03743-7	48	5	6	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136148	10.1371/journal.pone.0136148	http://dx.doi.org/10.1371/journal.pone.0136148			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291323	Green Submitted, Green Published, gold			2022-12-26	WOS:000359919900059
J	Renz, PB; Cavagnolli, G; Weinert, LS; Silveiro, SP; Camargo, JL				Renz, Paula Breitenbach; Cavagnolli, Gabriela; Weinert, Leticia Schwerz; Silveiro, Sandra Pinho; Camargo, Joiza Lins			HbA1c Test as a Tool in the Diagnosis of Gestational Diabetes Mellitus	PLOS ONE			English	Article							REFERENCE INTERVALS; PREGNANCY; WOMEN; A1C; HYPERGLYCEMIA; GLUCOSE; HBA(1C)	Aims Gestational diabetes mellitus (GDM) is a prevalent and potentially serious condition which may put both mothers and neonates at risk. The current recommendation for diagnosis is the oral glucose tolerance test (OGTT). This study aimed to determine the usefulness of HbA1c test as a diagnostic tool for GDM as compared to the traditional criteria based on the OGTT. Methods This was a diagnostic test accuracy study. We performed OGTT and HbA1c test in women attending prenatal visits at a tertiary hospital. GDM was defined according to WHO1999 or ADA/WHO 2013 criteria. ROC curve was used to evaluate the diagnostic performance of HbA1c. Sensitivity, specificity and likelihood ratios for different HbA1c cut-off points were calculated. Results Of the 262 women in the third trimester of gestation enrolled in the study, 86 (33%) were diagnosed with GDM. Only five of these women presented HbA1c >= 48 mmol/mol (6.5%). This cut-off point presented 100% specificity but very low sensitivity (7%). Based on ROC curve, and considering OGTT as the reference criterion, HbA1c >= 40 mmol/mol (5.8%) showed adequate specificity in diagnosing GDM (94.9%) but low sensitivity (26.4%). Unlike, HbA1c values of 31 mmol/mol (5.0%) presented adequate sensitivity (89.7%) but low specificity (32.6%) to detect GDM. For women with HbA1c >= 40 mmol/mol (5.8%), the positive and negative likelihood ratios were 5.14 (95%CI 2.49-10.63) and 0.78 (0.68-0.88), respectively. The post-test probability of GDM was about 40%, representing a 4.0-fold increase in the mean pre-test probability. This cut-off point could eliminate the need for the unpleasant and laborious OGTT tests in almost one third of cases, as 38% of patients with GDM may be diagnosable by HbA1c test alone. Conclusions Our results show that combined HbA1c and OGTT measurements may be useful in diagnosing GDM.	[Renz, Paula Breitenbach; Cavagnolli, Gabriela; Weinert, Leticia Schwerz; Silveiro, Sandra Pinho; Camargo, Joiza Lins] Univ Fed Rio Grande Sul UFRGS, Grad Program Endocrinol, Porto Alegre, RS, Brazil; [Weinert, Leticia Schwerz] Univ Catolica Pelotas UCPEL, Sch Med, Pelotas, Brazil; [Silveiro, Sandra Pinho; Camargo, Joiza Lins] Hosp Clin Porto Alegre HCPA, Dept Endocrinol, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Catolica de Pelotas	Camargo, JL (corresponding author), Univ Fed Rio Grande Sul UFRGS, Grad Program Endocrinol, Porto Alegre, RS, Brazil.	jcamargo@hcpa.ufrgs.br	Camargo, Joiza Lins/G-9301-2011; Silveiro, Sandra Pinho/V-7922-2019	Camargo, Joiza Lins/0000-0001-8834-4075; Silveiro, Sandra Pinho/0000-0003-4891-4074	Research Incentive Fund (FIPE) of the Hospital de Clinicas de Porto Alegre (HCPA); Coordination for the Enhancement of Higher Level Personnel (CAPES); National Council for Scientific and Technological Development (CNPq)	Research Incentive Fund (FIPE) of the Hospital de Clinicas de Porto Alegre (HCPA); Coordination for the Enhancement of Higher Level Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by the Research Incentive Fund (FIPE) of the Hospital de Clinicas de Porto Alegre (HCPA). PBR and GC received scholarships from the Coordination for the Enhancement of Higher Level Personnel (CAPES) and the National Council for Scientific and Technological Development (CNPq), respectively.	Agarwal MM, 2014, DIABETES RES CLIN PR, V103, P341, DOI 10.1016/j.diabres.2013.10.012; Akobeng AK, 2007, ACTA PAEDIATR, V96, P487, DOI 10.1111/j.1651-2227.2006.00179.x; American Diabetes Association, 2017, Diabetes Care, V40, pS11, DOI 10.2337/dc15-S005; Balaji V, 2007, DIABETES CARE, V30, P1865, DOI 10.2337/dc06-2329; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Buckley BS, 2012, DIABETIC MED, V29, P844, DOI 10.1111/j.1464-5491.2011.03541.x; Carson AP, 2010, DIABETES CARE, V33, P95, DOI 10.2337/dc09-1227; Cavagnolli G, 2011, DIABETIC MED, V28, P31, DOI 10.1111/j.1464-5491.2010.03159.x; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; Donovan L, 2013, ANN INTERN MED, V159, P115, DOI 10.7326/0003-4819-159-2-201307160-00657; FAGAN TJ, 1975, NEW ENGL J MED, V293, P257; Falavigna M, 2012, DIABETES RES CLIN PR, V98, P396, DOI 10.1016/j.diabres.2012.09.002; Farrar D, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007122.pub3; Gui J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064585; Hiramatsu Y, 2012, ENDOCR J, V59, P145, DOI 10.1507/endocrj.K10E-410; Kramer CK, 2010, DIABETES CARE, V33, P101, DOI 10.2337/dc09-1366; Lowe LP, 2012, DIABETES CARE, V35, P574, DOI 10.2337/dc11-1687; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Mosca A, 2006, CLIN CHEM, V52, P1138, DOI 10.1373/clinchem.2005.064899; O'Connor C, 2012, CLIN CHEM LAB MED, V50, P905, DOI 10.1515/CCLM.2011.397; Rajput R, 2012, DIABETES RES CLIN PR, V98, P104, DOI 10.1016/j.diabres.2012.02.018; Rowan JA, 2014, AUST NZ J OBSTET GYN, V54, P177, DOI 10.1111/ajo.12166; Sacks DB, 2011, CLIN CHEM, V57, pE1, DOI 10.1373/clinchem.2010.161596; Sacks DB, 2011, DIABETES CARE, V34, P518, DOI 10.2337/dc10-1546; Suhonen L, 2000, DIABETOLOGIA, V43, P79, DOI 10.1007/s001250050010; Waugh N, 2010, BEST PRACT RES CL EN, V24, P553, DOI 10.1016/j.beem.2010.06.004; Wendland EM, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-23; World Health Organization, US GLYC HAEM HBA1C D; World Health Organization, 1999, WHONCDNCS99	29	41	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135989	10.1371/journal.pone.0135989	http://dx.doi.org/10.1371/journal.pone.0135989			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26292213	gold, Green Published, Green Submitted			2022-12-26	WOS:000359919900045
J	Chiang, SH; Harrington, WW; Luo, GZ; Milliken, NO; Ulrich, JC; Chen, J; Rajpal, DK; Qian, Y; Carpenter, T; Murray, R; Geske, RS; Stimpson, SA; Kramer, HF; Haffner, CD; Becherer, JD; Preugschat, F; Billin, AN				Chiang, Shian-Huey; Harrington, W. Wallace; Luo, Guizhen; Milliken, Naphtali O.; Ulrich, John C.; Chen, Jing; Rajpal, Deepak K.; Qian, Ying; Carpenter, Tiffany; Murray, Rusty; Geske, Robert S.; Stimpson, Stephen A.; Kramer, Henning F.; Haffner, Curt D.; Becherer, J. David; Preugschat, Frank; Billin, Andrew N.			Genetic Ablation of CD38 Protects against Western Diet-Induced Exercise Intolerance and Metabolic Inflexibility	PLOS ONE			English	Article							SKELETAL-MUSCLE; INDUCED OBESITY; HIGH-FAT; NAD(+); MICE; FLEXIBILITY; ACETYLATION; LIPOLYSIS; DISEASE; SIRT1	Nicotinamide adenine dinucleotide (NAD(+)) is a key cofactor required for essential metabolic oxidation-reduction reactions. It also regulates various cellular activities, including gene expression, signaling, DNA repair and calcium homeostasis. Intracellular NAD(+) levels are tightly regulated and often respond rapidly to nutritional and environmental changes. Numerous studies indicate that elevating NAD(+) may be therapeutically beneficial in the context of numerous diseases. However, the role of NAD(+) on skeletal muscle exercise performance is poorly understood. CD38, a multi-functional membrane receptor and enzyme, consumes NAD(+) to generate products such as cyclic-ADP-ribose. CD38 knockout mice show elevated tissue and blood NAD(+) level. Chronic feeding of high-fat, high-sucrose diet to wild type mice leads to exercise intolerance and reduced metabolic flexibility. Loss of CD38 by genetic mutation protects mice from diet-induced metabolic deficit. These animal model results suggest that elevation of tissue NAD(+) through genetic ablation of CD38 can profoundly alter energy homeostasis in animals that are maintained on a calorically-excessive Western diet.	[Chiang, Shian-Huey; Harrington, W. Wallace; Luo, Guizhen; Milliken, Naphtali O.; Ulrich, John C.; Qian, Ying; Carpenter, Tiffany; Stimpson, Stephen A.; Kramer, Henning F.; Haffner, Curt D.; Becherer, J. David; Preugschat, Frank; Billin, Andrew N.] GlaxoSmithKline, Muscle Metab Discovery Performance Unit, Res Triangle Pk, NC 27709 USA; [Chen, Jing; Rajpal, Deepak K.] GlaxoSmithKline, QSCI Computat Biol, Res Triangle Pk, NC 27709 USA; [Murray, Rusty] GlaxoSmithKline, Lab Anim Sci, Res Triangle Pk, NC 27709 USA; [Geske, Robert S.] GlaxoSmithKline, Target & Pathway Validat, Res Triangle Pk, NC 27709 USA	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Chiang, SH (corresponding author), GlaxoSmithKline, Muscle Metab Discovery Performance Unit, Res Triangle Pk, NC 27709 USA.	shianhuey.chiang@gmail.com		Billin, Andrew/0000-0001-7752-0934	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	The author(s) received no specific funding for this work. GlaxoSmithKline provided support in the form of salaries for all the authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Anderson KA, 2012, ESSAYS BIOCHEM, V52, P23, DOI [10.1042/BSE0520023, 10.1042/bse0520023]; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; Barbieri Elena, 2012, J Signal Transduct, V2012, P982794, DOI 10.1155/2012/982794; Barbosa MTP, 2007, FASEB J, V21, P3629, DOI 10.1096/fj.07-8290com; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Corpeleijn E, 2009, OBES REV, V10, P178, DOI 10.1111/j.1467-789X.2008.00544.x; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Escande C, 2013, DIABETES, V62, P1084, DOI 10.2337/db12-1139; Grahnert A, 2011, INNATE IMMUN-LONDON, V17, P212, DOI 10.1177/1753425910361989; Guarente L, 2011, COLD SH Q B, V76, P81, DOI 10.1101/sqb.2011.76.010629; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hipkiss AR, 2009, BIOGERONTOLOGY, V10, P523, DOI 10.1007/s10522-008-9188-9; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Imai S, 2011, FEBS LETT, V585, P1657, DOI 10.1016/j.febslet.2011.04.060; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Johnson JD, 2006, DIABETES, V55, P2737, DOI 10.2337/db05-1455; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Kelley DE, 2005, J CLIN INVEST, V115, P1699, DOI 10.1172/JCI25758; Kendrick AA, 2011, BIOCHEM J, V433, P505, DOI 10.1042/BJ20100791; KLIPPERAURBACH Y, 1995, MED HYPOTHESES, V45, P486, DOI 10.1016/0306-9877(95)90228-7; Langin D, 2005, DIABETES, V54, P3190, DOI 10.2337/diabetes.54.11.3190; Langin D, 2006, PHARMACOL RES, V53, P482, DOI 10.1016/j.phrs.2006.03.009; Vieira DCL, 2013, CLIN INTERV AGING, V8, P1377, DOI 10.2147/CIA.S50333; Li M, 2006, ENDOCRINOLOGY, V147, P2163, DOI 10.1210/en.2005-1313; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Mowers J, 2013, ELIFE, V2, DOI 10.7554/eLife.01119; Parks BW, 2013, CELL METAB, V17, P141, DOI 10.1016/j.cmet.2012.12.007; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Storlien L, 2004, P NUTR SOC, V63, P363, DOI 10.1079/PNS2004349; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Wagner Gregory R, 2011, J Aging Res, V2011, P234875, DOI 10.4061/2011/234875; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014	35	30	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0134927	10.1371/journal.pone.0134927	http://dx.doi.org/10.1371/journal.pone.0134927			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287487	Green Published, gold, Green Submitted			2022-12-26	WOS:000360018600031
J	Koyama, S; Omura, T; Yonezawa, A; Imai, S; Nakagawa, S; Nakagawa, T; Yano, I; Matsubara, K				Koyama, Satoshi; Omura, Tomohiro; Yonezawa, Atsushi; Imai, Satoshi; Nakagawa, Shunsaku; Nakagawa, Takayuki; Yano, Ikuko; Matsubara, Kazuo			Gefitinib and Erlotinib Lead to Phosphorylation of Eukaryotic Initiation Factor 2 Alpha Independent of Epidermal Growth Factor Receptor in A549 Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; INTERSTITIAL LUNG-DISEASE; INDUCED APOPTOSIS; HUMAN HRD1; EIF2-ALPHA KINASE; CARCINOMA-CELLS; ER STRESS; CYCLIN D1; DEATH	Gefitinib and erlotinib are anticancer agents, which inhibit epidermal growth factor receptor (EGFR) tyrosine kinase. Interstitial lung disease (ILD) occurs in patients with non-small cell lung cancer receiving EGFR inhibitors. In the present study, we examined whether gefitinib- and erlotinib-induced lung injury related to ILD through endoplasmic reticulum (ER) stress, which is a causative intracellular mechanism in cytotoxicity caused by various chemicals in adenocarcinomic human alveolar basal epithelial cells. These two EGFR inhibitors increased Parkinson juvenile disease protein 2 and C/EBP homologous protein mRNA expressions, and activated the eukaryotic initiation factor (eIF) 2 alpha/activating transcription factor 4 pathway without protein kinase R-like ER kinase activation in A549 cells. Gefitinib and erlotinib caused neither ER stress nor cell death; however, these agents inhibited cell growth via the reduction of cyclin-D1 expression. Tauroursodeoxycholic acid, which is known to suppress eIF2 alpha phosphorylation, cancelled the effects of EGFR inhibitors on cyclin-D1 expression and cell proliferation in a concentration-dependent manner. The results of an EGFR-silencing study using siRNA showed that gefitinib and erlotinib affected eIF2 alpha phosphorylation and cyclin-D1 expression independent of EGFR inhibition. Therefore, the inhibition of cell growth by these EGFR inhibitors might equate to impairment of the alveolar epithelial cell repair system via eIF2 alpha phosphorylation and reduced cyclin-D1 expression.	[Koyama, Satoshi; Omura, Tomohiro; Yonezawa, Atsushi; Imai, Satoshi; Nakagawa, Shunsaku; Nakagawa, Takayuki; Yano, Ikuko; Matsubara, Kazuo] Kyoto Univ Hosp, Dept Clin Pharmacol & Therapeut, Kyoto 606, Japan	Kyoto University	Omura, T (corresponding author), Kyoto Univ Hosp, Dept Clin Pharmacol & Therapeut, Kyoto 606, Japan.	omurat@kuhp.kyoto-u.ac.jp	Tomohiro, Omura/AAR-8420-2021; Yonezawa, Atsushi/AAS-8423-2020	Yonezawa, Atsushi/0000-0002-8057-6768; Imai, Satoshi/0000-0003-4737-8695; Nakagawa, Shunsaku/0000-0002-1285-122X; Nakagawa, Takayuki/0000-0003-1890-0843	MEXT/JSPS KAKENHI [25136710, 24590176, 25860112]	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by MEXT/JSPS KAKENHI (https://kaken.nii.ac.jp/en/) Grant Numbers 25136710, 24590176 and 25860112.	Barber GN, 2005, CELL DEATH DIFFER, V12, P563, DOI 10.1038/sj.cdd.4401643; Bouman L, 2011, CELL DEATH DIFFER, V18, P769, DOI 10.1038/cdd.2010.142; Bruhat A, 2000, MOL CELL BIOL, V20, P7192, DOI 10.1128/MCB.20.19.7192-7204.2000; Cersosimo RJ, 2006, EXPERT OPIN DRUG SAF, V5, P469, DOI 10.1517/14740338.5.3.469; Chen JJ, 2007, BLOOD, V109, P2693, DOI 10.1182/blood-2006-08-041830; Cybulsky AV, 2005, J BIOL CHEM, V280, P24396, DOI 10.1074/jbc.M500729200; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gotoh T, 2002, J BIOL CHEM, V277, P12343, DOI 10.1074/jbc.M107988200; Hamanaka RB, 2005, MOL BIOL CELL, V16, P5493, DOI 10.1091/mbc.E05-03-0268; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Henkel AS, 2012, AM J PHYSIOL-GASTR L, V303, pG54, DOI 10.1152/ajpgi.00052.2012; Higenbottam T, 2004, BRIT J CANCER, V91, pS31, DOI 10.1038/sj.bjc.6602065; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Inoue A, 2003, LANCET, V361, P137, DOI 10.1016/S0140-6736(03)12190-3; Jorgensen E, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-229; Kalish LH, 2004, CLIN CANCER RES, V10, P7764, DOI 10.1158/1078-0432.CCR-04-0012; Kaneko M, 2002, FEBS LETT, V532, P147, DOI 10.1016/S0014-5793(02)03660-8; Kaneko M, 2003, LIFE SCI, V74, P199, DOI 10.1016/j.lfs.2003.09.007; Kaneko M, 2007, FEBS LETT, V581, P5355, DOI 10.1016/j.febslet.2007.10.033; Kerkela R, 2006, NAT MED, V12, P908, DOI 10.1038/nm1446; Kudoh S, 2008, AM J RESP CRIT CARE, V177, P1348, DOI 10.1164/rccm.200710-1501OC; Lawson WE, 2011, P NATL ACAD SCI USA, V108, P10562, DOI 10.1073/pnas.1107559108; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Lin YC, 2014, ONCOTARGET, V5, P298, DOI 10.18632/oncotarget.1628; Macedo B, 2008, BBA-MOL BASIS DIS, V1782, P517, DOI 10.1016/j.bbadis.2008.05.005; Marsh LM, 2009, AM J PHYSIOL-LUNG C, V296, pL442, DOI 10.1152/ajplung.00525.2007; McGrath-Morrow S, 2009, AM J PHYSIOL-LUNG C, V296, pL565, DOI 10.1152/ajplung.90487.2008; Moriuchi A, 2001, BIOCHEM BIOPH RES CO, V280, P368, DOI 10.1006/bbrc.2000.4063; Namba T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027296; Omura T, 2013, BIOCHEM BIOPH RES CO, V432, P689, DOI 10.1016/j.bbrc.2013.01.131; Orzaez M, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.155; Palam LR, 2011, J BIOL CHEM, V286, P10939, DOI 10.1074/jbc.M110.216093; Park OK, 1996, P NATL ACAD SCI USA, V93, P13704, DOI 10.1073/pnas.93.24.13704; Petty WJ, 2004, CLIN CANCER RES, V10, P7547, DOI 10.1158/1078-0432.CCR-04-1169; Rahmani M, 2007, MOL CELL BIOL, V27, P5499, DOI 10.1128/MCB.01080-06; Raven JF, 2008, J BIOL CHEM, V283, P3097, DOI 10.1074/jbc.M709677200; ROWLANDS AG, 1988, J BIOL CHEM, V263, P5526; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Thomas AQ, 2002, AM J RESP CRIT CARE, V165, P1322, DOI 10.1164/rccm.200112-123OC; Uhal BD, 1997, AM J PHYSIOL-LUNG C, V272, pL1031, DOI 10.1152/ajplung.1997.272.6.L1031; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yamamoto K, 2008, J BIOCHEM, V144, P477, DOI 10.1093/jb/mvn091; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	48	5	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136176	10.1371/journal.pone.0136176	http://dx.doi.org/10.1371/journal.pone.0136176			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288223	Green Submitted, Green Published, gold			2022-12-26	WOS:000360018600117
J	Lebenberg, J; Lalande, A; Clarysse, P; Buvat, I; Casta, C; Cochet, A; ConstantinidSs, C; Cousty, J; de Cesare, A; Jehan-Besson, S; Lefort, M; Najman, L; Roullot, E; Sarry, L; Tilmant, C; Frouin, F; Garreau, M				Lebenberg, Jessica; Lalande, Alain; Clarysse, Patrick; Buvat, Irene; Casta, Christopher; Cochet, Alexandre; ConstantinidSs, Constantin; Cousty, Jean; de Cesare, Alain; Jehan-Besson, Stephanie; Lefort, Muriel; Najman, Laurent; Roullot, Elodie; Sarry, Laurent; Tilmant, Christophe; Frouin, Frederique; Garreau, Mireille			Improved Estimation of Cardiac Function Parameters Using a Combination of Independent Automated Segmentation Results in Cardiovascular Magnetic Resonance Imaging	PLOS ONE			English	Article							VENTRICULAR EJECTION FRACTION; ALGORITHMS; HEART	This work aimed at combining different segmentation approaches to produce a robust and accurate segmentation result. Three to five segmentation results of the left ventricle were combined using the STAPLE algorithm and the reliability of the resulting segmentation was evaluated in comparison with the result of each individual segmentation method. This comparison was performed using a supervised approach based on a reference method. Then, we used an unsupervised statistical evaluation, the extended Regression Without Truth (eRWT) that ranks different methods according to their accuracy in estimating a specific biomarker in a population. The segmentation accuracy was evaluated by estimating six cardiac function parameters resulting from the left ventricle contour delineation using a public cardiac cine MRI database. Eight different segmentation methods, including three expert delineations and five automated methods, were considered, and sixteen combinations of the automated methods using STAPLE were investigated. The supervised and unsupervised evaluations demonstrated that in most cases, STAPLE results provided better estimates than individual automated segmentation methods. Overall, combining different automated segmentation methods improved the reliability of the segmentation result compared to that obtained using an individual method and could achieve the accuracy of an expert.	[Lebenberg, Jessica; ConstantinidSs, Constantin; de Cesare, Alain; Lefort, Muriel] Univ Paris 06, CNRS, INSERM, Lab Imagerie Biomed, Paris, France; [Lebenberg, Jessica; ConstantinidSs, Constantin; Roullot, Elodie] Ecole Speciale Mecan & Elect Sudria, Ivry, France; [Lalande, Alain; Cochet, Alexandre] Univ Bourgogne, CNRS, Lab Elect Informat & Image, Dijon, France; [Clarysse, Patrick; Casta, Christopher] Univ Lyon 1, CNRS, INSERM, Inst Natl Sci Appl Lyon,Ctr Rech Acquisit & Trait, F-69622 Villeurbanne, France; [Buvat, Irene; Frouin, Frederique] Univ Paris 11, CNRS, Commissariat Energie Atom,Inst Natl Sante & Rech, Unite Imagerie Mol Vivo,Serv Hosp Frederic Joliot, F-91405 Orsay, France; [Cousty, Jean; Najman, Laurent] Univ Paris Est Marne la Vallee, Ecole Super Ingenieurs Electrotech & Elect, CNRS, Lab Informat Gaspard Monge, Marne La Vallee, France; [Jehan-Besson, Stephanie] CNRS, Grp Rech Informat Image Automat & Instrumentat Ca, Caen, France; [Sarry, Laurent] Univ Auvergne, CNRS, Image Sci Intervent Tech, Clermont Ferrand, France; [Tilmant, Christophe] Univ Blaise Pascal, CNRS, Inst Pascal, Clermont Ferrand, France; [Garreau, Mireille] Univ Rennes, INSERM, Lab Traitement Signal & Images, Rennes, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CEA; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Gustave-Eiffel; Centre National de la Recherche Scientifique (CNRS); Universite de Caen Normandie; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes	Lebenberg, J (corresponding author), CEA, Inst Imagerie Biomed, Neurospin, Gif Sur Yvette, France.	jessica.lebenberg@gmail.com	Clarysse, Patrick/G-6371-2014; Najman, Laurent/AAB-4212-2020; Garreau, Mireille/ABC-4360-2020; Frouin, Frédérique/N-7709-2015; Lalande, Alain/T-1050-2017; Sarry, Laurent/K-5708-2018; Jehan-Besson, Stéphanie/ABF-3965-2020; lebenberg, jessica/AAQ-7790-2021; Buvat, Irene/U-8447-2018	Clarysse, Patrick/0000-0002-5495-7655; Najman, Laurent/0000-0002-6190-0235; Garreau, Mireille/0000-0001-5728-1403; Frouin, Frédérique/0000-0002-7288-1543; Sarry, Laurent/0000-0002-2237-0497; lebenberg, jessica/0000-0002-5403-8288; Buvat, Irene/0000-0002-7053-6471; Lalande, Alain/0000-0002-7970-366X; Jehan-Besson, Stephanie/0000-0002-1850-3445	Stic-Sante [GdR 2647]; NIH from National Center for Research Resources [R01 RR021885]; Neuroscience Blueprint I/C from National Institute of Biomedical Imaging and Bioengineering [R01 EB008015]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR021885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008015] Funding Source: NIH RePORTER	Stic-Sante; NIH from National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Neuroscience Blueprint I/C from National Institute of Biomedical Imaging and Bioengineering; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Funding: This work was performed in the framework of the French MedIEval (Medical Image segmentation Evaluation) working group. The authors gratefully acknowledge the GdR 2647 Stic-Sante for its support to the MedIEval action. The research concerning the STAPLE algorithm was supported in part by NIH R01 RR021885 from the National Center for Research Resources, and by an award from the Neuroscience Blueprint I/C through R01 EB008015 from the National Institute of Biomedical Imaging and Bioengineering.	Chalana V, 1997, IEEE T MED IMAGING, V16, P642, DOI 10.1109/42.640755; Chen A, 2012, PHYS MED BIOL, V57, P93, DOI 10.1088/0031-9155/57/1/93; Constantinides C, 2010, COMPUT CARDIOL CONF, V37, P911; Constantinides C., 2009, MIDAS J CARDIAC MR L; Constantinides C, 2012, IEEE ENG MED BIO, P3207, DOI 10.1109/EMBC.2012.6346647; Cousty J, 2010, IMAGE VISION COMPUT, V28, P1229, DOI 10.1016/j.imavis.2010.01.001; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Hoppin JW, 2002, IEEE T MED IMAGING, V21, P441, DOI 10.1109/TMI.2002.1009380; Jehan-Besson S, 2014, IEEE IMAGE PROC, P887, DOI 10.1109/ICIP.2014.7025178; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Kupinski MA, 2006, ACAD RADIOL, V13, P329, DOI 10.1016/j.acra.2005.12.005; Kupinski MA, 2002, ACAD RADIOL, V9, P290, DOI 10.1016/S1076-6332(03)80372-0; Lalande A, 2004, J CARDIOVASC MAGN R, V6, P817, DOI 10.1081/JCMR-200036143; Lebenberg J, 2012, IEEE T MED IMAGING, V31, P1651, DOI 10.1109/TMI.2012.2201737; McLachlan GJ., 1996, WILEY SERIES PROBABI; Miller Rupert G., 1981, SIMULTANEOUS STAT IN, V2nd, DOI [DOI 10.1007/978-1-4613-8122-8, 10.1007/978-1-4613-8122-8_1]; Petitjean C, 2011, MED IMAGE ANAL, V15, P169, DOI 10.1016/j.media.2010.12.004; Radau P., 2009, MIDAS JCARDIAC MR LE, DOI [DOI 10.54294/G80RUO, 10.54294/g80ruo]; Robitaille N, 2012, INT J BIOMED IMAGING, V2012, DOI 10.1155/2012/431095; Schaerer J, 2010, MED IMAGE ANAL, V14, P738, DOI 10.1016/j.media.2010.05.009; Soret M, 2007, NUCL INSTRUM METH A, V571, P173, DOI 10.1016/j.nima.2006.10.236; Suinesiaputra A, 2014, MED IMAGE ANAL, V18, P50, DOI 10.1016/j.media.2013.09.001; Warfield SK, 2004, IEEE T MED IMAGING, V23, P903, DOI 10.1109/TMI.2004.828354	25	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135715	10.1371/journal.pone.0135715	http://dx.doi.org/10.1371/journal.pone.0135715			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287691	Green Published, gold, Green Submitted			2022-12-26	WOS:000360018600064
J	Moreau, JD; Neraudeau, D; Tafforeau, P; Depre, E				Moreau, Jean-David; Neraudeau, Didier; Tafforeau, Paul; Depre, Eric			Study of the Histology of Leafy Axes and Male Cones of Glenrosa carentonensis sp nov (Cenomanian Flints of Charente-Maritime, France) Using Synchrotron Microtomography Linked with Palaeoecology	PLOS ONE			English	Article							RAY TOMOGRAPHIC MICROSCOPY; SOUTHWESTERN FRANCE; CONIFER GLENROSA; NORTH-AMERICA; AMBER; PLANT; PORTUGAL; FLOWER; PHASE; GEN.	We report exceptionally well-preserved plant remains ascribed to the extinct conifer Glenrosa J. Watson et H.L. Fisher emend. V. Srinivasan inside silica-rich nodules from the Cenomanian of the Font-de-Benon quarry, Charente-Maritime, western France. Remains are preserved in three dimensions and mainly consist of fragmented leafy axes. Pollen cones of this conifer are for the first time reported and in some cases remain connected to leafy stems. Histology of Glenrosa has not previously been observed; here, most of internal tissues and cells are well-preserved and allow us to describe a new species, Glenrosa carentonensis sp. nov., using propagation phase-contrast X-ray synchrotron microtomography, a non-destructive technique. Leafy axes consist of characteristic helically arranged leaves bearing stomatal crypts. Glenrosa carentonensis sp. nov. differs from the other described species in developing a phyllotaxy 8/21, claw-shaped leaves, a thicker cuticle, a higher number of papillae and stomata per crypt. Pollen cones consist of peltate, helically arranged microsporophylls, each of them bearing 6-7 pollen sacs. The new high resolution tomographic approach tested here allows virtual palaeohistology on plants included inside a dense rock to be made. Most tissues of Glenrosa carentonensis sp. nov. are described. Lithological and palaeontological data combined with xerophytic features of Glenrosa carentonensis sp. nov. suggest that this conifer has been adapted to survive in harsh and instable environments such as coastal area exposed to hot, dry conditions.	[Moreau, Jean-David; Neraudeau, Didier] Univ Rennes 1, CNRS UMR 6118, Geosci Rennes, Rennes, France; [Moreau, Jean-David; Tafforeau, Paul] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Depre, Eric] GIP GEVES Grp Etud & Controle Varietes & Semences, Surgeres, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Rennes; European Synchrotron Radiation Facility (ESRF)	Moreau, JD (corresponding author), Univ Rennes 1, CNRS UMR 6118, Geosci Rennes, Rennes, France.	jean.david.moreau@gmail.com	MOREAU, Jean-David/AAH-4652-2019	MOREAU, Jean-David/0000-0003-2978-5983; Tafforeau, Paul/0000-0002-5962-1683	Geosciences Rennes [CNRS-UMR6118]; European Synchrotron Radiation Facility	Geosciences Rennes; European Synchrotron Radiation Facility	This work was supported by funding from Geosciences Rennes, CNRS-UMR6118, to J-DM, DN; and the European Synchrotron Radiation Facility, to J-DM, PT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARALE G, 1997, GEOBIOS, V21, P17; BREWER CA, 1995, AM J BOT, V82, P1271, DOI 10.2307/2446250; Coiffard C, 2009, PALAEONTOLOGY, V52, P323, DOI 10.1111/j.1475-4983.2009.00845.x; DARLING MS, 1989, AM J BOT, V76, P1698, DOI 10.2307/2444408; Feist M, 2005, AM J BOT, V92, P1152, DOI 10.3732/ajb.92.7.1152; Fontaine W.M., 1893, P NATL MUSEUM, V16, P261; Friis E. M., 2011, EARLY FLOWERS ANGIOS; Friis EM, 2007, NATURE, V450, P549, DOI 10.1038/nature06278; Friis EM, 2014, J PALEONTOL, V88, P684, DOI 10.1666/13-099; Friis EM, 2013, INT J PLANT SCI, V174, P647, DOI 10.1086/669908; Friis EM, 2011, GRANA, V50, P3, DOI 10.1080/00173134.2011.559728; Friis EM, 2010, REV PALAEOBOT PALYNO, V162, P341, DOI 10.1016/j.revpalbo.2009.11.009; Friis EM, 2009, INT J PLANT SCI, V170, P1086, DOI 10.1086/605120; Gomez B, 2001, PALAEOGEOGR PALAEOCL, V170, P133, DOI 10.1016/S0031-0182(01)00232-2; Gomez B, 2008, CR PALEVOL, V7, P135, DOI 10.1016/j.crpv.2007.12.006; Gomez Bernard, 2004, Annales de Paleontologie, V90, P147, DOI 10.1016/j.annpal.2004.03.003; Gomez B, 2012, REV PALAEOBOT PALYNO, V172, P21, DOI 10.1016/j.revpalbo.2012.01.009; Hassiotou F, 2009, J EXP BOT, V60, P2303, DOI 10.1093/jxb/erp021; Hermanova Z, 2011, INT J PLANT SCI, V172, P285, DOI 10.1086/657278; Jordan GJ, 2008, AM J BOT, V95, P521, DOI 10.3732/ajb.2007333; Kunzmann L, 2010, REV PALAEOBOT PALYNO, V159, P123, DOI 10.1016/j.revpalbo.2009.11.006; Lak M, 2008, MICROSC MICROANAL, V14, P251, DOI 10.1017/S1431927608080264; Larcher W, 2003, PHYSL PLANT ECOLOGY; LEVIN DA, 1973, Q REV BIOL, V48, P3, DOI 10.1086/407484; LOSCH R, 1982, FLORA, V172, P138; Moreau JD, 2014, CR PALEVOL, V13, P455, DOI 10.1016/j.crpv.2014.03.007; Moreau JD, 2014, LETHAIA, V47, P313, DOI 10.1111/let.12049; Moreau JD, 2014, MICROSC MICROANAL, V20, P305, DOI 10.1017/S1431927613014025; Nel A., 2004, Geologica Acta, V2, P23; Neraudeau D, 2005, CR PALEVOL, V4, P79, DOI 10.1016/j.crpv.2004.11.008; Neraudeau D, 2002, GEOBIOS-LYON, V35, P233, DOI 10.1016/S0016-6995(02)00024-4; Neraudeau D, 2008, CRETACEOUS RES, V29, P925, DOI 10.1016/j.cretres.2008.05.009; Neraudeau D, 2013, ANN PALEONTOL, V99, P361, DOI 10.1016/j.annpal.2013.10.001; Neraudeau D, 2009, GEODIVERSITAS, V31, P13, DOI 10.5252/g2009n1a2; Paganin D, 2002, J MICROSC-OXFORD, V206, P33, DOI 10.1046/j.1365-2818.2002.01010.x; Perrichot Vincent, 2010, P192; Roth-Nebelsick A, 2007, ANN BOT-LONDON, V100, P23, DOI 10.1093/aob/mcm075; Roth-Nebelsick A, 2009, PLANT PHYSIOL, V151, P2018, DOI 10.1104/pp.109.146969; Saint Martin JP, 2013, ANN PALEONTOL, V99, P289; Sanchez S, 2012, MICROSC MICROANAL, V18, P1095, DOI 10.1017/S1431927612001079; Schonenberger J, 2012, ANN BOT-LONDON, V109, P921, DOI 10.1093/aob/mcs009; Scott AC, 2009, MICROSC MICROANAL, V15, P166, DOI 10.1017/S1431927609090126; SRINIVASAN V, 1992, REV PALAEOBOT PALYNO, V72, P245, DOI 10.1016/0034-6667(92)90029-G; Steart DC, 2014, PEERJ, V2, DOI 10.7717/peerj.624; Strullu-Derrien C, 2014, BOT J LINN SOC, V175, P423, DOI 10.1111/boj.12175; Tafforeau P, 2006, APPL PHYS A-MATER, V83, P195, DOI 10.1007/s00339-006-3507-2; Thevenard F, 2005, CR PALEVOL, V4, P67, DOI 10.1016/j.crpv.2004.11.012; von Balthazar M, 2007, AM J BOT, V94, P2041, DOI 10.3732/ajb.94.12.2041; Vullo Romain, 2003, Annales de Paleontologie, V89, P171, DOI 10.1016/S0753-3969(03)00025-9; Watson J., 1984, PALAEONTOLOGY, V77, P719; Zhou ZY, 2000, PALAEONTOLOGY, V43, P561	51	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0134515	10.1371/journal.pone.0134515	http://dx.doi.org/10.1371/journal.pone.0134515			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288019	Green Published, Green Submitted, gold			2022-12-26	WOS:000360018600023
J	Wang, SS; Hu, SW; Zhang, QH; Xia, AX; Jiang, ZX; Chen, XM				Wang, Shuang-shuang; Hu, Si-wang; Zhang, Qing-hua; Xia, Ai-xiang; Jiang, Zhi-xin; Chen, Xiao-min			Mesenchymal Stem Cells Stabilize Atherosclerotic Vulnerable Plaque by Anti-Inflammatory Properties	PLOS ONE			English	Article							ACUTE CORONARY SYNDROME; NECROSIS-FACTOR-ALPHA; C-REACTIVE PROTEIN; MYOCARDIAL-INFARCTION; MATRIX METALLOPROTEINASES; STROMAL CELLS; LUNG INJURY; IN-VIVO; TSG-6; INFLAMMATION	Background and objectives Formation and progression of atherosclerotic vulnerable plaque (VP) is the primary cause of many cardio-cerebrovascular diseases such as acute coronary syndrome and stroke. It has been reported that bone marrow mesenchymal stem cells (MSC) exhibit protective effects against many kinds of diseases including myocardial infarction. Here, we examined the effects of intravenous MSC infusion on a VP model and provide novel evidence of its influence as a therapy in this animal disease model. Subjects and methods Thirty healthy male New Zealand white rabbits were randomly divided into a MSC, VP or stable plaque (SP) group (n = 10/group) and received high fat diet and cold-induced common carotid artery intimal injury with liquid nitrogen to form atherosclerotic plaques. Serum hs-CRP, TNF-alpha, IL-6 and IL-10 levels were measured by ELISA at 1, 2, 3, 7, 14, 21 and 28 days after MSC transplantation. The animals were sacrificed at 4 weeks after MSC transplantation. Lesions in the right common carotid were observed using H&E and Masson staining, and the fibrous cap/lipid core ratio of atherosclerotic plaques were calculated. The expression of nuclear factor kappa B (NF-kappa B) and matrix metalloproteinase 1, 2, 9 (MMP-1,2,9) in the plaque were detected using immunohistochemistry, and apoptotic cells in the plaques were detected by TUNEL. In addition, the level of TNF-alpha stimulated gene/protein 6 (TSG-6) mRNA and protein were measured by quantitative Real-Time PCR and Western blotting, respectively. Results Two rabbits in the VP group died of lung infection and cerebral infarction respectively at 1 week after plaque injury by liquid nitrogen. Both H&E and Masson staining revealed that the plaques from the SP and MSC groups had more stable morphological structure and a larger fibrous cap/lipid core ratio than the VP group. Serum hs-CRP, TNF-alpha and IL-6 were significantly down-regulated, whereas IL-10 was significantly up-regulated in the MSC group compared with the VP group.. Immunohistochemistry analysis revealed that NF-kappa B and MMP expression was reduced in the MSC and SP groups compared to the VP group. Cell apoptosis decreased significantly in both the MSC and SP groups in comparison to the VP group. TSG-6 mRNA and protein expression were higher in the plaques of the MSC group compared to the VP and SP groups. Conclusions Our study results suggest that MSC transplantation can effectively stabilize vulnerable plaques in atherosclerotic rabbits. This may potentially offer a new clinical application of MSC in atherosclerosis.	[Wang, Shuang-shuang] Zhejiang Univ, Coll Med, Hangzhou 310009, Zhejiang, Peoples R China; [Wang, Shuang-shuang; Chen, Xiao-min] Ningbo First Hosp, Dept Cardiol, Ningbo 315000, Zhejiang, Peoples R China; [Hu, Si-wang] Ningbo Univ, Coll Med, Affiliated Hosp, Dept Spine Surg, Ningbo 315000, Zhejiang, Peoples R China; [Zhang, Qing-hua; Xia, Ai-xiang; Jiang, Zhi-xin] Chinese PLA 305 Hosp, Beijing 100017, Peoples R China	Zhejiang University; Ningbo University	Jiang, ZX (corresponding author), Chinese PLA 305 Hosp, Beijing 100017, Peoples R China.	658jzx@163.com; chenxm_nfh@126.com	chen, xi/GXH-3653-2022; chen, xia/GYR-3948-2022; Wang, Shuangshuang/ABE-9819-2020; chen, xia/GXM-5435-2022		Natural Science Foundation of China [30971235]; Post-doctoral scientific research station Foundation of Ningbo	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Post-doctoral scientific research station Foundation of Ningbo	This study was supported by the Natural Science Foundation of China (No. 30971235) and Post-doctoral scientific research station Foundation of Ningbo.	[Anonymous], 2005, PHYSL REV, V85, P1; Bardos T, 2001, AM J PATHOL, V159, P1711, DOI 10.1016/S0002-9440(10)63018-0; Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001; Cao TV, 2004, MICROCIRCULATION, V11, P615, DOI 10.1080/10739680490503438; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Christodoulidis G, 2014, CARDIOL REV, V22, P279, DOI 10.1097/CRD.0000000000000006; Comite P, 2010, TRANSPL P, V42, P1341, DOI 10.1016/j.transproceed.2010.03.080; Dixon JA, 2009, CIRCULATION, V120, pS220, DOI 10.1161/CIRCULATIONAHA.108.842302; Du YY, 2008, CYTOTHERAPY, V10, P469, DOI 10.1080/14653240802129893; Fang SM, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-39; Guo J, 2007, INFLAMMATION, V30, P97, DOI 10.1007/s10753-007-9025-3; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; Heeschen C, 2003, CIRCULATION, V107, P2109, DOI 10.1161/01.CIR.0000065232.57371.25; Igarashi A, 2007, TISSUE ENG, V13, P2405, DOI 10.1089/ten.2006.0340; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Jones CB, 2003, CARDIOVASC RES, V59, P812, DOI 10.1016/S0008-6363(03)00516-9; Jungebluth P, 2011, CELL TRANSPLANT, V20, P1561, DOI 10.3727/096368910X557254; Kablak-Ziembicka A, 2011, KARDIOL POL, V69, P1024; Kleemann R, 2008, CARDIOVASC RES, V79, P360, DOI 10.1093/cvr/cvn120; Koukkunen H, 2001, ANN MED, V33, P37, DOI 10.3109/07853890109002058; Lee JK, 2010, STEM CELLS, V28, P329, DOI 10.1002/stem.277; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Li YK, 2006, J BIOL CHEM, V281, P6707, DOI 10.1074/jbc.M510579200; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Lozito TP, 2011, J CELL PHYSIOL, V226, P385, DOI 10.1002/jcp.22344; Mahoney DJ, 2011, ARTHRITIS RHEUM-US, V63, P1034, DOI 10.1002/art.30201; Mallat Z, 2000, BRIT J PHARMACOL, V130, P947, DOI 10.1038/sj.bjp.0703407; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Naghavi M, 2003, CIRCULATION, V108, P1772, DOI 10.1161/01.CIR.0000087481.55887.C9; Oh JY, 2008, STEM CELLS, V26, P1047, DOI 10.1634/stemcells.2007-0737; Ortiz LA, 2007, P NATL ACAD SCI USA, V104, P11002, DOI 10.1073/pnas.0704421104; Prockop DJ, 2012, MOL THER, V20, P14, DOI 10.1038/mt.2011.211; Roddy GW, 2011, STEM CELLS, V29, P1572, DOI 10.1002/stem.708; Rossig L, 2001, BASIC RES CARDIOL, V96, P11, DOI 10.1007/s003950170073; Shah Svati H, 2003, Cardiol Rev, V11, P169, DOI 10.1097/01.CRD.0000077906.74217.6E; Sheikh AM, 2011, NEUROBIOL DIS, V41, P717, DOI 10.1016/j.nbd.2010.12.009; Spagnoli LG, 2004, JAMA-J AM MED ASSOC, V292, P1845, DOI 10.1001/jama.292.15.1845; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; Su J, 2014, CELL DEATH DIFFER, V21, P388, DOI 10.1038/cdd.2013.149; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; van Buul GM, 2012, OSTEOARTHR CARTILAGE, V20, P1186, DOI 10.1016/j.joca.2012.06.003; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Wang N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043768; Wang SP, 2012, MOL MED REP, V6, P848, DOI 10.3892/mmr.2012.997; Wang XH, 2014, GENET MOL RES, V13, P4260, DOI 10.4238/2014.June.9.11; Williams MS, 2014, PSYCHOSOMATICS, V55, P252, DOI 10.1016/j.psym.2013.09.004; Wisniewski Hans-Georg, 1997, Cytokine and Growth Factor Reviews, V8, P143, DOI 10.1016/S1359-6101(97)00008-7; WISNIEWSKI HG, 1993, J IMMUNOL, V151, P6593; Wisniewski HG, 1996, J IMMUNOL, V156, P1609; Wu X, 2014, HEART VESSELS; Yao L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030842; Yeung TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038189; You Q, 2008, INT J GYNECOL OBSTET, V103, P149, DOI 10.1016/j.ijgo.2008.06.012	53	36	36	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136026	10.1371/journal.pone.0136026	http://dx.doi.org/10.1371/journal.pone.0136026			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288013	Green Published, Green Submitted, gold			2022-12-26	WOS:000360018600098
J	Aberese-Ako, M; Agyepong, IA; Gerrits, T; Van Dijk, H				Aberese-Ako, Matilda; Agyepong, Irene Akua; Gerrits, Trudie; Van Dijk, Han			'I Used to Fight with Them but Now I Have Stopped!': Conflict and Doctor-Nurse-Anaesthetists' Motivation in Maternal and Neonatal Care Provision in a Specialist Referral Hospital	PLOS ONE			English	Article							HEALTH WORKER MOTIVATION; PUBLIC-SECTOR; TRUST; SATISFACTION; PERFORMANCE; MANAGEMENT; CONSEQUENCES	Background and Objectives This paper analyses why and how conflicts occur and their influence on doctors and nurse-anaesthetists' motivation in the provision of maternal and neonatal health care in a specialist hospital. Methodology The study used ethnographic methods including participant observation, conversation and in-depth interviews over eleven months in a specialist referral hospital in Ghana. Qualitative analysis software Nvivo 8 was used for coding and analysis of data. Main themes identified in the analysis form the basis for interpreting and reporting study findings. Ethics Statement Ethical clearance was obtained from the Ghana Health Service Ethics Review board (approval number GHS-ERC: 06/01/12) and from the University of Wageningen. Written consent was obtained from interview participants, while verbal consent was obtained for conversations. To protect the identity of the hospital and research participants pseudonyms are used in the article and the part of Ghana in which the study was conducted is not mentioned. Results Individual characteristics, interpersonal and organisational factors contributed to conflicts. Unequal power relations and distrust relations among doctors and nurse-anaesthetists affected how they responded to conflicts. Responses to conflicts including forcing, avoiding, accommodating and compromising contributed to persistent conflicts, which frustrated and demotivated doctors and nurse-anaesthetists. Demotivated workers exhibited poor attitudes in collaborating with co-workers in the provision of maternal and neonatal care, which sometimes led to poor health worker response to client care, consequently compromising the hospital's goal of providing quality health care to clients. Conclusion To improve health care delivery in health facilities in Ghana, health managers and supervisors need to identify conflicts as an important phenomenon that should be addressed whenever they occur. Effective mechanisms including training managers and health workers on conflict management should be put in place. Additionally promoting communication and interaction among health workers can foster team spirit. Also resolving conflicts using the collaborating response may help to create a conducive work environment that will promote healthy work relations, which can facilitate the delivery of quality maternal and neonatal health care. However, such an approach requires that unequal power relations, which is a root cause of the conflicts is addressed.	[Aberese-Ako, Matilda; Van Dijk, Han] Wageningen Univ, Sociol Dev & Change SDC Grp, NL-6700 AP Wageningen, Netherlands; [Aberese-Ako, Matilda; Agyepong, Irene Akua] Ghana Hlth Serv, Accra, Ghana; [Agyepong, Irene Akua] Univ Ghana, Sch Publ Hlth, Legon, Ghana; [Gerrits, Trudie] Univ Amsterdam, Amsterdam Sch Social Sci Res, Amsterdam, Netherlands	Wageningen University & Research; Ghana Health Service; University of Ghana; University of Amsterdam	Aberese-Ako, M (corresponding author), Wageningen Univ, Sociol Dev & Change SDC Grp, NL-6700 AP Wageningen, Netherlands.	matilda.aberese-ako@wur.nl	van Dijk, Han/L-6710-2016	van Dijk, Han/0000-0002-4406-4909; Agyepong, Irene Akua/0000-0002-0193-5882	Netherlands Organization for Scientific Research (NWO/WOTRO) [WOTRO-IP W 07.45.102.00]	Netherlands Organization for Scientific Research (NWO/WOTRO)(Netherlands Organization for Scientific Research (NWO))	This work was funded by the Netherlands Organization for Scientific Research (NWO/WOTRO) on the project "Accelerating progress towards attainment of MDG 4 and 5 in Ghana through basic health systems function strengthening," grant number [WOTRO-IP W 07.45.102.00]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agyepong I A, 2001, Qual Manag Health Care, V9, P1; Agyepong IA, 2004, INT J HEALTH PLAN M, V19, P319, DOI 10.1002/hpm.770; Almost J, 2006, J ADV NURS, V53, P444, DOI 10.1111/j.1365-2648.2006.03738.x; Almost J, 2010, J NURS MANAGE, V18, P981, DOI 10.1111/j.1365-2834.2010.01154.x; Ansong-Tornui Janet, 2007, Ghana Med J, V41, P125; Bazin JE, 2014, ANN FR ANESTH, V33, P335, DOI 10.1016/j.annfar.2014.04.006; Bercovitch J, 1983, ASIAN J PUBLIC ADM, V5, P104; Board E, 1994, ANAESTHETISTS DISCUO; Bonenberger M, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-43; Booij LHDJ, 2007, CURR OPIN ANESTHESIO, V20, P152, DOI 10.1097/ACO.0b013e32809f9506; Bosu Wk, 2007, Ghana Med J, V41, P118; Bousari M. P., 2009, Research Journal of Biological Sciences, V4, P236; Brinkert R, 2010, J NURS MANAGE, V18, P145, DOI 10.1111/j.1365-2834.2010.01061.x; Capitulo KL, 2009, NURSE LEAD, V7, P38, DOI 10.1016/j.mnl.2009.01.009; Cinar F, 2012, PROCD SOC BEHV, V58, P197, DOI 10.1016/j.sbspro.2012.09.993; Coe R, 2008, J ADV NURS, V61, P609, DOI 10.1111/j.1365-2648.2007.04544.x; Coombs Maureen, 2003, Intensive Crit Care Nurs, V19, P125, DOI 10.1016/S0964-3397(03)00040-5; DAHL RA, 1957, BEHAV SCI, V2, P201, DOI 10.1002/bs.3830020303; De Dreu CKW, 2003, J APPL PSYCHOL, V88, P741, DOI 10.1037/0021-9010.88.4.741; Dieleman M, 2006, HUMAN RESOURCES HLTH, V4, P1; Dieleman Marjolein, 2003, Hum Resour Health, V1, P10, DOI 10.1186/1478-4491-1-10; DISCOMBE G, 1954, BRIT MED J, V1, P326, DOI 10.1136/bmj.1.4857.326; Emerson M.R., 2005, WRITING ETHNOGRAPHIC, P353; Encyclopedia Wikipedia, 2014, UT MYOM; Ferres N., 2004, J MANAGE PSYCHOL, V19, P608, DOI [10.1108/02683940410551516, DOI 10.1108/02683940410551516]; Fox A., 1974, CONTRACT WORK POWER; Franco LM, 2004, SOC SCI MED, V58, P343, DOI 10.1016/S0277-9536(03)00203-X; Franco LM, 2002, SOC SCI MED, V54, P1255, DOI 10.1016/S0277-9536(01)00094-6; Gilson L, 2003, SOC SCI MED, V56, P1453, DOI 10.1016/S0277-9536(02)00142-9; Gilson L, 2005, SOC SCI MED, V61, P1418, DOI 10.1016/j.socscimed.2004.11.062; Gilson Lucy, 2006, J Health Organ Manag, V20, P359, DOI 10.1108/14777260610701768; Guerra ST, 2011, REV LAT-AM ENFERM, V19, P362, DOI 10.1590/S0104-11692011000200019; Jack H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057940; Jehn KA, 2006, INT J CONFL MANAGE, V17, P96, DOI 10.1108/10444060610736594; Johns JL, 1996, J ADV NURS, V24, P76, DOI 10.1046/j.1365-2648.1996.16310.x; Katiliute E, 2007, BALT J MANAG, V2, P213, DOI DOI 10.1108/17465260710751008; Katz JD, 2007, J CLIN ANESTH, V19, P152, DOI 10.1016/j.jclinane.2006.07.007; Laschinger HKS, 2000, J NURS ADMIN, V30, P413, DOI 10.1097/00005110-200009000-00008; Lipsky M., 1980, STREET LEVEL BUREAUC, DOI DOI 10.1007/s13178-012-0092-3; Mansour JB, 2005, MANAGERS WHO LEAD HD; Mathauer Inke, 2006, Hum Resour Health, V4, P24, DOI 10.1186/1478-4491-4-24; Mintzberg H., 1983, POWER ORG, DOI DOI 10.1177/017084068400500419; Mohammed A, 2012, INT FEDERATION GYNEC; National Development Planning Commission Government of Ghana United Nations Development Programme (UNDP) Ghana, 2010, 2008 GHAN MILL DEV G; Pavlakis A, 2011, INT NURS REV, V58, P242, DOI 10.1111/j.1466-7657.2011.00880.x; PONDY LR, 1967, ADMIN SCI QUART, V12, P296, DOI 10.2307/2391553; Purohit B, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-12; Rosenstein AH, 2011, AM J OBSTET GYNECOL, V204, P187, DOI 10.1016/j.ajog.2010.10.899; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Slack T., 2006, UNDERSTANDING SPORT, V2nd ed.; Thom DH, 2004, HEALTH AFFAIR, V23, P124, DOI 10.1377/hlthaff.23.4.124; Van der Geest S, 1998, SOC SCI MED, V47, P1373, DOI 10.1016/S0277-9536(98)00179-8; Vivar Cristina Garcia, 2006, J Nurs Manag, V14, P201; Whetten DA, 1996, EFFECTIVE CONFLICT M; ZAND DE, 1972, ADMIN SCI QUART, V17, P229, DOI 10.2307/2393957	55	24	24	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135129	10.1371/journal.pone.0135129	http://dx.doi.org/10.1371/journal.pone.0135129			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP1VY	26285108	Green Published, Green Submitted, gold			2022-12-26	WOS:000359666100022
J	Escudero, L; Al-Refai, M; Nieto, C; Laatsch, H; Malpartida, F; Seco, EM				Escudero, Leticia; Al-Refai, Mahmoud; Nieto, Cristina; Laatsch, Hartmut; Malpartida, Francisco; Seco, Elena M.			New Rimocidin/CE-108 Derivatives Obtained by a Crotonyl-CoA Carboxylase/Reductase Gene Disruption in Streptomyces diastaticus var. 108: Substrates for the Polyene Carboxamide Synthase PcsA	PLOS ONE			English	Article							POLYKETIDE SYNTHASE; AMPHOTERICIN-B; ENGINEERED BIOSYNTHESIS; ANTIFUNGAL ACTIVITY; AMIDE DERIVATIVES; CLONING VECTORS; MACROLIDES; NYSTATIN; ANTIBIOTICS; GLUTAMINE	The rimJ gene, which codes for a crotonyl-CoA carboxylase/reductase, lies within the bio-synthetic gene cluster for two polyketides belonging to the polyene macrolide group (CE-108 and rimocidin) produced by Streptomyces diastaticus var. 108. Disruption of rimJ by insertional inactivation gave rise to a recombinant strain overproducing new polyene derivatives besides the parental CE-108 (2a) and rimocidin (4a). The structure elucidation of one of them, CE-108D (3a), confirmed the incorporation of an alternative extender unit for elongation step 13. Other compounds were also overproduced in the fermentation broth of rimJ disruptant. The new compounds are in vivo substrates for the previously described polyene carboxamide synthase PcsA. The rimJ disruptant strain, constitutively expressing the pcsA gene, allowed the overproduction of CE-108E (3b), the corresponding carboxamide derivative of CE-108D (3a), with improved pharmacological properties.	[Escudero, Leticia; Nieto, Cristina; Malpartida, Francisco; Seco, Elena M.] CSIC, CNB, Madrid 28049, Spain; [Al-Refai, Mahmoud; Laatsch, Hartmut] Univ Gottingen, Dept Organ & Biomol Chem, D-37077 Gottingen, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); University of Gottingen	Seco, EM (corresponding author), CSIC, CNB, Campus Univ Autonoma Madrid, Madrid 28049, Spain.	eseco@cnb.csic.es	Al-Refai, Mahmoud/GOH-0260-2022	Seco, Elena M./0000-0003-1431-4441	Spanish Ministerio de Ciencia e Innovacion [BIO2005-02785, BIO2008-03683]; Spanish Ministerio de Economia y Competitividad [BFU2012-39879-C02-01]; German Academic Exchange Service (DAAD)	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Spanish Ministerio de Economia y Competitividad(Spanish Government); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by grants to F.M. from the Spanish Ministerio de Ciencia e Innovacion BIO2005-02785 and BIO2008-03683, and to J.C.A. from Spanish Ministerio de Economia y Competitividad BFU2012-39879-C02-01. The German Academic Exchange Service (DAAD) supported M.A.R. with a Ph.D. grant.	[Anonymous], 1997, M27A NCFCLS; Aparicio JF, 2003, APPL MICROBIOL BIOT, V61, P179, DOI 10.1007/s00253-002-1183-5; Aparicio JF, 1999, J BIOL CHEM, V274, P10133, DOI 10.1074/jbc.274.15.10133; Atlas RM, 1993, MICROBIOLOGICAL MEDI; BIBB MJ, 1985, GENE, V38, P215, DOI 10.1016/0378-1119(85)90220-3; Bisang C, 1999, NATURE, V401, P502, DOI 10.1038/46829; Borgos SEF, 2006, J MED CHEM, V49, P2431, DOI 10.1021/jm050895w; Brautaset T, 2000, CHEM BIOL, V7, P395, DOI 10.1016/S1074-5521(00)00120-4; Brautaset T, 2002, CHEM BIOL, V9, P367, DOI 10.1016/S1074-5521(02)00108-4; Brautaset T, 2008, CHEM BIOL, V15, P1198, DOI 10.1016/j.chembiol.2008.08.009; Bruzzese T, 1996, EUR J MED CHEM, V31, P965, DOI 10.1016/S0223-5234(97)86175-2; Caffrey P, 2001, CHEM BIOL, V8, P713, DOI 10.1016/S1074-5521(01)00046-1; Caffrey P, 2008, CURR TOP MED CHEM, V8, P639, DOI 10.2174/156802608784221479; Carmody M, 2005, J BIOL CHEM, V280, P34420, DOI 10.1074/jbc.M506689200; Cybulska B, 1995, BBA-BIOMEMBRANES, V1240, P167, DOI 10.1016/0005-2736(95)00170-0; DONADIO S, 1991, SCIENCE, V252, P675, DOI 10.1126/science.2024119; Erb TJ, 2007, P NATL ACAD SCI USA, V104, P10631, DOI 10.1073/pnas.0702791104; Erb TJ, 2009, P NATL ACAD SCI USA, V106, P8871, DOI 10.1073/pnas.0903939106; Goldman RD, 2007, J CLIN PHARMACOL, V47, P1049, DOI 10.1177/0091270007301799; Heia S, 2011, APPL ENVIRON MICROB, V77, P6982, DOI 10.1128/AEM.05781-11; Jung WS, 2011, APPL MICROBIOL BIOT, V91, P1389, DOI 10.1007/s00253-011-3348-6; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kosec G, 2012, METAB ENG, V14, P39, DOI 10.1016/j.ymben.2011.11.003; LARSON JL, 1986, PLASMID, V15, P199, DOI 10.1016/0147-619X(86)90038-7; Liu Y, 2009, J AM CHEM SOC, V131, P10376, DOI 10.1021/ja9042824; LYDIATE DJ, 1985, GENE, V35, P223, DOI 10.1016/0378-1119(85)90001-0; MALPARTIDA F, 1986, MOL GEN GENET, V205, P66, DOI 10.1007/BF02428033; Maniatis T., 1982, MOL CLONING; Massiere F, 1998, CELL MOL LIFE SCI, V54, P205, DOI 10.1007/s000180050145; Mendes MV, 2001, CHEM BIOL, V8, P635, DOI 10.1016/S1074-5521(01)00033-3; Miranzo D, 2010, APPL MICROBIOL BIOT, V85, P1809, DOI 10.1007/s00253-009-2195-1; Paquet V, 2008, CHEM-EUR J, V14, P2465, DOI 10.1002/chem.200701237; Perez-Zuniga FJ, 2004, J ANTIBIOT, V57, P197, DOI 10.7164/antibiotics.57.197; Power P, 2008, CHEM BIOL, V15, P78, DOI 10.1016/j.chembiol.2007.11.008; Preobrazhenskaya MN, 2009, J MED CHEM, V52, P189, DOI 10.1021/jm800695k; Seco EM, 2010, APPL MICROBIOL BIOT, V85, P1797, DOI 10.1007/s00253-009-2193-3; Seco EM, 2005, CHEM BIOL, V12, P1093, DOI 10.1016/j.chembiol.2005.08.007; Seco EM, 2005, CHEM BIOL, V12, P535, DOI 10.1016/j.chembiol.2005.02.015; Seco EM, 2004, CHEM BIOL, V11, P357, DOI 10.1016/j.chembiol.2004.02.017; Standards NCfCL, 1998, M38P NCFCL, V18; Szlinder-Richert J, 2001, BBA-GEN SUBJECTS, V1528, P15, DOI 10.1016/S0304-4165(01)00166-0; Tevyashova AN, 2013, ANTIMICROB AGENTS CH, V57, P3815, DOI 10.1128/AAC.00270-13; WALLACE KK, 1995, FEMS MICROBIOL LETT, V131, P227, DOI 10.1016/0378-1097(95)00263-5; WALLACE KK, 1995, EUR J BIOCHEM, V233, P954, DOI 10.1111/j.1432-1033.1995.954_3.x; Witkowski A, 1999, BIOCHEMISTRY-US, V38, P11643, DOI 10.1021/bi990993h; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zalkin H, 1998, ADV ENZYMOL RAMB, V72, P87	47	8	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135891	10.1371/journal.pone.0135891	http://dx.doi.org/10.1371/journal.pone.0135891			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284936	gold, Green Submitted, Green Published			2022-12-26	WOS:000359666100084
J	Streit, S; Baumann, P; Barth, J; Mattle, HP; Arnold, M; Bassetti, CL; Meli, DN; Fischer, U				Streit, Sven; Baumann, Philippe; Barth, Juergen; Mattle, Heinrich P.; Arnold, Marcel; Bassetti, Claudio L.; Meli, Damian N.; Fischer, Urs			Awareness of Stroke Risk after TIA in Swiss General Practitioners and Hospital Physicians	PLOS ONE			English	Article							TRANSIENT ISCHEMIC ATTACK; PRIMARY-CARE-PHYSICIANS; MINOR STROKE; QUESTIONNAIRE SURVEY; MANAGEMENT	Background Transient ischemic attacks (TIA) are stroke warning signs and emergency situations, and, if immediately investigated, doctors can intervene to prevent strokes. Nevertheless, many patients delay going to the doctor, and doctors might delay urgently needed investigations and preventative treatments. We set out to determine how much general practitioners (GPs) and hospital physicians (HPs) knew about stroke risk after TIA, and to measure their referral rates. Methods We used a structured questionnaire to ask GPs and HPs in the catchment area of the University Hospital of Bern to estimate a patient's risk of stroke after TIA. We also assessed their referral behavior. We then statistically analysed their reasons for deciding not to immediately refer patients. Results Of the 1545 physicians, 40% (614) returned the survey. Of these, 75%(457) overestimated stroke risk within 24 hours, and 40% (245) overestimated risk within 3 months after TIA. Only 9% (53) underestimated stroke risk within 24 hours and 26%(158) underestimated risk within 3 months; 78% (473) of physicians overestimated the amount that carotid endarterectomy reduces stroke risk; 93%(543) would rigorously investigate the cause of a TIA, but only 38%(229) would refer TIA patients for urgent investigations "very often". Physicians most commonly gave these reasons for not making emergency referrals: patient's advanced age; patient's preference; patient was multimorbid; and, patient needed long-term care. Conclusions Although physicians overestimate stroke risk after TIA, their rate of emergency referral is modest, mainly because they tend not to refer multimorbid and elderly patients at the appropriate rate. Since old and frail patients benefit from urgent investigations and treatment after TIA as much as younger patients, future educational campaigns should focus on the importance of emergency evaluations for all TIA patients.	[Streit, Sven; Baumann, Philippe; Meli, Damian N.] Univ Bern, Inst Primary Hlth Care BIHAM, Bern, Switzerland; [Barth, Juergen] Univ Zurich Hosp, Inst Complementary & Integrat Med, CH-8091 Zurich, Switzerland; [Mattle, Heinrich P.; Arnold, Marcel; Bassetti, Claudio L.; Fischer, Urs] Univ Bern, Dept Neurol, Univ Hosp Bern, Bern, Switzerland	University of Bern; University of Zurich; University Zurich Hospital; University of Bern; University Hospital of Bern	Fischer, U (corresponding author), Univ Bern, Dept Neurol, Univ Hosp Bern, Bern, Switzerland.	urs.fischer@insel.ch	Streit, Sven/I-3788-2019	Streit, Sven/0000-0002-3813-4616; Fischer, Urs/0000-0003-0521-4051; Bassetti, Claudio/0000-0002-4535-0245	Swiss University Conference; State Secretariat for Education, Research and Innovation (SUC project) [P-10]	Swiss University Conference; State Secretariat for Education, Research and Innovation (SUC project)	Sven Streit who was funded in part by the Swiss University Conference and the State Secretariat for Education, Research and Innovation (SUC project P-10). No other funding was needed to conduct this study.	Chandratheva A, 2010, STROKE, V41, P1108, DOI 10.1161/STROKEAHA.109.576611; Coull AJ, 2004, BMJ-BRIT MED J, V328, P326, DOI 10.1136/bmj.37991.635266.44; Del Mar C, 2014, JAMA INTERNAL MED; Engelter S, 2006, SCHW MED FORUM, V6, P479; Goldstein LB, 2000, ARCH INTERN MED, V160, P2941, DOI 10.1001/archinte.160.19.2941; Heldner M R, 2012, Praxis (Bern 1994), V101, P389, DOI 10.1024/1661-8157/a000866; Johnston SC, 1999, EUR NEUROL, V42, P105, DOI 10.1159/000069419; Lasserson DS, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1569; Leung Elaine Stephanie, 2012, BMC Res Notes, V5, P278, DOI 10.1186/1756-0500-5-278; Massengo SA, 2013, CLIN NEUROL NEUROSUR, V115, P1457, DOI 10.1016/j.clineuro.2013.01.026; Nedeltchev K, 2007, J NEUROL, V254, P179, DOI 10.1007/s00415-006-0313-x; Rothwell PM, 2007, LANCET, V370, P1432, DOI 10.1016/S0140-6736(07)61448-2; Slezak A, 2014, SCHW MED FORUM, V14, P333; Suzuki R, 2014, INT J STROKE, V9, pE16, DOI 10.1111/ijs.12266; Tomasik T, 2003, FAM PRACT, V20, P464, DOI 10.1093/fampra/cmg423	15	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135885	10.1371/journal.pone.0135885	http://dx.doi.org/10.1371/journal.pone.0135885			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284533	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000359666100081
J	van Kerkhof, LWM; Van Dycke, KCG; Jansen, EHJM; Beekhof, PK; van Oostrom, CTM; Ruskovska, T; Velickova, N; Kamcev, N; Pennings, JLA; van Steeg, H; Rodenburg, W				van Kerkhof, Linda W. M.; Van Dycke, Kirsten C. G.; Jansen, Eugene H. J. M.; Beekhof, Piet K.; van Oostrom, Conny T. M.; Ruskovska, Tatjana; Velickova, Nevenka; Kamcev, Nikola; Pennings, Jeroen L. A.; van Steeg, Harry; Rodenburg, Wendy			Diurnal Variation of Hormonal and Lipid Biomarkers in a Molecular Epidemiology-Like Setting	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; CLOCK GENES; CIRCADIAN-RHYTHM; LUTEINIZING-HORMONE; SERUM TESTOSTERONE; GROWTH-HORMONE; BREAST-CANCER; NORMAL-WEIGHT; BRIGHT LIGHT; NORMAL WOMEN	Introduction Many molecular epidemiology studies focusing on high prevalent diseases, such as metabolic disorders and cancer, investigate metabolic and hormonal markers. In general, sampling for these markers can occur at any time-point during the day or after an overnight fast. However, environmental factors, such as light exposure and food intake might affect the levels of these markers, since they provide input for the internal time-keeping system. When diurnal variation is larger than the inter-individual variation, time of day should be taken into account. Importantly, heterogeneity in diurnal variation and disturbance of circadian rhythms among a study population might increasingly occur as a result of our increasing 24/7 economy and related variation in exposure to environmental factors (such as light and food). Aim The aim of the present study was to determine whether a set of often used biomarkers shows diurnal variation in a setting resembling large molecular epidemiology studies, i.e., non-fasted and limited control possibilities for other environmental influences. Results We show that markers for which diurnal variation is not an issue are adrenocorticotropic hormone, follicle stimulating hormone, estradiol and high-density lipoprotein. For all other tested markers diurnal variation was observed in at least one gender (cholesterol, cortisol, dehydroepiandrosterone sulfate, free fatty acids, low-density lipoprotein, luteinizing hormone, prolactin, progesterone, testosterone, triglycerides, total triiodothyronine and thyroid-stimulating hormone) or could not reliably be detected (human growth hormone). Discussion Thus, studies investigating these markers should take diurnal variation into account, for which we provide some options. Furthermore, our study indicates the need for investigating diurnal variation (in literature or experimentally) before setting up studies measuring markers in routine and controlled settings, especially since time-of-day likely matters for many more markers than the ones investigated in the present study.	[van Kerkhof, Linda W. M.; Van Dycke, Kirsten C. G.; Jansen, Eugene H. J. M.; Beekhof, Piet K.; van Oostrom, Conny T. M.; Pennings, Jeroen L. A.; van Steeg, Harry; Rodenburg, Wendy] Natl Inst Publ Hlth & Environm RIVM, Ctr Hlth Protect, Bilthoven, Netherlands; [Van Dycke, Kirsten C. G.] Erasmus Univ, Med Ctr, Dept Genet, Ctr Biomed Genet, Rotterdam, Netherlands; [Ruskovska, Tatjana; Velickova, Nevenka; Kamcev, Nikola] Goce Delcev Univ, Fac Med Sci, Stip, Macedonia; [van Steeg, Harry] Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands	Netherlands National Institute for Public Health & the Environment; Erasmus University Rotterdam; Erasmus MC; Goce Delcev University of Stip; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Rodenburg, W (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Hlth Protect, Bilthoven, Netherlands.	wendy.rodenburg@rivm.nl	Ruskovska, Tatjana/V-4885-2019	Ruskovska, Tatjana/0000-0002-4300-4891; Pennings, Jeroen L.A./0000-0002-9188-6358				Ang JE, 2012, CHRONOBIOL INT, V29, P868, DOI 10.3109/07420528.2012.699122; Archer SN, 2014, P NATL ACAD SCI USA, V111, pE682, DOI 10.1073/pnas.1316335111; Birketvedt GS, 2012, APPETITE, V59, P688, DOI 10.1016/j.appet.2012.07.015; Brambilla DJ, 2009, J CLIN ENDOCR METAB, V94, P907, DOI 10.1210/jc.2008-1902; Carneiro BTS, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00083; Chua ECP, 2013, P NATL ACAD SCI USA, V110, P14468, DOI 10.1073/pnas.1222647110; Dallmann R, 2012, P NATL ACAD SCI USA, V109, P2625, DOI 10.1073/pnas.1114410109; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Davies SK, 2014, P NATL ACAD SCI USA, V111, P10761, DOI 10.1073/pnas.1402663111; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Diver MJ, 2003, CLIN ENDOCRINOL, V58, P710, DOI 10.1046/j.1365-2265.2003.01772.x; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; FUJIMOTO VY, 1990, OBSTET GYNECOL, V76, P71; Gamble KL, 2014, NAT REV ENDOCRINOL, V10, P466, DOI 10.1038/nrendo.2014.78; Gooley JJ, 2014, J GENET GENOMICS, V41, P231, DOI 10.1016/j.jgg.2014.04.001; Hadji P, 2014, BREAST CANCER RES TR, V144, P343, DOI 10.1007/s10549-014-2860-7; Hastings MH, 1998, CHRONOBIOL INT, V15, P425, DOI 10.3109/07420529808998700; Hirschfeld U, 1996, J CLIN ENDOCR METAB, V81, P3270, DOI 10.1210/jc.81.9.3270; James FO, 2007, CHRONOBIOL INT, V24, P1009, DOI 10.1080/07420520701800736; Jiang J, 2014, METABOLISM, V63, P1398, DOI 10.1016/j.metabol.2014.07.011; Jung CM, 2010, J BIOL RHYTHM, V25, P208, DOI 10.1177/0748730410368413; Klingman KM, 2011, J CLIN ENDOCR METAB, V96, P1456, DOI 10.1210/jc.2010-2739; Kusanagi H, 2008, NEUROSCI RES, V61, P136, DOI 10.1016/j.neures.2008.01.012; Li SX, 2013, PSYCHONEUROENDOCRINO, V38, P2789, DOI 10.1016/j.psyneuen.2013.07.009; Mazzoccoli G, 2011, BIOMED PHARMACOTHER, V65, P275, DOI 10.1016/j.biopha.2011.02.002; Mester B, 2010, INT J OCCUP ENV MED, V1, P160; Miida T, 2002, ANN CLIN BIOCHEM, V39, P241, DOI 10.1258/0004563021901946; MIYATAKE A, 1980, J CLIN ENDOCR METAB, V51, P1365, DOI 10.1210/jcem-51-6-1365; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Moller-Levet CS, 2013, P NATL ACAD SCI USA, V110, pE1132, DOI 10.1073/pnas.1217154110; MORTOLA JF, 1992, J CLIN ENDOCR METAB, V75, P861, DOI 10.1210/jc.75.3.861; Nicolau G Y, 1989, Endocrinologie, V27, P153; Niklowitz P, 2006, BIOFACTORS, V28, P47, DOI 10.1002/biof.5520280105; Ollila HM, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.20; Ostrowska, 1998, Endocr Regul, V32, P169; PLYMATE SR, 1989, J ANDROL, V10, P366; RIEDEL M, 1995, METABOLISM, V44, P605, DOI 10.1016/0026-0495(95)90117-5; SPRATT DI, 1988, AM J PHYSIOL, V254, pE658, DOI 10.1152/ajpendo.1988.254.5.E658; Stevens RG, 2005, EPIDEMIOLOGY, V16, P254, DOI 10.1097/01.ede.0000152525.21924.54; Takimoto M, 2005, AM J PHYSIOL-REG I, V289, pR1273, DOI 10.1152/ajpregu.00126.2005; Teboul M, 2005, J MOL MED, V83, P693, DOI 10.1007/s00109-005-0697-6; VELDHUIS JD, 1988, J CLIN ENDOCR METAB, V66, P414, DOI 10.1210/jcem-66-2-414; WHO, 2013, FACT SH DIAB 2013; Yoshino J, 2014, J CLIN ENDOCR METAB, V99, pE1666, DOI 10.1210/jc.2014-1579; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111	45	35	35	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135652	10.1371/journal.pone.0135652	http://dx.doi.org/10.1371/journal.pone.0135652			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285127	Green Published, gold, Green Submitted			2022-12-26	WOS:000359666100054
J	Meng, X; Vander Ark, A; Lee, P; Hostetter, G; Bhowmick, NA; Matrisian, LM; Williams, BO; Miranti, CK; Li, X				Meng, X.; Vander Ark, A.; Lee, P.; Hostetter, G.; Bhowmick, N. A.; Matrisian, L. M.; Williams, B. O.; Miranti, C. K.; Li, X.			Myeloid-specific TGF-beta signaling in bone promotes basic-FGF and breast cancer bone metastasis	ONCOGENE			English	Article							TUMOR-METASTASIS; II RECEPTOR; GROWTH; CELLS; PROGRESSION; EXPRESSION	Breast cancer (BCa) bone metastases cause osteolytic bone lesions, which result from the interactions of metastatic BCa cells with osteoclasts and osteoblasts. Osteoclasts differentiate from myeloid lineage cells. To understand the cell-specific role of transforming growth factor beta (TGF-beta) in the myeloid lineage, in BCa bone metastases, MDA-MB-231 BCa cells were intra-tibially or intra-cardially injected into LysM(Cre)/Tgfbr2(floxE2/floxE2) knockout (LysM(Cre)/Tgfbr2 KO) or Tgfbr2(floxE2/floxE2) mice. Metastatic bone lesion development was compared by analysis of both lesion number and area. We found that LysM(Cre)/Tgfbr2 knockout significantly decreased MDA-MB-231 bone lesion development in both the cardiac and tibial injection models. LysM(Cre)/Tgfbr2 knockout inhibited the tumor cell proliferation, angiogenesis and osteoclastogenesis of the metastatic bones. Cytokine array analysis showed that basic fibroblast growth factor (bFGF) was downregulated in MDA-MB-231-injected tibiae from the LysM(Cre)/Tgfbr2 KO group, and intravenous injection of the recombinant bFGF to LysM(Cre)/Tgfbr2 KO mice rescued the inhibited metastatic bone lesion development. The mechanism by which bFGF rescued the bone lesion development was by promotion of tumor cell proliferation through the downstream mitogen-activated protein kinase (MAPK)-extracellular signal-regulated kinase (ERK)-cFos pathway after binding to the FGF receptor 1 (FGFR1). Consistent with animal studies, we found that in human BCa bone metastatic tissues, TGF-beta type II receptor (T beta RII) and p-Smad2 were expressed in osteoclasts and tumor cells, and were correlated with the expression of FGFR1. Our studies suggest that myeloid-specific TGF-beta signaling-mediated bFGF in the bone promotes BCa bone metastasis.	[Meng, X.; Vander Ark, A.; Lee, P.; Williams, B. O.; Miranti, C. K.; Li, X.] Van Andel Res Inst, Ctr Canc & Cell Biol, Program Skeletal Dis & Tumor Microenvironm, Grand Rapids, MI 49503 USA; [Hostetter, G.] Van Andel Res Inst, Pathol & Biorepository Core, Grand Rapids, MI 49503 USA; [Bhowmick, N. A.] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Bhowmick, N. A.] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Matrisian, L. M.] Pancreat Canc Act Network, Washington, DC USA	Van Andel Institute; Van Andel Institute; Cedars Sinai Medical Center; Cedars Sinai Medical Center	Li, X (corresponding author), Van Andel Res Inst, Ctr Canc & Cell Biol, Program Skeletal Dis & Tumor Microenvironm, Grand Rapids, MI 49503 USA.	xiaohong.li@vai.org	Miranti, Cindy/AAJ-3783-2020; Williams, Bart/A-3539-2013; Bhowmick, Neil/AAA-7302-2019	Williams, Bart/0000-0002-5261-5301; Bhowmick, Neil/0000-0001-8747-5989; Meng, Xiangqi/0000-0002-6407-6122; , Xiaohong/0000-0001-5074-193X	Van Andel Research Institute [53010A]	Van Andel Research Institute	We thank Dr Julie A Sterling from Vanderbilt University and Dr Yibin Kang from Princeton University for providing cell lines. The Van Andel Research Institute supported this research (VARI start-up to X Li, 53010A). We thank Lisa Turner of the Pathology and Biorepository Core for her pathology expertise, the Vivarium and Transgenics Core for animal technical assistance and Diana Lewis for administrative support. We thank Dr Travis Burgers for the construction of 3D micro-CT pictures. Special thanks to Dr Mary E Winn from the Bioinformatics and Biostatistics Core for her great help in answering statistical questions. Finally, we thank David Nadziejka for his technical editing of this manuscript. The content is solely the responsibility of the authors.	Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; BRUNNER G, 1993, BLOOD, V81, P631; Busch S, 2015, ONCOGENE, V34, P27, DOI 10.1038/onc.2013.527; Cheng N, 2005, ONCOGENE, V24, P5053, DOI 10.1038/sj.onc.1208685; Cheng N, 2007, CANCER RES, V67, P4869, DOI 10.1158/0008-5472.CAN-06-3381; Chytil A, 2002, GENESIS, V32, P73, DOI 10.1002/gene.10046; Coleman RE, 2006, CLIN CANCER RES, V12, p6243S, DOI 10.1158/1078-0432.CCR-06-0931; Courjal F, 1997, CANCER RES, V57, P4360; Ell B, 2013, CANCER CELL, V24, P542, DOI 10.1016/j.ccr.2013.09.008; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Johnson RW, 2014, CLIN EXP METASTAS, V31, P945, DOI 10.1007/s10585-014-9682-1; Kim BG, 2006, NATURE, V441, P1015, DOI 10.1038/nature04846; Li X, 2008, ONCOGENE, V27, P7118, DOI 10.1038/onc.2008.293; Li XH, 2012, MOL CANCER RES, V10, P494, DOI 10.1158/1541-7786.MCR-11-0506; Novitskiy SV, 2012, J LEUKOCYTE BIOL, V92, P641, DOI 10.1189/jlb.1211639; Pang YL, 2013, CANCER DISCOV, V3, P936, DOI 10.1158/2159-8290.CD-12-0527; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Reddi AH, 2003, J BONE MINER RES, V18, P190, DOI 10.1359/jbmr.2003.18.2.190; Sethi N, 2011, CANCER CELL, V19, P192, DOI 10.1016/j.ccr.2010.12.022; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Wan XH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009332; Zhong ZD, 2012, P NATL ACAD SCI USA, V109, pE2197, DOI 10.1073/pnas.1120407109	23	33	34	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 5	2016	35	18					2370	2378		10.1038/onc.2015.297	http://dx.doi.org/10.1038/onc.2015.297			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DM2GL	26279296				2022-12-26	WOS:000376165000009
J	Herrmann, J; Nathin, D; Lee, SG; Sun, T; Jez, JM				Herrmann, Jonathan; Nathin, David; Lee, Soon Goo; Sun, Tony; Jez, Joseph M.			Recapitulating the Structural Evolution of Redox Regulation in Adenosine 5 '-Phosphosulfate Kinase from Cyanobacteria to Plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMATE-CYSTEINE LIGASE; SOYBEAN ATP SULFURYLASE; CRYSTAL-STRUCTURE; APS-KINASE; ADENOSINE-5'-PHOSPHOSULFATE KINASE; PENICILLIUM-CHRYSOGENUM; SULFATE ASSIMILATION; NUCLEOTIDE-BINDING; METABOLISM; MECHANISM	In plants, adenosine 5'-phosphosulfate (APS) kinase (APSK) is required for reproductive viability and the production of 3'-phosphoadenosine 5'-phosphosulfate (PAPS) as a sulfur donor in specialized metabolism. Previous studies of the APSK from Arabidopsis thaliana (AtAPSK) identified a regulatory disulfide bond formed between the N-terminal domain (NTD) and a cysteine on the core scaffold. This thiol switch is unique to mosses, gymnosperms, and angiosperms. To understand the structural evolution of redox control of APSK, we investigated the redox-insensitive APSK from the cyanobacterium Synechocystis sp. PCC6803 (SynAPSK). Crystallographic analysis of SynAPSK in complex with either APS and a non-hydrolyzable ATP analog or APS and sulfate revealed the overall structure of the enzyme, which lacks the NTD found in homologs from mosses and plants. A series of engineered SynAPSK variants reconstructed the structural evolution of the plant APSK. Biochemical analyses of SynAPSK, SynAPSK H23C mutant, SynAPSK fused to the AtAPSK NTD, and the fusion protein with the H23C mutation showed that the addition of the NTD and cysteines recapitulated thiol-based regulation. These results reveal the molecular basis for structural changes leading to the evolution of redox control of APSK in the green lineage from cyanobacteria to plants.	[Herrmann, Jonathan; Nathin, David; Lee, Soon Goo; Sun, Tony; Jez, Joseph M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Jez, JM (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	jjez@biology2.wustl.edu		Lee, Soon Goo/0000-0002-1541-8587	National Science Foundation [MCB-0904215]; American Society of Plant Biologists	National Science Foundation(National Science Foundation (NSF)); American Society of Plant Biologists	This work was supported by Grant MCB-0904215 from the National Science Foundation. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Summer Undergraduate Research Fellowship from the American Society of Plant Biologists.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allen A, 2004, BIOCHEMISTRY-US, V43, P14431, DOI 10.1021/bi048817i; ASAHI T, 1964, BIOCHIM BIOPHYS ACTA, V82, P58, DOI 10.1016/0304-4165(64)90007-8; Ballicora MA, 2005, J BIOL CHEM, V280, P10189, DOI 10.1074/jbc.M413540200; Bick JA, 2001, BIOCHEMISTRY-US, V40, P9040, DOI 10.1021/bi010518v; Carter CW, 2014, J BIOL CHEM, V289, P30213, DOI 10.1074/jbc.R114.567495; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gaucher EA, 2003, NATURE, V425, P285, DOI 10.1038/nature01977; Gay SC, 2009, ACTA CRYSTALLOGR D, V65, P1021, DOI 10.1107/S0907444909026547; Gould SB, 2008, ANNU REV PLANT BIOL, V59, P491, DOI 10.1146/annurev.arplant.59.032607.092915; Gromes R, 2008, PLANT J, V54, P1063, DOI 10.1111/j.1365-313X.2008.03477.x; Harjes S, 2005, J MOL BIOL, V347, P623, DOI 10.1016/j.jmb.2005.01.005; Harms MJ, 2013, NAT REV GENET, V14, P559, DOI 10.1038/nrg3540; Hatzios SK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002036; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Herrmann J, 2014, J BIOL CHEM, V289, P10919, DOI 10.1074/jbc.M113.540401; Hicks LM, 2007, PLANT CELL, V19, P2653, DOI 10.1105/tpc.107.052597; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hothorn M, 2006, J BIOL CHEM, V281, P27557, DOI 10.1074/jbc.M602770200; Jez JM, 2004, J BIOL CHEM, V279, P33463, DOI 10.1074/jbc.M405127200; Kopriva S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00163; Koprivova A, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00589; Lansdon EB, 2002, BIOCHEMISTRY-US, V41, P13672, DOI 10.1021/bi026556b; Lillig CH, 2001, ARCH BIOCHEM BIOPHYS, V392, P303, DOI 10.1006/abbi.2001.2453; MacRae IJ, 2000, BIOCHEMISTRY-US, V39, P1613, DOI 10.1021/bi9924157; MacRae IJ, 2001, BIOCHEMISTRY-US, V40, P6795, DOI 10.1021/bi010367w; Martin MN, 2005, PHOTOSYNTH RES, V86, P309, DOI 10.1007/s11120-005-9006-z; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mendoza-Cozatl D, 2005, FEMS MICROBIOL REV, V29, P653, DOI 10.1016/j.femsre.2004.09.004; Mueller JW, 2013, FEBS J, V280, P3050, DOI 10.1111/febs.12252; Mugford SG, 2010, FEBS LETT, V584, P119, DOI 10.1016/j.febslet.2009.11.014; Mugford SG, 2009, PLANT CELL, V21, P910, DOI 10.1105/tpc.109.065581; OSSLUND T, 1982, PLANT PHYSIOL, V70, P39, DOI 10.1104/pp.70.1.39; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palde PB, 2015, P NATL ACAD SCI USA, V112, P7960, DOI 10.1073/pnas.1504376112; Perez-Jimenez R, 2011, NAT STRUCT MOL BIOL, V18, P592, DOI 10.1038/nsmb.2020; Phartiyal P, 2006, ARCH BIOCHEM BIOPHYS, V450, P20, DOI 10.1016/j.abb.2006.03.033; Prioretti L, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00597; Ravilious GE, 2013, BIOSCIENCE REP, V33, P585, DOI 10.1042/BSR20130073; Ravilious GE, 2013, J BIOL CHEM, V288, P6107, DOI 10.1074/jbc.M112.439414; Ravilious GE, 2012, NAT PROD REP, V29, P1138, DOI 10.1039/c2np20009k; Ravilious GE, 2012, J BIOL CHEM, V287, P30385, DOI 10.1074/jbc.M112.387001; Ravilious GE, 2012, P NATL ACAD SCI USA, V109, P309, DOI 10.1073/pnas.1115772108; RENOSTO F, 1985, J BIOL CHEM, V260, P1903; Reyes-Prieto A, 2007, ANNU REV GENET, V41, P147, DOI 10.1146/annurev.genet.41.110306.130134; Satishchandran C, 2000, ARCH BIOCHEM BIOPHYS, V378, P210, DOI 10.1006/abbi.2000.1841; Schnell R, 2010, BIOCHEM BIOPH RES CO, V396, P33, DOI 10.1016/j.bbrc.2010.02.118; Sekulic N, 2007, J MOL BIOL, V367, P488, DOI 10.1016/j.jmb.2007.01.025; Takahashi H, 2011, ANNU REV PLANT BIOL, V62, P157, DOI 10.1146/annurev-arplant-042110-103921; van der Ploeg JR, 2001, ARCH MICROBIOL, V176, P1, DOI 10.1007/s002030100298; Vogel C, 2004, CURR OPIN STRUC BIOL, V14, P208, DOI 10.1016/j.sbi.2004.03.011; Yatusevich R, 2010, PLANT J, V62, P1, DOI 10.1111/j.1365-313X.2009.04118.x; Yi H, 2010, AMINO ACIDS, V39, P963, DOI 10.1007/s00726-010-0572-9; Yi H, 2010, MOL PLANT, V3, P269, DOI 10.1093/mp/ssp112; Yu ZH, 2007, J MOL BIOL, V365, P732, DOI 10.1016/j.jmb.2006.10.035; Zhang M, 2012, J AM CHEM SOC, V134, P16979, DOI 10.1021/ja3078522	57	6	7	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 9	2015	290	41					24705	24714		10.1074/jbc.M115.679514	http://dx.doi.org/10.1074/jbc.M115.679514			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CT1YF	26294763	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000362598300007
J	Trianni, V; Lopez-Ibanez, M				Trianni, Vito; Lopez-Ibanez, Manuel			Advantages of Task-Specific Multi-Objective Optimisation in Evolutionary Robotics	PLOS ONE			English	Article							INCREMENTAL EVOLUTION; SELF-ORGANIZATION; CONTROLLERS; COMPLEXITY; GENERATION; MORPHOLOGY; BEHAVIORS	The application of multi-objective optimisation to evolutionary robotics is receiving increasing attention. A survey of the literature reveals the different possibilities it offers to improve the automatic design of efficient and adaptive robotic systems, and points to the successful demonstrations available for both task-specific and task-agnostic approaches (i.e., with or without reference to the specific design problem to be tackled). However, the advantages of multi-objective approaches over single-objective ones have not been clearly spelled out and experimentally demonstrated. This paper fills this gap for task-specific approaches: starting from well-known results in multi-objective optimisation, we discuss how to tackle commonly recognised problems in evolutionary robotics. In particular, we show that multi-objective optimisation (i) allows evolving a more varied set of behaviours by exploring multiple trade-offs of the objectives to optimise, (ii) supports the evolution of the desired behaviour through the introduction of objectives as proxies, (iii) avoids the premature convergence to local optima possibly introduced by multi-component fitness functions, and (iv) solves the bootstrap problem exploiting ancillary objectives to guide evolution in the early phases. We present an experimental demonstration of these benefits in three different case studies: maze navigation in a single robot domain, flocking in a swarm robotics context, and a strictly collaborative task in collective robotics.	[Trianni, Vito] CNR, ISTC, Rome, Italy; [Lopez-Ibanez, Manuel] ULB, IRIDIA, CoDE, Brussels, Belgium	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR); Universite Libre de Bruxelles	Trianni, V (corresponding author), CNR, ISTC, Rome, Italy.	vito.trianni@istc.cnr.it	López-Ibáñez, Manuel/L-4517-2014; Trianni, Vito/B-8332-2015	López-Ibáñez, Manuel/0000-0001-9974-1295; Trianni, Vito/0000-0002-9114-8486				Agapitos A, 2007, IEEE C EVOL COMPUTAT, P1562, DOI 10.1109/CEC.2007.4424659; Auerbach JE, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003399; Bader J, 2011, EVOL COMPUT, V19, P45, DOI 10.1162/EVCO_a_00009; Baldassarre G, 2003, ARTIF LIFE, V9, P255, DOI 10.1162/106454603322392460; Barlow GJ, 2004, CONF CYBERN INTELL S, P689; Bernatskiy A., 2014, ARTIFICIAL LIFE 14 I, V14, P726; Beume N, 2007, EUR J OPER RES, V181, P1653, DOI 10.1016/j.ejor.2006.08.008; Bonani M, 2010, IEEE INT C INT ROBOT, P4187, DOI 10.1109/IROS.2010.5649153; Bongard J, 2010, ARTIF LIFE, V16, P201, DOI 10.1162/artl.2010.Bongard.024; Bongard JC, 2013, GECCO'13: PROCEEDINGS OF THE 2013 GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P159; Bongard JC, 2011, IEEE T EVOLUT COMPUT, V15, P571, DOI 10.1109/TEVC.2010.2096540; Branke J., 2008, LNCS, V5252; Capi G, 2007, IEEE T ROBOT, V23, P1225, DOI 10.1109/TRO.2007.910773; da Fonseca V.G., 2010, EXPT METHODS ANAL OP, P103; da Fonseca VG, 2001, LECT NOTES COMPUT SC, V1993, P213; Das I, 1997, STRUCT OPTIMIZATION, V14, P63, DOI 10.1007/BF01197559; de Margerie E, 2007, BIOINSPIR BIOMIM, V2, P65, DOI 10.1088/1748-3182/2/4/002; Deb K., 2001, WIL INT S SYS OPT; Doncieux S, 2013, PROCEEDINGS OF THE 2, P1; Doncieux S, 2015, FRONT ROBOT AI, DOI 10.3389/frobt.2015.00004; Doncieux S, 2014, EVOL INTELL, V7, P71, DOI 10.1007/s12065-014-0110-x; Fehervari I, 2013, 2013 IEEE CONGRESS ON EVOLUTIONARY COMPUTATION (CEC), P1209; FLOREANO D, 1994, COM ADAP SY, P421; Floreano D, 2000, NEURAL NETWORKS, V13, P431, DOI 10.1016/S0893-6080(00)00032-0; Floreano D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000292; GRUAU F, 1997, COM ADAP SY, P368; Handl J., 2008, MULTIOBJECTIVE PROBL, P131; Ortiz JAH, 2013, ENG OPTIMIZ, V45, P19, DOI 10.1080/0305215X.2012.658781; Ijspeert AJ, 2001, AUTON ROBOT, V11, P149, DOI 10.1023/A:1011227210047; Ishibuchi H, 2008, IEEE C EVOL COMPUTAT, P2419, DOI 10.1109/CEC.2008.4631121; Jaszkiewicz A, 2008, LECT NOTES COMPUT SC, V5252, P179, DOI 10.1007/978-3-540-88908-3_7; Koos S, 2013, INT J ROBOT RES, V32, P1700, DOI 10.1177/0278364913499192; Koos S, 2013, IEEE T EVOLUT COMPUT, V17, P122, DOI 10.1109/TEVC.2012.2185849; Lehman J, 2013, ADAPT BEHAV, V21, P484, DOI 10.1177/1059712313487390; Lehman J, 2013, GECCO'13: PROCEEDINGS OF THE 2013 GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P215; Lehman J, 2011, GECCO-2011: PROCEEDINGS OF THE 13TH ANNUAL GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P211; Lehman J, 2011, EVOL COMPUT, V19, P189, DOI 10.1162/EVCO_a_00025; Lipson H, 2006, BIOMIMETICS: BIOLOGICALLY INSPIRED TECHNOLOGIES, P129; Lopes MA, 2010, ESTUD HUMAN, P209, DOI 10.1007/978-3-642-02538-9_9; Marler RT, 2004, STRUCT MULTIDISCIP O, V26, P369, DOI 10.1007/s00158-003-0368-6; Miglino O, 2008, ARTIF LIFE ROBOT, V13, P1, DOI 10.1007/s10015-008-0503-y; Moshaiov A, 2014, 2014 IEEE CONGRESS ON EVOLUTIONARY COMPUTATION (CEC), P2809, DOI 10.1109/CEC.2014.6900433; Moshaiov A, 2009, IEEE C EVOL COMPUTAT, P1093, DOI 10.1109/CEC.2009.4983068; Mouret JB, 2012, EVOL COMPUT, V20, P91, DOI 10.1162/EVCO_a_00048; Mouret JB, 2008, LECT NOTES ARTIF INT, V5040, P210; Mouret JB, 2006, LECT NOTES COMPUT SC, V4095, P606; Mouret JB, 2011, STUD COMPUT INTELL, V341, P139; Mouret JB, 2009, IEEE C EVOL COMPUTAT, P1161, DOI 10.1109/CEC.2009.4983077; Nelson AL, 2009, ROBOT AUTON SYST, V57, P345, DOI 10.1016/j.robot.2008.09.009; Nolfi S., 2000, EVOLUTIONARY ROBOTIC; Oliveira M, 2013, IEEE-RAS INT C HUMAN, P106, DOI 10.1109/HUMANOIDS.2013.7029963; Oliveira M, 2013, IEEE INT CONF ROBOT, P3130, DOI 10.1109/ICRA.2013.6631012; Ollion C, 2012, ARTIF LIFE, V13, P407; Pfeifer R, 2007, SCIENCE, V318, P1088, DOI 10.1126/science.1145803; Pinciroli C, 2012, SWARM INTELL-US, V6, P271, DOI 10.1007/s11721-012-0072-5; Pinville T, 2011, GECCO-2011: PROCEEDINGS OF THE 13TH ANNUAL GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P259; Quinn M, 2003, PHILOS T R SOC A, V361, P2321, DOI 10.1098/rsta.2003.1258; Reynolds C.W., 1987, P 14 ANN C COMPUTER, V21, P25, DOI DOI 10.1145/37402.37406; Takagi H, 2001, P IEEE, V89, P1275, DOI 10.1109/5.949485; Teo J, 2005, IEEE T EVOLUT COMPUT, V9, P337, DOI 10.1109/TEVC.2005.846902; Teo J, 2004, EVOL COMPUT, V12, P355, DOI 10.1162/1063656041774974; Terekhov AV, 2011, IEEE INT C INT ROBOT, P4360, DOI 10.1109/IROS.2011.6048597; Terekhov AV, 2010, IEEE INT C INT ROBOT, P4782, DOI 10.1109/IROS.2010.5651397; Trianni V, 2011, ARTIF LIFE, V17, P183, DOI 10.1162/artl_a_00031; Van Veldhuizen D. A., 2007, EVOLUTIONARY ALGORIT, V5; Vicsek T, 2012, PHYS REP, V517, P71, DOI 10.1016/j.physrep.2012.03.004; Wagner GP, 1996, EVOLUTION, V50, P967, DOI [10.2307/2410639, 10.1111/j.1558-5646.1996.tb02339.x]; Zitzler E, 1998, LECT NOTES COMPUT SC, V1498, P292, DOI 10.1007/BFb0056872	68	15	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136406	10.1371/journal.pone.0136406	http://dx.doi.org/10.1371/journal.pone.0136406			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295151	Green Submitted, gold, Green Published			2022-12-26	WOS:000359926900106
J	Gonzalez-Martin, A; Gorostiza, A; Regalado-Liu, L; Arroyo-Pena, S; Tirado, S; Nuno-Arana, I; Rubi-Castellanos, R; Sandoval, K; Coble, MD; Rangel-Villalobos, H				Gonzalez-Martin, Antonio; Gorostiza, Amaya; Regalado-Liu, Lucia; Arroyo-Pena, Sergio; Tirado, Sergio; Nuno-Arana, Ismael; Rubi-Castellanos, Rodrigo; Sandoval, Karla; Coble, Michael D.; Rangel-Villalobos, Hector			Demographic History of Indigenous Populations in Mesoamerica Based on mtDNA Sequence Data	PLOS ONE			English	Article							CONTROL REGION SEQUENCES; LATE PLEISTOCENE HUMAN; BAYESIAN-INFERENCE; AMERICA; GENOME; ORIGIN; DIVERSITY; COLONIZATION; SELECTION; GENETICS	The genetic characterization of Native American groups provides insights into their history and demographic events. We sequenced the mitochondrial D-loop region (control region) of 520 samples from eight Mexican indigenous groups. In addition to an analysis of the genetic diversity, structure and genetic relationship between 28 Native American populations, we applied Bayesian skyline methodology for a deeper insight into the history of Mesoamerica. AMOVA tests applying cultural, linguistic and geographic criteria were performed. MDS plots showed a central cluster of Oaxaca and Maya populations, whereas those from the North and West were located on the periphery. Demographic reconstruction indicates higher values of the effective number of breeding females (Nef) in Central Mesoamerica during the Preclassic period, whereas this pattern moves toward the Classic period for groups in the North and West. Conversely, Nef minimum values are distributed either in the Lithic period (i.e. founder effects) or in recent periods (i.e. population declines). The Mesomerican regions showed differences in population fluctuation as indicated by the maximum Inter-Generational Rate (IGRmax): i) Center-South from the lithic period until the Preclassic; ii) West from the beginning of the Preclassic period until early Classic; iii) North characterized by a wide range of temporal variation from the Lithic to the Preclassic. Our findings are consistent with the genetic variations observed between central, South and Southeast Mesoamerica and the North-West region that are related to differences in genetic drift, structure, and temporal survival strategies (agriculture versus hunter-gathering, respectively). Interestingly, although the European contact had a major negative	[Gonzalez-Martin, Antonio; Gorostiza, Amaya; Regalado-Liu, Lucia; Arroyo-Pena, Sergio; Tirado, Sergio] Univ Complutense Madrid, Fac Biol, Dept Zool & Antropol Fis, Madrid, Spain; [Gorostiza, Amaya] GENOM SAU, Grp Zeltia, Lab Identificac Genet, Madrid 28033, Spain; [Nuno-Arana, Ismael; Rangel-Villalobos, Hector] Univ Guadalajara, Inst Invest Genet Mol, Ctr Univ Cienega, Ocotlan, Jalisco, Mexico; [Rubi-Castellanos, Rodrigo] Univ Autonoma Yucatan UADY, Ctr Invest Reg Hideyo Noguchi, Lab Genet, Merida, Yucatan, Mexico; [Sandoval, Karla] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Coble, Michael D.] Armed Forces DNA Identificat Lab, Amer Registry Pathol, Dover, DE USA	Complutense University of Madrid; PharmaMar; Universidad de Guadalajara; Universidad Autonoma de Yucatan; Stanford University	Rangel-Villalobos, H (corresponding author), Univ Guadalajara, Inst Invest Genet Mol, Ctr Univ Cienega, Ocotlan, Jalisco, Mexico.	hrangel13@hotmail.com	Gonzalez-Martin, Antonio/A-5489-2015; RANGEL-VILLALOBOS, HECTOR/C-5081-2018	Gonzalez-Martin, Antonio/0000-0003-0276-0778; RANGEL-VILLALOBOS, HECTOR/0000-0003-2641-8782; Rubi Castellanos, Rodrigo/0000-0002-5990-8326; Sandoval, Karla/0000-0002-6175-2463; Coble, Michael/0000-0003-3687-0342	CONACyT-Mexico [129693]; National Institute of Justice [2005-DN-R-086]; Ministerio de Economia y Competitividad, Espana [Project HAR2010-21063]	CONACyT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Institute of Justice(US National Institute of Justice); Ministerio de Economia y Competitividad, Espana(Spanish Government)	This work was supported by CONACyT-Mexico, grant 129693 to HRV (http://www.conacyt.mx/) for anthropological study design; National Institute of Justice (http://www.nij.gov/), InterAgency agreement 2005-DN-R-086 to MDC for Global mtDNA Databasing Project; and Ministerio de Economia y Competitividad, Espana (http://www.mineco.gob.es/), Project HAR2010-21063 to AGM for study design and analysis.	Achilli A, 2013, P NATL ACAD SCI USA, V110, P14308, DOI 10.1073/pnas.1306290110; Adams Richard E. W, 1996, PREHISTORIC MESOAMER; Aguilar-Moreno M, 2004, HDB LIFE AZTEC WORLD; Atkinson QD, 2008, MOL BIOL EVOL, V25, P468, DOI 10.1093/molbev/msm277; Bandelt HJ, 2003, ANN HUM GENET, V67, P512, DOI 10.1046/j.1469-1809.2003.00049.x; Blake Michael, 2006, HIST MAIZE MULTIDISC, P55; Blanto RE, 1981, COMP CHANGE 3 REGION; Bodner M, 2012, GENOME RES, V22, P811, DOI 10.1101/gr.131722.111; Brandstatter A, 2004, INT J LEGAL MED, V118, P294, DOI 10.1007/s00414-004-0466-z; Brandstatter A, 2007, FORENSIC SCI INT, V166, P164, DOI 10.1016/j.forsciint.2006.05.006; CAMPBELL L, 1986, LANGUAGE, V62, P530, DOI 10.2307/415477; Campos PF, 2010, P NATL ACAD SCI USA, V107, P5675, DOI 10.1073/pnas.0907189107; Carmack RM, 1996, LEGACY MESOAMERICA H; Chatters JC, 2014, SCIENCE, V344, P750, DOI 10.1126/science.1252619; Clark John E., 2000, HIST ANTIGUA MEXICO, V1, P437; Coe MD, 1996, MEXICO OLMECS AZTECS; CREAMER W, 1987, LAT AM RES REV, V22, P35; de St Pierre M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051311; Derenko M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032179; Dillehay TD, 2009, P NATL ACAD SCI USA, V106, P971, DOI 10.1073/pnas.0808424106; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Duverger C, 2007, PRIMER MESTIZAJE CLA; Edson S. M., 2004, FORENSIC SCI REV, V16, P64; Endicott P, 2008, AM J HUM GENET, V82, P895, DOI 10.1016/j.ajhg.2008.01.019; Evans S.T., 2001, ARCHAEOLOGY ANCIENT; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fagundes NJR, 2008, AM J HUM GENET, V82, P583, DOI 10.1016/j.ajhg.2007.11.013; Fagundes NJR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003157; FAMSI-LACMA, FDN ADV MES STUD LOS; Finlay EK, 2007, BIOLOGY LETT, V3, P449, DOI 10.1098/rsbl.2007.0146; FU YX, 1993, GENETICS, V133, P693; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Gonzalez-Jose R, 2007, P ROY SOC B-BIOL SCI, V274, P681, DOI 10.1098/rspb.2006.0151; Gorostiza A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044666; Gronau I, 2011, NAT GENET, V43, P1031, DOI 10.1038/ng.937; Guillot EG, 2013, HUM BIOL, V85, P135; Gunnarsdottir ED, 2011, GENOME RES, V21, P1, DOI 10.1101/gr.107615.110; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; Heller R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062992; Henn BM, 2012, P NATL ACAD SCI USA, V109, P17758, DOI 10.1073/pnas.1212380109; Ho SYW, 2011, MOL ECOL RESOUR, V11, P423, DOI 10.1111/j.1755-0998.2011.02988.x; Irwin JA, 2007, FORENSIC SCI INT-GEN, V1, P154, DOI 10.1016/j.fsigen.2007.01.019; Kelly IT, 1980, CERAMIC SEQUENCE COL; Kemp BM, 2007, AM J PHYS ANTHROPOL, V132, P605, DOI 10.1002/ajpa.20543; Kemp BM, 2010, P NATL ACAD SCI USA, V107, P6759, DOI 10.1073/pnas.0905753107; Kennett DJ, 2012, SCIENCE, V338, P788, DOI 10.1126/science.1226299; Kirchhoff P, 1952, MESOAMERICA ITS GEOG; Kirchoff Paul, 1943, ACTA AM, V1, P92; Kitchen A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001596; Kroeber Alfred Louis, 1947, CULTURAL NATURAL ARE; Kumar S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-293; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lippold Sebastian, 2014, Investig Genet, V5, P13, DOI 10.1186/2041-2223-5-13; Lopez-Austin A., 2001, MEXICOS INDIGENOUS; Magiorkinis G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000198; Malhi RS, 2010, AM J PHYS ANTHROPOL, V141, P494, DOI 10.1002/ajpa.21238; Malhi RS, 2002, AM J HUM GENET, V70, P905, DOI 10.1086/339690; Malhi RS, 2001, HUM BIOL, V73, P17, DOI 10.1353/hub.2001.0008; Manzanilla L, 1989, ATLAS HIST MESOAMERI; Martinez-Cortes G, 2013, AM J PHYS ANTHROPOL, V151, P526, DOI 10.1002/ajpa.22293; McGuire RH., 2012, OXFORD HDB MESOAMERI, P513; Melgar Tisoc ER, 2010, RELECTURA COMERCIO T; Miller HC, 2009, TRENDS GENET, V25, P13, DOI 10.1016/j.tig.2008.09.007; Mizuno F, 2014, J HUM GENET, V59, P359, DOI 10.1038/jhg.2014.35; Moreno-Estrada A, 2014, SCIENCE, V344, P1280, DOI 10.1126/science.1251688; Navascues M, 2009, MOL ECOL, V18, P4390, DOI 10.1111/j.1365-294X.2009.04333.x; Neurath J, 2003, PUEBLOS INDIGENAS ME; O'Fallon BD, 2011, P NATL ACAD SCI USA, V108, P20444, DOI 10.1073/pnas.1112563108; O'Rourke DH, 2010, CURR BIOL, V20, pR202, DOI 10.1016/j.cub.2009.11.051; Paez-Riberos L. A., 2006, Legal Medicine, V8, P220, DOI 10.1016/j.legalmed.2006.02.003; Pannell JR, 2003, EVOLUTION, V57, P949; Perego UA, 2010, GENOME RES, V20, P1174, DOI 10.1101/gr.109231.110; Perego UA, 2009, CURR BIOL, V19, P1, DOI 10.1016/j.cub.2008.11.058; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Raff JA, 2014, NATURE, V506, P162, DOI 10.1038/506162a; Ragsdale CS, 2015, AM J PHYS ANTHROPOL, V157, P121, DOI 10.1002/ajpa.22701; Rasmussen M, 2014, NATURE, V506, P225, DOI 10.1038/nature13025; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Reidla M, 2003, AM J HUM GENET, V73, P1178, DOI 10.1086/379380; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Sanders William T., 1968, MESOAMERICA EVOLUTIO; Sandoval K, 2009, HUM GENET, V126, P521, DOI 10.1007/s00439-009-0693-y; Schaefer S., 1996, PEOPLE PEYOTE HUICHO; SHIELDS GF, 1993, AM J HUM GENET, V53, P549; Silva-Zolezzi I, 2009, P NATL ACAD SCI USA, V106, P8611, DOI 10.1073/pnas.0903045106; Smith M. E., 2003, POSTCLASSIC MESOAMER; Smith ME, 2000, CURR ANTHROPOL, V41, P283, DOI 10.1086/300134; Smith MichaelE., 2001, EMPIRES COMP PERSPEC, P128; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Solanes Carraro MC, 2005, ATLAS MEXICO PREHISP; Stiller M, 2010, MOL BIOL EVOL, V27, P975, DOI 10.1093/molbev/msq083; Strimmer K, 2001, MOL BIOL EVOL, V18, P2298, DOI 10.1093/oxfordjournals.molbev.a003776; Subramanian S, 2009, TRENDS GENET, V25, P16, DOI 10.1016/j.tig.2008.11.001; Subramanian S, 2009, MOL BIOL EVOL, V26, P715, DOI 10.1093/molbev/msp005; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Tillmar AO, 2010, INT J LEGAL MED, V124, P91, DOI 10.1007/s00414-009-0354-7; Townsend R., 1998, ANCIENT W MEXICO ART; TRIGGER BG, 1980, AM ANTIQUITY, V45, P662, DOI 10.2307/280140; Voorhies B, 2007, CLIMATE CHANGE CULTU, P157; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Wauchope R, 1964, HDB MIDDLE AM INDIAN; Weaver Muriel Porter, 1993, AZTECS MAYA THEIR PR; West CR, 1989, MIDDLE AM ITS LANDS; Williamson S, 2002, MOL BIOL EVOL, V19, P1376, DOI 10.1093/oxfordjournals.molbev.a004199	104	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0131791	10.1371/journal.pone.0131791	http://dx.doi.org/10.1371/journal.pone.0131791			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26292226	Green Submitted, Green Published, gold			2022-12-26	WOS:000359919900001
J	Hashimoto, Y; Saito, W; Fujiya, A; Yoshizawa, C; Hirooka, K; Mori, S; Noda, K; Ishida, S				Hashimoto, Yuki; Saito, Wataru; Fujiya, Akio; Yoshizawa, Chikako; Hirooka, Kiriko; Mori, Shohei; Noda, Kousuke; Ishida, Susumu			Changes in Inner and Outer Retinal Layer Thicknesses after Vitrectomy for Idiopathic Macular Hole: Implications for Visual Prognosis	PLOS ONE			English	Article							BRILLIANT-BLUE-G; SPECTRAL-DOMAIN OCT; LIMITING MEMBRANE; SEGMENT LENGTH; FOVEAL MICROSTRUCTURE; EPIRETINAL MEMBRANE; SURGERY; ACUITY; INCREASES; DEFECT	Purpose To investigate sequential post-operative thickness changes in inner and outer retinal layers in eyes with an idiopathic macular hole (MH). Methods Retrospective case series. Twenty-four eyes of 23 patients who had received pars plana vitrectomy (PPV) for the closure of MH were included in the study. Spectral domain optical coherence tomography C-scan was used to automatically measure the mean thickness of the inner and outer retinal layers pre-operatively and up to 6 months following surgery. The photoreceptor outer segment (PROS) length was measured manually and was used to assess its relationship with best-corrected visual acuity (BCVA). Results Compared with the pre-operative thickness, the inner layers significantly thinned during follow-up (P = 0.02), particularly in the parafoveal (P = 0.01), but not perifoveal, area. The post-operative inner layer thinning ranged from the ganglion cell layer to the inner plexiform layer (P = 0.002), whereas the nerve fiber layer was unaltered. Outer layer thickness was significantly greater post-operatively (P = 0.002), and especially the PROS lengthened not only in the fovea but also in the parafovea (P < 0.001). Six months after surgery, BCVA was significantly correlated exclusively with the elongated foveal PROS (R = 0.42, P = 0.03), but not with any of the other thickness parameters examined. Conclusions Following PPV for MH, retinal inner layers other than the nerve fiber layer thinned, suggestive of subclinical thickening in the inner layers where no cyst was evident pre-operatively. In contrast, retinal outer layer thickness significantly increased, potentially as a result of PROS elongation linking tightly with favorable visual prognosis in MH eyes.	[Hashimoto, Yuki; Saito, Wataru; Fujiya, Akio; Yoshizawa, Chikako; Hirooka, Kiriko; Mori, Shohei; Noda, Kousuke; Ishida, Susumu] Hokkaido Univ, Grad Sch Med, Dept Ophthalmol, Sapporo, Hokkaido, Japan; [Saito, Wataru; Noda, Kousuke; Ishida, Susumu] Hokkaido Univ, Grad Sch Med, Dept Ocular Circulat & Metab, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Saito, W (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Ophthalmol, Sapporo, Hokkaido, Japan.	wsaito@med.hokudai.ac.jp		Saito, Wataru/0000-0001-8181-6252				Arias L, 2015, RETINA-J RET VIT DIS, V35, P423, DOI 10.1097/IAE.0000000000000335; Baba T, 2012, EYE, V26, P1173, DOI 10.1038/eye.2012.170; Baba T, 2012, OPHTHALMOLOGY, V119, P2609, DOI 10.1016/j.ophtha.2012.06.048; Barak Y, 2011, INVEST OPHTH VIS SCI, V52, P8266, DOI 10.1167/iovs.11-8191; Chan G, 2012, INVEST OPHTH VIS SCI, V53, P5502, DOI 10.1167/iovs.12-10265; Enaida H, 2006, RETINA-J RET VIT DIS, V26, P631, DOI 10.1097/00006982-200607000-00007; Forooghian F, 2010, RETINA-J RET VIT DIS, V30, P63, DOI 10.1097/IAE.0b013e3181bd2c5a; GUYER DR, 1990, OPHTHALMOLOGY, V97, P1045; Hashimoto Y, 2014, ACTA OPHTHALMOL, V92, pe591, DOI 10.1111/aos.12413; Hashimoto Y, 2014, GRAEF ARCH CLIN EXP, V252, P219, DOI 10.1007/s00417-013-2432-2; Iriyama A, 2012, RETINA-J RET VIT DIS, V32, P613, DOI 10.1097/IAE.0b013e31822091df; Itoh Y, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.01.023; Landa G, 2012, EYE, V26, P61, DOI 10.1038/eye.2011.237; Mester V, 2000, AM J OPHTHALMOL, V129, P769, DOI 10.1016/S0002-9394(00)00358-5; Notomi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053338; Notomi S, 2011, AM J PATHOL, V179, P2798, DOI 10.1016/j.ajpath.2011.08.035; Oh J, 2010, INVEST OPHTH VIS SCI, V51, P1651, DOI 10.1167/iovs.09-4420; Ohta K, 2013, GRAEF ARCH CLIN EXP, V251, P1273, DOI 10.1007/s00417-012-2173-7; Ooka E, 2011, AM J OPHTHALMOL, V152, P283, DOI 10.1016/j.ajo.2011.02.001; Park DW, 1999, OPHTHALMOLOGY, V106, P1392, DOI 10.1016/S0161-6420(99)00730-7; Remy M, 2008, BRIT J OPHTHALMOL, V92, P1142, DOI 10.1136/bjo.2008.138164; Shiono A, 2013, OPHTHALMOLOGY, V120, P788, DOI 10.1016/j.ophtha.2012.09.044; Si YJ, 1999, BRIT J OPHTHALMOL, V83, P420, DOI 10.1136/bjo.83.4.420; Toba Y, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/187308; Wakabayashi T, 2010, OPHTHALMOLOGY, V117, P1815, DOI 10.1016/j.ophtha.2010.01.017; Yuksel K, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000182	26	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135925	10.1371/journal.pone.0135925	http://dx.doi.org/10.1371/journal.pone.0135925			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291526	Green Submitted, Green Published, gold			2022-12-26	WOS:000359919900039
J	Jeon, YJ; Jung, N; Park, JW; Park, HY; Jung, SC				Jeon, Yeo Jin; Jung, Namhee; Park, Joo-Won; Park, Hae-Young; Jung, Sung-Chul			Epithelial-Mesenchymal Transition in Kidney Tubular Epithelial Cells Induced by Globotriaosylsphingosine and Globotriaosylceramide	PLOS ONE			English	Article							FABRY-DISEASE; RENAL PATHOLOGY; BIOPSY FINDINGS; FIBROSIS; NEPHROPATHY; FIBROBLASTS; MECHANISMS; DIAGNOSIS; CHILDREN	Fabry disease is a lysosomal storage disorder caused by deficiency of alpha-galactosidase A (alpha-gal A), which results in the deposition of globotriaosylceramide (Gb3) in the vascular endothelium. Globotriaosylsphingosine (lyso-Gb3), a deacylated Gb3, is also increased in the plasma of patients with Fabry disease. Renal fibrosis is a key feature of advanced Fabry disease patients. Therefore, we evaluated the association of Gb3 and lyso-Gb3 accumulation and the epithelial-mesenchymal transition (EMT) on tubular epithelial cells of the kidney. In HK2 cells, exogenous treatments of Gb3 and lyso-Gb3 increased the expression of TGF-beta, EMT markers (N-cadherin and alpha-SMA), and phosphorylation of PI3K/AKT, and decreased the expression of E-cadherin. Lyso-Gb3, rather than Gb3, strongly induced EMT in HK2 cells. In the mouse renal mesangial cell line, SV40 MES 13 cells, Gb3 strongly induced phenotype changes. The EMT induced by Gb3 was inhibited by enzyme a-gal A treatment, but EMT induced by lyso-Gb3 was not abrogated by enzyme treatment. However, TGF-beta receptor inhibitor (TRI, SB525334) inhibited the activation of TGF-beta and EMT markers in HK2 cells with Gb3 and lyso-Gb3 treatments. This study suggested that increased plasma lyso-Gb3 has a crucial role in the development of renal fibrosis through the cell-specific induction of the EMT in Fabry disease, and that TRI treatment, alongside enzyme replacement therapy, could be a potential therapeutic option for patients with Fabry disease.	[Jeon, Yeo Jin; Jung, Namhee; Park, Joo-Won; Park, Hae-Young; Jung, Sung-Chul] Ewha Womans Univ, Sch Med, Dept Biochem, Seoul, South Korea	Ewha Womans University	Jung, SC (corresponding author), Ewha Womans Univ, Sch Med, Dept Biochem, Seoul, South Korea.	jungsc@ewha.ac.kr	Jung, Sung-Chul/I-3277-2019	Jung, Sung-Chul/0000-0002-3174-8965	Ministry of Health and Welfare, Republic of Korea [HI12C0598]	Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by grants from the Health Technology R&D project (HI12C0598) of the Ministry of Health and Welfare, Republic of Korea (SCJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts JM, 2008, P NATL ACAD SCI USA, V105, P2812, DOI 10.1073/pnas.0712309105; Alroy J, 2002, J AM SOC NEPHROL, V13, pS134, DOI 10.1097/01.ASN.0000016684.07368.75; Askari H, 2007, VIRCHOWS ARCH, V451, P823, DOI 10.1007/s00428-007-0468-6; Barbey F, 2006, ARTERIOSCL THROM VAS, V26, P839, DOI 10.1161/01.ATV.0000209649.60409.38; Boutin M, 2012, CLIN CHIM ACTA, V414, P273, DOI 10.1016/j.cca.2012.09.026; BRADY RO, 1967, NEW ENGL J MED, V276, P1163, DOI 10.1056/NEJM196705252762101; Campanholle G, 2013, AM J PHYSIOL-CELL PH, V304, pC591, DOI 10.1152/ajpcell.00414.2012; Du R, 2014, MOL BIOL CELL, V25, P2650, DOI 10.1091/mbc.E14-01-0044; Fogo AB, 2010, NEPHROL DIAL TRANSPL, V25, P2168, DOI 10.1093/ndt/gfp528; Germain DP, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-30; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; ITO M, 1995, J BIOL CHEM, V270, P24370, DOI 10.1074/jbc.270.41.24370; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; KINT J A, 1970, Science (Washington D C), V167, P1268, DOI 10.1126/science.167.3922.1268; Lee MH, 2012, INT J MOL MED, V30, P1275, DOI 10.3892/ijmm.2012.1139; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Najafian B, 2013, PEDIATR NEPHROL, V28, P679, DOI 10.1007/s00467-012-2222-9; Okada H, 2000, KIDNEY INT, V58, P587, DOI 10.1046/j.1523-1755.2000.00205.x; Ortiz A, 2008, NAT CLIN PRACT NEPHR, V4, P327, DOI 10.1038/ncpneph0806; Sanchez-Nino MD, 2011, NEPHROL DIAL TRANSPL, V26, P1797, DOI 10.1093/ndt/gfq306; Terryn W, 2013, NEPHROL DIAL TRANSPL, V28, P505, DOI 10.1093/ndt/gfs526; Thomaidis T, 2009, KIDNEY INT, V75, P399, DOI 10.1038/ki.2008.576; Tondel C, 2008, AM J KIDNEY DIS, V51, P767, DOI 10.1053/j.ajkd.2007.12.032; Valbuena C, 2008, VIRCHOWS ARCH, V453, P329, DOI 10.1007/s00428-008-0653-2; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; van Breemen MJ, 2011, BBA-MOL BASIS DIS, V1812, P70, DOI 10.1016/j.bbadis.2010.09.007; Weidemann F, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-116; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793; Zeng R, 2008, J AM SOC NEPHROL, V19, P380, DOI 10.1681/ASN.2006111194	31	18	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0136442	10.1371/journal.pone.0136442	http://dx.doi.org/10.1371/journal.pone.0136442			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291612	gold, Green Published, Green Submitted			2022-12-26	WOS:000359919900084
J	Billings, E; Sanders-Buell, E; Bose, M; Bradfield, A; Lei, E; Kijak, GH; Arroyo, MA; Kibaya, RM; Scott, PT; Wasunna, MK; Sawe, FK; Shaffer, DN; Birx, DL; McCutchan, FE; Michael, NL; Robb, ML; Kim, JH; Tovanabutra, S				Billings, Erik; Sanders-Buell, Eric; Bose, Meera; Bradfield, Andrea; Lei, Esther; Kijak, Gustavo H.; Arroyo, Miguel A.; Kibaya, Rukia M.; Scott, Paul T.; Wasunna, Monique K.; Sawe, Frederick K.; Shaffer, Douglas N.; Birx, Deborah L.; McCutchan, Francine E.; Michael, Nelson L.; Robb, Merlin L.; Kim, Jerome H.; Tovanabutra, Sodsai			The Number and Complexity of Pure and Recombinant HIV-1 Strains Observed within Incident Infections during the HIV and Malaria Cohort Study Conducted in Kericho, Kenya, from 2003 to 2006	PLOS ONE			English	Article							FEMALE SEX WORKERS; TYPE-1 SUBTYPES; DISEASE PROGRESSION; GENOME SEQUENCES; RAKAI DISTRICT; FOLLOW-UP; CHALLENGES; VACCINE; DIVERSITY; UGANDA	Characterization of HIV-1 subtype diversity in regions where vaccine trials are conducted is critical for vaccine development and testing. This study describes the molecular epidemiology of HIV-1 within a tea-plantation community cohort in Kericho, Kenya. Sixty-three incident infections were ascertained in the HIV and Malaria Cohort Study conducted in Kericho from 2003 to 2006. HIV-1 strains from 58 of those individuals were full genome characterized and compared to two previous Kenyan studies describing 41 prevalent infections from a blood bank survey (1999-2000) and 21 infections from a higher-risk cohort containing a mix of incident and prevalent infections (2006). Among the 58 strains from the community cohort, 43.1% were pure subtypes (36.2% A1, 5.2% C, and 1.7% G) and 56.9% were intersubtype recombinants (29.3% A1D, 8.6% A1CD, 6.9% A1A2D, 5.2% A1C, 3.4% A1A2CD, and 3.4% A2D). This diversity and the resulting genetic distance between the observed strains will need to be addressed when vaccine immunogens are chosen. In consideration of current vaccine development efforts, the strains from these three studies were compared to five candidate vaccines (each of which are viral vectored, carrying inserts corresponding to parts of gag, pol, and envelope), which have been developed for possible use in sub-Saharan Africa. The sequence comparison between the observed strains and the candidate vaccines indicates that in the presence of diverse recombinants, a bivalent vaccine is more likely to provide T-cell epitope coverage than monovalent vaccines even when the inserts of the bivalent vaccine are not subtype-matched to the local epidemic.	[Billings, Erik; Sanders-Buell, Eric; Bose, Meera; Bradfield, Andrea; Lei, Esther; Kijak, Gustavo H.; Scott, Paul T.; McCutchan, Francine E.; Robb, Merlin L.; Tovanabutra, Sodsai] Henry M Jackson Fdn, US Mil HIV Res Program, Rockville, MD 20817 USA; [Arroyo, Miguel A.; Birx, Deborah L.; Michael, Nelson L.] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD USA; [Kibaya, Rukia M.] Kenya Govt Med Res Ctr, Walter Reed Project Clin Res Ctr, Kericho, Kenya; [Wasunna, Monique K.] Kenya Govt Med Res Ctr, Kericho, Kenya; [Wasunna, Monique K.] Kenya Govt Med Res Ctr, Nairobi, Kenya; [Sawe, Frederick K.] Kenya Govt Med Res Ctr, Walter Reed Project HIV Program, Kericho, Kenya; [Shaffer, Douglas N.] Kenya Walter Reed Project HIV Program, US Army Med Res Unit, Kericho, Kenya; [Kim, Jerome H.] Int Vaccine Inst, Seoul, South Korea	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Walter Reed Army Institute of Research (WRAIR); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Kenya Medical Research Institute; Kenya Medical Research Institute; Kenya Medical Research Institute; Kenya Medical Research Institute; International Vaccine Institute	Tovanabutra, S (corresponding author), Henry M Jackson Fdn, US Mil HIV Res Program, Rockville, MD 20817 USA.	stovanabutra@hivresearch.org		Arroyo, Miguel/0000-0001-7416-8867	United States Military HIV Research Program (the Walter Reed Army Institute of Research); United States Military HIV Research Program (Henry M. Jackson Foundation for the Advancement of Military Medicine); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. [DAMD17-98-2-7007, W81XWH-04-2-0005, W81XWH-07-2-0067, W81XWH-11-2-0174]; U.S. Department of Defense (DOD) [DAMD17-98-2-7007, W81XWH-04-2-0005, W81XWH-07-2-0067, W81XWH-11-2-0174]	United States Military HIV Research Program (the Walter Reed Army Institute of Research); United States Military HIV Research Program (Henry M. Jackson Foundation for the Advancement of Military Medicine); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; U.S. Department of Defense (DOD)(United States Department of Defense)	The Walter Reed Army Institute of Research Institutional Research Board human use protocol #855 (RV142), "HIV and Malaria Cohort Study Among Plantation Workers and Adult Dependents in Kericho, Kenya," is funded through the United States Military HIV Research Program (the Walter Reed Army Institute of Research and the Henry M. Jackson Foundation for the Advancement of Military Medicine). This work was supported by cooperative agreements (DAMD17-98-2-7007, W81XWH-04-2-0005, W81XWH-07-2-0067, W81XWH-11-2-0174) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., and the U.S. Department of Defense (DOD).	Arroyo MA, 2004, AIDS RES HUM RETROV, V20, P895, DOI 10.1089/0889222041725235; Arroyo MA, 2009, AIDS RES HUM RETROV, V25, P1061, DOI 10.1089/aid.2009.0092; Baeten JM, 2007, J INFECT DIS, V195, P1177, DOI 10.1086/512682; Barouch DH, 2013, CELL, V155, P531, DOI 10.1016/j.cell.2013.09.061; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; Carr JK, 1998, VIROLOGY, V247, P22, DOI 10.1006/viro.1998.9211; Conroy SA, 2010, AIDS RES HUM RETROV, V26, P1087, DOI 10.1089/aid.2010.0054; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262; Deng WJ, 2010, BIOTECHNIQUES, V48, P405, DOI 10.2144/000113370; Dowling WE, 2002, AIDS, V16, P1809, DOI 10.1097/00002030-200209060-00015; Earl PL, 2009, VACCINE, V27, P5885, DOI 10.1016/j.vaccine.2009.07.039; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Foglia G, 2008, EPIDEMIOL INFECT, V136, P694, DOI 10.1017/S0950268807009028; Foglia G, 2004, J CLIN MICROBIOL, V42, P3850, DOI 10.1128/JCM.42.8.3850-3852.2004; Gaschen B, 2001, BIOINFORMATICS, V17, P415, DOI 10.1093/bioinformatics/17.5.415; Gomez-Carrillo M, 2004, AIDS RES HUM RETROV, V20, P885, DOI 10.1089/0889222041725172; Gouws E, 2012, SEX TRANSM INFECT, V88, pI76, DOI 10.1136/sextrans-2012-050719; Harris ME, 2002, AIDS RES HUM RETROV, V18, P1281, DOI 10.1089/088922202320886325; Kageha S, 2012, AIDS RES HUM RETROV, V28, P228, DOI 10.1089/aid.2011.0089; Kibaya RS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003327; Kijak Gustavo H, 2005, Curr Infect Dis Rep, V7, P480, DOI 10.1007/s11908-005-0051-8; Kiwanuka N, 2008, J INFECT DIS, V197, P707, DOI 10.1086/527416; Korber B, 2001, BRIT MED BULL, V58, P19, DOI 10.1093/bmb/58.1.19; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Merson MH, 2012, HEALTH AFFAIR, V31, P1380, DOI 10.1377/hlthaff.2012.0206; Middelkoop K, 2014, JAIDS-J ACQ IMM DEF, V65, P473, DOI 10.1097/QAI.0000000000000067; NACC, 2014, KEN AIDS RESP PROGR; NACC NASCOP, 2011, KEN AIDS EP UPD; National AIDS and STI Control Programme (NASCOP), 2012, KEN AIDS IND SURV 20; Nyamache AK, 2013, AIDS RES HUM RETROV, V29, P400, DOI [10.1089/AID.2012.0213, 10.1089/aid.2012.0213]; Osman S, 2013, AIDS RES HUM RETROV, V29, P187, DOI [10.1089/aid.2012.0182, 10.1089/AID.2012.0182]; Oyaro M, 2011, AIDS RES HUM RETROV, V27, P257, DOI 10.1089/aid.2010.0061; Rozanov M, 2004, NUCLEIC ACIDS RES, V32, pW654, DOI 10.1093/nar/gkh419; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Schultz AK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-265; Shaffer DN, 2007, JAIDS-J ACQ IMM DEF, V45, P371, DOI 10.1097/QAI.0b013e318095a3da; Shaffer DN, 2010, JAIDS-J ACQ IMM DEF, V53, P514, DOI 10.1097/QAI.0b013e3181bcdae0; Ssemwanga D, 2012, AIDS RES HUM RETROV, V28, P357, DOI [10.1089/aid.2011.0024, 10.1089/AID.2011.0024]; Stephenson KE, 2012, J VIROL, V86, P9583, DOI 10.1128/JVI.00996-12; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thurmond J, 2008, BIOINFORMATICS, V24, P1639, DOI 10.1093/bioinformatics/btn251; Tovanabutra S, 2003, AIDS RES HUM RETROV, V19, P561, DOI 10.1089/088922203322230923; Tovanabutra S, 2010, AIDS RES HUM RETROV, V26, P123, DOI 10.1089/aid.2009.0115; Tully DC, 2010, AIDS, V24, P1577, DOI 10.1097/QAD.0b013e32833999e1; Visawapoka U, 2006, AIDS RES HUM RETROV, V22, P695, DOI 10.1089/aid.2006.22.695	47	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135124	10.1371/journal.pone.0135124	http://dx.doi.org/10.1371/journal.pone.0135124			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287814	Green Published, Green Submitted, gold			2022-12-26	WOS:000360018600036
J	Indira, P; Kumar, PM; Shalini, S; Vaman, K				Indira, Poojary; Kumar, Papanna Mohan; Shalini, Shenoy; Vaman, Kulkarni			Opportunistic Infections among People Living with HIV (PLHIV) with Diabetes Mellitus (DM) Attending a Tertiary Care Hospital in Coastal City of South India	PLOS ONE			English	Article							CLINICAL-DISEASE; PREVALENCE; RESISTANCE; FLUCONAZOLE; ALBICANS	Background HIV/AIDS and Diabetes Mellitus are the diseases' known to supress cell mediated immunity and predispose patients for opportunistic infections. Hence, we conducted a study to compare the common opportunistic infections (OIs) between People Living with HIV with DM (PLHIV-DM) and PLHIV without DM (PLHIV). Methodology PLHIV with DM and without DM (1: 1) were prospectively included in the study from January 2011 to January 2012 at a tertiary care hospital in Mangalore city. Patients were classified as Diabetic if their fasting plasma glucose was >= 7.0mmol/l (126mg/dl) or 2-h plasma glucose was >= 11.1mmol/l (200mg/dl). Standard procedures and techniques were followed for diagnosis of OIs as per WHO guidelines. The data was entered and analyzed using Statistical Package for Social Sciences (SPSS) version 11.5. Findings The study included 37 PLHIV with DM and 37 PLHIV without DM and both groups were treated with Anti-Retroviral Therapy (ART). The median age was 47 years (IQR: 41-55years) for PLHIV-DM as compared to 40 years (IQR: 35-45.5 years) for PLHIV (p<0.0001). PLHIV-DM had median CD4 counts of 245 (IQR: 148-348) cells/mu l compared to 150(IQR: 70-278) cells/mu l for PLHIV (p = 0.02). Common OIs included oral candidiasis (49% of PLHIV-DM and 35% of PLHIV); Cryptococcal meningitis (19% of PLHIV-DMand 16% of PLHIV); Pneumocystis jiroveci pneumonia (5% of PLHIV-DM and 18% of PLHIV); extra pulmonary tuberculosis (22% of PLHIV-DM and 34.5% of PLHIV); and Cerebral toxoplasmosis (11% of PLHIV-DM and 13.5% of PLHIV). Microbiological testing of samples from PLHIV-DM, C krusei was the most common Candida species isolated from 9 out of 18 samples. Out of six pulmonary TB samples cultured, four grew Non-tuberculosis mycobacteria (NTM) and two Mycobacterium tuberculosis complexes. Conclusions Study did not identify any significant difference in profile of opportunistic infections (OIs) between PLHIV with and without Diabetes.	[Indira, Poojary] Apollo Hosp, Dept Microbiol, Madras, Tamil Nadu, India; [Kumar, Papanna Mohan; Vaman, Kulkarni] Manipal Univ, Kasturba Med Coll, Dept Community Med, Mangalore, Karnataka, India; [Shalini, Shenoy] Manipal Univ, Kasturba Med Coll, Dept Microbiol, Mangalore, Karnataka, India	Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Mangalore; Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Mangalore	Indira, P (corresponding author), Apollo Hosp, Dept Microbiol, Madras, Tamil Nadu, India.	poojaryindira02@gmail.com		Kulkarni, Vaman/0000-0002-6518-2277				[Anonymous], 2013, HIV IND PAC UNAIDS R; [Anonymous], DEFINITION DIAGNOSIS; Ayyagari A, 1999, IJMM, V17, P78; Brown TT, 2005, ARCH INTERN MED, V165, P1179, DOI 10.1001/archinte.165.10.1179; Cartledge JD, 1999, J ANTIMICROB CHEMOTH, V43, P419, DOI 10.1093/jac/43.3.419; Census of India, 2011, PROV POP TOT; Fidel PL, 1999, CLIN MICROBIOL REV, V12, P80, DOI 10.1128/CMR.12.1.80; HORSBURGH CR, 1991, NEW ENGL J MED, V324, P1332, DOI 10.1056/NEJM199105093241906; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Kothavade RJ, 2010, J MED MICROBIOL, V59, P873, DOI 10.1099/jmm.0.013227-0; Ministry of Health and Family Welfare New Delhi Department of AIDS Control, 2007, ANT THER GUID HIV IN; Monoharan G, 2001, INDIAN J MED MICROBI, V19, P157; Mulligan K, 2000, J ACQ IMMUN DEF SYND, V23, P35, DOI 10.1097/00042560-200001010-00005; MURRAY JF, 1990, AM REV RESPIR DIS, V141, P1356, DOI 10.1164/ajrccm/141.5_Pt_1.1356; REX JH, 1995, ANTIMICROB AGENTS CH, V39, P1, DOI 10.1128/AAC.39.1.1; Ryan JG., 2010, INSULIN, V5, P37, DOI DOI 10.1016/S1557-0843(10)80008-9; Saldanha D, 2008, TROP DOCT, V38, P172, DOI 10.1258/td.2007.070171; Sharma SK, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-52; Sicree R., 2006, DIABETES ATLAS, P15; SRIYABHAYA N, 1981, REV INFECT DIS, V3, P1085; TAN JS, 1975, J LAB CLIN MED, V85, P26; Udwadia Z F, 2005, J Assoc Physicians India, V53, P437; Vigouroux C, 1999, DIABETES METAB, V25, P383; WHO, TUBERCULOSIS; Yoon C, 2004, J ACQUIR IMMUNE DEFI, V37, P4	25	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136280	10.1371/journal.pone.0136280	http://dx.doi.org/10.1371/journal.pone.0136280			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287949	gold, Green Published, Green Submitted			2022-12-26	WOS:000360018600127
J	Schiop, ST; Al Hassan, M; Sestras, AF; Boscaiu, M; Sestras, RE; Vicente, O				Schiop, Sorin T.; Al Hassan, Mohamad; Sestras, Adriana F.; Boscaiu, Monica; Sestras, Radu E.; Vicente, Oscar			Identification of Salt Stress Biomarkers in Romanian Carpathian Populations of Picea abies (L.) Karst.	PLOS ONE			English	Article							SALICORNIA-EUROPAEA; SALINITY; TOLERANCE; SODIUM; CAROTENOIDS; POTASSIUM; PLANTS; ACCUMULATION; TRANSPORTERS; MECHANISMS	The Norway spruce (Picea abies), the most important tree species in European forests, is relatively sensitive to salt and does not grow in natural saline environments. Yet many trees are actually exposed to salt stress due to the common practice of de-icing of mountain roads in winter, using large amounts of NaCl. To help develop strategies for an appropriate use of reproductive seed material on reforestation sites, ensuring better chances of seedling survival in salt-affected areas, we have studied the responses of young spruce seedlings to salt treatments. The specific aim of the work was to identify the optimal salt stress biomarkers in Picea abies, using as experimental material seedlings obtained by germination of seeds with origin in seven populations from the Romanian Carpathian Mountains. These responses included general, conserved reactions such as the accumulation of ions and different osmolytes in the seedlings needles, reduction in photosynthetic pigments levels, or activation of antioxidant systems. Although changes in the contents of different compounds involved in these reactions can be associated to the degree of stress affecting the plants, we propose that the (decreasing) levels of total phenolics or total carotenoids and the (increasing) levels of Na+ or K+ ions in Picea abies needles, should be considered as the most reliable and useful biomarkers for salt stress in this species. They all show very high correlation with the intensity of salt stress, independently of the genetic background of the seeds parental population, and relatively easy, quantitative assays are available to determine their concentrations, requiring simple equipment and little amount of plant material.	[Schiop, Sorin T.; Sestras, Adriana F.] Univ Agr Sci & Vet Med, Fac Hort, Dept Forestry, Cluj Napoca, Cluj, Romania; [Al Hassan, Mohamad; Vicente, Oscar] Univ Politecn Valencia, CSIC, IBMCP, Valencia, Spain; [Boscaiu, Monica] Univ Politecn Valencia, Mediterranean Agroforestal Inst IAM, Valencia, Spain; [Sestras, Radu E.] Univ Agr Sci & Vet Med, Fac Hort, Dept Hort & Landscaping, Cluj Napoca, Cluj, Romania	University of Agricultural Sciences & Veterinary Medicine Cluj Napoca; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); Universitat Politecnica de Valencia; University of Agricultural Sciences & Veterinary Medicine Cluj Napoca	Schiop, ST (corresponding author), Univ Agr Sci & Vet Med, Fac Hort, Dept Forestry, Cluj Napoca, Cluj, Romania.	sorinschiop@yahoo.com	Al Hassan, Mohamad/E-3097-2017; Sestras, Adriana F./C-1647-2012; SESTRAS, Radu E./C-1563-2012; Boscaiu, Monica/H-7878-2015; Vicente, Oscar/A-3858-2009	Al Hassan, Mohamad/0000-0002-2297-3394; Sestras, Adriana F./0000-0001-5768-4296; SESTRAS, Radu E./0000-0003-3073-1616; Boscaiu, Monica/0000-0002-9691-4223; Vicente, Oscar/0000-0001-5076-3784	European Social Found, Human Resources Development Operational Programme [POSDRU/159/1.5/S/132765]; Erasmus Mundus pre-doctoral scholarship by European Commission (Welcome Consortium)	European Social Found, Human Resources Development Operational Programme; Erasmus Mundus pre-doctoral scholarship by European Commission (Welcome Consortium)	Funding: Sorin Schiop is a PhD student at the University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca. This paper was published under the frame of European Social Found, Human Resources Development Operational Programme 2007-2013, project no. POSDRU/159/1.5/S/132765. Mohamad Al Hassan is a recipient of an Erasmus Mundus pre-doctoral scholarship financed by the European Commission (Welcome Consortium).	Adams E, 2014, J INTEGR PLANT BIOL, V56, P231, DOI 10.1111/jipb.12159; Ashraf M, 2004, PLANT SCI, V166, P3, DOI 10.1016/j.plantsci.2003.10.024; Ashraf M, 2013, PHOTOSYNTHETICA, V51, P163, DOI 10.1007/s11099-013-0021-6; Babu Merlene Ann, 2011, [Журнал стресс-физиологии и биохимии, Zhurnal stress-fiziologii i biokhimii], V7, P87; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Blainski A, 2013, MOLECULES, V18, P6852, DOI 10.3390/molecules18066852; Blomqvist G., 2001, THESIS ROYAL I TECHN; BOGEMANS J, 1989, PLANT SOIL, V113, P3, DOI 10.1007/BF02181915; Budeanu M, 2013, NOT BOT HORTI AGROBO, V41, P593; Cazzonelli CI, 2011, FUNCT PLANT BIOL, V38, P833, DOI 10.1071/FP11192; Chandna R., 2013, SALT STRESS PLANTS, P1; Chen XY, 2011, PLANT CELL PHYSIOL, V52, P909, DOI 10.1093/pcp/pcr043; COGDELL RJ, 1978, PHILOS T ROY SOC B, V284, P569, DOI 10.1098/rstb.1978.0090; DellaPenna D, 1999, PURE APPL CHEM, V71, P2205, DOI 10.1351/pac199971122205; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; European Task Force TG3, 2002, SNOW IC CONTR EUR RO; Farah Adriana, 2006, Braz. J. Plant Physiol., V18, P23, DOI 10.1590/S1677-04202006000100003; FLUCKIGER W, 1981, PLANT SOIL, V63, P527, DOI 10.1007/BF02370056; Forczek ST, 2011, PLANT SOIL ENVIRON, V57, P344, DOI 10.17221/356/2010-PSE; Ghassemi F., 1995, SALINISATION LAND WA; Gierth M, 2007, FEBS LETT, V581, P2348, DOI 10.1016/j.febslet.2007.03.035; GREENWAY H, 1980, ANNU REV PLANT PHYS, V31, P149, DOI 10.1146/annurev.pp.31.060180.001053; Gupta B, 2014, INT J GENOMICS, V2014, DOI 10.1155/2014/701596; Han HP, 2008, BIOTECHNOL LETT, V30, P1501, DOI 10.1007/s10529-008-9705-6; Hauser F, 2010, PLANT CELL ENVIRON, V33, P552, DOI 10.1111/j.1365-3040.2009.02056.x; Hussain M, 2013, INT J AGRIC BIOL, V15, P113; Hussain T. M., 2008, Biotechnology and Molecular Biology Reviews, V3, P008; Jansson G., 2013, FOREST TREE BREEDING, P123; Jesus J, 2014, CLIM 2014 4 C NAC AL; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Jouyban Z., 2012, Technical Journal of Engineering and Applied Sciences, V2, P7; Kim SH, 2012, PHYTOCHEMISTRY, V74, P69, DOI 10.1016/j.phytochem.2011.11.003; Konijnendijk C. C., 2005, URBAN FORESTS TREES, DOI DOI 10.1007/3-540-27684-X_9; Kotuby-Amacher J, 2000, PUBLICATION UTAH STA; Larcher W., 2001, PHYSL PLANT ECOLOGY; Lauchli A., 2007, ADV MOL BREEDING DRO, P1, DOI DOI 10.1007/978-1-4020-5578-2_1; Lichtenthaler H., 1983, BIOCHEM SOC T, V11, P591, DOI [10.1042/bst0110591, 10.1042/BST0110591, DOI 10.1042/BST0110591]; Maynard DG, 1997, CAN J SOIL SCI, V77, P99, DOI 10.4141/S96-048; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; Pareek A, 2010, ABIOTIC STRESS ADAPTATION IN PLANTS: PHYSIOLOGICAL, MOLECULAR AND GENOMIC FOUNDATION, P1, DOI 10.1007/978-90-481-3112-9; Parida AK, 2004, AQUAT BOT, V80, P77, DOI 10.1016/j.aquabot.2004.07.005; Parvaiz A, 2008, PLANT SOIL ENVIRON, V54, P89, DOI 10.17221/2774-PSE; Raherison E, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-434; Renault S, 2005, CAN J FOREST RES, V35, P2806, DOI 10.1139/X05-194; Rodriguez-Navarro A, 2006, J EXP BOT, V57, P1149, DOI 10.1093/jxb/erj068; Sabbagh E, 2014, INT J FARM ALLI SCI, V3, P988; Saha P, 2010, INDIAN J EXP BIOL, V48, P593; Sai Kachout S, 2013, NOT BOT HORTI AGROBO, V41, P115; Sairam RK, 2002, PLANT SCI, V163, P1037, DOI 10.1016/S0168-9452(02)00278-9; Schofield RV, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001935; Shabala S, 2008, PHYSIOL PLANTARUM, V133, P651, DOI 10.1111/j.1399-3054.2007.01008.x; Sudhir P, 2004, PHOTOSYNTHETICA, V42, P481, DOI 10.1007/S11099-005-0001-6; Varallyay G, 2010, AGRON RES, V8, P385; Volkov V, 2004, PLANT CELL ENVIRON, V27, P1, DOI 10.1046/j.0016-8025.2003.01116.x; Wakiewicz A., 2013, ECOPHYSIOLOGY RESPON, P283, DOI DOI 10.1007/978-1-4614-4747-4_11; Webber J, 2011, PATHOLOGY ADVISORY N, V11, P1; WEIMBERG R, 1987, PHYSIOL PLANTARUM, V70, P381, DOI 10.1111/j.1399-3054.1987.tb02832.x; Yadav S, 2011, J ENVIRON BIOL, V32, P667; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	62	24	26	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135419	10.1371/journal.pone.0135419	http://dx.doi.org/10.1371/journal.pone.0135419			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26287687	Green Published, gold			2022-12-26	WOS:000360018600049
J	Alcaraz, A; Mrowiec, A; Insausti, CL; Bernabe-Garcia, A; Garcia-Vizcaino, EM; Lopez-Martinez, MC; Monfort, A; Izeta, A; Moraleda, JM; Castellanos, G; Nicolas, FJ				Alcaraz, Antonia; Mrowiec, Anna; Luisa Insausti, Carmen; Bernabe-Garcia, Angel; Maria Garcia-Vizcaino, Eva; Concepcion Lopez-Martinez, Maria; Monfort, Asuncion; Izeta, Ander; Maria Moraleda, Jose; Castellanos, Gregorio; Jose Nicolas, Francisco			Amniotic Membrane Modifies the Genetic Program Induced by TGF beta, Stimulating Keratinocyte Proliferation and Migration in Chronic Wounds	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; EPITHELIAL-CELL MIGRATION; N-TERMINAL KINASE; TRANSFORMING GROWTH-FACTOR-BETA-1; DOWN-REGULATION; C-JUN; MESENCHYMAL TRANSITION; CONDITIONED MEDIUM; CANCER CELLS; MAP KINASE	Background Post-traumatic large-surface or deep wounds often cannot progress to reepithelialisation because they become irresponsive in the inflammatory stage, so intervention is necessary to provide the final sealing epidermis. Previously we have shown that Amniotic Membrane (AM) induced a robust epithelialisation in deep traumatic wounds. Methods and Findings To better understand this phenomenon, we used keratinocytes to investigate the effect of AM on chronic wounds. Using keratinocytes, we saw that AM treatment is able to exert an attenuating effect upon Smad2 and Smad3 TGF beta-induced phosphorylation while triggering the activation of several MAPK signalling pathways, including ERK and JNK1, 2. This also has a consequence for TGF beta-induced regulation on cell cycle control key players CDK1A (p21) and CDK2B (p15). The study of a wider set of TGF beta regulated genes showed that the effect of AM was not wide but very concrete for some genes. TGF beta exerted a powerful cell cycle arrest; the presence of AM however prevented TGF beta-induced cell cycle arrest. Moreover, AM induced a powerful cell migration response that correlates well with the expression of c-Jun protein at the border of the healing assay. Consistently, the treatment with AM of human chronic wounds induced a robust expression of c-Jun at the wound border. Conclusions The effect of AM on the modulation of TGF beta responses in keratinocytes that favours proliferation together with AM-induced keratinocyte migration is the perfect match that allows chronic wounds to move on from their non-healing state and progress into epithelialization. Our results may explain why the application of AM on chronic wounds is able to promote epithelialisation.	[Alcaraz, Antonia; Mrowiec, Anna; Bernabe-Garcia, Angel; Maria Garcia-Vizcaino, Eva; Concepcion Lopez-Martinez, Maria; Jose Nicolas, Francisco] Hosp Univ Virgen de la Arrixaca, Oncol Mol, Murcia, Spain; [Alcaraz, Antonia; Mrowiec, Anna; Bernabe-Garcia, Angel; Maria Garcia-Vizcaino, Eva; Concepcion Lopez-Martinez, Maria; Jose Nicolas, Francisco] Hosp Univ Virgen de la Arrixaca, TGFSS, Unidad Invest, Murcia, Spain; [Luisa Insausti, Carmen; Maria Moraleda, Jose] Hosp Clin Univ Virgen de la Arrixaca, Unidad Terapia Celular, Murcia, Spain; [Monfort, Asuncion; Izeta, Ander] Hosp Univ Donostia, Inst Biodonostia, San Sebastian, Spain; [Castellanos, Gregorio] Hosp Univ Virgen de la Arrixaca, Serv Cirugia, Murcia, Spain	Hospital Clinico Universitario Virgen de la Arrixaca; Hospital Clinico Universitario Virgen de la Arrixaca; Hospital Clinico Universitario Virgen de la Arrixaca; Instituto de Investigacion Sanitaria Biodonostia; Hospital Clinico Universitario Virgen de la Arrixaca	Nicolas, FJ (corresponding author), Hosp Univ Virgen de la Arrixaca, Oncol Mol, Murcia, Spain.	franciscoj.nicolas2@carm.es	Bernabé-García, Ángel/AAB-2934-2020; Moraleda, José María/AAB-4119-2020; Izeta, Ander/H-6376-2011; Nicolás, Francisco José/H-9422-2019; Izeta, Ander/ABG-8973-2020	Bernabé-García, Ángel/0000-0002-2266-5949; Nicolás, Francisco José/0000-0002-3969-1430; Izeta, Ander/0000-0003-1879-7401; Mrowiec, Anna/0000-0001-8745-5494	Fundacion Seneca de la Region de Murcia; Instituto de Salud Carlos III/Fondo de Investigaciones Sanitarias; Ministerio de Competitividad e Innovacion; Hospital Clinico Universitario Virgen de la Arrixaca; Spanish Ministry of Science and Innovation; Ramon y Cajal program of the Spanish Ministry for Education and Science; Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia	Fundacion Seneca de la Region de Murcia(Fundacion Seneca); Instituto de Salud Carlos III/Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Ministerio de Competitividad e Innovacion; Hospital Clinico Universitario Virgen de la Arrixaca; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ramon y Cajal program of the Spanish Ministry for Education and Science(German Research Foundation (DFG)); Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia	Fundacion Seneca de la Region de Murcia: http://fseneca.es/, Instituto de Salud Carlos III/Fondo de Investigaciones Sanitarias http://www.isciii.es/, Ministerio de Competitividad e Innovacion: http://www.mineco.gob.es, Hospital Clinico Universitario Virgen de la Arrixaca: http://arrinet.carm.es/index.htm. EMGV was the recipient of a fellowship from Fundacion Seneca de la Region de Murcia. AA was the recipient of a fellowship of the Spanish Ministry of Science and Innovation. FJN was supported by the Ramon y Cajal program of the Spanish Ministry for Education and Science and the Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alio JL, 2005, EXPERT REV MED DEVIC, V2, P153, DOI 10.1586/17434440.2.2.153; Altan ZM, 2004, BIOCHEM BIOPH RES CO, V322, P56, DOI 10.1016/j.bbrc.2004.07.079; Andreasen PA, 2000, CELL MOL LIFE SCI, V57, P25, DOI 10.1007/s000180050497; Angel P, 2001, ONCOGENE, V20, P2413, DOI 10.1038/sj.onc.1204380; Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Ashcroft GS, 2000, CYTOKINE GROWTH F R, V11, P125, DOI 10.1016/S1359-6101(99)00036-2; Baskovich B, 2008, INT WOUND J, V5, P543, DOI 10.1111/j.1742-481X.2007.00422.x; Bello YM, 2000, JAMA-J AM MED ASSOC, V283, P716, DOI 10.1001/jama.283.6.716; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Cargnoni A, 2014, CYTOTHERAPY, V16, P17, DOI 10.1016/j.jcyt.2013.07.002; Cargnoni A, 2012, CYTOTHERAPY, V14, P153, DOI 10.3109/14653249.2011.613930; Cargnoni A, 2009, CELL TRANSPLANT, V18, P405, DOI 10.3727/096368909788809857; Chan T, 2002, WOUND REPAIR REGEN, V10, P177, DOI 10.1046/j.1524-475X.2002.11101.x; COOPER DM, 1994, ANN SURG, V219, P688, DOI 10.1097/00000658-199406000-00012; Czekay Ralf-Peter, 2011, Int J Cell Biol, V2011, P562481, DOI 10.1155/2011/562481; DEMETRIOU M, 1995, J CELL BIOL, V130, P383, DOI 10.1083/jcb.130.2.383; DIMILLA PA, 1993, J CELL BIOL, V122, P729, DOI 10.1083/jcb.122.3.729; Ferguson MWJ, 2004, PHILOS T R SOC B, V359, P839, DOI 10.1098/rstb.2004.1475; Fernandes M, 2005, CORNEA, V24, P643, DOI 10.1097/01.ico.0000151501.80952.c5; Finnson KW, 2013, ADV WOUND CARE, V2, P195, DOI 10.1089/wound.2013.0429; Fitsialos G, 2007, J BIOL CHEM, V282, P15090, DOI 10.1074/jbc.M606094200; Gangnuss S, 2004, J INVEST DERMATOL, V122, P791, DOI 10.1111/j.0022-202X.2004.22319.x; Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783; Heldin CH, 2012, CELL TISSUE RES, V347, P21, DOI 10.1007/s00441-011-1190-x; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Hodge A, 2014, CYTOTHERAPY, V16, P1132, DOI 10.1016/j.jcyt.2014.01.005; Hong HJ, 2008, BIOMATERIALS, V29, P4831, DOI 10.1016/j.biomaterials.2008.08.023; Hu Y, 2013, CARCINOGENESIS, V34, P1764, DOI 10.1093/carcin/bgt132; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Hudson LG, 2009, J DERMATOL SCI, V56, P19, DOI 10.1016/j.jdermsci.2009.06.009; Insausti CL, 2010, WOUND REPAIR REGEN, V18, P368, DOI 10.1111/j.1524-475X.2010.00604.x; Insausti CL, 2010, HISTOL HISTOPATHOL, V25, P91, DOI 10.14670/HH-25.91; Kang JS, 2009, TRENDS CELL BIOL, V19, P385, DOI 10.1016/j.tcb.2009.05.008; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Koizumi N, 2000, CURR EYE RES, V20, P173, DOI 10.1076/0271-3683(200003)20:3;1-9;FT173; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lee MH, 2009, FASEB J, V23, P3874, DOI 10.1096/fj.08-117804; Lee SH, 1997, AM J OPHTHALMOL, V123, P303, DOI 10.1016/S0002-9394(14)70125-4; Levy L, 2005, MOL CELL BIOL, V25, P8108, DOI 10.1128/MCB.25.18.8108-8125.2005; Li GC, 2003, DEV CELL, V4, P865, DOI 10.1016/S1534-5807(03)00159-X; Maas-Szabowski N, 2003, J CELL SCI, V116, P2937, DOI 10.1242/jcs.00474; Martinez-Mora C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042271; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; McInroy L, 2007, BIOCHEM BIOPH RES CO, V360, P109, DOI 10.1016/j.bbrc.2007.06.036; Menke NB, 2007, CLIN DERMATOL, V25, P19, DOI 10.1016/j.clindermatol.2006.12.005; Mermet I, 2007, WOUND REPAIR REGEN, V15, P459, DOI 10.1111/j.1524-475X.2007.00252.x; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Mu YB, 2012, CELL TISSUE RES, V347, P11, DOI 10.1007/s00441-011-1201-y; Nicolas FJ, 2003, ONCOGENE, V22, P3698, DOI 10.1038/sj.onc.1206420; Nicolas FJ, 2003, J BIOL CHEM, V278, P3251, DOI 10.1074/jbc.M209019200; Parolini O, 2008, STEM CELLS, V26, P300, DOI 10.1634/stemcells.2007-0594; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Philipp K, 2004, INT J MOL MED, V14, P589; Pontillo CA, 2011, TOXICOL SCI, V120, P284, DOI 10.1093/toxsci/kfq390; Providence KM, 2004, J CELL PHYSIOL, V200, P297, DOI 10.1002/jcp.20016; Rahimi N, 1998, J BIOL CHEM, V273, P33714, DOI 10.1074/jbc.273.50.33714; Ridgway PF, 2005, WOUND REPAIR REGEN, V13, P158, DOI 10.1111/j.1067-1927.2005.130206.x; RiesgoEscovar JR, 1996, GENE DEV, V10, P2759, DOI 10.1101/gad.10.21.2759; Ronai Z, 2004, MOL CELL, V15, P843, DOI 10.1016/j.molcel.2004.09.011; Ruiz-Canada C, AMNIOTIC MEMBR UNPUB; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Saika S, 2004, INVEST OPHTH VIS SCI, V45, P100, DOI 10.1167/iovs.03-0700; Sant'Anna LB, 2011, CELL TRANSPLANT, V20, P441, DOI 10.3727/096368910X522252; Santoro MM, 2005, EXP CELL RES, V304, P274, DOI 10.1016/j.yexcr.2004.10.033; Savagner P, 2005, J CELL PHYSIOL, V202, P858, DOI 10.1002/jcp.20188; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Singh Rita, 2004, Cell and Tissue Banking, V5, P129, DOI 10.1023/B:CATB.0000034077.05000.29; Singha PK, 2010, CANCER RES, V70, P6377, DOI 10.1158/0008-5472.CAN-10-1180; Soncini M, 2006, J REPRODUKTIONSMED E, V3; Stupack DG, 2000, IMMUNOL RES, V21, P83, DOI 10.1385/IR:21:2-3:83; Tredget EB, 2005, WOUND REPAIR REGEN, V13, P61, DOI 10.1111/j.1067-1927.2005.130108.x; Trengove NJ, 1999, WOUND REPAIR REGEN, V7, P442, DOI 10.1046/j.1524-475X.1999.00442.x; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Webb Donna J., 2004, V294, P3; Yan XH, 2009, ACTA BIOCH BIOPH SIN, V41, P263, DOI 10.1093/abbs/gmp018; Yang LJ, 2001, AM J PATHOL, V159, P2147, DOI 10.1016/S0002-9440(10)63066-0; Yates S, 2002, WOUND REPAIR REGEN, V10, P5, DOI 10.1046/j.1524-475X.2002.10902.x; Yoneda N, 2013, J DENT RES, V92, P716, DOI 10.1177/0022034513491575; ZAMBRUNO G, 1995, J CELL BIOL, V129, P853, DOI 10.1083/jcb.129.3.853; Zhang N, 2010, CANCER SCI, V101, P2375, DOI 10.1111/j.1349-7006.2010.01680.x; Zou YL, 2003, J BIOL CHEM, V278, P49573, DOI 10.1074/jbc.M307556200	81	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135324	10.1371/journal.pone.0135324	http://dx.doi.org/10.1371/journal.pone.0135324			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284363	Green Published, gold			2022-12-26	WOS:000359666100032
J	Ganapathi, L; Van Haren, S; Dowling, DJ; Bergelson, I; Shukla, NM; Malladi, SS; Balakrishna, R; Tanji, H; Ohto, U; Shimizu, T; David, SA; Levy, O				Ganapathi, Lakshmi; Van Haren, Simon; Dowling, David J.; Bergelson, Ilana; Shukla, Nikunj M.; Malladi, Subbalakshmi S.; Balakrishna, Rajalakshmi; Tanji, Hiromi; Ohto, Umeharu; Shimizu, Toshiyuki; David, Sunil A.; Levy, Ofer			The Imidazoquinoline Toll-Like Receptor-7/8 Agonist Hybrid-2 Potently Induces Cytokine Production by Human Newborn and Adult Leukocytes	PLOS ONE			English	Article							INNATE IMMUNITY; EARLY-LIFE; VACCINE ADJUVANTS; RESPONSES; INFECTION; IMMUNIZATION; MECHANISMS; CHALLENGES; SURVIVAL; DISTINCT	Background Newborns and young infants are at higher risk for infections than adults, and manifest sub-optimal vaccine responses, motivating a search for novel immunomodulators and/or vaccine adjuvants effective in early life. In contrast to most TLR agonists (TLRA), TLR8 agonists such as imidazoquinolines (IMQs) induce adult-level Th1-polarizing cytokine production from human neonatal cord blood monocytes and are candidate early life adjuvants. We assessed whether TLR8-activating IMQ congeners may differ in potency and efficacy in inducing neonatal cytokine production in vitro, comparing the novel TLR7/8-activating IMQ analogues Hybrid-2, Meta-amine, and Para-amine to the benchmark IMQ resiquimod (R848). Methods TLRA-induced NF-kappa B activation was measured in TLR-transfected HEK cells. Cytokine production in human newborn cord and adult peripheral blood and in monocyte-derived dendritic cell cultures were measured by ELISA and multiplex assays. X-ray crystallography characterized the interaction of human TLR8 with Hybrid-2. Results Hybrid-2 selectively activated both TLR7 and 8 and was more potent than R848 in inducing adult-like levels of TNF-alpha, and IL-1 beta. Consistent with its relatively high in vitro activity, crystallographic studies suggest that absence in Hybrid-2 of an ether oxygen of the C2-ethoxy-methyl substituent, which can engage in unfavorable electrostatic and/or dipolar interactions with the carbonyl oxygen of Gly572 in human TLR8, may confer greater efficacy and potency compared to R848. Conclusions Hybrid-2 is a selective and potent TLR7/8 agonist that is a candidate adjuvant for early life immunization.	[Ganapathi, Lakshmi; Van Haren, Simon; Dowling, David J.; Bergelson, Ilana; Levy, Ofer] Boston Childrens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Ganapathi, Lakshmi; Van Haren, Simon; Dowling, David J.; Levy, Ofer] Harvard Univ, Sch Med, Boston, MA USA; [Shukla, Nikunj M.; Malladi, Subbalakshmi S.; Balakrishna, Rajalakshmi; David, Sunil A.] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA; [Tanji, Hiromi; Ohto, Umeharu; Shimizu, Toshiyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Kansas; University of Tokyo	Levy, O (corresponding author), Boston Childrens Hosp, Div Infect Dis, Boston, MA 02115 USA.	ofer.levy@childrens.harvard.edu	van Haren, Simon/K-7066-2019	van Haren, Simon/0000-0002-1791-0161; Dowling, David/0000-0003-1095-6156; Levy, Ofer/0000-0002-5859-1945	U.S. National Institutes of Health (NIH) grant [1R01AI100135-01]; NIH Adjuvant Discovery Contract [HHSN272201400052C]; Bill & Melinda Gates Foundation [OPPGH5284, OPP1035192]; VentiRx Pharmaceuticals; 3M Drug Delivery Systems; Shire; MedImmune; Crucell (Johnson Johnson); Grants-in-Aid for Scientific Research [15K14471, 26711002] Funding Source: KAKEN; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100135] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Adjuvant Discovery Contract; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); VentiRx Pharmaceuticals; 3M Drug Delivery Systems(3M); Shire; MedImmune(AstraZenecaMedimmune); Crucell (Johnson Johnson); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	OL's laboratory is supported by U.S. National Institutes of Health (NIH) grant 1R01AI100135-01, Administrative Supplement (PA14-027), and an NIH Adjuvant Discovery Contract (HHSN272201400052C), as well as Global Health (OPPGH5284) and Grand Challenges Explorations (OPP1035192) awards from the Bill & Melinda Gates Foundation. The Levy Laboratory has received sponsored research support from VentiRx Pharmaceuticals, 3M Drug Delivery Systems, MedImmune, Crucell (Johnson & Johnson) and Shire. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. In addition, funding that the authors' laboratory receives from commercial sources is not directly related to this study.	Aryan Z, 2014, INT ARCH ALLERGY IMM, V164, P46, DOI 10.1159/000362553; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Coombs MRP, 2011, EXPERT REV ANTI-INFE, V9, P261, DOI [10.1586/eri.10.158, 10.1586/ERI.10.158]; Cuenca AG, 2013, AM J PERINAT, V30, P105, DOI 10.1055/s-0032-1333412; Dasari P, 2011, PEDIAT ALLERG IMM-UK, V22, P221, DOI 10.1111/j.1399-3038.2010.01091.x; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Dowling DJ, 2014, TRENDS IMMUNOL, V35, P299, DOI 10.1016/j.it.2014.04.007; Dowling DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058164; Duthie MS, 2011, IMMUNOL REV, V239, P178, DOI 10.1111/j.1600-065X.2010.00978.x; Elahi S, 2013, NATURE, V504, P158, DOI 10.1038/nature12675; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gay NJ, 2014, NAT REV IMMUNOL, V14, P546, DOI 10.1038/nri3713; Govindaraj RG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025118; Kaczanowska S, 2013, J LEUKOCYTE BIOL, V93, P847, DOI 10.1189/jlb.1012501; Kokatla HP, 2013, J MED CHEM, V56, P6871, DOI 10.1021/jm400694d; Kollmann TR, 2012, IMMUNITY, V37, P771, DOI 10.1016/j.immuni.2012.10.014; Kollmann TR, 2009, J IMMUNOL, V183, P7150, DOI 10.4049/jimmunol.0901481; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2012, HEALTH POLICY PLANN, V27, P6, DOI 10.1093/heapol/czs053; Levy O, 2004, J IMMUNOL, V173, P4627, DOI 10.4049/jimmunol.173.7.4627; Levy O, 2006, J IMMUNOL, V177, P1956, DOI 10.4049/jimmunol.177.3.1956; Levy O, 2013, VACCINE, V31, P2500, DOI 10.1016/j.vaccine.2012.10.016; Luiza-Silva M, 2011, J INFECT DIS, V204, P873, DOI 10.1093/infdis/jir439; Mifsud EJ, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00079; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettengill MA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00457; Philbin VJ, 2012, J ALLERGY CLIN IMMUN, V130, P195, DOI 10.1016/j.jaci.2012.02.042; Philbin VJ, 2005, IMMUNOLOGY, V114, P507, DOI 10.1111/j.1365-2567.2005.02125.x; PrabhuDas M, 2011, NAT IMMUNOL, V12, P189, DOI 10.1038/ni0311-189; Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Shukla NM, 2010, BIOORG MED CHEM LETT, V20, P6384, DOI 10.1016/j.bmcl.2010.09.093; Shukla NM, 2010, J MED CHEM, V53, P4450, DOI 10.1021/jm100358c; Siegrist CA, 2007, J COMP PATHOL, V137, pS4, DOI 10.1016/j.jcpa.2007.04.004; Spruance SL, 2001, J INFECT DIS, V184, P196, DOI 10.1086/322007; Tanji H, 2013, SCIENCE, V339, P1426, DOI 10.1126/science.1229159; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; van den Biggelaar AHJ, 2013, VACCINE, V31, P2525, DOI 10.1016/j.vaccine.2012.06.019; Wille-Reece U, 2006, J EXP MED, V203, P1249, DOI 10.1084/jem.20052433; Yoo E, 2014, J MED CHEM, V57, P7955, DOI 10.1021/jm500744f	45	32	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0134640	10.1371/journal.pone.0134640	http://dx.doi.org/10.1371/journal.pone.0134640			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26274907	Green Submitted, Green Published, gold			2022-12-26	WOS:000359493600037
J	Tsaktanis, T; Kremling, H; Pavslc, M; von Stackelberg, R; Mack, B; Fukumori, A; Steiner, H; Vielmuth, F; Spindler, V; Huang, Z; Jakubowski, J; Stoecklein, NH; Luxenburger, E; Lauber, K; Lenarcic, B; Gires, O				Tsaktanis, Thanos; Kremling, Heidi; Pavslc, Miha; von Stackelberg, Ricarda; Mack, Brigitte; Fukumori, Akio; Steiner, Harald; Vielmuth, Franziska; Spindler, Volker; Huang, Zhe; Jakubowski, Jasmine; Stoecklein, Nikolas H.; Luxenburger, Elke; Lauber, Kirsten; Lenarcic, Brigita; Gires, Olivier			Cleavage and Cell Adhesion Properties of Human Epithelial Cell Adhesion Molecule (HEPCAM)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATED INTRAMEMBRANE PROTEOLYSIS; AMYLOID PRECURSOR PROTEIN; ATOMIC-FORCE MICROSCOPY; EP-CAM; ANTIGEN EPCAM; MESENCHYMAL TRANSITION; COLORECTAL-CARCINOMA; STRUCTURE PREDICTION; GAMMA-SECRETASE; TIGHT JUNCTION	Human epithelial cell adhesion molecule (HEPCAM) is a tumor-associated antigen frequently expressed in carcinomas, which promotes proliferation after regulated intramembrane proteolysis. Here, we describe extracellular shedding of HEPCAM at two alpha-sites through a disintegrin and metalloprotease (ADAM) and at one beta-site through BACE1. Transmembrane cleavage by gamma-secretase occurs at three gamma-sites to generate extracellular A beta-like fragments and at two epsilon-sites to release human EPCAM intracellular domain HEPICD, which is efficiently degraded by the proteasome. Mapping of cleavage sites onto three-dimensional structures of HEPEX cis-dimer predicted conditional availability of alpha- and beta-sites. Endocytosis of HEPCAM warrants acidification in cytoplasmic vesicles to dissociate protein cis-dimers required for cleavage by BACE1 at low pH values. Intramembrane cleavage sites are accessible and not part of the structurally important transmembrane helix dimer crossing region. Surprisingly, neither chemical inhibition of cleavage nor cellular knock-out of HEPCAM using CRISPR-Cas9 technology impacted the adhesion of carcinoma cell lines. Hence, a direct function of HEPCAM as an adhesion molecule in carcinoma cells is not supported and appears to be questionable.	[Tsaktanis, Thanos; Kremling, Heidi; Pavslc, Miha; von Stackelberg, Ricarda; Huang, Zhe; Jakubowski, Jasmine; Luxenburger, Elke; Gires, Olivier] Univ Munich, Grosshadern Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Marchioninistr 15, D-81377 Munich, Germany; [Steiner, Harald] Univ Munich, Biomed Ctr, Biochem, D-81377 Munich, Germany; [Spindler, Volker] Univ Munich, Inst Anat & Cell Biol, Dept 1, D-81377 Munich, Germany; [Lauber, Kirsten] Univ Munich, Clin Radiotherapy & Radiat Oncol, D-81377 Munich, Germany; [Lauber, Kirsten] Univ Munich, Clin Cooperat Grp Personalized Radiotherapy Head, D-81377 Munich, Germany; [Lenarcic, Brigita] Univ Ljubljana, Fac Chem & Chem Technol, Dept Chem & Biochem, SI-511000 Ljubljana, Slovenia; [Fukumori, Akio; Steiner, Harald] DZNE German Ctr Neurodegenerat Dis, D-81377 Munich, Germany; [Jakubowski, Jasmine] Univ Munich, AMGEN Scholars Programme, LMU Bioctr, Munich Ctr Neurosci, D-82152 Martinsried, Germany; [Stoecklein, Nikolas H.] Univ Dusseldorf, Univ Hosp, Dept Gen Visceral & Pediat Surg, D-40225 Dusseldorf, Germany; [Stoecklein, Nikolas H.] Univ Dusseldorf, Fac Med, D-40225 Dusseldorf, Germany	University of Munich; University of Munich; University of Munich; University of Munich; University of Munich; University of Ljubljana; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Gires, O (corresponding author), Univ Munich, Grosshadern Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Marchioninistr 15, D-81377 Munich, Germany.	Olivier.gires@med.uni-muenchen.de	Gires, Olivier/V-2689-2017; Spindler, Volker/G-1704-2019; Vielmuth, Franziska/AGF-7873-2022; Pavšič, Miha/AAZ-4772-2020	Gires, Olivier/0000-0002-2292-7064; Spindler, Volker/0000-0002-1302-5421; Pavšič, Miha/0000-0002-2230-1758; Lenarcic, Brigita/0000-0002-2508-3776	Wilhelm-Sander-Stiftung [2009.083.1]; Deutsche Krebshilfe Grant [109080]; AMGEN Scholar Program; FoFoLe Program of the Ludwig-Maximilians-Universitat Munchen	Wilhelm-Sander-Stiftung; Deutsche Krebshilfe Grant(Deutsche Krebshilfe); AMGEN Scholar Program; FoFoLe Program of the Ludwig-Maximilians-Universitat Munchen	This work was supported by Wilhelm-Sander-Stiftung Grant 2009.083.1, Deutsche Krebshilfe Grant 109080, the AMGEN Scholar Program, and the FoFoLe Program of the Ludwig-Maximilians-Universitat Munchen. The authors declare that they have no conflicts of interest with the contents of this article.	AKESON AL, 1993, J IMMUNOL METHODS, V163, P181, DOI 10.1016/0022-1759(93)90121-M; Baeuerle PA, 2007, BRIT J CANCER, V96, P417, DOI 10.1038/sj.bjc.6603494; Balzar M, 1999, J MOL MED, V77, P699, DOI 10.1007/s001099900038; Blazar M, 2001, MOL CELL BIOL, V21, P2570, DOI 10.1128/MCB.21.7.2570-2580.2001; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Chaves-Perez A, 2013, ONCOGENE, V32, P641, DOI 10.1038/onc.2012.75; Cole SL, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-22; Doedens JR, 2003, BIOCHEM BIOPH RES CO, V308, P331, DOI 10.1016/S0006-291X(03)01381-0; Dolle L, 2015, AM J PHYSIOL-GASTR L, V308, pG233, DOI 10.1152/ajpgi.00069.2014; Driemel C, 2014, ONCOGENE, V33, P4904, DOI 10.1038/onc.2013.441; Gires O, 2014, CELL MOL LIFE SCI, V71, P4393, DOI 10.1007/s00018-014-1693-1; Gonzalez B, 2009, STEM CELLS, V27, P1782, DOI 10.1002/stem.97; Gorges TM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-178; Guerra E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049302; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Hachmeister M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071836; HERLYN D, 1979, EUR J IMMUNOL, V9, P657, DOI 10.1002/eji.1830090817; Hinterdorfer P, 2006, NAT METHODS, V3, P347, DOI 10.1038/NMETH871; Imrich S, 2012, CELL ADHES MIGR, V6, P30, DOI 10.4161/cam.18953; JOACHIM CL, 1992, ALZ DIS ASSOC DIS, V6, P7, DOI 10.1097/00002093-199205000-00003; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kuhn S, 2007, MOL CANCER RES, V5, P553, DOI 10.1158/1541-7786.MCR-06-0384; Ladwein M, 2005, EXP CELL RES, V309, P345, DOI 10.1016/j.yexcr.2005.06.013; Lei ZL, 2012, DEV BIOL, V371, P136, DOI 10.1016/j.ydbio.2012.07.005; Lichtenthaler SF, 2011, J NEUROCHEM, V117, P779, DOI 10.1111/j.1471-4159.2011.07248.x; LITVINOV SV, 1994, CELL ADHES COMMUN, V2, P417, DOI 10.3109/15419069409004452; Litvinov SV, 1997, J CELL BIOL, V139, P1337, DOI 10.1083/jcb.139.5.1337; LITVINOV SV, 1994, J CELL BIOL, V125, P437, DOI 10.1083/jcb.125.2.437; Litvinov SV, 1996, AM J PATHOL, V148, P865; Lu TY, 2010, J BIOL CHEM, V285, P8719, DOI 10.1074/jbc.M109.077081; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Maghzal N, 2013, DEV CELL, V27, P263, DOI 10.1016/j.devcel.2013.10.003; Maghzal N, 2010, J CELL BIOL, V191, P645, DOI 10.1083/jcb.201004074; Monteiro AC, 2014, MOL BIOL CELL, V25, P1574, DOI 10.1091/mbc.E14-01-0018; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Munz M, 2004, ONCOGENE, V23, P5748, DOI 10.1038/sj.onc.1207610; Munz M, 2008, FRONT BIOSCI-LANDMRK, V13, P5195, DOI 10.2741/3075; Nagao K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008543; Ng VY, 2010, STEM CELLS, V28, P29, DOI 10.1002/stem.221; Osta WA, 2004, CANCER RES, V64, P5818, DOI 10.1158/0008-5472.CAN-04-0754; Patriarca C, 2012, CANCER TREAT REV, V38, P68, DOI 10.1016/j.ctrv.2011.04.002; Pavsic M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5764; Pavsic M, 2011, ACTA CRYSTALLOGR F, V67, P1363, DOI 10.1107/S1744309111031897; Philip R, 2015, ONCOTARGET, V6, P2046, DOI 10.18632/oncotarget.2858; Raman S, 2009, PROTEINS, V77, P89, DOI 10.1002/prot.22540; Rao CG, 2005, INT J ONCOL, V27, P49; RIETHMULLER G, 1994, LANCET, V343, P1177, DOI 10.1016/S0140-6736(94)92398-1; Sankpal NV, 2009, CANCER RES, V69, P753, DOI 10.1158/0008-5472.CAN-08-2708; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; SCHON MP, 1994, J INVEST DERMATOL, V102, P987, DOI 10.1111/1523-1747.ep12384258; Simon M, 2013, EXPERT OPIN DRUG DEL, V10, P451, DOI 10.1517/17425247.2013.759938; Sivagnanam M, 2008, GASTROENTEROLOGY, V135, P429, DOI 10.1053/j.gastro.2008.05.036; Slanchev K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000563; Thuma F, 2013, INT J CANCER, V133, P855, DOI 10.1002/ijc.28085; Trzpis M, 2008, J PATHOL, V216, P201, DOI 10.1002/path.2396; Vannier C, 2013, J BIOL CHEM, V288, P18643, DOI 10.1074/jbc.M113.467787; Vielmuth F, 2015, NANOMED-NANOTECHNOL, V11, P511, DOI 10.1016/j.nano.2014.10.006; Waschke J, 2005, J CLIN INVEST, V115, P3157, DOI 10.1172/JCI23475; Waschke J, 2008, HISTOCHEM CELL BIOL, V130, P21, DOI 10.1007/s00418-008-0420-0; Went PT, 2004, HUM PATHOL, V35, P122, DOI 10.1016/j.humpath.2003.08.026; Wildling L, 2011, BIOCONJUGATE CHEM, V22, P1239, DOI 10.1021/bc200099t; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187	63	37	37	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 2	2015	290	40					24574	24591		10.1074/jbc.M115.662700	http://dx.doi.org/10.1074/jbc.M115.662700			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CS6UR	26292218	Green Published, hybrid			2022-12-26	WOS:000362218900041
J	Beleznai, O; Tholt, G; Toth, Z; Horvath, V; Marczali, Z; Samu, F				Beleznai, Orsolya; Tholt, Gergely; Toth, Zoltan; Horvath, Vivien; Marczali, Zsolt; Samu, Ferenc			Cool Headed Individuals Are Better Survivors: Non-Consumptive and Consumptive Effects of a Generalist Predator on a Sap Feeding Insect	PLOS ONE			English	Article							ANTIPREDATOR RESPONSES; RISK; BEHAVIOR; VIRUS; LEAFHOPPER; SPIDERS; FEAR; CICADELLIDAE; LANDSCAPE; DEFENSE	Non-consumptive effects (NCEs) of predators are part of the complex interactions among insect natural enemies and prey. NCEs have been shown to significantly affect prey foraging and feeding. Leafhopper's (Auchenorrhyncha) lengthy phloem feeding bouts may play a role in pathogen transmission in vector species and also exposes them to predation risk. However, NCEs on leafhoppers have been scarcely studied, and we lack basic information about how anti-predator behaviour influences foraging and feeding in these species. Here we report a study on non-consumptive and consumptive predator-prey interactions in a naturally co-occurring spider-leafhopper system. In mesocosm arenas we studied movement patterns during foraging and feeding of the leafhopper Psammotettix alienus in the presence of the spider predator Tibellus oblongus. Leafhoppers delayed feeding and fed much less often when the spider was present. Foraging movement pattern changed under predation risk: movements became more frequent and brief. There was considerable individual variation in foraging movement activity. Those individuals that increased movement activity in the presence of predators exposed themselves to higher predation risk. However, surviving individuals exhibited a 'cool headed' reaction to spider presence by moving less than leafhoppers in control trials. No leafhoppers were preyed upon while feeding. We consider delayed feeding as a "paradoxical" antipredator tactic, since it is not necessarily an optimal strategy against a sit-and-wait generalist predator.	[Beleznai, Orsolya; Tholt, Gergely; Horvath, Vivien; Samu, Ferenc] Hungarian Acad Sci, Inst Plant Protect, Dept Zool, Agr Res Ctr, Budapest, Hungary; [Beleznai, Orsolya; Tholt, Gergely; Horvath, Vivien; Samu, Ferenc] Univ Pannonia, Inst Plant Protect, Georgikon Fac, Keszthely, Hungary; [Tholt, Gergely] Eotvos Lorand Univ, Fac Sci, Inst Biol, Budapest, Hungary; [Toth, Zoltan] Hungarian Acad Sci, Inst Plant Protect, Lendulet Evolutionary Ecol Res Grp, Budapest, Hungary; [Horvath, Vivien] Szent Istvan Univ, Fac Agr & Environm Sci, Inst Genet & Biotechnol, Godollo, Hungary	Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; University of Pannonia; Eotvos Lorand University; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Hungarian University of Agriculture & Life Sciences	Samu, F (corresponding author), Hungarian Acad Sci, Inst Plant Protect, Dept Zool, Agr Res Ctr, Budapest, Hungary.	samu.ferenc@agrar.mta.hu	Tholt, Gergely/J-7308-2017; Tholt, Gergely/S-3748-2019; Horvath, Vivien/ABH-8684-2020; Zsolt, Marczali/AAG-3058-2020; Samu, Ferenc/B-2827-2011	Horvath, Vivien/0000-0001-6536-1710; Samu, Ferenc/0000-0002-6591-2284; Toth, Zoltan/0000-0002-2634-8393; Tholt, Gergely/0000-0003-3364-0322	British Ecological Society Research grant [4768/5806]; Orszagos Tudomanyos Kutatasi Alapprogramok [K81971]; 'Lendulet' programme of the Hungarian Academy of Sciences (MTA) [LP2012-24/2012]; Orszagos Tudomanyos Kutatasi Alapprogramok grant [PD108938]; Hungarian Academy of Sciences [SZ-029/2013]	British Ecological Society Research grant; Orszagos Tudomanyos Kutatasi Alapprogramok(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); 'Lendulet' programme of the Hungarian Academy of Sciences (MTA); Orszagos Tudomanyos Kutatasi Alapprogramok grant; Hungarian Academy of Sciences(Hungarian Academy of Sciences)	Funding for the study was provided by British Ecological Society Research grant (http://www.britishecologicalsociety.org) 4768/5806 to FS and Orszagos Tudomanyos Kutatasi Alapprogramok (K81971; www.otka.hu/en/) to FS. During the study, ZT was supported by the 'Lendulet' programme of the Hungarian Academy of Sciences (MTA, LP2012-24/2012; www.mta.hu), Orszagos Tudomanyos Kutatasi Alapprogramok grant (PD108938; www.otka.hu/en/) and the postdoctoral research programme of the Hungarian Academy of Sciences (SZ-029/2013; www.mta.hu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks PB, 2000, P ROY SOC B-BIOL SCI, V267, P1621, DOI 10.1098/rspb.2000.1187; Barcos AKS, 2014, PHILIPP AGRIC SCI, V97, P155; Barnier F, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0446; Bell RD, 2006, ETHOLOGY, V112, P903, DOI 10.1111/j.1439-0310.2006.01244.x; Bowler DE, 2013, J ZOOL, V289, P52, DOI 10.1111/j.1469-7998.2012.00961.x; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; Cohen J.E., 1988, STAT POWER ANAL BEHA; COX DR, 1972, J R STAT SOC B, V34, P187; Daane KM, 1996, ENVIRON ENTOMOL, V25, P1224, DOI 10.1093/ee/25.5.1224; Embar K, 2011, OIKOS, V120, P1657, DOI 10.1111/j.1600-0706.2011.19278.x; Englund G, 1997, ECOLOGY, V78, P2316; Fereres A, 2009, VIRUS RES, V141, P158, DOI 10.1016/j.virusres.2008.10.020; Fievet V, 2008, OIKOS, V117, P1380, DOI 10.1111/j.0030-1299.2008.16629.x; Garamszegi LZ, 2006, BEHAV ECOL, V17, P682, DOI 10.1093/beheco/ark005; Grafen A., 2002, MODERN STAT LIFE SCI; Hardie J, 1996, ENTOMOL EXP APPL, V80, P73, DOI 10.1007/BF00194727; Hawlena D, 2012, SCIENCE, V336, P1434, DOI 10.1126/science.1220097; Hawlena D, 2010, AM NAT, V176, P537, DOI 10.1086/656495; Hein AM, 2012, P NATL ACAD SCI USA, V109, P12070, DOI 10.1073/pnas.1202686109; Hogg BN, 2014, ECOL ENTOMOL, V39, P149, DOI 10.1111/een.12079; Honma A, 2006, P ROY SOC B-BIOL SCI, V273, P1631, DOI 10.1098/rspb.2006.3501; Jones EI, 2011, BEHAV ECOL SOCIOBIOL, V65, P1505, DOI 10.1007/s00265-011-1160-z; Klingauf F.A., 1987, World Crop Pests, V2A, P209; Laundre JW, 2001, CAN J ZOOL, V79, P1401, DOI 10.1139/cjz-79-8-1401; Li DQ, 2005, J CHEM ECOL, V31, P333, DOI 10.1007/s10886-005-1344-y; Lima SL, 2002, TRENDS ECOL EVOL, V17, P70, DOI 10.1016/S0169-5347(01)02393-X; Lima SL, 1998, BIOSCIENCE, V48, P25, DOI 10.2307/1313225; Lone K, 2014, OIKOS, V123, P641, DOI 10.1111/j.1600-0706.2013.00938.x; Martin J, 2009, ANIM BEHAV, V78, P1011, DOI 10.1016/j.anbehav.2009.07.026; McDermott DR, 2014, BEHAV ECOL SOCIOBIOL, V68, P425, DOI 10.1007/s00265-013-1657-8; Pinheiro J, 2000, MIXED EFFECTS MODELS; Pompon J, 2010, J INSECT PHYSIOL, V56, P610, DOI 10.1016/j.jinsphys.2009.12.009; Preisser EL, 2007, ECOLOGY, V88, P2744, DOI 10.1890/07-0260.1; R Core Team, 2021, R LANGUAGE ENV STAT; Reader T, 2006, BEHAV ECOL, V17, P933, DOI 10.1093/beheco/arl027; Rothley KD, 1997, BEHAV ECOL, V8, P551, DOI 10.1093/beheco/8.5.551; Rypstra AL, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0948; Samu F, 2002, J ARACHNOL, V30, P389, DOI 10.1636/0161-8202(2002)030[0389:OTNOAS]2.0.CO;2; Samu F, 2013, BIOL CONTROL, V67, P390, DOI 10.1016/j.biocontrol.2013.08.016; SAS Institute, 2005, JMP STAT GRAPH GUID; Schmidt-Entling Martin H, 2009, Biol Lett, V5, P773, DOI 10.1098/rsbl.2009.0436; Schmitz OJ, 2008, ECOLOGY, V89, P2436, DOI 10.1890/07-1030.1; SKELLY DK, 1994, ANIM BEHAV, V47, P465, DOI 10.1006/anbe.1994.1063; Slos S, 2009, ECOL ENTOMOL, V34, P297, DOI 10.1111/j.1365-2311.2008.01077.x; STADLER B, 1994, J ANIM ECOL, V63, P419, DOI 10.2307/5559; Stafford CA, 2009, ENTOMOL EXP APPL, V130, P130, DOI 10.1111/j.1570-7458.2008.00813.x; Straub CS, 2013, J PEST SCI, V86, P235, DOI 10.1007/s10340-012-0465-7; Tholt G, 2015, ENTOMOL EXP APPL, V155, P123, DOI 10.1111/eea.12290; VACKE J, 1961, BIOL PLANTARUM, V3, P228, DOI 10.1007/BF02933566; Verdolin JL, 2006, BEHAV ECOL SOCIOBIOL, V60, P457, DOI 10.1007/s00265-006-0172-6; Villagra CA, 2002, ANIM BEHAV, V64, P677, DOI 10.1006/anbe.2002.4015; Wajnberg E, 2003, J ANIM ECOL, V72, P618, DOI 10.1046/j.1365-2656.2003.00731.x; Wegener C, 1998, ENTOMOL GEN, V22, P295; Welton NJ, 2003, THEOR POPUL BIOL, V64, P417, DOI 10.1016/S0040-5809(03)00097-2; Wisniewska J, 1997, EUR J ENTOMOL, V94, P243; Zhang T, 2013, P NATL ACAD SCI USA, V110, P15431, DOI 10.1073/pnas.1308816110; Zhao LQ, 2010, MICRON, V41, P754, DOI 10.1016/j.micron.2010.06.001; Zrubecz Peter, 2004, Novenyvedelem, V40, P527	58	15	15	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135954	10.1371/journal.pone.0135954	http://dx.doi.org/10.1371/journal.pone.0135954			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295476	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000359926900054
J	Dugbartey, GJ; Bouma, HR; Strijkstra, AM; Boerema, AS; Henning, RH				Dugbartey, George J.; Bouma, Hjalmar R.; Strijkstra, Arjen M.; Boerema, Ate S.; Henning, Robert H.			Induction of a Torpor-Like State by 5 '-AMP Does Not Depend on H2S Production	PLOS ONE			English	Article							ANIMATION-LIKE STATE; HYDROGEN-SULFIDE; RENAL ISCHEMIA/REPERFUSION; COLD ISCHEMIA; LUNG-TISSUE; HIBERNATION; REPERFUSION; RESPONSES; PROTECTS; INJURY	Background Therapeutic hypothermia is used to reduce ischemia/reperfusion injury (IRI) during organ transplantation and major surgery, but does not fully prevent organ injury. Interestingly, hibernating animals undergo repetitive periods of low body temperature called 'torpor' without signs of organ injury. Recently, we identified an essential role of hydrogen sulfide (H2S) in entrance into torpor and preservation of kidney integrity during hibernation. A torpor-like state can be induced pharmacologically by injecting 5'-Adenosine monophosphate (5'-AMP). The mechanism by which 5'-AMP leads to the induction of a torpor-like state, and the role of H2S herein, remains to be unraveled. Therefore, we investigated whether induction of a torpor-like state by 5-AMP depends on H2S production. Methods To study the role of H2S on the induction of torpor, amino-oxyacetic acid (AOAA), a nonspecific inhibitor of H2S, was administered before injection with 5'-AMP to block endogenous H2S production in Syrian hamster. To assess the role of H2S on maintenance of torpor induced by 5'-AMP, additional animals were injected with AOAA during torpor. Key Results During the torpor-like state induced by 5'-AMP, the expression of H2S-synthesizing enzymes in the kidneys and plasma levels of H2S were increased. Blockade of these enzymes inhibited the rise in the plasma level of H2S, but neither precluded torpor nor induced arousal. Remarkably, blockade of endogenous H2S production was associated with increased renal injury. Conclusions Induction of a torpor-like state by 5'-AMP does not depend on H2S, although production of H2S seems to attenuate renal injury. Unraveling the mechanisms by which 5'-AMP reduces the metabolism without organ injury may allow optimization of current strategies to limit (hypothermic) IRI and improve outcome following organ transplantation, major cardiac and brain surgery.	[Dugbartey, George J.; Bouma, Hjalmar R.; Henning, Robert H.] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands; [Strijkstra, Arjen M.; Boerema, Ate S.] Univ Groningen, Groningen Inst Evolutionary Life Sci, Dept Chronobiol, NL-9700 RB Groningen, Netherlands; [Strijkstra, Arjen M.; Boerema, Ate S.] Univ Groningen, Groningen Inst Evolutionary Life Sci, Dept Mol Neurobiol, NL-9700 RB Groningen, Netherlands; [Boerema, Ate S.] Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	Dugbartey, GJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands.	g.j.dugbartey@umcg.nl	Boerema, A.S./W-9810-2018; Henning, Robert H/AAY-5222-2020; Bouma, Hjalmar/F-9737-2015	Boerema, A.S./0000-0002-4771-5156; Henning, Robert/0000-0002-5135-4621; Bouma, Hjalmar/0000-0003-1032-321X; Dugbartey, George/0000-0001-8161-7202	Groningen Institute for Drug Exploration (GUIDE), Netherlands; University Medical Center Groningen (UMCG), Netherlands	Groningen Institute for Drug Exploration (GUIDE), Netherlands(Netherlands Government); University Medical Center Groningen (UMCG), Netherlands(Netherlands Government)	The work was funded by Groningen Institute for Drug Exploration (GUIDE), Netherlands and University Medical Center Groningen (UMCG), Netherlands.	Adams J, 2004, PROTEIN SCI, V13, P155, DOI 10.1110/ps.03340004; BARNES BM, 1989, SCIENCE, V244, P1593, DOI 10.1126/science.2740905; Blackstone E, 2005, SCIENCE, V308, P518, DOI 10.1126/science.1108581; Blackstone E, 2007, SHOCK, V27, P370, DOI 10.1097/SHK.0b013e31802e27a0; Bos EM, 2013, J AM SOC NEPHROL, V24, P759, DOI 10.1681/ASN.2012030268; Bos EM, 2009, J AM SOC NEPHROL, V20, P1901, DOI 10.1681/ASN.2008121269; Bouma HR, 2010, VET IMMUNOL IMMUNOP, V136, P319, DOI 10.1016/j.vetimm.2010.03.016; Bouma HR, 2013, J LEUKOCYTE BIOL, V94, P431, DOI 10.1189/jlb.0611298; Bouma HR, 2013, DEV COMP IMMUNOL, V39, P154, DOI 10.1016/j.dci.2012.11.004; Carden DL, 2000, J PATHOL, V190, P255, DOI 10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; de Vrij EL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093218; ELNAHAS AM, 1991, KIDNEY INT, V40, P29, DOI 10.1038/ki.1991.175; Florant GL, 2010, J EXP BIOL, V213, P2031, DOI 10.1242/jeb.039131; Gross MLP, 2006, LAB INVEST, V86, P262, DOI 10.1038/labinvest.3700383; Jani A, 2011, TRANSPLANTATION, V92, P1215, DOI 10.1097/TP.0b013e3182366401; Lee CC, 2008, ANNU REV MED, V59, P177, DOI 10.1146/annurev.med.59.061506.110403; Lindsley JE, 2004, COMP BIOCHEM PHYS B, V139, P543, DOI 10.1016/j.cbpc.2004.06.014; Lobb Ian, 2014, Can Urol Assoc J, V8, pE413, DOI 10.5489/cuaj.1694; Miao ZM, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/459617; Nikolic-Paterson DJ, 2001, NEPHROL DIAL TRANSPL, V16, P3, DOI 10.1093/ndt/16.suppl_5.3; Olson KR, 2009, BBA-BIOENERGETICS, V1787, P856, DOI 10.1016/j.bbabio.2009.03.019; Peralta C, 2001, HEPATOLOGY, V34, P1164, DOI 10.1053/jhep.2001.29197; Revsbech IG, 2014, FREE RADICAL BIO MED, V73, P349, DOI 10.1016/j.freeradbiomed.2014.05.025; Swoap SJ, 2007, AM J PHYSIOL-REG I, V293, pR468, DOI 10.1152/ajpregu.00888.2006; Talaei F, 2012, J EXP BIOL, V215, P2912, DOI 10.1242/jeb.067363; Talaei F, 2011, J EXP BIOL, V214, P1276, DOI 10.1242/jeb.052704; Wang YL, 2014, J GASTROEN HEPATOL, V29, P742, DOI 10.1111/jgh.12448; Zancanaro C, 1999, NEPHROL DIAL TRANSPL, V14, P1982, DOI 10.1093/ndt/14.8.1982; Zhang JF, 2006, NATURE, V439, P340, DOI 10.1038/nature04368	30	23	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136113	10.1371/journal.pone.0136113	http://dx.doi.org/10.1371/journal.pone.0136113			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295351	Green Published, gold, Green Submitted			2022-12-26	WOS:000359926900071
J	Luo, Y; Wang, JG; Liu, B; Wang, ZL; Yuan, YH; Yue, TL				Luo, Ying; Wang, Jianguo; Liu, Bin; Wang, Zhouli; Yuan, Yahong; Yue, Tianli			Effect of Yeast Cell Morphology, Cell Wall Physical Structure and Chemical Composition on Patulin Adsorption	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; MYCOTOXINS CITRININ; APPLE JUICE	The capability of yeast to adsorb patulin in fruit juice can aid in substantially reducing the patulin toxic effect on human health. This study aimed to investigate the capability of yeast cell morphology and cell wall internal structure and composition to adsorb patulin. To compare different yeast cell morphologies, cell wall internal structure and composition, scanning electron microscope, transmission electron microscope and ion chromatography were used. The results indicated that patulin adsorption capability of yeast was influenced by cell surface areas, volume, and cell wall thickness, as well as 1,3-beta-glucan content. Among these factors, cell wall thickness and 1,3-beta-glucan content serve significant functions. The investigation revealed that patulin adsorption capability was mainly affected by the three-dimensional network structure of the cell wall composed of 1,3-beta-glucan. Finally, patulin adsorption in commercial kiwi fruit juice was investigated, and the results indicated that yeast cells could adsorb patulin from commercial kiwi fruit juice efficiently. This study can potentially simulate in vitro cell walls to enhance patulin adsorption capability and successfully apply to fruit juice industry.	[Luo, Ying; Wang, Jianguo; Liu, Bin; Wang, Zhouli; Yuan, Yahong; Yue, Tianli] Northwest A&F Univ, Coll Food Sci & Engn, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China	Yue, TL (corresponding author), Northwest A&F Univ, Coll Food Sci & Engn, Yangling 712100, Shaanxi, Peoples R China.	yuetl305@nwsuaf.edu.cn	yue, tianli/AEY-3384-2022; Wang, JianGuo/L-6445-2018	yue, tianli/0000-0002-4768-5831; Wang, JianGuo/0000-0001-7060-8212	National Natural Science Foundation of China [31371814]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by the National Natural Science Foundation of China under Grant No. 31371814, and TY received the funding; the funders supported data collection and analysis of the manuscript.	Aguilar-Uscanga B, 2003, LETT APPL MICROBIOL, V37, P268, DOI 10.1046/j.1472-765X.2003.01394.x; ARAFAT W, 1995, RES COMMUN MOL PATH, V87, P177; Baptista AS, 2004, WORLD J MICROB BIOT, V20, P475, DOI 10.1023/B:WIBI.0000040397.48873.3b; Burroughs LF, 1997, J AOAC, V60, P100; Celyk K, 2003, REV BRAS ZOOTECN, V32, P615, DOI 10.1590/S1516-35982003000300013; Dallies N, 1998, YEAST, V14, P1297, DOI 10.1002/(SICI)1097-0061(1998100)14:14<1297::AID-YEA310>3.0.CO;2-L; DEVEGOWDA G, 1996, P AUST POULT SCI S, V8, P103, DOI DOI 10.1080/09712119.2004.9706502; FLEET GH, 1976, J GEN MICROBIOL, V94, P180, DOI 10.1099/00221287-94-1-180; Fuchs S, 2008, FOOD CHEM TOXICOL, V46, P1398, DOI 10.1016/j.fct.2007.10.008; Gokmen V, 2001, EUR FOOD RES TECHNOL, V213, P194, DOI 10.1007/s002170100354; Hatab S, 2012, J APPL MICROBIOL, V112, P892, DOI 10.1111/j.1365-2672.2012.05279.x; Huebner HJ, 2000, J FOOD PROTECT, V63, P106, DOI 10.4315/0362-028X-63.1.106; Huwig A, 2001, TOXICOL LETT, V122, P179, DOI 10.1016/S0378-4274(01)00360-5; Joint F, 1995, WHO TECH REP SER; Klis FM, 2006, YEAST, V23, P185, DOI 10.1002/yea.1349; Kollar R, 1997, J BIOL CHEM, V272, P17762, DOI 10.1074/jbc.272.28.17762; KREGER DR, 1975, J GEN MICROBIOLOGY, V0092; Lugauskas A, 2005, ANN AGR ENV MED, V12, P109; MacDonald S, 2000, J AOAC INT, V83, P1387; Magnelli P, 2002, ANAL BIOCHEM, V301, P136, DOI 10.1006/abio.2001.5473; MANNERS DJ, 1973, BIOCHEM J, V135, P19, DOI 10.1042/bj1350019; Morris GJ, 1983, J GEN MICROBIOL, V129, P2023; Nguyen TH, 1998, APPL MICROBIOL BIOT, V50, P206, DOI 10.1007/s002530051278; Pfeiffer E, 1998, CARCINOGENESIS, V19, P1313, DOI 10.1093/carcin/19.7.1313; Popolo L, 1997, J BACTERIOL, V179, P463, DOI 10.1128/jb.179.2.463-469.1997; Reddy K R N, 2010, Mycotoxin Res, V26, P257, DOI 10.1007/s12550-010-0064-5; Salomao BCM, 2008, J FOOD PROTECT, V71, P643, DOI 10.4315/0362-028X-71.3.643; Santin E., 2003, International Journal of Poultry Science, V2, P465; Schiavone M, 2014, FEMS YEAST RES, V14, P933, DOI 10.1111/1567-1364.12182; Shephard GS, 2000, J CHROMATOGR A, V882, P17, DOI 10.1016/S0021-9673(99)01341-2; Shetty PH, 2006, TRENDS FOOD SCI TECH, V17, P48, DOI 10.1016/j.tifs.2005.10.004; STINSON EE, 1978, APPL ENVIRON MICROB, V36, P620, DOI 10.1128/AEM.36.4.620-622.1978; Wang L., 2007, THESIS NW A F U; Wichmann G, 2002, ENVIRON TOXICOL, V17, P211, DOI 10.1002/tox.10050; Yiannikouris A, 2004, J AGR FOOD CHEM, V52, P3666, DOI 10.1021/jf035127x; Yiannikouris A, 2006, BIOMACROMOLECULES, V7, P1147, DOI 10.1021/bm050968t; Yiannikouris A, 2003, BIOTECHNOL LETT, V25, P783, DOI 10.1023/A:1023576520932; Yue TL, 2011, J FOOD PROTECT, V74, P149, DOI 10.4315/0362-028X.JFP-10-326	38	39	43	3	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0136045	10.1371/journal.pone.0136045	http://dx.doi.org/10.1371/journal.pone.0136045			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26295574	Green Published, gold, Green Submitted			2022-12-26	WOS:000359926900064
J	Choudhury, AR; Sikorska, E; van den Boom, J; Bayer, P; Popenda, L; Szutkowski, K; Jurga, S; Bonomi, M; Sali, A; Zhukov, I; Passamonti, S; Novic, M				Choudhury, Amrita Roy; Sikorska, Emilia; van den Boom, Johannes; Bayer, Peter; Popenda, Lukasz; Szutkowski, Kosma; Jurga, Stefan; Bonomi, Massimiliano; Sali, Andrej; Zhukov, Igor; Passamonti, Sabina; Novic, Marjana			Structural Model of the Bilitranslocase Transmembrane Domain Supported by NMR and FRET Data	PLOS ONE			English	Article							HELIX-PACKING; PREDICTION; TRANSPORT; INHIBITION; BILIRUBIN; PROTEINS; RESIDUES; DYNAMICS; BINDING; MOTIFS	We present a 3D model of the four transmembrane (TM) helical regions of bilitranslocase (BTL), a structurally uncharacterized protein that transports organic anions across the cell membrane. The model was computed by considering helix-helix interactions as primary constraints, using Monte Carlo simulations. The interactions between the TM2 and TM3 segments have been confirmed by Forster resonance energy transfer (FRET) spectroscopy and nuclear magnetic resonance (NMR) spectroscopy, increasing our confidence in the model. Several insights into the BTL transport mechanism were obtained by analyzing the model. For example, the observed cis-trans Leu-Pro peptide bond isomerization in the TM3 fragment may indicate a key conformational change during anion transport by BTL. Our structural model of BTL may facilitate further studies, including drug discovery.	[Choudhury, Amrita Roy; Novic, Marjana] Natl Inst Chem, Ljubljana, Slovenia; [Sikorska, Emilia] Univ Gdansk, Fac Chem, PL-80952 Gdansk, Poland; [van den Boom, Johannes; Bayer, Peter] Univ Duisburg Essen, Ctr Med Biotechnol, Inst Struct & Med Biochem, Essen, Germany; [Popenda, Lukasz; Szutkowski, Kosma; Jurga, Stefan; Zhukov, Igor] Adam Mickiewicz Univ, NanoBioMed Ctr, Poznan, Poland; [Szutkowski, Kosma; Jurga, Stefan] Adam Mickiewicz Univ, Fac Phys, Poznan, Poland; [Bonomi, Massimiliano] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Bonomi, Massimiliano; Sali, Andrej] Univ Calif San Francisco, Dept Pharmaceut Chem, Dept Bioengn & Therapeut Sci, San Francisco, CA USA; [Bonomi, Massimiliano; Sali, Andrej] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94143 USA; [Zhukov, Igor] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland; [Passamonti, Sabina] Univ Trieste, Dept Life Sci, Trieste, Italy	National Institute of Chemistry - Slovenia; Fahrenheit Universities; University of Gdansk; University of Duisburg Essen; Adam Mickiewicz University; Adam Mickiewicz University; University of Cambridge; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of Trieste	Zhukov, I (corresponding author), Adam Mickiewicz Univ, NanoBioMed Ctr, Poznan, Poland.	igor@ibb.waw.pl; spassamonti@units.it; marjana.novic@ki.si	Szutkowski, Kosma/M-1541-2019; Jurga, Stefan/E-8862-2017; Popenda, Lukasz/J-7386-2015; Bayer, Peter/B-8803-2009; Sabina Passamonti, Medical degree/G-4299-2012; Zhukov, Igor/J-4069-2015	Szutkowski, Kosma/0000-0002-6091-9049; Jurga, Stefan/0000-0002-1665-6077; Popenda, Lukasz/0000-0003-1117-3081; Bayer, Peter/0000-0003-0435-7202; Sabina Passamonti, Medical degree/0000-0001-7876-4666; Sikorska, Emilia/0000-0001-7851-6371; Bonomi, Massimiliano/0000-0002-7321-0004; Zhukov, Igor/0000-0002-9912-1018	Ministry of Higher Education, Science and Technology of Republic of Slovenia [P1-017, J1-2151]; European Regional Development Fund (Cross-border Cooperation Programme Italy-Slovenia, TRANS2CARE strategic project); Polish National Centre for Research and Development [PBS1/A9/13/2012]; NIH [R01 GM083960]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083960] Funding Source: NIH RePORTER	Ministry of Higher Education, Science and Technology of Republic of Slovenia; European Regional Development Fund (Cross-border Cooperation Programme Italy-Slovenia, TRANS2CARE strategic project); Polish National Centre for Research and Development; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Ministry of Higher Education, Science and Technology of the Republic of Slovenia, grants P1-017 and J1-2151 (ARC, MN), European Regional Development Fund (Cross-border Cooperation Programme Italy-Slovenia 2007-2013, TRANS2CARE strategic project) (SP), Polish National Centre for Research and Development under research grant "Nanomaterials and their application to biomedicine", contract number PBS1/A9/13/2012, (SJ, KS and IZ), NIH R01 GM083960 grant (AS, MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamian L, 2001, J MOL BIOL, V311, P891, DOI 10.1006/jmbi.2001.4908; Baker M, 2010, NAT METHODS, V7, P429, DOI 10.1038/nmeth0610-429; Battiston L, 1998, BIOCHEM BIOPH RES CO, V247, P687, DOI 10.1006/bbrc.1998.8868; Buxhofer-Ausch V, 2013, J DRUG DELIV, V2013, DOI 10.1155/2013/863539; Carpenter EP, 2008, CURR OPIN STRUC BIOL, V18, P581, DOI 10.1016/j.sbi.2008.07.001; Case D, 2006, AMBER 9; Choudhury AR, 2009, SAR QSAR ENVIRON RES, V20, P741, DOI 10.1080/10629360903438602; Choudhury AR, 2013, BBA-BIOMEMBRANES, V1828, P2609, DOI 10.1016/j.bbamem.2013.06.006; Gront D, 2007, J COMPUT CHEM, V28, P1593, DOI 10.1002/jcc.20624; Hicks RP, 2003, BIOPOLYMERS, V68, P459, DOI 10.1002/bip.10325; Jarvet J, 2007, J BIOMOL NMR, V39, P63, DOI 10.1007/s10858-007-9176-4; Karawajczyk A, 2007, BIOCHEM PHARMACOL, V73, P308, DOI 10.1016/j.bcp.2006.09.024; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Li E, 2012, BBA-BIOMEMBRANES, V1818, P183, DOI 10.1016/j.bbamem.2011.08.031; LIPARI G, 1981, BIOCHEMISTRY-US, V20, P6250, DOI 10.1021/bi00524a053; Lo A, 2009, BIOINFORMATICS, V25, P996, DOI 10.1093/bioinformatics/btp114; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Maestro A, 2010, CARDIOVASC RES, V85, P175, DOI 10.1093/cvr/cvp290; Montanic S, 2013, RADIOL ONCOL, V47, P128, DOI 10.2478/raon-2013-0026; Nugent T, 2012, J STRUCT BIOL, V179, P327, DOI 10.1016/j.jsb.2011.10.008; Passamonti S, 2005, FEBS J, V272, P5522, DOI 10.1111/j.1742-4658.2005.04949.x; Passamonti S, 2005, FEBS J, V272, P3282, DOI 10.1111/j.1742-4658.2005.04751.x; Passamonti S, 1998, EUR J BIOCHEM, V253, P84, DOI 10.1046/j.1432-1327.1998.2530084.x; Passamonti S, 2009, CURR DRUG METAB, V10, P369, DOI 10.2174/138920009788498950; Perdih A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038967; Pieper U, 2013, NAT STRUCT MOL BIOL, V20, P135, DOI 10.1038/nsmb.2508; Russel D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001244; Schmidpeter PAM, 2014, ACS CHEM BIOL, V9, P1145, DOI 10.1021/cb500001n; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Terdoslavich Michela, 2012, Drug Metab Lett, V6, P165; Tzakos AG, 2013, J DRUG DELIV, V2013, DOI 10.1155/2013/918304; Vashisth H, 2013, ACS CHEM BIOL, V8, P2778, DOI 10.1021/cb400568g; Walters RFS, 2006, P NATL ACAD SCI USA, V103, P13658, DOI 10.1073/pnas.0605878103; Ziberna L, 2012, FREE RADICAL BIO MED, V52, P1750, DOI 10.1016/j.freeradbiomed.2012.02.027; Zuperl S, 2011, ANAL CHIM ACTA, V705, P322, DOI 10.1016/j.aca.2011.07.004	37	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135455	10.1371/journal.pone.0135455	http://dx.doi.org/10.1371/journal.pone.0135455			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26291722	Green Published, Green Submitted, gold			2022-12-26	WOS:000359919900019
J	Lu, JH; Ma, D				Lu, Jianhua; Ma, Dan			Repellent and Contact Toxicity of Alpinia officinarum Rhizome Extract against Lasioderma serricorne Adults	PLOS ONE			English	Article							TRIBOLIUM-CASTANEUM HERBST; SITOPHILUS-ZEAMAIS MOTSCHULSKY; STORED-PRODUCT INSECTS; ESSENTIAL OILS; FUMIGANT TOXICITY; BOTANICAL INSECTICIDES; PHOSPHINE RESISTANCE; PACKAGING MATERIALS; STORAGE INSECTS; GRANARY WEEVIL	The repellent and contact toxicities of Alpinia officinarum rhizome extract on Lasioderma serricorne adults, and its ability to protect stored wheat flour from L. serricorne adults infestation were investigated. The A. officinarum extract exhibited strong repellent and contact toxicities against L. serricorne adults. The toxicities enhanced significantly with the increasing treatment time and treatment dose. The mean percentage repellency value reached 91.3% at class V at the dose of 0.20 mu L/cm(2) after 48 h of exposure. The corrected mortality reached over 80.0% at the dose of 0.16 mu L/cm(2) after 48 h of exposure. The A. officinarum extract could significantly reduce L. serricorne infestation level against stored wheat flour. Particularly, the insect infestation was nil in wheat flour packaged with kraft paper bags coated with the A. officinarum extract at the dose of above 0.05 mu L/cm(2). The naturally occurring A. officinarum extract could be useful for integrated management of L. serricorne.	[Lu, Jianhua; Ma, Dan] Henan Univ Technol, Sch Food Sci & Technol, Zhengzhou 450001, Henan, Peoples R China	Henan University of Technology	Lu, JH (corresponding author), Henan Univ Technol, Sch Food Sci & Technol, Lianhua St, Zhengzhou 450001, Henan, Peoples R China.	jianhlv@163.com			National Research Plan for the High-tech R & D Program during the Twelfth Five-year Plan Period (National 863 plan) [2012AA101705-2]; Plan of Nature Science Fundamental Research in Henan University of Technology [11JCYJ01]; Key Technologies R & D Program of the Education Department of Henan Province [12A210003]; Basic and Cutting-edge Technology Research Projects of Henan Province	National Research Plan for the High-tech R & D Program during the Twelfth Five-year Plan Period (National 863 plan); Plan of Nature Science Fundamental Research in Henan University of Technology; Key Technologies R & D Program of the Education Department of Henan Province; Basic and Cutting-edge Technology Research Projects of Henan Province	This research was supported by the National Research Plan for the High-tech R & D Program during the Twelfth Five-year Plan Period (National 863 plan, No. 2012AA101705-2), Plan of Nature Science Fundamental Research in Henan University of Technology (No. 11JCYJ01), Key Technologies R & D Program of the Education Department of Henan Province (No. 12A210003) and the Basic and Cutting-edge Technology Research Projects of Henan Province (No. 2015).	Abdelghany AY, 2010, J STORED PROD RES, V46, P93, DOI 10.1016/j.jspr.2009.11.001; Allahvaisi S, 2010, NOT BOT HORTI AGROBO, V38, P21; [Anonymous], 1925, J ECON ENTOMOL; BARRER PM, 1980, J STORED PROD RES, V16, P1, DOI 10.1016/0022-474X(80)90028-4; BELL CH, 1995, J STORED PROD RES, V31, P199, DOI 10.1016/0022-474X(95)00012-V; BLOSZYK E, 1990, J APPL ENTOMOL, V110, P96, DOI 10.1111/j.1439-0418.1990.tb00100.x; BUTLER JH, 1996, METHYL BROMIDE ISSUE, V1, P27; Cosimi S, 2009, J STORED PROD RES, V45, P125, DOI 10.1016/j.jspr.2008.10.002; Daglish GJ, 1998, STORED PRODUCT PROTE, P584; Fan GJ, 2007, BIOORG MED CHEM LETT, V17, P6720, DOI 10.1016/j.bmcl.2007.10.054; Fardisi M, 2013, J STORED PROD RES, V52, P93, DOI 10.1016/j.jspr.2012.12.006; Germinara GS, 2012, J FOOD PROTECT, V75, P366, DOI 10.4315/0362-028X.JFP-11-142; Highland H.A., 1984, P311; Highland HA, 1991, ECOLOGY MANAGEMENT F, P345; Hill J.M., 1981, RECENT ADV FOOD SCI, V1, P473; Hou XW, 2004, J STORED PROD RES, V40, P47, DOI 10.1016/S0022-474X(02)00063-2; Isman MB, 2006, ANNU REV ENTOMOL, V51, P45, DOI 10.1146/annurev.ento.51.110104.151146; Isman MB, 2008, PEST MANAG SCI, V64, P8, DOI 10.1002/ps.1470; Jovanovic Z, 2007, IND CROP PROD, V26, P100, DOI 10.1016/j.indcrop.2007.01.010; JULIANA G, 1983, J ECON ENTOMOL, V76, P154; Kim SI, 2003, J STORED PROD RES, V39, P11, DOI 10.1016/S0022-474X(02)00013-9; Kljajic P, 2006, J STORED PROD RES, V42, P149, DOI 10.1016/j.jspr.2005.01.002; Lee BH, 2004, J STORED PROD RES, V40, P553, DOI 10.1016/j.jspr.2003.09.001; Lee BH, 2001, CROP PROT, V20, P317, DOI 10.1016/S0261-2194(00)00158-7; Lee SE, 2003, LIFE SCI, V73, P167, DOI 10.1016/S0024-3205(03)00259-5; Lee SE, 2001, PEST MANAG SCI, V57, P548, DOI 10.1002/ps.322; Liu ZL, 2007, J STORED PROD RES, V43, P290, DOI 10.1016/j.jspr.2006.06.010; Liu ZL, 1999, J STORED PROD RES, V35, P317, DOI 10.1016/S0022-474X(99)00015-6; MBTOC, 1998, METHYL BROMIDE TECHN, P374; Mikhaiel AA, 2011, J STORED PROD RES, V47, P357, DOI 10.1016/j.jspr.2011.06.002; Mowery SV, 2002, J ECON ENTOMOL, V95, P1333, DOI 10.1603/0022-0493-95.6.1333; Mullen M. A., 2000, International Food Hygiene, V11, P13; MULLEN MA, 1994, J STORED PROD RES, V30, P95, DOI 10.1016/0022-474X(94)90278-X; Papadopoulou SC, 2004, J PEST SCI, V77, P183, DOI 10.1007/s10340-004-0052-7; Paul UV, 2009, J STORED PROD RES, V45, P97, DOI 10.1016/j.jspr.2008.09.006; Radwan R. N., 1997, U. S. Patent, Patent No. [5,688,509, 5688509]; RAJENDRAN S, 1994, INT J PEST MANAGE, V40, P207, DOI 10.1080/09670879409371883; Shaaya E, 1997, J STORED PROD RES, V33, P7, DOI 10.1016/S0022-474X(96)00032-X; Tapondjou AL, 2005, J STORED PROD RES, V41, P91, DOI 10.1016/j.jspr.2004.01.004; Wang J, 2006, J STORED PROD RES, V42, P339, DOI 10.1016/j.jspr.2005.06.001; White N.D.G., 1995, INTREGATED PEST MANA; Wong KKY, 2005, J AGR FOOD CHEM, V53, P4633, DOI 10.1021/jf050096m; YANG RZ, 1988, ECON BOT, V42, P376, DOI 10.1007/BF02860162; ZETTLER JL, 1994, J ECON ENTOMOL, V87, P546, DOI 10.1093/jee/87.3.546; Zhang BB, 2010, FITOTERAPIA, V81, P948, DOI 10.1016/j.fitote.2010.06.015	45	9	10	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135631	10.1371/journal.pone.0135631	http://dx.doi.org/10.1371/journal.pone.0135631			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26292097	Green Published, gold, Green Submitted			2022-12-26	WOS:000359919900022
J	Ying, BW; Honda, T; Tsuru, S; Seno, S; Matsuda, H; Kazuta, Y; Yomo, T				Ying, Bei-Wen; Honda, Tomoya; Tsuru, Saburo; Seno, Shigeto; Matsuda, Hideo; Kazuta, Yasuaki; Yomo, Tetsuya			Evolutionary Consequence of a Trade-Off between Growth and Maintenance along with Ribosomal Damages	PLOS ONE			English	Article							ESCHERICHIA-COLI; STATIONARY-PHASE; GENE-EXPRESSION; TRANSLATION; SELECTION; SURVIVAL; ADAPTATION; STARVATION; MUTATIONS; BACTERIA	Microorganisms in nature are constantly subjected to a limited availability of resources and experience repeated starvation and nutrition. Therefore, microbial life may evolve for both growth fitness and sustainability. By contrast, experimental evolution, as a powerful approach to investigate microbial evolutionary strategies, often targets the increased growth fitness in controlled, steady-state conditions. Here, we address evolutionary changes balanced between growth and maintenance while taking nutritional fluctuations into account. We performed a 290-day-long evolution experiment with a histidine-requiring Escherichia coli strain that encountered repeated histidine-rich and histidine-starved conditions. The cells that experienced seven rounds of starvation and re-feed grew more sustainably under prolonged starvation but dramatically lost growth fitness under rich conditions. The improved sustainability arose from the evolved capability to use a trace amount of histidine for cell propagation. The reduced growth rate was attributed to mutations genetically disturbing the translation machinery, that is, the ribosome, ultimately slowing protein translation. This study provides the experimental demonstration of slow growth accompanied by an enhanced affinity to resources as an evolutionary adaptation to oscillated environments and verifies that it is possible to evolve for reduced growth fitness. Growth economics favored for population increase under extreme resource limitations is most likely a common survival strategy adopted by natural microbes.	[Ying, Bei-Wen] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Honda, Tomoya] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA; [Tsuru, Saburo; Seno, Shigeto; Matsuda, Hideo; Yomo, Tetsuya] Osaka Univ, Grad Sch Informat Sci & Technol, Suita, Osaka 5650871, Japan; [Kazuta, Yasuaki; Yomo, Tetsuya] JST, ERATO, Suita, Osaka 5650871, Japan; [Yomo, Tetsuya] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan	University of Tsukuba; University of California System; University of California San Diego; Osaka University; Japan Science & Technology Agency (JST); Osaka University	Yomo, T (corresponding author), Osaka Univ, Grad Sch Informat Sci & Technol, 1-5 Yamadaoka, Suita, Osaka 5650871, Japan.	yomo@ist.osaka-u.ac.jp	Tsuru, Saburo/M-5069-2017; Seno, Shigeto/W-1426-2019; Ying, Bei-Wen/Q-9750-2019	Tsuru, Saburo/0000-0002-7182-1637; Seno, Shigeto/0000-0003-3861-6444; Ying, Bei-Wen/0000-0003-2517-5686; Matsuda, Hideo/0000-0002-4701-3779; Honda, Tomoya/0000-0003-2391-4799	Ministry of Education, Culture, Sports, Science and Technology, Japan [26506003, 26119702]; Grants-in-Aid for Scientific Research [26506003, 26119702] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially supported by Grant-in-Aid for Scientific Research (C) no. 26506003 (to BWY) and Grant-in-Aid for Scientific Research on Innovative Areas no. 26119702 (to BWY) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Basturea GN, 2011, RNA, V17, P338, DOI 10.1261/rna.2448911; Blokpoel MCJ, 2005, J BACTERIOL, V187, P6691, DOI 10.1128/JB.187.19.6691-6700.2005; BONI IV, 1991, NUCLEIC ACIDS RES, V19, P155, DOI 10.1093/nar/19.1.155; Bremer H, 1996, ESCHERICHIA COLI SAL, V1, P1553; BROCK TD, 1971, BACTERIOL REV, V35, P39, DOI 10.1128/MMBR.35.1.39-58.1971; Carroll SM, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-2; Cheng ZF, 2005, MOL CELL, V17, P313, DOI 10.1016/j.molcel.2004.11.048; Cheng ZF, 2003, P NATL ACAD SCI USA, V100, P6388, DOI 10.1073/pnas.1231041100; Conrad TM, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.42; Cooper TF, 2003, P NATL ACAD SCI USA, V100, P1072, DOI 10.1073/pnas.0334340100; Davey HM, 2011, APPL ENVIRON MICROB, V77, P5571, DOI 10.1128/AEM.00744-11; Dethlefsen L, 2007, J BACTERIOL, V189, P3237, DOI 10.1128/JB.01686-06; Durfee T, 2008, J BACTERIOL, V190, P1084, DOI 10.1128/JB.01092-07; Duval M, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001731; Egli T, 2010, WATER RES, V44, P4826, DOI 10.1016/j.watres.2010.07.023; Farrell MJ, 2003, J BACTERIOL, V185, P7044, DOI 10.1128/JB.185.24.7044-7052.2003; Faure D, 2004, J BACTERIOL, V186, P6437, DOI 10.1128/JB.186.19.6437-6442.2004; Ferenci T, 2005, MOL MICROBIOL, V57, P1, DOI 10.1111/j.1365-2958.2005.04649.x; Ferenci T, 2001, ENVIRON MICROBIOL, V3, P605, DOI 10.1046/j.1462-2920.2001.00238.x; Finkel SE, 2006, NAT REV MICROBIOL, V4, P113, DOI 10.1038/nrmicro1340; Finkel SE, 1999, P NATL ACAD SCI USA, V96, P4023, DOI 10.1073/pnas.96.7.4023; Fujii S, 2014, NAT PROTOC, V9, P1578, DOI 10.1038/nprot.2014.107; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Hoehler TM, 2013, NAT REV MICROBIOL, V11, P83, DOI 10.1038/nrmicro2939; Horinouchi T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-579; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jones SE, 2010, P NATL ACAD SCI USA, V107, P5881, DOI 10.1073/pnas.0912765107; Kaczanowska M, 2004, J BACTERIOL, V186, P3046, DOI 10.1128/JB.186.10.3046-3055.2004; Kaczanowska M, 2007, MICROBIOL MOL BIOL R, V71, P477, DOI 10.1128/MMBR.00013-07; KAPRELYANTS AS, 1993, FEMS MICROBIOL LETT, V104, P271, DOI 10.1016/0378-1097(93)90600-7; Kazuta Y, 2008, MOL CELL PROTEOMICS, V7, P1530, DOI 10.1074/mcp.M800051-MCP200; Kazuta Y, 2014, J BIOSCI BIOENG, V118, P554, DOI 10.1016/j.jbiosc.2014.04.019; Kell DB, 1998, ANTON LEEUW INT J G, V73, P169, DOI 10.1023/A:1000664013047; King T, 2004, J BACTERIOL, V186, P5614, DOI 10.1128/JB.186.17.5614-5620.2004; Kishimoto T, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001164; KOLTER R, 1993, ANNU REV MICROBIOL, V47, P855, DOI 10.1146/annurev.micro.47.1.855; KURLAND CG, 1992, ANNU REV GENET, V26, P29, DOI 10.1146/annurev.ge.26.120192.000333; LAPPINSCOTT HM, 1988, APPL ENVIRON MICROB, V54, P1373, DOI 10.1128/AEM.54.6.1373-1382.1988; Lee DH, 2010, APPL ENVIRON MICROB, V76, P4158, DOI 10.1128/AEM.00373-10; Lennon JT, 2011, NAT REV MICROBIOL, V9, P119, DOI 10.1038/nrmicro2504; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; Liu XQ, 2001, MICROBIOL-SGM, V147, P2981, DOI 10.1099/00221287-147-11-2981; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; LUCKINBILL LS, 1978, SCIENCE, V202, P1201, DOI 10.1126/science.202.4373.1201; Madrid RE, 2005, CRIT REV BIOTECHNOL, V25, P97, DOI 10.1080/07388550500248563; Matsumoto Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-808; MIKKOLA R, 1992, MOL BIOL EVOL, V9, P394; MUKAMOLOVA GV, 1995, ARCH MICROBIOL, V163, P373, DOI 10.1007/BF00404211; Nystrom T, 1996, EMBO J, V15, P3219, DOI 10.1002/j.1460-2075.1996.tb00686.x; Nystrom T, 2003, BIOESSAYS, V25, P204, DOI 10.1002/bies.10233; Nystrom T, 1998, FEMS MICROBIOL REV, V21, P283, DOI 10.1111/j.1574-6976.1998.tb00354.x; Nystrom T, 1998, BBA-BIOENERGETICS, V1365, P225, DOI 10.1016/S0005-2728(98)00072-3; Ohashi H, 2007, BIOCHEM BIOPH RES CO, V352, P270, DOI 10.1016/j.bbrc.2006.11.017; Oliver JD, 2010, FEMS MICROBIOL REV, V34, P415, DOI 10.1111/j.1574-6976.2009.00200.x; Phan K, 2013, ISME J, V7, P2034, DOI 10.1038/ismej.2013.82; Posfai G, 2006, SCIENCE, V312, P1044, DOI 10.1126/science.1126439; Raffaghello L, 2008, P NATL ACAD SCI USA, V105, P8215, DOI 10.1073/pnas.0708100105; Ryall B, 2012, MICROBIOL MOL BIOL R, V76, P597, DOI 10.1128/MMBR.05028-11; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; Schoener TW, 2011, SCIENCE, V331, P426, DOI 10.1126/science.1193954; Scott M, 2010, SCIENCE, V330, P1099, DOI 10.1126/science.1192588; Sengupta J, 2001, P NATL ACAD SCI USA, V98, P11991, DOI 10.1073/pnas.211266898; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Srivatsan A, 2008, CURR OPIN MICROBIOL, V11, P100, DOI 10.1016/j.mib.2008.02.001; Stevens MHH, 2007, GENETICS, V177, P2243, DOI 10.1534/genetics.107.076869; Subramaniam AR, 2014, CELL, V159, P1200, DOI 10.1016/j.cell.2014.10.043; Szekely P, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003163; Tsuru S, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.24; Usui K, 2014, FEBS LETT, V588, P117, DOI 10.1016/j.febslet.2013.11.018; Vulic M, 2001, GENETICS, V158, P519; Watson SP, 1998, J BACTERIOL, V180, P1750, DOI 10.1128/JB.180.7.1750-1758.1998; Wilson DN, 2007, CRIT REV BIOCHEM MOL, V42, P187, DOI 10.1080/10409230701360843; Ying BW, 2014, MOL BIOSYST, V10, P375, DOI 10.1039/c3mb70254e; Ying BW, 2010, J BIOSCI BIOENG, V110, P529, DOI 10.1016/j.jbiosc.2010.05.014; ZAMBRANO MM, 1993, SCIENCE, V259, P1757, DOI 10.1126/science.7681219; Zinser ER, 2004, RES MICROBIOL, V155, P328, DOI 10.1016/j.resmic.2004.01.014; Zinser ER, 1999, J BACTERIOL, V181, P5800, DOI 10.1128/JB.181.18.5800-5807.1999; Zundel MA, 2009, RNA, V15, P977, DOI 10.1261/rna.1381309	80	12	12	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135639	10.1371/journal.pone.0135639	http://dx.doi.org/10.1371/journal.pone.0135639			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5KH	26292224	Green Published, Green Submitted, gold			2022-12-26	WOS:000359919900023
J	Yuasa, K; Yotsumoto, Y				Yuasa, Kenichi; Yotsumoto, Yuko			Opposite Distortions in Interval Timing Perception for Visual and Auditory Stimuli with Temporal Modulations	PLOS ONE			English	Article							TIME PERCEPTION; INTERNAL CLOCK; SPEEDING-UP; SUBJECTIVE TIME; CROSSMODAL INTERACTION; PERCEIVED DURATION; NEURAL BASIS; CHILDREN; FLICKER; VISION	When an object is presented visually and moves or flickers, the perception of its duration tends to be overestimated. Such an overestimation is called time dilation. Perceived time can also be distorted when a stimulus is presented aurally as an auditory flutter, but the mechanisms and their relationship to visual processing remains unclear. In the present study, we measured interval timing perception while modulating the temporal characteristics of visual and auditory stimuli, and investigated whether the interval times of visually and aurally presented objects shared a common mechanism. In these experiments, participants compared the durations of flickering or fluttering stimuli to standard stimuli, which were presented continuously. Perceived durations for auditory flutters were underestimated, while perceived durations of visual flickers were overestimated. When auditory flutters and visual flickers were presented simultaneously, these distortion effects were cancelled out. When auditory flutters were presented with a constantly presented visual stimulus, the interval timing perception of the visual stimulus was affected by the auditory flutters. These results indicate that interval timing perception is governed by independent mechanisms for visual and auditory processing, and that there are some interactions between the two processing systems.	[Yuasa, Kenichi; Yotsumoto, Yuko] Univ Tokyo, Dept Life Sci, Tokyo, Japan	University of Tokyo	Yotsumoto, Y (corresponding author), Univ Tokyo, Dept Life Sci, Tokyo, Japan.	cyuko@mail.ecc.u-tokyo.ac.jp	Yuasa, Kenichi/ABC-4428-2021	Yuasa, Kenichi/0000-0002-5697-7537	Japan Society for the Promotion of Science, Research fellowship for young scientists [02601927];  [25119003];  [24330208]	Japan Society for the Promotion of Science, Research fellowship for young scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; 	This work was supported by Grants-in-Aid for Scientific Research, Grant-in-Aid for Scientific Research on Innovative Areas (25119003) for YY; Grant-in-Aid for Scientific Research(B)(24330208) for YY; and Japan Society for the Promotion of Science, Research fellowship for young scientists (02601927) for KY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Allman MJ, 2014, ANNU REV PSYCHOL, V65, P743, DOI 10.1146/annurev-psych-010213-115117; Allman MJ, 2012, BRAIN, V135, P656, DOI 10.1093/brain/awr210; Arnal LH, 2015, CEREB CORTEX, V25, P3077, DOI 10.1093/cercor/bhu103; Aschersleben G, 2003, INT J PSYCHOPHYSIOL, V50, P157, DOI 10.1016/S0167-8760(03)00131-4; BERTELSON P, 1981, PERCEPT PSYCHOPHYS, V29, P578, DOI 10.3758/BF03207374; Bertelson P, 2003, INT J PSYCHOPHYSIOL, V50, P147, DOI 10.1016/S0167-8760(03)00130-2; Binetti N, 2012, J VISION, V12, DOI 10.1167/12.7.8; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Buhusi CV, 2013, BEHAV PROCESS, V95, P60, DOI 10.1016/j.beproc.2013.02.015; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Burle B, 2001, J EXP PSYCHOL HUMAN, V27, P195, DOI 10.1037/0096-1523.27.1.195; Burr D, 2009, EXP BRAIN RES, V198, P49, DOI 10.1007/s00221-009-1933-z; Chen KM, 2009, ACTA PSYCHOL, V130, P225, DOI 10.1016/j.actpsy.2008.12.008; Cordes S, 2014, J EXP PSYCHOL GEN, V143, P710, DOI 10.1037/a0032439; CREELMAN CD, 1962, J ACOUST SOC AM, V34, P582, DOI 10.1121/1.1918172; Droit-Volet S, 2004, Q J EXP PSYCHOL-A, V57, P797, DOI 10.1080/02724980343000495; Droit-Volet S, 2002, Q J EXP PSYCHOL-B, V55, P193, DOI 10.1080/02724990143000252; Droit-Volet S, 2007, BEHAV PROCESS, V74, P244, DOI 10.1016/j.beproc.2006.09.012; Droit-Volet S, 2010, BEHAV PROCESS, V85, P126, DOI 10.1016/j.beproc.2010.06.017; Escoffier N, 2015, NEUROIMAGE, V111, P267, DOI 10.1016/j.neuroimage.2015.02.024; Fendrich R, 2001, PERCEPT PSYCHOPHYS, V63, P719, DOI 10.3758/BF03194432; Gibbon J, 1997, CURR OPIN NEUROBIOL, V7, P170, DOI 10.1016/S0959-4388(97)80005-0; Gil S, 2011, ACTA PSYCHOL, V136, P354, DOI 10.1016/j.actpsy.2010.12.010; Grahn JA, 2011, NEUROIMAGE, V54, P1231, DOI 10.1016/j.neuroimage.2010.09.033; Grondin S, 2010, ATTEN PERCEPT PSYCHO, V72, P561, DOI 10.3758/APP.72.3.561; Gu BM, 2015, NEUROSCI BIOBEHAV R, V48, P160, DOI 10.1016/j.neubiorev.2014.10.008; Harrington DL, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00032; Hashimoto Y, TIMING TIME PERCEPTI; Hayashi MJ, 2014, J COGNITIVE NEUROSCI, V26, P1685, DOI 10.1162/jocn_a_00580; Herbst SK, 2015, BRAIN TOPOGR, V28, P559, DOI 10.1007/s10548-014-0389-z; Herbst SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076074; Heron J, 2013, J VISION, V13, DOI 10.1167/13.14.4; Johnston A, 2006, CURR BIOL, V16, P472, DOI 10.1016/j.cub.2006.01.032; Kanai R, 2006, J VISION, V6, P1421, DOI 10.1167/16.12.8; Kanai R, 2011, EXP BRAIN RES, V209, P465, DOI 10.1007/s00221-011-2577-3; Kanai R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001253; Kleiner M, 2007, PERCEPTION, V36, P14; Koch G, 2009, PHILOS T R SOC B, V364, P1907, DOI 10.1098/rstb.2009.0018; Kosem A, 2014, NEUROIMAGE, V92, P274, DOI 10.1016/j.neuroimage.2014.02.010; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; Lewis PA, 2006, TRENDS COGN SCI, V10, P401, DOI 10.1016/j.tics.2006.07.006; Matell MS, 2004, COGNITIVE BRAIN RES, V21, P139, DOI 10.1016/j.cogbrainres.2004.06.012; Matthews WJ, 2014, WIRES COGN SCI, V5, P429, DOI 10.1002/wcs.1298; Matthews WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019815; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; Merchant H, 2013, ANNU REV NEUROSCI, V36, P313, DOI 10.1146/annurev-neuro-062012-170349; Morillon B, 2009, J NEUROSCI, V29, P14803, DOI 10.1523/JNEUROSCI.3222-09.2009; Ono F, 2010, ATTEN PERCEPT PSYCHO, V72, P492, DOI 10.3758/APP.72.2.492; Ortega L, 2008, BEHAV PROCESS, V78, P380, DOI 10.1016/j.beproc.2008.02.004; Pariyadath V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001264; Park J, 2003, EXP BRAIN RES, V149, P527, DOI 10.1007/s00221-003-1376-x; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Penney TB, 2000, J EXP PSYCHOL HUMAN, V26, P1770, DOI 10.1037//0096-1523.26.6.1770; Penney TB, 2014, ACTA PSYCHOL, V147, P97, DOI 10.1016/j.actpsy.2013.07.017; PentonVoak IS, 1996, J EXP PSYCHOL ANIM B, V22, P307, DOI 10.1037/0097-7403.22.3.307; Pouthas V, 2005, HUM BRAIN MAPP, V25, P433, DOI 10.1002/hbm.20126; Repp BH, 2002, J EXP PSYCHOL HUMAN, V28, P1085, DOI 10.1037//0096-1523.28.5.1085; Repp BH, 2013, TIMING TIME PERCEPTI, V1, P65, DOI [10.1163/22134468-00002001, DOI 10.1163/22134468-00002001]; Rousseau L, 1996, PERCEPT PSYCHOPHYS, V58, P434, DOI 10.3758/BF03206819; Schwartze M, 2012, NEUROIMAGE, V60, P290, DOI 10.1016/j.neuroimage.2011.11.089; Shams L, 2002, COGNITIVE BRAIN RES, V14, P147, DOI 10.1016/S0926-6410(02)00069-1; Shi ZH, 2013, TRENDS COGN SCI, V17, P556, DOI 10.1016/j.tics.2013.09.009; Shimojo S., 2001, Acoustical Science and Technology, V22, P61, DOI 10.1250/ast.22.61; Shimojo S, 2001, CURR OPIN NEUROBIOL, V11, P505, DOI 10.1016/S0959-4388(00)00241-5; TREISMAN M, 1963, PSYCHOL MONOGR, V77, P1, DOI 10.1037/h0093864; TREISMAN M, 1990, PERCEPTION, V19, P705, DOI 10.1068/p190705; TREISMAN M, 1992, EUR J COGN PSYCHOL, V4, P41, DOI 10.1080/09541449208406242; Ulrich R, 2006, PSYCHOL RES-PSYCH FO, V70, P77, DOI 10.1007/S00426-004-0195-4; van Rijn H, 2014, ADV EXP MED BIOL, V829, P75, DOI 10.1007/978-1-4939-1782-2_5; van Rijn H, 2008, ACTA PSYCHOL, V129, P365, DOI 10.1016/j.actpsy.2008.09.002; van Wassenhove V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001437; Wada Y, 2003, INT J PSYCHOPHYSIOL, V50, P117, DOI 10.1016/S0167-8760(03)00128-4; Wearden JH, 2006, Q J EXP PSYCHOL, V59, P1709, DOI 10.1080/17470210500314729; Wearden JH, 1998, Q J EXP PSYCHOL-B, V51, P97; Wearden JH, 1999, BEHAV PROCESS, V46, P63, DOI 10.1016/S0376-6357(99)00004-2; Wearden JH, 2009, Q J EXP PSYCHOL, V62, P33, DOI 10.1080/17470210802229047; WELCH RB, 1980, PSYCHOL BULL, V88, P638, DOI 10.1037/0033-2909.88.3.638; Wiener M, 2010, NEUROIMAGE, V49, P1728, DOI 10.1016/j.neuroimage.2009.09.064; Yarrow K, 2003, CURR BIOL, V13, P1134, DOI 10.1016/S0960-9822(03)00413-5	80	10	10	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2015	10	8							e0135646	10.1371/journal.pone.0135646	http://dx.doi.org/10.1371/journal.pone.0135646			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP5KH	26292285	Green Published, gold, Green Submitted			2022-12-26	WOS:000359919900024
J	Hoshiba, T; Nemoto, E; Sato, K; Orui, T; Otaki, T; Yoshihiro, A; Tanaka, M				Hoshiba, Takashi; Nemoto, Eri; Sato, Kazuhiro; Orui, Toshihiko; Otaki, Takayuki; Yoshihiro, Ayano; Tanaka, Masaru			Regulation of the Contribution of Integrin to Cell Attachment on Poly(2-Methoxyethyl Acrylate) (PMEA) Analogous Polymers for Attachment-Based Cell Enrichment	PLOS ONE			English	Article							FIBRONECTIN ADSORPTION; BLOOD COMPATIBILITY; PROTEIN ADSORPTION; WATER-STRUCTURE; ADHESION; EXPRESSION; CADHERIN; BINDING; SURFACE	Cell enrichment is currently in high demand in medical engineering. We have reported that non-blood cells can attach to a blood-compatible poly(2-methoxyethyl acrylate) (PMEA) substrate through integrin-dependent and integrin-independent mechanisms because the PMEA substrate suppresses protein adsorption. Therefore, we assumed that PMEA analogous polymers can change the contribution of integrin to cell attachment through the regulation of protein adsorption. In the present study, we investigated protein adsorption, cell attachment profiles, and attachment mechanisms on PMEA analogous polymer substrates. Additionally, we demonstrated the possibility of attachment-based cell enrichment on PMEA analogous polymer substrates. HT-1080 and MDA-MB-231 cells started to attach to poly(butyl acrylate) (PBA) and poly(tetrahydrofurfuryl acrylate) (PTHFA), on which proteins could adsorb well, within 1 h. HepG2 cells started to attach after 1 h. HT-1080, MDA-MB-231, and HepG2 cells started to attach within 30 min to PMEA, poly(2-(2-methoxyethoxy) ethyl acrylate-co-butyl acrylate) (30:70 mol%, PMe2A) and poly(2-(2-methoxyethoxy) ethoxy ethyl acrylate-co-butyl acrylate) (30: 70 mol%, PMe3A), which suppress protein adsorption. Moreover, the ratio of attached cells from a cell mixture can be changed on PMEA analogous polymers. These findings suggested that PMEA analogous polymers can be used for attachment-based cell enrichment.	[Hoshiba, Takashi; Nemoto, Eri; Sato, Kazuhiro; Orui, Toshihiko; Otaki, Takayuki; Tanaka, Masaru] Yamagata Univ, Grad Sch Sci & Engn, Yonezawa, Yamagata, Japan; [Hoshiba, Takashi] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton, Tsukuba, Ibaraki, Japan; [Yoshihiro, Ayano] Yamagata Univ, Dept Biochem Engn, Yonezawa, Yamagata, Japan; [Tanaka, Masaru] Kyushu Univ, Inst Mat Chem & Engn, Nishi Ku, Fukuoka 812, Japan	Yamagata University; National Institute for Materials Science; Yamagata University; Kyushu University	Hoshiba, T (corresponding author), Yamagata Univ, Grad Sch Sci & Engn, Yonezawa, Yamagata, Japan.	thoshiba@yz.yamagata-u.ac.jp; masaru_tanaka@ms.ifoc.kyushu-u.ac.jp	Tanaka, Masaru/O-3388-2018	Tanaka, Masaru/0000-0002-1115-2080	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; MEXT, Japan [26702016]	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Funding Program for the Next Generation World-Leading Researchers (NEXT Program) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan and a Grant-in-Aid for Young Scientists (A) (26702016) from MEXT, Japan.	Cho CS, 2006, BIOMATERIALS, V27, P576, DOI 10.1016/j.biomaterials.2005.06.008; Elvington ES, 2013, JOVE-J VIS EXP, DOI 10.3791/50634; Goessler UR, 2006, OTOLARYNG HEAD NECK, V134, P510, DOI 10.1016/j.otohns.2005.10.026; GRINNELL F, 1982, J BIOL CHEM, V257, P4888; Hatakeyama T, 2010, ACTA BIOMATER, V6, P2077, DOI 10.1016/j.actbio.2009.12.018; Hoshiba T, 2014, ADV HEALTHC MATER, V3, P775, DOI 10.1002/adhm.201300309; Jasaitis A, 2012, BIOPHYS J, V103, P175, DOI 10.1016/j.bpj.2012.06.009; Jaye DL, 2012, J IMMUNOL, V188, P4715, DOI 10.4049/jimmunol.1290017; Kai Z, 2014, STEM CELLS DEV, V23, P1340, DOI [10.1089/scd.2013.0510, DOI 10.1089/SCD.2013.0510]; Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537; Kikkawa Y, 2009, BIOMATERIALS, V30, P6888, DOI 10.1016/j.biomaterials.2009.09.011; Koenig AL, 2003, J BIOMED MATER RES A, V64A, P20, DOI 10.1002/jbm.a.10316; Liu J, 2005, CELL METAB, V2, P165, DOI 10.1016/j.cmet.2005.08.006; Mahara A, 2010, BIOMATERIALS, V31, P4231, DOI 10.1016/j.biomaterials.2010.01.126; Mochizuki A, 2009, J BIOMAT SCI-POLYM E, V20, P591, DOI 10.1163/156856209X426411; Sato K, MACROMOL BI IN PRESS; Sheng WA, 2012, ANAL CHEM, V84, P4199, DOI 10.1021/ac3005633; Singh A, 2013, NAT METHODS, V10, P438, DOI [10.1038/nmeth.2437, 10.1038/NMETH.2437]; Tanaka M, 2000, BIOMATERIALS, V21, P1471, DOI 10.1016/S0142-9612(00)00031-4; Tanaka M, 2004, J BIOMED MATER RES A, V68A, P684, DOI 10.1002/jbm.a.20088; Tanaka M, 2001, COLLOID SURFACE A, V193, P145, DOI 10.1016/S0927-7757(01)00682-3; Tanaka M, 2013, POLYM J, V45, P701, DOI 10.1038/pj.2012.229; Tian J, RHEUMATOL I IN PRESS; Tuli R, 2003, J BIOL CHEM, V278, P41227, DOI 10.1074/jbc.M305312200; UNDERWOOD PA, 1989, J CELL SCI, V93, P641; Wadajkar AS, 2014, BIOMATERIALS, V35, P654, DOI 10.1016/j.biomaterials.2013.10.015; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Yoon DS, 2014, FASEB J, V28, P3273, DOI 10.1096/fj.13-248567; Yu M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/jcb.201010021; Zhu BL, 2013, CURR OPIN CHEM ENG, V2, P3, DOI 10.1016/j.coche.2012.11.002	30	31	31	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0136066	10.1371/journal.pone.0136066	http://dx.doi.org/10.1371/journal.pone.0136066			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288362	gold, Green Published, Green Submitted			2022-12-26	WOS:000360018600104
J	Itkonen, T; Pekkanen, J; Lappi, O				Itkonen, Teemu; Pekkanen, Jami; Lappi, Otto			Driver Gaze Behavior Is Different in Normal Curve Driving and when Looking at the Tangent Point	PLOS ONE			English	Article							MODEL	Several steering models in the visual science literature attempt to capture the visual strategies in curve driving. Some of them are based on steering points on the future path (FP), others on tangent points (TP). It is, however, challenging to differentiate between the models' predictions in real-world contexts. Analysis of optokinetic nystagmus (OKN) parameters is one useful measure, as the different strategies predict measurably different OKN patterns. Here, we directly test this prediction by asking drivers to either a) "drive as they normally would" or b) to "look at the TP". The design of the experiment is similar to a previous study by Kandil et al., but uses more sophisticated methods of eye-movement analysis. We find that the eye-movement patterns in the "normal" condition are indeed markedly different from the "tp" condition, and consistent with drivers looking at waypoints on the future path. This is the case for both overall fixation distribution, as well as the more informative fixation-by-fixation analysis of OKN. We find that the horizontal gaze speed during OKN corresponds well to the quantitative prediction of the future path models. The results also definitively rule out the alternative explanation that the OKN is produced by an involuntary reflex even while the driver is "trying" to look at the TP. The results are discussed in terms of the sequential organization of curve driving.	[Itkonen, Teemu; Pekkanen, Jami; Lappi, Otto] Univ Helsinki, Inst Behav Sci, Cognit Sci Div, Traff Res Unit, Helsinki, Finland; [Itkonen, Teemu] Aalto Univ, Dept Civil & Environm Engn, Transportat Engn, Aalto, Finland	University of Helsinki; Aalto University	Lappi, O (corresponding author), Univ Helsinki, Inst Behav Sci, Cognit Sci Div, Traff Res Unit, Helsinki, Finland.	otto.lappi@helsinki.fi	Lappi, Otto/I-2295-2019	Lappi, Otto/0000-0002-7996-7665; Pekkanen, Jami/0000-0001-6974-8760	Finnish Academy [1279905]	Finnish Academy(Academy of Finland)	Funding: Mr. Jami Pekkanen was employed in MULSIMCO project funded by the Finnish Academy (www.aka.fi, project no. 1279905 PI prof. Heikki Summala). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Authie CN, 2010, VISION RES, V51, P1791; Authie CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031479; Boer ER, 1996, PROCEEDINGS OF THE 1996 IEEE INTELLIGENT VEHICLES SYMPOSIUM, P7, DOI 10.1109/IVS.1996.566341; Bradski G., 2000, DOBBS J SOFTWARE TOO; DONGES E, 1978, HUM FACTORS, V20, P691, DOI 10.1177/001872087802000607; Jackson B, 2005, IEEE SIGNAL PROC LET, V12, P105, DOI 10.1109/LSP.2001.838216; Kandil FI, 2009, J VISION, V9, DOI 10.1167/9.1.11; Killick R, 2012, J AM STAT ASSOC, V107, P1590, DOI 10.1080/01621459.2012.737745; Kim NG, 1999, ECOL PSYCHOL, V11, P233, DOI 10.1207/s15326969eco1103_3; Land M. F., 1998, VISION AND ACTION, P163, DOI DOI 10.1016/S0960-9822(01)0; LAND MF, 1994, NATURE, V369, P742, DOI 10.1038/369742a0; Lappi O, 2013, THESIS U HELSINKI; Lappi O, 2014, J VISION, V14, DOI 10.1167/14.12.21; Lappi O, 2013, J EYE MOVEMENT RES, V6; Lappi O, 2013, J VISION, V13, DOI 10.1167/13.13.11; Lappi O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068326; Raviv D., 1991, Proceedings of the IEEE Workshop on Visual Motion (Cat. No.91TH0390-5), P217, DOI 10.1109/WVM.1991.212804; Salvucci DD, 2004, PERCEPTION, V33, P1233, DOI 10.1068/p5343; Wann J, 2000, TRENDS COGN SCI, V4, P319, DOI 10.1016/S1364-6613(00)01513-8; Wann J. P., 2004, OPTIC FLOW, P371; Wann JP, 2000, NAT NEUROSCI, V3, P647, DOI 10.1038/76602; Wilkie RM, 2008, J EXP PSYCHOL HUMAN, V34, P1150, DOI 10.1037/0096-1523.34.5.1150	22	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135505	10.1371/journal.pone.0135505	http://dx.doi.org/10.1371/journal.pone.0135505			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CP6SN	26287914	Green Published, gold, Green Submitted			2022-12-26	WOS:000360018600051
J	Carvalho, MAM; Saintrain, MVD; Dos Anjos, RED; Pinheiro, SS; Cardoso, LDP; Moizan, JAH; de Aguiar, ASW				Melo Carvalho Filho, Marcus Antonio; de Lima Saintrain, Maria Vieira; da Silveira Dos Anjos, Rita Edna; Pinheiro, Solange Sousa; Padua Cardoso, Luciana de Carvalho; Herve Moizan, Jean Andre; Walter de Aguiar, Andrea Silvia			Prevalence of Oral and Maxillofacial Trauma in Elders Admitted to a Reference Hospital in Northeastern Brazil	PLOS ONE			English	Article							POPULATION	Objective To know the prevalence and etiology of oral and maxillofacial trauma in elders. Methods Analytical quantitative cross-sectional study conducted at a public trauma hospital located in Fortaleza-Ceara, Brazil. The study population comprised patients with trauma who were hospitalized from April to August 2014. Of these patients, patients with oral and maxillofacial trauma were chosen to be included in the research. A questionnaire was administered in order to obtain information on socio-demographics, systemic comorbidities, use of medication, deleterious habits (smoking and alcohol consumption), etiology of oral and maxillofacial trauma and type of pre-hospital care. Results Of the 280 elderly hospitalized with trauma, 47 had oral and maxillofacial trauma, with a prevalence of 16.8%. In this group, the age ranged from 60 to 88 years, with a mean age of 72.4 years (SD +/- 8.38). The elderly were mostly women (55.3%), self-declared pardos (53.2%), who presented with cardiovascular disorders (48.9%), and who received formal pre-hospital care (70.2%). Elderly who were in the 60-69 years age group, spent 6-9 years at school and drank alcohol were 2.64, 3.75, and 1.97, respectively, more likely to suffer oral and maxillofacial trauma. The main causes of trauma were physical aggression, traffic accidents, falls and domestic accidents. All of the physical aggressions resulted in oral and maxillofacial traumas, and the elderly who suffered traffic accidents were four times more likely to have oral and maxillofacial trauma. Conclusion The prevalence of 16.8% and the lack of research on oral and maxillofacial traumas in the elderly is worrisome and should be included in the oral health indicators for the elderly population to support the importance of oral health.	[Melo Carvalho Filho, Marcus Antonio; da Silveira Dos Anjos, Rita Edna; Pinheiro, Solange Sousa; Padua Cardoso, Luciana de Carvalho] Univ Fortaleza UNIFOR, Collect Hlth Masters Degree Program, Ctr Hlth Sci, Fortaleza, Ceara, Brazil; [de Lima Saintrain, Maria Vieira] Univ Fortaleza UNIFOR, Ctr Hlth Sci, Fortaleza, Ceara, Brazil; [Herve Moizan, Jean Andre] Univ Rouen, Rouen Univ Hosp, Dept Dent, Rouen, France; [Walter de Aguiar, Andrea Silvia] Univ Fed Ceara, Dent Clin Dept, Fortaleza, Ceara, Brazil	Universidade Fortaleza; Universidade Fortaleza; CHU de Rouen; Universite de Rouen Normandie; Universidade Federal do Ceara	Saintrain, MVD (corresponding author), Univ Fortaleza UNIFOR, Ctr Hlth Sci, Fortaleza, Ceara, Brazil.	mariavieira@yahoo.com.br			Coordination for the Improvement of Higher Education Personnel (CAPES-PRODAD)	Coordination for the Improvement of Higher Education Personnel (CAPES-PRODAD)	Funding: This study was supported by the Coordination for the Improvement of Higher Education Personnel (CAPES-PRODAD), for the scholarship provided to co-authors LCPC and SSP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qamachi LH, 2012, GERODONTOLOGY, V29, pE147, DOI 10.1111/j.1741-2358.2010.00431.x; Almasri M, 2013, SAUDI DENT J, V25, P107, DOI 10.1016/j.sdentj.2013.04.001; [Anonymous], 2022, TABLES 84F0209X MORT; Brasil, 2006, DIARIO OFICIAL UNIAO; Brasil, 2012, SAUD BRAS 2011 AN SI; Brasil, 2011, SAUD BRAS 2010 AN SI; Chrcanovic BR, 2008, REV ABO NACL, V16, P39; Zaitune MPD, 2012, CAD SAUDE PUBLICA, V28, P583; dos Reis LA, 2011, TEXTO CONTEXTO ENFER, V20, P52, DOI 10.1590/S0104-07072011000500006; Gassner R, 2003, J CRANIO MAXILL SURG, V31, P51, DOI 10.1016/S1010-5182(02)00168-3; Gowing R, 2007, CAN J SURG, V50, P437; Guarnizo-Herreno CC, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-827; Hsia RY, 2011, ARCH SURG-CHICAGO, V146, P585, DOI 10.1001/archsurg.2010.311; Instituto Brasileiro de Geografia e Estatistica (IBGE), 2012, CENS DEM 2010 RES GE; Instituto Brasileiro de Geografia e Estatistica (IBGE), 2014, PESQ NAC AM DOM SINT; Iwaki-Filho L, 2010, REV ODONTOL UNESP, V39, P363; Kapoor Pranav, 2012, Int J Crit Illn Inj Sci, V2, P6, DOI 10.4103/2229-5151.94872; Kara H, 2014, CLIN INTERV AGING, V9, P17, DOI 10.2147/CIA.S56542; Lima Rogério Silva, 2011, Rev. esc. enferm. USP, V45, P659; Maliska Maximiana Cristina de Souza, 2009, Braz. oral res., V23, P268, DOI 10.1590/S1806-83242009000300008; Martinez AY, 2014, J ORAL MAXIL SURG, V72, P750, DOI 10.1016/j.joms.2013.11.018; Organisation Mondiale de la Sante (OMS), 2009, FEMM SANT REAL AUJ P; Paes Jefferson Viapiana, 2012, Indian J Dent Res, V23, P80, DOI 10.4103/0970-9290.99045; Rahman NA, 2010, GERIATR GERONTOL INT, V10, P64, DOI 10.1111/j.1447-0594.2009.00561.x; Rodrigues J, 2012, REV ESC ENFERM USP, V46, P1401; Leles JLR, 2010, J APPL ORAL SCI, V18, P23, DOI 10.1590/S1678-77572010000100006; Secretaria da Saude do Ceara (SESA), 2014, HOSP REG CAR REF CIR; Silva Andréia Lobato da, 2006, Rev. bras. epidemiol., V9, P242, DOI 10.1590/S1415-790X2006000200011; Soares MDA, 2012, SAUDE IDOSOESTUDOS P; Sociedade Brasileira de Diabetes (SBD), 2014, DIR SOC BRAS DIAB 20; Thoren H, 2010, INT J ORAL MAX SURG, V39, P774, DOI 10.1016/j.ijom.2010.03.024; United Nations Population Division, WORLD POP PROSP 2010; Velayutham L, 2013, BRIT J ORAL MAX SURG, V51, P128, DOI 10.1016/j.bjoms.2012.05.003; Veras R., 2008, TERCEIRA IDADE GESTA; Watts Hannah F, 2012, J Emerg Trauma Shock, V5, P131, DOI 10.4103/0974-2700.96481; World Health Organization, WHO GLOB BURD COR HE; Wulkan Marcelo, 2005, Rev. Assoc. Med. Bras., V51, P290, DOI 10.1590/S0104-42302005000500022; Yamamoto K, 2011, J ORAL MAXIL SURG, V69, P2204, DOI 10.1016/j.joms.2011.02.115; Yildiz M, 2012, EUR REV MED PHARMACO, V16, P62	39	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2015	10	8							e0135813	10.1371/journal.pone.0135813	http://dx.doi.org/10.1371/journal.pone.0135813			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP6SN	26288229	Green Published, gold			2022-12-26	WOS:000360018600072
J	Bailes, F; Dean, RT; Broughton, MC				Bailes, Freya; Dean, Roger T.; Broughton, Mary C.			How Different Are Our Perceptions of Equal-Tempered and Microtonal Intervals? A Behavioural and EEG Survey	PLOS ONE			English	Article							SENSORY CONSONANCE; MOVEMENT TIME; MUSICIANS; NONMUSICIANS; POTENTIALS; CONTEXT; ERP	For listeners familiar with Western twelve-tone equal-tempered (12-TET) music, a novel microtonal tuning system is expected to present additional processing challenges. We aimed to determine whether this was the case, focusing on the extent to which our perceptions can be considered bottom-up (psychoacoustic and primarily perceptual) and top-down (dependent on familiarity and cognitive processing). We elicited both overt response ratings, and covert event-related potentials (ERPs), so as to compare subjective impressions of sounds with the neurophysiological processing of the acoustic signal. We hypothesised that microtonal intervals are perceived differently from 12-TET intervals, and that the responses of musicians (n = 10) and non-musicians (n = 10) are distinct. Two-note chords were presented comprising 12-TET intervals (consonant and dissonant) or microtonal (quarter tone) intervals, and ERP, subjective roughness ratings, and liking ratings were recorded successively. Musical experience mediated the perception of differences between dissonant and microtone intervals, with non-musicians giving similar ratings for each, and musicians preferring dissonant over the less commonly used microtonal intervals, rating them as less rough. ERP response amplitude was greater for consonant intervals than other intervals. Musical experience interacted with interval type, suggesting that musical expertise facilitates the sensory and perceptual discrimination of microtonal intervals from 12-TET intervals, and an increased ability to categorize such intervals. Non-musicians appear to have perceived microtonal intervals as instances of neighbouring 12-TET intervals.	[Bailes, Freya] Univ Hull, Sch Drama Mus & Screen, Kingston Upon Hull HU6 7RX, N Humberside, England; [Dean, Roger T.] Univ Western Sydney, MARCS Inst, Penrith, NSW 1797, Australia; [Broughton, Mary C.] Univ Queensland, Sch Mus, Brisbane, Qld, Australia	University of Hull; Western Sydney University; University of Queensland	Bailes, F (corresponding author), Univ Hull, Sch Drama Mus & Screen, Kingston Upon Hull HU6 7RX, N Humberside, England.	F.Bailes@hull.ac.uk	Broughton, Mary/C-2861-2014	Broughton, Mary/0000-0003-3490-6073; Bailes, Freya/0000-0003-2723-3579; Dean, Roger Thornton/0000-0002-8859-8902				Bates D.M., 2010, LME4 MIXED EFFECTS M; Blood AJ, 1999, NAT NEUROSCI, V2, P382, DOI 10.1038/7299; Bradley MM, 2000, PSYCHOPHYSIOLOGY, V37, P204, DOI 10.1111/1469-8986.3720204; Brattico E, 2001, MUSIC PERCEPT, V19, P199, DOI 10.1525/mp.2001.19.2.199; Brattico E, 2009, J COGNITIVE NEUROSCI, V21, P2230, DOI 10.1162/jocn.2008.21144; Dean RT, 2009, LEONARDO, V42, P94, DOI 10.1162/leon.2009.42.1.94; Doucet C, 1999, PSYCHOPHYSIOLOGY, V36, P351, DOI 10.1017/S0048577299980563; Hasegawa R, 2006, CONT MUSIC REV, V25, P263; HOULIHAN M, 1994, INTELLIGENCE, V18, P289, DOI 10.1016/0160-2896(94)90031-0; Itoh K, 2008, ICMPC10; Itoh K, 2010, J ACOUST SOC AM, V128, P3781, DOI 10.1121/1.3500685; Klein ME, 2011, NEUROPSYCHOLOGIA, V49, P878, DOI 10.1016/j.neuropsychologia.2011.01.008; Krumhansl C.L., 1990, COGNITIVE FDN MUSICA, P77; Kung CC, 2014, CLIN NEUROPHYSIOL, V125, P971, DOI 10.1016/j.clinph.2013.10.016; Luck S, 2005, EVENTRELATED POTENTI, P17; Minati L, 2009, NEUROREPORT, V20, P87, DOI 10.1097/WNR.0b013e32831af235; Ollen J. E., 2006, CRITERION RELATED VA; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1111/1469-8986.3720127; PLOMP R, 1965, J ACOUST SOC AM, V38, P548, DOI 10.1121/1.1909741; Regnault P, 2001, J COGNITIVE NEUROSCI, V13, P241, DOI 10.1162/089892901564298; Schon D, 2005, MUSIC PERCEPT, V23, P105, DOI 10.1525/mp.2005.23.2.105; Thompson WF, 2015, MUSIC THOUGHT FEELIN; Wan CY, 2010, NEUROSCIENTIST, V16, P566, DOI 10.1177/1073858410377805	23	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135082	10.1371/journal.pone.0135082	http://dx.doi.org/10.1371/journal.pone.0135082			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285010	Green Published, gold, Green Submitted			2022-12-26	WOS:000359666100021
J	Minguet, EG; Segard, S; Charavay, C; Parcy, F				Minguet, Eugenio Gomez; Segard, Stephane; Charavay, Celine; Parcy, Francois			MORPHEUS, a Webtool for Transcription Factor Binding Analysis Using Position Weight Matrices with Dependency	PLOS ONE			English	Article							FLORAL HOMEOTIC GENE; WEB TOOL; DNA; EVOLUTION; SITES; ACTIVATION; IDENTIFICATION; AFFINITIES; SEQUENCES	Transcriptional networks are central to any biological process and changes affecting transcription factors or their binding sites in the genome are a key factor driving evolution. As more organisms are being sequenced, tools are needed to easily predict transcription factor binding sites (TFBS) presence and affinity from mere inspection of genomic sequences. Although many TFBS discovery algorithms exist, tools for using the DNA binding models they generate are relatively scarce and their use is limited among the biologist community by the lack of flexible and user-friendly tools. We have developed a suite of web tools (called Morpheus) based on the proven Position Weight Matrices (PWM) formalism that can be used without any programing skills and incorporates some unique features such as the presence of dependencies between nucleotides positions or the possibility to compute the predicted occupancy of a large regulatory region using a biophysical model. To illustrate the possibilities and simplicity of Morpheus tools in functional and evolutionary analysis, we have analysed the regulatory link between LEAFY, a key plant transcription factor involved in flower development, and its direct target gene APETALA1 during the divergence of Brassicales clade.	[Minguet, Eugenio Gomez; Parcy, Francois] Univ Grenoble 1, CEA, INRA, Physiol Cellulaire Vegetale Lab,CNRS,UMR 5168, F-38054 Grenoble, France; [Segard, Stephane; Charavay, Celine] Univ Grenoble 1, CEA, Lab Biol Grande Echelle, INSERM,U1038,IRTSV, F-38054 Grenoble 9, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Parcy, F (corresponding author), Univ Grenoble 1, CEA, INRA, Physiol Cellulaire Vegetale Lab,CNRS,UMR 5168, F-38054 Grenoble, France.	francois.parcy@cea.fr	Minguet, Eugenio G/L-4037-2014; Parcy, François/G-9177-2011	Minguet, Eugenio G/0000-0003-0568-4299; Parcy, François/0000-0003-2191-500X	Charmful Program from the Agence Nationale de la Recherche Program [ANR11-BSV2-005-01]; ATIP+ Program from the Centre National de la Recherche Scientifique	Charmful Program from the Agence Nationale de la Recherche Program(French National Research Agency (ANR)); ATIP+ Program from the Centre National de la Recherche Scientifique	This work was supported by the Charmful Program (ANR11-BSV2-005-01) from the Agence Nationale de la Recherche Program to FP and an ATIP+ Program from the Centre National de la Recherche Scientifique to FP and EGM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annala M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020059; Benlloch R, 2011, PLANT J, V67, P1094, DOI 10.1111/j.1365-313X.2011.04660.x; Benos PV, 2002, NUCLEIC ACIDS RES, V30, P4442, DOI 10.1093/nar/gkf578; BERG OG, 1987, J MOL BIOL, V193, P723, DOI 10.1016/0022-2836(87)90354-8; Berger MF, 2009, NAT PROTOC, V4, P393, DOI 10.1038/nprot.2008.195; Bulyk ML, 2002, NUCLEIC ACIDS RES, V30, P1255, DOI 10.1093/nar/30.5.1255; Busch MA, 1999, SCIENCE, V285, P585, DOI 10.1126/science.285.5427.585; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Fourquin C, 2012, PLANT J, V71, P990, DOI 10.1111/j.1365-313X.2012.05046.x; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Granek JA, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r87; Hames C, 2008, EMBO J, V27, P2628, DOI 10.1038/emboj.2008.184; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Lee C, 2013, BIOTECHNIQUES, V54, P141, DOI 10.2144/000113999; Litt A, 2003, GENETICS, V165, P821; Liu C, 2009, DEVELOPMENT, V136, P3379, DOI 10.1242/dev.033076; Man TK, 2001, NUCLEIC ACIDS RES, V29, P2471, DOI 10.1093/nar/29.12.2471; Mathelier A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003214; Medina-Rivera A, 2015, NUCLEIC ACIDS RES, V43, pW50, DOI 10.1093/nar/gkv362; Moyroud E, 2011, PLANT CELL, V23, P1293, DOI 10.1105/tpc.111.083329; Moyroud E, 2010, TRENDS PLANT SCI, V15, P346, DOI 10.1016/j.tplants.2010.03.007; O'Flanagan RA, 2005, BIOINFORMATICS, V21, P2254, DOI 10.1093/bioinformatics/bti361; Parcy F, 1998, NATURE, V395, P561, DOI 10.1038/26903; Purugganan MD, 1997, J MOL EVOL, V45, P392, DOI 10.1007/PL00006244; Purugganan MD, 1998, P NATL ACAD SCI USA, V95, P8130, DOI 10.1073/pnas.95.14.8130; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Rhee Ho Sung, 2012, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2124s100; Roider HG, 2007, BIOINFORMATICS, V23, P134, DOI 10.1093/bioinformatics/btl565; Sayou C, 2014, SCIENCE, V343, P645, DOI 10.1126/science.1248229; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Serwatowska J, 2014, PLOS ONE IN PRESS; Siddharthan R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009722; Stormo Gary D, 2013, Quant Biol, V1, P115; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Wagner D, 1999, SCIENCE, V285, P582, DOI 10.1126/science.285.5427.582; Ward LD, 2008, BIOINFORMATICS, V24, pI165, DOI 10.1093/bioinformatics/btn154; Winter CM, 2011, DEV CELL, V20, P430, DOI 10.1016/j.devcel.2011.03.019; Workman CT, 2005, NUCLEIC ACIDS RES, V33, pW389, DOI 10.1093/nar/gki439; Zhao Y, 2012, GENETICS, V191, P781, DOI 10.1534/genetics.112.138685	43	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135586	10.1371/journal.pone.0135586	http://dx.doi.org/10.1371/journal.pone.0135586			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26285209	Green Published, Green Submitted, gold			2022-12-26	WOS:000359666100047
J	Portis, E; Cericola, F; Barchi, L; Toppino, L; Acciarri, N; Pulcini, L; Sala, T; Lanteri, S; Rotino, GL				Portis, Ezio; Cericola, Fabio; Barchi, Lorenzo; Toppino, Laura; Acciarri, Nazzareno; Pulcini, Laura; Sala, Tea; Lanteri, Sergio; Rotino, Giuseppe Leonardo			Association Mapping for Fruit, Plant and Leaf Morphology Traits in Eggplant	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RNA-BINDING PROTEINS; QTL ANALYSIS; PECTIN METHYLESTERASES; LINKAGE DISEQUILIBRIUM; GENE-FUNCTION; TOMATO; SIZE; IDENTIFICATION; EVOLUTION	An eggplant (Solanum melongena) association panel of 191 accessions, comprising a mixture of breeding lines, old varieties and landrace selections was SNP genotyped and pheno-typed for key breeding fruit and plant traits at two locations over two seasons. A genomewide association (GWA) analysis was performed using the mixed linear model, which takes into account both a kinship matrix and the sub-population membership of the accessions. Overall, 194 phenotype/genotype associations were uncovered, relating to 30 of the 33 measured traits. These associations involved 79 SNP loci mapping to 39 distinct chromosomal regions distributed over all 12 eggplant chromosomes. A comparison of the map positions of these SNPs with those of loci derived from conventional linkage mapping showed that GWA analysis both validated many of the known controlling loci and detected a large number of new marker/trait associations. Exploiting established syntenic relationships between eggplant chromosomes and those of tomato and pepper recognized orthologous regions in ten eggplant chromosomes harbouring genes influencing breeders' traits.	[Portis, Ezio; Cericola, Fabio; Barchi, Lorenzo; Lanteri, Sergio] Univ Turin, Dipartimento Sci Agr Forestali & Alimentari DISAF, I-10095 Turin, Italy; [Cericola, Fabio; Toppino, Laura; Sala, Tea; Rotino, Giuseppe Leonardo] Consiglio Ric Agr & Anal Econ Agr CREA, Res Unit Vegetable Crops, I-26836 Lodi, Italy; [Acciarri, Nazzareno; Pulcini, Laura] Consiglio Ric Agr & Anal Econ Agr CREA, Res Unit Vegetable Crops, I-63030 Monsampolo Del Tronto, Ascoli Piceno, Italy	University of Turin; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA)	Rotino, GL (corresponding author), Consiglio Ric Agr & Anal Econ Agr CREA, Res Unit Vegetable Crops, I-26836 Lodi, Italy.	giuseppeleonardo.rotino@entecra.it	BARCHI, Lorenzo/ABC-4206-2020; Sala, Tea/AAA-4156-2021	BARCHI, Lorenzo/0000-0001-6414-4239; PORTIS, Ezio/0000-0002-1548-6096; Toppino, Laura/0000-0002-8664-1233; PULCINI, LAURA/0000-0002-8335-4108; Acciarri, Nazzareno/0000-0002-0892-5994	Italian Ministry of Agricultural Alimentary and Forest Politics	Italian Ministry of Agricultural Alimentary and Forest Politics	This research was partially supported by the Italian Ministry of Agricultural Alimentary and Forest Politics in the framework of the "ESPLORA" project. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi N, 2011, PLANT SIGNAL BEHAV, V6, P364, DOI 10.4161/psb.6.3.14380; Ano G., 2001, TROPICAL PLANT BREED, P200; [Anonymous], 2014, R LANG ENV STAT COMP; Barchi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043740; Barchi L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-304; Barchi L, 2009, THEOR APPL GENET, V118, P1157, DOI 10.1007/s00122-009-0970-0; Barrero LS, 2004, THEOR APPL GENET, V109, P669, DOI 10.1007/s00122-004-1676-y; Ben Chaim A, 2001, THEOR APPL GENET, V102, P1016, DOI 10.1007/s001220000461; Bosch M, 2005, PLANT CELL, V17, P3219, DOI 10.1105/tpc.105.037473; Brachi B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-232; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brummell DA, 2001, PLANT MOL BIOL, V47, P311, DOI 10.1023/A:1010656104304; Cagas C. C., 2008, Journal of Applied Horticulture (Lucknow), V10, P106; Cericola F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-896; Cericola F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073702; Cong B, 2008, NAT GENET, V40, P800, DOI 10.1038/ng.144; Doganlar S, 2002, GENETICS, V161, P1713; ECPGR, 2008, MIN DESCR EGGPL CAPS; Francischini CW, 2009, FEBS J, V276, P5456, DOI 10.1111/j.1742-4658.2009.07230.x; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; Frary A, 2004, THEOR APPL GENET, V108, P485, DOI 10.1007/s00122-003-1422-x; Frary A, 2003, THEOR APPL GENET, V107, P359, DOI 10.1007/s00122-003-1257-5; Frary A, 2006, E GENOME MAPPING MOL, VV; Frary A, 2014, EUPHYTICA, V197, P211, DOI 10.1007/s10681-013-1060-6; Ge HY, 2013, SCI HORTIC-AMSTERDAM, V162, P71, DOI 10.1016/j.scienta.2013.08.004; Gramazio P, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0350-z; Grandillo S, 1999, THEOR APPL GENET, V99, P978, DOI 10.1007/s001220051405; Hackbusch J, 2005, P NATL ACAD SCI USA, V102, P4908, DOI 10.1073/pnas.0501181102; Huang ZJ, 2013, MOL GENET GENOMICS, V288, P111, DOI 10.1007/s00438-013-0733-0; Huang ZJ, 2011, THEOR APPL GENET, V123, P465, DOI 10.1007/s00122-011-1599-3; IBPGR, 1990, PLANT GENETIC RESOUR; Kashyap V, 2003, SCI HORTIC-AMSTERDAM, V97, P1, DOI 10.1016/S0304-4238(02)00140-1; Kaya H, 2001, CELL, V104, P131, DOI 10.1016/S0092-8674(01)00197-0; Ku HM, 2000, THEOR APPL GENET, V101, P873, DOI 10.1007/s001220051555; Laux T, 1996, DEVELOPMENT, V122, P87; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin T, 2014, NAT GENET, V46, P1220, DOI 10.1038/ng.3117; Lippman Z, 2001, GENETICS, V158, P413; Liu JP, 2002, P NATL ACAD SCI USA, V99, P13302, DOI 10.1073/pnas.162485999; Mackay I, 2007, TRENDS PLANT SCI, V12, P57, DOI 10.1016/j.tplants.2006.12.001; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Micheli F, 2001, TRENDS PLANT SCI, V6, P414, DOI 10.1016/S1360-1385(01)02045-3; Moussian B, 2003, DEV GENES EVOL, V213, P534, DOI 10.1007/s00427-003-0359-z; Munos S, 2011, PLANT PHYSIOL, V156, P2244, DOI 10.1104/pp.111.173997; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Portis E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089499; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Tam PPC, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-44; TUCKER G, 2004, TEXTURE FOODS, V2, P321; Vivian-Smith A, 2001, DEVELOPMENT, V128, P2321; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang YC, 2005, PLANT GROWTH REGUL, V46, P97, DOI 10.1007/s10725-005-7358-1; Wu FN, 2009, THEOR APPL GENET, V118, P927, DOI 10.1007/s00122-008-0950-9; Xiao H, 2008, SCIENCE, V319, P1527, DOI 10.1126/science.1153040; Xiao H, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-49; Yu JM, 2006, CURR OPIN BIOTECH, V17, P155, DOI 10.1016/j.copbio.2006.02.003; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zygier S, 2005, THEOR APPL GENET, V111, P437, DOI 10.1007/s00122-005-2015-7	59	39	39	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135200	10.1371/journal.pone.0135200	http://dx.doi.org/10.1371/journal.pone.0135200			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284782	Green Published, Green Submitted, gold			2022-12-26	WOS:000359666100027
J	Shen, JL; Xu, LF; Zhang, BL; Hu, ZM				Shen, Jieliang; Xu, Linfei; Zhang, Baolong; Hu, Zhenming			Risk Factors for the Failure of Spinal Burst Fractures Treated Conservatively According to the Thoracolumbar Injury Classification and Severity Score (TLICS): A Retrospective Cohort Trial	PLOS ONE			English	Article							POSTERIOR LIGAMENTOUS COMPLEX; PROGRESSIVE KYPHOTIC DEFORMITY; NONOPERATIVE TREATMENT; ACHILLES-TENDON; SYSTEM; RELIABILITY; VALIDITY; MORPHOLOGY; MECHANISM; INTEGRITY	Background The management of thoracolumbar (TL) burst fractures is still controversial. The thoracolumbar injury classification and severity score (TLICS) algorithm is now widely used to guide clinical decision making, however, in clinical practice, we come to realize that TLICS also has its limitations for treating patients with total scores less than 4, for which conservative treatment may not be optimal in all cases. Purpose The aim of this study is to identify several risk factors for the failure of conservative treatment of TL burst fractures according to TLICS algorithm. Methods From June 2008 to December 2013, a cohort of 129 patients with T10-l2 TL burst fractures with a TLISC score <= 3 treated non-operatively were identified and included into this retrospective study. Age, sex, pain intensity, interpedicular distance (IPD), canal compromise, loss of vertebral body height and kyphotic angle (KA) were selected as potential risk factors and compared between the non-operative success group and the non-operative failure group. Results One hundred and four patients successfully completed non-operative treatment, the other 25 patients were converted to surgical treatment because of persistent local back pain or progressive neurological deficits during follow-up. Our results showed that age, visual analogue scale (VAS) score and IPD, KA were significantly different between the two groups. Furthermore, regression analysis indicated that VAS score and IPD could be considered as significant predictors for the failure of conservative treatment. Conclusion The recommendation of non-operative treatment for TLICS score <= 3 has limitations in some patients, and VAS score and IPD could be considered as risk factors for the failure of conservative treatment. Thus, conservative treatment should be decided with caution in patients with greater VAS scores or IPD. If non-operative management is decided, a close follow-up is necessary.	[Shen, Jieliang; Hu, Zhenming] Chongqing Med Univ, Affiliated Hosp 1, Dept Orthopaed Surg, Chongqing 400016, Peoples R China; [Xu, Linfei; Zhang, Baolong] Peoples Hosp Zhengzhou, Dept Orthopaed Surg, Zhengzhou 450003, Henan Province, Peoples R China	Chongqing Medical University	Zhang, BL (corresponding author), Peoples Hosp Zhengzhou, Dept Orthopaed Surg, 33 Huanghe Rd, Zhengzhou 450003, Henan Province, Peoples R China.	blzhang111@163.com; spinecenter_hu@126.com						Bailey CS, 2014, SPINE J, V14, P2557, DOI 10.1016/j.spinee.2013.10.017; Bensch FV, 2006, EMERG RADIOL, V12, P124, DOI 10.1007/s0010140-005-0457-5; DENIS F, 1983, SPINE, V8, P817, DOI 10.1097/00007632-198311000-00003; Haba H, 2003, J NEUROSURG, V99, P20, DOI 10.3171/spi.2003.99.1.0020; Harrop JS, 2006, J NEUROSURG-SPINE, V4, P118, DOI 10.3171/spi.2006.4.2.118; Joaquim AF, 2013, SPINE J, V13, P1760, DOI 10.1016/j.spinee.2013.03.014; Mattei TA, 2014, EUR SPINE J, V23, P2255, DOI 10.1007/s00586-014-3312-0; MUMFORD J, 1993, SPINE, V18, P955, DOI 10.1097/00007632-199306150-00003; NAGEL DA, 1981, J BONE JOINT SURG AM, V63, P62, DOI 10.2106/00004623-198163010-00008; Patel AA, 2007, SPINE, V32, pE105, DOI 10.1097/01.brs.0000254107.57551.8a; Patel AA, 2009, J NEUROSURG-SPINE, V10, P201, DOI 10.3171/2008.12.SPINE08388; PETERSILGE CA, 1995, RADIOLOGY, V194, P49, DOI 10.1148/radiology.194.1.7997581; Pizones J, 2013, SPINE, V38, P745, DOI 10.1097/BRS.0b013e31827934e4; Radcliff K, 2012, SPINE, V37, P1142, DOI 10.1097/BRS.0b013e318240fcd3; Rampersaud YR, 2006, J SPINAL DISORD TECH, V19, P477, DOI 10.1097/01.bsd.0000211237.14211.21; Reinhold M, 2010, EUR SPINE J, V19, P1657, DOI 10.1007/s00586-010-1451-5; Schnake KJ, 2014, EUR SPINE J, V23, P2263, DOI 10.1007/s00586-014-3591-5; Schnake KJ, 2014, J NEUROSURG-SPINE, V20, P497, DOI 10.3171/2014.1.SPINE13246; Shen WJ, 2001, SPINE, V26, P1038, DOI 10.1097/00007632-200105010-00010; Siebenga J, 2006, SPINE, V31, P2881, DOI 10.1097/01.brs.0000247804.91869.1e; Caffaro MFS, 2012, SPINE, V37, pE231, DOI 10.1097/BRS.0b013e318237b0cf; Vaccaro AR, 2005, SPINE, V30, P2325, DOI 10.1097/01.brs.0000182986.43345.cb; WEINSTEIN JN, 1988, SPINE, V13, P33, DOI 10.1097/00007632-198801000-00008; Whang PG, 2007, SPINE, V32, P791, DOI 10.1097/01.brs.0000258882.96011.47; Wood K, 2003, J BONE JOINT SURG AM, V85A, P773, DOI 10.2106/00004623-200305000-00001; Wood KB, 2015, J BONE JOINT SURG AM, V97A, P3, DOI 10.2106/JBJS.N.00226	26	11	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135735	10.1371/journal.pone.0135735	http://dx.doi.org/10.1371/journal.pone.0135735			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284373	Green Published, gold, Green Submitted			2022-12-26	WOS:000359666100064
J	Zhi, YD; Mou, ZR; Chen, J; He, YJ; Dong, H; Fu, XL; Wu, YZ				Zhi, Yidan; Mou, Zhirong; Chen, Jun; He, Yujun; Dong, Hui; Fu, Xiaolan; Wu, Yuzhang			B7H1 Expression and Epithelial-To-Mesenchymal Transition Phenotypes on Colorectal Cancer Stem-Like Cells	PLOS ONE			English	Article							TUMOR-INITIATING CELLS; B7-H1; CD133; EMT; METASTASIS; LIGANDS; PROMISE; EPCAM	Cancer stem cells (CSCs) can invade and metastasize by epithelial-to-mesenchymal transition (EMT). However, how they escape immune surveillance is unclear. B7H1 is crucial negative co-stimulatory molecule but little information about whether it works in CSCs. Therefore, we determined the expression of B7H1 and EMT-associated markers in colorectal cancer stem-like cells to investigate a possible immunoevasion way of CSCs. We enriched CD133(+) colorectal cancer cells which manifested the CSCs-like properties such as higher levels of other stem cell markers Oct-4 and Sox-2, tumor sphere forming ability and more tumorigenic in NOD/SCID mice. These CD133(+) cells possess EMT gene expression profile including higher level of Snail, Twist, vimentin, fibronectin and lower level of E-cadherin. Moreover, CD133(+) cells in both cell line and colorectal cancer tissues expressed high level of negative co-stimulate molecule B7H1. Furthermore, some B7H1(+) cancer cells also showed the characteristic of EMT, indicating EMT cells could escape immune attack during metastasis. B7H1 expression and EMT phenotypes on CSCs indicates a possible immunoevasion way.	[Zhi, Yidan; Mou, Zhirong; Dong, Hui; Fu, Xiaolan; Wu, Yuzhang] Third Mil Med Univ, Inst Immunol PLA, Chongqing, Peoples R China; [Chen, Jun] Southwest Hosp, Dept Gen Surg, Chongqing, Peoples R China; [He, Yujun] Daping Hosp, Dept Gen Surg, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Mou, ZR (corresponding author), Third Mil Med Univ, Inst Immunol PLA, Chongqing, Peoples R China.	mouzr@yahoo.com; wuyuzhang@yahoo.com		Wu, Yuzhang/0000-0002-4049-0214	National Natural Science Foundation of China [30872466]; National Program on Key Basic Research Project (973 Program) of China [2010CB529404]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program on Key Basic Research Project (973 Program) of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China (to ZM, No. 30872466), National Program on Key Basic Research Project (973 Program) of China (to ZM, No. 2010CB529404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026740; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Biddle A, 2012, CANCER METAST REV, V31, P285, DOI 10.1007/s10555-012-9345-0; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Brown JA, 2003, J IMMUNOL, V170, P1257, DOI 10.4049/jimmunol.170.3.1257; Cao YJ, 2011, CANCER RES, V71, P1235, DOI 10.1158/0008-5472.CAN-10-2217; Dalerba P, 2007, CELL STEM CELL, V1, P241, DOI 10.1016/j.stem.2007.08.012; Darini CY, 2012, ONCOGENE, V31, P2438, DOI 10.1038/onc.2011.421; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Flies DB, 2007, J IMMUNOTHER, V30, P251, DOI 10.1097/CJI.0b013e31802e085a; Frank NY, 2010, J CLIN INVEST, V120, P41, DOI 10.1172/JCI41004; Gires O, 2009, NAT REV CANCER, V9, P143, DOI 10.1038/nrc2499-c1; Hollier BG, 2013, CANCER RES, V73, P1981, DOI 10.1158/0008-5472.CAN-12-2962; Hollier BG, 2009, J MAMMARY GLAND BIOL, V14, P29, DOI 10.1007/s10911-009-9110-3; Hua D, 2012, WORLD J GASTROENTERO, V18, P971, DOI 10.3748/wjg.v18.i9.971; Ieta K, 2008, ANN SURG ONCOL, V15, P638, DOI 10.1245/s10434-007-9605-3; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kong Dejuan, 2011, Cancers (Basel), V3, P716, DOI 10.3390/cancers30100716; Kudo-Saito C, 2009, CANCER CELL, V15, P195, DOI 10.1016/j.ccr.2009.01.023; LaBarge MA, 2008, J CLIN INVEST, V118, P2021, DOI 10.1172/JCI36046; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Matsumoto K, 2009, CANCER RES, V69, P7160, DOI 10.1158/0008-5472.CAN-09-1289; Navarro-Alvarez N, 2010, CELL TRANSPLANT, V19, P865, DOI 10.3727/096368910X508997; O'Brien CA, 2007, ANN SURG ONCOL, V14, P22; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Santisteban M, 2009, CANCER RES, V69, P2887, DOI 10.1158/0008-5472.CAN-08-3343; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Strippoli R, 2008, DIS MODEL MECH, V1, P264, DOI 10.1242/dmm.001321; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Todaro M, 2010, GASTROENTEROLOGY, V138, P2151, DOI 10.1053/j.gastro.2009.12.063; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Vaiopoulos AG, 2012, STEM CELLS, V30, P363, DOI 10.1002/stem.1031; Wen KM, 2013, CANCER LETT, V333, P56, DOI 10.1016/j.canlet.2013.01.009; Went PT, 2004, HUM PATHOL, V35, P122, DOI 10.1016/j.humpath.2003.08.026; Xue ZF, 2012, J CELL BIOCHEM, V113, P302, DOI 10.1002/jcb.23356; Yao Y, 2009, NEURO-ONCOLOGY, V11, P757, DOI 10.1215/15228517-2009-014; Zhang Y, 2012, ONCOL REP, V27, P1599, DOI 10.3892/or.2012.1681; Zhang YF, 2013, HEPATO-GASTROENTEROL, V60, P1766, DOI 10.5754/hge13237; Zhu LF, 2012, LAB INVEST, V92, P744, DOI 10.1038/labinvest.2012.8	44	49	51	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 18	2015	10	8							e0135528	10.1371/journal.pone.0135528	http://dx.doi.org/10.1371/journal.pone.0135528			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VY	26284927	Green Published, Green Submitted, gold			2022-12-26	WOS:000359666100044
J	Tseng, SP; Wang, SF; Kuo, CY; Huang, JW; Hung, WC; Ke, GM; Lu, PL				Tseng, Sung-Pin; Wang, Sheng-Fan; Kuo, Cheng-Yu; Huang, Jun-Wei; Hung, Wei-Chun; Ke, Guan-Ming; Lu, Po-Liang			Characterization of Fosfomycin Resistant Extended-Spectrum beta-Lactamase-Producing Escherichia coli Isolates from Human and Pig in Taiwan	PLOS ONE			English	Article							KLEBSIELLA-PNEUMONIAE; GENE FOSA3; ANTIMICROBIAL SUSCEPTIBILITIES; MULTIDRUG-RESISTANT; DISODIUM-FOSFOMYCIN; DISSEMINATION; PLASMIDS; PREVALENCE; MECHANISMS; ENTEROBACTERIACEAE	To investigate the efficacy of fosfomycin against extended-spectrum beta-lactamases (ESBL) producing Escherichia coli in Taiwan and the resistance mechanisms and characterization of human and pig isolates, we analyzed 145 ESBL-producing isolates collected from two hospitals (n = 123) and five farms (n = 22) in Taiwan from February to May, 2013. Antimicrobial susceptibilities were determined. Clonal relatedness was determined by PFGE and multi-locus sequence typing. ESBLs, ampC, and fosfomycin resistant genes were detected by PCR, and their flanking regions were determined by PCR mapping and sequencing. The fosfomycin resistant mechanisms, including modification of the antibiotic target (MurA), functionless transporters (GlpT and UhpT) and their regulating genes such as uhpA, cyaA, and ptsI, and antibiotic inactivation by enzymes (FosA and FosC), were examined. The size and replicon type of plasmids carrying fosfomycin resistant genes were analyzed. Our results revealed the susceptibility rates of fosfomycin were 94% for human ESBL-producing E. coli isolates and 77% for pig isolates. The PFGE analysis revealed 79 pulsotypes. No pulsotype was found existing in both human and pig isolates. Three pulsotypes were distributed among isolates from two hospitals. ISEcp1 carrying blaCTX-M-group 9 was the predominant transposable elements of the ESBL genes. Among the thirteen fosfomycin resistant isolates, functionless transporters were identified in 9 isolates. Three isolates contained novel amino acid substitutions (Asn67Ile, Phe151Ser and Trp164Ser, Val146Ala and His159Tyr, respectively) in MurA (the target of fosfomycin). Four isolates had fosfomycin modified enzyme (fosA3) in their plasmids. The fosA3 gene was harboured in an IncN-type plasmid (101 kbp) in the three pig isolates and an IncB/O-type plasmid (113 kbp) in the human isolate. In conclusion, we identified that 6% and 23% of the ESBL-producing E. coli from human and pigs were resistant to fosfomycin, respectively, in Taiwan. No clonal spread was found between human and pig isolates. Functionless transporters were the major cause of fosfomycin resistance, and the fosA3-transferring plasmid between isolates warrants further monitoring.	[Tseng, Sung-Pin; Wang, Sheng-Fan; Huang, Jun-Wei] Kaohsiung Med Univ, Coll Hlth Sci, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan; [Tseng, Sung-Pin] Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Kaohsiung 80424, Taiwan; [Kuo, Cheng-Yu] Kaohsiung Med Univ, Chung Ho Mem Hosp, Div Infect Dis, Kaohsiung, Taiwan; [Kuo, Cheng-Yu] Pingtung Hosp, Minist Hlth & Welf, Dept Internal Med, Kaohsiung, Taiwan; [Hung, Wei-Chun] Kaohsiung Med Univ, Dept Microbiol & Immunol, Kaohsiung, Taiwan; [Ke, Guan-Ming] Natl Pingtung Univ Sci & Technol, Grad Inst Anim Vaccine Technol, Neipu, Pingtung, Taiwan; [Lu, Po-Liang] Kaohsiung Med Univ Hosp, Dept Lab Med, Kaohsiung, Taiwan; [Lu, Po-Liang] Kaohsiung Med Univ, Coll Med, Kaohsiung, Taiwan; [Lu, Po-Liang] Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan	Kaohsiung Medical University; National Sun Yat Sen University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; National Pingtung University Science & Technology; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Lu, PL (corresponding author), Kaohsiung Med Univ Hosp, Dept Lab Med, Kaohsiung, Taiwan.	d830166@gmail.com	Wang, Sheng-Fan/ABA-7842-2020; Lu, Po-Liang/D-4499-2009	Wang, Sheng-Fan/0000-0002-8142-4707; Lu, Po-Liang/0000-0002-7423-6783; Wang, Sheng-Fan/0000-0002-4183-3872; Tseng, sung-pin/0000-0001-8915-5268	Ministry of Science and Technology (MOST) [103-2320-B-037-023]; NSYSU-KMU Joint Research Project [NSYSUKMU103-I005]; Kaohsiung Medical University Hospital, Taiwan	Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China); NSYSU-KMU Joint Research Project; Kaohsiung Medical University Hospital, Taiwan	This work was supported by Ministry of Science and Technology (MOST 103-2320-B-037-023) and NSYSU-KMU Joint Research Project (NSYSUKMU103-I005) and Kaohsiung Medical University Hospital, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey JK, 2011, J ANTIMICROB CHEMOTH, V66, P745, DOI 10.1093/jac/dkq529; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Carattoli A, 2013, INT J MED MICROBIOL, V303, P298, DOI 10.1016/j.ijmm.2013.02.001; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; Castaneda-Garcia A, 2013, ANTIBIOTICS-BASEL, V2, P217, DOI 10.3390/antibiotics2020217; Clinical and Laboratory Standards Institute, 2013, M100S23 CLSI; Coque TM, 2008, EMERG INFECT DIS, V14, P195, DOI 10.3201/eid1402.070350; Couce A, 2012, ANTIMICROB AGENTS CH, V56, P2767, DOI 10.1128/AAC.06122-11; Diestra K, 2009, J ANTIMICROB CHEMOTH, V63, P60, DOI 10.1093/jac/dkn453; Falagas ME, 2010, LANCET INFECT DIS, V10, P43, DOI 10.1016/S1473-3099(09)70325-1; Gutierrez L, 2010, POULTRY SCI, V89, P2106, DOI 10.3382/ps.2010-00892; Ho PL, 2013, J APPL MICROBIOL, V114, P695, DOI 10.1111/jam.12099; Ho PL, 2013, J MED MICROBIOL, V62, P1707, DOI 10.1099/jmm.0.062653-0; Hou JX, 2013, J ANTIMICROB CHEMOTH, V68, P766, DOI 10.1093/jac/dks465; Hou JX, 2012, ANTIMICROB AGENTS CH, V56, P2135, DOI 10.1128/AAC.05104-11; Keating GM, 2013, DRUGS, V73, P1951, DOI 10.1007/s40265-013-0143-y; Lartigue MF, 2004, FEMS MICROBIOL LETT, V234, P201, DOI 10.1016/j.femsle.2004.01.051; Lee SY, 2012, J ANTIMICROB CHEMOTH, V67, P2843, DOI 10.1093/jac/dks319; Liu HY, 2011, J MICROBIOL IMMUNOL, V44, P364, DOI 10.1016/j.jmii.2010.08.012; Lu CL, 2011, ANTIMICROB AGENTS CH, V55, P4295, DOI 10.1128/AAC.00349-11; Ma L, 2013, J MED MICROBIOL, V62, P101, DOI 10.1099/jmm.0.050492-0; Ma L, 2011, J MED MICROBIOL, V60, P1787, DOI 10.1099/jmm.0.033910-0; Miriagou V, 2005, ANTIMICROB AGENTS CH, V49, P3541, DOI 10.1128/AAC.49.8.3541-3543.2005; MOLLET B, 1983, NUCLEIC ACIDS RES, V11, P6319, DOI 10.1093/nar/11.18.6319; Nilsson AI, 2003, ANTIMICROB AGENTS CH, V47, P2850, DOI 10.1128/AAC.47.9.2850-2858.2003; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Sato N, 2013, MICROB DRUG RESIST, V19, P477, DOI 10.1089/mdr.2013.0061; Skarzynski T, 1996, STRUCTURE, V4, P1465, DOI 10.1016/S0969-2126(96)00153-0; Soraci AL, 2011, RES VET SCI, V90, P498, DOI 10.1016/j.rvsc.2010.07.011; Takahata S, 2010, INT J ANTIMICROB AG, V35, P333, DOI 10.1016/j.ijantimicag.2009.11.011; Tseng SP, 2014, ANTIMICROB AGENTS CH, V58, P593, DOI 10.1128/AAC.00231-13; Wachino J, 2010, ANTIMICROB AGENTS CH, V54, P3061, DOI 10.1128/AAC.01834-09; Yan JJ, 2000, J CLIN MICROBIOL, V38, P4320, DOI 10.1128/JCM.38.12.4320-4325.2000; Yu Wen-Liang, 2006, Journal of Microbiology Immunology and Infection, V39, P264; Zahar JR, 2009, CURR OPIN INVEST DR, V10, P172	35	37	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0135864	10.1371/journal.pone.0135864	http://dx.doi.org/10.1371/journal.pone.0135864			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26280832	Green Published, gold, Green Submitted			2022-12-26	WOS:000359664300025
J	Yu, MH; Ding, GD; Gao, GL; Sun, BP; Zhao, YY; Wan, L; Wang, DY; Gui, ZY				Yu, Ming-Han; Ding, Guo-Dong; Gao, Guang-Lei; Sun, Bao-Ping; Zhao, Yuan-Yuan; Wan, Li; Wang, De-Ying; Gui, Zi-Yang			How the Plant Temperature Links to the Air Temperature in the Desert Plant Artemisia ordosica	PLOS ONE			English	Article							LEAF TEMPERATURES; STOMATAL CONDUCTANCE; HEAT-STORAGE; TRANSPIRATION; RESPONSES; DROUGHT	Plant temperature (Tp) is an important indicator of plant health. To determine the dynamics of plant temperature and self-cooling ability of the plant, we measured Tp in Artemisia ordosica in July, in the Mu Us Desert of Northwest China. Related factors were also monitored to investigate their effects on Tp, including environmental factors, such as air temperature (Ta), relative humidity, wind speed; and physiological factors, such as leaf water potential, sap flow, and water content. The results indicate that: 1) Tp generally changes in conjunction with Ta mainly, and varies with height and among the plant organs. Tp in the young branches is most constant, while it is the most sensitive in the leaves. 2) Correlations between Tp and environmental factors show that Tp is affected mainly by Ta. 3) The self-cooling ability of the plant was effective by midday, with Tp being lower than Ta. 4) Increasing sap flow and leaf water potential showed that transpiration formed part of the mechanism that supported self-cooling. Increased in water conductance and specific heat at midday may be additional factors that contribute to plant cooling ability. Therefore, our results confirmed plant self-cooling ability. The response to high temperatures is regulated by both transpiration speed and an increase in stem water conductance. This study provides quantitative data for plant management in terms of temperature control. Moreover, our findings will assist species selection with taking plant temperature as an index.	[Yu, Ming-Han; Ding, Guo-Dong; Gao, Guang-Lei; Zhao, Yuan-Yuan; Wan, Li; Wang, De-Ying; Gui, Zi-Yang] Beijing Forestry Univ, Sch Soil & Water Conservat, Yanchi Res Stn, Beijing 100083, Peoples R China; [Ding, Guo-Dong; Gao, Guang-Lei; Sun, Bao-Ping; Zhao, Yuan-Yuan] Beijing Forestry Univ, Minist Educ, Key Lab Soil & Water Conservat & Desertificat Com, Beijing 100083, Peoples R China	Beijing Forestry University; Beijing Forestry University	Ding, GD (corresponding author), Beijing Forestry Univ, Sch Soil & Water Conservat, Yanchi Res Stn, Beijing 100083, Peoples R China.	dingguodong@bjfu.edu.cn; gaoguanglei@bjfu.edu.cn	GAO, Guang-Lei/X-7720-2019; ZHAO, YUAN/HCI-5831-2022		National Basic Research Program of China [2013CB429906]; National Technology and Science Support Program of China [2012BAD16B02]	National Basic Research Program of China(National Basic Research Program of China); National Technology and Science Support Program of China	This work was funded by one of National Basic Research Program of China (2013CB429906) (http://www.973.gov.cn/English/Index.aspx) and the National Technology and Science Support Program of China (2012BAD16B02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HD, 2009, P NATL ACAD SCI USA, V106, P7063, DOI 10.1073/pnas.0901438106; BARTHAKUR N, 1975, INT J BIOMETEOROL, V19, P21, DOI 10.1007/BF01459837; Crawford AJ, 2012, CURR BIOL, V22, pR396, DOI 10.1016/j.cub.2012.03.044; Dethier BE, 1965, ENERGY EXCHANGE BIOS; Green RM, 2002, REMOTE SENS ENVIRON, V79, P166, DOI 10.1016/S0034-4257(01)00270-X; Guilioni L, 2008, AGR FOREST METEOROL, V148, P1908, DOI 10.1016/j.agrformet.2008.07.009; Haverd V, 2007, AGR FOREST METEOROL, V147, P125, DOI 10.1016/j.agrformet.2007.07.006; Hegazy AK, 1998, AFR J ECOL, V36, P34, DOI 10.1046/j.1365-2028.1998.109-89109.x; JARVIS PG, 1976, PHILOS T ROY SOC B, V273, P593, DOI 10.1098/rstb.1976.0035; Jones H. G., 1992, Plants and microclimate: a quantitative approach to environmental plant physiology.; Lambers H., 2008, PLANT PHYSL ECOLOGY, DOI DOI 10.1007/978-0-387-78341-3; Lindroth A, 2010, BIOGEOSCIENCES, V7, P301, DOI 10.5194/bg-7-301-2010; Lu CG, 2008, RICE SCI, V15, P223, DOI 10.1016/S1672-6308(08)60046-3; MEINZER FC, 1995, OECOLOGIA, V101, P514, DOI 10.1007/BF00329432; MELLOR RS, 1964, PLANTA, V61, P56, DOI 10.1007/BF01895390; Munns R, 2010, J EXP BOT, V61, P3499, DOI 10.1093/jxb/erq199; Nobel P. S., 1991, Physicochemical and environmental plant physiology.; Penfield S, 2008, NEW PHYTOL, V179, P615, DOI 10.1111/j.1469-8137.2008.02478.x; RASCHKE K, 1960, ANNU REV PLANT PHYS, V11, P111, DOI 10.1146/annurev.pp.11.060160.000551; SANDERS TH, 1984, MYCOPATHOLOGIA, V86, P51, DOI 10.1007/BF00437229; SCHULZE ED, 1972, PLANTA, V108, P259, DOI 10.1007/BF00384113; TANNER CB, 1963, AGRON J, V55, P210, DOI 10.2134/agronj1963.00021962005500020043x; Urban J, 2012, BIOLOGIA, V67, P917, DOI 10.2478/s11756-012-0080-3; Wheeler TR, 2000, AGR ECOSYST ENVIRON, V82, P159, DOI 10.1016/S0167-8809(00)00224-3; Williams LE, 2007, AM J ENOL VITICULT, V58, P173; WOODHOUSE RM, 1983, OECOLOGIA, V57, P291, DOI 10.1007/BF00377170; Yuan W, 2011, BIOGEOSCIENCES, V8, P1453, DOI 10.5194/bg-8-1453-2011	27	12	14	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 17	2015	10	8							e0135452	10.1371/journal.pone.0135452	http://dx.doi.org/10.1371/journal.pone.0135452			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP1VK	26280557	Green Published, gold, Green Submitted			2022-12-26	WOS:000359664300014
J	Declercq, J; Brouwers, B; Pruniau, VPEG; Stijnen, P; de Faudeur, G; Tuand, K; Meulemans, S; Serneels, L; Schraenen, A; Schuit, F; Creemers, JWM				Declercq, Jeroen; Brouwers, Bas; Pruniau, Vincent P. E. G.; Stijnen, Pieter; de Faudeur, Geoffroy; Tuand, Krizia; Meulemans, Sandra; Serneels, Lutgarde; Schraenen, Anica; Schuit, Frans; Creemers, John W. M.			Metabolic and Behavioural Phenotypes in Nestin-Cre Mice Are Caused by Hypothalamic Expression of Human Growth Hormone	PLOS ONE			English	Article							RECEPTOR MESSENGER-RNA; TRANSGENIC MOUSE; PROLACTIN RECEPTOR; MEDIATED RECOMBINATION; NERVOUS-SYSTEM; BRAIN; DEFECTS; GENE; GH; DISRUPTION	The Nestin-Cre driver mouse line has mild hypopituitarism, reduced body weight, a metabolic phenotype and reduced anxiety. Although several causes have been suggested, a comprehensive explanation is still lacking. In this study we examined the molecular mechanisms leading to this compound phenotype. Upon generation of the Nestin-Cre mice, the human growth hormone (hGH) minigene was inserted downstream of the Cre recombinase to ensure efficient transgene expression. As a result, hGH is expressed in the hypothalamus. This results in the auto/paracrine activation of the GH receptor as demonstrated by the increased phosphorylation of signal transducer and activator of transcription 5 (STAT5) and reduced expression of growth hormone releasing hormone (Ghrh). Low Ghrh levels cause hypopituitarism consistent with the observed mouse growth hormone (mGH) deficiency. mGH deficiency caused reduced activation of the GH receptor and hence reduced phosphorylation of STAT5 in the liver. This led to decreased levels of hepatic Igf-1 mRNA and consequently postnatal growth retardation. Furthermore, genes involved in lipid uptake and synthesis, such as CD36 and very low-density lipoprotein receptor were upregulated, resulting in liver steatosis. In conclusion, this study demonstrates the unexpected expression of hGH in the hypothalamus of Nestin-Cre mice which is able to activate both the GH receptor and the prolactin receptor. Increased hypothalamic GH receptor signaling explains the observed hypopituitarism, reduced growth and metabolic phenotype of Nestin-Cre mice. Activation of either receptor is consistent with reduced anxiety.	[Declercq, Jeroen; Brouwers, Bas; Pruniau, Vincent P. E. G.; Stijnen, Pieter; Tuand, Krizia; Meulemans, Sandra; Creemers, John W. M.] Katholieke Univ Leuven, Biochem Neuroendocrinol Lab, Dept Human Genet, B-3000 Leuven, Belgium; [de Faudeur, Geoffroy; Schraenen, Anica; Schuit, Frans] Katholieke Univ Leuven, Gene Express Unit, Dept Cellular & Mol Med, B-3000 Leuven, Belgium; [Serneels, Lutgarde] Katholieke Univ Leuven, Lab Res Degenerat Dis, B-3000 Leuven, Belgium	KU Leuven; KU Leuven; KU Leuven	Creemers, JWM (corresponding author), Katholieke Univ Leuven, Biochem Neuroendocrinol Lab, Dept Human Genet, KU Leuven, B-3000 Leuven, Belgium.	john.creemers@med.kuleuven.be	Tuand, Krizia/E-1657-2015; Tuand, Krizia/AAF-7888-2019	Tuand, Krizia/0000-0003-2670-5415; Tuand, Krizia/0000-0003-2670-5415; Brouwers, Bas/0000-0001-6541-4835; Serneels, Lutgarde/0000-0002-5463-4231; stijnen, pieter/0000-0002-3047-6902	FWO Vlaanderen [G.0738.15N]; KU Leuven [GOA 12/016]	FWO Vlaanderen(FWO); KU Leuven(KU Leuven)	This work was supported by FWO Vlaanderen, grant G.0738.15N and "Geconcerteerde Onderzoeksacties" GOA 12/016 grant of the KU Leuven. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auerbach AB, 2004, ACTA BIOCHIM POL, V51, P9; Augustine RA, 2003, J MOL ENDOCRINOL, V31, P221, DOI 10.1677/jme.0.0310221; Barclay JL, 2011, ENDOCRINOLOGY, V152, P181, DOI 10.1210/en.2010-0537; Briancon N, 2010, DIABETES, V59, P3074, DOI 10.2337/db10-0481; BRINSTER RL, 1988, P NATL ACAD SCI USA, V85, P836, DOI 10.1073/pnas.85.3.836; Brouwers B, 2014, CELL METAB, V20, P979, DOI 10.1016/j.cmet.2014.11.004; CHIU SF, 1994, J NEUROENDOCRINOL, V6, P191, DOI 10.1111/j.1365-2826.1994.tb00572.x; Delacour A, 2004, MECH DEVELOP, V121, P3, DOI 10.1016/j.mod.2003.11.004; Dubois NC, 2006, GENESIS, V44, P355, DOI 10.1002/dvg.20226; Forni PE, 2006, J NEUROSCI, V26, P9593, DOI 10.1523/JNEUROSCI.2815-06.2006; Galichet C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011443; Gannon M, 2000, GENESIS, V26, P143, DOI 10.1002/(SICI)1526-968X(200002)26:2<143::AID-GENE13>3.0.CO;2-L; Giusti SA, 2014, J PSYCHIATR RES, V55, P87, DOI 10.1016/j.jpsychires.2014.04.002; Goffin V, 1996, ENDOCR REV, V17, P385, DOI 10.1210/er.17.4.385; Harno E, 2013, CELL METAB, V18, P21, DOI 10.1016/j.cmet.2013.05.019; Kineman RD, 1996, ENDOCRINOLOGY, V137, P4630, DOI 10.1210/endo.137.11.8895326; LeDoux J, 1998, BIOL PSYCHIAT, V44, P1229, DOI 10.1016/S0006-3223(98)00282-0; Lee JY, 2006, J BIOL CHEM, V281, P2649, DOI 10.1074/jbc.M512373200; Leone S, 2014, GROWTH HORM IGF RES, V24, P192, DOI 10.1016/j.ghir.2014.06.004; LIN SC, 1993, NATURE, V364, P208, DOI 10.1038/364208a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MINAMI S, 1993, J NEUROENDOCRINOL, V5, P691, DOI 10.1111/j.1365-2826.1993.tb00541.x; Naiche LA, 2007, GENESIS, V45, P768, DOI 10.1002/dvg.20353; Nuytens K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109598; ORBAN PC, 1992, P NATL ACAD SCI USA, V89, P6861, DOI 10.1073/pnas.89.15.6861; Pruniau VPEG, 2013, HEPATOLOGY, V58, P2209, DOI 10.1002/hep.26483; Qiu LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018778; Rosenfeld RG, 2007, TRENDS ENDOCRIN MET, V18, P134, DOI 10.1016/j.tem.2007.03.004; Schmidt EE, 2000, P NATL ACAD SCI USA, V97, P13702, DOI 10.1073/pnas.240471297; STERNBERG N, 1981, J MOL BIOL, V150, P467, DOI 10.1016/0022-2836(81)90375-2; SZABO M, 1995, ENDOCRINOLOGY, V136, P4044, DOI 10.1210/en.136.9.4044; Takahashi Y, 2012, ENDOCR J, V59, P955, DOI 10.1507/endocrj.EJ12-0322; Torner L, 2001, J NEUROSCI, V21, P3207, DOI 10.1523/JNEUROSCI.21-09-03207.2001; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; van den Burg EH, 2011, J MOL NEUROSCI, V43, P200, DOI 10.1007/s12031-010-9452-8; Xiao F, 2014, DIABETOLOGIA, V57, P2136, DOI 10.1007/s00125-014-3336-3; Zhu XR, 2002, P NATL ACAD SCI USA, V99, P10293, DOI 10.1073/pnas.162352599	37	44	46	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135502	10.1371/journal.pone.0135502	http://dx.doi.org/10.1371/journal.pone.0135502			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275221	Green Submitted, Green Published, gold			2022-12-26	WOS:000359493600070
J	Yu, N; Zhang, Z; Chen, P; Zhong, YM; Cai, XX; Hu, H; Yang, Y; Zhang, J; Li, KJ; Ge, J; Yu, KM; Liu, X; Zhuang, J				Yu, Na; Zhang, Zhang; Chen, Pei; Zhong, Yimin; Cai, Xiaoxiao; Hu, Huan; Yang, Ying; Zhang, Jing; Li, Kaijing; Ge, Jian; Yu, Keming; Liu, Xing; Zhuang, Jing			Tetramethylpyrazine (TMP), an Active Ingredient of Chinese Herb Medicine Chuanxiong, Attenuates the Degeneration of Trabecular Meshwork through SDF-1/CXCR4 Axis	PLOS ONE			English	Article							RECEPTOR CXCR4 EXPRESSION; NERVOUS-SYSTEM; CULTURED HUMAN; CELLS; GLAUCOMA; MIGRATION; MATRIX; NEOVASCULARIZATION; CHEMOKINES; INHIBITION	Background A traditional Chinese medicine, Tetramethylpyrazine (TMP), has been prescribed as a complementary treatment for glaucoma to improve patient prognosis. However, the pharmacological mechanism of action of TMP is poorly understood. In previous studies, we demonstrated that TMP exerts potent inhibitory effects on neovascularization, suppresses the tumorigenic behavior of glioma cells, and protects neural cells by regulating CXCR4 expression. Here, we further investigated whether the SDF-1/CXCR4 pathway is also involved in the TMP-mediated activity in trabecular meshwork cells. Methodology/Principal Findings CXCR4 expression was examined by quantitative real-time PCR in trabecular and iris specimens from 54 primary open-angle glaucoma (POAG) patients who required surgery and 19 non-glaucomatous donors. Our data revealed markedly elevated CXCR4 expression in the trabecular meshwork of POAG patients compared with that of controls. Consistently, CXCR4 expression was much higher in glaucomatous trabecular meshwork cells than in normal trabecular meshwork cells. Using RT-PCR and western blot assays, we determined that glaucoma-related cytokines and dexamethasone (DEX) also significantly up-regulated CXCR4 expression in primary human trabecular meshwork (PHTM) cells. Moreover, the TGF-beta 1-mediated induction of CXCR4 expression in PHTM cells was markedly down-regulated by TMP compared with control treatment (PBS) and the CXCR4 antagonist AMD3100. In addition, TMP could counteract the TGF-beta 1-induced effects on stress fiber accumulation and expansion of PHTM cells. TMP markedly suppressed the migration of PHTM cells stimulated by TGF-beta 1 in transwell and scratch wound assays. TMP also suppressed the extracellular matrix (ECM) accumulation induced by TGF-beta 2. Conclusions Our findings demonstrate that CXCR4 might be involved in the pathogenetic changes in the trabecular meshwork of patients with POAG. Additionally, TMP might exert its beneficial effects in POAG patients by down-regulating CXCR4 expression.	[Yu, Na; Zhang, Zhang; Chen, Pei; Zhong, Yimin; Cai, Xiaoxiao; Hu, Huan; Yang, Ying; Zhang, Jing; Li, Kaijing; Ge, Jian; Yu, Keming; Liu, Xing; Zhuang, Jing] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Yu, KM (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	yukeming@mail.sysu.edu.cn; liuxing@mail.sysu.edu.cn; zhuangj@mail.sysu.edu.cn	Cai, Xiaoxiao/C-4868-2018	Cai, Xiaoxiao/0000-0002-5654-7414	National Natural Science Foundation [81370987]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	All the studies were funded by the grants from the National Natural Science Foundation (Project: 81370987) [KMY].	Acott TS, 2008, EXP EYE RES, V86, P543, DOI 10.1016/j.exer.2008.01.013; Sanchez-Alcaniz JA, 2011, NEURON, V69, P77, DOI 10.1016/j.neuron.2010.12.006; Banisadr G, 2002, EUR J NEUROSCI, V16, P1661, DOI 10.1046/j.1460-9568.2002.02237.x; Baudouin Christophe, 2012, Trans Am Ophthalmol Soc, V110, P40; Bertran E, 2013, HEPATOLOGY, V58, P2032, DOI 10.1002/hep.26597; Cai XX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088176; Chen M, 2011, INVEST OPHTH VIS SCI, V52, P7027, DOI 10.1167/iovs.11-7524; Chen Z, 2013, CANCER LETT, V336, P281, DOI 10.1016/j.canlet.2013.03.015; Chu CY, 2007, ONCOGENE, V26, P2491, DOI 10.1038/sj.onc.1210040; De Groef L, 2013, INVEST OPHTH VIS SCI, V54, P7756, DOI 10.1167/iovs.13-13088; Denoyer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037873; Foster Paul J, 2002, Semin Ophthalmol, V17, P50; Fu YS, 2008, NEURO-ONCOLOGY, V10, P139, DOI 10.1215/15228517-2007-051; Fuchshofer R, 2012, CELL TISSUE RES, V347, P279, DOI 10.1007/s00441-011-1274-7; Guyon A, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00065; Kitagawa K, 2001, JPN J OPHTHALMOL, V45, P227, DOI 10.1016/S0021-5155(01)00320-3; Kucia M, 2004, J MOL HISTOL, V35, P233; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Lee E, 2010, INVEST OPHTH VIS SCI, V51, P3666, DOI 10.1167/iovs.09-3802; Liang XL, 2012, INVEST OPHTH VIS SCI, V53, P2157, DOI 10.1167/iovs.11-9315; Liu M, 2004, CHIN J CLIN REHAB, V8, P1299; Liu Y, 1998, HUBEI J TRADITIONAL, V20, P54; Luo X, 2013, J LIAONING U TCM, P1673; Man D, 2011, CLIN J CHINESE MED, V14, P1674; Nguyen TD, 1998, J BIOL CHEM, V273, P6341, DOI 10.1074/jbc.273.11.6341; Pang PKT, 1996, PLANTA MED, V62, P431, DOI 10.1055/s-2006-957933; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Robertson JV, 2010, INVEST OPHTH VIS SCI, V51, P308, DOI 10.1167/iovs.09-3380; Rostene W, 2011, J NEUROCHEM, V118, P680, DOI 10.1111/j.1471-4159.2011.07371.x; Scala S, 2007, CANCER IMMUNOL IMMUN, V56, P1589, DOI 10.1007/s00262-007-0303-6; Shifera AS, 2010, EXP EYE RES, V91, P42, DOI 10.1016/j.exer.2010.04.001; SOMMER A, 1989, AM J OPHTHALMOL, V107, P186, DOI 10.1016/0002-9394(89)90221-3; Son BR, 2006, STEM CELLS, V24, P1254, DOI 10.1634/stemcells.2005-0271; Strasser GA, 2010, BLOOD, V115, P5102, DOI 10.1182/blood-2009-07-230284; Stumm RK, 2002, J NEUROSCI, V22, P5865; Takai Y, 2012, INVEST OPHTH VIS SCI, V53, P241, DOI 10.1167/iovs.11-8434; Tamm ER, 1996, EXP EYE RES, V62, P389, DOI 10.1006/exer.1996.0044; Tang Ze-yao, 2011, Zhongguo Yaolixue Yu Dulixue Zazhi, V25, P114, DOI 10.3867/j.issn.1000-3002.2011.01.023; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Tektas OY, 2009, EXP EYE RES, V88, P769, DOI 10.1016/j.exer.2008.11.025; Xia CL, 2009, J XIAN JIAOTONG U ME, V30, P423; Yang JN, 2005, ACTA PHARMACOL SIN, V26, P887, DOI 10.1111/j.1745-7254.2005.00141.x; Yang ZK, 2008, NEUROCHEM INT, V52, P1176, DOI 10.1016/j.neuint.2007.12.008; You JM, 2010, CHIN MED, V28, P2666; Yu KM, 2007, BIOCHEM BIOPH RES CO, V358, P990, DOI 10.1016/j.bbrc.2007.05.004; Yu KM, 2012, ONCOL REP, V28, P955, DOI 10.3892/or.2012.1866; Zhang HQ, 2011, J NEUROSCI, V31, P15894, DOI 10.1523/JNEUROSCI.3943-11.2011	48	13	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0133055	10.1371/journal.pone.0133055	http://dx.doi.org/10.1371/journal.pone.0133055			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26275042	Green Published, Green Submitted, gold			2022-12-26	WOS:000359493600008
J	Zhang, YQ; Wei, XL; Liang, YK; Chen, WL; Zhang, F; Bai, JW; Qiu, SQ; Du, CW; Huang, WH; Zhang, GJ				Zhang, Yong-Qu; Wei, Xiao-Long; Liang, Yuan-Ke; Chen, Wei-Ling; Zhang, Fan; Bai, Jing-Wen; Qiu, Si-Qi; Du, Cal-Wen; Huang, Wen-He; Zhang, Guo-Jun			Over-Expressed Twist Associates with Markers of Epithelial Mesenchymal Transition and Predicts Poor Prognosis in Breast Cancers via ERK and Akt Activation	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; TRANSCRIPTION FACTORS; CONSERVING THERAPY; LOCAL RECURRENCE; BETA-CATENIN; PHOSPHORYLATION; METASTASIS; RESISTANCE; CARCINOMA; PROTEIN	Overexpression of Twist, a highly conserved basic helix-loop-helix transcription factor, is associated with epithelial-mesenchymal transition (EMT) and predicts poor prognosis in various kinds of cancers, including breast cancer. In order to further clarify Twist's role in breast cancer, we detected Twist expression in breast cancer tissues by immunohistochemistry. Twist expression was observed in 54% (220/408) of breast cancer patients and was positively associated with tumor size, Ki67, VEGF-C and HER2 expression. Conversely, Twist was negatively associated with estrogen receptor (ER), progesterone receptor (PgR) and E-cadherin expression. Patients with Twist expression had a poorer prognosis for 30-month disease free survival (DFS) (82.9%) than patients with negative Twist (92.3%). Overexpression of Twist led to dramatic changes in cellular morphology, proliferation, migratory/ invasive capability, and expression of EMT-related biomarkers in breast cancer cells. Moreover, we show that Twist serves as a driver of tumorigenesis, as well as an inducer of EMT, at least in part, through activation of the Akt and extracellular signal-regulated protein kinase (ERK) pathways which are critical for Twist-mediated EMT. Our results demonstrate that Twist expression is an important prognostic factor in breast cancer patients.	[Zhang, Yong-Qu; Chen, Wei-Ling; Bai, Jing-Wen; Qiu, Si-Qi; Huang, Wen-He; Zhang, Guo-Jun] Shantou Univ, Coll Med, Canc Hosp, Breast Ctr, Shantou, Guangdong, Peoples R China; [Zhang, Yong-Qu; Liang, Yuan-Ke; Bai, Jing-Wen; Zhang, Guo-Jun] Shantou Univ, Coll Med, Canc Res Ctr, Shantou, Guangdong, Peoples R China; [Wei, Xiao-Long] Shantou Univ, Coll Med, Canc Hosp, Dept Pathol, Shantou, Guangdong, Peoples R China; [Liang, Yuan-Ke; Chen, Wei-Ling; Zhang, Fan; Bai, Jing-Wen; Zhang, Guo-Jun] Shantou Univ, Coll Med, Canc Hosp, Changjiang Scholars Res Lab, Shantou, Guangdong, Peoples R China; [Du, Cal-Wen] Shantou Univ, Coll Med, Canc Hosp, Dept Breast Med Oncol, Shantou, Guangdong, Peoples R China	Shantou University; Shantou University; Shantou University; Shantou University; Shantou University	Zhang, GJ (corresponding author), Shantou Univ, Coll Med, Canc Hosp, Breast Ctr, Shantou, Guangdong, Peoples R China.	huangwenhe2009@163.com; guoj_zhang@yahoo.com	Zhang, Guo-Jun/H-3890-2015; Bai, Jingwen/AAG-3794-2019; Liang, Yuanke/AAG-2045-2021	Zhang, Guo-Jun/0000-0001-5182-5887; bai, jingwen/0000-0002-2107-2746	Major State Basic Research Development Program of China [2011CB707705]; Natural Science Foundation Committee [31271068, 81302331]; Guangdong Provincial Science and Technology Planning Project [2011B031800305]; Guangdong Provincial Key Laboratory on Breast Cancer Diagnosis and Treatment Research	Major State Basic Research Development Program of China(National Basic Research Program of China); Natural Science Foundation Committee(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Science and Technology Planning Project; Guangdong Provincial Key Laboratory on Breast Cancer Diagnosis and Treatment Research	This work was partly supported by the funds from the Major State Basic Research Development Program of China (No. 2011CB707705. http://www.973.gov.cn/English/Index.aspx); Natural Science Foundation Committee (No. 31271068, 81302331/http://www.nsfc.gov.cn/publish/portal1/); Guangdong Provincial Science and Technology Planning Project (2011B031800305/http://www.gdstc.gov.cn/eng/mission.html) and Guangdong Provincial Key Laboratory on Breast Cancer Diagnosis and Treatment Research.	Alexander NR, 2006, CANCER RES, V66, P3365, DOI 10.1158/0008-5472.CAN-05-3401; [Anonymous], 2012, J THEOR PHYS, DOI DOI 10.1103/PHYSREVA.85; Cheng GZ, 2008, J BIOL CHEM, V283, P14665, DOI 10.1074/jbc.M707429200; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Doble BW, 2007, CELLS TISSUES ORGANS, V185, P73, DOI 10.1159/000101306; Dong AL, 2011, J PHARMACOL EXP THER, V339, P238, DOI 10.1124/jpet.111.181081; Elkhuizen PHM, 1999, INT J RADIAT ONCOL, V45, P73, DOI 10.1016/S0360-3016(99)00158-3; Elkhuizen PHM, 2000, J CLIN ONCOL, V18, P1075, DOI 10.1200/JCO.2000.18.5.1075; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Hong J, 2011, CANCER RES, V71, P3980, DOI 10.1158/0008-5472.CAN-10-2914; Howe LR, 2003, CANCER RES, V63, P1906; Huang J, 2014, EUR REV MED PHARMACO, V18, P2662; Hung JJ, 2009, THORAX, V64, P1082, DOI 10.1136/thx.2009.115691; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Li JL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-49; Li NY, 2013, SURGERY, V154, P404, DOI 10.1016/j.surg.2013.05.012; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Luo GQ, 2008, WORLD J GASTROENTERO, V14, P2487, DOI 10.3748/wjg.14.2487; Martin TA, 2005, ANN SURG ONCOL, V12, P488, DOI 10.1245/ASO.2005.04.010; Mechera R, 2009, BREAST CANCER RES TR, V116, P171, DOI 10.1007/s10549-008-0187-y; Millar EKA, 2009, J CLIN ONCOL, V27, P4701, DOI 10.1200/JCO.2008.21.7075; Mironchik Y, 2005, CANCER RES, V65, P10801, DOI 10.1158/0008-5472.CAN-05-0712; Mirza NQ, 2002, ANN SURG ONCOL, V9, P256, DOI 10.1245/aso.2002.9.3.256; Pai HC, 2013, J MOL MED, V91, P347, DOI 10.1007/s00109-012-0945-5; Piccinin S, 2012, CANCER CELL, V22, P404, DOI 10.1016/j.ccr.2012.08.003; Pinho AV, 2011, CELL CYCLE, V10, P1312, DOI 10.4161/cc.10.8.15363; Rausei S, 2010, BREAST J, V16, pS29, DOI 10.1111/j.1524-4741.2010.01000.x; Saadai P, 2011, BREAST CANCER-TOKYO, V18, P221, DOI 10.1007/s12282-011-0262-9; Seng TJ, 2007, ONCOGENE, V26, P934, DOI 10.1038/sj.onc.1209839; Shibata K, 2008, ANN ONCOL, V19, P81, DOI 10.1093/annonc/mdm344; Shiota M, 2011, BJU INT, V108, pE142, DOI 10.1111/j.1464-410X.2010.09810.x; Soini Y, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-73; Sun SR, 2012, AM J NEPHROL, V35, P141, DOI 10.1159/000335191; Teng Y, 2014, CLIN EXP METASTAS, V31, P367, DOI 10.1007/s10585-013-9621-6; van Nes JGH, 2012, BREAST CANCER RES TR, V133, P49, DOI 10.1007/s10549-011-1684-y; Vesuna F, 2012, ONCOGENE, V31, P3223, DOI 10.1038/onc.2011.483; Vichalkovski A, 2010, ONCOGENE, V29, P3554, DOI 10.1038/onc.2010.115; Wallerand H, 2010, UROL ONCOL-SEMIN ORI, V28, P473, DOI 10.1016/j.urolonc.2008.12.018; Wang XH, 2004, ONCOGENE, V23, P474, DOI 10.1038/sj.onc.1207128; Watanabe O, 2004, ANTICANCER RES, V24, P3851; Way TD, 2014, EUR J CANCER, V50, P366, DOI 10.1016/j.ejca.2013.09.025; Wei XM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-248; Wei XL, 2015, ONCOTARGET; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang P, 2014, CURR MOL MED, V14, P174, DOI 10.2174/1566524013666131121115656; Yuen HF, 2007, HISTOPATHOLOGY, V50, P648, DOI 10.1111/j.1365-2559.2007.02665.x; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173; Zhuo WL, 2008, BIOCHEM BIOPH RES CO, V369, P1098, DOI 10.1016/j.bbrc.2008.02.143	51	59	63	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2015	10	8							e0135851	10.1371/journal.pone.0135851	http://dx.doi.org/10.1371/journal.pone.0135851			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP5MR	26251878	Green Published, gold, Green Submitted			2022-12-26	WOS:000359926900045
